https://ascopost.com/tap-hompagenew/ 2025-07-22T19:38:42+00:00 https://ascopost.com/news/ 2025-08-21T21:24:37+00:00 https://ascopost.com/news/june-2021/ 2021-07-01T15:10:57+00:00 https://ascopost.com/news/june-2021/continuous-coverage-of-covid-19/ 2021-06-01T18:17:57+00:00 https://ascopost.com/news/june-2021/overall-survival-benefit-with-upfront-daratumumab-plus-lenalidomidedexamethasone-for-newly-diagnosed-transplant-ineligible-patients-with-multiple-myeloma/ 2021-06-15T19:55:23+00:00 https://ascopost.com/news/june-2021/adjuvant-platinum-vs-capecitabine-in-patients-with-basal-subtype-triple-negative-breast-cancer/ 2021-06-15T19:47:58+00:00 https://ascopost.com/news/june-2021/venetoclax-plus-flag-ida-induction-and-consolidation-for-aml/ 2021-06-21T19:33:16+00:00 https://ascopost.com/news/june-2021/pralsetinib-in-advanced-ret-fusion-positive-nsclc-arrow-trial/ 2021-07-23T14:05:55+00:00 https://ascopost.com/news/june-2021/computational-tool-suggests-optimal-treatment-for-patients-with-high-grade-ovarian-cancer/ 2021-06-15T19:48:03+00:00 https://ascopost.com/news/june-2021/adjuvant-trastuzumab-emtansine-vs-paclitaxeltrastuzumab-in-stage-i-her2-positive-breast-cancer/ 2021-06-15T19:48:04+00:00 https://ascopost.com/news/june-2021/pet-response-adapted-chemoradiotherapy-for-esophageal-and-esophagogastric-junction-adenocarcinoma/ 2021-06-15T19:48:07+00:00 https://ascopost.com/news/june-2021/real-world-survival-outcomes-with-targeted-therapy-for-intracranial-metastatic-disease/ 2021-06-15T19:48:09+00:00 https://ascopost.com/news/june-2021/ibrutinibvenetoclax-provides-durable-remission-for-patients-with-newly-diagnosed-cll/ 2021-06-18T18:06:25+00:00 https://ascopost.com/news/june-2021/global-registry-analysis-of-nrg1-fusion-positive-lung-cancer/ 2021-06-15T19:48:11+00:00 https://ascopost.com/news/june-2021/breast-cancer-risk-prediction-model-for-childhood-cancer-survivors-who-received-chest-radiation/ 2021-06-15T19:48:13+00:00 https://ascopost.com/news/june-2021/effect-of-the-covid-19-pandemic-on-delivery-of-oncology-services-in-india/ 2021-06-15T19:48:14+00:00 https://ascopost.com/news/june-2021/fda-approves-new-pediatric-indication-for-technetium-tc-99m-tilmanocept-injection/ 2021-06-15T19:48:15+00:00 https://ascopost.com/news/june-2021/apollo-trial-addition-of-subcutaneous-daratumumab-to-pomalidomidedexamethasone-in-previously-treated-patients-with-multiple-myeloma/ 2021-06-15T19:48:16+00:00 https://ascopost.com/news/june-2021/keynote-361-first-line-pembrolizumab-with-or-without-chemotherapy-vs-chemotherapy-in-advanced-urothelial-carcinoma/ 2021-06-15T19:48:17+00:00 https://ascopost.com/news/june-2021/study-finds-need-to-improve-knowledge-about-palliative-care-among-us-adults/ 2021-06-15T19:48:19+00:00 https://ascopost.com/news/june-2021/new-web-based-lesion-selection-tool-may-improve-coordination-performance-and-management-of-biopsy-specimens/ 2021-06-15T19:48:21+00:00 https://ascopost.com/news/june-2021/choice-of-first-line-platinum-chemotherapy-does-not-significantly-impact-efficacy-of-second-line-immunotherapy-in-advanced-urothelial-carcinoma/ 2021-06-15T19:48:23+00:00 https://ascopost.com/news/june-2021/does-vitamin-d-supplementation-improve-prognosis-for-patients-with-breast-cancer/ 2021-06-15T19:48:24+00:00 https://ascopost.com/news/june-2021/checkmate-274-adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma/ 2021-06-15T19:48:25+00:00 https://ascopost.com/news/june-2021/lay-health-worker-led-intervention-may-improve-care-for-low-income-and-minority-patients-with-cancer/ 2021-06-15T19:48:27+00:00 https://ascopost.com/news/june-2021/adapt-survival-outcomes-after-neoadjuvant-dual-her2-therapy-for-hr-negative-her2-positive-breast-cancer/ 2021-06-15T19:48:28+00:00 https://ascopost.com/news/june-2021/high-dose-interferon-or-ipilimumab-vs-pembrolizumab-for-high-risk-resected-melanoma/ 2021-06-15T19:48:29+00:00 https://ascopost.com/news/june-2021/no-survival-difference-for-front-line-combination-regimens-in-intermediate-and-poor-risk-clear-cell-rcc/ 2021-06-15T19:48:30+00:00 https://ascopost.com/news/june-2021/results-of-a-restrictive-opioid-prescription-protocol-for-patients-with-cancer-undergoing-surgery/ 2021-06-15T19:48:31+00:00 https://ascopost.com/news/june-2021/use-of-integrative-medicine-by-patients-with-breast-cancer/ 2021-06-15T19:48:32+00:00 https://ascopost.com/news/june-2021/adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/ 2021-06-15T19:48:33+00:00 https://ascopost.com/news/june-2021/nivolumab-plus-chemotherapy-and-nivolumab-plus-ipilimumab-as-first-line-treatment-for-patients-with-advanced-esophageal-cancer/ 2021-06-15T19:48:34+00:00 https://ascopost.com/news/june-2021/extended-follow-up-of-nivolumabipilimumab-for-metastatic-melanoma/ 2021-06-15T19:48:35+00:00 https://ascopost.com/news/june-2021/efficacy-of-platinum-chemotherapy-vs-capecitabine-for-basal-like-triple-negative-breast-cancer/ 2021-06-15T19:48:35+00:00 https://ascopost.com/news/june-2021/remote-monitoring-program-reduced-hospitalization-among-patients-with-cancer-infected-with-covid-19/ 2021-06-15T19:48:36+00:00 https://ascopost.com/news/june-2021/novel-psma-targeted-radiotherapy-improves-radiographic-progression-free-and-overall-survival-in-metastatic-prostate-cancer/ 2021-06-15T19:48:37+00:00 https://ascopost.com/news/june-2021/sotorasib-for-kras-g12c-mutated-nsclc-overall-survival-and-exploratory-subgroup-analyses/ 2021-06-24T18:23:44+00:00 https://ascopost.com/news/june-2021/outback-trial-no-survival-benefit-with-adjuvant-chemotherapy-after-standard-chemoradiation-for-locally-advanced-cervical-cancer/ 2021-06-15T19:48:39+00:00 https://ascopost.com/news/june-2021/transoral-surgery-followed-by-lower-dose-radiation-in-patients-with-hpv-associated-oropharyngeal-cancer-at-intermediate-risk-of-recurrence/ 2026-01-29T16:15:35+00:00 https://ascopost.com/news/june-2021/study-examines-relationship-between-risk-of-covid-19-infection-and-breast-cancer-treatment/ 2021-06-15T19:48:41+00:00 https://ascopost.com/news/june-2021/electronic-olfaction-system-under-study-as-screening-tool-for-pancreatic-and-ovarian-cancers/ 2021-06-15T19:48:42+00:00 https://ascopost.com/news/june-2021/olympia-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-stage-her2-negative-breast-cancer/ 2021-06-15T19:48:43+00:00 https://ascopost.com/news/june-2021/toripalimab-plus-gemcitabinecisplatin-extends-progression-free-survival-in-recurrent-or-metastatic-nasopharyngeal-carcinoma-jupiter-02/ 2026-01-29T16:17:31+00:00 https://ascopost.com/news/june-2021/ponatinibblinatumomab-demonstrates-high-rates-of-complete-molecular-response-in-philadelphia-chromosome-positive-all/ 2021-06-15T19:48:44+00:00 https://ascopost.com/news/june-2021/community-based-engagement-initiative-improves-accrual-of-black-participants-in-clinical-trials/ 2021-06-15T19:48:45+00:00 https://ascopost.com/news/june-2021/study-examines-aromatase-inhibitor-associated-musculoskeletal-symptoms-in-a-diverse-population-with-early-breast-cancer/ 2021-06-15T19:48:46+00:00 https://ascopost.com/news/june-2021/pertuzumabtrastuzumab-demonstrates-activity-in-tissue-agnostic-trial-for-patients-with-her2-positive-tumors/ 2021-06-15T19:48:47+00:00 https://ascopost.com/news/june-2021/noninvasive-imaging-biomarker-and-pathologic-complete-response-to-neoadjuvant-pertuzumabtrastuzumab-in-her2-positive-breast-cancer/ 2021-06-15T19:48:48+00:00 https://ascopost.com/news/june-2021/third-party-bk-virus-specific-cytotoxic-t-lymphocyte-therapy-for-bk-virus-associated-hemorrhagic-cystitis-after-stem-cell-transplant/ 2021-06-15T19:48:49+00:00 https://ascopost.com/news/june-2021/hipec-with-carboplatin-for-platinum-sensitive-recurrent-ovarian-cancer-safety-and-outcomes/ 2021-06-15T19:48:50+00:00 https://ascopost.com/news/june-2021/predictors-of-emergency-department-visits-after-a-new-diagnosis-of-cancer/ 2021-06-15T19:48:50+00:00 https://ascopost.com/news/june-2021/study-examines-barriers-to-survivorship-care/ 2021-06-15T19:48:51+00:00 https://ascopost.com/news/june-2021/organizations-issue-statement-encouraging-return-to-hpv-vaccination/ 2021-06-15T19:48:52+00:00 https://ascopost.com/news/june-2021/neoadjuvant-chemotherapy-de-escalation-using-f-18-fdg-pet-response-based-strategy-in-her2-positive-breast-cancer/ 2021-06-15T19:48:54+00:00 https://ascopost.com/news/june-2021/pembrolizumab-in-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer-keynote-057/ 2021-06-15T19:48:55+00:00 https://ascopost.com/news/june-2021/are-there-differences-in-the-prevalence-of-germline-pathogenic-variants-in-susceptibility-genes-in-black-vs-white-women-with-breast-cancer/ 2021-06-15T19:48:57+00:00 https://ascopost.com/news/june-2021/real-world-survival-outcomes-with-various-treatment-regimens-for-metastatic-renal-cell-carcinoma/ 2021-06-15T19:48:58+00:00 https://ascopost.com/news/june-2021/nearly-half-of-surveyed-patients-with-gynecologic-cancer-report-experiencing-financial-toxicity/ 2021-06-16T16:14:59+00:00 https://ascopost.com/news/june-2021/all-cause-mortality-risk-with-adjuvant-vs-early-salvage-radiotherapy-after-radical-prostatectomy/ 2021-06-16T16:30:42+00:00 https://ascopost.com/news/june-2021/axicabtagene-ciloleucel-demonstrates-improvement-across-multiple-endpoints-in-relapsed-or-refractory-follicular-lymphoma/ 2021-06-16T18:54:09+00:00 https://ascopost.com/news/june-2021/colorectal-cancer-incidence-and-mortality-in-european-countries/ 2021-06-16T17:21:04+00:00 https://ascopost.com/news/june-2021/reduced-intensity-conditioning-allogeneic-hct-based-on-donor-availability-in-older-patients-with-advanced-myelodysplastic-syndrome/ 2021-06-17T15:40:30+00:00 https://ascopost.com/news/june-2021/addition-of-gemtuzumab-ozogamicin-to-conventional-background-chemotherapy-in-pediatric-patients-with-kmt2a-rearranged-aml/ 2021-06-18T18:07:14+00:00 https://ascopost.com/news/june-2021/alkylating-signature-in-colorectal-cancer-linked-to-high-red-meat-intake/ 2021-07-07T20:11:09+00:00 https://ascopost.com/news/june-2021/zanubrutinib-vs-ibrutinib-in-relapsedrefractory-cllsll-alpine-trial/ 2021-06-21T19:30:55+00:00 https://ascopost.com/news/june-2021/epov-anthony-tc-chan/ 2021-06-17T16:59:25+00:00 https://ascopost.com/news/june-2021/all-cause-mortality-in-covid-19-positive-and-covid-19-negative-patients-with-cancer/ 2021-06-18T19:10:36+00:00 https://ascopost.com/news/june-2021/effect-of-polygenic-risk-score-on-estimated-breast-cancer-risk-among-carriers-of-pathogenic-variants-in-predisposition-genes/ 2021-06-18T16:39:00+00:00 https://ascopost.com/news/june-2021/retrospective-study-explores-variation-in-colorectal-cancer-risk-in-families-with-lynch-syndrome/ 2021-07-07T20:07:30+00:00 https://ascopost.com/news/june-2021/addition-of-first-line-nivolumab-to-chemotherapy-in-advanced-gastric-cancers-checkmate-649/ 2021-06-18T18:16:35+00:00 https://ascopost.com/news/june-2021/prevalence-of-germline-brca-mutations-in-women-with-ovarian-cancer-in-india/ 2021-06-21T19:27:17+00:00 https://ascopost.com/news/june-2021/effect-of-radiotherapy-dose-escalation-in-definitive-chemoradiation-for-locally-advanced-esophageal-cancer/ 2021-06-21T16:28:44+00:00 https://ascopost.com/news/june-2021/addition-of-isatuximab-irfc-to-carfilzomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma-ikema-trial/ 2021-06-21T16:44:39+00:00 https://ascopost.com/news/june-2021/ibrutinibvenetoclax-vs-chlorambucilobinutuzumab-in-previously-untreated-older-patients-with-cllsll/ 2021-06-22T17:29:07+00:00 https://ascopost.com/news/june-2021/study-explores-incidence-rates-for-various-pediatric-cancers-across-age-and-racial-groups/ 2021-06-21T18:45:45+00:00 https://ascopost.com/news/june-2021/testing-of-lymph-nodes-for-breast-cancer-recurrence-after-neoadjuvant-chemotherapy/ 2021-06-21T18:53:57+00:00 https://ascopost.com/news/june-2021/brexucabtagene-autoleucel-in-adults-with-relapsed-or-refractory-b-cell-all-zuma-3/ 2021-06-22T15:47:40+00:00 https://ascopost.com/news/june-2021/is-lenvatinib-plus-pembrolizumab-an-effective-treatment-for-patients-with-metastatic-renal-cell-carcinoma/ 2021-06-22T15:54:13+00:00 https://ascopost.com/news/june-2021/ascofriends-of-cancer-research-joint-position-statement-encourages-enrollment-of-patients-with-cancer-in-covid-19-vaccine-studies/ 2021-06-22T16:38:22+00:00 https://ascopost.com/news/june-2021/avelumab-with-or-without-pegylated-liposomal-doxorubicin-in-platinum-resistantrefractory-ovarian-cancer/ 2021-06-22T16:54:54+00:00 https://ascopost.com/news/june-2021/phase-ii-study-of-naratuximab-emtansine-plus-rituximab-in-diffuse-large-b-cell-lymphoma/ 2021-06-23T18:52:21+00:00 https://ascopost.com/news/june-2021/study-evaluates-residential-racial-segregation-and-nsclc-treatment-and-outcomes/ 2021-07-23T14:06:22+00:00 https://ascopost.com/news/june-2021/ctdna-and-early-relapse-after-axicabtagene-ciloleucel-infusion-in-large-b-cell-lymphoma/ 2021-06-23T16:05:37+00:00 https://ascopost.com/news/june-2021/reduced-dose-and-reduced-volume-radiotherapy-plus-chemotherapy-in-newly-diagnosed-patients-with-average-risk-medulloblastoma/ 2021-06-23T16:37:15+00:00 https://ascopost.com/news/june-2021/overall-survival-with-the-addition-of-ixazomib-to-lenalidomidedexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2021-06-23T17:01:30+00:00 https://ascopost.com/news/june-2021/fda-pipeline-priority-reviews-in-multiple-myeloma-cervical-cancer-neutropenia-and-myelofibrosis/ 2021-06-23T19:00:07+00:00 https://ascopost.com/news/june-2021/stereotactic-body-radiotherapy-vs-conventional-external-beam-radiotherapy-for-pain-control-of-spinal-metastases/ 2021-06-24T15:27:23+00:00 https://ascopost.com/news/june-2021/convalescent-plasma-therapy-for-patients-with-hematologic-cancers-hospitalized-for-covid-19/ 2021-06-24T15:46:11+00:00 https://ascopost.com/news/june-2021/survival-of-patients-with-colon-cancer-enrolled-in-the-us-military-health-system/ 2021-06-24T16:02:14+00:00 https://ascopost.com/news/june-2021/study-finds-patients-with-bladder-cancer-and-ureteric-obstruction-may-safely-receive-chemotherapy/ 2021-06-24T20:10:21+00:00 https://ascopost.com/news/june-2021/study-explores-taste-and-smell-dysfunction-in-head-and-neck-cancer-survivors/ 2026-01-29T16:02:45+00:00 https://ascopost.com/news/june-2021/addition-of-neoadjuvant-chemotherapy-to-surgery-and-adjuvant-s-1-in-locally-advanced-gastric-cancer/ 2021-06-24T18:57:55+00:00 https://ascopost.com/news/june-2021/fda-encourages-inclusion-of-patients-with-incurable-cancers-in-oncology-clinical-trials-regardless-of-prior-therapies/ 2021-06-28T15:07:59+00:00 https://ascopost.com/news/june-2021/vision-trial-lu-177-psma-617-radioligand-therapy-prolongs-survival-in-metastatic-castration-resistant-prostate-cancer/ 2021-06-28T19:49:39+00:00 https://ascopost.com/news/june-2021/effects-of-foxr2-expression-in-neuroblastoma/ 2021-06-28T15:49:55+00:00 https://ascopost.com/news/june-2021/neoadjuvant-trastuzumab-emtansine-vs-trastuzumab-pertuzumab-and-docetaxel-in-her2-positive-breast-cancer/ 2021-06-28T19:52:02+00:00 https://ascopost.com/news/june-2021/are-patients-with-primary-lung-cancer-detected-by-low-dose-ct-at-reduced-risk-of-brain-metastases/ 2021-06-28T18:23:03+00:00 https://ascopost.com/news/june-2021/addition-of-first-line-camrelizumab-to-gemcitabinecisplatin-in-recurrent-or-metastatic-nasopharyngeal-carcinoma/ 2021-06-29T19:38:15+00:00 https://ascopost.com/news/june-2021/risk-factors-for-early-discontinuation-of-adjuvant-endocrine-therapy-for-breast-cancer/ 2021-06-29T16:15:07+00:00 https://ascopost.com/news/june-2021/use-of-germline-mutation-profiling-in-patients-with-advanced-cancers/ 2021-06-30T17:24:35+00:00 https://ascopost.com/news/june-2021/immunotherapy-may-be-effective-for-subset-of-patients-with-prostate-cancer/ 2021-06-29T18:52:03+00:00 https://ascopost.com/news/june-2021/study-examines-mechanisms-of-resistance-in-early-stage-breast-cancer-after-endocrine-plus-cdk46-therapy/ 2021-06-29T19:04:37+00:00 https://ascopost.com/news/june-2021/sintilimab-plus-bevacizumab-biosimilar-vs-sorafenib-in-unresectable-or-metastatic-hbv-associated-hepatocellular-carcinoma/ 2021-06-30T18:15:27+00:00 https://ascopost.com/news/june-2021/survey-finds-covid-19-vaccine-hesitancy-among-many-adolescent-and-young-adult-cancer-survivors/ 2021-06-30T18:30:51+00:00 https://ascopost.com/news/june-2021/outcomes-with-5-vs-2-years-of-zoledronate-treatment-following-adjuvant-chemotherapy-in-early-breast-cancer/ 2021-06-30T18:21:32+00:00 https://ascopost.com/news/june-2021/study-examines-impact-of-covid-19-on-breast-and-cervical-cancer-screening-programs/ 2021-07-09T15:02:04+00:00 https://ascopost.com/news/june-2021/association-between-increased-bmi-and-endometrial-cancer-risk-in-asian-women-with-postmenopausal-bleeding/ 2021-06-30T18:52:43+00:00 https://ascopost.com/news/may-2021/ 2021-07-01T15:10:57+00:00 https://ascopost.com/news/may-2021/three-year-outcomes-after-neoadjuvant-chemotherapy-with-or-without-anthracycline-plus-dual-her2-blockade-in-her2-positive-breast-cancer/ 2021-05-28T17:45:02+00:00 https://ascopost.com/news/may-2021/neoadjuvant-durvalumab-with-vs-without-stereotactic-body-radiotherapy-in-early-stage-nsclc/ 2021-05-28T18:02:08+00:00 https://ascopost.com/news/may-2021/does-the-addition-of-bevacizumab-to-gemcitabinecisplatin-for-metastatic-urothelial-carcinoma-improve-survival/ 2021-05-28T17:45:02+00:00 https://ascopost.com/news/may-2021/stereotactic-radiosurgery-for-brainstem-metastases/ 2021-05-28T18:04:48+00:00 https://ascopost.com/news/may-2021/cemiplimab-rwlc-for-patients-with-locally-advanced-basal-cell-carcinoma-after-hedgehog-inhibitor-therapy/ 2021-05-28T17:45:02+00:00 https://ascopost.com/news/may-2021/effect-of-lower-endoscopy-on-colorectal-cancer-incidence-and-mortality-in-individuals-older-than-75/ 2021-05-28T17:45:02+00:00 https://ascopost.com/news/may-2021/use-of-systemic-therapy-at-the-end-of-life-in-patients-with-cancer-effect-of-approval-of-immunotherapies/ 2021-05-28T17:45:03+00:00 https://ascopost.com/news/may-2021/aua-announces-updates-to-clinical-guidance-for-renal-mass-and-localized-renal-cancer/ 2021-05-28T17:45:03+00:00 https://ascopost.com/news/may-2021/school-based-hpv-vaccination-program-reduces-rates-of-hpv-in-gay-and-bisexual-men/ 2021-05-28T17:45:03+00:00 https://ascopost.com/news/may-2021/adjuvant-and-concurrent-temozolomide-in-1p19q-non-co-deleted-anaplastic-glioma-survival-benefit-analysis/ 2021-05-28T17:45:03+00:00 https://ascopost.com/news/may-2021/perioperative-systemic-therapy-for-patients-with-resectable-colorectal-peritoneal-metastases/ 2021-05-28T17:45:03+00:00 https://ascopost.com/news/may-2021/orient-12-study-addition-of-sintilimab-to-gemcitabineplatinum-in-advanced-squamous-nsclc/ 2021-06-24T19:47:59+00:00 https://ascopost.com/news/may-2021/oncology-hospital-at-home-program-reduced-unplanned-health-care-utilization-and-costs/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/association-of-community-cancer-centers-releases-report-trending-now-in-cancer-care-2020/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/enfortumab-vedotin-ejfv-after-pd-1-or-pd-l1-inhibitor-therapy-for-cisplatin-ineligible-patients-with-advanced-urothelial-carcinoma/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/fluciclovine-f-18-petct-vs-conventional-imaging-alone-in-guiding-postsurgery-salvage-radiotherapy-for-prostate-cancer/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/cognitive-performance-at-baseline-and-over-time-in-infants-treated-for-brain-tumors/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/inequities-in-breast-cancer-screening-during-the-covid-19-pandemic/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/does-long-term-suppression-of-hepatitis-b-in-patients-with-hiv-lower-risk-of-hcc/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/ipilimumab-plus-anti-pd-1-therapy-vs-ipilimumab-alone-for-patients-with-advanced-melanoma-resistant-to-anti-pd-1l1-monotherapy/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/reduced-intensity-oxaliplatincapecitabine-for-older-and-frail-patients-with-advanced-gastroesophageal-cancer/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/study-investigates-nongenetic-factors-linked-to-development-of-early-onset-colorectal-cancer/ 2021-05-28T17:45:04+00:00 https://ascopost.com/news/may-2021/avapritinib-vs-other-tyrosine-kinase-inhibitors-for-pdgfra-d842v-mutated-gastrointestinal-stromal-tumors/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/fda-pipeline-applications-accepted-for-marginal-zone-lymphoma-and-lung-cancer/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/pembrolizumab-plus-cetuximab-in-recurrent-or-metastatic-head-and-neck-cancer/ 2026-01-29T16:24:24+00:00 https://ascopost.com/news/may-2021/black-and-white-women-with-nonmetastatic-triple-negative-breast-cancer-differences-in-treatment-and-mortality/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/receptor-tyrosine-kinase-inhibitor-lenvatinib-for-anaplastic-thyroid-cancer/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/american-cancer-society-releases-report-on-cancer-prevention-and-screening/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/standard-multigene-testing-could-detect-more-hereditary-cancer-syndromes-in-patients-with-colorectal-cancer/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/does-adjuvant-atezolizumab-extend-disease-free-survival-in-patients-with-resected-early-stage-nsclc/ 2021-06-21T18:36:48+00:00 https://ascopost.com/news/may-2021/first-line-nivolumabrelatlimab-vs-nivolumab-alone-for-advanced-melanoma/ 2021-05-28T18:40:45+00:00 https://ascopost.com/news/may-2021/uspstf-issues-new-recommendation-statement-on-colorectal-cancer-screening/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/income-eligibility-limits-for-medicaid-and-long-term-survival-among-newly-diagnosed-patients-with-cancer/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/increased-psa-screening-linked-to-lower-risk-of-advanced-prostate-cancer-at-diagnosis-and-death-from-the-disease-in-younger-black-patients/ 2021-05-28T17:45:05+00:00 https://ascopost.com/news/may-2021/sacituzumab-govitecan-hziy-for-patients-with-pretreated-metastatic-urothelial-carcinoma/ 2021-05-28T17:45:06+00:00 https://ascopost.com/news/may-2021/loncastuximab-tesirine-lpyl-for-heavily-pretreated-patients-with-relapsed-or-refractory-dlbcl/ 2021-05-28T17:45:06+00:00 https://ascopost.com/news/may-2021/lifileucel-for-patients-with-previously-treated-metastatic-melanoma/ 2021-05-28T17:45:06+00:00 https://ascopost.com/news/may-2021/longitudinal-evaluation-of-functioning-in-children-with-retinoblastoma/ 2021-05-28T17:45:06+00:00 https://ascopost.com/news/may-2021/risk-of-second-cancer-by-hormone-receptor-status-among-breast-cancer-survivors/ 2021-06-14T15:35:18+00:00 https://ascopost.com/news/may-2021/pertuzumabhigh-dose-trastuzumab-in-patients-with-her2-positive-metastatic-breast-cancer-and-progressive-brain-metastases/ 2021-05-28T17:45:06+00:00 https://ascopost.com/news/may-2021/axillary-node-pathologic-complete-response-after-systemic-neoadjuvant-therapy-according-to-breast-cancer-subtype/ 2021-06-14T15:23:18+00:00 https://ascopost.com/news/may-2021/uk-collaborative-trial-of-ovarian-cancer-screening/ 2021-05-28T17:45:06+00:00 https://ascopost.com/news/may-2021/tlr4-as-a-possible-therapeutic-target-to-mitigate-cisplatin-induced-hearing-loss/ 2021-05-28T17:45:06+00:00 https://ascopost.com/news/may-2021/report-shows-medicaid-expansion-alone-does-not-resolve-disparities-in-cancer-care/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/trastuzumab-deruxtecan-nxki-in-her2-positive-metastatic-colorectal-cancer-destiny-crc01/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/frail-patients-with-newly-diagnosed-multiple-myeloma-triplet-regimen/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/effect-of-publication-of-the-lacc-trial-on-use-of-minimally-invasive-surgery-for-cervical-cancer/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/abemaciclib-associated-adverse-events-safety-analysis-of-monarche/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/disparities-in-enrollment-into-electronic-health-record-patient-portals-for-oncology-patients/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/mutational-profile-of-acral-nevi-may-differ-from-acral-melanoma/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/apalutamide-in-metastatic-castration-sensitive-prostate-cancer-final-overall-survival-analysis-of-the-titan-trial/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/cardiac-safety-efficacy-of-neoadjuvant-pertuzumabtrastuzumab-for-early-stage-her2-positive-breast-cancer/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/long-term-follow-up-of-premenopausal-patients-with-er-positive-breast-cancer-goserelin-and-tamoxifen/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/addition-of-celecoxib-to-standard-adjuvant-therapy-in-stage-iii-colon-cancer/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/pembrolizumabipilimumab-after-disease-progression-on-pd-1pd-l1-inhibitor-therapy-in-advanced-melanoma/ 2021-05-28T17:45:07+00:00 https://ascopost.com/news/may-2021/acmg-clinical-practice-resource-provides-new-guidance-for-management-of-individuals-with-palb2-gene-variants/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/maintenance-rucaparib-in-patients-with-platinum-sensitive-pancreatic-cancer-and-germline-or-somatic-brca1-brca2-or-palb2-variants/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/incidence-of-interstitial-lung-disease-related-to-trastuzumab-deruxtecan-nxki-in-patients-with-her2-positive-metastatic-breast-cancer/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/atezolizumabcarboplatin-as-immune-induction-in-patients-with-metastatic-invasive-lobular-breast-cancer/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/lenvatinib-for-previously-treated-advanced-pancreatic-and-gastrointestinal-neuroendocrine-tumors/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/shorter-duration-of-adjuvant-trastuzumab-in-her2-positive-early-breast-cancer/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/biomarker-analysis-of-the-kaitlin-trial-no-subgroup-benefits-more-from-t-dm1-plus-chemo/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/evolution-to-her2-low-breast-cancer-investigating-potential-therapeutics/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/surveillance-protocol-and-early-cancer-detection-in-patients-with-constitutional-mismatch-repair-deficiency-syndrome/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/fda-pipeline-priority-reviews-in-kidney-and-endometrial-cancers-cholangiocarcinoma/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/fda-authorizes-pfizer-biontech-covid-19-vaccine-for-emergency-use-in-adolescents/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/phase-ii-study-of-trilaciclib-in-pretreated-patients-with-metastatic-nsclc-initiated-preserve-4/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/relationship-between-germline-brca-pathogenic-variants-and-diminished-ovarian-reserve/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/effect-of-oral-chemotherapy-management-program-on-capecitabine-toxicity/ 2021-05-28T17:45:08+00:00 https://ascopost.com/news/may-2021/study-explores-racial-disparities-in-renal-cell-carcinoma-by-stage-and-mortality/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/increased-loneliness-among-patients-with-cancer-during-the-covid-19-pandemic-may-affect-symptom-burden/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/imagyn050-trial-addition-of-atezolizumab-to-bevacizumab-and-chemotherapy-for-newly-diagnosed-stage-iii-or-iv-ovarian-cancer/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/hla-mismatched-unrelated-donor-bone-marrow-transplant-with-posttransplant-cyclophosphamide/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/ai-system-may-aid-in-diagnosing-cancer-of-unknown-primary/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/prospective-study-explores-prostate-cancer-and-treatment-outcomes-by-race/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/the-covid-19-pandemic-and-cancer-screening-deficits-in-the-united-states/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/oncologists-views-on-challenges-in-opioid-prescribing-for-patients-with-cancer-related-pain/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/diagnosis-to-treatment-interval-and-circulating-tumor-dna-levels-in-diffuse-large-b-cell-lymphoma/ 2022-02-24T19:40:57+00:00 https://ascopost.com/news/may-2021/accuracy-of-lung-cancer-risk-model-in-diverse-populations/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/expert-panel-endorsed-quality-measures-for-end-of-life-care-for-children-with-cancer/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/one-vs-two-doses-of-the-bnt162b2-covid-19-vaccine-in-patients-with-cancer-immunogenicity-and-efficacy/ 2021-05-28T17:45:09+00:00 https://ascopost.com/news/may-2021/ten-year-outcomes-with-neoadjuvant-chemoradiotherapy-plus-surgery-vs-surgery-alone-for-esophageal-cancer/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/may-2021/variations-in-testing-and-treatment-across-medical-specialties-for-men-initiating-active-surveillance-for-prostate-cancer/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/may-2021/risk-of-colorectal-cancer-and-colorectal-polyps-in-first-degree-family-members/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/may-2021/imaging-study-aims-to-detect-rates-of-cancer-in-medieval-britain/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/may-2021/brentuximab-vedotin-plus-chemotherapy-in-newly-diagnosed-early-stage-unfavorable-risk-hodgkin-lymphoma/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/may-2021/antiviral-t-cells-for-bk-virus-associated-hemorrhagic-cystitis/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/may-2021/first-line-single-agent-carboplatin-vs-carboplatinpaclitaxel-in-older-women-with-ovarian-cancer/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/may-2021/fda-pipeline-priority-reviews-of-treatments-for-bladder-and-lung-cancers/ 2021-05-28T17:45:10+00:00 https://ascopost.com/news/april-2021/ 2021-07-01T15:10:58+00:00 https://ascopost.com/news/april-2021/five-year-efficacy-outcomes-with-pembrolizumab-vs-chemotherapy-in-metastatic-nsclc-with-pd-l1-tps-of-at-least-50/ 2021-05-03T20:44:07+00:00 https://ascopost.com/news/april-2021/more-from-the-fda-odac-votes-on-agents-for-pretreated-hepatocellular-carcinoma-and-gastric-cancer/ 2021-05-07T15:54:10+00:00 https://ascopost.com/news/april-2021/adjuvant-trastuzumab-with-or-without-chemotherapy-in-older-patients-with-her2-positive-breast-cancer-hrqol/ 2021-04-30T19:43:48+00:00 https://ascopost.com/news/april-2021/factors-associated-with-unplanned-hospitalizations-among-older-patients-receiving-chemotherapy/ 2021-04-30T19:43:48+00:00 https://ascopost.com/news/april-2021/fertility-concerns-may-influence-decisions-about-endocrine-therapy-in-young-women-with-breast-cancer/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/fda-odac-votes-in-favor-of-retaining-accelerated-approval-for-bladder-cancer-treatments/ 2021-05-11T20:02:25+00:00 https://ascopost.com/news/april-2021/patient-centered-outcomes-in-the-solo-1-trial-of-maintenance-olaparib-for-advanced-ovarian-cancer/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/cryoablation-emerging-as-effective-treatment-for-low-risk-breast-cancers/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/covid-19-pandemic-drove-strategic-new-breast-cancer-approaches-to-avoid-hospitalization/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/low-risk-breast-cancer-survivors-may-experience-long-term-physical-and-psychological-effects/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/breast-reconstruction-disparities-improved-with-medicaid-expansion/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/health-related-quality-of-life-with-adjuvant-pembrolizumab-vs-placebo-in-resected-stage-iii-melanoma/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/sentinel-lymph-node-biopsy-navigated-vs-elective-neck-dissection-for-early-oral-cancer/ 2026-01-29T16:29:17+00:00 https://ascopost.com/news/april-2021/fda-odac-votes-in-favor-of-maintaining-accelerated-approval-of-atezolizumabnab-paclitaxel-for-pd-l1-positive-metastatic-triple-negative-breast-cancer/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/youtube-videos-on-bladder-cancer-study-focuses-on-quality-of-content/ 2021-04-30T19:43:49+00:00 https://ascopost.com/news/april-2021/new-research-finds-few-young-adult-men-have-received-the-hpv-vaccine/ 2026-01-29T16:27:35+00:00 https://ascopost.com/news/april-2021/lobaplatin-vs-cisplatin-based-induction-and-chemoradiotherapy-in-previously-untreated-locoregionally-advanced-nasopharyngeal-carcinoma/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/safety-of-stereotactic-body-radiotherapy-for-treatment-of-patients-with-multiple-metastases/ 2021-05-11T20:03:43+00:00 https://ascopost.com/news/april-2021/rock2-inhibitor-belumosudil-for-chronic-graft-vs-host-disease/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/dangling-accelerated-approvals-of-anti-pd-1pd-l1-antibodies-to-be-discussed-at-fda-oncologic-drugs-advisory-committee-meeting/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/glofitamab-for-relapsed-or-refractory-b-cell-lymphoma/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/meta-analysis-of-treatment-modalities-for-locally-advanced-head-and-neck-cancer/ 2026-01-29T16:31:19+00:00 https://ascopost.com/news/april-2021/can-brachytherapy-for-cervical-cancer-continue-after-uterine-perforation/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/fda-pipeline-bemarituzumab-granted-breakthrough-therapy-designation-for-fgfr2b-overexpressing-her2-negative-gastric-cancer/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/fda-grants-accelerated-approval-to-dostarlimab-gxly-for-dmmr-endometrial-cancer/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/improvement-in-survival-with-adjuvant-pembrolizumab-for-resected-stage-iii-melanoma/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/tisotumab-vedotin-in-recurrent-or-metastatic-cervical-cancer/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/pembrolizumab-monotherapy-for-heavily-pretreated-patients-with-metastatic-breast-cancer-and-high-tumor-mutational-burden/ 2021-04-30T19:43:50+00:00 https://ascopost.com/news/april-2021/national-survey-finds-average-risk-individuals-prefer-stool-based-tests-over-colonoscopy-for-colorectal-cancer-screening/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/study-explores-rates-of-germline-mutations-in-patients-with-colorectal-cancer/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/alpelisib-plus-fulvestrant-in-pik3ca-mutant-hr-positive-her2-negative-advanced-breast-cancer-after-disease-progression/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/effect-of-antihypertensive-medications-on-risk-of-cancer/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/long-term-outcomes-with-electron-intraoperative-irradiation-vs-whole-breast-irradiation-for-early-breast-cancer/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/effect-of-genomic-prostate-score-testing-on-choice-of-active-surveillance-in-a-predominantly-black-patient-population/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/immune-checkpoint-inhibitors-and-cutaneous-toxicity-population-level-analysis/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/acute-myeloid-leukemia-world-awareness-day-2021-april-21/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/addition-of-avelumab-to-chemoradiotherapy-in-previously-untreated-patients-with-locally-advanced-head-and-neck-cancer/ 2026-01-29T16:32:36+00:00 https://ascopost.com/news/april-2021/palbociclib-for-residual-invasive-hr-positive-her2-negative-early-breast-cancer-after-neoadjuvant-chemotherapy/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/pediatric-adrenocortical-carcinoma-different-treatment-strategies-by-disease-stage/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/recent-studies-explore-efficacy-of-covid-19-vaccination-in-patients-with-leukemia-and-myeloma/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/overweight-breast-cancer-survivors-may-be-at-increased-risk-of-developing-a-secondary-malignancy/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/fda-pipeline-recent-designations-in-urothelial-cancer-cervical-cancer-cholangiocarcinoma-and-more/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/fda-approves-nivolumab-in-combination-with-chemotherapy-for-metastatic-gastric-cancer-and-esophageal-adenocarcinoma/ 2021-04-30T19:43:51+00:00 https://ascopost.com/news/april-2021/outcomes-with-mri-based-image-guided-adaptive-brachytherapy-for-locally-advanced-cervical-cancer/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/first-line-pembrolizumab-vs-chemotherapy-for-msi-h-or-dmmr-metastatic-colorectal-cancer-health-related-quality-of-life/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/updated-outcomes-for-patients-with-metastatic-nonseminomatous-germ-cell-tumors-and-development-of-new-prognostic-model/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/patient-knowledge-and-expectations-regarding-genomic-testing-results/ 2021-05-03T20:48:16+00:00 https://ascopost.com/news/april-2021/adult-survivors-of-aya-cancers-may-be-more-likely-to-experience-medical-financial-hardship/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/short-term-safety-of-the-bnt162b2-mrna-covid-19-vaccine-in-patients-receiving-immunotherapy/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/addition-of-alpelisib-to-fulvestrant-for-pik3ca-mutant-hr-positive-her2-negative-advanced-breast-cancer-patient-reported-outcomes/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/integration-of-brentuximab-vedotin-into-front-line-treatment-for-pediatric-patients-with-high-risk-hodgkin-lymphoma/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/genome-wide-association-study-of-variants-linked-to-cervical-preinvasive-and-invasive-disease/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/new-study-finds-baseline-brain-imaging-should-be-considered-for-patients-with-metastatic-rcc/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/certain-genetic-mutations-may-increase-risk-of-death-from-infection-in-patients-with-cll/ 2021-05-17T17:28:29+00:00 https://ascopost.com/news/april-2021/first-line-tislelizumab-plus-chemotherapy-vs-chemotherapy-alone-in-advanced-squamous-nsclc/ 2021-05-03T20:50:26+00:00 https://ascopost.com/news/april-2021/adjuvant-nivolumab-for-resected-esophageal-or-gastroesophageal-junction-cancer-after-neoadjuvant-chemoradiotherapy/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/tumor-mutational-burden-as-predictor-of-immune-response-variance-between-female-and-male-patients-with-melanoma/ 2021-04-30T19:43:52+00:00 https://ascopost.com/news/april-2021/cancer-aneuploidy-may-predict-response-to-immunotherapy-in-patients-with-nsclc/ 2021-05-03T20:51:11+00:00 https://ascopost.com/news/april-2021/study-evaluates-method-to-reduce-medication-errors-and-side-effects-of-newer-oral-anticancer-drugs/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/estimated-shifts-in-cancer-incidence-and-death-over-next-2-decades/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/pediatric-patients-with-high-grade-gliomas-treatment-with-oncolytic-hsv-1-g207-immunovirotherapy/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/liquid-biopsy-plus-mri-for-predicting-response-to-neoadjuvant-chemotherapy-in-patients-with-breast-cancer/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/patients-of-different-races-with-early-onset-colorectal-cancer-exhibit-distinct-genetic-features/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/patients-with-ovarian-cancer-face-an-increased-risk-of-mental-illness/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/long-term-follow-up-of-children-and-young-adults-with-b-cell-all-treated-with-cd19-car-t-cell-therapy/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/anesthesiologist-volume-and-adverse-short-term-outcomes-after-complex-surgery-for-gastrointestinal-cancer/ 2021-04-30T19:43:53+00:00 https://ascopost.com/news/april-2021/neoadjuvant-nivolumab-plus-chemotherapy-boosts-pathologic-complete-response-rate-for-patients-with-resectable-nsclc/ 2021-05-03T20:54:30+00:00 https://ascopost.com/news/april-2021/copanlisib-rituximab-extends-progression-free-survival-vs-rituximab-placebo-in-indolent-non-hodgkin-lymphoma/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/tebentafusp-first-treatment-to-improve-overall-survival-in-metastatic-uveal-melanoma/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/small-study-explores-car-t-cell-therapy-for-relapsed-or-refractory-b-cell-lymphoma/ 2021-05-13T18:39:30+00:00 https://ascopost.com/news/april-2021/unselected-autologous-tumor-infiltrating-lymphocyte-therapy-for-metastatic-cutaneous-melanoma/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/outcomes-with-ribociclib-across-intrinsic-subtypes-of-hr-positive-her2-negative-breast-cancer/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/discrepancies-in-her2-assessment-for-metastatic-gastric-cancer/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/adverse-events-in-patients-with-melanoma-treated-with-ipilimumab-results-of-a-toxicity-monitoring-program/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/risk-of-leukemia-in-pediatric-patients-with-down-syndrome/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/oral-azacitidine-in-lower-risk-myelodysplastic-syndromes/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/diet-and-exercise-intervention-may-increase-efficacy-of-chemotherapy-in-pediatric-patients-with-leukemia/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/inpatient-radiation-oncology-consult-model-for-metastatic-cancer-to-reduce-hospital-length-of-stay/ 2021-04-30T19:43:54+00:00 https://ascopost.com/news/april-2021/end-of-life-care-remains-aggressive-for-patients-with-ovarian-cancer/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/is-tumor-mutational-burden-alone-sufficient-to-predict-response-to-immunotherapy/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/germline-brca12-and-other-predisposition-genes-in-patients-with-metastatic-breast-cancer-prevalence-and-association-with-prognosis/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/screening-and-education-in-melanoma-prone-families-may-improve-early-detection-of-disease/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/gene-sequencing-esophageal-brushings-may-identify-patients-with-barrett-s-esophagus-at-risk-for-cancer-progression/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/image-guided-percutaneous-thermal-ablation-for-advanced-gynecologic-cancers/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/tipifarnib-for-patients-with-advanced-hras-mutant-head-and-neck-cancer-and-high-variant-allele-frequency/ 2026-01-29T16:41:00+00:00 https://ascopost.com/news/april-2021/locally-advanced-esophageal-cancer-neoadjuvant-chemoradiotherapy-vs-chemotherapy-followed-by-minimally-invasive-esophagectomy/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/low-dose-tamoxifen-for-reduction-of-mammographic-density-in-women-undergoing-breast-cancer-screening/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/improving-survival-for-patients-with-stage-ii-pancreatic-cancer-chemotherapy-followed-by-resection/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/patients-with-nsclc-and-driver-mutations-may-be-more-likely-to-present-with-brain-metastasis-at-diagnosis/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/expert-panel-issues-recommendations-for-addressing-inequities-in-cancer-care/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/detection-of-emphysema-among-patients-with-or-without-prior-copd-diagnosis-undergoing-low-dose-ct-screening-for-lung-cancer/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/addition-of-pegaspargase-intensification-to-standard-low-intensity-chemotherapy-backbone-in-pediatric-low-risk-b-all/ 2021-04-30T19:43:55+00:00 https://ascopost.com/news/april-2021/impact-of-covid-19-pandemic-on-delivery-of-breast-cancer-care-in-new-york/ 2021-04-30T19:43:56+00:00 https://ascopost.com/news/april-2021/role-of-whole-genome-sequencing-in-identifying-patients-with-mgus-at-risk-of-progression-to-multiple-myeloma/ 2021-05-13T18:40:46+00:00 https://ascopost.com/news/april-2021/astro-survey-explores-effect-of-the-covid-19-pandemic-on-radiation-oncology/ 2021-04-30T19:43:56+00:00 https://ascopost.com/news/april-2021/medicaid-expansion-is-associated-with-earlier-diagnosis-of-gastric-cancer-improved-survival/ 2021-04-30T19:43:56+00:00 https://ascopost.com/news/april-2021/chronic-immune-related-adverse-events-associated-with-adjuvant-immunotherapy-for-advanced-melanoma/ 2021-04-30T19:43:56+00:00 https://ascopost.com/news/april-2021/risk-of-venous-and-arterial-thromboembolism-in-patients-with-cancer-receiving-immune-checkpoint-inhibitors/ 2021-04-30T19:43:56+00:00 https://ascopost.com/news/april-2021/effect-of-gamification-with-social-incentives-on-increased-mobility-after-hospital-discharge/ 2021-04-30T19:43:56+00:00 https://ascopost.com/news/april-2021/mutations-in-ctcs-may-predict-clinical-outcomes-in-patients-with-metastatic-castration-resistant-prostate-cancer/ 2021-04-30T19:43:56+00:00 https://ascopost.com/news/april-2021/meta-analysis-finds-liver-tumors-may-be-resistant-to-immunotherapy-in-patients-with-underlying-nonalcoholic-steatohepatitis/ 2021-04-30T19:43:57+00:00 https://ascopost.com/news/april-2021/president-biden-issues-proclamation-on-national-cancer-control-month-2021/ 2021-04-30T19:43:57+00:00 https://ascopost.com/news/march-2021/ 2021-07-01T15:10:58+00:00 https://ascopost.com/news/march-2021/pembrolizumab-vs-brentuximab-vedotin-in-relapsed-or-refractory-classical-hodgkin-lymphoma/ 2021-03-31T20:31:54+00:00 https://ascopost.com/news/march-2021/electroacupuncture-and-auricular-acupuncture-vs-usual-care-for-chronic-musculoskeletal-pain-in-cancer-survivors/ 2021-03-31T20:31:54+00:00 https://ascopost.com/news/march-2021/does-adding-adjuvant-concurrent-trastuzumab-to-radiotherapy-after-lumpectomy-for-her2-positive-dcis-reduce-ipsilateral-recurrence/ 2021-03-31T20:31:54+00:00 https://ascopost.com/news/march-2021/lymph-node-collection-kit-may-help-improve-outcomes-after-lung-cancer-surgery/ 2021-04-29T23:35:51+00:00 https://ascopost.com/news/march-2021/analysis-identifies-frequency-of-pi3k-pathway-alterations-in-patients-with-nsclc/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/studies-presented-at-sgo-examine-racial-health-care-disparities-in-patients-with-gynecologic-cancers/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/wee1-inhibition-in-patients-with-recurrent-uterine-serous-carcinoma/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/despite-access-to-clinical-trials-patients-from-socioeconomically-disadvantaged-areas-have-worse-cancer-outcomes/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/risk-of-artery-dissection-or-aneurysm-with-use-of-antiangiogenic-drugs/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/incidence-of-brain-metastases-in-patients-diagnosed-with-stage-iv-nsclc-during-the-covid-19-pandemic/ 2021-04-20T19:07:41+00:00 https://ascopost.com/news/march-2021/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer-following-neoadjuvant-chemoradiation-therapy/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/does-consumption-of-ultra-processed-food-and-drink-increase-colorectal-cancer-risk/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/inclusion-of-surveillance-ejection-fraction-in-predicting-risk-of-10-year-left-ventricular-systolic-dysfunction-in-survivors-of-childhood-cancer/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/adagrasib-for-patients-with-advanced-kras-g12c-mutated-nsclc/ 2021-05-21T17:19:42+00:00 https://ascopost.com/news/march-2021/definitive-ablative-radiation-therapy-in-inoperable-locally-advanced-pancreatic-cancer/ 2021-03-31T20:31:55+00:00 https://ascopost.com/news/march-2021/some-patients-with-lung-cancer-report-feeling-uninformed-about-their-disease-uninvolved-with-their-treatment/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/fda-grants-two-new-breakthrough-device-designations-for-molecular-residual-disease-test/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/uc-davis-comprehensive-cancer-center-elected-as-nccn-member-institution/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/distant-metastasis-free-survival-with-adjuvant-vs-no-adjuvant-chemotherapy-according-to-genomic-and-clinical-risk-in-early-breast-cancer/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/discontinuation-of-development-of-oral-taxane-tesetaxel-announced/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/adjuvant-atezolizumab-in-muscle-invasive-urothelial-carcinoma-imvigor010/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/time-to-treatment-initiation-for-breast-cancer-during-the-covid-19-pandemic-single-institution-study/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/rates-of-seroconversion-among-patients-with-cancer-infected-with-covid-19/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/surgical-management-of-melanoma-with-the-advent-of-adjuvant-systemic-therapy/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/study-establishes-global-burden-of-gallbladder-and-biliary-tract-cancer/ 2021-03-31T20:31:56+00:00 https://ascopost.com/news/march-2021/identification-of-genomic-subgroups-of-patients-with-myelodysplastic-syndromes-new-prognostic-modeling/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/analysis-from-the-international-germ-cell-cancer-collaborative-group-update-consortium/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/outcomes-of-complex-gastrointestinal-cancer-surgeries-at-ranked-vs-nonranked-hospitals/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/factors-associated-with-severity-of-covid-19-infection-in-patients-with-cancer-data-from-ccc19/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/image-guided-intensity-modulated-radiotherapy-in-patients-with-cervical-cancer/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/first-line-tpex-vs-extreme-regimen-for-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma/ 2026-01-29T16:44:02+00:00 https://ascopost.com/news/march-2021/niraparib-plus-bevacizumab-shows-clinical-benefit-in-patients-with-advanced-ovarian-cancer/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/older-patients-with-multiple-myeloma-may-be-able-to-avoid-long-term-steroid-use/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/patient-refusal-of-provider-recommended-locoregional-treatment-for-prostate-cancer-sociodemographic-factors/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/kras-mutation-status-may-predict-outcomes-after-hepatic-arterial-infusion-pump-therapy-for-unresectable-colorectal-liver-metastases/ 2021-03-31T20:31:57+00:00 https://ascopost.com/news/march-2021/maintenance-olaparib-yields-strong-and-sustained-benefit-in-ovarian-cancer/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/phase-iii-ariel4-trial-confirms-benefit-of-rucaparib-in-brca-mutated-relapsed-ovarian-cancer/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/benefit-of-niraparib-maintenance-therapy-extends-beyond-first-disease-progression-in-recurrent-ovarian-cancer/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/frailty-may-impact-surgical-outcomes-in-patients-with-ovarian-cancer/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/hormonal-iud-may-be-a-potential-nonsurgical-treatment-for-early-endometrial-cancer-or-precancer/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/pembrolizumablenvatinib-may-improve-survival-in-advanced-endometrial-cancer/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/survey-reveals-workplace-bullying-gender-discrimination-and-microaggressions-not-uncommon-for-women-gynecologic-oncologists/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/olaparib-shows-efficacy-in-ovarian-cancer-regardless-of-number-of-prior-lines-of-chemotherapy-brca-mutation-status/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/recent-chemotherapy-or-immunotherapy-for-gynecologic-cancer-does-not-raise-risk-of-death-due-to-covid-19/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/association-of-cardiovascular-risk-factors-with-risk-of-subsequent-cancer/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/noncovalent-btk-inhibitor-pirtobrutinib-in-relapsed-or-refractory-b-cell-malignancies/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/hybrid-minimally-invasive-vs-open-esophagectomy-for-esophageal-cancer-5-year-outcomes/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/dcis-biologic-risk-signature-may-predict-risk-of-recurrence-and-radiation-benefit-after-breast-conserving-surgery/ 2021-04-05T17:35:00+00:00 https://ascopost.com/news/march-2021/utilization-and-survival-benefit-of-adjuvant-immunotherapy-for-resected-high-risk-stage-ii-melanoma/ 2021-03-31T20:31:58+00:00 https://ascopost.com/news/march-2021/predicting-survival-in-patients-with-extremity-and-trunk-sarcomas-in-the-united-states/ 2021-03-31T20:31:59+00:00 https://ascopost.com/news/march-2021/umbralisib-for-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/ 2021-03-31T20:31:59+00:00 https://ascopost.com/news/march-2021/immunotherapy-doublet-as-maintenance-therapy-for-extensive-disease-small-cell-lung-cancer/ 2021-04-20T19:06:27+00:00 https://ascopost.com/news/march-2021/improving-the-prognostic-accuracy-of-residual-cancer-burden-after-neoadjuvant-chemotherapy-for-breast-cancer/ 2021-03-31T20:31:59+00:00 https://ascopost.com/news/march-2021/use-of-chemotherapy-and-risk-of-alzheimer-s-disease-in-colorectal-cancer-survivors/ 2021-05-05T19:23:41+00:00 https://ascopost.com/news/march-2021/circulating-hybrid-cells-may-help-to-monitor-treatment-response-in-patients-with-rectal-and-esophageal-cancers/ 2021-03-31T20:31:59+00:00 https://ascopost.com/news/march-2021/fda-approves-therasphere-y-90-glass-microspheres-for-unresectable-hepatocellular-carcinoma/ 2021-03-31T20:31:59+00:00 https://ascopost.com/news/march-2021/pembrolizumab-vs-chemotherapy-in-previously-treated-patients-with-metastatic-triple-negative-breast-cancer/ 2021-03-31T20:31:59+00:00 https://ascopost.com/news/march-2021/updated-evidence-report-and-systematic-review-of-low-dose-ct-screening-for-lung-cancer/ 2021-03-31T20:31:59+00:00 https://ascopost.com/news/march-2021/whole-genome-sequencing-vs-cytogenetic-analysis-in-myeloid-cancers/ 2021-04-19T18:02:14+00:00 https://ascopost.com/news/march-2021/using-ct-colonography-as-a-noninvasive-colorectal-cancer-screening-test-for-advanced-neoplasia/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/can-treatment-for-prostate-cancer-affect-smell-and-taste/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/fda-pipeline-priority-review-for-kidney-cancer-treatment-fast-track-designation-for-nsclc-treatment/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/secondary-cytoreduction-plus-chemotherapy-vs-chemotherapy-alone-in-relapsed-platinum-sensitive-epithelial-ovarian-cancer/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/robust-trial-addition-of-lenalidomide-to-r-chop-in-previously-untreated-abc-type-dlbcl/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/persistent-use-of-low-value-breast-cancer-surgeries-designated-for-deimplementation-by-choosing-wisely/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/high-tumor-mutational-burden-predicts-immunotherapy-response-in-some-but-not-all-cancers/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/study-identifies-factors-that-may-lower-the-risk-of-cns-relapse-in-pediatric-patients-with-all/ 2021-04-19T17:10:47+00:00 https://ascopost.com/news/march-2021/is-hpv-vaccination-for-adults-aged-26-and-older-cost-effective/ 2021-03-31T20:32:00+00:00 https://ascopost.com/news/march-2021/checkmate-9er-first-line-nivolumab-plus-cabozantinib-vs-sunitinib-for-advanced-renal-cell-carcinoma/ 2021-03-31T20:32:01+00:00 https://ascopost.com/news/march-2021/fda-oncologic-drugs-advisory-committee-to-review-status-of-six-indications-granted-accelerated-approval/ 2021-03-31T20:32:01+00:00 https://ascopost.com/news/march-2021/high-vs-standard-dose-thoracic-radiotherapy-for-limited-stage-small-cell-lung-cancer/ 2021-03-31T20:32:01+00:00 https://ascopost.com/news/march-2021/value-of-global-scale-up-of-cancer-care-investment-in-treatment-imaging-and-quality-of-care/ 2021-03-31T20:32:01+00:00 https://ascopost.com/news/march-2021/study-finds-regularly-drinking-sugar-sweetened-soda-may-increase-total-and-breast-cancer-mortality/ 2021-03-31T20:32:01+00:00 https://ascopost.com/news/march-2021/lowering-kras-activity-may-lead-to-improved-therapy-response-in-pancreatic-cancer/ 2021-03-31T20:32:01+00:00 https://ascopost.com/news/march-2021/meta-analysis-of-intermediate-clinical-endpoints-as-surrogates-for-overall-survival-in-localized-prostate-cancer/ 2021-03-31T20:32:01+00:00 https://ascopost.com/news/march-2021/immunotherapy-for-advanced-kidney-cancer-effect-of-body-mass-index/ 2021-03-31T20:32:02+00:00 https://ascopost.com/news/march-2021/weight-gain-in-childhood-brain-tumor-survivors-and-potential-association-with-hypothalamic-pituitary-dysfunction/ 2021-03-31T20:32:02+00:00 https://ascopost.com/news/march-2021/why-might-night-shift-workers-have-a-higher-risk-of-developing-cancer/ 2021-03-31T20:32:02+00:00 https://ascopost.com/news/march-2021/new-survey-reveals-hesitancy-around-covid-19-vaccination-among-patients-with-hematologic-malignancies-and-survivors/ 2021-03-31T20:32:02+00:00 https://ascopost.com/news/march-2021/responses-to-conjugate-pneumococcal-vaccine-in-patients-with-chronic-lymphocytic-leukemia/ 2021-05-17T17:26:02+00:00 https://ascopost.com/news/march-2021/assays-show-utility-in-predicting-pathologic-complete-response-rate-in-pre-and-postmenopausal-patients-with-breast-cancer/ 2021-03-31T20:32:03+00:00 https://ascopost.com/news/march-2021/effect-of-risk-adapted-therapy-on-long-term-morbidity-in-pediatric-patients-with-hodgkin-lymphoma/ 2021-03-31T20:32:03+00:00 https://ascopost.com/news/march-2021/new-study-finds-muscle-mass-and-density-are-correlated-with-survival-and-outcomes-in-patients-with-advanced-cancer/ 2021-03-31T20:32:03+00:00 https://ascopost.com/news/march-2021/updated-destiny-breast01-results-show-trastuzumab-deruxtecan-nxki-delivers-durable-responses/ 2021-03-31T20:32:03+00:00 https://ascopost.com/news/march-2021/updated-analysis-of-outcomes-with-entrectinib-for-advanced-ros1-fusion-positive-nsclc/ 2021-03-31T20:32:04+00:00 https://ascopost.com/news/march-2021/nomograms-to-predict-local-regional-and-distant-recurrence-in-patients-with-thin-melanomas/ 2021-03-31T20:32:04+00:00 https://ascopost.com/news/march-2021/new-global-breast-cancer-initiative-highlights-renewed-commitment-to-improve-survival/ 2021-03-31T20:32:04+00:00 https://ascopost.com/news/march-2021/atezolizumab-s-indication-in-previously-treated-metastatic-bladder-cancer-is-withdrawn/ 2021-03-31T20:32:05+00:00 https://ascopost.com/news/march-2021/eprenetapopt-plus-azacitidine-in-tp53-mutated-mds-and-aml/ 2021-03-31T20:32:05+00:00 https://ascopost.com/news/march-2021/childhood-cancer-survivors-and-health-care-providers-satisfied-with-video-visits-during-the-covid-19-pandemic/ 2021-03-31T20:32:05+00:00 https://ascopost.com/news/march-2021/new-whoiaea-publication-provides-guidance-on-radiotherapy-equipment-procurement/ 2021-03-31T20:32:05+00:00 https://ascopost.com/news/march-2021/idecabtagene-vicleucel-for-heavily-pretreated-patients-with-relapsed-or-refractory-multiple-myeloma/ 2021-03-31T20:32:05+00:00 https://ascopost.com/news/march-2021/study-finds-cancer-survivors-with-poor-ambulatory-function-may-be-at-an-increased-risk-of-death/ 2021-03-31T20:32:05+00:00 https://ascopost.com/news/march-2021/adherence-to-adjuvant-hormonal-therapy-among-commercially-insured-women-with-breast-cancer/ 2021-03-31T20:32:06+00:00 https://ascopost.com/news/march-2021/increase-in-diagnosis-of-node-positive-and-stage-iii-breast-cancer-after-screening-interruption-due-to-the-covid-19-pandemic/ 2021-03-31T20:32:06+00:00 https://ascopost.com/news/march-2021/role-of-collagen-in-pancreatic-cancer-development/ 2021-03-31T20:32:06+00:00 https://ascopost.com/news/march-2021/fda-pipeline-designations-in-ovarian-head-and-neck-and-thyroid-cancers/ 2026-01-29T16:46:15+00:00 https://ascopost.com/news/march-2021/effect-of-clinical-breast-examination-screening-on-stage-at-diagnosis-and-breast-cancer-mortality/ 2021-03-31T20:32:07+00:00 https://ascopost.com/news/march-2021/study-examines-response-to-neoadjuvant-chemotherapy-in-hispanic-and-black-patients/ 2021-03-31T20:32:07+00:00 https://ascopost.com/news/march-2021/long-term-follow-up-of-adjuvant-imatinib-for-localized-gastrointestinal-stromal-tumors/ 2021-03-31T20:32:07+00:00 https://ascopost.com/news/march-2021/mental-health-service-use-among-testicular-cancer-survivors/ 2021-03-31T20:32:07+00:00 https://ascopost.com/news/march-2021/study-identifies-mechanisms-tied-to-immunotherapy-resistance-among-patients-with-melanoma/ 2021-03-31T20:32:07+00:00 https://ascopost.com/news/march-2021/un-human-rights-experts-comment-on-environmental-racism-in-louisiana-s-cancer-alley/ 2021-03-31T20:32:07+00:00 https://ascopost.com/news/march-2021/five-year-outcomes-with-tisagenlecleucel-in-patients-with-relapsed-or-refractory-b-cell-lymphomas/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/study-examines-extrapleural-pneumonectomy-after-imrt-for-malignant-pleural-mesothelioma/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/bipolar-androgen-therapy-vs-enzalutamide-in-asymptomatic-patients-with-metastatic-castration-resistant-prostate-cancer/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/study-finds-missing-annual-mammogram-increases-risk-of-death-from-breast-cancer/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/recent-study-examines-potential-new-therapies-assessment-of-biomarkers-in-endometrial-cancer/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/preclinical-research-shows-activity-of-fidaxomicin-combination-therapy-in-mll-aml/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/pembrolizumabs-indication-in-small-cell-lung-cancer-is-withdrawn/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/machine-learning-algorithm-is-successful-in-predicting-malignancy-in-patients-with-multiple-pulmonary-nodules/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/swog-1500-cabozantinib-crizotinib-or-savolitinib-vs-sunitinib-in-metastatic-papillary-renal-cell-carcinoma/ 2021-03-31T20:32:08+00:00 https://ascopost.com/news/march-2021/pyrotinibcapecitabine-vs-lapatinibcapecitabine-in-her2-positive-metastatic-breast-cancer-previously-treated-with-trastuzumab/ 2021-03-31T20:32:09+00:00 https://ascopost.com/news/march-2021/first-line-cemiplimab-rwlc-vs-platinum-doublet-chemotherapy-in-advanced-nsclc-with-pd-l1-expression-50/ 2021-03-31T20:32:09+00:00 https://ascopost.com/news/march-2021/enfortumab-vedotin-ejfv-in-previously-treated-advanced-urothelial-carcinoma/ 2021-03-31T20:32:09+00:00 https://ascopost.com/news/march-2021/fda-issues-emergency-use-authorization-for-third-covid-19-vaccine/ 2021-03-31T20:32:09+00:00 https://ascopost.com/news/february-2021/ 2021-07-01T15:10:58+00:00 https://ascopost.com/news/february-2021/keynote-427-first-line-pembrolizumab-in-advanced-non-clear-cell-renal-cell-carcinoma/ 2021-02-26T21:12:52+00:00 https://ascopost.com/news/february-2021/endoscopic-nasopharyngectomy-vs-imrt-for-previously-treated-resectable-locally-recurrent-nasopharyngeal-carcinoma/ 2026-01-29T16:48:33+00:00 https://ascopost.com/news/february-2021/lupsma-leads-to-improved-psa-response-fewer-severe-adverse-events-than-cabazitaxel-in-patients-with-metastatic-prostate-cancer/ 2021-03-09T20:29:37+00:00 https://ascopost.com/news/february-2021/new-report-reviews-methods-for-reducing-waste-improving-efficiency-with-expensive-injectable-medications/ 2021-02-26T21:12:52+00:00 https://ascopost.com/news/february-2021/addition-of-lenalidomide-to-r-chop-in-newly-diagnosed-patients-with-dlbcl/ 2021-03-17T18:27:29+00:00 https://ascopost.com/news/february-2021/bone-metastatic-burden-and-survival-outcomes-with-prostate-radiotherapy-for-newly-diagnosed-metastatic-disease/ 2021-03-09T20:36:52+00:00 https://ascopost.com/news/february-2021/one-third-of-cancer-survivors-reported-worry-about-health-care-disruptions-early-in-the-covid-19-pandemic/ 2021-02-26T21:12:53+00:00 https://ascopost.com/news/february-2021/responses-to-anti-pd-1pd-l1-immunotherapy-in-patients-with-mss-solid-tumors-and-high-tumor-mutational-burden/ 2021-02-26T21:12:53+00:00 https://ascopost.com/news/february-2021/united-states-surpasses-500-000-deaths-due-to-covid-19/ 2021-02-26T21:12:53+00:00 https://ascopost.com/news/february-2021/bevacizumab-beyond-disease-progression-plus-carboplatin-based-doublet-in-platinum-sensitive-ovarian-cancer/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/trends-in-germline-genetic-testing-in-women-diagnosed-with-breast-or-ovarian-cancer/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/addition-of-andecaliximab-to-mfolfox6-in-first-line-treatment-of-her2-negative-advanced-gastric-cancer/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/can-weight-loss-during-treatment-and-follow-up-affect-breast-cancer-outcomes/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/chemotherapy-induced-dormancy-in-aml-allows-cancer-cell-survival-may-contribute-to-relapse/ 2021-04-19T17:13:31+00:00 https://ascopost.com/news/february-2021/pet-guided-omission-of-consolidation-radiotherapy-in-early-stage-unfavorable-hodgkin-lymphoma/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/addition-of-second-line-pegilodecakin-to-folfox-in-metastatic-pancreatic-cancer-sequoia-trial/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/neostar-neoadjuvant-nivolumab-or-nivolumabipilimumab-in-operable-nsclc/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/new-recommendations-aim-to-eliminate-racial-disparities-in-multiple-myeloma-therapies-and-trials/ 2021-02-26T21:12:54+00:00 https://ascopost.com/news/february-2021/telephone-supported-depression-self-care-intervention-for-cancer-survivors/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/addition-of-adjuvant-pertuzumab-to-chemotherapy-plus-trastuzumab-in-early-her2-positive-breast-cancer/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/joint-ascoacs-can-letter-states-must-include-patients-with-cancer-on-their-covid-19-vaccine-priority-lists/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/effect-of-organ-function-based-eligibility-criteria-on-clinical-trial-enrollment-for-patients-with-dlbcl/ 2021-03-17T18:29:05+00:00 https://ascopost.com/news/february-2021/comparison-of-imaging-regimens-for-stage-i-seminoma-after-orchiectomy/ 2021-03-09T20:33:02+00:00 https://ascopost.com/news/february-2021/prevalence-of-cisplatin-related-hearing-loss-in-pediatric-adolescent-and-young-adult-patients/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/fda-pipeline-priority-reviews-in-kras-g12c-mutated-nsclc-non-muscle-invasive-bladder-cancer/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/lupsma-vs-cabazitaxel-for-metastatic-castration-resistant-prostate-cancer/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/keynote-427-first-line-pembrolizumab-in-advanced-clear-cell-renal-cell-carcinoma/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/addition-of-primary-tumor-resection-to-chemotherapy-for-asymptomatic-primary-colorectal-cancer-tumors-and-synchronous-unresectable-metastases/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/have-breast-cancer-mortality-rates-stopped-declining-for-younger-women/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/new-report-says-cancer-and-its-therapies-may-impair-survivors-ability-to-work/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/addition-of-ipilimumab-to-pembrolizumab-in-previously-untreated-patients-with-metastatic-nsclc-and-high-pd-l1-expression/ 2021-02-26T21:12:55+00:00 https://ascopost.com/news/february-2021/lenvatinib-combination-regimens-vs-sunitinib-in-renal-cell-carcinoma-phase-iii-clear-trial/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/dose-intensified-radiotherapy-not-superior-to-conventional-regimen-for-biochemically-recurrent-prostate-cancer-after-radical-prostatectomy/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/elacestrant-for-heavily-pretreated-patients-with-er-positive-her2-negative-metastatic-breast-cancer/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/optimal-radiotherapy-dose-for-follicular-and-marginal-zone-lymphoma/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/genetic-mutations-linked-to-worse-b-cell-all-outcomes-in-pediatric-hispanic-and-latino-patients/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/fecal-microbiota-transplants-may-help-patients-with-advanced-melanoma-respond-to-immunotherapy/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/update-from-acis-trial-of-apalutamide-plus-abirateroneprednisone-in-metastatic-prostate-cancer/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/enfortumab-vedotin-ejfv-prolongs-survival-in-patients-with-metastatic-urothelial-carcinoma/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/implications-of-delaying-surgery-for-renal-cell-carcinoma-during-the-covid-19-pandemic/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/ash-2021-guidelines-for-prevention-and-treatment-of-venous-thromboembolism-in-patients-with-cancer/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/achievement-and-maintenance-of-mrd-negativity-with-daratumumab-containing-regimens-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/fda-pipeline-breakthrough-designations-in-cml-and-for-cachexia-eua-for-covid-19/ 2021-02-26T21:12:56+00:00 https://ascopost.com/news/february-2021/nivolumab-plus-cabozantinib-shows-sustained-benefits-as-first-line-treatment-for-advanced-rcc/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/nivolumabipilimumab-vs-chemotherapy-as-first-line-treatment-for-unresectable-malignant-pleural-mesothelioma-checkmate-743-trial/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/sitagliptin-added-to-tacrolimussirolimus-prophylaxis-regimen-for-acute-graft-vs-host-disease-after-hsct/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/jak-inhibitor-yields-long-term-survival-benefit-and-transfusion-independence-in-myelofibrosis/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/epov-lucia-masarova/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/study-links-exposure-to-nighttime-artificial-lights-with-possible-elevated-risk-of-thyroid-cancer/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/checkmate-274-adjuvant-nivolumab-may-improve-disease-free-survival-in-patients-with-muscle-invasive-urothelial-carcinoma/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/increase-in-metastatic-prostate-cancer-diagnoses-in-the-united-states-after-reduction-in-psa-screening/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/reduced-dose-intensity-modulated-radiation-therapy-for-hpv-associated-oropharyngeal-carcinoma/ 2026-01-29T16:53:28+00:00 https://ascopost.com/news/february-2021/mapkerk-inhibitor-mirdametinib-in-adolescents-and-adult-patients-with-nf1-related-plexiform-neurofibromas/ 2021-03-11T18:20:27+00:00 https://ascopost.com/news/february-2021/hero-together-opportunity-for-health-care-workers-to-share-their-experience-with-covid-19-vaccination/ 2021-02-26T21:12:57+00:00 https://ascopost.com/news/february-2021/five-year-outcomes-from-the-checkmate-017-and-057-trials-of-nivolumab-vs-docetaxel-in-previously-treated-patients-with-nsclc/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/mental-health-related-symptoms-among-cancer-survivors-during-the-first-wave-of-the-covid-19-pandemic-in-the-us/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/delay-in-time-between-abnormal-at-home-screening-and-colonoscopy-may-increase-colorectal-cancer-risk/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/role-of-twitter-in-identifying-barriers-to-care-among-patients-with-metastatic-breast-cancer/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/patients-on-active-chemotherapy-may-not-be-at-increased-risk-for-covid-19-infection/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/patients-with-lymphoma-receiving-b-cell-depleting-therapies-may-be-at-greater-risk-for-persistent-covid-19-infection/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/socially-distant-drive-by-flufit-clinics-may-increase-colorectal-cancer-screening-rates-among-black-patients-during-the-covid-19-pandemic/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/fda-update-advisory-committee-meeting-to-discuss-covid-19-vaccine-candidate-statement-on-product-development-to-address-virus-variants/ 2021-02-26T21:12:58+00:00 https://ascopost.com/news/february-2021/hic-assays-may-aid-in-predicting-response-to-immunotherapy-among-patients-with-nsclc/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/study-shows-aspirin-use-before-diagnosis-may-lower-colorectal-cancer-mortality/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/impact-of-covid-19-on-cancer-care-has-been-profound-according-to-who/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/long-term-quality-of-life-with-ultrahypofractionated-vs-conventionally-fractionated-radiotherapy-for-prostate-cancer/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/patient-reported-outcomes-from-the-crown-trial-first-line-lorlatinib-vs-crizotinib-for-alk-positive-nsclc/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/germline-whole-exome-sequencing-reveals-the-potential-role-of-hereditary-predisposition-and-therapeutic-implications-in-sclc/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/study-finds-more-than-half-of-us-cancer-survivors-have-underlying-medical-conditions-associated-with-severe-covid-19-illness/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/margetuximab-vs-trastuzumab-in-heavily-pretreated-patients-with-her2-positive-breast-cancer-sophia-trial/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/protein-truncating-and-rare-missense-variants-in-breast-cancer-risk-genes/ 2021-02-26T21:12:59+00:00 https://ascopost.com/news/february-2021/two-adaura-analyses-support-the-use-of-osimertinib-in-patients-with-surgically-resected-nsclc/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/taiwanese-talent-study-supports-effectiveness-of-low-dose-ct-for-lung-cancer-in-certain-populations/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/new-burkitt-lymphoma-international-prognostic-index/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/asco-names-advance-of-the-year-molecular-profiling-drives-progress-in-gastrointestinal-cancers/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/lcmc3-trial-neoadjuvant-atezolizumab-for-patients-with-stage-ib-to-iiib-resectable-lung-cancer/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/nivolumab-monotherapy-improves-survival-in-patients-with-relapsed-malignant-mesothelioma/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/emil-j-freireich-md-dies-at-93/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/lenalidomide-plus-subcutaneous-rituximab-minichop-in-patients-aged-80-or-older-with-dlbcl/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/adolescent-and-young-adult-cancer-survivors-are-at-increased-risk-for-adverse-mental-health-outcomes/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/wclc-press-briefing-focuses-on-the-connection-between-lung-cancer-and-covid-19/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/phase-ii-codebreak-100-validates-early-benefit-for-kras-inhibitor-in-nsclc/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/ipilimumab-adds-no-benefit-to-pembrolizumab-as-first-line-therapy-for-nsclc-with-high-pd-l1-expression/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/featured-presentations-at-wclc-focus-on-disparities-in-patients-with-lung-cancer/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/outcomes-and-patterns-of-relapse-in-pediatric-medulloblastoma/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/first-in-class-eprenetapopt-plus-azacitidine-for-tp53-mutant-myelodysplastic-syndromes/ 2021-02-26T21:13:00+00:00 https://ascopost.com/news/february-2021/familiarity-with-complementary-and-integrative-therapies-among-patients-with-cancer-and-caregivers/ 2021-02-26T21:13:01+00:00 https://ascopost.com/news/january-2021/ 2021-07-01T15:10:59+00:00 https://ascopost.com/news/january-2021/addition-of-intraprostatic-focal-boost-to-external-beam-radiotherapy-in-localized-prostate-cancer/ 2021-01-29T21:08:23+00:00 https://ascopost.com/news/january-2021/variation-in-postoperative-mortality-and-complications-after-cancer-surgery-between-high-vs-low-and-middle-income-countries/ 2021-01-29T21:08:23+00:00 https://ascopost.com/news/january-2021/addition-of-abatacept-to-acute-graft-vs-host-disease-prophylaxis/ 2021-01-29T21:08:23+00:00 https://ascopost.com/news/january-2021/state-of-tobacco-control-2021-report-says-ending-tobacco-use-is-critical-especially-during-the-covid-19-pandemic/ 2021-01-29T21:08:23+00:00 https://ascopost.com/news/january-2021/checkmate-9la-trial-first-line-nivolumabipilimumab-plus-chemotherapy-vs-chemotherapy-alone-in-stage-iv-or-recurrent-nsclc/ 2021-01-29T21:08:24+00:00 https://ascopost.com/news/january-2021/new-surveillance-mammography-screening-guidelines-issued-for-breast-cancer-survivors-aged-75-and-older/ 2021-02-04T19:42:26+00:00 https://ascopost.com/news/january-2021/adjuvant-doublet-chemotherapy-for-high-risk-stage-ii-colorectal-cancer-3-or-6-month-duration/ 2021-01-29T21:08:24+00:00 https://ascopost.com/news/january-2021/new-clinical-calculator-may-predict-recurrence-risk-after-curative-colectomy-for-colon-cancer/ 2021-01-29T21:08:25+00:00 https://ascopost.com/news/january-2021/world-cancer-day-2021-to-focus-on-adaptations-and-innovations-in-cancer-care-through-covid-19-and-beyond/ 2021-01-29T21:08:25+00:00 https://ascopost.com/news/january-2021/shorter-radiation-course-for-men-with-advanced-prostate-cancer/ 2021-01-29T21:08:25+00:00 https://ascopost.com/news/january-2021/addition-of-vemurafenib-to-irinotecancetuximab-in-previously-treated-patients-with-braf-v600e-mutant-metastatic-colorectal-cancer/ 2021-01-29T21:08:25+00:00 https://ascopost.com/news/january-2021/early-integration-of-nutritional-and-psychological-interventions-for-previously-untreated-patients-with-metastatic-esophagogastric-cancer/ 2021-01-29T21:08:25+00:00 https://ascopost.com/news/january-2021/estimated-global-demand-for-cancer-surgery-and-its-associated-workforce-over-the-next-2-decades/ 2021-01-29T21:08:26+00:00 https://ascopost.com/news/january-2021/single-institution-study-examines-safety-of-routine-thoracic-surgery-examinations-during-the-covid-19-pandemic/ 2021-01-29T21:08:26+00:00 https://ascopost.com/news/january-2021/fda-pipeline-priority-reviews-for-immunotherapies-in-gastric-cancers-anal-cancer/ 2021-01-29T21:08:26+00:00 https://ascopost.com/news/january-2021/prevalence-of-and-risk-associated-with-breast-cancer-predisposition-genes/ 2021-01-29T21:08:26+00:00 https://ascopost.com/news/january-2021/preemptive-tocilizumab-for-cytokine-release-syndrome-in-pediatric-patients-with-b-cell-all-receiving-car-t-cell-therapy/ 2021-02-16T19:10:48+00:00 https://ascopost.com/news/january-2021/emergency-department-use-and-unplanned-hospitalization-among-patients-with-head-and-neck-cancer/ 2026-01-29T16:54:40+00:00 https://ascopost.com/news/january-2021/study-identifies-four-unique-subtypes-of-small-cell-lung-cancer/ 2021-01-29T21:08:26+00:00 https://ascopost.com/news/january-2021/patients-in-cancer-remission-also-at-higher-risk-for-severe-covid-19-illness/ 2021-01-29T21:08:27+00:00 https://ascopost.com/news/january-2021/small-study-finds-personalized-neoantigen-vaccines-may-result-in-durable-immune-response-for-patients-with-melanoma/ 2021-01-29T21:08:27+00:00 https://ascopost.com/news/january-2021/impower133-update-atezolizumab-plus-carboplatinetoposide-for-extensive-stage-small-cell-lung-cancer/ 2021-01-29T21:08:27+00:00 https://ascopost.com/news/january-2021/risk-of-atrial-fibrillation-and-associated-outcomes-after-allogeneic-hematopoietic-stem-cell-transplantation/ 2021-01-29T21:08:27+00:00 https://ascopost.com/news/january-2021/nccn-shares-new-recommendations-for-vaccinating-patients-with-cancer-against-covid-19/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/first-line-nivolumabipilimumab-in-metastatic-uveal-melanoma/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/new-study-finds-suspicious-lesions-on-breast-mri-in-neoadjuvant-setting-are-unlikely-to-be-malignant/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/novel-risk-tool-for-predicting-severe-toxicity-in-older-patients-receiving-chemotherapy-for-early-stage-breast-cancer/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/lenalidomide-plus-epoetin-alfa-vs-lenalidomide-alone-in-refractory-non-del-5q-mds/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/risk-categories-for-pediatric-patients-with-medulloblastoma/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/janet-woodcock-md-named-acting-fda-commissioner/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/new-report-shows-alcohol-consumption-is-linked-to-cancer-incidence-and-mortality-in-all-50-states/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/are-some-oral-pathogens-more-common-in-patients-with-esophageal-cancer/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/dense-breast-notification-legislation-recorded-effects-and-future-recommendations/ 2021-02-01T21:00:28+00:00 https://ascopost.com/news/january-2021/prevalence-of-kras-g12c-somatic-mutations-by-cancer-type-race-and-sex/ 2021-01-29T21:08:28+00:00 https://ascopost.com/news/january-2021/reduced-frequency-of-vincristinedexamethasone-pulses-in-maintenance-therapy-for-pediatric-patients-with-average-risk-b-cell-all/ 2021-02-16T19:12:59+00:00 https://ascopost.com/news/january-2021/cancer-related-suicide-has-declined-in-the-united-states-over-the-past-2-decades/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/single-institution-study-finds-decrease-in-cancer-screenings-diagnoses-during-the-first-wave-of-the-covid-19-pandemic/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/bemarituzumab-plus-chemotherapy-improves-outcomes-in-advanced-gastricgastroesophageal-junction-cancer/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/anti-pd-1-therapy-dostarlimab-for-dmmr-gastrointestinal-cancers/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/addition-of-sitagliptin-to-tacrolimussirolimus-prophylaxis-for-acute-graft-vs-host-disease/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/electronic-patient-self-reporting-of-adverse-events-during-cancer-chemotherapy-erapid-system/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/does-cabozantinib-reduce-tumor-volume-and-pain-in-patients-with-nf1/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/performing-mammograms-for-targeted-hospitalized-patients/ 2021-02-01T21:04:03+00:00 https://ascopost.com/news/january-2021/idh-inhibitor-ivosidenib-improves-overall-survival-in-previously-treated-patients-with-cholangiocarcinoma/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/postsurgical-disease-recurrence-in-stage-i-iii-colorectal-cancer-may-be-predicted-by-ctdna/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/length-of-hospital-stay-with-laparoscopic-vs-open-gastrectomy-for-gastric-cancer/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/patients-with-recurrent-glioblastoma-and-a-very-low-mutation-burden-may-respond-best-to-immunotherapy/ 2021-01-29T21:08:29+00:00 https://ascopost.com/news/january-2021/italian-study-of-electronic-medical-record-assisted-telephone-follow-up-of-breast-cancer-survivors-during-the-covid-19-pandemic/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/study-finds-artificial-intelligence-may-help-to-identify-new-risk-factors-for-early-onset-colorectal-cancer/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/fda-pipeline-two-fast-track-designations-for-cavrotolimod-in-nonmelanoma-skin-cancers/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/adding-oxaliplatin-to-fluoropyrimidine-for-patients-with-stage-iii-colon-cancer-and-microsatellite-instability/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/palbociclib-plus-endocrine-therapy-vs-capecitabine-for-patients-with-hr-positive-her2-negative-breast-cancer/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/rates-of-eligible-people-missing-timely-cancer-screenings-a-canadian-analysis/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/capivasertib-for-akt1-e17k-mutated-metastatic-cancers-nci-match-subprotocol-eay131-y/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/stereotactic-ablative-body-radiotherapy-in-extracranial-oligometastatic-cancers/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/new-study-examines-patterns-of-opioid-use-among-patients-with-metastatic-breast-cancer/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/maintenance-oral-azacitidine-for-patients-with-aml-in-first-remission/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/intensified-reduced-intensity-conditioning-for-allogeneic-stem-cell-transplantation-in-aml-or-mds/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/association-between-toxoplasma-gondii-infection-and-risk-of-glioma/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/new-study-investigates-role-of-ultraviolet-radiation-in-conjunctival-melanoma/ 2021-01-29T21:08:30+00:00 https://ascopost.com/news/january-2021/transmission-of-maternal-cancer-in-two-infants-from-mothers-with-cervical-cancer-during-delivery/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/effect-of-covid-19-infection-on-cancer-management/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/analysis-of-cardiac-data-among-patients-treated-with-osimertinib/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/fda-issues-alert-regarding-sars-cov-2-viral-mutation-to-health-care-providers-and-clinical-laboratory-staff/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/comprehensive-multiomic-resource-for-hpv-negative-head-and-neck-cancers/ 2026-01-29T16:56:28+00:00 https://ascopost.com/news/january-2021/can-use-of-opioids-contribute-to-pancreatic-cancer-risk/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/three-vs-four-courses-of-chemotherapy-in-younger-patients-with-acute-myeloid-leukemia/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/total-neoadjuvant-therapy-vs-standard-therapy-for-locally-advanced-rectal-cancer/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/invasive-diagnostic-procedure-complication-rates-after-lung-cancer-screening/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/immune-response-to-covid-19-reduced-in-patients-with-hematologic-malignancies-vs-solid-tumors/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/does-following-a-mediterranean-diet-reduce-the-risk-of-disease-progression-in-men-on-active-surveillance-for-prostate-cancer/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/fda-pipeline-two-reviews-in-nsclc-plus-prescribing-information-update-for-darolutamide/ 2021-01-29T21:08:31+00:00 https://ascopost.com/news/january-2021/total-body-irradiationetoposide-vs-chemotherapy-conditioning-before-stem-cell-transplant-for-pediatric-patients-with-all/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/does-anticancer-therapy-impact-unplanned-hospital-care-in-patients-with-nsclc/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/distinct-t-cell-signature-in-black-patients-with-breast-cancer-may-contribute-to-more-aggressive-disease/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/facebook-posts-and-the-spread-of-incorrect-information-about-perceived-risks-of-hpv-vaccination/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/addition-of-gemcitabine-to-pazopanib-for-refractory-soft-tissue-sarcoma/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/outcomes-after-neoadjuvant-carboplatinpaclitaxel-in-women-with-ovarian-cancer-and-planned-delayed-surgery/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/adjuvant-gefitinib-vs-vinorelbinecisplatin-in-stage-ii-iiia-egfr-mutant-nsclc/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/study-finds-inflammation-due-to-androgen-deprivation-therapy-may-contribute-to-fatigue-other-side-effects-in-men-with-prostate-cancer/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/new-study-explores-the-use-of-focused-ultradeep-dna-sequencing-to-quantify-skin-cancer-risk/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/use-of-a-novel-car-t-cell-therapy-in-pediatric-and-adult-patients-with-advanced-b-cell-all/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/fda-statement-on-following-the-authorized-dosing-schedules-for-covid-19-vaccines/ 2021-01-29T21:08:32+00:00 https://ascopost.com/news/january-2021/feasibility-study-of-radical-cystectomy-vs-intravesical-bcg-for-high-grade-non-muscle-invasive-bladder-cancer/ 2021-02-09T23:15:05+00:00 https://ascopost.com/news/january-2021/sars-cov-2-infection-among-patients-in-italy-undergoing-active-cancer-treatment/ 2021-01-29T21:08:33+00:00 https://ascopost.com/news/january-2021/study-focuses-on-single-cell-analysis-of-peritoneal-carcinomatosis/ 2021-01-29T21:08:33+00:00 https://ascopost.com/news/january-2021/multiancestry-meta-analysis-of-prostate-cancer-genetics/ 2021-01-29T21:08:33+00:00 https://ascopost.com/news/january-2021/final-overall-survival-results-of-the-idea-collaboration-3-vs-6-months-of-adjuvant-chemotherapy-for-stage-iii-colon-cancer/ 2021-01-29T21:08:33+00:00 https://ascopost.com/news/january-2021/integrated-palliative-and-oncology-care-for-patients-receiving-treatment-for-acute-myeloid-leukemia/ 2021-01-29T21:08:33+00:00 https://ascopost.com/news/january-2021/patient-reported-outcomes-with-triplet-therapy-for-newly-diagnosed-multiple-myeloma/ 2021-01-29T21:08:33+00:00 https://ascopost.com/news/january-2021/surgical-intervention-may-offer-survival-advantage-for-certain-patients-with-metastatic-breast-cancer/ 2021-01-29T21:08:34+00:00 https://ascopost.com/news/january-2021/do-adult-onset-cancer-survivors-have-a-higher-risk-of-developing-a-subsequent-malignancy/ 2021-01-29T21:08:34+00:00 https://ascopost.com/news/december-2020/ 2021-07-01T15:10:59+00:00 https://ascopost.com/news/december-2020/ganglioside-vaccine-plus-oral-therapy-for-patients-with-high-risk-neuroblastoma-and-prior-disease-progression/ 2020-12-23T20:10:24+00:00 https://ascopost.com/news/december-2020/left-anterior-descending-coronary-artery-radiation-exposure-cardiac-events-and-mortality-in-nsclc/ 2021-01-22T19:52:54+00:00 https://ascopost.com/news/december-2020/time-dependent-effects-of-oral-contraceptives-on-risk-of-ovarian-and-endometrial-cancers/ 2020-12-23T20:15:52+00:00 https://ascopost.com/news/december-2020/global-burden-of-cervical-cancer-and-association-with-hiv/ 2020-12-23T19:45:21+00:00 https://ascopost.com/news/december-2020/fda-approves-adjuvant-osimertinib-for-egfr-mutated-nsclc/ 2020-12-23T19:45:21+00:00 https://ascopost.com/news/december-2020/addition-of-first-line-pembrolizumab-to-chemotherapy-in-metastatic-triple-negative-breast-cancer/ 2020-12-23T19:45:21+00:00 https://ascopost.com/news/december-2020/fda-issues-emergency-use-authorization-for-second-covid-19-vaccine/ 2020-12-23T19:45:21+00:00 https://ascopost.com/news/december-2020/gemogenovatucel-t-maintenance-in-stage-iiiiv-ovarian-cancer/ 2020-12-23T19:45:21+00:00 https://ascopost.com/news/december-2020/globocan-2020-database-provides-latest-global-data-on-cancer-burden-cancer-deaths/ 2021-01-27T20:49:24+00:00 https://ascopost.com/news/december-2020/risk-of-covid-19-infection-in-patients-with-cancer-effect-of-time-of-diagnosis-and-race/ 2020-12-23T19:45:22+00:00 https://ascopost.com/news/december-2020/american-cancer-society-report-identifies-critical-gaps-and-research-opportunities-for-improved-cancer-care/ 2020-12-23T19:45:22+00:00 https://ascopost.com/news/december-2020/risk-for-osteonecrosis-of-the-jaw-after-treatment-with-zoledronic-acid-for-metastatic-bone-disease/ 2020-12-23T19:56:44+00:00 https://ascopost.com/news/december-2020/addition-of-capivasertib-to-docetaxelprednisolone-in-patients-with-metastatic-castration-resistant-prostate-cancer/ 2021-01-12T19:48:10+00:00 https://ascopost.com/news/december-2020/intensity-of-active-surveillance-in-patients-with-rectal-cancer-managed-with-a-watch-and-wait-approach/ 2020-12-23T19:56:44+00:00 https://ascopost.com/news/december-2020/effect-of-the-covid-19-pandemic-on-lung-cancer-screening/ 2020-12-23T19:56:44+00:00 https://ascopost.com/news/december-2020/radiotherapy-and-chemotherapy-before-total-mesorectal-excision-for-locally-advanced-rectal-cancer/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/study-finds-incidence-of-young-onset-esophageal-adenocarcinoma-is-rapidly-increasing/ 2021-01-08T20:09:45+00:00 https://ascopost.com/news/december-2020/association-of-out-of-pocket-costs-for-tyrosine-kinase-inhibitors-with-outcomes-in-patients-with-egfr-and-alk-positive-advanced-nsclc/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/first-line-anti-pd-1-therapy-vs-brafmek-inhibition-for-advanced-braf-v600-mutated-melanoma/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/addition-of-durvalumab-with-or-without-tremelimumab-to-chemotherapy-in-extensive-stage-sclc/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/pembrolizumab-in-combination-with-a-therapeutic-dna-vaccine-for-hpv-positive-advanced-cervical-cancer/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/does-melflufen-plus-dexamethasone-show-activity-in-heavily-pretreated-patients-with-relapsed-and-refractory-multiple-myeloma/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/sintilimab-vs-docetaxel-for-advanced-squamous-nsclc/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/addition-of-chemotherapy-to-local-therapy-in-women-aged-70-or-older-with-triple-negative-breast-cancer/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/spectrum-of-germline-somatic-interactions-in-advanced-urothelial-cancer/ 2021-01-12T19:47:08+00:00 https://ascopost.com/news/december-2020/changes-in-care-and-well-being-among-patients-with-cancer-during-initial-stage-of-the-covid-19-pandemic/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/tebentafusp-shows-activity-in-metastatic-uveal-melanoma/ 2020-12-23T19:56:45+00:00 https://ascopost.com/news/december-2020/oral-panobinostat-and-dexamethasone-plus-subcutaneous-bortezomib-for-patients-with-relapsed-or-refractory-multiple-myeloma/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/meta-analysis-of-radiotherapy-with-adjuvant-vs-neoadjuvant-androgen-deprivation-therapy-for-localized-prostate-cancer/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/adjuvant-atezoliumab-for-patients-with-muscle-invasive-urothelial-cancer-and-presence-of-postsurgical-ctdna/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/initiative-to-increase-referrals-of-patients-with-gastrointestinal-cancer-to-a-specialized-rehabilitation-program/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/trends-in-aya-cancer-incidence-in-the-united-states-over-4-decades/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/pembrolizumab-vs-chemotherapy-in-first-line-treatment-of-microsatellite-instability-high-advanced-colorectal-cancer/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/meta-analysis-of-toxicity-and-treatment-outcomes-with-stereotactic-ablative-radiotherapy-for-oligometastatic-cancer/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/does-pleural-effusion-affect-survival-in-patients-treated-with-immunotherapy-for-nsclc/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/ctdna-may-indicate-increased-risk-of-relapse-after-stem-cell-transplant-in-patients-with-dlbcl/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/postoperative-cancer-surgery-mortality-rates-have-improved-but-gap-still-exists-between-black-and-white-patients/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/ctc-enumeration-may-be-predictive-of-survival-during-treatment-for-metastatic-breast-cancer/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/new-prognostic-tool-to-determine-individual-risk-of-distant-recurrence-benefit-of-adjuvant-chemotherapy-in-early-breast-cancer/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/patient-reported-outcomes-from-the-phase-iii-impassion031-trial/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/rxponder-study-shows-postmenopausal-patients-with-node-positive-breast-cancer-may-be-able-to-avoid-chemotherapy/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/follow-up-data-from-monarche-show-continued-abemaciclib-benefit-in-high-risk-hr-positive-her2-negative-breast-cancer/ 2020-12-23T19:56:46+00:00 https://ascopost.com/news/december-2020/can-mindfulness-meditation-and-survivorship-education-help-to-reduce-depression-in-young-breast-cancer-survivors/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/phase-ii-zuma-12-study-investigates-axicabtagene-ciloleucel-for-high-risk-large-b-cell-lymphoma/ 2021-07-26T17:59:16+00:00 https://ascopost.com/news/december-2020/potential-impact-of-state-government-crisis-standards-of-care-guidelines-on-resource-allocation-for-patients-with-cancer/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/radiotherapy-omission-after-breast-conserving-surgery-for-older-patients-with-hr-positive-breast-cancer/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/meta-analysis-of-pregnancy-outcomes-in-breast-cancer-survivors/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/opioid-and-sedative-hypnotic-use-after-mastectomy-with-reconstructive-surgery/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/patients-with-breast-cancer-undergoing-radiotherapy-may-have-underrecognized-side-effects/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/how-did-the-covid-19-pandemic-affect-initiation-of-cancer-treatment-in-england/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/early-signs-of-risk-for-myeloproliferative-neoplasms-may-appear-in-childhood-or-in-utero/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/chemotherapy-plus-blinatumomab-for-philadelphia-chromosome-negative-b-cell-all/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/proportion-of-never-smokers-among-patients-with-lung-cancer-in-seven-us-states/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/circulating-tumor-dna-and-disease-free-survival-in-patients-with-breast-cancer/ 2020-12-23T19:56:47+00:00 https://ascopost.com/news/december-2020/zuma-5-trial-finds-axicabtagene-ciloleucel-shows-activity-in-patients-with-indolent-non-hodgkin-lymphoma/ 2021-01-14T02:52:40+00:00 https://ascopost.com/news/december-2020/multiple-myeloma-patient-similarity-network-identifies-prognostic-subgroups-with-distinct-genetic-and-clinical-features/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/role-of-venetoclax-in-high-risk-myeloid-malignancies/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/subcutaneous-teclistamab-for-relapsed-or-refractory-multiple-myeloma-studied-in-phase-i-trial/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/environmental-surface-testing-for-presence-of-sars-cov-2-in-inpatient-and-outpatient-hematologyoncology-settings/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/reduced-intensity-allogeneic-hematopoietic-stem-cell-transplant-may-improve-survival-in-older-patients-with-high-risk-mds/ 2021-01-14T02:53:32+00:00 https://ascopost.com/news/december-2020/novel-antibody-drug-conjugate-shows-activity-in-rare-aggressive-form-of-leukemia/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/clonal-hematopoiesis-in-donors-aged-40-and-older-may-be-linked-to-improved-survival-in-stem-cell-transplant-recipients/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/early-research-shows-cd58-may-be-a-biomarker-for-response-to-axicabtagene-ciloleucel-in-patients-with-large-b-cell-lymphoma/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/subcutaneous-daratumumab-plus-pomalidomidedexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2021-01-12T20:09:12+00:00 https://ascopost.com/news/december-2020/information-on-patients-with-covid-19-and-hematologic-malignancies-provided-by-ash-research-collaborative-data-hub/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/ruxolitinib-for-steroid-refractorysteroid-dependent-chronic-graft-vs-host-disease/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/sars-cov-2-multivirus-specific-t-cells-for-the-treatment-of-hospitalized-patients-with-covid-19/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/does-race-contribute-to-poor-outcomes-in-younger-black-patients-diagnosed-with-aml/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/study-examines-impact-of-neighborhood-socioeconomic-status-on-outcomes-in-minority-patients-with-aml/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/study-finds-prophylactic-tranexamic-acid-has-no-effect-on-bleeding-in-patients-with-hematologic-malignancies/ 2020-12-23T19:56:48+00:00 https://ascopost.com/news/december-2020/the-covid-19-pandemic-and-cancer-care-for-older-patients-in-the-united-states/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/analysis-of-adjuvant-therapies-for-early-stage-triple-negative-breast-cancer/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/association-of-fall-and-fracture-risk-with-androgen-receptor-inhibitor-therapy-for-prostate-cancer/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/native-american-ancestry-may-impact-somatic-alterations-among-latin-american-patients-with-lung-cancer/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/study-shows-regional-variation-in-genomic-testing-for-men-with-prostate-cancer/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/preoperative-radiotherapy-dose-reduction-in-patients-with-myxoid-liposarcoma/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/definitive-sbrt-and-outcomes-in-adult-patients-with-extracranial-oligometastasis/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/end-of-life-care-among-commercially-insured-women-younger-than-65-with-metastatic-breast-cancer/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/social-needs-may-be-linked-to-low-health-related-quality-of-life-among-black-cancer-survivors/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/fda-pipeline-agents-in-dlbcl-sclc-aml-and-more/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/avelumab-maintenance-vs-continued-chemotherapy-after-first-line-induction-for-advanced-gastric-cancer/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/fda-announces-advisory-committee-meeting-to-discuss-second-covid-19-vaccine-candidate/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/positive-brca-test-result-trends-among-women-aged-65-and-older-in-the-united-states/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/discordance-among-risk-models-for-smoldering-multiple-myeloma/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/december-2020/does-concurrent-treatment-with-dexamethasone-diminish-the-efficacy-of-immune-checkpoint-inhibitors-in-patients-with-glioblastoma/ 2020-12-23T19:56:49+00:00 https://ascopost.com/news/november-2020/ 2021-07-01T15:10:59+00:00 https://ascopost.com/news/november-2020/no-reduction-in-recurrence-risk-with-perioperative-aromatase-inhibitor-therapy-in-postmenopausal-patients-with-hr-positive-breast-cancer/ 2020-12-09T19:54:09+00:00 https://ascopost.com/news/november-2020/machine-learning-algorithms-may-help-predict-response-to-immunotherapy-in-patients-with-advanced-melanoma/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/performance-of-immunoscore-in-asian-patients-with-early-stage-colon-cancer/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/once-weekly-selinexor-plus-bortezomibdexamethasone-vs-twice-weekly-bortezomibdexamethasone-in-previously-treated-patients-with-multiple-myeloma/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/adoption-of-hypofractionated-radiation-therapy-after-change-in-prostate-cancer-clinical-pathway/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/analysis-seeks-to-identify-characteristics-of-exceptional-responders-to-cancer-therapy/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/first-line-lorlatinib-vs-crizotinib-in-advanced-alk-positive-nsclc/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/pembrolizumab-plus-bevacizumab-and-oral-metronomic-cyclophosphamide-for-recurrent-ovarian-cancer/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/fda-announces-advisory-committee-meeting-to-discuss-covid-19-vaccine-candidate/ 2020-11-30T21:16:51+00:00 https://ascopost.com/news/november-2020/asco-announces-julie-r-gralow-md-facp-fasco-as-new-chief-medical-officer/ 2020-12-10T21:40:29+00:00 https://ascopost.com/news/november-2020/effect-of-anterior-approach-vs-conventional-hepatectomy-in-resection-of-colorectal-liver-metastases-on-intraoperative-tumor-cell-dissemination/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/futibatinib-for-patients-with-refractory-intrahepatic-cholangiocarcinoma-and-fgfr2-fusionsrearrangements/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/novel-pd-l1-antibody-shows-activity-in-advanced-msi-hdmmr-tumors/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/emergency-use-authorization-request-to-be-submitted-to-fda-today-for-covid-19-vaccine/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/self-reported-financial-distress-among-older-adults-with-cancer-prior-to-initiating-therapy/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/association-of-fdg-uptake-according-to-deauville-criteria-with-survival-outcomes-in-newly-diagnosed-multiple-myeloma/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/does-supplementation-with-vitamin-d-reduce-the-risk-of-developing-advanced-cancer/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/study-finds-medicaid-expansion-in-louisiana-increased-early-stage-breast-cancer-diagnosis-and-access-to-treatment/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/effects-of-stopping-tyrosine-kinase-inhibitor-treatment-for-chronic-myeloid-leukemia-on-molecular-response-and-patient-reported-outcomes/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/study-finds-the-lung-microbiome-may-affect-tumor-progression-and-prognosis-in-patients-with-lung-cancer/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/screening-younger-women-for-variants-linked-to-breast-and-ovarian-cancers-may-be-cost-effective/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/state-of-lung-cancer-report-finds-people-of-color-face-greater-burden-worse-lung-cancer-outcomes-in-the-united-states/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/paclitaxel-plus-trastuzumab-with-or-without-lapatinib-in-her2-positive-breast-cancer-long-term-follow-up-and-genomic-analysis/ 2020-11-30T21:16:52+00:00 https://ascopost.com/news/november-2020/addition-of-irinotecan-to-neoadjuvant-capecitabine-chemoradiation-guided-by-ugt1a1-genotype-in-locally-advanced-rectal-cancer/ 2020-12-14T14:38:14+00:00 https://ascopost.com/news/november-2020/cancer-deaths-linked-to-4-million-potential-years-of-life-lost-in-2017/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/fda-pipeline-fast-track-designations-in-liver-and-pancreatic-cancers/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/addition-of-venetoclax-to-bortezomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/ivosidenib-plus-azacitidine-in-newly-diagnosed-idh1-mutant-acute-myeloid-leukemia/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/survey-finds-patients-with-cancer-may-be-less-likely-to-enroll-in-clinical-trials-during-the-covid-19-pandemic/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/fda-grants-accelerated-approval-to-pembrolizumab-for-locally-recurrent-unresectable-or-metastatic-triple-negative-breast-cancer/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/surgical-technical-skill-and-long-term-survival-after-surgery-for-colon-cancer/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/adjuvant-irinotecancisplatin-vs-etoposidecisplatin-for-resected-high-grade-neuroendocrine-carcinoma-of-the-lung/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/meta-analysis-of-outcomes-with-gamma-knife-radiosurgery-for-uveal-melanoma-or-ocular-metastases/ 2020-12-17T19:57:50+00:00 https://ascopost.com/news/november-2020/is-maintenance-treatment-with-olaparib-for-brca-mutated-pancreatic-cancer-cost-effective/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/serial-covid-19-screening-in-asymptomatic-patients-receiving-treatment-for-cancer/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/comanagement-of-induction-therapy-for-acute-promyelocytic-leukemia-by-experts-and-community-practices/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/addition-of-indoximod-to-taxane-chemotherapy-in-first-line-treatment-of-her2-negative-metastatic-breast-cancer/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/state-level-lung-cancer-screening-rates-not-aligned-with-lung-cancer-burden-in-the-united-states/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/reduced-breast-cancer-mortality-and-risk-of-recurrence-with-internal-mammary-and-medial-supraclavicular-nodal-irradiation-in-stage-i-to-iii-breast-cancer/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/rhg-csf-and-decitabine-to-reduce-risk-of-relapse-in-patients-with-aml-after-stem-cell-transplant/ 2020-11-30T21:16:53+00:00 https://ascopost.com/news/november-2020/risk-of-metachronous-contralateral-testicular-cancer-according-to-platinum-based-chemotherapy-exposure/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/medicaid-expansion-associated-with-decreased-mortality-in-patients-with-newly-diagnosed-breast-colorectal-and-lung-cancers/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/nivolumab-plus-ipilimumab-for-metastatic-uveal-melanoma/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/fda-expands-approval-of-companion-diagnostic-for-olaparib-in-prostate-cancer/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/bispecific-anti-cd20anti-cd19-car-t-cells-for-patients-with-relapsed-b-cell-malignancies/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/effect-of-ash-choosing-wisely-recommendations-on-frequency-of-surveillance-imaging-in-patients-with-dlbcl/ 2020-12-05T18:37:48+00:00 https://ascopost.com/news/november-2020/uk-based-study-finds-evidence-of-covid-19-infection-antibody-presence-in-oncology-health-care-staff/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/impact-of-covid-19-on-well-being-in-the-oncology-workforce/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/olaparib-for-patients-with-metastatic-breast-cancer-and-mutations-in-homologous-recombination-related-genes/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/effect-of-a-pay-for-performance-program-on-prescriptions-and-spending-for-oncology-drugs/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/first-line-pembrolizumabaxitinib-vs-sunitinib-in-advanced-renal-cell-carcinoma/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/potential-factors-in-prognostic-discrepancies-among-tests-for-recurrence-risk-in-patients-with-breast-cancer-receiving-endocrine-therapy/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/predicting-mortality-outcomes-after-intensive-chemotherapy-for-aml/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/study-identifies-genetic-variants-linked-to-bevacizumab-induced-adverse-events/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/fda-pipeline-priority-reviews-in-nsclc-gastric-cancer/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/multisystem-immune-related-adverse-events-and-disease-outcomes-among-patients-with-nsclc-treated-with-immunotherapy/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/outcomes-with-second-line-therapy-after-relapse-in-patients-with-early-stage-favorable-classical-hodgkin-lymphoma/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/response-based-management-of-nivolumab-and-ipilimumab-therapy-in-metastatic-renal-cell-carcinoma/ 2020-11-30T21:16:54+00:00 https://ascopost.com/news/november-2020/intermittent-dosing-schedules-of-rafmek-inhibitor-in-rasraf-mutant-solid-tumors-and-multiple-myeloma/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/study-finds-universal-genetic-testing-uncovers-more-inherited-mutations-vs-guideline-based-genetic-testing/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/systemic-therapy-in-the-first-and-second-line-treatment-of-advanced-hcc/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/first-in-human-study-of-lsd1-inhibitor-iadademstat-for-patients-with-relapsed-or-refractory-aml/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/study-finds-distinct-genomic-alterations-may-contribute-to-more-aggressive-prostate-cancer-in-black-men/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/is-a-high-dose-intermittent-sunitinib-regimen-for-advanced-solid-tumors-linked-to-improved-survival/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/are-neighborhood-poverty-public-insurance-linked-to-poorer-outcomes-in-children-with-cancer-undergoing-stem-cell-transplant/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/imetelstat-in-lower-risk-mds-with-high-transfusion-dependence/ 2021-01-14T03:04:17+00:00 https://ascopost.com/news/november-2020/development-of-a-clinical-prognostic-stage-group-system-for-nonmetastatic-prostate-cancer/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/prediagnosis-and-postdiagnosis-physical-activity-and-survival-in-endometrial-cancer/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/should-patients-with-a-complete-response-to-neoadjuvant-chemoradiation-for-rectal-cancer-also-undergo-surgery/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/november-2020/breast-cancer-risk-and-disease-causing-genetic-mutations-in-women-older-than-65/ 2020-11-30T21:16:55+00:00 https://ascopost.com/news/october-2020/ 2021-07-01T15:11:00+00:00 https://ascopost.com/news/october-2020/first-line-dasatinib-plus-blinatumomab-for-adult-patients-with-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/time-at-home-vs-in-health-care-institutions-for-older-patients-after-cancer-surgery/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/effect-of-early-trastuzumab-interruption-on-recurrence-free-survival-in-her2-positive-breast-cancer/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/gemcitabine-and-daily-radiation-for-patients-with-muscle-invasive-bladder-cancer/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/effect-of-angiotensin-ii-inhibition-on-response-to-immunotherapy/ 2020-10-30T19:09:03+00:00 https://ascopost.com/news/october-2020/study-finds-further-efforts-needed-for-inclusion-of-underrepresented-populations-in-radiotherapy-clinical-trials/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/geographic-access-to-radiotherapy-facilities-in-the-united-states/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/sexual-health-often-overlooked-in-cancer-survivorship-care/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/pretreatment-ctdna-may-help-predict-outcomes-with-first-line-but-not-second-line-immunotherapy-for-patients-with-melanoma/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/sbrt-may-provide-superior-pain-relief-from-spinal-metastases-vs-conventional-radiotherapy/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/sbrt-for-multiple-lung-metastases-how-many-treatment-sessions-are-optimal/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/uspstf-issues-draft-recommendation-on-screening-for-colorectal-cancer/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/next-generation-braf-inhibitor-shows-activity-in-phase-iii-trial/ 2020-10-30T18:56:13+00:00 https://ascopost.com/news/october-2020/radiotherapy-with-cisplatin-vs-cetuximab-in-previously-untreated-patients-with-locoregionally-advanced-head-and-neck-cancer/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/fluciclovine-pet-imaging-vs-conventional-imaging-in-prostate-cancer/ 2020-11-09T18:49:24+00:00 https://ascopost.com/news/october-2020/stereotactic-radiosurgery-may-delay-cognitive-deterioration-vs-wbrt-in-patients-with-numerous-brain-metastases/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/fda-approves-companion-diagnostic-for-three-targeted-therapies-for-advanced-ovarian-breast-and-non-small-cell-lung-cancers/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/companion-diagnostic-to-identify-ntrk-fusions-in-patients-with-solid-tumors-eligible-for-treatment-with-larotrectinib-approved-by-the-fda/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/targeted-inhibitor-of-mutant-kras-gene-shows-activity-in-early-trial/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/trends-and-outcomes-among-hispanic-women-of-different-races-with-breast-cancer/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/surufatinib-in-advanced-pancreatic-neuroendocrine-tumors/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/adjuvant-vs-salvage-radiotherapy-plus-short-term-adt-after-radical-prostatectomy-for-localized-prostate-cancer/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/fda-pipeline-priority-reviews-in-egfr-mutant-lung-cancer-advanced-renal-cell-carcinoma-fast-track-designations-in-cll-and-solid-tumors/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/camrelizumab-plus-apatinib-in-previously-treated-patients-with-advanced-cervical-cancer/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/effect-of-virtual-tumor-board-implementation-on-use-of-whole-breast-hypofractionated-radiation-therapy/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/radiation-induced-genetic-deletions-may-be-associated-with-poorer-patient-outcomes/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/final-efficacy-results-from-the-extenet-trial-neratinib-in-pretreated-patients-with-hr-positive-her2-positive-early-breast-cancer/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/adjuvant-sorafenib-vs-placebo-in-patients-with-kidney-cancer-at-intermediate-or-high-risk-of-relapse/ 2020-10-30T18:56:14+00:00 https://ascopost.com/news/october-2020/neoadjuvant-dual-checkpoint-blockade-in-certain-patients-with-localized-bladder-cancer/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/behavioral-nudges-combined-with-machine-learning-mortality-estimates-may-improve-rate-of-advanced-cancer-care-conversations/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/dr-christina-cone-honored-with-the-mary-pazdur-award-for-excellence-in-advanced-practice-in-oncology-by-apsho/ 2022-03-07T20:15:58+00:00 https://ascopost.com/news/october-2020/sentinel-node-biopsy-vs-neck-node-dissection-in-operable-oral-or-oropharyngeal-cancer-equivalence-trial/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/study-finds-combined-hdac-and-mtor-inhibition-may-improve-outcomes-in-patients-with-relapsed-or-refractory-hodgkin-lymphoma/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/fragment-analysis-as-a-met-exon-14-screening-strategy-in-nsclc-tumors/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/ixazomib-maintenance-in-newly-diagnosed-patients-with-multiple-myeloma-not-undergoing-stem-cell-transplant/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/addition-of-oxaliplatin-to-preoperative-capecitabine-based-chemoradiation-and-adjuvant-capecitabine-in-locally-advanced-rectal-cancer/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/limited-english-language-proficiency-may-affect-frequency-of-screening-mammograms/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/molecular-profiles-and-actionable-alterations-identified-in-the-nci-match-trial/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/long-term-follow-up-of-anti-cd19-car-t-cell-therapy-in-relapsed-b-cell-malignancies/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/urine-based-liquid-biopsy-may-perform-similarly-to-urine-cytology-in-detecting-urothelial-carcinoma/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/tazemetostat-in-patients-with-advanced-epithelioid-sarcoma-and-loss-of-ini1smarcb1/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/addition-of-atezolizumab-to-trastuzumab-emtansine-in-previously-treated-patients-with-her2-positive-advanced-breast-cancer/ 2020-10-30T18:56:15+00:00 https://ascopost.com/news/october-2020/addition-of-cetuximab-to-afatinib-in-first-line-treatment-of-egfr-mutant-nsclc/ 2020-11-03T18:29:21+00:00 https://ascopost.com/news/october-2020/keynote-181-trial-second-line-pembrolizumab-vs-chemotherapy-in-advanced-esophageal-cancer/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/prognostic-model-for-outcomes-with-ibrutinib-treatment-for-chronic-lymphocytic-leukemia/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/new-study-offers-a-global-review-of-the-impact-of-covid-19-on-cancer-treatment-and-research/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/do-hospitals-that-primarily-serve-minority-patients-offer-standard-surgical-care-for-patients-with-breast-cancer/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/biochemical-progression-free-survival-with-adjuvant-vs-salvage-radiotherapy-after-radical-prostatectomy/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/pulmonary-complication-rates-after-elective-cancer-surgery-in-hospitals-with-vs-without-covid-19-free-surgical-pathways/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/association-of-adjuvant-chemotherapy-with-survival-in-early-stage-nsclc/ 2020-11-03T18:30:20+00:00 https://ascopost.com/news/october-2020/can-routine-scans-help-predict-which-patients-with-breast-cancer-may-be-at-risk-for-heart-disease/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/identifying-characteristics-of-infused-car-t-cells-associated-with-efficacy-and-toxicity-in-patients-with-large-b-cell-lymphoma/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/oral-cancer-pain-may-predict-likelihood-of-metastasis/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/addition-of-nivolumab-to-neoadjuvant-chemotherapy-in-resectable-stage-iiia-nsclc/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/nab-paclitaxel-vs-paclitaxel-in-platinum-refractory-metastatic-urothelial-cancer/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/neoadjuvant-lapatinibtrastuzumab-in-her2-positive-breast-cancer/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/new-study-finds-low-rates-of-bone-mineral-density-testing-in-men-treated-with-adt-for-prostate-cancer/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/designations-for-treatments-of-rare-blood-cancer-b-cell-malignancies-and-gastric-cancers/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/avelumab-maintenance-therapy-in-advanced-or-metastatic-urothelial-carcinoma/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/emmanuelle-charpentier-and-jennifer-a-doudna-honored-with-the-nobel-prize-in-chemistry-2020/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/five-year-outcomes-first-line-nivolumab-vs-dacarbazine-in-advanced-braf-wild-type-melanoma/ 2020-10-30T18:56:16+00:00 https://ascopost.com/news/october-2020/breast-cancer-risk-after-benign-breast-disease/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/long-term-evaluation-of-treatment-efficacy-after-primary-dcis-diagnosis/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/cancer-therapy-based-on-molecular-tumor-board-recommendations/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/first-line-atezolizumab-vs-chemotherapy-in-pd-l1-positive-metastatic-nsclc/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/study-finds-disparities-in-microsatellite-instabilitymismatch-repair-biomarker-testing-for-patients-with-stage-iv-colorectal-cancer/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/survey-of-health-care-providers-finds-knowledge-about-unique-needs-of-lgbtq-patients-with-cancer-is-limited/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/2020-nobel-prize-in-physiology-or-medicine-awarded-to-team-who-discovered-hepatitis-c-virus/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/four-year-findings-from-the-murano-trial-venetoclax-plus-rituximab-for-relapsed-chronic-lymphocytic-leukemia/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/patient-experiences-of-acute-toxicity-from-breast-radiotherapy-according-to-fractionation-scheme/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/adjuvant-nivolumab-vs-ipilimumab-in-stage-iiib-iiic-and-iv-melanoma/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/adjuvant-trastuzumab-with-or-without-chemotherapy-for-older-patients-with-her2-positive-early-breast-cancer/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/priority-review-for-agents-in-multiple-myeloma-anaplastic-large-cell-lymphoma/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/asco-s-national-cancer-opinion-survey/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/addition-of-atezolizumab-to-neoadjuvant-chemotherapy-in-early-stage-triple-negative-breast-cancer/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/first-line-durvalumab-with-or-without-tremelimumab-vs-chemotherapy-for-metastatic-urothelial-carcinoma/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/novel-small-molecule-inhibitor-surufatinib-for-advanced-extrapancreatic-neuroendocrine-tumors/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/october-2020/is-cancer-mortality-higher-in-counties-that-experience-persistent-poverty/ 2020-10-30T18:56:17+00:00 https://ascopost.com/news/september-2020/ 2021-07-01T15:11:00+00:00 https://ascopost.com/news/september-2020/adjuvant-abemaciclib-plus-endocrine-therapy-in-patients-with-early-breast-cancer-at-high-risk-of-recurrence/ 2020-09-30T18:53:59+00:00 https://ascopost.com/news/september-2020/consolidation-radiotherapy-for-patients-with-advanced-hodgkin-lymphoma-and-a-large-nodal-mass/ 2020-09-30T18:53:59+00:00 https://ascopost.com/news/september-2020/activity-of-the-kras-g12c-inhibitor-sotorasib-in-kras-pg12c-mutant-advanced-solid-tumors/ 2020-09-30T18:53:59+00:00 https://ascopost.com/news/september-2020/genetic-testing-may-be-cost-effective-for-newly-diagnosed-patients-with-gist/ 2020-09-30T19:44:11+00:00 https://ascopost.com/news/september-2020/benefit-of-pembrolizumab-in-high-risk-stage-iii-melanoma-3-year-follow-up/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/nonlymphoma-mortality-following-initial-chemotherapy-in-patients-with-classical-hodgkin-lymphoma/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/first-in-class-human-igg4-monoclonal-antibody-shows-activity-alone-and-combined-with-pembrolizumab-in-advanced-solid-tumors/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/is-ctdna-effective-in-detecting-genomic-alterations-in-patients-with-metastatic-kidney-cancer/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/breast-induration-with-hypofractionated-vs-standard-fractionated-radiotherapy-in-patients-with-early-breast-cancer-or-dcis/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/quality-of-life-with-cabazitaxel-vs-abiraterone-or-enzalutamide-in-metastatic-prostate-cancer/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/pralsetinib-in-ret-mutated-medullary-thyroid-cancer/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/does-pembrolizumab-monotherapy-demonstrate-benefit-in-rare-sarcomas/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/malnutrition-among-patients-with-cancer-admitted-to-the-hospital-may-increase-the-risk-for-infection/ 2020-09-30T18:54:00+00:00 https://ascopost.com/news/september-2020/continuous-vs-fixed-duration-immunotherapy-in-previously-treated-patients-with-advanced-nsclc/ 2020-10-13T17:54:54+00:00 https://ascopost.com/news/september-2020/elderly-patients-with-advanced-colorectal-cancer-treated-with-adjuvant-oxaliplatin-plus-fluoropyrimidines/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/nivolumab-shows-activity-in-edpole-mutated-mmr-proficient-advanced-cancers/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/meta-analyses-of-quality-of-life-in-patients-treated-with-checkpoint-inhibitors/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/abbreviated-breast-mri-as-supplementary-screening-method-in-women-with-dense-breasts/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/adjuvant-nivolumab-vs-ipilimumab-in-resected-advanced-melanoma/ 2020-10-03T20:09:44+00:00 https://ascopost.com/news/september-2020/does-radical-hysterectomy-improve-survival-in-patients-with-cervical-cancer-and-intraoperative-detection-of-positive-lymph-nodes/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/cabozantinib-and-nivolumab-with-or-without-ipilimumab-in-advanced-genitourinary-malignancies/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/disease-free-survival-with-adjuvant-osimertinib-in-resected-egfr-mutant-nsclc/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/overall-survival-with-apalutamide-in-nonmetastatic-castration-resistant-prostate-cancer/ 2020-09-30T18:54:01+00:00 https://ascopost.com/news/september-2020/solo1-5-year-follow-up-maintenance-olaparib-for-brca-mutated-advanced-ovarian-cancer/ 2020-09-30T18:54:02+00:00 https://ascopost.com/news/september-2020/olanzapine-for-children-and-adolescents-receiving-highly-emetogenic-chemotherapy/ 2020-09-30T18:54:02+00:00 https://ascopost.com/news/september-2020/joint-statement-from-the-ama-aha-and-ana-on-us-coronavirus-death-toll/ 2020-09-30T18:54:02+00:00 https://ascopost.com/news/september-2020/first-line-checkpoint-inhibitors-may-improve-survival-in-gastroesophageal-cancers/ 2020-09-30T18:54:02+00:00 https://ascopost.com/news/september-2020/overall-survival-analysis-in-the-profound-trial-of-olaparib-for-metastatic-castration-resistant-prostate-cancer/ 2020-09-30T18:54:02+00:00 https://ascopost.com/news/september-2020/new-report-focuses-on-cancer-statistics-in-adolescents-and-young-adults/ 2020-09-30T18:54:02+00:00 https://ascopost.com/news/september-2020/abemaciclib-plus-endocrine-therapy-may-reduce-recurrence-in-early-breast-cancer/ 2020-10-03T20:07:39+00:00 https://ascopost.com/news/september-2020/study-questions-role-of-routine-postoperative-radiotherapy-in-nsclc-with-mediastinal-nodes/ 2020-10-03T20:06:32+00:00 https://ascopost.com/news/september-2020/kras-g12c-inhibitor-shows-activity-in-solid-tumors-lung-cancer/ 2020-10-03T20:05:31+00:00 https://ascopost.com/news/september-2020/world-gynecologic-oncology-awareness-day-world-go-day/ 2020-09-30T18:54:03+00:00 https://ascopost.com/news/september-2020/checkmate-9er-trial-shows-benefit-of-nivolumabcabozantinib-for-advanced-kidney-cancer/ 2020-10-03T20:03:47+00:00 https://ascopost.com/news/september-2020/effects-of-the-covid-19-pandemic-on-cancer-care-provider-well-being/ 2020-09-30T18:54:03+00:00 https://ascopost.com/news/september-2020/maintenance-avelumab-plus-best-supportive-care-in-advanced-bladder-cancer/ 2020-09-30T18:54:03+00:00 https://ascopost.com/news/september-2020/cancer-treatment-related-outcomes-in-patients-with-cancer-and-covid-19/ 2020-09-30T18:54:03+00:00 https://ascopost.com/news/september-2020/access-to-treatments-and-trials-varies-widely-for-patients-with-cancer-across-europe/ 2020-09-30T18:54:03+00:00 https://ascopost.com/news/september-2020/addition-of-pembrolizumab-to-eribulin-in-hr-positive-her2-negative-metastatic-breast-cancer/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/role-of-f-18-naf-petct-in-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-enzalutamide/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/designations-in-prostate-cancer-glioblastoma-and-pediatric-leukemia/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/viral-load-may-help-predict-mortality-rate-in-hospitalized-patients-with-cancer-and-covid-19/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/proton-pump-inhibitor-use-may-be-associated-with-worse-outcomes-in-patients-treated-with-atezolizumab-for-urothelial-cancer/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/effect-of-machine-learning-directed-clinical-evaluations-on-acute-care-visits-during-outpatient-therapy/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/overall-survival-with-darolutamide-in-patients-with-nonmetastatic-castration-resistant-prostate-cancer/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/eflornithine-plus-sulindac-vs-either-agent-alone-in-preventing-progression-of-familial-adenomatous-polyposis/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/meta-analysis-of-duration-of-adjuvant-trastuzumab-in-early-breast-cancer/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/researchers-report-on-comprehensive-analysis-of-adenosquamous-carcinoma-of-the-pancreas/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/addition-of-debio-1143-to-cisplatin-chemoradiotherapy-in-locoregionally-advanced-head-and-neck-cancer/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/association-of-immunoscore-with-time-to-recurrence-in-stage-iii-colon-cancer/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/racial-differences-in-genomic-profiles-of-primary-and-metastatic-prostate-cancer/ 2020-09-30T18:54:04+00:00 https://ascopost.com/news/september-2020/role-of-inherited-gata3-variant-in-response-to-treatment-disease-relapse-in-pediatric-all/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/adjuvant-dabrafenibtrametinib-in-patients-with-stage-iii-melanoma-and-braf-v600-mutations/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/phase-ii-trial-of-capmatinib-for-met-exon-14-mutated-or-met-amplified-advanced-nsclc/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/first-line-pazopanib-vs-doxorubicin-in-patients-aged-60-or-older-with-metastatic-soft-tissue-sarcoma/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/efficacy-of-high-intensity-ultrasound-ablation-for-prostate-cancer/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/immune-checkpoint-inhibitor-therapy-may-contribute-to-arterial-inflammation/ 2023-08-22T19:41:43+00:00 https://ascopost.com/news/september-2020/retrospective-study-explores-association-between-raceethnicity-and-overall-survival-in-colorectal-liver-metastases/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/lisocabtagene-maraleucel-for-relapsed-or-refractory-large-b-cell-lymphomas/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/first-line-durvalumab-plus-cisplatinpemetrexed-in-malignant-pleural-mesothelioma/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/cryopreservation-may-be-associated-with-loss-of-quality-in-donor-stem-cell-products/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/nyts-shows-decline-in-overall-youth-e-cigarette-use-uptick-in-use-of-disposable-products/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/carfilzomib-vs-bortezomib-combined-with-lenalidomidedexamethasone-in-newly-diagnosed-patients-with-multiple-myeloma/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/local-recurrence-with-radiation-boost-in-her2-positive-breast-cancer/ 2020-09-30T18:54:05+00:00 https://ascopost.com/news/september-2020/qa-pfs-and-q-twist-in-the-ariel3-trial-of-rucaparib-maintenance-therapy-for-recurrent-ovarian-cancer/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/new-study-focuses-on-multiorgan-immunotherapy-related-adverse-events-in-clinical-trials/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/research-seeks-to-provide-information-on-the-immune-microenvironment-of-pancreatic-neuroendocrine-tumors/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/fda-approves-pralsetinib-for-metastatic-ret-fusion-positive-nsclc/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/venetoclax-plus-obinutuzumab-in-previously-untreated-patients-with-cll/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/social-smoking-raises-risk-of-death-from-lung-disease-and-lung-cancer/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/fda-pipeline-priority-reviews-in-multiple-myeloma-metastatic-breast-cancer-and-nsclc/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/long-term-outcomes-with-apbi-vs-wbi-in-patients-with-early-breast-cancer/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/updated-results-of-the-alternative-trial-of-lapatinibtrastuzumab-plus-ai-in-her2-positive-hr-positive-metastatic-breast-cancer/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/osimertinib-vs-platinumpemetrexed-in-patients-with-egfr-t790m-advanced-nsclc/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/addition-of-veliparib-to-carboplatinpaclitaxel-in-previously-treated-patients-with-brca-mutated-advanced-breast-cancer/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/does-binimetinib-improve-progression-free-survival-in-recurrent-or-persistent-low-grade-serous-ovarian-carcinomas/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/association-of-adjuvant-endocrine-therapy-with-overall-survival-in-small-hr-positive-her2-negative-breast-cancer/ 2020-09-30T18:54:06+00:00 https://ascopost.com/news/september-2020/comparing-pazopanib-to-doxorubicin-in-patients-aged-60-and-older-with-soft-tissue-sarcoma/ 2020-09-30T18:54:07+00:00 https://ascopost.com/news/september-2020/risk-reducing-early-salpingectomy-and-delayed-oophorectomy-among-premenopausal-women/ 2020-09-30T18:54:07+00:00 https://ascopost.com/news/september-2020/assessment-of-potential-abscopal-effect-of-sbrt-added-to-nivolumab-in-metastatic-head-and-neck-cancer/ 2020-09-30T18:54:07+00:00 https://ascopost.com/news/september-2020/geriatric-comanagement-after-cancer-surgery-in-patients-aged-75-and-older/ 2020-09-30T18:54:07+00:00 https://ascopost.com/news/september-2020/changes-in-reoperation-rates-after-publication-of-ssoastro-guideline-on-margins-for-breast-conserving-surgery/ 2020-09-30T18:54:07+00:00 https://ascopost.com/news/september-2020/are-patients-with-hematologic-cancers-more-vulnerable-to-the-effects-of-covid-19/ 2020-09-30T18:54:07+00:00 https://ascopost.com/news/september-2020/impact-of-prior-insurance-coverage-disruptions-on-health-care-access-and-affordability-for-currently-insured-cancer-survivors/ 2020-09-30T18:54:07+00:00 https://ascopost.com/news/august-2020/ 2021-07-01T15:11:00+00:00 https://ascopost.com/news/august-2020/meta-analysis-of-folfoxiribevacizumab-vs-doubletsbevacizumab-as-initial-treatment-for-unresectable-metastatic-colorectal-cancer/ 2020-08-31T19:01:36+00:00 https://ascopost.com/news/august-2020/race-disparities-in-receipt-of-proton-radiotherapy-in-children-s-oncology-group-trials/ 2020-08-31T19:42:32+00:00 https://ascopost.com/news/august-2020/fda-approves-foundationone-liquid-cdx-a-pan-tumor-liquid-biopsy-test/ 2020-09-01T14:07:36+00:00 https://ascopost.com/news/august-2020/use-of-risk-prediction-model-for-bloodstream-infection-in-febrile-pediatric-patients-with-cancer-without-severe-neutropenia/ 2020-08-31T19:42:33+00:00 https://ascopost.com/news/august-2020/cost-effectiveness-of-screening-guidelines-to-prevent-heart-failure-in-survivors-of-childhood-cancer/ 2020-08-31T19:42:33+00:00 https://ascopost.com/news/august-2020/effect-of-timing-of-radiotherapy-relative-to-adt-on-overall-survival-in-prostate-cancer/ 2020-09-17T18:33:23+00:00 https://ascopost.com/news/august-2020/ret-inhibitor-selpercatinib-achieves-durable-responses-in-majority-of-patients-with-ret-gene-fusions/ 2020-08-31T19:42:33+00:00 https://ascopost.com/news/august-2020/austrian-study-of-sars-cov-2-testing-in-patients-with-cancer-treated-at-a-tertiary-care-hospital-during-the-covid-19-pandemic/ 2020-08-31T19:42:33+00:00 https://ascopost.com/news/august-2020/medicare-part-d-spending-on-oncology-drugs/ 2020-08-31T19:42:33+00:00 https://ascopost.com/news/august-2020/addition-of-nelarabine-to-standard-therapy-in-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia/ 2020-08-31T19:42:34+00:00 https://ascopost.com/news/august-2020/breast-cancer-survival-is-significantly-decreased-among-premenopausal-women-previously-treated-with-radiation-for-childhood-or-aya-cancer/ 2020-09-09T21:53:18+00:00 https://ascopost.com/news/august-2020/obinutuzumab-ibrutinib-and-venetoclax-in-treatment-naive-and-relapsed-or-refractory-chronic-lymphocytic-leukemia/ 2020-08-31T19:42:34+00:00 https://ascopost.com/news/august-2020/transoral-robotic-surgery-may-improve-outcomes-in-early-stage-oropharyngeal-cancer/ 2020-08-31T19:42:34+00:00 https://ascopost.com/news/august-2020/sortilin-may-be-a-potential-therapeutic-target-in-pancreatic-cancer/ 2020-08-31T19:42:34+00:00 https://ascopost.com/news/august-2020/chemotherapy-and-covid-19-outcomes-in-patients-with-cancer-at-memorial-sloan-kettering-cancer-center/ 2020-08-31T19:42:35+00:00 https://ascopost.com/news/august-2020/essential-components-of-palliative-medicine/ 2020-08-31T19:42:35+00:00 https://ascopost.com/news/august-2020/has-racial-disparity-in-lung-cancer-incidence-lessened-among-young-adults/ 2020-09-09T21:50:38+00:00 https://ascopost.com/news/august-2020/rucaparib-in-metastatic-castration-resistant-prostate-cancer-with-deleterious-brca-alterations/ 2020-08-31T19:54:07+00:00 https://ascopost.com/news/august-2020/effect-of-mammography-screening-from-age-40-on-breast-cancer-mortality/ 2020-08-31T19:42:35+00:00 https://ascopost.com/news/august-2020/priority-reviews-for-immunotherapy-dose-regimen-small-cell-lung-cancer-fast-track-designations-in-brain-cancer-and-leukemia/ 2020-08-31T19:42:36+00:00 https://ascopost.com/news/august-2020/sorafenib-maintenance-after-stem-cell-transplant-in-flt3-itd-acute-myeloid-leukemia/ 2020-08-31T19:42:36+00:00 https://ascopost.com/news/august-2020/effect-of-muscle-mass-and-radiodensity-on-postoperative-complications-and-outcomes-of-colon-cancer-surgery/ 2020-08-31T19:42:36+00:00 https://ascopost.com/news/august-2020/link-between-gut-microbiome-and-treatment-outcomes-in-patients-with-metastatic-kidney-cancer/ 2020-08-31T19:42:36+00:00 https://ascopost.com/news/august-2020/study-finds-treatment-delays-for-patients-with-breast-cancer-early-in-the-covid-19-pandemic/ 2020-08-31T19:42:36+00:00 https://ascopost.com/news/august-2020/characteristics-of-neuroendocrine-carcinomas-of-the-gallbladder/ 2020-08-31T19:42:36+00:00 https://ascopost.com/news/august-2020/hypofractionated-vs-conventionally-fractionated-radiotherapy-after-breast-conserving-surgery-in-women-with-breast-cancer/ 2020-08-31T19:42:36+00:00 https://ascopost.com/news/august-2020/three-novel-genetic-variants-linked-to-male-breast-cancer-discovered/ 2020-08-31T19:42:37+00:00 https://ascopost.com/news/august-2020/current-lung-cancer-screening-guidelines-may-underselect-eligible-black-ever-smokers/ 2020-08-31T19:42:37+00:00 https://ascopost.com/news/august-2020/dabrafenib-plus-trametinib-in-braf-v600e-mutated-tumors/ 2020-08-31T19:42:37+00:00 https://ascopost.com/news/august-2020/association-of-surgical-volume-pledge-with-short-term-outcomes-after-lung-cancer-resection/ 2020-08-31T19:42:37+00:00 https://ascopost.com/news/august-2020/addition-of-venetoclax-to-azacitidine-in-previously-untreated-patients-with-aml-ineligible-for-induction-therapy/ 2020-08-31T19:42:37+00:00 https://ascopost.com/news/august-2020/genomic-analysis-of-cervical-cancer-in-ugandan-patients/ 2020-08-31T19:42:38+00:00 https://ascopost.com/news/august-2020/dabrafenibtrametinib-for-patients-with-braf-v600e-mutated-cholangiocarcinoma/ 2020-08-31T19:42:38+00:00 https://ascopost.com/news/august-2020/asco-members-can-access-special-offer-for-ppe-through-project-n95-register-by-august-24/ 2020-08-31T19:42:38+00:00 https://ascopost.com/news/august-2020/brigatinib-vs-crizotinib-in-alk-inhibitor-naive-patients-with-alk-positive-advanced-nsclc/ 2020-08-31T19:42:38+00:00 https://ascopost.com/news/august-2020/risk-stratified-stem-cell-transplant-and-vinblastine-monotherapy-for-relapsed-pediatric-anaplastic-large-cell-lymphoma/ 2020-08-31T19:42:38+00:00 https://ascopost.com/news/august-2020/aspirin-may-accelerate-the-progression-of-advanced-cancers-in-older-adults/ 2020-08-31T19:42:38+00:00 https://ascopost.com/news/august-2020/early-rituximab-intensification-in-r-chop-for-diffuse-large-b-cell-lymphoma/ 2020-08-31T19:42:38+00:00 https://ascopost.com/news/august-2020/effect-of-axillary-surgery-approach-and-nodal-irradiation-on-risk-of-lymphedema-in-patients-with-breast-cancer/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/study-finds-radiotherapy-may-be-associated-with-long-term-impact-on-the-cardiovascular-and-metabolic-health-of-childhood-cancer-survivors/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/approval-for-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/classification-of-prostate-cancer-using-tests-for-small-noncoding-rnas-in-urinary-exosomes/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/study-finds-residents-of-low-income-neighborhoods-have-less-access-to-icu-beds-amidst-coronavirus-pandemic/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/addition-of-bevacizumab-to-mfolfox6-for-the-first-line-treatment-of-ras-mutant-unresectable-colorectal-liver-metastases/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/impact-of-chromogranin-a-expression-on-disease-characteristics-and-prognosis-in-rectal-neuroendocrine-tumors/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/providing-aid-for-patients-with-cancer-affected-by-the-beirut-explosion/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/study-suggests-drop-in-non-small-cell-lung-cancer-mortality-rates-due-to-treatment-advances-reduction-in-incidence/ 2020-08-31T19:42:39+00:00 https://ascopost.com/news/august-2020/new-masccisoo-guidelines-for-managing-mucositis/ 2020-08-31T19:42:40+00:00 https://ascopost.com/news/august-2020/pfs-subgroup-analysis-of-olaparib-maintenance-therapy-in-advanced-brca-mutated-ovarian-cancer/ 2020-08-31T19:42:40+00:00 https://ascopost.com/news/august-2020/ash-releases-new-clinical-practice-guidelines-on-the-treatment-of-older-adults-with-newly-diagnosed-aml/ 2020-08-31T19:42:40+00:00 https://ascopost.com/news/august-2020/pembrolizumab-monotherapy-as-first-line-treatment-for-patients-with-unresectable-cutaneous-squamous-cell-carcinoma/ 2020-09-09T21:28:09+00:00 https://ascopost.com/news/august-2020/effect-of-molecular-classification-of-endometrial-cancer-on-adjuvant-therapy-outcomes/ 2020-08-31T19:42:40+00:00 https://ascopost.com/news/august-2020/increased-time-to-breast-cancer-surgery-may-not-impact-overall-survival-for-patients-with-early-stage-disease/ 2020-08-31T19:42:41+00:00 https://ascopost.com/news/august-2020/refinement-of-european-leukemianet-classification-recommendations-for-younger-patients-with-aml/ 2020-08-31T19:42:41+00:00 https://ascopost.com/news/august-2020/avelumab-for-patients-with-gestational-trophoblastic-tumors-resistant-to-single-agent-chemotherapy/ 2020-08-31T19:42:41+00:00 https://ascopost.com/news/august-2020/association-of-pathologic-complete-response-with-3-year-outcomes-in-the-i-spy2-trial-of-neoadjuvant-therapy-for-stage-ii-or-iii-breast-cancer/ 2020-08-31T19:42:41+00:00 https://ascopost.com/news/august-2020/first-line-lenvatinib-plus-pembrolizumab-in-patients-with-unresectable-hepatocellular-carcinoma/ 2020-08-31T19:42:41+00:00 https://ascopost.com/news/august-2020/fda-pipeline-designations-in-kidney-and-lung-cancers-myelodysplastic-syndromes-and-more/ 2020-08-31T19:42:41+00:00 https://ascopost.com/news/august-2020/anti-cd30-car-t-cell-therapy-for-patients-with-relapsed-or-refractory-hodgkin-lymphoma/ 2020-08-31T19:42:41+00:00 https://ascopost.com/news/august-2020/addition-of-pegvorhyaluronidase-alfa-to-nab-paclitaxel-and-gemcitabine-in-hyaluronan-high-metastatic-pancreatic-cancer/ 2020-08-31T19:42:42+00:00 https://ascopost.com/news/august-2020/severe-hearing-impairment-associated-with-neurocognitive-deficits-in-childhood-cancer-survivors/ 2020-08-31T19:42:42+00:00 https://ascopost.com/news/august-2020/risk-of-breast-cancer-after-total-body-irradiation-and-blood-or-marrow-transplantation-for-hematologic-malignancies/ 2020-08-31T19:42:42+00:00 https://ascopost.com/news/august-2020/outcomes-with-adjuvant-postradiation-chemotherapy-vs-radiotherapy-in-high-risk-low-grade-glioma/ 2020-08-31T19:42:42+00:00 https://ascopost.com/news/august-2020/role-of-tp53-mutations-on-disease-severity-in-myelodysplastic-syndromes/ 2020-08-31T19:42:43+00:00 https://ascopost.com/news/august-2020/ash-annual-meeting-announced-as-an-all-virtual-event/ 2020-08-31T19:42:43+00:00 https://ascopost.com/news/august-2020/nationwide-trends-show-fewer-patients-with-cancer-in-the-united-states-seeking-care-since-start-of-the-covid-19-pandemic/ 2020-08-31T19:42:43+00:00 https://ascopost.com/news/august-2020/does-adding-neoadjuvant-chemohormonal-therapy-to-surgery-in-patients-with-localized-high-risk-prostate-cancer-improve-biochemical-pfs/ 2020-08-31T19:42:43+00:00 https://ascopost.com/news/august-2020/late-morbidity-and-mortality-in-survivors-of-childhood-all-receiving-contemporary-risk-stratified-therapy/ 2020-08-31T19:42:43+00:00 https://ascopost.com/news/august-2020/pyrotinib-for-pretreated-patients-with-her2-mutated-advanced-nsclc/ 2020-08-31T19:42:43+00:00 https://ascopost.com/news/august-2020/pan-bet-bromodomain-inhibitor-plus-enzalutamide-in-advanced-prostate-cancer/ 2020-08-31T19:42:43+00:00 https://ascopost.com/news/august-2020/esmo-issues-consensus-on-the-management-of-patients-with-cancer-during-the-covid-19-pandemic/ 2020-08-31T19:42:44+00:00 https://ascopost.com/news/august-2020/neratinibcapecitabine-vs-lapatinibcapecitabine-for-pretreated-patients-with-her2-positive-metastatic-breast-cancer/ 2020-08-31T19:42:44+00:00 https://ascopost.com/news/august-2020/sorafenib-maintenance-after-allogeneic-hct-in-patients-with-flt3-itd-positive-aml/ 2020-08-31T19:42:44+00:00 https://ascopost.com/news/july-2020/ 2021-07-01T15:11:01+00:00 https://ascopost.com/news/july-2020/american-cancer-society-updates-guideline-for-cervical-cancer-screening/ 2020-08-11T21:03:43+00:00 https://ascopost.com/news/july-2020/pembrolizumab-in-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma/ 2020-07-31T16:45:36+00:00 https://ascopost.com/news/july-2020/first-line-s-1-plus-leucovorin-and-oxaliplatin-vs-s-1-plus-cisplatin-in-advanced-gastric-cancer/ 2020-07-31T16:45:36+00:00 https://ascopost.com/news/july-2020/addition-of-pazopanib-to-preoperative-chemoradiotherapy-in-children-and-adults-with-soft-tissue-sarcoma/ 2020-07-31T18:26:29+00:00 https://ascopost.com/news/july-2020/analysis-of-deep-whole-genome-sequencing-in-patients-with-multiple-myeloma-identifies-superior-outcome-subgroup/ 2020-09-22T19:49:25+00:00 https://ascopost.com/news/july-2020/does-periodontal-disease-increase-the-risk-of-colorectal-cancer/ 2020-07-31T16:45:37+00:00 https://ascopost.com/news/july-2020/outcomes-with-pet-directed-therapy-for-limited-stage-dlbcl/ 2020-07-31T16:45:37+00:00 https://ascopost.com/news/july-2020/modeling-study-aims-to-estimate-the-effect-of-the-covid-19-pandemic-on-cancer-deaths-in-england/ 2020-07-31T16:45:37+00:00 https://ascopost.com/news/july-2020/impact-of-pregnancy-after-breast-cancer-in-women-with-deleterious-germline-brca-mutations/ 2020-07-31T16:45:37+00:00 https://ascopost.com/news/july-2020/study-finds-lack-of-parental-intent-to-initiate-and-complete-hpv-vaccination-in-the-united-states/ 2020-07-31T16:45:37+00:00 https://ascopost.com/news/july-2020/carfilzomib-dexamethasone-and-daratumumab-vs-carfilzomib-and-dexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2020-07-31T16:45:37+00:00 https://ascopost.com/news/july-2020/does-adjuvant-chemotherapy-improve-survival-among-older-patients-with-er-positive-node-positive-breast-cancer-and-multiple-comorbidities/ 2020-07-31T16:45:38+00:00 https://ascopost.com/news/july-2020/are-patients-with-a-longer-established-diagnosis-of-cancer-at-higher-risk-for-more-severe-infection-or-death-from-covid-19/ 2020-07-31T16:45:38+00:00 https://ascopost.com/news/july-2020/risk-of-chronic-comorbidities-among-survivors-of-adolescent-and-young-adult-cancer/ 2020-07-31T16:45:38+00:00 https://ascopost.com/news/july-2020/san-antonio-breast-cancer-symposium-to-be-held-virtually/ 2020-07-31T16:45:38+00:00 https://ascopost.com/news/july-2020/neuroleptic-strategies-for-improving-terminal-agitation-in-patients-with-cancer-and-delirium/ 2020-07-31T16:45:38+00:00 https://ascopost.com/news/july-2020/first-line-folfirinox-vs-gemcitabinenab-paclitaxel-for-localized-pancreatic-cancer/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/updated-ccc19-data-offer-insights-on-treatment-for-patients-with-cancer-infected-with-covid-19/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/outcomes-with-axicabtagene-ciloleucel-in-the-nontrial-setting-in-patients-with-b-cell-non-hodgkin-lymphoma/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/t-dm1-in-patients-with-her2-positive-breast-cancer-and-brain-metastases/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/effect-of-breast-cancer-pathway-implementation-on-rate-of-referrals-for-genetic-counseling-and-testing/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/avapritinib-in-advanced-pdgfra-d842v-mutant-gastrointestinal-stromal-tumors/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/study-finds-higher-risk-for-covid-19-infection-among-minorities-and-patients-with-cancer/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/commnetsnanets-guideline-for-the-diagnosis-and-management-of-lung-neuroendocrine-tumors/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/addition-of-antithymocyte-globulin-to-gvhd-prophylaxis-in-matched-sibling-donor-stem-cell-transplant/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/euproms-study-investigates-effect-of-prostate-cancer-treatment-on-quality-of-life/ 2020-07-31T16:45:39+00:00 https://ascopost.com/news/july-2020/margetuximabpembrolizumab-for-previously-treated-patients-with-her2-positive-advanced-gastroesophageal-adenocarcinoma/ 2020-07-31T16:45:40+00:00 https://ascopost.com/news/july-2020/cancer-survivors-are-adhering-to-covid-19-related-preventive-behaviors-but-continuity-of-care-may-be-impacted/ 2020-08-08T01:39:37+00:00 https://ascopost.com/news/july-2020/long-term-normal-tissue-effects-with-five-fraction-whole-breast-radiotherapy-for-early-breast-cancer/ 2020-07-31T16:45:40+00:00 https://ascopost.com/news/july-2020/survival-after-resection-of-isolated-synchronous-colorectal-peritoneal-metastases/ 2020-07-31T16:45:40+00:00 https://ascopost.com/news/july-2020/phase-ib-trial-of-atezolizumab-with-or-without-bevacizumab-in-patients-with-unresectable-hepatocellular-carcinoma/ 2020-08-07T17:07:14+00:00 https://ascopost.com/news/july-2020/longitudinal-analysis-of-health-related-quality-of-life-in-patients-with-hodgkin-lymphoma/ 2020-07-31T16:45:40+00:00 https://ascopost.com/news/july-2020/fda-pipeline-novel-treatments-for-hematologic-malignancies/ 2020-07-31T16:45:40+00:00 https://ascopost.com/news/july-2020/qol-with-open-vs-minimally-invasive-radical-hysterectomy-for-patients-with-cervical-cancer/ 2020-08-11T20:09:30+00:00 https://ascopost.com/news/july-2020/effect-of-complete-vs-incomplete-macroscopic-excision-on-survival-in-stage-iv-high-risk-neuroblastoma/ 2020-07-31T16:45:40+00:00 https://ascopost.com/news/july-2020/role-of-psma-petct-in-the-management-of-recurrent-prostate-cancer/ 2020-07-31T16:45:40+00:00 https://ascopost.com/news/july-2020/novel-pet-radiotracer-for-glioblastoma/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/first-results-of-total-body-dynamic-pet-scan/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/outcomes-according-to-bmi-in-women-receiving-adjuvant-docetaxel-based-chemotherapy-for-early-breast-cancer/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/qol-with-timing-of-platinum-based-regimens-in-newly-diagnosed-patients-with-ovarian-cancer/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/effectiveness-of-routine-blood-testing-in-detection-of-disease-during-active-surveillance-for-indolent-non-hodgkin-lymphoma/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/study-identifies-factors-that-may-predict-toxicities-in-patients-treated-with-car-t-cell-therapy/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/study-links-mental-health-treatment-to-possible-improved-cancer-survival/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/experimental-covid-19-vaccine-generates-immune-response-deemed-safe/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/teriparatide-for-medication-related-osteonecrosis-of-the-jaw/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/effects-of-exercise-intolerance-on-adult-survivors-of-childhood-cancer/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/lung-cancer-in-nonsmoking-individuals-shows-genetic-differences-is-likely-to-respond-differently-to-treatment/ 2020-07-31T16:45:41+00:00 https://ascopost.com/news/july-2020/two-studies-focus-on-emerging-treatment-options-for-patients-with-neuroendocrine-tumors/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/liver-transplantation-after-tumor-downstaging-in-patients-with-hepatocellular-carcinoma/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/effect-of-medicaid-expansion-on-breast-cancer-stage-at-diagnosis/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/presence-of-ctdna-and-ctcs-and-prediction-of-disease-recurrence-in-patients-with-triple-negative-breast-cancer/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/dental-infection-screening-before-induction-chemotherapy-for-aml/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/common-hypertension-medications-may-also-reduce-risk-of-colorectal-cancer/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/cabozantinib-in-platinum-refractory-metastatic-urothelial-carcinoma/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/american-cancer-society-updates-guideline-for-hpv-vaccination/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/trends-in-policy-coverage-for-ctdna-testing/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/early-screening-with-mri-may-reduce-breast-cancer-mortality-in-survivors-of-childhood-cancer-treated-with-chest-radiation/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/gi-related-patient-reported-outcomes-in-those-receiving-chemoradiation-for-anal-cancer/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/efs-as-a-surrogate-for-os-in-patients-with-localized-prostate-cancer-treated-with-radiotherapy/ 2020-07-31T16:45:42+00:00 https://ascopost.com/news/july-2020/number-of-hospitalizations-may-be-an-important-indicator-of-survival-for-patients-with-head-and-neck-cancer/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/addition-of-trastuzumab-to-carboplatinpaclitaxel-for-advanced-or-recurrent-her2-positive-uterine-serous-carcinoma/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/post-hoc-analysis-of-outcomes-with-vandetanib-for-progressive-and-symptomatic-medullary-thyroid-cancer/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/survival-with-different-reduced-intensity-conditioning-regimens-for-allogeneic-stem-cell-transplant-in-patients-with-non-hodgkin-lymphoma/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/geographic-patterns-of-early-onset-colorectal-cancer-diagnoses-in-the-united-states/ 2020-07-31T18:14:34+00:00 https://ascopost.com/news/july-2020/selinexor-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/phase-i-trial-of-berzosertib-alone-or-combined-with-carboplatin-in-advanced-solid-tumors/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/can-use-of-an-algorithm-improve-the-accuracy-and-efficiency-of-cervical-cancer-screening/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/novel-radiopharmaceutical-aids-in-imaging-for-patients-with-neuroendocrine-tumors-and-liver-metastases/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/study-finds-significant-variation-in-hispanic-patients-trust-of-cancer-information-sources/ 2020-07-31T16:45:43+00:00 https://ascopost.com/news/july-2020/lenvatinib-plus-pembrolizumab-for-advanced-gastric-cancer/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/adding-cyclophosphamide-to-bortezomibdexamethasone-in-patients-with-multiple-myeloma-and-acute-kidney-injury-from-cast-nephropathy/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/patient-factors-associated-with-lack-of-provider-recommendation-for-hpv-vaccination-in-young-cancer-survivors/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/fda-pipeline-agents-for-the-treatment-of-prostate-and-pancreatic-cancers-marginal-zone-lymphoma/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/ursodeoxycholic-acid-for-preventing-gallstones-after-gastrectomy-for-gastric-cancer/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/a-visiting-resident-oncologist-s-training-during-the-covid-19-pandemic/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/risk-of-breast-cancer-recurrence-serum-detection-of-nonadherence-to-adjuvant-tamoxifen/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/effectiveness-of-maintenance-olaparib-for-germline-brca-mutated-pancreatic-cancer-across-age-groups-additional-analysis-of-the-polo-trial/ 2020-07-31T16:45:44+00:00 https://ascopost.com/news/july-2020/esmo-world-gi-third-or-later-line-treatment-with-infigratinib-in-patients-with-cholangiocarcinoma-and-fgr2-fusions/ 2020-08-07T17:07:53+00:00 https://ascopost.com/news/june-2020/ 2021-07-01T15:11:01+00:00 https://ascopost.com/news/june-2020/addition-of-first-line-atezolizumab-to-vemurafenib-and-cobimetinib-in-patients-with-unresectable-advanced-braf-v600-mutant-melanoma/ 2020-06-30T20:42:15+00:00 https://ascopost.com/news/june-2020/meta-analysis-of-survival-after-minimally-invasive-vs-open-radical-hysterectomy-for-early-stage-cervical-cancer/ 2020-06-30T20:42:15+00:00 https://ascopost.com/news/june-2020/picos-score-may-help-to-identify-patients-with-brain-metastases-at-risk-of-vte/ 2020-06-30T20:53:22+00:00 https://ascopost.com/news/june-2020/study-finds-racial-disparities-in-esophageal-cancer-surgical-rates/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/initial-report-from-the-teravolt-registry-study/ 2020-08-04T19:45:39+00:00 https://ascopost.com/news/june-2020/long-term-outcomes-with-pembrolizumab-for-cisplatin-ineligible-advanced-urothelial-cancer/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/novel-risk-calculator-for-sentinel-node-positivity-in-patients-with-melanoma/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/biomarker-combination-may-help-predict-response-to-immunotherapy-in-patients-with-metastatic-urothelial-carcinoma/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/addition-of-rituximab-to-standard-chemotherapy-in-pediatric-patients-with-high-risk-mature-b-cell-non-hodgkin-lymphoma/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/long-term-survival-outcomes-with-3-years-vs-1-year-of-adjuvant-imatinib-for-high-risk-gist/ 2020-07-13T16:58:55+00:00 https://ascopost.com/news/june-2020/effect-of-radiation-boost-to-residual-disease-in-high-risk-neuroblastoma/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/variant-in-gene-may-increase-cancer-risk-in-those-with-common-tp53-r337h-mutations/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/sedentary-behavior-and-risk-of-cancer-mortality/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/fda-approves-pembrolizumab-for-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma/ 2020-08-10T19:19:08+00:00 https://ascopost.com/news/june-2020/results-of-a-covid-19-and-cancer-consortium-ccc19-cohort-study/ 2020-06-30T20:42:16+00:00 https://ascopost.com/news/june-2020/efficacy-outcomes-with-c-mtx-in-newly-diagnosed-patients-with-pediatric-t-cell-lymphoblastic-lymphoma/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/lipophilic-statins-may-reduce-mortality-in-patients-with-ovarian-cancer/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/ivosidenib-for-idh1-mutant-advanced-glioma/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/prognosis-of-patients-with-stage-iii-melanoma-according-to-ajccv8-vs-independent-cohorts/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/astro-issues-clinical-guideline-on-radiation-therapy-for-cervical-cancer/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/study-links-financial-hardship-to-more-emergency-room-visits-less-preventive-care-among-cancer-survivors/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/young-adults-with-cancer-may-benefit-from-germline-genetic-testing/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/salvage-nivolumabipilimumab-after-prior-immune-checkpoint-inhibitor-therapy-in-patients-with-metastatic-rcc/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/factors-associated-with-covid-19-infection-severity-in-patients-with-cancer/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/cisplatinfluorouracil-vs-carboplatinpaclitaxel-in-chemotherapy-naive-patients-with-advanced-anal-cancer/ 2020-06-30T20:42:17+00:00 https://ascopost.com/news/june-2020/impact-of-medicare-ocm-reporting-requirements-on-biomarker-testing-and-treatment-in-advanced-nsclc/ 2020-06-30T20:42:18+00:00 https://ascopost.com/news/june-2020/transarterial-chemoperfusion-for-patients-with-mesothelioma/ 2020-08-04T21:07:47+00:00 https://ascopost.com/news/june-2020/holographic-visualization-for-ablation-of-liver-tumors/ 2020-06-30T20:42:18+00:00 https://ascopost.com/news/june-2020/fast-track-designations-in-colorectal-and-pancreatic-cancers-lymphoplasmacytic-lymphomawaldenstrom-s-macroglobulinemia/ 2020-06-30T20:42:18+00:00 https://ascopost.com/news/june-2020/tafasitamab-plus-lenalidomide-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2020-06-30T20:42:18+00:00 https://ascopost.com/news/june-2020/role-of-genetic-mutations-and-treatment-exposures-in-increased-subsequent-malignancy-risk-for-childhood-cancer-survivors/ 2020-06-30T20:42:18+00:00 https://ascopost.com/news/june-2020/ukccmp-prospective-cohort-study-of-covid-19-mortality-in-patients-with-cancer/ 2020-06-30T20:42:18+00:00 https://ascopost.com/news/june-2020/percutaneous-cryoablation-vs-partial-or-radical-nephrectomy-for-early-stage-kidney-cancer/ 2020-06-30T20:42:18+00:00 https://ascopost.com/news/june-2020/ripretinib-in-previously-treated-patients-with-advanced-gist/ 2020-06-30T20:42:19+00:00 https://ascopost.com/news/june-2020/immunogenomic-characteristics-of-advanced-clear-cell-kidney-cancer-treated-with-checkpoint-inhibitors/ 2020-06-30T20:42:19+00:00 https://ascopost.com/news/june-2020/hla-dp-expression-and-risk-of-acute-gvhd-after-unrelated-donor-hematopoietic-cell-transplantation/ 2020-06-30T20:42:19+00:00 https://ascopost.com/news/june-2020/american-cancer-society-updates-guideline-for-diet-and-physical-activity/ 2020-06-30T20:42:19+00:00 https://ascopost.com/news/june-2020/stereotactic-ablative-radiotherapy-for-oligometastatic-cancer-long-term-findings-from-sabr-comet/ 2020-06-30T20:42:19+00:00 https://ascopost.com/news/june-2020/retrospective-study-of-characteristics-and-outcomes-in-patients-with-cancer-hospitalized-with-covid-19-in-hubei/ 2020-06-30T20:42:19+00:00 https://ascopost.com/news/june-2020/effect-of-functional-impairment-on-hospitalized-patients-with-cancer/ 2020-06-30T20:42:19+00:00 https://ascopost.com/news/june-2020/acalabrutinib-vs-idelalisibrituximab-or-bendamustinerituximab-for-relapsed-or-refractory-cll/ 2020-06-30T20:42:20+00:00 https://ascopost.com/news/june-2020/immune-checkpoint-inhibitor-rechallenge-in-metastatic-renal-cell-carcinoma/ 2020-06-30T20:42:20+00:00 https://ascopost.com/news/june-2020/fgfr1-3-inhibitor-azd4547-in-refractory-tumors-harboring-fgfr-activating-mutations-and-fusions/ 2020-06-30T20:42:20+00:00 https://ascopost.com/news/june-2020/factors-associated-with-all-cause-30-day-mortality-in-patients-with-cancer-infected-with-covid-19/ 2020-06-30T20:42:20+00:00 https://ascopost.com/news/june-2020/addition-of-pemetrexed-vs-vinorelbine-to-adjuvant-cisplatin-for-nonsquamous-nsclc/ 2020-06-30T20:42:20+00:00 https://ascopost.com/news/june-2020/pembrolizumab-plus-chemoradiotherapy-for-locally-advanced-hnscc/ 2020-06-30T20:42:21+00:00 https://ascopost.com/news/june-2020/first-line-platinum-based-chemotherapy-for-patients-with-metastatic-pancreatic-cancer-and-defects-in-homologous-recombination-genes/ 2020-06-30T20:42:21+00:00 https://ascopost.com/news/june-2020/national-cost-of-cancer-care-in-the-united-states-expected-to-rise-to-over-246-billion-by-2030/ 2020-06-30T20:42:21+00:00 https://ascopost.com/news/june-2020/real-world-outcomes-with-axicabtagene-ciloleucel-therapy-in-relapsed-or-refractory-large-b-cell-lymphoma/ 2020-06-30T20:42:21+00:00 https://ascopost.com/news/june-2020/meta-analysis-of-outcomes-with-checkpoint-inhibitor-treatment-in-advanced-msi-h-cancers/ 2020-06-30T20:42:21+00:00 https://ascopost.com/news/june-2020/safety-and-patient-reported-outcomes-from-the-impower150-trial-in-metastatic-nonsquamous-nsclc/ 2020-06-30T20:42:21+00:00 https://ascopost.com/news/june-2020/outcomes-with-minimally-invasive-vs-open-esophagectomy-in-routine-practice/ 2020-06-30T20:42:22+00:00 https://ascopost.com/news/june-2020/impact-of-the-covid-19-pandemic-on-pediatric-cancer-care-in-latin-america/ 2020-06-30T20:42:22+00:00 https://ascopost.com/news/june-2020/rates-of-testicular-cancer-rising-among-racialethnic-minorities-in-the-united-states/ 2020-06-30T20:42:22+00:00 https://ascopost.com/news/june-2020/relationship-between-type-3c-diabetes-and-pancreatic-cancer/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/genomic-characteristics-of-smoldering-multiple-myeloma-and-risk-of-progression/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/study-explores-adding-trastuzumab-to-radiotherapy-for-women-with-her2-positive-dcis/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/trastuzumab-deruxtecan-vs-chemotherapy-for-previously-treated-patients-with-her2-positive-advanced-gastric-cancer/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/risk-adapted-dose-adjusted-epoch-r-for-previously-untreated-adult-patients-with-burkitt-lymphoma/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/adjuvant-nivolumabipilimumab-or-nivolumab-alone-vs-placebo-in-patients-with-resected-stage-iv-melanoma/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/ret-kinase-inhibitor-for-patients-with-solid-tumors-and-ret-genetic-fusions/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/results-from-an-oncology-hospital-at-home-evaluation/ 2020-06-30T20:42:23+00:00 https://ascopost.com/news/june-2020/study-finds-substantial-racialethnic-disparities-in-lost-earnings-from-cancer-mortality/ 2020-06-30T20:42:24+00:00 https://ascopost.com/news/june-2020/androgen-deprivation-with-oral-relugolix-vs-leuprolide-in-advanced-prostate-cancer-hero-trial/ 2020-06-30T20:42:24+00:00 https://ascopost.com/news/june-2020/liposomal-daunorubicin-and-cytarabine-followed-by-flag-for-pediatric-relapsed-aml/ 2020-06-30T20:42:24+00:00 https://ascopost.com/news/june-2020/does-treatment-with-immune-checkpoint-inhibitors-cause-flare-ups-in-patients-with-preexisting-ibd-or-microscopic-colitis/ 2020-06-30T20:42:24+00:00 https://ascopost.com/news/june-2020/final-overall-survival-analysis-of-the-prosper-trial-in-nonmetastatic-castration-resistant-prostate-cancer/ 2020-06-30T20:42:24+00:00 https://ascopost.com/news/june-2020/first-line-atezolizumab-plus-chemotherapy-vs-chemotherapy-alone-in-advanced-urothelial-cancer/ 2020-06-30T20:42:24+00:00 https://ascopost.com/news/june-2020/cediranibolaparib-vs-standard-of-care-chemotherapy-for-platinum-sensitive-ovarian-cancer/ 2020-06-30T20:42:25+00:00 https://ascopost.com/news/june-2020/remote-pre-and-post-test-genetic-counseling-for-breast-and-ovarian-cancer-risk/ 2020-06-30T20:42:25+00:00 https://ascopost.com/news/june-2020/standard-vs-histology-tailored-neoadjuvant-chemotherapy-for-high-risk-soft-tissue-sarcoma/ 2020-06-30T20:42:25+00:00 https://ascopost.com/news/june-2020/carfilzomib-vs-bortezomib-in-addition-to-lenalidomidedexamethasone-in-newly-diagnosed-multiple-myeloma/ 2020-06-30T20:42:25+00:00 https://ascopost.com/news/june-2020/early-local-therapy-did-not-extend-survival-in-patients-with-newly-diagnosed-metastatic-breast-cancer/ 2020-06-30T20:42:25+00:00 https://ascopost.com/news/june-2020/ivosidenib-plus-venetoclax-with-or-without-azacitidine-for-idh1-mutated-aml/ 2020-06-30T20:42:25+00:00 https://ascopost.com/news/june-2020/durvalumab-added-to-standard-chemotherapy-improved-os-in-patients-with-malignant-pleural-mesothelioma/ 2020-06-30T20:42:25+00:00 https://ascopost.com/news/may-2020/ 2021-07-01T15:11:01+00:00 https://ascopost.com/news/may-2020/data-from-tapur-study-cohorts-on-olaparib-for-brca-mutated-advanced-prostate-and-pancreatic-cancers/ 2020-05-31T18:35:06+00:00 https://ascopost.com/news/may-2020/tepotinib-shows-activity-in-patients-with-nsclc-and-met-exon-14-skipping-mutation/ 2020-05-31T20:07:47+00:00 https://ascopost.com/news/may-2020/hif2a-inhibitor-for-von-hippel-lindau-disease-associated-renal-cell-carcinoma/ 2020-06-26T21:05:23+00:00 https://ascopost.com/news/may-2020/first-line-pembrolizumab-plus-etoposideplatinum-for-extensive-stage-small-cell-lung-cancer/ 2020-06-14T21:17:30+00:00 https://ascopost.com/news/may-2020/intensive-remote-monitoring-of-high-risk-patients-initiating-antineoplastic-treatment/ 2020-05-31T18:35:07+00:00 https://ascopost.com/news/may-2020/fda-approves-atezolizumab-plus-bevacizumab-for-patients-with-unresectable-or-metastatic-hcc/ 2020-05-31T18:35:07+00:00 https://ascopost.com/news/may-2020/fda-approves-first-line-ramucirumab-plus-erlotinib-for-metastatic-egfr-mutated-nsclc/ 2020-05-31T18:35:08+00:00 https://ascopost.com/news/may-2020/transoral-resection-followed-by-low-dose-radiation-for-some-oropharyngeal-cancers/ 2020-05-31T18:35:08+00:00 https://ascopost.com/news/may-2020/is-sentinel-lymph-node-biopsy-alone-oncologically-safe-for-patients-with-early-stage-cervical-cancer/ 2020-05-31T18:35:08+00:00 https://ascopost.com/news/may-2020/study-finds-patients-with-lung-cancer-infected-with-covid-19-recently-treated-with-chemotherapy-at-higher-risk-of-death/ 2020-06-26T20:59:25+00:00 https://ascopost.com/news/may-2020/ivosidenib-for-idh1-mutant-chemotherapy-refractory-cholangiocarcinoma/ 2020-05-31T18:35:12+00:00 https://ascopost.com/news/may-2020/sources-for-better-gvhd-free-relapse-free-survival-after-adult-alternative-donor-hct/ 2020-05-31T18:35:12+00:00 https://ascopost.com/news/may-2020/use-of-symptom-assessment-scale-vs-routine-management-in-patients-with-cancer-receiving-radiotherapy/ 2020-05-31T18:35:12+00:00 https://ascopost.com/news/may-2020/ipatasertibpaclitaxel-vs-paclitaxel-alone-in-advanced-triple-negative-breast-cancer/ 2020-05-31T18:35:12+00:00 https://ascopost.com/news/may-2020/patient-preference-for-subcutaneous-vs-intravenous-pertuzumabtrastuzumab-for-her2-positive-early-breast-cancer/ 2020-05-31T18:35:12+00:00 https://ascopost.com/news/may-2020/novel-biomarkers-may-predict-immunotherapy-benefit-in-metastatic-breast-cancer/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/physical-activity-supportive-care-to-relieve-cancer-related-fatigue-may-be-underutilized-by-breast-cancer-survivors/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/analysis-of-women-younger-than-40-with-breast-cancer/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/cosmetic-outcomes-with-lumpectomy-for-multiple-ipsilateral-breast-cancer/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/phone-outreach-and-scheduling-assistance-boost-mammography-uptake-at-an-urban-safety-net-hospital/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/exposure-to-fine-particulate-matter-may-increase-mortality-among-pediatric-and-aya-patients-with-certain-cancers/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/prevalence-of-endosalpingiosis-and-association-with-ovarian-cancer/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/astro-survey-finds-fewer-patients-visiting-radiation-oncology-clinics-despite-enhanced-covid-19-safety-measures/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/covid-19-infection-in-pediatric-patients-with-cancer/ 2020-05-31T18:35:13+00:00 https://ascopost.com/news/may-2020/do-marital-status-and-race-affect-the-treatment-of-esophageal-cancer/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/germline-genetic-variants-in-atm-and-lung-cancer-susceptibility/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/antihistamines-may-improve-survival-among-patients-with-malignant-melanoma/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/fda-approves-olaparib-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/atezolizumab-plus-bevacizumab-vs-sorafenib-in-treatment-naive-patients-with-unresectable-hepatocellular-carcinoma/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/asco-special-report-provides-guidance-to-oncology-practices-on-resuming-cancer-care-during-the-covid-19-pandemic/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/do-men-treated-with-adt-for-prostate-cancer-have-a-lesser-chance-of-acquiring-covid-19/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/nih-led-activ-program-for-the-development-of-covid-19-vaccines/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/os-with-the-addition-of-adt-or-brachytherapy-boost-to-external-beam-radiotherapy-in-patients-with-localized-prostate-cancer/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/detecting-relapse-in-patients-with-lymphoma-in-first-remission-value-of-surveillance-laboratory-testing/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/low-intensity-surveillance-as-an-option-for-some-patients-with-non-muscle-invasive-bladder-cancer/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/can-pain-after-prostatectomy-or-nephrectomy-be-managed-without-opioids/ 2020-05-31T18:35:14+00:00 https://ascopost.com/news/may-2020/fda-approves-rucaparib-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/fda-approves-ripretinib-for-previously-treated-patients-with-advanced-gastrointestinal-stromal-tumor/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/cancer-care-at-tata-memorial-centre-during-the-covid-19-pandemic/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/physical-activity-and-neurocognitive-function-in-adult-survivors-of-childhood-cancers/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/two-breakthrough-therapy-designations-for-fam-trastuzumab-deruxtecan-nxki-and-more/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/fda-approves-nivolumabipilimumab-for-the-first-line-treatment-of-patients-with-metastatic-nsclc-and-pd-l1-tumor-expression-1/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/does-text-messaging-support-adherence-to-adjuvant-aromatase-inhibitor-therapy-in-women-with-early-stage-breast-cancer/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/study-finds-a-high-rate-of-intra-and-postoperative-conversions-to-total-thyroidectomy/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/first-line-concomitant-and-sequential-nivolumabavd-for-early-stage-unfavorable-classical-hodgkin-lymphoma/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/quitting-smoking-at-any-point-improves-lung-cancer-survival/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/combining-pembrolizumab-with-il-12-electroporation-may-improve-clinical-response-in-patients-with-immunologically-cold-melanoma/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/new-study-shows-patients-with-cancer-had-lower-rates-of-detected-covid-19-antibodies-vs-health-care-workers/ 2020-05-31T18:35:15+00:00 https://ascopost.com/news/may-2020/effectiveness-of-different-severity-thresholds-for-chemotherapy-related-symptom-alerts/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/spartalizumab-for-locally-advanced-or-metastatic-anaplastic-thyroid-carcinoma/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/ruxolitinib-in-glucocorticoid-refractory-acute-graft-vs-host-disease-after-stem-cell-transplant/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/half-of-surveyed-cancer-researchers-report-their-work-is-on-hold-due-to-the-covid-19-pandemic/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/communication-skills-training-for-oncologists-and-discussion-of-goals-of-care/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/don-t-touch-me-with-a-6-foot-pole/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/can-a-culturally-tailored-education-program-improve-colorectal-cancer-awareness-and-screening/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/chemoimmunotherapy-for-pediatric-refractory-or-relapsed-neuroblastoma/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/benefit-of-increased-dietary-antioxidants-during-induction-therapy-for-pediatric-all/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/distinct-new-mds-subtype-proposed-based-on-presence-of-genetic-mutation/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/reduction-in-cancer-diagnoses-in-the-netherlands-during-the-covid-19-pandemic/ 2020-05-31T18:35:16+00:00 https://ascopost.com/news/may-2020/wee1-inhibition-in-recurrent-uterine-serous-carcinoma/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/chemoablation-of-low-grade-upper-tract-urothelial-cancer-with-mitomycin-containing-reverse-thermal-gel/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/long-term-outcomes-with-adjuvant-hypofractionated-radiotherapy-for-1-vs-3-weeks-in-early-breast-cancer/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/dexrazoxane-cardiac-function-and-treatment-outcomes-in-pediatric-aml/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/olaparib-for-patients-with-mcrpc-and-homologous-recombination-repair-gene-alterations/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/regorafenib-plus-nivolumab-in-advanced-gastric-and-colorectal-cancers/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/atezolizumab-alone-or-in-combination-with-cobimetinib-for-biliary-tract-cancer/ 2020-06-22T16:45:11+00:00 https://ascopost.com/news/may-2020/issues-with-travel-faced-by-patients-undergoing-lu-177-dotatate-radiation-therapy/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/asco-survey-on-early-impact-of-covid-19-on-the-performance-of-oncology-clinical-trials/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/outcomes-with-autologous-allogeneic-vs-tandem-autologous-hematopoietic-cell-transplantation-in-patients-with-newly-diagnosed-multiple-myeloma/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/neoadjuvant-nivolumab-for-resectable-merkel-cell-carcinoma/ 2020-05-31T18:35:17+00:00 https://ascopost.com/news/may-2020/ai-model-accurately-classifies-colorectal-polyps-from-histopathologic-slides/ 2020-05-31T18:35:18+00:00 https://ascopost.com/news/may-2020/avoiding-use-of-prophylactic-peg-filgrastim-during-paclitaxel-treatment-in-dose-dense-chemotherapy-for-breast-cancer/ 2020-05-31T18:35:18+00:00 https://ascopost.com/news/may-2020/treatment-and-outcomes-in-patients-with-metastatic-colorectal-cancer-in-washington-state-and-canada/ 2020-05-31T18:35:18+00:00 https://ascopost.com/news/may-2020/are-there-racial-differences-in-time-to-treatment-for-melanoma/ 2020-05-31T18:35:18+00:00 https://ascopost.com/news/may-2020/priority-review-in-aml-fast-track-designations-for-pancreatic-cancer-and-neuroendocrine-tumors/ 2020-05-31T18:35:18+00:00 https://ascopost.com/news/april-2020/ 2021-07-01T15:11:02+00:00 https://ascopost.com/news/april-2020/risk-of-thromboembolic-complications-in-patients-with-covid-19/ 2020-04-30T19:23:46+00:00 https://ascopost.com/news/april-2020/high-vs-low-dose-anti-cd19-car-t-cell-therapy-in-patients-with-relapsed-or-refractory-cll/ 2020-04-30T20:31:32+00:00 https://ascopost.com/news/april-2020/disruptions-in-health-insurance-coverage-and-cancer-care-survival/ 2020-04-30T19:23:46+00:00 https://ascopost.com/news/april-2020/outcomes-of-covid-19-infection-in-patients-with-vs-without-cancer/ 2020-06-22T16:39:50+00:00 https://ascopost.com/news/april-2020/mortality-rate-from-covid-19-in-patients-with-thoracic-cancers/ 2020-06-22T16:40:48+00:00 https://ascopost.com/news/april-2020/nivolumabipilimumab-vs-nivolumab-alone-in-recurrent-or-persistent-ovarian-cancer/ 2020-04-30T19:23:47+00:00 https://ascopost.com/news/april-2020/risk-prediction-model-for-pancreatic-cancer/ 2020-04-30T19:23:47+00:00 https://ascopost.com/news/april-2020/cfdna-liquid-biopsy-may-provide-an-early-detection-test-for-patients-with-suspected-cancer/ 2020-06-22T16:38:49+00:00 https://ascopost.com/news/april-2020/continuous-vs-intermittent-dabrafenibtrametinib-dosing-in-patients-with-braf-mutated-melanoma/ 2020-06-22T16:37:13+00:00 https://ascopost.com/news/april-2020/study-finds-vape-shops-are-mostly-concentrated-in-low-resource-minority-communities/ 2020-06-22T16:38:28+00:00 https://ascopost.com/news/april-2020/asco-shares-new-clinical-trial-data-initiatives-and-path-forward-for-post-covid-19-cancer-care-delivery-system/ 2020-04-30T19:23:47+00:00 https://ascopost.com/news/april-2020/prognosis-of-patients-with-cancer-and-covid-19-outcomes-from-a-center-in-new-york-city/ 2020-04-30T19:23:47+00:00 https://ascopost.com/news/april-2020/final-overall-survival-results-from-the-phase-iii-embraca-trial/ 2020-06-22T16:36:09+00:00 https://ascopost.com/news/april-2020/ctdna-may-be-a-prognostic-biomarker-of-disease-recurrence-in-patients-with-lung-cancer/ 2020-06-22T16:36:57+00:00 https://ascopost.com/news/april-2020/long-term-outcomes-with-triplet-induction-and-risk-adapted-maintenance-therapy-for-newly-diagnosed-multiple-myeloma/ 2020-04-30T19:23:48+00:00 https://ascopost.com/news/april-2020/progression-of-advanced-small-bowel-neuroendocrine-tumors-after-multimodal-surgical-therapy/ 2020-04-30T19:23:48+00:00 https://ascopost.com/news/april-2020/acalabrutinib-with-or-without-obinutuzumab-vs-chlorambucilobinutuzumab-in-patients-with-previously-untreated-cll/ 2020-04-30T19:23:48+00:00 https://ascopost.com/news/april-2020/asparaginase-discontinuation-and-outcomes-in-pediatric-all/ 2020-04-30T19:23:48+00:00 https://ascopost.com/news/april-2020/effect-of-payer-s-utilization-management-policy-on-uptake-of-hypofractionated-radiotherapy-among-eligible-patients-with-early-stage-breast-cancer/ 2020-04-30T19:23:48+00:00 https://ascopost.com/news/april-2020/intermittent-dawn-to-sunset-fasting-and-anticancer-serum-proteome/ 2020-04-30T19:23:48+00:00 https://ascopost.com/news/april-2020/potential-protective-effect-of-ibrutinib-against-pulmonary-injury-in-patients-with-covid-19/ 2020-04-30T19:23:48+00:00 https://ascopost.com/news/april-2020/cognitive-impairment-with-adjuvant-chemoendocrine-vs-endocrine-therapy-for-early-breast-cancer-in-the-tailorx-trial/ 2020-04-30T19:23:49+00:00 https://ascopost.com/news/april-2020/anti-cd22-car-t-cell-therapy-for-cd22-positive-b-cell-malignancies/ 2020-04-30T19:23:49+00:00 https://ascopost.com/news/april-2020/acs-releases-new-guidance-on-resuming-elective-surgery-past-covid-19-peak/ 2020-04-30T19:23:49+00:00 https://ascopost.com/news/april-2020/addition-of-capecitabine-to-taxaneanthracycline-adjuvant-chemotherapy-for-triple-negative-breast-cancer/ 2020-04-30T19:23:49+00:00 https://ascopost.com/news/april-2020/switch-maintenance-pembrolizumab-for-metastatic-urothelial-cancer/ 2020-04-30T19:23:49+00:00 https://ascopost.com/news/april-2020/survey-shows-covid-19-pandemic-is-affecting-patients-access-to-cancer-care/ 2020-04-30T19:23:49+00:00 https://ascopost.com/news/april-2020/patients-may-experience-increased-infections-preceding-a-cancer-diagnosis/ 2020-04-30T19:23:50+00:00 https://ascopost.com/news/april-2020/fda-authorizes-first-covid-19-test-for-patient-at-home-sample-collection/ 2020-04-30T19:23:50+00:00 https://ascopost.com/news/april-2020/a-segregated-team-workflow-model-during-the-covid-19-pandemic-in-a-cancer-center/ 2020-04-30T19:23:50+00:00 https://ascopost.com/news/april-2020/quantitative-micro-elastography-for-tumor-detection-in-breast-conserving-surgical-margins/ 2020-04-30T19:23:51+00:00 https://ascopost.com/news/april-2020/psa-dynamics-and-response-to-androgen-deprivation-therapy/ 2020-04-30T19:23:51+00:00 https://ascopost.com/news/april-2020/pooled-meta-analysis-of-cancer-prevalence-in-patients-with-covid-19-infection/ 2020-04-30T19:23:51+00:00 https://ascopost.com/news/april-2020/hospitals-report-challenges-in-responding-to-the-covid-19-pandemic/ 2020-04-30T19:23:51+00:00 https://ascopost.com/news/april-2020/program-for-improving-vte-risk-assessment-patient-education-and-prophylaxis-use-in-an-ambulatory-cancer-clinic/ 2020-04-30T19:23:52+00:00 https://ascopost.com/news/april-2020/fda-encourages-plasma-donation-from-recovered-covid-19-patients-collaborates-to-produce-supplies-for-testing/ 2020-04-30T19:23:52+00:00 https://ascopost.com/news/april-2020/aspirin-use-and-risk-of-cancers-of-the-digestive-tract/ 2020-04-30T19:23:52+00:00 https://ascopost.com/news/april-2020/patterns-in-physician-use-of-extended-fraction-radiation-therapy-for-bone-metastases/ 2020-04-30T19:23:52+00:00 https://ascopost.com/news/april-2020/multidisciplinary-recommendations-for-breast-cancer-care-during-the-covid-19-pandemic/ 2020-04-30T19:23:52+00:00 https://ascopost.com/news/april-2020/immune-checkpoint-inhibitor-treatment-for-patients-with-cancer-during-the-covid-19-pandemic/ 2020-04-30T19:23:53+00:00 https://ascopost.com/news/april-2020/first-line-durvalumab-with-or-without-tremelimumab-vs-chemotherapy-for-metastatic-nsclc/ 2020-04-30T19:23:53+00:00 https://ascopost.com/news/april-2020/joint-publication-focuses-on-clinical-practice-guidelines-on-opioid-use-for-pain-management/ 2020-04-30T19:23:53+00:00 https://ascopost.com/news/april-2020/outcomes-in-patients-with-retroperitoneal-soft-tissue-sarcoma-by-hospital-type/ 2020-04-30T19:23:53+00:00 https://ascopost.com/news/april-2020/online-mind-body-resources-for-oncologists-and-health-care-workers-during-the-covid-19-pandemic/ 2020-04-30T19:23:53+00:00 https://ascopost.com/news/april-2020/activity-of-pembrolizumab-in-patients-with-nsclc-brain-metastases/ 2020-05-03T22:07:46+00:00 https://ascopost.com/news/april-2020/asco-releases-new-guidance-on-allocation-of-limited-resources-in-the-oncology-community-during-covid-19-pandemic/ 2020-04-30T19:23:54+00:00 https://ascopost.com/news/april-2020/postdiagnosis-weight-and-mortality-by-cause-in-survivors-of-nonmetastatic-prostate-cancer/ 2020-04-30T19:23:54+00:00 https://ascopost.com/news/april-2020/differences-in-melanoma-incidence-in-men-vs-women-by-age-and-anatomic-site/ 2020-04-30T19:23:54+00:00 https://ascopost.com/news/april-2020/neoadjuvant-immunotherapy-in-early-stage-colon-cancer/ 2020-04-30T19:23:54+00:00 https://ascopost.com/news/april-2020/asco-s-new-covid-19-cancer-registry/ 2020-04-30T19:23:54+00:00 https://ascopost.com/news/april-2020/textbook-outcome-in-patients-undergoing-resection-of-pancreatic-neuroendocrine-tumors/ 2020-04-30T19:23:54+00:00 https://ascopost.com/news/april-2020/nccn-issues-guidance-on-improving-covid-19-safety-for-patients-and-health-care-providers/ 2020-04-30T19:23:54+00:00 https://ascopost.com/news/april-2020/fda-pipeline-priority-reviews-for-immunotherapy-based-on-biomarker-status-combination-first-line-therapy-in-lung-cancer/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/fda-approves-encorafenibcetuximab-for-braf-v600e-mutated-metastatic-colorectal-cancer/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/pre-salvage-radiotherapy-psa-levels-and-outcomes-with-long-term-antiandrogen-therapy-in-prostate-cancer/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/factors-associated-with-early-readmissions-to-hospital-oncology-services/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/t-cell-responses-and-benefit-from-treatment-with-ipilimumab-in-patients-with-mcrpc/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/new-prognostic-score-for-asymptomatic-patients-with-early-stage-cll/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/stereotactic-ablative-radiation-vs-observation-in-oligometastatic-prostate-cancer-oriole-trial/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/pediatric-cancer-investment-needs-and-benefitsfindings-from-a-commission-created-by-the-lancet-oncology/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/kte-x19-for-relapsed-or-refractory-mantle-cell-lymphoma-zuma-2-trial/ 2020-04-30T19:23:55+00:00 https://ascopost.com/news/april-2020/does-breastfeeding-affect-invasive-ovarian-cancer-risk/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/daratumumab-for-relapsed-or-refractory-multiple-myeloma-subcutaneous-vs-intravenous-dosing/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/methylation-signatures-from-sequencing-cfdna-detected-different-types-of-cancer-across-multiple-stages/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/treatment-with-checkpoint-inhibitors-may-cause-thyroid-dysfunction/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/second-line-lurbinectedin-in-small-cell-lung-cancer/ 2020-12-12T22:18:23+00:00 https://ascopost.com/news/april-2020/clinical-trials-to-evaluate-activity-of-biologics-other-agents-against-covid-19/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/first-in-human-study-of-anteumab-ravtansine-for-advanced-solid-tumors/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/aacr-annual-meeting-2020-to-be-held-in-a-virtual-only-format/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/gallium-68-psma-petct-prior-to-surgery-or-radiotherapy-in-high-risk-prostate-cancer/ 2020-05-03T20:58:11+00:00 https://ascopost.com/news/april-2020/cancer-care-in-the-time-of-covid-19-statement-from-fox-chase-cancer-center/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/trastuzumab-beyond-progression-in-her2-positive-advanced-gastricgastroesophageal-junction-cancer/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/apixaban-for-cancer-associated-vte/ 2020-04-30T19:23:56+00:00 https://ascopost.com/news/april-2020/fda-pipeline-approval-of-new-dosing-for-biosimilar-plus-two-fast-track-designations/ 2020-04-30T19:23:57+00:00 https://ascopost.com/news/april-2020/pembrolizumab-in-previously-treated-metastatic-high-grade-neuroendocrine-neoplasms/ 2020-04-30T19:23:57+00:00 https://ascopost.com/news/april-2020/factors-associated-with-small-adult-height-in-childhood-cancer-survivors/ 2020-04-30T19:23:57+00:00 https://ascopost.com/news/april-2020/covid-19-and-pediatric-patients-with-cancer/ 2020-04-30T19:23:57+00:00 https://ascopost.com/news/april-2020/ivosidenib-in-patients-with-advanced-idh1-mutated-chondrosarcoma/ 2020-06-08T16:30:13+00:00 https://ascopost.com/news/april-2020/effect-of-familial-and-hereditary-cancer-syndromes-on-risk-of-prostate-cancer/ 2020-05-03T20:54:38+00:00 https://ascopost.com/news/april-2020/disparities-in-receipt-of-chemotherapy-among-patients-with-pn1-lung-cancer/ 2020-04-30T19:23:57+00:00 https://ascopost.com/news/april-2020/gynecologic-cancer-screening-after-a-natural-disaster/ 2020-04-30T19:23:57+00:00 https://ascopost.com/news/march-2020/ 2021-07-01T15:11:02+00:00 https://ascopost.com/news/march-2020/selumetinib-for-inoperable-plexiform-neurofibromas-in-children-with-nf1/ 2020-03-31T21:27:52+00:00 https://ascopost.com/news/march-2020/imaging-based-radiotherapy-target-volume-reduction-in-locally-advanced-nsclc/ 2020-03-31T19:54:28+00:00 https://ascopost.com/news/march-2020/evidence-based-anticancer-drug-use-in-physician-offices-vs-hospital-outpatient-facilities/ 2020-03-31T19:54:29+00:00 https://ascopost.com/news/march-2020/polypharmacy-and-inpatient-hospitalization-rates-in-older-patients-with-cancer/ 2020-03-31T19:54:29+00:00 https://ascopost.com/news/march-2020/end-of-study-results-from-cleopatra/ 2020-03-31T19:54:29+00:00 https://ascopost.com/news/march-2020/first-in-human-study-of-raf-family-kinase-inhibitor-lifirafenib-in-solid-tumors/ 2020-03-31T19:54:29+00:00 https://ascopost.com/news/march-2020/american-college-of-surgeons-issues-covid-19-guidelines-for-triage-of-patients-undergoing-cancer-surgery/ 2020-04-03T14:43:59+00:00 https://ascopost.com/news/march-2020/trends-in-global-rates-of-liver-cancer-from-1990-to-2017/ 2020-03-31T19:54:29+00:00 https://ascopost.com/news/march-2020/prognostic-impact-of-tumor-deposits-in-patients-receiving-adjuvant-therapy-for-stage-iii-colon-cancer/ 2020-03-31T19:54:30+00:00 https://ascopost.com/news/march-2020/international-uptake-of-molecular-testing-across-tumor-types/ 2020-03-31T19:54:30+00:00 https://ascopost.com/news/march-2020/predicting-which-patients-with-ovarian-cancer-may-respond-to-combination-parp-and-pd-1-inhibition/ 2020-03-31T19:54:31+00:00 https://ascopost.com/news/march-2020/lenvatinibpembrolizumab-in-previously-treated-patients-with-advanced-endometrial-cancer/ 2020-03-31T19:54:31+00:00 https://ascopost.com/news/march-2020/nivolumab-for-children-and-young-adults-with-relapsed-or-refractory-solid-tumors-or-lymphoma/ 2020-03-31T19:54:31+00:00 https://ascopost.com/news/march-2020/patients-with-certain-cancers-may-be-at-a-higher-risk-for-atrial-fibrillation/ 2020-03-31T19:54:31+00:00 https://ascopost.com/news/march-2020/clinical-and-dermoscopic-features-of-uncommon-melanoma-variants/ 2020-03-31T19:54:31+00:00 https://ascopost.com/news/march-2020/adding-pembrolizumab-to-pemetrexedplatinum-for-nonsquamous-nsclc/ 2020-03-31T19:54:31+00:00 https://ascopost.com/news/march-2020/managing-cancer-care-during-the-covid-19-pandemic/ 2020-04-03T14:49:32+00:00 https://ascopost.com/news/march-2020/association-of-germline-variant-status-and-response-to-neoadjuvant-chemotherapy-in-high-risk-early-breast-cancer/ 2020-03-31T19:54:32+00:00 https://ascopost.com/news/march-2020/trends-in-deaths-from-cutaneous-melanoma-in-the-united-states/ 2020-03-31T19:54:32+00:00 https://ascopost.com/news/march-2020/reintroduction-of-folfoxiri-plus-bevacizumab-after-first-line-progression-in-patients-with-metastatic-colorectal-cancer/ 2020-03-31T19:54:32+00:00 https://ascopost.com/news/march-2020/does-aspirin-use-lower-the-risk-of-hcc-and-liver-related-mortality-in-patients-with-chronic-viral-hepatitis/ 2020-03-31T19:54:33+00:00 https://ascopost.com/news/march-2020/surveillance-for-second-malignant-neoplasms-and-cardiac-dysfunction-in-childhood-cancer-survivors/ 2020-03-31T19:54:33+00:00 https://ascopost.com/news/march-2020/digital-breast-tomosynthesis-vs-digital-mammography-outcomes-comparison-over-5-years/ 2020-03-31T19:54:33+00:00 https://ascopost.com/news/march-2020/addition-of-vincristineirinotecan-to-established-chemotherapy-regimen-in-patients-with-diffuse-anaplastic-wilms-tumor/ 2020-03-31T19:54:34+00:00 https://ascopost.com/news/march-2020/proton-beam-therapy-vs-intensity-modulated-radiation-therapy-for-locally-advanced-esophageal-cancer/ 2020-03-31T19:54:34+00:00 https://ascopost.com/news/march-2020/cancer-incidence-and-survivorship-in-transgender-patients/ 2020-03-31T19:54:34+00:00 https://ascopost.com/news/march-2020/neoadjuvant-cisplatin-vs-doxorubicincyclophosphamide-for-patients-with-her2-negative-breast-cancer-and-a-brca-mutation/ 2020-03-31T19:54:35+00:00 https://ascopost.com/news/march-2020/adjuvant-etoposidecisplatin-for-pathologic-stage-ii-nonseminomatous-germ-cell-tumors/ 2020-03-31T19:54:35+00:00 https://ascopost.com/news/march-2020/risk-of-cervical-cancer-with-different-types-of-intrauterine-devices/ 2020-03-31T19:54:35+00:00 https://ascopost.com/news/march-2020/younger-cancer-survivors-and-financialfood-insecurity/ 2020-03-31T19:54:35+00:00 https://ascopost.com/news/march-2020/conventionally-fractionated-vs-moderate-hypofractionated-radiation-therapy-for-localized-prostate-cancer/ 2020-03-31T19:54:35+00:00 https://ascopost.com/news/march-2020/addition-of-venetoclax-to-cytarabine-in-pediatric-patients-with-relapsed-or-refractory-acute-myeloid-leukemia/ 2020-03-31T19:54:35+00:00 https://ascopost.com/news/march-2020/evaluation-of-genetic-testing-in-nccn-criteria-for-women-with-breast-cancer/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/colorectal-cancer-statistics-2020-published/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/breakthrough-therapy-for-nsclc-with-specific-mutation-approval-of-test-for-cervical-cancer-and-more/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/preoperative-letrozole-for-postmenopausal-patients-with-estrogen-receptor-positive-dcis/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/bendamustinedexamethasone-in-relapsedrefractory-systemic-light-chain-amyloidosis/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/survival-in-patients-with-pancreatic-cancer-receiving-molecularly-matched-therapies/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/annual-report-to-the-nation-on-the-status-of-cancer-released/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/pembrolizumab-plus-radiotherapy-in-locally-advanced-squamous-cell-head-and-neck-cancer/ 2020-03-31T19:54:36+00:00 https://ascopost.com/news/march-2020/epov-sue-sun-yom/ 2020-03-31T19:54:37+00:00 https://ascopost.com/news/march-2020/preoperative-chemoradiotherapy-vs-immediate-surgery-for-pancreatic-cancer/ 2020-03-31T19:54:37+00:00 https://ascopost.com/news/march-2020/ho-166-radioembolization-after-peptide-receptor-radionuclide-therapy-for-neuroendocrine-tumor-liver-metastases/ 2020-03-31T19:54:37+00:00 https://ascopost.com/news/march-2020/association-of-genomic-prostate-score-with-adverse-pathology-at-radical-prostatectomy-after-initial-active-surveillance/ 2020-03-31T19:54:37+00:00 https://ascopost.com/news/march-2020/receipt-of-adjuvant-vs-neoadjuvant-chemotherapy-and-start-of-treatment-in-patients-with-breast-cancer/ 2020-03-31T19:54:37+00:00 https://ascopost.com/news/march-2020/4-decade-analysis-of-5-year-survival-for-cancers-in-adolescents-and-young-adults/ 2020-03-31T19:54:37+00:00 https://ascopost.com/news/march-2020/first-line-cladribine-with-concurrent-or-delayed-rituximab-for-hairy-cell-leukemia/ 2020-03-31T19:54:38+00:00 https://ascopost.com/news/march-2020/evaluation-of-different-methods-of-biopsy-for-the-diagnosis-of-prostate-cancer/ 2020-03-31T19:54:38+00:00 https://ascopost.com/news/march-2020/prognostic-value-of-teratoma-in-metastatic-nonseminomatous-germ-cell-tumor/ 2020-03-31T19:54:38+00:00 https://ascopost.com/news/march-2020/study-examines-survival-rates-in-pediatric-and-young-adult-patients-with-colon-cancer/ 2020-03-31T19:54:38+00:00 https://ascopost.com/news/march-2020/diversity-of-intestinal-microbiota-and-mortality-in-patients-undergoing-allogeneic-hematopoietic-cell-transplantation/ 2020-03-31T19:54:38+00:00 https://ascopost.com/news/march-2020/young-women-diagnosed-with-breast-cancer-may-face-employment-disruption-and-financial-hardship/ 2020-03-31T19:54:38+00:00 https://ascopost.com/news/march-2020/priority-review-in-dlbcl-fast-track-designations-in-t-cell-lymphoma-and-adenoid-cystic-carcinoma/ 2020-03-31T19:54:38+00:00 https://ascopost.com/news/march-2020/nccn-postpones-2020-annual-conference-citing-precautions-against-potential-exposure-to-covid-19/ 2020-04-03T14:56:03+00:00 https://ascopost.com/news/march-2020/pembrolizumab-plus-bevacizumab-for-metastatic-renal-cell-carcinoma/ 2020-03-31T19:54:39+00:00 https://ascopost.com/news/march-2020/adjuvant-anthracycline-based-chemotherapy-vs-docetaxelcapecitabine-for-early-breast-cancer/ 2020-03-31T19:54:39+00:00 https://ascopost.com/news/march-2020/pooled-analysis-of-phase-iii-trials-of-larotrectinib-in-trk-fusion-positive-solid-tumors/ 2020-03-31T19:54:39+00:00 https://ascopost.com/news/march-2020/phenelzine-for-biochemical-recurrent-castration-sensitive-prostate-cancer/ 2020-03-31T19:54:39+00:00 https://ascopost.com/news/march-2020/olaparib-vs-nonplatinum-chemotherapy-in-platinum-sensitive-relapsed-brca12-mutated-ovarian-cancer/ 2020-03-31T19:54:39+00:00 https://ascopost.com/news/march-2020/geographic-and-racial-variability-in-germline-brca-mutation-prevalence-among-patients-with-metastatic-pancreatic-cancer/ 2020-03-31T19:54:40+00:00 https://ascopost.com/news/march-2020/ai-algorithms-plus-radiologist-assessment-may-help-to-improve-accuracy-in-reading-mammography-results/ 2020-03-31T19:54:40+00:00 https://ascopost.com/news/march-2020/are-those-who-have-lost-a-partner-at-a-higher-risk-of-dying-of-melanoma/ 2020-03-31T19:54:40+00:00 https://ascopost.com/news/march-2020/neoadjuvant-and-adjuvant-pembrolizumab-in-early-triple-negative-breast-cancer/ 2020-03-31T19:54:40+00:00 https://ascopost.com/news/march-2020/gi-pros-with-postoperative-intensity-modulated-radiotherapy-vs-standard-radiotherapy/ 2020-03-31T19:54:41+00:00 https://ascopost.com/news/march-2020/initiative-to-reduce-petct-radiotracer-infiltrations/ 2020-03-31T19:54:41+00:00 https://ascopost.com/news/march-2020/malnutrition-evaluation-before-oncologic-surgery/ 2020-03-31T19:54:41+00:00 https://ascopost.com/news/march-2020/long-term-outcomes-and-retreatment-outcomes-with-pembrolizumab-in-pd-l1-positive-advanced-nsclc/ 2020-03-31T19:54:41+00:00 https://ascopost.com/news/march-2020/cabozantinib-for-advanced-ewing-sarcoma-or-osteosarcoma/ 2020-03-31T19:54:42+00:00 https://ascopost.com/news/march-2020/two-recent-studies-show-low-nicotine-cigarettes-are-unlikely-to-increase-compensatory-smoking/ 2020-03-31T19:54:42+00:00 https://ascopost.com/news/march-2020/weight-gain-after-breast-cancer-diagnosis-in-australia/ 2020-03-31T19:54:42+00:00 https://ascopost.com/news/march-2020/plasma-based-tumor-mutational-burden-may-predict-response-to-immunotherapy-in-patients-with-metastatic-nsclc/ 2020-03-31T19:54:43+00:00 https://ascopost.com/news/february-2020/ 2021-07-01T15:11:04+00:00 https://ascopost.com/news/february-2020/adjuvant-everolimus-for-advanced-head-and-neck-cancer/ 2020-02-28T20:34:57+00:00 https://ascopost.com/news/february-2020/immune-restorative-agent-may-boost-immunotherapy-response-in-advanced-head-and-neck-cancer/ 2020-02-28T20:34:57+00:00 https://ascopost.com/news/february-2020/three-vs-six-months-of-adjuvant-chemotherapy-for-high-risk-stage-ii-colorectal-cancer/ 2020-02-28T20:34:58+00:00 https://ascopost.com/news/february-2020/abbreviated-breast-mri-vs-digital-breast-tomosynthesis-screening-in-women-with-dense-breasts/ 2020-02-28T20:34:59+00:00 https://ascopost.com/news/february-2020/priority-review-in-lung-cancer-breakthrough-therapy-designation-in-head-and-neck-cancer-and-more/ 2020-02-28T20:34:59+00:00 https://ascopost.com/news/february-2020/pembrolizumab-plus-radiotherapy-for-platinum-ineligible-patients-with-locally-advanced-hnscc/ 2020-03-06T23:46:24+00:00 https://ascopost.com/news/february-2020/nivolumab-with-or-without-ipilimumab-for-the-neoadjuvant-treatment-of-patients-with-oral-cavity-cancer/ 2020-03-06T23:44:54+00:00 https://ascopost.com/news/february-2020/trends-in-lung-cancer-incidence-in-young-women-vs-young-men-across-40-countries/ 2020-02-28T20:35:00+00:00 https://ascopost.com/news/february-2020/treatment-and-outcomes-for-african-american-and-white-women-with-triple-negative-breast-cancer/ 2020-02-28T20:35:01+00:00 https://ascopost.com/news/february-2020/depression-and-suicidal-ideation-in-patients-with-cancer/ 2020-02-28T20:35:01+00:00 https://ascopost.com/news/february-2020/trastuzumab-deruxtecan-in-her2-low-expressing-previously-treated-advanced-breast-cancer/ 2020-03-11T21:13:32+00:00 https://ascopost.com/news/february-2020/treating-typical-solitary-fibrous-tumor-with-a-tyrosine-kinase-inhibitor/ 2020-02-28T20:35:02+00:00 https://ascopost.com/news/february-2020/models-for-predicting-acute-ovarian-failure-in-survivors-of-childhood-cancer/ 2020-02-28T20:35:04+00:00 https://ascopost.com/news/february-2020/physical-activity-and-quality-of-life-in-african-american-cancer-survivors/ 2020-02-28T20:35:04+00:00 https://ascopost.com/news/february-2020/late-mortality-and-chronic-health-conditions-in-long-term-survivors-of-aya-cancers/ 2020-02-28T20:35:04+00:00 https://ascopost.com/news/february-2020/capivasertib-and-fulvestrant-in-advanced-er-positive-breast-cancer-after-relapse-or-progression-with-ai-treatment/ 2020-02-28T20:35:05+00:00 https://ascopost.com/news/february-2020/hippocampal-avoidance-during-whole-brain-radiotherapy/ 2020-02-28T20:35:05+00:00 https://ascopost.com/news/february-2020/psa-stratified-screening-for-prostate-cancer/ 2020-02-28T20:35:05+00:00 https://ascopost.com/news/february-2020/immunogenomic-profiling-of-osteosarcoma/ 2020-02-28T20:35:06+00:00 https://ascopost.com/news/february-2020/long-term-outcomes-with-pd-1-inhibitor-treatment-and-response-to-retreatment-in-advanced-melanoma/ 2020-02-28T20:35:06+00:00 https://ascopost.com/news/february-2020/pros-with-addition-of-pembrolizumab-vs-placebo-to-pemetrexed-and-platinum-for-nonsquamous-nsclc/ 2020-02-28T20:35:06+00:00 https://ascopost.com/news/february-2020/quality-of-life-with-tisagenlecleucel-therapy-for-relapsed-or-refractory-dlbcl/ 2020-02-28T20:35:06+00:00 https://ascopost.com/news/february-2020/priority-reviews-in-lung-cancers-lymphoma/ 2020-02-28T20:35:08+00:00 https://ascopost.com/news/february-2020/osimertinib-plus-savolitinib-for-egfr-mutated-met-amplified-nsclc-after-progression-on-egfr-tyrosine-kinase-inhibitors/ 2020-02-28T20:35:08+00:00 https://ascopost.com/news/february-2020/haploidentical-related-donor-vs-unrelated-cord-blood-hematopoietic-cell-transplantation-for-hodgkin-and-non-hodgkin-lymphoma/ 2020-02-28T20:35:08+00:00 https://ascopost.com/news/february-2020/hsd3b1-genotype-and-its-effect-on-castration-resistance-and-overall-survival-in-prostate-cancer/ 2020-02-28T20:35:10+00:00 https://ascopost.com/news/february-2020/diagnostic-and-treatment-technology-disparities-among-patients-with-colorectal-cancer/ 2020-02-28T20:35:10+00:00 https://ascopost.com/news/february-2020/proteomic-analysis-of-endometrial-cancer/ 2020-02-28T20:35:10+00:00 https://ascopost.com/news/february-2020/cervical-cancer-recurrence-open-vs-minimally-invasive-radical-hysterectomy/ 2020-02-28T20:35:12+00:00 https://ascopost.com/news/february-2020/states-with-highest-rates-of-cutaneous-melanoma-due-to-ultraviolet-exposure/ 2020-02-28T20:35:13+00:00 https://ascopost.com/news/february-2020/prh-hhex-transcription-factor-as-a-treatment-target-in-patients-with-cholangiocarcinoma/ 2020-02-28T20:35:13+00:00 https://ascopost.com/news/february-2020/enfortumab-vedotin-plus-pembrolizumab-in-bladder-cancer/ 2020-02-28T20:35:13+00:00 https://ascopost.com/news/february-2020/priority-reviews-in-lymphoma-lung-cancer-gist-and-breast-cancer/ 2020-02-28T20:35:13+00:00 https://ascopost.com/news/february-2020/talazoparib-for-pretreated-patients-with-metastatic-castration-resistant-prostate-cancer/ 2020-02-28T20:35:14+00:00 https://ascopost.com/news/february-2020/iraes-in-patients-with-cancer-receiving-influenza-vaccination-during-treatment-with-pembrolizumab/ 2020-02-28T20:35:14+00:00 https://ascopost.com/news/february-2020/oral-hif2a-inhibitor-for-advanced-clear-cell-renal-cell-carcinoma/ 2020-02-28T20:35:14+00:00 https://ascopost.com/news/february-2020/fear-of-recurrence-patients-prognostic-understanding-examined-in-genitourinary-cancers/ 2020-02-28T20:35:15+00:00 https://ascopost.com/news/february-2020/plasma-circulating-tumor-hpv-dna-for-the-detection-of-recurrent-hpv-associated-oropharyngeal-cancer/ 2020-02-28T20:35:15+00:00 https://ascopost.com/news/february-2020/low-fat-diets-with-increased-vegetable-fruit-and-grain-intake-linked-to-reduced-risk-of-breast-cancer-mortality-in-postmenopausal-women/ 2020-02-28T20:35:15+00:00 https://ascopost.com/news/february-2020/therapy-associated-polyposis-in-survivors-of-childhood-cancer/ 2020-02-28T20:35:16+00:00 https://ascopost.com/news/february-2020/iaslc-early-lung-imaging-confederation-initiative-for-analysis-of-low-dose-ct-images/ 2020-02-28T20:35:16+00:00 https://ascopost.com/news/february-2020/dengue-virus-infection-may-increase-risk-of-developing-leukemia/ 2020-02-28T20:35:16+00:00 https://ascopost.com/news/february-2020/enfortumab-vedotin-in-metastatic-urothelial-carcinoma/ 2020-02-28T20:35:16+00:00 https://ascopost.com/news/february-2020/do-gay-and-bisexual-men-have-an-increased-risk-of-developing-skin-cancer/ 2020-02-28T20:35:17+00:00 https://ascopost.com/news/february-2020/biomarker-analysis-in-the-combi-ad-trial/ 2020-02-28T20:35:17+00:00 https://ascopost.com/news/february-2020/impact-of-hpv-vaccination-and-cervical-screening-on-cervical-cancer-elimination/ 2020-03-16T20:32:24+00:00 https://ascopost.com/news/february-2020/genetic-mutations-in-donor-stem-cells-may-affect-hematopoietic-transplant-recipients/ 2020-02-28T20:35:17+00:00 https://ascopost.com/news/february-2020/five-year-patient-reported-outcomes-for-various-prostate-cancer-treatments/ 2020-02-28T20:35:18+00:00 https://ascopost.com/news/february-2020/ilixadencelsunitinib-vs-sunitinib-alone-in-synchronous-metastatic-kidney-cancer/ 2020-02-28T20:35:18+00:00 https://ascopost.com/news/february-2020/low-incidence-of-nivolumab-induced-radiation-recall-pneumonitis-among-patients-with-nsclc/ 2020-02-28T20:35:18+00:00 https://ascopost.com/news/february-2020/preliminary-results-show-antitumor-activity-with-pepinemabavelumab-in-patients-with-advanced-nsclc/ 2020-02-28T20:35:18+00:00 https://ascopost.com/news/february-2020/vitamin-d-may-reduce-risk-for-immune-checkpoint-inhibitor-associated-colitis/ 2020-02-28T20:35:18+00:00 https://ascopost.com/news/february-2020/do-socioeconomic-factors-play-a-role-in-outcomes-for-hpv-positive-head-and-neck-cancer/ 2020-02-28T20:35:19+00:00 https://ascopost.com/news/february-2020/women-with-variants-in-breast-cancer-associated-genes-may-not-always-be-receiving-guideline-concordant-care/ 2020-02-28T20:35:19+00:00 https://ascopost.com/news/february-2020/circulating-tumor-cell-assessment-to-predict-melanoma-relapse/ 2020-02-28T20:35:19+00:00 https://ascopost.com/news/february-2020/incidence-increases-in-new-colorectal-cancer-diagnoses-in-patients-between-49-and-50-years-old/ 2020-02-28T20:35:20+00:00 https://ascopost.com/news/february-2020/is-distance-to-treatment-a-burden-for-rural-patients-with-breast-cancer/ 2020-02-28T20:35:20+00:00 https://ascopost.com/news/february-2020/world-cancer-day-2020/ 2020-02-28T20:35:20+00:00 https://ascopost.com/news/february-2020/who-and-iarc-release-reports-in-response-to-government-s-role-in-cancer-control/ 2020-02-28T20:35:20+00:00 https://ascopost.com/news/february-2020/diffusion-weighted-mri-may-help-to-predict-treatment-response-in-patients-with-advanced-ovarian-cancer/ 2020-02-28T20:35:20+00:00 https://ascopost.com/news/february-2020/peripheral-blood-lymphocytes-and-t-cells-targeting-tp53-mutations-in-patients-with-metastatic-solid-tumors/ 2020-02-28T20:35:21+00:00 https://ascopost.com/news/february-2020/patient-aid-improved-lung-cancer-screening-informed-decision-making/ 2020-02-28T20:35:21+00:00 https://ascopost.com/news/february-2020/dasatinib-vs-imatinib-in-pediatric-philadelphia-chromosome-positive-all/ 2020-02-28T20:35:21+00:00 https://ascopost.com/news/january-2020/ 2021-07-01T15:11:04+00:00 https://ascopost.com/news/january-2020/talimogene-laherparepvecpembrolizumab-in-previously-treated-advanced-sarcoma/ 2020-02-24T19:29:06+00:00 https://ascopost.com/news/january-2020/risk-of-cns-metastasis-in-patients-with-ajcc-8th-edition-stage-iii-melanoma/ 2020-02-28T15:01:35+00:00 https://ascopost.com/news/january-2020/fda-pipeline-priority-review-for-product-for-lung-and-thyroid-cancers/ 2020-02-17T20:23:40+00:00 https://ascopost.com/news/january-2020/psilocybin-assisted-psychotherapy-and-cancer-related-psychiatric-distress/ 2020-02-17T20:23:40+00:00 https://ascopost.com/news/january-2020/activity-of-anti-bcma-bite-molecule-amg-420-in-relapsed-or-refractory-multiple-myeloma/ 2020-02-17T20:23:41+00:00 https://ascopost.com/news/january-2020/gabapentin-and-methadone-for-patients-undergoing-treatment-of-head-and-neck-cancer/ 2020-02-17T20:23:41+00:00 https://ascopost.com/news/january-2020/are-patient-reported-outcomes-predictive-of-survival-and-likelihood-of-hospitalization/ 2020-02-17T20:23:41+00:00 https://ascopost.com/news/january-2020/equal-access-health-care-system-for-african-american-and-white-men-with-prostate-cancer/ 2020-02-17T20:23:42+00:00 https://ascopost.com/news/january-2020/dual-vegf-and-pd-1-inhibition-in-advanced-solid-tumors/ 2020-02-17T20:23:42+00:00 https://ascopost.com/news/january-2020/intraoperative-molecular-imaging-technology-helps-surgeons-to-detect-nsclc/ 2020-02-17T20:23:42+00:00 https://ascopost.com/news/january-2020/late-stage-cancer-diagnoses-after-massachusetts-health-insurance-reform-law/ 2020-02-17T20:23:43+00:00 https://ascopost.com/news/january-2020/aya-cancer-survivors-at-greater-risk-of-inpatient-hospitalization/ 2020-02-17T20:23:43+00:00 https://ascopost.com/news/january-2020/few-patients-enroll-in-clinical-trials-of-first-line-therapies/ 2020-02-17T20:23:43+00:00 https://ascopost.com/news/january-2020/obstacles-to-early-detection-of-skin-cancer-in-patients-living-in-rural-western-states/ 2020-02-17T20:23:43+00:00 https://ascopost.com/news/january-2020/data-from-colorectal-cancer-cohorts-of-tapur-study-presented/ 2020-02-18T23:10:40+00:00 https://ascopost.com/news/january-2020/cost-of-pancreatic-cancer-care-over-time/ 2020-02-17T20:23:44+00:00 https://ascopost.com/news/january-2020/fda-pipeline-priority-reviews-in-multiple-myeloma-prostate-cancer/ 2020-02-17T20:23:44+00:00 https://ascopost.com/news/january-2020/addition-of-ramucirumab-or-merestinib-to-gemcitabinecisplatin-for-biliary-tract-cancer/ 2020-02-17T20:23:44+00:00 https://ascopost.com/news/january-2020/higher-concentration-of-fusobacterium-nucleatum-found-in-colorectal-tumors-in-patients-younger-than-45/ 2020-02-17T20:23:44+00:00 https://ascopost.com/news/january-2020/pathologic-fracture-and-prognosis-in-adult-and-pediatric-patients-with-high-grade-osteosarcoma/ 2020-02-17T20:23:44+00:00 https://ascopost.com/news/january-2020/everolimusoctreotide-shows-antitumor-activity-in-recurrent-meningioma/ 2020-02-17T20:23:44+00:00 https://ascopost.com/news/january-2020/does-receipt-of-palliative-care-increase-survival-in-patients-with-metastatic-esophageal-cancer-declining-chemotherapy/ 2020-02-17T20:23:44+00:00 https://ascopost.com/news/january-2020/detecting-gi-tumors-using-a-cell-free-dna-test/ 2020-02-18T23:07:13+00:00 https://ascopost.com/news/january-2020/patient-reported-outcomes-from-imbrave150-beacon-crc/ 2020-02-18T23:09:09+00:00 https://ascopost.com/news/january-2020/young-adults-with-colorectal-cancer-living-in-areas-of-low-income-education-likely-to-have-worse-survival-outcomes/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/price-transparency-and-variation-for-prostate-cancer-radiation-therapy/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/iraes-and-recurrence-free-survival-with-adjuvant-immunotherapy-vs-placebo-in-stage-iii-melanoma/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/does-proton-pump-inhibitor-use-affect-cognition-in-breast-cancer-survivors/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/using-t-cell-fraction-to-predict-melanoma-recurrence/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/entrectinib-in-advanced-ros1-fusion-positive-nsclc/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/relapse-and-outcomes-in-men-receiving-adjuvant-bleomycinetoposidecisplatin-for-clinical-stage-i-nonseminoma/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/three-studies-examine-relationship-between-b-cell-enrichment-and-response-to-immunotherapy/ 2020-02-17T20:23:45+00:00 https://ascopost.com/news/january-2020/cancer-incidence-in-general-wtc-responders-to-the-september-11-attacks/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/conditioning-intensity-for-allogeneic-transplantation-in-patients-with-aml/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/external-beam-apbi-vs-wbi-after-breast-conserving-surgery-in-dcis-or-node-negative-breast-cancer/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/treatment-resistance-and-novel-therapies-in-fgfr-mutated-cholangiocarcinoma/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/are-women-in-europe-or-asia-more-likely-to-have-breast-conserving-therapy-than-those-in-the-united-states/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/fda-pipeline-priority-reviews-in-ovarian-cancer-prostate-cancer-and-nsclc/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/maintenance-bevacizumab-with-or-without-pemetrexed-in-advanced-nonsquamous-nsclc/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/genomic-aberrations-and-pancreatic-cancer-subtypes/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/different-doses-of-adjuvant-ipilimumab-vs-high-dose-interferon-alfa-2b-in-patients-with-resected-high-risk-melanoma/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/higher-21-gene-recurrence-score-may-be-associated-with-increased-risk-of-locoregional-recurrence-in-patients-with-breast-cancer/ 2020-02-17T20:23:46+00:00 https://ascopost.com/news/january-2020/cancer-survivors-face-substantial-medical-financial-hardship/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/use-of-ai-for-diagnosing-and-grading-prostate-cancer/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/patient-reported-functional-outcomes-with-hypofractionated-vs-conventionally-fractionated-radiotherapy-for-nonmetastatic-prostate-cancer/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/are-racialethnic-disparities-in-breast-cancer-diagnosis-caused-by-health-insurance-coverage/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/patients-with-hpv-positive-and-hpv-negative-oropharyngeal-cancer-may-have-different-rates-of-mortality/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/entrectinib-in-advanced-or-metastatic-ntrk-fusion-positive-solid-tumors/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/activity-of-ruxolitinib-in-chronic-neutrophilic-leukemia-and-atypical-chronic-myeloid-leukemia/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/association-between-colorectal-cancer-and-ulcerative-colitis/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/molecular-characteristics-of-leptomeningeal-melanoma-metastases/ 2020-02-17T20:23:47+00:00 https://ascopost.com/news/january-2020/does-adding-trastuzumab-to-adjuvant-chemotherapy-improve-idfs-for-patients-with-her2-negative-breast-cancer/ 2020-02-17T20:23:48+00:00 https://ascopost.com/news/january-2020/does-statin-use-increase-overall-survival-in-patients-with-colorectal-cancer/ 2020-02-17T20:23:48+00:00 https://ascopost.com/news/january-2020/fast-trackorphan-drug-designation-for-cholangiocarcinoma-treatment-breakthrough-device-designation-for-bladder-cancer-test/ 2020-02-17T20:23:48+00:00 https://ascopost.com/news/january-2020/dietary-supplement-use-during-adjuvant-chemotherapy-and-treatment-outcomes-in-patients-with-early-breast-cancer/ 2020-02-17T20:23:48+00:00 https://ascopost.com/news/january-2020/prevalence-of-alcohol-use-among-patients-with-cancer-and-survivors/ 2025-05-21T17:42:48+00:00 https://ascopost.com/news/january-2020/step-counts-may-help-predict-treatment-outcomes-for-patients-with-nsclc/ 2020-02-17T20:23:48+00:00 https://ascopost.com/news/january-2020/olaparib-for-previously-treated-metastatic-castration-resistant-prostate-cancer-with-dna-repair-gene-aberrations/ 2020-02-17T20:23:49+00:00 https://ascopost.com/news/january-2020/largest-single-year-drop-in-cancer-mortality-reported-in-cancer-statistics-2020/ 2020-02-17T20:23:49+00:00 https://ascopost.com/news/january-2020/recurrence-risk-with-accelerated-partial-vs-whole-breast-irradiation-after-breast-conserving-surgery-for-early-breast-cancer/ 2020-02-17T20:23:49+00:00 https://ascopost.com/news/january-2020/does-weight-loss-surgery-lower-the-risk-of-malignant-melanoma/ 2020-02-17T20:23:49+00:00 https://ascopost.com/news/january-2020/many-pelvic-examinations-and-papanicolaou-tests-performed-on-young-women-may-be-unnecessary/ 2020-02-17T20:23:49+00:00 https://ascopost.com/news/january-2020/long-term-results-of-standard-vs-high-dose-chemoradiotherapy-with-or-without-cetuximab-in-patients-with-stage-iii-nsclc/ 2020-02-17T20:23:49+00:00 https://ascopost.com/news/january-2020/fda-pooled-analysis-of-cdk46-inhibitor-treatment-for-advanced-hr-positive-her2-negative-breast-cancer/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/is-pembrolizumab-active-in-pediatric-patients-with-pd-l1-positive-advanced-solid-tumors-or-lymphoma/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/t-dm1-shows-activity-in-her2-amplified-salivary-gland-cancer-in-small-patient-sample-of-nci-match/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/physical-activity-at-recommended-levels-may-lower-risk-of-multiple-cancers/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/os-with-the-addition-of-ribociclib-to-fulvestrant-in-hr-positive-her2-negative-advanced-breast-cancer/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/neoadjuvant-vs-concurrent-adt-with-dose-escalated-radiotherapy-for-localized-prostate-cancer/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/rates-of-guideline-aligned-genomic-profiling-in-patients-diagnosed-with-metastatic-colon-cancer/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/one-cycle-of-bleomycinetoposidecisplatin-may-be-as-effective-as-two-for-patients-with-testicular-cancer/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/overall-survival-with-the-addition-of-daratumumab-to-vmp-in-newly-diagnosed-transplant-ineligible-multiple-myeloma/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/long-term-results-of-ibis-ii/ 2020-02-17T20:23:50+00:00 https://ascopost.com/news/january-2020/cardiovascular-risks-after-bleomycinetoposidecisplatin-treatment-for-germ-cell-cancer/ 2020-02-17T20:23:51+00:00 https://ascopost.com/news/january-2020/saliva-test-may-play-a-role-in-the-early-detection-of-hpv-related-oropharyngeal-cancer/ 2020-02-17T20:23:51+00:00 https://ascopost.com/news/january-2020/fda-finalizes-enforcement-policy-on-unauthorized-flavored-cartridge-based-e-cigarettes/ 2020-02-17T20:23:51+00:00 https://ascopost.com/news/january-2020/osimertinib-in-patients-with-nsclc-harboring-uncommon-egfr-mutations/ 2020-02-17T20:23:51+00:00 https://ascopost.com/news/january-2020/adjuvant-denosumab-for-patients-with-early-breast-cancer/ 2020-02-17T20:23:51+00:00 https://ascopost.com/news/january-2020/asciminib-for-patients-with-cml-after-failure-of-abl-kinase-inhibitor-treatment/ 2020-02-17T20:23:51+00:00 https://ascopost.com/news/january-2020/screening-rates-rose-among-people-age-45-49-after-release-of-updated-colorectal-cancer-guidelines/ 2020-02-17T20:23:51+00:00 https://ascopost.com/news/december-2019/ 2021-07-01T15:11:04+00:00 https://ascopost.com/news/december-2019/fractionated-tisagenlecleucel-infusion-for-adults-with-b-cell-all/ 2019-12-23T18:00:42+00:00 https://ascopost.com/news/december-2019/treatment-of-advanced-esophagogastric-cancer-according-to-ercc1-expression/ 2019-12-23T18:00:42+00:00 https://ascopost.com/news/december-2019/how-effective-is-supplemental-mri-screening-for-women-with-extremely-dense-breasts/ 2019-12-23T18:00:43+00:00 https://ascopost.com/news/december-2019/fda-pipeline-priority-reviews-in-sclc-bladder-cancer-colorectal-cancer/ 2019-12-23T18:20:10+00:00 https://ascopost.com/news/december-2019/nivolumab-for-mismatch-repair-deficient-noncolorectal-cancers/ 2019-12-23T18:00:43+00:00 https://ascopost.com/news/december-2019/acupuncture-may-reduce-radiation-induced-dry-mouth-for-patients-with-head-and-neck-cancer/ 2019-12-23T18:00:43+00:00 https://ascopost.com/news/december-2019/first-line-weekly-dose-dense-chemotherapy-in-epithelial-ovarian-cancer/ 2019-12-23T18:00:43+00:00 https://ascopost.com/news/december-2019/fda-approves-enfortumab-vedotin-ejfv-for-previously-treated-advanced-urothelial-cancer/ 2019-12-23T18:00:43+00:00 https://ascopost.com/news/december-2019/does-second-line-pembrolizumab-in-patients-with-advanced-hcc-previously-treated-with-sorafenib-confer-a-survival-benefit/ 2019-12-23T18:00:43+00:00 https://ascopost.com/news/december-2019/commercial-gene-expression-tests-for-prostate-cancer-may-not-accurately-predict-disease-progression-in-african-american-men/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/rising-cost-and-use-of-oral-anticancer-drugs-and-increased-medicare-part-d-spending/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/pembrolizumab-in-refractory-metastatic-castration-resistant-prostate-cancer/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/survey-of-anticipation-and-experience-of-adverse-effects-in-patients-receiving-radiotherapy/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/recurrence-risk-in-black-and-white-women-with-borderline-estrogen-receptor-positive-breast-cancer/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/single-fraction-vs-multifraction-radiotherapy-for-patients-with-spine-metastases/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/astro-issues-clinical-guideline-on-radiation-therapy-for-basal-cell-and-cutaneous-squamous-cell-carcinomas/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/cancercare-to-provide-support-for-patients-with-cancer-impacted-by-the-california-wildfires/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/everett-vokes-elected-asco-president-for-2021-2022-term/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/second-os-analysis-of-first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/ 2019-12-23T18:00:44+00:00 https://ascopost.com/news/december-2019/risk-of-asparaginase-associated-pancreatitis-in-patients-with-all/ 2019-12-23T18:00:45+00:00 https://ascopost.com/news/december-2019/people-with-mental-illness-receive-less-cancer-screening-vs-general-population/ 2019-12-23T18:00:45+00:00 https://ascopost.com/news/december-2019/third-or-fourth-line-tivozanib-vs-sorafenib-in-metastatic-renal-cell-carcinoma/ 2019-12-23T18:00:45+00:00 https://ascopost.com/news/december-2019/evaluation-of-residual-disease-in-patients-with-multiple-myeloma-using-imwg-flow-cytometry-criteria/ 2019-12-23T18:00:45+00:00 https://ascopost.com/news/december-2019/oral-vs-intravenous-paclitaxel-for-patients-with-metastatic-breast-cancer/ 2019-12-23T20:03:17+00:00 https://ascopost.com/news/december-2019/ctdna-may-be-an-independent-predictor-of-disease-recurrence-in-patients-with-early-stage-tnbc/ 2019-12-23T18:00:45+00:00 https://ascopost.com/news/december-2019/breast-cancer-incidence-with-estrogenprogestin-vs-estrogen-alone-in-postmenopausal-women/ 2019-12-23T20:04:42+00:00 https://ascopost.com/news/december-2019/residual-cancer-burden-after-neoadjuvant-chemotherapy-as-a-predictive-tool/ 2019-12-23T18:00:50+00:00 https://ascopost.com/news/december-2019/long-term-preventive-benefit-with-anastrozole-among-postmenopausal-women-at-high-risk-for-breast-cancer/ 2019-12-23T18:00:50+00:00 https://ascopost.com/news/december-2019/ribociclibletrozole-vs-multiagent-chemotherapy-in-patients-with-high-risk-luminal-b-breast-cancer/ 2019-12-23T18:00:50+00:00 https://ascopost.com/news/december-2019/10-year-follow-up-of-adjuvant-apbi-vs-adjuvant-wbi/ 2019-12-23T18:00:50+00:00 https://ascopost.com/news/december-2019/6-year-analysis-of-the-addition-of-pertuzumab-to-trastuzumab-plus-chemotherapy-as-adjuvant-therapy/ 2019-12-23T18:00:51+00:00 https://ascopost.com/news/december-2019/does-treatment-with-pembrolizumab-improve-pcr-in-patients-with-tnbc-and-lymph-node-involvement/ 2019-12-23T18:00:51+00:00 https://ascopost.com/news/december-2019/adding-tucatinib-to-capecitabinetrastuzumab-improved-survival-for-patients-with-advanced-her2-positive-breast-cancer/ 2019-12-23T19:59:41+00:00 https://ascopost.com/news/december-2019/t-dxd-in-patients-with-pretreated-her2-positive-metastatic-breast-cancer/ 2019-12-23T18:00:51+00:00 https://ascopost.com/news/december-2019/postoperative-s-1-plus-endocrine-therapy-for-hr-positive-her2-negative-breast-cancer/ 2019-12-23T20:01:41+00:00 https://ascopost.com/news/december-2019/blinatumomab-vs-standard-chemotherapy-for-pediatric-patients-with-relapsed-b-all/ 2019-12-23T18:00:51+00:00 https://ascopost.com/news/december-2019/oral-azacitidine-improves-survival-in-older-patients-with-aml-in-first-remission/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/new-genomic-mutational-and-expressional-data-in-aml-mds/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/pet-directed-therapy-for-early-stage-dlbcl/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/genomic-features-of-aml-in-patients-aged-60-or-older-may-predict-stem-cell-transplant-outcome/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/ngs-for-undetectable-mrd-in-patients-with-follicular-lymphoma/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/should-african-american-patients-with-aml-be-enrolled-into-clinical-trials-with-evidence-of-abnormal-kidney-function/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/is-ahct-safe-and-effective-for-patients-age-70-or-older-with-multiple-myeloma/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/lower-area-based-income-and-educational-attainment-associated-with-poorer-survival-among-pediatric-patients-with-aml/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/car-t-cell-therapy-shows-activity-reduces-health-care-utilization-in-older-patients-with-dlbcl/ 2019-12-23T20:37:01+00:00 https://ascopost.com/news/december-2019/venetoclax-in-reduced-intensity-transplant-conditioning-regimen-for-patients-with-high-risk-myeloid-malignancies/ 2019-12-23T18:00:52+00:00 https://ascopost.com/news/december-2019/phase-ibii-study-of-bcma-directed-car-t-cell-therapy-for-pretreated-multiple-myeloma/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/dose-climbing-trial-of-dual-target-car-t-cell-therapy-for-relapsed-or-refractory-multiple-myeloma/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/car-nk-therapy-for-b-cell-malignancies-shows-activity-in-preclinical-studies/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/breast-conserving-surgery-and-partial-breast-reirradiation-in-patients-with-ipsilateral-disease-recurrence/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/factors-associated-with-prolonged-grief-symptom-levels-in-parents-of-children-who-have-died-of-cancer/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/atezolizumab-for-pediatric-and-young-adult-patients-with-previously-treated-solid-tumors-or-lymphomas/ 2019-12-23T20:39:49+00:00 https://ascopost.com/news/december-2019/fda-approves-atezolizumab-in-combination-with-chemotherapy-for-first-line-treatment-of-metastatic-nonsquamous-nsclc/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/fda-approves-foundationone-cdx-as-a-companion-diagnostic-for-alpelisibfulvestrant-treatment-in-breast-cancer/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/cardiovascular-disease-risk-may-be-associated-with-cancer-risk/ 2023-08-31T20:12:30+00:00 https://ascopost.com/news/december-2019/does-adding-pembrolizumab-or-placebo-to-chemotherapy-for-patients-with-metastatic-squamous-nsclc-improve-quality-of-life/ 2019-12-23T18:00:53+00:00 https://ascopost.com/news/december-2019/high-dose-brachytherapy-for-older-patients-with-nonmelanoma-skin-cancer/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/os-analysis-in-the-range-trial-for-urothelial-carcinoma/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/os-with-laparoscopic-vs-open-resection-for-colorectal-liver-metastases/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/use-of-on-site-touchscreen-based-geriatric-assessment-for-older-patients-with-multiple-myeloma/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/pembrolizumab-in-previously-treated-metastatic-msi-hdmmr-colorectal-cancer/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/swedish-population-study-of-risk-adapted-screening-starting-ages-for-relatives-of-patients-with-breast-cancer/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/associations-of-oncotype-dx-breast-recurrence-score-with-mortality-prediction-and-difference-between-sexes/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/quality-of-life-and-neurocognitive-function-in-patients-with-gliomas-treated-with-temozolomide-based-chemoradiotherapy/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/sequencing-of-enzalutamide-and-abiraterone-acetate-in-metastatic-castration-resistant-prostate-cancer/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/activity-of-gitr-agonist-alone-or-with-nivolumab-in-advanced-solid-tumors/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/pik3ca-mutation-status-and-disease-free-survival-in-patients-with-hpv-associated-opscc/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/duox2-mutation-in-familial-thyroid-cancers/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/december-2019/geriatric-assessment-guided-multidisciplinary-care-may-benefit-older-patients-undergoing-hct/ 2019-12-23T18:00:54+00:00 https://ascopost.com/news/november-2019/ 2021-07-01T15:11:05+00:00 https://ascopost.com/news/november-2019/secondary-surgical-cytoreduction-plus-chemotherapy-vs-chemotherapy-alone-in-recurrent-platinum-sensitive-ovarian-cancer/ 2019-11-27T19:03:57+00:00 https://ascopost.com/news/november-2019/molecular-changes-in-progression-of-idh-wild-type-glioblastoma/ 2019-11-27T19:03:57+00:00 https://ascopost.com/news/november-2019/fda-pipeline-recent-designations-in-hepatocellular-carcinoma-cholangiocarcioma-lymphoma-and-more/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/addition-of-isatuximab-to-pomalidomidedexamethasone-in-relapsed-and-refractory-multiple-myeloma/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/combination-of-atezolizumab-and-bevacizumab-for-unresectable-hcc/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/trastuzumab-biosimilar-hlx02-shows-activity-in-her2-positive-metastatic-breast-cancer/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/fda-approves-voxelotor-for-sickle-cell-disease/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/thermal-ablation-vs-cryotherapy-or-loop-excision-in-zambian-women-positive-for-cervical-precancer/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/activity-of-anti-steap1-antibody-drug-conjugate-in-patients-with-mcrpc/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/characteristics-of-metastatic-lesion-responses-to-pd-1-inhibition/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/machine-learning-algorithm-for-genome-derived-prediction-of-tumor-type/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/mental-health-outcomes-in-mothers-and-siblings-of-children-with-cancer/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/mirna-panel-could-aid-in-the-detection-of-uveal-melanoma/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/2019-state-of-lung-cancer-report-released/ 2019-11-27T19:03:58+00:00 https://ascopost.com/news/november-2019/fda-approves-acalabrutinib-for-cllsll-as-part-of-project-orbis/ 2019-11-27T19:03:59+00:00 https://ascopost.com/news/november-2019/pembrolizumab-with-or-without-chemotherapy-vs-cetuximab-plus-chemotherapy-in-recurrent-or-metastatic-hnscc/ 2019-11-27T19:03:59+00:00 https://ascopost.com/news/november-2019/long-term-analysis-of-vemurafenibcobimetinib-in-patients-with-braf-mutated-melanoma/ 2019-11-27T19:03:59+00:00 https://ascopost.com/news/november-2019/opioid-prescriptions-in-patients-with-cancer-in-southwest-virginia/ 2019-11-27T19:03:59+00:00 https://ascopost.com/news/november-2019/atezolizumabbevacizumab-in-metastatic-rcc-with-variant-histology-or-sarcomatoid-features/ 2019-11-27T19:03:59+00:00 https://ascopost.com/news/november-2019/prescribed-opioid-use-and-infection-risk-in-patients-with-cancer-and-treatment-associated-neutropenia/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/late-bone-marrow-relapse-risk-stratification-in-pediatric-patients-with-bcp-all/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/does-testosterone-replacement-therapy-benefit-young-male-cancer-survivors/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/gefitinib-alone-vs-gefitinib-plus-chemotherapy-in-egfr-mutated-metastatic-nsclc/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/pembrolizumab-in-noncolorectal-msi-hdmmr-solid-tumors/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/outcomes-with-hsct-plus-cyclophosphamide-in-adults-with-hematologic-cancers/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/disparities-in-culturally-competent-cancer-care/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/role-of-voriconazole-in-cutaneous-squamous-cell-carcinoma-development/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/polatuzumab-vedotin-plus-bendamustinerituximab-for-transplantation-ineligible-relapsed-or-refractory-dlbcl/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/maximizing-benefit-in-the-treatment-of-immune-mediated-colitis/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/improving-communication-with-older-patients-using-geriatric-assessment-during-oncology-visits/ 2019-11-27T19:04:00+00:00 https://ascopost.com/news/november-2019/nivolumab-plus-bevacizumab-in-relapsed-ovarian-cancer/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/long-term-effects-of-denosumab-in-patients-with-giant-cell-tumor-of-bone/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/presenting-symptoms-and-cancer-stage-at-diagnosis/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/lenalidomide-vs-observation-in-asymptomatic-smoldering-multiple-myeloma/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/hai-of-floxuridine-plus-systemic-gemcitabineoxaliplatin-for-unresectable-intrahepatic-cholangiocarcinoma/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/exercise-intolerance-in-adult-survivors-of-childhood-cancer/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/oral-daa-therapy-may-improve-survival-in-patients-with-hepatitis-c-virus-related-hcc/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/rates-of-non-guideline-concordant-lung-cancer-treatment-in-the-united-states/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/prognostic-biomarkers-in-triple-negative-breast-cancer-treated-with-adjuvant-doxorubicincyclophosphamide/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/use-of-mendelian-randomization-to-determine-role-of-human-gut-microbiome-in-crc-development/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/bendamustinerituximab-followed-by-y-90-ibritumomab-tiuxetan-in-previously-untreated-follicular-lymphoma/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/risk-of-subsequent-malignant-neoplasms-in-childhood-cancer-survivors-after-treatment-with-chemotherapy-alone/ 2019-11-27T19:04:01+00:00 https://ascopost.com/news/november-2019/incidence-of-head-and-neck-melanoma-in-north-american-youth/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/short-term-survival-in-patients-aged-85-years-and-older-after-colorectal-cancer-surgery/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/financial-burdens-of-patients-with-cirrhosis-and-impact-on-screening-for-hcc/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/dietary-fiber-yogurt-consumption-and-lung-cancer-risk/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/hcc-incidence-and-mortality-rates-in-england-have-tripled-over-the-past-20-years/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/ca125-testing-may-help-general-practitioners-to-detect-ovarian-cancer/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/higher-igf-1-and-free-testosterone-levels-may-be-risk-factors-for-prostate-cancer/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/high-dose-bevacizumab-for-patients-with-neurofibromatosis-type-2-and-progressive-vestibular-schwannomas/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/regional-disparities-in-metastatic-breast-cancer-survival-between-1990-and-2011/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/studies-report-efficacy-of-proton-radiotherapy-for-hepatocellular-carcinoma/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/nearly-one-quarter-of-completed-lung-cancer-clinical-trials-remain-unpublished/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/gilteritinib-vs-chemotherapy-in-relapsed-or-refractory-flt3-mutated-aml/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/acp-issues-guidance-on-colorectal-cancer-screening/ 2019-11-27T19:04:02+00:00 https://ascopost.com/news/november-2019/dna-vaccine-for-patients-with-progressive-nonmetastatic-castration-sensitive-prostate-cancer/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/is-there-a-difference-in-breast-cancer-recurrence-rates-after-surgery-with-regional-vs-general-anesthesia/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/fda-office-of-hematology-oncology-products-reorganizes-renamed-office-of-oncologic-diseases/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/secondary-analysis-of-tailorx/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/ctdna-and-recurrence-risk-after-surgery-and-adjuvant-chemotherapy-for-stage-iii-colon-cancer/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/long-term-follow-up-of-patients-with-nodular-lymphocyte-predominant-hodgkin-lymphoma/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/study-finds-nearly-one-in-four-oncologists-rarely-or-never-mention-cost-when-discussing-genomic-testing/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/levofloxacin-prophylaxis-during-treatment-of-newly-diagnosed-multiple-myeloma/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/pros-observed-with-durvalumab-treatment-after-chemoradiotherapy-for-stage-iii-unresectable-nsclc/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/factors-influencing-freedom-from-distant-recurrence-in-premenopausal-women-with-hr-positive-her2-negative-breast-cancer/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/do-poorly-differentiated-clusters-in-liver-metastases-from-colorectal-cancer-offer-prognostic-value/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/2019-annual-meeting-of-the-american-thyroid-association-briefs/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/activity-of-tipifarnib-in-patients-with-hras-mutant-head-and-neck-squamous-cell-carcinoma/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/investigational-kras-g12c-inhibitor-for-kras-mutant-solid-tumors/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/selumetinib-for-adult-patients-with-nf1-and-inoperable-plexiform-neurofibromas/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/association-between-prior-antibiotic-treatment-and-immune-checkpoint-inhibitor-therapy-outcomes/ 2019-11-27T19:04:03+00:00 https://ascopost.com/news/november-2019/postdiagnosis-use-of-aspirin-in-patients-with-biliary-tract-cancer/ 2019-11-27T19:04:04+00:00 https://ascopost.com/news/october-2019/ 2021-07-01T15:11:05+00:00 https://ascopost.com/news/october-2019/pretreatment-vitamin-d-deficiency-and-outcomes-in-hodgkin-lymphoma/ 2019-11-01T15:00:11+00:00 https://ascopost.com/news/october-2019/long-term-follow-up-of-salvage-short-term-adt-plus-radiotherapy-after-radical-prostatectomy/ 2019-11-01T15:00:11+00:00 https://ascopost.com/news/october-2019/long-term-rfs-with-the-addition-of-adjuvant-trastuzumab-to-chemotherapy-in-her2-positive-breast-cancer/ 2019-11-01T15:00:11+00:00 https://ascopost.com/news/october-2019/first-survivor-views-survey-highlights-barriers-to-addressing-side-effects-of-cancer-treatment/ 2019-11-01T15:00:11+00:00 https://ascopost.com/news/october-2019/asco-national-cancer-opinion-survey/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/interim-analysis-of-overall-survival-in-monarch-2/ 2019-11-07T15:31:39+00:00 https://ascopost.com/news/october-2019/panitumumab-plus-modified-folfoxiri-for-first-line-treatment-of-ras-wild-type-metastatic-colorectal-cancer/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/leydig-cell-failure-and-dysfunction-and-associated-adverse-health-outcomes-in-male-survivors-of-childhood-cancer/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/ceus-may-help-to-predict-cirrhotic-nodule-transformation-to-hcc/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/pcheta/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/durvalumab-plus-platinumetoposide-for-first-line-treatment-of-extensive-stage-sclc/ 2019-11-07T18:32:35+00:00 https://ascopost.com/news/october-2019/pembrolizumab-for-patients-with-advanced-adrenocortical-carcinoma/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/superoxide-dismutase-mimetic-for-reducing-severe-oral-mucositis/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/rfs-after-vismodegib-discontinuation-in-patients-with-complete-remission-of-locally-advanced-bcc/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/global-burden-of-pancreatic-cancer-from-1990-2017/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/trifluridinetipiracil-for-patients-with-metastatic-gastric-cancer-who-had-or-had-not-undergone-prior-gastrectomy/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/addition-of-trilaciclib-to-chemotherapy-in-metastatic-triple-negative-breast-cancer/ 2019-11-01T15:00:12+00:00 https://ascopost.com/news/october-2019/nab-paclitaxelgemcitabinecisplatin-for-previously-untreated-advanced-pancreatic-cancer/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/factors-in-genetic-testing-decisions-among-women-with-a-personal-and-family-history-of-breast-cancer/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/health-insurance-literacy-and-financial-hardship-in-cancer-survivors/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/fda-pipeline-treatments-for-her2-positive-breast-cancer-aml/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/addition-of-bevacizumab-to-chemotherapy-in-recurrent-or-metastatic-head-and-neck-cancer/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/immunotherapy-in-relapsed-or-refractory-primary-mediastinal-large-b-cell-lymphoma/ 2019-11-08T14:52:20+00:00 https://ascopost.com/news/october-2019/gene-signature-to-identify-benefit-of-front-line-fludarabinecyclophosphamiderituximab-in-ighv-unmutated-cll/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/study-finds-disparities-in-treatment-of-african-american-and-hispanic-patients-with-multiple-myeloma/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/racial-disparities-in-use-of-hospice-care-near-death-among-patients-with-pancreatic-cancer/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/anxiety-depression-and-low-social-support-are-significant-factors-in-cancer-pain-intensity/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/oncology-massage-may-relieve-symptoms-of-chemotherapy-induced-peripheral-neuropathy/ 2019-11-01T15:00:13+00:00 https://ascopost.com/news/october-2019/algorithm-for-identifying-genetic-mutations-likely-to-respond-to-immunotherapy/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/complete-lymph-node-dissection-vs-observation-in-sentinel-node-positive-melanoma/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/pegilodecakin-plus-pembrolizumab-or-nivolumab-in-advanced-solid-tumors/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/apalutamide-treatment-for-metastatic-castration-sensitive-prostate-cancer-and-hrqol/ 2019-11-08T16:19:32+00:00 https://ascopost.com/news/october-2019/exercise-for-patients-with-cancer-to-minimize-treatment-cardiotoxicity/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/fda-pipeline-designations-for-acute-gvhd-ptcl/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/patient-preference-for-more-vs-less-medical-care-for-thyroid-cancer/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/older-women-with-hr-positive-her2-negative-metastatic-breast-cancer-receiving-cdk46-inhibitor-plus-aromatase-inhibitor-therapy/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/virtual-molecular-tumor-boards/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/lung-cancer-screening-among-first-responders/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/romiplostim-for-patients-with-chemotherapy-induced-thrombocytopenia/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/addition-of-ramucirumab-to-erlotinib-in-previously-untreated-egfr-mutated-advanced-nsclc/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/nivolumab-vs-chemotherapy-in-previously-treated-advanced-esophageal-squamous-cell-carcinoma/ 2019-11-01T15:00:14+00:00 https://ascopost.com/news/october-2019/deviation-from-nccn-guidelines-may-result-in-greater-costs-for-patients-with-metastatic-breast-cancer/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/anti-gd2-monoclonal-antibody-plus-induction-chemotherapy-in-high-risk-neuroblastoma/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/braf-and-mek-inhibition-in-advanced-melanoma-with-rare-braf-mutations/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/maintenance-chemotherapy-improves-survival-in-high-risk-rhabdomyosarcoma/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/colorectal-cancer-screening-guideline-for-patients-aged-50-to-79-years-old/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/effect-of-race-and-ethnicity-on-survival-in-pediatric-and-adolescent-hodgkin-lymphoma/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/high-blood-pressure-and-cardiac-adverse-events-in-patients-treated-with-ibrutinib/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/acute-toxicity-with-imrt-vs-sbrt-for-prostate-cancer/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/computer-aided-diagnosis-system-for-detecting-lung-nodule-locations-and-characteristics/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/plasma-mir371-expression-as-a-biomarker-for-active-germ-cell-malignancy/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/blood-based-screening-assay-with-a-novel-multivariate-cancer-risk-score-model/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/targeted-methylation-sequencing-assay-may-provide-new-tool-for-cancer-detection/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/effect-of-tumor-sidedness-and-molecular-alterations-on-colorectal-cancer-outcomes/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/care-of-malignant-bowel-obstruction-in-patients-with-advanced-gynecologic-cancer/ 2019-11-01T15:00:15+00:00 https://ascopost.com/news/october-2019/parenchymal-sparing-hepatectomy-for-colorectal-cancer-liver-metastases/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/wbrt-vs-observation-after-local-treatment-of-melanoma-brain-metastases/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/addition-of-metformin-to-tki-therapy-in-egfr-mutant-nsclc/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/high-dose-chemotherapy-vs-standard-chemotherapy-and-whole-lung-radiation-in-ewing-sarcoma-with-pulmonary-metastases/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/treating-facility-provider-volume-and-patient-sharing-in-treating-patients-with-multiple-myeloma/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/recent-trends-in-the-treatment-and-prognosis-of-male-breast-cancer/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/overall-survival-with-nivolumabipilimumab-vs-chemotherapy-in-advanced-nsclc/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/interim-analysis-of-the-beacon-crc-trial/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/addition-of-doxorubicin-to-sorafenib-in-advanced-hepatocellular-carcinoma/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/use-of-adjuvant-chemotherapy-for-unilateral-retinoblastoma-with-and-without-histopathologic-high-risk-features/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/preclinical-study-finds-exposure-to-e-cigarette-smoke-increased-risk-of-cancer-in-mice/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/association-between-cutaneous-squamous-cell-carcinoma-risk-and-indoor-tanning-use-in-women/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/cabazitaxel-vs-abiraterone-or-enzalutamide-in-previously-treated-mcrpc/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/veliparib-plus-first-line-chemotherapy-and-as-maintenance-therapy-in-high-grade-serous-ovarian-cancer/ 2019-11-01T15:00:16+00:00 https://ascopost.com/news/october-2019/pembrolizumab-for-relapsed-or-refractory-mycosis-fungoides-and-sézary-syndrome/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/individual-patient-meta-analysis-of-msi-as-a-prognostic-marker-in-resectable-gastric-cancer/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/addition-of-ovarian-function-suppression-to-ongoing-tamoxifen-in-premenopausal-breast-cancer/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/molecular-classification-for-adjuvant-treatment-in-women-with-high-risk-endometrial-cancer/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/liquid-biopsy-to-determine-best-treatment-for-patients-with-nsclc/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/fda-pipeline-advances-in-prostate-cancer-urothelial-cancer-myelofibrosis-and-more/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/high-conversion-rate-with-certain-induction-chemotherapy-regimens-is-associated-with-improved-os-in-lapc/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/3-year-results-from-checkmate-238-adjuvant-nivolumab-vs-ipilimumab-in-advanced-melanoma/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/complete-mesocolic-excision-in-right-sided-colon-cancer/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/twist-analysis-of-niraparib-maintenance-therapy-in-recurrent-ovarian-cancer/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/study-suggests-difference-in-response-to-immunotherapy-regimens-between-sexes/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/addition-of-atezolizumab-to-platinum-based-chemotherapy-in-advanced-urothelial-carcinoma/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/lenvatinib-for-advanced-thymic-carcinoma/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/personalized-treatment-for-head-and-neck-cancer-based-on-geriatric-assessment/ 2019-11-01T15:00:17+00:00 https://ascopost.com/news/october-2019/ceritinib-for-patients-with-alk-positive-nsclc-metastatic-to-the-brain/ 2019-11-01T15:00:18+00:00 https://ascopost.com/news/october-2019/selpercatinib-in-ret-fusion-positive-thyroid-cancer/ 2019-11-01T15:00:18+00:00 https://ascopost.com/news/october-2019/veliparib-plus-carboplatinpaclitaxel-in-her2-negative-germline-brca-mutated-advanced-breast-cancer/ 2019-11-01T15:00:18+00:00 https://ascopost.com/news/october-2019/ivosidenib-in-idh1-mutated-advanced-cholangiocarcinoma/ 2019-11-01T15:00:18+00:00 https://ascopost.com/news/september-2019/ 2021-07-01T15:11:06+00:00 https://ascopost.com/news/september-2019/is-implicit-bias-contributing-to-time-disparities-in-conversations-with-minority-pa/ 2019-10-01T18:21:21+00:00 https://ascopost.com/news/september-2019/ctdna-as-a-marker-for-disease-free-survival-with-oxaliplatin-treatment-in-stage-iii-colon-cancer/ 2019-10-01T18:21:21+00:00 https://ascopost.com/news/september-2019/parp-inhibitors-in-newly-diagnosed-ovarian-cancer/ 2019-10-03T14:50:22+00:00 https://ascopost.com/news/september-2019/tailored-treatment-vs-empiric-chemotherapy-for-cancer-of-an-unknown-primary/ 2019-10-31T02:26:33+00:00 https://ascopost.com/news/september-2019/5-year-survival-and-response-with-nivolumabipilimumab-in-advanced-melanoma/ 2019-10-01T18:21:21+00:00 https://ascopost.com/news/september-2019/men-with-prostate-cancer-can-be-spared-radiotherapy-after-surgery/ 2019-10-01T18:21:22+00:00 https://ascopost.com/news/september-2019/immunotherapy-shows-benefit-in-advanced-hepatocellular-carcinoma/ 2019-10-01T18:21:22+00:00 https://ascopost.com/news/september-2019/prior-antibiotic-treatment-and-response-to-immune-checkpoint-inhibitor-therapy/ 2019-10-01T18:21:22+00:00 https://ascopost.com/news/september-2019/fda-announces-voluntary-recall-of-certain-ranitidine-capsules/ 2019-10-01T18:21:22+00:00 https://ascopost.com/news/september-2019/treatment-free-survival-as-an-outcome-measure-of-nivolumabipilimumab-therapy-in-advanced-melanoma/ 2019-10-01T18:21:22+00:00 https://ascopost.com/news/september-2019/addition-of-induction-gemcitabinecisplatin-to-chemoradiotherapy-in-nasopharyngeal-carcinoma/ 2019-10-01T18:21:23+00:00 https://ascopost.com/news/september-2019/immunotherapy-for-recurrent-or-metastatic-cervical-vaginal-or-vulvar-carcinoma/ 2019-10-01T18:21:23+00:00 https://ascopost.com/news/september-2019/risk-of-subsequent-neoplasms-in-childhood-cancer-survivors-with-neurofibromatosis-type-1/ 2019-10-01T18:21:23+00:00 https://ascopost.com/news/september-2019/uninsuredunderinsured-lower-income-and-minority-patients-more-likely-to-receive-cancer-diagnosis-after-ed-visit/ 2019-10-01T18:21:23+00:00 https://ascopost.com/news/september-2019/origin-and-taxonomy-of-mucinous-ovarian-cancer/ 2019-10-01T18:21:23+00:00 https://ascopost.com/news/september-2019/effect-of-myc-rearrangement-and-translocation-partner-in-dlbcl/ 2019-10-01T18:21:24+00:00 https://ascopost.com/news/september-2019/mortality-rate-for-colorectal-cancer-higher-for-blacks-than-for-whites-in-major-us-cities/ 2019-10-01T18:21:24+00:00 https://ascopost.com/news/september-2019/lgbtqiplus-latinx-community-members-are-not-receiving-tailored-cancer-related-information-and-care/ 2019-10-01T18:21:24+00:00 https://ascopost.com/news/september-2019/risk-model-for-advanced-systemic-mastocytosis/ 2019-10-01T18:21:24+00:00 https://ascopost.com/news/september-2019/adoption-of-conservative-management-of-prostate-cancer-among-urology-practices/ 2019-10-10T22:48:19+00:00 https://ascopost.com/news/september-2019/two-studies-show-variation-in-effectiveness-of-mammography-across-populations/ 2019-10-01T18:21:25+00:00 https://ascopost.com/news/september-2019/sorafenib-plus-transarterial-chemoembolization-for-advanced-hcc/ 2019-10-01T18:21:25+00:00 https://ascopost.com/news/september-2019/final-results-of-a-phase-iii-trial-of-pet-guided-treatment-in-early-stage-favorable-hodgkin-lymphoma/ 2019-10-01T18:21:25+00:00 https://ascopost.com/news/september-2019/patients-with-metastatic-colorectal-cancer-carrying-class-3-braf-mutations-and-anti-egfr-therapy/ 2019-10-01T18:21:25+00:00 https://ascopost.com/news/september-2019/cancer-survival-incidence-and-mortality-in-seven-high-income-countries-from-1995-2014/ 2019-10-01T18:21:25+00:00 https://ascopost.com/news/september-2019/international-guidelines-for-treatment-and-prophylaxis-of-vte-in-patients-with-cancer/ 2019-10-01T18:21:25+00:00 https://ascopost.com/news/september-2019/asciminibimatinib-in-patients-with-previously-treated-cml/ 2019-10-14T20:52:51+00:00 https://ascopost.com/news/september-2019/polepold1-mutations-and-outcomes-with-immune-checkpoint-inhibitor-therapy/ 2019-10-01T18:21:25+00:00 https://ascopost.com/news/september-2019/addition-of-sirt-to-chemotherapy-may-improve-resectability-of-colorectal-cancer-liver-metastases/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/long-term-hormone-therapy-in-men-with-prostate-cancer-receiving-early-salvage-radiotherapy/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/patterns-of-disease-progression-in-patients-with-unresectable-stage-iii-nsclc/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/bevacizumabniraparib-vs-niraparib-alone-for-platinum-sensitive-recurrent-ovarian-cancer/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/machine-learning-model-may-accurately-predict-radiation-side-effects-in-patients-with-head-and-neck-cancers/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/access-to-cannabis-products-for-patients-with-cancer/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/observation-vs-sabr-for-oligometastatic-prostate-cancer/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/sbrt-after-progression-on-immunotherapy-in-metastatic-nsclc/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/effect-of-closure-of-women-s-health-clinics-on-cervical-cancer/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/hhv-6b-detection-in-bronchoalveolar-lavage-fluid-after-hematopoietic-cell-transplantation/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/home-based-exercise-and-weight-loss-programs-for-lymphedema-management/ 2019-10-01T18:21:26+00:00 https://ascopost.com/news/september-2019/fda-issues-drug-safety-communication-on-lung-inflammation-due-to-treatment-with-cdk46-inhibitors/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/neoadjuvant-cisplatingemcitabine-followed-by-standard-chemoradiation-in-locally-advanced-cervical-cancer/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/keynote-024-survival-update/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/selpercatinib-in-ret-fusion-positive-nsclc/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/video-assisted-thoracic-surgery-vs-open-surgery-in-lung-cancer/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/fda-pipeline-btd-in-lung-cancer-odds-in-myeloma-and-soft-tissue-sarcoma/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/final-overall-survival-results-of-impower131-trial-in-advanced-squamous-nsclc/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/autoantibody-diagnostic-test-followed-by-ct-imaging-in-lung-cancer/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/blood-microrna-plus-low-dose-ct-to-reduce-ct-repeats-in-lung-cancer-screening/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/declaration-from-iaslc-on-tobacco-cessation-after-cancer-diagnosis/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/5-year-outcomes-with-nivolumab-vs-docetaxel-in-previously-treated-nsclc/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/addition-of-durvalumab-to-chemotherapy-improves-os-in-patients-with-extensive-stage-sclc/ 2019-10-01T18:21:27+00:00 https://ascopost.com/news/september-2019/2019-lasker-awards-announced/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/t-dm1-plus-neratinib-in-metastatic-her2-positive-breast-cancer/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/pamiparib-plus-tislelizumab-in-advanced-solid-tumors/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/screening-efficacy-of-plcom2012-vs-uspstf-criteria/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/survey-findings-on-evidence-based-guidelines-for-molecular-testing-in-lung-cancer/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/first-line-nivolumabipilimumab-in-special-populations-with-nsclc/ 2019-11-15T17:08:42+00:00 https://ascopost.com/news/september-2019/amg-510-for-kras-g12c-mutated-advanced-nsclc/ 2019-10-21T18:11:21+00:00 https://ascopost.com/news/september-2019/tmb-not-associated-with-pembrolizumab-efficacy-in-nsclc/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/improving-caregiver-identification-and-support-in-a-gynecologic-oncology-practice/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/improving-documentation-of-pain-and-constipation-assessment-and-management/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/intervention-to-improve-rates-of-resident-advanced-care-planning-documentation/ 2019-10-01T18:21:28+00:00 https://ascopost.com/news/september-2019/avelumab-for-mmrd-and-mmrp-endometrial-cancer/ 2019-10-01T18:21:30+00:00 https://ascopost.com/news/september-2019/real-time-ctdna-evaluation-in-patients-with-hcc/ 2019-10-01T18:21:30+00:00 https://ascopost.com/news/september-2019/fda-pipeline-fast-track-designation-in-mds-and-aml-plus-multiple-breakthrough-designations/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/tumor-immune-infiltration-and-disease-progression-in-follicular-lymphoma/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/astro-guideline-on-use-of-radiation-therapy-for-patients-with-pancreatic-cancer/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/does-ptsd-increase-the-risk-of-developing-ovarian-cancer/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/does-the-addition-of-bevacizumab-to-erlotinib-in-advanced-egfr-mutant-nsclc-improve-pfs/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/neoadjuvant-talazoparib-for-operable-brca-mutated-breast-cancer/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/solid-organ-transplantation-in-aging-survivors-of-childhood-cancer/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/postdischarge-bleeding-in-patients-with-acute-coronary-syndrome-and-cancer-diagnosis/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/cancer-drugs-account-for-over-a-quarter-of-all-new-drug-approvals-in-the-us/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/cost-of-treatment-prior-authorization-of-treatment-plans-may-cause-barriers-to-care/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/socioeconomic-deprivation-and-outcomes-in-cancer-clinical-trials/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/end-of-life-care-in-western-washington-state-vs-alberta-canada/ 2019-10-01T18:21:31+00:00 https://ascopost.com/news/september-2019/individualized-axitinib-regimens-after-immunotherapy-for-rcc/ 2019-10-01T18:21:32+00:00 https://ascopost.com/news/august-2019/ 2021-07-01T15:11:06+00:00 https://ascopost.com/news/august-2019/risk-of-infections-in-survivors-of-childhood-leukemia/ 2019-08-30T16:07:31+00:00 https://ascopost.com/news/august-2019/reducing-time-to-chemotherapy-initiation/ 2019-08-30T16:07:31+00:00 https://ascopost.com/news/august-2019/analysis-of-hpv-related-cancers-reported-from-2012-2016/ 2019-08-30T16:07:31+00:00 https://ascopost.com/news/august-2019/fda-recommendation-on-duodenoscopes-with-disposable-components/ 2019-09-03T14:30:46+00:00 https://ascopost.com/news/august-2019/pyrotinib-or-lapatinib-with-capecitabine-in-previously-treated-her2-positive-metastatic-breast-cancer/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/chromosomal-abnormalities-and-prognosis-in-npm1-mutant-aml/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/palbociclib-for-pancreatic-cancer-and-cholangiocarcinoma/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/what-role-do-physicians-play-in-health-promotion-among-patients-with-cancer/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/nivolumab-plus-ipilimumab-vs-sunitinib-as-first-line-treatment-for-advanced-rcc/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/high-deductible-health-plan-use-among-cancer-survivors/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/exposure-to-second-hand-e-cigarette-aerosols-increasing-among-students/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/text-instructions-and-reminders-may-improve-colonoscopy-adherence-rates/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/prognostic-tool-for-neuroendocrine-tumors-treated-with-a-somatostatin-analog/ 2019-08-30T15:52:17+00:00 https://ascopost.com/news/august-2019/fda-issues-draft-guidance-encouraging-inclusion-of-male-patients-in-breast-cancer-clinical-trials/ 2019-08-30T15:52:18+00:00 https://ascopost.com/news/august-2019/role-of-the-yap-regulatory-network-in-pancreatic-ductal-adenocarcinoma/ 2019-08-30T15:52:18+00:00 https://ascopost.com/news/august-2019/daa-therapy-and-reduced-mortality-in-patients-with-hepatitis-c-and-a-history-of-liver-cancer/ 2019-08-30T15:52:18+00:00 https://ascopost.com/news/august-2019/phase-ib-trial-of-toripalimabaxitinib-in-asian-patients-with-advanced-mucosal-melanoma/ 2019-08-30T15:52:18+00:00 https://ascopost.com/news/august-2019/testarticlepleaseignore/ 2021-04-29T20:59:50+00:00 https://ascopost.com/news/july-2021/ 2021-07-07T15:22:51+00:00 https://ascopost.com/news/july-2021/humanized-cd19-targeted-car-t-cell-treatment-in-patients-with-relapsed-or-refractory-b-cell-all/ 2021-07-19T18:36:38+00:00 https://ascopost.com/news/july-2021/recovery-of-gonadal-function-with-pet-adapted-regimen-for-advanced-hodgkin-lymphoma/ 2021-07-07T15:22:52+00:00 https://ascopost.com/news/july-2021/study-suggests-substantial-delays-in-diagnosis-and-treatment-for-cancer-during-the-covid-19-pandemic/ 2021-07-07T15:22:54+00:00 https://ascopost.com/news/july-2021/study-explores-co-occurring-mutations-in-her2-and-her3/ 2021-07-07T15:22:55+00:00 https://ascopost.com/news/july-2021/fda-approves-alternative-to-e-coli-derived-asparaginase-for-leukemia-and-lymphoma/ 2021-07-07T15:22:58+00:00 https://ascopost.com/news/july-2021/mortgage-lending-bias-and-survival-among-older-women-with-breast-cancer-in-the-united-states/ 2021-07-07T15:22:59+00:00 https://ascopost.com/news/july-2021/despite-gains-in-breast-cancer-survival-black-women-continue-to-experience-significant-mortality-disparities/ 2021-07-07T15:23:00+00:00 https://ascopost.com/news/july-2021/effect-of-myeloid-progenitor-cell-product-on-the-risk-of-infection-during-induction-chemotherapy-for-acute-myeloid-leukemia/ 2021-07-07T15:23:00+00:00 https://ascopost.com/news/july-2021/phase-iii-trial-compares-induction-regimens-in-high-risk-neuroblastoma/ 2021-07-07T15:23:01+00:00 https://ascopost.com/news/july-2021/fda-pipeline-recent-designations-in-nsclc-leukemia-and-lymphoma/ 2021-07-07T15:23:02+00:00 https://ascopost.com/news/july-2021/second-line-pembrolizumab-plus-chemotherapy-regimen-for-relapsed-or-refractory-classical-hodgkin-lymphoma/ 2021-07-21T19:18:19+00:00 https://ascopost.com/news/july-2021/assessment-of-targeted-methylation-based-multicancer-early-detection-test-in-independent-validation-cohort/ 2021-07-07T15:23:04+00:00 https://ascopost.com/news/july-2021/effect-of-alk-amplification-and-mutation-on-outcomes-in-high-risk-neuroblastoma/ 2021-07-07T15:23:05+00:00 https://ascopost.com/news/july-2021/efficiency-of-virtual-care-for-oncology-patients-during-the-covid-19-pandemic/ 2021-07-07T15:23:05+00:00 https://ascopost.com/news/july-2021/oncolytic-adenovirus-for-malignant-glioma-feasibility-and-safety/ 2021-07-07T16:09:40+00:00 https://ascopost.com/news/july-2021/addition-of-pembrolizumab-to-chemoradiotherapy-in-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/ 2021-07-07T16:51:23+00:00 https://ascopost.com/news/july-2021/individualized-nutritional-support-for-patients-with-cancer/ 2021-07-07T17:20:18+00:00 https://ascopost.com/news/july-2021/study-finds-reduced-treatment-delays-for-patients-with-breast-cancer-may-improve-survival-rates/ 2021-07-07T19:42:03+00:00 https://ascopost.com/news/july-2021/new-recommendations-from-who-and-hrp-for-the-screening-and-treatment-of-cervical-cancer/ 2021-07-07T19:54:55+00:00 https://ascopost.com/news/july-2021/mechanisms-of-acquired-resistance-to-kras-g12c-inhibition-in-patients-with-cancer/ 2021-08-04T18:38:21+00:00 https://ascopost.com/news/july-2021/arsenic-plus-all-trans-retinoic-acid-for-pediatric-patients-with-acute-promyelocytic-leukemia/ 2021-07-08T16:29:10+00:00 https://ascopost.com/news/july-2021/donafenib-may-improve-survival-vs-sorafenib-in-first-line-treatment-of-unresectable-or-metastatic-hepatocellular-carcinoma/ 2021-07-08T16:25:36+00:00 https://ascopost.com/news/july-2021/study-recommends-improvements-for-cancer-care-at-network-sites/ 2021-07-08T19:23:56+00:00 https://ascopost.com/news/july-2021/molecular-imaging-may-improve-the-staging-and-treatment-of-pancreatic-ductal-adenocarcinoma/ 2021-07-08T17:17:15+00:00 https://ascopost.com/news/july-2021/using-ctdna-to-measure-molecular-residual-disease-in-patients-with-colorectal-cancer/ 2021-08-04T19:15:45+00:00 https://ascopost.com/news/july-2021/parenthood-status-and-use-of-assisted-reproductive-techniques-in-younger-hodgkin-lymphoma-survivors/ 2021-07-09T16:25:36+00:00 https://ascopost.com/news/july-2021/is-chemotherapy-associated-with-complications-or-poorer-outcomes-among-women-undergoing-immediate-breast-reconstruction/ 2021-07-09T18:05:24+00:00 https://ascopost.com/news/july-2021/bcma-directed-car-t-cell-therapy-ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/ 2021-07-09T18:37:47+00:00 https://ascopost.com/news/july-2021/is-there-a-link-between-use-of-antibiotics-and-early-onset-colorectal-cancer/ 2021-07-09T18:51:02+00:00 https://ascopost.com/news/july-2021/study-finds-response-to-covid-19-vaccination-varies-widely-in-patients-with-multiple-myeloma/ 2021-07-09T18:56:18+00:00 https://ascopost.com/news/july-2021/genomic-characteristics-of-pediatric-rhabdomyosarcoma-tumors/ 2021-07-13T17:27:18+00:00 https://ascopost.com/news/july-2021/evaluation-of-two-doses-of-imetelstat-in-patients-with-relapsed-or-refractory-myelofibrosis-after-jak-inhibitor-treatment/ 2021-07-13T17:35:55+00:00 https://ascopost.com/news/july-2021/study-investigates-influence-of-race-on-receipt-of-care-for-prostate-cancer/ 2021-07-13T17:47:25+00:00 https://ascopost.com/news/july-2021/registry-provides-information-on-pediatric-melanoma/ 2021-07-13T17:55:05+00:00 https://ascopost.com/news/july-2021/cabozantinib-in-previously-treated-radioiodine-refractory-differentiated-thyroid-cancer-cosmic-311/ 2021-07-14T15:11:41+00:00 https://ascopost.com/news/july-2021/quality-of-life-with-general-practitioner-vs-surgeon-led-colon-cancer-survivorship-care/ 2021-07-14T15:33:18+00:00 https://ascopost.com/news/july-2021/calaspargase-pegol-vs-pegaspargase-in-pediatric-acute-lymphoblastic-leukemia/ 2021-07-19T18:37:19+00:00 https://ascopost.com/news/july-2021/five-year-overall-survival-data-suggest-improved-outcomes-in-pancreatic-cancer-with-nab-paclitaxel-plus-gemcitabine/ 2021-07-14T19:34:55+00:00 https://ascopost.com/news/july-2021/destiny-gastric01-exploratory-biomarker-analysis-examines-efficacy-of-trastuzumab-deruxtecan-nxki-among-patients-with-her2-positive-and-low-gastric-cancer/ 2021-07-14T19:36:00+00:00 https://ascopost.com/news/july-2021/epov-thomas-seufferlein/ 2021-07-14T17:59:54+00:00 https://ascopost.com/news/july-2021/asco-and-coa-jointly-release-oncology-medical-home-standards/ 2021-07-14T18:50:43+00:00 https://ascopost.com/news/july-2021/effect-of-obesity-on-receipt-of-chemotherapy-in-patients-with-colorectal-cancer/ 2021-07-14T19:16:12+00:00 https://ascopost.com/news/july-2021/identification-of-prognostic-transcriptional-profile-in-ctcs-with-multiplex-liquid-biopsy-in-metastatic-prostate-cancer/ 2021-07-15T15:32:03+00:00 https://ascopost.com/news/july-2021/oral-anticancer-agent-use-in-patients-with-metastatic-renal-cell-carcinoma/ 2021-07-15T16:07:08+00:00 https://ascopost.com/news/july-2021/sbrt-plus-pembrolizumabtrametinib-vs-gemcitabine-in-locally-recurrent-resected-pancreatic-cancer/ 2021-07-15T17:52:14+00:00 https://ascopost.com/news/july-2021/study-explores-ketogenic-diet-and-intermittent-fasting-in-patients-with-brain-cancer/ 2021-07-15T18:17:01+00:00 https://ascopost.com/news/july-2021/majority-of-patients-with-cancer-achieve-immune-response-after-covid-19-vaccination/ 2021-07-15T18:36:16+00:00 https://ascopost.com/news/july-2021/prevalence-of-homologous-recombination-deficiency-in-patients-with-pancreatic-cancer/ 2021-07-16T15:54:01+00:00 https://ascopost.com/news/july-2021/addition-of-docetaxel-to-radiotherapy-and-adt-in-nonmetastatic-unfavorable-risk-prostate-cancer/ 2021-07-16T13:15:44+00:00 https://ascopost.com/news/july-2021/risk-of-bleeding-complications-during-central-venous-catheter-placement-in-pediatric-patients-with-cancer/ 2021-07-16T13:26:43+00:00 https://ascopost.com/news/july-2021/study-identifies-gut-microbes-associated-with-combination-immunotherapy-response-and-adverse-events/ 2021-07-16T14:01:07+00:00 https://ascopost.com/news/july-2021/kit-inhibitor-combination-shows-efficacy-in-refractory-gist/ 2021-07-19T16:04:50+00:00 https://ascopost.com/news/july-2021/real-world-survival-outcomes-with-pertuzumab-plus-t-dm1-for-her2-positive-metastatic-breast-cancer/ 2021-07-19T16:44:26+00:00 https://ascopost.com/news/july-2021/initial-pandemic-related-disruptions-in-breast-cancer-care-may-result-in-increased-mortality-over-the-next-decade/ 2021-07-19T16:53:20+00:00 https://ascopost.com/news/july-2021/her2-specific-car-t-cell-trial-addresses-pediatric-brain-and-spinal-cord-tumors/ 2021-07-19T17:42:28+00:00 https://ascopost.com/news/july-2021/consensus-statement-from-iaslc-on-liquid-biopsy-for-advanced-nsclc/ 2021-07-19T17:52:07+00:00 https://ascopost.com/news/july-2021/adding-perioperative-durvalumab-to-neoadjuvant-chemotherapy-in-stage-iiia-nsclc/ 2021-08-19T19:27:56+00:00 https://ascopost.com/news/july-2021/pregnancy-outcomes-and-maternal-complications-among-survivors-of-breast-cancer/ 2021-07-20T18:11:51+00:00 https://ascopost.com/news/july-2021/mri-targeted-vs-standard-biopsy-for-prostate-cancer-screening-in-men-with-elevated-psa-levels/ 2021-07-20T18:37:54+00:00 https://ascopost.com/news/july-2021/study-estimates-costs-associated-with-metastatic-breast-cancer-treatment-may-increase-substantially-in-the-coming-decade/ 2021-07-20T19:17:22+00:00 https://ascopost.com/news/july-2021/atezolizumab-plus-bevacizumab-in-malignant-peritoneal-mesothelioma/ 2021-07-20T18:52:13+00:00 https://ascopost.com/news/july-2021/combination-ficlatuzumab-and-cytarabine-show-clinical-activity-in-relapsedrefractory-acute-myeloid-leukemia/ 2021-08-16T19:22:11+00:00 https://ascopost.com/news/july-2021/addition-of-prime-boost-vaccination-regimen-to-atezolizumab-in-soft-tissue-sarcomas-expressing-ny-eso-1/ 2021-07-21T15:43:05+00:00 https://ascopost.com/news/july-2021/breast-conserving-surgery-plus-radiotherapy-may-yield-better-survival-than-mastectomy-with-or-without-radiotherapy/ 2021-07-21T15:51:23+00:00 https://ascopost.com/news/july-2021/addition-of-akt-inhibitor-ipatasertib-to-abirateroneprednisolone-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/ 2021-07-21T16:06:14+00:00 https://ascopost.com/news/july-2021/study-identifies-met-amplification-as-a-driver-for-some-non-small-cell-lung-cancers/ 2021-08-19T19:39:08+00:00 https://ascopost.com/news/july-2021/efficacy-of-dendritic-cell-vaccines-plus-standard-therapy-for-breast-cancer/ 2021-07-21T18:39:15+00:00 https://ascopost.com/news/july-2021/transvaginal-ultrasound-screening-misses-more-cases-of-endometrial-cancer-in-black-women-vs-white-women/ 2021-07-21T18:38:07+00:00 https://ascopost.com/news/july-2021/interleukin-2-pathway-agonist-bempegaldesleukin-plus-nivolumab-in-the-first-line-treatment-of-metastatic-melanoma/ 2021-07-22T15:54:49+00:00 https://ascopost.com/news/july-2021/is-there-a-disease-free-survival-benefit-with-adjuvant-celecoxib-in-her2-negative-breast-cancer/ 2021-07-22T16:00:03+00:00 https://ascopost.com/news/july-2021/ruxolitinib-for-glucocorticoid-refractory-or-dependent-chronic-graft-vs-host-disease-after-allogeneic-stem-cell-transplantation/ 2021-07-22T16:05:53+00:00 https://ascopost.com/news/july-2021/study-finds-the-covid-19-pandemic-created-significant-disruptions-in-cancer-screenings-at-federally-qualified-health-centers/ 2021-07-22T16:10:48+00:00 https://ascopost.com/news/july-2021/outcomes-in-patients-with-her2-low-positive-breast-cancer-participating-in-neoadjuvant-clinical-trials/ 2021-07-23T13:03:48+00:00 https://ascopost.com/news/july-2021/implementation-of-a-program-providing-free-cancer-screenings-same-day-results/ 2021-07-23T13:18:17+00:00 https://ascopost.com/news/july-2021/addition-of-ipilimumab-to-nivolumab-in-previously-treated-immunotherapy-naive-stage-iv-squamous-nsclc/ 2021-08-19T19:36:27+00:00 https://ascopost.com/news/july-2021/nomograms-for-predicting-outcomes-with-lupsma-therapy-in-metastatic-castration-resistant-prostate-cancer/ 2021-07-23T14:08:19+00:00 https://ascopost.com/news/july-2021/fda-pipeline-designations-for-therapies-in-myelodysplastic-syndromes-and-triple-negative-breast-cancer/ 2021-07-23T14:21:01+00:00 https://ascopost.com/news/july-2021/prostate-cancer-surgery-rates-in-black-vs-white-men-with-nonmetastatic-disease-during-the-covid-19-pandemic/ 2021-07-27T17:03:58+00:00 https://ascopost.com/news/july-2021/weekly-outpatient-palliative-care-interventions-among-patients-with-head-and-neck-cancer/ 2026-01-29T15:56:16+00:00 https://ascopost.com/news/july-2021/pembrolizumab-shows-durable-antitumor-activity-in-both-locally-advanced-and-recurrentmetastatic-squamous-cell-carcinomas/ 2021-07-28T14:45:05+00:00 https://ascopost.com/news/july-2021/survival-trends-for-adolescents-and-young-adults-with-cancer-40-year-analysis/ 2021-07-28T15:01:00+00:00 https://ascopost.com/news/july-2021/study-explores-cost-effectiveness-of-chop-therapy-for-patients-with-dlbcl-in-sub-saharan-africa/ 2021-08-12T19:15:08+00:00 https://ascopost.com/news/july-2021/can-treatment-with-thiopurines-induce-mutations-that-may-lead-to-pediatric-leukemia-relapse/ 2021-07-28T19:24:22+00:00 https://ascopost.com/news/july-2021/trends-in-opioid-prescriptions-among-patients-with-cancer-near-the-end-of-life/ 2021-07-28T17:16:12+00:00 https://ascopost.com/news/july-2021/comparison-of-first-line-chemotherapy-strategies-in-metastatic-pancreatic-cancer/ 2021-07-28T17:46:48+00:00 https://ascopost.com/news/july-2021/complication-rates-among-central-venous-access-devices-compared/ 2021-07-28T17:58:38+00:00 https://ascopost.com/news/july-2021/clinical-trial-results-show-an-increased-risk-of-death-associated-with-melphalan-flufenamide/ 2021-07-29T17:58:40+00:00 https://ascopost.com/news/july-2021/study-explores-rates-of-reconstruction-for-women-with-inflammatory-breast-cancer-undergoing-mastectomy/ 2021-07-29T17:59:18+00:00 https://ascopost.com/news/july-2021/astro-issues-new-clinical-guideline-on-radiation-therapy-for-adult-patients-with-soft-tissue-sarcoma/ 2021-07-29T16:48:42+00:00 https://ascopost.com/news/july-2021/risk-of-breast-cancer-in-women-older-than-age-65-with-germline-pathogenic-variants-in-predisposition-genes/ 2021-07-29T17:01:01+00:00 https://ascopost.com/news/july-2021/study-examines-prevalence-of-cancer-misinformation-and-harmful-information-on-social-media/ 2021-07-29T17:07:21+00:00 https://ascopost.com/news/july-2021/perioperative-or-postoperative-oxaliplatins-1-vs-postoperative-oxaliplatincapecitabine-for-locally-advanced-gastric-cancer/ 2021-07-29T17:12:53+00:00 https://ascopost.com/news/july-2021/association-of-baseline-fatigue-with-survival-and-adverse-events-in-patients-with-advanced-cancer/ 2021-07-29T19:53:02+00:00 https://ascopost.com/news/july-2021/frailty-and-neurocognitive-decline-among-young-adult-childhood-cancer-survivors/ 2021-07-29T20:16:28+00:00 https://ascopost.com/news/july-2021/incidence-of-axillary-adenopathy-in-screening-or-diagnostic-mammography-after-covid-19-vaccination/ 2021-07-30T13:20:08+00:00 https://ascopost.com/news/july-2021/meta-analysis-identifies-genetic-markers-for-inherited-testicular-cancer/ 2021-07-30T13:25:26+00:00 https://ascopost.com/news/july-2021/study-shows-cancer-trials-adapted-rapidly-during-the-covid-19-pandemic/ 2021-07-30T13:32:37+00:00 https://ascopost.com/news/august-2021/ 2021-08-02T13:44:21+00:00 https://ascopost.com/news/august-2021/carboplatin-intensification-for-the-treatment-of-pediatric-high-risk-medulloblastoma/ 2021-08-02T15:37:46+00:00 https://ascopost.com/news/august-2021/continuous-azacitidine-vs-reduced-intensity-conditioning-hsct-in-older-patients-with-advanced-myelodysplastic-syndrome/ 2021-08-02T15:45:25+00:00 https://ascopost.com/news/august-2021/neoadjuvant-cabozantinibnivolumab-may-make-resection-possible-for-some-patients-with-liver-cancer/ 2021-08-02T17:25:21+00:00 https://ascopost.com/news/august-2021/addition-of-metformin-to-chemoradiotherapy-for-locally-advanced-nsclc/ 2021-08-03T13:13:00+00:00 https://ascopost.com/news/august-2021/tremelimumab-durvalumab-or-both-in-unresectable-hepatocellular-carcinoma/ 2021-08-03T13:22:27+00:00 https://ascopost.com/news/august-2021/racialethnic-disparities-in-emergency-department-visits-after-breast-cancer-surgery/ 2021-08-03T13:44:45+00:00 https://ascopost.com/news/august-2021/maintaining-a-healthy-lifestyle-may-decrease-cancer-incidence-in-high-risk-individuals/ 2021-08-03T13:59:10+00:00 https://ascopost.com/news/august-2021/second-generation-androgen-receptor-inhibitors-for-older-men-with-nonmetastatic-castration-resistant-prostate-cancer/ 2021-08-04T15:32:59+00:00 https://ascopost.com/news/august-2021/revised-children-s-oncology-group-neuroblastoma-risk-classification-system/ 2021-08-04T15:39:24+00:00 https://ascopost.com/news/august-2021/does-pain-affect-the-employment-and-financial-outcomes-of-cancer-survivors/ 2021-08-04T15:55:54+00:00 https://ascopost.com/news/august-2021/study-highlights-gaps-in-mental-health-and-chemical-dependency-care-at-us-cancer-centers/ 2021-08-04T16:02:30+00:00 https://ascopost.com/news/august-2021/use-of-statins-and-survival-outcomes-among-patients-with-triple-negative-breast-cancer/ 2021-08-04T17:05:25+00:00 https://ascopost.com/news/august-2021/lung-cancer-screening-rates-improved-in-19-states-despite-the-covid-19-pandemic/ 2021-08-05T13:44:55+00:00 https://ascopost.com/news/august-2021/cutaneous-hpv-may-be-a-predictor-of-cutaneous-squamous-cell-carcinoma-risk/ 2021-08-05T13:55:17+00:00 https://ascopost.com/news/august-2021/2-vs-5-years-of-hormone-therapy-following-adjuvant-endocrine-therapy-in-postmenopausal-women-with-hr-positive-breast-cancer/ 2021-08-05T16:03:20+00:00 https://ascopost.com/news/august-2021/elevate-rr-trial-acalabrutinib-vs-ibrutinib-in-previously-treated-patients-with-cll/ 2021-08-16T19:22:46+00:00 https://ascopost.com/news/august-2021/adding-short-term-androgen-suppression-to-radiotherapy-for-patients-with-localized-intermediate-risk-prostate-cancer/ 2021-08-05T16:30:02+00:00 https://ascopost.com/news/august-2021/i-131-metaiodobenzylguanidine-containing-regimens-in-relapsed-or-refractory-neuroblastoma/ 2021-08-06T13:29:11+00:00 https://ascopost.com/news/august-2021/addition-of-metformin-to-chemoradiation-in-locally-advanced-nsclc/ 2021-08-19T19:35:31+00:00 https://ascopost.com/news/august-2021/minimally-invasive-esophagectomy-followed-by-intrathoracic-vs-cervical-anastomosis-for-esophageal-cancer/ 2021-08-06T13:32:15+00:00 https://ascopost.com/news/august-2021/covid-19-vaccine-is-safe-in-patients-with-hematologic-malignancies-but-some-do-not-produce-detectable-antibodies/ 2021-08-06T13:34:03+00:00 https://ascopost.com/news/august-2021/pertuzumab-and-trastuzumab-in-previously-treated-patients-with-her2-positive-metastatic-biliary-tract-cancer/ 2021-08-09T16:32:15+00:00 https://ascopost.com/news/august-2021/s-1-chemoradiation-vs-radiotherapy-alone-in-patients-aged-70-to-85-with-esophageal-cancer/ 2021-08-09T16:47:05+00:00 https://ascopost.com/news/august-2021/topical-hdac-inhibitor-remetinostat-for-basal-cell-carcinoma/ 2021-08-09T16:56:09+00:00 https://ascopost.com/news/august-2021/disparities-observed-in-follow-up-care-among-young-adult-childhood-cancer-survivors/ 2021-08-09T19:12:52+00:00 https://ascopost.com/news/august-2021/study-investigates-relationship-between-peanut-agglutinin-and-cancer-metastasis/ 2021-08-09T17:16:17+00:00 https://ascopost.com/news/august-2021/adjuvant-nivolumab-improves-disease-free-survival-in-high-risk-muscle-invasive-urothelial-carcinoma/ 2021-08-09T18:22:31+00:00 https://ascopost.com/news/august-2021/ribociclib-plus-topotecantemozolomide-or-everolimus-in-pediatric-patients-with-advanced-cancer-enriched-for-target-pathway-alterations/ 2021-08-11T14:04:11+00:00 https://ascopost.com/news/august-2021/addition-of-avelumab-to-chemotherapy-in-previously-untreated-patients-with-advanced-epithelial-ovarian-cancer/ 2021-08-11T14:11:27+00:00 https://ascopost.com/news/august-2021/association-of-incomplete-polyp-removal-with-risk-of-post-colonoscopy-colorectal-cancer/ 2021-08-11T15:38:03+00:00 https://ascopost.com/news/august-2021/enrollment-of-aya-patients-into-nci-sponsored-clinical-trials-25-year-analysis/ 2021-08-11T15:20:31+00:00 https://ascopost.com/news/august-2021/outcomes-and-behaviors-among-women-receiving-or-declining-their-breast-cancer-polygenic-risk-score/ 2021-08-11T14:56:57+00:00 https://ascopost.com/news/august-2021/risk-of-early-cardiac-toxicity-with-posttransplantation-cyclophosphamide-after-hsct/ 2021-08-11T15:10:41+00:00 https://ascopost.com/news/august-2021/evaluation-of-baseline-cancer-mortality-risk-in-medicaid-expansion-and-nonexpansion-states/ 2021-08-12T16:35:14+00:00 https://ascopost.com/news/august-2021/effect-of-regionalization-of-gastric-cancer-care-in-an-integrated-health-care-system/ 2021-08-12T17:20:29+00:00 https://ascopost.com/news/august-2021/amivantamab-for-patients-with-egfr-exon-20-insertion-mutated-nsclc-after-disease-progression-on-platinum-therapy/ 2021-08-12T17:23:44+00:00 https://ascopost.com/news/august-2021/do-muscle-strengthening-activities-plus-aerobic-activities-reduce-cancer-mortality/ 2021-08-12T17:26:55+00:00 https://ascopost.com/news/august-2021/fda-pipeline-reviews-for-agents-in-lung-cancer-thyroid-cancer-kidney-cancer-and-more/ 2021-08-12T19:08:34+00:00 https://ascopost.com/news/august-2021/vincristineirinotecan-with-or-without-temozolomide-for-relapsed-or-refractory-rhabdomyosarcoma/ 2021-08-13T14:50:42+00:00 https://ascopost.com/news/august-2021/causes-of-death-among-men-diagnosed-with-metastatic-prostate-cancer/ 2021-08-13T16:29:34+00:00 https://ascopost.com/news/august-2021/financial-toxicity-associated-with-atherosclerotic-cardiovascular-disease-and-cancer/ 2021-08-13T15:25:58+00:00 https://ascopost.com/news/august-2021/fda-approves-belzutifan-for-cancers-associated-with-von-hippel-lindau-disease/ 2021-08-13T15:39:00+00:00 https://ascopost.com/news/august-2021/meta-analysis-of-outcomes-with-the-addition-of-adjuvant-trastuzumab-to-chemotherapy-for-her2-positive-breast-cancer/ 2021-08-13T16:27:29+00:00 https://ascopost.com/news/august-2021/seroconversion-after-covid-19-vaccination-in-adult-patients-with-hematologic-malignancies/ 2021-08-16T15:09:02+00:00 https://ascopost.com/news/august-2021/avapritinib-vs-regorafenib-in-molecularly-unselected-previously-treated-advanced-gist/ 2021-08-16T15:35:28+00:00 https://ascopost.com/news/august-2021/genomic-adjusted-radiation-dose-model-to-predict-radiotherapy-benefit-across-cancer-types/ 2021-08-16T15:33:28+00:00 https://ascopost.com/news/august-2021/wearable-temperature-sensor-may-aid-in-detecting-febrile-adverse-events-in-patients-with-cancer/ 2021-08-16T15:50:28+00:00 https://ascopost.com/news/august-2021/teclistamab-shows-efficacy-produces-durable-responses-in-relapsed-or-refractory-multiple-myeloma/ 2021-08-16T16:14:06+00:00 https://ascopost.com/news/august-2021/analyses-examine-relationship-between-treatment-with-parp-inhibitors-and-risk-of-secondary-malignancies/ 2021-08-16T19:41:01+00:00 https://ascopost.com/news/august-2021/addition-of-entinostat-to-exemestane-in-aromatase-inhibitor-resistant-hr-positive-her2-negative-advanced-breast-cancer/ 2021-09-01T18:03:57+00:00 https://ascopost.com/news/august-2021/hypofractionated-image-guided-vs-conventional-radiotherapy-in-patients-with-stage-iiiii-nsclc-ineligible-for-concurrent-chemoradiation/ 2021-08-19T19:28:41+00:00 https://ascopost.com/news/august-2021/simulation-model-based-clinical-decision-tool-for-predicting-benefit-of-adjuvant-chemoendocrine-vs-endocrine-therapy-in-hr-positive-her2-negative-breast-cancer/ 2021-08-17T19:07:10+00:00 https://ascopost.com/news/august-2021/small-study-evaluates-combination-ipilimumabnivolumab-in-patients-with-angiosarcoma/ 2021-08-17T17:32:59+00:00 https://ascopost.com/news/august-2021/does-sparing-the-hippocampus-during-prophylactic-cranial-irradiation-for-sclc-help-to-preserve-cognitive-function/ 2021-08-17T18:20:20+00:00 https://ascopost.com/news/august-2021/removing-race-from-kidney-function-estimates-may-impact-care-of-black-patients-with-cancer/ 2021-08-17T18:28:22+00:00 https://ascopost.com/news/august-2021/study-identifies-potential-mechanisms-of-resistance-to-sacituzumab-govitecan-in-patients-with-triple-negative-breast-cancer/ 2021-08-18T17:52:02+00:00 https://ascopost.com/news/august-2021/retrospective-study-compares-characteristics-of-early-onset-vs-average-onset-colorectal-cancer/ 2021-08-18T15:49:26+00:00 https://ascopost.com/news/august-2021/experimental-small-molecule-inhibitor-may-improve-responses-to-cellular-therapies-in-advanced-cll/ 2021-09-20T18:27:06+00:00 https://ascopost.com/news/august-2021/talazoparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-and-dna-repair-gene-alterations/ 2021-08-18T16:55:42+00:00 https://ascopost.com/news/august-2021/donor-derived-cd7-car-t-cells-may-lead-to-remissions-in-patients-with-relapsed-or-refractory-t-all/ 2021-09-20T18:26:06+00:00 https://ascopost.com/news/august-2021/first-line-cisplatin-plus-gemcitabine-or-fluorouracil-for-advanced-nasopharyngeal-carcinoma/ 2026-01-29T16:40:12+00:00 https://ascopost.com/news/august-2021/study-finds-cannabis-use-is-lower-among-patients-with-cancer-than-those-with-no-cancer-history/ 2021-08-19T19:24:05+00:00 https://ascopost.com/news/august-2021/can-consumption-of-vitamin-d-reduce-the-risk-of-early-onset-colorectal-cancer/ 2021-08-19T18:43:53+00:00 https://ascopost.com/news/august-2021/prediction-models-may-reduce-false-positives-in-women-with-dense-breasts-undergoing-mri-screening/ 2021-08-19T18:52:54+00:00 https://ascopost.com/news/august-2021/cetuximab-plus-avelumab-as-rechallenge-therapy-for-ras-wild-type-metastatic-colorectal-cancer/ 2021-08-20T14:31:20+00:00 https://ascopost.com/news/august-2021/study-identifies-possible-new-genetic-biomarkers-of-pediatric-leukemia/ 2021-08-20T16:05:37+00:00 https://ascopost.com/news/august-2021/does-antibiotic-exposure-affect-response-to-first-line-chemoimmunotherapy-in-patients-with-nsclc/ 2021-08-20T16:07:15+00:00 https://ascopost.com/news/august-2021/study-examines-association-between-benign-prostatic-hyperplasia-and-prostate-cancer/ 2021-08-20T15:53:23+00:00 https://ascopost.com/news/august-2021/physical-activity-and-cognitive-function-before-during-and-after-chemotherapy-for-breast-cancer/ 2021-08-23T15:09:01+00:00 https://ascopost.com/news/august-2021/excess-cardiovascular-disease-risk-in-patients-with-early-stage-lymphoma-personalizing-radiotherapy-delivery/ 2021-08-23T16:30:15+00:00 https://ascopost.com/news/august-2021/caution-with-robotically-assisted-surgical-devices-for-mastectomy-fda-safety-communication/ 2021-08-23T19:34:02+00:00 https://ascopost.com/news/august-2021/extended-follow-up-of-paloma-3-supports-survival-benefit-of-palbociclib-plus-fulvestrant-in-advanced-breast-cancer/ 2021-08-24T14:22:55+00:00 https://ascopost.com/news/august-2021/non-testicular-cancer-mortality-rates-in-men-with-testicular-cancer-in-the-cisplatin-era/ 2021-08-24T18:56:55+00:00 https://ascopost.com/news/august-2021/adjuvant-pembrolizumab-may-improve-disease-free-survival-in-patients-with-high-risk-renal-cell-carcinoma/ 2021-08-24T18:55:53+00:00 https://ascopost.com/news/august-2021/patients-with-melanoma-previously-treated-with-pd-1-or-mapk-inhibitors-may-be-less-likely-to-respond-to-act-til-therapy/ 2021-08-24T16:39:41+00:00 https://ascopost.com/news/august-2021/study-examines-link-between-obesity-in-long-term-cancer-survivors-and-increased-health-care-utilization-and-spending/ 2021-08-24T19:02:54+00:00 https://ascopost.com/news/august-2021/fda-pipeline-reviews-for-agents-in-acute-graft-vs-host-disease-nasopharyngeal-and-ovarian-cancers/ 2026-01-29T16:42:26+00:00 https://ascopost.com/news/august-2021/profile-of-adverse-events-related-to-pd-1-and-pd-l1-inhibitor-based-therapy/ 2021-08-26T18:13:05+00:00 https://ascopost.com/news/august-2021/does-radiotherapy-reduce-the-long-term-risk-of-ipsilateral-breast-recurrence-in-women-with-dcis-who-underwent-lumpectomy/ 2021-08-26T16:16:53+00:00 https://ascopost.com/news/august-2021/report-aims-to-assess-contemporary-burden-of-brain-tumors-in-the-united-states/ 2021-08-26T16:53:21+00:00 https://ascopost.com/news/august-2021/antihypertensive-medications-may-improve-survival-among-patients-with-stage-i-to-iii-colorectal-cancer/ 2021-08-26T16:43:00+00:00 https://ascopost.com/news/august-2021/japanese-study-examines-how-intervention-encourages-screening-for-colorectal-cancer-among-patients-with-schizophrenia/ 2021-08-26T16:38:51+00:00 https://ascopost.com/news/august-2021/cancer-predisposition-screening-tool-for-predicting-subsequent-malignancies-in-childhood-cancer-survivors/ 2021-08-27T14:06:33+00:00 https://ascopost.com/news/august-2021/ixazomibrituximabdexamethasone-for-relapsed-or-refractory-waldenstroem-s-macroglobulinemia/ 2021-08-27T14:45:36+00:00 https://ascopost.com/news/august-2021/prostate-cancer-screening-using-the-stockholm3-screening-test-with-mri-guided-biopsy/ 2021-08-27T14:54:16+00:00 https://ascopost.com/news/august-2021/two-studies-explore-the-role-of-primary-care-providers-in-effective-cancer-care/ 2021-08-27T15:41:28+00:00 https://ascopost.com/news/august-2021/study-finds-drop-in-breast-cancer-screening-rates-in-low-income-communities-during-the-covid-19-pandemic/ 2021-08-27T16:52:41+00:00 https://ascopost.com/news/august-2021/personalized-risk-prediction-model-for-patients-with-myelodysplastic-syndromes/ 2021-08-30T19:08:22+00:00 https://ascopost.com/news/august-2021/effects-of-removing-race-in-the-ckd-epi-equation-for-estimated-glomerular-filtration-rate/ 2021-08-30T16:57:09+00:00 https://ascopost.com/news/august-2021/alk-fusion-positive-high-grade-glioma-response-to-lorlatinib-in-a-single-pediatric-case/ 2021-08-30T17:07:59+00:00 https://ascopost.com/news/august-2021/study-examines-cancer-specific-mortality-among-patients-with-neuroendocrine-tumors/ 2021-08-30T18:30:20+00:00 https://ascopost.com/news/august-2021/pharmacologic-cardioprotection-in-women-with-nonmetastatic-breast-cancer-receiving-anthracycline-based-chemotherapy/ 2021-08-31T15:05:05+00:00 https://ascopost.com/news/august-2021/first-line-veliparib-plus-platinum-based-chemotherapy-in-current-smokers-with-advanced-squamous-cell-nsclc/ 2021-08-31T19:42:31+00:00 https://ascopost.com/news/august-2021/study-explores-relationship-between-anti-cd20-therapy-and-reduced-responses-to-mrna-covid-19-vaccines/ 2021-08-31T15:13:47+00:00 https://ascopost.com/news/august-2021/study-highlights-gaps-between-lung-cancer-treatment-recommendations-and-real-world-use-of-durvalumab/ 2021-08-31T19:49:00+00:00 https://ascopost.com/news/august-2021/cross-sectional-survey-reveals-disparities-in-care-of-patients-with-brain-metastases/ 2021-09-01T18:28:46+00:00 https://ascopost.com/news/august-2021/addition-of-pembrolizumab-to-chemotherapy-for-the-first-line-treatment-of-advanced-esophageal-cancer-keynote-590/ 2021-08-31T18:48:07+00:00 https://ascopost.com/news/september-2021/ 2021-09-01T14:39:07+00:00 https://ascopost.com/news/september-2021/global-breast-cancer-survival-estimated-impact-of-scaling-up-access-to-treatmentimaging-modalities-and-quality-of-care/ 2021-09-01T15:29:19+00:00 https://ascopost.com/news/september-2021/inguinofemoral-radiotherapy-vs-inguinofemoral-lymphadenectomy-for-patients-with-vulvar-cancer-and-sentinel-node-metastasis/ 2021-09-01T15:37:58+00:00 https://ascopost.com/news/september-2021/addition-of-atr-inhibitor-berzosertib-to-cisplatingemcitabine-in-metastatic-urothelial-carcinoma/ 2021-09-01T15:58:14+00:00 https://ascopost.com/news/september-2021/study-examines-link-between-in-utero-events-and-risk-of-colorectal-cancer-in-adult-offspring/ 2021-09-01T16:27:06+00:00 https://ascopost.com/news/september-2021/addition-of-venetoclax-to-daratumumabdexamethasone-with-or-without-bortezomib-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2021-09-02T15:50:26+00:00 https://ascopost.com/news/september-2021/effects-of-covid-19-infection-in-children-and-adolescents-with-cancer-global-analysis/ 2021-09-02T15:57:23+00:00 https://ascopost.com/news/september-2021/early-stage-research-on-dual-action-estrogen-receptor-inhibitors-for-breast-cancer/ 2021-09-02T16:20:59+00:00 https://ascopost.com/news/september-2021/pembrolizumabentinostat-for-metastatic-uveal-melanoma/ 2021-09-02T16:25:51+00:00 https://ascopost.com/news/september-2021/addition-of-everolimus-to-letrozole-in-premenopausal-women-with-advanced-hr-positive-her2-negative-breast-cancer/ 2021-10-04T18:32:40+00:00 https://ascopost.com/news/september-2021/effect-of-concurrent-focal-22q1122-deletions-and-ikzf1-alterations-on-outcomes-in-pediatric-patients-with-b-cell-all/ 2021-09-20T17:48:17+00:00 https://ascopost.com/news/september-2021/neoadjuvant-gemcitabine-and-split-dose-cisplatin-plus-pembrolizumab-for-muscle-invasive-bladder-cancer/ 2021-09-03T15:34:29+00:00 https://ascopost.com/news/september-2021/cell-free-dna-analysis-to-distinguish-development-of-malignant-peripheral-nerve-sheath-tumors-from-plexiform-neurofibromas/ 2021-09-03T16:40:03+00:00 https://ascopost.com/news/september-2021/study-suggests-demographic-enrollment-reporting-requirements-for-acute-leukemia-clinical-trials-are-lacking/ 2021-09-03T16:32:45+00:00 https://ascopost.com/news/september-2021/ibrutinib-and-cardiovascular-risk-in-patients-with-chronic-lymphocytic-leukemia/ 2021-09-07T16:34:32+00:00 https://ascopost.com/news/september-2021/phase-ii-trial-evaluates-oncolytic-coxsackievirus-a21-for-unresectable-advanced-melanoma/ 2021-09-07T16:50:25+00:00 https://ascopost.com/news/september-2021/teleoncology-for-veterans-with-cancer-during-the-covid-19-pandemic/ 2021-09-07T17:55:26+00:00 https://ascopost.com/news/september-2021/several-studies-show-rovalpituzumab-tesirine-is-ineffective-against-sclc/ 2021-09-07T18:53:43+00:00 https://ascopost.com/news/september-2021/pharmacy-strategy-to-decrease-patient-copayments-for-high-cost-cancer-drugs-through-financial-assistance-applications/ 2021-09-08T16:33:58+00:00 https://ascopost.com/news/september-2021/biomarker-analysis-evaluates-potential-for-immune-checkpoint-blockade-response-in-older-patients-with-cancer/ 2021-09-08T16:44:09+00:00 https://ascopost.com/news/september-2021/genomic-analysis-of-lung-cancer-in-never-smokers/ 2021-09-08T17:28:24+00:00 https://ascopost.com/news/september-2021/effect-of-high-intensity-interval-training-on-biochemical-progression-in-patients-with-localized-prostate-cancer-under-active-surveillance/ 2021-09-09T16:29:04+00:00 https://ascopost.com/news/september-2021/resurgence-of-covid-19-infection-in-a-large-vaccinated-health-system-workforce/ 2021-09-09T19:09:41+00:00 https://ascopost.com/news/september-2021/study-finds-low-poverty-us-counties-may-eliminate-cervical-cancer-14-years-earlier-than-high-poverty-counties/ 2021-09-09T16:44:57+00:00 https://ascopost.com/news/september-2021/iaslc-2021-study-examines-global-risk-of-lung-cancer-due-to-air-pollution/ 2021-09-10T21:04:15+00:00 https://ascopost.com/news/september-2021/iaslc-2021-enrollment-in-clinical-trials-for-lung-cancer-declined-significantly-during-the-covid-19-pandemic/ 2021-09-09T21:16:51+00:00 https://ascopost.com/news/september-2021/iaslc-2021-single-center-study-examines-psychological-impact-of-the-covid-19-pandemic-on-patients-with-lung-cancer/ 2021-09-09T19:15:10+00:00 https://ascopost.com/news/september-2021/technology-enabled-monitoring-of-adverse-reactions-to-immune-checkpoint-inhibitors/ 2021-09-13T20:09:03+00:00 https://ascopost.com/news/september-2021/racial-disparities-among-men-with-prostate-cancer/ 2021-09-14T19:54:10+00:00 https://ascopost.com/news/september-2021/no-overall-survival-benefit-with-lurbinectedindoxorubicin-in-small-cell-lung-cancer/ 2021-09-13T20:08:22+00:00 https://ascopost.com/news/september-2021/impower010-study-of-atezolizumab-in-resectable-nsclc-benefits-observed-regardless-of-stage-type-of-prior-treatment/ 2021-09-23T19:16:12+00:00 https://ascopost.com/news/september-2021/poseidon-trial-dual-checkpoint-blockade-plus-chemotherapy-improves-survival-in-first-line-metastatic-nsclc/ 2021-09-13T18:02:05+00:00 https://ascopost.com/news/september-2021/effect-of-mindfulness-meditation-and-survivorship-education-on-depressive-symptoms-in-younger-breast-cancer-survivors/ 2021-09-14T15:51:18+00:00 https://ascopost.com/news/september-2021/cancer-specific-urgent-care-center-effect-on-emergency-department-use-and-hospitalization-rate/ 2021-09-14T16:24:23+00:00 https://ascopost.com/news/september-2021/auto1-car-t-cell-product-for-adult-patients-with-relapsed-or-refractory-b-cell-all/ 2021-09-20T17:44:21+00:00 https://ascopost.com/news/september-2021/maintenance-durvalumab-increased-utilization-could-improve-nsclc-outcomes/ 2021-09-23T19:20:39+00:00 https://ascopost.com/news/september-2021/radical-cystectomy-early-stage-micropapillary-bladder-cancer-outcomes-similar-to-late-stage-conventional-urothelial-carcinoma/ 2021-10-12T15:57:53+00:00 https://ascopost.com/news/september-2021/neoadjuvant-atezolizumab-under-study-for-resectable-pleural-mesothelioma/ 2021-09-23T19:22:12+00:00 https://ascopost.com/news/september-2021/rates-of-adverse-reactions-to-the-moderna-mrna-1273-covid-19-vaccine-in-patients-with-cancer-and-recent-radiotherapy/ 2021-09-15T16:50:52+00:00 https://ascopost.com/news/september-2021/inclusion-of-women-in-oncology-clinical-trials-from-2000-to-2020/ 2021-09-15T19:35:57+00:00 https://ascopost.com/news/september-2021/nivolumab-vs-gemcitabine-or-pegylated-liposomal-doxorubicin-what-regimen-improves-survival-in-platinum-resistant-ovarian-cancer/ 2021-09-15T16:58:57+00:00 https://ascopost.com/news/september-2021/survey-examines-oncology-clinician-perceptions-of-biomarker-testing-for-underserved-patients-with-lung-cancer/ 2021-09-15T19:37:44+00:00 https://ascopost.com/news/september-2021/almost-two-thirds-of-thoracic-oncologists-reported-using-telehealth-for-the-first-time-during-the-covid-19-pandemic/ 2021-09-23T20:05:21+00:00 https://ascopost.com/news/september-2021/atezolizumab-plus-chemotherapy-in-patients-with-advanced-nsclc-and-brain-metastases/ 2021-09-23T19:17:22+00:00 https://ascopost.com/news/september-2021/can-diabetes-affect-the-efficacy-of-immune-checkpoint-inhibitors-in-patients-with-advanced-cancer/ 2021-09-18T13:39:03+00:00 https://ascopost.com/news/september-2021/study-examines-how-children-cope-with-a-parent-s-cancer-diagnosis/ 2021-09-18T13:29:41+00:00 https://ascopost.com/news/september-2021/study-finds-up-to-15-of-patients-with-cancer-experience-long-haul-covid-19/ 2021-09-18T13:48:26+00:00 https://ascopost.com/news/september-2021/phase-iii-trial-investigates-extended-adjuvant-endocrine-therapy-for-postmenopausal-patients-with-breast-cancer/ 2021-09-18T14:12:20+00:00 https://ascopost.com/news/september-2021/atr-inhibitor-ceralasertib-in-arid1a-deficient-and-arid1a-intact-solid-tumors/ 2021-09-19T13:29:03+00:00 https://ascopost.com/news/september-2021/long-term-therapy-with-bintrafusp-alfa-in-hpv-associated-cancers/ 2021-09-19T15:34:31+00:00 https://ascopost.com/news/september-2021/destiny-gastric02-trastuzumab-deruxtecan-produces-responses-in-patients-with-her2-positive-gastric-cancers/ 2021-09-19T15:44:44+00:00 https://ascopost.com/news/september-2021/keynote-826-pembrolizumab-plus-chemotherapy-in-advanced-cervical-cancer/ 2021-09-22T20:49:27+00:00 https://ascopost.com/news/september-2021/destiny-breast03-second-line-trastuzumab-deruxtecan-for-metastatic-her2-positive-breast-cancer/ 2021-10-04T18:28:27+00:00 https://ascopost.com/news/september-2021/association-of-skeletal-muscle-area-and-adiposity-measures-with-inflammation-and-outcomes-in-nonmetastatic-colon-cancer/ 2021-09-20T14:21:31+00:00 https://ascopost.com/news/september-2021/bispecific-antibody-epcoritamab-in-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma/ 2021-09-20T14:40:57+00:00 https://ascopost.com/news/september-2021/estimated-impact-of-the-covid-19-pandemic-on-cancer-diagnosis-and-survival-in-chile-over-the-next-decade/ 2021-09-20T15:18:00+00:00 https://ascopost.com/news/september-2021/monaleesa-2-ribociclib-plus-endocrine-therapy-extends-overall-survival-in-postmenopausal-patients-with-metastatic-breast-cancer/ 2021-09-22T20:38:29+00:00 https://ascopost.com/news/september-2021/adjuvant-pembrolizumab-for-high-risk-stage-ii-melanoma-efficacy-and-safety-examined/ 2021-09-22T20:40:35+00:00 https://ascopost.com/news/september-2021/integrating-community-based-interventions-into-cancer-care-for-low-income-and-minority-patients-may-improve-quality-of-life-reduce-care-disparities/ 2021-09-20T21:11:55+00:00 https://ascopost.com/news/september-2021/study-finds-prior-authorization-may-be-associated-with-delayed-receipt-of-oral-anticancer-drugs/ 2021-09-20T21:13:40+00:00 https://ascopost.com/news/september-2021/mortality-trends-after-allogeneic-blood-or-marrow-transplantation/ 2021-09-21T17:06:03+00:00 https://ascopost.com/news/september-2021/covid-19-lockdown-may-be-associated-with-higher-tumor-burden-in-newly-diagnosed-patients-with-metastatic-colorectal-cancer/ 2021-11-03T20:04:21+00:00 https://ascopost.com/news/september-2021/addition-of-ramucirumab-to-gemcitabine-in-second-line-treatment-of-malignant-pleural-mesothelioma/ 2021-09-21T18:01:15+00:00 https://ascopost.com/news/september-2021/cosmic-021-cabozantinib-plus-atezolizumab-for-advanced-renal-cell-carcinoma/ 2021-09-21T18:18:44+00:00 https://ascopost.com/news/september-2021/destiny-lung01-fam-trastuzumab-deruxtecan-nxki-in-previously-treated-her2-mutant-nsclc/ 2021-09-23T20:03:59+00:00 https://ascopost.com/news/september-2021/role-of-geriatric-assessment-in-personalizing-therapy-for-elderly-patients-with-head-and-neck-cancer/ 2026-01-29T16:22:48+00:00 https://ascopost.com/news/september-2021/association-of-pathologic-residual-cancer-burden-and-event-free-survival-after-neoadjuvant-treatment-for-high-risk-breast-cancer/ 2021-09-22T16:44:54+00:00 https://ascopost.com/news/september-2021/single-fraction-vs-multifraction-sabr-for-pulmonary-oligometastases/ 2021-09-22T17:03:30+00:00 https://ascopost.com/news/september-2021/long-term-outcomes-in-juliet-trial-of-tisagenlecleucel-for-relapsed-or-refractory-aggressive-b-cell-lymphomas/ 2021-09-22T17:14:57+00:00 https://ascopost.com/news/september-2021/dd-mvac-vs-gemcitabinecisplatin-for-muscle-invasive-bladder-cancer/ 2021-10-12T16:07:11+00:00 https://ascopost.com/news/september-2021/relacorilant-plus-nab-paclitaxel-may-improve-progression-free-survival-in-recurrent-platinum-resistant-ovarian-cancer/ 2021-09-22T20:04:05+00:00 https://ascopost.com/news/september-2021/first-line-acalabrutinib-venetoclax-and-obinutuzumab-for-chronic-lymphocytic-leukemia/ 2021-09-23T18:10:39+00:00 https://ascopost.com/news/september-2021/does-adjuvant-image-guided-intensity-modulated-radiotherapy-for-cervical-cancer-lead-to-increased-rates-of-late-toxicity/ 2021-09-23T18:24:41+00:00 https://ascopost.com/news/september-2021/consolidation-treatment-with-vrd-followed-by-lenalidomide-maintenance-in-newly-diagnosed-patients-with-multiple-myeloma/ 2021-09-23T18:34:29+00:00 https://ascopost.com/news/september-2021/study-examines-efficacy-of-sunitinib-in-malignant-pheochromocytoma-and-paraganglioma/ 2021-09-23T18:51:19+00:00 https://ascopost.com/news/september-2021/peace-1-and-stampede-trials-abiraterone-acetate-plus-prednisolone-in-prostate-cancer/ 2021-09-23T18:42:28+00:00 https://ascopost.com/news/september-2021/capecitabine-maintenance-after-first-line-therapy-for-metastatic-colorectal-cancer/ 2021-09-27T14:55:10+00:00 https://ascopost.com/news/september-2021/overall-survival-with-stereotactic-ablative-radiotherapy-for-operable-stage-ia-nsclc/ 2021-09-27T14:59:11+00:00 https://ascopost.com/news/september-2021/new-study-aims-to-measure-success-of-phase-iii-oncology-trials/ 2021-09-27T16:26:44+00:00 https://ascopost.com/news/september-2021/active-living-after-cancer-program-may-improve-physical-functioning-for-breast-cancer-survivors/ 2021-09-27T16:47:08+00:00 https://ascopost.com/news/september-2021/are-rates-of-hepatocellular-carcinoma-rising-in-rural-areas-of-the-united-states/ 2021-09-27T16:55:59+00:00 https://ascopost.com/news/september-2021/overall-survival-with-the-bispecific-fusion-protein-tebentafusp-for-metastatic-uveal-melanoma/ 2021-09-28T16:26:58+00:00 https://ascopost.com/news/september-2021/hepatectomy-with-or-without-adjuvant-mfolfox6-for-liver-only-metastatic-colorectal-cancer-disease-free-and-overall-survival/ 2021-09-28T18:52:41+00:00 https://ascopost.com/news/september-2021/classifying-egfr-mutations-by-structure-and-function-may-help-to-match-patients-with-nsclc-to-more-effective-treatments/ 2021-09-28T18:01:11+00:00 https://ascopost.com/news/september-2021/study-shows-benefits-of-a-next-day-access-program-for-patients-with-cancer/ 2021-09-28T17:06:52+00:00 https://ascopost.com/news/september-2021/efficacy-of-risk-calculator-in-treating-elderly-patients-with-cancer/ 2021-09-28T19:38:38+00:00 https://ascopost.com/news/september-2021/cassiopeia-part-2-maintenance-daratumumab-after-initial-therapy-for-newly-diagnosed-multiple-myeloma/ 2021-09-28T18:59:06+00:00 https://ascopost.com/news/september-2021/extended-adjuvant-letrozole-after-tamoxifen-in-postmenopausal-women-with-early-stage-breast-cancer-gim4/ 2021-09-29T14:31:56+00:00 https://ascopost.com/news/september-2021/poziotinib-a-tyrosine-kinase-inhibitor-for-her2-exon-20-mutant-nsclc/ 2021-10-22T19:05:33+00:00 https://ascopost.com/news/september-2021/is-mri-cost-effective-for-detecting-cancer-in-women-with-very-dense-breasts/ 2021-09-29T16:02:44+00:00 https://ascopost.com/news/september-2021/fda-expands-cetuximab-label-with-combination-of-encorafenib-for-pretreated-braf-v600e-mutation-positive-metastatic-colorectal-cancer/ 2021-09-29T16:28:12+00:00 https://ascopost.com/news/september-2021/triplet-therapy-and-maintenance-to-prevent-disease-progression-in-high-risk-smoldering-myeloma/ 2021-09-30T19:45:49+00:00 https://ascopost.com/news/september-2021/liver-biopsy-for-evaluation-of-hepatitis-associated-with-immunotherapy/ 2021-09-30T19:47:48+00:00 https://ascopost.com/news/september-2021/adavosertib-for-patients-with-tp53-and-ras-mutant-metastatic-colorectal-cancer/ 2021-09-30T17:42:09+00:00 https://ascopost.com/news/september-2021/effectiveness-of-mrna-covid-19-vaccination-in-preventing-symptomatic-infection-in-health-care-personnel/ 2021-09-30T17:57:26+00:00 https://ascopost.com/news/september-2021/study-finds-genetic-predisposition-to-higher-lymphocyte-production-may-lead-to-higher-all-risk/ 2021-10-14T18:32:17+00:00 https://ascopost.com/news/september-2021/biomarker-may-help-to-predict-response-to-gemcitabine-for-patients-with-high-grade-serous-ovarian-cancer/ 2021-09-30T18:39:12+00:00 https://ascopost.com/news/october-2021/ 2021-10-01T14:24:47+00:00 https://ascopost.com/news/october-2021/addition-of-panitumumab-to-fluorouracilleucovorin-as-maintenance-therapy-for-ras-wild-type-metastatic-colorectal-cancer/ 2021-10-01T19:18:02+00:00 https://ascopost.com/news/october-2021/ivosidenib-vs-placebo-for-previously-treated-advanced-idh1-mutated-cholangiocarcinoma-final-overall-survival-analysis-of-the-claridhy-trial/ 2021-10-01T16:49:26+00:00 https://ascopost.com/news/october-2021/radioembolization-plus-second-line-chemotherapy-for-colorectal-liver-metastases/ 2021-10-01T19:48:53+00:00 https://ascopost.com/news/october-2021/improved-health-insurance-coverage-access-to-care-may-lessen-racialethnic-disparities-in-childhood-cancer-survival/ 2021-10-01T19:45:27+00:00 https://ascopost.com/news/october-2021/characteristics-of-and-outcomes-in-luminal-and-basal-subtypes-of-metastatic-castration-resistant-prostate-cancer/ 2021-10-01T18:52:43+00:00 https://ascopost.com/news/october-2021/two-studies-show-health-care-costs-may-impact-follow-up-care-after-cancer-screening/ 2021-10-01T19:08:27+00:00 https://ascopost.com/news/october-2021/axicabtagene-ciloleucel-for-adult-patients-with-primary-mediastinal-b-cell-lymphoma-real-world-outcomes/ 2021-10-04T15:46:23+00:00 https://ascopost.com/news/october-2021/trends-in-use-of-neoadjuvant-chemotherapy-and-association-with-overall-survival-in-patients-with-advanced-ovarian-cancer/ 2021-10-04T15:55:13+00:00 https://ascopost.com/news/october-2021/factors-associated-with-early-discontinuation-of-endocrine-therapy-for-ductal-carcinoma-in-situ/ 2021-10-04T16:37:15+00:00 https://ascopost.com/news/october-2021/adjuvant-atezolizumab-following-adjuvant-chemotherapy-for-resected-stage-ib-to-iiia-nsclc/ 2021-10-22T19:01:13+00:00 https://ascopost.com/news/october-2021/rates-of-post-protocol-immunotherapy-use-in-patients-enrolled-in-kidney-cancer-clinical-trials/ 2021-10-05T16:36:22+00:00 https://ascopost.com/news/october-2021/da-epoch-r-for-children-and-adolescents-with-newly-diagnosed-primary-mediastinal-b-cell-lymphoma/ 2021-10-05T17:38:31+00:00 https://ascopost.com/news/october-2021/factors-associated-with-risk-of-hearing-loss-in-pediatric-patients-receiving-radiation-and-chemotherapy/ 2026-01-29T16:14:25+00:00 https://ascopost.com/news/october-2021/black-patients-with-advanced-nsclc-receiving-immunotherapy-may-have-a-lower-risk-of-death-than-white-patients/ 2021-10-06T18:47:07+00:00 https://ascopost.com/news/october-2021/study-examines-benefits-of-cervical-cancer-screening-program-tailored-to-transgender-men-and-nonbinary-people/ 2021-10-06T18:52:25+00:00 https://ascopost.com/news/october-2021/disparities-in-terminal-hospitalization-among-adults-with-metastatic-cancer/ 2021-10-07T15:57:58+00:00 https://ascopost.com/news/october-2021/antibody-response-to-covid-19-vaccination-in-patients-with-hematologic-or-solid-cancers/ 2021-10-07T16:00:46+00:00 https://ascopost.com/news/october-2021/rates-and-causes-of-second-primary-cancers-in-patients-with-neuroendocrine-tumors/ 2021-10-08T15:03:04+00:00 https://ascopost.com/news/october-2021/fda-recognizes-memorial-sloan-kettering-database-of-molecular-tumor-marker-information/ 2021-10-07T16:46:16+00:00 https://ascopost.com/news/october-2021/study-finds-some-pancreatic-cancer-trial-eligibility-criteria-disproportionately-exclude-black-patients/ 2021-10-07T18:54:44+00:00 https://ascopost.com/news/october-2021/rates-of-diagnosis-of-gastrointestinal-cancers-and-stage-at-diagnosis-before-and-during-the-covid-19-pandemic-in-japan/ 2021-10-08T14:58:32+00:00 https://ascopost.com/news/october-2021/study-finds-significant-variation-in-the-incidence-of-nasopharyngeal-cancer-among-ethnic-subgroups-of-asian-americans/ 2026-01-29T16:11:23+00:00 https://ascopost.com/news/october-2021/aramis-analysis-darolutamide-shows-similar-benefits-for-black-patients-as-observed-in-the-overall-population/ 2021-10-08T16:20:23+00:00 https://ascopost.com/news/october-2021/effect-of-chronic-stress-on-treatment-completion-and-survival-outcomes-in-patients-with-breast-cancer/ 2021-10-08T17:41:37+00:00 https://ascopost.com/news/october-2021/fda-pipeline-recent-reviews-designations-applications-and-authorizations-in-the-oncology-space/ 2021-10-08T19:06:25+00:00 https://ascopost.com/news/october-2021/study-tracks-parental-hesitancy-trends-over-the-hpv-vaccine-from-2010-to-2019/ 2021-10-12T13:56:58+00:00 https://ascopost.com/news/october-2021/goal-focused-emotion-regulation-therapy-for-young-adult-testicular-cancer-survivors/ 2021-10-12T15:52:25+00:00 https://ascopost.com/news/october-2021/camrelizumabapatinib-for-high-risk-chemorefractory-or-relapsed-gestational-trophoblastic-neoplasia/ 2021-10-12T14:42:31+00:00 https://ascopost.com/news/october-2021/study-examines-cost-of-cancer-care-in-the-united-states-in-2018/ 2021-10-12T14:56:08+00:00 https://ascopost.com/news/october-2021/acis-trial-addition-of-apalutamide-to-abiraterone-acetateprednisone-for-metastatic-castration-resistant-prostate-cancer/ 2021-10-12T15:09:37+00:00 https://ascopost.com/news/october-2021/is-baseline-brain-white-matter-microstructure-associated-with-cognitive-decline-after-chemotherapy-for-breast-cancer/ 2021-10-14T16:26:06+00:00 https://ascopost.com/news/october-2021/risk-of-cancer-in-children-with-fanconi-anemia-and-ataxia-telangiectasia/ 2021-10-14T18:19:15+00:00 https://ascopost.com/news/october-2021/international-study-of-the-effects-of-covid-19-lockdowns-on-planned-cancer-surgeries/ 2021-10-14T16:53:21+00:00 https://ascopost.com/news/october-2021/aacr-cancer-progress-report-2021-showcases-50-years-of-advances-in-cancer-research-and-treatment/ 2021-10-14T18:16:51+00:00 https://ascopost.com/news/october-2021/who-director-general-grants-posthumous-award-to-henrietta-lacks/ 2021-10-15T15:27:14+00:00 https://ascopost.com/news/october-2021/characteristics-of-genomically-targeted-single-patient-use-requests-for-pediatric-cancers/ 2021-10-15T15:36:29+00:00 https://ascopost.com/news/october-2021/genomic-profiling-of-lung-adenocarcinoma-in-never-smokers-vs-smokers/ 2021-10-15T17:03:11+00:00 https://ascopost.com/news/october-2021/study-examines-potential-link-between-cancer-and-physical-inactivity/ 2021-10-15T20:12:29+00:00 https://ascopost.com/news/october-2021/nodal-recurrence-with-sentinel-node-biopsy-alone-following-neoadjuvant-chemotherapy-for-node-positive-breast-cancer/ 2021-10-15T18:45:48+00:00 https://ascopost.com/news/october-2021/final-analysis-of-innovate-addition-of-ibrutinib-to-rituximab-for-waldenstroem-s-macroglobulinemia/ 2021-10-18T14:50:47+00:00 https://ascopost.com/news/october-2021/abiraterone-for-castration-resistant-androgen-receptor-expressing-salivary-gland-cancer/ 2026-01-29T16:08:58+00:00 https://ascopost.com/news/october-2021/fda-perspective-on-drug-dosing-in-oncology-from-more-is-better-to-less-can-be-more/ 2021-10-18T15:39:15+00:00 https://ascopost.com/news/october-2021/can-inhibition-of-the-aurora-kinase-a-protein-help-to-overcome-resistance-to-kras-inhibition-in-patients-with-lung-cancer/ 2021-10-18T15:56:01+00:00 https://ascopost.com/news/october-2021/dm-choc-pen-may-improve-outcomes-for-adolescents-and-young-adults-with-central-nervous-system-tumors/ 2021-10-18T16:15:26+00:00 https://ascopost.com/news/october-2021/second-line-sotorasib-plus-afatinib-for-kras-mutant-nsclc/ 2021-10-22T19:26:23+00:00 https://ascopost.com/news/october-2021/ibrutinib-vs-placebo-following-achievement-of-undetectable-mrd-with-first-line-ibrutinibvenetoclax-in-cll/ 2021-10-19T16:28:59+00:00 https://ascopost.com/news/october-2021/global-analysis-of-national-health-system-characteristics-and-breast-cancer-mortality-and-stage-at-diagnosis/ 2021-10-19T16:34:46+00:00 https://ascopost.com/news/october-2021/first-line-fulvestrantpalbociclib-vs-letrozolepalbociclib-for-endocrine-sensitive-hr-positive-her2-negative-advanced-breast-cancer/ 2021-10-19T17:54:27+00:00 https://ascopost.com/news/october-2021/primary-tumor-resection-followed-by-systemic-treatment-vs-systemic-treatment-in-metastatic-colorectal-cancer-60-day-mortality/ 2021-10-19T19:12:07+00:00 https://ascopost.com/news/october-2021/preclinical-study-examines-relationship-between-aging-breast-tissue-and-invasive-breast-cancer/ 2021-10-19T19:12:36+00:00 https://ascopost.com/news/october-2021/efficacy-of-quadrivalent-hpv-vaccine-in-girls-in-india-against-persistent-hpv-1618-infection-10-year-protection-analysis/ 2021-10-20T19:56:03+00:00 https://ascopost.com/news/october-2021/nivolumablow-dose-ipilimumab-produces-responses-in-patients-with-msi-hdmmr-metastatic-colorectal-cancer/ 2021-10-20T17:57:43+00:00 https://ascopost.com/news/october-2021/mobocertinib-for-platinum-pretreated-patients-with-egfr-exon-20-insertion-positive-metastatic-nsclc/ 2021-10-22T18:55:34+00:00 https://ascopost.com/news/october-2021/study-examines-opinions-on-telemedicine-among-patients-undergoing-radiotherapy/ 2021-10-20T18:13:11+00:00 https://ascopost.com/news/october-2021/do-patients-diagnosed-with-cancer-living-in-low-income-and-rural-areas-face-an-increased-risk-of-suicide/ 2021-10-20T18:38:54+00:00 https://ascopost.com/news/october-2021/relationship-between-preexisting-tp53-chip-variants-and-risk-of-secondary-myeloid-neoplasms-in-high-grade-ovarian-cancer/ 2021-10-21T18:47:30+00:00 https://ascopost.com/news/october-2021/development-of-a-breast-cancer-risk-prediction-model-for-black-women-in-the-united-states/ 2021-10-21T17:32:53+00:00 https://ascopost.com/news/october-2021/activity-of-nab-sirolimus-in-malignant-perivascular-epithelioid-cell-tumors/ 2021-10-21T17:30:19+00:00 https://ascopost.com/news/october-2021/risk-based-treatment-of-pediatric-and-young-adult-synovial-sarcoma/ 2021-10-22T15:12:01+00:00 https://ascopost.com/news/october-2021/overall-survival-in-the-maia-trial-daratumumab-lenalidomide-and-dexamethasone-for-newly-diagnosed-transplant-ineligible-patients-with-multiple-myeloma/ 2021-10-22T16:16:04+00:00 https://ascopost.com/news/october-2021/two-studies-examine-the-efficacy-of-immunotherapy-for-leptomeningeal-carcinomatosis/ 2021-10-22T17:02:52+00:00 https://ascopost.com/news/october-2021/study-assesses-benefit-of-digital-health-tools-for-cancer-survivors/ 2021-10-22T18:45:23+00:00 https://ascopost.com/news/october-2021/melphalan-flufenamide-withdrawn-from-the-us-market/ 2021-10-26T15:41:13+00:00 https://ascopost.com/news/october-2021/study-examines-relationship-between-risk-of-cancer-and-age-of-smoking-initiationcessation/ 2021-10-26T19:59:52+00:00 https://ascopost.com/news/october-2021/22-gene-classifier-score-may-allow-for-personalization-of-therapy-in-patients-with-high-risk-prostate-cancer/ 2021-11-09T19:51:44+00:00 https://ascopost.com/news/october-2021/accure-trial-aims-to-eliminate-disparities-in-survival-in-black-and-white-patients-with-early-stage-lung-and-breast-cancers/ 2021-11-02T18:14:00+00:00 https://ascopost.com/news/october-2021/study-finds-prior-authorization-costs-academic-radiation-oncology-clinics-more-than-40-million-every-year/ 2021-10-26T21:03:56+00:00 https://ascopost.com/news/october-2021/annual-report-to-the-nation-part-2-focus-on-patient-economic-burden-associated-with-cancer-care/ 2021-10-27T15:11:08+00:00 https://ascopost.com/news/october-2021/baseline-health-related-quality-of-life-and-outcomes-in-patients-with-advanced-cancer/ 2021-10-27T15:21:51+00:00 https://ascopost.com/news/october-2021/addition-of-vincristine-topotecan-and-cyclophosphamide-to-five-drug-interval-compressed-chemotherapy-for-ewing-sarcoma/ 2021-10-27T15:53:33+00:00 https://ascopost.com/news/october-2021/study-examines-use-of-external-beam-radiotherapy-as-a-bridging-therapy-for-patients-with-hcc-awaiting-transplant/ 2021-10-27T19:26:10+00:00 https://ascopost.com/news/october-2021/phase-iii-trial-evaluates-efficacy-of-total-androgen-suppression-plus-dose-escalated-radiotherapy-for-patients-with-intermediate-risk-prostate-cancer/ 2021-11-09T19:50:25+00:00 https://ascopost.com/news/october-2021/nivolumab-for-relapsed-malignant-mesothelioma-improvements-in-progression-free-and-overall-survival/ 2021-10-28T14:59:41+00:00 https://ascopost.com/news/october-2021/addition-of-enasidenib-to-azacitidine-in-newly-diagnosed-idh2-mutant-acute-myeloid-leukemia/ 2021-10-28T15:32:06+00:00 https://ascopost.com/news/october-2021/study-finds-similar-survival-rates-among-patients-with-metastatic-colorectal-cancer-younger-and-older-than-age-50/ 2021-11-03T19:43:30+00:00 https://ascopost.com/news/october-2021/survey-of-us-oncologists-on-genetic-counseling-and-testing-for-black-women-with-breast-cancer/ 2021-10-28T16:31:37+00:00 https://ascopost.com/news/october-2021/hypofractionated-postoperative-prostate-bed-radiotherapy-does-not-increase-patient-reported-toxicity-for-men-with-prostate-cancer/ 2021-11-09T19:55:00+00:00 https://ascopost.com/news/october-2021/first-round-results-of-prostate-cancer-screening-for-men-with-pathogenic-variants-in-mismatch-repair-genes/ 2021-10-29T15:56:24+00:00 https://ascopost.com/news/october-2021/rates-of-occult-gastric-carcinoma-in-patients-with-hereditary-lobular-breast-cancer-due-to-cdh1-genetic-variants/ 2021-10-29T16:24:04+00:00 https://ascopost.com/news/october-2021/integrated-molecular-morphologic-risk-predictor-for-recurrence-of-meningioma/ 2021-10-29T16:53:33+00:00 https://ascopost.com/news/october-2021/hepatic-arterial-infusion-of-folfox-vs-transarterial-chemoembolization-for-unresectable-large-hepatocellular-carcinoma/ 2021-10-29T17:29:26+00:00 https://ascopost.com/news/october-2021/study-finds-incidence-of-pancreatic-cancer-may-be-rising-in-younger-women/ 2021-10-29T17:59:32+00:00 https://ascopost.com/news/october-2021/do-diet-related-molecules-play-a-role-in-the-development-of-aggressive-prostate-cancer/ 2021-10-29T18:48:43+00:00 https://ascopost.com/news/november-2021/ 2021-11-01T14:37:01+00:00 https://ascopost.com/news/november-2021/overall-survival-with-laparoscopic-vs-open-distal-gastrectomy-for-locally-advanced-gastric-cancer/ 2021-11-30T19:09:41+00:00 https://ascopost.com/news/november-2021/modified-folfirinox-vs-cisplatingemcitabine-for-advanced-biliary-tract-cancer/ 2021-11-01T15:54:24+00:00 https://ascopost.com/news/november-2021/definitive-radiotherapy-without-systemic-therapy-for-oligometastatic-renal-cell-carcinoma/ 2021-11-01T16:19:36+00:00 https://ascopost.com/news/november-2021/five-year-follow-up-of-olaparib-maintenance-for-newly-diagnosed-patients-with-advanced-brca-mutant-ovarian-cancer/ 2021-11-02T15:07:07+00:00 https://ascopost.com/news/november-2021/primary-transoral-surgery-and-reduced-dose-adjuvant-radiation-therapy-for-hpv-positive-locally-advanced-oropharyngeal-cancer/ 2026-01-29T15:05:08+00:00 https://ascopost.com/news/november-2021/characteristics-effects-and-outcomes-of-sars-cov-2-infection-in-pediatric-patients-with-cancer/ 2021-11-02T16:01:05+00:00 https://ascopost.com/news/november-2021/effect-of-social-determinants-of-health-on-receipt-of-survivorship-care-plans/ 2021-11-02T19:34:46+00:00 https://ascopost.com/news/november-2021/fda-pipeline-novel-treatments-in-lymphoma-nasopharyngeal-cancer-solid-tumors-and-more/ 2026-01-29T16:45:29+00:00 https://ascopost.com/news/november-2021/do-solid-organ-transplant-recipients-with-a-previous-cancer-diagnosis-have-high-cure-probabilities/ 2021-11-03T15:35:16+00:00 https://ascopost.com/news/november-2021/role-of-age-at-smoking-start-and-cessation-in-risk-of-overall-cancer-mortality-among-current-smokers-vs-never-smokers/ 2021-11-03T15:48:58+00:00 https://ascopost.com/news/november-2021/addition-of-fdg-petct-and-staging-laparoscopy-to-the-initial-staging-of-locally-advanced-gastric-cancer/ 2021-11-03T15:58:48+00:00 https://ascopost.com/news/november-2021/study-finds-type-1-interferon-may-enhance-the-anti-leukemia-effect-of-allogeneic-transplantation/ 2021-11-03T20:56:56+00:00 https://ascopost.com/news/november-2021/study-finds-younger-b-cell-non-hodgkin-lymphoma-survivors-may-have-a-higher-risk-of-age-related-diseases-than-older-survivors/ 2021-11-03T19:52:44+00:00 https://ascopost.com/news/november-2021/retrospective-study-examines-real-world-survival-in-us-women-treated-for-early-stage-breast-cancer/ 2021-11-04T15:52:58+00:00 https://ascopost.com/news/november-2021/germline-pathogenic-variants-in-cancer-predisposition-genes-and-risk-for-invasive-lobular-carcinoma-of-the-breast/ 2021-11-04T16:00:56+00:00 https://ascopost.com/news/november-2021/esmo-women-for-oncology-studies-examine-female-leadership-in-oncology-over-time/ 2021-11-04T19:19:27+00:00 https://ascopost.com/news/november-2021/studies-find-b7-h3-protein-may-be-a-target-for-prostate-cancer-treatment/ 2021-11-04T17:28:18+00:00 https://ascopost.com/news/november-2021/risks-and-benefits-associated-with-gastrostomy-tubes-for-patients-with-cancer/ 2021-11-04T19:16:37+00:00 https://ascopost.com/news/november-2021/adjuvant-internal-mammary-node-irradiation-in-node-positive-breast-cancer/ 2021-11-05T16:31:57+00:00 https://ascopost.com/news/november-2021/ibrutinib-plus-r-chop-for-younger-patients-with-dlbcl/ 2021-11-05T18:01:07+00:00 https://ascopost.com/news/november-2021/early-warning-system-model-may-help-to-predict-deterioration-of-hospitalized-patients-with-cancer/ 2021-11-05T17:32:14+00:00 https://ascopost.com/news/november-2021/nsclc-in-the-united-states-update-on-incidence-prevalence-and-survival/ 2021-11-30T21:22:00+00:00 https://ascopost.com/news/november-2021/covid-19-sequelae-prevalence-risk-factors-and-outcomes-in-patients-with-cancer/ 2021-11-08T16:32:14+00:00 https://ascopost.com/news/november-2021/study-finds-lack-of-health-insurance-may-hinder-recommended-cancer-screening-in-unemployed-adults/ 2021-11-08T21:18:50+00:00 https://ascopost.com/news/november-2021/adjuvant-gefitinib-vs-cisplatinvinorelbine-for-completely-resected-egfr-mutant-stage-ii-to-iiia-nsclc/ 2021-11-30T21:17:56+00:00 https://ascopost.com/news/november-2021/racial-disparities-in-use-of-prostate-mri-after-detection-of-elevated-psa-levels/ 2021-11-08T21:14:43+00:00 https://ascopost.com/news/november-2021/health-related-quality-of-life-with-pembrolizumab-vs-chemotherapy-for-advanced-esophageal-cancer/ 2021-11-09T16:29:51+00:00 https://ascopost.com/news/november-2021/international-medullary-thyroid-carcinoma-grading-system-detecting-adverse-outcomes/ 2021-11-09T18:28:45+00:00 https://ascopost.com/news/november-2021/arginine-may-enhance-effectiveness-of-radiation-therapy-for-brain-metastases/ 2021-11-09T18:44:40+00:00 https://ascopost.com/news/november-2021/study-examines-breakthrough-covid-19-infection-in-vaccinated-patients-with-hematologic-cancers/ 2021-11-09T19:13:12+00:00 https://ascopost.com/news/november-2021/cdk46-inhibitors-combined-with-fulvestrant-for-hr-positive-her2-negative-advanced-breast-cancer-fda-analysis-of-overall-survival/ 2021-11-09T19:45:26+00:00 https://ascopost.com/news/november-2021/international-conference-updates-guidelines-for-advanced-breast-cancer/ 2021-11-11T18:09:51+00:00 https://ascopost.com/news/november-2021/outcomes-and-toxicity-with-single-agent-immune-checkpoint-inhibitor-treatment-in-patients-with-cancer-aged-80-years/ 2021-11-11T18:23:01+00:00 https://ascopost.com/news/november-2021/study-examines-covid-19-outcomes-in-pediatric-patients-with-cancer/ 2021-11-11T19:01:05+00:00 https://ascopost.com/news/november-2021/researchers-identify-key-link-between-stress-and-cancer/ 2021-11-11T19:10:25+00:00 https://ascopost.com/news/november-2021/checkmate-214-longer-treatment-free-survival-with-immunotherapy-vs-targeted-therapy-in-patients-with-advanced-renal-cell-carcinoma/ 2021-11-11T19:39:44+00:00 https://ascopost.com/news/november-2021/nci-designated-cancer-center-compliance-with-cms-price-transparency-rules/ 2021-11-12T16:40:38+00:00 https://ascopost.com/news/november-2021/effect-of-national-hpv-vaccination-program-on-the-incidence-of-cervical-cancer-and-intraepithelial-neoplasia-in-young-women-in-england/ 2021-11-12T21:38:29+00:00 https://ascopost.com/news/november-2021/rituximab-maintenance-vs-response-adapted-postinduction-strategy-in-advanced-follicular-lymphoma/ 2021-11-12T17:01:55+00:00 https://ascopost.com/news/november-2021/president-biden-nominates-robert-m-califf-md-macc-as-fda-commissioner/ 2021-11-12T17:38:51+00:00 https://ascopost.com/news/november-2021/study-examines-immunotherapy-outcomes-in-patients-with-solid-tumors-who-are-ineligible-for-clinical-trials/ 2021-11-12T20:30:14+00:00 https://ascopost.com/news/november-2021/extended-follow-up-in-cll14-trial-of-venetoclaxobinutuzumab-in-previously-untreated-chronic-lymphocytic-leukemia/ 2021-11-15T19:30:55+00:00 https://ascopost.com/news/november-2021/long-term-outcomes-with-nivolumab-plus-ipilimumab-in-active-melanoma-brain-metastases/ 2021-11-15T16:54:19+00:00 https://ascopost.com/news/november-2021/novel-drug-combination-may-help-children-with-acute-promyelocytic-leukemia-avoid-conventional-chemotherapy/ 2021-11-15T18:20:33+00:00 https://ascopost.com/news/november-2021/immunogenicity-of-sars-cov-2-vaccines-in-patients-with-cancer/ 2021-11-15T17:27:10+00:00 https://ascopost.com/news/november-2021/us-multisociety-task-force-on-colorectal-cancer-releases-updated-screening-recommendations/ 2022-01-04T22:23:26+00:00 https://ascopost.com/news/november-2021/fda-approves-ropeginterferon-alfa-2b-njft-for-adults-with-polycythemia-vera/ 2025-09-30T19:37:24+00:00 https://ascopost.com/news/november-2021/method-to-selectively-grow-tumor-targeting-t-cells-for-cancer-therapy/ 2021-11-16T19:40:19+00:00 https://ascopost.com/news/november-2021/incidence-of-pancreatic-cancer-in-the-united-states-by-age-and-sex-2000-2018/ 2021-11-16T17:40:51+00:00 https://ascopost.com/news/november-2021/treatment-adherence-toxicity-and-outcomes-with-adjuvant-fluoropyrimidine-plus-oxaliplatin-in-early-onset-colorectal-cancer/ 2021-11-16T18:10:13+00:00 https://ascopost.com/news/november-2021/french-study-finds-covid-19-vaccine-effective-in-patients-with-lung-cancer/ 2021-11-16T19:40:30+00:00 https://ascopost.com/news/november-2021/study-reveals-genomic-differences-between-14-tumor-types-in-younger-vs-older-adults/ 2021-11-16T19:14:55+00:00 https://ascopost.com/news/november-2021/association-of-kras-variants-with-outcomes-after-curative-resection-of-intrahepatic-cholangiocarcinoma/ 2021-11-17T16:49:05+00:00 https://ascopost.com/news/november-2021/stampede-trial-quality-of-life-with-abiraterone-vs-docetaxel-in-advanced-hormone-sensitive-prostate-cancer/ 2021-11-17T17:10:14+00:00 https://ascopost.com/news/november-2021/immunotherapy-followed-by-targeted-therapy-yields-greater-overall-survival-in-patients-with-braf-v600-mutated-advanced-melanoma/ 2021-12-01T19:11:52+00:00 https://ascopost.com/news/november-2021/digital-symptom-monitoring-system-may-improve-patients-symptom-control-and-physical-function-during-cancer-therapy/ 2021-12-01T19:10:58+00:00 https://ascopost.com/news/november-2021/brain-substructure-informed-radiotherapy-planning-may-improve-neurocognitive-outcomes-in-pediatric-patients-with-medulloblastoma/ 2021-11-18T18:16:33+00:00 https://ascopost.com/news/november-2021/development-of-phenotypic-spectrum-categorization-for-li-fraumeni-syndrome/ 2021-11-18T19:01:16+00:00 https://ascopost.com/news/november-2021/immunogenicity-of-covid-19-vaccination-in-patients-receiving-systemic-therapy-for-solid-tumors/ 2021-11-18T21:06:51+00:00 https://ascopost.com/news/november-2021/study-examines-availability-of-all-trans-retinoic-acid-in-us-hospitals/ 2021-11-18T21:04:41+00:00 https://ascopost.com/news/november-2021/effect-of-embedding-a-palliative-care-nurse-practitioner-in-an-oncology-clinic/ 2021-11-19T16:16:42+00:00 https://ascopost.com/news/november-2021/model-may-help-identify-subtypes-of-multiple-myeloma/ 2021-11-19T17:56:33+00:00 https://ascopost.com/news/november-2021/2021-state-of-lung-cancer-report-finds-survival-has-increased-but-remains-significantly-lower-for-people-of-color/ 2021-11-30T21:38:27+00:00 https://ascopost.com/news/november-2021/evorpacept-alone-and-combined-with-pembrolizumab-or-trastuzumab-for-advanced-solid-tumors/ 2021-11-22T16:05:05+00:00 https://ascopost.com/news/november-2021/exercise-program-may-help-to-reduce-upper-limb-disability-after-breast-cancer-surgery/ 2021-11-22T17:26:34+00:00 https://ascopost.com/news/november-2021/early-study-examines-potential-benefits-of-a-fasting-mimicking-diet-in-patients-with-cancer/ 2021-11-22T20:17:57+00:00 https://ascopost.com/news/november-2021/ai-based-breast-cancer-risk-model-multi-institution-validation/ 2021-11-22T18:05:30+00:00 https://ascopost.com/news/november-2021/novel-therapies-under-study-in-acute-myeloid-leukemia/ 2022-01-17T19:46:29+00:00 https://ascopost.com/news/november-2021/long-term-outcomes-with-chemoradiotherapy-before-vs-after-chemotherapy-in-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/ 2022-02-02T21:15:56+00:00 https://ascopost.com/news/november-2021/study-finds-unique-genomic-and-molecular-features-in-young-adult-patients-with-cancer/ 2021-11-23T17:45:51+00:00 https://ascopost.com/news/november-2021/netter-1-trial-final-overall-survival-analysis-of-lu-177-dotatate-plus-long-acting-octreotide-vs-high-dose-long-acting-octreotide-for-midgut-neuroendocrine-tumors/ 2021-11-23T17:51:49+00:00 https://ascopost.com/news/november-2021/fda-pipeline-reviews-and-designations-in-hematology/ 2021-11-23T19:51:24+00:00 https://ascopost.com/news/november-2021/research-letter-examines-changes-in-cancer-mortality-50-years-after-passage-of-the-national-cancer-act/ 2021-11-29T17:34:23+00:00 https://ascopost.com/news/november-2021/research-assesses-molecular-hallmarks-of-moles-and-melanomas/ 2021-11-29T19:15:32+00:00 https://ascopost.com/news/november-2021/impact-of-prior-blinatumomab-exposure-on-cd19-targeted-car-t-cell-therapy-outcomes-in-pediatric-patients-with-b-cell-all/ 2021-11-30T19:29:25+00:00 https://ascopost.com/news/november-2021/does-yoga-improve-quality-of-life-in-men-with-prostate-cancer/ 2021-11-30T20:01:47+00:00 https://ascopost.com/news/november-2021/alk-inhibition-for-pediatric-patients-with-advanced-alk-positive-malignancies/ 2021-11-30T19:46:04+00:00 https://ascopost.com/news/november-2021/cancer-related-financial-toxicity-role-of-race/ 2021-11-30T19:51:43+00:00 https://ascopost.com/news/december-2021/ 2021-12-01T16:00:47+00:00 https://ascopost.com/news/december-2021/response-to-sars-cov-2-mrna-vaccination-in-patients-with-b-cell-depletion-associated-with-car-t-cell-therapy/ 2021-12-01T16:46:58+00:00 https://ascopost.com/news/december-2021/belzutifan-shows-activity-in-patients-with-von-hippel-lindau-disease-associated-renal-cell-carcinoma/ 2021-12-01T16:48:10+00:00 https://ascopost.com/news/december-2021/cancer-incidence-and-patterns-in-individuals-with-pathogeniclikely-pathogenic-germline-tp53-variants/ 2021-12-01T17:02:31+00:00 https://ascopost.com/news/december-2021/high-response-rate-with-venetoclax-in-previously-treated-patients-with-waldenstroms-macroglobulinemia/ 2021-12-01T17:49:15+00:00 https://ascopost.com/news/december-2021/can-antihistamines-influence-response-to-immunotherapy/ 2021-12-01T18:17:05+00:00 https://ascopost.com/news/december-2021/phase-i-trial-investigates-her-targeted-car-m-for-her2-overexpressing-solid-tumors/ 2021-12-02T21:38:49+00:00 https://ascopost.com/news/december-2021/neoadjuvant-chemoradiation-plus-pembrolizumab-shows-no-effect-on-tumor-infiltrating-lymphocytes-in-pancreatic-cancer/ 2021-12-06T15:25:53+00:00 https://ascopost.com/news/december-2021/immunomodulatory-effects-of-neoadjuvant-nivolumab-chemotherapy-in-nsclc/ 2021-12-17T20:05:12+00:00 https://ascopost.com/news/december-2021/cog-aaml1331-trial-arsenic-trioxide-and-all-trans-retinoic-acid-in-pediatric-patients-with-apl/ 2021-12-02T16:50:40+00:00 https://ascopost.com/news/december-2021/first-line-ibrutinibrituximab-in-patients-with-mantle-cell-lymphoma-aged-65-and-older/ 2021-12-02T17:33:37+00:00 https://ascopost.com/news/december-2021/study-examines-the-effect-of-breast-mri-on-short-term-quality-of-life-in-women-with-dcis/ 2021-12-02T18:42:12+00:00 https://ascopost.com/news/december-2021/fosnetupitant-vs-fosaprepitant-for-prevention-of-chemotherapy-induced-nausea-and-vomiting/ 2021-12-02T18:53:24+00:00 https://ascopost.com/news/december-2021/effect-of-the-covid-19-pandemic-on-cancer-imaging/ 2021-12-02T18:46:49+00:00 https://ascopost.com/news/december-2021/to-elect-or-forgo-radiation-therapy-an-informed-decision-for-patients-with-breast-cancer/ 2021-12-03T18:13:46+00:00 https://ascopost.com/news/december-2021/trends-in-incidence-of-colorectal-cancer-among-black-and-white-individuals-aged-40-to-49-years-from-2000-to-2017/ 2021-12-03T16:20:43+00:00 https://ascopost.com/news/december-2021/managing-illness-expectations-in-patients-with-advanced-cancer/ 2021-12-03T17:45:14+00:00 https://ascopost.com/news/december-2021/dabrafenib-plus-trametinib-in-braf-v600e-mutant-high-and-low-grade-glioma/ 2021-12-03T17:55:52+00:00 https://ascopost.com/news/december-2021/next-generation-sequencing-of-bone-marrow-dna-to-predict-relapse-following-car-t-cell-therapy-in-patients-with-all/ 2021-12-03T18:21:33+00:00 https://ascopost.com/news/december-2021/study-examines-safety-and-efficacy-of-retifanlimab-in-recurrent-msi-hdmmr-endometrial-cancer/ 2021-12-03T21:21:00+00:00 https://ascopost.com/news/december-2021/vidutolimad-plus-pembrolizumab-in-pd-1-refractory-melanoma/ 2021-12-03T20:41:26+00:00 https://ascopost.com/news/december-2021/evaluation-of-carfilzomib-based-induction-consolidation-and-maintenance-strategies-in-newly-diagnosed-multiple-myeloma/ 2021-12-06T18:11:27+00:00 https://ascopost.com/news/december-2021/association-of-donor-clonal-hematopoiesis-with-outcomes-in-hematopoietic-stem-cell-transplant-recipients/ 2021-12-06T18:17:20+00:00 https://ascopost.com/news/december-2021/response-to-third-dose-of-sars-cov-2-bnt162b2-mrna-vaccine-in-patients-with-solid-tumors-undergoing-active-treatment/ 2021-12-06T18:21:56+00:00 https://ascopost.com/news/december-2021/addition-of-cytoreductive-surgery-to-platinum-based-chemotherapy-in-relapsed-ovarian-cancer/ 2021-12-06T18:27:16+00:00 https://ascopost.com/news/december-2021/covid-19-vaccination-patients-with-multiple-myeloma-may-lack-t-cell-response/ 2021-12-06T17:30:37+00:00 https://ascopost.com/news/december-2021/fully-vaccinated-patients-with-multiple-myeloma-rates-of-sars-cov-2-breakthrough-infection-and-hospitalization/ 2021-12-07T15:50:29+00:00 https://ascopost.com/news/december-2021/poziotinib-in-previously-treated-patients-with-nsclc-and-her2-exon-20-insertion-mutations/ 2021-12-17T20:03:21+00:00 https://ascopost.com/news/december-2021/study-examines-rates-of-lymphedema-in-black-and-white-patients-with-breast-cancer/ 2022-01-03T22:21:23+00:00 https://ascopost.com/news/december-2021/i-spy2-study-finds-tumor-biology-is-a-more-significant-factor-than-race-in-predicting-response-to-breast-cancer-treatment/ 2022-01-03T22:19:37+00:00 https://ascopost.com/news/december-2021/molecular-tumor-profiling-may-improve-treatment-matching-for-patients-with-metastatic-breast-cancer/ 2022-01-03T22:18:40+00:00 https://ascopost.com/news/december-2021/researchers-identify-significant-differences-in-tumor-characteristics-between-younger-and-older-patients-with-cancer/ 2021-12-07T19:40:40+00:00 https://ascopost.com/news/december-2021/covid-19-infection-after-sars-cov-2-messenger-rna-vaccination-in-patients-with-cancer/ 2021-12-08T16:46:40+00:00 https://ascopost.com/news/december-2021/telemedicine-use-among-us-patients-with-newly-diagnosed-cancer-impact-of-socioeconomic-status/ 2021-12-08T16:58:41+00:00 https://ascopost.com/news/december-2021/single-cell-spatial-analysis-may-help-to-predict-response-to-neoadjuvant-atezolizumab-in-patients-with-triple-negative-breast-cancer/ 2021-12-08T17:36:52+00:00 https://ascopost.com/news/december-2021/pallas-trial-addition-of-adjuvant-palbociclib-to-endocrine-therapy-in-early-hr-positive-her2-negative-breast-cancer/ 2021-12-12T20:34:06+00:00 https://ascopost.com/news/december-2021/elacestrant-may-improve-outcomes-for-postmenopausal-patients-with-progressive-er-positive-her2-negative-metastatic-breast-cancer-1/ 2021-12-08T20:48:52+00:00 https://ascopost.com/news/december-2021/epov-keith-flaherty/ 2021-12-08T20:54:43+00:00 https://ascopost.com/news/december-2021/use-of-adjuvant-chemotherapy-in-older-patients-with-pancreatic-cancer-and-its-effect-on-overall-survival/ 2021-12-09T17:22:17+00:00 https://ascopost.com/news/december-2021/long-term-outcomes-from-checkmate-067-nivolumabipilimumab-nivolumab-or-ipilimumab-in-advanced-melanoma/ 2021-12-09T17:31:25+00:00 https://ascopost.com/news/december-2021/association-of-tp53-gain-of-function-and-non-gain-of-function-mutations-with-outcomes-in-left-sided-vs-right-sided-metastatic-colorectal-cancer/ 2021-12-09T17:52:09+00:00 https://ascopost.com/news/december-2021/phoebe-trial-pyrotinibcapecitabine-vs-lapatinibcapecitabine-for-previously-treated-patients-with-her2-positive-metastatic-breast-cancer/ 2021-12-09T18:36:15+00:00 https://ascopost.com/news/december-2021/patients-with-hr-positive-breast-cancer-and-emergent-esr1-mutations-may-benefit-from-early-switch-to-fulvestrantpalbociclib/ 2021-12-12T20:37:06+00:00 https://ascopost.com/news/december-2021/profiles-of-cancer-risk-associated-with-immune-mediated-diseases/ 2021-12-09T19:18:13+00:00 https://ascopost.com/news/december-2021/outcomes-among-pediatric-and-young-adult-patients-with-all-differ-by-race-ethnicity-and-socioeconomic-status/ 2021-12-11T20:12:25+00:00 https://ascopost.com/news/december-2021/study-reveals-underrepresentation-of-aya-hispanic-patients-in-a-large-all-clinical-trial/ 2021-12-11T18:06:04+00:00 https://ascopost.com/news/december-2021/activity-of-mosunetuzumab-in-pretreated-patients-with-relapsed-or-refractory-follicular-lymphoma/ 2021-12-20T21:14:01+00:00 https://ascopost.com/news/december-2021/transform-trial-lisocabtagene-maraleucel-vs-standard-of-care-for-relapsed-or-refractory-large-b-cell-lymphoma/ 2021-12-20T21:15:07+00:00 https://ascopost.com/news/december-2021/antibody-response-to-second-dose-of-mrna-covid-19-vaccine-in-patients-with-aml-and-mds/ 2021-12-11T19:52:47+00:00 https://ascopost.com/news/december-2021/ivosidenibazacitidine-vs-azacitidine-alone-in-patients-with-newly-diagnosed-idh1-mutated-aml/ 2021-12-12T18:31:49+00:00 https://ascopost.com/news/december-2021/ash-rc-covid-19-registry-for-hematology-risk-factors-for-hospitalization-and-death-among-patients-with-hematologic-malignancies-infected-with-covid-19/ 2021-12-20T21:49:39+00:00 https://ascopost.com/news/december-2021/antibody-response-to-covid-19-vaccination-in-patients-with-myeloid-and-lymphoid-neoplasms/ 2021-12-12T16:33:56+00:00 https://ascopost.com/news/december-2021/study-reveals-gaps-in-code-status-discussions-among-patients-with-high-risk-aml/ 2022-01-17T18:50:32+00:00 https://ascopost.com/news/december-2021/isatuximabrvd-meets-primary-endpoint-for-newly-diagnosed-transplant-eligible-patients-with-multiple-myeloma/ 2021-12-23T20:21:14+00:00 https://ascopost.com/news/december-2021/immune-checkpoint-inhibitor-treatment-in-patients-aged-65-and-older-with-advanced-melanoma-association-between-sex-and-survival/ 2021-12-13T15:46:45+00:00 https://ascopost.com/news/december-2021/european-oncovid-registry-analysis-of-time-dependent-covid-19-mortality-in-patients-with-cancer/ 2021-12-13T15:52:54+00:00 https://ascopost.com/news/december-2021/addition-of-romidepsin-to-chop-in-previously-untreated-patients-with-peripheral-t-cell-lymphoma/ 2021-12-13T15:57:24+00:00 https://ascopost.com/news/december-2021/study-identifies-factors-for-severe-covid-19-illness-among-patients-with-acute-leukemia-or-mds/ 2022-01-14T20:38:31+00:00 https://ascopost.com/news/december-2021/zuma-7-primary-analysis-axicabtagene-ciloleucel-quadruples-event-free-survival/ 2021-12-13T20:05:48+00:00 https://ascopost.com/news/december-2021/hhs-secretary-becerra-names-dr-lawrence-tabak-acting-director-of-nih/ 2021-12-13T19:10:37+00:00 https://ascopost.com/news/december-2021/study-examines-socioeconomic-status-and-cervical-cancer-incidence-in-new-york-city/ 2021-12-14T17:45:27+00:00 https://ascopost.com/news/december-2021/study-suggests-lack-of-benefit-with-the-addition-of-immune-checkpoint-inhibition-to-chemotherapy-in-low-pd-l1-expressing-gastric-or-esophageal-adenocarcinomas/ 2022-01-20T19:33:55+00:00 https://ascopost.com/news/december-2021/outcomes-with-adjuvant-chemoendocrine-vs-endocrine-therapy-in-node-positive-breast-cancer-and-association-with-21-gene-assay-recurrence-score/ 2021-12-14T17:58:47+00:00 https://ascopost.com/news/december-2021/belinda-study-second-line-tisagenlecleucel-equivalent-to-standard-of-care-for-relapsed-or-refractory-aggressive-b-cell-non-hodgkin-lymphoma/ 2021-12-20T21:32:11+00:00 https://ascopost.com/news/december-2021/polarix-pola-r-chp-vs-r-chop-for-previously-untreated-patients-with-dlbcl/ 2021-12-20T21:13:11+00:00 https://ascopost.com/news/december-2021/american-cancer-society-releases-updated-report-on-status-of-cancer-disparities-in-the-united-states/ 2021-12-14T21:00:49+00:00 https://ascopost.com/news/december-2021/global-burden-of-cancer-in-adolescent-and-young-adult-patients-in-2019/ 2021-12-15T18:21:25+00:00 https://ascopost.com/news/december-2021/neoadjuvant-chemotherapy-and-mandibular-preservation-in-operable-oral-cavity-cancer/ 2026-01-29T15:47:52+00:00 https://ascopost.com/news/december-2021/ibrutinib-plus-fludarabine-cyclophosphamide-and-rituximab-for-younger-patients-with-cll/ 2022-01-17T18:52:00+00:00 https://ascopost.com/news/december-2021/study-examines-a-potential-approach-to-mitigate-car-t-cell-therapy-toxicity/ 2021-12-15T18:48:27+00:00 https://ascopost.com/news/december-2021/zuma-5-trial-axicabtagene-ciloleucel-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/ 2022-01-18T19:18:18+00:00 https://ascopost.com/news/december-2021/study-examines-possible-clinical-trial-bias-from-undisclosed-censoring/ 2021-12-16T20:57:12+00:00 https://ascopost.com/news/december-2021/colorectal-cancer-screening-preferences-of-gastroenterologists-and-primary-care-clinicians/ 2021-12-16T19:37:11+00:00 https://ascopost.com/news/december-2021/impact-of-small-cell-undifferentiated-histology-on-outcomes-in-pediatric-hepatoblastoma/ 2021-12-16T20:56:18+00:00 https://ascopost.com/news/december-2021/effect-of-tp53-alterations-on-outcomes-of-cd19-targeted-car-t-cell-therapy-for-patients-with-large-b-cell-lymphoma/ 2021-12-17T17:35:03+00:00 https://ascopost.com/news/december-2021/addition-of-monoclonal-antibody-hu1418k322a-to-chemotherapy-in-pediatric-patients-with-newly-diagnosed-high-risk-neuroblastoma/ 2021-12-17T17:58:28+00:00 https://ascopost.com/news/december-2021/who-launches-a-new-classification-system-for-pediatric-tumors/ 2021-12-17T21:01:46+00:00 https://ascopost.com/news/december-2021/association-of-cd123-expression-with-high-risk-disease-characteristics-and-outcomes-in-pediatric-aml/ 2021-12-20T16:16:12+00:00 https://ascopost.com/news/december-2021/adjuvant-t-dm1pertuzumab-vs-taxanetrastuzumabpertuzumab-in-high-risk-her2-positive-breast-cancer/ 2021-12-20T21:20:30+00:00 https://ascopost.com/news/december-2021/first-line-nivolumab-vs-sorafenib-in-advanced-hepatocellular-carcinoma-effect-on-overall-survival/ 2021-12-20T16:56:44+00:00 https://ascopost.com/news/december-2021/study-examines-rates-of-breast-and-colorectal-cancer-screening-among-rural-women/ 2022-02-02T21:18:07+00:00 https://ascopost.com/news/december-2021/calcineurin-inhibitor-free-chronic-graft-vs-host-disease-interventions-in-myeloablative-hct-for-hematologic-malignancies/ 2021-12-22T21:42:24+00:00 https://ascopost.com/news/december-2021/postoperative-radiotherapy-for-patients-with-completely-resected-stage-iiia-nsclc-and-n2-involvement/ 2022-01-26T20:23:28+00:00 https://ascopost.com/news/december-2021/effect-of-bupropion-vs-placebo-on-sexual-desire-in-postmenopausal-female-cancer-survivors/ 2021-12-22T17:38:04+00:00 https://ascopost.com/news/december-2021/personalized-therapy-vs-physician-s-choice-of-treatment-for-patients-with-residual-triple-negative-breast-cancer-after-neoadjuvant-chemotherapy/ 2021-12-22T19:26:42+00:00 https://ascopost.com/news/december-2021/molecular-analysis-advances-risk-profiling-and-assessment-of-immunotherapy-response-in-smoldering-myeloma/ 2021-12-23T19:31:48+00:00 https://ascopost.com/news/december-2021/breast-cancer-index-may-predict-benefit-of-extended-endocrine-therapy-in-certain-patients-with-hormone-receptor-positive-disease/ 2021-12-22T20:18:35+00:00 https://ascopost.com/news/december-2021/second-line-tisagenlecleucel-vs-standard-of-care-in-aggressive-b-cell-lymphoma/ 2021-12-23T16:25:45+00:00 https://ascopost.com/news/december-2021/hepatic-arterial-infusion-chemotherapy-vs-sorafenib-for-advanced-hepatocellular-carcinoma/ 2021-12-23T16:38:04+00:00 https://ascopost.com/news/december-2021/association-of-mrd-response-and-prognosis-in-patients-with-aml-treated-with-venetoclax-and-azacitidine/ 2021-12-23T20:14:18+00:00 https://ascopost.com/news/december-2021/eight-substances-added-to-the-15th-report-on-carcinogens/ 2021-12-23T17:41:20+00:00 https://ascopost.com/news/december-2021/new-national-study-finds-oropharyngeal-cancer-incidence-and-mortality-is-rising-in-the-united-states/ 2026-01-29T15:42:07+00:00 https://ascopost.com/news/december-2021/polatuzumab-vedotin-piiq-plus-r-chp-vs-r-chop-for-previously-untreated-patients-with-dlbcl/ 2021-12-23T19:11:12+00:00 https://ascopost.com/news/january-2022/ 2022-01-03T15:29:07+00:00 https://ascopost.com/news/january-2022/balstilimab-plus-zalifrelimab-for-the-second-line-treatment-of-advanced-cervical-cancer/ 2022-01-03T15:49:12+00:00 https://ascopost.com/news/january-2022/mrd-response-adapted-therapy-in-patients-receiving-daratumumab-carfilzomib-lenalidomide-and-dexamethasone-plus-ahct-for-newly-diagnosed-multiple-myeloma/ 2022-01-03T16:47:04+00:00 https://ascopost.com/news/january-2022/fda-takes-multiple-actions-to-expand-use-of-pfizer-biontech-covid-19-vaccine/ 2022-03-11T14:36:33+00:00 https://ascopost.com/news/january-2022/is-a-high-fiber-diet-associated-with-improved-survival-and-treatment-response-in-patients-with-melanoma/ 2022-01-03T17:55:47+00:00 https://ascopost.com/news/january-2022/study-finds-third-covid-19-vaccine-dose-effectively-boosts-immunity-for-patients-with-solid-tumors/ 2022-01-03T20:09:51+00:00 https://ascopost.com/news/january-2022/long-term-outcomes-according-to-residual-cancer-burden-after-neoadjuvant-chemotherapy-for-breast-cancer/ 2022-01-05T19:14:54+00:00 https://ascopost.com/news/january-2022/association-of-response-rate-and-event-free-survival-with-overall-survival-in-newly-diagnosed-aml-fda-analysis/ 2022-02-14T19:17:54+00:00 https://ascopost.com/news/january-2022/study-finds-fully-vaccinated-patients-with-cancer-and-breakthrough-covid-19-infection-remain-at-high-risk-for-severe-outcomes/ 2022-01-07T15:15:30+00:00 https://ascopost.com/news/january-2022/study-examines-global-cancer-burden-from-2010-to-2019/ 2022-01-04T18:43:29+00:00 https://ascopost.com/news/january-2022/nccn-updates-recommendations-on-covid-19-vaccination-and-preexposure-prophylaxis/ 2022-01-04T19:46:02+00:00 https://ascopost.com/news/january-2022/pretreatment-disease-burden-and-outcomes-with-commercial-tisagenlecleucel-in-pediatricyoung-adult-b-cell-acute-lymphoblastic-leukemia/ 2022-02-14T20:11:36+00:00 https://ascopost.com/news/january-2022/comparison-of-efficiency-of-uspstf-vs-plco-criteria-in-determining-eligibility-for-lung-cancer-screening/ 2022-01-05T16:47:08+00:00 https://ascopost.com/news/january-2022/apatinib-for-advanced-radioactive-iodine-refractory-differentiated-thyroid-cancer/ 2022-01-07T18:18:47+00:00 https://ascopost.com/news/january-2022/interim-radiographic-assessment-for-adaptive-dosing-of-combination-immunotherapy-in-advanced-melanoma/ 2022-01-05T17:51:09+00:00 https://ascopost.com/news/january-2022/smoking-cessation-after-lung-cancer-diagnosis-may-improve-overall-survival/ 2022-01-05T17:58:28+00:00 https://ascopost.com/news/january-2022/stereotactic-radiation-may-prolong-duration-of-systemic-therapy-for-metastatic-kidney-cancer/ 2022-01-05T18:08:37+00:00 https://ascopost.com/news/january-2022/bispecific-antibody-mosunetuzumab-in-relapsed-or-refractory-b-cell-lymphomas/ 2022-01-06T16:29:56+00:00 https://ascopost.com/news/january-2022/does-armodafinil-improve-cancer-related-fatigue-in-patients-with-high-grade-glioma/ 2022-01-06T16:52:05+00:00 https://ascopost.com/news/january-2022/hrqol-with-enzalutamide-vs-standard-of-care-for-metastatic-hormone-sensitive-prostate-cancer-enzamet-trial/ 2022-01-06T17:00:42+00:00 https://ascopost.com/news/january-2022/portable-prostate-cancer-screening-test-may-help-reach-underserved-patients/ 2022-01-06T20:52:33+00:00 https://ascopost.com/news/january-2022/imaging-biomarker-may-help-to-risk-stratify-patients-with-head-and-neck-cancer/ 2026-01-29T15:40:06+00:00 https://ascopost.com/news/january-2022/trends-in-population-level-stage-shift-and-mortality-among-us-patients-with-nsclc-2006-2016/ 2022-01-26T20:21:07+00:00 https://ascopost.com/news/january-2022/fda-shortens-interval-for-booster-dose-of-moderna-covid-19-vaccine-to-5-months/ 2022-01-07T18:06:37+00:00 https://ascopost.com/news/january-2022/study-finds-depression-screening-improves-behavioral-care-for-patients-with-breast-cancer/ 2022-01-07T18:24:18+00:00 https://ascopost.com/news/january-2022/addition-of-anti-lag-3-antibody-relatlimab-to-nivolumab-in-previously-untreated-patients-with-advanced-melanoma/ 2022-01-07T18:38:03+00:00 https://ascopost.com/news/january-2022/single-cell-transcriptomic-and-imaging-atlas-of-colorectal-polyps-provides-insights-for-cancer-surveillance/ 2022-01-07T20:32:25+00:00 https://ascopost.com/news/january-2022/response-adapted-omission-of-radiotherapy-and-comparison-of-consolidation-therapy-in-pediatric-classical-hodgkin-lymphoma/ 2022-01-10T20:08:17+00:00 https://ascopost.com/news/january-2022/effect-of-recent-prior-radiotherapy-on-adverse-events-in-patients-receiving-immune-checkpoint-inhibitors/ 2022-01-10T15:41:59+00:00 https://ascopost.com/news/january-2022/immunogenicity-of-covid-19-bnt162b2-mrna-vaccine-booster-in-patients-with-cancer-receiving-active-treatment/ 2022-01-10T16:08:47+00:00 https://ascopost.com/news/january-2022/study-examines-role-of-psychological-distress-in-aya-cancer-survivors/ 2022-01-10T16:15:23+00:00 https://ascopost.com/news/january-2022/addition-of-abiraterone-acetate-and-prednisolone-with-or-without-enzalutamide-to-adt-in-high-risk-nonmetastatic-prostate-cancer/ 2022-01-11T16:50:22+00:00 https://ascopost.com/news/january-2022/incidence-of-chronic-graft-vs-host-disease-effect-of-depleting-naive-t-cells-from-peripheral-blood-stem-cell-allografts-in-patients-with-leukemia/ 2022-01-11T16:57:16+00:00 https://ascopost.com/news/january-2022/study-uses-data-from-a-nationally-representative-colonoscopy-registry-to-gather-information-on-early-onset-colorectal-precancerous-lesions/ 2022-01-11T17:18:58+00:00 https://ascopost.com/news/january-2022/role-of-radiologist-experience-and-fatigue-level-in-recommending-additional-imaging-for-patients-undergoing-breast-cancer-screening/ 2022-01-11T17:33:45+00:00 https://ascopost.com/news/january-2022/palliative-care-use-among-commercially-insured-us-patients-with-metastatic-cancer-2001-2016/ 2022-01-11T19:33:51+00:00 https://ascopost.com/news/january-2022/is-there-an-association-between-maternal-hormonal-contraception-use-and-risk-of-cns-tumors-in-children/ 2022-01-11T19:37:25+00:00 https://ascopost.com/news/january-2022/atezolizumabbevacizumab-vs-sunitinib-in-previously-untreated-patients-with-metastatic-rcc-final-overall-survival-analysis-of-immotion151/ 2022-01-12T20:55:41+00:00 https://ascopost.com/news/january-2022/new-study-examines-septic-shock-in-patients-with-hematologic-malignancies/ 2022-01-12T17:03:17+00:00 https://ascopost.com/news/january-2022/effect-of-daily-sitting-time-and-weekly-physical-activity-on-cancer-survivorship/ 2022-01-12T20:35:18+00:00 https://ascopost.com/news/january-2022/astro-issues-clinical-guideline-on-external-beam-radiation-therapy-for-primary-liver-cancers/ 2022-01-12T18:18:03+00:00 https://ascopost.com/news/january-2022/association-of-autoantibodies-to-gastric-mucosa-and-risk-of-gastric-cancer/ 2022-01-12T18:26:43+00:00 https://ascopost.com/news/january-2022/is-the-development-of-cutaneous-immune-related-adverse-events-correlated-with-response-to-immunotherapy/ 2022-01-19T16:57:36+00:00 https://ascopost.com/news/january-2022/report-describes-identification-of-a-novel-therapeutic-target-for-multiple-myeloma/ 2022-01-24T20:10:43+00:00 https://ascopost.com/news/january-2022/global-burden-of-cancer-from-2010-to-2019/ 2022-01-13T19:54:03+00:00 https://ascopost.com/news/january-2022/role-of-expression-of-erv-rna-in-prostate-cancer/ 2022-01-13T18:43:45+00:00 https://ascopost.com/news/january-2022/paclitaxelcarboplatin-vs-paclitaxelifosfamide-in-chemotherapy-naive-patients-with-uterine-carcinosarcoma/ 2022-01-13T18:48:01+00:00 https://ascopost.com/news/january-2022/antibiotics-after-endoprosthetic-reconstruction-for-lower-extremity-bone-tumors-comparison-of-two-intravenous-regimens/ 2022-01-13T19:10:44+00:00 https://ascopost.com/news/january-2022/composition-of-academic-radiation-oncology-workforces-in-national-cancer-institute-designated-comprehensive-cancer-centers/ 2022-01-14T16:55:59+00:00 https://ascopost.com/news/january-2022/new-research-aims-to-uncover-cellular-source-of-barrett-s-esophagus/ 2022-01-14T20:59:21+00:00 https://ascopost.com/news/january-2022/educational-intervention-increases-knowledge-about-prostate-cancer-and-intention-to-screen-among-high-risk-patients/ 2022-01-14T20:55:57+00:00 https://ascopost.com/news/january-2022/study-finds-improved-2-year-survival-rate-for-adult-patients-with-relapsed-philadelphia-chromosome-positive-all-after-allogeneic-hematopoietic-cell-transplantation-over-20-years/ 2022-01-14T19:00:54+00:00 https://ascopost.com/news/january-2022/association-of-genetic-alterations-with-disease-characteristics-and-response-to-treatment-in-pediatric-differentiated-thyroid-cancer/ 2022-01-17T15:32:50+00:00 https://ascopost.com/news/january-2022/addition-of-capecitabine-to-taxaneanthracycline-adjuvant-chemotherapy-for-early-breast-cancer-15-year-overall-survival-results-of-the-finxx-trial/ 2022-01-17T15:49:25+00:00 https://ascopost.com/news/january-2022/first-line-nivolumabcabozantinib-vs-sunitinib-for-advanced-renal-cell-carcinoma-patient-reported-outcomes/ 2022-01-17T16:44:37+00:00 https://ascopost.com/news/january-2022/presurgical-chemosensitivity-may-play-a-role-in-informing-postsurgical-treatment-for-patients-with-gastric-cancer/ 2022-01-17T18:59:04+00:00 https://ascopost.com/news/january-2022/durvalumabtremelimumab-with-or-without-radiotherapy-in-resistant-nsclc/ 2022-01-26T20:18:00+00:00 https://ascopost.com/news/january-2022/new-study-examines-genetic-effects-on-genitourinary-toxicity-in-patients-with-prostate-cancer/ 2022-01-17T18:16:46+00:00 https://ascopost.com/news/january-2022/depression-screening-and-behavioral-health-referrals-for-patients-with-newly-diagnosed-breast-cancer-in-the-community-oncology-setting/ 2022-01-18T16:22:01+00:00 https://ascopost.com/news/january-2022/interferon-alfa-vs-hydroxyurea-in-previously-untreated-patients-with-polycythemia-vera-and-essential-thrombocythemia/ 2025-09-30T19:36:40+00:00 https://ascopost.com/news/january-2022/uicc-to-launch-3-year-campaign-to-create-more-equitable-access-to-cancer-services/ 2022-01-18T17:10:20+00:00 https://ascopost.com/news/january-2022/study-finds-guideline-concordant-cervical-cancer-screening-dropped-from-2005-to-2019-among-women-in-the-united-states/ 2022-01-18T20:00:58+00:00 https://ascopost.com/news/january-2022/durvalumab-plus-gemcitabinecisplatin-improves-survival-in-patients-with-advanced-biliary-tract-cancer-topaz-1/ 2022-01-19T16:36:39+00:00 https://ascopost.com/news/january-2022/addition-of-nivolumab-to-oxaliplatin-based-chemotherapy-for-her2-negative-unresectable-advanced-or-recurrent-gastric-or-gastroesophageal-junction-cancer/ 2022-01-19T15:10:49+00:00 https://ascopost.com/news/january-2022/inotuzumab-ozogamicin-for-pediatric-patients-with-relapsed-or-refractory-b-cell-all/ 2022-02-14T19:19:32+00:00 https://ascopost.com/news/january-2022/study-finds-direct-oral-anticoagulants-significantly-decrease-recurrent-venous-thrombosis-for-adult-patients-with-cancer/ 2022-01-19T20:39:22+00:00 https://ascopost.com/news/january-2022/personalized-lung-cancer-risk-assessment-using-a-blood-based-biomarker-panel/ 2022-01-26T20:51:22+00:00 https://ascopost.com/news/january-2022/durvalumabtremelimumab-improves-overall-survival-vs-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma-himalaya/ 2022-01-19T20:11:42+00:00 https://ascopost.com/news/january-2022/selecting-patients-with-barrett-s-esophagus-for-endoscopic-surveillance-role-of-nonendoscopic-device-biomarkers/ 2022-01-20T19:27:21+00:00 https://ascopost.com/news/january-2022/addition-of-diet-and-lifestyle-factors-to-recurrence-and-mortality-prediction-models-for-patients-with-stage-iii-colon-cancer/ 2022-01-20T16:33:36+00:00 https://ascopost.com/news/january-2022/impact-of-a-healthy-lifestyle-on-risk-of-developing-cancer-cardiovascular-disease-or-type-2-diabetes/ 2022-01-20T16:59:08+00:00 https://ascopost.com/news/january-2022/combination-therapies-may-improve-outcomes-due-to-independent-rather-than-synergistic-or-additive-drug-action/ 2022-01-20T17:04:28+00:00 https://ascopost.com/news/january-2022/clinical-score-may-assist-in-guiding-peptide-receptor-radionuclide-therapy-decisions-for-patients-with-neuroendocrine-tumors/ 2022-01-20T19:29:46+00:00 https://ascopost.com/news/january-2022/does-early-locoregional-therapy-for-the-primary-site-improve-survival-in-newly-diagnosed-metastatic-breast-cancer/ 2022-01-21T15:54:38+00:00 https://ascopost.com/news/january-2022/long-term-swallowing-quality-of-life-results-with-radiotherapy-vs-transoral-robotic-surgery-for-oropharyngeal-cancer/ 2022-01-21T15:45:59+00:00 https://ascopost.com/news/january-2022/erdafitinib-for-patients-with-advanced-urothelial-carcinoma-and-fgfr-alterations/ 2022-01-21T16:03:39+00:00 https://ascopost.com/news/january-2022/pretreatment-cardiovascular-disease-and-events-during-follow-up-in-patients-receiving-curative-intent-chemoradiation-for-esophageal-cancer/ 2022-01-21T20:28:27+00:00 https://ascopost.com/news/january-2022/pembrolizumab-in-previously-treated-patients-with-msi-hdmmr-endometrial-cancer/ 2022-01-21T19:49:06+00:00 https://ascopost.com/news/january-2022/report-examines-online-learning-for-children-with-cancer-during-the-covid-19-pandemic/ 2022-01-24T15:49:06+00:00 https://ascopost.com/news/january-2022/long-term-outcomes-after-neoadjuvant-chemotherapy-with-or-without-carboplatin-and-bevacizumab-for-triple-negative-breast-cancer/ 2022-01-24T17:02:06+00:00 https://ascopost.com/news/january-2022/t-dxd-for-previously-treated-patients-with-metastatic-her2-mutant-nsclc/ 2022-01-26T20:15:45+00:00 https://ascopost.com/news/january-2022/cardiometabolic-risk-factors-in-breast-cancer-survivors/ 2022-01-26T20:32:55+00:00 https://ascopost.com/news/january-2022/risk-of-second-primary-malignancies-after-radioactive-iodine-treatment-for-pediatric-and-young-adult-patients-with-differentiated-thyroid-cancer/ 2022-01-26T20:30:58+00:00 https://ascopost.com/news/january-2022/lenvatinibpembrolizumab-vs-chemotherapy-in-previously-treated-patients-with-advanced-endometrial-cancer/ 2022-01-27T20:01:33+00:00 https://ascopost.com/news/january-2022/similar-efficacy-but-better-tolerability-for-ripretinib-vs-sunitinib-in-previously-treated-patients-with-advanced-gist/ 2022-01-26T19:02:20+00:00 https://ascopost.com/news/january-2022/addition-of-perioperative-trastuzumab-to-neoadjuvant-chemoradiation-for-patients-with-her2-overexpressing-esophageal-adenocarcinoma/ 2022-01-27T15:52:22+00:00 https://ascopost.com/news/january-2022/risk-of-multiple-cancers-in-male-carriers-of-brca1-and-brca2-gene-mutations/ 2022-01-27T18:11:48+00:00 https://ascopost.com/news/january-2022/addition-of-spartalizumab-to-dabrafenibtrametinib-for-braf-v600-mutant-advanced-melanoma/ 2022-01-27T18:17:11+00:00 https://ascopost.com/news/january-2022/young-adults-may-have-the-greatest-risk-of-distant-stage-colorectal-cancer-with-the-highest-risk-among-black-and-hispanic-patients/ 2022-01-27T18:38:35+00:00 https://ascopost.com/news/january-2022/pet-based-de-escalation-strategy-for-previously-untreated-advanced-hodgkin-lymphoma/ 2022-01-28T16:11:19+00:00 https://ascopost.com/news/january-2022/binimetinib-plus-imatinib-in-previously-untreated-patients-with-advanced-gastrointestinal-stromal-tumor/ 2022-01-28T16:16:19+00:00 https://ascopost.com/news/january-2022/palbociclib-exposure-and-discontinuation-and-potential-impact-on-outcome-in-the-pallas-trial/ 2022-01-28T18:30:33+00:00 https://ascopost.com/news/january-2022/early-research-shows-low-dose-light-therapy-may-aid-in-treating-skin-damage-from-radiation-therapy/ 2022-01-28T18:40:41+00:00 https://ascopost.com/news/january-2022/study-finds-that-compared-to-urban-residents-rural-residents-are-more-likely-to-have-fatalistic-beliefs-about-cancer/ 2022-01-28T18:50:03+00:00 https://ascopost.com/news/january-2022/invasive-cervical-cancer-prognosis-according-to-high-risk-hpv-status/ 2022-01-31T18:43:02+00:00 https://ascopost.com/news/january-2022/use-of-cancer-registry-and-credit-records-data-to-assess-risk-of-adverse-financial-events-in-patients-with-cancer/ 2022-01-31T16:00:54+00:00 https://ascopost.com/news/january-2022/genetic-and-lifestyle-calculator-may-help-to-identify-younger-adults-at-risk-of-colorectal-cancer/ 2022-01-31T16:45:08+00:00 https://ascopost.com/news/january-2022/addition-of-radiotherapy-to-durvalumab-plus-tremelimumab-in-patients-with-metastatic-nsclc-refractory-to-pd-1pd-l1-inhibitor-therapy/ 2022-02-08T20:04:38+00:00 https://ascopost.com/news/january-2022/new-study-examines-role-of-genetic-ancestry-in-pediatric-leukemia/ 2022-01-31T17:32:29+00:00 https://ascopost.com/news/february-2022/ 2022-02-01T14:55:58+00:00 https://ascopost.com/news/february-2022/trastuzumab-pertuzumab-and-docetaxel-for-advanced-her2-mutant-nsclc/ 2022-02-08T19:54:12+00:00 https://ascopost.com/news/february-2022/fda-approves-second-covid-19-vaccine/ 2022-02-01T16:13:39+00:00 https://ascopost.com/news/february-2022/study-examines-head-and-neck-cancer-incidence-in-black-populations-around-the-world/ 2026-01-29T15:36:23+00:00 https://ascopost.com/news/february-2022/fda-approves-new-label-update-for-car-t-cell-therapy-axicabtagene-ciloleucel/ 2022-02-01T16:00:14+00:00 https://ascopost.com/news/february-2022/asco-and-american-cancer-society-announce-collaboration-to-empower-people-with-cancer-information-they-can-trust/ 2022-02-01T17:48:52+00:00 https://ascopost.com/news/february-2022/teravolt-study-identifies-seven-factors-that-increase-mortality-risk-for-patients-with-lung-cancer-infected-with-covid-19/ 2022-02-02T17:14:54+00:00 https://ascopost.com/news/february-2022/use-of-polygenic-cytarabine-response-score-to-identify-candidates-with-pediatric-aml-for-chemotherapy-augmentation/ 2022-02-14T19:20:49+00:00 https://ascopost.com/news/february-2022/long-term-morbidity-in-patients-with-stage-i-to-iia-hodgkin-lymphoma-treated-with-abvd-and-limited-field-radiotherapy/ 2022-02-02T21:24:13+00:00 https://ascopost.com/news/february-2022/addition-of-sugemalimab-to-platinum-based-chemotherapy-for-metastatic-squamous-or-nonsquamous-nsclc/ 2022-02-08T19:53:08+00:00 https://ascopost.com/news/february-2022/president-biden-reignites-cancer-moonshot/ 2022-02-04T14:48:53+00:00 https://ascopost.com/news/february-2022/ibrutinibrituximab-for-indolent-clinical-types-of-mantle-cell-lymphoma/ 2022-02-16T19:47:27+00:00 https://ascopost.com/news/february-2022/outcomes-in-a-large-cohort-of-patients-with-ultra-low-risk-breast-cancer-analysis-from-the-mindact-trial/ 2022-02-07T17:24:50+00:00 https://ascopost.com/news/february-2022/can-postsurgical-monoclonal-antibody-treatment-reduce-her2-positive-early-stage-breast-cancer-recurrence/ 2022-02-03T17:46:32+00:00 https://ascopost.com/news/february-2022/can-weight-loss-in-adulthood-reduce-the-risk-of-developing-colorectal-adenomas/ 2022-02-03T18:02:22+00:00 https://ascopost.com/news/february-2022/study-examines-role-of-hyaluronic-acid-in-pancreatic-cancer-growth/ 2022-02-03T18:49:05+00:00 https://ascopost.com/news/february-2022/asco-statement-on-world-cancer-day/ 2022-02-04T15:39:48+00:00 https://ascopost.com/news/february-2022/risk-standardized-mortality-rates-as-quality-proxy-for-surgical-oncology/ 2022-02-04T18:24:03+00:00 https://ascopost.com/news/february-2022/cancercare-offers-patients-financial-assistance-for-transportation-pet-care/ 2022-02-04T18:33:36+00:00 https://ascopost.com/news/february-2022/study-examines-risk-of-cancers-other-than-female-breast-and-ovarian-cancers-associated-with-brca1-and-brca2-pathogenic-variants/ 2022-02-04T19:12:00+00:00 https://ascopost.com/news/february-2022/fda-investigating-possible-increased-risk-of-death-with-lymphoma-treatment-umbralisib/ 2022-02-04T20:27:40+00:00 https://ascopost.com/news/february-2022/use-of-autologous-metastasis-mutation-reactive-tils-in-metastatic-breast-cancer/ 2022-02-04T21:14:08+00:00 https://ascopost.com/news/february-2022/nivolumab-plus-chemotherapy-or-ipilimumab-vs-chemotherapy-in-previously-untreated-advanced-esophageal-squamous-cell-carcinoma/ 2022-02-07T18:56:02+00:00 https://ascopost.com/news/february-2022/reduced-intensity-chemoradiotherapy-in-ebv-dna-selected-locoregionally-advanced-nasopharyngeal-carcinoma/ 2026-01-29T15:33:31+00:00 https://ascopost.com/news/february-2022/pacific-trial-5-year-survival-outcomes-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/ 2022-02-07T17:47:23+00:00 https://ascopost.com/news/february-2022/efficacy-of-trametinib-in-recurrent-low-grade-serous-ovarian-carcinoma/ 2022-02-08T20:08:48+00:00 https://ascopost.com/news/february-2022/study-provides-insights-into-the-genomic-basis-of-cancer-metastasis/ 2022-02-08T18:10:28+00:00 https://ascopost.com/news/february-2022/role-of-cecr2-gene-in-advanced-triple-negative-breast-cancer/ 2022-02-08T19:12:31+00:00 https://ascopost.com/news/february-2022/predictive-model-for-severe-fatigue-after-breast-cancer-diagnosis/ 2022-02-08T19:19:39+00:00 https://ascopost.com/news/february-2022/sugemalimab-after-concurrent-or-sequential-chemoradiation-for-unresectable-stage-iii-nsclc/ 2022-02-08T20:12:55+00:00 https://ascopost.com/news/february-2022/neoadjuvant-chemoradiotherapy-vs-upfront-surgery-in-resectable-and-borderline-resectable-pancreatic-cancer/ 2022-02-09T16:04:51+00:00 https://ascopost.com/news/february-2022/can-an-intelligent-vacuum-assisted-biopsy-algorithm-reliably-identify-patients-with-breast-cancer-who-have-a-pathologic-complete-response-to-neoadjuvant-therapy/ 2022-02-09T16:54:43+00:00 https://ascopost.com/news/february-2022/adverse-event-rates-after-two-doses-of-mrna-covid-19-vaccine-in-patients-with-vs-without-cancer/ 2022-02-14T19:12:30+00:00 https://ascopost.com/news/february-2022/compression-sleeves-to-reduce-risk-of-arm-swelling-in-women-undergoing-surgery-for-breast-cancer/ 2022-02-09T17:10:05+00:00 https://ascopost.com/news/february-2022/aacr-releases-report-on-the-impact-of-covid-19-on-cancer-research-and-patient-care/ 2022-02-09T17:30:41+00:00 https://ascopost.com/news/february-2022/concordance-for-low-her2-protein-expression-in-breast-cancer-tissue-using-standard-immunohistochemistry-assays/ 2022-02-11T16:38:42+00:00 https://ascopost.com/news/february-2022/study-finds-patients-with-lung-cancer-demonstrated-psychological-resilience-in-the-face-of-the-covid-19-pandemic/ 2022-02-11T17:50:22+00:00 https://ascopost.com/news/february-2022/study-identifies-factors-impacting-adherence-to-oral-medications-for-metastatic-breast-cancer/ 2022-02-11T18:08:46+00:00 https://ascopost.com/news/february-2022/importing-oncology-trials-from-china-or-other-single-countries-for-consideration-of-us-regulatory-approvals/ 2022-02-11T20:16:28+00:00 https://ascopost.com/news/february-2022/neoadjuvant-atezolizumab-plus-gemcitabine-and-cisplatin-in-muscle-invasive-bladder-cancer/ 2022-02-14T20:24:48+00:00 https://ascopost.com/news/february-2022/ibrutinibrituximab-induction-followed-by-r-hcvad-in-front-line-treatment-of-patients-aged-65-and-younger-with-mantle-cell-lymphoma/ 2022-02-14T17:01:53+00:00 https://ascopost.com/news/february-2022/american-cancer-society-publishes-cancer-statistics-for-african-americanblack-people-2022/ 2022-02-14T17:30:35+00:00 https://ascopost.com/news/february-2022/report-finds-cancer-immunotherapy-clinical-trials-continue-to-grow-globally/ 2022-02-14T20:25:48+00:00 https://ascopost.com/news/february-2022/updated-efficacy-and-safety-data-from-checkmate-743-first-line-nivolumabipilimumab-vs-chemotherapy-for-unresectable-malignant-pleural-mesothelioma/ 2022-02-14T17:55:57+00:00 https://ascopost.com/news/february-2022/comprehensive-genetic-risk-score-may-predict-risk-of-developing-metastatic-prostate-cancer-or-death-from-prostate-cancer-across-diverse-populations/ 2022-02-18T20:42:54+00:00 https://ascopost.com/news/february-2022/cemiplimab-rwlc-vs-single-agent-chemotherapy-in-recurrent-cervical-cancer-after-first-line-platinum-based-chemotherapy/ 2022-02-15T16:06:22+00:00 https://ascopost.com/news/february-2022/h1-antihistamine-use-and-risk-of-hepatocellular-carcinoma-in-patients-with-hepatitis-b-virus-hepatitis-c-virus-or-dual-infection/ 2022-02-15T17:39:33+00:00 https://ascopost.com/news/february-2022/are-patients-undergoing-active-cancer-treatment-more-likely-to-believe-covid-19-misinformation/ 2022-02-15T17:43:09+00:00 https://ascopost.com/news/february-2022/potential-use-of-fdg-pet-findings-in-reducing-duration-of-immunotherapy-in-patients-with-advanced-melanoma/ 2022-02-15T17:57:02+00:00 https://ascopost.com/news/february-2022/differences-in-risk-of-severe-adverse-events-in-women-vs-men-receiving-immunotherapy-targeted-therapy-or-chemotherapy-in-cancer-clinical-trials/ 2022-02-15T19:34:22+00:00 https://ascopost.com/news/february-2022/niraparib-in-previously-treated-patients-with-metastatic-castration-resistant-prostate-cancer-and-dna-repair-gene-defects/ 2022-02-16T17:00:14+00:00 https://ascopost.com/news/february-2022/report-documents-third-known-case-of-hiv-remission-involving-stem-cell-transplant/ 2022-03-23T19:26:45+00:00 https://ascopost.com/news/february-2022/kras-g12c-inhibitor-sotorasib-shows-activity-in-certain-patients-with-pancreatic-cancer/ 2022-02-16T21:00:47+00:00 https://ascopost.com/news/february-2022/does-daily-aspirin-help-prevent-breast-cancer-recurrence/ 2022-02-16T19:42:54+00:00 https://ascopost.com/news/february-2022/web-based-intervention-to-manage-symptoms-and-quality-of-life-in-women-with-recurrent-ovarian-cancer/ 2022-02-17T20:53:17+00:00 https://ascopost.com/news/february-2022/neoadjuvant-enfortumab-vedotin-ejfv-in-cisplatin-ineligible-patients-with-muscle-invasive-bladder-cancer/ 2022-02-17T17:55:23+00:00 https://ascopost.com/news/february-2022/study-examines-predictive-biomarker-for-bladder-cancer-survival/ 2022-02-17T18:43:48+00:00 https://ascopost.com/news/february-2022/study-evaluates-effectiveness-of-existing-risk-stratification-system-for-hepatoblastoma/ 2022-02-17T19:34:46+00:00 https://ascopost.com/news/february-2022/copanlisib-in-patients-with-pik3ca-mutated-tumors/ 2022-02-18T16:01:03+00:00 https://ascopost.com/news/february-2022/does-mri-guided-radiotherapy-reduce-treatment-related-side-effects-in-patients-with-prostate-cancer/ 2022-02-18T16:21:33+00:00 https://ascopost.com/news/february-2022/researchers-identify-biomarkers-that-may-help-to-predict-response-to-immunotherapy-for-melanoma/ 2022-02-18T17:51:53+00:00 https://ascopost.com/news/february-2022/new-data-validate-clinical-utility-of-genomic-classifier-test-to-help-guide-therapy-for-men-with-intermediate-risk-prostate-cancer/ 2022-02-18T20:26:54+00:00 https://ascopost.com/news/february-2022/study-examines-relationship-between-angiotensin-blockade-and-pancreatic-cancer-survival/ 2022-02-18T18:43:25+00:00 https://ascopost.com/news/february-2022/paul-farmer-md-phd-dies-at-62/ 2022-02-22T20:52:05+00:00 https://ascopost.com/news/february-2022/fda-approves-foundationone-cdx-as-a-companion-diagnostic-for-pembrolizumab-to-identify-patients-with-msi-h-solid-tumors/ 2022-02-22T19:32:56+00:00 https://ascopost.com/news/february-2022/gog-281logs-trametinib-vs-standard-of-care-in-recurrent-low-grade-serous-ovarian-carcinoma/ 2022-02-22T19:38:01+00:00 https://ascopost.com/news/february-2022/adagrasib-in-advanced-kras-g12c-mutant-solid-tumors/ 2022-02-22T19:41:43+00:00 https://ascopost.com/news/february-2022/keynote-522-event-free-survival-with-neoadjuvant-and-adjuvant-pembrolizumab-in-triple-negative-breast-cancer/ 2022-02-22T19:47:28+00:00 https://ascopost.com/news/february-2022/study-investigates-the-risk-of-breast-cancer-mortality-after-late-breast-cancer-recurrence/ 2022-02-22T19:53:50+00:00 https://ascopost.com/news/february-2022/jeffrey-peppercorn-md-mph-named-editor-in-chief-of-jco-oncology-practice/ 2022-02-23T19:44:34+00:00 https://ascopost.com/news/february-2022/first-line-blinatumomab-and-pomp-maintenance-in-older-patients-with-philadelphia-chromosome-negative-b-cell-all/ 2022-02-23T20:00:28+00:00 https://ascopost.com/news/february-2022/arasens-trial-addition-of-darolutamide-to-androgen-deprivation-therapy-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/ 2022-03-08T20:48:54+00:00 https://ascopost.com/news/february-2022/incidental-findings-on-low-dose-ct-lung-cancer-screening-in-the-nlst-and-risk-of-respiratory-disease-mortality/ 2022-02-23T17:54:41+00:00 https://ascopost.com/news/february-2022/t-cell-responses-may-help-predict-protection-against-sars-cov-2-infection-in-individuals-with-and-without-cancer/ 2022-02-23T19:10:16+00:00 https://ascopost.com/news/february-2022/predictive-models-for-outcomes-with-immune-checkpoint-inhibitor-treatment-in-metastatic-melanoma/ 2022-02-23T19:26:11+00:00 https://ascopost.com/news/february-2022/addition-of-autologous-dendritic-cell-based-immunotherapy-to-chemotherapy-in-metastatic-castration-resistant-prostate-cancer/ 2022-02-24T19:32:59+00:00 https://ascopost.com/news/february-2022/long-term-rates-of-hospital-readmission-for-venous-thromboembolism-after-complex-cancer-surgery/ 2022-02-24T17:54:29+00:00 https://ascopost.com/news/february-2022/pembrolizumab-plus-trastuzumab-and-chemotherapy-in-previously-untreated-advanced-her2-positive-gastric-adenocarcinoma/ 2022-02-24T18:10:22+00:00 https://ascopost.com/news/february-2022/older-patients-with-cancer-and-high-risk-geriatric-profiles-at-greater-risk-for-death-and-other-adverse-sequelae-of-covid-19/ 2022-02-24T18:19:13+00:00 https://ascopost.com/news/february-2022/study-identifies-new-mutation-that-may-define-novel-pediatric-aml-subtype/ 2022-03-23T19:03:57+00:00 https://ascopost.com/news/february-2022/prediction-model-for-brca-mutation-carrying-status-in-asian-patients-with-breast-cancer/ 2022-02-24T18:45:43+00:00 https://ascopost.com/news/march-2022/ 2022-03-01T16:22:17+00:00 https://ascopost.com/news/march-2022/interim-analysis-of-overall-survival-in-icaria-mm-addition-of-isatuximab-to-pomalidomidedexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2022-03-01T17:18:27+00:00 https://ascopost.com/news/march-2022/axicabtagene-ciloleucel-vs-standard-of-care-as-second-line-treatment-for-large-b-cell-lymphoma/ 2022-03-01T19:16:25+00:00 https://ascopost.com/news/march-2022/biomarker-test-may-predict-recurrence-of-hpv-driven-oropharyngeal-cancer/ 2026-01-29T15:20:19+00:00 https://ascopost.com/news/march-2022/fda-clinical-trial-guidances-share-biden-administration-s-goals-for-advancing-development-of-cancer-treatments/ 2022-03-02T17:38:36+00:00 https://ascopost.com/news/march-2022/racial-disparities-in-outcomes-for-patients-with-early-hr-positive-breast-cancer-after-adjustment-for-insurance-status-and-neighborhood-deprivation-index/ 2022-03-02T17:46:16+00:00 https://ascopost.com/news/march-2022/do-diagnostic-delays-impact-overall-survival-in-patients-with-nsclc/ 2022-03-17T20:33:15+00:00 https://ascopost.com/news/march-2022/prediction-model-for-brca-mutation-carrying-status-in-asian-patients-with-breast-cancer/ 2022-03-02T19:44:59+00:00 https://ascopost.com/news/march-2022/pain-and-quality-of-life-in-the-profound-trial-olaparib-vs-next-generation-hormonal-agent-in-metastatic-castration-resistant-prostate-cancer-with-hrr-gene-alterations/ 2022-03-02T18:47:14+00:00 https://ascopost.com/news/march-2022/midtreatment-imaging-de-escalates-therapy-for-half-of-patients-with-oropharyngeal-cancer/ 2026-01-29T15:18:00+00:00 https://ascopost.com/news/march-2022/effect-of-screening-initiative-on-disparity-in-colorectal-cancer-mortality-between-black-and-white-patients/ 2022-03-03T15:22:30+00:00 https://ascopost.com/news/march-2022/esophagus-sparing-vs-standard-palliative-radiation-for-patients-with-advanced-central-nsclc/ 2022-03-17T20:32:47+00:00 https://ascopost.com/news/march-2022/mri-and-mammography-breast-cancer-screening-strategies-for-women-with-atm-chek2-and-palb2-pathogenic-variants/ 2022-03-03T17:41:36+00:00 https://ascopost.com/news/march-2022/minority-enrollment-in-us-phase-ii-and-iii-trials-in-genitourinary-cancers/ 2022-03-03T18:00:04+00:00 https://ascopost.com/news/march-2022/upfront-peptide-receptor-radionuclide-therapy-for-enteropancreatic-neuroendocrine-tumors/ 2022-03-03T18:09:38+00:00 https://ascopost.com/news/march-2022/ai-model-may-aid-in-screening-staging-and-treatment-planning-for-thyroid-cancer/ 2022-03-03T18:18:18+00:00 https://ascopost.com/news/march-2022/potential-contribution-of-nonmalignant-etiologies-to-back-pain-in-patients-with-metastatic-prostate-cancer/ 2022-03-04T16:29:10+00:00 https://ascopost.com/news/march-2022/effect-of-secondary-cytoreductive-surgery-on-survival-in-patients-with-platinum-sensitive-recurrent-ovarian-cancer/ 2022-03-04T16:33:45+00:00 https://ascopost.com/news/march-2022/addition-of-bcl-xlbcl-2-inhibitor-navitoclax-to-ongoing-ruxolitinib-in-patients-with-myelofibrosis-with-progression-or-suboptimal-response/ 2022-03-04T16:40:57+00:00 https://ascopost.com/news/march-2022/addition-of-selumetinib-to-adjuvant-radioactive-iodine-in-high-risk-differentiated-thyroid-cancer/ 2022-03-04T17:32:11+00:00 https://ascopost.com/news/march-2022/patients-with-merkel-cell-carcinoma-face-40-5-year-recurrence-rate-according-to-recent-study/ 2022-03-04T18:05:46+00:00 https://ascopost.com/news/march-2022/study-finds-taller-adults-may-be-at-increased-risk-for-colorectal-cancer/ 2022-03-04T19:37:12+00:00 https://ascopost.com/news/march-2022/fda-approves-neoadjuvant-nivolumab-and-platinum-doublet-chemotherapy-for-early-stage-nsclc/ 2022-03-17T20:31:16+00:00 https://ascopost.com/news/march-2022/mutations-associated-with-resistance-to-noncovalent-btk-inhibitors-in-patients-with-cll/ 2022-03-07T17:28:13+00:00 https://ascopost.com/news/march-2022/how-does-intake-of-unprocessed-red-meat-and-processed-meat-impact-risk-of-recurrence-and-mortality-in-patients-with-colon-cancer/ 2022-03-07T17:43:23+00:00 https://ascopost.com/news/march-2022/pathologic-response-of-index-lymph-node-and-concordance-with-total-nodal-basin-pathologic-response-in-stage-iii-melanoma/ 2022-03-07T17:51:31+00:00 https://ascopost.com/news/march-2022/study-defines-stem-cell-groups-that-may-drive-development-of-myelodysplastic-syndromes/ 2022-03-07T18:15:29+00:00 https://ascopost.com/news/march-2022/disadvantaged-patients-less-likely-to-receive-advanced-radiotherapy-techniques-for-head-and-neck-cancer/ 2026-01-29T15:16:31+00:00 https://ascopost.com/news/march-2022/epigenetic-predisposing-factors-in-wilms-tumor/ 2022-03-08T15:55:00+00:00 https://ascopost.com/news/march-2022/elective-upper-neck-vs-whole-neck-irradiation-in-nasopharyngeal-carcinoma/ 2026-01-29T15:15:03+00:00 https://ascopost.com/news/march-2022/risk-of-major-adverse-cardiovascular-events-with-combined-immune-checkpoint-inhibition-and-vegfr-inhibition-in-patients-with-advanced-rcc/ 2022-04-06T19:28:59+00:00 https://ascopost.com/news/march-2022/symptom-monitoring-intervention-for-hospitalized-patients-with-advanced-cancer/ 2022-03-08T20:23:12+00:00 https://ascopost.com/news/march-2022/comparison-of-multiparametric-ultrasound-and-multiparametric-mri-for-the-diagnosis-of-prostate-cancer/ 2022-03-09T16:53:19+00:00 https://ascopost.com/news/march-2022/risk-of-covid-19-infection-and-complications-among-survivors-of-childhood-adolescent-and-young-adult-cancers/ 2022-03-09T17:43:59+00:00 https://ascopost.com/news/march-2022/sbrt-in-combination-with-pembrolizumabtrametinib-vs-gemcitabine-in-locally-recurrent-pancreatic-cancer/ 2022-03-11T20:26:43+00:00 https://ascopost.com/news/march-2022/study-finds-world-trade-center-first-responders-have-high-burden-of-clonal-hematopoiesis/ 2022-03-09T18:44:08+00:00 https://ascopost.com/news/march-2022/research-outlines-obstetric-and-perinatal-outcomes-for-female-survivors-of-childhood-cancer/ 2022-03-09T19:04:43+00:00 https://ascopost.com/news/march-2022/postoperative-weekly-vs-every-3-week-cisplatin-in-chemoradiation-for-locally-advanced-head-and-neck-cancer/ 2026-01-29T15:11:30+00:00 https://ascopost.com/news/march-2022/intervention-for-racial-disparities-in-time-to-lung-cancer-surgery/ 2022-03-18T18:50:49+00:00 https://ascopost.com/news/march-2022/cancer-risk-among-patients-with-pediatric-onset-inflammatory-bowel-disease/ 2022-03-11T17:56:43+00:00 https://ascopost.com/news/march-2022/study-shows-structural-racism-may-contribute-to-poorer-outcomes-in-patients-with-leukemia/ 2022-03-23T19:27:58+00:00 https://ascopost.com/news/march-2022/study-patients-with-dual-medicare-and-medicaid-eligibility-have-poorer-outcomes-higher-spending-after-oncologic-surgery/ 2022-03-11T19:25:45+00:00 https://ascopost.com/news/march-2022/final-overall-survival-analysis-of-monaleesa-2/ 2022-03-11T19:34:04+00:00 https://ascopost.com/news/march-2022/keynote-564-update-supports-benefit-of-adjuvant-pembrolizumab-in-high-risk-renal-cell-carcinoma/ 2022-03-14T20:02:25+00:00 https://ascopost.com/news/march-2022/epov-daniel-geynisman/ 2022-03-14T14:14:52+00:00 https://ascopost.com/news/march-2022/factors-contributing-to-racial-disparities-in-the-use-of-prostate-mri-in-older-patients-with-prostate-cancer/ 2022-03-14T15:56:31+00:00 https://ascopost.com/news/march-2022/racial-genomic-profiles-of-primary-and-metastatic-breast-cancer/ 2022-03-14T17:04:16+00:00 https://ascopost.com/news/march-2022/novel-radioligand-therapy-improves-progression-free-and-overall-survival-in-patients-with-metastatic-prostate-cancer/ 2022-03-14T20:18:28+00:00 https://ascopost.com/news/march-2022/new-research-measures-decrease-in-cancer-detection-due-to-the-covid-19-pandemic/ 2022-03-15T16:09:35+00:00 https://ascopost.com/news/march-2022/thyroidectomy-with-or-without-radioiodine-for-low-risk-thyroid-cancer/ 2022-03-15T16:12:35+00:00 https://ascopost.com/news/march-2022/addition-of-bortezomib-to-chemotherapy-in-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia-and-lymphoma/ 2022-03-15T16:36:10+00:00 https://ascopost.com/news/march-2022/pfizer-announces-plan-to-maintain-humanitarian-supply-of-medicines-to-russians-donate-all-proceeds-to-humanitarian-support-for-the-people-of-ukraine/ 2022-03-15T19:19:03+00:00 https://ascopost.com/news/march-2022/late-mortality-and-life-expectancy-after-autologous-blood-or-marrow-transplant-analysis-from-1981-to-2014/ 2022-03-16T15:20:11+00:00 https://ascopost.com/news/march-2022/study-finds-cancer-treatment-creates-employment-difficulties-for-some-rural-women/ 2022-03-16T15:44:50+00:00 https://ascopost.com/news/march-2022/asco-and-the-european-cancer-organisation-to-hold-briefing-on-providing-cancer-care-during-the-war-in-ukraine/ 2022-03-16T16:31:54+00:00 https://ascopost.com/news/march-2022/immunotherapy-duo-delays-disease-progression-in-previously-untreated-patients-with-melanoma-relativity-047/ 2022-03-16T19:20:01+00:00 https://ascopost.com/news/march-2022/front-line-toripalimab-plus-chemotherapy-improves-survival-in-patients-with-advanced-nsclc-without-actionable-mutations/ 2022-03-16T19:19:25+00:00 https://ascopost.com/news/march-2022/trends-in-grade-5-toxicity-and-response-rates-in-phase-i-trials-for-hematologic-malignancies/ 2022-03-18T14:05:42+00:00 https://ascopost.com/news/march-2022/genetic-testing-of-samples-from-deceased-patients-with-tubo-ovarian-cancer-to-inform-families-of-identification-of-pathogenic-variants/ 2022-03-18T14:30:24+00:00 https://ascopost.com/news/march-2022/half-of-patients-with-cancer-and-survivors-report-incurring-cancer-related-medical-debt/ 2022-03-18T16:55:39+00:00 https://ascopost.com/news/march-2022/asco-and-eco-present-update-on-how-the-war-in-ukraine-is-impacting-care-for-patients-with-cancer/ 2022-03-18T17:03:27+00:00 https://ascopost.com/news/march-2022/adjuvant-olaparib-significantly-improves-overall-survival-in-germline-brca-mutated-breast-cancer/ 2022-04-05T17:47:44+00:00 https://ascopost.com/news/march-2022/temozolomide-followed-by-low-dose-ipilimumabnivolumab-in-mss-and-mgmt-silenced-metastatic-colorectal-cancer/ 2022-03-21T19:05:31+00:00 https://ascopost.com/news/march-2022/perioperative-dose-dense-mvac-vs-gemcitabinecisplatin-in-nonmetastatic-muscle-invasive-bladder-cancer/ 2022-03-21T16:11:36+00:00 https://ascopost.com/news/march-2022/lung-cancer-diagnosis-with-low-dose-ct-screening-and-a-program-for-management-of-incidentally-detected-lung-nodules/ 2022-03-21T17:32:44+00:00 https://ascopost.com/news/march-2022/researchers-identify-trends-in-treatment-for-retroperitoneal-soft-tissue-sarcoma/ 2022-03-21T17:52:06+00:00 https://ascopost.com/news/march-2022/adjuvant-pembrolizumab-may-improve-disease-free-survival-in-patients-with-early-stage-nsclc/ 2022-04-28T16:16:28+00:00 https://ascopost.com/news/march-2022/early-intrathecal-therapy-for-high-grade-icans-in-patients-receiving-car-t-cell-therapy/ 2022-04-14T19:43:00+00:00 https://ascopost.com/news/march-2022/characteristics-of-nonalcoholic-fatty-liver-disease-related-hcc-vs-hcc-from-other-causes/ 2022-03-22T17:02:27+00:00 https://ascopost.com/news/march-2022/abemaciclibletrozole-in-patients-with-recurrent-er-positive-endometrial-cancer/ 2022-03-22T15:55:02+00:00 https://ascopost.com/news/march-2022/soraya-trial-conjugate-therapy-produces-remissions-in-one-third-of-patients-with-drug-resistant-ovarian-cancer/ 2022-03-22T16:09:16+00:00 https://ascopost.com/news/march-2022/atezolizumab-plus-chemoradiation-is-safe-demonstrates-signs-of-immune-activation-in-patients-with-cervical-cancer/ 2022-03-22T16:58:17+00:00 https://ascopost.com/news/march-2022/all-cause-mortality-after-adjuvant-vs-early-salvage-radiation-therapy-following-radical-prostatectomy-for-pn1-prostate-cancer/ 2022-03-23T16:36:20+00:00 https://ascopost.com/news/march-2022/sequencing-of-drug-combinations-could-amplify-antitumor-immune-response-in-liver-cancer/ 2022-03-23T16:47:37+00:00 https://ascopost.com/news/march-2022/how-do-lifestyle-and-cardiovascular-risk-factors-relate-to-heart-failure-subtypes-in-postmenopausal-breast-cancer-survivors/ 2023-08-31T20:08:46+00:00 https://ascopost.com/news/march-2022/younger-patients-with-appendicitis-may-be-at-increased-risk-for-appendiceal-cancer/ 2022-04-28T18:25:20+00:00 https://ascopost.com/news/march-2022/hrr-mutational-status-may-be-prognostic-of-survival-outcomes-for-women-with-recurrent-platinum-sensitive-ovarian-cancer/ 2022-03-23T18:16:25+00:00 https://ascopost.com/news/march-2022/study-identifies-genetic-variants-that-may-contribute-to-accelerated-aging-in-childhood-cancer-survivors/ 2022-03-24T15:35:03+00:00 https://ascopost.com/news/march-2022/olaparib-with-or-without-cediranib-vs-platinum-based-chemotherapy-in-recurrent-platinum-sensitive-ovarian-cancer/ 2022-03-24T15:47:51+00:00 https://ascopost.com/news/march-2022/checkmate-9er-final-results-support-first-line-regimen-of-nivolumab-plus-cabozantinib-in-advanced-kidney-cancer/ 2022-03-24T18:23:33+00:00 https://ascopost.com/news/march-2022/the-university-of-texas-md-anderson-cancer-center-launches-james-p-allison-institute/ 2022-05-25T14:54:03+00:00 https://ascopost.com/news/march-2022/observation-vs-screening-spinal-mri-in-patients-with-castration-resistant-prostate-cancer-and-asymptomatic-spinal-metastases/ 2022-03-24T18:04:15+00:00 https://ascopost.com/news/march-2022/guideline-concordant-surgery-and-adjuvant-chemotherapy-for-early-stage-nsclc/ 2022-04-28T16:18:39+00:00 https://ascopost.com/news/march-2022/oncologists-use-of-geriatric-assessment-instruments-in-older-patients-with-cancer/ 2022-03-29T16:44:18+00:00 https://ascopost.com/news/march-2022/study-evaluates-response-based-immunotherapy-strategy-in-patients-with-advanced-urothelial-carcinoma/ 2022-04-06T19:27:14+00:00 https://ascopost.com/news/march-2022/concordance-in-symptomatic-adverse-event-reporting-by-children-clinicians-and-caregivers/ 2022-03-29T18:02:19+00:00 https://ascopost.com/news/march-2022/results-from-mappyacts-trial-show-the-feasibility-and-benefit-of-molecular-profiling-at-cancer-recurrence-in-pediatric-patients/ 2022-03-29T18:11:02+00:00 https://ascopost.com/news/march-2022/short-term-radiotherapy-plus-preoperative-chemotherapy-vs-long-term-chemoradiotherapy-for-locally-advanced-rectal-cancer/ 2022-03-30T15:23:34+00:00 https://ascopost.com/news/march-2022/pd-1-inhibition-in-patients-with-classic-or-endemic-kaposi-sarcoma/ 2022-03-30T19:43:52+00:00 https://ascopost.com/news/march-2022/risk-of-colorectal-cancer-linked-to-cumulative-time-with-excess-body-weight/ 2022-03-30T19:44:26+00:00 https://ascopost.com/news/march-2022/third-covid-19-vaccine-dose-may-improve-immune-response-in-patients-with-lymphoma/ 2022-03-30T16:57:55+00:00 https://ascopost.com/news/march-2022/thickness-specific-incidence-of-cutaneous-melanoma-in-the-united-states/ 2022-03-30T18:28:44+00:00 https://ascopost.com/news/march-2022/study-finds-black-patients-with-cancer-diagnosed-with-covid-19-have-worse-outcomes-than-white-patients/ 2022-03-30T19:45:06+00:00 https://ascopost.com/news/march-2022/long-term-survival-outcomes-with-adjuvant-capecitabine-in-biliary-tract-cancer/ 2022-03-31T15:17:03+00:00 https://ascopost.com/news/march-2022/transportation-barriers-to-health-care-among-cancer-survivors-in-the-united-states/ 2022-03-31T15:27:10+00:00 https://ascopost.com/news/march-2022/cabozantinib-plus-nivolumab-in-advanced-non-clear-cell-renal-cell-carcinoma/ 2022-03-31T15:46:52+00:00 https://ascopost.com/news/march-2022/ariel4-trial-rucaparib-vs-chemotherapy-in-patients-with-relapsed-ovarian-cancer-and-deleterious-brca1-or-brca2-mutations/ 2022-03-31T15:57:24+00:00 https://ascopost.com/news/march-2022/registry-study-shows-a-real-world-increase-in-biomarker-testing-among-patients-with-advanced-nsclc/ 2022-04-28T16:24:43+00:00 https://ascopost.com/news/april-2022/ 2022-04-01T15:59:08+00:00 https://ascopost.com/news/april-2022/study-compares-surveillance-methods-and-schedules-in-stage-i-testicular-seminoma/ 2022-04-01T16:23:02+00:00 https://ascopost.com/news/april-2022/association-of-serous-tubal-intraepithelial-carcinoma-at-risk-reducing-salpingo-oophorectomy-with-risk-of-subsequent-peritoneal-carcinomatosis/ 2022-04-01T19:36:40+00:00 https://ascopost.com/news/april-2022/collaboration-finds-international-disparities-in-screening-treatment-and-outcomes-for-patients-with-lung-cancer/ 2022-04-01T19:35:02+00:00 https://ascopost.com/news/april-2022/destiny-breast03-trial-t-dxd-vs-t-dm1-in-previously-treated-patients-with-metastatic-her2-positive-breast-cancer/ 2022-04-01T17:34:03+00:00 https://ascopost.com/news/april-2022/effect-of-traditional-eligibility-criteria-on-enrollment-of-black-patients-in-pancreatic-cancer-clinical-trials/ 2022-04-01T17:40:10+00:00 https://ascopost.com/news/april-2022/norman-sharpless-md-to-step-down-as-director-of-the-nci/ 2022-04-04T15:52:29+00:00 https://ascopost.com/news/april-2022/induction-chemotherapy-with-paclitaxel-cisplatin-and-capecitabine-vs-cisplatin-and-fluorouracil-for-nasopharyngeal-carcinoma/ 2026-01-29T14:37:52+00:00 https://ascopost.com/news/april-2022/hyperthermic-intraperitoneal-chemotherapy-with-primary-or-interval-cytoreductive-surgery-for-advanced-ovarian-cancer/ 2022-04-04T14:56:46+00:00 https://ascopost.com/news/april-2022/telemedicine-vs-in-person-postoperative-follow-up-after-inpatient-oncologic-surgery/ 2022-04-04T15:29:41+00:00 https://ascopost.com/news/april-2022/outcomes-with-pembrolizumab-pembrolizumabchemotherapy-and-cetuximabchemotherapy-by-pd-l1-cps-in-recurrentmetastatic-head-and-neck-cancer/ 2026-01-29T14:36:27+00:00 https://ascopost.com/news/april-2022/addition-of-sorafenib-to-standard-chemotherapy-in-pediatric-patients-with-high-allelic-ratio-flt3-itd-positive-aml/ 2022-04-05T16:15:19+00:00 https://ascopost.com/news/april-2022/immune-related-adverse-events-with-immune-checkpoint-inhibitor-treatment-for-melanoma-in-older-white-patients/ 2022-05-26T20:21:56+00:00 https://ascopost.com/news/april-2022/study-explores-racial-disparities-among-patients-undergoing-gastrointestinal-cancer-surgery/ 2022-04-05T19:27:22+00:00 https://ascopost.com/news/april-2022/tumor-budding-may-provide-independent-prognostic-value-for-disease-free-and-overall-survival-in-patients-with-stage-iii-colon-cancer/ 2022-04-05T19:23:25+00:00 https://ascopost.com/news/april-2022/combined-bcma-and-cd19-car-t-cells-in-relapsed-or-refractory-multiple-myeloma-long-term-follow-up/ 2022-04-06T15:53:17+00:00 https://ascopost.com/news/april-2022/egfr-inhibition-in-egfr-amplified-advanced-gastroesophageal-cancer/ 2022-04-06T16:03:42+00:00 https://ascopost.com/news/april-2022/fda-approves-alpelisib-for-pik3ca-related-overgrowth-spectrum/ 2022-04-06T17:42:46+00:00 https://ascopost.com/news/april-2022/prognostic-value-of-stils-in-young-women-with-node-negative-triple-negative-breast-cancer-who-did-not-receive-neoadjuvant-systemic-therapy/ 2022-04-07T15:50:30+00:00 https://ascopost.com/news/april-2022/study-finds-covid-19-restrictions-delayed-breast-cancer-care-at-a-safety-net-hospital/ 2022-04-07T19:41:05+00:00 https://ascopost.com/news/april-2022/positive-lymph-nodes-may-not-be-an-indicator-for-chemotherapy-in-older-patients-with-breast-cancer/ 2022-04-07T17:32:11+00:00 https://ascopost.com/news/april-2022/study-finds-lumpectomy-may-be-as-effective-as-mastectomy-for-patients-with-nonmetastatic-breast-cancer-younger-than-40/ 2022-04-07T19:37:48+00:00 https://ascopost.com/news/april-2022/study-identifies-decline-in-annual-screening-for-breast-cancer-survivors/ 2022-04-08T18:57:03+00:00 https://ascopost.com/news/april-2022/multilevel-factors-related-to-changes-in-body-adiposity-in-black-survivors-of-breast-cancer/ 2022-04-08T18:59:22+00:00 https://ascopost.com/news/april-2022/research-finds-covid-19-vaccine-protects-most-patients-with-cancer-but-risk-remains-higher-for-patients-with-blood-cancers/ 2022-04-08T15:40:44+00:00 https://ascopost.com/news/april-2022/screening-platform-may-contribute-to-detection-of-early-stage-pancreatic-cancers-other-malignancies/ 2022-04-08T15:50:55+00:00 https://ascopost.com/news/april-2022/an-ai-model-may-predict-elevated-pancreatic-cancer-risk-using-electronic-health-records/ 2022-04-12T19:20:59+00:00 https://ascopost.com/news/april-2022/recurrent-noninvasive-breast-tumors-may-not-always-be-related-to-the-primary-lesion/ 2022-04-12T19:21:37+00:00 https://ascopost.com/news/april-2022/patients-with-lung-cancer-and-a-genetic-variant-linked-to-autoimmune-disease-may-be-especially-responsive-to-immunotherapy/ 2022-04-12T19:54:26+00:00 https://ascopost.com/news/april-2022/pediatric-patients-with-cancer-in-lower-and-middle-income-countries-faced-a-significantly-higher-mortality-risk-during-the-covid-19-pandemic/ 2022-04-12T19:24:38+00:00 https://ascopost.com/news/april-2022/sotorasib-achieves-durable-responses-in-kras-g12c-mutated-lung-cancer/ 2022-04-12T19:50:30+00:00 https://ascopost.com/news/april-2022/novel-approach-using-off-the-shelf-preactivated-nk-cells-achieves-promising-responses-in-cd30-positive-lymphoma/ 2022-04-21T18:44:28+00:00 https://ascopost.com/news/april-2022/study-examines-disparities-in-relapse-among-pediatric-patients-with-all/ 2022-04-18T19:29:30+00:00 https://ascopost.com/news/april-2022/accounting-for-genetic-factors-that-cause-normal-variations-in-psa-levels-may-improve-the-accuracy-of-prostate-cancer-detection/ 2022-04-13T18:21:18+00:00 https://ascopost.com/news/april-2022/new-car-t-cell-therapy-for-solid-tumors-was-safe-and-showed-early-efficacy/ 2022-04-13T18:12:21+00:00 https://ascopost.com/news/april-2022/in-the-neoadjuvant-setting-combination-immunotherapy-with-durvalumab-is-more-effective-than-durvalumab-alone-for-early-stage-nsclc/ 2022-04-28T16:14:31+00:00 https://ascopost.com/news/april-2022/novel-covid-19-vaccine-may-provide-protection-for-patients-with-b-cell-deficiencies/ 2022-04-13T18:25:50+00:00 https://ascopost.com/news/april-2022/adjuvant-pembrolizumab-in-resected-stage-iib-or-iic-melanoma/ 2022-04-14T15:39:10+00:00 https://ascopost.com/news/april-2022/ipilimumab-plus-nivolumab-improves-progression-free-survival-in-advanced-melanoma/ 2022-06-23T19:58:24+00:00 https://ascopost.com/news/april-2022/association-of-pretreatment-lymphocyte-count-with-overall-survival-and-benefit-of-addition-of-cisplatin-to-radiotherapy-in-oropharyngeal-squamous-cell-carcinoma/ 2026-01-29T14:31:04+00:00 https://ascopost.com/news/april-2022/patients-with-all-and-certain-gene-regulation-patterns-may-be-less-likely-to-respond-to-car-t-cell-therapy/ 2022-04-18T18:41:57+00:00 https://ascopost.com/news/april-2022/new-bioinformatics-platform-optimizes-selection-of-combination-cancer-therapies/ 2022-04-14T18:41:12+00:00 https://ascopost.com/news/april-2022/biomarker-driven-assessment-of-nivolumab-nivolumabipilimumab-and-vegfr-tyrosine-kinase-inhibitors-in-first-line-treatment-of-metastatic-clear-cell-rcc/ 2022-04-15T15:14:46+00:00 https://ascopost.com/news/april-2022/ai-model-may-help-predict-adverse-events-from-new-drug-combinations/ 2022-04-15T19:35:10+00:00 https://ascopost.com/news/april-2022/risk-of-cardiovascular-disease-and-mortality-in-women-with-breast-cancer-the-pathways-heart-study/ 2022-04-15T16:32:51+00:00 https://ascopost.com/news/april-2022/turnaround-times-in-melanoma-braf-testing-and-effect-on-time-to-treatment-initiation/ 2022-04-15T17:35:31+00:00 https://ascopost.com/news/april-2022/third-dose-of-covid-19-vaccine-significantly-increases-immune-responses-in-most-patients-with-multiple-myeloma/ 2022-04-15T17:53:05+00:00 https://ascopost.com/news/april-2022/study-findings-broaden-repertoire-of-cancer-relevant-genes/ 2022-04-15T17:57:57+00:00 https://ascopost.com/news/april-2022/selumetinib-in-children-and-young-adults-with-tumors-with-activating-mapk-pathway-alterations/ 2022-04-18T15:52:28+00:00 https://ascopost.com/news/april-2022/longitudinal-patterns-of-fatigue-after-breast-cancer-diagnosis-and-treatment/ 2022-04-18T16:19:25+00:00 https://ascopost.com/news/april-2022/association-between-venous-thromboembolism-risk-and-blood-type/ 2022-04-18T19:36:46+00:00 https://ascopost.com/news/april-2022/researchers-seek-to-expand-immunotherapy-options-for-patients-with-advanced-breast-and-colorectal-cancers/ 2022-04-18T19:35:59+00:00 https://ascopost.com/news/april-2022/therapies-targeting-dna-damage-response-show-antitumor-activity/ 2022-04-18T17:43:39+00:00 https://ascopost.com/news/april-2022/changes-in-the-nccn-guidelines-on-colorectal-cancer-screening/ 2022-04-18T18:36:01+00:00 https://ascopost.com/news/april-2022/association-of-mrd-status-with-outcomes-after-autologous-stem-cell-transplantation-for-multiple-myeloma/ 2022-04-19T15:30:26+00:00 https://ascopost.com/news/april-2022/factors-contributing-to-mortality-and-second-cancer-incidence-after-treatment-for-testicular-cancer/ 2022-04-19T16:49:02+00:00 https://ascopost.com/news/april-2022/effect-of-changes-to-california-medicaid-dental-benefits-on-earlier-diagnosis-of-oral-cavity-cancer/ 2026-01-29T14:23:28+00:00 https://ascopost.com/news/april-2022/diagnosis-of-cancer-within-30-days-after-emergency-hospital-admission/ 2022-04-19T17:05:16+00:00 https://ascopost.com/news/april-2022/raceethnicity-mortality-disparity-in-patients-with-de-novo-stage-iv-breast-cancer-effect-of-medicaid-expansion/ 2022-04-20T15:19:15+00:00 https://ascopost.com/news/april-2022/association-of-preexisting-thyroid-autoimmunity-with-risk-of-papillary-thyroid-cancer/ 2022-04-20T15:31:25+00:00 https://ascopost.com/news/april-2022/breast-cancer-screening-with-digital-breast-tomosynthesis-plus-synthesized-mammography-vs-digital-mammography/ 2022-04-20T15:44:10+00:00 https://ascopost.com/news/april-2022/ai-may-reduce-miss-rate-of-precancerous-polyps-during-colorectal-cancer-screening/ 2022-04-20T15:48:47+00:00 https://ascopost.com/news/april-2022/tislelizumab-plus-chemotherapy-improves-progression-free-survival-in-nasopharyngeal-cancer/ 2026-01-29T04:52:03+00:00 https://ascopost.com/news/april-2022/peace-1-trial-addition-of-abiraterone-plus-prednisone-to-adt-and-docetaxel-in-de-novo-metastatic-castration-sensitive-prostate-cancer/ 2022-04-21T16:11:56+00:00 https://ascopost.com/news/april-2022/addition-of-nintedanib-to-neoadjuvant-gemcitabinecisplatin-in-locally-advanced-muscle-invasive-bladder-cancer/ 2022-04-21T16:54:05+00:00 https://ascopost.com/news/april-2022/role-of-21-gene-recurrence-score-and-preoperative-endocrine-therapy-response-in-guiding-treatment-in-early-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-04-21T17:10:03+00:00 https://ascopost.com/news/april-2022/nominations-open-for-king-hussein-award-for-cancer-research/ 2022-04-21T20:40:57+00:00 https://ascopost.com/news/april-2022/virtual-panel-explores-impact-of-racism-on-the-cancer-burden-facing-asian-americans/ 2022-04-21T18:19:52+00:00 https://ascopost.com/news/april-2022/study-shows-medical-financial-hardship-increases-mortality-risk-for-cancer-survivors/ 2022-04-21T18:42:43+00:00 https://ascopost.com/news/april-2022/internal-mammary-node-irradiation-in-node-positive-early-breast-cancer-15-year-outcomes/ 2022-04-22T16:15:25+00:00 https://ascopost.com/news/april-2022/checkmate-816-neoadjuvant-nivolumab-plus-chemotherapy-in-resectable-nsclc/ 2022-04-22T15:49:23+00:00 https://ascopost.com/news/april-2022/overall-survival-in-keynote-177-pembrolizumab-vs-chemotherapy-in-microsatellite-instability-high-or-mismatch-repair-deficient-metastatic-colorectal-cancer/ 2022-04-22T16:32:42+00:00 https://ascopost.com/news/april-2022/new-factors-that-can-predict-breast-cancer-recurrence-identified/ 2022-04-22T17:56:27+00:00 https://ascopost.com/news/april-2022/less-prostate-cancer-screening-reduces-overdiagnosis-but-may-miss-aggressive-cases/ 2022-04-22T18:38:26+00:00 https://ascopost.com/news/april-2022/selinexor-in-previously-treated-advanced-dedifferentiated-liposarcoma/ 2022-04-22T18:12:20+00:00 https://ascopost.com/news/april-2022/maternal-malignancies-may-be-identified-through-noninvasive-prenatal-test-results/ 2022-04-26T17:13:00+00:00 https://ascopost.com/news/april-2022/fuzuloparib-maintenance-therapy-in-patients-with-platinum-sensitive-recurrent-ovarian-carcinoma/ 2022-04-26T18:48:06+00:00 https://ascopost.com/news/april-2022/high-dose-radiotherapy-with-short-vs-long-term-androgen-deprivation-in-localized-prostate-cancer/ 2022-04-26T18:58:02+00:00 https://ascopost.com/news/april-2022/ai-may-assist-physicians-in-better-assessing-the-effectiveness-of-bladder-cancer-treatment/ 2022-04-26T19:12:21+00:00 https://ascopost.com/news/april-2022/addition-of-high-dose-treosulfan-and-melphalan-to-consolidation-in-high-risk-ewing-sarcoma/ 2022-04-26T19:23:28+00:00 https://ascopost.com/news/april-2022/study-examines-rates-of-psychiatric-disorders-and-self-harm-among-patients-diagnosed-across-26-cancer-types/ 2022-04-26T20:34:47+00:00 https://ascopost.com/news/april-2022/narsoplimab-for-hematopoietic-stem-cell-transplantation-associated-thrombotic-microangiopathy/ 2022-05-12T19:54:36+00:00 https://ascopost.com/news/april-2022/assessment-of-cancer-risk-profile-for-germline-brca1-and-brca2-pathogenic-variants-in-patients-with-common-cancers/ 2022-04-27T18:28:14+00:00 https://ascopost.com/news/april-2022/navicixizumab-plus-paclitaxel-in-platinum-resistant-ovarian-cancer/ 2022-04-27T18:37:26+00:00 https://ascopost.com/news/april-2022/new-study-examining-women-s-breast-density-knowledge-suggests-opportunities-for-improvement/ 2022-04-27T18:49:48+00:00 https://ascopost.com/news/april-2022/two-studies-examine-use-of-proton-beam-therapy-in-the-united-states/ 2022-04-27T19:00:42+00:00 https://ascopost.com/news/april-2022/updated-guidance-for-covid-19-vaccination-from-nccn-recommends-fifth-mrna-shot-second-booster-dose-for-immunocompromised-people/ 2022-04-28T16:42:44+00:00 https://ascopost.com/news/april-2022/overall-survival-in-the-arches-trial-addition-of-enzalutamide-to-adt-for-metastatic-hormone-sensitive-prostate-cancer/ 2022-04-28T17:08:15+00:00 https://ascopost.com/news/april-2022/study-finds-car-t-cell-therapy-outcomes-side-effects-are-similar-in-black-and-hispanic-patients-compared-to-white-and-asian-patients/ 2022-05-12T19:24:25+00:00 https://ascopost.com/news/april-2022/switch-to-maintenance-endocrine-therapy-plus-bevacizumab-after-first-line-paclitaxelbevacizumab-induction-in-advanced-er-positive-her2-negative-breast-cancer/ 2022-04-29T19:54:37+00:00 https://ascopost.com/news/april-2022/gut-microbiome-may-alter-response-to-cancer-therapy/ 2022-04-29T18:00:05+00:00 https://ascopost.com/news/april-2022/increased-risk-of-cancer-in-early-life-among-individuals-with-autism-spectrum-disorders/ 2022-04-29T17:49:50+00:00 https://ascopost.com/news/april-2022/study-identifies-genetic-changes-in-patients-with-barrett-s-esophagus-that-progresses-to-esophageal-cancer/ 2022-04-29T19:09:47+00:00 https://ascopost.com/news/april-2022/patients-with-cancer-face-greater-risks-from-abdominal-aneurysm-repair/ 2022-04-29T19:26:13+00:00 https://ascopost.com/news/may-2022/ 2022-05-02T14:06:15+00:00 https://ascopost.com/news/may-2022/addition-of-ivosidenib-to-azacitidine-in-newly-diagnosed-idh1-mutated-acute-myeloid-leukemia/ 2022-05-16T17:17:45+00:00 https://ascopost.com/news/may-2022/cancer-rates-declining-in-canada-but-cases-and-deaths-increasing-because-of-demographic-factors/ 2022-05-02T16:16:04+00:00 https://ascopost.com/news/may-2022/cancer-screening-accessibility-among-native-americans/ 2022-05-02T19:05:36+00:00 https://ascopost.com/news/may-2022/patient-reported-outcomes-and-toxicity-with-adjuvant-stereotactic-pelvic-radiation-therapy-in-uterine-cancers/ 2022-05-02T18:07:50+00:00 https://ascopost.com/news/may-2022/study-finds-long-term-increase-in-cancer-risk-after-high-childhood-bmi/ 2022-05-02T18:20:08+00:00 https://ascopost.com/news/may-2022/concordance-with-pretreatment-staging-imaging-guidelines-in-rectal-cancer-asco-qopi-findings/ 2022-05-03T16:48:21+00:00 https://ascopost.com/news/may-2022/case-study-examines-differences-between-ai-and-radiologist-perception-in-breast-cancer-screening/ 2022-05-03T17:17:19+00:00 https://ascopost.com/news/may-2022/asco-s-cancerlinq-and-atropos-health-collaborate-to-harness-real-world-data-to-provide-point-of-care-informatics-consult-to-oncologists/ 2022-05-03T17:22:05+00:00 https://ascopost.com/news/may-2022/research-suggests-over-half-of-eligible-women-would-prefer-self-sampling-for-cervical-screening/ 2022-05-03T19:42:27+00:00 https://ascopost.com/news/may-2022/cemiplimab-rwlc-improves-overall-survival-vs-chemotherapy-in-recurrent-cervical-cancer-after-first-line-platinum-based-chemotherapy/ 2022-05-03T19:59:01+00:00 https://ascopost.com/news/may-2022/do-aya-cancer-survivors-face-a-higher-risk-of-developing-and-dying-from-a-new-primary-cancer/ 2022-05-04T17:10:49+00:00 https://ascopost.com/news/may-2022/study-reports-new-potential-target-for-car-t-cell-therapy/ 2022-05-04T20:53:56+00:00 https://ascopost.com/news/may-2022/swog-1216-orteronel-vs-bicalutamide-with-adt-for-metastatic-hormone-sensitive-prostate-cancer/ 2022-05-04T18:05:55+00:00 https://ascopost.com/news/may-2022/sbrt-plus-nivolumab-with-or-without-ipilimumab-in-refractory-metastatic-pancreatic-cancer/ 2022-05-04T20:53:19+00:00 https://ascopost.com/news/may-2022/study-examines-link-between-emphysema-and-lung-cancer-risk/ 2022-05-04T19:28:30+00:00 https://ascopost.com/news/may-2022/segmentectomy-vs-lobectomy-in-small-sized-peripheral-nsclc/ 2022-05-20T18:32:13+00:00 https://ascopost.com/news/may-2022/lenvatinibpembrolizumab-vs-sunitinib-in-patients-with-advanced-renal-cell-carcinoma-hrqol-outcomes/ 2022-05-05T19:05:15+00:00 https://ascopost.com/news/may-2022/consolidation-durvalumab-alone-or-combined-with-oleclumab-or-monalizumab-for-unresectable-stage-iii-nsclc/ 2022-05-20T18:31:26+00:00 https://ascopost.com/news/may-2022/can-ai-assist-in-predicting-spinal-fractures-in-patients-with-cancer/ 2022-05-05T21:38:32+00:00 https://ascopost.com/news/may-2022/association-of-pathogenic-variants-in-hereditary-cancer-genes-with-additional-cancers-and-non-neoplastic-diseases/ 2022-05-09T16:34:38+00:00 https://ascopost.com/news/may-2022/nivolumab-and-salvage-nivolumabipilimumab-for-previously-untreated-advanced-clear-cell-renal-cell-carcinoma/ 2022-05-09T16:45:16+00:00 https://ascopost.com/news/may-2022/treatment-de-escalation-in-hpv-associated-oropharyngeal-cancer-using-primary-radiotherapy-vs-transoral-surgery/ 2026-01-29T04:47:46+00:00 https://ascopost.com/news/may-2022/absence-of-fam19a4mir124-2-dna-methylation-and-clinical-regression-of-high-grade-cervical-intraepithelial-neoplasia/ 2022-05-09T18:12:15+00:00 https://ascopost.com/news/may-2022/tuxedo-1-efficacy-of-t-dxd-for-patients-with-her2-positive-breast-cancer-and-active-brain-metastases/ 2022-05-09T17:18:39+00:00 https://ascopost.com/news/may-2022/updated-overall-survival-results-from-monaleesa-3-show-improved-overall-survival-in-patients-with-hr-positiveher2-negative-breast-cancer/ 2022-05-09T17:36:47+00:00 https://ascopost.com/news/may-2022/second-line-tislelizumab-vs-chemotherapy-for-advanced-esophageal-squamous-cell-carcinoma/ 2022-05-11T14:43:27+00:00 https://ascopost.com/news/may-2022/addition-of-ibandronate-to-adjuvant-endocrine-therapy-in-postmenopausal-women-with-er-positive-breast-cancer/ 2022-05-11T14:48:00+00:00 https://ascopost.com/news/may-2022/comparison-of-2020-nice-criteria-for-preoperative-radiotherapy-in-rectal-cancer-treated-by-surgery-alone-with-established-mri-prognostic-factors/ 2022-05-11T16:07:06+00:00 https://ascopost.com/news/may-2022/astro-issues-clinical-guideline-on-radiation-therapy-for-brain-metastases/ 2022-05-11T17:13:07+00:00 https://ascopost.com/news/may-2022/rehospitalization-and-emergency-department-visits-after-car-t-cell-therapy-in-commercially-insured-patients-with-cancer/ 2022-05-18T19:27:50+00:00 https://ascopost.com/news/may-2022/report-finds-targeting-il-6-may-help-to-relieve-immunotherapy-side-effects/ 2022-05-12T16:40:31+00:00 https://ascopost.com/news/may-2022/anti-ctla-4-antibody-based-treatment-in-patients-with-metastatic-melanoma-experiencing-disease-progression-on-relatlimabnivolumab/ 2022-05-12T19:05:01+00:00 https://ascopost.com/news/may-2022/new-research-encourages-harnessing-health-technology-to-help-patients-with-cancer-quit-smoking/ 2022-05-12T19:28:17+00:00 https://ascopost.com/news/may-2022/patients-with-nsclc-brain-metastases-undergoing-neurosurgical-resection-comparison-of-treatment-regimens/ 2022-05-20T18:34:03+00:00 https://ascopost.com/news/may-2022/association-of-chromosome-3p253-gain-with-cisplatin-resistance-and-outcomes-in-male-malignant-germ-cell-tumors/ 2022-05-13T15:55:00+00:00 https://ascopost.com/news/may-2022/mortality-and-perioperative-outcomes-with-open-vs-robot-assisted-radical-cystectomy-for-bladder-cancer/ 2022-05-13T16:42:16+00:00 https://ascopost.com/news/may-2022/3-vs-6-months-of-adjuvant-oxaliplatin-and-fluoropyrimidine-based-therapy-for-stage-iii-colon-cancer/ 2022-05-13T18:21:50+00:00 https://ascopost.com/news/may-2022/prevalence-of-plasma-cell-and-lymphoproliferative-disorders-in-relatives-of-probands-with-light-chain-amyloidosis/ 2022-05-13T17:11:36+00:00 https://ascopost.com/news/may-2022/aya-leukemia-survivors-have-higher-mortality-rates-than-the-general-population/ 2022-05-16T15:05:14+00:00 https://ascopost.com/news/may-2022/watch-and-wait-strategy-for-organ-preservation-in-patients-receiving-total-neoadjuvant-therapy-for-rectal-adenocarcinoma/ 2022-05-26T20:47:52+00:00 https://ascopost.com/news/may-2022/report-investigates-potential-causes-of-decreasing-responses-to-car-t-cell-therapy-in-patients-with-non-hodgkin-lymphoma/ 2022-05-18T19:26:29+00:00 https://ascopost.com/news/may-2022/delays-in-surgery-for-advanced-esophageal-cancer-result-in-significantly-worse-survival/ 2022-05-16T17:00:49+00:00 https://ascopost.com/news/may-2022/neurologic-and-survival-outcomes-after-awake-craniotomy-for-glioblastoma/ 2022-05-17T18:13:30+00:00 https://ascopost.com/news/may-2022/addition-of-vistusertib-to-anastrozole-for-hr-positive-recurrent-or-metastatic-endometrial-cancer/ 2022-05-17T15:19:04+00:00 https://ascopost.com/news/may-2022/addition-of-adt-and-pelvic-lymph-node-radiotherapy-to-salvage-prostate-bed-radiotherapy-after-prostatectomy/ 2022-06-08T19:24:51+00:00 https://ascopost.com/news/may-2022/report-finds-uptake-of-erdafitinib-for-urothelial-cancer-may-be-limited-despite-positive-real-world-survival-data/ 2022-05-17T16:01:06+00:00 https://ascopost.com/news/may-2022/colonoscopy-after-positive-fit-test-may-reduce-risk-of-death-from-colorectal-cancer/ 2022-05-18T18:08:35+00:00 https://ascopost.com/news/may-2022/guideline-concordant-treatment-of-women-with-nonmetastatic-breast-cancer-in-sub-saharan-africa/ 2022-06-02T18:29:10+00:00 https://ascopost.com/news/may-2022/do-electronic-health-interventions-improve-quality-of-life-and-other-health-outcomes-in-patients-with-breast-cancer/ 2022-05-18T17:21:06+00:00 https://ascopost.com/news/may-2022/early-postoperative-algorithm-based-vs-usual-care-after-pancreatic-resection/ 2022-05-18T17:40:39+00:00 https://ascopost.com/news/may-2022/study-investigates-possible-link-between-risk-of-breast-cancer-in-males-and-male-infertility/ 2022-05-18T18:00:11+00:00 https://ascopost.com/news/may-2022/longer-follow-up-shows-adjuvant-immunotherapy-after-bladder-cancer-surgery-may-be-associated-with-reduced-disease-recurrence/ 2022-06-08T19:28:22+00:00 https://ascopost.com/news/may-2022/using-a-transcriptomic-profile-to-identify-plasma-cell-leukemia-like-disease-in-patients-with-newly-diagnosed-multiple-myeloma/ 2022-05-19T17:02:04+00:00 https://ascopost.com/news/may-2022/medicaid-expansion-is-associated-with-increased-survival-in-newly-diagnosed-patients-with-cancer/ 2022-05-19T17:07:20+00:00 https://ascopost.com/news/may-2022/hepatic-arterial-infusion-pump-chemotherapy-vs-resection-for-multifocal-intrahepatic-cholangiocarcinoma/ 2022-05-19T17:45:35+00:00 https://ascopost.com/news/may-2022/etirinotecan-pegol-vs-physician-s-choice-of-chemotherapy-for-patients-with-metastatic-breast-cancer-and-brain-metastases/ 2022-05-19T17:55:50+00:00 https://ascopost.com/news/may-2022/surgery-preference-and-surgery-received-in-women-with-dcis/ 2022-06-02T18:27:09+00:00 https://ascopost.com/news/may-2022/intraoperative-margin-assessment-in-breast-conserving-surgery-using-a-pegulicianine-fluorescence-guided-system/ 2022-05-20T15:44:39+00:00 https://ascopost.com/news/may-2022/mortality-and-associated-factors-among-patients-with-cancer-vs-no-cancer-infected-with-sars-cov-2/ 2022-05-20T16:40:38+00:00 https://ascopost.com/news/may-2022/asco-and-accc-release-wide-ranging-recommendations-to-expand-diverse-participation-in-cancer-clinical-trials/ 2022-05-20T17:01:54+00:00 https://ascopost.com/news/may-2022/researchers-develop-and-monitor-approaches-to-fix-blood-vessel-abnormalities-that-make-tumors-difficult-to-treat/ 2022-05-20T17:20:12+00:00 https://ascopost.com/news/may-2022/report-examines-imaging-approach-with-potential-to-detect-lung-cancer-at-the-cellular-level/ 2022-05-23T15:03:26+00:00 https://ascopost.com/news/may-2022/adverse-events-seen-with-abiraterone-or-enzalutamide-among-patients-with-advanced-prostate-cancer/ 2022-05-23T18:10:32+00:00 https://ascopost.com/news/may-2022/tazemetostat-for-patients-with-relapsed-or-refractory-bap1-inactivated-malignant-pleural-mesothelioma/ 2022-05-26T20:43:39+00:00 https://ascopost.com/news/may-2022/emerald-trial-elacestrant-vs-standard-endocrine-therapy-in-previously-treated-patients-with-er-positive-her2-negative-advanced-breast-cancer/ 2022-05-23T16:34:44+00:00 https://ascopost.com/news/may-2022/does-treatment-with-5-aris-impact-the-risk-of-dying-of-prostate-cancer-among-men-without-a-prior-diagnosis-of-the-disease/ 2022-05-24T16:45:47+00:00 https://ascopost.com/news/may-2022/gabapentin-may-be-an-effective-alternative-to-opioids-for-patients-with-head-and-neck-cancer-receiving-radiation/ 2026-01-29T04:43:59+00:00 https://ascopost.com/news/may-2022/study-finds-screen-detected-colorectal-cancers-may-have-more-favorable-stage-distribution-than-colorectal-cancers-detected-otherwise/ 2022-05-24T15:47:44+00:00 https://ascopost.com/news/may-2022/f-18-fes-pet-assessment-of-er-status-in-metastases-from-newly-diagnosed-patients-with-metastatic-breast-cancer/ 2022-05-24T16:25:54+00:00 https://ascopost.com/news/may-2022/use-of-telemedicine-for-cancer-care-increased-during-the-covid-19-pandemic-but-varied-by-race-socioeconomic-status-and-other-factors/ 2022-06-08T21:27:55+00:00 https://ascopost.com/news/may-2022/nearly-half-of-black-patients-with-metastatic-breast-cancer-report-not-being-informed-about-clinical-trials/ 2022-06-08T21:30:37+00:00 https://ascopost.com/news/may-2022/persistent-racial-ethnic-disparities-found-in-survival-rates-for-early-onset-colon-cancer/ 2022-05-27T16:26:45+00:00 https://ascopost.com/news/may-2022/rise-of-esophageal-cancer-and-barrett-s-esophagus-rates-in-middle-aged-adults/ 2022-05-27T15:19:28+00:00 https://ascopost.com/news/may-2022/incidence-of-cholelithiasis-or-cholecystitis-in-the-year-prior-to-a-diagnosis-of-pancreatic-ductal-adenocarcinoma/ 2022-05-27T16:30:57+00:00 https://ascopost.com/news/may-2022/cancer-mortality-among-black-patients-in-the-united-states-1999-to-2019/ 2022-05-31T16:30:51+00:00 https://ascopost.com/news/may-2022/association-of-chronic-hepatitis-b-virus-infection-and-antiviral-treatment-with-risk-of-extrahepatic-malignancies/ 2022-05-31T16:37:28+00:00 https://ascopost.com/news/may-2022/neoadjuvant-nivolumab-plus-chemotherapy-in-resectable-stage-iiia-nsclc-overall-survival-and-biomarker-analyses/ 2022-06-17T15:42:15+00:00 https://ascopost.com/news/may-2022/addition-of-everolimus-to-adjuvant-endocrine-therapy-for-high-risk-hr-positive-her2-negative-breast-cancer/ 2022-05-31T17:58:34+00:00 https://ascopost.com/news/may-2022/fda-approves-tisagenlecleucel-for-adult-patients-with-relapsed-or-refractory-follicular-lymphoma/ 2022-05-31T18:22:19+00:00 https://ascopost.com/news/june-2022/ 2022-06-02T14:03:50+00:00 https://ascopost.com/news/june-2022/addition-of-adebrelimab-to-carboplatinetoposide-in-first-line-treatment-of-extensive-stage-sclc/ 2022-06-02T16:34:38+00:00 https://ascopost.com/news/june-2022/vaccine-effectiveness-against-covid-19-breakthrough-infection-in-patients-with-cancer/ 2022-06-02T18:34:47+00:00 https://ascopost.com/news/june-2022/postoperative-outcomes-with-robot-assisted-vs-open-radical-cystectomy-for-bladder-cancer/ 2022-06-02T15:32:34+00:00 https://ascopost.com/news/june-2022/aumolertinib-vs-gefitinib-in-patients-with-advanced-nsclc-and-egfr-exon-19-deletion-or-l858r-mutation/ 2022-06-02T15:04:43+00:00 https://ascopost.com/news/june-2022/new-research-finds-computer-assisted-colonoscopy-may-identify-more-precancerous-polyps-than-traditional-colonoscopy/ 2022-06-02T18:36:01+00:00 https://ascopost.com/news/june-2022/nimotuzumab-may-improve-overall-survival-in-patients-with-kras-wild-type-advanced-pancreatic-cancer/ 2022-06-03T14:34:21+00:00 https://ascopost.com/news/june-2022/new-study-assesses-oncologists-ratings-of-the-importance-of-health-insurance-and-costs-for-genomic-testing/ 2022-06-03T14:41:40+00:00 https://ascopost.com/news/june-2022/survival-and-surgery-to-radiotherapy-intervals-among-asian-american-and-pacific-islander-women-with-early-breast-cancer/ 2022-06-03T14:53:50+00:00 https://ascopost.com/news/june-2022/analysis-of-circulating-tumor-dna-as-a-biomarker-in-stage-iii-or-iv-wilms-tumor/ 2022-06-08T19:32:22+00:00 https://ascopost.com/news/june-2022/nemvaleukin-alfa-alone-and-in-combination-with-pembrolizumab-for-advanced-stage-solid-tumors/ 2022-06-03T15:51:12+00:00 https://ascopost.com/news/june-2022/sacituzumab-govitecan-hziy-improves-progression-free-survival-in-endocrine-resistant-hormone-receptor-positiveher2-negative-metastatic-breast-cancer/ 2022-06-08T21:33:55+00:00 https://ascopost.com/news/june-2022/ctdna-may-help-identify-the-need-for-adjuvant-therapy-in-stage-ii-colon-cancer/ 2022-06-08T21:37:57+00:00 https://ascopost.com/news/june-2022/asco-and-who-to-collaborate-on-quality-indicators-for-cancer-facilities/ 2022-06-04T15:29:51+00:00 https://ascopost.com/news/june-2022/adagrasib-improves-outcomes-in-kras-mutated-nsclc-phase-ii-study-shows/ 2022-06-17T15:38:54+00:00 https://ascopost.com/news/june-2022/new-report-shows-covid-19-pandemic-increased-cancer-related-deaths-in-the-united-states/ 2022-06-04T15:45:56+00:00 https://ascopost.com/news/june-2022/study-reveals-racial-disparities-in-guideline-concordant-care-for-patients-with-early-onset-colorectal-cancer/ 2022-06-16T18:03:42+00:00 https://ascopost.com/news/june-2022/endocrine-sensitivity-test-predicts-survival-benefit-of-dose-dense-chemotherapy-for-patients-with-hormone-receptor-positive-breast-cancer/ 2022-06-04T16:46:26+00:00 https://ascopost.com/news/june-2022/panitumumab-plus-mfolfox6-improves-overall-survival-in-a-type-of-newly-diagnosed-metastatic-colorectal-cancer/ 2022-06-05T21:56:35+00:00 https://ascopost.com/news/june-2022/fam-trastuzumab-deruxtecan-nxki-doubles-progression-free-survival-in-her2-low-metastatic-breast-cancer/ 2022-06-14T21:17:41+00:00 https://ascopost.com/news/june-2022/study-finds-high-dose-ifosfamide-superior-to-other-standard-of-care-treatments-in-recurrent-and-primary-refractory-ewing-sarcomas/ 2022-06-20T21:17:09+00:00 https://ascopost.com/news/june-2022/including-asct-as-part-of-initial-therapy-improves-progression-free-survival-in-newly-diagnosed-patients-with-multiple-myeloma/ 2022-06-05T21:58:46+00:00 https://ascopost.com/news/june-2022/study-offers-guidance-for-future-trials-of-adjuvant-therapy-for-early-stage-hormone-receptor-positiveher2-negative-breast-cancer/ 2022-06-05T16:48:33+00:00 https://ascopost.com/news/june-2022/racialethnic-disparities-and-cardiovascular-mortality-among-cancer-survivors/ 2022-06-05T16:57:11+00:00 https://ascopost.com/news/june-2022/brentuximab-vedotin-plus-chemotherapy-vs-chemotherapy-alone-for-pediatric-patients-with-hodgkin-lymphoma/ 2022-06-05T17:23:20+00:00 https://ascopost.com/news/june-2022/dabrafenib-plus-trametinib-improve-overall-response-rates-vs-standard-of-care-chemotherapy-in-pediatric-patients-with-low-grade-gliomas/ 2022-06-06T15:41:02+00:00 https://ascopost.com/news/june-2022/unprecedented-100-of-first-14-untreated-patients-with-rectal-cancer-respond-to-pd-1-blocker-dostarlimab-gxly/ 2022-06-16T18:00:43+00:00 https://ascopost.com/news/june-2022/study-shows-children-whose-parents-have-a-cancer-history-have-increased-unmet-economic-needs-in-food-housing-and-transportation/ 2022-06-06T17:46:48+00:00 https://ascopost.com/news/june-2022/study-examines-ancestry-specific-genetic-risk-for-triple-negative-breast-cancer/ 2022-06-06T17:57:52+00:00 https://ascopost.com/news/june-2022/researchers-examine-racial-differences-in-treatment-and-outcomes-of-first-line-therapies-for-kidney-cancer/ 2022-06-06T18:18:51+00:00 https://ascopost.com/news/june-2022/neoadjuvant-immunotherapy-may-improve-survival-for-patients-with-soft-tissue-sarcoma/ 2022-06-06T18:28:30+00:00 https://ascopost.com/news/june-2022/biomarker-guidance-may-allow-patients-aged-55-or-older-with-low-grade-luminal-a-type-breast-cancer-to-avoid-radiation-therapy/ 2022-06-08T21:43:11+00:00 https://ascopost.com/news/june-2022/did-the-aca-s-medicaid-expansion-affect-cancer-clinical-trial-enrollment/ 2022-06-07T16:12:05+00:00 https://ascopost.com/news/june-2022/study-finds-genetic-mutations-differ-across-younger-and-older-patients-with-breast-cancer/ 2022-06-07T16:17:32+00:00 https://ascopost.com/news/june-2022/three-arm-first-line-chemoimmunotherapy-study-in-patients-with-metastatic-pancreatic-cancer/ 2022-06-07T16:57:13+00:00 https://ascopost.com/news/june-2022/immunotherapy-combination-in-newly-diagnosed-glioblastoma/ 2022-06-07T17:32:39+00:00 https://ascopost.com/news/june-2022/patient-facing-screening-tool-could-increase-detection-of-individuals-with-lynch-syndrome/ 2022-06-07T17:38:42+00:00 https://ascopost.com/news/june-2022/athena-mono-trial-rucaparib-maintenance-in-newly-diagnosed-patients-with-advanced-ovarian-cancer/ 2022-07-13T20:27:42+00:00 https://ascopost.com/news/june-2022/ramucirumabpembrolizumab-vs-standard-of-care-in-patients-with-advanced-nsclc-previously-treated-with-immune-checkpoint-inhibitors/ 2022-06-14T21:14:31+00:00 https://ascopost.com/news/june-2022/mfolfoxiripanitumumab-vs-mfolfoxpanitumumab-for-the-initial-treatment-of-ras-and-braf-wild-type-metastatic-colorectal-cancer/ 2022-06-08T17:21:32+00:00 https://ascopost.com/news/june-2022/weekly-electronic-reporting-of-symptoms-improved-outcomes-in-patients-with-advanced-cancer/ 2022-06-08T17:24:16+00:00 https://ascopost.com/news/june-2022/flt3-inhibitor-crenolanib-in-combination-with-chemotherapy-for-newly-diagnosed-flt3-mutant-aml/ 2022-06-20T21:19:45+00:00 https://ascopost.com/news/june-2022/brexucabtagene-autoleucel-in-relapsed-or-refractory-mantle-cell-lymphoma-3-year-follow-up-of-zuma-2-trial/ 2022-06-09T20:31:44+00:00 https://ascopost.com/news/june-2022/incidence-of-major-adverse-cardiac-events-in-patients-receiving-immune-checkpoint-inhibitors/ 2022-06-09T16:52:41+00:00 https://ascopost.com/news/june-2022/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma-2-year-follow-up-of-cartitude-1-trial/ 2022-06-09T20:33:20+00:00 https://ascopost.com/news/june-2022/fda-approves-foundationone-cdx-as-a-companion-diagnostic-for-entrectinib/ 2022-06-09T20:14:52+00:00 https://ascopost.com/news/june-2022/momelotinib-for-symptomatic-and-anemic-patients-with-myelofibrosis/ 2022-06-09T20:36:07+00:00 https://ascopost.com/news/june-2022/aacr-report-finds-racial-and-ethnic-minorities-continue-to-shoulder-a-disproportionate-burden-of-cancer/ 2022-06-09T18:02:08+00:00 https://ascopost.com/news/june-2022/differences-in-germline-variant-spectrum-between-black-and-white-men-with-prostate-cancer/ 2022-06-13T15:00:21+00:00 https://ascopost.com/news/june-2022/personalized-ctdna-testing-and-late-recurrence-in-high-risk-hr-positive-her2-negative-breast-cancer/ 2022-06-13T15:19:19+00:00 https://ascopost.com/news/june-2022/majestec-1-bispecific-antibody-teclistamab-for-relapsed-or-refractory-multiple-myeloma/ 2022-06-13T16:39:20+00:00 https://ascopost.com/news/june-2022/ponatinib-plus-blinatumomab-for-patients-with-philadelphia-chromosome-positive-all/ 2022-06-13T16:56:01+00:00 https://ascopost.com/news/june-2022/allogeneic-car-t-cell-therapy-for-relapsed-or-refractory-t-cell-lymphoma/ 2022-06-13T17:00:33+00:00 https://ascopost.com/news/june-2022/targeted-therapy-emavusertib-shows-activity-in-patients-with-mds-or-aml-with-specific-mutations/ 2022-06-13T18:50:43+00:00 https://ascopost.com/news/june-2022/metformin-vs-placebo-in-patients-with-high-risk-operable-breast-cancer-receiving-standard-treatment/ 2022-06-14T14:53:37+00:00 https://ascopost.com/news/june-2022/real-world-uptake-of-fgfr-alteration-testing-and-gene-targeted-therapy-for-patients-with-urothelial-cancer/ 2022-06-14T15:39:06+00:00 https://ascopost.com/news/june-2022/intracranial-efficacy-of-lorlatinib-vs-crizotinib-in-alk-positive-advanced-nsclc/ 2022-06-17T15:39:56+00:00 https://ascopost.com/news/june-2022/triplet-combination-therapy-yields-high-response-rates-in-patients-with-flt3-mutated-aml/ 2022-07-18T20:04:43+00:00 https://ascopost.com/news/june-2022/magrolimab-plus-azacitidine-in-tp53-mutant-aml/ 2022-06-14T16:48:06+00:00 https://ascopost.com/news/june-2022/adding-targeted-therapy-to-chemoimmunotherapy-may-offer-long-term-benefits-for-patients-with-ighv-mutated-cll/ 2022-06-14T16:46:08+00:00 https://ascopost.com/news/june-2022/longitudinal-liquid-biopsy-for-circulating-tumor-cells-in-metastatic-renal-cell-carcinoma/ 2022-06-15T15:25:11+00:00 https://ascopost.com/news/june-2022/risk-of-skin-desquamation-with-breast-radiotherapy-does-position-change-outcomes-in-large-breasted-women/ 2022-06-15T15:29:26+00:00 https://ascopost.com/news/june-2022/proposed-second-revision-of-the-international-staging-system-for-survival-in-multiple-myeloma/ 2022-06-15T15:34:22+00:00 https://ascopost.com/news/june-2022/potential-association-of-the-2012-uspstf-grade-d-recommendation-against-psa-screening-with-changes-in-prostate-cancer-specific-mortality/ 2022-06-15T15:49:28+00:00 https://ascopost.com/news/june-2022/demethylation-and-upregulation-of-the-oncogene-sall4-after-hypomethylating-therapy/ 2022-06-15T18:15:03+00:00 https://ascopost.com/news/june-2022/study-finds-adult-survivors-of-childhood-cancer-may-often-be-undertreated-for-modifiable-cardiovascular-risk-factors/ 2022-06-15T18:19:24+00:00 https://ascopost.com/news/june-2022/survival-with-stereotactic-radiosurgery-vs-whole-brain-radiotherapy-in-patients-with-sclc-and-intracranial-metastatic-disease/ 2022-06-17T15:43:13+00:00 https://ascopost.com/news/june-2022/addition-of-atezolizumab-to-folfoxiribevacizumab-for-metastatic-colorectal-cancer/ 2022-06-16T18:01:45+00:00 https://ascopost.com/news/june-2022/real-world-association-between-smoking-history-and-overall-survival-with-first-line-pembrolizumab-in-patients-with-advanced-nsclc/ 2022-06-17T15:44:13+00:00 https://ascopost.com/news/june-2022/can-abemaciclib-provide-good-clinical-outcomes-in-patients-with-high-risk-hr-positive-her2-negative-breast-cancer-who-received-neoadjuvant-chemotherapy/ 2022-06-16T17:34:24+00:00 https://ascopost.com/news/june-2022/androgen-receptor-signaling-may-contribute-to-targeted-therapy-resistance-in-patients-with-melanoma/ 2022-06-16T17:28:09+00:00 https://ascopost.com/news/june-2022/mrd-guided-cessation-of-treatment-in-patients-receiving-venetoclaxibrutinib-for-relapsed-or-refractory-cll/ 2022-07-18T19:04:33+00:00 https://ascopost.com/news/june-2022/fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-for-children-as-young-as-6-months-of-age/ 2022-06-17T16:21:19+00:00 https://ascopost.com/news/june-2022/mmp-7-expression-and-pathologic-response-to-neoadjuvant-treatment-in-patients-with-pancreatic-cancer-undergoing-resection/ 2022-06-20T15:49:08+00:00 https://ascopost.com/news/june-2022/study-finds-diagnostic-mammography-performance-varies-across-racial-and-ethnic-groups/ 2022-06-20T17:13:38+00:00 https://ascopost.com/news/june-2022/four-new-teams-receive-100m-to-take-on-cancers-toughest-challenges/ 2022-06-21T14:14:21+00:00 https://ascopost.com/news/june-2022/cabozantinib-and-atezolizumab-for-patients-with-progressive-metastatic-castration-resistant-prostate-cancer-post-hormonal-therapy/ 2022-06-21T15:18:00+00:00 https://ascopost.com/news/june-2022/treatment-of-anal-high-grade-squamous-intraepithelial-lesions-to-prevent-anal-cancer-in-persons-with-hiv/ 2022-06-21T15:22:07+00:00 https://ascopost.com/news/june-2022/does-receipt-of-adjuvant-chemotherapy-after-primary-retroperitoneal-lymph-node-dissection-affect-outcomes-for-patients-with-nonseminomatous-germ-cell-tumors/ 2022-06-21T15:40:08+00:00 https://ascopost.com/news/june-2022/study-identifies-three-gene-signature-that-may-predict-response-to-selinexor-in-patients-with-multiple-myeloma/ 2022-06-21T18:54:49+00:00 https://ascopost.com/news/june-2022/new-perspective-shows-higher-breast-cancer-mortality-for-black-women-emerged-40-years-ago/ 2022-06-21T18:53:48+00:00 https://ascopost.com/news/june-2022/ovarian-cancer-first-line-every-3-week-carboplatinpaclitaxel-vs-weekly-dose-dense-regimens/ 2022-06-22T20:09:53+00:00 https://ascopost.com/news/june-2022/factors-that-may-predict-response-to-the-addition-of-bevacizumab-to-front-line-chemotherapy-in-patients-with-endometrial-cancer/ 2022-06-22T20:07:18+00:00 https://ascopost.com/news/june-2022/study-examines-how-diet-quality-may-affect-breast-cancer-risk/ 2022-06-22T20:03:55+00:00 https://ascopost.com/news/june-2022/study-links-sugar-sweetened-beverage-consumption-and-liver-cancer-risk/ 2022-06-22T20:06:28+00:00 https://ascopost.com/news/june-2022/mismatch-in-breast-cancer-trial-results-and-real-world-outcomes-based-on-treatment-discontinuation/ 2022-06-22T16:29:48+00:00 https://ascopost.com/news/june-2022/outcomes-of-pancreas-surveillance-in-the-caps5-study-and-total-caps-cohort/ 2022-06-23T15:21:18+00:00 https://ascopost.com/news/june-2022/venetoclax-plus-cladribine-and-low-dose-cytarabine-alternating-with-azacitidine-and-venetoclax-in-newly-diagnosed-older-or-unfit-patients-with-aml/ 2022-07-18T18:59:56+00:00 https://ascopost.com/news/june-2022/nivolumabcabozantinib-vs-sunitinib-in-first-line-treatment-for-advanced-rcc-overall-survival-analysis-of-checkmate-9er-trial/ 2022-06-23T15:32:25+00:00 https://ascopost.com/news/june-2022/study-predicts-cancer-cases-and-deaths-in-africa-could-double-by-2040/ 2022-06-23T15:40:15+00:00 https://ascopost.com/news/june-2022/fda-denies-authorization-to-market-juul-products/ 2022-06-23T17:12:11+00:00 https://ascopost.com/news/june-2022/ctcs-in-the-staging-of-newly-diagnosed-patients-with-transplant-eligible-multiple-myeloma/ 2022-08-22T19:59:12+00:00 https://ascopost.com/news/june-2022/ai-may-be-used-to-identify-benign-thyroid-nodules-and-reduce-unnecessary-biopsies/ 2022-06-27T19:33:41+00:00 https://ascopost.com/news/june-2022/study-links-diabetes-and-worse-outcomes-in-long-term-survivors-of-metastatic-breast-cancer/ 2022-06-27T19:31:07+00:00 https://ascopost.com/news/june-2022/chemicals-in-personal-care-products-may-cause-harmful-effects-in-breast-cancer-cells-in-black-women/ 2022-06-27T18:11:56+00:00 https://ascopost.com/news/june-2022/asco-statement-on-supreme-court-decision-in-dobbs-v-jackson-women-s-health/ 2022-06-28T15:25:40+00:00 https://ascopost.com/news/june-2022/biden-administration-announces-new-model-to-improve-cancer-care-for-medicare-patients/ 2022-06-28T15:30:40+00:00 https://ascopost.com/news/june-2022/long-term-morbidity-in-aml-survivors-treated-with-blood-or-marrow-transplantation/ 2022-07-18T18:58:29+00:00 https://ascopost.com/news/june-2022/role-of-combined-positive-score-with-treatment-outcomes-in-recurrent-or-metastatic-head-and-neck-cancer/ 2026-01-29T04:38:32+00:00 https://ascopost.com/news/june-2022/structural-racism-and-health-care-system-barriers-may-contribute-to-breast-biopsy-delays/ 2022-06-28T17:10:43+00:00 https://ascopost.com/news/june-2022/18-million-cancer-survivors-in-the-united-states-new-report-shows/ 2022-06-28T19:28:49+00:00 https://ascopost.com/news/june-2022/children-s-cancer-cause-accepting-applications-through-july-31-for-2022-survivorship-champion-s-prize/ 2022-06-28T20:48:47+00:00 https://ascopost.com/news/june-2022/risk-of-interval-invasive-and-advanced-breast-cancer-screening-with-digital-breast-tomosynthesis-vs-digital-mammography/ 2022-06-29T15:40:59+00:00 https://ascopost.com/news/june-2022/is-focal-therapy-with-mri-guided-focused-ultrasound-safe-and-effective-for-grade-group-2-or-3-prostate-cancer/ 2022-06-29T19:21:35+00:00 https://ascopost.com/news/june-2022/addition-of-trastuzumabpertuzumab-to-perioperative-flot-chemotherapy-in-her2-positive-esophagogastric-adenocarcinoma/ 2022-06-29T16:02:39+00:00 https://ascopost.com/news/june-2022/study-finds-covid-19-vaccines-are-safe-for-patients-treated-with-immune-checkpoint-inhibitors-for-lung-cancer/ 2022-06-29T16:11:56+00:00 https://ascopost.com/news/june-2022/nejm-editors-publish-opinion-following-dobbs-v-jackson-decision/ 2022-06-29T19:14:19+00:00 https://ascopost.com/news/june-2022/fulvestrantcapivasertib-for-aromatase-inhibitor-resistant-advanced-breast-cancer-overall-survival-and-expanded-genetic-panel-analysis-from-the-faktion-trial/ 2022-06-30T15:07:45+00:00 https://ascopost.com/news/june-2022/direct-acting-antivirals-in-hcv-associated-indolent-non-hodgkin-lymphomas/ 2022-06-30T15:41:00+00:00 https://ascopost.com/news/june-2022/outcomes-in-pancreatic-cancer-surveillance-program-for-carriers-of-germline-cdkn2a-pathogenic-variants/ 2022-06-30T15:49:30+00:00 https://ascopost.com/news/june-2022/study-seeks-to-determine-if-her2-low-breast-cancer-is-a-distinct-biological-and-prognostic-subtype-of-disease/ 2022-06-30T15:56:40+00:00 https://ascopost.com/news/june-2022/analysis-finds-prevalence-of-colorectal-cancer-screenings-remains-low-in-younger-adults/ 2022-06-30T17:19:55+00:00 https://ascopost.com/news/july-2022/ 2022-07-01T14:45:16+00:00 https://ascopost.com/news/july-2022/association-of-ctc-levels-with-outcomes-in-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma/ 2022-07-14T20:17:01+00:00 https://ascopost.com/news/july-2022/fda-warns-about-possible-increased-risk-of-death-and-serious-side-effects-with-duvelisib/ 2022-07-01T15:35:39+00:00 https://ascopost.com/news/july-2022/screening-study-to-identify-risk-factors-for-breast-cancer-related-lymphedema/ 2022-07-01T15:39:43+00:00 https://ascopost.com/news/july-2022/food-interventions-and-cancer-treatment-completion-rates-among-food-insecure-patients-in-new-york-city/ 2022-07-01T15:51:56+00:00 https://ascopost.com/news/july-2022/lisocabtagene-maraleucel-as-second-line-treatment-for-relapsed-or-refractory-large-b-cell-lymphoma-transform-trial/ 2022-07-05T19:27:32+00:00 https://ascopost.com/news/july-2022/trastuzumab-and-nivolumab-plus-either-ipilimumab-or-folfox-as-first-line-treatment-for-her2-positive-advanced-esophagogastric-adenocarcinoma/ 2022-07-05T19:30:48+00:00 https://ascopost.com/news/july-2022/new-consensus-based-guidance-on-managing-cancer-pain-in-patients-with-opioid-use-disorder-or-opioid-misuse/ 2022-07-05T16:15:15+00:00 https://ascopost.com/news/july-2022/eau22-study-finds-gut-microbes-differ-in-patients-with-prostate-cancer-vs-those-with-benign-biopsy-results/ 2022-07-12T15:53:43+00:00 https://ascopost.com/news/july-2022/eau22-new-research-supports-risk-based-prostate-cancer-screening/ 2022-07-12T15:55:01+00:00 https://ascopost.com/news/july-2022/real-world-treatment-outcomes-with-transplantation-and-maintenance-rituximab-in-previously-untreated-patients-with-mantle-cell-lymphoma/ 2022-07-06T14:47:52+00:00 https://ascopost.com/news/july-2022/addition-of-olaparib-to-durvalumab-in-previously-untreated-platinum-ineligible-patients-with-metastatic-urothelial-carcinoma/ 2022-07-06T14:54:13+00:00 https://ascopost.com/news/july-2022/taxane-maintenance-vs-surveillance-in-advanced-ovarian-cancer/ 2022-07-06T15:03:15+00:00 https://ascopost.com/news/july-2022/aacr-statement-on-the-us-supreme-court-decision-in-the-dobbs-v-jackson-women-s-health-organization-case/ 2022-07-06T16:27:21+00:00 https://ascopost.com/news/july-2022/addition-of-enzalutamide-to-active-surveillance-in-low-or-intermediate-risk-localized-prostate-cancer/ 2022-07-06T16:32:12+00:00 https://ascopost.com/news/july-2022/study-examines-high-early-death-rates-treatment-resistance-and-short-survival-among-black-aya-patients-with-aml/ 2022-07-14T20:13:37+00:00 https://ascopost.com/news/july-2022/analysis-of-high-risk-hpv-mrna-vs-dna-testing-in-screening-for-cervical-cancer/ 2022-07-07T17:50:33+00:00 https://ascopost.com/news/july-2022/outcomes-of-the-sars-cov-2-omicron-variant-outbreak-among-european-patients-with-cancer/ 2022-07-07T17:53:31+00:00 https://ascopost.com/news/july-2022/physician-adenoma-detection-rates-and-risk-of-postcolonoscopy-colorectal-cancer-is-there-a-correlation/ 2022-07-07T18:00:56+00:00 https://ascopost.com/news/july-2022/addition-of-atezolizumab-to-neoadjuvant-anti-her2-therapy-and-chemotherapy-in-her2-positive-breast-cancer-impassion050/ 2022-07-08T19:17:05+00:00 https://ascopost.com/news/july-2022/new-report-patients-report-increased-likelihood-to-enroll-in-decentralized-clinical-trials/ 2022-07-07T20:08:58+00:00 https://ascopost.com/news/july-2022/first-line-radiotherapy-with-or-without-procarbazine-lomustine-and-vincristine-chemotherapy-for-anaplastic-oligodendroglial-tumors/ 2022-07-08T14:49:26+00:00 https://ascopost.com/news/july-2022/oncolytic-virus-dnx-2401-for-newly-diagnosed-pediatric-patients-with-dipg/ 2022-07-08T15:16:10+00:00 https://ascopost.com/news/july-2022/does-tmb-influence-response-to-pd-1pd-l1-inhibitors-among-patients-with-advanced-nsclc/ 2022-07-22T16:04:39+00:00 https://ascopost.com/news/july-2022/study-finds-black-and-hispanic-men-with-throat-cancer-are-experiencing-higher-mortality-white-men-are-increasingly-being-diagnosed-at-a-late-stage/ 2026-01-29T04:35:58+00:00 https://ascopost.com/news/july-2022/bispecific-antibody-mosunetuzumab-in-relapsed-or-refractory-follicular-lymphoma/ 2022-07-12T15:10:28+00:00 https://ascopost.com/news/july-2022/rates-of-major-adverse-cardiovascular-events-in-patients-receiving-immune-checkpoint-inhibitors/ 2022-07-12T15:18:13+00:00 https://ascopost.com/news/july-2022/risk-of-oropharyngeal-cancer-after-a-positive-hpv16-e6-serology-test/ 2026-01-29T04:33:03+00:00 https://ascopost.com/news/july-2022/eau22-ctdna-may-help-to-predict-response-to-atezolizumab-in-patients-with-bladder-cancer/ 2022-07-12T16:34:18+00:00 https://ascopost.com/news/july-2022/eau22-trial-shows-new-imaging-technology-may-be-less-accurate-than-mri-in-detecting-prostate-cancer/ 2022-07-12T16:47:30+00:00 https://ascopost.com/news/july-2022/phase-iii-trial-of-cabozantinib-and-atezolizumab-vs-sorafenib-in-advanced-hepatocellular-carcinoma/ 2022-07-13T16:23:39+00:00 https://ascopost.com/news/july-2022/initial-risk-factors-and-time-to-cure-in-childhood-and-young-adult-acute-lymphoblastic-leukemia/ 2022-07-13T19:06:34+00:00 https://ascopost.com/news/july-2022/antibody-response-to-sars-cov-2-wild-type-virus-and-variants-after-mrna-vaccination-in-patients-with-nsclc/ 2022-07-22T16:03:03+00:00 https://ascopost.com/news/july-2022/new-gene-profiling-technology-reveals-potential-melanoma-biomarkers/ 2022-07-28T19:42:36+00:00 https://ascopost.com/news/july-2022/poziotinib-shows-activity-in-egfr-exon-20-mutant-nsclc-with-efficacy-dependent-on-insertion-location/ 2022-07-22T16:19:43+00:00 https://ascopost.com/news/july-2022/geriatrics-experts-explore-relationship-between-heart-disease-and-cancer/ 2023-08-29T19:59:05+00:00 https://ascopost.com/news/july-2022/immune-checkpoint-inhibitors-for-solid-tumors-in-kidney-transplant-recipients-with-maintained-immunosuppression/ 2022-07-14T20:06:36+00:00 https://ascopost.com/news/july-2022/do-bone-marrow-biopsies-aid-in-response-assessment-for-patients-with-follicular-lymphoma/ 2022-07-14T17:34:23+00:00 https://ascopost.com/news/july-2022/president-biden-appoints-cancer-panel-members-and-cancer-cabinet-unveils-priority-actions/ 2022-07-14T18:52:24+00:00 https://ascopost.com/news/july-2022/study-reveals-cancer-screening-decreased-worldwide-during-height-of-covid-19-pandemic/ 2022-07-14T20:07:37+00:00 https://ascopost.com/news/july-2022/fda-authorizes-emergency-use-of-novavax-covid-19-vaccine-adjuvanted/ 2022-07-14T20:02:23+00:00 https://ascopost.com/news/july-2022/epov-susan-slovin/ 2022-07-15T13:36:20+00:00 https://ascopost.com/news/july-2022/addition-of-atezolizumab-to-neoadjuvant-pertuzumabtrastuzumab-and-docetaxel-in-her2-positive-early-breast-cancer/ 2022-07-15T15:33:28+00:00 https://ascopost.com/news/july-2022/immune-related-toxic-effects-and-treatment-outcomes-in-patients-with-cancer-and-autoimmune-diseases-receiving-ici-therapy/ 2022-07-15T15:40:16+00:00 https://ascopost.com/news/july-2022/new-report-underscores-importance-of-health-insurance-status-and-cancer-stage-at-diagnosis-in-relation-to-patient-survival/ 2022-07-15T15:45:29+00:00 https://ascopost.com/news/july-2022/new-antibody-therapy-shows-activity-in-patients-with-medulloblastoma/ 2022-07-15T15:55:24+00:00 https://ascopost.com/news/july-2022/study-explores-community-health-worker-led-intervention-s-impact-on-acute-care-use-advance-care-planning-and-patient-reported-outcomes/ 2022-07-18T15:44:39+00:00 https://ascopost.com/news/july-2022/tumor-grade-and-response-to-immune-checkpoint-inhibition-in-recurrent-or-metastatic-mucosal-hnscc/ 2026-01-29T04:29:10+00:00 https://ascopost.com/news/july-2022/clinical-practice-guidelines-for-treatment-and-prophylaxis-of-vte-in-patients-with-cancer-including-those-infected-with-covid-19/ 2022-07-18T16:11:12+00:00 https://ascopost.com/news/july-2022/addition-of-brentuximab-vedotin-to-chemotherapy-in-patients-with-stage-iii-or-iv-hodgkin-lymphoma-overall-survival-analysis-from-echelon-1/ 2022-07-18T17:33:03+00:00 https://ascopost.com/news/july-2022/research-examines-which-demographic-is-most-likely-to-use-medical-aid-in-dying/ 2022-07-18T18:19:43+00:00 https://ascopost.com/news/july-2022/second-line-lisocabtagene-maraleucel-in-patients-with-relapsed-or-refractory-large-b-cell-lymphoma-not-intended-for-hsct/ 2022-07-19T17:51:37+00:00 https://ascopost.com/news/july-2022/zanubrutinib-vs-bendamustinerituximab-in-previously-untreated-patients-with-cll-or-sll/ 2022-08-15T19:19:24+00:00 https://ascopost.com/news/july-2022/study-examines-quality-of-life-outcomes-among-patients-participating-in-phase-iii-randomized-trials-of-cancer-drugs/ 2022-07-19T18:29:33+00:00 https://ascopost.com/news/july-2022/for-medicaid-insured-patients-with-cancer-health-insurance-does-not-always-mean-health-care-access/ 2022-07-19T18:40:52+00:00 https://ascopost.com/news/july-2022/adagrasib-in-previously-treated-patients-with-kras-g12c-mutated-advanced-nsclc/ 2022-07-22T16:00:53+00:00 https://ascopost.com/news/july-2022/caregivers-for-patients-with-multiple-myeloma-face-mental-health-challenges/ 2022-07-20T14:45:06+00:00 https://ascopost.com/news/july-2022/cancercare-s-caregiver-decision-making-survey-results-reveal-gaps-in-support-for-caregivers-give-rise-to-recommendations-for-improving-caregiver-support/ 2022-07-20T18:44:44+00:00 https://ascopost.com/news/july-2022/addition-of-trabectedin-to-doxorubicin-in-the-first-line-treatment-of-advanced-leiomyosarcoma/ 2022-07-20T14:57:31+00:00 https://ascopost.com/news/july-2022/eprenetapoptazacitidine-maintenance-after-allogeneic-hsct-for-tp53-mutant-aml-and-mds/ 2022-08-15T19:21:46+00:00 https://ascopost.com/news/july-2022/use-of-menopausal-hormone-therapy-and-breast-cancer-mortality/ 2022-07-20T18:43:48+00:00 https://ascopost.com/news/july-2022/children-with-in-utero-exposure-to-maternal-cancer-short-and-long-term-outcomes/ 2022-07-21T15:12:25+00:00 https://ascopost.com/news/july-2022/cog-trial-of-intensive-multimodality-therapy-for-extraocular-retinoblastoma/ 2022-07-21T15:45:53+00:00 https://ascopost.com/news/july-2022/noncytotoxic-maintenance-with-niraparib-plus-either-nivolumab-or-ipilimumab-in-platinum-sensitive-advanced-pancreatic-cancer/ 2022-07-21T15:49:57+00:00 https://ascopost.com/news/july-2022/judging-melanoma-thickness-comparison-of-dermatologists-and-machine-learning-algorithm/ 2022-07-21T16:28:03+00:00 https://ascopost.com/news/july-2022/does-disclosing-maternal-brca-status-affect-children-s-health-behaviors/ 2022-07-21T19:06:04+00:00 https://ascopost.com/news/july-2022/survey-finds-more-than-80-of-patients-with-cancer-and-survivors-say-copay-assistance-programs-help-them-afford-their-prescription-drugs/ 2022-07-22T15:21:42+00:00 https://ascopost.com/news/july-2022/researchers-discover-protein-that-may-be-associated-with-better-prognosis-for-patients-with-ovarian-cancer/ 2022-07-22T15:29:28+00:00 https://ascopost.com/news/july-2022/do-patients-tend-to-adhere-to-vte-prophylaxis-guidelines-after-pancreatic-cancer-surgery/ 2022-08-05T17:15:07+00:00 https://ascopost.com/news/july-2022/venetoclax-plus-gilteritinib-in-flt3-mutated-relapsed-or-refractory-acute-myeloid-leukemia/ 2022-08-15T19:17:05+00:00 https://ascopost.com/news/july-2022/effectiveness-and-risk-of-preterm-birth-with-local-treatments-for-cervical-malignancies/ 2022-07-26T17:06:25+00:00 https://ascopost.com/news/july-2022/new-poster-track-at-jadpro-live-announced-apsho-patientadvocacy-perspective/ 2022-07-26T19:03:32+00:00 https://ascopost.com/news/july-2022/downstaging-hepatocellular-carcinoma-prior-to-liver-transplant-10-year-outcomes/ 2022-07-26T19:37:49+00:00 https://ascopost.com/news/july-2022/diagnosing-basal-cell-carcinoma-optical-coherence-tomography-vs-punch-biopsy/ 2022-07-27T14:56:15+00:00 https://ascopost.com/news/july-2022/overall-survival-with-the-addition-of-pembrolizumab-to-chemotherapy-in-advanced-triple-negative-breast-cancer/ 2022-07-27T15:04:41+00:00 https://ascopost.com/news/july-2022/neoadjuvant-mfolfirinox-with-or-without-radiotherapy-for-borderline-resectable-pancreatic-cancer/ 2022-07-27T15:11:03+00:00 https://ascopost.com/news/july-2022/investigational-blood-test-may-help-improve-diagnosis-and-monitoring-of-glioma/ 2022-07-27T17:29:29+00:00 https://ascopost.com/news/july-2022/study-examines-role-of-per-and-polyfluoroalkyl-substances-in-development-of-cancer-health-care-costs/ 2022-07-27T17:32:36+00:00 https://ascopost.com/news/july-2022/study-sheds-light-on-mechanisms-driving-cancer-induced-by-organic-solvent-used-in-printing-industry/ 2022-07-27T17:28:18+00:00 https://ascopost.com/news/july-2022/maintenance-olaparib-vs-placebo-in-germline-brca-mutated-metastatic-pancreatic-cancer/ 2022-07-28T19:52:29+00:00 https://ascopost.com/news/july-2022/intensive-vs-minimalist-follow-up-strategies-for-patients-in-remission-after-surgery-for-endometrial-cancer/ 2022-07-28T17:43:21+00:00 https://ascopost.com/news/july-2022/zandelisib-in-continuous-or-intermittent-dosing-schedules-with-or-without-rituximab-for-relapsed-or-refractory-b-cell-malignancies/ 2022-07-28T18:08:04+00:00 https://ascopost.com/news/july-2022/researchers-find-potential-link-between-genetic-mutations-and-treatment-resistance-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2022-07-28T19:47:54+00:00 https://ascopost.com/news/july-2022/meta-analysis-examines-link-between-aspirin-use-and-ovarian-cancer-risk/ 2022-07-28T18:45:41+00:00 https://ascopost.com/news/july-2022/risk-stratification-and-treatment-implications-for-patients-with-early-stage-melanoma-and-sentinel-node-metastasis/ 2022-07-29T16:55:29+00:00 https://ascopost.com/news/july-2022/consolidation-radiotherapy-vs-autologous-stem-cell-transplantation-for-primary-cns-lymphoma/ 2022-07-29T15:09:34+00:00 https://ascopost.com/news/july-2022/proton-craniospinal-irradiation-vs-photon-involved-field-radiotherapy-for-solid-tumor-leptomeningeal-metastasis/ 2022-07-29T15:15:47+00:00 https://ascopost.com/news/july-2022/new-report-documents-lack-of-senior-leadership-diversity-in-the-nation-s-cancer-centers/ 2022-07-29T15:28:30+00:00 https://ascopost.com/news/july-2022/early-research-finds-link-may-connect-cell-signaling-pathway-to-development-of-esophageal-cancers-barrett-s-esophagus/ 2022-07-29T15:50:15+00:00 https://ascopost.com/news/august-2022/ 2022-08-01T13:54:51+00:00 https://ascopost.com/news/august-2022/brentuximab-vedotin-plus-avd-vs-abvd-for-the-first-line-treatment-of-early-stage-unfavorable-risk-hodgkin-lymphoma/ 2022-08-11T20:13:26+00:00 https://ascopost.com/news/august-2022/long-term-risk-of-hospitalization-for-infection-in-childhood-cancer-survivors/ 2022-08-01T15:19:50+00:00 https://ascopost.com/news/august-2022/adhering-to-a-healthy-diet-after-a-head-and-neck-cancer-diagnosis-may-boost-survival/ 2026-01-29T04:25:43+00:00 https://ascopost.com/news/august-2022/study-evaluates-availability-of-imatinib-in-online-pharmacies/ 2022-08-01T15:43:53+00:00 https://ascopost.com/news/august-2022/oral-paclitaxel-plus-p-glycoprotein-pump-inhibitor-encequidar-vs-intravenous-paclitaxel-in-metastatic-breast-cancer/ 2022-08-02T17:15:54+00:00 https://ascopost.com/news/august-2022/frequent-aspirin-use-and-risk-of-ovarian-cancer/ 2022-08-02T16:32:09+00:00 https://ascopost.com/news/august-2022/survey-reveals-that-most-americans-are-not-concerned-about-getting-lung-cancer/ 2022-08-02T16:39:39+00:00 https://ascopost.com/news/august-2022/gaps-in-representation-of-women-and-younger-scholars-among-medical-educators/ 2022-08-02T16:49:14+00:00 https://ascopost.com/news/august-2022/duration-of-adjuvant-oxaliplatin-with-6-months-of-fluoropyrimidine-treatment-in-high-risk-stage-ii-or-iii-colorectal-cancer/ 2022-08-02T17:23:29+00:00 https://ascopost.com/news/august-2022/new-study-shows-options-for-older-patients-with-liver-cancer/ 2022-08-02T17:08:36+00:00 https://ascopost.com/news/august-2022/patients-with-triple-negative-breast-cancer-benefited-from-presurgical-immunotherapy-regardless-of-race/ 2022-08-03T19:06:30+00:00 https://ascopost.com/news/august-2022/lenvatinib-plus-pembrolizumab-for-advanced-melanoma-progressing-on-pd-1pd-l1-inhibitor-therapy/ 2022-08-03T16:11:17+00:00 https://ascopost.com/news/august-2022/is-there-a-link-between-high-insulin-dosage-and-cancer/ 2022-08-03T18:43:49+00:00 https://ascopost.com/news/august-2022/fewer-people-tried-to-quit-smoking-during-covid-19-pandemic-study-shows/ 2022-08-03T19:08:14+00:00 https://ascopost.com/news/august-2022/outcomes-with-postconsolidation-dinutuximab-based-immunotherapy-for-neuroblastoma/ 2022-08-03T18:40:02+00:00 https://ascopost.com/news/august-2022/study-could-lead-to-better-education-and-treatment-of-sexual-health-for-patients-with-breast-cancer/ 2022-08-03T18:52:15+00:00 https://ascopost.com/news/august-2022/enzalutamide-in-advanced-androgen-receptor-positive-salivary-gland-cancer/ 2026-01-29T04:23:13+00:00 https://ascopost.com/news/august-2022/talazoparib-plus-avelumab-in-recurrent-mismatch-repair-proficient-endometrial-cancer/ 2022-08-04T16:28:21+00:00 https://ascopost.com/news/august-2022/study-suggests-hpv-vaccination-alongside-local-excision-of-cervical-lesions-may-reduce-risk-of-recurrence/ 2022-08-04T19:44:33+00:00 https://ascopost.com/news/august-2022/older-age-and-smoking-are-the-most-important-risk-factors-for-developing-any-cancer-study-shows/ 2022-08-04T19:47:50+00:00 https://ascopost.com/news/august-2022/media-emphasis-on-urinary-symptoms-may-delay-diagnosis-of-early-prostate-cancer/ 2022-08-04T19:47:03+00:00 https://ascopost.com/news/august-2022/mrd-adapted-study-of-elotuzumab-plus-carfilzomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-without-transplantation-intent/ 2022-08-04T19:16:18+00:00 https://ascopost.com/news/august-2022/long-term-outcomes-with-adjuvant-goserelin-and-tamoxifen-in-premenopausal-er-positive-breast-cancer/ 2022-08-05T14:20:08+00:00 https://ascopost.com/news/august-2022/columbus-trial-5-year-update-encorafenibbinimetinib-vs-vemurafenib-or-encorafenib-in-advanced-braf-v600-mutant-melanoma/ 2022-08-05T16:21:04+00:00 https://ascopost.com/news/august-2022/research-shows-poor-patient-comprehension-of-terms-commonly-found-in-electronic-health-information/ 2022-08-05T16:50:47+00:00 https://ascopost.com/news/august-2022/genetics-may-predict-bladder-cancer-immunotherapy-response/ 2022-08-05T16:04:31+00:00 https://ascopost.com/news/august-2022/global-phase-iii-fresco-2-study-has-met-its-primary-endpoint-in-evaluation-of-fruquintinib-for-metastatic-colorectal-cancer/ 2022-08-08T15:28:16+00:00 https://ascopost.com/news/august-2022/second-primary-cancer-risk-after-primary-radiotherapy-vs-surgery-or-other-treatment-in-veterans-with-localized-prostate-cancer/ 2022-08-08T16:26:11+00:00 https://ascopost.com/news/august-2022/5-year-outcomes-with-laparoscopic-vs-open-distal-gastrectomy-in-locally-advanced-gastric-cancer/ 2022-08-08T17:58:50+00:00 https://ascopost.com/news/august-2022/why-do-men-face-a-higher-risk-of-most-types-of-cancer-than-women/ 2022-08-08T16:49:24+00:00 https://ascopost.com/news/august-2022/addition-of-transarterial-chemoembolization-to-lenvatinib-in-first-line-treatment-of-advanced-hepatocellular-carcinoma/ 2022-08-09T18:58:50+00:00 https://ascopost.com/news/august-2022/us-cancer-care-facility-acceptance-of-medicaid-for-simulated-patients-with-newly-diagnosed-common-cancers/ 2022-08-09T16:59:51+00:00 https://ascopost.com/news/august-2022/long-term-regional-disease-control-with-sentinel-lymph-node-biopsy-in-patients-with-melanoma/ 2022-08-09T17:37:08+00:00 https://ascopost.com/news/august-2022/study-finds-adding-tremelimumab-and-durvalumab-to-chemotherapy-improves-overall-survival-in-metastatic-nsclc-regardless-of-krasstk11keap1-mutations/ 2022-08-11T16:11:46+00:00 https://ascopost.com/news/august-2022/increased-utilization-of-sbrt-has-decreased-treatment-disparities-for-early-stage-nsclc/ 2022-08-11T16:15:40+00:00 https://ascopost.com/news/august-2022/characteristics-of-data-supporting-fda-initial-approval-and-subsequent-indications-for-new-cancer-drugs/ 2022-08-11T18:27:24+00:00 https://ascopost.com/news/august-2022/evaluating-strategies-for-treating-pediatric-metastatic-rhabdomyosarcoma/ 2022-08-11T19:57:59+00:00 https://ascopost.com/news/august-2022/psa-screening-and-prostate-cancer-mortality-among-black-and-white-veterans/ 2022-08-11T16:41:11+00:00 https://ascopost.com/news/august-2022/fda-approves-ventana-mmr-rxdx-panel-to-identify-patients-with-dmmr-solid-tumors-and-pmmr-endometrial-cancer-eligible-for-treatment-with-pembrolizumab/ 2022-08-11T18:25:52+00:00 https://ascopost.com/news/august-2022/disparities-in-the-diagnosis-of-lung-cancer-among-younger-vs-older-adults/ 2022-08-11T17:05:53+00:00 https://ascopost.com/news/august-2022/research-suggests-air-pollution-be-included-as-risk-factor-for-nonsmoking-patients-with-lung-cancer/ 2022-08-11T18:27:47+00:00 https://ascopost.com/news/august-2022/time-to-initiation-of-adjuvant-endocrine-therapy-and-likelihood-of-adherence-in-medicaid-insured-women-with-breast-cancer/ 2022-08-12T14:48:20+00:00 https://ascopost.com/news/august-2022/models-to-assess-impact-of-centralization-of-specialist-cancer-services-in-england/ 2022-08-12T14:55:16+00:00 https://ascopost.com/news/august-2022/does-daily-insulin-dose-affect-cancer-risk-in-patients-with-type-1-diabetes/ 2022-08-12T15:44:26+00:00 https://ascopost.com/news/august-2022/durvalumab-plus-concurrent-radiotherapy-in-unresectable-locally-advanced-nsclc-dolphin-study/ 2022-08-15T18:06:44+00:00 https://ascopost.com/news/august-2022/informed-consent-forms-for-lung-cancer-clinical-trials-may-be-a-barrier-to-informed-participation/ 2022-08-12T16:44:54+00:00 https://ascopost.com/news/august-2022/intrigue-trial-second-line-ripretinib-vs-sunitinib-in-advanced-gist/ 2022-08-15T17:37:56+00:00 https://ascopost.com/news/august-2022/locoregional-recurrence-with-predefined-risk-based-de-escalation-of-radiotherapy-after-primary-chemotherapy-in-ct1-2n1-breast-cancer/ 2022-08-15T17:44:05+00:00 https://ascopost.com/news/august-2022/perspective-article-explores-implications-of-supreme-court-abortion-ruling-on-pregnant-women-with-cancer/ 2022-08-15T19:09:06+00:00 https://ascopost.com/news/august-2022/nelson-trial-protocol-may-be-more-sensitive-than-nlst-may-increase-benefits-of-lung-cancer-screening/ 2022-08-15T18:30:53+00:00 https://ascopost.com/news/august-2022/study-investigates-incidence-timing-and-survival-of-patients-with-second-primary-lung-cancer/ 2022-08-15T19:11:03+00:00 https://ascopost.com/news/august-2022/sexual-dysfunction-is-prevalent-among-women-with-lung-cancer/ 2022-08-26T16:51:12+00:00 https://ascopost.com/news/august-2022/breast-induration-risk-with-partial-vs-whole-breast-irradiation-after-breast-conserving-surgery-for-node-negative-early-disease/ 2022-08-16T15:12:43+00:00 https://ascopost.com/news/august-2022/higher-doses-of-car-t-cell-therapy-may-improve-survival-for-young-patients-with-b-cell-all/ 2022-08-16T20:13:09+00:00 https://ascopost.com/news/august-2022/sugemalimab-found-to-be-a-safe-and-effective-consolidation-therapy-for-patients-with-unresectable-stage-iii-nsclc/ 2022-08-16T19:00:51+00:00 https://ascopost.com/news/august-2022/molecular-map-reveals-insights-into-the-genetic-drivers-of-cll/ 2022-09-19T18:48:39+00:00 https://ascopost.com/news/august-2022/relationship-between-polypharmacy-and-frailty-among-older-adults-with-blood-cancers/ 2022-08-16T19:16:31+00:00 https://ascopost.com/news/august-2022/gnrh-agonist-therapy-for-prostate-cancer-and-cardiovascular-disease-risk-in-men-with-type-2-diabetes/ 2022-08-16T19:46:13+00:00 https://ascopost.com/news/august-2022/wbi-with-boost-after-breast-conserving-surgery-in-non-low-risk-dcis/ 2022-08-17T17:43:53+00:00 https://ascopost.com/news/august-2022/study-reveals-potential-genomic-contributors-to-the-development-of-dlbcl/ 2022-08-17T18:09:06+00:00 https://ascopost.com/news/august-2022/pralsetinib-achieves-tissue-agnostic-benefits-for-patients-with-ret-fusion-positive-cancers/ 2022-08-17T18:24:56+00:00 https://ascopost.com/news/august-2022/fda-approves-first-cell-based-gene-therapy-to-treat-adult-and-pediatric-patients-with-beta-thalassemia-who-require-regular-blood-transfusions/ 2022-08-17T19:33:12+00:00 https://ascopost.com/news/august-2022/study-shows-germline-testing-may-be-warranted-for-all-patients-with-lung-cancer/ 2022-08-17T20:18:49+00:00 https://ascopost.com/news/august-2022/first-line-lenalidomiderituximab-vs-rituximabchemotherapy-with-rituximab-maintenance-for-advanced-follicular-lymphoma/ 2022-08-18T16:39:43+00:00 https://ascopost.com/news/august-2022/low-dose-decitabine-and-azacitidine-in-lower-risk-mds/ 2022-08-18T16:49:32+00:00 https://ascopost.com/news/august-2022/t-dxd-shows-high-intracranial-response-rate-in-patients-with-active-brain-metastases-from-her2-positive-breast-cancer/ 2022-10-03T16:36:22+00:00 https://ascopost.com/news/august-2022/does-exposure-to-pfos-elevate-risk-of-developing-hepatocellular-carcinoma/ 2022-09-02T16:58:17+00:00 https://ascopost.com/news/august-2022/risk-prediction-models-for-coronary-heart-disease-and-heart-failure-after-treatment-for-hodgkin-lymphoma/ 2022-08-19T14:48:36+00:00 https://ascopost.com/news/august-2022/study-tests-strategy-for-reducing-colorectal-cancer-risk-among-patients-with-familial-adenomatous-polyposis/ 2022-08-19T14:58:49+00:00 https://ascopost.com/news/august-2022/premmplus-tool-may-assist-in-identifying-people-likely-to-benefit-from-multigene-hereditary-cancer-risk-assessment/ 2022-08-19T15:21:29+00:00 https://ascopost.com/news/august-2022/atezolizumab-plus-vemurafenibcobimetinib-for-patients-with-braf-v600-mutated-melanoma-and-cns-metastases/ 2022-08-19T15:44:53+00:00 https://ascopost.com/news/august-2022/effect-of-physical-activity-on-disease-free-survival-in-patients-receiving-adjuvant-therapy-for-stage-iii-colon-cancer/ 2022-08-22T15:40:43+00:00 https://ascopost.com/news/august-2022/stem-cell-boost-as-salvage-therapy-for-severe-hematologic-toxicity-after-cd19-car-t-cell-therapy/ 2022-08-22T15:45:55+00:00 https://ascopost.com/news/august-2022/study-evaluates-uv-protective-behaviors-in-american-indian-and-alaskan-native-populations/ 2022-08-29T19:10:52+00:00 https://ascopost.com/news/august-2022/racial-trends-in-advanced-cervical-cancer-in-the-united-states/ 2022-08-22T16:21:39+00:00 https://ascopost.com/news/august-2022/rucaparib-maintenance-after-platinum-based-chemotherapy-for-metastatic-urothelial-carcinoma/ 2022-08-22T16:44:14+00:00 https://ascopost.com/news/august-2022/anthony-fauci-md-to-step-down-from-current-roles-in-december/ 2022-08-22T17:57:49+00:00 https://ascopost.com/news/august-2022/durvalumabtremelimumab-for-previously-treated-patients-with-advanced-soft-tissue-and-bone-sarcomas/ 2022-08-23T17:38:42+00:00 https://ascopost.com/news/august-2022/global-burden-of-cancer-attributable-to-modifiable-risk-factors-in-2019/ 2022-08-23T19:41:38+00:00 https://ascopost.com/news/august-2022/rituximab-lenalidomide-and-ibrutinib-with-sequential-addition-of-chemotherapy-in-newly-diagnosed-dlbcl/ 2022-08-23T17:56:20+00:00 https://ascopost.com/news/august-2022/cancer-related-fatigue-linked-to-balance-problems-after-chemotherapy-for-breast-cancer/ 2022-08-23T18:17:39+00:00 https://ascopost.com/news/august-2022/proximity-to-fracking-sites-may-be-associated-with-risk-of-pediatric-leukemia/ 2022-08-23T18:30:30+00:00 https://ascopost.com/news/august-2022/study-examines-effects-of-advance-care-planning-for-adolescents-with-cancer/ 2022-08-23T18:36:28+00:00 https://ascopost.com/news/august-2022/adding-ct-to-x-ray-for-follow-up-of-completely-resected-nsclc/ 2022-08-26T15:43:14+00:00 https://ascopost.com/news/august-2022/elotuzumab-plus-pomalidomidedexamethasone-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2022-08-24T18:44:48+00:00 https://ascopost.com/news/august-2022/neoadjuvant-nivolumab-plus-ipilimumab-in-localized-dmmrmsi-h-gastric-cancer/ 2022-08-24T19:02:50+00:00 https://ascopost.com/news/august-2022/how-did-the-first-year-of-the-covid-19-pandemic-affect-cancer-survivors/ 2022-08-24T19:09:20+00:00 https://ascopost.com/news/august-2022/long-term-benefit-of-radiotherapy-confirmed-in-advanced-prostate-cancer-stampede-trial-follow-up/ 2022-08-24T19:54:05+00:00 https://ascopost.com/news/august-2022/clinical-and-translational-researcher-rossana-berardi-works-to-overcome-the-gender-gap-in-oncology-in-italy/ 2022-08-26T14:11:02+00:00 https://ascopost.com/news/august-2022/racialethnic-representation-in-pivotal-clinical-trials-for-drugs-approved-for-leukemias-and-multiple-myeloma/ 2022-09-27T18:44:12+00:00 https://ascopost.com/news/august-2022/etoposidecisplatin-vs-irinotecancisplatin-in-advanced-digestive-system-neuroendocrine-carcinoma/ 2022-08-26T15:40:42+00:00 https://ascopost.com/news/august-2022/researchers-identify-markers-of-chemotherapy-resistance-and-outcome-in-patients-with-triple-negative-breast-cancer/ 2022-08-26T15:47:49+00:00 https://ascopost.com/news/august-2022/deep-learning-algorithm-may-streamline-lung-cancer-radiotherapy-treatment/ 2022-08-26T15:53:55+00:00 https://ascopost.com/news/august-2022/analysis-of-outcomes-in-nci-sponsored-phase-i-trials-in-solid-tumors-2000-2019/ 2022-08-29T16:18:57+00:00 https://ascopost.com/news/august-2022/chronic-toxicity-with-adjuvant-intensity-modulated-vs-conventional-radiation-therapy-for-cervical-or-endometrial-cancer/ 2022-08-29T16:54:40+00:00 https://ascopost.com/news/august-2022/cabazitaxel-in-advanced-dedifferentiated-liposarcoma/ 2022-08-29T17:01:04+00:00 https://ascopost.com/news/august-2022/researchers-outline-a-path-to-representation-in-cancer-clinical-trials/ 2022-08-29T17:11:40+00:00 https://ascopost.com/news/august-2022/study-shows-ai-may-improve-prediction-of-colorectal-cancer-recurrence/ 2022-08-29T17:15:47+00:00 https://ascopost.com/news/august-2022/do-perioperative-beta-blockers-improve-survival-in-patients-with-cardiovascular-conditions-undergoing-surgery-for-ovarian-cancer/ 2022-08-30T18:12:07+00:00 https://ascopost.com/news/august-2022/addition-of-galunisertib-to-neoadjuvant-chemoradiotherapy-in-locally-advanced-rectal-cancer/ 2022-08-30T18:41:11+00:00 https://ascopost.com/news/august-2022/prevalence-of-mgus-among-rescue-and-recovery-workers-exposed-to-the-world-trade-center-disaster/ 2022-09-27T16:56:43+00:00 https://ascopost.com/news/august-2022/fertility-preservation-measures-do-not-appear-to-increase-the-risk-of-breast-cancer-recurrence/ 2022-08-30T19:21:19+00:00 https://ascopost.com/news/august-2022/addition-of-chemotherapy-to-gefitinib-in-first-line-treatment-of-advanced-nsclc-with-egfr-mutations/ 2022-09-23T18:37:45+00:00 https://ascopost.com/news/august-2022/radiotherapy-alone-vs-concurrent-chemoradiotherapy-in-low-risk-nasopharyngeal-cancer/ 2026-01-29T03:56:19+00:00 https://ascopost.com/news/september-2022/ 2022-09-01T15:41:10+00:00 https://ascopost.com/news/september-2022/astro-issues-clinical-guideline-on-radiation-therapy-for-idh-mutant-glioma/ 2022-09-01T16:25:18+00:00 https://ascopost.com/news/september-2022/neoadjuvant-chemotherapy-and-organ-preserving-surgery-in-early-rectal-cancer/ 2022-09-01T19:00:46+00:00 https://ascopost.com/news/september-2022/addition-of-t-vec-to-pembrolizumab-in-advanced-melanoma/ 2022-09-01T19:12:40+00:00 https://ascopost.com/news/september-2022/new-cervicovaginal-epigenetic-test-for-screening-of-suspected-endometrial-cancer/ 2022-09-01T20:03:36+00:00 https://ascopost.com/news/september-2022/durability-of-responses-to-bcma-car-t-cell-therapy-in-patients-with-multiple-myeloma-may-depend-on-specific-components-of-the-tumor-microenvironment/ 2022-09-27T17:07:22+00:00 https://ascopost.com/news/september-2022/new-risk-stratification-system-for-completely-resected-stage-ii-or-iii-colorectal-cancer/ 2022-09-02T14:44:48+00:00 https://ascopost.com/news/september-2022/combination-of-sephb4-hsa-plus-pembrolizumab-in-metastatic-urothelial-carcinoma/ 2022-09-13T15:42:29+00:00 https://ascopost.com/news/september-2022/luspatercept-for-anemia-in-patients-with-lower-risk-myelodysplastic-syndromes-long-term-follow-up/ 2022-09-02T16:24:35+00:00 https://ascopost.com/news/september-2022/study-examines-how-genetic-mutations-may-contribute-to-the-development-of-cholangiocarcinoma/ 2022-09-02T17:04:10+00:00 https://ascopost.com/news/september-2022/two-new-studies-find-aggressive-prostate-cancer-may-be-linked-to-ancestral-heritage/ 2022-09-02T17:03:34+00:00 https://ascopost.com/news/september-2022/long-term-findings-of-metastasis-directed-therapy-in-oligometastatic-castration-sensitive-prostate-cancer/ 2022-09-06T19:20:28+00:00 https://ascopost.com/news/september-2022/fertility-preservation-procedures-at-breast-cancer-diagnosis-risk-of-relapse-and-disease-specific-mortality/ 2022-10-03T18:14:59+00:00 https://ascopost.com/news/september-2022/is-pd-l1-expression-a-good-predictor-of-survival-benefit-in-patients-with-advanced-gastroesophageal-cancer-treated-with-immunotherapy/ 2022-09-06T19:54:27+00:00 https://ascopost.com/news/september-2022/addition-of-sintilimab-and-bevacizumab-biosimilar-to-chemotherapy-for-patients-with-advanced-egfr-mutated-nsclc-and-disease-progression-on-egfr-inhibitors/ 2022-09-23T17:34:53+00:00 https://ascopost.com/news/september-2022/addition-of-telaglenastat-to-cabozantinib-in-previously-treated-patients-with-metastatic-renal-cell-carcinoma/ 2022-09-07T15:11:49+00:00 https://ascopost.com/news/september-2022/report-finds-batwing-mastopexy-may-enable-more-women-to-undergo-nipple-sparing-mastectomy/ 2022-09-07T16:09:08+00:00 https://ascopost.com/news/september-2022/final-analysis-of-griffin-study-presented-for-daratumumab-based-investigational-quadruplet-regimen-in-newly-diagnosed-transplant-eligible-patients-with-multiple-myeloma/ 2022-09-07T18:26:10+00:00 https://ascopost.com/news/september-2022/asco-remembers-saul-a-rosenberg-asco-past-president-and-pioneer-of-hodgkin-lymphoma-treatment/ 2022-09-07T16:00:37+00:00 https://ascopost.com/news/september-2022/postmarketing-colitis-cases-may-be-associated-with-alpelisib-use/ 2022-09-07T18:26:42+00:00 https://ascopost.com/news/september-2022/bcma-cd3-bispecific-t-cell-redirecting-antibody-abbv-383-in-relapsed-or-refractory-multiple-myeloma/ 2022-09-15T17:56:59+00:00 https://ascopost.com/news/september-2022/adjuvant-pembrolizumab-in-patients-with-clear-cell-renal-cell-carcinoma-and-increased-risk-of-recurrence/ 2022-09-08T16:25:47+00:00 https://ascopost.com/news/september-2022/sacituzumab-govitecan-in-pretreated-patients-with-hr-positive-her2-negative-endocrine-resistant-advanced-breast-cancer/ 2022-09-08T18:39:29+00:00 https://ascopost.com/news/september-2022/study-examines-efficacy-of-t-cell-redirection-therapies-for-patients-with-relapsed-multiple-myeloma/ 2022-10-31T18:43:11+00:00 https://ascopost.com/news/september-2022/report-finds-cancers-in-adults-younger-than-age-50-are-on-the-rise-globally/ 2022-09-08T17:29:19+00:00 https://ascopost.com/news/september-2022/researchers-find-dopa-may-protect-against-melanoma-and-identify-potential-new-therapeutic-targets-to-treat-melanoma/ 2022-09-08T17:12:22+00:00 https://ascopost.com/news/september-2022/esmo-and-eons-announce-launch-of-prevcan/ 2022-09-10T12:30:48+00:00 https://ascopost.com/news/september-2022/researchers-examine-how-air-pollution-may-drive-lung-cancer-in-neversmokers/ 2022-09-23T18:34:59+00:00 https://ascopost.com/news/september-2022/fda-approves-eflapegrastim-xnst-injection-for-chemotherapy-induced-neutropenia/ 2022-09-10T12:48:13+00:00 https://ascopost.com/news/september-2022/prosper-rcc-neoadjuvant-nivolumab-prior-to-nephrectomy-followed-by-additional-nivolumab-in-patients-with-renal-cell-carcinoma/ 2022-09-13T15:43:04+00:00 https://ascopost.com/news/september-2022/cosmic-313-cabozantinib-nivolumab-and-ipilimumab-in-previously-untreated-patients-with-advanced-renal-cell-carcinoma/ 2022-09-13T15:36:22+00:00 https://ascopost.com/news/september-2022/nirogacestat-for-progressive-desmoid-tumors-defi-trial/ 2022-09-11T14:25:45+00:00 https://ascopost.com/news/september-2022/m14til-tumor-infiltrating-lymphocytes-for-patients-with-advanced-melanoma/ 2022-09-29T19:39:48+00:00 https://ascopost.com/news/september-2022/t-dxd-for-patients-with-her2-low-metastatic-breast-cancer-patient-reported-outcomes/ 2022-10-03T16:38:10+00:00 https://ascopost.com/news/september-2022/tropics-02-update-sacituzumab-govitecan-improves-overall-survival-in-previously-treated-patients-with-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-09-11T14:23:37+00:00 https://ascopost.com/news/september-2022/presto-treatment-beyond-androgen-deprivation-therapy-for-relapsed-patients-with-high-risk-prostate-cancer/ 2022-09-23T21:51:13+00:00 https://ascopost.com/news/september-2022/swog-s1801-neoadjuvant-and-adjuvant-pembrolizumab-for-patients-with-stage-iiib-to-iv-melanoma/ 2022-09-12T12:33:47+00:00 https://ascopost.com/news/september-2022/research-explores-multicancer-early-detection-blood-testing/ 2022-09-12T13:09:54+00:00 https://ascopost.com/news/september-2022/updated-results-from-the-krystal-1-study-of-adagrasib-in-advanced-kras-g12c-mutated-colorectal-cancer/ 2022-09-12T13:51:00+00:00 https://ascopost.com/news/september-2022/neoadjuvant-cemiplimab-in-patients-with-stage-ii-to-iv-cutaneous-squamous-cell-carcinoma/ 2022-09-29T19:37:53+00:00 https://ascopost.com/news/september-2022/fresco-2-fruquintinib-for-patients-with-refractory-metastatic-colorectal-cancer/ 2022-09-12T13:22:44+00:00 https://ascopost.com/news/september-2022/asco-applauds-president-biden-s-leadership-in-relaunching-the-cancer-moonshot/ 2022-09-13T13:58:48+00:00 https://ascopost.com/news/september-2022/early-research-identifies-effective-combination-immunotherapy-for-subgroup-of-patients-with-metastatic-colorectal-cancer/ 2022-09-13T15:09:43+00:00 https://ascopost.com/news/september-2022/dual-checkpoint-inhibitor-blockade-as-first-line-and-salvage-therapy-for-patients-with-advanced-merkel-cell-carcinoma/ 2022-09-13T15:44:13+00:00 https://ascopost.com/news/september-2022/updated-results-from-the-adaura-trial-of-adjuvant-osimertinib-in-egfr-mutated-nsclc/ 2022-09-23T17:33:58+00:00 https://ascopost.com/news/september-2022/updated-overall-survival-findings-with-adjuvant-erlotinib-vs-vinorelbinecisplatin-in-egfr-mutant-stage-iiia-nsclc/ 2022-09-23T17:37:30+00:00 https://ascopost.com/news/september-2022/acquired-egfr-inhibitor-resistance-alterations-identified-in-ctdna-analysis-in-patients-with-refractory-metastatic-colorectal-cancer/ 2022-09-14T14:13:44+00:00 https://ascopost.com/news/september-2022/5-year-outcomes-with-adjuvant-mfolfirinox-vs-gemcitabine-in-pancreatic-cancer/ 2022-09-14T14:29:31+00:00 https://ascopost.com/news/september-2022/outcomes-of-lung-cancer-screening-in-individuals-with-or-without-lung-related-comorbidities/ 2022-09-14T14:44:06+00:00 https://ascopost.com/news/september-2022/patient-reported-outcomes-with-the-addition-of-olaparib-to-abiraterone-in-castration-resistant-prostate-cancer/ 2022-09-14T15:00:55+00:00 https://ascopost.com/news/september-2022/study-explores-link-between-use-of-antipsychotic-agents-and-increased-breast-cancer-risk/ 2022-09-15T17:13:53+00:00 https://ascopost.com/news/september-2022/lung-cancer-screening-increases-percentage-of-stage-i-cases-detected-while-reducing-percentage-of-stage-iv-cases-detected/ 2022-09-15T17:16:40+00:00 https://ascopost.com/news/september-2022/association-of-neurofilament-light-chain-levels-with-icans-risk-after-car-t-cell-therapy/ 2022-09-15T15:54:35+00:00 https://ascopost.com/news/september-2022/trends-in-incidence-of-cutaneous-t-cell-lymphoma-in-the-united-states/ 2022-09-15T16:09:15+00:00 https://ascopost.com/news/september-2022/sequencing-of-ipilimumabnivolumab-with-encorafenibbinimetinib-in-braf-mutant-metastatic-melanoma/ 2022-09-15T16:21:34+00:00 https://ascopost.com/news/september-2022/rezvilutamide-vs-bicalutamide-combined-with-adt-in-high-volume-metastatic-hormone-sensitive-prostate-cancer/ 2022-09-16T15:48:29+00:00 https://ascopost.com/news/september-2022/use-of-trimodality-therapy-in-stage-iiiii-rectal-cancer-in-the-united-states-10-year-period/ 2022-09-16T15:54:12+00:00 https://ascopost.com/news/september-2022/cost-effectiveness-of-chemotherapy-sequences-in-metastatic-breast-cancer-according-to-prior-therapy-exposure/ 2022-09-16T16:05:21+00:00 https://ascopost.com/news/september-2022/new-study-shows-patients-paying-more-out-of-pocket-costs-for-cancer-care/ 2022-09-16T17:24:12+00:00 https://ascopost.com/news/september-2022/new-research-from-cohort-k-of-the-ev-103-trial-of-enfortumab-vedotin-for-patients-with-urothelial-cancer/ 2022-10-11T19:58:15+00:00 https://ascopost.com/news/september-2022/reporting-of-hispanic-ethnicity-and-race-in-breast-cancer-studies/ 2022-09-19T12:55:33+00:00 https://ascopost.com/news/september-2022/compliance-of-nci-designated-cancer-centers-with-january-2021-cms-price-transparency-requirements/ 2022-09-19T13:08:35+00:00 https://ascopost.com/news/september-2022/recurrence-free-survival-as-surrogate-for-overall-survival-in-patients-undergoing-resection-of-colorectal-liver-metastases/ 2022-09-19T13:12:33+00:00 https://ascopost.com/news/september-2022/novel-photon-counting-ct-may-improve-myeloma-bone-disease-detection/ 2022-09-19T13:22:26+00:00 https://ascopost.com/news/september-2022/new-study-shows-sugar-sweetened-drinks-may-increase-risk-of-cancer-mortality/ 2022-09-19T13:37:20+00:00 https://ascopost.com/news/september-2022/many-families-of-children-with-leukemia-may-experience-food-insecurity-that-is-not-alleviated-by-federal-assistance-program/ 2022-10-24T19:13:55+00:00 https://ascopost.com/news/september-2022/neoadjuvant-endocrine-therapy-may-elicit-differential-responses-in-black-vs-white-women-with-breast-cancer/ 2022-09-20T15:49:42+00:00 https://ascopost.com/news/september-2022/antibody-response-to-three-dose-covid-19-mrna-1273-vaccination-schedule-in-immunocompromised-patients-with-hematologic-cancers/ 2022-09-20T15:21:38+00:00 https://ascopost.com/news/september-2022/most-lgbtqi-patients-with-cancer-do-not-receive-information-tailored-to-their-needs/ 2022-09-20T16:24:17+00:00 https://ascopost.com/news/september-2022/prostate-tumor-biology-may-be-influenced-by-genetic-ancestry/ 2022-09-20T15:36:58+00:00 https://ascopost.com/news/september-2022/individuals-of-mexican-descent-may-have-higher-risk-of-liver-cancer-with-each-successive-generation/ 2022-09-20T15:57:46+00:00 https://ascopost.com/news/september-2022/asco-announces-election-candidates-voting-opens-on-november-2/ 2022-09-21T19:42:16+00:00 https://ascopost.com/news/september-2022/study-finds-cancer-mortality-rates-correlate-with-geography-as-well-as-known-behavioral-risk-factors/ 2022-09-21T17:59:04+00:00 https://ascopost.com/news/september-2022/preclinical-study-finds-new-synthetic-lethal-agent-could-be-potential-treatment-for-pancreatic-cancer/ 2022-09-21T18:05:46+00:00 https://ascopost.com/news/september-2022/ctdna-analysis-of-acquired-egfr-resistance-alterations-with-first-line-cetuximab-plus-chemotherapy-in-patients-with-metastatic-colorectal-cancer/ 2022-09-21T18:25:28+00:00 https://ascopost.com/news/september-2022/association-of-distance-to-treatment-facility-region-and-insurance-status-with-diagnosis-of-advanced-colon-cancer/ 2022-09-21T19:43:11+00:00 https://ascopost.com/news/september-2022/adjuvant-nivolumab-with-or-without-ipilimumab-in-patients-with-resected-stage-iv-melanoma-with-no-evidence-of-disease/ 2022-09-21T18:48:58+00:00 https://ascopost.com/news/september-2022/neoadjuvant-atezolizumab-may-be-safe-effective-option-for-localized-non-small-cell-lung-cancer/ 2022-09-22T19:38:25+00:00 https://ascopost.com/news/september-2022/housing-instability-and-risk-of-mortality-in-patients-with-cancer/ 2022-09-22T19:38:48+00:00 https://ascopost.com/news/september-2022/new-imaging-technique-may-improve-accuracy-of-basal-cell-carcinoma-diagnosis/ 2022-09-22T17:46:21+00:00 https://ascopost.com/news/september-2022/adjuvant-pembrolizumab-in-patients-with-completely-resected-stage-ib-to-iiia-nsclc/ 2022-09-22T19:37:44+00:00 https://ascopost.com/news/september-2022/pafolacianine-for-intraoperative-imaging-of-folate-receptor-positive-ovarian-cancer/ 2022-09-22T18:07:55+00:00 https://ascopost.com/news/september-2022/new-long-term-opioid-use-after-lung-cancer-surgery-linked-to-reduced-2-year-survival/ 2022-09-23T18:30:33+00:00 https://ascopost.com/news/september-2022/precision-physical-activity-prescriptions-may-improve-survival-in-patients-with-stage-iii-colon-cancer/ 2022-09-23T14:59:30+00:00 https://ascopost.com/news/september-2022/study-shows-many-patients-prefer-stool-test-to-colonoscopy-for-colorectal-cancer-screening/ 2022-09-23T18:31:35+00:00 https://ascopost.com/news/september-2022/conditioning-with-busulfan-cyclophosphamide-vs-total-body-irradiation-cyclophosphamide-for-b-cell-all/ 2022-09-23T15:19:32+00:00 https://ascopost.com/news/september-2022/september-24-is-world-cancer-research-day/ 2022-09-23T15:36:39+00:00 https://ascopost.com/news/september-2022/selpercatinib-in-ret-fusion-positive-solid-tumors-other-than-lung-or-thyroid-malignancies/ 2022-09-23T16:24:34+00:00 https://ascopost.com/news/september-2022/aacr-cancer-progress-report-2022-shows-cancer-mortality-rates-continue-to-decline-but-challenges-remain/ 2022-09-23T16:44:25+00:00 https://ascopost.com/news/september-2022/total-cost-of-cancer-care-may-be-reduced-with-lower-cost-alternate-drugs-without-compromising-quality-of-care/ 2022-09-27T19:21:10+00:00 https://ascopost.com/news/september-2022/can-a-navigation-program-lower-care-costs-for-patients-with-cancer/ 2022-09-27T19:22:57+00:00 https://ascopost.com/news/september-2022/research-finds-medicaid-expansion-led-to-decreases-in-cancer-incidence-and-mortality-rates/ 2022-09-27T15:59:30+00:00 https://ascopost.com/news/september-2022/effectiveness-of-dexamethasone-for-dyspnea-in-patients-with-cancer/ 2022-09-27T16:50:50+00:00 https://ascopost.com/news/september-2022/risk-factors-for-heart-failure-among-survivors-of-childhood-cancer/ 2022-09-27T19:22:20+00:00 https://ascopost.com/news/september-2022/overall-survival-with-maintenance-olaparib-in-newly-diagnosed-patients-with-advanced-brca-mutated-ovarian-cancer/ 2022-09-27T17:52:34+00:00 https://ascopost.com/news/september-2022/genomic-testing-may-aid-in-identifying-patients-of-african-descent-with-high-risk-prostate-cancer/ 2022-09-28T17:36:03+00:00 https://ascopost.com/news/september-2022/unhealthy-gut-may-set-the-stage-for-breast-cancer-to-spread-preclinical-research-reveals/ 2022-09-28T18:17:43+00:00 https://ascopost.com/news/september-2022/uams-winthrop-p-rockefeller-cancer-institute-welcomes-pebbles-fagan-phd-mph-to-leadership-team/ 2022-09-28T17:10:21+00:00 https://ascopost.com/news/september-2022/blood-pressure-and-risk-of-heart-failure-in-patients-with-cancer/ 2022-09-28T18:30:25+00:00 https://ascopost.com/news/september-2022/therapeutic-universal-cancer-peptide-based-vaccine-in-refractory-advanced-nsclc/ 2022-09-28T19:47:57+00:00 https://ascopost.com/news/september-2022/avelumab-plus-axitinib-in-advanced-type-b3-thymomas-and-thymic-carcinomas/ 2022-09-28T18:52:35+00:00 https://ascopost.com/news/september-2022/financial-burden-of-high-cost-targeted-oral-anticancer-drugs-among-medicare-patients/ 2022-09-28T19:01:24+00:00 https://ascopost.com/news/september-2022/cancer-phenotypes-associated-with-germline-chek2-variants/ 2022-09-29T16:44:05+00:00 https://ascopost.com/news/september-2022/constitutional-brca1-methylation-and-risk-of-triple-negative-breast-cancer-and-ovarian-cancer/ 2022-09-29T17:41:26+00:00 https://ascopost.com/news/september-2022/lasker-foundation-announces-2022-lasker-award-winners/ 2022-09-29T18:54:52+00:00 https://ascopost.com/news/september-2022/report-emphasizes-continued-access-to-fertility-preservation-is-critical-for-ayas-with-cancer-following-scotus-decision/ 2022-09-29T19:03:40+00:00 https://ascopost.com/news/september-2022/study-examines-potential-benefits-of-a-fourth-covid-19-vaccination-for-patients-with-cancer/ 2022-09-29T19:10:34+00:00 https://ascopost.com/news/september-2022/genetic-variation-may-explain-racial-disparity-in-esophageal-cancer-cases/ 2022-09-29T19:45:38+00:00 https://ascopost.com/news/september-2022/fda-approves-biosimilar-bevacizumab-adcd-for-the-treatment-of-six-types-of-cancer/ 2022-09-30T16:18:01+00:00 https://ascopost.com/news/september-2022/outcomes-after-nonresponse-and-relapse-in-childrenyoung-adults-receiving-tisagenlecleucel-for-b-cell-all/ 2022-10-13T18:07:03+00:00 https://ascopost.com/news/september-2022/association-of-breast-cancer-recurrence-in-patients-achieving-pcr-with-vs-without-residual-dcis-after-neoadjuvant-chemotherapy/ 2022-09-30T19:32:23+00:00 https://ascopost.com/news/september-2022/2-year-toxicity-with-conventional-imrt-vs-hypofractionated-sbrt-for-localized-prostate-cancer/ 2022-09-30T19:34:04+00:00 https://ascopost.com/news/september-2022/inflammatory-markers-and-clinical-decline-after-adjuvant-chemotherapy-in-older-women-with-breast-cancer/ 2022-09-30T17:37:16+00:00 https://ascopost.com/news/september-2022/tissue-vs-ctdna-ngs-for-detecting-actionable-alterations-in-patients-with-advanced-cancer/ 2022-09-30T18:47:56+00:00 https://ascopost.com/news/october-2022/ 2022-10-03T14:43:42+00:00 https://ascopost.com/news/october-2022/extended-interval-vs-standard-interval-dosing-of-single-agent-pembrolizumab/ 2022-10-03T15:52:04+00:00 https://ascopost.com/news/october-2022/risks-associated-with-sinoatrial-node-radiation-dose-in-patients-with-lung-cancer-receiving-definitive-chemoradiotherapy/ 2022-10-03T15:55:42+00:00 https://ascopost.com/news/october-2022/selpercatinib-in-ret-fusion-positive-advanced-nsclc/ 2022-10-21T18:09:44+00:00 https://ascopost.com/news/october-2022/researchers-identify-potential-biomarker-to-distinguish-group-3-and-group-4-medulloblastomas/ 2022-10-03T18:34:43+00:00 https://ascopost.com/news/october-2022/study-focuses-on-molecular-details-of-precancerous-clonal-outgrowth-in-blood-cells/ 2022-10-03T18:41:52+00:00 https://ascopost.com/news/october-2022/active-surveillance-for-low-risk-papillary-thyroid-carcinoma/ 2022-10-05T14:17:10+00:00 https://ascopost.com/news/october-2022/oncologist-use-of-reduced-doses-of-new-systemic-treatments-in-patients-with-metastatic-cancer/ 2022-10-05T14:42:03+00:00 https://ascopost.com/news/october-2022/minimally-invasive-vs-open-nephrectomy-for-kidney-cancer-1-year-health-care-expenditure-and-utilization/ 2022-10-05T14:44:22+00:00 https://ascopost.com/news/october-2022/gprc5d-targeted-car-t-cell-therapy-in-heavily-pretreated-patients-with-multiple-myeloma/ 2022-12-19T20:13:56+00:00 https://ascopost.com/news/october-2022/research-examines-a-new-tool-for-discovering-cancer-driving-structural-variations/ 2022-10-05T19:21:50+00:00 https://ascopost.com/news/october-2022/study-investigates-potential-embryonic-origin-of-medulloblastomas/ 2022-10-05T19:22:17+00:00 https://ascopost.com/news/october-2022/single-vs-multiple-doses-of-prophylactic-iv-antibiotics-to-prevent-surgical-site-infection-in-implant-based-breast-reconstruction/ 2022-10-06T15:17:55+00:00 https://ascopost.com/news/october-2022/symptom-clusters-in-adult-survivors-of-childhood-cancer/ 2022-10-06T15:56:15+00:00 https://ascopost.com/news/october-2022/adjuvant-nivolumabipilimumab-vs-nivolumab-in-resected-stage-iiib-d-or-iv-melanoma/ 2022-10-06T16:27:10+00:00 https://ascopost.com/news/october-2022/is-mortgage-discrimination-adversely-associated-with-receipt-of-guideline-concordant-nsclc-care/ 2022-10-21T18:10:55+00:00 https://ascopost.com/news/october-2022/transportation-barriers-among-cancer-survivors-effect-on-er-use-and-mortality/ 2022-10-06T17:07:01+00:00 https://ascopost.com/news/october-2022/new-study-highlights-sexual-problems-among-young-women-who-have-had-cancer/ 2022-10-06T18:23:40+00:00 https://ascopost.com/news/october-2022/addition-of-pd-1-inhibitor-serplulimab-to-chemotherapy-in-the-first-line-treatment-of-extensive-stage-sclc/ 2022-10-06T17:20:36+00:00 https://ascopost.com/news/october-2022/chemotherapy-for-children-with-type-ii-or-iii-pleuropulmonary-blastoma/ 2022-10-07T15:06:23+00:00 https://ascopost.com/news/october-2022/toxicity-outcomes-with-stereotactic-ablative-radiotherapy-for-patients-with-up-to-five-oligometastases/ 2022-10-07T15:11:29+00:00 https://ascopost.com/news/october-2022/association-of-social-vulnerability-with-mortality-from-comorbid-cancer-and-cardiovascular-disease/ 2023-08-29T19:50:56+00:00 https://ascopost.com/news/october-2022/historical-housing-discrimination-may-adversely-affect-contemporary-colon-cancer-care-and-outcomes/ 2022-10-07T19:39:10+00:00 https://ascopost.com/news/october-2022/medicaid-expansion-and-palliative-care-use-among-patients-newly-diagnosed-with-advanced-cancer/ 2022-10-07T16:57:23+00:00 https://ascopost.com/news/october-2022/health-related-quality-of-life-for-survivors-of-metastatic-prostate-cancer/ 2022-10-07T19:45:27+00:00 https://ascopost.com/news/october-2022/decrease-in-breast-cancer-mortality-rate-continues-but-gap-persists-for-black-women-from-american-cancer-society-report/ 2022-10-11T17:29:40+00:00 https://ascopost.com/news/october-2022/study-finds-cost-of-cancer-care-may-impact-health-of-low-income-survivors/ 2022-10-11T18:44:58+00:00 https://ascopost.com/news/october-2022/real-world-cost-of-care-for-pediatric-all-among-commercially-insured-patients/ 2022-10-13T18:06:25+00:00 https://ascopost.com/news/october-2022/treatments-and-outcomes-for-locally-advanced-rectal-cancer-in-patients-aged-80-and-older/ 2022-10-11T19:05:25+00:00 https://ascopost.com/news/october-2022/impact-of-cdc-opioid-prescribing-guideline-on-prescriptions-and-potential-misusesubstance-use-disorder-among-childhood-cancer-survivors/ 2022-10-11T19:20:00+00:00 https://ascopost.com/news/october-2022/nivolumabipilimumab-vs-dabrafenibtrametinib-with-switch-at-disease-progression-for-metastatic-braf-mutant-melanoma/ 2022-10-11T19:44:43+00:00 https://ascopost.com/news/october-2022/financial-hardship-and-risk-factors-in-patients-with-cancer-receiving-routine-clinical-care/ 2022-10-12T17:52:33+00:00 https://ascopost.com/news/october-2022/oncologist-participation-in-medicare-ocm-and-patient-receipt-of-novel-therapies/ 2022-10-12T18:00:15+00:00 https://ascopost.com/news/october-2022/c-reactive-protein-level-and-cognitive-function-in-breast-cancer-survivors-aged-60-and-older/ 2022-10-12T18:05:36+00:00 https://ascopost.com/news/october-2022/deaths-attributed-to-both-cancer-and-covid-19-in-the-united-states/ 2022-10-12T18:35:48+00:00 https://ascopost.com/news/october-2022/switch-to-fulvestrantpalbociclib-with-rising-esr1-mutation-level-in-blood-during-aipalbociclib-therapy-in-patients-with-advanced-breast-cancer/ 2022-10-12T20:25:34+00:00 https://ascopost.com/news/october-2022/eligibility-for-lung-cancer-screening-among-women-with-a-smoking-history-undergoing-breast-cancer-screening/ 2022-10-13T17:37:09+00:00 https://ascopost.com/news/october-2022/letrozoleabemaciclib-for-estrogen-receptor-positive-recurrent-endometrial-cancer/ 2022-10-13T17:41:59+00:00 https://ascopost.com/news/october-2022/study-analyzes-postimaging-diagnoses-of-pancreatic-cancer/ 2022-10-13T19:33:01+00:00 https://ascopost.com/news/october-2022/mediterranean-diet-may-improve-immunotherapy-response-rates-and-progression-free-survival-in-advanced-melanoma/ 2022-11-30T21:18:50+00:00 https://ascopost.com/news/october-2022/effect-of-social-factors-on-cancer-screening-rates-across-us-counties/ 2022-10-13T19:16:36+00:00 https://ascopost.com/news/october-2022/risk-of-meningioma-in-childhood-cancer-survivors/ 2022-10-14T14:33:11+00:00 https://ascopost.com/news/october-2022/neoadjuvant-intensity-modulated-radiotherapy-in-centrally-located-hepatocellular-carcinoma/ 2022-10-14T14:56:06+00:00 https://ascopost.com/news/october-2022/polycystic-ovary-syndrome-and-risk-of-pancreatic-cancer/ 2022-10-14T15:02:58+00:00 https://ascopost.com/news/october-2022/computer-platform-may-help-match-patients-with-cancer-to-targeted-therapy-trials/ 2022-10-14T15:55:32+00:00 https://ascopost.com/news/october-2022/long-term-outcomes-with-minimal-access-vs-conventional-breast-surgery-in-stage-0-to-iii-breast-cancer/ 2022-10-14T15:41:42+00:00 https://ascopost.com/news/october-2022/researchers-discover-predictive-biomarker-of-response-to-therapy-in-patients-with-microsatellite-stable-metastatic-colorectal-cancer/ 2022-10-14T16:00:43+00:00 https://ascopost.com/news/october-2022/asco-launches-webinar-series-to-close-the-global-divide-between-survivorship-and-palliative-care-in-breast-cancer/ 2022-10-20T14:02:25+00:00 https://ascopost.com/news/october-2022/financial-hardship-among-adult-survivors-of-childhood-cancer-after-implementation-of-the-affordable-care-act/ 2022-10-18T18:17:41+00:00 https://ascopost.com/news/october-2022/prevalence-of-and-risks-for-thoracic-soft-tissue-sarcomas-in-breast-cancer-survivors/ 2022-10-18T18:22:31+00:00 https://ascopost.com/news/october-2022/first-line-nivolumab-ipilimumab-vs-chemotherapy-in-metastatic-nsclc-without-egfr-or-alk-alterations/ 2022-10-21T18:09:08+00:00 https://ascopost.com/news/october-2022/researchers-find-possible-link-between-immune-cells-closest-neighbors-and-survival-time-in-patients-with-pancreatic-cancer/ 2022-10-18T20:05:17+00:00 https://ascopost.com/news/october-2022/study-identifies-how-cancer-causing-gene-might-regulate-genetic-variation-in-prostate-cancer/ 2022-10-18T19:12:15+00:00 https://ascopost.com/news/october-2022/pembrolizumab-with-or-without-chemotherapy-vs-cetuximabchemotherapy-in-recurrent-or-metastatic-head-and-neck-cancer/ 2026-01-29T03:33:10+00:00 https://ascopost.com/news/october-2022/single-dose-carboplatin-plus-involved-node-radiotherapy-in-stage-iiaiib-seminoma/ 2022-10-19T15:03:36+00:00 https://ascopost.com/news/october-2022/timely-surveillance-with-chest-imaging-may-benefit-patients-with-metastatic-colorectal-cancer/ 2022-10-19T19:49:08+00:00 https://ascopost.com/news/october-2022/study-examines-efficacy-cost-of-fit-vs-multitarget-stool-dna-testing-for-colorectal-cancer-screening/ 2022-10-19T19:48:31+00:00 https://ascopost.com/news/october-2022/no-benefit-for-adjuvant-palbociclib-in-stage-iia-breast-cancer-analysis-from-the-pallas-trial/ 2022-10-19T17:00:04+00:00 https://ascopost.com/news/october-2022/silicone-based-polyurethane-film-may-reduce-acute-radiation-dermatitis-in-patients-with-breast-cancer/ 2022-10-19T18:30:11+00:00 https://ascopost.com/news/october-2022/responses-to-irinotecan-temozolomide-dinutuximab-and-gm-csf-regimen-in-patients-with-relapsed-high-risk-neuroblastoma/ 2022-10-20T20:16:26+00:00 https://ascopost.com/news/october-2022/intensive-chemoresection-with-mitomycin-to-reduce-need-for-surgical-procedures-in-patients-with-recurrent-non-muscle-invasive-bladder-cancer/ 2022-11-08T20:11:43+00:00 https://ascopost.com/news/october-2022/maternal-deaths-from-cancer-worldwide-have-led-to-approximately-1-million-new-maternal-orphans/ 2022-10-20T20:20:40+00:00 https://ascopost.com/news/october-2022/use-of-remote-interventions-increased-adherence-to-cancer-screenings-among-women-in-rural-areas/ 2022-10-20T20:21:29+00:00 https://ascopost.com/news/october-2022/acs-can-survey-female-patients-with-cancer-report-less-satisfaction-more-challenges-with-cancer-care/ 2022-10-20T20:23:24+00:00 https://ascopost.com/news/october-2022/hair-straightening-chemicals-may-be-associated-with-higher-uterine-cancer-risk/ 2022-10-20T19:28:38+00:00 https://ascopost.com/news/october-2022/effect-of-goals-of-care-program-for-inpatients-at-a-comprehensive-cancer-center-during-the-covid-19-pandemic/ 2022-10-21T16:40:55+00:00 https://ascopost.com/news/october-2022/incidence-of-cutaneous-adverse-events-with-adjuvant-pi3k-inhibitor-therapy/ 2022-10-21T16:55:48+00:00 https://ascopost.com/news/october-2022/incidence-of-neurologic-side-effects-from-car-t-cell-therapy-is-higher-in-patients-with-hypophosphatemia-study-finds/ 2022-10-21T17:08:06+00:00 https://ascopost.com/news/october-2022/exercise-may-improve-cardiorespiratory-fitness-during-and-after-chemotherapy/ 2022-10-21T17:33:55+00:00 https://ascopost.com/news/october-2022/multicenter-study-sheds-light-on-features-of-invasive-lobular-carcinoma/ 2022-10-21T17:52:51+00:00 https://ascopost.com/news/october-2022/can-patients-with-cancer-treated-with-immunotherapy-safely-receive-mrna-covid-19-vaccines/ 2022-10-21T18:39:47+00:00 https://ascopost.com/news/october-2022/nci-honors-augusto-ochoa-for-his-contributions-to-community-based-cancer-clinical-trials/ 2022-10-21T20:12:26+00:00 https://ascopost.com/news/october-2022/ai-model-using-daily-step-counts-may-help-predict-unplanned-hospitalizations-during-cancer-therapy/ 2022-10-24T16:34:16+00:00 https://ascopost.com/news/october-2022/adding-sbrt-to-sorafenib-may-improve-survival-and-time-to-disease-progression-in-patients-with-advanced-hcc/ 2022-11-04T20:02:28+00:00 https://ascopost.com/news/october-2022/small-first-in-human-trial-investigates-flash-proton-radiotherapy-for-patients-with-bone-metastases/ 2022-10-24T17:07:24+00:00 https://ascopost.com/news/october-2022/pcs5-trial-long-term-outcomes-of-moderately-shortened-radiation-course-for-high-risk-prostate-cancer/ 2022-10-24T19:11:03+00:00 https://ascopost.com/news/october-2022/prophylactic-radiation-for-asymptomatic-bone-metastases-may-reduce-pain-and-extend-survival/ 2022-10-24T18:32:24+00:00 https://ascopost.com/news/october-2022/fda-approves-tremelimumab-plus-durvalumab-for-adult-patients-with-unresectable-hcc/ 2022-11-04T20:00:31+00:00 https://ascopost.com/news/october-2022/fda-approves-teclistamab-cqyv-for-relapsed-or-refractory-multiple-myeloma/ 2022-10-31T17:28:07+00:00 https://ascopost.com/news/october-2022/medical-physicist-consults-may-help-reduce-patient-anxiety-and-increase-satisfaction-with-radiation-care/ 2022-10-26T17:38:06+00:00 https://ascopost.com/news/october-2022/sexual-side-effects-of-cancer-treatment-often-unaddressed-with-female-patients/ 2022-10-26T17:58:47+00:00 https://ascopost.com/news/october-2022/response-adapted-ultra-low-dose-radiation-achieves-complete-response-in-majority-of-patients-with-orbital-indolent-b-cell-lymphomas/ 2022-10-26T18:10:12+00:00 https://ascopost.com/news/october-2022/metastasis-directed-radiation-therapy-plus-hormone-therapy-may-improve-progression-free-survival-in-patients-with-advanced-prostate-cancer/ 2022-10-26T18:17:10+00:00 https://ascopost.com/news/october-2022/3-week-course-of-radiotherapy-with-concurrent-radiation-boost-found-to-be-safe-and-effective-for-patients-with-early-stage-breast-cancer-and-elevated-risk-of-recurrence/ 2022-10-26T20:08:53+00:00 https://ascopost.com/news/october-2022/aacr-and-asco-release-joint-policy-statement-on-electronic-nicotine-delivery-systems/ 2022-10-27T15:10:55+00:00 https://ascopost.com/news/october-2022/small-study-examines-repeated-convection-enhanced-delivery-of-topotecan-for-recurrent-glioblastoma/ 2022-10-27T15:46:13+00:00 https://ascopost.com/news/october-2022/have-changes-in-cancer-therapy-over-time-affected-the-risk-of-breast-cancer-among-female-childhood-cancer-survivors/ 2022-10-27T15:58:00+00:00 https://ascopost.com/news/october-2022/2022-annual-report-to-the-nation-on-the-status-of-cancer-released/ 2022-10-27T20:00:47+00:00 https://ascopost.com/news/october-2022/multimodal-artificial-intelligence-models-may-offer-an-accurate-prognostication-method-for-intermediate-to-high-risk-localized-prostate-cancer/ 2022-10-27T16:21:18+00:00 https://ascopost.com/news/october-2022/analysis-of-radiotherapy-and-breast-cancer-recurrence-in-the-rxponder-trial/ 2022-10-27T16:26:35+00:00 https://ascopost.com/news/october-2022/new-cervical-screening-test-could-predict-cell-changes-years-before-they-occur/ 2022-10-28T16:35:24+00:00 https://ascopost.com/news/october-2022/minority-patients-face-longer-waits-for-non-small-cell-lung-cancer-treatment/ 2022-10-28T19:24:14+00:00 https://ascopost.com/news/october-2022/can-genetic-mutations-impact-radiation-sensitivity/ 2022-10-28T16:47:16+00:00 https://ascopost.com/news/october-2022/continuous-enzalutamide-plus-docetaxel-for-patients-with-metastatic-castration-resistant-prostate-cancer-with-disease-progression-on-enzalutamide/ 2022-10-28T16:55:06+00:00 https://ascopost.com/news/october-2022/concurrent-bevacizumab-and-reirradiation-vs-bevacizumab-alone-in-recurrent-glioblastoma/ 2022-10-28T17:24:28+00:00 https://ascopost.com/news/october-2022/first-line-toripalimab-plus-chemotherapy-in-advanced-nsclc-choice-01/ 2022-11-17T22:53:02+00:00 https://ascopost.com/news/october-2022/addition-of-cediranib-to-olaparib-for-metastatic-castration-resistant-prostate-cancer/ 2022-10-31T17:02:51+00:00 https://ascopost.com/news/october-2022/rogaratinib-vs-chemotherapy-in-previously-treated-patients-with-advanced-urothelial-carcinoma-and-fgfr13-mrna-overexpression/ 2022-10-31T17:14:52+00:00 https://ascopost.com/news/october-2022/addition-of-bemarituzumab-to-mfolfox-in-fgfr2b-selected-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2022-10-31T17:31:01+00:00 https://ascopost.com/news/october-2022/identifying-patients-with-ovarian-cancer-with-greatest-potential-benefit-from-first-line-bevacizumab/ 2022-10-31T18:51:13+00:00 https://ascopost.com/news/october-2022/neoadjuvant-immunotherapy-with-relatlimab-and-nivolumab-in-stage-iii-melanoma/ 2022-10-31T17:40:14+00:00 https://ascopost.com/news/october-2022/legal-and-ethical-use-of-complementary-and-alternative-medicine-interventions-in-oncology/ 2022-10-31T18:47:35+00:00 https://ascopost.com/news/november-2022/ 2022-11-01T15:56:14+00:00 https://ascopost.com/news/november-2022/chemotherapy-outcomes-in-noninfant-childhood-all-with-11q23kmt2a-rearrangements/ 2022-11-01T16:34:16+00:00 https://ascopost.com/news/november-2022/genomic-microsatellite-signature-assay-to-identify-germline-mmrd-in-patients-with-cmmrd/ 2022-11-01T19:58:14+00:00 https://ascopost.com/news/november-2022/addition-of-capecitabine-to-temozolomide-in-advanced-pancreatic-neuroendocrine-tumors/ 2022-11-01T19:13:23+00:00 https://ascopost.com/news/november-2022/psa-screening-rates-and-incidence-of-metastatic-prostate-cancer-at-vha-facilities/ 2022-11-01T19:56:10+00:00 https://ascopost.com/news/november-2022/researchers-discover-differences-in-response-to-pembrolizumab-among-patients-with-endometrial-cancer/ 2022-11-01T19:42:56+00:00 https://ascopost.com/news/november-2022/andrea-and-brady-mckee-honored-with-the-james-mulshine-national-leadership-award/ 2022-11-17T22:57:33+00:00 https://ascopost.com/news/november-2022/the-nordicc-trial-the-devil-is-in-the-details/ 2022-11-02T19:53:19+00:00 https://ascopost.com/news/november-2022/focal-adhesion-kinase-inhibitor-in-patients-with-meningioma-and-somatic-nf2-mutations/ 2022-11-02T16:51:58+00:00 https://ascopost.com/news/november-2022/managing-primary-prophylactic-colony-stimulating-factor-use-in-patients-receiving-regimens-associated-with-intermediate-risk-for-febrile-neutropenia/ 2022-11-02T17:33:46+00:00 https://ascopost.com/news/november-2022/biomarker-assessment-for-benefit-of-lupsma-vs-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer/ 2022-11-04T14:31:38+00:00 https://ascopost.com/news/november-2022/telisotuzumab-vedotin-plus-erlotinib-in-c-met-protein-expressing-nsclc/ 2022-11-17T22:55:02+00:00 https://ascopost.com/news/november-2022/keynote-716-distant-metastasis-free-survival-with-adjuvant-pembrolizumab-in-resected-stage-iib-or-iic-melanoma/ 2022-11-04T15:49:57+00:00 https://ascopost.com/news/november-2022/researchers-identify-specific-mutations-in-the-braf-gene-that-may-affect-response-to-treatment-and-survival-in-adult-brain-cancers/ 2022-11-07T17:19:57+00:00 https://ascopost.com/news/november-2022/sequential-dosing-of-olaparib-and-adavosertib-in-patients-with-advanced-tumors/ 2022-11-07T17:33:46+00:00 https://ascopost.com/news/november-2022/cell-free-dna-profiling-in-patients-with-advanced-cancers-may-lead-to-early-detection-of-myeloid-malignancies/ 2022-11-07T17:51:43+00:00 https://ascopost.com/news/november-2022/concurrent-olaparib-and-radiotherapy-for-triple-negative-breast-cancer/ 2022-11-07T17:29:26+00:00 https://ascopost.com/news/november-2022/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/ 2022-11-07T17:42:30+00:00 https://ascopost.com/news/november-2022/mosaic-chromosomal-alterations-and-risk-of-lung-cancer/ 2022-11-07T17:46:57+00:00 https://ascopost.com/news/november-2022/small-study-of-experimental-drug-to-treat-liver-cancer-shows-evidence-of-activity-with-manageable-side-effects/ 2022-11-07T19:19:43+00:00 https://ascopost.com/news/november-2022/preliminary-results-from-arros-1-phase-i-clinical-trial-suggest-that-nvl-520-may-be-well-tolerated-and-active-in-nsclc/ 2022-11-07T19:59:34+00:00 https://ascopost.com/news/november-2022/repotrectinib-for-ros1-positive-nsclc-examined-in-phase-i-and-ii-trident-1-trial/ 2022-11-07T20:05:52+00:00 https://ascopost.com/news/november-2022/avoidance-of-surgery-in-patients-with-invasive-breast-cancer-and-exceptional-response-to-neoadjuvant-systemic-therapy/ 2022-12-05T18:46:08+00:00 https://ascopost.com/news/november-2022/pet-adapted-therapy-for-bulky-stage-iii-classical-hodgkin-lymphoma/ 2022-11-08T16:53:27+00:00 https://ascopost.com/news/november-2022/sequencing-of-short-duration-adt-with-radiotherapy-in-nonmetastatic-prostate-cancer/ 2022-11-08T16:56:36+00:00 https://ascopost.com/news/november-2022/indian-trial-explores-addition-of-low-dose-nivolumab-to-chemotherapy-in-advanced-head-and-neck-cancer/ 2026-01-29T03:26:34+00:00 https://ascopost.com/news/november-2022/phase-i-trial-shows-experimental-mini-protein-may-be-able-to-inhibit-the-cancer-driving-myc-gene/ 2022-11-09T18:42:43+00:00 https://ascopost.com/news/november-2022/nci-match-trial-ipatasertib-shows-signs-of-effectiveness-in-patients-with-akt1-e17k-mutant-solid-tumors/ 2022-11-08T21:33:28+00:00 https://ascopost.com/news/november-2022/effect-of-smartphone-psychotherapy-apps-on-fear-of-recurrence-among-young-breast-cancer-survivors/ 2022-11-09T15:07:57+00:00 https://ascopost.com/news/november-2022/association-of-flt3-itd-mrd-with-outcomes-in-newly-diagnosed-acute-myeloid-leukemia/ 2022-11-14T18:03:15+00:00 https://ascopost.com/news/november-2022/addition-of-brentuximab-vedotin-to-chemotherapy-in-pediatric-high-risk-hodgkin-lymphoma/ 2022-11-09T15:52:19+00:00 https://ascopost.com/news/november-2022/some-head-and-neck-cancer-survivors-may-be-at-greater-risk-for-long-term-gastrostomy-tube-use/ 2026-01-29T03:23:45+00:00 https://ascopost.com/news/november-2022/shorter-course-of-hypofractionated-radiation-therapy-yields-comparable-results-to-conventional-radiotherapy-for-patients-with-nonmetastatic-soft-tissue-sarcoma/ 2022-11-09T20:00:16+00:00 https://ascopost.com/news/november-2022/fda-approves-brentuximab-vedotin-in-combination-with-chemotherapy-for-pediatric-patients-with-classical-hodgkin-lymphoma/ 2022-11-11T19:04:38+00:00 https://ascopost.com/news/november-2022/fda-approves-tremelimumab-in-combination-with-durvalumab-and-platinum-based-chemotherapy-for-metastatic-nsclc/ 2022-11-17T22:20:59+00:00 https://ascopost.com/news/november-2022/comparison-of-two-chemotherapy-regimens-for-newly-diagnosed-ewing-sarcoma/ 2022-11-11T17:35:46+00:00 https://ascopost.com/news/november-2022/cns-directed-therapy-and-neurocognitive-outcomes-in-survivors-of-childhood-all-receiving-no-cranial-irradiation/ 2022-11-14T18:07:02+00:00 https://ascopost.com/news/november-2022/hormone-therapy-may-lower-risk-of-immune-checkpoint-inhibitor-associated-myocarditis-in-female-patients/ 2023-08-29T19:39:53+00:00 https://ascopost.com/news/november-2022/potential-treatment-options-for-patients-with-relapsed-multiple-myeloma-following-car-t-cell-therapy/ 2022-11-11T18:37:03+00:00 https://ascopost.com/news/november-2022/immune-checkpoint-inhibitors-for-patients-living-with-hiv-safe-and-effective-in-metastatic-nsclc/ 2022-12-22T19:52:36+00:00 https://ascopost.com/news/november-2022/first-line-pembrolizumab-vs-chemotherapy-in-advanced-pd-l1-positive-nsclc-without-egfralk-alterations/ 2022-12-22T19:53:45+00:00 https://ascopost.com/news/november-2022/rare-germline-atm-variants-in-chronic-lymphocytic-leukemia/ 2022-11-14T15:47:46+00:00 https://ascopost.com/news/november-2022/prevalence-of-mismatch-repair-deficiency-in-rectal-adenocarcinoma-in-a-prospective-screening-program/ 2022-11-14T17:27:28+00:00 https://ascopost.com/news/november-2022/management-of-severe-immune-related-adverse-events-with-ipilimumabnivolumab-and-survival-in-advanced-melanoma/ 2022-11-14T17:35:45+00:00 https://ascopost.com/news/november-2022/cost-effectiveness-of-cog-breast-cancer-screening-guidelines-for-hodgkin-lymphoma-survivors-who-received-chest-irradiation/ 2022-11-14T18:33:02+00:00 https://ascopost.com/news/november-2022/new-phase-iii-data-on-the-cd40-antibody-sotigalimab-in-combination-with-pembrolizumab-in-patients-with-metastatic-melanoma/ 2022-11-14T17:52:38+00:00 https://ascopost.com/news/november-2022/early-discontinuation-of-full-treatment-regimen-or-oxaliplatin-alone-in-patients-receiving-adjuvant-oxaliplatinfluoropyrimidine-therapy-for-stage-iii-colon-cancer/ 2022-11-15T16:40:40+00:00 https://ascopost.com/news/november-2022/cancer-clinical-trial-participation-among-medicare-fee-for-service-beneficiaries-with-cancer/ 2022-11-15T16:58:36+00:00 https://ascopost.com/news/november-2022/researchers-identify-subset-of-patients-with-stage-i-melanoma-who-have-low-risk-of-melanoma-mortality/ 2022-11-15T20:39:56+00:00 https://ascopost.com/news/november-2022/nationwide-study-finds-higher-rates-of-cancer-mortality-increasing-cases-of-early-onset-colorectal-cancer-among-american-indian-and-alaska-native-individuals/ 2022-11-15T18:43:34+00:00 https://ascopost.com/news/november-2022/new-research-highlights-disparities-in-receipt-of-guideline-concordant-treatment-among-patients-with-ovarian-cancer/ 2022-11-15T20:03:58+00:00 https://ascopost.com/news/november-2022/proposed-threshold-for-circulating-tumor-plasma-cells-to-define-plasma-cell-leukemia-like-multiple-myeloma/ 2022-11-16T17:03:59+00:00 https://ascopost.com/news/november-2022/fracture-risk-among-older-cancer-survivors/ 2022-11-16T17:20:22+00:00 https://ascopost.com/news/november-2022/addition-of-fluorouracil-to-adjuvant-chemotherapy-and-comparison-of-standard-vs-dose-dense-treatment-in-node-positive-early-breast-cancer/ 2022-11-16T17:50:08+00:00 https://ascopost.com/news/november-2022/prevalence-of-tumor-thrombus-at-rcc-diagnosis-and-risk-of-venous-thromboembolism/ 2022-11-16T17:43:58+00:00 https://ascopost.com/news/november-2022/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer/ 2022-11-16T19:40:25+00:00 https://ascopost.com/news/november-2022/used-as-a-biomarker-microrna-may-help-predict-which-patients-with-breast-cancer-are-more-likely-to-have-cancer-recurrence/ 2022-11-16T20:35:36+00:00 https://ascopost.com/news/november-2022/2022-state-of-lung-cancer-report-critically-low-lung-cancer-screening-rates-reveal-opportunity-to-save-more-lives/ 2022-11-16T20:57:57+00:00 https://ascopost.com/news/november-2022/selpercatinib-approved-for-advanced-ret-fusion-positive-solid-tumors-and-advanced-ret-fusion-positive-nsclc/ 2022-11-16T20:42:21+00:00 https://ascopost.com/news/november-2022/sodium-thiosulfate-to-reduce-the-risk-of-cisplatin-related-ototoxicity-in-pediatric-patients-with-localized-solid-tumors/ 2022-11-16T21:16:15+00:00 https://ascopost.com/news/november-2022/futibatinib-for-cholangiocarcinoma-with-fgfr2-gene-fusion-or-other-rearrangements/ 2022-11-16T22:06:03+00:00 https://ascopost.com/news/november-2022/prophylactic-bilateral-mastectomy-among-women-with-breast-cancer-and-pathogenic-variants-in-high-penetrance-and-moderate-penetrance-genes/ 2022-11-17T16:04:25+00:00 https://ascopost.com/news/november-2022/study-shows-that-immune-cells-may-help-identify-patients-with-high-risk-smoldering-myeloma-most-likely-to-benefit-from-treatment/ 2022-11-21T18:52:40+00:00 https://ascopost.com/news/november-2022/moderate-exercise-may-help-reduce-inflammation-increase-survival-in-patients-with-colorectal-cancer-by-improving-gut-microbiota/ 2022-11-17T19:27:57+00:00 https://ascopost.com/news/november-2022/teclistamab-cqyv-in-the-treatment-of-relapsed-or-refractory-multiple-myeloma/ 2022-11-17T16:52:34+00:00 https://ascopost.com/news/november-2022/cemiplimab-rwlc-in-combination-with-platinum-based-chemotherapy-in-advanced-nsclc-with-no-egfr-alk-or-ros1-aberrations/ 2022-11-17T17:00:07+00:00 https://ascopost.com/news/november-2022/margetuximab-cmkb-vs-trastuzumab-with-chemotherapy-in-previously-treated-advanced-her2-positive-breast-cancer/ 2022-11-17T18:54:37+00:00 https://ascopost.com/news/november-2022/dabrafenib-in-combination-with-trametinib-for-unresectable-or-metastatic-solid-tumors-with-braf-v600e-mutation/ 2022-11-17T17:26:13+00:00 https://ascopost.com/news/november-2022/poseidon-trial-first-line-durvalumab-with-or-without-tremelimumab-plus-chemotherapy-in-metastatic-nsclc/ 2022-11-17T18:56:59+00:00 https://ascopost.com/news/november-2022/evaluation-of-plasmid-dna-vaccine-encoding-her2-intracellular-domain-in-patients-with-advanced-her2-positive-breast-cancer/ 2022-11-18T16:02:04+00:00 https://ascopost.com/news/november-2022/presence-of-small-subclonal-populations-of-high-risk-genetic-events-at-diagnosis-in-multiple-myeloma/ 2022-11-18T16:10:02+00:00 https://ascopost.com/news/november-2022/car-t-cell-therapy-outcomes-similar-across-different-socioeconomic-levels-among-patients-with-pediatric-all/ 2022-11-18T17:48:37+00:00 https://ascopost.com/news/november-2022/study-examines-potential-factors-leading-to-recurrence-of-cancers-caused-by-brca-mutations/ 2022-11-18T16:32:49+00:00 https://ascopost.com/news/november-2022/comparison-of-bevacizumab-durations-in-front-line-therapy-for-advanced-ovarian-cancer/ 2022-11-18T16:36:17+00:00 https://ascopost.com/news/november-2022/coadministration-of-cd19-cd22-directed-car-t-cell-therapy-in-pediatric-b-cell-all/ 2022-11-18T16:46:05+00:00 https://ascopost.com/news/november-2022/fda-approves-new-dosing-regimen-for-asparaginase-erwinia-chrysanthemi-recombinant-rywn/ 2022-11-21T15:44:05+00:00 https://ascopost.com/news/november-2022/cost-effectiveness-of-polatuzumab-vedotin-piiq-plus-r-chp-and-car-t-cell-therapy-vs-standard-of-care-in-dlbcl/ 2022-12-21T20:46:07+00:00 https://ascopost.com/news/november-2022/effect-of-baseline-immunosuppression-on-covid-19-severity-and-risk-of-cytokine-storm-in-patients-receiving-immunotherapy-for-cancer/ 2022-11-21T17:02:51+00:00 https://ascopost.com/news/november-2022/intraindividual-comparison-of-f-18-naf-pet-ct-vs-tc-99m-mdp-spect-in-detecting-bone-metastasis-in-high-risk-prostate-and-breast-cancers/ 2022-11-21T17:33:10+00:00 https://ascopost.com/news/november-2022/gradual-increase-in-daily-activity-with-psychological-therapies-may-improve-mental-and-physical-health-for-patients-and-survivors-of-breast-cancer/ 2022-11-21T19:41:51+00:00 https://ascopost.com/news/november-2022/researchers-find-changes-in-blood-proteins-up-to-2-years-before-breast-cancer-diagnosis/ 2022-11-21T20:35:36+00:00 https://ascopost.com/news/november-2022/long-term-quality-of-life-and-cognition-outcomes-in-patients-receiving-srs-vs-wbrt-for-resected-brain-metastasis/ 2022-11-22T20:21:43+00:00 https://ascopost.com/news/november-2022/addition-of-enzalutamide-to-salvage-radiotherapy-in-patients-with-biochemically-recurrent-prostate-cancer-after-radical-prostatectomy/ 2022-11-22T17:40:54+00:00 https://ascopost.com/news/november-2022/trametinib-with-or-without-dabrafenib-in-pediatric-braf-v600-mutant-low-grade-glioma/ 2022-11-22T18:03:35+00:00 https://ascopost.com/news/november-2022/uicc-outlines-antimicrobial-resistance-in-cancer-treatment/ 2022-11-22T20:25:53+00:00 https://ascopost.com/news/november-2022/personalized-breast-cancer-screening-model-may-improve-outcomes-and-reduce-overdiagnosis/ 2022-11-22T20:22:49+00:00 https://ascopost.com/news/november-2022/more-cancers-are-diagnosed-at-an-advanced-stage-if-patients-already-have-type-2-diabetes/ 2022-11-22T20:03:04+00:00 https://ascopost.com/news/november-2022/alnd-vs-axillary-radiotherapy-in-sentinel-node-positive-breast-cancer/ 2022-11-28T16:17:29+00:00 https://ascopost.com/news/november-2022/5-year-survival-and-cure-fraction-estimates-for-childhood-cancer-in-europe-from-2000-to-2014-eurocare-6/ 2022-11-28T17:57:23+00:00 https://ascopost.com/news/november-2022/5-year-outcomes-with-stereotactic-ablative-body-radiotherapy-for-primary-renal-cell-carcinoma/ 2022-11-28T18:10:10+00:00 https://ascopost.com/news/november-2022/effect-of-geriatric-assessment-intervention-on-patient-reported-symptomatic-toxicity-in-patients-aged-70-and-older-receiving-treatment-for-advanced-cancer/ 2022-11-29T14:54:56+00:00 https://ascopost.com/news/november-2022/intraoperative-ultrasound-vs-wire-localization-in-surgery-for-ductal-carcinoma-in-situ/ 2022-11-28T20:51:03+00:00 https://ascopost.com/news/november-2022/presence-of-tumor-infiltrating-lymphocytes-following-neoadjuvant-treatment-may-contribute-to-worse-survival-in-patients-with-her2-positive-breast-cancer/ 2022-11-28T20:56:50+00:00 https://ascopost.com/news/november-2022/patients-who-are-hiv-positive-and-have-cancer-may-have-accelerated-epigenetic-aging/ 2022-11-29T19:29:20+00:00 https://ascopost.com/news/november-2022/high-sugar-consumption-may-be-linked-to-increased-risk-of-premature-aging-in-pediatric-cancer-survivors/ 2022-11-29T19:53:03+00:00 https://ascopost.com/news/november-2022/study-examines-coping-strategies-used-by-caregivers-of-patients-undergoing-stem-cell-transplants/ 2022-11-29T21:32:38+00:00 https://ascopost.com/news/november-2022/zanubrutinib-vs-ibrutinib-in-relapsed-or-refractory-cll/ 2022-11-29T20:32:48+00:00 https://ascopost.com/news/november-2022/avelumab-plus-talazoparib-in-patients-with-brca12-or-atm-altered-advanced-solid-tumors/ 2022-11-29T20:38:38+00:00 https://ascopost.com/news/november-2022/t-dxd-in-pretreated-patients-with-her2-low-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2022-11-29T20:58:05+00:00 https://ascopost.com/news/november-2022/potential-factors-in-oxaliplatin-induced-peripheral-neuropathy-in-patients-with-stage-iii-colon-cancer/ 2022-12-07T19:55:05+00:00 https://ascopost.com/news/november-2022/novel-bispecific-antibody-zanidatamab-in-advanced-her2-expressing-or-her2-amplified-cancers/ 2022-11-30T16:17:02+00:00 https://ascopost.com/news/november-2022/medicare-advantage-vs-traditional-medicare-for-elective-inpatient-cancer-surgery-access-postoperative-outcomes-and-estimated-cost/ 2022-11-30T16:22:46+00:00 https://ascopost.com/news/november-2022/ethnic-diversity-and-disparities-in-access-to-genetic-testing-may-impact-prostate-cancer-development-and-treatment-research-shows/ 2022-11-30T21:16:55+00:00 https://ascopost.com/news/november-2022/novel-research-suggests-new-way-to-target-mantle-cell-lymphoma-using-foxo1-inhibitors/ 2022-11-30T21:18:55+00:00 https://ascopost.com/news/november-2022/novel-delfi-ai-blood-test-may-aid-in-detecting-hepatocellular-carcinoma/ 2022-11-30T19:58:38+00:00 https://ascopost.com/news/december-2022/ 2022-12-01T15:03:07+00:00 https://ascopost.com/news/december-2022/incidence-of-cervical-cancer-in-women-in-the-united-states-2001-to-2019/ 2022-12-01T16:54:14+00:00 https://ascopost.com/news/december-2022/autologous-tumor-lysate-loaded-dendritic-cell-vaccine-for-glioblastoma/ 2022-12-01T16:28:06+00:00 https://ascopost.com/news/december-2022/does-cbd-oil-improve-symptom-distress-in-patients-with-advanced-cancer-receiving-palliative-care/ 2022-12-01T17:06:47+00:00 https://ascopost.com/news/december-2022/study-finds-americans-have-a-low-awareness-of-the-link-between-alcohol-use-and-increased-cancer-risk/ 2022-12-01T18:05:02+00:00 https://ascopost.com/news/december-2022/high-deductibles-may-discourage-patients-from-receiving-additional-testing-after-an-abnormal-mammogram/ 2022-12-01T20:33:50+00:00 https://ascopost.com/news/december-2022/lung-cancer-screening-may-increase-long-term-survival-rate/ 2022-12-01T20:38:34+00:00 https://ascopost.com/news/december-2022/are-patients-older-than-65-years-being-overscreened-for-cervical-cancer/ 2022-12-02T17:32:13+00:00 https://ascopost.com/news/december-2022/risk-of-cancer-may-double-for-patients-with-skewed-blood-cells/ 2022-12-02T17:49:00+00:00 https://ascopost.com/news/december-2022/fda-approves-olutasidenib-for-relapsed-or-refractory-aml-with-a-susceptible-idh1-mutation/ 2023-01-09T18:29:34+00:00 https://ascopost.com/news/december-2022/breast-cervical-and-colorectal-cancer-screening-rates-before-vs-after-the-covid-19-pandemic/ 2022-12-02T18:22:15+00:00 https://ascopost.com/news/december-2022/residential-racial-and-economic-segregation-and-cancer-mortality-in-the-united-states/ 2022-12-02T18:52:38+00:00 https://ascopost.com/news/december-2022/physical-activity-and-all-cause-mortality-among-postmenopausal-breast-cancer-survivors/ 2022-12-05T16:27:37+00:00 https://ascopost.com/news/december-2022/eliana-trial-3-year-update-tisagenlecleucel-in-pediatric-and-young-adult-patients-with-relapsed-or-refractory-b-cell-all/ 2022-12-05T16:38:15+00:00 https://ascopost.com/news/december-2022/dna-repair-protein-mre11-expression-and-disease-specific-mortality-among-patients-with-muscle-invasive-bladder-cancer-receiving-trimodality-therapy/ 2022-12-05T16:49:33+00:00 https://ascopost.com/news/december-2022/avelumab-plus-talazoparib-in-patients-with-advanced-solid-tumors/ 2022-12-05T17:38:39+00:00 https://ascopost.com/news/december-2022/lu-177-vipivotide-tetraxetan-shows-benefit-in-patients-with-psma-positive-metastatic-castration-resistant-prostate-cancer/ 2022-12-05T19:27:25+00:00 https://ascopost.com/news/december-2022/adjuvant-pembrolizumab-may-improve-quality-of-life-in-patients-with-high-risk-resected-melanoma/ 2022-12-05T18:31:42+00:00 https://ascopost.com/news/december-2022/black-patients-with-breast-cancer-may-have-worse-outcomes-than-other-patients-despite-similar-genetic-recurrence-scores/ 2022-12-07T20:01:39+00:00 https://ascopost.com/news/december-2022/genomic-assay-may-predict-long-term-prognosis-in-premenopausal-patients-with-hormone-receptor-positive-early-stage-breast-cancer/ 2022-12-07T20:02:50+00:00 https://ascopost.com/news/december-2022/study-finds-racial-disparity-in-prometastatic-tumor-microenvironment-among-patients-with-residual-breast-cancer-after-neoadjuvant-chemotherapy/ 2022-12-06T22:03:31+00:00 https://ascopost.com/news/december-2022/machine-learning-based-scoring-of-tils-and-outcomes-with-immunotherapy-in-patients-with-nsclc/ 2022-12-22T19:59:13+00:00 https://ascopost.com/news/december-2022/breast-implants-after-mastectomy-associated-with-very-low-risk-of-alcl/ 2022-12-06T20:40:32+00:00 https://ascopost.com/news/december-2022/first-line-ribociclib-plus-endocrine-therapy-may-be-more-effective-than-combination-chemotherapy-in-patients-with-aggressive-breast-cancer/ 2022-12-06T22:24:00+00:00 https://ascopost.com/news/december-2022/neoadjuvant-t-dxd-shows-clinical-activity-in-patients-with-her2-low-breast-cancer/ 2022-12-07T23:56:14+00:00 https://ascopost.com/news/december-2022/t-dxd-yields-longer-overall-survival-than-t-dm1-as-second-line-treatment-in-patients-with-her2-positive-metastatic-breast-cancer/ 2022-12-07T23:50:23+00:00 https://ascopost.com/news/december-2022/astro-issues-updated-guideline-on-radiation-therapy-for-patients-with-endometrial-cancer/ 2022-12-07T18:41:44+00:00 https://ascopost.com/news/december-2022/t-dxd-yields-superior-outcomes-over-chemotherapy-based-regimens-in-patients-previously-treated-with-t-dm1-destiny-breast02/ 2023-01-05T19:55:42+00:00 https://ascopost.com/news/december-2022/addition-of-daratumumab-to-bortezomib-plus-dexamethasone-in-relapsed-or-refractory-multiple-myeloma-castor-trial-final-overall-survival-analysis/ 2022-12-07T20:23:25+00:00 https://ascopost.com/news/december-2022/addition-of-first-line-atezolizumab-to-vemurafenibcobimetinib-in-braf-v600-mutant-advanced-melanoma/ 2022-12-07T19:06:24+00:00 https://ascopost.com/news/december-2022/adding-capivasertib-to-fulvestrant-may-improve-progression-free-survival-in-patients-with-advanced-hr-positive-breast-cancer/ 2022-12-08T17:29:31+00:00 https://ascopost.com/news/december-2022/patients-with-breast-cancer-who-interrupted-endocrine-therapy-to-pursue-pregnancy-did-not-experience-worse-short-term-recurrence-rates/ 2022-12-10T22:15:30+00:00 https://ascopost.com/news/december-2022/camizestrant-may-be-superior-to-fulvestrant-in-patients-with-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-12-10T22:06:23+00:00 https://ascopost.com/news/december-2022/circulating-tumor-cell-count-driven-treatment-decisions-may-improve-long-term-outcomes-for-patients-with-metastatic-breast-cancer/ 2022-12-08T20:05:08+00:00 https://ascopost.com/news/december-2022/trends-in-squamous-cell-carcinoma-of-the-anus-incidence-and-mortality-in-the-united-states/ 2022-12-08T19:09:03+00:00 https://ascopost.com/news/december-2022/potential-impact-of-the-covid-19-pandemic-on-place-of-death-among-medicaid-insured-and-commercially-insured-patients-with-cancer-in-washington-state/ 2022-12-08T20:09:15+00:00 https://ascopost.com/news/december-2022/fda-grants-approval-to-atezolizumab-in-treatment-of-alveolar-soft-part-sarcoma/ 2022-12-10T14:24:15+00:00 https://ascopost.com/news/december-2022/breast-conserving-therapy-may-be-a-treatment-option-for-some-patients-with-multiple-ipsilateral-breast-lesions/ 2022-12-10T19:59:28+00:00 https://ascopost.com/news/december-2022/genetic-profiling-may-identify-patients-with-breast-cancer-who-can-safely-omit-radiation-therapy-after-breast-conserving-surgery/ 2022-12-10T20:07:13+00:00 https://ascopost.com/news/december-2022/impact-on-cognitive-function-of-adding-chemotherapy-to-endocrine-therapy-for-breast-cancer/ 2022-12-10T16:16:55+00:00 https://ascopost.com/news/december-2022/will-ibrutinib-replace-stem-cell-transplantation-as-first-line-treatment-for-mantle-cell-lymphoma/ 2022-12-21T20:41:05+00:00 https://ascopost.com/news/december-2022/study-explores-when-to-proceed-to-stem-cell-transplantation-for-patients-with-resistant-aml/ 2022-12-15T18:42:41+00:00 https://ascopost.com/news/december-2022/elacestrant-vs-endocrine-monotherapy-in-advanced-breast-cancer-phase-iii-emerald-trial/ 2022-12-10T19:48:41+00:00 https://ascopost.com/news/december-2022/talquetamab-generates-high-response-rate-in-relapsed-or-refractory-multiple-myeloma/ 2022-12-19T17:57:45+00:00 https://ascopost.com/news/december-2022/high-dose-methotrexate-may-make-posttreatment-steroids-unnecessary-for-some-pediatric-patients-with-all-or-lbl/ 2022-12-15T17:54:55+00:00 https://ascopost.com/news/december-2022/commonly-prescribed-restrictive-diet-may-be-unnecessary-before-autologous-stem-cell-transplantation/ 2022-12-15T18:49:48+00:00 https://ascopost.com/news/december-2022/survey-finds-sexuality-and-fertility-discussions-remain-sidelined-among-young-patients-diagnosed-with-breast-cancer/ 2022-12-11T12:32:38+00:00 https://ascopost.com/news/december-2022/monarche-update-benefit-of-abemaciclib-increases-over-time/ 2022-12-11T15:43:45+00:00 https://ascopost.com/news/december-2022/efficacy-of-sacituzumab-govitecan-in-tropics-02-trial-not-dependent-on-trop-2-expression/ 2022-12-11T16:24:24+00:00 https://ascopost.com/news/december-2022/targeting-menin-may-induce-responses-in-patients-with-acute-leukemias-and-kmt2a-rearrangements-or-npm1-mutations/ 2022-12-12T17:48:35+00:00 https://ascopost.com/news/december-2022/report-outlines-advance-in-retreatment-with-car-t-cell-therapy-in-patients-with-relapsed-or-refractory-non-hodgkin-lymphoma-or-cll/ 2023-01-18T18:54:07+00:00 https://ascopost.com/news/december-2022/clinical-trial-lab-based-eligibility-criteria-disproportionately-excluded-non-white-patients-with-dlbcl-from-study-participation/ 2022-12-15T17:48:30+00:00 https://ascopost.com/news/december-2022/study-finds-adult-survivors-of-pediatric-hodgkin-lymphoma-experience-significant-epigenetic-age-acceleration-associated-with-neurocognitive-deficits/ 2022-12-12T20:07:19+00:00 https://ascopost.com/news/december-2022/identifying-which-patients-receive-the-most-specialized-types-of-stem-cell-transplant-requiring-the-highest-level-of-care/ 2022-12-12T20:13:06+00:00 https://ascopost.com/news/december-2022/global-study-uncovers-regional-differences-in-the-use-of-curative-transplants-for-patients-with-acute-myeloid-leukemia/ 2023-01-18T18:51:23+00:00 https://ascopost.com/news/december-2022/fda-grants-accelerated-approval-to-adagrasib-for-kras-g12c-mutated-nsclc/ 2022-12-22T19:57:07+00:00 https://ascopost.com/news/december-2022/tailorx-update-12-year-recurrence-and-survival-outcomes-for-patients-with-early-stage-breast-cancer/ 2023-05-31T18:13:09+00:00 https://ascopost.com/news/december-2022/three-drug-combination-therapy-may-be-effective-in-patients-with-high-risk-cll/ 2022-12-16T20:52:40+00:00 https://ascopost.com/news/december-2022/new-clinical-tool-for-clonal-hematopoiesis-may-identify-patients-at-high-risk-for-hematologic-cancer/ 2022-12-13T17:23:12+00:00 https://ascopost.com/news/december-2022/pilot-study-investigates-axicabtagene-ciloleucel-in-primary-and-secondary-cns-lymphoma/ 2022-12-13T16:54:06+00:00 https://ascopost.com/news/december-2022/simplified-treatment-regimen-reduces-early-deaths-in-patients-with-apl/ 2022-12-16T20:41:44+00:00 https://ascopost.com/news/december-2022/blinatumomab-further-improves-survival-among-patients-with-b-lineage-all-and-a-good-prognosis/ 2022-12-15T18:39:52+00:00 https://ascopost.com/news/december-2022/older-or-high-risk-patients-with-newly-diagnosed-acute-myeloid-leukemia-may-respond-to-triplet-therapy/ 2022-12-16T20:47:03+00:00 https://ascopost.com/news/december-2022/chemotherapy-free-regimen-of-ponatinib-and-blinatumomab-may-be-effective-for-patients-with-newly-diagnosed-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia/ 2022-12-14T19:53:38+00:00 https://ascopost.com/news/december-2022/venetoclax-with-intensive-chemotherapy-regimen-may-be-effective-in-younger-patients-with-newly-diagnosed-acute-myeloid-leukemia-high-risk-myelodysplastic-syndrome/ 2022-12-16T20:44:29+00:00 https://ascopost.com/news/december-2022/zanubrutinib-found-superior-to-ibrutinib-for-cll-and-sll/ 2022-12-14T16:22:04+00:00 https://ascopost.com/news/december-2022/scientists-map-genetic-evolution-of-cll-to-richter-syndrome/ 2023-01-18T18:08:39+00:00 https://ascopost.com/news/december-2022/nci-director-monica-bertagnolli-announces-breast-cancer-diagnosis/ 2022-12-14T18:32:44+00:00 https://ascopost.com/news/december-2022/genome-sequencing-of-circulating-tumor-cells-in-detection-of-myeloma-and-precursor-conditions/ 2022-12-15T18:04:04+00:00 https://ascopost.com/news/december-2022/modakafusp-alfa-may-be-effective-at-treating-patients-with-multiple-myeloma/ 2022-12-19T20:17:40+00:00 https://ascopost.com/news/december-2022/new-study-shows-travel-time-for-breast-cancer-screening-may-remain-long-for-many-patients/ 2022-12-15T15:39:49+00:00 https://ascopost.com/news/december-2022/bipartisan-comprehensive-cancer-survivorship-act-introduced/ 2022-12-15T16:07:18+00:00 https://ascopost.com/news/december-2022/updated-subgroup-analyses-from-the-her2climb-trial-in-previously-treated-patients-with-her2-positive-breast-cancer/ 2022-12-15T16:40:24+00:00 https://ascopost.com/news/december-2022/impact-of-adjuvant-therapy-on-outcomes-in-patients-with-node-negative-disease-after-neoadjuvant-therapy-and-resection-of-pancreatic-carcinoma/ 2022-12-15T16:52:20+00:00 https://ascopost.com/news/december-2022/fda-approves-updated-drug-labeling-for-capecitabine-tablets-under-project-renewal/ 2022-12-15T17:15:54+00:00 https://ascopost.com/news/december-2022/study-finds-that-patients-with-neuroendocrine-cancer-and-doctors-may-agree-on-treatment-goals-only-half-of-the-time/ 2022-12-16T15:56:24+00:00 https://ascopost.com/news/december-2022/impact-of-geriatric-assessment-and-management-on-quality-of-life-and-other-outcomes-in-older-patients-with-cancer/ 2022-12-16T16:15:55+00:00 https://ascopost.com/news/december-2022/brain-cancer-after-ct-scans-in-children-and-young-adults/ 2022-12-16T17:38:19+00:00 https://ascopost.com/news/december-2022/til-therapy-vs-ipilimumab-in-advanced-melanoma/ 2022-12-16T18:06:05+00:00 https://ascopost.com/news/december-2022/adavosertib-in-refractory-solid-tumors-with-ccne1-amplification/ 2022-12-16T18:14:50+00:00 https://ascopost.com/news/december-2022/study-reports-activity-with-oncolytic-vaccine-plus-pembrolizumab-in-bcg-unresponsive-bladder-cancer/ 2023-01-13T17:56:39+00:00 https://ascopost.com/news/december-2022/fda-approves-first-gene-therapy-for-the-treatment-of-high-risk-non-muscle-invasive-bladder-cancer/ 2022-12-19T20:16:47+00:00 https://ascopost.com/news/december-2022/first-line-nivolumabipilimumab-vs-extreme-regimen-in-recurrent-or-metastatic-head-and-neck-cancer/ 2026-01-29T03:11:16+00:00 https://ascopost.com/news/december-2022/prostate-cancer-screening-with-mri-targeted-vs-mri-targeted-and-systemic-biopsy/ 2022-12-19T20:32:58+00:00 https://ascopost.com/news/december-2022/financial-burden-for-blood-or-marrow-transplantation-survivors-during-the-covid-19-pandemic/ 2022-12-19T20:30:49+00:00 https://ascopost.com/news/december-2022/chemotherapy-dose-intensity-and-survival-in-older-women-with-early-stage-breast-cancer/ 2023-05-31T18:19:31+00:00 https://ascopost.com/news/december-2022/risk-of-adverse-side-effects-from-cancer-immunotherapy-may-be-higher-in-patients-with-certain-inherited-genetic-variations/ 2022-12-19T19:24:25+00:00 https://ascopost.com/news/december-2022/robin-zon-md-facp-fasco-elected-asco-president-for-2024-2025-term/ 2022-12-19T20:08:13+00:00 https://ascopost.com/news/december-2022/fda-approves-pafolacianine-to-aid-lung-cancer-surgery/ 2022-12-22T20:02:16+00:00 https://ascopost.com/news/december-2022/risk-model-for-predicting-the-development-of-prostate-cancer/ 2022-12-20T19:30:30+00:00 https://ascopost.com/news/december-2022/interim-analysis-of-overall-survival-in-the-monarche-trial/ 2022-12-20T20:31:25+00:00 https://ascopost.com/news/december-2022/long-term-follow-up-of-high-dose-cytarabine-and-autologous-stem-cell-transplantation-in-mantle-cell-lymphoma/ 2023-01-09T19:16:09+00:00 https://ascopost.com/news/december-2022/cervical-cancer-incidence-and-survival-by-histologic-subtype-among-racialethnic-groups/ 2022-12-20T21:00:59+00:00 https://ascopost.com/news/december-2022/phase-iii-nora-study-niraparib-maintenance-shows-favorable-overall-survival-trend-in-platinum-sensitive-recurrent-ovarian-cancer/ 2022-12-20T21:08:06+00:00 https://ascopost.com/news/december-2022/fda-approves-foundationone-liquid-cdx-as-a-companion-diagnostic-for-a-certain-group-of-tyrosine-kinase-inhibitors/ 2022-12-22T19:58:29+00:00 https://ascopost.com/news/december-2022/nivolumab-plus-cabozantinib-with-or-without-ipilimumab-in-advanced-hepatocellular-carcinoma/ 2022-12-21T18:09:12+00:00 https://ascopost.com/news/december-2022/cardiovascular-events-before-and-after-initiation-of-immune-checkpoint-inhibitor-therapy-for-cancer-agreement-between-icd-coded-and-adjudicated-events/ 2022-12-21T18:21:13+00:00 https://ascopost.com/news/december-2022/quantifying-the-population-clinical-and-scientific-impact-of-nctn-research/ 2022-12-21T20:39:12+00:00 https://ascopost.com/news/december-2022/study-finds-medicaid-expansion-may-improve-survival-outcomes-for-young-adult-patients-with-cancer/ 2022-12-21T18:39:21+00:00 https://ascopost.com/news/december-2022/in-stage-iv-nsclc-anti-tigit-antibody-boosts-immunotherapy-benefit/ 2022-12-22T19:56:37+00:00 https://ascopost.com/news/december-2022/concomitant-and-sequential-nivolumab-doxorubicin-vinblastine-and-dacarbazine-in-early-stage-unfavorable-hodgkin-lymphoma/ 2022-12-22T19:42:01+00:00 https://ascopost.com/news/december-2022/associations-between-cdh1-germline-variants-and-hereditary-diffuse-gastric-cancer-syndrome-cancer-phenotypes/ 2022-12-22T20:18:13+00:00 https://ascopost.com/news/december-2022/preexisting-autoimmune-disease-and-risk-for-cardiovascular-events-in-patients-receiving-immune-checkpoint-inhibitor-therapy-for-cancer/ 2022-12-22T20:23:30+00:00 https://ascopost.com/news/december-2022/study-examines-genitourinary-cancer-trends-disparities-in-the-united-states/ 2022-12-22T21:09:22+00:00 https://ascopost.com/news/december-2022/sotorasib-shows-clinically-meaningful-activity-among-patients-with-kras-g12c-mutated-advanced-pancreatic-cancer/ 2022-12-22T20:37:04+00:00 https://ascopost.com/news/december-2022/forte-trial-of-carfilzomib-containing-induction-consolidation-and-maintenance-in-newly-diagnosed-multiple-myeloma-subgroup-analysis-by-cytogenetic-risk/ 2022-12-22T21:21:49+00:00 https://ascopost.com/news/december-2022/fda-approves-mosunetuzumab-axgb-a-first-in-class-bispecific-antibody-in-relapsed-or-refractory-follicular-lymphoma/ 2023-01-31T19:34:57+00:00 https://ascopost.com/news/january-2023/ 2023-01-03T15:00:12+00:00 https://ascopost.com/news/january-2023/silicone-film-to-prevent-acute-radiation-dermatitis-in-patients-with-breast-cancer/ 2023-01-03T16:46:37+00:00 https://ascopost.com/news/january-2023/racial-ethnic-disparities-in-recommendations-for-surgical-resection-of-newly-diagnosed-brain-tumors/ 2023-01-03T16:51:30+00:00 https://ascopost.com/news/january-2023/hypofractionated-3-week-course-of-preoperative-radiotherapy-for-soft-tissue-sarcomas/ 2023-01-03T18:37:12+00:00 https://ascopost.com/news/january-2023/risk-of-incident-lung-cancer-in-individuals-with-clonal-hematopoiesis/ 2023-01-03T16:42:27+00:00 https://ascopost.com/news/january-2023/study-examines-reconstructive-burnout-phenomenon-patients-who-start-breast-reconstruction-after-mastectomy-but-dont-complete-it/ 2023-01-03T20:40:51+00:00 https://ascopost.com/news/january-2023/one-in-seven-diagnosed-cancers-is-found-by-recommended-screening-tests/ 2023-01-03T20:43:28+00:00 https://ascopost.com/news/january-2023/risk-prediction-model-for-contralateral-breast-cancer-in-brca-carriers-with-breast-cancer/ 2023-01-04T15:55:59+00:00 https://ascopost.com/news/january-2023/adjuvant-endocrine-therapy-and-ovarian-suppression-for-premenopausal-patients-with-hr-positive-breast-cancer/ 2023-01-04T16:02:01+00:00 https://ascopost.com/news/january-2023/study-compares-the-cost-and-efficacy-of-anticoagulant-therapies/ 2023-01-04T16:05:30+00:00 https://ascopost.com/news/january-2023/triple-immunotherapy-combination-studied-preclinically-for-pancreatic-cancer/ 2023-01-04T17:13:32+00:00 https://ascopost.com/news/january-2023/updated-data-from-a-phase-ii-trial-of-triplet-therapy-in-hpv-positive-cancers/ 2023-01-04T20:14:57+00:00 https://ascopost.com/news/january-2023/world-cancer-day-2023-february-4/ 2023-01-04T20:16:07+00:00 https://ascopost.com/news/january-2023/late-mortality-subsequent-malignant-neoplasms-and-chronic-health-conditions-among-survivors-of-neuroblastoma-diagnosed-during-infancy/ 2023-01-05T15:28:30+00:00 https://ascopost.com/news/january-2023/endoscopic-surveillance-with-systematic-random-biopsy-vs-targeted-biopsy-for-early-diagnosis-of-hereditary-diffuse-gastric-cancer/ 2023-01-05T15:59:40+00:00 https://ascopost.com/news/january-2023/crizotinib-combined-with-chemotherapy-in-pediatric-alk-positive-anaplastic-large-cell-lymphoma/ 2023-01-05T19:53:45+00:00 https://ascopost.com/news/january-2023/phase-iii-imerge-trial-of-imetelstat-in-lower-risk-mds/ 2023-01-05T21:12:06+00:00 https://ascopost.com/news/january-2023/mitomycin-gel-for-upper-tract-urothelial-cancers-postmarket-analysis/ 2023-01-05T21:16:03+00:00 https://ascopost.com/news/january-2023/addition-of-adjuvant-nab-paclitaxel-to-gemcitabine-in-pancreatic-ductal-adenocarcinoma/ 2023-01-06T16:37:14+00:00 https://ascopost.com/news/january-2023/pembrolizumab-as-second-line-therapy-in-asian-patients-with-advanced-hcc/ 2023-01-06T17:31:39+00:00 https://ascopost.com/news/january-2023/risk-reducing-medication-in-patients-with-high-risk-er-positive-breast-cancer-benefits-and-harms/ 2023-01-06T17:39:00+00:00 https://ascopost.com/news/january-2023/foundationone-liquid-cdx-receives-fda-approval-as-a-companion-diagnostic-for-entrectinib/ 2023-01-11T20:49:50+00:00 https://ascopost.com/news/january-2023/prostate-cancer-screening-among-primary-care-providers/ 2023-01-06T19:14:31+00:00 https://ascopost.com/news/january-2023/new-ai-based-biomarker-may-help-predict-immunotherapy-response-for-patients-with-nsclc/ 2023-01-11T20:52:14+00:00 https://ascopost.com/news/january-2023/first-line-atezolizumab-plus-bevacizumab-in-metastatic-nonsquamous-nsclc-with-high-tumor-mutation-burden/ 2023-01-09T16:16:43+00:00 https://ascopost.com/news/january-2023/immune-system-b-cells-may-help-to-predict-treatment-response-among-patients-with-her2-positive-breast-cancer/ 2023-01-09T16:47:26+00:00 https://ascopost.com/news/january-2023/adagrasib-with-or-without-cetuximab-in-previously-treated-patients-with-metastatic-colorectal-cancer-and-a-kras-g12c-mutation/ 2023-01-09T17:23:58+00:00 https://ascopost.com/news/january-2023/effect-of-adjuvant-chemotherapy-on-survival-in-patients-with-resected-pancreatic-adenocarcinoma-after-multiagent-neoadjuvant-chemotherapy/ 2023-01-09T17:42:06+00:00 https://ascopost.com/news/january-2023/genomic-profile-to-identify-candidates-for-omission-of-local-adjuvant-radiation-among-patients-with-breast-cancer/ 2023-01-09T17:55:32+00:00 https://ascopost.com/news/january-2023/delaying-antibiotics-may-not-affect-overall-survival-among-inpatients-with-cancer-who-have-neutropenic-fever/ 2023-01-09T18:25:23+00:00 https://ascopost.com/news/january-2023/addition-of-apalutamide-may-slow-progression-of-early-stage-prostate-cancer-during-active-surveillance/ 2023-01-10T18:19:07+00:00 https://ascopost.com/news/january-2023/novel-therapy-afamitresgene-autoleucel-shows-early-potential-for-antitumor-activity/ 2023-01-10T18:46:58+00:00 https://ascopost.com/news/january-2023/study-investigates-burden-of-cervical-cancer-among-patients-aged-65-and-older/ 2023-01-10T18:43:44+00:00 https://ascopost.com/news/january-2023/study-identifies-potential-molecular-differences-between-primary-breast-cancer-and-its-metastases/ 2023-01-11T18:19:39+00:00 https://ascopost.com/news/january-2023/fewer-cases-of-melanoma-found-among-individuals-taking-vitamin-d-supplements/ 2023-01-11T18:32:38+00:00 https://ascopost.com/news/january-2023/cancer-survival-in-africa-central-and-south-america-and-asia-survcan-3-study/ 2023-01-11T18:45:10+00:00 https://ascopost.com/news/january-2023/study-finds-posoleucel-demonstrated-antiviral-efficacy-and-safety-against-viral-infections-following-allogeneic-stem-cell-transplantation/ 2023-01-11T19:39:18+00:00 https://ascopost.com/news/january-2023/older-minority-patients-with-cancer-face-inequities-in-opioid-access-near-the-end-of-life/ 2023-01-11T19:56:42+00:00 https://ascopost.com/news/january-2023/new-scoring-system-measures-inflammation-levels-may-improve-risk-stratification-in-aml/ 2023-01-12T18:39:58+00:00 https://ascopost.com/news/january-2023/neoadjuvant-immunotherapy-in-patients-with-localized-dmmr-colorectal-cancer/ 2023-01-12T20:25:33+00:00 https://ascopost.com/news/january-2023/experts-publish-consensus-statement-on-classification-system-for-pathology-and-diagnosis-of-melanocytic-lesions/ 2023-01-12T20:52:23+00:00 https://ascopost.com/news/january-2023/trends-in-us-e-cigarette-sales-price-and-nicotine-strength/ 2023-01-12T18:57:10+00:00 https://ascopost.com/news/january-2023/subcutaneous-epcoritamab-for-relapsed-or-refractory-large-b-cell-lymphoma/ 2023-01-31T19:37:16+00:00 https://ascopost.com/news/january-2023/effect-of-medicaid-expansion-on-survival-for-young-adults-with-cancer/ 2023-01-13T16:26:40+00:00 https://ascopost.com/news/january-2023/circulating-tumor-dna-profiling-and-outcomes-in-cns-lymphoma/ 2023-01-13T16:33:57+00:00 https://ascopost.com/news/january-2023/nonablative-fractional-laser-therapy-may-help-prevent-nonmelanoma-skin-cancers/ 2023-01-13T16:49:52+00:00 https://ascopost.com/news/january-2023/novel-artificial-intelligence-tool-may-predict-risk-of-lung-cancer-using-low-dose-ct-scan-data/ 2023-02-08T16:51:32+00:00 https://ascopost.com/news/january-2023/american-cancer-society-cancer-statistics-2023-report-released/ 2023-01-13T17:56:24+00:00 https://ascopost.com/news/january-2023/neoadjuvant-pembrolizumab-in-localized-msi-hdmmr-solid-tumors/ 2023-01-17T17:14:50+00:00 https://ascopost.com/news/january-2023/long-term-follow-up-of-combined-text-and-soft-trials/ 2023-01-17T17:28:31+00:00 https://ascopost.com/news/january-2023/robo2-as-a-novel-susceptibility-gene-for-risk-of-anthracycline-related-cardiomyopathy-in-childhood-cancer-survivors/ 2023-01-17T17:41:53+00:00 https://ascopost.com/news/january-2023/molecular-tumor-board-offers-assistance-that-may-boost-effectiveness-of-precision-oncology/ 2023-01-17T20:16:12+00:00 https://ascopost.com/news/january-2023/reminders-based-on-machine-learning-algorithms-may-improve-end-of-life-care-for-patients-with-cancer/ 2023-01-17T20:30:22+00:00 https://ascopost.com/news/january-2023/frequency-and-dosage-of-radiotherapy-in-chemoradiotherapy-for-limited-stage-sclc/ 2023-01-18T16:50:11+00:00 https://ascopost.com/news/january-2023/carfilzomib-lenalidomide-and-dexamethasone-vs-lenalidomide-in-maintenance-therapy-after-asct-in-newly-diagnosed-multiple-myeloma/ 2023-03-23T17:37:20+00:00 https://ascopost.com/news/january-2023/mri-guided-vs-ct-guided-sbrt-for-localized-prostate-cancer/ 2023-01-18T17:46:20+00:00 https://ascopost.com/news/january-2023/study-suggests-ibrutinib-may-obviate-need-for-asct-in-some-younger-patients-with-mantle-cell-lymphoma/ 2023-01-18T19:28:38+00:00 https://ascopost.com/news/january-2023/epov-jeremy-abramson/ 2023-01-18T17:25:29+00:00 https://ascopost.com/news/january-2023/acupuncture-and-acupressure-may-help-alleviate-pain-and-anxiety-for-patients-undergoing-surgery-for-gynecologic-cancer/ 2023-01-18T17:56:48+00:00 https://ascopost.com/news/january-2023/ovarian-cancer-may-be-linked-to-pathogenic-microbe-colonization-in-reproductive-tract/ 2023-01-18T18:06:31+00:00 https://ascopost.com/news/january-2023/neoadjuvant-gemcitabinecisplatin-in-high-risk-upper-tract-urothelial-carcinoma/ 2023-01-19T16:23:26+00:00 https://ascopost.com/news/january-2023/new-study-shows-impact-of-low-adherence-to-guideline-based-imaging-before-radiotherapy-on-outcomes-in-medicare-patients-with-nsclc/ 2023-02-08T16:45:03+00:00 https://ascopost.com/news/january-2023/uterine-cancer-now-covered-by-wtc-health-program/ 2023-01-19T16:43:13+00:00 https://ascopost.com/news/january-2023/appendectomy-with-or-without-hemicolectomy-for-1-to-2-cm-appendiceal-neuroendocrine-tumors/ 2023-01-19T16:54:45+00:00 https://ascopost.com/news/january-2023/risk-of-contralateral-breast-cancer-among-patients-with-invasive-breast-cancer-and-various-germline-pathogenic-variants/ 2023-01-19T17:29:44+00:00 https://ascopost.com/news/january-2023/fda-grants-accelerated-approval-to-tucatinib-plus-trastuzumab-for-advanced-her2-positive-colorectal-cancer/ 2023-01-20T17:10:32+00:00 https://ascopost.com/news/january-2023/fda-approves-zanubrutinib-for-cll-or-sll/ 2023-02-15T18:21:52+00:00 https://ascopost.com/news/january-2023/futibatinib-in-previously-treated-patients-with-advanced-fgfr2-rearranged-intrahepatic-cholangiocarcinoma/ 2023-01-20T17:47:33+00:00 https://ascopost.com/news/january-2023/first-line-zanidatamab-plus-chemotherapy-for-her2-expressing-metastatic-gastroesophageal-adenocarcinoma/ 2023-01-20T18:03:46+00:00 https://ascopost.com/news/january-2023/is-the-risk-of-suicide-higher-among-individuals-with-cancer/ 2023-01-20T18:01:36+00:00 https://ascopost.com/news/january-2023/subset-of-patients-with-advanced-gastricgej-cancer-may-benefit-from-cldn182-targeted-drug-zolbetuximab/ 2023-01-31T21:56:56+00:00 https://ascopost.com/news/january-2023/accelerated-partial-breast-irradiation-vs-whole-breast-irradiation-long-term-cosmetic-results-and-toxicity/ 2023-01-23T16:35:54+00:00 https://ascopost.com/news/january-2023/addition-of-veliparib-to-cisplatin-in-advanced-triple-negative-breast-cancer-with-brca-like-and-non-brca-like-phenotype/ 2023-01-23T18:19:24+00:00 https://ascopost.com/news/january-2023/combination-of-botensilimab-and-balstilimab-shows-activity-in-patients-with-metastatic-mss-colorectal-cancer/ 2023-01-23T20:43:13+00:00 https://ascopost.com/news/january-2023/first-line-nalirifox-regimen-improves-overall-survival-in-metastatic-pancreatic-cancer/ 2023-01-31T21:59:06+00:00 https://ascopost.com/news/january-2023/addition-of-ultrasound-to-dbt-for-breast-cancer-screening-in-patients-with-dense-breasts/ 2023-01-24T17:08:37+00:00 https://ascopost.com/news/january-2023/trends-in-stage-treatment-and-outcomes-in-rectal-adenocarcinoma-in-the-united-states-2004-to-2019/ 2023-01-24T17:21:18+00:00 https://ascopost.com/news/january-2023/interventions-to-improve-skin-cancer-surveillance-in-childhood-cancer-survivors-who-received-radiotherapy/ 2023-01-24T17:32:30+00:00 https://ascopost.com/news/january-2023/real-world-use-of-idecabtagene-vicleucel-for-patients-with-relapsed-or-refractory-multiple-myeloma/ 2023-01-24T17:57:07+00:00 https://ascopost.com/news/january-2023/new-study-evaluates-online-colorectal-cancer-risk-calculators/ 2023-02-09T21:53:20+00:00 https://ascopost.com/news/january-2023/receiving-chemotherapy-in-the-afternoon-may-improve-treatment-outcomes-in-some-patients-with-dlbcl/ 2023-01-26T16:35:43+00:00 https://ascopost.com/news/january-2023/risk-of-major-psychiatric-disorders-among-survivors-of-childhood-and-adolescent-cancers/ 2023-01-26T16:35:52+00:00 https://ascopost.com/news/january-2023/updated-results-of-destiny-breast03-t-dxd-vs-t-dm1-for-previously-treated-patients-with-her2-positive-metastatic-breast-cancer/ 2023-01-26T16:58:20+00:00 https://ascopost.com/news/january-2023/analysis-of-mutations-associated-with-high-tumor-mutation-burden-in-microsatellite-stable-gastrointestinal-cancers/ 2023-01-26T18:53:05+00:00 https://ascopost.com/news/january-2023/ctdna-analysis-may-predict-optimal-treatment-for-patients-with-gist/ 2023-01-26T18:50:55+00:00 https://ascopost.com/news/january-2023/fda-approves-pembrolizumab-as-adjuvant-treatment-for-nsclc/ 2023-12-27T17:10:03+00:00 https://ascopost.com/news/january-2023/trends-in-use-of-next-generation-sequencing-in-us-patients-according-to-genetic-ancestry/ 2023-01-27T18:34:46+00:00 https://ascopost.com/news/january-2023/new-study-shows-increased-cancer-mortality-among-patients-with-type-2-diabetes-in-england/ 2023-01-27T18:50:29+00:00 https://ascopost.com/news/january-2023/new-analysis-sheds-light-on-potential-link-between-ovulation-and-ovarian-cancer/ 2023-01-27T17:51:01+00:00 https://ascopost.com/news/january-2023/risk-of-subsequent-gastrointestinal-tract-malignancies-after-blood-or-marrow-transplantation/ 2023-01-27T18:17:53+00:00 https://ascopost.com/news/january-2023/adjuvant-folfox-hepatic-arterial-infusion-in-hepatocellular-carcinoma-with-microvascular-invasion/ 2023-01-30T16:24:54+00:00 https://ascopost.com/news/january-2023/adjuvant-s-1-vs-observation-for-resected-biliary-tract-cancer/ 2023-01-30T17:31:59+00:00 https://ascopost.com/news/january-2023/two-methods-studied-in-defining-prognosis-for-patients-with-er-positive-node-positive-breast-cancer/ 2023-03-02T19:36:27+00:00 https://ascopost.com/news/january-2023/immunotherapy-combined-with-targeted-therapy-in-patients-with-braf-v600e-mutated-colorectal-cancer/ 2023-01-30T19:30:19+00:00 https://ascopost.com/news/january-2023/association-of-immune-related-gene-expression-signatures-and-tils-with-outcomes-in-early-stage-her2-positive-breast-cancer/ 2023-03-02T19:22:41+00:00 https://ascopost.com/news/january-2023/momelotinib-may-effectively-reduce-anemia-and-other-symptoms-for-patients-with-myelofibrosis/ 2023-02-02T19:43:15+00:00 https://ascopost.com/news/january-2023/sex-disparities-in-childhood-cancer-diagnoses-in-india/ 2023-01-31T17:24:18+00:00 https://ascopost.com/news/january-2023/uptake-of-immune-checkpoint-inhibitors-and-survival-among-younger-and-older-patients-with-advanced-nsclc/ 2023-02-08T16:32:09+00:00 https://ascopost.com/news/january-2023/association-of-prs313-polygenic-risk-score-with-tumor-characteristics-and-survival-in-patients-with-invasive-breast-cancer/ 2023-03-02T19:25:26+00:00 https://ascopost.com/news/february-2023/ 2023-02-01T15:23:25+00:00 https://ascopost.com/news/february-2023/mdm2-inhibitor-milademetan-in-advanced-liposarcoma-solid-tumors-or-lymphomas/ 2023-02-01T15:49:56+00:00 https://ascopost.com/news/february-2023/gap-discovered-in-breast-cancer-radiotherapy-recommendations-for-patients-aged-70-vs-69-years/ 2023-03-02T19:33:09+00:00 https://ascopost.com/news/february-2023/study-finds-breast-mri-superior-vs-other-supplementary-screening-tests-for-detecting-breast-cancer-in-patients-with-dense-breasts/ 2023-02-01T16:15:45+00:00 https://ascopost.com/news/february-2023/levels-of-inflammatory-biomarkers-and-survival-in-patients-receiving-adjuvant-therapy-for-stage-iii-colon-cancer/ 2023-02-01T16:24:44+00:00 https://ascopost.com/news/february-2023/canadian-trial-highlights-adverse-outcomes-in-survivors-of-childhood-medulloblastoma/ 2023-02-01T16:28:53+00:00 https://ascopost.com/news/february-2023/dexrazoxane-and-long-term-heart-function-in-survivors-of-childhood-cancer-treated-with-doxorubicin/ 2023-02-01T16:55:19+00:00 https://ascopost.com/news/february-2023/addition-of-anti-igf-1r-antibody-ganitumab-to-interval-compressed-chemotherapy-in-newly-diagnosed-patients-with-metastatic-ewing-sarcoma/ 2023-02-02T15:59:11+00:00 https://ascopost.com/news/february-2023/adjuvant-osimertinib-significantly-improves-disease-free-survival-for-patients-with-resected-egfr-mutant-nsclc/ 2023-02-09T18:19:35+00:00 https://ascopost.com/news/february-2023/consuming-ultraprocessed-foods-may-be-linked-to-increased-cancer-risk-and-mortality/ 2023-02-02T17:17:48+00:00 https://ascopost.com/news/february-2023/surgical-quality-metric-scoring-and-survival-among-us-veterans-with-early-stage-nsclc/ 2023-02-08T16:39:43+00:00 https://ascopost.com/news/february-2023/neoadjuvant-plus-adjuvant-chemotherapy-vs-adjuvant-chemotherapy-alone-for-locally-advanced-colon-cancer/ 2023-02-02T19:10:03+00:00 https://ascopost.com/news/february-2023/review-provides-recommendations-on-cancer-treatment-in-the-context-of-preexisting-dementia/ 2023-02-02T19:30:30+00:00 https://ascopost.com/news/february-2023/ocra-issues-consensus-statement-calling-for-consideration-of-fallopian-tube-removal-to-prevent-ovarian-cancer/ 2023-02-03T16:25:55+00:00 https://ascopost.com/news/february-2023/researchers-develop-ai-algorithm-to-gain-new-insights-into-glioblastoma/ 2023-02-03T16:32:26+00:00 https://ascopost.com/news/february-2023/world-cancer-day-commercial-interests-may-drive-millions-of-avoidable-cancer-deaths/ 2023-02-03T16:50:15+00:00 https://ascopost.com/news/february-2023/massage-therapy-may-improve-symptom-burden-for-pediatric-patients-with-hematologic-andor-oncologic-conditions/ 2023-02-03T17:17:43+00:00 https://ascopost.com/news/february-2023/who-launches-new-roadmap-on-breast-cancer/ 2023-02-06T16:05:35+00:00 https://ascopost.com/news/february-2023/mirvetuximab-soravtansine-in-patients-with-platinum-resistant-ovarian-cancer-and-high-fra-expression/ 2023-02-06T17:36:41+00:00 https://ascopost.com/news/february-2023/association-of-radiation-and-procarbazine-dose-with-risk-of-colorectal-cancer-in-survivors-of-hodgkin-lymphoma/ 2023-02-06T16:26:35+00:00 https://ascopost.com/news/february-2023/ctdna-as-a-prognostic-marker-in-intermediate-risk-rhabdomyosarcoma/ 2023-02-06T17:26:15+00:00 https://ascopost.com/news/february-2023/preclinical-study-shows-losartan-may-prevent-immune-checkpoint-inhibitor-induced-cerebral-edema-in-glioblastoma/ 2023-02-06T18:27:36+00:00 https://ascopost.com/news/february-2023/researchers-uncover-racial-and-ethnic-disparities-in-widely-used-precision-oncology-data-registry/ 2023-02-06T17:57:48+00:00 https://ascopost.com/news/february-2023/defensive-beliefs-may-prevent-individuals-from-partaking-in-screening-for-colorectal-cancer/ 2023-02-07T20:02:39+00:00 https://ascopost.com/news/february-2023/sbrt-for-patients-with-primary-lung-neuroendocrine-tumors/ 2023-02-14T18:20:58+00:00 https://ascopost.com/news/february-2023/10-year-outcomes-with-adjuvant-apbi-using-multicatheter-brachytherapy-vs-wbi-after-breast-conserving-surgery-for-early-breast-cancer/ 2023-03-02T19:30:04+00:00 https://ascopost.com/news/february-2023/axatilimab-for-refractory-chronic-graft-vs-host-disease/ 2023-02-07T19:48:25+00:00 https://ascopost.com/news/february-2023/oncologists-look-for-strong-health-care-priorities-in-the-state-of-the-union-address/ 2023-02-07T19:55:53+00:00 https://ascopost.com/news/february-2023/covid-19-outcomes-across-pandemic-phases-in-european-patients-with-breast-cancer/ 2023-02-08T15:29:06+00:00 https://ascopost.com/news/february-2023/lung-cancer-screening-may-be-more-cost-effective-when-using-risk-model-based-strategies/ 2023-02-08T18:19:12+00:00 https://ascopost.com/news/february-2023/methotrexate-may-be-associated-with-an-increased-risk-for-some-skin-cancers/ 2024-01-04T18:59:24+00:00 https://ascopost.com/news/february-2023/carl-june-honored-with-2023-aacr-award-for-lifetime-achievement-in-cancer-research/ 2023-02-08T18:37:51+00:00 https://ascopost.com/news/february-2023/long-term-outcomes-among-survivors-of-wilms-tumor/ 2023-02-08T19:20:19+00:00 https://ascopost.com/news/february-2023/higher-rate-of-clonal-hematopoiesis-in-pediatric-cancer-survivors-may-be-linked-with-treatment-induced-stat3-gene-mutations-and-risk-of-adverse-long-term-outcomes/ 2023-02-08T19:44:12+00:00 https://ascopost.com/news/february-2023/half-of-patients-with-cancer-may-develop-long-covid-with-risk-higher-in-female-patients/ 2023-02-09T18:26:42+00:00 https://ascopost.com/news/february-2023/new-study-highlights-impact-of-covid-19-pandemic-on-cancer-screening-delays/ 2023-02-09T18:34:14+00:00 https://ascopost.com/news/february-2023/findings-on-cardiovascular-imaging-in-patients-receiving-ibrutinib-association-with-cardiotoxicity/ 2023-08-29T19:36:20+00:00 https://ascopost.com/news/february-2023/oncologists-applaud-state-of-the-union-s-focus-on-ending-cancer-as-we-know-it/ 2023-02-09T18:29:25+00:00 https://ascopost.com/news/february-2023/proton-therapy-reirradiation-in-recurrent-head-and-neck-squamous-cell-carcinoma/ 2026-01-29T03:05:58+00:00 https://ascopost.com/news/february-2023/docetaxel-as-a-radiosensitizer-in-cisplatin-ineligible-patients-with-locally-advanced-head-and-neck-cancer/ 2026-01-29T03:04:04+00:00 https://ascopost.com/news/february-2023/fda-grants-regular-approval-to-dostarlimab-gxly-for-dmmr-endometrial-cancer/ 2023-02-13T16:19:11+00:00 https://ascopost.com/news/february-2023/diagnosis-treatment-and-outcomes-of-breast-cancer-in-patients-from-sex-and-gender-minority-groups/ 2023-02-13T16:56:30+00:00 https://ascopost.com/news/february-2023/focal-vs-extended-irreversible-electroporation-in-ablation-of-localized-low-or-intermediate-risk-prostate-cancer/ 2023-02-13T17:39:03+00:00 https://ascopost.com/news/february-2023/addition-of-pembrolizumab-to-chemotherapy-in-first-line-treatment-of-metastatic-squamous-nsclc/ 2023-03-08T14:25:19+00:00 https://ascopost.com/news/february-2023/dietary-intervention-may-help-reduce-chronic-fatigue-improve-quality-of-life-for-cancer-survivors/ 2023-02-13T18:19:12+00:00 https://ascopost.com/news/february-2023/lack-of-resources-may-be-associated-with-increased-mortality-rates-among-pediatric-cancer-survivors/ 2023-02-13T18:24:45+00:00 https://ascopost.com/news/february-2023/sublobar-vs-lobar-resection-for-peripheral-stage-ia-nsclc/ 2023-03-08T14:23:09+00:00 https://ascopost.com/news/february-2023/darolutamide-maintenance-in-patients-with-metastatic-castration-resistant-prostate-cancer-without-disease-progression-on-taxane-treatment/ 2023-02-14T17:19:19+00:00 https://ascopost.com/news/february-2023/second-line-bevacizumab-plus-folfiri-for-advanced-gastroenteropancreatic-neuroendocrine-carcinoma/ 2023-02-14T19:58:53+00:00 https://ascopost.com/news/february-2023/pancreatic-cancer-rates-may-be-rising-faster-among-younger-women-patients-than-younger-men/ 2023-02-21T18:47:45+00:00 https://ascopost.com/news/february-2023/new-predictive-epidemiologic-model-may-identify-individuals-at-high-risk-for-endometrial-cancer/ 2023-02-14T18:54:31+00:00 https://ascopost.com/news/february-2023/decline-in-psa-level-after-treatment-with-enzalutamide-effect-on-metastasis-and-survival/ 2023-02-14T19:21:17+00:00 https://ascopost.com/news/february-2023/codebreak-200-trial-sotorasib-vs-docetaxel-in-previously-treated-patients-with-advanced-kras-g12c-mutated-nsclc/ 2023-03-08T14:26:21+00:00 https://ascopost.com/news/february-2023/new-study-calls-for-lgbtqia-community-inclusion-in-stem-cell-donor-recruitment/ 2023-02-16T14:57:02+00:00 https://ascopost.com/news/february-2023/hyaluronic-acid-rectal-spacer-in-hypofractionated-radiation-therapy-for-prostate-cancer/ 2023-02-15T18:03:58+00:00 https://ascopost.com/news/february-2023/is-a-diet-higher-in-plant-based-foods-associated-with-a-lower-risk-of-prostate-cancer-progression-and-recurrence/ 2023-02-17T19:26:53+00:00 https://ascopost.com/news/february-2023/outcomes-after-minimally-invasive-vs-open-surgery-for-pancreatic-adenocarcinoma/ 2023-02-15T18:12:46+00:00 https://ascopost.com/news/february-2023/ponatinib-may-be-more-effective-than-imatinib-for-newly-diagnosed-patients-with-ph-positive-all/ 2023-02-15T18:18:18+00:00 https://ascopost.com/news/february-2023/talapro-2-talazoparib-plus-enzalutamide-improves-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer/ 2023-02-17T19:25:11+00:00 https://ascopost.com/news/february-2023/association-of-anthracycline-use-with-risk-of-congestive-heart-failure-among-patients-treated-for-breast-cancer-or-lymphoma/ 2023-02-17T18:48:03+00:00 https://ascopost.com/news/february-2023/cancer-symptom-algorithm-may-aid-oncologists-in-predicting-which-patients-are-at-risk-for-unplanned-ed-visits/ 2023-02-17T19:30:35+00:00 https://ascopost.com/news/february-2023/study-finds-neoadjuvant-nivolumab-led-to-improved-5-year-survival-outcomes-in-patients-with-resectable-nsclc/ 2023-02-17T18:40:35+00:00 https://ascopost.com/news/february-2023/allogeneic-hct-vs-consolidation-chemotherapy-in-patients-aged-60-years-or-younger-with-intermediate-risk-aml/ 2023-02-20T16:37:47+00:00 https://ascopost.com/news/february-2023/intensified-drug-regimen-added-to-standard-of-care-improves-outcomes-in-subset-of-patients-with-high-risk-prostate-cancer/ 2023-02-21T18:38:39+00:00 https://ascopost.com/news/february-2023/single-arm-phase-ii-noninferiority-trial-evaluates-active-surveillance-vs-cystectomy-following-neoadjuvant-chemotherapy-for-muscle-invasive-urothelial-carcinoma/ 2023-02-20T19:14:02+00:00 https://ascopost.com/news/february-2023/nivolumab-after-surgical-resection-improves-disease-free-survival-in-patients-with-high-risk-muscle-invasive-urothelial-carcinoma/ 2023-02-20T18:23:45+00:00 https://ascopost.com/news/february-2023/adding-talazoparib-to-enzalutamide-extends-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer/ 2023-02-20T18:32:23+00:00 https://ascopost.com/news/february-2023/triton3-rucaparib-vs-physician-s-choice-of-single-agent-therapy-in-metastatic-castration-resistant-prostate-cancer-with-brca-or-atm-alterations/ 2023-02-21T18:49:47+00:00 https://ascopost.com/news/february-2023/nivolumab-and-relatlimab-in-patients-with-advanced-melanoma-progressing-on-anti-pd-1pd-l1-therapy/ 2023-02-21T17:31:55+00:00 https://ascopost.com/news/february-2023/keynote-859-interim-analysis-overall-survival-benefit-for-first-line-pembrolizumab-in-advanced-gastric-cancer/ 2023-02-24T15:41:07+00:00 https://ascopost.com/news/february-2023/pediatric-patients-with-all-living-along-the-texas-mexico-border-may-experience-lower-rates-of-survival/ 2023-02-21T18:53:03+00:00 https://ascopost.com/news/february-2023/first-line-tyrosine-kinase-inhibitor-therapy-for-advanced-clear-cell-renal-cell-carcinoma-temporary-treatment-cessation-vs-continuation/ 2023-02-22T16:55:58+00:00 https://ascopost.com/news/february-2023/low-income-linked-to-high-recurrence-risk-poorer-survival-in-patients-with-er-positive-breast-cancer/ 2023-02-22T17:02:01+00:00 https://ascopost.com/news/february-2023/study-examines-stress-and-social-support-for-lgbtqi-patients-with-cancer-and-their-caregivers/ 2023-02-22T17:22:16+00:00 https://ascopost.com/news/february-2023/prime-ii-trial-breast-conserving-surgery-with-or-without-radiotherapy-in-early-breast-cancer/ 2023-02-22T18:18:15+00:00 https://ascopost.com/news/february-2023/discordance-of-p16-and-hpv-dnarna-status-prognostic-implication-in-squamous-cell-oropharyngeal-carcinoma/ 2026-01-28T19:59:02+00:00 https://ascopost.com/news/february-2023/adjuvant-nivolumabipilimumab-vs-placebo-in-localized-renal-cell-carcinoma/ 2023-02-23T18:12:54+00:00 https://ascopost.com/news/february-2023/karmma-3-idecabtagene-vicleucel-vs-standard-regimens-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2023-02-23T18:23:21+00:00 https://ascopost.com/news/february-2023/whole-genome-sequencing-may-illuminate-the-genetic-evolution-of-classical-hodgkin-lymphoma/ 2023-02-23T18:33:13+00:00 https://ascopost.com/news/february-2023/estimating-the-environmental-impact-of-prostate-biopsies-and-mris-may-help-reduce-health-care-pollution/ 2023-02-23T19:17:57+00:00 https://ascopost.com/news/february-2023/residual-nonretroperitoneal-disease-after-chemotherapy-for-nonseminomatous-germ-cell-tumors/ 2023-02-27T16:25:18+00:00 https://ascopost.com/news/february-2023/new-study-demonstrates-inferior-vena-cava-filters-may-be-safe-and-effective-way-to-prevent-venous-thromboembolism/ 2023-02-27T16:33:02+00:00 https://ascopost.com/news/february-2023/millions-of-us-individuals-may-have-missed-cancer-screenings-during-second-year-of-covid-19-pandemic/ 2023-02-27T16:36:29+00:00 https://ascopost.com/news/february-2023/remote-interventions-to-improve-uptake-of-cancer-genetic-risk-assessment-in-patients-with-ovarian-cancer-or-high-risk-breast-cancer/ 2023-02-27T16:53:04+00:00 https://ascopost.com/news/february-2023/association-of-immune-related-adverse-events-with-overall-survival-in-patients-receiving-atezolizumab-containing-therapy-for-metastatic-nonsquamous-nsclc/ 2023-03-08T14:27:32+00:00 https://ascopost.com/news/february-2023/mediterranean-diet-and-immune-checkpoint-blockade-outcomes-in-advanced-melanoma/ 2023-02-27T17:51:35+00:00 https://ascopost.com/news/february-2023/darolutamide-plus-adt-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer-outcomes-by-disease-volume-and-risk-status-in-the-arasens-trial/ 2023-02-28T15:22:02+00:00 https://ascopost.com/news/february-2023/prevalence-of-high-grade-serous-carcinoma-at-risk-reducing-salpingo-oophorectomy-in-asymptomatic-patients-with-brca12-pathogenic-variants/ 2023-02-28T16:09:00+00:00 https://ascopost.com/news/february-2023/combination-abatacept-ruxolitinib-andor-mechanical-ventilation-may-decrease-mortality-in-patients-with-immune-checkpoint-inhibitor-associated-cardiotoxicity/ 2023-02-28T16:28:36+00:00 https://ascopost.com/news/february-2023/immunotherapy-costs-may-drive-increase-in-medicare-spending-for-outpatient-end-of-life-cancer-care/ 2023-02-28T17:20:15+00:00 https://ascopost.com/news/february-2023/de-escalated-neoadjuvant-t-dm1-with-or-without-et-vs-trastuzumab-with-et-in-hr-positiveher2-positive-early-breast-cancer/ 2023-02-28T17:04:52+00:00 https://ascopost.com/news/february-2023/hospital-surgical-volume-may-impact-survival-in-patients-with-pancreatic-cancer-whose-minimally-invasive-surgery-is-converted-to-an-open-procedure/ 2023-02-28T19:29:54+00:00 https://ascopost.com/news/march-2023/ 2023-03-01T15:10:14+00:00 https://ascopost.com/news/march-2023/survival-in-patients-with-brain-metastases-limited-or-stable-extracranial-disease/ 2023-03-01T15:22:16+00:00 https://ascopost.com/news/march-2023/prediction-models-for-kidney-failure-in-long-term-survivors-of-childhood-cancer/ 2023-03-01T15:39:10+00:00 https://ascopost.com/news/march-2023/combination-chemotherapy-may-be-safe-and-effective-alternative-for-the-treatment-of-patients-with-non-muscle-invasive-bladder-cancer-amid-bcg-shortage/ 2023-03-01T16:20:01+00:00 https://ascopost.com/news/march-2023/addition-of-pembrolizumab-to-pemetrexedplatinum-in-the-first-line-treatment-of-metastatic-nonsquamous-nsclc-5-year-outcomes-in-the-keynote-189-study/ 2023-04-12T18:45:52+00:00 https://ascopost.com/news/march-2023/association-of-baseline-and-subsequent-cardiovascular-health-metrics-with-risk-for-incident-cancers/ 2023-03-01T17:02:06+00:00 https://ascopost.com/news/march-2023/american-cancer-society-data-show-colorectal-cancer-rates-are-rising-in-younger-adults-and-shifting-to-more-advanced-disease-in-people-of-all-ages/ 2023-03-01T17:19:55+00:00 https://ascopost.com/news/march-2023/can-long-noncoding-rna-expression-help-predict-outcomes-in-pediatric-patients-with-aml/ 2023-03-14T22:39:03+00:00 https://ascopost.com/news/march-2023/prognosis-of-her2-low-vs-her2-negative-breast-cancer/ 2023-03-02T16:54:50+00:00 https://ascopost.com/news/march-2023/racialethnic-disparities-in-all-cause-and-cardiovascular-mortality-among-patients-with-cancer/ 2023-03-02T17:46:42+00:00 https://ascopost.com/news/march-2023/vitamin-b5-may-help-improve-red-blood-cell-production-in-patients-with-myelodysplastic-syndromes/ 2023-03-06T19:21:54+00:00 https://ascopost.com/news/march-2023/black-women-at-high-risk-of-breast-cancer-may-face-obstacles-in-receiving-preventive-care/ 2023-03-02T18:15:08+00:00 https://ascopost.com/news/march-2023/cancer-organizations-respond-to-turkey-and-syria-earthquakes/ 2023-03-03T16:09:36+00:00 https://ascopost.com/news/march-2023/surgeon-anesthesiologist-familiarity-and-short-term-outcomes-in-complex-gastrointestinal-cancer-surgery/ 2023-03-03T16:17:32+00:00 https://ascopost.com/news/march-2023/hormone-therapy-may-reduce-risk-of-lung-cancer-in-female-patients-despite-former-misperceptions/ 2023-03-03T16:38:00+00:00 https://ascopost.com/news/march-2023/access-to-paid-sick-leave-may-result-in-more-cancer-screenings/ 2023-03-03T16:48:25+00:00 https://ascopost.com/news/march-2023/fda-expands-early-breast-cancer-indication-for-abemaciclib-plus-endocrine-therapy/ 2023-03-06T19:49:19+00:00 https://ascopost.com/news/march-2023/researchers-find-new-genetic-risk-factors-in-large-study-of-prostate-cancer-in-black-patients/ 2023-03-06T19:54:38+00:00 https://ascopost.com/news/march-2023/regardless-of-income-american-indiannative-american-women-may-be-less-likely-to-undergo-mammography-than-white-women/ 2023-03-06T19:56:23+00:00 https://ascopost.com/news/march-2023/chemotherapy-may-alter-immune-cell-landscape-in-patients-with-pancreatic-cancer/ 2023-03-07T16:45:53+00:00 https://ascopost.com/news/march-2023/depression-may-be-linked-to-higher-levels-of-inflammation-poorer-outcomes-in-patients-with-lung-cancer/ 2023-03-07T16:53:37+00:00 https://ascopost.com/news/march-2023/first-line-lenvatinibpembrolizumab-vs-sunitinib-in-advanced-renal-cell-carcinoma-extended-follow-up-of-the-clear-trial/ 2023-03-07T17:31:52+00:00 https://ascopost.com/news/march-2023/psa-level-at-time-of-salvage-radiation-therapy-after-radical-prostatectomy-and-risk-of-all-cause-mortality/ 2023-03-07T17:50:51+00:00 https://ascopost.com/news/march-2023/adjuvant-paclitaxel-and-trastuzumab-in-node-negative-her2-positive-breast-cancer-long-term-follow-up/ 2023-03-07T18:01:28+00:00 https://ascopost.com/news/march-2023/fewer-cases-of-melanoma-and-extracutaneous-malignancies-detected-among-patients-with-atopic-diseases/ 2023-03-08T14:50:54+00:00 https://ascopost.com/news/march-2023/cancer-stage-and-receptor-status-may-indicate-risk-of-disease-recurrence-in-breast-cancer-survivors/ 2023-03-08T15:00:17+00:00 https://ascopost.com/news/march-2023/antibiotic-exposure-before-immune-checkpoint-inhibitor-treatment-and-overall-survival-in-older-patients-with-cancer/ 2023-03-08T15:12:15+00:00 https://ascopost.com/news/march-2023/nivolumab-followed-by-nivolumabipilimumab-boosting-in-nonresponders-among-previously-treated-patients-with-advanced-urothelial-carcinoma/ 2023-03-08T15:52:04+00:00 https://ascopost.com/news/march-2023/study-finds-cancer-screening-in-the-united-states-lagged-during-the-second-year-of-the-covid-19-pandemic/ 2023-03-08T15:55:25+00:00 https://ascopost.com/news/march-2023/blood-test-may-identify-patients-with-aml-at-greater-risk-of-relapse-after-bone-marrow-transplant/ 2023-03-14T22:39:33+00:00 https://ascopost.com/news/march-2023/radiation-oncology-workforce-expected-to-remain-stable-through-2030-according-to-astro-report/ 2023-03-09T16:30:47+00:00 https://ascopost.com/news/march-2023/nicotinamide-for-chemoprevention-of-skin-cancer-in-solid-organ-transplant-recipients/ 2023-03-09T19:07:35+00:00 https://ascopost.com/news/march-2023/long-term-results-of-european-pediatric-soft-tissue-sarcoma-study-in-nonmetastatic-rhabdomyosarcoma/ 2023-03-09T18:04:13+00:00 https://ascopost.com/news/march-2023/omission-of-radiotherapy-in-children-and-adolescents-with-early-stage-classical-hodgkin-lymphoma-with-adequate-response-to-oepa-chemotherapy/ 2023-03-13T16:23:24+00:00 https://ascopost.com/news/march-2023/fda-updates-mammography-regulations-to-require-reporting-of-breast-density-information-and-enhance-facility-oversight/ 2023-03-09T18:35:18+00:00 https://ascopost.com/news/march-2023/nirogacestat-may-benefit-patients-with-desmoid-tumors/ 2023-03-13T15:37:03+00:00 https://ascopost.com/news/march-2023/study-reveals-new-understanding-of-how-androgen-therapy-affects-breast-tissue/ 2023-03-13T16:12:35+00:00 https://ascopost.com/news/march-2023/trends-in-active-surveillance-for-management-of-low-risk-prostate-cancer-in-the-united-states/ 2023-03-13T16:29:33+00:00 https://ascopost.com/news/march-2023/impact-of-tai-ji-quan-or-strength-training-vs-stretching-in-preventing-falls-in-postmenopausal-women-who-received-chemotherapy-for-cancer/ 2023-03-13T16:37:43+00:00 https://ascopost.com/news/march-2023/psma-petct-may-help-improve-clinical-treatment-of-prostate-cancer/ 2023-03-13T19:36:56+00:00 https://ascopost.com/news/march-2023/digital-rectal-examination-fails-to-detect-early-prostate-cancer-study-shows/ 2023-03-13T19:37:23+00:00 https://ascopost.com/news/march-2023/european-oncovid-registry-analysis-of-covid-19-sequelae-during-omicron-phase-vs-earlier-phases-in-patients-with-cancer/ 2023-03-14T19:54:54+00:00 https://ascopost.com/news/march-2023/pelabresib-plus-ruxolitinib-in-patients-with-myelofibrosis-and-no-prior-jak-inhibitor-treatment/ 2023-03-15T17:36:46+00:00 https://ascopost.com/news/march-2023/fda-issues-safety-communication-on-reports-of-squamous-cell-carcinoma-in-the-capsule-around-breast-implants/ 2023-03-14T20:01:19+00:00 https://ascopost.com/news/march-2023/hyperfractionated-vs-standard-fractionation-imrt-in-locally-advanced-recurrent-nasopharyngeal-carcinoma/ 2026-01-28T19:56:34+00:00 https://ascopost.com/news/march-2023/new-technique-may-reduce-postoperative-complications-in-prostate-cancer-surgery/ 2023-03-14T19:55:37+00:00 https://ascopost.com/news/march-2023/novel-urine-test-may-play-a-role-in-bladder-cancer-prediction/ 2023-03-14T19:56:49+00:00 https://ascopost.com/news/march-2023/regorafenib-ipilimumab-and-nivolumab-in-microsatellite-stable-metastatic-colorectal-cancer/ 2023-03-15T13:47:20+00:00 https://ascopost.com/news/march-2023/health-related-quality-of-life-in-the-keynote-826-trial-in-patients-with-cervical-cancer/ 2023-03-15T13:52:59+00:00 https://ascopost.com/news/march-2023/large-study-finds-dbt-may-be-superior-to-digital-mammography-for-breast-cancer-detection/ 2023-03-15T14:35:30+00:00 https://ascopost.com/news/march-2023/delaying-treatment-for-patients-with-localized-prostate-cancer-may-not-increase-mortality-risk-protect-trial-shows/ 2023-03-15T14:51:45+00:00 https://ascopost.com/news/march-2023/involving-hospitalists-in-inpatient-cancer-care-may-reduce-patient-stays-oncologist-stress/ 2023-03-15T15:04:49+00:00 https://ascopost.com/news/march-2023/magrolimab-plus-azacitidine-in-higher-risk-myelodysplastic-syndromes/ 2023-03-16T15:36:37+00:00 https://ascopost.com/news/march-2023/costs-of-cancer-in-adolescents-and-young-adults-in-the-united-states/ 2023-03-16T15:55:55+00:00 https://ascopost.com/news/march-2023/ai-based-model-for-nodal-metastasis-detection-using-whole-slide-images-in-bladder-cancer/ 2023-03-16T16:36:06+00:00 https://ascopost.com/news/march-2023/new-research-highlights-the-negative-impact-of-continued-exclusion-of-patients-with-african-ancestry-from-research-on-cancer-genomics/ 2023-03-16T19:31:29+00:00 https://ascopost.com/news/march-2023/covid-19-vaccination-rates-may-be-lower-in-patients-with-cancer-who-have-comorbidities-certain-types-of-cancer-and-specific-sociodemographic-factors/ 2023-03-16T19:37:56+00:00 https://ascopost.com/news/march-2023/racial-inequalities-in-prostate-cancer-care-may-be-associated-with-facility-level-disparities/ 2023-03-17T16:13:40+00:00 https://ascopost.com/news/march-2023/gut-microbiome-may-influence-how-patients-with-non-hodgkin-lymphoma-respond-to-car-t-cell-therapy/ 2023-04-26T19:05:23+00:00 https://ascopost.com/news/march-2023/vitamin-a-and-risk-for-pancreatitis-during-chemotherapy-for-all/ 2023-04-19T20:56:18+00:00 https://ascopost.com/news/march-2023/addition-of-fulvestrant-to-alisertib-in-endocrine-resistant-metastatic-breast-cancer/ 2023-03-17T17:07:41+00:00 https://ascopost.com/news/march-2023/activity-of-novel-car-t-cells-in-relapsed-or-refractory-multiple-myeloma/ 2023-03-17T19:06:54+00:00 https://ascopost.com/news/march-2023/fda-approves-dabrafenibtrametinib-for-pediatric-patients-with-braf-v600e-mutated-low-grade-glioma/ 2023-12-27T17:15:06+00:00 https://ascopost.com/news/march-2023/detection-of-emphysema-during-lung-cancer-screening/ 2023-03-23T13:47:34+00:00 https://ascopost.com/news/march-2023/neoadjuvant-dual-immunotherapy-plus-chemotherapy-improves-patient-outcomes-in-operable-lung-cancer/ 2023-03-20T12:49:40+00:00 https://ascopost.com/news/march-2023/axitinib-and-avelumab-in-recurrentmetastatic-adenoid-cystic-carcinoma/ 2026-01-28T19:54:41+00:00 https://ascopost.com/news/march-2023/low-dose-tamoxifen-to-prevent-recurrence-in-patients-with-breast-noninvasive-neoplasia-10-year-follow-up-of-tam-01-trial/ 2023-03-20T13:04:21+00:00 https://ascopost.com/news/march-2023/study-reveals-potential-cause-of-resistance-to-revumenib-in-patients-with-acute-leukemia/ 2023-04-19T20:50:53+00:00 https://ascopost.com/news/march-2023/trust-in-cancer-information-may-have-declined-among-black-individuals-during-covid-19-pandemic/ 2023-03-20T17:43:16+00:00 https://ascopost.com/news/march-2023/does-discrimination-accelerate-aging-in-black-cancer-survivors/ 2023-03-21T17:19:43+00:00 https://ascopost.com/news/march-2023/pembrolizumab-plus-ifosfamide-carboplatin-and-etoposide-in-relapsed-or-refractory-classical-hodgkin-lymphoma/ 2023-03-28T17:41:31+00:00 https://ascopost.com/news/march-2023/laparoscopy-assisted-vs-open-distal-gastrectomy-for-locally-advanced-gastric-cancer-relapse-free-survival-at-5-years/ 2023-03-21T13:59:43+00:00 https://ascopost.com/news/march-2023/active-monitoring-surgery-or-radiotherapy-for-localized-prostate-cancer-15-year-outcomes-in-the-uk-protect-trial/ 2023-03-21T13:41:30+00:00 https://ascopost.com/news/march-2023/isolated-hepatic-perfusion-may-improve-response-and-survival-among-patients-with-metastatic-uveal-melanoma/ 2023-03-21T17:18:51+00:00 https://ascopost.com/news/march-2023/accc-releases-2022-impact-report/ 2023-03-22T13:51:08+00:00 https://ascopost.com/news/march-2023/cancer-diagnostic-services-offered-at-a-community-health-center-may-speed-diagnoses-for-underserved-patients/ 2023-03-22T16:00:23+00:00 https://ascopost.com/news/march-2023/retroperitoneal-lymph-node-dissection-for-early-metastatic-testicular-seminoma/ 2023-03-22T14:31:29+00:00 https://ascopost.com/news/march-2023/prevalence-of-hpv-dna-and-p16ink4a-positivity-in-vulvar-cancer-and-vulvar-intraepithelial-neoplasia/ 2023-03-22T14:41:18+00:00 https://ascopost.com/news/march-2023/report-examines-accuracy-of-chatgpt-in-providing-information-on-common-cancer-myths-and-misconceptions/ 2023-03-22T15:18:22+00:00 https://ascopost.com/news/march-2023/fda-grants-accelerated-approval-to-retifanlimab-dlwr-for-metastatic-or-recurrent-locally-advanced-merkel-cell-carcinoma/ 2023-03-23T15:37:20+00:00 https://ascopost.com/news/march-2023/patricia-m-lorusso-do-phd-hc-elected-2023-2024-aacr-president-elect/ 2023-03-23T16:28:52+00:00 https://ascopost.com/news/march-2023/study-examines-effect-of-physical-activity-on-recurrence-in-patients-previously-treated-for-colorectal-cancer/ 2023-03-23T16:55:35+00:00 https://ascopost.com/news/march-2023/addition-of-vistusertib-to-paclitaxel-in-platinum-resistant-ovarian-high-grade-serous-carcinoma/ 2023-03-23T15:45:07+00:00 https://ascopost.com/news/march-2023/glow-trial-zolbetuximab-plus-capox-extends-survival-in-gastric-cancer-subtype/ 2023-03-23T17:19:24+00:00 https://ascopost.com/news/march-2023/fda-issues-draft-guidance-aimed-at-improving-oncology-clinical-trials-for-accelerated-approval/ 2023-03-27T15:19:04+00:00 https://ascopost.com/news/march-2023/first-line-systemic-treatments-in-metastatic-castration-sensitive-prostate-cancer/ 2023-03-27T15:23:56+00:00 https://ascopost.com/news/march-2023/lower-income-patients-with-early-stage-esophageal-adenocarcinoma-may-face-disparities-in-cancer-care-and-higher-mortality-rates/ 2023-03-27T15:31:06+00:00 https://ascopost.com/news/march-2023/obesity-may-contribute-to-breast-cancer-risk-in-high-risk-patients-with-brca-mutations/ 2023-03-27T15:39:18+00:00 https://ascopost.com/news/march-2023/smoking-cessation-intervention-in-patients-with-a-history-of-cervical-intraepithelial-neoplasia-or-cervical-cancer/ 2023-03-27T15:47:28+00:00 https://ascopost.com/news/march-2023/significance-of-the-mgus-like-phenotype-in-patients-with-multiple-myeloma-and-light-chain-amyloidosis/ 2023-03-28T15:43:50+00:00 https://ascopost.com/news/march-2023/naporafenib-plus-trametinib-in-advanced-nras-mutant-melanoma/ 2023-03-28T14:44:54+00:00 https://ascopost.com/news/march-2023/change-in-frailty-status-among-older-patients-undergoing-locoregional-therapy-for-early-stage-breast-cancer/ 2023-03-28T18:01:01+00:00 https://ascopost.com/news/march-2023/new-prognostic-staging-system-for-de-novo-metastatic-breast-cancer/ 2023-03-28T16:51:27+00:00 https://ascopost.com/news/march-2023/risk-of-cervical-cancer-may-be-twice-as-high-in-patients-with-mental-illnesses/ 2023-03-28T18:14:27+00:00 https://ascopost.com/news/march-2023/brown-adipose-tissue-may-not-be-associated-with-cancer-cachexia-may-not-worsen-cancer-mortality/ 2023-03-28T17:55:17+00:00 https://ascopost.com/news/march-2023/lower-dose-regimens-of-exemestane-in-postmenopausal-patients-with-stage-0-to-ii-er-positive-breast-cancer/ 2023-03-29T12:46:50+00:00 https://ascopost.com/news/march-2023/antibiotic-use-and-survival-among-patients-with-metastatic-pancreatic-cancer-receiving-specific-chemotherapy-regimens/ 2023-03-29T13:01:54+00:00 https://ascopost.com/news/march-2023/ruby-trial-dostarlimab-plus-carboplatin-and-paclitaxel-in-advanced-endometrial-cancer/ 2023-03-29T17:23:43+00:00 https://ascopost.com/news/march-2023/atezolizumab-may-be-an-effective-primer-for-chemoradiation-in-patients-with-locally-advanced-cervical-cancer/ 2023-03-29T18:34:37+00:00 https://ascopost.com/news/march-2023/positive-outcomes-demonstrated-in-patients-with-ovarian-cancer-treated-with-olaparib-prior-to-surgical-intervention-and-subsequent-chemotherapy/ 2023-03-29T18:35:18+00:00 https://ascopost.com/news/march-2023/researchers-find-no-significant-differences-in-overall-survival-among-patients-with-platinum-sensitive-recurrent-ovarian-cancer-who-received-niraparib-maintenance-therapy-vs-placebo/ 2023-03-29T17:42:12+00:00 https://ascopost.com/news/march-2023/fda-grants-full-approval-to-pembrolizumab-for-certain-adult-and-pediatric-patients-with-advanced-msi-h-or-dmmr-solid-tumors/ 2023-03-30T19:22:14+00:00 https://ascopost.com/news/march-2023/subcutaneous-vs-iv-administration-of-medications-and-fluids-in-patients-with-cancer/ 2023-03-30T16:33:27+00:00 https://ascopost.com/news/march-2023/addition-of-gemcitabine-to-cisplatin-and-intensity-modulated-radiation-therapy-may-improve-outcomes-for-patients-with-locally-advanced-vulvar-cancer/ 2023-03-30T18:57:12+00:00 https://ascopost.com/news/march-2023/addition-of-immunotherapy-to-chemotherapy-regimen-may-increase-progression-free-survival-in-patients-with-advanced-or-recurrent-endometrial-cancer/ 2023-03-30T19:01:23+00:00 https://ascopost.com/news/march-2023/time-related-and-financial-burdens-may-impact-quality-of-life-for-patients-with-gynecologic-cancer/ 2023-03-30T19:23:59+00:00 https://ascopost.com/news/march-2023/how-do-novel-genetic-subtypes-of-urothelial-carcinoma-respond-to-immune-checkpoint-blockade/ 2023-03-30T17:06:30+00:00 https://ascopost.com/news/march-2023/clinical-trial-participation-may-be-associated-with-improved-overall-survival-in-patients-with-ovarian-cancer/ 2023-03-31T14:08:14+00:00 https://ascopost.com/news/march-2023/researchers-uncover-how-incurable-skin-cancer-may-resist-treatment-at-the-end-of-life/ 2023-04-21T18:44:47+00:00 https://ascopost.com/news/march-2023/nivolumab-injected-directly-into-spinal-fluid-may-be-safe-and-effective-for-some-patients-with-melanoma-who-have-leptomeningeal-disease/ 2023-03-31T15:15:40+00:00 https://ascopost.com/news/march-2023/extended-performance-of-an-image-based-short-term-risk-model-for-predicting-breast-cancer/ 2023-03-31T14:41:42+00:00 https://ascopost.com/news/march-2023/effect-of-insurance-status-on-racial-and-ethnic-inequities-in-the-diagnosis-of-advanced-stage-cervical-cancer/ 2023-03-31T14:53:39+00:00 https://ascopost.com/news/march-2023/hypercalcemia-in-patients-with-cholangiocarcinoma/ 2023-03-31T14:57:56+00:00 https://ascopost.com/news/april-2023/ 2023-04-03T14:31:38+00:00 https://ascopost.com/news/april-2023/prognostic-performance-of-a-molecular-international-prognostic-scoring-system-for-mds/ 2023-04-03T14:59:45+00:00 https://ascopost.com/news/april-2023/addition-of-bortezomib-to-r-chop-in-patients-with-dlbcl-according-to-molecular-subgroups/ 2023-04-03T15:52:21+00:00 https://ascopost.com/news/april-2023/addition-of-niraparib-to-abiraterone-acetate-and-prednisone-for-patients-with-metastatic-castration-resistant-prostate-cancer/ 2023-04-03T18:37:06+00:00 https://ascopost.com/news/april-2023/study-assesses-prevalence-severity-and-co-occurrence-of-common-symptoms-that-may-be-undertreated-in-patients-with-cancer/ 2023-04-03T17:31:38+00:00 https://ascopost.com/news/april-2023/car-t-cell-therapy-may-improve-quality-of-life-of-patients-with-hematologic-malignancies/ 2023-04-03T17:40:47+00:00 https://ascopost.com/news/april-2023/new-data-on-amivantamab-vmjw-in-patients-with-advanced-nsclc-and-egfr-exon-20-insertion-mutations/ 2023-04-12T18:45:10+00:00 https://ascopost.com/news/april-2023/initiative-for-managing-adverse-events-of-immunotherapy-leads-to-clinical-practice-changes-at-md-anderson/ 2023-04-04T16:13:05+00:00 https://ascopost.com/news/april-2023/menin-inhibitors-under-study-in-kmt2a-rearranged-or-npm1-mutant-acute-myeloid-leukemia/ 2023-04-04T16:42:09+00:00 https://ascopost.com/news/april-2023/epov-mikkael-sekeres/ 2023-04-04T16:40:32+00:00 https://ascopost.com/news/april-2023/chatgpt-may-have-potential-to-help-educate-patients-with-cirrhosis-and-hepatic-cancer-in-basic-knowledge-lifestyle-and-treatment-domains/ 2023-04-04T17:08:06+00:00 https://ascopost.com/news/april-2023/more-us-patients-with-prostate-cancer-may-be-electing-for-active-surveillance/ 2023-04-04T17:12:03+00:00 https://ascopost.com/news/april-2023/pathologic-complete-responses-may-be-prognostic-of-outcomes-for-patients-with-soft-tissue-sarcoma/ 2023-04-04T17:32:17+00:00 https://ascopost.com/news/april-2023/fda-grants-accelerated-approval-to-enfortumab-vedotin-ejfvpembrolizumab-for-locally-advanced-or-metastatic-urothelial-carcinoma/ 2023-04-04T19:22:38+00:00 https://ascopost.com/news/april-2023/hhs-releases-national-cancer-plan-to-advance-the-goals-of-the-cancer-moonshot-and-improve-outcomes-for-all-patients/ 2023-04-04T19:32:30+00:00 https://ascopost.com/news/april-2023/risk-of-local-recurrence-after-breast-conserving-therapy-in-patients-with-multiple-ipsilateral-breast-cancer/ 2023-04-05T15:11:02+00:00 https://ascopost.com/news/april-2023/addition-of-toripalimab-to-definitive-chemoradiotherapy-in-locally-advanced-esophageal-squamous-cell-carcinoma/ 2023-04-05T15:30:57+00:00 https://ascopost.com/news/april-2023/deductibles-copays-may-discourage-patients-from-receiving-follow-up-breast-cancer-screenings/ 2023-04-05T16:24:13+00:00 https://ascopost.com/news/april-2023/nccn-names-uchicago-medicine-comprehensive-cancer-center-as-33rd-member-institution/ 2023-04-05T15:50:30+00:00 https://ascopost.com/news/april-2023/primary-overall-survival-analysis-of-the-enzamet-trial-in-metastatic-hormone-sensitive-prostate-cancer/ 2023-04-05T15:54:20+00:00 https://ascopost.com/news/april-2023/training-oncology-nurses-on-primary-palliative-care-may-improve-end-of-life-care-and-spur-creation-of-advance-directives-for-patients-with-cancer/ 2023-04-06T16:27:53+00:00 https://ascopost.com/news/april-2023/interferon-alfa-2b-may-substantially-increase-survival-in-patients-with-lymphomatoid-granulomatosis/ 2023-04-06T16:35:53+00:00 https://ascopost.com/news/april-2023/study-examines-utility-accuracy-of-chatgpt-in-offering-breast-cancer-screening-recommendations/ 2023-04-06T16:20:22+00:00 https://ascopost.com/news/april-2023/effect-of-smoking-cessation-after-diagnosis-of-renal-cell-carcinoma-on-disease-progression-and-survival-outcomes/ 2023-04-06T16:12:43+00:00 https://ascopost.com/news/april-2023/researchers-identify-potential-biomarkers-of-response-to-immunotherapy-in-patients-with-renal-cell-carcinoma/ 2023-04-07T15:10:48+00:00 https://ascopost.com/news/april-2023/healthy-lifestyles-may-be-associated-with-reduced-mortality-risk-in-pediatric-cancer-survivors/ 2023-04-07T15:20:15+00:00 https://ascopost.com/news/april-2023/azacitidine-in-combination-with-trametinib-may-be-effective-for-pediatric-patients-with-jmml/ 2023-04-07T15:47:27+00:00 https://ascopost.com/news/april-2023/interaction-of-h-pylori-infection-and-germline-pathogenic-variants-in-risk-for-gastric-cancer/ 2023-04-07T16:24:17+00:00 https://ascopost.com/news/april-2023/t-dxd-in-her2-expressing-advanced-or-recurrent-uterine-carcinosarcoma/ 2023-04-07T16:33:27+00:00 https://ascopost.com/news/april-2023/olanzapine-to-prevent-chemotherapy-related-anorexia-in-newly-diagnosed-patients-with-advanced-cancers/ 2023-04-07T16:37:20+00:00 https://ascopost.com/news/april-2023/endoscopic-surveillance-in-patients-at-risk-for-hereditary-diffuse-gastric-cancer/ 2023-04-11T16:08:44+00:00 https://ascopost.com/news/april-2023/mortality-after-colonoscopy-detected-vs-postcolonoscopy-diagnosed-colorectal-cancer-in-the-va-health-care-system/ 2023-04-11T16:57:30+00:00 https://ascopost.com/news/april-2023/pathologic-complete-response-as-surrogate-for-event-free-and-overall-survival-in-neoadjuvant-trials-in-her2-positive-early-breast-cancer/ 2023-04-11T17:48:27+00:00 https://ascopost.com/news/april-2023/study-finds-precursor-pancreatic-lesions-occur-frequently-in-healthy-human-pancreases/ 2023-04-11T19:20:38+00:00 https://ascopost.com/news/april-2023/combination-therapy-may-help-patients-with-kmt2a-mutated-all-or-aml-overcome-bet-inhibitor-resistance/ 2023-04-19T20:54:20+00:00 https://ascopost.com/news/april-2023/prior-ctla-4-inhibition-may-influence-response-to-pd-1-inhibitors-in-patients-with-advanced-melanoma/ 2023-04-11T18:22:49+00:00 https://ascopost.com/news/april-2023/financial-toxicity-of-cancer-may-impact-partners-quality-of-life/ 2023-05-05T17:27:54+00:00 https://ascopost.com/news/april-2023/novel-device-may-be-safe-effective-chemotherapy-delivery-system-for-patients-with-muscle-invasive-bladder-cancer-who-are-unfit-for-standard-therapy/ 2023-04-12T20:11:48+00:00 https://ascopost.com/news/april-2023/gd2-car-t-cells-for-relapsed-or-refractory-high-risk-neuroblastoma/ 2023-04-12T16:35:30+00:00 https://ascopost.com/news/april-2023/consensus-molecular-subtypes-as-markers-for-maintenance-therapy-regimens-for-ras-wild-type-metastatic-colorectal-cancer/ 2023-04-12T16:41:32+00:00 https://ascopost.com/news/april-2023/addition-of-ipilimumab-to-nivolumab-in-recurrent-or-metastatic-head-and-neck-cancer/ 2026-01-28T19:50:42+00:00 https://ascopost.com/news/april-2023/statewide-survey-may-provide-insight-into-cancer-related-knowledge-beliefs-and-behaviors-of-hispanic-individuals-in-indiana/ 2023-04-13T16:49:20+00:00 https://ascopost.com/news/april-2023/digital-breast-tomosynthesis-may-improve-breast-cancer-screening-performance-in-community-settings/ 2023-04-13T16:54:04+00:00 https://ascopost.com/news/april-2023/new-study-examines-cancer-related-mortality-rates-during-first-year-of-covid-19-pandemic/ 2023-04-13T17:33:53+00:00 https://ascopost.com/news/april-2023/pragmatica-lung-trial-begins-enrolling-patients-with-nsclc-who-did-not-respond-to-previous-therapy/ 2023-05-09T18:16:25+00:00 https://ascopost.com/news/april-2023/update-on-withdrawal-of-ibrutinib-accelerated-approvals-for-mcl-and-mzl-in-the-united-states/ 2023-04-14T17:48:46+00:00 https://ascopost.com/news/april-2023/confirmatory-mediastinoscopy-vs-immediate-resection-after-endosonography-for-resectable-nsclc/ 2023-05-09T18:10:16+00:00 https://ascopost.com/news/april-2023/belzutifan-plus-cabozantinib-in-advanced-clear-cell-renal-cell-carcinoma-previously-treated-with-pd-1-or-pd-l1-inhibitors/ 2023-04-13T20:07:28+00:00 https://ascopost.com/news/april-2023/pathologic-complete-response-and-outcomes-in-localized-soft-tissue-sarcoma-treated-with-neoadjuvant-chemoradiotherapy-or-radiotherapy/ 2023-04-13T16:40:01+00:00 https://ascopost.com/news/april-2023/addition-of-abiraterone-acetate-and-prednisone-to-enzalutamide-in-metastatic-castration-resistant-prostate-cancer/ 2023-04-14T15:47:55+00:00 https://ascopost.com/news/april-2023/mrd-and-kmt2a-fusion-partners-in-predicting-outcomes-of-childhood-kmt2a-rearranged-acute-myeloid-leukemia/ 2023-04-14T18:16:06+00:00 https://ascopost.com/news/april-2023/addition-of-metastasis-directed-therapy-to-intermittent-hormone-therapy-for-oligometastatic-prostate-cancer/ 2023-04-14T17:43:05+00:00 https://ascopost.com/news/april-2023/addressing-racial-disparities-in-cancer-pain-management-a-potential-role-for-music-therapy/ 2023-04-14T17:49:29+00:00 https://ascopost.com/news/april-2023/neoadjuvant-durvalumab-plus-chemotherapy-followed-by-adjuvant-durvalumab-in-patients-with-resectable-nsclc-aegean/ 2023-04-17T18:53:00+00:00 https://ascopost.com/news/april-2023/first-line-pembrolizumab-plus-gemcitabinecisplatin-may-improve-overall-survival-in-advanced-biliary-tract-cancer/ 2023-04-17T19:19:09+00:00 https://ascopost.com/news/april-2023/personalized-mrna-based-cancer-vaccine-plus-pembrolizumab-for-high-risk-melanoma/ 2023-04-21T18:04:55+00:00 https://ascopost.com/news/april-2023/single-agent-pembrolizumab-may-benefit-patients-with-advanced-desmoplastic-melanoma/ 2023-04-17T14:45:49+00:00 https://ascopost.com/news/april-2023/nih-study-outlines-opportunities-to-achieve-president-biden-s-cancer-moonshot-goal-of-reducing-cancer-mortality-in-the-united-states/ 2023-04-17T15:07:26+00:00 https://ascopost.com/news/april-2023/imbrave050-recurrence-free-survival-with-adjuvant-atezolizumab-plus-bevacizumab-for-hcc/ 2023-04-17T17:29:44+00:00 https://ascopost.com/news/april-2023/awareness-of-the-link-between-hpv-and-cervical-cancer-has-declined-between-2014-and-2020/ 2023-04-18T18:50:21+00:00 https://ascopost.com/news/april-2023/study-finds-lung-cancer-incidence-rates-vary-significantly-among-florida-s-black-and-hispanic-ethnic-subgroups/ 2023-04-18T14:39:14+00:00 https://ascopost.com/news/april-2023/study-explores-genomic-basis-of-racial-disparities-among-patients-with-colorectal-cancer/ 2023-05-05T19:11:09+00:00 https://ascopost.com/news/april-2023/liquid-biopsy-based-multicancer-early-detection-test-may-find-early-stage-and-low-dna-shedding-cancers/ 2023-04-18T17:31:56+00:00 https://ascopost.com/news/april-2023/bispecific-antibody-regn5459-shows-activity-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2023-04-27T18:56:45+00:00 https://ascopost.com/news/april-2023/preoperative-peritumoral-infiltration-of-local-anesthetic-in-patients-with-early-breast-cancer-effect-on-survival/ 2023-04-19T14:50:16+00:00 https://ascopost.com/news/april-2023/psilocybin-therapy-for-patients-with-cancer-and-major-depression-disorder/ 2023-04-19T15:05:23+00:00 https://ascopost.com/news/april-2023/immune-checkpoint-inhibition-and-long-term-survival-in-patients-with-metastatic-urothelial-cancer/ 2023-04-19T15:15:59+00:00 https://ascopost.com/news/april-2023/olaparib-plus-ceralasertib-may-benefit-patients-with-pediatric-cancer-who-have-dna-replication-or-repair-deficient-tumors/ 2023-04-19T20:46:54+00:00 https://ascopost.com/news/april-2023/investigational-deep-learning-model-may-help-stratify-risk-of-distant-recurrence-in-patients-with-endometrial-cancer/ 2023-04-19T20:44:20+00:00 https://ascopost.com/news/april-2023/whole-exome-sequencing-may-help-identify-individuals-with-cancer-predisposition-syndromes-missed-by-current-screening-guidelines/ 2023-04-19T20:45:30+00:00 https://ascopost.com/news/april-2023/long-term-survival-in-patients-diagnosed-with-cancer-during-pregnancy-or-postpartum/ 2023-04-20T19:28:17+00:00 https://ascopost.com/news/april-2023/tumor-genomic-profile-and-risk-for-arterial-thromboembolism-in-patients-with-solid-cancers/ 2023-04-20T17:56:57+00:00 https://ascopost.com/news/april-2023/vt3989-may-be-safe-effective-in-patients-with-advanced-mesothelioma-and-nf2-mutant-solid-tumors/ 2023-04-20T18:27:18+00:00 https://ascopost.com/news/april-2023/novel-car-t-cell-therapy-demonstrated-promising-early-results-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma/ 2023-04-20T19:25:07+00:00 https://ascopost.com/news/april-2023/study-identifies-mutations-that-may-be-associated-with-poor-outcomes-in-patients-with-nsclc-treated-with-kras-g12c-inhibitors/ 2023-05-09T18:12:56+00:00 https://ascopost.com/news/april-2023/validation-of-a-prognostic-model-for-overall-survival-in-chemotherapy-naive-patients-with-metastatic-castration-resistant-prostate-cancer/ 2023-04-21T15:42:29+00:00 https://ascopost.com/news/april-2023/sugemalimab-in-relapsed-or-refractory-extranodal-natural-killert-cell-lymphoma/ 2023-04-21T15:46:44+00:00 https://ascopost.com/news/april-2023/association-of-delayed-or-foregone-care-among-patients-with-cancer-and-patient-clinician-identity-discordance/ 2023-04-21T20:21:06+00:00 https://ascopost.com/news/april-2023/covid-19-pandemic-may-have-disrupted-cancer-reporting-in-2020-and-beyond/ 2023-04-21T18:45:57+00:00 https://ascopost.com/news/april-2023/patients-with-brain-metastases-from-renal-cell-carcinoma-may-have-distinct-immunosuppressive-tumor-microenvironment/ 2023-04-21T19:38:21+00:00 https://ascopost.com/news/april-2023/early-trial-results-show-potential-benefits-of-fgfr-inhibitors-and-parpatr-inhibitor-combinations-in-multiple-tumor-types/ 2023-04-21T19:41:40+00:00 https://ascopost.com/news/april-2023/racialethnic-disparities-in-locoregional-recurrence-among-patients-with-breast-cancer-treated-in-the-tailorx-trial/ 2023-04-24T13:28:47+00:00 https://ascopost.com/news/april-2023/toripalimab-plus-chemotherapy-may-improve-event-free-survival-in-resectable-stage-iii-nsclc/ 2023-05-09T18:09:01+00:00 https://ascopost.com/news/april-2023/neoadjuvant-trabectedin-and-radiotherapy-in-myxoid-liposarcoma/ 2023-04-24T15:08:08+00:00 https://ascopost.com/news/april-2023/extreme-poverty-may-be-a-key-driver-for-relapse-in-pediatric-patients-with-all/ 2023-05-17T16:28:30+00:00 https://ascopost.com/news/april-2023/black-patients-with-cancer-may-be-more-likely-to-experience-cardiotoxicity-following-chemotherapy/ 2023-04-24T20:14:25+00:00 https://ascopost.com/news/april-2023/vitamin-d-deficiencies-may-lead-to-health-disparities-in-black-patients-with-prostate-cancer/ 2023-04-24T18:23:01+00:00 https://ascopost.com/news/april-2023/study-investigates-prevalence-of-low-value-psa-screening-for-prostate-cancer-in-older-patients/ 2023-04-26T18:49:46+00:00 https://ascopost.com/news/april-2023/financial-impact-on-caregivers-of-spouses-with-cancer/ 2023-04-28T17:41:12+00:00 https://ascopost.com/news/april-2023/second-line-liposomal-irinotecan-plus-fluorouracilleucovorin-in-metastatic-biliary-tract-cancer/ 2023-04-28T13:27:58+00:00 https://ascopost.com/news/april-2023/krystal-1-update-adagrasib-yields-benefit-in-variety-of-kras-g12c-mutated-tumors/ 2023-04-26T15:14:55+00:00 https://ascopost.com/news/april-2023/trastuzumab-deruxtecan-vs-physician-s-choice-in-her2-positive-metastatic-breast-cancer-previously-treated-with-trastuzumab-emtansine/ 2023-04-26T15:44:51+00:00 https://ascopost.com/news/april-2023/advance-care-planning-may-lead-to-less-aggressive-more-comfort-focused-care-for-patients-with-cancer/ 2023-04-26T17:04:36+00:00 https://ascopost.com/news/april-2023/are-patients-with-inflammatory-bowel-disease-at-increased-risk-for-developing-lymphoma/ 2023-10-31T17:24:09+00:00 https://ascopost.com/news/april-2023/tonsl-gene-may-be-potential-new-target-for-breast-cancer-therapy/ 2023-04-26T17:24:57+00:00 https://ascopost.com/news/april-2023/long-term-cardiac-safety-and-efficacy-of-sb3-trastuzumab-biosimilar-vs-reference-trastuzumab-in-her2-positive-early-breast-cancer/ 2023-04-27T16:47:30+00:00 https://ascopost.com/news/april-2023/updated-findings-from-javelin-bladder-100-trial-of-avelumab-first-line-maintenance-in-advanced-urothelial-carcinoma/ 2023-04-27T16:53:21+00:00 https://ascopost.com/news/april-2023/e-cigarette-use-increased-significantly-among-younger-us-adults-between-2019-and-2021/ 2023-04-27T17:07:34+00:00 https://ascopost.com/news/april-2023/astro-and-estro-issue-new-clinical-guidelines-on-local-therapy-for-patients-with-oligometastatic-nsclc/ 2023-05-09T18:15:17+00:00 https://ascopost.com/news/april-2023/study-explores-impact-of-radiation-therapy-on-immune-cells-and-tumor-cells-in-renal-cell-carcinoma/ 2023-04-27T17:41:38+00:00 https://ascopost.com/news/april-2023/aua-and-suo-release-new-guidelines-for-the-diagnosis-and-treatment-of-patients-with-nonmetastatic-upper-tract-urothelial-carcinoma/ 2023-04-28T13:56:04+00:00 https://ascopost.com/news/april-2023/cancer-survivors-with-transportation-challenges-may-face-higher-risk-of-emergency-room-use-and-mortality/ 2023-04-28T14:10:54+00:00 https://ascopost.com/news/april-2023/extended-antibiotic-prophylaxis-may-not-prevent-infections-improve-outcomes-in-patients-with-breast-cancer-undergoing-postmastectomy-breast-reconstruction/ 2023-04-28T14:26:43+00:00 https://ascopost.com/news/may-2023/ 2023-05-01T12:52:21+00:00 https://ascopost.com/news/may-2023/response-assessment-in-neuro-oncology-criteria-in-determining-correlation-of-survival-outcomes-in-glioblastoma/ 2023-05-01T13:47:53+00:00 https://ascopost.com/news/may-2023/adjuvant-chemotherapy-after-standard-chemoradiotherapy-in-locally-advanced-cervical-cancer/ 2023-05-01T13:37:01+00:00 https://ascopost.com/news/may-2023/subcutaneous-vs-intravenous-rituximab-in-first-line-treatment-of-low-tumor-burden-follicular-lymphoma/ 2023-05-01T15:42:13+00:00 https://ascopost.com/news/may-2023/does-surveillance-mammography-benefit-geriatric-patients-with-breast-cancer/ 2023-05-01T17:05:26+00:00 https://ascopost.com/news/may-2023/exercise-and-wellness-programs-may-enhance-well-being-and-reduce-health-care-costs-in-patients-with-breast-cancer/ 2023-05-01T17:07:40+00:00 https://ascopost.com/news/may-2023/intraoperative-vs-postoperative-lymph-node-pathology-evaluation-in-patients-with-breast-cancer-undergoing-mastectomy/ 2023-05-01T16:13:27+00:00 https://ascopost.com/news/may-2023/meta-analysis-of-outcomes-with-anthracycline-containing-and-taxane-containing-chemotherapy-in-early-stage-breast-cancer/ 2023-05-02T14:29:04+00:00 https://ascopost.com/news/may-2023/addition-of-quizartinib-to-chemotherapy-in-newly-diagnosed-flt3-itd-positive-acute-myeloid-leukemia/ 2023-05-17T17:57:17+00:00 https://ascopost.com/news/may-2023/cardiovascular-disease-in-survivors-of-testicular-cancer/ 2023-05-02T18:29:54+00:00 https://ascopost.com/news/may-2023/preoperative-mri-scans-may-not-reduce-positive-margins-and-reoperations-in-patients-with-breast-cancer-undergoing-lumpectomy/ 2023-05-02T14:49:34+00:00 https://ascopost.com/news/may-2023/researchers-identify-lethal-molecular-alterations-in-patients-with-metastatic-melanoma-who-failed-to-respond-to-previous-therapies/ 2023-07-28T17:04:59+00:00 https://ascopost.com/news/may-2023/remote-outreach-may-boost-cancer-screenings-in-rural-female-patients-by-sixfold/ 2023-05-02T16:30:33+00:00 https://ascopost.com/news/may-2023/despite-gender-affirming-surgery-transgender-women-may-still-be-at-risk-of-developing-prostate-cancer/ 2023-05-03T14:59:33+00:00 https://ascopost.com/news/may-2023/ai-based-decision-support-systems-for-mammography/ 2023-05-03T16:27:53+00:00 https://ascopost.com/news/may-2023/lifestyle-habits-risk-factors-and-cancer-screening-during-covid-19-pandemic/ 2023-05-03T16:31:19+00:00 https://ascopost.com/news/may-2023/lenvatinib-plus-pembrolizumab-in-previously-treated-patients-with-advanced-endometrial-cancer/ 2023-05-03T15:31:20+00:00 https://ascopost.com/news/may-2023/first-line-zolbetuximab-plus-mfolfox6-in-cldn182-positive-her2-negative-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2023-05-03T16:25:22+00:00 https://ascopost.com/news/may-2023/clonal-hematopoiesis-risk-score-for-myeloid-neoplasms-in-patients-with-myeloid-precursor-conditions/ 2023-05-03T16:00:57+00:00 https://ascopost.com/news/may-2023/survival-in-patients-with-neuroblastoma-on-reduced-therapy-as-a-result-of-change-in-cog-risk-stratification/ 2023-05-04T16:25:05+00:00 https://ascopost.com/news/may-2023/addition-of-blinatumomab-to-chemotherapy-in-infant-patients-with-kmt2a-rearranged-all/ 2023-05-04T15:01:53+00:00 https://ascopost.com/news/may-2023/economic-hardship-may-be-predictive-of-neurocognitive-outcomes-in-pediatric-patients-undergoing-radiation-therapy/ 2023-05-04T15:28:00+00:00 https://ascopost.com/news/may-2023/novel-imaging-agent-may-help-surgeons-detect-residual-tumor-tissue-following-breast-conserving-surgery/ 2023-05-04T15:45:19+00:00 https://ascopost.com/news/may-2023/pcr-and-individual-patient-prognosis-after-neoadjuvant-chemotherapy-and-anti-her2-therapy-in-her2-positive-early-breast-cancer/ 2023-05-04T15:13:34+00:00 https://ascopost.com/news/may-2023/addition-of-tislelizumab-to-chemotherapy-in-first-line-treatment-of-advanced-or-metastatic-esophageal-squamous-cell-carcinoma/ 2023-05-04T15:19:05+00:00 https://ascopost.com/news/may-2023/novel-ai-model-offers-potential-for-earlier-lung-cancer-diagnoses/ 2023-05-05T19:18:54+00:00 https://ascopost.com/news/may-2023/newly-identified-risk-factors-may-point-to-a-heightened-risk-for-early-onset-colorectal-cancer-among-younger-adult-patients/ 2023-05-05T16:09:02+00:00 https://ascopost.com/news/may-2023/limited-surgery-plus-proton-therapy-in-pediatric-and-adolescent-patients-with-craniopharyngioma/ 2023-05-05T16:40:18+00:00 https://ascopost.com/news/may-2023/risk-of-early-onset-digestive-tract-cancers-among-young-adults-with-nonalcoholic-fatty-liver-disease/ 2023-05-05T16:49:19+00:00 https://ascopost.com/news/may-2023/first-in-patient-study-of-psma-targeted-fluorescent-tracer-for-intraoperative-imaging-of-psma-positive-prostate-cancer/ 2023-05-05T16:54:59+00:00 https://ascopost.com/news/may-2023/birth-by-cesarean-delivery-and-development-of-early-onset-colorectal-cancer/ 2023-05-08T14:14:03+00:00 https://ascopost.com/news/may-2023/sotorasib-in-pretreated-patients-with-kras-g12c-mutated-nsclc-2-year-analysis-of-codebreak100/ 2023-06-07T16:59:52+00:00 https://ascopost.com/news/may-2023/induction-failure-in-pediatric-and-young-adult-patients-with-t-cell-all/ 2023-05-17T16:24:12+00:00 https://ascopost.com/news/may-2023/antibacterial-treatment-may-resolve-acute-radiation-dermatitis-in-patients-with-breast-cancer-undergoing-radiation-therapy/ 2023-05-08T16:13:55+00:00 https://ascopost.com/news/may-2023/enrollment-criteria-for-multiple-myeloma-clinical-trials-may-exclude-patients-from-racial-and-ethnic-minorities/ 2023-05-08T15:45:40+00:00 https://ascopost.com/news/may-2023/does-stem-cell-transplantation-extend-survival-in-patients-with-advanced-cutaneous-t-cell-lymphomas/ 2023-05-09T17:16:35+00:00 https://ascopost.com/news/may-2023/extension-of-adjuvant-anastrozole-after-initial-therapeutic-regimen-in-postmenopausal-patients-with-hr-positive-breast-cancer/ 2023-05-09T17:24:42+00:00 https://ascopost.com/news/may-2023/three-new-studies-unveil-recent-developments-in-the-screening-and-treatment-of-biliary-tract-cancer-and-colorectal-cancer/ 2023-05-09T18:57:56+00:00 https://ascopost.com/news/may-2023/bariatric-surgery-may-reduce-risk-of-obesity-related-cancers-by-more-than-half/ 2023-05-09T19:01:26+00:00 https://ascopost.com/news/may-2023/pain-control-for-localized-spine-metastases-stereotactic-radiosurgery-vs-conventional-radiotherapy/ 2023-05-09T18:06:11+00:00 https://ascopost.com/news/may-2023/tucatinib-plus-trastuzumab-in-her2-positive-refractory-ras-wild-type-unresectable-or-metastatic-colorectal-cancer/ 2023-05-09T19:07:40+00:00 https://ascopost.com/news/may-2023/new-breast-cancer-screening-guidelines-call-for-earlier-more-intensive-screenings-for-women-at-high-risk/ 2023-05-12T15:45:49+00:00 https://ascopost.com/news/may-2023/novel-calculator-may-identify-patients-with-favorable-prognosis-hematologic-cancers/ 2023-05-12T18:07:58+00:00 https://ascopost.com/news/may-2023/racial-disparities-in-the-risk-of-ovarian-cancer-for-patients-with-fibroids-and-endometriosis/ 2023-05-12T16:56:53+00:00 https://ascopost.com/news/may-2023/abiraterone-acetate-plus-prednisolone-with-or-without-enzalutamide-in-patients-with-metastatic-prostate-cancer-initiating-adt/ 2023-05-12T17:03:33+00:00 https://ascopost.com/news/may-2023/longitudinal-change-in-mammographic-breast-density-and-risk-of-breast-cancer/ 2023-05-12T17:13:01+00:00 https://ascopost.com/news/may-2023/lenalidomide-in-previously-treated-children-with-low-grade-gliomas/ 2023-05-12T17:57:56+00:00 https://ascopost.com/news/may-2023/ruxolitinib-for-patients-with-polycythemia-vera-intolerant-or-resistant-to-hydroxycarbamide/ 2025-09-30T19:29:30+00:00 https://ascopost.com/news/may-2023/interruption-of-adjuvant-endocrine-therapy-to-attempt-pregnancy-in-women-with-breast-cancer/ 2023-05-15T14:49:25+00:00 https://ascopost.com/news/may-2023/ibrutinib-and-rituximab-vs-fludarabine-cyclophosphamide-and-rituximab-in-previously-untreated-patients-with-cll/ 2023-05-15T14:54:38+00:00 https://ascopost.com/news/may-2023/adding-azacitidine-to-standard-chemotherapy-may-be-effective-for-patients-with-ptcl-tfh/ 2023-05-15T17:15:00+00:00 https://ascopost.com/news/may-2023/cabozantinib-in-combination-with-nivolumab-and-ipilimumab-may-slow-progression-of-advanced-renal-cell-carcinoma/ 2023-05-15T17:23:33+00:00 https://ascopost.com/news/may-2023/young-native-hawaiians-and-pacific-islanders-may-face-highest-rates-of-cancer-mortality/ 2023-05-15T17:31:44+00:00 https://ascopost.com/news/may-2023/president-biden-announces-intent-to-nominate-monica-m-bertagnolli-md-as-director-of-the-nih/ 2023-05-15T17:39:27+00:00 https://ascopost.com/news/may-2023/addition-of-short-term-adt-to-dose-escalated-radiotherapy-in-intermediate-risk-prostate-cancer/ 2023-05-16T16:10:33+00:00 https://ascopost.com/news/may-2023/patient-reported-outcomes-from-the-nrg-oncologyrtog-0815-in-intermediate-risk-prostate-cancer/ 2023-05-16T17:07:09+00:00 https://ascopost.com/news/may-2023/familial-clonal-hematopoiesis-in-individuals-with-a-mutation-in-telomere-related-gene-pot1/ 2023-05-16T17:11:11+00:00 https://ascopost.com/news/may-2023/long-term-risk-prediction-for-invasive-breast-cancer-ai-system-plus-volumetric-density-on-screening-mammography/ 2023-05-16T17:20:30+00:00 https://ascopost.com/news/may-2023/immigrant-adults-with-hepatocellular-carcinoma-may-have-higher-survival-rates-than-those-born-in-the-united-states/ 2023-05-16T18:12:21+00:00 https://ascopost.com/news/may-2023/patients-with-cancer-may-prefer-telemedicine-appointments-over-in-person-visits-when-both-are-available/ 2023-05-16T18:47:41+00:00 https://ascopost.com/news/may-2023/potential-utility-of-polygenic-risk-scores-in-cancer-screening-in-the-united-kingdom/ 2023-05-17T14:17:13+00:00 https://ascopost.com/news/may-2023/addition-of-bevacizumab-to-trifluridinetipiracil-in-refractory-metastatic-colorectal-cancer/ 2023-05-17T16:26:36+00:00 https://ascopost.com/news/may-2023/immune-checkpoint-inhibitors-show-promise-for-people-living-with-hiv/ 2023-05-17T16:28:34+00:00 https://ascopost.com/news/may-2023/phase-ii-trial-of-guadecitabine-plus-atezolizumab-in-patients-with-metastatic-bladder-cancer/ 2023-05-17T17:08:38+00:00 https://ascopost.com/news/may-2023/combined-delivery-of-dnx-2401-plus-pembrolizumab-may-be-safe-and-effective-in-patients-with-recurrent-glioblastoma/ 2023-05-17T17:19:12+00:00 https://ascopost.com/news/may-2023/hpv-self-collection-kits-may-increase-cervical-cancer-screenings-among-underscreened-underserved-patients/ 2023-05-17T17:34:42+00:00 https://ascopost.com/news/may-2023/patients-with-cervical-cancer-may-be-at-higher-risk-for-urinary-tract-infections-after-radical-hysterectomies/ 2023-05-18T17:50:56+00:00 https://ascopost.com/news/may-2023/cancer-specific-mortality-rates-vary-widely-across-the-globe-study-finds/ 2023-05-18T19:48:10+00:00 https://ascopost.com/news/may-2023/does-prediagnosis-smoking-cessation-improve-overall-survival-in-patients-with-nsclc/ 2023-05-18T19:22:05+00:00 https://ascopost.com/news/may-2023/implantable-ultrasound-device-to-open-blood-brain-barrier-for-peritumoral-delivery-of-albumin-bound-paclitaxel-in-recurrent-glioblastoma/ 2023-05-18T18:53:53+00:00 https://ascopost.com/news/may-2023/trastuzumabpertuzumab-plus-neoadjuvant-paclitaxel-or-endocrine-therapy-in-hr-positive-her2-positive-early-breast-cancer/ 2023-05-18T18:44:29+00:00 https://ascopost.com/news/may-2023/first-line-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll/ 2023-05-18T19:17:01+00:00 https://ascopost.com/news/may-2023/use-of-5-aris-and-prostate-cancer-mortality/ 2023-05-19T16:18:37+00:00 https://ascopost.com/news/may-2023/augmented-early-intensification-and-higher-consolidation-methotrexate-dosing-show-no-benefit-in-childhood-all/ 2023-06-21T17:22:36+00:00 https://ascopost.com/news/may-2023/association-between-overweightobesity-and-risk-of-gastrointestinal-cancer/ 2023-05-19T16:36:47+00:00 https://ascopost.com/news/may-2023/specialist-palliative-care-for-patients-undergoing-major-abdominal-surgery-for-cancer/ 2023-05-19T14:39:51+00:00 https://ascopost.com/news/may-2023/nccn-clinical-practice-guidelines-in-oncology-2023-updates/ 2023-05-19T15:55:25+00:00 https://ascopost.com/news/may-2023/fda-grants-accelerated-approval-to-epcoritamab-bysp-for-relapsed-or-refractory-b-cell-lymphoma/ 2023-05-22T16:17:07+00:00 https://ascopost.com/news/may-2023/late-major-surgical-intervention-in-survivors-of-childhood-cancer/ 2023-05-22T15:07:02+00:00 https://ascopost.com/news/may-2023/study-analyzes-relationship-between-cancer-survivors-tobacco-use-symptom-burden-and-motivation-to-quit-smoking/ 2023-05-22T15:16:34+00:00 https://ascopost.com/news/may-2023/multisystem-inflammatory-syndrome-in-children-with-cancer-and-covid-19/ 2023-05-22T15:27:58+00:00 https://ascopost.com/news/may-2023/assay-prediction-of-pcr-in-patients-with-her2-positive-breast-cancer-treated-with-neoadjuvant-paclitaxel-trastuzumab-and-pertuzumab/ 2023-05-22T15:56:50+00:00 https://ascopost.com/news/may-2023/radical-cystectomy-vs-trimodality-therapy-for-muscle-invasive-bladder-cancer/ 2023-05-23T15:03:23+00:00 https://ascopost.com/news/may-2023/addition-of-panitumumab-to-trifluridinetipiracil-in-anti-egfr-treatment-rechallenge-in-refractory-ras-wild-type-metastatic-colorectal-cancer/ 2023-05-23T15:16:30+00:00 https://ascopost.com/news/may-2023/bcg-vaccines-may-provide-protective-effect-against-alzheimers-disease/ 2023-05-23T17:18:47+00:00 https://ascopost.com/news/may-2023/tumor-mutational-burden-and-outcomes-in-patients-with-advanced-cancers-treated-with-immune-checkpoint-inhibitors/ 2023-05-23T15:22:41+00:00 https://ascopost.com/news/may-2023/fda-approves-avapritinib-for-indolent-systemic-mastocytosis/ 2023-05-23T16:31:21+00:00 https://ascopost.com/news/may-2023/prevalence-of-functional-limitations-in-us-cancer-survivors/ 2023-05-24T15:58:17+00:00 https://ascopost.com/news/may-2023/interleukin-21-identified-as-potential-new-therapeutic-target-to-prevent-endocrine-autoimmune-adverse-effects-from-cancer-immunotherapy/ 2023-05-24T17:16:33+00:00 https://ascopost.com/news/may-2023/computer-aided-diagnosis-may-improve-breast-ultrasound-performance/ 2023-05-24T17:35:18+00:00 https://ascopost.com/news/may-2023/anti-pd-l1-combination-vs-sunitinib-in-metastatic-renal-cell-carcinoma/ 2023-05-24T17:40:00+00:00 https://ascopost.com/news/may-2023/effect-of-her2-expression-levels-on-survival-outcomes-in-patients-with-metastatic-breast-cancer-receiving-targeted-therapy-plus-endocrine-therapy/ 2023-05-24T17:47:30+00:00 https://ascopost.com/news/may-2023/adding-pembrolizumab-to-chemotherapy-may-improve-survival-in-patients-with-advanced-cervical-cancer/ 2023-05-26T15:42:29+00:00 https://ascopost.com/news/may-2023/luspatercept-improves-reliance-on-blood-transfusions-for-patients-with-lower-risk-mds/ 2023-06-12T15:59:27+00:00 https://ascopost.com/news/may-2023/medicaid-expansion-associated-with-a-reduction-in-mortality-for-black-patients-with-gastrointestinal-cancers/ 2023-06-19T19:49:42+00:00 https://ascopost.com/news/may-2023/telephone-based-weight-loss-intervention-for-patients-with-breast-cancer-and-overweightobesity/ 2023-06-15T15:39:22+00:00 https://ascopost.com/news/may-2023/using-a-health-systems-strengthening-approach-in-the-united-states-mexico-border-region-improved-survival-rates-for-children-with-all/ 2023-06-21T17:24:34+00:00 https://ascopost.com/news/may-2023/minimally-invasive-distal-pancreatectomy-in-patients-with-resectable-pancreatic-cancer/ 2023-06-19T19:47:50+00:00 https://ascopost.com/news/may-2023/mgmt-promoter-methylation-and-survival-outcomes-in-low-grade-and-anaplastic-gliomas-after-alkylating-chemotherapy/ 2023-05-30T14:55:01+00:00 https://ascopost.com/news/may-2023/long-term-outcomes-with-single-fraction-vs-multifraction-sabr-for-pulmonary-oligometastases/ 2023-05-30T15:09:37+00:00 https://ascopost.com/news/may-2023/addition-of-first-line-dalpiciclib-to-letrozole-or-anastrozole-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/ 2023-05-30T15:17:48+00:00 https://ascopost.com/news/may-2023/new-bladder-cancer-classification-may-predict-response-to-bcg-immunotherapy-in-patients-with-non-muscle-invasive-bladder-cancer/ 2023-05-30T18:23:58+00:00 https://ascopost.com/news/may-2023/incidence-of-colorectal-lung-and-breast-cancers-may-be-rising-due-to-covid-19-related-screening-delays/ 2023-05-30T19:07:19+00:00 https://ascopost.com/news/may-2023/fda-approves-flotufolastat-fluorine-18-injection-first-radiohybrid-psma-targeted-pet-imaging-agent-for-prostate-cancer/ 2023-05-30T19:34:56+00:00 https://ascopost.com/news/may-2023/patients-who-practice-qigong-may-be-able-to-improve-their-cancer-related-fatigue/ 2023-05-31T15:06:33+00:00 https://ascopost.com/news/may-2023/uicc-urges-action-on-world-no-tobacco-day-to-prevent-tobacco-related-cancer-deaths/ 2023-05-31T15:14:18+00:00 https://ascopost.com/news/may-2023/crispr-approach-may-help-identify-therapeutic-targets-in-patients-with-multiple-myeloma/ 2023-07-31T17:32:23+00:00 https://ascopost.com/news/may-2023/diffusing-alpha-emitter-radiation-therapy-for-recurrent-or-unresectable-skin-cancers/ 2023-05-31T18:01:36+00:00 https://ascopost.com/news/may-2023/sglt2-inhibitors-and-cardiovascular-outcomes-in-older-anthracycline-treated-patients-with-cancer/ 2023-05-31T18:06:17+00:00 https://ascopost.com/news/june-2023/ 2023-06-02T16:38:38+00:00 https://ascopost.com/news/june-2023/atom-coalition-seeks-to-ensure-equitable-cancer-care-in-low-and-middle-income-countries/ 2023-06-02T17:42:22+00:00 https://ascopost.com/news/june-2023/study-finds-wide-variations-in-intratumoral-microbiome-of-patients-with-early-vs-late-onset-colorectal-cancer/ 2023-06-02T18:03:57+00:00 https://ascopost.com/news/june-2023/extended-lymphadenectomy-may-not-benefit-patients-with-clinically-localized-muscle-invasive-bladder-cancer/ 2023-06-02T18:18:29+00:00 https://ascopost.com/news/june-2023/simple-hysterectomy-may-be-a-safe-option-for-patients-with-early-stage-low-risk-cervical-cancer/ 2023-06-02T18:49:33+00:00 https://ascopost.com/news/june-2023/adding-ribociclib-to-endocrine-therapy-may-reduce-recurrence-risk-in-patients-with-hr-positive-her2-negative-early-stage-breast-cancer/ 2023-06-15T17:30:33+00:00 https://ascopost.com/news/june-2023/addition-of-olaparib-and-durvalumab-to-standard-of-care-may-prolong-progression-free-survival-in-patients-with-advanced-ovarian-cancer/ 2023-06-03T14:45:31+00:00 https://ascopost.com/news/june-2023/zanidatamab-shows-activity-in-refractory-her2-amplified-biliary-tract-cancer/ 2023-06-03T14:55:31+00:00 https://ascopost.com/news/june-2023/early-cessation-of-neoadjuvant-chemotherapy-may-lead-to-worse-outcomes-in-patients-with-muscle-invasive-bladder-cancer/ 2023-06-03T15:01:20+00:00 https://ascopost.com/news/june-2023/impact-of-changing-opioid-prescription-landscape-for-patients-with-cancer/ 2023-06-03T15:08:42+00:00 https://ascopost.com/news/june-2023/veterans-exposed-to-agent-orange-may-be-at-increased-risk-of-developing-myeloproliferative-neoplasms/ 2023-06-03T16:47:30+00:00 https://ascopost.com/news/june-2023/is-pembrolizumab-effective-in-patients-with-brain-metastases/ 2023-06-03T17:59:53+00:00 https://ascopost.com/news/june-2023/changes-in-recist-tumor-measures-correlate-linearly-with-survival-in-patients-treated-with-checkpoint-inhibitors/ 2023-06-04T10:51:01+00:00 https://ascopost.com/news/june-2023/patients-with-slfn11-expressing-sclc-may-benefit-from-immune-checkpoint-inhibitor-plus-parp-inhibitor/ 2023-06-05T17:43:51+00:00 https://ascopost.com/news/june-2023/nivolumab-may-reduce-risk-of-disease-progression-or-death-in-previously-untreated-patients-with-hodgkin-lymphoma-compared-to-brentuximab-vedotin/ 2023-06-04T15:17:31+00:00 https://ascopost.com/news/june-2023/mirvetuximab-soravtansine-improves-survival-in-patients-with-recurrent-ovarian-cancer/ 2023-06-04T14:50:46+00:00 https://ascopost.com/news/june-2023/adjuvant-osimertinib-improves-survival-in-patients-with-resected-egfr-mutated-nsclc/ 2023-06-04T15:37:09+00:00 https://ascopost.com/news/june-2023/vorasidenib-delays-disease-progression-or-death-in-patients-with-grade-2-idh-mutated-glioma/ 2023-06-04T16:26:46+00:00 https://ascopost.com/news/june-2023/radiation-may-be-safely-omitted-in-select-patients-with-locally-advanced-rectal-cancer/ 2023-06-19T19:45:36+00:00 https://ascopost.com/news/june-2023/black-patients-with-metastatic-prostate-cancer-may-benefit-from-apalutamide-and-abiraterone-acetate-plus-prednisone/ 2023-07-14T17:25:48+00:00 https://ascopost.com/news/june-2023/chemotherapy-induced-peripheral-neuropathy-may-be-more-severe-with-paclitaxel-than-with-docetaxel/ 2023-06-05T10:37:55+00:00 https://ascopost.com/news/june-2023/transcriptional-profiling-may-provide-clues-to-treating-colorectal-cancer-more-effectively-in-younger-patients/ 2023-06-05T17:13:39+00:00 https://ascopost.com/news/june-2023/study-finds-t-dxd-effectively-treats-her2-expressing-cancers-regardless-of-tumor-location/ 2023-06-05T18:23:23+00:00 https://ascopost.com/news/june-2023/ciltacabtagene-autoleucel-reduces-risk-of-disease-progression-in-patients-with-lenalidomide-refractory-multiple-myeloma/ 2023-06-12T15:35:50+00:00 https://ascopost.com/news/june-2023/erdafitinib-achieves-responses-across-multiple-cancer-types-with-fgfr-alterations/ 2023-06-06T14:49:20+00:00 https://ascopost.com/news/june-2023/axicabtagene-ciloleucel-improves-overall-survival-in-patients-with-relapsed-or-refractory-large-b-cell-lymphoma/ 2023-06-12T15:37:46+00:00 https://ascopost.com/news/june-2023/exercise-may-strengthen-immune-system-in-patients-with-multiple-myeloma/ 2023-06-06T16:11:59+00:00 https://ascopost.com/news/june-2023/race-and-ethnicity-may-affect-21-gene-recurrence-score-in-patients-with-estrogen-receptor-positive-breast-cancer/ 2023-06-06T16:46:06+00:00 https://ascopost.com/news/june-2023/stopping-immunotherapy-after-2-years-vs-continuing-treatment-may-yield-similar-survival-outcomes-in-patients-with-advanced-nsclc/ 2023-06-07T16:45:39+00:00 https://ascopost.com/news/june-2023/radiation-treatment-may-not-be-necessary-after-chemoimmunotherapy-for-primary-mediastinal-b-cell-lymphoma/ 2023-06-06T16:42:09+00:00 https://ascopost.com/news/june-2023/asco-issues-clinical-guidance-for-treating-gastrointestinal-cancers-amid-acute-drug-shortages/ 2023-06-19T19:42:21+00:00 https://ascopost.com/news/june-2023/cancer-survivors-with-transportation-barriers-to-care-may-also-experience-financial-hardship-food-insecurity-and-delays-in-timely-care/ 2023-06-07T15:30:41+00:00 https://ascopost.com/news/june-2023/black-and-hispanic-cancer-survivors-may-have-highest-risk-of-death-from-subsequent-primary-cancers-and-cardiovascular-disease/ 2023-06-07T16:59:56+00:00 https://ascopost.com/news/june-2023/microdoses-of-incisional-antibiotics-and-surgical-site-infections-in-surgery-for-skin-cancer/ 2023-06-07T15:59:10+00:00 https://ascopost.com/news/june-2023/allostatic-load-and-mortality-in-patients-with-breast-cancer/ 2023-06-07T16:05:20+00:00 https://ascopost.com/news/june-2023/anthracycline-related-cardiomyopathy-and-hp-gene-expression-in-childhood-cancer-survivors/ 2023-06-07T16:28:27+00:00 https://ascopost.com/news/june-2023/second-generation-antiandrogens-and-cognitive-and-functional-toxicity-in-patients-with-prostate-cancer/ 2023-06-08T15:43:05+00:00 https://ascopost.com/news/june-2023/nccn-addresses-ongoing-chemotherapy-shortages-as-new-survey-suggests-more-than-90-percent-of-cancer-centers-may-be-impacted/ 2023-06-08T19:07:50+00:00 https://ascopost.com/news/june-2023/cancer-survivors-who-quit-smoking-may-have-36-percent-lower-cardiovascular-risk-than-those-who-continue-smoking/ 2023-06-08T17:54:12+00:00 https://ascopost.com/news/june-2023/reducing-air-pollution-may-contribute-to-healthier-lifestyles-and-lower-cancer-risks-globally/ 2023-06-08T17:45:27+00:00 https://ascopost.com/news/june-2023/5a-reductase-inhibitor-use-and-progression-of-bladder-cancer-in-south-korean-males/ 2023-06-08T18:29:59+00:00 https://ascopost.com/news/june-2023/endocrine-therapy-switch-with-or-without-ribociclib-after-disease-progression-on-endocrine-therapy-and-cdk46-inhibition-for-metastatic-breast-cancer/ 2023-06-08T19:13:15+00:00 https://ascopost.com/news/june-2023/risk-of-dementia-and-mortality-with-bcg-vaccine-in-non-muscle-invasive-bladder-cancer/ 2023-06-12T12:40:19+00:00 https://ascopost.com/news/june-2023/olvimulogene-nanivacirepvec-primed-immunochemotherapy-in-platinum-resistant-or-refractory-ovarian-cancer/ 2023-06-12T12:48:29+00:00 https://ascopost.com/news/june-2023/ncis-combomatch-initiative-will-evaluate-new-drug-combinations-guided-by-tumor-biology/ 2023-06-12T20:15:29+00:00 https://ascopost.com/news/june-2023/patients-with-lymphoma-who-have-depression-or-anxiety-may-experience-worse-survival-outcomes/ 2023-10-31T17:47:52+00:00 https://ascopost.com/news/june-2023/new-data-may-inform-treatment-of-pregnant-patients-with-relapsed-or-refractory-lymphoma/ 2023-09-26T15:25:30+00:00 https://ascopost.com/news/june-2023/accumulation-of-chronic-comorbidities-among-survivors-of-childhood-cancer/ 2023-06-13T14:28:14+00:00 https://ascopost.com/news/june-2023/fecal-microbiota-transplantation-its-role-for-patients-undergoing-allogeneic-hct-and-receiving-induction-therapy-for-aml/ 2023-06-13T14:44:46+00:00 https://ascopost.com/news/june-2023/factors-associated-with-nonadherence-to-lung-cancer-screening-recommendations/ 2023-06-13T15:06:24+00:00 https://ascopost.com/news/june-2023/exposure-to-ultraviolet-radiation-may-propel-transformation-of-bpdcn-cells-to-leukemia-in-the-skin/ 2023-06-13T15:47:11+00:00 https://ascopost.com/news/june-2023/personalized-mrna-vaccines-may-transform-the-treatment-of-melanoma/ 2023-06-13T15:54:50+00:00 https://ascopost.com/news/june-2023/study-illuminates-potential-marked-disparities-in-federal-cancer-research-funding/ 2023-06-13T16:00:19+00:00 https://ascopost.com/news/june-2023/noncovalent-btk-inhibitor-pirtobrutinib-in-patients-with-mantle-cell-lymphoma-previously-treated-with-covalent-btk-inhibitors/ 2023-06-14T14:43:04+00:00 https://ascopost.com/news/june-2023/effect-of-cancer-history-on-disability-unemployment-and-medical-expenditures/ 2023-06-14T20:13:54+00:00 https://ascopost.com/news/june-2023/risk-factors-for-primary-bone-cancer-in-childhood-cancer-survivors-bone-tissue-radiation-exposure-and-alkylating-agent-dose/ 2023-06-14T17:43:45+00:00 https://ascopost.com/news/june-2023/preoperative-stereotactic-radiosurgery-may-help-patients-with-metastatic-brain-tumors-reduce-the-risk-of-disease-progression-and-adverse-effects/ 2023-06-14T19:17:39+00:00 https://ascopost.com/news/june-2023/impact-of-mccpdc-prices-of-generic-oncology-drugs-on-medicare-beneficiaries/ 2023-06-14T20:06:11+00:00 https://ascopost.com/news/june-2023/mortality-rates-from-second-cancers-in-hispanic-and-non-hispanic-black-breast-cancer-survivors/ 2023-06-14T20:09:04+00:00 https://ascopost.com/news/june-2023/trauma-and-long-term-risk-of-death-or-immune-mediated-disease-or-cancer-in-twin-pairs/ 2023-06-15T13:23:46+00:00 https://ascopost.com/news/june-2023/perioperative-palliative-care-and-health-related-quality-of-life-in-patients-undergoing-curative-intent-surgery-for-upper-gastrointestinal-cancers/ 2023-06-15T13:32:38+00:00 https://ascopost.com/news/june-2023/adagrasib-in-treatment-of-kras-g12c-mutated-advanced-solid-tumors/ 2023-06-15T13:38:28+00:00 https://ascopost.com/news/june-2023/s-1-chemoradiotherapy-for-older-patients-with-inoperable-esophageal-squamous-cell-carcinoma/ 2023-06-15T19:05:27+00:00 https://ascopost.com/news/june-2023/alectinib-may-be-more-effective-when-taken-with-larger-meals-in-some-patients-with-nsclc/ 2023-06-15T17:22:43+00:00 https://ascopost.com/news/june-2023/research-sheds-light-on-the-evolution-of-precursor-conditions-to-multiple-myeloma/ 2023-06-15T17:34:48+00:00 https://ascopost.com/news/june-2023/study-evaluates-clinical-utility-of-novel-liquid-biopsy-breast-cancer-methylation-prototype-assay/ 2023-06-16T18:22:34+00:00 https://ascopost.com/news/june-2023/impact-of-historic-redlining-practices-on-cancer-screening-rates/ 2023-06-16T16:58:49+00:00 https://ascopost.com/news/june-2023/food-deserts-food-swamps-and-obesity-related-cancer-mortality-in-the-united-states/ 2023-06-16T18:29:58+00:00 https://ascopost.com/news/june-2023/adherence-to-cancer-prevention-lifestyle-recommendations-before-during-and-after-treatment-for-high-risk-breast-cancer-association-with-recurrence-and-mortality/ 2023-06-16T16:43:07+00:00 https://ascopost.com/news/june-2023/fda-grants-accelerated-approval-to-glofitamab-gxbm-for-relapsed-or-refractory-dlbcl/ 2023-07-05T18:37:23+00:00 https://ascopost.com/news/june-2023/longitudinal-ctdna-methylation-status-and-risk-of-recurrence-after-surgery-in-patients-with-stage-i-to-iii-colorectal-cancer/ 2023-06-19T16:29:58+00:00 https://ascopost.com/news/june-2023/patient-reported-outcomes-from-the-prospect-trial-neoadjuvant-folfox-vs-chemoradiation-for-locally-advanced-rectal-cancer/ 2023-06-19T19:51:35+00:00 https://ascopost.com/news/june-2023/global-funding-for-cancer-research-2016-2020/ 2023-06-19T16:35:54+00:00 https://ascopost.com/news/june-2023/vision-trial-hrqol-with-the-addition-of-lu-177-vipivotide-tetraxetan-to-standard-of-care-in-patients-with-advanced-prostate-cancer/ 2023-06-19T19:18:11+00:00 https://ascopost.com/news/june-2023/older-breast-cancer-survivors-may-experience-accelerated-aging-worse-functional-outcomes-following-chemotherapy/ 2023-06-19T17:56:11+00:00 https://ascopost.com/news/june-2023/aromatase-inhibitors-may-limit-effectiveness-of-weight-loss-medications-in-breast-cancer-survivors/ 2023-06-19T19:22:49+00:00 https://ascopost.com/news/june-2023/patients-with-refractory-metastatic-colorectal-cancer-may-experience-survival-benefits-with-fruquintinib/ 2023-06-21T12:56:16+00:00 https://ascopost.com/news/june-2023/retrospective-analysis-of-survival-with-surgery-in-the-treatment-of-small-cell-carcinoma-of-the-cervix/ 2023-06-20T15:34:03+00:00 https://ascopost.com/news/june-2023/adagrasib-shows-activity-in-patients-with-kras-g12c-mutated-nsclc-and-untreated-brain-metastases/ 2023-06-20T16:48:51+00:00 https://ascopost.com/news/june-2023/adjuvant-cisplatingemcitabine-vs-cisplatinfluorouracil-after-chemoradiotherapy-for-nasopharyngeal-carcinoma/ 2026-01-28T19:45:44+00:00 https://ascopost.com/news/june-2023/late-onset-memory-impairment-in-adult-survivors-of-childhood-cancer/ 2023-06-20T15:49:48+00:00 https://ascopost.com/news/june-2023/petct-fdg-vs-conventional-staging-in-locally-advanced-breast-cancer/ 2023-06-20T15:55:38+00:00 https://ascopost.com/news/june-2023/fda-launches-pilot-program-to-help-reduce-risks-associated-with-using-laboratory-developed-tests-to-identify-cancer-biomarkers/ 2023-06-21T16:13:11+00:00 https://ascopost.com/news/june-2023/cancer-disparities-potentially-responsible-for-higher-incidence-and-mortality-rates-in-appalachian-kentucky/ 2023-06-21T14:55:33+00:00 https://ascopost.com/news/june-2023/fda-approves-talazoparib-with-enzalutamide-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-12-27T17:20:46+00:00 https://ascopost.com/news/june-2023/first-line-nivolumabipilimumab-followed-by-nivolumab-in-a-clinically-diverse-population-with-unresectable-stage-iii-or-iv-melanoma/ 2023-06-21T16:49:37+00:00 https://ascopost.com/news/june-2023/addition-of-blinatumomab-to-standard-chemotherapy-in-b-cell-all-in-low-risk-first-relapse/ 2023-06-21T17:18:05+00:00 https://ascopost.com/news/june-2023/surgeon-quality-metrics-and-survival-after-curative-intent-surgery-for-nsclc/ 2023-07-12T18:36:32+00:00 https://ascopost.com/news/june-2023/loss-of-y-chromosome-in-men-and-bladder-cancer-progression/ 2023-06-22T14:34:36+00:00 https://ascopost.com/news/june-2023/effect-of-upregulated-kdm5d-gene-on-y-chromosome-in-male-patients-with-kras-mutated-colorectal-cancer/ 2023-06-22T14:46:32+00:00 https://ascopost.com/news/june-2023/dose-escalated-simultaneous-integrated-boost-radiotherapy-for-early-stage-breast-cancer/ 2023-06-22T15:26:03+00:00 https://ascopost.com/news/june-2023/ibrutinibvenetoclax-vs-chlorambucilobinutuzumab-in-previously-untreated-patients-with-cll-association-of-mrd-with-progression-free-survival/ 2023-07-05T18:33:02+00:00 https://ascopost.com/news/june-2023/risk-of-intracranial-hemorrhage-with-direct-oral-anticoagulants-vs-low-molecular-weight-heparin-in-patients-with-glioblastoma-and-vte/ 2023-06-22T15:39:58+00:00 https://ascopost.com/news/june-2023/fda-grants-full-approval-to-blinatumomab-for-mrd-positive-b-cell-precursor-all/ 2023-07-19T19:17:37+00:00 https://ascopost.com/news/june-2023/egfr-and-erbb2-mutations-may-be-associated-with-lenvatinib-resistant-hepatocellular-carcinoma/ 2023-06-26T14:14:23+00:00 https://ascopost.com/news/june-2023/pretherapy-imaging-and-dosimetry-may-inform-personalized-treatment-strategies-for-patients-with-refractory-differentiated-thyroid-cancer/ 2023-06-26T14:02:38+00:00 https://ascopost.com/news/june-2023/role-of-chemotherapy-in-patients-with-nonmetastatic-nasopharyngeal-carcinoma-treated-with-radiotherapy/ 2026-01-28T19:40:05+00:00 https://ascopost.com/news/june-2023/association-of-cardiac-substructure-radiation-dose-and-risk-of-late-cardiac-disease-in-survivors-of-childhood-cancer/ 2023-06-26T17:26:15+00:00 https://ascopost.com/news/june-2023/children-of-parents-with-a-history-of-cancer-may-experience-housing-food-and-financial-hardship-as-well-as-delays-in-medical-care/ 2023-06-26T18:24:46+00:00 https://ascopost.com/news/june-2023/endometrial-cancer-risks-and-trends-among-different-populations-of-african-descent/ 2023-06-27T15:59:20+00:00 https://ascopost.com/news/june-2023/potential-role-of-chatgpt-4-in-selecting-appropriate-imaging-tests-for-breast-cancer-screenings-and-breast-pain/ 2023-06-27T17:30:23+00:00 https://ascopost.com/news/june-2023/outcomes-with-an-anthracycline-free-treatment-protocol-in-favorable-risk-childhood-all/ 2023-07-19T19:16:23+00:00 https://ascopost.com/news/june-2023/use-of-eltrombopag-in-low-risk-myelodysplastic-syndrome-with-thrombocytopenia/ 2023-06-27T16:26:41+00:00 https://ascopost.com/news/june-2023/t-dxd-in-her2-positive-advanced-gastric-or-gastroesophageal-junction-cancer-destiny-gastric02/ 2023-06-27T16:36:20+00:00 https://ascopost.com/news/june-2023/fda-approves-iopromide-injection-for-contrast-enhanced-mammography/ 2023-06-27T16:57:12+00:00 https://ascopost.com/news/june-2023/biden-harris-administration-launches-initiative-to-improve-cancer-outcomes-in-low-income-areas/ 2023-06-28T17:50:10+00:00 https://ascopost.com/news/june-2023/curettage-and-cryosurgery-may-be-effective-for-patients-with-basal-cell-carcinoma/ 2023-09-22T16:20:27+00:00 https://ascopost.com/news/june-2023/lgbtq-patients-and-survivors-of-cancer-expressed-concern-over-discrimination-in-health-care-settings-according-to-new-survey/ 2023-06-28T18:01:02+00:00 https://ascopost.com/news/june-2023/risk-adapted-neoadjuvant-chemoradiotherapy-in-rectal-cancer/ 2023-06-28T18:20:29+00:00 https://ascopost.com/news/june-2023/direct-oral-anticoagulants-vs-low-molecular-weight-heparin-in-preventing-recurrent-vte-in-patients-with-cancer/ 2023-06-28T18:27:32+00:00 https://ascopost.com/news/june-2023/amcenestrant-vs-standard-endocrine-therapy-in-er-positive-her2-negative-advanced-breast-cancer/ 2023-06-28T18:34:23+00:00 https://ascopost.com/news/june-2023/use-of-fruquintinib-in-treating-refractory-metastatic-colorectal-cancer/ 2023-06-29T18:18:23+00:00 https://ascopost.com/news/june-2023/daratumumab-plus-chemotherapy-as-induction-and-extended-consolidation-therapy-for-ultra-high-risk-multiple-myeloma/ 2023-06-29T15:05:51+00:00 https://ascopost.com/news/june-2023/long-term-survival-outcomes-with-pembrolizumab-vs-ipilimumab-in-advanced-melanoma-7-year-follow-up-of-keynote-006/ 2023-06-29T15:13:53+00:00 https://ascopost.com/news/june-2023/study-identifies-potential-risk-factors-for-early-onset-colorectal-cancer-in-male-patients/ 2023-06-29T17:29:27+00:00 https://ascopost.com/news/june-2023/fertility-in-female-survivors-treated-for-hodgkin-lymphoma-as-children/ 2023-06-29T18:29:30+00:00 https://ascopost.com/news/june-2023/risk-of-ovarian-cancer-in-postmenopausal-patients-with-polycystic-ovary-syndrome/ 2023-06-29T17:51:52+00:00 https://ascopost.com/news/june-2023/addition-of-external-beam-radiation-therapy-to-brachytherapy-in-intermediate-risk-prostate-cancer/ 2023-06-30T14:17:02+00:00 https://ascopost.com/news/june-2023/largest-human-breast-cell-atlas-to-date-may-offer-insights-into-mammary-biology/ 2023-06-30T18:21:37+00:00 https://ascopost.com/news/june-2023/cdcp1-may-be-an-effective-therapeutic-target-for-patients-with-metastatic-bladder-cancer/ 2023-06-30T18:16:51+00:00 https://ascopost.com/news/june-2023/novel-radiotracer-may-accurately-detect-and-differentiate-renal-cell-carcinomas/ 2023-07-14T17:24:21+00:00 https://ascopost.com/news/june-2023/posttransplantation-cyclophosphamide-based-gvhd-prophylaxis-in-patients-with-hematologic-cancers-undergoing-allogeneic-hsct/ 2023-06-30T17:31:58+00:00 https://ascopost.com/news/june-2023/asco-chief-executive-officer-issues-statement-on-affirmative-action-ruling/ 2023-06-30T18:22:59+00:00 https://ascopost.com/news/july-2023/ 2023-07-03T17:35:59+00:00 https://ascopost.com/news/july-2023/comparison-of-conditioning-treatments-in-patients-with-aml-undergoing-hla-haploidentical-hematopoietic-stem-cell-transplant/ 2023-09-05T17:31:27+00:00 https://ascopost.com/news/july-2023/multicancer-early-detection-test-in-symptomatic-patients-referred-from-primary-care/ 2023-07-03T20:12:34+00:00 https://ascopost.com/news/july-2023/first-line-enfortumab-vedotin-plus-pembrolizumab-in-cisplatin-ineligible-patients-with-locally-advanced-or-metastatic-urothelial-cancer/ 2023-07-03T20:19:14+00:00 https://ascopost.com/news/july-2023/first-line-systemic-treatment-strategies-for-initially-unresectable-colorectal-cancer-liver-metastases/ 2023-07-05T18:56:12+00:00 https://ascopost.com/news/july-2023/personalized-dosing-may-improve-outcomes-in-patients-with-prostate-cancer/ 2023-07-05T18:58:19+00:00 https://ascopost.com/news/july-2023/investigators-identify-requirements-to-potentially-optimize-cancer-survivorship-care-for-patients-in-rural-areas/ 2023-07-05T17:11:57+00:00 https://ascopost.com/news/july-2023/patients-whose-pancreatic-cysts-remain-stable-for-5-years-may-have-decreased-risk-of-pancreatic-cancer/ 2023-07-06T16:24:15+00:00 https://ascopost.com/news/july-2023/staging-laparoscopy-may-help-identify-early-metastases-in-patients-with-pancreatic-cancer/ 2023-07-06T16:21:12+00:00 https://ascopost.com/news/july-2023/covid-19-booster-doses-may-strengthen-immunity-in-patients-with-lymphoma/ 2023-09-26T15:22:49+00:00 https://ascopost.com/news/july-2023/first-line-folfoxiri-plus-cetuximab-or-bevacizumab-in-braf-v600e-mutant-metastatic-colorectal-cancer/ 2023-07-06T18:02:34+00:00 https://ascopost.com/news/july-2023/medicaid-expansion-may-be-linked-to-increase-in-palliative-care-for-patients-with-advanced-cancers/ 2023-07-07T17:26:33+00:00 https://ascopost.com/news/july-2023/robotic-assisted-resection-of-challenging-gastric-gists-may-be-safe-and-effective/ 2023-07-07T15:10:42+00:00 https://ascopost.com/news/july-2023/investigators-evaluate-the-role-of-bmi-in-outcomes-in-patients-with-head-and-neck-cancer/ 2026-01-28T19:17:37+00:00 https://ascopost.com/news/july-2023/cancer-mortality-trends-among-us-hispanic-populations-from-1999-to-2020/ 2023-07-07T16:53:22+00:00 https://ascopost.com/news/july-2023/intracranial-activity-of-adagrasib-in-patients-with-kras-g12c-mutated-nsclc-and-untreated-cns-metastases/ 2023-07-12T18:35:17+00:00 https://ascopost.com/news/july-2023/second-line-trastuzumab-ramucirumab-and-paclitaxel-in-previously-treated-patients-with-her2-positive-advanced-gastric-or-gastroesophageal-junction-cancer/ 2023-07-11T16:48:07+00:00 https://ascopost.com/news/july-2023/prevalence-of-prior-cancer-among-patients-with-newly-diagnosed-cancer/ 2023-07-11T16:59:46+00:00 https://ascopost.com/news/july-2023/germline-variants-in-colorectal-cancer-susceptibility-genes-by-raceethnicity-in-patients-with-early-onset-colorectal-cancer/ 2023-07-11T17:04:16+00:00 https://ascopost.com/news/july-2023/patients-with-prostate-cancer-may-face-high-rates-of-financial-toxicity/ 2023-07-11T18:36:52+00:00 https://ascopost.com/news/july-2023/fecal-microbiota-transplants-show-potential-in-improving-melanoma-treatment/ 2023-07-11T19:14:47+00:00 https://ascopost.com/news/july-2023/changing-how-immune-checkpoint-inhibitors-are-delivered-could-reduce-costs-by-14-study-finds/ 2023-07-12T18:44:47+00:00 https://ascopost.com/news/july-2023/overweight-and-obese-bmi-may-be-linked-to-adverse-treatment-outcomes-in-aya-patients-with-all/ 2023-07-19T19:19:15+00:00 https://ascopost.com/news/july-2023/prediction-of-lung-cancer-mortality-with-blood-based-biomarker-panel-and-plco-risk-model/ 2023-07-12T17:39:38+00:00 https://ascopost.com/news/july-2023/intraoperative-mri-guided-vs-aminolevulinic-acid-guided-resection-in-newly-diagnosed-patients-with-glioblastoma/ 2023-07-12T17:55:42+00:00 https://ascopost.com/news/july-2023/pirtobrutinib-after-covalent-btk-inhibitor-treatment-in-relapsed-or-refractory-cllsll/ 2023-10-31T15:50:47+00:00 https://ascopost.com/news/july-2023/zanidatamab-in-her2-positive-advanced-biliary-tract-cancer/ 2023-07-13T15:53:47+00:00 https://ascopost.com/news/july-2023/functional-recovery-and-quality-of-life-in-older-patients-undergoing-colorectal-cancer-surgery/ 2023-07-13T16:03:07+00:00 https://ascopost.com/news/july-2023/academically-developed-bcma-directed-car-t-cell-therapy-in-relapsed-or-refractory-multiple-myeloma/ 2023-07-31T17:30:26+00:00 https://ascopost.com/news/july-2023/new-tool-may-help-physicians-pinpoint-gaps-in-hematologic-malignancy-awareness/ 2023-07-13T17:08:59+00:00 https://ascopost.com/news/july-2023/incidence-and-outcomes-of-severe-hepatopathy-in-national-wilms-tumor-study-protocols/ 2023-07-13T16:27:04+00:00 https://ascopost.com/news/july-2023/mlh1-methylation-status-and-screenings-for-colorectal-or-endometrial-cancer/ 2023-07-13T19:07:11+00:00 https://ascopost.com/news/july-2023/decimation-of-gut-bacteria-and-chemotherapy-induced-weight-gain-in-patients-with-breast-cancer/ 2023-07-14T17:34:20+00:00 https://ascopost.com/news/july-2023/pembrolizumab-based-combination-therapies-may-improve-outcomes-in-advanced-nsclc/ 2023-07-14T17:30:15+00:00 https://ascopost.com/news/july-2023/use-of-zipalertinib-in-previously-treated-patients-with-advanced-nsclc-and-egfr-exon-20-insertions/ 2023-08-09T17:50:53+00:00 https://ascopost.com/news/july-2023/meta-analysis-of-the-addition-of-docetaxel-to-adt-in-metastatic-hormone-sensitive-prostate-cancer/ 2023-07-14T17:02:42+00:00 https://ascopost.com/news/july-2023/crenigacestat-plus-bcma-car-t-cell-therapy-in-relapsed-or-refractory-multiple-myeloma/ 2023-09-28T15:31:52+00:00 https://ascopost.com/news/july-2023/aspartame-hazard-and-risk-assessment-results-released-by-iarc-and-jecfa/ 2023-07-14T16:58:54+00:00 https://ascopost.com/news/july-2023/apobec3a-protein-may-be-linked-to-drug-resistance-in-patients-with-nsclc/ 2023-07-17T17:09:49+00:00 https://ascopost.com/news/july-2023/cetuximab-plus-radiotherapy-shows-activity-in-patients-with-locally-advanced-cutaneous-squamous-cell-carcinoma/ 2023-09-22T16:14:29+00:00 https://ascopost.com/news/july-2023/lazertinib-vs-gefitinib-in-the-first-line-treatment-of-egfr-mutated-advanced-nsclc/ 2023-07-17T16:36:37+00:00 https://ascopost.com/news/july-2023/vemurafenib-plus-cobimetinib-in-newly-diagnosed-patients-with-papillary-craniopharyngiomas/ 2023-07-17T16:59:20+00:00 https://ascopost.com/news/july-2023/regional-nodal-irradiation-and-locoregional-recurrence-in-patients-with-favorable-risk-node-positive-breast-cancer/ 2023-07-17T17:06:26+00:00 https://ascopost.com/news/july-2023/trends-in-receipt-of-end-of-life-systemic-treatment-for-patients-with-cancer/ 2023-07-18T16:12:03+00:00 https://ascopost.com/news/july-2023/neoadjuvant-and-adjuvant-gvax-plus-nivolumab-and-urelemab-may-increase-immune-response-in-patients-with-resectable-pancreatic-cancer/ 2023-07-18T17:30:11+00:00 https://ascopost.com/news/july-2023/study-examines-impact-of-modified-treatment-protocols-on-survival-in-pediatric-patients-with-all/ 2023-08-10T21:33:48+00:00 https://ascopost.com/news/july-2023/diversity-may-play-a-key-role-in-black-patients-trust-of-videos-about-prostate-cancer/ 2023-07-19T16:02:16+00:00 https://ascopost.com/news/july-2023/investigators-offer-guidance-for-improving-access-to-oncology-drugs-in-sub-saharan-africa/ 2023-07-19T16:11:53+00:00 https://ascopost.com/news/july-2023/adjuvant-osimertinib-in-resected-egfr-mutant-nsclc-overall-survival-analysis-of-the-adaura-trial/ 2023-08-09T17:47:50+00:00 https://ascopost.com/news/july-2023/activity-and-toxicity-of-pembrolizumab-in-rare-sarcomas/ 2023-07-19T16:23:33+00:00 https://ascopost.com/news/july-2023/dysphagia-optimized-vs-standard-imrt-in-newly-diagnosed-patients-with-head-and-neck-cancer/ 2026-01-28T18:12:19+00:00 https://ascopost.com/news/july-2023/pediatric-early-warning-systems-implementation-in-resource-limited-latin-american-hospitals/ 2023-07-20T16:46:03+00:00 https://ascopost.com/news/july-2023/biological-aging-and-radiation-therapy-for-breast-cancer/ 2023-07-20T18:50:43+00:00 https://ascopost.com/news/july-2023/psilocybin-and-other-psychedelics-may-help-patients-with-late-stage-gynecologic-cancer-tackle-mental-health-symptoms/ 2023-07-20T18:28:08+00:00 https://ascopost.com/news/july-2023/fda-approves-quizartinib-for-newly-diagnosed-flt3-itd-positive-acute-myeloid-leukemia/ 2023-07-21T17:55:03+00:00 https://ascopost.com/news/july-2023/individual-patient-meta-analysis-of-neoadjuvant-chemotherapy-and-chemoradiotherapy-for-esophageal-or-gej-carcinoma/ 2023-07-21T15:05:54+00:00 https://ascopost.com/news/july-2023/overall-survival-with-axicabtagene-ciloleucel-in-large-b-cell-lymphoma-results-from-zuma-7/ 2023-07-21T16:08:19+00:00 https://ascopost.com/news/july-2023/addition-of-sbrt-to-immunotherapy-in-advanced-solid-tumors/ 2023-07-24T17:24:11+00:00 https://ascopost.com/news/july-2023/olaparib-and-temozolomide-in-advanced-uterine-leiomyosarcoma/ 2023-07-24T15:46:48+00:00 https://ascopost.com/news/july-2023/intervention-to-increase-uptake-of-tobacco-use-treatment-for-patients-with-cancer-who-smoke/ 2023-07-24T15:57:08+00:00 https://ascopost.com/news/july-2023/stereotactic-radiosurgery-before-resection-of-brain-metastases-from-solid-tumors/ 2023-07-24T16:05:07+00:00 https://ascopost.com/news/july-2023/improving-screening-and-surveillance-practices-for-early-cancer-detection-in-patients-with-barretts-esophagus/ 2023-07-24T17:23:11+00:00 https://ascopost.com/news/july-2023/novel-imaging-guided-radiotherapy-technique-may-reduce-short-term-side-effects-for-patients-with-prostate-cancer/ 2023-07-24T17:32:14+00:00 https://ascopost.com/news/july-2023/addition-of-nivolumab-to-sabr-in-early-stage-or-isolated-lung-parenchymal-recurrent-nsclc/ 2023-08-09T17:53:10+00:00 https://ascopost.com/news/july-2023/atezolizumab-vemurafenib-and-cobimetinib-in-patients-with-braf-v600-mutated-melanoma-and-cns-metastases/ 2023-09-22T16:11:24+00:00 https://ascopost.com/news/july-2023/integrated-clinical-molecular-classification-of-colorectal-liver-metastases/ 2023-07-26T14:57:57+00:00 https://ascopost.com/news/july-2023/polygenic-risk-score-and-chemotherapy-related-subsequent-malignant-neoplasms-in-childhood-cancer-survivors/ 2023-07-26T15:11:37+00:00 https://ascopost.com/news/july-2023/study-explores-incidence-and-mortality-rates-of-cardiovascular-disease-among-black-vs-white-cancer-survivors/ 2023-07-26T16:00:29+00:00 https://ascopost.com/news/july-2023/volume-of-liver-resected-during-gallbladder-surgery-may-not-significantly-affect-overall-survival-in-patients-with-gallbladder-cancer/ 2023-07-26T16:12:10+00:00 https://ascopost.com/news/july-2023/vaccine-rollout-may-reduce-covid-19-related-mortality-by-84-among-patients-with-cancer-study-predicts/ 2023-07-27T14:13:57+00:00 https://ascopost.com/news/july-2023/forced-displacement-and-diagnosis-of-cancer-in-syrian-refugees/ 2023-07-27T14:24:11+00:00 https://ascopost.com/news/july-2023/acupuncture-may-improve-sleep-among-patients-with-multiple-myeloma-undergoing-hsct/ 2023-09-28T15:33:16+00:00 https://ascopost.com/news/july-2023/niraparib-maintenance-in-newly-diagnosed-advanced-ovarian-cancer/ 2023-07-31T13:16:27+00:00 https://ascopost.com/news/july-2023/primary-cancer-and-noncancer-mortality-among-long-term-survivors-of-solid-tumors/ 2023-07-27T16:00:28+00:00 https://ascopost.com/news/july-2023/selinexor-as-maintenance-therapy-for-p53-wild-type-endometrial-cancer/ 2023-07-27T16:24:30+00:00 https://ascopost.com/news/july-2023/can-an-ai-model-improve-mortality-risk-prediction-linked-to-lung-cancer-or-cardiovascular-disease/ 2023-07-28T13:59:38+00:00 https://ascopost.com/news/july-2023/the-role-of-us-cancer-centers-in-preparing-patients-with-cancer-for-climate-change-emergencies/ 2023-07-28T14:11:45+00:00 https://ascopost.com/news/july-2023/modeled-effects-of-reducing-the-recommended-screening-age-for-colorectal-cancer-in-canada/ 2023-07-28T14:23:28+00:00 https://ascopost.com/news/july-2023/outcomes-in-pediatric-all-with-prolonged-therapy-for-ikzf1-deletion-and-reduced-therapy-for-other-risk-groups/ 2023-07-28T14:57:37+00:00 https://ascopost.com/news/july-2023/skin-cancer-screenings-and-melanoma-outcomes-among-racial-and-ethnic-minority-patients/ 2023-08-01T12:51:47+00:00 https://ascopost.com/news/july-2023/reasons-for-nonparticipation-in-a-colorectal-cancer-screening-trial-comparing-outcomes-with-colonoscopy-vs-fit/ 2023-07-31T14:11:01+00:00 https://ascopost.com/news/july-2023/atezolizumab-with-or-without-radiotherapy-in-advanced-penile-cancer/ 2023-07-31T14:35:59+00:00 https://ascopost.com/news/july-2023/ciltacabtagene-autoleucel-vs-standard-care-in-lenalidomide-refractory-patients-with-multiple-myeloma/ 2023-11-16T20:24:06+00:00 https://ascopost.com/news/july-2023/patients-in-lower-income-communities-may-be-less-likely-to-receive-ct-colonography-than-those-in-higher-income-communities/ 2023-07-31T17:42:02+00:00 https://ascopost.com/news/july-2023/short-bursts-of-vigorous-daily-activity-may-be-linked-to-reduced-cancer-incidence/ 2023-07-31T17:46:44+00:00 https://ascopost.com/news/august-2023/ 2023-08-01T13:20:20+00:00 https://ascopost.com/news/august-2023/fda-approves-dostarlimab-gxly-plus-chemotherapy-for-dmmr-or-msi-h-endometrial-cancer/ 2023-12-27T17:22:15+00:00 https://ascopost.com/news/august-2023/molecular-classification-and-response-to-radiotherapy-in-early-stage-endometrioid-endometrial-cancer/ 2023-08-01T15:47:45+00:00 https://ascopost.com/news/august-2023/exercise-may-reduce-sexual-dysfunction-caused-by-prostate-cancer-treatment/ 2023-08-11T17:09:39+00:00 https://ascopost.com/news/august-2023/can-an-ai-based-tool-accurately-detect-precancerous-cervical-lesions/ 2023-08-01T19:20:45+00:00 https://ascopost.com/news/august-2023/researchers-may-have-uncovered-two-new-subtypes-of-hpv-positive-head-and-neck-squamous-cell-carcinomas/ 2026-01-28T19:08:54+00:00 https://ascopost.com/news/august-2023/addition-of-talazoparib-to-enzalutamide-in-the-first-line-treatment-of-metastatic-castration-resistant-prostate-cancer/ 2023-08-02T16:23:29+00:00 https://ascopost.com/news/august-2023/liquid-biopsy-assay-demonstrates-effective-early-cancer-detection-in-asymptomatic-individuals-in-vietnam/ 2023-08-02T19:00:16+00:00 https://ascopost.com/news/august-2023/noninvasive-multitarget-stool-dna-methylation-assay-in-the-early-detection-of-multiple-gastrointestinal-cancers/ 2023-09-12T18:12:52+00:00 https://ascopost.com/news/august-2023/researchers-characterize-adverse-immune-events-in-patients-with-cancer-who-experience-immune-checkpoint-inhibitor-associated-arthritis/ 2023-08-02T17:22:43+00:00 https://ascopost.com/news/august-2023/gastrointestinal-symptoms-may-be-prevalent-in-geriatric-female-colorectal-cancer-survivors/ 2023-08-02T17:29:45+00:00 https://ascopost.com/news/august-2023/acp-issues-updated-clinical-guidelines-for-screening-asymptomatic-average-risk-adults-for-colorectal-cancer/ 2023-08-03T17:27:37+00:00 https://ascopost.com/news/august-2023/early-stage-cancer-diagnoses-in-the-united-states-may-have-decreased-during-the-first-year-of-the-covid-19-pandemic/ 2023-08-03T17:36:45+00:00 https://ascopost.com/news/august-2023/bladder-sparing-trimodal-therapy-vs-radical-cystectomy-in-patients-with-clinically-node-positive-nonmetastatic-bladder-cancer/ 2023-08-03T17:14:54+00:00 https://ascopost.com/news/august-2023/long-term-outcomes-with-zanubrutinib-vs-ibrutinib-in-symptomatic-waldenstroms-macroglobulinemia/ 2023-10-31T15:53:24+00:00 https://ascopost.com/news/august-2023/camrelizumab-plus-rivoceranib-vs-sorafenib-in-unresectable-hepatocellular-carcinoma/ 2023-08-04T15:16:47+00:00 https://ascopost.com/news/august-2023/comparison-of-outcomes-of-surgical-vs-nonsurgical-approaches-in-patients-with-malignant-bowel-obstructions/ 2023-08-04T14:00:49+00:00 https://ascopost.com/news/august-2023/wildfire-exposure-and-survival-outcomes-after-surgery-for-nsclc/ 2023-08-09T18:01:39+00:00 https://ascopost.com/news/august-2023/contribution-of-mek-inhibition-to-combined-brafmek-inhibitor-treatment-in-advanced-braf-mutant-melanoma/ 2023-08-04T19:48:55+00:00 https://ascopost.com/news/august-2023/outcomes-in-children-and-young-adults-with-t-cell-all-and-induction-failure-in-contemporary-treatment-trials/ 2023-09-20T16:53:36+00:00 https://ascopost.com/news/august-2023/ebv-based-screening-methods-for-identifying-nasopharyngeal-carcinoma/ 2026-01-28T19:02:56+00:00 https://ascopost.com/news/august-2023/outcomes-with-cancer-associated-isolated-distal-deep-vein-thrombosis/ 2023-08-07T14:56:01+00:00 https://ascopost.com/news/august-2023/how-does-bmi-affect-cardiac-health-for-patients-with-breast-cancer-receiving-chemotherapy/ 2023-08-07T19:06:31+00:00 https://ascopost.com/news/august-2023/analysis-challenges-theory-that-depression-and-anxiety-may-increase-cancer-risk/ 2023-08-07T19:01:11+00:00 https://ascopost.com/news/august-2023/translating-consent-documents-potential-barrier-for-including-underrepresented-groups-in-clinical-trials/ 2023-08-07T17:17:05+00:00 https://ascopost.com/news/august-2023/treatment-related-mortality-among-children-with-cancer-in-low-and-middle-income-countries/ 2023-08-08T15:04:13+00:00 https://ascopost.com/news/august-2023/preoperative-chemoradiation-with-or-without-pazopanib-in-nonrhabdomyosarcoma-soft-tissue-sarcoma/ 2023-08-08T19:28:17+00:00 https://ascopost.com/news/august-2023/study-shows-substantial-racial-and-ethnic-disparities-among-survivors-of-second-primary-cancers-in-the-united-states/ 2023-08-08T19:29:55+00:00 https://ascopost.com/news/august-2023/report-highlights-rapid-adoption-of-clinical-research-results-into-colon-cancer-chemotherapy-prescribing-patterns/ 2023-08-08T17:27:39+00:00 https://ascopost.com/news/august-2023/fine-particulate-matter-exposure-may-increase-risk-of-primary-cancers-other-than-lung-cancer/ 2023-08-11T21:05:31+00:00 https://ascopost.com/news/august-2023/panda-trial-first-line-treatment-regimens-for-elderly-patients-with-rasbraf-wild-type-metastatic-colorectal-cancer/ 2023-08-09T14:37:26+00:00 https://ascopost.com/news/august-2023/erdafitinib-for-patients-with-fgfr-altered-advanced-solid-tumors/ 2023-08-09T14:45:40+00:00 https://ascopost.com/news/august-2023/adjuvant-everolimus-in-patients-with-renal-cell-carcinoma-at-high-risk-of-recurrence/ 2023-09-15T16:15:44+00:00 https://ascopost.com/news/august-2023/elevated-mri-enhancement-may-indicate-increased-risk-of-cancer-in-patients-with-very-dense-breasts/ 2023-08-09T15:57:13+00:00 https://ascopost.com/news/august-2023/does-daily-consumption-of-sugar-sweetened-beverages-increase-the-risk-of-liver-disease-among-postmenopausal-women/ 2023-08-09T16:07:33+00:00 https://ascopost.com/news/august-2023/alcohol-consumption-and-risk-of-breast-cancer-recurrence/ 2023-09-18T19:39:38+00:00 https://ascopost.com/news/august-2023/fda-grants-accelerated-approval-to-talquetamab-tgvs-for-treatment-of-relapsed-or-refractory-multiple-myeloma/ 2023-08-11T14:44:01+00:00 https://ascopost.com/news/august-2023/fda-approves-pralsetinib-for-ret-fusion-positive-nsclc/ 2023-08-11T14:32:52+00:00 https://ascopost.com/news/august-2023/impact-of-interventions-to-promote-adjuvant-endocrine-therapy-adherence-among-breast-cancer-survivors/ 2023-08-11T17:12:03+00:00 https://ascopost.com/news/august-2023/risk-of-death-cancer-and-autoimmune-disease-among-patients-undergoing-thymectomy/ 2023-08-11T17:14:03+00:00 https://ascopost.com/news/august-2023/avelumab-vs-standard-second-line-chemotherapy-in-dmmrmsi-metastatic-colorectal-cancer/ 2023-08-11T15:40:55+00:00 https://ascopost.com/news/august-2023/ai-driven-muscle-mass-assessment-may-aid-in-detecting-sarcopenia-in-patients-with-head-and-neck-cancer/ 2026-01-28T19:01:10+00:00 https://ascopost.com/news/august-2023/fda-approves-niraparib-and-abiraterone-acetate-plus-prednisone-for-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-08-14T14:14:51+00:00 https://ascopost.com/news/august-2023/are-immune-checkpoint-inhibitors-efficacious-among-patients-with-penile-squamous-cell-carcinoma/ 2023-08-14T17:55:19+00:00 https://ascopost.com/news/august-2023/ai-supported-screen-reading-vs-standard-double-reading-in-mammography-screening-for-breast-cancer/ 2023-08-14T17:54:38+00:00 https://ascopost.com/news/august-2023/homoharringtonine-based-induction-in-pediatric-aml/ 2023-09-20T16:55:57+00:00 https://ascopost.com/news/august-2023/vigorous-intermittent-lifestyle-physical-activity-and-cancer-incidence-among-nonexercising-adults/ 2023-08-14T16:48:57+00:00 https://ascopost.com/news/august-2023/t-cell-tolerant-fraction-may-predict-immune-related-adverse-events-among-patients-receiving-immunotherapy/ 2023-08-14T16:55:56+00:00 https://ascopost.com/news/august-2023/association-of-pathologic-lymph-node-regression-after-neoadjuvant-chemotherapy-with-outcomes-in-esophageal-adenocarcinoma/ 2023-08-15T15:28:19+00:00 https://ascopost.com/news/august-2023/neoadjuvant-pembrolizumabchemotherapy-and-adjuvant-pembrolizumab-in-early-stage-nsclc/ 2023-09-13T17:57:38+00:00 https://ascopost.com/news/august-2023/psma-petct-imaging-may-eliminate-the-need-for-preimaging-biopsy-in-older-patients-undergoing-screening-for-prostate-cancer/ 2023-08-15T18:05:29+00:00 https://ascopost.com/news/august-2023/novel-mepenk-test-may-be-effective-at-diagnosing-early-stage-bladder-cancer-in-patients-with-hematuria/ 2023-09-15T16:25:58+00:00 https://ascopost.com/news/august-2023/effects-of-bmi-in-patients-with-hormone-receptor-positive-breast-cancer-receiving-adjuvant-palbociclib-and-endocrine-therapy/ 2023-08-16T14:03:39+00:00 https://ascopost.com/news/august-2023/time-to-treatment-and-survival-among-adults-aged-50-years-with-colorectal-cancer/ 2023-08-16T13:59:11+00:00 https://ascopost.com/news/august-2023/effect-of-atorvastatin-on-cardiac-dysfunction-in-patients-receiving-anthracyclines-for-lymphoma/ 2023-10-31T15:48:34+00:00 https://ascopost.com/news/august-2023/four-novel-biomarkers-may-help-detect-black-patients-at-risk-of-advanced-prostate-cancer/ 2023-08-16T17:45:28+00:00 https://ascopost.com/news/august-2023/do-mds-diagnoses-require-second-opinions/ 2023-09-05T17:35:08+00:00 https://ascopost.com/news/august-2023/breast-cancer-overdiagnosis-may-be-common-among-older-female-patients/ 2023-08-16T19:00:30+00:00 https://ascopost.com/news/august-2023/use-of-lorazepam-and-survival-outcomes-for-patients-with-pancreatic-cancer/ 2023-09-12T19:00:12+00:00 https://ascopost.com/news/august-2023/locoregional-recurrence-patterns-among-molecular-subtypes-of-breast-cancer/ 2023-08-21T13:31:22+00:00 https://ascopost.com/news/august-2023/radiation-facility-volume-and-survival-in-very-high-risk-prostate-cancer-treated-with-curative-radiation-and-androgen-deprivation-therapy/ 2023-08-21T13:54:05+00:00 https://ascopost.com/news/august-2023/medicaid-expansion-and-participation-in-cancer-clinical-trials-among-patients-insured-by-medicaid/ 2023-08-21T16:04:20+00:00 https://ascopost.com/news/august-2023/therapeutic-implications-of-dna-repair-discoveries-in-patients-with-homologous-recombination-deficiencies/ 2023-08-21T16:14:00+00:00 https://ascopost.com/news/august-2023/ipilimumab-plus-nivolumab-may-improve-outcomes-in-patients-with-refractory-metastatic-melanoma-study-suggests/ 2023-08-21T16:21:30+00:00 https://ascopost.com/news/august-2023/first-line-cemiplimab-vs-chemotherapy-in-advanced-nsclc-35-month-follow-up-of-empower-lung-1/ 2023-09-13T17:59:29+00:00 https://ascopost.com/news/august-2023/addition-of-neoadjuvant-talimogene-laherparepvec-to-surgery-in-advanced-melanoma-5-year-follow-up/ 2023-08-23T13:30:08+00:00 https://ascopost.com/news/august-2023/researchers-may-have-identified-several-new-breast-cancer-susceptibility-genes/ 2023-08-22T14:55:12+00:00 https://ascopost.com/news/august-2023/understanding-how-tet2-gene-deficiency-may-fuel-development-of-aml/ 2023-10-17T21:10:44+00:00 https://ascopost.com/news/august-2023/breast-cancer-screening-and-10-year-net-survival-in-canadian-women-aged-40-to-49/ 2023-08-22T18:34:41+00:00 https://ascopost.com/news/august-2023/unraveling-the-mechanisms-behind-the-antichemotherapy-effects-of-abcg2-proteins/ 2023-08-22T16:39:26+00:00 https://ascopost.com/news/august-2023/use-of-abiraterone-acetate-with-or-without-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer/ 2023-09-15T16:21:15+00:00 https://ascopost.com/news/august-2023/addition-of-zanubrutinib-to-obinutuzumab-in-relapsed-or-refractory-follicular-lymphoma/ 2023-09-26T15:18:04+00:00 https://ascopost.com/news/august-2023/targeted-axillary-dissection-after-neoadjuvant-therapy-in-node-positive-breast-cancer/ 2023-08-23T15:00:43+00:00 https://ascopost.com/news/august-2023/personalized-calculator-may-be-predictive-of-benefits-from-adjuvant-tace-in-patients-with-hepatocellular-carcinoma-undergoing-hepatectomy/ 2023-08-23T14:46:12+00:00 https://ascopost.com/news/august-2023/bariatric-surgery-and-cancer-incidence-and-mortality-for-patients-with-severe-obesity/ 2023-08-23T15:18:07+00:00 https://ascopost.com/news/august-2023/crystal-s-denlinger-md-facp-named-new-chief-executive-officer-of-nccn/ 2023-08-23T18:27:52+00:00 https://ascopost.com/news/august-2023/addition-of-neoadjuvant-monoclonal-antibody-to-platinum-based-chemotherapy-in-resectable-nsclc/ 2023-09-13T18:03:00+00:00 https://ascopost.com/news/august-2023/alcohol-consumption-behaviors-among-patients-diagnosed-with-cancer/ 2023-08-24T16:05:20+00:00 https://ascopost.com/news/august-2023/pertuzumabtrastuzumab-with-or-without-chemotherapy-followed-by-t-dm1-in-her2-positive-metastatic-breast-cancer/ 2023-08-24T16:14:15+00:00 https://ascopost.com/news/august-2023/sacituzumab-continues-to-show-benefit-in-patients-with-hr-positive-her2-negative-metastatic-breast-cancer/ 2023-08-29T13:09:32+00:00 https://ascopost.com/news/august-2023/novel-targeted-therapy-combination-may-be-an-effective-first-line-option-for-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2023-08-24T16:52:18+00:00 https://ascopost.com/news/august-2023/modified-citrus-pectin-treatment-for-nonmetastatic-biochemically-relapsed-prostate-cancer/ 2023-09-21T16:21:48+00:00 https://ascopost.com/news/august-2023/patterns-in-early-onset-cancer-incidence-in-the-united-states-from-2010-to-2019/ 2023-08-28T18:31:35+00:00 https://ascopost.com/news/august-2023/cardiorespiratory-fitness-in-youth-may-be-associated-with-a-lower-risk-of-nine-cancer-types/ 2023-08-28T17:45:13+00:00 https://ascopost.com/news/august-2023/short-term-use-of-immunosuppressants-may-not-be-linked-to-increased-cancer-risk-in-patients-with-ocular-inflammatory-diseases/ 2023-08-28T18:10:53+00:00 https://ascopost.com/news/august-2023/adherence-to-mediterranean-lifestyle-may-be-associated-with-lower-risk-of-all-cause-and-cancer-mortality/ 2023-08-28T18:19:11+00:00 https://ascopost.com/news/august-2023/rural-patients-with-cancer-receipt-of-surgical-care-at-high-vs-low-volume-hospitals/ 2023-08-28T19:05:02+00:00 https://ascopost.com/news/august-2023/high-temporalhigh-spatial-resolution-breast-mri-for-patients-with-high-background-parenchymal-enhancement/ 2023-08-29T15:11:41+00:00 https://ascopost.com/news/august-2023/follow-up-of-chronic-immune-related-adverse-events-after-adjuvant-immunotherapy-for-high-risk-resected-melanoma/ 2023-08-29T14:49:28+00:00 https://ascopost.com/news/august-2023/study-shows-potential-of-cabozantinib-to-treat-patients-with-advanced-neuroendocrine-tumors/ 2023-08-29T18:20:23+00:00 https://ascopost.com/news/august-2023/how-guideline-concordant-are-cancer-treatment-recommendations-from-chatgpt/ 2023-08-29T19:17:15+00:00 https://ascopost.com/news/august-2023/cllsll-efficacy-of-cd19-directed-car-t-cell-therapy-in-relapsed-or-refractory-disease/ 2023-09-20T16:40:03+00:00 https://ascopost.com/news/august-2023/fda-approves-luspatercept-aamt-as-first-line-treatment-for-adult-patients-with-lower-risk-mds-and-anemia-who-may-require-transfusions/ 2023-08-29T18:28:04+00:00 https://ascopost.com/news/august-2023/optimizing-tobacco-cessation-treatment-with-lung-cancer-screenings/ 2023-08-30T19:26:23+00:00 https://ascopost.com/news/august-2023/are-cannabinoids-safe-and-effective-for-reducing-symptoms-in-pediatric-patients-with-cancer/ 2023-08-30T16:11:46+00:00 https://ascopost.com/news/august-2023/er-positive-breast-cancer-addition-of-adjuvant-ovarian-function-suppression-to-tamoxifen-in-premenopausal-patients/ 2023-08-30T17:13:05+00:00 https://ascopost.com/news/august-2023/addition-of-perioperative-pd-l1-inhibition-to-neoadjuvant-chemotherapy-in-muscle-invasive-urothelial-carcinoma/ 2023-09-15T16:17:37+00:00 https://ascopost.com/news/august-2023/divarasib-in-patients-with-advanced-solid-tumors-and-a-kras-g12c-mutation/ 2023-08-30T17:53:42+00:00 https://ascopost.com/news/august-2023/how-is-administrative-payment-burden-associated-with-cost-related-delays-in-cancer-care/ 2023-08-31T20:29:46+00:00 https://ascopost.com/news/august-2023/new-clinical-trial-seeks-to-reduce-cardiovascular-damage-in-patients-undergoing-anticancer-therapy-for-breast-cancer/ 2023-08-31T20:20:12+00:00 https://ascopost.com/news/august-2023/edoxaban-taken-for-12-months-may-improve-outcomes-in-patients-with-cancer-and-isolated-distal-deep-vein-thrombosis/ 2023-09-29T17:03:16+00:00 https://ascopost.com/news/august-2023/time-gaps-may-be-critical-parameters-when-sparing-skin-during-flash-radiation-therapy/ 2023-08-31T20:32:00+00:00 https://ascopost.com/news/august-2023/immunochemotherapy-triplet-in-patients-with-advanced-nonsquamous-nsclc-and-untreated-brain-metastases/ 2023-09-13T18:05:47+00:00 https://ascopost.com/news/september-2023/ 2023-08-31T21:36:09+00:00 https://ascopost.com/news/september-2023/risk-factors-for-melanoma-among-individuals-living-in-atlantic-canada/ 2023-09-22T17:56:26+00:00 https://ascopost.com/news/september-2023/improving-nutrition-guidance-may-optimize-fertility-treatments-for-female-cancer-survivors/ 2023-09-01T13:43:39+00:00 https://ascopost.com/news/september-2023/dlbcl-benefit-from-polatuzumab-vedotin-containing-regimens-based-on-cell-of-origin-subtype/ 2023-09-26T15:20:01+00:00 https://ascopost.com/news/september-2023/newly-published-data-on-a-response-biomarker-for-dovitinib-in-patients-with-rcc/ 2023-09-15T17:22:28+00:00 https://ascopost.com/news/september-2023/strategies-to-predict-immunotherapy-benefit-among-patients-with-advanced-colorectal-cancer/ 2023-09-05T18:24:10+00:00 https://ascopost.com/news/september-2023/statins-may-be-linked-to-lower-risk-of-colorectal-cancer-in-patients-with-ulcerative-colitis/ 2023-10-06T17:22:46+00:00 https://ascopost.com/news/september-2023/23andme-granted-fda-510k-clearance-to-report-additional-brca-variants/ 2023-09-05T16:25:37+00:00 https://ascopost.com/news/september-2023/platinum-sensitive-ovarian-cancer-addition-of-atezolizumab-to-bevacizumab-and-platinum-based-therapy/ 2023-09-05T16:13:13+00:00 https://ascopost.com/news/september-2023/receptor-status-among-patients-with-invasive-breast-cancer-what-s-missing/ 2023-09-05T18:55:03+00:00 https://ascopost.com/news/september-2023/addition-of-tumor-treating-fields-therapy-to-standard-systemic-therapy-in-metastatic-nsclc-after-disease-progression/ 2023-09-13T18:07:41+00:00 https://ascopost.com/news/september-2023/examining-disparities-in-endometrial-cancer-outcomes-among-black-patients/ 2023-09-06T16:53:54+00:00 https://ascopost.com/news/september-2023/can-ai-assessment-of-screening-mammograms-offer-similar-accuracy-to-human-readers/ 2023-09-06T17:18:32+00:00 https://ascopost.com/news/september-2023/allogeneic-hct-outcomes-in-patients-with-mds-and-high-risk-genetics/ 2023-10-02T18:24:24+00:00 https://ascopost.com/news/september-2023/germline-predisposition-and-homologous-recombination-deficiency-in-pancreatic-acinar-cell-carcinoma/ 2023-09-06T17:32:07+00:00 https://ascopost.com/news/september-2023/is-cardiovascular-disease-linked-to-increased-risk-of-cancer/ 2023-09-06T19:54:03+00:00 https://ascopost.com/news/september-2023/snmmi-provides-new-consensus-statement-on-lupsma-therapy/ 2023-09-07T19:52:20+00:00 https://ascopost.com/news/september-2023/enhanced-recovery-program-may-be-effective-at-reducing-opioid-use-after-pancreatic-cancer-surgery/ 2023-09-07T18:26:32+00:00 https://ascopost.com/news/september-2023/high-grade-serous-ovarian-cancer-impact-of-multimodal-screening-on-survival/ 2023-09-07T16:05:20+00:00 https://ascopost.com/news/september-2023/immune-checkpoint-inhibitors-for-patients-with-child-pugh-class-b-vs-a-advanced-hepatocellular-carcinoma/ 2023-09-07T16:17:33+00:00 https://ascopost.com/news/september-2023/efficacy-of-the-9-valent-hpv-vaccine-10-year-follow-up/ 2026-01-28T18:58:58+00:00 https://ascopost.com/news/september-2023/asco-participates-in-president-s-cancer-panel-event/ 2023-09-07T19:51:25+00:00 https://ascopost.com/news/september-2023/vitamin-c-and-d-supplements-for-patients-with-aml-undergoing-intensive-chemotherapy/ 2023-11-15T18:08:08+00:00 https://ascopost.com/news/september-2023/radiation-exposure-from-medical-imaging-in-pediatric-patients-with-down-syndrome/ 2023-09-08T16:40:08+00:00 https://ascopost.com/news/september-2023/dabrafenib-plus-trametinib-in-relapsed-or-refractory-braf-v600-mutant-pediatric-high-grade-glioma/ 2023-09-08T15:45:57+00:00 https://ascopost.com/news/september-2023/risk-factors-for-incident-heart-failure-among-cancer-survivors-aged-18-to-39/ 2023-09-08T15:50:47+00:00 https://ascopost.com/news/september-2023/cytotoxic-and-immune-stimulatory-gene-therapy-for-adults-with-primary-high-grade-glioma/ 2023-09-08T15:57:44+00:00 https://ascopost.com/news/september-2023/neoadjuvant-palbociclib-plus-giredestrant-or-anastrozole-in-er-positive-her2-negative-breast-cancer/ 2023-10-05T19:07:31+00:00 https://ascopost.com/news/september-2023/egfr-tyrosine-kinase-inhibitors-vs-durvalumab-in-egfr-mutated-nsclc-impact-on-survival/ 2023-11-16T23:12:17+00:00 https://ascopost.com/news/september-2023/nsclc-osimertinib-plus-chemo-vs-osimertinib-alone/ 2023-11-16T23:15:33+00:00 https://ascopost.com/news/september-2023/study-questions-role-of-extended-pleurectomy-decortication-in-patients-with-mesothelioma/ 2023-11-17T16:56:02+00:00 https://ascopost.com/news/september-2023/fda-approves-new-multiple-myeloma-combination-therapy/ 2023-12-27T17:26:57+00:00 https://ascopost.com/news/september-2023/patients-with-cancer-and-dpyd-variant-alleles-outcomes-with-reduced-dose-fluoropyrimidine-therapy/ 2023-09-12T17:18:24+00:00 https://ascopost.com/news/september-2023/can-an-anti-ebv-antibody-assist-in-screening-for-nasopharyngeal-cancer/ 2026-01-28T18:51:48+00:00 https://ascopost.com/news/september-2023/montefiore-einstein-comprehensive-cancer-center-awarded-comprehensive-designation-from-the-nci/ 2023-09-12T17:02:25+00:00 https://ascopost.com/news/september-2023/kras-wild-type-advanced-pancreatic-cancer-addition-of-monoclonal-antibody-to-chemotherapy/ 2023-09-13T14:28:59+00:00 https://ascopost.com/news/september-2023/modified-classification-of-pulmonary-adenocarcinomas-may-be-more-accurate-than-who-classification-system/ 2023-11-17T16:52:17+00:00 https://ascopost.com/news/september-2023/taiwanese-program-shows-potential-for-detecting-early-stage-lung-cancer/ 2023-11-17T16:48:41+00:00 https://ascopost.com/news/september-2023/aegean-trial-demonstrates-positive-surgical-outcomes-with-the-addition-of-perioperative-durvalumab-to-neoadjuvant-chemotherapy/ 2023-11-17T16:44:40+00:00 https://ascopost.com/news/september-2023/relapsed-or-refractory-multiple-myeloma-mezigdomide-plus-dexamethasone/ 2023-10-02T18:51:12+00:00 https://ascopost.com/news/september-2023/selinexor-maintenance-therapy-in-advanced-or-recurrent-endometrial-cancer/ 2023-09-13T16:46:18+00:00 https://ascopost.com/news/september-2023/pd-l1-inhibition-for-advanced-alveolar-soft-part-sarcoma/ 2023-09-15T14:00:06+00:00 https://ascopost.com/news/september-2023/immunotherapy-combination-vs-standard-chemotherapy-for-metastatic-nsclc/ 2023-11-17T16:39:59+00:00 https://ascopost.com/news/september-2023/is-adagrasib-active-in-kras-g12c-mutated-nsclc/ 2023-11-17T16:38:58+00:00 https://ascopost.com/news/september-2023/impact-of-stigmatization-on-patients-with-lung-cancer/ 2023-11-17T16:36:45+00:00 https://ascopost.com/news/september-2023/aacr-issues-annual-cancer-progress-report/ 2023-09-15T16:53:30+00:00 https://ascopost.com/news/september-2023/extensive-stage-small-cell-lung-cancer-triplet-combination-vs-chemotherapy-alone/ 2023-11-17T16:34:26+00:00 https://ascopost.com/news/september-2023/comparing-radiation-therapies-for-nsclc/ 2023-11-17T16:32:30+00:00 https://ascopost.com/news/september-2023/accuracy-of-iaslcs-2009-database-for-pleural-mesothelioma-staging/ 2023-11-17T16:30:09+00:00 https://ascopost.com/news/september-2023/localized-ewing-sarcoma-interval-compressed-vs-standard-timing-chemotherapy/ 2023-09-18T15:01:33+00:00 https://ascopost.com/news/september-2023/relapsed-pediatric-t-cell-all-base-edited-car7-t-cells/ 2023-10-17T21:08:20+00:00 https://ascopost.com/news/september-2023/cancer-moonshot-initiative-receives-240-million-boost/ 2023-09-18T15:49:20+00:00 https://ascopost.com/news/september-2023/fda-approves-momelotinib-for-patients-with-myelofibrosis-and-anemia/ 2025-09-30T19:27:52+00:00 https://ascopost.com/news/september-2023/study-examines-disparities-in-access-to-cancer-care-among-non-english-speaking-patients-in-the-united-states/ 2023-09-19T17:36:43+00:00 https://ascopost.com/news/september-2023/ctdna-identified-in-breast-milk-from-women-with-breast-cancer/ 2023-09-19T18:44:34+00:00 https://ascopost.com/news/september-2023/addition-of-first-line-regorafenib-to-nivolumab-and-chemotherapy-in-metastatic-esophageal-cancer/ 2023-09-29T15:14:17+00:00 https://ascopost.com/news/september-2023/previously-untreated-advanced-melanoma-addition-of-bempegaldesleukin-to-nivolumab/ 2023-09-19T17:40:14+00:00 https://ascopost.com/news/september-2023/tisotumab-vedotin-based-combinations-in-advanced-cervical-cancer/ 2023-09-19T17:37:40+00:00 https://ascopost.com/news/september-2023/lungcan-advocacy-program-nets-25-percent-increase-in-lcrp-funding/ 2023-11-17T16:28:43+00:00 https://ascopost.com/news/september-2023/reproductive-factors-may-be-associated-with-higher-risk-of-lung-cancer-in-women/ 2023-11-17T16:27:11+00:00 https://ascopost.com/news/september-2023/psa-screening-for-him-act-introduced-in-senate-aims-to-reduce-costs-for-prostate-cancer-screening/ 2023-09-20T15:57:18+00:00 https://ascopost.com/news/september-2023/effect-of-adjuvant-metformin-on-risk-of-new-primary-cancers-in-patients-with-early-breast-cancer/ 2023-09-20T19:04:38+00:00 https://ascopost.com/news/september-2023/addition-of-olaparib-to-abiraterone-in-metastatic-castration-resistant-prostate-cancer/ 2023-09-20T15:15:53+00:00 https://ascopost.com/news/september-2023/colorectal-cancer-screening-major-communication-gap-in-the-clinical-setting/ 2023-09-20T19:44:53+00:00 https://ascopost.com/news/september-2023/effect-of-diet-and-exercise-intervention-on-chemotherapy-dose-intensity-response-rate-among-patients-with-breast-cancer/ 2023-09-21T15:48:20+00:00 https://ascopost.com/news/september-2023/first-line-nalirifox-vs-nab-paclitaxelgemcitabine-in-metastatic-pancreatic-cancer-napoli-3/ 2023-09-21T16:05:04+00:00 https://ascopost.com/news/september-2023/the-immune-system-may-play-vital-role-in-remission-duration-among-patients-with-multiple-myeloma/ 2023-09-21T16:10:18+00:00 https://ascopost.com/news/september-2023/neocoast-durvalumab-monotherapy-vs-combined-with-other-immunotherapies-for-early-stage-nsclc/ 2023-09-21T17:50:33+00:00 https://ascopost.com/news/september-2023/herthena-lung01-patritumab-deruxtecan-for-advanced-egfr-mutant-nsclc/ 2023-09-21T16:20:50+00:00 https://ascopost.com/news/september-2023/testicular-cancer-surveillance-vs-chemotherapy-after-postchemotherapy-rplnd-shows-viable-residual-cancer/ 2023-09-22T15:23:15+00:00 https://ascopost.com/news/september-2023/magrolimab-plus-azacitidine-in-previously-untreated-patients-with-aml-ineligible-for-intensive-chemotherapy/ 2023-09-22T16:29:29+00:00 https://ascopost.com/news/september-2023/adjuvant-pemetrexedcisplatin-vs-vinorelbinecisplatin-in-stage-ii-iiia-nonsquamous-nsclc/ 2023-09-22T15:28:32+00:00 https://ascopost.com/news/september-2023/neoadjuvant-chemotherapy-followed-by-surgery-vs-standard-chemoradiation-for-cervical-cancer/ 2023-09-22T15:52:45+00:00 https://ascopost.com/news/september-2023/lung-map-study-may-improve-access-to-clinical-trials-for-underrepresented-patients/ 2023-09-22T16:30:50+00:00 https://ascopost.com/news/september-2023/particulate-matter-concentrations-and-incidence-of-breast-cancer/ 2023-10-05T19:10:03+00:00 https://ascopost.com/news/september-2023/exposure-to-pfas-and-phenols-may-be-linked-to-cancer-risk/ 2023-09-26T15:50:36+00:00 https://ascopost.com/news/september-2023/high-intensity-training-may-reduce-the-risk-of-colorectal-cancer-in-patients-with-lynch-syndrome/ 2023-09-26T15:53:28+00:00 https://ascopost.com/news/september-2023/personalized-biomarker-based-umbrella-trial-in-recurrent-or-metastatic-hnscc/ 2026-01-28T18:08:03+00:00 https://ascopost.com/news/september-2023/hypofractionated-vs-conventional-fractionated-proton-radiotherapy-after-mastectomy-for-breast-cancer/ 2023-09-26T16:16:19+00:00 https://ascopost.com/news/september-2023/addition-of-hyperthermic-intraperitoneal-chemotherapy-to-interval-cytoreductive-surgery-in-advanced-ovarian-cancer/ 2023-09-26T18:15:04+00:00 https://ascopost.com/news/september-2023/do-checkpoint-inhibitors-show-benefit-in-egfr-mutated-nsclc-after-progression/ 2023-11-17T16:25:41+00:00 https://ascopost.com/news/september-2023/oral-health-may-be-linked-to-survival-in-patients-with-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T18:05:56+00:00 https://ascopost.com/news/september-2023/gynecologic-cancer-misinformation-may-be-widespread-on-tiktok/ 2023-09-27T16:06:10+00:00 https://ascopost.com/news/september-2023/fda-approves-bosutinib-for-pediatric-patients-with-chronic-myelogenous-leukemia/ 2023-09-27T17:10:55+00:00 https://ascopost.com/news/september-2023/destiny-lung02-t-dxd-for-her2-mutant-metastatic-nsclc/ 2023-09-27T19:54:18+00:00 https://ascopost.com/news/september-2023/annual-report-to-the-nation-on-the-status-of-cancer-part-2-focuses-on-covid-19-s-impact-on-cancer-diagnoses/ 2023-09-27T18:53:27+00:00 https://ascopost.com/news/september-2023/carfilzomib-and-lenalidomide-based-therapy-in-primary-plasma-cell-leukemia/ 2023-11-06T20:20:41+00:00 https://ascopost.com/news/september-2023/bariatric-surgery-may-reduce-the-risk-of-hematologic-malignancies-particularly-among-female-patients/ 2023-09-28T13:47:28+00:00 https://ascopost.com/news/september-2023/mutations-in-11-genes-may-be-associated-with-aggressive-prostate-cancer/ 2023-09-28T13:54:43+00:00 https://ascopost.com/news/september-2023/first-line-dabrafenibtrametinib-in-pediatric-braf-v600-mutated-low-grade-glioma/ 2023-09-28T14:39:03+00:00 https://ascopost.com/news/september-2023/quality-of-life-with-nivolumab-plus-chemotherapy-in-advanced-gastricgej-cancer-or-esophageal-adenocarcinoma/ 2023-09-28T19:12:28+00:00 https://ascopost.com/news/september-2023/effect-of-travel-time-and-distance-to-cancer-center-on-participation-of-patients-in-genotype-matched-trials/ 2023-09-28T15:02:52+00:00 https://ascopost.com/news/september-2023/does-colon-tumor-location-play-a-role-in-metastasis-and-survival/ 2023-09-28T19:21:06+00:00 https://ascopost.com/news/september-2023/hyperglycemia-among-patients-with-breast-cancer-receiving-alpelisib/ 2023-09-29T15:08:57+00:00 https://ascopost.com/news/september-2023/using-whole-body-imaging-agent-to-predict-response-to-treatment-in-her2-positive-metastatic-breast-cancer/ 2023-09-29T12:49:47+00:00 https://ascopost.com/news/september-2023/feminist-approach-to-address-gender-inequalities-may-improve-women-s-access-to-cancer-prevention-detection-and-care/ 2023-09-29T19:25:46+00:00 https://ascopost.com/news/september-2023/ambulatory-thromboprophylaxis-in-patients-with-lung-and-gastrointestinal-cancers/ 2023-09-29T13:12:33+00:00 https://ascopost.com/news/october-2023/ 2023-10-02T15:21:32+00:00 https://ascopost.com/news/october-2023/neoadjuvant-immune-checkpoint-blockade-may-be-effective-across-multiple-cancer-types/ 2023-10-02T17:04:12+00:00 https://ascopost.com/news/october-2023/long-term-low-grade-intestinal-inflammation-may-be-prevalent-among-patients-who-have-undergone-radiotherapy/ 2023-10-02T17:21:24+00:00 https://ascopost.com/news/october-2023/fda-grants-first-marketing-authorization-for-a-dna-test-to-assess-predisposition-for-dozens-of-cancer-types/ 2023-10-02T18:20:16+00:00 https://ascopost.com/news/october-2023/postdiagnosis-exercise-and-mortality-risk-among-patients-with-cancer/ 2023-10-02T17:35:35+00:00 https://ascopost.com/news/october-2023/prophylactic-radiation-for-high-risk-asymptomatic-bone-metastases/ 2023-10-02T17:41:41+00:00 https://ascopost.com/news/october-2023/tucatinibtrastuzumab-for-previously-treated-patients-with-her2-positive-metastatic-biliary-tract-cancer/ 2023-10-02T17:51:36+00:00 https://ascopost.com/news/october-2023/sbrt-vs-standard-radiotherapy-for-localized-prostate-cancer-5-year-analysis-of-pace-b/ 2023-10-03T16:06:07+00:00 https://ascopost.com/news/october-2023/stereotactic-radiotherapy-for-patients-with-primary-rcc-unsuitable-for-surgery-fastrack-ii/ 2023-10-03T16:12:00+00:00 https://ascopost.com/news/october-2023/hypofractionated-vs-conventionally-fractionated-postmastectomy-radiation-fabrec-trial/ 2023-10-03T20:11:57+00:00 https://ascopost.com/news/october-2023/precision-medicine-navigators-may-increase-genomic-testing-rates-among-black-patients-with-prostate-cancer/ 2023-10-03T19:17:50+00:00 https://ascopost.com/news/october-2023/liquid-biopsies-may-be-predictive-of-cancer-recurrence-following-chemoradiation-in-patients-with-cervical-cancer/ 2023-10-03T20:11:05+00:00 https://ascopost.com/news/october-2023/hypofractionated-radiotherapy-may-reduce-burden-of-head-and-neck-cancer-in-low-and-middle-income-countries/ 2023-10-03T19:51:36+00:00 https://ascopost.com/news/october-2023/sexual-activity-and-vaginal-dilation-associated-with-fewer-side-effects-after-chemoradiation-for-cervical-cancer/ 2023-10-04T14:50:11+00:00 https://ascopost.com/news/october-2023/using-recent-diagnostic-scans-may-cut-time-to-treatment-for-patients-needing-urgent-palliative-radiotherapy/ 2023-10-04T15:10:56+00:00 https://ascopost.com/news/october-2023/racial-and-ethnic-minority-patients-with-breast-cancer-may-be-less-likely-to-receive-palliative-care-than-white-patients/ 2023-10-04T16:40:29+00:00 https://ascopost.com/news/october-2023/liquid-biopsy-may-help-identify-patients-with-nsclc-that-could-benefit-from-radiation-therapy/ 2023-10-05T15:41:20+00:00 https://ascopost.com/news/october-2023/diabetes-may-be-linked-to-lower-survival-among-patients-with-multiple-myeloma-survival-outcomes-may-be-race-dependent/ 2023-10-04T17:00:00+00:00 https://ascopost.com/news/october-2023/new-poll-weighs-necessity-of-life-expectancy-in-cancer-screening-guidelines/ 2023-10-05T16:17:11+00:00 https://ascopost.com/news/october-2023/addition-of-sbrt-to-abiraterone-acetate-in-oligometastatic-castrate-resistant-prostate-cancer/ 2023-10-05T16:43:11+00:00 https://ascopost.com/news/october-2023/shorther-update-10-year-survival-outcomes-with-9-weeks-vs-1-year-of-adjuvant-trastuzumab-in-her2-positive-breast-cancer/ 2023-10-05T17:28:18+00:00 https://ascopost.com/news/october-2023/addition-of-lapatinib-to-chemoradiotherapy-in-non-hpv-related-head-and-neck-cancer/ 2026-01-28T17:58:00+00:00 https://ascopost.com/news/october-2023/isa-krd-for-transplant-eligible-and-ineligible-high-risk-newly-diagnosed-multiple-myeloma/ 2023-10-26T15:20:48+00:00 https://ascopost.com/news/october-2023/structural-racism-s-effect-on-cancer-mortality-rates/ 2023-10-05T18:58:00+00:00 https://ascopost.com/news/october-2023/neighborhood-walkability-and-risk-of-obesity-related-cancers/ 2023-10-06T13:38:42+00:00 https://ascopost.com/news/october-2023/chemotherapy-shortages-ongoing-according-to-new-survey/ 2023-10-06T16:58:52+00:00 https://ascopost.com/news/october-2023/dendritic-cell-vaccine-plus-stem-cell-transplant-for-multiple-myeloma/ 2023-10-06T16:36:15+00:00 https://ascopost.com/news/october-2023/adjuvant-pembrolizumab-may-offer-survival-benefit-over-observation-in-patients-with-muscle-invasive-or-locally-advanced-urothelial-carcinoma/ 2023-10-09T17:04:29+00:00 https://ascopost.com/news/october-2023/do-patients-with-advanced-cancer-value-quality-over-quantity-of-life/ 2023-10-09T17:11:09+00:00 https://ascopost.com/news/october-2023/individualized-sabr-for-lung-tumors/ 2023-10-09T15:21:18+00:00 https://ascopost.com/news/october-2023/pertuzumabtrastuzumab-for-nonindicated-her2-altered-advanced-solid-tumors-mypathway-update/ 2023-10-09T17:02:30+00:00 https://ascopost.com/news/october-2023/her3-expressing-metastatic-breast-cancer-patritumab-deruxtecan-in-previously-treated-patients/ 2023-10-09T16:46:15+00:00 https://ascopost.com/news/october-2023/children-of-young-female-patients-with-a-history-of-cancer-may-be-at-risk-of-birth-defects/ 2023-10-11T14:14:37+00:00 https://ascopost.com/news/october-2023/investigators-compare-health-information-exchange-data-with-patient-self-reported-data-to-measure-cancer-screening-uptake/ 2023-10-11T14:18:12+00:00 https://ascopost.com/news/october-2023/adjuvant-canakinumab-in-completely-resected-nsclc/ 2023-10-11T19:27:12+00:00 https://ascopost.com/news/october-2023/ivig-may-reduce-infection-risk-among-patients-with-multiple-myeloma-receiving-anti-bcma-therapy/ 2023-10-11T16:15:32+00:00 https://ascopost.com/news/october-2023/fda-grants-marketing-authorization-to-edison-histotripsy-system-for-treatment-of-liver-tumors/ 2023-10-12T14:03:55+00:00 https://ascopost.com/news/october-2023/cadonilimab-an-anti-pd-1ctla-4-bispecific-antibody-for-advanced-solid-tumors/ 2023-10-11T19:04:58+00:00 https://ascopost.com/news/october-2023/fda-approves-encorafenib-with-binimetinib-for-metastatic-braf-v600e-mutated-nsclc/ 2023-10-12T16:19:47+00:00 https://ascopost.com/news/october-2023/germline-variants-and-risk-of-aggressive-prostate-cancer/ 2023-10-12T15:53:24+00:00 https://ascopost.com/news/october-2023/nonmelanoma-skin-cancers-may-have-higher-mortality-rate-than-melanoma/ 2023-10-12T16:15:38+00:00 https://ascopost.com/news/october-2023/chemical-hair-relaxers-may-increase-risk-of-uterine-cancer-among-black-women/ 2023-10-12T16:38:50+00:00 https://ascopost.com/news/october-2023/rectal-cancer-managed-by-watch-and-wait-strategy-validation-of-immunoscore-biopsy/ 2023-10-16T16:52:53+00:00 https://ascopost.com/news/october-2023/ai-software-demonstrates-potential-to-accurately-detect-skin-cancer/ 2023-10-13T17:08:17+00:00 https://ascopost.com/news/october-2023/prophylactic-salpingo-oophorectomy-and-survival-after-resection-of-germline-brca12-mutant-breast-cancer/ 2023-10-13T17:06:55+00:00 https://ascopost.com/news/october-2023/patients-with-cancer-may-be-interested-in-complementary-therapies-survey-says/ 2023-10-13T14:43:07+00:00 https://ascopost.com/news/october-2023/how-war-has-disrupted-the-management-of-patients-with-breast-cancer-in-sudan/ 2023-10-18T14:46:14+00:00 https://ascopost.com/news/october-2023/can-ai-help-identify-kidney-tumors-that-may-respond-to-immunotherapy/ 2023-10-13T16:24:18+00:00 https://ascopost.com/news/october-2023/lung-art-trial-end-of-the-road-for-postoperative-radiotherapy/ 2023-10-16T19:14:35+00:00 https://ascopost.com/news/october-2023/asco-launches-new-webinar-making-palliative-care-a-part-of-your-oncology-practice/ 2023-10-13T17:22:45+00:00 https://ascopost.com/news/october-2023/fda-approves-adjuvant-nivolumab-for-stage-ii-bc-melanoma/ 2023-10-16T16:57:03+00:00 https://ascopost.com/news/october-2023/tumor-debulking-plus-palliative-chemotherapy-may-not-impact-quality-of-life-in-patients-with-metastatic-colorectal-cancer/ 2023-10-16T15:03:44+00:00 https://ascopost.com/news/october-2023/pet-imaging-may-validate-use-of-antibody-drug-conjugates-plus-lovastatin-to-enhance-her2-targeted-cancer-therapy/ 2023-10-16T15:58:07+00:00 https://ascopost.com/news/october-2023/rates-of-vte-chemoprophylaxis-prescriptions-and-vte-diagnosis-after-major-cancer-surgery/ 2023-10-16T15:35:52+00:00 https://ascopost.com/news/october-2023/many-survivors-of-childhood-cancer-experience-lifelong-chronic-health-problems-and-shorter-lifespans-than-their-healthier-peers/ 2023-10-16T16:55:15+00:00 https://ascopost.com/news/october-2023/fda-approves-neoadjuvantadjuvant-pembrolizumab-for-resectable-nsclc/ 2023-10-18T13:48:01+00:00 https://ascopost.com/news/october-2023/addition-of-berzosertib-to-topotecan-in-relapsed-sclc/ 2023-10-18T13:51:47+00:00 https://ascopost.com/news/october-2023/do-low-and-moderate-grade-adverse-events-affect-rates-of-treatment-discontinuation-in-cll/ 2023-10-18T13:58:12+00:00 https://ascopost.com/news/october-2023/the-future-of-ai-in-cancer-care/ 2023-10-19T14:35:39+00:00 https://ascopost.com/news/october-2023/gut-microbiome-variations-and-colorectal-cancer-risk/ 2023-10-18T14:39:08+00:00 https://ascopost.com/news/october-2023/air-pollution-and-breast-cancer-risk-residential-and-workplace-exposure/ 2023-11-02T18:42:40+00:00 https://ascopost.com/news/october-2023/cns-prophylaxis-with-high-dose-methotrexate-in-high-risk-aggressive-b-cell-lymphoma/ 2023-11-28T19:01:49+00:00 https://ascopost.com/news/october-2023/mri-scans-could-predict-postradiation-urinary-side-effects-in-patients-with-prostate-cancer/ 2023-10-19T17:54:31+00:00 https://ascopost.com/news/october-2023/almost-half-of-oncology-drugs-approved-since-1998-have-been-precision-therapies-new-study-finds/ 2023-10-19T18:35:09+00:00 https://ascopost.com/news/october-2023/blood-based-testing-for-multicancer-early-detection/ 2023-10-19T18:59:52+00:00 https://ascopost.com/news/october-2023/efficacy-of-radiotherapy-in-rhabdomyosarcoma/ 2023-10-20T17:02:30+00:00 https://ascopost.com/news/october-2023/tislelizumab-vs-sorafenib-in-first-line-treatment-of-unresectable-hepatocellular-carcinoma/ 2023-10-20T17:21:05+00:00 https://ascopost.com/news/october-2023/patients-and-survivors-of-cancer-may-be-impacted-by-us-drug-shortages/ 2023-10-20T18:21:52+00:00 https://ascopost.com/news/october-2023/is-idecabtagene-vicleucel-effective-in-patients-with-multiple-myeloma-regardless-of-race/ 2023-10-20T20:00:54+00:00 https://ascopost.com/news/october-2023/pre-and-postsurgical-immunotherapy-improves-outcomes-for-patients-with-resectable-early-stage-nsclc/ 2023-11-08T21:04:22+00:00 https://ascopost.com/news/october-2023/everest-trial-adjuvant-everolimus-for-high-risk-clear-cell-renal-cell-carcinoma/ 2023-11-13T17:28:50+00:00 https://ascopost.com/news/october-2023/fda-expands-pediatric-indication-for-entrectinib-and-approves-new-pellet-formulation/ 2023-10-21T16:04:59+00:00 https://ascopost.com/news/october-2023/belzutifan-improves-outcomes-for-pretreated-patients-with-clear-cell-renal-cell-carcinoma-compared-to-everolimus/ 2023-11-13T17:32:28+00:00 https://ascopost.com/news/october-2023/parp-inhibitor-plus-immunotherapy-added-to-chemotherapy-lowers-risk-of-disease-progression-in-patients-with-advanced-endometrial-cancer/ 2023-11-08T21:18:37+00:00 https://ascopost.com/news/october-2023/esmo-2023-new-data-in-skin-cancers/ 2024-01-04T19:03:05+00:00 https://ascopost.com/news/october-2023/erdafitinib-demonstrates-improved-responses-in-fgfr-altered-advanced-urothelial-carcinoma/ 2023-10-23T14:35:26+00:00 https://ascopost.com/news/october-2023/cabozantinib-for-pretreated-patients-with-advanced-neuroendocrine-tumors-cabinet-trial/ 2023-11-08T21:27:41+00:00 https://ascopost.com/news/october-2023/nivolumab-plus-gemcitabine-and-cisplatin-may-improve-survival-in-patients-with-metastatic-urothelial-carcinoma/ 2023-10-23T16:06:52+00:00 https://ascopost.com/news/october-2023/induction-chemotherapy-and-subsequent-chemoradiation-may-improve-survival-and-recurrence-rates-in-patients-with-cervical-cancer/ 2023-10-23T16:12:29+00:00 https://ascopost.com/news/october-2023/trends-in-lung-cancer-incidence-among-women-and-men-in-the-united-states/ 2023-10-23T16:21:35+00:00 https://ascopost.com/news/october-2023/germline-cancer-predisposing-variants-and-increased-risk-of-late-mortality-from-subsequent-malignant-neoplasms-in-long-term-childhood-cancer-survivors/ 2023-10-23T16:39:50+00:00 https://ascopost.com/news/october-2023/major-pathologic-response-to-neoadjuvant-pembrolizumab-in-advanced-melanoma-trial-exceeds-50-percent/ 2023-11-20T17:59:28+00:00 https://ascopost.com/news/october-2023/psmafore-lutetium-lu-177-vipivotide-tetraxetan-in-metastatic-prostate-cancer/ 2023-11-13T17:27:24+00:00 https://ascopost.com/news/october-2023/adults-living-alone-are-at-higher-risk-of-cancer-mortality-compared-to-adults-living-with-others/ 2023-10-24T17:52:49+00:00 https://ascopost.com/news/october-2023/novel-strategies-for-eliminating-dormant-tumor-cells-in-breast-cancer-survivors/ 2023-10-24T18:01:43+00:00 https://ascopost.com/news/october-2023/ai-based-calculator-may-accurately-predict-long-term-cancer-survival/ 2023-10-24T18:07:36+00:00 https://ascopost.com/news/october-2023/patient-education-materials-on-breast-cancer-may-be-difficult-to-access/ 2023-10-24T18:13:08+00:00 https://ascopost.com/news/october-2023/fda-approves-ivosidenib-for-myelodysplastic-syndromes/ 2023-11-06T18:10:47+00:00 https://ascopost.com/news/october-2023/primary-care-intervention-to-improve-follow-up-of-overdue-abnormal-cancer-screening-test-results/ 2023-10-26T13:37:24+00:00 https://ascopost.com/news/october-2023/perioperative-chemotherapy-and-pembrolizumab-in-locally-advanced-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/ 2023-10-26T15:25:40+00:00 https://ascopost.com/news/october-2023/mind-body-fitness-classes-may-reduce-unplanned-hospitalizations-urgent-care-visits-during-cancer-care/ 2023-10-26T15:04:05+00:00 https://ascopost.com/news/october-2023/yoga-based-supportive-care-may-prevent-treatment-related-complications-in-patients-with-head-and-neck-cancer/ 2026-01-28T18:02:08+00:00 https://ascopost.com/news/october-2023/text-message-based-prescreening-could-benefit-patients-receiving-immunotherapy/ 2023-10-26T15:12:28+00:00 https://ascopost.com/news/october-2023/pfas-exposure-may-increase-risk-of-thyroid-cancer/ 2023-10-27T15:47:33+00:00 https://ascopost.com/news/october-2023/asco-launches-asco-certified-to-ensure-the-delivery-of-high-quality-patient-centered-cancer-care-to-every-patient/ 2023-10-27T15:45:14+00:00 https://ascopost.com/news/october-2023/pembrolizumab-plus-lenvatinib-as-second-and-third-line-treatments-of-pleural-mesothelioma/ 2023-10-27T15:42:14+00:00 https://ascopost.com/news/october-2023/enzalutamide-with-or-without-leuprolide-and-leuprolide-alone-in-biochemically-recurrent-prostate-cancer/ 2023-10-27T15:23:01+00:00 https://ascopost.com/news/october-2023/sequential-cd19-and-cd22-directed-car-t-cell-therapy-in-pediatric-b-cell-all/ 2023-10-27T15:43:40+00:00 https://ascopost.com/news/october-2023/datopotamab-deruxtecan-may-improve-progression-free-survival-in-patients-with-metastatic-nsclc/ 2023-10-30T19:13:04+00:00 https://ascopost.com/news/october-2023/two-new-studies-using-cancerlinq-data/ 2023-10-30T15:19:51+00:00 https://ascopost.com/news/october-2023/fda-approves-toripalimab-tpzi-for-nasopharyngeal-carcinoma/ 2026-01-28T19:40:15+00:00 https://ascopost.com/news/october-2023/intraductal-papillary-mucinous-neoplasms-risk-of-pancreatic-cancer/ 2023-11-13T16:05:50+00:00 https://ascopost.com/news/october-2023/sotorasib-plus-panitumumab-in-kras-g12c-mutated-advanced-colorectal-cancer-codebreak-300/ 2023-11-08T21:00:32+00:00 https://ascopost.com/news/october-2023/role-of-crowdfunding-campaigns-in-covering-medical-expenses-for-cancer-survivors/ 2023-10-31T17:32:29+00:00 https://ascopost.com/news/october-2023/nivolumab-with-or-without-nivolumabipilimumab-boost-in-metastatic-renal-cell-carcinoma/ 2023-10-31T14:45:49+00:00 https://ascopost.com/news/october-2023/patients-with-newly-diagnosed-nsclc-or-melanoma-may-receive-limited-documentation-of-treatment-cost-discussions/ 2023-10-31T15:51:55+00:00 https://ascopost.com/news/october-2023/association-of-germline-egfr-mutations-with-familial-lung-cancer/ 2023-10-31T17:18:41+00:00 https://ascopost.com/news/october-2023/addition-of-amivantamab-to-chemotherapy-in-first-line-treatment-of-advanced-nsclc-with-egfr-exon-20-insertions/ 2023-11-08T21:19:46+00:00 https://ascopost.com/news/november-2023/ 2023-11-01T14:18:35+00:00 https://ascopost.com/news/november-2023/soy-expansion-in-brazil-may-be-linked-to-increased-mortality-among-pediatric-patients-with-all/ 2023-11-01T15:19:53+00:00 https://ascopost.com/news/november-2023/insurance-coverage-disruptions-may-reduce-rate-of-cancer-screenings/ 2023-11-01T15:15:40+00:00 https://ascopost.com/news/november-2023/fda-approves-pembrolizumab-plus-chemotherapy-for-biliary-tract-cancer/ 2023-11-01T17:34:54+00:00 https://ascopost.com/news/november-2023/three-year-overall-survival-with-tebentafusp-in-previously-untreated-advanced-uveal-melanoma/ 2023-11-01T17:44:21+00:00 https://ascopost.com/news/november-2023/advanced-ret-mutant-medullary-thyroid-cancer-first-line-selpercatinib/ 2023-11-01T18:21:32+00:00 https://ascopost.com/news/november-2023/acs-releases-updated-lung-cancer-screening-guideline/ 2023-11-08T18:29:30+00:00 https://ascopost.com/news/november-2023/international-group-of-surgical-oncologists-presents-new-commission-outlining-pragmatic-solutions-to-improve-cancer-surgery-outcomes-worldwide/ 2023-11-02T17:08:14+00:00 https://ascopost.com/news/november-2023/immune-checkpoint-inhibition-with-single-fraction-stereotactic-radiosurgery-may-not-increase-risk-of-radiation-necrosis-in-patients-with-nsclc-brain-metastases/ 2023-11-02T17:53:23+00:00 https://ascopost.com/news/november-2023/novel-blood-test-may-offer-early-cancer-detection/ 2023-11-03T16:58:02+00:00 https://ascopost.com/news/november-2023/perioperative-durvalumab-in-resectable-nsclc-aegean-trial/ 2023-11-02T17:48:36+00:00 https://ascopost.com/news/november-2023/2023-national-youth-tobacco-survey-shows-drop-in-e-cigarette-use-among-high-school-students/ 2023-11-02T20:13:14+00:00 https://ascopost.com/news/november-2023/bispecific-t-cell-engager-tarlatamab-in-previously-treated-patients-with-small-cell-lung-cancer/ 2023-11-02T20:19:41+00:00 https://ascopost.com/news/november-2023/personalized-care-may-prevent-overscreening-for-colorectal-cancer-in-older-patients/ 2023-11-03T15:03:36+00:00 https://ascopost.com/news/november-2023/secondary-pik3ca-mutations-drug-resistance-and-novel-pi3k-alpha-inhibitors-in-breast-cancer/ 2023-11-03T15:11:05+00:00 https://ascopost.com/news/november-2023/novel-strategy-may-improve-outcomes-in-patients-with-treatment-resistant-dlbcl/ 2025-10-31T16:37:21+00:00 https://ascopost.com/news/november-2023/novel-machine-learning-model-may-accurately-calculate-chemotherapy-success-in-patients-with-osteosarcoma/ 2023-11-06T16:11:03+00:00 https://ascopost.com/news/november-2023/addition-of-first-line-pembrolizumab-to-chemotherapy-with-or-without-bevacizumab-in-advanced-cervical-cancer-final-overall-survival-results-from-keynote-826/ 2023-11-06T16:22:26+00:00 https://ascopost.com/news/november-2023/adding-hipec-to-cytoreductive-surgery-in-gastric-cancer-with-synchronous-peritoneal-metastases/ 2023-11-06T20:33:06+00:00 https://ascopost.com/news/november-2023/adjuvant-atezolizumabbevacizumab-vs-active-surveillance-in-resected-or-ablated-high-risk-hepatocellular-carcinoma/ 2023-11-06T17:28:34+00:00 https://ascopost.com/news/november-2023/can-high-bmi-in-youth-affect-cancer-risk-later-on/ 2023-11-06T17:59:52+00:00 https://ascopost.com/news/november-2023/race-psa-level-and-risk-of-prostate-cancer/ 2023-11-07T18:43:59+00:00 https://ascopost.com/news/november-2023/lung-cancer-screenings-may-increase-long-term-survival-rates/ 2023-11-07T17:29:19+00:00 https://ascopost.com/news/november-2023/nemtabrutinib-may-provide-benefit-in-patients-with-relapsed-hematologic-malignancies/ 2023-11-07T17:34:36+00:00 https://ascopost.com/news/november-2023/patient-facing-ai-in-cancer-care/ 2023-11-07T16:59:04+00:00 https://ascopost.com/news/november-2023/adding-pembrolizumab-to-trastuzumab-and-chemotherapy-in-her2-positive-gastricgastroesophageal-junction-adenocarcinoma-keynote-811/ 2023-11-07T17:10:58+00:00 https://ascopost.com/news/november-2023/asco-applauds-confirmation-of-monica-bertagnolli-as-nih-director/ 2023-11-08T18:32:39+00:00 https://ascopost.com/news/november-2023/computer-models-may-help-reduce-cancer-disparities/ 2023-11-08T16:16:37+00:00 https://ascopost.com/news/november-2023/metastatic-castration-resistant-prostate-cancer-single-dose-lupsma-plus-maintenance-pembrolizumab/ 2023-11-08T16:20:59+00:00 https://ascopost.com/news/november-2023/genetics-of-nearby-healthy-tissue-may-help-predict-lung-cancer-recurrence/ 2023-11-08T16:32:55+00:00 https://ascopost.com/news/november-2023/subsequent-cancer-diagnosis-after-no-diagnosis-with-urgent-suspected-cancer-referral/ 2023-11-08T16:42:38+00:00 https://ascopost.com/news/november-2023/novel-antibody-drug-conjugate-shows-potential-in-treating-cldn182-positive-gastric-and-gej-cancers/ 2023-11-08T17:32:58+00:00 https://ascopost.com/news/november-2023/fda-approves-fruquintinib-for-refractory-metastatic-colorectal-cancer/ 2023-11-13T13:55:54+00:00 https://ascopost.com/news/november-2023/fda-amends-pembrolizumab-s-gastric-cancer-indication/ 2025-06-27T21:26:24+00:00 https://ascopost.com/news/november-2023/advancing-clinical-research-on-ovarian-cancer-and-overcoming-gender-inequity-in-low-and-middle-income-countries/ 2023-11-14T19:39:35+00:00 https://ascopost.com/news/november-2023/fda-approves-first-treatment-for-patients-with-rare-congenital-blood-disorder/ 2023-11-13T17:05:35+00:00 https://ascopost.com/news/november-2023/vitamin-d-supplements-may-help-reduce-chemotherapy-induced-peripheral-neuropathy/ 2023-11-13T16:35:34+00:00 https://ascopost.com/news/november-2023/patients-with-lower-extremity-lymphedema-may-face-increased-risk-of-skin-cancer/ 2023-11-13T16:41:06+00:00 https://ascopost.com/news/november-2023/investigational-dual-pd-1-and-tigit-blockade-in-advanced-gastroesophageal-cancer/ 2025-06-27T21:25:07+00:00 https://ascopost.com/news/november-2023/effect-of-bendamustine-prior-to-apheresis-on-outcomes-in-large-b-cell-lymphoma-treated-with-car-t-cell-therapy/ 2023-11-14T14:40:50+00:00 https://ascopost.com/news/november-2023/osimertinib-with-or-without-chemotherapy-in-egfr-mutant-advanced-nsclc/ 2023-12-12T19:45:47+00:00 https://ascopost.com/news/november-2023/cancer-care-disparities-among-patients-with-early-onset-colorectal-cancer/ 2023-11-14T15:59:23+00:00 https://ascopost.com/news/november-2023/comparing-the-accuracy-of-initial-staging-methods-in-prostate-cancer/ 2023-11-14T19:42:51+00:00 https://ascopost.com/news/november-2023/exposure-to-ct-radiation-and-risk-of-blood-cancers-in-young-patients/ 2023-11-14T17:47:46+00:00 https://ascopost.com/news/november-2023/long-term-organ-preservation-with-total-neoadjuvant-therapy-in-rectal-adenocarcinoma/ 2023-11-15T16:23:26+00:00 https://ascopost.com/news/november-2023/researchers-identify-novel-genetic-variants-predictive-of-prostate-cancer-risk-and-severity/ 2023-11-15T16:53:32+00:00 https://ascopost.com/news/november-2023/novel-assay-may-help-detect-and-treat-patients-with-aml/ 2023-11-15T18:06:02+00:00 https://ascopost.com/news/november-2023/ai-based-pathology-for-sensitivity-to-atezolizumabbevacizumab-in-hcc/ 2023-11-15T19:20:03+00:00 https://ascopost.com/news/november-2023/ofranergene-obadenovec-with-weekly-paclitaxel-for-platinum-resistant-ovarian-cancer/ 2023-11-15T17:46:52+00:00 https://ascopost.com/news/november-2023/racial-disparities-in-guideline-concordant-care-in-early-onset-colorectal-cancer-in-the-united-states/ 2023-11-16T14:46:28+00:00 https://ascopost.com/news/november-2023/number-of-cancer-treatments-performed-during-early-covid-19-pandemic/ 2023-11-16T14:52:57+00:00 https://ascopost.com/news/november-2023/occupational-exposure-to-solar-uv-radiation-and-nonmelanoma-skin-cancer/ 2023-11-16T15:08:18+00:00 https://ascopost.com/news/november-2023/ibrutinibvenetoclax-vs-chlorambucilobinutuzumab-in-previously-untreated-chronic-lymphocytic-leukemia-glow-trial-4-year-follow-up/ 2023-11-16T15:55:14+00:00 https://ascopost.com/news/november-2023/modified-vs-standard-ipilimumab-plus-nivolumab-in-advanced-renal-cell-carcinoma/ 2023-12-15T17:14:59+00:00 https://ascopost.com/news/november-2023/fda-approves-next-generation-tyrosine-kinase-inhibitor-repotrectinib-for-ros1-positive-nsclc/ 2023-12-12T20:15:11+00:00 https://ascopost.com/news/november-2023/fda-approves-capivasertib-with-fulvestrant-for-breast-cancer/ 2023-11-17T16:56:07+00:00 https://ascopost.com/news/november-2023/updated-findings-on-increased-cancer-occurrence-in-sweden-after-1986-chernobyl-accident/ 2023-11-17T18:21:21+00:00 https://ascopost.com/news/november-2023/partial-breast-irradiation-in-patients-with-early-stage-invasive-breast-cancer-or-dcis/ 2023-11-17T17:35:44+00:00 https://ascopost.com/news/november-2023/fda-approves-enzalutamide-for-nonmetastatic-castration-sensitive-prostate-cancer-with-biochemical-recurrence/ 2023-11-20T15:23:35+00:00 https://ascopost.com/news/november-2023/addition-of-adjuvant-hipec-to-standard-chemotherapy-in-locally-advanced-colon-cancer/ 2023-11-20T15:51:23+00:00 https://ascopost.com/news/november-2023/overall-survival-with-ctc-count-driven-treatment-in-advanced-breast-cancer/ 2023-11-20T16:03:08+00:00 https://ascopost.com/news/november-2023/early-breast-cancer-effect-of-radiotherapy-to-regional-nodes/ 2023-11-20T16:21:08+00:00 https://ascopost.com/news/november-2023/prevalence-of-unsatisfactory-samples-from-fit-tests-for-colorectal-cancer-screening/ 2023-11-20T17:48:54+00:00 https://ascopost.com/news/november-2023/asco-applauds-appointment-of-w-kimryn-rathmell-as-next-nci-director/ 2023-11-21T16:02:42+00:00 https://ascopost.com/news/november-2023/adding-pembrolizumab-to-chemotherapy-for-previously-untreated-advanced-pleural-mesothelioma/ 2023-11-21T16:20:04+00:00 https://ascopost.com/news/november-2023/blinatumomab-as-an-alternative-to-first-line-intensive-chemotherapy-in-pediatric-b-all/ 2023-11-21T20:57:50+00:00 https://ascopost.com/news/november-2023/axillary-soft-tissue-involvement-in-lymph-node-positive-breast-cancer/ 2023-11-21T20:57:17+00:00 https://ascopost.com/news/november-2023/early-stage-cervical-cancer-defining-follow-up-after-fertility-sparing-surgery/ 2023-11-21T19:55:45+00:00 https://ascopost.com/news/november-2023/metastatic-castration-resistant-prostate-cancer-efficacy-of-anti-psma-antibody-with-alpha-emitter/ 2023-11-21T19:21:46+00:00 https://ascopost.com/news/november-2023/fda-approves-nirogacestat-for-desmoid-tumors/ 2023-11-28T16:17:29+00:00 https://ascopost.com/news/november-2023/outcomes-with-olaparib-in-metastatic-castration-resistant-prostate-cancer-and-brca-alterations-in-the-profound-trial/ 2023-11-28T17:29:43+00:00 https://ascopost.com/news/november-2023/lack-of-basic-care-in-patients-with-colorectal-cancer-in-sub-saharan-africa/ 2023-11-28T17:26:21+00:00 https://ascopost.com/news/november-2023/novel-uterine-cancer-detection-method-for-women-with-abnormal-uterine-bleeding/ 2023-11-28T17:29:38+00:00 https://ascopost.com/news/november-2023/durvalumab-may-offer-survival-benefit-in-patients-with-nsclc-and-borderline-performance-status/ 2023-11-28T17:57:12+00:00 https://ascopost.com/news/november-2023/urban-environmental-exposures-and-incidence-of-breast-cancer-in-north-carolina/ 2023-11-28T17:46:47+00:00 https://ascopost.com/news/november-2023/adding-atezolizumab-to-perioperative-chemotherapy-in-resectable-esophagogastric-cancer/ 2023-11-28T17:33:43+00:00 https://ascopost.com/news/november-2023/fda-investigating-risk-of-t-cell-malignancy-following-bcma-or-cd19-directed-autologous-car-t-cell-immunotherapies/ 2023-11-29T15:29:58+00:00 https://ascopost.com/news/november-2023/incidence-of-breast-cancer-after-false-positive-mammography/ 2023-11-29T15:54:36+00:00 https://ascopost.com/news/november-2023/ultraprocessed-food-may-heighten-risk-of-head-and-neck-cancer-and-esophageal-adenocarcinoma/ 2026-01-28T19:38:44+00:00 https://ascopost.com/news/november-2023/trastuzumab-plus-gemcitabinecisplatin-in-advanced-her2-positive-biliary-tract-adenocarcinoma/ 2023-11-29T16:18:25+00:00 https://ascopost.com/news/november-2023/novel-ai-model-may-predict-nonsmokers-at-high-risk-for-lung-cancer/ 2023-11-29T16:28:48+00:00 https://ascopost.com/news/november-2023/inotuzumab-ozogamicin-based-induction-in-older-patients-with-philadelphia-chromosome-negative-b-cell-precursor-all/ 2023-11-29T19:46:49+00:00 https://ascopost.com/news/december-2023/ 2023-12-01T14:59:05+00:00 https://ascopost.com/news/december-2023/risk-of-subsequent-colorectal-cancer-after-abdominopelvic-radiotherapy-among-childhood-cancer-survivors/ 2023-12-01T15:09:32+00:00 https://ascopost.com/news/december-2023/risk-adapted-radioimmunotherapy-for-locally-advanced-pd-l1-positive-nsclc/ 2023-12-01T16:25:13+00:00 https://ascopost.com/news/december-2023/toxicities-potentially-linked-to-combination-immunotherapy-for-mesothelioma/ 2023-12-01T17:15:11+00:00 https://ascopost.com/news/december-2023/regular-screening-mammograms-may-significantly-reduce-breast-cancer-mortality-swedish-study-shows/ 2023-12-01T17:16:08+00:00 https://ascopost.com/news/december-2023/colorectal-cancer-incidence-and-time-to-recurrence/ 2023-12-01T16:50:34+00:00 https://ascopost.com/news/december-2023/consuming-navy-beans-may-improve-gut-health-regulate-immune-and-inflammatory-processes-in-colorectal-cancer-survivors/ 2023-12-04T15:40:25+00:00 https://ascopost.com/news/december-2023/black-men-with-advanced-prostate-cancer-may-be-less-likely-to-receive-treatment/ 2024-01-09T03:05:15+00:00 https://ascopost.com/news/december-2023/fda-grants-accelerated-approval-to-pirtobrutinib-for-cllsll/ 2023-12-04T16:42:38+00:00 https://ascopost.com/news/december-2023/predicting-primary-ovarian-insufficiency-in-childhood-cancer-survivors/ 2023-12-04T17:09:54+00:00 https://ascopost.com/news/december-2023/adding-tiragolumab-to-atezolizumab-and-chemotherapy-in-previously-untreated-extensive-stage-sclc/ 2023-12-04T18:02:00+00:00 https://ascopost.com/news/december-2023/disitamab-vedotin-in-previously-treated-patients-with-advanced-her2-positive-urothelial-carcinoma/ 2023-12-04T18:11:15+00:00 https://ascopost.com/news/december-2023/lung-map-trial-demonstrates-potential-of-public-private-partnerships-in-advancement-of-cancer-therapy/ 2023-12-05T15:12:59+00:00 https://ascopost.com/news/december-2023/chronic-health-conditions-may-be-prevalent-among-lgb-adolescent-and-young-adult-cancer-survivors/ 2023-12-05T15:24:57+00:00 https://ascopost.com/news/december-2023/everolimus-for-pediatric-recurrentprogressive-low-grade-glioma/ 2023-12-05T15:37:40+00:00 https://ascopost.com/news/december-2023/first-line-treatment-of-advanced-hcc-addition-of-pembrolizumab-to-lenvatinib/ 2023-12-05T16:35:46+00:00 https://ascopost.com/news/december-2023/adding-durvalumab-to-chemoradiotherapy-in-locally-advanced-cervical-cancer/ 2023-12-05T16:57:51+00:00 https://ascopost.com/news/december-2023/neoadjuvant-chemotherapy-may-help-some-patients-with-breast-cancer-skip-regional-nodal-irradiation/ 2023-12-08T20:44:58+00:00 https://ascopost.com/news/december-2023/tucatinib-plus-t-dm1-may-benefit-patients-with-advanced-or-metastatic-her2-positive-breast-cancer/ 2023-12-08T20:51:01+00:00 https://ascopost.com/news/december-2023/car-t-cell-therapy-may-be-effective-but-unaffordable-as-second-line-therapy-for-patients-with-dlbcl/ 2025-10-31T16:31:48+00:00 https://ascopost.com/news/december-2023/erdafitinib-vs-chemotherapy-in-previously-treated-fgfr-mutated-advanced-urothelial-carcinoma/ 2023-12-06T16:06:49+00:00 https://ascopost.com/news/december-2023/mantle-cell-lymphoma-predictive-value-of-measurable-residual-disease-with-rituximab-maintenance/ 2023-12-06T16:22:43+00:00 https://ascopost.com/news/december-2023/study-finds-link-between-t-cell-diversity-in-peripheral-blood-patient-age-and-stage-of-breast-cancer-development/ 2023-12-06T16:34:54+00:00 https://ascopost.com/news/december-2023/novel-selective-biomarker-tool-may-help-select-effective-targeted-therapies-in-patients-with-metastatic-breast-cancer/ 2023-12-08T21:24:04+00:00 https://ascopost.com/news/december-2023/risk-model-may-accurately-predict-aromatase-inhibitor-nonadherence/ 2023-12-07T19:28:17+00:00 https://ascopost.com/news/december-2023/novel-targeted-therapies-may-benefit-patients-with-metastatic-hr-positiveher2-negative-breast-cancer/ 2023-12-08T20:56:00+00:00 https://ascopost.com/news/december-2023/exercise-may-boost-quality-of-life-for-patients-with-metastatic-breast-cancer/ 2023-12-07T19:29:14+00:00 https://ascopost.com/news/december-2023/patients-with-hr-positive-breast-cancer-may-use-fertility-preservation-and-assisted-reproductive-technologies-without-increased-risk-of-recurrence/ 2024-01-05T17:41:50+00:00 https://ascopost.com/news/december-2023/younger-postmenopausal-patients-with-early-stage-breast-cancer-may-be-able-to-safely-omit-adjuvant-radiotherapy/ 2024-01-05T18:58:21+00:00 https://ascopost.com/news/december-2023/using-estrogen-levels-to-predict-who-may-benefit-from-preventive-treatment-with-anastrozole/ 2023-12-08T15:56:40+00:00 https://ascopost.com/news/december-2023/genetic-characteristics-of-her2-low-advanced-breast-cancers-may-guide-treatment-selection/ 2023-12-08T16:46:48+00:00 https://ascopost.com/news/december-2023/recipients-of-2023-susan-g-komen-breast-cancer-awards-honored/ 2023-12-08T17:40:39+00:00 https://ascopost.com/news/december-2023/potentially-targetable-fusion-rnas-may-be-more-common-in-metastatic-breast-cancer-than-previously-realized/ 2023-12-08T17:03:27+00:00 https://ascopost.com/news/december-2023/skipping-adjuvant-radiotherapy-may-not-impact-risk-of-recurrence-or-progression-in-patients-with-low-risk-dcis/ 2023-12-08T17:11:49+00:00 https://ascopost.com/news/december-2023/some-breast-cancer-survivors-may-safely-de-escalate-mammography-3-years-after-surgery/ 2023-12-08T17:18:43+00:00 https://ascopost.com/news/december-2023/abemaciclib-plus-ai-in-postmenopausal-patients-with-advanced-breast-cancer-final-overall-survival-analysis-from-monarch-3/ 2023-12-08T17:27:52+00:00 https://ascopost.com/news/december-2023/combining-ribociclib-with-hormone-therapy-improves-patient-outcomes-in-early-stage-breast-cancer-natalee/ 2023-12-08T20:39:39+00:00 https://ascopost.com/news/december-2023/acs10-score-may-help-inform-treatment-reduce-racial-disparities-in-black-pediatric-patients-with-aml/ 2023-12-14T19:30:34+00:00 https://ascopost.com/news/december-2023/male-researchers-lead-majority-of-nihs-active-r01-grants-in-classical-hematology-research/ 2023-12-14T19:31:25+00:00 https://ascopost.com/news/december-2023/patients-with-multiple-myeloma-may-experience-poorer-outcomes-in-the-real-world-compared-with-reported-outcomes-from-clinical-trials/ 2023-12-15T19:09:21+00:00 https://ascopost.com/news/december-2023/psychiatric-and-substance-use-disorders-may-be-linked-to-poorer-outcomes-in-aml-following-venetoclax-combination-therapies/ 2023-12-12T16:54:02+00:00 https://ascopost.com/news/december-2023/ibrutinib-plus-venetoclax-with-duration-of-treatment-determined-by-mrd-in-newly-diagnosed-cll/ 2023-12-20T17:47:28+00:00 https://ascopost.com/news/december-2023/autologous-stem-cell-transplant-vs-car-t-cell-therapy-in-patients-with-lbcl-in-complete-remission/ 2023-12-19T18:50:37+00:00 https://ascopost.com/news/december-2023/oral-regimen-with-minimal-chemotherapy-found-to-be-safe-effective-for-patients-with-apl/ 2023-12-20T17:49:52+00:00 https://ascopost.com/news/december-2023/car-t-cell-therapy-for-lymphoma-in-remission/ 2023-12-18T19:31:10+00:00 https://ascopost.com/news/december-2023/ai-model-may-help-distinguish-between-two-rare-hematologic-malignancies/ 2023-12-13T15:47:57+00:00 https://ascopost.com/news/december-2023/novel-car-t-cell-therapy-may-show-early-efficacy-in-patients-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma/ 2023-12-13T17:05:07+00:00 https://ascopost.com/news/december-2023/ibrutinibvenetoclax-in-relapsedrefractory-mantle-cell-lymphoma/ 2023-12-19T18:18:57+00:00 https://ascopost.com/news/december-2023/potential-underlying-genetic-mutations-identified-in-patients-with-myelodysplastic-syndromes/ 2023-12-13T16:50:30+00:00 https://ascopost.com/news/december-2023/daratumumab-plus-vrd-outperforms-vrd-alone-for-multiple-myeloma/ 2023-12-15T19:52:03+00:00 https://ascopost.com/news/december-2023/fda-approves-eflornithine-for-adult-and-pediatric-patients-with-high-risk-neuroblastoma/ 2023-12-14T17:37:19+00:00 https://ascopost.com/news/december-2023/presence-of-mrd-after-chemotherapy-may-predict-benefit-from-donor-transplant-in-npm1-mutated-aml/ 2024-01-11T15:46:29+00:00 https://ascopost.com/news/december-2023/menin-inhibitors-in-patients-with-advanced-aml-and-gene-mutations/ 2023-12-14T18:16:52+00:00 https://ascopost.com/news/december-2023/novel-bet-inhibitor-for-advanced-myelofibrosis/ 2023-12-18T19:20:31+00:00 https://ascopost.com/news/december-2023/ruxolitinib-plus-navitoclax-may-reduce-spleen-volume-in-patients-with-myelofibrosis/ 2023-12-14T17:59:47+00:00 https://ascopost.com/news/december-2023/revumenib-in-high-risk-kmt2ar-acute-leukemia/ 2023-12-20T18:16:10+00:00 https://ascopost.com/news/december-2023/use-of-elranatamab-for-black-patients-with-multiple-myeloma/ 2023-12-15T17:16:45+00:00 https://ascopost.com/news/december-2023/bezuclastinib-may-reduce-symptoms-in-patients-with-nonadvanced-systemic-mastocytosis/ 2023-12-15T14:44:12+00:00 https://ascopost.com/news/december-2023/understanding-racial-and-ethnic-disparities-in-modern-aml-care-after-the-approval-of-venetoclax/ 2023-12-15T14:56:21+00:00 https://ascopost.com/news/december-2023/fda-approves-belzutifan-for-advanced-renal-cell-carcinoma/ 2023-12-27T17:27:58+00:00 https://ascopost.com/news/december-2023/concertai-to-acquire-cancerlinq/ 2023-12-15T15:59:34+00:00 https://ascopost.com/news/december-2023/fda-approves-enfortumab-vedotin-ejfv-with-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-cancer/ 2023-12-18T15:49:35+00:00 https://ascopost.com/news/december-2023/first-line-treatment-for-older-patients-with-mantle-cell-lymphoma-venetoclax-plus-standard-chemoimmunotherapy/ 2023-12-18T17:50:58+00:00 https://ascopost.com/news/december-2023/combination-treatment-that-skips-chemotherapy-may-be-effective-for-older-patients-with-philadelphia-chromosome-positive-all/ 2023-12-18T19:14:37+00:00 https://ascopost.com/news/december-2023/glp-1-receptor-agonists-may-reduce-risk-of-colorectal-cancer-in-patients-with-high-bmi-and-diabetes/ 2023-12-19T19:18:21+00:00 https://ascopost.com/news/december-2023/w-kimryn-rathmell-begins-work-as-17th-director-of-the-nci/ 2023-12-19T17:41:00+00:00 https://ascopost.com/news/december-2023/adding-immune-checkpoint-inhibitors-to-perioperative-treatment-for-solid-tumors-associated-toxicity/ 2023-12-19T18:51:36+00:00 https://ascopost.com/news/december-2023/hpv-ctdna-detection-after-chemoradiation-in-patients-with-cervical-cancer/ 2023-12-19T18:37:32+00:00 https://ascopost.com/news/december-2023/dna-mutational-profiling-in-patients-with-metastatic-colorectal-cancer/ 2023-12-19T18:28:38+00:00 https://ascopost.com/news/december-2023/childhood-cancer-survivors-risk-of-second-cancer-and-heart-disease/ 2023-12-19T18:10:04+00:00 https://ascopost.com/news/december-2023/lung-nodule-program-may-help-detect-lung-cancer-in-patients-age-ineligible-for-lung-cancer-screening/ 2023-12-20T15:53:52+00:00 https://ascopost.com/news/december-2023/psilocybin-assisted-therapy-may-reduce-depressive-symptoms-in-patients-with-cancer/ 2023-12-20T16:06:22+00:00 https://ascopost.com/news/december-2023/targeted-therapy-for-fr-alpha-positive-platinum-resistant-ovarian-cancer/ 2023-12-20T16:39:57+00:00 https://ascopost.com/news/december-2023/advanced-nsclc-adding-canakinumab-to-first-line-chemoimmunotherapy/ 2023-12-20T16:47:24+00:00 https://ascopost.com/news/december-2023/5-year-outcomes-of-the-idea-trial-omission-of-radiotherapy-after-breast-conserving-surgery-for-low-risk-patients/ 2023-12-20T17:26:00+00:00 https://ascopost.com/news/december-2023/is-prediabetes-linked-to-cardiovascular-and-kidney-diseases-in-adult-survivors-of-childhood-cancer/ 2023-12-20T18:14:58+00:00 https://ascopost.com/news/december-2023/age-race-and-sex-found-to-impact-survival-rates-in-patients-with-bpdcn/ 2023-12-21T20:24:03+00:00 https://ascopost.com/news/december-2023/overcoming-bpdcn-tagraxofusp-sets-new-landmark-in-patient-survival/ 2023-12-20T19:59:02+00:00 https://ascopost.com/news/december-2023/allogeneic-hematopoietic-stem-cell-transplantation-for-dendritic-cell-neoplasm-subtype/ 2023-12-21T20:23:31+00:00 https://ascopost.com/news/december-2023/international-collaborative-research-efforts-in-cardio-oncology-focus-on-basic-and-translational-science/ 2023-12-21T16:29:33+00:00 https://ascopost.com/news/december-2023/imetelstat-for-rbc-transfusion-independence-in-lower-risk-myelodysplastic-syndromes/ 2023-12-21T16:35:22+00:00 https://ascopost.com/news/december-2023/new-findings-challenge-widely-accepted-beliefs-about-the-relative-efficacy-of-opioids-in-treating-cancer-pain/ 2023-12-21T16:53:51+00:00 https://ascopost.com/news/december-2023/implementation-of-updated-who-screening-guidelines-could-cut-cervical-cancer-mortality-rates-in-half-in-lower-income-countries/ 2023-12-21T18:03:22+00:00 https://ascopost.com/news/december-2023/egfr-mutated-advanced-nsclc-cns-efficacy-with-combination-of-osimertinib-and-chemotherapy/ 2023-12-21T17:38:54+00:00 https://ascopost.com/news/december-2023/overall-survival-with-lupsma-vs-cabazitaxel-in-previously-treated-patients-with-metastatic-castration-resistant-prostate-cancer/ 2023-12-21T18:06:44+00:00 https://ascopost.com/news/january-2024/ 2024-01-02T15:40:03+00:00 https://ascopost.com/news/january-2024/immune-checkpoint-inhibitor-induced-myocarditis-contemporary-retrospective-analysis/ 2024-01-02T16:18:26+00:00 https://ascopost.com/news/january-2024/imvigor130-atezolizumab-vs-chemotherapy-in-locally-advanced-or-metastatic-urothelial-carcinoma/ 2024-01-02T16:43:13+00:00 https://ascopost.com/news/january-2024/incidence-of-second-primary-cancers-in-adult-cancer-survivors/ 2024-01-02T16:54:43+00:00 https://ascopost.com/news/january-2024/addition-of-atezolizumab-to-bevacizumab-and-chemotherapy-in-metastatic-persistent-or-recurrent-cervical-cancer/ 2024-01-02T17:20:30+00:00 https://ascopost.com/news/january-2024/can-immunotherapy-induce-sustained-disease-control-among-patients-with-colorectal-cancer/ 2024-01-02T17:52:05+00:00 https://ascopost.com/news/january-2024/phase-iii-trial-shows-novel-four-drug-regimen-improves-survival-outcomes-in-extensive-stage-small-cell-lung-cancer/ 2024-01-03T19:34:10+00:00 https://ascopost.com/news/january-2024/epov-noemí-reguart/ 2024-01-02T21:36:37+00:00 https://ascopost.com/news/january-2024/second-line-lisocabtagene-maraleucel-may-be-more-cost-effective-than-standard-care-dlbcl-therapy/ 2025-10-31T16:30:36+00:00 https://ascopost.com/news/january-2024/next-generation-sequencing-may-help-improve-access-to-immunotherapy-among-patients-with-cancer-and-mismatch-repair-deficiency/ 2024-01-03T19:35:09+00:00 https://ascopost.com/news/january-2024/mrd-guided-ibrutinibvenetoclax-for-previously-untreated-patients-with-cll/ 2024-01-10T19:40:44+00:00 https://ascopost.com/news/january-2024/overall-survival-with-atezolizumabchemotherapy-vs-chemotherapy-in-untreated-locally-advanced-or-metastatic-urothelial-carcinoma/ 2024-01-03T17:37:37+00:00 https://ascopost.com/news/january-2024/ovhipec1-trial-hyperthermic-intraperitoneal-chemotherapy-plus-interval-cytoreductive-surgery-improves-survival-in-advanced-ovarian-cancer/ 2024-01-04T18:51:40+00:00 https://ascopost.com/news/january-2024/antibody-drug-conjugate-ifinatamab-deruxtecan-shows-robust-activity-in-refractory-small-cell-lung-cancer/ 2024-01-04T19:35:26+00:00 https://ascopost.com/news/january-2024/rare-t-cells-may-help-predict-immunotherapy-response-in-patients-with-skin-cancer/ 2024-01-05T18:37:12+00:00 https://ascopost.com/news/january-2024/treatment-at-community-cancer-centers-may-be-linked-to-poorer-outcomes-in-patients-with-hpv-related-oropharyngeal-squamous-cell-carcinoma/ 2026-01-28T19:35:37+00:00 https://ascopost.com/news/january-2024/baseline-estradiol-and-prevention-of-breast-cancer-in-high-risk-postmenopausal-women/ 2024-01-04T16:48:09+00:00 https://ascopost.com/news/january-2024/perioperative-pembrolizumab-plus-chemotherapy-in-locally-advanced-gastricgastroesophageal-cancer/ 2025-06-27T21:23:33+00:00 https://ascopost.com/news/january-2024/addition-of-sbrt-to-standard-of-care-systemic-therapy-in-oligoprogressive-disease/ 2024-01-05T15:38:16+00:00 https://ascopost.com/news/january-2024/muscle-invasive-bladder-cancer-5-year-survival-with-dd-mvac/ 2024-01-05T16:19:11+00:00 https://ascopost.com/news/january-2024/minimizing-the-severe-side-effects-of-immunotherapy-in-patients-with-multiple-myeloma/ 2024-01-05T16:29:05+00:00 https://ascopost.com/news/january-2024/comparing-outcomes-of-robotic-and-laparoscopic-surgeries-for-colorectal-cancer/ 2024-01-05T16:38:48+00:00 https://ascopost.com/news/january-2024/lapatinib-increases-overall-survival-in-patients-with-metastatic-breast-cancer-and-her2-positive-ctcs/ 2024-01-05T17:13:02+00:00 https://ascopost.com/news/january-2024/long-term-results-with-front-line-dasatinibblinatumomab-for-philadelphia-chromosome-positive-all/ 2024-01-08T15:47:49+00:00 https://ascopost.com/news/january-2024/non-locally-advanced-rectal-cancer-impact-of-reduced-use-of-neoadjuvant-radiotherapy/ 2024-01-08T15:53:32+00:00 https://ascopost.com/news/january-2024/leisure-time-physical-activity-and-breast-cancer-risk-in-premenopausal-women/ 2024-01-08T15:59:21+00:00 https://ascopost.com/news/january-2024/patient-choice-of-location-for-breast-cancer-surgery/ 2024-01-08T20:25:00+00:00 https://ascopost.com/news/january-2024/new-study-uncovers-potential-factors-contributing-to-development-of-colitis-in-patients-undergoing-cancer-immunotherapy/ 2024-01-08T19:59:20+00:00 https://ascopost.com/news/january-2024/triple-negative-breast-cancer-several-treatment-response-trajectories-identified/ 2024-01-08T19:56:39+00:00 https://ascopost.com/news/january-2024/real-world-data-show-impact-of-immunotherapy-in-populations-underrepresented-in-lung-cancer-clinical-trials/ 2024-01-09T14:20:19+00:00 https://ascopost.com/news/january-2024/atezolizumab-plus-carboplatin-in-metastatic-triple-negative-breast-cancer/ 2024-02-02T18:24:11+00:00 https://ascopost.com/news/january-2024/attitudes-toward-climate-change-may-impact-cancer-screening-behavior/ 2024-01-09T19:45:35+00:00 https://ascopost.com/news/january-2024/novel-vaccine-may-delay-relapse-in-kras-mutated-pancreatic-and-colorectal-cancers/ 2024-01-10T15:15:09+00:00 https://ascopost.com/news/january-2024/use-of-carvedilol-to-help-prevent-heart-failure-in-childhood-cancer-survivors/ 2024-01-10T18:08:06+00:00 https://ascopost.com/news/january-2024/call-to-action-issued-to-expand-access-to-clinical-trials/ 2024-01-10T18:08:47+00:00 https://ascopost.com/news/january-2024/addition-of-mri-to-ct-in-patients-scheduled-for-colorectal-liver-metastases-local-therapy/ 2024-01-10T16:50:23+00:00 https://ascopost.com/news/january-2024/immunotherapy-initiation-at-the-end-of-life-for-patients-with-metastatic-cancers/ 2024-01-10T16:36:28+00:00 https://ascopost.com/news/january-2024/locally-advanced-cervical-cancer-addition-of-camrelizumab-to-neoadjuvant-chemotherapy/ 2024-01-10T16:40:19+00:00 https://ascopost.com/news/january-2024/acro-acr-astro-and-asco-unite-to-ensure-patient-access-to-quality-cancer-care/ 2024-01-11T15:47:49+00:00 https://ascopost.com/news/january-2024/novel-risk-model-may-personalize-prognosis-prediction-in-patients-with-multiple-myeloma/ 2024-01-11T14:22:58+00:00 https://ascopost.com/news/january-2024/a-new-approach-to-identifying-consumer-products-that-contain-cancer-causing-chemicals/ 2024-01-12T15:28:57+00:00 https://ascopost.com/news/january-2024/novel-blood-test-may-help-distinguish-neuroendocrine-prostate-cancer-from-other-subtypes/ 2024-01-12T15:48:47+00:00 https://ascopost.com/news/january-2024/rituximab-maintenance-in-younger-patients-with-mantle-cell-lymphoma-long-term-follow-up/ 2024-01-12T16:06:56+00:00 https://ascopost.com/news/january-2024/addition-of-avasopasem-to-sbrt-in-localized-pancreatic-cancer/ 2024-01-16T20:18:35+00:00 https://ascopost.com/news/january-2024/genetic-identification-of-women-at-lower-risk-of-breast-cancer/ 2024-01-12T16:54:23+00:00 https://ascopost.com/news/january-2024/young-women-with-breast-cancer-discussing-vs-pursuing-fertility-preservation/ 2024-01-12T17:38:02+00:00 https://ascopost.com/news/january-2024/study-identifies-potential-variations-in-us-health-insurance-coverage-at-cancer-diagnosis-by-state/ 2024-01-16T15:37:32+00:00 https://ascopost.com/news/january-2024/obesity-and-a-precursor-of-multiple-myeloma/ 2024-01-16T15:45:14+00:00 https://ascopost.com/news/january-2024/fda-approves-pembrolizumab-plus-chemoradiotherapy-for-figo-2014-stage-iii-iva-cervical-cancer/ 2024-01-16T15:50:04+00:00 https://ascopost.com/news/january-2024/mrd-status-and-outcomes-with-obinutuzumab-and-rituximab-based-treatment-in-follicular-lymphoma/ 2024-01-16T17:49:24+00:00 https://ascopost.com/news/january-2024/use-of-lower-than-recommended-doses-of-immune-checkpoint-inhibitors-in-various-tumor-types-indian-study/ 2024-01-16T17:55:47+00:00 https://ascopost.com/news/january-2024/repotrectinib-in-ros1-fusion-positive-nsclc/ 2024-01-16T18:02:51+00:00 https://ascopost.com/news/january-2024/medicaid-expansion-may-improve-postsurgical-survival-outcomes-in-patients-with-nsclc/ 2024-01-17T14:56:21+00:00 https://ascopost.com/news/january-2024/dxh9-depletion-may-expose-small-cell-lung-cancer-tumors-to-immune-system-attack/ 2024-01-17T15:29:17+00:00 https://ascopost.com/news/january-2024/cannabis-use-during-pregnancy-may-be-linked-to-cns-cancers-in-children/ 2024-01-17T15:49:13+00:00 https://ascopost.com/news/january-2024/normal-risk-ovarian-screening-study-long-term-update/ 2024-01-17T17:45:06+00:00 https://ascopost.com/news/january-2024/investigators-highlight-characteristics-potentially-linked-to-improved-car-t-cell-therapy-outcomes-in-large-b-cell-lymphoma/ 2024-01-18T15:44:44+00:00 https://ascopost.com/news/january-2024/combating-racial-and-ethnic-disparities-in-precision-medicine-for-colorectal-cancer/ 2024-01-18T15:58:05+00:00 https://ascopost.com/news/january-2024/follicular-lymphoma-long-term-follow-up-of-rituximab-dosing-strategies-among-patients-with-low-tumor-burden/ 2024-01-18T16:15:38+00:00 https://ascopost.com/news/january-2024/addition-of-cetuximab-maintenance-to-first-line-folfiricetuximab-in-emrasbrafem-wild-type-colorectal-cancer/ 2024-01-18T16:21:24+00:00 https://ascopost.com/news/january-2024/overall-survival-and-long-term-outcomes-in-the-monarche-trial/ 2024-01-18T17:29:49+00:00 https://ascopost.com/news/january-2024/use-of-antiviral-therapy-and-10-year-outcomes-in-resected-hepatitis-related-hepatocellular-carcinoma/ 2024-01-19T15:45:41+00:00 https://ascopost.com/news/january-2024/prevalence-of-substance-use-disorders-among-us-adult-cancer-survivors/ 2024-01-19T15:54:01+00:00 https://ascopost.com/news/january-2024/combining-pd-l1-and-tigit-inhibitors-plus-chemotherapy-in-esophageal-cancer/ 2024-01-19T18:46:57+00:00 https://ascopost.com/news/january-2024/role-of-postoperative-ctdna-in-patients-with-low-risk-stage-iia-colon-cancer/ 2024-02-15T20:16:36+00:00 https://ascopost.com/news/january-2024/do-patients-with-molecular-mrd-detected-after-colorectal-cancer-surgery-benefit-from-adjuvant-chemotherapy/ 2024-02-15T20:20:59+00:00 https://ascopost.com/news/january-2024/novel-car-nk-cell-therapy-may-offer-benefit-in-patients-with-b-cell-malignancies/ 2024-01-22T14:59:47+00:00 https://ascopost.com/news/january-2024/fda-approves-erdafitinib-for-locally-advanced-or-metastatic-urothelial-carcinoma/ 2024-01-22T15:38:01+00:00 https://ascopost.com/news/january-2024/standard-vs-histology-tailored-neoadjuvant-chemotherapy-in-high-grade-myxoid-liposarcoma/ 2025-08-25T16:55:25+00:00 https://ascopost.com/news/january-2024/final-overall-survival-analysis-of-clearkeynote-581-lenvatinibpembrolizumab-vs-sunitinib-in-first-line-treatment-of-advanced-rcc/ 2024-01-22T16:59:54+00:00 https://ascopost.com/news/january-2024/adding-immunotherapy-based-combination-to-tace-improves-progression-free-survival-in-hcc/ 2024-01-22T17:38:49+00:00 https://ascopost.com/news/january-2024/netter-2-lu-177-dotatate-for-advanced-gastroenteropancreatic-neuroendocrine-tumors/ 2024-01-22T17:50:30+00:00 https://ascopost.com/news/january-2024/factors-influencing-selection-of-active-surveillance-for-low-risk-prostate-cancer/ 2024-01-23T16:23:05+00:00 https://ascopost.com/news/january-2024/novel-molecular-twin-tool-may-improve-precision-medicine-care-in-patients-with-pancreatic-cancer/ 2024-01-23T16:30:01+00:00 https://ascopost.com/news/january-2024/antiemetic-strategies-for-patients-receiving-highly-emetogenic-chemotherapy/ 2024-01-23T16:39:59+00:00 https://ascopost.com/news/january-2024/first-line-nivolumab-plus-ipilimumab-shows-benefit-in-metastatic-colorectal-cancer-subset/ 2024-01-23T16:49:03+00:00 https://ascopost.com/news/january-2024/long-term-follow-up-of-keynote-590-benefit-of-pembrolizumab-plus-chemotherapy-affirmed-in-advanced-esophageal-cancer/ 2024-03-20T20:46:57+00:00 https://ascopost.com/news/january-2024/study-finds-most-patients-with-lynch-syndrome-are-not-using-aspirin-to-reduce-risk-of-colon-cancer/ 2024-01-24T17:34:35+00:00 https://ascopost.com/news/january-2024/melanoma-overdiagnoses-may-be-rising-among-white-us-patients/ 2024-01-24T15:41:44+00:00 https://ascopost.com/news/january-2024/fda-issues-safety-labeling-change-notification-to-car-t-cell-therapy-manufacturers/ 2024-01-24T18:02:57+00:00 https://ascopost.com/news/january-2024/gemcitabinepaclitaxel-vs-gemcitabine-alone-after-folfirinox-in-metastatic-pancreatic-cancer/ 2024-01-24T16:33:44+00:00 https://ascopost.com/news/january-2024/use-of-direct-oral-anticoagulant-agents-in-active-cancer-meta-analysis/ 2024-01-24T16:56:55+00:00 https://ascopost.com/news/january-2024/additional-analysis-of-matterhorn-confirms-global-benefit-of-durvalumab-plus-flot-in-gastricgastroesophageal-cancer/ 2025-06-27T21:22:31+00:00 https://ascopost.com/news/january-2024/unintentional-weight-loss-may-be-a-warning-sign-of-cancer-study-finds/ 2024-01-26T15:16:16+00:00 https://ascopost.com/news/january-2024/study-finds-plant-rich-foods-nutsseeds-may-benefit-childhood-cancer-survivors/ 2024-01-26T15:32:59+00:00 https://ascopost.com/news/january-2024/cabozantinib-and-atezolizumab-in-metastatic-castration-resistant-prostate-cancer/ 2024-01-29T19:34:56+00:00 https://ascopost.com/news/january-2024/rate-of-second-primary-lung-cancers-with-lobar-vs-sublobar-resection-of-t1an0-nsclc/ 2024-01-26T16:18:46+00:00 https://ascopost.com/news/january-2024/intensified-vs-standard-induction-in-younger-patients-with-newly-diagnosed-aml/ 2024-01-26T16:30:56+00:00 https://ascopost.com/news/january-2024/secondary-cancers-may-be-rare-in-patients-treated-with-car-t-cell-therapy/ 2024-01-29T15:16:55+00:00 https://ascopost.com/news/january-2024/cervical-cancer-rates-may-be-rising-in-low-income-us-counties/ 2024-01-29T15:20:15+00:00 https://ascopost.com/news/january-2024/ambassador-pembrolizumab-in-muscle-invasive-and-locally-advanced-urothelial-carcinoma/ 2024-01-29T16:06:06+00:00 https://ascopost.com/news/january-2024/survival-benefit-with-adjuvant-immunotherapy-in-patients-with-clear-cell-rcc/ 2025-06-30T01:30:15+00:00 https://ascopost.com/news/january-2024/fdg-petct-imaging-performed-after-1-week-of-immunotherapy-may-predict-treatment-response-in-patients-with-advanced-melanoma/ 2024-02-05T19:04:49+00:00 https://ascopost.com/news/january-2024/more-intensified-salvage-regimen-for-prostate-cancer-does-not-impair-health-related-quality-of-life/ 2024-01-29T18:16:18+00:00 https://ascopost.com/news/january-2024/immune-checkpoint-inhibitor-based-therapy-may-have-comparative-efficacy-in-black-and-white-patients-with-metastatic-renal-cell-carcinoma/ 2025-06-30T01:29:17+00:00 https://ascopost.com/news/january-2024/use-of-adjuvant-nivolumab-in-patients-with-muscle-invasive-urothelial-carcinoma/ 2024-01-30T15:56:54+00:00 https://ascopost.com/news/january-2024/uicc-offers-recommendations-in-preparation-for-world-cancer-day-2024/ 2024-01-30T17:37:27+00:00 https://ascopost.com/news/january-2024/immunotherapy-outcomes-in-patients-with-primary-cardiac-soft-tissue-sarcomas/ 2025-08-25T16:53:35+00:00 https://ascopost.com/news/january-2024/is-hrr-testing-underused-in-patients-with-prostate-cancer/ 2024-01-30T18:39:12+00:00 https://ascopost.com/news/january-2024/subcutaneous-vs-intravenous-nivolumab-in-advanced-clear-cell-rcc/ 2025-06-30T01:25:09+00:00 https://ascopost.com/news/january-2024/potential-risk-factors-for-postoperative-venous-thromboembolism-in-lung-cancer-identified/ 2024-01-31T16:00:07+00:00 https://ascopost.com/news/january-2024/colon-cancer-mortality-rates-predictions-across-the-european-union-and-united-kingdom/ 2024-01-31T16:10:00+00:00 https://ascopost.com/news/january-2024/uchl1-protein-potential-biomarker-and-therapeutic-target-in-neuroendocrine-carcinomas-and-neuroblastoma/ 2024-01-31T16:27:36+00:00 https://ascopost.com/news/january-2024/accelerated-hypofractionated-chemoradiation-with-adaptive-sabr-boost-in-locally-advanced-unresectable-nsclc/ 2024-01-31T18:27:52+00:00 https://ascopost.com/news/january-2024/sacituzumab-govitecan-plus-pembrolizumab-in-metastatic-urothelial-cancer-progressing-after-platinum-based-chemotherapy/ 2024-01-31T18:34:20+00:00 https://ascopost.com/news/january-2024/adjuvant-treatment-of-resected-melanoma-mrna-based-personalized-therapy-plus-immunotherapy/ 2024-01-31T19:21:09+00:00 https://ascopost.com/news/february-2024/ 2024-02-01T15:12:52+00:00 https://ascopost.com/news/february-2024/mtor-inhibitor-prednisone-and-cemiplimab-for-kidney-transplant-recipients-with-advanced-cutaneous-squamous-cell-carcinoma/ 2024-02-01T18:46:15+00:00 https://ascopost.com/news/february-2024/annual-increases-in-cardiorespiratory-fitness-may-help-reduce-risk-of-prostate-cancer/ 2024-02-01T18:45:06+00:00 https://ascopost.com/news/february-2024/blood-tests-could-help-predict-which-patients-with-lymphoma-may-respond-poorly-to-car-t-cell-therapy/ 2024-02-01T18:22:03+00:00 https://ascopost.com/news/february-2024/addition-of-palbociclib-to-letrozole-in-er-positive-her2-negative-advanced-breast-cancer-overall-survival-in-paloma-2/ 2024-02-01T18:08:34+00:00 https://ascopost.com/news/february-2024/addition-of-nivolumab-to-chemotherapy-in-egfr-mutant-metastatic-nsclc-after-disease-progression-on-prior-therapy/ 2024-02-01T18:12:28+00:00 https://ascopost.com/news/february-2024/effects-of-switch-to-high-deductible-health-plans-for-patients-with-cancer/ 2024-02-02T15:32:52+00:00 https://ascopost.com/news/february-2024/report-sheds-light-on-critical-pathway-responsible-for-treatment-resistance-in-melanoma/ 2024-02-02T15:42:49+00:00 https://ascopost.com/news/february-2024/survivors-of-childhood-cancer-with-high-anthracycline-exposure-can-a-beta-blocker-improve-cardiac-function/ 2024-02-02T16:46:36+00:00 https://ascopost.com/news/february-2024/actinium-225-psma-radioligand-therapy-for-prostate-cancer/ 2024-02-02T17:47:10+00:00 https://ascopost.com/news/february-2024/osimertinib-may-offer-survival-benefit-over-immunotherapy-in-some-patients-with-unresectable-nsclc/ 2024-02-05T19:09:33+00:00 https://ascopost.com/news/february-2024/global-cancer-burden-may-be-growing-amidst-mounting-need-for-cancer-services/ 2024-02-05T16:53:14+00:00 https://ascopost.com/news/february-2024/hpv-related-oropharyngeal-carcinoma-tumor-hypoxia-directed-treatment/ 2026-01-28T19:30:57+00:00 https://ascopost.com/news/february-2024/golidocitinib-in-relapsed-or-refractory-peripheral-t-cell-lymphoma/ 2024-02-05T17:54:09+00:00 https://ascopost.com/news/february-2024/intensification-of-adt-in-patients-with-high-risk-biochemically-relapsed-castration-sensitive-prostate-cancer-after-radical-prostatectomy/ 2024-02-05T18:23:44+00:00 https://ascopost.com/news/february-2024/btk-degrader-may-target-treatment-resistance-in-patients-with-cll/ 2024-02-06T19:02:08+00:00 https://ascopost.com/news/february-2024/antihypertensive-drug-combinations-may-help-reduce-blood-pressure-in-patients-receiving-ibrutinib/ 2024-02-06T18:44:49+00:00 https://ascopost.com/news/february-2024/triplet-without-or-with-ipilimumab-in-kidney-transplant-recipients-with-advanced-cutaneous-cancers/ 2024-02-06T18:17:15+00:00 https://ascopost.com/news/february-2024/azacitidine-venetoclax-and-gilteritinib-in-newly-diagnosed-and-relapsed-or-refractory-flt3-mutated-aml/ 2024-02-06T18:04:56+00:00 https://ascopost.com/news/february-2024/metastatic-castration-resistant-prostate-cancer-lupsma-vs-cabazitaxel/ 2024-02-06T18:03:06+00:00 https://ascopost.com/news/february-2024/high-reoperation-rates-following-breast-conserving-surgery-may-increase-cost-of-care-and-risk-of-complications/ 2024-02-07T15:59:47+00:00 https://ascopost.com/news/february-2024/insufficiencies-discovered-in-patient-reported-outcomes-data-from-genitourinary-cancer-clinical-trials/ 2024-02-07T16:13:37+00:00 https://ascopost.com/news/february-2024/localized-prostate-cancer-functional-outcomes-after-specific-treatments/ 2024-02-07T17:22:34+00:00 https://ascopost.com/news/february-2024/skin-microbiome-and-severe-radiodermatitis-in-patients-with-breast-cancer/ 2024-02-07T17:26:45+00:00 https://ascopost.com/news/february-2024/fruquintinib-plus-paclitaxel-as-second-line-treatment-for-gastric-or-gastroesophageal-junction-cancer/ 2025-06-27T21:21:09+00:00 https://ascopost.com/news/february-2024/dreamm-7-confirms-benefit-of-triplet-regimen-in-relapsed-or-refractory-multiple-myeloma/ 2024-02-07T18:47:48+00:00 https://ascopost.com/news/february-2024/ephrin-b2-identified-as-potential-therapeutic-target-to-inhibit-multiple-myeloma-growth/ 2024-02-26T18:40:15+00:00 https://ascopost.com/news/february-2024/machine-learning-model-may-predict-oxaliplatin-benefit-in-colon-cancer/ 2024-02-08T16:20:39+00:00 https://ascopost.com/news/february-2024/mrd-markers-and-outcomes-in-patients-with-mds-after-stem-cell-transplant/ 2024-02-08T19:25:37+00:00 https://ascopost.com/news/february-2024/ebv-positive-posttransplantation-lymphoproliferative-disease-t-cell-immunotherapy-efficacy/ 2024-02-08T16:58:20+00:00 https://ascopost.com/news/february-2024/multiplex-analysis-of-intratumoral-immune-infiltrate-and-prognosis-in-colorectal-cancer/ 2024-02-08T18:53:47+00:00 https://ascopost.com/news/february-2024/are-major-adverse-financial-events-linked-to-a-later-stage-cancer-diagnosis/ 2024-02-08T22:02:27+00:00 https://ascopost.com/news/february-2024/shedding-light-on-mechanisms-behind-fulvestrant-resistance-in-advanced-er-positive-breast-cancer/ 2024-02-09T15:13:58+00:00 https://ascopost.com/news/february-2024/novel-biomarker-in-cancer-survivors-may-be-linked-to-higher-risk-of-mortality/ 2024-02-09T15:18:47+00:00 https://ascopost.com/news/february-2024/osimertinib-vs-sequential-gefitinibosimertinib-in-advanced-egfr-mutant-nsclc/ 2024-02-12T16:05:19+00:00 https://ascopost.com/news/february-2024/low-dose-pem-may-help-transform-breast-cancer-detection/ 2024-02-12T16:42:38+00:00 https://ascopost.com/news/february-2024/can-physical-activity-lessen-pain-intensity-in-cancer-survivors/ 2024-02-12T16:28:11+00:00 https://ascopost.com/news/february-2024/breast-cancer-incidence-by-race-stage-and-hormone-receptor-status-in-us-women/ 2024-02-12T18:23:44+00:00 https://ascopost.com/news/february-2024/crenolanib-and-intensive-chemotherapy-in-newly-diagnosed-flt3-mutated-aml/ 2024-02-12T18:27:28+00:00 https://ascopost.com/news/february-2024/trabectedin-vs-chemotherapy-in-recurrent-ovarian-cancer-with-brca-mutation-or-brcaness-phenotype/ 2024-02-12T17:58:04+00:00 https://ascopost.com/news/february-2024/sleep-apnea-may-be-prevalent-among-patients-with-cancer-at-high-risk-of-congestive-heart-failure/ 2024-02-13T22:02:25+00:00 https://ascopost.com/news/february-2024/plant-based-diet-may-be-linked-to-improved-sexual-health-in-men-treated-for-prostate-cancer/ 2024-02-13T17:22:03+00:00 https://ascopost.com/news/february-2024/postmenopausal-patients-with-er-richher2-negative-breast-cancer-neoadjuvant-therapies/ 2024-02-13T17:26:19+00:00 https://ascopost.com/news/february-2024/mia-calculator-for-predicting-recurrence-free-and-overall-survival-in-stage-ii-melanoma/ 2024-02-13T19:38:06+00:00 https://ascopost.com/news/february-2024/molecular-subtype-based-therapy-in-the-first-line-treatment-of-metastatic-or-recurrent-triple-negative-breast-cancer/ 2024-02-13T19:47:20+00:00 https://ascopost.com/news/february-2024/neoadjuvant-immunotherapy-may-improve-long-term-survival-in-patients-with-soft-tissue-sarcoma/ 2025-08-25T16:51:51+00:00 https://ascopost.com/news/february-2024/durvalumab-plus-ceralasertib-in-patients-with-immunotherapy-resistant-nsclc/ 2024-02-14T21:18:30+00:00 https://ascopost.com/news/february-2024/system-to-improve-clinical-staging-in-localized-pancreatic-cancer/ 2024-02-14T16:44:07+00:00 https://ascopost.com/news/february-2024/triplet-for-advanced-her2-negative-breast-cancer/ 2024-02-14T20:43:14+00:00 https://ascopost.com/news/february-2024/representation-may-be-essential-for-black-men-seeking-prostate-cancer-information-online/ 2024-02-15T16:09:41+00:00 https://ascopost.com/news/february-2024/stab-t-cell-based-immunotherapy-in-multiple-myeloma/ 2024-02-15T16:17:49+00:00 https://ascopost.com/news/february-2024/adjuvant-olaparib-for-germline-brca12-mutant-high-risk-her2-negative-early-breast-cancer-pros-from-the-olympia-trial/ 2024-02-15T19:59:01+00:00 https://ascopost.com/news/february-2024/pegasparaginase-dosing-and-risk-of-hypersensitivity-reactions-in-pediatric-all/ 2024-02-15T18:55:45+00:00 https://ascopost.com/news/february-2024/steven-rosenberg-honored-with-2024-aacr-award-for-lifetime-achievement-in-cancer-research/ 2024-02-15T19:53:05+00:00 https://ascopost.com/news/february-2024/fda-approves-tepotinib-for-metastatic-nsclc/ 2024-02-19T15:27:09+00:00 https://ascopost.com/news/february-2024/ablative-stereotactic-mr-guided-adaptive-radiation-therapy-in-pancreatic-ductal-adenocarcinoma/ 2024-02-19T15:39:19+00:00 https://ascopost.com/news/february-2024/neoadjuvant-chemotherapy-may-benefit-patients-with-penile-squamous-cell-carcinoma/ 2024-03-04T17:06:11+00:00 https://ascopost.com/news/february-2024/fda-approves-osimertinib-with-chemotherapy-for-egfr-mutated-nsclc/ 2024-02-19T17:18:41+00:00 https://ascopost.com/news/february-2024/analysis-of-cancer-diagnoses-after-recent-weight-loss/ 2024-02-19T16:59:59+00:00 https://ascopost.com/news/february-2024/modified-chemotherapy-regimens-may-improve-quality-of-life-in-older-patients-with-advanced-cancer/ 2024-02-20T15:45:12+00:00 https://ascopost.com/news/february-2024/does-risk-reducing-mastectomy-reduce-breast-cancer-mortality/ 2024-02-20T18:17:11+00:00 https://ascopost.com/news/february-2024/tbi-and-risk-of-brain-cancer-in-veterans-of-the-iraq-and-afghanistan-wars/ 2024-02-20T17:16:57+00:00 https://ascopost.com/news/february-2024/genetic-alterations-associated-with-interval-breast-cancer-diagnosis/ 2024-02-20T17:21:13+00:00 https://ascopost.com/news/february-2024/final-results-of-the-pout-trial-adjuvant-chemotherapy-vs-surveillance-after-nephroureterectomy-for-upper-tract-urothelial-cancer/ 2024-02-20T18:11:36+00:00 https://ascopost.com/news/february-2024/perioperative-tislelizumab-plus-chemotherapy-in-resectable-nsclc/ 2024-02-20T17:40:14+00:00 https://ascopost.com/news/february-2024/does-annual-breast-cancer-screening-starting-at-age-40-offer-benefit/ 2024-02-21T18:28:52+00:00 https://ascopost.com/news/february-2024/strategies-to-reduce-burden-of-colorectal-cancer-in-latin-america/ 2024-02-21T15:22:01+00:00 https://ascopost.com/news/february-2024/postdiagnosis-mental-disorders-among-ayas-with-cancer/ 2024-02-21T15:32:13+00:00 https://ascopost.com/news/february-2024/hyperbaric-oxygen-therapy-for-late-local-toxic-effects-in-patients-receiving-adjuvant-radiotherapy-for-breast-cancer/ 2024-02-21T16:13:28+00:00 https://ascopost.com/news/february-2024/long-term-follow-up-of-the-anthracyclines-in-early-breast-cancer-abc-trials/ 2024-02-21T18:31:43+00:00 https://ascopost.com/news/february-2024/fda-approves-biweekly-teclistamab-dosing-regimen-for-patients-with-multiple-myeloma/ 2024-02-21T16:34:57+00:00 https://ascopost.com/news/february-2024/prophylactic-oral-vancomycin-may-prevent-c-difficile-infections-raise-risk-of-gram-negative-bacteremia-in-stem-cell-transplant-recipients/ 2024-02-22T17:26:37+00:00 https://ascopost.com/news/february-2024/nihs-new-cancer-screening-research-network-could-help-determine-effective-cancer-screening-technologies/ 2024-02-22T17:28:33+00:00 https://ascopost.com/news/february-2024/high-risk-non-muscle-invasive-bladder-cancer-reduced-induction-courses-of-bcg/ 2024-06-19T15:59:59+00:00 https://ascopost.com/news/february-2024/enobosarm-in-previously-treated-patients-with-ar-positive-er-positive-her2-negative-advanced-breast-cancer/ 2024-03-01T17:53:21+00:00 https://ascopost.com/news/february-2024/metastatic-castration-resistant-prostate-cancer-tumor-mutational-burden-and-response-to-checkpoint-inhibition/ 2024-03-05T20:25:19+00:00 https://ascopost.com/news/february-2024/sbrt-vs-conventional-external-beam-radiotherapy-for-painful-bone-metastases/ 2024-02-22T19:15:28+00:00 https://ascopost.com/news/february-2024/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/ 2024-02-26T15:38:26+00:00 https://ascopost.com/news/february-2024/families-of-men-with-subfertility-may-have-increased-risk-of-several-types-of-cancers/ 2024-02-26T18:38:28+00:00 https://ascopost.com/news/february-2024/8-year-follow-up-of-mindact-trial-locoregional-breast-cancer-recurrence-in-patients-undergoing-breast-conserving-surgery/ 2024-02-26T16:36:52+00:00 https://ascopost.com/news/february-2024/covid-19-risk-in-pediatric-patients-receiving-treatment-for-leukemia-or-lymphoma/ 2025-10-03T15:53:32+00:00 https://ascopost.com/news/february-2024/gene-signature-may-predict-response-to-combination-therapy-in-patients-with-nsclc/ 2024-02-27T17:54:33+00:00 https://ascopost.com/news/february-2024/psychological-distress-may-contribute-to-cancer-treatment-delays/ 2024-02-27T18:34:59+00:00 https://ascopost.com/news/february-2024/doxorubicin-exposure-and-risk-of-breast-cancer-in-survivors-of-hodgkin-lymphoma/ 2024-02-27T18:41:30+00:00 https://ascopost.com/news/february-2024/rusfertide-for-erythrocytosis-in-polycythemia-vera/ 2025-09-30T19:26:43+00:00 https://ascopost.com/news/february-2024/adding-first-line-nivolumab-to-chemotherapy-in-advanced-gastric-gastroesophageal-junction-and-esophageal-adenocarcinoma/ 2025-06-27T21:19:52+00:00 https://ascopost.com/news/february-2024/us-individuals-with-incarceration-history-may-have-lower-likelihood-of-undergoing-cancer-screenings/ 2024-02-28T19:54:52+00:00 https://ascopost.com/news/february-2024/exposure-to-secondhand-smoke-during-chemotherapy-may-decrease-treatment-efficacy-in-patients-with-head-and-neck-cancer/ 2026-01-28T19:28:44+00:00 https://ascopost.com/news/february-2024/risk-of-stroke-in-survivors-of-head-and-neck-cancer/ 2026-01-28T19:24:11+00:00 https://ascopost.com/news/february-2024/novel-monotherapy-in-recurrent-h3-k27m-mutant-diffuse-midline-glioma/ 2024-02-28T17:53:33+00:00 https://ascopost.com/news/march-2024/ 2024-03-01T15:10:02+00:00 https://ascopost.com/news/march-2024/online-genetic-education-programs-may-spur-testing-for-patients-at-risk-for-cancer/ 2024-03-01T15:57:56+00:00 https://ascopost.com/news/march-2024/aua-astro-suo-release-clinical-practice-guidelines-on-salvage-therapy-for-prostate-cancer/ 2024-03-01T16:06:41+00:00 https://ascopost.com/news/march-2024/nasopharyngeal-carcinoma-radiotherapy-vs-chemoradiotherapy-after-induction-chemotherapy/ 2026-01-28T19:20:35+00:00 https://ascopost.com/news/march-2024/advanced-multiple-myeloma-prediction-model-for-outcomes-after-bcma-directed-car-t-cell-therapy/ 2024-03-01T17:12:11+00:00 https://ascopost.com/news/march-2024/circulating-leukocyte-subsets-after-breast-cancer-diagnosis-and-treatment/ 2024-03-01T17:50:20+00:00 https://ascopost.com/news/march-2024/impact-of-behavioral-health-disorders-on-cancer-surgery-outcomes/ 2024-03-04T15:11:26+00:00 https://ascopost.com/news/march-2024/disparities-in-treatment-outcomes-among-non-hispanic-black-patients-with-locally-advanced-rectal-cancer/ 2024-03-04T15:22:55+00:00 https://ascopost.com/news/march-2024/racialethnic-differences-in-treatment-outcomes-among-patients-with-triple-negative-breast-cancer/ 2024-03-04T17:24:43+00:00 https://ascopost.com/news/march-2024/can-hpv-ctdna-guide-the-adjuvant-treatment-of-oropharyngeal-cancer/ 2026-01-28T19:19:01+00:00 https://ascopost.com/news/march-2024/nccn-updates-treatment-recommendations-for-breast-colorectal-lung-and-other-cancers/ 2024-03-05T16:56:27+00:00 https://ascopost.com/news/march-2024/social-determinants-of-health-potentially-responsible-for-low-breast-cancer-screening-rates/ 2024-03-05T20:28:08+00:00 https://ascopost.com/news/march-2024/can-dual-her2-blockade-treat-more-than-just-breast-or-gastric-cancer/ 2026-01-28T18:18:35+00:00 https://ascopost.com/news/march-2024/hpv-vaccination-among-young-adults-prior-to-and-during-the-covid-19-pandemic/ 2024-03-05T18:15:50+00:00 https://ascopost.com/news/march-2024/variations-in-use-of-chemotherapy-in-patients-with-newly-diagnosed-common-cancers/ 2024-03-05T17:57:28+00:00 https://ascopost.com/news/march-2024/hpv-associated-oropharyngeal-cancer-adjuvant-treatment-deintensification/ 2026-01-28T18:14:59+00:00 https://ascopost.com/news/march-2024/could-smoking-related-dna-changes-reflect-differential-lung-cancer-risks-by-race-and-ethnicity/ 2024-03-06T18:03:03+00:00 https://ascopost.com/news/march-2024/medical-debt-may-be-associated-with-poorer-health-status-and-survival-outcomes-at-us-county-level/ 2024-03-06T15:39:13+00:00 https://ascopost.com/news/march-2024/fda-approves-denosumab-biosimilars/ 2024-03-06T19:34:29+00:00 https://ascopost.com/news/march-2024/low-risk-cervical-cancer-pelvic-recurrence-with-simple-vs-radical-hysterectomy/ 2024-03-06T18:24:07+00:00 https://ascopost.com/news/march-2024/novel-cd123-targeting-antibody-drug-conjugate-in-relapsed-or-refractory-aml/ 2024-03-06T17:55:36+00:00 https://ascopost.com/news/march-2024/factors-associated-with-myeloid-neoplasms-following-car-t-cell-therapy/ 2024-03-06T18:00:42+00:00 https://ascopost.com/news/march-2024/fda-approves-inotuzumab-ozogamicin-for-pediatric-patients-with-all/ 2024-03-07T18:55:25+00:00 https://ascopost.com/news/march-2024/finding-new-therapeutic-targets-for-male-breast-cancer/ 2024-03-07T17:38:05+00:00 https://ascopost.com/news/march-2024/physician-attitudes-toward-2020-acs-cervical-cancer-screening-guidelines/ 2024-03-07T17:36:02+00:00 https://ascopost.com/news/march-2024/patients-with-early-stage-hr-positive-breast-cancer-may-be-over-or-undertreated-without-breast-cancer-index-genomic-testing/ 2024-03-07T20:55:06+00:00 https://ascopost.com/news/march-2024/topical-diclofenac-to-prevent-capecitabine-associated-hand-foot-syndrome/ 2025-06-27T21:17:59+00:00 https://ascopost.com/news/march-2024/inherited-genetic-factors-may-influence-risk-of-subsequent-cancer-diagnoses-in-childhood-cancer-survivors/ 2024-03-08T15:08:50+00:00 https://ascopost.com/news/march-2024/five-new-cancer-grand-challenges-teams-named-in-global-effort-to-resolve-hurdles-in-cancer-research/ 2024-03-08T15:21:49+00:00 https://ascopost.com/news/march-2024/primary-tumor-resection-before-chemotherapy-in-patients-with-colon-cancer-and-unresectable-metastases/ 2024-03-08T17:48:41+00:00 https://ascopost.com/news/march-2024/novel-mdm2-inhibitor-for-salivary-gland-cancers/ 2026-01-28T17:52:01+00:00 https://ascopost.com/news/march-2024/higher-bmi-may-be-linked-to-complications-following-autologous-breast-reconstruction/ 2024-03-12T14:33:49+00:00 https://ascopost.com/news/march-2024/worsening-metabolic-syndrome-may-increase-cancer-risk/ 2024-03-12T14:55:19+00:00 https://ascopost.com/news/march-2024/zanubrutinib-vs-acalabrutinib-in-relapsed-or-refractory-cll-new-efficacy-analysis/ 2024-03-18T16:46:59+00:00 https://ascopost.com/news/march-2024/variations-in-use-of-radiotherapy-in-patients-with-newly-diagnosed-common-cancers/ 2024-03-12T16:10:51+00:00 https://ascopost.com/news/march-2024/patients-with-biochemical-recurrence-of-prostate-cancer-ga-68-rm2-pet-mri-vs-mri-alone-for-lesion-detection/ 2024-03-12T16:28:23+00:00 https://ascopost.com/news/march-2024/hpv-associated-oropharyngeal-cancer-intratreatment-fdg-pet-response-as-a-biomarker-for-de-escalation-of-radiotherapy/ 2026-01-28T17:27:31+00:00 https://ascopost.com/news/march-2024/collaborative-care-intervention-may-benefit-patients-with-cancer-health-care-systems/ 2024-03-13T14:38:04+00:00 https://ascopost.com/news/march-2024/risk-score-to-assess-cardiovascular-complications-in-hematopoietic-stem-cell-transplant-recipients/ 2024-03-15T20:45:15+00:00 https://ascopost.com/news/march-2024/immunotherapy-trials-for-metastatic-nsclc-fda-pooled-analysis/ 2024-03-13T15:48:30+00:00 https://ascopost.com/news/march-2024/sunitinib-in-metastatic-progressive-pheochromocytomas-and-paragangliomas/ 2024-03-13T16:40:57+00:00 https://ascopost.com/news/march-2024/metastatic-triple-negative-breast-cancer-sacituzumab-govitecan-vs-single-agent-chemotherapy-in-previously-treated-patients/ 2024-03-13T16:11:35+00:00 https://ascopost.com/news/march-2024/cancer-prevalence-in-europe-as-of-2020/ 2024-03-13T16:18:19+00:00 https://ascopost.com/news/march-2024/germ-cell-tumors-survival-rates-in-female-vs-male-patients/ 2024-03-14T16:23:49+00:00 https://ascopost.com/news/march-2024/novel-dual-target-car-t-cell-therapy-for-recurrent-glioblastoma/ 2024-03-14T16:28:49+00:00 https://ascopost.com/news/march-2024/acs-and-flatiron-health-announce-recipients-of-fourth-annual-real-world-data-impact-awards/ 2024-03-14T19:57:29+00:00 https://ascopost.com/news/march-2024/nab-sirolimus-in-advanced-malignant-perivascular-epithelioid-cell-tumors-ampect-trial-final-analysis/ 2025-08-25T16:47:29+00:00 https://ascopost.com/news/march-2024/sabr-in-patients-with-early-nsclc-and-interstitial-lung-disease/ 2024-03-14T17:16:48+00:00 https://ascopost.com/news/march-2024/previously-untreated-advanced-urothelial-cancer-antibody-drug-conjugate-plus-pd-1-inhibitor/ 2024-03-14T18:28:21+00:00 https://ascopost.com/news/march-2024/trends-in-breast-cancer-diagnoses-during-the-covid-19-pandemic/ 2024-03-15T14:03:54+00:00 https://ascopost.com/news/march-2024/p16-positive-oropharyngeal-cancer-surrogate-endpoints-for-overall-survival-in-clinical-trials/ 2026-01-28T17:17:38+00:00 https://ascopost.com/news/march-2024/fda-approves-tislelizumab-for-previously-treated-patients-with-advanced-esophageal-cancer/ 2024-03-15T17:38:34+00:00 https://ascopost.com/news/march-2024/accelerated-approval-granted-to-first-car-t-cell-therapy-for-relapsed-or-refractory-cllsll/ 2024-03-15T17:32:19+00:00 https://ascopost.com/news/march-2024/h-pylori-infection-risk-of-colorectal-cancer-and-colorectal-cancer-related-mortality/ 2024-03-18T15:41:09+00:00 https://ascopost.com/news/march-2024/sabr-for-patients-with-primary-kidney-cancer-not-undergoing-resection/ 2024-03-18T15:54:13+00:00 https://ascopost.com/news/march-2024/exploring-the-genetic-link-between-colorectal-cancer-and-meat-consumption/ 2024-03-18T15:56:58+00:00 https://ascopost.com/news/march-2024/chatgpt-may-accurately-answer-common-patient-questions-regarding-gynecologic-cancer/ 2026-01-22T17:05:03+00:00 https://ascopost.com/news/march-2024/localized-or-advanced-prostate-cancer-short-or-longer-term-relugolix-plus-radiotherapy/ 2024-03-18T16:36:39+00:00 https://ascopost.com/news/march-2024/durvalumab-based-regimens-improve-response-over-chemotherapy-alone-in-pmmr-advanced-endometrial-cancer/ 2024-03-19T17:10:05+00:00 https://ascopost.com/news/march-2024/performance-of-cfdna-blood-based-test-for-colorectal-cancer-screening/ 2024-03-19T16:26:28+00:00 https://ascopost.com/news/march-2024/hormonal-therapy-plus-sbrt-for-advanced-prostate-cancer/ 2024-03-19T17:18:43+00:00 https://ascopost.com/news/march-2024/lillian-siu-named-2024-2025-aacr-president-elect/ 2024-03-19T16:34:38+00:00 https://ascopost.com/news/march-2024/adjuvant-pembrolizumab-in-resected-stage-iib-or-iic-melanoma/ 2024-03-19T16:40:11+00:00 https://ascopost.com/news/march-2024/next-generation-multitarget-stool-dna-test-for-colorectal-cancer-screening/ 2024-03-20T14:37:04+00:00 https://ascopost.com/news/march-2024/fda-grants-accelerated-approval-to-ponatinib-with-chemotherapy-for-newly-diagnosed-philadelphia-chromosome-positive-all/ 2024-04-11T15:50:10+00:00 https://ascopost.com/news/march-2024/liquid-biopsy-may-help-predict-outcomes-in-patients-with-gastroesophageal-cancers-following-immunotherapy/ 2024-03-20T14:42:21+00:00 https://ascopost.com/news/march-2024/avelumab-plus-axitinib-in-mismatch-repair-proficient-recurrent-or-persistent-endometrial-cancer/ 2024-03-20T14:46:40+00:00 https://ascopost.com/news/march-2024/localized-prostate-cancer-association-of-psa-nadir-within-6-months-of-radiotherapy-with-outcomes/ 2024-03-20T17:11:31+00:00 https://ascopost.com/news/march-2024/effect-of-her2-gene-expression-levels-on-outcomes-in-metastatic-colorectal-cancer/ 2024-03-20T17:18:19+00:00 https://ascopost.com/news/march-2024/car-t-cell-therapy-complications-comparison-of-three-testing-modalities/ 2024-03-20T17:42:29+00:00 https://ascopost.com/news/march-2024/venetoclax-in-relapsed-or-refractory-chronic-lymphocytic-leukemia/ 2024-03-21T16:47:40+00:00 https://ascopost.com/news/march-2024/racialethnic-differences-in-care-intensity-at-the-end-of-life-for-patients-with-lung-cancer/ 2024-03-21T16:49:09+00:00 https://ascopost.com/news/march-2024/pembrolizumab-may-improve-breast-cancer-outcomes-regardless-of-age-or-menopausal-status/ 2024-04-05T18:54:41+00:00 https://ascopost.com/news/march-2024/updated-immune-classifier-imprinttn-may-accurately-identify-patients-with-triple-negative-breast-cancer-who-are-unlikely-to-respond-to-immunotherapy/ 2024-03-21T16:17:01+00:00 https://ascopost.com/news/march-2024/incidence-of-secondary-t-cell-malignancies-following-car-t-cell-therapy/ 2024-03-21T16:48:19+00:00 https://ascopost.com/news/march-2024/effect-of-exercise-on-symptom-burden-and-quality-of-life-in-patients-with-metastatic-breast-cancer/ 2024-03-22T16:23:46+00:00 https://ascopost.com/news/march-2024/addition-of-atezolizumab-to-adjuvant-chemotherapy-in-triple-negative-breast-cancer/ 2024-03-22T16:29:05+00:00 https://ascopost.com/news/march-2024/fda-approves-safety-labeling-changes-regarding-dpd-deficiency-for-fluorouracil-injection-products/ 2024-03-22T16:31:56+00:00 https://ascopost.com/news/march-2024/flt3-itd-mutated-aml-gilteritinib-in-posttransplantation-maintenance/ 2024-03-22T17:05:40+00:00 https://ascopost.com/news/march-2024/is-hypofractionated-radiotherapy-emerging-as-the-new-standard-of-care-after-prostatectomy/ 2024-03-22T16:37:49+00:00 https://ascopost.com/news/march-2024/combined-pet-mri-scan-could-benefit-patients-with-early-stage-breast-cancer/ 2024-03-26T14:03:04+00:00 https://ascopost.com/news/march-2024/response-to-primary-systemic-therapy-could-dictate-whether-extensive-lymph-node-removal-is-needed-in-patients-with-breast-cancer/ 2024-03-26T14:09:04+00:00 https://ascopost.com/news/march-2024/low-dose-radiotherapy-boost-in-young-patients-with-breast-cancer/ 2024-03-26T14:12:48+00:00 https://ascopost.com/news/march-2024/fda-approves-mirvetuximab-soravtansine-gynx-for-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer/ 2024-03-26T16:27:36+00:00 https://ascopost.com/news/march-2024/early-breast-cancer-adding-adjuvant-ribociclib-to-nonsteroidal-aromatase-inhibitor-therapy/ 2024-03-26T16:46:10+00:00 https://ascopost.com/news/march-2024/dostarlimab-based-combinations-in-advanced-endometrial-cancer/ 2024-03-26T17:10:34+00:00 https://ascopost.com/news/march-2024/subtype-of-fusobacterium-nucleatum-may-be-linked-to-colorectal-cancer-progression-and-poor-outcomes/ 2024-03-27T14:31:16+00:00 https://ascopost.com/news/march-2024/gut-microbiome-signatures-may-help-unravel-disparities-in-early-onset-colorectal-cancer/ 2024-03-27T14:40:44+00:00 https://ascopost.com/news/march-2024/integrated-screening-and-stepped-collaborative-care-intervention-effect-on-health-related-quality-of-life-in-patients-with-cancer/ 2024-03-27T14:54:13+00:00 https://ascopost.com/news/march-2024/stopping-tki-treatment-in-chronic-myeloid-leukemia/ 2024-03-27T15:35:49+00:00 https://ascopost.com/news/march-2024/endoscopic-screening-and-esophageal-cancer-incidence-and-mortality/ 2024-03-27T15:39:18+00:00 https://ascopost.com/news/march-2024/stage-iii-colorectal-cancer-association-of-immunoscore-with-disease-free-survival/ 2024-03-28T13:13:16+00:00 https://ascopost.com/news/march-2024/novel-drug-combination-in-multiple-myeloma/ 2024-03-28T14:44:31+00:00 https://ascopost.com/news/march-2024/ikzf1-genetic-variant-may-contribute-to-disparities-in-risk-of-all-in-pediatric-hispanic-and-latino-patients/ 2024-03-28T17:03:04+00:00 https://ascopost.com/news/march-2024/pembrolizumab-with-chemoradiotherapy-for-figo-2014-stage-iii-iva-cervical-cancer/ 2024-03-28T13:32:04+00:00 https://ascopost.com/news/march-2024/belzutifan-in-previously-treated-advanced-renal-cell-carcinoma/ 2024-03-28T14:20:38+00:00 https://ascopost.com/news/march-2024/early-breast-cancer-nurse-led-follow-up-intervention-and-quality-of-life-after-treatment/ 2024-03-28T14:52:05+00:00 https://ascopost.com/news/march-2024/eflornithine-for-adult-and-pediatric-patients-with-high-risk-neuroblastoma/ 2024-03-28T14:32:37+00:00 https://ascopost.com/news/march-2024/amivantamab-vmjw-in-nsclc-with-egfr-exon-20-insertion-mutations/ 2024-03-28T14:40:27+00:00 https://ascopost.com/news/march-2024/inotuzumab-ozogamicin-for-relapsed-or-refractory-pediatric-acute-lymphoblastic-leukemia/ 2025-10-03T15:50:22+00:00 https://ascopost.com/news/march-2024/eligibility-for-and-prevalence-of-lung-cancer-screening-in-the-united-states-in-2022/ 2024-03-28T15:31:55+00:00 https://ascopost.com/news/march-2024/chemoradiotherapy-with-or-without-pembrolizumab-for-newly-diagnosed-high-risk-locally-advanced-cervical-cancer/ 2024-03-28T15:50:06+00:00 https://ascopost.com/news/march-2024/older-patients-with-aml-does-stem-cell-transplant-improve-long-term-outcomes/ 2024-03-28T17:02:33+00:00 https://ascopost.com/news/march-2024/malpractice-risk-with-active-surveillance-for-patients-with-low-risk-cancer/ 2024-04-29T18:21:49+00:00 https://ascopost.com/news/march-2024/prolonged-use-of-progestogens-may-be-linked-to-increased-risk-of-brain-cancer/ 2024-03-29T14:04:58+00:00 https://ascopost.com/news/march-2024/nsclc-neoadjuvant-chemoimmunotherapy-vs-neoadjuvant-chemotherapy/ 2024-03-29T14:46:02+00:00 https://ascopost.com/news/march-2024/gu-and-gi-symptoms-with-postprostatectomy-radiotherapy-for-prostate-cancer/ 2024-03-29T14:50:33+00:00 https://ascopost.com/news/april-2024/ 2024-04-19T14:36:41+00:00 https://ascopost.com/news/april-2024/naprc-accredited-hospitals-vs-nonaccredited-hospitals-proctectomy-outcomes/ 2024-04-01T16:18:05+00:00 https://ascopost.com/news/april-2024/surveyed-oncologists-attitudes-toward-ethical-implications-of-ai-in-cancer-care/ 2024-04-01T13:50:18+00:00 https://ascopost.com/news/april-2024/t-dxd-in-her2-overexpressing-unresectable-or-metastatic-nsclc/ 2024-04-04T17:47:59+00:00 https://ascopost.com/news/april-2024/pazopanib-in-patients-with-metastatic-renal-cell-carcinoma-and-no-evidence-of-disease-after-metastasectomy/ 2025-06-30T01:22:35+00:00 https://ascopost.com/news/april-2024/giredestrant-in-previously-treated-patients-with-er-positive-her2-negative-advanced-breast-cancer/ 2024-04-01T15:54:15+00:00 https://ascopost.com/news/april-2024/tuberculosis-may-be-linked-to-increased-risk-of-various-cancer-types/ 2024-04-02T19:30:02+00:00 https://ascopost.com/news/april-2024/benefit-of-prostate-mri-plus-psa-density-test-in-patients-suspected-of-having-prostate-cancer/ 2024-04-02T19:27:47+00:00 https://ascopost.com/news/april-2024/advanced-anal-cancer-addition-of-atezolizumab-to-first-line-modified-docetaxel-cisplatin-and-fluorouracil/ 2024-04-02T17:11:25+00:00 https://ascopost.com/news/april-2024/t-cell-therapy-in-advanced-synovial-sarcoma-and-myxoid-round-cell-liposarcoma/ 2025-08-25T16:45:52+00:00 https://ascopost.com/news/april-2024/microwave-ablation-vs-surgical-resection-in-multifocal-papillary-thyroid-carcinoma/ 2024-04-03T14:29:19+00:00 https://ascopost.com/news/april-2024/can-tils-help-to-determine-outcomes-in-triple-negative-breast-cancer/ 2024-04-03T14:40:20+00:00 https://ascopost.com/news/april-2024/one-in-five-people-with-cancer-participate-in-clinical-research-new-study-finds/ 2024-04-03T15:21:23+00:00 https://ascopost.com/news/april-2024/gedatolisib-plus-palbociclib-and-endocrine-therapy-in-hr-positive-her2-negative-advanced-breast-cancer/ 2024-04-03T16:59:55+00:00 https://ascopost.com/news/april-2024/hr-positive-her2-negative-metastatic-breast-cancer-treatment-after-progression-on-cdk46-and-aromatase-inhibitors/ 2024-04-03T17:19:45+00:00 https://ascopost.com/news/april-2024/asking-chatgpt-about-radiation-oncology-treatment/ 2024-04-04T15:58:39+00:00 https://ascopost.com/news/april-2024/study-examines-shared-decision-making-policies-and-practices-around-lung-cancer-screening/ 2024-04-04T16:07:19+00:00 https://ascopost.com/news/april-2024/feasibility-of-ending-specialist-follow-up-in-patients-with-low-risk-cll/ 2024-04-04T15:30:20+00:00 https://ascopost.com/news/april-2024/advanced-pancreatic-cancer-oncolytic-virus-based-immunostimulatory-gene-therapy-plus-chemotherapy/ 2024-04-05T15:59:35+00:00 https://ascopost.com/news/april-2024/danicopan-approved-as-add-on-therapy-to-ravulizumab-or-eculizumab-for-extravascular-hemolysis-in-adults-with-paroxysmal-nocturnal-hemoglobinuria/ 2024-04-05T16:31:39+00:00 https://ascopost.com/news/april-2024/american-cancer-society-releases-latest-global-cancer-statistics-cancer-cases-expected-to-rise-to-35-million-worldwide-by-2050/ 2024-04-05T17:13:55+00:00 https://ascopost.com/news/april-2024/distinct-microbial-signature-uncovered-in-kras-mutated-colorectal-cancer/ 2024-04-05T16:41:13+00:00 https://ascopost.com/news/april-2024/improving-adjuvant-treatment-in-patients-with-muscle-invasive-urothelial-carcinoma/ 2025-06-27T18:25:14+00:00 https://ascopost.com/news/april-2024/fewer-than-half-of-accelerated-approval-drugs-demonstrated-benefit-within-5-years/ 2024-04-08T14:11:56+00:00 https://ascopost.com/news/april-2024/accelerated-aging-may-be-a-risk-factor-for-early-onset-cancers-in-younger-generations/ 2024-04-29T18:15:10+00:00 https://ascopost.com/news/april-2024/fda-grants-accelerated-approval-to-fam-trastuzumab-deruxtecan-nxki-for-unresectable-or-metastatic-her2-positive-solid-tumors/ 2024-04-08T14:30:04+00:00 https://ascopost.com/news/april-2024/can-a-personalized-antitumor-vaccine-plus-pembrolizumab-improve-outcomes-in-hepatocellular-carcinoma/ 2024-04-09T16:41:08+00:00 https://ascopost.com/news/april-2024/mirvetuximab-soravtansine-plus-pembrolizumab-in-patients-with-endometrial-cancer-subtype/ 2024-04-08T17:06:26+00:00 https://ascopost.com/news/april-2024/ciltacabtagene-autoleucel-and-idecabtagene-vicleucel-approved-by-the-fda-for-pretreated-patients-with-multiple-myeloma/ 2024-04-08T17:13:03+00:00 https://ascopost.com/news/april-2024/novel-car-t-cell-therapy-may-show-benefit-in-patients-with-advanced-clear-cell-renal-cell-carcinoma/ 2025-06-30T01:19:07+00:00 https://ascopost.com/news/april-2024/rp1-immunotherapy-in-solid-organ-transplant-recipients-with-skin-cancer/ 2024-04-09T14:04:54+00:00 https://ascopost.com/news/april-2024/bispecific-immune-checkpoint-inhibitor-improves-survival-in-patients-with-gastric-cancer-regardless-of-pd-l1-status/ 2025-06-27T21:16:32+00:00 https://ascopost.com/news/april-2024/immune-response-to-investigational-rna-vaccine-for-pancreatic-cancer-continues-to-correlate-with-clinical-benefit/ 2024-04-09T15:23:44+00:00 https://ascopost.com/news/april-2024/biologic-drug-device-combination-immunotherapy-in-metastatic-prostate-cancer/ 2024-04-09T16:17:54+00:00 https://ascopost.com/news/april-2024/adagrasib-plus-cetuximab-in-kras-g12c-mutated-colorectal-cancer/ 2024-04-23T17:26:23+00:00 https://ascopost.com/news/april-2024/atm-kinase-inhibitor-plus-radiotherapy-for-patients-with-glioblastoma/ 2024-04-10T15:19:46+00:00 https://ascopost.com/news/april-2024/investigational-personalized-vaccine-in-resected-head-and-neck-cancers/ 2026-01-28T21:35:23+00:00 https://ascopost.com/news/april-2024/parp1-selective-inhibitor-in-hrr-deficient-breast-cancer/ 2024-04-10T15:58:15+00:00 https://ascopost.com/news/april-2024/aacr-inaugurates-new-leadership/ 2024-04-10T15:50:22+00:00 https://ascopost.com/news/april-2024/proteogenomic-signatures-may-help-identify-risk-of-prostate-cancer-progression-in-certain-populations/ 2024-04-10T17:42:20+00:00 https://ascopost.com/news/april-2024/an-exosome-based-liquid-biopsy-for-early-detection-of-pancreatic-cancer/ 2024-04-29T18:16:19+00:00 https://ascopost.com/news/april-2024/bap1-mutations-may-increase-susceptibility-to-asbestos-induced-malignant-mesothelioma/ 2024-04-11T18:03:30+00:00 https://ascopost.com/news/april-2024/educational-videos-may-encourage-prostate-cancer-screening-in-black-patients/ 2024-04-11T15:23:26+00:00 https://ascopost.com/news/april-2024/anti-cd19-car-t-cell-therapy-for-richter-transformation/ 2024-04-11T14:57:43+00:00 https://ascopost.com/news/april-2024/effect-of-virtually-delivered-cbt-for-insomnia-on-cancer-related-cognitive-impairment/ 2024-04-11T15:31:37+00:00 https://ascopost.com/news/april-2024/blood-based-machine-learning-assay-may-noninvasively-detect-early-ovarian-cancer/ 2024-04-11T15:42:32+00:00 https://ascopost.com/news/april-2024/the-lancet-commission-on-prostate-cancer-strategies-to-prepare-for-predicted-increases-in-disease-burden-by-2040/ 2024-04-12T14:59:19+00:00 https://ascopost.com/news/april-2024/longer-interval-may-be-safe-for-prostate-cancer-screening-in-low-risk-patients/ 2024-04-12T15:39:46+00:00 https://ascopost.com/news/april-2024/novel-urine-biomarker-test-may-reduce-unnecessary-cystoscopies-in-patients-with-bladder-cancer/ 2025-06-27T18:24:30+00:00 https://ascopost.com/news/april-2024/lung-cancer-screening-eligibility-effect-of-using-history-vs-pack-year-history-of-smoking/ 2024-04-12T16:43:53+00:00 https://ascopost.com/news/april-2024/b-cell-non-hodgkin-lymphoma-extended-follow-up-with-mosunetuzumab/ 2024-04-12T16:42:23+00:00 https://ascopost.com/news/april-2024/radon-gas-exposure-may-be-linked-to-increased-incidence-of-lung-cancer-in-nonsmokers/ 2024-04-15T15:09:15+00:00 https://ascopost.com/news/april-2024/illuminating-a-potential-culprit-in-melanoma-treatment-resistance/ 2024-04-15T17:06:44+00:00 https://ascopost.com/news/april-2024/oxaliplatin-based-adjuvant-therapy-in-older-patients-with-stage-iii-colon-cancer/ 2024-04-15T16:20:56+00:00 https://ascopost.com/news/april-2024/newly-diagnosed-locally-advanced-hnscc-adding-pembrolizumab-to-concurrent-chemoradiotherapy/ 2026-01-28T21:34:46+00:00 https://ascopost.com/news/april-2024/genetic-variants-potentially-linked-to-prevalent-or-persistent-hpv-infections-identified/ 2024-04-16T16:13:19+00:00 https://ascopost.com/news/april-2024/new-findings-suggest-no-correlation-between-glp-1-receptor-agonists-and-thyroid-cancer-risk/ 2024-04-16T16:24:46+00:00 https://ascopost.com/news/april-2024/atezolizumabcabozantinib-vs-docetaxel-in-previously-treated-metastatic-nsclc/ 2024-05-14T16:04:37+00:00 https://ascopost.com/news/april-2024/alk-positive-nsclc-adjuvant-alectinib-vs-platinum-based-chemotherapy/ 2024-04-16T17:21:36+00:00 https://ascopost.com/news/april-2024/cabozantinib-in-advanced-adrenocortical-carcinoma/ 2024-04-16T16:58:39+00:00 https://ascopost.com/news/april-2024/her2-positive-early-breast-cancer-pet-based-pcr-adapted-strategy/ 2024-04-17T12:40:26+00:00 https://ascopost.com/news/april-2024/cisplatin-gemcitabine-and-imrt-in-locally-advanced-vulvar-cancer/ 2024-04-17T12:48:47+00:00 https://ascopost.com/news/april-2024/the-lancet-commission-on-breast-cancer-reducing-overlooked-inequities-in-breast-cancer/ 2024-04-17T14:51:26+00:00 https://ascopost.com/news/april-2024/immunotherapy-resistance-and-response-to-adoptive-therapy-in-patients-with-metastatic-uveal-melanoma/ 2024-04-17T15:12:14+00:00 https://ascopost.com/news/april-2024/risk-of-second-primary-breast-cancer-in-young-breast-cancer-survivors/ 2024-04-18T15:22:16+00:00 https://ascopost.com/news/april-2024/survival-rates-in-patients-with-cancer-and-intellectual-and-developmental-disabilities/ 2024-04-18T13:34:41+00:00 https://ascopost.com/news/april-2024/improving-early-detection-of-pancreatic-cancer-in-high-risk-patients/ 2024-04-18T13:41:11+00:00 https://ascopost.com/news/april-2024/professional-societies-introduce-new-evidence-based-guidelines-on-testing-immunotherapy-biomarkers-in-nsclc/ 2024-04-19T16:47:01+00:00 https://ascopost.com/news/april-2024/novel-spectct-imaging-technique-under-study-in-prostate-cancer/ 2024-04-19T14:27:14+00:00 https://ascopost.com/news/april-2024/functional-disability-among-us-cancer-survivors-2017-2022/ 2024-04-19T14:21:27+00:00 https://ascopost.com/news/april-2024/observing-a-healthy-diet-may-reduce-risk-of-cardiovascular-disease-in-breast-cancer-survivors/ 2024-04-22T13:58:17+00:00 https://ascopost.com/news/april-2024/propofol-based-anesthesia-may-offer-improved-detection-of-serrated-polyps-during-colonoscopy/ 2024-04-22T14:07:33+00:00 https://ascopost.com/news/april-2024/nivolumab-with-or-without-ipilimumab-in-recurrent-or-metastatic-cervical-cancer/ 2024-04-22T17:24:17+00:00 https://ascopost.com/news/april-2024/cabozantinib-in-metastatic-pheochromocytomas-or-paragangliomas/ 2024-04-22T15:52:28+00:00 https://ascopost.com/news/april-2024/chemohormonal-therapy-for-locally-advanced-prostate-cancer/ 2024-04-23T14:02:07+00:00 https://ascopost.com/news/april-2024/predicting-ovarian-cancer-relapse-with-spatial-tissue-analysis/ 2024-04-23T14:14:11+00:00 https://ascopost.com/news/april-2024/fda-approves-nogapendekin-alfa-inbakicept-pmln-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/ 2025-06-27T18:23:23+00:00 https://ascopost.com/news/april-2024/induction-and-concurrent-vismodegib-with-radiation-therapy-for-locally-advanced-unresectable-basal-cell-carcinoma/ 2024-04-23T14:24:50+00:00 https://ascopost.com/news/april-2024/fda-grants-accelerated-approval-to-tovorafenib-for-patients-with-relapsed-or-refractory-braf-altered-pediatric-low-grade-glioma/ 2024-04-24T14:59:00+00:00 https://ascopost.com/news/april-2024/potential-protective-effects-of-aspirin-against-colorectal-cancer/ 2024-04-24T15:14:44+00:00 https://ascopost.com/news/april-2024/fda-approves-lu-177-dotatate-for-pediatric-patients-with-gep-nets/ 2024-04-24T19:01:28+00:00 https://ascopost.com/news/april-2024/imaging-drug-to-assist-in-detection-of-cancerous-tissue-following-lumpectomy-approved/ 2024-04-24T15:53:32+00:00 https://ascopost.com/news/april-2024/in-hospital-mortality-among-patients-with-covid-19-infection-with-or-without-cancer/ 2024-04-24T16:31:47+00:00 https://ascopost.com/news/april-2024/ai-model-may-help-predict-treatment-responses-select-most-effective-cancer-therapies-in-patients-with-cancer/ 2024-04-24T16:37:51+00:00 https://ascopost.com/news/april-2024/breast-cancer-survivors-relationship-satisfaction-and-emotional-and-physical-well-being/ 2024-04-26T14:00:50+00:00 https://ascopost.com/news/april-2024/lack-of-research-focused-on-older-adults-with-cancer-may-be-contributing-to-disparities-in-care/ 2024-04-26T14:05:25+00:00 https://ascopost.com/news/april-2024/risk-of-t-cell-and-second-primary-malignant-neoplasms-after-car-t-cell-therapy/ 2024-04-26T14:41:37+00:00 https://ascopost.com/news/april-2024/combined-ici-and-vegf-inhibitor-trials-in-cancer-cardiovascular-eligibility-criteria-and-adverse-event-reporting/ 2024-04-26T14:47:40+00:00 https://ascopost.com/news/april-2024/adjuvant-pembrolizumab-in-renal-cell-carcinoma-overall-survival-in-keynote-564/ 2025-06-30T01:17:52+00:00 https://ascopost.com/news/april-2024/barriers-to-autologous-hematopoietic-cell-transplantation-in-multiple-myeloma/ 2024-04-29T17:07:49+00:00 https://ascopost.com/news/april-2024/immunotherapy-plus-folfiri-for-advanced-gastricgastroesophageal-junction-adenocarcinoma/ 2025-06-27T21:15:49+00:00 https://ascopost.com/news/april-2024/mri-guided-duration-of-neoadjuvant-chemotherapy-in-her2-positive-breast-cancer/ 2024-04-29T14:37:45+00:00 https://ascopost.com/news/april-2024/financial-hardships-caused-by-cancer-are-long-lasting-for-many-working-age-adults/ 2024-04-29T15:03:11+00:00 https://ascopost.com/news/april-2024/trends-in-hematopoietic-cell-transplantation-survival-rates-across-racial-and-ethnic-groups/ 2024-04-30T19:11:08+00:00 https://ascopost.com/news/april-2024/combination-of-preketone-supplements-and-immunotherapy-may-be-effective-in-patients-with-prostate-cancer/ 2024-04-30T16:50:02+00:00 https://ascopost.com/news/april-2024/fda-approves-tisotumab-vedotin-tftv-for-recurrent-or-metastatic-cervical-cancer/ 2024-04-30T16:31:14+00:00 https://ascopost.com/news/april-2024/fda-approves-trastuzumab-biosimilar-trastuzumab-strf/ 2025-06-27T21:15:21+00:00 https://ascopost.com/news/april-2024/neoadjuvant-chemoimmunotherapy-in-patients-with-early-stage-nsclc/ 2024-04-30T16:37:07+00:00 https://ascopost.com/news/april-2024/propofol-exposure-and-neurocognitive-outcomes-in-children-with-high-risk-all/ 2024-04-30T19:13:20+00:00 https://ascopost.com/news/april-2024/uspstf-issues-final-recommendation-statement-on-screening-for-breast-cancer/ 2024-05-03T15:21:53+00:00 https://ascopost.com/news/may-2024/ 2024-05-01T14:35:38+00:00 https://ascopost.com/news/may-2024/aspirin-use-among-breast-cancer-survivors-navigating-negative-results-age-and-health-equity/ 2024-05-01T16:01:17+00:00 https://ascopost.com/news/may-2024/cancer-screening-rates-may-be-significantly-lower-in-us-federally-qualified-health-centers/ 2024-05-01T16:05:19+00:00 https://ascopost.com/news/may-2024/older-patients-with-newly-diagnosed-hodgkin-lymphoma-preexisting-heart-failure-and-survival-outcomes/ 2024-05-01T16:08:33+00:00 https://ascopost.com/news/may-2024/pediatric-aml-comparison-of-induction-regimens/ 2024-05-01T16:58:56+00:00 https://ascopost.com/news/may-2024/metastatic-castration-resistant-prostate-cancer-addition-of-lupsma-to-enzalutamide/ 2024-05-01T17:53:56+00:00 https://ascopost.com/news/may-2024/glecirasib-shows-efficacy-and-safety-in-kras-g12c-mutated-nsclc/ 2024-05-01T18:23:17+00:00 https://ascopost.com/news/may-2024/mortality-trends-among-asian-american-native-hawaiian-and-other-pacific-islander-patients-with-preventable-cancers/ 2024-05-02T15:45:29+00:00 https://ascopost.com/news/may-2024/effect-of-mindfulness-audio-recordings-on-physical-emotional-side-effects-during-radiation-therapy-for-prostate-cancer/ 2024-05-02T16:05:49+00:00 https://ascopost.com/news/may-2024/salvage-reirradiation-for-locally-recurrent-prostate-cancer-7-year-follow-up/ 2024-05-02T16:15:48+00:00 https://ascopost.com/news/may-2024/metastatic-urothelial-cancer-nectin4-amplification-and-response-to-enfortumab-vedotin/ 2025-06-27T18:19:06+00:00 https://ascopost.com/news/may-2024/risk-of-arterial-thromboembolism-in-japanese-patients-with-cancer/ 2024-05-02T16:44:29+00:00 https://ascopost.com/news/may-2024/preferred-sites-of-cancer-care-community-oncology-practices-vs-hospitals-and-academic-centers/ 2024-05-03T14:07:27+00:00 https://ascopost.com/news/may-2024/smoking-cessation-regimens-does-dose-of-therapy-matter/ 2024-05-03T14:13:58+00:00 https://ascopost.com/news/may-2024/liposomal-irinotecan-vs-topotecan-in-relapsed-small-cell-lung-cancer/ 2024-05-03T14:18:18+00:00 https://ascopost.com/news/may-2024/premastectomy-radiotherapy-surgery-and-immediate-breast-reconstruction/ 2024-05-03T14:51:56+00:00 https://ascopost.com/news/may-2024/relapsed-or-refractory-cd7-positive-leukemia-or-lymphoma-car-t-cell-therapy-plus-hsct-without-gvhd-prophylaxis/ 2024-05-03T14:57:10+00:00 https://ascopost.com/news/may-2024/ai-model-may-accurately-predict-mental-health-outcomes-in-patients-with-cancer/ 2024-05-06T15:11:58+00:00 https://ascopost.com/news/may-2024/improving-aml-outcomes-testing-for-mrd-prior-to-bone-marrow-transplant/ 2024-05-20T17:05:22+00:00 https://ascopost.com/news/may-2024/united-kingdoms-first-cardio-oncology-service-10-year-experience/ 2024-05-06T16:59:30+00:00 https://ascopost.com/news/may-2024/durvalumab-after-chemoradiotherapy-in-unresectable-nsclc-real-world-use-and-outcomes/ 2024-05-06T18:08:56+00:00 https://ascopost.com/news/may-2024/dato-dxd-in-advanced-or-metastatic-hr-positive-her2-negative-or-triple-negative-breast-cancer/ 2024-05-06T17:11:59+00:00 https://ascopost.com/news/may-2024/bavituximab-plus-pembrolizumab-for-patients-with-hepatocellular-carcinoma/ 2024-05-07T17:06:22+00:00 https://ascopost.com/news/may-2024/effects-of-radiation-therapy-timing-on-lifespan-of-artificial-urinary-sphincters-in-prostate-cancer-survivors/ 2024-05-07T16:48:19+00:00 https://ascopost.com/news/may-2024/t-dxd-vs-physicians-choice-of-therapy-in-her2-positive-metastatic-breast-cancer-pros-in-destiny-breast02/ 2024-05-07T16:27:54+00:00 https://ascopost.com/news/may-2024/hemihepatectomy-outcomes-with-laparoscopic-vs-open-surgery/ 2024-05-07T16:43:32+00:00 https://ascopost.com/news/may-2024/newly-identified-biomarkers-may-improve-diagnosis-and-treatment-of-rcc-subtypes/ 2025-06-30T01:15:56+00:00 https://ascopost.com/news/may-2024/historical-community-outreach-and-engagement-efforts-at-nci-designated-cancer-centers/ 2024-05-08T15:05:05+00:00 https://ascopost.com/news/may-2024/local-recurrence-of-endometrial-cancer-radiotherapy-with-or-without-cisplatin/ 2024-05-08T15:14:29+00:00 https://ascopost.com/news/may-2024/omission-of-axillary-dissection-after-nodal-downstaging-with-neoadjuvant-chemotherapy-in-breast-cancer/ 2024-05-08T15:21:13+00:00 https://ascopost.com/news/may-2024/addition-of-durvalumab-to-gemcitabinecisplatin-in-advanced-biliary-tract-cancer-pros-in-topaz-1/ 2024-05-08T15:28:26+00:00 https://ascopost.com/news/may-2024/chemical-related-epigenetic-modifications-may-increase-risk-of-prostate-cancer-among-firefighters/ 2024-05-09T17:43:36+00:00 https://ascopost.com/news/may-2024/novel-pet-agent-may-accelerate-imaging-in-patients-with-clear-cell-renal-cell-carcinoma/ 2025-06-30T01:14:43+00:00 https://ascopost.com/news/may-2024/impact-of-age-on-outcomes-in-endometrial-cancer/ 2024-05-09T15:57:12+00:00 https://ascopost.com/news/may-2024/head-and-neck-cancer-osteoradionecrosis-of-the-jaw-classification-system/ 2026-01-28T21:22:54+00:00 https://ascopost.com/news/may-2024/whole-pelvic-radiation-therapy-for-unfavorable-risk-prostate-cancer/ 2024-05-09T17:38:49+00:00 https://ascopost.com/news/may-2024/venetoclax-plus-hypomethylating-agents-analyzing-standard-of-care-outcomes-in-older-patients-with-aml/ 2024-05-13T15:05:54+00:00 https://ascopost.com/news/may-2024/oral-rinse-could-provide-early-screening-for-gastric-cancer/ 2024-05-13T15:21:19+00:00 https://ascopost.com/news/may-2024/colorectal-cancer-incidence-is-rising-among-teenagers-and-young-adults/ 2024-05-13T17:36:36+00:00 https://ascopost.com/news/may-2024/survey-finds-majority-of-patients-with-cancer-and-survivors-have-or-expect-to-incur-medical-debt-even-those-with-insurance/ 2024-05-13T15:32:58+00:00 https://ascopost.com/news/may-2024/doublet-for-previously-treated-patients-with-advanced-leiomyosarcoma/ 2025-08-25T16:44:04+00:00 https://ascopost.com/news/may-2024/lymphoid-neoplasms-european-national-health-expenditure-and-long-term-survival/ 2024-05-13T15:59:10+00:00 https://ascopost.com/news/may-2024/appendectomy-may-lower-risk-of-colorectal-cancer-subtype/ 2024-05-14T14:18:18+00:00 https://ascopost.com/news/may-2024/childrens-cancer-cause-opens-applications-for-the-2024-survivorship-champions-prize/ 2024-05-14T14:36:20+00:00 https://ascopost.com/news/may-2024/childhood-cancer-survivors-genetic-risk-factors-for-treatment-related-type-2-diabetes-mellitus/ 2024-05-14T14:43:53+00:00 https://ascopost.com/news/may-2024/t-dxd-for-advanced-solid-tumors-with-activating-her2-mutations/ 2024-05-14T14:57:56+00:00 https://ascopost.com/news/may-2024/chemotherapy-may-accelerate-physical-decline-in-older-patients-with-early-stage-breast-cancer/ 2024-05-15T14:16:28+00:00 https://ascopost.com/news/may-2024/disparities-in-melanoma-outcomes-among-black-patients/ 2024-05-15T14:22:48+00:00 https://ascopost.com/news/may-2024/fda-approves-hpv-self-collection-solution/ 2026-01-28T21:18:50+00:00 https://ascopost.com/news/may-2024/marker-for-distinguishing-renal-cell-carcinoma-from-benign-renal-masses/ 2025-06-30T01:10:09+00:00 https://ascopost.com/news/may-2024/previously-untreated-mantle-cell-lymphoma-ibrutinib-immunochemotherapy-and-asct/ 2024-05-15T16:59:32+00:00 https://ascopost.com/news/may-2024/plant-based-diet-may-offer-benefit-in-patients-with-prostate-cancer/ 2024-05-16T14:36:51+00:00 https://ascopost.com/news/may-2024/newly-identified-genetic-variants-linked-to-breast-cancer-risk-in-women-of-african-ancestry/ 2024-05-16T14:43:57+00:00 https://ascopost.com/news/may-2024/daniel-geynisman-named-new-jnccn-editor-in-chief/ 2024-05-16T16:53:53+00:00 https://ascopost.com/news/may-2024/providing-culturally-sensitive-palliative-care-to-children-with-cancer/ 2024-05-17T16:43:03+00:00 https://ascopost.com/news/may-2024/donepezil-for-the-treatment-of-cognitive-impairment-in-breast-cancer-survivors-after-adjuvant-chemotherapy/ 2024-05-16T16:35:41+00:00 https://ascopost.com/news/may-2024/childhood-adiposity-and-risk-for-breast-cancer/ 2024-05-17T14:19:43+00:00 https://ascopost.com/news/may-2024/half-matched-family-donors-may-improve-asct-outcomes-in-hispanic-patients-with-all/ 2024-05-17T14:26:39+00:00 https://ascopost.com/news/may-2024/fda-grants-accelerated-approval-to-tarlatamab-dlle-for-extensive-stage-sclc/ 2024-05-17T14:31:51+00:00 https://ascopost.com/news/may-2024/definitive-concurrent-chemoradiotherapy-for-unresectable-locally-advanced-esophageal-cancer-comparison-of-agents/ 2024-05-17T15:24:19+00:00 https://ascopost.com/news/may-2024/multiple-myeloma-is-mrd-status-at-1-year-after-treatment-predictive-of-survival/ 2024-05-17T15:35:20+00:00 https://ascopost.com/news/may-2024/bariatric-surgery-may-help-reduce-the-risk-of-breast-cancer-in-female-patients-with-obesity-hyperinsulinemia/ 2024-05-20T14:10:53+00:00 https://ascopost.com/news/may-2024/end-of-life-systemic-therapy-may-not-improve-survival-in-patients-with-advanced-solid-tumors/ 2024-05-20T14:48:19+00:00 https://ascopost.com/news/may-2024/pertuzumab-plus-trastuzumab-for-advanced-biliary-tract-cancer-with-her23-alterations/ 2024-05-20T15:47:19+00:00 https://ascopost.com/news/may-2024/nivolumabipilimumab-boost-in-metastatic-urothelial-carcinoma/ 2024-05-20T15:54:58+00:00 https://ascopost.com/news/may-2024/adding-perioperative-nivolumab-to-neoadjuvant-chemotherapy-in-resectable-nsclc-checkmate-77t/ 2024-05-20T16:40:56+00:00 https://ascopost.com/news/may-2024/advanced-gastric-or-gastroesophageal-junction-cancer-addition-of-relatlimab-to-immunochemotherapy/ 2025-06-27T21:13:43+00:00 https://ascopost.com/news/may-2024/metformin-may-help-reduce-the-risk-of-developing-myeloproliferative-neoplasms/ 2024-05-21T17:27:21+00:00 https://ascopost.com/news/may-2024/onychopapilloma-may-be-linked-to-bap1-tumor-predisposition-syndrome/ 2024-05-21T17:34:30+00:00 https://ascopost.com/news/may-2024/outcomes-for-cancer-drugs-initially-fda-approved-with-immature-overall-survival-data/ 2024-05-21T17:13:04+00:00 https://ascopost.com/news/may-2024/gallbladder-cancer-rates-among-black-patients-in-the-united-states/ 2024-05-21T19:29:18+00:00 https://ascopost.com/news/may-2024/sexual-well-being-in-the-female-partners-of-patients-with-prostate-cancer/ 2024-05-22T19:31:16+00:00 https://ascopost.com/news/may-2024/survival-outcomes-following-adjuvant-therapy-in-patients-with-clinical-t2n0-rectal-adenocarcinoma/ 2024-05-22T15:30:50+00:00 https://ascopost.com/news/may-2024/fda-withdraws-approval-of-cholangiocarcinoma-drug-indication-for-fgfr-inhibitor/ 2024-05-22T15:36:46+00:00 https://ascopost.com/news/may-2024/hpv-screening-intervals-for-cervical-cancer-may-be-safely-extended-beyond-the-current-5-year-recommendation-study-finds/ 2024-05-22T15:48:16+00:00 https://ascopost.com/news/may-2024/pembrolizumab-in-high-risk-non-muscle-invasive-bladder-cancer/ 2025-06-27T18:17:01+00:00 https://ascopost.com/news/may-2024/most-breast-cancer-survivors-able-to-achieve-pregnancy-after-diagnosis-study-finds/ 2024-05-23T21:13:57+00:00 https://ascopost.com/news/may-2024/influence-of-menopausal-hormone-therapy-on-gynecologic-cancer-incidence-and-mortality/ 2024-05-23T21:25:29+00:00 https://ascopost.com/news/may-2024/ai-based-virtual-patient-navigator-boosts-colonoscopy-adherence/ 2024-05-23T21:28:59+00:00 https://ascopost.com/news/may-2024/patient-characteristics-may-impact-results-of-ai-algorithm-interpreted-screening-mammograms/ 2024-05-28T17:40:02+00:00 https://ascopost.com/news/may-2024/can-exercise-boost-the-efficacy-of-rituximab-in-treatment-of-cll/ 2024-05-28T17:38:08+00:00 https://ascopost.com/news/may-2024/pancreatic-cancer-sociodemographic-disparities-and-fragmented-care/ 2024-05-28T15:16:45+00:00 https://ascopost.com/news/may-2024/interval-between-first-colonoscopy-with-negative-findings-and-repeat-colonoscopy/ 2024-05-28T15:21:53+00:00 https://ascopost.com/news/may-2024/early-breast-cancer-alnd-or-slnb-for-ypn-positive-disease-after-neoadjuvant-chemotherapy/ 2024-05-28T17:20:10+00:00 https://ascopost.com/news/may-2024/astro-releases-updated-clinical-guidelines-on-radiation-therapy-for-patients-with-bone-metastases/ 2024-05-29T16:17:27+00:00 https://ascopost.com/news/may-2024/are-tattoos-linked-to-a-heightened-risk-of-lymphoma/ 2024-05-29T16:24:11+00:00 https://ascopost.com/news/may-2024/fda-grants-accelerated-approval-to-selpercatinib-for-pediatric-patients-with-ret-altered-metastatic-thyroid-cancer-or-solid-tumors/ 2024-05-29T17:16:57+00:00 https://ascopost.com/news/may-2024/advanced-ovarian-cancer-adding-ruxolitinib-to-front-line-neoadjuvant-chemotherapy-plus-interval-debulking-surgery/ 2024-05-29T18:50:30+00:00 https://ascopost.com/news/may-2024/cancer-incidence-curative-treatment-and-overall-survival-in-the-english-prison-population/ 2024-05-29T18:58:31+00:00 https://ascopost.com/news/may-2024/cyclophosphamide-may-enable-more-patients-with-high-risk-hematologic-malignancies-to-receive-stem-cell-transplantation/ 2024-05-31T14:14:15+00:00 https://ascopost.com/news/may-2024/differences-in-prostate-cancer-genomics-among-us-veterans/ 2024-05-31T14:18:23+00:00 https://ascopost.com/news/may-2024/can-a-novel-combination-therapy-improve-metastatic-colorectal-cancer-outcomes/ 2024-06-20T18:17:35+00:00 https://ascopost.com/news/may-2024/asciminib-shows-superior-efficacy-vs-standard-of-care-frontline-tkis-in-cml/ 2024-05-31T15:19:47+00:00 https://ascopost.com/news/may-2024/lorlatinib-vs-crizotinib-for-advanced-alk-positive-nsclc-extended-crown-follow-up/ 2024-05-31T15:27:55+00:00 https://ascopost.com/news/june-2024/ 2024-06-01T14:16:37+00:00 https://ascopost.com/news/june-2024/american-cancer-society-and-asco-announce-expanded-patient-centered-online-collaboration/ 2024-06-01T14:54:40+00:00 https://ascopost.com/news/june-2024/relapsed-or-refractory-b-cell-all-novel-car-t-cell-therapy-yields-strong-remission-rates/ 2025-10-03T15:48:56+00:00 https://ascopost.com/news/june-2024/shorter-durations-of-venetoclax-yield-similar-response-rates-in-aml/ 2024-06-06T18:50:45+00:00 https://ascopost.com/news/june-2024/combination-brecadd-is-significantly-more-effective-than-beacopp-for-classical-hodgkin-lymphoma-study-finds/ 2024-06-26T17:23:59+00:00 https://ascopost.com/news/june-2024/antibody-drug-conjugate-plus-checkpoint-inhibitor-for-pd-l1-positive-hr-positiveher2-negative-breast-cancer/ 2024-06-01T16:01:15+00:00 https://ascopost.com/news/june-2024/car-t-cell-therapy-in-patients-with-central-nervous-system-lymphoma/ 2024-06-01T17:26:45+00:00 https://ascopost.com/news/june-2024/adding-belantamab-mafodotin-to-doublet-may-slow-disease-progression-or-death-in-relapsed-or-refractory-myeloma/ 2024-06-02T14:40:14+00:00 https://ascopost.com/news/june-2024/perioperative-chemotherapy-vs-neoadjuvant-chemoradiation-in-esophageal-cancer/ 2024-06-02T15:54:26+00:00 https://ascopost.com/news/june-2024/telehealth-shown-to-be-effective-for-palliative-care-delivery-in-patients-with-advanced-lung-cancer/ 2024-06-02T15:13:18+00:00 https://ascopost.com/news/june-2024/t-dxd-improves-progression-free-survival-in-patients-with-breast-cancer-previously-treated-with-endocrine-therapy/ 2024-06-14T17:58:00+00:00 https://ascopost.com/news/june-2024/consolidation-therapy-with-durvalumab-for-limited-stage-sclc/ 2024-06-02T15:52:43+00:00 https://ascopost.com/news/june-2024/osimertinib-for-patients-with-locally-advanced-egfr-mutated-nsclc-a-new-standard-of-care/ 2024-06-02T16:16:11+00:00 https://ascopost.com/news/june-2024/advanced-ovarian-cancer-can-lymphadenectomy-be-avoided-for-some-patients/ 2024-06-03T12:09:45+00:00 https://ascopost.com/news/june-2024/neoadjuvant-immunotherapy-combination-improves-outcomes-in-patients-with-melanoma/ 2024-06-03T12:25:54+00:00 https://ascopost.com/news/june-2024/novel-antibody-drug-conjugate-may-improve-response-in-advanced-colorectal-cancer/ 2024-06-03T15:00:09+00:00 https://ascopost.com/news/june-2024/usp1-inhibitor-in-metastatic-solid-tumors/ 2024-06-03T22:08:21+00:00 https://ascopost.com/news/june-2024/study-including-only-black-patients-with-breast-cancer-compares-rates-of-taxane-induced-peripheral-neuropathy/ 2024-06-03T15:39:42+00:00 https://ascopost.com/news/june-2024/telehealth-may-reduce-greenhouse-gas-emissions-associated-with-cancer-care/ 2024-06-03T15:49:25+00:00 https://ascopost.com/news/june-2024/risk-factors-and-outcomes-among-women-with-interval-vs-screen-detected-breast-cancer/ 2024-06-04T13:33:23+00:00 https://ascopost.com/news/june-2024/novel-car-t-cell-therapy-under-study-in-relapsed-or-refractory-non-hodgkin-lymphoma/ 2024-06-04T13:53:56+00:00 https://ascopost.com/news/june-2024/novel-ctdna-liquid-biopsy-may-help-predict-breast-cancer-recurrence-years-before-relapse/ 2024-06-14T17:58:37+00:00 https://ascopost.com/news/june-2024/many-breast-cancer-survivors-may-experience-excess-weight-gain/ 2024-06-04T14:18:06+00:00 https://ascopost.com/news/june-2024/adjuvant-radiotherapy-with-24-vs-6-months-of-adt-in-prostate-cancer/ 2024-06-06T15:13:34+00:00 https://ascopost.com/news/june-2024/imrt-reirradiation-plus-nivolumab-in-recurrent-or-second-primary-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T21:11:38+00:00 https://ascopost.com/news/june-2024/stress-related-to-residing-in-violent-neighborhoods-may-be-tied-to-aggressive-lung-cancer-in-black-men/ 2024-06-05T13:56:28+00:00 https://ascopost.com/news/june-2024/impact-of-high-blood-insulin-levels-on-triple-negative-breast-cancer-survival-in-black-women/ 2024-06-05T14:27:30+00:00 https://ascopost.com/news/june-2024/new-study-highlights-benefits-of-stepped-palliative-care-in-advanced-lung-cancer/ 2024-06-05T16:58:37+00:00 https://ascopost.com/news/june-2024/dennis-slamon-awarded-2024-szent-gyorgyi-prize-for-progress-in-cancer-research/ 2024-06-05T15:47:23+00:00 https://ascopost.com/news/june-2024/aspirin-as-adjuvant-therapy-for-breast-cancer/ 2024-06-05T16:54:47+00:00 https://ascopost.com/news/june-2024/chemotherapy-administration-and-survival-in-patients-with-very-advanced-solid-tumors/ 2024-06-05T18:22:53+00:00 https://ascopost.com/news/june-2024/neoadjuvant-pembrolizumab-may-improve-outcomes-in-some-patients-with-colorectal-cancer-surgery/ 2024-06-06T15:03:13+00:00 https://ascopost.com/news/june-2024/study-finds-early-menopause-may-be-linked-to-greater-risk-of-breast-and-ovarian-cancers/ 2024-06-06T18:44:12+00:00 https://ascopost.com/news/june-2024/proton-therapy-vs-traditional-radiation-therapy-in-patients-with-oropharyngeal-cancer/ 2026-01-28T21:07:38+00:00 https://ascopost.com/news/june-2024/patient-reported-outcomes-from-the-himalaya-trial-in-unresectable-hepatocellular-carcinoma/ 2024-06-06T18:41:59+00:00 https://ascopost.com/news/june-2024/childhood-cancer-survivors-burden-of-cardiovascular-disease-and-risk-of-major-cardiovascular-events/ 2024-06-06T17:25:59+00:00 https://ascopost.com/news/june-2024/prostate-cancer-adjuvant-radiotherapy-with-6-months-of-adt-vs-no-adt/ 2024-06-06T17:16:43+00:00 https://ascopost.com/news/june-2024/study-identifies-subset-of-patients-with-lung-adenocarcinoma-who-have-her2-alterations/ 2024-06-07T14:03:57+00:00 https://ascopost.com/news/june-2024/addition-of-chemoradiation-to-adjuvant-systemic-therapy-differences-in-node-negative-vs-node-positive-pancreatic-cancer/ 2024-06-07T14:11:40+00:00 https://ascopost.com/news/june-2024/can-pembrolizumab-improve-outcomes-in-soft-tissue-sarcoma/ 2025-08-25T16:42:17+00:00 https://ascopost.com/news/june-2024/fda-approves-imetelstat-for-patients-with-low-to-intermediate-1-risk-mds-and-transfusion-dependent-anemia/ 2024-06-07T14:29:09+00:00 https://ascopost.com/news/june-2024/new-risk-stratification-model-for-waldenstrom-s-macroglobulinemia/ 2024-06-07T16:02:26+00:00 https://ascopost.com/news/june-2024/first-line-venetoclax-combinations-in-fit-patients-with-cll/ 2024-06-10T17:39:04+00:00 https://ascopost.com/news/june-2024/methylphenidate-for-treating-fatigue-in-patients-with-advanced-cancer/ 2024-06-11T14:18:05+00:00 https://ascopost.com/news/june-2024/low-risk-prostate-cancer-disease-free-survival-with-hypofractionated-vs-conventionally-fractionated-radiotherapy/ 2024-06-11T14:30:07+00:00 https://ascopost.com/news/june-2024/more-on-using-ai-to-enhance-cancer-care/ 2024-06-10T18:30:54+00:00 https://ascopost.com/news/june-2024/integrating-palliative-care-education-into-hematology-oncology-fellowships/ 2024-06-11T14:44:20+00:00 https://ascopost.com/news/june-2024/novel-gamma-delta-t-cell-based-therapy-plus-temozolomide-maintenance-in-glioblastoma-multiforme/ 2024-06-11T14:51:54+00:00 https://ascopost.com/news/june-2024/lung-cancer-screening-prevalence-among-eligible-us-individuals/ 2024-06-11T15:53:36+00:00 https://ascopost.com/news/june-2024/ribociclib-plus-endocrine-therapy-vs-combination-chemotherapy-in-premenopausal-women-with-hr-positive-her2-negative-advanced-breast-cancer/ 2024-06-12T13:27:29+00:00 https://ascopost.com/news/june-2024/cardiac-dysfunction-among-breast-cancer-survivors/ 2024-06-12T13:31:07+00:00 https://ascopost.com/news/june-2024/newly-diagnosed-patients-with-multiple-myeloma-ineligible-for-transplant-addition-of-isatuximab-to-vrd/ 2024-06-12T15:45:00+00:00 https://ascopost.com/news/june-2024/lung-cancer-screening-may-improve-early-detection-survival-in-u-s-veterans/ 2024-06-12T15:53:11+00:00 https://ascopost.com/news/june-2024/how-often-do-patients-with-cancer-face-barriers-when-attempting-to-access-care/ 2024-06-12T16:47:54+00:00 https://ascopost.com/news/june-2024/drug-resistance-in-melanoma-related-leptomeningeal-disease/ 2024-06-13T17:16:59+00:00 https://ascopost.com/news/june-2024/can-positive-psychology-influence-outcomes-in-hematopoietic-stem-cell-transplantation-recipients/ 2024-06-13T17:51:44+00:00 https://ascopost.com/news/june-2024/previously-treated-metastatic-nsclc-sacituzumab-govitecan-vs-docetaxel/ 2024-06-13T17:28:21+00:00 https://ascopost.com/news/june-2024/dendritic-cell-therapy-in-pleural-mesothelioma/ 2024-06-13T17:46:12+00:00 https://ascopost.com/news/june-2024/relapsed-or-refractory-jmml-study-evaluates-trametinib/ 2024-06-13T17:56:54+00:00 https://ascopost.com/news/june-2024/mobile-monitoring-system-may-improve-detection-of-ethylene-oxide-in-louisianas-cancer-alley/ 2024-06-14T13:42:20+00:00 https://ascopost.com/news/june-2024/advanced-neuroendocrine-tumors-adding-lu-177-dotatate-to-standard-first-line-therapy/ 2025-06-27T21:12:14+00:00 https://ascopost.com/news/june-2024/lenalidomide-exposed-relapsed-or-refractory-multiple-myeloma-bpd-vs-pvd/ 2024-06-14T17:31:08+00:00 https://ascopost.com/news/june-2024/previously-treated-metastatic-colorectal-cancer-lenvatinibpembrolizumab-vs-standard-of-care/ 2024-06-14T17:39:36+00:00 https://ascopost.com/news/june-2024/using-a-novel-ai-tool-for-cancer-detection-on-whole-body-petct-scans/ 2024-06-17T18:06:19+00:00 https://ascopost.com/news/june-2024/pretargeted-dual-isotope-radionuclide-therapy-in-colorectal-cancer/ 2024-06-17T17:00:46+00:00 https://ascopost.com/news/june-2024/chelating-agent-may-reduce-toxicity-associated-with-psma-radiopharmaceutical-therapy/ 2024-06-17T17:07:50+00:00 https://ascopost.com/news/june-2024/fda-approves-two-immunochemotherapy-combinations-for-endometrial-cancer/ 2024-06-17T19:06:11+00:00 https://ascopost.com/news/june-2024/fda-approves-blinatumomab-as-consolidation-for-cd19-positive-ph-negative-b-cell-precursor-all/ 2024-06-17T17:50:32+00:00 https://ascopost.com/news/june-2024/efficacy-of-adjuvant-everolimus-plus-endocrine-therapy-in-high-risk-hr-positive-her2-negative-breast-cancer/ 2024-06-17T19:10:39+00:00 https://ascopost.com/news/june-2024/fapi-petct-may-improve-staging-in-newly-diagnosed-breast-cancer/ 2024-06-18T18:52:50+00:00 https://ascopost.com/news/june-2024/can-fap-targeted-radioligand-therapy-benefit-patients-with-advanced-sarcomas/ 2025-08-25T16:40:41+00:00 https://ascopost.com/news/june-2024/radioligand-therapy-may-improve-radiographic-progression-free-survival-in-taxane-naive-patients-with-advanced-prostate-cancer/ 2024-07-02T18:05:56+00:00 https://ascopost.com/news/june-2024/carboplatin-induced-nausea-and-vomiting-addition-of-olanzapine-to-triple-antiemetic-therapy/ 2024-06-18T16:13:21+00:00 https://ascopost.com/news/june-2024/previously-untreated-metastatic-pancreatic-cancer-cd40-agonist-plus-mfolfirinox/ 2024-06-18T16:18:08+00:00 https://ascopost.com/news/june-2024/lorlatinib-vs-crizotinib-in-previously-untreated-advanced-alk-positive-nsclc/ 2024-06-18T16:22:51+00:00 https://ascopost.com/news/june-2024/esophageal-cancer-neoadjuvant-triplet-or-doublet-chemotherapy-with-or-without-radiotherapy/ 2024-06-19T13:45:52+00:00 https://ascopost.com/news/june-2024/risk-of-secondary-cancer-after-car-t-cell-therapy/ 2024-06-19T13:51:26+00:00 https://ascopost.com/news/june-2024/machine-learning-model-may-aid-in-early-diagnosis-of-hepatocellular-carcinoma/ 2024-06-19T14:04:18+00:00 https://ascopost.com/news/june-2024/study-evaluates-cancer-screening-behaviors-among-a-population-of-muslim-individuals/ 2024-06-19T16:35:43+00:00 https://ascopost.com/news/june-2024/robert-ferris-appointed-executive-director-of-unc-lineberger-comprehensive-cancer-center/ 2024-06-20T15:04:55+00:00 https://ascopost.com/news/june-2024/do-patients-with-cancer-require-additional-covid-19-vaccine-doses/ 2024-06-20T15:16:50+00:00 https://ascopost.com/news/june-2024/previously-untreated-advanced-clear-cell-rcc-bempegaldesleukinnivolumab-vs-tki-therapy/ 2025-06-30T01:05:07+00:00 https://ascopost.com/news/june-2024/updated-astro-clinical-guidelines-on-radiation-therapy-in-hpv-positive-oropharyngeal-cancer/ 2026-01-28T20:50:04+00:00 https://ascopost.com/news/june-2024/celecoxib-may-benefit-a-subset-of-patients-with-empik3caem-mutations/ 2024-06-20T17:26:30+00:00 https://ascopost.com/news/june-2024/metastatic-colorectal-cancer-addition-of-atezolizumab-to-first-line-folfoxiribevacizumab/ 2024-06-20T18:31:01+00:00 https://ascopost.com/news/june-2024/clinical-trial-testing-brenetafusp-plus-nivolumab-in-advanced-or-metastatic-cutaneous-melanoma-kicks-off/ 2024-06-21T13:40:58+00:00 https://ascopost.com/news/june-2024/repurposing-brigatinib-to-treat-nf2-related-schwannomatosis/ 2024-06-21T16:58:41+00:00 https://ascopost.com/news/june-2024/air-pollution-may-increase-cardiovascular-risk-in-patients-with-cancer/ 2024-06-21T16:23:42+00:00 https://ascopost.com/news/june-2024/lgbtq-cancer-survivors-have-a-higher-burden-of-chronic-health-conditions-disabilities-than-cisgender-cancer-survivors/ 2024-06-21T16:59:44+00:00 https://ascopost.com/news/june-2024/socioeconomic-disparities-in-quality-of-life-after-early-stage-breast-cancer-diagnosis/ 2024-06-21T16:36:30+00:00 https://ascopost.com/news/june-2024/fda-grants-accelerated-approval-to-adagrasib-with-cetuximab-for-kras-g12c-mutated-colorectal-cancer/ 2024-06-24T17:55:59+00:00 https://ascopost.com/news/june-2024/modified-perioperative-chemotherapy-regimen-may-benefit-patients-with-pancreatic-ductal-adenocarcinoma/ 2024-07-10T20:17:30+00:00 https://ascopost.com/news/june-2024/immunoglobulin-g-testing-may-reduce-infections-increase-receipt-of-immunoglobulin-replacement-therapy-in-patients-with-cll-and-nhl/ 2024-07-11T16:47:06+00:00 https://ascopost.com/news/june-2024/combination-targeted-therapy-produces-durable-responses-in-patients-with-relapsed-dlbcl/ 2025-10-31T16:26:45+00:00 https://ascopost.com/news/june-2024/adjuvant-dabrafenib-plus-trametinib-for-stage-iii-braf-v600-mutated-melanoma/ 2024-06-24T18:24:18+00:00 https://ascopost.com/news/june-2024/early-surveillance-in-pediatric-patients-genetically-predisposed-to-cancer/ 2024-06-26T14:43:57+00:00 https://ascopost.com/news/june-2024/can-acupuncture-improve-hormonal-side-effects-in-women-undergoing-breast-cancer-therapy/ 2024-06-26T14:55:40+00:00 https://ascopost.com/news/june-2024/new-survey-finds-cancer-drug-shortage-management-remains-a-moving-target/ 2024-06-26T15:11:55+00:00 https://ascopost.com/news/june-2024/er-positive-advanced-breast-cancer-oral-serd-plus-palbociclib-in-first-line-setting/ 2024-06-26T16:44:36+00:00 https://ascopost.com/news/june-2024/recurrent-or-metastatic-hnscc-first-line-vegfr2-plus-pd-1-inhibition/ 2026-01-28T20:47:45+00:00 https://ascopost.com/news/june-2024/novel-biomarker-may-be-predictive-of-clear-cell-renal-cell-carcinoma-recurrence/ 2025-06-30T01:02:44+00:00 https://ascopost.com/news/june-2024/can-chemotherapy-impact-the-gut-microbiome-in-patients-with-breast-cancer/ 2024-06-27T16:53:34+00:00 https://ascopost.com/news/june-2024/fda-grants-accelerated-approval-to-epcoritamab-bysp-for-relapsed-or-refractory-follicular-lymphoma/ 2024-06-27T15:16:19+00:00 https://ascopost.com/news/june-2024/adding-cox-2-inhibition-to-chemotherapy-in-pik3ca-activated-stage-iii-colon-cancer/ 2024-06-27T16:25:37+00:00 https://ascopost.com/news/june-2024/neoadjuvant-combination-of-pd-1-and-angiogenesis-inhibitors-in-genomically-unstable-colorectal-cancer-neocap/ 2024-06-27T17:52:25+00:00 https://ascopost.com/news/june-2024/novel-spatial-gene-signature-approach-may-help-to-predict-immunotherapy-outcomes-in-patients-with-melanoma/ 2024-06-28T14:00:13+00:00 https://ascopost.com/news/june-2024/strategies-for-reducing-the-risk-of-cancers-in-patients-with-alcohol-dependence/ 2024-06-28T14:15:40+00:00 https://ascopost.com/news/june-2024/transplant-eligible-newly-diagnosed-multiple-myeloma-long-term-follow-up-of-the-cassiopeia-trial/ 2024-06-28T16:06:22+00:00 https://ascopost.com/news/june-2024/primary-breast-cancer-pretreatment-exercise-level-and-distant-recurrence-free-interval/ 2024-06-28T16:34:53+00:00 https://ascopost.com/news/july-2024/ 2024-06-28T18:09:18+00:00 https://ascopost.com/news/july-2024/asco-to-present-ethan-basch-with-the-joseph-simone-quality-care-award/ 2024-07-01T13:10:33+00:00 https://ascopost.com/news/july-2024/asco-friends-of-cancer-research-applaud-fda-draft-guidance/ 2024-07-01T15:28:03+00:00 https://ascopost.com/news/july-2024/asco-scotus-ruling-upends-country-s-regulatory-framework-threatens-to-complicate-and-delay-health-care-delivery/ 2024-07-01T15:26:53+00:00 https://ascopost.com/news/july-2024/new-study-demonstrates-similar-outcomes-between-patients-with-protocol-exceptions-to-participate-in-targeted-therapy-trial-and-eligible-participants/ 2024-07-01T14:54:14+00:00 https://ascopost.com/news/july-2024/tai-chi-vs-cognitive-behavioral-therapy-measuring-inflammatory-biomarkers-in-breast-cancer-survivors-with-insomnia/ 2024-07-01T15:17:03+00:00 https://ascopost.com/news/july-2024/perioperative-nivolumab-in-renal-cell-carcinoma/ 2025-06-30T01:00:55+00:00 https://ascopost.com/news/july-2024/impact-of-cisplatin-based-chemotherapy-on-hearing-in-cancer-survivors/ 2024-07-02T17:07:07+00:00 https://ascopost.com/news/july-2024/psa-may-insufficiently-detect-early-prostate-cancer-in-transgender-women/ 2024-07-02T17:31:02+00:00 https://ascopost.com/news/july-2024/relapsed-or-refractory-multiple-myeloma-activity-of-bcma-x-cd3-bispecific-antibody/ 2024-07-02T15:49:48+00:00 https://ascopost.com/news/july-2024/previously-untreated-egfr-mutated-advanced-nsclc-amivantamablazertinib-vs-osimertinib/ 2024-07-02T17:59:39+00:00 https://ascopost.com/news/july-2024/nonplatinum-chemotherapy-regimen-for-advanced-cholangiocarcinoma/ 2024-07-02T17:56:38+00:00 https://ascopost.com/news/july-2024/risk-of-adverse-obstetric-outcomes-in-adolescent-and-young-adult-cancer-survivors/ 2024-07-03T13:29:45+00:00 https://ascopost.com/news/july-2024/previously-untreated-intermediate-risk-rhabdomyosarcoma-addition-of-temsirolimus-to-chemotherapy-in-young-patients/ 2025-08-25T16:38:34+00:00 https://ascopost.com/news/july-2024/exercise-may-prevent-nerve-damage-during-chemotherapy/ 2024-07-03T14:54:46+00:00 https://ascopost.com/news/july-2024/american-indian-and-alaskan-native-women-may-be-less-likely-to-undergo-breast-reconstruction/ 2024-07-03T14:50:58+00:00 https://ascopost.com/news/july-2024/exploring-health-care-provider-attitudes-toward-hpv-self-collection-testing/ 2024-07-03T17:44:47+00:00 https://ascopost.com/news/july-2024/novel-algorithm-may-help-to-identify-aggressive-basal-cell-carcinoma/ 2024-07-03T17:53:53+00:00 https://ascopost.com/news/july-2024/endometrial-thickness-in-triage-for-endometrial-cancer-among-black-women/ 2024-07-03T18:16:12+00:00 https://ascopost.com/news/july-2024/advanced-melanoma-efficacy-of-monoclonal-antibody-doublet/ 2024-07-08T18:45:54+00:00 https://ascopost.com/news/july-2024/can-adhering-to-a-mediterranean-diet-reduce-mortality-in-cancer-survivors/ 2024-07-08T18:42:05+00:00 https://ascopost.com/news/july-2024/survivorship-standards-at-commission-on-cancer-accredited-cancer-care-facilities-may-help-address-needs-of-adult-cancer-survivors/ 2024-07-08T18:42:40+00:00 https://ascopost.com/news/july-2024/tumor-surveillance-in-pediatric-patients-with-cancer-predisposition-syndromes/ 2024-07-08T15:40:25+00:00 https://ascopost.com/news/july-2024/germline-risk-of-taxane-induced-peripheral-neuropathy-in-black-women-with-early-stage-breast-cancer/ 2024-07-08T15:54:37+00:00 https://ascopost.com/news/july-2024/advancedmetastatic-genitourinary-tumors-cabozantinibnivolumab-with-or-without-ipilimumab/ 2024-07-08T16:37:54+00:00 https://ascopost.com/news/july-2024/nasopharyngeal-carcinoma-adding-sintilimab-to-standard-chemoradiotherapy-for-locoregionally-advanced-disease/ 2026-01-28T20:44:23+00:00 https://ascopost.com/news/july-2024/infection-risk-in-patients-with-mantle-cell-lymphoma/ 2024-07-09T15:21:50+00:00 https://ascopost.com/news/july-2024/stiripentol-could-prolong-efficacy-of-chemotherapy-in-patients-with-gastric-cancer/ 2025-06-27T21:10:48+00:00 https://ascopost.com/news/july-2024/relapsed-or-refractory-neuroblastoma-addition-of-dasatinibrapamycin-to-irinotecantemozolomide/ 2024-07-09T15:57:43+00:00 https://ascopost.com/news/july-2024/factors-impacting-adherence-to-adjuvant-endocrine-therapy-in-premenopausal-women-with-breast-cancer/ 2024-07-09T17:25:14+00:00 https://ascopost.com/news/july-2024/new-study-may-provide-insights-into-common-immune-system-mechanism-between-pregnancy-and-cancer/ 2024-07-11T17:54:54+00:00 https://ascopost.com/news/july-2024/certain-patients-diagnosed-with-benign-classification-of-prostate-cancer-may-actually-have-high-risk-disease/ 2024-07-11T15:55:06+00:00 https://ascopost.com/news/july-2024/predictive-models-for-disease-recurrence-after-breast-conserving-surgery-for-dcis/ 2024-07-11T16:05:48+00:00 https://ascopost.com/news/july-2024/association-of-genetic-risk-for-prostate-cancer-with-early-prostate-cancer-death/ 2024-07-11T16:07:54+00:00 https://ascopost.com/news/july-2024/resected-pancreatic-cancer-autologous-dendritic-cell-vaccination/ 2024-07-11T16:17:51+00:00 https://ascopost.com/news/july-2024/can-glp-1-receptor-agonists-prevent-obesity-associated-cancers-in-patients-with-type-2-diabetes/ 2024-07-11T16:28:40+00:00 https://ascopost.com/news/july-2024/predicting-taxane-induced-peripheral-neuropathy-after-breast-cancer-therapy/ 2024-07-12T14:27:31+00:00 https://ascopost.com/news/july-2024/rnas-may-help-to-identify-patients-with-stage-ii-colorectal-cancer-who-may-benefit-from-adjuvant-chemotherapy/ 2024-07-12T14:01:13+00:00 https://ascopost.com/news/july-2024/40-percent-of-cancer-cases-and-almost-half-of-all-cancer-deaths-in-the-united-states-linked-to-modifiable-risk-factors/ 2024-07-12T15:30:24+00:00 https://ascopost.com/news/july-2024/surveillance-for-pancreatic-cancer-in-high-risk-individuals/ 2024-07-12T15:34:52+00:00 https://ascopost.com/news/july-2024/adjuvant-therapeutic-regimens-for-gallbladder-cancer/ 2024-07-12T16:08:08+00:00 https://ascopost.com/news/july-2024/stage-i-her2-positive-breast-cancer-long-term-follow-up-of-adjuvant-t-dm1/ 2024-07-12T16:00:50+00:00 https://ascopost.com/news/july-2024/outcomes-for-brca-pathogenic-variant-carriers-undergoing-breast-conserving-therapy/ 2024-07-15T14:45:49+00:00 https://ascopost.com/news/july-2024/prostate-cancer-detection-with-ai-vs-radiologist-readings-of-mri/ 2024-07-15T15:20:56+00:00 https://ascopost.com/news/july-2024/novel-immunotherapy-approach-in-metastatic-solid-tumors/ 2024-07-15T15:26:08+00:00 https://ascopost.com/news/july-2024/high-risk-melanoma-inhibiting-mek-and-pd-l1-in-tandem/ 2024-07-15T15:35:11+00:00 https://ascopost.com/news/july-2024/uk-based-survey-finds-cancer-is-the-leading-health-concern-among-the-public/ 2024-07-15T16:12:38+00:00 https://ascopost.com/news/july-2024/advanced-classical-hodgkin-lymphoma-pet-guided-brecadd-vs-ebeacopp/ 2024-07-15T15:51:30+00:00 https://ascopost.com/news/july-2024/out-of-pocket-costs-from-diagnostic-testing-after-prostate-cancer-screening/ 2024-07-16T15:48:48+00:00 https://ascopost.com/news/july-2024/premenopausal-women-with-breast-cancer-receiving-estradiol-suppression-therapy-effect-of-denosumab-on-bone-loss/ 2024-07-16T16:33:02+00:00 https://ascopost.com/news/july-2024/hormone-modulating-therapy-may-be-linked-to-lower-dementia-risk-in-patients-with-breast-cancer/ 2024-07-16T16:41:10+00:00 https://ascopost.com/news/july-2024/new-study-demonstrates-safe-successful-pregnancy-may-be-possible-following-allo-hct/ 2024-07-16T18:14:22+00:00 https://ascopost.com/news/july-2024/recurrent-cervical-cancer-tisotumab-vedotin-in-second-or-third-line-therapy/ 2024-07-16T16:53:43+00:00 https://ascopost.com/news/july-2024/lbcl-cd22-directed-car-t-cell-therapy-after-disease-progression-on-cd19-directed-car-t-cell-therapy/ 2024-07-17T18:04:57+00:00 https://ascopost.com/news/july-2024/electronic-health-record-based-prompt-may-help-reduce-breast-cancer-overtreatment/ 2024-07-17T17:13:26+00:00 https://ascopost.com/news/july-2024/new-imaging-guidelines-for-head-and-neck-cancers-published/ 2026-01-28T20:40:31+00:00 https://ascopost.com/news/july-2024/neha-vapiwala-voted-president-elect-of-astro/ 2024-07-17T18:22:43+00:00 https://ascopost.com/news/july-2024/egfr-her3-bispecific-antibody-drug-conjugate-in-locally-advanced-or-metastatic-solid-tumors/ 2024-07-18T14:51:44+00:00 https://ascopost.com/news/july-2024/how-does-endometriosis-typology-influence-ovarian-cancer-risk/ 2024-07-18T20:03:45+00:00 https://ascopost.com/news/july-2024/donor-socioeconomic-status-may-influence-outcomes-in-hematopoietic-cell-transplantation/ 2024-07-18T15:35:39+00:00 https://ascopost.com/news/july-2024/testosterone-therapy-may-protect-against-breast-cancer-in-transmasculine-patients/ 2024-07-18T16:43:01+00:00 https://ascopost.com/news/july-2024/response-adapted-radiation-therapy-for-orbital-indolent-b-cell-lymphoma/ 2024-07-19T14:30:06+00:00 https://ascopost.com/news/july-2024/immunotherapy-induced-multiorgan-immune-related-adverse-events-co-occurrence-patterns-and-prognostic-implications/ 2024-07-19T15:34:26+00:00 https://ascopost.com/news/july-2024/uncovering-the-genetic-risk-of-hereditary-breast-and-ovarian-cancer-syndrome-lynch-syndrome/ 2024-07-19T16:14:09+00:00 https://ascopost.com/news/july-2024/are-eligible-breast-cancer-survivors-receiving-genetic-testing/ 2024-07-19T16:21:39+00:00 https://ascopost.com/news/july-2024/can-living-in-a-disadvantaged-area-increase-the-risk-of-aggressive-prostate-cancer/ 2024-07-19T18:41:46+00:00 https://ascopost.com/news/july-2024/early-breast-cancer-genetic-testing-and-communication-of-results-with-family-after-diagnosis/ 2024-07-22T15:04:32+00:00 https://ascopost.com/news/july-2024/pmmrmss-locally-advanced-rectal-cancer-immunotherapy-based-total-neoadjuvant-therapy/ 2024-07-22T15:20:35+00:00 https://ascopost.com/news/july-2024/panel-issues-first-guidelines-to-prevent-anal-cancer-in-patients-with-hiv/ 2024-07-22T15:31:04+00:00 https://ascopost.com/news/july-2024/liquid-biopsy-may-enable-monitoring-of-disease-evolution-in-patients-with-metastatic-prostate-cancer/ 2024-08-06T18:14:42+00:00 https://ascopost.com/news/july-2024/tailored-dose-dense-adjuvant-chemotherapy-in-high-risk-early-breast-cancer/ 2024-07-22T15:40:58+00:00 https://ascopost.com/news/july-2024/aacr-asa-fda-outline-considerations-for-overall-survival-analyses-in-clinical-trials/ 2024-07-23T17:37:32+00:00 https://ascopost.com/news/july-2024/novel-target-identified-for-treating-htlv-1-associated-diseases/ 2024-07-23T17:46:02+00:00 https://ascopost.com/news/july-2024/does-neighborhood-walkability-impact-the-burden-of-cardiovascular-risk-factors-in-patients-with-cancer/ 2024-07-23T17:22:29+00:00 https://ascopost.com/news/july-2024/immunotherapy-in-unresectable-hcc-with-child-pugh-class-b-dysfunction/ 2024-07-23T19:14:58+00:00 https://ascopost.com/news/july-2024/pancreatic-cancer-celiac-plexus-radiosurgery-for-retroperitoneal-pain-syndrome/ 2024-07-23T19:18:27+00:00 https://ascopost.com/news/july-2024/eliminating-racial-disparities-in-colorectal-cancer-screening/ 2024-07-24T16:17:20+00:00 https://ascopost.com/news/july-2024/shortening-fda-mandated-car-t-cell-therapy-monitoring-periods-could-improve-access-to-treatment-in-patients-with-dlbcl/ 2025-10-31T16:24:34+00:00 https://ascopost.com/news/july-2024/multiple-myeloma-using-absolute-lymphocyte-count-to-predict-outcomes-after-car-t-cell-therapy/ 2024-07-24T17:41:42+00:00 https://ascopost.com/news/july-2024/neoadjuvant-camrelizumab-plus-apatinib-in-locally-advanced-colorectal-cancer/ 2024-07-24T17:57:41+00:00 https://ascopost.com/news/july-2024/rsclin-tool-and-risk-for-late-distant-recurrence-in-breast-cancer/ 2024-07-24T18:25:35+00:00 https://ascopost.com/news/july-2024/cancer-risk-from-exposure-to-pesticides-may-be-comparable-to-risk-from-smoking-study-finds/ 2024-07-26T13:55:52+00:00 https://ascopost.com/news/july-2024/new-study-highlights-improvements-in-treating-pediatric-patients-with-retinoblastoma/ 2024-07-26T14:04:29+00:00 https://ascopost.com/news/july-2024/triplet-as-initial-salvage-treatment-for-advanced-germ-cell-tumors-long-term-outcomes/ 2024-07-26T14:11:12+00:00 https://ascopost.com/news/july-2024/patients-with-prostate-cancer-social-factors-may-be-tied-to-racial-disparities-in-cardiovascular-outcomes/ 2024-07-26T17:04:13+00:00 https://ascopost.com/news/july-2024/does-bilateral-mastectomy-for-unilateral-breast-cancer-impact-mortality/ 2024-07-26T19:00:37+00:00 https://ascopost.com/news/july-2024/risk-of-breast-cancer-may-be-lower-within-first-years-following-ovarian-cancer-diagnosis/ 2024-07-29T14:40:52+00:00 https://ascopost.com/news/july-2024/is-lower-dose-radiopharmaceutical-therapy-effective-in-advanced-prostate-cancer/ 2024-07-29T14:25:05+00:00 https://ascopost.com/news/july-2024/guardant-health-s-shield-blood-test-approved-by-the-fda-as-a-primary-screening-option-for-colorectal-cancer/ 2024-08-15T17:03:41+00:00 https://ascopost.com/news/july-2024/baseline-bone-pain-and-survival-in-newly-diagnosed-prostate-cancer/ 2024-07-29T16:25:18+00:00 https://ascopost.com/news/july-2024/mrd-negative-all-addition-of-blinatumomab-to-consolidation-chemotherapy/ 2024-07-29T17:14:54+00:00 https://ascopost.com/news/july-2024/effect-of-posttransplantation-cyclophosphamide-based-gvhd-prophylaxis-on-patients-with-hematologic-malignancies/ 2024-07-29T17:20:34+00:00 https://ascopost.com/news/july-2024/fecal-microbiota-transplant-may-help-patients-with-gastrointestinal-cancers-overcome-immunotherapy-resistance/ 2024-07-30T16:54:45+00:00 https://ascopost.com/news/july-2024/key-immune-cells-for-combating-aggressive-merkel-cell-carcinoma-uncovered/ 2024-07-30T17:08:25+00:00 https://ascopost.com/news/july-2024/cancer-research-and-care-beyond-borders-for-global-oncologist-dario-trapani/ 2024-07-30T17:50:19+00:00 https://ascopost.com/news/july-2024/making-a-difference-in-global-oncology/ 2024-07-30T14:38:07+00:00 https://ascopost.com/news/july-2024/advanced-nsclc-association-of-intratumoral-escherichia-with-overall-survival/ 2024-07-30T17:13:10+00:00 https://ascopost.com/news/july-2024/do-nonstatin-cholesterol-lowering-drugs-influence-the-risk-of-hepatic-cancer/ 2024-07-31T14:24:37+00:00 https://ascopost.com/news/july-2024/fda-approves-daratumumab-and-hyaluronidase-fihj-with-vrd-for-multiple-myeloma/ 2024-08-23T16:34:27+00:00 https://ascopost.com/news/july-2024/can-mutations-in-dna-damage-repair-genes-predict-cisplatin-response-in-muscle-invasive-urothelial-carcinoma/ 2025-06-27T18:13:12+00:00 https://ascopost.com/news/july-2024/early-stage-breast-cancer-mammaprint-prediction-of-extended-letrozole-benefit/ 2024-07-31T14:49:39+00:00 https://ascopost.com/news/july-2024/recurrentmetastatic-hnscc-pembrolizumab-plus-carboplatin-and-paclitaxel/ 2024-07-31T18:22:56+00:00 https://ascopost.com/news/august-2024/ 2024-09-03T14:44:19+00:00 https://ascopost.com/news/august-2024/new-report-shows-vaping-and-smoking-together-increases-lung-cancer-risk-fourfold/ 2024-08-01T14:00:23+00:00 https://ascopost.com/news/august-2024/generation-x-and-millennials-have-higher-risk-for-many-cancers-compared-to-older-generations/ 2024-08-01T15:20:02+00:00 https://ascopost.com/news/august-2024/education-level-social-media-awareness-may-be-linked-to-cancer-fatalism/ 2024-08-01T15:39:30+00:00 https://ascopost.com/news/august-2024/liver-transplantation-vs-standard-therapies-in-patients-with-colorectal-cancer-liver-metastasis/ 2024-08-01T14:15:09+00:00 https://ascopost.com/news/august-2024/heart-sparing-radiation-therapy-technique-in-left-sided-breast-cancer-benefits-and-costs/ 2024-08-01T14:23:36+00:00 https://ascopost.com/news/august-2024/estrogen-plus-progestin-and-risk-of-colorectal-cancer/ 2024-08-02T14:10:18+00:00 https://ascopost.com/news/august-2024/ponatinib-and-blinatumomab-in-newly-diagnosed-ph-positive-all/ 2025-10-03T16:17:26+00:00 https://ascopost.com/news/august-2024/fda-expands-endometrial-cancer-indication-for-dostarlimab-gxly-with-chemotherapy/ 2024-08-02T14:20:52+00:00 https://ascopost.com/news/august-2024/novel-ai-tool-may-predict-risk-of-chronic-pain-in-patients-with-breast-cancer/ 2024-08-02T14:28:39+00:00 https://ascopost.com/news/august-2024/fda-grants-accelerated-approval-to-t-cell-therapy-for-unresectable-or-metastatic-synovial-sarcoma/ 2025-08-25T16:36:50+00:00 https://ascopost.com/news/august-2024/common-blood-tests-may-improve-early-cancer-diagnosis/ 2024-08-15T18:01:49+00:00 https://ascopost.com/news/august-2024/investigating-fungal-bloodstream-infections-in-bone-marrow-transplant-recipients/ 2024-08-05T15:15:14+00:00 https://ascopost.com/news/august-2024/sacituzumab-govitecan-in-advanced-endometrial-cancer/ 2024-08-05T15:49:01+00:00 https://ascopost.com/news/august-2024/egfr-mutated-nsclc-tepotinibosimertinib-in-patients-with-met-amplification/ 2024-08-05T17:52:43+00:00 https://ascopost.com/news/august-2024/births-and-adverse-obstetric-outcomes-among-female-survivors-of-adolescent-and-young-adult-cancers/ 2024-08-05T16:33:58+00:00 https://ascopost.com/news/august-2024/daily-e-cigarette-use-may-be-linked-to-higher-combustible-cigarette-cessation/ 2024-08-06T15:03:44+00:00 https://ascopost.com/news/august-2024/should-low-dose-ct-screening-be-recommended-for-those-at-low-risk-for-lung-cancer/ 2024-08-06T15:14:44+00:00 https://ascopost.com/news/august-2024/selpercatinib-in-east-asian-patients-with-ret-fusion-positive-nsclc-libretto-431/ 2024-08-20T17:24:08+00:00 https://ascopost.com/news/august-2024/active-surveillance-may-enable-patients-with-esophageal-cancer-to-delay-or-avoid-surgery/ 2024-08-06T17:09:57+00:00 https://ascopost.com/news/august-2024/radiation-alone-may-be-as-effective-as-chemoradiation-in-patients-with-low-risk-nasopharyngeal-cancer/ 2026-01-28T20:34:49+00:00 https://ascopost.com/news/august-2024/metastatic-nsclc-survival-rates-in-the-immunotherapy-era/ 2024-08-07T14:59:05+00:00 https://ascopost.com/news/august-2024/physician-community-comes-together-to-urge-congress-to-act-on-medicare-payment-reform/ 2024-08-07T17:23:16+00:00 https://ascopost.com/news/august-2024/primary-ovarian-insufficiency-early-menopause-may-be-linked-to-increased-risk-of-breast-cancer/ 2024-08-08T15:00:21+00:00 https://ascopost.com/news/august-2024/efficacy-of-a-jak2mtor-inhibitor-combination-in-controlling-acute-graft-vs-host-disease/ 2024-08-12T19:09:44+00:00 https://ascopost.com/news/august-2024/cancer-of-unknown-primary-molecularly-guided-therapy-after-disease-control-on-platinum-based-chemotherapy/ 2024-08-08T15:22:30+00:00 https://ascopost.com/news/august-2024/egfr-and-alk-altered-nsclc-tkis-with-and-stereotactic-radiosurgery-for-brain-metastases/ 2024-08-08T17:28:50+00:00 https://ascopost.com/news/august-2024/merkel-cell-carcinoma-association-of-ctdna-with-recurrence-risk/ 2024-08-09T14:36:07+00:00 https://ascopost.com/news/august-2024/visceral-pleural-invasion-and-recurrence-risk-in-patients-undergoing-surgery-for-nsclc/ 2024-08-09T17:27:59+00:00 https://ascopost.com/news/august-2024/can-neoadjuvant-atezolizumab-set-a-new-standard-for-unresectable-stage-iii-nsclc/ 2024-08-09T14:47:36+00:00 https://ascopost.com/news/august-2024/metastasis-directed-radiation-therapy-plus-chemotherapy-in-oligometastatic-pancreatic-cancer/ 2024-08-09T15:31:32+00:00 https://ascopost.com/news/august-2024/gestational-diabetes-and-risk-for-breast-cancer/ 2024-08-09T16:02:32+00:00 https://ascopost.com/news/august-2024/cannabis-use-and-risk-of-head-and-neck-cancer/ 2026-01-28T20:29:46+00:00 https://ascopost.com/news/august-2024/association-of-regular-aspirin-use-with-colorectal-cancer-risk-according-to-lifestyle-factors/ 2024-08-12T14:58:28+00:00 https://ascopost.com/news/august-2024/pattern-in-protein-production-may-be-predictive-of-side-effects-from-immunotherapy-in-patients-with-melanoma/ 2024-08-12T15:34:49+00:00 https://ascopost.com/news/august-2024/sacituzumab-govitecan-may-be-effective-at-treating-breast-cancer-related-brain-tumors/ 2024-08-12T15:44:12+00:00 https://ascopost.com/news/august-2024/advanced-gist-long-term-outcomes-with-discontinuation-vs-continuation-of-imatinib/ 2025-06-27T21:09:16+00:00 https://ascopost.com/news/august-2024/cancer-cases-and-mortality-among-men-predicted-to-increase-globally/ 2024-08-13T16:00:41+00:00 https://ascopost.com/news/august-2024/salpingectomy-vs-tubal-occlusion/ 2024-08-13T18:01:10+00:00 https://ascopost.com/news/august-2024/resected-melanoma-subsequent-systemic-therapy-after-recurrence-on-adjuvant-nivolumab/ 2024-08-13T16:18:16+00:00 https://ascopost.com/news/august-2024/t-dxd-in-her2-positive-advanced-colorectal-cancer/ 2024-08-13T17:21:24+00:00 https://ascopost.com/news/august-2024/arpa-h-awards-to-develop-novel-technologies-in-cancer-surgery/ 2024-08-14T14:18:26+00:00 https://ascopost.com/news/august-2024/new-study-may-unveil-prognostic-genetic-insights-into-colorectal-cancer/ 2024-08-14T14:51:27+00:00 https://ascopost.com/news/august-2024/combination-immunotherapies-may-boost-t-cell-responses-in-patients-with-melanoma/ 2024-08-14T15:07:12+00:00 https://ascopost.com/news/august-2024/efficacy-of-symptom-triggered-testing-for-detection-of-ovarian-cancer/ 2024-08-14T15:15:30+00:00 https://ascopost.com/news/august-2024/completion-axillary-lymph-node-dissection-to-select-adjuvant-treatment-in-breast-cancer-and-associated-impairment-of-arm-function/ 2024-08-14T19:12:17+00:00 https://ascopost.com/news/august-2024/fda-approves-axatilimab-csfr-for-chronic-gvhd/ 2024-08-14T19:31:08+00:00 https://ascopost.com/news/august-2024/corticosteroids-for-immune-related-adverse-events-and-clinical-outcomes-with-icis-for-solid-tumors/ 2024-08-15T14:31:19+00:00 https://ascopost.com/news/august-2024/novel-insights-may-transform-diagnosis-and-treatment-of-pediatric-patients-with-t-lineage-all/ 2025-10-03T16:14:48+00:00 https://ascopost.com/news/august-2024/dietary-risk-factors-for-early-onset-colorectal-cancer/ 2024-08-15T15:30:33+00:00 https://ascopost.com/news/august-2024/recurrent-or-advanced-endometrial-cancer-atezolizumab-plus-chemotherapy/ 2024-08-15T15:38:01+00:00 https://ascopost.com/news/august-2024/are-some-uterine-tumors-more-aggressive-in-black-patients/ 2024-08-15T15:54:09+00:00 https://ascopost.com/news/august-2024/mouthwash-based-test-may-help-predict-head-and-neck-cancer-recurrence/ 2026-01-28T20:27:26+00:00 https://ascopost.com/news/august-2024/fda-approves-neoadjuvantadjuvant-durvalumab-for-resectable-nsclc/ 2024-08-16T16:19:51+00:00 https://ascopost.com/news/august-2024/cancer-mortality-among-adults-with-learning-disabilities/ 2024-08-16T18:37:08+00:00 https://ascopost.com/news/august-2024/risk-of-suicidal-behavior-among-spouses-of-patients-with-cancer/ 2024-08-16T16:53:39+00:00 https://ascopost.com/news/august-2024/high-risk-localized-hcc-efficacy-of-neoadjuvant-immunotherapy-vs-upfront-surgery/ 2024-08-16T17:47:30+00:00 https://ascopost.com/news/august-2024/fda-oce-invites-pediatric-cancer-advocates-to-meet-on-october-15/ 2024-08-16T18:39:32+00:00 https://ascopost.com/news/august-2024/causal-attribution-of-hpv-genotypes-to-invasive-cervical-cancer/ 2024-08-19T18:32:02+00:00 https://ascopost.com/news/august-2024/long-term-look-at-selpercatinib-in-ret-activated-thyroid-cancer/ 2024-08-19T14:57:15+00:00 https://ascopost.com/news/august-2024/patients-with-rare-cancers-may-face-increased-risk-of-anxiety-and-depression/ 2024-08-19T15:12:51+00:00 https://ascopost.com/news/august-2024/breast-cancer-index-confirmed-as-prognostic-in-a-soft-trial-derived-population/ 2024-08-19T15:44:14+00:00 https://ascopost.com/news/august-2024/new-modeling-data-show-effective-detection-and-health-care-savings-associated-with-the-multitarget-stool-dna-test/ 2024-08-19T18:10:14+00:00 https://ascopost.com/news/august-2024/exercise-program-may-improve-symptoms-quality-of-life-in-patients-with-metastatic-breast-cancer/ 2024-08-20T16:45:18+00:00 https://ascopost.com/news/august-2024/can-alternative-criteria-help-identify-patients-who-may-benefit-from-lung-cancer-screening/ 2024-08-20T16:52:07+00:00 https://ascopost.com/news/august-2024/fda-approves-lazertinib-with-amivantamab-vmjw-for-egfr-mutated-nsclc/ 2024-08-20T17:07:11+00:00 https://ascopost.com/news/august-2024/breast-conserving-surgery-with-or-without-postoperative-radiotherapy-in-early-stage-breast-cancer-30-year-update/ 2024-08-20T16:57:45+00:00 https://ascopost.com/news/august-2024/metastatic-pancreatic-adenocarcinoma-addition-of-devimistat-to-mffx/ 2024-08-20T16:39:36+00:00 https://ascopost.com/news/august-2024/exploring-targeted-therapies-in-multiple-myeloma/ 2024-08-21T15:30:32+00:00 https://ascopost.com/news/august-2024/ai-may-help-uncover-relationship-between-radiation-therapy-for-nsclc-and-cardiac-arrhythmias/ 2024-08-21T18:03:20+00:00 https://ascopost.com/news/august-2024/can-mindful-breathing-reduce-the-intensity-of-cancer-related-pain/ 2024-08-21T18:09:23+00:00 https://ascopost.com/news/august-2024/first-line-nivolumabrelatlimab-vs-nivolumabipilimumab-in-advanced-melanoma/ 2024-08-21T17:38:09+00:00 https://ascopost.com/news/august-2024/advanced-biliary-tract-cancers-bevacizumaberlotinib-maintenance-vs-active-surveillance/ 2024-08-21T17:42:32+00:00 https://ascopost.com/news/august-2024/menin-inhibitor-in-kmt2a-rearranged-relapsed-or-refractory-acute-leukemia/ 2024-08-22T14:40:54+00:00 https://ascopost.com/news/august-2024/the-power-of-patient-reported-outcome-measures-in-assessing-chemotherapy-induced-peripheral-neuropathy/ 2024-08-22T14:48:28+00:00 https://ascopost.com/news/august-2024/targetable-variant-found-in-chinese-patients-with-ovarian-cancer/ 2024-08-22T15:46:25+00:00 https://ascopost.com/news/august-2024/novel-insights-into-multiple-myeloma-progression/ 2024-08-22T16:35:33+00:00 https://ascopost.com/news/august-2024/the-evolving-epidemiology-of-gastrointestinal-stromal-tumors-in-major-organ-sites/ 2025-06-27T21:08:13+00:00 https://ascopost.com/news/august-2024/early-interventions-may-improve-long-term-academic-achievement-in-pediatric-brain-tumor-survivors/ 2024-08-23T15:12:08+00:00 https://ascopost.com/news/august-2024/hypofractionated-vs-conventionally-fractionated-radiation-after-implant-based-breast-reconstruction/ 2024-08-23T16:24:33+00:00 https://ascopost.com/news/august-2024/pregnancy-associated-cancer-incidence-and-risks-of-adverse-obstetric-perinatal-outcomes/ 2024-08-27T16:00:27+00:00 https://ascopost.com/news/august-2024/olaparib-may-be-effective-without-hormone-therapy-in-some-men-with-biochemically-recurrent-prostate-cancer/ 2024-08-27T15:23:30+00:00 https://ascopost.com/news/august-2024/medication-related-osteonecrosis-of-the-jaw-in-patients-with-breast-cancer/ 2024-08-27T15:07:56+00:00 https://ascopost.com/news/august-2024/adjuvant-everolimus-in-localized-papillary-and-chromophobe-non-clear-cell-renal-cell-carcinoma/ 2025-06-30T00:58:45+00:00 https://ascopost.com/news/august-2024/many-women-unaware-of-preventive-benefits-of-diet-for-breast-cancer-risk/ 2024-08-28T15:16:27+00:00 https://ascopost.com/news/august-2024/can-a-blood-test-predict-obesity-related-cancer-risk-in-patients-with-type-2-diabetes/ 2024-08-28T15:24:27+00:00 https://ascopost.com/news/august-2024/previously-untreated-cancer-of-unknown-primary-site-specific-therapy-guided-by-a-90-gene-expression-assay/ 2024-08-28T16:13:18+00:00 https://ascopost.com/news/august-2024/ici-based-strategies-in-advanced-progressing-egfr-mutated-nsclc/ 2024-08-28T16:32:25+00:00 https://ascopost.com/news/august-2024/fda-approves-cancer-biomarker-test-companion-diagnostic-indications/ 2024-08-28T17:18:35+00:00 https://ascopost.com/news/august-2024/preclinical-study-examines-novel-pancreatic-cancer-treatment/ 2024-08-29T17:15:21+00:00 https://ascopost.com/news/august-2024/hpv-vaccination-rate-among-young-female-patients-with-psychiatric-diagnoses/ 2024-08-29T17:09:07+00:00 https://ascopost.com/news/august-2024/ruxolitinib-for-corticosteroid-refractory-sclerotic-chronic-gvhd/ 2024-08-29T15:35:42+00:00 https://ascopost.com/news/august-2024/genomic-determinants-of-relapse-in-childhood-all/ 2025-10-03T16:04:10+00:00 https://ascopost.com/news/august-2024/impact-of-breast-cancer-screening-interval-on-stage-at-diagnosis-and-overall-survival/ 2024-08-29T15:48:51+00:00 https://ascopost.com/news/august-2024/structural-racism-and-cancer-risk-from-traffic-related-air-pollution/ 2024-08-30T15:06:54+00:00 https://ascopost.com/news/august-2024/early-onset-colorectal-cancer-rurality-and-poverty-may-be-linked-to-lower-survival/ 2024-08-30T16:04:05+00:00 https://ascopost.com/news/august-2024/oral-cannabis-extract-for-refractory-chemotherapy-induced-nausea-and-vomiting/ 2024-08-30T16:14:19+00:00 https://ascopost.com/news/august-2024/adjuvant-pembrolizumab-vs-placebo-in-stage-iii-melanoma-long-term-health-related-quality-of-life/ 2024-08-30T16:45:52+00:00 https://ascopost.com/news/september-2024/ 2024-09-03T14:47:53+00:00 https://ascopost.com/news/september-2024/menopausal-hormone-therapy-and-risk-of-ovarian-and-endometrial-cancers/ 2024-09-03T15:34:33+00:00 https://ascopost.com/news/september-2024/chronic-conditions-could-delay-lung-cancer-diagnoses/ 2024-09-03T19:34:55+00:00 https://ascopost.com/news/september-2024/effect-of-false-positives-on-adherence-to-subsequent-breast-cancer-screening/ 2024-09-03T19:26:51+00:00 https://ascopost.com/news/september-2024/recurrent-or-metastatic-hnscc-overall-survival-with-immunotherapy/ 2026-01-28T20:26:16+00:00 https://ascopost.com/news/september-2024/use-of-immune-checkpoint-inhibitors-under-study-in-high-risk-hormone-receptor-positive-early-stage-breast-cancer/ 2024-09-04T16:59:07+00:00 https://ascopost.com/news/september-2024/delays-in-oral-antimyeloma-treatment-initiation-role-of-social-determinants-of-health/ 2024-09-04T16:53:03+00:00 https://ascopost.com/news/september-2024/belzutifan-vs-everolimus-in-previously-treated-advanced-renal-cell-carcinoma/ 2025-06-30T00:55:39+00:00 https://ascopost.com/news/september-2024/new-study-illuminates-variations-in-performance-characteristics-between-fit-tests/ 2024-09-04T16:47:23+00:00 https://ascopost.com/news/september-2024/mobile-phones-may-not-be-linked-to-brain-cancer-who-backed-study-finds/ 2024-09-04T17:58:17+00:00 https://ascopost.com/news/september-2024/ici-related-cardiotoxicity-in-patients-with-cancer/ 2024-09-05T19:18:40+00:00 https://ascopost.com/news/september-2024/can-ai-tool-improve-detection-of-immune-related-adverse-events-in-patients-with-cancer/ 2024-09-05T15:06:55+00:00 https://ascopost.com/news/september-2024/liquid-biopsy-may-predict-risk-of-venous-thromboembolism-in-patients-with-cancer/ 2024-09-05T14:03:18+00:00 https://ascopost.com/news/september-2024/sacituzumab-govitecan-in-advanced-urothelial-cancer-after-ici-therapy/ 2025-06-27T18:09:29+00:00 https://ascopost.com/news/september-2024/addition-of-oxaliplatin-to-fluoropyrimidinebevacizumab-in-initial-therapy-for-metastatic-colorectal-cancer-in-older-patients/ 2024-09-05T19:14:38+00:00 https://ascopost.com/news/september-2024/prostate-cancer-mortality-and-5-ari-use/ 2024-09-06T14:25:31+00:00 https://ascopost.com/news/september-2024/study-supports-universal-genetic-testing-of-newly-diagnosed-patients-with-invasive-breast-cancer/ 2024-09-06T14:37:52+00:00 https://ascopost.com/news/september-2024/omitting-5-fu-bolus-may-reduce-side-effects-in-patients-with-gastrointestinal-cancers/ 2024-09-06T16:01:12+00:00 https://ascopost.com/news/september-2024/how-accurate-is-staging-in-early-pancreatic-cancer/ 2024-09-06T15:50:10+00:00 https://ascopost.com/news/september-2024/fda-approves-ready-to-use-version-of-bortezomib-for-subcutaneous-administration/ 2024-09-06T16:35:37+00:00 https://ascopost.com/news/september-2024/iaslc-ai-method-transforms-gene-mutation-prediction-in-lung-cancer/ 2024-09-09T20:05:04+00:00 https://ascopost.com/news/september-2024/high-proportion-of-us-men-older-than-45-years-may-have-misconceptions-about-prostate-cancer-screening-as-rates-of-late-stage-diagnoses-continue-to-rise/ 2024-09-09T15:29:08+00:00 https://ascopost.com/news/september-2024/treating-tki-resistant-egfr-mutant-metastatic-nonsquamous-nsclc/ 2024-09-09T18:42:55+00:00 https://ascopost.com/news/september-2024/youth-e-cigarette-use-may-have-declined-to-lowest-level-in-a-decade/ 2024-09-09T15:51:05+00:00 https://ascopost.com/news/september-2024/hrqol-in-advanced-breast-cancer-capitello-291-trial/ 2024-09-11T13:06:01+00:00 https://ascopost.com/news/september-2024/neoadjuvant-chemotherapy-for-early-breast-cancer/ 2024-09-11T18:54:24+00:00 https://ascopost.com/news/september-2024/pathway-to-developing-predictive-biomarkers-for-immune-checkpoint-inhibitors-in-nsclc/ 2024-09-11T19:09:27+00:00 https://ascopost.com/news/september-2024/iaslc-global-survey-on-biomarker-testing-reveals-progress-and-persistent-barriers-in-lung-cancer-biomarker-testing/ 2024-09-11T19:05:43+00:00 https://ascopost.com/news/september-2024/perioperative-nivolumab-may-improve-event-free-survival-compared-with-neoadjuvant-nivolumab-plus-chemotherapy-alone-in-patients-with-resectable-nsclc/ 2024-09-12T19:21:32+00:00 https://ascopost.com/news/september-2024/right-sided-colon-cancer-complete-mesocolic-excision-vs-d2-dissection/ 2024-09-12T17:17:59+00:00 https://ascopost.com/news/september-2024/study-compares-lung-cancer-screening-triage-protocols/ 2024-09-12T18:59:32+00:00 https://ascopost.com/news/september-2024/poor-prognosis-germ-cell-tumors/ 2024-09-12T17:14:21+00:00 https://ascopost.com/news/september-2024/recurrent-high-grade-t1-bladder-cancer/ 2025-06-27T18:08:45+00:00 https://ascopost.com/news/september-2024/bmi-impact-on-crc-risk-mortality-in-asia/ 2024-09-12T17:33:25+00:00 https://ascopost.com/news/september-2024/using-trop2-expression-to-predict-outcomes-in-advanced-nsclc/ 2024-09-13T18:12:11+00:00 https://ascopost.com/news/september-2024/neocoast-2-trial-durvalumab-plus-novel-agents-may-increase-pathologic-responses-in-resectable-nsclc/ 2024-09-13T18:40:43+00:00 https://ascopost.com/news/september-2024/iaslc-taletrectinib-in-ros1-positive-nsclc/ 2024-09-13T18:47:22+00:00 https://ascopost.com/news/september-2024/secondary-cancers-after-car-t-cell-therapy/ 2024-09-13T16:17:14+00:00 https://ascopost.com/news/september-2024/fda-approves-atezolizumab-and-hyaluronidase-tqjs-for-subcutaneous-injection/ 2024-09-13T18:45:10+00:00 https://ascopost.com/news/september-2024/fda-seeks-consumer-representatives-for-odac/ 2024-09-13T18:30:06+00:00 https://ascopost.com/news/september-2024/leap-012-pembrolizumab-plus-lenvatinib-added-to-tace-improved-progression-free-survival-in-hcc/ 2024-09-20T20:24:28+00:00 https://ascopost.com/news/september-2024/two-recent-studies-provide-evidence-that-breastfeeding-after-breast-cancer-may-be-safe/ 2024-09-20T20:29:14+00:00 https://ascopost.com/news/september-2024/nasal-and-paranasal-sinus-cancer-neoadjuvant-chemotherapy-and-organ-preservation/ 2026-01-28T20:16:15+00:00 https://ascopost.com/news/september-2024/5-year-analysis-of-phase-iii-himalaya-confirms-survival-benefit-of-stride-in-hepatocellular-carcinoma/ 2024-09-20T20:26:24+00:00 https://ascopost.com/news/september-2024/studies-show-immunotherapy-improves-long-term-survival-in-growing-number-of-cancers/ 2024-09-17T20:56:25+00:00 https://ascopost.com/news/september-2024/immunotherapy-and-novel-targeted-drug-appear-beneficial-in-women-with-early-stage-gynecologic-disease/ 2024-09-17T15:04:20+00:00 https://ascopost.com/news/september-2024/perioperative-durvalumab-reduced-risk-of-recurrence-or-death-vs-neoadjuvant-chemotherapy-alone-in-muscle-invasive-bladder-cancer/ 2025-06-27T18:07:15+00:00 https://ascopost.com/news/september-2024/novel-antibody-drug-conjugate-puxitatug-samrotecan-may-demonstrate-manageable-safety-profile-and-preliminary-efficacy-in-first-in-human-trial/ 2024-11-06T19:12:46+00:00 https://ascopost.com/news/september-2024/high-dose-vitamin-d3-does-not-provide-benefit-for-metastatic-colorectal-cancer/ 2024-09-20T20:29:50+00:00 https://ascopost.com/news/september-2024/retifanlimab-plus-chemotherapy-may-extend-progression-free-survival-in-patients-with-squamous-cell-anal-carcinoma/ 2024-09-20T20:27:45+00:00 https://ascopost.com/news/september-2024/fda-approves-ribociclib-with-an-aromatase-inhibitor-and-ribociclibletrozole-co-pack-for-early-high-risk-breast-cancer/ 2024-09-17T18:18:35+00:00 https://ascopost.com/news/september-2024/nure-combo-first-results-for-a-perioperative-chemoimmunotherapy-approach-in-muscle-invasive-bladder-cancer/ 2025-06-27T18:06:34+00:00 https://ascopost.com/news/september-2024/novel-triplet-combination-may-yield-positive-response-in-patients-with-advanced-phase-cml/ 2024-09-18T13:57:42+00:00 https://ascopost.com/news/september-2024/fda-draft-guidance-on-conducting-multiregional-oncology-clinical-trials/ 2024-09-18T14:03:14+00:00 https://ascopost.com/news/september-2024/fda-approves-pembrolizumab-with-chemotherapy-for-unresectable-advanced-or-metastatic-malignant-pleural-mesothelioma/ 2024-09-18T14:44:04+00:00 https://ascopost.com/news/september-2024/addition-of-palliative-radiotherapy-to-best-supportive-care-in-painful-hepatic-cancer/ 2024-09-18T14:50:41+00:00 https://ascopost.com/news/september-2024/aegean-update-confirms-benefit-of-perioperative-durvalumab-in-resectable-nsclc/ 2024-10-15T19:39:18+00:00 https://ascopost.com/news/september-2024/overall-survival-with-cabozantinib-vs-sunitinib-in-advanced-papillary-renal-cell-carcinoma/ 2025-06-27T16:42:27+00:00 https://ascopost.com/news/september-2024/impact-of-adjuvant-chemotherapy-on-resected-intraductal-papillary-mucinous-neoplasm-derived-pancreatic-cancer/ 2024-09-19T15:22:31+00:00 https://ascopost.com/news/september-2024/risk-of-immune-checkpoint-inhibitor-induced-diabetes/ 2024-09-19T18:28:47+00:00 https://ascopost.com/news/september-2024/breast-and-ovarian-cancers-may-be-newly-linked-to-thousands-of-rad51c-gene-variants/ 2024-09-19T15:33:09+00:00 https://ascopost.com/news/september-2024/black-women-may-have-a-higher-risk-of-mortality-from-all-breast-cancer-subtypes/ 2024-09-19T18:33:39+00:00 https://ascopost.com/news/september-2024/atezolizumab-venetoclax-and-obinutuzumab-in-richter-transformation-diffuse-large-b-cell-lymphoma/ 2025-10-31T16:21:38+00:00 https://ascopost.com/news/september-2024/tarlatamab-in-previously-treated-small-cell-lung-cancer/ 2024-09-20T14:21:06+00:00 https://ascopost.com/news/september-2024/immunotherapy-combination-may-improve-long-term-survival-in-patients-with-metastatic-melanoma/ 2024-09-20T14:58:18+00:00 https://ascopost.com/news/september-2024/phase-iii-cabinet-trial-cabozantinib-in-advanced-neuroendocrine-tumors/ 2024-09-20T15:07:23+00:00 https://ascopost.com/news/september-2024/long-term-outcomes-with-adjuvant-trastuzumab-for-9-weeks-or-1-year-in-her2-positive-breast-cancer-analysis-from-sold-trial/ 2024-09-20T15:40:19+00:00 https://ascopost.com/news/september-2024/detecting-clear-cell-renal-cell-carcinoma-use-of-zr-89-girentuximab-pet-ct-imaging/ 2025-06-27T16:40:00+00:00 https://ascopost.com/news/september-2024/addition-of-lu-177-psma-617-to-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/ 2024-09-23T14:22:46+00:00 https://ascopost.com/news/september-2024/aca-may-increase-access-to-colorectal-cancer-care-among-underserved-groups/ 2024-10-22T18:24:35+00:00 https://ascopost.com/news/september-2024/sexual-health-symptoms-may-be-linked-to-poor-adherence-to-adjuvant-endocrine-therapy-in-black-women-with-breast-cancer/ 2024-09-23T18:30:32+00:00 https://ascopost.com/news/september-2024/survival-outcomes-with-addition-of-trabectedin-to-docetaxel-in-leiomyosarcoma/ 2025-08-25T16:33:33+00:00 https://ascopost.com/news/september-2024/world-cancer-research-day-2024/ 2024-09-24T15:01:13+00:00 https://ascopost.com/news/september-2024/black-patients-with-triple-negative-breast-cancer-may-be-less-likely-to-receive-immunotherapy-compared-with-white-patients/ 2024-09-24T15:32:52+00:00 https://ascopost.com/news/september-2024/adjuvant-pembrolizumab-following-surgery-may-improve-cancer-free-survival-in-patients-with-high-risk-urothelial-carcinoma/ 2025-06-27T18:05:53+00:00 https://ascopost.com/news/september-2024/cisplatin-shortage-led-to-treatment-alternatives-for-head-and-neck-cancer-significantly-increasing-cost/ 2026-01-28T20:12:27+00:00 https://ascopost.com/news/september-2024/neighborhood-environment-may-be-linked-to-prostate-cancer-risk-in-men-with-west-african-genetic-ancestry/ 2024-09-26T14:44:28+00:00 https://ascopost.com/news/september-2024/quality-of-life-outcomes-with-whole-breast-irradiation-vs-accelerated-partial-breast-irradiation-following-breast-conserving-surgery/ 2024-09-26T14:53:41+00:00 https://ascopost.com/news/september-2024/overall-survival-results-with-pembrolizumab-and-chemoradiotherapy-in-newly-diagnosed-high-risk-locally-advanced-cervical-cancer/ 2024-09-26T15:10:41+00:00 https://ascopost.com/news/september-2024/datopotamab-deruxtecan-vs-docetaxel-in-previously-treated-advanced-or-metastatic-nsclc/ 2024-09-27T17:09:09+00:00 https://ascopost.com/news/september-2024/olanzapine-may-reduce-chemotherapy-induced-nausea-and-improve-quality-of-life-among-patients-with-cancer/ 2024-09-27T15:20:06+00:00 https://ascopost.com/news/september-2024/community-academic-partnership-may-successfully-reduce-radon-related-lung-cancer-risk-in-native-population/ 2024-09-27T17:17:04+00:00 https://ascopost.com/news/september-2024/fda-approves-selpercatinib-for-ret-fusion-positive-medullary-thyroid-cancer/ 2026-01-28T20:10:50+00:00 https://ascopost.com/news/september-2024/conversations-between-physicians-and-older-patients-about-physical-activity-may-reduce-falls-during-cancer-treatment/ 2024-09-30T15:22:22+00:00 https://ascopost.com/news/september-2024/quality-improvements-in-lung-cancer-surgery-and-tumor-pathology-may-extend-survival-postsurgery/ 2024-09-30T15:26:28+00:00 https://ascopost.com/news/september-2024/impact-of-whole-lung-irradiation-in-newly-diagnosed-rhabdomyosarcoma-with-lung-metastases/ 2025-08-25T16:10:16+00:00 https://ascopost.com/news/september-2024/updated-findings-with-belzutifan-in-von-hippel-lindau-disease-associated-cns-hemangioblastomas/ 2024-09-30T18:37:01+00:00 https://ascopost.com/news/october-2024/ 2024-10-01T14:11:13+00:00 https://ascopost.com/news/october-2024/pharmaceutical-industry-sponsors-and-clinical-cancer-research-in-the-united-states/ 2024-10-01T16:14:36+00:00 https://ascopost.com/news/october-2024/cancer-and-cancer-related-therapy-may-increase-cardiovascular-disease-risk-in-older-cancer-survivors/ 2024-10-01T16:21:31+00:00 https://ascopost.com/news/october-2024/ember-imlunestrant-in-estrogen-receptor-positive-her2-negative-advanced-breast-cancer/ 2024-10-01T16:28:21+00:00 https://ascopost.com/news/october-2024/keynote-671-overall-survival-with-perioperative-pembrolizumab-in-resectable-nsclc/ 2024-10-01T16:51:06+00:00 https://ascopost.com/news/october-2024/immunotherapychemoradiotherapy-in-limited-stage-small-cell-lung-cancer/ 2024-10-02T13:26:01+00:00 https://ascopost.com/news/october-2024/intensity-modulated-radiation-therapy-and-proton-beam-therapy-may-offer-equally-high-quality-of-life-and-tumor-control-in-patients-with-localized-prostate-cancer/ 2024-10-02T20:54:24+00:00 https://ascopost.com/news/october-2024/standard-chemoradiation-may-be-superior-to-deintensification-approaches-in-patients-with-hpv-associated-oropharyngeal-cancer/ 2026-01-28T20:09:39+00:00 https://ascopost.com/news/october-2024/addition-of-nivolumab-to-tivozanib-following-immune-checkpoint-inhibitor-treatment-in-metastatic-renal-cell-carcinoma/ 2025-06-27T16:37:38+00:00 https://ascopost.com/news/october-2024/lupsma-vs-change-of-androgen-receptor-pathway-inhibitor-in-taxane-naive-patients-with-metastatic-castration-resistant-prostate-cancer/ 2024-10-02T15:52:23+00:00 https://ascopost.com/news/october-2024/radiotherapy-vs-transoral-robotic-surgery-for-oropharyngeal-squamous-cell-carcinoma/ 2026-01-28T21:48:59+00:00 https://ascopost.com/news/october-2024/adjuvant-nivolumab-vs-placebo-in-localized-renal-cell-carcinoma-at-high-risk-of-recurrence-after-nephrectomy/ 2025-06-27T16:37:01+00:00 https://ascopost.com/news/october-2024/duration-of-postmastectomy-radiation-therapy-in-patients-planning-breast-reconstruction/ 2024-10-03T15:07:05+00:00 https://ascopost.com/news/october-2024/conversations-on-cancer-exploring-religious-literacy-and-spirituality-in-cancer-care/ 2024-10-03T15:19:20+00:00 https://ascopost.com/news/october-2024/strategies-for-recovering-neurocognitive-function-after-cranial-radiation-therapy/ 2024-10-03T15:40:04+00:00 https://ascopost.com/news/october-2024/autologous-vs-allogeneic-stem-cell-transplantation-in-younger-patients-with-peripheral-t-cell-lymphoma-7-year-follow-up/ 2024-10-03T15:47:53+00:00 https://ascopost.com/news/october-2024/variations-in-kras-gene-mutations-linked-to-prognosis-in-pancreatic-cancer/ 2024-10-07T18:15:46+00:00 https://ascopost.com/news/october-2024/radiopharmaceutical-therapy-may-offer-benefit-in-patients-with-refractory-meningioma/ 2024-10-07T18:12:03+00:00 https://ascopost.com/news/october-2024/spiritual-themes-distrust-may-factor-into-black-patients-reluctance-to-participate-in-cancer-clinical-trials/ 2024-10-04T18:00:01+00:00 https://ascopost.com/news/october-2024/atezolizumab-plus-platinum-doublet-and-maintenance-niraparib-for-late-relapsing-recurrent-ovarian-cancer/ 2024-10-04T15:58:55+00:00 https://ascopost.com/news/october-2024/novel-radioconjugate-or-conventional-care-prior-to-allogeneic-hematopoietic-cell-transplantation-in-relapsedrefractory-aml/ 2024-10-04T16:33:16+00:00 https://ascopost.com/news/october-2024/chatgpt-may-demonstrate-human-level-assessment-of-brain-tumor-mri-reports/ 2024-10-07T15:53:12+00:00 https://ascopost.com/news/october-2024/ai-language-models-may-generate-effective-physicians-letters/ 2024-10-07T16:01:28+00:00 https://ascopost.com/news/october-2024/two-us-scientists-receive-2024-nobel-prize-in-physiology-or-medicine/ 2024-10-07T19:20:20+00:00 https://ascopost.com/news/october-2024/addition-of-liver-transplantation-to-chemotherapy-for-permanently-unresectable-colorectal-cancer-liver-metastases/ 2024-10-08T14:45:11+00:00 https://ascopost.com/news/october-2024/acas-dependent-coverage-expansion-may-have-benefited-young-adult-patients-diagnosed-with-cancer/ 2024-10-08T15:26:27+00:00 https://ascopost.com/news/october-2024/common-breast-cancer-treatments-may-speed-aging-process/ 2024-10-08T15:35:54+00:00 https://ascopost.com/news/october-2024/sexual-health-and-quality-of-life-with-simple-vs-radical-hysterectomy-in-low-risk-early-stage-cervical-cancer/ 2024-10-08T16:50:06+00:00 https://ascopost.com/news/october-2024/transperineal-vs-transrectal-prostate-biopsy-for-suspicion-of-prostate-cancer/ 2024-10-08T18:06:36+00:00 https://ascopost.com/news/october-2024/exercise-linked-to-fewer-falls-in-older-adults-with-cancer/ 2024-10-09T14:45:42+00:00 https://ascopost.com/news/october-2024/stereotactic-vs-hypofractionated-radiotherapy-for-inoperable-stage-i-nsclc/ 2024-10-09T14:56:09+00:00 https://ascopost.com/news/october-2024/novel-cell-therapy-may-offer-benefit-in-patients-with-relapsed-or-refractory-t-cell-all/ 2025-10-03T15:59:43+00:00 https://ascopost.com/news/october-2024/one-dose-hpv-vaccination-approach-may-help-to-eliminate-cervical-cancer/ 2024-10-09T20:00:14+00:00 https://ascopost.com/news/october-2024/can-blood-test-predict-survival-in-metastatic-prostate-cancer/ 2024-10-09T17:40:16+00:00 https://ascopost.com/news/october-2024/bridging-the-gap-in-cancer-clinical-trial-funding/ 2024-10-09T17:33:30+00:00 https://ascopost.com/news/october-2024/two-universities-to-develop-incisionless-prostate-cancer-surgery-using-mri-and-robotics/ 2024-10-11T14:37:49+00:00 https://ascopost.com/news/october-2024/global-disparities-may-exist-in-availability-timeliness-of-new-cancer-drugs/ 2024-10-11T14:45:54+00:00 https://ascopost.com/news/october-2024/fda-approves-inavolisib-combination-in-pik3ca-mutated-hr-positive-her2-negative-advanced-breast-cancer/ 2024-10-11T15:10:42+00:00 https://ascopost.com/news/october-2024/sintilimabbevacizumab-in-relapsed-or-persistent-ovarian-clear-cell-carcinoma/ 2024-10-11T14:55:31+00:00 https://ascopost.com/news/october-2024/higher-dosage-of-radioembolization-with-y-90-therapy-may-improve-survival-rates-and-facilitate-curative-treatment-in-patients-with-hepatocellular-carcinoma/ 2024-10-14T15:24:02+00:00 https://ascopost.com/news/october-2024/african-men-may-have-higher-risk-of-developing-prostate-cancer-earlier/ 2024-10-14T15:29:51+00:00 https://ascopost.com/news/october-2024/radiation-associated-secondary-cancers-in-breast-cancer-harboring-tp53-germline-pathogenic-variants/ 2024-10-14T15:33:19+00:00 https://ascopost.com/news/october-2024/updated-findings-in-prostate-cancer-screening-with-systemic-biopsy-vs-mri-targeted-biopsy/ 2024-10-14T15:37:33+00:00 https://ascopost.com/news/october-2024/association-of-excess-body-weight-and-risk-of-second-primary-cancers-among-survivors-of-first-primary-cancers/ 2024-10-15T14:53:10+00:00 https://ascopost.com/news/october-2024/capmatinib-in-met-exon-14-mutated-nsclc/ 2024-10-15T14:57:14+00:00 https://ascopost.com/news/october-2024/patients-with-multiple-sclerosis-may-have-an-increased-risk-of-certain-types-of-cancer/ 2024-10-15T15:53:54+00:00 https://ascopost.com/news/october-2024/cancer-clinical-trials-may-continue-to-be-inaccessible-for-many-patients/ 2024-10-15T16:02:56+00:00 https://ascopost.com/news/october-2024/head-and-neck-cancer-clinical-trials-may-be-becoming-less-diverse-despite-national-efforts/ 2026-01-28T21:47:03+00:00 https://ascopost.com/news/october-2024/standard-vs-extended-lymphadenectomy-in-radical-cystectomy-for-muscle-invasive-bladder-cancer/ 2025-06-27T18:04:57+00:00 https://ascopost.com/news/october-2024/addition-of-ramucirumab-to-osimertinib-in-tki-naive-egfr-mutant-metastatic-nsclc/ 2024-10-16T15:55:31+00:00 https://ascopost.com/news/october-2024/addition-of-thoracic-radiotherapy-to-first-line-treatment-of-egfr-mutated-metastatic-nsclc/ 2024-10-17T16:07:19+00:00 https://ascopost.com/news/october-2024/association-of-tert-expression-and-survival-in-pulmonary-carcinoids/ 2024-10-17T16:24:20+00:00 https://ascopost.com/news/october-2024/new-data-from-swog-s1826-trial-may-confirm-benefit-of-nivolumab-plus-avd-in-patients-with-hodgkin-lymphoma/ 2024-10-17T16:30:55+00:00 https://ascopost.com/news/october-2024/large-proportion-of-childhood-cancer-survivors-may-experience-significant-fear-of-cancer-recurrence/ 2024-10-17T16:35:21+00:00 https://ascopost.com/news/october-2024/large-proportion-of-postmenopausal-hormone-receptor-positive-breast-cancers-may-be-linked-to-excess-body-fat/ 2024-10-18T15:21:35+00:00 https://ascopost.com/news/october-2024/sts-launches-two-new-thoracic-surgery-risk-calculators/ 2024-10-18T15:28:12+00:00 https://ascopost.com/news/october-2024/what-is-the-impact-of-a-colon-or-colorectal-cancer-diagnosis-on-younger-adults/ 2024-11-19T19:55:49+00:00 https://ascopost.com/news/october-2024/skin-cancer-risk-after-radioactive-iodine-treatment-for-thyroid-cancer/ 2024-10-18T16:00:59+00:00 https://ascopost.com/news/october-2024/do-social-support-measures-improve-uptake-of-cancer-screening/ 2024-10-18T17:48:01+00:00 https://ascopost.com/news/october-2024/accelerated-approval-for-bladder-cancer-drug-to-be-withdrawn-after-negative-trial/ 2025-06-27T18:03:33+00:00 https://ascopost.com/news/october-2024/regorafenib-in-refractory-advanced-gastric-cancer/ 2025-06-27T21:06:41+00:00 https://ascopost.com/news/october-2024/cancer-diagnoses-may-be-linked-to-lasting-financial-challenges/ 2024-10-21T18:57:22+00:00 https://ascopost.com/news/october-2024/acs-program-may-reduce-postsurgical-mortality-improve-care-among-older-patients/ 2024-10-21T16:35:25+00:00 https://ascopost.com/news/october-2024/rogaratinibatezolizumab-in-cisplatin-ineligible-fgfr-mrna-overexpressing-urothelial-cancer/ 2025-06-27T18:02:41+00:00 https://ascopost.com/news/october-2024/listening-to-music-may-accelerate-postsurgical-recovery/ 2024-10-22T18:11:56+00:00 https://ascopost.com/news/october-2024/heart-failure-and-cancer-new-insights-into-reciprocal-relationship/ 2024-10-22T15:48:11+00:00 https://ascopost.com/news/october-2024/carmen-lc03-tusamitamab-ravtansine-vs-docetaxel-in-previously-treated-advanced-nonsquamous-nsclc/ 2024-10-22T15:34:07+00:00 https://ascopost.com/news/october-2024/cosmetic-outcomes-with-two-schedules-of-partial-breast-irradiation-in-early-breast-cancer/ 2024-10-22T18:09:43+00:00 https://ascopost.com/news/october-2024/outcomes-with-adjuvant-ici-treatment-in-resected-stage-iiiiv-melanoma/ 2024-10-22T18:06:48+00:00 https://ascopost.com/news/october-2024/mri-may-help-prevent-unnecessary-surgery-in-patients-with-rectal-cancer/ 2024-10-23T14:11:19+00:00 https://ascopost.com/news/october-2024/new-33-million-dollar-nci-grant-may-facilitate-development-of-more-accurate-comfortable-breast-cancer-screening-technology/ 2024-10-23T14:19:17+00:00 https://ascopost.com/news/october-2024/preoperative-chemotherapy-and-perioperative-nivolumab-in-nsclc/ 2024-10-23T14:26:06+00:00 https://ascopost.com/news/october-2024/risk-of-subsequent-neoplasms-in-survivors-of-childhood-neuroblastoma/ 2024-10-23T14:31:39+00:00 https://ascopost.com/news/october-2024/impact-of-hormonal-contraception-on-breast-cancer-risk-in-brca12-germline-mutation-carriers/ 2024-10-24T16:42:15+00:00 https://ascopost.com/news/october-2024/sbrt-vs-conventional-radiotherapy-for-localized-prostate-cancer/ 2024-10-24T19:04:20+00:00 https://ascopost.com/news/october-2024/national-academy-of-medicine-elects-100-new-members/ 2024-10-24T19:41:54+00:00 https://ascopost.com/news/october-2024/mutations-and-dna-structures-may-drive-urothelial-carcinoma/ 2025-06-27T18:01:26+00:00 https://ascopost.com/news/october-2024/ecog-acrin-cancer-research-group-caris-life-sciences-partner-to-learn-more-from-tailorx-trial/ 2024-10-28T19:43:34+00:00 https://ascopost.com/news/october-2024/addition-of-induction-chemotherapy-to-standard-chemoradiotherapy-in-locally-advanced-cervical-cancer/ 2024-10-28T15:38:56+00:00 https://ascopost.com/news/october-2024/immunotherapy-plus-targeted-therapy-for-anaplastic-thyroid-carcinoma/ 2024-10-28T15:33:51+00:00 https://ascopost.com/news/october-2024/early-results-show-novel-agent-has-clinical-activity-in-fgfr3-driven-advanced-bladder-cancer/ 2025-06-27T18:00:45+00:00 https://ascopost.com/news/october-2024/scientists-develop-a-digital-twin-model-to-predict-cancer-treatment-responses/ 2024-10-28T17:08:10+00:00 https://ascopost.com/news/october-2024/new-marker-for-immunotherapy-response-in-hepatocellular-carcinoma/ 2024-10-29T15:36:08+00:00 https://ascopost.com/news/october-2024/medicaid-expansion-may-improve-cancer-care-survival-among-patients-with-hormone-receptor-negative-her2-positive-breast-cancer/ 2024-10-29T15:45:24+00:00 https://ascopost.com/news/october-2024/association-between-pathologic-response-and-relapse-free-survival-with-neoadjuvant-immune-checkpoint-inhibitor-therapy-for-hepatocellular-carcinoma/ 2024-10-29T16:03:04+00:00 https://ascopost.com/news/october-2024/distant-recurrence-risk-among-women-with-early-breast-cancer-enrolled-in-clinical-trials-between-1990-and-2009-ebctcg-analysis/ 2024-10-29T16:07:20+00:00 https://ascopost.com/news/october-2024/fda-grants-accelerated-approval-to-asciminib-for-newly-diagnosed-chronic-myeloid-leukemia/ 2024-11-07T19:33:41+00:00 https://ascopost.com/news/october-2024/chinese-phase-iii-trial-explores-novel-treatment-options-in-cervical-cancer/ 2024-10-30T14:59:12+00:00 https://ascopost.com/news/october-2024/novel-treatment-options-for-children-and-young-adults-with-relapsed-osteosarcoma/ 2025-08-25T16:09:08+00:00 https://ascopost.com/news/october-2024/new-computational-tool-may-predict-immunotherapy-outcomes-in-patients-with-metastatic-breast-cancer/ 2024-10-30T15:15:48+00:00 https://ascopost.com/news/october-2024/lung-cancer-screening-model-may-remove-barriers-for-vulnerable-patients-residing-in-central-texas/ 2024-10-30T15:20:23+00:00 https://ascopost.com/news/october-2024/using-ai-to-measure-prostate-cancer-lesions-could-aid-diagnosis-and-treatment/ 2024-10-31T16:23:51+00:00 https://ascopost.com/news/october-2024/weighing-blood-based-vs-standard-colorectal-cancer-screening-options/ 2024-10-31T16:19:12+00:00 https://ascopost.com/news/october-2024/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma/ 2025-06-27T17:59:37+00:00 https://ascopost.com/news/october-2024/outcomes-with-brexucabtagene-autoleucel-as-standard-therapy-for-adults-with-relapsedrefractory-b-cell-acute-lymphoblastic-leukemia/ 2025-10-03T14:28:38+00:00 https://ascopost.com/news/october-2024/cdk46-inhibition-in-peritoneal-mucinous-carcinomatosis-with-gnas-mutation/ 2024-10-31T16:27:39+00:00 https://ascopost.com/news/november-2024/ 2024-11-01T14:23:52+00:00 https://ascopost.com/news/november-2024/dkn-01-with-tislelizumab-and-chemotherapy-in-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2024-11-01T14:38:53+00:00 https://ascopost.com/news/november-2024/inotuzumab-ozogamicin-with-low-intensity-chemotherapy-in-older-patients-with-cd22-positive-philadelphia-chromosome-negative-b-cell-precursor-all/ 2025-10-03T15:57:37+00:00 https://ascopost.com/news/november-2024/nccn-harmonized-guidelines-for-sub-saharan-africa-experts-convene-in-ghana-to-update-cancer-treatment-guidelines/ 2024-11-01T16:24:04+00:00 https://ascopost.com/news/november-2024/quantifying-the-benefit-of-smoking-cessation-within-6-months-of-a-cancer-diagnosis/ 2024-11-01T16:33:34+00:00 https://ascopost.com/news/november-2024/valemetostat-in-relapsed-or-refractory-peripheral-t-cell-lymphoma/ 2024-11-04T16:17:28+00:00 https://ascopost.com/news/november-2024/prediction-of-fracture-risk-in-patients-with-cancer/ 2024-11-04T16:20:58+00:00 https://ascopost.com/news/november-2024/novel-method-for-liquid-biopsies-may-streamline-cancer-detection/ 2024-11-04T16:26:41+00:00 https://ascopost.com/news/november-2024/immunotherapy-combination-may-demonstrate-benefit-in-patients-with-cutaneous-melanoma/ 2024-11-04T16:33:20+00:00 https://ascopost.com/news/november-2024/jennifer-bickel-md-named-md-anderson-vice-president-and-chief-wellness-officer/ 2024-11-04T20:01:49+00:00 https://ascopost.com/news/november-2024/trends-in-use-of-primary-cytoreductive-surgery-and-neoadjuvant-chemotherapy-in-advanced-stage-ovarian-cancer/ 2024-11-05T17:24:27+00:00 https://ascopost.com/news/november-2024/case-study-shows-striking-improvements-in-patient-with-metastatic-prostate-cancer/ 2024-11-05T18:09:33+00:00 https://ascopost.com/news/november-2024/grant-of-over-2-million-dollars-may-help-increase-lung-cancer-screenings-in-underserved-communities/ 2024-11-05T18:18:08+00:00 https://ascopost.com/news/november-2024/risk-of-second-primary-cancers-after-breast-cancer-in-brca1-and-brca2-pathogenic-variant-carriers/ 2024-11-05T18:26:28+00:00 https://ascopost.com/news/november-2024/resection-of-stage-i-to-iii-thymic-tumors-in-high-volume-us-centers/ 2024-11-05T18:33:28+00:00 https://ascopost.com/news/november-2024/next-generation-oral-serd-in-postmenopausal-women-with-er-positive-her2-negative-advanced-breast-cancer/ 2024-11-06T15:10:31+00:00 https://ascopost.com/news/november-2024/addition-of-atezolizumab-plus-bevacizumab-to-chemotherapy-in-advanced-biliary-tract-cancer/ 2024-11-06T15:28:14+00:00 https://ascopost.com/news/november-2024/how-hypoxia-may-help-cancer-metastasize/ 2024-11-06T17:21:01+00:00 https://ascopost.com/news/november-2024/researchers-may-have-uncovered-why-some-aml-cells-resist-treatment/ 2024-11-06T19:13:48+00:00 https://ascopost.com/news/november-2024/risk-of-ischemic-cardiotoxicity-with-aromatase-inhibitors-in-postmenopausal-patients-with-early-breast-cancer/ 2024-11-07T16:02:20+00:00 https://ascopost.com/news/november-2024/sitc-study-finds-io102-io103-vaccine-plus-pembrolizumab-active-in-patients-with-non-small-cell-lung-cancer/ 2024-12-05T20:32:53+00:00 https://ascopost.com/news/november-2024/detecting-evidence-of-lung-cancer-in-exhaled-breath/ 2024-11-15T21:16:05+00:00 https://ascopost.com/news/november-2024/study-explores-underpinnings-of-immunotherapy-releated-myocarditis-in-patients-with-cancer/ 2024-11-07T17:12:54+00:00 https://ascopost.com/news/november-2024/tanning-bed-access-usage-may-be-driving-higher-rates-of-melanoma-in-new-england/ 2024-11-08T16:00:51+00:00 https://ascopost.com/news/november-2024/nccn-guidelines-have-expanded-to-meet-growing-understanding-of-hereditary-risk/ 2024-11-08T15:54:22+00:00 https://ascopost.com/news/november-2024/trastuzumab-duocarmazine-in-previously-treated-her2-positive-metastatic-breast-cancer/ 2024-12-06T18:55:57+00:00 https://ascopost.com/news/november-2024/nivolumab-plus-ipilimumab-in-aggressive-thyroid-carcinoma/ 2024-11-08T15:35:05+00:00 https://ascopost.com/news/november-2024/study-finds-long-term-risks-associated-with-prostate-cancer-treatment/ 2024-11-08T17:43:56+00:00 https://ascopost.com/news/november-2024/fda-approves-novel-t-cell-immunotherapy-for-adults-with-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukemia/ 2025-10-03T14:25:29+00:00 https://ascopost.com/news/november-2024/new-insights-into-innate-resistance-for-immunotherapies-in-colorectal-cancer/ 2024-11-12T16:06:54+00:00 https://ascopost.com/news/november-2024/breast-cancer-vaccine-could-be-preventive-well-tolerated-in-high-risk-patients/ 2024-11-12T17:25:29+00:00 https://ascopost.com/news/november-2024/study-finds-in-situ-vaccination-using-tumor-treating-fields-plus-immune-checkpoint-inhibitors-extended-survival-in-patients-with-glioblastoma/ 2024-11-12T17:28:29+00:00 https://ascopost.com/news/november-2024/study-finds-long-term-risks-associated-with-prostate-cancer-treatment-and-highlights-the-importance-of-counseling-prior-to-screening-and-treatment/ 2024-11-12T17:43:40+00:00 https://ascopost.com/news/november-2024/effect-of-smoking-cessation-intervention-on-survival-after-a-cancer-diagnosis/ 2024-11-13T18:34:29+00:00 https://ascopost.com/news/november-2024/pembrolizumab-plus-standard-chemotherapy-may-benefit-patients-with-rare-aggressive-cancers/ 2024-11-13T18:54:17+00:00 https://ascopost.com/news/november-2024/valemetostat-in-relapsed-or-refractory-non-hodgkin-lymphoma/ 2024-11-13T19:01:54+00:00 https://ascopost.com/news/november-2024/addition-of-adjuvant-epirubicin-to-docetaxel-cyclophosphamide-in-early-top2a-normal-breast-cancer/ 2024-11-14T14:16:31+00:00 https://ascopost.com/news/november-2024/prostatectomy-with-or-without-postprostatectomy-radiotherapy-and-long-term-hrqol-in-localized-prostate-cancer/ 2024-11-14T15:11:27+00:00 https://ascopost.com/news/november-2024/are-young-patients-with-cancer-discussing-fertility-preservation-with-physicians/ 2024-11-14T16:28:54+00:00 https://ascopost.com/news/november-2024/treatment-advances-predictive-biomarkers-may-improve-urothelial-carcinoma-care/ 2025-06-27T17:56:18+00:00 https://ascopost.com/news/november-2024/addition-of-veliparib-to-temozolomide-in-newly-diagnosed-mgmt-methylated-glioblastoma/ 2024-11-15T14:42:24+00:00 https://ascopost.com/news/november-2024/enfortumab-vedotin-in-previously-treated-advanced-head-and-neck-cancer/ 2026-01-28T21:41:05+00:00 https://ascopost.com/news/november-2024/novel-liquid-biopsies-and-cancer-detection/ 2024-11-15T16:46:50+00:00 https://ascopost.com/news/november-2024/immunotherapy-combination-for-cutaneous-melanoma/ 2024-11-15T16:52:36+00:00 https://ascopost.com/news/november-2024/study-identifies-new-approach-to-overcome-docetaxel-resistance-in-patients-with-advanced-prostate-cancer/ 2024-11-15T19:02:34+00:00 https://ascopost.com/news/november-2024/onvansertib-with-chemotherapy-and-bevacizumab-in-second-line-treatment-of-kras-mutant-metastatic-colorectal-cancer/ 2024-11-18T14:44:49+00:00 https://ascopost.com/news/november-2024/addition-of-pembrolizumab-to-radiation-therapy-and-surgery-in-stage-iii-soft-tissue-sarcoma-of-the-extremity/ 2025-08-25T16:08:13+00:00 https://ascopost.com/news/november-2024/cancer-specific-mortality-trends-among-us-asian-and-pacific-islander-populations/ 2024-11-18T14:57:30+00:00 https://ascopost.com/news/november-2024/ai-tool-may-detect-cancer-gene-signatures-in-biopsy-images/ 2024-11-18T16:49:31+00:00 https://ascopost.com/news/november-2024/new-technique-may-allow-for-visualization-of-car-t-cells-postinjection/ 2024-11-18T16:53:56+00:00 https://ascopost.com/news/november-2024/performance-of-first-line-chemotherapy-regimens-in-unresectable-advanced-or-metastatic-pancreatic-cancer/ 2024-11-19T14:01:58+00:00 https://ascopost.com/news/november-2024/international-cancer-organizations-present-collaborative-work-during-oncology-event-in-china/ 2024-11-19T18:45:46+00:00 https://ascopost.com/news/november-2024/suicide-related-mortality-in-male-aya-cancer-survivors/ 2024-11-19T16:18:26+00:00 https://ascopost.com/news/november-2024/firefighters-may-be-exposed-to-chemicals-associated-with-breast-cancer/ 2024-11-21T20:14:10+00:00 https://ascopost.com/news/november-2024/neuro-oncology-guidelines-reveal-how-ai-could-improve-brain-cancer-diagnosis-monitoring-and-treatment/ 2024-11-21T17:24:38+00:00 https://ascopost.com/news/november-2024/fda-grants-accelerated-approval-to-zanidatamab-hrii-for-previously-treated-unresectable-or-metastatic-her2-positive-biliary-tract-cancer/ 2024-11-21T18:56:15+00:00 https://ascopost.com/news/november-2024/healthy-women-may-have-aneuploid-epithelial-cells-resembling-breast-cancer/ 2024-11-22T18:28:41+00:00 https://ascopost.com/news/november-2024/global-adaptive-platform-trial-for-glioblastoma-to-evaluate-novel-atm-kinase-inhibitor/ 2024-11-22T18:32:45+00:00 https://ascopost.com/news/november-2024/penpulimab-combination-therapy-for-first-line-treatment-of-hepatocellular-carcinoma/ 2024-11-22T18:42:20+00:00 https://ascopost.com/news/november-2024/novel-hypofractionated-proton-beam-therapy-for-older-patients-with-newly-diagnosed-glioblastoma/ 2024-11-26T18:49:18+00:00 https://ascopost.com/news/november-2024/adding-temozolomide-to-radiation-therapy-may-improve-survival-in-adults-with-low-grade-gliomas/ 2024-11-26T19:09:04+00:00 https://ascopost.com/news/november-2024/effect-of-myeloma-therapy-in-a-patient-with-monoclonal-gammopathy-of-thrombotic-significance/ 2024-11-26T19:17:01+00:00 https://ascopost.com/news/november-2024/glofitamab-or-rituximab-plus-gemcitabineoxaliplatin-in-relapsedrefractory-dlbcl/ 2025-10-31T16:21:05+00:00 https://ascopost.com/news/november-2024/mirdametinib-in-adults-and-children-with-symptomatic-neurofibromatosis-type-1-associated-plexiform-neurofibroma/ 2024-11-27T21:37:30+00:00 https://ascopost.com/news/november-2024/prognostic-factors-in-limited-stage-sclc-treated-with-escalated-radiotherapy-doses/ 2024-11-26T21:28:23+00:00 https://ascopost.com/news/november-2024/fda-approves-oral-liquid-imatinib-to-treat-patients-with-leukemia-and-other-cancer-types/ 2024-11-27T17:09:51+00:00 https://ascopost.com/news/november-2024/peer-support-intervention-may-help-improve-psychological-outcomes-among-patients-with-cancer-in-low-resource-settings/ 2024-11-27T17:22:37+00:00 https://ascopost.com/news/november-2024/at-home-testing-kits-coordinated-outreach-may-improve-colorectal-cancer-screening-rates/ 2024-11-27T17:35:15+00:00 https://ascopost.com/news/december-2024/ 2024-12-02T15:24:04+00:00 https://ascopost.com/news/december-2024/radiotherapy-with-durvalumab-or-cetuximab-in-locoregionally-advanced-head-and-neck-cancer-with-contraindication-for-cisplatin/ 2026-01-28T21:33:15+00:00 https://ascopost.com/news/december-2024/study-may-illuminate-cause-of-common-checkpoint-inhibitor-adverse-effect/ 2024-12-02T16:20:17+00:00 https://ascopost.com/news/december-2024/pharmacokinetic-comparison-of-aumolertinib-osimertinib-gefitinib-and-their-major-metabolites-in-nsclc/ 2024-12-02T21:08:49+00:00 https://ascopost.com/news/december-2024/mrd-guided-chemotherapy-intensification-after-induction-in-fit-older-patients-with-aml/ 2024-12-02T18:00:45+00:00 https://ascopost.com/news/december-2024/evidence-based-recommendations-and-knowledge-gaps-regarding-cardio-oncology/ 2024-12-03T16:56:55+00:00 https://ascopost.com/news/december-2024/ramucirumab-paclitaxel-as-switch-maintenance-in-advanced-her2-negative-gastric-gastroesophageal-junction-cancer/ 2024-12-19T18:49:03+00:00 https://ascopost.com/news/december-2024/lung-cancer-ct-screening-may-help-to-detect-coronary-artery-disease/ 2024-12-03T17:41:33+00:00 https://ascopost.com/news/december-2024/poor-diets-may-increase-risk-of-gastrointestinal-cancer/ 2025-06-27T21:05:28+00:00 https://ascopost.com/news/december-2024/obecabtagene-autoleucel-in-adults-with-b-cell-all/ 2025-10-03T15:55:00+00:00 https://ascopost.com/news/december-2024/lenvatinib-pembrolizumab-vs-chemotherapy-in-advanced-endometrial-cancer/ 2024-12-04T17:53:59+00:00 https://ascopost.com/news/december-2024/toripalimab-plus-chemotherapy-in-first-line-therapy-for-extensive-stage-small-cell-lung-cancer/ 2024-12-04T17:49:15+00:00 https://ascopost.com/news/december-2024/challenges-and-potential-of-mesenchymal-stem-cells-in-cancer-immunotherapy/ 2024-12-04T18:02:14+00:00 https://ascopost.com/news/december-2024/regional-racial-economic-disparities-in-air-pollution-related-cancer-risk-may-be-improving-but-still-persist/ 2024-12-04T18:13:52+00:00 https://ascopost.com/news/december-2024/impact-of-menopausal-status-on-long-term-benefit-from-antihormonal-treatment-in-women-with-breast-cancer/ 2024-12-04T19:28:03+00:00 https://ascopost.com/news/december-2024/prophylactic-surgical-menopause-for-women-with-familial-risk-of-ovarian-cancer-impact-on-coronary-artery-calcium-development/ 2024-12-05T16:55:48+00:00 https://ascopost.com/news/december-2024/prior-authorization-delays-may-lead-to-severe-consequences-for-patients-with-cancer/ 2024-12-05T17:09:32+00:00 https://ascopost.com/news/december-2024/potential-cancer-vaccine-target-uncovered-in-e-coli-bacteria/ 2024-12-06T14:35:12+00:00 https://ascopost.com/news/december-2024/fda-grants-approval-to-new-bispecific-antibody-for-nsclc-and-pancreatic-adenocarcinoma/ 2024-12-05T16:59:07+00:00 https://ascopost.com/news/december-2024/de-escalated-neoadjuvant-combination-therapy-for-her2-positive-early-breast-cancer/ 2025-01-03T20:01:45+00:00 https://ascopost.com/news/december-2024/alkylating-agent-based-treatment-in-neuroendocrine-tumors-according-to-mgmt-status/ 2024-12-05T17:32:03+00:00 https://ascopost.com/news/december-2024/fda-approves-durvalumab-for-limited-stage-small-cell-lung-cancer/ 2024-12-05T20:43:26+00:00 https://ascopost.com/news/december-2024/self-pay-ai-based-program-may-help-boost-mammogram-findings/ 2024-12-06T15:24:36+00:00 https://ascopost.com/news/december-2024/novel-immunotherapy-may-offer-benefit-in-early-clinical-trial-for-breast-cancer/ 2024-12-06T15:29:28+00:00 https://ascopost.com/news/december-2024/impact-of-prevention-and-screening-on-mortality-from-five-common-cancers/ 2024-12-06T18:29:02+00:00 https://ascopost.com/news/december-2024/novel-oncolytic-immunotherapy-yields-durable-responses-in-high-risk-bladder-cancer/ 2025-06-27T17:55:22+00:00 https://ascopost.com/news/december-2024/cancer-risk-associated-with-use-of-disease-modifying-antirheumatic-drugs/ 2024-12-06T16:58:13+00:00 https://ascopost.com/news/december-2024/preclinical-findings-show-ketogenic-diet-enhances-car-t-cell-function-improves-tumor-control/ 2024-12-09T16:07:19+00:00 https://ascopost.com/news/december-2024/lower-socioeconomic-status-impacts-aml-patients-ability-to-receive-hematopoietic-cell-transplantation/ 2024-12-09T19:32:40+00:00 https://ascopost.com/news/december-2024/study-finds-daratumumab-monotherapy-prevented-or-delayed-progression-from-smoldering-to-active-multiple-myeloma/ 2024-12-20T19:38:41+00:00 https://ascopost.com/news/december-2024/rilzabrutinib-found-safe-and-effective-for-refractory-immune-thrombocytopenia/ 2024-12-09T19:39:09+00:00 https://ascopost.com/news/december-2024/loncastuximab-tesirine-may-improve-outcomes-in-high-risk-follicular-lymphoma-marginal-zone-lymphoma/ 2024-12-09T18:37:13+00:00 https://ascopost.com/news/december-2024/common-bacterial-toxin-may-speed-up-colorectal-cancer-metastasis/ 2024-12-09T18:45:09+00:00 https://ascopost.com/news/december-2024/imlunestrant-alone-and-combined-with-abemaciclib-effective-in-esr1-mutated-breast-cancer/ 2025-01-03T19:41:32+00:00 https://ascopost.com/news/december-2024/high-fiber-diet-may-slow-disease-progression-to-multiple-myeloma/ 2025-04-25T15:07:37+00:00 https://ascopost.com/news/december-2024/combination-of-two-oral-agents-may-improve-progression-free-survival-in-patients-with-previously-untreated-cll/ 2025-06-27T17:48:59+00:00 https://ascopost.com/news/december-2024/pirtobrutinib-may-improve-survival-outcomes-in-pretreated-patients-with-cll-or-sll/ 2025-06-27T17:47:45+00:00 https://ascopost.com/news/december-2024/fiber-rich-diet-may-help-prevent-complications-after-stem-cell-transplant/ 2024-12-11T17:16:07+00:00 https://ascopost.com/news/december-2024/brca-mutation-carriers-with-prior-diagnosis-of-early-onset-breast-cancer-may-benefit-from-risk-reducing-surgery/ 2025-01-03T19:50:10+00:00 https://ascopost.com/news/december-2024/nivolumabipilimumab-vs-chemotherapy-with-or-without-targeted-agents-in-msi-h-or-dmmr-metastatic-colorectal-cancer/ 2024-12-12T17:44:07+00:00 https://ascopost.com/news/december-2024/bicistronic-car-t-cell-therapy-achieved-durable-remissions-in-children-with-relapsed-refractory-b-cell-all/ 2025-10-03T14:18:49+00:00 https://ascopost.com/news/december-2024/active-monitoring-may-be-a-viable-option-for-some-patients-with-low-risk-dcis/ 2025-01-07T17:39:54+00:00 https://ascopost.com/news/december-2024/quality-of-life-similar-among-patients-with-low-risk-dcis-whether-they-received-active-monitoring-or-surgery/ 2025-01-07T17:37:45+00:00 https://ascopost.com/news/december-2024/blinatumomab-in-combination-with-chemotherapy-may-improve-survival-in-pediatric-patients-newly-diagnosed-with-b-cell-precursor-all/ 2025-10-03T14:14:41+00:00 https://ascopost.com/news/december-2024/autologous-stem-cell-transplantation-may-not-improve-survival-in-patients-with-mcl-undetectable-measurable-residual-disease/ 2024-12-12T19:39:36+00:00 https://ascopost.com/news/december-2024/intermittent-or-continuous-panitumumab-plus-folfiri-in-first-line-treatment-of-ras-and-braf-wild-type-metastatic-colorectal-cancer/ 2024-12-13T15:38:13+00:00 https://ascopost.com/news/december-2024/most-patients-with-intermediate-risk-breast-cancer-may-safely-avoid-chest-wall-irradiation-after-mastectomy/ 2025-01-03T20:02:18+00:00 https://ascopost.com/news/december-2024/adjuvant-tamoxifen-may-reduce-recurrence-risk-for-patients-with-good-risk-dcis-who-forgo-radiation/ 2025-01-07T17:28:07+00:00 https://ascopost.com/news/december-2024/trastuzumab-deruxtecan-vs-chemotherapy-in-advanced-breast-cancer/ 2025-01-07T17:27:33+00:00 https://ascopost.com/news/december-2024/geriatric-surgery-verification-program-may-improve-outcomes-in-older-patients-with-cancer-in-community-hospitals/ 2024-12-13T16:43:10+00:00 https://ascopost.com/news/december-2024/negative-colonoscopy-screening-results-and-risk-for-colorectal-cancer-and-mortality/ 2024-12-16T15:29:45+00:00 https://ascopost.com/news/december-2024/cosibelimab-ipdl-approved-by-fda-for-treatment-of-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma/ 2024-12-16T15:58:06+00:00 https://ascopost.com/news/december-2024/learning-from-the-zest-trial-in-using-ctdna-to-predict-breast-cancer-recurrence/ 2025-01-03T19:59:36+00:00 https://ascopost.com/news/december-2024/low-omega-6-high-omega-3-diet-and-fish-oil-supplementation-may-help-slow-prostate-cancer-growth/ 2024-12-16T17:04:19+00:00 https://ascopost.com/news/december-2024/improving-hepatocellular-carcinoma-outcomes-through-enhanced-immunotherapy/ 2024-12-16T17:10:34+00:00 https://ascopost.com/news/december-2024/effectiveness-of-multimodal-machine-learning-model-in-predicting-response-to-treatment-in-breast-cancer-subtype/ 2025-01-07T17:23:48+00:00 https://ascopost.com/news/december-2024/hipec-in-platinum-sensitive-recurrent-ovarian-cancer/ 2024-12-17T14:21:39+00:00 https://ascopost.com/news/december-2024/anthracyclines-plus-taxane-based-chemotherapy-for-certain-patients-at-high-risk-for-breast-cancer-recurrence/ 2025-01-03T19:54:00+00:00 https://ascopost.com/news/december-2024/generic-platinum-chemotherapy-shortages-may-not-have-increased-mortality/ 2024-12-17T15:58:03+00:00 https://ascopost.com/news/december-2024/cbd-may-not-reduce-scan-related-anxiety-in-patients-with-advanced-breast-cancer/ 2024-12-17T16:34:10+00:00 https://ascopost.com/news/december-2024/primary-lung-tumor-sbrt-followed-by-concurrent-mediastinal-chemoradiotherapy-and-immunotherapy-consolidation-in-locally-advanced-nsclc/ 2025-01-10T19:49:42+00:00 https://ascopost.com/news/december-2024/mixed-formulation-fosrolapitant-and-palonosetron-in-preventing-cisplatin-based-highly-emetogenic-chemotherapy-induced-nausea-and-vomiting/ 2024-12-18T16:27:32+00:00 https://ascopost.com/news/december-2024/larotrectinib-in-newly-diagnosed-infantile-fibrosarcoma-and-other-pediatric-ntrk-fusion-positive-solid-tumors/ 2025-08-25T16:05:50+00:00 https://ascopost.com/news/december-2024/uicc-iccp-landmark-review-of-national-cancer-strategies-illuminates-progress-persistent-challenges/ 2024-12-18T19:05:40+00:00 https://ascopost.com/news/december-2024/researchers-may-have-uncovered-protein-that-helps-cancer-cells-dodge-car-t-cell-therapy/ 2025-06-27T17:43:54+00:00 https://ascopost.com/news/december-2024/primary-analysis-of-zuma-2-treatment-of-btk-inhibitor-naive-relapsedrefractory-mantle-cell-lymphoma/ 2024-12-23T18:41:09+00:00 https://ascopost.com/news/december-2024/car-t-cell-therapy-for-relapsedrefractory-mantle-cell-lymphoma-zuma-2/ 2025-01-29T19:36:55+00:00 https://ascopost.com/news/december-2024/fda-approves-ensartinib-for-alk-positive-locally-advanced-or-metastatic-nsclc/ 2024-12-19T15:05:32+00:00 https://ascopost.com/news/december-2024/alpelisib-plus-fulvestrant-in-pik3ca-mutated-hormone-receptor-positive-her2-negative-advanced-breast-cancer-after-previous-therapy/ 2024-12-19T15:23:18+00:00 https://ascopost.com/news/december-2024/detection-of-occult-maternal-cancer-through-prenatal-cell-free-dna-sequencing/ 2024-12-19T15:45:44+00:00 https://ascopost.com/news/december-2024/asco-elects-2026-2027-president-six-new-members-of-board-of-directors-nominating-committee/ 2024-12-19T17:01:05+00:00 https://ascopost.com/news/december-2024/mesenchymal-cell-therapy-approved-for-steroid-refractory-acute-gvhd/ 2024-12-19T17:16:45+00:00 https://ascopost.com/news/december-2024/influence-of-social-networks-among-older-patients-with-cancer/ 2024-12-19T17:35:28+00:00 https://ascopost.com/news/december-2024/use-of-ibrutinib-in-early-stage-chronic-lymphocytic-leukemia/ 2025-06-27T17:41:29+00:00 https://ascopost.com/news/december-2024/epcoritamab-monotherapy-for-pretreated-relapsed-or-refractory-cll/ 2025-06-27T17:39:51+00:00 https://ascopost.com/news/december-2024/addition-of-sbrt-to-systemic-therapy-may-improve-outcomes-in-select-patients-with-locally-advanced-hepatocellular-carcinoma/ 2024-12-20T17:22:02+00:00 https://ascopost.com/news/december-2024/mri-first-strategy-may-be-safe-for-prostate-cancer-detection/ 2024-12-20T17:27:25+00:00 https://ascopost.com/news/december-2024/study-finds-genetic-changes-elevated-leukemia-risk-in-ground-zero-first-responders/ 2025-06-27T17:38:18+00:00 https://ascopost.com/news/december-2024/long-term-overall-survival-with-adjuvant-gemcitabine-capecitabine-vs-gemcitabine-in-pancreatic-adenocarcinoma/ 2024-12-23T15:15:54+00:00 https://ascopost.com/news/december-2024/ctx130-car-t-cell-therapy-for-relapsed-or-refractory-t-cell-lymphoma/ 2024-12-23T15:30:43+00:00 https://ascopost.com/news/december-2024/sequoia-5-year-follow-up-zanubrutinib-vs-bendamustinerituximab-in-treatment-naive-cllsll/ 2024-12-23T15:43:25+00:00 https://ascopost.com/news/december-2024/fda-grants-accelerated-approval-to-encorafenib-combination-for-braf-v600e-mutant-metastatic-colorectal-cancer/ 2024-12-23T15:58:45+00:00 https://ascopost.com/news/december-2024/primary-analysis-of-zuma-2-treatment-of-btk-inhibitor-naive-relapsed-refractory-mantle-cell-lymphoma/ 2024-12-23T16:01:53+00:00 https://ascopost.com/news/january-2025/ 2025-01-02T15:19:59+00:00 https://ascopost.com/news/january-2025/fda-approves-nivolumab-and-hyaluronidase-nvhy-for-subcutaneous-injection/ 2025-01-02T20:31:54+00:00 https://ascopost.com/news/january-2025/ai-may-improve-ovarian-cancer-diagnoses/ 2026-01-07T19:58:43+00:00 https://ascopost.com/news/january-2025/nuclear-speckle-signatures-in-clear-cell-rcc/ 2025-06-27T15:45:33+00:00 https://ascopost.com/news/january-2025/npm1-genotypes-and-outcomes-in-aml/ 2025-01-02T19:49:32+00:00 https://ascopost.com/news/january-2025/maintenance-therapy-after-induction-with-rvd-with-or-without-isatuximab-in-transplant-eligible-newly-diagnosed-multiple-myeloma/ 2025-01-02T20:34:02+00:00 https://ascopost.com/news/january-2025/tool-for-prognosis-in-hormone-receptor-positive-her2-negative-node-positive-breast-cancer/ 2025-01-03T19:29:10+00:00 https://ascopost.com/news/january-2025/addition-of-nab-paclitaxel-to-gemcitabine-cisplatin-in-advanced-biliary-tract-cancers/ 2025-01-03T16:55:23+00:00 https://ascopost.com/news/january-2025/novel-topical-combination-may-prevent-squamous-cell-carcinoma/ 2025-01-03T17:22:07+00:00 https://ascopost.com/news/january-2025/new-research-approaches-to-metastatic-breast-cancer/ 2025-01-03T17:35:45+00:00 https://ascopost.com/news/january-2025/surgeon-general-s-report-calls-for-cancer-warning-labels-on-alcoholic-beverages/ 2025-01-03T17:45:47+00:00 https://ascopost.com/news/january-2025/trends-in-early-onset-colorectal-cancer/ 2025-01-06T16:40:46+00:00 https://ascopost.com/news/january-2025/advanced-imaging-may-uncover-hidden-metastases-in-high-risk-prostate-cancer-cases/ 2025-01-06T17:46:56+00:00 https://ascopost.com/news/january-2025/psilocybin-based-therapy-may-address-mental-health-issues-in-patients-with-cancer-addiction/ 2025-01-06T17:55:05+00:00 https://ascopost.com/news/january-2025/relativity-047-extended-analysis-of-overall-survival-with-nivolumab-relatlimab-vs-nivolumab-in-previously-untreated-advanced-melanoma/ 2025-01-06T18:08:10+00:00 https://ascopost.com/news/january-2025/hrqol-with-endocrine-therapy-vs-radiotherapy-after-breast-conserving-surgery-in-older-women-with-luminal-a-like-early-breast-cancer/ 2025-01-06T18:14:14+00:00 https://ascopost.com/news/january-2025/glucarpidase-may-improve-recovery-following-methotrexate-induced-kidney-toxicity/ 2025-01-07T16:49:16+00:00 https://ascopost.com/news/january-2025/role-of-cancer-gene-in-esophageal-adenocarcinoma-may-support-paradigm-shift-in-predicting-disease/ 2025-01-07T16:54:51+00:00 https://ascopost.com/news/january-2025/risk-adapted-active-surveillance-after-neoadjuvant-chemotherapy-for-muscle-invasive-bladder-cancer/ 2025-06-27T17:54:09+00:00 https://ascopost.com/news/january-2025/effect-on-ki67-index-of-high-omega-3-low-omega-6-diet-with-fish-oil-in-prostate-cancer-during-active-surveillance/ 2025-01-07T17:07:54+00:00 https://ascopost.com/news/january-2025/oncology-society-urges-americans-to-heed-surgeon-general-s-advisory-on-alcohol-and-cancer/ 2025-01-07T17:12:13+00:00 https://ascopost.com/news/january-2025/nivolumab-plus-avd-as-front-line-therapy-in-older-adults-with-classical-hodgkin-lymphoma/ 2025-01-29T20:31:40+00:00 https://ascopost.com/news/january-2025/final-overall-survival-results-from-solo3-trial-olaparib-vs-nonplatinum-chemotherapy-in-platinum-sensitive-brca-mutated-relapsed-ovarian-cancer/ 2025-01-08T16:07:27+00:00 https://ascopost.com/news/january-2025/study-identifies-potential-new-target-to-overcome-breast-cancer-resistance/ 2025-01-08T15:15:53+00:00 https://ascopost.com/news/january-2025/benefit-of-regular-physical-activity-prior-to-cancer-diagnosis/ 2025-01-08T16:24:52+00:00 https://ascopost.com/news/january-2025/belinda-avalos-begins-term-as-2025-ash-president/ 2025-01-08T18:50:36+00:00 https://ascopost.com/news/january-2025/belzutifan-plus-cabozantinib-as-first-line-treatment-in-advanced-clear-cell-renal-cell-carcinoma/ 2025-06-27T16:28:59+00:00 https://ascopost.com/news/january-2025/use-of-denileukin-diftitox-cxdl-in-relapsed-or-refractory-ctcl/ 2025-01-09T15:10:40+00:00 https://ascopost.com/news/january-2025/novel-tool-for-predicting-response-to-immunotherapy-in-melanoma-under-study/ 2025-01-09T19:47:29+00:00 https://ascopost.com/news/january-2025/new-study-identifies-genes-that-could-be-implicated-in-glioblastoma-in-adulthood/ 2025-01-09T17:23:20+00:00 https://ascopost.com/news/january-2025/improvements-in-brca2-testing-could-enhance-cancer-risk-assessment-patient-care/ 2025-01-09T19:49:46+00:00 https://ascopost.com/news/january-2025/mobility-patterns-and-survival-disparities-in-patients-with-cancer/ 2025-01-09T18:05:17+00:00 https://ascopost.com/news/january-2025/adjuvant-dose-dense-vs-conventional-chemotherapy-in-node-positive-breast-cancer/ 2025-01-10T15:11:10+00:00 https://ascopost.com/news/january-2025/primary-lung-tumor-sbrt-followed-by-mediastinal-chemoradiotherapy-in-locally-advanced-nsclc/ 2025-01-10T15:21:15+00:00 https://ascopost.com/news/january-2025/long-term-follow-up-of-nrg258-trial-adjuvant-chemoradiation-vs-chemotherapy-in-locally-advanced-endometrial-carcinoma/ 2025-01-10T16:51:29+00:00 https://ascopost.com/news/january-2025/oracle-test-may-predict-survival-in-early-stages-of-lung-cancer/ 2025-01-10T17:16:59+00:00 https://ascopost.com/news/january-2025/novel-ai-platform-may-help-identify-patients-likely-to-benefit-most-from-clinical-trials/ 2026-01-07T20:07:05+00:00 https://ascopost.com/news/january-2025/former-unmc-cancer-center-director-kenneth-h-cowan-md-phd-dies-at-77/ 2025-01-10T21:59:46+00:00 https://ascopost.com/news/january-2025/datopotamab-deruxtecan-in-advanced-or-metastatic-nsclc-with-actionable-genomic-alterations/ 2025-01-13T16:58:06+00:00 https://ascopost.com/news/january-2025/medicare-advantage-vs-traditional-medicare-cost-differences-in-cancer-drugs/ 2025-01-13T17:04:36+00:00 https://ascopost.com/news/january-2025/nccn-joins-international-meeting-to-improve-cancer-care-in-the-middle-east-north-africa-region/ 2025-01-13T17:49:08+00:00 https://ascopost.com/news/january-2025/investigators-have-uncovered-global-trends-in-risk-factors-linked-to-lung-cancer-mortality/ 2025-01-13T17:57:15+00:00 https://ascopost.com/news/january-2025/therapeutic-de-escalation-in-breast-cancer-can-omitting-axillary-surgery-match-survival-while-improving-patient-outcomes/ 2025-01-13T20:28:06+00:00 https://ascopost.com/news/january-2025/ai-may-enhance-cervical-cancer-detection/ 2025-01-13T20:34:47+00:00 https://ascopost.com/news/january-2025/effects-of-obesity-on-survival-outcomes-following-cancer-diagnosis-in-pediatric-patients/ 2025-01-14T16:16:22+00:00 https://ascopost.com/news/january-2025/potential-of-rad51-testing-in-tailoring-treatment-strategies-in-early-breast-cancer/ 2025-01-14T16:23:04+00:00 https://ascopost.com/news/january-2025/addition-of-brentuximab-vedotin-to-lenalidomide-rituximab-in-relapsed-or-refractory-dlbcl/ 2025-10-31T16:19:14+00:00 https://ascopost.com/news/january-2025/study-finds-travel-distance-to-lung-cancer-screening-facilities-differs-by-race-and-ethnicity/ 2025-01-14T17:20:13+00:00 https://ascopost.com/news/january-2025/fda-grants-orphan-drug-designation-to-new-agent-for-pancreatic-neuroendocrine-tumors/ 2025-01-14T17:43:42+00:00 https://ascopost.com/news/january-2025/even-low-levels-of-ctdna-may-be-linked-to-recurrence-risk-in-early-lung-cancer-study-finds/ 2025-01-14T18:11:19+00:00 https://ascopost.com/news/january-2025/novel-antibody-drug-conjugate-in-advanced-gastricgastroesophageal-junction-cancer/ 2025-06-27T21:03:51+00:00 https://ascopost.com/news/january-2025/transplant-free-treatment-approach-in-relapsed-classical-hodgkin-lymphoma-in-children-and-adolescents-and-young-adults/ 2025-01-29T20:35:23+00:00 https://ascopost.com/news/january-2025/ecog-acrin-breast-cancer-screening-trial-compares-standard-vs-three-dimensional-mammography/ 2025-01-15T19:37:29+00:00 https://ascopost.com/news/january-2025/pfas-contamination-in-drinking-water-may-be-linked-to-several-rare-cancers/ 2025-01-15T15:39:12+00:00 https://ascopost.com/news/january-2025/fda-proposes-significant-step-to-reduce-nicotine-levels-in-cigarettes-tobacco-products/ 2025-01-15T16:59:20+00:00 https://ascopost.com/news/january-2025/dr-monica-bertagnolli-steps-down-as-nih-director/ 2025-01-15T19:07:21+00:00 https://ascopost.com/news/january-2025/adjuvant-t-dm1-in-patients-with-her2-positive-breast-cancer-long-term-results-of-the-katherine-trial/ 2025-01-16T16:59:12+00:00 https://ascopost.com/news/january-2025/mri-and-biopsy-may-reduce-treatment-delays-for-muscle-invasive-urothelial-carcinoma/ 2025-06-27T17:52:04+00:00 https://ascopost.com/news/january-2025/extent-and-impact-of-primary-mmrd-in-gliomas-among-children-adolescents-and-young-adults/ 2025-01-16T17:24:25+00:00 https://ascopost.com/news/january-2025/trastuzumabpertuzumab-vs-cetuximabirinotecan-in-rasbraf-wild-type-her2-positive-metastatic-colorectal-cancer/ 2025-01-16T19:50:42+00:00 https://ascopost.com/news/january-2025/acs-annual-report-cancer-mortality-rates-decline-but-challenges-remain/ 2025-01-16T19:44:50+00:00 https://ascopost.com/news/january-2025/risks-of-preterm-birth-low-birth-weight-birth-defects-among-children-born-to-young-men-with-cancer/ 2025-06-27T21:02:29+00:00 https://ascopost.com/news/january-2025/aacr-expresses-sincere-appreciation-after-nih-director-monica-m-bertagnolli-md-steps-down/ 2025-01-17T18:27:36+00:00 https://ascopost.com/news/january-2025/fda-approves-sotorasib-with-panitumumab-for-kras-g12c-mutated-colorectal-cancer/ 2025-01-17T19:43:20+00:00 https://ascopost.com/news/january-2025/fulvestrant-vs-anastrozole-in-endocrine-therapy-naive-hr-positive-her2-negative-advanced-breast-cancer/ 2025-01-17T18:30:45+00:00 https://ascopost.com/news/january-2025/fda-approves-datopotamab-deruxtecan-dlnk-for-advanced-hr-positive-her2-negative-breast-cancer/ 2025-01-17T19:47:41+00:00 https://ascopost.com/news/january-2025/asco-thanks-drs-bertagnolli-rathmell-for-their-service-leading-nih-nci/ 2025-01-21T19:08:09+00:00 https://ascopost.com/news/january-2025/new-study-identifies-potential-dose-dependent-relationship-among-alcohol-consumption-hbv-associated-cirrhosis-hepatocellular-carcinoma/ 2025-01-21T16:02:34+00:00 https://ascopost.com/news/january-2025/does-a-new-blood-based-screening-test-accurately-detect-colorectal-cancer-risk/ 2025-02-18T20:07:21+00:00 https://ascopost.com/news/january-2025/everolimuslanreotide-vs-everolimus-in-gastroenteropancreatic-neuroendocrine-tumors/ 2025-06-27T21:01:44+00:00 https://ascopost.com/news/january-2025/telephone-based-therapy-may-reduce-fatigue-interference-with-functioning-in-metastatic-breast-cancer-survivors/ 2025-01-22T17:42:00+00:00 https://ascopost.com/news/january-2025/genomic-classifier-tests-may-influence-treatment-decisions-in-prostate-cancer-despite-lack-of-evidence-for-long-term-outcomes/ 2025-01-22T19:33:12+00:00 https://ascopost.com/news/january-2025/talquetamab-plus-teclistamab-in-relapsed-or-refractory-multiple-myeloma/ 2025-01-22T17:49:30+00:00 https://ascopost.com/news/january-2025/effect-of-kras-mutation-status-on-treatment-outcomes-in-metastatic-pancreatic-adenocarcinoma/ 2025-01-22T17:53:06+00:00 https://ascopost.com/news/january-2025/muscular-strength-cardiorespiratory-fitness-may-be-linked-to-lower-risk-of-mortality-in-patients-with-cancer/ 2025-01-24T16:18:24+00:00 https://ascopost.com/news/january-2025/new-study-highlights-financial-burden-of-medical-equipment-on-cancer-survivors/ 2025-01-24T16:26:09+00:00 https://ascopost.com/news/january-2025/addition-of-lenvatinibpembrolizumab-to-tace-in-unresectable-nonmetastatic-hcc/ 2025-01-24T16:31:22+00:00 https://ascopost.com/news/january-2025/advanced-nsclc-with-brain-metastases-potential-novel-therapeutic-option/ 2025-01-24T17:47:45+00:00 https://ascopost.com/news/january-2025/addition-of-cyclophosphamide-to-posttransplantation-gvhd-prophylaxis/ 2025-01-24T17:54:35+00:00 https://ascopost.com/news/january-2025/eular-balancing-treatment-risks-for-inflammatory-arthritis-and-cancer/ 2025-01-27T16:47:05+00:00 https://ascopost.com/news/january-2025/new-research-explores-blood-test-to-determine-prognosis-benefit-of-celecoxib-in-stage-iii-colon-cancer/ 2025-01-27T16:22:51+00:00 https://ascopost.com/news/january-2025/new-findings-on-aspirin-and-risk-of-colorectal-cancer-recurrence/ 2025-02-13T21:26:10+00:00 https://ascopost.com/news/january-2025/melanoma-among-adult-survivors-of-childhood-cancer/ 2025-01-27T17:03:42+00:00 https://ascopost.com/news/january-2025/novel-combination-targeted-therapies-chemotherapy-in-braf-mutated-metastatic-colorectal-cancer/ 2025-01-27T17:56:52+00:00 https://ascopost.com/news/january-2025/anatomic-lung-resection-may-be-linked-to-improved-survival-in-early-stage-nsclc/ 2025-01-28T19:12:15+00:00 https://ascopost.com/news/january-2025/pinpointing-contributing-factors-in-response-to-posttransplant-donor-lymphocyte-infusion-in-patients-with-aml/ 2025-01-28T19:37:53+00:00 https://ascopost.com/news/january-2025/clearance-of-driver-mutations-after-allogeneic-hematopoietic-stem-cell-transplantation-for-myelofibrosis/ 2025-09-30T19:24:01+00:00 https://ascopost.com/news/january-2025/study-finds-therapeutic-vaccine-targeting-hpv16-is-safe-and-effective-in-eradicating-precancerous-cervical-lesions/ 2025-01-28T17:52:18+00:00 https://ascopost.com/news/january-2025/addition-of-cetuximab-to-postoperative-radiotherapy-in-intermediate-risk-head-and-neck-cancer/ 2026-01-28T17:21:33+00:00 https://ascopost.com/news/january-2025/neoadjuvant-nivolumab-ipilimumab-vs-chemotherapy-in-resectable-nsclc/ 2025-01-29T14:38:01+00:00 https://ascopost.com/news/january-2025/young-patients-with-cancer-living-in-historic-redlined-neighborhoods-are-dying-at-higher-rates-than-those-in-nonredlined-areas/ 2025-01-29T14:48:20+00:00 https://ascopost.com/news/january-2025/uiccs-new-world-cancer-day-campaign-calls-for-fundamental-shift-in-cancer-care-delivery/ 2025-01-29T16:41:00+00:00 https://ascopost.com/news/january-2025/fda-highlights-importance-of-dpd-deficiency-discussions-with-patients-prior-to-capecitabine-or-fluorouracil-treatment/ 2025-01-29T16:47:57+00:00 https://ascopost.com/news/january-2025/perioperative-chemotherapy-vs-preoperative-chemoradiotherapy-in-resectable-locally-advanced-esophageal-carcinoma/ 2025-01-30T17:54:31+00:00 https://ascopost.com/news/january-2025/fecal-microbiota-transplantation-following-asct/ 2025-01-30T16:15:18+00:00 https://ascopost.com/news/january-2025/talimogene-laherparepvec-may-effectively-reduce-basal-cell-carcinoma-size-prior-to-surgical-resection/ 2025-01-30T16:16:30+00:00 https://ascopost.com/news/january-2025/expediting-cancer-diagnoses-with-acoustofluidics/ 2025-01-30T16:21:45+00:00 https://ascopost.com/news/january-2025/tiragolumab-plus-atezolizumab-bevacizumab-in-unresectable-locally-advanced-or-metastatic-hepatocellular-carcinoma/ 2025-01-30T16:45:55+00:00 https://ascopost.com/news/january-2025/checkmate-7fl-neoadjuvant-immunochemotherapy-in-er-positive-her2-negative-breast-cancer/ 2025-01-31T18:10:30+00:00 https://ascopost.com/news/january-2025/tace-and-durvalumabbevacizumab-in-unresectable-hcc/ 2025-01-31T18:06:28+00:00 https://ascopost.com/news/january-2025/does-brain-mri-surveillance-benefit-asymptomatic-patients-with-stage-iv-breast-cancer/ 2025-01-31T15:52:32+00:00 https://ascopost.com/news/january-2025/hereditary-ovarian-cancer-risk-unlocking-new-insights/ 2025-01-31T18:25:36+00:00 https://ascopost.com/news/february-2025/ 2025-02-03T15:02:23+00:00 https://ascopost.com/news/february-2025/salpingectomy-during-other-abdominal-surgeries-may-lower-ovarian-cancer-risk/ 2025-02-03T20:46:38+00:00 https://ascopost.com/news/february-2025/cancer-symptoms-mistaken-for-pregnancy-symptoms-could-lead-to-delays-in-cancer-diagnosis/ 2025-02-03T16:36:57+00:00 https://ascopost.com/news/february-2025/addition-of-bevacizumab-to-pembrolizumab-in-platinum-resistant-recurrent-or-metastatic-nasopharyngeal-carcinoma/ 2026-01-28T17:20:55+00:00 https://ascopost.com/news/february-2025/thermal-ablation-vs-surgical-resection-of-small-resectable-colorectal-liver-metastases/ 2025-02-03T18:49:02+00:00 https://ascopost.com/news/february-2025/chemotherapy-linked-to-chronic-neuropathy-for-4-in-every-10-patients/ 2025-02-03T19:30:11+00:00 https://ascopost.com/news/february-2025/trastuzumab-pertuzumab-plus-eribulin-or-taxane-in-locally-advanced-or-metastatic-breast-cancer/ 2025-02-04T16:21:11+00:00 https://ascopost.com/news/february-2025/rising-advanced-prostate-cancer-rates-in-california-follow-changes-to-recommendations/ 2025-02-04T16:26:59+00:00 https://ascopost.com/news/february-2025/predicting-response-to-kras-g12c-inhibitors-in-nsclc/ 2025-02-04T16:32:56+00:00 https://ascopost.com/news/february-2025/adjuvant-chemotherapy-after-preoperative-mfolfirinox-and-resection-of-localized-pancreatic-adenocarcinoma/ 2025-02-05T15:24:34+00:00 https://ascopost.com/news/february-2025/gastroenteropancreatic-neuroendocrine-tumor-incidence-in-the-united-states/ 2025-02-05T15:22:50+00:00 https://ascopost.com/news/february-2025/neoadjuvant-radiotherapy-may-hamper-immunotherapy-response-in-patients-with-breast-cancer/ 2025-02-05T15:38:44+00:00 https://ascopost.com/news/february-2025/ai-may-boost-efficacy-of-cancer-care-but-physicians-remain-critical-to-decision-making/ 2026-01-07T20:09:21+00:00 https://ascopost.com/news/february-2025/results-from-fire-4-show-liquid-biopsy-can-detect-ras-braf-mutated-metastatic-colorectal-cancer/ 2025-02-06T18:14:36+00:00 https://ascopost.com/news/february-2025/discontinuation-and-resumption-of-larotrectinib-in-pediatric-patients-with-trk-fusion-sarcomas-and-related-mesenchymal-tumors/ 2025-08-25T16:02:20+00:00 https://ascopost.com/news/february-2025/botensilimab-plus-balstilimab-in-relapsed-or-refractory-metastatic-sarcomas/ 2025-08-25T16:00:22+00:00 https://ascopost.com/news/february-2025/potential-link-between-early-side-effects-from-radiation-therapy-and-long-term-side-effects-in-patients-with-prostate-cancer/ 2025-02-06T16:37:34+00:00 https://ascopost.com/news/february-2025/car-t-cell-therapy-not-linked-to-secondary-cancers/ 2025-02-06T16:49:31+00:00 https://ascopost.com/news/february-2025/triplet-for-untreated-tp53-mutated-mantle-cell-lymphoma/ 2025-02-07T16:37:20+00:00 https://ascopost.com/news/february-2025/survival-outcomes-in-patients-with-erbb2-positive-metastatic-breast-cancer-with-cns-involvement/ 2025-02-07T17:07:52+00:00 https://ascopost.com/news/february-2025/is-thyroid-cancer-overdiagnosed/ 2025-02-07T19:29:50+00:00 https://ascopost.com/news/february-2025/new-study-identifies-potential-genes-implicated-in-treatment-resistant-melanoma/ 2025-02-07T19:37:32+00:00 https://ascopost.com/news/february-2025/novel-personalized-cancer-vaccine-may-be-effective-in-patients-with-stage-iii-and-iv-clear-cell-renal-cell-carcinoma/ 2025-06-27T16:17:18+00:00 https://ascopost.com/news/february-2025/using-ai-to-identify-treatment-options-for-castleman-disease/ 2025-02-10T20:11:57+00:00 https://ascopost.com/news/february-2025/trends-in-cancer-incidence-and-mortality-in-appalachia/ 2025-02-10T20:19:27+00:00 https://ascopost.com/news/february-2025/pertuzumab-retreatment-in-her2-positive-locally-advancedmetastatic-breast-cancer/ 2025-02-10T20:22:29+00:00 https://ascopost.com/news/february-2025/adjuvant-t-dm1-vs-trastuzumab-for-residual-her2-positive-breast-cancer-overall-survival-in-katherine/ 2025-02-10T20:24:55+00:00 https://ascopost.com/news/february-2025/anticancer-drug-pharmacokinetics-may-differ-by-sex/ 2025-06-27T20:59:17+00:00 https://ascopost.com/news/february-2025/pain-may-influence-use-of-nonopioid-substances-among-cancer-survivors/ 2025-02-11T20:36:11+00:00 https://ascopost.com/news/february-2025/survey-finds-more-than-half-of-oncologists-are-experiencing-professional-burnout/ 2025-02-11T20:27:33+00:00 https://ascopost.com/news/february-2025/weight-change-and-heart-failure-risk-after-breast-cancer-diagnosis/ 2025-02-11T16:31:57+00:00 https://ascopost.com/news/february-2025/mobile-prostate-cancer-screening-clinic-was-effective-in-detecting-prostate-cancer-in-underserved-men/ 2025-02-13T17:13:11+00:00 https://ascopost.com/news/february-2025/fda-approves-mirdametinib-for-nf1/ 2025-02-11T21:28:38+00:00 https://ascopost.com/news/february-2025/short-vs-standard-course-radiation-therapy-for-endometrial-cancer/ 2025-06-27T20:23:55+00:00 https://ascopost.com/news/february-2025/does-epstein-barr-virus-increase-cancer-risk-among-kidney-transplant-recipients/ 2025-02-12T16:52:45+00:00 https://ascopost.com/news/february-2025/fda-approves-brentuximab-vedotin-with-lenalidomide-and-rituximab-for-relapsed-or-refractory-lbcl/ 2025-10-31T16:17:59+00:00 https://ascopost.com/news/february-2025/mobocertinib-vs-platinum-based-chemotherapy-in-first-line-treatment-of-egfr-exon-20-insertion-positive-metastatic-nsclc/ 2025-02-12T17:14:01+00:00 https://ascopost.com/news/february-2025/intratumoral-injection-of-mrna-2752-and-pembrolizumab-in-high-risk-dcis/ 2025-02-12T17:17:16+00:00 https://ascopost.com/news/february-2025/who-st-jude-launch-new-global-platform-to-deliver-cancer-drugs-to-pediatric-patients-in-low-middle-income-countries/ 2025-02-13T18:15:50+00:00 https://ascopost.com/news/february-2025/ariel4-rucaparib-vs-chemotherapy-for-relapsed-ovarian-cancer-with-deleterious-brca1-or-brca2-mutations/ 2025-06-27T20:20:59+00:00 https://ascopost.com/news/february-2025/triplet-regimen-demonstrates-benefit-in-braf-v600e-mutant-metastatic-colorectal-cancer/ 2025-02-13T21:07:14+00:00 https://ascopost.com/news/february-2025/talazoparib-plus-enzalutamide-significantly-improves-overall-survival-in-prostate-cancer-regardless-of-hrr-gene-status/ 2025-02-13T21:40:57+00:00 https://ascopost.com/news/february-2025/enrgy-trial-zenocutuzumab-for-nrg1-gene-fusion-positive-solid-tumors/ 2025-02-14T16:36:58+00:00 https://ascopost.com/news/february-2025/final-overall-survival-results-from-talapro-2-in-unselected-patients-with-metastatic-castration-resistant-prostate-cancer/ 2025-03-05T16:54:50+00:00 https://ascopost.com/news/february-2025/baseline-liquid-biopsy-vs-tissue-based-findings-in-metastatic-colorectal-cancer/ 2025-02-14T20:07:28+00:00 https://ascopost.com/news/february-2025/association-of-acute-and-late-toxicity-in-radiotherapy-for-prostate-cancer/ 2025-02-14T17:17:19+00:00 https://ascopost.com/news/february-2025/annual-vs-less-frequent-mammographic-surveillance-in-breast-cancer-patients-aged-50-years-or-older/ 2025-02-14T16:43:19+00:00 https://ascopost.com/news/february-2025/novel-blood-test-may-help-to-identify-pancreatic-ductal-adenocarcinoma-at-an-earlier-stage/ 2025-02-14T16:54:43+00:00 https://ascopost.com/news/february-2025/potential-benefit-of-consuming-yogurt-in-decreasing-the-risk-of-certain-types-of-colorectal-cancers/ 2025-02-14T16:24:15+00:00 https://ascopost.com/news/february-2025/ctdna-and-immunoscore-in-resected-stage-iii-colon-cancer/ 2025-02-14T17:00:10+00:00 https://ascopost.com/news/february-2025/colorectal-cancer-treatment-resistance-oncofetal-reprogramming/ 2025-02-14T18:24:11+00:00 https://ascopost.com/news/february-2025/flagellin-and-immune-checkpoint-inhibition-in-patients-with-ovarian-cancer/ 2025-06-27T20:18:56+00:00 https://ascopost.com/news/february-2025/effectiveness-of-immune-checkpoint-inhibitors-in-hospitalized-patients-with-cancer/ 2025-02-18T15:29:04+00:00 https://ascopost.com/news/february-2025/comprehensive-ct-scans-may-help-to-identify-atherosclerosis-among-patients-with-lung-cancer/ 2025-02-18T14:57:47+00:00 https://ascopost.com/news/february-2025/merkel-cell-carcinoma-nivolumab-with-or-without-ipilimumab-in-recurrent-or-metastatic-disease/ 2025-02-18T16:23:17+00:00 https://ascopost.com/news/february-2025/mantle-cell-lymphoma-addition-of-venetoclax-to-ibrutinib/ 2025-02-18T17:53:53+00:00 https://ascopost.com/news/february-2025/vimseltinib-approved-by-the-fda-for-symptomatic-tgct/ 2025-02-18T18:10:23+00:00 https://ascopost.com/news/february-2025/untreated-cll-acalabrutinib-combinations-vs-chemoimmunotherapy/ 2025-06-27T17:25:49+00:00 https://ascopost.com/news/february-2025/safety-of-ceasing-combination-therapy-after-2-years-in-patients-with-renal-cell-carcinoma/ 2025-06-27T16:16:37+00:00 https://ascopost.com/news/february-2025/racial-ethnic-disparities-in-same-day-care-may-exist-following-abnormal-mammograms/ 2025-02-19T18:34:47+00:00 https://ascopost.com/news/february-2025/pembrolizumab-in-previously-treated-advanced-clear-cell-gynecological-cancers/ 2025-06-27T20:10:37+00:00 https://ascopost.com/news/february-2025/combination-immunotherapy-plus-radiotherapy-in-muscle-invasive-bladder-cancer/ 2025-06-27T17:50:57+00:00 https://ascopost.com/news/february-2025/chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma/ 2025-06-27T17:24:41+00:00 https://ascopost.com/news/february-2025/novel-cd19-1xx-car-with-calibrated-signaling-in-lbcl/ 2025-02-19T22:18:24+00:00 https://ascopost.com/news/february-2025/locally-advanced-gastric-cancer-adjuvant-or-perioperative-therapy-with-d2-resection/ 2025-06-27T20:57:53+00:00 https://ascopost.com/news/february-2025/adding-tumor-deposit-status-to-cancer-staging-may-improve-prognostication-in-colorectal-cancer/ 2025-02-20T16:11:19+00:00 https://ascopost.com/news/february-2025/genetic-testing-may-identify-high-risk-cytogenetic-abnormalities-in-patients-with-multiple-myeloma/ 2025-02-20T16:21:53+00:00 https://ascopost.com/news/february-2025/cryotherapy-with-taxane-infusion-strategy-for-preventing-peripheral-neuropathy-in-breast-cancer/ 2025-02-24T15:31:08+00:00 https://ascopost.com/news/february-2025/darolutamide-in-triple-negative-ar-positive-advanced-breast-cancer/ 2025-02-24T15:39:07+00:00 https://ascopost.com/news/february-2025/effect-of-high-risk-cytogenetic-abnormalities-in-multiple-myeloma/ 2025-02-24T15:49:36+00:00 https://ascopost.com/news/february-2025/text-message-platform-may-help-to-address-time-toxicity-in-patients-with-cancer/ 2025-02-24T15:59:56+00:00 https://ascopost.com/news/february-2025/the-death-of-alexei-navalny-and-the-discovery-of-cancer-chemotherapy/ 2025-02-24T16:57:09+00:00 https://ascopost.com/news/february-2025/cancer-mortality-rates-among-black-patients-vs-other-racial-ethnic-groups/ 2025-02-24T16:29:55+00:00 https://ascopost.com/news/february-2025/asco-engages-in-judicial-and-legislative-advocacy-to-protect-nih-funding/ 2025-02-25T15:47:11+00:00 https://ascopost.com/news/february-2025/activity-of-ipilimumab-nivolumab-in-melanoma-brain-metastases-after-progression-on-anti-pd-1-therapy/ 2025-02-25T15:53:15+00:00 https://ascopost.com/news/february-2025/evaluation-of-surrogate-endpoints-for-overall-survival-in-neoadjuvant-randomized-trials-in-early-breast-cancer/ 2025-02-25T16:06:13+00:00 https://ascopost.com/news/february-2025/physical-activity-may-help-colorectal-cancer-survivors-live-as-long-as-those-in-general-population/ 2025-02-25T16:12:14+00:00 https://ascopost.com/news/february-2025/new-study-uncovers-low-uptake-of-supportive-care-at-end-of-life-in-patients-with-advanced-cancer/ 2025-02-25T16:08:37+00:00 https://ascopost.com/news/february-2025/novel-antibody-toxin-conjugate-evaluated-in-early-study/ 2025-02-26T16:41:53+00:00 https://ascopost.com/news/february-2025/brca1-gene-mutations-may-not-be-key-to-prostate-cancer/ 2025-06-27T20:18:20+00:00 https://ascopost.com/news/february-2025/participation-in-early-trials-may-provide-some-patients-with-access-to-cancer-drugs-later-fda-approved/ 2025-02-26T15:21:02+00:00 https://ascopost.com/news/february-2025/cabozantinibatezolizumab-in-locally-advanced-or-metastatic-urothelial-carcinoma/ 2025-06-27T17:49:36+00:00 https://ascopost.com/news/february-2025/tumor-infiltrating-lymphocytes-and-survival-outcomes-in-early-her2-positive-breast-cancer/ 2025-02-27T19:44:54+00:00 https://ascopost.com/news/february-2025/overall-survival-and-hrqol-in-metastatic-castration-resistant-prostate-cancer/ 2025-06-27T20:16:26+00:00 https://ascopost.com/news/february-2025/astro-issues-its-first-clinical-guideline-on-radiation-therapy-for-anal-cancer/ 2025-06-27T20:56:30+00:00 https://ascopost.com/news/february-2025/bacterial-leakage-across-gastric-lining-could-signify-cancer-risk/ 2025-06-27T20:55:47+00:00 https://ascopost.com/news/february-2025/breast-conserving-surgery-may-improve-sexual-well-being-compared-with-postmastectomy-breast-reconstruction/ 2025-02-27T17:05:50+00:00 https://ascopost.com/news/february-2025/ipilimumab-nivolumab-vs-nivolumab-alone-in-melanoma-brain-metastases/ 2025-02-28T14:57:24+00:00 https://ascopost.com/news/february-2025/decoding-varying-risk-of-colorectal-cancer-among-different-steatotic-liver-disease-subgroups/ 2025-02-28T16:33:32+00:00 https://ascopost.com/news/february-2025/combination-of-mcl-1-and-src-inhibitors-may-increase-cell-death-in-aml/ 2025-02-28T16:43:44+00:00 https://ascopost.com/news/march-2025/ 2025-03-03T15:04:09+00:00 https://ascopost.com/news/march-2025/palbociclib-plus-endocrine-therapy-vs-capecitabine-in-hr-positive-her2-negative-metastatic-breast-cancer/ 2025-03-03T17:20:27+00:00 https://ascopost.com/news/march-2025/idecabtagene-vicleucel-vs-ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/ 2025-03-03T17:53:32+00:00 https://ascopost.com/news/march-2025/chemotherapy-endocrine-therapy-may-have-different-long-term-physical-health-effects-in-breast-cancer-survivors/ 2025-03-03T18:04:21+00:00 https://ascopost.com/news/march-2025/novel-prediction-score-may-estimate-risk-of-early-onset-colorectal-cancer-precancerous-polyps/ 2025-03-03T18:27:35+00:00 https://ascopost.com/news/march-2025/francis-collins-retires-from-the-national-institutes-of-health/ 2025-03-04T19:13:02+00:00 https://ascopost.com/news/march-2025/clinical-characteristics-of-breast-cancer-in-young-brca-carriers/ 2025-03-04T15:26:55+00:00 https://ascopost.com/news/march-2025/prophylactic-strategy-for-preventing-infusion-related-reactions-with-iv-amivantamab-in-egfr-mutated-nsclc/ 2025-03-04T15:34:19+00:00 https://ascopost.com/news/march-2025/tattoos-may-be-linked-to-increased-cancer-risk/ 2025-03-04T19:10:48+00:00 https://ascopost.com/news/march-2025/postradiotherapy-survival-in-patients-with-glioblastoma-multiforme-and-low-grade-gliomas/ 2025-03-04T15:45:21+00:00 https://ascopost.com/news/march-2025/mstfcrc-updates-recommendations-for-colonoscopy-preparation/ 2025-03-04T17:05:41+00:00 https://ascopost.com/news/march-2025/overcoming-resistance-to-kras-g12c-inhibitors-in-pancreatic-and-colorectal-cancers/ 2025-06-27T20:53:40+00:00 https://ascopost.com/news/march-2025/trastuzumab-rezetecan-in-advanced-her2-positive-nsclc/ 2025-03-18T17:54:22+00:00 https://ascopost.com/news/march-2025/mrd-based-endpoint-to-support-accelerated-approval-of-treatment-for-multiple-myeloma/ 2025-03-05T15:40:03+00:00 https://ascopost.com/news/march-2025/consumer-survey-reveals-common-misconceptions-about-hpv-and-hpv-related-cancer/ 2025-06-27T20:04:25+00:00 https://ascopost.com/news/march-2025/novel-biomarkers-may-improve-diagnosis-of-gallbladder-cancer/ 2025-03-05T15:59:31+00:00 https://ascopost.com/news/march-2025/combination-of-immunotherapies-for-advanced-hpv-associated-cancers/ 2025-03-06T15:27:52+00:00 https://ascopost.com/news/march-2025/can-plasma-ctdna-kinetics-predict-response-to-systemic-therapy-in-advanced-nsclc/ 2025-06-16T19:09:10+00:00 https://ascopost.com/news/march-2025/outcomes-after-complete-response-to-immunotherapy-in-patients-with-advanced-hepatocellular-carcinoma/ 2025-03-06T15:53:13+00:00 https://ascopost.com/news/march-2025/genetic-factors-could-illuminate-which-patients-with-prostate-cancer-could-benefit-from-combination-of-ipatasertib-abiraterone/ 2025-06-27T20:11:16+00:00 https://ascopost.com/news/march-2025/sglt2-inhibitors-could-help-protect-against-heart-failure-in-patients-with-cancer/ 2025-03-06T18:47:45+00:00 https://ascopost.com/news/march-2025/breast-cancer-mortality-rates-may-have-stopped-declining/ 2025-03-07T15:47:12+00:00 https://ascopost.com/news/march-2025/greater-plant-based-oil-lower-butter-intake-could-improve-risk-of-cancer-related-mortality/ 2025-03-07T16:33:39+00:00 https://ascopost.com/news/march-2025/acs-awards-dr-w-kimryn-rathmell-the-2025-medal-of-honor/ 2025-03-10T16:23:56+00:00 https://ascopost.com/news/march-2025/clonal-and-subclonal-pathogenic-alterations-at-diagnosis-in-high-risk-neuroblastoma/ 2025-03-10T14:28:47+00:00 https://ascopost.com/news/march-2025/chemoimmunotherapy-approach-for-advanced-hpv-negative-head-and-neck-cancer/ 2026-01-28T17:18:11+00:00 https://ascopost.com/news/march-2025/novel-nanoliposome-radiotherapeutic-may-enhance-survival-in-patients-with-glioblastoma/ 2025-03-10T16:13:08+00:00 https://ascopost.com/news/march-2025/cancer-incidence-and-mortality-in-southeast-asia-for-2022/ 2025-03-11T15:55:50+00:00 https://ascopost.com/news/march-2025/addition-of-adt-to-sbrt-in-hormone-sensitive-oligorecurrent-prostate-cancer/ 2025-06-27T20:05:02+00:00 https://ascopost.com/news/march-2025/liquid-biopsies-could-help-guide-colorectal-cancer-treatment/ 2025-03-11T16:51:25+00:00 https://ascopost.com/news/march-2025/two-initiatives-could-help-increase-oncogene-testing-in-primary-care-settings/ 2025-03-11T16:59:54+00:00 https://ascopost.com/news/march-2025/addition-of-pembrolizumab-to-chemotherapy-for-previously-treated-metastatic-castration-resistant-prostate-cancer/ 2025-06-27T19:59:47+00:00 https://ascopost.com/news/march-2025/genomic-differences-and-treatment-inequities-in-black-and-white-patients-with-metastatic-breast-cancer/ 2025-03-12T14:14:58+00:00 https://ascopost.com/news/march-2025/study-finds-wildfires-pose-health-threat-for-patients-recovering-from-lung-cancer-surgery/ 2025-06-16T19:07:31+00:00 https://ascopost.com/news/march-2025/moderate-to-vigorous-physical-activity-may-lower-risk-of-cardiovascular-disease-related-mortality-in-women-with-cancer-history/ 2025-03-12T15:27:13+00:00 https://ascopost.com/news/march-2025/firefighters-may-face-higher-risk-of-gliomas-associated-with-gene-mutations-caused-by-haloalkanes/ 2025-03-12T15:31:30+00:00 https://ascopost.com/news/march-2025/impact-of-duration-of-neoadjuvant-immunotherapy-in-mmrd-colorectal-cancer/ 2025-03-13T14:29:04+00:00 https://ascopost.com/news/march-2025/association-of-pathogenic-variants-in-atm-chek2-or-palb2-with-cancer-mortality/ 2025-03-13T20:33:46+00:00 https://ascopost.com/news/march-2025/breakthrough-combination-therapy-could-help-avoid-drug-resistance-in-patients-with-kras-mutated-nsclc/ 2025-06-16T19:03:29+00:00 https://ascopost.com/news/march-2025/cervical-precancer-incidence-decreases-as-hpv-vaccination-rates-rise/ 2025-06-27T20:03:23+00:00 https://ascopost.com/news/march-2025/genomic-study-reveals-similarities-differences-in-ovarian-cancer-mutations-among-black-white-patients/ 2025-06-27T19:56:56+00:00 https://ascopost.com/news/march-2025/neoadjuvant-combination-immunotherapy-for-head-and-neck-cancer/ 2026-01-28T17:16:58+00:00 https://ascopost.com/news/march-2025/pembrolizumab-and-bevacizumab-in-untreated-melanoma-brain-metastases/ 2025-03-17T19:25:28+00:00 https://ascopost.com/news/march-2025/atezolizumab-plus-carboplatin-paclitaxel-in-advanced-thymic-carcinoma/ 2025-03-17T15:35:02+00:00 https://ascopost.com/news/march-2025/advances-in-endometrial-cancer-detection-treatment/ 2025-06-27T19:46:54+00:00 https://ascopost.com/news/march-2025/bvac-c-plus-durvalumab-may-show-potential-in-patients-with-recurrent-cervical-cancer/ 2025-06-27T19:54:53+00:00 https://ascopost.com/news/march-2025/mrd-and-adjuvant-osimertinib-in-resected-egfr-mutated-stage-ib-iiia-nsclc/ 2025-06-16T18:59:41+00:00 https://ascopost.com/news/march-2025/do-congenital-heart-defects-affect-cancer-risk-in-newborns-and-their-mothers/ 2025-03-17T18:47:45+00:00 https://ascopost.com/news/march-2025/radiotherapy-alone-following-radical-hysterectomy-for-cervical-cancer/ 2025-06-27T19:41:51+00:00 https://ascopost.com/news/march-2025/cervical-cancer-outcomes-according-to-urban-vs-rural-residence/ 2025-06-27T19:37:17+00:00 https://ascopost.com/news/march-2025/high-risk-rhabdomyosarcoma-long-term-outcomes-with-maintenance-chemotherapy/ 2025-08-25T15:57:28+00:00 https://ascopost.com/news/march-2025/receipt-of-guideline-concordant-care-in-patients-with-inflammatory-breast-cancer/ 2025-03-18T15:39:29+00:00 https://ascopost.com/news/march-2025/the-real-cost-campaign-may-have-prevented-thousands-of-youths-from-initiating-e-cigarette-use/ 2025-03-18T15:46:17+00:00 https://ascopost.com/news/march-2025/race-associated-molecular-differences-and-treatment-response-in-pancreatic-cancer/ 2025-03-19T16:41:46+00:00 https://ascopost.com/news/march-2025/exercise-intervention-may-improve-sexual-dysfunction-in-men-with-prostate-cancer/ 2025-06-27T19:57:36+00:00 https://ascopost.com/news/march-2025/triple-negative-breast-cancer-neoadjuvant-nivolumab-initiation/ 2025-03-19T18:30:45+00:00 https://ascopost.com/news/march-2025/checking-psa-levels-too-soon-after-prostatectomy-may-lead-to-overtreatment/ 2025-06-27T19:54:28+00:00 https://ascopost.com/news/march-2025/definitive-radiation-therapy-effectively-treats-locally-advanced-bcc/ 2025-03-19T18:33:06+00:00 https://ascopost.com/news/march-2025/techniques-for-preventing-taxane-induced-neuropathy-in-breast-cancer/ 2025-03-19T20:31:15+00:00 https://ascopost.com/news/march-2025/fda-approves-pembrolizumab-for-her2-positive-gastric-or-gej-cancer-expressing-pd-l1/ 2025-06-27T20:53:12+00:00 https://ascopost.com/news/march-2025/advanced-pd-l1-positive-nsclc-ivonescimab-vs-pembrolizumab/ 2025-06-16T18:56:51+00:00 https://ascopost.com/news/march-2025/ai-tool-may-help-to-predict-which-patients-with-prostate-cancer-may-benefit-from-focal-therapy/ 2026-01-07T19:57:01+00:00 https://ascopost.com/news/march-2025/misconceptions-regarding-skin-cancer-risk-in-the-united-states/ 2025-09-02T20:49:20+00:00 https://ascopost.com/news/march-2025/advanced-refractory-melanoma-addition-of-tilsotolimod-to-ipilimumab/ 2025-09-02T20:45:57+00:00 https://ascopost.com/news/march-2025/can-adding-antihistamines-to-second-line-therapy-improve-outcomes-in-advanced-urothelial-carcinoma/ 2025-06-27T17:44:17+00:00 https://ascopost.com/news/march-2025/colorectal-cancer-may-be-linked-to-heightened-risk-of-cardiovascular-mortality/ 2025-03-21T14:52:39+00:00 https://ascopost.com/news/march-2025/high-levels-of-ptsd-may-exist-among-caregivers-of-adult-patients-with-cancer/ 2025-03-21T14:59:30+00:00 https://ascopost.com/news/march-2025/virtual-reality-therapy-may-improve-chemotherapy-associated-side-effects/ 2025-03-25T14:49:02+00:00 https://ascopost.com/news/march-2025/novel-strategy-could-help-recover-erectile-function-following-prostate-cancer-surgery/ 2025-06-27T19:46:25+00:00 https://ascopost.com/news/march-2025/can-a-urine-test-minimize-postoperative-scans-for-rcc-recurrence/ 2025-06-27T15:44:49+00:00 https://ascopost.com/news/march-2025/tb-vaccination-could-enhance-bcg-response-in-patients-with-non-muscle-invasive-bladder-cancer-study-finds/ 2025-06-27T17:43:05+00:00 https://ascopost.com/news/march-2025/microultrasound-vs-mri-guided-biopsy-for-prostate-cancer-diagnosis/ 2025-06-27T19:44:24+00:00 https://ascopost.com/news/march-2025/her2-selective-tki-in-advanced-solid-tumors-with-her2-alterations/ 2025-03-26T20:34:47+00:00 https://ascopost.com/news/march-2025/sex-differences-in-waist-circumference-vs-bmi-as-risk-factors-for-obesity-related-cancers/ 2025-03-26T17:05:20+00:00 https://ascopost.com/news/march-2025/hypofractionated-radiotherapy-in-prostate-cancer/ 2025-03-26T17:12:14+00:00 https://ascopost.com/news/march-2025/are-new-onset-type-2-diabetes-and-obesity-related-cancers-linked/ 2025-03-26T17:16:24+00:00 https://ascopost.com/news/march-2025/fda-approves-cabozantinib-for-pnet-and-epnet/ 2025-03-26T14:28:55+00:00 https://ascopost.com/news/march-2025/delays-in-breast-cancer-surgery-could-raise-mortality-risk-for-certain-subtypes/ 2025-06-13T21:05:14+00:00 https://ascopost.com/news/march-2025/lifetime-body-weight-patterns-could-affect-risk-of-developing-renal-cell-carcinoma/ 2025-06-27T15:56:58+00:00 https://ascopost.com/news/march-2025/enfortumab-vedotin-based-approaches-to-metastatic-urothelial-carcinoma/ 2025-06-27T17:45:30+00:00 https://ascopost.com/news/march-2025/adjuvant-chemoradiotherapy-vs-radiotherapy-alone-in-intermediate-risk-cervical-cancer/ 2025-06-27T19:24:22+00:00 https://ascopost.com/news/march-2025/interventions-to-improve-uptake-of-fit-colorectal-cancer-screening-in-scotland/ 2025-03-27T20:08:30+00:00 https://ascopost.com/news/march-2025/age-et-persistence-and-disease-free-survival-in-hr-positive-early-breast-cancer/ 2025-06-13T20:59:00+00:00 https://ascopost.com/news/march-2025/early-stage-nsclc-geographic-access-to-cancer-care-and-outcomes/ 2025-03-28T14:36:44+00:00 https://ascopost.com/news/march-2025/prevalence-of-genetic-testing-in-women-with-ovarian-cancer/ 2025-06-27T19:11:33+00:00 https://ascopost.com/news/march-2025/novel-limonene-lipid-formulation-may-help-alleviate-xerostomia-in-patients-with-cancer/ 2026-01-28T17:10:14+00:00 https://ascopost.com/news/march-2025/health-related-qol-with-belzutifan-vs-everolimus-in-advanced-renal-cell-carcinoma/ 2025-06-27T15:52:04+00:00 https://ascopost.com/news/march-2025/neoadjuvant-nivolumab-plus-chemotherapy-and-response-stratified-crt-in-hpv-negative-head-and-neck-cancer/ 2026-01-28T17:06:01+00:00 https://ascopost.com/news/march-2025/tobacco-control-may-have-prevented-millions-of-premature-lung-cancer-deaths-in-united-states/ 2025-06-16T18:53:01+00:00 https://ascopost.com/news/march-2025/parker-institute-for-cancer-immunotherapy-names-new-ceo/ 2025-03-31T18:49:29+00:00 https://ascopost.com/news/april-2025/ 2025-04-01T13:17:18+00:00 https://ascopost.com/news/april-2025/active-surveillance-vs-standard-surgery-after-complete-response-to-neoadjuvant-chemoradiotherapy-in-esophageal-cancer/ 2025-06-27T20:51:50+00:00 https://ascopost.com/news/april-2025/presymptomatic-awareness-of-brca1brca2-status-and-outcomes-in-ovarian-cancer/ 2025-06-27T19:15:27+00:00 https://ascopost.com/news/april-2025/could-brain-imaging-plus-vr-minimize-cancer-related-pain/ 2025-04-01T15:22:34+00:00 https://ascopost.com/news/april-2025/daily-physical-activity-even-at-light-intensities-may-reduce-cancer-risk/ 2025-04-01T15:25:39+00:00 https://ascopost.com/news/april-2025/low-dose-ct-screening-for-lung-cancer-in-a-high-risk-population/ 2025-06-16T18:50:44+00:00 https://ascopost.com/news/april-2025/accelerated-onset-of-aging-related-diseases-in-childhood-cancer-survivors/ 2025-04-02T14:41:41+00:00 https://ascopost.com/news/april-2025/breast-shrinkage-following-breast-conserving-therapy/ 2025-06-13T20:56:29+00:00 https://ascopost.com/news/april-2025/treatment-discontinuation-in-patients-with-cml-role-of-digital-pcr/ 2025-04-02T14:54:53+00:00 https://ascopost.com/news/april-2025/neoadjuvant-durvalumab-plus-chemotherapy-for-high-risk-upper-tract-urothelial-carcinoma/ 2025-06-30T17:19:29+00:00 https://ascopost.com/news/april-2025/patterns-in-adherence-to-uspstf-lung-cancer-screening-guidelines/ 2025-06-16T18:36:52+00:00 https://ascopost.com/news/april-2025/machine-learning-program-may-enhance-transplantation-risk-assessment-in-patients-with-myelofibrosis/ 2026-01-07T19:52:47+00:00 https://ascopost.com/news/april-2025/exploring-impact-of-covid-19-pandemic-on-colorectal-cancer-screening-diagnosis/ 2025-04-03T14:39:18+00:00 https://ascopost.com/news/april-2025/smoking-status-of-the-us-cancer-population/ 2025-04-04T16:40:58+00:00 https://ascopost.com/news/april-2025/local-excision-may-be-feasible-in-patients-with-low-rectal-adenocarcinoma/ 2025-04-04T19:00:15+00:00 https://ascopost.com/news/april-2025/awareness-of-alcohol-related-cancer-risks-may-be-growing/ 2025-04-04T14:52:56+00:00 https://ascopost.com/news/april-2025/is-surgery-necessary-to-treat-invasive-breast-cancer/ 2025-04-04T18:58:43+00:00 https://ascopost.com/news/april-2025/grocery-store-choice-could-impact-obesity-related-cancer-mortality/ 2025-04-07T16:17:06+00:00 https://ascopost.com/news/april-2025/characteristics-of-nasopharyngeal-carcinoma-in-the-united-states/ 2026-01-28T17:02:29+00:00 https://ascopost.com/news/april-2025/comparing-biopsy-techniques-for-prostate-cancer-detection/ 2025-06-27T19:40:14+00:00 https://ascopost.com/news/april-2025/rates-of-breast-crc-screenings-almost-four-times-higher-than-lung-cancer-screenings/ 2025-06-16T21:04:27+00:00 https://ascopost.com/news/april-2025/study-identifies-biologic-reasons-for-selective-benefit-of-parp-inhibitors/ 2025-04-08T13:23:33+00:00 https://ascopost.com/news/april-2025/nk-cells-complexed-with-bispecific-antibody-may-be-of-benefit-to-patients-with-lymphoma/ 2025-04-08T18:08:54+00:00 https://ascopost.com/news/april-2025/patterns-of-ici-use-and-survival-outcomes-in-metastatic-colorectal-cancer/ 2025-06-30T16:18:09+00:00 https://ascopost.com/news/april-2025/patient-reported-outcomes-with-mirvetuximab-soravtansine-vs-chemotherapy-in-ovarian-cancer/ 2025-06-27T19:10:05+00:00 https://ascopost.com/news/april-2025/preclinical-study-finds-fgfr2-inhibition-may-prevent-some-kras-expressing-pancreatic-cancers/ 2025-04-08T16:06:58+00:00 https://ascopost.com/news/april-2025/talazoparib-plus-enzalutamide-in-advanced-prostate-cancer-patient-reported-outcomes/ 2025-06-27T19:37:56+00:00 https://ascopost.com/news/april-2025/rescue-therapy-for-newly-diagnosed-high-grade-osteosarcoma/ 2025-08-25T15:21:19+00:00 https://ascopost.com/news/april-2025/crossing-state-borders-addressing-residential-barriers-to-cancer-care/ 2025-04-09T14:51:34+00:00 https://ascopost.com/news/april-2025/prostate-cancer-biomarker-test-may-predict-gu-toxicity-from-sbrt/ 2025-06-27T19:35:37+00:00 https://ascopost.com/news/april-2025/frailty-following-chemotherapy-may-be-linked-to-poorer-survival-in-older-women-with-breast-cancer/ 2025-06-16T21:03:17+00:00 https://ascopost.com/news/april-2025/american-cancer-society-launches-ceo-search/ 2025-04-10T13:20:22+00:00 https://ascopost.com/news/april-2025/study-illuminates-disparities-in-treatment-survival-in-metastatic-pancreatic-ductal-adenocarcinoma/ 2025-04-10T13:55:30+00:00 https://ascopost.com/news/april-2025/invitation-to-colonoscopy-vs-fecal-immunochemical-test-screening-for-colorectal-cancer/ 2025-06-30T16:07:10+00:00 https://ascopost.com/news/april-2025/pausing-vs-continuing-btk-inhibitors-at-time-of-covid-19-vaccination-in-patients-with-cll/ 2025-06-27T17:18:26+00:00 https://ascopost.com/news/april-2025/low-dose-vs-regular-dose-apixaban-for-prevention-of-vte-recurrence-in-patients-with-cancer/ 2025-04-11T17:04:22+00:00 https://ascopost.com/news/april-2025/fda-approves-nivolumab-plus-ipilimumab-for-unresectable-or-metastatic-hcc/ 2025-04-11T16:57:59+00:00 https://ascopost.com/news/april-2025/neoantigen-selected-tils-boost-response-to-immunotherapy-in-heavily-pretreated-gi-cancers/ 2025-04-11T19:12:51+00:00 https://ascopost.com/news/april-2025/novel-strategy-may-enhance-sensitivity-of-monitoring-cancer-in-blood-samples/ 2025-09-16T18:29:03+00:00 https://ascopost.com/news/april-2025/metastatic-castration-resistant-prostate-cancer-immune-modulating-adc-targeting-cd46/ 2025-06-27T19:33:28+00:00 https://ascopost.com/news/april-2025/ideal-apixaban-dose-for-cancer-associated-vte/ 2025-04-14T16:31:17+00:00 https://ascopost.com/news/april-2025/fda-approves-bevacizumab-biosimilar/ 2025-06-27T18:54:24+00:00 https://ascopost.com/news/april-2025/most-pediatric-cancer-deaths-occur-in-regions-of-conflict/ 2025-04-14T16:56:57+00:00 https://ascopost.com/news/april-2025/immunotherapy-radiosurgery-combination-and-risk-of-radiation-necrosis-in-patients-with-cancer-who-have-brain-metastases/ 2025-09-02T20:42:09+00:00 https://ascopost.com/news/april-2025/link-between-ct-scans-and-future-cancer-incidence/ 2025-04-15T14:37:22+00:00 https://ascopost.com/news/april-2025/incidence-rates-of-colorectal-and-pancreatic-cancers-are-rising-most-among-young-adults/ 2025-06-30T16:02:25+00:00 https://ascopost.com/news/april-2025/pediatric-all-or-lymphoblastic-lymphoma-reduced-induction-dexamethasone-and-high-dose-methotrexate/ 2025-10-03T14:04:42+00:00 https://ascopost.com/news/april-2025/adar1-gene-and-response-to-lenalidomide-in-patients-with-multiple-myeloma/ 2025-04-15T17:11:06+00:00 https://ascopost.com/news/april-2025/novel-drug-device-combination-may-improve-outcomes-in-metastatic-uveal-melanoma/ 2025-04-16T15:18:55+00:00 https://ascopost.com/news/april-2025/parasitic-infection-and-its-treatment-linked-to-cancer-related-gene-activity-in-the-cervix/ 2025-06-27T18:46:23+00:00 https://ascopost.com/news/april-2025/neoadjuvant-chemotherapy-for-resectable-pancreatic-cancer/ 2025-04-16T16:44:33+00:00 https://ascopost.com/news/april-2025/can-ctdna-monitoring-help-to-predict-melanoma-recurrence/ 2025-09-02T20:40:28+00:00 https://ascopost.com/news/april-2025/germline-variants-may-impact-unique-nature-of-patients-cancer/ 2025-04-16T17:59:26+00:00 https://ascopost.com/news/april-2025/dual-use-of-cigarettes-and-e-cigarettes-on-par-with-sole-cigarette-use-in-terms-of-toxic-exposure/ 2025-06-16T18:35:52+00:00 https://ascopost.com/news/april-2025/poor-agreement-reported-among-diagnostic-tests-for-breast-cancer-related-lymphedema/ 2025-06-16T21:02:08+00:00 https://ascopost.com/news/april-2025/advanced-esophageal-cancer-notch1-mutation-and-efficacy-of-immunotherapy/ 2025-04-17T14:08:20+00:00 https://ascopost.com/news/april-2025/how-does-medicaid-expansion-affect-access-to-care-in-patients-with-nsclc/ 2025-06-16T18:34:33+00:00 https://ascopost.com/news/april-2025/metabolic-syndrome-may-increase-risk-of-cancer-recurrence-subsequent-mortality-among-breast-cancer-survivors/ 2025-06-16T20:59:52+00:00 https://ascopost.com/news/april-2025/early-life-exposure-to-environmental-carcinogens-may-increase-risk-of-pediatric-papillary-thyroid-cancer/ 2025-04-18T17:17:09+00:00 https://ascopost.com/news/april-2025/activity-of-ros1-tki-in-nsclc/ 2025-06-16T18:33:31+00:00 https://ascopost.com/news/april-2025/cap-issues-new-and-updated-cancer-protocols/ 2025-06-16T20:58:32+00:00 https://ascopost.com/news/april-2025/some-patients-with-advanced-nsclc-experience-durable-disease-control-after-immunotherapy-discontinuation/ 2025-06-16T18:31:56+00:00 https://ascopost.com/news/april-2025/patient-support-found-for-ai-use-as-second-reader-of-mammograms/ 2026-01-07T19:51:56+00:00 https://ascopost.com/news/april-2025/updated-cap-guideline-aims-to-address-rising-rates-of-hpv-associated-squamous-cell-carcinomas/ 2026-01-28T17:01:20+00:00 https://ascopost.com/news/april-2025/adaptive-manufactured-lentiviral-anti-cd20-anti-cd19-car-t-cells-in-relapsed-refractory-mantle-cell-lymphoma/ 2025-05-28T19:27:23+00:00 https://ascopost.com/news/april-2025/2024-annual-report-to-the-nation-on-the-status-of-cancer-released/ 2025-04-21T16:32:47+00:00 https://ascopost.com/news/april-2025/detecting-invasive-nodules-could-be-key-to-preventing-unnecessary-pancreatic-cancer-surgery/ 2025-04-22T14:25:32+00:00 https://ascopost.com/news/april-2025/claim-denials-for-medicare-cancer-related-ngs-testing-show-uncertainty-of-coverage/ 2025-04-22T16:51:58+00:00 https://ascopost.com/news/april-2025/role-of-pathologists-in-improving-access-to-safer-more-effective-allogeneic-cell-therapies/ 2025-04-22T14:44:38+00:00 https://ascopost.com/news/april-2025/extended-follow-up-of-belzutifan-treatment-for-von-hippel-lindau-disease-associated-rcc/ 2025-06-27T15:50:44+00:00 https://ascopost.com/news/april-2025/radiotherapy-dosing-for-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T16:59:47+00:00 https://ascopost.com/news/april-2025/response-to-immune-checkpoint-inhibitors-not-affected-by-age/ 2025-04-23T13:55:33+00:00 https://ascopost.com/news/april-2025/addition-of-daratumumab-to-treatment-regimen-in-transplant-ineligible-newly-diagnosed-multiple-myeloma/ 2025-04-23T14:57:23+00:00 https://ascopost.com/news/april-2025/benefits-of-walnut-consumption-curbing-inflammation-colorectal-cancer-risk/ 2025-06-30T15:59:58+00:00 https://ascopost.com/news/april-2025/polygenic-risk-score-for-prostate-cancer-screening/ 2025-06-27T19:31:06+00:00 https://ascopost.com/news/april-2025/whi-funding-future-unclear/ 2025-04-25T14:01:53+00:00 https://ascopost.com/news/april-2025/w-kimryn-rathmell-named-ceo-of-the-ohio-state-james-cancer-hospital-and-solove-research-institute/ 2025-04-24T19:39:47+00:00 https://ascopost.com/news/april-2025/use-of-statins-in-cllsll/ 2025-06-27T17:15:17+00:00 https://ascopost.com/news/april-2025/childhood-exposure-to-bacterial-toxin-may-trigger-early-onset-colorectal-cancer/ 2025-06-30T15:57:32+00:00 https://ascopost.com/news/april-2025/omission-of-endocrine-therapy-in-estrogen-receptor-low-early-stage-breast-cancer/ 2025-06-16T20:50:50+00:00 https://ascopost.com/news/april-2025/addition-of-neoadjuvant-adjuvant-pembrolizumab-significantly-improves-outcomes-in-locally-advanced-hnscc/ 2026-01-28T16:55:34+00:00 https://ascopost.com/news/april-2025/nonoperative-management-of-mismatch-repair-deficient-tumors/ 2025-04-28T18:19:42+00:00 https://ascopost.com/news/april-2025/use-of-ctdna-based-liquid-biopsy-assay-in-resectable-colorectal-cancer/ 2025-06-30T15:56:04+00:00 https://ascopost.com/news/april-2025/zoldonrasib-may-elicit-objective-responses-in-patients-with-kras-g12d-mutated-nsclc/ 2025-06-16T18:24:21+00:00 https://ascopost.com/news/april-2025/off-the-shelf-natural-killer-car-therapy-active-in-hematologic-malignancies/ 2025-10-03T14:23:16+00:00 https://ascopost.com/news/april-2025/aacr-2025-oral-her2-targeted-therapy-for-advanced-her2-mutated-lung-cancer/ 2025-06-16T18:22:13+00:00 https://ascopost.com/news/april-2025/novel-targeted-therapy-under-study-in-selected-patients-with-advanced-solid-tumors/ 2025-04-29T16:15:33+00:00 https://ascopost.com/news/april-2025/survival-outcomes-may-improve-when-treatment-is-guided-by-using-both-tissue-and-liquid-biopsies/ 2025-04-29T19:09:31+00:00 https://ascopost.com/news/april-2025/pretrained-ai-models-could-help-accurately-diagnose-nonmelanoma-skin-cancers-in-resource-limited-settings/ 2026-01-07T19:48:12+00:00 https://ascopost.com/news/april-2025/ai-driven-model-for-identifying-cancer-cachexia/ 2025-06-27T18:40:08+00:00 https://ascopost.com/news/april-2025/sex-disparities-identified-in-fatigue-and-depression-for-cancer-survivors/ 2025-04-30T18:00:43+00:00 https://ascopost.com/news/april-2025/ai-driven-analysis-of-digital-pathology-images-may-improve-sarcoma-subtyping-among-pediatric-patients/ 2025-08-25T15:14:41+00:00 https://ascopost.com/news/april-2025/topical-braf-inhibitor-under-study-for-managing-acneiform-rash/ 2025-04-30T15:31:02+00:00 https://ascopost.com/news/april-2025/molecularly-selected-tumor-agnostic-phase-ii-trial-focuses-on-combination-therapy/ 2025-04-30T15:22:53+00:00 https://ascopost.com/news/april-2025/using-single-cell-rna-sequencing-to-evaluate-cell-states-in-aml/ 2025-04-30T15:04:42+00:00 https://ascopost.com/news/may-2025/ 2025-04-30T19:55:17+00:00 https://ascopost.com/news/may-2025/genetic-mutations-linked-to-worse-stomach-cancer-outcomes/ 2025-06-27T20:50:19+00:00 https://ascopost.com/news/may-2025/20-year-screening-program-drives-down-colorectal-cancer-cases-deaths/ 2025-06-30T15:51:47+00:00 https://ascopost.com/news/may-2025/novel-car-t-cell-therapy-induces-response-in-patients-with-advanced-thyroid-cancers/ 2025-05-01T13:57:26+00:00 https://ascopost.com/news/may-2025/2025-acs-cancer-prevention-early-detection-report-cancer-screening-rates-modifiable-risk-factors/ 2025-05-01T14:48:25+00:00 https://ascopost.com/news/may-2025/cannabis-use-disorder-significantly-increases-mortality-risk-in-colorectal-cancer/ 2025-06-30T15:50:11+00:00 https://ascopost.com/news/may-2025/use-of-ruxolitinib-to-resolve-ciltacabtagene-autoleucel-induced-parkinsonism-in-patients-with-multiple-myeloma/ 2025-05-02T15:15:47+00:00 https://ascopost.com/news/may-2025/use-of-ruxolitinib-to-resolve-ciltacabtagene-autoleucel-induced-parkinsonism-in-patients-with-multiple-myeloma/summary/ 2025-05-06T17:49:23+00:00 https://ascopost.com/news/may-2025/use-of-ruxolitinib-to-resolve-ciltacabtagene-autoleucel-induced-parkinsonism-in-patients-with-multiple-myeloma/notecards/ 2025-05-06T17:52:52+00:00 https://ascopost.com/news/may-2025/malaria-subtype-may-be-linked-to-development-of-burkitt-lymphoma/ 2025-05-02T15:23:47+00:00 https://ascopost.com/news/may-2025/adavosertib-in-recurrent-or-persistent-uterine-serous-carcinoma/ 2025-06-27T18:38:21+00:00 https://ascopost.com/news/may-2025/use-of-cad-cam-may-improve-jaw-reconstruction-outcomes-among-patients-with-head-and-neck-cancer/ 2026-01-28T16:54:23+00:00 https://ascopost.com/news/may-2025/dose-escalation-of-fluorodeoxyglucose-pet-guided-radiotherapy-for-locally-advanced-nsclc/ 2025-06-16T18:16:02+00:00 https://ascopost.com/news/may-2025/aml-mrd-testing-led-to-survival-benefits-in-subset-of-patients/ 2025-05-06T16:56:05+00:00 https://ascopost.com/news/may-2025/financial-toxicity-tumor-board-can-it-reduce-treatment-costs/ 2025-05-05T16:04:30+00:00 https://ascopost.com/news/may-2025/anal-cancer-rates-rising-most-among-older-white-and-hispanic-women/ 2025-06-27T20:49:48+00:00 https://ascopost.com/news/may-2025/early-stage-stomach-cancer-diagnoses-on-the-rise/ 2025-05-05T19:19:20+00:00 https://ascopost.com/news/may-2025/cancer-briefs-from-digestive-disease-week-2025/ 2025-06-27T20:46:59+00:00 https://ascopost.com/news/may-2025/new-treatment-approach-could-enhance-care-for-aggressive-relapsed-refractory-t-and-nk-cell-lymphomas/ 2025-05-06T19:53:03+00:00 https://ascopost.com/news/may-2025/smoking-cessation-may-be-critical-to-mitigate-burden-of-second-primary-cancers/ 2025-05-06T19:51:52+00:00 https://ascopost.com/news/may-2025/five-major-advances-in-radiotherapy-for-anal-and-rectal-cancer-presented-at-estro-2025/ 2025-06-30T15:47:05+00:00 https://ascopost.com/news/may-2025/molecular-profiling-may-optimize-treatment-for-endometrial-cancer/ 2025-06-27T18:37:48+00:00 https://ascopost.com/news/may-2025/influence-of-aca-on-breast-reconstruction-disparities/ 2025-06-16T20:49:06+00:00 https://ascopost.com/news/may-2025/hiv-related-structural-barriers-in-cancer-care/ 2025-06-16T18:19:36+00:00 https://ascopost.com/news/may-2025/symptoms-preceding-unplanned-acute-care-in-patients-with-cancer/ 2025-05-07T15:09:12+00:00 https://ascopost.com/news/may-2025/outcomes-with-hsct-in-pediatric-high-risk-aml/ 2025-06-05T18:00:24+00:00 https://ascopost.com/news/may-2025/survival-trends-in-melanoma-brain-metastases-update-of-melanoma-graded-prognostic-assessment/ 2025-09-02T20:35:59+00:00 https://ascopost.com/news/may-2025/ablative-radiation-therapy-for-resectable-pancreatic-ductal-adenocarcinoma/ 2025-05-08T21:12:17+00:00 https://ascopost.com/news/may-2025/breast-cancer-radiotherapy-1-vs-3-week-course/ 2025-06-16T20:47:38+00:00 https://ascopost.com/news/may-2025/collaborative-strategy-involving-ai-human-task-sharing-could-help-minimize-mammogram-costs/ 2025-10-30T14:31:01+00:00 https://ascopost.com/news/may-2025/patterns-in-oncology-drug-use-after-accelerated-approval-is-withdrawn/ 2025-05-08T21:07:37+00:00 https://ascopost.com/news/may-2025/early-onset-breast-colorectal-endometrial-pancreatic-and-kidney-cancers-on-the-rise/ 2025-05-12T14:22:35+00:00 https://ascopost.com/news/may-2025/early-onset-breast-colorectal-endometrial-pancreatic-and-kidney-cancers-on-the-rise/summary/ 2025-05-14T19:35:42+00:00 https://ascopost.com/news/may-2025/early-onset-breast-colorectal-endometrial-pancreatic-and-kidney-cancers-on-the-rise/notecards/ 2025-05-14T19:36:24+00:00 https://ascopost.com/news/may-2025/effects-of-tumor-infiltrating-clonal-hematopoiesis/ 2025-06-16T18:03:05+00:00 https://ascopost.com/news/may-2025/effects-of-tumor-infiltrating-clonal-hematopoiesis/summary/ 2025-05-14T19:38:11+00:00 https://ascopost.com/news/may-2025/effects-of-tumor-infiltrating-clonal-hematopoiesis/notecards/ 2025-05-14T19:38:42+00:00 https://ascopost.com/news/may-2025/fda-approves-at-home-self-collection-device-for-cervical-cancer-screening/ 2025-06-27T18:27:15+00:00 https://ascopost.com/news/may-2025/fda-approves-at-home-self-collection-device-for-cervical-cancer-screening/summary/ 2025-05-14T19:06:21+00:00 https://ascopost.com/news/may-2025/fda-approves-at-home-self-collection-device-for-cervical-cancer-screening/notecards/ 2025-05-14T19:09:50+00:00 https://ascopost.com/news/may-2025/icymi-additional-abstracts-of-interest-from-aacr/ 2025-06-16T18:00:13+00:00 https://ascopost.com/news/may-2025/icymi-additional-abstracts-of-interest-from-aacr/summary/ 2025-05-14T19:26:28+00:00 https://ascopost.com/news/may-2025/icymi-additional-abstracts-of-interest-from-aacr/notecards/ 2025-05-14T19:33:47+00:00 https://ascopost.com/news/may-2025/annual-or-biennial-multicancer-early-detection-screening-improves-patient-outcomes/ 2025-05-12T16:11:38+00:00 https://ascopost.com/news/may-2025/annual-or-biennial-multicancer-early-detection-screening-improves-patient-outcomes/summary/ 2025-05-14T19:42:09+00:00 https://ascopost.com/news/may-2025/annual-or-biennial-multicancer-early-detection-screening-improves-patient-outcomes/notecards/ 2025-05-14T19:44:54+00:00 https://ascopost.com/news/may-2025/crispr-cas9-edited-tils-targeting-intracellular-immune-checkpoint-cish-in-metastatic-colorectal-cancer/ 2025-05-20T18:57:46+00:00 https://ascopost.com/news/may-2025/crispr-cas9-edited-tils-targeting-intracellular-immune-checkpoint-cish-in-metastatic-colorectal-cancer/summary/ 2025-05-14T19:47:09+00:00 https://ascopost.com/news/may-2025/crispr-cas9-edited-tils-targeting-intracellular-immune-checkpoint-cish-in-metastatic-colorectal-cancer/notecards/ 2025-05-14T19:50:10+00:00 https://ascopost.com/news/may-2025/combination-of-weight-gain-late-age-at-pregnancy-could-increase-risk-of-breast-cancer/ 2025-06-16T20:40:52+00:00 https://ascopost.com/news/may-2025/glp-1-receptor-agonists-could-show-anticancer-benefits-beyond-weight-loss/ 2025-05-13T18:15:10+00:00 https://ascopost.com/news/may-2025/cohort-study-shows-benefits-of-bilateral-salpingo-oophorectomy-without-increased-health-risks/ 2025-06-27T18:28:10+00:00 https://ascopost.com/news/may-2025/overall-survival-analysis-in-codebreak-300-sotorasib-plus-panitumumab-vs-investigator-s-choice-in-chemorefractory-kras-g12c-colorectal-cancer/ 2025-05-13T20:29:22+00:00 https://ascopost.com/news/may-2025/ai-model-estimates-biological-age-and-predicts-survival-in-patients-with-cancer/ 2025-10-30T14:26:48+00:00 https://ascopost.com/news/may-2025/afatinib-vs-chemotherapy-in-nsclc-with-uncommon-activating-egfr-mutations/ 2025-06-16T17:55:56+00:00 https://ascopost.com/news/may-2025/first-line-tfox-vs-folfox-in-advanced-her2-negative-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2025-06-27T20:46:17+00:00 https://ascopost.com/news/may-2025/elective-nodal-radiotherapy-for-oligorecurrent-nodal-prostate-cancer-metastases/ 2025-06-27T19:25:29+00:00 https://ascopost.com/news/may-2025/patient-advocacy-groups-health-care-programs-are-lifelines-not-line-items/ 2025-05-15T14:45:55+00:00 https://ascopost.com/news/may-2025/breast-parenchymal-phenotypes-and-risk-of-breast-cancer/ 2025-06-16T20:31:21+00:00 https://ascopost.com/news/may-2025/chemotherapy-free-triplet-in-previously-treated-hr-positive-her2-positive-advanced-breast-cancer/ 2025-06-16T20:27:49+00:00 https://ascopost.com/news/may-2025/retifanlimab-dlwr-approved-for-anal-cancer/ 2025-06-30T15:36:23+00:00 https://ascopost.com/news/may-2025/second-line-endocrine-therapy-with-or-without-palbociclib-rechallenge-in-hr-positiveher2-negative-advanced-breast-cancer/ 2025-06-16T20:26:48+00:00 https://ascopost.com/news/may-2025/neoadjuvant-therapy-for-ibd-related-rectal-cancer/ 2025-06-30T15:34:19+00:00 https://ascopost.com/news/may-2025/novel-prediction-model-for-hearing-loss-from-chemotherapy-in-pediatric-patients-with-cancer/ 2025-05-16T13:45:14+00:00 https://ascopost.com/news/may-2025/risk-of-gynecologic-cancers-after-5-years-of-testosterone-use/ 2025-06-27T18:20:48+00:00 https://ascopost.com/news/may-2025/reduced-dose-chemoradiotherapy-for-early-stage-anal-cancer/ 2025-06-30T15:30:03+00:00 https://ascopost.com/news/may-2025/antimicrobial-resistance-in-outpatients-with-cancer/ 2025-05-20T18:37:50+00:00 https://ascopost.com/news/may-2025/chemotherapy-free-neoadjuvant-therapy-for-her2-enriched-early-breast-cancer/ 2025-06-16T20:29:06+00:00 https://ascopost.com/news/may-2025/former-president-biden-diagnosed-with-metastatic-prostate-cancer/ 2025-06-27T19:22:18+00:00 https://ascopost.com/news/may-2025/stromal-disruption-associated-with-higher-risk-of-developing-aggressive-breast-cancer/ 2025-06-16T20:24:41+00:00 https://ascopost.com/news/may-2025/gabapentin-may-extend-survival-in-patients-with-glioblastoma/ 2025-05-19T15:40:56+00:00 https://ascopost.com/news/may-2025/a-high-proportion-of-us-adults-are-behind-on-cancer-screenings/ 2025-05-20T15:21:43+00:00 https://ascopost.com/news/may-2025/breast-cancer-genome-wide-study-identifies-two-new-risk-genes-in-black-south-african-women/ 2025-06-16T20:21:26+00:00 https://ascopost.com/news/may-2025/anlotinib-plus-penpulimab-in-first-line-treatment-of-unresectable-hepatocellular-carcinoma/ 2025-05-20T18:22:37+00:00 https://ascopost.com/news/may-2025/p53-dysfunction-in-myelodysplastic-syndromes/ 2025-05-20T15:35:03+00:00 https://ascopost.com/news/may-2025/association-between-risk-reducing-surgeries-and-survival-in-young-brca-carriers-with-breast-cancer/ 2025-06-16T20:19:59+00:00 https://ascopost.com/news/may-2025/addition-of-tocilizumab-to-nab-paclitaxel-and-gemcitabine-in-first-line-treatment-of-advanced-pancreatic-cancer/ 2025-05-21T13:52:09+00:00 https://ascopost.com/news/may-2025/revealing-critical-insights-for-precision-medicine-in-patients-with-metastatic-prostate-cancer/ 2025-06-27T19:19:16+00:00 https://ascopost.com/news/may-2025/abbreviated-mri-scans-in-detecting-breast-cancer-for-women-with-dense-breasts/ 2025-06-16T20:17:18+00:00 https://ascopost.com/news/may-2025/wgs-liquid-biopsies-for-hpv-associated-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T16:47:56+00:00 https://ascopost.com/news/may-2025/use-of-ai-assistance-to-improve-her2-breast-cancer-classifications/ 2025-10-30T14:29:11+00:00 https://ascopost.com/news/may-2025/extensive-stage-sclc-lurbinectedin-and-atezolizumab/ 2025-06-16T17:25:23+00:00 https://ascopost.com/news/may-2025/glp-1-ras-may-lower-risk-of-obesity-related-cancers/ 2025-05-22T21:08:22+00:00 https://ascopost.com/news/may-2025/inavolisib-based-regimen-in-pik3ca-mutated-hr-positive-her2-negative-advanced-breast-cancer/ 2025-06-16T20:13:57+00:00 https://ascopost.com/news/may-2025/use-of-niraparib-in-patients-with-advanced-melanoma/ 2025-09-02T20:34:03+00:00 https://ascopost.com/news/may-2025/mortality-associated-with-risk-adapted-adjuvant-therapy-in-postmenopausal-women-with-early-breast-cancer/ 2025-06-16T20:11:55+00:00 https://ascopost.com/news/may-2025/dose-escalated-stereotactic-body-radiotherapy-vs-conventional-radiotherapy-for-painful-bone-metastases/ 2025-05-27T15:32:37+00:00 https://ascopost.com/news/may-2025/doj-finds-federal-bureau-of-prisons-colorectal-cancer-screening-practices-lacking/ 2025-06-30T15:26:55+00:00 https://ascopost.com/news/may-2025/esmo-releases-version-20-of-the-magnitude-of-clinical-benefit-scale/ 2025-05-27T17:15:36+00:00 https://ascopost.com/news/may-2025/enhanced-car-t-cell-therapy-for-lymphoma-after-previous-failure-on-car-t-cell-therapy/ 2025-05-28T17:46:55+00:00 https://ascopost.com/news/may-2025/first-line-nivolumab-ipilimumab-vs-lenvatinib-or-sorafenib-in-unresectable-hepatocellular-carcinoma/ 2025-05-28T19:01:52+00:00 https://ascopost.com/news/may-2025/alcohol-may-be-linked-to-higher-risk-of-pancreatic-cancer/ 2025-05-28T19:06:34+00:00 https://ascopost.com/news/may-2025/physical-function-acts-as-predictor-of-survival-for-daratumumab-based-therapy-in-multiple-myeloma/ 2025-05-28T18:01:22+00:00 https://ascopost.com/news/may-2025/climate-change-and-risk-for-breast-and-gynecologic-cancers/ 2025-06-16T19:19:41+00:00 https://ascopost.com/news/may-2025/harm-benefit-balance-of-immune-checkpoint-inhibitor-treatment-in-non-small-cell-lung-cancer/ 2025-06-16T17:12:25+00:00 https://ascopost.com/news/may-2025/folfirinox-vs-gemcitabine-in-nonresectable-locally-advanced-pancreatic-carcinoma/ 2025-05-29T15:04:22+00:00 https://ascopost.com/news/may-2025/addition-of-radium-223-to-stereotactic-ablative-radiotherapy-in-oligometastatic-prostate-cancer/ 2025-06-27T19:16:40+00:00 https://ascopost.com/news/may-2025/genomic-score-may-predict-progression-from-precursor-condition-to-active-multiple-myeloma/ 2025-05-29T15:21:33+00:00 https://ascopost.com/news/may-2025/online-genetic-testing-platform-demonstrates-engagement-among-patients-with-young-onset-colorectal-cancer/ 2025-06-30T15:25:26+00:00 https://ascopost.com/news/may-2025/car-t-cell-therapy-continues-to-demonstrate-activity-in-advanced-clear-cell-renal-cell-carcinoma/ 2025-06-27T15:48:04+00:00 https://ascopost.com/news/may-2025/study-finds-novel-triplet-regimen-safe-and-effective-for-patients-with-higher-risk-mds-and-cmml/ 2025-05-30T15:56:09+00:00 https://ascopost.com/news/may-2025/spatial-transcriptomics-identifies-novel-subtypes-associated-with-disease-prognosis-in-leiomyosarcoma/ 2025-08-25T15:12:20+00:00 https://ascopost.com/news/may-2025/subset-of-men-with-rare-prostate-cancer-may-benefit-from-immunotherapy-added-to-chemotherapy-and-targeted-maintenance-therapy/ 2025-06-27T19:11:15+00:00 https://ascopost.com/news/may-2025/impact-of-wildfire-related-pollution-on-survival-in-nsclc/ 2025-06-16T17:09:51+00:00 https://ascopost.com/news/may-2025/alcohol-related-cancer-deaths-are-on-the-rise-in-the-united-states/ 2025-05-31T14:28:07+00:00 https://ascopost.com/news/may-2025/encorafenib-cetuximab-plus-chemotherapy-improves-survival-in-braf-v600e-mutant-metastatic-colorectal-cancer/ 2025-06-30T15:18:34+00:00 https://ascopost.com/news/may-2025/vepdegestrant-improves-pfs-in-select-patients-with-esr1-mutant-advanced-breast-cancer/ 2025-06-16T19:17:39+00:00 https://ascopost.com/news/may-2025/trastuzumab-deruxtecan-improves-survival-outcomes-in-patients-with-her2-positive-gastric-gej-cancer/ 2025-05-31T15:57:45+00:00 https://ascopost.com/news/may-2025/sacituzumab-govitecan-and-pembrolizumab-improve-disease-control-in-advanced-pd-l1-positive-tnbc/ 2025-06-16T19:11:45+00:00 https://ascopost.com/news/june-2025/ 2025-06-01T15:27:38+00:00 https://ascopost.com/news/june-2025/adding-atezolizumab-to-adjuvant-chemotherapy-improves-disease-free-survival-in-dmmr-colon-cancer/ 2025-06-30T15:16:17+00:00 https://ascopost.com/news/june-2025/structured-exercise-program-improves-survival-in-some-patients-with-colon-cancer/ 2025-06-30T15:14:12+00:00 https://ascopost.com/news/june-2025/perioperative-durvalumab-boosts-flot-chemotherapy-benefit-for-some-gastric-cancers/ 2025-06-01T17:44:59+00:00 https://ascopost.com/news/june-2025/switching-to-camizestrant-after-detection-of-an-esr1-mutation-improves-progression-free-survival-for-some-patients-with-advanced-breast-cancer/ 2025-06-13T21:24:55+00:00 https://ascopost.com/news/june-2025/trastuzumab-deruxtecan-pertuzumab-leads-to-improved-pfs-for-her2-positive-breast-cancer/ 2025-06-13T21:23:53+00:00 https://ascopost.com/news/june-2025/her3-targeted-antibody-drug-conjugate-for-treatment-resistant-solid-tumors/ 2025-06-13T21:37:38+00:00 https://ascopost.com/news/june-2025/meta-analysis-reveals-how-icis-may-impact-solid-organ-transplant-responses/ 2025-06-02T18:29:21+00:00 https://ascopost.com/news/june-2025/new-application-may-help-caregivers-of-patients-undergoing-bone-marrow-transplant/ 2025-06-02T18:30:40+00:00 https://ascopost.com/news/june-2025/scholastic-performance-among-adolescents-and-young-adults-with-cancer/ 2025-06-02T18:32:07+00:00 https://ascopost.com/news/june-2025/potential-new-standard-of-care-emerges-in-multiple-myeloma/ 2025-06-03T17:47:09+00:00 https://ascopost.com/news/june-2025/biomarkers-may-shed-light-on-treatment-options-for-high-risk-prostate-cancer/ 2025-06-27T19:07:31+00:00 https://ascopost.com/news/june-2025/dual-immunotherapy-may-improve-progression-free-survival-in-advanced-squamous-cell-carcinoma/ 2025-09-02T20:32:04+00:00 https://ascopost.com/news/june-2025/presurgical-combination-therapy-boosts-survival-in-rare-thyroid-cancer-study-finds/ 2025-06-03T20:20:42+00:00 https://ascopost.com/news/june-2025/niraparib-plus-abiraterone-in-hrr-mutant-metastatic-castration-sensitive-prostate-cancer/ 2025-06-27T19:03:45+00:00 https://ascopost.com/news/june-2025/investigational-menin-inhibitor-under-study-in-npm1-mutant-aml/ 2025-06-05T17:58:52+00:00 https://ascopost.com/news/june-2025/married-people-may-have-better-colorectal-cancer-outcomes-study-shows/ 2025-06-30T15:08:11+00:00 https://ascopost.com/news/june-2025/neoadjuvant-nivolumab-and-chemotherapy-shows-significant-os-benefit-at-5-years-in-resectable-nsclc/ 2025-06-13T21:36:31+00:00 https://ascopost.com/news/june-2025/study-explores-the-impact-of-prediagnosis-adverse-financial-events-on-risk-of-cancer-mortality/ 2025-06-04T18:46:25+00:00 https://ascopost.com/news/june-2025/emr-integrated-messaging-drastically-increases-cancer-related-fertility-preservation-referrals/ 2025-06-04T19:35:22+00:00 https://ascopost.com/news/june-2025/novel-dual-target-car-t-cell-therapy-may-slow-growth-of-recurrent-glioblastoma/ 2025-06-04T19:32:19+00:00 https://ascopost.com/news/june-2025/anti-inflammatory-diet-could-influence-survival-following-stage-iii-colorectal-cancer/ 2025-06-30T15:05:56+00:00 https://ascopost.com/news/june-2025/ciltacabtagene-autoleucel-delivers-lasting-remissions-in-relapsed-or-refractory-multiple-myeloma/ 2025-06-27T17:37:25+00:00 https://ascopost.com/news/june-2025/preoperative-thp-leads-to-pcr-in-two-thirds-of-patients-with-early-stage-her2-positive-er-negative-breast-cancer/ 2025-06-13T21:21:05+00:00 https://ascopost.com/news/june-2025/early-driver-of-lineage-plasticity-in-prostate-cancer-cells/ 2025-06-27T19:02:01+00:00 https://ascopost.com/news/june-2025/swog-s2302-pragmatica-lung-study-design-still-significant-even-with-negative-results-in-advanced-nsclc/ 2025-06-13T21:34:53+00:00 https://ascopost.com/news/june-2025/novel-antibody-drug-conjugate-for-newly-diagnosed-bpdcn/ 2025-06-05T16:06:24+00:00 https://ascopost.com/news/june-2025/first-line-nivolumab-plus-low-dose-ipilimumab-in-msi-h-advanced-gastricgej-cancer/ 2025-06-06T15:59:01+00:00 https://ascopost.com/news/june-2025/are-most-americans-aware-of-the-link-between-alcohol-and-cancer-risk/ 2025-06-06T16:02:13+00:00 https://ascopost.com/news/june-2025/treatment-for-intractable-cancer-pain-pioneered/ 2025-06-06T16:09:58+00:00 https://ascopost.com/news/june-2025/diagnostic-accuracy-of-navigational-bronchoscopy-vs-transthoracic-needle-biopsy-in-lung-nodules/ 2025-06-13T21:32:16+00:00 https://ascopost.com/news/june-2025/acs-can-statement-on-federal-cuts-to-cancer-research/ 2025-06-06T17:53:26+00:00 https://ascopost.com/news/june-2025/breast-cancer-radiotherapy-leads-to-moderate-cardiac-function-decline-over-years/ 2025-06-13T21:19:20+00:00 https://ascopost.com/news/june-2025/prophylactic-radiation-therapy-of-the-contralateral-breast-in-brca-carriers-with-early-stage-breast-cancer/ 2025-06-13T21:18:18+00:00 https://ascopost.com/news/june-2025/localized-prostate-cancer-long-term-follow-up-of-hypofractionated-dose-escalated-vs-conventionally-fractionated-rt/ 2025-06-27T18:57:21+00:00 https://ascopost.com/news/june-2025/cancer-may-be-detectable-in-bloodstream-3-years-prior-to-diagnosis/ 2025-06-09T15:25:55+00:00 https://ascopost.com/news/june-2025/inherited-genetic-differences-may-predict-resistance-to-immunotherapy-in-metastatic-melanoma/ 2025-09-02T20:29:34+00:00 https://ascopost.com/news/june-2025/low-value-cancer-screenings-may-continue-for-years-following-guideline-change-to-limit-unnecessary-tests/ 2025-06-27T18:16:57+00:00 https://ascopost.com/news/june-2025/self-collection-kit-mailings-may-increase-cervical-cancer-screening-rates-in-underserved-settings/ 2025-06-27T18:07:06+00:00 https://ascopost.com/news/june-2025/adjuvant-cemiplimab-in-high-risk-cutaneous-squamous-cell-carcinoma/ 2025-09-02T20:23:28+00:00 https://ascopost.com/news/june-2025/mrd-guided-treatment-in-newly-diagnosed-multiple-myeloma/ 2025-06-20T17:41:53+00:00 https://ascopost.com/news/june-2025/study-reports-increasing-incidence-rates-of-appendiceal-adenocarcinoma-in-those-born-after-1945/ 2025-07-17T17:14:17+00:00 https://ascopost.com/news/june-2025/fda-approves-taletrectinib-for-ros1-positive-non-small-cell-lung-cancer/ 2025-06-13T21:28:18+00:00 https://ascopost.com/news/june-2025/nomogram-model-may-predict-dvt-risk-in-patients-with-ovarian-cancer/ 2025-06-27T18:03:30+00:00 https://ascopost.com/news/june-2025/elinzanetant-for-vasomotor-symptoms-from-endocrine-therapy-for-breast-cancer/ 2025-06-13T21:10:45+00:00 https://ascopost.com/news/june-2025/resectable-nsclc-overall-survival-with-neoadjuvant-nivolumab-plus-chemotherapy/ 2025-07-15T18:11:36+00:00 https://ascopost.com/news/june-2025/cell-free-dna-fragmentomics-based-model-for-early-detection-of-pancreatic-cancer/ 2025-06-12T14:19:44+00:00 https://ascopost.com/news/june-2025/cancercare-survey-reveals-how-insurance-red-tape-impacts-cancer-treatment-delays/ 2025-06-12T15:52:18+00:00 https://ascopost.com/news/june-2025/fda-approves-mitomycin-intravesical-solution-for-recurrent-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer/ 2025-06-27T17:26:44+00:00 https://ascopost.com/news/june-2025/relacorilant-and-nab-paclitaxel-in-platinum-resistant-ovarian-cancer/ 2025-07-10T18:38:19+00:00 https://ascopost.com/news/june-2025/reduced-dose-chemoradiotherapy-in-early-stage-anal-cancer/ 2025-06-30T14:48:17+00:00 https://ascopost.com/news/june-2025/ramucirumab-beyond-progression-plus-irinotecan-in-ramucirumab-refractory-advanced-gastric-cancer/ 2025-06-27T20:44:03+00:00 https://ascopost.com/news/june-2025/could-a-telehealth-program-enhance-geriatric-cancer-care/ 2025-06-13T15:55:31+00:00 https://ascopost.com/news/june-2025/fda-approves-neoadjuvant-and-adjuvant-pembrolizumab-for-resectable-locally-advanced-head-and-neck-cancer/ 2026-01-28T16:42:36+00:00 https://ascopost.com/news/june-2025/colorectal-cancer-screening-ct-colonography-vs-stool-testing/ 2025-06-30T14:45:21+00:00 https://ascopost.com/news/june-2025/concurrent-vs-sequential-pembrolizumab-with-chemoradiation-in-locally-advanced-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T16:40:27+00:00 https://ascopost.com/news/june-2025/do-the-benefits-of-fluoropyrimidine-for-gi-cancers-outweigh-cardiovascular-risk/ 2025-09-18T18:38:25+00:00 https://ascopost.com/news/june-2025/neoadjuvant-pd-1pd-l1-inhibition-plus-chemotherapy-in-borderline-resectable-or-unresectable-stage-iii-nsclc/ 2025-06-16T16:45:10+00:00 https://ascopost.com/news/june-2025/patient-reported-outcomes-and-symptomatic-skeletal-events-with-lu-psma-in-progressive-metastatic-castration-resistant-prostate-cancer/ 2025-06-27T18:48:47+00:00 https://ascopost.com/news/june-2025/early-results-for-car-t-cell-therapy-for-relapsed-or-refractory-al-amyloidosis/ 2025-06-16T17:42:16+00:00 https://ascopost.com/news/june-2025/revumenib-in-triplet-regimen-under-study-in-newly-diagnosed-aml-with-npm1-kmt2a-alterations/ 2025-09-11T17:34:41+00:00 https://ascopost.com/news/june-2025/study-defines-divergent-molecular-pathways-in-hpv-associated-vs-hpv-independent-sinonasal-cancers/ 2026-01-28T16:38:08+00:00 https://ascopost.com/news/june-2025/brca-mutations-could-increase-risk-of-rare-lymphoma-among-women-who-received-textured-breast-implants-during-breast-cancer-treatment/ 2025-06-17T18:34:13+00:00 https://ascopost.com/news/june-2025/avelumab-plus-cetuximab-in-advanced-cutaneous-squamous-cell-carcinoma/ 2025-09-02T20:21:07+00:00 https://ascopost.com/news/june-2025/proposed-budget-cuts-to-medicaid-may-result-in-more-than-16-500-medically-preventable-deaths-annually/ 2025-06-17T15:35:04+00:00 https://ascopost.com/news/june-2025/four-drug-induction-regimen-under-study-in-advanced-melanoma-with-braf-mutation/ 2025-09-02T20:18:37+00:00 https://ascopost.com/news/june-2025/order-of-crc-diagnosis-may-influence-survival-in-patients-with-multiple-malignancies/ 2025-06-30T14:43:00+00:00 https://ascopost.com/news/june-2025/noncovalent-btk-inhibitor-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma/ 2025-07-23T17:31:45+00:00 https://ascopost.com/news/june-2025/psilocybin-may-benefit-patients-with-cancer-major-depressive-disorder/ 2025-06-18T14:58:15+00:00 https://ascopost.com/news/june-2025/regional-nodal-irradiation-in-node-negative-breast-cancer-after-neoadjuvant-chemotherapy/ 2025-06-18T21:46:37+00:00 https://ascopost.com/news/june-2025/elevated-cardiac-biomarkers-associated-with-increased-cancer-risk/ 2025-06-19T16:19:06+00:00 https://ascopost.com/news/june-2025/key-lbcl-traits-tied-to-greatest-benefit-from-cd19-car-t-cell-therapy/ 2025-06-19T14:23:55+00:00 https://ascopost.com/news/june-2025/fda-approves-cd19-directed-antibody-based-regimen-for-follicular-lymphoma/ 2025-06-19T14:15:34+00:00 https://ascopost.com/news/june-2025/addition-of-tumor-treating-fields-to-gemcitabinenab-paclitaxel-in-locally-advanced-pancreatic-adenocarcinoma/ 2025-06-19T16:22:35+00:00 https://ascopost.com/news/june-2025/contributors-to-risk-of-subsequent-neoplasms-in-long-term-survivors-of-childhood-cancer/ 2025-06-19T16:25:28+00:00 https://ascopost.com/news/june-2025/tafasitamab-plus-lenalidomide-and-rituximab-significantly-improves-outcomes-in-relapsedrefractory-follicular-lymphoma/ 2025-06-19T15:40:47+00:00 https://ascopost.com/news/june-2025/ropeginterferon-alfa-2b-outperforms-anagrelide-as-second-line-therapy-for-et/ 2025-09-30T19:22:50+00:00 https://ascopost.com/news/june-2025/novel-tri-specific-antibody-shows-efficacy-and-safety-in-refractory-myeloma/ 2025-06-19T16:27:09+00:00 https://ascopost.com/news/june-2025/outcomes-of-oncologic-extended-resection-for-gallbladder-cancer-results-of-a-global-analysis/ 2025-09-18T18:35:26+00:00 https://ascopost.com/news/june-2025/ash-2025-awardees-hematologists-to-be-honored-with-highest-distinctions/ 2025-06-20T15:42:09+00:00 https://ascopost.com/news/june-2025/symptom-detected-breast-cancers-may-be-linked-to-higher-mortality-and-advanced-disease-risk/ 2025-06-20T15:51:32+00:00 https://ascopost.com/news/june-2025/gut-microbiome-may-hold-key-to-avoiding-chemotherapy-related-cardiotoxicity-in-patients-with-breast-cancer/ 2025-06-23T14:43:23+00:00 https://ascopost.com/news/june-2025/new-model-predicts-risk-of-progression-in-early-stage-classical-hodgkin-lymphoma/ 2025-07-16T19:51:59+00:00 https://ascopost.com/news/june-2025/mrd-guided-therapy-with-ibrutinib-venetoclax-or-ibrutinib-alone-in-chronic-lymphocytic-leukemia/ 2025-07-14T19:54:47+00:00 https://ascopost.com/news/june-2025/mindfulness-and-tai-chi-interventions-for-mood-improvement-in-cancer-survivors-with-distress/ 2025-06-23T16:48:07+00:00 https://ascopost.com/news/june-2025/cohort-study-finds-genetics-of-cardiomyopathy-risk-in-cancer-survivors-differ-by-age-of-onset/ 2025-06-23T15:52:58+00:00 https://ascopost.com/news/june-2025/fda-grants-accelerated-approval-to-datopotamab-deruxtecan-dlnk-for-egfr-mutated-nsclc/ 2025-06-23T18:16:35+00:00 https://ascopost.com/news/june-2025/adding-olanzapine-to-triplet-antiemetics-post-anthracyclinecyclophosphamide-chemotherapy/ 2025-06-24T15:26:36+00:00 https://ascopost.com/news/june-2025/addition-of-lenvatinib-pembrolizumab-to-chemotherapy-in-advancedmetastatic-gastroesophageal-adenocarcinoma/ 2025-06-24T15:18:05+00:00 https://ascopost.com/news/june-2025/role-of-mitochondrial-pathways-in-melanoma-progression-treatment-resistance/ 2025-09-02T20:16:58+00:00 https://ascopost.com/news/june-2025/fda-approves-label-expansion-for-agent-used-in-patient-selection-for-pre-taxane-radioligand-therapy/ 2025-06-27T18:45:48+00:00 https://ascopost.com/news/june-2025/national-comprehensive-cancer-network-launches-nccn-guidelines-navigator/ 2025-06-26T14:10:11+00:00 https://ascopost.com/news/june-2025/gpc3-targeted-immunopet-helps-detect-earlier-stage-hepatocellular-carcinoma/ 2025-06-26T15:29:07+00:00 https://ascopost.com/news/june-2025/study-finds-ai-chatbots-are-vulnerable-to-spreading-malicious-false-health-information/ 2025-10-30T14:23:54+00:00 https://ascopost.com/news/june-2025/dual-menin-and-kat6a-7-inhibition-improves-outcomes-in-nup98-rearranged-pediatric-aml-models/ 2025-07-14T16:51:12+00:00 https://ascopost.com/news/june-2025/breast-cancer-new-study-finds-survivors-may-face-lower-risk-of-alzheimer-dementia/ 2025-06-26T20:05:22+00:00 https://ascopost.com/news/june-2025/perioperative-pembrolizumab-in-locally-advanced-head-and-neck-cancer/ 2026-01-28T16:33:12+00:00 https://ascopost.com/news/june-2025/early-toxicity-with-intensity-modulated-moderately-hypofractionated-radiotherapy-vs-stereotactic-body-radiotherapy-in-intermediate-and-high-risk-prostate-cancer/ 2025-06-27T18:42:40+00:00 https://ascopost.com/news/june-2025/best-practice-recommendations-for-clinical-homologous-recombination-deficiency-testing/ 2025-06-27T14:17:02+00:00 https://ascopost.com/news/june-2025/predictive-biomarker-under-study-in-colorectal-cancer/ 2025-06-30T14:34:01+00:00 https://ascopost.com/news/june-2025/botulinum-toxin-and-scopolamine-for-radiation-induced-salivary-gland-toxicity-in-metastatic-prostate-cancer/ 2025-06-27T18:39:39+00:00 https://ascopost.com/news/june-2025/addition-of-retifanlimab-to-first-line-chemotherapy-in-advanced-squamous-cell-carcinoma-of-the-anal-canal/ 2025-07-22T16:00:46+00:00 https://ascopost.com/news/june-2025/astro-updates-guideline-on-radiation-therapy-for-high-grade-diffuse-glioma/ 2025-06-30T14:00:41+00:00 https://ascopost.com/news/june-2025/study-finds-about-one-in-six-chemotherapy-drugs-in-sub-saharan-africa-fails-quality-tests/ 2025-06-30T20:24:39+00:00 https://ascopost.com/news/june-2025/partial-breast-radiotherapy-after-breast-conserving-surgery-10-year-outcomes/ 2025-06-30T18:34:28+00:00 https://ascopost.com/news/june-2025/frontline-triplet-regimens-for-intensive-chemotherapy-ineligible-idh-mutant-aml/ 2025-07-23T17:21:47+00:00 https://ascopost.com/news/july-2025/ 2025-07-01T13:53:42+00:00 https://ascopost.com/news/july-2025/survey-shows-inaccuracies-in-us-perceptions-of-testicular-cancer/ 2025-07-01T15:16:49+00:00 https://ascopost.com/news/july-2025/survey-shows-inaccuracies-in-us-perceptions-of-testicular-cancer/summary/ 2025-07-17T19:58:09+00:00 https://ascopost.com/news/july-2025/survey-shows-inaccuracies-in-us-perceptions-of-testicular-cancer/notecards/ 2025-07-17T19:56:35+00:00 https://ascopost.com/news/july-2025/her3-dxd-in-nsclc-without-egfr-activating-mutations/ 2025-07-01T15:19:09+00:00 https://ascopost.com/news/july-2025/metastatic-castration-resistant-prostate-cancer-comparison-of-second-line-regimens/ 2025-07-01T16:59:50+00:00 https://ascopost.com/news/july-2025/utdna-may-help-to-personalize-bladder-cancer-treatment/ 2025-07-01T14:54:37+00:00 https://ascopost.com/news/july-2025/ai-enhanced-pact-as-a-noninvasive-breast-imaging-alternative/ 2025-10-29T16:39:07+00:00 https://ascopost.com/news/july-2025/uterine-cancer-incidence-and-mortality-rates-projected-to-rise-substantially-by-2050/ 2025-07-02T14:17:10+00:00 https://ascopost.com/news/july-2025/can-hormone-therapy-affect-breast-cancer-risk-in-younger-women/ 2025-07-02T14:23:28+00:00 https://ascopost.com/news/july-2025/lean-body-mass-based-oxaliplatin-dosing-and-risk-of-neurotoxicity-in-adjuvant-treatment-of-stage-iii-colon-cancer/ 2025-07-02T17:30:10+00:00 https://ascopost.com/news/july-2025/study-reveals-long-term-consequences-of-chemotherapy-on-healthy-blood-cells/ 2025-07-02T15:32:00+00:00 https://ascopost.com/news/july-2025/fda-grants-accelerated-approval-to-linvoseltamab-gcpt-for-relapsed-or-refractory-multiple-myeloma/ 2025-07-29T18:36:55+00:00 https://ascopost.com/news/july-2025/ppp2r1a-mutations-linked-to-improved-immunotherapy-outcomes-in-ovarian-clear-cell-carcinoma/ 2025-07-03T15:49:48+00:00 https://ascopost.com/news/july-2025/bevacizumab-plus-erlotinib-in-hereditary-and-sporadic-papillary-kidney-cancer/ 2025-07-03T15:03:11+00:00 https://ascopost.com/news/july-2025/addition-of-glofitamab-to-r-chop-or-pola-r-chp-in-younger-patients-with-high-risk-lbcl/ 2025-07-07T18:39:36+00:00 https://ascopost.com/news/july-2025/fda-grants-accelerated-approval-to-sunvozertinib-for-metastatic-nsclc-with-egfr-exon-20-insertion-mutations/ 2025-07-03T15:56:33+00:00 https://ascopost.com/news/july-2025/air-pollution-linked-to-distinct-genomic-signatures-in-lung-cancers-among-never-smokers/ 2025-07-07T14:08:18+00:00 https://ascopost.com/news/july-2025/preclinical-leukemia-chip-platform-improves-evaluation-of-car-t-cell-therapies/ 2025-07-07T19:08:46+00:00 https://ascopost.com/news/july-2025/survival-disparities-rise-in-patients-with-advanced-cancer-depending-on-whether-they-have-insurance-to-cover-immune-checkpoint-inhibitors/ 2025-07-07T16:55:10+00:00 https://ascopost.com/news/july-2025/intratumoral-bo-112-with-pembrolizumab-in-anti-pd-1-resistant-melanoma/ 2025-09-02T20:14:38+00:00 https://ascopost.com/news/july-2025/y-90-resin-microspheres-receive-fda-approval-for-the-treatment-of-unresectable-hcc/ 2026-01-02T20:04:58+00:00 https://ascopost.com/news/july-2025/survey-finds-confusion-over-mammogram-guidelines/ 2025-07-07T18:24:42+00:00 https://ascopost.com/news/july-2025/zanidatamab-plus-chemotherapy-in-advanced-her2-positive-gastroesophageal-adenocarcinoma/ 2025-07-09T18:06:02+00:00 https://ascopost.com/news/july-2025/bmi-and-cardiovascular-disease-associated-with-increased-breast-cancer-risk/ 2025-07-08T13:21:37+00:00 https://ascopost.com/news/july-2025/can-planned-c-sections-increase-the-risk-of-childhood-all/ 2025-10-03T13:57:32+00:00 https://ascopost.com/news/july-2025/adult-survivors-of-childhood-cancer-may-be-at-increased-risk-of-severe-covid-19-infection/ 2025-07-08T14:48:21+00:00 https://ascopost.com/news/july-2025/nivolumab-or-brentuximab-vedotin-with-avd-in-older-patients-with-advanced-classical-hodgkin-lymphoma/ 2025-07-09T16:04:43+00:00 https://ascopost.com/news/july-2025/subsequent-neoplasm-risk-among-childhood-cancer-survivors-effect-of-bmi-and-physical-activity/ 2025-07-09T16:09:28+00:00 https://ascopost.com/news/july-2025/study-supports-multi-contaminant-water-treatment-to-reduce-cancer-risk/ 2025-07-12T14:47:49+00:00 https://ascopost.com/news/july-2025/corticosteroids-may-limit-efficacy-of-immunotherapy-in-patients-with-nsclc/ 2025-07-09T17:17:45+00:00 https://ascopost.com/news/july-2025/women-aged-65-plus-still-at-heightened-risk-of-hpv-related-cervical-cancer/ 2025-07-09T17:27:45+00:00 https://ascopost.com/news/july-2025/ruxolitinib-for-steroid-refractory-or-dependent-chronic-graft-vs-host-disease/ 2025-07-10T17:09:28+00:00 https://ascopost.com/news/july-2025/ajcc-guideline-reassessment-aims-to-improve-hpv-positive-throat-cancer-staging/ 2026-01-28T16:32:03+00:00 https://ascopost.com/news/july-2025/literature-review-highlights-rising-incidence-and-disparities-in-many-early-onset-gi-cancers/ 2025-07-10T16:38:42+00:00 https://ascopost.com/news/july-2025/rp1-plus-nivolumab-in-anti-pd-1-resistant-advanced-melanoma/ 2025-09-02T20:10:33+00:00 https://ascopost.com/news/july-2025/chemoimmunotherapy-for-advanced-btc-3-year-overall-survival-update-from-the-topaz-trial/ 2025-07-11T15:46:59+00:00 https://ascopost.com/news/july-2025/new-research-offers-reassurance-about-localized-prostate-cancer-prognosis/ 2025-07-11T18:39:07+00:00 https://ascopost.com/news/july-2025/surgery-vs-ablation-in-small-hepatocellular-carcinoma/ 2026-01-02T20:10:16+00:00 https://ascopost.com/news/july-2025/four-year-outcomes-highlight-efficacy-of-neoadjuvant-nivolumab-and-relatlimab-in-advanced-resectable-melanoma/ 2025-09-02T20:08:32+00:00 https://ascopost.com/news/july-2025/sharp-rise-in-obesity-linked-cancer-mortality-highlights-geographic-and-demographic-gaps/ 2025-07-14T15:51:27+00:00 https://ascopost.com/news/july-2025/outcomes-with-perioperative-immunotherapy-in-resectable-nsclc/ 2025-07-14T15:58:20+00:00 https://ascopost.com/news/july-2025/metformin-in-metastatic-prostate-cancer/ 2025-07-14T18:36:44+00:00 https://ascopost.com/news/july-2025/phase-ii-trial-supports-srt-as-alternative-to-wbrt-in-sclc/ 2025-07-14T16:18:06+00:00 https://ascopost.com/news/july-2025/teclistamab-for-high-risk-heavily-pretreated-multiple-myeloma-real-world-data/ 2025-07-14T17:58:32+00:00 https://ascopost.com/news/july-2025/new-guidelines-on-comprehensive-biomarker-testing-of-bronchoscopic-biopsies/ 2025-07-15T16:03:19+00:00 https://ascopost.com/news/july-2025/people-with-acromegaly-face-elevated-cancer-risk-study-finds/ 2025-07-15T18:22:14+00:00 https://ascopost.com/news/july-2025/online-ai-tool-offers-rapid-accurate-diagnosis-for-endocrine-cancers/ 2025-10-29T19:04:25+00:00 https://ascopost.com/news/july-2025/lisocabtagene-maraleucel-as-second-line-therapy-in-relapsedrefractory-large-b-cell-lymphoma-3-year-follow-up/ 2025-07-16T16:48:46+00:00 https://ascopost.com/news/july-2025/can-use-of-aprepitant-during-chemotherapy-improve-triple-negative-breast-cancer-outcomes/ 2025-07-18T17:56:23+00:00 https://ascopost.com/news/july-2025/risk-of-liver-cancer-with-oral-contraceptive-use/ 2026-01-02T20:11:24+00:00 https://ascopost.com/news/july-2025/survey-highlights-top-anxiety-points-for-caregivers-after-a-cancer-diagnosis/ 2025-07-16T17:03:34+00:00 https://ascopost.com/news/july-2025/study-links-childhood-proximity-to-radiation-contaminated-coldwater-creek-with-elevated-cancer-odds/ 2025-07-17T16:01:24+00:00 https://ascopost.com/news/july-2025/classifying-pancreatic-cysts-using-ai-models/ 2025-10-29T19:06:21+00:00 https://ascopost.com/news/july-2025/early-ctdna-change-and-outcomes-with-ici-treatment-in-metastatic-colorectal-cancer/ 2025-07-18T17:02:16+00:00 https://ascopost.com/news/july-2025/thyroidectomy-without-postoperative-radioiodine-ablation-in-low-risk-differentiated-thyroid-cancer/ 2025-07-18T16:32:14+00:00 https://ascopost.com/news/july-2025/urothelial-cancer-survival-in-the-eras-before-and-after-immune-checkpoint-inhibitors-and-antibody-drug-conjugates/ 2025-07-18T17:03:15+00:00 https://ascopost.com/news/july-2025/outcomes-support-car-t-cell-therapy-use-in-elderly-patients-with-b-cell-lymphomas/ 2025-07-18T16:50:05+00:00 https://ascopost.com/news/july-2025/covid-19-boosters-offer-protection-for-patients-with-cancer/ 2025-07-18T18:26:20+00:00 https://ascopost.com/news/july-2025/extended-follow-up-for-neoadjuvant-and-adjuvant-relatlimab-plus-nivolumab-in-resectable-melanoma/ 2025-09-02T20:05:45+00:00 https://ascopost.com/news/july-2025/dreamm-7-analysis-compares-survival-outcomes-between-triplet-regimens-for-rr-multiple-myeloma/ 2025-08-07T17:53:07+00:00 https://ascopost.com/news/july-2025/study-finds-no-difference-in-dietary-habits-between-cancer-survivors-and-general-population/ 2025-07-21T16:05:08+00:00 https://ascopost.com/news/july-2025/camrelizumab-plus-famitinib-vs-camrelizumab-alone-in-recurrent-or-metastatic-cervical-cancer/ 2025-07-21T15:24:30+00:00 https://ascopost.com/news/july-2025/breastfeeding-patterns-after-treatment-of-early-hormone-receptor-positive-breast-cancer/ 2025-07-22T14:11:41+00:00 https://ascopost.com/news/july-2025/biomarker-testing-in-advanced-cancer-suboptimal-rates-despite-guideline-recommendations-and-growing-insurance-coverage/ 2025-07-22T15:33:17+00:00 https://ascopost.com/news/july-2025/cbo-report-finds-federal-cuts-to-nih-would-threaten-new-drug-development-and-innovation/ 2025-07-22T15:47:57+00:00 https://ascopost.com/news/july-2025/final-overall-survival-analysis-of-flaura2-osimertinib-plus-chemotherapy-in-egfr-mutant-nsclc/ 2025-08-21T21:19:04+00:00 https://ascopost.com/news/july-2025/evaluation-of-racial-classification-standards-in-us-cancer-surveillance-systems/ 2025-07-22T15:06:44+00:00 https://ascopost.com/news/july-2025/short-term-hormonal-treatment-offers-early-insight-into-tumor-behavior-and-resistance-for-er-her2-breast-cancer/ 2025-08-01T18:28:35+00:00 https://ascopost.com/news/july-2025/her2dx-assay-and-survival-outcomes-in-her2-positive-breast-cancer/ 2025-07-23T16:04:06+00:00 https://ascopost.com/news/july-2025/her2dx-assay-and-survival-outcomes-in-her2-positive-breast-cancer/summary/ 2025-07-24T17:20:57+00:00 https://ascopost.com/news/july-2025/her2dx-assay-and-survival-outcomes-in-her2-positive-breast-cancer/notecards/ 2025-07-24T17:23:01+00:00 https://ascopost.com/news/july-2025/association-of-type-2-diabetes-with-colorectal-cancer-risk-and-survival-by-tumor-immunity-status/ 2025-07-23T16:00:19+00:00 https://ascopost.com/news/july-2025/association-of-type-2-diabetes-with-colorectal-cancer-risk-and-survival-by-tumor-immunity-status/summary/ 2025-07-24T17:16:36+00:00 https://ascopost.com/news/july-2025/association-of-type-2-diabetes-with-colorectal-cancer-risk-and-survival-by-tumor-immunity-status/notecards/ 2025-07-24T17:18:35+00:00 https://ascopost.com/news/july-2025/american-cancer-society-names-new-ceo/ 2025-07-23T14:35:08+00:00 https://ascopost.com/news/july-2025/american-cancer-society-names-new-ceo/summary/ 2025-07-24T17:08:48+00:00 https://ascopost.com/news/july-2025/american-cancer-society-names-new-ceo/notecards/ 2025-07-24T17:11:34+00:00 https://ascopost.com/news/july-2025/nsclc-trial-shows-radiation-may-overcome-primary-resistance-to-pembrolizumab/ 2025-07-23T14:49:42+00:00 https://ascopost.com/news/july-2025/nsclc-trial-shows-radiation-may-overcome-primary-resistance-to-pembrolizumab/summary/ 2025-07-24T17:02:27+00:00 https://ascopost.com/news/july-2025/nsclc-trial-shows-radiation-may-overcome-primary-resistance-to-pembrolizumab/notecards/ 2025-07-24T17:06:12+00:00 https://ascopost.com/news/july-2025/astro-announces-new-president-elect-officers/ 2025-07-24T14:05:30+00:00 https://ascopost.com/news/july-2025/intense-resistance-training-for-breast-cancer-survivors-with-lymphedema-risk/ 2025-07-24T16:39:35+00:00 https://ascopost.com/news/july-2025/fertility-outcomes-in-patients-of-childbearing-potential-receiving-first-line-therapy-for-advanced-lymphoma/ 2025-07-24T14:34:27+00:00 https://ascopost.com/news/july-2025/patritumab-deruxtecan-shows-efficacy-in-leptomeningeal-metastases-from-solid-tumors/ 2025-07-24T16:10:51+00:00 https://ascopost.com/news/july-2025/patients-with-interstitial-lung-disease-face-elevated-lung-cancer-risk-study-finds/ 2025-07-24T16:40:31+00:00 https://ascopost.com/news/july-2025/studies-on-egfr-mutations-and-nrg1-fusions-included-in-asco-nsclc-living-guideline-update/ 2025-07-24T18:10:59+00:00 https://ascopost.com/news/july-2025/update-to-asco-living-guideline-for-nsclc-without-driver-alterations-includes-first-comparison-of-immunotherapy-options/ 2025-07-29T16:58:56+00:00 https://ascopost.com/news/july-2025/standard-dna-testing-may-miss-majority-of-nut-carcinomas-study-finds/ 2025-07-28T16:00:44+00:00 https://ascopost.com/news/july-2025/reevaluating-pathologic-complete-response-as-a-surrogate-for-survival-in-rectal-cancer/ 2025-07-28T14:39:48+00:00 https://ascopost.com/news/july-2025/stride-in-unresectable-hcc-5-year-overall-survival-results-from-himalaya/ 2026-01-02T20:12:04+00:00 https://ascopost.com/news/july-2025/study-finds-racial-and-economic-segregation-may-impact-advanced-stage-breast-and-cervical-cancer-diagnoses/ 2025-07-29T17:52:35+00:00 https://ascopost.com/news/july-2025/acs-study-finds-firefighters-face-increased-cancer-risk-and-mortality-especially-for-skin-and-kidney-cancers/ 2025-07-29T14:59:28+00:00 https://ascopost.com/news/july-2025/extended-outcomes-with-addition-of-sugemalimab-to-first-line-chemotherapy-in-metastatic-nsclc/ 2025-07-29T18:37:55+00:00 https://ascopost.com/news/july-2025/esophageal-adenocarcinoma-recurrence-patterns-with-perioperative-chemotherapy-vs-preoperative-chemoradiotherapy/ 2025-07-29T17:50:03+00:00 https://ascopost.com/news/july-2025/addition-of-talazoparib-to-enzalutamide-in-metastatic-crpc-in-genetically-unselected-cohort/ 2025-07-30T19:18:03+00:00 https://ascopost.com/news/july-2025/final-overall-survival-analysis-in-hrr-deficient-cohort-in-talapro-2-addition-of-talazoparib-to-enzalutamide-in-metastatic-crpc/ 2025-07-30T20:20:37+00:00 https://ascopost.com/news/july-2025/three-in-five-liver-cancer-cases-may-be-due-to-preventable-risk-factors/ 2026-01-02T20:12:45+00:00 https://ascopost.com/news/july-2025/ai-enhances-detection-of-missed-breast-cancers-on-screening-tomosynthesis/ 2026-01-07T20:26:25+00:00 https://ascopost.com/news/july-2025/llm-trained-on-somatic-mutations-shows-prognostic-and-predictive-utility/ 2025-10-29T19:15:20+00:00 https://ascopost.com/news/july-2025/pembrolizumab-and-de-escalation-of-treatment-in-resectable-cutaneous-squamous-cell-cancer/ 2025-09-02T20:02:59+00:00 https://ascopost.com/news/july-2025/study-shows-increased-prescribing-after-accelerated-vs-regular-approval-of-cancer-drugs/ 2025-07-31T18:37:58+00:00 https://ascopost.com/news/july-2025/figo-releases-best-practice-advice-on-cancer-during-pregnancy/ 2025-07-31T15:19:32+00:00 https://ascopost.com/news/july-2025/cannabis-use-disorder-and-risk-of-oral-cancer/ 2026-01-28T16:26:51+00:00 https://ascopost.com/news/august-2025/ 2025-08-22T13:37:55+00:00 https://ascopost.com/news/august-2025/study-finds-weather-disasters-increase-risk-for-us-drug-supply-chain-disruption/ 2025-08-22T13:26:06+00:00 https://ascopost.com/news/august-2025/nivolumab-plus-rp1-shows-durable-responses-in-advanced-melanoma-after-pd-1-inhibitor-resistance/ 2025-09-02T19:54:56+00:00 https://ascopost.com/news/august-2025/adagrasib-vs-docetaxel-in-previously-treated-advanced-or-metastatic-krasg12c-mutated-nsclc/ 2025-08-21T21:17:08+00:00 https://ascopost.com/news/august-2025/can-beta-blockers-help-halt-the-progression-of-triple-negative-breast-cancer/ 2025-08-21T21:20:44+00:00 https://ascopost.com/news/august-2025/identification-of-fap-expressing-tumors-with-radiotracer/ 2025-08-21T21:20:35+00:00 https://ascopost.com/news/august-2025/cancer-induced-nerve-injury-identified-as-driver-of-pd-1-resistance-across-tumor-types/ 2025-09-18T20:06:26+00:00 https://ascopost.com/news/august-2025/rural-and-urban-differences-in-prostate-cancer-recurrence/ 2025-08-21T21:35:07+00:00 https://ascopost.com/news/august-2025/hybrid-ai-approach-with-uncertainty-quantification-for-mammography-reading-supports-safe-workload-reduction/ 2026-01-07T20:25:20+00:00 https://ascopost.com/news/august-2025/friends-of-cancer-research-advances-work-to-improve-interpretation-of-interim-os-data-in-oncology-trials/ 2025-08-22T13:38:32+00:00 https://ascopost.com/news/august-2025/patient-and-health-care-professional-groups-express-support-for-bipartisan-clinical-trial-bill/ 2025-08-22T13:40:09+00:00 https://ascopost.com/news/august-2025/kinase-inhibitor-approved-for-nonsquamous-nsclc-with-her2-tkd-activating-mutations/ 2025-08-22T13:42:57+00:00 https://ascopost.com/news/august-2025/new-recommendations-released-for-managing-aromatase-inhibitor-induced-bone-loss/ 2025-08-22T14:22:34+00:00 https://ascopost.com/news/august-2025/metastatic-colorectal-cancer-pros-with-sotorasib-and-panitumumab-vs-standard-of-care/ 2025-08-22T14:24:10+00:00 https://ascopost.com/news/august-2025/locoregionally-advanced-nasopharyngeal-carcinoma-comparison-of-regimens-following-induction-chemotherapy/ 2026-01-27T18:02:20+00:00 https://ascopost.com/news/august-2025/are-postmastectomy-implant-based-breast-reconstructions-associated-with-lymphomas-of-the-breast/ 2025-08-22T14:57:49+00:00 https://ascopost.com/news/august-2025/can-autoimmune-diseases-increase-the-risk-of-digestive-system-cancer/ 2025-08-22T14:58:33+00:00 https://ascopost.com/news/august-2025/underlying-mechanisms-of-chemoresistance-in-aml/ 2025-11-12T17:34:29+00:00 https://ascopost.com/news/august-2025/effect-of-hippocampal-avoidance-in-prophylactic-cranial-irradiation-in-sclc/ 2025-08-22T14:48:36+00:00 https://ascopost.com/news/august-2025/treatment-resistant-melanoma-novel-checkpoint-inhibitor-combination/ 2025-09-02T19:57:23+00:00 https://ascopost.com/news/august-2025/can-a-mitochondrial-antioxidant-drive-metastasis/ 2025-08-22T14:50:45+00:00 https://ascopost.com/news/august-2025/endocrine-therapy-with-aromatase-inhibitor-for-postmenopausal-women-with-breast-cancer/ 2025-08-22T14:51:25+00:00 https://ascopost.com/news/august-2025/psma-petct-and-salvage-radiotherapy-in-recurrent-prostate-cancer/ 2025-08-22T14:52:39+00:00 https://ascopost.com/news/august-2025/patient-awareness-of-pharmacogenomic-testing-remains-low-acs-can-survey-reports/ 2025-08-22T14:54:16+00:00 https://ascopost.com/news/august-2025/dendrimer-based-sn38-nanoparticle-shows-favorable-safety-and-activity-in-advanced-solid-tumors/ 2025-08-22T14:54:22+00:00 https://ascopost.com/news/august-2025/glioblastoma-dual-immunotherapy-plus-radiotherapy-in-newly-diagnosed-mgmt-unmethylated-disease/ 2025-08-22T14:39:43+00:00 https://ascopost.com/news/august-2025/stronger-primary-care-ties-may-improve-cancer-survivorship/ 2025-08-22T14:40:43+00:00 https://ascopost.com/news/august-2025/ebrt-with-focal-boost-to-intraprostatic-tumor-in-localized-prostate-cancer/ 2025-08-22T14:42:18+00:00 https://ascopost.com/news/august-2025/age-threshold-for-survival-benefit-of-adding-oxaliplatin-to-adjuvant-chemotherapy-in-stage-ii-and-iii-colorectal-cancer/ 2025-08-22T14:43:25+00:00 https://ascopost.com/news/august-2025/breast-cancer-surveillance-in-pre-vs-post-covid-19-periods/ 2025-08-22T14:43:32+00:00 https://ascopost.com/news/august-2025/new-drug-releasing-system-eliminates-bladder-cancer-in-over-80-of-patients-in-a-phase-ii-trial/ 2025-08-22T14:44:17+00:00 https://ascopost.com/news/august-2025/clinically-significant-fatigue-and-inflammation-in-breast-cancer-survivors/ 2025-08-22T14:45:01+00:00 https://ascopost.com/news/august-2025/rsna-challenge-ai-models-enhance-mammography-detection-of-invasive-breast-cancer/ 2025-10-29T16:35:14+00:00 https://ascopost.com/news/august-2025/routine-ai-assistance-may-lead-to-loss-of-skills-in-endoscopists-study-shows/ 2025-11-11T19:09:02+00:00 https://ascopost.com/news/august-2025/can-baseline-psma-pet-help-to-predict-response-to-lupsma-and-enzalutamide-in-mcrpc/ 2025-08-22T14:47:39+00:00 https://ascopost.com/news/august-2025/older-women-with-high-risk-breast-cancer-addition-of-adjuvant-chemotherapy-to-hormone-therapy/ 2025-10-03T18:52:35+00:00 https://ascopost.com/news/august-2025/subspecialization-in-oncology-is-increasing-but-unevenly-distributed-across-the-country/ 2025-08-29T17:42:01+00:00 https://ascopost.com/news/august-2025/childhood-cancer-survivors-and-long-term-risks-for-health-conditions-new-data/ 2025-08-22T14:40:12+00:00 https://ascopost.com/news/august-2025/web-tool-seeks-to-reduce-state-lung-cancer-mortality-rates/ 2025-08-22T14:39:12+00:00 https://ascopost.com/news/august-2025/genomics-guided-tool-to-inform-treatment-of-advanced-kidney-cancers/ 2025-08-22T14:36:41+00:00 https://ascopost.com/news/august-2025/mortality-in-advanced-stage-ovarian-cancer-effect-of-neoadjuvant-chemotherapy-and-cytoreductive-surgery-case-volume/ 2025-08-22T14:33:46+00:00 https://ascopost.com/news/august-2025/smoking-cessation-in-cancer-care-challenges-and-opportunities/ 2025-08-22T14:32:51+00:00 https://ascopost.com/news/august-2025/glp-1-receptor-agonists-vs-other-glucose-lowering-drugs-survival-in-older-patients-with-cancer-and-diabetes/ 2025-08-22T14:31:59+00:00 https://ascopost.com/news/august-2025/genetic-testing-may-reduce-chemotherapy-side-effects-for-patients-with-gi-cancers/ 2025-08-22T14:31:01+00:00 https://ascopost.com/news/august-2025/novel-single-cell-sequencing-blood-test-for-multiple-myeloma/ 2025-08-22T13:53:59+00:00 https://ascopost.com/news/august-2025/real-world-study-highlights-gaps-in-hypomethylating-agent-treatment-for-mds/ 2025-08-22T14:29:33+00:00 https://ascopost.com/news/august-2025/alpelisib-plus-olaparib-vs-single-agent-chemotherapy-in-platinum-resistant-or-refractory-hgsoc-without-brca-mutation/ 2025-08-22T14:28:28+00:00 https://ascopost.com/news/august-2025/mfolfirinox-and-s-irox-vs-nab-paclitaxel-plus-gemcitabine-in-metastatic-or-recurrent-pancreatic-cancer/ 2025-08-22T14:06:15+00:00 https://ascopost.com/news/august-2025/protease-activator-approved-by-the-fda-for-diffuse-midline-glioma/ 2025-08-22T14:05:21+00:00 https://ascopost.com/news/august-2025/rcc-genetic-testing-key-to-avoiding-misdiagnosis-of-rare-subtypes/ 2025-08-22T14:04:15+00:00 https://ascopost.com/news/august-2025/two-acs-studies-show-colorectal-cancer-screening-and-early-diagnosis-have-soared-in-adults-aged-45-to-49-years/ 2025-08-26T18:00:46+00:00 https://ascopost.com/news/august-2025/nivolumab-plus-ipilimumab-in-advanced-ovarian-and-endometrial-clear-cell-cancers/ 2025-08-22T14:02:17+00:00 https://ascopost.com/news/august-2025/immunoglobulin-replacement-therapy-and-infection-risks-in-cll/ 2025-09-11T17:32:05+00:00 https://ascopost.com/news/august-2025/asco-edge-launches-for-all-members/ 2025-08-22T13:57:56+00:00 https://ascopost.com/news/august-2025/nivolumab-plus-ipilimumab-in-mcrpc-with-an-immunogenic-signature/ 2025-08-22T13:56:52+00:00 https://ascopost.com/news/august-2025/perceived-dermatologic-side-effects-of-cancer-treatment/ 2025-08-22T13:56:06+00:00 https://ascopost.com/news/august-2025/pediatric-gliomas-early-research-on-targeted-therapies/ 2025-08-22T13:47:22+00:00 https://ascopost.com/news/august-2025/outcomes-associated-with-covid-19-infection-in-patients-with-cancer/ 2025-08-22T13:44:04+00:00 https://ascopost.com/news/august-2025/prostate-cancer-one-in-six-grade-group-1-cases-linked-to-higher-risk-disease/ 2025-08-22T13:42:46+00:00 https://ascopost.com/news/august-2025/ultraprocessed-food-consumption-linked-to-increased-lung-cancer-risk/ 2025-08-22T13:40:51+00:00 https://ascopost.com/news/august-2025/pediatric-cns-tumors-long-term-survival-and-cure-fraction-estimates/ 2025-08-22T13:36:55+00:00 https://ascopost.com/news/august-2025/avutometinib-plus-defactinib-in-recurrent-low-grade-serous-ovarian-cancer/ 2025-08-22T13:33:48+00:00 https://ascopost.com/news/august-2025/lls-unveils-name-change/ 2025-08-22T13:29:07+00:00 https://ascopost.com/news/august-2025/updated-chest-guidelines-emphasize-minimally-invasive-surgery-for-early-stage-nsclc/ 2025-08-22T13:27:26+00:00 https://ascopost.com/news/august-2025/does-preexisting-depression-impact-prostate-cancer-survival/ 2025-08-22T13:24:02+00:00 https://ascopost.com/news/august-2025/bacterial-decolonization-to-manage-radiation-induced-oral-mucositis-in-nasopharyngeal-carcinoma/ 2026-01-27T18:01:00+00:00 https://ascopost.com/news/august-2025/racial-and-ethnic-disparities-in-guideline-concordant-pancreatic-cancer-care-among-older-adults/ 2025-08-22T14:37:28+00:00 https://ascopost.com/news/august-2025/rare-secondary-cancer-after-car-t-cell-therapy-successfully-treated-case-report-shows/ 2025-08-22T14:51:35+00:00 https://ascopost.com/news/august-2025/basal-cell-carcinoma-early-research-on-a-novel-topical-fluorescent-imaging-technique/ 2025-09-02T19:48:04+00:00 https://ascopost.com/news/august-2025/unmet-social-needs-distort-trust-in-cancer-information-study-shows/ 2025-08-26T15:02:34+00:00 https://ascopost.com/news/august-2025/added-everolimus-reduces-risk-for-advanced-tnbc/ 2025-08-26T15:51:10+00:00 https://ascopost.com/news/august-2025/factors-influencing-symptom-burden-in-pediatric-patients-with-cancer-insights-from-routine-screening/ 2025-08-26T16:01:08+00:00 https://ascopost.com/news/august-2025/which-first-line-systemic-therapy-balances-survival-and-quality-of-life-in-advanced-hepatocellular-carcinoma/ 2026-01-02T20:16:02+00:00 https://ascopost.com/news/august-2025/bwel-weight-loss-trial-reports-success-for-patients-with-breast-cancer-at-1-year-mark/ 2025-08-26T19:38:23+00:00 https://ascopost.com/news/august-2025/can-baseline-kidney-function-predict-chronic-kidney-disease-after-cisplatin-treatment/ 2025-08-26T19:44:13+00:00 https://ascopost.com/news/august-2025/asco-thanks-richard-schilsky-for-his-vision-and-leadership-of-tapur/ 2025-08-26T19:58:42+00:00 https://ascopost.com/news/august-2025/pembrolizumab-plus-chemotherapy-vs-chemotherapy-in-advanced-gastric-cancers-final-survival-analysis-from-keynote-585/ 2025-08-27T14:40:10+00:00 https://ascopost.com/news/august-2025/association-of-germline-pathogeniclikely-pathogenic-mutations-and-subsequent-neoplasms-in-childhood-cancer-survivors/ 2025-08-28T14:32:52+00:00 https://ascopost.com/news/august-2025/analysis-shows-no-major-racial-differences-in-somatic-mutations-of-triple-negative-breast-cancer/ 2025-08-28T17:45:51+00:00 https://ascopost.com/news/august-2025/disparities-in-us-county-level-cervical-cancer-screening-coverage-lead-to-differences-in-outcomes/ 2025-08-28T15:37:13+00:00 https://ascopost.com/news/august-2025/survey-finds-discordance-between-treatment-preferences-and-clinical-care-for-advanced-cancer/ 2025-08-28T17:43:35+00:00 https://ascopost.com/news/august-2025/lu-177-dotatate-in-progressive-metastatic-pheochromocytomas-and-paragangliomas/ 2025-08-28T15:53:53+00:00 https://ascopost.com/news/august-2025/identifying-cns-tumors-with-multianalyte-cerebrospinal-fluid-test/ 2025-08-29T17:39:23+00:00 https://ascopost.com/news/august-2025/adding-dendritic-cell-vaccination-to-hepatocellular-carcinoma-therapy/ 2026-01-02T20:15:39+00:00 https://ascopost.com/news/august-2025/mifamurtide-plus-chemotherapy-for-nonmetastatic-high-grade-osteosarcoma/ 2025-08-29T14:31:42+00:00 https://ascopost.com/news/august-2025/real-world-incidence-and-management-of-infusion-related-reactions-to-monoclonal-antibody-therapy/ 2025-08-29T14:42:06+00:00 https://ascopost.com/news/september-2025/ 2025-09-29T16:25:00+00:00 https://ascopost.com/news/september-2025/government-housing-assistance-linked-to-reduced-medical-financial-hardship-among-cancer-survivors/ 2025-09-02T14:32:36+00:00 https://ascopost.com/news/september-2025/gastrointestinal-tumor-microbes-may-predict-prognosis-and-therapeutic-response/ 2025-09-02T15:06:48+00:00 https://ascopost.com/news/september-2025/geriatric-assessment-guided-approach-to-treatment-intensity-in-older-adults-with-aml/ 2025-09-24T18:43:20+00:00 https://ascopost.com/news/september-2025/do-breast-and-gynecologic-cancers-contribute-to-job-resignation-in-working-women/ 2025-09-02T15:31:24+00:00 https://ascopost.com/news/september-2025/fda-approves-btk-inhibitor-for-itp/ 2025-09-03T14:33:33+00:00 https://ascopost.com/news/september-2025/ido1-inhibition-mitigates-diet-induced-risk-of-cancer-associated-vte-in-preclinical-models/ 2025-09-03T15:36:44+00:00 https://ascopost.com/news/september-2025/public-awareness-of-hpv-hpv-vaccine-and-the-association-of-hpv-with-cancer/ 2025-09-08T20:19:47+00:00 https://ascopost.com/news/september-2025/study-shows-that-after-early-breast-cancer-diagnosis-risk-of-a-second-cancer-is-low/ 2025-10-03T18:49:51+00:00 https://ascopost.com/news/september-2025/lifileucel-demonstrates-feasibility-and-disease-stability-in-advanced-head-and-neck-squamous-cell-carcinoma/ 2026-01-27T17:51:25+00:00 https://ascopost.com/news/september-2025/ai-shear-wave-elastography-model-for-diagnosing-breast-cancer-in-bi-rads-3-or-4-masses/ 2025-10-28T21:04:06+00:00 https://ascopost.com/news/september-2025/model-to-identify-patients-with-clinical-high-risk-early-breast-cancer-who-may-avoid-escalated-adjuvant-therapy/ 2025-09-04T15:07:20+00:00 https://ascopost.com/news/september-2025/new-report-on-breast-reconstruction-preferences-among-african-american-women/ 2025-09-04T18:05:15+00:00 https://ascopost.com/news/september-2025/could-a-nasal-spray-help-protect-patients-with-cancer-against-covid-19-infection/ 2025-09-05T16:42:19+00:00 https://ascopost.com/news/september-2025/study-finds-personalized-risk-messages-had-no-effect-in-raising-colorectal-cancer-screening-participation/ 2025-11-18T18:52:20+00:00 https://ascopost.com/news/september-2025/can-a-common-anti-inflammatory-drug-help-to-control-progression-of-clonal-hematopoiesis/ 2025-09-05T15:21:47+00:00 https://ascopost.com/news/september-2025/inherited-variants-in-16-genes-may-double-the-risk-of-multiple-primary-cancers/ 2025-09-05T16:48:28+00:00 https://ascopost.com/news/september-2025/glp-1-ras-and-cancer-risk-in-adults-with-overweightobesity/ 2025-09-08T18:29:09+00:00 https://ascopost.com/news/september-2025/all-trans-retinoic-acid-and-arsenic-trioxide-in-high-risk-acute-promyelocytic-leukemia/ 2025-09-08T15:26:44+00:00 https://ascopost.com/news/september-2025/egfr-mutated-nsclc-continuing-osimertinib-plus-chemotherapy-through-disease-progression-improves-pfs/ 2025-09-08T17:22:59+00:00 https://ascopost.com/news/september-2025/urine-based-biomarker-panel-for-the-detection-of-prostate-cancer/ 2025-09-08T15:54:42+00:00 https://ascopost.com/news/september-2025/observation-outperforms-adjuvant-crizotinib-for-resected-alk-nsclc/ 2025-09-18T14:29:05+00:00 https://ascopost.com/news/september-2025/fdas-oce-invites-external-research-questions-to-advance-science-benefit-patients/ 2025-09-09T15:24:06+00:00 https://ascopost.com/news/september-2025/novel-adc-under-study-in-previously-treated-egfr-mutated-nsclc/ 2025-09-12T18:21:50+00:00 https://ascopost.com/news/september-2025/izalontamab-brengitecan-plus-osimertinib-shows-activity-in-first-line-egfr-mutant-nsclc/ 2025-09-09T18:44:13+00:00 https://ascopost.com/news/september-2025/zidesamtinib-demonstrates-responses-in-ros1-positive-nsclc-after-prior-tki-treatment/ 2025-09-09T17:37:36+00:00 https://ascopost.com/news/september-2025/aumolertinib-plus-chemotherapy-improves-pfs-in-nsclc-with-egfr-and-concomitant-tumor-suppressor-genes/ 2025-09-09T15:57:10+00:00 https://ascopost.com/news/september-2025/previously-treated-es-sclc-i-dxd-demonstrates-high-response-rate/ 2025-09-09T16:05:22+00:00 https://ascopost.com/news/september-2025/dll3-targeted-antibody-drug-conjugate-in-relapsed-sclc/ 2025-09-09T16:33:19+00:00 https://ascopost.com/news/september-2025/fda-approves-gemcitabine-intravesical-system-for-non-muscle-invasive-bladder-cancer/ 2025-09-11T14:48:48+00:00 https://ascopost.com/news/september-2025/fda-approves-kinase-inhibitor-for-pediatric-patients-with-nf1/ 2025-09-10T17:21:25+00:00 https://ascopost.com/news/september-2025/adjuvant-chemoimmunotherapy-for-resected-stage-ib-iiia-nsclc/ 2025-09-10T19:35:05+00:00 https://ascopost.com/news/september-2025/no-os-benefit-for-concurrent-and-consolidative-durvalumab-vs-consolidation-alone-in-unresectable-stage-iii-nsclc/ 2025-09-10T19:42:57+00:00 https://ascopost.com/news/september-2025/lung-cancer-screening-may-benefit-adults-up-to-age-80-who-are-fit-for-surgery/ 2025-09-11T17:43:28+00:00 https://ascopost.com/news/september-2025/overall-survival-risk-for-vats-vs-open-lobectomy-for-early-lung-cancer/ 2025-09-11T17:44:54+00:00 https://ascopost.com/news/september-2025/novel-targeted-agent-under-study-in-mtap-deleted-nsclc/ 2025-09-11T17:46:29+00:00 https://ascopost.com/news/september-2025/new-subcutaneous-amivantamab-combo-dosing-schedule-shows-safety-and-efficacy-in-egfr-positive-nsclc/ 2025-09-12T18:10:11+00:00 https://ascopost.com/news/september-2025/tarlatamab-and-anti-pd-1-therapy-as-first-line-maintenance-for-es-sclc/ 2025-09-15T12:53:34+00:00 https://ascopost.com/news/september-2025/hypofractionated-vs-conventional-radiotherapy-in-phase-iii-trial-for-ls-sclc/ 2025-09-12T18:06:24+00:00 https://ascopost.com/news/september-2025/stas-predicts-prognosis-in-early-nsclc-regardless-of-surgical-approach/ 2025-09-12T18:08:15+00:00 https://ascopost.com/news/september-2025/is-ifitm3-a-driver-of-immunotherapy-response-in-sclc/ 2025-09-15T15:17:34+00:00 https://ascopost.com/news/september-2025/ctdna-may-guide-immunotherapy-in-limited-stage-sclc/ 2025-09-15T15:49:16+00:00 https://ascopost.com/news/september-2025/surgical-resection-with-egfr-tki-demonstrates-promising-pfs-in-egfr-mutant-nsclc/ 2025-10-14T15:19:33+00:00 https://ascopost.com/news/september-2025/viral-immunotherapy-may-extend-survival-in-advanced-nsclc-after-progression-on-immune-checkpoint-inhibition/ 2025-09-15T18:37:30+00:00 https://ascopost.com/news/september-2025/new-acs-prostate-cancer-report-late-stage-incidence-rates-continue-to-increase-rapidly-as-mortality-declines-slow/ 2025-09-15T19:51:38+00:00 https://ascopost.com/news/september-2025/addition-of-neoadjuvant-tar-200-to-cetrelimab-in-cisplatin-ineligible-muscle-invasive-bladder-cancer/ 2025-09-16T19:48:03+00:00 https://ascopost.com/news/september-2025/tislelizumab-based-triplet-therapy-for-conversion-of-unresectable-to-resectable-locally-advanced-biliary-tract-cancer/ 2025-09-16T16:24:00+00:00 https://ascopost.com/news/september-2025/noncancer-related-mortality-in-rcts-with-targeted-screening/ 2025-09-16T15:55:13+00:00 https://ascopost.com/news/september-2025/study-finds-high-risk-prescriptions-drive-frailty-hospitalization-and-mortality-in-older-adults-with-cancer/ 2025-09-16T15:37:05+00:00 https://ascopost.com/news/september-2025/benmelstobart-plus-anlotinib-vs-sunitinib-as-first-line-treatment-of-advanced-renal-cell-carcinoma/ 2025-09-17T14:12:16+00:00 https://ascopost.com/news/september-2025/new-liquid-biopsy-test-for-early-detection-of-head-and-neck-cancers/ 2026-01-27T17:49:39+00:00 https://ascopost.com/news/september-2025/is-tbi-associated-with-malignant-brain-tumors/ 2025-09-17T15:54:36+00:00 https://ascopost.com/news/september-2025/clear-margin-diagnostic-excisional-biopsy-may-adequately-treat-melanoma-in-situ-study-finds/ 2025-09-17T16:04:26+00:00 https://ascopost.com/news/september-2025/incorporating-family-caregivers-into-shared-decision-making-for-patients-with-cancer/ 2025-09-17T16:12:40+00:00 https://ascopost.com/news/september-2025/study-finds-postapproval-cancer-trials-fell-after-inflation-reduction-act/ 2025-09-17T16:21:46+00:00 https://ascopost.com/news/september-2025/study-finds-insufficient-evidence-demonstrating-clinical-benefit-of-multicancer-detection-tests/ 2025-09-18T15:08:39+00:00 https://ascopost.com/news/september-2025/addition-of-metastasis-directed-sbrt-to-standard-therapy-in-oligometastatic-castration-resistant-prostate-cancer/ 2025-09-18T15:51:55+00:00 https://ascopost.com/news/september-2025/chronic-toxicity-rates-with-de-escalated-vs-standard-adjuvant-radiotherapy-in-hpv-associated-oropharyngeal-squamous-cell-carcinoma/ 2026-01-27T17:49:06+00:00 https://ascopost.com/news/september-2025/policy-review-hrqol-data-in-clinical-trials-for-advanced-cancer/ 2025-09-18T15:31:11+00:00 https://ascopost.com/news/september-2025/leading-societies-update-clinical-guideline-on-postmastectomy-radiation-therapy/ 2025-09-18T14:53:30+00:00 https://ascopost.com/news/september-2025/oral-microbiota-and-risk-for-pancreatic-cancer/ 2025-09-18T16:43:08+00:00 https://ascopost.com/news/september-2025/adjuvant-chemoradiotherapy-vs-radiotherapy-for-high-risk-endometrial-cancer-10-year-portec-3-outcomes/ 2025-09-19T17:56:56+00:00 https://ascopost.com/news/september-2025/overall-survival-after-hormonal-therapy-vs-hysterectomy-in-early-endometrial-cancer/ 2025-10-30T17:28:17+00:00 https://ascopost.com/news/september-2025/proton-craniospinal-irradiation-for-leptomeningeal-metastasis-in-lung-or-breast-cancer/ 2025-09-19T14:36:19+00:00 https://ascopost.com/news/september-2025/metastasis-directed-radiotherapy-for-oligometastatic-clear-cell-renal-cell-carcinoma/ 2025-09-22T13:59:03+00:00 https://ascopost.com/news/september-2025/use-of-pazopanib-in-advanced-extrapancreatic-neuroendocrine-tumors/ 2025-09-22T14:06:35+00:00 https://ascopost.com/news/september-2025/acute-cystitis-may-signal-urogenital-cancer/ 2025-09-22T18:34:52+00:00 https://ascopost.com/news/september-2025/fda-approves-pembrolizumab-and-berahyaluronidase-alfa-pmph-for-subcutaneous-injection/ 2025-09-22T15:20:01+00:00 https://ascopost.com/news/september-2025/does-early-pesticide-exposure-lead-to-higher-mortality-risk-in-pediatric-all/ 2025-10-03T14:00:45+00:00 https://ascopost.com/news/september-2025/perioperative-use-of-nivolumab-with-or-without-ipilimumab-for-resectable-diffuse-pleural-mesothelioma/ 2025-09-24T18:21:40+00:00 https://ascopost.com/news/september-2025/surgery-for-early-stage-cancer-and-opioid-use/ 2025-09-23T15:22:26+00:00 https://ascopost.com/news/september-2025/amivantamab-plus-lazertinib-vs-osimertinib-in-egfr-mutated-advanced-nsclc/ 2025-10-14T17:46:22+00:00 https://ascopost.com/news/september-2025/hpv-self-sampling-collection-test-improved-cervical-cancer-screening-rates-among-asian-american-women/ 2025-09-23T15:58:20+00:00 https://ascopost.com/news/september-2025/aya-cancer-survivors-face-increased-social-risks/ 2025-09-23T16:22:58+00:00 https://ascopost.com/news/september-2025/more-tattoos-lessened-risk-of-melanoma-new-study-investigates/ 2025-10-06T16:35:51+00:00 https://ascopost.com/news/september-2025/medical-imaging-and-risk-of-pediatric-and-adolescent-hematologic-cancer/ 2025-09-24T18:19:39+00:00 https://ascopost.com/news/september-2025/can-nicotinamide-lessen-the-risk-of-skin-cancer-development/ 2025-10-06T16:36:48+00:00 https://ascopost.com/news/september-2025/advanced-or-metastatic-breast-cancer-fda-approves-imlunestrant-for-er-positive-her2-negative-esr1-mutated-disease/ 2025-10-03T18:47:50+00:00 https://ascopost.com/news/september-2025/cutaneous-squamous-cell-carcinoma-ai-model-rivals-dermatologists-in-differentiation-assessment/ 2025-10-29T16:04:21+00:00 https://ascopost.com/news/september-2025/neoadjuvant-folfirinox-vs-gemcitabine-based-chemoradiotherapy-in-pdac/ 2025-09-26T14:16:40+00:00 https://ascopost.com/news/september-2025/localized-pi3k-altered-colorectal-cancer-does-low-dose-aspirin-reduce-the-risk-of-recurrence/ 2025-10-21T18:05:33+00:00 https://ascopost.com/news/september-2025/fda-removes-vandetanib-rems-program/ 2025-10-02T13:18:30+00:00 https://ascopost.com/news/september-2025/16-million-prism-trial-will-explore-ai-in-breast-cancer-screening/ 2025-11-04T17:51:37+00:00 https://ascopost.com/news/september-2025/addition-of-xevinapant-to-platinum-based-chemoradiotherapy-in-unresected-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck/ 2026-01-27T17:48:12+00:00 https://ascopost.com/news/september-2025/modified-folfirinox-vs-gemcitabinenab-paclitaxel-in-metastatic-pancreatic-cancer/ 2025-09-29T16:31:49+00:00 https://ascopost.com/news/september-2025/cancer-deaths-expected-to-rise-to-over-18-million-in-2050/ 2025-09-29T16:14:48+00:00 https://ascopost.com/news/september-2025/impact-of-novel-donor-search-strategy-on-outcomes-for-potential-hct-recipients/ 2025-09-30T17:21:42+00:00 https://ascopost.com/news/september-2025/association-of-tert-expression-with-outcomes-in-meningioma/ 2025-09-30T15:20:04+00:00 https://ascopost.com/news/september-2025/prostate-cancer-radiopharmaceutical-plus-sbrt-delays-progression-in-patients-with-limited-metastatic-disease/ 2025-09-30T18:35:48+00:00 https://ascopost.com/news/september-2025/pam50-subtyping-identifies-patients-with-prostate-cancer-most-likely-to-benefit-from-apalutamide/ 2025-09-30T17:47:03+00:00 https://ascopost.com/news/september-2025/adjuvant-radiation-therapy-safe-and-beneficial-in-locally-advanced-mibc/ 2025-09-30T20:22:58+00:00 https://ascopost.com/news/october-2025/ 2025-10-01T13:36:47+00:00 https://ascopost.com/news/october-2025/nci-issues-request-for-2027-budget/ 2025-10-01T14:37:28+00:00 https://ascopost.com/news/october-2025/impact-of-her2-receptor-status-in-mcrc-treated-with-chemotherapy-plus-bevacizumab-or-anti-egfrs/ 2025-10-21T18:06:12+00:00 https://ascopost.com/news/october-2025/sabr-may-be-comparable-to-surgery-for-early-stage-nsclc/ 2025-11-14T18:57:06+00:00 https://ascopost.com/news/october-2025/oropharyngeal-cancer-quality-of-life-outcomes-imrt-vs-proton-beam-therapy/ 2026-01-27T17:32:39+00:00 https://ascopost.com/news/october-2025/intermediate-risk-prostate-cancer-shorter-radiation-improves-patient-experience-but-not-disease-control/ 2025-10-01T15:59:48+00:00 https://ascopost.com/news/october-2025/impact-of-proton-and-photon-therapy-on-hrqol-in-breast-cancer/ 2025-10-03T20:18:52+00:00 https://ascopost.com/news/october-2025/kidney-cancer-cases-expected-to-double-by-2050/ 2025-10-02T17:39:23+00:00 https://ascopost.com/news/october-2025/sunvozertinib-in-platinum-pretreated-nsclc-with-egfr-exon-20-insertion-mutations/ 2025-10-02T20:05:51+00:00 https://ascopost.com/news/october-2025/ct-adapative-sbrt-for-recurrent-retroperitoneal-sarcomas/ 2025-10-02T15:14:01+00:00 https://ascopost.com/news/october-2025/cd19-car-t-cell-therapy-may-be-effective-in-treating-resistant-ulcerative-colitis/ 2025-10-03T18:41:37+00:00 https://ascopost.com/news/october-2025/pembrolizumab-plus-platinum-based-chemotherapy-in-advanced-penile-cancer/ 2025-10-03T15:33:09+00:00 https://ascopost.com/news/october-2025/fda-approves-combination-regimen-for-extensive-stage-sclc/ 2025-10-14T17:47:42+00:00 https://ascopost.com/news/october-2025/medicare-telehealth-flexibilities-and-cms-operations-during-government-shutdown/ 2025-10-03T15:28:46+00:00 https://ascopost.com/news/october-2025/cytogenetic-remission-linked-to-improved-survival-in-patients-with-aml/ 2025-10-03T17:06:07+00:00 https://ascopost.com/news/october-2025/911-first-responder-study-shows-how-toxic-exposures-may-lead-to-blood-cancers/ 2025-10-06T13:19:43+00:00 https://ascopost.com/news/october-2025/dose-intensified-proton-therapy-for-newly-diagnosed-glioblastoma/ 2025-10-06T16:19:26+00:00 https://ascopost.com/news/october-2025/patient-reported-outcomes-and-overall-survival-in-cancer/ 2025-10-06T16:27:47+00:00 https://ascopost.com/news/october-2025/association-of-survival-with-treatment-recommendation-and-receipt-in-older-patients-with-early-stage-cervical-cancer/ 2025-10-06T14:56:20+00:00 https://ascopost.com/news/october-2025/immunotherapy-addition-yields-qol-benefits-in-limited-stage-small-cell-lung-cancer/ 2025-10-06T16:48:29+00:00 https://ascopost.com/news/october-2025/dexamethasone-sparing-regimen-for-frail-patients-with-newly-diagnosed-multiple-myeloma/ 2025-10-07T15:09:14+00:00 https://ascopost.com/news/october-2025/genetic-modification-of-the-ajcc-classification-for-papillary-thyroid-cancer/ 2025-10-07T15:14:03+00:00 https://ascopost.com/news/october-2025/breast-volume-preservation-comparable-after-five-fraction-whole-or-partial-breast-radiotherapy/ 2025-10-07T15:25:44+00:00 https://ascopost.com/news/october-2025/network-of-cancer-drug-repositories-improves-access-to-treatment-reduces-waste/ 2025-10-07T18:22:01+00:00 https://ascopost.com/news/october-2025/immunogenicity-of-rsv-vaccines-in-immunocompromised-allogeneic-hsct-recipients/ 2025-10-08T13:54:50+00:00 https://ascopost.com/news/october-2025/predicting-future-breast-cancer-outcomes-efficacy-of-a-polygenic-risk-score/ 2025-10-08T16:29:36+00:00 https://ascopost.com/news/october-2025/pulsed-low-dose-rate-chemoradiation-reduces-severe-esophagitis-in-esophageal-cancer-and-nsclc/ 2025-10-08T16:20:10+00:00 https://ascopost.com/news/october-2025/inflammatory-activity-and-cancer-related-fatigue-in-early-breast-cancer/ 2025-10-09T18:11:37+00:00 https://ascopost.com/news/october-2025/inotuzumab-ozogamicin-followed-by-blinatumomab-in-older-patients-with-newly-diagnosed-b-cell-all/ 2025-10-09T14:10:55+00:00 https://ascopost.com/news/october-2025/systemic-anticancer-therapy-at-end-of-life-and-health-care-use-among-older-patients/ 2025-10-09T14:16:49+00:00 https://ascopost.com/news/october-2025/pd-1-inhibitor-approved-for-adjuvant-treatment-of-cscc/ 2025-10-09T15:03:58+00:00 https://ascopost.com/news/october-2025/patients-value-communication-skills-from-cancer-surgeons-across-six-key-areas/ 2025-10-10T14:52:50+00:00 https://ascopost.com/news/october-2025/mastectomy-linked-to-worsened-sexual-health-and-body-image-after-surgery-study-finds/ 2025-10-09T19:39:28+00:00 https://ascopost.com/news/october-2025/john-l-cameron-receives-wangensteen-scientific-forum-award/ 2025-10-09T20:17:47+00:00 https://ascopost.com/news/october-2025/antidepressants-may-improve-surgical-outcomes-in-patients-with-gi-cancer-and-depression/ 2025-10-10T15:21:10+00:00 https://ascopost.com/news/october-2025/financial-toxicity-tied-to-increased-risk-of-mortality-among-patients-with-cancer/ 2025-10-10T14:45:13+00:00 https://ascopost.com/news/october-2025/study-identifies-rectal-bleeding-as-key-predictor-of-early-onset-colorectal-cancer/ 2025-12-09T20:33:26+00:00 https://ascopost.com/news/october-2025/advanced-biliary-tract-cancer-adding-a-polymeric-micellar-paclitaxel-to-gemcitabine-plus-cisplatin/ 2025-10-13T13:36:09+00:00 https://ascopost.com/news/october-2025/ziftomenib-in-relapsed-or-refractory-npm1-mutant-aml/ 2025-10-13T13:44:00+00:00 https://ascopost.com/news/october-2025/gaps-persist-in-follow-up-care-among-young-survivors-of-breast-cancer/ 2025-10-13T14:34:33+00:00 https://ascopost.com/news/october-2025/incidence-of-invasive-lobular-carcinoma-rising-faster-than-other-breast-cancers/ 2025-10-13T17:38:51+00:00 https://ascopost.com/news/october-2025/fertility-sparing-surgery-vs-hysterectomy-for-early-stage-cervical-cancer-comparable-survival-rates-but-higher-recurrence-risk/ 2025-10-14T17:41:22+00:00 https://ascopost.com/news/october-2025/first-line-ribociclib-at-400-vs-600-mg-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/ 2025-10-14T14:41:47+00:00 https://ascopost.com/news/october-2025/study-confirms-it-is-never-too-late-to-see-survival-benefits-from-quitting-smoking-even-with-late-stage-cancer/ 2025-10-14T14:46:26+00:00 https://ascopost.com/news/october-2025/eha-publishes-guidelines-for-lbcl-and-multiple-myeloma/ 2025-10-14T15:06:10+00:00 https://ascopost.com/news/october-2025/10-year-incidence-of-second-cancers-in-hpv-oropharyngeal-cancer/ 2026-01-27T17:28:10+00:00 https://ascopost.com/news/october-2025/combination-therapies-for-diffuse-large-b-cell-lymphoma-5-year-outcomes-of-polarix-trial/ 2025-10-31T16:14:50+00:00 https://ascopost.com/news/october-2025/chemotherapy-free-regimen-vs-standard-immunochemotherapy-in-mantle-cell-lymphoma-in-older-patients/ 2025-10-15T15:54:12+00:00 https://ascopost.com/news/october-2025/individuals-with-rare-cancers-present-distinct-diagnosis-patterns-many-experience-treatment-delays/ 2025-10-15T16:22:02+00:00 https://ascopost.com/news/october-2025/new-aaci-president-elect-selected-two-cancer-center-leaders-join-board/ 2025-10-15T16:25:16+00:00 https://ascopost.com/news/october-2025/palliative-care-remains-underused-among-young-adults-with-advanced-cancer/ 2025-10-15T15:43:37+00:00 https://ascopost.com/news/october-2025/aml-alliance-global-study-challenges-age-based-treatment-decisions/ 2025-10-15T19:52:34+00:00 https://ascopost.com/news/october-2025/survival-with-dual-ctla-4-and-pd-l1pd-1-blockade-in-advanced-nsclc/ 2025-10-16T14:00:41+00:00 https://ascopost.com/news/october-2025/risk-of-colorectal-subsequent-malignant-neoplasms-in-childhood-cancer-survivors/ 2025-10-16T14:12:29+00:00 https://ascopost.com/news/october-2025/lisaftoclax-regimens-effective-in-plasma-cell-disorders/ 2025-10-16T15:52:29+00:00 https://ascopost.com/news/october-2025/new-leadership-elected-to-the-american-society-of-hematology/ 2025-10-17T14:11:38+00:00 https://ascopost.com/news/october-2025/first-line-pd-1pd-l1-inhibitors-vs-braf-plus-mek-inhibitors-in-braf-v600e-mutated-metastatic-nsclc/ 2025-10-17T15:09:52+00:00 https://ascopost.com/news/october-2025/thymic-health-associated-with-ici-response/ 2025-10-23T19:14:39+00:00 https://ascopost.com/news/october-2025/multidisciplinary-program-doubles-lung-cancer-screening-rates/ 2025-10-17T15:06:02+00:00 https://ascopost.com/news/october-2025/vt3989-demonstrates-antitumor-activity-and-tolerability-in-refractory-mesothelioma/ 2025-10-20T16:17:45+00:00 https://ascopost.com/news/october-2025/mrna-based-covid-vaccines-may-generate-improved-responses-to-immunotherapy/ 2025-10-20T14:27:32+00:00 https://ascopost.com/news/october-2025/rcc-lenvatinibeverolimus-extends-pfs-after-pd-1-inhibition/ 2025-11-05T20:07:04+00:00 https://ascopost.com/news/october-2025/metastatic-er-positive-her2-negative-breast-cancer-novel-treatment-combination-improves-progression-free-survival/ 2025-11-03T19:09:45+00:00 https://ascopost.com/news/october-2025/belzutifan-achieves-durable-responses-without-surgery-in-advanced-pheochromocytoma-paraganglioma/ 2025-10-20T16:32:58+00:00 https://ascopost.com/news/october-2025/adc-improves-outcomes-for-patients-with-advanced-tnbc-ineligible-for-immunotherapy/ 2025-10-20T16:50:59+00:00 https://ascopost.com/news/october-2025/muscle-invasive-bladder-cancer-imvigor011-trial-investigates-ctdna-guided-adjuvant-pd-l1-inhibition/ 2025-10-21T14:49:51+00:00 https://ascopost.com/news/october-2025/final-flaura2-analysis-confirms-first-line-benefit-of-osimertinib-chemotherapy-in-egfr-positive-nsclc/ 2025-11-11T19:10:23+00:00 https://ascopost.com/news/october-2025/adjuvant-pembrolizumab-in-merkel-cell-carcinoma/ 2025-10-21T18:11:25+00:00 https://ascopost.com/news/october-2025/reversible-tki-in-her2-mutant-nsclc/ 2025-10-21T15:20:55+00:00 https://ascopost.com/news/october-2025/significant-os-benefit-with-enzalutamide-plus-leuprolide-for-biochemically-recurrent-prostate-cancer/ 2025-10-21T17:34:39+00:00 https://ascopost.com/news/october-2025/esmo-publishes-guidance-on-large-language-model-use-for-oncology-practice/ 2025-10-28T21:01:44+00:00 https://ascopost.com/news/october-2025/state-of-the-hematology-and-medical-oncologist-workforce-in-the-united-states/ 2025-10-22T14:44:14+00:00 https://ascopost.com/news/october-2025/obesity-related-cancers-are-rising-among-both-younger-and-older-adults-worldwide/ 2025-10-22T15:02:51+00:00 https://ascopost.com/news/october-2025/clinical-usefulness-of-linking-whole-genome-data-to-mortality-statistics-in-uk-patients-with-breast-cancer/ 2025-10-22T15:21:08+00:00 https://ascopost.com/news/october-2025/aga-issues-new-guideline-urging-risk-based-surveillance-in-barrett-s-esophagus/ 2025-10-22T18:04:58+00:00 https://ascopost.com/news/october-2025/local-consolidative-therapy-enhances-outcomes-with-osimertinib-in-egfr-mutant-nsclc/ 2025-11-11T19:21:04+00:00 https://ascopost.com/news/october-2025/slnb-alone-vs-lymphadenectomy-in-cervical-cancer/ 2025-11-20T18:42:17+00:00 https://ascopost.com/news/october-2025/pd-l1-plus-ctla-4-inhibition-for-renal-cell-carcinoma-following-resection-rampart/ 2025-10-23T15:20:04+00:00 https://ascopost.com/news/october-2025/risk-factors-for-valvular-heart-disease-among-childhood-cancer-survivors/ 2025-10-23T15:51:58+00:00 https://ascopost.com/news/october-2025/president-biden-completes-radiation-therapy-course/ 2025-10-23T15:29:34+00:00 https://ascopost.com/news/october-2025/unresectable-stage-iii-nsclc-addition-of-simultaneous-durvalumab-to-chemoradiotherapy/ 2025-10-23T16:05:36+00:00 https://ascopost.com/news/october-2025/fda-approves-belantamab-mafodotin-for-relapsed-or-refractory-multiple-myeloma/ 2025-10-24T13:32:24+00:00 https://ascopost.com/news/october-2025/revumenib-approved-by-fda-for-npm1-aml/ 2025-10-28T15:36:25+00:00 https://ascopost.com/news/october-2025/sacituzumab-tirumotecan-in-egfr-mutated-advanced-nsclc/ 2025-10-27T15:56:50+00:00 https://ascopost.com/news/october-2025/disitamab-vedotin-plus-toripalimab-vs-chemotherapy-in-her2-expressing-advanced-urothelial-cancer/ 2025-10-27T15:59:21+00:00 https://ascopost.com/news/october-2025/astro-announces-2025-awards-and-research-grants/ 2025-10-28T14:10:55+00:00 https://ascopost.com/news/october-2025/nivolumab-vs-ipilimumab-in-resected-stage-iii-or-iv-melanoma-9-year-follow-up-of-checkmate-238/ 2025-10-27T16:20:44+00:00 https://ascopost.com/news/october-2025/neoadjuvant-dual-ici-blockade-vs-perioperative-flot-in-dmmrmsi-h-gastroesophageal-adenocarcinoma/ 2025-11-13T19:51:08+00:00 https://ascopost.com/news/october-2025/pembrolizumab-plus-chemotherapy-without-radiotherapy-in-unresectable-locally-advanced-nsclc-with-high-pd-l1-expression/ 2025-10-28T14:24:36+00:00 https://ascopost.com/news/october-2025/ruxolitinib-in-steroid-refractory-acute-gvhd-final-analysis-from-the-reach2-trial/ 2025-10-29T13:53:10+00:00 https://ascopost.com/news/october-2025/elironrasib-active-in-kras-g12c-resistant-nsclc/ 2025-10-29T14:13:40+00:00 https://ascopost.com/news/october-2025/zenocutuzumab-potential-explored-in-nrg1-cholangiocarcinoma/ 2025-10-29T17:54:59+00:00 https://ascopost.com/news/october-2025/testing-for-melanoma-sentinel-lymph-node-status/ 2025-10-31T14:49:01+00:00 https://ascopost.com/news/october-2025/glofitamab-plus-polatuzumab-vedotin-in-relapsed-or-refractory-large-b-cell-lymphoma/ 2025-10-30T14:19:00+00:00 https://ascopost.com/news/october-2025/cancer-data-scientist-joins-translational-research-institute-at-cedars-sinai/ 2025-10-31T13:53:35+00:00 https://ascopost.com/news/october-2025/global-analysis-uncovers-wide-inequalities-in-care-for-breast-cervical-and-ovarian-cancers/ 2025-10-30T14:55:20+00:00 https://ascopost.com/news/october-2025/advanced-urothelial-carcinoma-pparg-inhibitor-shows-preliminary-efficacy/ 2025-10-30T15:11:51+00:00 https://ascopost.com/news/october-2025/investigational-antibody-drug-conjugate-in-previously-treated-sclc/ 2025-10-30T15:25:04+00:00 https://ascopost.com/news/october-2025/jobs-commonly-held-by-immigrant-women-may-put-them-at-increased-risk-for-breast-cancer/ 2025-10-30T20:26:40+00:00 https://ascopost.com/news/october-2025/carboplatin-plus-taxane-anthracycline-neoadjuvant-chemotherapy-for-triple-negative-breast-cancer/ 2025-10-31T13:12:59+00:00 https://ascopost.com/news/october-2025/perioperative-camrelizumab-plus-rivoceranib-vs-surgery-alone-in-hepatocellular-carcinoma/ 2026-01-02T20:17:21+00:00 https://ascopost.com/news/october-2025/physician-complementing-artificial-intelligence-in-oncology/ 2025-11-06T16:16:26+00:00 https://ascopost.com/news/november-2025/ 2025-10-31T15:47:46+00:00 https://ascopost.com/news/november-2025/deep-learning-and-mammography-for-identifying-interval-breast-cancers/ 2025-11-03T15:47:28+00:00 https://ascopost.com/news/november-2025/addition-of-abemaciclib-to-abiraterone-in-mcrpc/ 2025-11-03T15:52:58+00:00 https://ascopost.com/news/november-2025/malignant-melanoma-addition-of-whole-body-imaging-in-postsurgery-follow-up/ 2025-11-03T15:57:31+00:00 https://ascopost.com/news/november-2025/experts-outline-roadmap-for-clinical-implementation-of-ai-in-pediatric-cns-tumor-management/ 2025-11-04T15:10:44+00:00 https://ascopost.com/news/november-2025/axicabtagene-ciloleucel-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/ 2025-11-04T17:19:34+00:00 https://ascopost.com/news/november-2025/zanzalintinib-plus-atezolizumab-vs-regorafenib-in-previously-treated-metastatic-colorectal-cancer-without-msi-h-or-dmmr-tumors/ 2025-11-04T15:45:58+00:00 https://ascopost.com/news/november-2025/study-finds-breast-cancer-risk-varies-between-different-hormonal-contraceptives/ 2025-11-04T16:50:22+00:00 https://ascopost.com/news/november-2025/oropharyngeal-cancer-in-the-us-recent-estimates-and-future-trends/ 2026-01-27T17:26:02+00:00 https://ascopost.com/news/november-2025/lung-cancer-advancements-are-saving-more-lives-than-ever-but-funding-cuts-may-hinder-progress/ 2025-11-05T19:15:25+00:00 https://ascopost.com/news/november-2025/extensive-la-area-fires-altered-blood-proteins-in-firefighters/ 2025-11-05T19:05:50+00:00 https://ascopost.com/news/november-2025/extended-erspc-analysis-demonstrates-long-term-mortality-benefit-of-psa-screening-for-prostate-cancer/ 2025-11-05T21:46:14+00:00 https://ascopost.com/news/november-2025/first-line-ivonescimab-or-tislelizumab-plus-chemotherapy-in-advanced-squamous-nsclc/ 2025-11-06T15:45:34+00:00 https://ascopost.com/news/november-2025/hepatic-arterial-infusion-pump-chemotherapy-in-unresectable-intrahepatic-cholangiocarcinoma/ 2025-11-06T16:35:00+00:00 https://ascopost.com/news/november-2025/adding-an-investigational-monoclonal-antibody-to-ibrutinib-may-allow-patients-with-cll-to-discontinue-daily-treatment/ 2025-11-07T14:51:07+00:00 https://ascopost.com/news/november-2025/nccn-guidelines-to-be-integrated-into-openevidence-medical-ai-platform/ 2025-11-07T18:01:50+00:00 https://ascopost.com/news/november-2025/impact-of-concomitant-noncancer-medications-on-outcomes-in-breast-cancer/ 2025-11-07T18:52:21+00:00 https://ascopost.com/news/november-2025/study-finds-gaps-exist-in-quality-of-cancer-care-for-incarcerated-people/ 2025-11-10T16:23:39+00:00 https://ascopost.com/news/november-2025/her3-dxd-in-patients-with-active-brain-metastases-from-nsclc-and-breast-cancer/ 2025-11-11T19:07:35+00:00 https://ascopost.com/news/november-2025/model-for-predicting-risk-of-heart-failure-or-cardiomyopathy-after-breast-cancer-treatment/ 2025-11-11T17:42:30+00:00 https://ascopost.com/news/november-2025/global-report-highlights-decade-of-uneven-progress-in-advanced-breast-cancer-care/ 2025-11-11T17:55:34+00:00 https://ascopost.com/news/november-2025/survey-highlights-unmet-needs-among-young-women-with-advanced-breast-cancer/ 2025-11-11T18:40:02+00:00 https://ascopost.com/news/november-2025/t-dxd-plus-pertuzumab-in-her2-positive-advanced-or-metastatic-breast-cancer/ 2025-12-05T17:58:16+00:00 https://ascopost.com/news/november-2025/addition-of-eryaspase-to-chemotherapy-in-advanced-pancreatic-ductal-adenocarcinoma/ 2025-11-12T16:28:52+00:00 https://ascopost.com/news/november-2025/longtime-fda-innovator-appointed-as-director-of-cder/ 2025-11-12T16:20:13+00:00 https://ascopost.com/news/november-2025/supportive-care-most-clinic-staff-prefer-people-focused-vs-digital-solutions/ 2025-11-12T16:35:20+00:00 https://ascopost.com/news/november-2025/exercise-training-improves-strength-and-quality-of-life-for-patients-with-metastatic-breast-cancer/ 2025-11-12T16:42:22+00:00 https://ascopost.com/news/november-2025/advanced-epithelial-ovarian-cancer-first-line-parp-inhibitor-maintenance-therapy-and-survival/ 2025-11-13T15:18:32+00:00 https://ascopost.com/news/november-2025/transfusion-access-prioritized-over-routine-hospice-services-among-patients-with-blood-cancers/ 2025-11-13T15:55:04+00:00 https://ascopost.com/news/november-2025/ezabenlimab-induction-chemotherapy-and-adaptive-chemoradiotherapy-in-stage-iii-squamous-cell-anal-carcinoma/ 2025-11-13T16:07:59+00:00 https://ascopost.com/news/november-2025/fda-approves-ziftomenib-for-npm1-positive-aml/ 2025-11-17T15:24:08+00:00 https://ascopost.com/news/november-2025/preliminary-activity-of-lupsma-it-plus-ra-223-in-metastatic-castration-resistant-prostate-cancer-with-bone-metastasis/ 2025-12-02T17:18:32+00:00 https://ascopost.com/news/november-2025/long-term-continuous-nirogacestat-in-adults-with-desmoid-tumors/ 2025-11-14T17:51:49+00:00 https://ascopost.com/news/november-2025/fda-approves-new-interchangeable-biosimilar-to-pertuzumab/ 2025-11-14T16:14:48+00:00 https://ascopost.com/news/november-2025/pancreatic-cancer-mild-duct-dilation-may-serve-as-early-indicator-in-high-risk-patients/ 2025-11-14T19:53:35+00:00 https://ascopost.com/news/november-2025/md-anderson-launches-25-billion-philanthropic-campaign/ 2025-11-14T18:21:07+00:00 https://ascopost.com/news/november-2025/more-patients-with-cancer-are-using-crowdfunding-to-pay-for-care-and-coming-up-short/ 2025-11-17T16:19:34+00:00 https://ascopost.com/news/november-2025/could-a-liquid-biopsy-lead-to-earlier-diagnoses-for-numerous-cancer-types/ 2025-11-17T16:31:05+00:00 https://ascopost.com/news/november-2025/does-regular-opioid-use-increase-risks-for-certain-cancers/ 2025-11-17T16:21:09+00:00 https://ascopost.com/news/november-2025/does-kidney-stone-history-impact-survival-outcomes-in-upper-tract-urothelial-carcinoma/ 2025-11-18T17:07:19+00:00 https://ascopost.com/news/november-2025/izalontamab-brengitecan-in-recurrent-or-metastatic-nasopharyngeal-carcinoma/ 2026-01-27T17:21:00+00:00 https://ascopost.com/news/november-2025/quality-improvement-program-cuts-missed-radiation-appointments-by-40-percent/ 2025-11-18T15:55:23+00:00 https://ascopost.com/news/november-2025/active-surveillance-with-metformin-vs-placebo-in-low-risk-prostate-cancer/ 2025-11-18T17:04:18+00:00 https://ascopost.com/news/november-2025/dexrazoxane-use-and-cardiovascular-health-care-utilization-in-children-with-acute-myeloid-leukemia/ 2025-11-18T16:26:20+00:00 https://ascopost.com/news/november-2025/fda-approves-epcoritamab-for-two-follicular-lymphoma-indications/ 2025-12-15T17:37:01+00:00 https://ascopost.com/news/november-2025/long-term-survival-with-vs-without-postmastectomy-chest-wall-irradiation-in-breast-cancer/ 2025-11-19T19:18:09+00:00 https://ascopost.com/news/november-2025/new-study-explores-why-male-patients-with-aml-may-have-worse-outcomes/ 2025-11-19T15:13:36+00:00 https://ascopost.com/news/november-2025/fda-approves-selumetinib-for-adults-with-nf1-with-symptomatic-inoperable-plexiform-neurofibromas/ 2025-11-19T15:53:07+00:00 https://ascopost.com/news/november-2025/curative-treatment-after-first-line-immunotherapy-improves-survival-in-hcc/ 2026-01-02T20:18:13+00:00 https://ascopost.com/news/november-2025/new-computational-tool-shows-strong-accuracy-in-predicting-cancer-drug-targets/ 2025-11-19T19:18:58+00:00 https://ascopost.com/news/november-2025/newly-diagnosed-al-amyloidosis-fda-grants-traditional-approval-to-regimen/ 2025-11-19T18:36:54+00:00 https://ascopost.com/news/november-2025/vorasidenib-in-idh12-mutant-low-grade-glioma/ 2025-11-20T15:10:33+00:00 https://ascopost.com/news/november-2025/patient-immune-system-characteristics-and-long-term-remission-from-car-t-cell-therapy-in-multiple-myeloma/ 2025-11-20T15:54:35+00:00 https://ascopost.com/news/november-2025/melanoma-cancer-cluster-found-in-parts-of-pennsylvania/ 2025-11-20T16:44:46+00:00 https://ascopost.com/news/november-2025/fda-grants-accelerated-approval-to-sevabertinib-for-nonsquamous-nsclc/ 2025-11-20T16:35:36+00:00 https://ascopost.com/news/november-2025/traditional-approval-granted-to-tarlatamab-dlle-for-extensive-stage-sclc/ 2025-11-20T18:05:25+00:00 https://ascopost.com/news/november-2025/could-opportunistic-salpingectomy-prevent-ovarian-cancer-in-postreproductive-women/ 2026-01-22T17:03:27+00:00 https://ascopost.com/news/november-2025/astro-experts-comment-on-the-results-of-the-supremo-trial/ 2025-11-20T20:14:57+00:00 https://ascopost.com/news/november-2025/addition-of-durvalumab-to-bcg-after-turbt-for-bcg-naive-high-risk-nmibc/ 2026-01-21T18:20:27+00:00 https://ascopost.com/news/november-2025/large-ai-breast-cancer-screening-trial-increases-detection-rate/ 2025-12-11T20:07:54+00:00 https://ascopost.com/news/november-2025/fda-approves-pembrolizumab-with-enfortumab-vedotin-ejfv-for-muscle-invasive-bladder-cancer/ 2025-12-12T17:51:36+00:00 https://ascopost.com/news/november-2025/astro-publishes-first-clinical-guideline-on-radiation-therapy-for-gastric-cancer/ 2025-11-24T17:18:24+00:00 https://ascopost.com/news/november-2025/ai-simplifies-patients-comprehension-of-ct-reports-but-are-errors-possible/ 2025-11-25T19:09:10+00:00 https://ascopost.com/news/november-2025/fda-approves-durvalumab-with-flot-for-resectable-gastric-gej-adenocarcinoma/ 2025-12-18T16:27:29+00:00 https://ascopost.com/news/december-2025/ 2025-12-01T15:40:58+00:00 https://ascopost.com/news/december-2025/lung-cancer-screening-criteria-nelson-vs-plcom2012/ 2025-12-01T16:24:50+00:00 https://ascopost.com/news/december-2025/addition-of-pirfenidone-to-glucocorticoids-in-grade-2-or-3-radiation-induced-lung-injury/ 2025-12-01T16:31:48+00:00 https://ascopost.com/news/december-2025/outcomes-associated-with-consensus-molecular-subtypes-in-first-line-treatment-in-ras-wild-type-metastatic-colorectal-cancer/ 2025-12-01T16:40:25+00:00 https://ascopost.com/news/december-2025/adcs-vs-standard-chemotherapy-cardiotoxicity-in-her2-positive-advanced-breast-cancer/ 2025-12-01T16:23:11+00:00 https://ascopost.com/news/december-2025/exploratory-flaura2-analysis-confirms-overall-survival-benefit-for-osimertinib-in-nsclc-subgroups/ 2025-12-01T19:02:49+00:00 https://ascopost.com/news/december-2025/image-only-ai-model-outperforms-breast-density-for-5-year-breast-cancer-risk-stratification/ 2025-12-02T16:45:50+00:00 https://ascopost.com/news/december-2025/is-chronic-hepatitis-c-infection-associated-with-pancreatic-cancer/ 2025-12-02T15:40:17+00:00 https://ascopost.com/news/december-2025/tisagenlecleucel-in-relapsed-or-refractory-large-b-cell-lymphoma/ 2025-12-02T16:42:43+00:00 https://ascopost.com/news/december-2025/addition-of-neoadjuvant-lupsma-pnt2002-to-sbrt-in-oligorecurrent-prostate-cancer/ 2025-12-02T19:59:18+00:00 https://ascopost.com/news/december-2025/retrospective-review-shows-persistent-breast-cancer-burden-in-younger-women/ 2025-12-02T16:37:00+00:00 https://ascopost.com/news/december-2025/aya-cancers-survival-for-metastatic-recurrence-worse-than-de-novo-metastatic-disease/ 2025-12-03T17:32:28+00:00 https://ascopost.com/news/december-2025/survey-finds-global-embrace-of-integrative-cancer-care/ 2025-12-03T15:02:25+00:00 https://ascopost.com/news/december-2025/nivolumab-and-ipilimumab-in-advanced-dmmrmsi-h-noncolorectal-cancers/ 2025-12-05T18:47:09+00:00 https://ascopost.com/news/december-2025/lung-cancer-deaths-prevented-and-life-years-gained-from-lung-cancer-screening/ 2025-12-03T17:45:27+00:00 https://ascopost.com/news/december-2025/second-line-pembrolizumab-plus-lenvatinib-in-pleural-mesothelioma/ 2025-12-04T15:28:03+00:00 https://ascopost.com/news/december-2025/fda-grants-traditional-approval-to-pirtobrutinib-for-cllsll/ 2026-01-08T13:58:58+00:00 https://ascopost.com/news/december-2025/pancreatic-cancer-detection-ai-vs-radiologists/ 2025-12-04T16:05:42+00:00 https://ascopost.com/news/december-2025/upfront-reduced-dose-enfortumab-vedotin-with-pembrolizumab-in-first-line-treatment-of-advanced-urothelial-cancer/ 2025-12-04T15:34:47+00:00 https://ascopost.com/news/december-2025/are-glycemic-index-and-load-associated-with-lung-cancer-risk/ 2025-12-04T15:45:43+00:00 https://ascopost.com/news/december-2025/mammography-based-outreach-increases-lung-cancer-screening-enrollment-in-eligible-women/ 2025-12-04T18:41:53+00:00 https://ascopost.com/news/december-2025/asco-statement-on-departure-of-richard-pazdur-from-fda/ 2025-12-04T19:03:11+00:00 https://ascopost.com/news/december-2025/renuka-iyer-md-named-new-chief-medical-officer-for-nccn/ 2025-12-05T15:28:27+00:00 https://ascopost.com/news/december-2025/fuzuloparib-in-her2-negative-metastatic-breast-cancer-with-germline-brca12-mutations/ 2025-12-05T16:10:23+00:00 https://ascopost.com/news/december-2025/total-neoadjuvant-therapy-and-nonoperative-management-in-pmmrmss-stage-ii-to-iii-rectal-cancer/ 2025-12-05T16:25:43+00:00 https://ascopost.com/news/december-2025/camrelizumab-plus-rivoceranib-vs-sorafenib-for-the-first-line-treatment-of-unresectable-hepatocellular-carcinoma/ 2026-01-02T20:23:10+00:00 https://ascopost.com/news/december-2025/aacr-pediatric-cancer-progress-report-2025/ 2025-12-05T17:09:51+00:00 https://ascopost.com/news/december-2025/fda-approves-car-t-cell-therapy-for-relapsedrefractory-marginal-zone-lymphoma/ 2025-12-17T15:17:14+00:00 https://ascopost.com/news/december-2025/fixed-duration-doublet-noninferior-to-continuous-ibrutinib-in-cll/ 2025-12-15T17:37:58+00:00 https://ascopost.com/news/december-2025/black-patients-with-aml-face-younger-onset-and-significantly-worse-survival-outcomes/ 2026-03-04T18:58:24+00:00 https://ascopost.com/news/december-2025/new-pooled-analysis-strengthens-case-for-mrd-as-surrogate-endpoint-in-aml/ 2026-01-08T17:47:58+00:00 https://ascopost.com/news/december-2025/cyclophosphamide-based-strategy-enables-safe-transplant-from-broadly-mismatched-donors/ 2025-12-08T17:25:01+00:00 https://ascopost.com/news/december-2025/non-total-body-irradiation-conditioning-regimen-for-young-patients-with-mrd-negative-b-all/ 2026-01-08T13:59:55+00:00 https://ascopost.com/news/december-2025/one-in-three-families-of-children-with-all-face-financial-hardship-during-treatment/ 2025-12-08T19:09:56+00:00 https://ascopost.com/news/december-2025/doublet-therapy-yields-higher-response-rates-and-fewer-complications-than-standard-induction-in-aml/ 2025-12-12T18:54:01+00:00 https://ascopost.com/news/december-2025/epcoritamab-added-to-second-line-lenalidomiderituximab-improves-responses-in-follicular-lymphoma/ 2025-12-09T15:56:40+00:00 https://ascopost.com/news/december-2025/experimental-car-t-cell-therapy-shows-high-efficacy-and-a-favorable-safety-profile-in-multiple-myeloma/ 2025-12-09T16:36:45+00:00 https://ascopost.com/news/december-2025/chemotherapy-free-regimen-improves-outcomes-in-newly-diagnosed-patients-with-ph-positive-all/ 2026-02-05T19:44:20+00:00 https://ascopost.com/news/december-2025/noninferiority-shown-for-pirtobrutinib-vs-ibrutinib-in-cllsll/ 2025-12-22T15:17:47+00:00 https://ascopost.com/news/december-2025/abbreviated-azacitidine-regimen-improves-outcomes-in-lower-risk-mds/ 2025-12-19T15:50:17+00:00 https://ascopost.com/news/december-2025/p-rad-trial-shows-increased-t-cell-infiltration-with-preoperative-radiation-added-to-anti-pd-1-therapy-in-early-breast-cancer/ 2025-12-11T20:03:19+00:00 https://ascopost.com/news/december-2025/phase-iii-trial-shows-no-oncologic-benefit-from-routine-preoperative-mri-for-some-early-breast-cancers/ 2025-12-15T18:01:25+00:00 https://ascopost.com/news/december-2025/oral-serd-improves-disease-free-survival-over-standard-of-care-for-patients-with-early-stage-breast-cancer/ 2025-12-11T17:25:22+00:00 https://ascopost.com/news/december-2025/sacituzumab-govitecan-vs-standard-of-care-for-certain-endocrine-therapy-refractory-advanced-breast-cancers/ 2025-12-11T18:55:44+00:00 https://ascopost.com/news/december-2025/regional-control-unchanged-by-avoiding-sentinel-lymph-node-biopsy-in-early-node-negative-breast-cancer/ 2025-12-11T19:50:23+00:00 https://ascopost.com/news/december-2025/cd40-overexpression-emerges-as-a-potential-biomarker-for-angioimmunoblastic-t-cell-lymphoma/ 2025-12-12T15:55:35+00:00 https://ascopost.com/news/december-2025/follicular-lymphoma-durable-remissions-and-sustained-safety-with-third-line-lisocabtagene-maraleucel/ 2025-12-12T16:03:04+00:00 https://ascopost.com/news/december-2025/acupuncture-may-improve-perceived-cognitive-difficulties-in-breast-cancer-survivors/ 2025-12-12T17:09:26+00:00 https://ascopost.com/news/december-2025/ianalumab-plus-eltrombopag-extends-time-to-treatment-failure-in-itp/ 2025-12-12T18:00:40+00:00 https://ascopost.com/news/december-2025/can-multimodal-ai-models-predict-distant-recurrence-risk-in-patients-with-early-breast-cancer/ 2026-01-15T16:54:18+00:00 https://ascopost.com/news/december-2025/mobile-health-intervention-offers-tailored-support-for-adolescent-and-young-adult-breast-cancer-survivors/ 2025-12-12T20:39:48+00:00 https://ascopost.com/news/december-2025/menopausal-hormone-therapy-not-associated-with-increased-breast-cancer-risk/ 2025-12-15T17:41:44+00:00 https://ascopost.com/news/december-2025/fda-approves-regimen-for-brca2-mutated-metastatic-castration-sensitive-prostate-cancer/ 2025-12-15T17:25:10+00:00 https://ascopost.com/news/december-2025/ai-models-advance-individualized-breast-cancer-recurrence-risk-assessments/ 2025-12-15T17:21:19+00:00 https://ascopost.com/news/december-2025/her2-positive-breast-cancer-fda-approves-t-dxd-plus-pertuzumab/ 2025-12-16T15:58:51+00:00 https://ascopost.com/news/december-2025/flipi24-new-prognostic-model-for-newly-diagnosed-follicular-lymphoma/ 2026-02-20T19:57:02+00:00 https://ascopost.com/news/december-2025/tanning-bed-exposure-and-melanoma-risks/ 2025-12-16T17:33:42+00:00 https://ascopost.com/news/december-2025/flipped-nivolumabipilimumab-dosing-improves-outcomes-in-advanced-melanoma/ 2026-01-09T18:05:49+00:00 https://ascopost.com/news/december-2025/preoperative-paxg-vs-mfolfirinox-in-pancreatic-ductal-adenocarcinoma/ 2026-01-05T17:53:34+00:00 https://ascopost.com/news/december-2025/amivantamab-plus-lazertinib-in-atypical-egfr-mutated-advanced-nsclc/ 2025-12-17T15:07:25+00:00 https://ascopost.com/news/december-2025/addition-of-eflornithine-to-lomustine-in-patients-with-recurrent-grade-3-astrocytoma/ 2025-12-17T15:11:50+00:00 https://ascopost.com/news/december-2025/distant-disease-free-survival-as-a-surrogate-for-overall-survival-in-trials-of-neoadjuvant-therapy-in-early-breast-cancer/ 2025-12-18T16:44:22+00:00 https://ascopost.com/news/december-2025/10-year-outcomes-with-adjuvant-metronomic-capecitabine-in-early-triple-negative-breast-cancer/ 2025-12-18T16:22:08+00:00 https://ascopost.com/news/december-2025/community-oncology-report-showcases-barriers-to-therapy-access-staffing-and-clinical-trial-participation/ 2025-12-17T16:21:05+00:00 https://ascopost.com/news/december-2025/keynote-905-perioperative-immunotherapy-regimen-active-in-cisplatin-ineligible-mibc/ 2026-01-21T18:17:06+00:00 https://ascopost.com/news/december-2025/intravesical-oncolytic-adenovirus-delivers-high-complete-response-rates-in-bcg-naive-high-risk-nmibc-with-carcinoma-in-situ/ 2025-12-19T15:19:41+00:00 https://ascopost.com/news/december-2025/intravesical-cretostimogene-grenadenorepvec-shows-strong-high-grade-recurrence-free-survival-in-bcg-unresponsive-papillary-only-non-muscle-invasive-bladder-cancer/ 2026-01-06T19:25:41+00:00 https://ascopost.com/news/december-2025/fda-grants-regular-approval-to-rucaparib-for-metastatic-castration-resistant-prostate-cancer/ 2025-12-18T16:09:30+00:00 https://ascopost.com/news/december-2025/cd123-targeting-adc-shows-activity-in-aml-and-bpdcn/ 2026-03-04T18:57:01+00:00 https://ascopost.com/news/december-2025/fda-approves-amivantamab-and-hyaluronidase-lpuj-for-subcutaneous-injection/ 2025-12-18T16:14:00+00:00 https://ascopost.com/news/december-2025/data-published-on-incidence-of-immune-checkpoint-inhibitor-associated-itp/ 2025-12-19T15:54:45+00:00 https://ascopost.com/news/december-2025/lymphocyte-kinetics-after-car-t-infusion-predict-survival-outcomes-in-non-hodgkin-lymphoma/ 2025-12-19T15:53:19+00:00 https://ascopost.com/news/december-2025/neoadjuvant-sabr-improves-outcomes-in-patients-with-rcc-and-ivc-tumor-thrombus/ 2025-12-19T15:18:27+00:00 https://ascopost.com/news/december-2025/nsaids-may-improve-survival-in-postoperative-ctdna-positive-patients-with-colon-cancer/ 2025-12-19T17:08:41+00:00 https://ascopost.com/news/december-2025/molecular-analysis-reveals-underlying-sex-linked-multiple-myeloma-progression-patterns/ 2025-12-19T16:41:00+00:00 https://ascopost.com/news/december-2025/deb-schrag-elected-2027-2028-asco-president/ 2025-12-22T14:38:53+00:00 https://ascopost.com/news/december-2025/study-explores-association-of-glp-1-ras-with-risk-of-obesity-related-cancers/ 2025-12-29T16:11:13+00:00 https://ascopost.com/news/january-2026/ 2026-01-02T14:16:46+00:00 https://ascopost.com/news/january-2026/a-novel-paradigm-in-acute-kidney-injury-congestive-nephropathy-in-rcc-with-ivc-thrombus/ 2026-01-06T18:58:11+00:00 https://ascopost.com/news/january-2026/county-level-obesity-prevalence-may-predict-obesity-related-cancer-rates-in-young-adults/ 2026-01-02T15:07:27+00:00 https://ascopost.com/news/january-2026/addition-of-tafasitamab-to-lenalidomide-plus-rituximab-in-relapsed-or-refractory-follicular-lymphoma/ 2026-01-02T15:31:51+00:00 https://ascopost.com/news/january-2026/determining-the-optimal-duration-of-androgen-deprivation-therapy-added-to-definitive-radiotherapy-in-localized-prostate-cancer/ 2026-02-16T19:24:04+00:00 https://ascopost.com/news/january-2026/astro-relaunches-research-foundation-under-a-single-focused-identity/ 2026-01-02T16:17:08+00:00 https://ascopost.com/news/january-2026/hcc-real-world-patterns-of-systemic-therapy-sequencing-and-survival/ 2026-01-05T14:59:56+00:00 https://ascopost.com/news/january-2026/high-neighborhood-fast-food-expenditure-and-early-onset-colorectal-cancer/ 2026-01-13T16:18:12+00:00 https://ascopost.com/news/january-2026/ai-based-imaging-model-predicts-extranodal-extension-burden-and-improves-risk-stratification-in-oropharyngeal-cancer/ 2026-01-27T17:18:51+00:00 https://ascopost.com/news/january-2026/braf-v600e-mutant-colorectal-cancer-first-line-encorafenib-cetuximab-and-folfiri/ 2026-01-06T15:23:52+00:00 https://ascopost.com/news/january-2026/triplet-therapy-demonstrates-superior-progression-free-survival-in-first-line-dmmr-msi-h-metastatic-colorectal-cancer/ 2026-01-15T17:38:27+00:00 https://ascopost.com/news/january-2026/do-glp-1-ras-reduce-the-risk-of-developing-colorectal-cancer-more-than-aspirin/ 2026-01-13T16:18:42+00:00 https://ascopost.com/news/january-2026/physical-activity-and-fatigue-qol-in-nonmetastatic-crc/ 2026-01-06T18:18:31+00:00 https://ascopost.com/news/january-2026/her2-positive-gastroesophageal-cancer-zanidatamab-plus-chemotherapy-prolongs-progression-free-survival/ 2026-01-15T16:51:56+00:00 https://ascopost.com/news/january-2026/adjuvant-epirubicin-plus-cyclophosphamide-followed-by-taxane-with-or-without-carboplatin-in-early-stage-triple-negative-breast-cancer/ 2026-01-07T15:43:08+00:00 https://ascopost.com/news/january-2026/addition-of-epcoritamab-to-lenalidomide-plus-rituximab-in-relapsed-or-refractory-follicular-lymphoma/ 2026-01-07T15:50:02+00:00 https://ascopost.com/news/january-2026/cancer-mortality-according-to-occupation-in-the-united-states/ 2026-01-07T16:58:48+00:00 https://ascopost.com/news/january-2026/atezolizumab-vs-placebo-with-bevacizumab-and-nonplatinum-chemotherapy-for-recurrent-ovarian-cancer/ 2026-01-22T17:13:48+00:00 https://ascopost.com/news/january-2026/early-results-show-pirtobrutinib-matches-ibrutinib-in-btk-inhibitor-naive-cll/ 2026-02-05T19:41:06+00:00 https://ascopost.com/news/january-2026/prostate-cancer-novel-psma-targeted-radioligand-shows-reduced-salivary-gland-uptake-in-preclinical-studies/ 2026-01-23T18:02:20+00:00 https://ascopost.com/news/january-2026/are-food-preservatives-linked-to-increased-cancer-risk/ 2026-01-09T16:02:26+00:00 https://ascopost.com/news/january-2026/small-study-examines-potential-of-artificial-saliva-in-patients-with-head-and-neck-cancer/ 2026-01-27T17:17:32+00:00 https://ascopost.com/news/january-2026/researchers-create-immune-cell-atlas-of-bone-marrow-in-patients-with-multiple-myeloma/ 2026-01-09T17:45:51+00:00 https://ascopost.com/news/january-2026/can-kdm6a-mutations-help-guide-treatment-selection-in-bladder-cancer/ 2026-01-12T20:23:02+00:00 https://ascopost.com/news/january-2026/refractory-lbcl-cd19-targeting-car-t-cell-therapy-plus-rituximab/ 2026-01-12T18:03:58+00:00 https://ascopost.com/news/january-2026/molecular-profile-based-adjuvant-treatment-in-high-intermediate-risk-endometrial-cancer/ 2026-01-12T18:09:39+00:00 https://ascopost.com/news/january-2026/anaplastic-glioma-concurrent-vs-adjuvant-temozolomide/ 2026-01-12T18:17:03+00:00 https://ascopost.com/news/january-2026/fda-increases-flexibility-on-requirements-for-cell-and-gene-therapies/ 2026-01-12T17:27:39+00:00 https://ascopost.com/news/january-2026/addition-of-postoperative-nivolumab-to-cisplatin-and-radiotherapy-in-high-risk-locally-advanced-hnscc/ 2026-01-27T17:13:44+00:00 https://ascopost.com/news/january-2026/addition-of-nivolumab-to-docetaxel-in-arpi-pretreated-chemotherapy-naive-mcrpc/ 2026-01-26T16:26:23+00:00 https://ascopost.com/news/january-2026/pirtobrutinib-vs-ibrutinib-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma/ 2026-01-13T21:41:05+00:00 https://ascopost.com/news/january-2026/multiple-myeloma-sex-differences-in-etiology-and-clinical-presentation/ 2026-01-13T19:15:01+00:00 https://ascopost.com/news/january-2026/can-dna-testing-of-colorectal-polyps-improve-insight-into-genetic-risks/ 2026-01-14T15:05:36+00:00 https://ascopost.com/news/january-2026/wgs-based-classifier-better-predicts-hrd-across-cancer-types/ 2026-01-14T17:07:59+00:00 https://ascopost.com/news/january-2026/nivolumab-plus-avd-reduces-disease-progression-risk-in-advanced-classical-hodgkin-lymphoma/ 2026-01-14T17:52:49+00:00 https://ascopost.com/news/january-2026/machine-learning-approach-accelerates-discovery-of-novel-cdk9-inhibitors/ 2026-01-15T15:31:39+00:00 https://ascopost.com/news/january-2026/machine-learning-guided-optical-biopsy-accurately-identifies-malignant-lung-nodules-intraoperatively/ 2026-01-15T15:44:33+00:00 https://ascopost.com/news/january-2026/improved-contralateral-breast-cancer-risk-knowledge-with-personalized-counseling-tool/ 2026-01-15T15:52:12+00:00 https://ascopost.com/news/january-2026/genetic-predisposition-to-higher-body-mass-index-linked-to-mortality-after-breast-cancer/ 2026-01-20T18:05:26+00:00 https://ascopost.com/news/january-2026/sclc-small-study-tests-efficacy-of-ctcs-in-predicting-response-to-tarlatamab/ 2026-01-15T15:18:10+00:00 https://ascopost.com/news/january-2026/can-a-genetic-variant-affect-the-efficacy-of-abiraterone/ 2026-01-16T20:11:59+00:00 https://ascopost.com/news/january-2026/global-cancer-survival-gaps-assessed-using-a-country-level-machine-learning-framework/ 2026-01-16T17:39:28+00:00 https://ascopost.com/news/january-2026/ctdna-positivity-after-neoadjuvant-t-dm1-may-predict-her2-positive-breast-cancer-recurrence/ 2026-01-16T17:03:12+00:00 https://ascopost.com/news/january-2026/breast-cancer-risk-may-be-linked-to-physical-activity-levels-in-adolescence/ 2026-01-16T17:48:23+00:00 https://ascopost.com/news/january-2026/hcc-llm-advice-and-treatment-concordance/ 2026-01-22T17:44:51+00:00 https://ascopost.com/news/january-2026/axillary-recurrence-with-or-without-alnd-in-patients-with-residual-micrometastases-after-neoadjuvant-chemotherapy-for-breast-cancer/ 2026-01-20T17:49:32+00:00 https://ascopost.com/news/january-2026/impt-vs-imrt-in-oropharyngeal-cancer/ 2026-01-27T17:10:14+00:00 https://ascopost.com/news/january-2026/regulatory-agencies-establish-principles-of-good-ai-use-in-drug-development/ 2026-01-21T18:26:53+00:00 https://ascopost.com/news/january-2026/investigational-vaccine-intercepts-cancer-cells-in-lynch-syndrome-carriers/ 2026-01-20T18:33:14+00:00 https://ascopost.com/news/january-2026/popular-supplement-may-interfere-with-cancer-treatment/ 2026-01-21T17:39:48+00:00 https://ascopost.com/news/january-2026/meningiomas-phase-ii-trial-shows-activity-of-targeted-therapy/ 2026-01-21T17:16:11+00:00 https://ascopost.com/news/january-2026/fda-releases-draft-guidance-for-use-of-mrd-and-cr-as-primary-endpoints-in-multiple-myeloma-trials/ 2026-02-23T18:58:21+00:00 https://ascopost.com/news/january-2026/limited-or-no-state-regulation-of-stld-health-plans-linked-to-decreases-in-timely-cancer-treatment-initiation/ 2026-01-21T20:19:28+00:00 https://ascopost.com/news/january-2026/past-nci-director-and-asco-president-elected-president-of-the-national-academy-of-medicine/ 2026-01-22T14:11:15+00:00 https://ascopost.com/news/january-2026/phased-variant-ctdna-as-biomarker-after-first-line-treatment-in-lbcl/ 2026-01-22T16:00:04+00:00 https://ascopost.com/news/january-2026/dual-antigen-targeting-of-drug-resistant-extramedullary-myeloma/ 2026-01-22T16:08:33+00:00 https://ascopost.com/news/january-2026/most-patients-support-use-of-ai-in-mammogram-readings-survey-reveals/ 2026-01-22T16:14:48+00:00 https://ascopost.com/news/january-2026/medical-societies-caution-misinformation-may-drive-underuse-of-lung-cancer-screening/ 2026-02-18T17:38:33+00:00 https://ascopost.com/news/january-2026/new-report-shows-colorectal-cancer-is-now-leading-cancer-death-among-those-under-50/ 2026-02-17T18:23:37+00:00 https://ascopost.com/news/january-2026/nutrition-muscle-loss-compromises-survival-in-patients-with-cervical-cancer-undergoing-chemoradiotherapy/ 2026-01-26T16:58:22+00:00 https://ascopost.com/news/january-2026/leader-in-global-cancer-care-paul-e-goss-md-phd-dies-at-70/ 2026-01-26T21:51:30+00:00 https://ascopost.com/news/january-2026/pembrolizumab-plus-lenvatinib-in-recurrent-gynecologic-clear-cell-carcinoma/ 2026-01-26T17:39:19+00:00 https://ascopost.com/news/january-2026/cabozantinib-and-temozolomide-in-unresectable-or-metastatic-leiomyosarcoma/ 2026-01-26T17:37:56+00:00 https://ascopost.com/news/january-2026/colorectal-cancer-how-does-lifetime-alcohol-consumption-affect-risk/ 2026-02-17T18:24:13+00:00 https://ascopost.com/news/january-2026/cancer-workforce-challenges-undermine-patient-care-and-jeopardize-momentum-in-research-report-finds/ 2026-01-27T16:11:29+00:00 https://ascopost.com/news/january-2026/cri-launches-open-database-for-immunotherapy-cancer-research/ 2026-02-02T16:36:22+00:00 https://ascopost.com/news/january-2026/outcomes-with-colorectal-cancer-screening-among-childhood-cancer-survivors-who-received-abdominopelvic-radiation/ 2026-01-27T15:51:47+00:00 https://ascopost.com/news/january-2026/addition-of-cetrelimab-to-erdafitinib-in-metastatic-urothelial-carcinoma-with-fgfr-alterations/ 2026-01-27T15:44:42+00:00 https://ascopost.com/news/january-2026/associations-found-between-air-pollutants-and-lung-cancer-subtypes/ 2026-01-28T15:36:07+00:00 https://ascopost.com/news/january-2026/multiple-myeloma-fda-approves-daratumumab-and-hyaluronidase-fihj-in-combination-with-vrd/ 2026-02-23T19:03:53+00:00 https://ascopost.com/news/january-2026/is-long-term-ppi-use-associated-with-increased-gastric-cancer-risk/ 2026-01-28T15:18:30+00:00 https://ascopost.com/news/january-2026/chemoradiation-plus-atezolizumab-in-limited-stage-small-cell-lung-cancer/ 2026-02-18T16:55:00+00:00 https://ascopost.com/news/january-2026/organ-sparing-pelvic-radiotherapy-may-reduce-female-sexual-toxicity/ 2026-01-28T15:42:52+00:00 https://ascopost.com/news/january-2026/can-color-vision-deficiency-impact-survival-in-bladder-or-colorectal-cancer/ 2026-02-17T17:43:14+00:00 https://ascopost.com/news/january-2026/savolitinib-plus-osimertinib-in-advanced-egfr-mutant-met-amplified-nsclc/ 2026-01-29T15:38:03+00:00 https://ascopost.com/news/january-2026/updated-analysis-of-cartitude-4-cilta-cel-in-lenalidomide-refractory-multiple-myeloma/ 2026-01-29T15:56:24+00:00 https://ascopost.com/news/january-2026/advanced-nsclc-dual-vs-single-checkpoint-blockade/ 2026-01-29T15:48:30+00:00 https://ascopost.com/news/january-2026/american-college-of-surgeons-publishes-annual-ncdb-report/ 2026-02-03T20:02:48+00:00 https://ascopost.com/news/january-2026/machine-learning-enhanced-prognostic-scoring-predicts-survival-and-classifies-risk-from-spinal-metastases/ 2026-01-30T17:24:08+00:00 https://ascopost.com/news/january-2026/consensus-recommendations-developed-for-use-of-liquid-nitrogen-spray-cryotherapy-in-barrett-esophagus-esophageal-cancer/ 2026-01-30T17:32:11+00:00 https://ascopost.com/news/january-2026/extended-endocrine-therapy-in-premenopausal-patients-with-node-positive-hormone-receptor-positive-breast-cancer/ 2026-03-02T16:17:15+00:00 https://ascopost.com/news/january-2026/adjuvant-durvalumab-in-resected-early-stage-nsclc/ 2026-02-13T15:27:47+00:00 https://ascopost.com/news/january-2026/ultrasound-guided-dot-may-reduce-unnecessary-breast-biopsies-by-nearly-25/ 2026-01-30T18:11:01+00:00 https://ascopost.com/news/january-2026/aacr-announces-fellows-of-the-aacr-academy-class-of-2026/ 2026-01-30T17:54:53+00:00 https://ascopost.com/news/february-2026/ 2026-02-02T01:43:01+00:00 https://ascopost.com/news/february-2026/randomized-trial-shows-ai-supported-mammography-improves-sensitivity-and-lowers-interval-cancer-rate/ 2026-02-02T17:39:33+00:00 https://ascopost.com/news/february-2026/head-and-neck-cancer-how-does-genetic-ancestry-impact-tumor-genomics/ 2026-02-02T16:51:14+00:00 https://ascopost.com/news/february-2026/deep-learning-ct-biomarker-predicts-survival-better-than-traditional-measures-in-immunotherapy-treated-advanced-nsclc/ 2026-02-02T20:16:18+00:00 https://ascopost.com/news/february-2026/novel-her2-targeted-bispecific-benefits-outcomes-in-gastroesophageal-cancer/ 2026-02-02T17:53:08+00:00 https://ascopost.com/news/february-2026/adjuvant-aumolertinib-in-egfr-mutated-nsclc/ 2026-02-03T15:32:48+00:00 https://ascopost.com/news/february-2026/overall-survival-with-3-vs-6-months-of-adjuvant-oxaliplatin-plus-fluoropyrimidine-for-colorectal-cancer/ 2026-02-03T15:50:57+00:00 https://ascopost.com/news/february-2026/ai-tool-predicts-cardiac-events-in-patients-with-cancer-and-acute-coronary-syndrome/ 2026-02-03T16:16:29+00:00 https://ascopost.com/news/february-2026/new-four-biomarker-blood-panel-may-improve-early-detection-of-pancreatic-cancer/ 2026-02-03T16:23:01+00:00 https://ascopost.com/news/february-2026/studies-move-away-from-whole-brain-radiotherapy-standard-of-care-for-sclc/ 2026-02-18T16:53:29+00:00 https://ascopost.com/news/february-2026/oxybutynin-may-improve-adt-induced-hot-flashes-in-patients-with-prostate-cancer/ 2026-02-16T19:24:57+00:00 https://ascopost.com/news/february-2026/addition-of-palbociclib-to-standard-therapy-in-hormone-receptor-positive-her2-positive-metastatic-breast-cancer/ 2026-02-04T18:06:27+00:00 https://ascopost.com/news/february-2026/world-cancer-day-2026-uiccs-campaign-united-by-unique/ 2026-02-04T15:58:47+00:00 https://ascopost.com/news/february-2026/who-analysis-finds-many-global-cancer-cases-attributable-to-modifiable-risk-factors/ 2026-02-05T14:46:00+00:00 https://ascopost.com/news/february-2026/metastasis-directed-therapy-for-oligometastatic-prostate-cancer/ 2026-02-05T15:03:09+00:00 https://ascopost.com/news/february-2026/first-line-mfolfoxiri-plus-panitumumab-for-rasbraf-wild-type-mcrc/ 2026-02-05T14:56:10+00:00 https://ascopost.com/news/february-2026/new-european-project-cluster-earlyscan-launched-to-advance-early-detection-of-heritable-cancers/ 2026-02-05T14:58:02+00:00 https://ascopost.com/news/february-2026/agent-orange-exposure-linked-with-risk-for-acral-melanoma-in-veterans/ 2026-02-06T16:31:35+00:00 https://ascopost.com/news/february-2026/vte-during-perioperative-therapy-in-resectable-and-borderline-resectable-pancreatic-cancer/ 2026-02-06T16:40:41+00:00 https://ascopost.com/news/february-2026/fda-provides-safety-labeling-update-for-capecitabine-and-fluorouracil-on-risks-associated-with-dpd-deficiency/ 2026-02-06T16:30:44+00:00 https://ascopost.com/news/february-2026/lymph-node-examination-should-be-expanded-to-accurately-assess-metastasis-in-nsclc-research-says/ 2026-02-06T16:44:59+00:00 https://ascopost.com/news/february-2026/ultraprocessed-food-associated-with-increased-mortality-risk-in-cancer-survivors/ 2026-02-09T15:27:09+00:00 https://ascopost.com/news/february-2026/tissue-free-ctdna-and-outcomes-in-patients-with-colorectal-cancer-receiving-folfox-based-adjuvant-therapy/ 2026-02-09T15:36:07+00:00 https://ascopost.com/news/february-2026/guidelines-harmonize-pan-tumor-pathologic-response-to-neoadjuvant-therapy/ 2026-02-09T15:42:19+00:00 https://ascopost.com/news/february-2026/hpv-testing-during-cervical-cancer-screening-potential-convenient-and-noninvasive-method/ 2026-02-09T16:39:51+00:00 https://ascopost.com/news/february-2026/self-acupressure-may-ease-fatigue-in-ovarian-cancer-survivors/ 2026-02-10T14:31:42+00:00 https://ascopost.com/news/february-2026/a-new-risk-model-for-esophagectomy-draws-on-the-sts-national-database/ 2026-02-10T16:08:16+00:00 https://ascopost.com/news/february-2026/olaparib-in-metastatic-breast-cancer-with-germline-mutations-in-palb2-or-somatic-mutations-in-brca/ 2026-02-10T15:49:01+00:00 https://ascopost.com/news/february-2026/asco-and-conexiant-launch-asco-ai-in-oncology/ 2026-02-12T18:10:20+00:00 https://ascopost.com/news/february-2026/psma-petct-guided-radiotherapy-after-prostatectomy/ 2026-02-11T23:02:54+00:00 https://ascopost.com/news/february-2026/rural-populations-face-greater-barriers-as-nonmedical-costs-hinder-cancer-clinical-trial-access/ 2026-02-11T22:57:05+00:00 https://ascopost.com/news/february-2026/coa-survey-shows-insurer-utilization-management-interferes-with-cancer-treatment-decisions/ 2026-02-12T15:16:01+00:00 https://ascopost.com/news/february-2026/interval-cancer-rate-with-ai-supported-mammography-screening/ 2026-02-12T15:24:29+00:00 https://ascopost.com/news/february-2026/fda-approves-ttfields-device-for-pancreatic-cancer/ 2026-02-12T15:34:28+00:00 https://ascopost.com/news/february-2026/young-onset-pancreatic-cancer-can-alcohol-consumption-raise-risk/ 2026-02-13T14:59:14+00:00 https://ascopost.com/news/february-2026/ash-publishes-clinical-guidelines-on-al-amyloidosis-diagnosis/ 2026-02-12T16:15:40+00:00 https://ascopost.com/news/february-2026/demographic-and-clinicopathologic-factors-in-colorectal-adenoma-recurrence-risk/ 2026-02-12T16:40:53+00:00 https://ascopost.com/news/february-2026/fda-approves-labeling-changes-to-menopausal-hormone-therapy-products/ 2026-02-13T15:08:13+00:00 https://ascopost.com/news/february-2026/oncolytic-virus-triggers-immune-system-against-glioblastoma-cells/ 2026-02-13T15:28:39+00:00 https://ascopost.com/news/february-2026/neoadjuvant-taxane-plus-trastuzumab-and-pertuzumab-with-or-without-carboplatin-in-her2-positive-breast-cancer/ 2026-02-16T16:51:17+00:00 https://ascopost.com/news/february-2026/induction-nivolumab-before-crt-in-high-risk-hpv-driven-opc/ 2026-02-16T16:56:47+00:00 https://ascopost.com/news/february-2026/nonmetastatic-breast-cancer-treatment-strategies-after-denosumab-discontinuation-in-patients-treated-with-aromatase-inhibitors/ 2026-02-16T16:50:35+00:00 https://ascopost.com/news/february-2026/ash-guidelines-on-management-of-newly-diagnosed-and-relapsedrefractory-all-in-aya-patients/ 2026-02-16T15:29:26+00:00 https://ascopost.com/news/february-2026/computational-histology-artificial-intelligence-powered-biomarker-for-selection-of-chemotherapy-in-advanced-pancreatic-cancer/ 2026-02-17T17:00:17+00:00 https://ascopost.com/news/february-2026/fda-approves-once-monthly-dosing-schedule-for-amivantamab-and-hyaluronidase-lpuj/ 2026-02-17T16:40:43+00:00 https://ascopost.com/news/february-2026/cancer-surgery-outcomes-similar-between-rural-and-urban-facilities/ 2026-02-17T17:21:56+00:00 https://ascopost.com/news/february-2026/cardiovascular-effects-and-risk-factors-identified-with-braf-and-mek-inhibition-in-melanoma/ 2026-02-17T17:12:10+00:00 https://ascopost.com/news/february-2026/can-a-game-based-intervention-reduce-cardiovascular-risk-in-minority-cancer-survivors/ 2026-02-18T14:29:17+00:00 https://ascopost.com/news/february-2026/topline-pfs-results-from-breakwater-in-mcrc-newly-announced/ 2026-02-18T18:35:23+00:00 https://ascopost.com/news/february-2026/ultra-hypofractionated-vs-conventionally-fractionated-rt-for-localized-prostate-cancer-10-year-outcomes/ 2026-02-18T15:07:55+00:00 https://ascopost.com/news/february-2026/pleurectomy-decortication-safe-in-select-patients-with-pleural-mesothelioma/ 2026-02-18T18:30:18+00:00 https://ascopost.com/news/february-2026/genetics-pioneer-zsofia-stadler-to-lead-jco-precision-oncology/ 2026-02-18T22:41:43+00:00 https://ascopost.com/news/february-2026/does-diabetes-increase-pancreatic-cystic-neoplasm-risk/ 2026-02-18T22:18:18+00:00 https://ascopost.com/news/february-2026/multidisciplinary-radiopharmaceutical-therapy-symposium-highlights-from-the-inaugural-new-meeting-from-astro/ 2026-02-19T16:45:14+00:00 https://ascopost.com/news/february-2026/high-response-rates-with-front-line-pivekimab-sunirine-in-bpdcn/ 2026-02-19T16:39:01+00:00 https://ascopost.com/news/february-2026/long-term-survival-results-with-addition-of-adjuvant-mfolfox6-to-hepatectomy-in-patients-with-liver-metastases-from-colorectal-cancer/ 2026-02-19T17:30:47+00:00 https://ascopost.com/news/february-2026/stage-ii-melanoma-adjuvant-pembrolizumab-and-risk-of-new-skin-cancers/ 2026-02-19T21:48:09+00:00 https://ascopost.com/news/february-2026/ai-tool-classifies-pediatric-brain-tumors-via-liquid-biopsy/ 2026-02-20T16:27:24+00:00 https://ascopost.com/news/february-2026/survival-outcomes-with-or-without-bilateral-risk-reducing-mastectomy-in-brca1brca2-pathogenic-variant-carriers/ 2026-02-20T19:54:08+00:00 https://ascopost.com/news/february-2026/metastasis-directed-therapy-in-oligometastatic-prostate-cancer/ 2026-02-20T16:40:05+00:00 https://ascopost.com/news/february-2026/cllsll-fda-approves-combination-of-acalabrutinib-and-venetoclax/ 2026-02-20T17:49:52+00:00 https://ascopost.com/news/february-2026/inequalities-in-use-of-minimally-invasive-surgical-resection-in-colon-cancer/ 2026-02-23T17:22:53+00:00 https://ascopost.com/news/february-2026/acral-melanoma-ancestry-and-genetics-impact-outcomes/ 2026-02-23T17:26:37+00:00 https://ascopost.com/news/february-2026/new-biomarker-may-predict-chemotherapy-response-in-patients-with-triple-negative-breast-cancer/ 2026-02-23T18:28:30+00:00 https://ascopost.com/news/february-2026/can-a-new-testing-method-allow-more-patients-with-bladder-cancer-to-avoid-radical-cystectomy/ 2026-02-24T16:15:21+00:00 https://ascopost.com/news/february-2026/proximity-to-nuclear-power-plants-and-cancer-risk/ 2026-02-24T15:28:33+00:00 https://ascopost.com/news/february-2026/microplastics-found-in-90-percent-of-prostate-cancer-samples/ 2026-03-04T16:28:10+00:00 https://ascopost.com/news/february-2026/adjuvant-coformulated-vibostolimab-plus-pembrolizumab-in-high-risk-stage-iib-to-iv-melanoma/ 2026-02-24T16:13:56+00:00 https://ascopost.com/news/february-2026/mri-based-neoadjuvant-chemotherapy-duration-in-her2-positive-breast-cancer/ 2026-02-24T16:19:24+00:00 https://ascopost.com/news/february-2026/fda-approves-encorafenib-for-metastatic-braf-v600e-mutated-colorectal-cancer/ 2026-02-24T18:43:42+00:00 https://ascopost.com/news/february-2026/long-term-health-risks-for-testicular-cancer-survivors-differ-by-chemotherapy-regimen/ 2026-02-26T16:15:00+00:00 https://ascopost.com/news/february-2026/cancer-diagnoses-during-covid-19-pandemic-impact-on-1-year-cause-specific-survival/ 2026-02-26T16:02:24+00:00 https://ascopost.com/news/february-2026/effect-of-medicaid-expansion-on-diagnosis-treatment-and-outcomes-in-nsclc/ 2026-02-26T15:51:44+00:00 https://ascopost.com/news/february-2026/variability-of-open-source-ai-models-in-egfr-mutation-prediction-in-lung-cancer/ 2026-02-26T15:26:05+00:00 https://ascopost.com/news/february-2026/nomogram-for-metastasis-directed-sbrt-in-psma-pet-staged-oligorecurrent-prostate-cancer/ 2026-02-26T15:38:14+00:00 https://ascopost.com/news/february-2026/sabcs-2025-top-picks-from-a-breast-cancer-specialist/ 2026-02-27T01:39:26+00:00 https://ascopost.com/news/february-2026/prostate-screening-saved-my-life-is-that-really-true-in-most-cases/ 2026-03-31T15:57:23+00:00 https://ascopost.com/news/february-2026/advanced-nonsquamous-nsclc-fda-grants-accelerated-approval-to-zongertinib/ 2026-02-26T19:32:10+00:00 https://ascopost.com/news/february-2026/medical-societies-and-more-respond-to-hhs-rfi-on-ai-use-in-clinical-care/ 2026-03-05T18:45:09+00:00 https://ascopost.com/news/february-2026/perioperative-enfortumab-vedotin-plus-pembrolizumab-may-reduce-risk-of-recurrence-in-patients-with-muscle-invasive-bladder-cancer/ 2026-03-04T16:29:14+00:00 https://ascopost.com/news/march-2026/ 2026-03-02T14:34:02+00:00 https://ascopost.com/news/march-2026/skin-fluorescent-imaging-shows-high-sensitivity-specificity-for-discriminating-melanoma-lesions/ 2026-03-02T15:49:11+00:00 https://ascopost.com/news/march-2026/stereotactic-vs-whole-brain-radiation-for-patients-with-brain-metastases/ 2026-03-02T16:05:14+00:00 https://ascopost.com/news/march-2026/advanced-rcc-after-immunotherapy-belzutifan-plus-lenvatinib-or-cabozantinib/ 2026-03-02T18:06:13+00:00 https://ascopost.com/news/march-2026/adjuvant-pembrolizumab-plus-belzutifan-in-patients-with-rcc-at-increased-risk-of-recurrence/ 2026-03-31T15:53:47+00:00 https://ascopost.com/news/march-2026/can-ctdna-negativity-predict-metastasis-free-survival-in-muscle-invasive-bladder-cancer/ 2026-03-04T16:30:40+00:00 https://ascopost.com/news/march-2026/ai-model-may-predict-cancer-risk-in-patients-with-colitis-associated-low-grade-dysplasia/ 2026-03-03T15:01:17+00:00 https://ascopost.com/news/march-2026/is-advanced-stage-follicular-lymphoma-curable/ 2026-03-03T18:11:10+00:00 https://ascopost.com/news/march-2026/addition-of-hormone-therapy-to-postoperative-radiotherapy-in-prostate-cancer/ 2026-03-04T16:30:13+00:00 https://ascopost.com/news/march-2026/dietary-influence-on-leukemia-and-lymphoma-progression/ 2026-03-23T18:40:16+00:00 https://ascopost.com/news/march-2026/combined-tests-could-avoid-unnecessary-cystectomy-study-finds/ 2026-03-04T18:06:12+00:00 https://ascopost.com/news/march-2026/perioperative-enfortumab-vedotin-plus-pembrolizumab-in-cisplatin-ineligible-bladder-cancer/ 2026-03-04T16:46:51+00:00 https://ascopost.com/news/march-2026/lisocabtagene-maraleucel-in-relapsed-or-refractory-mzl/ 2026-03-23T20:03:50+00:00 https://ascopost.com/news/march-2026/research-suggests-ai-pathology-models-may-take-unreliable-shortcuts-to-identify-cancer-biomarkers/ 2026-03-04T18:04:27+00:00 https://ascopost.com/news/march-2026/colorectal-cancer-acs-report-shows-increasing-incidence-mortality-rates-in-younger-adults/ 2026-03-04T17:08:21+00:00 https://ascopost.com/news/march-2026/social-cue-prompts-reduce-sharing-of-cancer-treatment-misinformation/ 2026-03-05T14:26:50+00:00 https://ascopost.com/news/march-2026/ablation-vs-surgery-for-small-kidney-tumors/ 2026-03-05T14:42:03+00:00 https://ascopost.com/news/march-2026/accuracy-of-molecular-inference-based-ai-model-for-cns-tumor-diagnosis/ 2026-03-05T18:39:08+00:00 https://ascopost.com/news/march-2026/short-term-vaginal-estrogen-therapy-does-not-increase-risks-of-endometrial-cancer-recurrence/ 2026-03-05T16:19:04+00:00 https://ascopost.com/news/march-2026/five-year-outcomes-with-first-line-nivolumab-plus-ipilimumab-in-unresectable-pleural-mesothelioma/ 2026-03-06T16:37:58+00:00 https://ascopost.com/news/march-2026/hpv-vaccination-protection-from-cervical-cancer-sustained-long-term/ 2026-03-06T16:44:06+00:00 https://ascopost.com/news/march-2026/cumulative-incidence-of-advanced-breast-cancer-in-japanese-women-aged-40-to-49-years-with-addition-of-ultrasonography-to-mammography-screening/ 2026-03-06T16:48:22+00:00 https://ascopost.com/news/march-2026/clinical-trials-may-misrepresent-true-thromboembolic-risks-from-cancer-drugs/ 2026-03-06T17:02:44+00:00 https://ascopost.com/news/march-2026/tace-with-camrelizumab-and-rivoceranib-in-unresectable-hepatocellular-carcinoma/ 2026-03-09T14:47:59+00:00 https://ascopost.com/news/march-2026/ai-backed-liquid-biopsies-identify-liver-diseases/ 2026-03-09T16:45:13+00:00 https://ascopost.com/news/march-2026/prostate-cancer-does-taking-arpis-and-anticoagulants-together-raise-risks/ 2026-03-10T15:15:29+00:00 https://ascopost.com/news/march-2026/addition-of-axitinib-to-long-acting-octreotide-in-advanced-extrapancreatic-neuroendocrine-tumors/ 2026-03-10T14:50:45+00:00 https://ascopost.com/news/march-2026/sabcs-2025-high-level-review-of-select-data/ 2026-03-10T14:55:22+00:00 https://ascopost.com/news/march-2026/neoadjuvant-sacituzumab-govitecan-plus-perioperative-pembrolizumab-in-muscle-invasive-bladder-cancer/ 2026-03-10T15:29:32+00:00 https://ascopost.com/news/march-2026/fda-releases-updated-guidance-on-biosimilar-development/ 2026-03-12T16:00:08+00:00 https://ascopost.com/news/march-2026/prostate-cancer-low-testosterone-levels-may-be-associated-with-increased-risk-of-progression-during-surveillance/ 2026-03-11T14:30:14+00:00 https://ascopost.com/news/march-2026/ai-integration-in-breast-cancer-screening-increases-detection-rate-reduces-work-burden/ 2026-03-11T16:24:05+00:00 https://ascopost.com/news/march-2026/metastatic-uveal-melanoma-nivoluma-and-ipilimumab-plus-percutaneous-hepatic-perfusion/ 2026-03-12T16:05:48+00:00 https://ascopost.com/news/march-2026/risk-of-breast-cancer-after-ovarian-cancer-in-women-with-brca12-variants/ 2026-03-12T16:13:50+00:00 https://ascopost.com/news/march-2026/structured-exercise-plan-for-patients-with-cancer-may-reduce-cognitive-effects-of-chemotherapy/ 2026-03-12T16:22:27+00:00 https://ascopost.com/news/march-2026/early-study-evaluates-two-vaccine-strategy-in-t-cell-lymphoma/ 2026-03-12T17:49:34+00:00 https://ascopost.com/news/march-2026/can-viral-respiratory-infections-increase-lung-cancer-risk/ 2026-03-12T20:33:47+00:00 https://ascopost.com/news/march-2026/disease-stage-at-breast-cancer-diagnosis-impacted-by-region-race-and-insurance/ 2026-03-13T14:36:42+00:00 https://ascopost.com/news/march-2026/bcma-car-t-cell-therapy-in-newly-diagnosed-multiple-myeloma/ 2026-03-13T14:43:24+00:00 https://ascopost.com/news/march-2026/p53-reactivator-rezatapopt-in-tp53-y220c-mutated-solid-tumors/ 2026-03-13T14:49:07+00:00 https://ascopost.com/news/march-2026/fda-consolidates-systems-into-one-cohesive-adverse-event-monitoring-tool/ 2026-03-16T14:49:56+00:00 https://ascopost.com/news/march-2026/optical-genome-mapping-detects-additional-genetic-variants-in-nearly-20-of-individuals-with-acute-leukemia/ 2026-03-16T16:03:31+00:00 https://ascopost.com/news/march-2026/benmelstobart-plus-anlotinib-in-first-line-treatment-for-pd-l1-positive-advanced-nsclc/ 2026-03-16T17:21:38+00:00 https://ascopost.com/news/march-2026/new-prostate-cancer-risk-classification-with-psma-pet/ 2026-03-16T15:54:11+00:00 https://ascopost.com/news/march-2026/romiplostim-may-improve-chemotherapy-induced-thrombocytopenia-in-patients-with-gi-cancers/ 2026-03-17T16:26:26+00:00 https://ascopost.com/news/march-2026/women-more-likely-to-survive-cancer-but-suffer-more-severe-side-effects/ 2026-03-17T14:47:05+00:00 https://ascopost.com/news/march-2026/addition-of-tislelizumab-to-chemotherapy-in-recurrent-or-metastatic-nasopharyngeal-cancer/ 2026-03-17T16:29:12+00:00 https://ascopost.com/news/march-2026/psma-pet-ct-scan-reduces-need-for-prostate-cancer-biopsies/ 2026-03-18T17:57:37+00:00 https://ascopost.com/news/march-2026/activity-observed-with-novel-kras-inhibitor-in-pancreatic-cancer-1/ 2026-04-01T20:11:34+00:00 https://ascopost.com/news/march-2026/new-aacr-president-elect-and-board-members-announced/ 2026-03-18T16:51:22+00:00 https://ascopost.com/news/march-2026/timely-scans-may-reduce-mortality-in-patients-who-present-to-the-er-with-hematuria/ 2026-03-18T18:52:25+00:00 https://ascopost.com/news/march-2026/studies-suggest-prostate-cancer-screening-may-be-equivalent-to-breast-cancer-screening-in-key-outcomes/ 2026-03-19T14:22:39+00:00 https://ascopost.com/news/march-2026/smfm-issues-new-clinical-guidance-for-cancer-diagnosis-and-treatment-during-pregnancy/ 2026-03-19T14:27:15+00:00 https://ascopost.com/news/march-2026/high-cancer-burden-shifted-from-urban-to-rural-areas/ 2026-03-19T14:39:11+00:00 https://ascopost.com/news/march-2026/study-finds-no-overall-increase-in-cancer-risk-after-medically-assisted-reproduction/ 2026-03-19T14:33:10+00:00 https://ascopost.com/news/march-2026/ama-survey-finds-rapid-growth-in-physician-ai-adoption/ 2026-03-19T20:20:53+00:00 https://ascopost.com/news/march-2026/breast-cancer-ultrasensitive-ctdna-assay-findings-and-outcomes-after-neoadjuvant-therapy/ 2026-03-20T14:45:56+00:00 https://ascopost.com/news/march-2026/hypofractionated-locoregional-rt-in-early-breast-cancer/ 2026-03-20T17:33:48+00:00 https://ascopost.com/news/march-2026/melanoma-specific-survival-with-sentinel-lymph-node-biopsy/ 2026-03-20T14:56:45+00:00 https://ascopost.com/news/march-2026/fda-approves-chemoimmunotherapy-regimen-for-hodgkin-lymphoma/ 2026-03-23T15:09:43+00:00 https://ascopost.com/news/march-2026/does-metformin-use-reduce-the-risk-of-esophageal-cancer/ 2026-03-23T14:28:34+00:00 https://ascopost.com/news/march-2026/small-phase-ii-study-examines-triplet-regimen-for-patients-with-her2-positive-breast-cancer-and-leptomeningeal-metastasis/ 2026-03-23T15:56:11+00:00 https://ascopost.com/news/march-2026/the-thymus-plays-a-part-in-adult-cancer-risk-and-treatment-response/ 2026-03-23T15:28:34+00:00 https://ascopost.com/news/march-2026/study-finds-inferior-survival-among-black-patients-with-aml-independent-of-cytogenetic-risk/ 2026-03-23T20:06:50+00:00 https://ascopost.com/news/march-2026/awareness-of-alcohol-cancer-link-holds-steady-despite-omission-in-new-us-dietary-guidelines/ 2026-03-24T16:17:30+00:00 https://ascopost.com/news/march-2026/myelofibrosis-treatment-landscape-is-poised-for-change/ 2026-03-24T16:15:36+00:00 https://ascopost.com/news/march-2026/ai-model-classifies-challenging-thymic-epithelial-tumors/ 2026-03-24T15:17:49+00:00 https://ascopost.com/news/march-2026/fda-approves-relacorilant-with-nab-paclitaxel-for-several-platinum-resistant-gynecologic-cancers/ 2026-03-25T15:23:43+00:00 https://ascopost.com/news/march-2026/hyperplasia-and-the-link-between-obesity-and-cancer/ 2026-03-26T13:40:14+00:00 https://ascopost.com/news/march-2026/gedatolisib-based-regimens-in-hr-positive-her2-negative-pik3ca-wild-type-advanced-breast-cancer/ 2026-03-26T14:01:44+00:00 https://ascopost.com/news/march-2026/using-ai-to-differentiate-primary-lung-squamous-cell-carcinomas-from-metastases/ 2026-03-26T13:23:54+00:00 https://ascopost.com/news/march-2026/neoadjuvant-golp-in-high-risk-intrahepatic-cholangiocarcinoma/ 2026-03-26T14:08:50+00:00 https://ascopost.com/news/march-2026/breast-reconstruction-using-polyurethane-coated-implants-may-reduce-the-risk-of-capsular-contracture-additional-surgery/ 2026-03-30T20:52:10+00:00 https://ascopost.com/news/march-2026/breast-cancer-recurrence-remains-low-even-after-10-years-with-radiotherapy-tailored-to-patient-s-individual-risk/ 2026-03-30T20:53:52+00:00 https://ascopost.com/news/march-2026/ai-use-in-cancer-diagnosis-prognosis-and-treatment-are-we-there-yet/ 2026-03-26T18:25:11+00:00 https://ascopost.com/news/march-2026/ai-as-collaborator-in-cancer-research-and-in-clinical-care/ 2026-03-30T17:21:50+00:00 https://ascopost.com/news/march-2026/ai-model-for-predicting-oncotype-dx-21-gene-recurrence-score/ 2026-03-27T16:11:55+00:00 https://ascopost.com/news/march-2026/dynamic-accessible-risk-stratification-tool-created-for-smoldering-multiple-myeloma/ 2026-03-27T17:54:06+00:00 https://ascopost.com/news/march-2026/pembrolizumab-with-or-without-lenvatinib-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma/ 2026-03-27T16:18:45+00:00 https://ascopost.com/news/march-2026/early-results-demonstrate-safety-and-efficacy-of-mutant-calreticulin-specific-monoclonal-antibody-in-myelofibrosis/ 2026-03-27T17:52:00+00:00 https://ascopost.com/news/march-2026/two-major-cancer-centers-announce-appointments-of-new-directors/ 2026-03-30T16:27:21+00:00 https://ascopost.com/news/march-2026/radiotherapy-may-reduce-risk-of-lymphedema-in-patients-with-breast-cancer-more-effectively-than-surgery/ 2026-03-30T20:58:31+00:00 https://ascopost.com/news/march-2026/adjuvant-atezolizumab-and-mfolfox6-in-stage-iii-mismatch-repair-deficient-colon-cancer/ 2026-03-30T16:45:28+00:00 https://ascopost.com/news/march-2026/metabolic-subtypes-of-nasopharyngeal-carcinoma-and-response-to-treatment/ 2026-03-30T17:07:04+00:00 https://ascopost.com/news/march-2026/molecular-test-doubles-detection-of-bile-duct-cancer/ 2026-03-31T16:24:47+00:00 https://ascopost.com/news/march-2026/transdermal-estradiol-patches-vs-lhrh-agonists-in-locally-advanced-prostate-cancer/ 2026-03-31T15:04:14+00:00 https://ascopost.com/news/march-2026/risk-of-subsequent-cancer-in-solid-organ-transplant-recipients-with-pretransplant-cancer-history/ 2026-03-31T15:28:13+00:00 https://ascopost.com/news/march-2026/elinzanetant-may-reduce-side-effects-of-endocrine-therapy-among-patients-with-breast-cancer/ 2026-03-31T15:15:12+00:00 https://ascopost.com/news/april-2026/ 2026-04-01T13:15:19+00:00 https://ascopost.com/news/april-2026/nivolumab-with-or-without-ipilimumab-in-platinum-refractory-advanced-neuroendocrine-carcinoma/ 2026-04-01T14:43:05+00:00 https://ascopost.com/news/april-2026/early-results-from-a-trial-of-active-surveillance-for-low-risk-dcis-are-reassuring-say-researchers/ 2026-04-01T16:20:05+00:00 https://ascopost.com/news/april-2026/ai-driven-multiagent-system-for-guiding-first-line-immunotherapy-for-nsclc/ 2026-04-01T15:34:38+00:00 https://ascopost.com/news/april-2026/machine-learning-model-for-hcc-risk-prediction-may-outperform-current-methods/ 2026-04-01T15:26:26+00:00 https://ascopost.com/news/april-2026/one-time-low-dose-ct-screening-may-reduce-lung-cancer-mortality-among-neversmokers-in-asia/ 2026-04-02T16:24:40+00:00 https://ascopost.com/news/april-2026/agent-orange-exposure-linked-to-mds-risk-and-progression/ 2026-04-02T16:33:41+00:00 https://ascopost.com/news/april-2026/financial-hardship-and-late-stage-cancer-diagnosis/ 2026-04-02T17:46:20+00:00 https://ascopost.com/news/april-2026/low-risk-endometrial-cancer-does-a-lack-of-adjuvant-therapy-affect-survival/ 2026-04-02T16:18:08+00:00 https://ascopost.com/news/april-2026/ctdna-at-the-end-of-neoadjuvant-therapy-may-predict-breast-cancer-recurrence/ 2026-04-02T16:03:39+00:00 https://ascopost.com/news/april-2026/ai-shows-dermatologist-level-accuracy-in-melanoma-diagnosis-but-needs-validation/ 2026-04-03T15:52:53+00:00 https://ascopost.com/news/april-2026/patients-with-lung-cancer-may-safely-receive-adequate-sbrt-dosage-in-one-treatment/ 2026-04-03T15:12:51+00:00 https://ascopost.com/news/april-2026/fda-grants-traditional-approval-to-brexucabtagene-autoleucel-for-relapsed-or-refractory-mcl/ 2026-04-03T16:37:02+00:00 https://ascopost.com/news/april-2026/prompting-strategies-improve-symptom-monitoring-in-childhood-cancer-survivors/ 2026-04-03T15:50:12+00:00 https://ascopost.com/news/april-2026/study-finds-glp-1ras-were-associated-with-a-reduced-risk-of-developing-colorectal-cancer-vs-aspirin/ 2026-04-03T16:56:10+00:00 https://ascopost.com/issues/ 2025-07-21T21:39:39+00:00 https://ascopost.com/issues/june-10-2021/ 2021-06-10T19:14:21+00:00 https://ascopost.com/issues/june-10-2021/atezolizumab-reduces-risk-of-disease-progression-in-patients-with-pd-l1-expressing-early-stage-nsclc/ 2024-07-15T17:09:21+00:00 https://ascopost.com/issues/june-10-2021/navigating-the-post-vaccine-pandemic/ 2024-07-15T17:15:25+00:00 https://ascopost.com/issues/june-10-2021/cabozantinib-with-nivolumab-for-metastatic-renal-cell-carcinoma/ 2021-06-10T20:42:48+00:00 https://ascopost.com/issues/june-10-2021/is-high-tumor-mutational-burden-predictive-of-immune-checkpoint-blockade-efficacy-across-all-cancer-types/ 2021-06-10T20:54:38+00:00 https://ascopost.com/issues/june-10-2021/dual-immune-checkpoint-blockade-with-nivolumab-and-ipilimumab-for-treatment-of-malignant-pleural-mesothelioma/ 2021-06-24T18:16:14+00:00 https://ascopost.com/issues/june-10-2021/disease-free-survival-benefit-with-adjuvant-immunotherapy-in-resectable-esophageal-cancer-practice-changing-for-all-patients/ 2021-06-11T18:16:18+00:00 https://ascopost.com/issues/june-10-2021/how-the-biden-administration-is-changing-oncology-care/ 2021-06-10T19:28:07+00:00 https://ascopost.com/issues/june-10-2021/adjuvant-imatinib-therapy-offers-survival-benefit-in-patients-with-resected-gist/ 2021-06-11T18:44:29+00:00 https://ascopost.com/issues/june-10-2021/global-responses-to-covid-19-pandemic-related-disruptions-in-cancer-care/ 2021-06-10T20:28:05+00:00 https://ascopost.com/issues/june-10-2021/could-risk-based-triage-system-alter-surgical-practice-in-ovarian-cancer/ 2021-06-10T20:28:06+00:00 https://ascopost.com/issues/june-10-2021/epov-thomas-herzog/ 2021-06-10T20:28:07+00:00 https://ascopost.com/issues/june-10-2021/machine-learning-based-algorithm-accurately-predicts-short-term-mortality-in-patients-with-cancer-and-prompts-serious-illness-conversations/ 2021-06-10T20:28:08+00:00 https://ascopost.com/issues/june-10-2021/first-lady-dr-jill-biden-assures-the-nci-of-the-administration-s-commitment-to-advancing-cancer-research/ 2021-06-10T20:28:10+00:00 https://ascopost.com/issues/june-10-2021/adding-targeted-agent-to-treatment-shows-significant-benefits-in-pediatric-patients-with-high-risk-hodgkin-lymphoma/ 2021-06-17T18:39:36+00:00 https://ascopost.com/issues/june-10-2021/selected-poster-presentations-from-the-nccn-2021-annual-conference/ 2021-06-10T20:28:12+00:00 https://ascopost.com/issues/june-10-2021/targeting-lag-3-and-pd-1-with-relatlimab-and-nivolumab-a-new-option-under-study-in-advanced-melanoma/ 2021-06-10T20:28:13+00:00 https://ascopost.com/issues/june-10-2021/omid-hamid-discusses-relativity-047/ 2021-06-10T20:28:14+00:00 https://ascopost.com/issues/june-10-2021/actionable-mutations-identified-in-majority-of-genome-sequenced-resected-cholangiocarcinomas/ 2021-06-10T20:28:15+00:00 https://ascopost.com/issues/june-10-2021/new-approaches-needed-for-patients-with-locoregional-breast-cancer-progression-during-neoadjuvant-systemic-therapy/ 2021-06-10T20:28:16+00:00 https://ascopost.com/issues/june-10-2021/update-on-clinical-trials-in-acute-myeloid-leukemia/ 2021-06-18T18:01:56+00:00 https://ascopost.com/issues/june-10-2021/is-tumor-mutational-burden-predictive-of-survival-outcomes-in-solid-tumors-treated-with-immune-checkpoint-inhibitors/ 2021-08-04T18:43:19+00:00 https://ascopost.com/issues/june-10-2021/nivolumabipilimumab-improves-overall-survival-vs-chemotherapy-in-first-line-treatment-for-unresectable-malignant-pleural-mesothelioma/ 2021-06-10T20:28:19+00:00 https://ascopost.com/issues/june-10-2021/adjuvant-nivolumab-improves-disease-free-survival-vs-placebo-in-resected-esophageal-or-gastroesophageal-junction-cancer-after-neoadjuvant-chemoradiotherapy/ 2021-06-10T20:28:20+00:00 https://ascopost.com/issues/june-10-2021/data-analysis-on-early-onset-colorectal-cancer-sheds-light-on-the-rising-rates-in-young-adults/ 2021-06-11T18:15:15+00:00 https://ascopost.com/issues/june-10-2021/lobaplatin-vs-cisplatin-based-induction-and-chemoradiotherapy-in-previously-untreated-locoregionally-advanced-nasopharyngeal-carcinoma/ 2026-01-29T16:09:03+00:00 https://ascopost.com/issues/june-10-2021/tisotumab-vedotin-in-recurrent-or-metastatic-cervical-cancer/ 2021-06-10T20:28:23+00:00 https://ascopost.com/issues/june-10-2021/seattle-s-fred-hutchinson-cancer-research-center-launches-redesigned-culinary-website-for-cancer-patients-and-survivors/ 2021-06-10T20:28:24+00:00 https://ascopost.com/issues/june-10-2021/fda-approves-nivolumab-for-resected-esophageal-or-gastroesophageal-junction-cancer/ 2021-06-10T20:28:25+00:00 https://ascopost.com/issues/june-10-2021/fda-approves-piflufolastat-f-18-injection-for-the-detection-of-metastatic-or-recurrent-prostate-cancer/ 2021-06-10T20:28:26+00:00 https://ascopost.com/issues/june-10-2021/fda-grants-accelerated-approval-to-amivantamab-vmjw-for-metastatic-egfr-exon-20-insertion-mutated-nsclc/ 2021-06-10T20:28:28+00:00 https://ascopost.com/issues/june-10-2021/fda-grants-accelerated-approval-to-pembrolizumab-combination-for-her2-positive-gastric-cancer/ 2021-06-10T20:28:29+00:00 https://ascopost.com/issues/june-10-2021/i-was-given-a-death-sentence-at-just-17/ 2026-01-29T16:12:10+00:00 https://ascopost.com/issues/june-10-2021/gouri-shankar-bhattacharyya-dies-of-covid-19-related-complications/ 2021-06-10T20:28:31+00:00 https://ascopost.com/issues/june-10-2021/new-study-shows-difficulty-in-identifying-transgender-individuals-using-ehr-data/ 2021-06-10T20:28:32+00:00 https://ascopost.com/issues/june-10-2021/jadpro-live-announces-dates-for-2021-annual-conference-for-oncology-advanced-practitioners/ 2021-06-10T20:28:33+00:00 https://ascopost.com/issues/june-10-2021/eduardo-m-sotomayor-md-to-lead-new-tampa-general-hospital-cancer-institute/ 2021-06-10T20:28:34+00:00 https://ascopost.com/issues/june-10-2021/the-ohio-state-recruits-marcos-j-de-lima-md-to-lead-blood-and-marrow-transplant-and-cellular-therapy-programs/ 2021-06-10T20:28:35+00:00 https://ascopost.com/issues/june-10-2021/gustavo-fonseca-assumes-new-role-at-florida-cancer-specialists-research-institute/ 2021-06-10T20:28:36+00:00 https://ascopost.com/issues/june-10-2021/updated-information-on-sotorasib-dose-comparison-study/ 2021-06-10T20:28:37+00:00 https://ascopost.com/issues/june-10-2021/radiation-is-not-the-enemy/ 2021-06-10T20:28:38+00:00 https://ascopost.com/issues/june-10-2021/jennifer-barsky-reese-receives-new-investigator-award/ 2021-06-10T20:28:39+00:00 https://ascopost.com/issues/june-10-2021/national-advocacy-organization-children-s-cancer-cause-invites-applications-for-2021-survivorship-champion-s-prize/ 2021-06-10T20:28:41+00:00 https://ascopost.com/issues/june-10-2021/pershing-square-sohn-cancer-research-alliance-awards-36-million-to-six-emerging-pioneers-in-cancer-research/ 2021-06-10T20:28:42+00:00 https://ascopost.com/issues/june-10-2021/roswell-park-immunologist-promoted-to-endowed-chair-role/ 2021-06-10T20:28:43+00:00 https://ascopost.com/issues/june-10-2021/the-brooklyn-cancer-center-announces-new-chief-of-hematology-and-medical-oncology/ 2021-06-10T20:28:44+00:00 https://ascopost.com/issues/june-10-2021/carol-prives-receives-aacr-gha-clowes-award-for-outstanding-basic-cancer-research/ 2021-06-10T20:28:45+00:00 https://ascopost.com/issues/june-10-2021/two-memorial-sloan-kettering-experts-awarded-for-pioneering-work/ 2021-06-15T17:48:21+00:00 https://ascopost.com/issues/june-10-2021/senators-richard-burr-and-ben-cardin-recognized-as-asco-congressional-champions-for-cancer-care/ 2021-06-10T20:28:48+00:00 https://ascopost.com/issues/june-10-2021/telehealth-flexibilities-helping-people-have-uninterrupted-access-to-cancer-care-should-continue-after-the-covid-19-pandemic/ 2021-06-10T20:28:49+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/a-love-for-surgery-underpins-a-career-devoted-to-patients-with-pancreatic-cancer/ 2021-06-03T17:01:59+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/a-doctor-s-daughter-becomes-a-pioneer-in-cancer-survivorship/ 2021-06-03T17:04:05+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/a-junior-high-school-teacher-sparks-a-love-for-science/ 2021-06-03T16:13:07+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/a-brooklyn-girl-bucks-her-old-fashioned-upbringing-to-become-a-leader-in-bone-marrow-transplantation/ 2021-06-03T17:06:35+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/a-pioneer-in-geriatric-oncology-leaves-his-mark-and-marches-forward/ 2021-06-03T16:13:07+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/serendipity-plays-a-role-in-a-journey-to-a-noted-career-in-surgical-oncology/ 2021-06-03T16:32:13+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/a-career-in-cardio-oncology-founded-on-simple-principles-taught-by-her-immigrant-parents/ 2023-09-01T18:44:00+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/a-pioneer-in-head-and-neck-cancer-surgery-whose-career-was-founded-on-passion-and-dedication/ 2026-01-29T16:20:17+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/after-a-flirtation-with-infectious-disease-hematology-calls-leading-to-a-notable-career/ 2021-06-03T16:13:08+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/working-on-the-night-shift-a-connection-to-a-patient-with-cancer-inspires-a-career/ 2021-06-03T16:13:08+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/the-daughter-of-a-fighter-pilot-becomes-a-leader-in-compassionate-cancer-care/ 2021-06-03T16:13:08+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/narratives-in-oncology-through-the-years/ 2021-06-03T16:13:08+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/new-fda-approved-oncology-drugs-and-label-updates-between-may-8-2020-and-may-8-2021/ 2021-06-03T16:13:08+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/mourned-and-missed/ 2021-06-03T16:13:08+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/eric-p-winer-elected-asco-president-for-2022-2023-term/ 2021-06-03T16:13:09+00:00 https://ascopost.com/issues/june-3-2021-narratives-special-issue/asco-board-of-directors-and-nominating-committee/ 2021-06-03T16:13:09+00:00 https://ascopost.com/issues/may-25-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/may-25-2021/stage-iv-pd-l1-high-non-small-cell-lung-cancer-immunotherapy-alone-or-with-chemotherapy/ 2021-05-25T19:41:18+00:00 https://ascopost.com/issues/may-25-2021/epov-federico-cappuzzo/ 2021-05-25T19:41:18+00:00 https://ascopost.com/issues/may-25-2021/equitable-cancer-care-steps-toward-meaningful-change/ 2021-05-25T20:26:16+00:00 https://ascopost.com/issues/may-25-2021/asco-s-president-elect-focuses-on-advancing-global-cancer-care-innovations-accelerated-by-the-covid-19-pandemic/ 2021-05-26T15:58:59+00:00 https://ascopost.com/issues/may-25-2021/nccn-clinical-practice-guidelines-in-oncology-2021-updates/ 2021-05-25T20:26:17+00:00 https://ascopost.com/issues/may-25-2021/pembrolizumab-as-long-term-treatment-option-in-relapsed-or-refractory-classic-hodgkin-lymphoma/ 2021-06-23T18:54:40+00:00 https://ascopost.com/issues/may-25-2021/empower-lung-1-trial-new-options-no-new-answers/ 2024-01-08T16:58:45+00:00 https://ascopost.com/issues/may-25-2021/refining-cardiovascular-risk-assessment-in-childhood-cancer-survivors/ 2021-05-25T20:26:17+00:00 https://ascopost.com/issues/may-25-2021/how-the-national-cancer-act-of-1971-revolutionized-cancer-care-and-what-lies-ahead/ 2021-05-25T20:26:17+00:00 https://ascopost.com/issues/may-25-2021/celebrating-50-years-of-cancer-progress-the-international-view/ 2021-05-25T20:26:17+00:00 https://ascopost.com/issues/may-25-2021/early-triple-negative-breast-cancer-are-checkpoint-inhibitors-ready-for-neoadjuvant-or-adjuvant-use/ 2021-05-25T20:26:17+00:00 https://ascopost.com/issues/may-25-2021/frailty-can-be-a-serious-issue-in-ovarian-cancer/ 2021-05-25T20:26:17+00:00 https://ascopost.com/issues/may-25-2021/epov-jamie-n-bakkum-gamez/ 2021-05-25T20:26:18+00:00 https://ascopost.com/issues/may-25-2021/advancements-in-the-care-of-older-adults-with-prostate-cancer/ 2021-05-27T17:13:49+00:00 https://ascopost.com/issues/may-25-2021/chernobyl-at-35-years-an-oncologist-s-perspective/ 2021-05-25T20:26:18+00:00 https://ascopost.com/issues/may-25-2021/balancing-a-reverence-for-life-with-a-belief-that-patients-have-a-right-to-a-dignified-death/ 2021-08-18T20:45:52+00:00 https://ascopost.com/issues/may-25-2021/ixabepilone-plus-bevacizumab-active-in-platinum-resistant-or-recurrent-ovarian-cancer/ 2021-05-25T20:26:18+00:00 https://ascopost.com/issues/may-25-2021/epov-thomas-herzog/ 2021-05-25T20:26:18+00:00 https://ascopost.com/issues/may-25-2021/fuzuloparib-maintenance-therapy-improves-progression-free-survival-in-patients-with-recurrent-ovarian-cancer/ 2021-05-25T20:26:18+00:00 https://ascopost.com/issues/may-25-2021/epov-thomas-herzog-1/ 2021-05-25T20:26:19+00:00 https://ascopost.com/issues/may-25-2021/single-agent-pembrolizumab-yields-high-response-rates-in-patients-with-cutaneous-squamous-cell-carcinoma/ 2021-05-27T18:22:43+00:00 https://ascopost.com/issues/may-25-2021/epov-stefania-scala/ 2021-05-25T20:26:19+00:00 https://ascopost.com/issues/may-25-2021/selpercatinib-makes-inroads-in-other-ret-fusion-positive-tumor-types/ 2021-05-25T20:26:19+00:00 https://ascopost.com/issues/may-25-2021/epov-ezra-ew-cohen/ 2021-05-25T20:26:19+00:00 https://ascopost.com/issues/may-25-2021/oncolytic-virotherapy-achieves-early-signs-of-success-in-high-grade-gliomas/ 2026-01-29T16:21:58+00:00 https://ascopost.com/issues/may-25-2021/epov-patrick-y-wen/ 2021-05-25T20:26:19+00:00 https://ascopost.com/issues/may-25-2021/dual-brafmek-inhibition-under-study-in-braf-v600e-mutant-gliomas/ 2021-05-25T20:26:19+00:00 https://ascopost.com/issues/may-25-2021/coagulopathy-and-covid-19-infection/ 2021-05-25T20:34:38+00:00 https://ascopost.com/issues/may-25-2021/pembrolizumab-improves-progression-free-survival-vs-brentuximab-vedotin-in-relapsed-or-refractory-classic-hodgkin-lymphoma/ 2021-07-21T18:33:33+00:00 https://ascopost.com/issues/may-25-2021/oral-azacitidine-improves-overall-survival-vs-placebo-as-maintenance-therapy-for-aml-in-first-remission/ 2021-06-18T18:10:49+00:00 https://ascopost.com/issues/may-25-2021/first-line-cemiplimab-rwlc-improves-outcomes-vs-platinum-doublet-chemotherapy-in-advanced-nsclc-pd-l1-expression/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/first-line-nivolumab-plus-cabozantinib-improves-progression-free-and-overall-survival-vs-sunitinib-in-advanced-renal-cell-carcinoma/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/improving-prediction-of-risk-for-10-year-left-ventricular-systolic-dysfunction-in-survivors-of-childhood-cancer/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/second-line-folfox-vs-active-symptom-control-in-advanced-biliary-tract-cancer/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/addition-of-neoadjuvant-folfirinox-to-preoperative-chemoradiotherapy-in-locally-advanced-rectal-cancer/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/melphalan-flufenamide-for-relapsed-or-refractory-multiple-myeloma/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/fam-trastuzumab-deruxtecan-nxki-for-trastuzumab-pretreated-advanced-her2-positive-gastric-adenocarcinoma/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/idecabtagene-vicleucel-for-relapsed-or-refractory-multiple-myeloma/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/fda-odac-meeting-focuses-on-dangling-accelerated-approvals-of-anti-pd-1pd-l1-antibodies/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/fda-grants-accelerated-approval-to-sacituzumab-govitecan-hziy-for-advanced-urothelial-cancer/ 2021-05-25T20:34:39+00:00 https://ascopost.com/issues/may-25-2021/fda-approves-new-dosing-regimen-for-cetuximab-in-colorectal-cancer-head-and-neck-cancer/ 2026-01-29T16:37:42+00:00 https://ascopost.com/issues/may-25-2021/fda-grants-regular-approval-to-sacituzumab-govitecan-hziy-for-pretreated-patients-with-triple-negative-breast-cancer/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/fda-grants-accelerated-approval-to-loncastuximab-tesirine-lpyl-for-large-b-cell-lymphoma/ 2021-05-25T20:26:22+00:00 https://ascopost.com/issues/may-25-2021/fda-approves-isatuximab-irfc-combination-for-relapsed-or-refractory-multiple-myeloma/ 2021-05-25T20:26:22+00:00 https://ascopost.com/issues/may-25-2021/new-president-and-executive-council-officers-for-the-society-of-surgical-oncology/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/drive-curiosity-and-a-love-of-science-one-nurse-s-road-to-a-leadership-role-in-oncology/ 2021-05-25T20:42:48+00:00 https://ascopost.com/issues/may-25-2021/an-epiphany-during-fellowship-led-to-a-career-in-geriatric-oncology-for-heidi-d-klepin/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/cancer-has-taught-me-to-live-with-purpose/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/a-seasoned-journalist-seeking-answers-reports-from-the-front-lines-of-the-covid-19-pandemic/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/enduring-cancer-and-its-treatment-with-resilience-and-humor/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/asco-issues-guideline-on-dyspnea-in-advanced-cancer/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/asco-honors-2021-special-awards-recipients/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/lisa-m-coussens-phd-faacr-elected-aacr-president-elect-for-2021-2022/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/aacr-to-recognize-the-st-baldrick-s-foundation-su2c-pediatric-cancer-dream-team-with-2021-team-science-award/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/aacr-announces-recipients-of-2021-scientific-achievement-awards-and-lectureships/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/douglas-r-lowy-md-faacr-honored-with-2021-aacr-margaret-foti-award/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/stand-up-to-cancer-funds-6-million-for-disparities-in-cancer-clinical-trials-research/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/ton-schumacher-receives-2021-aacr-cri-lloyd-j-old-award-in-cancer-immunology/ 2021-05-25T20:34:40+00:00 https://ascopost.com/issues/may-25-2021/nima-sharifi-receives-2021-aacr-waun-ki-hong-award-in-translational-and-clinical-cancer-research/ 2021-05-25T20:34:41+00:00 https://ascopost.com/issues/may-25-2021/roswell-park-wilmot-cancer-institute-collaborate-in-study-of-immunotherapy-for-black-patients-with-cancer/ 2021-05-25T20:34:41+00:00 https://ascopost.com/issues/may-25-2021/st-jude-children-s-research-hospital-announces-its-largest-strategic-expansion/ 2021-05-25T20:34:41+00:00 https://ascopost.com/issues/may-25-2021/sloan-kettering-institute-researchers-awarded-2021-kravis-women-in-science-endeavor-fellowship-grants/ 2021-05-25T20:34:41+00:00 https://ascopost.com/issues/may-25-2021/aua-names-2021-award-recipients/ 2021-05-25T20:34:41+00:00 https://ascopost.com/issues/may-25-2021/american-academy-of-hiv-medicine-names-leslie-mcgorman-as-director-of-public-policy/ 2021-05-25T20:34:41+00:00 https://ascopost.com/issues/may-25-2021/agnes-witkiewicz-to-lead-roswell-park-s-cancer-genetics-and-genomics-department/ 2021-05-25T20:34:41+00:00 https://ascopost.com/issues/may-25-2021/lustgarten-foundation-aacr-career-development-awards-for-pancreatic-cancer-research/ 2021-05-25T20:26:25+00:00 https://ascopost.com/issues/may-10-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/may-10-2021/neoadjuvant-nivolumab-plus-chemotherapy-boosts-pathologic-complete-response-in-resectable-nsclc/ 2021-05-10T19:12:21+00:00 https://ascopost.com/issues/may-10-2021/epov-jhanelle-gray/ 2021-05-10T19:12:22+00:00 https://ascopost.com/issues/may-10-2021/how-mrd-assessment-may-help-guide-treatment-selection-for-patients-with-aml/ 2021-05-17T17:24:43+00:00 https://ascopost.com/issues/may-10-2021/margetuximab-cmkb-a-novel-agent-overshadowed-by-an-abundance-of-options-in-her2-positive-breast-cancer/ 2021-05-10T19:12:22+00:00 https://ascopost.com/issues/may-10-2021/phase-iii-ariel4-confirms-rucaparib-s-benefit-in-brca-mutated-relapsed-ovarian-cancer/ 2021-05-10T19:12:22+00:00 https://ascopost.com/issues/may-10-2021/epov-ursula-matulonis-and-konstantin-zakashansky/ 2021-05-10T19:12:22+00:00 https://ascopost.com/issues/may-10-2021/shared-risk-factors-for-preventing-cancer-and-cardiovascular-disease-the-evolving-focus-of-cardio-oncology/ 2023-09-01T18:47:05+00:00 https://ascopost.com/issues/may-10-2021/tebentafusp-shows-overall-survival-benefit-in-first-line-treatment-of-metastatic-uveal-melanoma/ 2021-05-27T18:25:08+00:00 https://ascopost.com/issues/may-10-2021/epov-caroline-robert/ 2021-05-10T19:12:22+00:00 https://ascopost.com/issues/may-10-2021/addition-of-copanlisib-to-rituximab-extends-progression-free-survival-in-relapsed-indolent-nhl/ 2021-05-12T17:12:03+00:00 https://ascopost.com/issues/may-10-2021/epov-peter-martin/ 2021-05-10T19:12:22+00:00 https://ascopost.com/issues/may-10-2021/rare-genitourinary-tumors-global-society/ 2021-05-11T19:11:26+00:00 https://ascopost.com/issues/may-10-2021/surge-of-patients-with-advanced-cancer-expected-due-to-delayed-diagnosis-and-treatment-during-pandemic/ 2021-05-10T19:12:22+00:00 https://ascopost.com/issues/may-10-2021/covid-19-pandemic-underscores-shortage-of-oncologists/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/heritability-genes-identified-in-childhood-neuroblastoma/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/epov-antoni-ribas/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/comparing-nivolumab-plus-ipilimumab-vs-nivolumab-alone-in-resected-stage-iii-to-iv-melanoma/ 2024-10-11T16:26:28+00:00 https://ascopost.com/issues/may-10-2021/epov-alexander-eggermont/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/phase-ii-trial-reports-anticancer-activity-with-novel-fgfr-inhibitor-in-advanced-intrahepatic-cholangiocarcinoma/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/epov-ezra-cohen/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/hormonal-intrauterine-device-under-study-for-managing-early-endometrial-cancer/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/epov-angeles-alvarez-secord/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/expanding-role-of-liquid-biopsies-in-cancer-detection-and-therapeutics-now-and-in-the-near-future/ 2021-05-10T19:12:23+00:00 https://ascopost.com/issues/may-10-2021/adjuvant-immunotherapy-of-benefit-to-patients-with-stage-iibc-melanoma/ 2021-05-27T18:32:29+00:00 https://ascopost.com/issues/may-10-2021/virtual-meetings-are-here-to-stay/ 2021-05-10T19:12:24+00:00 https://ascopost.com/issues/may-10-2021/squamous-cell-carcinoma-of-the-head-and-neck-current-status-and-future-directions/ 2026-01-29T16:33:39+00:00 https://ascopost.com/issues/may-10-2021/bispecific-antibody-platform-early-data-in-relapsed-and-refractory-myeloma/ 2021-05-10T19:12:24+00:00 https://ascopost.com/issues/may-10-2021/margetuximab-cmkb-plus-chemotherapy-prolongs-progression-free-survival-in-heavily-pretreated-her2-positive-breast-cancer/ 2021-05-10T19:12:24+00:00 https://ascopost.com/issues/may-10-2021/first-line-pembrolizumab-plus-chemotherapy-in-pd-l1-positive-locally-recurrent-triple-negative-breast-cancer/ 2021-05-10T19:12:24+00:00 https://ascopost.com/issues/may-10-2021/are-prevalent-cardiovascular-risk-factors-associated-with-increased-risk-of-subsequent-cancer/ 2021-05-10T19:12:24+00:00 https://ascopost.com/issues/may-10-2021/overall-survival-with-olaparib-vs-placebo-maintenance-in-patients-with-platinum-sensitive-relapsed-ovarian-cancer-and-brca12-mutation/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/pembrolizumab-in-microsatellite-instability-high-advanced-gastric-or-gastroesophageal-junction-cancer/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/cemiplimab-rwlc-for-first-line-treatment-of-nsclc-with-high-pd-l1-expression/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/fda-approves-nivolumab-in-combination-with-chemotherapy-for-metastatic-gastric-cancer-and-esophageal-adenocarcinoma/ 2021-05-10T18:56:28+00:00 https://ascopost.com/issues/may-10-2021/patrizia-cavazzoni-named-director-of-the-fda-center-for-drug-evaluation-and-research/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/a-sense-of-duty-shapes-the-career-of-medical-oncologist-aparna-parikh-md/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/cannabis/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/what-you-need-to-know-about-cancer-and-the-coronavirus/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/asco-and-ontario-health-publish-joint-update-on-guideline-for-targeted-therapy-in-nsclc-with-driver-alterations/ 2021-05-21T17:16:45+00:00 https://ascopost.com/issues/may-10-2021/chênevert-family-brain-tumor-center-launched-at-yale/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/maryam-lustberg-md-mph-accepts-leadership-roles-at-smilow-cancer-hospital-yale-cancer-center/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/frederick-w-alt-phd-honored-with-2021-aacr-award-for-lifetime-achievement-in-cancer-research/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/new-director-of-neuro-oncology-named-to-rutgers-cancer-institute-of-new-jersey/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/ucla-team-receives-6-million-from-nih-to-explore-new-pancreatic-cancer-therapies/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/methylationtoactivity-a-deep-learning-framework-for-epigenetic-research/ 2021-05-10T19:12:25+00:00 https://ascopost.com/issues/may-10-2021/dana-farber-cancer-institute-opens-new-state-of-the-art-location/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/city-of-hope-renames-research-center-as-the-arthur-riggs-diabetes-metabolism-research-institute/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/american-cancer-society-names-karen-knudsen-its-next-chief-executive-officer/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/aacr-inaugurates-new-leadership-at-virtual-aacr-annual-business-meeting-2021/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/roswell-park-is-first-site-in-region-named-a-resource-for-patients-with-rare-genetic-disease/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/lombardi-comprehensive-cancer-center-georgetown-university-names-kieron-dunleavy-md-to-leadership-positions-in-hematology/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/cleveland-clinic-appoints-brian-bolwell-to-new-leadership-role-jame-abraham-to-serve-as-acting-chair-taussig-cancer-institute/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/randall-holcombe-named-director-of-uvm-cancer-center-and-chief-of-hematology-and-oncology/ 2021-05-10T19:12:26+00:00 https://ascopost.com/issues/may-10-2021/upmc-hillman-names-new-hematology-oncology-chief/ 2021-05-10T19:12:27+00:00 https://ascopost.com/issues/may-10-2021/fostering-a-global-community-of-early-career-oncologists-virtually/ 2021-05-10T19:12:27+00:00 https://ascopost.com/issues/may-10-2021/asco-answers-guide-cancer-survivorship/ 2021-05-10T19:12:27+00:00 https://ascopost.com/issues/may-10-2021/new-savings-on-healthcaregov-follow-covid-relief-package/ 2021-05-10T19:12:27+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/genitourinary-oncology-highlights-2020-2021-almanac/ 2021-04-27T13:46:37+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/adding-apalutamide-to-abirateroneprednisone-extends-radiographic-progression-free-but-not-overall-survival/ 2021-04-21T15:59:01+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-joshi-j-alumkal/ 2021-04-21T16:00:36+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/comparing-radiotherapy-regimens-for-biochemically-recurrent-prostate-cancer-after-radical-prostatectomy/ 2021-04-21T16:05:00+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-richard-k-valicenti/ 2021-04-21T16:06:29+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/lupsma-outperforms-cabazitaxel-for-metastatic-castration-resistant-prostate-cancer-in-phase-ii-trial/ 2021-04-21T16:07:20+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-oliver-sartor/ 2021-04-21T16:08:35+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/adjuvant-vs-neoadjuvant-androgen-deprivation-therapy-with-radiotherapy-for-prostate-cancer/ 2021-04-21T16:10:24+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-alejandro-berlin/ 2021-04-21T16:11:26+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/ipatasertibabiraterone-combination-shows-potential-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/ 2021-04-21T16:12:45+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-henrik-groenberg/ 2021-04-21T16:14:31+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/olaparib-improves-outcomes-in-metastatic-castration-resistant-prostate-cancer-with-brca12-alterations/ 2021-04-21T16:16:18+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-henrik-groenberg-1/ 2021-04-21T16:16:29+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/presalvage-radiotherapy-psa-levels-and-outcomes-with-long-term-antiandrogen-therapy-in-prostate-ca/ 2021-04-21T16:18:11+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/psa-level-prior-to-salvage-radiotherapy/ 2021-07-20T20:05:36+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/swog-1500-cabozantinib-extends-progression-free-survival-vs-sunitinib-in-metastatic-papillary-renal-cell-carcinoma/ 2021-04-21T16:20:44+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-stephanie-berg-1/ 2021-04-21T16:40:47+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/continued-progression-free-and-overall-survival-superiority-of-first-line-pembrolizumabaxitinib-vs-sunitinib/ 2021-04-21T16:41:17+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/evolving-landscape-of-first-line-therapy-for-metastatic-renal-cell-carcinoma/ 2021-04-21T16:42:41+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/first-line-nivolumab-plus-cabozantinib-improves-outcomes-vs-sunitinib-in-advanced-renal-cell-carcinoma/ 2021-04-21T16:44:04+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/ev-301-and-ev-201-trials-enfortumab-vedotin-ejfv-improves-survival-in-metastatic-urothelial-cancer/ 2021-04-21T16:45:27+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-arlene-o-siefker-radtke/ 2021-04-21T16:47:07+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/nivolumab-first-adjuvant-immunotherapy-to-show-survival-benefit-in-high-risk-muscle-invasive-urothelial-cancer/ 2021-04-21T16:48:46+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-sumanta-pal/ 2021-04-21T16:49:15+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/checkpoint-inhibitor-and-chemotherapy-combinations-as-first-line-therapy-for-advanced-urothelial-cancer/ 2021-04-21T16:51:03+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-richard-cathomas/ 2021-04-21T16:51:57+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/front-line-avelumab-maintenance-improved-survival-across-subgroups-with-advanced-urothelial-carcinoma/ 2021-04-21T16:54:20+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-kilian-gust/ 2021-04-21T16:55:14+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/adjuvant-atezolizumab-fails-to-meet-primary-study-endpoint-in-high-risk-bladder-cancer/ 2021-04-21T16:57:19+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/epov-daniel-heng-and-toni-choueiri/ 2021-04-21T16:57:49+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2020-2021/first-line-atezolizumab-plus-platinum-based-chemotherapy-vs-chemotherapy-alone-in-advanced-urothelial-cancer/ 2021-04-21T16:59:48+00:00 https://ascopost.com/issues/april-25-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/april-25-2021/sustained-benefit-for-maintenance-olaparib-in-ovarian-cancer/ 2021-04-27T20:23:08+00:00 https://ascopost.com/issues/april-25-2021/epov-deborah-armstrong/ 2021-04-26T17:24:23+00:00 https://ascopost.com/issues/april-25-2021/to-advance-health-equity-put-real-world-cancer-data-to-work/ 2025-08-22T08:53:55+00:00 https://ascopost.com/issues/april-25-2021/clear-trial-is-lenvatinib-plus-pembrolizumab-the-best-first-line-immunotherapy-doublet-in-metastatic-renal-cell-carcinoma/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/nivolumabipilimumab-plus-two-cycles-of-histology-based-chemotherapy-another-option-in-first-line-metastatic-nsclc/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/cardiovascular-disease-in-hematologic-malignancies/ 2023-09-01T18:49:07+00:00 https://ascopost.com/issues/april-25-2021/novel-her2-targeted-therapies-pose-sequencing-challenges/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/how-interested-are-patients-in-integrative-therapies-and-how-much-are-they-willing-to-pay-for-them/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/clinician-recommendations-may-pique-patients-interest-in-complementary-and-integrative-therapies/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/ethical-considerations-before-launching-a-clinical-cancer-trial/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/a-physician-scientist-s-mother-fueled-his-passion-for-biomedical-research/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/cancer-care-in-sudan-during-the-covid-19-pandemic/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/role-of-antibody-drug-conjugates-across-breast-cancer-subtypes/ 2021-04-27T20:21:27+00:00 https://ascopost.com/issues/april-25-2021/belzutifan-shows-activity-in-advanced-renal-cell-carcinoma-both-as-a-single-agent-and-in-combination-therapy/ 2021-04-27T20:26:23+00:00 https://ascopost.com/issues/april-25-2021/epov-david-braun/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/manifest-2-cpi-0610-shows-benefit-in-myelofibrosis/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/epov-aaron-t-gerds/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/study-finds-tranexamic-acid-unable-to-prevent-bleeding-in-patients-with-hematologic-malignancies/ 2021-05-13T17:36:40+00:00 https://ascopost.com/issues/april-25-2021/epov-lisa-baumann-kreuziger/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/nccn-2021-virtual-annual-conference/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/rara-agonist-plus-azacitidine-shows-encouraging-activity-in-relapsedrefractory-aml/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/epov-jacqueline-s-garcia/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/two-lenvatinib-combinations-improve-progression-free-survival-vs-sunitinib-alone-in-first-line-treatment-of-advanced-renal-cell-carcinoma/ 2021-04-27T20:30:26+00:00 https://ascopost.com/issues/april-25-2021/first-line-nivolumabipilimumab-plus-chemotherapy-improves-overall-survival-vs-chemotherapy-in-stage-iv-or-recurrent-nsclc/ 2021-04-27T20:21:29+00:00 https://ascopost.com/issues/april-25-2021/transmission-of-cancer-to-infants-from-mothers-with-cervical-cancer-during-vaginal-delivery/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/sitagliptin-added-to-tacrolimussirolimus-prophylaxis-regimen-for-acute-graft-vs-host-disease-after-hsct/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/anti-bcma-directed-car-t-cell-gene-therapy-in-relapsed-or-refractory-myeloma/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/cardiovascular-events-with-transdermal-estradiol-vs-lhrh-agonists-for-androgen-suppression-in-advanced-prostate-cancer/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/complete-mesocolic-excision-vs-d2-dissection-in-patients-undergoing-laparoscopic-colectomy-for-right-sided-colon-cancer/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/olaparib-for-previously-treated-patients-with-pancreatic-cancer-and-ddr-genetic-alterations-other-than-brca-variants/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/cemiplimab-rwlc-for-locally-advanced-and-metastatic-basal-cell-carcinoma/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/umbralisib-for-previously-treated-relapsed-or-refractory-marginal-zone-lymphoma-and-follicular-lymphoma/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/fda-approves-tivozanib-for-relapsed-or-refractory-advanced-renal-cell-carcinoma/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/fda-approves-pembrolizumab-combination-for-advanced-esophageal-or-gastroesophageal-junction-carcinoma/ 2021-04-27T20:21:30+00:00 https://ascopost.com/issues/april-25-2021/fda-approves-new-indication-for-daunorubicincytarabine-secondary-acute-myeloid-leukemia-in-pediatric-patients/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/fda-approves-idecabtagene-vicleucel-for-heavily-pretreated-patients-with-multiple-myeloma/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/incidence-and-cancer-related-mortality-in-belize/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/grateful-to-be-alive/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/turning-confusion-into-clarity-lessons-learned-from-autism-spectrum-disorder/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/new-asco-guideline-offers-recommendations-for-neoadjuvant-breast-cancer-treatment/ 2021-05-03T14:09:28+00:00 https://ascopost.com/issues/april-25-2021/increasing-cervical-cancer-prevention-and-care-in-nepal/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/addressing-oncologist-burnout-emotional-well-being-and-moral-distress-in-the-pandemic/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/improvement-programs-to-optimize-patient-care-for-black-americans-with-breast-cancer/ 2021-04-30T20:43:19+00:00 https://ascopost.com/issues/april-25-2021/neeraj-agarwal-named-senior-director-of-clinical-research-innovation-by-huntsman-cancer-institute/ 2021-04-27T20:21:31+00:00 https://ascopost.com/issues/april-25-2021/cancercare-appoints-mark-d-peters-ii-pharmd-as-vice-president-for-new-business-development-and-outreach/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-25-2021/brendon-stiles-named-chief-of-thoracic-surgery-and-surgical-oncology-at-montefiore-and-albert-einstein/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-25-2021/narjust-duma-md-appointed-to-dual-role-at-dana-farber-cancer-institute-harvard-medical-school/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-25-2021/imf-launches-initiative-to-improve-outcomes-in-multiple-myeloma-among-black-americans/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-25-2021/aacr-distinguished-public-service-awards/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-25-2021/ama-salutes-end-to-ban-on-transgender-americans-in-the-military/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-25-2021/nci-statement-on-ending-structural-racism-in-biomedical-research/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-25-2021/aacr-and-the-mark-foundation-for-cancer-research-announce-new-grants/ 2021-04-27T20:21:32+00:00 https://ascopost.com/issues/april-10-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/april-10-2021/lenvatinibpembrolizumab-improves-survival-in-advanced-endometrial-cancer/ 2021-04-09T17:15:40+00:00 https://ascopost.com/issues/april-10-2021/epov-ursula-matulonis/ 2021-04-09T17:11:57+00:00 https://ascopost.com/issues/april-10-2021/breast-cancer-screening-with-clinical-breast-examination-in-low-and-middle-income-countries/ 2021-05-03T17:12:09+00:00 https://ascopost.com/issues/april-10-2021/pembrolizumab-in-first-line-treatment-of-metastatic-clear-cell-and-non-clear-cell-renal-cell-carcinoma/ 2021-04-09T17:05:35+00:00 https://ascopost.com/issues/april-10-2021/cancer-and-covid-19-reflections-at-1-year/ 2021-04-09T17:11:57+00:00 https://ascopost.com/issues/april-10-2021/cardiovascular-risks-associated-with-checkpoint-inhibitors-and-car-t-cell-therapy/ 2021-04-09T17:11:57+00:00 https://ascopost.com/issues/april-10-2021/cardiovascular-concerns-with-the-use-of-vegfr-tyrosine-kinase-inhibitors/ 2023-09-01T18:53:02+00:00 https://ascopost.com/issues/april-10-2021/younger-vs-older-women-with-breast-cancer-understanding-the-differences/ 2021-04-09T17:11:57+00:00 https://ascopost.com/issues/april-10-2021/lung-cancers-with-rare-egfr-mutations-being-tackled-by-novel-agents/ 2021-04-20T18:30:59+00:00 https://ascopost.com/issues/april-10-2021/epov-gillianne-lai/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/how-exceptional-responders-are-providing-clues-to-personalizing-cancer-treatment/ 2021-04-09T17:14:52+00:00 https://ascopost.com/issues/april-10-2021/yoga-in-oncologic-care-an-evidence-based-treatment-to-improve-outcomes/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/patient-reported-outcomes-with-nivolumab-plus-cabozantinib-in-advanced-renal-cell-carcinoma/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/epov-xin-gao/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/novel-decision-making-tool-for-androgen-deprivation-therapy-for-patients-with-prostate-cancer/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/epov-richard-valicenti/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/novel-insights-in-myelodysplastic-syndromes-highlights-from-2020-ash-meeting/ 2021-05-13T17:33:33+00:00 https://ascopost.com/issues/april-10-2021/stand-up-to-cancer-announces-325-million-in-grants-for-headneck-cancer-research/ 2026-01-29T16:35:43+00:00 https://ascopost.com/issues/april-10-2021/first-line-pembrolizumab-shows-activity-in-advanced-clear-cell-and-non-clear-cell-kidney-cancers/ 2021-04-13T18:37:07+00:00 https://ascopost.com/issues/april-10-2021/clinical-breast-examination-screening-results-in-lower-stage-at-breast-cancer-diagnosis-and-reduced-breast-cancer-mortality-in-india/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/meta-analysis-of-hypofractionated-vs-conventionally-fractionated-radiotherapy-for-locally-advanced-bladder-cancer/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/effect-of-salpingo-oophorectomy-on-breast-cancer-risk-in-women-with-brca1-or-brca2-pathogenic-variants/ 2021-04-09T17:11:58+00:00 https://ascopost.com/issues/april-10-2021/fda-approves-lorlatinib-for-metastatic-alk-positive-nsclc/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/towering-figure-in-cancer-drug-development-josé-baselga-md-phd-fasco-dies-at-age-61/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/i-m-living-the-life-i-was-destined-to-have/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/an-oncologist-and-his-wife-share-a-personal-cancer-story/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/new-jersey-oncology-care-providers-form-astera-cancer-care-join-oneoncology/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/william-tseng-md-joins-sarcoma-alliance-board-of-directors/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/dana-farber-oncologist-benjamin-ebert-awarded-sjoberg-prize-for-cancer-research/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/association-of-community-cancer-centers-names-new-president/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/fox-chase-welcomes-cihangir-duy/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/city-of-hope-announces-new-radiation-oncology-chair/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/ze-ev-ronai-named-director-of-sanford-burnham-prebys-cancer-center/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/johan-vansteenkiste-and-fiona-blackhall-honored-for-lung-cancer-research-by-esmo-and-iaslc/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/andrew-ewald-named-director-of-johns-hopkins-medicine-s-department-of-cell-biology/ 2021-04-09T17:11:59+00:00 https://ascopost.com/issues/april-10-2021/leslie-boyd-appointed-director-of-gynecologic-oncology-at-perlmutter-cancer-center/ 2021-04-09T17:12:00+00:00 https://ascopost.com/issues/april-10-2021/jeff-walker-returns-to-roswell-park-in-newly-created-executive-role/ 2021-04-09T17:12:00+00:00 https://ascopost.com/issues/april-10-2021/knuckles/ 2021-04-09T17:05:39+00:00 https://ascopost.com/issues/april-10-2021/legislation-aims-to-increase-hpv-vaccine-awareness-access-and-research/ 2021-04-09T17:12:00+00:00 https://ascopost.com/issues/april-10-2021/executive-order-aims-to-secure-access-to-essential-pharmaceuticals-by-strengthening-supply-chains/ 2021-04-09T17:12:00+00:00 https://ascopost.com/issues/april-10-2021/oncology-clinician-well-being-roadmap-provides-5-year-plan-to-address-provider-burnout/ 2021-04-09T17:12:00+00:00 https://ascopost.com/issues/march-25-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/march-25-2021/lenvatinibpembrolizumab-combination-improves-outcomes-vs-sunitinib-in-renal-cell-carcinoma/ 2021-03-25T17:56:52+00:00 https://ascopost.com/issues/march-25-2021/epov-stephanie-berg/ 2021-03-25T16:55:54+00:00 https://ascopost.com/issues/march-25-2021/breast-cancer-susceptibility-genes-putting-the-pieces-together/ 2021-04-05T17:32:25+00:00 https://ascopost.com/issues/march-25-2021/physician-patient-relationship-sacred-and-sacrosanct/ 2021-03-25T17:18:09+00:00 https://ascopost.com/issues/march-25-2021/no-benefit-found-for-everolimus-plus-adjuvant-hormone-therapy-in-high-risk-early-stage-breast-cancer/ 2021-04-05T17:08:53+00:00 https://ascopost.com/issues/march-25-2021/epov-peter-schmid/ 2021-03-25T17:18:09+00:00 https://ascopost.com/issues/march-25-2021/overcoming-gender-disparity-in-evaluating-sexual-health-following-a-cancer-diagnosis/ 2021-03-25T17:18:09+00:00 https://ascopost.com/issues/march-25-2021/hematologic-cancers-increase-risk-of-covid-19-related-death-vs-solid-tumors/ 2021-03-25T18:00:39+00:00 https://ascopost.com/issues/march-25-2021/epov-joseph-alvarnas/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/older-breast-cancer-survivors-may-consider-discontinuing-screening-mammography-in-the-setting-of-limited-life-expectancy/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/expect-questions-from-older-breast-cancer-survivors-about-discontinuing-routine-surveillance-mammography/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/female-breast-cancer-surpasses-lung-cancer-as-the-most-commonly-diagnosed-cancer-worldwide/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/repurposing-available-drugs-for-covid-19/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/evidence-based-strategy-for-improving-access-to-colorectal-cancer-screening-for-diverse-populations/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/epov-ana-maria-lopez/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/study-reports-little-benefit-to-adding-pembrolizumab-to-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/epov-john-c-krauss/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/itaca-trial-no-survival-benefit-for-tailoring-adjuvant-chemotherapy-in-nsclc/ 2021-04-20T18:33:48+00:00 https://ascopost.com/issues/march-25-2021/epov-tetsuya-mitsudomi/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/next-up-in-nsclc-antibody-drug-conjugates/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/epov-ignatius-ou/ 2021-03-25T17:18:10+00:00 https://ascopost.com/issues/march-25-2021/challenges-in-managing-hodgkin-lymphoma-focus-on-use-of-brentuximab-vedotin/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/us-population-based-study-of-prevalence-of-and-risk-associated-with-breast-cancer-predisposition-genes/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/updated-recommendations-on-the-treatment-of-multiple-myeloma-related-bone-disease-from-the-bone-working-group-of-the-international-myeloma-working-group/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/association-of-braf-v600-mutant-ctdna-with-outcomes-in-patients-with-advanced-melanoma-receiving-dabrafenib-or-dabrafenibtrametinib/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/mri-targeted-biopsy-vs-systematic-transrectal-ultrasonography-biopsy-for-detection-of-disease-in-men-at-risk-for-prostate-cancer/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/fda-approves-cemiplimab-rwlc-for-patients-with-nsclc-and-high-pd-l1-expression/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/fda-grants-accelerated-approval-to-axicabtagene-ciloleucel-for-relapsed-or-refractory-follicular-lymphoma/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/fda-grants-accelerated-approval-to-melphalan-flufenamide-for-relapsed-or-refractory-multiple-myeloma/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/nivolumab-plus-cabozantinib-as-first-line-treatment-of-advanced-renal-cell-carcinoma/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/cancer-control-in-egypt/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/brian-druker-shows-no-signs-of-slowing-down/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/lydia-pace-a-primary-care-physician-on-the-front-lines-of-oncology-both-nationally-and-globally/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/international-perspectives-on-integrative-medicine-for-cancer-prevention-and-management/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/i-want-to-live-long-and-i-want-to-live-well/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/asco-publishes-guideline-endorsement-of-astro-guideline-for-radiation-therapy-in-sclc/ 2021-04-20T19:05:10+00:00 https://ascopost.com/issues/march-25-2021/cancer-cell-therapy-pioneer-carl-june-md-named-2021-dan-david-prize-laureate/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/roswell-park-bristol-myers-squibb-foundation-team-up-to-fight-cancer-in-native-and-rural-communities/ 2021-03-25T17:18:11+00:00 https://ascopost.com/issues/march-25-2021/winthrop-p-rockefeller-cancer-institute-appoints-new-deputy-director/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/patrick-delaney-named-new-executive-director-of-nccn-foundation/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/gynecologic-oncology-leader-named-at-new-jersey-s-only-nci-designated-comprehensive-cancer-center/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/sachin-apte-joins-huntsman-cancer-institute-as-chief-clinical-officer/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/sara-schottenstein-foundation-dedicated-to-gastric-cancer-announces-launch/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/sgo-and-fwc-issue-joint-statement-on-the-elimination-of-hpv/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/prevent-cancer-foundation-awards-nine-new-research-grants/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/american-cancer-society-announces-new-diversity-in-cancer-research-program/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/leading-health-and-cancer-advocacy-groups-unite-to-reduce-racial-disparities-in-cancer-care/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/hans-clevers-recognized-with-2021-pezcoller-foundation-aacr-international-award/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/ravi-bellamkonda-named-provost-of-emory-university/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/memorial-sloan-kettering-establishes-tow-center-for-developmental-oncology/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/astro-recommendation-on-covid-19-vaccination-for-patients-receiving-radiation-therapy/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/uspstf-issues-final-recommendation-statement-on-screening-for-lung-cancer/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/health-care-policy-expert-sybil-r-green-jd-rph-mha-brings-wealth-of-experience-as-asco-s-first-diversity-and-inclusion-officer/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/oncology-clinician-well-being-roadmap-provides-5-year-plan-to-address-provider-burnout/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/actions-early-in-biden-administration-mirror-asco-road-to-recovery-report/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021/eleven-oncology-practices-receive-quality-certification-from-the-association-for-clinical-oncology/ 2021-03-25T17:18:12+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/gastrointestinal-oncology-highlights-2020-2021-almanac/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/treating-colorectal-cancer-in-the-time-of-covid-19/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/keynote-177-new-analysis-confirms-benefit-of-pembrolizumab-vs-chemotherapy-in-microsatellite-instability-high-advanced-colorectal-cancer/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-michael-overman/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/fam-trastuzumab-deruxtecan-nxki-shows-benefit-in-refractory-colorectal-cancer/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-autumn-mcree/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/two-studies-validate-neoadjuvant-chemotherapy-with-short-course-radiotherapy-or-long-term-chemoradiotherapy-in-locally-advanced-rectal-cancer/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-christopher-leigh-hallemeier/ 2021-03-28T21:46:16+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/molecular-testing-in-metastatic-colorectal-cancer/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/novel-therapies-and-new-indications-for-use-in-the-treatment-of-gastrointestinal-cancers/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/solving-the-mystery-of-why-colorectal-cancer-is-on-the-rise-in-young-adults/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/atezolizumab-plus-bevacizumab-improves-survival-in-unresectable-hepatocellular-carcinoma/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/imbrave150-a-new-standard-of-care-to-treat-hepatocellular-cancers/ 2021-03-28T21:53:25+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/asco-names-advance-of-the-year-molecular-profiling-drives-progress-in-gastrointestinal-cancers/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/claridhy-trial-idh1-inhibitor-ivosidenib-improves-survival-in-cholangiocarcinoma/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-rachna-shroff/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/fgfr2-inhibitor-infigratinib-active-in-chemotherapy-refractory-cholangiocarcinoma/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-rachna-shroff-and-gentry-king/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/in-cholangiocarcinoma-does-chemotherapy-response-vary-according-to-fgfr2-status/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/novel-ck2-inhibitor-silmitasertib-shows-promise-in-cholangiocarcinoma/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/cholangiocarcinoma-often-misdiagnosed-always-impactful/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/swog-s1505-trial-evaluates-neoadjuvant-regimens-in-pancreatic-cancer/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-marcus-noel-and-susan-tsai/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/new-maintenance-therapies-in-metastatic-pancreatic-cancer-aim-to-end-perpetual-chemotherapy/ 2021-03-28T21:46:17+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/an-integrated-framework-for-improving-outcomes-in-pancreatic-cancer/ 2021-03-28T21:46:18+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/nivolumab-plus-chemotherapy-new-standard-of-care-in-advanced-gastric-cancer/ 2021-03-28T21:46:18+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-elizabeth-smyth/ 2021-03-28T21:46:18+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/targeting-fgfr2b-with-bemarituzumab-plus-chemotherapy-in-gastric-or-gastroesophageal-junction-cancer/ 2021-03-28T21:46:18+00:00 https://ascopost.com/issues/march-25-2021-supplement-gastrointestinal-oncology-almanac/epov-rutika-mehta/ 2021-03-28T21:46:18+00:00 https://ascopost.com/issues/march-10-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/march-10-2021/confirm-trial-reports-improvement-in-survival-with-nivolumab-in-relapsed-malignant-mesothelioma/ 2022-03-01T16:16:00+00:00 https://ascopost.com/issues/march-10-2021/epov-rina-hui-and-melina-marmarelis/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/asco-s-road-to-recovery-report-outlines-lessons-learned-from-the-covid-19-pandemic-to-improve-oncology-care/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/the-impact-of-a-pandemic-on-mentorship-in-medicine/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/updates-from-selected-clinical-trials-in-breast-cancer/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/the-emerging-role-of-exercise-in-cancer-prevention-and-treatment/ 2023-09-01T18:57:12+00:00 https://ascopost.com/issues/march-10-2021/anti-cd20-monoclonal-antibodies-and-risk-of-severe-covid-19-infection-and-death-in-patients-with-lymphoma/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/fallout-from-covid-19-decline-in-cancer-screening-and-increase-in-cancer-related-deaths/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/epov-ana-maria-lopez/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/neoadjuvant-atezolizumab-in-lung-cancer-lcmc3-trial-meets-primary-endpoint/ 2021-03-19T17:35:22+00:00 https://ascopost.com/issues/march-10-2021/epov-roy-herbst-and-shinichi-toyooka/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/new-analysis-confirms-benefit-of-pembrolizumab-vs-chemotherapy-in-microsatellite-instability-high-advanced-colorectal-ca/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/epov-michael-overman/ 2021-03-10T17:39:58+00:00 https://ascopost.com/issues/march-10-2021/oncologist-survey-identifies-knowledge-gaps-in-cholangiocarcinoma-mutations/ 2021-03-18T18:26:00+00:00 https://ascopost.com/issues/march-10-2021/in-cholangiocarcinoma-does-chemotherapy-response-vary-according-to-fgfr2-status/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/belantamab-mafodotin-blmf-plus-pomalidomide-and-dexamethasone-elicits-responses-in-myeloma/ 2021-03-23T19:24:27+00:00 https://ascopost.com/issues/march-10-2021/studies-provide-guidance-on-the-use-of-blinatumomab-in-pediatric-acute-lymphoblastic-leukemia/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/epov-frank-keller-and-e-anders-kolb/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/prognostic-tool-rsclin-introduced-for-early-breast-cancer/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/epov-meredith-regan-and-sara-hurvitz/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/novel-therapies-under-study-in-chronic-myeloid-leukemia/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/outcomes-with-internal-mammary-and-medial-supraclavicular-nodal-irradiation-in-stage-i-to-iii-breast-cancer/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/continued-survival-benefit-with-durvalumab-plus-chemotherapy-vs-chemotherapy-alone-in-extensive-stage-sclc/ 2021-03-19T17:36:35+00:00 https://ascopost.com/issues/march-10-2021/once-weekly-selinexor-plus-bortezomibdexamethasone-vs-twice-weekly-bortezomibdexamethasone-in-multiple-myeloma/ 2021-03-23T18:51:53+00:00 https://ascopost.com/issues/march-10-2021/study-finds-more-than-half-of-cancer-survivors-have-underlying-medical-conditions-associated-with-developing-severe-covid-19/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/mfolfirinox-or-gemcitabinenab-paclitaxel-for-resectable-pancreatic-cancer/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/development-and-performance-of-a-population-based-benchmark-model-for-use-of-cancer-surgery-in-high-income-countries/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/changes-in-radiotherapy-use-in-england-during-the-first-peak-of-the-covid-19-pandemic/ 2021-03-10T17:39:59+00:00 https://ascopost.com/issues/march-10-2021/breast-cancer-specific-mortality-by-raceethnicity-and-21-gene-recurrence-scores/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/fda-approves-trilaciclib-to-reduce-chemotherapy-induced-bone-marrow-suppression-in-adults-being-treated-for-sclc/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/fda-grants-accelerated-approval-to-umbralisib-for-the-treatment-of-marginal-zone-lymphoma-and-follicular-lymphoma/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/fda-approves-lisocabtagene-maraleucel-for-patients-with-relapsed-or-refractory-large-b-cell-lymphoma/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/fda-approves-cemiplimab-rwlc-for-locally-advanced-and-metastatic-basal-cell-carcinoma/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/tepotinib-for-metastatic-nsclc-with-met-exon-14-skipping-alterations/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/crizotinib-for-children-and-young-adults-with-relapsed-or-refractory-systemic-alk-positive-anaplastic-large-cell-lymphoma/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/kratom/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/memorial-sloan-kettering-announces-newly-endowed-chair-and-fellowships-for-health-equity-and-diversity/ 2021-03-12T15:44:29+00:00 https://ascopost.com/issues/march-10-2021/moise-danielpour-md-named-editor-in-chief-of-pediatric-neurosurgery/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/caroline-dive-honored-with-mary-j-matthews-pathologytranslational-research-award/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/yale-school-of-medicine-announces-new-section-chief-of-breast-surgery/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/arthur-w-nienhuis-dies-at-79/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/asco-and-friends-of-cancer-research-recommend-expanding-patient-access-to-cancer-clinical-trials-by-further-broadening-eligibility-criteria/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/new-research-statement-recommends-streamlining-and-standardizing-clinical-trial-site-feasibility-assessments/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/march-10-2021/asco-guideline-update-offers-four-standards-of-care-for-noncastrate-advanced-recurrent-or-metastatic-prostate-cancer/ 2021-03-10T17:40:00+00:00 https://ascopost.com/issues/february-25-2021/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/february-25-2021/phase-ii-codebreak-100-validates-benefit-of-kras-inhibitor-sotorasib-in-advanced-lung-cancer/ 2021-05-21T17:18:24+00:00 https://ascopost.com/issues/february-25-2021/epov-pasi-a-jaenne-and-charu-aggarwal/ 2021-02-25T19:33:24+00:00 https://ascopost.com/issues/february-25-2021/updated-findings-bolster-the-use-of-checkpoint-inhibitors-in-treatment-of-liver-cancer/ 2021-02-25T19:33:25+00:00 https://ascopost.com/issues/february-25-2021/how-the-covid-19-pandemic-can-help-improve-cancer-research/ 2021-02-25T19:33:25+00:00 https://ascopost.com/issues/february-25-2021/b-cell-and-t-cell-non-hodgkin-lymphomas/ 2021-03-17T17:17:34+00:00 https://ascopost.com/issues/february-25-2021/fgfr2-inhibitor-infigratinib-active-in-chemotherapy-refractory-cholangiocarcinoma/ 2021-03-05T19:06:06+00:00 https://ascopost.com/issues/february-25-2021/epov-rachna-t-shroff-and-gentry-king/ 2021-02-25T19:33:25+00:00 https://ascopost.com/issues/february-25-2021/novel-approaches-in-chronic-lymphocytic-leukemia/ 2021-04-01T17:40:24+00:00 https://ascopost.com/issues/february-25-2021/genome-edited-donor-derived-anti-cd19-car-t-cell-therapy-is-active-in-b-cell-acute-lymphoblastic-leukemia/ 2021-02-25T19:33:25+00:00 https://ascopost.com/issues/february-25-2021/covid-19-and-cancer-a-toxic-combination/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/the-carg-bc-score-novel-tool-for-predicting-chemotherapy-toxicity-in-early-stage-breast-cancer/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/oncology-community-mourns-the-death-of-chemotherapy-pioneer-emil-j-freireich/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/conversations-with-the-pioneers-of-oncology-emil-j-freireich-md-fasco/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/joseph-simone-visionary-pediatric-oncologist-and-quintessential-mentor-dies-at-85/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/gert-brieger-historian-of-medicine-and-public-health-dies-at-89/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/john-bartlett-pioneer-in-infectious-diseases-research-and-treatment-dies-at-83/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/professor-gordon-mcvie-international-cancer-researcher-and-patient-advocate-dies-at-76/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/no-improvement-with-addition-of-ipilimumab-to-pembrolizumab-in-nsclc/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/ongoing-surveillance-and-efforts-to-reduce-smoking-and-obesity-needed-to-lower-cancer-survivors-risks-of-new-cancers/ 2021-02-25T19:33:26+00:00 https://ascopost.com/issues/february-25-2021/when-to-start-a-conversation-with-patients-about-subsequent-primary-cancers/ 2021-02-25T19:33:27+00:00 https://ascopost.com/issues/february-25-2021/epov-yun-fan-and-deborah-doroshow/ 2021-02-25T19:33:27+00:00 https://ascopost.com/issues/february-25-2021/variation-in-active-surveillance-for-low-risk-prostate-cancer-in-the-united-states/ 2021-02-25T19:33:27+00:00 https://ascopost.com/issues/february-25-2021/addition-of-adjuvant-palbociclib-to-ongoing-endocrine-therapy-in-hr-positive-her2-negative-early-breast-cancer-pallas-trial/ 2021-02-25T19:33:27+00:00 https://ascopost.com/issues/february-25-2021/iaslc-honors-pan-chyr-yang-md-phd-for-contributions-to-lung-cancer-prevention/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/addition-of-wee1-inhibitor-adavosertib-to-gemcitabine-in-platinum-resistantrefractory-recurrent-ovarian-cancer/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/hyperthermic-intraperitoneal-chemotherapy-plus-cytoreductive-surgery-for-colorectal-cancer-metastases-does-not-improve-overall-survival/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/crystal-denlinger-named-chief-scientific-officer-for-nccn/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/paul-a-bunn-jr-scientific-award-presented-to-joan-h-schiller-md-fasco/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/i-let-science-not-emotion-dictate-my-treatment/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/fda-grants-accelerated-approval-to-tepotinib-for-patients-with-metastatic-nsclc-and-met-exon-14-skipping-alterations/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/simplify-trials-jak-inhibitor-yields-long-term-survival-benefit-and-transfusion-independence-in-myelofibrosis/ 2021-02-25T19:33:28+00:00 https://ascopost.com/issues/february-25-2021/epov-lucia-masarova/ 2021-02-25T19:33:29+00:00 https://ascopost.com/issues/february-25-2021/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-kenya/ 2021-02-25T19:33:29+00:00 https://ascopost.com/issues/february-25-2021/brief-highlights-from-ash-2020/ 2021-02-25T19:33:29+00:00 https://ascopost.com/issues/february-25-2021/asco-names-advance-of-the-year-molecular-profiling-drives-progress-in-gastrointestinal-cancers/ 2021-02-25T19:33:29+00:00 https://ascopost.com/issues/february-25-2021/new-framework-to-address-cancer-care-disparities-in-medically-underserved-populations/ 2021-02-25T19:33:29+00:00 https://ascopost.com/issues/february-25-2021/standardized-streamlined-processes-key-to-implementing-electronic-prior-authorization/ 2021-02-25T19:33:29+00:00 https://ascopost.com/issues/february-25-2021/medicare-physician-fee-schedule-conversion-factor-updated-to-reflect-2021-federal-funding-package/ 2021-02-25T19:33:30+00:00 https://ascopost.com/issues/february-25-2021/biden-administration-new-congress-review-recent-rules-affecting-cancer-care-delivery/ 2021-02-25T19:33:30+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/ 2021-06-08T17:57:14+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/ash-2020-meeting-highlights/ 2021-02-19T20:06:26+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/study-finds-asciminib-safer-more-effective-than-bosutinib-in-chronic-phase-cml/ 2021-02-19T19:09:46+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/epov-david-snyder/ 2021-02-19T19:09:46+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/study-finds-survival-disparities-and-mutational-differences-for-black-patients-younger-than-60-with-aml/ 2021-02-19T19:09:46+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/chemotherapy-plus-blinatumomab-for-philadelphia-chromosome-negative-b-cell-all/ 2021-02-19T19:09:46+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/zuma-5-axicabtagene-ciloleucel-elicits-response-in-indolent-non-hodgkin-lymphoma/ 2021-02-19T19:09:46+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/epov-james-essell/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/overcoming-cd58-loss-may-be-promising-path-to-overcoming-resistance-to-car-t-cell-therapies/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/epov-marco-ruella/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/novel-therapies-and-new-indications-for-use-in-treatment-of-hematologic-malignancies/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/treatment-with-loxo-305-results-in-durable-efficacy-in-heavily-pretreated-patients-with-cllsll/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/subcutaneous-daratumumab-meets-primary-endpoint-in-apollo-trial-in-myeloma/ 2021-03-23T19:26:49+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/epov-sagar-lonial/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/new-targets-explored-for-bispecific-t-cell-engaging-antibodies-in-myeloma/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/epov-ajay-nooka/ 2021-02-19T19:09:47+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/belantamab-mafodotin-blmf-plus-pomalidomide-and-dexamethasone-elicits-responses-in-myeloma/ 2021-02-19T19:09:48+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/ash-recognizes-choosing-wisely-champions/ 2021-02-19T19:09:48+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/dreamm-2-analysis-number-of-prior-treatments-no-hindrance-to-efficacy-of-belantamab-mafodotin-blmf/ 2021-02-22T22:31:56+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/transplant-may-improve-survival-in-older-patients-with-high-risk-myelodysplastic-syndrome/ 2021-02-19T19:09:48+00:00 https://ascopost.com/issues/february-25-2021-supplement-conference-highlights-ash-2020/ruxolitinib-improves-outcomes-in-steroid-refractory-or-steroid-dependent-graft-vs-host-disease/ 2021-02-19T19:09:48+00:00 https://ascopost.com/issues/february-10-2021/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/february-10-2021/claridhy-trial-idh1-inhibitor-ivosidenib-benefits-survival-in-cholangiocarcinoma/ 2021-02-18T19:58:42+00:00 https://ascopost.com/issues/february-10-2021/epov-rachna-shroff/ 2021-02-10T20:50:07+00:00 https://ascopost.com/issues/february-10-2021/patients-with-chronic-graft-vs-host-disease-face-lifelong-complications/ 2021-02-11T20:28:27+00:00 https://ascopost.com/issues/february-10-2021/looking-back-on-the-40-year-career-of-richard-l-schilsky-md-facp-fsct-fasco/ 2021-02-10T20:50:08+00:00 https://ascopost.com/issues/february-10-2021/high-risk-cutaneous-squamous-cell-carcinomas-the-present-and-future/ 2021-03-25T18:34:11+00:00 https://ascopost.com/issues/february-10-2021/understanding-patients-needs-and-preferences-cancer-care-stakeholders-explore-barriers-and-best-practices/ 2021-02-12T20:55:37+00:00 https://ascopost.com/issues/february-10-2021/predicting-postoperative-recurrence-in-stage-i-to-iii-colorectal-cancer-with-circulating-tumor-dna/ 2021-02-10T20:50:08+00:00 https://ascopost.com/issues/february-10-2021/epov-michael-overman/ 2021-02-10T20:50:08+00:00 https://ascopost.com/issues/february-10-2021/anti-pd-1-antibody-dostarlimab-active-in-mismatch-repair-deficient-gastrointestinal-tumors/ 2021-02-10T20:50:08+00:00 https://ascopost.com/issues/february-10-2021/epov-john-krauss/ 2021-02-10T20:50:08+00:00 https://ascopost.com/issues/february-10-2021/zuma-5-axicabtagene-ciloleucel-elicits-response-in-indolent-non-hodgkin-lymphoma/ 2021-02-16T20:56:28+00:00 https://ascopost.com/issues/february-10-2021/epov-james-essell/ 2021-02-10T20:50:08+00:00 https://ascopost.com/issues/february-10-2021/can-a-high-carbohydrate-diet-increase-the-risk-for-breast-cancer/ 2021-02-12T02:00:14+00:00 https://ascopost.com/issues/february-10-2021/epov-neil-iyengar/ 2021-02-10T20:50:09+00:00 https://ascopost.com/issues/february-10-2021/is-trop-2-expression-associated-with-benefit-from-sacituzumab-govitecan/ 2021-03-01T20:05:25+00:00 https://ascopost.com/issues/february-10-2021/epov-william-gradishar/ 2021-02-10T20:50:09+00:00 https://ascopost.com/issues/february-10-2021/severity-of-patients-symptoms-may-be-underrecognized-during-and-after-breast-radiotherapy/ 2021-02-10T21:10:20+00:00 https://ascopost.com/issues/february-10-2021/epov-virginia-kaklamani/ 2021-02-10T21:10:20+00:00 https://ascopost.com/issues/february-10-2021/study-examines-pregnancy-outcomes-in-breast-cancer-survivors/ 2021-02-12T02:01:54+00:00 https://ascopost.com/issues/february-10-2021/meditation-and-education-interventions-may-improve-depressive-symptoms-in-young-breast-cancer-survivors/ 2021-02-10T21:10:20+00:00 https://ascopost.com/issues/february-10-2021/epov-shoshana-rosenberg/ 2021-02-10T21:10:20+00:00 https://ascopost.com/issues/february-10-2021/early-research-explores-relationship-between-cd58-loss-and-resistance-to-car-t-cell-therapies/ 2021-02-10T21:10:20+00:00 https://ascopost.com/issues/february-10-2021/epov-marco-ruella/ 2021-02-10T21:10:20+00:00 https://ascopost.com/issues/february-10-2021/murano-trial-venetoclax-plus-rituximab-achieves-durable-progression-free-survival-in-resistant-cll/ 2021-02-16T19:09:19+00:00 https://ascopost.com/issues/february-10-2021/epov-jacob-soumerai/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/allogeneic-stem-cell-transplant-improves-survival-in-peripheral-t-cell-lymphoma/ 2021-02-17T21:01:30+00:00 https://ascopost.com/issues/february-10-2021/epov-deepa-jagadeesh/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/phase-ii-primo-dose-optimization-trial-of-duvelisib-in-peripheral-t-cell-lymphoma/ 2021-02-17T21:01:14+00:00 https://ascopost.com/issues/february-10-2021/epov-deepa-jagadeesh-1/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/novel-insights-into-multiple-myeloma/ 2021-02-22T22:34:01+00:00 https://ascopost.com/issues/february-10-2021/first-line-lorlatinib-improves-progression-free-survival-vs-crizotinib-in-advanced-alk-positive-nsclc/ 2021-02-22T18:52:29+00:00 https://ascopost.com/issues/february-10-2021/improvement-in-patient-reported-outcomes-after-stopping-tyrosine-kinase-inhibitor-therapy-for-chronic-myeloid-leukemia/ 2021-02-11T20:29:23+00:00 https://ascopost.com/issues/february-10-2021/capivasertib-for-akt1-e17k-mutated-metastatic-cancers-nci-match-subprotocol-eay131-y/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/stereotactic-ablative-body-radiotherapy-in-extracranial-oligometastatic-cancers/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/addition-of-sitagliptin-to-prophylaxis-for-acute-graft-vs-host-disease/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/i-credit-cancer-research-with-saving-my-life/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-previously-treated-patients-with-her2-positive-gastric-cancers/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/fda-grants-accelerated-approval-to-daratumumab-plus-hyaluronidase-fihj-for-newly-diagnosed-light-chain-amyloidosis/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/fda-approves-nivolumab-plus-cabozantinib-for-advanced-renal-cell-carcinoma/ 2021-02-10T21:10:21+00:00 https://ascopost.com/issues/february-10-2021/janet-woodcock-md-named-acting-fda-commissioner/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/nccn-shares-new-recommendations-for-vaccinating-patients-with-cancer-against-covid-19/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/the-lustgarten-foundation-and-aacr-honor-two-american-icons-by-establishing-new-career-development-awards/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/miami-cancer-institute-appoints-new-deputy-director-chief-scientific-officer-and-chief-of-solid-tumor-medical-oncology/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/enrollment-up-at-us-medical-schools/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/vanderbilt-university-medical-center-appoints-interim-director-of-the-division-of-hematology-and-oncology/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/tuya-pal-md-named-to-cancer-research-national-leadership-posts/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/covid-virus-specific-t-cells-potential-treatment-of-severe-covid-19-infection-under-study/ 2021-02-10T21:10:22+00:00 https://ascopost.com/issues/february-10-2021/chinese-society-of-clinical-oncology-and-asco-approve-first-joint-guideline-for-treatment-of-stage-ii-to-iva-nasopharyngeal-carcinoma/ 2026-01-29T16:52:02+00:00 https://ascopost.com/issues/february-10-2021/sean-khozin-named-new-chief-executive-officer-of-cancerlinq/ 2021-02-10T21:19:13+00:00 https://ascopost.com/issues/february-10-2021/asco-congratulates-joseph-r-biden-jr-on-presidential-inauguration/ 2021-02-10T21:21:01+00:00 https://ascopost.com/issues/february-10-2021/asco-advocates-for-priority-status-for-patients-with-cancer-in-covid-19-vaccine-distribution-plans/ 2021-02-10T21:26:58+00:00 https://ascopost.com/issues/february-10-2021/asco-statement-on-2021-annual-meeting/ 2021-02-10T21:30:13+00:00 https://ascopost.com/issues/january-25-2021/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/january-25-2021/unexpected-survival-benefit-reported-with-trilaciclib-in-metastatic-triple-negative-breast-cancer/ 2021-02-01T20:33:51+00:00 https://ascopost.com/issues/january-25-2021/epov-cristina-saura-manich/ 2021-01-25T20:21:15+00:00 https://ascopost.com/issues/january-25-2021/asco-s-new-chief-medical-officer-plans-to-tackle-the-global-burden-of-cancer-and-disparities-in-access-to-care/ 2021-01-25T20:21:15+00:00 https://ascopost.com/issues/january-25-2021/empowering-the-fda-to-require-dose-optimization-of-all-new-oncology-drugs/ 2021-01-25T20:21:15+00:00 https://ascopost.com/issues/january-25-2021/chronic-graft-vs-host-disease-future-directions-in-treatment/ 2021-01-25T20:21:15+00:00 https://ascopost.com/issues/january-25-2021/significant-survival-benefit-from-chemotherapy-for-older-women-with-triple-negative-breast-cancer/ 2021-01-25T20:21:15+00:00 https://ascopost.com/issues/january-25-2021/expect-questions-about-adjuvant-chemotherapy-for-older-women/ 2021-01-25T20:21:15+00:00 https://ascopost.com/issues/january-25-2021/oral-taxanes-moving-forward-in-metastatic-breast-cancer/ 2021-03-24T21:09:22+00:00 https://ascopost.com/issues/january-25-2021/epov-william-gradishar/ 2021-03-24T21:13:17+00:00 https://ascopost.com/issues/january-25-2021/anastrozole-vs-tamoxifen-to-prevent-dcis-recurrence-key-difference-may-be-side-effect-profile/ 2021-02-01T20:37:53+00:00 https://ascopost.com/issues/january-25-2021/epov-hatem-soliman/ 2021-01-25T20:21:16+00:00 https://ascopost.com/issues/january-25-2021/long-term-follow-up-of-ifm-2009-confirms-benefit-of-front-line-transplant-in-myeloma/ 2021-01-26T20:25:18+00:00 https://ascopost.com/issues/january-25-2021/epov-suzanne-lentzsch/ 2021-01-25T20:21:16+00:00 https://ascopost.com/issues/january-25-2021/oral-azacitidine-is-noninferior-to-placebo-for-health-related-quality-of-life-in-aml/ 2021-01-25T20:21:16+00:00 https://ascopost.com/issues/january-25-2021/epov-marlise-luskin/ 2021-01-25T20:21:16+00:00 https://ascopost.com/issues/january-25-2021/indian-surgical-oncologist-offers-insights-into-delivering-equitable-cancer-care-in-a-resource-challenged-country/ 2021-02-02T20:59:45+00:00 https://ascopost.com/issues/january-25-2021/adding-entinostat-to-exemestane-fails-to-overcome-aromatase-inhibitor-resistance-in-advanced-breast-cancer/ 2021-01-25T21:39:53+00:00 https://ascopost.com/issues/january-25-2021/epov-yuan-yuan/ 2021-01-25T21:39:54+00:00 https://ascopost.com/issues/january-25-2021/a-tale-of-two-cdk46-inhibitors-in-early-breast-cancer/ 2021-01-25T21:39:54+00:00 https://ascopost.com/issues/january-25-2021/epov-c-kent-osborne-and-ruth-m-o-regan/ 2021-01-25T21:39:54+00:00 https://ascopost.com/issues/january-25-2021/keynote-355-pembrolizumab-plus-chemotherapy-improves-progression-free-survival-in-pd-l1-enriched-advanced-triple-negative-breast-cancer/ 2021-01-25T21:39:54+00:00 https://ascopost.com/issues/january-25-2021/epov-yuan-yuan-and-elizabeth-mittendorf/ 2021-01-25T21:39:54+00:00 https://ascopost.com/issues/january-25-2021/ipatasertib-plus-paclitaxel-falters-in-advanced-triple-negative-breast-cancer-phase-iii-trial/ 2021-01-25T21:48:05+00:00 https://ascopost.com/issues/january-25-2021/epov-yuan-yuan-1/ 2021-01-25T21:48:05+00:00 https://ascopost.com/issues/january-25-2021/can-postoperative-whole-breast-irradiation-be-safely-omitted-in-older-women-with-low-risk-breast-cancer/ 2021-01-25T21:48:05+00:00 https://ascopost.com/issues/january-25-2021/epov-alphonse-taghian/ 2021-01-25T21:48:05+00:00 https://ascopost.com/issues/january-25-2021/subcutaneous-daratumumab-meets-primary-endpoint-in-apollo-trial-in-myeloma/ 2021-01-25T21:48:05+00:00 https://ascopost.com/issues/january-25-2021/epov-sagar-lonial/ 2021-01-25T21:48:05+00:00 https://ascopost.com/issues/january-25-2021/belantamab-mafodotin-blmf-in-multiple-myeloma-number-of-prior-treatments-no-hindrance-to-efficacy/ 2021-01-26T20:26:53+00:00 https://ascopost.com/issues/january-25-2021/novel-anti-bcma-car-t-cell-therapies-show-activity-in-myeloma/ 2021-01-26T20:50:00+00:00 https://ascopost.com/issues/january-25-2021/epov-sagar-lonial-and-adam-cohen/ 2021-01-25T21:48:05+00:00 https://ascopost.com/issues/january-25-2021/new-targets-explored-for-bispecific-t-cell-engaging-antibodies-in-myeloma/ 2021-01-26T20:29:07+00:00 https://ascopost.com/issues/january-25-2021/epov-ajay-nooka/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/allogeneic-hematopoietic-cell-transplantation-in-acute-leukemias-and-myelodysplastic-syndromes/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/record-drop-in-cancer-mortality-for-second-straight-year-due-to-improved-lung-cancer-treatment-reported-in-cancer-statistics-2021/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/duration-of-adjuvant-chemotherapy-assessed-in-stage-iii-colon-cancer/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/high-recurrence-free-survival-rates-in-rectal-cancer-after-clinical-complete-response-to-neoadjuvant-chemoradiotherapy/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/venetoclax-added-to-bortezomib-plus-dexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2021-01-26T20:23:35+00:00 https://ascopost.com/issues/january-25-2021/chemotherapy-added-to-local-therapy-improves-overall-survival-in-older-women-with-triple-negative-breast-cancer/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/interference-of-clonal-hematopoiesis-in-dna-repair-genes-with-prostate-cancer-plasma-cell-free-dna-testing/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/radiation-facility-volume-and-overall-survival-in-patients-with-node-positive-prostate-cancer-treated-with-external-beam-radiation-therapy-and-adt/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/neoadjuvant-chemotherapy-and-overall-survival-in-metastatic-endometrial-cancer/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/cost-effectiveness-of-neoadjuvantadjuvant-treatment-strategies-for-her2-positive-breast-cancer/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/subcutaneous-fixed-dose-vs-intravenous-pertuzumabtrastuzumab-for-her2-positive-early-breast-cancer/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/nivolumab-indication-in-small-cell-lung-cancer-withdrawn-in-us-market/ 2021-01-25T21:48:06+00:00 https://ascopost.com/issues/january-25-2021/fda-approves-first-oral-hormone-therapy-for-treating-advanced-prostate-cancer/ 2021-01-25T21:48:07+00:00 https://ascopost.com/issues/january-25-2021/fda-approves-margetuximab-cmkb-plus-chemotherapy-for-previously-treated-patients-with-metastatic-her2-positive-breast-cancer/ 2021-01-25T21:48:07+00:00 https://ascopost.com/issues/january-25-2021/fda-approves-crizotinib-for-children-and-young-adults-with-relapsed-or-refractory-systemic-alk-positive-alcl/ 2021-01-25T21:48:07+00:00 https://ascopost.com/issues/january-25-2021/fda-approves-selinexor-for-refractory-or-relapsed-multiple-myeloma/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/fda-approves-rituximab-arrx-a-biosimilar-to-rituximab/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/osimertinib-in-adjuvant-therapy-for-nsclc-with-egfr-mutations/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/margetuximab-cmkb-for-previously-treated-metastatic-her2-positive-breast-cancer/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/selinexor-in-relapsed-or-refractory-multiple-myeloma/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/relugolix-for-advanced-prostate-cancer/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-burkina-faso/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/covid-19-and-integrative-oncology-meeting-the-global-challenges-of-health-equity/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/gastrointestinal-oncologist-laura-goff-md-sees-potential-in-emerging-immunotherapies-and-novel-targeted-agents/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/finding-hope-with-cancer/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/it-all-began-with-a-lump-in-the-throat/ 2021-01-25T21:54:22+00:00 https://ascopost.com/issues/january-25-2021/dr-eric-p-winer-elected-asco-president-for-2022-2023-term/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/asco-statement-on-cancer-statistics-2021/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/conquer-cancer-announces-2020-career-development-award-in-breast-cancer-recipient/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/asco-applauds-congress-for-expanding-clinical-trial-access-for-medicaid-beneficiaries/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/continuing-education-credits-for-gastrointestinal-cancers-symposium/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/clinician-scientist-hopes-to-attract-new-investigators-in-gynecologic-cancer-by-establishing-conquer-cancer-award/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/coa-submits-letter-to-governors-public-health-officials-to-request-independent-oncology-practices-be-given-priority-approval-to-administer-covid-19-vaccines/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/community-oncology-alliance-elects-new-president-officers-and-board-members/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/genesiscare-announces-new-global-chief-medical-officer-and-winship-cancer-institute-names-interim-executive-director/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/city-of-hope-announces-its-first-chief-diversity-equity-and-inclusion-officer/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/ama-underscores-need-for-coordinated-comprehensive-pandemic-response/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/ama-statement-on-the-nominations-of-xavier-becerra-jd-as-hhs-secretary-and-vivek-murthy-md-as-us-surgeon-general/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/innovation-discovery-grants-awarded-to-mass-general-brigham-for-scientific-advancements-in-2020/ 2021-02-10T19:08:58+00:00 https://ascopost.com/issues/january-25-2021/researchers-use-artificial-intelligence-in-oral-cancers-with-33-million-nih-grant/ 2021-01-25T21:54:23+00:00 https://ascopost.com/issues/january-25-2021/association-of-community-cancer-centers-announces-new-senior-director/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/nih-radx-rad-grants-support-investigation-of-novel-covid-19-testing-and-surveillance-approaches/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/research-leader-named-to-rutgers-cancer-institute-to-build-world-class-cancer-immunology-and-immunotherapy-programs/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/winners-of-40-under-40-in-cancer-awards-announced/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/aaas-announces-leading-scientists-elected-as-2020-fellows/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/huntsman-cancer-institute-appoints-cancer-center-research-program-leaders/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/cdc-awards-huntsman-cancer-institute-3-million-to-improve-colorectal-cancer-screening/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/kenneth-kim-to-lead-cedars-sinai-women-s-cancer-program/ 2021-01-25T20:54:29+00:00 https://ascopost.com/issues/january-25-2021/mayo-clinic-care-network-expands-to-include-minnesota-oncology/ 2021-01-25T20:54:30+00:00 https://ascopost.com/issues/january-25-2021/sarah-cannon-names-melissa-johnson-program-director-of-lung-cancer-research/ 2021-01-25T20:54:30+00:00 https://ascopost.com/issues/january-25-2021/new-nccn-resource-offers-practical-suggestions-for-cancer-survivors/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/january-25-2021/erratum/ 2021-01-25T21:54:24+00:00 https://ascopost.com/issues/december-25-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/december-25-2020/transplant-may-improve-survival-in-older-patients-with-high-risk-myelodysplastic-syndrome-study-reports/ 2020-12-21T21:56:16+00:00 https://ascopost.com/issues/december-25-2020/rxponder-many-postmenopausal-patients-with-node-positive-breast-cancer-can-avoid-chemotherapy/ 2021-01-04T20:47:16+00:00 https://ascopost.com/issues/december-25-2020/epov-c-kent-osborne-md/ 2020-12-21T19:23:28+00:00 https://ascopost.com/issues/december-25-2020/reducing-disparities-in-cancer-care-for-sexual-and-gender-minority-patients/ 2020-12-21T21:49:06+00:00 https://ascopost.com/issues/december-25-2020/challenges-related-to-informed-consent-and-information-sharing-for-minors-with-cancer/ 2020-12-22T19:10:31+00:00 https://ascopost.com/issues/december-25-2020/study-shows-sentinel-lymph-node-biopsy-to-be-viable-option-for-surgical-staging-of-endometrial-cancer/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/strict-adherence-to-algorithm-required/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/life-and-death-under-covid-19/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/ruxolitinib-improves-outcomes-in-patients-with-steroid-refractory-or-steroid-dependent-graft-vs-host-disease/ 2021-01-18T16:28:36+00:00 https://ascopost.com/issues/december-25-2020/first-sign-of-myeloproliferative-neoplasms-may-be-in-utero/ 2020-12-21T21:57:38+00:00 https://ascopost.com/issues/december-25-2020/ctc-enumeration-predicts-survival-early-in-treatment-of-metastatic-breast-cancer/ 2021-01-04T20:48:21+00:00 https://ascopost.com/issues/december-25-2020/fixed-duration-first-line-ibrutinib-plus-venetoclax-yields-treatment-free-remission-in-some-patients-with-cll/ 2021-02-16T20:26:41+00:00 https://ascopost.com/issues/december-25-2020/epov-jacob-soumerai/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/ash-registry-treasure-trove-of-data-on-covid-19-and-hematologic-malignancies/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/epov-stephanie-lee-md-mph/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/overcoming-the-challenges-of-addressing-race-culture-and-structural-inequality-in-medical-education/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/eric-p-winer-md-fasco-elected-asco-president-for-2022-2023-term/ 2020-12-21T21:18:43+00:00 https://ascopost.com/issues/december-25-2020/anthony-fauci-md-encourages-patients-with-cancer-to-receive-covid-19-vaccine/ 2020-12-23T23:50:44+00:00 https://ascopost.com/issues/december-25-2020/disparities-in-socioeconomic-status-treatment-complications-and-obesity-impact-outcomes-in-minority-patients-with-aml/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/identifying-multiple-myeloma-prognostic-subgroups-with-distinct-genetic-and-clinical-features/ 2021-01-26T20:31:39+00:00 https://ascopost.com/issues/december-25-2020/study-finds-survival-disparities-and-mutational-differences-for-black-patients-younger-than-60-with-aml/ 2021-01-18T14:49:39+00:00 https://ascopost.com/issues/december-25-2020/novel-radiomodulation-approach-with-dismutase-mimetic-plus-sbrt-in-resectable-pancreatic-cancer/ 2021-01-11T18:26:12+00:00 https://ascopost.com/issues/december-25-2020/epov-laura-dawson/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/sexual-health-an-issue-for-many-survivors-of-cancer/ 2020-12-22T15:42:31+00:00 https://ascopost.com/issues/december-25-2020/epov-karen-winkfield/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/novel-combination-under-study-in-first-line-treatment-of-metastatic-melanoma/ 2021-01-28T19:35:02+00:00 https://ascopost.com/issues/december-25-2020/epov-omid-hamid/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/intratumoral-injections-may-boost-neoadjuvant-response-in-resectable-melanoma/ 2021-01-28T20:09:07+00:00 https://ascopost.com/issues/december-25-2020/addressing-inequality-in-cancer-care-on-a-global-scale/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/panel-on-global-cancer-control-looks-for-ways-forward-in-a-war-that-s-proving-hard-to-win/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/european-experts-tackle-hpv-related-cancers/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/study-reports-highly-skilled-surgeons-significantly-reduce-death-from-colon-cancer/ 2020-12-21T21:18:44+00:00 https://ascopost.com/issues/december-25-2020/epov-cathy-eng/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/initial-therapy-for-asymptomatic-follicular-lymphoma-start-with-watch-and-wait-or-rituximab/ 2021-01-14T02:57:52+00:00 https://ascopost.com/issues/december-25-2020/phase-iii-gemstone-302-trial-finds-cs1001-plus-platinum-chemotherapy-prolongs-progression-free-survival-in-nsclc/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/phase-ii-study-investigates-efficacy-of-anlotinib-in-radioiodine-refractory-differentiated-thyroid-cancer/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/phase-ii-study-of-combination-immunotherapy-for-advanced-nasopharyngeal-cancer/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/subgroup-analysis-of-japanese-patients-with-ovarian-cancer-treated-with-maintenance-olaparibbevacizumab/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/baseline-characteristics-of-asian-patients-enrolled-in-the-monarche-trial/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/first-line-sintilimab-plus-bevacizumab-biosimilar-for-advanced-hepatocellular-carcinoma/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/early-detection-and-localization-of-cancer-using-a-blood-based-assay/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/selected-ash-abstracts-on-novel-treatments-of-polycythemia-vera/ 2025-09-30T19:38:30+00:00 https://ascopost.com/issues/december-25-2020/pembrolizumab-improves-progression-free-survival-vs-chemotherapy-in-first-line-treatment-of-microsatellite-instability-high-advanced-colorectal-cancer/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/germline-somatic-interactions-in-advanced-urothelial-cancer-and-their-role-in-disease-progression/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/fan-therapy-may-relieve-breathlessness-associated-with-advanced-cancers/ 2021-01-07T20:24:13+00:00 https://ascopost.com/issues/december-25-2020/study-explores-duration-of-shedding-of-viable-sars-cov-2-in-patients-with-cancer-after-immunosuppressive-therapy/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/case-series-study-explores-experiences-of-transgender-patients-with-cancer/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/reconstruction-implant-surface-texture-and-risk-of-breast-cancer-recurrence/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/effect-of-fertility-preservation-on-reproductive-outcomes-in-patients-after-breast-cancer/ 2020-12-21T21:18:45+00:00 https://ascopost.com/issues/december-25-2020/2020-fda-approvals-of-drugs-for-cancer-treatment/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/fda-authorizes-antigen-test-as-first-over-the-counter-fully-at-home-diagnostic-test-for-covid-19/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/fda-issues-emergency-use-authorization-for-first-covid-19-vaccine/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/pralsetinib-for-ret-altered-thyroid-cancers/ 2026-01-29T16:59:13+00:00 https://ascopost.com/issues/december-25-2020/pembrolizumab-plus-chemotherapy-for-locally-recurrent-unresectable-or-metastatic-triple-negative-breast-cancer/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/naxitamab-for-high-risk-neuroblastoma-in-bone-or-bone-marrow/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/roy-herbst-named-accc-2020-clinical-research-award-winner/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/daughter-of-a-dance-band-leader-becomes-nationally-regarded-expert-in-disparities-of-cancer-care/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/my-life-of-service-to-other-cancer-survivors/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/cancer-survivor-offers-roadmap-for-managing-the-turmoil-of-diagnosis-and-treatment/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/stephanie-halene-appointed-chief-of-hematology-at-yale-cancer-center-and-smilow-cancer-hospital/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/adamantinoma-of-the-mandible/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/tabaré-vázquez-dies-at-80/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/epov-robert-brodsky/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/ash-announces-donation-of-next-generation-sequencing-equipment-to-countries-in-the-international-consortium/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/welela-tereffe-md-mph-named-chief-medical-executive-at-md-anderson/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/edith-mitchell-md-elected-to-fellowship-in-the-royal-college-of-physicians-of-london/ 2020-12-21T21:18:46+00:00 https://ascopost.com/issues/december-25-2020/iu-simon-researcher-receives-13-million-grant-to-improve-breast-cancer-treatment-for-black-women/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/ash-recognizes-choosing-wisely-champions-at-annual-meeting-exposition/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/rutgers-researcher-receives-400k-grant-to-examine-racial-health-disparities-in-cancer-care/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/2020-basser-global-prize-awarded-to-bella-kaufman-md-of-israel-s-sheba-medical-center/ 2021-01-26T13:51:38+00:00 https://ascopost.com/issues/december-25-2020/city-of-hope-physician-joins-carol-emmott-fellowship/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/sue-s-yom-md-phd-fastro-named-editor-in-chief-of-astro-s-red-journal/ 2021-01-26T13:59:24+00:00 https://ascopost.com/issues/december-25-2020/reducing-the-risk-of-lymphedema-in-patients-with-cancer/ 2021-01-06T21:11:16+00:00 https://ascopost.com/issues/december-25-2020/two-leading-institutions-collaborate-to-advance-treatment-of-smoldering-multiple-myeloma/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/chronicling-a-family-s-history-of-cancer/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/john-ryan-jd-named-senior-vice-president-and-general-counsel-at-dana-farber-cancer-institute/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/northwell-invests-6m-in-comprehensive-cancer-center-in-riverhead-new-york/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/susan-e-hankinson-scd-mph-receives-aacr-distinguished-lectureship-in-breast-cancer-research-award/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/roswell-park-experts-named-to-highly-cited-researchers-list/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/increase-your-knowledge-and-practice-of-cultural-competence-with-asco-elearning-course-collection/ 2020-12-21T21:18:47+00:00 https://ascopost.com/issues/december-25-2020/the-heart-of-catherine-handy-marshalls-work/ 2020-12-21T21:18:48+00:00 https://ascopost.com/issues/december-25-2020/asco-s-oncologist-approved-patient-information-website-cancernet/ 2020-12-21T21:18:48+00:00 https://ascopost.com/issues/december-25-2020/cms-increases-access-to-telemedicine-in-home-health-care/ 2020-12-21T21:18:48+00:00 https://ascopost.com/issues/december-25-2020/new-recommendations-for-advancing-the-scholarly-discipline-of-global-oncology/ 2020-12-21T21:18:48+00:00 https://ascopost.com/issues/december-10-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/december-10-2020/study-finds-asciminib-safer-more-effective-than-bosutinib-in-chronic-phase-cml/ 2020-12-10T21:11:28+00:00 https://ascopost.com/issues/december-10-2020/epov-david-snyder/ 2020-12-10T21:11:28+00:00 https://ascopost.com/issues/december-10-2020/surgical-resection-of-stage-i-lung-cancer-rating-the-evidence-of-benefit/ 2020-12-11T18:54:53+00:00 https://ascopost.com/issues/december-10-2020/the-problem-of-heterogeneity-within-stage/ 2025-03-13T15:31:31+00:00 https://ascopost.com/issues/december-10-2020/what-is-the-measure-of-minimal-residual-disease-in-aml/ 2021-01-14T02:39:45+00:00 https://ascopost.com/issues/december-10-2020/discerning-the-underlying-mechanisms-of-endometrial-cancer-disparities-in-black-women/ 2020-12-10T21:11:28+00:00 https://ascopost.com/issues/december-10-2020/assessing-the-progress-made-in-global-cancer-care-and-looking-toward-the-future/ 2020-12-10T21:11:28+00:00 https://ascopost.com/issues/december-10-2020/single-fraction-sbrt-may-be-equivalent-to-four-in-patients-with-oligometastatic-lung-disease/ 2020-12-10T21:11:28+00:00 https://ascopost.com/issues/december-10-2020/epov-thomas-dilling/ 2020-12-10T21:11:28+00:00 https://ascopost.com/issues/december-10-2020/low-dose-radiotherapy-for-covid-19-related-pneumonia/ 2020-12-10T21:11:29+00:00 https://ascopost.com/issues/december-10-2020/epov-ramesh-rengan/ 2020-12-10T21:11:29+00:00 https://ascopost.com/issues/december-10-2020/front-line-nonchemotherapy-regimens-may-improve-long-term-outcomes-in-cll/ 2021-01-14T03:01:37+00:00 https://ascopost.com/issues/december-10-2020/progress-report-on-checkpoint-inhibitors-in-rare-tumors/ 2020-12-11T04:00:26+00:00 https://ascopost.com/issues/december-10-2020/project-orbis-partnering-with-international-regulatory-agencies-to-bring-earlier-global-access-to-novel-cancer-treatments/ 2020-12-10T21:11:29+00:00 https://ascopost.com/issues/december-10-2020/geriatric-assessment-vital-element-in-individualizing-care-for-older-patients-with-cancer/ 2022-02-17T20:45:16+00:00 https://ascopost.com/issues/december-10-2020/understanding-breast-cancer-diagnosis-and-treatment-disparities-in-resource-challenged-nations/ 2020-12-10T21:11:29+00:00 https://ascopost.com/issues/december-10-2020/early-stage-lung-cancer-an-overview-of-the-clinical-trial-landscape/ 2020-12-23T21:53:56+00:00 https://ascopost.com/issues/december-10-2020/lung-cancer-pfs-with-immunotherapy-varies-significantly-by-tumor-mutation-subtype-real-world-data-show/ 2020-12-11T19:08:26+00:00 https://ascopost.com/issues/december-10-2020/epov-joel-neal/ 2020-12-10T21:34:43+00:00 https://ascopost.com/issues/december-10-2020/managing-checkpoint-inhibitor-mediated-colitis/ 2020-12-10T21:34:43+00:00 https://ascopost.com/issues/december-10-2020/epov-brooks-cash/ 2020-12-10T21:34:43+00:00 https://ascopost.com/issues/december-10-2020/statins-reduced-risk-of-colorectal-cancer-in-meta-analysis/ 2020-12-14T14:37:21+00:00 https://ascopost.com/issues/december-10-2020/options-for-maintenance-therapy-for-metastatic-pancreatic-cancer/ 2020-12-10T21:34:43+00:00 https://ascopost.com/issues/december-10-2020/emerging-data-on-parp-inhibition-in-prostate-cancer/ 2020-12-23T22:34:44+00:00 https://ascopost.com/issues/december-10-2020/complexity-of-designing-clinical-trials-for-sarcoma/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/immunotherapy-for-triple-negative-breast-cancer-an-evolving-story/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/extranodal-marginal-zone-lymphoma-of-mucosa-associated-lymphoid-neoplasms/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/meta-analysis-shows-superior-disease-free-and-overall-survival-with-measurable-residual-disease-negativity-in-aml/ 2021-01-18T18:30:13+00:00 https://ascopost.com/issues/december-10-2020/asco-releases-guideline-on-systemic-therapy-for-advanced-hepatocellular-carcinoma/ 2020-12-14T20:09:56+00:00 https://ascopost.com/issues/december-10-2020/no-reduced-recurrence-risk-with-perioperative-aromatase-inhibitor-use-in-hr-positive-breast-cancer/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/improved-outcomes-with-neoadjuvant-paclitaxel-plus-trastuzumablapatinib-vs-paclitaxeltrastuzumab-in-her2-positive-breast-cancer/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/meta-analysis-of-outcomes-with-systemic-therapy-in-first-and-second-line-treatments-of-advanced-hcc/ 2020-12-14T20:08:32+00:00 https://ascopost.com/issues/december-10-2020/fda-approves-pralsetinib-for-ret-altered-thyroid-cancers/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/fda-issues-emergency-use-authorization-for-first-covid-19-test-for-self-testing-at-home/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/fda-grants-accelerated-approval-to-naxitamab-for-high-risk-neuroblastoma-in-bone-or-bone-marrow/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/fda-approves-gallium-68-psma-11-for-psma-targeted-pet-imaging-in-prostate-cancer/ 2020-12-10T21:34:44+00:00 https://ascopost.com/issues/december-10-2020/incidence-and-cancer-related-mortality-in-colombia/ 2020-12-23T17:20:03+00:00 https://ascopost.com/issues/december-10-2020/breaking-the-cultural-norms-a-young-indian-girl-attains-her-dream-of-becoming-a-global-oncologist/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/an-early-love-of-the-duck-billed-platypus-sparks-a-career-in-cancer-research/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/cu-cancer-center-leukemia-researcher-receives-nci-outstanding-investigator-award/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/erratum/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/living-well-before-we-die/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/fda-and-aacr-launch-project-livin-label/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/epov-matthijs-oudkerk/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/daniel-von-hoff-receives-inaugural-aacr-scientific-achievement-award-established-in-his-honor/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/2020-ernest-beutler-lecture-and-prize-presented-to-ari-melnick-md-and-courtney-dinardo-md/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/hannah-hazard-jenkins-named-permanent-director-of-the-wvu-cancer-institute/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/ash-recognizes-admiral-brett-giroir-with-2020-outstanding-service-award/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/physician-scientist-judah-folkman-md-faced-years-of-skepticism-before-his-theory-of-angiogenesis-was-proven/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/researchers-join-10-million-project-to-better-understand-sex-differences-in-brain-cancer-outcomes/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/mohandas-narla-receives-2020-wallace-h-coulter-award-for-lifetime-achievement-in-hematology/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/dana-farberbrigham-and-women-s-cancer-center-and-stamford-hospital-expand-collaboration/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/the-lung-microbiome-may-affect-lung-cancer-pathogenesis-and-prognosis/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/addressing-disparities-in-care-among-black-men-and-women-with-cancer/ 2020-12-10T21:34:45+00:00 https://ascopost.com/issues/december-10-2020/edward-benz-jr-receives-2020-ash-award-for-leadership-in-promoting-diversity/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/facing-life-s-adversities-even-cancer-from-the-back-of-a-horse-named-buddy/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/older-woman-with-eye-tumor/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/bristol-myers-squibb-foundation-and-national-medical-fellowships-launch-program-to-increase-diversity-in-clinical-trials/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/huntsman-cancer-institute-leadership-announces-two-new-appointments/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/world-health-organization-launches-first-ever-global-commitment-to-eliminate-cervical-cancer/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/abraham-chachoua-md-announced-as-new-director-of-perlmutter-cancer-center-s-lung-cancer-center/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/city-of-hope-orange-county-names-edward-kim-its-physician-in-chief/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/albert-einstein-college-of-medicine-researchers-receive-grant-from-the-national-institutes-of-health/ 2020-12-22T20:28:39+00:00 https://ascopost.com/issues/december-10-2020/shilpi-gupta-md-joins-atlantic-health-system-cancer-care-s-comprehensive-breast-health-program/ 2020-12-22T20:27:59+00:00 https://ascopost.com/issues/december-10-2020/ash-awards-henry-m-stratton-medal-to-hematology-researchers/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/2020-william-dameshek-prize-awarded-to-adolfo-ferrando-md-phd/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/2020-e-donnall-thomas-lecture-and-prize-awarded-to-toshio-suda-md-phd/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/can-circulating-tumor-cell-count-guide-first-line-chemotherapy-or-endocrine-therapy-for-hr-positive-her2-negative-metastatic-breast-cancer/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/researchers-develop-prognostic-model-to-guide-systemic-therapy-for-early-stage-her2-positive-breast-cancer/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/addition-of-ablative-therapy-to-transarterial-chemoembolization-in-nonmetastatic-unresectable-hepatocellular-carcinoma/ 2021-02-05T20:11:32+00:00 https://ascopost.com/issues/december-10-2020/sentinel-lymph-node-biopsy-vs-lymphadenectomy-for-staging-of-intermediate-and-high-grade-endometrial-cancer/ 2020-12-10T21:34:46+00:00 https://ascopost.com/issues/december-10-2020/staying-a-step-ahead-of-cancer/ 2020-12-10T21:34:47+00:00 https://ascopost.com/issues/december-10-2020/sara-federico-md-receives-nci-award-for-leadership-in-developing-clinical-trials-for-pediatric-cancer/ 2020-12-10T21:34:47+00:00 https://ascopost.com/issues/december-10-2020/sitc-announces-creation-of-steven-a-rosenberg-md-phd-endowed-scholars-fund/ 2021-01-06T17:55:46+00:00 https://ascopost.com/issues/december-10-2020/asco-issues-comprehensive-recommendations-to-strengthen-cancer-care-and-research-during-and-beyond-the-covid-19-pandemic/ 2020-12-11T19:10:45+00:00 https://ascopost.com/issues/december-10-2020/career-development-award-winner-dr-aparna-parikh/ 2020-12-11T19:10:45+00:00 https://ascopost.com/issues/december-10-2020/new-asco-series-for-early-career-cancer-providers-on-impacts-of-social-determinants-of-health/ 2020-12-11T19:10:45+00:00 https://ascopost.com/issues/december-10-2020/save-20-when-you-stock-your-practice-with-asco-answers-materials-for-2021/ 2020-12-11T19:10:45+00:00 https://ascopost.com/issues/december-10-2020/new-rules-on-health-care-price-transparency-and-coverage-for-covid-19-vaccines/ 2020-12-11T19:13:04+00:00 https://ascopost.com/issues/november-25-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/november-25-2020/fluciclovine-pet-imaging-benefits-radiotherapy-treatment-planning-compared-with-conventional-imaging-in-prostate-cancer/ 2020-11-25T18:46:57+00:00 https://ascopost.com/issues/november-25-2020/nivolumab-plus-ipilimumab-in-first-line-nsclc-two-new-indications-many-more-questions/ 2020-12-11T19:06:57+00:00 https://ascopost.com/issues/november-25-2020/epov-deborah-doroshow/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/impact-of-covid-19-on-cancer-care-in-india/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/image-guided-imrt-reduces-gi-toxicity-without-compromising-pelvic-recurrence-in-intermediate-to-high-risk-cervical-cancer/ 2020-12-08T19:51:01+00:00 https://ascopost.com/issues/november-25-2020/management-of-painful-spinal-metastases-sbrt-vs-conventional-radiotherapy/ 2020-12-01T19:45:04+00:00 https://ascopost.com/issues/november-25-2020/epov-kristin-redmond/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/stereotactic-radiosurgery-may-delay-cognitive-deterioration-vs-whole-brain-radiotherapy-for-multiple-brain-metastases/ 2020-11-25T18:50:18+00:00 https://ascopost.com/issues/november-25-2020/nagi-s-el-saghir-md-facp-fasco-receives-lebanon-s-national-cedar-medal-award/ 2020-11-30T19:58:57+00:00 https://ascopost.com/issues/november-25-2020/use-of-pembrolizumab-in-advanced-pleural-mesothelioma-results-from-keynote-158/ 2020-12-11T19:07:33+00:00 https://ascopost.com/issues/november-25-2020/epov-melina-marmarelis/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/daniel-sullivan-md-honored-for-leadership-in-quantitative-imaging-biomarkers/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/kras-inhibitor-adagrasib-shows-activity-in-non-small-cell-lung-cancer/ 2020-12-04T19:40:31+00:00 https://ascopost.com/issues/november-25-2020/epov-howard-west-md-and-william-sellers/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/can-antihypertensives-improve-outcomes-with-immunotherapy/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/epov-emiliano-calvo-and-udai-banerji/ 2020-11-25T18:05:22+00:00 https://ascopost.com/issues/november-25-2020/genetic-variants-linked-to-bevacizumab-induced-adverse-effects/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/epov-william-r-sellers-md/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/hairy-cell-leukemia-foundation-and-leukemia-lymphoma-society-join-forces/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/mindact-at-87-years-primary-findings-confirmed/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/epov-keerthi-gogineni/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/mode-of-detection-of-high-risk-breast-cancer-linked-to-prognosis/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/epov-david-cameron/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/guideline-update-offers-new-directions-about-trastuzumab-emtansine-for-her2-positive-breast-cancer/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/pembrolizumab-in-adult-and-pediatric-classical-hodgkin-lymphoma/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/growing-interest-in-antiandrogens-to-treat-male-breast-cancer/ 2020-12-09T19:22:21+00:00 https://ascopost.com/issues/november-25-2020/aacr-announces-move-to-virtual-meeting-for-2021/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/final-analysis-of-solar-1-8-month-survival-benefit-misses-statistical-significance-for-alpelisib/ 2021-08-19T20:24:29+00:00 https://ascopost.com/issues/november-25-2020/epov-fatima-cardoso/ 2020-11-25T18:05:23+00:00 https://ascopost.com/issues/november-25-2020/new-pediatric-neuro-oncology-research-lab-established-at-hackensack-university-medical-center/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/adam-bass-md-named-director-center-for-precision-cancer-medicine-at-columbia-university/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/support-builds-for-anti-bcma-car-t-cell-therapy-in-multiple-myeloma/ 2020-12-02T21:34:01+00:00 https://ascopost.com/issues/november-25-2020/epov-ajay-nooka/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/new-leadership-elected-to-american-society-of-hematology/ 2020-12-05T18:43:31+00:00 https://ascopost.com/issues/november-25-2020/this-year-s-fda-asco-workshop-focused-on-collection-of-patient-reported-tolerability-data-from-clinical-trials/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/a-urologic-surgeon-assesses-the-current-state-of-prostate-cancer/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/update-on-multiple-myeloma-highlights-from-nccn-virtual-congress-on-hematologic-malignancies/ 2020-12-02T20:47:47+00:00 https://ascopost.com/issues/november-25-2020/ask-patients-with-advanced-cancer-about-fatigue-the-answer-may-reveal-survival-odds/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/epov-therese-marie-mulvey/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/colorectal-cancer-alliance-launches-comprehensive-campaign-to-increase-screening-rates-during-covid-19-and-beyond/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/md-anderson-partners-with-investment-fund-to-generate-support-for-investigational-therapies/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/venetoclax-in-combination-therapy-for-untreated-acute-myeloid-leukemia/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/understanding-the-uniqueness-of-cancer-and-survival-in-adolescents-and-young-adults/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/rutgers-awarded-fema-grant-to-support-volunteer-firefighter-cancer-research-and-prevention/ 2020-11-25T18:05:24+00:00 https://ascopost.com/issues/november-25-2020/ut-austin-and-md-anderson-announce-first-collaborative-projects-in-improving-cancer-outcomes/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/racial-disparities-in-treatment-of-common-lung-cancer-persist-despite-gains/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/hci-researcher-receives-awards-for-community-contributions-and-neuroendocrine-tumor-research/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/acs-cancer-action-network-issues-new-recommendations-to-increase-access-to-cancer-biomarker-testing/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/ola-landgren-md-phd-joins-sylvester-comprehensive-cancer-center-at-university-of-miami/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/addition-of-abemaciclib-to-endocrine-therapy-improves-invasive-disease-free-survival-in-high-risk-early-breast-cancer/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/first-line-atezolizumab-improves-overall-survival-vs-chemotherapy-in-certain-patients-with-metastatic-nsclc/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/final-efficacy-results-from-extenet-trial-of-neratinib-in-subgroup-of-patients-with-hr-positive-her2-positive-early-breast-cancer/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/the-us-oncology-network-welcomes-two-more-practices/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/do-patients-with-early-stage-nsclc-have-a-higher-tumor-mutational-burden/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/ixazomib-maintenance-in-patients-with-newly-diagnosed-multiple-myeloma-who-did-not-receive-asct/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/dasatinibblinatumomab-produces-high-rates-of-molecular-response-and-survival-in-philadelphia-chromosome-positive-all/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/darolutamide-improves-overall-survival-in-nonmetastatic-castration-resistant-prostate-cancer-aramis-trial/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/william-dameshek-helped-take-hematology-from-a-minor-medical-discipline-to-a-major-scientific-field/ 2020-12-05T20:06:50+00:00 https://ascopost.com/issues/november-25-2020/what-is-quality-oncology-care-during-the-covid-19-pandemic/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/study-shows-equivalence-of-sentinel-node-biopsy-vs-neck-node-dissection-in-operable-oral-or-oropharyngeal-cancer/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/a-daughter-of-immigrants-chooses-a-challenging-but-rewarding-career-in-surgical-oncology/ 2020-11-25T18:05:25+00:00 https://ascopost.com/issues/november-25-2020/medicaid-expansion-may-be-linked-to-lower-mortality-rates-for-three-major-types-of-cancer/ 2020-11-25T18:05:26+00:00 https://ascopost.com/issues/november-25-2020/fda-offers-guidance-to-enhance-diversity-in-clinical-trials-encourage-inclusivity-in-medical-product-development/ 2020-11-25T18:05:26+00:00 https://ascopost.com/issues/november-25-2020/south-florida-cancer-experts-make-the-move-to-sylvester/ 2020-11-25T18:05:26+00:00 https://ascopost.com/issues/november-25-2020/closing-the-gap-in-integrative-oncology-education/ 2020-11-25T18:05:26+00:00 https://ascopost.com/issues/november-25-2020/virtual-mind-body-services-for-patients-with-cancer-during-the-covid-19-pandemic/ 2020-11-25T18:05:26+00:00 https://ascopost.com/issues/november-25-2020/no-benefit-of-adjuvant-sorafenib-in-intermediate-or-high-risk-renal-cell-carcinoma/ 2021-01-12T18:25:13+00:00 https://ascopost.com/issues/november-25-2020/mount-sinai-receives-4-million-gift-to-support-prostate-health-and-urology-department/ 2020-11-25T18:05:26+00:00 https://ascopost.com/issues/november-25-2020/sio-and-asco-collaborate-to-develop-evidence-based-guidelines-for-integrative-therapies-for-oncology/ 2020-11-25T18:05:26+00:00 https://ascopost.com/issues/november-25-2020/penn-medicine-researchers-receive-54-million-grant-to-find-genetic-drivers-of-testicular-cancer/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/yes-men-get-breast-cancer-too/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/mohs-surgery-vs-wide-local-excision-for-trunk-and-extremity-melanomas/ 2020-12-17T19:53:58+00:00 https://ascopost.com/issues/november-25-2020/expect-questions-about-mohs-micrographic-surgery/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/global-cancer-institute-extends-programs-to-bangladesh-for-underserved-patients-with-cancer/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/us-multisociety-task-force-on-colorectal-cancer-offers-management-strategies-for-malignant-colorectal-polyps/ 2020-12-21T18:16:46+00:00 https://ascopost.com/issues/november-25-2020/addition-of-bevacizumab-to-paclitaxel-in-relapsed-ovarian-sex-cord-stromal-tumors/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/association-of-minimal-residual-disease-with-disease-free-and-overall-survival-in-patients-with-aml/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/immediate-breast-reconstruction-vs-conventional-mastectomy-after-neoadjuvant-chemotherapy/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/biomarker-driven-master-protocol-to-test-therapies-for-previously-treated-patients-with-squamous-nsclc/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/rogel-team-at-university-of-michigan-receives-112m-to-leverage-the-microbiome-against-graft-vs-host-disease/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/elnec-project-reaches-historic-milestone-in-end-of-life-care/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/job-loss-during-cancer-how-to-cope-and-continue-treatment/ 2020-11-25T18:05:27+00:00 https://ascopost.com/issues/november-25-2020/gateway-for-cancer-research-and-conquer-cancer-offer-grant-funding-to-research-health-disparities/ 2020-11-25T18:09:07+00:00 https://ascopost.com/issues/november-25-2020/time-is-running-out-prepare-for-2021-em-changes-today/ 2020-11-25T19:22:03+00:00 https://ascopost.com/issues/november-25-2020/new-global-survey-finds-more-education-needed-to-increase-provider-geriatric-assessments-for-older-adults-with-cancer/ 2020-11-25T19:24:02+00:00 https://ascopost.com/issues/november-25-2020/asco-launches-educational-series-on-social-determinants-of-health/ 2020-11-25T18:30:42+00:00 https://ascopost.com/issues/november-25-2020/asco-s-free-app-for-patients-cancernet-mobile/ 2020-11-25T18:37:34+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/hematologic-oncology-highlights-2019-2020-almanac/ 2022-01-17T19:04:00+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/novel-therapies-and-new-indications-for-use-in-treatment-of-hematologic-malignancies/ 2020-11-19T22:11:10+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/novel-treatment-approaches-on-the-horizon-in-multiple-myeloma/ 2020-11-19T23:01:55+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/novel-therapies-and-new-indications-for-use-in-treatment-of-hematologic-malignancies-1/ 2020-11-19T22:11:10+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/responses-achieved-with-belantamab-mafodotin-in-relapsed-or-refractory-myeloma/ 2020-11-19T23:03:21+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/epov-philip-mccarthy/ 2020-11-19T22:11:10+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/support-builds-for-anti-bcma-car-t-cell-therapy-in-multiple-myeloma/ 2020-11-19T23:05:43+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/epov-ajay-nooka/ 2020-11-19T22:11:10+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/carfilzomib-vs-bortezomib-each-combined-with-lenalidomidedexamethasone-in-newly-diagnosed-patients-with-multiple-myeloma/ 2020-11-19T23:08:03+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/acalabrutinib-improves-progression-free-survival-vs-idelalisib-plus-rituximab-or-bendamustine-plus-rituximab-in-relapsed-or-refractory-cll/ 2020-11-19T23:09:57+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/final-ascend-results-confirm-acalabrutinib-as-a-standard-for-relapsed-cll/ 2020-11-19T23:13:09+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/4-year-findings-from-murano-trial-venetoclax-plus-rituximab-for-relapsed-chronic-lymphocytic-leukemia/ 2020-11-19T23:14:42+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/optimizing-the-treatment-of-adults-with-acute-lymphoblastic-leukemia/ 2020-11-20T14:42:26+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/ash-releases-new-clinical-practice-guidelines-on-treatment-of-older-adults-with-newly-diagnosed-acute-myeloid-leukemia/ 2020-12-05T18:47:31+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/venetoclax-combination-in-newly-diagnosed-aml/ 2020-11-20T14:50:08+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/addition-of-rituximab-to-standard-chemotherapy-improves-event-free-and-overall-survival-in-children-with-high-risk-mature-b-cell-non-hodgkin-lymphoma/ 2020-11-20T14:53:45+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/role-of-rituximab-in-treatment-of-children-and-adolescents-with-mature-b-cell-non-hodgkin-lymphoma/ 2020-11-20T15:02:03+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/newer-therapeutic-approaches-improving-outcomes-in-hodgkin-lymphoma/ 2021-01-20T02:27:56+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/chemotherapy-free-approaches-in-follicular-and-mantle-cell-lymphomas/ 2020-11-20T15:05:39+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/bispecific-antibodies-poised-to-impact-treatment-of-lymphoma-and-other-blood-cancers/ 2020-11-20T15:13:12+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/epov-basem-m-william-and-caron-jacobson/ 2020-11-20T15:16:51+00:00 https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/study-results-with-pet-directed-therapy-for-limited-stage-diffuse-large-b-cell-lymphoma/ 2021-01-20T02:29:38+00:00 https://ascopost.com/issues/november-10-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/november-10-2020/surgery-improves-survival-in-older-women-with-early-estrogen-receptor-positive-breast-cancer/ 2020-11-17T20:00:15+00:00 https://ascopost.com/issues/november-10-2020/lung-cancer-precision-therapies-at-the-forefront/ 2020-11-18T02:57:52+00:00 https://ascopost.com/issues/november-10-2020/results-from-asco-s-2020-national-cancer-opinions-survey/ 2020-11-10T20:14:46+00:00 https://ascopost.com/issues/november-10-2020/no-biochemical-pfs-benefit-with-adjuvant-vs-salvage-radiotherapy-after-radical-prostatectomy-for-prostate-cancer/ 2020-11-18T03:28:59+00:00 https://ascopost.com/issues/november-10-2020/just-the-beginning-for-veliparib-based-therapy-in-advanced-brca-mutated-breast-cancer/ 2021-03-12T21:28:38+00:00 https://ascopost.com/issues/november-10-2020/do-all-patients-with-refractory-diffuse-large-b-cell-lymphoma-need-car-t-cell-therapy/ 2021-01-20T02:19:52+00:00 https://ascopost.com/issues/november-10-2020/chronic-lymphocytic-leukemia-new-treatments-achieve-deeper-remissions/ 2020-11-10T22:09:54+00:00 https://ascopost.com/issues/november-10-2020/reducing-symptomatic-toxicity-burden-in-older-patients-with-advanced-cancer-via-geriatric-assessment/ 2020-11-10T20:27:12+00:00 https://ascopost.com/issues/november-10-2020/epov-monika-krzyzanowska/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/medical-financial-hardship-pervasive-and-possibly-linked-to-mortality-among-patients-with-cancer/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/epov-reginald-tucker-seeley/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/reducing-emergency-department-visits-better-patient-outreach-may-improve-care-treatment-costs/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/epov-sonali-smith/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/liquid-biopsy-mounting-evidence-shows-clinical-utility-in-tumor-monitoring/ 2020-11-10T22:15:58+00:00 https://ascopost.com/issues/november-10-2020/an-integrated-framework-for-improving-outcomes-in-pancreatic-cancer/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/new-maintenance-therapies-in-metastatic-pancreatic-cancer-aim-to-end-perpetual-chemotherapy/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/pancreatic-adenocarcinoma-leveraging-molecular-data-to-drive-clinical-advances/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/oneoncology-launches-community-oncology-research-network/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/fda-approves-venetoclax-combination-regimen-for-certain-adult-patients-with-aml/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/fda-approves-remdesivir-for-patients-with-covid-19-requiring-hospitalization/ 2020-11-10T20:27:13+00:00 https://ascopost.com/issues/november-10-2020/fda-extends-the-approval-of-pembrolizumab-for-patients-with-classical-hodgkin-lymphoma/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/paloma-3-exploratory-analysis-who-benefits-most-from-palbociclib/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/epov-charles-shapiro/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/predicting-cardiovascular-disease-risk-via-routine-ct-scans-in-women-with-breast-cancer/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/novel-treatments-show-activity-in-advanced-cervical-cancer/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/epov-ana-oaknin/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/solo-1-trial-after-5-years-maintenance-olaparib-still-keeps-ovarian-cancer-at-bay/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/epov-jonathan-ledermann/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/danube-trial-reports-no-survival-benefit-with-first-line-durvalumab-in-metastatic-urothelial-carcinoma/ 2021-02-09T20:05:54+00:00 https://ascopost.com/issues/november-10-2020/astro-issues-clinical-guideline-on-radiation-therapy-for-rectal-cancer/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/tazemetostat-in-relapsed-or-refractory-follicular-lymphoma/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/swedish-study-of-hpv-vaccination-and-risk-of-invasive-cervical-cancer/ 2020-11-10T20:27:14+00:00 https://ascopost.com/issues/november-10-2020/adjuvant-vs-early-salvage-radiotherapy-after-radical-prostatectomy-in-high-risk-prostate-cancer/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/hypofractionated-stereotactic-radiotherapy-to-the-resection-cavity-in-patients-with-brain-metastases/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/avelumab-maintenance-therapy-improves-overall-survival-in-advanced-or-metastatic-urothelial-carcinoma/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/incidence-and-cancer-related-mortality-in-chile/ 2020-11-16T16:03:37+00:00 https://ascopost.com/issues/november-10-2020/fda-approves-companion-diagnostic-for-three-targeted-therapies-for-advanced-ovarian-breast-and-non-small-cell-lung-cancers/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/huntsman-cancer-institute-names-new-chief-academic-officer-and-senior-director-of-basic-science/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/aaci-president-knudsen-to-focus-2-year-term-on-mitigating-health-disparities/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/selpercatinib-shows-activity-in-ret-fusion-positive-nsclc-and-ret-altered-thyroid-cancer/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/second-line-pembrolizumab-improves-overall-survival-vs-chemotherapy-in-patients-with-advanced-esophageal-cancer/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/national-academy-of-medicine-elects-new-members/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/cancer-in-older-adults-the-history-of-geriatric-oncology-part-3/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/lungevity-launches-new-lung-cancer-advocacy-program/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/recently-approved-and-emerging-therapies-for-triple-negative-breast-cancer/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/cancercare-welcomes-j-leonard-lichtenfeld-md-macp-to-board-of-trustees/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/erratum/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/jame-abraham-md-facp-named-deputy-editor-of-jco-oncology-practice/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/first-line-pembrolizumab-delays-disease-progression-in-pd-l1-expressing-metastatic-triple-negative-breast-cancer/ 2020-11-10T20:27:15+00:00 https://ascopost.com/issues/november-10-2020/epov-amy-tiersten-and-erika-hamilton/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/richard-pazdur-md-awarded-the-simon-m-shubitz-cancer-prize-and-lectureship/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/after-surgery-for-colorectal-cancer-intensive-monitoring-of-little-benefit-prodige-13/ 2020-11-23T21:03:24+00:00 https://ascopost.com/issues/november-10-2020/epov-tim-price/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/nccn-announces-beth-gaffney-mba-as-new-vice-president-of-us-and-global-business-development/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/fragment-analysis-as-a-met-exon-14-screening-strategy-in-nsclc-tumors/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/cure-media-group-announces-recipients-of-2020-lung-cancer-heroes-award/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/after-leaving-his-home-in-syria-to-train-abroad-an-oncologist-makes-a-tough-decision-to-return/ 2020-11-10T20:36:02+00:00 https://ascopost.com/issues/november-10-2020/oncology-drug-development-marches-on-amid-a-pandemic/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/companion-diagnostic-to-identify-ntrk-fusions-in-patients-with-solid-tumors-eligible-for-larotrectinib-treatment-approved-by-fda/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/enrique-soto-pérez-de-celis-met-a-career-changing-mentor-at-the-asco-annual-meeting/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/accc-statement-on-rise-of-cancer-mortality-and-advanced-cancer-rates-in-2020/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/using-meaning-centered-interventions-to-address-suffering-on-the-cancer-journey/ 2020-11-10T20:39:58+00:00 https://ascopost.com/issues/november-10-2020/astro-honors-2020-gold-medalists/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/dr-christina-cone-honored-with-mary-pazdur-award-for-excellence-in-advanced-practice-in-oncology/ 2022-03-07T20:16:42+00:00 https://ascopost.com/issues/november-10-2020/three-new-transatlantic-research-teams-to-study-difficult-to-treat-childhood-cancers/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/an-emergency-room-physician-explores-her-own-healing-through-a-life-of-medical-service/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/a-doctor-shares-his-rich-life-in-medicine-and-cancer-research/ 2020-11-10T20:27:16+00:00 https://ascopost.com/issues/november-10-2020/combination-of-nivolumab-and-ipilimumab-for-unresectable-malignant-pleural-mesothelioma/ 2020-11-10T20:14:58+00:00 https://ascopost.com/issues/november-10-2020/michaela-a-dinan-phd-named-co-leader-of-cancer-prevention-and-control-research-program-at-yale/ 2020-11-10T20:14:58+00:00 https://ascopost.com/issues/november-10-2020/my-age-may-have-been-a-barrier-to-timely-diagnosis-of-glioblastoma-multiforme/ 2020-11-10T20:14:59+00:00 https://ascopost.com/issues/november-10-2020/stereo-x-ray-of-stomach-cancer/ 2020-11-10T20:14:59+00:00 https://ascopost.com/issues/november-10-2020/inaugural-class-of-fda-aacr-oncology-educational-fellows-announced/ 2020-11-10T20:14:59+00:00 https://ascopost.com/issues/november-10-2020/platinum-based-regimens-remain-standard-of-care-in-recurrent-platinum-sensitive-ovarian-cancer/ 2020-11-10T20:14:59+00:00 https://ascopost.com/issues/november-10-2020/epov-andreas-du-bois/ 2020-11-10T20:14:59+00:00 https://ascopost.com/issues/november-10-2020/covid-19-s-impact-on-cancer-care-around-the-world/ 2020-11-10T21:14:01+00:00 https://ascopost.com/issues/november-10-2020/support-caregivers-during-national-family-caregivers-month-with-asco-answers/ 2020-11-10T21:14:09+00:00 https://ascopost.com/issues/november-10-2020/your-stories-being-your-own-advocate/ 2020-11-10T21:24:11+00:00 https://ascopost.com/issues/november-10-2020/hospital-outpatient-payment-proposal-has-potential-to-undermine-patient-access-to-cancer-care/ 2020-11-10T21:25:10+00:00 https://ascopost.com/issues/november-10-2020/project-n95-partnership-provided-asco-members-with-access-to-personal-protective-equipment/ 2020-11-10T21:08:18+00:00 https://ascopost.com/issues/november-10-2020/rising-tide-foundation-for-clinical-cancer-research-career-pathway-grants-in-symptom-management/ 2020-11-10T21:11:33+00:00 https://ascopost.com/issues/october-25-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/october-25-2020/lorlatinib-improves-outcomes-over-crizotinib-in-first-line-setting-of-alk-positive-nsclc-crown-trial/ 2020-11-03T18:34:46+00:00 https://ascopost.com/issues/october-25-2020/epov-christine-m-lovly/ 2020-10-26T18:54:20+00:00 https://ascopost.com/issues/october-25-2020/should-body-mass-index-guide-the-choice-of-chemotherapy-in-patients-with-breast-cancer/ 2020-10-26T18:54:20+00:00 https://ascopost.com/issues/october-25-2020/covid-19-cancer-and-the-older-adult/ 2020-10-26T18:54:20+00:00 https://ascopost.com/issues/october-25-2020/sacituzumab-govitecan-yields-survival-benefit-as-third-line-treatment-in-triple-negative-breast-cancer-ascent-trial/ 2020-10-26T18:54:20+00:00 https://ascopost.com/issues/october-25-2020/epov-fatima-cardoso/ 2020-10-26T18:54:20+00:00 https://ascopost.com/issues/october-25-2020/novel-iap-blocker-plus-chemoradiotherapy-improved-outcomes-in-head-and-neck-cancer-trial/ 2020-10-26T18:54:20+00:00 https://ascopost.com/issues/october-25-2020/epov-sjoukje-oosting/ 2020-10-26T18:54:20+00:00 https://ascopost.com/issues/october-25-2020/co-leader-of-immunotherapy-trial-reflects-on-practice-changing-results-in-advanced-bladder-and-other-urinary-tract-cancers/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/empower-lung-1-trial-cemiplimab-improves-survival-over-chemotherapy-in-advanced-nsclc/ 2020-11-03T18:32:39+00:00 https://ascopost.com/issues/october-25-2020/epov-roy-herbst/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/early-phase-study-reports-progress-in-targeting-kras-mutated-tumors-with-sotorasib/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/2020-nobel-prize-in-physiology-or-medicine-awarded-to-team-who-discovered-hepatitis-c-virus/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/emmanuelle-charpentier-phd-and-jennifer-a-doudna-phd-honored-with-nobel-prize-in-chemistry-2020/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/steven-d-wexner-md-facs-elected-vice-chair-of-board-of-regents-of-american-college-of-surgeons/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/making-strides-in-the-management-of-pancreatic-cancer/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/research-into-cold-tumors-heating-up-in-pancreatic-cancer/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/study-finds-black-and-hispanic-patients-with-cancer-used-telehealth-less-often-than-white-patients-during-the-covid-19-pandemic/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/black-patients-with-cancer-may-be-at-increased-risk-for-hospitalization-related-to-covid-19-infection/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/cancerlinq-data-reveal-black-and-hispanic-patients-with-cancer-face-greater-risk-of-covid-19-infection/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/rutgers-cancer-institute-of-new-jersey-awarded-16m-for-youth-science-program/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/thinking-out-of-the-box-to-advance-the-management-of-chronic-graft-vs-host-disease/ 2020-10-26T18:54:21+00:00 https://ascopost.com/issues/october-25-2020/yale-cancer-center-awarded-nih-spore-grant-for-head-and-neck-cancer-research/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/anthony-fauci-md-to-receive-lifetime-achievement-award-from-national-minority-quality-forum/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/lourdes-a-báezconde-garbanati-receives-aacr-distinguished-lectureship-on-cancer-health-disparities/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/liquid-biopsy-may-be-a-timely-and-effective-testing-method-for-patients-with-nsclc/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/pilot-study-finds-liquid-biopsy-delivers-results-faster-than-tissue-biopsy/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/capmatinib-active-in-advanced-nsclc-with-met-exon-14-skipping-mutations/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/asco-approves-first-joint-mstsastroasco-guideline-on-treatment-of-metastatic-carcinoma-and-myeloma-of-the-femur/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/clinical-challenges-of-managing-breast-cancer-brain-metastases/ 2020-10-26T18:54:22+00:00 https://ascopost.com/issues/october-25-2020/uicc-launches-new-program-at-the-start-of-breast-cancer-awareness-month/ 2020-10-26T19:10:16+00:00 https://ascopost.com/issues/october-25-2020/activity-of-the-kras-g12c-inhibitor-sotorasib-in-kras-g12c-mutant-advanced-solid-tumors/ 2020-10-26T19:10:16+00:00 https://ascopost.com/issues/october-25-2020/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2020-10-26T19:10:16+00:00 https://ascopost.com/issues/october-25-2020/first-line-pembrolizumab-in-metastatic-colorectal-cancer/ 2020-10-26T19:10:16+00:00 https://ascopost.com/issues/october-25-2020/epov-chiara-cremolini/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/fda-awards-six-grants-to-fund-new-clinical-trials-of-medical-products-for-treatment-of-rare-diseases/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/fda-approves-nivolumab-plus-ipilimumab-for-the-first-line-treatment-of-unresectable-malignant-pleural-mesothelioma/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/mountainside-medical-center-appoints-co-medical-director/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/2020-nih-director-s-early-independence-awards-announced/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/dana-farber-announces-center-for-salivary-and-rare-head-and-neck-cancers/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/city-of-hope-launches-innovative-support-model-for-employers/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/isabelle-tabah-fisch-md-drug-researcher-industry-executive-dies-at-64/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/first-line-pembrolizumab-plus-chemotherapy-improves-survival-in-esophageal-cancer/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/epov-salah-eddin-al-batran/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/pay-for-performance-program-to-reimburse-oncology-practices-for-prescribing-evidence-based-cancer-drugs/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/advanced-melanoma-lenvatinib-plus-pembrolizumab-after-disease-progression-on-anti-pd-1-based-therapy/ 2020-11-13T19:49:22+00:00 https://ascopost.com/issues/october-25-2020/combi-i-trial-no-statistical-benefit-to-adding-spartalizumab-to-dabrafenibtrametinib-in-melanoma/ 2020-11-13T19:47:24+00:00 https://ascopost.com/issues/october-25-2020/epov-bartosz-chmielowski/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/ucla-researchers-efforts-in-melanoma-receive-13m-boost-from-nih/ 2020-10-26T19:10:17+00:00 https://ascopost.com/issues/october-25-2020/long-term-benefit-of-adjuvant-immunotherapy-sustained-in-stage-iii-or-iv-melanoma/ 2020-11-13T19:44:09+00:00 https://ascopost.com/issues/october-25-2020/epov-rodabe-amaria/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/recurrence-free-survival-benefit-maintained-with-adjuvant-nivolumab-vs-ipilimumab-in-stage-iiib-iiic-and-iv-melanoma/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/new-asco-sep-edition-available-expands-reach-to-global-oncology-community/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/2020-snapshot-state-of-the-oncology-workforce-in-america/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/impactful-2020-virtual-advocacy-summit-new-environment-same-goals/ 2020-10-29T21:16:34+00:00 https://ascopost.com/issues/october-25-2020/breaking-social-barriers-to-conquer-cancer/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/your-stories-the-family-business/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/did-you-know-asco-has-resources-on-covid-19-for-people-with-cancer/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/james-k-mccloskey-ii-named-division-chief-of-the-division-of-leukemia-at-john-theurer-cancer-center/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/cancer-in-older-adults-the-history-of-geriatric-oncology-part-2-1990-2020/ 2020-11-02T22:17:51+00:00 https://ascopost.com/issues/october-25-2020/surgical-and-radiation-oncology-in-elderly-patients-with-cancer/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/lesley-solomon-receives-extraordinary-women-advancing-healthcare-award/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/susan-g-komen-to-present-2020-brinker-awards-for-scientific-distinction/ 2020-12-12T18:50:43+00:00 https://ascopost.com/issues/october-25-2020/how-telemedicine-is-impacting-oncology-care-during-the-covid-19-pandemic/ 2020-10-29T20:40:45+00:00 https://ascopost.com/issues/october-25-2020/astro-calls-for-changes-to-benefits-manager-policy/ 2020-10-26T19:10:18+00:00 https://ascopost.com/issues/october-25-2020/abigail-berman-finds-radiation-oncology-intriguing/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/asco-s-policy-statement-on-skin-cancer-prevention-focuses-on-four-key-areas-to-reduce-incidence-and-save-lives/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/small-case-study-explores-novel-approach-to-neoadjuvant-therapy-for-skin-cancer/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/is-drinking-coffee-daily-linked-to-improved-survival-in-patients-with-advanced-colorectal-cancer/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/advanced-practitioner-leadership-in-times-of-crisis/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/panel-with-diverse-perspectives-explores-strategies-to-reduce-costs-for-cancer-care/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/are-delays-in-breast-cancer-treatment-as-harmful-as-commonly-thought/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/dana-farberharvard-cancer-center-wins-federal-grant-to-accelerate-ovarian-cancer-research/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/epov-bartosz-chmielowski-1/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/the-gut-our-choices-and-gynecologic-cancers/ 2020-11-02T20:32:28+00:00 https://ascopost.com/issues/october-25-2020/cleveland-clinic-announces-oncology-staff-appointments/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/a-gritty-journey-into-a-rare-cancer-and-back/ 2021-05-13T13:59:32+00:00 https://ascopost.com/issues/october-25-2020/the-secret-history-of-cancer-chemotherapy/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/breast-cancer-and-radiation-researcher-david-gius-md-phd-joins-mays-cancer-center/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/uicc-welcomes-new-president-president-elect-and-board-of-directors-for-2020-2022/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/bloodletting-by-a-phleam/ 2020-10-26T19:10:19+00:00 https://ascopost.com/issues/october-25-2020/preliminary-progress-with-genetically-engineered-t-cells-in-treating-childhood-all/ 2020-11-25T19:06:22+00:00 https://ascopost.com/issues/october-25-2020/personal-testimonial-car-modified-t-cells-in-adults/ 2020-11-25T19:13:31+00:00 https://ascopost.com/issues/october-25-2020/emily-whitehead-celebrates-8-years-cancer-free/ 2020-10-26T20:20:59+00:00 https://ascopost.com/issues/october-25-2020/focus-on-preventing-invasive-recurrence-in-women-with-dcis-does-not-sufficiently-address-breast-cancer-mortality/ 2020-10-26T19:10:20+00:00 https://ascopost.com/issues/october-25-2020/expect-questions-about-increased-cancer-mortality-risk-among-patients-diagnosed-with-dcis/ 2020-10-26T19:10:20+00:00 https://ascopost.com/issues/october-25-2020/continued-benefit-of-first-line-nivolumab-vs-dacarbazine-in-advanced-braf-wild-type-melanoma/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/joan-h-marks-pioneer-in-genetic-counseling-dies-at-91/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/tomas-lyons-dies-at-38/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/remembering-patrick-h-beauregard/ 2020-11-13T18:56:06+00:00 https://ascopost.com/issues/october-25-2020/becoming-acquainted-with-cancer/ 2023-06-23T15:38:20+00:00 https://ascopost.com/issues/october-25-2020/study-examines-combined-impact-of-aspirin-metformin-and-statins-on-lung-cancer-risk/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/shp2-inhibition-may-counter-resistance-mechanisms-in-lung-cancer/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/use-of-ctdna-to-direct-therapy-in-advanced-breast-cancer/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/meta-analysis-of-adjuvant-vs-early-salvage-radiotherapy-in-localized-and-locally-advanced-prostate-cancer/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/long-term-impact-of-adt-in-favorable-vs-unfavorable-intermediate-risk-prostate-cancer/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-25-2020/addition-of-immunotherapy-to-other-treatments-in-patients-with-brain-metastases-after-definitive-surgery/ 2020-10-26T19:10:20+00:00 https://ascopost.com/issues/october-25-2020/association-of-tmb-with-response-to-pembrolizumab-in-previously-treated-patients-with-advanced-solid-tumors/ 2020-10-26T19:10:20+00:00 https://ascopost.com/issues/october-25-2020/survey-shows-many-patients-with-cancer-willing-to-take-part-in-clinical-trials-despite-coronavirus/ 2020-10-26T18:54:26+00:00 https://ascopost.com/issues/october-10-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/october-10-2020/addition-of-abemaciclib-to-endocrine-therapy-reduces-recurrence-in-early-breast-cancer/ 2020-10-09T18:45:58+00:00 https://ascopost.com/issues/october-10-2020/epov-george-sledge/ 2020-10-09T18:43:06+00:00 https://ascopost.com/issues/october-10-2020/mobilizing-for-greater-equity-in-health-care-despite-the-challenges-of-covid-19/ 2020-10-09T20:28:40+00:00 https://ascopost.com/issues/october-10-2020/a-primary-care-physician-explores-barriers-to-cancer-prevention-and-clinical-trial-accrual/ 2020-11-03T21:24:28+00:00 https://ascopost.com/issues/october-10-2020/epov-camillo-porta/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/study-questions-role-of-routine-postoperative-radiotherapy-in-nsclc-with-mediastinal-nodes/ 2020-10-13T18:42:19+00:00 https://ascopost.com/issues/october-10-2020/epov-rafal-dziadziuszko/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/impact-of-adjuvant-osimertinib-on-cns-recurrence-of-nsclc-adaura-trial/ 2020-10-13T17:51:04+00:00 https://ascopost.com/issues/october-10-2020/epov-johan-vansteenkiste/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/total-neoadjuvant-therapy-for-pancreatic-adenocarcinoma/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/long-term-outcomes-with-neoadjuvant-therapy-followed-by-surgery-in-rectal-adenocarcinoma/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/carfilzomib-and-daratumumab-with-dexamethasone-for-relapsed-or-refractory-multiple-myeloma/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/newer-therapeutic-approaches-improving-outcomes-in-hodgkin-lymphoma/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/immunologist-thirumala-devi-kanneganti-receives-nci-outstanding-investigator-award/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/neoadjuvant-therapy-for-borderline-resectable-pancreatic-cancer/ 2020-10-09T18:43:07+00:00 https://ascopost.com/issues/october-10-2020/impassion131-no-benefit-for-atezolizumab-plus-paclitaxel-in-triple-negative-breast-cancer/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/epov-lisa-carey/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/nivolumab-plus-chemotherapy-new-standard-of-care-in-advanced-gastric-cancer/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/epov-elizabeth-smyth/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/debbie-s-dream-foundation-launches-new-covid-19-resources-and-support-program/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/addition-of-nelarabine-to-standard-therapy-improves-disease-free-survival-in-newly-diagnosed-t-cell-all/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/eliminating-routine-opioids-while-maintaining-pain-control-for-women-undergoing-lumpectomy-or-excisional-biopsy/ 2020-10-09T18:59:47+00:00 https://ascopost.com/issues/october-10-2020/rucaparib-produces-durable-responses-in-previously-treated-metastatic-castration-resistant-prostate-cancer/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/impact-of-cytotoxic-chemotherapy-within-5-weeks-of-covid-19-diagnosis-in-patients-with-cancer/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/how-anxiety-depression-and-low-social-support-impact-the-intensity-of-cancer-pain/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/dana-farber-cancer-institute-to-establish-benderson-family-program-for-triple-negative-breast-cancer/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/patricia-keegan-reflects-on-making-a-difference-in-cancer-care/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/pralsetinib-for-nsclc-with-ret-gene-fusions/ 2020-10-09T18:43:08+00:00 https://ascopost.com/issues/october-10-2020/trends-to-watch-in-early-onset-cancer-among-young-adults/ 2020-10-09T20:40:08+00:00 https://ascopost.com/issues/october-10-2020/addition-of-veliparib-to-carboplatinpaclitaxel-in-brca-mutated-advanced-breast-cancer/ 2021-03-12T21:27:08+00:00 https://ascopost.com/issues/october-10-2020/surgical-oncologist-diane-simeone-strives-to-improve-outcomes-for-patients-with-pancreatic-cancer/ 2020-10-19T18:30:46+00:00 https://ascopost.com/issues/october-10-2020/dana-farber-opens-clinical-trial-to-evaluate-simple-blood-test-for-many-types-of-cancer/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/red-flag-presentations-of-immunoglobulin-light-chain-amyloidosis-in-patients-with-multiple-myeloma/ 2020-10-19T16:58:53+00:00 https://ascopost.com/issues/october-10-2020/cancer-centers-nationwide-join-to-address-the-impact-of-covid-19-on-cancer-prevention-and-treatment/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/aacr-releases-10th-edition-of-annual-cancer-progress-report/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/retrospective-analysis-from-the-big-2-98-trial-of-adjuvant-docetaxel-based-chemotherapy-for-early-breast-cancer/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/astragalus/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/dana-farber-researcher-receives-victoria-mock-new-investigator-award/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/the-history-of-geriatric-oncology-1980-2015/ 2020-10-19T16:35:57+00:00 https://ascopost.com/issues/october-10-2020/the-history-of-geriatric-oncology-1980-2015-part-1/ 2020-10-19T16:40:47+00:00 https://ascopost.com/issues/october-10-2020/an-msk-hospitalist-looks-at-oncologists-attitudes-about-inpatient-cancer-care/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/a-leading-light-in-cancer-advances-mary-lasker-used-wealth-and-connections-to-increase-funding-for-medical-research/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/managing-breast-cancer-in-a-pregnant-patient/ 2020-11-20T19:01:14+00:00 https://ascopost.com/issues/october-10-2020/timeless-lessons-from-oncology-fellowship/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/deirdre-j-cohen-md-ms-appointed-director-of-mount-sinai-health-system-s-gi-oncology-program/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/wesley-family-donates-10-million-to-seidman-cancer-center/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/city-of-hope-scientists-explore-combination-immunotherapy-for-solid-tumors/ 2020-10-09T18:43:09+00:00 https://ascopost.com/issues/october-10-2020/a-young-oncologist-cares-for-patients-with-cancer-amid-covid-19-pandemic/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/cedars-sinai-announces-addition-of-new-researchers-physicians-to-faculty/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/ending-systemic-racism-in-oncology-is-everyone-s-responsibility/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/university-of-rochester-school-of-medicine-and-dentistry-names-ruth-o-regan-md-chair-department-of-medicine/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/neck-tumor/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/study-finds-racial-disparities-in-management-of-colorectal-cancer-spreading-to-the-liver/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/2020-class-of-giants-of-cancer-care-announced/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/city-of-hope-hires-stephen-gruber-md-phd-mph-to-head-its-center-for-precision-medicine/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/my-inherited-condition-has-led-to-a-life-and-career-i-love/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/lungevity-foundation-recognizes-recipients-of-2020-career-development-awards/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/adjuvant-chemotherapy-after-pancreatic-cancer-resection-and-neoadjuvant-folfirinox/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/first-line-pd-1-inhibitor-with-or-without-chemotherapy-vs-chemotherapy-alone-in-advanced-gastric-cancer/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/surgery-with-or-without-preoperative-radiotherapy-for-primary-retroperitoneal-sarcoma/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/111-million-nih-grant-awarded-to-prevent-and-treat-hiv-associated-cancers/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/art-of-oncology-on-the-page-and-in-a-podcast/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/conquer-cancer-offers-new-research-grants-targeting-diversity-in-research-underserved-patients/ 2020-10-09T18:43:10+00:00 https://ascopost.com/issues/october-10-2020/bolder-more-aggressive-steps-needed-to-achieve-cancer-care-equity/ 2020-10-09T20:58:20+00:00 https://ascopost.com/issues/october-10-2020/conquer-cancer-announces-2020-quality-care-symposium-merit-awards/ 2020-10-09T18:43:11+00:00 https://ascopost.com/issues/october-10-2020/unique-patient-identifiers-could-help-streamline-nation-s-health-information-technology-infrastructure/ 2020-10-09T20:54:00+00:00 https://ascopost.com/issues/october-10-2020/tell-your-patients-about-asco-s-oncologist-approved-patient-information-website/ 2020-10-09T18:43:11+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/her2-positive-metastatic-breast-cancer-highlights-2019-2020-almanac/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/high-risk-her2-positive-breast-cancer-neoadjuvant-and-adjuvant-treatment-options/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/tucatinib-combination-extends-survival-in-her2-positive-metastatic-breast-cancer-including-patients-with-brain-metastases/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/phase-iii-nala-trial-meets-primary-endpoint-in-previously-treated-her2-positive-breast-cancer/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/neratinib-in-previously-treated-her2-positive-metastatic-breast-cancer/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/abemaciclibfulvestranttrastuzumab-for-patients-with-previously-treated-hr-positive-her2-positive-advanced-breast-cancer/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/phase-iii-sophia-trial-evaluates-margetuximabchemotherapy-vs-trastuzumabchemotherapy-for-her2-positive-breast-cancer/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/epov-ian-krop-angela-demichele-and-carlos-arteaga/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/updates-from-additional-clinical-trials-in-her2-positive-breast-cancer/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/advanced-her2-positive-breast-cancer/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/local-recurrence-with-radiation-boost-in-her2-positive-breast-cancer/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/tucatinib-combination-in-previously-treated-her2-positive-metastatic-breast-cancer-with-brain-metastases/ 2020-10-08T16:34:35+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/emerging-alternatives-in-the-third-line-setting-for-metastatic-her2-positive-breast-cancer/ 2020-10-08T16:34:36+00:00 https://ascopost.com/issues/october-10-2020-supplement-breast-almanac/novel-indications-and-new-drugs-for-the-treatment-of-patients-with-breast-cancer/ 2020-10-08T16:34:36+00:00 https://ascopost.com/issues/september-25-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/september-25-2020/enthusiastic-response-to-novel-therapies-on-the-horizon-in-multiple-myeloma/ 2020-10-19T13:38:53+00:00 https://ascopost.com/issues/september-25-2020/efforts-to-broaden-eligibility-criteria-for-clinical-trials-seek-to-include-more-racial-and-ethnic-minority-patients/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/the-new-face-of-medical-visits/ 2020-09-28T19:20:00+00:00 https://ascopost.com/issues/september-25-2020/dr-kantarjian-shares-his-thoughts-on-optimizing-the-treatment-of-adults-with-all/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/disparities-and-incidence-of-late-effects-of-treatment-for-aya-lymphoma-survivors/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/epov-christopher-flowers/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/cigarette-smoking-associated-with-worse-outcomes-for-patients-with-bladder-cancer-after-surgery/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/applications-of-circulating-tumor-dna-liquid-biopsy-continue-to-expand-in-lymphomas/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/epov-david-scott/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/azacitidine-tablets-for-continued-treatment-in-acute-myeloid-leukemia/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/corticosteroids-improve-survival-in-critically-ill-patients-with-covid-19-according-to-international-trial/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/is-infiltrating-tumor-border-configuration-linked-to-poor-survival-in-colon-adenocarcinoma/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/epov-george-j-chang/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/neoadjuvant-chemotherapy-alone-vs-chemoradiation-in-esophageal-cancer-no-difference-found-in-long-term-survival/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/epov-christopher-anker/ 2020-09-25T18:54:03+00:00 https://ascopost.com/issues/september-25-2020/impact-of-neoadjuvant-endocrine-therapy-and-neoadjuvant-chemotherapy-on-rates-of-breast-conserving-surgery/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/age-at-diagnosis-may-improve-risk-stratification-for-patients-with-breast-cancer/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/avapritinib-produces-high-response-rate-in-advanced-pdgfra-d842v-mutant-gist/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/city-of-hope-leads-novel-clinical-trial-to-treat-patients-with-cancer-and-covid-19/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/sentinel-lymph-node-biopsy-and-age-related-mutations-therapeutic-and-predictive-implications-in-melanoma/ 2020-10-15T19:39:54+00:00 https://ascopost.com/issues/september-25-2020/phase-iii-nala-trial-meets-primary-endpoint-in-previously-treated-her2-positive-breast-cancer/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/neratinib-in-previously-treated-her2-positive-metastatic-breast-cancer/ 2020-09-28T19:32:34+00:00 https://ascopost.com/issues/september-25-2020/new-breast-cancer-agents-and-concurrent-radiation/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/many-reasons-to-geriatricize-your-oncology-practice-research-updates-from-asco20/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/world-gynecologic-oncology-awareness-day/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/national-survey-shows-decline-in-overall-youth-e-cigarette-use-uptick-in-use-of-disposable-products/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/good-outcomes-with-pet-directed-therapy-for-limited-stage-diffuse-large-b-cell-lymphoma/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/pembrolizumab-produces-durable-responses-in-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/effect-of-mammography-screening-from-age-40-on-breast-cancer-mortality-in-the-uk-age-trial/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/addition-of-venetoclax-to-azacitidine-in-acute-myeloid-leukemia/ 2020-10-06T16:04:23+00:00 https://ascopost.com/issues/september-25-2020/nygc-launches-collaborative-cancer-genomics-research-projects-focused-on-underserved-populations/ 2020-09-25T18:54:04+00:00 https://ascopost.com/issues/september-25-2020/updates-on-bcma-directed-car-modified-t-cell-gene-therapies/ 2020-10-19T17:02:10+00:00 https://ascopost.com/issues/september-25-2020/caring-for-undocumented-patients-with-cancer/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/fda-issues-alert-about-efficacy-and-potential-safety-concerns-regarding-atezolizumab-plus-paclitaxel-in-metastatic-triple-negative-breast-cancer/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/brexucabtagene-autoleucel-for-relapsed-or-refractory-mantle-cell-lymphoma/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/irish-boy-with-his-scapula/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/iu-cancer-center-researcher-awarded-grant-to-study-chemotherapy-induced-hearing-loss-toxicities/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/early-cancer-experience-plants-the-seed-for-a-career-in-oncology-to-grow-for-joyce-liu/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/botswana/ 2020-10-08T20:36:27+00:00 https://ascopost.com/issues/september-25-2020/karmanos-receives-catch-up-grant-to-recruit-minority-rural-patients-to-clinical-trials/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/eric-winer-recipient-of-lifetime-achievement-in-mentoring-award/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/combination-immunotherapy-benefits-subset-of-patients-with-advanced-prostate-cancer/ 2020-09-25T18:54:05+00:00 https://ascopost.com/issues/september-25-2020/ezra-greenspan-helped-usher-in-the-modern-era-of-chemotherapy/ 2020-11-20T18:58:33+00:00 https://ascopost.com/issues/september-25-2020/never-say-never/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/i-ve-turned-my-pain-into-a-new-life-purpose/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/covid-19-pandemic-delays-cancer-care-and-strains-resources/ 2020-09-29T13:47:00+00:00 https://ascopost.com/issues/september-25-2020/cancer-center-at-brown-university-established/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/cleveland-clinic-appoints-new-chair-of-head-and-neck-institute/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/leading-cancer-treatment-recommendations-from-nccn-available-in-several-languages/ 2020-09-25T18:46:03+00:00 https://ascopost.com/issues/september-25-2020/fda-approves-oral-azacitidine-as-maintenance-therapy-for-adults-with-aml-in-first-remission/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/nccn-adds-tafasitamab-cxix-to-its-clinical-practice-guidelines-in-oncology-for-b-cell-lymphomas/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/study-finds-recent-onset-diabetes-with-unintentional-weight-loss-linked-to-increased-risk-of-pancreatic-cancer/ 2020-09-29T13:49:52+00:00 https://ascopost.com/issues/september-25-2020/recognizing-the-coexistence-of-symptoms-of-pancreatic-cancer/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/covid-19-prevalence-and-mortality-in-patients-with-cancer-in-the-uk/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/selective-met-inhibitor-tepotinib-in-patients-with-advanced-nsclc-and-met-exon-14-skipping-mutation/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/second-line-carboplatinetoposide-vs-topotecan-in-relapsed-small-cell-lung-cancer/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/sylvester-comprehensive-cancer-center-receives-gift/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/leukemia-lymphoma-society-launches-first-clinical-trial-in-patients-with-hematologic-malignancy-and-covid-19/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/inaugural-aacr-cancer-disparities-progress-report-released/ 2020-09-25T18:54:06+00:00 https://ascopost.com/issues/september-25-2020/cancer-in-my-community-caring-for-children-with-cancer-in-armenia/ 2020-09-25T18:54:07+00:00 https://ascopost.com/issues/september-25-2020/conquer-cancer-collaborates-with-israel-cancer-research-fund-for-career-development-award-in-israel/ 2020-09-25T18:54:07+00:00 https://ascopost.com/issues/september-25-2020/october-cancer-awareness-month-patient-resources-from-asco/ 2020-09-25T18:54:07+00:00 https://ascopost.com/issues/september-25-2020/regional-council-for-a-stronger-society/ 2020-09-25T18:54:07+00:00 https://ascopost.com/issues/september-25-2020/greater-coverage-patient-education-and-research-for-telemedicine-needed-during-the-covid-19-pandemic-and-beyond/ 2020-09-25T18:54:07+00:00 https://ascopost.com/issues/september-25-2020/in-marriage-and-medicine-judith-and-alan-kaur-vow-to-advance-cancer-research/ 2020-09-25T18:54:07+00:00 https://ascopost.com/issues/september-10-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/september-10-2020/nivolumab-plus-ipilimumab-in-first-line-treatment-of-unresectable-malignant-pleural-mesothelioma/ 2020-09-14T02:04:46+00:00 https://ascopost.com/issues/september-10-2020/epov-dean-fennell/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/targeting-kras-mutated-tumors/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/developing-policies-to-address-patient-racial-bias-and-race-based-provider-requests/ 2020-09-28T19:19:46+00:00 https://ascopost.com/issues/september-10-2020/chemotherapy-free-approaches-in-follicular-and-mantle-cell-lymphomas/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/fda-approves-daratumumab-plus-carfilzomib-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/strategies-for-early-detection-and-management-of-lymphedema/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/is-it-time-to-add-checkpoint-inhibitors-to-the-treatment-of-locally-advanced-lung-cancer/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/metastatic-prostate-cancer-sorting-through-the-treatment-maze/ 2023-09-01T19:05:04+00:00 https://ascopost.com/issues/september-10-2020/study-indicates-delaying-antiviral-treatment-may-boost-immunity-in-stem-cell-transplant-recipients/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/orient-11-trial-shows-sintilimab-plus-chemotherapy-improves-progression-free-survival-in-advanced-nsclc/ 2020-09-14T02:06:28+00:00 https://ascopost.com/issues/september-10-2020/epov-misako-nagasaka/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/ensartinib-doubles-progression-free-survival-in-alk-positive-nsclc/ 2020-09-14T02:07:02+00:00 https://ascopost.com/issues/september-10-2020/epov-christine-lovly/ 2020-09-10T19:06:22+00:00 https://ascopost.com/issues/september-10-2020/messino-cancer-centers-founder-receives-north-carolina-governor-s-award/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/tracy-onega-named-senior-director-of-population-sciences-at-huntsman-cancer-institute/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/moffitt-cancer-center-names-patrick-hwu-president-and-chief-executive-officer/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/adjuvant-nivolumab-plus-ipilimumab-vs-nivolumab-alone-in-resected-stage-iv-melanoma-with-no-evidence-of-disease/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/growing-body-of-evidence-supports-adjuvant-immunotherapy-for-stage-iv-melanoma-with-no-evidence-of-disease/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/personalized-medicine-meets-geriatric-oncology-tailoring-oncologic-care-for-older-adults/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/fox-chase-cancer-center-welcomes-robert-brenchak/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/primary-prevention-strategies-for-avoiding-cardiotoxicity-in-patients-with-cancer/ 2023-09-01T19:00:32+00:00 https://ascopost.com/issues/september-10-2020/high-risk-her2-positive-breast-cancer-neoadjuvant-and-adjuvant-treatment-options/ 2020-09-28T19:03:27+00:00 https://ascopost.com/issues/september-10-2020/large-study-finds-no-link-between-antihypertensives-and-cancer/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/profound-trial-evaluates-olaparib-in-homologous-recombination-repair-gene-mutant-prostate-cancer/ 2020-09-17T17:44:10+00:00 https://ascopost.com/issues/september-10-2020/avelumab-in-maintenance-treatment-of-urothelial-carcinoma/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/setting-an-ambitious-path-to-ensure-health-equity-for-all-patients-with-cancer/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/lungevity-fda-launch-lung-cancer-patient-research-project/ 2020-09-10T19:06:23+00:00 https://ascopost.com/issues/september-10-2020/three-scientists-at-johns-hopkins-tapped-to-join-exclusive-research-network/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/atezolizumab-plus-cobimetinibvemurafenib-in-braf-v600-positive-unresectable-or-metastatic-melanoma/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/reevaluating-the-delivery-of-palliative-care-in-the-era-of-covid-19/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/implementation-of-race-for-children-act-helps-address-unmet-needs-of-children-with-cancer/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/fine-tuning-car-t-cell-therapy-for-lymphomas/ 2020-09-15T17:42:18+00:00 https://ascopost.com/issues/september-10-2020/karmanos-receives-630-000-catch-up-grant-to-recruit-minority-rural-patients-to-clinical-trials/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/lymphomas-in-adolescents-and-young-adults-deserve-further-study/ 2020-09-23T18:29:25+00:00 https://ascopost.com/issues/september-10-2020/american-college-of-surgeons-launches-new-cancer-surgery-standards-program-to-improve-quality-of-care/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/how-delays-in-screening-and-early-cancer-diagnosis-amid-the-covid-19-pandemic-may-result-in-increased-cancer-mortality/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/nci-cancer-research-uk-launch-cancer-grand-challenges-partnership/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/challenges-to-providing-appropriate-care-in-the-age-of-covid-19/ 2020-09-10T21:56:33+00:00 https://ascopost.com/issues/september-10-2020/mobilizing-to-meet-challenges-and-improve-survival-for-covid-19-positive-patients-and-health-care-professionals/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/update-on-novel-immunotherapies-for-plasma-cell-disorders/ 2020-09-10T19:06:24+00:00 https://ascopost.com/issues/september-10-2020/leaders-in-radiation-oncology-awarded-astro-fellow-designation/ 2020-09-10T19:06:25+00:00 https://ascopost.com/issues/september-10-2020/cdc-data-show-disproportionate-covid-19-impact-in-american-indian-and-alaska-native-populations/ 2020-09-10T19:06:25+00:00 https://ascopost.com/issues/september-10-2020/a-moment-to-pause-reflect-and-act-amid-a-pandemic/ 2020-09-10T19:06:25+00:00 https://ascopost.com/issues/september-10-2020/how-patients-add-life-to-their-days/ 2020-09-10T19:06:25+00:00 https://ascopost.com/issues/september-10-2020/fitness-based-treatment-of-older-adults-with-multiple-myeloma-who-are-transplant-ineligible/ 2020-09-10T19:06:25+00:00 https://ascopost.com/issues/september-10-2020/dana-farber-launches-new-center-for-prevention-and-treatment-of-brca-related-cancers/ 2020-09-10T19:06:25+00:00 https://ascopost.com/issues/september-10-2020/web-based-tool-may-help-patients-with-cancer-choose-the-best-insurance-for-their-needs/ 2020-09-10T19:06:25+00:00 https://ascopost.com/issues/september-10-2020/oral-combination-of-decitabine-and-cedazuridine-for-myelodysplastic-syndromes/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/belantamab-mafodotin-blmf-for-relapsed-or-refractory-multiple-myeloma/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/from-behind-the-iron-curtain-to-a-career-in-gynecologic-cancer-research-for-daniela-matei-md/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/seattle-cancer-care-alliance-expands-south-lake-union-campus/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/simple-rapid-vinegar-screening-test-cuts-cervical-cancer-death-rates-by-one-third-in-rural-india/ 2020-11-20T18:56:20+00:00 https://ascopost.com/issues/september-10-2020/epov-electra-paskett/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/cervical-cancer-screening-and-prevention-in-low-and-middle-income-countries-2020/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/addition-of-atr-inhibitor-berzosertib-to-gemcitabine-improves-progression-free-survival-in-recurrent-platinum-resistant-high-grade-serous-ovarian-cancer/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/acupuncture-vs-sham-procedure-and-usual-care-for-chemotherapy-induced-peripheral-neuropathy/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/theodore-laetsch-md-joins-children-s-hospital-of-philadelphia-to-launch-very-rare-malignant-tumors-program/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/changes-in-overall-survival-in-patients-with-anaplastic-thyroid-carcinoma-from-2000-2019/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/activity-of-olaparib-and-durvalumab-in-germline-brca-mutated-metastatic-breast-cancer/ 2020-09-12T18:00:06+00:00 https://ascopost.com/issues/september-10-2020/meta-analysis-of-overall-survival-with-immunotherapy-in-patients-with-advanced-cancer-according-to-sex-age-and-performance-status/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/roger-h-herzig-md-pioneer-in-the-treatment-of-leukemia-dies-at-age-74/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/new-chief-of-oncologic-quality-at-rutgersrobert-wood-johnson/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/i-say-yes-to-life/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/asco-position-statement-recommends-specific-actions-for-applying-telemedicine-in-cancer-care-during-pandemic-and-beyond/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/quality-payment-program-provisions-in-fee-schedule-proposal-set-stage-for-2021-and-postpandemic-landscape/ 2020-09-12T18:02:04+00:00 https://ascopost.com/issues/september-10-2020/global-oncology-young-investigator-award/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/doctor-and-a-patient-advocate-team-up-to-conquer-desmoid-tumors/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/marc-citron-establishes-grants-through-conquer-cancer/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020/getting-up-to-speed-on-2021-updates-to-evaluation-and-management-codes/ 2020-09-12T18:07:16+00:00 https://ascopost.com/issues/september-10-2020/educate-patients-at-home-with-asco-answers/ 2020-09-12T18:00:07+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/gynecologic-oncology-highlights-2019-2020-almanac/ 2020-09-29T20:51:13+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/addition-of-olaparib-to-bevacizumab-maintenance-in-advanced-ovarian-cancer-paola-1-trial/ 2020-09-03T17:57:18+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/clinical-perspective-on-paola-1-maintenance-therapy-for-advanced-ovarian-cancer/ 2020-09-03T17:57:18+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/updated-data-from-prima-trial-niraparib-as-first-line-maintenance-therapy-for-advanced-ovarian-cancer/ 2020-09-03T17:57:18+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/epov-thomas-j-herzog/ 2020-09-03T17:57:18+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/novel-drug-approvals-and-new-indications-for-gynecologic-cancers/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/prima-trial-reports-benefit-with-niraparib-across-ovarian-cancer-subsets/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/epov-ana-oaknin/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/veliparib-plus-first-line-chemotherapy-and-as-maintenance-therapy-in-high-grade-ovarian-cancer/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/secondary-surgery-may-extend-survival-in-recurrent-ovarian-cancer/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/epov-robert-coleman/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/final-overall-survival-analysis-from-solo2-in-ovarian-cancer/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/in-women-with-advanced-ovarian-cancer-pembrolizumab-yields-modest-antitumor-efficacy/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/effect-of-statins-on-survival-in-ovarian-cancer/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/cediranib-plus-olaparib-vs-standard-of-care-chemotherapy-for-platinum-sensitive-ovarian-cancer/ 2020-09-03T17:57:19+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/updated-analysis-of-velia-trial-shows-antitumor-activity-in-ovarian-cancer-but-is-it-enough/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/epov-kathleen-moore/ 2020-09-03T17:59:18+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/immunotherapy-in-cervical-and-endometrial-cancers/ 2020-09-03T17:59:18+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/epov-nicoletta-colombo/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/wee1-inhibitor-shows-activity-in-recurrent-uterine-serous-carcinoma/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/epov-shannon-westin/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/gynecologic-oncologist-describes-practice-in-the-era-of-covid-19/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/effect-of-molecular-classification-of-endometrial-cancer-on-outcomes-with-adjuvant-therapy/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/quality-of-life-with-open-vs-minimally-invasive-radical-hysterectomy-for-patients-with-cervical-cancer/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/addition-of-trastuzumab-to-carboplatinpaclitaxel-for-advanced-or-recurrent-her2-positive-uterine-serous-carcinoma/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/lenvatinibpembrolizumab-in-previously-treated-patients-with-advanced-endometrial-cancer/ 2020-09-03T17:57:20+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/higher-risk-of-disease-recurrence-and-death-with-minimally-invasive-vs-open-surgery-for-early-stage-cervical-cancer/ 2020-09-03T17:57:21+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/american-cancer-society-updates-guideline-for-cervical-cancer-screening/ 2020-09-03T17:57:21+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/trophimmun-trial-finds-avelumab-effective-in-rare-gynecologic-tumor-resistant-to-chemotherapy/ 2020-09-03T17:57:21+00:00 https://ascopost.com/issues/september-10-2020-supplement-gynecologic-cancers-almanac/epov-trophimmun/ 2020-09-03T17:57:21+00:00 https://ascopost.com/issues/august-25-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/august-25-2020/novel-tremelimumabdurvalumab-regimen-active-in-advanced-hepatocelluar-carcinoma/ 2020-08-25T15:27:13+00:00 https://ascopost.com/issues/august-25-2020/epov-amit-mahipal/ 2020-08-25T15:27:13+00:00 https://ascopost.com/issues/august-25-2020/past-cms-and-fda-head-discusses-challenges-in-us-health-care-policy-and-possible-solutions/ 2020-08-25T15:30:41+00:00 https://ascopost.com/issues/august-25-2020/pet-therapy-how-the-cat-i-never-wanted-saved-my-life/ 2020-08-25T15:31:13+00:00 https://ascopost.com/issues/august-25-2020/updated-registry-data-confirm-higher-covid-19-related-mortality-in-patients-with-cancer/ 2020-08-25T15:27:13+00:00 https://ascopost.com/issues/august-25-2020/impact-of-immune-checkpoint-inhibitors-on-covid-19-in-patients-with-cancer/ 2020-08-25T15:31:43+00:00 https://ascopost.com/issues/august-25-2020/tumor-mutational-burden-and-the-future-of-complex-biomarkers/ 2020-08-25T15:27:13+00:00 https://ascopost.com/issues/august-25-2020/third-or-later-line-treatment-with-infigratinib-in-patients-with-cholangiocarcinoma-and-fgfr2-fusions/ 2020-08-28T14:28:39+00:00 https://ascopost.com/issues/august-25-2020/fda-approves-tafasitamab-cxix-plus-lenalidomide-to-treat-adults-with-relapsedrefractory-dlbcl/ 2020-08-25T15:27:13+00:00 https://ascopost.com/issues/august-25-2020/fda-approves-atezolizumab-plus-cobimetinibvemurafenib-for-advanced-braf-v600-mutated-melanoma/ 2020-08-25T15:27:14+00:00 https://ascopost.com/issues/august-25-2020/subcutaneous-daratumumab-improves-outcomes-for-patients-with-light-chain-amyloidosis-study-finds/ 2020-08-25T15:27:14+00:00 https://ascopost.com/issues/august-25-2020/epov-taimur-sher/ 2020-08-25T15:27:14+00:00 https://ascopost.com/issues/august-25-2020/asco-provisional-clinical-update-offers-new-recommendations-for-hbv-management-in-patients-with-cancer/ 2020-08-25T15:37:21+00:00 https://ascopost.com/issues/august-25-2020/ripretinib-improves-progression-free-survival-vs-placebo-in-previously-treated-advanced-gist/ 2020-08-25T15:40:24+00:00 https://ascopost.com/issues/august-25-2020/switch-control-inhibitor-for-gists-harboring-drug-resistance-mutations/ 2020-08-25T15:40:58+00:00 https://ascopost.com/issues/august-25-2020/fda-grants-accelerated-approval-to-belantamab-mafodotin-blmf-for-pretreated-patients-with-relapsed-or-refractory-multiple-myeloma/ 2020-08-25T15:27:14+00:00 https://ascopost.com/issues/august-25-2020/repurposing-drugs-for-the-treatment-of-covid-19/ 2020-08-25T15:41:10+00:00 https://ascopost.com/issues/august-25-2020/tafasitamab-cxix-in-the-treatment-of-diffuse-large-b-cell-lymphoma/ 2020-08-25T15:41:49+00:00 https://ascopost.com/issues/august-25-2020/bert-o-malley-jr-named-president-and-chief-executive-officer-of-the-university-of-maryland-medical-center/ 2020-08-25T15:42:10+00:00 https://ascopost.com/issues/august-25-2020/association-of-american-cancer-institutes-to-honor-nobel-laureate-william-g-kaelin-jr-md/ 2020-08-25T15:42:47+00:00 https://ascopost.com/issues/august-25-2020/heather-brandt-to-lead-cancer-prevention-community-outreach-projects-for-st-jude/ 2020-08-25T15:43:43+00:00 https://ascopost.com/issues/august-25-2020/raymond-n-dubois-md-phd-named-director-musc-hollings-cancer-center/ 2020-08-25T15:44:14+00:00 https://ascopost.com/issues/august-25-2020/steven-grossman-named-cancer-physician-in-chief-of-usc-norris-comprehensive-cancer-center/ 2020-08-25T15:44:39+00:00 https://ascopost.com/issues/august-25-2020/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2020-08-25T15:46:01+00:00 https://ascopost.com/issues/august-25-2020/balancing-efficacy-and-safety-of-targeted-therapy-in-breast-cancer-care/ 2020-08-25T15:27:15+00:00 https://ascopost.com/issues/august-25-2020/researchers-outline-need-for-evaluation-of-gene-expression-profiling-in-melanoma/ 2020-08-25T15:47:55+00:00 https://ascopost.com/issues/august-25-2020/the-parker-institute-for-cancer-immunotherapy-appoints-john-connolly-phd-as-chief-scientific-officer/ 2020-08-25T15:48:30+00:00 https://ascopost.com/issues/august-25-2020/addition-of-atezolizumab-to-vemurafenibcobimetinib-in-unresectable-advanced-braf-v600-mutant-melanoma/ 2020-08-25T15:48:55+00:00 https://ascopost.com/issues/august-25-2020/adding-immunotherapy-to-brafmek-inhibition-in-braf-v600-mutant-melanoma-first-step-on-the-journey/ 2020-09-01T13:39:11+00:00 https://ascopost.com/issues/august-25-2020/jae-jung-phd-appointed-chair-of-cleveland-clinic-lerner-research-institute-s-cancer-biology-department/ 2020-08-25T15:49:52+00:00 https://ascopost.com/issues/august-25-2020/acalabrutinib-improves-progression-free-survival-vs-idelalisib-plus-rituximab-or-bendamustine-plus-rituximab-in-relapsed-or-refractory-cll/ 2020-09-23T18:31:24+00:00 https://ascopost.com/issues/august-25-2020/final-ascend-results-confirm-acalabrutinib-as-a-standard-for-relapsed-cll/ 2020-08-25T15:51:11+00:00 https://ascopost.com/issues/august-25-2020/asco-updates-metastatic-pancreatic-cancer-guideline/ 2020-08-25T15:27:16+00:00 https://ascopost.com/issues/august-25-2020/an-expert-qa-on-cancer-disparities-and-health-equity/ 2020-08-25T15:51:51+00:00 https://ascopost.com/issues/august-25-2020/brca-study-clinic-is-saving-men-s-lives-in-israel/ 2020-08-25T15:52:11+00:00 https://ascopost.com/issues/august-25-2020/health-groups-oppose-suspending-immigration-for-health-care-providers-and-family-members/ 2020-08-25T15:53:14+00:00 https://ascopost.com/issues/august-25-2020/into-the-ring-with-tap-cancer-out/ 2020-08-25T15:55:26+00:00 https://ascopost.com/issues/august-25-2020/rural-cancer-care-models-of-success-and-barriers-highlighted-in-new-state-of-cancer-care-in-america-package/ 2020-08-25T15:55:56+00:00 https://ascopost.com/issues/august-25-2020/asco-answers-guide-to-cancer-survivorship/ 2020-08-25T15:57:31+00:00 https://ascopost.com/issues/august-25-2020/how-the-first-international-summit-on-interventional-pharmacoeconomics-is-sparking-discussion-on-reducing-cancer-costs/ 2021-01-18T11:29:34+00:00 https://ascopost.com/issues/august-25-2020/how-to-treat-patients-with-multiple-myeloma-cost-effectively-without-compromising-outcome/ 2020-09-15T17:44:29+00:00 https://ascopost.com/issues/august-25-2020/david-a-karnofsky-s-early-contributions-to-cancer-research-helped-establish-oncology-as-a-medical-discipline/ 2020-08-25T15:58:56+00:00 https://ascopost.com/issues/august-25-2020/molecular-testing-in-metastatic-colorectal-cancer-understanding-how-when-and-what-to-profile/ 2020-08-25T15:27:17+00:00 https://ascopost.com/issues/august-25-2020/update-on-detecting-and-treating-biologically-diverse-neuroendocrine-tumors/ 2020-08-25T15:27:17+00:00 https://ascopost.com/issues/august-25-2020/association-of-community-cancer-centers-announces-2020-innovator-award-recipients/ 2023-09-01T19:11:02+00:00 https://ascopost.com/issues/august-25-2020/mary-claire-king-phd-honored-with-2020-william-l-mcguire-memorial-lecture-award/ 2020-12-12T18:17:14+00:00 https://ascopost.com/issues/august-25-2020/go2-foundation-for-lung-cancer-to-honor-charles-swanton-md-with-the-2020-bonnie-j-addario-lectureship-award/ 2020-08-25T16:01:17+00:00 https://ascopost.com/issues/august-25-2020/managing-cancer-in-older-adults-during-the-covid-19-pandemic/ 2020-08-25T16:02:10+00:00 https://ascopost.com/issues/august-25-2020/penn-medicine-receives-49-million-grant-to-improve-uptake-of-cancer-care-best-practices/ 2020-08-25T16:03:12+00:00 https://ascopost.com/issues/august-25-2020/incidence-and-cancer-related-mortality-in-cambodia/ 2020-09-15T15:43:12+00:00 https://ascopost.com/issues/august-25-2020/ashwagandha/ 2020-09-03T17:34:39+00:00 https://ascopost.com/issues/august-25-2020/after-immigrating-from-india-neha-vapiwala-md-facr-followed-her-dream-of-a-career-in-medicine/ 2020-08-25T16:07:47+00:00 https://ascopost.com/issues/august-25-2020/dana-farber-launches-new-center-for-prevention-and-treatment-of-brca-related-cancers/ 2020-08-25T16:08:08+00:00 https://ascopost.com/issues/august-25-2020/tumeur-fibro-plastique/ 2020-08-25T16:08:47+00:00 https://ascopost.com/issues/august-25-2020/one-in-six-premenopausal-women-with-invasive-breast-cancer-is-nonadherent-to-tamoxifen-therapy/ 2020-08-25T16:09:52+00:00 https://ascopost.com/issues/august-25-2020/anticipate-difficulties-by-patients-in-adhering-to-tamoxifen-therapy/ 2020-08-25T16:10:27+00:00 https://ascopost.com/issues/august-25-2020/cornelius-o-skip-granai-md-champion-of-cancer-care-for-women-dies-at-71/ 2020-08-25T16:10:59+00:00 https://ascopost.com/issues/august-25-2020/gynecologic-cancer-advocate-wendy-noelle-ericsson-dies-at-age-60/ 2020-08-25T16:11:34+00:00 https://ascopost.com/issues/august-25-2020/sanjiv-sam-gambhir-md-phd-pioneer-in-molecular-imaging-dies-at-57/ 2020-08-25T16:12:09+00:00 https://ascopost.com/issues/august-25-2020/two-organizations-collaborate-to-evaluate-the-utility-of-liquid-biopsy-in-treating-lung-cancer/ 2020-08-25T16:12:47+00:00 https://ascopost.com/issues/august-25-2020/roswell-park-care-network-and-oneida-health-name-new-radiation-oncology-medical-director/ 2020-09-03T18:53:59+00:00 https://ascopost.com/issues/august-25-2020/addition-of-locoregional-radiotherapy-to-chemotherapy-for-metastatic-nasopharyngeal-carcinoma/ 2020-08-25T15:27:19+00:00 https://ascopost.com/issues/august-25-2020/second-look-surgery-plus-hipec-vs-surveillance-for-patients-at-high-risk-for-colorectal-peritoneal-metastases/ 2020-08-25T15:27:19+00:00 https://ascopost.com/issues/august-25-2020/nivolumab-and-ipilimumab-in-advanced-biliary-tract-cancers/ 2020-08-25T15:27:19+00:00 https://ascopost.com/issues/august-25-2020/uicc-applauds-who-global-strategy-on-eliminating-cervical-cancer-as-a-public-health-problem/ 2020-08-25T15:27:19+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/genitourinary-oncology-highlights-2019-2020-almanac/ 2020-08-13T02:17:43+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/lutetium-177-labeled-psma-617-improves-psa-response-in-first-analysis-from-therap-trial-in-metastatic-prostate-cancer/ 2020-08-13T02:20:26+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/epov-scott-tagawa/ 2020-08-12T18:51:02+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/in-biochemically-recurrent-prostate-cancer-psma-targeted-petct-imaging-may-be-useful/ 2020-08-13T02:24:17+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/androgen-deprivation-with-oral-relugolix-vs-leuprolide-in-advanced-prostate-cancer/ 2020-08-13T02:26:15+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/final-overall-survival-analysis-of-the-prosper-trial-in-nonmetastatic-castration-resistant-prostate-cancer/ 2020-08-13T02:27:07+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/final-analysis-of-the-aramis-trial-in-men-with-nonmetastatic-castration-resistant-prostate-cancer/ 2020-08-13T02:28:21+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/phase-iii-study-of-ar-antagonist-in-nonmetastatic-castration-resistant-prostate-cancer/ 2020-08-13T02:29:02+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/nonmetastatic-castration-resistant-prostate-cancer/ 2020-08-13T02:33:04+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/phase-ii-triton2-study-in-metastatic-castration-resistant-prostate-cancer/ 2020-08-13T02:36:33+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/titan-trial-apalutamide-adds-to-options-for-men-with-metastatic-hormone-sensitive-prostate-cancer/ 2020-08-13T02:40:00+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/enzalutamide-improves-survival-vs-standard-first-linetreatment-in-hormone-sensitive-metastatic-prostate-cancer/ 2020-08-13T02:44:56+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/many-choices-now-for-men-with-metastatic-hormone-sensitive-prostate-cancer-how-to-decide/ 2020-08-13T02:49:32+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/novel-indications-and-new-drugs-for-castration-resistant-or-castrate-sensitive-prostate-cancer/ 2020-08-12T20:00:30+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/addition-of-apalutamide-to-androgen-deprivation-therapy-in-metastatic-castration-sensitive-prostate-cancer/ 2020-08-13T02:52:50+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/study-supports-pembrolizumab-plus-axitinib-in-previously-untreated-advanced-renal-cell-carcinoma/ 2020-08-13T02:54:08+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/immune-checkpoint-inhibitor-rechallenge-in-metastatic-renal-cell-carcinoma/ 2020-08-13T02:55:12+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/novel-indications-and-new-drugs-for-the-treament-of-patients-with-renal-cell-carcinoma/ 2020-08-12T20:00:31+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/first-line-combination-treatments-improve-outcomes-vs-sunitinib-in-advanced-renal-cell-carcinoma/ 2020-08-13T02:56:34+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/salvage-nivolumab-plus-ipilimumab-after-prior-immune-checkpoint-inhibitor-therapy-in-patients-with-metastatic-rcc/ 2020-08-13T03:00:33+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/maintenance-avelumab-improves-survival-in-advanced-bladder-cancer/ 2020-08-13T03:01:38+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/erdafitinib-in-fgfr-altered-advanced-urothelial-carcinoma/ 2020-08-13T03:04:58+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/early-data-show-activity-for-enfortumab-vedotin-plus-pembrolizumab-in-advanced-bladder-cancer/ 2020-08-13T03:07:13+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/epov-philip-saylor/ 2020-08-12T20:00:32+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/novel-indications-and-new-drugs-for-the-treatment-of-bladder-cancer/ 2021-02-09T23:11:17+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/epov-toni-choueiri/ 2020-08-12T20:00:32+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/switch-maintenance-pembrolizumab-for-metastatic-urothelial-cancer/ 2020-08-13T03:07:51+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/long-term-outcomes-with-pembrolizumab-for-cisplatin-ineligible-advanced-urothelial-cancer/ 2020-08-13T03:08:33+00:00 https://ascopost.com/issues/august-25-2020-supplement-genitourinary-cancers-almanac/first-line-atezolizumab-plus-platinum-based-chemotherapy-vs-chemotherapy-alone-in-advanced-urothelial-cancer/ 2020-08-13T03:09:29+00:00 https://ascopost.com/issues/august-10-2020/ 2021-06-08T17:57:15+00:00 https://ascopost.com/issues/august-10-2020/multiple-lesions-not-a-contraindication-for-cosmetically-acceptable-lumpectomy/ 2020-08-10T20:35:03+00:00 https://ascopost.com/issues/august-10-2020/incorporating-immunotherapy-into-treatment-of-early-stage-nsclc/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/physicians-new-drugs-and-pharma/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/can-radiotherapy-be-omitted-for-some-patients-with-pet-negative-early-stage-unfavorable-hodgkin-lymphoma/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/epov-stephen-ansell/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/pevonedistat-plus-azacitidine-may-be-of-benefit-in-higher-risk-myelodysplastic-syndromes/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/epov-david-sallman/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/novel-treatments-emerge-for-patients-with-lower-risk-myelodysplastic-syndromes/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/epov-david-sallman-1/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/first-line-liposomal-irinotecan-containing-regimen-studied-in-advanced-pancreatic-cancer/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/epov-philip-a-philip/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/ntrk-fusions-in-gastrointestinal-cancers-rare-but-responsive-to-treatment/ 2020-08-10T20:35:04+00:00 https://ascopost.com/issues/august-10-2020/epov-juan-valle/ 2020-08-11T14:21:45+00:00 https://ascopost.com/issues/august-10-2020/sabcs-teams-with-tigerlily-foundation/ 2020-12-12T18:21:54+00:00 https://ascopost.com/issues/august-10-2020/mustafa-raoof-recognized-for-pancreatic-cancer-research/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/anti-tigit-antibody-plus-atezolizumab-move-forward-in-advanced-nsclc/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/epov-michele-teng/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/statin-use-linked-to-improvement-in-survival-in-ovarian-cancer/ 2020-08-17T16:32:20+00:00 https://ascopost.com/issues/august-10-2020/epov-antoni-ribas-and-richard-penson/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/higher-prevalence-of-germline-mutations-identified-in-young-adults-with-cancer/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/nccn-clinical-practice-guidelines-in-oncology-2020-updates/ 2023-09-01T19:15:32+00:00 https://ascopost.com/issues/august-10-2020/fda-approves-brexucabtagene-autoleucel-for-relapsed-or-refractory-mantle-cell-lymphoma/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/updated-asco-guideline-revisits-evidence-on-prevention-and-treatment-of-chemotherapy-induced-neuropathy/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/asco-guideline-supports-continued-use-of-dexamethasone-for-patients-receiving-checkpoint-inhibitors-and-emetogenic-chemotherapy/ 2020-08-10T20:35:05+00:00 https://ascopost.com/issues/august-10-2020/tazemetostat-for-adults-with-relapsed-or-refractory-follicular-lymphoma/ 2020-08-10T20:35:06+00:00 https://ascopost.com/issues/august-10-2020/highlights-of-research-in-lymphomas-presented-during-the-eha25-virtual-congress/ 2020-08-10T20:35:06+00:00 https://ascopost.com/issues/august-10-2020/fixed-dose-subcutaneous-combination-of-pertuzumab-trastuzumab-and-hyaluronidase-zzxf-in-her2-positive-breast-cancer/ 2020-08-10T20:35:06+00:00 https://ascopost.com/issues/august-10-2020/neoadjuvant-atezolizumab-plus-chemotherapy-produces-high-major-and-complete-pathologic-response-rates-in-resectable-nsclc/ 2020-08-10T20:35:06+00:00 https://ascopost.com/issues/august-10-2020/selinexor-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2020-08-10T20:35:06+00:00 https://ascopost.com/issues/august-10-2020/cicero-software-may-enable-detection-of-cancer-causing-gene-fusions/ 2020-08-10T20:35:06+00:00 https://ascopost.com/issues/august-10-2020/american-cancer-society-and-flatiron-health-announce-recipients-of-the-real-world-data-impact-award/ 2020-08-10T20:35:06+00:00 https://ascopost.com/issues/august-10-2020/gemtuzumab-ozogamicin-in-pediatric-patients-with-newly-diagnosed-cd33-positive-aml/ 2020-08-10T20:42:21+00:00 https://ascopost.com/issues/august-10-2020/a-pioneering-neurosurgeon-shares-hard-earned-wisdom-gained-along-the-road-from-the-segregated-south/ 2020-08-10T20:49:36+00:00 https://ascopost.com/issues/august-10-2020/jonathan-w-friedberg-md-mmsc-named-next-editor-in-chief-of-the-journal-of-clinical-oncology/ 2020-08-10T20:42:21+00:00 https://ascopost.com/issues/august-10-2020/nrg-oncology-biospecimen-bank-awarded-nci-funding-for-next-6-years/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/pembrolizumab-for-first-line-treatment-of-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/fda-approves-pembrolizumab-for-adults-and-children-with-tmb-h-solid-tumors/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/anthony-fauci-explores-what-we-know-about-covid-19-and-what-s-being-done-to-combat-it/ 2020-08-19T19:15:51+00:00 https://ascopost.com/issues/august-10-2020/nci-funds-studies-of-impact-of-telehealth-and-telemedicine-capacity-for-rural-patients-amid-covid-19-pandemic/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/cleveland-clinic-cancer-center-oncologists-earn-national-recognition-as-institution-expands-staff/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/florida-cancer-specialists-appoints-new-chief-executive-officer/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/new-effort-to-address-health-disparities-for-black-men/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/top-scientists-share-early-research-on-intersection-of-covid-19-and-cancer-care-at-aacr-virtual-meeting/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/asco-and-accc-join-forces-to-increase-participation-of-racial-and-ethnic-minority-populations-in-cancer-treatment-trials/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/stand-up-to-cancer-announces-new-research-and-education-effort-to-improve-care-for-underserved-patients-with-lung-cancer/ 2020-08-10T20:42:22+00:00 https://ascopost.com/issues/august-10-2020/managing-anxiety-in-older-adults-with-cancer/ 2020-10-01T17:58:51+00:00 https://ascopost.com/issues/august-10-2020/yoram-unguru-explains-the-economic-origins-of-drug-shortages-and-other-ethical-issues/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/snmmi-names-alan-packard-as-president-and-richard-wahl-as-president-elect/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/fred-hutch-announces-new-additions-and-leadership-to-board-of-trustees/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/gita-suneja-holds-community-service-in-high-esteem/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/memorial-sloan-kettering-launches-women-in-science-endeavor/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/measuring-the-impact-of-the-plunge-in-cancer-screenings-during-the-covid-19-pandemic/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/juanita-merchant-appointed-to-ludwig-institute-s-scientific-advisory-committee/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/geraldine-jacobson-elected-as-future-chair-of-astro/ 2020-08-10T20:42:23+00:00 https://ascopost.com/issues/august-10-2020/huntsman-cancer-institute-brings-home-cancer-care-to-rural-utah/ 2020-08-10T20:42:24+00:00 https://ascopost.com/issues/august-10-2020/edward-chu-to-lead-cancer-medicine-at-albert-einstein-college-of-medicine-and-montefiore-health-system/ 2020-08-10T20:42:24+00:00 https://ascopost.com/issues/august-10-2020/roswell-park-gynecologic-oncologists-awarded-leadership-roles/ 2020-08-10T20:42:24+00:00 https://ascopost.com/issues/august-10-2020/improving-communication-skills-for-oncology-clinicians-during-the-covid-pandemic/ 2020-08-10T20:42:24+00:00 https://ascopost.com/issues/august-10-2020/national-comprehensive-cancer-network-celebrates-its-25th-year/ 2020-08-10T20:42:24+00:00 https://ascopost.com/issues/august-10-2020/nccn-member-institutions/ 2020-08-10T20:42:24+00:00 https://ascopost.com/issues/august-10-2020/lost-in-translation-a-fisherman-s-tale/ 2020-09-23T01:52:53+00:00 https://ascopost.com/issues/august-10-2020/jimmie-holland-s-research-has-long-underscored-the-importance-of-caring-for-the-whole-patient/ 2020-08-10T20:42:24+00:00 https://ascopost.com/issues/august-10-2020/translated-tool-from-nccn-measures-mental-health-temperature-of-people-with-cancer/ 2020-09-23T01:57:33+00:00 https://ascopost.com/issues/august-10-2020/overcoming-the-challenges-of-improving-psychosocial-care-for-patients-with-cancer/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/fox-chase-cancer-center-welcomes-new-staff-members/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/flossie-wong-staal-molecular-biologist-who-uncovered-the-secrets-of-human-immunodeficiency-virus-dies-at-73/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/pembrolizumab-for-cutaneous-squamous-cell-carcinoma/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/a-health-care-journalist-explores-breast-cancer-in-america-through-the-lens-of-her-own-diagnosis/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/having-cancer-has-not-affected-me-in-any-negative-way/ 2020-08-10T19:55:03+00:00 https://ascopost.com/issues/august-10-2020/pembrolizumab-for-advanced-melanoma-impact-of-braf-mutation-status-and-prior-therapy-regimens/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/potential-association-of-impaired-spermatogenesis-and-immune-checkpoint-inhibitor-therapy-in-patients-with-metastatic-melanoma/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/addition-of-capecitabine-to-t-dm1-in-previously-treated-patients-with-her2-positive-metastatic-breast-cancer/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/10-year-study-indicates-pembrolizumab-provides-long-term-benefits-for-patients-with-metastatic-melanoma/ 2020-08-10T20:42:25+00:00 https://ascopost.com/issues/august-10-2020/asco-special-report-resuming-cancer-care-delivery-during-the-covid-19-pandemic/ 2020-08-10T20:42:26+00:00 https://ascopost.com/issues/august-10-2020/conquer-cancer-donors-provide-key-resources-for-patients-and-providers-during-the-covid-19-pandemic/ 2020-08-10T20:42:26+00:00 https://ascopost.com/issues/august-10-2020/asco-conducting-open-search-for-chief-medical-officer/ 2020-08-10T20:42:26+00:00 https://ascopost.com/issues/august-10-2020/cms-cmmi-announce-flexibilities-for-oncology-practices-impacted-by-covid-19/ 2020-08-10T20:42:26+00:00 https://ascopost.com/issues/august-10-2020/managing-the-cost-of-cancer-care-can-be-overwhelming/ 2020-08-10T20:42:26+00:00 https://ascopost.com/issues/july-25-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/july-25-2020/nivolumabipilimumab-shows-benefit-in-patients-with-non-small-cell-lung-cancer-and-brain-metastases/ 2020-07-28T20:19:22+00:00 https://ascopost.com/issues/july-25-2020/the-need-for-solid-data-during-a-global-pandemic/ 2020-07-24T16:33:29+00:00 https://ascopost.com/issues/july-25-2020/monumental-progress-in-the-treatment-of-diffuse-large-b-cell-lymphoma/ 2020-07-24T19:58:42+00:00 https://ascopost.com/issues/july-25-2020/can-radiomics-predict-survival-in-patients-with-nsclc-receiving-immunotherapy/ 2020-07-28T18:52:02+00:00 https://ascopost.com/issues/july-25-2020/epov-john-minna/ 2020-07-24T16:33:29+00:00 https://ascopost.com/issues/july-25-2020/ctdna-clearance-predicts-progression-free-survival-with-osimertinibsavolitinib-in-egfr-mutant-met-amplified-nsclc/ 2020-07-28T20:20:04+00:00 https://ascopost.com/issues/july-25-2020/epov-alexander-drilon/ 2020-07-24T16:33:29+00:00 https://ascopost.com/issues/july-25-2020/aacr-holds-covid-19-and-cancer-virtual-meeting/ 2020-07-24T16:33:29+00:00 https://ascopost.com/issues/july-25-2020/astro-to-host-virtual-annual-meeting-october-25-28-2020/ 2020-07-24T16:33:29+00:00 https://ascopost.com/issues/july-25-2020/small-study-evaluates-neoadjuvant-vs-adjuvant-nivolumab-plus-ipilimumab-in-stage-iii-melanoma/ 2020-08-06T19:14:10+00:00 https://ascopost.com/issues/july-25-2020/epov-ahmad-tarhini-and-larisa-geskin/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/double-pik3ca-mutations-and-response-benefit-in-breast-cancer/ 2020-07-29T19:56:08+00:00 https://ascopost.com/issues/july-25-2020/viale-a-trial-supports-survival-benefit-of-venetoclax-plus-azacitidine-in-elderly-patients-with-aml/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/epov-alice-mims/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/combination-of-isatuximab-carfilzomib-and-dexamethasone-reduces-risk-of-disease-progression-in-myeloma/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/epov-craig-hofmeister/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/quick-takes-on-novel-therapies-for-solid-and-hematologic-malignancies/ 2020-07-29T17:51:48+00:00 https://ascopost.com/issues/july-25-2020/fda-approves-oral-combination-of-decitabine-and-cedazuridine-for-adult-patients-with-mds/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/marilyn-j-heine-md-facep-facp-fcpp-elected-ama-council-on-legislation-chair/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/when-paired-with-palbociclib-fulvestrant-and-letrozole-yield-comparable-results-in-parsifal-trial/ 2020-07-29T19:10:57+00:00 https://ascopost.com/issues/july-25-2020/epov-komal-jhaveri/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/fda-approves-maintenance-avelumab-for-the-treatment-of-advanced-urothelial-carcinoma/ 2020-07-24T16:33:30+00:00 https://ascopost.com/issues/july-25-2020/robert-winn-md-joins-lungevity-foundation-s-board-of-directors/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/pada-1-trial-examines-the-impact-of-esr1-mutations-in-metastatic-breast-cancer/ 2020-07-29T19:09:41+00:00 https://ascopost.com/issues/july-25-2020/epov-erika-hamilton-and-nikhil-wagle/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/swog-s1505-trial-evaluates-neoadjuvant-regimens-in-pancreatic-cancer/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/epov-marcus-noel-and-susan-tsai/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/nivolumab-in-previously-treated-esophageal-squamous-cell-carcinoma/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/new-guideline-for-locally-advanced-esophageal-cancer-supports-multimodality-therapy-and-multidisciplinary-treatment/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/pembrolizumab-for-adult-and-pediatric-patients-with-tumor-mutational-burden-high-solid-tumors/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/expanded-access-to-cancer-drugs-in-africa-and-asia/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/two-cohort-studies-identify-risk-factors-for-mortality-in-patients-with-cancer-and-covid-19/ 2020-07-24T16:33:31+00:00 https://ascopost.com/issues/july-25-2020/bishal-gyawali-receives-young-health-researcher-award-from-nepali-government/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/esmo-names-george-pentheroudakis-new-chief-medical-officer/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/perlmutter-cancer-center-welcomes-janice-mehnert-as-associate-director-for-clinical-research/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/yang-shi-appointed-member-of-ludwig-institute-for-cancer-research/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/blood-cancer-discoveries-program-names-grant-recipients/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/yale-cancer-center-awarded-nih-spore-renewal-for-lung-cancer-research/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/the-importance-of-measuring-health-related-quality-of-life-in-older-adults/ 2020-07-24T16:16:01+00:00 https://ascopost.com/issues/july-25-2020/joann-sweasy-named-director-of-university-of-arizona-cancer-center/ 2020-08-10T20:00:16+00:00 https://ascopost.com/issues/july-25-2020/fox-chase-cancer-center-welcomes-two-new-staff-members/ 2020-07-24T16:16:01+00:00 https://ascopost.com/issues/july-25-2020/usc-norris-comprehensive-cancer-center-receives-5-million-for-cancer-drug-discoveries/ 2020-07-24T16:16:01+00:00 https://ascopost.com/issues/july-25-2020/addition-of-rituximab-to-standard-chemotherapy-improves-efs-and-os-in-children-with-high-risk-mature-b-cell-non-hodgkin-lymphoma/ 2020-07-24T20:00:15+00:00 https://ascopost.com/issues/july-25-2020/role-of-rituximab-in-the-treatment-of-children-and-adolescents-with-mature-b-cell-non-hodgkin-lymphoma/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/leading-organizations-release-new-clinical-guideline-on-advanced-prostate-cancer/ 2020-07-24T19:14:55+00:00 https://ascopost.com/issues/july-25-2020/lurbinectedin-in-previously-treated-metastatic-small-cell-lung-cancer/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/cultivating-emotional-equanimity/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/uspstf-issues-draft-recommendation-statement-on-screening-for-lung-cancer/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/lasalle-leffall-jr-promotes-hard-work-and-education-to-overcome-boundaries/ 2020-07-24T16:33:32+00:00 https://ascopost.com/issues/july-25-2020/carolyn-anderson-receives-snmmi-2020-paul-c-aebersold-award/ 2020-08-11T18:36:54+00:00 https://ascopost.com/issues/july-25-2020/yale-names-markus-mueschen-inaugural-director-of-center-of-molecular-and-cellular-oncology/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/a-diagnosis-of-advanced-lung-cancer-is-no-longer-a-death-sentence/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/the-wake/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/first-line-osimertinibbevacizumab-for-metastatic-egfr-mutant-lung-cancer/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/addition-of-an-atr-inhibitor-to-gemcitabine-in-platinum-resistant-high-grade-serous-ovarian-cancer/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/personal-steps-toward-racial-equity-in-oncology/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/marcella-nunez-smith-named-director-of-center-for-community-engagement-and-health-equity-for-yale-cancer-center-and-smilow-cancer-hospital/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/if-you-have-self-doubt-when-caring-for-a-loved-one-with-cancer/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/small-goals-big-victories/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/mark-lewis-md-and-jonathan-bleeker-md-reflect-in-from-every-angle/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/palliative-care-resource-for-your-patients-from-asco/ 2020-07-24T16:33:33+00:00 https://ascopost.com/issues/july-25-2020/responding-to-racism-and-health-inequality-as-a-cancer-care-community/ 2020-07-24T20:05:30+00:00 https://ascopost.com/issues/july-25-2020/asco-s-cancerlinq-launches-the-smartlinq-qopi-certification-pathway/ 2020-07-24T16:33:34+00:00 https://ascopost.com/issues/july-25-2020/new-updated-asco-elearning-courses-put-oncology-education-at-your-fingertips/ 2020-07-24T16:33:34+00:00 https://ascopost.com/issues/july-10-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/july-10-2020/responses-achieved-with-belantamab-mafodotin-in-relapsed-or-refractory-myeloma/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/epov-philip-mccarthy/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/geriatric-assessment-what-are-you-waiting-for/ 2020-07-10T18:14:26+00:00 https://ascopost.com/issues/july-10-2020/imbrave150-trial-atezolizumab-plus-bevacizumab-improves-survival-in-unresectable-hcc/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/pembrolizumab-plus-axitinib-in-previously-untreated-advanced-renal-cell-carcinoma/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/epov-toni-choueiri/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/roundup-of-high-impact-studies-in-early-breast-cancer/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/elotuzumab-fails-to-add-benefit-in-newly-diagnosed-high-risk-myeloma/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/epov-suzanne-lentzsch-and-joshua-richter/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/fda-extends-indication-of-gemtuzumab-ozogamicin-for-pediatric-patients-with-cd33-positive-aml/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/fda-approves-nine-valent-hpv-vaccine-for-the-prevention-of-certain-hpv-related-head-and-neck-cancers/ 2020-07-10T17:18:59+00:00 https://ascopost.com/issues/july-10-2020/jessica-karen-wong-joins-radiation-oncology-department-at-fox-chase/ 2020-07-10T17:19:00+00:00 https://ascopost.com/issues/july-10-2020/two-studies-validate-neoadjuvant-chemotherapy-with-short-course-radiotherapy-or-long-term-chemoradiotherapy-in-locally-advanced-rectal-cancer/ 2020-07-31T17:04:40+00:00 https://ascopost.com/issues/july-10-2020/epov-christopher-hallemeier/ 2020-07-10T17:19:00+00:00 https://ascopost.com/issues/july-10-2020/fda-grants-accelerated-approval-to-lurbinectedin-for-metastatic-sclc/ 2020-07-10T17:19:00+00:00 https://ascopost.com/issues/july-10-2020/two-studies-report-secondary-surgery-extends-survival-in-recurrent-ovarian-cancer/ 2020-07-10T17:19:00+00:00 https://ascopost.com/issues/july-10-2020/epov-robert-coleman/ 2020-07-10T17:19:00+00:00 https://ascopost.com/issues/july-10-2020/rucaparib-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/novel-androgen-deprivation-therapy-with-relugolix-causes-fewer-cardiac-events-than-leuprolide-in-advanced-prostate-cancer/ 2020-07-20T19:40:30+00:00 https://ascopost.com/issues/july-10-2020/epov-david-wise-and-celestia-higano/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/adoptive-cell-therapy-with-tumor-infiltrating-lymphocytes-proves-active-in-refractory-metastatic-melanoma/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/epov-ryan-sullivan/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/fda-collaborating-on-use-of-real-world-data-to-inform-covid-19-response-effort/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/imbrave150-a-new-standard-of-care-to-treat-hepatocellular-cancers/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/atezolizumab-plus-bevacizumab-for-unresectable-or-metastatic-hepatocellular-carcinoma/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/new-recommendations-offer-guidance-for-clinicians-and-patients-on-genetic-testing-for-prostate-cancer/ 2020-07-20T19:47:37+00:00 https://ascopost.com/issues/july-10-2020/young-adults-with-cancer-may-harbor-germline-mutations-and-benefit-from-germline-genetic-testing/ 2020-07-10T17:48:59+00:00 https://ascopost.com/issues/july-10-2020/personalized-rna-based-vaccineatezolizumab-combination-produces-immune-response/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/epov-lynn-schuchter-and-ravi-salgia/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/survival-disparities-seen-in-hispanic-patients-with-blood-cancers-living-near-the-united-statesmexico-border/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/real-world-data-show-survival-benefit-for-adjuvant-immunotherapy-in-stage-iii-melanoma/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/prolonged-overall-survival-with-autologous-allogeneic-vs-tandem-autologous-transplant-in-newly-diagnosed-myeloma/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/do-not-rush-to-high-dose-twice-daily-radiation-for-limited-small-cell-lung-cancer/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/kunle-odunsi-elected-at-large-director-of-sitc-board-of-directors/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/fda-approves-pembrolizumab-for-the-first-line-treatment-of-msi-hdmmr-colorectal-cancer/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/fda-approves-selinexor-for-relapsed-or-refractory-dlbcl/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/fda-approves-combination-of-pertuzumab-trastuzumab-and-hyaluronidase-zzxf-for-her2-positive-breast-cancer/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/international-consortium-aims-to-enhance-decision-making-in-hodgkin-lymphoma/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/black-patient-representation-in-different-types-of-clinical-trials/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/fda-grants-accelerated-approval-to-tazemetostat-for-some-patients-with-follicular-lymphoma/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/pembrolizumab-trastuzumab-and-chemotherapy-in-her2-positive-metastatic-esophagogastric-cancer/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/first-line-stereotactic-radiosurgery-vs-whole-brain-radiotherapy-for-sclc-brain-metastases/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/fda-announces-project-patient-voice-to-communicate-patient-reported-outcomes-from-cancer-clinical-trials/ 2020-07-10T17:49:00+00:00 https://ascopost.com/issues/july-10-2020/addressing-discrimination-and-bias-in-medical-education/ 2020-07-10T17:49:01+00:00 https://ascopost.com/issues/july-10-2020/society-for-immunotherapy-of-cancer-names-recipients-of-memorial-award-and-lectureship/ 2020-07-10T17:49:01+00:00 https://ascopost.com/issues/july-10-2020/insomnia-in-adolescent-and-young-adult-cancer-survivors/ 2020-07-10T17:49:01+00:00 https://ascopost.com/issues/july-10-2020/eha25-virtual-roundup-of-findings-in-leukemia-lymphoma-and-more/ 2020-07-13T13:55:28+00:00 https://ascopost.com/issues/july-10-2020/new-nccn-guidelines-offer-patients-help-in-recognizing-side-effects-from-immunotherapy/ 2020-07-13T13:55:28+00:00 https://ascopost.com/issues/july-10-2020/glenn-d-steele-jr-md-phd-named-chair-of-city-of-hope-board-of-directors/ 2020-07-13T13:55:28+00:00 https://ascopost.com/issues/july-10-2020/go2-foundation-for-lung-cancer-unifies-to-drive-change/ 2020-07-13T13:55:28+00:00 https://ascopost.com/issues/july-10-2020/improving-the-quality-of-care-and-research-for-patients-with-cancer-and-the-ethics-behind-its-delivery/ 2020-07-13T13:55:28+00:00 https://ascopost.com/issues/july-10-2020/understanding-the-underlying-mechanisms-of-pain-in-patients-with-cancer/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/a-visiting-resident-oncologist-s-training-during-the-covid-19-pandemic/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/a-new-website-offers-support-for-adolescent-and-young-adults-with-cancer-during-the-covid-19-pandemic/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/daratumumab-and-hyaluronidase-fihj-for-multiple-myeloma/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/her-grandfather-s-medical-practice-inspired-nathalie-levasseur-md-bsc-frcpc-to-improve-the-lives-of-women-with-breast-cancer/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/nivolumab-plus-ipilimumab-in-two-new-lung-cancer-indications/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/phase-ii-study-evaluates-chemotherapy-and-immunotherapy-in-patients-with-malignant-pleural-mesothelioma/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/lung-cancer-research-foundation-names-trudy-oliver-phd-to-its-scientific-advisory-board/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/aacr-recognizes-new-2019-2020-research-grantees/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/brian-j-bolwel-ultimately-takes-the-reins-at-the-taussig-cancer-institute/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/aacr-recognizes-achievements-of-three-cancer-researchers/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/a-palliative-care-specialist-explores-what-it-means-to-live-and-die-with-dignity-and-purpose/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/the-21st-century-cures-act-a-look-back-a-look-ahead/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/nccn-working-group-policy-recommendations/ 2020-07-13T13:55:29+00:00 https://ascopost.com/issues/july-10-2020/elderberry/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/cancer-genome-atlas-founding-members-and-current-project-team-awarded-2020-aacr-team-science-awards/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/a-doctor-battles-a-deadly-disease-and-turns-hope-into-action/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/the-piano/ 2020-07-29T20:47:48+00:00 https://ascopost.com/issues/july-10-2020/atezolizumab-as-first-line-treatment-of-metastatic-nsclc-with-high-pd-l1-expression-and-no-egfr-or-alk-aberrations/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/new-james-cancer-diagnostic-center-to-expedite-access-to-diagnostic-testing/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/oscar-colegio-dies-at-47/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/beth-levine-renowned-doctor-and-researcher-dies/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/neil-spector-physician-scientist-dies-at-63/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/charles-l-sawyers-md-faacr-voted-aacr-academy-president-elect-for-2020-2021/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/benjamin-f-cravatt-receives-award-for-outstanding-achievement-in-chemistry-in-cancer-research/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/christopher-i-amos-receives-award-for-research-excellence-in-cancer-epidemiology-and-prevention/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/patricia-s-steeg-phd-receives-women-in-cancer-research-charlotte-friend-lectureship/ 2020-07-13T13:55:30+00:00 https://ascopost.com/issues/july-10-2020/higher-risk-of-disease-recurrence-and-death-with-minimally-invasive-vs-open-surgery-for-early-stage-cervical-cancer/ 2020-07-10T17:55:07+00:00 https://ascopost.com/issues/july-10-2020/expect-questions-about-minimally-invasive-surgery-for-early-stage-cervical-cancer/ 2020-07-10T17:55:07+00:00 https://ascopost.com/issues/july-10-2020/facing-death-and-appreciating-life/ 2020-07-10T17:55:07+00:00 https://ascopost.com/issues/july-10-2020/asco-opens-search-for-chief-medical-officer/ 2020-07-10T17:55:07+00:00 https://ascopost.com/issues/july-10-2020/2020-asco-presidential-address/ 2020-07-10T17:55:07+00:00 https://ascopost.com/issues/july-10-2020/guidance-available-on-telemedicine-coverage-during-covid-19-pandemic/ 2020-07-10T22:39:34+00:00 https://ascopost.com/issues/july-10-2020/asco-covid-19-registry/ 2020-07-10T22:42:15+00:00 https://ascopost.com/issues/july-10-2020/conquer-cancer-grants-more-than-8-million-to-cancer-research/ 2020-07-10T17:55:07+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/conference-highlights-from-the-asco20-virtual-scientific-program/ 2020-07-07T19:42:44+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/disease-free-survival-in-early-stage-egfr-positive-nsclc-improved-by-adjuvant-osimertinib/ 2020-07-07T19:42:44+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-lecia-sequist/ 2020-07-07T20:17:22+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/advanced-bladder-cancer-survival-improved-with-maintenance-avelumab/ 2020-07-07T19:42:44+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-jonathan-rosenberg/ 2020-07-07T19:42:44+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/rates-of-progression-free-survival-in-msi-hdmmr-metastatic-colorectal-cancer-doubled-by-pembrolizumab/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-axel-grothey/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/outcomes-in-newly-diagnosed-multiple-myeloma-unimproved-by-carfilzomib-triplet-vs-standard-bortezomib-based-regimen/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-jesús-berdeja/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/no-survival-benefit-from-local-therapy-in-de-novo-metastatic-breast-cancer-study/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/belantamab-mafodotin-shows-activity-in-relapsed-or-refractory-myeloma/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-philip-mccarthy/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/pembrolizumab-improves-pfs-vs-brentuximab-vedotin-in-patients-with-relapsedrefractory-classical-hodgkin-lymphoma/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/phase-iii-boston-study-finds-selinexor-improves-outcomes-in-myeloma/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/first-line-nivolumab-plus-ipilimumab-shows-activity-in-nsclc-with-or-without-chemotherapy/ 2020-07-07T19:42:45+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-scott-gettinger/ 2020-07-07T19:42:46+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/tucatinib-combination-in-previously-treated-her2-positive-metastatic-breast-cancer-with-brain-metastases/ 2020-07-07T19:42:46+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/alpelisib-deemed-effective-in-advanced-breast-cancer-after-treatment-with-cdk46-inhibitor/ 2020-07-07T19:42:46+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/for-patients-with-early-stage-cervical-cancer-sentinel-lymph-node-biopsy-declared-oncologically-safe/ 2020-07-07T19:42:46+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/avelumab-shown-effective-in-rare-chemotherapy-resistant-gynecologic-tumor-in-trophimmun-trial/ 2020-07-07T19:42:46+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-trophimmun/ 2020-07-07T19:42:47+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/maintenance-olaparib-shows-overall-survival-benefit-in-ovarian-cancer/ 2020-07-08T18:05:07+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-don-dizon/ 2020-07-07T20:05:20+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/final-analysis-of-phase-ii-trial-in-recurrent-platinum-sensitive-ovarian-cancer/ 2020-07-07T20:05:20+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/savolitinib-vs-sunitinib-in-met-driven-papillary-renal-cell-carcinoma/ 2020-07-07T20:05:20+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/psma-targeted-petct-imaging-may-be-useful-in-biochemically-recurrent-prostate-cancer/ 2020-07-07T20:05:20+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/epov-scott-tagawa/ 2020-07-07T20:05:20+00:00 https://ascopost.com/issues/july-10-2020-supplement-conference-highlights-asco20-virtual-scientific-program/longer-term-results-of-pivotal-study-in-advanced-cutaneous-squamous-cell-carcinoma/ 2020-07-07T20:05:21+00:00 https://ascopost.com/issues/june-25-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/june-25-2020/first-line-pembrolizumab-added-to-standard-chemotherapy-improved-progression-free-survival-in-extensive-stage-small-cell-lung-cancer/ 2020-06-25T18:06:43+00:00 https://ascopost.com/issues/june-25-2020/epov-taofeek-kunie-owonikoko/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/responding-to-racism-and-health-inequality-as-a-cancer-care-community/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/repeat-breast-preservation-first-consideration-in-a-second-ipsilateral-breast-tumor-event/ 2020-06-26T14:12:40+00:00 https://ascopost.com/issues/june-25-2020/carfilzomib-triplet-fails-to-improve-outcomes-vs-standard-bortezomib-based-regimen-in-newly-diagnosed-myeloma/ 2020-06-26T21:07:00+00:00 https://ascopost.com/issues/june-25-2020/epov-jesús-berdeja/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/study-finds-no-survival-benefit-from-local-therapy-for-de-novo-metastatic-breast-cancer/ 2020-06-26T21:10:08+00:00 https://ascopost.com/issues/june-25-2020/epov-julia-white/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/asco20-virtual-scientific-program-convened-record-number-of-oncology-professionals-from-across-the-globe/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/in-biochemically-recurrent-prostate-cancer-psma-targeted-petct-imaging-may-be-useful/ 2020-06-26T21:15:04+00:00 https://ascopost.com/issues/june-25-2020/epov-scott-tagawa/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/lutetium-177-labeled-psma-617-improves-psa-response-in-first-analysis-from-therap-trial-in-metastatic-prostate-cancer/ 2020-06-26T21:14:21+00:00 https://ascopost.com/issues/june-25-2020/epov-scott-tagawa-1/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/geriatric-assessment-driven-intervention-benefits-older-adults-with-cancer/ 2020-06-25T18:09:22+00:00 https://ascopost.com/issues/june-25-2020/northwell-health-cancer-institute-of-new-york-appoints-oncology-experts-to-lead-new-programs/ 2020-06-25T18:06:44+00:00 https://ascopost.com/issues/june-25-2020/newer-late-line-treatments-may-change-front-line-standard-of-care-in-her2-positive-metastatic-breast-cancer/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/epov-antonio-llombart-cussac/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/early-data-suggest-activity-for-oral-selective-estrogen-receptor-degrader-in-combination-regimen/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/benefit-shown-for-akt-inhibitor-in-lotus-survival-analysis/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/epov-suzette-delaloge/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/role-of-race-ethnicity-and-region-in-mortality-among-pediatric-patients-with-cancer-admitted-to-the-icu/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/ripretinib-in-previously-treated-advanced-gastrointestinal-stromal-tumor/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/olaparib-for-homologous-recombination-repair-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/improving-care-for-women-with-late-stage-breast-cancer/ 2020-08-05T01:31:12+00:00 https://ascopost.com/issues/june-25-2020/men-of-color-remain-underrepresented-in-prostate-cancer-clinical-trials/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/ramucirumab-plus-erlotinib-in-treatment-of-egfr-mutant-metastatic-nsclc/ 2020-06-25T18:06:45+00:00 https://ascopost.com/issues/june-25-2020/acalabrutinib-with-or-without-obinutuzumab-vs-chlorambucilobinutuzumab-in-previously-untreated-cll/ 2020-06-30T16:28:07+00:00 https://ascopost.com/issues/june-25-2020/ruxolitinib-improves-response-rates-in-glucocorticoid-refractory-acute-graft-vs-host-disease-after-allogeneic-sct/ 2020-06-25T18:10:15+00:00 https://ascopost.com/issues/june-25-2020/asco-survey-on-early-impact-of-covid-19-on-performance-of-oncology-clinical-trials/ 2020-06-25T18:12:09+00:00 https://ascopost.com/issues/june-25-2020/positive-findings-in-nsclc-for-first-line-nivolumab-plus-ipilimumab-with-or-without-chemo/ 2020-06-25T18:06:46+00:00 https://ascopost.com/issues/june-25-2020/epov-scott-gettinger/ 2020-06-25T18:06:46+00:00 https://ascopost.com/issues/june-25-2020/global-study-indicates-oncology-pharmacists-face-restricted-access-to-essential-ppe/ 2020-06-25T18:06:46+00:00 https://ascopost.com/issues/june-25-2020/trastuzumab-deruxtecan-shows-benefit-in-refractory-colorectal-cancer/ 2020-06-29T14:39:31+00:00 https://ascopost.com/issues/june-25-2020/epov-michael-lee-autumn-mcree/ 2020-06-29T14:39:32+00:00 https://ascopost.com/issues/june-25-2020/ganesh-rao-named-chair-of-neurosurgery-at-baylor-college-of-medicine/ 2020-06-29T14:39:32+00:00 https://ascopost.com/issues/june-25-2020/fda-approves-nivolumab-for-pretreated-patients-with-esophageal-squamous-cell-carcinoma/ 2020-06-29T14:39:32+00:00 https://ascopost.com/issues/june-25-2020/highlights-from-complementary-and-integrative-medicine-research-and-implications-for-clinical-practice/ 2020-06-29T14:39:32+00:00 https://ascopost.com/issues/june-25-2020/study-finds-alpelisib-effective-after-cdk46-inhibition-in-advanced-breast-cancer/ 2021-08-19T20:29:00+00:00 https://ascopost.com/issues/june-25-2020/epov-komal-jhaveri/ 2020-06-29T14:39:32+00:00 https://ascopost.com/issues/june-25-2020/fda-approves-pegfilgrastim-biosimilar-pegfilgrastim-apgf/ 2020-06-29T14:39:32+00:00 https://ascopost.com/issues/june-25-2020/pomalidomide-for-treatment-of-kaposi-sarcoma/ 2020-06-29T14:39:32+00:00 https://ascopost.com/issues/june-25-2020/mickie-mcgraw-channels-the-power-of-creative-arts-to-heal-broken-bodies-and-minds/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/american-urological-association-recognizes-roswell-park-surgeon-eric-kauffman-md/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/penn-medicine-announces-appointment-of-daniel-yoshor/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/leaders-of-the-promise-study-address-racial-inequities-in-the-united-states/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/blood-test-improves-screening-for-hepatocellular-carcinoma/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/determining-the-best-place-to-die-for-patients-with-cancer/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/aacr-inaugurates-new-leadership/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/brigatinib-for-alk-positive-metastatic-non-small-cell-lung-cancer/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/grzegorz-ira-honored-with-baylor-s-debakey-award/ 2020-06-29T14:39:33+00:00 https://ascopost.com/issues/june-25-2020/fox-chase-temple-university-hospital-announces-bone-marrow-transplant-program/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/jackson-laboratory-cancer-center-receives-continued-recognition-funding-by-nci/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/msk-hackensack-meridian-health-partnership-collaborate-on-immunology-research-projects/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/aacr-announces-distinguished-public-service-award-recipients/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/asco20-virtual-scientific-program-next-generation-oncology-highlights/ 2020-06-30T21:00:43+00:00 https://ascopost.com/issues/june-25-2020/survey-shows-young-onset-colorectal-cancer-may-be-overlooked-in-exam-rooms/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/study-identifies-potential-approach-to-treat-severe-respiratory-distress-in-patients-with-covid-19/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/woman-with-an-ovarian-tumor/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/you-can-do-anything-philosophy-early-in-life-inspired-breast-surgeon-laura-dominici/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/study-confirms-effective-less-toxic-alternative-to-standard-treatment-of-adults-with-burkitt-lymphoma/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/seattle-cancer-care-alliance-opens-new-clinic-dedicated-to-gastrointestinal-cancer-care/ 2020-06-29T14:39:34+00:00 https://ascopost.com/issues/june-25-2020/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues-1/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/small-study-finds-olanzapine-reduces-nausea-and-vomiting-caused-by-advanced-cancer/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/pigeon-english/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/aacr-stands-against-racial-discrimination-and-inequality/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/covid-19-and-patients-with-cancer-a-call-to-action-for-trainees/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/nci-renews-comprehensive-cancer-center-designation-for-norris-cotton-cancer-center/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/aids-research-led-to-appreciation-of-the-power-of-plants-and-integrative-medicine-in-cancer-care-for-donald-abrams/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/capmatinib-for-metastatic-nsclc-with-met-exon-14-skipping-mutation/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/integrating-physical-activity-into-cancer-care/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/advanced-practitioner-society-issues-statement-against-systemic-racism-discrimination/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/an-honored-poet-explores-a-lust-for-life-on-the-boundaries-of-near-death/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/extended-fraction-radiation-therapy-for-bone-metastases-represents-low-value-care-but-continues-to-be-widely-practiced/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/initiate-conversations-about-radiation-therapy-for-bone-metastases/ 2020-06-29T14:39:35+00:00 https://ascopost.com/issues/june-25-2020/melanoma-awareness-outlook-from-a-young-adult/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/neoadjuvant-atezolizumab-plus-chemotherapy-for-resectable-nsclc/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/opioid-related-deaths-in-the-cancer-population-vs-the-general-population/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/nivolumab-vs-bevacizumab-in-recurrent-glioblastoma/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/new-information-from-nccn-on-overcoming-challenges-for-people-with-head-and-neck-cancer/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/ama-board-of-trustees-pledges-action-against-racism-and-police-brutality/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/ama-announces-new-president-and-president-elect/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/i-m-not-too-young-for-colorectal-cancer/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/association-of-american-cancer-institutes-issues-statement-about-racial-discrimination/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/asco-welcomes-2020-2021-board-of-directors/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/infographic-commentaries-in-jco-oncology-practice-examine-updates-to-asco-s-alternative-payment-model/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/do-you-know-about-asco-s-patient-education-materials/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/special-report-provides-guidance-to-oncology-practices-on-resuming-care-during-the-covid-19-pandemic/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-25-2020/conquer-cancer-honors-early-career-medical-professionals-from-around-the-world/ 2020-06-29T14:39:36+00:00 https://ascopost.com/issues/june-10-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/june-10-2020/adjuvant-osimertinib-exceeds-expectations-in-egfr-positive-nsclc/ 2020-12-12T22:03:20+00:00 https://ascopost.com/issues/june-10-2020/epov-lecia-sequist/ 2020-06-22T16:43:59+00:00 https://ascopost.com/issues/june-10-2020/pembrolizumab-doubles-progression-free-survival-in-msi-hdmmr-metastatic-colorectal-cancer/ 2020-12-12T22:14:31+00:00 https://ascopost.com/issues/june-10-2020/epov-axel-grothey/ 2020-06-22T16:44:00+00:00 https://ascopost.com/issues/june-10-2020/when-is-it-time-to-pass/ 2020-06-22T16:44:00+00:00 https://ascopost.com/issues/june-10-2020/maintenance-avelumab-improves-survival-in-advanced-bladder-cancer/ 2020-06-26T20:56:01+00:00 https://ascopost.com/issues/june-10-2020/epov-jonathan-rosenberg/ 2020-06-22T16:44:00+00:00 https://ascopost.com/issues/june-10-2020/trophimmun-trial-finds-avelumab-effective-in-rare-gynecologic-tumor-resistant-to-chemotherapy/ 2020-08-21T14:51:22+00:00 https://ascopost.com/issues/june-10-2020/epov-trophimmun/ 2020-06-22T16:44:00+00:00 https://ascopost.com/issues/june-10-2020/precision-medicine-on-a-large-scale-for-pediatric-patients-with-cancer/ 2020-06-22T16:44:00+00:00 https://ascopost.com/issues/june-10-2020/fda-approves-atezolizumab-for-the-first-line-treatment-of-patients-with-metastatic-nsclc-and-high-pd-l1-expression/ 2020-06-22T16:44:00+00:00 https://ascopost.com/issues/june-10-2020/patients-with-cancer-especially-progressive-disease-infected-with-covid-19-may-have-an-increased-risk-of-death/ 2020-06-26T21:00:37+00:00 https://ascopost.com/issues/june-10-2020/tucatinib-combination-in-previously-treated-her2-positive-metastatic-breast-cancer-with-brain-metastases/ 2020-06-26T21:04:24+00:00 https://ascopost.com/issues/june-10-2020/new-cancer-cachexia-guideline-addresses-common-quality-of-life-issue/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/fda-approves-nivolumabipilimumab-plus-chemotherapy-for-first-line-treatment-of-metastatic-or-recurrent-nsclc/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/off-the-shelf-car-t-cell-therapy-makes-inroads-in-acute-lymphoblastic-leukemia/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/epov-yvonne-chen-and-joseph-alvarnas/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/tyler-jacks-honored-with-2020-aacr-princess-takamatsu-memorial-lectureship/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/fda-approves-brigatinib-for-alk-positive-metastatic-nsclc/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/aacr-names-barbara-wold-recipient-of-distinguished-lectureship/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/sarcoma-foundation-of-america-announces-2020-research-grants/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/aacr-honors-nobel-laureate-phillip-sharp-phd-for-lifetime-achievement/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/study-finds-blood-test-detects-cancer-and-tissue-of-origin-in-those-with-or-suspected-to-have-cancer/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/epov-david-huntsman/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/study-shows-blood-test-can-identify-multiple-cancers-in-asymptomatic-women/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/epov-david-huntsman-1/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/app-calculates-risk-of-delaying-cancer-care-during-the-covid-19-pandemic/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/talazoparib-yields-no-overall-survival-benefit-in-embraca-trial-update/ 2020-06-22T16:44:01+00:00 https://ascopost.com/issues/june-10-2020/epov-susan-domchek-and-aditya-bardia/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/acs-survey-finds-covid-19-health-impact-increasing-on-patients-with-cancer/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/keynote-555-supports-6-week-pembrolizumab-dosing-schedule-in-melanoma/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/epov-siwen-hu-lieskovan/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/front-line-maintenance-with-olaparibbevacizumab-improves-outcomes-in-advanced-ovarian-cancer/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/epov-thomas-herzog-and-kathleen-moore/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/niraparib-for-first-line-maintenance-treatment-of-advanced-ovarian-cancer/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/veliparib-plus-chemotherapy-shows-antitumor-activity-in-front-line-treatment-of-ovarian-cancer/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/epov-kathleen-moore/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/roswell-park-names-eunice-wang-medical-director-of-infusion-services/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/breastfeeding-associated-with-reduced-risk-of-invasive-ovarian-cancer/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/breastfeeding-a-public-health-strategy-for-reducing-risk-of-ovarian-cancer/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/addition-of-cd38-directed-antibody-isatuximab-to-multiple-myeloma-armamentarium/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/francis-collins-awarded-2020-templeton-prize/ 2020-06-22T16:44:02+00:00 https://ascopost.com/issues/june-10-2020/imbassador250-trial/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/sacituzumab-govitecan-hziy-for-previously-treated-metastatic-triple-negative-breast-cancer/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/epov-padmanee-sharma/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/pamela-hull-phd-appointed-associate-director-of-population-science-and-community-impact-at-kentucky-cancer-center/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/phyllis-f-cantor-center-for-research-in-nursing-and-patient-care-services-awarded-13-million-for-cancer-projects/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/olaparib-plus-bevacizumab-in-maintenance-treatment-for-ovarian-fallopian-tube-or-primary-peritoneal-cancers/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/an-early-path-to-a-career-in-medicine-for-carlos-l-arteaga-md/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/cancer-and-covid-19/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/five-new-recipients-of-nccn-foundation-young-investigator-awards/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/ibrutinib-in-combination-with-rituximab-in-chronic-lymphocytic-leukemia/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/andrew-e-aplin-receives-humanitarian-award-from-the-melanoma-research-foundation/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/selpercatinib-for-lung-and-thyroid-cancers-with-ret-gene-mutations-or-fusions/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/comprehensive-overview-of-how-to-start-or-improve-a-breast-cancer-unit-on-the-global-stage/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/fda-approves-combination-regimens-in-nsclc-hcc/ 2020-06-22T16:44:03+00:00 https://ascopost.com/issues/june-10-2020/the-gambler/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/abemaciclibfulvestranttrastuzumab-for-patients-with-previously-treated-hr-positive-her2-positive-advanced-breast-cancer/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/nivolumab-for-advanced-refractory-biliary-tract-cancer/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/cognitive-impairment-in-women-treated-for-early-breast-cancer/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/staying-alert-to-lingering-cognitive-impairment-with-adjuvant-therapy-for-early-breast-cancer/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/my-future-is-doled-out-in-increments-of-6-months/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/spotlight-on-women-who-conquer-cancer/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/conquer-cancer-names-2020-women-who-conquer-cancer-mentorship-award-recipients/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/the-power-of-mcode/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/new-recommendations-outline-approaches-to-reduce-burnout-in-oncology/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/news-highlights-for-patients-with-cancer-from-the-asco20-virtual-scientific-program/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-10-2020/future-covid-19-legislation-must-protect-patient-access-to-cancer-care/ 2020-06-22T16:44:04+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/the-asco-post-and-narratives-in-oncology-through-the-years/ 2021-05-13T19:41:46+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/from-the-united-states-to-germany-and-back-again-to-become-asco-president-in-2021-2022/ 2020-06-03T17:57:32+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/asco-s-president-aims-to-ensure-equitable-cancer-care-for-every-patient/ 2020-06-03T17:57:32+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/an-early-interest-in-cancer-immunology-inspires-a-life-s-work-in-melanoma/ 2020-06-03T17:57:33+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/a-lung-cancer-specialist-s-winding-journey-from-venezuela-to-wisconsin/ 2020-06-03T17:57:33+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/international-medical-and-radiation-oncologist-balances-cancer-research-and-clinical-practice/ 2020-06-03T17:57:33+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/a-nobel-laureate-s-road-to-research-is-not-without-challenges/ 2020-06-04T17:18:32+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/love-of-science-and-a-family-tragedy-set-the-course-for-this-breast-cancer-researcher/ 2020-06-03T17:59:32+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/love-of-science-passion-for-research-and-belief-in-the-power-of-the-immune-system/ 2020-06-03T17:59:43+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/expert-in-clinical-trial-methodology-makes-his-mark-in-genitourinary-cancer/ 2020-06-03T18:00:47+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/internationally-regarded-cancer-immunologist-did-not-stray-far-from-home/ 2020-06-03T18:03:02+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/renowned-researcher-and-surgeon-helps-to-transform-treatment-of-breast-cancer/ 2020-06-03T18:03:42+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/tribute-to-bernard-fisher-md/ 2020-06-03T17:57:33+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/reflections-of-an-asco-president/ 2020-06-03T17:57:33+00:00 https://ascopost.com/issues/june-3-2020-narratives-special-issue/mourned-and-missed/ 2020-06-03T17:57:33+00:00 https://ascopost.com/issues/may-25-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/may-25-2020/united-against-cancer-to-accelerate-progress-for-patients/ 2020-06-22T16:42:50+00:00 https://ascopost.com/issues/may-25-2020/overall-survival-benefit-shown-for-maintenance-olaparib-in-ovarian-cancer/ 2020-06-26T21:02:05+00:00 https://ascopost.com/issues/may-25-2020/epov-don-dizon/ 2020-06-22T16:42:50+00:00 https://ascopost.com/issues/may-25-2020/overcoming-the-challenges-of-presenting-the-asco-annual-meeting-during-the-covid-19-pandemic/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/geriatrician-assessment-and-integrated-care-may-help-older-patients-as-well-as-the-health-care-system/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/epov-william-dale/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/videoconference-intervention-can-reduce-levels-of-anxiety-and-distress-among-distance-caregivers/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/triplet-regimen-improves-progression-free-survival-in-advanced-melanoma/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/epov-charles-sawyers/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/durvalumabolaparibpaclitaxel-graduates-in-her2-negative-breast-cancer/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/epov-pamela-munster/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/selected-poster-presentations-on-cancer-therapeutics-and-more/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/use-of-neoadjuvant-chemotherapy-increasing-along-with-survival-in-advanced-ovarian-cancer/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/epov-alexandra-leary/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/wee1-inhibitor-shows-activity-in-recurrent-uterine-serous-carcinoma/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/epov-shannon-westin-and-alexander-melamed/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/niraparib-as-first-line-maintenance-therapy-for-advanced-ovarian-cancers/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/epov-thomas-herzog/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/fda-approves-olaparib-plus-bevacizumab-as-maintenance-treatment-for-ovarian-fallopian-tube-or-primary-peritoneal-cancers/ 2020-06-22T16:42:51+00:00 https://ascopost.com/issues/may-25-2020/fda-approves-niraparib-as-maintenance-therapy-for-advanced-ovarian-cancer/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/perspectives-on-how-the-covid-19-pandemic-is-impacting-oncology-care/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/fda-approves-new-pembrolizumab-dosing-regimen/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/evolving-insights-into-covid-19-and-cancer-care/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/continuous-dosing-of-dabrafenib-plus-trametinib-improves-pfs-vs-intermittent-dosing-in-advanced-melanoma/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/epov-charles-sawyers-1/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/aacr-virtual-annual-meeting-i-draws-over-61-000-registrants/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/pemigatinib-for-previously-treated-cholangiocarcinoma-with-fgfr2-rearrangement-or-fusion/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/new-asco-guideline-addresses-headneck-squamous-cell-carcinoma-of-unknown-primary/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/asco-s-president-elect-aims-to-ensure-equitable-cancer-care-for-every-patient/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/fda-approves-selpercatinib-for-lung-and-thyroid-cancers-with-ret-mutations-or-fusions/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/eric-brown-joins-staff-at-karmanos-cancer-institute/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/city-of-hope-welcomes-stanley-hamilton-and-alexey-danilov/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/selumetinib-for-pediatric-neurofibromatosis-type-1-with-symptomatic-inoperable-plexiform-neurofibromas/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/luspatercept-aamt-for-anemia-in-adults-with-myelodysplastic-syndromes/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/hypercoagulability-in-critically-ill-patients-with-covid-19/ 2020-06-22T16:42:52+00:00 https://ascopost.com/issues/may-25-2020/genetics-may-soon-guide-targeted-treatment-of-brain-metastases/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/mitomycin-gel-for-low-grade-upper-tract-urothelial-cancer/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/tucatinib-in-previously-treated-her2-positive-metastatic-breast-cancer/ 2020-06-26T21:03:21+00:00 https://ascopost.com/issues/may-25-2020/yale-cancer-center-announces-hematology-leadership-appointments/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/how-the-covid-19-pandemic-is-propelling-the-delivery-of-home-care-for-patients-with-cancer/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/treating-colorectal-cancer-in-the-time-of-covid-19/ 2021-02-18T19:16:29+00:00 https://ascopost.com/issues/may-25-2020/fda-approves-capmatinib-for-patients-with-metastatic-nsclc-with-confirmed-met-exon-14-skipping/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/john-craig-venter-sequencing-the-human-genome/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/moffitt-appoints-john-cleveland-as-new-director/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/martin-dietrich-joins-florida-cancer-institute/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/online-guide-offers-tips-for-communicating-with-patients-during-the-covid-19-pandemic/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/being-interviewed-on-zoom/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/treatment-related-sequelae-in-pediatric-neuro-oncology/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/robert-bona-named-director-of-benign-hematology-program/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/melanoma-research-alliance-announces-funding-for-grant-awards/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/oneoncology-names-jeff-patton-chief-executive-officer/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/nih-aims-to-quantify-undetected-cases-of-coronavirus-infection/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/ecog-acrin-conducts-smoking-cessation-study-in-patients-with-cancer/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/treating-patients-with-leukemia-during-the-covid-19-era-at-md-anderson-cancer-center/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/roswell-park-investigators-study-immunotherapy-combination-in-patients-with-cancer-infected-with-covid-19/ 2020-06-22T16:42:53+00:00 https://ascopost.com/issues/may-25-2020/how-the-lung-cancer-community-came-together-during-the-covid-19-pandemic/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/is-estrogen-protective-against-covid-19/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/cancer-vs-covid-19-clinical-trial-research-during-the-pandemic/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/on-the-shoulders-of-giants/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/10-changes-i-will-make-in-my-oncology-practice-as-a-result-of-covid-19/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/fda-approves-daratumumab-and-hyaluronidase-fihj-in-multiple-myeloma/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/celebrating-the-role-of-nurses-in-meeting-the-current-challenges-of-cancer-care-delivery/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/novel-imaging-application-illuminates-processes-in-cancer-covid-19/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/patient-centered-research-for-treatment-of-insomnia/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/american-academy-of-arts-sciences-inducts-members-of-class-of-2020/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/fda-issues-emergency-use-authorization-for-remdesivir-for-treatment-of-severe-covid-19/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/indiana-university-researcher-receives-nci-grant-for-multiple-myeloma/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/nih-begins-clinical-trial-of-combination-regimen-to-treat-covid-19/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/lessons-learned-on-rotation-at-covid-19-inpatient-service-at-new-york-city-hospital/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/prioritizing-patients-with-metastatic-disease-for-palliative-radiotherapy/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/gynecologic-oncologist-describes-his-new-normal-in-a-new-york-hospital/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/mortality-rate-of-patients-with-cancer-and-covid-19-in-a-new-york-hospital/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/artificial-blood-substitute/ 2020-06-22T16:42:54+00:00 https://ascopost.com/issues/may-25-2020/ancestry-and-molecular-makeup-of-cancer-evaluated-in-new-study/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/the-story-of-three-patients-with-leukemia/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/what-have-i-learned-in-more-than-half-a-century-in-cancer-medicine/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/rosemary-yancik-dies-at-86/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/john-yarbro-dies-at-88/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/paul-marks-dies-at-93/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/allocating-ventilators-in-times-of-crisis/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/covid-19-evidence-accelerator-leverages-real-world-data/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/nina-kadan-lottick-chose-a-career-in-pediatric-oncology/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/the-arc-of-therapy-from-cure-to-humbling-legacy/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/durvalumab-for-solid-tumors-in-patients-with-virologically-controlled-hiv-1-infection/ 2020-06-22T16:42:55+00:00 https://ascopost.com/issues/may-25-2020/recurrence-of-iraes-after-checkpoint-inhibitor-rechallenge-in-patients-with-cancer/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/radiation-and-chemoradiation-interruption-and-noncompletion-in-squamous-cell-anal-carcinoma/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/addition-of-pembrolizumab-to-docetaxel-for-previously-treated-immunotherapy-naive-patients-with-advanced-nsclc/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/brain-cancer-prepared-me-for-the-isolation-and-uncertainty-of-the-covid-19-pandemic/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/jennifer-king-named-cso-of-go2-foundation/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/a-long-crusade-against-some-of-the-world-s-most-virulent-diseases-for-anthony-fauci/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/study-finds-cancer-related-deaths-declined-in-states-with-expanded-access-to-medicaid/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/fda-approves-pomalidomide-for-kaposi-sarcoma/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/tips-for-first-time-abstract-presenters/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/conquer-cancer-researcher-searches-for-colorectal-cancer-cures/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/fundraising-to-help-patients-and-oncologists-during-the-covid-19-pandemic/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/help-your-patients-manage-their-weight-with-this-asco-resource/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/new-guidance-released-for-oncology-community-on-allocation-of-limited-resources-during-the-covid-19-pandemic/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-25-2020/new-article-analyzes-impact-of-pbms-on-quality-cancer-care/ 2020-06-22T16:42:56+00:00 https://ascopost.com/issues/may-10-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/may-10-2020/parp-inhibitors-in-maintenance-treatment-for-advanced-ovarian-cancer/ 2020-05-12T01:48:34+00:00 https://ascopost.com/issues/may-10-2020/april-is-the-cruelest-month/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/new-guideline-on-systemic-therapy-for-melanoma-tackles-rapid-developments-in-treatment-options/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/novel-treatment-strategies-under-study-in-advanced-melanoma/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/epov-omid-hamid/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/early-signs-of-activity-with-immunotherapies-in-low-incidence-cancers/ 2020-05-12T01:34:34+00:00 https://ascopost.com/issues/may-10-2020/fda-approves-tucatinib-in-combination-with-trastuzumabcapecitabine-for-advanced-unresectable-or-metastatic-her2-positive-breast-cancer/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/fda-approves-sacituzumab-govitecan-hziy-for-patients-with-previously-treated-metastatic-triple-negative-breast-cancer/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/can-breast-cancer-surgery-be-eliminated-in-exceptional-responders-to-neoadjuvant-therapy/ 2020-05-12T01:39:51+00:00 https://ascopost.com/issues/may-10-2020/timothy-chan-named-director-of-cleveland-clinic-s-center-for-immunotherapy-and-precision-immuno-oncology/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/vascular-imaging-for-detection-of-breast-cancer/ 2020-05-12T01:46:13+00:00 https://ascopost.com/issues/may-10-2020/joint-guideline-sheds-light-on-management-of-hereditary-breast-cancer/ 2020-05-11T19:54:03+00:00 https://ascopost.com/issues/may-10-2020/addition-of-olaparib-to-bevacizumab-maintenance-in-advanced-ovarian-cancer/ 2020-05-12T01:57:02+00:00 https://ascopost.com/issues/may-10-2020/addition-of-pembrolizumab-to-docetaxel-for-previously-treated-immunotherapy-naive-patients-with-advanced-lung-cancer/ 2020-05-11T19:54:04+00:00 https://ascopost.com/issues/may-10-2020/actively-recruiting-clinical-trials-studying-cancer-prevention-measures/ 2020-05-11T19:54:04+00:00 https://ascopost.com/issues/may-10-2020/bispecific-antibodies-poised-to-impact-treatment-of-lymphoma-and-other-blood-cancers/ 2020-05-12T02:00:19+00:00 https://ascopost.com/issues/may-10-2020/epov-basem-william-and-caron-jacobson/ 2020-05-11T19:54:04+00:00 https://ascopost.com/issues/may-10-2020/noninferiority-of-four-vs-six-cycles-of-chop-for-patients-with-favorable-prognosis-b-cell-lymphoma/ 2020-05-11T19:54:04+00:00 https://ascopost.com/issues/may-10-2020/fda-approves-ibrutinibrituximab-for-cllsll/ 2020-05-11T19:54:04+00:00 https://ascopost.com/issues/may-10-2020/studies-show-circulating-tumor-material-may-predict-outcomes-after-neoadjuvant-therapy-for-breast-cancer/ 2020-05-12T02:04:34+00:00 https://ascopost.com/issues/may-10-2020/epov-virginia-kaklamani-and-minetta-liu/ 2020-05-11T19:54:05+00:00 https://ascopost.com/issues/may-10-2020/fda-approves-mitomycin-for-low-grade-upper-tract-urothelial-cancer/ 2020-05-11T19:54:05+00:00 https://ascopost.com/issues/may-10-2020/fda-approves-selumetinib-for-pediatric-patients-with-nf1-and-symptomatic-inoperable-plexiform-neurofibromas/ 2020-05-11T19:54:05+00:00 https://ascopost.com/issues/may-10-2020/fda-approves-pemigatinib-for-patients-with-cholangiocarcinoma-and-an-fgfr2-rearrangement-or-fusion/ 2020-05-11T19:54:05+00:00 https://ascopost.com/issues/may-10-2020/neoadjuvant-and-adjuvant-pembrolizumab-improves-outcomes-in-early-triple-negative-breast-cancer/ 2020-05-12T02:07:27+00:00 https://ascopost.com/issues/may-10-2020/a-biomarker-resource-for-pd-1-inhibition-in-early-triple-negative-breast-cancer/ 2020-05-12T02:10:37+00:00 https://ascopost.com/issues/may-10-2020/pooled-analysis-supports-benefit-of-dual-her2-targeted-therapy/ 2020-05-12T02:15:16+00:00 https://ascopost.com/issues/may-10-2020/american-cancer-society-awards-new-research-training-grants/ 2020-05-11T19:54:06+00:00 https://ascopost.com/issues/may-10-2020/negotiating-the-obstacles-to-conducting-clinical-trials-of-immunotherapy-during-the-coronavirus-pandemic/ 2020-05-11T19:54:06+00:00 https://ascopost.com/issues/may-10-2020/practical-approach-to-management-of-patients-with-cancer-during-the-covid-19-pandemic/ 2020-05-11T19:54:06+00:00 https://ascopost.com/issues/may-10-2020/outcomes-of-covid-19-infection-in-patients-with-cancer-in-wuhan/ 2020-12-12T22:09:00+00:00 https://ascopost.com/issues/may-10-2020/managing-multiple-myeloma-during-the-covid-19-pandemic/ 2020-05-11T19:54:06+00:00 https://ascopost.com/issues/may-10-2020/highlights-from-ash-2019/ 2022-02-24T19:44:11+00:00 https://ascopost.com/issues/may-10-2020/the-role-of-adipose-tissue-in-cancer-aggressiveness/ 2020-05-11T19:54:07+00:00 https://ascopost.com/issues/may-10-2020/understanding-patient-reported-outcomes-in-cancer-trials/ 2020-05-12T02:52:12+00:00 https://ascopost.com/issues/may-10-2020/encorafenib-combined-with-cetuximab-in-previously-treated-braf-v600e-mutant-metastatic-colorectal-cancer/ 2020-05-11T19:54:07+00:00 https://ascopost.com/issues/may-10-2020/grace-and-forgiveness/ 2020-05-11T19:54:07+00:00 https://ascopost.com/issues/may-10-2020/durvalumab-plus-chemotherapy-for-extensive-stage-small-cell-lung-cancer/ 2020-05-11T19:54:07+00:00 https://ascopost.com/issues/may-10-2020/parker-institute-for-cancer-immunotherapy-appoints-frederic-pla-as-coo/ 2020-05-11T19:54:07+00:00 https://ascopost.com/issues/may-10-2020/fox-chase-cancer-center-welcomes-andres-correa/ 2020-05-11T19:54:08+00:00 https://ascopost.com/issues/may-10-2020/aria-vaishnavi-receives-nci-s-pathway-to-independence-award/ 2020-05-11T19:54:08+00:00 https://ascopost.com/issues/may-10-2020/larry-kwak-named-aimbe-fellow/ 2020-05-11T19:54:08+00:00 https://ascopost.com/issues/may-10-2020/kristin-brill-joins-sidney-kimmel-cancer-center/ 2020-05-11T19:54:08+00:00 https://ascopost.com/issues/may-10-2020/global-covid-19-observatory-and-resource-center-for-childhood-cancer/ 2020-05-11T19:54:08+00:00 https://ascopost.com/issues/may-10-2020/yoga-for-pediatric-and-adolescent-patients-with-cancer/ 2020-05-12T03:04:47+00:00 https://ascopost.com/issues/may-10-2020/david-a-tuveson-md-phd-faacr-elected-aacr-president-elect-for-2020-2021/ 2020-05-11T19:54:08+00:00 https://ascopost.com/issues/may-10-2020/delayed-targeted-intraoperative-radiotherapy-vs-whole-breast-radiotherapy-in-early-breast-cancer/ 2020-05-11T19:54:08+00:00 https://ascopost.com/issues/may-10-2020/quality-of-life-after-adjuvant-radiotherapy-with-vs-without-tumor-bed-boost-for-patients-with-non-low-risk-dcis/ 2020-05-11T19:54:09+00:00 https://ascopost.com/issues/may-10-2020/camrelizumab-for-previously-treated-advanced-hepatocellular-carcinoma/ 2020-05-11T19:54:09+00:00 https://ascopost.com/issues/may-10-2020/surgical-margins-and-survival-in-trial-of-adjuvant-imatinib-for-localized-gist/ 2020-05-11T19:54:09+00:00 https://ascopost.com/issues/may-10-2020/i-have-multiple-myeloma-and-am-concerned-about-the-coronavirus/ 2020-05-11T19:54:09+00:00 https://ascopost.com/issues/may-10-2020/ongoing-efforts-toward-vaccine-development-for-covid-19/ 2020-05-11T19:54:09+00:00 https://ascopost.com/issues/may-10-2020/my-asco-journey-opportunities-for-gratitude-and-breaking-glass-ceilings/ 2020-05-11T20:27:20+00:00 https://ascopost.com/issues/may-10-2020/breakthroughs-in-combination-therapy-for-colorectal-cancer/ 2020-05-11T20:29:48+00:00 https://ascopost.com/issues/may-10-2020/covid-19-what-people-with-cancer-need-to-know/ 2020-05-11T20:34:12+00:00 https://ascopost.com/issues/may-10-2020/asco-s-covid-19-cancer-registry/ 2020-05-13T02:02:22+00:00 https://ascopost.com/issues/may-10-2020/financial-support-available-to-providers-during-covid-19-pandemic/ 2020-05-13T02:07:50+00:00 https://ascopost.com/issues/may-10-2020/in-remembering-mum-siblings-honor-their-mother-with-action-and-innovation/ 2020-05-11T20:42:09+00:00 https://ascopost.com/issues/april-25-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/april-25-2020/intestinal-microbiota-and-mortality-in-recipients-of-allogeneic-hematopoietic-cell-transplantation/ 2020-04-24T21:28:55+00:00 https://ascopost.com/issues/april-25-2020/gut-bacterial-diversity-a-marker-or-driver-of-outcomes-after-hematopoietic-cell-transplantation/ 2020-04-24T21:30:28+00:00 https://ascopost.com/issues/april-25-2020/it-s-t-time-for-peripheral-t-cell-lymphoma/ 2020-05-10T19:52:12+00:00 https://ascopost.com/issues/april-25-2020/covid-19-cancer-and-the-need-for-more-data/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/pembrolizumab-plus-cetuximab-shows-antitumor-activity-in-squamous-cell-head-and-neck-cancer/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/epov-charu-aggarwal/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/chemoradiation-plus-bevacizumab-in-locally-or-regionally-advanced-nasopharyngeal-cancer/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/better-mental-health-screening-needed-for-survivors-of-head-and-neck-cancer/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/upfront-apalutamide-delays-time-to-second-progression-in-metastatic-castration-sensitive-prostate-cancer/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/epov-dana-rathkopf/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/what-s-the-current-status-of-neoadjuvant-immunotherapy/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/gut-microbiota-emerging-as-key-player-in-response-to-immunotherapy/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/do-hiv-positivity-and-autoimmune-disease-preclude-treatment-with-checkpoint-inhibitors/ 2020-04-24T19:05:07+00:00 https://ascopost.com/issues/april-25-2020/more-antibody-drug-conjugates-on-the-horizon-for-breast-cancer/ 2020-05-03T20:28:25+00:00 https://ascopost.com/issues/april-25-2020/beyond-cdk46-inhibitors-what-subsequent-treatment-is-best/ 2021-08-19T20:35:57+00:00 https://ascopost.com/issues/april-25-2020/ascent-study-halted/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/checkmate-142-updated-analysis/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/epov-john-carethers-and-joseph-sung/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/fda-approves-durvalumab-as-part-of-a-first-line-combination-regimen-for-extensive-stage-sclc/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/addition-of-isatuximab-to-pomalidomide-and-dexamethasone-in-relapsed-and-refractory-multiple-myeloma/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/nci-match-subprotocol-finds-nivolumab-active-in-mismatch-repair-deficient-cancers-other-than-colorectal-cancer/ 2021-08-19T20:32:08+00:00 https://ascopost.com/issues/april-25-2020/pd-1-inhibition-in-mismatch-repair-deficientmicrosatellite-instability-high-cancers-other-than-colorectal-cancer/ 2020-04-24T21:35:49+00:00 https://ascopost.com/issues/april-25-2020/21-gene-assay-recurrence-score-and-risk-of-locoregional-recurrence/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/adapting-adjuvant-endocrine-therapy-by-patient-age-and-risk/ 2020-04-26T23:53:05+00:00 https://ascopost.com/issues/april-25-2020/does-pembrolizumab-show-activity-in-some-rare-cancers/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/fda-accelerates-development-of-novel-therapies-for-covid-19/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/oncologists-on-the-front-lines-of-the-covid-19-pandemic-miriam-knoll/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/covid-19-may-remain-stable-for-hours-to-days-in-aerosols-and-on-surfaces/ 2021-08-16T20:41:46+00:00 https://ascopost.com/issues/april-25-2020/ash-research-collaboratives-data-hub-creates-international-data-registry-for-patients-with-blood-cancers-and-covid-19/ 2020-12-06T19:22:45+00:00 https://ascopost.com/issues/april-25-2020/virtual-appointments-help-patients-with-cancer-continue-care-during-covid-19-health-crisis/ 2020-04-24T19:05:08+00:00 https://ascopost.com/issues/april-25-2020/maintaining-blood-donations-during-the-covid-19-pandemic/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/mind-body-therapies-for-relieving-anxiety-and-stress-in-patients-with-cancer-during-covid-19-pandemic/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/ama-highlights-mental-health-resources-for-physicians-during-covid-19-pandemic/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/smilow-cancer-hospital-and-yale-cancer-center-appoint-deputy-chief-medical-officer/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/nci-awards-grant-for-immunotherapy-research/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/robert-l-coleman-named-chief-scientific-officer-for-the-us-oncology-network/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/isatuximab-irfc-for-previously-treated-multiple-myeloma/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/merry-jennifer-markham-md-facp-fasco-rose-from-humble-beginnings-to-a-leadership-role-in-oncology/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/how-crispr-cas9-gene-editing-may-improve-the-effectiveness-of-cellular-therapeutics-in-patients-with-cancer/ 2020-04-24T21:08:56+00:00 https://ascopost.com/issues/april-25-2020/selected-ash-abstracts-on-novel-treatments-for-non-hodgkin-lymphomas/ 2020-08-21T16:38:07+00:00 https://ascopost.com/issues/april-25-2020/actively-recruiting-clinical-trials-studying-multiple-myeloma/ 2020-09-18T20:48:31+00:00 https://ascopost.com/issues/april-25-2020/radon-exposure-a-leading-environmental-cause-of-cancer-mortality-in-the-united-states/ 2020-04-28T13:03:24+00:00 https://ascopost.com/issues/april-25-2020/vitamin-d-and-lymphoma-an-apparent-benefit-but-further-study-required/ 2020-05-03T22:25:54+00:00 https://ascopost.com/issues/april-25-2020/fda-approves-luspatercept-aamt-for-second-line-treatment-of-anemia-in-mds/ 2020-04-24T19:05:09+00:00 https://ascopost.com/issues/april-25-2020/budwig-diet/ 2020-04-24T21:15:59+00:00 https://ascopost.com/issues/april-25-2020/after-training-across-three-continents-a-hematologist-leads-the-wisconsin-hematologyoncology-division/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/ringing-a-bell-on-the-last-day-of-radiation-therapy/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/survey-of-patients-experience-with-radiation-therapy-for-cancer-finds-some-gaps-in-expectation-vs-reality/ 2020-09-18T20:51:43+00:00 https://ascopost.com/issues/april-25-2020/helping-patients-to-feel-informed-about-goals-and-adverse-effects-of-cancer-treatments/ 2020-04-24T19:35:04+00:00 https://ascopost.com/issues/april-25-2020/harvard-medical-student-s-innovation-disinfection-you-can-see/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/fox-chase-cancer-center-announces-new-name-and-recertification-for-palliative-care-program/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/nih-launches-1-million-competition-to-target-disease-diagnostics/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/unnecessary-barrier-to-blood-donation-for-british-nationals/ 2020-04-24T21:19:35+00:00 https://ascopost.com/issues/april-25-2020/chemotherapy-and-the-sweat-lodge/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/patient-with-multiple-myeloma-treated-for-covid-19-with-tocilizumab/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/inoperable-carcinoma-of-the-breast/ 2020-04-24T19:05:10+00:00 https://ascopost.com/issues/april-25-2020/nivolumabipilimumab-in-patients-with-sorafenib-pretreated-hepatocellular-carcinoma/ 2020-04-24T21:22:44+00:00 https://ascopost.com/issues/april-25-2020/a-clinical-trial-saved-my-life/ 2020-04-24T21:25:31+00:00 https://ascopost.com/issues/april-25-2020/statins-with-or-without-metformin-are-associated-with-increased-survival-in-patients-with-high-risk-prostate-cancer/ 2020-04-24T21:24:59+00:00 https://ascopost.com/issues/april-25-2020/expect-interest-and-questions-about-statins-and-metformin/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/aacr-provides-scientific-expertise-to-assist-fda-s-public-health-initiative/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/aacr-annual-meeting-to-be-held-in-two-part-virtual-platform/ 2020-09-18T20:47:08+00:00 https://ascopost.com/issues/april-25-2020/indigenous-american-ancestry-may-be-associated-with-her2-positive-breast-cancer/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/covid-19-infection-in-patients-with-cancer-in-china/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/french-guidelines-on-patients-with-cancer-and-sars-cov-2-infection/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/pemigatinib-for-previously-treated-advanced-cholangiocarcinoma/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/20-million-in-grants-awarded-to-identify-therapies-for-covid-19/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/asco-conquer-cancer-honor-leaders-in-cancer-care-with-2020-special-awards/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/fda-s-draft-guidance-will-improve-evidence-base-for-older-adults-with-cancer/ 2020-04-24T20:40:32+00:00 https://ascopost.com/issues/april-25-2020/conquer-cancer-researchers-remember-jane-c-wright-md-fasco/ 2020-04-24T19:05:11+00:00 https://ascopost.com/issues/april-25-2020/asco-resources-on-covid-19-for-the-oncology-community/ 2020-04-24T20:36:13+00:00 https://ascopost.com/issues/april-25-2020/free-practice-resource-cancernet-patient-referral-cards-from-asco/ 2020-04-24T19:05:12+00:00 https://ascopost.com/issues/april-10-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/april-10-2020/immunotherapy-comes-of-age-in-breast-cancer/ 2020-04-10T19:07:41+00:00 https://ascopost.com/issues/april-10-2020/practicing-oncology-in-the-era-of-covid-19/ 2020-04-10T19:07:41+00:00 https://ascopost.com/issues/april-10-2020/asco-releases-resource-stratified-guideline-on-the-treatment-of-late-stage-colorectal-cancer/ 2020-04-10T19:07:41+00:00 https://ascopost.com/issues/april-10-2020/study-suggests-adjuvant-everolimus-may-benefit-patients-with-advanced-head-and-neck-cancer/ 2020-04-10T19:07:41+00:00 https://ascopost.com/issues/april-10-2020/epov-tanguy-seiwert/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/abstracts-from-the-nccn-2020-annual-conference-now-available/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/pembrolizumab-plus-radiotherapy-in-locally-advanced-squamous-cell-head-and-neck-cancer/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/epov-sue-sun-yom/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/brief-highlights-on-novel-therapies-for-prostate-bladder-and-kidney-cancers/ 2020-04-13T18:21:22+00:00 https://ascopost.com/issues/april-10-2020/bispecific-antibodies-successes-and-challenges/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/asco-board-concludes-annual-meeting-cannot-occur-in-person/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/mitigating-the-spread-of-covid-19-and-its-impact-on-cancer/ 2020-12-14T14:36:01+00:00 https://ascopost.com/issues/april-10-2020/how-covid-19-is-affecting-the-oncology-community/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/strategies-for-protecting-patients-and-health-care-providers-against-covid-19/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/testing-ppe-and-practice-support-needed-during-covid-19-crisis/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/should-restrictions-on-genetic-testing-be-loosened/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/prior-antibiotic-use-and-survival-in-patients-with-advanced-melanoma-receiving-immune-checkpoint-inhibitors/ 2020-04-10T19:07:42+00:00 https://ascopost.com/issues/april-10-2020/epov-jarushka-naidoo/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/sema4d-inhibition-a-novel-means-of-improving-immune-response/ 2020-04-13T15:52:40+00:00 https://ascopost.com/issues/april-10-2020/epov-timothy-yap/ 2020-04-13T17:28:11+00:00 https://ascopost.com/issues/april-10-2020/reshma-jagsi-tirelessly-advocates-for-women-s-health-and-careers-in-medicine/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/msk-and-city-college-of-new-york-researchers-awarded-grant-from-nci/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/updates-from-selected-clinical-trials-in-breast-cancer/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/philadelphia-t-cell-lymphomaleukemia-initiative-to-be-launched/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/donald-sullivan-receives-ats-foundation-research-programamerican-lung-association-partner-grant/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/fda-approves-nivolumabipilimumab-for-pretreated-patients-with-hepatocellular-carcinoma/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/highlights-from-transplantation-and-cellular-therapy-meetings-of-astct-and-cibmtr/ 2021-08-16T19:26:15+00:00 https://ascopost.com/issues/april-10-2020/oncologists-on-the-front-lines-of-covid-19/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/using-respectful-language-to-reduce-unconscious-bias-in-oncology-care/ 2020-04-10T19:07:43+00:00 https://ascopost.com/issues/april-10-2020/what-s-in-a-name/ 2020-04-10T19:07:44+00:00 https://ascopost.com/issues/april-10-2020/a-hallmark-moment/ 2020-04-10T19:07:44+00:00 https://ascopost.com/issues/april-10-2020/concurrent-pembrolizumab-and-chemoradiotherapy-in-locally-advanced-nsclc/ 2020-04-10T19:07:44+00:00 https://ascopost.com/issues/april-10-2020/adjuvant-gemcitabineplatinum-based-chemotherapy-vs-surveillance-for-upper-tract-urothelial-carcinoma/ 2020-04-10T19:07:44+00:00 https://ascopost.com/issues/april-10-2020/city-of-hope-deploys-platform-makes-study-data-accessible/ 2020-04-10T19:07:44+00:00 https://ascopost.com/issues/april-10-2020/living-a-full-life-after-pancreatic-cancer/ 2020-04-10T19:07:44+00:00 https://ascopost.com/issues/april-10-2020/breast-cancer-specialist-lawrence-solin-dies/ 2020-04-10T19:07:45+00:00 https://ascopost.com/issues/april-10-2020/spring-2020-abim-maintenance-of-certification-exams-canceled/ 2020-04-10T19:07:45+00:00 https://ascopost.com/issues/april-10-2020/a-message-from-the-fda-oce-on-covid-19/ 2020-04-10T19:07:45+00:00 https://ascopost.com/issues/april-10-2020/international-palliative-care-workshop-in-russia/ 2020-04-10T21:29:20+00:00 https://ascopost.com/issues/april-10-2020/r-kate-kelley-breakthroughs-for-hepatocellular-carcinoma/ 2020-04-10T21:33:33+00:00 https://ascopost.com/issues/april-10-2020/house-bill-supports-innovative-payment-models/ 2020-04-10T21:50:23+00:00 https://ascopost.com/issues/april-10-2020/lawrence-einhorn-reflects-on-the-path-to-a-cure/ 2020-04-10T21:37:40+00:00 https://ascopost.com/issues/april-10-2020/join-the-conquerors-community/ 2020-04-10T21:40:10+00:00 https://ascopost.com/issues/april-10-2020/asco-answers-fact-sheet-on-fertility-and-cancer-treatment/ 2020-04-10T21:42:01+00:00 https://ascopost.com/issues/april-10-2020/significant-changes-to-evaluation-and-management-codes-in-2021/ 2020-04-10T21:47:21+00:00 https://ascopost.com/issues/march-25-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/march-25-2020/enfortumab-vedotin-plus-pembrolizumab-in-advanced-bladder-cancer/ 2020-03-25T19:57:21+00:00 https://ascopost.com/issues/march-25-2020/epov-philip-saylor/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/how-exercise-oncology-can-improve-cancer-outcome-and-survivorship/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/cancer-during-pregnancy/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/immune-restorative-agent-may-boost-immunotherapy-response-in-advanced-head-and-neck-cancer/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/phase-ii-trial-finds-neoadjuvant-immunotherapy-feasible-in-oral-cavity-cancer/ 2020-03-26T14:24:37+00:00 https://ascopost.com/issues/march-25-2020/epov-tanguy-seiwert/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/vitamin-d-supplementation-may-protect-against-checkpoint-inhibitor-induced-colitis/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/epov-jarushka-naidoo/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/off-the-shelf-dendritic-vaccine-shows-benefit-in-kidney-cancer/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/epov-navid-hafez/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/former-fda-commissioner-relays-opinions-on-coronavirus/ 2020-04-03T14:57:56+00:00 https://ascopost.com/issues/march-25-2020/study-focuses-on-role-of-microbes-in-pancreatic-cancer/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/neratinib-combined-with-capecitabine-in-previously-treated-advanced-her2-positive-breast-cancer/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/fda-approves-isatuximab-irfc-based-triplet-regimen-for-patients-with-relapsed-and-refractory-multiple-myeloma/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/psma-petct-may-have-major-impact-on-treatment-of-patients-with-prostate-cancer/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/epov-charles-drake/ 2020-03-25T19:57:22+00:00 https://ascopost.com/issues/march-25-2020/mixed-results-with-adding-radiotherapy-to-immunotherapy-in-renal-cell-carcinoma/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/early-fdg-pet-allows-de-escalation-of-chemotherapy-in-metastatic-seminoma/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/epov-peter-albers/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/new-asco-guideline-highlights-the-management-of-male-breast-cancer/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/actively-recruiting-clinical-trials-on-colorectal-cancer/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/haplo2019-advances-in-haploidentical-transplantation-and-other-novel-cellular-therapies/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/memorial-sloan-kettering-announces-two-new-appointments/ 2022-05-26T14:57:39+00:00 https://ascopost.com/issues/march-25-2020/charles-sawyers-receives-knudson-award-in-cancer-genetics/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/iaslc-names-research-award-after-fred-hirsch/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/randall-oyer-named-president-of-accc/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/survival-benefits-achieved-with-pembrolizumab-in-some-gastric-and-gastroesophageal-junction-cancers/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/epov-daniel-catenacci/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/veterans-health-bill-promotes-comprehensive-prostate-cancer-care-program/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/studies-aim-to-understand-young-onset-colorectal-cancer/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/epov-john-carethers/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/selected-abstracts-on-novel-treatments-in-colon-hepatocellular-and-biliary-tract-cancers/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/expert-on-public-health-and-policy-looks-at-precision-oncology/ 2020-03-25T19:57:23+00:00 https://ascopost.com/issues/march-25-2020/pulmonary-pathology-of-early-covid-19-pneumonia-identified-retrospectively-in-two-patients-with-lung-cancer/ 2020-12-14T14:29:39+00:00 https://ascopost.com/issues/march-25-2020/selected-ash-abstracts-on-cll-and-sll-newly-diagnosed-disease/ 2020-03-30T19:11:36+00:00 https://ascopost.com/issues/march-25-2020/selected-ash-abstracts-on-cll-and-sll-relapsed-or-refractory-disease/ 2020-03-30T19:12:47+00:00 https://ascopost.com/issues/march-25-2020/a-cello-for-michayla/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/the-opioid-crisis-as-told-from-the-streets-to-the-clinics-and-its-unintended-consequences/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/i-wasn-t-prepared-for-the-emotional-turmoil-of-breast-cancer/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/aml-pioneer-and-giant-clara-d-bloomfield-md-fasco-dies-at-77/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/addressing-the-needs-of-transgender-patients-for-breast-cancer-screening/ 2020-03-29T20:10:21+00:00 https://ascopost.com/issues/march-25-2020/don-t-expect-transgender-patients-to-out-themselves/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/addition-of-pembrolizumab-to-neoadjuvant-chemotherapy-in-early-stage-her2-negative-breast-cancer/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/anti-cd19-car-nk-therapy-in-relapsed-or-refractory-cd19-positive-lymphoid-tumors/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/the-parker-institute-for-cancer-immunotherapy-awards-275-million/ 2020-03-25T19:57:24+00:00 https://ascopost.com/issues/march-25-2020/asco-and-project-echo-in-nepal/ 2020-03-25T20:46:30+00:00 https://ascopost.com/issues/march-25-2020/a-low-tech-approach-leads-to-high-quality-care-in-south-africa/ 2020-03-25T20:48:30+00:00 https://ascopost.com/issues/march-25-2020/surgeon-general-s-report-on-smoking-cessation/ 2020-03-25T20:51:25+00:00 https://ascopost.com/issues/march-25-2020/study-highlights-smoking-cessation-initiative-success-for-patients-with-cancer/ 2020-03-25T21:06:33+00:00 https://ascopost.com/issues/march-25-2020/conquer-cancer-rtfccr-career-pathway-grants/ 2020-03-25T20:55:06+00:00 https://ascopost.com/issues/march-25-2020/leaving-no-stone-unturned-in-research-to-cure-a-rare-kidney-cancer/ 2020-03-25T20:59:24+00:00 https://ascopost.com/issues/march-25-2020/prepare-your-patients-for-potential-side-effects-with-asco-answers-fact-sheets/ 2020-03-25T21:04:58+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/conference-highlights-from-the-2020-gastrointestinal-cancers-symposium/ 2020-03-23T19:05:14+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/imbrave150-prespecified-analysis-quality-of-life-with-atezolizumab-plus-bevacizumab/ 2020-03-23T19:09:15+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/epov-a-craig-lockhart/ 2020-03-23T18:49:50+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/tapur-basket-study-biomarker-driven-treatment-strategies-yield-benefits-in-colorectal-cancer/ 2020-03-23T19:11:21+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/mature-follow-up-of-beacon-crc-study-reports-quality-of-life-measures-and-survival-outcomes/ 2020-03-23T19:12:20+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/epov-christopher-booth/ 2020-03-23T19:12:38+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/maintenance-olaparib-in-brca12-positive-pancreatic-cancer-yields-improved-pfs-preserves-qol/ 2020-03-23T19:19:17+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/genetic-counseling-and-testing-of-patients-with-pancreatic-cancer/ 2020-03-23T19:19:54+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/cisplatingemcitabine-alone-and-with-veliparib-in-brca-mutated-advanced-pancreatic-cancer/ 2020-03-23T19:25:16+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/epov-richard-schilsky/ 2020-03-24T14:23:41+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/subanalysis-of-keynote-059-061-and-062/ 2020-03-23T19:27:18+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/epov-daniel-catenacci/ 2020-03-23T18:49:50+00:00 https://ascopost.com/issues/march-25-2020-supplement-conference-highlights-gi-cancers/phase-iii-javelin-gastric-100-trial-finds-no-survival-benefit-for-maintenance-avelumab/ 2020-03-23T19:28:33+00:00 https://ascopost.com/issues/march-10-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/march-10-2020/mk-6482-shows-activity-across-all-risk-categories-in-metastatic-clear-cell-kidney-cancer/ 2020-03-10T18:27:28+00:00 https://ascopost.com/issues/march-10-2020/epov-daniel-geynisman/ 2020-03-10T18:27:28+00:00 https://ascopost.com/issues/march-10-2020/an-education-in-human-suffering/ 2020-03-10T18:27:28+00:00 https://ascopost.com/issues/march-10-2020/asco-and-cap-release-updated-guideline-on-estrogen-and-progesterone-testing-in-breast-cancer/ 2020-03-10T18:27:28+00:00 https://ascopost.com/issues/march-10-2020/immune-checkpoint-inhibitors-in-solid-organ-transplant-recipients/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/richard-schilsky-designated-a-national-associate-of-the-national-academies-of-sciences-engineering-and-medicine/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/tapur-study-biomarker-driven-treatment-paying-off-in-colorectal-cancer/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/epov-richard-schilsky/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/new-polo-data-further-support-maintenance-olaparib-in-brca-positive-pancreatic-cancer/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/no-survival-benefit-for-maintenance-avelumab-in-advanced-gastric-or-gastroesophageal-junction-cancer/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/epov-daniel-catenacci/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/automated-referral-process-for-genetic-counseling-and-testing-of-patients-with-pancreatic-cancer/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/cabozantinib-plus-atezolizumab-shows-benefit-in-patients-with-advanced-prostate-cancer/ 2020-03-29T20:53:00+00:00 https://ascopost.com/issues/march-10-2020/epov-charles-drake/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/rush-university-medical-center-earns-national-center-of-excellence-for-pancreatic-cancer-designation/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/translational-research-in-oncology-board-of-directors/ 2020-03-10T18:27:29+00:00 https://ascopost.com/issues/march-10-2020/new-guideline-tackles-rapidly-evolving-imaging-strategies-for-advanced-prostate-cancer/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/acalabrutinib-plus-obinutuzumab-as-front-line-treatment-of-cll/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/epov-javier-pinilla-ibarz/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/treating-patients-with-chronic-lymphocytic-leukemia-in-2020/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/oral-regimen-of-ibrutinibvenetoclax-achieves-high-rates-of-undetectable-minimal-residual-disease-in-cll/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/epov-james-gerson/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/h-timothy-hsiao-joins-astro-as-director-of-scientific-affairs/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/smilow-cancer-hospital-and-yale-cancer-center-to-welcome-pamela-kunz/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/brief-highlights-from-the-2019-san-antonio-breast-cancer-symposium/ 2020-03-10T22:09:17+00:00 https://ascopost.com/issues/march-10-2020/21-gene-assay-recurrence-score-and-risk-of-locoregional-recurrence/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/avapritinib-for-gastrointestinal-stromal-tumor-with-pdgfra-exon-18-mutation/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/selected-ash-abstracts-on-novel-treatments-in-acute-lymphoblastic-leukemia/ 2020-03-10T22:15:56+00:00 https://ascopost.com/issues/march-10-2020/nci-awards-grant-to-cedars-sinai-for-research-on-dietary-fat-and-liver-metastasis/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/tazemetostat-for-advanced-epithelioid-sarcoma/ 2020-03-10T18:27:30+00:00 https://ascopost.com/issues/march-10-2020/participating-in-tremendous-progress-in-hematologic-oncology/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/attempt-to-transform-venipuncture/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/former-asco-president-sandra-swain-shares-highlights-of-a-noted-career/ 2020-04-13T14:13:47+00:00 https://ascopost.com/issues/march-10-2020/building-onco-primary-care-to-close-the-black-hole-in-cancer-survivorship-care/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/fda-approves-neratinibcapecitabine-for-pretreated-patients-with-metastatic-her2-positive-breast-cancer/ 2020-03-11T21:17:03+00:00 https://ascopost.com/issues/march-10-2020/reflections-on-a-career-in-hematologyoncology/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/susan-band-horwitz-named-recipient-of-2020-szent-gyoergyi-prize/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/active-hexose-correlated-compound/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/therapy-is-keeping-my-metastatic-breast-cancer-manageable/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/zelia-correa-joins-sylvester-comprehensive-cancer-center-and-bascom-palmer-eye-institute/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/trifluridinetipiracil-plus-bevacizumab-for-chemorefractory-metastatic-colorectal-cancer/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/perioperative-chemotherapy-with-or-without-cetuximab-in-patients-with-resectable-colorectal-cancer-liver-metastases/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/drug-repository-programs/ 2020-03-10T18:27:31+00:00 https://ascopost.com/issues/march-10-2020/conquer-cancer-funded-research-highlighted-in-clinical-cancer-advances-2020/ 2020-03-10T21:02:54+00:00 https://ascopost.com/issues/march-10-2020/33-oncology-practices-receive-qopi-certification-from-the-association-for-clinical-oncology/ 2020-03-10T22:24:19+00:00 https://ascopost.com/issues/march-10-2020/conquer-cancer-honors-early-career-cancer-researchers-with-merit-awards/ 2020-03-10T21:46:49+00:00 https://ascopost.com/issues/march-10-2020/medicaid-block-grants-threaten-beneficiary-access-to-cancer-care/ 2020-03-10T22:27:07+00:00 https://ascopost.com/issues/march-10-2020/roles-are-reversed-in-personalized-medicine-as-physicians-care-for-parents-with-cancer/ 2020-03-10T21:58:33+00:00 https://ascopost.com/issues/march-10-2020/qopi-round-1-now-open-for-data-abstraction/ 2020-03-10T22:00:52+00:00 https://ascopost.com/issues/march-10-2020/help-patients-do-more-to-cope-with-cancer-related-pain/ 2020-03-10T22:03:02+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/conference-highlights-from-the-2019-san-antonio-breast-cancer-symposium/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/phase-iii-her2climb-trial-yields-positive-data-in-patients-with-her2-positive-metastatic-breast-cancer-and-brain-metastasis/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/six-year-follow-up-of-aphinity-trial/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/epov-steven-isakoff/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/t-dxd-effective-in-pretreated-metastatic-her2-positive-breast-cancer/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/epov-steven-isakoff-1/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/adjuvant-ado-trastuzumab-emtansine-vs-paclitaxel-plus-trastuzumab-in-early-her2-positive-breast-cancer/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/epov-a-jo-chien/ 2020-03-06T20:18:26+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/adding-capecitabine-to-systemic-therapies-improves-outcomes-in-triple-negative-breast-cancer/ 2020-03-06T20:18:27+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/pembrolizumab-benefits-outcome-in-neoadjuvant-adjuvant-settings-in-triple-negative-breast-cancer/ 2020-03-06T20:18:27+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/margetuximab-plus-chemotherapy-vs-trastuzumab-plus-chemotherapy-for-her2-positive-breast-cancer/ 2020-03-06T21:20:50+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/small-study-explores-impact-of-novel-regimen-on-pembrolizumab-for-triple-negative-breast-cancer/ 2020-03-06T20:18:27+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/epov-sara-tolaney/ 2020-03-06T20:18:27+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/availability-cost-and-use-of-biosimilar-trastuzumab-in-patients-with-her2-positive-breast-cancer/ 2020-03-06T20:18:28+00:00 https://ascopost.com/issues/march-10-2020-supplement-conference-highlights-sabcs-2019/nsabp-b-42-trial-10-year-update/ 2020-03-06T20:18:28+00:00 https://ascopost.com/issues/february-25-2020/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/february-25-2020/patient-reported-outcomes-from-imbrave150/ 2020-02-25T19:21:54+00:00 https://ascopost.com/issues/february-25-2020/epov-a-craig-lockhart/ 2020-02-25T19:21:54+00:00 https://ascopost.com/issues/february-25-2020/redefining-what-it-means-to-have-precursor-myeloma/ 2020-02-25T19:21:54+00:00 https://ascopost.com/issues/february-25-2020/value-is-the-benefit-worth-the-cost/ 2020-02-25T19:21:54+00:00 https://ascopost.com/issues/february-25-2020/epov-marcia-cruz-correa/ 2020-02-25T19:21:55+00:00 https://ascopost.com/issues/february-25-2020/two-novel-pegylated-agents-fail-in-metastatic-pancreatic-cancer/ 2020-02-25T19:21:55+00:00 https://ascopost.com/issues/february-25-2020/epov-andrea-wang-gillam/ 2020-02-25T19:21:55+00:00 https://ascopost.com/issues/february-25-2020/use-of-cell-free-dna-methylation-based-blood-test-in-detecting-gi-cancers/ 2020-02-25T19:21:55+00:00 https://ascopost.com/issues/february-25-2020/epov-george-fisher/ 2020-02-25T19:21:55+00:00 https://ascopost.com/issues/february-25-2020/cancer-in-the-aging-population/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/safety-analysis-results-for-first-line-durvalumab-plus-platinumetoposide-in-extensive-stage-sclc/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/venetoclax-plus-dexamethasone-shows-activity-in-multiple-myeloma/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/epov-suzanne-lentzsch/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/study-finds-bridge-to-car-t-cell-therapy-may-be-detrimental-to-survival/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/epov-edmund-waller/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/new-asco-guideline-highlights-need-to-improve-germline-somatic-tumor-testing-in-epithelial-ovarian-cancer/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/asco-cco-update-guideline-for-selecting-systemic-treatment-in-stage-iv-nsclc-without-driver-mutations/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/no-improved-pcr-with-atezolizumab-in-early-triple-negative-breast-cancer/ 2020-02-25T19:21:56+00:00 https://ascopost.com/issues/february-25-2020/mixed-results-with-durvalumab-maintenance-in-her2-negative-advanced-breast-cancer/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/epov-kevin-kalinsky/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/prevent-cancer-foundation-awards-cancer-research-and-global-grants/ 2020-02-27T18:37:48+00:00 https://ascopost.com/issues/february-25-2020/update-on-project-facilitate-at-the-oncology-center-of-excellence/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/cms-expands-coverage-of-ngs-for-patients-with-breast-or-ovarian-cancer/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/updates-in-hematopoietic-cell-transplantation/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/eileen-smith-named-chair-of-department-of-hematology-and-hematopoietic-cell-transplantation/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/dana-farber-cancer-institute-to-establish-riney-family-multiple-myeloma-initiative/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/ehe-foundation-receives-award-from-the-chan-zuckerberg-initiative/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/asco-endorses-cco-guideline-on-bone-health-and-bone-targeted-therapies-for-prostate-cancer/ 2020-02-25T19:21:57+00:00 https://ascopost.com/issues/february-25-2020/beacon-crc-quality-of-life-may-be-well-maintained-with-targeted-treatment/ 2020-02-25T19:21:58+00:00 https://ascopost.com/issues/february-25-2020/epov-christopher-booth/ 2020-02-25T19:21:58+00:00 https://ascopost.com/issues/february-25-2020/nci-s-james-n-kochenderfer-md-receives-clinical-research-achievement-award/ 2020-02-25T19:21:58+00:00 https://ascopost.com/issues/february-25-2020/data-from-colorectal-cancer-cohorts-of-tapur-study-presented/ 2020-02-25T21:46:59+00:00 https://ascopost.com/issues/february-25-2020/pembrolizumab-for-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer/ 2021-02-09T23:06:36+00:00 https://ascopost.com/issues/february-25-2020/stand-up-to-cancer-announces-gastric-cancer-interception-research-team/ 2020-02-25T19:21:59+00:00 https://ascopost.com/issues/february-25-2020/poster-to-bedside-geriatric-oncology-research-updates-from-2019-asco-annual-meeting/ 2020-02-25T21:50:48+00:00 https://ascopost.com/issues/february-25-2020/edna-cukierman-phd-receives-grant-to-study-biology-of-pancreatic-cancer/ 2020-02-25T19:21:59+00:00 https://ascopost.com/issues/february-25-2020/strong-activity-shown-for-lisocabtagene-maraleucel-car-t-cell-therapy-in-aggressive-large-b-cell-lymphoma/ 2020-02-25T19:21:59+00:00 https://ascopost.com/issues/february-25-2020/epov-basem-william/ 2020-02-25T19:21:59+00:00 https://ascopost.com/issues/february-25-2020/flag-go-achieves-deeper-remission-than-flag-ida-in-favorable-risk-aml/ 2020-02-25T21:52:21+00:00 https://ascopost.com/issues/february-25-2020/epov-chetasi-talati/ 2020-02-25T19:22:00+00:00 https://ascopost.com/issues/february-25-2020/using-machine-learning-to-prompt-serious-illness-conversations/ 2020-02-25T21:54:59+00:00 https://ascopost.com/issues/february-25-2020/rami-k-daya-md-leads-perlmutter-cancer-center-s-new-location-in-sunset-park-brooklyn/ 2020-02-25T19:22:00+00:00 https://ascopost.com/issues/february-25-2020/postmenopausal-estrogen-and-risk-of-breast-cancer-what-is-the-real-story/ 2020-02-25T22:52:15+00:00 https://ascopost.com/issues/february-25-2020/neoadjuvant-cisplatin-for-brca-mutation-carriers-pruning-the-dead-branches/ 2020-02-25T21:59:20+00:00 https://ascopost.com/issues/february-25-2020/the-ohio-state-james-cancer-repository-program-now-accepting-oral-cancer-therapy-donations-for-patients-in-need/ 2020-02-25T19:22:00+00:00 https://ascopost.com/issues/february-25-2020/searching-for-evidence-based-reassurance-where-none-could-be-found/ 2020-02-25T19:22:01+00:00 https://ascopost.com/issues/february-25-2020/new-center-for-indigenous-cancer-research-at-roswell-park-has-regional-focus-global-reach/ 2020-02-25T19:22:01+00:00 https://ascopost.com/issues/february-25-2020/cancer-has-made-me-the-person-i-am-and-i-m-grateful/ 2020-02-25T22:01:31+00:00 https://ascopost.com/issues/february-25-2020/hematologist-usama-gergis-md-mba-joins-sidney-kimmel-cancer-center/ 2020-02-25T19:22:01+00:00 https://ascopost.com/issues/february-25-2020/new-cancer-center-established-at-johns-hopkins-university/ 2020-02-25T19:22:01+00:00 https://ascopost.com/issues/february-25-2020/collaborative-team-receives-funding-to-enhance-participation-of-black-women-in-cancer-clinical-trials/ 2020-02-25T19:22:01+00:00 https://ascopost.com/issues/february-25-2020/using-antioxidants-and-other-supplements-with-chemotherapy-may-increase-risk-of-breast-cancer-recurrence-and-mortality/ 2020-02-25T22:04:29+00:00 https://ascopost.com/issues/february-25-2020/ask-patients-about-their-use-of-dietary-supplements/ 2020-02-25T19:22:02+00:00 https://ascopost.com/issues/february-25-2020/jason-luke-md-facp-receives-sy-holzer-endowed-immunotherapy-research-award/ 2020-02-25T19:22:02+00:00 https://ascopost.com/issues/february-25-2020/nci-appoints-satish-gopal-md-mph-as-director-of-center-for-global-health/ 2020-02-25T19:22:02+00:00 https://ascopost.com/issues/february-25-2020/effect-of-volume-based-ct-screening-on-lung-cancer-mortality-in-high-risk-patients/ 2020-02-25T19:22:02+00:00 https://ascopost.com/issues/february-25-2020/pooled-analysis-of-bmi-and-overall-survival-with-immune-checkpoint-inhibitor-therapy-in-nsclc/ 2020-02-25T19:22:02+00:00 https://ascopost.com/issues/february-25-2020/cemiplimab-in-locally-advanced-cutaneous-squamous-cell-carcinoma/ 2020-02-25T19:22:02+00:00 https://ascopost.com/issues/february-25-2020/h-pylori-infection-treatment-and-gastric-cancer-risk/ 2020-02-25T22:11:18+00:00 https://ascopost.com/issues/february-25-2020/nobel-laureate-stanley-cohen-phd-dies-at-97/ 2020-02-25T22:11:19+00:00 https://ascopost.com/issues/february-25-2020/new-maintenance-of-certification-pathway/ 2020-02-25T22:11:19+00:00 https://ascopost.com/issues/february-25-2020/nebraska-oncology-society/ 2020-02-25T22:11:20+00:00 https://ascopost.com/issues/february-25-2020/qopi-round-1-now-open/ 2020-02-25T22:11:20+00:00 https://ascopost.com/issues/february-25-2020/asco-submits-pcop-model/ 2020-02-25T22:11:21+00:00 https://ascopost.com/issues/february-25-2020/preliminary-study-finds-asco-decision-aid-may-improve-quality-of-serious-adverse-events-reporting/ 2020-02-25T20:26:47+00:00 https://ascopost.com/issues/february-25-2020/stock-your-practice-for-cancer-awareness-month-in-march-with-asco-answers-materials/ 2020-02-25T20:30:12+00:00 https://ascopost.com/issues/february-25-2020/join-the-conquerors-community/ 2020-02-25T20:39:17+00:00 https://ascopost.com/issues/february-25-2020/your-stories-podcast/ 2020-02-25T20:42:25+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/ 2021-06-08T17:57:16+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/conference-highlights-from-2019-ash/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/will-bispecific-antibodies-compete-with-car-t-cell-therapy-in-lymphoma/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/epov-basem-william-and-caron-jacobson/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/blinatumomab-in-young-patients-with-b-cell-all/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/epov-howard-weinstein-and-robert-brodsky/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/bispecific-antibody-shows-activity-in-post-car-t-cell-therapy-for-non-hodgkin-lymphoma/ 2020-02-22T17:10:45+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/early-data-suggest-efficacy-of-innovative-car-nk-cell-therapy-for-b-cell-malignancies/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/combination-brentuximab-vedotin-and-nivolumab-explored-in-hodgkin-lymphoma/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/bcma-targeted-car-t-cell-therapies-for-relapsed-or-refractory-multiple-myeloma/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/epov-thierry-facon-and-michael-jain/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/btk-inhibitor-yields-high-overall-response-rates-in-del17p-cll-and-sll/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/second-generation-btk-inhibitor-alone-and-in-combination-with-obinutuzumab-for-cll/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/epov-javier-pinilla-ibarz/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-25-2020-supplement-conference-highlights-ash-2019/new-data-in-leukemia-lymphoma-and-multiple-myeloma/ 2020-02-20T18:01:08+00:00 https://ascopost.com/issues/february-10-2020/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/february-10-2020/unprecedented-responses-to-cisplatingemcitabine-in-brca-mutated-advanced-pancreatic-cancer/ 2020-02-10T18:20:17+00:00 https://ascopost.com/issues/february-10-2020/epov-richard-schilsky/ 2020-02-10T20:41:28+00:00 https://ascopost.com/issues/february-10-2020/overcoming-barriers-to-alleviating-cancer-related-pain-in-ethiopia/ 2020-02-10T20:41:28+00:00 https://ascopost.com/issues/february-10-2020/a-hopeful-look-ahead-in-oncology/ 2020-02-10T20:41:28+00:00 https://ascopost.com/issues/february-10-2020/neoadjuvant-and-adjuvant-pembrolizumab-improves-pcr-rate-in-tnbc/ 2020-02-18T22:09:05+00:00 https://ascopost.com/issues/february-10-2020/triple-negative-breast-cancer-responds-to-novel-therapy/ 2020-02-18T22:06:30+00:00 https://ascopost.com/issues/february-10-2020/epov-sarah-tolaney/ 2020-02-10T20:41:29+00:00 https://ascopost.com/issues/february-10-2020/real-world-use-of-palbociclib-and-abemaciclib-explored-in-two-studies-based-on-ehr-database/ 2020-02-10T20:41:29+00:00 https://ascopost.com/issues/february-10-2020/epov-harold-burstein/ 2020-02-10T20:41:29+00:00 https://ascopost.com/issues/february-10-2020/addition-of-secondary-surgical-cytoreduction-to-chemotherapy-in-recurrent-platinum-sensitive-ovarian-cancer/ 2020-02-10T20:41:29+00:00 https://ascopost.com/issues/february-10-2020/is-there-a-future-role-for-secondary-cytoreductive-surgery-in-the-treatment-of-recurrent-ovarian-cancer/ 2020-02-10T20:41:29+00:00 https://ascopost.com/issues/february-10-2020/when-added-to-other-systemic-therapies-capecitabine-improves-outcomes-in-triple-negative-breast-cancer/ 2020-02-10T20:41:29+00:00 https://ascopost.com/issues/february-10-2020/fox-chase-cancer-center-welcomes-claudia-kasales/ 2020-02-10T20:41:30+00:00 https://ascopost.com/issues/february-10-2020/susan-sturgeon-receives-nih-grant/ 2020-02-10T20:41:30+00:00 https://ascopost.com/issues/february-10-2020/urology-of-virginia-welcomes-new-chief-medical-officer-joshua-langston/ 2020-02-10T20:41:30+00:00 https://ascopost.com/issues/february-10-2020/ash-presents-2019-joanne-levy-memorial-award-for-outstanding-achievement/ 2020-02-10T20:41:30+00:00 https://ascopost.com/issues/february-10-2020/study-reports-similar-efficacy-but-no-less-toxicity-with-adjuvant-t-dm1-vs-taxanetrastuzumab-in-early-breast-cancer/ 2020-02-10T20:41:31+00:00 https://ascopost.com/issues/february-10-2020/epov-a-jo-chien/ 2020-02-10T20:41:31+00:00 https://ascopost.com/issues/february-10-2020/stand-up-to-cancer-announces-initiative-to-increase-diversity-in-clinical-trials/ 2020-02-10T20:41:31+00:00 https://ascopost.com/issues/february-10-2020/novel-guideline-addresses-the-clinical-utility-of-molecular-biomarkers-in-localized-prostate-cancer/ 2020-02-10T20:41:32+00:00 https://ascopost.com/issues/february-10-2020/asco-guideline-addresses-surveillance-of-lung-cancer-after-curative-intent-therapy/ 2020-02-10T20:41:32+00:00 https://ascopost.com/issues/february-10-2020/fox-chase-cancer-center-certified-under-asco-s-quality-oncology-practice-initiative/ 2020-02-10T20:41:32+00:00 https://ascopost.com/issues/february-10-2020/car-t-cell-therapy-comes-to-mantle-cell-lymphoma/ 2020-02-10T20:41:32+00:00 https://ascopost.com/issues/february-10-2020/epov-basem-william/ 2020-02-10T20:41:33+00:00 https://ascopost.com/issues/february-10-2020/early-steroid-use-may-reduce-toxicity-with-car-t-cell-therapy/ 2020-02-10T20:41:33+00:00 https://ascopost.com/issues/february-10-2020/epov-jeremy-abramson/ 2020-02-10T20:41:33+00:00 https://ascopost.com/issues/february-10-2020/two-clinical-trials-show-zanubrutinib-achieves-high-response-rates-in-del-17p-cll-and-sll/ 2020-02-10T20:41:34+00:00 https://ascopost.com/issues/february-10-2020/epov-joshua-brody/ 2020-02-10T20:41:35+00:00 https://ascopost.com/issues/february-10-2020/real-world-data-for-car-t-cell-therapy-show-benefit-in-older-patients-with-lymphoma/ 2020-02-10T20:41:35+00:00 https://ascopost.com/issues/february-10-2020/epov-michael-jain/ 2020-02-10T20:41:35+00:00 https://ascopost.com/issues/february-10-2020/university-of-maryland-greenebaum-comprehensive-cancer-center-joins-big-ten-cancer-research-consortium/ 2020-02-10T20:41:35+00:00 https://ascopost.com/issues/february-10-2020/how-real-world-data-can-help-contextualize-new-treatments-in-older-patients/ 2020-02-14T14:09:00+00:00 https://ascopost.com/issues/february-10-2020/fda-approves-tazemetostat-for-epithelioid-sarcoma/ 2020-02-10T20:41:36+00:00 https://ascopost.com/issues/february-10-2020/comparing-prescribing-habits-in-academic-and-nonacademic-oncology-settings/ 2020-02-10T20:41:36+00:00 https://ascopost.com/issues/february-10-2020/keynote-158-trial-pembrolizumab-produces-durable-responses-in-select-noncolorectal-tumors/ 2020-02-22T17:14:16+00:00 https://ascopost.com/issues/february-10-2020/asco-s-inaugural-breakthrough-global-summit-showcased-evolving-technologies-poised-to-revolutionize-cancer-care/ 2020-02-22T17:16:33+00:00 https://ascopost.com/issues/february-10-2020/gabrielle-rocque-followed-three-generations-of-doctors-into-a-career-in-medicine/ 2020-02-10T20:41:38+00:00 https://ascopost.com/issues/february-10-2020/ama-foundation-launches-new-initiative-to-address-lgbtq-health-disparities/ 2020-02-10T20:41:38+00:00 https://ascopost.com/issues/february-10-2020/actively-recruiting-clinical-trials-for-cervical-cancer/ 2020-02-10T20:41:38+00:00 https://ascopost.com/issues/february-10-2020/selected-ash-abstracts-on-myelodysplastic-syndromes/ 2020-02-10T20:41:39+00:00 https://ascopost.com/issues/february-10-2020/car-t-cell-gene-therapy-in-non-hodgkin-lymphomas-present-and-future/ 2020-02-22T17:20:21+00:00 https://ascopost.com/issues/february-10-2020/a-retired-oncologist-remains-involved-in-the-science-and-policy-of-oncology/ 2020-02-10T20:41:39+00:00 https://ascopost.com/issues/february-10-2020/doctoring-in-the-digital-age-modern-stressors-ancient-strategies-to-cope/ 2020-02-22T17:23:43+00:00 https://ascopost.com/issues/february-10-2020/addressing-symptom-control-and-palliative-care-needs/ 2020-02-22T17:27:58+00:00 https://ascopost.com/issues/february-10-2020/denial-s-many-faces/ 2020-02-22T17:28:29+00:00 https://ascopost.com/issues/february-10-2020/karen-l-reckamp-md-ms-to-head-medical-oncology-at-cedars-sinai-cancer/ 2020-02-10T20:41:40+00:00 https://ascopost.com/issues/february-10-2020/seattle-cancer-care-alliance-appoints-aaron-crane-as-executive-vice-president/ 2020-02-10T20:41:40+00:00 https://ascopost.com/issues/february-10-2020/dolores-hambardzumyan-phd-mba-joins-neurosurgery-faculty-at-mount-sinai/ 2020-02-10T20:41:40+00:00 https://ascopost.com/issues/february-10-2020/prevent-cancer-foundation-benefits-global-cancer-research/ 2020-02-10T20:41:40+00:00 https://ascopost.com/issues/february-10-2020/laura-van-t-veer-phd-honored-with-precision-medicine-world-conference-luminary-award/ 2020-02-10T20:41:40+00:00 https://ascopost.com/issues/february-10-2020/luspatercept-in-transfusion-dependent-lower-risk-myelodysplastic-syndromes/ 2020-02-10T20:41:40+00:00 https://ascopost.com/issues/february-10-2020/activity-of-belantamab-mafodotin-in-patients-with-heavily-pretreated-relapsed-or-refractory-multiple-myeloma/ 2020-10-15T18:03:33+00:00 https://ascopost.com/issues/february-10-2020/is-there-an-association-between-powder-use-and-risk-of-ovarian-cancer/ 2020-02-10T20:41:41+00:00 https://ascopost.com/issues/february-10-2020/addition-of-olaparib-to-bevacizumab-maintenance-in-patients-with-advanced-ovarian-cancer-responding-to-first-line-therapy/ 2020-02-10T20:41:41+00:00 https://ascopost.com/issues/february-10-2020/genomics-guided-molecular-targeted-therapy-gave-me-back-my-life/ 2020-02-10T20:41:41+00:00 https://ascopost.com/issues/february-10-2020/douglas-hanahan-phd-appointed-distinguished-scholar-of-the-ludwig-institute-for-cancer-research/ 2020-02-10T20:41:41+00:00 https://ascopost.com/issues/february-10-2020/damon-runyon-cancer-research-foundation-awards-early-career-scientists/ 2020-02-10T20:41:41+00:00 https://ascopost.com/issues/february-10-2020/surgeon-general-releases-report-focused-on-smoking-cessation/ 2020-02-10T20:41:42+00:00 https://ascopost.com/issues/february-10-2020/clinical-cancer-advances-2020/ 2020-02-10T20:41:42+00:00 https://ascopost.com/issues/february-10-2020/clinical-cancer-advances-2020-asco-names-advance-of-the-year-issues-research-priorities-for-the-cancer-community/ 2020-02-10T20:41:42+00:00 https://ascopost.com/issues/february-10-2020/free-practice-resource-cancernet-patient-referral-cards/ 2020-02-10T20:41:42+00:00 https://ascopost.com/issues/february-10-2020/join-the-conquerors-community/ 2020-02-10T20:41:42+00:00 https://ascopost.com/issues/february-10-2020/over-30-oncology-practices-achieve-asco-s-qopi-certification-in-fourth-quarter-of-2019/ 2020-02-10T20:41:42+00:00 https://ascopost.com/issues/february-10-2020/asco-analysis-demonstrates-need-to-harmonize-disclosure-policies-across-medicine/ 2020-02-10T20:41:43+00:00 https://ascopost.com/issues/february-10-2020/congress-increases-federal-investment-in-cancer-research-raises-tobacco-purchasing-age/ 2020-02-10T20:41:43+00:00 https://ascopost.com/issues/february-10-2020/a-breast-cancer-clinical-trial-includes-a-meal-delivery-service-in-prescribing-a-diet-to-conquer-cancer/ 2020-02-10T20:41:43+00:00 https://ascopost.com/issues/january-25-2020/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/january-25-2020/tucatinib-combination-extends-survival-in-her2-positive-metastatic-breast-cancer/ 2020-02-26T15:36:22+00:00 https://ascopost.com/issues/january-25-2020/practicing-wellness-to-reduce-burnout/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/blinatumomab-outperforms-chemotherapy-as-post-reinduction-consolidation-therapy-in-younger-patients-with-b-cell-all/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/epov-howard-weinstein/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/preliminary-data-on-multiantigen-targeted-car-nk-cell-therapy-for-b-cell-malignancies/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/epov-gary-schiller/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/breast-cancer-chemoprevention-effect-maintained-long-after-stopping-anastrozole-therapy/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/epov-debra-patt-and-c-kent-osborne/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/ovarian-tissue-cryopreservation-to-preserve-fertility-in-pediatric-patients-with-cancer/ 2020-01-24T20:33:10+00:00 https://ascopost.com/issues/january-25-2020/emerging-fertoprotective-therapeutic-options-for-female-fertility-preservation/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/first-line-immunotherapy-combination-for-patients-with-advanced-nsclc-and-comorbidities-or-poor-performance-status/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/sitravatinibtislelizumab-shows-antitumor-activity-in-ovarian-cancer/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/cxcr4-inhibitor-in-combination-with-pembrolizumabchemotherapy-for-metastatic-pancreatic-cancer/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/gilteritinib-improves-overall-survival-in-relapsed-or-refractory-flt3-mutated-aml/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/more-than-standard-chemotherapy-needed-for-flt3-mutant-advanced-aml/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/fda-approves-avapritinib-for-pdgfra-mutated-gastrointestinal-stromal-tumor/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/fda-approves-pd-1-inhibitor-for-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer/ 2020-01-24T20:33:11+00:00 https://ascopost.com/issues/january-25-2020/brentuximab-vedotin-plus-nivolumab-in-hodgkin-lymphoma/ 2020-01-24T20:44:28+00:00 https://ascopost.com/issues/january-25-2020/epov-michael-jain/ 2020-01-24T20:44:28+00:00 https://ascopost.com/issues/january-25-2020/olaparib-as-maintenance-therapy-for-germline-brca-mutated-metastatic-pancreatic-adenocarcinoma/ 2020-01-24T20:44:28+00:00 https://ascopost.com/issues/january-25-2020/selected-abstracts-on-new-therapies-for-newly-diagnosed-multiple-myeloma/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/fda-approves-olaparib-for-patients-with-germline-brca-mutated-metastatic-pancreatic-cancer/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-patients-with-unresectable-or-metastatic-her2-positive-breast-cancer/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/selected-abstracts-on-novel-therapies-for-chronic-myeloid-leukemia/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/oral-cc-486-maintenance-therapy-extends-survival-in-older-patients-with-aml/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/study-suggests-new-approaches-needed-to-manage-ibrutinib-related-toxicities-in-patients-with-cll/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/mixed-results-with-weekly-nab-paclitaxel-denosumab-in-primary-breast-cancer/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/fda-approves-enzalutamide-for-patients-with-metastatic-castration-sensitive-prostate-cancer/ 2020-01-24T20:44:29+00:00 https://ascopost.com/issues/january-25-2020/extended-letrozole-boosts-disease-free-survival-in-10-year-update-of-nsabp-b-42-trial/ 2020-01-24T20:44:30+00:00 https://ascopost.com/issues/january-25-2020/epov-debra-patt/ 2020-01-24T20:44:30+00:00 https://ascopost.com/issues/january-25-2020/residual-cancer-burden-is-prognostic-of-outcomes-across-breast-cancer-subtypes/ 2020-12-12T22:10:58+00:00 https://ascopost.com/issues/january-25-2020/epov-hope-rugo-and-laura-esserman/ 2020-01-24T20:44:30+00:00 https://ascopost.com/issues/january-25-2020/partial-breast-irradiation-favored-over-whole-breast-in-early-breast-cancer/ 2020-01-24T20:44:30+00:00 https://ascopost.com/issues/january-25-2020/epov-shelley-hwang/ 2020-01-24T20:44:30+00:00 https://ascopost.com/issues/january-25-2020/kunle-odunsi-elected-to-lead-aacr-immunology-working-group/ 2020-01-24T20:44:30+00:00 https://ascopost.com/issues/january-25-2020/elizabeth-fox-named-svp-of-clinical-trials-research-at-st-jude/ 2020-01-24T20:44:30+00:00 https://ascopost.com/issues/january-25-2020/studies-find-estrogen-alone-protective-estrogen-plus-progestin-detrimental-in-postmenopausal-women/ 2020-01-29T22:31:26+00:00 https://ascopost.com/issues/january-25-2020/epov-charles-shapiro/ 2020-01-24T20:53:38+00:00 https://ascopost.com/issues/january-25-2020/six-year-aphinity-trial-update/ 2020-01-29T22:30:05+00:00 https://ascopost.com/issues/january-25-2020/epov-steven-isakoff/ 2020-01-24T20:53:38+00:00 https://ascopost.com/issues/january-25-2020/celebrating-20-years-of-world-cancer-day/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/dana-farber-to-establish-chen-huang-center-for-egfr-mutant-lung-cancers/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/dolores-hambardzumyan-joins-faculty-at-mount-sinai/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/oral-paclitaxel-outperforms-intravenous-formulation-in-phase-iii-trial/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/epov-virginia-kaklamani-steven-vogl-gary-lyman-ginny-mason/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/yale-cancer-center-launches-center-for-community-engagement-and-health-equity/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/acs-welcomes-three-new-members-to-the-board-of-directors/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/patient-access-to-high-quality-oncologic-pathology-improves-care/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/stephanie-lee-begins-term-as-ash-president/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/two-new-grants-to-support-transformative-cancer-research/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/value-based-and-patient-centered-cancer-care/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/fda-s-pilot-project-patient-voice-website-and-workshop-with-asco/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/transplantation-specialist-karen-ballen-treasures-long-term-connections-with-her-patients/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/steven-kalkanis-selected-to-lead-henry-ford-medical-group/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/cancercare-to-provide-support-for-patients-with-cancer-impacted-by-the-california-wildfires/ 2020-01-24T20:53:39+00:00 https://ascopost.com/issues/january-25-2020/felix-feng-strives-for-balance-between-work-and-family-life/ 2020-01-24T20:53:40+00:00 https://ascopost.com/issues/january-25-2020/javelin-bladder-100-study-of-avelumab-for-urothelial-cancer-meets-primary-endpoint/ 2020-12-12T22:16:48+00:00 https://ascopost.com/issues/january-25-2020/new-nccn-pediatric-cancer-guidelines-for-b-cell-lymphomas/ 2020-01-24T20:53:40+00:00 https://ascopost.com/issues/january-25-2020/supportive-care-in-oncology-symposium-emphasized-caring-for-the-whole-patient-from-diagnosis-to-end-of-life/ 2020-01-24T20:53:40+00:00 https://ascopost.com/issues/january-25-2020/impact-of-the-nci-cell-line-database/ 2020-02-25T17:54:55+00:00 https://ascopost.com/issues/january-25-2020/pembrolizumab-in-kras-mutant-and-wild-type-pd-l1-positive-nonsquamous-nsclc/ 2020-01-24T20:53:40+00:00 https://ascopost.com/issues/january-25-2020/african-americans-with-cancer-at-higher-risk-for-blood-clots/ 2020-01-27T21:36:06+00:00 https://ascopost.com/issues/january-25-2020/enzalutamide-for-metastatic-castration-sensitive-prostate-cancer/ 2020-01-24T20:53:40+00:00 https://ascopost.com/issues/january-25-2020/fda-grants-breakthrough-therapy-designation-to-tucatinib-in-combination-therapy-for-her2-positive-breast-cancer/ 2020-01-24T21:20:53+00:00 https://ascopost.com/issues/january-25-2020/seven-haircuts/ 2020-01-28T17:24:38+00:00 https://ascopost.com/issues/january-25-2020/forbes-magazine-names-2020-class-of-30-under-30/ 2020-01-24T20:53:40+00:00 https://ascopost.com/issues/january-25-2020/society-for-integrative-oncology-s-16th-international-conference/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/the-anesthesia-era-1845-1875/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/a-caregiver-s-tale-of-struggle-and-lingering-questions/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/a-deeper-understanding-of-the-miracle-of-the-human-body/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/ash-honors-member-of-congress-and-leaders-of-niddk-and-nci/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/atezolizumab-with-chemotherapy-for-metastatic-nonsquamous-nsclc-without-egfralk-aberrations/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/fam-trastuzumab-deruxtecan-nxki-for-previously-treated-unresectable-or-metastatic-her2-positive-breast-cancer/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/enfortumab-vedotin-ejfv-for-previously-treated-advanced-urothelial-cancer/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/fred-hutch-names-thomas-j-lynch-new-president-and-director/ 2020-01-24T20:53:41+00:00 https://ascopost.com/issues/january-25-2020/recurrence-risk-in-black-and-white-women-with-borderline-estrogen-receptor-positive-breast-cancer/ 2020-04-13T14:41:47+00:00 https://ascopost.com/issues/january-25-2020/first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/tivo-3-third-or-fourth-line-tivozanib-vs-sorafenib-in-metastatic-renal-cell-carcinoma/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/olaparib-for-previously-treated-metastatic-castration-resistant-prostate-cancer-with-dna-repair-gene-aberrations/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/community-oncology-alliance-elects-officers-and-new-board-members-for-2020/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/aaci-marks-milestone-with-new-member/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/cancer-no-longer-scares-me/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/accc-project-focuses-on-improving-care-of-older-adults-with-cancer/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/cleveland-clinic-taussig-cancer-institute-recognizes-new-staff-new-appointments/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/innovator-and-leader-in-radiation-oncology-eli-j-glatstein-dies/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/largest-single-year-drop-in-cancer-mortality-ever-reported-2016-2017/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/asco-announces-newly-elected-leadership/ 2020-01-24T20:53:42+00:00 https://ascopost.com/issues/january-25-2020/asco-releases-major-update-to-payment-reform-model/ 2020-01-24T20:53:43+00:00 https://ascopost.com/issues/january-25-2020/motivating-yourself-for-exercise-goals-in-the-new-year/ 2020-01-24T20:53:43+00:00 https://ascopost.com/issues/january-25-2020/stock-your-practice-with-trusted-patient-information-resources-from-asco/ 2020-01-24T20:53:43+00:00 https://ascopost.com/issues/january-25-2020/optimizing-metabolic-discoveries/ 2020-01-24T20:53:43+00:00 https://ascopost.com/issues/january-25-2020/ten-oncology-practices-in-underserved-communities-receive-funding-to-participate-in-quality-improvement-programs/ 2020-01-24T20:53:43+00:00 https://ascopost.com/issues/december-25-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/december-25-2019/novel-antibody-drug-conjugate-shows-efficacy-in-women-with-pretreated-metastatic-her2-positive-breast-cancer/ 2019-12-24T15:26:32+00:00 https://ascopost.com/issues/december-25-2019/epov-steven-isakoff/ 2019-12-24T15:26:32+00:00 https://ascopost.com/issues/december-25-2019/bispecific-antibody-in-non-hodgkin-lymphoma/ 2019-12-24T15:26:32+00:00 https://ascopost.com/issues/december-25-2019/time-to-treatment-is-a-priority/ 2019-12-24T15:26:32+00:00 https://ascopost.com/issues/december-25-2019/phase-ibii-studies-explore-next-generation-bcma-targeted-car-t-cell-therapies-in-multiple-myeloma/ 2019-12-24T15:26:32+00:00 https://ascopost.com/issues/december-25-2019/epov-thierry-facon-and-michael-jain/ 2019-12-24T15:26:33+00:00 https://ascopost.com/issues/december-25-2019/veliparibchemotherapy-combination-active-in-her2-negative-brca-positive-advanced-breast-cancer/ 2019-12-24T15:26:33+00:00 https://ascopost.com/issues/december-25-2019/epov-sherene-loi/ 2019-12-24T15:26:33+00:00 https://ascopost.com/issues/december-25-2019/stephen-hahn-confirmed-as-fda-commissioner-by-senate/ 2019-12-24T15:26:33+00:00 https://ascopost.com/issues/december-25-2019/mri-guided-ultrasound-treatment-for-localized-prostate-cancer/ 2019-12-24T15:26:33+00:00 https://ascopost.com/issues/december-25-2019/improved-prevention-of-gvhd-reported-with-posttransplant-cyclophosphamide/ 2019-12-24T15:26:33+00:00 https://ascopost.com/issues/december-25-2019/epov-preet-chaudhary/ 2019-12-24T15:26:33+00:00 https://ascopost.com/issues/december-25-2019/lls-and-ash-team-up-to-connect-patients-with-blood-cancer-to-clinical-trials/ 2019-12-24T15:26:34+00:00 https://ascopost.com/issues/december-25-2019/pembrolizumab-vs-cetuximab-plus-chemotherapy-in-recurrent-or-metastatic-headneck-squamous-cell-cancer/ 2019-12-24T15:26:34+00:00 https://ascopost.com/issues/december-25-2019/immunotherapy-for-headneck-squamous-cell-carcinoma-questions-raised-by-keynote-048/ 2019-12-24T15:26:34+00:00 https://ascopost.com/issues/december-25-2019/new-award-and-grant-to-support-pediatric-cancer-research/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/oncology-analytics-appoints-lee-newcomer-as-strategic-advisor/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/pembrolizumab-in-relapsed-or-refractory-primary-mediastinal-large-b-cell-lymphoma/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/improving-the-precision-of-checkpoint-blockade-in-patients-with-diffuse-large-b-cell-lymphoma/ 2020-01-19T20:40:21+00:00 https://ascopost.com/issues/december-25-2019/relapsed-or-refractory-multiple-myeloma-outcomes-improving-exponentially/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/taking-a-reasonable-approach-to-treating-newly-diagnosed-multiple-myeloma/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/a-systematic-approach-to-identifying-the-molecular-factors-that-lead-to-cancer-progression/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/biosimilar-to-rituximab-for-non-hodgkin-lymphoma/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/targeted-triplet-therapy-improved-overall-survival-in-braf-mutated-colorectal-cancer/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/epov-alfredo-falcone/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/study-links-sustained-weight-loss-to-reduced-breast-cancer-risk/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/v-craig-jordan-receives-award-at-buckingham-palace/ 2019-12-24T15:26:35+00:00 https://ascopost.com/issues/december-25-2019/asco-s-national-cancer-opinion-survey-finds-gaps-in-knowledge-on-cancer-prevention-and-the-dangers-of-e-cigarettes/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/asconcoda-release-standards-for-medically-integrated-dispensing-of-oral-anticancer-drugs/ 2020-01-07T19:41:56+00:00 https://ascopost.com/issues/december-25-2019/acalabrutinib-for-adult-patients-with-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/ashwani-rajput-md-named-director-of-johns-hopkins-kimmel-cancer-center-for-washington-dc-region/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/j-jack-lee-phd-of-md-anderson-cancer-center-earns-election-as-aaas-fellow/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/new-cancer-center-and-partnership-with-sarah-cannon-cancer-institute-at-hca-midwest-health/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/accc-project-focuses-on-multidisciplinary-care-of-cutaneous-squamous-cell-carcinoma/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/coexisting-with-cancer-and-depression/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/how-to-give-effective-presentation-feedback/ 2025-03-13T18:51:50+00:00 https://ascopost.com/issues/december-25-2019/grief-symptom-levels-in-parents-of-children-who-have-died-of-cancer/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/long-term-data-on-brigatinib-in-first-line-setting-of-alk-positive-non-small-cell-lung-cancer/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/mobile-app-designed-to-match-patients-with-metastatic-breast-cancer-with-clinical-trials/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/early-research-shows-potential-new-targets-in-treating-glioblastoma-colorectal-cancer-and-pancreatic-ductal-adenocarcinoma/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/pembrolizumab-in-adjuvant-treatment-of-melanoma-with-involvement-of-lymph-nodes-after-complete-resection/ 2019-12-24T15:26:36+00:00 https://ascopost.com/issues/december-25-2019/lung-cancer-expert-julie-brahmer-was-an-early-believer-in-immunotherapy/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2020-02-04T15:54:35+00:00 https://ascopost.com/issues/december-25-2019/selected-abstracts-from-the-2019-ash-annual-meeting-exposition/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/gilteritinib-for-relapsed-or-refractory-aml-with-flt3-mutation/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/american-cancer-society-and-flatiron-health-launch-real-world-data-impact-award/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/companion-diagnostic-approved-for-alpelisibfulvestrant-therapy/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/global-survey-shows-misperceptions-about-lung-cancer-among-the-general-public/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/dana-farber-researcher-receives-victoria-mock-new-investigator-award-from-ons/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/the-antiseptic-era-1876-1900/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/the-rise-and-fall-of-tobacco-products-in-the-united-states/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/incidence-of-squamous-cell-carcinoma-of-the-anus-has-increased-in-older-women-and-young-black-men/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/explaining-risk-factors-related-to-anal-cancer/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/hair-dye-and-chemical-straightener-use-may-increase-breast-cancer-risk/ 2019-12-24T15:26:37+00:00 https://ascopost.com/issues/december-25-2019/does-the-addition-of-ramucirumab-to-docetaxel-improve-overall-survival-in-previously-treated-urothelial-carcinoma/ 2019-12-24T15:26:38+00:00 https://ascopost.com/issues/december-25-2019/sequencing-of-enzalutamide-and-abiraterone-acetate-in-metastatic-castration-resistant-prostate-cancer/ 2019-12-24T15:26:38+00:00 https://ascopost.com/issues/december-25-2019/swedish-study-of-risk-adapted-screening-starting-ages-for-relatives-of-patients-with-breast-cancer/ 2019-12-24T15:26:38+00:00 https://ascopost.com/issues/december-25-2019/breast-conserving-surgery-and-partial-breast-reirradiation-in-patients-with-ipsilateral-disease-recurrence/ 2019-12-24T15:26:38+00:00 https://ascopost.com/issues/december-25-2019/my-dream-is-that-multiple-myeloma-will-one-day-be-in-my-past-and-no-longer-a-part-of-my-future/ 2019-12-24T15:26:38+00:00 https://ascopost.com/issues/december-25-2019/edmondo-robinson-joins-moffitt-as-chief-digital-innovation-officer/ 2020-01-10T20:55:15+00:00 https://ascopost.com/issues/december-25-2019/professor-jean-charles-soria-appointed-general-director-of-gustave-roussy/ 2019-12-24T15:26:38+00:00 https://ascopost.com/issues/december-25-2019/trastuzumab-and-hyaluronidase-oysk-for-subcutaneous-use-in-her2-positive-breast-cancer/ 2019-12-24T15:42:47+00:00 https://ascopost.com/issues/december-25-2019/asco-and-iaslc-collaborate-to-improve-the-quality-of-lung-cancer-care-in-brazil/ 2019-12-24T17:26:16+00:00 https://ascopost.com/issues/december-25-2019/cms-finalizes-updates-to-em-codes-establishes-mips-value-pathways/ 2019-12-24T17:28:43+00:00 https://ascopost.com/issues/december-25-2019/spotlight-on-women-who-conquer-cancer/ 2019-12-24T17:32:25+00:00 https://ascopost.com/issues/december-25-2019/highlights-from-the-2019-asco-research-community-forum-annual-meeting/ 2019-12-24T17:34:36+00:00 https://ascopost.com/issues/december-25-2019/make-a-holiday-gift-to-conquer-cancer/ 2019-12-24T17:37:54+00:00 https://ascopost.com/issues/december-25-2019/preliminary-study-finds-asco-decision-aid-may-improve-quality-of-serious-adverse-events-reporting/ 2019-12-24T17:40:11+00:00 https://ascopost.com/issues/december-25-2019/final-answers/ 2019-12-24T17:43:42+00:00 https://ascopost.com/issues/december-25-2019/help-patients-learn-how-to-manage-pain-effectively/ 2019-12-24T17:48:42+00:00 https://ascopost.com/issues/december-25-2019/your-stories-podcast-to-return-in-2020-with-new-episodes/ 2019-12-24T17:50:49+00:00 https://ascopost.com/issues/december-10-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/december-10-2019/addition-of-daratumumab-increases-benefit-of-carfilzomibdexamethasone-in-multiple-myeloma/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/epov-joshua-richter/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/ramucirumab-plus-erlotinib-improves-progression-free-survival-in-previously-untreated-egfr-mutated-advanced-nsclc/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/databases-where-math-meets-medicine/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/immunotherapy-strategies-in-renal-cell-carcinoma/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/biomarker-driven-treatment-selection-for-prostate-and-other-genitourinary-cancers/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/is-nonmetastatic-castration-resistant-prostate-cancer-a-valid-disease-category/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/emerging-alternatives-in-the-third-line-setting-for-metastatic-her2-positive-breast-cancer/ 2019-12-10T17:25:07+00:00 https://ascopost.com/issues/december-10-2019/claridhy-and-fight-202-trials-show-positive-results-in-the-treatment-of-patients-with-biliary-tract-cancer/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/epov-angela-lamarca-ian-chau-and-per-pfeiffer/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/ash-recognized-choosing-wisely-champions-at-2019-annual-meeting/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/multidimensional-palliative-care/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/fda-approves-voxelotor-for-sickle-cell-disease/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/making-inroads-with-interventional-oncology-in-the-treatment-of-solid-tumors/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/survival-benefit-with-trilaciclib-plus-chemotherapy-in-triple-negative-breast-cancer/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/epov-mafalda-oliveira/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/2019-advanced-breast-cancer-award-goes-to-fatima-cardoso-md/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/checkpoint-inhibitor-pneumonitis/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/elaine-fuchs-to-present-annual-block-lecture-at-ohio-state-university-comprehensive-ca-center/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/potential-new-treatments-for-triple-negative-breast-cancer/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/trastuzumab-biosimilar-hlx02-shows-activity-in-her2-positive-metastatic-breast-cancer/ 2020-09-25T01:17:42+00:00 https://ascopost.com/issues/december-10-2019/combination-of-atezolizumab-and-bevacizumab-for-unresectable-hepatocellular-carcinoma/ 2020-09-25T01:11:22+00:00 https://ascopost.com/issues/december-10-2019/erlotinib-plus-ramucirumab/ 2020-01-15T21:06:31+00:00 https://ascopost.com/issues/december-10-2019/niraparib-for-homologous-recombination-deficiency-positive-advanced-ovarian-cancer/ 2019-12-10T17:25:08+00:00 https://ascopost.com/issues/december-10-2019/how-the-promise-study-aims-to-convert-multiple-myeloma-into-a-preventable-cancer/ 2019-12-10T17:25:09+00:00 https://ascopost.com/issues/december-10-2019/i-do-not-have-a-multiple-myeloma-precursor-condition/ 2019-12-19T17:42:05+00:00 https://ascopost.com/issues/december-10-2019/jop-editor-in-chief-brings-value-based-care-to-journal-s-forefront/ 2019-12-10T17:25:09+00:00 https://ascopost.com/issues/december-10-2019/conquer-cancer-the-asco-foundation-hosts-scientific-and-career-development-retreat/ 2019-12-10T17:25:09+00:00 https://ascopost.com/issues/december-10-2019/what-are-tumor-marker-tests-for-cancer/ 2020-09-25T01:20:26+00:00 https://ascopost.com/issues/december-10-2019/new-policy-brief-explains-how-co-pay-accumulators-maximizers-increase-cost-of-cancer-care-for-patients/ 2020-09-25T01:14:27+00:00 https://ascopost.com/issues/december-10-2019/your-stories-podcast-returns-in-2020-with-new-episodes/ 2020-09-25T01:22:14+00:00 https://ascopost.com/issues/december-10-2019/first-department-of-veterans-affairs-system-achieves-qopi-certification/ 2019-12-10T17:25:09+00:00 https://ascopost.com/issues/december-10-2019/make-a-holiday-gift-to-conquer-cancer/ 2020-09-25T01:13:39+00:00 https://ascopost.com/issues/december-10-2019/iaslc-appoints-chandra-belani-as-new-chief-science-officer/ 2019-12-10T17:25:09+00:00 https://ascopost.com/issues/december-10-2019/mary-claire-king-joins-new-york-genome-center/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/assessing-cancer-pain-management-in-the-era-of-the-opioid-epidemic/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/enfortumab-vedotin-active-in-platinum-and-pd-1l1-pretreated-urothelial-carcinoma/ 2020-09-25T01:12:35+00:00 https://ascopost.com/issues/december-10-2019/enfortumab-vedotin-and-other-developments/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/impact-of-malnutrition-and-physical-inactivity-on-cancer-care/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/mary-jo-turk-named-o-ross-mcintyre-professor-at-dartmouth/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/first-line-pembrolizumab-plus-axitinib-for-advanced-renal-cell-carcinoma/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/fda-approves-pd-l1-inhibitor-plus-chemotherapy-for-first-line-treatment-of-metastatic-nonsquamous-non-small-cell-lung-cancer/ 2019-12-23T20:24:06+00:00 https://ascopost.com/issues/december-10-2019/an-early-interest-in-biology-and-people-led-to-a-career-in-oncology-for-nina-shah/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/carolyn-meltzer-joins-board-of-directors-for-rsna/ 2019-12-10T17:25:10+00:00 https://ascopost.com/issues/december-10-2019/prior-antibiotic-treatment-linked-to-poorer-outcomes-with-immunotherapy-in-patients-with-cancer/ 2020-09-25T01:16:33+00:00 https://ascopost.com/issues/december-10-2019/antibiotics-and-immune-checkpoint-blockade-in-patients-with-cancer/ 2019-12-20T15:44:58+00:00 https://ascopost.com/issues/december-10-2019/working-to-improve-survival-rates-in-pancreatic-cancer/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/ash-releases-new-clinical-practice-guidelines-on-immune-thrombocytopenia/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/collaborative-trial-to-evaluate-imaging-methods-for-women-with-dense-breasts/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/studies-show-us-health-care-system-hampered-by-waste-and-trailing-other-high-income-countries/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/nccn-updates-genetic-screening-guidelines/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/partners-healthcare-to-become-mass-general-brigham/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/alan-hutson-to-serve-on-st-jude-children-s-research-hospital-data-safety-monitoring-board/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/accc-project-focuses-on-multidisciplinary-care-of-cutaneous-squamous-cell-carcinoma/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/global-survey-shows-misperceptions-about-lung-cancer-among-the-general-public/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/pretreatment-vitamin-d-deficiency-in-patients-receiving-first-line-treatment-for-hodgkin-lymphoma/ 2020-09-25T01:15:29+00:00 https://ascopost.com/issues/december-10-2019/zanubrutinib-in-previously-treated-mantle-cell-lymphoma/ 2019-12-10T17:25:11+00:00 https://ascopost.com/issues/december-10-2019/role-of-integrative-therapies-for-patients-with-colorectal-cancer/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/study-investigates-quality-of-life-scores-as-prognostic-factors-in-patients-with-cancer/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/having-cancer-should-not-make-you-homeless/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/ctdna-and-recurrence-risk-after-surgery-and-adjuvant-chemotherapy-for-stage-iii-colon-cancer/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/colorectal-cancer-screening-with-fecal-immunochemical-testing-sigmoidoscopy-or-colonoscopy-for-patients-aged-50-to-79/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/nivolumab-plus-bevacizumab-in-relapsed-ovarian-cancer/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/thermal-ablation-vs-cryotherapy-or-loop-excision-in-zambian-women-positive-for-cervical-precancer/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/scott-gerber-named-inaugural-kenneth-e-and-carol-l-weg-distinguished-professor-at-dartmouth/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/december-10-2019/hematologist-oncologist-augustine-perrotta-dies/ 2019-12-10T17:25:12+00:00 https://ascopost.com/issues/november-25-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/november-25-2019/nivolumabipilimumab-another-first-line-option-for-advanced-nsclc/ 2019-11-25T20:36:56+00:00 https://ascopost.com/issues/november-25-2019/epov-sanjay-popat/ 2019-11-25T21:30:31+00:00 https://ascopost.com/issues/november-25-2019/challenging-the-global-community-to-deliver-equitable-cancer-care-for-all/ 2019-11-25T21:49:45+00:00 https://ascopost.com/issues/november-25-2019/prescribing-hope/ 2019-11-25T21:30:31+00:00 https://ascopost.com/issues/november-25-2019/breast-cancer-treatments-targeting-estrogen-may-be-putting-patients-at-risk-for-long-term-comorbidities/ 2019-12-04T16:18:28+00:00 https://ascopost.com/issues/november-25-2019/circulating-tumor-dna-a-prognostic-marker-in-stage-iii-colon-cancer/ 2019-11-25T21:30:32+00:00 https://ascopost.com/issues/november-25-2019/pivotal-study-reports-positive-findings-in-fourth-line-setting-for-advanced-gist/ 2019-11-25T21:30:32+00:00 https://ascopost.com/issues/november-25-2019/confirmation-hearing-for-fda-commissioner-nominee-stephen-hahn-md/ 2019-11-25T21:30:32+00:00 https://ascopost.com/issues/november-25-2019/role-of-physical-activity-in-cancer-treatment-and-survivorship/ 2019-11-25T21:30:32+00:00 https://ascopost.com/issues/november-25-2019/ethan-basch-receives-accc-clinical-research-award/ 2019-11-25T21:30:32+00:00 https://ascopost.com/issues/november-25-2019/ash-honors-posthumously-stanley-l-schrier-with-2019-exemplary-service-award/ 2019-11-25T21:30:33+00:00 https://ascopost.com/issues/november-25-2019/clinically-meaningful-outcomes-seen-in-two-studies-of-first-line-immunotherapy-for-hepatocellular-carcinoma/ 2019-11-25T21:30:33+00:00 https://ascopost.com/issues/november-25-2019/epov-arndt-vogel-and-angela-lamarca/ 2019-11-25T21:30:33+00:00 https://ascopost.com/issues/november-25-2019/award-winners-named-for-2019-san-antonio-breast-cancer-symposium/ 2019-11-25T21:30:33+00:00 https://ascopost.com/issues/november-25-2019/new-collaboration-offers-personalized-guidelines-for-patients/ 2019-11-25T21:30:33+00:00 https://ascopost.com/issues/november-25-2019/fda-office-of-hematology-oncology-products-reorganized-renamed-office-of-oncologic-diseases/ 2019-11-25T21:30:33+00:00 https://ascopost.com/issues/november-25-2019/nivolumab-vs-chemotherapy-in-advanced-esophageal-cancer/ 2019-11-25T21:30:33+00:00 https://ascopost.com/issues/november-25-2019/epov-ian-chau/ 2019-11-25T21:30:34+00:00 https://ascopost.com/issues/november-25-2019/immunotherapy-shows-strong-benefit-in-two-gynecologic-cancers/ 2019-11-25T21:30:34+00:00 https://ascopost.com/issues/november-25-2019/epov-nicoletta-colombo/ 2019-11-25T21:30:34+00:00 https://ascopost.com/issues/november-25-2019/2019-mary-pazdur-award-for-excellence-in-advanced-practice-in-oncology/ 2019-11-25T21:30:34+00:00 https://ascopost.com/issues/november-25-2019/study-finds-durvalumab-retreatment-active-in-some-patients-with-advanced-solid-tumors/ 2019-11-25T21:30:34+00:00 https://ascopost.com/issues/november-25-2019/epov-marleen-kok/ 2019-11-25T21:30:34+00:00 https://ascopost.com/issues/november-25-2019/christian-a-koch-joins-fox-chase/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/stanford-medicine-division-of-oncology-welcomes-three-new-faculty-members/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/novel-therapies-for-small-cell-lung-cancer-and-neuroendocrine-tumors/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/thomas-gajewski-receives-esmo-award-for-immuno-oncology/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/first-line-nivolumab-plus-ipilimumab-in-special-populations-with-non-small-cell-lung-cancer/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/final-overall-survival-results-of-impower131-trial-in-advanced-squamous-nsclc/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/oncology-massage-therapy-for-chemotherapy-induced-peripheral-neuropathy/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/epov-charles-l-loprinzi/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/analysis-of-4-year-survival-with-nivolumab-in-patients-previously-treated-for-advanced-nsclc/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/long-term-survival-with-pd-1pd-l1-inhibitors-in-nsclc/ 2019-12-23T20:28:19+00:00 https://ascopost.com/issues/november-25-2019/university-of-michigan-cancer-programs-receive-92m-grant-for-prostate-cancer-research/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/pioneer-in-ct-screening-for-early-lung-cancer-works-to-move-the-field-forward/ 2019-12-23T20:30:14+00:00 https://ascopost.com/issues/november-25-2019/study-finds-sexual-health-issues-are-a-concern-among-majority-of-women-with-breast-cancer/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/epov-charles-loprinzi/ 2019-11-25T21:30:35+00:00 https://ascopost.com/issues/november-25-2019/early-palliative-care-for-patients-with-hematologic-malignancies-beneficial-but-underused/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/epov-oreofe-olukemi-odejide/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/dexamethasone-plus-exercise-may-reduce-fatigue-in-patients-with-advanced-cancer/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/epov-eduardo-bruera/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/what-is-the-best-palliation-for-end-stage-lung-cancer/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/new-alliance-established-to-help-improve-cancer-care-in-sub-saharan-africa/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/when-to-consider-local-therapy-for-stage-iv-breast-cancer/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/using-the-nobel-prize-to-champion-curiosity-driven-research-in-cancer/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/national-academy-of-medicine-elects-new-members-including-many-from-oncology-community/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/accc-award-presented-to-paul-d-hansen/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/nicholas-petrelli-receives-tilton-award-from-medical-society-of-delaware/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/5-year-efficacy-outcomes-with-dabrafenib-plus-trametinib-in-braf-mutated-metastatic-melanoma/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/reflections-on-long-term-outcomes-with-brafmek-inhibition-in-advanced-melanoma/ 2019-11-25T21:30:36+00:00 https://ascopost.com/issues/november-25-2019/fda-grants-accelerated-approval-to-zanubrutinib-for-pretreated-mantle-cell-lymphoma/ 2019-11-25T21:30:37+00:00 https://ascopost.com/issues/november-25-2019/fda-approves-luspatercept-aamt-for-anemia-in-patients-with-beta-thalassemia/ 2019-11-25T21:30:37+00:00 https://ascopost.com/issues/november-25-2019/breast-cancer-research-foundation-honors-eric-winer-with-jill-rose-award/ 2019-11-25T21:30:37+00:00 https://ascopost.com/issues/november-25-2019/mskcc-awards-young-investigators-2019-paul-marks-prize-for-cancer-research/ 2019-11-25T21:30:37+00:00 https://ascopost.com/issues/november-25-2019/updated-data-from-clinical-trials-on-nivolumabipilimumab-in-advanced-melanoma/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/glasdegib-in-older-patients-with-aml-or-those-with-comorbidities/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/project-socrates/ 2019-11-26T14:57:52+00:00 https://ascopost.com/issues/november-25-2019/friends-of-cancer-research-launches-ctdna-pilot-project/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/car-t-cell-gene-therapy-toxicities-and-management-principles-questions/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/answers-to-hematology-expert-review-questions/ 2019-12-19T20:05:48+00:00 https://ascopost.com/issues/november-25-2019/cdc-foundation-offers-new-educational-resources-to-prevent-infections-in-patients-with-cancer/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/asco-updates-breast-cancer-risk-reduction-guideline-to-include-anastrozole/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/selinexor-plus-dexamethasone-studied-in-triple-class-refractory-multiple-myeloma/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/selinexordexamethasone-in-refractory-multiple-myeloma/ 2019-11-25T21:35:14+00:00 https://ascopost.com/issues/november-25-2019/nccn-orp-supports-clinical-trial-for-lung-cancer/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/michael-caligiuri-appointed-to-deana-and-stave-campbell-physician-in-chief-distinguished-chair/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/asds-awards-eight-research-grants/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/maximizing-benefit-in-the-treatment-of-immune-mediated-colitis/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/md-anderson-names-new-senior-vice-president-and-chief-legal-officer/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/apalutamide-for-metastatic-castration-sensitive-prostate-cancer/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/answers-to-hematology-expert-review-questions-1/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/ash-names-recipients-of-outstanding-abstract-achievement-awards/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/affirming-universal-health-care-as-a-fundamental-human-right/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/asco-provides-guidance-on-managing-osteoporosis-in-cancer-survivors/ 2019-11-25T21:35:15+00:00 https://ascopost.com/issues/november-25-2019/social-support-linked-to-pain-reduction-in-patients-with-cancer/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/epov-richard-lee/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/the-obesity-epidemic-and-barriers-to-implementing-weight-management-programs-for-cancer-survivors/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/navneet-majhail-was-inspired-by-his-father-s-career-as-a-military-doctor-and-his-mother-s-battle-with-cancer/ 2019-11-26T15:47:59+00:00 https://ascopost.com/issues/november-25-2019/physicians-should-lead-by-example-to-combat-the-obesity-epidemic/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/fda-approves-givosiran-for-acute-hepatic-porphyria/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/an-oncologist-s-thoughtful-examination-of-cancer-and-personal-loss/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/elotuzumab-in-combination-therapy-for-previously-treated-multiple-myeloma/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/a-need-for-human-connection-led-to-a-rewarding-career-in-geriatric-oncology-for-lodovico-balducci/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/accc-presents-annual-achievement-award-posthumously-to-arti-hurria/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/trifluridinetipiracil-in-recurrent-metastatic-gastric-or-gej-adenocarcinoma/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/the-anesthesia-era-1845-1875/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/clinical-happenings-and-highlights-at-the-2019-ash-annual-meeting/ 2019-11-25T21:35:16+00:00 https://ascopost.com/issues/november-25-2019/david-gutmann-receives-neuro-oncology-award/ 2019-12-10T15:14:15+00:00 https://ascopost.com/issues/november-25-2019/calaspargase-pegol-mknl-for-pediatric-and-young-adult-patients-with-all/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/boswellia/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/stanley-l-schrier-dies-at-90/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/a-call-to-action-for-oncology-clinicians-to-help-patients-move-through-cancer/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/oncology-clinicians-play-a-role-in-telling-patients-about-the-importance-of-exercise/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/two-societies-issue-statements-on-e-cigarettes/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/wake-forest-baptist-awarded-grant-to-study-web-based-pain-management-program/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/adetokunbo-oluwasanjo-joins-florida-group/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/md-anderson-and-university-of-puerto-rico-receive-grant-renewal/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/lorlatinib-in-advanced-ros1-positive-nsclc/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/a-diagnosis-of-multiple-myeloma-taught-me-to-live-in-the-moment/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/asco-president-elect-candidates-discuss-key-issues-in-oncology/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/make-a-holiday-gift-to-conquer-cancer-the-asco-foundation/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/shape-the-future-of-asco-vote-in-the-asco-election/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/new-asco-answers-fact-sheet-on-constipation/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/asco-statement-says-fda-should-implement-proposed-rule-for-graphic-labels-on-cigarette-packs-and-ads/ 2019-11-25T21:35:17+00:00 https://ascopost.com/issues/november-25-2019/your-stories-behind-the-breakthroughs/ 2019-11-25T21:35:18+00:00 https://ascopost.com/issues/november-25-2019/2020-asco-election-candidates/ 2019-11-25T21:35:18+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/esmo-congress-2019-offers-a-global-stage-for-important-clinical-data/ 2019-11-13T22:50:59+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/cdk46-inhibitors-plus-fulvestrant-benefit-survival-in-advanced-breast-cancer/ 2019-12-04T21:27:35+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/neoadjuvant-immunotherapy-plus-chemotherapy-active-in-women-with-early-triple-negative-breast-cancer/ 2019-11-13T22:50:59+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/phase-iii-trials-suggest-paradigm-shift-with-parp-inhibitors-in-ovarian-cancer/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/checkpoint-inhibitors-benefit-women-with-advanced-stages-of-cervical-endometrial-cancers/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/epov-nicoletta-colombo/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/osimertinib-improves-overall-survival-vs-gefitinib-erlotinib-in-advanced-egfr-mutated-non-small-cell-lung-cancer/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/epov-pilar-garrido/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/nivolumab-plus-ipilimumab-presents-another-option-in-first-line-treatment-of-advanced-nsclc/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/epov-sanjay-popat/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/phase-iii-profound-study-evaluates-olaparib-in-setting-of-mcrpc/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/epov-eleni-efstathiou/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/targeted-treatment-advances-in-cholangiocarcinoma/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/pivotal-phase-iii-study-evaluates-investigational-tki-in-fourth-line-setting-for-advanced-gist/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/novel-therapies-for-sclc-and-neuroendocrine-tumors/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019-supplement-esmo-highlights/quick-takes-from-key-clinical-trials/ 2019-11-13T22:51:00+00:00 https://ascopost.com/issues/november-10-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/november-10-2019/third-line-cabazitaxel-improves-outcomes-in-patients-with-metastatic-prostate-cancer/ 2019-11-11T20:37:01+00:00 https://ascopost.com/issues/november-10-2019/epov-silke-gillessen/ 2019-11-11T20:37:02+00:00 https://ascopost.com/issues/november-10-2019/the-oncology-care-model-and-quality-of-care/ 2019-11-11T20:37:02+00:00 https://ascopost.com/issues/november-10-2019/management-of-locally-advanced-pancreatic-cancer/ 2019-11-11T20:37:02+00:00 https://ascopost.com/issues/november-10-2019/early-lung-cancer-detection-followed-by-minimally-invasive-surgery-saves-lives/ 2019-11-11T20:54:01+00:00 https://ascopost.com/issues/november-10-2019/barry-paul-sleckman-to-lead-o-neal-comprehensive-cancer-center/ 2019-11-11T20:37:02+00:00 https://ascopost.com/issues/november-10-2019/astro-scientific-session-on-breast-cancer/ 2019-11-11T20:37:02+00:00 https://ascopost.com/issues/november-10-2019/omitting-radiation-from-treatment-for-early-stage-hodgkin-lymphoma-increases-risk-of-recurrence/ 2019-11-11T20:37:02+00:00 https://ascopost.com/issues/november-10-2019/astro-and-acr-update-practice-parameters-for-radiation-therapies/ 2019-11-11T20:37:02+00:00 https://ascopost.com/issues/november-10-2019/targeted-therapy-for-prostate-cancer-with-strong-showing-by-olaparib-and-rucaparib/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/epov-eleni-efstathiou/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/atezolizumab-plus-chemotherapy-for-metastatic-urothelial-cancer/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/epov-thomas-powles/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/abemaciclib-benefits-patients-with-her2-positive-breast-cancer-in-monarcher-trial/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/epov-mafalda-oliveira/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/continuous-therapy-for-multiple-myeloma-offers-survival-advantage-but-questions-remain/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/personalized-treatment-approaches-on-the-horizon-for-myelodysplastic-syndromes/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/cleveland-clinic-names-halle-moore-director-of-breast-medical-oncology/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/venetoclax-for-cll-or-sll/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/machine-learning-model-may-predict-unplanned-hospitalizations-after-rt-for-gi-cancer/ 2019-11-11T20:37:03+00:00 https://ascopost.com/issues/november-10-2019/fedratinib-for-the-treatment-of-myeloproliferative-neoplasms/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/stephen-hahn-md-to-be-nominated-fda-commissioner/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/fda-approves-pegfilgrastim-biosimilar/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/how-clonal-hematopoiesis-of-indeterminate-potential-increases-the-risk-of-heart-disease-and-blood-cancers-as-people-age/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/fda-approves-niraparib-for-patients-with-hrd-positive-advanced-ovarian-cancer/ 2020-01-03T23:18:21+00:00 https://ascopost.com/issues/november-10-2019/veliparib-plus-chemotherapy-meets-primary-endpoint-in-advanced-ovarian-cancer/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/epov-mansoor-mirza/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/fda-approves-label-expansion-for-single-dose-regimen-of-aprepitant-for-patients-receiving-moderately-emetogenic-chemotherapy/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/update-to-fda-prescribing-information-for-romiplostim-for-adults-with-immune-thrombocytopenia/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/prima-trial-reports-benefit-with-niraparib-across-ovarian-cancer-subsets/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/epov-ana-oaknin/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/front-line-olaparibbevacizumab-maintenance-benefits-women-with-advanced-ovarian-cancer/ 2019-11-11T20:37:04+00:00 https://ascopost.com/issues/november-10-2019/epov-ana-oaknin-1/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/unc-health-care-introduces-new-blood-research-center/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/accc-honors-seven-cancer-programs-with-innovator-awards/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/ravi-thadhani-named-chief-academic-officer-at-partners-healthcare/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/love-of-nature-s-biodiversity-leads-to-career-in-cancer-research-for-lisa-coussens/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/lead-conference-awards-2019-woman-oncologist-of-the-year/ 2019-11-12T16:15:50+00:00 https://ascopost.com/issues/november-10-2019/nivolumabipilimumab-vs-sunitinib-in-first-line-treatment-of-advanced-renal-cell-carcinoma/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/immunotherapy-combinations-redefine-outcomes-for-patients-with-renal-cell-carcinoma/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/astro-honors-2019-gold-medalists-and-other-award-recipients/ 2019-11-11T20:37:05+00:00 https://ascopost.com/issues/november-10-2019/targeted-methylation-sequencing-assay-may-provide-new-tool-for-cancer-detection-across-stages-and-tissues-of-origin/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/deep-learning-assists-in-detection-of-lung-nodule-locations-characteristics/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/the-role-of-oncologists-in-helping-cancer-survivors-to-quit-smoking/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/race-reporting-and-representation-in-clinical-trials-leading-to-cancer-drug-approvals/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/daratumumab-combination-therapy-for-patients-with-multiple-myeloma-who-are-eligible-for-transplantation/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/thomas-smith-honored-with-asco-s-palliative-and-supportive-care-in-oncology-endowed-award-and-lecture/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/how-patients-add-life-to-their-days/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/breast-surgeon-and-nsabp-chair-bernard-fisher-dies/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/asco-presidents-through-the-years/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/fda-awards-research-grants-for-the-study-of-rare-cancers/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/kazuaki-takabe-delivered-keynote-on-immunotherapy-for-breast-cancer-at-jsco-meeting/ 2019-11-11T20:37:06+00:00 https://ascopost.com/issues/november-10-2019/robert-winn-named-director-of-vcu-massey-cancer-center/ 2019-11-11T20:37:07+00:00 https://ascopost.com/issues/november-10-2019/remembering-craig-alguire/ 2019-11-11T21:51:06+00:00 https://ascopost.com/issues/november-10-2019/aacr-project-genie-begins-research-project-with-new-funding/ 2019-11-11T20:37:07+00:00 https://ascopost.com/issues/november-10-2019/acute-toxicity-with-intensity-modulated-fractionated-radiotherapy-vs-stereotactic-body-radiotherapy-for-prostate-cancer/ 2019-11-11T20:37:07+00:00 https://ascopost.com/issues/november-10-2019/apalutamide-treatment-for-metastatic-castration-sensitive-prostate-cancer-and-health-related-quality-of-life/ 2019-11-11T20:37:07+00:00 https://ascopost.com/issues/november-10-2019/nivolumab-vs-taxane-therapy-in-refractory-esophageal-squamous-cell-carcinoma/ 2019-11-11T20:37:07+00:00 https://ascopost.com/issues/november-10-2019/cancernet-physician-generated-content-for-patients-with-cancer-worldwide/ 2019-11-11T21:09:04+00:00 https://ascopost.com/issues/november-10-2019/make-a-holiday-gift-to-conquer-cancer/ 2019-11-11T21:11:26+00:00 https://ascopost.com/issues/november-10-2019/advocates-urge-action-on-cancer-care-access-at-asco-advocacy-summit/ 2019-11-11T21:20:28+00:00 https://ascopost.com/issues/november-10-2019/new-jco-cci-article-discusses-difficulties-in-gathering-real-world-evidence/ 2019-11-11T21:23:09+00:00 https://ascopost.com/issues/november-10-2019/your-stories-behind-the-breakthroughs/ 2019-11-11T21:25:34+00:00 https://ascopost.com/issues/november-10-2019/new-asco-answers-fact-sheet-on-anxiety-and-depression/ 2019-11-11T21:28:15+00:00 https://ascopost.com/issues/october-25-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/october-25-2019/first-line-osimertinib-improves-survival-in-egfr-mutated-advanced-lung-cancer/ 2019-11-07T18:28:24+00:00 https://ascopost.com/issues/october-25-2019/epov-pilar-garrido/ 2019-10-25T19:34:26+00:00 https://ascopost.com/issues/october-25-2019/long-term-survival-outcomes-with-new-treatments-for-advanced-melanoma/ 2019-11-01T19:13:24+00:00 https://ascopost.com/issues/october-25-2019/the-future-of-the-radiation-abscopal-response/ 2019-10-25T19:34:26+00:00 https://ascopost.com/issues/october-25-2019/paradigm-shift-with-parp-inhibitors-in-ovarian-cancer/ 2019-10-25T19:34:26+00:00 https://ascopost.com/issues/october-25-2019/evidence-supports-immunotherapy-plus-chemo-for-early-triple-negative-breast-ca/ 2019-10-25T19:34:26+00:00 https://ascopost.com/issues/october-25-2019/epov-sherene-loi/ 2019-10-25T19:34:26+00:00 https://ascopost.com/issues/october-25-2019/studies-suggest-early-salvage-radiotherapy-may-be-preferable-to-adjuvant-radiotherapy-after-prostatectomy/ 2019-10-25T19:34:26+00:00 https://ascopost.com/issues/october-25-2019/epov-gert-de-meerleer/ 2019-10-25T19:34:26+00:00 https://ascopost.com/issues/october-25-2019/5-million-gift-to-advance-ovarian-cancer-research/ 2019-10-25T19:41:57+00:00 https://ascopost.com/issues/october-25-2019/ceritinib-active-in-treating-brain-metastases-in-non-small-cell-lung-cancer/ 2019-10-25T19:34:27+00:00 https://ascopost.com/issues/october-25-2019/epov-lizza-hendriks/ 2019-10-25T19:34:27+00:00 https://ascopost.com/issues/october-25-2019/cdk46-inhibitors-in-advanced-breast-cancer/ 2019-11-19T14:22:55+00:00 https://ascopost.com/issues/october-25-2019/epov-sibylle-loibl-md-and-nadia-harbeck-md-phd/ 2019-10-25T19:34:27+00:00 https://ascopost.com/issues/october-25-2019/radiotherapy-for-refractory-lymphoma-during-car-t-cell-therapy/ 2019-11-08T14:49:11+00:00 https://ascopost.com/issues/october-25-2019/astro-honors-2019-gold-medalists-honorary-member-and-other-award-recipients/ 2019-10-25T19:43:46+00:00 https://ascopost.com/issues/october-25-2019/out-of-pocket-costs-for-oral-tyrosine-kinase-inhibitors-and-survival-in-advanced-lung-cancer/ 2019-10-25T19:34:28+00:00 https://ascopost.com/issues/october-25-2019/epov-kelvin-kar-wing-chan/ 2019-10-25T19:34:28+00:00 https://ascopost.com/issues/october-25-2019/community-health-workers-may-improve-value-of-end-of-life-cancer-care/ 2019-10-25T19:34:28+00:00 https://ascopost.com/issues/october-25-2019/epov-paul-jacobsen/ 2019-10-25T19:34:28+00:00 https://ascopost.com/issues/october-25-2019/zanetta-lamar-md-joins-florida-cancer-specialists/ 2019-10-25T19:45:54+00:00 https://ascopost.com/issues/october-25-2019/friends-of-cancer-research-hosts-annual-leadership-awards/ 2019-10-25T19:46:32+00:00 https://ascopost.com/issues/october-25-2019/fda-issues-drug-safety-communication-on-lung-inflammation-linked-to-treatment-with-cdk46-inhibitors/ 2019-10-25T19:59:23+00:00 https://ascopost.com/issues/october-25-2019/2019-nobel-prize-in-physiology-or-medicine-announced/ 2019-10-25T19:34:29+00:00 https://ascopost.com/issues/october-25-2019/chemoimmunotherapy-in-first-line-setting-of-cll/ 2019-10-25T19:34:29+00:00 https://ascopost.com/issues/october-25-2019/pembrolizumablenvatinib-in-advanced-endometrial-carcinoma-without-msi-h-or-mmr-d-disease/ 2019-10-25T19:34:29+00:00 https://ascopost.com/issues/october-25-2019/dana-farber-receives-gift-to-create-the-center-for-myelodysplastic-syndromes/ 2019-10-25T20:04:09+00:00 https://ascopost.com/issues/october-25-2019/komen-names-recipients-of-brinker-awards-for-scientific-distinction/ 2019-10-25T20:07:34+00:00 https://ascopost.com/issues/october-25-2019/5-year-follow-up-of-pembrolizumab-vs-ipilimumab-in-advanced-melanoma/ 2019-10-25T19:34:30+00:00 https://ascopost.com/issues/october-25-2019/norman-wolmark-looks-back-on-his-practice-changing-accomplishments/ 2019-10-25T20:14:52+00:00 https://ascopost.com/issues/october-25-2019/asciminibimatinib-in-patients-with-previously-treated-cml/ 2019-10-25T20:16:56+00:00 https://ascopost.com/issues/october-25-2019/effect-of-atm-mutations-on-response-to-radiotherapy/ 2019-10-25T19:34:30+00:00 https://ascopost.com/issues/october-25-2019/vipul-patel-and-craig-reynolds-join-aon-board/ 2019-10-25T20:20:20+00:00 https://ascopost.com/issues/october-25-2019/how-cancernet-is-changing-to-help-young-adults-and-teenagers-with-cancer/ 2019-10-25T20:23:48+00:00 https://ascopost.com/issues/october-25-2019/support-your-patients-with-asco-answers-fact-sheets/ 2019-10-25T20:28:27+00:00 https://ascopost.com/issues/october-25-2019/asco-s-journal-of-global-oncology-informs-cancer-care-everywhere/ 2019-10-25T20:34:31+00:00 https://ascopost.com/issues/october-25-2019/research-from-2019-quality-care-symposium-focuses-on-cost-of-cancer-care-patient-participation-in-clinical-trials/ 2019-10-25T20:34:54+00:00 https://ascopost.com/issues/october-25-2019/leave-a-legacy-of-hope/ 2019-10-25T20:38:07+00:00 https://ascopost.com/issues/october-25-2019/why-do-you-live-to-conquer-cancer/ 2019-10-25T20:49:56+00:00 https://ascopost.com/issues/october-25-2019/behind-the-breakthroughs-the-family-plan/ 2019-10-25T20:52:06+00:00 https://ascopost.com/issues/october-25-2019/conquerors-circle-recognizes-donors/ 2019-10-25T20:54:58+00:00 https://ascopost.com/issues/october-25-2019/american-college-of-clinical-pharmacology-honors-peter-wiernik/ 2019-10-28T14:53:59+00:00 https://ascopost.com/issues/october-25-2019/addressing-the-gap-in-integrative-oncology-education/ 2020-11-03T20:21:31+00:00 https://ascopost.com/issues/october-25-2019/cancer-researcher-mary-jc-hendrix-phd-returns-to-west-virginia-to-lead-her-alma-mater/ 2019-10-28T13:40:45+00:00 https://ascopost.com/issues/october-25-2019/breast-cancer-gene-expression-signature-may-help-to-predict-recurrence-postradiotherapy/ 2019-10-28T14:53:59+00:00 https://ascopost.com/issues/october-25-2019/2019-nih-director-s-pioneer-award-recipients-in-cancer-research/ 2019-10-28T14:53:59+00:00 https://ascopost.com/issues/october-25-2019/lung-cancer-program-at-nyu-langone-joins-thoracic-surgery-oncology-group/ 2019-10-28T14:54:00+00:00 https://ascopost.com/issues/october-25-2019/roswell-park-names-thaer-khoury-md-chief-of-breast-pathology/ 2019-10-28T14:54:00+00:00 https://ascopost.com/issues/october-25-2019/mindfulness-training-for-men-diagnosed-with-prostate-cancer-who-are-on-active-surveillance/ 2019-11-08T16:11:56+00:00 https://ascopost.com/issues/october-25-2019/city-of-hope-enrolling-patients-with-brain-tumors-in-first-of-its-kind-clinical-trial/ 2019-10-28T14:00:36+00:00 https://ascopost.com/issues/october-25-2019/our-role-as-patient-advocates/ 2019-10-28T14:03:04+00:00 https://ascopost.com/issues/october-25-2019/physical-activity-delays-disease-progression-and-risk-of-adverse-events-in-metastatic-colorectal-ca/ 2019-10-28T14:07:16+00:00 https://ascopost.com/issues/october-25-2019/applying-results-from-calgb-alliance-swog-80405-study/ 2019-10-25T19:34:33+00:00 https://ascopost.com/issues/october-25-2019/linda-l-hogan-dies-at-age-72/ 2019-10-28T14:10:23+00:00 https://ascopost.com/issues/october-25-2019/two-new-research-grants-focus-on-metastasis-of-melanoma/ 2019-10-25T19:34:34+00:00 https://ascopost.com/issues/october-25-2019/fedratinib-for-myelofibrosis/ 2025-09-30T19:39:42+00:00 https://ascopost.com/issues/october-25-2019/polepold1-mutations-and-outcomes-with-immune-checkpoint-inhibitor-therapy/ 2019-10-28T14:24:55+00:00 https://ascopost.com/issues/october-25-2019/prior-antibiotic-treatment-and-response-to-immune-checkpoint-inhibitor-therapy-in-patients-with-cancer/ 2019-10-28T14:27:40+00:00 https://ascopost.com/issues/october-25-2019/addition-of-induction-gemcitabinecisplatin-to-chemoradiotherapy-in-nasopharyngeal-carcinoma/ 2019-10-25T19:34:34+00:00 https://ascopost.com/issues/october-25-2019/swallowing-related-quality-of-life-after-radiotherapy-vs-surgery-for-oropharyngeal-squamous-cell-carcinoma/ 2019-10-28T14:35:26+00:00 https://ascopost.com/issues/october-25-2019/susan-g-komen-launches-komen-center-for-public-policy/ 2019-10-28T14:37:46+00:00 https://ascopost.com/issues/october-25-2019/tony-hunter-receives-nci-outstanding-investigator-award/ 2019-10-25T19:34:35+00:00 https://ascopost.com/issues/october-25-2019/a-clinical-trial-was-the-right-choice-for-me/ 2019-10-28T14:42:51+00:00 https://ascopost.com/issues/october-25-2019/andrew-c-von-eschenbach-honored-for-leadership-in-nlst/ 2019-10-28T14:44:57+00:00 https://ascopost.com/issues/october-10-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/october-10-2019/prolonged-long-term-survival-with-immunotherapy-vs-chemo-in-advanced-nsclc/ 2019-10-10T18:51:36+00:00 https://ascopost.com/issues/october-10-2019/is-bias-contributing-to-time-disparities-in-goals-of-care-conversations-with-minority-patients/ 2019-10-10T17:50:01+00:00 https://ascopost.com/issues/october-10-2019/reflecting-on-my-first-national-presentation/ 2019-10-10T17:50:01+00:00 https://ascopost.com/issues/october-10-2019/durvalumab-plus-chemotherapy-new-option-for-extensive-stage-sclc/ 2019-10-10T18:50:16+00:00 https://ascopost.com/issues/october-10-2019/precision-medicine-for-ret-fusion-positive-nsclc/ 2019-10-10T17:50:01+00:00 https://ascopost.com/issues/october-10-2019/cleveland-clinic-appoints-jame-abraham-as-department-chair-of-hematology-medical-onc/ 2019-10-10T17:50:01+00:00 https://ascopost.com/issues/october-10-2019/kras-inhibitor-shows-activity-in-early-study-of-advanced-nsclc/ 2019-10-10T17:50:01+00:00 https://ascopost.com/issues/october-10-2019/resonate-trial-shows-benefit-of-ibrutinib-in-cll/ 2019-10-10T18:56:46+00:00 https://ascopost.com/issues/october-10-2019/rituximab-adds-no-benefit-for-patients-with-lymphoma/ 2019-10-10T19:43:27+00:00 https://ascopost.com/issues/october-10-2019/gilteritinib-effective-across-mutation-cohorts-of-aml/ 2019-10-10T19:32:40+00:00 https://ascopost.com/issues/october-10-2019/temozolomide-may-offer-benefit-in-idh-mutant-anaplastic-glioma/ 2019-10-10T19:33:05+00:00 https://ascopost.com/issues/october-10-2019/lisa-m-deangelis-named-physician-in-chief-and-chief-medical-officer-of-memorial-sloan/ 2019-10-10T17:50:02+00:00 https://ascopost.com/issues/october-10-2019/researchers-link-hyperglycemia-to-dna-damage/ 2019-10-10T19:38:06+00:00 https://ascopost.com/issues/october-10-2019/entrectinib-for-ntrk-positive-solid-tumors-and-ros1-positive-lung-cancer/ 2020-07-08T15:28:37+00:00 https://ascopost.com/issues/october-10-2019/hpv-positive-oropharyngeal-cancer-burden-rising-among-white-men-in-the-united-states/ 2019-10-10T17:50:02+00:00 https://ascopost.com/issues/october-10-2019/fda-grants-approval-to-lenvatinibpembrolizumab-in-advanced-endometrial-cancer-announces-project-orbis/ 2019-10-10T17:50:02+00:00 https://ascopost.com/issues/october-10-2019/fda-approves-cologuard-for-persons-aged-45-and-older-at-average-risk-for-colorectal-cancer/ 2019-10-10T17:50:02+00:00 https://ascopost.com/issues/october-10-2019/older-sexual-and-gender-minorities-with-cancer/ 2019-10-21T17:09:18+00:00 https://ascopost.com/issues/october-10-2019/greater-consensus-from-global-experts-on-controversies-in-prostate-cancer/ 2019-10-10T19:36:48+00:00 https://ascopost.com/issues/october-10-2019/resistance-to-immune-checkpoint-blocker-may-be-linked-to-metabolic-imbalance/ 2019-10-10T19:46:56+00:00 https://ascopost.com/issues/october-10-2019/ibrutinibrituximab-improves-outcomes-vs-standard-chemoimmunotherapy-in-previously-untreated-cll/ 2019-10-10T20:17:24+00:00 https://ascopost.com/issues/october-10-2019/younger-fit-patients-with-cll-goal-remains-undetectable-minimal-residual-disease-and-time-limited-therapy/ 2019-10-10T20:19:09+00:00 https://ascopost.com/issues/october-10-2019/ribociclib-for-endocrine-therapy-in-advanced-breast-cancer/ 2019-10-10T20:06:52+00:00 https://ascopost.com/issues/october-10-2019/benefit-of-adjuvant-chemoradiotherapy-vs-radiotherapy-alone-in-high-risk-endometrial-cancer/ 2019-10-10T19:55:26+00:00 https://ascopost.com/issues/october-10-2019/multimodal-therapy-for-high-risk-or-locally-advanced-endometrial-cancer/ 2019-10-10T20:03:41+00:00 https://ascopost.com/issues/october-10-2019/gene-therapy-a-march-forward/ 2019-10-10T18:48:08+00:00 https://ascopost.com/issues/october-10-2019/fda-approves-daratumumab-for-transplant-eligible-multiple-myeloma/ 2019-10-10T17:50:03+00:00 https://ascopost.com/issues/october-10-2019/kidney-cancer-association-announces-award-recipients/ 2019-10-10T17:50:03+00:00 https://ascopost.com/issues/october-10-2019/early-research-on-novel-interleukin-12-gene-therapy-in-glioblastoma/ 2019-10-10T19:40:28+00:00 https://ascopost.com/issues/october-10-2019/managing-rectal-cancer/ 2019-10-10T17:50:04+00:00 https://ascopost.com/issues/october-10-2019/study-shows-benefits-of-comprehensive-tobacco-treatment-program/ 2019-10-11T15:14:27+00:00 https://ascopost.com/issues/october-10-2019/biosimilar-to-trastuzumab/ 2019-10-10T20:23:24+00:00 https://ascopost.com/issues/october-10-2019/how-to-help-terminally-ill-patients-find-peace-in-the-dying-process/ 2019-10-10T17:50:04+00:00 https://ascopost.com/issues/october-10-2019/inequities-in-care-for-patients-with-cancer-and-serious-mental-illness/ 2019-10-10T17:50:04+00:00 https://ascopost.com/issues/october-10-2019/city-of-hope-researchers-receive-awards-and-grants/ 2019-10-10T17:50:04+00:00 https://ascopost.com/issues/october-10-2019/higher-volume-cancer-centers-and-patient-outcomes-studies/ 2019-10-10T20:26:04+00:00 https://ascopost.com/issues/october-10-2019/horwitz-prize-awarded-to-three-scientists-for-work-on-critical-cancer-pathway/ 2019-10-10T17:50:04+00:00 https://ascopost.com/issues/october-10-2019/researchers-examine-the-rise-in-hpv-related-oropharyngeal-cancers/ 2019-10-10T20:26:53+00:00 https://ascopost.com/issues/october-10-2019/atezolizumab-for-triple-negative-breast-cancer/ 2019-10-10T20:28:33+00:00 https://ascopost.com/issues/october-10-2019/ivosidenibazacitidine-for-newly-diagnosed-aml/ 2019-10-10T19:45:56+00:00 https://ascopost.com/issues/october-10-2019/melflufen-for-patients-with-late-stage-relapsed-or-refractory-multiple-myeloma/ 2019-10-10T19:45:11+00:00 https://ascopost.com/issues/october-10-2019/fedratinib-in-patients-with-myelofibrosis-jakarta-trials-update/ 2025-09-30T19:45:52+00:00 https://ascopost.com/issues/october-10-2019/vassiliki-papadimitrakopoulou-appointed-clinical-development-leader-of-pfizer-oncology/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/a-tale-of-two-eugenes/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/gap-in-culturally-competent-cancer-care-for-lgbtqiplus-latinx-population/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/liquid-biopsy-to-determine-patient-response-to-immune-checkpoint-blockade/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/being-an-expert-witness-in-a-legal-proceeding-a-learning-experience/ 2019-10-18T18:53:44+00:00 https://ascopost.com/issues/october-10-2019/fda-approves-apalutamide-for-metastatic-castration-sensitive-prostate-cancer/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/epov-myung-ju-ahn-and-roy-herbst/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/epov-robert-doebele-and-roy-herbst/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/epov-alex-a-adjei/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/qol-and-neurocognitive-function-with-lomustinetemozolomide-for-glioblastoma/ 2022-10-07T15:02:09+00:00 https://ascopost.com/issues/october-10-2019/chemotherapy-and-hormonal-treatments-for-postmenopausal-metastatic-breast-cancer/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/menopausal-hormone-therapy-use-and-risk-of-breast-cancer/ 2019-10-10T17:50:05+00:00 https://ascopost.com/issues/october-10-2019/cancer-taught-me-what-it-means-to-be-a-man/ 2019-10-10T20:20:05+00:00 https://ascopost.com/issues/october-10-2019/susan-g-komen-unveils-26-million-investment/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/fda-acting-commissioner-testifies-before-house-subcommittee-on-fda-investigation-of-vaping-illnesses-and-regulation-of-e-cigarettes/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/ariel-hollinshead-hyun-dies-at-age-90/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/aacr-cancer-progress-report-2019-released/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/asco-advocacy-and-policy-initiatives-activities-in-2019/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/connect-with-research-colleagues-by-joining-the-asco-research-community-forum-online/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/asco-elearning-multidisciplinary-molecular-tumor-boards/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/2019-international-women-who-conquer-cancer-mentorship-award-recipient-verna-vanderpuye/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/submit-your-research-project-applications-for-asco-research-survey-pool/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/updated-asco-resource-helps-educate-patients-about-cancer-costs/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/results-from-the-tapur-study-reported-in-jco-precision-oncology/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/assessing-full-impact-of-prior-authorization-plus-electronic-prior-authorization-needed-to-remove-barriers-to-care/ 2019-10-10T18:41:14+00:00 https://ascopost.com/issues/october-10-2019/featured-conversations/ 2019-10-10T17:50:06+00:00 https://ascopost.com/issues/october-10-2019/graviola/ 2019-10-30T14:49:10+00:00 https://ascopost.com/issues/september-25-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/september-25-2019/tmb-disappoints-as-biomarker-for-treatment-response-in-nonsquamous-nsclc/ 2019-09-26T17:04:44+00:00 https://ascopost.com/issues/september-25-2019/epov-alex-adjei/ 2019-09-25T17:40:43+00:00 https://ascopost.com/issues/september-25-2019/tumor-vulnerability-with-olaparib-in-pancreatic-cancer/ 2019-09-25T20:15:35+00:00 https://ascopost.com/issues/september-25-2019/polo-trial/ 2019-09-26T13:41:15+00:00 https://ascopost.com/issues/september-25-2019/breast-cancer-and-health-care-challenges-of-women-in-poverty/ 2019-09-25T19:21:02+00:00 https://ascopost.com/issues/september-25-2019/suboptimal-insurance-linked-to-worse-survival-outcomes-in-positive-clinical-trials/ 2019-09-25T17:40:43+00:00 https://ascopost.com/issues/september-25-2019/current-controversies-in-lymphoma/ 2019-09-25T20:21:01+00:00 https://ascopost.com/issues/september-25-2019/conundrums-in-managing-cancer-associated-thrombosis/ 2019-09-25T20:25:33+00:00 https://ascopost.com/issues/september-25-2019/tailoring-upfront-daratumumab-treatment-for-some-patients-with-multiple-myeloma/ 2019-09-26T17:00:25+00:00 https://ascopost.com/issues/september-25-2019/denise-aberle-honored-by-iaslc/ 2019-09-25T17:40:43+00:00 https://ascopost.com/issues/september-25-2019/charles-rudin-and-andrew-nicholson-honored-by-iaslc/ 2019-09-25T17:40:44+00:00 https://ascopost.com/issues/september-25-2019/olaparib-improves-outcomes-in-ovarian-cancer/ 2019-09-26T16:58:12+00:00 https://ascopost.com/issues/september-25-2019/addition-of-isatuximab-to-pomalidomide-and-dexamethasone-in-resistant-multiple-myeloma/ 2019-09-26T16:59:29+00:00 https://ascopost.com/issues/september-25-2019/ultrahigh-dose-radiation-therapy-interferon-car-t-cells-and-immunotherapy-effectiveness/ 2019-09-25T19:25:28+00:00 https://ascopost.com/issues/september-25-2019/announces-additional-nccn-harmonized-guidelines-for-sub-saharan-africa/ 2019-09-25T19:26:38+00:00 https://ascopost.com/issues/september-25-2019/differences-by-sex-in-lung-cancer-incidence-and-mortality/ 2019-09-25T17:40:44+00:00 https://ascopost.com/issues/september-25-2019/inflammatory-mechanisms-and-prostate-cancer-in-wtc-first-responders/ 2020-09-11T19:41:28+00:00 https://ascopost.com/issues/september-25-2019/cprit-awards-new-grants/ 2019-09-25T17:40:44+00:00 https://ascopost.com/issues/september-25-2019/update-on-treatments-under-study-for-cll/ 2019-09-25T20:18:08+00:00 https://ascopost.com/issues/september-25-2019/the-role-of-primary-care-physicians-in-cancer-care/ 2019-09-25T19:49:51+00:00 https://ascopost.com/issues/september-25-2019/canadian-organizations-team-up-to-focus-on-new-approach-to-breast-ca/ 2019-09-25T17:40:44+00:00 https://ascopost.com/issues/september-25-2019/treatment-with-ado-trastuzumab-emtansine-in-her2-positive-breast-ca/ 2019-09-25T20:07:53+00:00 https://ascopost.com/issues/september-25-2019/patient-centered-initiatives-at-the-fda/ 2019-11-26T14:56:02+00:00 https://ascopost.com/issues/september-25-2019/lasker-foundation-names-recipients-of-awards/ 2019-09-25T17:40:44+00:00 https://ascopost.com/issues/september-25-2019/fred-hutch-scientists-receive-fellowships-for-prostate-ca-research/ 2019-09-25T17:40:44+00:00 https://ascopost.com/issues/september-25-2019/uspstf-recommendation-on-medication-use-to-reduce-breast-cancer-risk/ 2019-09-26T17:05:45+00:00 https://ascopost.com/issues/september-25-2019/astro-names-class-of-2019-fellows-designation/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/flu-vaccine-effectiveness-in-patients-with-cancer/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/oncology-communications-online/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/chef-uses-flavor-to-fuel-her-mother-s-appetite-during-cancer-treatment/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/esmo-2019-award-winners/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/aacr-honors-steven-r-patierno-phd/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/upmc-east-cancer-program-earns-national-accreditation/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/flaxseed/ 2019-09-26T16:56:37+00:00 https://ascopost.com/issues/september-25-2019/personalizing-medicine/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/prevent-cancer-foundation-awards-250-000-in-community-grants/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/lung-disease-associated-with-e-cigarette-use/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/ramucirumab-in-hepatocellular-carcinoma/ 2019-09-25T20:08:23+00:00 https://ascopost.com/issues/september-25-2019/selinexor-plus-dexamethasone-in-triple-class-refractory-multiple-myeloma/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/key-predictors-of-response-rates-to-pd1-and-pdl1-inhibitors/ 2019-09-25T17:40:45+00:00 https://ascopost.com/issues/september-25-2019/risks-of-cardiovascular-diseases-in-survivors-of-adult-cancers/ 2019-09-25T17:40:46+00:00 https://ascopost.com/issues/september-25-2019/finding-a-new-focus-after-cancer/ 2019-09-26T16:56:07+00:00 https://ascopost.com/issues/september-25-2019/avelumab-plus-axitinib-in-advanced-renal-cell-carcinoma/ 2019-09-25T20:11:01+00:00 https://ascopost.com/issues/september-25-2019/special-events-at-the-2019-asco-annual-meeting/ 2019-09-25T17:40:46+00:00 https://ascopost.com/issues/september-25-2019/international-innovation-grants-expand-global-reach-of-training-and-care/ 2019-09-25T17:40:46+00:00 https://ascopost.com/issues/september-25-2019/cms-expands-coverage-of-car-t-cell-therapy-for-medicare-beneficiaries/ 2019-09-25T19:46:46+00:00 https://ascopost.com/issues/september-25-2019/conquer-cancer-council-unites-for-patients-everywhere/ 2019-09-25T17:40:46+00:00 https://ascopost.com/issues/september-25-2019/asco-print-resource-for-those-facing-an-advanced-cancer-diagnosis/ 2019-09-25T17:40:46+00:00 https://ascopost.com/issues/september-25-2019/jgo-commentary-reflects-on-the-legacy-of-arti-hurria/ 2019-09-25T17:40:47+00:00 https://ascopost.com/issues/september-25-2019/raising-the-quality-of-cancer-care-globally/ 2019-09-25T17:40:47+00:00 https://ascopost.com/issues/september-25-2019/asco-announces-cancerlinq-discovery-research-support-grant-recipients/ 2019-09-25T17:40:47+00:00 https://ascopost.com/issues/september-10-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/september-10-2019/enzalutamide-improves-survival-vs-standard-first-line-treatment-in-hormone-sensitive-metastatic-prostate-cancer/ 2019-09-23T01:59:01+00:00 https://ascopost.com/issues/september-10-2019/how-patient-advocacy-is-integral-to-high-quality-oncology-care/ 2019-09-10T18:04:19+00:00 https://ascopost.com/issues/september-10-2019/hey-siri-should-i-get-a-medical-degree/ 2019-09-10T18:04:19+00:00 https://ascopost.com/issues/september-10-2019/is-it-time-to-intervene-in-smoldering-myeloma/ 2019-09-23T01:39:17+00:00 https://ascopost.com/issues/september-10-2019/stage-iv-melanoma-and-the-current-role-of-surgery/ 2019-09-23T01:40:10+00:00 https://ascopost.com/issues/september-10-2019/the-mark-foundation-awards-grant-for-lung-ca-research/ 2019-09-10T18:04:19+00:00 https://ascopost.com/issues/september-10-2019/germline-brca2-mutation-and-risk-of-pediatric-or-adolescent-lymphoma/ 2019-09-13T21:14:15+00:00 https://ascopost.com/issues/september-10-2019/sitc-publishes-clinical-immuno-guidelines-for-treatment-of-head-neck-squamous-cell/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/fda-approves-fedratinib-for-treatment-of-myelofibrosis/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/fda-approves-entrectinib-for-ntrk-fusion-cancers-ros1-positive-nsclc/ 2019-10-09T15:18:36+00:00 https://ascopost.com/issues/september-10-2019/asco-expands-therapeutic-options-for-vte-prophylaxis/ 2019-09-23T01:30:15+00:00 https://ascopost.com/issues/september-10-2019/clinical-practice-guideline-on-medication-related-osteonecrosis-of-the-jaw/ 2019-09-23T01:29:15+00:00 https://ascopost.com/issues/september-10-2019/many-choices-for-men-with-metastatic-hormone-sensitive-prostate-cancer/ 2019-09-23T02:01:37+00:00 https://ascopost.com/issues/september-10-2019/pregnancy-after-treatment-for-breast-cancer-in-patients-with-brca-mutations/ 2019-09-12T20:16:00+00:00 https://ascopost.com/issues/september-10-2019/efficacy-of-lower-dose-olanzapine-in-combination-with-standard-antiemetic-regimen/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/clinical-trial-enrollment-and-reduced-mortality-in-metastatic-lung-cancer/ 2019-09-18T21:32:14+00:00 https://ascopost.com/issues/september-10-2019/addition-of-apalutamide-to-androgen-deprivation-therapy-in-metastatic-castration-sensitive-prostate-cancer/ 2019-09-23T02:04:24+00:00 https://ascopost.com/issues/september-10-2019/apalutamide-adds-to-options-in-metastatic-hormone-sensitive-prostate-cancer/ 2019-09-23T02:04:56+00:00 https://ascopost.com/issues/september-10-2019/update-on-fda-approved-car-t-cell-gene-therapy-for-b-cell-lymphomas/ 2019-09-23T01:50:18+00:00 https://ascopost.com/issues/september-10-2019/nci-community-oncology-research-program-expands-to-more-sites/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/iu-simon-ca-center-earns-nci-s-comprehensive-ca-center-designation/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/1-million-gift-for-epithelioid-hemangioendothelioma-research/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/northern-california-prostate-ca-center-joins-us-oncology-network/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/david-sternberg-joins-karmanos-ca-institute/ 2019-09-10T18:04:20+00:00 https://ascopost.com/issues/september-10-2019/curemd-oncology-integrates-nccn-templates/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/primary-central-nervous-system-lymphoma/ 2019-09-23T01:54:24+00:00 https://ascopost.com/issues/september-10-2019/nancy-davidson-and-jerry-radich-receive-endowed-chairs-at-fred-hutch/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/sita-kugel-receives-grant-to-study-aggressive-type-of-pancreatic-can/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/apply-by-september-25-to-asco-s-health-policy-leadership-development-program/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/2020-fee-schedule-proposal-outlines-em-code-and-mips-changes/ 2019-09-17T21:22:36+00:00 https://ascopost.com/issues/september-10-2019/new-asco-ethical-framework-for-including-research-biopsies-in-clinical-trials/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/asco-welcomes-2019-2020-leadership-development-program-participants-education-scholars/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/stock-your-practice-with-asco-answers-materials/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/spotlight-on-women-who-conquer-cancer/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/women-who-conquer-cancer/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/2019-albany-medical-center-prize/ 2019-09-23T01:56:00+00:00 https://ascopost.com/issues/september-10-2019/physical-activity-level-and-outcomes-in-metastatic-colorectal-cancer/ 2019-09-10T18:04:21+00:00 https://ascopost.com/issues/september-10-2019/how-to-terminate-a-treatment-relationship/ 2019-09-10T17:58:34+00:00 https://ascopost.com/issues/september-10-2019/acs-names-william-cance-chief-medical-and-scientific-officer/ 2019-09-10T17:58:34+00:00 https://ascopost.com/issues/september-10-2019/fda-oce-and-syapse-announce-research-collaboration/ 2019-09-10T17:58:34+00:00 https://ascopost.com/issues/september-10-2019/md-anderson-to-expand-proton-therapy-center/ 2019-09-10T17:58:34+00:00 https://ascopost.com/issues/september-10-2019/confronting-the-criticisms-facing-watson-for-oncology/ 2019-09-10T17:58:34+00:00 https://ascopost.com/issues/september-10-2019/maura-gillison-pioneer-in-hpv-related-head-and-neck-ca-has-often-changed-lanes-in-her-career/ 2019-09-10T17:58:34+00:00 https://ascopost.com/issues/september-10-2019/lenalidomide-for-previously-treated-follicular-and-marginal-zone-lymphomas/ 2019-09-23T01:06:52+00:00 https://ascopost.com/issues/september-10-2019/insightful-advice-from-a-college-advisor-leads-to-an-unexpected-career-in-oncology/ 2019-09-10T17:58:34+00:00 https://ascopost.com/issues/september-10-2019/daratumumab-based-therapy-for-myeloma-ineligible-for-transplantation/ 2019-09-23T01:26:40+00:00 https://ascopost.com/issues/september-10-2019/2019-edogawa-niche-prize/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/light-intervention-for-cancer-related-fatigue-depression-and-sleep-disturbance/ 2019-09-17T20:52:55+00:00 https://ascopost.com/issues/september-10-2019/nakul-singhal-and-nicole-carreau-join-new-york-cancer-blood-specialists/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/doctor-where-art-thou/ 2019-09-23T01:27:39+00:00 https://ascopost.com/issues/september-10-2019/pembrolizumab-in-first-line-treatment-of-headneck-squamous-cell-carcinoma/ 2019-09-23T01:10:29+00:00 https://ascopost.com/issues/september-10-2019/pembrolizumab-in-advanced-esophageal-squamous-cell-cancer/ 2019-09-23T01:47:22+00:00 https://ascopost.com/issues/september-10-2019/florida-cancer-specialists-welcomes-luis-carrascosa/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/surgery-in-the-19th-century/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/alpelisib-for-pik3ca-mutated-advanced-breast-cancer/ 2019-09-23T01:06:04+00:00 https://ascopost.com/issues/september-10-2019/a-vigorous-life-through-the-prism-of-impending-death/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/having-cancer-as-a-teenager-derailed-my-life-course/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/john-hansen-transplant-expert-who-founded-volunteer-donor-registries-dies/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/donald-lindberg-former-director-of-the-national-library-of-medicine-dies/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/hiv-positive-older-adults-with-cancer-and-worsened-disease-outcomes/ 2019-09-10T17:58:35+00:00 https://ascopost.com/issues/september-10-2019/combination-cdk46-and-egfr-inhibition-in-hpv-unrelated-head-and-neck-cancer/ 2019-09-10T17:58:36+00:00 https://ascopost.com/issues/september-10-2019/combined-use-of-identification-methods-for-dense-breasts-and-discussion-of-supplemental-imaging/ 2019-09-10T17:58:36+00:00 https://ascopost.com/issues/september-10-2019/circulating-tumor-dna-and-relapse-in-early-stage-breast-cancer/ 2019-09-10T17:58:36+00:00 https://ascopost.com/issues/september-10-2019/uspstf-recommendation-on-brca-related-cancer/ 2019-09-10T17:58:36+00:00 https://ascopost.com/issues/september-10-2019/fda-proposes-new-required-health-warnings-with-images-for-cigarette-packages-and-advertisements/ 2019-09-10T17:58:36+00:00 https://ascopost.com/issues/september-10-2019/erratum/ 2019-09-10T17:58:36+00:00 https://ascopost.com/issues/september-10-2019/lead-conference/ 2019-09-10T17:58:37+00:00 https://ascopost.com/issues/august-25-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/august-25-2019/exploratory-analysis-shows-dna-methylation-assay-highly-specific-for-cancer-detection/ 2019-08-26T19:50:41+00:00 https://ascopost.com/issues/august-25-2019/epov-thomas-paul-slavin/ 2019-08-26T17:14:26+00:00 https://ascopost.com/issues/august-25-2019/all-oncologists-are-geriatric-oncologists/ 2020-02-17T17:30:03+00:00 https://ascopost.com/issues/august-25-2019/optimal-first-line-therapy-for-stage-iv-non-small-cell-lung-cancer/ 2019-08-28T21:11:24+00:00 https://ascopost.com/issues/august-25-2019/cms-finalizes-decision-to-cover-car-t-cell-therapy-for-medicare-beneficiaries/ 2019-08-26T17:14:26+00:00 https://ascopost.com/issues/august-25-2019/opioids-for-cancer-pain/ 2019-08-26T17:14:26+00:00 https://ascopost.com/issues/august-25-2019/fda-approves-darolutamide-for-nonmetastatic-castration-resistant-prostate-cancer/ 2019-08-26T17:14:26+00:00 https://ascopost.com/issues/august-25-2019/fda-approves-pexidartinib-for-tenosynovial-giant-cell-tumor/ 2019-08-26T17:14:26+00:00 https://ascopost.com/issues/august-25-2019/fda-clears-next-generation-scalp-cooling-device/ 2019-08-27T14:41:38+00:00 https://ascopost.com/issues/august-25-2019/polypharmacy-associated-with-functional-decline-in-older-patients-with-advanced-cancer/ 2019-08-26T19:52:36+00:00 https://ascopost.com/issues/august-25-2019/virtual-reality-and-patients-with-cancer/ 2019-08-26T17:14:27+00:00 https://ascopost.com/issues/august-25-2019/selinexor-in-relapsed-or-refractory-multiple-myeloma/ 2019-08-27T21:26:35+00:00 https://ascopost.com/issues/august-25-2019/can-some-women-with-her2-positive-breast-cancer-forgo-surgery/ 2019-08-27T21:27:46+00:00 https://ascopost.com/issues/august-25-2019/epov-carla-fisher/ 2019-08-26T17:14:27+00:00 https://ascopost.com/issues/august-25-2019/novel-treatments-under-study-in-renal-cell-carcinoma-and-prostate-cancer/ 2019-08-27T21:23:48+00:00 https://ascopost.com/issues/august-25-2019/dana-farber-researchers-win-grand-challenge-funding-from-cancer-research-uk/ 2019-08-26T17:14:27+00:00 https://ascopost.com/issues/august-25-2019/pelotonia-institute-for-immuno-oncology-launched-at-osucc/ 2019-08-26T17:14:27+00:00 https://ascopost.com/issues/august-25-2019/tumor-size-and-grade-matter/ 2019-08-27T21:29:46+00:00 https://ascopost.com/issues/august-25-2019/darolutamide-for-nonmetastatic-castration-resistant-prostate-cancer/ 2019-08-27T21:31:06+00:00 https://ascopost.com/issues/august-25-2019/looking-at-prostate-cancer-specific-mortality-by-gleason-score-and-race/ 2019-08-27T17:32:29+00:00 https://ascopost.com/issues/august-25-2019/new-nccn-guidelines-on-small-intestine-cancers/ 2019-08-26T17:14:27+00:00 https://ascopost.com/issues/august-25-2019/should-you-become-an-expert-witness-in-a-legal-proceeding/ 2019-08-26T17:14:27+00:00 https://ascopost.com/issues/august-25-2019/atezolizumab-plus-chemotherapy-and-bevacizumab-in-first-line-treatment-of-metastatic-lung-cancer/ 2019-08-27T21:21:23+00:00 https://ascopost.com/issues/august-25-2019/west-virginia-university-cancer-institute-welcomes-eight-new-doctors/ 2019-08-26T17:14:27+00:00 https://ascopost.com/issues/august-25-2019/an-early-decision-to-become-an-oncologist/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/fda-approves-pembrolizumab-for-some-patients-with-pd-l1-positive-esophageal-cancer/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/v-craig-jordan-cmg-obe-phd-dsc-honored-for-accomplishments-in-women-s-health/ 2019-09-06T19:23:42+00:00 https://ascopost.com/issues/august-25-2019/george-j-bosl-named-memorial-sloan-kettering-s-first-ombudsperson/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/more-health-collaborates-with-memorial-sloan-kettering/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/cholangiocarcinoma-foundation-awards-365k-in-research-fellowship-grants/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/mmrf-launches-curecloud-to-advance-precision-medicine/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/almost-20-years-later-breast-fitness-is-more-relevant-than-ever/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/healthy-lifestyle-for-young-adult-cancer-survivors/ 2019-08-27T19:08:56+00:00 https://ascopost.com/issues/august-25-2019/astro-elects-four-new-officers-to-board-of-directors/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/pexidartinib-for-tenosynovial-giant-cell-tumor/ 2019-08-27T19:08:05+00:00 https://ascopost.com/issues/august-25-2019/a-clinical-trial-was-the-right-choice-for-me/ 2019-08-27T21:25:08+00:00 https://ascopost.com/issues/august-25-2019/cancer-research-institute-names-new-stars-of-cancer-immunotherapy-research/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/5-year-follow-up-of-keynote-006-trial-of-immunotherapy-regimens-in-advanced-melanoma/ 2019-08-26T17:14:28+00:00 https://ascopost.com/issues/august-25-2019/long-term-follow-up-of-patients-with-melanoma-kidney-cancer-and-lung-cancer-receiving-nivolumab/ 2019-08-26T17:14:29+00:00 https://ascopost.com/issues/august-25-2019/adjuvant-chemoradiotherapy-vs-radiotherapy-alone-in-high-risk-endometrial-cancer/ 2019-08-26T17:14:29+00:00 https://ascopost.com/issues/august-25-2019/uspstf-recommendation-on-screening-for-pancreatic-cancer-in-asymptomatic-adults/ 2020-09-24T01:28:54+00:00 https://ascopost.com/issues/august-25-2019/register-for-asco-s-research-community-forum-2019-annual-meeting/ 2019-08-26T17:23:55+00:00 https://ascopost.com/issues/august-25-2019/some-practices-may-not-be-subject-to-usp-797-and-800-standards/ 2019-08-26T17:58:56+00:00 https://ascopost.com/issues/august-25-2019/asco-breakthrough-why-now-why-bangkok/ 2019-08-26T17:28:41+00:00 https://ascopost.com/issues/august-25-2019/20-oncology-practices-achieve-asco-s-qopi-certification-in-second-quarter-of-2019/ 2019-08-26T17:30:14+00:00 https://ascopost.com/issues/august-25-2019/newly-updated-asco-answers-resource-to-help-your-patients-quit-tobacco/ 2019-08-26T17:31:12+00:00 https://ascopost.com/issues/august-25-2019/your-stories-how-to-become-a-conqueror/ 2019-08-26T17:32:08+00:00 https://ascopost.com/issues/august-25-2019/spotlight-on-women-who-conquer-cancer/ 2019-08-26T17:37:33+00:00 https://ascopost.com/issues/august-25-2019/new-from-asco-elearning/ 2019-08-26T17:39:19+00:00 https://ascopost.com/issues/august-10-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/august-10-2019/beacon-crc/ 2020-09-23T01:50:00+00:00 https://ascopost.com/issues/august-10-2019/how-an-innovative-ai-based-smartphone-application-is-addressing-patients-palliative-care-needs/ 2019-08-12T16:53:54+00:00 https://ascopost.com/issues/august-10-2019/gender-equity/ 2019-08-12T16:53:54+00:00 https://ascopost.com/issues/august-10-2019/notable-presentations-at-asco-2019/ 2019-08-13T17:43:31+00:00 https://ascopost.com/issues/august-10-2019/studies-find-trilaciclib-may-improve-chemotherapy-experience-for-patients-with-small-cell-lung-cancer/ 2019-08-14T18:25:12+00:00 https://ascopost.com/issues/august-10-2019/novel-therapeutics-on-the-horizon-for-treating-chemotherapy-induced-peripheral-neuropathy/ 2019-08-13T18:09:11+00:00 https://ascopost.com/issues/august-10-2019/fda-approves-rituximab-biosimilar/ 2019-08-12T16:53:54+00:00 https://ascopost.com/issues/august-10-2019/blue-distinction-center-for-cellular-immunotherapy-status-granted-to-huntsman-cancer-institute/ 2019-08-12T18:16:35+00:00 https://ascopost.com/issues/august-10-2019/fda-requests-manufacturer-recall-of-some-textured-breast-implants/ 2019-08-12T16:53:54+00:00 https://ascopost.com/issues/august-10-2019/global-coalition-for-adaptive-research-in-glioblastoma/ 2019-08-12T18:17:01+00:00 https://ascopost.com/issues/august-10-2019/atezolizumab-combined-with-chemotherapy-in-first-line-extensive-stage-small-cell-lung-cancer/ 2019-08-13T17:18:21+00:00 https://ascopost.com/issues/august-10-2019/preserving-sexuality-and-restoring-sexual-function-in-male-and-female-cancer-survivors/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/mascc-s-2019-distinguished-service-award-winner/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/pembrolizumab-in-metastatic-small-cell-lung-cancer/ 2019-08-13T17:39:33+00:00 https://ascopost.com/issues/august-10-2019/treatment-update-on-selected-non-hodgkin-lymphomas/ 2019-08-13T17:47:42+00:00 https://ascopost.com/issues/august-10-2019/aacr-announces-2019-class-of-fellows-of-the-aacr-academy/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/johns-hopkins-awarded-32-million-nih-grant-for-early-stage-bladder-cancer-research/ 2019-08-12T18:17:51+00:00 https://ascopost.com/issues/august-10-2019/leading-city-of-hope-hematologists-appointed-to-new-positions/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/cota-signs-research-collaboration-agreement-with-fda/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/polatuzumab-vedotin-piiq-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2019-08-13T17:38:20+00:00 https://ascopost.com/issues/august-10-2019/how-laura-j-van-t-veer-phd-became-an-expert-in-genetic-testing-for-breast-cancer/ 2019-08-12T20:31:43+00:00 https://ascopost.com/issues/august-10-2019/broad-institute-launches-cancer-diagnostics-center/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/hope-cancer-care-of-nevada-joins-the-american-oncology-network/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/nci-boosts-university-of-hawai-i-cancer-center-support-to-84m/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/looking-at-the-impact-of-state-policies-on-access-to-high-quality-care/ 2019-08-19T21:30:59+00:00 https://ascopost.com/issues/august-10-2019/sylvester-comprehensive-cancer-center-earns-nci-designation/ 2019-08-12T16:53:55+00:00 https://ascopost.com/issues/august-10-2019/highlights-in-geriatric-hematology-from-the-ash-annual-meeting-exposition/ 2020-02-17T17:32:15+00:00 https://ascopost.com/issues/august-10-2019/ash-honors-richard-aster-md/ 2019-08-12T18:19:42+00:00 https://ascopost.com/issues/august-10-2019/conquer-cancer-honors-oncology-professionals-with-merit-awards-at-the-2019-asco-annual-meeting/ 2019-08-12T16:53:56+00:00 https://ascopost.com/issues/august-10-2019/call-for-papers-physician-wellness-burnout-and-moral-distress-in-oncology-practice-special-series/ 2019-08-12T18:21:47+00:00 https://ascopost.com/issues/august-10-2019/share-asco-answers-fact-sheets-with-your-patients/ 2020-09-23T01:51:14+00:00 https://ascopost.com/issues/august-10-2019/medicaid-patients-need-clinical-trial-access-coalition-tells-congress/ 2019-08-12T18:10:02+00:00 https://ascopost.com/issues/august-10-2019/icr-annual-science-and-medical-image-competition/ 2019-08-12T16:53:56+00:00 https://ascopost.com/issues/august-10-2019/the-role-of-primary-care-physicians-in-pediatric-cancer-survivorship/ 2019-08-12T18:22:41+00:00 https://ascopost.com/issues/august-10-2019/eighth-edition-of-the-ajcc-staging-manual/ 2019-08-12T16:53:56+00:00 https://ascopost.com/issues/august-10-2019/how-technology-is-transforming-the-assessment-of-inherited-cancer-risk/ 2019-08-20T21:06:18+00:00 https://ascopost.com/issues/august-10-2019/actively-recruiting-clinical-trials-focused-on-survivorship/ 2019-08-12T16:53:56+00:00 https://ascopost.com/issues/august-10-2019/out-of-the-mouths-of-babes/ 2019-08-12T16:53:56+00:00 https://ascopost.com/issues/august-10-2019/the-obesity-epidemic-from-a-neuroscience-perspective/ 2019-08-12T16:53:56+00:00 https://ascopost.com/issues/august-10-2019/pembrolizumab-for-advanced-merkel-cell-carcinoma/ 2019-08-13T17:17:10+00:00 https://ascopost.com/issues/august-10-2019/echinacea/ 2019-08-13T17:19:32+00:00 https://ascopost.com/issues/august-10-2019/the-radium-era-1916-1945/ 2019-08-12T16:53:57+00:00 https://ascopost.com/issues/august-10-2019/joseph-a-sparano-md-to-receive-william-l-mcguire-memorial-lecture-award/ 2019-08-12T16:53:57+00:00 https://ascopost.com/issues/august-10-2019/the-opioid-overdose-crisis/ 2019-08-13T17:17:35+00:00 https://ascopost.com/issues/august-10-2019/addition-of-ido1-inhibitor-to-immunotherapy-in-melanoma/ 2019-08-12T18:23:44+00:00 https://ascopost.com/issues/august-10-2019/early-trial-of-iph4102-in-cutaneous-t-cell-lymphoma/ 2019-08-22T19:10:49+00:00 https://ascopost.com/issues/august-10-2019/regorafenib-dose-escalation-strategy-vs-standard-dosing-in-colorectal-cancer/ 2019-08-12T16:53:57+00:00 https://ascopost.com/issues/august-10-2019/anti-pd-1pd-l1-rechallenge-after-immune-related-adverse-events/ 2019-08-12T16:53:57+00:00 https://ascopost.com/issues/august-10-2019/remembering-michael-d-becker/ 2019-08-12T16:53:57+00:00 https://ascopost.com/issues/august-10-2019/american-cancer-society-and-ovarian-cancer-research-alliance-launch-new-ovarian-cancer-research-collaboration/ 2019-08-12T16:53:57+00:00 https://ascopost.com/issues/august-10-2019/who-releases-report-on-the-global-tobacco-epidemic/ 2019-08-12T16:53:57+00:00 https://ascopost.com/issues/july-25-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/july-25-2019/iraes-herald-benefit-with-adjuvant-pembrolizumab-in-melanoma/ 2019-07-25T18:26:11+00:00 https://ascopost.com/issues/july-25-2019/epov-vernon-sondak/ 2019-07-25T15:50:44+00:00 https://ascopost.com/issues/july-25-2019/reflections-from-an-asco-idea-recipient/ 2019-07-25T18:29:45+00:00 https://ascopost.com/issues/july-25-2019/how-the-asco-breakthrough-global-summit-is-bringing-together-innovators/ 2019-07-25T16:31:01+00:00 https://ascopost.com/issues/july-25-2019/two-pivotal-studies-in-breast-cancer-report-further-analyses/ 2019-07-29T17:17:50+00:00 https://ascopost.com/issues/july-25-2019/is-heterogeneity-within-her2-positive-tumors-clinically-relevant/ 2019-07-29T17:20:26+00:00 https://ascopost.com/issues/july-25-2019/epov-mark-pegram-and-sandra-swain/ 2019-07-25T15:50:45+00:00 https://ascopost.com/issues/july-25-2019/study-highlights-on-novel-agents-and-supportive-care-strategies-in-prostate-cancer/ 2019-07-30T17:03:13+00:00 https://ascopost.com/issues/july-25-2019/fda-grants-accelerated-approval-to-selinexor-in-combination-with-dexamethasone-in-pentarefractory-multiple-myeloma/ 2019-07-25T15:50:45+00:00 https://ascopost.com/issues/july-25-2019/fda-expands-indication-for-pembrolizumab-to-metastatic-small-cell-lung-cancer/ 2019-07-25T15:50:45+00:00 https://ascopost.com/issues/july-25-2019/fda-approves-bevacizumab-biosimilar-for-five-cancer-types/ 2019-07-25T15:50:45+00:00 https://ascopost.com/issues/july-25-2019/update-on-newer-treatments-in-non-hodgkin-lymphomas/ 2019-07-25T18:37:34+00:00 https://ascopost.com/issues/july-25-2019/jason-lewis-receives-snmmi-award/ 2019-07-25T15:50:45+00:00 https://ascopost.com/issues/july-25-2019/two-investigational-agents-demonstrate-safety-efficacy-in-lung-cancer/ 2019-08-07T13:40:01+00:00 https://ascopost.com/issues/july-25-2019/epov-sarina-anne-piha-paul-and-benjamin-besse/ 2019-07-25T15:50:45+00:00 https://ascopost.com/issues/july-25-2019/friends-of-cancer-research-launches-next-phase-in-real-world-evidence-initiative/ 2019-07-25T15:50:45+00:00 https://ascopost.com/issues/july-25-2019/brief-update-on-clinical-trials-of-new-treatments-in-gastrointestinal-cancers/ 2019-07-25T18:40:12+00:00 https://ascopost.com/issues/july-25-2019/cathy-eng-named-to-gastrointestinal-cancer-leadership-position/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/new-members-join-stand-up-to-cancer-s-advisory-committee/ 2019-07-31T18:43:53+00:00 https://ascopost.com/issues/july-25-2019/william-cance-named-interim-director-of-university-of-arizona-cancer-center/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/is-it-time-to-reevaluate-the-p-value-in-biomedical-research/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/new-nccn-guidelines-for-patients-bladder-cancer/ 2019-07-29T16:56:28+00:00 https://ascopost.com/issues/july-25-2019/patientpoint-campaign-brings-nccn-resources-to-oncology-practices/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/krista-nelson-receives-leadership-in-oncology-social-work-award/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/ucsf-opens-cancer-facility-devoted-to-precision-medicine/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/florida-cancer-specialists-welcomes-barry-berman/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/parental-treatment-refusals/ 2019-08-05T15:05:17+00:00 https://ascopost.com/issues/july-25-2019/cancercare-publishes-patient-manifesto/ 2019-07-25T17:29:12+00:00 https://ascopost.com/issues/july-25-2019/asco-conquer-cancer-congratulate-2019-grant-and-award-recipients/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/director-of-the-fda-oce-on-latest-asco-in-action-podcast/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/asco-answers-topic-specific-booklet-bundle/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/asco-now-accepting-research-project-applications-for-research-survey-pool/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/indiana-oncology-society-launches-cancer-caucus-to-serve-local-policymakers/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/winship-cancer-institute-awarded-lung-cancer-spore-grant/ 2019-07-25T15:50:46+00:00 https://ascopost.com/issues/july-25-2019/brentuximab-vedotin-in-untreated-systemic-anaplastic-large-cell-lymphoma-and-cd30-expressing-peripheral-t-cell-lymphomas/ 2019-08-08T18:47:01+00:00 https://ascopost.com/issues/july-25-2019/society-of-nuclear-medicine-and-molecular-imaging-elects-new-officers/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/laughter-in-oncology-is-more-common-than-you-think/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/looking-into-the-future-of-psychosocial-oncology/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/emerging-interest-in-metabolic-pathways-to-tumorigenesis/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/integrative-medicine-in-pediatric-and-adolescent-patients-with-cancer/ 2019-07-25T18:42:45+00:00 https://ascopost.com/issues/july-25-2019/a-compassionate-family-doctor-sparked-an-interest-in-medicine-for-lori-pierce-md-fastro-fasco/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/fda-approves-daratumumab-in-combination-with-lenalidomide-and-dexamethasone-for-newly-diagnosed-multiple-myeloma/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/emergency-medicine-doctor-reflects-on-5-decades-of-career-experiences/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/the-unhealthy-health-care-system-and-how-to-fix-it/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/physicians-and-the-threat-of-nuclear-war/ 2019-07-25T19:13:37+00:00 https://ascopost.com/issues/july-25-2019/active-surveillance-for-early-stage-prostate-cancer-requires-active-participation-by-patient-and-clinician/ 2019-07-30T17:04:34+00:00 https://ascopost.com/issues/july-25-2019/two-takeaways-from-study-on-active-surveillance-for-prostate-cancer/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/active-regimen-for-high-risk-and-older-patients-with-previously-untreated-chronic-lymphocytic-leukemia/ 2019-07-25T18:43:43+00:00 https://ascopost.com/issues/july-25-2019/activity-of-a-mek-12-inhibitor-in-select-pediatric-brain-cancers/ 2019-07-25T15:50:47+00:00 https://ascopost.com/issues/july-25-2019/becoming-acquainted-with-cancer/ 2023-06-23T15:35:39+00:00 https://ascopost.com/issues/july-10-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/july-10-2019/cleopatra-end-of-study-analysis-in-metastatic-breast-cancer/ 2019-07-15T17:56:47+00:00 https://ascopost.com/issues/july-10-2019/epov-john-cole-and-carlos-barrios/ 2019-07-10T17:09:17+00:00 https://ascopost.com/issues/july-10-2019/project-facilitate/ 2019-07-10T17:09:17+00:00 https://ascopost.com/issues/july-10-2019/winning-the-lottery/ 2019-07-10T17:09:17+00:00 https://ascopost.com/issues/july-10-2019/clinical-risk-enhances-utility-of-tailorx-findings-in-young-women-with-breast-cancer/ 2019-07-10T17:09:17+00:00 https://ascopost.com/issues/july-10-2019/epov-eric-winer-and-sandra-swain/ 2019-07-10T17:09:17+00:00 https://ascopost.com/issues/july-10-2019/nala-trial/ 2019-07-15T18:11:54+00:00 https://ascopost.com/issues/july-10-2019/epov-carlos-barrios-and-jame-abraham/ 2019-07-10T17:09:17+00:00 https://ascopost.com/issues/july-10-2019/neoadjuvant-immunotherapy-may-benefit-patients-with-early-stage-nsclc/ 2019-07-10T21:12:17+00:00 https://ascopost.com/issues/july-10-2019/epov-maximilian-diehn/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/advances-in-targeted-therapy-for-non-small-cell-lung-cancer/ 2019-07-10T21:11:25+00:00 https://ascopost.com/issues/july-10-2019/epov-christine-lovly/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/idea-collaboration-turns-to-duration-of-adjuvant-treatment-in-stage-ii-colon-cancer/ 2019-07-11T19:50:08+00:00 https://ascopost.com/issues/july-10-2019/epov-david-ryan/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/targeting-folfoxiri-plus-bevacizumab-to-a-metastatic-colorectal-cancer-subset/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/epov-hanna-sanoff/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/study-supports-neoadjuvant-chemotherapy-in-operable-colon-cancer/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/epov-jordan-berlin/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/study-shows-benefit-with-pazopanib-in-treatment-of-carcinoid-tumors/ 2019-07-11T21:27:47+00:00 https://ascopost.com/issues/july-10-2019/epov-william-harris/ 2019-07-11T21:28:49+00:00 https://ascopost.com/issues/july-10-2019/enfortumab-vedotin-after-checkpoint-inhibition-in-metastatic-urothelial-cancer/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/epov-andrea-necchi/ 2019-07-10T17:09:18+00:00 https://ascopost.com/issues/july-10-2019/sophia-trial/ 2019-07-15T18:00:01+00:00 https://ascopost.com/issues/july-10-2019/epov-carlos-barrios/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/apact-trial/ 2019-07-10T21:12:48+00:00 https://ascopost.com/issues/july-10-2019/epov-jiping-wang/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/actively-recruiting-clinical-trials-for-muscle-invasive-and-non-muscle-invasive-bladder-cancers/ 2021-02-09T23:03:30+00:00 https://ascopost.com/issues/july-10-2019/combination-immunotherapy-and-inhibitors-of-dna-damage-repair-in-the-treatment-of-small-cell-lung-cancer/ 2019-07-10T21:13:21+00:00 https://ascopost.com/issues/july-10-2019/asco-endorses-tobacco-free-youth-act/ 2019-07-10T17:49:55+00:00 https://ascopost.com/issues/july-10-2019/2019-presidential-address/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/head-and-neck-cancer-researcher-earns-spot-in-clinical-cancer-advances-2019/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/your-stories-kindred-spirits/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/positive-findings-from-two-tapur-study-cohorts-presented-at-the-2019-asco-annual-meeting/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/improve-quality-of-life-with-this-palliative-care-education-resource-for-your-patients/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/fda-approves-first-line-ivosidenib-for-idh1-mutated-aml/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/joann-sweasy-joins-university-of-arizona-cancer-center-as-associate-director-for-basic-sciences/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/erratum/ 2019-07-10T17:09:19+00:00 https://ascopost.com/issues/july-10-2019/willie-underwood-iii-elected-to-ama-board-of-trustees/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/queen-elizabeth-ii-bestows-honor-on-v-craig-jordan/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/george-washington-university-cancer-center-to-create-position-of-dr-cyrus-katzen-family-director/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/trifluridinetipiracil-in-recurrent-metastatic-gastric-and-gej-adenocarcinoma/ 2019-07-10T17:51:42+00:00 https://ascopost.com/issues/july-10-2019/growing-up-in-a-medical-family-planted-the-seed-for-a-career-in-oncology-for-karen-gelmon/ 2019-07-11T18:19:09+00:00 https://ascopost.com/issues/july-10-2019/the-bomb/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/fda-approves-new-trastuzumab-biosimilar/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/immunologic-dysregulation-in-the-multiple-myeloma-microenvironment/ 2019-07-10T21:10:23+00:00 https://ascopost.com/issues/july-10-2019/chaga-mushroom/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/henry-t-lynch-dies-at-91/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/lasalle-d-leffall-jr-dies-at-89/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/addition-of-antiangiogenic-agent-to-first-line-carboplatinpaclitaxel-in-ovarian-cancer/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/optimismm-trial/ 2019-07-10T17:09:20+00:00 https://ascopost.com/issues/july-10-2019/combination-therapy-with-immunochemotherapy-and-an-antibody-drug-conjugate-in-dlbcl/ 2019-07-19T16:49:00+00:00 https://ascopost.com/issues/june-25-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/june-25-2019/enzalutamide-improves-overall-survival-in-hormone-sensitive-metastatic-prostate-cancer/ 2019-06-25T20:56:49+00:00 https://ascopost.com/issues/june-25-2019/chemotherapy-andor-hormonal-agents/ 2019-06-25T16:45:01+00:00 https://ascopost.com/issues/june-25-2019/an-asco-survey-hope-and-conventional-therapies/ 2019-06-25T20:57:59+00:00 https://ascopost.com/issues/june-25-2019/solving-the-mystery-of-why-colorectal-cancer-is-on-the-rise-in-young-adults/ 2020-08-31T19:33:13+00:00 https://ascopost.com/issues/june-25-2019/polo-trial-shows-maintenance-olaparib-improves-pfs-in-metastatic-pancreatic-cancer/ 2019-06-25T21:54:36+00:00 https://ascopost.com/issues/june-25-2019/epov-wells-messersmith-allyson-ocean/ 2019-06-25T16:45:02+00:00 https://ascopost.com/issues/june-25-2019/keynote-062-pembrolizumab-in-gastricgej-cancer/ 2019-06-25T21:53:53+00:00 https://ascopost.com/issues/june-25-2019/epov-ian-chau/ 2019-06-25T16:45:02+00:00 https://ascopost.com/issues/june-25-2019/fda-approves-pembrolizumab-for-the-first-line-treatment-of-hnscc/ 2019-06-25T16:45:02+00:00 https://ascopost.com/issues/june-25-2019/oneoncology-expands-executive-leadership-team/ 2019-06-25T16:45:02+00:00 https://ascopost.com/issues/june-25-2019/apalutamide-improves-survival-outcomes-in-castration-sensitive-metastatic-prostate-cancer/ 2019-07-02T17:17:01+00:00 https://ascopost.com/issues/june-25-2019/epov-charles-drake/ 2019-06-25T16:45:02+00:00 https://ascopost.com/issues/june-25-2019/fixed-duration-venetoclax-plus-obinutuzumab-as-first-line-treatment-in-older-patients-with-cll/ 2019-06-26T16:17:24+00:00 https://ascopost.com/issues/june-25-2019/continuous-lhrh-antagonists-in-metastatic-castration-resistant-prostate-cancer/ 2019-07-02T17:13:45+00:00 https://ascopost.com/issues/june-25-2019/improved-survival-shown-with-first-line-pembrolizumab-in-advanced-head-and-neck-cancer/ 2019-06-25T22:07:42+00:00 https://ascopost.com/issues/june-25-2019/epov-vanita-noronha/ 2019-06-25T16:45:02+00:00 https://ascopost.com/issues/june-25-2019/update-on-early-stage-studies-of-novel-treatments-in-glioblastoma/ 2019-06-25T22:08:55+00:00 https://ascopost.com/issues/june-25-2019/asco-launches-task-force-to-address-the-cancer-care-gap-in-rural-america/ 2019-06-25T22:11:23+00:00 https://ascopost.com/issues/june-25-2019/immune-therapies-emerging-in-disease-specific-treatment-of-hpv-positive-head-and-neck-cancer/ 2019-06-25T22:12:21+00:00 https://ascopost.com/issues/june-25-2019/radiotherapy-and-immunotherapy-for-squamous-cell-carcinoma-of-the-head-and-neck/ 2019-06-25T22:14:34+00:00 https://ascopost.com/issues/june-25-2019/actively-recruiting-clinical-trials-for-oral-head-and-neck-cancers/ 2019-06-25T16:45:03+00:00 https://ascopost.com/issues/june-25-2019/chemoradiotherapy-regimen-as-first-standard-of-care-for-hpv-positive-oral-cancer/ 2019-06-25T22:16:27+00:00 https://ascopost.com/issues/june-25-2019/accelerated-approval-program-for-the-benefit-of-patients/ 2019-06-25T22:18:32+00:00 https://ascopost.com/issues/june-25-2019/access-program-to-be-established-for-patients-after-olaratumab-withdrawn-from-global-market/ 2019-06-25T18:21:04+00:00 https://ascopost.com/issues/june-25-2019/dan-theodorescu-elected-to-association-of-american-physicians/ 2019-06-25T18:21:04+00:00 https://ascopost.com/issues/june-25-2019/aramis-trial/ 2019-06-25T20:53:07+00:00 https://ascopost.com/issues/june-25-2019/darolutamide-in-nonmetastatic-castration-resistant-prostate-cancer/ 2019-06-25T20:54:22+00:00 https://ascopost.com/issues/june-25-2019/new-liability-risks-to-avoid-when-you-are-not-a-patient-s-physician/ 2019-06-25T18:21:04+00:00 https://ascopost.com/issues/june-25-2019/perlmutter-cancer-center-expands-care-with-new-outpatient-facility/ 2019-06-25T18:21:04+00:00 https://ascopost.com/issues/june-25-2019/new-nccn-guidelines-for-pediatric-acute-lymphoblastic-leukemia/ 2019-06-25T18:21:04+00:00 https://ascopost.com/issues/june-25-2019/denosumab-prevents-neither-breast-cancer-relapse-nor-death/ 2019-07-08T19:14:29+00:00 https://ascopost.com/issues/june-25-2019/are-your-patients-using-complementary-and-alternative-therapies/ 2019-06-26T22:13:09+00:00 https://ascopost.com/issues/june-25-2019/ask-your-patients-about-complementary-and-alternative-therapies/ 2019-06-26T15:33:20+00:00 https://ascopost.com/issues/june-25-2019/transitioning-from-healthy-physician-to-patient-with-cancer/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/roswell-park-and-partners-launch-community-based-care-network/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/evidence-lacking-that-denosumab-alters-the-course-of-breast-cancer/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/nccn-names-2019-young-investigator-award-recipients/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/oral-hpv-dna-persistence-and-disease-progression-in-oral-cavity-and-oropharyngeal-squamous-cell-carcinoma/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/from-d-day-to-cancer-care/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/fda-announces-project-facilitate-to-access-investigational-therapies-for-patients-with-cancer/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/2019-asco-educational-book-explores-practice-changing-cancer-research/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/researchers-supported-by-conquer-cancer/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/register-early-for-asco-s-research-community-forum-2019-annual-meeting/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/trainee-and-early-career-members/ 2019-06-25T18:21:05+00:00 https://ascopost.com/issues/june-25-2019/caregivers-are-your-partners-in-patient-care/ 2019-06-25T18:21:06+00:00 https://ascopost.com/issues/june-10-2019/ 2021-06-08T17:57:17+00:00 https://ascopost.com/issues/june-10-2019/monaleesa-7-shows-overall-survival-benefit-for-ribociclibendocrine-therapy/ 2019-07-25T20:18:04+00:00 https://ascopost.com/issues/june-10-2019/epov-harold-burstein-and-jame-abraham/ 2019-06-10T14:45:55+00:00 https://ascopost.com/issues/june-10-2019/aca-increases-access-to-health-care-early-diagnosis-and-timely-treatment-for-patients-with-cancer/ 2019-06-10T14:35:44+00:00 https://ascopost.com/issues/june-10-2019/epov-yousuf-zafar/ 2019-06-10T11:58:14+00:00 https://ascopost.com/issues/june-10-2019/how-have-we-got-it-so-wrong/ 2019-07-10T21:03:22+00:00 https://ascopost.com/issues/june-10-2019/keynote-001-shows-long-term-survival-benefit-with-pembrolizumab-in-advanced-nsclc/ 2019-06-10T14:40:05+00:00 https://ascopost.com/issues/june-10-2019/two-pediatric-trials-find-targets-for-treatment-refractory-cancers/ 2019-07-10T21:07:49+00:00 https://ascopost.com/issues/june-10-2019/alpelisib-plus-fulvestrant-approved-for-pik3ca-mutated-breast-cancer/ 2019-06-10T11:58:15+00:00 https://ascopost.com/issues/june-10-2019/novottf-100l-system-in-combination-with-chemotherapy-approved-for-malignant-pleural-mesothelioma/ 2019-06-10T11:58:15+00:00 https://ascopost.com/issues/june-10-2019/ruxolitinib-approved-for-acute-graft-vs-host-disease/ 2019-06-10T11:58:15+00:00 https://ascopost.com/issues/june-10-2019/pembrolizumab-improves-survival-vs-chemotherapy-in-previously-untreated-advanced-nsclc-with-pd-l1-expression-1/ 2019-07-10T21:04:13+00:00 https://ascopost.com/issues/june-10-2019/head-and-neck-cancer-immunotherapy-in-locally-advanced-disease-clinical-trial-updates/ 2019-07-10T21:05:54+00:00 https://ascopost.com/issues/june-10-2019/using-bioimpedance-spectroscopy-to-prevent-progression-of-lymphedema/ 2019-06-10T14:50:55+00:00 https://ascopost.com/issues/june-10-2019/epov-julie-margenthaler/ 2019-06-10T11:58:15+00:00 https://ascopost.com/issues/june-10-2019/nipple-sparing-mastectomy-may-be-suitable-for-growing-number-of-well-selected-patients/ 2019-06-10T14:51:45+00:00 https://ascopost.com/issues/june-10-2019/epov-sarah-blair/ 2019-06-10T11:58:15+00:00 https://ascopost.com/issues/june-10-2019/studies-report-early-success-with-same-day-mastectomy-and-home-recovery-programs/ 2019-06-10T14:52:44+00:00 https://ascopost.com/issues/june-10-2019/epov-jeffrey-falk/ 2019-06-10T11:58:15+00:00 https://ascopost.com/issues/june-10-2019/survey-finds-prophylactic-cranial-irradiation-use-in-decline-for-extensive-stage-small-cell-lung-cancer/ 2019-06-10T14:54:32+00:00 https://ascopost.com/issues/june-10-2019/epov-kristin-higgins/ 2019-06-10T14:56:06+00:00 https://ascopost.com/issues/june-10-2019/northern-new-england-clinical-oncology-society-supports-2019-international-development-and-education-award-and-merit-awards/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/new-infographic-commentaries-highlight-role-of-opioids-in-managing-cancer-related-pain/ 2019-06-10T13:08:35+00:00 https://ascopost.com/issues/june-10-2019/offerings-from-the-asco-research-community-forum/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/engage-with-centra/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/experience-the-next-breakthrough-in-cancer-care/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/2019-integra-connect-golf-classic-raises-more-than-1-million-for-conquer-cancer-the-asco-foundation/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/new-content-collection-in-jco-clinical-cancer-informatics-delves-into-the-field-of-mathematical-oncology/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/asco-answers-fact-sheet-on-fertility-and-cancer-treatment/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/umass-lowell-student-wins-award-for-research-in-skin-cancers/ 2019-06-10T11:58:16+00:00 https://ascopost.com/issues/june-10-2019/regular-aspirin-use-and-risk-of-hepatocellular-carcinoma-and-epithelial-ovarian-cancer/ 2019-07-10T21:00:05+00:00 https://ascopost.com/issues/june-10-2019/aspirin-use-and-cancer-prevention-long-term-data-needed-on-benefits-and-risks/ 2019-07-10T21:00:32+00:00 https://ascopost.com/issues/june-10-2019/ibrutinib-in-combination-with-obinutuzumab-in-treatment-naive-cllsll/ 2019-06-10T14:23:49+00:00 https://ascopost.com/issues/june-10-2019/selected-abstracts-from-the-2019-asco-annual-meeting/ 2019-07-10T21:06:55+00:00 https://ascopost.com/issues/june-10-2019/dana-farber-opens-center-for-the-prevention-of-progression-for-precursor-hematologic-conditions/ 2019-06-10T11:58:17+00:00 https://ascopost.com/issues/june-10-2019/major-settlement-raises-questions-about-evidence-based-value-in-cancer-care/ 2019-06-10T14:34:41+00:00 https://ascopost.com/issues/june-10-2019/actively-recruiting-clinical-trials-focused-on-novel-drug-combinations-for-gallbladder-and-biliary-tract-cancers/ 2019-07-10T21:01:56+00:00 https://ascopost.com/issues/june-10-2019/scientist-father-of-a-child-with-autism-pushes-back-on-the-antivaccine-movement/ 2019-06-10T11:58:17+00:00 https://ascopost.com/issues/june-10-2019/from-leeches-to-liquid-biopsy-uncovering-the-mysteries-of-blood/ 2019-06-10T11:58:17+00:00 https://ascopost.com/issues/june-10-2019/ronald-walters-md-and-ruth-o-regan-md-elected-to-nccn-board-of-directors/ 2019-06-21T19:05:55+00:00 https://ascopost.com/issues/june-10-2019/george-laramore-awarded-national-association-for-proton-therapy-award/ 2019-06-10T11:58:17+00:00 https://ascopost.com/issues/june-10-2019/richard-t-silver-md-receives-2019-eln-merit-award/ 2019-06-10T11:58:17+00:00 https://ascopost.com/issues/june-10-2019/cornelis-melief-honored-with-aacr-cri-award-in-cancer-immunology/ 2019-06-10T11:58:17+00:00 https://ascopost.com/issues/june-10-2019/addition-of-bevacizumab-to-erlotinib-improves-progression-free-survival-in-egfr-mutated-nonsquamous-nsclc/ 2019-06-10T14:37:57+00:00 https://ascopost.com/issues/june-10-2019/addition-of-a-tyrosine-kinase-inhibitor-to-immunotherapy-in-advanced-sarcomas/ 2019-06-10T14:38:30+00:00 https://ascopost.com/issues/june-10-2019/nci-approves-john-theurer-cancer-center-as-member-of-research-consortium/ 2019-06-10T11:58:18+00:00 https://ascopost.com/issues/june-10-2019/memorial-sloan-kettering-unveils-new-site-on-long-island/ 2019-06-10T11:58:18+00:00 https://ascopost.com/issues/june-10-2019/florida-cancer-specialists-research-institute-welcomes-awais-khan-md/ 2019-06-10T11:58:18+00:00 https://ascopost.com/issues/june-10-2019/latest-practice-to-join-oneoncology-arizona-blood-cancer-specialists/ 2019-06-10T11:58:18+00:00 https://ascopost.com/issues/june-10-2019/first-full-time-cancer-center-to-serve-members-of-navajo-nation/ 2019-06-10T11:58:18+00:00 https://ascopost.com/issues/june-10-2019/as-my-outside-world-became-smaller-my-family-focus-became-larger/ 2019-07-10T21:04:59+00:00 https://ascopost.com/issues/june-10-2019/nci-annual-report-to-the-nation-on-the-status-of-cancer/ 2019-06-10T14:39:43+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/a-brilliant-career-in-oncology-decided-on-a-coin-toss/ 2019-05-29T22:52:52+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/a-lifetime-dedicated-to-patients-with-lung-cancer/ 2019-05-29T22:52:52+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/from-the-lab-to-the-clinic-to-the-sea-balancing-a-challenging-career/ 2019-05-31T14:46:02+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/asco-honors-leaders-in-cancer-care-with-2019-special-awards/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/never-forgetting-his-roots-helps-surgical-oncologist-better-connect-with-his-patients/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/new-data-at-2019-asco-annual-meeting/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/news-from-the-centers-for-medicare-medicaid-services/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/breast-cancer-specialist-advocates-prevention-through-exercise-and-lifestyle/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/an-aspiring-musician-changes-course/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/arti-hurria-md-fasco/ 2020-02-17T17:33:38+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/nih-selects-three-oncology-investigators-as-lasker-clinical-research-scholars/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/an-extended-family-with-many-physicians-inspired-a-career-in-oncology/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/fda-oncology-drug-approvals-granted-between-may-21-2018-and-may-14-2019/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/a-career-path-balancing-research-patient-care-and-everyday-life/ 2019-05-29T22:52:53+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/2019-fellows-of-the-american-society-of-clinical-oncology-fasco-recognized-during-annual-meeting-in-chicago/ 2019-05-29T22:52:54+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/cancer-researcher-continues-to-push-the-envelope-in-immunotherapy-to-help-patients-live-longer/ 2019-05-29T22:52:54+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/james-p-allison-phd/ 2019-05-29T22:52:54+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/aacr-inaugurated-new-leadership-at-2019-annual-meeting/ 2019-05-29T22:52:54+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/aacr-public-service-award-recipients/ 2019-05-29T22:52:54+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/breast-cancer-specialist-focuses-on-educational-side-of-oncology-connecting-patients-with-cancer-around-the-world/ 2019-05-29T22:57:39+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/nearly-25-oncology-practices-achieve-asco-s-qopi-certification-to-date-in-2019/ 2019-05-29T22:52:55+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/lori-pierce-enjoys-balancing-administrative-and-clinical-roles/ 2019-05-30T13:34:34+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/the-asco-post-remembers/ 2019-05-29T22:52:55+00:00 https://ascopost.com/issues/june-3-2019-narratives-special-issue/stand-up-to-cancer-names-grant-recipients-of-innovation-in-collaboration/ 2019-05-29T22:52:55+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/a-year-in-review/ 2019-05-24T20:51:13+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/pembrolizumab-in-advanced-non-clear-cell-kidney-cancer/ 2019-07-10T20:41:50+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/epov-tracy-rose/ 2019-05-21T16:00:24+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/first-line-therapy-for-advanced-kidney-cancer/ 2019-07-10T20:42:40+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/front-line-therapy-in-advanced-renal-cell-carcinoma/ 2019-05-24T20:55:58+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/early-tumor-shrinkage-and-outcomes-following-cabozantinib-or-everolimus/ 2019-07-10T20:43:35+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/tivo-3-tivozanib-vs-sorafenib-in-refractory-advanced-renal-cell-carcinoma/ 2019-07-10T20:44:15+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/cabozantinib-in-advanced-non-clear-cell-rcc/ 2019-07-10T20:44:58+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/cytoreductive-nephrectomy-in-patients-with-metastatic-rcc-treated-with-sunitinib/ 2019-07-10T20:47:04+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/epov-daniel-george/ 2019-07-10T20:48:57+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/final-overall-survival-analysis-of-latitude/ 2019-07-10T20:54:44+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/enzalutamide-plus-adt-in-metastatic-hormone-sensitive-prostate-cancer/ 2019-07-10T20:56:42+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/new-drugs-and-novel-indications-for-genitourinary-cancers-fda-approved-2017-2019/ 2019-05-21T16:00:26+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/adjuvant-sequential-chemotherapy-plus-radiotherapy-vs-radiotherapy-alone-for-locally-advanced-bladder-cancer/ 2019-05-24T21:05:26+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/sacituzumab-govitecan-shows-activity-in-heavily-pretreated-bladder-cancer/ 2019-05-24T21:06:28+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/lenvatinib-plus-pembrolizumab-shows-activity-in-advanced-urothelial-cancer/ 2019-07-10T20:57:42+00:00 https://ascopost.com/issues/may-25-2019-almanac-genitourinary-cancers/2019-updates-to-nccn-clinical-practice-guidelines-in-genitourinary-oncology/ 2019-07-10T20:58:35+00:00 https://ascopost.com/issues/may-25-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/may-25-2019/evidence-builds-for-treating-smoldering-myeloma/ 2019-07-10T20:40:28+00:00 https://ascopost.com/issues/may-25-2019/epov-irene-ghobrial-and-monica-bertagnolli/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/incoming-asco-president-sets-his-sights-on-conquering-cancer/ 2019-07-10T20:22:30+00:00 https://ascopost.com/issues/may-25-2019/marking-a-year-of-learning-from-asco-members/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/study-finds-less-chemotherapy-noninferior-to-more-in-frail-and-elderly-patients-with-advanced-gastroesophageal-cancer/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/epov-armin-shahrokni/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/nccn-clinical-practice-guidelines/ 2019-07-10T20:29:58+00:00 https://ascopost.com/issues/may-25-2019/asco-clinical-opinion-recommends-germline-testing-for-all-patients-with-pancreatic-cancer/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/study-shows-rucaparib-active-as-maintenance-therapy-in-pancreatic-cancer/ 2019-07-10T20:27:06+00:00 https://ascopost.com/issues/may-25-2019/epov-efrat-dotan-and-colin-weekes/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/evidence-mounts-for-tumor-mutational-burden-as-biomarker-of-immune-checkpoint-inhibitor-benefit-in-nsclc/ 2019-07-10T20:28:11+00:00 https://ascopost.com/issues/may-25-2019/epov-david-gandara/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/fda-approves-t-dm1-for-her2-positive-early-breast-cancer/ 2019-05-24T17:00:47+00:00 https://ascopost.com/issues/may-25-2019/fda-approves-avelumabaxitinib-combination-for-advanced-renal-cell-carcinoma/ 2019-05-24T17:00:48+00:00 https://ascopost.com/issues/may-25-2019/adjuvant-trastuzumab-emtansine-vs-standard-trastuzumab-in-residual-her2-positive-breast-cancer-after-neoadjuvant-therapy/ 2019-07-10T20:20:37+00:00 https://ascopost.com/issues/may-25-2019/trastuzumab-emtansine-in-treatment-of-residual-breast-cancer-after-neoadjuvant-therapy/ 2019-07-10T20:21:00+00:00 https://ascopost.com/issues/may-25-2019/susan-g-komen-welcomes-five-leaders-to-new-research-advisory-roles/ 2019-05-24T17:00:48+00:00 https://ascopost.com/issues/may-25-2019/locoregional-recurrence-after-mastectomy-for-dcis-more-common-among-younger-women/ 2019-05-24T17:00:48+00:00 https://ascopost.com/issues/may-25-2019/epov-julie-margenthaler/ 2019-05-24T17:00:48+00:00 https://ascopost.com/issues/may-25-2019/study-finds-timing-of-therapy-does-not-influence-outcomes-in-her2-positive-breast-cancer/ 2019-07-10T20:32:27+00:00 https://ascopost.com/issues/may-25-2019/epov-julie-margenthaler-1/ 2019-05-24T17:00:48+00:00 https://ascopost.com/issues/may-25-2019/erythropoiesis-stimulating-agents-recommended-for-some-patients-with-cancer-and-anemia/ 2019-05-24T17:00:48+00:00 https://ascopost.com/issues/may-25-2019/asco-guideline-recommends-shorter-course-adjuvant-chemotherapy-for-some-patients-with-stage-iii-colon-cancer/ 2019-05-24T17:00:48+00:00 https://ascopost.com/issues/may-25-2019/t-cell-therapy-for-ebv-associated-posttransplant-lymphoproliferative-disorder-with-cns-involvement/ 2019-06-12T13:53:46+00:00 https://ascopost.com/issues/may-25-2019/epov-marcie-l-riches/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/impact-study-aimed-at-increasing-diversity-among-clinical-trial-participants-launches/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/mary-beckerle-phd-and-martin-mcmahon-phd-appointed-to-national-scientific-leadership-roles/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/enhance-your-asco-annual-meeting-experience-with-attendee-resources/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/access-asco-s-quality-programs-to-accelerate-quality-care-delivery-in-your-practice/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/two-lung-cancer-organizations-launch-go2-foundation-for-lung-ca/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/researchers-supported-by-conquer-cancer-the-asco-foundation-earn-spot-in-clinical-cancer-advances-2019/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/four-reasons-to-use-social-media-at-the-asco-annual-meeting/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/help-your-patients-catch-up-on-the-latest-research-from-the-2019-asco-annual-meeting-with-cancernet/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/asco-announces-new-task-force-to-address-rural-cancer-care-gap/ 2019-05-24T17:00:49+00:00 https://ascopost.com/issues/may-25-2019/members-of-congress-express-support-for-cancer-policy-priorities-during-capitol-hill-event/ 2019-05-24T17:00:50+00:00 https://ascopost.com/issues/may-25-2019/targeted-brachytherapy-may-improve-outcomes-in-recurrent-brain-tumors/ 2019-05-24T17:00:50+00:00 https://ascopost.com/issues/may-25-2019/introducing-cancerlinq-20-and-a-new-era-in-precision-oncology/ 2019-05-24T17:00:50+00:00 https://ascopost.com/issues/may-25-2019/prolonged-exposure-to-ibrutinib-may-increase-effectiveness-of-car-t-cell-therapy-in-patients-with-cll/ 2019-07-10T20:21:52+00:00 https://ascopost.com/issues/may-25-2019/next-generation-sequencing-cancer-burden-vs-funding-cardiac-monitoring-and-scalp-cooling/ 2019-07-10T20:36:01+00:00 https://ascopost.com/issues/may-25-2019/city-of-hope-announces-faculty-awards/ 2019-05-24T17:00:50+00:00 https://ascopost.com/issues/may-25-2019/augment-trial/ 2019-07-10T20:31:33+00:00 https://ascopost.com/issues/may-25-2019/gareth-morgan-and-faith-davies-join-new-center-for-blood-cancers-at-nyu-langone-health/ 2019-05-24T17:00:50+00:00 https://ascopost.com/issues/may-25-2019/jonas-bergh-md-phd-frcp-receives-first-esmo-breast-cancer-award/ 2019-05-24T17:00:50+00:00 https://ascopost.com/issues/may-25-2019/dana-farber-opens-new-center-for-patients-with-lynch-syndrome/ 2019-05-24T17:00:50+00:00 https://ascopost.com/issues/may-25-2019/combination-immunotherapy-with-lenalidomide-plus-rituximab-in-indolent-nhl/ 2019-07-10T20:31:43+00:00 https://ascopost.com/issues/may-25-2019/fda-approves-first-line-ivosidenib-for-idh1-mutated-aml/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/baylor-scott-white-health-names-new-chief-of-oncology/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/aim-at-melanoma-foundation-opens-first-melanoma-tissue-bank-in-the-united-states/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/fda-expands-pembrolizumab-indication-for-nsclc-in-first-line-setting/ 2019-05-31T14:25:49+00:00 https://ascopost.com/issues/may-25-2019/fda-approves-chemotherapy-free-regimen-venetoclax-plus-obinutuzumab-as-first-line-treatment-for-cllsll/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/erdafitinib-for-metastatic-urothelial-carcinoma/ 2019-07-10T20:39:49+00:00 https://ascopost.com/issues/may-25-2019/nccn-roundtable-tackles-issues-with-innovative-immunotherapies/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/lisa-kachnic-joins-columbia-university-as-chair-of-radiation-oncology/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/staff-join-sidney-kimmel-cancer-center-at-jefferson-health/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/charles-mullighan-named-st-jude-comprehensive-cancer-center-deputy-director/ 2019-05-24T17:00:51+00:00 https://ascopost.com/issues/may-25-2019/new-radiation-options-for-localized-prostate-cancer-may-improve-patient-outcomes/ 2019-05-28T20:37:52+00:00 https://ascopost.com/issues/may-25-2019/how-cancer-affects-adolescents-and-young-adults/ 2019-07-10T20:23:37+00:00 https://ascopost.com/issues/may-25-2019/teen-cancer-america-announces-new-advisory-council/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/st-jude-children-s-research-hospital-and-who-join-forces/ 2019-05-24T19:57:49+00:00 https://ascopost.com/issues/may-25-2019/ash-president-comments-on-medicare-proposal-for-car-t-cell-therapy/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/elaine-fuchs-receives-2019-aacr-gha-clowes-memorial-award/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/pat-basu-named-president-and-ceo-of-cancer-treatment-centers-of-america/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/margo-shoup-appointed-network-chair-of-nuvance-health-cancer-service-line/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/uniting-the-global-cancer-community-to-reduce-deaths-from-noncommunicable-diseases/ 2019-05-24T20:00:38+00:00 https://ascopost.com/issues/may-25-2019/lasker-clinical-research-scholars/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/measuring-the-burden-of-global-cancer-as-a-tool-for-policymakers/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/ghanaian-oncologist-yehoda-martei/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/francoise-mornex-receives-heine-h-hansen-award/ 2019-05-24T17:00:52+00:00 https://ascopost.com/issues/may-25-2019/capsaicin/ 2019-07-10T20:37:18+00:00 https://ascopost.com/issues/may-25-2019/barriers-to-cervical-cancer-screening-among-hiv-infected-women-in-tanzania/ 2019-05-24T20:01:25+00:00 https://ascopost.com/issues/may-25-2019/living-a-full-life-otis-brawley/ 2019-05-28T16:29:36+00:00 https://ascopost.com/issues/may-25-2019/margaret-foti-receives-2019-women-of-inspiration-and-influence-award/ 2019-05-24T17:00:53+00:00 https://ascopost.com/issues/may-25-2019/usc-norris-comprehensive-cancer-center-appoints-caryn-lerman-as-director/ 2019-05-24T17:00:53+00:00 https://ascopost.com/issues/may-25-2019/miami-cancer-institute-opens-multidisciplinary-skin-cancer-clinic/ 2019-05-24T17:00:53+00:00 https://ascopost.com/issues/may-25-2019/andrew-chan-receives-2019-aacr-waun-ki-hong-award/ 2019-05-24T17:00:53+00:00 https://ascopost.com/issues/may-25-2019/debating-the-role-of-opioids-in-the-management-of-chronic-cancer-pain/ 2019-05-24T20:10:46+00:00 https://ascopost.com/issues/may-25-2019/city-of-hope-research-in-cutaneous-t-cell-lymphoma/ 2019-05-24T17:00:53+00:00 https://ascopost.com/issues/may-25-2019/pancreatic-cancer-collective-funds-two-research-teams/ 2019-05-24T17:00:53+00:00 https://ascopost.com/issues/may-25-2019/nccn-recognizes-five-individuals-for-achievements-in-cancer-care/ 2019-05-24T17:00:53+00:00 https://ascopost.com/issues/may-25-2019/fda-approves-ramucirumab-for-hepatocellular-carcinoma/ 2019-05-24T17:00:54+00:00 https://ascopost.com/issues/may-25-2019/rookie/ 2019-05-24T17:00:54+00:00 https://ascopost.com/issues/may-25-2019/aacr-inaugurated-new-leadership-at-2019-annual-meeting/ 2019-05-24T17:00:54+00:00 https://ascopost.com/issues/may-25-2019/reducing-deaths-from-pancreatic-cancer/ 2019-07-10T20:39:10+00:00 https://ascopost.com/issues/may-25-2019/expect-questions-about-screening-for-pancreatic-cancer/ 2019-05-24T20:16:41+00:00 https://ascopost.com/issues/may-25-2019/nobel-prize-winning-race-to-uncover-the-secret-of-the-ribosome/ 2019-05-24T17:12:03+00:00 https://ascopost.com/issues/may-25-2019/unlocking-the-secrets-of-the-immune-system/ 2019-05-24T17:16:58+00:00 https://ascopost.com/issues/may-25-2019/aya-survivors-should-be-allowed-to-participate-in-adult-clinical-trials/ 2019-05-24T20:17:45+00:00 https://ascopost.com/issues/may-25-2019/acp-issues-guidance-for-breast-screening-in-average-risk-women/ 2019-05-24T20:26:36+00:00 https://ascopost.com/issues/may-25-2019/fulvestrantanastrozole-in-metastatic-breast-cancer/ 2019-05-24T20:27:05+00:00 https://ascopost.com/issues/may-25-2019/triplet-chemotherapy-in-unresectable-locally-advanced-or-metastatic-biliary-tract-cancers/ 2019-05-24T20:27:33+00:00 https://ascopost.com/issues/may-25-2019/emily-whitehead-celebrates-7-years-cancer-free/ 2019-05-24T17:31:33+00:00 https://ascopost.com/issues/may-10-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/may-10-2019/neoadjuvant-immunotherapy-in-locally-advanced-melanoma/ 2019-05-10T16:20:51+00:00 https://ascopost.com/issues/may-10-2019/front-line-therapy-in-advanced-renal-cell-carcinoma/ 2019-05-10T20:01:47+00:00 https://ascopost.com/issues/may-10-2019/harnessing-the-power-of-twitter-for-clinical-trial-enrollment-and-success/ 2019-05-10T16:20:51+00:00 https://ascopost.com/issues/may-10-2019/osimertinib-plus-savolitinib-in-advanced-nsclc-driven-by-met-resistance/ 2019-05-10T20:05:42+00:00 https://ascopost.com/issues/may-10-2019/epov-roy-herbst/ 2019-05-10T16:20:51+00:00 https://ascopost.com/issues/may-10-2019/dual-immunotherapy-in-high-grade-neuroendocrine-tumors/ 2019-05-10T20:06:22+00:00 https://ascopost.com/issues/may-10-2019/epov-namrata-vijayvergia/ 2019-05-10T16:20:52+00:00 https://ascopost.com/issues/may-10-2019/umbralisib-potential-option-for-relapsed-or-refractory-marginal-zone-lymphoma/ 2019-05-10T20:04:59+00:00 https://ascopost.com/issues/may-10-2019/epov-louis-weiner-thomas-habermann/ 2019-05-10T16:20:53+00:00 https://ascopost.com/issues/may-10-2019/new-data-in-aacr-study-presentations/ 2019-05-10T20:13:59+00:00 https://ascopost.com/issues/may-10-2019/pembrolizumab-as-third-line-option-for-extensive-stage-sclc/ 2019-05-10T20:03:50+00:00 https://ascopost.com/issues/may-10-2019/emil-j-freireich-wins-aacr-award-for-lifetime-achievement-in-cancer-research/ 2019-05-10T16:20:53+00:00 https://ascopost.com/issues/may-10-2019/postprogression-treatment-of-estrogen-receptor-positive-breast-cancer/ 2019-05-20T15:59:11+00:00 https://ascopost.com/issues/may-10-2019/fda-advances-policy-changes-to-modernize-mammography-services/ 2019-05-10T16:20:53+00:00 https://ascopost.com/issues/may-10-2019/immune-enrichment-improves-outcomes-in-some-pancreatic-cancers/ 2019-05-10T16:20:54+00:00 https://ascopost.com/issues/may-10-2019/cdc-issues-clarification-on-guideline-for-prescribing-opioids-for-chronic-pain/ 2019-05-10T16:20:54+00:00 https://ascopost.com/issues/may-10-2019/oneoncology-announces-lee-schwartzberg-as-chief-medical-officer/ 2019-05-10T16:20:54+00:00 https://ascopost.com/issues/may-10-2019/mark-thompson-named-medical-director-for-public-policy-at-community-oncology-alliance/ 2019-05-10T16:20:54+00:00 https://ascopost.com/issues/may-10-2019/local-consolidative-therapy-linked-to-survival-benefit-in-oligometastatic-non-small-cell-lung-cancer/ 2019-05-10T16:22:50+00:00 https://ascopost.com/issues/may-10-2019/epov-charles-simone/ 2019-05-10T16:20:54+00:00 https://ascopost.com/issues/may-10-2019/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2019-05-10T16:24:43+00:00 https://ascopost.com/issues/may-10-2019/fda-grants-accelerated-approval-to-erdafitinib-for-metastatic-urothelial-carcinoma/ 2019-05-10T16:20:54+00:00 https://ascopost.com/issues/may-10-2019/fda-oncology-center-of-excellence-issues-annual-report/ 2019-05-10T16:20:55+00:00 https://ascopost.com/issues/may-10-2019/first-line-combination-treatments-improve-outcomes-vs-sunitinib-in-advanced-renal-cell-carcinoma/ 2019-05-10T20:02:19+00:00 https://ascopost.com/issues/may-10-2019/ali-mcbride-named-accc-president/ 2019-05-10T16:20:55+00:00 https://ascopost.com/issues/may-10-2019/how-hepatitis-c-virus-screening-may-improve-survival-in-patients-with-cancer/ 2019-05-10T16:30:56+00:00 https://ascopost.com/issues/may-10-2019/cigall-kadoch-phd-chosen-for-2019-martin-and-rose-wachtel-cancer-research-prize/ 2019-05-10T16:20:56+00:00 https://ascopost.com/issues/may-10-2019/physician-identity-and-physician-wellness-are-inextricably-linked/ 2019-05-10T16:38:59+00:00 https://ascopost.com/issues/may-10-2019/the-skin-cancer-foundation-awards-125-000-in-research-grants/ 2019-05-10T16:20:56+00:00 https://ascopost.com/issues/may-10-2019/sydney-brenner-dies-at-92/ 2019-05-10T16:20:56+00:00 https://ascopost.com/issues/may-10-2019/robert-o-hickman-inventor-of-hickman-catheter-dies/ 2019-05-10T16:20:56+00:00 https://ascopost.com/issues/may-10-2019/francesco-lo-coco-dies-in-rome-at-63/ 2019-05-10T16:20:56+00:00 https://ascopost.com/issues/may-10-2019/hope-and-fear-are-two-constants-in-the-lives-of-patients-with-cancer/ 2019-05-10T20:14:34+00:00 https://ascopost.com/issues/may-10-2019/risk-of-cardiomyopathy-in-childhood-cancer-survivors/ 2019-05-10T16:40:01+00:00 https://ascopost.com/issues/may-10-2019/adjuvant-capecitabine-after-resection-for-biliary-tract-cancer/ 2019-05-10T16:40:25+00:00 https://ascopost.com/issues/may-10-2019/psychosocial-care-is-a-critical-component-of-value-based-oncology/ 2019-05-10T16:41:10+00:00 https://ascopost.com/issues/may-10-2019/conquer-cancer-and-swim-across-america/ 2019-05-10T16:20:57+00:00 https://ascopost.com/issues/may-10-2019/2019-asco-annual-meeting-podcast-listening-station/ 2019-05-10T16:20:57+00:00 https://ascopost.com/issues/may-10-2019/asco-launches-fy-2020-advocacy-campaign-for-federally-funded-cancer-research/ 2019-05-10T17:52:19+00:00 https://ascopost.com/issues/may-10-2019/conquer-cancer-podcast-series/ 2019-05-10T16:20:57+00:00 https://ascopost.com/issues/may-10-2019/third-brazilian-practice-achieves-qopi-certification/ 2019-05-10T16:20:57+00:00 https://ascopost.com/issues/may-10-2019/asco-answers-fact-sheet-on-immunotherapy-side-effects/ 2019-05-10T16:20:57+00:00 https://ascopost.com/issues/april-25-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/april-25-2019/phase-iii-data-support-use-of-gilteritinib-in-relapsed-or-refractory-flt3-mutated-aml/ 2019-05-10T20:30:36+00:00 https://ascopost.com/issues/april-25-2019/epov-tapan-kadia-and-louis-weiner/ 2019-04-25T16:01:56+00:00 https://ascopost.com/issues/april-25-2019/tale-of-two-flt3-inhibitors-in-aml-gilteritinib-and-quizartinib/ 2019-04-25T18:31:16+00:00 https://ascopost.com/issues/april-25-2019/the-microbiome-the-next-target-in-cancer-therapy/ 2019-04-25T16:01:56+00:00 https://ascopost.com/issues/april-25-2019/shared-decision-making-in-lung-cancer-screening/ 2019-05-01T19:55:58+00:00 https://ascopost.com/issues/april-25-2019/tumor-treating-fields-plus-chemotherapy-improved-survival-in-unresectable-malignant-pleural-mesothelioma/ 2019-05-10T20:29:11+00:00 https://ascopost.com/issues/april-25-2019/expert-point-of-view-aaron-s-mansfield-md/ 2019-04-25T16:01:56+00:00 https://ascopost.com/issues/april-25-2019/mitigating-frailty-and-sarcopenia-to-improve-treatment-outcomes-in-lung-cancer/ 2019-05-01T20:01:11+00:00 https://ascopost.com/issues/april-25-2019/role-of-repeat-petct-scans-in-ensuring-accuracy-of-staging-of-locally-advanced-nsclc/ 2019-04-26T14:58:07+00:00 https://ascopost.com/issues/april-25-2019/epov-kristin-higgins/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/online-tool-may-improve-guideline-concordance-for-patients-with-lung-cancer/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/epov-charles-simone-and-aaron-mansfield/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/preliminary-results-show-activity-for-mesothelin-directed-car-t-cell-therapy-in-malignant-mesothelioma/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/antoni-ribas-md-phd-elected-aacr-president-elect-2019-2020/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/ryan-c-fields-md-named-chief-of-surgical-oncology-at-washington-university-in-st-louis/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/biomarkers-can-now-help-guide-treatment-selections-in-breast-cancer/ 2019-05-10T20:26:44+00:00 https://ascopost.com/issues/april-25-2019/primer-study-explores-meaning-of-minimal-residual-disease-in-myeloma/ 2019-06-12T13:53:02+00:00 https://ascopost.com/issues/april-25-2019/epov-rafael-fonseca/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/new-asco-guidelines-on-early-detection-and-treatment-of-colorectal-cancer/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/nccn-awards-grants-to-study-trifluridine-and-tipiracil/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/giulio-draetta-md-phd-named-chief-scientific-officer-at-md-anderson/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/molecular-profiles-and-immunotherapy-outcomes-in-braf-v600e-and-v600k-mutant-melanoma/ 2019-04-25T16:01:57+00:00 https://ascopost.com/issues/april-25-2019/ramucirumab-in-sorafenib-pretreated-patients-with-advanced-hepatocellular-carcinoma/ 2019-05-10T20:20:28+00:00 https://ascopost.com/issues/april-25-2019/ramucirumab-after-sorafenib-in-advanced-hepatocellular-carcinoma/ 2019-05-10T20:20:38+00:00 https://ascopost.com/issues/april-25-2019/asco-honors-leaders-in-cancer-care-with-2019-special-awards/ 2019-04-26T20:39:12+00:00 https://ascopost.com/issues/april-25-2019/today-s-breakthroughs-require-year-round-support/ 2020-09-18T20:45:02+00:00 https://ascopost.com/issues/april-25-2019/register-now-for-the-ascofda-workshop-on-oncology-clinical-trial-outcomes/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/2019-asco-annual-meeting-global-health-track/ 2020-09-18T20:43:40+00:00 https://ascopost.com/issues/april-25-2019/managing-the-cost-of-cancer-care/ 2020-09-18T20:44:39+00:00 https://ascopost.com/issues/april-25-2019/robert-kyle-luminary-in-myeloma-research/ 2019-05-10T20:29:47+00:00 https://ascopost.com/issues/april-25-2019/interest-in-palliative-care-for-janet-abrahm/ 2019-05-10T20:23:40+00:00 https://ascopost.com/issues/april-25-2019/cancer-research-uk-tackles-global-cancer-challenges/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/new-model-may-improve-prediction-of-risk-in-myelodysplastic-syndromes/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/epov-joseph-mikhael/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/regimens-show-benefit-in-high-risk-smoldering-multiple-myeloma/ 2019-05-10T20:17:03+00:00 https://ascopost.com/issues/april-25-2019/epov-smoldering-myeloma/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/evolving-role-of-pathologists-in-the-diagnosis-and-treatment-of-cancer/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/city-of-hope-recognizes-two-professors-for-oncology-advances/ 2019-04-29T18:50:29+00:00 https://ascopost.com/issues/april-25-2019/dancemovement-therapy/ 2019-05-02T18:32:33+00:00 https://ascopost.com/issues/april-25-2019/the-boy-i-never-knew/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/effect-of-lymphadenectomy-on-survival-in-advanced-ovarian-cancer/ 2019-04-25T16:25:12+00:00 https://ascopost.com/issues/april-25-2019/modeling-projections-of-global-cervical-cancer-control/ 2019-04-25T16:25:13+00:00 https://ascopost.com/issues/april-25-2019/well-deserved-attention-on-lung-cancer-screening/ 2019-04-25T16:25:13+00:00 https://ascopost.com/issues/april-25-2019/rising-rates-of-six-obesity-related-cancers-among-younger-adults/ 2019-04-25T16:25:13+00:00 https://ascopost.com/issues/april-25-2019/assess-and-address-weight-issues/ 2019-04-25T16:25:13+00:00 https://ascopost.com/issues/april-25-2019/radiation-therapy-after-surgery-for-pediatric-ependymoma/ 2019-05-01T20:11:39+00:00 https://ascopost.com/issues/april-25-2019/young-people-get-lung-cancer-too/ 2019-04-25T16:25:13+00:00 https://ascopost.com/issues/april-25-2019/visible-ink-hosts-11th-year-of-live-patient-performances/ 2019-04-25T16:25:13+00:00 https://ascopost.com/issues/april-10-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/april-10-2019/pembrolizumab-active-in-advanced-non-clear-cell-kidney-cancer/ 2019-04-10T20:50:11+00:00 https://ascopost.com/issues/april-10-2019/epov-tracy-rose/ 2019-04-10T17:20:34+00:00 https://ascopost.com/issues/april-10-2019/fine-tuning-an-airport-diagnosis/ 2019-04-10T20:47:31+00:00 https://ascopost.com/issues/april-10-2019/advanced-her2positive-breast-cancer-all-eyes-on-these-novel-agents/ 2019-05-10T20:37:54+00:00 https://ascopost.com/issues/april-10-2019/lenvatinib-plus-pembrolizumab-in-advanced-urothelial-cancer/ 2019-04-10T20:53:30+00:00 https://ascopost.com/issues/april-10-2019/anti-tim-3-antibody-well-tolerated-as-monotherapy-and-in-combination-with-anti-pd-l1-antibody/ 2019-04-10T17:25:10+00:00 https://ascopost.com/issues/april-10-2019/epov-michael-morse/ 2019-04-10T17:20:34+00:00 https://ascopost.com/issues/april-10-2019/photos-from-asco-sitc/ 2019-04-10T17:20:34+00:00 https://ascopost.com/issues/april-10-2019/the-future-of-immunotherapy/ 2019-04-10T20:54:29+00:00 https://ascopost.com/issues/april-10-2019/vaccine-plus-trastuzumab-in-her2-low-expressing-breast-cancer/ 2019-04-10T20:53:11+00:00 https://ascopost.com/issues/april-10-2019/epov-kunle-odunsi/ 2019-04-10T17:20:34+00:00 https://ascopost.com/issues/april-10-2019/better-techniques-coming-to-breast-cancer-screening/ 2019-05-10T20:36:58+00:00 https://ascopost.com/issues/april-10-2019/warner-huh-new-president-of-society-of-gynecologic-oncology/ 2019-04-10T17:20:34+00:00 https://ascopost.com/issues/april-10-2019/alberto-mantovani-wins-2019-pezcoller-foundation-aacr-international-award/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/charles-sawyers-2019-aacr-princess-takamatsu-memorial-lectureship/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/enzalutamide-plus-adt-extends-progression-free-survival-in-prostate-cancer/ 2019-04-15T19:56:04+00:00 https://ascopost.com/issues/april-10-2019/epov-ian-davis-and-howard-scher/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/nivolumab-combined-with-ipilimumab-shows-activity-in-prostate-cancer-subsets/ 2019-04-15T19:54:32+00:00 https://ascopost.com/issues/april-10-2019/epov-william-kevin-kelly/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/study-finds-shorter-treatment-course-for-rectal-cancer-may-actually-improve-outcomes/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/epov-christopher-hallemeier-and-andrew-kennedy/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/fda-approves-atezolizumab-for-extensive-stage-small-cell-lung-cancer/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/fda-warning-investigational-use-of-venetoclax-in-multiple-myeloma/ 2020-09-17T20:23:23+00:00 https://ascopost.com/issues/april-10-2019/dana-farber-launches-young-onset-colorectal-cancer-center/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/cigall-kadoch-chosen-for-2019-cancer-research-prize/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/allogeneic-hematopoietic-cell-transplantation-and-cell-therapy/ 2019-04-10T20:51:14+00:00 https://ascopost.com/issues/april-10-2019/vista-checkpoint-implicated-in-pancreatic-cancer-immunotherapy-resistance/ 2019-04-10T17:20:35+00:00 https://ascopost.com/issues/april-10-2019/full-disclosure-what-oncologists-must-tell-patients-about-their-experience-and-training/ 2019-04-10T19:28:52+00:00 https://ascopost.com/issues/april-10-2019/harborside-s-oncologygo-wins-2019-mobile-star-award-for-innovative-mobile-health-care-application/ 2020-09-17T20:25:53+00:00 https://ascopost.com/issues/april-10-2019/opioid-toolkit-helping-nebraskan-hospitals-to-provide-appropriate-pain-management/ 2019-04-10T17:20:36+00:00 https://ascopost.com/issues/april-10-2019/human-gene-therapy-progress-and-oversight/ 2019-04-15T14:38:58+00:00 https://ascopost.com/issues/april-10-2019/maitake-mushroom/ 2019-04-10T20:39:23+00:00 https://ascopost.com/issues/april-10-2019/i-was-not-prepared-for-the-emotional-toll-of-cancer/ 2019-04-10T17:20:36+00:00 https://ascopost.com/issues/april-10-2019/aacr-and-lung-cancer-initiative-announce-grant-recipients/ 2019-04-10T17:20:36+00:00 https://ascopost.com/issues/april-10-2019/biologic-age-and-elevated-risk-of-breast-cancer/ 2020-09-17T20:22:43+00:00 https://ascopost.com/issues/april-10-2019/raymond-dubois-wins-aacr-margaret-foti-award/ 2019-04-10T17:44:37+00:00 https://ascopost.com/issues/april-10-2019/carson-leslie-foundation-joins-forces-with-asco-conquer-cancer-foundation/ 2019-04-10T17:51:08+00:00 https://ascopost.com/issues/april-10-2019/self-evaluation-app-offers-topic-specific-information/ 2019-04-10T17:54:50+00:00 https://ascopost.com/issues/april-10-2019/help-patients-do-more-to-cope-with-cancer-related-pain/ 2019-04-10T17:56:20+00:00 https://ascopost.com/issues/april-10-2019/read-the-latest-posts-on-jop-dais/ 2019-04-10T17:58:39+00:00 https://ascopost.com/issues/april-10-2019/asco-in-action-policy-podcast/ 2019-04-10T18:02:20+00:00 https://ascopost.com/issues/april-10-2019/asco-seeks-applicants-for-research-grants-to-use-data-from-cancerlinq-discovery/ 2019-04-10T18:10:23+00:00 https://ascopost.com/issues/april-10-2019/lymphoma-trial-in-clinical-cancer-advances-2019/ 2019-04-10T18:13:36+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/conference-highlights/ 2019-04-08T00:04:57+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/pembrolizumab-plus-axitinib-vs-sunitinib-in-first-line-therapy-for-advanced-rcc/ 2019-04-10T19:46:32+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/epov-lori-wood/ 2019-04-05T22:22:57+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/javelin-renal-101/ 2019-04-10T19:47:18+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/evaluating-outcomes-of-cabozantinib-vs-everolimus-in-advanced-rcc/ 2019-04-10T19:47:53+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/nivolumab-and-ipilimumab-in-intermediate-or-poor-risk-advanced-rcc/ 2019-04-08T13:12:42+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/pembrolizumab-cabozantinib-shows-activity-in-previously-treated-rcc/ 2019-04-05T22:37:26+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/savolitinib-plus-durvalumab-in-metastatic-papillary-rcc/ 2019-04-05T22:37:51+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/darolutamide-in-high-risk-nonmetastatic-prostate-cancer/ 2019-04-10T19:49:04+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/epov-ian-davis/ 2019-04-05T22:41:28+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/interim-analysis-of-the-arches-trial/ 2019-04-07T23:51:21+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/epov-ian-davis-2/ 2019-04-05T20:53:44+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/sbrt-for-localized-prostate-cancer/ 2019-04-15T20:02:42+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/checkmate-650-in-metastatic-castration-resistant-prostate-cancer/ 2019-04-15T19:59:02+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/antibody-drug-conjugate-shows-activity-in-heavily-pretreated-bladder-cancer/ 2019-04-07T23:54:39+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/epov-matthew-milosky/ 2019-04-05T21:44:17+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/trends-in-neoadjuvant-therapy-for-resectable-pancreatic-cancer/ 2019-04-07T23:55:54+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/celestial-trial-in-advanced-hepatocellular-carcinoma/ 2019-04-10T19:51:21+00:00 https://ascopost.com/issues/april-10-2019-supplement-conference-highlights-gugi-2019/keynote-181-in-esophageal-cancer/ 2019-05-07T18:50:59+00:00 https://ascopost.com/issues/march-25-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/march-25-2019/more-convenient-dosing-of-nivolumab-in-advanced-nsclc/ 2019-04-02T20:50:29+00:00 https://ascopost.com/issues/march-25-2019/epov-siwen-hu-lieskovan/ 2019-03-25T03:15:39+00:00 https://ascopost.com/issues/march-25-2019/caring-isn-t-that-why-we-went-to-medical-school/ 2019-03-25T03:15:39+00:00 https://ascopost.com/issues/march-25-2019/new-data-in-colorectal-neuroendocrine-gastric-and-hepatocellular-cancers/ 2019-04-02T20:52:34+00:00 https://ascopost.com/issues/march-25-2019/antibody-drug-conjugate-shows-activity-in-heavily-pretreated-bladder-cancer/ 2019-04-02T20:53:35+00:00 https://ascopost.com/issues/march-25-2019/epov-matthew-milowsky/ 2019-03-25T03:15:39+00:00 https://ascopost.com/issues/march-25-2019/erratum/ 2019-03-26T17:05:34+00:00 https://ascopost.com/issues/march-25-2019/trastuzumab-biosimilar-her2-overexpressing-breast-cancer/ 2019-04-02T21:06:26+00:00 https://ascopost.com/issues/march-25-2019/parp-inhibitors-moving-ahead-in-prostate-cancer/ 2019-04-02T20:54:41+00:00 https://ascopost.com/issues/march-25-2019/epov-emmanuel-antonarakis/ 2019-03-25T03:15:39+00:00 https://ascopost.com/issues/march-25-2019/antibiotic-treatment-prior-to-immune-checkpoint-inhibitor-therapy/ 2019-03-31T13:38:10+00:00 https://ascopost.com/issues/march-25-2019/epov-jason-luke/ 2019-03-25T03:15:40+00:00 https://ascopost.com/issues/march-25-2019/city-of-hope-awarded-lymphoma-spore-grant/ 2019-03-25T03:15:40+00:00 https://ascopost.com/issues/march-25-2019/asbrs-recommends-genetic-testing-for-newly-diagnosed-patients-with-breast-cancer/ 2019-03-31T15:40:16+00:00 https://ascopost.com/issues/march-25-2019/nccn-summit-tackles-inequities-in-access-to-care/ 2019-03-25T03:15:40+00:00 https://ascopost.com/issues/march-25-2019/fda-commissioner-scott-gottlieb-resigns/ 2019-03-25T03:15:40+00:00 https://ascopost.com/issues/march-25-2019/new-asco-guideline-on-head-and-neck-cancer/ 2019-03-31T13:44:19+00:00 https://ascopost.com/issues/march-25-2019/fda-approves-atezolizumab-and-nab-paclitaxel-in-tnbc/ 2019-03-25T03:15:40+00:00 https://ascopost.com/issues/march-25-2019/uf-receives-12-million-gift-for-brain-tumor-research/ 2019-03-25T03:15:40+00:00 https://ascopost.com/issues/march-25-2019/impassion130-substudy/ 2019-04-02T20:57:46+00:00 https://ascopost.com/issues/march-25-2019/epov-matthew-goetz/ 2019-03-25T03:15:40+00:00 https://ascopost.com/issues/march-25-2019/benefit-of-adding-daratumumab-to-initial-therapy-in-multiple-myeloma/ 2019-04-02T20:58:46+00:00 https://ascopost.com/issues/march-25-2019/epov-ajay-nooka/ 2019-04-23T18:40:28+00:00 https://ascopost.com/issues/march-25-2019/maintenance-ixazomib-delays-disease-progression-in-newly-diagnosed-myeloma/ 2019-04-02T20:59:22+00:00 https://ascopost.com/issues/march-25-2019/epov-kenneth-shain/ 2019-03-25T03:15:41+00:00 https://ascopost.com/issues/march-25-2019/radical-prostatectomy-or-watchful-waiting/ 2019-04-10T19:40:14+00:00 https://ascopost.com/issues/march-25-2019/nci-designates-comprehensive-cancer-center-status-to-nyu-perlmutter/ 2019-03-25T03:15:41+00:00 https://ascopost.com/issues/march-25-2019/prostatectomy-vs-watchful-waiting-clinical-dilemma/ 2019-04-10T20:10:04+00:00 https://ascopost.com/issues/march-25-2019/cancercare-celebrates-75-years/ 2019-03-25T03:15:41+00:00 https://ascopost.com/issues/march-25-2019/asco-endorses-active-surveillance-guideline-for-low-risk-prostate-cancer/ 2019-03-31T14:01:54+00:00 https://ascopost.com/issues/march-25-2019/new-asco-guideline-makes-safe-handling-of-hazardous-drugs-a-priority/ 2019-03-31T14:12:25+00:00 https://ascopost.com/issues/march-25-2019/asco-multidisciplinary-cancer-management-course-in-azerbaijan/ 2019-03-25T03:15:41+00:00 https://ascopost.com/issues/march-25-2019/conquer-cancer-honors-researchers-with-merit-awards/ 2019-03-25T03:15:41+00:00 https://ascopost.com/issues/march-25-2019/urge-congress-to-support-medicaid-coverage-of-routine-care-costs-for-clinical-trials/ 2019-03-25T03:15:41+00:00 https://ascopost.com/issues/march-25-2019/asco-weighs-in-on-widespread-youth-tobacco-use/ 2019-03-31T14:13:49+00:00 https://ascopost.com/issues/march-25-2019/looking-for-trusted-patient-information-resources/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/assessing-the-clinical-utility-of-asco-s-and-esmo-s-value-frameworks/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/actively-recruiting-clinical-trials-focused-on-treatments-of-kidney-cancer/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/american-skin-association-announces-18-new-grants-for-skin-cancer-and-disease-research/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/fred-r-hirsch-md-phd-named-executive-director-of-new-center-for-thoracic-oncology-at-mount-sinai/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/tisagenlecleucel-active-in-adult-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2019-04-10T19:43:40+00:00 https://ascopost.com/issues/march-25-2019/car-t-cell-therapy-for-dlbcl-at-the-crossroads-of-hype-and-reality/ 2019-04-10T19:44:41+00:00 https://ascopost.com/issues/march-25-2019/stephen-j-forman-awarded-two-bone-marrow-transplantation-honors/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/asco-president-elect-howard-a-burris-iii-md-facp-fasco-gained-leadership-skills-from-his-experience-at-west-point/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/johns-hopkins-greenberg-bladder-cancer-institute-awards-research-grants-to-women-s-bladder-cancer-projects/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/jeffrey-bluestone-phd-awarded-distinguished-lectureship/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/national-brain-tumor-society-and-brain-science-foundation-partner-to-fund-research-in-meningioma/ 2019-03-25T03:15:42+00:00 https://ascopost.com/issues/march-25-2019/sarcoma-coalition-launched-as-collaboration-of-advocacy-organizations/ 2019-03-25T03:15:43+00:00 https://ascopost.com/issues/march-25-2019/the-risks-of-drug-approval-based-on-shaky-evidence/ 2019-04-11T20:32:01+00:00 https://ascopost.com/issues/march-25-2019/webmd-recognizes-seven-cancer-innovators-with-its-health-heroes-award/ 2019-04-02T21:04:18+00:00 https://ascopost.com/issues/march-25-2019/sweet-surrender/ 2019-03-25T14:01:55+00:00 https://ascopost.com/issues/march-25-2019/florida-cancer-specialists-welcomes-nalini-hasija-md/ 2019-03-25T14:10:53+00:00 https://ascopost.com/issues/march-25-2019/royal-swedish-academy-of-sciences-accepting-candidates-for-sjoeberg-prize-2020/ 2019-03-25T14:12:47+00:00 https://ascopost.com/issues/march-25-2019/new-england-cancer-specialists-to-join-dana-farber-cancer-care-collaborative/ 2019-03-25T14:13:49+00:00 https://ascopost.com/issues/march-25-2019/obesity-examined-and-explained/ 2019-03-25T14:14:55+00:00 https://ascopost.com/issues/march-25-2019/restarting-my-life-after-terminal-cancer/ 2019-03-25T14:17:09+00:00 https://ascopost.com/issues/march-25-2019/knowing-gender-identity-and-sexual-orientation-of-patients-is-a-vital-aspect-of-medical-care/ 2019-03-25T14:18:59+00:00 https://ascopost.com/issues/march-25-2019/use-technology-and-appreciate-the-importance-of-partners/ 2019-03-25T03:15:43+00:00 https://ascopost.com/issues/march-25-2019/patient-reported-outcomes-with-enzalutamide-treatment-in-nonmetastatic-castration-resistant-prostate-cancer/ 2019-03-25T14:20:12+00:00 https://ascopost.com/issues/march-25-2019/docetaxel-plus-androgen-deprivation-therapy-after-primary-local-therapy-in-high-risk-prostate-cancer/ 2019-03-25T14:21:20+00:00 https://ascopost.com/issues/march-25-2019/intracranial-malignancy-after-stereotactic-radiosurgery-for-nonmalignant-conditions/ 2019-03-25T14:25:45+00:00 https://ascopost.com/issues/march-25-2019/president-s-fy2020-budget-threatens-progress-against-cancer-patient-access-to-care/ 2019-03-25T15:03:37+00:00 https://ascopost.com/issues/march-25-2019/coming-in-future-issues-of-the-asco-post/ 2019-03-25T15:15:29+00:00 https://ascopost.com/issues/march-10-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/march-10-2019/pembrolizumabaxitinib-combination-improves-outcomes-vs-sunitinib-in-kidney-cancer/ 2019-04-02T20:25:27+00:00 https://ascopost.com/issues/march-10-2019/epov-lori-wood-md/ 2019-03-11T15:55:51+00:00 https://ascopost.com/issues/march-10-2019/mutations-in-dna-damage-repair-predict-benefit-with-platinum-agents-in-pancreatic-cancer/ 2019-04-02T20:27:53+00:00 https://ascopost.com/issues/march-10-2019/epov-allyson-ocean-md/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/10-patient-centered-principles-for-more-conservative-cancer-diagnosis/ 2019-03-12T19:08:12+00:00 https://ascopost.com/issues/march-10-2019/radioligand-therapy-achieves-responses-in-metastatic-prostate-cancer/ 2019-04-02T20:32:07+00:00 https://ascopost.com/issues/march-10-2019/epov-robert-dreicer-and-sumanta-k-pal/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/aramis-trial-reports-darolutamide-improves-outcomes-in-high-risk-nonmetastatic-prostate-cancer/ 2019-04-02T20:29:47+00:00 https://ascopost.com/issues/march-10-2019/epov-ian-davis/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/study-shows-limited-antitumor-activity-of-pembrolizumab-in-neuroendocrine-tumors/ 2019-04-02T20:32:57+00:00 https://ascopost.com/issues/march-10-2019/epov-parag-parikh/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/more-data-show-small-benefit-from-extended-endocrine-therapy/ 2019-03-12T19:30:20+00:00 https://ascopost.com/issues/march-10-2019/epov-eleftherios-mamounas-william-sikov-laura-esserman/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/perlmutter-cancer-center-receives-anonymous-75-million-gift-to-create-center-for-blood-cancers/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/long-term-study-finds-axillary-radiotherapy-safe-and-effective-after-positive-sentinel-node-biopsy/ 2019-03-11T20:46:17+00:00 https://ascopost.com/issues/march-10-2019/neoadjuvant-palbociclib-plus-letrozole-reduces-ki67-levels/ 2019-04-02T20:34:05+00:00 https://ascopost.com/issues/march-10-2019/epov-aditya-bardia/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/otis-w-brawley-md-joins-faculty-of-johns-hopkins-kimmel-cancer-center/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/innovative-research-to-improve-the-supportive-care-needs-of-cancer-survivors/ 2019-04-02T20:35:02+00:00 https://ascopost.com/issues/march-10-2019/national-consensus-project-releases-4th-edition-of-clinical-practice-guidelines-for-quality-palliative-care/ 2019-03-11T19:22:12+00:00 https://ascopost.com/issues/march-10-2019/damon-runyon-cancer-research-foundation-scientists-receive-2019-innovation-award/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/national-consensus-project-clinical-practice-guidelines-improving-education-on-the-tenets-of-palliative-care/ 2019-03-11T19:24:38+00:00 https://ascopost.com/issues/march-10-2019/advances-in-haploidentical-transplantation-and-cellular-therapies/ 2019-04-02T20:37:29+00:00 https://ascopost.com/issues/march-10-2019/cancer-drug-development-award-given-to-geoffrey-shapiro-phd-md/ 2019-03-11T15:55:52+00:00 https://ascopost.com/issues/march-10-2019/the-pancreatic-cancer-collective-awards-7-million-to-teams-of-researchers-in-pancreatic-cancer/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/researcher-supported-by-asco-s-conquer-cancer-foundation-earns-spot-in-clinical-cancer-advances-2019-for-lung-cancer-study/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/more-than-50-groups-sign-letter-urging-hhs-to-reject-proposed-changes-to-medicare-part-d/ 2019-03-11T19:28:41+00:00 https://ascopost.com/issues/march-10-2019/who-i-am-and-what-i-will-do/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/qopi-round-1-now-open-for-data-abstraction/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/asco-university-course-focuses-on-fertility-preservation/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/cancernet-patient-referral-cards-from-asco/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/eliminating-the-taboo-of-cancer/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/conquer-cancer-podcast-series-goes-unscripted-with-doctors-patients-and-caregivers/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/michael-cabana-and-lori-pbert-join-uspstf/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/robin-zon-elected-president-of-michiana-hematology-oncology/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/lung-cancer-screening-evidence-and-adoption/ 2019-03-13T19:34:18+00:00 https://ascopost.com/issues/march-10-2019/roy-silverstein-issues-comment-on-moc-recommendations-draft/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/addition-of-elotuzumab-to-pomalidomide-and-dexamethasone-in-previously-treated-multiple-myeloma/ 2019-04-02T20:39:07+00:00 https://ascopost.com/issues/march-10-2019/reshaping-the-treatment-landscape-in-refractory-multiple-myeloma/ 2019-04-02T20:41:55+00:00 https://ascopost.com/issues/march-10-2019/cabozantinib-for-hepatocellular-carcinoma-previously-treated-with-sorafenib/ 2019-04-02T20:43:08+00:00 https://ascopost.com/issues/march-10-2019/health-care-fraud-prosecutions-are-on-the-rise/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/roy-silverstein-begins-term-as-2019-ash-president/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/origin-of-the-frederick-national-laboratory/ 2019-04-02T20:44:08+00:00 https://ascopost.com/issues/march-10-2019/omega-3-fatty-acids/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/fda-approves-trifluridine-tipiracil-for-gastric-and-gej-adenocarcinoma/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/update-on-newer-treatments-in-non-hodgkin-lymphomas/ 2019-04-02T20:45:07+00:00 https://ascopost.com/issues/march-10-2019/we-need-better-screening-methods-for-detecting-breast-cancer/ 2019-03-11T15:55:53+00:00 https://ascopost.com/issues/march-10-2019/outcomes-with-dose-intense-adjuvant-chemotherapy-in-early-breast-cancer/ 2019-03-11T15:55:54+00:00 https://ascopost.com/issues/march-10-2019/factors-influencing-conversion-to-mastectomy-in-dcis/ 2019-03-11T15:55:54+00:00 https://ascopost.com/issues/march-10-2019/conservatively-managing-ovarian-tumors/ 2019-03-11T15:55:54+00:00 https://ascopost.com/issues/march-10-2019/universal-access-to-care-as-a-basic-human-right/ 2019-03-11T15:55:54+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/conference-highlights/ 2019-03-11T15:56:47+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/front-line-ibrutinib-improves-progression-free-survival-in-older-patients-with-cll/ 2019-03-11T15:56:47+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/luspatercept-may-reduce-the-need-for-transfusion-in-lower-risk-myelodysplastic-syndromes/ 2019-03-11T15:56:47+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/epov-mrinal-patnaik-david-steensma/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/hydroxyurea-for-sickle-cell-anemia-in-sub-saharan-africa/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/first-line-ibrutinibrituximab-combination-shows-benefit-for-younger-patients-with-cll/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/mutation-in-bcl2-protein-impacts-outcomes-in-patients-with-progressive-cll/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/daratumumab-lenalidomide-and-dexamethasone-in-patients-with-newly-diagnosed-multiple-myeloma-outcomes-from-the-maia-trial/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/epov-kenneth-shain-md-phd-and-vincent-rajkumar-md/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/j-evan-sadler-md-phd-expert-in-blood-clotting-disorders-dies-at-67/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/low-dose-rituximab-effective-for-acquired-thrombotic-thrombocytopenic-purpura-with-severe-adamts13-deficiency/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/pilot-study-tests-novel-approach-to-gene-therapy-for-sickle-cell-disease/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/direct-oral-anticoagulants-show-reduced-risk-of-venous-thromboembolism-in-patients-with-cancer/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/epov-mark-crowther-md-msc-frcpc/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/crizanlizumab-improves-prevention-of-vaso-occlusive-crises-in-patients-with-sickle-cell-disease/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/pause-study-establishes-simple-approach-to-perioperative-management-of-direct-oral-anticoagulants/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/epov-mark-crowther-md-msc-frcpc-1/ 2019-03-11T15:56:48+00:00 https://ascopost.com/issues/february-25-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/february-25-2019/emerging-role-for-neoadjuvant-treatment-of-resectable-pancreatic-cancer/ 2019-03-11T15:57:28+00:00 https://ascopost.com/issues/february-25-2019/epov-andrew-zhu/ 2019-03-11T15:57:28+00:00 https://ascopost.com/issues/february-25-2019/curve-2-and-oncology/ 2019-03-11T15:57:28+00:00 https://ascopost.com/issues/february-25-2019/how-to-improve-care-for-young-sexual-and-gender-minority-cancer-survivors/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/durvalumab-and-tremelimumab-in-refractory-microsatellite-stable-colorectal-cancer/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/epov-michael-overman/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/brafmek-targeting-in-biliary-tract-cancer/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/sabcs-presentations-offer-new-data/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/prognostic-value-of-disseminated-tumor-cells-in-early-breast-cancer/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/epov-carlos-arteaga/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/highlights-from-the-2018-ash-annual-meeting-exposition/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/fda-approves-split-dosing-regimen-of-therapy-for-multiple-myeloma/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/fda-approves-caplacizumab-yhdp-for-acquired-thrombotic-thrombocytopenic-purpura/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/update-on-fda-approved-car-t-cell-products-tisagenlecleucel/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/update-on-fda-approved-car-t-cell-products-axicabtagene-ciloleucel/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/immunotherapy-for-head-and-neck-cancer-expands/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/radiation-therapy-systemic-cancer-treatment/ 2019-03-11T15:57:29+00:00 https://ascopost.com/issues/february-25-2019/asco-clinical-trial-data-sharing-policy/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/conquer-cancer-podcast-series/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/jco-fast-track-presubmission-rapid-review/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/highlights-from-the-2019-gastrointestinal-and-genitourinary-cancers-symposiums/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/researcher-supported-by-asco-s-conquer-cancer-foundation-earns-advance-of-the-year/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/cancerlinq-leader-contributes-to-new-brca-exchange-to-inform-understanding-of-cancer-risk/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/medicaid-enrollees-must-have-access-to-high-quality-cancer-care/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/pembrolizumab-in-combination-with-chemotherapy-in-first-line-treatment-of-metastatic-squamous-nsclc/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/norman-e-sharpless-md-from-director-of-a-comprehensive-cancer-center-to-director-of-the-nci/ 2019-03-13T18:52:39+00:00 https://ascopost.com/issues/february-25-2019/artificial-intelligence-and-the-brave-new-world-of-cancer-diagnostics/ 2025-03-13T15:33:48+00:00 https://ascopost.com/issues/february-25-2019/physician-wellness-time-to-heal-the-healer/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/asco-statement-on-the-effect-of-lower-drug-costs-on-people-with-cancer/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/nagi-el-saghir-md-facp-fasco-recognized-by-american-university-of-beirut-medical-center/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/30-million-gift-to-huntsman-cancer-institute-doubles-the-size-of-planned-expansion/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/steven-a-rosenberg-md-phd-awarded-the-2019-szent-gyoergyi-prize/ 2019-03-11T15:57:30+00:00 https://ascopost.com/issues/february-25-2019/increased-risk-of-bone-loss-extends-to-younger-women-treated-for-breast-cancer/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-25-2019/expect-questions-about-bone-loss-among-younger-breast-cancer-survivors/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-25-2019/cancer-has-given-me-the-life-i-was-meant-to-live/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-25-2019/northwestern-medicine-receives-10-million-gift-to-create-urologic-cancer-institute/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-25-2019/no-survival-benefit-with-avelumab-vs-docetaxel-in-platinum-treated-advanced-pd-l1-positive-nsclc/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-25-2019/estradiol-as-potential-treatment-for-subset-of-triple-negative-breast-cancers/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-25-2019/adherence-to-endocrine-therapy-for-breast-cancer-in-black-women-and-white-women/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-25-2019/former-jama-editor-offers-perspective-on-challenges-past-and-present-in-american-health-care/ 2019-03-11T15:57:31+00:00 https://ascopost.com/issues/february-10-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/february-10-2019/keynote-181-pembrolizumab-vs-chemotherapy-in-advanced-esophageal-cancer/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/epov-harry-h-yoon-md/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/progress-with-alk-inhibitors/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/essential-elements-of-an-effective-clinical-trials-system/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/andecaliximab-in-untreated-gastric-or-gastroesophageal-junction-cancer/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/epov-martine-extermann-md-phd/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/first-line-trastuzumab-plus-pembrolizumab-shows-efficacy-in-patients-with-metastatic-esophagogastric-cancer/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/epov-harry-yoon-md/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/selected-abstracts-from-the-san-antonio-breast-cancer-symposium/ 2019-03-11T16:04:48+00:00 https://ascopost.com/issues/february-10-2019/small-differences-found-in-breast-cancer-recurrence-with-partial-breast-vs-whole-breast-irradiation/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/epov-virginia-kaklamani-md-and-wendy-a-woodward-md/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/luspatercept-may-reduce-the-need-for-transfusion-in-lower-risk-myelodysplastic-syndromes/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/epov-mrinal-s-patnaik-mbbs-and-david-p-steensma-md/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/multiple-myeloma-pipeline-filled-with-car-t-cell-therapies/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/epov-ravi-vij-and-saad-usmani/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/data-mount-for-venetoclax-as-add-on-therapy-in-acute-myeloid-leukemia/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/epov-steven-gore-eyten-stein-and-elihu-h-estey/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/clinical-cancer-advances-2019/ 2019-07-11T21:23:09+00:00 https://ascopost.com/issues/february-10-2019/leave-a-legacy-of-hope/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/new-asco-answers-fact-sheet/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/new-jop-article-highlights-challenges-oncologists-face-due-to-a-lack-of-interoperability-and-how-cancerlinq-can-help/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/how-asco-develops-policy-guidance-and-position-statements/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/new-standards-for-safe-handling-of-hazardous-drugs-focus-on-developing-evidence-based-measures/ 2019-03-11T16:04:49+00:00 https://ascopost.com/issues/february-10-2019/integrative-oncology-scholars-program/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/nccn-guidelines-exceed-10-million-downloads-in-2018/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/novel-treatments-of-myelodysplastic-syndromes/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/julian-schink-named-chief-medical-officer-of-ctca/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/v-craig-jordan-receives-reynold-spector-award/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/turning-cold-tumors-into-hot-ones/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/encourage-lung-cancer-screening-to-prevent-early-deaths/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/fda-approves-ibrutinib/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/direct-to-consumer-genetic-test/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/lorlatinib-in-alk-positive-nsclc/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/living-my-best-life/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/breast-cancer-surgical-terminology-update/ 2019-03-11T16:04:50+00:00 https://ascopost.com/issues/february-10-2019/advancing-the-science-and-art-of-integrative-oncology/ 2019-03-11T16:04:51+00:00 https://ascopost.com/issues/february-10-2019/neoadjuvant-combination-checkpoint-blockade-in-advanced-melanoma/ 2019-03-11T16:04:51+00:00 https://ascopost.com/issues/february-10-2019/gentian-violet-in-cutaneous-t-cell-lymphoma/ 2022-06-10T20:07:44+00:00 https://ascopost.com/issues/february-10-2019/opioid-use-following-thoracoscopic-surgery/ 2019-03-11T16:04:51+00:00 https://ascopost.com/issues/february-10-2019/leaders-of-harborside-medical-education-recognized/ 2019-03-11T16:04:51+00:00 https://ascopost.com/issues/january-25-2019/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/january-25-2019/low-dose-tamoxifen-in-women-with-preinvasive-breast-lesions/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/epov-virginia-kaklamani-monica-morrow-and-john-cole/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/the-potential-of-value-based-prescribing-in-oncology/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/pacific-trial-of-durvalumab-in-stage-iii-unresectable-nsclc/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/role-of-adjuvant-capecitabine-in-triple-negative-breast-cancer/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/epov-carlos-arteaga/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/oxybutynin-for-managing-hot-flashes/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/epov-c-kent-osborne/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/beat-aml-umbrella-trial/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/epov-joseph-mikhael/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/primary-prophylaxis-with-a-direct-oral-anticoagulation-agent-reduces-vte/ 2019-03-11T16:07:06+00:00 https://ascopost.com/issues/january-25-2019/ash-research-collaborative-established/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/use-of-idh-inhibitors-in-induction-therapy-for-newly-diagnosed-aml/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/epov-idh-aml/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/md-anderson-grants/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/accc-relaunches-immuno-oncology-institute-with-online-portal/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/amy-abernethy-named-principal-deputy-commissioner-of-food-and-drugs/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/risk-of-local-recurrence-in-breast-cancer/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/preventing-locoregional-recurrence-of-breast-cancer-should-not-deter-efforts-to-decelerate-therapy/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/challenge-moving-forward-in-breast-cancer-treatment/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/changing-perceptions-on-surgical-intervention-for-geriatric-patients-with-cancer/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/medical-associations-win-concessions-in-cvsaetna-merger/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/mmrf-launches-first-platform-trial-in-multiple-myeloma/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/addition-of-atezolizumab-to-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/impassion130-trial-changing-the-treatment-landscape/ 2019-03-11T16:07:07+00:00 https://ascopost.com/issues/january-25-2019/genomic-classifier-for-luminal-androgen-receptor-triple-negative-breast-cancer/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/community-oncology-alliance-elects-new-officers-and-board-members/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/development-of-novel-therapies-for-peripheral-t-cell-lymphomas/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/emad-alnemri-named-national-academy-of-inventors-fellow/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/national-brain-tumor-society-names-kirk-tanner-chief-scientific-officer/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/oncology-pioneer-v-shanta-md/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/four-nonprofits-join-forces-to-advance-cholangiocarcinoma-research/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/lori-j-pierce-elected-asco-president-for-2020-2021/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/asco-and-esmo-publish-joint-assessment-of-value-frameworks/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/improved-data-sharing-through-cancerlinq-certification-continues-to-expand/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/asco-to-convene-global-summit-on-latest-innovations-in-technology-and-cancer/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/new-regulations-require-better-communication-with-patients-who-have-disabilities-and-limited-english-proficiency/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/novel-treatments-in-newly-diagnosed-multiple-myeloma-part-1/ 2019-03-11T16:07:08+00:00 https://ascopost.com/issues/january-25-2019/clinical-trial-commences-on-personalized-vaccine-in-kidney-cancer/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/findings-from-asco-s-second-national-cancer-opinion-survey/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/fda-approves-cabozantinib-in-previously-treated-hepatocellular-carcinoma/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/novel-therapeutics-for-relapsed-or-refractory-multiple-myeloma-part-2/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/27-drop-in-overall-us-cancer-mortality-rate-from-1991-to-2016/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/use-of-valerian-to-relieve-anxiety-in-patients-with-cancer/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/american-association-for-the-advancement-of-science-honors-2018-elected-fellows/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/adoptive-t-cell-therapy-for-progressive-multifocal-leukoencephalopathy/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/established-modifiable-cancer-risk-factors/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/remnants-of-cancer-remain-but-demons-are-now-gone/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/adi-gazdar-md-cell-line-pioneer-and-groundbreaking-pathologist-dies/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/j-evan-sadler-md-phd-expert-in-blood-clotting-disorders-dies-at-67/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/a-visionary-in-lymphoma-bertrand-coiffier-md-phd-dies-at-71/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/waun-ki-hong-md-facp-fasco-innovator-in-the-treatment-of-head-and-neck-cancer-dies-at-76/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/huntsman-cancer-institute-announces-construction-of-proton-therapy-center/ 2019-03-11T16:07:09+00:00 https://ascopost.com/issues/january-25-2019/a-tribute-to-arti-hurria-md-fasco-a-leader-in-geriatric-oncology/ 2020-02-17T17:35:38+00:00 https://ascopost.com/issues/january-25-2019/patient-navigation-program-reduces-time-to-cancer-treatment/ 2019-03-11T16:07:10+00:00 https://ascopost.com/issues/january-25-2019/md-anderson-president-emeritus-john-mendelsohn-md-dies-at-age-82/ 2019-03-11T16:07:10+00:00 https://ascopost.com/issues/december-25-2018/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/december-25-2018/katherine-trial/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/epov-eric-winer-and-jame-abraham/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/first-line-ibrutinibrituximab-combination-shows-benefit-for-younger-patients-with-cll/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/epov-aaron-gerds/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/will-the-trump-administration-s-plan-to-reduce-cancer-drug-prices-work/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/association-between-pathologic-complete-response-after-neoadjuvant-chemotherapy-and-breast-cancer-outcomes/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/epov-carlos-arteaga-laura-esserman-and-joseph-sparano/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/rishi-jain-joins-fox-chase-gi-program/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/cdc-foundation-launches-virtual-tool-to-prevent-infections-in-patients-with-cancer/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/jonathan-chernoff-receives-grant-to-investigate-rac1-mutant-melanoma/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/grace-lu-yao-phd-receives-siog-nursing-award/ 2019-03-11T16:08:13+00:00 https://ascopost.com/issues/december-25-2018/nicholas-petrelli-receives-commendation-for-excellence-award-from-christiana-care-health-system/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/cornelis-melief-receives-2018-esmo-immuno-oncology-award/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/low-dose-ct-lung-screening/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/prevent-cancer-foundation-award-goes-to-big-tobacco-foe-sharon-y-eubanks-jd/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/controlling-the-global-burden-of-liver-cancer/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/frederick-national-laboratory-names-leonard-p-freedman-phd-chief-science-officer/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/larotrectinib-for-solid-tumors-with-ntrk-gene-fusions/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/early-studies-of-ibrutinib-plus-car-t-cell-combination-in-chronic-lymphocytic-leukemia/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/epov-joseph-alvarnas-and-henry-fung/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/combining-a-checkpoint-inhibitor-with-car-t-cell-therapy-may-augment-immune-response/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/epov-joseph-alvarnas/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/ai-technology-for-digital-breast-tomosynthesis-receives-fda-clearance-for-clinical-use/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/fixed-duration-venetoclax-plus-rituximab-in-relapsed-or-refractory-cll/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/front-line-daratumumab-combination-regimen-improves-outcomes-in-multiple-myeloma/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/epov-kenneth-shain-and-vincent-rajkumar/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/aacr-remembers-george-hw-bush-for-role-in-cancer-research-support/ 2019-03-11T16:08:14+00:00 https://ascopost.com/issues/december-25-2018/has-scalp-cooling-reached-the-level-of-standard-of-care/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/new-nccn-member-institution/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/immunotherapy-related-toxicities-may-be-more-common-than-originally-reported/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/the-great-opioid-debate/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/pembrolizumab-plus-chemoradiotherapy-in-hpv-positive-head-and-neck-cancer/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/epov-charles-g-drake/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/optimal-duration-of-checkpoint-inhibition-in-melanoma-is-no-more-than-2-years/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/international-trials-present-new-findings-in-treatment-of-breast-cancer/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/priority-review-for-atezolizumab-in-combination-with-chemotherapy-for-small-cell-lung-cancer/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/statement-from-fda-commissioner-on-in-vitro-companion-diagnostics/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/new-data-reported-from-international-studies-of-lung-cancer-treatment/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/lorlatinib-in-second-or-third-line-treatment-of-alk-positive-metastatic-non-small-cell-lung-cancer/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/improving-palliative-care-in-low-resource-settings/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/check-out-the-top-five-most-popular-asco-university-courses-of-2018/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/apply-to-join-asco-s-education-council-by-january-31/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/fda-announces-new-updates-to-expanded-access-program/ 2019-03-11T16:08:15+00:00 https://ascopost.com/issues/december-25-2018/global-oncology-education-and-professional-development-asco-international-s-impact/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/breakthroughs-save-lives/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/asco-resolutions-on-step-therapy-competitive-acquisition-program-proposed-at-ama-house-of-delegates/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/managing-the-cost-of-cancer-care/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/new-year-new-resolutions/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/venetoclax-in-combination-regimens-for-older-patients-with-aml-or-those-with-comorbidities-precluding-intensive-induction/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/update-on-immune-checkpoint-inhibitors/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/ut-dallas-researchers-receive-funding/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/overscreening-for-prostate-cancer-in-older-men-remains-an-issue/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/hysterectomy-in-early-stage-cervical-cancer/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/should-i-have-lied/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/durvalumab-in-unresectable-stage-iii-nsclc/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/fda-approves-trastuzumab-pkrb-for-her2-overexpressing-breast-cancer/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/clinical-trial-infrastructure-in-the-community-oncology-setting/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/study-findings-on-myeloproliferative-neoplasms/ 2025-09-30T19:48:17+00:00 https://ascopost.com/issues/december-25-2018/clinician-survey-to-explore-doacs-in-vte/ 2019-03-11T16:08:16+00:00 https://ascopost.com/issues/december-25-2018/illustrating-genius/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/pembrolizumab-in-sorafenib-pretreated-hepatocellular-carcinoma/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/new-report-demonstrates-cost-of-blood-cancer-care/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/comparing-surgical-approaches-in-early-stage-cervical-cancer/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/welcome-questions-about-cervical-cancer-treatment-options/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/priority-review-for-quizartinib-in-relapsed-or-refractory-flt3-itd-positive-aml/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/btd-for-brentuximab-vedotin-in-front-line-treatment-of-peripheral-t-cell-lymphomas/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/stories-of-the-scientists-behind-immunotherapy/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/anil-rustgi-named-director-of-herbert-irving-comprehensive-cancer-center/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/fecal-microbiota-transplantation-in-patients-with-cancer/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/postoperative-outcomes-in-colorectal-cancers/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/nivolumab-and-tumor-specific-vaccine-for-incurable-hpv16-related-cancer/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/maria-papaleontiou-and-improving-care-of-patients-with-thyroid-cancer/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/asco-remembers-charles-a-coltman/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/i-welcome-being-the-face-of-multiple-myeloma/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/iaslc-announces-dave-mesko-as-new-chief-executive/ 2019-03-11T16:08:17+00:00 https://ascopost.com/issues/december-25-2018/louis-weiner-named-nai-fellow/ 2019-03-11T16:08:18+00:00 https://ascopost.com/issues/december-25-2018/asco-and-esmo-publish-joint-assessment-of-their-value-frameworks/ 2019-03-11T16:08:18+00:00 https://ascopost.com/issues/december-10-2018/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/december-10-2018/ibrutinib-vs-standard-of-care-in-older-patients-with-cll/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/epov-susan-obrien/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/should-oncologists-recommend-cannabis/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/beyond-checkpoint-inhibitors-novel-immunotherapy-combinations/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/epov-aung-naing/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/de-escalation-of-chemotherapy-in-favorable-risk-dlbcl/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/epov-laurie-sehn/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/local-consolidative-therapy-in-oligometastatic-nsclc/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/epov-catherine-park/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/stereotactic-ablative-radiotherapy-in-oligometastatic-tumors/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/hippocampus-sparing-wbrt-and-neurocognitive-function-in-patients-with-brain-metastases/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/epov-christina-tsien/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/antonio-omuro-named-neuro-oncology-chief-at-smilow-cancer-hospital/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/using-tumor-infiltrating-lymphocytes-to-treat-metastatic-melanoma/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/epov-cara-haymaker/ 2019-03-11T16:08:43+00:00 https://ascopost.com/issues/december-10-2018/gene-signature-biomarkers-in-renal-cell-carcinoma/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/epov-manuela-schmidinger/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/parp-inhibitor-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/epov-joaquin-mateo/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/pembrolizumab-triplet-in-braf-mutant-melanoma/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/epov-reinhard-dummer/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/no-benefit-for-atezolizumab-plus-standard-of-care-for-maintenance-in-colorectal-cancer-subset/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/epov-julien-taieb/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/hdac-inhibitor-may-overcome-endocrine-resistance-in-advanced-breast-cancer/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/epov-rebecca-dent-suzette-delaloge/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/management-of-her2-positive-breast-cancer/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/resistance-to-treatment-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/bladder-cancer-strategies-to-address-checkpoint-inhibitor-failure/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/duvelisib-for-relapsed-or-refractory-leukemia-or-lymphoma/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/encorafenib-plus-binimetinib-in-advanced-braf-mutant-melanoma/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/encorafenib-and-binimetinib/ 2019-03-11T16:08:44+00:00 https://ascopost.com/issues/december-10-2018/moxetumomab-pasudotox-tdfk-for-relapsed-or-refractory-hairy-cell-leukemia/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/oncology-researcher-catherine-wu/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/role-of-genomic-profiling-in-younger-patients-with-cancer/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/patient-partnered-research/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/lenvatinib-in-unresectable-hepatocellular-carcinoma/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/talazoparib-for-germline-brca-mutated-her2-negative-advanced-breast-cancer/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/global-burden-of-cancer-on-the-rise/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/unequal-burden-of-cancer-related-suffering-and-need-for-palliative-care/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/the-politics-and-economics-of-cancer-prevention/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/current-perspectives-on-the-treatment-of-breast-cancer/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/lynn-sage-breast-cancer-symposium/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/palliative-care-in-the-pediatric-oncology-setting/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/upmc-hillman-cancer-center-scientists-receive-grant/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/new-glioblastoma-translational-center-at-penn-medicine/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/padmanee-sharma-receives-pandolfi-award/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/palliative-care-trailblazer-charles-von-gunten-shares-insights/ 2019-03-11T16:08:45+00:00 https://ascopost.com/issues/december-10-2018/jadpro-live/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/smartphone-app-decreases-pain-and-reduces-inpatient-hospitalizations/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/epov-karen-mustian/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/study-finds-poor-adherence-to-guidelines-in-preventing-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/the-chemotherapy-foundation-innovation-gala/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/addressing-patient-expectations-regarding-the-use-of-alternative-therapies/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/pembrolizumab-with-chemotherapy-for-first-line-treatment-of-metastatic-nonsquamous-nsclc/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/the-skin-cancer-foundation-raises-600-000-at-gala/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/university-collaboration-aims-to-tackle-cancer-health-disparities/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/denial-s-many-faces/ 2020-09-24T01:54:15+00:00 https://ascopost.com/issues/december-10-2018/a-feminist-take-on-health-care-disparities/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/lucio-gordan-named-new-managing-physician-and-president-of-florida-cancer-specialists/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/a-diagnosis-of-li-fraumeni-syndrome-has-focused-my-life-direction/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/st-baldrick-s-foundation-grants-institutional-funding-for-clinical-trials-research-in-children-with-cancer/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/neurologic-knowledge-to-enhance-well-being-and-happiness/ 2019-03-11T16:08:46+00:00 https://ascopost.com/issues/december-10-2018/a-battle-with-leukemia-part-memoir-part-oncology-history/ 2019-03-11T16:08:47+00:00 https://ascopost.com/issues/december-10-2018/bonnie-addario-lung-cancer-foundation-honors-investigators-clinicians-caregivers/ 2019-03-11T16:08:47+00:00 https://ascopost.com/issues/december-10-2018/scientific-and-career-development-retreat/ 2019-03-11T16:08:47+00:00 https://ascopost.com/issues/december-10-2018/oncology-care-team-reduces-opioid-use-after-surgery/ 2019-03-11T16:08:47+00:00 https://ascopost.com/issues/december-10-2018/join-asco-s-research-survey-pool/ 2019-03-11T16:08:47+00:00 https://ascopost.com/issues/december-10-2018/2019-medicare-physician-fee-schedule-and-qpp-final-rule-released/ 2019-03-11T16:08:47+00:00 https://ascopost.com/issues/december-10-2018/every-cancer-treatment-plan-is-different/ 2019-03-11T16:08:47+00:00 https://ascopost.com/issues/november-25-2018/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/november-25-2018/impact-of-palbociclib-on-survival-in-advanced-breast-cancer/ 2019-03-11T16:09:56+00:00 https://ascopost.com/issues/november-25-2018/epov-nadia-harbeck-and-fatima-cardoso/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/lung-cancer-screening/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/dealing-with-the-challenges-presented-by-the-parenteral-opioid-shortage/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/radiotherapy-reduces-risk-of-recurrence-by-more-than-70-in-some-patients-with-ductal-carcinoma-in-situ/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/epov-catherine-c-park/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/adding-pelvic-node-radiation-and-hormone-therapy-to-radiation-provides-significant-benefit-in-prostate-ca/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/epov-richard-k-valicenti/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/neoadjuvant-immunotherapy-yields-major-response-in-colon-cancer-subset/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/epov-george-coukos-md-phd/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/ivy-brain-tumor-center-to-study-treatments-for-brain-malignancies/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/first-line-immunotherapy-shows-benefit-in-metastatic-colorectal-cancer-subset/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/epov-julien-taieb/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/pembrolizumab-improves-survival-in-advanced-head-and-neck-cancer/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/epov-jean-pascal-machiels-and-tanguy-seiwert/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/phase-iii-study-supports-use-of-cisplatin-over-cetuximab-in-hpv-positive-oropharyngeal-cancer/ 2019-03-11T16:09:57+00:00 https://ascopost.com/issues/november-25-2018/epov-amanda-psyrri/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/immunotherapy-and-tyrosine-kinase-inhibitor-combination-in-advanced-renal-cell-carcinoma/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/epov-viktor-gruenwald/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/treatment-with-radium-223-plus-abiraterone-not-advisable-in-metastatic-prostate-cancer/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/epov-daniel-heinrich-and-silke-gillessen/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/neoadjuvant-therapy-with-reduced-dose-immunotherapy-for-stage-iii-melanoma/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/epov-caroline-robert/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/study-identifies-suitable-partner-for-bevacizumab-in-recurrent-ovarian-cancer/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/epov-sandro-pignata-md/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/modern-clinical-trials/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/charles-gawad-receives-new-innovator-award/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/heidi-nelson-named-medical-director-of-acs-cancer-programs/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/building-improved-and-sustainable-health-care-systems-through-telemedicine/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/atlantic-health-system-announces-collaboration-to-further-patient-access-to-innovative-cancer-therapies/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/astroascoaua-guideline-for-early-stage-prostate-cancer-supports-use-of-hypofractionated-radiotherapy/ 2019-03-11T16:09:58+00:00 https://ascopost.com/issues/november-25-2018/quality-of-life-with-postmastectomy-radiotherapy-vs-no-radiotherapy-in-breast-ca/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/steven-a-rosenberg-works-to-unmask-cancer-s-achilles-heel/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/ibrutinib-plus-rituximab-in-patients-with-waldenstroem-s-macroglobulinemia/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/fda-approves-lorlatinib-for-second-or-third-line-treatment-of-nsclc/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/dacomitinib-for-metastatic-egfr-mutant-nsclc/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/global-liver-institute-supports-frequent-liver-cancer-screening/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/leukemia-lymphoma-society-receives-funding-for-new-grants/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/johns-hopkins-medicine-appoints-allen-kachalia/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/inflammation-dna-damage-and-cancer/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/oncologist-s-research-recognized-by-radiation-oncology-institute/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/upmc-opens-new-radiotherapy-center-in-italy/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/nci-awards-grant-to-team-at-baylor/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/parenteral-opioid-shortage-threatens-appropriate-pain-care-for-patients-with-cancer/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/duvelisib-vs-ofatumumab-in-relapsed-or-refractory-cllsll/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/duvelisib-in-resistant-cll/ 2019-03-11T16:09:59+00:00 https://ascopost.com/issues/november-25-2018/patients-with-cancer-in-rural-america-remain-underserved/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/cemiplimab-rwlc-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/vote-in-the-asco-election-by-december-3/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/2019-asco-election-candidates/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/asco-sitc-release-recommendations-for-reporting-of-immuno-oncology-clinical-trials/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/asco-president-elect-candidates-identify-issues-facing-oncology/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/pharmacy-bills-signed-into-law/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/share-asco-resources-with-your-newly-diagnosed-patients/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/thank-you-from-conquer-cancer/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/chanita-hughes-halbert-receives-aacr-distinguished-lecture-on-the-science-of-cancer-health-disparities/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/new-leadership-elected-to-ash-executive-committee/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/fda-approves-elotuzumab-plus-pomalidomide-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/iobenguane-i-131-for-advanced-pheochromocytoma-or-paraganglioma/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/2018-san-antonio-breast-cancer-symposium-award-winners-announced/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/fda-expands-approved-use-of-brentuximab-vedotin-in-some-types-of-ptcl/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/the-abscopal-effect-a-reemerging-field-of-interest/ 2019-03-11T16:10:00+00:00 https://ascopost.com/issues/november-25-2018/california-researchers-to-develop-immunotherapies-in-head-and-neck-cancer/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/a-career-path-shaped-by-unlimited-possibilities-for-clifford-a-hudis/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/electronic-datarrhea-and-wellness/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/when-illness-and-culture-collide/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/lung-cancer-researcher-melissa-johnson-md/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/ash-award-for-leadership-in-promoting-diversity/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/ash-2018-henry-m-stratton-medal/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/six-hospital-systems-launch-research-center-on-symptom-management/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/how-to-tell-patients-they-have-cancer/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/at-sea/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/michael-caligiuri-elected-to-national-academy-of-medicine/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/focus-on-the-rocky-mountain-oncology-society/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/nivolumab-for-third-line-treatment-of-metastatic-small-cell-lung-cancer/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/probiotics/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/fda-approves-pembrolizumab-for-hcc-previously-treated-with-a-kinase-inhibitor/ 2019-03-11T16:10:01+00:00 https://ascopost.com/issues/november-25-2018/founder-of-the-harvard-stem-cell-institute-relates-the-history-of-cancer-research/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/a-pediatric-oncologist-recounts-7-years-at-a-hospital-in-jerusalem/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/obligation-to-evaluate-features-that-may-affect-outcomes-for-patients-with-breast-cancer/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/advise-patients-about-the-implications-of-racial-disparities-for-breast-cancer-screening/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/a-single-car-t-cell-cured-my-chronic-lymphocytic-leukemia/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/pazopanib-plus-cetuximab-in-metastatic-head-and-neck-squamous-cell-carcinoma/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/dna-vaccine-leads-to-immune-responses-in-hpv-related-head-and-neck-cancer-in-small-study/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/causes-of-inferior-outcomes-in-ayas-with-leukemia/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-25-2018/leader-in-geriatric-oncology-arti-hurria-dies-at-age-48/ 2019-03-11T16:10:02+00:00 https://ascopost.com/issues/november-10-2018/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/november-10-2018/io-in-subset-of-patients-with-metastatic-triple-negative-breast-cancer/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/epov-giuseppe-curigliano/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/outcomes-with-brigatinib-vs-crizotinib-in-alk-positive-nsclc/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/epov-fiona-blackhall/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/cancer-taught-me-to-help-patients-find-healing-hope/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/results-reported-for-olaparib-maintenance-in-ovarian-cancer/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/epov-jonathan-ledermann-and-clara-mackay/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/radiation-to-primary-tumor-in-metastatic-prostate-cancer/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/epov-robert-bristow-ignacio-duran-karim-fizazi/ 2019-03-11T16:11:13+00:00 https://ascopost.com/issues/november-10-2018/pembrolizumab-shows-antitumor-activity-in-non-muscle-invasive-bladder-cancer/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/epov-shahrokh-shariat/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/adding-the-patient-s-voice-to-collaborative-clinical-trial-efforts/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/atezolizumab-plus-chemotherapy-improves-outcomes-in-sclc/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/who-announces-new-global-childhood-cancer-initiative/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/alan-d-andrea-and-neal-young-to-present-ash-ernest-beutler-lecture/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/end-of-life-dashboard-drives-transformation-with-actionable-personalized-data/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/challenges-and-successes-of-adopting-an-oncology-care-model/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/do-incident-learning-systems-prevent-medical-errors/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/venetoclax-for-cll-or-sll-with-or-without-17p-deletion-after-prior-therapy/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/tackling-financial-toxicity/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/developing-patient-centered-palliative-care-from-diagnosis-to-end-of-life/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/corticosteroid-use-at-start-of-pd1-pdl1-inhibitor-therapy-in-nsclc/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/corticosteroids-and-immunotherapy/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2019-03-11T16:11:14+00:00 https://ascopost.com/issues/november-10-2018/novel-physician-driven-practice-model-offers-alternative-to-community-oncologists/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/health-policy-forum-focuses-on-new-care-delivery-paradigms/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/the-persephone-trial-reconsidered-part-1/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/the-persephone-trial-reconsidered-part-2/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/ash-honors-victor-hoffbrand-with-lifetime-achievement-award/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/ash-honors-john-e-dick-and-reed-e-drews-with-mentor-award/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/the-antiseptic-era-1876-1900/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/connie-j-eaves-to-give-honorary-lecture-at-ash/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/actively-recruiting-clinical-trials-focused-on-immunotherapies-for-lung-cancer/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/cancer-care-in-the-us-prison-system/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/never-a-doubt-about-a-career-in-medicine-for-anne-s-tsao-md/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/fda-approves-levoleucovorin-for-osteosarcoma-colorectal-cancer/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/melanoma-research-alliance-appoints-marc-hurlbert/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/new-york-based-collaboration-launches-oncofertility-program/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/neil-bacon-appointed-new-president-and-chief-executive-officer-of-ichom/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/nilotinib-for-pediatric-patients-with-philadelphia-chromosome-positive-cml-in-chronic-phase/ 2019-03-11T16:11:15+00:00 https://ascopost.com/issues/november-10-2018/acupuncture-for-joint-symptoms-caused-by-aromatase-inhibitors/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/family-archivist-holds-joyful-memories-amid-grief-of-losing-loved-ones/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/fda-releases-draft-guidance-for-clinical-trial-design/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/nccn-relocates-global-headquarters/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/living-a-full-life-after-a-diagnosis-of-cancer/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/without-genomic-sequencing-i-would-not-be-alive-today/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/thomas-j-dougherty-dies-at-age-85/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/early-psa-testing-could-help-predict-prostate-cancer-among-black-men/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/robot-assisted-laparoscopic-prostatectomy-in-newly-diagnosed-prostate-cancer/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/ar-v7-as-marker-for-taxane-therapy-in-castration-resistant-prostate-cancer/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/samuel-waxman-receives-award/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/iaslc-issues-statement-on-lung-cancer-screening/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/listening-and-learning-from-our-patients-in-appalachia/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/survey-of-apps-in-oncology-shows-growing-role-for-nps-pas/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/conquer-cancer-foundation/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/first-oncology-practice-in-romania-certified-by-qopi/ 2019-03-11T16:11:16+00:00 https://ascopost.com/issues/november-10-2018/after-visit-summary-patient-resource/ 2019-03-11T16:11:17+00:00 https://ascopost.com/issues/november-10-2018/me-strong-joins-with-conquer-cancer-foundation/ 2019-03-11T16:11:17+00:00 https://ascopost.com/issues/october-25-2018/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/october-25-2018/atezolizumab-plus-standard-chemotherapy-improves-survival-in-nsclc/ 2019-03-11T16:14:08+00:00 https://ascopost.com/issues/october-25-2018/epov-hossein-borghaei-ms-do/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/how-the-nobel-prize-could-spur-more-cancer-advances/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/cancer-care-in-the-palestinian-territories/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/durvalumab-improves-overall-survival-in-unresectable-stage-iii-nsclc/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/epov-everett-vokes-md/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/nelson-trial/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/epov-john-k-field-phd-frcp/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/entrectinib-shows-activity-in-ros1-positive-nsclc/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/epov-shengxiang-ren-md-phd/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/regardless-of-taxane-used-pembrolizumab-plus-chemotherapy-improves-survival-in-squamous-nsclc/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/epov-antoinette-wozniak-md/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/current-treatment-landscape-of-relapsed-or-refractory-chronic-lymphocytic-leukemia/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/margaret-foti-receives-esmo-women-for-oncology-award/ 2019-03-11T16:14:09+00:00 https://ascopost.com/issues/october-25-2018/next-generation-sequencing/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/jean-charles-soria-receives-esmo-award/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/novel-treatment-approaches-in-early-relapse-of-follicular-lymphoma/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/fadlo-r-khuri-acknowledged-with-iaslc-award/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/nivolumab-plus-ipilimumab-in-intermediate-or-poor-risk-advanced-renal-cell-carcinoma/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/cabozantinib-improves-survival-in-patients-with-previously-treated-hepatocellular-carcinoma/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/cabozantinib-in-advanced-hepatocellular-cancer/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/nice-yamaguchi-honored-with-iaslc-award/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/ignacio-i-wistuba-receives-iaslc-award/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/nancy-berliner-md-named-next-editor-in-chief-of-blood/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/assay-uses-big-data-to-predict-responses-to-immunotherapy/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/fda-awards-research-grants-in-development-of-treatments-of-rare-diseases-cancers/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/the-opioid-crisis-from-the-oncology-perspective/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/françoise-mornex-honored-with-iaslc-award/ 2019-03-11T16:14:10+00:00 https://ascopost.com/issues/october-25-2018/labeling-act-to-keep-drug-label-information-up-to-date-introduced-to-senate/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/talazoparib-approved-for-brca-mutated-her2-negative-breast-cancer/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/three-scientists-recognized-with-awards-for-distinguished-research-in-tumor-immunology/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/quality-improvement-worth-the-effort-but-not-always-easy-to-execute/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/nih-grants-funding-to-collaboration-for-genomic-research-program/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/aril-chinnaiyan-granted-nci-award/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/cancer-moonshot-awards-grant-to-roswell-park/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/subha-madhavan-named-chief-data-scientist-at-georgetown/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/new-vice-chairs-for-su2c-scientific-advisory-committee-announced/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/cancer-policy-priorities-highlighted-during-2018-asco-advocacy-summit/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/asco-s-conquer-cancer-foundation-launches-national-awareness-campaign/ 2019-03-11T16:14:11+00:00 https://ascopost.com/issues/october-25-2018/the-sontag-foundation/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/help-your-patients-manage-their-weight-with-this-asco-answers-resource/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/asco-rcf-meeting-facilitated-discussion-on-conducting-clinical-trials/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/financial-barriers-impede-patient-participation-in-cancer-clinical-trials/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/ama-awards-research-grants-to-honor-women-in-medicine/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/on-the-frontier-of-breast-cancer-research-with-joyce-a-o-shaughnessy-md/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/overcoming-long-term-health-and-economic-impact-of-cancer-on-young-adult-survivors/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/everolimus-tablets-for-oral-suspension-for-tuberous-sclerosis-complex-associated-partial-onset-seizures/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/has-the-promise-of-precision-medicine-been-oversold/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/big-data-and-breast-cancer-moving-the-field-forward-through-comprehensive-analysis/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/i-m-not-dying-of-cancer-i-m-living-with-cancer/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/humbled-by-challenges-renowned-hematologist-kanti-r-rai-md-recalls-a-rich-career/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/exercise-therapy-for-symptom-management-and-treatment-in-patients-with-cancer/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/friends-of-cancer-research-launches-tumor-mutational-burden-harmonization-project/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/biden-cancer-initiative-supports-lynch-syndrome-research/ 2019-03-11T16:14:12+00:00 https://ascopost.com/issues/october-25-2018/gastric-cancer-foundation-introduces-online-clinical-trials-navigator/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-25-2018/children-s-hospital-of-philadelphia-led-collaboration-launches-first-childhood-disease-research-portal/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-25-2018/many-patients-with-early-stage-follicular-lymphoma-may-not-receive-guideline-recommended-radiation-therapy/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-25-2018/expect-patient-concerns-about-radiation-therapy/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-25-2018/sunitinib-vs-nephrectomy-followed-by-sunitinib-in-metastatic-renal-cell-carcinoma/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-25-2018/meta-analysis-of-patients-with-early-kidney-cancer-treated-with-robotic-partial-nephrectomy/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-25-2018/germline-mutations-in-cancer-susceptibility-genes-in-patients-with-advanced-renal-cell-carcinoma/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-25-2018/philip-j-disaia-md-former-president-society-of-gynecologic-oncology-american-board-of-obstetrics-gynecology-dies-at-81/ 2019-03-11T16:14:13+00:00 https://ascopost.com/issues/october-10-2018/ 2021-06-08T17:57:18+00:00 https://ascopost.com/issues/october-10-2018/update-on-cml/ 2019-03-11T16:14:39+00:00 https://ascopost.com/issues/october-10-2018/relevance-trial-in-follicular-lymphoma/ 2019-03-11T16:14:39+00:00 https://ascopost.com/issues/october-10-2018/wear-that-white-coat-with-pride/ 2019-03-11T16:14:39+00:00 https://ascopost.com/issues/october-10-2018/beat-aml-trial-seeking-to-change-treatment-paradigm/ 2019-03-11T16:14:39+00:00 https://ascopost.com/issues/october-10-2018/durvalumab-improves-overall-survival-in-stage-iii-nsclc/ 2019-03-11T16:14:39+00:00 https://ascopost.com/issues/october-10-2018/neuroendocrine-tumors-new-data-new-options/ 2019-07-11T21:21:14+00:00 https://ascopost.com/issues/october-10-2018/strategies-for-using-anticoagulation-therapy-in-patients-with-cancer/ 2019-03-11T16:14:39+00:00 https://ascopost.com/issues/october-10-2018/vamsidhar-velcheti-joins-nyu-langone/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/aacr-releases-annual-cancer-progress-report/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/fox-chase-appoints-jeffrey-farma/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/baylor-college-of-medicine-welcomes-robert-taylor-ripley/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/lisa-newman-appointed-chief-of-breast-surgery-at-newyork-presbyterian/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/osimertinib-in-first-line-treatment-of-egfr-mutant-metastatic-nsclc/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/rituximablenalidomide-vs-rituximabchemotherapy-in-advanced-untreated-follicular-lymphoma/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/mogamulizumab-improves-progression-free-survival-vs-vorinostat-in-cutaneous-t-cell-lymphoma/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/targeting-ccr4-in-cutaneous-t-cell-lymphoma-the-mavoric-trial/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/mogamulizumab-kpkc-for-mycosis-fungoides-and-sézary-syndrome/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/talazoparib-improves-survival-in-advanced-breast-cancer-with-germline-brca-mutation/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/more-to-learn-about-using-parp-inhibitors-for-advanced-breast-cancer-with-germline-brca-mutation/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/emerging-options-and-sequencing-therapy-in-relapsed-multiple-myeloma/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/how-do-you-know-what-you-don-t-know/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/asco-analysis-finds-pharmacy-benefit-manager-practices-may-erode-patient-access-to-care/ 2019-03-11T16:14:40+00:00 https://ascopost.com/issues/october-10-2018/cancernet-information-for-patients-and-caregivers-useful-tools-for-providers/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/conquer-cancer-podcast-series-goes-unscripted-with-doctors-patients-and-caregivers/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/asco-quality-training-program-reaches-over-100-team-milestone/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/updated-asco-answers-fact-sheets-for-your-practice/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/tony-mok-wins-esmo-lifetime-achievement-award/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/pasi-jaenne-receives-esmo-translational-research-award/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/cleveland-clinic-researchers-study-cancer-associated-thrombosis/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/fda-approves-duvelisib-in-relapsed-or-refractory-hematologic-malignancies/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/intraoperative-guided-imagery-techniques-in-patients-with-cancer/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/fda-approves-dacomitinib-for-metastatic-nsclc/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/closing-the-gender-divide-in-preference-for-palliative-care/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/james-allison-and-tasuku-honjo-win-nobel-prize-in-physiology-or-medicine/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/a-career-in-breast-cancer-research-for-jennifer-litton/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/helping-survivors-of-cancer-to-move-forward/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/charles-swanton-receives-iaslc-award/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/rucaparib-for-maintenance-treatment-of-gynecologic-cancers/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/on-aging-and-the-wellness-industry/ 2019-03-11T16:14:41+00:00 https://ascopost.com/issues/october-10-2018/learning-to-listen-and-returning-to-the-art-of-medicine/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/accc-grants-2018-innovator-awards/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/clinical-trials-on-targeted-therapy-for-her2-positive-breast-cancer/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/living-a-purposeful-life-is-my-revenge-on-cancer/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/monthly-vitamin-d-and-cancer-risk/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/analgesics-and-ovarian-cancer-survival/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/niraparib-maintenance-therapy-in-recurrent-ovarian-cancer/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/eva-koziolek-wins-fmflc-iaslc-award/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/radiation-oncology-pioneer-moody-wharam-dies/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/proton-therapy-leader-james-d-cox-dies/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/october-10-2018/a-pathologic-fascination-with-humanity/ 2019-03-11T16:14:42+00:00 https://ascopost.com/issues/september-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/september-10-2018/encorafenib-and-binimetinib-in-braf-mutant-melanoma/ 2019-03-11T16:16:41+00:00 https://ascopost.com/issues/september-10-2018/implications-of-the-prosper-trial/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/if-it-isn-t-documented-does-it-count/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/optimizing-salvage-therapy-in-hodgkin-lymphoma/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/complexity-of-genomic-testing-in-nhl/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/fda-approval-in-waldenstroems-macroglobulinemia/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/nimotuzumab-and-chemoradiation-in-locally-advanced-head-and-neck-cancer/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/recent-drug-approvals-and-revisions-in-prescribing-information/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/epacadostat-plus-pembrolizumab-in-advanced-melanoma/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/cardiac-issues-related-to-checkpoint-inhibitors-still-largely-understudied/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/epov-ian-olver/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/researchers-receive-albany-medical-center-prize/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/suboptimal-use-of-initial-chemotherapy-in-newly-diagnosed-aml/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/where-should-chemotherapy-for-aml-be-given/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/ana-maría-lópez-becomes-chief-of-cancer-services-at-sidney-kimmel/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/pershing-square-sohn-cancer-research-prize/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/brian-capell-receives-award-for-skin-cancer-research/ 2019-03-11T16:16:42+00:00 https://ascopost.com/issues/september-10-2018/challenges-of-managing-older-patients-with-dlbcl/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/expanding-the-use-of-provider-orders-for-life-sustaining-treatment/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/male-breast-cancer-an-understudied-malignancy/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/georgetown-launches-open-access-brain-cancer-biomedical-database/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/leora-horn-recalls-her-journey-to-a-career-in-oncology/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/actively-recruiting-clinical-trials-focused-on-thyroid-cancer/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/asco-leadership-development-program/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/cory-wiegert-named-new-ceo-of-cancerlinq-llc/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/applying-for-a-conquer-cancer-research-grant/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/conquer-cancer-podcast-series-goes-unscripted/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/2018-advocacy-summit/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/asco-answers-palliative-care/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/bringing-together-industry-academia-nonprofits-to-advance-breast-cancer-research/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/active-surveillance-of-nodules-may-reduce-unnecessary-surgery-and-overtreatment/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/improving-the-lives-of-patients-with-cancer/ 2019-03-11T16:16:43+00:00 https://ascopost.com/issues/september-10-2018/cancer-on-the-global-stage-barbados/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/first-large-scale-survey-of-apps-in-oncology/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/andrea-hayes-jordan-joins-university-of-north-carolina/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/ipilimumab-in-combination-with-nivolumab-for-colorectal-cancer/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/love-in-the-time-of-cancer/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/a-daughter-struggles-through-her-fathers-battle-with-cancer/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/nccn-publishes-new-guidelines-for-rare-cancers-associated-with-pregnancy/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/cheryl-lyn-walker-receives-award/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/ribociclib-in-advanced-breast-cancer/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/ronald-alvarez-elected-to-abog-board-of-directors/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/e-john-wherry-named-chair-of-systems-pharmacology/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/kristen-whitaker-joins-fox-chase/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/karen-e-knudsen-named-president-elect-of-aaci-board-of-directors/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/coriolus-versicolor/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/nccn-and-caoh-develop-guidelines/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/erratum/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/a-story-of-a-mother-and-daughter-and-cancer/ 2019-03-11T16:16:44+00:00 https://ascopost.com/issues/september-10-2018/trametinib-treatment-for-histiocytic-sarcoma/ 2019-03-11T16:16:45+00:00 https://ascopost.com/issues/september-10-2018/pdl1-amplification-in-solid-tumors/ 2019-03-11T16:16:45+00:00 https://ascopost.com/issues/september-10-2018/outcomes-after-discontinuation-of-inhibitor-therapy-in-cml/ 2019-03-11T16:16:45+00:00 https://ascopost.com/issues/september-10-2018/every-day-is-a-bonus/ 2019-03-11T16:16:45+00:00 https://ascopost.com/issues/september-10-2018/prostate-cancer-foundation-and-movember-foundation-announce-winners/ 2019-03-11T16:16:45+00:00 https://ascopost.com/issues/september-10-2018/oncology-organizations-remember-senator-john-mccain/ 2019-03-11T16:16:45+00:00 https://ascopost.com/issues/september-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/september-25-2018/cabozantinib-in-hepatocellular-carcinoma/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/treatment-of-breast-cancer-with-brca12-mutations/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/an-invitation-to-be-quiet-no-longer/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/update-on-clinical-trials-of-novel-therapies/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/durable-response-with-venetoclax-and-azacitidine-in-elderly-patients-with-aml/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/pembrolizumab-in-large-b-cell-lymphoma/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/durable-responses-with-moxetumomab-pasudotox-in-pretreated-hairy-cell-leukemia/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/actively-recruiting-clinical-trials-focused-on-prostate-cancer/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/addition-of-bevacizumab-to-neoadjuvant-therapy-in-breast-cancer/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/ash-honors-ross-l-levine-md/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/pembrolizumab-for-advanced-cervical-cancer/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/maintenance-therapy-for-metastatic-colorectal-cancer/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/car-t-cell-therapy-for-cll/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/new-laws-limiting-opioid-prescriptions-create-undue-barriers/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/are-e-cigarettes-a-dangerous-alternative-to-traditional-cigarettes/ 2019-03-11T16:15:23+00:00 https://ascopost.com/issues/september-25-2018/actively-recruiting-clinical-trials-focused-on-gynecologic-cancers/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/wally-curran-reflects-on-a-career-in-academic-oncology/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/meet-your-asco-president-elect-howard-burris/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/medicaid-work-requirements-could-reduce-access-to-cancer-care/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/asco-answers-guide-to-small-cell-lung-cancer/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/dr-zhang-takes-on-lung-cancer/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/asco-and-friends-of-cancer-research-submit-recommendations-to-fda-aimed-at-reducing-barriers-to-clinical-trial-participation/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/asco-journals-editorial-fellowship/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/pcf-young-investigator-award-recipients/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/different-perspectives-on-cost-and-value-in-cancer-care/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/care-for-the-cancer-caregiver/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/abiraterone-acetate-plus-prednisone-in-prostate-cancer/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/dod-grant-to-prostate-cancer-researchers/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/r-lor-randall-appointed-chair-at-uc-davis-health/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/brave-journey-home/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/lasker-foundation-announces-2018-awards/ 2019-03-11T16:15:24+00:00 https://ascopost.com/issues/september-25-2018/effort-to-raise-awareness-for-egfr-positive-lung-cancer/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/american-oncology-network-welcomes-two-cancer-centers/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/beth-lenegan-elected-to-board-of-national-association-of-catholic-chaplains/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/mayo-clinic-physicians-receive-su2c-award-for-melanoma-research/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/educating-nps-on-the-care-of-older-patients-in-a-comprehensive-cancer-center/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/pertuzumab-in-adjuvant-treatment-of-her2-positive-breast-cancer/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/a-journey-through-the-immune-system/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/cancer-doesnt-frighten-me/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/mutations-in-five-genes-linked-to-higher-lifetime-risks-for-aggressive-breast-cancer/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/expect-questions-about-genetic-testing-for-breast-cancer/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/cprit-grants-research-awards/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/second-allogeneic-hct-vs-donor-lymphocyte-infusion-in-relapsed-aml/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/neoadjuvant-therapy-changes-in-body-composition-and-resectability-in-pancreatic-cancer/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/triplet-combination-for-advanced-anal-squamous-cell-carcinoma/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/tgfβ-polymorphism-and-radiation-induced-fibrosis-in-breast-cancer/ 2019-03-11T16:15:25+00:00 https://ascopost.com/issues/september-25-2018/omission-of-axillary-dissection-in-early-breast-cancer/ 2019-03-11T16:15:26+00:00 https://ascopost.com/issues/september-25-2018/fda-approves-moxetumomab-pasudotox-tdfk-for-the-treatment-of-hcl/ 2019-03-11T16:15:26+00:00 https://ascopost.com/issues/september-25-2018/david-j-sugarbaker-dies-at-65/ 2019-03-11T16:15:26+00:00 https://ascopost.com/issues/august-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/august-25-2018/for-hodgkin-lymphoma-pd-1-blockade-is-not-the-final-answer/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/unraveling-the-mystery-of-what-gives-exceptional-responders-their-superpower/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/medical-marijuana-research-not-anecdotes/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/venetoclax-and-beyond-successfully-targeting-bcl2/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/first-james-o-armitage-clinical-investigator-award/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/fda-approves-mogamulizumab-kpkc/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/value-in-cancer-care-depends-on-perspective/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/therapeutic-applications-for-cannabinoids-in-oncology/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/cannabinoids-for-cancer-pain/ 2019-03-11T16:18:00+00:00 https://ascopost.com/issues/august-25-2018/expert-point-of-view-ian-olver/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/nccn-summit-examines-access-to-high-quality-cancer-care/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/breast-reconstruction/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/be-prepared-to-assist-patients-to-make-informed-decisions-about-breast-reconstruction-options/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/university-of-pittsburgh-medical-center-to-assist-cancer-center-in-beijing/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/enzalutamide-in-nonmetastatic-castration-resistant-prostate-cancer/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/obesity-and-cancer-complex-interplay-of-multiple-factors/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/aacr-appoints-new-editors-in-chief-of-cancer-prevention-research/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/daratumumab-in-newly-diagnosed-transplant-ineligible-multiple-myeloma/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/breast-cancer-surgeon-hannah-hazard-jenkins-md/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/inaugural-award-recipient-studies-potential-of-he4-blockade/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/new-tool-for-assessing-frailty-predicts-survival-in-newly-diagnosed-multiple-myeloma/ 2020-09-24T01:25:30+00:00 https://ascopost.com/issues/august-25-2018/2019-physician-fee-schedule-and-quality-payment-program-proposed-rules-released/ 2020-09-24T01:22:11+00:00 https://ascopost.com/issues/august-25-2018/a-new-way-to-contribute-to-research/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/asco-resource-to-help-patients-quit-tobacco/ 2020-09-24T01:22:57+00:00 https://ascopost.com/issues/august-25-2018/don-t-forget-to-register-for-asco-s-research-community-forum-annual-meeting/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/asco-myconnection/ 2019-03-11T16:18:01+00:00 https://ascopost.com/issues/august-25-2018/asco-university-certificate-programs-for-advanced-practitioners/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/step-therapy-creates-barriers-to-care-for-medicare-advantage-beneficiaries/ 2020-09-24T01:27:19+00:00 https://ascopost.com/issues/august-25-2018/nccn-publishes-guidelines-for-gestational-trophoblastic-neoplasia/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/smartie-initiative-for-aps-recognized-by-alliance-for-continuing-education/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/psycho-oncology-as-an-emerging-field/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/ivosidenib-for-relapsed-or-refractory-aml/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/blinatumomab-in-b-cell-precursor-all/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/oncofertility/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/a-firsthand-account-of-cancer-and-mental-illness/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/focus-on-the-empire-state-hematology-oncology-society/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/i-am-too-young-for-breast-cancer/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/on-not-being-ready/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/matthew-ingham-joins-bwh/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/fox-chase-cancer-center-welcomes-shreyas-joshi/ 2019-03-11T16:18:02+00:00 https://ascopost.com/issues/august-25-2018/erbb2-erbb3-mutant-colorectal-cancer/ 2019-03-11T16:18:03+00:00 https://ascopost.com/issues/august-25-2018/cutaneous-scc-of-the-lip-and-risk-of-nodal-metastasis/ 2019-03-11T16:18:03+00:00 https://ascopost.com/issues/august-25-2018/activity-of-t-cells-in-metastatic-melanoma-resistant-to-immune-checkpoint-inhibitor-treatment/ 2019-03-11T16:18:03+00:00 https://ascopost.com/issues/august-25-2018/survival-in-male-vs-female-patients-receiving-immune-checkpoint-inhibitors/ 2019-03-11T16:18:03+00:00 https://ascopost.com/issues/august-25-2018/ngr-htnf-combined-with-investigator-choice-of-therapy-in-malignant-pleural-mesothelioma/ 2019-03-11T16:18:03+00:00 https://ascopost.com/issues/august-25-2018/most-oncologists-have-discussed-medical-marijuana-with-patients/ 2019-03-11T16:18:03+00:00 https://ascopost.com/issues/august-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/august-10-2018/enzalutamide-in-nonmetastatic-castration-resistant-prostate-cancer/ 2019-03-11T16:19:37+00:00 https://ascopost.com/issues/august-10-2018/declining-to-participate-in-the-right-to-try-act/ 2019-03-11T16:19:37+00:00 https://ascopost.com/issues/august-10-2018/medical-preparedness-for-nuclear-disaster/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/abiraterone-or-enzalutamide-in-prostate-cancer/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/us-oncology-network-promotes-marcus-neubauer/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/rebecca-yang-joins-atlantic-health-system/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/new-frontiers-in-multiple-myeloma/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/car-t-cell-therapy-in-lymphoma/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/antibody-drug-conjugates-in-lymphoma/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/duration-of-chemoradiotherapy-induced-mucositis-in-hnscc/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/epov-rajesh-lalla/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/tools-to-assess-cancer-related-cognitive-dysfunction/ 2019-03-11T16:19:38+00:00 https://ascopost.com/issues/august-10-2018/frailty-in-newly-diagnosed-multiple-myeloma/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/ensuring-quality-with-pros-and-ehrs/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/encorafenib-in-melanoma-with-braf-mutations/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/neurotoxicities-of-treatment/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/challenges-of-immunotherapy-related-toxicities/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/nutrition-and-physical-activity-guidelines-for-cancer-survivors/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/fda-approves-hpv-test/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/how-to-apply-tailorx/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/cms-proposes-extended-340b-cuts-for-2019/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/american-cancer-society-outlines-blueprint-for-cancer-control-in-the-21st-century/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/abemaciclib-as-initial-therapy-for-hormone-receptor-positive-her2-negative-advanced-or-metastatic-breast-cancer/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/real-world-evidence-gaining-credibility-and-practicality-in-treatment-evaluation/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/academic-oncology-and-industry-offer-the-best-of-both-worlds-for-mace-l-rothenberg-md/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/clinical-cancer-researcher-gini-fleming-md-firmly-believes-in-the-power-of-ideas/ 2019-03-11T16:19:39+00:00 https://ascopost.com/issues/august-10-2018/fda-approves-ivosidenib-for-relapsed-or-refractory-acute-myeloid-leukemia/ 2020-09-23T01:48:31+00:00 https://ascopost.com/issues/august-10-2018/st-baldrick-summer-grant-recipients/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/researchers-at-baylor-awarded-multiple-grants-to-study-treatment-resistance-in-breast-cancer/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/andrea-m-abbott-md-joins-fox-chase-cancer-center/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/acs-commission-on-cancer-announces-outstanding-achievement-awards/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/nccn-announces-new-patient-guideline/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/durvalumab-after-chemoradiation-in-unresectable-nsclc/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/reishi-mushroom/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/following-a-healthy-diet-and-avoiding-alcohol-may-reduce-overall-cancer-risk/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/fda-expands-ribociclib-indication-in-breast-cancer/ 2020-09-23T01:47:13+00:00 https://ascopost.com/issues/august-10-2018/cedars-sinai-affiliate-announces-new-cancer-center/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/is-universal-health-care-a-human-right/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/fda-approves-first-treatment-for-rare-adrenal-tumors/ 2020-09-23T01:46:09+00:00 https://ascopost.com/issues/august-10-2018/nih-and-prostate-cancer-foundation-launch-study-on-prostate-cancer/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/the-story-of-a-notorious-cluster-of-childhood-cancers/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/a-celebrity-gadfly-s-reflections-on-his-death-and-other-things-meant-to-irritate/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/is-some-dna-worthless/ 2019-03-11T16:19:40+00:00 https://ascopost.com/issues/august-10-2018/risk-of-breast-cancer-after-negative-screening-mammography/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/cxcr4-antagonist-plus-eribulin-in-her2-negative-metastatic-breast-cancer/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/braf-mutations-survival-and-recurrence-in-colorectal-cancer-liver-metastases/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/my-incidentally-discovered-cancer/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/asco-annual-meeting-merit-awards/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/ama-house-of-delegates-adopt-asco-resolutions/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/asco-answers-guide-to-prostate-cancer/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/un-disease-burden/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/august-10-2018/live-to-conquer-cancer/ 2019-03-11T16:19:41+00:00 https://ascopost.com/issues/july-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/july-25-2018/neoadjuvant-chemoradiotherapy-may-improve-outcomes-in-pancreatic-cancer/ 2020-09-16T13:19:44+00:00 https://ascopost.com/issues/july-25-2018/epov-colin-weekes-and-manish-a-shah/ 2020-09-16T13:19:22+00:00 https://ascopost.com/issues/july-25-2018/immunotherapy-in-merkel-cell-carcinoma/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/epov-selma-ugurel/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/8-year-update-of-soft-and-text-trials/ 2019-08-06T17:34:18+00:00 https://ascopost.com/issues/july-25-2018/atezolizumab-plus-chemotherapy-extends-survival-in-squamous-nsclc/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/epov-david-graham-and-richard-schilsky/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/msi-high-status-and-lynch-syndrome/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/epov-shannon-westin/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/oral-taxane-shows-strong-activity-and-good-tolerability-in-metastatic-breast-cancer/ 2021-03-24T21:04:00+00:00 https://ascopost.com/issues/july-25-2018/nivolumab-plus-ipilimumab-approved-for-metastatic-colorectal-cancer/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/short-takes-on-current-cancer-research/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/update-on-breast-cancer-research/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/gender-disparities-in-head-and-neck-cancer/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/nci-and-va-launch-navigate/ 2019-03-11T16:20:42+00:00 https://ascopost.com/issues/july-25-2018/nccn-releases-new-guidelines-for-patients-with-aml/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/early-detection-of-metastatic-disease-routine-surveillance/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/loren-rourke-joins-us-oncology-network/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/when-can-patients-with-gleason-6-prostate-cancer-safely-undergo-active-surveillance/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/new-lungevity-foundation-campaign-launched/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/pooja-ghatalia-joins-fox-chase-cancer-center/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/opportunities-issues-and-challenges-for-biosimilars-in-oncology/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/no-survival-benefit-for-atezolizumab-in-pd-l1-positive-urothelial-cancer/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/pegfilgrastim-jmdb-as-biosimilar-to-pegfilgrastim/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/is-a-value-based-health-care-delivery-system-feasible/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/asco-conquer-cancer-congratulate-2018-grant-and-award-recipients/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/jop-launches-new-blog/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/correction/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/compassionate-asco-print-resource-for-families-facing-serious-illness/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/fda-approves-enzalutamide-for-crpc/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/four-generations-of-doctors-one-oncologist/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/abiraterone-plus-prednisone-in-prostate-cancer/ 2019-03-11T16:20:43+00:00 https://ascopost.com/issues/july-25-2018/who-classification-essential-thrombocythemia/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/answers-to-hematology-expert-review-questions/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/olaparib-for-germline-brca-mutated-metastatic-breast-cancer/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/acupressure-for-cancer-related-fatigue/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/aap-welcomes-stephen-forman-as-honorary-member/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/eric-tetzlaff-receives-aapa-publishing-award/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/guidelines-for-integrative-therapies-during-and-after-breast-cancer-treatment/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/questions-about-integrative-therapy/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/bevacizumab-plus-chemotherapy-in-advanced-ovarian-cancer/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/new-journal-advances-in-cell-and-gene-therapy-now-available/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/multiple-gene-sequencing-vs-brca-alone-testing/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/circulating-tumor-cells-and-adjuvant-radiotherapy-in-early-breast-cancer/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/risk-of-breast-cancer-after-negative-screening-mammography/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/long-term-follow-up-of-des-related-vaginal-and-cervical-clear-cell-adenocarcinoma/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/immunotherapy-gave-me-back-my-life/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/pseudosophisticated-language-and-needless-confusion/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/nimhd-minority-health-and-health-disparities-research-innovation-award/ 2019-03-11T16:20:44+00:00 https://ascopost.com/issues/july-25-2018/alan-rabson-dies-at-age-92/ 2019-03-11T16:20:45+00:00 https://ascopost.com/issues/july-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/july-10-2018/keynote-407-pembrolizumab-plus-chemotherapy-in-squamous-nsclc/ 2019-03-11T16:22:49+00:00 https://ascopost.com/issues/july-10-2018/epov-charles-drake/ 2019-03-11T16:22:49+00:00 https://ascopost.com/issues/july-10-2018/with-compassion-toward-none-with-technology-for-all/ 2019-03-11T16:22:49+00:00 https://ascopost.com/issues/july-10-2018/use-of-cdk4-6-inhibitors-in-metastatic-breast-cancer/ 2019-03-11T16:22:49+00:00 https://ascopost.com/issues/july-10-2018/ibrutinib-plus-venetoclax-in-cll/ 2019-03-11T16:22:49+00:00 https://ascopost.com/issues/july-10-2018/epov-susan-obrien-and-bruce-cheson/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/maintenance-therapy-improved-5-year-survival-in-rhabdomyosarcoma/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/epov-warren-chow-and-douglas-hawkins/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/chemotherapy-free-regimen-as-front-line-therapy-for-follicular-lymphoma/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/epov-bruce-cheson/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/benefit-with-immunotherapy-and-chemotherapy-in-nonsquamous-nsclc/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/epov-marina-chiara-garassino-and-justin-gainor/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/genome-sequencing-and-detection-of-early-stage-lung-cancer/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/epov-david-graham/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/study-of-pi3k-inhibitor-added-to-fulvestrant-in-advanced-breast-cancer/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/epov-harold-burstein/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/car-t-cell-therapy-in-heavily-pretreated-patients-with-myeloma/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/epov-parameswaran-hari/ 2019-03-11T16:22:50+00:00 https://ascopost.com/issues/july-10-2018/tlr9-agonist-may-combat-pd1-resistance-in-advanced-melanoma/ 2019-03-11T16:22:51+00:00 https://ascopost.com/issues/july-10-2018/epov-jedd-wolchok-md-phd/ 2019-03-11T16:22:51+00:00 https://ascopost.com/issues/july-10-2018/evidence-builds-for-tumor-mutational-burden-as-biomarker-in-lung-cancer/ 2019-03-11T16:22:51+00:00 https://ascopost.com/issues/july-10-2018/epov-david-rimm/ 2019-03-11T16:22:51+00:00 https://ascopost.com/issues/july-10-2018/outcomes-in-patients-with-melanoma-treated-with-antipd1-antibody-beyond-disease-progression/ 2019-03-11T16:22:52+00:00 https://ascopost.com/issues/july-10-2018/treatment-beyond-disease-progression-in-melanoma/ 2019-10-02T14:29:36+00:00 https://ascopost.com/issues/july-10-2018/carnegie-corporation-honors-antoni-ribas-md/ 2019-03-11T16:22:52+00:00 https://ascopost.com/issues/july-10-2018/mariusz-wasik-joins-fox-chase-as-chair-of-pathology/ 2019-03-11T16:22:52+00:00 https://ascopost.com/issues/july-10-2018/a-humble-beginning-built-on-commitment/ 2019-03-11T16:22:52+00:00 https://ascopost.com/issues/july-10-2018/testicular-cancer-survivors-and-for-long-term-heart-disease/ 2019-03-11T16:22:52+00:00 https://ascopost.com/issues/july-10-2018/outcomes-of-tisagenlecleucel-therapy-in-lymphoblastic-leukemia/ 2019-03-11T16:22:52+00:00 https://ascopost.com/issues/july-10-2018/oncology-care-for-patients-with-intellectual-disabilities/ 2019-03-11T16:22:52+00:00 https://ascopost.com/issues/july-10-2018/financial-impact-of-cancer-on-young-adult-survivors/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/mindfulness-in-cancer-care/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/christine-m-eischen-phd-receives-professorship/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/steven-rosen-inducted-into-aimbe-college-of-fellows/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/marc-e-lippman-returns-to-georgetown-s-cancer-center/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/three-cancer-researchers-share-tang-prize/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/expensive-cancer-drugs/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/a-medical-oncologist-urges-men-to-keep-their-prostates/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/a-conversation-with-the-author/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/fda-approves-encorafenib-and-binimetinib/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/benjamin-djulbegovic-named-director/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/tanya-dorff-joins-city-of-hope/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/oxybutynin-in-prostate-cancer/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/racial-ethnic-disparities-in-end-of-life-care/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/socioeconomic-and-racial-disparities-in-management-of-brain-metastases/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/apalutamide-in-prostate-cancer/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/lessons-in-the-chill-of-early-morning/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/2018-asco-presidential-address-excerpt/ 2019-03-11T16:22:53+00:00 https://ascopost.com/issues/july-10-2018/todays-breakthroughs-require-year-round-support/ 2019-03-11T16:22:54+00:00 https://ascopost.com/issues/july-10-2018/asco-resource-helps-patients-learn-about-cancer-costs/ 2019-03-11T16:22:54+00:00 https://ascopost.com/issues/july-10-2018/asco-health-policy-fellowship-program/ 2019-03-11T16:22:54+00:00 https://ascopost.com/issues/july-10-2018/nci-designated-cancer-centers-goal-of-eliminating-hpv-related-cancers/ 2019-03-11T16:22:54+00:00 https://ascopost.com/issues/june-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/june-25-2018/adjuvant-modified-folfirinox-in-pancreatic-cancer/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/epov-colin-weekes-and-andrew-epstein/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/minimal-residual-disease-testing-in-aml/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/the-raven/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/nephrectomy-may-be-avoided-with-advanced-renal-cell-carcinoma/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/epov-daniel-george-robert-motzer-and-paul-russo/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/neoadjuvant-durvalumab-plus-chemotherapy-in-triple-negative-breast-cancer/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/epov-charles-drake-and-hatem-soliman/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/no-benefit-for-hyperthermic-intraperitoneal-chemotherapy-in-colorectal-cancer/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/epov-andrew-epstein/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/outcomes-in-waldenstroem-s-macroglobulinemia-improved-with-ibrutinib-plus-rituximab/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/epov-kenneth-anderson-adam-cohen-craig-hofmeister-and-bruce-cheson/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/care-for-colorectal-cancer-costs-twice-as-much-in-western-washington-vs-british-columbia/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/epov-richard-schilsky/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/richard-bleicher-appointed-vice-chair/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/esomeprazole-with-aspirin-in-patients-with-barrett-s-esophagus/ 2019-03-11T16:23:48+00:00 https://ascopost.com/issues/june-25-2018/phase-i-study-shows-safety-efficacy-of-ivosidenib-in-acute-myeloid-leukemia/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/epov-amir-fathi-and-eunice-wang/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/optimizing-biologics-in-metastatic-colon-cancer/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/11-new-institutions-join-aacr-project-genie-consortium/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/nivolumab-plus-ipilimumab-improves-survival-in-nsclc/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/epov-naiyer-rizvi/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/asco-clinical-practice-guideline/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/de-novo-metastatic-prostate-cancer/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/prostate-cancer-therapy-in-evolution/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/changes-to-maintenance-of-certification/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/be-counted-complete-the-2018-asco-practice-census-today/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/researchers-can-access-wide-array-of-asco-data-through-centra/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/resilience-while-caring-for-seriously-ill-patients-skills-and-strategies-to-prevent-burnout/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/cancernet-mobile-app/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/asco-research-community-forum-2018-annual-meeting/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/leave-a-legacy-of-hope/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/meet-federal-reporting-requirements-with-qopi-reporting-registry/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/dan-theodorescu-director-of-samuel-oschin-comprehensive-cancer-institute/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/folakemi-odedina-fellowship-for-oncology-clinical-trials-in-africa/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/ajcc-breast-cancer-staging-system-more-clinically-relevant/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/regular-mammograms-linked-to-less-aggressive-treatment/ 2019-03-11T16:23:49+00:00 https://ascopost.com/issues/june-25-2018/epov-julie-margenthaler/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/patients-with-aml-have-reduced-risk-of-early-mortality-at-nci-designated-cancer-centers/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/voluntarily-stopping-eating-and-drinking-is-legal-and-ethical/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/esmo-prioritizes-cancer-care-at-wha/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/bucket-list-may-improve-care/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/steven-rosenberg-receives-acs-jacobson-innovation-award/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/richard-schulick-named-director-of-university-of-colorado-cancer-center/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/love-of-molecular-diagnostics-shapes-a-career-for-valentina-nardi/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/harvard-business-school-launches-initiative-to-accelerate-precision-medicine/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/green-tea/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/clinical-trials-pancreatic-cancer/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/lung-cancer-care-in-united-states-vs-england/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/baylor-grants-to-study-treatment-resistance-in-breast-cancer/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/who-names-st-jude-its-first-collaborating-center-for-childhood-cancer/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/jens-hillengass-named-chief-of-myeloma-at-roswell-park/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/colorectal-cancer-alliance-research-funding/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/proud-to-have-contributed-to-the-fda-approval-of-car-tcell-therapy/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/endangered-art-of-medicine/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/addition-of-tumor-treating-fields-to-maintenance-temozolomide-in-glioblastoma/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/california-trends-in-cancer-survival-by-health-insurance-status/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/bipolar-androgen-therapy-after-disease-progression-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/pembrolizumab-receives-fda-approval-for-lymphoma-and-advanced-cervical-cancer/ 2019-03-11T16:23:50+00:00 https://ascopost.com/issues/june-25-2018/fda-approves-bevacizumab-in-combination-with-chemotherapy-for-ovarian-cancer/ 2019-03-11T16:23:51+00:00 https://ascopost.com/issues/june-25-2018/inside-story-on-the-genesis-of-teen-cancer-america/ 2019-03-11T16:23:51+00:00 https://ascopost.com/issues/june-25-2018/2018-asco-annual-meeting-events-and-highlights/ 2019-03-11T16:23:51+00:00 https://ascopost.com/issues/june-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/june-10-2018/tailorx-endocrine-therapy-alone-in-intermediate-risk-breast-cancer/ 2019-03-19T15:21:09+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-lisa-carey-and-dawn-hershman/ 2019-03-19T15:21:09+00:00 https://ascopost.com/issues/june-10-2018/adherence-to-oral-anticancer-treatment-priorities-in-lymphoma-and-cll/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/pearls-of-wisdom-for-leadership-and-success-in-academic-medicine/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/immunotherapy-vs-platinum-based-chemotherapy-for-pdl1-expressing-nsclc/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-john-heymach-and-leena-gandhi/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/asco-applauds-increased-funding-for-nctn/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/mobile-and-sensor-technology-in-head-and-neck-cancer/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-bruce-johnson/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/despite-uspstf-recommendations-majority-of-heavy-smokers-not-screened-for-lung-cancer/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-bruce-johnson-1/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/upfront-comprehensive-genetic-testing-in-advanced-lung-cancer-is-cost-efficient/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-bruce-johnson-2/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/geriatric-assessment-improves-communication/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-joshua-jones/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/recurrence-rates-after-lumpectomy-significantly-improved-with-modern-era-therapy/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-carla-fisher/ 2019-03-19T15:21:10+00:00 https://ascopost.com/issues/june-10-2018/relevance-of-genetic-testing-guidelines-for-breast-cancer/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-judy-boughey/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/early-detection-and-intervention-reduce-breast-cancer-related-lymphedema/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-sarah-blair/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/durable-responses-observed-with-novel-oncolytic-therapy-in-recurrent-glioma/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/using-neoadjuvant-therapy-in-pancreatic-cancer/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/original-research-quick-takes-at-the-2018-nccn-annual-conference/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/early-treatment-discontinuation-in-patients-receiving-immunotherapy-for-ovarian-cancer/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-oliver-dorigo/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/minimally-invasive-surgery-vs-open-approach-in-early-cervical-cancer/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-shitanshu-uppal/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/restrictive-opioid-protocol-after-gynecologic-surgery/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/early-evidence-of-neoadjuvant-pd1-blockade-in-nsclc/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/expert-point-of-view-john-heymach/ 2019-03-19T15:21:11+00:00 https://ascopost.com/issues/june-10-2018/pembrolizumab-in-metastatic-melanoma/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/checkmate-214/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/nivolumab-plus-ipilimumab-in-advanced-renal-cell-carcinoma/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/hematopoietic-cell-transplantation-for-follicular-lymphoma/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/adolfo-ferrando-joins-advisory-board/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/henry-ford-health-system-launches-pancreatic-cancer-center/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/biospecimen-core-resource-receives-nih-funding/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/aacr-and-cancer-research-uk-form-alliance/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/dabrafenib-plus-trametinib-for-cancers-with-braf-mutations/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/inside-look-at-widowers-coping-with-grief/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/st-baldrick-and-su2c-support-pediatric-cancer-research/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/aamc-study-examines-career-trends-among-graduates/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/tai-chi/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/fda-approves-biosimilar-to-pegfilgrastim/ 2019-03-19T15:21:12+00:00 https://ascopost.com/issues/june-10-2018/the-x-ray-era/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/following-guidelines-for-healthy-eating-and-physical-activity-may-improve-survival/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/when-patients-are-open-to-lifestyle-changes/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/hpv-vaccine-could-have-prevented-my-cancer/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/phase-i-study-of-erk12-inhibitor-in-advanced-solid-tumors/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/does-warfarin-have-anticancer-potential-in-persons-older-than-age-50/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/chemoradiation-in-elderly-patients-with-stage-iii-nsclc-improves-overall-survival/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/addition-of-pazopanib-to-paclitaxel-in-ovarian-cancer/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/hearing-loss/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/astro-asco-conquer-cancer-methods-workshop/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/asco-to-present-douglas-blayney-with-joseph-v-simone-award-and-lecture/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/what-right-to-try-legislation-means-for-practices-and-patients/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/spotlight-on-women-who-conquer-cancer/ 2019-03-19T15:21:13+00:00 https://ascopost.com/issues/june-10-2018/share-asco-answers-fact-sheets-with-your-patients/ 2019-03-19T15:21:14+00:00 https://ascopost.com/issues/june-10-2018/john-cox-reflects-on-10-years-as-editor-in-chief-of-jop/ 2019-03-19T15:21:14+00:00 https://ascopost.com/issues/june-10-2018/ascos-tapur-study-website-updates/ 2019-03-19T15:21:14+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/monica-bertagnolli-becomes-asco-president/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/nancy-l-bartlett-moved-from-engineering-to-medicine/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/asco-honors-leaders-in-cancer-care/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/2018-fellows-of-asco-recognized-during-annual-meeting/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/sir-murray-brennan-a-lifetime-of-accomplishments-in-oncology/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/asco-at-a-glance/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/nccn-names-wui-jin-koh-chief-medical-officer/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/asco-through-the-years-past-presidents/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/pioneering-researcher-and-oncologist-volker-s-diehl/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/asco-abim-collaborate-on-pathway-to-maintenance-of-board-certification/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/nagi-s-el-saghir-returned-home-to-make-a-difference-in-lebanon-and-worldwide/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/husband-and-wife-leave-a-giant-legacy-in-oncology/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/jose-r-germa-lluch-sheds-light-on-treating-rare-tumors/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/a-love-of-older-patients-with-cancer-drives-a-career-path-for-arti-hurria/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/fda-oncology-drug-approvals-granted-between-june-2017-and-may-16-2018/ 2019-07-11T21:19:00+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/new-fellows-selected-for-asco-health-policy-fellowship-program/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/esteemed-career-in-cancer-research-for-razelle-kurzrock/ 2019-03-11T16:24:24+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/education-came-first-for-breast-cancer-expert-beverly-moy/ 2019-03-11T16:24:25+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/nih-completes-genomic-analysis-of-33-cancer-types/ 2019-03-11T16:24:25+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/paved-the-road-to-oncology-for-alice-tsang-shaw/ 2019-03-11T16:24:25+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/narayanankutty-warrier-battles-tobacco-use-and-builds-a-cancer-center-in-india/ 2019-03-11T16:24:25+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/karen-m-winkfield-faced-her-own-barriers/ 2019-03-11T16:24:25+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/conquer-cancer-2018-awards-presented-at-asco-annual-meeting/ 2019-03-11T16:24:25+00:00 https://ascopost.com/issues/june-3-2018-narratives-special-issue/the-asco-post-rememberances-and-tributes/ 2019-03-11T16:24:25+00:00 https://ascopost.com/issues/may-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/may-25-2018/adjuvant-trastuzumab-6-months-is-noninferior-to-12-months/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/epov-william-m-sikov-and-sunil-verma/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/asco-incoming-president-sets-her-goals/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/serving-as-asco-president/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/nelarabine-plus-chemotherapy-improves-survival-in-t-cell-malignancies/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/epov-howard-weinstein-md/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/endocrine-therapy-major-challenges/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/fda-expands-tisagenlecleucel-approval/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/surgery-after-checkpoint-blockade-for-melanoma/ 2019-03-19T15:29:20+00:00 https://ascopost.com/issues/may-25-2018/nccn-2018-guidelines-updates/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/curbing-financial-toxicity/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/pharmacist-role-in-educating-the-health-care-team/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/first-selective-ret-inhibitor-shows-efficacy/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/epov-alexander-drilon/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/new-data-on-alk-inhibitors-and-car-t-cell-therapies/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/ultrahypofractionated-radiotherapy-for-prostate-cancer/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/asco-is-joining-with-other-organizations-to-reduce-obesity-and-cancer-rates/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/robert-m-arnold-receives-award/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/asco-clinical-practice-guideline-immune-related-adverse-events/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/next-big-step-in-immune-checkpoint-inhibitors/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/challenges-in-recognizing-and-reporting-iraes/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/fda-approves-daratumumab-vmp-combination/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/fda-approves-first-epoetin-alfa-biosimilar/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/weighing-the-cost-and-value-of-car-t-cell-therapy/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/treatment-centers-authorized-to-administer-car-t-cell-therapy/ 2020-03-29T22:00:50+00:00 https://ascopost.com/issues/may-25-2018/tisagenlecleucel-for-adults-with-relapsed-or-refractory-lbcl/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/new-leadership-hassenfeld-childrens-hospital/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/leena-gandhi-to-lead-lilly-immuno-oncology/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/new-advisors-and-scholars-in-breast-cancer/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/brentuximab-vedotin-in-stage-iii-iv-classical-hodgkin-lymphoma/ 2019-03-19T15:29:21+00:00 https://ascopost.com/issues/may-25-2018/mri-targeted-vs-standard-biopsy-in-prostate-cancer-diagnosis/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/role-of-mri-in-detection-of-clinically-significant-prostate-cancer/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/baylor-st-lukes-medical-center-establishes-annual-oncology-lecture/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/endowed-yia-gifts-for-ascos-conquer-cancer-foundation/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/four-reasons-to-use-social-media-at-the-asco-annual-meeting/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/register-now-for-the-asco-research-community-forum-2018-annual-meeting/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/what-to-download-and-where-to-shop-dine-and-network-at-asco18/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/enhance-your-annual-meeting-experience-with-attendee-resources/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/new-updates-to-common-rule-for-researchers/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/apply-for-the-alexandria-quality-training-program-session/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/help-your-patients-catch-up-on-the-latest-research/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/award-recipients-for-translational-clinical-protocol-development/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/update-on-atlas-trial-of-axitinib-for-rcc-recurrence-risk/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/hyperthermic-intraperitoneal-chemotherapy-plus-cytoreductive-surgery-in-advanced-ovarian-cancer/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/debate-over-intraperitoneal-chemotherapy-in-newly-diagnosed-advanced-ovarian-cancer/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/cisplatin-chemoradiation-course-in-locally-advanced-head-and-neck-cancer/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/targeted-sequencing-detection-of-mmrd-and-prognosis-in-aml/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/mmrd-detection-shows-further-promise-in-aml/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/st-jude-cloud-launched-for-researchers-worldwide/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/closing-the-gap-in-oncology-care-for-ayas/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/new-international-translations-of-nccn-guidelines-for-patients/ 2019-03-19T15:29:22+00:00 https://ascopost.com/issues/may-25-2018/accp-statement-on-organ-impaired-patients-in-oncology-trials/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/fccs-awarded-funds-to-minimize-disparities-in-pancreatic-cancer/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/evidence-informed-approach-to-lifestyle-and-behavior-change/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/treating-insomnia-in-cancer-survivors/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/focus-on-the-tennessee-oncology-practice-society/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/james-allison-perseverance-and-hard-science-in-cancer-research/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/logistics-of-car-t-cell-therapy-in-real-world-practice/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/su2c-precursor-conditions-of-multiple-myeloma/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/malignant-pleural-mesothelioma-asco-clinical-practice-guideline/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/visible-ink-celebrates-10-years-of-live-patient-performances/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/antoni-ribas-research-in-cancer-immunology/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/cancer-support-community-executive-director-of-research-and-training-institute/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/stage-iv-lung-cancer-climbing-mera-peak/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/acs-research-and-training-grants/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/acs-and-mra-fund-immunotherapy-research/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/aacr-scientific-achievement-awards-lectureships/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/american-skin-association-award-for-skin-cancer-research/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/hormonal-contraception-and-breast-cancer-risk/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/tils-prognosis-in-breast-cancer-subtypes/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/metastatic-lymph-nodes-and-survival-hypopharyngeal-laryngeal-cancer/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/recurrence-stage-iii-colon-cancer-ras-braf-mutation-status/ 2019-03-19T15:29:23+00:00 https://ascopost.com/issues/may-25-2018/asco-launches-its-education-scholars-program/ 2019-03-19T15:29:24+00:00 https://ascopost.com/issues/may-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/may-10-2018/evolving-standards-and-quality-metrics-in-cancer-programs/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/minimal-residual-disease-in-aml/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/pembrolizumab-plus-chemotherapy-in-newly-diagnosed-nsclc/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/epov-roy-herbst/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/adjuvant-pembrolizumab-improves-rfs-in-melanoma/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/epov-antoni-ribas/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/nccn-debuts-three-new-sets-of-guidelines/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/can-some-patients-with-early-breast-cancer-avoid-surgery/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/aacr-special-recognition-awards/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/ctdna-treatment-intensity-in-hpv-head-and-neck-cancers/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/microenvironment-heterogeneity-and-immunotherapy-in-ovarian-cancer/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/epov-oliver-dorigo/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/followup-in-ovarian-cancer-and-gynecologic-malignancies/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/patient-attitude-and-fears-of-gynecologic-cancer-recurrence/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/obesity-in-cancer-survivors/ 2019-03-11T16:24:43+00:00 https://ascopost.com/issues/may-10-2018/nonmelanoma-skin-cancer-clinical-trials/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/sentinel-lymph-node-biopsy-melanoma-asco-sso/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/fundamental-clinical-questions-on-sentinel-lymph-node-biopsy-in-melanoma/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/coa-practice-impact-report/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/potential-adverse-effects-of-oral-chemotherapy/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/oncology-pharmacist-and-the-healthcare-team/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/aacr-welcomes-new-leadership-at-2018-annual-meeting/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/afatinib-in-egfr-mutated-metastatic-nsclc/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/new-laws-reduce-costs-of-oral-cancer-drugs/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/melanoma-research-alliance-grants/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/first-line-therapy-in-clear-cell-kidney-cancer/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/exciting-yet-challenging-time-for-renal-cancer-therapeutics/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/nilotinib-label-updated-for-cml/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/end-of-life-discussions-with-patients/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/rising-psa-in-men-with-castrate-androgen-levels/ 2019-03-11T16:24:44+00:00 https://ascopost.com/issues/may-10-2018/editor-s-note/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/nivolumab-in-adjuvant-treatment-of-melanoma/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/decision-aids-reflect-patients-values-and-preferences-for-care/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/linda-bosserman-named-editor-in-chief-of-jop/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/primo-nery-lara-appointed-director-of-uc-davis-ccc/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/agnieszka-witkiewicz-appointed-director-at-roswell-park/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/chamomile/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/foundation-awards-7m-to-immunotherapy-research/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/doctoring-is-a-family-tradition/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/spring/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/bone-modifying-agents-in-multiple-myeloma/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/modern-techniques-and-side-effects-in-breast-cancer-radiotherapy/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/radiotherapy-for-breast-cancer/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/desmoplastic-melanoma-highly-responsive-to-pd-1pd-l1-blockade/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/durvalumab-in-urothelial-carcinoma/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/hpv-related-cancers-are-avoidable/ 2019-03-11T16:24:45+00:00 https://ascopost.com/issues/may-10-2018/fda-approves-drug-combination-for-melanoma/ 2019-03-11T16:24:46+00:00 https://ascopost.com/issues/may-10-2018/asco-socca/ 2019-03-11T16:24:46+00:00 https://ascopost.com/issues/may-10-2018/state-level-cancer-policy-priorities-advocacy/ 2019-03-11T16:24:46+00:00 https://ascopost.com/issues/may-10-2018/thriving-at-your-first-asco-annual-meeting/ 2019-03-11T16:24:46+00:00 https://ascopost.com/issues/may-10-2018/listen-now-to-remembering-dad/ 2019-03-11T16:24:46+00:00 https://ascopost.com/issues/april-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/april-25-2018/2018-treatment-algorithm-for-metastatic-her2-positive-breast-cancer/ 2019-03-19T15:30:24+00:00 https://ascopost.com/issues/april-25-2018/zuma-1-trial-car-t-cell-therapy-for-lymphoma/ 2019-03-19T15:30:24+00:00 https://ascopost.com/issues/april-25-2018/cost-of-failure-to-screen-smokers-for-lung-nodules/ 2019-03-19T15:30:24+00:00 https://ascopost.com/issues/april-25-2018/radiation-in-head-and-neck-cancers-after-induction-chemotherapy/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/suicide-risk-among-head-and-neck-cancer-survivors/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/epov-christopher-j-recklitis/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/arm-mobility-after-lymph-node-dissection-in-women-with-breast-cancer/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/epov-timothy-gilligan-md-msc/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/efforts-to-make-tobacco-cessation-in-survivors-standard-practice/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/long-term-psychosocial-care-for-cancer-survivors/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/apos-welcomes-new-president-president-elect/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/leslie-bernstein-receives-aacr-acs-award/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/randi-cohen-joins-fox-chase-cancer-center/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/elaine-mardis-named-aacr-president-elect/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/scott-weir-recipient-of-janet-davison-rowley-patient-impact-research-award/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/distress-screening-underestimated-by-cancer-specialists/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/talazoparib-reduces-risk-of-progression-in-brca-mutated-breast-cancer/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/epov-c-kent-osborne-md/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/modest-weight-loss-reduces-breast-cancer-risk/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/epov-marisa-weiss-md/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/fine-tuning-treatment-in-myeloma-and-leukemia/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/asco-honors-leaders-in-cancer-care/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/educate-on-safe-storage-and-disposal-of-pain-medications/ 2019-03-19T15:30:25+00:00 https://ascopost.com/issues/april-25-2018/asco-launches-website-on-the-business-of-oncology/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/quality-payment-program-asco-s-top-10/ 2020-09-18T20:41:21+00:00 https://ascopost.com/issues/april-25-2018/an-inspiring-experience-at-cancer-control-for-primary-care-course-in-bhutan/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/axicabtagene-ciloleucel-car-t-cell-therapy-active-in-lymphoma/ 2020-09-18T20:36:14+00:00 https://ascopost.com/issues/april-25-2018/wendy-harpham-writes-gift-book-about-hope-for-ca-survivors/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/nut-consumption-in-patients-with-colon-cancer/ 2020-09-18T20:37:51+00:00 https://ascopost.com/issues/april-25-2018/xiang-zhang-sue-eccles-young-investigator-award/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/nih-completes-in-depth-genomic-analysis/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/a-career-based-on-service-both-medical-and-military/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/clinicians-guide-to-glioblastoma/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/aacr-announces-2018-class-of-fellows/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/updated-nccn-guidelines-for-newly-diagnosed-glioblastoma/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/skin-cancer-foundation-awards-research-grants/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/nccn-honors-global-cancer-care/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/updated-international-myeloma-working-group-criteria-diagnostic-challenges/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/massage-therapy-for-patients-with-cancer/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/fabrice-barlesi-heine-hansen-award/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/neuroendocrine-tumor-research-foundation-grants/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/pembrolizumab-vs-ipilimumab-in-advanced-melanoma/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/immune-related-toxicity-with-combination-immunotherapy-for-melanoma/ 2019-03-19T15:30:26+00:00 https://ascopost.com/issues/april-25-2018/cooperative-group-trial-pioneer-james-holland-dies/ 2019-03-19T15:30:27+00:00 https://ascopost.com/issues/april-25-2018/asco-remembers-patient-advocate-karen-durham/ 2019-03-19T15:30:27+00:00 https://ascopost.com/issues/april-25-2018/woolmark-and-fisher-honored-for-leadership-of-nsabp/ 2019-03-19T15:30:27+00:00 https://ascopost.com/issues/april-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/april-10-2018/a-tribute-to-two-amazing-scientists/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/encorafenib-plus-binimetinib-in-braf-melanoma/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/potent-anti-her2-agents-on-the-horizon/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/delays-in-radiation-therapy-for-head-and-neck-cancer/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/epov-francis-worden/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/durvalumab-in-recurrent-metastatic-head-and-neck-cancer/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/epov-young-jun-kim/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/panitumumab-based-contrast-agent-in-head-and-neck-cancer-surgery/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/intratumor-heterogeneity-of-head-and-neck-cancers/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/epov-young-jun-kim-1/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/gu-symposium-focuses/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/vinflunine-may-benefit-selected-patients-with-penile-cancer/ 2019-03-11T16:25:11+00:00 https://ascopost.com/issues/april-10-2018/epov-aaron-richard-hansen/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/how-will-ctdna-assays-aid-in-managing-breast-cancer/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/destroy-pancreatic-cancer-donates-1-million-for-unique-trial/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/edward-wolin-director-of-center-for-carcinoid-and-neuroendocrine-tumors/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/samuel-waxman-cancer-research-foundation-research-grant/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/greater-understanding-of-family-dynamics/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/fda-approval-of-brentuximab-vedotin/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/four-years-posttreatment-exercise/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/epov-timothy-gilligan/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/emerging-thoughts-about-the-immune-landscape-in-pancreatic-cancer/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/2018-gastrointestinal-cancers-symposium/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/future-treatment-of-cholangiocarcinoma/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/medical-director-of-community-oncology-alliance/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/breast-cancer-specialist-hernan-vargas/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/maura-dickler-lilly-oncology/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/car-tcell-therapy-standard-of-care-in-lymphoma/ 2019-03-11T16:25:12+00:00 https://ascopost.com/issues/april-10-2018/how-to-respond-to-a-discriminatory-request-for-a-different-clinician/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/aacr-launches-initiative/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/sarcoma-foundation-of-america-ccf/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/ccf-iig-idea-awards/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/asco-professional-resources-pain-management/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/updated-asco-answers-guides/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/conqueror-in-action-kurtz/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/business-of-oncology/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/inaugural-content-collection-jco-cci/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/acupuncture-for-joint-pain-associated-with-aromatase-inhibition/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/epov-kathryn-ruddy/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/unstoppable/ 2020-09-17T20:19:33+00:00 https://ascopost.com/issues/april-10-2018/solid-organ-transplantation-and-lymphoma/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/clinical-trials-cancer-prevention/ 2020-09-17T20:15:47+00:00 https://ascopost.com/issues/april-10-2018/challenge-to-defeat-cervical-cancer/ 2019-03-11T16:25:13+00:00 https://ascopost.com/issues/april-10-2018/yale-cancer-center-launches-immunooncology-center/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/huda-zoghbi-ross-prize/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/james-wittig-atlantic-health-system/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/aacr-welcomes-new-leadership/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/extended-duration-of-aromatase-inhibitors/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/more-on-the-abcsg-16-trial/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/fda-expands-nilotinib-indication/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/nccn-adopts-new-web-based-software/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/thomas-gallo-accc-president/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/asco-commends-congress-for-nih-funding/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/undefeated/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/physician-patient-partnership-is-key-to-managing-side-effects/ 2020-09-17T20:18:20+00:00 https://ascopost.com/issues/april-10-2018/encourage-patients-report-immunotherapy-side-effects/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/the-clinical-significance-of-clinicaltrialsgov/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/btk-inhibitor-relapsed-refractory-mantle-cell-lymphoma/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/venetoclax-chronic-lymphocytic-leukemia-after-ibrutinib/ 2019-03-11T16:25:14+00:00 https://ascopost.com/issues/april-10-2018/cardiovascular-toxicity-carfilzomib-multiple-myeloma/ 2019-03-11T16:25:15+00:00 https://ascopost.com/issues/april-10-2018/brentuximab-vedotin-bendamustine-relapsed-refractory-hodgkin-lymphoma/ 2019-03-11T16:25:15+00:00 https://ascopost.com/issues/april-10-2018/in-remembrance-of-james-holland/ 2019-03-11T16:25:15+00:00 https://ascopost.com/issues/march-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/march-25-2018/cabozantinib-therapy-shows-activity-in-differentiated-thyroid-cancer/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-francis-p-worden-md/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/asco-names-car-t-cell-immunotherapy-its-clinical-advance-of-the-year/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/why-right-to-try-laws-are-dangerous/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/pembrolizumab-survival-advantage-upheld-in-advanced-urothelial-carcinoma/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-robert-jones-md-phd/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/positive-preliminary-data-seen-for-axitinib-plus-pembrolizumab-in-renal-cell-carcinoma/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-sumanta-k-pal-md/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/small-study-evaluates-novel-combination-in-metastatic-prostate-cancer/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-robert-bruce-montgomery-md/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/cancer-drug-development-award-given-to-jean-charles-soria-md-phd/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/targetable-immune-biology-found-in-some-patients-with-early-stage-prostate-cancer/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-ezra-cohen-md-phd/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/testing-for-pd-l1-amplification-may-help-predict-response-to-immune-checkpoint-blockade-in-solid-tumors/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-ravindra-uppaluri-md-phd/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/trivalent-car-t-cell-design-may-enhance-antitumor-efficacy-in-acute-lymphoblastic-leukemia/ 2019-03-11T16:25:41+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-malcolm-k-brenner-md-phd/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/studies-explore-colon-tumor-sidedness-lung-radiation-dose-in-esophageal-cancer-pembrolizumab-in-liver-cancer-and-more/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/triplet-therapy-poses-a-triple-threat-to-braf-mutated-colorectal-cancers/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/impact-of-lifestyle-choices-on-outcomes-in-survivors-of-gastrointestinal-cancers/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/ashwagandha/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/martin-s-tallman-md-joins-samuel-waxman-cancer-research-foundation-s-scientific-advisory-board/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/frederick-national-laboratory-and-georgetown-university-launch-research-collaboration/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/new-nccn-guidelines-aim-to-encourage-more-people-living-with-hiv-and-cancer-to-receive-appropriate-cancer-treatment/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/conquer-cancer-foundation-recognizes-70-young-oncology-researchers-findings-with-merit-awards/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/asco-advocate-of-the-year-stresses-importance-of-congressional-advocacy-on-asco-in-action-podcast/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/asco-international-2017-year-in-review/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/conquer-cancer-podcast-series-goes-unscripted-with-doctors-patients-and-caregivers/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/support-inform-patients-with-asco-resources/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/unique-car-t-cell-construct-studied-in-multiple-myeloma/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-kenneth-c-anderson-md-and-s-vincent-rajkumar-md/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/breast-cancer-care-in-us-territories-seems-to-lag-behind-care-in-continental-united-states/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/raising-awareness-of-the-link-between-alcohol-and-cancer/ 2019-03-11T16:25:42+00:00 https://ascopost.com/issues/march-25-2018/cancercare-publishes-new-white-paper-on-the-provider-perspective-in-treatment-decision-making/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/long-term-risk-of-cardiovascular-disease-increased-among-colorectal-cancer-survivors/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/expert-point-of-view-julia-rowland-phd/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/duration-of-adjuvant-oxaliplatin-based-therapy-for-stage-iii-colon-cancer/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/when-is-active-surveillance-appropriate-in-the-treatment-of-dcis/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/baylor-receives-3-million-to-fund-grants-in-tobacco-control-cancer-screening-and-cancer-treatments/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/we-need-to-fill-the-gap-between-pediatric-and-adult-oncology-care/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/bruton-tyrosine-kinase-inhibitor-in-relapsed-or-refractory-mantle-cell-lymphoma/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/venetoclax-in-chronic-lymphocytic-leukemia-progressing-after-ibrutinib/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-25-2018/addition-of-pazopanib-to-paclitaxel-in-persistent-or-recurrent-ovarian-cancer/ 2019-03-11T16:25:43+00:00 https://ascopost.com/issues/march-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/march-10-2018/new-agents-for-initial-treatment-of-metastatic-prostate-cancer-a-new-standard-of-care/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/atezolizumab-plus-bevacizumab-improves-progression-free-survival-in-first-line-treatment-of-advanced-renal-cell-carcinoma/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-sumanta-k-pal-md/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/advancing-cancer-research-in-challenging-times/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/apalutamide-enzalutamide-improve-metastasis-free-survival-in-nonmetastatic-castrate-resistant-prostate-cancer/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-philip-kantoff-md/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/responses-reported-with-car-t-cell-therapy-in-high-risk-nhl/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/combination-parp-and-pd-1-inhibition-shows-antitumor-activity-in-advanced-malignancies/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-deborah-jl-wong-md-phd/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/expression-of-endogenous-retroviruses-may-explain-response-to-immune-checkpoint-therapy-in-renal-cell-cancer/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/small-study-evaluates-novel-immunotherapeutic-in-metastatic-pancreatic-cancer/ 2019-03-11T16:26:04+00:00 https://ascopost.com/issues/march-10-2018/investigational-genomic-tool-identifies-consensus-molecular-subtype-of-colon-tumor-and-may-predict-risk-of-recurrence/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/small-study-evaluates-treatment-sequencing-in-patients-with-metastatic-colorectal-cancer/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-wafik-s-el-deiry-md-phd-facp/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/yale-law-school-hosts-interdisciplinary-conference-on-cancer-policy-politics-and-law/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/in-unresectable-liver-cancer-progression-free-survival-doubled-when-sorafenib-added-to-tace/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-jordi-bruix-md-phd-and-flavio-g-rocha-md/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/richard-r-barakat-md-to-lead-northwell-health-cancer-services-and-research/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/rutgers-cancer-institute-welcomes-new-oncology-leadership/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/adolescent-and-young-adult-cancer-survivors-often-struggle-with-reproductive-and-sexual-health-concerns/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/adjuvant-chemotherapy-for-upper-tract-urothelial-cancer/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-timothy-gilligan-md/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/european-study-shows-double-transplant-improves-survival-in-myeloma/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-andrzej-jakubowiak-md-phd/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/selected-abstracts-from-the-san-antonio-breast-cancer-symposium/ 2019-03-11T16:26:05+00:00 https://ascopost.com/issues/march-10-2018/no-evidence-of-celecoxib-benefit-reported-in-patients-with-early-breast-cancer/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/expert-point-of-view-aditya-bardia-md/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/osimertinib-improves-progression-free-survival-vs-standard-egfr-inhibitors-in-egfr-mutant-nsclc/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/osimertinib-a-new-standard-of-care-in-initial-treatment-of-egfr-mutant-nsclc/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/university-of-pittsburgh-plans-to-create-new-immunotherapy-facility/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/interventions-to-address-sexual-problems-in-people-with-cancer-asco-clinical-practice-guideline-adaptation-of-cco-guideline/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/it-starts-with-a-discussion-asco-guideline-on-interventions-to-address-sexual-problems-in-people-with-cancer/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/bosutinib-in-newly-diagnosed-chronic-phase-philadelphia-chromosome-positive-chronic-myeloid-leukemia/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/national-comprehensive-cancer-network-reports-new-milestones-fosters-novel-collaborations/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/cabozantinib-in-advanced-renal-cell-carcinoma/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/legal-duties-of-clinicians-when-terminally-ill-patients-with-cancer-or-their-surrogates-insist-on-futile-treatment/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/answers-to-hematology-expert-review-questions/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/the-skin-cancer-foundation-announces-office-relocation/ 2019-03-11T16:26:06+00:00 https://ascopost.com/issues/march-10-2018/alex-huang-md-phd-receives-450-000-from-pediatric-cancer-research-foundation/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/bevacizumab-in-recurrent-glioblastoma/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/clinical-trials-actively-recruiting-patients-with-melanoma/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/called-to-lead-tara-o-henderson-md-mph-selected-for-presidential-leadership-scholars-program/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/conqueror-in-action-katherine-reeder-hayes-md-takes-on-breast-cancer/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/asco-nccn-provide-guidance-on-understanding-and-managing-immunotherapy-side-effects/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/second-brazilian-practice-achieves-qopi-certification/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/stay-up-to-date-on-new-patient-materials-from-cancernet/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/texas-society-of-clinical-oncology-makes-investment-in-young-investigators/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/statement-on-biosimilars-in-oncology-aims-to-educate-asco-members/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/e-john-wherry-phd-awarded-su2c-funding-to-lead-investigation-of-gynecologic-cancer-therapies/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/lutetium-lu-177-dotatate-in-gastroenteropancreatic-neuroendocrine-tumors/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/acupuncture-for-the-management-of-chemotherapy-induced-peripheral-neuropathy/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/study-uses-music-medicine-to-reduce-stress-in-pediatric-patients/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/proud-to-be-a-pioneer-in-car-t-cell-therapy/ 2019-03-11T16:26:07+00:00 https://ascopost.com/issues/march-10-2018/the-challenge-of-prognostication-in-the-era-of-immunotherapy/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/mentorship-from-a-past-asco-president-and-others-steers-a-career-to-academic-research/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/fast-food-nation-and-america-s-sick-diet/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/seeking-beauty-from-the-inside-out-after-cancer-treatment/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/fda-approves-abemaciclib-as-initial-therapy-for-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/fda-grants-orphan-drug-designation-to-ys-on-001-for-the-treatment-of-pancreatic-cancer/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/fda-accepts-nda-grants-priority-review-for-ivosidenib-in-relapsed-or-refractory-idh1-mutated-aml/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/a-river-runs-through-the-life-of-a-leukemia-specialist/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/effect-of-azithromycin-on-airflow-decline-free-survival-after-allogeneic-hsct/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/car-t-cell-therapy-in-refractory-b-cell-lymphomas/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-10-2018/the-anesthesia-era-1845-1875/ 2019-03-11T16:26:08+00:00 https://ascopost.com/issues/march-5-2018-special-report/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/march-5-2018-special-report/why-right-to-try-laws-are-dangerous/ 2019-03-11T16:26:41+00:00 https://ascopost.com/issues/february-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/february-25-2018/combination-radiotherapy-and-immunotherapy-appears-safe-and-clinically-active-in-advanced-solid-tumors/ 2019-03-11T16:26:56+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-ravindra-uppaluri-md-phd/ 2019-03-11T16:26:56+00:00 https://ascopost.com/issues/february-25-2018/laryngeal-preservation-all-patients-need-a-voice/ 2019-03-11T16:26:56+00:00 https://ascopost.com/issues/february-25-2018/releasing-follicular-lymphoma-from-the-curse-of-frankenstein/ 2020-08-07T13:28:31+00:00 https://ascopost.com/issues/february-25-2018/cabozantinib-improves-survival-in-advanced-hepatocellular-carcinoma/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-jordi-bruix-md-phd-and-flavio-g-rocha-md/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/use-of-circulating-tumor-cells-to-detect-colorectal-cancer-and-adenomas/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-douglas-corley-md-phd-and-nancy-baxter-md/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/lapact-trial-confirms-efficacy-of-nab-paclitaxel-plus-gemcitabine-as-induction-therapy-in-pancreatic-cancer/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-brian-m-wolpin-md-mph/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/james-p-allison-phd-granted-bbva-foundation-award-for-groundbreaking-work-in-immunotherapy/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/stand-up-to-cancer-awards-11m-to-study-immune-response-to-cancer/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/combined-medical-and-psychological-approach-may-help-couples-reclaim-intimacy-after-prostate-cancer-treatment/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/sabcs-highlights-focus-on-predicting-residual-tumor-burden-therapy-related-arm-morbidity-lifestyle-and-cancer-risk/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/perioperative-aromatase-inhibitors-no-effect-on-recurrence-but-ki67-level-important/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-matthew-j-ellis-mb-phd/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/ovarian-function-suppression-during-and-after-chemotherapy-valid-for-some-patients-with-early-breast-cancer/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-ann-h-partridge-md-mph-fasco/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/clinical-hold-on-bpx-501-trials-in-the-united-states-announced/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/nccn-summit-explores-survivorship-issues-for-patients-and-clinicians/ 2019-03-11T16:26:57+00:00 https://ascopost.com/issues/february-25-2018/huntsman-cancer-institute-to-use-national-cancer-institute-grant-for-breast-cancer-trial-center/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/2018-william-l-mcguire-award-nominations-now-being-accepted/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/asco-data-sharing-initiatives-support-innovative-cancer-research/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/team-wellness-reflections-from-front-line-clinical-teams/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/asco-in-action-s-new-podcast-series-addresses-critical-cancer-policy-and-practice-issues/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/asco-answers-guide-to-cancer-survivorship/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/medical-and-radiation-oncologists-now-able-to-meet-all-federal-reporting-requirements-through-qopi-reporting-registry/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/study-findings-on-novel-agents-in-neoplastic-hematology/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/new-edition-of-hematology-basic-principles-and-practice-now-available/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/world-cancer-day-addresses-global-disparities-in-cancer-care/ 2019-03-11T16:26:58+00:00 https://ascopost.com/issues/february-25-2018/cancercare-raises-nearly-665-000-to-support-patients-with-cancer-affected-by-hurricanes/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/use-of-direct-oral-anticoagulants-in-preventing-vte-in-patients-with-cancer/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-robert-brodsky-md/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/does-treatment-with-tumor-treating-fields-plus-temozolomide-influence-quality-of-life-in-patients-with-newly-diagnosed-glioblastoma/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/asco-clinical-practice-guideline-update-use-of-larynx-preservation-strategies-in-the-treatment-of-laryngeal-cancer/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/retrospective-analysis-suggests-obesity-associated-with-longer-survival-for-men-with-metastatic-melanoma/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/results-from-phase-iii-arrow-study-of-once-weekly-carfilzomib-in-relapsed-or-refractory-multiple-myeloma/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/providing-cancer-treatment-without-patient-consent/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/why-palliative-care-isn-t-just-for-older-patients-with-cancer/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/fda-approves-abiraterone-acetate-plus-prednisone-for-high-risk-metastatic-castration-sensitive-prostate-cancer/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/madhav-v-dhodapkar-mbbs-named-director-of-new-center-for-cancer-immunology-at-winship-cancer-institute/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/human-genome-project-receives-thai-annual-award/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/new-head-of-gi-medical-oncology-at-perlmutter-cancer-center/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/priyanka-sharma-md-appointed-vice-chair-of-swog-breast-committee/ 2019-03-11T16:26:59+00:00 https://ascopost.com/issues/february-25-2018/kathleen-m-schmeler-md-a-gynecologic-oncology-activist-for-underserved-women/ 2019-03-11T16:27:00+00:00 https://ascopost.com/issues/february-25-2018/ucla-scientists-receive-nih-research-grant-to-advance-adoption-of-focal-laser-therapy-for-prostate-cancer/ 2019-03-11T16:27:00+00:00 https://ascopost.com/issues/february-25-2018/overall-survival-with-carfilzomib-vs-bortezomib-in-relapsed-or-refractory-multiple-myeloma/ 2019-03-11T16:27:00+00:00 https://ascopost.com/issues/february-25-2018/guadecitabine-in-treatment-naive-older-patients-with-acute-myeloid-leukemia/ 2019-03-11T16:27:00+00:00 https://ascopost.com/issues/february-25-2018/uspstf-recommends-against-screening-for-ovarian-cancer-in-asymptomatic-women/ 2019-03-11T16:27:00+00:00 https://ascopost.com/issues/february-25-2018/data-favoring-maintenance-therapy-in-older-patients-with-aml-accumulate/ 2019-03-11T16:27:00+00:00 https://ascopost.com/issues/february-25-2018/expert-point-of-view-amir-t-fathi-md/ 2019-03-11T16:27:00+00:00 https://ascopost.com/issues/february-10-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/february-10-2018/nivolumab-plus-ipilimumab-improves-outcomes-in-metastatic-colorectal-cancer/ 2019-03-11T16:27:46+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-zsofia-kinga-stadler-md/ 2019-03-11T16:27:46+00:00 https://ascopost.com/issues/february-10-2018/changing-negative-perceptions-on-the-impact-of-clinical-trials-in-brazil/ 2019-03-11T16:27:46+00:00 https://ascopost.com/issues/february-10-2018/bone-modifying-agents-in-metastatic-breast-cancer-time-to-de-escalate-dosing-intervals/ 2019-03-11T16:27:46+00:00 https://ascopost.com/issues/february-10-2018/ramucirumabchemotherapy-in-gastric-cancer-positive-trial-but-insufficient-benefit/ 2019-03-11T16:27:46+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-stephen-leong-md/ 2019-03-11T16:27:46+00:00 https://ascopost.com/issues/february-10-2018/nccn-awards-nine-grants-for-quality-improvement-in-breast-cancer-care/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/for-patients-treated-for-myeloma-antibiotic-prophylaxis-may-reduce-infections-and-deaths/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-ken-shain-md/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/daratumumab-shows-efficacy-in-amyloid-light-chain-amyloidosis/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-dan-vogl-md/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/amyloid-targeting-antibody-elicits-organ-responses-in-patients-with-amyloidosis/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-dan-vogl-md-1/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/novel-agent-appears-active-in-advanced-or-aggressive-systemic-mastocytosis/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-neil-p-shah-md-phd-joseph-m-connors-md-and-kenneth-c-anderson-md/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/precision-medicine-hope-or-hype/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/trastuzumab-for-9-weeks-fails-to-show-noninferiority-in-her2-positive-breast-cancer/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-william-sikov-md-and-carlos-l-arteaga-md/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/cdk-46-inhibitors-may-be-effective-but-more-toxic-in-older-women/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-c-kent-osborne-md-and-joseph-sparano-md/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/adjuvant-zoledronic-acid-in-early-breast-cancer-is-5-years-better/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-julie-gralow-md-fasco/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/updates-of-key-studies-differ-on-relative-benefit-of-nab-paclitaxel-in-breast-cancer/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/expert-point-of-view-eric-p-winer-md-fasco-heikki-joensuu-md-and-julie-gralow-md-fasco/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/photos-from-the-2018-gastrointestinal-cancers-symposium-san-francisco/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/avelumab-active-in-advanced-urothelial-carcinoma-after-platinum-failure/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/avelumab-in-advanced-urothelial-carcinoma-further-study-needed-to-clarify-its-role/ 2019-03-11T16:27:47+00:00 https://ascopost.com/issues/february-10-2018/attila-seyhan-phd-appointed-director-of-translational-medicine-operations-at-fox-chase-cancer-center/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/viviane-tabar-md-named-chair-of-the-department-of-neurosurgery-at-memorial-sloan-kettering-cancer-center/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/ascocco-focused-guideline-update-on-role-of-bone-modifying-agents-in-metastatic-breast-cancer/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/asco-names-adoptive-cell-immunotherapy-as-cancer-advance-of-the-year/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/asco-offers-oncology-perspective-on-2018-federal-agency-activities-and-rulemaking/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/highlights-from-the-2018-gastrointestinal-and-genitourinary-cancers-symposia/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/cancerlinq-llc-partners-with-the-national-society-of-genetic-counselors/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/now-available-limited-edition-conquer-cancer-foundation-nike-sneakers/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/gateway-for-cancer-research-renews-commitment-to-young-investigators/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/for-holly-g-prigerson-phd-psychosocial-issues-are-at-the-heart-of-end-of-life-cancer-care/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/fda-takes-steps-to-improve-transparency-in-clinical-trial-information-related-to-new-drugs/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/the-state-of-integrative-oncology-a-new-era/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/making-personalized-medicine-a-reality-for-more-patients-with-cancer/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/alexis-a-thompson-md-mph-appointed-2018-ash-president/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/the-roller-coaster/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/blinatumomab-in-relapsed-or-refractory-b-cell-precursor-all/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/enasidenib-in-idh2-mutant-relapsed-or-refractory-acute-myeloid-leukemia/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/pembrolizumab-in-msi-h-or-dmmr-solid-tumors-first-tissuesite-agnostic-approval-by-fda/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/daratumumab-in-previously-treated-multiple-myeloma/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/pathology-laboratory-bordeaux-france-1889/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/fox-chase-researchers-earn-privately-funded-grants-for-five-pilot-projects/ 2019-03-11T16:27:48+00:00 https://ascopost.com/issues/february-10-2018/up-to-date-labels-for-older-drugs-essential-for-appropriate-use/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/the-toxicity-of-time/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/i-m-not-a-victim-of-cancer/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/steep-decline-in-chemotherapy-use-for-early-stage-breast-cancer/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/expect-questions-about-necessity-of-chemotherapy-for-early-stage-breast-cancer/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/four-new-scientists-and-researchers-join-city-of-hope/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/addition-of-egfr-targeting-vaccine-to-temozolomide-in-egfrviii-expressing-glioblastoma/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/health-related-quality-of-life-in-everolimus-treated-patients-with-neuroendocrine-tumors/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/individualized-adaptive-stereotactic-body-radiotherapy-for-primary-and-metastatic-liver-tumors/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/cancer-collaboration-launches-new-lung-cancer-patient-registry/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/howard-s-hochster-md-joins-rutgers-cancer-institute/ 2019-03-11T16:27:49+00:00 https://ascopost.com/issues/february-10-2018/fda-approves-radiopharmaceutical-for-rare-gastrointestinal-cancers/ 2019-07-11T20:56:14+00:00 https://ascopost.com/issues/january-25-2018/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/january-25-2018/novel-antibody-drug-conjugate-active-in-refractory-triple-negative-breast-cancer/ 2019-03-19T15:32:32+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-howard-skip-burris-iii-md-facp-fasco-and-harold-burstein-md-phd-fasco/ 2019-03-19T15:32:32+00:00 https://ascopost.com/issues/january-25-2018/echelon-1-a-commendable-study-but-questions-remain/ 2019-03-19T15:32:32+00:00 https://ascopost.com/issues/january-25-2018/celebrating-the-life-of-jimmie-holland-md/ 2019-03-19T15:32:32+00:00 https://ascopost.com/issues/january-25-2018/mogamulizumab-in-cutaneous-t-cell-lymphoma/ 2019-03-19T15:32:32+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-laurie-sehn-md-and-kenneth-c-anderson-md/ 2019-03-19T15:32:32+00:00 https://ascopost.com/issues/january-25-2018/nsabp-b-47-no-benefit-for-adjuvant-trastuzumab-in-her2-low-breast-cancer/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-virginia-kaklamani-md-and-harold-burstein-md-phd-fasco/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/proof-of-principle-study-of-combination-checkpoint-inhibitor-plus-trastuzumab-in-her2-positive-advanced-breast-cancer/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-virginia-kaklamani-md/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/power-of-pathologic-complete-response-to-neoadjuvant-therapy-demonstrated-in-i-spy-2-trial/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-steven-vogl-md-and-eric-p-winer-md-fasco/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/circulating-tumor-cells-may-predict-late-recurrence-in-hormone-receptor-positive-breast-cancer/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-c-kent-osborne-md-fasco-and-lisa-carey-md/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/nci-awards-16m-research-grant-to-ponce-health-sciences-university-and-moffitt-cancer-center/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/trastuzumab-dkst-approved-as-biosimilar-to-trastuzumab/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/study-findings-on-novel-therapies-for-hematologic-malignancies/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/carfilzomib-based-treatment-and-transplant-in-smoldering-myeloma/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-andrzej-jakubowiak-md-phd/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/best-outcomes-to-date-in-older-patients-with-hodgkin-lymphoma/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-jennifer-amengual-md/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/update-on-car-t-cell-breakthrough-therapy-in-lymphoma/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-renier-j-brentjens-md-phd/ 2019-03-19T15:32:33+00:00 https://ascopost.com/issues/january-25-2018/venetoclax-plus-rituximab-outperforms-standard-bendamustine-plus-rituximab-in-cll/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/expert-point-of-view-robert-brodsky-md-and-henry-fung-md-facp-frcpe/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/preserving-sexual-function-in-women-treated-for-cancer/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/asco-endorses-astro-guideline-on-stereotactic-body-radiotherapy-for-early-stage-nsclc/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/asco-endorsement-of-astro-guideline-on-stereotactic-body-radiotherapy-for-nsclc-highlights-shared-patient-decision-making/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/mary-beckerle-phd-honored-by-national-cancer-institute/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/ursula-matulonis-md-named-brock-wilson-family-chair-at-dana-farber-cancer-institute/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/levine-cancer-institute-creates-integrated-department-of-supportive-oncology-to-be-led-by-declan-walsh-md/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/durvalumab-takes-a-giant-leap-into-stage-iii-nsclc/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/fda-approves-afatinib-for-previously-untreated-metastatic-nsclc-with-other-nonresistant-egfr-mutations/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/fda-approves-olaparib-for-germline-brca-mutated-metastatic-breast-cancer/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/second-global-aya-cancer-congress-highlights-research-advances-and-the-global-burden-of-cancer-among-young-adults/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/israel-cancer-research-fund-appoints-national-executive-director/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/fox-chase-announces-winners-of-acs-institutional-research-grant-for-junior-investigators/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/laura-levin-md-joins-fox-chase-cancer-center-department-of-diagnostic-imaging/ 2019-03-19T15:32:34+00:00 https://ascopost.com/issues/january-25-2018/chi-van-dang-md-phd-named-editor-in-chief-of-cancer-research/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/howard-a-skip-burris-iii-md-facp-fasco-elected-asco-president-for-2019-2020-term/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/2018-asco-annual-meeting-call-for-abstracts-submit-by-february-13/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/educate-and-support-your-patients-with-asco-answers-materials/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/asco-calls-for-streamlining-of-adverse-events-reporting-for-cancer-clinical-trials/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/cancerlinq-partners-with-leading-global-life-sciences-nonprofit/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/now-available-limited-edition-conquer-cancer-foundation-nike-sneakers/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/listen-to-conquer-cancer-mini-podcasts-inspired-by-storycorps-and-asco-members-grantees/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/mackenzi-pergolotti-phd-otrl-a-leader-in-the-emerging-field-of-occupational-therapy-in-oncology/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/cancer-statistics-2018-us-cancer-mortality-continues-decades-long-drop/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/roswell-park-cancer-institute-appoints-new-leaders-for-2018/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/ceritinib-in-alk-positive-metastatic-non-small-cell-lung-cancer/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/pembrolizumab-in-advanced-urothelial-carcinoma/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/erratum/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/diary-of-a-storm/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/reports-from-the-journal-of-clinical-oncology/ 2019-03-19T15:32:35+00:00 https://ascopost.com/issues/january-25-2018/fda-approves-arsenic-trioxide-with-tretinoin-for-first-line-treatment-of-acute-promyelocytic-leukemia/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/pomegranates-and-other-polyphenols-new-evidence-to-share-with-prostate-cancer-patients/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/working-together-to-help-pediatric-patients-with-cancer-live-and-live-well/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/against-all-odds/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/community-oncology-alliance-elects-officers-and-new-board-members-for-2018/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/a-neuroscientist-examines-intact-minds-adrift-in-damaged-brains-and-bodies/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/internationally-renowned-prostate-cancer-expert-gerald-e-hanks-md-dies/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/the-telltale-heart-a-surgeon-s-memoir/ 2019-03-19T15:32:36+00:00 https://ascopost.com/issues/january-25-2018/nodal-stage-migration-and-prognosis-in-anal-cancer/ 2019-03-19T15:32:37+00:00 https://ascopost.com/issues/january-25-2018/plasma-epstein-barr-virus-dna-screening-for-nasopharyngeal-cancer/ 2019-03-19T15:32:37+00:00 https://ascopost.com/issues/january-25-2018/adjuvant-temozolomide-in-1p19q-non-codeleted-anaplastic-glioma/ 2019-03-19T15:32:37+00:00 https://ascopost.com/issues/january-25-2018/former-president-and-director-of-fred-hutchinson-cancer-research-center-robert-w-day-md-dies-at-87/ 2019-03-19T15:32:37+00:00 https://ascopost.com/issues/december-26-2017-web-announcement/ 2021-06-08T17:57:19+00:00 https://ascopost.com/issues/december-26-2017-web-announcement/oncology-world-mourns-the-loss-of-jimmie-c-holland-md-founder-field-of-psycho-oncology/ 2019-03-11T16:28:04+00:00 https://ascopost.com/issues/december-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/december-25-2017/alexander-fleming-would-have-loved-our-success-with-cancer-immunotherapy/ 2019-03-11T16:28:23+00:00 https://ascopost.com/issues/december-25-2017/updated-follow-up-of-zuma-1-confirms-benefit-of-car-t-cell-therapy-in-aggressive-b-cell-lymphoma/ 2019-03-11T16:28:23+00:00 https://ascopost.com/issues/december-25-2017/bosutinib-improves-response-rate-vs-imatinib-as-first-line-treatment-of-chronic-myeloid-leukemia/ 2019-03-11T16:28:23+00:00 https://ascopost.com/issues/december-25-2017/daratumumab-improves-progression-free-survival-in-front-line-myeloma-setting/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/expert-point-of-view-keith-stewart-mb-chb/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/phase-ii-data-for-venetoclaxibrutinib-combination-in-relapsed-or-refractory-chronic-lymphocytic-leukemia/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/reports-from-the-journal-of-clinical-oncology/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/front-line-brentuximab-plus-avd-vs-standard-abvd-in-advanced-hodgkin-lymphoma/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/ribociclib-doubles-progression-free-survival-in-premenopausal-breast-cancer/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/extended-endocrine-therapy-in-postmenopausal-women-with-breast-cancer-2-years-as-effective-as-5-years/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/expert-point-of-view-marisa-weiss-md-carlos-arteaga-md-and-kathryn-ruddy-md/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/mohamad-cherry-md-joins-atlantic-hematology-oncology/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/new-vice-president-of-early-phase-development-and-immuno-oncology-at-lilly-oncology/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/dose-dense-chemotherapy-in-early-breast-cancer-a-win-win-treatment-approach/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/bosutinib-for-first-line-use-in-chronic-myeloid-leukemia-is-three-a-crowd/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/outcomes-associated-with-higher-fiber-intake-after-colorectal-cancer-diagnosis/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/fiber-is-only-one-component-in-improving-outcomes-in-cancer-survivors/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/disease-progression-and-deterioration-of-health-related-quality-of-life-in-advanced-breast-cancer/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/exercise-counteracts-fatigue-pain-in-women-with-advanced-breast-cancer/ 2019-03-11T16:28:24+00:00 https://ascopost.com/issues/december-25-2017/european-union-expert-group-releases-position-statement-on-lung-cancer-screening-in-europe/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/obinutuzumab-in-previously-untreated-follicular-lymphoma/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/pi3k-inhibition-with-copanlisib-in-relapsed-or-refractory-indolent-lymphoma/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/another-pi3k-inhibitor-welcome-for-use-in-indolent-lymphoma/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/nih-research-program-partners-with-national-library-of-medicine-to-advance-precision-medicine/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/slovenia-s-first-medical-oncology-resident-reflects-on-his-career-in-a-rapidly-changing-field/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/pembrolizumab-in-pd-l1-positive-advanced-cervical-cancer/ 2020-09-25T01:40:50+00:00 https://ascopost.com/issues/december-25-2017/checkpoint-inhibition-for-patients-with-recurrent-or-advanced-cervical-cancer-a-promising-strategy-but-which-patients-will-benefit-the-most/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/medical-aid-in-dying-when-legal-safeguards-become-burdensome-obstacles/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/fda-approves-cabozantinib-for-first-line-treatment-of-advanced-renal-cell-carcinoma/ 2020-09-25T01:37:14+00:00 https://ascopost.com/issues/december-25-2017/lung-cancer-in-never-smokers-a-complex-clinical-phenomenon/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/nih-grants-64-million-to-better-identify-breast-cancer-biomarkers/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/sunitinib-malate-for-adjuvant-treatment-of-renal-cell-carcinoma/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/national-cancer-institute-sponsors-training-program-on-supportive-cancer-care/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/broadening-the-evidence-base-for-older-patients-fda-asco-workshop-explores-emerging-strategies/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/asco-resolutions-approved-by-ama-house-of-delegates/ 2019-03-11T16:28:25+00:00 https://ascopost.com/issues/december-25-2017/asco-expands-tapur-study-enrollment-after-promising-initial-treatment-outcomes/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/deadline-approaching-give-a-year-end-gift-by-december-31/ 2020-09-25T01:35:03+00:00 https://ascopost.com/issues/december-25-2017/conquer-cancer-researcher-spotlight-dr-xiuning-le/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/asco-kicks-off-strategic-planning-to-support-women-in-oncology/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/a-letter-of-thanks-from-the-conquer-cancer-foundation/ 2020-09-25T01:32:13+00:00 https://ascopost.com/issues/december-25-2017/new-asco-answers-fact-sheets-for-your-practice/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/providing-a-safe-haven-for-patients-with-advanced-lung-cancer/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/mount-sinai-surgeons-remove-cancerous-lymph-nodes-using-novel-robot-assisted-procedure/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/neratinib-is-approved-should-we-reject-it-anyway/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/what-should-puma-do/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/fda-helps-streamline-approval-process-for-supplemental-drug-indications/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/data-must-be-generated-to-support-cross-labeling-of-combination-therapies-for-cancer/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/medical-oncologist-takes-the-paths-less-traveled-to-unwind-and-reboot/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/assuming-the-role-of-nci-director-working-to-accelerate-progress/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/27-breast-oncologists-recognized-on-forbes-physician-honor-roll/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/samuel-oschin-comprehensive-cancer-institute-receives-3-year-accreditation-from-acs/ 2019-03-11T16:28:26+00:00 https://ascopost.com/issues/december-25-2017/maximiliano-d-angelo-phd-receives-acs-research-grant/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/helping-patients-with-head-and-neck-cancer-and-their-caregivers-face-treatment-associated-challenges/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/dyadic-yoga-program-for-patients-with-lung-cancer-and-their-caregivers-may-optimize-treatment-response/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/expert-point-of-view-eduardo-bruera-md-faahpm/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/lower-dose-of-cabazitaxel-in-prostate-cancer/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/durvalumab-consolidation-after-chemoradiotherapy-improves-progression-free-survival-in-stage-iii-non-small-cell-lung-cancer/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/is-medical-assistance-in-dying-compassionate-care/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/harborside-partners-with-maz-to-launch-oncologygo-cancer-resource-for-mobile-devices-and-tv/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/balancing-opioid-use-to-relieve-cancer-related-pain-and-protecting-patients-from-addiction-and-death/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/columbia-and-newyork-presbyterian-receive-700-million-donation-for-cancer-research-and-care/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/ackc-secures-10-million-for-kidney-cancer-research/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/fulvestrant-monotherapy-for-postmenopausal-women-with-advanced-breast-cancer/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/katherine-e-reeder-hayes-md-sees-equity-as-next-big-challenge-in-breast-cancer-care/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/fda-grants-regular-approval-to-pertuzumab-for-adjuvant-treatment-of-her2-positive-breast-cancer/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/st-john-s-wort/ 2019-03-11T16:28:27+00:00 https://ascopost.com/issues/december-25-2017/gemtuzumab-ozogamicin-in-cd33-positive-acute-myeloid-leukemia/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/alectinib-in-alk-positive-metastatic-non-small-cell-lung-cancer/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/seven-leaders-join-md-anderson-cancer-center-board-of-visitors/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/the-puzzle-table/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/fcc-nci-working-to-improve-rural-cancer-care-via-broadband-access/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/american-association-for-the-advancement-of-science-inducts-new-fellows/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/fda-grants-accelerated-approval-to-bosutinib-for-treatment-of-newly-diagnosed-philadelphia-chromosome-positive-cml/ 2020-09-25T01:39:09+00:00 https://ascopost.com/issues/december-25-2017/giving-back-after-cancer/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/brentuximab-vedotin-for-adult-patients-with-primary-cutaneous-anaplastic-large-cell-lymphoma/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/oncologists-urged-to-be-proactive-in-advising-patients-to-reduce-risk-of-alcohol-related-cancers/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/expect-questions-about-link-between-alcohol-and-cancer/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/asco-remembers-cancer-research-advocate-patrick-gavin-rph/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/adding-bevacizumab-to-chemotherapy-in-advanced-cervical-cancer/ 2019-03-11T16:28:28+00:00 https://ascopost.com/issues/december-25-2017/colorectal-cancer-mortality-rates/ 2019-03-11T16:28:29+00:00 https://ascopost.com/issues/december-25-2017/adding-first-line-radiotherapy-to-chemotherapy-for-liver-metastases-from-colorectal-cancer/ 2019-03-11T16:28:29+00:00 https://ascopost.com/issues/december-25-2017/association-of-systemic-inflammation-and-sarcopenia-with-survival-in-colorectal-cancer/ 2019-03-11T16:28:29+00:00 https://ascopost.com/issues/december-25-2017/alcohol-and-cancer-risk-reconsidered/ 2019-03-11T16:28:29+00:00 https://ascopost.com/issues/december-25-2017/howard-a-skip-burris-iii-md-facp-fasco-elected-asco-president-for-2019-2020-term/ 2019-03-11T16:28:29+00:00 https://ascopost.com/issues/december-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/december-10-2017/targeted-therapies-highlighted-at-this-year-s-ash-annual-meeting/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/how-asco-s-new-initiatives-are-helping-oncologists-transition-to-macra/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/evidence-based-support-for-triplet-therapies-in-multiple-myeloma/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/car-t-cell-therapy-makes-further-inroads-in-lymphoma-and-myeloma/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/ash-2017-outstanding-service-and-public-service-awards/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/durvalumab-therapy-improves-outcomes-in-patients-with-unresectable-stage-iii-nsclc/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/expert-point-of-view-michael-boyer-mbbs-phd/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/managing-low-dose-ct-screening-for-lung-cancer/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/seattle-children-s-hospital-opens-car-t-cell-immunotherapy-trial-in-pediatric-leukemia/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/managing-neurotoxicity-in-advanced-breast-cancer/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/combined-therapies-increase-adverse-events-in-patients-with-hormone-receptor-positive-metastatic-breast-cancer/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/preparing-for-steep-increase-in-breast-cancer-among-the-elderly/ 2019-03-11T16:28:54+00:00 https://ascopost.com/issues/december-10-2017/international-society-of-geriatric-oncology-awards-leaders-at-2017-conference/ 2020-02-17T17:42:24+00:00 https://ascopost.com/issues/december-10-2017/launching-harmonized-nccn-guidelines-for-sub-saharan-africa/ 2019-03-11T16:28:57+00:00 https://ascopost.com/issues/december-10-2017/the-27-nccn-member-institutions/ 2019-03-11T16:28:57+00:00 https://ascopost.com/issues/december-10-2017/concurrent-palliative-care-recommendations-from-the-asco-clinical-practice-guideline/ 2019-03-11T16:28:57+00:00 https://ascopost.com/issues/december-10-2017/triple-threat-conditions-may-predict-mortality-in-patients-with-cancer-presenting-to-emergency-departments/ 2019-03-11T16:28:57+00:00 https://ascopost.com/issues/december-10-2017/expert-point-of-view-eduardo-bruera-md-faahpm/ 2019-03-11T16:28:57+00:00 https://ascopost.com/issues/december-10-2017/young-investigators-named-winners-of-2017-paul-marks-prize-for-cancer-research/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/louis-m-weiner-md-appointed-director-of-medstar-georgetown-cancer-institute/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/caring-for-the-frail-older-patient-with-cancer-four-practical-approaches/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/cancer-and-obesity-not-such-a-linear-relationship/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/mount-sinai-institutes-join-215-million-partnership-to-increase-patients-immunotherapy-success/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/shifting-landscape-of-oncology-drug-development-and-approvals/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/mary-pazdur-award-for-excellence-in-advanced-practice-in-oncology-announced/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/vemurafenib-in-erdheim-chester-disease/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/obinutuzumab-based-first-line-treatment-improves-progression-free-survival-vs-rituximab-based-treatment-in-follicular-lymphoma/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/follicular-lymphoma-is-the-road-to-cure-paved-with-gallium/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/recent-study-findings-in-car-t-cell-therapy-for-neoplastic-malignancies/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/new-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/answers-to-hematology-expert-review-questions/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/dasatinib-in-pediatric-patients-with-chronic-myeloid-leukemia/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/highlights-from-the-conquer-cancer-foundation-s-third-annual-career-development-retreat/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/walther-cancer-foundation-endows-new-asco-special-award-and-lecture-for-palliative-and-supportive-care/ 2019-03-11T16:28:58+00:00 https://ascopost.com/issues/december-10-2017/cms-finalizes-340b-cuts-part-b-drugs-in-quality-payment-program-2018-physician-fee-schedule/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/honor-a-loved-one-with-a-gift-to-conquer-cancer/ 2020-09-24T01:50:21+00:00 https://ascopost.com/issues/december-10-2017/read-the-inaugural-asco-connection-cancer-policy-issue/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/asco-answers-palliative-care-a-resource-for-patients/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/national-cancer-institute-awards-12-million-for-breast-cancer-genetics-study/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/helping-patients-with-advanced-disease-transition-from-focused-to-intrinsic-hope/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/nccn-introduces-new-guidelines-for-patients-with-aids-related-kaposi-sarcoma/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/intravenous-rolapitant-for-chemotherapy-induced-delayed-nausea-and-vomiting/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/immunotherapy-plus-chemotherapy-in-non-small-cell-lung-cancer-despite-the-failure-of-ipilimumab-guarded-optimism-persists/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/first-line-pembrolizumab-in-cisplatin-ineligible-advanced-urothelial-cancer/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/immunotherapy-has-indelibly-changed-the-treatment-paradigm-in-urothelial-carcinoma/ 2021-02-09T23:00:19+00:00 https://ascopost.com/issues/december-10-2017/nccn-awards-nine-grants-for-quality-improvement-in-breast-cancer-care/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/born-in-chicago-lymphoma-specialist-sonali-m-smith-md-never-left-the-windy-city/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/seattle-translational-tumor-research-presents-precision-medicine-grant-winners/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/olaparib-tablets-for-maintenance-treatment-in-ovarian-cancer/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/future-directions-for-car-t-cell-therapy/ 2019-03-11T16:28:59+00:00 https://ascopost.com/issues/december-10-2017/virginia-cancer-specialists-and-the-us-oncology-network-welcome-stephanie-akbari-md-facs/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/barbara-savoldo-md-phd-awarded-grant-for-immunotherapy-research/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/acalabrutinib-in-previously-treated-mantle-cell-lymphoma/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/ibrutinib-in-chronic-graft-vs-host-disease/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/liposome-encapsulated-daunorubicin-and-cytarabine-for-aml-subtypes/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/sitc-spearheads-initiative-for-management-of-immunotherapy-related-side-effects/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/gratitude/ 2020-09-24T01:46:21+00:00 https://ascopost.com/issues/december-10-2017/perlmutter-cancer-center-expands-clinical-leukemia-program/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/clinical-trials-actively-recruiting-patients-with-pediatric-leukemia/ 2020-09-24T01:41:24+00:00 https://ascopost.com/issues/december-10-2017/love-triumphs-amid-a-battle-with-cancer/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/achieving-one-s-childhood-dreams-while-facing-pancreatic-cancer/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/old-and-new-perspectives-on-the-theory-of-cancer/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/radiation-oncologist-gives-clear-advice-to-patients-with-cancer/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/untangling-the-controversies-of-hematopoietic-cell-transplantation/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/michael-a-caligiuri-md-named-president-of-city-of-hope-national-medical-center/ 2019-03-11T16:29:00+00:00 https://ascopost.com/issues/december-10-2017/living-a-full-life-with-stage-iv-non-small-cell-lung-cancer/ 2019-03-11T16:29:01+00:00 https://ascopost.com/issues/december-10-2017/asparaginase-associated-pancreatitis-in-childhood-acute-lymphoblastic-leukemia/ 2019-03-11T16:29:01+00:00 https://ascopost.com/issues/december-10-2017/radiotherapy-fractionation-for-head-and-neck-cancers/ 2019-03-11T16:29:01+00:00 https://ascopost.com/issues/december-10-2017/genomic-characteristics-and-immune-infiltration-in-triple-negative-breast-cancer/ 2019-03-11T16:29:01+00:00 https://ascopost.com/issues/december-10-2017/partial-breast-and-reduced-dose-radiotherapy-after-breast-conserving-surgery/ 2019-03-11T16:29:01+00:00 https://ascopost.com/issues/december-10-2017/akt-inhibitor-ipatasertib-in-metastatic-triple-negative-breast-cancer/ 2019-03-11T16:29:01+00:00 https://ascopost.com/issues/december-10-2017/fda-approves-first-biosimilar-for-the-treatment-of-certain-breast-and-stomach-cancers/ 2020-09-24T01:43:17+00:00 https://ascopost.com/issues/december-10-2017/fda-announces-approval-cms-proposes-coverage-of-diagnostic-test-for-cancer-biomarkers/ 2020-09-24T01:44:20+00:00 https://ascopost.com/issues/december-10-2017/chemotherapy-foundation-honors-oncology-pioneer-james-f-holland-md-fasco-and-actor-comedian-martin-short/ 2019-03-11T16:29:01+00:00 https://ascopost.com/issues/november-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/november-25-2017/parp-inhibitors-in-brca-related-ovarian-cancer-and-beyond/ 2019-03-11T16:30:31+00:00 https://ascopost.com/issues/november-25-2017/asco-issues-statement-on-alcohol-consumption-and-cancer-risk/ 2019-03-11T16:30:31+00:00 https://ascopost.com/issues/november-25-2017/asco-survey-reveals-concerning-trends-in-americans-knowledge-about-cancer-risks-and-impact-of-costs-on-compliance/ 2019-03-11T16:30:31+00:00 https://ascopost.com/issues/november-25-2017/sequencing-therapy-in-chronic-lymphocytic-leukemia/ 2019-03-11T16:30:31+00:00 https://ascopost.com/issues/november-25-2017/new-options-for-the-management-of-hodgkin-lymphoma/ 2019-03-11T16:30:31+00:00 https://ascopost.com/issues/november-25-2017/nccn-hits-1-million-registered-users-accessing-nccn-guidelines-and-related-content/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/clinical-relevance-of-minimal-residual-disease-monitoring-limited-in-acute-myeloid-leukemia/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/axicabtagene-ciloleucel-for-large-b-cell-lymphoma/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/copanlisib-in-relapsed-follicular-lymphoma/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/gauging-the-impact-of-weight-loss-intervention-on-breast-cancer-outcomes/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/where-are-we-now-in-triple-negative-breast-cancer/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/what-can-we-do-differently-for-premenopausal-patients-with-breast-cancer/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/computer-based-support-may-allow-physicians-to-spend-more-time-on-human-aspects-of-cancer-care/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/abemaciclib-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/neratinib-for-extended-adjuvant-treatment-of-early-stage-her2-positive-breast-cancer/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/unraveling-pd-l1-assays-in-nsclc-are-they-interchangeable/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/stand-up-to-cancer-launches-cancer-interception-teams-to-detect-and-treat-cancer-at-earliest-stages/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/dabrafenib-and-trametinib-in-braf-v600e-mutant-metastatic-nsclc/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/brigatinib-in-crizotinib-pretreated-metastatic-alk-positive-non-small-cell-lung-cancer/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/pathologic-complete-response-rates-not-improved-with-neoadjuvant-letrozolepalbociclib/ 2019-03-11T16:30:32+00:00 https://ascopost.com/issues/november-25-2017/expert-point-of-view-nadia-harbeck-md-phd/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/about-one-in-four-women-with-small-breast-tumors-may-benefit-from-chemotherapy/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/expert-point-of-view-hope-s-rugo-md/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/idea-trial-going-beyond-statistics-in-stage-iii-colon-cancer/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/metastatic-gastric-cancer-dual-her2-targeting-study-does-not-meet-primary-endpoint/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/expert-point-of-view-eric-van-cutsem-md-phd/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/pembrolizumab-in-advanced-gastric-cancer/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/new-head-named-to-fred-hutch-cancer-prevention-program/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/huntsman-cancer-institute-names-new-clinical-research-director/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/johns-hopkins-researcher-awarded-300-000-to-investigate-genetics-of-lung-cancer/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/accc-honors-barbara-l-mcaneny-md-fasco-macp-with-annual-achievement-award/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/advancing-care-across-the-cancer-continuum/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/early-integrated-palliative-care-improves-patient-coping-strategies-quality-of-life-and-symptoms-of-depression/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/digital-palliative-care-curriculum-improves-knowledge-skills-and-opioid-prescribing-behavior/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/palliative-care-intervention-reduces-total-health-care-costs-in-patients-with-advanced-cancer/ 2019-03-11T16:30:33+00:00 https://ascopost.com/issues/november-25-2017/parker-institute-dana-farber-collaboration/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/surgeon-initiated-gene-expression-profile-testing-in-early-stage-breast-cancer-reduces-time-to-start-of-chemotherapy/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/genomic-profiling-with-multidisciplinary-collaboration-improving-breast-cancer-outcomes-through-timely-chemotherapy-initiation/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/gene-expression-assays-in-early-stage-breast-cancer-who-should-order-them-and-when/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/susan-g-komen-launches-crowdfunding-initiative-to-support-metastatic-breast-cancer-research/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/reports-from-jco-and-jop/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/experts-address-cancer-health-disparities-in-facebook-live-session-at-aacr-meeting/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/health-care-access-unlikely-to-explain-racialethnic-disparities-in-breast-cancer-outcomes/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/addressing-disparities-in-use-of-lung-cancer-screening-with-community-outreach/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/asco-releases-guideline-to-help-oncologists-improve-communication-with-patients-and-their-own-well-being/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/new-interdisciplinary-lung-cancer-center-at-nyu-langone-health/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/helping-oncologists-to-become-better-communicators-with-their-patients/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/nih-partners-with-11-biopharmaceutical-companies-on-pact-collaboration/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/cast-your-vote-in-asco-election-by-december-4/ 2019-03-11T16:30:34+00:00 https://ascopost.com/issues/november-25-2017/recommendations-from-asco-summit-promote-multidisciplinary-collaboration-to-focus-on-obesity-prevention-and-treatment/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/president-elect-candidates-discuss-asco-s-role-in-shaping-global-oncology-community/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/this-givingtuesday-help-conquer-cancer/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/encourage-your-lawmakers-to-increase-funding-for-nih-in-fy-2018/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/asco-election-candidates/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/asco-s-patient-resources-for-national-marrow-awareness-and-family-caregivers-month/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/west-cancer-center-joins-cancerlinq-as-participating-practice/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/melanoma-mutations-what-you-need-to-know/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/fda-approves-car-t-cell-therapy-for-adults-with-certain-types-of-large-b-cell-lymphoma/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/arif-kamal-md-mba-mhs-named-visionary-in-hospice-and-palliative-medicine/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/angela-m-stover-phd-presented-with-inaugural-michael-s-o-malley-alumni-award/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/clinical-trials-actively-recruiting-geriatric-oncology-patients/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/a-pioneer-in-bloodless-transplant-discusses-advances-in-blood-management/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/update-on-nci-match-precision-medicine-trial/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/restorative-effects-of-painting-offset-the-demands-of-oncology/ 2019-03-11T16:30:35+00:00 https://ascopost.com/issues/november-25-2017/moffitt-researcher-awarded-grant-to-study-new-treatments-for-triple-negative-breast-cancer/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/early-findings-on-ezh2-inhibitor-in-children-with-rare-solid-tumors/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/novel-risk-assessment-model-for-acute-myeloid-leukemia/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/the-man-in-the-vest/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/mary-pazdur-award-for-excellence-in-advanced-practice-in-oncology-announced-at-jadpro-live/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/cognitive-behavior-therapy-for-insomnia-sleeping-well-with-cancer-and-beyond/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/fleeing-a-revolution-becoming-an-oncologist/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/role-of-the-e7-gene-in-high-risk-hpv/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/stephanie-lee-md-mph-elected-ash-vice-president-two-councillors-appointed-to-4-year-terms/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/informed-consent-and-the-oncologist-legal-duties-to-discuss-costs-of-treatment/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/university-of-michigan-medical-school-launches-integrative-oncology-scholars-program/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/tackling-the-high-cost-of-cancer-care/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/ash-honors-benjamin-l-ebert-md-phd-with-the-2017-william-dameshek-prize/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/ash-honors-josef-t-prchal-md-and-sherrill-j-slichter-md-with-2017-henry-m-stratton-medal/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/recent-study-findings-in-hematologic-malignancies/ 2019-03-11T16:30:36+00:00 https://ascopost.com/issues/november-25-2017/luigi-naldini-md-phd-and-marina-cavazzana-md-phd-to-present-2017-ash-ernest-beutler-lecture/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/relieving-pain-during-an-opioid-epidemic/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/expect-questions-about-the-risk-of-opioid-addiction/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/gene-therapy-shows-early-efficacy-against-recurrent-brain-cancer/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/nivolumab-in-hepatocellular-carcinoma-previously-treated-with-sorafenib/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/fda-approvals-in-november-2017-novel-drugs-new-indications/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/a-vivid-look-back-a-cogent-look-forward/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/comparison-of-circulating-tumor-dna-and-metastatic-tissue-biopsy-in-identifying-mutations-in-prostate-cancer/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/adverse-pathologic-findings-in-low-volume-intermediate-risk-prostate-cancer/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/bone-targeted-therapies-for-men-with-prostate-cancer-receiving-androgen-deprivation-therapy/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/health-related-quality-of-life-with-immediate-vs-delayed-adt-in-prostate-cancer/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/olaparib-tablets-as-maintenance-in-brca12-mutant-relapsed-ovarian-cancer/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/vertical-roentgenography-patient-of-james-t-case-md/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/james-r-downing-md-to-present-the-2017-ash-e-donnall-thomas-lecture/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/the-runner/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-25-2017/donald-coffey-phd-cancer-pioneer-dies-at-85/ 2019-03-11T16:30:37+00:00 https://ascopost.com/issues/november-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/november-10-2017/treatment-based-on-brca1-expression-did-not-improve-survival-in-nsclc/ 2019-03-11T16:31:07+00:00 https://ascopost.com/issues/november-10-2017/expert-point-of-view-joan-h-schiller-md/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/endeavor-trial-endeavors-to-make-case-for-carfilzomib-despite-survival-advantage-should-we-be-surprised/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/model-emphasizes-long-term-risks-of-ovarian-ablation-plus-aromatase-inhibitor/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/residual-tumor-uncertain-classification-validated-in-non-small-cell-lung-cancer/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/expert-point-of-view-kemp-kernstine-md-phd/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/no-additional-benefit-found-for-routine-early-palliative-care-in-mesothelioma/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/tumor-mutation-burden-shows-promise-as-a-response-biomarker-in-small-cell-lung-cancer/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/expert-point-of-view-balazs-halmos-md/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/in-patients-with-non-small-cell-lung-cancer-tumor-mutation-load-emerging-as-biomarker-for-immunotherapy/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/anti-pd-1-agents-gaining-momentum-in-gastric-cancer/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/expert-point-of-view-eric-van-cutsem-md-phd/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/fda-approves-novel-therapies-for-lymphoma-indications/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/quick-takes-on-studies-in-noncolorectal-gastrointestinal-cancers/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/international-trials-reveal-new-findings-in-the-management-of-breast-and-ovarian-cancers/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/more-data-from-esmo-2017/ 2019-03-11T16:31:08+00:00 https://ascopost.com/issues/november-10-2017/resectable-pancreatic-cancer-neoadjuvant-or-adjuvant-therapy/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/pembrolizumab-benefits-patients-with-recurrent-metastatic-head-and-neck-cancer-mainly-high-pd-l1-expressing-tumors/ 2020-09-16T13:24:14+00:00 https://ascopost.com/issues/november-10-2017/expert-point-of-view-sandrine-faivre-md-phd/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/first-esmo-award-for-immuno-oncology-presented-to-laurence-zitvogel-md-phd/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/how-effective-communication-is-integral-to-patient-centered-care/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/2017-palliative-care-in-oncology-symposium/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/immunotherapeutic-approaches-for-b-cell-acute-lymphocytic-leukemia/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/management-of-newly-diagnosed-multiple-myeloma-in-transplant-eligible-patients/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/life-after-treatment-managing-lymphoma-survivors/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/recent-clinical-trials-in-hematopoietic-cell-transplantation-setting-for-hematologic-malignancies/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/norman-e-sharpless-md-sworn-in-as-director-of-the-national-cancer-institute/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/new-biosimilar-educational-materials-for-health-care-professionals-from-the-fda/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/emeritus-membership-what-does-retirement-mean-to-you/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/twisted-pink-joins-forces-with-the-conquer-cancer-foundation-to-support-metastatic-breast-cancer-research/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/ccf-conquerors-circle-recognizes-donors/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/conqueror-in-action-six-time-survivor-brittany-sullivan-takes-on-sarcoma/ 2019-03-11T16:31:09+00:00 https://ascopost.com/issues/november-10-2017/fall-wrap-up-research-community-forum-and-2017-asco-advocacy-summit/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/asco-s-patient-resources-for-lung-cancer-awareness-month/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/national-academy-of-medicine-elects-80-new-members/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/new-editor-in-chief-named-to-annals-of-surgical-oncology/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/dacomitinib-prolongs-progression-free-survival-vs-gefitinib-in-first-line-treatment-of-egfr-mutant-nsclc/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/dacomitinib-vs-gefitinib-in-advanced-nsclc-improving-upon-established-first-line-targeted-therapy/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/study-finds-more-patients-treated-for-and-surviving-early-stage-nsclc/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/pelvic-radiation-therapy-preferred-over-brachytherapy-plus-chemotherapy-in-treatment-of-high-risk-endometrial-cancer/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/expert-point-of-view-geraldine-m-jacobson-md-mph-mba/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/long-term-survival-rates-more-than-double-previous-estimates-for-locally-advanced-lung-cancer/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/balancing-immune-related-adverse-events-with-efficacy-of-dual-checkpoint-inhibitor-therapy-in-melanoma/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/fda-approves-intravenous-rolapitant-for-prevention-of-delayed-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/ucla-researchers-awarded-1m-grant-to-advance-prostate-cancer-research/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/fox-chase-cancer-center-receives-historic-gift-to-establish-pancreatic-cancer-institute/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/clinical-trials-actively-recruiting-patients-with-lung-cancer/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/two-individuals-recognized-with-nccs-ellen-l-stovall-award/ 2019-03-11T16:31:10+00:00 https://ascopost.com/issues/november-10-2017/national-cancer-institute-awards-dr-ruth-etzioni-5-year-grant-to-fill-gaps-in-cancer-recurrence-data/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/barrie-cassileth-phd-a-pioneer-in-integrative-oncology/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/new-cancer-care-collaboration-brings-memorial-sloan-kettering-cancer-care-to-norwalk-hospital/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/gerold-bepler-md-phd-elected-to-association-of-american-cancer-institute-s-board-of-directors/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/a-revolutionary-technology-offers-hope-and-ethical-concern/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/life-with-death-in-the-room/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/paul-neiman-md-phd-founding-member-of-fred-hutch-dies-at-78/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/brca12-status-in-response-to-therapy-in-triple-negative-breast-cancer/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/10-year-follow-up-on-adjuvant-therapy-in-postmenopausal-early-breast-cancer/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/ovarian-function-recovery-during-anastrozole-therapy-in-postmenopausal-patients-with-breast-cancer/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/predisposition-to-breast-cancer-due-to-mutations-other-than-brca1brca2-in-ashkenazi-jewish-women/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/november-10-2017/ariel3-investigators-clarify-the-effects-of-rucaparib-on-the-liver/ 2019-03-11T16:31:11+00:00 https://ascopost.com/issues/october-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/october-25-2017/smashing-the-glass-ceiling-in-medicine/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/second-line-pembrolizumab-extends-survival-in-urothelial-cancer/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-maria-de-santis-md/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/could-the-rising-rates-of-colorectal-cancer-in-ayas-be-linked-to-hpv-infection/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/consolidative-radiation-therapy-new-paradigm-for-limited-metastatic-nsclc/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-brian-g-czito-md-and-benjamin-movsas-md/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/immunotherapy-plus-radiation-appears-active-in-patients-with-solid-tumors-and-lung-or-liver-metastases/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-brian-g-czito-md-and-phuoc-t-tran-md-phd/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/cutting-radiation-exposure-by-50-appears-safe-and-effective-in-hpv-positive-head-and-neck-cancer/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-paul-harari-md/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/astro-names-recipients-of-junior-faculty-residentfellow-awards-at-annual-meeting/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/positive-early-data-on-second-line-ramucirumabdocetaxel-in-platinum-refractory-advanced-urothelial-cancer/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-yohann-loriot-md-phd/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/asco-chief-medical-officer-scheduled-to-speak-at-ecri-annual-conference/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/asco-recognizes-new-jersey-representative-leonard-lance-with-congressional-leadership-award/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/patient-physician-communication-and-quality-of-life-featured-at-2017-palliative-and-supportive-care-in-oncology-symposium/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/abiraterone-or-docetaxel-which-is-optimal-for-hormone-sensitive-high-risk-prostate-cancer/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-cora-sternberg-md/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-stéphane-oudard-md/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/alectinib-yields-favorable-results-in-phase-iii-trials-of-alk-positive-nsclc/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-luis-paz-ares-md/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/adjuvant-brafmek-inhibition-improves-survival-in-resectable-melanoma/ 2019-03-11T16:32:07+00:00 https://ascopost.com/issues/october-25-2017/checkmate-238-nivolumab-shows-benefit-as-adjuvant-melanoma-treatment/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-alexander-eggermont-md-phd/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/standard-of-care-upheld-for-locally-advanced-cervical-cancer/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/expert-point-of-view-markus-joerger-md-phd-and-domenica-lorusso-md-phd/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/fda-conducts-global-operation-to-protect-consumers-from-potentially-dangerous-prescription-drugs-sold-online/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/nivolumabipilimumab-in-patients-with-advanced-melanoma-who-did-or-did-not-discontinue-induction-treatment-due-to-adverse-events/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/asco-clinical-practice-guideline-update-on-antiemetics-in-patients-with-cancer/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/phase-iii-trial-shows-no-survival-benefit-to-adding-first-line-ipilimumab-to-chemotherapy-in-advanced-squamous-nsclc/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/no-progression-free-survival-benefit-with-first-line-nivolumab-vs-chemotherapy-in-advanced-pd-l1-positive-nsclc/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/regional-radiation-therapy-reduces-risk-of-regional-recurrence-in-node-positive-cutaneous-melanoma/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/carfilzomib-improves-overall-survival-vs-bortezomib-in-relapsedrefractory-multiple-myeloma/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/carfilzomib-may-be-a-strong-candidate-for-salvage-therapy-in-relapsedrefractory-multiple-myeloma-but-questions-remain/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/fda-awards-grants-for-clinical-trials-to-stimulate-product-development-for-rare-diseases/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/asco-university-offers-new-course-covering-resource-stratified-guidelines/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/funding-the-future-of-cancer-research-led-by-women-making-an-impact/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/documentary-film-takes-a-walk-on-the-wild-side-with-oncology-pioneers/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/recommend-an-early-career-oncologist-for-asco-s-2018-health-policy-fellowship/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/quality-training-program-now-accepting-applications-for-2018-courses-to-be-held-in-miami-and-northern-virginia/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/for-your-patients-asco-answers-managing-cancer-related-pain-booklet/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/register-for-december-1-fda-workshop-on-cardiovascular-toxicities-in-immunotherapy-trials/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/asco-guideline-on-stage-iv-nsclc-therapy-updated/ 2019-03-11T16:32:08+00:00 https://ascopost.com/issues/october-25-2017/stand-up-to-cancer-catalyst-launches-10-clinical-trial-projects/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/engaging-patients-in-value-based-care/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/melatonin/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/2018-integrative-oncology-scholars-program-accepting-applications/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/chronicling-a-family-s-history-of-cancer/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/early-love-of-science-and-famous-mentor-paved-the-way-for-gwen-l-nichols-md-in-hematologic-cancer/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/magee-womens-research-institute-announces-2018-women-s-health-award/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/four-pitt-researchers-receive-american-cancer-society-grants/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/23-astro-members-awarded-fellows-designation/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/stalked-by-brca1-a-women-struggles-to-survive-the-same-disease-that-killed-her-mother/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/breast-cancer-has-changed-me-but-the-change-has-been-positive/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/howard-a-fine-md-wins-nih-director-s-pioneer-award/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/julie-r-palmer-scd-honored-with-2017-aacr-distinguished-lecture-on-cancer-health-disparities/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/edward-e-partridge-md-named-chief-medical-officer-of-guideway-care/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/nivolumab-treatment-beyond-disease-progression-in-advanced-melanoma/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/tremelimumab-in-previously-treated-advanced-malignant-mesothelioma/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/for-hpv-vaccine-to-have-optimal-impact-provider-hesitancy-must-be-overcome/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/be-prepared-to-encourage-hpv-vaccination/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/leading-lymphoma-clinician-researcher-and-mentor-oliver-ollie-press-md-phd-dies-at-65/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/moffitt-cancer-center-holds-leadership-series-in-new-york/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-25-2017/erratum-adoptive-cell-therapy-act-1-the-beginning/ 2019-03-11T16:32:09+00:00 https://ascopost.com/issues/october-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/october-10-2017/can-we-have-a-successful-vaccine-against-cancer/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/abemaciclib-plus-endocrine-therapy-extends-progression-free-survival-in-first-line-therapy-for-advanced-breast-cancer/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/expert-point-of-view-nicholas-turner-md/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/mslt-ii-completion-lymph-node-dissection-trial-practice-changing-but-not-likely-practice-abandoning/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/nivolumab-plus-ipilimumab-vs-sunitinib-alone-as-first-line-therapy-for-metastatic-renal-cell-carcinoma/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/expert-point-of-view-manuela-schmidinger-md/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/clinically-meaningful-results-with-first-line-osimertinib-in-egfr-positive-nsclc/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/expert-point-of-view-tony-mok-md-fasco/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/relapsed-mesothelioma-controlled-by-checkpoint-inhibition/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/expert-point-of-view-paul-baas-md-phd/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/journal-of-clinical-oncology-literature-update/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/fda-approves-copanlisib-for-relapsed-follicular-lymphoma/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/strong-showing-for-rucaparib-maintenance-therapy-for-platinum-sensitive-ovarian-cancer/ 2019-03-11T16:32:38+00:00 https://ascopost.com/issues/october-10-2017/expert-point-of-view-sandro-pignata-md/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/selective-pi3k-inhibitor-boosts-effect-of-letrozole-in-neoadjuvant-setting/ 2021-08-19T20:41:33+00:00 https://ascopost.com/issues/october-10-2017/expert-point-of-view-nadia-harbeck-md-phd-and-sibylle-loibl-md/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/blood-based-biomarker-predicting-efficacy-of-immunotherapy-in-patients-with-melanoma/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/overview-of-the-phase-iii-mslt-ii-trial/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/cord-blood-transplantation-proves-beneficial-in-high-risk-patients-with-leukemia/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/fda-grants-accelerated-approval-to-nivolumab-for-hepatocellular-carcinoma-previously-treated-with-sorafenib/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/nivolumab-in-advanced-dna-mismatch-repair-deficient-or-microsatellite-instability-high-colorectal-cancer/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/immunotherapy-for-metastatic-mismatch-repair-deficient-metastatic-colorectal-cancer-game-changer-for-small-group-of-patients/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/nivolumab-in-msi-h-or-dmmr-metastatic-colorectal-cancer/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/for-breast-cancer-specialist-ann-h-partridge-md-mph-medicine-is-a-family-tradition/ 2019-03-11T16:32:39+00:00 https://ascopost.com/issues/october-10-2017/ama-awards-research-grants-to-advance-the-study-of-women-in-medicine/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/dana-farber-opens-new-facility-for-integrative-therapies/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/treating-breast-cancer-during-pregnancy-calls-for-careful-timing-of-therapies-and-sensitive-discussions-with-patients/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/fda-expands-approval-of-ipilimumab-to-pediatric-patients-12-years-and-older/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/clinical-trials-actively-recruiting-patients-with-breast-cancer/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/ccf-researcher-spotlight-rizwan-romee-md/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/spotlight-on-women-who-conquer-cancer/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/educate-and-support-your-patients-with-asco-answers-materials/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/asco-s-qopi-certification-program-recognizes-three-oncology-practices-in-spain/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/asco-concerned-with-mips-part-b-reimbursement-assessments-in-qpp-proposal/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/asco-and-friends-of-cancer-research-release-comprehensive-recommendations-to-broaden-eligibility-criteria-for-cancer-clinical-trials/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/obtaining-a-second-graduate-degree-during-fellowship-things-to-consider/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/cancer-policy-priorities-front-and-center-on-capitol-hill/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/recognizing-the-importance-of-a-work-life-balance-in-oncology/ 2019-03-11T16:32:40+00:00 https://ascopost.com/issues/october-10-2017/anthony-back-md-to-receive-inaugural-walther-cancer-foundation-award/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/with-financial-toxicity-in-oncology-care-on-the-rise-providers-need-to-help-address-patients-financial-issues/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/adjuvant-pertuzumab-in-her2-positive-breast-cancer-value-yet-to-be-demonstrated/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/endocrine-society-names-v-craig-jordan-obe-phd-2018-laureate/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/combination-of-rituximab-and-hyaluronidase-human-for-subcutaneous-use-in-lymphoma-and-leukemia/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/national-committee-for-quality-assurance-recognizes-sidney-kimmel-cancer-center-at-jefferson/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/increasing-racial-and-ethnic-diversity-in-the-oncology-workforce/ 2022-10-13T15:05:35+00:00 https://ascopost.com/issues/october-10-2017/current-oncology-landscape/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/durvalumab-in-advanced-urothelial-carcinoma-progressing-after-platinum-therapy/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/avelumab-in-locally-advanced-or-metastatic-urothelial-carcinoma/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/fda-grants-accelerated-approval-to-pembrolizumab-for-advanced-gastric-cancer/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/epithelioma-tubule-de-nez-albumen-print-paris-1872/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/cancer-has-plagued-my-family/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/shorter-course-of-radiation-therapy-safe-for-younger-women-with-breast-cancer/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/adding-sorafenib-to-transarterial-chemoembolization-in-hepatocellular-carcinoma/ 2019-03-11T16:32:41+00:00 https://ascopost.com/issues/october-10-2017/performance-measures-for-cervical-cancer-screening/ 2019-03-11T16:32:42+00:00 https://ascopost.com/issues/october-10-2017/adjuvant-nivolumab-vs-ipilimumab-in-resected-stage-iii-or-iv-melanoma/ 2019-03-11T16:32:42+00:00 https://ascopost.com/issues/october-10-2017/association-between-vasectomy-and-prostate-cancer/ 2019-03-11T16:32:42+00:00 https://ascopost.com/issues/october-10-2017/addition-of-cetuximab-to-concurrent-chemoradiation-in-esophageal-cancer/ 2019-03-11T16:32:42+00:00 https://ascopost.com/issues/october-10-2017/biden-cancer-initiative-accelerating-progress-in-cancer-research/ 2019-03-11T16:32:42+00:00 https://ascopost.com/issues/october-10-2017/2nd-annual-asco-advocacy-summit/ 2019-03-11T16:32:42+00:00 https://ascopost.com/issues/september-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/september-25-2017/adoptive-cell-therapy-act-1-the-beginning/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/significant-improvement-in-outcomes-reported-with-adjuvant-therapy-for-melanoma/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/expert-point-of-view-reinhard-dummer-md-and-jeffrey-weber-md-phd/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/hepatocellular-carcinoma-current-thoughts-on-liver-transplantation/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/pd-l1-inhibitor-consolidation-therapy-for-nsclc-new-standard-of-care/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/expert-point-of-view-johan-vansteenkiste-md-phd/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/update-on-nonimmunotherapy-advances-in-endometrial-cervical-and-ovarian-cancers/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/amyloidosis-pearls-for-simplifying-the-diagnosis/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/is-complete-lymphadenectomy-still-standard-of-care-in-melanoma/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/small-steps-forward-in-brain-tumor-therapy/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/sarcoma-management-is-slowly-evolving/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/news-from-jco-and-jop/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/no-improvement-in-melanoma-specific-survival-with-completion-dissection-vs-observation-for-sentinel-node-metastasis/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/duration-studies-in-oncology-have-often-been-poorly-designed-and-analyzed/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/fda-recent-approvals-include-first-oncology-biosimilar/ 2019-03-11T16:33:07+00:00 https://ascopost.com/issues/september-25-2017/inotuzumab-ozogamicin-for-relapsedrefractory-b-cell-precursor-all/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/how-early-palliative-care-may-benefit-patients-with-incurable-cancer/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/balancing-harms-and-benefits-of-cancer-screening-the-debate-continues/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/us-preventive-services-task-force-recommends-screening-most-adult-women-for-cervical-cancer/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/nccn-guidelines-to-be-integrated-into-evinance-decision-support-platform/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/kunle-odunsi-md-phd-frcog-facog-named-to-nih-immunology-grant-review-board/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/gary-kohanbash-phd-receives-grant-from-st-baldrick-s-foundation/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/ama-applauds-surgeon-general-nominee/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/tisagenlecleucel-for-b-cell-acute-lymphoblastic-leukemia/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/clinical-practice-committee-state-affiliate-council-support-innovative-clinical-research-and-so-can-you/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/weconquercancer/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/original-report-in-jco-cci-describes-how-authors-developed-a-process-to-automate-a-qopi-measure/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/talking-about-physician-burnout-practical-strategies-for-starting-the-conversation/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/are-you-ready-for-october-2-plan-ahead-for-key-qpp-deadline/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/anco-supports-young-investigator-award-for-a-northern-california-researcher/ 2019-03-11T16:33:08+00:00 https://ascopost.com/issues/september-25-2017/survivorship-resources-for-providers-and-patients/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/weill-cornell-medicine-awarded-113-million-grant-for-prostate-cancer-research/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/new-response-evaluation-criteria-for-lymphoma-clinical-trials-recil-2017/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/douglas-r-lowy-md-and-john-t-schiller-phd-receive-2017-lasker-award/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/regorafenib-in-hepatocellular-carcinoma-previously-treated-with-sorafenib/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-benin/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/fox-chase-cancer-center-announces-new-faculty-appointments/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/overdiagnosis-of-those-in-higher-income-brackets/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/how-a-child-with-cancer-moved-from-vulnerability-to-resilience/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/emotional-and-psychological-distress-associated-with-prostate-cancer/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/rhodiola/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/stemming-the-growing-cancer-crisis-in-rural-appalachia/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/bringing-oncology-care-to-rural-communities/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/acs-awards-grants-to-reduce-colorectal-cancer-disparities-in-american-indian-and-alaska-native-populations/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/wisdom-study-to-test-personalized-approach-to-breast-cancer-screening/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/nci-cog-pediatric-match-trial-to-test-targeted-drugs-in-childhood-cancers/ 2019-03-11T16:33:09+00:00 https://ascopost.com/issues/september-25-2017/the-dark-side-of-medicine-physician-suicide/ 2019-03-11T16:33:10+00:00 https://ascopost.com/issues/september-25-2017/ash-honors-marshall-a-lichtman-md-with-lifetime-achievement-in-hematology-award/ 2019-03-11T16:33:10+00:00 https://ascopost.com/issues/september-25-2017/trastuzumab-based-regimens-in-older-women-with-early-breast-cancer/ 2019-03-11T16:33:10+00:00 https://ascopost.com/issues/september-25-2017/adding-midostaurin-to-chemotherapy-in-aml-with-flt3-mutation/ 2019-03-11T16:33:10+00:00 https://ascopost.com/issues/september-25-2017/neurocognitive-function-in-patients-treated-for-b-lineage-all/ 2019-03-11T16:33:10+00:00 https://ascopost.com/issues/september-25-2017/i-don-t-feel-like-i-have-incurable-cancer/ 2019-03-11T16:33:10+00:00 https://ascopost.com/issues/september-25-2017/heart-disease-cancer-leading-causes-of-death-due-to-noncommunicable-diseases-global-study-finds/ 2019-03-11T16:33:10+00:00 https://ascopost.com/issues/september-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/september-10-2017/for-the-impoverished-health-care-is-a-luxury/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/update-on-hematopoietic-cell-transplant-includes-new-data-in-hiv-infected-and-follicular-lymphoma-patients/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/long-term-follow-up-of-pivot-argues-for-immediate-treatment-of-men-with-unfavorable-risk-and-possibly-high-volume-low-risk-prostate-cancer/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/targeted-treatments-and-health-related-quality-of-life-in-ovarian-cancer/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/multiple-myeloma-researchers-are-digging-deeper-than-ever/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/extraordinary-caregivers/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/recent-fda-actions-include-new-formulation-expanded-indications-for-oncology-hematology-drug-products/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/erratum-immunotherapy-combination-trial/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/sidedness-in-colon-cancer-using-the-data-in-the-clinic/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/non-small-cell-lung-cancer-emerging-concepts-for-checkpoint-inhibitors/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/award-for-early-career-scientists-in-new-york-applications-open-october-2-2017/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/long-term-follow-up-in-pivot-trial-shows-no-significant-benefit-of-surgery-vs-observation-for-overall-or-prostate-cancer-mortality/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/journal-of-clinical-oncology-literature-update/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/peter-wt-pisters-md-mhcm-named-sole-finalist-in-search-for-president-md-anderson/ 2019-03-11T16:33:33+00:00 https://ascopost.com/issues/september-10-2017/pediatric-cancer-research-collective-awarded-millions-by-nih/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/edith-peterson-mitchell-md-awarded-astro-honorary-membership/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/nicholas-g-nickols-md-phd-awarded-grant-to-identify-drivers-of-prostate-cancer-metastasis/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/maha-hussain-md-facp-fasco-credits-collaboration-for-her-contributions-to-genitourinary-cancer/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/prostate-cancer-foundation-announces-2017-young-investigator-awards-recipients/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/atezolizumab-in-patients-with-advanced-urothelial-carcinoma-who-are-ineligible-for-cisplatin/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/testing-alpha-emitting-radiolabeled-immunotherapy-to-treat-and-potentially-cure-multiple-myeloma/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/fred-hutch-launches-pathogen-associated-malignancies-integrated-research-center/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/initiating-the-topic-of-weight-and-health-with-patients-with-obesity/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/positioning-lu-177-dotatate-therapy-and-68-ga-dotatate-scans-in-management-of-neuroendocrine-tumors/ 2019-07-11T20:52:40+00:00 https://ascopost.com/issues/september-10-2017/shaping-real-careers-with-virtual-mentorship/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/your-monthly-gift-can-have-a-huge-impact/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/get-to-know-your-asco-president-elect-monica-m-bertagnolli-md-fasco/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/cancernet-resource-helps-patients-manage-cancer-costs/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/fda-announces-new-comprehensive-plan-for-tobacco-and-nicotine-regulation/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/global-cancer-institute-launches-new-patient-navigation-program-to-accelerate-treatment-for-patients-in-brazil/ 2019-03-11T16:33:34+00:00 https://ascopost.com/issues/september-10-2017/register-for-the-geriatric-oncology-workshop/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/addressing-the-societal-impact-of-financial-toxicity/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/emerging-global-leaders-in-biosimilar-development-regulatory-guidance-and-cost-impact/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/bridging-the-survivorship-care-gap-for-young-adult-survivors-of-thyroid-cancer/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/pembrolizumab-in-classical-hodgkin-lymphoma/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/midostaurin-in-flt3-mutation-positive-acute-myeloid-leukemia-and-systemic-mastocytosis/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/fda-approves-betrixaban-for-prophylaxis-of-venous-thromboembolism/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/fda-approves-first-car-t-cell-therapy-for-pediatric-young-adult-patients-with-all/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/expert-point-of-view-david-maloney-md-and-kenneth-c-anderson-md/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/the-rising-incidence-of-thyroid-cancer-reconsidered/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/a-new-manual-for-the-expanding-field-of-bone-marrow-transplantation/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/a-doctor-s-call-to-arms-about-the-overuse-of-antibiotics/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/tales-from-the-or-a-pediatric-surgeon-s-memoir/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/addressing-the-challenges-of-intimacy-after-cancer/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/to-the-last-drop/ 2019-03-11T16:33:35+00:00 https://ascopost.com/issues/september-10-2017/clinical-trials-actively-recruiting-patients-with-prostate-cancer/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/cancer-has-robbed-me-of-a-life-i-loved/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/control/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/nccn-foundation-announces-fifth-2017-young-investigator-award/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/fever-therapy-for-cancer/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/substantial-improvements-in-the-treatment-of-glioblastoma/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/expect-questions-about-glioblastoma-symptoms/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/astro-welcomes-new-officers-to-board-of-directors/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/accelerated-vs-standard-epirubicin-and-capecitabine-vs-cmf-in-breast-cancer/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/dinutuximab-vs-temsirolimus-in-combination-therapy-for-children-with-resistant-neuroblastoma/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/first-line-cetuximab-vs-bevacizumab-plus-chemotherapy-in-kras-wild-type-colorectal-cancer/ 2019-03-11T16:33:36+00:00 https://ascopost.com/issues/september-10-2017/relationship-between-molecular-subtypes-of-gastric-cancer-and-prognosis/ 2019-03-11T16:33:37+00:00 https://ascopost.com/issues/september-10-2017/conquer-cancer-foundation-and-asco-international-development-and-education-award/ 2019-03-11T16:33:37+00:00 https://ascopost.com/issues/september-10-2017/fda-pilot-program-aims-to-encourage-students-to-pursue-stem-careers/ 2019-03-11T16:33:37+00:00 https://ascopost.com/issues/august-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/august-25-2017/fighting-misinformation-in-hpv-related-cancer-prevention/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/updates-of-key-trials-in-metastatic-non-small-cell-lung-cancer-keynote-024-and-avaall/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/deep-androgen-suppression-plus-abiraterone-and-prednisone-effective-strategy-for-hormone-naive-prostate-cancer/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/cutting-edge-induction-strategies-and-novel-approach-to-reducing-skeletal-related-events-explored-in-multiple-myeloma/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/first-universal-childhood-cancer-data-lab-opens/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/international-consensus-or-not-on-management-of-advanced-prostate-cancer/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/new-asco-recommendations-for-controlling-nausea-and-vomiting-related-to-cancer-treatment/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/checkmate-040-nivolumab-is-active-in-advanced-hepatocellular-carcinoma/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/pursuing-combination-strategies-with-checkpoint-and-tyrosine-kinase-inhibitors-in-hepatocellular-carcinoma/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/team-aims-to-apply-car-t-cell-therapy-to-pancreatic-cancer/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/ascocancer-care-ontario-joint-guideline-update-brachytherapy-for-patients-with-prostate-cancer/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/brachytherapy-for-prostate-cancer-an-old-form-of-radiation-treatment-that-is-still-one-of-the-most-effective/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/patricia-ganz-md-appointed-editor-in-chief-of-jnci/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/carlos-l-arteaga-md-named-director-of-ut-southwestern-cancer-center/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/asco-ccf-congratulate-2017-grant-and-award-recipients/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/be-a-conqueror-with-ccf-s-simple-fundraising-platform/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/charting-the-future-of-cancer-health-disparities-research/ 2019-03-11T16:34:21+00:00 https://ascopost.com/issues/august-25-2017/asco-offers-path-to-addressing-affordability-of-cancer-drugs/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/resource-for-your-patients-on-weight-management/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/reagan-udall-foundation-for-the-fda-launches-expanded-access-navigator-website/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/theodoros-n-teknos-md-named-president-and-scientific-officer-of-uh-seidman-cancer-center/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/anti-trop-2-antibody-drug-conjugate-produces-durable-responses-in-metastatic-triple-negative-breast-cancer/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/sacituzumab-govitecan-in-heavily-pretreated-metastatic-triple-negative-breast-cancer-a-step-in-the-right-direction/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/osimertinib-for-egfr-positive-nsclc-the-phase-iii-flaura-trial/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/chi-van-dang-md-phd-appointed-professor-at-the-wistar-institute/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/triple-negative-breast-cancer-practical-approach-promising-research/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/clinical-trials-actively-recruiting-patients-with-stage-iiiii-colorectal-cancer/ 2020-09-23T02:13:28+00:00 https://ascopost.com/issues/august-25-2017/unraveling-the-complexities-of-cellular-immunotherapy-and-its-potential-to-cure-some-cancers/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/turmeric/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/making-our-future-plans-happen-now/ 2020-09-23T02:14:29+00:00 https://ascopost.com/issues/august-25-2017/claire-verschraegen-md-joins-osuccc-james/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/on-my-way-to-hospice-care-immunotherapy-saved-my-life/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/robert-l-ferris-md-phd-named-director-of-upmc-hillman-cancer-center/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/recent-fda-actions-include-new-drug-approvals-in-leukemia-expanded-approvals-in-colorectal-cancer-and-graft-vs-host-disease/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/a-personal-tribute-to-angela-h-brodie-phd-a-scientist-who-transformed-breast-cancer-treatment/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/hospice-and-palliative-medicine-fellowship-created-at-fox-chase-cancer-center/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/slow-incremental-changes-are-increasing-participation-of-older-adults-in-clinical-trials/ 2020-02-17T17:45:28+00:00 https://ascopost.com/issues/august-25-2017/look-for-opportunities-to-lower-barriers-to-participation-of-older-patients-in-oncology-clinical-trials/ 2020-02-17T17:44:53+00:00 https://ascopost.com/issues/august-25-2017/reuben-shaw-phd-receives-nci-outstanding-investigator-award/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/pd-l1-expression-and-radiation-resistance-in-head-and-neck-squamous-cell-carcinoma/ 2019-03-11T16:34:22+00:00 https://ascopost.com/issues/august-25-2017/dabrafenib-plus-trametinib-in-braf-v600-mutant-melanoma-brain-metastases/ 2019-03-11T16:34:23+00:00 https://ascopost.com/issues/august-25-2017/world-oncology-leaders-reunion/ 2019-03-11T16:34:23+00:00 https://ascopost.com/issues/august-25-2017/clinically-meaningful-results-with-first-line-osimertinib-in-egfr-positive-nsclc/ 2019-03-19T15:39:29+00:00 https://ascopost.com/issues/august-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/august-10-2017/tissue-specimens-in-clinical-trials-a-double-edged-sword/ 2019-03-11T16:34:45+00:00 https://ascopost.com/issues/august-10-2017/a-new-triumvirate-in-estrogen-receptor-positive-metastatic-breast-cancer/ 2019-03-11T16:34:45+00:00 https://ascopost.com/issues/august-10-2017/fda-s-first-site-agnostic-drug-approval-marks-a-paradigm-shift-in-regulatory-criteria/ 2019-03-11T16:34:45+00:00 https://ascopost.com/issues/august-10-2017/in-case-you-missed-it-short-takes-on-current-cancer-research/ 2019-03-11T16:34:45+00:00 https://ascopost.com/issues/august-10-2017/fda-actions-yield-extended-approvals-of-novel-agents-advisory-committee-votes-favorably-on-two-biosimilars-and-pediatric-indication-for-car-t-cell-therapy/ 2019-03-11T16:34:45+00:00 https://ascopost.com/issues/august-10-2017/more-support-for-folfoxiribevacizumab-in-advanced-colorectal-cancer/ 2019-03-11T16:34:45+00:00 https://ascopost.com/issues/august-10-2017/expert-point-of-view-frank-sinicrope-md/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/new-data-reported-on-vemurafenib-vitamin-d-selective-internal-radiotherapy-and-circulating-tumor-dna-in-colorectal-cancer/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/convergence-of-precision-medicine-and-immuno-oncology/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/selected-abstracts-on-novel-therapies-for-hematologic-malignancies/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/syed-abutalib-md-appointed-to-education-committee-for-asbmt/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/financial-toxicity-cancer-supportive-care-professionals-consider-the-side-effects-of-soaring-costs/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/advances-in-the-treatment-of-triple-negative-breast-cancer/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/breast-cancer-surveillance-consortium-receives-17-million-nci-grant/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/challenges-in-geriatric-oncology-in-low-and-middle-income-countries-focus-on-latin-america/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/fox-chase-announces-new-immunotherapy-trial-in-breast-cancer/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/trends-in-thyroid-cancer-incidence-and-mortality-in-the-united-states/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/are-thyroid-cancer-incidence-and-mortality-rates-truly-increasing-in-the-united-states/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/us-preventive-services-task-force-recommends-against-screening-for-thyroid-cancer-in-asymptomatic-individuals/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/sai-yendamuri-md-facs-receives-2017-brompton-prize/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/alectinib-a-new-standard-for-first-line-therapy-of-alk-rearranged-nsclc/ 2019-03-11T16:34:46+00:00 https://ascopost.com/issues/august-10-2017/nyu-perlmutter-creates-new-pancreatic-cancer-center/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/improved-overall-survival-with-blinatumomab-vs-chemotherapy-in-advanced-acute-lymphoblastic-leukemia/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/blinatumomab-in-advanced-acute-lymphoblastic-leukemia-a-brighter-therapeutic-outlook/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/conquer-cancer-foundation-researcher-spotlight/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/spotlight-on-women-who-conquer-cancer/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/asco-president-bruce-e-johnson-seeks-to-bring-personalized-medicine-real-time-data-to-every-oncology-practice/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/practice-engagement-program-connects-practices-to-resources-to-adapt-to-health-care-changes/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/don-t-miss-your-chance-to-participate-in-the-2017-asco-practice-census/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/asco-resource-to-help-your-patients-quit-tobacco/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/steven-d-leach-md-named-director-of-norris-cotton-cancer-center/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/brenda-fitzgerald-md-appointed-cdc-director-and-atsdr-administrator/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/netrf-commits-4-million-for-neuroendocrine-tumor-research/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/two-san-diego-nonprofits-to-receive-2017-astro-survivor-circle-grants/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/julian-schink-md-named-chief-of-gynecologic-oncology-at-cancer-treatment-centers-of-america/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/first-oncologist-elected-ama-president-barbara-l-mcaneny-md-advocates-for-access-to-health-care-for-everyone/ 2019-03-11T16:34:47+00:00 https://ascopost.com/issues/august-10-2017/mammaprint-test-addressed-in-asco-breast-cancer-guideline-update/ 2020-09-18T21:03:10+00:00 https://ascopost.com/issues/august-10-2017/an-educational-program-for-safe-handling-of-opioids/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-angola/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/clinical-trials-actively-recruiting-patients-with-sarcomas/ 2020-09-18T21:01:25+00:00 https://ascopost.com/issues/august-10-2017/cancer-care-ontario-and-asco-clinical-practice-guideline-use-of-adjuvant-bisphosphonates-and-other-bone-modifying-agents-in-breast-cancer/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/one-size-may-not-fit-all-thoughts-on-the-new-adjuvant-bisphosphonate-guideline-for-early-stage-breast-cancer/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/how-to-help-young-patients-preserve-their-fertility/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/fertility-preservation-resources-for-ayas-with-cancer/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/searching-for-happiness/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/the-x-ray-era-1901-1915/ 2020-09-18T21:06:48+00:00 https://ascopost.com/issues/august-10-2017/i-live-my-life-in-3-to-6-month-increments/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/a-textbook-that-fills-a-special-need-in-oncology-uncommon-cancers/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/a-deep-and-incisive-look-into-the-health-care-system/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/an-expert-on-end-of-life-care-shares-her-stories/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/roswell-park-graduate-student-honored-by-national-cancer-institute/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/sylvia/ 2020-09-18T21:04:02+00:00 https://ascopost.com/issues/august-10-2017/ash-selects-11-fellows-for-research-award-in-academic-hematology/ 2019-03-11T16:34:48+00:00 https://ascopost.com/issues/august-10-2017/vaccine-chemotherapy-combination-in-glioblastoma/ 2019-03-11T16:34:49+00:00 https://ascopost.com/issues/august-10-2017/sacituzumab-govitecan-in-metastatic-nsclc/ 2019-03-11T16:34:49+00:00 https://ascopost.com/issues/august-10-2017/cost-of-hospitalization-for-cancer-related-neutropenia-or-fever/ 2019-03-11T16:34:49+00:00 https://ascopost.com/issues/august-10-2017/first-in-class-t-cell-stimulator-varlilumab-in-advanced-tumors/ 2019-03-11T16:34:49+00:00 https://ascopost.com/issues/august-10-2017/asco-tackles-the-issue-of-the-high-cost-of-cancer-drugs/ 2019-03-11T16:34:49+00:00 https://ascopost.com/issues/july-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/july-25-2017/maintaining-predictable-increases-in-nih-funding-for-cancer-research/ 2019-03-11T16:35:08+00:00 https://ascopost.com/issues/july-25-2017/drug-combinations-prove-effective-against-melanoma-brain-metastases/ 2019-03-11T16:35:08+00:00 https://ascopost.com/issues/july-25-2017/expert-point-of-view-lynn-schuchter-md/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/pivotal-car-t-cell-data-reported-in-relapsedrefractory-b-cell-all/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/ongoing-research-in-cancer-immunotherapy-for-children-with-leukemia/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/radiation-therapy-for-spinal-cord-compression-one-treatment-is-sufficient/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/expert-point-of-view-joshua-jones-md/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/tumor-sidedness-in-colon-cancer-studies-look-for-explanations/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/expert-point-of-view-steven-j-cohen-md-and-josep-tabarnero-md-phd/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/combination-strategies-for-jump-starting-the-immune-response/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/expert-point-of-view-siwen-hu-lieskovan-md/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/study-supports-omission-of-lymphadenectomy-in-node-negative-advanced-ovarian-cancer/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/expert-point-of-view-ritu-salani-md-mba/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/checkpoint-inhibitors-may-prove-to-be-effective-in-mesothelioma/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/expert-point-of-view-anne-tsao-md-and-john-heymach-md-phd/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/are-wearable-physical-activity-monitors-coming-of-age-in-oncology/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/breast-cancer-and-brain-metastases-whole-brain-radiotherapy-may-not-be-the-answer/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/digital-tomosynthesis-vs-mammography-in-unmasking-breast-cancer/ 2019-03-11T16:35:09+00:00 https://ascopost.com/issues/july-25-2017/nccn-panelists-relay-what-s-hot-in-their-fields/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/pembrolizumab-improves-overall-survival-vs-chemotherapy-in-second-line-therapy-for-advanced-urothelial-carcinoma/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/pembrolizumab-in-second-line-therapy-for-advanced-urothelial-carcinoma/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/pembrolizumab-is-active-in-platinum-and-cetuximab-refractory-head-and-neck-cancer/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/pembrolizumab-and-cetuximab-treated-head-and-neck-cancer-activity-confirmed-but-no-surprises/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/solange-peters-md-phd-elected-2020-2021-esmo-president/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/khurshid-guru-md-named-chair-of-urology-at-roswell-park/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/mike-heller-phd-joins-ohsu-knight-cancer-institute/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/2017-astro-gold-medalists-named/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/the-art-of-networking-advice-for-the-oncologist-in-training/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/asco-aaci-s-best-practices-in-cancer-clinical-trials-initiative-streamlining-adverse-events-reporting-and-research-community-forum-activities/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/register-now-for-qopi-qcdr-for-2017-cms-mips-reporting-one-patient-one-measure-no-penalty/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/key-leadership-in-place-in-trump-administration/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/proposed-2018-qpp-rule-adds-flexibility-but-questions-on-medicare-part-b-drugs-provision-remain/ 2019-03-11T16:35:10+00:00 https://ascopost.com/issues/july-25-2017/caregivers-have-an-essential-role-in-cancer-care-help-them-be-prepared/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/fda-takes-action-against-14-companies-for-selling-illegal-cancer-treatments/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/the-immune-system-deciphering-recent-advances/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/no-survival-benefit-when-pravastatin-is-added-to-standard-chemotherapy-in-small-cell-lung-cancer/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/adding-pravastatin-to-chemotherapy-in-small-cell-lung-cancer/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/advance-care-planning-ensuring-patients-end-of-life-wishes-are-honored/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/ensuring-advance-directives-are-followed-and-lawsuits-are-avoided/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/a-social-media-guide-by-a-doctor-for-doctors/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/huntsman-unveils-new-primary-children-s-and-families-cancer-research-center/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/living-with-cancer-survivorship-guilt/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/stereotactic-body-radiotherapy-for-poor-performance-status-patients-with-pancreatic-cancer/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/a-frank-memoir-about-doctors-patients-and-the-health-care-system/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/shiitake-mushroom-insufficient-evidence-to-support-it-boosts-immune-system/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/music-therapy-relevance-in-oncology/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/avelumab-in-refractory-metastatic-urothelial-carcinoma/ 2019-03-11T16:35:11+00:00 https://ascopost.com/issues/july-25-2017/prophylactic-cranial-irradiation-vs-observation-in-extensive-disease-small-cell-lung-cancer/ 2019-03-11T16:35:12+00:00 https://ascopost.com/issues/july-25-2017/educating-young-people-on-sun-safe-behaviors-and-reducing-the-risk-of-melanoma/ 2019-03-11T16:35:12+00:00 https://ascopost.com/issues/july-25-2017/spark-discussions-about-indoor-tanning-devices/ 2019-03-11T16:35:12+00:00 https://ascopost.com/issues/july-25-2017/edus-h-warren-md-phd-named-leader-of-fred-hutch-global-oncology-program/ 2019-03-11T16:35:12+00:00 https://ascopost.com/issues/july-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/july-10-2017/the-emperor-s-new-clothes-biosimilars-and-cost-in-oncology/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/pembrolizumab-moving-forward-in-triple-negative-breast-cancer/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/expert-point-of-view-leisha-a-emens-md-phd/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/overcoming-sexism-in-academic-medicine/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/car-t-cell-therapy-in-multiple-myeloma-yields-100-response-rate/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/expert-point-of-view-michael-s-sabel-md-marcela-maus-md-phd-and-carl-june-md/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/ublituximabibrutinib-beneficial-in-patients-with-chronic-lymphocytic-leukemia/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/expert-point-of-view-nitin-jain-md-and-susan-obrien-md/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/atezolizumabbevacizumab-moves-forward-in-metastatic-renal-cell-carcinoma/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/expert-point-of-view-hans-hammers-md-phd/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/dacomitinib-outperforms-gefitinib-in-egfr-positive-nsclc/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/expert-point-of-view-john-heymach-md/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/retreatment-with-checkpoint-inhibitors-may-be-feasible-for-some-patients-with-nsclc/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/potent-parp-inhibitor-moves-ahead-in-brca-mutated-breast-cancer/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/expert-point-of-view-leisha-a-emens-md-phd-1/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/update-on-nci-projects-aimed-at-advancing-precision-medicine/ 2019-03-11T16:35:32+00:00 https://ascopost.com/issues/july-10-2017/what-about-sharing-clinical-data/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/autologous-and-allogeneic-hematopoietic-cell-transplantation/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/preparing-for-future-challenges-in-geriatric-surgical-oncology/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/pembrolizumab-is-highly-active-in-relapsedrefractory-classical-hodgkin-lymphoma/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/encouraging-results-with-pembrolizumab-in-relapsedrefractory-classical-hodgkin-lymphoma/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/addition-of-adjuvant-capecitabine-to-gemcitabine-improves-survival-in-patients-with-resected-pancreatic-cancer/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/has-a-new-standard-really-been-established-for-the-adjuvant-treatment-of-pancreatic-cancer/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/fda-approves-aminolevulinic-acid-hydrochloride-as-an-optical-imaging-agent-indicated-in-gliomas/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/no-efficacy-difference-between-adjuvant-letrozole-and-anastrozole-in-postmenopausal-women-with-early-breast-cancer/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/neoadjuvant-studies-of-endocrine-approaches-in-breast-cancer-mandated-before-embarking-on-large-adjuvant-studies/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/second-cancers-may-be-deadlier-in-child-adolescent-and-young-adult-patients/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/asco-s-tapur-study-continues-its-expansion-of-sites-participants-and-collaborators/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/asco-s-new-macra-decision-tree-tool-helps-determine-which-qpp-reporting-requirements-apply-to-your-practice/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/stay-up-to-date-on-new-patient-materials-from-cancernet/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/a-great-idea-celebrating-15-years-of-the-international-development-and-education-award/ 2019-03-11T16:35:33+00:00 https://ascopost.com/issues/july-10-2017/conquer-cancer-foundation-researcher-spotlight-dr-supriya-mohile/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/cancer-research-grant-opportunities-for-early-career-and-junior-faculty-researchers/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/gideon-m-blumenthal-md-appointed-ohop-acting-deputy-office-director/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/newyork-presbyterian-establishes-william-rhodes-and-louise-tilzer-rhodes-center-for-glioblastoma/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/adding-idelalisib-to-bendamustinerituximab-in-relapsedrefractory-cll/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/idelalisib-in-resistant-cll-benefit-shown-questions-remain/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/phase-iii-cascade-trial-of-vadastuximab-talirine-in-front-line-aml-discontinued/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/understanding-the-cultural-differences-among-ethnic-minorities-in-palliative-and-end-of-life-care/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/wchn-launches-trial-to-screen-newly-diagnosed-patients-with-diabetes-for-early-stage-pancreatic-cancer/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/two-studies-show-scalp-cooling-reduces-hair-loss-in-women-receiving-chemotherapy-for-breast-cancer/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/scalp-cooling-to-prevent-chemotherapy-induced-alopecia-is-it-now-ready-for-prime-time/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/fda-approves-daratumumab-in-combination-with-pomalidomide-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/fda-approves-panitumumab-for-use-in-wild-type-ras-metastatic-colorectal-cancer/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/first-comprehensive-pediatric-hematologyoncology-initiative-launched-in-africa/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/world-health-assembly-s-new-cancer-resolution-reflects-new-realities/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/angela-alistar-md-joins-atlantic-health-system-cancer-care/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/mutations-in-myelodysplastic-syndrome-associated-with-poorer-outcome-after-stem-cell-transplantation/ 2019-03-11T16:35:34+00:00 https://ascopost.com/issues/july-10-2017/high-risk-mutations-predict-poor-outcomes-for-patients-with-myelodysplastic-syndromes-undergoing-transplantation/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/new-supportive-care-resources-from-nccn-help-patients-with-cancer-confront-distress/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/pediatric-cancer-pain-may-be-misunderstood-and-largely-undertreated/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/annual-report-to-the-nation-cancer-death-rates-continue-to-decline/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/i-reject-the-notion-i-m-on-a-cancer-journey/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/big-data-and-the-learning-machine/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/cancer-survivor-publishes-book-for-children-about-cancer/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/final-results-of-european-trial-in-mucosa-associated-lymphoid-tissue-lymphoma/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/blinatumomab-in-b-precursor-acute-lymphoblastic-leukemia/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/missak-haigentz-md-joins-atlantic-health-system-cancer-care/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/july-10-2017/james-francis-mccarthy/ 2019-03-11T16:35:35+00:00 https://ascopost.com/issues/june-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/june-25-2017/will-the-uk-s-departure-from-the-eu-impact-oncology-in-europe/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/some-patients-with-stage-iii-low-risk-colon-cancer-may-require-less-oxaliplatin-therapy/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-cathy-eng-md-facp-and-alfred-neugut-md-phd/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/online-self-reporting-of-symptoms-improves-quality-of-life-extends-survival/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-monika-k-krzyzanowska-md-mph/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/two-studies-show-abiraterone-plus-prednisoloneprednisone-added-to-standard-hormone-therapy-improves-survival-in-advanced-prostate-cancer/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-sumanta-pal-md/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/olaparib-improves-progression-free-survival-in-brca-associated-breast-cancer/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-allison-kurian-md-msc/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/abemaciclib-plus-fulvestrant-delays-breast-cancer-progression-in-monarch-2/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-richard-s-finn-md-and-ingrid-a-mayer-md/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/novel-tropomyosin-receptor-kinase-inhibitor-yields-high-response-rates-across-tumor-types/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-sumanta-kumar-pal-md-and-john-v-heymach-md-phd/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/swog-clinical-trials-have-yielded-positive-return-on-investment/ 2019-03-11T16:35:55+00:00 https://ascopost.com/issues/june-25-2017/oncologist-barbara-l-mcaneny-md-fasco-macp-elected-ama-president-elect/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/asco-statement-norman-sharpless-md-brings-proven-scientific-leadership-to-the-national-cancer-institute/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/asco-applauds-nih-director-francis-collins-md-phd-for-remaining-in-critical-leadership-position/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/alectinib-vs-crizotinib-in-first-line-treatment-of-alk-positive-nsclc/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-john-v-heymach-md-phd/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/pregnancy-after-breast-cancer/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/positive-results-for-aphinity-but-value-of-benefit-of-dual-her2-blockade-questioned/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-harold-burstein-md-carey-anders-md-and-william-sikov-md/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/fda-approves-daratumumab-in-combination-with-pomalidomide-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/newer-approaches-with-car-t-cells-explored-in-cll/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-susan-obrien-md/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/jeffrey-l-molter-joins-nyu-langone-as-director-of-cancer-center-communication/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/identifying-genetic-basis-for-extraordinary-clinical-responses-may-accelerate-development-of-new-therapies/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/iaslc-endorses-tobacco-reform-report/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/strides-being-made-in-advanced-urothelial-cancer/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/ascpcapampasco-guideline-on-molecular-biomarkers-in-colorectal-cancer/ 2019-03-11T16:35:56+00:00 https://ascopost.com/issues/june-25-2017/ascpcapampasco-colorectal-cancer-biomarker-guideline-a-clinicians-perspective/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/lu-177-dotatate-improves-progression-free-survival-in-advanced-progressive-midgut-neuroendocrine-tumors/ 2019-07-11T20:40:50+00:00 https://ascopost.com/issues/june-25-2017/major-breakthrough-in-development-of-systemic-targeted-therapy-for-midgut-neuroendocrine-tumors/ 2019-07-11T20:43:21+00:00 https://ascopost.com/issues/june-25-2017/asco-university-business-of-health-care-fundamentals-course-education-for-the-complete-care-team/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/early-symptom-reporting-can-extend-life-for-patients-with-advanced-cancer/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/promoting-physician-wellness-an-overview-of-asco-initiatives/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/direct-your-patients-to-cancernet-to-watch-patient-friendly-videos/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/asco-launches-centra-a-new-hub-for-cancer-care-research-data-and-analysis/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/asco-comments-on-interchangeability-of-biosimilars/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/president-s-budget-threatens-nation-s-progress-against-cancer/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/sidney-kimmel-elected-to-american-academy-of-arts-and-sciences/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/brief-psychological-interventions-positively-affect-cancer-patients-well-being/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/expert-point-of-view-richard-l-schilsky-md-and-don-dizon-md/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/learn-how-to-implement-a-biopsychosocial-screening-training-program/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/clifford-a-hudis-md-facp-fasco-selected-for-drexel-100/ 2019-03-11T16:35:57+00:00 https://ascopost.com/issues/june-25-2017/decreasing-but-still-elevated-risk-for-subsequent-neoplasms-in-survivors-of-childhood-cancer/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/lessons-learned-and-to-be-learned-reducing-risk-of-subsequent-malignancies-in-childhood-cancer-survivors/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/national-cancer-institute-awards-fred-hutch-24-million-for-contact-center/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/seattle-children-s-clinical-trial-on-molecular-diagnostics-opens-for-pediatric-patients/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/using-a-pediatric-treatment-approach-to-improve-outcomes-for-young-adults-with-all/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/monica-morrow-md-tumbled-gender-barriers-to-build-a-career-in-surgical-oncology/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/cancercare-releases-research-on-patient-values-initiative/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/incorporating-the-goals-of-medicine-with-the-goals-of-care/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/shiitake-mushroom/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/how-watson-for-oncology-is-advancing-personalized-patient-care/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/growing-use-of-molecular-pathology-may-help-avoid-overtreatment-of-early-breast-cancer/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/testosterone-replacement-therapy-and-the-risk-of-prostate-cancer/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/adding-vandetanib-to-gemcitabine-in-locally-advanced-or-metastatic-pancreatic-carcinoma/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/uspstf-emphasizes-importance-of-informed-discussions-about-psa-screening-for-men-aged-55-to-69-years/ 2019-03-11T16:35:58+00:00 https://ascopost.com/issues/june-25-2017/expect-questions-about-shift-in-prostate-cancer-screening-recommendation/ 2019-03-11T16:35:59+00:00 https://ascopost.com/issues/june-25-2017/renowned-breast-cancer-researcher-angela-hartley-brodie-phd-dies-at-82/ 2019-03-11T16:35:59+00:00 https://ascopost.com/issues/june-25-2017/cancer-gave-me-the-impetus-to-lose-weight/ 2019-03-11T16:35:59+00:00 https://ascopost.com/issues/june-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/june-10-2017/adjuvant-gefitinib-delays-recurrence-in-egfr-positive-nsclc/ 2019-03-11T16:36:21+00:00 https://ascopost.com/issues/june-10-2017/expert-point-of-view-trever-bivona-md-phd/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/value-based-decision-making-tools-the-view-ahead/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/making-american-research-great-again/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/tree-nut-consumption-may-improve-outcomes-in-stage-iii-colon-cancer/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/expert-point-of-view-manish-shah-md-and-daniel-f-hayes-md-facp-fasco/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/fda-approves-pembrolizumab-for-first-tissuesite-agnostic-indication/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/venetoclax-achieves-durable-and-deep-remissions-in-cll/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/idelalisib-toxicities-appear-to-be-immune-related/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/lack-of-access-to-transfusions-limits-hospice-use-by-patients-with-hematologic-malignancies/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/new-horizons-in-immunotherapy-for-head-and-neck-cancer/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/targeted-therapy-in-the-age-of-immunotherapy-in-head-and-neck-cancer/ 2019-03-11T16:36:22+00:00 https://ascopost.com/issues/june-10-2017/proton-therapy-associated-with-fewer-sequelae-in-the-treatment-of-head-and-neck-cancer/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/optimizing-quality-of-life-in-head-and-neck-cancer-survivors/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/lymphedema-risk-it-s-not-just-about-the-surgery/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/expert-point-of-view-michael-berry-md/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/targeting-the-androgen-receptor-in-breast-cancer/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/selected-novel-agents-in-development-for-multiple-myeloma/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/fda-broadens-ceritinib-indication/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/combination-therapy-with-pembrolizumab-in-metastatic-nonsquamous-nsclc/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/wendy-s-rubinstein-md-phd-facmg-facp-joins-cancerlinq-llc-as-division-director-clinical-data-management-and-curation/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/leave-a-legacy-of-hope/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/asco-resources-help-practices-navigate-quality-reporting-under-macra/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/help-your-patients-catch-up-on-the-latest-research-from-the-2017-asco-annual-meeting/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/proposed-categories-of-cancer-survivors-aim-to-bring-survivorship-into-precision-medicine-era/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/asco-come-home-offers-direct-support-to-practices-transitioning-to-quality-payment-program/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/asco-launches-volunteer-corps/ 2019-03-11T16:36:23+00:00 https://ascopost.com/issues/june-10-2017/geriatric-oncology-a-multidisciplinary-approach-in-a-global-environment/ 2020-02-17T17:50:14+00:00 https://ascopost.com/issues/june-10-2017/combinations-of-novel-treatment-approaches-continue-to-make-progress-in-overcoming-challenges-of-pediatric-brain-tumors/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/brian-wolpin-md-mph-named-director-of-gastrointestinal-cancer-center-at-dana-farber/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/brian-marr-md-joins-division-of-ophthalmic-oncology-at-newyork-presbyteriancolumbia-university-medical-center/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/who-to-begin-pilot-prequalification-of-biosimilars-for-cancer-treatment/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/lenalidomide-bortezomib-and-dexamethasone-with-or-without-transplantation-in-younger-myeloma-patients/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/autologous-transplantation-for-myeloma-don-t-change-the-winning-team/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/atezolizumab-improves-overall-survival-vs-docetaxel-in-previously-treated-non-small-cell-lung-cancer/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/atezolizumab-another-therapeutic-option-for-patients-with-previously-treated-non-small-cell-lung-cancer/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/robert-j-cerfolio-md-joins-nyu-langone-perlmutter-cancer-center/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/survival-benefit-of-adding-antiandrogen-therapy-to-radiation-in-recurrent-prostate-cancer-final-results-of-rtog-9601/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/androgen-blockade-and-salvage-radiation-therapy-in-prostate-cancer-cautious-optimism-amid-unanswered-questions/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/ipilimumab-vs-placebo-in-metastatic-chemotherapy-naive-castration-resistant-prostate-cancer-without-visceral-metastases/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/fred-pamela-buffett-cancer-center-dedicated-at-unmc/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/anthracyclines-in-her2-negative-breast-cancer/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/clofarabine-based-consolidation-in-younger-patients-with-aml/ 2019-03-11T16:36:24+00:00 https://ascopost.com/issues/june-10-2017/the-serendipitous-road-to-drug-development/ 2019-03-11T16:36:25+00:00 https://ascopost.com/issues/june-10-2017/refocusing-doctor-patient-conversations/ 2019-03-11T16:36:25+00:00 https://ascopost.com/issues/june-10-2017/cancer-has-made-me-a-better-person/ 2019-03-11T16:36:25+00:00 https://ascopost.com/issues/june-10-2017/a-remembrance-of-h-jean-khoury-md/ 2019-03-11T16:36:25+00:00 https://ascopost.com/issues/june-10-2017/memorial-sloan-kettering-cancer-center-s-visible-ink-writing-program-gives-voice-to-the-experiences-of-cancer-survivors/ 2019-03-11T16:36:25+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/narratives-in-oncology/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/asco-president-bruce-e-johnson-md-fasco-participates-in-key-research-with-egfr-mutation-in-lung-cancer/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/asco-presidents-through-the-years/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/renowned-hematologist-mojtaba-akhtari-md-reflects-on-a-new-era-in-treating-blood-cancers/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/nobel-laureate-david-baltimore-phd-plays-integral-role-in-linking-cell-biology-and-cancer-genetics/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/nobel-prize-in-physiology-or-medicine-laureates-in-oncology/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/daniel-von-hoff-md-facp-receives-gold-medal-from-columbia-university/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/clinical-researcher-george-p-canellos-md-closely-involved-with-two-of-the-most-influential-treatments-in-cancer-care/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/waun-ki-hong-md-facp-helped-change-the-standard-of-care-in-laryngeal-cancer-now-focuses-on-chemoprevention-and-precision-medicine/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/fda-oncology-drug-approvals-granted-between-august-2016-and-may-18-2017/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/distinguished-pediatric-oncologist-anna-t-meadows-md-led-the-way-for-studies-in-childhood-cancer-survivors/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/asco-2017-presents-women-who-conquer-cancer-mentorship-award/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/pioneer-in-geriatric-oncology-hyman-muss-md-continues-to-improve-care-for-older-patients/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/robert-vonderheide-md-dphil-named-director-of-abramson-cancer-center/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/special-awards-and-lectures-presented-during-2017-asco-annual-meeting/ 2019-03-11T16:36:46+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/radiation-oncologist-lori-j-pierce-md-fasco-fastro-enjoys-balancing-administrative-and-clinical-roles/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/susan-g-komen-names-eight-advisors-to-guide-breast-cancer-research-program/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/scott-gottlieb-md-receives-confirmation-as-fda-commissioner/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/eliezer-robinson-md-traveled-a-long-hard-road-and-became-an-international-leader-in-oncology/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/at-the-forefront-of-cancer-genetics-bert-vogelstein-md-calls-for-focus-on-early-detection-and-prevention/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/su2c-awards-innovative-research-grants-in-immuno-oncology-to-10-early-career-scientists/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/conquer-cancer-foundation-of-asco-awards-celebrate-innovation-and-diversity/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/for-eric-p-winer-md-empathy-and-a-sense-of-purpose-lead-to-a-career-in-oncology/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/the-asco-post-remembers-and-pays-tribute-to/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/leader-in-international-clinical-trials-robert-l-comis-md-fasco-dies-at-71/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/aacr-honors-mina-j-bissell-phd-faacr-with-award-for-lifetime-achievement-in-cancer-research/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/after-nearly-4-decades-of-research-wk-alfred-yung-md-sees-a-new-era-ahead-for-advances-in-brain-tumors/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/2017-fellows-of-the-american-society-of-clinical-oncology-fasco/ 2019-03-11T16:36:47+00:00 https://ascopost.com/issues/june-3-2017-narratives-special-issue/celebrating-cancer-survivorship/ 2019-03-11T16:36:48+00:00 https://ascopost.com/issues/may-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/may-25-2017/my-year-of-living-wonderfully-12-months-as-asco-president/ 2019-03-11T16:37:01+00:00 https://ascopost.com/issues/may-25-2017/adjuvant-capecitabine-for-biliary-tract-cancer-yields-significant-improvement-in-overall-survival/ 2019-03-11T16:37:01+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-lipika-goyal-md/ 2019-03-11T16:37:01+00:00 https://ascopost.com/issues/may-25-2017/asco-ceo-reflects-on-his-first-year-in-office-and-what-is-ahead/ 2019-03-11T16:37:01+00:00 https://ascopost.com/issues/may-25-2017/nccn-clinical-practice-guidelines-in-oncology-nccn-guidelines-2017-guidelines/ 2019-03-11T16:37:02+00:00 https://ascopost.com/issues/may-25-2017/prognostic-model-may-prove-useful-after-nephrectomy/ 2019-03-11T16:37:02+00:00 https://ascopost.com/issues/may-25-2017/rates-of-oral-hpv-infection-plummet-after-vaccination/ 2019-03-11T16:37:02+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-denise-a-galloway-phd/ 2019-03-11T16:37:02+00:00 https://ascopost.com/issues/may-25-2017/asco-provisional-clinical-opinion-on-hormonal-therapy-for-castration-resistant-prostate-cancer/ 2019-03-11T16:37:02+00:00 https://ascopost.com/issues/may-25-2017/intratumoral-plasmid-interleukin-12-boosts-response-to-pembrolizumab/ 2019-03-11T16:37:02+00:00 https://ascopost.com/issues/may-25-2017/triple-modality-therapy-achieves-good-control-in-inflammatory-breast-cancer/ 2019-03-11T16:37:02+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-judy-c-boughey-md/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/study-establishes-low-risk-for-contralateral-breast-cancer-after-diagnosis-of-ductal-carcinoma-in-situ/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-julie-margenthaler-md/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/anticipate-sexual-dysfunction-in-patients-on-aromatase-inhibitors/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/abemaciclib-active-in-metastatic-breast-cancer/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-filipa-lynce-md/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/neratinib-in-combination-with-ado-trastuzumab-emtansine-in-her2-positive-metastatic-breast-cancer/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/atezolizumab-improves-overall-survival-in-small-subset-of-patients-with-triple-negative-breast-cancer/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-aditya-bardia-md-mph/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/marie-bleakley-md-phd-receives-research-grant-in-immuno-oncology-from-stand-up-to-cancer/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/rafal-dziadziuszko-md-phd-receives-2017-heine-h-hansen-award/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/car-t-cells-in-relapsed-b-cell-acute-lymphoblastic-leukemia/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-david-l-porter-md-jonathan-s-serody-md/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/new-immunotherapy-combinations-gain-ground-in-advanced-melanoma-but-results-preliminary/ 2019-03-11T16:37:03+00:00 https://ascopost.com/issues/may-25-2017/two-faculty-members-from-johns-hopkins-elected-to-national-academy-of-sciences/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/common-causes-of-death-predominate-among-long-term-colorectal-cancer-survivors/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/expert-point-of-view-patrick-s-sullivan-md/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/jnccn-360-the-source-for-tumor-specific-news-and-treatment-updates-available-now/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/ronald-p-dematteo-md-facs-named-chair-of-the-department-of-surgery-at-penn-medicine/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/hydroxychloroquine-boosts-antitumor-activity-of-neoadjuvant-chemotherapy-for-pancreatic-cancer/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/smoldering-and-relapsed-or-refractory-multiple-myeloma/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/new-partnership-seeks-to-raise-skin-cancer-awareness/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/suboptimal-genetic-testing-and-counseling-among-women-with-newly-diagnosed-breast-cancer/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/provision-of-genetic-services-to-women-with-breast-cancer-we-must-do-much-better/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/wendy-s-rubinstein-md-phd-joins-cancerlinq-llc-as-division-director-clinical-data-management-and-curation/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/germline-genetic-testing-and-treatment-decisions-in-early-stage-breast-cancer/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/accrual-of-older-patients-to-breast-cancer-trials-a-critical-need/ 2019-03-11T16:37:04+00:00 https://ascopost.com/issues/may-25-2017/texas-medical-center-names-william-f-mckeon-president-and-ceo/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/aspo-honors-kurt-ribisl-phd-with-joseph-w-cullen-memorial-award/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/asco-clinical-practice-guideline-management-of-small-renal-masses/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/managing-small-renal-masses-a-point-by-point-consideration-of-asco-s-clinical-practice-guideline/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/european-commission-approves-nivolumab-for-head-and-neck-squamous-cell-carcinoma-progressing-after-platinum-therapy/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/su2c-names-top-researchers-to-12-million-dream-team-on-colorectal-cancer/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/short-course-radiotherapy-plus-temozolomide-improves-survival-in-older-patients-with-glioblastoma/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/optimizing-treatment-for-elderly-patients-with-glioblastoma/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/first-in-human-clinical-trial-in-children-and-young-adults-with-leukemia/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/henry-ford-cancer-institute-appoints-spencer-c-hoover-vice-president-executive-director/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/key-gene-controlling-tumor-growth-in-gliomas-pinpointed/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/the-ongoing-challenges-of-lung-cancer-screening/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/checkmate-275-supports-fda-approval-of-nivolumab-in-metastatic-urothelial-carcinoma-after-platinum-therapy/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/metastatic-urothelial-carcinoma-a-model-malignancy-for-immune-checkpoint-blockade/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/new-chief-of-chop-s-cellular-therapy-and-transplant-section/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/pharmaceutical-companies-collaborate-in-nccn-oncology-research-program/ 2019-03-11T16:37:05+00:00 https://ascopost.com/issues/may-25-2017/alice-t-shaw-md-phd-joins-lungevity-foundation-scientific-advisory-board/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/asco-issues-recommendations-for-reducing-cancer-disparities-among-sexual-and-gender-minority-populations/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/4-reasons-to-use-social-media-at-the-asco-annual-meeting/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/new-asco-answers-fact-sheets-for-your-patients/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/enhance-your-annual-meeting-experience-with-attendee-resources/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/asco-s-new-strategic-plan-for-increasing-racial-and-ethnic-diversity-in-the-oncology-workforce/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/asco-wants-to-hear-from-your-practice-take-part-in-the-2017-asco-practice-census/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/daniel-w-kulp-phd-joins-the-wistar-institute-in-the-vaccine-center/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/estro-2017-study-suggests-role-for-radiotherapy-in-extending-survival-in-patients-with-early-stage-pancreatic-cancer/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/setting-his-presidential-course-on-making-precision-medicine-a-reality-for-more-patients/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/what-is-appropriate-treatment-of-oligometastatic-hormone-sensitive-prostate-cancer/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/niraparib-in-recurrent-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/clark-chen-md-phd-to-join-university-of-minnesota/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/aacr-honors-mina-j-bissell-phd-faacr-with-award-for-lifetime-achievement-in-cancer-research/ 2019-03-11T16:37:06+00:00 https://ascopost.com/issues/may-25-2017/six-ny-scientists-win-pershing-square-sohn-prize-for-young-investigators-in-cancer-research/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/palbociclib-combined-with-aromatase-inhibitor-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/sir-richard-peto-frs-to-receive-mcguire-award-at-2017-sabcs/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/unique-challenges-facing-young-women-with-breast-cancer/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/james-allison-phd-named-one-of-time-s-100-most-influential-people-in-2017/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/statement-from-ash-president-on-cancer-drug-parity-act/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/osimertinib-in-metastatic-egfr-t790m-mutant-nsclc-after-egfr-inhibitor-therapy/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/new-immunotherapy-trial-in-breast-cancer-at-fox-chase-cancer-center/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/tackling-the-obesity-and-cancer-epidemic/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/weight-management-and-physical-activity-in-cancer-care-from-research-to-real-world/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/zoledronic-acid-every-12-weeks-noninferior-to-every-4-weeks-in-skeletal-related-event-rate-for-breast-cancer-with-bone-metastases/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/optimize-2-trial-offers-reassuring-data-on-deescalation-of-bisphosphonate-therapy-for-breast-cancer-related-bone-metastases/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/impact-of-proposed-cuts-to-nih-budget-more-than-just-about-cancer/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/former-vice-president-joe-biden-and-congressman-kevin-yoder-pledge-continued-support-to-conquer-cancer/ 2019-03-11T16:37:07+00:00 https://ascopost.com/issues/may-25-2017/precision-medicine-and-my-own-activism-are-keeping-me-alive/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/new-spanish-language-videos-and-brochures-from-astro-provide-overview-of-radiation-therapy/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/erratum-father-son-confusion/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/it-is-what-it-is/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/lung-cancer-hope-from-science/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/recognizing-major-role-of-random-mutations-in-causing-cancer-does-not-diminish-importance-of-primary-prevention/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/expect-questions-from-patients-who-do-everything-right-but-still-develop-cancer/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/the-role-of-meditation-in-cancer-care/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/robert-vonderheide-md-dphil-named-director-of-abramson-cancer-center/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/immunotherapy-clinical-trials-in-metastatic-melanoma/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/cholesterol-lowering-medication-use-and-breast-cancer-outcome/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/pediatric-oncology-patient-and-parent-attitudes-on-early-palliative-care-integration/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-25-2017/leader-in-international-clinical-trials-robert-l-comis-md-fasco-dies-at-71/ 2019-03-11T16:37:08+00:00 https://ascopost.com/issues/may-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/may-10-2017/out-of-the-box-approach-plus-temozolomide-extends-survival-in-glioblastoma/ 2019-03-11T16:37:35+00:00 https://ascopost.com/issues/may-10-2017/expert-point-of-view-george-demetri-md/ 2019-03-11T16:37:35+00:00 https://ascopost.com/issues/may-10-2017/one-physician-s-experience/ 2019-03-11T16:37:35+00:00 https://ascopost.com/issues/may-10-2017/ensuring-equitable-cancer-care-for-all-patients/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/cancer-mortality-trends-in-the-united-states-vary-widely-by-county-from-1980-to-2014/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/on-the-variance-of-cancer-outcomes-by-time-and-geography/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/nivolumabipilimumab-combination-improves-survival-over-ipilimumab-alone-in-patients-with-melanoma/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/expert-point-of-view-gary-k-schwartz-md/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/five-year-survival-quadrupled-in-responders-to-immunotherapy-for-non-small-cell-lung-cancer/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/expert-point-of-view-ashish-saxena-md-phd/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/hyperthermic-intraperitoneal-chemoperfusion-may-be-efficacious-for-peritoneal-metastases/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/expert-point-of-view-daniel-g-coit-md/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/neo-bioscore-improves-staging-of-breast-cancer-treated-with-neoadjuvant-chemotherapy/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/expert-point-of-view-kelly-m-mcmasters-md-phd/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/selected-abstracts-from-the-2016-ash-annual-meeting/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/karmanos-cancer-institute-now-offers-image-fusion-technology-to-detect-prostate-cancer/ 2019-03-11T16:37:36+00:00 https://ascopost.com/issues/may-10-2017/swog-launches-first-prospective-registration-trial-with-atezolizumab-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer/ 2021-02-09T22:58:05+00:00 https://ascopost.com/issues/may-10-2017/neoadjuvant-immunotherapy-in-high-risk-melanoma-a-new-approach/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/cancer-research-uk-awards-six-us-scientists-87-million-as-part-of-grand-challenge/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/donor-spotlight-conquering-cancer-with-kelly-cares-foundation/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/support-the-conquer-cancer-foundation-at-the-2017-asco-annual-meeting/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/qopi-certification-program-certifies-first-practice-in-brazil/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/social-media-a-knowledge-sharing-tool-in-oncology/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/asco-selects-2017-2018-health-policy-fellows/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/register-today-for-the-asco-research-community-forum-2017-annual-meeting/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/asco-answers-palliative-care-a-resource-for-patients/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/immune-system-is-shaping-the-future-of-multiple-myeloma-treatment/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/blinatumomab-takes-a-bite-out-of-acute-lymphoblastic-leukemia/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/expanding-role-seen-for-minimal-residual-disease-in-managing-multiple-myeloma/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/leukemia-lymphoma-society-launches-myeloma-link-in-collaboration-with-national-black-church-initiative/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/avelumab-in-merkel-cell-carcinoma/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/ahmad-samer-al-homsi-md-mba-to-lead-new-bone-marrow-transplantation-initiative-at-nyu/ 2019-03-11T16:37:37+00:00 https://ascopost.com/issues/may-10-2017/lenalidomide-as-maintenance-therapy-in-multiple-myeloma-after-autologous-stem-cell-transplantation/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017/a-new-book-deals-with-an-age-old-crisis-cancer-patients-and-mortality/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017/luis-a-diaz-md-named-head-of-solid-tumor-oncology-at-msk/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017/saving-my-hair-changed-my-perception-of-having-cancer/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017/gefitinib-or-erlotinib-vs-chemotherapy-in-advanced-nsclc/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017/never-smokers-account-for-increased-proportion-of-nsclc-cases/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017/sentinel-lymph-node-biopsy-vs-lymphadenectomy-in-endometrial-cancer-staging/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017/intermittent-vismodegib-regimens-in-basal-cell-cancers/ 2019-03-11T16:37:38+00:00 https://ascopost.com/issues/may-10-2017-supplement-cdk46-inhibitors/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/may-10-2017-supplement-cdk46-inhibitors/introduction-cdk46-inhibitors-moving-beyond-the-breast-cancer-setting/ 2019-03-11T16:37:56+00:00 https://ascopost.com/issues/may-10-2017-supplement-cdk46-inhibitors/cdk46-inhibitors-their-role-in-breast-cancer/ 2019-03-11T16:37:56+00:00 https://ascopost.com/issues/may-10-2017-supplement-cdk46-inhibitors/cdk46-inhibitors-where-they-are-now-and-where-they-are-headed-in-the-future/ 2019-03-11T16:37:56+00:00 https://ascopost.com/issues/may-10-2017-supplement-cdk46-inhibitors/first-in-human-experience-with-abemaciclib/ 2019-03-11T16:37:57+00:00 https://ascopost.com/issues/may-10-2017-supplement-cdk46-inhibitors/selected-clinical-trials-of-cdk46-inhibitors/ 2019-03-11T16:37:57+00:00 https://ascopost.com/issues/april-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/april-25-2017/dual-her2-targeting-of-her2-positive-metastatic-colorectal-cancer-shows-clinical-benefit/ 2019-03-11T16:38:12+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-rodrigo-dienstmann-md/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/aacr-introduces-new-incoming-officers-of-the-associate-member-council/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/how-asco-s-cancerlinq-discovery-will-help-speed-research-advances-and-improve-patient-outcomes/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/next-generation-genitourinary-oncology-keeping-one-s-powder-dry/ 2021-02-09T22:55:29+00:00 https://ascopost.com/issues/april-25-2017/avelumab-produces-durable-responses-in-merkel-cell-carcinoma-becomes-first-drug-approved-for-the-rare-disease/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-suzanne-l-topalian-md/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/machine-learning-model-predicts-colorectal-cancer-recurrence/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-kelly-m-mcmasters-md-phd/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/decision-aid-improves-breast-cancer-patients-knowledge-of-surgical-options/ 2020-09-18T20:21:02+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-steven-l-chen-md/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/featured-lectures-presented-at-society-of-surgical-oncology/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/james-mohler-md-receives-2017-rodger-winn-award/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/rucaparib-leads-to-frequent-durable-remissions-in-brca-mutated-relapsed-ovarian-cancer/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-jonathan-ledermann-md/ 2019-03-11T16:38:13+00:00 https://ascopost.com/issues/april-25-2017/onset-of-diabetes-or-its-rapid-deterioration-can-be-an-early-warning-sign-of-pancreatic-cancer/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/breath-test-might-help-detect-stomach-and-esophageal-cancers/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/pembrolizumab-active-in-mucosal-melanoma-in-keynote-studies/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/progress-in-defining-molecular-signature-for-aggressive-androgen-indifferent-prostate-cancer/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/one-cycle-of-bep-as-good-as-two-in-high-risk-testicular-cancer/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-prof-noel-clarke-mbbs-frcs-chm/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/combination-of-atezolizumab-and-bevacizumab-in-pd-l1-positive-patients-with-metastatic-kidney-cancer/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-eric-jonasch-md/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/nivolumab-in-urothelial-carcinoma-after-platinum-therapy/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/nccn-foundation-board-of-directors-names-new-leadership/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/judy-e-garber-md-mph-receives-aacr-joseph-h-burchenal-memorial-award/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/treatment-of-diffuse-large-b-cell-lymphoma-continues-to-evolve/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/treating-human-immunodeficiency-virus-related-lymphoma/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/study-projects-hiv-related-cancer-burden-to-decline/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/adding-daratumumab-to-lenalidomidedexamethasone-increases-progression-free-survival-in-previously-treated-multiple-myeloma/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/monoclonal-antibody-therapy-with-daratumumab-in-multiple-myeloma-expanding-therapeutic-horizons/ 2019-03-11T16:38:14+00:00 https://ascopost.com/issues/april-25-2017/equivalent-response-rates-with-trastuzumab-or-a-trastuzumab-biosimilar-plus-taxane-in-her2-positive-metastatic-breast-cancer/ 2020-09-18T20:23:35+00:00 https://ascopost.com/issues/april-25-2017/trastuzumab-biosimilar-could-lead-to-lower-health-care-costs-and-greater-drug-access-for-patients-with-metastatic-breast-cancer/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/better-vision-function-may-be-related-to-better-quality-of-life-in-patients-with-head-and-neck-cancer/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/attrition-high-but-positive-trends-observed-in-web-based-intervention-addressing-caregiver-burden/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/resilience-linked-to-less-distress-in-lesbian-and-bisexual-breast-cancer-survivors/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/mark-s-soberman-md-mba-facs-named-accc-president/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/we-ed-bosarge-jr-phd-honored-with-2017-aacr-distinguished-public-service-award/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/deintensifiying-treatment-of-hpv-positive-oropharyngeal-cancer-could-reduce-toxicity-while-maintaining-function-and-survival/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/asco-releases-position-statement-on-access-to-investigational-drugs/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/an-oncology-care-model-one-institute-s-experience/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/can-you-hear-me-now-listening-to-the-cancer-patient/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/asco-honors-researchers-scientists-for-significant-advances-in-cancer-treatment-and-care/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/macra-implementation-has-begun-will-you-avoid-a-4-reimbursement-penalty/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/new-asco-answers-managing-cancer-related-pain-booklet-for-your-patients/ 2019-03-11T16:38:15+00:00 https://ascopost.com/issues/april-25-2017/conquer-cancer-foundation-recognizes-global-oncology-researchers-with-international-innovation-grant/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/research-reveals-new-treatment-possibilities-for-prostate-cancer/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/new-study-finds-global-smoking-rates-on-decline-but-shows-more-work-is-still-needed/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/joanne-berger-sweeney-phd-mph-elected-to-cold-spring-harbor-laboratory-board-of-trustees/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/kristy-l-weber-md-named-second-vice-president-aaos-board-of-directors/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/paula-h-finestone-phd-joins-fox-chase-cancer-center/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/roswell-park-names-chair-of-cancer-genetics-and-genomics/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/david-m-livingston-md-receives-aacr-international-award/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/ophira-ginsburg-md-to-lead-new-high-risk-program-at-nyu-langone-s-perlmutter-cancer-center/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/stage-i-lung-cancer-treatment-advances-have-changed-the-game/ 2020-09-18T20:27:40+00:00 https://ascopost.com/issues/april-25-2017/using-geriatric-assessment-strategies-to-inform-patient-centered-end-of-life-care/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/roger-s-lo-md-phd-receives-inaugural-aacr-waun-ki-hong-award-for-cancer-research/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/utilizing-physiatrists-to-evaluate-and-manage-cancer-related-cognitive-impairment/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/keith-t-flaherty-md-named-new-editor-in-chief-of-clinical-cancer-research/ 2019-03-11T16:38:16+00:00 https://ascopost.com/issues/april-25-2017/study-finds-link-between-telomere-length-and-sociodemographic-circumstances-linked-to-neighborhood/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/cranberry/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/different-subtypes-of-acute-myeloid-leukemia-create-both-clinical-and-research-challenges/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/asco-selects-2017-2018-health-policy-fellows/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/fnih-awards-lurie-prize-in-biomedical-sciences-to-david-m-sabatini-md-phd/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/two-studies-show-potential-of-venetoclax-as-single-agent-and-in-combination-for-myeloma/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-review-amrita-krishnan-md/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/car-t-cell-therapy-shows-benefit-in-patients-with-treatment-resistant-chronic-lymphocytic-leukemia/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/institute-for-clinical-immuno-oncology-white-paper-highlights-challenges-progress-and-priorities-in-immunotherapy/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/updated-data-on-treatment-with-ibrutinib-and-venetoclax-in-patients-with-cllsll/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/expert-point-of-view-susan-obrien-md/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/accelerating-pediatric-drug-development-master-protocols-may-be-a-way-to-go/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/pigmented-vascular-tumor/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/carlo-m-croce-md-faacr-recognized-with-2017-aacr-margaret-foti-award/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/living-beyond-breast-cancer-translates-metastatic-breast-cancer-guide-into-five-languages/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/fear-has-become-a-big-part-of-my-survivorship/ 2019-03-11T16:38:17+00:00 https://ascopost.com/issues/april-25-2017/some-melanoma-survivors-continue-to-seek-sun-exposure-risking-second-potentially-more-serious-melanoma/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-25-2017/expect-questions-about-continued-risk-of-melanoma/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-25-2017/leonard-i-zon-md-honored-with-2017-aacr-irving-weinstein-foundation-distinguished-lecture/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-25-2017/link-between-obesity-and-transformation-of-mgus-to-myeloma/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-25-2017/adding-bevacizumab-to-cisplatinetoposide-in-extensive-disease-small-cell-lung-cancer/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-25-2017/addition-of-buparlisib-to-paclitaxel-in-squamous-cell-carcinoma-of-the-head-and-neck/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-25-2017/olaparib-maintenance-in-ovarian-cancer-outcomes-reconsidered/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-25-2017/more-on-treatment-decisions-in-esophageal-cancer/ 2019-03-11T16:38:18+00:00 https://ascopost.com/issues/april-10-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/april-10-2017/olaparib-maintenance-prolongs-progression-free-survival-in-ovarian-cancer/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/expert-point-of-view-eloise-chapman-davis-md/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/asco-s-state-of-cancer-care-in-america-2017-report-acknowledges-both-the-progress-made-in-oncology-care-and-the-challenges-ahead/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/the-mystery-of-grace/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/non-engineered-t-cell-therapy-produces-durable-responses-in-hematologic-malignancies/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/gut-bacteria-may-enhance-or-hamper-response-to-anti-pd-1-agents/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/expert-point-of-view-shridar-ganesan-md-phd/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/fda-approves-avelumab-for-metastatic-merkel-cell-carcinoma/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/harnessing-implementation-science-to-improve-cancer-care-delivery/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/jop-publishes-clinical-pathways-and-patient-safety-studies-from-quality-care-symposium/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/cancerlinq-big-data-for-quality-benchmarking/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/new-constructs-for-use-in-the-identification-of-depression-in-older-patients-with-cancer/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/young-women-with-metastatic-breast-cancer-unique-needs-and-concerns/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/deane-l-wolcott-md-fapos-receives-holland-distinguished-leadership-award/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/elizabeth-m-jaffee-md-named-aacr-president-elect-2017-2018/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/evolving-role-for-cryoablation-in-treating-small-renal-masses/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/expert-point-of-view-alessandro-volpe-md/ 2019-03-11T16:39:21+00:00 https://ascopost.com/issues/april-10-2017/cryoablation-for-small-renal-tumors-one-radiologist-s-experience/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/lauren-lawrence-mba-rhia-appointed-vice-president-of-karmanos-cancer-network/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/listeria-based-immunotherapy-improves-survival-in-metastatic-cervical-cancer/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/expert-point-of-view-al-covens-md/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/fda-approves-maintenance-niraparib-for-recurrent-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/conquer-cancer-foundation-honors-65-young-oncology-professionals-with-merit-awards/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/asco-asks-congress-to-prioritize-federal-research-funding-in-fy18/ 2020-09-17T20:11:07+00:00 https://ascopost.com/issues/april-10-2017/leading-oncology-professional-societies-launch-cancerlinq-ambassadors-program/ 2020-09-17T20:13:58+00:00 https://ascopost.com/issues/april-10-2017/asco-congratulates-seema-verma-on-confirmation-as-cms-administrator/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/updated-cancernet-mobile-app-for-your-patients/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/fred-hutchinson-s-paulovich-laboratory-to-lead-protein-assay-work-for-national-cancer-moonshot/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/asco-clinical-practice-guideline-on-prevention-and-monitoring-of-cardiac-dysfunction-in-survivors-of-adult-cancers/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/cardiac-dysfunction-in-survivors-of-adult-cancers/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/asco-clinical-practice-guideline-update-integration-of-palliative-care-into-standard-oncology-care/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/practice-changing-research-making-palliative-care-a-routine-part-of-cancer-care-in-the-united-states-and-abroad/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/forging-a-new-role-to-make-curing-more-cancers-a-reality/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/aacr-inducts-2017-class-of-fellows-at-annual-meeting/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/increased-recognition-of-colorectal-cancer-in-young-adults-even-those-aged-20-to-29-as-evidence-continues-to-accumulate/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/expect-questions-about-colorectal-cancer-among-younger-adults/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/ribociclib-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/april-10-2017/thomas-e-starzl-md-phd-father-of-modern-transplantation-dies-at-age-90/ 2019-03-11T16:39:22+00:00 https://ascopost.com/issues/march-25-2017/ 2021-06-08T17:57:20+00:00 https://ascopost.com/issues/march-25-2017/pembrolizumab-affords-long-term-survival-to-one-fourth-of-selected-patients-with-nsclc-alternative-statistical-model-suggests/ 2019-03-11T16:40:10+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-ann-w-silk-md/ 2019-03-11T16:40:10+00:00 https://ascopost.com/issues/march-25-2017/active-surveillance-appears-to-be-safe-for-small-renal-masses/ 2019-03-11T16:40:10+00:00 https://ascopost.com/issues/march-25-2017/the-path-forward-for-clinical-pathways-in-oncology/ 2019-03-11T16:40:10+00:00 https://ascopost.com/issues/march-25-2017/novel-immunotherapeutic-vaccine-studied-in-colorectal-cancer/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/progress-being-made-in-understanding-immunotherapy-resistance/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/new-antiviral-agent-may-prevent-posttransplant-cytomegalovirus-infections/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-partow-kebriaei-md/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/nivolumab-shows-benefit-in-advanced-hepatocellular-carcinoma/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-milind-javle-md/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/early-pet-imaging-may-guide-treatment-decisions-in-esophageal-cancer/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-nancy-baxter-md-phd-steven-h-lin-md-phd/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/moderate-activity-may-improve-overall-and-progression-free-survival-in-patients-with-metastatic-colorectal-cancer/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-manish-a-shah-md/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/search-continues-for-effective-way-to-prevent-lymphedema-in-breast-cancer-survivors/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-ann-h-partridge-md-mph/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/online-symptom-management-curriculum-may-improve-depression-and-fatigue-in-breast-cancer-survivors/ 2019-03-11T16:40:11+00:00 https://ascopost.com/issues/march-25-2017/making-the-case-for-sentinel-node-biopsy-in-early-cancers-of-the-oral-cavity/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/developing-better-multidisciplinary-strategies/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/leukemia-lymphoma-society-appoints-gwen-nichols-md-as-chief-medical-officer/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/aligning-patient-expectations-with-treatment-goals-in-the-metastatic-setting/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-joseph-greer-phd/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/keynote-trial-data-suggest-features-predicting-response-to-pembrolizumab/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-shridar-ganesan-md-phd/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/early-phase-study-of-hpv-type-16-directed-vaccine-combined-with-chemotherapy-in-advanced-cervical-cancer/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-heather-l-mcarthur-md-mph/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/future-perspectives-in-geriatric-oncology-how-the-young-can-care-for-the-old/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/siog-2017-advanced-course-in-treviso-italy/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/mammography-detected-small-breast-cancers-may-represent-overdiagnosis-with-declining-mortality-reflecting-improved-systemic-therapy/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/asco-launches-its-new-journal-dedicated-to-informatics/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/asco-research-community-forum-offers-tools-resources-to-support-cancer-research-sites/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/new-asco-answers-fact-sheets-on-mds-bone-marrow-transplant-for-your-practice/ 2019-03-11T16:40:12+00:00 https://ascopost.com/issues/march-25-2017/an-evening-for-cancer-survivors-and-caregivers-bringing-together-a-community-of-support/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/conquer-cancer-foundation-conquerors-circle-donors/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/guidelines-planned-on-management-of-immunotherapy-side-effects-asco-and-nccn-to-collaborate-on-development/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/breast-surgeon-sheldon-m-feldman-md-joins-montefiore-and-einstein-cancer-centers/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/benjamin-levy-md-to-lead-medical-oncology-at-sibley-memorial/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/plinabulin-improves-survival-in-subset-of-patients-with-non-small-cell-lung-cancer/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/expert-point-of-view-heather-l-mcarthur-md-mph-1/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/for-one-hematologist-no-disease-progressions-in-follicular-lymphoma-with-rituximab-maintenance/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/the-art-of-medicine-in-the-world-of-evidence-based-medicine/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/asco-addresses-new-policies-that-threaten-access-to-opioids/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/a-case-of-mistaken-identity/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/pacritinib-update/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/eric-m-horwitz-md-inducted-into-inaugural-class-of-fellows-of-the-american-brachytherapy-society/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/markedly-improved-progression-free-survival-with-first-line-ceritinib-vs-platinum-chemotherapy-in-alk-rearranged-nsclc/ 2019-03-11T16:40:13+00:00 https://ascopost.com/issues/march-25-2017/new-first-line-options-for-alk-positive-lung-cancer-on-the-horizon/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/adding-bortezomib-to-lenalidomidedexamethasone-improves-survival-in-patients-with-newly-diagnosed-multiple-myeloma/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/suresh-vedantham-md-fsir-named-president-of-sir/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/implications-of-swog-s0777-and-the-future-of-combination-treatments-for-multiple-myeloma/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/acupuncture-for-the-management-of-hot-flashes/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/coping-with-an-uncommon-cancer/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/chief-clinical-officer-s-distinguished-chair-created-at-city-of-hope-to-honor-alexandra-m-levine-md-macp/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/arti-hurria-md-named-vice-provost-at-city-of-hope/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/discrimination-in-medical-education-another-perspective/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/examining-the-impact-of-death-with-dignity-legislation/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/fox-chase-junior-investigators-win-awards-for-pilot-projects/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/reducing-debilitating-symptoms-of-advanced-colorectal-cancer/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/potential-surrogate-for-all-cause-mortality-risk-in-localized-prostate-cancer/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/intermittent-sunitinib-in-metastatic-renal-cell-carcinoma/ 2019-03-11T16:40:14+00:00 https://ascopost.com/issues/march-25-2017/predicting-acute-cardiac-events-in-patients-with-breast-cancer-receiving-radiotherapy/ 2019-03-11T16:40:15+00:00 https://ascopost.com/issues/march-25-2017/financial-burden-of-targeted-oral-therapy-for-patients-with-chronic-myeloid-leukemia/ 2019-03-11T16:40:15+00:00 https://ascopost.com/issues/march-25-2017/anne-friedman-glauber-cofounder-of-online-pancreatic-cancer-forum-dies-at-age-63/ 2019-03-11T16:40:15+00:00 https://ascopost.com/issues/march-10-2017/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/march-10-2017/falcon-trial-informs-the-evolving-role-of-fulvestrant-in-advanced-hormone-receptor-positive-breast-cancer/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/how-stupid-cancer-is-building-a-support-community-for-aya-survivors/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/make-vaccination-great-again/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/phase-ii-trial-evaluates-new-gene-therapy-for-non-muscle-invasive-bladder-cancer-after-bcg/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/no-benefit-from-older-standard-of-care-drug-in-adjuvant-chemotherapy-for-high-risk-prostate-cancer-but-newer-trials-feasible/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-susan-f-slovin-md-phd/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/update-on-overall-survival-for-newly-diagnosed-patients-with-metastatic-pancreatic-cancer/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-allyson-j-ocean-md/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/immunotherapy-combinations-gain-traction-in-lung-cancer/ 2019-03-11T16:40:31+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-david-planchard-md-phd-luboš-petruželka-md-phd-and-clarissa-baldotto-md-msc/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/a-decade-of-lessons-learned-from-egfr-targeted-therapy/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/no-improvement-in-overall-survival-with-addition-of-ganetespib-to-docetaxel-in-patients-with-non-small-cell-lung-cancer/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-david-r-gandara-md/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/immunotherapy-challenges-in-lung-cancer-from-patient-selection-to-clinical-and-financial-toxicity/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/immunotherapy-for-head-and-neck-cancer-the-fourth-modality-has-arrived/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/honoring-the-life-of-nancy-e-armitage/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/can-antiviral-therapy-prevent-liver-cancer-in-patients-with-chronic-hepatitis/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/scientists-tackle-next-set-of-immunotherapy-challenges/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/novel-immunotherapy-added-to-standard-care-did-not-meet-endpoint-in-patients-with-advanced-head-and-neck-cancer/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-cornelius-jm-melief-md-phd/ 2020-03-03T14:14:36+00:00 https://ascopost.com/issues/march-10-2017/value-based-approaches-to-the-rising-costs-of-cancer-drugs/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/royal-swedish-academy-of-sciences-inaugural-sjoeberg-prize-awarded-to-james-p-allison-phd-and-tony-hunter-phd/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/alice-t-shaw-md-phd-and-pasi-a-jaenne-md-phd-named-co-leaders-of-su2c-acs-dream-team-on-lung-cancer/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/low-grade-gliomas-understanding-the-new-treatment-paradigm/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/ibrutinib-in-marginal-zone-lymphoma/ 2019-03-11T16:40:32+00:00 https://ascopost.com/issues/march-10-2017/close-to-home-dr-rick-boulay-s-experience-with-cancer-survivorship-and-caregiving/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/clinical-practice-committee-state-affiliate-council-support-innovative-clinical-research-and-so-can-you/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/university-of-virginia-cancer-center-joins-cancerlinq-as-participating-practice/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/asco-s-patient-resources-for-colorectal-cancer-awareness-month/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/spotlight-asco-clinical-affairs/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/asco-urges-lawmakers-to-fund-cancer-research-on-capitol-hill/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/sandra-j-horning-md-received-duane-roth-memorial-award/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/fox-chase-temple-university-hospital-bone-marrow-transplant-program-awarded-fact-accreditation/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/phase-iii-trial-shows-improved-progression-free-survival-with-fulvestrant-vs-anastrozole-in-advanced-breast-cancer/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/new-nccn-treatment-guides-to-help-patients-with-waldenstroem-s-macroglobulinemia-make-informed-care-decisions/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/car-t-cell-therapy-emerging-in-multiple-myeloma/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-edward-a-stadtmauer-md/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/iaslc-statement-regarding-philip-morris-smoke-free-future/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/cleveland-clinic-opens-new-taussig-cancer-center/ 2019-03-11T16:40:33+00:00 https://ascopost.com/issues/march-10-2017/asco-and-nccn-to-collaborate-on-guidelines-on-management-of-immunotherapy-side-effects/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/building-a-multidisciplinary-model-of-care-for-cancer-survivors/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/platinum-study-finds-high-risk-of-metabolic-syndrome-in-testicular-cancer-survivors/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-kevin-c-oeffinger-md/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/an-oncologist-s-straightforward-guide-for-women-with-breast-cancer/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/eric-d-tetzlaff-mhs-pa-c-receives-national-recognition-as-aapa-distinguished-fellow/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/cancer-has-aged-me/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/fda-approves-lenalidomide-as-maintenance-therapy-for-patients-with-multiple-myeloma-following-autologous-stem-cell-transplant/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/potential-biomarker-of-recurrent-venous-thromboembolism-in-patients-receiving-anticoagulants/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/germline-cancer-susceptibility-mutations-in-early-onset-colorectal-cancer/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/addition-of-cetuximab-to-chemoradiotherapy-for-anal-carcinoma/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/pembrolizumab-in-locally-advanced-or-metastatic-urothelial-cancer/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/2017-oncology-meetings/ 2019-03-11T16:40:34+00:00 https://ascopost.com/issues/march-10-2017/cervical-cancer-mortality-is-higher-and-racial-disparity-wider-than-previously-reported/ 2019-03-11T16:40:35+00:00 https://ascopost.com/issues/march-10-2017/expect-questions-about-the-cervical-cancer-mortality-study/ 2019-03-11T16:40:35+00:00 https://ascopost.com/issues/march-10-2017/scripps-florida-collaboration-awarded-33-million-to-develop-next-generation-breast-cancer-therapies/ 2019-03-11T16:40:35+00:00 https://ascopost.com/issues/march-10-2017/clinical-trials-actively-recruiting-patients-with-colorectal-cancer/ 2019-03-11T16:40:35+00:00 https://ascopost.com/issues/march-10-2017/pacritinib-reduces-spleen-volume-in-myelofibrosis/ 2019-03-11T16:40:35+00:00 https://ascopost.com/issues/march-10-2017/expert-point-of-view-selina-luger-md-stephanie-lee-md-and-gabriela-hobbs-md/ 2019-03-11T16:40:35+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/introduction-immunotherapy-for-non-small-cell-lung-cancer-advances-and-challenges/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/understanding-the-role-of-immunotherapy-for-lung-cancer-a-paradigm-shift-for-the-better/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/clinical-trials-study-the-role-of-immunotherapy-in-the-first-line-setting-of-non-small-cell-lung-cancer/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/expert-point-of-view-edward-b-garon-md/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/quality-of-life-data-from-keynote-024-first-line-pembrolizumab-vs-chemotherapy-in-advanced-nsclc/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/expert-point-of-view-michael-boyer-mbbs-phd/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/atezolizumab-benefits-survival-vs-docetaxel-across-multiple-subtypes-of-non-small-cell-lung-cancer/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/expert-point-of-view-michael-boyer-mbbs-phd-2/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/durvalumab-shows-activity-in-heavily-pretreated-patients-with-non-small-cell-lung-cancer/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/expert-point-of-view-michael-boyer-mbbs-phd-3/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/keynote-010-update-shows-striking-durability-of-second-line-pembrolizumab-in-nsclc/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/expert-point-of-view-paul-mitchell-md/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/new-analysis-of-checkmate-057-search-continues-for-predictors-of-outcome-with-nivolumab/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/expert-point-of-view-paul-mitchell-md-1/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/managing-toxicities-associated-with-immunotherapy-for-lung-cancer/ 2019-03-11T16:40:52+00:00 https://ascopost.com/issues/february-25-2017-supplement-immunotherapies-for-nsclc/ongoing-phase-iii-clinical-trials-of-immunotherapy-in-advanced-non-small-cell-lung-cancer/ 2019-03-11T16:40:53+00:00 https://ascopost.com/issues/february-25-2017/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/february-25-2017/checkmate-142-update-prolonged-disease-control-with-nivolumab-in-deficient-mismatch-repair-colorectal-cancer/ 2019-03-11T16:43:03+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-frank-sinicrope-md/ 2019-03-11T16:43:03+00:00 https://ascopost.com/issues/february-25-2017/combating-untreated-cancer-related-pain/ 2019-03-11T16:43:03+00:00 https://ascopost.com/issues/february-25-2017/timing-is-everything/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/watch-and-wait-strategy-does-not-compromise-survival-in-selected-patients-with-rectal-cancer/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-philip-b-paty-md/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/novel-bridge-to-liver-transplant-may-improve-upon-standard-of-care/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-ghassan-k-abou-alfa-md/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/cabozantinib-elicits-responses-in-neuroendocrine-and-carcinoid-tumors/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-vincent-j-picozzi-md/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/twice-daily-radiation-therapy-may-reduce-mortality-in-headneck-cancer/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-philip-poortmans-md-phd/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/new-data-on-prognostic-factors-disease-detection-drug-toxicities-and-treatment-adherence-presented-at-sabcs/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/fda-approves-ibrutinib-in-relapsedrefractory-marginal-zone-lymphoma/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/selected-abstracts-from-the-2016-ash-annual-meeting/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/2017-ash-amfdp-scholars-to-study-basic-insights-in-blood-cancer-development/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/american-skin-association-names-david-norris-md-president/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/elisabeth-heath-md-facp-appointed-associate-center-director-for-translational-sciences-at-karmanos/ 2019-03-11T16:43:04+00:00 https://ascopost.com/issues/february-25-2017/combination-immunotherapy-for-lung-cancer-the-wave-of-the-future/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/edward-garon-md-receives-32-million-nih-grant-to-study-immunotherapy-responses-in-lung-cancer/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/durable-responses-reported-with-pembrolizumab-in-heavily-pretreated-extensive-stage-small-cell-lung-cancer/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-leora-horn-md-msc/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/efficacy-toxicity-on-a-par-for-different-classes-of-immune-checkpoint-inhibitors/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-paul-mitchell-md/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/new-lung-cancer-staging-manual-set-to-modify-clinical-practice/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/three-assays-and-several-laboratory-developed-tests-highly-concordant-across-platforms-in-pd-l1-immunohistochemistry-testing-for-nsclc/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-michael-boyer-md/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/many-cancer-survivors-find-online-and-telephone-communication-with-health-care-professionals-beneficial/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/exploring-the-opportunities-and-challenges-of-seamless-drug-development/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/american-cancer-society-honors-william-breitbart-md-with-the-trish-greene-quality-of-life-award/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/phase-ii-studies-evaluate-new-approaches-in-richter-transformation/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/expert-point-of-view-jose-leis-md-phd/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/18m-grant-to-wenwei-hu-phd-to-aid-exploration-of-role-of-chronic-stress-in-cancer-development/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/asco-submits-comments-on-nih-data-sharing-request-for-information/ 2019-03-11T16:43:05+00:00 https://ascopost.com/issues/february-25-2017/spotlight-on-women-who-conquer-cancer/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/asco-collaborates-with-health-care-provider-organizations-on-study-of-advanced-practice-providers/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/an-introduction-to-recognizing-and-managing-professional-burnout/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/help-your-patients-better-understand-immunotherapy/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/ccf-researcher-spotlight-david-m-waterhouse-md-mph/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/tailoring-treatment-for-older-adults-with-colorectal-cancer/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/update-on-fertility-outcomes-among-survivors-of-childhood-cancer/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/clinical-trial-to-explore-genetic-cancer-test-to-offer-safe-thyroid-preserving-surgery/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/study-finds-children-parents-overreport-adherence-to-leukemia-treatment/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/radiotherapy-vs-temozolomide-in-low-grade-glioma-the-importance-of-molecular-classification/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/american-cancer-society-awards-medal-of-honor-to-three-cancer-researchers/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/pittsburgh-cancer-center-researchers-to-receive-2017-paul-ehrlich-and-ludwig-darmstaedter-prize/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-bangladesh/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/osimertinib-improves-progression-free-survival-vs-platinumpemetrexed-in-egfr-t790m-positive-nsclc/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/bright-future-for-osimertinib-in-egfr-t790m-positive-lung-cancer/ 2019-03-11T16:43:06+00:00 https://ascopost.com/issues/february-25-2017/regorafenib-improves-survival-in-patients-with-hepatocellular-carcinoma-progressing-on-sorafenib/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/regorafenib-in-second-line-setting-for-hepatocellular-carcinoma-balancing-benefit-with-toxicity/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/university-of-pittsburgh-medical-center-joins-international-coalition-to-improve-cancer-care/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/clinical-trials-actively-recruiting-patients-with-gynecologic-cancers/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/first-line-ribociclib-prolongs-progression-free-survival-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/results-from-monaleesa-2-are-all-cdk46-inhibitors-equal/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/harold-h-tara-jr-md-appointed-medical-director-of-smilow-care-centers-in-connecticut/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/suresh-ramalingam-md-elected-to-the-american-society-for-clinical-investigation/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/soy/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/lisa-lange-anp-bc-aocn-of-karmanos-cancer-institute-promoted-to-vice-president-of-clinical-trials-office/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/stephen-gottschalk-md-named-chair-of-bmt-and-cell-therapy-at-st-jude/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/continued-reduction-in-cancer-mortality-requires-increasing-healthy-behaviors-and-removing-inequities-in-care/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/expect-questions-about-screening-and-potential-overdiagnosis/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/columbia-newyork-presbyterian-and-life-raft-group-form-cancer-research-partnership/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/assessment-of-therapeutic-response-by-intrinsic-subtype-for-her2-positive-breast-tumors/ 2019-03-11T16:43:07+00:00 https://ascopost.com/issues/february-25-2017/rucaparib-in-relapsed-platinum-sensitive-high-grade-ovarian-cancer/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/mirvetuximab-soravtansine-in-platinum-sensitive-ovarian-cancer/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/circulating-tumor-dna-as-a-prognostic-marker-in-pancreatic-cancer/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/first-in-class-rovalpituzumab-tesirine-in-recurrent-small-cell-lung-cancer/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/effect-of-sorafenib-and-hepatitis-status-in-advanced-hepatocellular-carcinoma/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/2017-oncology-meetings/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/cancer-has-made-me-the-person-i-am/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/remembering-stephen-k-carter-md-and-his-national-and-international-impact-on-early-drug-development/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/swog-launches-national-immunotherapy-clinical-trial-for-rare-cancers/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-25-2017/leader-in-cancer-care-and-prevention-charles-a-lemaistre-md-dies/ 2019-03-11T16:43:08+00:00 https://ascopost.com/issues/february-10-2017/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/february-10-2017/dual-inhibition-proves-effective-for-braf-mutated-colorectal-tumors/ 2019-03-11T16:47:19+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-frank-a-sinicrope-md/ 2019-03-11T16:47:19+00:00 https://ascopost.com/issues/february-10-2017/fda-establishes-oncology-center-of-excellence-names-richard-pazdur-md-director/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/the-cost-of-a-patient-s-last-ride/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/nivolumab-as-salvage-improves-overall-survival-in-gastric-cancer/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-heinz-josef-lenz-md/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/tumor-infiltrating-lymphocytes-prognostic-in-the-metastatic-and-neoadjuvant-breast-cancer-settings/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-melinda-l-telli-md/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/randomized-trial-demonstrates-benefit-of-scalp-cooling-in-prevention-of-chemotherapy-induced-hair-loss/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/veliparib-improves-reponse-but-not-progression-free-survival-in-brca-mutation-carriers/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-virginia-kaklamani-md-and-melinda-l-telli-md/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/autologous-breast-reconstruction-associated-with-fewer-complications-and-failures-than-implants-in-women-who-have-received-radiation/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-amber-orman-md/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/studies-advance-the-use-of-pd-1-blockade-in-classical-hodgkin-lymphoma/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-stephen-ansell-md-phd/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/selected-abstracts-from-the-2016-ash-annual-meeting/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/early-success-reported-with-two-new-agents-for-high-risk-myelodysplastic-syndromes/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-steven-d-gore-md-and-rami-komrokji-md/ 2019-03-11T16:47:20+00:00 https://ascopost.com/issues/february-10-2017/growing-leadership-development-program-tasks-participants-with-increasing-society-engagement/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/asco-participates-in-final-white-house-moonshot-event/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/from-azerbaijan-to-america-an-idea-recipient-s-experience/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/double-your-impact-donate-to-the-conquer-cancer-foundation-today/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/tell-your-patients-about-pre-act/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/conquer-cancer-foundation-hosts-successful-scientific-and-career-development-retreat/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/asco-releases-principles-for-patient-centered-health-care-reform/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/study-finds-durvalumab-of-benefit-in-advanced-and-metastatic-non-small-cell-lung-cancer/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-michael-boyer-mbbs-phd/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/ascend-4-study-shows-45-reduction-in-risk-of-disease-progression-for-nsclc-patients-on-first-line-ceritinib/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/expert-point-of-view-fiona-blackhall-phd-frcp/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/on-the-horizon-new-tools-for-prostate-cancer/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/circulating-tumor-dna-profiling-identifies-clonal-evolution-patterns-and-permits-classification-of-tumor-subtypes-in-dlbcl/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/liquid-biopsies-show-promise-in-diffuse-large-b-cell-lymphoma/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/telotristat-ethyl-reduces-frequency-of-bowel-movements-in-patients-with-metastatic-neuroendocrine-tumors-and-carcinoid-syndrome/ 2019-03-11T16:47:21+00:00 https://ascopost.com/issues/february-10-2017/telotristat-ethyl-a-novel-therapy-for-carcinoid-syndrome-not-a-panacea-but-a-step-in-the-right-direction/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/nccn-working-group-on-value-tools-presents-preliminary-findings-and-recommendations/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/collateral-lethality-may-offer-new-therapeutic-approach-to-cancers-of-the-pancreas-stomach-and-colon/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/richard-m-goldberg-md-named-director-of-west-virginia-university-cancer-institute/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/clinical-trials-actively-recruiting-patients-with-cancer-related-pain/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/2017-oncology-meetings/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/kerry-and-simone-vickar-family-foundation-commits-2-million-for-levine-cancer-institute-hematologic-oncology-chair/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/i-plan-to-live-long-enough-to-be-cured-of-multiple-myeloma/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/retinoic-acid-and-arsenic-trioxide-vs-retinoic-acid-and-chemotherapy-in-apl/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/postinduction-mrd-predicts-outcome-from-transplantation-in-npm1-mutant-aml/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/serum-dna-methylation-as-predictive-marker-in-metastatic-breast-cancer/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/link-between-alcohol-intake-and-increased-risk-for-melanoma/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/justin-f-klamerus-md-mmm-appointed-president-of-karmanos-cancer-hospital/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/oliver-smithies-phd-nobel-laureate-who-discovered-gene-targeting-dies/ 2019-03-11T16:47:22+00:00 https://ascopost.com/issues/february-10-2017/co-discoverer-of-the-philadelphia-chromosome-peter-nowell-md-dies/ 2019-03-11T16:47:23+00:00 https://ascopost.com/issues/february-10-2017/albert-h-owens-jr-md-pioneering-johns-hopkins-oncologist-dies/ 2019-03-11T16:47:23+00:00 https://ascopost.com/issues/january-25-2017/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/january-25-2017/lenalidomide-maintenance-extends-progression-free-survival-in-cll/ 2019-03-11T16:47:40+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-richard-furman-md/ 2019-03-11T16:47:40+00:00 https://ascopost.com/issues/january-25-2017/oncology-drug-approvals-in-2016/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/what-precisely-is-precision-oncology-and-will-it-work/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/osimertinib-significantly-improves-survival-for-patients-with-non-small-cell-lung-cancer/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-tetsuya-mitsudomi-md/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/novel-antibody-drug-conjugate-targets-triple-negative-breast-cancer/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-howard-a-skip-burris-md/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/pertuzumab-trastuzumab-plus-aromatase-inhibitor-beneficial-in-metastatic-breast-cancer/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-steven-vogl-md/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/selected-abstracts-from-the-2016-san-antonio-breast-cancer-symposium/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/breast-cancer-experts-question-new-recommendations-for-21-gene-recurrence-score-assay/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/ibandronate-fails-to-improve-disease-free-survival-in-early-breast-cancer-patients-but-with-favorable-trends/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-sara-hurvitz-md-mothaffar-rimawi-md-and-carlos-l-arteaga-md/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/high-response-rates-to-triplet-therapy-in-smoldering-myeloma/ 2019-03-11T16:47:41+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-philip-mccarthy-md/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/car-t-cell-therapy-kte-c19-appears-successful-in-aggressive-b-cell-lymphoma/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/brentuximab-vedotin-plus-nivolumab-highly-active-in-relapsed-classical-hodgkin-lymphoma/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-anas-younes-md/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/antiretroviral-agent-makes-strong-showing-in-refractory-multiple-myeloma/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/managing-breast-cancer-in-a-pregnant-patient/ 2020-09-23T13:49:34+00:00 https://ascopost.com/issues/january-25-2017/optimizing-access-to-fertility-preservation-options/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/moffitt-cancer-center-names-robert-wenham-md-ms-facog-facs-gynecologic-oncology-program-chair/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/asco-endorses-astro-guideline-on-radiation-therapy-for-glioblastoma/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/radiation-therapy-for-glioblastoma-what-is-new-and-what-is-missing-in-the-asco-endorsed-astro-guidelines/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/chi-van-dang-md-phd-appointed-scientific-director-of-the-ludwig-institute-for-cancer-research/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/new-aaci-president-stanton-l-gerson-md-aims-to-integrate-cancer-treatment-advances-into-the-community/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/nivolumab-improves-overall-survival-in-recurrent-platinum-refractory-squamous-cell-carcinoma-of-the-head-and-neck/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/nivolumab-in-squamous-cell-carcinoma-of-the-head-and-neck-in-checkmate-141-game-not-over/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/falls-in-older-patients-with-cancer-recognizing-and-reducing-the-risk/ 2019-03-11T16:47:42+00:00 https://ascopost.com/issues/january-25-2017/safety-of-stopping-imatinib-in-cml-with-undetectable-minimal-residual-disease-for-at-least-2-years/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/diamonds-are-forever-tyrosine-kinase-inhibitors-are-not/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/umass-memorial-medical-center-seeks-to-join-dana-farber-cancer-care-collaborative/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/paul-sondel-md-phd-receives-2017-sitc-memorial-lectureship-award/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/understanding-cancer-epigenetics-and-its-clinical-implications/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/diane-m-simeone-md-to-lead-new-pancreatic-cancer-center-at-nyu-langone/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/niraparib-maintenance-improves-progression-free-survival-in-platinum-sensitive-recurrent-ovarian-cancer/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/parp-inhibitor-niraparib-yields-unprecedented-results-in-ovarian-cancer-in-phase-iii-trial/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/asco-amp-and-cap-issue-new-joint-guidelines-to-standardize-interpretation-and-reporting-of-sequence-variants-in-cancer/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/conquer-cancer-foundation-researcher-spotlight-vamsidhar-velcheti-md/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/world-cancer-day-the-campaign-to-conquer-cancer-and-collaboration/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/monica-m-bertagnolli-md-elected-asco-president-for-2018-2019-term/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/asco-comments-on-final-macra-implementation-rule/ 2019-03-11T16:47:43+00:00 https://ascopost.com/issues/january-25-2017/asco-launches-first-journal-dedicated-to-precision-oncology/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/asco-launches-jco-clinical-cancer-informatics/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/highlights-from-the-2017-gastrointestinal-cancers-symposium-and-cancer-survivorship-symposium/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/asco-s-state-affiliate-council-helping-practices-to-meet-the-challenges-ahead/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/vanderbilt-study-to-explore-lymphedema-self-care-for-head-and-neck-cancer-survivors/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/addressing-discrimination-and-bias-in-medical-education/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/aacr-receives-1125-million-national-cancer-institute-grant-to-continue-annual-clinical-trials-workshop/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/selected-abstracts-from-the-2016-ash-annual-meeting/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/ibrutinib-a-potential-option-for-chronic-graft-vs-host-disease/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/expert-point-of-view-kanti-r-rai-md/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/new-president-of-the-skin-cancer-foundation-emphasizes-public-education-to-reduce-skin-cancer-incidence-and-deaths/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/levine-cancer-institute-named-a-planetree-designated-patient-centered-organization/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/jennifer-lycette-md-takes-pride-in-delivering-cancer-care-to-those-most-in-need-in-northwest-oregon/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/pamela-laszewski-rn-ocn-receives-2017-ons-excellence-in-radiation-therapy-nursing-award/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/joan-font-burgada-phd-joins-fox-chase-in-cancer-biology-program/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/telemedicine-transforming-health-care-one-computer-at-a-time/ 2019-03-11T16:47:44+00:00 https://ascopost.com/issues/january-25-2017/nccn-publishes-patient-education-resources-for-gliomas-its-first-in-a-series-on-brain-cancer/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/how-asco-s-new-health-policy-fellowship-program-is-helping-shape-future-cancer-care-policy/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/asco-releases-principles-for-patient-centered-health-care-reform/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/eastern-maine-medical-center-cancer-care-joins-dana-farber-cancer-care-collaborative/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/canadian-study-looks-at-an-integrated-palliative-care-model/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/fda-approves-extended-release-morphine-product-formulated-with-abuse-deterrent-properties/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/vitamin-d-and-cancer-a-uniform-dose-is-unlikely-to-fit-all-patients/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/an-ovarian-cancer-survivor-s-story/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/an-insider-s-account-of-the-aids-epidemic/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/rucaparib-in-previously-treated-brca-mutation-associated-ovarian-cancer/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/what-cancer/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/clinical-trials-actively-recruiting-patients-with-bladder-cancer/ 2021-02-09T22:52:04+00:00 https://ascopost.com/issues/january-25-2017/what-have-we-got-to-lose/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/breast-cancer-researchers-at-baylor-receive-komen-grants-to-support-study-of-drug-efficacy-treatment-resistance/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/i-m-learning-to-live-with-chronic-cancer/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/kenneth-c-anderson-md-begins-term-as-2017-ash-president/ 2019-03-11T16:47:45+00:00 https://ascopost.com/issues/january-25-2017/2017-oncology-meetings/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/esophagoscopy-by-the-high-low-method/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/cabozantinib-alone-or-with-erlotinib-in-egfr-wild-type-nsclc/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/second-line-ramucirumab-in-advanced-hcc/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/regorafenib-in-advanced-nonadipocytic-soft-tissue-sarcoma/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/addition-of-palifosfamide-to-doxorubicin-in-metastatic-soft-tissue-sarcoma/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/24-gene-predictor-of-response-to-postoperative-radiotherapy-in-prostate-cancer/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/androgen-maintenance-in-elderly-patients-with-aml/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/philip-e-bourne-phd-leaves-nih-accepts-position-at-university-of-virginia/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/january-25-2017/martin-j-edelman-md-joins-fox-chase-cancer-center-as-chair-of-the-department-of-hematologyoncology/ 2019-03-11T16:47:46+00:00 https://ascopost.com/issues/december-25-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/december-25-2016/benefit-of-extended-adjuvant-endocrine-therapy-not-upheld-in-multiple-studies-reported-in-san-antonio/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-michael-gnant-md/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/as-we-strive-for-a-cancer-cure-we-must-not-forget-the-survivors/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/a-gleason-6-tumor-is-it-cancer-and-should-it-be-treated/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/reduced-intensity-chemotherapy-leads-to-more-relapses-in-childhood-all/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-stephen-p-hunger-md/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/reducing-doses-and-stopping-tyrosine-kinase-inhibitors-gain-favor-in-chronic-myeloid-leukemia/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-mikkael-sekeres-md/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/achieving-complete-response-is-key-to-improving-survival-in-older-patients-with-aml/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-amir-t-fathi-md/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/individuals-honored-as-2016-mpn-heroes/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/lawrence-n-shulman-md-facp-named-chair-of-american-college-of-surgeons-commission-on-cancer/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/nancy-thomas-md-phd-named-chair-of-dermatology-at-university-of-north-carolina/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/single-autotransplant-not-enhanced-by-additional-interventions-in-multiple-myeloma/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-sergio-a-giralt-md/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/obinutuzumab-prolongs-disease-free-survival-vs-rituximab-in-follicular-lymphoma/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-brad-s-kahl-md/ 2019-03-11T16:49:51+00:00 https://ascopost.com/issues/december-25-2016/dose-adjusted-epoch-r-no-better-than-r-chop-in-diffuse-large-b-cell-lymphoma/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-lawrence-kaplan-md/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/vadastuximab-talirine-shows-early-promise-in-newly-diagnosed-acute-myeloid-leukemia/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-mikkael-a-sekeres-md-ms/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/cpx-351-improves-survival-post-transplant-in-older-high-risk-patients-with-acute-myeloid-leukemia/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-armand-keating-md/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/gilberto-de-lima-lopes-jr-md-mba-fams-named-new-editor-in-chief-of-asco-s-journal-of-global-oncology/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/oncology-organizations-applaud-passage-of-the-21st-century-cures-act/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/fulvestrant-plus-everolimus-new-second-line-option-for-postmenopausal-metastatic-breast-cancer/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-virginia-kaklamani-md/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/genomic-landscape-of-metastatic-breast-cancer-differs-from-that-of-primary-breast-cancer/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/brca-status-does-not-seem-to-affect-survival-outcomes-in-young-women-with-early-breast-cancer/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-leif-ellisen-md-phd/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/abemaciclib-plus-anastrozole-promising-signals-reported-in-phase-ii-study-of-early-breast-cancer/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-carlos-l-arteaga-md/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/pathologic-complete-response-not-boosted-by-addition-of-estrogen-deprivation-to-chemotherapy-and-dual-her2-blockade/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-myles-brown-md/ 2019-03-11T16:49:52+00:00 https://ascopost.com/issues/december-25-2016/buparlisib-phase-iii-findings-glass-half-empty-or-half-full/ 2021-08-19T20:44:49+00:00 https://ascopost.com/issues/december-25-2016/expert-point-of-view-carlos-l-arteaga-md-1/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/advancing-the-global-impact-of-integrative-oncology/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/the-best-of-sio/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/co-occurrence-of-cancer-and-cognitive-impairment-in-older-adults/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/exploring-practical-strategies-for-cancer-care-in-low-resource-settings/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/abbvie-and-lurie-cancer-center-johns-hopkins-announce-5-year-oncology-research-collaborations/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/nancy-g-hesse-msn-rn-named-president-and-ceo-of-ctca-at-eastern-regional-medical-center/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/richard-gorlick-md-joins-md-anderson-to-lead-pediatrics/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/women-in-oncology-breaking-down-barriers-and-looking-to-the-future/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/conquer-cancer-foundation-matching-gift-challenge-offers-chance-to-double-your-impact/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/asco-and-new-presidential-administration-congress-advancing-patient-focused-cancer-policies/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/asco-and-ons-release-updated-chemotherapy-administration-standards-to-include-pediatric-oncology-care/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/cancernet-resource-helps-patients-manage-cancer-costs/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/addition-of-palbociclib-to-letrozole-in-previously-untreated-advanced-estrogen-receptor-positive-her2-negative-breast-cancer/ 2019-03-11T16:49:53+00:00 https://ascopost.com/issues/december-25-2016/confirmation-or-transformation-the-case-of-palbociclib-in-hormone-receptor-positive-metastatic-breast-cancer/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/study-identifies-factors-in-clonal-evolution-of-chemotherapy-resistant-urothelial-carcinoma/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/mutational-characteristics-of-chemotherapy-treated-bladder-urothelial-neoplasms/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/updated-astro-guideline-expands-pool-of-suitable-candidates-for-accelerated-partial-breast-irradiation/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/accelerating-progress-in-the-treatment-of-glioblastoma-multiforme/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/weighing-the-benefits-and-risks-of-medical-marijuana/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/st-jude-names-ellis-j-neufeld-md-phd-clinical-director-physician-in-chief-and-executive-vice-president/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/monica-m-bertagnolli-md-elected-asco-president-for-2018-2019-term/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/2017-oncology-meetings/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/a-lesson-from-david/ 2020-09-25T01:29:43+00:00 https://ascopost.com/issues/december-25-2016/american-cancer-society-welcomes-three-new-members-and-newly-elected-officers-to-board-of-directors/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/study-suggests-no-evidence-for-screening-mammography-cutoff-age/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/expect-questions-about-screening-mammography-for-women-aged-75-years-and-older/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/r-daniel-beauchamp-md-receives-2016-dr-rodman-e-and-thomas-g-sheen-award/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/treating-the-whole-person/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/weekly-vinblastine-in-chemotherapy-naive-children-with-progressive-low-grade-glioma/ 2019-03-11T16:49:54+00:00 https://ascopost.com/issues/december-25-2016/colonoscopy-screening-in-older-adults/ 2019-03-11T16:49:55+00:00 https://ascopost.com/issues/december-25-2016/osimertinib-shows-activity-in-pretreated-egfr-thr790met-positive-advanced-nsclc/ 2019-03-11T16:49:55+00:00 https://ascopost.com/issues/december-25-2016/maintenance-olaparib-in-platinum-sensitive-recurrent-serous-ovarian-cancer-with-brca-mutation/ 2019-03-11T16:49:55+00:00 https://ascopost.com/issues/december-25-2016/use-of-genetic-testing-to-identify-patients-with-breast-cancer-at-high-risk-for-venous-thromboembolism/ 2019-03-11T16:49:55+00:00 https://ascopost.com/issues/december-10-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/december-10-2016/medicare-access-and-chip-reauthorization-act-the-final-rule/ 2019-03-11T16:53:59+00:00 https://ascopost.com/issues/december-10-2016/clinically-useful-findings-for-brentuximab-vedotin-in-ctcl-rituximab-maintenance-in-mcl/ 2019-03-11T16:53:59+00:00 https://ascopost.com/issues/december-10-2016/experts-consider-the-new-immunotherapy-paradigm-in-advanced-lung-cancer/ 2019-03-11T16:53:59+00:00 https://ascopost.com/issues/december-10-2016/md-anderson-cancer-center-marks-75-years-of-research-to-end-cancer/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/fda-approves-daratumumab-in-combination-therapy-for-patients-with-multiple-myeloma-receiving-at-least-one-prior-treatment/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/novel-immunotherapy-combinations-may-be-the-future-of-melanoma-treatment/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/city-of-hope-translational-genomics-research-institute-combine-to-advance-precision-medicine-and-speed-translational-research/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/genetic-link-may-explain-outcomes-differences-in-multiple-myeloma-in-african-americans/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/mutanome-directed-immunotherapy-finding-the-best-treatment-match/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/bad-year-for-brain-tumors-but-still-reasons-for-hope/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/expert-point-of-view-steven-piantadosi-md-phd/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/nci-study-affirms-there-is-no-safe-level-of-smoking/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/new-treatments-for-lung-cancer-in-2016/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/expert-point-of-view-barry-e-rosenbloom-md/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/johns-hopkins-kimmel-cancer-center-expands-cancer-care-and-research-facility-at-sibley-memorial-hospital-in-washington-dc/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/daratumumab-in-previously-treated-multiple-myeloma/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/randi-kaplan-lmsw-named-schwartz-center-s-2016-national-compassionate-caregiver-of-the-year/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/cancer-metastasis-international-symposium-abstract-award-winners-announced/ 2019-03-11T16:54:00+00:00 https://ascopost.com/issues/december-10-2016/city-of-hope-s-ravi-salgia-md-phd-receives-2016-asclepius-award-from-the-bonnie-j-addario-lung-cancer-foundation/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/concerns-about-safety-of-generic-oncology-drugs-made-in-developing-countries/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/the-fda-ensures-quality-and-safety-of-generic-drugs-in-the-united-states/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/treatment-of-early-her2-positive-breast-cancer-one-size-does-not-fit-all/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/what-s-new-in-antiemesis-therapy/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/make-funding-for-cancer-research-a-global-priority-say-european-and-american-organizations/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/university-of-hawaii-cancer-center-receives-3-million-r01-nci-grant-for-bladder-cancer-research/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/christine-laronga-md-facs-elected-president-of-the-association-of-women-surgeons/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/noteworthy-antitumor-activity-seen-in-phase-i-studies-of-pdgfrα-and-kit-mutation-inhibitors/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/liquid-biopsies-identify-molecular-alterations-driving-drug-resistance-in-nearly-80-of-patients-with-gastrointestinal-cancers/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/nivolumab-in-recurrent-or-metastatic-squamous-cell-carcinoma-of-the-head-and-neck/ 2019-03-11T16:54:01+00:00 https://ascopost.com/issues/december-10-2016/disparities-of-care-navigation-system-helps-connect-underserved-populations-to-cancer-services/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/no-progression-free-survival-difference-with-temozolomide-vs-radiotherapy-in-high-risk-low-grade-glioma/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/center-for-leukemia-and-lymphoma-research-at-unmc-renamed-dr-james-o-armitage-center-for-leukemia-and-lymphoma-research/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/elizabeth-m-swisher-md-finds-juggling-research-projects-and-clinical-care-improves-both/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/reducing-the-risk-of-oral-complications-during-and-after-cancer-therapy/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/fergus-j-couch-phd-and-max-s-wicha-md-recognized-for-significant-contributions-to-breast-cancer-research-at-2016-sabcs/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/nccn-imaging-appropriate-use-criteria-published-for-15-additional-guidelines/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/david-tuveson-md-phd-named-director-of-the-cold-spring-harbor-laboratory-cancer-center/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/clinical-trials-actively-recruiting-patients-with-renal-cell-carcinoma/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/reagan-udall-foundation-announces-appointments-of-ellen-v-sigal-phd-and-richard-l-schilsky-md/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/ash-honors-member-of-congress-and-former-nci-grants-chief-with-service-awards/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/ash-launches-digital-open-access-journal-blood-advances-at-2016-annual-meeting/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/a-decade-of-impact-conquer-cancer-foundationkidney-cancer-association-young-investigator-awards/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/conquer-cancer-foundation-researcher-spotlight-dr-priscilla-brastianos/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/double-your-impact-during-the-conquer-cancer-foundation-matching-gift-challenge/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/asco-s-tapur-study-now-has-more-than-100-participants-receiving-treatment-drugs-and-25-new-clinical-trial-sites/ 2019-03-11T16:54:02+00:00 https://ascopost.com/issues/december-10-2016/team-based-cancer-care-explored-in-special-series-of-journal-of-oncology-practice/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/complete-the-free-pqrs-reporting-available-through-qopi-by-december-31-to-avoid-a-2-medicare-reimbursement-cut-in-2018/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/tell-your-patients-about-asco-s-award-winning-cancernet-mobile-app/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/mylin-a-torres-md-to-hold-glenn-family-chair-in-breast-cancer-research-at-winship-cancer-institute/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/aaas-names-winship-s-dong-moon-shin-md-as-a-2016-fellow/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/roy-s-herbst-md-phd-receives-2016-paul-a-bunn-jr-scientific-award/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/precautions-in-cancer-rehabilitation-services-imperative-or-impediment-in-patient-care/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/statement-from-the-american-association-for-cancer-research-on-the-house-passage-of-the-21st-century-cures-act/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/maura-gillison-md-phd-elected-to-national-academy-of-medicine/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/peer-reviewed-indian-journal-of-surgical-oncology-meets-challenges-succeeds-in-developing-country/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/integrating-aya-oncology-care-into-the-worlds-of-pediatric-and-adult-oncology-care-to-improve-cancer-outcomes/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/approval-of-dinutuximab-for-high-risk-neuroblastoma-lessons-learned-in-expediting-the-development-of-pediatric-cancer-drugs/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/using-art-to-humanize-medicine/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/palliative-care-improves-quality-of-life-relieves-symptoms/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/seven-md-anderson-faculty-elected-fellows-of-the-american-association-for-the-advancement-of-science/ 2019-03-11T16:54:03+00:00 https://ascopost.com/issues/december-10-2016/matt-ewend-md-facs-named-president-of-the-university-of-north-carolina-physicians/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/nccn-launches-campaign-to-eradicate-fatal-vincristine-errors/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/unc-lineberger-s-michael-r-kosorok-phd-elected-aaas-fellow/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/asco-releases-criteria-for-high-quality-clinical-pathways-in-oncology/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/friends-of-cancer-research-rethinks-traditional-clinical-trials/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/william-sellers-md-appointed-to-faculty-at-broad-institute-dana-farber-cancer-institute-and-harvard-medical-school/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/the-leukemia-lymphoma-society-invests-403-million-in-new-research-to-find-cures-for-hematologic-malignancies/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/steven-k-libutti-md-facs-named-director-of-rutgers-cancer-institute-of-new-jersey/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/faculty-development-in-oncology-advancing-the-field-by-optimizing-opportunities-for-educators-to-learn-and-grow/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/team-based-care-in-oncology-national-cancer-institute-and-asco-launch-unique-project/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/advocacy-group-to-fund-16-million-in-grants-for-8-early-detection-ovarian-cancer-research-projects/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/profound-answers-to-simple-questions/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/2017-oncology-meetings/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/valerian/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/overcoming-the-physical-emotional-and-financial-effects-of-cancer/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/nih-statement-on-the-death-of-former-congressman-melvin-r-laird/ 2019-03-11T16:54:04+00:00 https://ascopost.com/issues/december-10-2016/cardiac-complications-in-patients-receiving-combination-checkpoint-inhibitors-are-rare-but-can-be-fatal/ 2019-03-11T16:54:05+00:00 https://ascopost.com/issues/december-10-2016/expect-questions-about-cardiovascular-risk-factors-among-cancer-survivors/ 2019-03-11T16:54:05+00:00 https://ascopost.com/issues/december-10-2016/george-a-komatsoulis-phd-joins-cancerlinq-llc-as-chief-of-bio-informatics/ 2019-03-11T16:54:05+00:00 https://ascopost.com/issues/december-10-2016/intensity-modulated-vs-three-dimensional-conformal-external-beam-radiation-therapy-in-locally-advanced-non-small-cell-lung-cancer/ 2019-03-11T16:54:05+00:00 https://ascopost.com/issues/december-10-2016/characteristics-of-hpv-driven-nonoropharyngeal-squamous-cell-carcinomas-of-the-head-and-neck/ 2019-03-11T16:54:05+00:00 https://ascopost.com/issues/december-10-2016/investigational-immunotherapy-for-advanced-melanoma/ 2019-03-11T16:54:05+00:00 https://ascopost.com/issues/december-10-2016/pioneer-in-cancer-immunology-richmond-t-prehn-md-dies/ 2019-03-11T16:54:05+00:00 https://ascopost.com/issues/november-25-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/november-25-2016/another-step-forward-for-genomic-assays-in-early-stage-breast-cancer-findings-with-mammaprint-in-the-mindact-trial/ 2019-03-11T16:55:05+00:00 https://ascopost.com/issues/november-25-2016/recent-progress-and-concepts-in-pancreatic-cancer/ 2019-03-11T16:55:05+00:00 https://ascopost.com/issues/november-25-2016/optimizing-allogeneic-stem-cell-transplantation-in-myelofibrosis/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/breakthrough-in-recurrent-ovarian-cancer-niraparib-extends-progression-free-survival-in-platinum-sensitive-disease/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/expert-point-of-view-sandro-pignata-md/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/neoadjuvant-chemotherapy-in-high-risk-soft-tissue-sarcoma-a-new-standard/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/expert-point-of-view-axel-le-cesne-md/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/neoadjuvant-nivolumab-appears-safe-and-feasible-in-lung-cancer/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/expert-point-of-view-paul-baas-md-phd/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/studies-confirm-ceritinib-s-benefit-in-alk-positive-patients/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/expert-point-of-view-alice-t-shaw-md-phd/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/new-leadership-elected-to-american-society-of-hematology/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/high-throughput-sequencing-of-t-cell-receptors-may-transform-diagnosis-and-treatment-of-cutaneous-t-cell-lymphomas/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/prospective-cutaneous-lymphoma-international-prognostic-index-initiative-moves-forward/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/expert-point-of-view-youn-kim-md/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/western-connecticut-health-network-names-john-a-martignetti-md-phd-network-director-of-the-laboratory-for-translational-research/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/encouraging-first-study-of-pembrolizumab-in-cutaneous-t-cell-lymphoma/ 2019-03-11T16:55:06+00:00 https://ascopost.com/issues/november-25-2016/skin-cancer-foundation-president-perry-robins-md-announces-retirement-names-deborah-s-sarnoff-md-his-successor/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/lack-of-standardized-definitions-of-cutaneous-t-cell-lymphomas-hampers-the-collection-of-reliable-data/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/androgen-receptor-antagonists-may-meet-unmet-need-in-triple-negative-breast-cancer/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/clinical-strategies-for-improving-endocrine-therapy-in-metastatic-breast-cancer/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/numerous-esmo-presentations-focused-on-anti-pd-1-therapy-in-lung-cancer-and-melanoma/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/locally-advanced-esophageal-cancer-outcomes-improved-with-neoadjuvant-therapy/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/expert-point-of-view-florian-lordick-md/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/anti-pd-1-contenders-in-advanced-urothelial-cancer/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/expert-point-of-view-laurence-albiges-md-phd/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/at-esmo-2016-many-phase-iii-trials-fail-to-meet-primary-endpoints/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/pembrolizumab-in-first-line-treatment-of-metastatic-non-small-cell-lung-cancer/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/adjuvant-sunitinib-improves-disease-free-survival-in-high-risk-renal-cell-carcinoma-after-nephrectomy/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/adjuvant-sunitinib-for-renal-cell-carcinoma-not-ready-for-prime-time/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/fred-hutch-opens-bezos-family-immunotherapy-clinic/ 2019-03-11T16:55:07+00:00 https://ascopost.com/issues/november-25-2016/dafna-bar-sagi-phd-receives-nci-outstanding-investigator-award/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/update-on-neoplastic-hematology-review-of-recent-clinical-trials/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/pembrolizumab-improves-outcomes-vs-platinum-based-chemotherapy-in-advanced-pd-l1-positive-nsclc/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/pembrolizumab-as-first-line-therapy-in-metastatic-nsclc-practice-changing-implications-of-keynote-024-trial/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/ama-statement-on-the-future-of-health-care-reform/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/phase-iii-trial-shows-no-survival-benefit-of-adding-first-line-ima901-vaccine-to-sunitinib-in-advanced-renal-cell-carcinoma/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/vaccine-therapy-in-metastatic-renal-cell-carcinoma-past-present-and-future/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/memorial-sloan-kettering-long-island-branch-expands-site-services/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/the-emergence-of-philanthropy-to-fund-high-risk-high-reward-cancer-research/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/immunotherapy-clinical-trials-actively-recruiting-patients-with-non-small-cell-lung-cancer/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/practices-provided-concrete-path-toward-alternative-payment-system/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/supriya-saha-md-phd-opens-laboratory-to-study-liver-cancer-at-fred-hutch-cancer-research-center/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/adding-olaratumab-to-doxorubicin-increases-overall-survival-in-advanced-soft-tissue-sarcoma/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/cautious-optimism-about-olaratumab-in-soft-tissue-sarcoma/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/adult-survivors-of-childhood-cancers-report-long-term-health-issues/ 2019-03-11T16:55:08+00:00 https://ascopost.com/issues/november-25-2016/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-albania/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/research-highlights-from-the-2016-palliative-care-in-oncology-symposium/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/apply-for-asco-health-policy-fellowship-to-improve-skills-needed-to-shape-cancer-policy/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/a-note-of-thanks-from-the-conquer-cancer-foundation/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/cancerlinq-platform-hits-milestone-of-having-more-than-1-million-patient-records-in-system/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/plan-ahead-for-the-holidays-with-the-conquer-cancer-foundation/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/asco-quality-improvement-grant-spotlight-the-ralph-lauren-center-for-cancer-care/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/asco-answers-fact-sheets-for-your-patients/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/johns-hopkins-awards-professorship-to-melanoma-researcher/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/charles-g-drake-md-phd-joins-newyork-presbyteriancolumbia-university-medical-center/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/understanding-biosimilars-and-their-impending-role-in-oncology-care/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/how-video-support-tools-help-patients-make-informed-decisions-about-end-of-life-care/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/ama-adopts-ethical-guidance-on-team-based-health-care/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/cary-a-presant-md-facp-fasco-receives-accc-david-king-community-clinical-scientist-award/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/a-lung-cancer-specialist-talks-about-value-in-cancer-care/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/anne-gross-phd-rn-nea-bc-faan-named-senior-vice-president-of-patient-care-services-and-chief-nursing-officer-at-dana-farber/ 2019-03-11T16:55:09+00:00 https://ascopost.com/issues/november-25-2016/susan-j-mandel-md-mph-named-president-elect-of-the-endocrine-society/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/making-peace-with-cancer/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/study-finds-cabozantinib-of-clinical-benefit-vs-sunitinib-in-advanced-renal-cell-carcinoma/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/sleep-disruption-in-cancer-survivors-yoga-offers-a-low-risk-intervention-with-high-potential-for-benefit/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/the-future-of-health-care-in-america-which-corridor/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/dana-farber-cancer-institute-lifespan-partner-to-advance-cancer-treatment-and-expand-research/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/julie-c-brabbs-mba-named-cancer-center-chief-administrative-officer-at-u-m/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/shirley-a-johnson-rn-ms-mba-joins-roswell-park-cancer-institute/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/carrie-lee-md-mph-named-chair-elect-of-aaci-s-clinical-research-initiative-steering-committee/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/how-when-breath-becomes-air-is-helping-the-public-and-physicians-confront-their-mortality/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/zhu-chen-md-phd-and-hugues-de-thé-md-phd-to-present-2016-ash-ernest-beutler-lecture/ 2019-07-31T18:53:27+00:00 https://ascopost.com/issues/november-25-2016/michael-o-connell-md-receives-the-2016-accc-clinical-research-award/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/2016-2017-oncology-meetings/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/bridge-medicines-launched-to-advance-promising-early-technologies-in-major-academic-institutions/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/dave-dave-dave/ 2019-03-11T16:55:10+00:00 https://ascopost.com/issues/november-25-2016/elisabeth-heath-md-facp-honored-with-2016-michigan-cancer-consortium-champion-award/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/helping-patients-with-breast-cancer-decide-whether-to-have-reconstruction/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/expect-and-encourage-questions-about-breast-reconstruction/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/drainage-of-massive-ascites-patient-of-nicholas-senn-md/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/ash-reports-highest-scoring-abstracts-by-early-career-researchers-for-annual-meeting/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/ash-honors-j-evan-sadler-md-phd-and-ayalew-tefferi-md-with-the-2016-henry-m-stratton-medal/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/american-society-of-hematology-honors-david-grimwade-phd-posthumously-with-the-2016-exemplary-service-award/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/advanced-practitioners-convene-at-fourth-annual-jadpro-live-at-apsho/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/fda-approves-nivolumab-for-the-treatment-of-recurrentmetastatic-squamous-cell-carcinoma-of-the-head-and-neck/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/baylor-welcomes-new-mcnair-scholar-bing-zhang-phd/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/adrian-lee-phd-named-director-of-the-institute-for-precision-medicine-at-pitt/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/su2c-launches-75-million-initiative-in-research-grants-focusing-on-immuno-oncology/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/primary-care-physician-involvement-in-decision-making-in-breast-cancer/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/genetic-markers-associated-with-pathologic-complete-response-identified-in-her2-positive-breast-cancer/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/long-term-effects-of-finasteride-in-patients-from-the-prostate-cancer-prevention-trial/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/nivolumab-in-recurrent-advanced-urothelial-carcinoma/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-25-2016/gleevec-is-saving-my-life-but-at-a-cost/ 2019-03-11T16:55:11+00:00 https://ascopost.com/issues/november-10-2016-supplement-biosimilars-in-oncology/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/november-10-2016-supplement-biosimilars-in-oncology/introduction/ 2019-03-11T16:55:45+00:00 https://ascopost.com/issues/november-10-2016-supplement-biosimilars-in-oncology/biosimilars-in-oncology/ 2019-03-11T16:55:45+00:00 https://ascopost.com/issues/november-10-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/november-10-2016/notable-gains-in-survival-achieved-with-atezolizumab-in-non-small-cell-lung-cancer/ 2019-03-11T16:56:03+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-corey-j-langer-md/ 2019-03-11T16:56:03+00:00 https://ascopost.com/issues/november-10-2016/how-asco-is-preparing-members-for-macra/ 2019-03-11T16:56:03+00:00 https://ascopost.com/issues/november-10-2016/putting-patients-first-my-journey-in-advocacy/ 2019-03-11T16:56:03+00:00 https://ascopost.com/issues/november-10-2016/cabozantinib-improves-progression-free-survival-and-response-rates-vs-sunitinib-in-first-line-treatment-of-metastatic-kidney-cancer/ 2019-03-11T16:56:03+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-bernard-escudier-md/ 2019-03-11T16:56:03+00:00 https://ascopost.com/issues/november-10-2016/phase-iii-study-of-sunitinib-is-first-to-show-benefit-in-adjuvant-setting-for-treatment-of-renal-cell-carcinoma/ 2019-03-11T16:56:03+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-axel-bex-md-phd/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/pembrolizumab-plus-chemotherapy-improves-outcomes-over-chemotherapy-alone-in-advanced-nsclc/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-jean-charles-soria-md-phd-1/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/pembrolizumab-but-not-nivolumab-improves-outcomes-in-front-line-setting-for-pd-l1-positive-advanced-nsclc/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-jean-charles-soria-md-phd/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/keynote-045-trial-finds-pembrolizumab-improves-survival-over-chemotherapy-in-advanced-urothelial-cancer/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/fulvestrant-superior-to-anastrozole-as-initial-therapy-in-advanced-breast-cancer/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-peter-schmid-md-phd/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/preliminary-data-indicate-potential-role-for-dabrafenib-as-part-of-therapy-for-pediatric-low-grade-gliomas-with-braf-v600-mutation/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-guido-reifenberger-md/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/better-quality-of-life-reported-in-patients-with-head-and-neck-cancer-receiving-nivolumab-vs-chemotherapy/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-anthony-tc-chan-md/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/combination-strategies-harness-the-power-of-the-oncolytic-virus-talimogene-laherparepvec/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/scientists-are-boosting-immune-responses-in-pancreatic-tumors/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/kunle-odunsi-md-phd-frcog-reelected-as-co-chair-of-nci-ovarian-task-force/ 2019-03-11T16:56:04+00:00 https://ascopost.com/issues/november-10-2016/bruce-clurman-md-phd-named-executive-vice-president-and-deputy-director-of-fred-hutchinson-cancer-research-center/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/vaccines-may-boost-immune-responsiveness-of-pancreatic-tumors/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/is-observation-without-surgery-a-viable-strategy-for-managing-ductal-carcinoma-in-situ/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/fda-approves-pembrolizumab-as-first-line-treatment-for-pd-l1-positive-non-small-cell-lung-cancer/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/fda-grants-accelerated-approval-to-olaratumab-for-treatment-of-advanced-soft-tissue-sarcoma/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/chemotherapy-may-be-avoidable-in-some-women-with-early-stage-breast-cancer-based-on-clinical-and-genomic-risks/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/small-study-tests-dual-checkpoint-blockade-in-high-risk-stage-iii-melanoma/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-celeste-lebbé-md/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/study-looks-for-optimal-dosing-of-single-agent-ipilimumab-in-metastatic-melanoma/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/expert-point-of-view-olivier-michielin-ms-md-phd/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/roger-stupp-md-appointed-associate-director-for-strategic-initiatives-at-robert-h-lurie-cancer-center/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/florida-atlantic-university-appoints-phillip-m-boiselle-md-as-dean-of-the-charles-e-schmidt-college-of-medicine/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/charles-s-fuchs-md-mph-to-lead-yale-cancer-center-and-smilow-cancer-hospital/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/ellen-and-gary-davis-immune-monitoring-core-established-at-weill-cornell-medicine/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/as-more-biosimilars-move-toward-us-market-questions-remain-about-cost-savings-and-uptake-by-physicians-and-patients/ 2019-03-11T16:56:05+00:00 https://ascopost.com/issues/november-10-2016/cancerlinq-platform-hits-milestone-of-having-more-than-1-million-patient-records-in-system/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/atezolizumab-in-previously-treated-metastatic-nsclc/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/interviews-with-asco-s-president-elect-candidates/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/asco-announces-candidates-for-2017-election/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/research-community-forum-2016-annual-meeting-using-collective-wisdom-to-improve-cancer-research/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/asco-s-quality-training-program-shifts-to-a-regional-setting-applications-now-open-for-2017/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/asco-introduces-two-new-journals-jco-precision-oncology-and-jco-clinical-cancer-informatics/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/conquer-cancer-foundation-s-international-programs/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/use-social-media-to-stay-up-to-date-on-new-patient-materials-from-cancernet/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/cardio-oncology-in-the-geriatric-patient/ 2020-02-17T17:52:51+00:00 https://ascopost.com/issues/november-10-2016/dana-farber-cancer-institute-cpdc-at-mcmaster-university-join-to-speed-cancer-research-with-molecular-probes/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/forging-collaboration-between-children-s-and-adult-oncology-groups-in-designing-trials-for-adolescents-and-young-adults/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/cdc-recommends-only-two-hpv-shots-for-younger-adolescents/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/diagnosing-and-managing-chemotherapy-induced-peripheral-neuropathy/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/talking-to-children-with-cancer-sometimes-less-is-more/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/development-and-validation-of-a-quality-assurance-score-for-robot-assisted-radical-cystectomy/ 2019-03-11T16:56:06+00:00 https://ascopost.com/issues/november-10-2016/fox-chase-cancer-center-designated-as-a-national-pancreas-foundation-center/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/kwok-kin-wong-md-phd-to-join-nyu-langone-as-chief-of-hematology-and-medical-oncology/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/suresh-s-ramalingam-md-honored-with-goizueta-chair-for-cancer-research-at-winship-cancer-institute/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/meeting-the-needs-of-older-adults-with-cancer/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/modified-indication-for-erlotinib-in-advanced-non-small-cell-lung-cancer/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/new-blood-test-for-colorectal-cancer-recurrence-twice-as-sensitive-as-cea-test/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/let-s-win-innovative-online-community-offers-guidance-to-patients-with-pancreatic-cancer-and-their-families/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/olaratumab-in-soft-tissue-sarcoma/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/david-scadden-md-to-present-the-2016-ash-e-donnall-thomas-lecture/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/ash-honors-thalia-papayannopoulou-md-with-wallace-h-coulter-award-for-lifetime-achievement-in-hematology/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/resuscitation-during-surgery/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/2016-2017-oncology-meetings/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/advanced-practitioners-convene-for-annual-jadpro-live-at-apsho-meeting/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/the-smartest-guys-in-the-room/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/david-cella-phd-receives-lienhard-award-from-national-academy-of-medicine/ 2019-03-11T16:56:07+00:00 https://ascopost.com/issues/november-10-2016/medical-marijuana-the-topic-you-can-t-escape/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/when-marijuana-was-legal-in-the-united-states/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/expect-questions-about-medical-marijuana/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/two-big-10-universities-compete-in-challenge-and-help-raise-more-than-59-million-for-childhood-cancer-research/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/meta-analysis-identifies-new-genetic-variants-for-barrett-s-esophagus-and-esophageal-adenocarcinoma/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/higher-baseline-metabolic-tumor-volume-and-poorer-outcomes-in-patients-with-high-tumor-burden-follicular-lymphoma/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/risk-for-non-hodgkin-lymphoma-in-hiv-infected-patients/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/study-suggests-benefit-of-adjuvant-radiation-therapy-but-not-chemotherapy-in-some-patients-with-merkel-cell-carcinoma/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/prevalence-of-early-endocrine-disorders-in-survivors-of-childhood-brain-tumors/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/impact-of-neoadjuvant-therapy-on-survival-in-resectable-pancreatic-cancer/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/enrollment-disparity-in-national-lung-cancer-trials/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/living-with-metastatic-breast-cancer-is-like-walking-a-tightrope/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/josé-r-conejo-garcia-md-phd-joins-moffitt-as-co-leader-of-immunology-program-chair-of-department-of-immunology/ 2019-03-11T16:56:08+00:00 https://ascopost.com/issues/november-10-2016/christine-mayr-md-phd-of-sloan-kettering-institute-honored-with-nih-director-s-pioneer-award/ 2019-03-11T16:56:09+00:00 https://ascopost.com/issues/october-25-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/october-25-2016/combination-of-ribociclib-and-letrozole-is-a-home-run-in-advanced-breast-cancer/ 2019-03-11T16:56:26+00:00 https://ascopost.com/issues/october-25-2016/expert-point-of-view-stephen-rd-johnston-md/ 2019-03-11T16:56:26+00:00 https://ascopost.com/issues/october-25-2016/study-shows-strong-evidence-supporting-radiation-boost-to-tumor-bed-in-ductal-carcinoma-in-situ/ 2019-03-11T16:56:26+00:00 https://ascopost.com/issues/october-25-2016/expert-point-of-view-geraldine-m-jacobson-md/ 2019-03-11T16:56:26+00:00 https://ascopost.com/issues/october-25-2016/dear-presidential-candidates-a-letter-from-an-oncologist/ 2019-03-11T16:56:26+00:00 https://ascopost.com/issues/october-25-2016/retrospective-studies-confirm-survival-benefit-of-stereotactic-body-radiotherapy-in-early-stage-nsclc/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/expert-point-of-view-brian-kavanagh-md/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/safety-of-extreme-hypofractionation-reassuring-in-intermediate-risk-prostate-cancer/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/stereotactic-radiosurgery-achieves-better-quality-of-life-and-improved-cognition-than-whole-brain-radiotherapy/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/expert-point-of-view-vinai-gondi-md/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/yanis-boumber-md-phd-returns-to-fox-chase-department-of-thoracic-oncology-and-molecular-therapeutics-program/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/nancy-e-davidson-md-to-lead-fred-hutchinsonuniversity-of-washington-cancer-consortium/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/prognostic-and-predictive-molecular-subtypes-of-prostate-cancer-identified/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/expert-point-of-view-colleen-a-lawton-md/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/nccn-issues-new-clinical-practice-guidelines-for-myeloproliferative-neoplasms/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/breast-cancer-study-finds-higher-mortality-rate-in-black-women-than-white-women-and-the-disparity-is-growing/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/consensus-on-defining-and-measuring-lymphedema-is-needed-to-advance-efforts-to-intervene-early-and-prevent-progression/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/german-society-salutes-big-four-for-pioneering-work-in-women-s-health-care/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/nih-expands-national-precision-medicine-initiative-cohort-program/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/with-changing-strategies-for-laryngeal-cancer-multidisciplinary-team-approach-is-key/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/huntsman-cancer-institute-names-ben-tanner-executive-director/ 2019-03-11T16:56:27+00:00 https://ascopost.com/issues/october-25-2016/upmc-honors-stanley-m-marks-md-with-endowed-chair-in-hematologyoncology-leadership/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/mount-sinai-and-thomas-jefferson-university-researchers-receive-falk-foundation-grant-to-study-uveal-melanoma/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/quality-science-at-esmo-2016/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/adjuvant-ipilimumab-improves-survival-in-high-risk-melanoma/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/expert-point-of-view-olivier-michielin-ms-md-phd/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/sgo-and-asco-clinical-practice-guideline-on-neoadjuvant-chemotherapy-for-newly-diagnosed-advanced-ovarian-cancer/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/what-we-know-and-what-we-need-to-know-about-neoadjuvant-chemotherapy-in-advanced-ovarian-cancer/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/st-jude-children-s-research-hospital-and-sanger-institute-uk-agree-to-full-exchange-of-cancer-data/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/margins-for-breast-conserving-surgery-with-whole-breast-irradiation-in-ductal-carcinoma-in-situ/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/new-sso-astro-asco-clinical-practice-guideline-clarifies-the-question-of-margins-for-breast-conserving-surgery-in-ductal-carcinoma-in-situ/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/modification-of-dosage-regimen-for-nivolumab-in-renal-cell-carcinoma-melanoma-and-nsclc/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/coa-releases-2016-community-oncology-practice-impact-report/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/precision-promise-clinical-trial-focuses-on-precision-medicine-collaboration-and-data-sharing-in-pancreatic-cancer/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/free-pqrs-reporting-now-available-through-qopi-no-additional-reporting-required/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/asco-presents-first-ever-asco-congressional-leadership-award-to-representative-michael-burgess-md/ 2019-03-11T16:56:28+00:00 https://ascopost.com/issues/october-25-2016/new-member-categories-provide-specialized-support-to-cancer-care-team-members/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/arti-hurria-md-from-leadership-development-program-to-board-of-directors/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/leave-a-legacy-of-hope/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/asco-answers-palliative-care-a-resource-for-patients/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/when-breath-becomes-air-dr-lucy-kalanithi-reflects-on-dr-paul-kalanithi-s-life-and-writing/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/personalized-vaccines-may-protect-patients-with-high-risk-melanoma/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/expert-point-of-view-elizabeth-jaffee-md/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/barriers-and-opportunities-reported-in-the-study-of-human-papillomavirus-education-and-immunization-efforts/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/rise-in-oropharyngeal-cancer-incidence-in-the-uk-not-solely-driven-by-hpv/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/sanford-research-in-south-dakota-receives-nih-grant-in-head-and-neck-pediatric-cancers/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/using-pharmacogenetics-to-predict-cancer-prognosis-response-to-treatment-and-toxicity/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/new-nccn-patient-resources-assist-decision-making-for-patients-with-stomach-cancer/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/bromelain/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/donor-selection-for-hla-matched-hematopoietic-cell-transplantation/ 2019-03-11T16:56:29+00:00 https://ascopost.com/issues/october-25-2016/donor-selection-for-hla-matched-hematopoietic-cell-transplantation-1/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/palliative-care-still-in-its-infancy-in-hematologic-malignancies/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/dexamethasone-mouth-rinse-should-be-routine-part-of-everolimus-treatment/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/food-as-medicine-study-sets-out-to-prove-its-effectiveness/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/quality-improvement-project-results-in-timelier-hospice-referrals/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/cedars-sinai-appoints-robert-a-figlin-md-to-lead-new-initiative-to-integrate-cancer-care-across-health-system/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/the-medicinal-power-of-minerals/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/a-cancer-diagnosis-brings-two-sisters-back-together/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/lombardi-s-ruesch-center-policy-briefing-features-strategies-to-reduce-costs/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/new-american-cancer-society-report-reveals-gaps-identifies-unique-barriers-in-pediatric-cancer-research/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/clinical-trials-actively-recruiting-patients-with-metastatic-breast-cancer/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/2016-2017-oncology-meetings/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/face-mask-for-radiation-therapy/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/affordable-care-act-increased-access-to-cancer-care-and-clinical-trial-participation-among-hispanics-in-california/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/study-finds-african-american-cancer-survivors-more-likely-to-experience-lasting-debt-related-to-cancer-and-its-treatment/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/my-catch-22-predicament/ 2019-03-11T16:56:30+00:00 https://ascopost.com/issues/october-25-2016/national-heart-lung-and-blood-institute-selects-moffitt-cancer-center-as-one-of-five-cell-therapies-processing-facilities/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/asco-issues-global-recommendations-to-increase-cervical-cancer-screening/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/key-guideline-recommendations/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/genetic-characteristics-of-recurrent-and-metastatic-head-and-neck-cancers/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/pembrolizumab-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/similar-functional-outcomes-with-robot-assisted-laparoscopic-and-open-radical-retropubic-prostatectomy/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/venetoclax-monotherapy-safe-and-clinically-active-in-acute-myelogenous-leukemia/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/minimal-residual-disease-assessment-and-prediction-of-outcome-in-cll-responders/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/evaluating-the-fda-s-approach-to-cancer-clinical-trials/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-25-2016/asco-applauds-macra-s-focus-on-high-quality-patient-centered-care/ 2019-03-11T16:56:31+00:00 https://ascopost.com/issues/october-10-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/october-10-2016/similar-10-year-survival-with-active-monitoring-surgery-or-radiotherapy-for-psa-detected-clinically-localized-prostate-cancer/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/risk-of-metastasis-with-active-monitoring-in-psa-detected-localized-prostate-cancer-the-protectt-trial/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/surgery-and-radiation-protect-against-progressionmetastasis-vs-active-monitoring-in-prostate-cancer-but-at-what-cost/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/bridging-the-gap-in-oncology-care/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/why-curing-cancer-will-take-decades/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/immunotherapy-brings-unique-challenges-for-clinicians/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/pearls-for-managing-immune-related-toxicities/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/palliative-care-let-s-use-the-tools-we-already-have/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/benefits-of-early-palliative-care-interventions-extend-beyond-the-patient/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/why-care-about-the-caregivers/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/internationally-renowned-statistician-on-cancer-clinical-trials-daniel-j-sargent-phd-dies/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/study-finds-adding-daratumumab-to-bortezomibdexamethasone-improves-progression-free-survival-in-relapsedrefractory-multiple-myeloma/ 2019-03-11T16:56:55+00:00 https://ascopost.com/issues/october-10-2016/daratumumab-plus-bortezomibdexamethasone-changing-the-treatment-paradigm-in-relapsed-or-refractory-myeloma/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/clinical-trials-actively-recruiting-patients-with-early-breast-cancer/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/friends-of-cancer-research-honors-oncology-leaders-at-20th-anniversary-and-announces-partnership/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/which-factors-influence-radiotherapy-for-brain-metastases/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/amelie-g-ramirez-drph-receives-aacr-distinguished-lecture-on-the-science-of-cancer-health-disparities/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/phase-iii-trial-finds-no-survival-benefit-of-adding-ipilimumab-to-etoposideplatinum-in-newly-diagnosed-extensive-stage-sclc/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/small-cell-lung-cancer-and-immunotherapy-a-change-is-coming-just-not-front-line-yet/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/asco-clinical-practice-guideline-on-management-of-chronic-pain-in-survivors-of-adult-cancers/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/a-helping-hand-just-in-time-the-asco-guideline-for-managing-chronic-pain-in-adult-cancer-survivors/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/susan-m-o-brien-md-embraces-the-challenge-of-balancing-patient-care-with-clinical-trial-investigation/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/multiple-myeloma-research-foundation-to-donate-data-to-nci-s-genomic-data-commons/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/eric-fearon-md-phd-named-director-of-university-of-michigan-comprehensive-cancer-center/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/bishoy-faltas-md-joins-weill-cornell-medicine-hematology-and-medical-oncology/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/asco-president-elect-bruce-e-johnson-md-fasco-reflects-on-volunteer-service-plans-for-presidential-term/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/ccf-conquerors-circle-recognizes-donors/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/asco-international-course-helps-ethiopia-realize-its-goal-of-improving-cancer-care/ 2019-03-11T16:56:56+00:00 https://ascopost.com/issues/october-10-2016/are-you-ready-for-macra-asco-offers-educational-resources-and-events-to-help-practices-prepare/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/advanced-cancer-care-planning-booklet-for-your-patients-and-caregivers/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/asco-supports-recent-tobacco-legislation/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/asco-recommends-quick-wins-for-national-cancer-moonshot/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/radiologic-associates-of-fredericksburg-welcomes-samer-hijaz-md/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/baylor-and-texas-children-s-hospital-partner-to-bring-fellowship-training-in-oncology-and-hematology-to-east-africa/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/aacr-s-cancer-progress-report-hails-research-advances-and-details-challenges-ahead/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/prehabilitation-and-rehabilitation-may-improve-work-related-outcomes-in-cancer-survivors/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/salk-institute-s-clodagh-o-shea-phd-named-howard-hughes-medical-institute-faculty-scholar/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/metastatic-breast-cancer-alliance-launches-help-keep-me-in-the-picture-campaign/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/ama-awards-research-grants-to-advance-the-study-of-women-in-medicine/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/update-on-neoplastic-hematology-review-of-recent-clinical-trials/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/asco-presents-first-ever-congressional-leadership-award-to-rep-michael-burgess-md/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/jacques-galipeau-md-frcp-c-brings-personalized-stem-cell-treatment-to-uw-carbone/ 2019-03-11T16:56:57+00:00 https://ascopost.com/issues/october-10-2016/oncology-researchers-clinicians-selected-as-endocrine-society-2017-laureate-award-winners/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/susan-g-komen-announces-27-million-initiative-to-reduce-breast-cancer-deaths-in-african-american-community/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/2016-2017-oncology-meetings/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/university-of-michigan-cancer-center-names-four-new-leaders/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/using-watson-to-analyze-genomic-data-to-personalize-treatment-for-patients-with-cancer/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/john-karanicolas-phd-joins-the-fox-chase-cancer-center-molecular-therapeutics-program/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/new-edition-of-the-md-anderson-manual-of-medical-oncology/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/friendship/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/paul-jacobsen-phd-named-associate-director-of-national-cancer-institute-healthcare-delivery-research-program/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/a-space-to-heal/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/the-medical-profession-has-to-become-culturally-sensitive-to-the-needs-of-lgbt-cancer-survivors/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/the-university-of-colorado-cancer-center-names-eric-clambey-phd-director-of-flow-cytometry-shared-resource/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/the-fda-urges-physicians-and-patients-to-forgo-ovarian-cancer-screening-tests/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/expect-questions-about-the-fda-discouraging-use-of-ovarian-cancer-screening-tests/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/hhs-takes-steps-to-provide-more-information-on-clinical-trials-to-the-public/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/lenalidomidedexamethasone-in-high-risk-smoldering-multiple-myeloma/ 2019-03-11T16:56:58+00:00 https://ascopost.com/issues/october-10-2016/risk-of-serousserous-like-endometrial-carcinoma-after-rrso-in-women-with-brca1-mutation/ 2019-03-11T16:56:59+00:00 https://ascopost.com/issues/october-10-2016/tailoring-breast-cancer-screening-for-older-women-by-breast-density-and-risk/ 2019-03-11T16:56:59+00:00 https://ascopost.com/issues/october-10-2016/bevacizumabcapecitabine-vs-bevacizumabpaclitaxel-in-her2-negative-breast-cancer/ 2019-03-11T16:56:59+00:00 https://ascopost.com/issues/october-10-2016/high-intensity-local-treatment-in-metastatic-urothelial-carcinoma-of-the-bladder/ 2019-03-11T16:56:59+00:00 https://ascopost.com/issues/october-10-2016/extended-active-surveillance-prior-to-systemic-therapy-may-be-safe-in-some-patients-with-metastatic-renal-cell-carcinoma/ 2019-03-11T16:56:59+00:00 https://ascopost.com/issues/september-25-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/september-25-2016/first-line-nivolumab-alone-and-combined-with-platinum-based-chemotherapy-in-advanced-nsclc/ 2019-03-11T16:57:19+00:00 https://ascopost.com/issues/september-25-2016/immune-checkpoint-inhibitors-march-to-first-line-treatment-in-advanced-nsclc/ 2019-03-11T16:57:19+00:00 https://ascopost.com/issues/september-25-2016/asco-and-aaci-initiative-to-reduce-administrative-and-regulatory-burden-in-cancer-clinical-trials/ 2019-03-11T16:57:19+00:00 https://ascopost.com/issues/september-25-2016/reducing-drug-costs-by-increasing-science-driven-drug-discovery/ 2019-03-11T16:57:19+00:00 https://ascopost.com/issues/september-25-2016/testosterone-therapy-may-be-cardioprotective-in-patients-undergoing-chemotherapy/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/expert-point-of-view-benjamin-l-judson-md/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/specimen-margin-tops-frozen-margin-as-prognostic-marker-in-oral-cancer-surgery/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/expert-point-of-view-allen-cheng-md-dds-susan-d-mccammon-md/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/routine-pet-surveillance-discouraged-in-large-cell-lymphoma/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/novel-agents-on-the-horizon-in-lymphoma/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/ash-presents-charles-mullighan-mbbs-hons-md-with-the-2016-william-dameshek-prize/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/everolimus-in-advanced-her2-positive-breast-cancer-with-pik3ca-mutation-pten-loss-or-hyperactive-pi3k-pathway/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/fda-approves-ofatumumab-in-combination-with-fludarabine-and-cyclophosphamide-for-relapsed-cll/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/continuation-of-docetaxel-may-improve-survival-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/testosterone-related-genetic-mutation-associated-with-poorer-survival-in-prostate-cancer/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/new-uspstf-recommendations-for-colorectal-cancer-screening/ 2019-03-11T16:57:20+00:00 https://ascopost.com/issues/september-25-2016/updated-uspstf-guidelines-for-colorectal-cancer-screening-more-methods-more-challenges-for-patients-and-providers-alike/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/lung-cancer-specialist-shares-clinical-pearls-for-managing-stage-iiia-non-small-cell-lung-cancer/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/fda-grants-priority-review-to-pembrolizumab-supplemental-biologics-license-application-for-first-line-treatment-of-advanced-nsclc/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/4th-annual-basser-global-prize-awarded-to-women-s-cancer-geneticist-steven-narod-md-frcpc-phd-hon-frsc/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/asco-astro-and-sso-issue-joint-update-to-guideline-on-postmastectomy-radiotherapy-for-women-with-breast-cancer/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/julie-e-bauman-md-mph-named-chief-of-hematologyoncology-associate-director-of-translational-research-at-ua-cancer-center/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/maha-h-hussain-md-joins-the-lurie-cancer-center/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/neoadjuvant-veliparibcarboplatin-and-neratinib-graduate-from-adaptive-randomization-i-spy-2-trial-in-early-breast-cancer/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/i-spy-2-separating-contenders-from-pretenders-in-breast-cancer/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/fda-takes-action-against-55-tobacco-retailers-for-selling-newly-regulated-products-to-minors/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/an-oncologist-battles-a-preventable-epidemic-cancer-of-the-cervix/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/why-patients-understanding-of-their-prognosis-often-differs-from-their-oncologists/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/aacr-and-ceo-margaret-foti-phd-md-hc-honored-with-phl-life-sciences-ultimate-solution-award/ 2019-03-11T16:57:21+00:00 https://ascopost.com/issues/september-25-2016/improving-management-of-sexual-problems-for-cancer-survivors/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/the-role-of-music-therapy-in-cancer-care/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/breaking-the-conspiracy-of-silence/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/stacey-ann-carter-md-joins-lester-and-sue-smith-breast-center-department-of-surgery-at-baylor/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/allison-aggon-do-joins-fox-chase-cancer-center/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/asco-continues-active-involvement-in-cancer-moonshot/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/asco-members-advocate-for-key-cancer-care-priorities-at-home-and-on-capitol-hill/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/order-cancernet-fact-sheets-for-your-practice/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/cancer-survivorship-symposium-brings-together-oncologists-and-primary-care-providers-to-improve-patient-care/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/asco-and-aahpm-joint-statement-provides-guidance-on-defining-and-providing-high-quality-palliative-care/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/researcher-spotlight-conquering-cancer-with-dr-effinger/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/patricia-lorusso-do-named-chair-of-aacr-s-women-in-cancer-research/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/jeff-allen-phd-named-friends-first-ceo/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/ainel-sewell-md-to-lead-houston-methodist-breast-care-center/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/bassel-el-rayes-md-to-hold-john-kauffman-family-professorship-at-winship/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/fda-approves-blinatumomab-for-use-in-pediatric-patients-with-ph-negative-relapsed-or-refractory-b-cell-precursor-all/ 2019-03-11T16:57:22+00:00 https://ascopost.com/issues/september-25-2016/recognizing-the-unique-experiences-of-cancer-among-adolescent-and-young-adult-survivors/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/pioneer-in-chemoradiation-robert-b-livingston-md-dies/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/clinical-trials-actively-recruiting-patients-with-acute-lymphoblastic-leukemia/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/the-halifax-project-a-new-approach-to-combination-therapy/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/2016-lasker-awards-honor-scientists-for-basic-and-clinical-medical-research-special-achievement/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/psychological-impact-of-genetic-testing-to-be-explored-in-subset-of-nci-match-trial-patients/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/cancer-moonshot-blue-ribbon-panel-recommends-10-ways-to-speed-cancer-advances/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/an-ovarian-cancer-expert-s-guide-offers-insight-wisdom-and-hope/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/michael-maitland-md-phd-named-director-of-therapeutics-for-the-inova-center-for-personalized-health/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/i-ve-survived-cancer-for-over-71-years/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/emily-l-sedgwick-md-receives-ben-and-margaret-love-foundation-bobby-alford-award-for-academic-clinical-professionalism/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/the-anesthesia-era-1845-1875-carte-de-visite-london-circa-1858/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/2016-2017-oncology-meetings/ 2019-03-11T16:57:23+00:00 https://ascopost.com/issues/september-25-2016/updated-outcomes-impact-of-age-in-multiple-myeloma/ 2019-03-11T16:57:24+00:00 https://ascopost.com/issues/september-25-2016/olanzapine-combination-reduces-nausea-and-vomiting-in-patients-receiving-highly-emetogenic-chemotherapy/ 2019-03-11T16:57:24+00:00 https://ascopost.com/issues/september-25-2016/combining-ipilimumab-with-radiotherapy-in-advanced-melanoma/ 2019-03-11T16:57:24+00:00 https://ascopost.com/issues/september-25-2016/study-confirms-benefit-of-cobimetinib-plus-vemurafenib-in-advanced-braf-v600-mutant-melanoma/ 2019-03-11T16:57:24+00:00 https://ascopost.com/issues/september-25-2016/nobel-laureate-roger-y-tsien-phd-dies/ 2019-03-11T16:57:24+00:00 https://ascopost.com/issues/september-25-2016/saul-j-sharkis-phd-stem-cell-researcher-dies/ 2019-03-11T16:57:24+00:00 https://ascopost.com/issues/september-25-2016/large-study-finds-no-link-between-vasectomy-and-prostate-cancer-risk/ 2019-03-11T16:57:24+00:00 https://ascopost.com/issues/september-10-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/september-10-2016/european-studies-compare-conventional-vs-hypofractionated-radiotherapy-for-localized-prostate-cancer/ 2019-03-11T16:57:57+00:00 https://ascopost.com/issues/september-10-2016/hypofractionated-radiotherapy-for-localized-prostate-cancer-a-new-standard-of-care/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/early-relapse-in-follicular-lymphoma-clinical-trial-data-may-guide-management-decisions/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/is-human-life-worth-no-more-than-a-text-message/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/use-of-lugol-s-iodine-stain-may-reduce-the-need-for-repeat-resection-of-oral-and-oropharyngeal-cancers/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/nerve-stimulation-during-oncologic-neck-dissection-may-help-to-preserve-shoulder-function/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/expert-point-of-view-william-b-armstrong-md/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/benefits-seen-from-extending-steroids-after-transoral-robotic-surgery-for-head-and-neck-cancer/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/expert-point-of-view-michael-l-hinni-md/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/good-showing-for-trastuzumabdocetaxel-combination-against-salivary-gland-carcinoma/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/expert-point-of-view-m-boyd-gillespie-md-mscr/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/predictors-of-readmission-in-patients-requiring-free-tissue-reconstruction-for-head-and-neck-cancer/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/expert-point-of-view-brian-burkey-md-med/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/phase-iii-study-launches-in-patients-with-small-cell-lung-cancer/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/for-high-grade-and-aggressive-non-hodgkin-lymphomas-treat-adults-like-children/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/learn-how-to-implement-the-psychosocial-distress-screening-quality-care-standard-at-the-2017-apos-annual-conference/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/roundup-of-selected-abstracts-in-multiple-myeloma-acute-and-chronic-leukemia-and-advanced-lymphoma/ 2019-03-11T16:57:58+00:00 https://ascopost.com/issues/september-10-2016/james-morgan-phd-named-scientific-director-at-st-jude/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/immune-analysis-of-on-treatment-longitudinal-biopsies-predicts-response-to-melanoma-immunotherapy/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/continued-abvd-vs-omission-of-bleomycin-avd-after-negative-imaging-findings-in-advanced-hodgkin-lymphoma/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/interim-pet-adapted-treatment-in-advanced-hodgkin-lymphoma/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/fda-grants-orphan-drug-designation-to-cd4car-for-the-treatment-of-peripheral-t-cell-lymphoma/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/aaci-names-three-new-members-to-board-of-directors/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/asco-2016-geriatric-oncology-highlights/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/matti-aapro-md-awarded-mascc-s-distinguished-service-award/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/president-obama-names-margaret-spitz-mph-to-national-cancer-advisory-board/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/global-curriculum-in-surgical-oncology-outlined-by-society-of-surgical-oncology-and-european-society-of-surgical-oncology/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/effect-of-radiosurgery-alone-vs-with-whole-brain-radiotherapy-on-cognitive-function-in-patients-with-brain-metastases/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/appointments-and-awards-at-the-2016-masccisoo-annual-meeting/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/use-of-pembrolizumab-in-recurrentmetastatic-head-and-neck-squamous-cell-carcinoma-after-platinum-containing-therapy/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/management-of-merkel-cell-carcinoma/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/clinical-trials-actively-recruiting-patients-with-basal-cell-carcinoma/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/multitude-of-mentors-help-shape-an-illustrious-career-in-oncology/ 2019-03-11T16:57:59+00:00 https://ascopost.com/issues/september-10-2016/weight-watchers-and-the-american-cancer-society-launch-initiative-to-support-holistic-health-for-breast-cancer-survivors/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/nivolumab-achieves-response-in-most-patients-with-classical-hodgkin-lymphoma-after-asct-and-brentuximab-vedotin/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/nivolumab-in-recurrent-classical-hodgkin-lymphoma-refreshingly-supportive-data/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/ronald-mcdonald-house-new-york-names-ruth-c-browne-sd-mpp-mph-president-and-chief-executive-officer/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/venetoclax-produces-high-response-rate-in-relapsed-or-refractory-cll-with-17p-deletion/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/addressing-the-significant-disparities-and-barriers-to-health-care-experienced-by-lgbt-cancer-survivors/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/uspstf-issues-final-research-plan-to-screen-for-intimate-partner-violence-elder-abuse-and-abuse-of-vulnerable-adults-including-lgbtq-population/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/asco-announces-14-practices-participating-in-the-2016-quality-training-program/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/last-chance-to-register-for-the-asco-research-community-forum-annual-meeting/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/new-online-tool-available-to-assess-the-quality-of-your-research-program/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/new-asco-sitc-symposium-dives-into-immuno-oncology-research-and-clinical-care/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/asco-university-essentials-subscription-now-provided-to-cancerlinqtm-practices/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/new-asco-answers-guide-to-small-cell-lung-cancer/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/your-monthly-gift-can-have-a-huge-impact/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/mastery-learning-a-new-paradigm-for-oncology-medical-education/ 2019-03-11T16:58:00+00:00 https://ascopost.com/issues/september-10-2016/2016-2017-oncology-meetings/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/nipple-sparing-mastectomy-shown-to-be-safe-and-increasingly-preferred/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/expert-point-of-view-julie-margenthaler-md/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/esmo-publishes-results-of-european-consortium-study-on-the-availability-of-antineoplastic-medicines/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/new-sso-astro-asco-joint-ductal-carcinoma-in-situ-consensus-guideline-could-curb-unnecessary-breast-surgery-and-reduce-health-system-costs/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/george-q-daley-md-phd-named-dean-for-faculty-of-medicine-at-harvard-medical-school/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/american-society-of-hematology-recognizes-laurence-boxer-md-and-ralph-nachman-md-for-outstanding-mentorship/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/the-best-oncology-lesson/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/oncologist-s-guilt/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/american-cancer-society-cancer-action-network-report-shows-states-are-making-progress-implementing-policies-to-reduce-toll-of-cancer/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/i-ve-survived-two-cancers/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/media-reports-of-dramatic-responses-to-immunotherapy-after-all-else-fails-may-prompt-patients-to-seek-it-out/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/immunotherapy-is-not-a-replacement-therapy/ 2019-03-11T16:58:01+00:00 https://ascopost.com/issues/september-10-2016/new-appointments-to-fox-chase-cancer-center-department-of-medicine/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/duncan-comprehensive-cancer-center-at-baylor-launches-specialty-team-for-comprehensive-esophageal-cancer-care/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/impact-of-adherence-to-cancer-prevention-guidelines-on-diet-physical-activity-on-cancer-risk-and-mortality/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/cyclophosphamidemethotrexate-maintenance-shows-no-benefit-in-hormone-receptor-negative-breast-cancer-but-subgroup-may-benefit/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/study-finds-wide-variation-in-breast-density-assessments-among-radiologists/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/regorafenib-increases-progression-free-survival-in-advanced-gastric-cancer/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/immune-cell-infiltrates-may-portend-better-prognosis-across-several-tumor-types/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/hematologic-oncologists-surveyed-on-quality-measures-of-end-of-life-care/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/limited-access-to-radioimmunotherapy-in-the-community-setting-may-lead-to-extinction-of-a-unique-lymphoma-treatment/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/september-10-2016/ecog-acrin-group-co-chair-robert-l-comis-md-to-step-down-in-2019/ 2019-03-11T16:58:02+00:00 https://ascopost.com/issues/august-25-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/august-25-2016/inotuzumab-ozogamicin-shows-clear-benefit-in-acute-lymphoblastic-leukemia/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/expert-point-of-view-amir-t-fathi-md/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/how-the-oncology-center-of-excellence-plans-to-foster-collaboration-among-researchers-to-advance-cancer-treatment/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/have-you-received-your-immune-checkpoint-inhibitor-yet/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/new-upfront-treatment-algorithm-emerges-for-chronic-lymphocytic-leukemia/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/asco-adapts-cco-guideline-on-selection-of-optimal-adjuvant-therapies-for-her2-negative-and-her2-positive-breast-cancers/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/asco-guideline-addresses-controversial-areas-in-adjuvant-therapy-for-breast-cancer/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/scalp-cooling-for-chemotherapy-induced-alopecia-becoming-mainstream/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/what-is-scalp-cooling/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/novel-approaches-harness-the-microenvironment-against-hodgkin-lymphoma/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/combination-obinutuzumab-regimen-active-in-aggressive-diffuse-large-b-cell-lymphoma/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/outcomes-with-rituximab-in-dlbcl-does-gender-matter/ 2020-09-23T02:07:41+00:00 https://ascopost.com/issues/august-25-2016/understanding-double-hit-lymphomas-and-optimizing-management/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/pediatric-regimen-yields-improved-survival-for-adults-with-all/ 2019-03-11T16:58:26+00:00 https://ascopost.com/issues/august-25-2016/ethan-basch-md-msc-receives-545m-grant-from-pcori-to-study-patient-reported-outcomes/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/hypofractionated-radiotherapy-not-inferior-to-conventional-radiotherapy-in-low-risk-prostate-cancer/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/hypofractionated-radiotherapy-balancing-benefits-vs-risks-in-men-with-localized-prostate-cancer/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/cancer-research-institute-to-honor-three-scientists-for-outstanding-contributions-to-cancer-immunotherapy-research/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/indiana-university-school-of-medicine-receives-2-million-gift/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/molly-e-collins-md-joins-the-fox-chase-temple-university-hospital-pain-and-palliative-care-program/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/asco-endorses-cancer-care-ontario-recommendations-on-role-of-patient-and-disease-factors-in-adjuvant-systemic-therapy-decisions-in-early-stage-operable-breast-cancer/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/esmo-releases-new-consensus-guidelines-on-the-management-of-metastatic-colorectal-cancer/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/study-shows-women-who-received-cancer-screening-invitation-letters-are-more-likely-to-have-a-pap-test/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/adding-bevacizumab-to-letrozole-improves-progression-free-survival-but-increases-toxicity-in-hormone-receptor-positive-metastatic-breast-cancer/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/prevalence-of-estrogen-receptor-mutations-in-patients-with-metastatic-breast-cancer/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/inotuzumab-ozogamicin-improves-outcomes-vs-standard-therapy-in-relapsedrefractory-acute-lymphoblastic-leukemia/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/six-perspectives-on-the-cancer-moonshot-goal-of-making-10-years-of-progress-in-5-years/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/surgical-oncologist-quan-p-ly-md-facs-flees-from-vietnam-and-finds-a-home-at-the-university-of-nebraska/ 2019-03-11T16:58:27+00:00 https://ascopost.com/issues/august-25-2016/spotlight-on-asco-s-geriatric-oncology-webpage/ 2020-09-23T02:11:16+00:00 https://ascopost.com/issues/august-25-2016/erratum/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/asco-conquer-cancer-foundation-congratulate-2016-grant-and-award-recipients/ 2020-09-23T02:03:13+00:00 https://ascopost.com/issues/august-25-2016/asco-unveils-new-resources-for-macra-transformation/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/supporting-cancer-research-through-the-conquer-cancer-foundation/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/weight-management-resource-for-patients/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/asco-announces-14-practices-participating-in-the-2016-quality-training-program/ 2020-09-23T02:02:29+00:00 https://ascopost.com/issues/august-25-2016/pitt-receives-623-million-5-year-nih-award-to-speed-up-translational-scientific-research-into-implementable-solutions/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/moffitt-cancer-center-receives-two-nci-grants-to-further-prostate-cancer-biomarker-research/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/helen-f-graham-cancer-center-and-the-wistar-institute-partner-to-expand-research-in-gene-editing/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/aacr-holds-congressional-briefing-to-reiterate-moonshot-goals-and-plans/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/aacr-pancreatic-cancer-action-network-awards-research-grants-to-early-career-investigators/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/the-late-cardiac-effects-of-cancer-treatment/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/phase-iii-trial-shows-adding-obinutuzumab-to-bendamustine-improves-progression-free-survival-in-rituximab-refractory-nhl/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/gadolin-and-the-perplexing-role-of-obinutuzumab-in-the-treatment-of-b-cell-malignancies/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/asco-s-2016-quality-training-program-meet-the-first-international-participant-from-greece/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/astro-awards-275-000-in-grants-to-support-early-career-researchers-in-radiation-oncology/ 2019-03-11T16:58:28+00:00 https://ascopost.com/issues/august-25-2016/a-complete-guide-to-breast-surgery-and-reconstruction/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/fda-approves-pembrolizumab-for-metastatic-head-and-neck-squamous-cell-carcinoma/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/schwartz-center-for-compassionate-healthcare-launches-new-education-and-training-programs/ 2020-09-23T02:09:58+00:00 https://ascopost.com/issues/august-25-2016/2016-2017-oncology-meetings/ 2020-09-18T20:55:56+00:00 https://ascopost.com/issues/august-25-2016/chamomile/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/clinical-trials-actively-recruiting-patients-with-chronic-lymphocytic-leukemia-and-small-lymphocytic-leukemia/ 2020-09-23T02:04:32+00:00 https://ascopost.com/issues/august-25-2016/fda-approves-extended-release-granisetron-injection-for-the-prevention-of-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/my-oncologists-make-me-feel-safe-even-while-living-with-terminal-cancer/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/four-young-scientists-receive-damon-runyon-sohn-pediatric-cancer-research-fellowship-awards/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/former-clinical-director-at-the-nci-gregory-a-curt-md-dies/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/nivolumab-in-recurrent-small-cell-lung-cancer/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/ceritinib-shows-overall-and-intracranial-activity-in-advanced-nsclc-previously-treated-with-crizotinib-and-chemotherapy/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/plasma-vs-tissue-genotyping-and-outcomes-with-osimertinib-in-advanced-non-small-cell-lung-cancer/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-25-2016/pembrolizumab-for-untreatedprogressive-brain-metastases-in-melanoma-or-nsclc/ 2019-03-11T16:58:29+00:00 https://ascopost.com/issues/august-10-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/august-10-2016/asco-plenary-studies-assessing-the-value-of-new-treatments/ 2019-03-11T16:59:11+00:00 https://ascopost.com/issues/august-10-2016/asco-and-friends-of-cancer-research-launch-initiative-to-modernize-eligibility-criteria-for-clinical-trials/ 2019-03-11T16:59:11+00:00 https://ascopost.com/issues/august-10-2016/moonshots-and-onco-nauts/ 2019-03-11T16:59:11+00:00 https://ascopost.com/issues/august-10-2016/hypofractionation-may-be-poised-to-become-new-standard-of-care-for-prostate-cancer/ 2019-03-11T16:59:11+00:00 https://ascopost.com/issues/august-10-2016/expert-point-of-view-w-robert-lee-md/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/car-t-cell-therapy-promising-in-non-hodgkin-lymphoma/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/anti-pd-l1-immunotherapy-shows-response-in-microsatellite-stable-metastatic-colorectal-cancer-in-combination-with-mek-inhibition/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/phase-iii-resorce-study-data-show-regorafenib-improves-overall-survival-in-previously-treated-patients-with-unresectable-liver-cancer/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/chemoradiotherapy-after-surgery-for-gastric-cancer-shows-similar-outcomes-to-postoperative-chemotherapy/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/anti-interleukin-1-alpha-antibody-mabp1-improves-outcomes-significantly-over-placebo-in-advanced-colorectal-cancer/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/dealing-with-gi-toxicities-after-chemoradiation/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/use-of-dexamethasone-mouthwash-in-managing-mtor-inhibitor-associated-stomatitis-in-patients-with-breast-cancer/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/more-focus-needed-on-chemotherapy-induced-nausea-as-a-cluster-of-symptoms/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/the-complexities-of-care-for-older-cancer-survivors/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/asco-and-cancerlinq-participated-in-landmark-cancer-moonshot-summit/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/daniel-f-hayes-md-fasco-leader-in-translational-research-begins-term-as-asco-president/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/survivorship-resources-for-providers-and-patients/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/making-a-difference-in-cancer-care-with-you-daniel-hayes-presidential-theme/ 2020-09-18T20:59:05+00:00 https://ascopost.com/issues/august-10-2016/spotlight-on-women-who-conquer-cancer/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/10-new-astro-fellows-named-in-10th-anniversary-of-fastro-designation/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/economic-crisis-associated-with-increased-cancer-mortality/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/effects-of-the-global-economic-crisis-on-cancer-care/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/reduced-intensity-related-donor-haploidentical-vs-hla-matched-sibling-donor-hematopoietic-cell-transplantation-in-lymphoma/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/is-post-transplantation-cyclophosphamide-disruptive-technology/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/effectiveness-of-organized-national-breast-cancer-screening-the-israeli-experience/ 2019-03-11T16:59:12+00:00 https://ascopost.com/issues/august-10-2016/safety-concerns-weigh-heavily-in-elderly-patients-with-cancer/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/rajeswari-nagarathinam-md-joins-department-of-pathology-at-fox-chase-cancer-center/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/abhishek-aphale-md-joins-department-of-dermatology-at-fox-chase-cancer-center/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/making-a-difference-in-the-lives-of-others/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/andrew-olshan-phd-elected-president-of-the-society-for-epidemiologic-research/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/omniseq-receives-new-york-clep-approval-for-144-gene-comprehensive-panel-partners-with-cure-forward/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/13-mid-career-clinical-investigators-receive-2016-nci-cancer-clinical-investigator-team-leadership-award/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/educating-people-about-clinical-trials-may-improve-their-likelihood-of-participation/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/2016-2017-oncology-meetings/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/actively-recruiting-clinical-trials-focused-on-the-role-of-obesity-in-cancer/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/new-analysis-shows-advertising-by-us-cancer-centers-has-soared-over-past-decade/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/epithelial-cells-on-the-tail-fin-of-genetically-engineered-zebrafish-1/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/nci-awards-12-million-for-multi-institution-breast-cancer-genetics-study/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/maryland-proton-treatment-center-appoints-charles-b-simone-ii-md-new-medical-director/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/nccn-imaging-appropriate-use-criteria-to-be-integrated-into-national-decision-support-company-s-careselect-imaging/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/juno-therapeutics-to-resume-jcar015-phase-ii-rocket-trial-after-fda-clinical-hold/ 2019-03-11T16:59:13+00:00 https://ascopost.com/issues/august-10-2016/fda-approves-first-hpv-test-for-use-with-surepath-preservative-fluid/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/fda-approves-sofosbuvirvelpatasvir-for-treatment-of-chronic-hepatitis-c-virus-infection/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/ash-commits-3-million-annually-to-help-preserve-critical-blood-disease-research/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/integrating-early-palliative-medicine-into-oncology-care-to-improve-patients-quality-of-life/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/measures-of-success/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/photonics-and-the-cancer-moonshot-initiative-partnership-highlights-role-of-technology-and-it-infrastructure-in-reaching-goals/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/david-leduc-named-executive-director-of-addario-lung-cancer-foundation/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/the-building-block-of-life-brick-by-brick/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/julienne-bower-phd-named-professor-of-psychobiology-in-cousins-center-for-psychoneuroimmunology-at-ucla/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/a-ruby-anniversary/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/multiple-means-to-realize-the-benefits-of-colorectal-cancer-screening/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/multiple-strategies-for-colorectal-cancer-screening-offer-an-opportunity-for-shared-decision-making/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/astro-members-elect-five-new-officers-to-board-of-directors/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/pancreatic-cancer-action-network-appoints-four-leaders-to-its-scientific-and-medical-advisory-board/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/late-effects-of-blood-and-marrow-transplantation-consensus-conference-maps-research-directions/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/i-m-the-luckiest-person-in-the-world/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/final-results-of-meteor-trial-cabozantinib-vs-everolimus-in-advanced-renal-cell-carcinoma/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/quality-of-life-with-nivolumab-vs-everolimus-in-advanced-renal-cell-carcinoma/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/anti-pd-l1-antibody-durvalumab-in-advanced-urothelial-bladder-cancer/ 2019-03-11T16:59:14+00:00 https://ascopost.com/issues/august-10-2016/low-dose-ct-screening-new-solid-nodules-and-lung-cancer-probability/ 2019-03-11T16:59:15+00:00 https://ascopost.com/issues/august-10-2016/ipilimumab-combined-with-antigen-specific-cytotoxic-t-lymphocytes-in-metastatic-melanoma/ 2019-03-11T16:59:15+00:00 https://ascopost.com/issues/august-10-2016/adding-pertuzumab-to-chemotherapy-in-platinum-resistant-ovarian-cancer/ 2019-03-11T16:59:15+00:00 https://ascopost.com/issues/august-10-2016/dabrafenib-plus-trametinib-in-braf-v600e-mutant-metastatic-nsclc/ 2019-03-11T16:59:15+00:00 https://ascopost.com/issues/august-10-2016/internationally-renowned-geneticist-alfred-george-knudson-md-phd-dies/ 2019-03-11T16:59:15+00:00 https://ascopost.com/issues/july-25-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/july-25-2016/results-of-two-practice-changing-breast-cancer-trials-upheld/ 2019-03-11T16:59:36+00:00 https://ascopost.com/issues/july-25-2016/charting-a-new-course-at-the-fda/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/cms-proposal-for-part-b-drug-payment-a-poorly-conceived-experiment/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/studies-suggest-bright-future-for-combination-immunotherapy-in-advanced-melanoma-but-questions-remain/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/expert-point-of-view-marc-s-ernstoff-md/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/pherexa-benefit-for-second-line-pertuzumab-questionable/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/expert-point-of-view-sunil-verma-md/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/benefit-strongly-suggested-with-hormonal-maintenance-in-low-grade-serous-carcinoma/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/expert-point-of-view-isabelle-ray-coquard-md-phd/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/app-triggers-earlier-detection-of-relapse-may-help-improve-survival-of-patients-with-lung-cancer/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/expert-point-of-view-patricia-a-ganz-md-gregory-a-masters-md/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/selected-hematology-abstracts-from-the-2016-asco-annual-meeting/ 2019-03-11T16:59:37+00:00 https://ascopost.com/issues/july-25-2016/brachytherapy-pioneer-haakon-ragde-md-chosen-as-astro-2016-honorary-member/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/hhs-announces-physician-groups-selected-for-initiative-promoting-better-cancer-care/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/quick-takes-on-promising-new-approaches-to-treating-breast-cancer/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/asco-resolutions-supported-by-ama-house-of-delegates/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/leave-a-legacy-of-hope/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/sarah-s-donaldson-md-fasco-honored-with-inaugural-women-who-conquer-cancer-mentorship-award/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/asco-and-mecc-sponsor-international-palliative-care-workshop-in-kazakhstan/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/asco-answers-guide-to-caregiving/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/using-social-media-to-accelerate-genomic-research/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/the-metastatic-breast-cancer-project-direct-to-patient-research-initiative/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/road-to-successful-use-of-real-world-evidence-for-drug-development-is-long-and-rocky/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/asco-guideline-on-endocrine-therapy-for-hormone-receptor-positive-metastatic-breast-cancer/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/asco-guideline-on-endocrine-therapy-for-metastatic-breast-cancer-reaffirming-principles-for-making-treatment-decisions/ 2019-03-11T16:59:38+00:00 https://ascopost.com/issues/july-25-2016/asco-guideline-on-potentially-curable-pancreatic-cancer/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/asco-2016-guidelines-for-the-treatment-of-pancreatic-cancer-why-another-guideline/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/asco-guideline-on-treatment-of-locally-advanced-unresectable-pancreatic-cancer/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/asco-guideline-on-metastatic-pancreatic-cancer/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/lung-cancer-screening-beneficial-for-certain-populations-but-not-without-controversy/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/as-low-dose-ct-screening-moves-into-the-clinic-implementation-issues-move-up-on-the-agenda/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/stanford-cancer-institute-designated-nci-comprehensive-cancer-center/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/fentanyl-nasal-spray-now-available-at-a-dose-of-300-µg-for-treatment-of-breakthrough-cancer-pain/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/acupuncture-does-it-alleviate-symptoms-associated-with-cancer-care/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/asco-outlines-opposition-to-medicare-part-b-demo-for-senate-finance-hearing/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/using-simulation-based-training-to-improve-the-procedural-skills-of-oncologyhematology-fellows/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/fred-hutchinson-cancer-research-center-appoints-2016-2017-board-members-including-microsoft-ceo-and-former-governor-of-washington/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/2016-2017-oncology-meetings/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/fda-advances-precision-medicine-initiative-by-issuing-draft-guidances-on-next-generation-sequencing-based-tests/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/an-epic-medical-story-by-an-old-style-doctor-on-the-front-lines-of-care/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/the-healing-power-of-words/ 2019-03-11T16:59:39+00:00 https://ascopost.com/issues/july-25-2016/dean-lee-md-phd-to-lead-cell-therapy-programs-at-nationwide-childrens-and-osuccc-james/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/rajesh-k-garg-md-jd-named-president-ceo-of-ctca/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/david-bartels-do-joins-summit-cancer-center-post-falls/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/university-of-kansas-school-of-medicine-names-allen-m-chen-md-department-of-radiation-oncology-chair/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/genomic-classification-and-outcome-in-acute-myeloid-leukemia/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/mindfulness-based-stress-reduction-program-may-reduce-psychological-and-physical-symptoms-in-breast-cancer-survivors/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/no-apparent-benefit-of-gnrh-in-preserving-ovarian-function-and-fertility-in-young-women-with-lymphoma/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/study-finds-poor-understanding-of-illness-in-patients-with-advanced-cancer/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/clinical-trials-actively-recruiting-patients-with-acute-myeloid-leukemia/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/nccn-publishes-new-patient-education-resources-about-myelodysplastic-syndromes/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/revisiting-ovarian-ablation-in-early-breast-cancer-a-mismatch-between-global-values-and-clinical-practice-guidelines/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/jeffrey-demanes-md-receives-ulrich-henschke-award-from-the-american-brachytherapy-society/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/my-commitment-to-helping-other-survivors-of-childhood-cancers/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/the-henry-and-marilyn-taub-foundation-gives-1-million-to-pancreatic-cancer-action-network-for-immunotherapy-research/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-25-2016/the-national-cancer-moonshot-lifts-off/ 2019-03-11T16:59:40+00:00 https://ascopost.com/issues/july-10-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/july-10-2016/combination-of-nivolumab-and-ipilimumab-moves-forward-in-nsclc/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/expert-point-of-view-david-r-spigel-md/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/assessment-of-fitness-function-and-quality-of-life-essential-in-treatment-of-older-patients-with-cll/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/the-age-of-the-atomic-hematologistsoncologists/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/ebctcg-analysis-identifies-recurrence-risk-by-tumor-subgroup-in-estrogen-receptor-positive-breast-cancer/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/expert-point-of-view-nancy-e-davidson-md/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/asco-applauds-selection-of-richard-pazdur-md-to-lead-new-fda-oncology-center-of-excellence/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/pertuzumab-containing-regimens-compared-for-neoadjuvant-treatment-in-early-breast-cancer/ 2019-03-11T17:00:02+00:00 https://ascopost.com/issues/july-10-2016/expert-point-of-view-stephen-kl-chia-md/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/mixed-results-with-resection-of-primary-tumor-in-stage-iv-breast-cancer/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/expert-point-of-view-elizabeth-mittendorf-md-phd/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/richard-pazdur-md-named-acting-director-of-fda-s-oncology-center-of-excellence/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/car-t-cell-dose-refinement-may-reduce-cytokine-release-syndrome-in-patients-with-advanced-acute-lymphoblastic-leukemia/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/expert-point-of-view-steven-m-devine-md/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/new-standard-of-care-emerges-for-anaplastic-glioma-without-1p19q-codeletion/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/expert-point-of-view-david-reardon-md/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/wk-alfred-yung-md-joins-national-brain-tumor-society/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/atezolizumab-promising-in-cisplatin-ineligible-metastatic-bladder-cancer/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/expert-point-of-view-charles-ryan-md/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/fdg-pet-evaluates-immunotherapy-for-non-small-cell-lung-cancer/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/novel-approach-to-petct-imaging-may-predict-location-and-extent-of-primary-prostate-cancer/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/computed-tomography-based-lean-body-mass-calculations-may-improve-accuracy-of-pet-for-patients-with-cancer/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/personalized-dosimetry-optimizes-radiotherapy-dose-in-patients-with-neuroendocrine-tumors/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/what-s-driving-the-rising-rates-of-colorectal-cancer-in-young-adults/ 2019-03-11T17:00:03+00:00 https://ascopost.com/issues/july-10-2016/asco-names-founding-editor-in-chief-of-jco-precision-oncology/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/aacr-awards-four-inaugural-nextgen-grants-for-transformative-cancer-research/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/regarding-beau/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/clinical-trials-actively-recruiting-patients-with-cardiotoxicity-resulting-from-treatment/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/mmrf-founder-kathy-giusti-to-co-chair-harvard-business-schoolkraft-precision-medicine-accelerator/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/recent-staff-announcements-at-fox-chase-cancer-center/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/asco-announces-new-award-honoring-visionary-leader-allen-s-lichter-md-fasco/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/qopi-certification-program-certifies-first-international-practice/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/women-s-networking-center-addresses-gender-gap-provides-mentorship-for-annual-meeting-attendees/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/new-asco-answers-guide-to-non-small-cell-lung-cancer/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/cancer-research-grant-opportunities-for-early-career-and-junior-faculty-researchers/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/four-nci-designated-cancer-centers-collaborate-to-establish-research-consortium/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/complexities-in-the-diagnosis-and-management-of-amyloidosis/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/complexities-in-the-diagnosis-and-management-of-amyloidosis-answers/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/greatest-benefit-of-adjuvant-exemestane-in-premenopausal-women-at-higher-risk-of-breast-cancer-recurrence/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/detection-of-breast-cancer-with-ultrasound-vs-tomosynthesis-in-women-with-mammography-negative-dense-breasts/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/managing-upper-extremity-dysfunction-in-breast-cancer-survivors/ 2019-03-11T17:00:04+00:00 https://ascopost.com/issues/july-10-2016/a-concerned-physician-reflects-on-today-s-doctor-patient-relationship/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/stereo-x-ray-of-stomach-cancer/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/prevention-needed-to-stem-global-rise-in-human-papillomavirus-related-anal-cancer/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/2016-oncology-meetings/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/u-m-comprehensive-cancer-center-receives-175-million-commitment-will-create-new-institute/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/erika-p-hamilton-md-named-director-of-breast-and-gynecologic-cancer-research/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/ash-and-lls-announce-aml-awareness-and-education-collaboration/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/thriving-with-cancer/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/andrew-l-kung-md-phd-named-chairman-of-the-department-of-pediatrics-at-memorial-sloan-kettering-cancer-center/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/ann-g-schwartz-phd-mph-elected-to-ilcco-steering-committee/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/increased-risk-for-cardiovascular-events-seen-in-patients-with-cml-taking-tyrosine-kinase-inhibitors/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/norwegian-study-shows-benefit-of-aspirin-as-secondary-prevention-in-patients-with-colorectal-cancer/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/july-10-2016/neoadjuvant-chemotherapy-may-render-advanced-ovarian-cancers-responsive-to-immunotherapy/ 2019-03-11T17:00:05+00:00 https://ascopost.com/issues/june-25-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/june-25-2016/for-high-risk-neuroblastoma-two-transplants-may-be-better-than-one/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-dominique-valteau-couanet-md-phd/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/asco-releases-the-updated-version-of-its-value-framework/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/supporting-policy-to-reduce-tobacco-related-deaths/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/joint-analysis-confirms-benefit-of-anthracyclines-for-high-risk-early-stage-breast-cancer/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-tiffany-a-traina-md-and-larry-norton-md/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/trastuzumab-biosimilar-shows-efficacy-and-safety-comparable-to-reference-product-in-phase-iii-heritage-trial/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/liquid-biopsy-stacks-up-well-to-tissue-biopsy-in-detecting-tumor-specific-mutations/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-sumanta-k-pal-md-and-richard-schilsky-md/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/in-the-neoadjuvant-era-intraperitoneal-chemotherapy-is-of-benefit-in-advanced-ovarian-cancer/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-don-dizon-md/ 2019-03-11T17:00:25+00:00 https://ascopost.com/issues/june-25-2016/aggressive-treatment-at-the-end-of-life-continues-to-be-common/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-patricia-ganz-md/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/asco-announces-new-award-honoring-visionary-leader-allen-s-lichter-md-fasco/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/vast-differences-globally-in-cancer-drug-retail-prices/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/matching-treatment-to-tumor-abnormalities-seems-to-pay-off/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-sumanta-k-pal-md-and-richard-l-schilsky-md/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/once-daily-radiation-66-gy-appears-no-better-than-twice-daily-radiation-45-gy-for-small-cell-lung-cancer/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-taofeek-kunle-owonikoko-md/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/first-in-class-antibody-reduces-gastric-cancer-recurrence/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-peter-c-enzinger-md/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/impressive-early-data-for-rovalpituzumab-tesirine-in-small-cell-lung-cancer/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-taofeek-kunle-owonikoko-md-1/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/young-onset-colorectal-cancer-diagnoses-rising/ 2019-03-11T17:00:26+00:00 https://ascopost.com/issues/june-25-2016/expert-point-of-view-samir-gupta-md/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/treatment-update-in-gastric-pancreatic-and-colorectal-cancers/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/updated-who-classification-of-hematologic-malignancies/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/updated-who-classification-of-hematologic-malignancies-answers/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/creating-hybrid-academic-community-cancer-centers-to-improve-patient-care/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/david-spigel-md-appointed-as-sarah-cannon-chief-scientific-officer/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/medical-decision-making-at-the-heart-of-care-for-older-patients-with-cancer/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/nccn-awards-research-grants-to-support-studies-of-mirvetuximab-soravtansine-in-various-cancers/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/addition-of-ixazomib-to-lenalidomidedexamethasone-improves-progression-free-survival-in-relapsedrefractory-multiple-myeloma/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/ixazomib-a-relevant-addition-to-myeloma-therapy/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/cervical-cancer-prevention-badly-needed-in-india/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/european-demand-for-radiotherapy-expected-to-rise-approximately-16-over-next-decade/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/a-conquer-cancer-foundation-award-helps-to-launch-a-pioneering-study-in-liposarcoma/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/global-oncology-appoints-donna-barry-as-first-executive-director/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/cancer-treatment-centers-of-america-names-rajesh-k-garg-md-jd-as-president-and-ceo/ 2019-03-11T17:00:27+00:00 https://ascopost.com/issues/june-25-2016/tackling-the-symptoms-of-long-term-fatigue-and-insomnia-in-cancer-survivors/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/guidelines-to-assess-and-manage-the-symptoms-of-fatigue-and-insomnia/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/five-early-career-cancer-researchers-selected-as-pew-stewart-scholars/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/three-leaders-in-radiation-oncology-awarded-the-astro-gold-medal/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/pembrolizumab-active-in-pd-l1-positive-advanced-gastric-cancer-and-triple-negative-breast-cancer/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/anti-pd-1-treatment-with-pembrolizumab-in-gastricgastroesophageal-junction-cancers-who-is-likely-to-respond/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/pembrolizumab-in-triple-negative-breast-cancer-emerging-new-treatment-modality/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/geriatric-patients-with-cancer-and-the-problem-of-polypharmacy/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/geriatric-oncology-in-asia-the-dawn-of-a-new-era-in-cancer-care/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/erratum/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/asco-endows-young-investigator-award-in-honor-of-society-founder-jane-cooke-wright-md/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/clinical-conversations-attendee-questions-from-the-cancer-survivorship-symposium/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/expanded-content-on-geriatric-oncology/ 2019-03-11T17:00:28+00:00 https://ascopost.com/issues/june-25-2016/meet-thomas-g-roberts-jr-md/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/initiative-to-modernize-eligibility-criteria-for-clinical-trials-launched/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/the-asco-research-community-forum-is-expanding/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/vanguard-practices-support-sharing-big-data-with-cancerlinq/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/katherine-l-nathanson-md-receives-aacr-s-frohlich-visiting-professorship/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/vumc-designated-as-a-lung-cancer-screening-center/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/clinical-trials-actively-recruiting-patients-with-ocular-cancer/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/moonshot-program-for-compassion/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/peter-s-conti-md-phd-receives-snmmi-2016-paul-c-aebersold-award-for-outstanding-achievement-in-basic-nuclear-medicine-science/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/2016-oncology-meetings/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/st-jude-children-s-research-hospital-names-michael-dyer-phd-chair-of-developmental-neurobiology/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/st-jude-is-first-us-children-s-hospital-to-earn-cap-iso15189-accreditation/ 2019-03-11T17:00:29+00:00 https://ascopost.com/issues/june-25-2016/newly-launched-genomic-data-commons-to-facilitate-data-and-clinical-information-sharing/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/an-exotic-journey-into-immunotherapy/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/a-journalist-s-cancer-saga/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/inside-knowledge-from-a-cancer-survivor/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/black-cohosh/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/ohio-state-names-timothy-pawlik-md-mph-phd-chair-of-surgery-and-chair-for-cancer-research/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/something-happened/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/taubman-prize-jointly-awarded-to-suzanne-l-topalian-md-and-jedd-d-wolchok-md-phd-for-groundbreaking-work-in-cancer-immunotherapy/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/surgery-and-radiation-therapy-remain-standard-of-care-for-managing-ductal-carcinoma-in-situ/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/use-questions-from-patients-to-help-them-make-informed-treatment-decisions/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/ama-announces-board-of-trustees-for-2016-2017/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/retroviral-replicating-vector-that-delivers-cytosine-deaminase-to-cancer-cells-active-in-recurrent-glioblastoma/ 2019-03-11T17:00:30+00:00 https://ascopost.com/issues/june-25-2016/adding-adjuvant-oxaliplatin-to-fluoropyrimidine-may-be-of-benefit-in-deficient-mismatch-repair-colon-cancer/ 2019-03-11T17:00:31+00:00 https://ascopost.com/issues/june-25-2016/increased-risk-of-gallbladder-cancer-may-be-associated-with-consuming-large-amounts-of-sweetened-beverages/ 2019-03-11T17:00:31+00:00 https://ascopost.com/issues/june-25-2016/four-biomarker-panel-identified-for-chronic-graft-vs-host-disease/ 2019-03-11T17:00:31+00:00 https://ascopost.com/issues/june-25-2016/precision-medicine-clinical-trial-for-metastatic-pancreatic-cancer-now-open-at-multiple-sites/ 2019-03-11T17:00:31+00:00 https://ascopost.com/issues/june-25-2016/i-was-not-shown-compassion-by-my-medical-team/ 2019-03-11T17:00:31+00:00 https://ascopost.com/issues/june-25-2016/lawrence-o-gostin-jd-lld-appointed-to-national-cancer-advisory-board/ 2019-03-11T17:00:31+00:00 https://ascopost.com/issues/june-25-2016/scenes-from-asco-2016/ 2020-02-17T17:55:12+00:00 https://ascopost.com/issues/june-10-2016/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/june-10-2016/daratumumab-hits-the-mark-in-early-relapsed-multiple-myeloma/ 2019-03-11T17:00:53+00:00 https://ascopost.com/issues/june-10-2016/expert-point-of-view-harold-j-burstein-md/ 2019-03-11T17:00:53+00:00 https://ascopost.com/issues/june-10-2016/extending-asco-s-influence-globally-to-improve-patient-care/ 2019-03-11T17:00:53+00:00 https://ascopost.com/issues/june-10-2016/the-endeavor-trial-a-case-study-in-the-interpretation-of-modern-cancer-trials/ 2019-03-11T17:00:53+00:00 https://ascopost.com/issues/june-10-2016/additional-5-years-of-letrozole-may-benefit-some-postmenopausal-women-with-early-stage-breast-cancer/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/expert-point-of-view-paul-g-richardson-md/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/chemoradiotherapy-improves-survival-in-patients-over-age-65-with-glioblastoma-a-new-standard-option/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/expert-point-of-view-stuart-a-grossman-md/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/adjuvant-chemotherapy-improves-survival-in-pancreatic-cancer/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/how-will-value-framework-tools-be-used-in-everyday-practice/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/comparing-treatments-by-efficacy-toxicity-and-cost/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/vice-president-joe-biden-addresses-attendees-at-asco-2016-annual-meeting/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/it-started-with-twitter-asbrs-immediate-past-president-deanna-attai-md-spearheads-patient-centered-care/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/university-of-catania-presents-margaret-foti-scholar-in-training-award-to-saverio-candido-phd/ 2019-03-11T17:00:54+00:00 https://ascopost.com/issues/june-10-2016/chemotherapy-after-radical-prostatectomy-may-benefit-african-americans-and-high-risk-patients/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/expert-point-of-view-sam-s-chang-md-mba/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/atezolizumab-in-platinum-treated-advanced-urothelial-carcinoma-a-new-standard-of-care/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/expert-point-of-view-michael-o-koch-md/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/asco-applauds-the-fda-for-regulating-e-cigarettes/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/nivolumab-in-classical-hodgkin-lymphoma/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/asco-clinical-practice-guideline-update-on-ovarian-suppressionadjuvant-endocrine-therapy-in-hormone-receptor-positive-breast-cancer/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/ovarian-suppression-in-premenopausal-women-with-estrogen-receptor-positive-breast-cancer/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/lisa-a-carey-md-and-ann-partridge-md-mph-appointed-co-chairs-of-the-alliance-for-clinical-trials-in-oncology-breast-committee/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/aacr-ceo-margaret-foti-phd-md-hc-honored-with-ovarcome-excellence-award/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/patient-advocate-michael-kaplan-to-lead-melanoma-research-alliance/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/richard-j-o-reilly-md-named-the-society-of-msk-s-inaugural-prize-winner-for-groundbreaking-contributions-in-pediatric-oncology/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/cancer-and-fertility-program-improves-patient-satisfaction-with-information-on-fertility-risks-and-preservation/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/learning-about-fertility-is-important-to-young-patients-with-cancer/ 2019-03-11T17:00:55+00:00 https://ascopost.com/issues/june-10-2016/anti-pd-1-inhibitor-gains-foothold-in-merkel-cell-carcinoma/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/expert-point-of-view-winald-gerritsen-md-phd/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/qopi-certification-program-certifies-first-international-practice/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/prolonged-progression-free-survival-with-addition-of-palbociclib-to-fulvestrant-in-her2-negative-metastatic-breast-cancer/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/paloma-3-trial-in-her2-negative-metastatic-breast-cancer-challenge-of-moving-beyond-estrogen-receptor-positivity/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/stephen-k-burley-md-dphil-named-co-program-leader-at-rutgers/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/peter-h-wiernik-md-receives-2016-walter-reed-distinguished-achievement-award-from-uva-medical/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/lung-cancer-alliance-supports-two-young-investigator-awards/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/asco-submits-comments-to-onc-on-enhanced-oversight-of-the-hit-certification-program/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/2016-asco-annual-meeting-planning-committees/ 2019-03-11T17:00:56+00:00 https://ascopost.com/issues/june-10-2016/newly-updated-resources-to-help-your-patients-quit-tobacco/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/prostate-cancer-opinions-vary-on-gleason-scores-and-surgery/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/asco-2016-cancerlinq-extends-its-reach-announces-new-partnerships/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/american-cancer-society-report-assesses-progress-against-goals-set-for-nation-25-years-ago/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/daratumumab-shows-high-activity-in-heavily-pretreated-and-refractory-multiple-myeloma/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/sirius-trial-heralds-a-new-era-of-promise-in-treating-resistant-myeloma/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/multi-institutional-metastatic-melanoma-research-team-receives-900-000-l-oréal-paris-usa-mra-team-science-award-for-women-in-scientific-research/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/clinical-trials-actively-recruiting-patients-with-liver-cancer/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/pembrolizumab-improves-survival-vs-docetaxel-in-previously-treated-pd-l1-positive-advanced-non-small-cell-lung-cancer/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/jeffrey-sosman-md-joins-northwestern-s-lurie-comprehensive-cancer-center/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/survey-finds-most-americans-unlikely-to-enroll-in-clinical-trials/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/rising-breast-cancer-incidence-in-sub-saharan-africa-challenges-and-opportunities/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/asco-urges-centers-for-medicare-medicaid-services-to-withdraw-medicare-part-b-demo-in-formal-comments/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/fred-hutchinson-cancer-research-center-hires-steve-stadum-as-executive-vice-president-and-chief-operating-officer/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/ronald-david-alvarez-md-named-chair-of-obstetrics-and-gynecology-at-vanderbilt-university-medical-center/ 2019-03-11T17:00:57+00:00 https://ascopost.com/issues/june-10-2016/2016-oncology-meetings/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/asco-statement-on-human-papillomavirus-vaccination-for-cancer-prevention/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/moving-the-needle-on-hpv-vaccination/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/providing-inpatient-physical-rehabilitation-for-patients-with-advanced-cancer/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/seattle-children-s-reports-promising-early-results-with-immunotherapy-in-relapsed-all/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/dr-william-morton-and-his-engineer/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/statement-from-fda-commissioner-robert-califf-md-on-the-release-of-the-final-individual-patient-expanded-access-form/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/pd-l1-inhibitor-atezolizumab-for-locally-advanced-or-metastatic-urothelial-carcinoma/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/improvement-in-overall-survival-with-addition-of-chemotherapy-to-radiotherapy-in-low-grade-glioma/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/combined-modality-therapy-for-low-grade-gliomas-balancing-toxicity-delivery-logistics-and-survival-benefit/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/lenvatinib-in-combination-with-everolimus-in-advanced-renal-cell-carcinoma/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/increased-survival-and-toxicity-with-docetaxel-no-benefit-of-zoledronic-acid-when-added-to-first-line-hormone-therapy-in-prostate-cancer/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/fda-approves-new-diagnostic-imaging-agent-to-detect-recurrent-prostate-cancer/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/low-dose-chemical-exposure-and-cancer/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/the-best-hcahps-score-a-rodeo-invitation/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/hopa-research-grants-announced-totaling-nearly-60-000-in-funding/ 2019-03-11T17:00:58+00:00 https://ascopost.com/issues/june-10-2016/dana-farber-president-to-receive-spark-award-for-health-promotion/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/university-of-maryland-greenebaum-cancer-center-designated-as-nci-comprehensive-cancer-center/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/an-unusual-memoir-of-cancer/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/rising/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/the-importance-of-listening-to-patients/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/cheryl-taylore-lee-md-named-urology-chair-at-the-ohio-state-university-wexner-medical-center/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/aua-honors-its-2016-annual-award-winners/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/philip-a-salem-md-honored-by-president-of-mexico-for-cancer-care/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/breast-density-legislation-an-opportunity-for-better-risk-assessment/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/yale-researchers-win-sokoloff-family-melanoma-research-alliance-award/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/asco-updates-value-in-cancer-care-framework/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/asco-value-in-cancer-care-task-force/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/fda-approves-new-diagnostic-imaging-agent-to-detect-rare-neuroendocrine-tumors/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/folfirinox-in-locally-advanced-pancreatic-cancer/ 2019-03-11T17:00:59+00:00 https://ascopost.com/issues/june-10-2016/early-lapatinib-related-rash-in-breast-cancer/ 2019-03-11T17:01:00+00:00 https://ascopost.com/issues/june-10-2016/international-prognostic-index-for-chronic-lymphocytic-leukemia/ 2019-03-11T17:01:00+00:00 https://ascopost.com/issues/june-10-2016/md-anderson-receives-106-million-from-cprit-for-lung-cancer-research/ 2019-03-11T17:01:00+00:00 https://ascopost.com/issues/june-10-2016/fda-approves-egfr-mutation-detecting-blood-test-for-nsclc/ 2019-03-11T17:01:00+00:00 https://ascopost.com/issues/june-10-2016/scenes-from-asco-2016/ 2019-03-11T17:01:00+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/ 2021-06-08T17:57:21+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/allen-s-lichter-md-fasco-reflects-on-his-career-path-and-his-tenure-as-asco-ceo-and-predicts-a-bright-future-for-radiation-oncology/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/with-an-illustrious-career-in-breast-oncology-daniel-f-hayes-md-fasco-follows-in-the-footsteps-of-giants-as-asco-president-elect/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/celebrating-asco-2016-awards-recipients/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/once-a-vocational-nomad-christine-h-chung-md-now-works-to-promote-patient-centered-care-in-head-and-neck-cancer/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/about-the-contributors/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/international-authority-on-radiation-effects-robert-peter-gale-md-phd-has-pushed-scientific-boundaries-in-search-of-answers/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/with-a-strong-personal-connection-to-his-patients-stephen-p-hunger-md-strives-for-a-cure-for-all-children-with-leukemia/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/a-pioneer-in-lung-cancer-research-james-l-mulshine-md-champions-early-population-based-lung-cancer-screening/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/lisa-a-newman-md-mph-facs-fasco-balances-her-passions-of-surgical-breast-oncology-and-breast-cancer-disparity-research-both-home-and-abroad/ 2019-03-11T17:01:25+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/physician-researcher-carolyn-jean-presley-md-envisions-enhancing-geriatric-oncology/ 2019-03-11T17:01:26+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/recipients-of-the-david-a-karnofsky-memorial-award-and-lecture/ 2019-03-11T17:01:26+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/in-memoriam/ 2019-03-11T17:01:26+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/noted-gastrointestinal-oncologist-leonard-saltz-md-tempers-optimism-with-reality-and-factors-cost-into-the-equation-of-value-in-cancer-care/ 2019-03-11T17:01:26+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/surgical-oncologist-suzanne-l-topalian-md-shines-at-the-forefront-of-groundbreaking-research-in-cancer-immunotherapy/ 2019-03-11T17:01:26+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/2016-oncology-meetings/ 2019-03-11T17:01:26+00:00 https://ascopost.com/issues/june-3-2016-narratives-special-issue/colleagues-tip-their-hats-to-allen-s-lichter-md-fasco/ 2019-03-11T17:01:26+00:00 https://ascopost.com/issues/may-25-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/may-25-2016/site-of-tumor-impacts-survival-and-choice-of-treatment-in-metastatic-colorectal-cancer/ 2019-03-11T17:01:42+00:00 https://ascopost.com/issues/may-25-2016/expert-point-of-view-deborah-schrag-md-mph/ 2019-03-11T17:01:42+00:00 https://ascopost.com/issues/may-25-2016/in-celebration-of-a-remarkable-career-at-asco/ 2019-03-11T17:01:42+00:00 https://ascopost.com/issues/may-25-2016/asco-presidents-serving-under-ceo-allen-s-lichter-md-fasco-2006-2016/ 2019-03-11T17:01:42+00:00 https://ascopost.com/issues/may-25-2016/what-asco-can-do-for-you-and-for-our-patients/ 2019-03-11T17:01:42+00:00 https://ascopost.com/issues/may-25-2016/pembrolizumab-survival-benefit-proves-durable-in-patients-with-advanced-melanoma/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/upfront-transplant-remains-standard-of-care-in-multiple-myeloma/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/expert-point-of-view-shaji-k-kumar-md-and-sergio-a-giralt-md/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/maximizing-cancer-cure-how-do-we-get-there/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/meta-analysis-of-breast-cancer-studies-demonstrates-value-of-pathologic-complete-response/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/durable-benefit-with-immunotherapy-combination-in-advanced-melanoma/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/expert-point-of-view-padmanee-sharma-md-phd/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/aacr-congratulates-newest-national-academy-of-sciences-members/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/william-g-kaelin-jr-md-receives-aacr-princess-takamatsu-award/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/fda-approves-nivolumab-for-heavily-pretreated-classical-hodgkin-lymphoma/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/nccn-clinical-practice-guidelines-in-oncology-nccn-guidelines-2016-guidelines/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/cases-of-mixed-hepatocellular-carcinoma-cholangiocarcinoma-emerging/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/highlights-from-the-2016-aacr-annual-meeting/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/aacr-inducts-2016-class-of-fellows-of-the-aacr-academy/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/crizotinib-active-in-orphan-kidney-malignancy/ 2019-03-11T17:01:43+00:00 https://ascopost.com/issues/may-25-2016/expert-point-of-view-mayer-fishman-md-phd/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/gene-rearrangements-attractive-targets-in-a-variety-of-cancers/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/expert-point-of-view-louis-m-weiner-md/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/10-things-you-need-to-know-about-the-cancer-moonshot-2020-program/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/fda-grants-selumetinib-orphan-drug-designation-for-adjuvant-treatment-of-differentiated-thyroid-cancer/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/venetoclax-for-previously-treated-chronic-lymphocytic-leukemia-with-17p-deletion/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/fda-maintains-ongoing-efforts-to-expedite-drug-approvals/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/odac-advises-the-fda-to-wait-for-phase-iii-results-for-rociletinib-in-non-small-cell-lung-cancer/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/young-women-require-formal-assessment-to-identify-breast-cancer-risk/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/expert-point-of-view-mahmoud-el-tamer-md/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/dr-susan-love-time-to-address-collateral-damage-of-breast-cancer-treatment/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/is-male-breast-cancer-overlooked-in-clinical-trials/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/andrew-bindman-md-named-new-ahrq-director/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/lifang-hou-md-phd-named-director-of-global-health-at-the-lurie-cancer-center/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/neratinib-improves-invasive-disease-free-survival-in-her2-positive-breast-cancer/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/extenet-trial-of-neratinib-one-size-does-not-fit-all-in-her2-positive-breast-cancer/ 2019-03-11T17:01:44+00:00 https://ascopost.com/issues/may-25-2016/no-survival-benefit-reported-with-chemoradiotherapy-vs-continued-chemotherapy-in-controlled-locally-advanced-pancreatic-cancer/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/asco-urges-aggressive-efforts-to-increase-hpv-vaccination-and-prevent-cancer/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/four-reasons-to-use-social-media-at-the-asco-annual-meeting/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/enhance-your-annual-meeting-experience-with-attendee-resources/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/a-quick-look-at-the-benefits-of-hpv-vaccination/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/asco-endorses-european-association-of-urology-guideline-on-muscle-invasive-and-metastatic-bladder-cancers/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/asco-and-european-association-of-urology-agree-on-bladder-cancer-guidelines/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/no-disease-free-survival-benefit-of-adjuvant-sunitinib-or-sorafenib-in-high-risk-nonmetastatic-renal-cell-carcinoma/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/curb-your-enthusiasm-no-benefit-of-adjuvant-sorafenib-or-sunitinib-in-nonmetastatic-renal-cell-carcinoma/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/al-b-benson-iii-md-elected-president-of-the-national-patient-advocate-foundation-executive-board/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/suresh-senan-mrcp-frcr-phd-receives-2016-heine-h-hansen-award/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/anti-pd-l1-antibody-atezolizumab-active-in-previously-treated-advanced-urothelial-carcinoma/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/atezolizumab-in-previously-treated-advanced-urothelial-carcinoma/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/fda-approves-lenvatinib-in-combination-with-everolimus-in-advanced-renal-cell-carcinoma/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/increased-physical-activity-associated-with-lower-risk-of-13-types-of-cancer/ 2019-03-11T17:01:45+00:00 https://ascopost.com/issues/may-25-2016/eribulin-improves-overall-survival-vs-dacarbazine-in-previously-treated-advanced-liposarcoma-or-leiomyosarcoma/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/eribulin-in-liposarcoma-a-closer-look-at-the-comparative-data/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/nih-appoints-patricia-flatley-brennan-rn-phd-to-lead-the-nlm/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/brian-czerniecki-md-phd-named-chair-of-breast-oncology-at-moffitt/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/robert-s-langer-scd-receives-2016-aacr-irving-weinstein-foundation-distinguished-lectureship/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/asco-past-president-anticipates-a-new-position-with-an-ongoing-goal-of-advancing-the-field-of-oncology/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/200-million-gift-launches-lawrence-j-ellison-institute-for-transformative-medicine-of-usc/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/aua-suo-release-new-clinical-practice-guideline-on-the-diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer/ 2021-02-09T22:48:58+00:00 https://ascopost.com/issues/may-25-2016/asco-s-state-affiliate-council-improves-communication-between-asco-and-community-physicians/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/leading-surgical-oncology-societies-call-for-global-curriculum-to-address-variations-inadequacies-in-training/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/a-physician-s-guide-to-pain-and-symptom-management-in-cancer-patients/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/a-toolkit-for-dealing-with-the-trauma-of-a-prostate-cancer-diagnosis/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/a-perilous-time-for-refugees-with-cancer/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/occupational-therapy-for-adults-with-cancer-an-unmet-need/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/the-role-of-occupational-and-physical-therapy-in-geriatric-oncology/ 2019-03-11T17:01:46+00:00 https://ascopost.com/issues/may-25-2016/monitoring-survivors-of-childhood-cancers-for-late-effects-of-treatment/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/a-psychotherapist-s-approach-to-end-of-life-care/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/oncology-and-diplomacy-in-the-middle-east/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/mary-jackson-scroggins-receives-2016-aacr-distinguished-public-service-award/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/the-arrival-of-generic-imatinib-into-the-us-market-an-educational-event/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/how-immunotherapy-is-revolutionizing-cancer-care/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/recent-reports-on-treatment-for-leukemias-sinusoidal-obstruction-syndrome-and-graft-vs-host-disease/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/breast-cancer-research-foundation-revitalizing-academic-research-in-breast-cancer-through-drug-research-collaborative/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/2016-oncology-meetings/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/cancerlinq-completes-agreements-with-36-vanguard-practices/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/3-million-nci-grant-awarded-to-study-links-between-liver-cancer-and-hiv/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/ushering-in-a-new-era-in-personalized-medicine/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/fitness-can-exercise-lengthen-survival-in-patients-with-cancer/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/white-knuckling/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/cabozantinib-in-advanced-renal-cell-carcinoma/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/the-10-year-club/ 2019-03-11T17:01:47+00:00 https://ascopost.com/issues/may-25-2016/new-fda-rule-prohibits-sale-of-e-cigarettes-to-anyone-under-age-18-and-requires-warning-labels/ 2019-03-11T17:01:48+00:00 https://ascopost.com/issues/may-25-2016/expect-questions-about-the-new-rule-on-e-cigarettes/ 2019-03-11T17:01:48+00:00 https://ascopost.com/issues/may-25-2016/significant-increased-risk-of-noncancer-hospitalization-following-diagnosis-of-prostate-cancer-in-the-elderly/ 2019-03-11T17:01:48+00:00 https://ascopost.com/issues/may-25-2016/relatives-of-patients-with-carcinoma-of-unknown-primary-at-increased-risk-for-this-and-other-cancers/ 2019-03-11T17:01:48+00:00 https://ascopost.com/issues/may-25-2016/william-j-gradishar-md-facp-named-deputy-director-for-lurie-cancer-center-clinical-network/ 2019-03-11T17:01:48+00:00 https://ascopost.com/issues/may-25-2016/asco-recognizes-2016-recipients-of-fasco-distinction/ 2019-03-11T17:01:48+00:00 https://ascopost.com/issues/may-10-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/may-10-2016/one-third-of-patients-with-advanced-melanoma-survive-at-least-5-years-after-nivolumab-treatment/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/expert-point-of-view-jedd-d-wolchok-md-phd/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/making-the-moonshot-initiative-a-reality/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/using-telemedicine-to-reduce-wait-times-for-veterans/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/dethroning-the-emperor-of-all-maladies/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/nivolumab-new-standard-of-care-for-progressive-head-and-neck-cancer-after-platinum-therapy/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/expert-point-of-view-lillian-l-siu-md-fasco/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/ado-trastuzumab-emtansine-plus-pertuzumab-promising-neoadjuvant-results-for-her2-positive-breast-cancer-from-the-i-spy-2-trial/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/expert-point-of-view-mark-pegram-md-martine-piccart-md-phd/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/first-results-from-mindact-confirm-the-benefit-of-genomic-profiling/ 2019-03-11T17:02:13+00:00 https://ascopost.com/issues/may-10-2016/expert-point-of-view-harold-burstein-md-phd/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/cancercare-issues-report-on-nationwide-surveys-of-3-000-people-diagnosed-with-cancer/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/selected-abstracts-from-the-2016-bmt-tandem-meetings/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/intraperitoneal-chemotherapy-in-question-in-ovarian-cancers/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/expert-point-of-view-gini-fleming-md/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/roundup-of-ovarian-cancer-abstracts-from-2016-sgo-annual-meeting-on-women-s-cancer/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/fda-approves-cabozantinib-in-patients-with-renal-cell-carcinoma-who-have-received-prior-antiangiogenic-therapy/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/waun-ki-hong-md-receives-10th-aacr-margaret-foti-award-for-leadership-and-extraordinary-achievements-in-cancer-research/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/robert-weinberg-phd-receives-aacr-award-for-lifetime-achievement-in-cancer-research/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/breaking-down-dogma-with-the-outgoing-president-of-sgo/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/enzalutamide-produces-large-progression-free-survival-benefit-vs-bicalutamide-in-two-trials-in-castration-resistant-prostate-cancer/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/moving-forward-in-castrate-resistant-prostate-cancer-the-terrain-and-strive-studies/ 2019-03-11T17:02:14+00:00 https://ascopost.com/issues/may-10-2016/asco-guideline-on-use-of-biomarkers-to-guide-decisions-on-adjuvant-systemic-therapy-in-early-stage-invasive-breast-cancer/ 2019-03-11T17:02:15+00:00 https://ascopost.com/issues/may-10-2016/shedding-light-on-a-cornucopia-of-breast-tumor-biomarker-assays/ 2019-03-11T17:02:15+00:00 https://ascopost.com/issues/may-10-2016/defibrotide-sodium-for-hepatic-veno-occlusive-disease-after-hsct/ 2019-03-11T17:02:15+00:00 https://ascopost.com/issues/may-10-2016/donor-spotlight-gateway-for-cancer-research/ 2019-03-11T17:02:15+00:00 https://ascopost.com/issues/may-10-2016/new-jop-articles-highlight-the-impact-of-nci-programs-on-clinical-trial-enrollment/ 2019-03-11T17:02:15+00:00 https://ascopost.com/issues/may-10-2016/interactive-focused-learning-at-the-asco-annual-meeting/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/redesigned-ascoorg-launches-with-improved-usability/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/shop-to-conquer-cancer/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/tell-your-patients-about-pre-act/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/ash-meets-with-officials-provides-recommendations-for-the-national-cancer-moonshot-initiative/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/recurrences-observed-in-more-than-50-of-inadequately-treated-patients-with-ductal-carcinoma-in-situ-1/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/expert-point-of-view-julie-margenthaler-md-and-mahmoud-el-tamer-md-1/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/sheldon-m-feldman-md-named-president-of-asbrs/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/chief-research-officer-named-at-the-pancreatic-cancer-action-network/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/sixteen-leaders-in-breast-cancer-research-join-susan-g-komen-as-advisors/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/clinical-trials-actively-recruiting-patients-with-ewing-sarcoma/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/2016-oncology-meetings/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/breakthrough-therapy-efforts-result-in-unprecedented-success/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/fda-launches-first-campaign-focused-on-dangers-of-smokeless-tobacco-among-rural-teens/ 2019-03-11T17:02:16+00:00 https://ascopost.com/issues/may-10-2016/inspirational-stories-for-cancer-survivors/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/a-history-of-medical-care-for-the-dying/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/so-how-long-do-i-have/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/the-parker-foundation-launches-the-parker-institute-for-cancer-immunotherapy-with-a-250-million-grant/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/cancer-stole-my-identity/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/overcoming-radiosensitization-in-head-and-neck-cancer/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/induced-phenotype-targeted-therapy-to-overcome-tumor-heterogeneity/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/corporate-angel-network-s-50-000th-patient-flight-benefits-young-retinoblastoma-patient/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/aacr-welcomes-new-board-of-directors-nominating-committee-members/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/improved-survival-with-shorter-delays-between-diagnosis-and-surgery-and-before-initiating-adjuvant-chemotherapy/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/some-diagnostic-variability-in-interpreting-breast-biopsy-slides/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/may-10-2016/hormone-combination-therapy-may-increase-risk-of-breast-cancer-in-african-american-women/ 2019-03-11T17:02:17+00:00 https://ascopost.com/issues/april-25-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/april-25-2016/novel-strategies-emerging-for-triple-negative-breast-cancer/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/benefits-and-risks-of-transplantation-the-changing-therapeutic-paradigm-for-multiple-myeloma/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/physicians-as-champions-for-quality-improvement/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/genetic-testing-in-women-with-ovarian-cancer-helps-to-determine-prognosis/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/expert-point-of-view-kristin-zorn-md/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/study-supports-initial-attempt-at-debulking-surgery-in-stage-iiic-ovarian-fallopian-tube-and-peritoneal-carcinoma/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/expert-point-of-view-kian-behbakht-md/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/liquid-biopsies-predict-treatment-response-and-survival-in-gynecologic-cancers/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/expert-point-of-view-douglas-a-levine-md/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/in-ductal-carcinoma-in-situ-benefit-of-wider-margins-tied-to-radiation-use/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/expert-point-of-view-patrick-borgen-md/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/neoadjuvant-endocrine-therapy-vastly-underutilized-by-us-clinicians/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/transcription-factor-cdx2-may-be-a-prognostic-biomarker-in-stage-ii-and-iii-colon-cancer/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/city-of-hope-awarded-nci-research-grant-for-potential-acute-myeloid-leukemia-drug/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/cdx2-in-stage-ii-colon-cancer-ready-for-prime-time/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/steven-j-cohen-md-fox-chase-gi-medical-oncology-chief-elected-as-nci-task-force-vice-chair/ 2019-03-11T17:02:52+00:00 https://ascopost.com/issues/april-25-2016/michael-a-caligiuri-md-named-aacr-president-elect-2016-2017/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/asco-endorses-cancer-care-ontario-guideline-on-active-surveillance-for-management-of-localized-prostate-cancer/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/dignicap-scalp-cooling-system-now-available-for-women-with-breast-cancer-at-10-us-cancer-treatment-centers/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/active-surveillance-has-become-standard-care-for-men-with-low-risk-localized-prostate-cancer/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/pembrolizumab-looks-promising-in-multiple-myeloma/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/expert-point-of-view-thierry-facon-md/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/updates-on-elotuzumab-in-multiple-myeloma-show-persistence-of-benefit/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/expert-point-of-view-thierry-facon-md-1/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/scott-a-armstrong-md-phd-to-lead-department-of-pediatric-oncology-at-dana-farber-cancer-institute/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/blue-ribbon-panel-to-help-guide-national-cancer-moonshot-initiative/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/boswellia/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/meet-w-charles-penley-md-fasco/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/2016-special-awards-researchers-and-scientists-recognized-for-significant-contributions-to-cancer-care/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/asco-convenes-obesity-work-group-meeting-on-multidisciplinary-collaboration/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/podcast-discusses-finding-easy-to-understand-cancer-information/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/timothy-j-eberlein-md-elected-chairman-of-the-nccn-board-of-directors/ 2019-03-11T17:02:53+00:00 https://ascopost.com/issues/april-25-2016/drug-prices-and-value-finding-middle-ground/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/johns-hopkins-launches-immunotherapy-center-with-125-million-gift/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/leena-gandhi-md-phd-named-director-of-thoracic-medical-oncology-at-nyu-langone-s-perlmutter-cancer-center/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/seven-new-members-elected-to-interurban-clinical-club/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/acsasco-breast-cancer-survivorship-care-guideline/ 2020-09-17T20:29:16+00:00 https://ascopost.com/issues/april-25-2016/praise-for-the-acsasco-breast-cancer-survivorship-care-guideline/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/asco-urges-aggressive-efforts-to-increase-hpv-vaccination-and-prevent-cancer/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/supportive-care-in-the-older-adult-with-cancer-what-you-need-to-know/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/immunotherapy-could-be-the-wave-of-the-future-but-problems-and-challenges-cannot-be-ignored/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/radiation-myths-facts-dangers-and-benefits/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/susannah-koontz-pharmd-bcop-fhopa-named-hopa-president-elect-for-2016-2017-term/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/2016-2017-hopa-president-sarah-scarpace-pharmd-mph-bcop-takes-office/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/raising-awareness-of-medullary-thyroid-carcinoma/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/larry-w-kwak-md-phd-awarded-ho-am-prize-in-medicine/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/friends-of-cancer-research-encourages-fda-to-modernize-and-consolidate/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/ed-sauter-md-phd-named-director-of-breast-surgery-program-at-hartford-healthcare-cancer-institute/ 2019-03-11T17:02:54+00:00 https://ascopost.com/issues/april-25-2016/2016-oncology-meetings/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/director-selected-for-nih-s-precision-medicine-initiative-cohort-program/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/city-of-hope-awarded-25-million-grant-to-launch-nutrition-initiative/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/quality-of-life-benefits-of-contralateral-prophylactic-mastectomy-may-be-too-small-to-be-clinically-meaningful/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/expect-questions-about-potential-trade-offs-of-contralateral-prophylactic-mastectomy/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/apsho-to-hold-skills-workshops-for-advanced-practitioners-in-oncology/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/ongoing-molecular-research-in-the-science-of-oncology-leukemia/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/ongoing-molecular-research-in-the-science-of-oncology-head-and-neck-cancer/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/ongoing-molecular-research-in-the-science-of-oncology-immunotherapy/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/ongoing-molecular-research-in-the-science-of-oncology-genitourinary-cancer/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/ongoing-molecular-research-in-the-science-of-oncology-gynecologic-cancer/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/earlier-hospice-enrollment-avoiding-icu-admissions-and-not-dying-in-the-hospital-associated-with-perceptions-of-better-end-of-life-care/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/severe-adverse-event-clusters-identified-using-nci-common-terminology-criteria/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/blue-ribbon-panel-to-help-guide-cancer-moonshot-initiative/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-25-2016/natural-cancer-remedies/ 2019-03-11T17:02:55+00:00 https://ascopost.com/issues/april-10-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/april-10-2016/atezolizumab-improves-survival-vs-docetaxel-in-previously-treated-nsclc-increased-benefit-with-increased-pd-l1-expression/ 2019-03-11T17:03:19+00:00 https://ascopost.com/issues/april-10-2016/the-poplar-trial-pd-l1-blockade-with-atezolizumab-in-second-or-third-line-non-small-cell-lung-cancer/ 2019-03-11T17:03:19+00:00 https://ascopost.com/issues/april-10-2016/throwing-out-the-baby-with-the-bathwater-a-critical-appraisal-of-the-uspstf-recommendation-against-screening-for-prostate-cancer/ 2019-03-11T17:03:19+00:00 https://ascopost.com/issues/april-10-2016/computer-assisted-decision-support-in-medical-oncology-we-need-it-now/ 2019-03-11T17:03:19+00:00 https://ascopost.com/issues/april-10-2016/clifford-a-hudis-md-facp-named-asco-s-next-ceo/ 2019-03-11T17:03:19+00:00 https://ascopost.com/issues/april-10-2016/trabectedin-improves-progression-free-survival-in-uterine-leiomyosarcoma/ 2019-03-11T17:03:19+00:00 https://ascopost.com/issues/april-10-2016/expert-point-of-view-kathleen-moore-md/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/breast-cancer-vaccines-moving-forward-at-a-fast-clip/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/jeffrey-fowler-md-begins-presidency-of-society-of-gynecologic-oncology/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/metastatic-breast-cancer-with-discordant-tumors-small-study-reports-treatment-by-primary-status-may-improve-survival/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/a-business-professor-and-husband-turns-breast-cancer-researcher/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/experts-consider-what-it-means-to-improve-quality-of-care-in-an-era-of-increasing-reliance-on-targeted-therapies/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/outcome-measures-in-quality-and-identifying-high-quality-practice/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/new-commission-on-cancer-standards-clarifies-and-emphasizes-process-quality-data-reporting-and-more/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/update-of-ascend-1-trial-shows-ceritinib-highly-active-in-alk-rearranged-nsclc-including-intracranial-disease/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/conquer-cancer-foundation-honors-74-oncologists-for-contributions-to-genitourinary-cancer-cancer-survivorship-gastrointestinal-cancer-and-quality-care-research/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/diversity-training-key-to-increasing-cultural-competence-among-oncology-surgeons/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/donate-now-to-access-the-conquer-cancer-foundation-donor-lounge-at-asco-annual-meeting/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/understanding-and-preparing-for-macra/ 2020-09-17T20:02:46+00:00 https://ascopost.com/issues/april-10-2016/asco-pledges-to-advance-interoperability-among-health-information-systems/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/highlights-from-the-2016-quality-care-symposium-and-multidisciplinary-head-and-neck-cancer-symposium/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/providing-perspective-on-pressing-economic-issues-facing-cancer-care-now-and-in-the-future/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/jennie-r-crews-md-facp-named-president-of-the-association-of-community-cancer-centers/ 2019-03-11T17:03:20+00:00 https://ascopost.com/issues/april-10-2016/patrick-moore-md-mph-named-nci-outstanding-investigator-awarded-64-million-for-discovering-cancer-viruses/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/fda-approves-defibrotide-for-complication-of-stem-cell-transplant/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/selected-abstracts-from-2015-ash-annual-meeting-part-4/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/survival-period-for-esophageal-cancer-is-tied-to-race-and-income/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/peter-paul-yu-md-fasco-named-physician-in-chief-of-hartford-healthcare-cancer-institute/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/decreased-psa-screening-and-decreased-diagnosis-of-early-stage-prostate-cancer/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/samuel-waxman-cancer-research-foundation-appoints-robert-hromas-md-to-its-scientific-advisory-board/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/everolimus-improves-progression-free-survival-in-advanced-neuroendocrine-tumors-of-the-lung-or-gastrointestinal-tract/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/susan-block-md-honored-with-aahpm-palliative-care-lifetime-achievement-award/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/itai-yanai-phd-to-lead-institute-for-computational-medicine-at-nyu-langone-medical-center/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/phase-ibii-study-reports-high-response-rates-seen-with-addition-of-cisplatin-to-regimen-for-advanced-pancreatic-cancer/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-israel/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/joan-massagué-phd-to-receive-2016-pezcoller-foundation-aacr-international-award-for-cancer-research/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/lili-yang-phd-receives-cirm-funding-to-investigate-inkt-modification-and-transplantation/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/crizotinib-in-ros1-positive-metastatic-non-small-cell-lung-cancer/ 2019-03-11T17:03:21+00:00 https://ascopost.com/issues/april-10-2016/michael-j-birrer-md-phd-named-recipient-of-the-2016-claudia-cohen-research-foundation-prize-for-outstanding-gynecologic-cancer-researcher/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/2016-oncology-meetings/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/things-may-not-be-what-they-seem-are-old-cancer-treatment-theories-new-again/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/a-political-activist-challenges-the-drug-approval-process-and-the-us-government/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/sadik-esener-phd-selected-to-lead-ohsu-s-large-scale-early-cancer-detection-initiative/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/aacr-ceo-margaret-foti-phd-md-hc-honored-with-james-ewing-layperson-s-award-from-sso/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/david-b-roth-md-phd-named-director-of-new-penn-center-for-precision-medicine/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/10-bladder-cancer-projects-awarded-research-grants-by-johns-hopkins-greenberg-bladder-cancer-institute/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/most-patients-with-melanoma-had-few-nevi-none-atypical/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/geriatric-assessment-is-key-to-treatment-decisions-for-patients-80-years-and-older/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/april-10-2016/compartmentalizing-cancer/ 2019-03-11T17:03:22+00:00 https://ascopost.com/issues/march-25-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/march-25-2016/first-line-ibrutinib-improves-progression-free-and-overall-survival-vs-chlorambucil-in-older-patients-with-chronic-lymphocytic-leukemia/ 2019-03-11T17:03:44+00:00 https://ascopost.com/issues/march-25-2016/chronic-lymphocytic-leukemia-the-golden-drug-only-for-golden-agers/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/anticoagulation-in-patients-with-cancer-understanding-the-complexities-of-prophylaxis-and-management/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/regulators-embrace-immunotherapy/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/update-on-cancerlinq-a-rapid-health-care-learning-system/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/phone-triage-system-offers-potential-to-reduce-patient-visits-to-the-emergency-department-for-cancer-treatment-related-symptoms/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/surgeons-yes-surgeons-have-a-role-in-translational-cancer-research/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/sso-2016-largest-surgical-oncology-conference-yet/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/fda-approves-crizotinib-for-ros1-positive-metastatic-non-small-cell-lung-cancer/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/fda-approves-everolimus-for-neuroendocrine-tumors-of-gi-or-lung-origin/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/fda-approves-obinutuzumab-in-follicular-lymphoma/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/annual-report-cites-continued-decline-in-most-cancer-mortality-but-trends-toward-increased-liver-cancer-incidence-mortality/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/mutational-profile-may-impact-treatment-decisions-for-smokers-with-human-papillomavirus-positive-oropharyngeal-cancer/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/study-supports-an-immune-effect-of-chemoradiation-in-head-and-neck-cancer/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/expert-point-of-view-brian-nussenbaum-md/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/late-toxicity-improved-with-response-adapted-volume-de-escalation-in-locally-advanced-head-and-neck-cancer/ 2019-03-11T17:03:45+00:00 https://ascopost.com/issues/march-25-2016/expert-point-of-view-david-raben-md/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/markedly-improved-toxicity-rates-with-proton-beam-reirradiation-for-recurrent-head-and-neck-cancer/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/expert-point-of-view-david-raben-md-1/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/everolimus-in-advanced-neuroendocrine-tumors/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/laurie-h-glimcher-md-named-president-of-dana-farber-cancer-institute/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/robert-seeger-md-awarded-lifetime-achievement-award-from-pediatric-blood-and-marrow-transplant-consortium/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/douglas-a-levine-md-facog-facs-appointed-director-of-gynecologic-oncology-at-nyu-langone/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/two-fellows-selected-for-asco-s-inaugural-health-policy-fellowship-program/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/reduction-in-late-mortality-in-childhood-cancer-survivors/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/cancer-survivorship-research-learning-from-the-past-to-improve-future-outcomes/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/palbociclib-combined-with-fulvestrant-in-advanced-breast-cancer-progressing-after-endocrine-therapy/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/2016-pre-annual-meeting-educational-programs-feature-important-topics-for-modern-cancer-care-providers/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/join-the-conversation-online-at-jgoorg/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/direct-your-patients-to-cancernet-for-patient-friendly-videos/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/asco-university-launches-new-certificate-programs-for-advanced-practitioners/ 2019-03-11T17:03:46+00:00 https://ascopost.com/issues/march-25-2016/conquering-cancer-with-dr-kim/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/study-finds-correlation-between-number-of-drug-suppliers-and-drug-shortages/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/no-apparent-benefit-of-long-term-mifepristone-in-the-treatment-of-unresectable-meningioma/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/scandinavian-sarcoma-group-trial-shows-continued-benefit-with-3-years-vs-1-year-of-adjuvant-imatinib-in-high-risk-gist/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/two-types-of-asparaginase-compared-in-newly-diagnosed-childhood-acute-lymphoblastic-leukemia/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/obinutuzumab-in-relapsed-or-refractory-follicular-lymphoma/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/is-this-the-dawn-of-cancer-biosimilars/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/2016-ash-amfdp-scholars-to-study-malaria-immunotherapy-for-hematologic-malignancies/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/geriatric-assessment-of-transplant-ineligible-older-adults-with-multiple-myeloma-a-novel-approach-in-the-era-of-novel-agents/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/astro-expands-its-advocacy-and-government-relations-team-with-new-assistant-director/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/lauren-streicher-md-announced-as-medical-director-for-northwestern-medicine-s-upcoming-center-for-sexual-health/ 2019-03-11T17:03:47+00:00 https://ascopost.com/issues/march-25-2016/closing-the-clinical-trial-gap-for-adolescents-and-young-adults-with-cancer/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/how-rehabilitation-services-provide-benefit-for-patients-with-spinal-metastases/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/potential-overdiagnosis-of-contralateral-breast-cancer-with-preoperative-breast-mri-in-older-women-with-breast-cancer/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/introduction-of-new-diagnostic-devices-in-oncology-new-is-not-necessarily-better/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/minimal-residual-disease-identified-by-npm1-mutation-is-a-powerful-marker-for-poorer-outcome-in-standard-risk-aml/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/minimal-residual-disease-in-aml-worth-looking-1/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/parp-inhibitor-olaparib-produces-high-response-rate-in-metastatic-prostate-cancer-with-dna-repair-defects/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/biomarkers-in-prostate-cancer-parp-inhibitors-and-defects-in-dna-repair/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/new-high-intensity-focused-ultrasound-advances-treatment-for-prostate-cancer/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/nccn-awards-10-grants-for-provider-performance-and-quality-in-treatment-of-metastatic-breast-cancer-initiatives/ 2019-03-11T17:03:48+00:00 https://ascopost.com/issues/march-25-2016/the-time-is-now-for-the-worldwide-cancer-community-to-be-proactive/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/studies-evaluate-bevacizumab-containing-regimens-in-metastatic-colorectal-cancer/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/expert-point-of-view-wells-messersmith-md/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/know-your-tumor-program-aids-patients-with-pancreatic-cancer/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/study-shows-breast-conserving-therapy-beats-mastectomy-but-questions-remain/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/expert-point-of-view-carlos-arteaga-md/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/benefiting-from-mind-body-therapy/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/actively-recruiting-clinical-trials-investigating-late-effects-in-childhood-cancer-survivors/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/a-fight-to-remember/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/a-drop-of-blood/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/2016-oncology-meetings/ 2019-03-11T17:03:49+00:00 https://ascopost.com/issues/march-25-2016/a-gene-hunter-s-advice-on-how-to-take-control-of-your-genetic-inheritance/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/a-doctor-s-prescription-for-a-long-life/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/a-hard-look-at-the-connection-between-germs-and-mental-illness/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/a-cancer-patient-s-harried-survivorship-story/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/the-perplexing-increase-in-bilateral-mastectomies/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/expect-questions-and-heightened-interest-about-bilateral-mastectomy/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/somebody-s-watching-you-meet-the-tweet-trackers-of-the-social-oncology-project/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/i-never-forget-i-have-cancer/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/fecal-immunochemical-test-highly-sensitive-and-effective-when-used-for-colorectal-cancer-annual-screening-programs/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/high-rate-of-overuse-of-serum-tumor-marker-testing/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/patients-diagnosed-with-stage-i-to-iii-rectal-cancer-at-younger-age-have-increased-risk-for-positive-lymph-nodes/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/quality-improvement-projects-aim-at-reducing-errors-in-prescribing-iv-and-oral-chemotherapy/ 2019-03-11T17:03:50+00:00 https://ascopost.com/issues/march-25-2016/340b-drug-pricing-program-revisited/ 2019-03-11T17:03:51+00:00 https://ascopost.com/issues/march-25-2016/a-century-of-progress-the-antiseptic-era-1876-1890/ 2019-03-11T17:03:51+00:00 https://ascopost.com/issues/march-25-2016/asco-issues-report-on-state-of-cancer-care-in-america-2016/ 2019-03-11T17:03:51+00:00 https://ascopost.com/issues/march-10-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/march-10-2016/everolimus-effective-in-neuroendocrine-tumors-of-gastrointestinal-origin/ 2019-03-11T17:04:48+00:00 https://ascopost.com/issues/march-10-2016/expert-point-of-view-irvin-m-modlin-md-and-eric-liu-md/ 2019-03-11T17:04:48+00:00 https://ascopost.com/issues/march-10-2016/asco-provides-support-and-guidance-for-the-white-house-cancer-moonshot-initiative/ 2019-03-11T17:04:48+00:00 https://ascopost.com/issues/march-10-2016/nuns-work-where-none-work/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/radiolabeled-somatostatin-analog-may-represent-a-paradigm-change-in-the-treatment-of-neuroendocrine-tumors/ 2019-07-11T20:29:46+00:00 https://ascopost.com/issues/march-10-2016/expert-point-of-view-irvin-m-modlin-md-lisa-bodei-md-and-eric-liu-md/ 2019-07-11T20:30:47+00:00 https://ascopost.com/issues/march-10-2016/marc-s-ernstoff-md-named-ub-chief-of-hematologyoncology-roswell-park-chair-of-medicine/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/hidayatullah-g-munshi-md-named-program-leader-of-tumor-environment-and-metastasis-program-at-robert-h-lurie-comprehensive-cancer-center/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/mylin-a-torres-md-named-director-of-winship-s-glenn-family-breast-center/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/hypofractionation-is-ready-for-prime-time-in-prostate-cancer-but-will-it-be-adopted/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/expert-point-of-view-daniel-hamstra-md/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/patient-and-provider-engagement-with-healthy-lifestyle-information/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/expert-point-of-view-kathryn-schmitz-phd-mph/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/survivorship-care-in-manitoba-transition-appointments-and-follow-up-care-plans/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/car-t-cell-therapy-may-have-role-in-treating-multiple-myeloma/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/expert-point-of-view-ravi-vij-md/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/pediatric-oncology-groups-endorse-ethical-framework-for-rationing-scarce-drugs/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/carfilzomib-plus-dexamethasone-in-previously-treated-multiple-myeloma/ 2019-03-11T17:04:49+00:00 https://ascopost.com/issues/march-10-2016/asco-s-incoming-president-elect-charts-his-course-for-2017/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/advanced-imaging-may-be-unnecessary-for-many-women-with-early-breast-cancer-but-rate-of-such-testing-remains-high/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/conquer-cancer-foundation-funded-research-published-in-high-impact-journals/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/asco-recommends-improvements-to-medicare-for-managing-multiple-chronic-conditions/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/spotlight-on-women-who-conquer-cancer/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/2015-palliative-care-in-oncology-symposium-highlights/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/asco-s-patient-resources-for-colorectal-cancer-awareness-month/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/making-the-most-of-poster-sessions/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/final-analysis-of-bcirg-006-supports-use-of-nonanthracycline-containing-regimen-in-treatment-of-women-with-early-breast-cancer/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/expert-point-of-view-kathy-s-albain-md-facp-fasco-and-jame-abraham-md/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/role-of-ado-trastuzumab-emtansine-in-metastatic-breast-cancer-solidified/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/expert-point-of-view-c-kent-osborne-md/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/eribulin-mesylate-in-advanced-liposarcoma-previously-treated-with-an-anthracycline/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/an-increase-for-the-national-institutes-of-health-budget/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/2016-oncology-meetings/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/adding-ibrutinib-to-bendamustinerituximab-improves-outcome-in-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/adding-targeted-therapy-to-chemoimmunotherapy-in-perspective-patients-with-chronic-lymphocytic-leukemia-questions-as-to-optimal-strategy-remain/ 2019-03-11T17:04:50+00:00 https://ascopost.com/issues/march-10-2016/keith-hanson-mcgregor-phd-appointed-new-esmo-ceo/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/selected-abstracts-from-2015-ash-annual-meeting-part-3/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/cancer-moonshot-2020-announces-the-formation-of-a-national-pediatrics-consortium/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/red-flag-symptoms-that-could-signal-colorectal-cancer-in-patients-under-50-years-old-should-be-taken-seriously/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/sidebar-questions-from-younger-patients-about-colorectal-cancer-should-be-addressed-promptly/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/a-tv-host-s-breast-cancer-survival-story/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/increasing-the-dose-of-obinutuzumab-monotherapy-raised-the-response-rate/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/melanoma-specific-survival-significantly-higher-with-wider-excision-margins/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/cultural-awareness-and-sensitivity-among-surgeons-do-not-always-result-in-culturally-competent-care/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/march-10-2016/us-senate-confirms-robert-m-califf-md-as-fda-commissioner/ 2019-03-11T17:04:51+00:00 https://ascopost.com/issues/february-25-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/february-25-2016/anti-pd-1pd-l1-antibodies-make-strong-showing-in-gastrointestinal-cancers/ 2019-03-11T17:05:23+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-bertram-wiedenmann-md-phd-and-markus-moehler-md-phd/ 2019-03-11T17:05:23+00:00 https://ascopost.com/issues/february-25-2016/surveillance-for-recurrence-and-second-cancers-guidelines-and-caveats/ 2019-03-11T17:05:23+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-chunkit-fung-md-msce/ 2019-03-11T17:05:23+00:00 https://ascopost.com/issues/february-25-2016/cost-in-the-context-of-value-for-cancer-medicines/ 2019-03-11T17:05:23+00:00 https://ascopost.com/issues/february-25-2016/receipt-of-adjuvant-therapy-at-high-volume-center-improves-survival-in-patients-with-pancreatic-cancer/ 2019-03-11T17:05:23+00:00 https://ascopost.com/issues/february-25-2016/optimizing-outcomes-in-pancreatic-cancer/ 2019-03-11T17:05:23+00:00 https://ascopost.com/issues/february-25-2016/shorter-radiation-course-may-benefit-patients-with-locally-advanced-rectal-cancer/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-claus-roedel-md/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/radiotherapy-for-rectal-cancer-study-reports-no-risk-for-subsequent-pelvic-tumors/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-claus-roedel-md-1/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/carboplatinpaclitaxel-tops-oxaliplatincapecitabine-as-neoadjuvant-regimen-for-esophageal-cancer/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-daniel-vt-catenacci-md/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/bridging-the-medical-gap-in-long-term-cancer-survivorship-care/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/three-industry-leaders-join-the-cancerlinq-team/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/detection-of-thyroid-cancer-most-cost-effective-with-physical-examination-not-ultrasound-screening/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-chunkit-fung-md-msce-1/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/clinic-based-weight-loss-intervention-successful-in-cancer-survivors/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-kathryn-schmitz-phd-mph/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/study-finds-abnormal-insulin-and-glucose-dynamics-in-childhood-survivors-treated-with-abdominal-radiation/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-kathryn-schmitz-phd-mph-1/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/new-technology-to-characterize-circulating-tumor-cells-suggests-better-treatment-decision-making-in-prostate-cancer/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-oliver-sartor-md/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/active-holistic-surveillance-may-prevent-unnecessary-biopsies-in-low-and-lowintermediate-risk-prostate-cancer/ 2019-03-11T17:05:24+00:00 https://ascopost.com/issues/february-25-2016/genomic-molecular-differences-in-tumor-biology-may-explain-inferior-survival-in-african-americans-with-kidney-cancer/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-guru-sonpavde-md/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/adjuvant-chemoradiotherapy-in-locally-advanced-bladder-cancer-hint-of-benefit-that-needs-confirmation/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/expert-point-of-view-elizabeth-plimack-md/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/david-j-mcconkey-phd-named-director-of-johns-hopkins-greenberg-bladder-cancer-institute/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/urologist-steven-brandes-md-joins-newyork-presbyteriancolumbia-university-medical-center/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/evolving-tools-for-clinical-decision-making/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/ofatumumab-for-extended-treatment-of-patients-with-recurrent-or-progressive-chronic-lymphocytic-leukemia/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/management-of-advanced-lung-cancer-in-the-elderly-a-reason-to-rejoice-or-a-cause-for-concern/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/134-million-awarded-to-study-treatment-for-low-grade-ductal-carcinoma-in-situ-in-a-prospective-randomized-trial/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/rolapitant-reduces-chemotherapy-induced-nausea-and-vomiting-in-patients-receiving-moderately-and-highly-emetogenic-chemotherapy/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/candid-discussions-on-living-with-and-after-cancer-at-an-evening-for-cancer-survivors-and-caregivers/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/conquer-cancer-foundation-awards-grants-to-drive-international-cancer-care-advances/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/asco-official-participates-in-vice-president-s-moonshot-launch/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/asco-announces-new-award-recognizing-extraordinary-contributions-to-cancer-survivorship-care/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/new-cancernet-fact-sheets-for-your-practice/ 2019-03-11T17:05:25+00:00 https://ascopost.com/issues/february-25-2016/selected-abstracts-from-2015-ash-annual-meeting-part-3/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/failure-of-updated-dietary-guidelines-to-advise-limiting-red-and-processed-meat-deemed-a-missed-opportunity/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/expect-questions-about-updated-dietary-guidelines/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/four-new-us-preventive-services-task-force-members-appointed/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/suresh-s-ramalingam-md-named-deputy-director-of-winship-cancer-institute/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/nivolumab-plus-ipilimumab-in-unresectable-or-metastatic-melanoma-regardless-of-braf-mutation-status/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/judy-keen-phd-announced-as-director-of-scientific-affairs-at-astro/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/emory-and-winship-announce-sagar-lonial-md-as-hematology-and-medical-oncology-department-chair/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/a-surgeon-s-inspiring-journey-to-death/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/global-cancer-the-current-reality-and-the-future-need-for-action/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/johannes-w-vieweg-md-facs-named-founding-dean-of-nova-southeastern-university-college-of-allopathic-medicine/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/carmen-solórzano-md-named-chief-of-surgical-oncology-at-vanderbilt/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/jaclyn-biegel-phd-joins-children-s-hospital-of-los-angeles-as-director-of-center-for-personalized-medicine/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/oncology-drug-approvals-year-in-review/ 2019-03-11T17:05:26+00:00 https://ascopost.com/issues/february-25-2016/men-get-breast-cancer-too/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-25-2016/mary-claire-king-phd-awarded-2016-szent-gyoergyi-prize-for-progress-in-cancer-research/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-25-2016/mistletoe/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-25-2016/junior-investigators-win-awards-for-pilot-projects/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-25-2016/patients-diagnosed-with-stage-i-to-iii-rectal-cancer-at-younger-age-have-increased-risk-for-positive-lymph-nodes/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-25-2016/100-of-nci-designated-cancer-centers-endorse-the-promotion-of-the-hpv-vaccination-for-cancer-prevention/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-25-2016/increased-cancer-mortality-among-recipients-of-solid-organ-transplants/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-25-2016/quality-improvement-projects-aim-at-reducing-errors-in-prescribing-iv-and-oral-chemotherapy/ 2019-03-11T17:05:27+00:00 https://ascopost.com/issues/february-10-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/february-10-2016/two-contenders-for-second-line-treatment-of-advanced-renal-cell-carcinoma/ 2019-03-11T17:05:59+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-sumanta-k-pal-md/ 2019-03-11T17:05:59+00:00 https://ascopost.com/issues/february-10-2016/doctor-we-prayed-for-you/ 2019-03-11T17:05:59+00:00 https://ascopost.com/issues/february-10-2016/cancer-registries-and-the-evolving-role-of-big-data-in-cancer-care/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/improved-outcomes-in-patients-with-germ-cell-testicular-tumors-in-the-modern-era/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-christian-k-kollmannsberger-md/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/atezolizumab-in-urothelial-cancer-ushering-in-a-new-standard-of-care/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-william-y-kim-md/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/pembrolizumab-label-updated-with-new-clinical-trial-information/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/new-appointments-within-fda-s-office-of-hematology-and-oncology-products/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/studies-confirm-and-extend-the-benefits-of-ixazomib-in-multiple-myeloma/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-thierry-facon-md/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/high-pathologic-complete-response-rates-observed-with-neoadjuvant-ado-trastuzumab-emtansine/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-suleiman-massarweh-md/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/selected-abstracts-from-2015-san-antonio-breast-cancer-symposium/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/dr-abraham-s-top-10-picks-for-the-most-clinically-relevant-breast-cancer-studies-of-2015/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/synthetic-2d-mammography-may-hold-advantages-over-2d3d-mammography/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-emily-sedgwick-md/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/tamoxifen-or-anastrozole-for-ductal-carcinoma-in-situ-choice-comes-down-to-side-effects-and-patient-preference/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-c-kent-osborne-md/ 2019-03-11T17:06:00+00:00 https://ascopost.com/issues/february-10-2016/neoadjuvant-her2-inhibitor-therapy-and-effect-of-molecular-heterogeneity-on-response-in-her2-positive-breast-cancer/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/researcher-spotlight-conquering-cancer-with-dr-wagle/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/stavros-niarchos-foundation-grant-brings-quality-improvement-program-to-practices-supporting-medically-underserved-communities/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/asco-names-advance-of-the-year-highlights-major-top-research-trends/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/asco-comments-with-fellow-leading-medical-organizations-on-proposed-changes-to-common-rule/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/dutch-trial-indicates-6-year-surveillance-interval-is-sufficient-for-many-individuals-with-familial-colorectal-cancer/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/dose-intensified-vs-standard-salvage-radiation-for-biochemically-recurrent-prostate-cancer-after-prostatectomy/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/comparing-recurrence-risk-with-anastrozole-vs-tamoxifen-in-postmenopausal-women-with-ductal-carcinoma-in-situ/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/for-postmenopausal-women-with-ductal-carcinoma-in-situ-nsabp-b-35-and-ibis-ii-dcis-trials-offer-a-choice-of-endocrine-therapy/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/apos-launches-psychosocial-oncology-institute/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/reduced-intensity-conditioning-hematopoietic-stem-cell-transplantation-in-older-patients-with-aml-in-first-remission/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/increased-incidence-of-in-situ-and-invasive-melanoma-in-denmark/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/how-cancer-and-its-treatments-affect-cognitive-function/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/defibrotide-under-review-for-transplant-related-complication/ 2019-03-11T17:06:01+00:00 https://ascopost.com/issues/february-10-2016/expert-point-of-view-sergio-a-giralt-md/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/looking-at-the-real-world-effects-of-genetic-testing/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/fda-approves-ofatumumab-for-patients-with-chronic-lymphocytic-leukemia-in-complete-or-partial-response/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/a-pioneering-oncologist-s-roadmap-forward/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/fear-s-many-deleterious-consequences/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/a-famous-french-oncologist-s-gastronomic-advice-for-reducing-cancer-risk/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/expanded-approval-of-pembrolizumab-in-unresectable-or-metastatic-melanoma/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/vice-president-joe-biden-discusses-big-data-in-cancer-research-at-world-economic-forum/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/selected-abstracts-from-2015-ash-annual-meeting-part-2/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/2016-oncology-meetings/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/misconstrued-review/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/new-ajcc-precision-medicine-guidelines-aimed-at-improving-personalized-cancer-treatment-plans-for-patients/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/james-kv-willson-md-named-chief-scientific-officer-of-cprit/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/certainty/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/patricia-a-ganz-md-awarded-joseph-v-simone-award-and-lecture-for-excellence-in-quality-and-safety-in-the-care-of-patients-with-cancer/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/a-brain-tumor-diagnosis-has-taken-my-life-in-new-directions/ 2019-03-11T17:06:02+00:00 https://ascopost.com/issues/february-10-2016/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/immunotherapy-expert-crystal-mackall-md-joins-stanford-medicine-faculty/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/lewis-c-cantley-phd-wins-israel-s-wolf-prize-in-medicine/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/hospira-foundation-donates-5-million-to-the-university-of-chicago-medicine/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/the-sohn-conference-foundation-unveils-the-sohn-precision-medicine-program-at-columbia-university-medical-center/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/richard-buz-cooper-md-noted-health-policy-expert-dies-at-79/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/similar-low-incidence-of-bowel-symptoms-with-hypofractionated-vs-conventionally-fractionated-radiotherapy-in-localized-prostate-cancer/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/no-benefit-of-adding-adjuvant-and-maintenance-lapatinib-to-chemoradiation-in-high-risk-patients-with-resected-squamous-cell-carcinoma-of-the-head-and-neck/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/asco-praises-president-for-white-house-s-support-of-moonshot-initiative/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/alectinib-in-alk-positive-metastatic-nsclc-after-crizotinib/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/february-10-2016/asco-issues-policy-statement-calling-for-improvements-to-clinical-pathway-programs-in-oncology/ 2019-03-11T17:06:03+00:00 https://ascopost.com/issues/january-25-2016/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/january-25-2016/multiple-myeloma-in-2015-a-year-for-the-record-books/ 2019-03-11T17:06:36+00:00 https://ascopost.com/issues/january-25-2016/the-340b-drug-pricing-program-background-concerns-and-solutions/ 2019-03-11T17:06:36+00:00 https://ascopost.com/issues/january-25-2016/bevacizumab-plus-chemotherapy-fails-to-prolong-survival-in-early-stage-lung-cancer/ 2019-03-11T17:06:36+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-paul-bunn-jr-md/ 2019-03-11T17:06:36+00:00 https://ascopost.com/issues/january-25-2016/could-car-t-therapy-be-moving-into-lymphoma/ 2019-03-11T17:06:36+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-marcela-maus-md/ 2019-03-11T17:06:36+00:00 https://ascopost.com/issues/january-25-2016/study-suggests-luminal-a-breast-cancer-patients-may-not-need-chemotherapy/ 2019-03-11T17:06:36+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-virginia-kaklamani-md/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/neoadjuvant-palbociclib-enhances-effect-of-anastrozole-on-complete-cell-cycle-arrest/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-ian-e-krop-md-phd/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/plasma-based-test-identifies-impactful-mutations-in-bolero-2-population/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-daniel-hayes-md/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/ado-trastuzumab-emtansine-improved-overall-survival-for-heavily-pretreated-patients-with-her2-positive-breast-cancer/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/elotuzumab-in-previously-treated-multiple-myeloma/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/patient-centric-care-translating-research-to-results/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/even-after-antiandrogen-therapy-docetaxel-remains-useful-in-prostate-cancer/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/alk-rearrangements-common-in-young-patients-with-lung-cancer/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/rituximab-adds-benefit-to-chemotherapy-in-adult-b-cell-precursor-all/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-robert-hromas-md/ 2019-03-11T17:06:37+00:00 https://ascopost.com/issues/january-25-2016/idelalisib-improves-progression-free-survival-over-bendamustine-plus-rituximab-in-chronic-lymphocytic-leukemia/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-susan-o-brien-md/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/severe-toxicities-seen-in-younger-patients-receiving-front-line-idelalisib-for-chronic-lymphocytic-leukemia/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/venetoclax-may-prove-to-be-strong-weapon-against-poor-prognosis-chronic-lymphocytic-leukemia/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-kanti-rai-md/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/new-use-for-car-t-cells-post-transplantation/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-george-daley-md-phd-and-david-williams-md/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/self-reports-overestimate-mercaptopurine-intake-in-childhood-acute-lymphoblastic-leukemia/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-mark-crowther-md/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/myeloablative-conditioning-for-stem-cell-transplantation-remains-standard-of-care-in-patients-with-mds-and-aml/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/study-finds-colorectal-cancer-more-likely-to-affect-minorities-at-younger-age/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/pi3k-inhibitor-buparlisib-extends-progression-free-survival-in-advanced-breast-cancer/ 2019-03-11T17:06:38+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-carlos-l-arteaga-md/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/surgical-margin-width-not-related-to-breast-cancer-recurrence/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-kevin-s-hughes-md/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/karmanos-cancer-institute-announces-new-leadership-roles-for-elisabeth-heath-md-facp-and-ulka-vaishampayan-md/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/sally-vernon-phd-appointed-to-national-cancer-institute-board/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/prophylactic-beta-blocker-preserves-left-ventricular-function-in-patients-receiving-trastuzumab/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-lisa-carey-md/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/immunotherapy-for-breast-cancer-early-lackluster-study-results-yet-promise-remains/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/role-of-carboplatin-in-triple-negative-breast-cancer-still-unclear/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-angela-demichele-md/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/uridine-triacetate-granules-for-fluorouracil-or-capecitabine-overdose-or-early-severe-toxicity/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/pancreas-cancer-liquid-biopsy-proof-of-principle-study/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/homologous-recombination-deficiency-score-correlated-with-response-to-platinum-in-breast-cancer/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-george-sledge-md/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/exploratory-analysis-of-extenet-trial-shows-consistency-of-benefit-with-neratinib/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-jame-abraham-md-facp/ 2019-03-11T17:06:39+00:00 https://ascopost.com/issues/january-25-2016/deconditioning-in-older-adults-with-cancer-a-cascade-to-dependency/ 2020-02-17T17:58:22+00:00 https://ascopost.com/issues/january-25-2016/computerized-cognitive-training-promising-for-reducing-cognitive-late-effects-in-childhood-cancer-survivors/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/i-am-not-afraid-of-cancer/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/study-confirms-benefit-of-triplet-vs-doublet-in-newly-diagnosed-multiple-myeloma/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-sagar-lonial-md/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/blood-test-can-predict-high-risk-cancers-in-patients-treated-with-car-t/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/expert-point-of-view-marcela-v-maus-md-phd/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/global-and-north-american-phase-ii-studies-show-alectinib-is-highly-active-in-crizotinib-resistantrefractory-alk-rearranged-nsclc/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/conquer-cancer-foundation-hosts-inaugural-scientific-and-career-development-retreat/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/ccf-names-thomas-g-roberts-jr-md-new-board-of-directors-chair-appoints-two-new-leaders/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/international-innovation-grant-supports-novel-breast-cancer-health-education-program-in-mexico/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/asco-submits-comments-to-cms-on-ehr-stage-3-of-meaningful-use-and-modifications-final-rule/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/asco-university-announces-new-immuno-oncology-program/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/raymond-n-dubois-md-phd-named-dean-of-the-musc-college-of-medicine/ 2019-03-11T17:06:40+00:00 https://ascopost.com/issues/january-25-2016/the-evolving-treatment-landscape-of-alk-positive-nsclc/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/how-effective-communication-can-improve-patient-care-and-reduce-physician-burnout/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/e-cigarette-advertisements-reach-nearly-7-in-10-middle-and-high-school-students/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/two-inherited-genetic-variants-predict-event-free-and-overall-survival-in-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/the-new-frontiers-of-breast-cancer/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/community-oncology-alliance-elects-new-officers-and-board-members-for-2016/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/terence-s-dermody-md-named-chair-of-pediatrics-at-upmc-and-scientific-director-of-children-s-hospital-of-pittsburgh/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/lenalidomide-plus-rituximab-highly-active-in-initial-treatment-of-mantle-cell-lymphoma/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/winning-the-battle-at-the-front-lines-lenalidomide-plus-rituximab-a-promising-initial-treatment-for-mantle-cell-lymphoma/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/new-society-of-breast-imaging-website-seeks-to-end-confusion-surrounding-mammography-screening/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/nccn-awards-research-grants-to-five-investigators-to-study-effectiveness-of-enzalutamide-in-various-cancers/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/phase-iii-trial-shows-improved-progression-free-survival-with-ibrutinib-vs-temsirolimus-in-relapsedrefractory-mantle-cell-lymphoma/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/ibrutinib-in-relapsed-mantle-cell-lymphoma/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/study-reveals-potential-therapy-targets-for-triple-negative-breast-cancer/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/acupuncture-for-cancer-symptom-clusters/ 2019-03-11T17:06:41+00:00 https://ascopost.com/issues/january-25-2016/stage-increase-in-lung-cancer-more-frequent-after-open-vs-closed-thoracic-surgery/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-afghanistan/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/saving-children-orphaned-by-aids-in-south-africa/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/cancer-incidence-in-indigenous-people-in-australia-new-zealand-canada-and-the-united-states/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/a-noted-breast-surgeon-s-book-of-solid-advice/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/ravi-salgia-md-phd-joins-city-of-hope/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/2016-oncology-meetings/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/american-psychosocial-oncology-society-endorses-psychosocial-standards-of-care-for-children-with-cancer-and-their-families/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/pieces-of-grief/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/mastectomy-healed-by-earth-dressing/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/rakesh-jain-phd-and-mary-claire-king-phd-awarded-the-national-medal-of-science/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/could-a-screening-test-that-would-reduce-deaths-from-ovarian-cancer-be-on-the-way/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/same-study-different-interpretations/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/expect-questions-about-ovarian-cancer-screening/ 2019-03-11T17:06:42+00:00 https://ascopost.com/issues/january-25-2016/keeping-up-with-how-drugs-work/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/january-25-2016/nationally-regarded-cancer-advocate-ellen-stovall-dies/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/january-25-2016/pilot-study-indicates-little-activity-of-vemurafenib-in-metastatic-braf-mutated-colorectal-cancer/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/january-25-2016/famed-cancer-biostatistician-norman-breslow-phd-dies/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/january-25-2016/journal-of-oncology-practice-increases-frequency-adds-clinical-reviews/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/january-25-2016/evolution/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/january-25-2016/uspstf-recommendation-confirms-value-of-screening-mammography/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/january-25-2016/asco-praises-president-s-sharp-focus-on-cancer/ 2019-03-11T17:06:43+00:00 https://ascopost.com/issues/december-25-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/december-25-2015/impressive-results-with-daratumumab-plus-lenalidomidedexamethasone-in-multiple-myeloma/ 2019-03-11T17:11:26+00:00 https://ascopost.com/issues/december-25-2015/expert-point-of-view-sagar-lonial-md/ 2019-03-11T17:11:26+00:00 https://ascopost.com/issues/december-25-2015/a-shot-to-end-cancer-hpv-vaccination/ 2019-03-11T17:11:26+00:00 https://ascopost.com/issues/december-25-2015/patients-with-incomplete-response-to-neoadjuvant-chemotherapy-benefit-from-capecitabine/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/adjuvant-denosumab-improves-disease-free-survival-in-estrogen-receptor-positive-postmenopausal-breast-cancer/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/expert-point-of-view-virginia-kaklamani-md/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/ibrutinib-bests-standard-of-care-for-elderly-patients-with-cll/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/expert-point-of-view-susan-m-o-brien-md/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/midostaurin-a-new-standard-of-care-in-acute-myeloid-leukemia/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/expert-point-of-view-mark-j-levis-md/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/ash-announces-top-trainee-abstracts-of-2015-annual-meeting/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/nivolumab-in-advanced-renal-cell-carcinoma-after-antiangiogenic-therapy/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/promising-upfront-combination-in-older-patients-with-acute-lymphoblastic-leukemia/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/expert-point-of-view-nikolai-podoltsev-md-phd/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/pediatric-regimen-achieves-higher-than-expected-survival-in-young-adults-with-acute-lymphoblastic-leukemia/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/expert-point-of-view-karen-ballen-md/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/jonathan-s-lewin-md-joins-emory-university/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/asco-and-aahpm-define-primary-palliative-care-in-oncology/ 2019-03-11T17:11:27+00:00 https://ascopost.com/issues/december-25-2015/more-earlier-and-better-goals-of-care-conversations-at-the-end-of-life-are-feasible/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/nivolumab-as-single-agent-treatment-for-braf-v600-wild-type-unresectable-or-metastatic-melanoma/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/optimizing-the-treatment-of-hiv-associated-lymphoma/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/st-jude-names-carlos-rodriguez-galindo-md-director-of-international-outreach-program/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/city-of-hope-gains-immunologist-breast-surgeon-and-geriatric-oncologist/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/partnering-therapies-for-estrogen-receptor-positive-breast-cancer-requires-close-monitoring-and-patient-communication/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/breast-cancer-survivors-may-expect-more-extensive-or-frequent-follow-up-testing-than-recommended/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/clinical-trial-system-badly-in-need-of-overhaul-say-panelists-at-friends-brookings-conference/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/friends-of-cancer-research-releases-white-paper-on-patient-reported-outcomes/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/journal-of-oncology-practice-expands-research-coverage-and-debuts-a-new-look/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/v-craig-jordan-obe-phd-dsc-fmedsci-receives-sir-james-black-award/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/surgery-for-head-and-neck-cancer-improves-survival-in-taiwan/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/expert-point-of-view-vincent-grégoire-md-phd/ 2019-03-11T17:11:28+00:00 https://ascopost.com/issues/december-25-2015/astro-launches-template-to-help-radiation-oncologists-guide-cancer-survivors-through-ongoing-care/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/phase-iii-trials-fail-to-show-noninferiority-of-surgical-outcome-for-laparoscopic-vs-open-resection-in-rectal-cancer/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/minimally-invasive-surgery-for-rectal-cancer-an-evolving-issue/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/surgical-excision-without-radiation-therapy-in-women-with-low-risk-ductal-carcinoma-in-situ/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/ductal-carcinoma-in-situ-and-relevant-endpoints-for-omission-of-standard-treatments-are-we-there-yet/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/asco-endorses-accp-guideline-on-treatment-of-small-cell-lung-cancer/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/asco-endorsement-of-accp-guideline-on-treating-sclc-moving-forward-to-better-outcomes-in-oncology/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/charles-s-abrams-md-named-president-of-ash/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/uams-becomes-home-to-cancer-imaging-archive-for-national-cancer-institute/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/necitumumab-in-metastatic-squamous-non-small-cell-lung-cancer/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/st-jude-opens-first-proton-therapy-center-for-children/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/select-abstracts-from-2015-ash-annual-meeting/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/q-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/a-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system/ 2019-03-11T17:11:29+00:00 https://ascopost.com/issues/december-25-2015/the-promise-of-immune-checkpoint-blockade-in-cancer-therapy/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/researcher-spotlight-conquering-cancer-with-dr-heske/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/asco-guides-members-through-macra-implementation-with-a-robust-set-of-new-resources/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/2015-2016-leadership-development-program-participants-examine-genomics-data-collection-team-based-cancer-care-and-meeting-experience/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/opening-doors-asco-aims-to-increase-workforce-diversity-through-physician-mentoring-program/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/updated-asco-answers-guide-to-colorectal-cancer/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/a-primary-care-doctor-s-tough-love-medicare-fix/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/acute-myeloid-leukemia-in-the-elderly-trial-data-stir-hope-for-the-transplant-option/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/2015-nci-outstanding-investigator-award-recipients/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/ash-honors-baseball-hall-of-famer-with-outstanding-service-award/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/ash-awards-inaugural-giuseppe-bigi-memorial-award-in-hematopoiesis-and-stem-cells-to-marilena-ciciarello-phd/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/are-academic-cancer-centers-a-national-treasure/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/cancer-survivor-suleika-jaouad-opens-aaciccaf-annual-meeting-susan-dentzer-moderates-discussion/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/joseph-smith-jr-md-awarded-huggins-medal/ 2019-03-11T17:11:30+00:00 https://ascopost.com/issues/december-25-2015/clinical-trials-actively-recruiting-patients-with-pancreatic-cancer/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/siog-annual-conference-explores-global-perspectives-on-geriatric-oncology-and-supportive-care/ 2020-02-17T18:51:57+00:00 https://ascopost.com/issues/december-25-2015/how-to-help-mentees-succeed/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/unitedhealthcare-signs-agreement-with-foundation-medicine-for-genomic-profiling-assay-for-non-small-cell-lung-cancer/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/the-lawless-and-uncertain-world-of-medicine/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/ash-announces-2016-scholar-award-recipients/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/perceptions-of-end-of-life-care-differ-sharply-between-african-americans-and-white-americans/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/drew-ridge-md-phd-facs-elected-to-medical-staff-president-at-fox-chase-cancer-center-temple-health/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/west-cancer-center-opens-east-campus-location/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/2016-oncology-meetings/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/beautiful-imperfections/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/the-department-of-veterans-affairs-astro-and-washington-university-combine-forces-to-drive-better-care-for-veterans-with-cancer/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/new-medical-director-of-supportive-care-services-at-cedars-sinai/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/hoping-for-a-cure/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/closure/ 2019-03-11T17:11:31+00:00 https://ascopost.com/issues/december-25-2015/nih-awards-city-of-hope-48-million-to-study-environment-and-breast-cancer/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/decline-in-psa-testing-and-incidence-of-early-prostate-cancer-coincide-with-2012-recommendation-against-psa-screening/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/expect-questions-about-prostate-cancer-screening-and-active-surveillance/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/better-quality-of-life-with-melphalan-and-prednisone-used-with-lenalidomide-than-with-thalidomide/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/women-coinfected-with-human-papillomavirus-had-reduced-risk-for-invasive-cervical-cancer/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/substantial-number-of-patients-requiring-palliative-radiotherapy-for-stage-iv-nsclc-are-overtreated/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/breast-care-services-at-henry-ford-health-system-gains-new-director-three-new-surgeons/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/aacr-recognizes-anne-lise-boerresen-dale-dsc-with-2015-distinguished-lectureship-in-breast-cancer-research/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/mohamed-bentires-alj-pharmd-phd-honored-with-2015-aacr-outstanding-investigator-award-for-breast-cancer-research/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/mixing-metaphors-to-change-the-language-of-cancer/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-25-2015/fda-oncology-new-drugnew-indication-approvals-for-2015-as-of-december-20-2015/ 2019-03-11T17:11:32+00:00 https://ascopost.com/issues/december-10-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/december-10-2015/november-yields-record-number-of-fda-approvals-for-new-oncology-drugs-and-drug-indications/ 2019-03-11T17:12:23+00:00 https://ascopost.com/issues/december-10-2015/filial-gaze-at-our-noble-profession/ 2019-03-11T17:12:23+00:00 https://ascopost.com/issues/december-10-2015/asco-guideline-on-the-use-of-biomarkers-in-treatment-decisions-in-metastatic-breast-cancer-shedding-light-on-an-often-mysterious-art/ 2019-03-11T17:12:23+00:00 https://ascopost.com/issues/december-10-2015/combining-molecular-driven-approach-and-immunotherapy-to-improve-treatment-for-patients-with-inflammatory-breast-cancer/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/olanzapine-significantly-reduces-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/anamorelin-improves-cachexia-symptoms-in-patients-with-advanced-non-small-cell-lung-cancer/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/expert-point-of-view-charles-loprinzi-md/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/cancer-care-through-nonpharmacologic-symptom-management/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/u-m-cancer-center-names-bhramar-mukherjee-phd-associate-director-for-population-science-research/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/tumor-profiling-of-breast-tumors-in-older-patients-reveals-differences-from-those-of-younger-patients/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/expert-point-of-view-charles-e-geyer-jr-md-facp/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/neoadjuvant-chemotherapy-appears-to-have-no-effect-on-short-term-outcomes-in-breast-cancer-surgery/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/expert-point-of-view-charles-e-geyer-jr-md-facp-2/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/ovarian-cancer-current-treatment-and-patient-management/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/2015-review-of-newly-approved-oncologic-therapies/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/fda-approves-elotuzumab-in-combination-with-lenalidomide-and-dexamethasone-for-multiple-myeloma/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/mind-body-therapies-were-the-focus-at-the-12th-international-conference-of-the-society-for-integrative-oncology/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/the-best-of-sio/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/clinical-trial-design-in-older-patients/ 2020-02-17T18:53:24+00:00 https://ascopost.com/issues/december-10-2015/braf-inhibition-successful-in-relapsedrefractory-hairy-cell-leukemia/ 2019-03-11T17:12:24+00:00 https://ascopost.com/issues/december-10-2015/nivolumab-receives-two-fda-approvals-in-november/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/molecularly-targeted-therapy-brings-new-hope-to-patients-with-relapsedrefractory-hairy-cell-leukemia/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/improved-progression-free-survival-with-trabectedin-vs-dacarbazine-after-chemotherapy-failure-in-liposarcoma-or-leiomyosarcoma/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/trabectedin-in-liposarcomaleiomyosarcoma-the-drug-is-approved-now-the-real-drug-development-begins/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/cobimetinib-in-braf-mutant-unresectable-or-metastatic-melanoma-in-combination-with-vemurafenib/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/nccn-names-robert-c-young-md-interim-vice-president-of-oncology-research-program/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/fda-approves-necitumumab-combination-for-metastatic-squamous-nsclc/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/amy-k-hara-md-named-chair-of-diagnostic-radiology-at-mayo-arizona/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/convergence-of-breast-cancer-incidence-but-continued-divergence-of-mortality-in-black-women-and-white-women/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/reducing-racial-disparities-in-breast-cancer-incidence-and-mortality-trends-to-improve-outcomes/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/closing-the-racial-survival-disparity-gap-in-breast-cancer-models-for-change-from-chicago-new-york-and-beyond/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/nih-awards-city-of-hope-22-million-grant-for-investigation-of-chronic-graft-vs-host-disease/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/understanding-health-care-disparities-among-lesbian-gay-bisexual-and-transgender-patients-to-ensure-more-effective-cancer-care/ 2019-03-11T17:12:25+00:00 https://ascopost.com/issues/december-10-2015/evidence-based-practice-needed-in-end-of-life-care/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/nivolumab-improves-overall-survival-vs-docetaxel-in-advanced-previously-treated-squamous-cell-nsclc/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/asco-clinical-practice-guideline-use-of-biomarkers-to-guide-systemic-therapy-for-women-with-metastatic-breast-cancer/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/regional-nodal-irradiation-in-early-breast-cancer-yields-significant-disease-free-survival-benefit-in-two-trials/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/nodal-irradiation-in-node-positive-breast-cancer-it-is-not-time-to-change-practice/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/nccn-foundation-appoints-three-new-representatives-to-board-of-directors/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/cancer-researchers-and-clinicians-elected-as-2015-aaas-fellows/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/making-a-difference-for-patients-an-interview-with-dr-daniel-f-hayes-2015-2016-president-elect/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/now-available-holiday-cards-from-the-conquer-cancer-foundation/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/this-december-triple-your-impact/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/barriers-to-oncology-careers-focused-on-cancer-prevention-could-be-addressed-through-education-research-opportunities-advocacy/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/earn-moc-points-with-asco/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/resource-to-help-patients-manage-cancer-costs/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/md-anderson-receives-222-million-in-cprit-research-funding/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/gut-bacteria-may-facilitate-efficacy-of-anti-pd-l1-agents/ 2019-03-11T17:12:26+00:00 https://ascopost.com/issues/december-10-2015/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-argentina/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/cancer-care-in-low-resource-areas-some-improvements-over-the-years-but-serious-problems-remain/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/uc-san-diego-robotic-surgeon-christopher-j-kane-md-named-joseph-d-schmidt-md-presidential-chair-in-urology/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/the-complex-interactions-of-treatment-costs-clinical-outcomes-and-patient-expectations/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/dario-marchetti-phd-named-director-of-the-center-for-biomarkers/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/montefiore-and-einstein-receive-39-million-nci-calabresi-grant/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/philip-w-kantoff-md-named-chairman-of-the-department-of-medicine-at-memorial-sloan-kettering-cancer-center/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/practicing-the-humanistic-and-holistic-approach-to-end-of-life-care/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/foot-care-in-oncology-the-cancer-patient-from-ankle-to-toe/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/a-blueprint-for-drugdiagnostic-development-expansion-and-use-of-curated-genetic-databases/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/city-of-hope-provost-steven-t-rosen-md-honored-by-israel-cancer-research-fund/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/alexandra-m-levine-md-macp-honored-by-la-county-medical-association/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/a-swiss-psychotherapist-gives-her-perspective-on-optimal-palliative-care/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/lung-cancer-hope-from-science/ 2019-03-11T17:12:27+00:00 https://ascopost.com/issues/december-10-2015/valerie-w-rusch-md-facs-elected-chair-of-acs-board-of-regents/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/osimertinib-for-metastatic-egfr-t790m-mutant-non-small-cell-lung-cancer-after-egfr-inhibitor-therapy/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/parotid-tumor-excision-albumen-print-paris-february-1872/ 2020-09-24T01:37:53+00:00 https://ascopost.com/issues/december-10-2015/daratumumab-in-previously-treated-multiple-myeloma/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/ixazomib-in-previously-treated-multiple-myeloma/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/2015-oncology-meetings/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/the-highs-and-lows-of-a-transplant-surgeon/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/racial-issues-on-the-road-to-medicine/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/yet-another-reason-why-dogs-are-our-best-friends/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/you-ve-lived-a-good-life/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/cancer-survival-improves-in-europe-with-wide-regional-variations/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/expert-point-of-view-martine-piccart-md-phd/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/selective-internal-radiation-therapy-impacts-liver-metastases-in-colorectal-cancer/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/chemoradiotherapy-for-liver-metastases/ 2019-03-11T17:12:28+00:00 https://ascopost.com/issues/december-10-2015/expert-point-of-view-ricky-a-sharma-ma-mb-bchir-phd/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/integrating-spirituality-into-palliative-care-services/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/consensus-conference-definition-of-spirituality/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/elizabeth-blackburn-phd-named-president-of-the-salk-institute/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/the-sixth-edition-of-the-essential-breast-cancer-book/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/mayo-clinic-names-bobbie-gostout-md-vice-president/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/starting-over/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/shift-in-treatment-patterns-of-ductal-carcinoma-in-situ/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/increased-risk-of-second-nonmelanoma-skin-cancer-among-patients-receiving-immunosuppressive-therapy/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/anemia-prevalent-and-independently-associated-with-functional-disability-in-older-patients-with-cancer/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/one-long-shift-with-a-nurse-on-a-cancer-ward/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/nationally-regarded-oncology-nurse-practitioner-mary-pazdur-rn-msn-remembered-by-friends-and-colleagues/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/december-10-2015/aacc-elects-michael-j-bennett-phd-2017-president-names-new-treasurer-and-board-members/ 2019-03-11T17:12:29+00:00 https://ascopost.com/issues/november-25-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/november-25-2015/chronic-myelogenous-leukemia-what-drug-for-which-patient/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/does-low-dose-radiation-cause-leukemia/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/5-year-results-of-gec-estro-trial-of-accelerated-partial-breast-irradiation-vs-whole-breast-irradiation-is-there-any-impact/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/neratinib-improves-disease-free-survival-in-early-stage-her2-positive-breast-cancer/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/expert-point-of-view-clifford-hudis-md-shanu-modi-md-and-richard-gelber-phd/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/apf530-superior-to-ondansetron-in-preventing-chemotherapy-induced-nausea-or-vomiting/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/expert-point-of-view-clifford-hudis-md/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/genomics-now-driving-treatment-of-waldenstroem-s-macroglobulinemia/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/antoni-ribas-md-phd-receives-nci-outstanding-investigator-award/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/changing-the-outlook-for-chronic-lymphocytic-leukemia/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/third-annual-jadpro-live-at-apsho-conference-attracts-over-700-advanced-practitioners-in-hematology-oncology/ 2019-03-11T17:13:17+00:00 https://ascopost.com/issues/november-25-2015/genomic-test-identifies-patients-with-prostate-cancer-in-need-of-intensified-salvage-therapy/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/preston-robert-tisch-brain-tumor-center-at-duke-receives-7-million-outstanding-investigator-award/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/hypofractionated-radiotherapy-makes-inroads-as-primary-treatment-of-prostate-cancer/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/expert-point-of-view-david-beyer-md/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/study-lowers-the-age-bar-for-radiation-in-children-with-ependymoma/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/expert-point-of-view-anita-mahajan-md/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/kara-kelly-md-will-head-joint-pediatric-hematologyoncology-program-at-roswell-park-and-three-other-buffalo-institutions/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/howard-hochster-md-named-president-elect-of-isgio/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/evidence-mounts-for-less-intense-chemoradiation-therapy-for-low-risk-oropharyngeal-cancer/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/expert-point-of-view-paul-m-busse-md-phd/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/quick-takes-from-ecc-2015-include-new-data-in-melanoma-prostate-and-breast-cancers-and-renal-cell-carcinoma/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/more-data-from-ecc-2015/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/lenvatinib-in-refractory-thyroid-cancer-survival-benefit-or-not/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/expert-point-of-view-vincent-grégoire-md-phd/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/actionable-targets-identified-in-brain-metastases/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/expert-point-of-view-peter-naredi-md-and-michael-brada-md/ 2019-03-11T17:13:18+00:00 https://ascopost.com/issues/november-25-2015/ash-announces-stephen-s-chung-md-as-inaugural-jake-wetchler-foundation-ash-scholar-for-pediatric-innovation-recipient/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/centers-for-medicare-medicaid-services-releases-2016-medicare-physician-fee-schedule-impact-on-radiation-oncology/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/oncologists-encouraged-to-learn-more-about-lesser-known-heritable-gastrointestinal-cancers/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/the-state-of-progress-in-hematologic-malignancies/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/alfred-goldberg-phd-and-paul-richardson-md-to-present-2015-ash-ernest-beutler-lecture/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/ash-honors-nancy-speck-phd-and-karl-welte-md-with-2015-henry-m-stratton-medal/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/ipilimumab-in-adjuvant-treatment-of-cutaneous-melanoma-with-nodal-involvement/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/talimogene-laherparepvec-for-treatment-of-unresectable-cutaneous-subcutaneous-and-nodal-melanoma-lesions/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/accelerated-partial-breast-vs-whole-breast-irradiation-after-surgery-for-early-breast-cancer/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/city-of-hope-announces-new-appointments/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/the-bridge-project-receives-20-million-gift-from-the-commonwealth-foundation-for-cancer-research/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/tapur-asco-s-first-clinical-trial-addresses-critical-gaps-in-understanding-of-and-access-to-targeted-therapies/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/applications-open-for-asco-s-new-policy-fellowship-program/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/asco-university-offers-resources-for-palliative-and-team-based-care/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/former-conquer-cancer-foundation-grant-recipients-present-research-advances-and-share-impact-of-ccf-grants/ 2019-03-11T17:13:19+00:00 https://ascopost.com/issues/november-25-2015/new-asco-answers-guide-to-caregiving/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/support-the-conquer-cancer-foundation-on-giving-tuesday/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/how-qopi-is-improving-oncology-care/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/acs-guideline-update-on-breast-cancer-screening-for-women-at-average-risk/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/getting-the-content-and-the-message-right-in-breast-cancer-screening-guidelines/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/acs-breast-cancer-screening-guidelines-balancing-the-benefits-and-harms-of-mammography/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/asco-clinical-practice-guideline-update-systemic-therapy-for-stage-iv-nsclc/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/updated-guidelines-for-treating-stage-iv-nsclc-trying-to-keep-up/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/changing-landscape-in-the-treatment-of-metastatic-renal-cell-carcinoma-findings-with-nivolumab-and-cabozantinib/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/a-shrink-tells-the-inside-story-of-psychiatry/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/graviola/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/checkmate-057-nivolumab-improves-survival-vs-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/the-x-ray-era-1901-1915/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/american-board-of-internal-medicine-names-richard-g-battaglia-md-facp-chief-medical-officer/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/mediterranean-diet-supplemented-with-extra-virgin-olive-oil-reduces-risk-for-invasive-breast-cancer/ 2019-03-11T17:13:20+00:00 https://ascopost.com/issues/november-25-2015/diet-and-cancer-how-will-we-make-progress/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/the-role-of-botulinum-toxin-in-head-and-neck-cancer/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/trabectedin-in-unresectable-or-metastatic-liposarcoma-or-leiomyosarcoma/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/asco-launches-tapur-to-assess-the-off-label-use-of-targeted-therapies-for-patients-with-advanced-cancers/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/pilot-study-research-team-used-focused-ultrasound-to-open-blood-brain-barrier-in-patient-with-malignant-brain-tumor/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/the-importance-of-supporting-the-role-of-women-leaders-in-oncology/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/clinical-trials-actively-recruiting-patients-with-hodgkin-lymphoma-non-hodgkin-lymphoma-and-myeloma/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/engaging-clinicians-in-the-collection-of-cancer-registry-data-to-improve-clinical-research/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/cancer-cured-my-life/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/a-selfless-act/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/fda-approves-cobimetinib-in-combination-with-vemurafenib-for-metastatic-melanoma/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/daratumumab-approved-in-multiple-myeloma/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/barbara-furie-phd-and-bruce-furie-md-to-present-2015-ash-e-donnall-thomas-lecture/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/car-t-cell-immunotherapy-saved-my-life/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/ash-selects-medical-students-and-residents-for-honors-award/ 2019-03-11T17:13:21+00:00 https://ascopost.com/issues/november-25-2015/2015-oncology-meetings/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/stepping-back-in-medical-history-a-groundbreaking-surgeon-s-battle-with-the-establishment/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/ash-recognizes-curt-civin-md-and-craig-kitchens-md-macp-for-outstanding-mentorship/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/updated-acs-breast-cancer-screening-guideline-recognizes-greater-role-for-individual-s-values-and-preferences/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/expect-questions-about-updated-breast-cancer-screening-guidelines/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/irinotecan-liposome-injection-plus-fluorouracilleucovorin-to-treat-patients-with-metastatic-pancreatic-cancer/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/aggressive-end-of-life-care-more-frequent-among-black-men-with-end-stage-prostate-cancer/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/falls-experienced-by-older-patients-are-often-not-recorded-or-responded-to-by-oncology-providers/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/increased-lifetime-risk-of-developing-cancer-in-patients-with-hiv/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/2015-recipients-of-the-susan-g-komen-brinker-awards-for-scientific-distinction-to-present-lectures-at-san-antonio-breast-cancer-symposium/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-25-2015/william-dameshek-md-helped-take-hematology-from-a-minor-medical-discipline-to-a-major-scientific-field/ 2019-03-11T17:13:22+00:00 https://ascopost.com/issues/november-10-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/november-10-2015/intensity-modulated-radiotherapy-gains-ground-for-treatment-of-stage-iii-non-small-cell-lung-cancer/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-brian-d-kavanagh-md-mph-fastro/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/is-health-care-in-the-united-states-a-basic-human-right-or-an-entitlement/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/debate-over-physician-assisted-suicide-continues-state-by-state/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/dexamethasone-to-preempt-radiation-induced-pain/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-brian-d-kavanagh-md-mph-fastro-and-zain-a-husain-md/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/cooperative-group-study-finds-radiation-may-benefit-patients-with-atypical-meningiomas/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-anita-mahajan-md/ 2019-03-11T17:14:14+00:00 https://ascopost.com/issues/november-10-2015/fda-approves-trabectedin-for-advanced-liposarcoma-and-leiomyosarcoma/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/fda-approves-liposomal-irinotecan-for-advanced-pancreatic-cancer/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/meta-analysis-evaluates-benefit-of-docetaxel-and-bisphosphonates-in-hormone-sensitive-prostate-cancer/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-ronald-de-wit-md-phd/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/update-on-clinical-trials-in-metastatic-prostate-cancer/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-bertrand-tombal-md-phd/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/survival-benefit-in-metastatic-melanoma-grows-larger-in-combi-v-update/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-christian-blank-md/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/pd-1pd-l1-inhibitors-show-promise-in-additional-tumor-types/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/fda-approves-ipilimumab-in-adjuvant-treatment-of-stage-iii-melanoma/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/primary-vs-metastatic-breast-cancer-the-genetic-landscape-varies/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-fabrice-andré-md-phd-and-peter-naredi-md-phd/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/combined-egfr-and-vegf-inhibition-ameliorates-the-impact-of-the-egfr-t790m-mutation-in-nsclc/ 2019-03-11T17:14:15+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-martin-reck-md-phd/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/sandra-l-wong-md-ms-named-chair-of-surgery-at-geisel-school-of-medicine-and-dartmouth-hitchcock/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/antibody-drug-conjugate-makes-strong-showing-in-small-cell-lung-cancer/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-martin-reck-md-phd-1/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/functional-subtyping-with-80-gene-assay-identifies-distinct-triple-positive-subtypes-in-breast-cancer-patients/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/expert-point-of-view-william-j-gradishar-md-fasco/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/beth-israel-deaconess-medical-center-names-manuel-hidalgo-md-phd-clinical-director-of-the-cancer-center-and-chief-of-hematology-oncology/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/nyu-langone-appoints-alec-kimmelman-md-phd-as-chair-of-radiation-oncology/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/national-coalition-for-cancer-survivorship-honors-richard-pazdur-md-and-ellen-goodman/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/ovarian-cancer-trialists-forming-work-group-to-standardize-definition-of-pathologic-complete-response/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/study-finds-quality-of-physician-recommendation-to-parents-key-to-encouragediscourage-hpv-vaccination-of-adolescents/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/nccn-unveils-graphic-evidence-blocks-to-guide-decision-making/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/end-of-life-clinical-decisions-still-need-conversations-about-improving-care/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/the-independent-payment-advisory-board-in-a-nutshell/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/the-breast-cancer-research-foundation-names-marc-hurlbert-phd-as-chief-mission-officer/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/nancy-a-speck-phd-named-chair-cell-and-developmental-biology-perelman-school-of-medicineuniversity-of-pennsylvania/ 2019-03-11T17:14:16+00:00 https://ascopost.com/issues/november-10-2015/victoria-seewaldt-md-joins-city-of-hope/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/maciej-lesniak-md-named-chair-of-neurological-surgery-at-northwestern/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/asco-clinical-practice-guideline-update-recommendations-for-the-use-of-white-blood-cell-growth-factors/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/asco-recommendations-for-use-of-white-blood-cell-growth-factors-what-remains-the-same-and-what-has-been-modified/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/ash-elects-new-leadership-to-its-executive-committee/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/improved-overall-survival-with-neoadjuvant-plus-adjuvant-bevacizumab-in-early-her2-negative-breast-cancer/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/survival-and-bevacizumab-in-early-breast-cancer-time-to-reconsider/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/ucla-and-va-launch-program-to-enhance-cancer-care-for-veterans/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/why-melanoma-rates-are-increasing-in-adolescents-and-young-adults-especially-among-females/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/lewis-cantley-phd-receives-2015-aaci-distinguished-scientist-award/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/geriatric-oncology-in-europe-a-commitment-to-improving-cancer-care-for-older-patients/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/clinical-trials-actively-recruiting-patients-with-lung-cancer/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/telotristat-etiprate-added-to-standard-therapy-for-carcinoid-syndrome-shows-clinical-benefit-in-patients-with-metastatic-neuroendocrine-tumors/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/martine-extermann-md-phd-recognized-for-her-work-in-geriatric-oncology-at-assembly-in-basel-switzerland/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/peter-a-kanetsky-phd-mph-named-next-president-of-aspo/ 2019-03-11T17:14:17+00:00 https://ascopost.com/issues/november-10-2015/lungevity-foundation-and-celgene-collaborate-to-create-resource-for-lung-cancer-caregivers/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-algeria/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/asco-calls-for-comprehensive-payment-reform-to-address-issue-of-site-neutrality/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/inotuzumab-ozogamicin-receives-fda-breakthrough-therapy-designation-for-acute-lymphoblastic-leukemia/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/management-of-aromatase-inhibitor-induced-musculoskeletal-symptoms-a-physiatric-approach/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/nivolumab-in-metastatic-nsclc-after-platinum-therapy/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/the-future-of-asco-president-elect-candidates-share-their-vision/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/tell-your-patients-about-asco-s-award-winning-cancernet-mobile-app/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/a-message-from-w-charles-penley-md-fasco/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/new-study-indicates-key-differences-between-trial-enrollees-and-patients-receiving-treatments/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/congress-passes-continuing-resolution-research-funding-dips-slightly/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/asco-announces-candidates-for-2016-election/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/be-a-voice-in-the-campaign-to-conquer-cancer/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/a-pandemic-s-story-of-tragedy-and-success/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/a-chemist-exposes-dangerous-chemicals/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/nci-division-of-cancer-control-and-population-sciences-names-kathy-j-helzlsouer-md-mhs-associate-director/ 2019-03-11T17:14:18+00:00 https://ascopost.com/issues/november-10-2015/2015-oncology-meetings/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/q-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/a-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/a-cancer-diagnosis-can-lead-to-significant-loss-of-working-hours-income/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/nci-names-thomas-kensler-phd-outstanding-investigator/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/equanimity/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/frances-giles-mb-md-frcpi-frcpath-appointed-chief-of-hematologyoncology-at-northwestern/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/shadowed-by-cancer/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/asco-endorses-astro-guideline-on-postoperative-radiation-therapy-for-endometrial-cancer/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/asco-endorsed-astro-guidelines-searching-for-consensus-on-radiotherapy-for-endometrial-cancer/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/tamoxifen-use-and-access-to-fertility-preservation-options-among-premenopausal-women-with-breast-cancer/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/multiple-copies-of-tp53-tumor-suppressor-gene-potentially-related-to-lower-than-expected-cancer-rate-in-elephants/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/national-academy-of-medicine-elects-new-members/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/ash-honors-aaron-j-marcus-md-posthumously-with-award-for-lifetime-achievement-in-hematology/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/november-10-2015/fda-approves-first-oncolytic-viral-therapy-in-the-united-states/ 2019-03-11T17:14:19+00:00 https://ascopost.com/issues/october-25-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/october-25-2015/nivolumab-produces-survival-benefit-in-advanced-renal-cell-carcinoma/ 2019-03-11T17:15:15+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-cora-n-sternberg-md-facp-1/ 2019-03-11T17:15:15+00:00 https://ascopost.com/issues/october-25-2015/discussing-financial-toxicity-with-patients-who-have-cancer/ 2019-03-11T17:15:15+00:00 https://ascopost.com/issues/october-25-2015/ovarian-suppression-during-chemotherapy-preserves-fertility-in-young-women-with-breast-cancer/ 2019-03-11T17:15:15+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-frederic-amant-md-phd/ 2019-03-11T17:15:15+00:00 https://ascopost.com/issues/october-25-2015/phase-iii-meteor-trial-finds-cabozantinib-improves-progression-free-survival-vs-everolimus-in-advanced-renal-cell-carcinoma/ 2019-03-11T17:15:15+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-cora-n-sternberg-md-facp/ 2019-03-11T17:15:15+00:00 https://ascopost.com/issues/october-25-2015/atezolizumab-makes-inroads-in-non-small-cell-lung-cancer/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-luis-paz-ares-md/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/chemotherapyradiotherapy-safe-in-second-and-third-trimesters-of-pregnancy/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-michael-f-greene-md-and-dan-l-longo-md/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/treatment-options-expanding-for-neuroendocrine-tumors/ 2019-07-11T20:12:38+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-enrique-grande-md/ 2019-07-11T20:19:19+00:00 https://ascopost.com/issues/october-25-2015/tailorx-chemotherapy-not-necessary-for-women-with-a-low-recurrence-score/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-clifford-hudis-md/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/aromatase-inhibitors-may-decrease-risk-of-contralateral-breast-cancer-in-brca-mutation-positive-patients/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/expert-point-of-view-william-j-gradishar-md/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/mri-improves-breast-cancer-detection-in-women-at-average-risk/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/smoking-cessation-reduces-mortality-in-lung-cancer-screening-population/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/delays-in-drug-approval-are-deadly-highlighting-the-need-for-improved-regulatory-efficiency/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/important-research-in-the-palliative-care-of-patients-with-cancer/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/philip-a-salem-md-awarded-the-foedus-supreme-medal-of-excellence/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/journal-of-clinical-oncology-s-fall-special-series-journal-of-global-oncology-s-inaugural-issue/ 2019-03-11T17:15:16+00:00 https://ascopost.com/issues/october-25-2015/community-research-forum-holds-2015-annual-meeting-explores-developments-and-strategies-in-conducting-clinical-research/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/conquer-cancer-foundation-grants-and-awards-funding-opportunities-now-available/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/new-asco-answers-fact-sheet-for-patients-on-blood-test-results/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/be-a-voice-in-the-campaign-to-conquer-cancer/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/alternative-therapies-knowledge-is-power-but-consider-the-source/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/many-patients-do-not-accurately-recall-important-colonoscopy-details-as-time-lapses/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/inconsistent-federal-regulations-undercut-us-research-productivity-national-academies-report-finds/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/endocrine-therapy-alone-linked-to-low-risk-of-breast-cancer-recurrence-in-women-with-a-low-risk-score-on-21-gene-assay/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/nivolumab-and-cabozantinib-improve-outcomes-vs-everolimus-in-previously-treated-advanced-renal-cell-carcinoma/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/unc-chapel-hill-researchers-awarded-113-million-for-four-cancer-nanotechnology-projects/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/upci-wins-109-million-grant-renewal-for-head-and-neck-cancer-research/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/ucsf-receives-5-million-nci-grant-to-integrate-data-from-cancer-research-models/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/children-s-healthcare-emory-name-douglas-graham-md-phd-director-of-aflac-cancer-and-blood-disorders-center/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/cancercare-welcomes-christine-verini-rph-as-chief-business-development-officer/ 2019-03-11T17:15:17+00:00 https://ascopost.com/issues/october-25-2015/maternal-cancer-during-pregnancy-does-not-appear-to-affect-cognitive-or-general-development-in-early-childhood/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/maternal-malignancy-treated-during-pregnancy-125-mothers/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/nivolumab-in-combination-with-ipilimumab-in-braf-v600-wild-type-unresectable-or-metastatic-melanoma/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/three-young-investigators-named-winners-of-2015-paul-marks-prize-for-cancer-research/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/fda-approves-use-of-nivolumab-in-metastatic-nonsquamous-lung-cancer/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/fda-grants-orphan-drug-designation-to-bivalent-vaccine-for-neuroblastoma/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/fda-grants-accelerated-approval-to-pembrolizumab-for-advanced-nsclc/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/pembrolizumab-in-previously-treated-pd-l1-positive-metastatic-nsclc/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/addition-of-necitumumab-to-first-line-gemcitabinecisplatin-improves-overall-survival-in-stage-iv-squamous-nsclc/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/fda-approves-expanded-indication-for-medical-device-to-treat-newly-diagnosed-glioblastoma-multiforme/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/anti-egfr-therapy-in-squamous-cell-lung-carcinoma-swimming-with-or-against-the-tide/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/addition-of-bevacizumab-to-standard-chemotherapy-improves-overall-survival-only-in-high-risk-ovarian-cancer/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/bevacizumab-in-ovarian-cancer-results-of-icon7/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/alexander-eggermont-md-phd-to-lead-gustave-roussy-for-5-more-years/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/california-agency-invests-20-million-in-clinical-trial-for-glioblastoma-vaccine/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/cancer-researchers-receive-the-nobel-prize-in-chemistry-2015/ 2019-03-11T17:15:18+00:00 https://ascopost.com/issues/october-25-2015/michael-reney-mba-named-cfo-at-dana-farber-cancer-institute/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/trifluridinetipiracil-in-previously-treated-metastatic-colorectal-cancer/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/glimpses-of-the-human-condition-through-lively-medically-themed-short-stories/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/pain-still-undertreated-and-misunderstood/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/a-neurologist-s-life-oliver-sacks-md/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/confessions-of-a-neurosurgeon/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/early-research-of-david-g-nathan-md-ushered-in-the-field-of-pediatric-hematology/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/12-million-multi-institutional-spore-grant-to-focus-on-mutations-in-the-nf1-gene/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/2015-oncology-meetings/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/q-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/a-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/a-snapshot-of-early-immunotherapy/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/clinical-trials-actively-recruiting-patients-with-breast-cancer/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/american-cancer-society-awards-2015-medals-of-honor/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/the-race-of-my-life/ 2019-03-11T17:15:19+00:00 https://ascopost.com/issues/october-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/important-caveats-to-consider-concerning-low-dose-daily-aspirin-for-the-primary-prevention-of-colorectal-cancer/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/expect-questions-from-patients-about-daily-aspirin-to-prevent-colorectal-cancer/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/uc-davis-granted-155-million-to-build-world-s-first-total-body-pet-scanner/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/patients-whose-treatment-included-bevacizumab-were-more-likely-to-experience-toxicity-but-less-likely-to-be-hospitalized/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/patient-characteristics-differ-in-some-clinical-trials-from-real-world-population/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/what-do-you-say-when-she-is-no-longer-living-with-cancer/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/mayo-clinic-receives-federal-grant-to-fund-clinical-test-of-triple-negative-breast-cancer-vaccine/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/noted-integrative-oncology-specialist-mitchell-l-gaynor-md-dies-at-59/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/joann-b-sweasy-phd-named-associate-director-for-basic-sciences-at-yale-cancer-center/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/constantinos-g-hadjipanayis-md-phd-joins-mount-sinai-beth-israel-tisch-cancer-institute/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-25-2015/edward-m-schaeffer-md-phd-joins-the-lurie-cancer-center/ 2019-03-11T17:15:20+00:00 https://ascopost.com/issues/october-10-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/october-10-2015/egfr-gene-copy-number-as-biomarker-for-antibody-treatment-in-squamous-cell-nsclc/ 2019-03-11T17:16:01+00:00 https://ascopost.com/issues/october-10-2015/expert-point-of-view-robert-pirker-md/ 2019-03-11T17:16:01+00:00 https://ascopost.com/issues/october-10-2015/nccn-turns-20-value-based-care-has-arrived/ 2019-03-11T17:16:01+00:00 https://ascopost.com/issues/october-10-2015/ductal-carcinoma-in-situ-where-we-have-been-and-where-we-can-be/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/azd9291-updates-encouraging-for-treatment-resistant-nsclc/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/expert-point-of-view-martin-reck-md-phd/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/lung-cancer-rates-doubling-among-nonsmokers/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/nivolumab-in-lung-cancer-supported-by-updated-trial-data/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/expert-point-of-view-solange-peters-md-phd/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/patient-and-survivor-care-studies-yield-useful-results-to-improve-quality-of-life/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/clinical-implications-of-survivorship-study-findings/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/mmrf-announces-enrollment-completion-of-commpass-studysm/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/fda-approves-new-oral-medication-for-the-treatment-of-refractory-metastatic-colorectal-cancer/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/better-definitions-and-biomarkers-needed-to-reduce-cancer-overdiagnosis/ 2019-03-11T17:16:02+00:00 https://ascopost.com/issues/october-10-2015/bridging-the-gap-between-pediatric-and-adult-oncology-care/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/teen-cancer-america-partners-with-cancer-centers/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/ebctcg-meta-analyses-show-improved-outcomes-with-aromatase-inhibitors-vs-tamoxifen-and-a-potential-benefit-of-adjuvant-bisphosphonates-limited-to-postmenopausal-women/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/adjuvant-treatment-of-early-stage-breast-cancer-meta-analyses-provide-more-clarity/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/male-breast-cancer-an-understudied-disease-and-clinical-challenge/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/adding-docetaxel-to-androgen-deprivation-therapy-prolongs-overall-survival-in-metastatic-prostate-cancer/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/docetaxel-chemohormonal-therapy-in-metastatic-hormone-sensitive-prostate-cancer/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/asco-statement-improving-the-evidence-base-for-treating-older-adults-with-cancer/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/older-patients-with-cancer-a-growing-population-in-need-of-evidence-based-care/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/bart-barolgie-md-joins-tisch-cancer-institute-at-mount-sinai/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/increased-risk-of-death-from-breast-cancer-for-women-with-ductal-carcinoma-in-situ-vs-general-population/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/focus-on-geriatric-oncology-asco-prepares-for-an-aging-nation/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/journal-of-oncology-practice-to-expand-in-2016-new-section-dedicated-to-practical-authoritative-clinical-reviews/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/updated-resource-for-your-patients-advanced-cancer-care-planning-booklet/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/asco-acs-astro-study-finds-increased-travel-distance-affects-whether-patients-receive-adjuvant-chemotherapy/ 2019-03-11T17:16:03+00:00 https://ascopost.com/issues/october-10-2015/be-a-voice-in-the-campaign-to-conquer-cancer/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/asco-asks-cms-to-revisit-its-payment-policy-to-support-optimal-cancer-care/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/pembrolizumab-increases-progression-free-survival-in-ipilimumab-refractory-advanced-melanoma/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/anti-pd-1-superior-to-chemotherapy-in-the-keynote-002-trial/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/cancer-increasing-awareness-and-addressing-this-lethal-disease-on-the-global-stage/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/the-need-for-a-multidisciplinary-approach-to-combating-cancer-related-pain/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/improving-management-of-cancer-related-pain/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/modern-surgical-scene-circa-1945/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/a-cancer-care-model-for-rural-areas/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/children-s-hospital-of-philadelphia-is-a-founding-member-of-the-new-pediatric-preclinical-testing-consortium/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/nih-awards-nearly-35-million-to-research-natural-products/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/2015-oncology-meetings/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/recent-johns-hopkins-oncology-faculty-appointments/ 2019-03-11T17:16:04+00:00 https://ascopost.com/issues/october-10-2015/todd-demmy-md-facs-fccp-joins-rutgers-cancer-institute-of-new-jersey/ 2019-03-11T17:16:05+00:00 https://ascopost.com/issues/october-10-2015/varied-reactions-to-study-finding-that-preventing-ipsilateral-recurrence-did-not-prevent-death-from-breast-cancer/ 2019-03-11T17:16:05+00:00 https://ascopost.com/issues/october-10-2015/expect-questions-about-treatment-for-ductal-carcinoma-in-situ/ 2019-03-11T17:16:05+00:00 https://ascopost.com/issues/october-10-2015/lisa-kachnic-md-named-chair-of-radiation-oncology-at-vanderbilt/ 2019-03-11T17:16:05+00:00 https://ascopost.com/issues/october-10-2015/melanoma-research-alliance-appoints-president-and-ceo-elect/ 2019-03-11T17:16:05+00:00 https://ascopost.com/issues/october-10-2015/measuring-global-health-issues-seven-billion-times/ 2019-03-11T17:16:05+00:00 https://ascopost.com/issues/october-10-2015/extraordinary-medical-advances-and-the-conundrum-they-pose/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/a-practical-guide-to-surviving-breast-cancer-and-its-treatments/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/scotty-s-gift/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/diagnosis-of-additional-small-cancers-suggests-screening-mammography-leads-to-overdiagnosis/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/decreased-mortality-in-men-with-unfavorable-risk-prostate-cancer-and-moderate-or-severe-comorbidities-treated-with-radiotherapy-alone/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/sidney-mirvish-phd-carcinogenesis-researcher-dies-at-86/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/thomas-a-stamey-md-noted-urologist-and-prostate-cancer-expert-dies-at-87/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/cancer-incidence-and-mortality-rates-worldwide/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/october-10-2015/over-three-quarters-of-people-with-cancer-worldwide-have-no-access-to-safe-surgery/ 2019-03-11T17:16:06+00:00 https://ascopost.com/issues/september-25-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/september-25-2015/first-line-nivolumabipilimumab-combination-in-non-small-cell-lung-cancer-shown-to-be-tolerable/ 2019-03-11T17:20:25+00:00 https://ascopost.com/issues/september-25-2015/expert-point-of-view-glenwood-goss-md-frcpc-fcpsa/ 2019-03-11T17:20:25+00:00 https://ascopost.com/issues/september-25-2015/our-childrens-future-is-our-responsibility/ 2019-03-11T17:20:25+00:00 https://ascopost.com/issues/september-25-2015/making-their-voices-heard-118-oncologists-speak-out-about-stemming-the-high-cost-of-cancer-drugs/ 2019-03-11T17:20:25+00:00 https://ascopost.com/issues/september-25-2015/double-hit-lymphoma-many-treatment-strategies-no-standard-of-care/ 2019-03-11T17:20:25+00:00 https://ascopost.com/issues/september-25-2015/dr-cohens-approach-to-managing-double-hit-lymphoma/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/asco-statement-addresses-recommendations-for-obesity-clinical-trials-in-cancer-survivors/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/about-the-summit/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/mantle-cell-lymphoma-is-transplantation-still-necessary/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/ash-honors-john-c-byrd-md-with-2015-william-dameshek-prize/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/fred-r-hirsch-md-phd-presented-with-2015-addario-lectureship-award/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/jinghui-zhang-phd-named-chair-of-computational-biology-at-st-jude/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/nci-awards-spore-grant-to-mayo-clinic-multiple-myeloma-research-team/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/yale-cancer-center-receives-11-million-spore-grant-for-lung-cancer-research/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/hpv-positive-head-and-neck-cancer-when-can-chemotherapy-be-omitted/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/rolapitant-for-prevention-of-delayed-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/managing-high-risk-patients-with-febrile-neutropenia/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/radiation-oncology-looks-to-collaboration-for-big-data-systems/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/for-big-data-projects-bigger-is-better/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/bevacizumab-plus-standard-chemotherapy-improves-survival-in-mesothelioma/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/expert-point-of-view-james-jett-md/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/james-p-allison-phd-wins-clinical-medical-research-lasker-debakey-award/ 2019-03-11T17:20:26+00:00 https://ascopost.com/issues/september-25-2015/one-doctors-road-to-palliative-care-services-in-the-inner-city/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/tari-king-md-named-chief-of-breast-surgical-services-at-dana-farberbrigham-and-women-s-cancer-center/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/2015-astro-gold-medal-recipients-announced/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/texas-center-for-proton-therapy-names-chang-chang-phd-director-of-physics/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/carl-h-june-md-awarded-the-2015-watanabe-prize/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/astro-awards-seven-physician-researchers-675-000-in-grants-for-radiation-oncology-research/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/fda-approves-rolapitant-for-prevention-of-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/barbara-pro-md-joins-the-lurie-cancer-center/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/lurie-cancer-center-receives-117-million-nci-grant-to-improve-treatment-using-nanotechnology/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/asco-university-releases-2015-curricula-for-advanced-practice-providers/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/conquer-cancer-foundation-donor-spotlight-fibrolamellar-cancer-foundation/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/be-a-voice-in-the-campaign-to-conquer-cancer/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/asco-urges-expansion-of-cancer-research-to-include-older-adults/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/food-safety-for-patients-with-cancer/ 2019-03-11T17:20:27+00:00 https://ascopost.com/issues/september-25-2015/asco-continues-to-support-21st-century-cures/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/fda-grants-regular-approval-to-brentuximab-vedotin-in-high-risk-classical-hodgkin-lymphoma/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/fda-accepts-for-priority-review-the-biologics-license-application-for-elotuzumab-for-the-treatment-of-relapsed-multiple-myeloma/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/nci-awards-huntsman-cancer-institute-university-of-new-mexico-cancer-center-comprehensive-cancer-center-designations/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/immune-checkpoint-inhibitor-nivolumab-is-active-in-patients-with-heavily-pretreated-advanced-non-small-cell-lung-cancer/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/differing-patterns-of-breast-cancer-risk-after-hormone-therapy-with-estrogen-plus-progestin-or-estrogen-alone/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/updated-analysis-of-menopausal-hormone-therapy-and-breast-cancer-risk/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/statin-use-at-start-of-androgen-deprivation-therapy-increases-time-to-progression-during-treatment-of-prostate-cancer/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/md-anderson-names-valerae-o-lewis-md-chair-of-orthopaedic-oncology/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/asco-2015-geriatric-oncology-highlights/ 2020-02-17T18:44:05+00:00 https://ascopost.com/issues/september-25-2015/why-it-is-important-to-have-a-physiatrist-on-a-cancer-care-team/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/microbes-by-the-trillions/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/2015-oncology-meetings/ 2019-03-11T17:20:28+00:00 https://ascopost.com/issues/september-25-2015/an-unvarnished-behind-the-scenes-look-at-the-hospital-nurse/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/in-search-of-a-good-ending-for-a-life-well-lived/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/asco-policy-statement-update-genetic-and-genomic-testing-for-cancer-susceptibility/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/internationally-acclaimed-cancer-researcher-gianni-bonadonna-md-dies-at-81/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/jeffrey-s-weber-md-phd-joins-nyu-langone-and-perlmutter-cancer-center/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/let-it-be-hard/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/my-positive-attitude-is-keeping-me-alive/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-25-2015/encouraging-results-with-newer-egfr-tkis-in-patients-with-nsclc-who-progressed-after-prior-egfr-tki-therapy/ 2025-09-15T18:23:52+00:00 https://ascopost.com/issues/september-25-2015/azacitidine-increased-median-overall-survival-among-patients-aged-65-and-older-with-30-blasts/ 2019-03-11T17:20:29+00:00 https://ascopost.com/issues/september-10-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/september-10-2015/adding-elotuzumab-to-lenalidomide-plus-dexamethasone-improves-progression-free-survival-in-refractory-multiple-myeloma/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/elotuzumab-ushers-in-a-new-era-in-myeloma-therapy/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/our-patients-are-the-true-heroes-of-cancer-research/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/charting-a-new-course-from-clinical-investigator-to-university-president/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/positioning-targeted-and-immunotherapy-based-approaches-in-lung-cancer/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/indolent-lymphoma-a-more-complex-malignancy-than-once-thought/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/colorectal-liver-metastases-thumbs-up-for-radiofrequency-ablation-jury-still-out-for-selective-internal-radiotherapy/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/secondary-prevention-in-metastatic-colorectal-cancer-benefits-of-vitamin-d-and-aspirin-explored/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/optimal-timing-of-hormonal-therapy-for-biochemically-recurrent-prostate-cancer-remains-unclear/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/role-of-surgery-and-adjuvant-radiotherapy-in-the-treatment-of-breast-cancer-explored/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/hpv16-dna-in-post-treatment-oral-rinses-signals-poor-prognosis-in-oropharyngeal-cancer/ 2019-03-11T17:21:01+00:00 https://ascopost.com/issues/september-10-2015/ipos-announces-2015-award-winners-at-the-world-congress-of-psycho-oncology/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/three-new-officers-elected-to-astros-board-of-directors/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/international-psycho-oncology-society-and-american-psychosocial-oncology-society-meet-to-foster-psychosocial-oncology-worldwide/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/suicide-after-cancer-understanding-the-challenges-across-the-treatment-trajectory/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/coping-with-aging-and-cancer-psychosocial-factors-and-geriatric-specific-interventions/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/brentuximab-vedotin-for-consolidation-therapy-in-high-risk-hodgkin-lymphoma/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/new-techniques-in-oncologic-surgery-and-radiology-some-worth-the-expense-some-not-so-much/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/nci-and-sage-bionetworks-present-up-for-a-challenge/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/novel-combination-increases-progression-free-survival-in-cll-patients-who-are-not-candidates-for-fludarabine/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/genetic-testing-in-breast-cancer-offers-much-information-but-poses-challenges-in-interpretation/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/emerging-technology-will-help-tackle-tumor-complexity/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/state-of-the-art-management-of-germ-cell-tumors-produces-high-cure-rates/ 2019-03-11T17:21:02+00:00 https://ascopost.com/issues/september-10-2015/resilient-new-orleans-10-years-after-katrina/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/roswell-park-cancer-institute-partners-with-cuban-scientists-to-develop-lung-cancer-vaccine/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/getting-there-from-here-what-you-need-to-know-about-traveling-to-cuba/ 2019-10-22T14:50:22+00:00 https://ascopost.com/issues/september-10-2015/st-jude-names-keith-perry-mba-as-chief-information-officer/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/asco-guidelines-a-collaborative-effort/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/order-asco-answers-guides-to-cancer-for-your-practice/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/journal-of-clinical-oncology-special-series-issues-provide-updates-on-important-topics-in-oncology-practice/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/conquer-cancer-foundation-young-investigator-award-applications-now-open/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/this-september-triple-your-impact/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/join-us-for-the-community-research-forum-annual-meeting/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/dabrafenib-plus-trametinib-improves-overall-survival-vs-dabrafenib-in-braf-v600-mutant-melanoma/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/combi-d-trial-and-the-need-to-guide-progress-in-melanoma-treatment/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/seventeen-astro-members-awarded-fellows-designation/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/massimo-cristofanilli-md-named-associate-director-for-precision-medicine-and-translational-research-at-lurie-cancer-center/ 2019-03-11T17:21:03+00:00 https://ascopost.com/issues/september-10-2015/access-to-cancer-medicines-not-uniform-across-europe/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/the-flipped-classroom-swapping-the-traditional-lecture-hall-for-an-online-version/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/w-kimryn-rathmell-md-phd-will-direct-division-of-hematology-and-oncology-at-vanderbilt/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/jeffrey-rathmell-phd-to-lead-new-center-for-immunobiology-at-vanderbilt/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/iuliana-shapira-md-named-chief-of-hematology-and-oncology-at-suny-downstate/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/andrew-s-chi-md-phd-named-head-of-neuro-oncology-at-nyus-laura-and-isaac-perlmutter-cancer-center/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/how-carolyn-d-runowicz-md-fasco-is-shaping-the-future-of-gynecologic-cancers/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/hypertrophic-tumor-of-the-forehead-philadelphia-circa-1870/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/never-say-never/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/a-cancer-handbook-for-inquisitive-laypersons-and-health-care-professionals/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/thomas-j-lynch-jr-md-leaves-yale-cancer-center/ 2019-03-11T17:21:04+00:00 https://ascopost.com/issues/september-10-2015/diane-simeone-md-named-upcoming-chair-of-pancan-scientific-board/ 2019-03-11T17:21:05+00:00 https://ascopost.com/issues/september-10-2015/i-m-living-a-full-and-happy-life-with-stage-iv-breast-cancer/ 2019-03-11T17:21:05+00:00 https://ascopost.com/issues/september-10-2015/share-the-journey-mobile-app-aims-to-understand-the-different-experiences-of-breast-cancer-survivors/ 2019-03-11T17:21:05+00:00 https://ascopost.com/issues/september-10-2015/coriolus-versicolor/ 2019-03-11T17:21:05+00:00 https://ascopost.com/issues/september-10-2015/to-the-one-of-the-many/ 2019-03-11T17:21:05+00:00 https://ascopost.com/issues/september-10-2015/breast-surgeon-carolyn-mary-kaelin-md-mph-facs-dies-at-54/ 2019-03-11T17:21:05+00:00 https://ascopost.com/issues/september-10-2015/chris-marshall-frs-fmedsci-dies-at-66-of-colorectal-cancer/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/from-small-town-mexico-to-big-pharma-a-look-at-opiates-for-good-and-bad/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/asco-and-uicc-collaborate-to-extend-reach-of-the-journal-of-global-oncology/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/2015-oncology-meetings/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/unneccessary-complexity-in-scientific-terminology/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/mayo-clinic-receives-11-million-grant-from-nci-to-study-nhl-survivorship/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/increased-interest-in-simple-injection-to-treat-women-with-postmastectomy-pain/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/expect-questions-or-ask-about-postmastectomy-pain/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/joxel-garcia-md-to-direct-md-anderson-moon-shots-program-prevention-efforts/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/clinical-trials-actively-recruiting-patients-with-thyroid-cancer/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/long-term-use-of-thyroid-hormone-replacement-linked-to-decreased-risk-of-colorectal-cancer/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/increased-lifetime-risk-of-cardiovascular-disease-for-patients-treated-for-hodgkin-lymphoma/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/determining-why-patients-with-hiv-infection-and-non-aids-defining-cancers-are-less-likely-to-receive-cancer-treatment/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/more-than-one-third-of-those-diagnosed-with-hepatocellular-carcinoma-as-outpatients-have-diagnostic-delays-of-3-or-more-months/ 2019-03-11T17:21:06+00:00 https://ascopost.com/issues/september-10-2015/cancer-diagnosis-among-patients-with-diabetes-reduced-adherence-to-evidence-based-medications/ 2019-03-11T17:21:07+00:00 https://ascopost.com/issues/september-10-2015/james-welsh-md-facro-elected-president-of-the-american-college-of-radiation-oncology/ 2019-03-11T17:21:07+00:00 https://ascopost.com/issues/august-25-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/august-25-2015/studies-explore-new-avenues-to-pursue-in-metastatic-triple-negative-breast-cancer/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/immune-checkpoint-inhibitors-the-dawn-of-a-new-era-for-lung-cancer-therapy/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/right-to-try-laws-helpful-or-harmful/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/moving-forward-in-non-small-cell-lung-cancer-targeted-combinations-and-immunotherapy/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/immunotherapy-makes-inroads-in-small-cell-lung-cancer/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/gefitinib-in-egfr-mutant-metastatic-nsclc/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/fda-approves-carfilzomib-combination-for-patients-with-relapsed-multiple-myeloma/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/fda-grants-breakthrough-therapy-designation-to-lenvatinib-for-metastatic-renal-cell-carcinoma/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/dactinomycin-formulation-gets-orphan-drug-designation/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/short-course-of-radiotherapy-may-be-adequate-for-elderly-and-frail-patients-with-glioblastoma-multiforme/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/dispelling-the-myths-associated-with-osteonecrosis-of-the-jaw/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/managing-cancer-pain-at-the-end-of-life/ 2019-03-11T17:25:20+00:00 https://ascopost.com/issues/august-25-2015/fda-approves-sonidegib-for-locally-advanced-basal-cell-carcinoma/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/regorafenib-improves-overall-survival-in-asian-patients-with-previously-treated-metastatic-colorectal-cancer/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/learning-to-refine-the-use-of-regorafenib-to-best-advantage-in-advanced-colorectal-cancer/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/carfilzomib-in-combination-with-lenalidomide-and-dexamethasone-in-relapsed-multiple-myeloma/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/children-s-hospital-of-philadelphia-appoints-madeline-bell-ms-as-ceo/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/calculating-the-value-of-cancer-drugs/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/adding-everolimus-to-first-line-trastuzumabpaclitaxel-does-not-increase-progression-free-survival-in-her2-positive-metastatic-breast-cancer/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/the-conundrum-of-estrogen-receptor-signaling-in-her2-positive-breast-cancer/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/new-molecular-classifications-of-gliomas-established/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/improved-understanding-of-glioma-tumor-biology/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/penn-s-basser-center-for-brca-names-david-livingston-md-winner-of-2015-annual-basser-global-prize/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/apos-announces-2015-award-winners-at-the-world-congress-of-psycho-oncology/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/clinical-trials-actively-recruiting-patients-with-genitourinary-cancers/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/geriatric-oncology-a-geriatrician-s-perspective/ 2020-02-17T18:42:17+00:00 https://ascopost.com/issues/august-25-2015/15th-annual-conference-of-the-international-society-of-geriatric-oncology/ 2019-03-11T17:25:21+00:00 https://ascopost.com/issues/august-25-2015/johnson-johnson-creates-independent-bioethics-panel-to-evaluate-compassionate-drug-use-requests/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/sonidegib-in-basal-cell-carcinoma/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/new-symposium-brings-together-oncologists-and-primary-care-providers-to-advance-survivorship-care-and-research/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/physician-fee-schedule-a-closer-look/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/conquer-cancer-foundation-donor-spotlight-ludwig-cancer-research/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/obesity-and-cancer-bundle-oncology-provider-guides-and-patient-booklets/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/strengthening-the-doctor-patient-relationship-an-interview-with-lidia-schapira-md-fasco/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/be-a-voice-in-the-campaign-to-conquer-cancer/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/microangiopathic-hemolytic-anemia-and-thrombocytopenia-questions/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/microangiopathic-hemolytic-anemia-and-thrombocytopenia-answers/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/accc-launches-immuno-oncology-program-for-community-based-cancer-care-providers/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/john-m-cunningham-md-to-chair-pediatrics-at-the-university-of-chicago/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/karen-reckamp-md-ms-named-medical-director-for-clinical-research-operations-at-city-of-hope/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/james-metz-md-named-chair-of-penn-medicine-department-of-radiation-oncology/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/pankaj-sharda-md-joins-fox-chase-cancer-center-department-of-medicine/ 2019-03-11T17:25:22+00:00 https://ascopost.com/issues/august-25-2015/american-university-of-beirut-appoints-its-16th-president-fadlo-r-khuri-md/ 2019-03-11T17:25:23+00:00 https://ascopost.com/issues/august-25-2015/2015-oncology-meetings/ 2019-03-11T17:25:23+00:00 https://ascopost.com/issues/august-25-2015/public-urged-not-to-overreact-to-study-finding-link-between-citrus-fruits-and-melanoma-risk/ 2019-03-11T17:25:23+00:00 https://ascopost.com/issues/august-25-2015/expect-questions-about-increased-risk-of-melanoma-from-consuming-grapefruits-and-orange-juice/ 2019-03-11T17:25:23+00:00 https://ascopost.com/issues/august-25-2015/collaboration-between-surgeons-and-medical-oncologists-improves-outcomes-for-patients-with-stage-iii-colon-cancer/ 2019-03-11T17:25:23+00:00 https://ascopost.com/issues/august-25-2015/statin-use-not-associated-with-reduced-mortality-among-patients-with-primary-colorectal-cancer/ 2019-03-11T17:25:23+00:00 https://ascopost.com/issues/august-10-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/august-10-2015/bevacizumab-more-cost-effective-than-cetuximab-in-metastatic-colorectal-cancer/ 2019-03-11T17:25:57+00:00 https://ascopost.com/issues/august-10-2015/expert-point-of-view-peter-b-bach-md-mapp-and-leonard-saltz-md/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/value-what-do-we-mean-who-should-decide/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/is-proton-beam-therapy-facing-a-difficult-future/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/glioblastoma-novel-immunotherapy-approaches-generate-responses-and-excitement/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/esmo-s-magnitude-of-clinical-benefit-scale-brings-unbiased-perspective-to-cancer-drugs-worth/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/the-value-proposition-in-oncology-asco-session-weighs-points-of-view/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/study-shows-current-blood-cancer-drug-prices-are-not-justified/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/fda-grants-orphan-drug-designation-to-antitropomyosin-drug-for-neuroblastoma/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/magnetic-resonance-imagingultrasound-fusion-guided-biopsy-improves-detection-of-high-risk-prostate-cancer/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/magnetic-resonance-imagingultrasound-fusion-a-promising-technology-for-image-guided-prostate-biopsy/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/odac-discussion-constructive-about-necitumumab-for-squamous-nsclc/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/no-survival-benefit-for-eribulin-vs-capecitabine-in-advanced-breast-cancer/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/comparing-regimens-guides-therapeutic-decisions-in-previously-treated-advanced-breast-cancer/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/past-president-of-asco-takes-on-new-role-at-memorial-sloan-kettering-cancer-center-to-improve-patient-care-and-public-health/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/jimmie-c-holland-md-receives-woman-of-influence-award/ 2019-03-11T17:25:58+00:00 https://ascopost.com/issues/august-10-2015/st-jude-to-receive-12-million-in-grants-from-nih/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/stephen-szabo-md-named-director-of-community-oncology-at-winship-cancer-institute/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/using-gene-analytics-to-identify-patients-at-risk-for-treatment-toxicity/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/an-oncologist-s-memoir/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/the-human-heart-tales-of-science-and-mystery/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/blame/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/collective-wisdom-patient-centered-care-and-research/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/2015-2016-asco-president-julie-m-vose-md-mba-fasco-leading-during-a-year-of-historic-changes/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/disease-prevention-practice-issues-put-asco-center-stage-at-ama-house-of-delegates-meeting/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/register-for-the-community-research-forum-2015-annual-meeting/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/summer-travel-help-your-patients-understand-why-getting-medical-clearance-is-important/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/community-oncologist-stephen-grubbs-md-to-lead-asco-s-new-clinical-affairs-department/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/american-college-of-physicians-releases-high-value-care-screening-advice-for-five-common-cancers/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/michael-allen-pulsipher-md-joins-children-s-hospital-los-angeles/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/stephen-l-lessnick-md-phd-named-director-of-the-center-for-childhood-cancer-and-blood-disorders-at-nationwide-children-s-hospital-columbus-ohio/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/2015-class-of-pew-stewart-scholars-for-cancer-research-announced/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/translational-research-dogs-and-humans-nearly-interchangeable-in-the-laboratory/ 2019-03-11T17:25:59+00:00 https://ascopost.com/issues/august-10-2015/timothy-l-lash-dsc-mph-named-head-of-winship-s-cancer-prevention-and-control-program/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/carrie-kitko-md-appointed-director-of-vanderbilt-s-pediatric-stem-cell-transplant-program/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/cancercare-announces-national-study-patient-access-and-engagement-report/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/advisory-board/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/a-lasting-legacy/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/charles-rubin-md-pediatric-cancer-specialist-dies-at-62/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/the-importance-of-including-adolescents-and-young-adults-with-cancer-in-their-advance-care-planning/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/aacr-launches-new-funding-initiative-to-promote-innovative-research-from-young-investigators/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/cost-vs-our-values-in-cancer-care/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/daratumumab-expanded-access-program-open-to-eligible-us-patients-with-heavily-pretreated-multiple-myeloma/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/2015-oncology-meetings/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/mount-sinai-honors-james-f-holland-md-fasco-on-the-occasion-of-his-90th-birthday/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/reflections/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/charles-roberts-md-phd-named-director-of-st-jude-comprehensive-cancer-center/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/medicare-to-reimburse-doctors-for-end-of-life-counseling/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/collaboration-between-surgeons-and-medical-oncologists-improves-outcomes-for-patients-with-stage-iii-colon-cancer/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/august-10-2015/more-than-one-third-of-those-diagnosed-with-hepatocellular-carcinoma-as-outpatients-have-diagnostic-delays-of-3-or-more-months/ 2019-03-11T17:26:00+00:00 https://ascopost.com/issues/july-25-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/july-25-2015/obinutuzumab-moves-into-lymphoma-treatment/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-jeremy-abramson-md/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/collaborating-toward-a-cure/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/astro-guidelines-on-radiotherapy-in-locally-advanced-nsclc-a-good-place-to-start/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/carfilzomibdexamethasone-doubles-progression-free-survival-vs-bortezomibdexamethasone-in-patients-with-relapsed-multiple-myeloma/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-jeffrey-l-wolf-md/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/immunotherapy-marches-on-making-headway-in-advanced-urothelial-bladder-cancer/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-noah-hahn-md/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/novel-enzyme-improves-outcomes-in-subset-of-patients-with-pancreatic-cancer/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-kenneth-yu-md-msc/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/george-wilding-md-named-vice-provost-for-clinical-and-interdisciplinary-research-at-md-anderson/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/jonathan-d-licht-md-appointed-director-of-the-university-of-florida-health-cancer-center-gainesville/ 2019-03-11T17:26:31+00:00 https://ascopost.com/issues/july-25-2015/kevin-fitzpatrick-named-ceo-of-cancerlinq-llc/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/triple-inhibition-may-cripple-braf-mutated-colorectal-cancer/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-keith-t-flaherty-md/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/new-concept-for-brain-tumors-tumor-treating-fields/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-martin-j-van-den-bent-md/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/advancing-classification-and-risk-stratification-for-leukemia-and-myelodysplastic-syndromes/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-wendy-stock-md/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/petct-detects-asymptomatic-melanoma-recurrences/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/expert-point-of-view-daniel-g-coit-md/ 2019-03-11T17:26:32+00:00 https://ascopost.com/issues/july-25-2015/precision-medicine-trials-bring-targeted-treatments-to-more-patients/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/new-appointments-announced-at-taussig-cancer-institute/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/cyrus-ghajar-phd-receives-41-million-from-department-of-defense/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/nccs-advocates-for-legislation-to-establish-medicare-service-for-cancer-survivorship-care-planning/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/early-phase-studies-show-activity-of-novel-egfr-inhibitors-rociletinib-and-azd9291-in-t790m-positive-nsclc/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/progress-in-the-treatment-of-patients-with-egfr-mutated-nsclc/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/asco-endorses-astro-guideline-on-definitive-and-adjuvant-radiotherapy-in-locally-advanced-nsclc/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/2015-palliative-care-in-oncology-symposium-to-highlight-the-science-of-symptom-management/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/asco-conquer-cancer-foundation-congratulate-2015-grant-and-award-recipients/ 2019-03-11T17:26:33+00:00 https://ascopost.com/issues/july-25-2015/asco-urges-evidence-based-flexible-drug-handling-requirements-in-comments-on-usp-800/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/order-cancernet-fact-sheets-for-your-practice/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/comprehensive-oncology-practice-business-guide-now-available/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/gynecologic-cancer-in-the-older-patient-the-activities-of-the-elderly-working-group-of-nrg-oncology/ 2020-02-17T18:39:12+00:00 https://ascopost.com/issues/july-25-2015/matthew-trunnell-named-vice-president-and-chief-information-officer-at-fred-hutchinson-cancer-research-center/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/john-a-zaia-md-named-director-of-center-for-gene-therapy-at-city-of-hope/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/david-gius-md-phd-named-co-leader-of-northwesterns-womens-cancer-research-program/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/laura-vant-veer-phd-receives-european-inventor-award-2015/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/microangiopathic-hemolytic-anemia-and-thrombocytopenia-questions/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/microangiopathic-hemolytic-anemia-and-thrombocytopenia-answers/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/clinical-trials-actively-recruiting-patients-with-melanoma/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/fdas-pregnancy-category-labeling/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/memorial-sloan-kettering-cancer-center-receives-gift-of-150-million-from-david-h-koch/ 2019-03-11T17:26:34+00:00 https://ascopost.com/issues/july-25-2015/american-ginseng/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/adjuvant-ipilimumab-increases-recurrence-free-survival-after-complete-resection-of-high-risk-stage-iii-melanoma/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/adjuvant-ipilimumab-in-high-risk-stage-iii-melanoma-encouraging-study-results-yet-questions-remain/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/capitalizing-on-increased-interest-in-skin-cancer-during-summer-to-reeducate-people-about-sunscreens-and-smart-sun-strategies/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/expect-questions-about-preventing-melanoma/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/my-faith-helped-me-choose-a-way-forward-with-cancer/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/2015-oncology-meetings/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/preeminent-cancer-researcher-brian-e-henderson-md-dies/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/michael-o-malley-phd-mph-former-unc-lineberger-associate-director-dies-at-64/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/irwin-rose-phd-nobel-laureate-and-biochemist-dies-at-88/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/durable-responses-at-3-year-follow-up-for-cll-patients-receiving-single-agent-ibrutinib/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-25-2015/thyroid-cancer-rarely-diagnosed-in-those-with-asymptomatic-benign-nodules/ 2019-03-11T17:26:35+00:00 https://ascopost.com/issues/july-10-2015/ 2021-06-08T17:57:22+00:00 https://ascopost.com/issues/july-10-2015/survivors-of-childhood-cancer-living-longer-largely-due-to-treatment-improvements/ 2019-03-11T17:28:03+00:00 https://ascopost.com/issues/july-10-2015/expert-point-of-view-michael-p-link-md/ 2019-03-11T17:28:03+00:00 https://ascopost.com/issues/july-10-2015/biosimilars-questions-remain/ 2019-03-11T17:28:03+00:00 https://ascopost.com/issues/july-10-2015/how-cancerlinq-can-benefit-people-living-with-cancer/ 2019-03-11T17:28:03+00:00 https://ascopost.com/issues/july-10-2015/ado-trastuzumab-emtansine-fails-to-replace-standard-of-care-in-first-line-metastatic-breast-cancer/ 2019-03-11T17:28:03+00:00 https://ascopost.com/issues/july-10-2015/expert-point-of-view-shanu-modi-md/ 2019-03-11T17:28:03+00:00 https://ascopost.com/issues/july-10-2015/anastrozole-and-tamoxifen-both-options-for-ductal-carcinoma-in-situ/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/expert-point-of-view-anees-b-chagpar-md/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/lenvatinibeverolimus-robust-combination-in-metastatic-renal-cell-carcinoma/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/expert-point-of-view-sumanta-k-pal-md/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/uab-study-on-lay-navigation-program-shows-trend-toward-cost-savings/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/pacritinib-for-myelofibrosis-effective-in-patients-with-thrombocytopenia/ 2025-09-30T19:57:08+00:00 https://ascopost.com/issues/july-10-2015/expert-point-of-view-lloyd-damon-md/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/investigators-update-pvs-ripo-data-in-glioblastoma/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/cost-of-immunotherapy-projected-to-top-1-million-per-patient-per-year/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/poliovirus-for-glioblastoma-grabs-national-attention/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/oncolytic-immunotherapy-in-melanoma-it-s-not-all-about-pd-1/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/five-presidential-appointees-named-to-national-cancer-advisory-board/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/assessing-and-improving-imaging-interpretation-in-breast-cancer-screening/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/breast-imaging-reporting-and-data-system-bi-rads/ 2019-03-11T17:28:04+00:00 https://ascopost.com/issues/july-10-2015/16-gene-assay-recurrence-score-predicts-recurrence-after-surgery-for-localized-renal-cell-carcinoma/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/predicting-recurrence-after-surgery-in-renal-cell-carcinoma-16-gene-assay-recurrence-score-ushers-in-new-era/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/pd-1-inhibitor-pembrolizumab-active-in-advanced-nsclc-outcomes-better-with-higher-pd-l1-expression/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/pembrolizumab-in-advanced-nsclc-the-promise-of-immune-checkpoint-inhibitors/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/bert-vogelstein-md-receives-2015-dr-paul-janssen-award-for-biomedical-research/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/2015-breast-cancer-symposium-to-encourage-collaboration-in-patient-care-education-and-research/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/asco-qopi-certification-program-benefits-oncology-practices-and-patients/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/asco-recommends-palliative-care-as-part-of-cancer-treatment/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/asco-releases-payment-reform-proposal-to-support-higher-quality-more-affordable-cancer-care/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/asco-members-public-working-together-to-take-down-cancer/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/roberto-pili-md-expert-in-prostate-renal-and-bladder-cancers-joins-indiana-university-simon-cancer-center/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/the-pediatric-fitness-program-a-mind-body-approach/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/the-mind-body-program-in-action/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/translating-study-recommendations-into-medicare-coverage/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/first-winners-of-tri-institutional-breakout-awards-announced/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/clara-d-bloomfield-md-fasco-never-one-to-back-down-from-a-challenge/ 2019-03-11T17:28:05+00:00 https://ascopost.com/issues/july-10-2015/noted-pediatric-oncologist-robert-j-arceci-md-phd-dies/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/july-10-2015/2015-oncology-meetings/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/july-10-2015/agreement-on-high-value-screening-for-five-common-cancers/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/july-10-2015/expect-and-encourage-questions-about-the-benefits-and-harms-of-cancer-screening/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/july-10-2015/building-and-adjusting-to-my-life-after-cancer/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/july-10-2015/significant-differences-in-age-at-diagnosis-between-blacks-and-whites-for-six-types-of-cancer/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/july-10-2015/date-of-last-chemotherapy-is-not-a-proxy-for-deciding-when-to-stop-treating-metastatic-nsclc/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/july-10-2015/frederick-pei-li-md-pioneer-of-cancer-genetics-dies-at-75/ 2019-03-11T17:28:06+00:00 https://ascopost.com/issues/june-25-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/june-25-2015/elective-neck-dissection-beats-watch-and-wait-approach-in-early-oral-cancer/ 2019-03-11T17:28:37+00:00 https://ascopost.com/issues/june-25-2015/expert-point-of-view-hisham-mehanna-phd/ 2019-03-11T17:28:37+00:00 https://ascopost.com/issues/june-25-2015/considering-clonality-in-precision-medicine/ 2019-03-11T17:28:37+00:00 https://ascopost.com/issues/june-25-2015/asco-releases-details-of-its-conceptual-framework-for-assessing-value-in-cancer-care/ 2019-03-11T17:28:37+00:00 https://ascopost.com/issues/june-25-2015/single-agent-daratumumab-activity-deemed-remarkable-in-refractory-multiple-myeloma/ 2019-03-11T17:28:37+00:00 https://ascopost.com/issues/june-25-2015/expert-point-of-view-suzanne-lentzsch-md-phd/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/expert-point-of-view-joseph-a-sparano-md-and-don-dizon-md/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/routine-resection-of-cavity-shave-margins-halved-reexcision-rates-in-breast-cancer/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/expert-point-of-view-george-somlo-md-facp/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/not-all-stage-iii-melanoma-patients-need-complete-nodal-dissection/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/expert-point-of-view-lynn-schuchter-md-and-vernon-sondak-md/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/eribulin-improves-overall-survival-in-difficult-to-treat-sarcoma-types/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/two-factors-predict-for-recurrent-venous-thromboembolism-in-patients-with-cancer/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/ibrutinib-plus-bendamustinerituximab-called-a-new-standard-in-patients-with-previously-treated-cll/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/expert-point-of-view-jeremy-abramson-md/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/adjuvant-chemotherapy-proves-effective-in-localized-high-risk-prostate-cancer/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/expert-point-of-view-ian-tannock-md-phd-dsc/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/asco-releases-payment-reform-proposal-to-support-higher-quality-more-affordable-cancer-care/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/asco-releases-updated-expanded-set-of-survivorship-care-planning-templates/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/registration-open-for-2015-community-research-forum-annual-meeting/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/new-resources-developed-by-ascos-community-research-forum/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/2015-asco-annual-meeting-planning-committees/ 2019-03-11T17:28:38+00:00 https://ascopost.com/issues/june-25-2015/help-your-patients-catch-up-on-the-latest-research-from-the-2015-asco-annual-meeting/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/national-cancer-institute-pulls-psa-data-from-seer/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/deciphering-the-genetic-variability-of-cancer-to-advance-precision-oncology-care/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/meta-analysis-shows-increased-risk-of-ovarian-cancer-with-menopausal-hormone-therapy/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/hormonal-therapy-and-risk-of-ovarian-cancer/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/frozen-sleep-as-cancer-treatment-springfield-illinois-1939/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/clinical-trials-actively-recruiting-patients-with-oral-cavity-and-oropharyngeal-cancers/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/redefining-cancer/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/2015-oncology-meetings/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/carpe-diem/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/patients-with-relapsedrefractory-cll-that-progresses-early-on-ibrutinib-have-poor-outcomes/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/patients-desire-for-rapid-notification-of-skin-biopsy-results-leads-to-preference-for-phone-call-over-face-to-face-visit/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/response-to-may-10-cartoon/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-25-2015/sexual-dysfunction-after-gynecologic-cancer-treatment/ 2019-03-11T17:28:39+00:00 https://ascopost.com/issues/june-10-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/june-10-2015/checkmate-067-dual-checkpoint-blockade-proves-effective-in-advanced-melanoma/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-michael-b-atkins-md/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/clinical-trials-drug-costs-and-restoring-the-primacy-of-the-patient-volunteer/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/mismatch-repair-deficiency-predicts-benefit-with-pembrolizumab-in-colorectal-cancer/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-neil-howard-segal-md-phd/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/second-line-nivolumab-therapy-improves-survival-in-patients-with-nonsquamous-non-small-cell-lung-cancer/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-roy-s-herbst-md-phd/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/clinically-meaningful-preliminary-results-with-pembrolizumab-in-recurrent-head-and-neck-cancer/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-lori-j-wirth-md/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/whole-brain-radiation-risks-outweigh-benefits-for-limited-brain-metastases/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-andrew-b-lassman-md/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/intensified-therapy-improves-survival-in-wilms-tumor-patients-with-rare-genetic-abnormality/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-alison-m-friedmann-md/ 2019-03-11T17:30:48+00:00 https://ascopost.com/issues/june-10-2015/cost-analysis-of-bilateral-prophylactic-mastectomy/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/nipple-sparing-mastectomy-shown-to-be-oncologically-safe/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-julie-a-margenthaler-md/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/new-studies-call-for-smarter-approach-to-prostate-cancer-screening/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/studies-evaluate-effectiveness-of-active-surveillance-in-prostate-cancer-patients/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/anti-pd-l1-agent-shows-activity-in-early-study-of-triple-negative-breast-cancer/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/expert-point-of-view-aditya-bardia-md/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/long-term-survival-advantage-seen-with-intraperitoneal-vs-intravenous-chemotherapy-in-advanced-ovarian-cancer/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/what-is-the-future-of-intraperitoneal-treatment-in-advanced-ovarian-cancer/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/outcomes-of-the-custom-basket-trial-of-molecular-profiling-and-targeted-therapy-in-advanced-thoracic-malignancies/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/the-basket-trial-an-evolving-clinical-trial-design/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/eduardo-m-sotomayor-md-named-director-of-gw-cancer-center/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/large-urology-group-practice-association-appoints-president-elect/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/institute-of-medicine-to-become-national-academy-of-medicine/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/first-national-data-on-breast-cancer-subtypes-mark-new-era-in-biomarker-epidemiology/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/new-asco-journal-to-focus-on-cancer-in-resource-constrained-countries/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/asco-launches-electronic-practical-tips-for-the-oncology-practice-6th-edition/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/inform-your-patients-about-common-cancer-myths/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/over-30-organizations-including-asco-call-for-fda-to-regulate-e-cigarettes/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/asco-s-community-research-forum-offers-helpful-tools-for-community-based-research-sites/ 2019-03-11T17:30:49+00:00 https://ascopost.com/issues/june-10-2015/new-asco-university-tumor-genomics-program-helps-cancer-care-providers-increase-their-understanding-of-next-generation-sequencing/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/merck-chairman-and-ceo-kenneth-c-frazier-becomes-phrma-board-chairman/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/nivolumab-increases-response-rate-vs-chemotherapy-in-advanced-melanoma-progressing-after-anti-ctla-4-treatment/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/the-promise-of-immune-checkpoint-inhibition-changing-the-therapeutic-landscape-for-melanoma-and-other-malignancies/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/asco-appoints-lidia-schapira-md-fasco-editor-in-chief-of-patient-information-website-cancernet/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/fulfilling-ncis-commitment-to-supporting-the-best-science/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/asco-2015-investigators-announce-patient-enrollment-for-nci-match-trial/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/roswell-park-cancer-institute-appoints-new-leadership-team/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/daniel-d-von-hoff-md-facp-receives-the-2015-wallace-a-reed-md-award/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/nancy-brinker-named-may-lungevity-hero/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/addition-of-ramucirumab-to-second-line-folfiri-improves-overall-survival-in-metastatic-colorectal-cancer/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/another-angiogenesis-inhibitor-shows-benefit-in-metastatic-colorectal-cancer-but-where-do-we-go-next/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/five-oncology-researchers-selected-as-howard-hughes-medical-institute-investigators/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/how-and-when-to-give-professional-feedback/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/giving-effective-feedback/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/mount-sinai-receives-88-million-grant-to-further-stem-cell-research/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/jonathan-l-finlay-mb-chb-frcp-recipient-of-the-elizabeth-and-richard-germain-endowed-chair-in-pediatric-cancer/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/martin-mcmahon-phd-joins-research-team-at-huntsman-cancer-institute/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/2015-oncology-meetings/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/alan-c-sartorelli-phd-pioneer-in-targeted-chemotherapy-and-aacr-past-president-dies-at-age-83/ 2019-03-11T17:30:50+00:00 https://ascopost.com/issues/june-10-2015/carol-a-kruse-phd-pioneer-in-brain-cancer-research-and-immunotherapy-dies-at-age-61/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/meir-wetzler-md-rpci-leukemia-chief-dies-at-age-60/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/margaret-foti-recognized-as-2015-honoree-of-the-one-hundred-by-massachusetts-general-hospital-cancer-center/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/cancer-will-always-be-part-of-my-life/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/gerstner-family-foundation-commits-10-million-to-broad-institute/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/incidence-of-fractures-is-compellingly-higher-after-hematopoietic-stem-cell-transplantation/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/expect-questions-about-preventing-fractures-after-stem-cell-transplant/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/effect-of-erg-gene-status-on-progression-free-survival-with-abiraterone-in-castration-resistant-prostate-cancer/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/pole-proofreading-mutations-predict-better-outcome-in-endometrial-cancer/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/ex-vivo-manipulation-of-tumor-microenvironment-improves-expansion-of-tumor-infiltrating-lymphocytes-for-adoptive-cell-therapy/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/first-line-imatinib-with-early-switch-to-nilotinib-may-be-preferable-to-first-line-use-of-more-potent-agents-in-cml/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/more-extensive-lymph-node-clearance-during-surgery-for-esophageal-cancer-may-not-improve-survival/ 2019-03-11T17:30:51+00:00 https://ascopost.com/issues/june-10-2015/asco-announces-first-ever-clinical-trial/ 2019-03-11T17:30:52+00:00 https://ascopost.com/issues/june-10-2015-supplement/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/june-10-2015-supplement/carolyn-r-bo-aldige-reflects-on-30-years-of-cancer-prevention/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/father-of-geriatric-oncology-lodovico-balducci-md-unearthed-a-new-understanding-of-aging-s-effect-on-cancer-treatment/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/bruce-a-chabner-md-and-his-innovative-pharmacology-research-led-to-the-development-of-practice-changing-therapies/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/pioneer-in-combination-chemotherapy-vincent-t-devita-jr-md-changed-the-face-of-modern-oncology/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/lymphoma-expert-and-industry-leader-sandra-j-horning-md-pushes-the-frontiers-of-drug-development-and-oncology-research/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/nationally-recognized-leader-in-myeloid-malignancies-alan-f-list-md-has-high-hopes-for-the-future-of-oncology/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/global-leader-in-drug-development-john-l-marshall-md-calls-for-a-smarter-war-on-cancer/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/andrew-c-von-eschenbach-md-went-from-the-front-lines-of-cancer-care-to-a-bird-s-eye-view-of-the-changing-oncology-landscape/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/wyndham-h-wilson-md-phd-shedding-light-on-the-complexity-of-lymphoma-through-a-lifetime-of-illuminating-research/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/after-a-long-and-distinguished-career-robert-c-young-md-shows-no-sign-of-slowing-down/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/2015-oncology-meetings/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/a-tribute-to-james-f-holland-md-in-celebration-of-his-90th-birthday/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/in-memoriam-eddie-reed-md/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/in-memoriam-john-michael-fitzpatrick-mch-frsci/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/in-memoriam-jesse-l-steinfeld-md/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/in-memoriam-lee-w-wattenberg-md/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/in-memoriam-dorothy-dottie-thomas/ 2019-03-11T17:31:26+00:00 https://ascopost.com/issues/june-10-2015-supplement/in-memoriam-john-h-saiki-md/ 2019-03-11T17:31:27+00:00 https://ascopost.com/issues/june-10-2015-supplement/about-the-contributors/ 2019-03-11T17:31:27+00:00 https://ascopost.com/issues/may-25-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/may-25-2015/docetaxel-combined-with-hormone-therapy-extends-survival-in-advanced-prostate-cancer/ 2019-03-11T17:31:46+00:00 https://ascopost.com/issues/may-25-2015/chaarted-and-getug-15-studies/ 2019-03-11T17:31:46+00:00 https://ascopost.com/issues/may-25-2015/expert-point-of-view-christopher-j-sweeney-mbbs/ 2019-03-11T17:31:46+00:00 https://ascopost.com/issues/may-25-2015/illumination-and-innovation-transforming-data-into-learning/ 2019-03-11T17:31:46+00:00 https://ascopost.com/issues/may-25-2015/novel-agent-elotuzumab-added-to-lenalidomidedexamethasone-extends-progression-free-survival-in-multiple-myeloma/ 2019-03-11T17:31:46+00:00 https://ascopost.com/issues/may-25-2015/expert-point-of-view-philip-l-mccarthy-md/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/simple-means-of-preventing-nonmelanoma-skin-cancer-reported/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/expert-point-of-view-isaac-brownell-md-phd/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/nccn-clinical-practice-guidelines-in-oncology-nccn-guidelines-2015-updates/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/nccn-presents-rodger-winn-award-to-daniel-g-coit-md/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/cancer-rates-significantly-increased-among-patients-with-hepatitis-c/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/genomic-analyses-point-to-the-potential-of-personalized-care-for-liver-cancer-patients/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/pembrolizumab-safe-and-effective-in-patients-with-nsclc-especially-in-those-with-tumors-showing-high-levels-of-pd-l1-expression/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/expert-point-of-view-d-ross-camidge-md-phd/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/many-miles-to-go-targeted-treatment-based-on-whole-genome-sequencing/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/expert-point-of-view-elaine-mardis-phd/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/adoptive-t-cell-therapy-successfully-treats-devastating-complication-of-stem-cell-transplantation/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/expert-point-of-view-suzanne-topalian-md-and-antoni-ribas-md-phd/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/richard-pazdur-md-receives-aacr-public-service-award/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/prostate-tumors-with-genetic-abnormalities-respond-to-olaparib/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/expert-point-of-view-william-nelson-md/ 2019-03-11T17:31:47+00:00 https://ascopost.com/issues/may-25-2015/managing-breast-cancer-in-2015/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/hpv-related-anal-cancer-on-the-rise/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/moffitt-cancer-center-hosts-first-hpv-summit/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/parp-inhibitors-have-clear-benefit-for-patients-with-ovarian-cancer-and-brca-mutations-but-when-and-at-what-cost/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/american-college-of-physicians-releases-best-practice-advice-for-cervical-cancer-screening-in-average-risk-women/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/parp-inhibitors-the-first-potential-treatment-of-hereditary-ovarian-cancers/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/karen-e-knudsen-phd-named-director-of-sidney-kimmel-cancer-center-at-thomas-jefferson-university/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/asco-endorses-american-cancer-society-prostate-cancer-survivorship-care-guidelines/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/prostate-cancer-survivorship-identifying-opportunities-for-improvement/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/stephen-grubbs-md-to-lead-asco-s-new-clinical-affairs-department/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/donald-s-coffey-phd-recongized-with-aacr-s-margaret-foti-award/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/prognostic-models-and-front-line-treatment-options-for-chronic-phase-chronic-myelogenous-leukemia/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/prognostic-models-in-cml/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/answers-case-report-on-chronic-myelogenous-leukemia/ 2019-03-11T17:31:48+00:00 https://ascopost.com/issues/may-25-2015/addition-of-lenalidomide-to-docetaxel-prednisone-worsens-survival-in-chemotherapy-naive-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/mainsail-trial-worse-outcomes-with-addition-of-lenalidomide-to-docetaxel-prednisone-in-prostate-cancer/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/will-the-pvs-ripo-poliovirus-be-a-game-changer-in-the-treatment-of-recurrent-glioblastoma/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/exploring-the-history-and-psychology-of-pain-beyond-the-clinical-setting/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/taking-the-next-step-in-a-storied-career/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/nih-names-eliseo-j-pérez-stable-md-director-of-the-national-institute-on-minority-health-and-health-disparities/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/june-mckoy-named-to-nci-council-of-research-advocates/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/asco-s-train-the-trainer-program-extends-the-reach-of-multidisciplinary-cancer-management-education/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/earn-maintenance-of-certification-points-on-the-go-with-asco-moc-app/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/asco-and-nci-calling-on-clinicians-and-researchers-for-best-oncology-clinical-care-practice-models/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/help-your-patients-understand-the-latest-research-from-the-2015-asco-annual-meeting/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/asco-announces-new-class-of-participants-in-quality-training-program/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/conquer-cancer-foundation/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/maitake/ 2019-03-11T17:31:49+00:00 https://ascopost.com/issues/may-25-2015/higher-than-expected-incidence-of-marrow-neoplasms-after-adjuvant-therapy-for-breast-cancer/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/increased-risk-of-secondary-bone-marrow-neoplasia-after-adjuvant-breast-cancer-treatment-riskbenefit-analysis-and-biologic-insights/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/meaning-centered-psychotherapy-benefits-advanced-cancer-patients/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/high-invasive-disease-free-survival-with-adjuvant-paclitaxel-and-trastuzumab-in-small-node-negative-her2-positive-breast-cancers/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/optimizing-treatment-for-small-lymph-node-negative-her2-overexpressing-breast-cancers/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/racial-ethnic-differences-in-diagnosis-of-breast-cancer-at-stage-i-and-subsequent-survival-reflect-biologic-differences/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/a-closer-look-at-the-disparities-in-breast-cancer-outcome-by-race-and-ethnicity/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/large-improvement-in-progression-free-survival-with-lenvatinib-in-radioiodine-refractory-thyroid-cancer/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/welcome-to-multikinase-inhibitors-in-radioiodine-refractory-thyroid-cancer/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/physiatry-has-become-a-valuable-component-of-survivorship-care-in-cancer-centers/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/james-allison-phd-receives-2015-aacr-pezcoller-award/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/meaning-centered-group-psychotherapy-improves-psychological-well-being-in-patients-with-advanced-cancer/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/potential-power-of-meaning-centered-group-psychotherapy-in-patients-with-advanced-cancer/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/guidelines-for-the-treatment-of-older-cancer-patients-task-forces-of-the-international-society-of-geriatric-oncology/ 2020-02-17T18:35:15+00:00 https://ascopost.com/issues/may-25-2015/anti-pd-1-antibody-pembrolizumab-improves-progression-free-and-overall-survival-vs-ipilimumab-in-advanced-melanoma/ 2019-03-11T17:31:50+00:00 https://ascopost.com/issues/may-25-2015/pembrolizumab-vs-ipilimumab-good-vs-better/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/mario-r-capecchi-phd-recognized-with-aacr-lifetime-achievement-in-cancer-research-award/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/venetoclax-receives-breakthrough-therapy-designation-in-relapsedrefractory-cll-with-17p-deletion/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/fda-grants-fast-track-designation-to-evofosfamide-for-advanced-pancreatic-cancer/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/ramucirumab-with-folfiri-in-metastatic-colorectal-cancer/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/in-search-of-meaning-a-personal-journey/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/clinical-trials-actively-recruiting-patients-with-cutaneous-lymphoma/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/fda-accepts-supplemental-biologics-license-application-for-nivolumab-in-patients-with-previously-untreated-advanced-melanoma/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/cobas-kras-mutation-test-receives-fda-approval/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/asco-accc-respond-to-repeal-of-medicare-sustainable-growth-rate-formula/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/the-anesthesia-era-1845-1875/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/taking-the-trauma-out-of-cancer-care-for-children-and-adolescents/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/8-steps-to-help-children-cope-with-cancer-and-its-treatment/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/the-mechanisms-driving-cancer-pain/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/building-a-better-federal-oncology-workforce/ 2019-03-11T17:31:51+00:00 https://ascopost.com/issues/may-25-2015/2015-oncology-meetings/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/a-less-is-more-view-of-medicine/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/courage-under-fire/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/living-with-a-rare-cancer-my-dr-seuss-world/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/learning-to-communicate-science-more-effectively/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/steps-to-more-effective-communication/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/cleopatra-overall-survival-analysis-significant-benefit-for-pertuzumab-plus-trastuzumabdocetaxel-in-her2-positive-metastatic-breast-cancer/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/unexpectedly-huge-survival-benefit-with-pertuzumab-and-trastuzumab-in-her2-positive-metastatic-breast-cancer/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/the-paradox-of-positive-thinking/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/bispecific-antibody-recruitment-to-increase-antitumor-activity-of-adoptive-t-cell-transfer/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/igf2-may-be-target-in-colorectal-cancer-with-stable-disease-as-response-to-anti-egfr-therapy/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/egfr-amplificationoverexpression-associated-with-improved-response-of-glioblastoma-to-metronomic-temozolomide/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/remembering-multiple-myeloma-patient-advocate-michael-s-katz-mba/ 2019-03-11T17:31:52+00:00 https://ascopost.com/issues/may-25-2015/andrew-parsa-md-phd-chair-of-neurological-surgery-at-northwestern-dies-at-48/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/remembering-mark-r-green-md-a-leader-in-lung-cancer-research-and-treatment/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/article-on-rare-cancer-generates-enthusiastic-response/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/just-engaging-in-some-leisure-time-physical-activity-reduces-overall-and-cancer-specific-mortality/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/expect-questions-about-physical-activity-and-reduced-mortality-risks/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/emergency-room-visits-and-hospitalizations-are-common-among-women-with-early-breast-cancer-receiving-chemotherapy/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/prior-cancer-does-not-affect-outcomes-among-patients-with-advanced-lung-cancer-suggesting-they-be-included-in-clinical-trials/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/egfr-l858r-mutation-in-blood-sample-may-serve-as-surrogate-for-biopsy-in-determining-egfr-mutation-status/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/therapy-for-hepatitis-c-virus-infection-in-patients-with-cancer-may-prevent-liver-disease-progression/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/people-living-with-hiv-in-the-united-states-have-a-50-excess-cancer-risk/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/cancer-survivors-facts-and-figures/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/nicholas-j-petrelli-md-receives-service-award/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/p53-takes-center-stage/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/hopa-announces-new-president-and-2015-membership-award-winners/ 2019-03-11T17:31:53+00:00 https://ascopost.com/issues/may-25-2015/profile-julie-m-vose-md-mba-fasco-making-a-difference-in-both-clinical-medicine-and-research/ 2019-03-11T17:31:54+00:00 https://ascopost.com/issues/may-10-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/may-10-2015/practice-changing-study-pembrolizumab-outperforms-ipilimumab-in-advanced-melanoma/ 2019-03-11T17:33:24+00:00 https://ascopost.com/issues/may-10-2015/expert-point-of-view-suzanne-l-topalian-md/ 2019-03-11T17:33:24+00:00 https://ascopost.com/issues/may-10-2015/creating-a-collective-path-forward-to-optimize-value-in-cancer-care/ 2019-03-11T17:33:24+00:00 https://ascopost.com/issues/may-10-2015/asco-releases-2015-report-on-the-state-of-cancer-care-in-america/ 2019-03-11T17:33:24+00:00 https://ascopost.com/issues/may-10-2015/experts-debate-can-we-cure-metastatic-breast-cancer/ 2019-03-11T17:33:24+00:00 https://ascopost.com/issues/may-10-2015/after-decades-of-uncertainty-the-sustainable-growth-rate-formula-is-repealed-by-congress/ 2019-03-11T17:33:24+00:00 https://ascopost.com/issues/may-10-2015/josé-baselga-md-phd-inaugurated-as-aacr-president/ 2019-03-11T17:33:24+00:00 https://ascopost.com/issues/may-10-2015/crizotinib-receives-breakthrough-therapy-designation-for-ros1-positive-nsclc/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/combination-immunotherapy-better-than-monotherapy-in-advanced-melanoma/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/expert-point-of-view-louis-weiner-md/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/nccn-posters-of-interest-included-studies-in-kidney-breast-and-endometrial-cancers-melanoma-and-cost-issues/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/nccn-foundation-awards-grants-to-six-young-investigators/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/immunosignature-technology-may-detect-ovarian-cancer-with-a-drop-of-blood/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/groups-join-together-to-form-ovarian-cancer-research-team/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/combining-antiangiogenic-and-vascular-disrupting-agents-improves-progression-free-survival-in-persistent-ovarian-cancer/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/improved-progression-free-survival-with-brentuximab-vedotin-after-transplantation-in-hodgkin-lymphoma-patients/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/brentuximab-vedotin-after-autologous-stem-cell-transplantation-in-high-risk-hodgkin-lymphoma-implications-of-the-aethera-trial/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/impact-of-informed-decision-making-on-breast-cancer-screening/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/informing-decision-making-about-mammography-screening/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/maryland-oncologists-faced-with-navigating-the-maze-of-chemotherapy-safety-regulations/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/usp-urged-to-work-with-asco-on-hazardous-drug-regulations/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/enhance-your-annual-meeting-experience-with-attendee-resources/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/asco-submits-comments-to-fda-on-next-generation-sequencing-tests/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/save-the-date-community-research-forum-2015-annual-meeting/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/five-reasons-to-use-social-media-at-the-asco-annual-meeting/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/providing-survivorship-care-bundle-oncology-provider-guides-and-patient-guides/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/maintenance-of-certification-activities-earn-points-at-the-asco-annual-meeting/ 2019-03-11T17:33:25+00:00 https://ascopost.com/issues/may-10-2015/conquer-cancer-foundation/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/childhood-cancers-significant-medical-success-but-many-psychosocial-needs-still-unmet/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/researchers-discuss-pilot-study-on-hallucinogenic-therapies-for-cancer-anxiety/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/a-cautionary-note-on-psilocybin-therapy/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/bombarded-with-changes-in-health-care-and-beyond-gynecologic-oncologists-prepare-for-the-challenges-ahead/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/fda-approves-ramucirumab-for-metastatic-colorectal-cancer/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/robert-coleman-md-begins-sgo-and-foundation-presidency/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/cancer-has-left-an-indelible-mark-on-me/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/clinical-trials-actively-recruiting-patients-with-neuroblastoma/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/2015-oncology-meetings/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/chemotherapy-trial-results-overestimate-survival-for-elderly-medicare-patients-with-lung-and-pancreatic-cancers/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/frailty-profile-predicts-survival-and-toxicities-in-elderly-patients-with-multiple-myeloma/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/escalation-of-oncology-services-at-end-of-life-may-be-moderated-by-coordinated-care/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/lower-30-day-mortality-increased-likelihood-of-adjuvant-chemotherapy-with-laparoscopic-vs-open-colectomy-for-stage-iii-colon-cancer/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/may-10-2015/mammographic-density-after-tamoxifen-initiation-linked-to-improved-prognosis-for-pre-and-postmenopausal-women-with-er-positive-breast-cancer/ 2019-03-11T17:33:26+00:00 https://ascopost.com/issues/april-25-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/april-25-2015/radiotherapy-or-not-in-older-women-receiving-breast-conserving-surgery-and-endocrine-treatment/ 2019-03-11T17:34:12+00:00 https://ascopost.com/issues/april-25-2015/prime-ii-and-the-omission-of-radiation-therapy-in-low-risk-elderly-patients-undergoing-breast-conservation-the-time-has-come/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/heal-thy-patient-reflections-on-the-human-side-of-medicine-physician-perspective/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/family-perspective/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/noncommunicable-diseases-are-the-leading-cause-of-death-in-low-and-middle-income-countries/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/how-the-international-innovation-grant-is-improving-cancer-care-for-women-in-myanmar/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/20-years-of-nccn-the-best-is-yet-to-come/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/remembering-dr-jane-weeks-pioneering-work-and-nccn-s-outcomes-research-initiative/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/analysis-shows-no-link-between-aromatase-inhibitor-related-musculoskeletalvasomotor-symptoms-and-relapse-free-survival/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/should-we-be-worried-if-patients-tolerate-endocrine-therapy-well/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/complete-regression-of-metastatic-cervical-cancer-is-observed-after-treatment-with-hpv-targeted-tumor-infiltrating-t-cells/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/opioid-reduction-strategy-for-postoperative-pain-after-breast-cancer-surgery/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/overweight-girls-face-increased-risk-of-colorectal-cancer-later-in-life/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/richard-pazdur-md-and-anthony-s-fauci-md-included-in-fortune-s-list-of-the-world-s-50-greatest-leaders/ 2019-03-11T17:34:13+00:00 https://ascopost.com/issues/april-25-2015/breast-cancer-management-in-review/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/evidence-of-recurrence-free-disease-free-and-overall-survival-benefit-of-aspirin-and-cox-2-inhibitor-use-in-stage-iii-colon-cancer/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/aspirin-as-adjuvant-therapy-for-colon-cancer-is-the-time-right/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/in-search-of-just-prices-questioning-the-high-cost-of-new-cancer-drugs/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/persistence-of-her2-specific-car-t-cells-in-her2-positive-sarcoma/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/preparing-for-the-silver-tsunami-and-the-impact-of-an-aging-population-on-cancer-care/ 2020-02-17T18:31:21+00:00 https://ascopost.com/issues/april-25-2015/michael-e-jung-phd-charles-sawyers-md-and-howard-i-scher-md-receive-team-science-award-from-american-association-for-cancer-research/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/triple-negative-breast-cancer-foundation-works-to-change-the-treatment-landscape-of-an-aggressive-form-of-breast-cancer/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/direct-your-patients-to-cancernet-for-informative-videos/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/cancer-control-in-primary-care-courses-offered-in-india/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/researcher-spotlight-on-conquer-cancer-foundation-international-innovation-grant-recipient-mya-thida-mbbs/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/fda-s-biosimilar-product-approval-process-a-closer-look/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/asco-s-oncology-interoperability-standard-highlighted-in-amia-s-bioinformatics-journal-club-webinar/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/ann-partridge-md-mph-confronts-challenges-facing-young-women-with-breast-cancer-with-support-from-conquer-cancer-foundation-improving-cancer-care-grant/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/fda-grants-breakthrough-therapy-designation-to-rucaparib-in-advanced-ovarian-cancer-with-brca-mutations/ 2019-03-11T17:34:14+00:00 https://ascopost.com/issues/april-25-2015/fda-grants-priority-review-to-carfilzomib-supplemental-new-drug-application-for-relapsed-multiple-myeloma/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/owen-n-witte-md-recognized-with-aacr-gha-clowes-memorial-award/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/staff-support-sessions-in-an-oncology-setting/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/recipients-of-the-2015-conquer-cancer-foundation-s-innovation-grants/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/richard-gilbertson-md-phd-leaves-st-jude-childrens-research-hospital/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/robert-h-lurie-names-associate-director-for-administration/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/dana-farber-president-and-ceo-edward-j-benz-jr-md-to-retire-in-2016/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/lewis-c-cantley-phd-honored-with-aacr-memorial-lectureship/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/aacr-honors-cancer-pioneers-at-the-2015-annual-meeting/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/too-young-to-have-cancer/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/2015-oncology-meetings/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/2015-canada-gairdner-awards-honor-top-medical-researchers-worldwide/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/scalp-cooling-caps-offer-option-to-prevent-hair-loss-during-chemotherapy/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/expect-questions-about-cold-caps-to-spare-hair-during-chemotherapy/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/widespread-use-of-docetaxel-preceded-phase-iii-evidence-of-usefulness-in-patients-with-metastatic-prostate-cancer/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/risk-assessment-for-hodgkin-lymphoma-evolving-and-promises-greater-precision-and-specific-clinical-relevance/ 2019-03-11T17:34:15+00:00 https://ascopost.com/issues/april-25-2015/objective-response-rate-of-44-among-patients-with-relapsedrefractory-dlbcl-receiving-brentuximab-vedotin/ 2019-03-11T17:34:16+00:00 https://ascopost.com/issues/april-25-2015/nivolumab-in-lung-cancer/ 2019-03-11T17:34:16+00:00 https://ascopost.com/issues/april-25-2015/the-asco-post-replies/ 2019-03-11T17:34:16+00:00 https://ascopost.com/issues/april-10-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/april-10-2015/no-survival-benefit-from-adjuvant-sorafenib-or-sunitinib-in-kidney-cancer/ 2019-03-11T17:34:46+00:00 https://ascopost.com/issues/april-10-2015/clinical-trial-participation-is-it-all-worth-it/ 2019-03-11T17:34:46+00:00 https://ascopost.com/issues/april-10-2015/immune-gene-profile-strongly-associated-with-benefit-of-adjuvant-trastuzumab-in-her2-positive-breast-cancer/ 2019-03-11T17:34:46+00:00 https://ascopost.com/issues/april-10-2015/understanding-the-role-of-immune-function-in-the-treatment-of-her2-positive-breast-cancer/ 2019-03-11T17:34:46+00:00 https://ascopost.com/issues/april-10-2015/should-oncologists-be-ordering-breast-cancer-gene-panels/ 2019-03-11T17:34:46+00:00 https://ascopost.com/issues/april-10-2015/too-early-to-use-genome-sequencing-for-breast-cancers-in-the-clinic/ 2019-03-11T17:34:46+00:00 https://ascopost.com/issues/april-10-2015/asco-commends-us-house-of-representatives-for-voting-to-repeal-the-sgr-urges-senate-to-pass-legislation/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/androgen-deprivation-therapy-added-to-radiation-therapy-improves-disease-control-in-intermediate-risk-prostate-cancer/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/expert-point-of-view-d-andrew-loblaw-md/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/evidence-mounts-for-clinical-utility-of-ar-v7-in-treatment-selection-for-advanced-prostate-cancer/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/expert-point-of-view-howard-scher-md/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/nccn-publishes-new-guidelines-for-smoking-cessation/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/cabozantinib-fails-to-improve-survival-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/expert-point-of-view-eric-j-small-md/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/state-oncology-societies-join-asco-s-call-on-congress-to-replace-sgr-formula/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/dinutuximab-in-pediatric-high-risk-neuroblastoma/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/new-tobacco-atlas-details-scale-and-harm-of-the-tobacco-epidemic/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/no-benefit-of-high-vs-standard-dose-radiotherapy-or-addition-of-cetuximab-to-chemoradiation-in-stage-iiiaiiib-nsclc/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/calculating-h-score/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/results-of-rtog-0617-reconsidered/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/fda-approves-first-biosimilar-product-filgrastim-sndz/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/fda-approves-nivolumab-to-treat-metastatic-squamous-nsclc/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/james-p-allison-phd-wins-2015-paul-ehrlich-and-ludwig-darmstaedter-prize/ 2019-03-11T17:34:47+00:00 https://ascopost.com/issues/april-10-2015/breast-cancer-management-in-review/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/emperor-science-award-program/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/biosimilar-filgrastim-sndz-in-filgrastim-indications/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/michael-h-levy-md-phd-receives-lifetime-achievement-award/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/nccn-honors-joseph-v-simone-md-fasco-and-john-a-gentile-jr-at-group-s-20th-annual-conference/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/no-overall-survival-difference-for-immediate-vs-deferred-chemotherapy-after-radical-cystectomy-in-muscle-invasive-bladder-cancer/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/adjuvant-chemotherapy-and-overall-survival-in-muscle-invasive-bladder-cancer-still-climbing-the-mountain/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/global-oncology-launches-global-cancer-project-map-with-nci/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/jim-hu-md-joins-newyork-presbyterian-hospital-and-weill-cornell-medical-college/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/current-progress-against-cancer-and-what-lies-ahead-in-the-next-decade/ 2020-09-17T19:57:30+00:00 https://ascopost.com/issues/april-10-2015/researcher-spotlight-conquering-cancer-with-emily-ko-md-mscr/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/stay-up-to-date-on-new-patient-materials-from-cancernet/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/conquer-cancer-foundation-grants-and-awards-program/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/researchers-and-scientists-honored-for-improving-cancer-prevention-treatment-and-patient-care/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/worker-safety-when-handling-hazardous-drugs-is-focus-of-statement-by-oncology-societies/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/st-jude-children-s-research-hospital-appoints-chair-of-department-of-radiation-oncology/ 2019-03-11T17:34:48+00:00 https://ascopost.com/issues/april-10-2015/the-emerging-role-of-radiation-therapy-in-gastrointestinal-cancers/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/increased-progression-free-survival-with-addition-of-carfilzomib-to-lenalidomidedexamethasone-in-relapsed-multiple-myeloma/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/the-aspire-trial-of-carfilzomib-in-relapsed-myeloma-a-major-step-forward/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/fda-approves-isavuconazonium-sulfate-for-the-treatment-of-invasive-aspergillosis-and-invasive-mucormycosis/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/nivolumab-in-metastatic-squamous-non-small-cell-lung-cancer-after-platinum-therapy/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/why-just-having-good-communication-skills-is-not-enough-for-talking-with-seriously-ill-patients/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/american-association-for-cancer-research-elects-new-board-of-directors-nominating-committee-members/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/ons-lifetime-achievement-award/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/adding-cetuximab-to-first-line-folfiri-does-not-benefit-metastatic-colorectal-cancer-patients-with-ras-mutations/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/refining-the-right-patient-right-drug-pairing-in-cancer-care-ras-profiling-in-metastatic-colorectal-cancer/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/the-ongoing-struggle-against-tobacco-past-accomplishments-future-steps/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/technology-s-double-edged-sword-one-woman-s-story/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/2015-oncology-meetings/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/a-surgeon-cuts-to-the-chase/ 2019-03-11T17:34:49+00:00 https://ascopost.com/issues/april-10-2015/shining-a-spotlight-on-epithelioid-hemangioendothelioma/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/colorectal-cancer-is-significantly-increasing-among-younger-adults-and-being-diagnosed-at-later-stages/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/don-t-disregard-questions-about-possible-symptoms-of-colorectal-cancer-just-because-the-patient-is-too-young/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/i-refuse-to-capitulate-to-cancer/ 2020-09-17T19:58:56+00:00 https://ascopost.com/issues/april-10-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/health-and-economic-burden-of-skin-cancer-substantial-and-increasing-highlighting-the-value-of-prevention-efforts/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/adding-aflibercept-to-folfiri-resulted-in-persistent-improvement-in-overall-survival-over-time-in-patients-with-metastatic-disease/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/use-of-minimally-invasive-colorectal-cancer-surgery-increases-at-nccn-centers-but-wide-variation-exists/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/are-physicians-choosing-wisely-when-imaging-for-distant-metastases-in-early-stage-breast-cancer/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/targeted-mrultrasound-fusion-guided-biopsy-increased-detection-of-high-risk-prostate-cancer/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/radiotherapy-in-good-prognosis-dlbcl/ 2020-09-17T20:01:37+00:00 https://ascopost.com/issues/april-10-2015/association-of-community-cancer-centers-names-steven-l-d-amato-bspharm-bcop-president/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/april-10-2015/remembering-neurosurgeon-and-writer-paul-kalanithi-md/ 2019-03-11T17:34:50+00:00 https://ascopost.com/issues/march-25-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/march-25-2015/intensified-immunotherapy-encouraging-in-chemotherapy-naive-metastatic-prostate-cancer/ 2019-03-11T17:35:27+00:00 https://ascopost.com/issues/march-25-2015/expert-point-of-view-charles-ryan-md/ 2019-03-11T17:35:27+00:00 https://ascopost.com/issues/march-25-2015/health-care-fraud-and-abuse-implications-for-oncology/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/our-aging-population-challenges-in-caring-for-older-patients-with-cancer/ 2020-02-17T18:28:14+00:00 https://ascopost.com/issues/march-25-2015/no-survival-benefit-reported-with-docetaxel-added-to-hormone-therapy-in-metastatic-prostate-cancer/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/expert-point-of-view-eric-j-small-md/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/high-dose-radiotherapy-provides-meaningful-improvements-in-localized-prostate-cancer-but-not-increased-survival-yet/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/expert-point-of-view-andrew-loblaw-md/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/antiangiogenesis-plus-chemotherapy-pursued-in-advanced-bladder-cancer/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/expert-point-of-view-jonathan-rosenberg-md/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/adjuvant-chemotherapy-favored-in-locally-advanced-bladder-cancer-not-treated-with-neoadjuvant-therapy/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/expert-point-of-view-matthew-i-milowsky-md/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/aacr-names-nancy-e-davidson-md-president-elect-for-2015-2016/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/winship-cancer-institute-of-emory-university-names-new-chief-medical-officer-and-chief-quality-officer/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/priority-review-granted-for-trabectedin-in-advanced-soft-tissue-sarcoma/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/many-cancer-patients-at-risk-for-hepatitis-b-virus-reactivation/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/optimal-timing-of-rectal-surgery-60-days-or-less-post-chemoradiation-therapy/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/expert-point-of-view-nancy-kemeny-md/ 2019-03-11T17:35:28+00:00 https://ascopost.com/issues/march-25-2015/hypofractionated-whole-breast-irradiation-after-breast-conserving-surgery-used-in-up-to-one-third-of-eligible-patients/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/increasing-the-use-of-hypofractionated-radiation-in-early-stage-breast-cancer-the-way-forward/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/new-analysis-reports-increased-risk-of-thyroid-cancer-after-breast-cancer-diagnosis/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/thyroid-cancer-risk/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/adjuvant-ovarian-suppression-may-benefit-women-with-premenopausal-breast-cancer-who-received-prior-chemotherapy/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/soft-trial-results-inconclusive-further-study-needed/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/physician-controlled-decisions-in-cancer-care-linked-to-lower-quality-rating/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/gastric-breast-cancer-risk-in-carriers-of-cdh1-gene-mutations/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/ongoing-controversies-in-allocating-our-health-care-resources/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/upmc-whitfield-cancer-centre-receives-joint-commission-international-accreditation/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/lenalidomide-in-combination-with-dexamethasone-in-newly-diagnosed-multiple-myeloma/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/new-lurie-cancer-center-program-combines-oncology-with-genomics-to-provide-more-personalized-cancer-care/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/development-and-approval-of-biosimilar-products/ 2019-03-11T17:35:29+00:00 https://ascopost.com/issues/march-25-2015/fda-names-geoffrey-kim-md-director-of-the-division-of-oncology-products/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/panobinostat-in-combination-with-bortezomib-dexamethasone-in-previously-treated-multiple-myeloma/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/2015-pre-annual-meeting-seminars-feature-important-topics-for-modern-cancer-care-providers/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/asco-supports-fda-s-proposed-regulation-of-laboratory-developed-tests/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/fda-takes-steps-to-simplify-compassionate-use-process-invites-comment/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/beating-the-odds-in-the-big-casino/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/helping-patients-understand-palliative-care/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/asco-s-patient-resources-for-colorectal-cancer-awareness-month/ 2019-03-11T17:35:30+00:00 https://ascopost.com/issues/march-25-2015/new-oncology-care-model-encouraging-better-coordination-for-cancer-care/ 2019-03-11T17:35:31+00:00 https://ascopost.com/issues/march-25-2015/asco-expresses-concern-over-new-oncology-care-model/ 2019-03-11T17:35:31+00:00 https://ascopost.com/issues/march-25-2015/avoiding-burnout-and-maintaining-well-being-while-caring-for-seriously-ill-patients/ 2019-03-11T17:35:31+00:00 https://ascopost.com/issues/march-25-2015/five-questions-can-guide-the-treatment-of-relapsed-myeloma/ 2019-03-11T17:35:31+00:00 https://ascopost.com/issues/march-25-2015/fda-launches-drug-shortages-mobile-app/ 2019-03-11T17:35:31+00:00 https://ascopost.com/issues/march-25-2015/seattle-children-s-names-jeff-sperring-md-new-chief-executive-officer/ 2019-03-11T17:35:31+00:00 https://ascopost.com/issues/march-25-2015/new-partnership-launches-to-empower-people-diagnosed-with-lymphoma/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/dinutuximab-combination-approved-for-pediatric-high-risk-neuroblastoma/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/silvia-c-formenti-md-appointed-chair-of-radiation-oncology-at-weill-cornell-and-radiation-oncologist-in-chief-at-new-york-presbyterian-weill-cornell/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/medicine-turned-upside-down/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/wrestling-with-the-challenges-of-breast-cancer/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/fred-hutchinson-health-economist-gary-lyman-md-mph-editor-of-recently-released-oncology-handbook/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/clinical-trials-actively-recruiting-patients-with-esophageal-cancer/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/herbal-supplements-increasing-problems/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/study-finds-websites-that-market-personalized-cancer-care-services-overemphasize-benefits/ 2019-03-11T17:35:32+00:00 https://ascopost.com/issues/march-25-2015/mobile-patient-centered-app-tracks-breast-cancer-survivors-experiences/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/dr-halsted-s-breast-amputation-specimens-johns-hopkins-hospital-1894/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/2015-oncology-meetings/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/harold-varmus-md-steps-down-as-nci-director-douglas-lowy-md-named-acting-director/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/asco-commends-dr-varmus-for-outstanding-leadership/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/the-center-of-who-we-are/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/having-cancer-so-early-in-life-gave-me-purpose/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/recognizing-physical-signs-associated-with-impending-death-can-assist-clinicians-patients-and-caregivers-with-complex-decisions/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/caregivers-may-want-to-know-about-a-patient-s-impending-death-but-may-be-afraid-to-ask/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/selenium-supplements-after-diagnosis-of-nonmetastatic-prostate-cancer-may-raise-prostate-cancer-mortality-risk/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/nearly-half-of-women-taking-tamoxifen-for-primary-prevention-discontinue-its-use-before-5-years/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-25-2015/key-evidence-gaps-and-research-priorities-should-be-addressed-so-physicians-can-identify-patients-most-likely-to-benefit-from-opioids/ 2019-03-11T17:35:33+00:00 https://ascopost.com/issues/march-10-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/march-10-2015/active-surveillance-in-intermediate-risk-prostate-cancer-called-into-question/ 2019-03-11T17:36:22+00:00 https://ascopost.com/issues/march-10-2015/big-data-and-the-promise-of-precision-medicine-in-cancer/ 2019-03-11T17:36:22+00:00 https://ascopost.com/issues/march-10-2015/addressing-the-global-cancer-burden/ 2019-03-11T17:36:22+00:00 https://ascopost.com/issues/march-10-2015/new-data-reported-in-colorectal-gastric-and-pancreatic-cancers/ 2019-03-11T17:36:22+00:00 https://ascopost.com/issues/march-10-2015/inhibiting-the-met-pathway-in-gastroesophageal-cancer-hits-and-misses/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/expert-point-of-view-jaffer-a-ajani-md/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/targeting-biliary-tract-cancers-through-genomic-profiling/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/expert-point-of-view-laura-a-dawson-md/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/lanreotide-evaluated-in-pancreatic-neuroendocrine-subgroup/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/expert-point-of-view-hagan-kennecke-md/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/pi3k-inhibition-in-hormone-receptor-positive-breast-cancer-not-ready-for-prime-time/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/from-ash-2014-what-s-new-in-the-myeloma-treatment-arsenal/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/hiv-related-lymphoma-can-be-safely-treated-with-transplant/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/expert-point-of-view-richard-little-md/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/nivolumab-shows-activity-in-previously-treated-metastatic-renal-cell-carcinoma/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/nivolumab-in-previously-treated-metastatic-renal-cell-cancer/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/lenvatinib-in-advanced-radioiodine-refractory-differentiated-thyroid-cancer/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/fda-approves-palbociclib-in-combination-with-letrozole-for-advanced-breast-cancer/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/fda-grants-cobimetinib-priority-review-for-use-in-combination-with-vemurafenib-in-advanced-melanoma/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/fda-grants-breakthrough-therapy-designation-to-mpdl3280a-for-non-small-cell-lung-cancer/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/fda-approves-lenvatinib-for-progressive-radioiodine-refractory-differentiated-thyroid-cancer/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/human-reovirus-formulation-gets-orphan-drug-designation-in-ovarian-and-pancreatic-cancer/ 2019-03-11T17:36:23+00:00 https://ascopost.com/issues/march-10-2015/first-line-crizotinib-improves-progression-free-survival-vs-chemotherapy-in-alk-positive-nsclc/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/crizotinib-crosses-another-finish-line-in-lung-cancer/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/determining-why-not-all-patients-respond-to-pd-1-inhibitors/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/jennifer-adair-phd-recognized-as-outstanding-new-investigator/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/clonal-hematopoiesis-with-somatic-mutations-increases-risk-of-hematologic-cancer-mortality-and-cardiovascular-disease/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/aged-to-im-perfection-age-related-clonal-hematopoiesis/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/conquer-cancer-foundation-researcher-spotlight/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/expanding-the-reach-of-asco-s-educational-efforts/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/highlights-from-the-2014-asco-quality-care-symposium/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/introduce-your-patients-to-pre-act/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/asco-supports-hhs-shift-toward-alternative-payment-models/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/highlights-from-the-2014-palliative-care-in-oncology-symposium/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/asco-collaborates-in-launch-of-crowd-sourced-molecular-oncology-tumor-board-series/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/combination-treatment-every-2-weeks-may-benefit-some-women-with-high-risk-early-stage-breast-cancer/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/the-search-for-optimal-adjuvant-breast-cancer-chemotherapy-the-end-of-an-era/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/md-anderson-receives-223-million-in-cprit-research-funding/ 2019-03-11T17:36:24+00:00 https://ascopost.com/issues/march-10-2015/pd-1-blockade-with-nivolumab-produces-high-response-rate-in-relapsedrefractory-hodgkin-lymphoma/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/for-hodgkin-lymphoma-patients-it-aint-over/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/clinically-inappropriate-patient-demands-of-oncologists-happen-more-infrequently-than-expected/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/treating-head-and-neck-cancer-in-2015/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/american-association-for-cancer-research-inducts-2015-class-of-fellows-of-the-aacr-academy/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/md-anderson-names-patrick-hwu-md-head-of-cancer-medicine/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/aahpm-unveils-list-of-inspiring-hospice-and-palliative-medicine-leaders-under-40/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/the-current-state-of-hematologic-malignancies/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/fda-approves-panobinostat-combination-for-the-treatment-of-multiple-myeloma/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/fda-approves-lenalidomide-in-combination-with-dexamethasone-for-newly-diagnosed-multiple-myeloma/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/improving-the-quality-of-palliative-care-in-oncology/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/kay-research-and-care-center-opens-at-st-jude-children-s-research-hospital/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/palbociclib-as-initial-endocrine-based-therapy-in-postmenopausal-women-with-metastatic-breast-cancer/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/international-marketing-expert-claire-huang-appointed-to-conquer-cancer-foundation-leadership/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/douglas-r-lowy-md-receives-harrington-prize-for-innovation-in-medicine/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/texas-center-for-proton-therapy-names-andrew-k-lee-md-medical-director/ 2019-03-11T17:36:25+00:00 https://ascopost.com/issues/march-10-2015/bringing-the-history-of-cancer-to-film/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/telling-the-story-of-cancer/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/the-journey-from-book-to-film/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/cancer-was-my-wake-up-call-to-a-healthier-life/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/2015-oncology-meetings/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/asco-commends-margaret-hamburg-md-for-leadership-as-fda-commissioner/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/thomas-j-rutherford-md-phd-named-network-physician-director-of-cancer-services-at-western-connecticut-health-network/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/john-a-hartford-foundation-names-terry-fulmer-phd-rn-as-new-president/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/theodore-lawrence-md-phd-named-director-of-university-of-michigan-comprehensive-cancer-center/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/lee-schwartzberg-md-appointed-vice-chairman-of-caris-centers-of-excellence-network/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/lee-w-wattenberg-md-the-father-of-chemoprevention-dies-at-92/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/measles-presents-greater-risks-in-children-being-treated-for-cancer/ 2019-03-11T17:36:26+00:00 https://ascopost.com/issues/march-10-2015/expect-questions-about-measles-from-parents-of-children-with-cancer/ 2019-03-11T17:36:27+00:00 https://ascopost.com/issues/march-10-2015/if-measles-was-declared-eliminated-in-2000-why-the-outbreak/ 2019-03-11T17:36:27+00:00 https://ascopost.com/issues/march-10-2015/dianne-knight-md-awarded-fellow-status-from-the-american-academy-of-hospice-and-palliative-medicine/ 2019-03-11T17:36:27+00:00 https://ascopost.com/issues/march-10-2015/high-quality-diet-before-ovarian-cancer-diagnosis-may-lengthen-survival/ 2019-03-11T17:36:27+00:00 https://ascopost.com/issues/march-10-2015/racial-disparities-in-survival-related-more-to-health-differences-at-diagnosis-than-to-subsequent-treatment/ 2019-03-11T17:36:27+00:00 https://ascopost.com/issues/march-10-2015/cutaneous-adverse-effects-associated-with-tyrosine-kinase-inhibitors-may-impact-quality-of-life-and-adherence-to-treatment/ 2019-03-11T17:36:27+00:00 https://ascopost.com/issues/february-25-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/february-25-2015/ramucirumab-added-to-folfiri-yields-results-similar-to-bevacizumab-or-aflibercept-in-second-line-colorectal-cancer/ 2019-03-11T17:37:13+00:00 https://ascopost.com/issues/february-25-2015/expert-point-of-view-smitha-s-krishnamurthi-md-and-leonard-b-saltz-md/ 2019-03-11T17:37:13+00:00 https://ascopost.com/issues/february-25-2015/translational-research-under-assault-from-the-bottom-line/ 2019-03-11T17:37:13+00:00 https://ascopost.com/issues/february-25-2015/abim-president-richard-j-baron-md-announces-immediate-changes-to-maintenance-of-certification-program/ 2019-03-11T17:37:13+00:00 https://ascopost.com/issues/february-25-2015/asco-president-on-abim-decision/ 2019-03-11T17:37:13+00:00 https://ascopost.com/issues/february-25-2015/statement-from-the-nbpas/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/surgery-plus-immunotherapy-improves-survival-in-melanoma-patients-with-gastrointestinal-metastases/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/pancreatic-cancer-latest-drug-development-hits-and-misses/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/folfirinox-plus-radiation-renders-some-locally-advanced-pancreatic-cancer-patients-resectable/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/radiotherapy-alone-as-effective-as-chemoradiation-therapy-in-palliation-of-dysphagia-in-patients-with-advanced-esophageal-cancer/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/expert-point-of-view-david-ilson-md/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/first-randomized-trial-to-show-benefit-of-tyrosine-kinase-inhibitor-in-newly-diagnosed-acute-myeloid-leukemia/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/expert-point-of-view-david-steensma-md-and-bob-loewenberg-md/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/high-hopes-for-ag-221-in-advanced-leukemia/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/expert-point-of-view-david-steensma-md/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/radiotherapy-in-good-prognosis-dlbcl/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/oral-proteasome-inhibitors-advancing-in-multiple-myeloma-trials/ 2019-03-11T17:37:14+00:00 https://ascopost.com/issues/february-25-2015/tailoring-therapy-for-diffuse-large-b-cell-lymphoma-by-interim-pet-may-be-problematic/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/international-society-of-geriatric-oncology-at-the-forefront-of-physician-education-and-research-dissemination-in-geriatric-oncology/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/cms-issues-final-decision-to-cover-lung-ct-screening/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/tnt-trial-supports-platinums-in-brca-mutated-breast-cancer/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/expert-point-of-view-george-sledge-md/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/shedding-light-on-the-mystery-of-male-breast-cancer/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/asco-endorses-esmo-guideline-on-hereditary-colorectal-cancer-syndromes/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/new-product-may-help-to-reduce-non-compliance/ 2019-03-11T17:37:15+00:00 https://ascopost.com/issues/february-25-2015/asco-endorsement-of-esmo-guidelines-on-hereditary-colorectal-cancer-syndromes/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/how-changes-to-acgme-s-accreditation-standards-are-affecting-fellowship-training/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/molecular-oncology-tumor-boards-invite-discussion-of-growing-field-in-cancer-care/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/conquer-cancer-foundation-researchers-lead-six-key-studies-featured-in-clinical-cancer-advances-2015/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/asco-aacr-call-for-regulation-of-electronic-nicotine-delivery-systems/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/funding-promising-women-researchers-women-who-conquer-cancer/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/health-care-issues-front-and-center-on-capitol-hill-in-statehouses-this-year/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/show-your-patients-the-latest-research-on-genitourinary-cancers/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/iom-report-recommends-guidelines-for-sharing-clinical-trial-data/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/two-case-reports-on-the-evaluation-of-myeloid-neoplasm/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/case-reports-on-myeloid-neoplasm/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/pharmacokinetics-and-exposure-response-in-drug-development/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/ibrutinib-for-waldenstroem-s-macroglobulinemia/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/no-benefit-of-adding-iniparib-to-gemcitabinecarboplatin-in-metastatic-triple-negative-breast-cancer/ 2019-03-11T17:37:16+00:00 https://ascopost.com/issues/february-25-2015/iniparib-the-fairy-tale-dream-comes-to-an-end/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/blinatumomab-in-philadelphia-chromosome-negative-relapsedrefractory-b-cell-precursor-all/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/capsaicin/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/astro-announces-additions-to-management-team/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/at-long-last-cms-will-cover-lung-cancer-screening/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/skull-sarcoma-removed-under-local-anesthesia-east-prussia-circa-1921/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/twenty-years-after-a-diagnosis-and-counting/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/2015-oncology-meetings/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/susan-m-o-brien-joins-uc-irvinechao-family-comprehensive-cancer-center/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/nci-funded-program-on-screening-for-psychosocial-distress-accepting-applications/ 2019-03-11T17:37:17+00:00 https://ascopost.com/issues/february-25-2015/roswell-park-cancer-institute-announces-candace-s-johnson-phd-as-15th-president-and-chief-executive-officer/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/first-line-crizotinib-superior-to-pemetrexed-plus-platinum-chemotherapy-in-patients-with-alk-positive-nsclc/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/primary-surgical-therapy-results-in-higher-5-year-survival-for-patients-with-advanced-stage-disease/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/thomas-j-smith-md-honored-by-the-american-cancer-society/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/physician-scientist-guido-marcucci-md-joins-city-of-hope/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/atypical-hyperplasia-as-a-predictor-of-future-breast-cancer-focus-on-chemoprevention-and-screening/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/expect-questions-about-atypical-hyperplasia-as-an-important-risk-factor-for-breast-cancer/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/asco-to-launch-journal-of-global-oncology-names-founding-editor-in-chief/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/more-on-ramucirumab-in-metastatic-colorectal-cancer/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/more-on-beating-the-odds/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/glioblastoma-clinical-trials/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-25-2015/dr-howard-fine-named-founding-director-of-the-brain-tumor-center-at-newyork-presbyterian-hospitalweill-cornell-medical-center/ 2019-03-11T17:37:18+00:00 https://ascopost.com/issues/february-10-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/february-10-2015/observation-appropriate-for-some-patients-with-rectal-cancer-following-neoadjuvant-therapy/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/expert-point-of-view-george-j-chang-md/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/cancer-genetics-looking-back-looking-ahead/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/asco-releases-annual-report-on-progress-against-cancer/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/modified-nab-paclitaxelgemcitabine-in-pancreatic-cancer-efficacious-less-toxic-less-costly/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/enzalutamide-shows-encouraging-activity-in-triple-negative-breast-cancer/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/expert-point-of-view-ramesh-narayanan-phd/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/e1199-update-it-s-weekly-paclitaxel-for-triple-negative-breast-cancer/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/expert-point-of-view-ann-h-partridge-md-mph/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/dr-mary-claire-king-proposes-population-screening-in-all-young-women-for-brca-mutations/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/news-roundup-from-the-2014-san-antonio-breast-cancer-symposium/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/strong-showing-for-anti-cd38-antibodies-in-multiple-myeloma/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/car-t-cells-impressive-in-acute-lymphocytic-leukemia/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/expert-point-of-view-timothy-graubert-md/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/inotuzumab-ozogamicin-plus-low-intensity-chemotherapy-a-winner-in-older-patients-with-leukemia/ 2019-03-11T17:38:05+00:00 https://ascopost.com/issues/february-10-2015/expert-point-of-view-yoav-messinger-md/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/fda-expands-approved-use-of-ibrutinib-for-waldenstroem-s-macroglobulinemia/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/minimally-invasive-techniques-used-to-address-small-gist-lesions/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/fda-appoints-robert-califf-md-deputy-commissioner-for-medical-products-and-tobacco/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/ruxolitinib-for-polycythemia-vera/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/treating-bladder-cancer-in-2015/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/university-of-pittsburgh-appoints-director-of-stem-cell-transplantation/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/novel-genomic-signature-predicts-postcystectomy-recurrence-in-high-risk-bladder-cancer/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/molecular-classification-predicts-postcystectomy-recurrence-in-high-risk-bladder-cancer/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/cornerstone-spotlight-frank-m-muller-jr/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/five-organizations-awarded-2015-international-innovation-grants-to-improve-cancer-care-in-low-and-middle-income-countries/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/asco-names-advance-of-the-year-reviews-top-research-trends/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/help-your-patients-understand-the-importance-of-phase-i-clinical-trials/ 2019-03-11T17:38:06+00:00 https://ascopost.com/issues/february-10-2015/asco-policy-statement-urges-removal-of-barriers-to-patient-participation-in-phase-i-clinical-trials/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/ramucirumab-in-metastatic-non-small-cell-lung-cancer/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/four-gene-panel-predicts-response-to-letrozole/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/expert-point-of-view-matthew-j-ellis-mb-bchir-phd/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/moffitt-cancer-center-reports-on-faculty-participants-in-international-discovery-of-genetic-risk-factors-for-ovarian-cancer/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/new-choosing-wisely-list-leukemia-quick-takes-from-ash/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/cpx-351-receives-fast-track-designation-for-secondary-acute-myeloid-leukemia-in-elderly-patients/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/supplemental-new-drug-application-for-carfilzomib/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/transitioning-from-volume-to-value-in-cancer-care/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/consensus-points-at-the-accc-institute-for-the-future-of-oncology-forum/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/friends-of-cancer-research-holds-annual-conference-on-clinical-cancer-research/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/west-cancer-center-announces-the-university-of-tennessee-west-institute-for-cancer-research/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/suzanne-topalian-md-recognized-for-pioneering-work-in-immunotherapy-treatment-of-melanoma-and-other-cancers/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/clinical-trials-actively-recruiting-patients-with-glioblastoma/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/2015-oncology-meetings/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/cancer-has-given-me-more-than-it-has-taken-away/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:38:07+00:00 https://ascopost.com/issues/february-10-2015/elizabeth-m-jaffee-md-named-deputy-director-of-johns-hopkins-kimmel-cancer-center/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/loretta-doan-phd-named-vice-president-of-policy-and-global-affairs-at-aacc/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/chemobrain-study-aims-to-correlate-structural-changes-within-the-brain-and-psychomotor-function/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/patients-may-voice-concerns-about-chemotherapy-effects-on-the-brain-even-if-they-have-never-heard-of-chemobrain/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/bipolar-androgen-therapy-in-castration-resistant-prostate-cancer/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/pedf-improves-lung-cancer-response-to-radiation-via-vasculature-normalization/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/lamc2-increases-the-metastatic-potential-of-lung-adenocarcinoma/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/zoledronic-acid-inhibits-angiogenesis-in-ovarian-cancer-patients/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/therapeutic-dna-vaccination-against-colorectal-cancer-via-myb-targeting/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/adding-cd47-to-artificial-antigen-presenting-cells-may-stimulate-t-cell-responses-and-improve-functionality/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/mammographically-dense-breasts-highly-prevalent-among-american-women/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/adding-sargramostim-to-ipilimumab-improved-overall-survival-among-patients-with-unresectable-stage-iii-or-iv-melanoma/ 2019-03-11T17:38:08+00:00 https://ascopost.com/issues/february-10-2015/high-genetic-propensity-to-obesity-raises-risk-of-esophageal-adenocarcinoma/ 2019-03-11T17:38:09+00:00 https://ascopost.com/issues/february-10-2015/unraveling-the-mysteries-of-epithelioid-hemangioendothelioma/ 2019-03-11T17:38:09+00:00 https://ascopost.com/issues/february-10-2015/growing-support-group-for-epithelioid-hemangioendothelioma-spins-the-wheel-of-hope/ 2019-03-11T17:38:09+00:00 https://ascopost.com/issues/january-25-2015/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/january-25-2015/carfilzomib-based-triplet-yields-unprecedented-duration-of-remission-in-relapsed-myeloma/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-david-h-vesole-md-phd-facp/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/what-is-a-physician-call-a-spade-a-spade/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/ovarian-suppression-plus-hormonal-therapy-may-be-practice-changing-in-premenopausal-hormone-receptor-positive-early-stage-breast-cancer/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/brentuximab-vedotin-added-to-standard-therapy-for-advanced-stage-hodgkin-lymphoma-may-improve-results/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-fredrick-hagemeister-md/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/post-transplant-brentuximab-vedotin-improved-progression-free-survival-in-hodgkin-lymphoma-patients/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-brad-s-kahl-md/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/nilotinib-with-low-intensity-chemotherapy-useful-in-elderly-patients-with-philadelphia-chromosome-positive-all/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-david-steensma-md/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/neoadjuvant-therapy-in-triple-negative-breast-cancer-impact-of-subtype/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/pembrolizumab-holds-promise-in-breast-cancer-early-studies-suggest/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-mary-l-disis-md/ 2019-03-11T17:38:56+00:00 https://ascopost.com/issues/january-25-2015/bolero-1-everolimus-plus-trastuzumabpaclitaxel-misses-the-mark-in-first-line-her2-positive-advanced-breast-cancer/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/fda-approves-nivolumab-for-advanced-melanoma/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/fda-approves-ramucirumab-combination-for-non-small-cell-lung-cancer/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/fda-approves-olaparib-to-treat-brca-mutated-advanced-ovarian-cancer/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/tamoxifen-prevention-of-breast-cancer-extends-more-than-16-years/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-erin-hofstatter-md/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/fulvestrant-surpasses-anastrozole-in-first-line-treatment-of-metastatic-breast-cancer/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/vitamin-d-protects-against-colorectal-cancer-by-boosting-the-immune-system/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/contralateral-prophylactic-mastectomy-know-the-data-when-discussing-the-option-with-patients/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/significant-improvement-in-progression-free-survival-using-sunitinib-as-switch-maintenance-in-advanced-nsclc/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/clinically-meaningful-improvements-in-survival-for-patients-with-nsclc-when-veliparib-is-added-to-carboplatin-and-paclitaxel/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/more-than-15-million-cancer-deaths-averted-during-2-decades-of-dropping-mortality/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/top-10-lessons-learned-so-far-about-treating-lung-cancer-with-immunotherapy/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/overdiagnosis-may-be-overblown-in-lung-cancer-screening/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/molecular-pathologists-vs-the-fda-proposed-regulation-of-laboratory-developed-tests-sparks-debate/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/fda-s-draft-guidance-for-laboratory-developed-tests/ 2019-03-11T17:38:57+00:00 https://ascopost.com/issues/january-25-2015/colorectal-cancer-2015/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/asco-and-aacr-call-for-regulation-of-e-cigarettes-and-other-electronic-nicotine-delivery-systems/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/treatment-paradigm-in-advanced-melanoma-poised-for-change-again/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/fda-s-janet-woodcock-md-receives-lifetime-achievement-award-from-the-institute-for-safe-medication-practices/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/oncologists-pathologists-partner-to-improve-practice-and-optimize-patient-care/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/fda-drug-approvals-2014/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/anti-pd-1-antibody-nivolumab-in-previously-treated-unresectable-or-metastatic-melanoma/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/rare-cancer-expert-richard-carvajal-md-appointed-director-of-experimental-therapeutics/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/top-10-myths-about-fda-s-office-of-hematology-and-oncology-products/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/cancernet-launches-pre-act-patient-clinical-trial-education-program/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/latest-asco-sep-edition-includes-20-point-maintenance-of-certification-course/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/palliative-care-in-the-middle-east/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/asco-s-international-palliative-care-workshops/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/save-the-date-world-cancer-day-2015/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/new-asco-study-aims-to-learn-from-patient-access-to-targeted-cancer-drugs-used-off-label/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/highlights-from-the-2015-gastrointestinal-cancers-symposium/ 2019-03-11T17:38:58+00:00 https://ascopost.com/issues/january-25-2015/gary-levine-md-president-of-national-consortium-of-breast-centers-to-lead-memorialcare-health-system-breast-centers-in-southern-california/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/victor-filadora-md-mba-named-chief-of-clinical-services-at-roswell-park-cancer-institute/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/low-fat-diet-reduces-mortality-in-breast-cancer-subset/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-amy-h-comander-md/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/no-benefit-for-adjuvant-capecitabine-monotherapy-in-elderly-patients-with-early-stage-breast-cancer/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/oncotype-dx-ductal-carcinoma-in-situ-score-reliably-predicts-tumor-recurrence/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-benjamin-o-anderson-md/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/nab-paclitaxel-boosts-pathologic-complete-response-in-high-risk-breast-cancer/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-lajos-pusztai-md/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/ultrasonography-detects-mammographically-occult-invasive-cancers/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/nivolumab-improves-outcomes-vs-dacarbazine-in-previously-untreated-advanced-melanoma-without-a-braf-mutation/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/survival-benefits-of-front-line-treatment-with-nivolumab-for-advanced-melanoma-confirmed-yet-questions-remain/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/lanreotide-in-gastroenteropancreatic-neuroendocrine-tumors/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/coupling-head-and-neck-cancer-screening-and-lung-cancer-scans-could-improve-early-detection-survival/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/crizotinib-in-ros1-positive-nsclc-a-next-step-forward/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/daniel-f-hayes-md-fasco-elected-asco-president-for-2016-2017-term/ 2019-03-11T17:38:59+00:00 https://ascopost.com/issues/january-25-2015/no-benefit-of-adding-lapatinib-to-fulvestrant-in-hormone-receptor-positive-advanced-breast-cancer/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/complexities-of-targeting-her2-in-estrogen-receptor-positive-breast-cancers/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/appointments-and-awards-announced-at-the-johns-hopkins-kimmel-cancer-center/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/physical-activity-improves-survival-for-men-with-localized-prostate-cancer/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/fda-approves-companion-diagnostic-for-the-detection-of-brca12-mutations-in-ovarian-cancer/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/breast-health-global-initiative-tackles-third-world-health-care/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/venetoclax-gaining-ground-in-two-types-of-leukemia/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-timothy-graubert-md/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/blinatumomab-achieves-complete-molecular-responses-in-majority-of-b-cell-leukemia-patients/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/expert-point-of-view-catherine-bollard-md/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/victory-for-pediatric-regimens-in-adolescents-and-young-adults-with-all/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/nih-recruits-three-lasker-clinical-research-scholars/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/two-oncology-leaders-elected-members-of-asco-nominating-committee/ 2019-03-11T17:39:00+00:00 https://ascopost.com/issues/january-25-2015/cleveland-clinic-piloting-adaptive-therapy-approach-in-multiple-myeloma/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/will-checkpoint-inhibitors-be-winners-in-hematologic-cancers-too/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/study-finds-whole-genome-sequencing-is-successful-in-identifying-patients-risk-for-inherited-cancers/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/panelists-lambast-explore-the-high-cost-of-cancer-drugs/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/2015-oncology-meetings/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/gardasil-9-adds-protection-against-cancer-caused-by-additional-human-papillomavirus-types/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/smarter-trial-design-saves-money-and-produces-better-drugs/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/city-of-hope-celebrates-hope-in-the-2015-tournament-of-roses-parade/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/what-it-means-to-be-mortal/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/mother-of-bone-marrow-transplantation-dorothy-dottie-thomas-dies-at-92/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/incorporating-physical-medicine-and-rehabilitation-into-palliative-care/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/md-anderson-unitedhealthcare-launch-new-cancer-care-payment-model/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/olaparib-for-brca-mutated-previously-treated-advanced-ovarian-cancer/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/personalized-integrative-cancer-care-focus-of-the-11th-international-conference-of-the-society-for-integrative-oncology/ 2019-03-11T17:39:01+00:00 https://ascopost.com/issues/january-25-2015/the-best-of-sio/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/sio-clinical-practice-guidelines-on-the-use-of-integrative-therapies-as-supportive-care-in-patients-treated-for-breast-cancer/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/the-long-and-winding-road-to-modern-integrative-oncology/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/cdc-awards-grant-to-program-for-young-women-with-breast-cancer-at-dana-farber-cancer-institute/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/life-is-like-riding-a-bicycle/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/fda-approves-denosumab-for-the-treatment-of-hypercalcemia-of-malignancy-refractory-to-bisphosphonate-therapy/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/clinical-trials-actively-recruiting-children-and-young-adults-with-cancer/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/ovarian-cancer-has-taught-me-to-be-fearless/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/man-with-tumor-of-the-breast-albumen-print-paris-1873/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/electro-gynecology-philadelphia-1883/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/physicians-need-to-maintain-flexibility-to-deviate-from-treatment-guidelines-without-financial-penalties/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/citing-guidelines-may-reassure-patients/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/ajcc-cancer-staging-system-is-most-accurate-measuring-response-to-chemoradiation-in-locally-advanced-rectal-cancer/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/patients-with-chronic-lymphocytic-leukemia-who-progress-after-front-line-treatment-may-be-candidates-for-novel-noncytotoxic-therapies/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/ten-best-practice-measures-improve-quality-of-care-during-perioperative-period-for-patients-with-glioma/ 2019-03-11T17:39:02+00:00 https://ascopost.com/issues/january-25-2015/about-25-of-patients-who-undergo-breast-conservation-surgery-for-stage-0-to-ii-carcinoma-have-subsequent-surgery/ 2019-03-11T17:39:03+00:00 https://ascopost.com/issues/january-25-2015/mammographic-density-is-highly-heritable-possibly-explaining-the-familial-aggregation-of-breast-cancer/ 2019-03-11T17:39:03+00:00 https://ascopost.com/issues/january-25-2015/better-studies-needed-to-dispel-confusion-over-when-to-refer-a-patient-to-hospice/ 2019-03-11T17:39:03+00:00 https://ascopost.com/issues/january-25-2015/asco-announces-major-steps-in-development-of-cancerlinq/ 2019-03-11T17:39:03+00:00 https://ascopost.com/issues/december-15-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/december-15-2014/pd-1-blockade-moves-into-hematology/ 2019-03-11T17:40:38+00:00 https://ascopost.com/issues/december-15-2014/transplants-for-aml-in-first-remission-a-great-leap-forward-sideways-or-backward/ 2019-03-11T17:40:38+00:00 https://ascopost.com/issues/december-15-2014/cms-issues-preliminary-decision-to-cover-annual-lung-cancer-screening/ 2019-03-11T17:40:38+00:00 https://ascopost.com/issues/december-15-2014/lung-cancer-expert-offers-recommendations-for-treating-toxicities-associated-with-targeted-therapies/ 2019-03-11T17:40:38+00:00 https://ascopost.com/issues/december-15-2014/revisiting-successes-in-advanced-nsclc-to-test-value-in-earlier-stage-disease/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/private-payer-and-academic-center-data-capture-inappropriate-use-of-end-of-life-care/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/expert-point-of-view-deborah-schrag-md-mph/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/study-reveals-gaps-in-symptom-management/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/expert-point-of-view-ethan-basch-md/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/breast-cancer-research-foundation-commits-record-586-million-in-research-grants/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/3d-mammography-improves-cancer-detection-in-dense-breasts/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/hedgehog-inhibitors-can-be-life-altering-in-patients-with-advanced-basal-cell-carcinoma/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/new-serologic-assay-may-help-predict-recurrences-in-merkel-cell-carcinoma/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/choice-for-metastatic-pancreatic-cancer-folfirinox-or-gemcitabinenab-paclitaxel/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/expert-point-of-view-alan-venook-md/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/lung-cancer-next-frontier-for-immunotherapy/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/expert-point-of-view-justin-gainor-md/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/asco-clinical-expert-statement-on-cancer-survivorship-care-planning/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/asco-expert-statement-on-cancer-survivorship-care-planning-timing-is-everything/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/marlo-thomas-receives-presidential-medal-of-freedom/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/crizotinib-is-highly-active-in-ros1-rearranged-nsclc/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/moving-a-mountain-crizotinib-in-ros1-rearranged-nsclc/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/phase-ii-study-shows-improved-survival-with-addition-of-sargramostim-to-ipilimumab-in-metastatic-melanoma/ 2019-03-11T17:40:39+00:00 https://ascopost.com/issues/december-15-2014/getting-the-most-out-of-ipilimumab-in-melanoma/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/racing-against-acute-lymphoblastic-leukemia-ctl019-is-a-fast-car-with-sustained-endurance/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/benefits-of-exercise-for-relieving-fatigue-in-cancer-survivors/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/immune-suppressing-protein-in-noncancerous-cells-of-cancer-patients-offers-clue-to-drug-response/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/policy-issues-in-molecularly-targeted-therapy-the-science-the-money-the-applications/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/conquer-cancer-foundation-and-michael-s-mission-work-together-to-conquer-colorectal-cancer/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/looking-to-the-future-asco-s-50th-anniversary-year-comes-to-a-close/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/cancer-care-incomplete-without-palliative-care-integration/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/don-t-forget-make-your-year-end-gift-to-the-conquer-cancer-foundation/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/latest-from-the-cancernet-blog/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/fda-guidance-on-the-use-of-pathologic-complete-response-in-development-of-new-treatments-for-high-risk-early-breast-cancer-includes-asco-suggestions/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/asco-institute-for-quality-launches-new-cancerlinq-microsite/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/rsna-awards-gold-medal-to-three-leaders-in-radiology/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/palliative-care-in-2014/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/center-to-advance-palliative-care/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/ixazomib-receives-breakthrough-therapy-designation-for-relapsed-or-refractory-systemic-light-chain-amyloidosis/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/fda-grants-breakthrough-therapy-designation-to-investigational-car-t-cell-therapy/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/dr-matthew-j-ellis-named-director-of-lester-and-sue-smith-breast-center/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/karmanos-cancer-institute-s-hayley-thompson-phd-awarded-18-million-grant-to-improve-access-to-cancer-survivor-resources/ 2019-03-11T17:40:40+00:00 https://ascopost.com/issues/december-15-2014/antacids-linked-to-better-survival-in-patients-with-head-and-neck-cancer/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/aacr-ceo-discusses-the-global-status-of-cancer-at-seminar-in-turin-italy/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/debate-over-legalizing-physician-assisted-death-for-the-terminally-ill/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/ash-releases-second-list-for-choosing-wisely-campaign/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/second-annual-jadpro-live-conference-attracts-400-advanced-practitioners-in-oncology-from-across-the-nation/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/aloe-vera/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/fda-approves-blinatumomab-to-treat-rare-form-of-acute-lymphoblastic-leukemia/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/necuparanib-receives-fast-track-designation-from-the-fda-for-the-treatment-of-metastatic-pancreatic-cancer/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/clinical-trials-actively-recruiting-patients-with-soft-tissue-sarcomas/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/internal-medicine-a-doctor-s-stories/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/working-stiff-two-years-262-bodies-and-the-making-of-a-medical-examiner/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/2014-oncology-meetings/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/top-10-articles-from-the-asco-post-in-2014/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/additional-articles-of-note/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/the-wedding-picture/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/fda-approves-ruxolitinib-to-treat-patients-with-polycythemia-vera/ 2025-09-30T19:54:51+00:00 https://ascopost.com/issues/december-15-2014/appetite-enhancing-agent-helps-patients-treated-for-nsclc-gain-weight-and-lean-body-mass-and-feel-better/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/expect-questions-about-cancer-cachexia-from-patients-and-family-members/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/regis-chair-for-breast-cancer-research-established/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/functional-kinomics-identifies-wee1-kinase-as-target-in-head-and-neck-cancer/ 2019-03-11T17:40:41+00:00 https://ascopost.com/issues/december-15-2014/lipophilic-bisphosphonate-plus-rapamycin-active-in-kras-mutant-lung-cancer/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/dual-her2-targeting-inhibits-her2-amplified-uterine-serous-carcinoma/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/intraperitoneal-oxidative-stress-induces-tumoricidal-immune-response-in-papillomavirus-linked-headneck-cancer/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/checkpoint-blockade-immunotherapy-targets-tumor-specific-mutant-antigens/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/wee1-inhibition-sensitizes-pancreatic-cancer-to-parp-inhibitor-radiosensitization/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/pd-l1-expression-by-tumor-infiltrating-cells-associated-with-activity-of-anti-pd-l1-antibody-in-multiple-cancer-types/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/predicting-immunogenic-tumor-neoantigens-with-combined-mass-spectrometry-and-exome-sequencing/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/obinutuzumab-may-have-synergistic-action-with-new-tyrosine-kinase-inhibitors/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/patients-with-metastatic-colorectal-cancer-have-improved-outcome-with-folfoxiri-and-bevacizumab/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/small-risk-adjusted-variation-in-hospital-readmissions-following-colorectal-cancer-surgery/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/personalized-genetic-and-environmental-risk-assessment-does-not-increase-use-of-colorectal-cancer-screening/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/vincent-t-devita-jr-helped-usher-in-the-era-of-chemotherapy-turning-lethal-cancers-into-curable-ones/ 2019-03-11T17:40:42+00:00 https://ascopost.com/issues/december-15-2014/ash-honors-senator-barbara-mikulski-and-patient-advocate-kathy-giusti/ 2019-03-11T17:40:43+00:00 https://ascopost.com/issues/december-15-2014/2014-featured-columnists/ 2019-03-11T17:40:43+00:00 https://ascopost.com/issues/december-1-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/december-1-2014/optimizing-her2-therapy-in-early-and-advanced-breast-cancers/ 2019-03-11T17:44:44+00:00 https://ascopost.com/issues/december-1-2014/when-should-we-stop-prescribing/ 2019-03-11T17:44:44+00:00 https://ascopost.com/issues/december-1-2014/cancerlinq-building-a-data-infrastructure-to-improve-quality-and-reduce-cost/ 2019-03-11T17:44:44+00:00 https://ascopost.com/issues/december-1-2014/new-agents-and-novel-targets-for-multiple-myeloma/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/hormonal-therapy-for-early-breast-cancer-do-we-learn-from-past-mistakes/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/fda-approves-bevacizumab-plus-chemotherapy-for-platinum-resistant-recurrent-ovarian-cancer/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/top-5-breakthroughs-in-the-treatment-of-advanced-lung-cancer/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/asco-calls-for-major-medicaid-reform-to-improve-quality-cancer-care-for-low-income-americans/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/ash-pairs-hematologists-from-developing-and-developed-nations-for-global-training-program/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/medicare-part-d-low-income-subsidy-program-improves-adherence-to-hormone-therapy-after-breast-cancer-surgery/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/checklists-simple-tools-that-enhance-quality/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/a-national-cancer-database-and-cancer-care-quality-improvement/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/having-dependent-children-motivates-parents-with-advanced-cancer-to-pursue-more-aggressive-life-extending-treatments/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/tumor-board-participation-associated-with-improved-survival-in-stage-iv-lung-and-colorectal-cancers/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/impact-of-tumor-boards-on-cancer-care/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/expert-point-of-view-deborah-schrag-md-mph/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/assessing-the-nature-of-unplanned-emergency-cancer-care-situations/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/childhood-obesity-and-leukemia-is-it-time-to-intervene/ 2019-03-11T17:44:45+00:00 https://ascopost.com/issues/december-1-2014/patients-with-advanced-papillary-kidney-cancer-respond-well-to-bevacizumaberlotinib-combination-therapy/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/cd19-directed-car-t-cells-produce-sustained-remission-in-relapsedrefractory-acute-lymphoblastic-leukemia/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/car-t-cell-therapy-in-cancer-driving-toward-the-clinic/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/power-behind-master-gene-for-cancer-discovered/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/fda-grants-orphan-drug-designation-to-bgb324-for-acute-myeloid-leukemia/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/the-harvard-global-equity-initiative-from-research-to-policy/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/new-imaging-technique-identifies-receptors-for-targeted-cancer-therapy/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/norccap-trial-shows-reduced-colorectal-cancer-incidence-and-mortality-with-flexible-sigmoidoscopy-screening-at-11-years/ 2019-03-11T17:44:46+00:00 https://ascopost.com/issues/december-1-2014/sigmoidoscopy-or-colonoscopy-for-colorectal-cancer-screening-is-it-still-the-question/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/systemic-therapy-in-men-with-metastatic-castration-resistant-prostate-cancer-ascocco-clinical-practice-guideline/ 2020-09-24T01:34:50+00:00 https://ascopost.com/issues/december-1-2014/from-clinical-judgment-to-evidence-based-medicine-thoughts-on-the-ascocco-guideline-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/with-new-innovator-award-biomedical-engineer-to-study-how-ovarian-cancer-spreads/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/focused-ultrasound-a-young-technology-begins-to-grow/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/asco-announces-top-5-advances-in-modern-oncology/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/why-they-voted-comments-from-the-oncology-community/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/top-5-features-of-asco-s-newly-redesigned-patient-education-website-highlighted/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/new-asco-survivorship-care-plan-template-is-simpler-faster-for-health-care-providers/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/charting-the-successes-cancerprogressnet-chronicles-more-than-50-years-of-asco-and-progress-against-cancer/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/now-in-spanish-on-cancernet-managing-your-weight-after-a-cancer-diagnosis-and-more/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/advancing-asco-s-commitment-to-quality-to-ensure-that-every-patient-receives-the-highest-level-of-cancer-care/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/cancer-killing-virus-plus-chemotherapy-studied-in-recurrent-ovarian-cancer/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/adding-pan-deacetylase-inhibitor-panobinostat-to-bortezomib-and-dexamethasone-improves-progression-free-survival-in-relapsed-myeloma/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/hdac-inhibitors-and-triple-therapy-in-relapsed-myeloma/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/study-finds-wide-variation-in-quality-content-of-clinical-cancer-guidelines/ 2019-03-11T17:44:47+00:00 https://ascopost.com/issues/december-1-2014/treating-brain-cancer-in-2014/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/scientists-develop-new-approach-to-treating-hpv-related-cervical-cancer/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/helping-adolescents-and-young-adults-cope-with-cancer/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/proteome-scale-map-of-the-human-interactome-network-created/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/how-the-earlier-introduction-of-palliative-care-improves-quality-of-life-for-patients-with-advanced-cancer/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/use-of-hospice-care-by-medicare-patients-associated-with-lower-rate-of-hospitalization-icu-admission-invasive-procedures-and-costs/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/expert-point-of-view-joan-m-teno-md-ms-and-pedro-l-gozalo-phd/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/experts-stress-the-need-for-integrating-palliative-care-into-standard-oncology-care/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/recipients-of-the-2014-conquer-cancer-foundation-of-asco-merit-awards-in-palliative-care-honored/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/the-american-society-of-hematology-elects-new-leadership/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/ash-awards-new-bridge-grants-to-help-alleviate-pain-of-federal-funding-cuts/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/major-strides-seen-this-year-in-survivorship-care/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/discussing-cessation-of-medications-near-the-end-of-life/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/tapping-palliative-care-s-survival-benefit/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/memorial-sloan-kettering-team-discovery-advances-understanding-of-immunotherapy-s-successes-and-its-failures/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/when-life-couldn-t-be-better/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/a-good-life-all-the-way-to-the-very-end/ 2019-03-11T17:44:48+00:00 https://ascopost.com/issues/december-1-2014/o-physician-my-physician/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/astro-commends-medicare-s-proposed-decision-to-cover-annual-low-dose-ct-screening-for-high-risk-lung-cancer-patients-aged-55-74/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/2014-oncology-meetings/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/bevacizumab-plus-chemotherapy-in-platinum-resistant-recurrent-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/preoperative-rodent-cancer-patient-of-charles-moore-md-albumen-print-london-1864/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/fluoroscopy-for-lung-disease-boston-1903/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/chevalier-jackson-md-performing-bronchoscopy-philadelphia-circa-1920/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/beating-the-odds/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/fda-approves-extended-release-single-entity-hydrocodone-product-with-abuse-deterrent-properties/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/rolf-detlef-treede-md-phd-elected-iasp-president/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/accc-honors-nicholas-j-petrelli-md-with-2014-clinical-research-award/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/yale-cancer-center-s-dr-susan-mayne-appointed-to-fda-position/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/clinical-trials-actively-recruiting-patients-with-hodgkin-lymphoma-and-non-hodgkin-lymphoma/ 2020-09-24T01:32:10+00:00 https://ascopost.com/issues/december-1-2014/fred-hutchinson-cancer-research-center-recruits-d-gary-gilliland-md-phd-as-new-president-and-director/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/south-korean-study-sparks-warnings-about-the-hazards-of-overscreening/ 2019-03-11T17:44:49+00:00 https://ascopost.com/issues/december-1-2014/expect-questions-from-patients/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/nccn-publishes-20th-annual-guidelines-in-nsclc-reflecting-advances-in-screening-diagnosis-radiology-and-systemic-therapies/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/huntsman-cancer-institute-investigator-receives-leadership-award-from-the-national-cancer-institute/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/antitumor-effect-of-intratumoral-injection-of-clostridium-spores/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/mitochondrial-respiration-as-target-in-kras-mutant-pancreatic-cancer/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/selective-generation-of-reactive-oxygen-species-in-tumor-cells/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/prc2-loss-amplifies-ras-driven-transcription-and-results-in-sensitivity-to-bromodomain-inhibition/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/hyperthermia-reduces-gemcitabine-resistance/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/single-nucleus-genome-sequencing-shows-early-aneuploid-rearrangement-and-gradual-clonal-evolution-in-breast-cancer/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/mtor-cotargeting-active-in-cetuximab-resistant-headneck-cancers-with-pik3ca-and-ras-mutations/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/over-14-million-major-medical-conditions-in-us-adults-linked-to-cigarette-smoking/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/customizing-surveillance-strategy-in-patients-with-esophageal-adenocarcinoma/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/second-line-gemcitabine-the-preferred-option-for-relapsed-or-refractory-lymphoma/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/risk-of-premature-menopause-raised-by-some-but-not-all-hodgkin-lymphoma-therapies/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/unique-barriers-to-pain-control/ 2020-09-24T01:35:42+00:00 https://ascopost.com/issues/december-1-2014/raising-consciousness-about-drug-costs-a-call-to-action/ 2019-03-11T17:44:50+00:00 https://ascopost.com/issues/december-1-2014/oncology-on-canvas-art-competition-winning-artwork/ 2019-03-11T17:44:51+00:00 https://ascopost.com/issues/november-15-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/november-15-2014/impress-trial-lung-cancer-progression-on-first-line-tyrosine-kinase-inhibitor-indicates-the-drug-should-be-stopped/ 2019-03-11T17:46:31+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-solange-peters-md-phd/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/the-next-to-last-frontier-in-managing-acute-promyelocytic-leukemia/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/striving-for-quality-not-quantity-of-life/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/why-i-think-dr-ezekiel-emanuel-is-wrong-about-aging/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/overutilization-a-key-target-in-efforts-to-control-health-care-costs/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/choosing-wildly-a-patient-s-perspective-on-overtreatment-and-quality-care/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/the-silver-oncologic-tsunami-rise-in-elderly-cancer-patients-brings-new-challenges-to-oncology-workforce/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/financial-toxicity-potentially-harmful-treatment-related-effect/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/studies-address-impact-of-social-factors-on-cancer-treatment-disparities/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/hhs-secretary-announces-840-million-initiative-to-improve-care-lower-costs/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/targeted-agents-making-inroads-against-sarcoma/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/advances-in-sarcoma-owe-much-to-children-s-oncology-group/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/magee-womens-hospital-of-upmc-offers-test-to-predict-possibility-of-breast-cancer-recurrence/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/past-drug-failures-help-create-cancer-s-next-successes/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/for-selected-patients-with-metastatic-colorectal-cancer-taking-a-break-from-combination-chemotherapy-might-be-appropriate-and-appreciated/ 2019-03-11T17:46:32+00:00 https://ascopost.com/issues/november-15-2014/incredible-changes-in-the-field-of-colorectal-cancer/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/asco-endorses-auaastro-guideline-on-adjuvant-and-salvage-radiotherapy-after-prostatectomy/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/targeted-therapies-in-indolent-lymphoma-challenging-the-current-paradigm/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-andrew-d-zelenetz-md-phd-and-jennifer-r-brown-md-phd/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/noteworthy-abstracts-from-the-breast-cancer-symposium-include-studies-of-novel-therapies-and-of-the-impact-of-disease-subtypes-on-outcomes/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/young-adults-with-cancer-unique-issues-highlight-importance-of-patient-centered-care/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/tackling-the-complexity-of-cancer-finding-common-ground-on-value-and-progress/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/the-ohio-state-and-moffitt-collaborate-on-orien-using-big-data-to-accelerate-trials-with-a-cancer-research-expressway/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/fda-grants-breakthrough-therapy-designation-pembrolizumab-in-advanced-non-small-cell-lung-cancer/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/fda-approves-labeling-with-abuse-deterrent-features-for-extended-release-opioid-analgesic/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/all-ras-testing-in-metastatic-colorectal-cancer-just-the-first-step/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-andrés-cervantes-md-phd/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/european-studies-explore-maintenance-strategies-for-metastatic-colorectal-cancer/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-axel-grothey-md/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/phase-iii-study-confirms-regorafenib-s-survival-benefit-in-metastatic-colorectal-cancer/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/oral-rivaroxaban-has-efficacy-similar-to-enoxaparin-plus-vitamin-k-antagonist-in-preventing-recurrent-venous-thromboembolism/ 2019-03-11T17:46:33+00:00 https://ascopost.com/issues/november-15-2014/quasar2-final-analysis-bevacizumab-still-of-no-value-in-adjuvant-treatment-of-colorectal-cancer/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-axel-grothey-md-1/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/clinically-relevant-survival-benefit-seen-for-everolimus-in-pancreatic-neuroendocrine-tumors/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-alexandria-phan-md/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/genomic-score-predicts-aggressiveness-of-prostate-cancer-in-biopsy-specimens/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-mark-a-rubin-md/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/pazopanib-improves-progression-free-survival-in-advanced-pretreated-gist/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-stefan-sleijfer-md-phd/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/single-agent-carfilzomib-compared-to-corticosteroids-plus-cyclophosphamide-fails-to-improve-survival-in-myeloma/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/emerging-drugs-effectively-tackle-non-small-cell-lung-cancer-mutations/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/postoperative-radiation-therapy-improves-overall-survival-for-patients-with-resected-pathologic-n2-non-small-cell-lung-cancer/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/moving-forward-with-biomarkers-in-non-small-cell-lung-cancer/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-giorgio-v-scagliotti-md-phd/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/studies-evaluate-maintenance-bevacizumab-in-metastatic-breast-cancer/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-hope-s-rugo-md/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/adding-sorafenib-to-capecitabine-fails-to-improve-progression-free-survival-in-advanced-breast-cancer/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/expert-point-of-view-hope-s-rugo-md-1/ 2019-03-11T17:46:34+00:00 https://ascopost.com/issues/november-15-2014/patient-reported-data-indicate-that-radiation-therapy-does-not-increase-risk-of-lymphedema-in-patients-with-node-negative-breast-cancer/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/interviews-with-candidates-for-2015-2016-asco-president-elect/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/clinical-trials-participation-awards-recognize-community-based-practice-dedicated-to-research/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/asco-submits-comments-to-nih-on-data-standards-in-biomedical-science/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/help-your-patients-learn-how-to-navigate-common-challenges/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/asco-members-reflect-on-lessons-from-chernobyl/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/a-gift-for-your-list-a-donation-to-help-conquer-cancer/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/david-g-nathan-md-wins-lifetime-impact-award-at-boston-children-s-hospital-innovation-summit/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/astro-initiatives-aimed-at-practice-improvement/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/incidence-of-colorectal-cancer-in-young-adults-expected-to-rise/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/commentary-screening-young-adults-for-nonhereditary-colorectal-cancer/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/continuous-lenalidomidedexamethasone-improves-progression-free-survival-in-transplant-ineligible-patients-with-myeloma/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/treatment-of-newly-diagnosed-multiple-myeloma-with-lenalidomide-plus-low-dose-dexamethasone/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/study-finds-significant-increase-in-bilateral-mastectomy-for-unilateral-breast-cancer-despite-lack-of-survival-benefit/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/complexity-of-the-contralateral-prophylactic-mastectomy-decision/ 2019-03-11T17:46:35+00:00 https://ascopost.com/issues/november-15-2014/pazopanib-maintenance-improves-progression-free-survival-in-ovarian-cancer/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/maintenance-therapy-in-ovarian-cancer-what-s-at-stake/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/us-skin-cancer-costs-rise-from-2002-through-2011/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/bortezomib-in-previously-untreated-mantle-cell-lymphoma/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/top-10-myths-about-fda-s-office-of-hematology-and-oncology-products/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/fda-approves-ramucirumab-in-combination-with-paclitaxel-for-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/study-sheds-light-on-factors-that-may-contribute-to-pancreatic-cancer/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/accc-to-develop-comprehensive-program-on-immuno-oncology-for-community-based-providers/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/fixed-combination-netupitantpalonosetron-for-prevention-of-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/pancreatic-cancer-in-2014/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/dream-team-principal/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/ipilimumabsargramostim-improves-overall-survival-vs-ipilimumab-alone-in-patients-with-advanced-metastatic-melanoma/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/nih-awards-aim-to-improve-understanding-of-cell-pathways-development-of-new-therapies/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/addressing-patients-sexual-dysfunction-throughout-survivorship/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/key-solutions-to-sexual-concerns-in-cancer-survivors/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/vigorous-exercise-lowers-risk-of-cardiovascular-events-in-adult-survivors-of-childhood-hodgkin-lymphoma/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/impact-of-high-dose-melphalanautologous-stem-cell-transplant-and-lenalidomide-maintenance-in-myeloma-patients-age-65/ 2019-03-11T17:46:36+00:00 https://ascopost.com/issues/november-15-2014/high-dose-melphalan-early-stem-cell-transplant-and-lenalidomide-maintenance-in-myeloma-one-size-still-does-not-fit-all/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/initiative-aims-to-accelerate-development-of-targeted-therapies-for-multiple-myeloma/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/long-term-overall-survival-benefit-seen-with-trastuzumab-added-to-adjuvant-chemotherapy-in-early-stage-her2-positive-breast-cancer/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/joint-analysis-further-confirms-well-established-standard-of-care-in-early-breast-cancer/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/new-chief-of-oncology-named-by-the-children-s-hospital-of-philadelphia/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/dying-in-america-ensuring-high-quality-care-at-the-end-of-life/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/dartmouth-study-finds-lung-cancer-screening-with-low-dose-ct-could-be-cost-effective/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/expert-panels-offer-five-proposals-to-address-challenges-in-regulating-implementing-next-generation-sequencing/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/old-woman-with-eye-tumor-circa-1878/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/radiation-treatment-for-facial-cancer-boston-1903/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/x-ray-of-metastatic-carcinoma-of-the-lungs-washington-dc-1924/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/expert-panel-explores-cost-value-and-patient-centered-care-in-cancer-treatment/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/two-phase-iii-trials-show-benefit-with-brafmek-inhibitor-combination-vs-braf-inhibitor-alone-in-advanced-melanoma/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/brafmek-inhibition-in-braf-mutant-advanced-melanoma/ 2019-03-11T17:46:37+00:00 https://ascopost.com/issues/november-15-2014/study-shows-integrative-medicine-can-relieve-pain-and-anxiety-for-cancer-inpatients/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/adding-vegfr2-inhibitor-ramucirumab-to-paclitaxel-increases-overall-survival-as-second-line-treatment-for-advanced-gastric-cancer/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/the-rainbow-trial-dawn-of-a-new-era-in-upper-gastrointestinal-malignancies/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/half-of-premature-colorectal-cancer-deaths-due-to-socioeconomic-inequality/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/kinase-activating-alterations-identified-in-most-cases-of-philadelphia-chromosome-like-acute-lymphoblastic-leukemia-may-be-targetable-with-available-tyrosine-kinase-inhibitors/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/from-the-genome-to-the-bedside-new-treatment-options-for-children-and-young-adults-with-philadelphia-chromosome-like-all/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/nih-awards-more-than-30-million-to-enhance-diversity-in-the-biomedical-research-workforce/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/three-initiatives-together-form-the-diversity-program-consortium/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/asco-endorses-guideline-for-molecular-testing-for-selecting-lung-cancer-patients-for-egfr-and-alk-inhibitor-treatment/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/asco-endorses-capiaslcamp-guidelines-for-molecular-testing-of-patients-with-non-small-cell-lung-cancer/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/lilly-oncology-on-canvas-art-competition-names-2014-winners/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/2014-ellen-stovall-award-presented-to-giuliana-rancic-e-news-co-anchor-and-co-host-of-the-fashion-police/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/tina-lundgren-elected-chairman-of-the-ronald-mcdonald-house-new-york-board-of-directors/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/whole-brain-radiation-therapy-plus-stereotactic-radiosurgery-improves-survival-in-better-prognosis-patients-with-brain-metastases/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/clinical-trials-actively-recruiting-patients-with-colon-or-rectal-cancer/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/metastatic-breast-cancer-alliance-report-finds-research-for-the-disease-is-underfunded-details-gaps-in-patient-services/ 2019-03-11T17:46:38+00:00 https://ascopost.com/issues/november-15-2014/fast-facts-about-metastatic-breast-cancer/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/institute-of-medicine-elects-70-new-members-10-foreign-associates/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/why-physician-scientists-are-indispensable-to-cancer-research/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/acupuncture-treatment-for-cancer-pain-and-chemotherapy-induced-peripheral-neuropathy/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/breast-cancer-researcher-to-lead-radiation-oncology-at-iu-school-of-medicine/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/martine-extermann-md-phd-honored-at-the-international-society-of-geriatric-oncology-s-annual-meeting-in-portugal/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/a-father-and-son-s-journey-through-medicine/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/a-candidly-humorous-approach-to-the-cancer-journey/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/2014-oncology-meetings/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/new-james-cancer-hospital-in-columbus-ohio-opening-in-december-2014/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/the-power-of-laughter/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/ramucirumab-in-combination-with-paclitaxel-in-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/printed-nccn-guidelines-for-patients-now-available-through-amazoncom/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/impressive-survival-data-for-women-with-her2-positive-breast-cancer-increase-first-line-use-of-pertuzumabtrastuzumab/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/expect-questions-about-pertuzumab-for-her2-positive-breast-cancer/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/rna-binding-protein-destabilizes-transcripts-of-novel-metastasis-suppressor-genes-in-breast-cancer/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/potential-roles-for-metformin-and-everolimus-in-obese-women-with-er-positive-breast-cancer/ 2019-03-11T17:46:39+00:00 https://ascopost.com/issues/november-15-2014/peripheral-nerve-schwann-cells-migrate-to-pancreas-and-colon-cancer-cells-before-invasion/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/dna-double-strand-break-repair-genes-and-oxidative-damage-in-brain-metastasis-of-breast-cancer/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/suppressor-of-cytokine-signaling-protein-promotes-breast-cancer-recurrence-by-potentiating-c-met-signaling/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/sonic-hedgehog-factor-gli1-induces-resistance-to-cytarabine-and-ribavirin-in-aml-via-glucuronidation/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/effect-of-micro-rna-on-m2-macrophages-and-murine-glioblastoma/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/neoadjuvant-chemotherapy-plus-two-anti-her2-agents-optimal-for-her2-positive-breast-cancer/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/the-2014-nobel-prize-in-physiology-or-medicine-awarded-to-john-o-keefe-phd-and-jointly-to-may-britt-moser-phd-and-edvard-i-moser-phd/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/more-on-chemotherapy-costs/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-15-2014/dr-conti-replies/ 2019-03-11T17:46:40+00:00 https://ascopost.com/issues/november-1-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/november-1-2014/cleopatra-survival-with-dual-her2-blockade-unprecedented/ 2019-03-11T17:47:42+00:00 https://ascopost.com/issues/november-1-2014/linking-biology-and-therapy-in-chronic-lymphocytic-leukemia/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/recent-reports-and-perspectives-on-chronic-lymphocytic-leukemia/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/partnering-with-community-centers-to-advance-oncology-care/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/novel-agents-may-address-endocrine-therapy-resistance/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/what-is-the-real-risk-of-breast-cancer-associated-with-atypical-hyperplasia/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/high-risk-benign-breast-lesions-some-patients-can-avoid-surgery/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/brca-mutations-found-in-many-breast-tumors-called-er-positive/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/ucsf-study-finds-18-billion-tobacco-toll-in-california-2009/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/encouraging-early-signals-for-cediranib-in-recurrent-cervical-cancer/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-andrés-poveda-md/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/practice-changing-results-at-esmo-2014/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/brafmek-inhibitor-combinations-impressive-in-melanoma-trials/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-christian-blank-md-phd/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/nivolumab-yields-impressive-duration-of-response-as-late-line-melanoma-treatment/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-ignacio-melero-md-phd/ 2019-03-11T17:47:43+00:00 https://ascopost.com/issues/november-1-2014/women-underrepresented-in-oncology-leadership-positions-greek-survey-shows/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/novel-oral-agent-treats-cachexia-in-patients-with-non-small-cell-lung-cancer/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-florian-scotté-md-phd/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/local-treatments-fail-to-improve-survival-in-mesothelioma/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-stefan-zimmermann-md/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/fda-approves-bortezomib-injection-for-previously-untreated-patients-with-mantle-cell-lymphoma/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/fda-approves-netupitant-and-palonosetron-combination-capsule-for-chemotherapy-induced-nausea-and-vomiting/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/blinatumomab-receives-fda-priority-review-designation-in-acute-lymphoblastic-leukemia/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/peter-carroll-md-mph-receives-grant-for-early-detection-of-prostate-cancer/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/long-term-results-of-cou-aa-302-confirm-abiraterone-benefit/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-bertrand-tombal-md-phd/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/radiotherapy-should-be-added-to-hormone-therapy-in-node-positive-prostate-cancer/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-bertrand-tombal-md-phd-1/ 2019-03-11T17:47:44+00:00 https://ascopost.com/issues/november-1-2014/e-cigarettes-unhelpful-in-smoking-cessation-among-patients-with-cancer/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/lenvatinib-receives-priority-review-designation-for-advanced-thyroid-cancer/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/despite-potential-to-overwhelm-surveys-still-essential-research-tool/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/progress-against-cancer-a-snapshot/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/illumination-and-innovation-transforming-data-into-learning/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/cancerlinq-receives-major-commitment-from-ctca/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/asco-recruits-members-to-help-improve-access-to-colorectal-cancer-screening-follow-up-care/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/latest-patient-booklet-from-asco-and-cancernet-palliative-care/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/for-triple-negative-breast-cancer-adding-carboplatin-to-anthracyclinetaxane-produces-benefit-but-how-much/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/50-years-of-advancements-in-treating-breast-cancer-have-led-to-tumor-centered-treatment-algorithm/ 2019-03-11T17:47:45+00:00 https://ascopost.com/issues/november-1-2014/variety-of-adjuvant-strategies-explored-in-her2-positive-and-other-breast-cancer-types/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/experts-debate-the-need-for-upfront-vs-late-stem-cell-transplant-in-multiple-myeloma/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/nih-2014-new-innovator-award-recipient-pamela-kreeger-phd-to-study-metastasis-in-ovarian-cancer/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/md-anderson-receives-5-million-grant-for-research-in-glioblastoma/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/beyond-r-chop-for-lymphoma/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/expert-point-of-view-andrew-d-zelenetz-md-phd/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/no-benefit-seen-for-cetuximab-added-to-cisplatin-and-accelerated-radiotherapy-in-advanced-head-and-neck-carcinoma/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/adding-cetuximab-to-chemoradiation-did-not-benefit-patients-with-advanced-head-and-neck-cancer-what-were-the-reasons/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/treating-testicular-cancer-in-2014/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/1-million-raised-in-honor-of-40th-anniversary-of-milestone/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/nearly-800-new-cancer-medicines-and-vaccines-in-development-phrma-reports/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/professional-associations-collaborate-to-launch-stereotactic-radiosurgery-patient-registry/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/2014-oncology-meetings/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/clinical-trials-actively-recruiting-patients-with-lung-cancer/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/a-history-of-medical-oncology/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/aacr-honors-zhu-chen-md-phd-for-distinguished-public-service-and-global-impact-in-cancer-research/ 2019-03-11T17:47:46+00:00 https://ascopost.com/issues/november-1-2014/lessons-from-cancer/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/in-memoriam-kelly-traw/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/nci-awards-2-million-grant-to-university-of-pittsburgh-school-of-dental-medicine-to-study-how-cancer-spreads-to-bone/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/egfr-a-potential-target-in-muscle-invasive-bladder-cancer-with-basal-like-phenotype/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/mhc-matched-graft-vs-host-disease-requires-recipient-intestinal-barrier-loss-and-natural-killer-cell-inactivation/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/successful-immunotherapy-with-mutation-specific-cd4-positive-t-cells-in-patient-with-epithelial-cancer/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/chemotherapy-induced-immunosuppressive-myeloid-cells-inhibit-tumor-control-via-pd-1-pd-l1-axis/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/androgen-estrogen-and-stem-cell-markers-help-predict-recurrence-and-survival-in-metastatic-prostate-cancer/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/polymorphisms-and-cetuximab-benefit-in-locally-advanced-rectal-cancer/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/cervical-cancer-risks-after-negative-hpv-test-lower-at-3-years-than-after-negative-pap-result/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/vitamin-d-deficiency-is-prevalent-among-patients-with-advanced-pancreatic-cancer/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/updated-gem2005-trial-confirms-benefit-of-melphalanbortezomib-combination-in-elderly-multiple-myeloma-patients/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/november-1-2014/obinutuzumab-could-have-synergistic-action-with-new-tyrosine-kinase-inhibitors/ 2019-03-11T17:47:47+00:00 https://ascopost.com/issues/october-15-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/october-15-2014/chest-radiation-improves-survival-and-intrathoracic-recurrence-rates-in-extended-stage-small-cell-lung-cancer/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/expert-point-of-view-benjamin-movsas-md/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/relevance-of-the-hippocratic-oath-in-the-21st-century/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/hippocratic-oath/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/health-care-reform-is-changing-the-oncology-landscape/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/tough-questions-about-health-care-reform-put-economist-in-hot-seat/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/stereotactic-body-radiation-therapy-benefits-patients-with-early-stage-inoperable-or-advanced-oligometastatic-lung-cancer/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/expert-point-of-view-benjamin-movsas-md-1/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/radiation-therapy-improves-10-year-survival-for-patients-with-early-hodgkin-lymphoma-but-frequently-omitted-in-treatment-plans/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/expert-point-of-view-theodore-deweese-md/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/hypofractionated-radiation-much-less-toxic-than-conventionally-fractionated-radiation-in-early-breast-cancer/ 2019-03-11T17:48:34+00:00 https://ascopost.com/issues/october-15-2014/expert-point-of-view-kenneth-b-roberts-md/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/radiation-alone-is-as-effective-as-and-less-toxic-than-chemoradiation-for-advanced-esophageal-cancer/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/expert-point-of-view-tracy-balboni-md/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/duration-of-androgen-deprivation-therapy-for-patients-with-high-risk-prostate-cancer/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/determining-androgen-deprivation-therapy/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/study-in-survivors-of-nsclc-reports-lower-risk-of-developing-secondary-primary-lung-cancers-in-never-and-former-smokers-vs-current-smokers/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/best-of-asco-seattle-proves-engaging-provocative/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/exciting-highlights-in-several-types-of-lymphoma-presented-at-best-of-asco/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/lymphatic-mapping-agent-receives-orphan-drug-designation-for-head-and-neck-cancers/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/managing-resistance-to-targeted-agents-the-future-of-nsclc-therapy/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/robert-s-miller-md-facp-fasco-joins-asco-as-medical-director-of-society-s-institute-for-quality/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/pathologic-complete-response-understanding-the-subtleties/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/margaret-foti-phd-md-hc-receives-ellen-v-sigal-advocacy-leadership-award/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/how-accurate-is-the-pathologic-assessment-of-the-partial-mastectomy-specimen/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/expert-point-of-view-harold-burstein-md/ 2019-03-11T17:48:35+00:00 https://ascopost.com/issues/october-15-2014/in-ductal-carcinoma-in-situ-margin-status-need-not-dictate-reexcision/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/with-breast-conserving-surgery-margin-status-not-a-factor-in-recurrence/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/testosteroneanastrozole-implants-relieve-menopausal-symptoms-in-breast-cancer-survivors/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/menopause-rating-scale/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/fertility-preservation-suggested-with-triptorelin-in-long-term-study/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/ctneobc-analysis-response-to-neoadjuvant-chemotherapy-varies-by-breast-tumor-subtype/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/expert-point-of-view-william-m-sikov-md/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/aron-goldhirsch-md-receives-2014-gianni-bonadonna-breast-cancer-award/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/fda-grants-orphan-drug-designation-to-bivalent-vaccine-for-neuroblastoma/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/aldoxorubicin-receives-fda-orphan-drug-designations-for-glioblastoma-small-cell-lung-cancer-and-ovarian-cancer/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/cancercare-awarded-15-million-grant-from-susan-g-komen/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/early-study-finds-brca-mutated-pancreatic-cancer-responds-to-parp-inhibition-trio/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/significant-improvement-in-overall-survival-with-second-line-addition-of-ramucirumab-to-docetaxel-in-stage-iv-nsclc/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/revel-winning-a-questionable-race/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/society-announces-candidates-for-2015-asco-election/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/asco-clinical-practice-guideline-chemotherapy-and-targeted-therapy-in-advanced-her2-negative-or-her2-status-unknown-breast-cancer/ 2019-03-11T17:48:36+00:00 https://ascopost.com/issues/october-15-2014/guidelines-and-care-what-comes-next/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/call-for-ideas-for-ovarian-cancer-translational-research-dream-team-grant/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/attaining-the-goal-of-preventing-ovarian-cancer/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/nci-s-center-for-global-health-announces-first-major-research-grants-to-support-portable-technologies/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/statement-from-ash-president-linda-j-burns-md-on-release-of-sunshine-act-data/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/women-at-higher-risk-for-breast-cancer-to-benefit-from-hereditary-risk-assessment-program-in-tucson-center/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/ohio-state-opens-first-fully-integrated-cancer-emergency-department/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/life-threatening-dermatologic-toxicity/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/despite-growing-awareness-the-global-crisis-of-untreated-cancer-pain-persists/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/exceptional-responders-to-cancer-therapy-study-begins/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/first-approval-of-pd-1-inhibitor-pembrolizumab-in-unresectable-or-metastatic-melanoma/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/advanced-robotic-technology-used-to-remove-kidney-tumor-in-first-time-outpatient-procedure/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/lower-vs-higher-than-expected-long-term-colorectal-cancer-mortality-after-removal-of-lower-vs-higher-risk-adenomas/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/colonoscopic-polypectomy-and-predicting-cancer-risk-a-work-in-progress/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/early-study-reports-modified-vitamin-d-has-potential-in-treatment-for-pancreatic-cancer/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/time-to-treatment-failure-similar-with-rituximab-retreatment-vs-maintenance-in-low-tumor-burden-follicular-lymphoma/ 2019-03-11T17:48:37+00:00 https://ascopost.com/issues/october-15-2014/ecog-e4402resort-trial-when-black-and-white-results-are-actually-gray/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/cancer-survivors-face-lasting-financial-struggles-long-after-treatment-ends-new-study-reports/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/fellows-expectations-of-work-life-balance-not-in-line-with-realities-of-practice/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/for-your-patients-video-series-for-newly-diagnosed-patients-on-navigating-common-challenges-to-quality-care/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/new-series-features-interviews-with-authors-of-jco-and-jop-research/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/the-latest-information-for-patients-from-asco-s-symposia/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/asco-aacr-urge-fda-to-regulate-all-tobacco-products-including-e-cigarettes/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/cms-announces-icd-10-testing-weeks-in-preparation-for-october-1-2015-compliance-deadline/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/asco-president-peter-p-yu-md-fasco-discusses-cancerlinq-at-stanford-medicine-x-conference/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/asco-seeks-editor-for-new-global-oncology-journal/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/louis-j-degennaro-phd-named-president-and-chief-executive-officer-of-the-leukemia-lymphoma-society/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/centric-trial-shows-no-benefit-of-adding-cilengitide-to-therapy-in-glioblastoma-with-methylated-mgmt-promoter/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/failure-of-cilengitide-in-newly-diagnosed-glioblastoma-with-methylated-mgmt-promoter/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/integrated-collaborative-care-program-highly-successful-in-treating-major-depression-in-patients-with-cancer/ 2019-03-11T17:48:38+00:00 https://ascopost.com/issues/october-15-2014/improving-treatment-of-depression-in-patients-with-cancer-the-smart-oncology-2-trial/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/enzalutamide-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/treating-sarcomas-in-2014/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/iarc-calls-on-countries-with-high-stomach-cancer-burden-to-act-to-prevent-the-disease/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/the-value-of-lifelong-mentorship-in-career-development/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/on-being-a-mentee-and-the-value-of-the-conquer-cancer-foundation-s-career-development-award/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/radiation-oncologist-stephen-hahn-md-to-join-md-anderson/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/breaking-the-silence-about-breast-cancer-in-the-arab-world/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/book-review-breast-cancer-break-the-silence/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/effective-prevention-measures-urgently-needed-to-prevent-global-cancer-crisis/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/now-in-its-71st-year-cancercare-looks-to-expand-services-to-patients-and-caregivers/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/asco-calls-for-new-action-to-address-obesity-and-cancer/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/choosing-wisely-campaign-identifies-five-radiation-treatments-not-for-routine-use/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/helping-patients-talk-to-their-children-about-cancer/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/addressing-the-needs-of-patients-with-children/ 2019-03-11T17:48:39+00:00 https://ascopost.com/issues/october-15-2014/one-in-three-people-with-cancer-has-anxiety-or-other-mental-health-challenges/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/100-years-of-progress-in-oncology-treatment/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/woman-with-ovarian-tumor-daguerreotype-wellington-ohio-june-1851/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/first-photographs-of-breast-surgery-new-york-city-1886/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/lympho-sarcoma-treated-by-radiation-patient-of-francis-h-williams-md-boston-1902/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/sluys-kessler-radium-apparatus-paris-1930/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/genetic-hotspot-linked-to-endometrial-cancer-aggressiveness/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/primary-androgen-deprivation-does-not-improve-long-term-survival-in-older-patients-with-localized-prostate-cancer/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/james-herman-md-named-co-leader-of-upci-lung-cancer-program/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/clinical-trials-actively-recruiting-patients-with-breast-cancer/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/researchers-at-roswell-park-receive-grants-to-study-new-anticancer-agent-in-lung-colorectal-and-gastrointestinal-cancers/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/ketan-k-badani-md-additional-staff-appointed-to-mount-sinai-health-system/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/milk-thistle/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/new-books-address-aging-survivorship/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/integrative-oncology-mind-body-and-more/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/the-audacity-of-courage/ 2019-03-11T17:48:40+00:00 https://ascopost.com/issues/october-15-2014/2014-oncology-meetings/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/roswell-park-researchers-awarded-nearly-5-million-to-support-research-projects/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/fear/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/social-media-is-helping-me-cope-with-cancer/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/nine-valent-hpv-vaccine-may-prevent-nearly-90-of-cervical-cancers/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/moderate-form-of-male-pattern-baldness-associated-with-increased-risk-of-aggressive-prostate-cancer/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/expect-questions-from-patients/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/livestrong-narrows-finalists-in-big-c-competition-winner-to-be-announced-this-month/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/expert-consensus-recommends-echocardiograph-as-cornerstone-to-protecting-cancer-patients-heart-health/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/tumor-pd-l1-mrna-expression-associated-with-improved-outcome-in-breast-cancer/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/tp53-mutation-associated-with-chromosome-3p-loss-in-head-and-neck-squamous-cell-carcinoma/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/cd44-expression-a-marker-for-chemotherapy-resistance-in-gastric-cancer-overcome-by-hedgehog-inhibition/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/potential-for-improved-effectiveness-and-reduced-toxicity-of-radiotherapy-with-ultrahigh-dose-rate-flash-irradiation/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/dissemination-of-glioblastoma-multiforme-outside-brain-is-common/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/msh6-mutations-may-influence-temozolomide-resistance-in-treatment-naive-gliomas-independent-of-mgmt-methylation/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/different-transcriptional-responses-to-fulvestrant-and-estrogen-deprivation-in-er-positive-breast-cancer/ 2019-03-11T17:48:41+00:00 https://ascopost.com/issues/october-15-2014/overscreening-for-prostate-breast-colorectal-and-cervical-cancer-can-raise-costs-and-harm-patients/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/enhanced-benefit-shown-with-folfiriziv-aflibercept-in-subset-of-patients-with-metastatic-colorectal-cancer/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/comorbidity-associated-with-shorter-overall-survival-but-not-with-time-to-relapse-or-toxicity-in-older-women-on-adjuvant-chemotherapy/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/patients-with-dcis-have-decreased-risk-of-cardiovascular-death-independent-of-treatment/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/fdg-pet-is-less-specific-in-diagnosing-lung-cancer-in-areas-with-endemic-infectious-lung-disease/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/aacr-2014-cancer-progress-report-call-to-action-prioritize-federal-funding-for-biomedical-research/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/letters-to-the-editor/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/asco-50th-anniversary-poll-names-the-top-5-advances-from-the-past-50-years/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/october-15-2014/top-5-advances-in-modern-oncology/ 2019-03-11T17:48:42+00:00 https://ascopost.com/issues/september-15-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/september-15-2014/can-metastatic-lung-cancer-be-cured/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/will-oncologists-be-the-first-to-cure-heart-disease/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/911-and-cancer-what-do-we-know/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/important-resources/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/in-advanced-lung-cancer-targeted-combinations-are-still-works-in-progress/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/hsp90-inhibitors-may-soon-transition-into-clinic/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/disparities-persist-in-early-stage-breast-cancer-treatment-md-anderson-study-finds/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/in-managing-ovarian-cancer-precision-medicine-is-a-work-in-progress/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/studies-help-refine-management-of-prostate-cancer/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/when-should-chemotherapy-be-used-in-metastatic-prostate-cancer/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/pros-and-cons-of-early-chemohormonal-therapy/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/what-constitutes-high-volumeextensive-disease/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/paradigm-shifting-results-in-treatment-of-hematologic-disorders/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/fda-approves-pembrolizumab-for-advanced-melanoma/ 2019-03-11T17:49:48+00:00 https://ascopost.com/issues/september-15-2014/novel-immunotherapy-for-ovarian-cancer-receives-fast-track-designation/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/fda-grants-fast-tract-designation-to-investigational-combination-therapy-in-metastatic-pancreatic-cancer/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/european-researchers-at-13-year-follow-up-increased-absolute-benefit-of-psa-screening-in-prostate-cancer-mortality-but-time-for-population-based-screening-has-not-arrived/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/psa-it-just-keeps-getting-better-so-why-should-it-stand-alone/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/early-study-finds-olaparib-tablet-safe-in-pretreated-ovarian-cancer-patients-more-effective-in-those-with-brca-mutations/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/adding-antiangiopoietin-agent-trebananib-to-paclitaxel-improves-progression-free-survival-in-recurrent-epithelial-ovarian-cancer/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/angiogenesis-in-ovarian-cancer-are-we-missing-the-clinical-target/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/2014-lasker-award/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/optimal-chemoradiotherapy-dosing-and-recurrence-after-stereotactic-body-radiotherapy-explored-in-lung-cancer-webinar/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/lung-cancer-webinar-highlights-brain-metastases-and-thoracic-radiotherapy/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/fox-chase-cancer-center-announces-new-staff/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/researchers-at-university-of-michigan-receive-23-million-grant-to-promote-safety-reduce-exposure-risk-at-chemotherapy-infusion-sites/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/patient-reported-outcomes-in-hematology-and-oncology-product-development/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/study-quantifies-risk-of-hereditary-breast-cancer-in-carriers-of-palb2-mutations/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/palb2-study-researchers-and-patients-must-pal-for-progress/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/nccn-marks-20-years-of-evidence-based-decision-making-in-small-cell-lung-cancer/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/rwanda-offers-women-free-cervical-cancer-screening-hpv-vaccination/ 2019-03-11T17:49:49+00:00 https://ascopost.com/issues/september-15-2014/city-of-hope-investigator-receives-grant-for-immunotherapy-research/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/no-difference-in-complication-rates-or-hospital-stay-with-robot-assisted-vs-open-surgery-cystectomy-in-bladder-cancer/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/complications-no-different-between-open-and-robot-assisted-radical-cystectomy-when-open-urinary-diversion-performed/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/cdc-s-breast-and-cervical-screening-program-benefits-millions-of-underserved-women-in-the-united-states/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/asco-launches-new-publication-for-oncology-trainees-and-early-career-professionals/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/issue-highlights/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/a-vision-that-endured-celebrating-asco-s-founders/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/cms-approval-new-platform-making-qopi-participation-easier/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/asco-to-participate-in-2014-rally-for-medical-research-hill-day/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/september-is-conquer-cancer-foundation-challenge-month/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/asco-university-s-new-cancer-genetics-program/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/new-cancernet-fact-sheets-now-available-for-your-practice/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/timing-and-meaning-of-do-not-resuscitate-orders-in-the-palliative-care-setting/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/kenneth-s-ramos-md-phd-pharmb-named-new-md-phd-head-at-university-of-arizona-college-of-medicine-tucson/ 2019-03-11T17:49:50+00:00 https://ascopost.com/issues/september-15-2014/nih-launches-human-safety-study-of-ebola-vaccine-candidate/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/national-cancer-institute-launches-the-national-clinical-trials-network-to-expedite-scientific-advances/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/adding-tomosynthesis-to-digital-mammography-decreased-recall-rate-increased-cancer-detection-rate-in-breast-cancer-screening/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/breast-cancer-screening-using-tomosynthesis-in-combination-with-digital-mammography/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/study-finds-increased-breast-cancer-screening-costs-in-medicare-population-but-no-increase-in-cancer-detection/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/expert-point-of-view-karla-kerlikowske-md/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/immunotherapy-research-of-james-p-allison-phd-has-led-to-a-paradigm-shift-in-the-treatment-of-cancer/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/unc-lineberger-secures-three-major-nci-grants-to-advance-the-nation-s-clinical-trials-program/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/moffitt-appoints-louis-b-harrison-md-new-chair-radiation-oncology/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/ongoing-clinical-trials-actively-recruiting-patients-with-intraocular-cancer/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/gene-therapy-betters-chemotherapy-tolerance-effectiveness-in-small-glioblastoma-study/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/drew-pinsky-md-elected-to-prostate-cancer-foundation-board-of-directors/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/using-electronic-health-records-to-improve-communication-with-patients/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/delivering-cancer-care-in-low-income-countries/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/prioritizing-cancer-care/ 2019-03-11T17:49:51+00:00 https://ascopost.com/issues/september-15-2014/fda-grants-priority-review-to-lanreotide-injection-for-gastroenteropancreatic-neuroendocrine-tumors/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/potential-of-liquid-biopsies-in-detecting-cancer-and-establishing-prognosis/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/sequencing-analysis-of-tumor-dna-is-it-all-in-the-plasma/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/2014-oncology-meetings/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/cancer-frontier-bringing-the-new-sciences-to-an-old-school/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/i-work-for-you/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/astro-awards-seven-physicians-a-total-of-675-000-to-fund-radiation-oncology-specific-studies/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/the-role-of-music-therapy-in-cancer-care/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/arizona-health-science-center-appoints-rick-kittles-phd-director-of-new-division-of-population-genetics/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/astro-honors-jasan-zimmerman-with-2014-survivor-circle-award/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/breast-cancer-has-led-me-to-careers-in-activism-and-filmmaking/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/news-of-mutations-in-palb2-gene-raising-risk-of-breast-cancer-offers-opportunity-to-explain-limits-of-genetic-testing/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/expect-questions-from-patients/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/everybody-has-a-mutation-or-more/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/trim44-amplification-in-esophagogastric-breast-tumors-may-be-marker-for-mtor-inhibitor-therapy/ 2019-03-11T17:49:52+00:00 https://ascopost.com/issues/september-15-2014/extracellular-matrix-stiffness-promotes-malignant-progression-via-pten-reducing-effect-of-micro-rna/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/potential-marker-for-response-to-anti-egfr-therapy-in-kras-wild-type-metastatic-colorectal-cancer/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/tissue-microenvironment-affects-activity-of-pten-in-leukemia/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/overexpression-of-sirt7-is-associated-with-tumorigenesis-and-poor-prognosis-in-colorectal-cancer/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/remarkable-response-to-sorafenib-in-advanced-lung-adenocarcinoma-and-oncogenic-araf-mutation/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/lcs6-genotype-not-associated-with-kras-mutation-status-or-outcome-in-stage-iii-colon-cancer/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/pd-1-identifies-patient-specific-cd8-positive-tumor-infiltrating-lymphocytes-in-melanoma/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/modification-of-t-cells-to-target-cs1-improves-eradication-of-myeloma-cells/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/potential-for-therapeutic-autovaccination-against-solid-tumors-with-intratumoral-poly-iclc/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/pro-oxidant-molecule-imexon-shows-clinical-activity-in-relapsedrefractory-b-cell-nhl/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/most-women-who-choose-breast-reconstruction-are-satisfied-with-decision-making-process/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/no-survival-benefits-with-erlotinib-and-whole-brain-radiotherapy-for-nsclc-with-multiple-brain-metastases/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/substantial-reductions-in-surgical-site-infections-after-colorectal-surgery-with-bundling-approach/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/allogeneic-conditioning-regimen-reduces-myelosuppression-graft-vs-host-disease-in-lymphocytic-leukemialymphoma/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/para-aortic-lymph-node-radiation-raises-risk-of-developing-diabetes-mellitus-in-hodgkin-lymphoma-survivors/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/residents-association-recognizes-57-mentors-and-teachers-with-2014-educator-of-the-year-award/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/memorial-sloan-kettering-cancer-center-launches-meaning-centered-psychotherapy-programs-for-terminally-ill-patients-cancer-survivors-and-caregivers/ 2019-03-11T17:49:53+00:00 https://ascopost.com/issues/september-15-2014/clinical-studies-in-psychotherapy-currently-recruiting-participants/ 2019-03-11T17:49:54+00:00 https://ascopost.com/issues/september-15-2014/how-evolutionary-game-theory-is-offering-clues-to-disrupt-cancer-cell-metabolism/ 2019-03-11T17:49:54+00:00 https://ascopost.com/issues/september-15-2014/john-h-saiki-md-swog-investigator-dies-at-77/ 2019-03-11T17:49:54+00:00 https://ascopost.com/issues/september-15-2014/st-jude-children-s-research-hospital-mourns-loss-of-friend-supporter-robin-williams/ 2019-03-11T17:49:54+00:00 https://ascopost.com/issues/september-1-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/september-1-2014/stereotactic-body-radiation-therapy-an-effective-option-for-early-stage-lung-cancer-patients/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/my-priorities-for-the-year-ahead/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/oncology-practice-what-are-the-factors-driving-change/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/expert-point-of-view-richard-l-schilsky-md/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/international-group-updates-recommendations-on-managing-lymphoma/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/jury-still-out-on-interim-pet-for-response-adapted-therapy-in-hodgkin-lymphoma/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/study-estimates-risk-of-premature-menopause-after-treatment-for-hodgkin-lymphoma/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/targeting-kras-mutations-in-lung-cancer-no-longer-impossible/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/september-is-ovarian-cancer-awareness-month/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/treating-multiple-myeloma-in-2014/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/quest-for-targeted-therapeutic-cocktails-hits-roadblocks/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/emerging-approaches-in-acute-myeloid-leukemia/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/charles-lemaistre-md-and-hans-mark-phd-named-chancellors-emeritus-by-the-university-of-texas-system-board-of-regents/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/understanding-the-impact-of-results-from-calgb-swog-80405-and-other-new-data-in-colorectal-cancer/ 2019-03-11T17:50:50+00:00 https://ascopost.com/issues/september-1-2014/systematic-model-identifies-factors-associated-with-adherence-in-prostate-cancer-prevention-trial/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/fda-approves-first-noninvasive-dna-screening-test-for-colorectal-cancer/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/fda-grants-fast-track-designation-to-novel-jak2-inhibitor-for-the-treatment-of-myelofibrosis/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/fda-approves-bevacizumab-for-aggressive-and-late-stage-cervical-cancer/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/fda-approves-bortezomib-retreatment-in-patients-with-multiple-myeloma/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/bortezomib-retreatment-in-multiple-myeloma/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/advances-in-hematopoietic-cell-transplant-for-pediatric-aml-reduce-toxicity-and-expand-access-but-relapse-remains-a-problem/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/protocol-modifications-decrease-toxicity-increase-event-free-survival-in-children-with-down-syndrome-treated-for-all/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/best-way-to-treat-mediastinal-lymphomas-is-still-unclear/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/a-cautionary-note-on-radiotherapy/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/expert-point-of-view-wyndham-h-wilson-md-phd/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/the-role-of-integrated-palliative-care-in-radiation-oncology/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/palbociclib-expanded-access-program-open-to-eligible-breast-cancer-patients/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/a-conversation-with-lidia-schapira-md-the-new-jco-art-of-oncology-editor/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/weconquercancer-creative-fundraisers-from-committed-conquerors/ 2019-03-11T17:50:51+00:00 https://ascopost.com/issues/september-1-2014/asco-experts-discuss-the-latest-advances-in-breast-cancer-care/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/a-world-free-from-the-fear-of-cancer-is-it-possible/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/asco-offers-input-on-21st-century-cures-pcast-white-paper/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/registration-open-for-the-community-research-forum-annual-meeting/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/asco-launches-the-asco-in-action-beat/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/bevacizumab-in-persistent-recurrent-or-metastatic-cervical-cancer/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/lung-screening-detected-abnormalities-other-than-cancer-result-in-smoking-cessation-national-lung-screening-trial-analysis/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/aaci-members-elect-new-leadership-members-to-board-of-directors/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/leaders-in-health-disparities-honored/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/phase-iii-trial-of-figitumumab-plus-chemotherapy-in-advanced-nsclc-stopped-early-for-futility-and-increased-harm/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/failure-of-igf-1r-inhibitor-figitumumab-in-advanced-nonadenocarcinoma-non-small-cell-lung-cancer/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/program-offers-unique-intervention-for-acute-promyelocytic-leukemia/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/astro-awards-35-500-in-individual-grants-to-43-researchers/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/identifying-impending-death-helps-patients-and-caregivers/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/a-new-book-explores-an-old-subject-aging/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/how-pharmaceutical-companies-are-partnering-with-patient-advocates-to-ensure-access-to-oncology-care/ 2019-03-11T17:50:52+00:00 https://ascopost.com/issues/september-1-2014/ongoing-clinical-trials-actively-recruiting-patients-with-kidney-cancer/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/gynecologic-cancer-care-collaboration-with-resource-challenged-ethiopia/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/nih-awards-two-new-grants-to-explore-the-understanding-of-genomics-research-in-africa/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/september-is-prostate-cancer-awareness-month/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/peter-pisters-md-appointed-president-and-chief-executive-officer-university-health-network-canada/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/mark-del-beccaro-md-named-senior-vice-president-chief-medical-officer-of-seattle-children-s-hospital/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/cancer-has-given-me-courage/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/survival-benefit-of-contralateral-prophylactic-mastectomy-less-than-1-at-20-years-but-numbers-of-procedures-have-increased/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/expect-questions-and-perhaps-unrealistic-expectations/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/royal-society-presents-2014-royal-medal-to-tony-hunter-phd-frs-salk-professor/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/postmenopausal-breast-cancer-risk-decreases-rapidly-after-starting-regular-physical-activity/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/nih-announces-launch-of-precision-medicine-trials-in-early-stage-lung-cancer/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/2014-oncology-meetings/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/bet-bromodomain-inhibition-highly-active-in-castration-resistant-prostate-cancer/ 2019-03-11T17:50:53+00:00 https://ascopost.com/issues/september-1-2014/fusion-protein-improves-dendritic-cell-penetration-raising-prospect-of-efficient-cancer-vaccine/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/dysregulated-cell-cycle-progression-and-akt-hyperactivation-in-cancer/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/small-molecule-induces-catastrophic-vacuolization-and-death-of-glioblastoma-cells/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/15-pgdh-expression-in-normal-mucosa-may-be-biomarker-for-aspirin-prevention-of-colorectal-cancer/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/prolonged-tv-viewing-other-sedentary-behaviors-linked-to-increased-risk-of-particular-cancers/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/patient-tumor-characteristics-associated-with-braf-and-kras-mutations/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/simple-bedside-assessment-of-pain-and-itch-is-valuable-tool-for-the-evaluation-of-suspicious-skin-lesions/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/first-prospective-study-of-rare-lymphoma-shows-promising-but-inconclusive-results-with-da-epoch-r/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/jesse-l-steinfeld-md-past-surgeon-general-asco-president-dies-at-87/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/jesse-l-steinfeld-md-and-the-war-on-cancer/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/september-1-2014/pioneer-in-fight-against-tobacco-emanuel-farber-md-phd-dies-at-85/ 2019-03-11T17:50:54+00:00 https://ascopost.com/issues/august-15-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/august-15-2014/recent-fda-drug-approvals-foster-growing-treatment-armamentarium-for-chronic-lymphocytic-leukemia-and-rare-b-cell-lymphomas/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/does-the-united-states-have-the-best-health-care-system-in-the-world/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/who-will-care-for-patients-with-cancer/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/anti-pd-1-agent-shows-activity-in-renal-cell-carcinoma/ 2020-09-23T01:58:39+00:00 https://ascopost.com/issues/august-15-2014/expert-point-of-view-lauren-c-harshman-md/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/studies-assess-response-to-platinum-therapy-in-triple-negative-breast-cancer/ 2020-09-23T01:59:43+00:00 https://ascopost.com/issues/august-15-2014/expert-point-of-view-melinda-l-telli-md/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/mixed-results-for-targeting-met-in-non-small-cell-lung-cancer/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/expert-point-of-view-federico-cappuzzo-md/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/new-research-presented-in-wilms-tumor-pediatric-sarcoma-head-and-neck-cancer-and-non-small-cell-lung-cancer/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/precision-medicine-precisely-where-are-we-really/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/rational-strategies-are-advancing-combination-lymphoma-therapies/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/tackling-the-heterogeneity-of-triple-negative-breast-cancer/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/90-countries-participate-in-the-5th-world-congress-of-the-international-federation-of-head-and-neck-oncologic-societies-in-new-york/ 2019-03-11T17:51:38+00:00 https://ascopost.com/issues/august-15-2014/mucositis-remains-a-challenge-in-head-and-neck-cancer/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/mascc-awards-honorary-lifetime-membership/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/nepa-for-chemotherapy-induced-nausea-and-vomiting-key-endpoints-and-additional-analyses-show-strong-efficacy/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/supportive-care-in-pediatric-patients-with-cancer-recent-developments-in-treating-febrile-neutropenia/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/no-overall-survival-improvement-but-some-palliative-benefit-with-gefitinib-in-esophageal-cancer-progressing-postchemotherapy/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/egfr-as-a-therapeutic-target-for-gastroesophageal-cancer-or-is-it-really/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/prevail-trial-enzalutamide-before-chemotherapy-prolongs-survival-in-metastatic-prostate-cancer/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/enzalutamide-and-the-landscape-of-castration-resistant-prostate-cancer-integrating-new-indications-with-existing-agents/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/college-of-american-pathologists-publishes-recommendations-for-prostate-cancer-active-surveillance/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/the-evolving-role-of-surgery-in-germ-cell-tumors/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/study-finds-new-genetic-risk-markers-in-pancreatic-cancer/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/fda-grants-bevacizumab-priority-review-for-certain-types-of-cervical-cancer/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/fda-grants-bevacizumab-priority-review-for-recurrent-platinum-resistant-ovarian-cancer/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/adjuvant-endocrine-therapy-for-hormone-receptor-positive-breast-cancer-asco-clinical-practice-guideline-focused-update/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/patience-remains-a-virtue-the-ongoing-quest-to-optimize-adjuvant-endocrine-therapy-in-breast-cancer/ 2019-03-11T17:51:39+00:00 https://ascopost.com/issues/august-15-2014/fred-hutchinson-cancer-research-center-researcher-veena-shankaran-md-to-receive-40-under-40-award/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/more-collaboration-needed-between-oncologists-and-primary-care-physicians/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/our-first-charge-fostering-the-next-generation-of-oncologists-and-cancer-researchers/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/center-for-medicare-and-medicaid-services-approves-qopi-as-pathway-for-federally-required-quality-reporting/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/proposed-2015-medicare-physician-fee-schedule-and-hospital-outpatient-prospective-payment-system-rules-released/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/asco-launches-online-resource-to-help-oncologists-understand-the-impact-of-the-affordable-care-act/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/order-asco-answers-guides-to-cancer-for-your-practice/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/asco-celebrates-oncology-luminaries-for-50th-anniversary/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/fda-approval-of-ceritinib-for-the-treatment-of-alk-positive-non-small-cell-lung-cancer/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/early-change-in-chemotherapy-based-on-elevated-circulating-tumor-cells-does-not-improve-outcome-in-metastatic-breast-cancer/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/circulating-tumor-cells-in-metastatic-breast-cancer-are-we-afraid-of-the-truth/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/nih-awards-145-million-to-research-groups-studying-newest-dna-sequencing-techniques/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/minority-of-older-patients-with-low-risk-prostate-cancer-managed-by-observation-rates-vary-widely-among-urologists-and-radiation-oncologists/ 2019-03-11T17:51:40+00:00 https://ascopost.com/issues/august-15-2014/active-surveillance-in-low-risk-prostate-cancer-when-will-we-pay-it-more-than-just-lip-service/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/low-risk-prostate-cancer-and-principles-of-active-surveillance/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/getting-results-how-oncologists-and-pathologists-can-work-together-to-facilitate-molecular-testing/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/life-magnified-exhibit-continues-to-heighten-public-awareness-about-science-on-display-and-online/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/astro-names-angelita-habr-gama-md-phd-honorary-member/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/prominent-immunotherapy-researcher-sees-success-beyond-the-challenges/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/michael-bookman-md-joins-us-oncology-research-as-medical-director-of-gynecology-research-program/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/holy-name-medical-center-of-new-jersey-welcomes-sharyn-n-lewin-md-facs-and-phyllis-tarallo-dnp-dcc/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/lynda-chin-md-named-a-recipient-of-the-chancellor-s-health-fellowship-by-the-university-of-texas-systems/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/idelalisib-for-relapsed-cll-in-combination-with-rituximab-and-for-relapsed-follicular-lymphoma-or-small-lymphocytic-lymphoma/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/ibrutinib-in-previously-treated-cll-and-cll-with-17p-deletion/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/pioneering-medical-oncologist-remembers-a-time-before-the-subspecialty-was-created/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/african-medical-education-is-being-transformed-by-us-program/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/discussing-sexual-health-issues-with-female-cancer-survivors/ 2019-03-11T17:51:41+00:00 https://ascopost.com/issues/august-15-2014/a-book-of-solid-advice-and-silver-linings-for-patients-with-breast-cancer/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/new-tv-ads-new-stories-for-cdc-s-tips-from-former-smokers-campaign/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/facing-cancer-together/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/ipos-celebrates-30th-anniversary-at-world-congress-in-lisbon/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/using-patient-reported-outcome-measures-in-palliative-care-clinical-practice/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/lung-cancer-alliance-commends-national-cancer-institute-for-its-new-scientific-framework-for-small-cell-lung-cancer/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/red-clover/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/patrick-soon-shiong-md-to-lead-providence-health-cancer-services-and-bioinformatics/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/oncologists-tell-inspiring-stories-of-what-it-s-like-to-treat-cancer-in-the-big-casino/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/book-excerpt-family/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/fda-takes-steps-to-help-ensure-the-reliability-of-certain-diagnostic-tests/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/aacr-issues-statement-to-applaud-fda-s-actions/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/michael-douglas-shares-his-experience-with-stage-iv-oropharyngeal-cancer/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/how-technology-is-helping-bring-health-care-to-patients/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/v-craig-jordan-phd-to-join-md-anderson-cancer-center/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/focus-on-the-florida-society-of-clinical-oncology/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/don-shula-foundation-donates-15-million-to-moffitt-cancer-center/ 2019-03-11T17:51:42+00:00 https://ascopost.com/issues/august-15-2014/2014-oncology-meetings/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/taking-charge-of-your-care/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/cancer-survivor-and-patient-advocate-michael-s-katz-mba-has-helped-alter-the-standard-of-care-for-myeloma-survivors/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/surgeon-general-call-to-action-to-prevent-skin-cancer/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/fda-commissioner-margaret-a-hamburg-s-statement-on-the-surgeon-general-s-call-to-action-to-prevent-skin-cancer/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/spleen-tyrosine-kinase-inhibition-has-promise-in-high-risk-precursor-b-cell-all/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/brca2-inhibits-genome-instability-by-preventing-r-loop-accumulation/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/prolyl-hydroxylase-inhibition-protects-against-gastrointestinal-radiation-toxicity/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/fbxw7-as-tumor-suppressor-and-notch1-inhibition-as-potential-strategy-in-melanoma/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/mesenchymal-stem-cells-with-oncolytic-hsv-variants-promising-in-glioblastoma-multiforme/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/mutations-in-igf-pathway-genes-associated-with-prostate-cancer-mortality/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/melanoma-metastases-exhibit-site-specific-antigen-heterogeneity-correlating-with-t-cell-infiltration/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/plasma-tumor-dna-detectable-before-and-after-surgery-in-patients-with-early-stage-breast-cancer/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/igf-2igf-1r-inhibition-shows-promise-in-esophageal-cancer/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/centrosome-amplification-promotes-cellular-invasion-in-mammary-epithelial-cells/ 2019-03-11T17:51:43+00:00 https://ascopost.com/issues/august-15-2014/dignity-personhood-and-the-culture-of-medicine/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/reasonable-to-advise-men-who-have-had-vasectomies-that-they-have-a-small-increased-risk-for-lethal-prostate-cancers/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/expect-questions-from-patients/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/new-clinical-study-aims-to-investigate-the-genomics-of-young-lung-cancer/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/ongoing-clinical-trials-actively-recruiting-patients-with-bladder-cancer/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/less-than-1-absolute-survival-benefit-at-20-years-found-for-contralateral-prophylactic-mastectomy/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/selected-patients-with-lung-cancer-and-poor-performance-status-may-benefit-from-standard-therapy/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/high-false-positive-rate-of-elevated-cea-seen-in-patients-with-resected-colorectal-cancer/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/everolimus-did-not-improve-survival-in-hepatocellular-cancer-after-progression-on-sorafenib/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/identifying-and-managing-distress-in-patients-with-head-and-neck-cancers/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/higher-dose-carfilzomib-produces-remarkable-response-duration-in-relapsedrefractory-multiple-myeloma/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/what-do-humans-and-laboratory-rats-have-in-common/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/childhood-cancer-survivors-hospitalized-frequently-years-after-cancer-treatment/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/august-15-2014/national-ovarian-cancer-coalition-featured-in-new-york-s-rockefeller-center-window-during-august/ 2019-03-11T17:51:44+00:00 https://ascopost.com/issues/july-25-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/july-25-2014/considerable-extension-of-survival-achieved-with-conventional-treatment-in-grade-2-glioma/ 2019-03-11T17:52:42+00:00 https://ascopost.com/issues/july-25-2014/expert-point-of-view-howard-a-fine-md-and-martin-j-van-den-bent-md/ 2019-03-11T17:52:42+00:00 https://ascopost.com/issues/july-25-2014/take-home-messages-from-ascos-immediate-past-president/ 2019-03-11T17:52:42+00:00 https://ascopost.com/issues/july-25-2014/sidebar-long-term-international-fellowship-life-award/ 2019-03-11T17:52:42+00:00 https://ascopost.com/issues/july-25-2014/stakeholders-are-uniting-around-value-in-cancer-care/ 2019-03-11T17:52:42+00:00 https://ascopost.com/issues/july-25-2014/multiple-myeloma-studies-explore-roles-of-panobinostat-in-relapsedrefractory-disease-and-thalidomide-compared-to-lenalidomide-as-part-of-initial-therapy/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/expert-point-of-view-philip-mccarthy-md/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/neoadjuvant-chemotherapy-less-invasive-option-for-advanced-ovarian-cancer-but-jury-still-out/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/expert-point-of-view-dennis-s-chi-md/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/intralesional-injections-trigger-immune-responses-in-melanoma/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/expert-point-of-view-axel-hauschild-md/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/benefit-confirmed-for-adjuvant-oxaliplatin-in-rectal-cancer/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/expert-point-of-view-carmen-j-allegra-md/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/impressive-delay-in-thyroid-cancer-progression-achieved-with-lenvatinib/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/women-with-brca-mutations-report-significant-side-effects-following-risk-reducing-salpingo-oophorectomy/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/breast-cancer-related-benefits-of-weight-loss/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/expert-point-of-view-wendy-demark-wahnefried-phd-rd/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/fda-grants-breakthrough-therapy-designation-to-investigational-chimeric-antigen-receptor-therapy-for-relapsedrefractory-all/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/orphan-drug-designation-granted-for-new-agent-in-hepatocellular-carcinoma/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/fda-approves-belinostat-for-relapsed-or-refractory-peripheral-t-cell-lymphoma/ 2019-03-11T17:52:43+00:00 https://ascopost.com/issues/july-25-2014/investigational-immunotherapy-demonstrates-response-in-patients-with-pd-l1-positive-metastatic-bladder-cancer/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/federally-funded-trials-praised-and-underfunded/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/aspho-abstracts-cover-broad-range-of-topics/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/fda-grants-breakthrough-therapy-designation-to-blinatumomab-for-acute-lymphoblastic-leukemia/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/fda-drug-safety-communication-docetaxel-may-cause-symptoms-of-alcohol-intoxication/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/phase-iii-trial-shows-improved-survival-with-tas-102-in-metastatic-colorectal-cancer-refractory-to-standard-therapies/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/expert-point-of-view-jean-yves-douillard-md-phd/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/adding-novel-agent-to-standard-therapy-improves-survival-in-patients-with-pancreatic-cancer-after-prior-gemcitabine-based-therapy/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/second-line-regorafenib-improves-survival-in-metastatic-colorectal-cancer/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/illumination-to-innovation-transforming-data-into-learning/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/asco-s-50th-anniversary-past-presidents-recall-top-issues-during-their-terms/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/asco-s-cancer-survivorship-compendium-offers-oncologists-help-with-survivorship-care/ 2019-03-11T17:52:44+00:00 https://ascopost.com/issues/july-25-2014/asco-invites-widespread-use-of-federally-funded-research-badge/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/look-for-changes-to-cancernet-s-design-and-navigation/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/conquer-cancer-foundation-past-grant-recipients-present-research-advances-in-melanoma-and-ovarian-cancer-at-2014-asco-annual-meeting/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/sorafenib-improves-progression-free-survival-in-progressive-radioactive-iodine-refractory-differentiated-thyroid-cancer/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/progress-in-differentiated-thyroid-cancer/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/rilotumumab-added-to-first-line-chemotherapy-may-benefit-patients-with-advanced-gastric-or-esophagogastric-junction-adenocarcinoma/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/swiss-medical-board-members-discuss-recommendation-to-phase-out-mammography-screening/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/swiss-medical-board-recommendation-to-end-mammography-screening-a-disturbing-proposal/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/belinostat-for-relapsedrefractory-peripheral-t-cell-lymphoma/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/hiv-infected-people-with-early-stage-cancers-are-up-to-four-times-more-likely-to-go-untreated-for-cancer/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/ongoing-clinical-trials-actively-recruiting-children-with-cancer/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/the-road-to-progress-in-lung-cancer-treatment/ 2019-03-11T17:52:45+00:00 https://ascopost.com/issues/july-25-2014/lung-map-trial-debuts-other-personalized-studies-will-follow/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/head-and-neck-societies-proclaim-july-27th-world-head-and-neck-cancer-day/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/how-to-recognize-and-manage-intertriginous-eruptions-related-to-doxorubicin/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/focus-on-the-ohio-hematology-oncology-society/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/from-ireland-to-america-and-back-patrick-g-johnston-md-phd-thrives-on-bringing-research-findings-to-clinical-practice/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/surgical-biopsy-proves-safe-for-selected-patients-with-late-stage-lung-cancer/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/prostate-cancer-biomarkers-improvement-in-predicting-clinically-significant-disease/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/do-we-need-so-much-emphasis-on-quality-care/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/coping-with-the-aftermath-of-cancer/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/2014-oncology-meetings/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/avoiding-antioxidant-drug-interactions-during-cancer-treatment/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/david-c-beyer-md-fastro-named-president-elect-astro-board-of-directors/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/moffitt-receives-16-million-grant-for-lung-cancer-screenings/ 2019-03-11T17:52:46+00:00 https://ascopost.com/issues/july-25-2014/mth1-inhibition-blocks-sanitation-of-deoxyribonucleotide-triphosphate-pool-and-causes-cancer-cell-death/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/high-macrophage-inhibitory-cytokine-1-levels-and-colorectal-cancer-risk/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/egfr-activation-increases-cancer-cell-visibility-for-cytotoxic-t-lymphocytes/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/vaccine-targeting-tumor-antigen-to-dendritic-cell-receptors-induces-antigen-specific-immunity/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/cancer-survivors-face-unique-challenges-reentering-the-workforce/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/international-leader-in-urology-professor-john-fitzpatrick-dies/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/women-with-small-node-negative-breast-tumors-have-excellent-prognosis-without-chemotherapy/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/colorectal-cancer-survivors-prefer-more-information-on-late-effects-of-treatment-and-recurrence-risks/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-25-2014/high-response-rate-and-good-safety-profile-for-carfilzomib-plus-cyclophosphamide-and-dexamethasone/ 2019-03-11T17:52:47+00:00 https://ascopost.com/issues/july-10-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/july-10-2014/impressive-outcomes-achieved-with-pembrolizumab-in-advanced-melanoma/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/expert-point-of-view-jeffrey-s-weber-md-phd/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/the-more-things-change-the-more-they-stay-the-same/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/iom-workshop-explores-growing-problems-in-patient-access-to-cancer-drugs/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/ipilimumab-reduces-recurrences-as-adjuvant-treatment-of-melanoma/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/long-term-follow-up-of-phase-i-nivolumab-trial/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/strong-showing-for-anti-pd-1-agents-in-non-small-cell-lung-cancer/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/expert-point-of-view-martin-reck-md-phd/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/ar-v7-predicts-resistance-to-enzalutamide-and-abiraterone-in-men-with-castration-resistant-prostate-cancer/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/expert-point-of-view-eleni-efstathiou-md-phd/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/r-squared-regimen-delivers-a-punch-to-diffuse-large-b-cell-lymphoma-subtype/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/expert-point-of-view-nathan-fowler-md/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/concurrent-immunotherapy-pays-off-in-advanced-melanoma/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/expert-point-of-view-jeffrey-s-weber-md-phd-1/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/fda-advisory-committee-votes-against-accelerated-approval-for-olaparib-in-ovarian-cancer/ 2019-03-11T17:53:44+00:00 https://ascopost.com/issues/july-10-2014/navigating-cancer-in-the-era-of-personalized-medicine-rev-2014-explores-emerging-issues-ideas-for-action/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/national-institutes-of-health-names-new-council-members/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/american-association-for-the-advancement-of-science-cancer-research-award/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/raja-flores-md-named-chair-of-new-thoracic-surgery-department-at-mount-sinai/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/james-r-downing-md-named-ceo-of-st-jude-children-s-research-hospital/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/ado-trastuzumab-emtansine-improves-progression-free-survival-vs-physician-s-choice-in-advanced-her2-positive-breast-cancer/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/ado-trastuzumab-emtansine-as-a-late-treatment-for-her2-positive-metastatic-breast-cancer-better-and-less-toxic-than-physician-s-choice/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/asco-clinical-practice-guideline-disease-management-in-advanced-her2-positive-breast-cancer-with-brain-metastases/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/asco-guideline-for-management-of-brain-metastases-from-her2-positive-breast-cancer-an-important-framework/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/panitumumab-plus-folfox-for-kras-wild-type-metastatic-colorectal-cancer/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/2014-breast-cancer-symposium-to-focus-on-collaborative-learning/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/yanyan-lou-md-phd-receives-inaugural-2014-young-investigator-award-supported-by-the-women-who-conquer-cancer-campaign/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/newly-updated-cancer-survivorship/ 2019-03-11T17:53:45+00:00 https://ascopost.com/issues/july-10-2014/2001-young-investigator-award-recipient-pasi-jaenne-md-phd-presents-research-on-promising-new-therapy-for-treatment-resistant-nsclc/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/be-counted-in-2014-asco-national-oncology-census-no-login-information-required/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/asco-to-hold-community-research-forum-annual-meeting-in-september/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/following-fruitful-year-of-collaboration-advocacy-and-growth-pediatric-hematologyoncology-moves-to-next-level/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/andrew-s-kraft-md-named-director-of-university-of-arizona-cancer-center/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/first-tang-prize-for-biopharmaceutical-science-awarded-to-james-p-allison-phd-and-tasuku-honjo-md-phd/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/2014-oncology-meetings/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/lung-cancer-mutation-consortium-finds-oncogenic-drivers-in-majority-of-metastatic-lung-adenocarcinomas/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/importance-of-using-multiplex-testing-for-oncogenic-drivers-to-select-targeted-drugs-in-lung-cancer/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/nonadherence-with-maintenance-medication-an-issue-in-children-with-leukemia/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/stronger-nicotine-dependency-associated-with-higher-lung-cancer-risk/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/patricia-m-lorusso-do-to-join-yale-cancer-center/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/asco-convenes-think-tank-to-tackle-disparities-in-cancer-care/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/physician-education-is-key-to-continued-advances-in-geriatric-oncology/ 2020-02-17T18:24:46+00:00 https://ascopost.com/issues/july-10-2014/uc-davis-comprehensive-cancer-center-tailors-pilot-program-to-help-patients-adhere-to-oral-chemotherapy/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/life-magnified/ 2019-03-11T17:53:46+00:00 https://ascopost.com/issues/july-10-2014/fda-launches-openfda-initiative-to-ease-access-to-public-health-data/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/diagnostic-imaging-agent-approved-for-use-in-patients-with-head-and-neck-cancer/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/astro-names-three-radiation-oncologists-as-recipients-of-society-s-2014-gold-medal/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/siltuximab-for-multicentric-castleman-s-disease/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/three-physician-scientists-join-st-jude-children-s-research-hospital/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/discontinuing-statins-near-the-end-of-life-is-safe-can-reduce-symptom-burden-and-is-generally-acceptable-to-patients/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/expect-questions-but-not-a-lot-of-resistance/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/underuse-of-trimodality-treatment-for-patients-with-inflammatory-breast-cancer-negatively-impacts-survival/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/limited-public-awareness-of-head-and-neck-cancers-raises-concerns-about-prevention-and-detection/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/modest-improvement-in-progression-free-but-not-overall-survival-with-selumetinib-vs-chemotherapy/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/coping-with-the-aftermath-of-cancer/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/july-10-2014/patient-guides-available-through-asco-university-bookstore/ 2019-03-11T17:53:47+00:00 https://ascopost.com/issues/june-25-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/june-25-2014/exemestaneovarian-suppression-reduces-recurrence-vs-tamoxifenovarian-suppression-in-premenopausal-breast-cancer/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-nancy-e-davidson-md-and-claudine-isaacs-md/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/time-to-move-forward-with-lung-screening/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/advancing-immune-checkpoint-targeting-in-cancer-treatment/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/combined-with-chemotherapy-cetuximab-and-bevacizumab-found-comparable-for-first-line-metastatic-colorectal-cancer-treatment/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-josep-tabernero-md-phd/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/updated-information-on-prostate-cancer-drugs-enzalutamide-orteronel-and-cixutumumab/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-scott-t-tagawa-md/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-cora-n-sternberg-md-facp/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/early-study-explores-new-approach-to-treating-advanced-cervical-cancer/ 2019-03-11T17:55:18+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-steven-j-o-day-md-don-s-dizon-md-michael-birrer-md-phd/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/ibrutinib-surpasses-ofatumumab-as-second-line-treatment-of-chronic-lymphocytic-leukemia/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-gregory-a-masters-md-fasco-olatoyosi-odenike-md-lee-greenberger-phd/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/pieces-of-the-puzzle-in-treating-early-non-small-cell-lung-cancer/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-nasser-h-hanna-md/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/barbara-l-mcaneny-md-to-serve-as-chair-of-the-ama-board-of-trustees/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/barbara-mcaneny-md-on-the-collective-power-of-doctors/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/oral-two-drug-regimen-appears-promising-in-phase-ii-trial-of-recurrent-platinum-sensitive-ovarian-cancer/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-gregory-a-masters-md-fasco/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/goserelin-with-chemotherapy-prevents-early-menopause-helps-preserve-fertility-in-younger-women-with-hormone-receptor-negative-breast-cancer/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-sharon-h-giordano-md-mph/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/immune-related-genes-predictive-of-trastuzumab-benefit/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-sherene-loi-md-phd/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/chemotherapy-plus-ramucirumab-provides-survival-advantage-over-chemotherapy-alone-in-non-small-cell-lung-cancer/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/expert-point-of-view-gregory-a-masters-md-fasco-2/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/fda-approves-magnetic-resonance-contrast-agent-for-evaluation-of-breast-cancer/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/research-insights-from-the-aacr-special-conference-on-pancreatic-cancer/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/lung-map-launches-first-precision-medicine-trial-from-national-clinical-trials-network/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/preoperative-breast-mri-does-higher-sensitivity-equal-better-outcomes/ 2019-03-11T17:55:19+00:00 https://ascopost.com/issues/june-25-2014/gastric-cancer-detected-in-a-breath-test/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/colorectal-cancer-screening-poised-for-change/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/many-patients-with-colorectal-cancer-fail-to-receive-adjuvant-chemotherapy/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/fda-approval-of-siltuximab-for-multicentric-castleman-s-disease/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/fda-approves-radioactive-diagnostic-imaging-agent-to-help-determine-the-extent-of-head-and-neck-cancer-in-the-body/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/conquering-cancer-with-2013-career-development-award-recipient-rebecca-a-gardner-md/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/congress-salutes-asco-s-50th-anniversary-on-house-floor/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/cancer-organizations-honor-congressmen-for-cancer-research-advocacy/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/help-your-patients-catch-up-on-the-latest-research-from-the-2014-asco-annual-meeting/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/asco-s-patient-information-website-cancernet-undergoes-redesign/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/the-2014-conquer-cancer-foundation-grants-and-awards/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/videos-tell-stories-of-50-years-of-progress-against-cancer/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/asco-clinical-practice-guideline-systemic-therapy-for-patients-with-advanced-her2-positive-breast-cancer/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/a-new-era-in-the-management-of-advanced-her2-positive-breast-cancer/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/issues-in-the-management-of-the-axilla-in-patients-with-breast-cancer/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/paying-it-forward-breakthrough-prize-winners-and-institutions-commit-3-million-in-support-of-next-generation-of-scientists/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/colonoscopy-adenoma-detection-rate-inversely-proportional-to-risk-of-interval-colorectal-cancer-and-colorectal-cancer-mortality/ 2019-03-11T17:55:20+00:00 https://ascopost.com/issues/june-25-2014/colon-cancer-prevention-it-s-all-about-mindset-and-minute-details/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/maurie-markman-md-named-president-of-medicine-science-unit-cancer-treatment-centers-of-america/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/marie-josée-and-henry-r-kravis-foundation-provides-100-million-gift-to-support-precision-oncology-work-at-memorial-sloan-kettering-cancer-center/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/david-craig-pharmd-named-to-fda-advisory-committee/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/federal-pain-research-database-launched/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/cancer-care-under-the-affordable-care-act/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/physician-attitudes-about-multiplex-tumor-genomic-testing-variation-in-projected-use-and-confidence/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/genomic-confidence-and-competence/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/2014-oncology-meetings/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/new-option-for-preserving-fertility-in-women-being-treated-with-chemotherapy-for-early-stage-breast-cancer/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/expect-questions-from-patients/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/focus-on-the-washington-state-medical-oncology-society/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/colorectal-cancer-screening-recommended-past-age-75-for-previously-unscreened-patients/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/long-term-follow-up-confirms-low-incidence-of-cardiac-events-associated-with-trastuzumab/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/aflibercept-more-active-than-bevacizumab-in-patient-derived-colorectal-cancer-xenografts/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/leading-cancer-researcher-and-public-health-care-expert-eddie-reed-md-dies/ 2019-03-11T17:55:21+00:00 https://ascopost.com/issues/june-25-2014/sharing-50-years-of-christmas-a-quality-metric/ 2019-03-11T17:55:22+00:00 https://ascopost.com/issues/june-10-2014/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/june-10-2014/unprecedented-survival-benefit-in-prostate-cancer-with-addition-of-docetaxel-to-hormone-therapy/ 2019-03-11T17:56:06+00:00 https://ascopost.com/issues/june-10-2014/expert-point-of-view-michael-j-morris-md/ 2019-03-11T17:56:06+00:00 https://ascopost.com/issues/june-10-2014/small-practices-like-mine/ 2019-03-11T17:56:06+00:00 https://ascopost.com/issues/june-10-2014/medicare-advisory-panel-cast-doubts-on-lung-cancer-screening-leaving-advocates-dismayed-but-undaunted/ 2019-03-11T17:56:06+00:00 https://ascopost.com/issues/june-10-2014/sidebar-how-the-medcac-panelists-voted/ 2019-03-11T17:56:06+00:00 https://ascopost.com/issues/june-10-2014/sidebar-medcac-roster/ 2019-03-11T17:56:06+00:00 https://ascopost.com/issues/june-10-2014/altto-trial-finds-dual-anti-her2-therapy-no-better-than-trastuzumab-alone/ 2019-03-11T17:56:06+00:00 https://ascopost.com/issues/june-10-2014/expert-point-of-view-george-w-sledge-jr-md/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/phase-i-study-of-novel-third-generation-egfr-inhibitor-holds-promise-against-resistance-mutation-in-patients-with-non-small-cell-lung-cancer/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/expert-point-of-view-peter-p-yu-md/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/delaying-androgen-deprivation-therapy-may-not-compromise-survival-in-men-with-prostate-cancer-and-psa-only-relapse/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/expert-point-of-view-peter-p-yu-md-1/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/obesity-increases-breast-cancer-mortality-in-premenopausal-women-with-estrogen-receptor-positive-disease/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/guides-for-oncology-providers-and-patients-now-available/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/expert-point-of-view-clifford-a-hudis-md-facp/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/cryoablation-of-breast-tumors-shows-promise-in-patients-with-early-stage-disease/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/axillary-radiotherapy-associated-with-fewer-side-effects-than-lymph-node-dissection-in-amaros-analysis/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/iaslc-issues-statement-on-e-cigarettes/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/mercaptopurine-oral-suspension-for-acute-lymphoblastic-leukemia/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/glioblastoma-can-we-make-this-intractable-disease-tractable/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/aacr-calls-on-congress-to-support-cancer-research-funding-to-meet-the-challenges-of-our-aging-population/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/phase-iii-study-of-talimogene-laherparepvec-in-patients-with-metastatic-melanoma-overall-survival-analysis-reported/ 2019-03-11T17:56:07+00:00 https://ascopost.com/issues/june-10-2014/surveillance-after-colon-cancer-surgery-too-much-of-a-good-thing/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/study-calls-for-revisiting-guidelines-for-screening-childhood-cancer-survivors-at-risk-of-congestive-heart-failure/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/nccn-scientific-posters-include-new-findings-in-bladder-cancer-survivorship-care-and-antiemetic-therapy/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/nccn-roundtable-when-a-parent-has-cancer/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/looking-ahead-in-treating-chronic-lymphocytic-leukemia/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/patients-benefit-from-faster-fda-drug-approval-process/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/unprecedented-release-of-medicare-data-raises-concerns-about-lack-of-context-statements-from-coa-and-astro/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/asco-clinical-practice-guideline-update-sentinel-lymph-node-biopsy-for-patients-with-early-stage-breast-cancer/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/asco-guideline-update-extends-sentinel-node-biopsy-indications-in-breast-cancer/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/postmastectomy-radiotherapy-reduces-breast-cancer-recurrence-and-mortality-in-women-with-one-to-three-positive-nodes/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/should-breast-cancer-patients-with-one-to-three-positive-nodes-routinely-receive-postmastectomy-radiation/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/helping-young-adults-cope-with-cancer/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/hookah-tobacco-smoking-among-students/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/demetrius-h-bagley-md-honored-with-aua-lifetime-achievement-award/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/a-way-forward-in-genomic-medicine/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/cancer-center-at-johns-hopkins-set-to-expand-with-65-million-gift/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/asco-takes-aim-at-the-link-between-obesity-and-cancer/ 2019-03-11T17:56:08+00:00 https://ascopost.com/issues/june-10-2014/explore-cancer-care-that-best-supports-patients-and-families-at-the-palliative-care-in-oncology-symposium/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/asco-s-latest-breast-cancer-guidelines/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/asco-immediate-past-president-hudis-urges-congress-to-invest-in-medical-research/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/icd-10-adoption-requirements-delayed-for-1-year/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/ceritinib-in-alk-positive-metastatic-nsclc-patients-with-progression-on-or-intolerance-to-crizotinib/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/experts-share-keys-to-a-successful-lung-screening-program/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/nih-addiction-science-award/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/asco-endorses-ssoastro-guideline-on-margins-for-breast-conserving-surgery-with-whole-breast-irradiation-in-stage-iii-breast-cancer/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/margin-reassessment-in-breast-conservation-therapy/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/ongoing-clinical-trials-actively-recruiting-patients-with-pancreatic-cancer/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/17-gene-assay-is-a-significant-predictor-of-prostate-cancer-aggressiveness/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/arizona-oncology-announces-retirement-of-kenneth-luk-md/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/us-team-to-read-pap-tests-in-botswana-campaign-against-cervical-cancer/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/university-of-louisville-receives-55-million-grant-from-helmsley-charitable-trust-to-support-innovative-cancer-research/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/randomized-trials-vs-meta-analyses-which-is-the-better-bet/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/st-johns-wort/ 2019-03-11T17:56:09+00:00 https://ascopost.com/issues/june-10-2014/bringing-palliative-care-services-to-local-community-clinical-practices-and-health-facilities-throughout-the-world/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/fda-approves-palonosetron-hydrochloride-for-prevention-of-chemotherapy-induced-nausea-and-vomiting-in-pediatric-patients/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/fda-approves-panitumumab-plus-folfox-for-wild-type-kras-metastatic-colorectal-cancer/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/a-proposal-for-patient-selected-controlled-trials-good-science-and-good-medicine/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/cancer-has-robbed-me-of-my-physical-beauty-but-not-my-inner-strength/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/2014-oncology-meetings/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/oncology-advanced-practitioners-in-the-midst-of-growth-change/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/water-pipe-smoking-may-increase-risk-for-cancer/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/copper-chelation-for-braf-mutated-disease/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/mth1-inhibition-blocks-sanitation-of-deoxyribonucleotide-triphosphate-pool-and-causes-cancer-cell-death/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/druggable-oncogene-fusions-found-in-kras-wild-type-lung-invasive-mucinous-adenocarcinoma/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/high-macrophage-inhibitory-cytokine-1-levels-and-colorectal-cancer-risk/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/speaking-up-against-high-cancer-drug-prices/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/encourage-questions-and-actions-about-the-high-cost-of-cancer-drugs/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/increased-hospice-use-among-minority-patients-treated-in-provider-based-research-networks/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/cancer-patients-at-high-recurrence-risk-for-venous-thromboembolism-should-be-considered-for-secondary-prophylaxis/ 2019-03-11T17:56:10+00:00 https://ascopost.com/issues/june-10-2014/for-hospitalized-cancer-patients-thromboprophylaxis-often-prescribed-without-regard-to-risk-factors/ 2019-03-11T17:56:11+00:00 https://ascopost.com/issues/june-10-2014/congress-celebrates-50-years-of-asco-special-order-on-house-floor-honors-society-s-mid-century-anniversary/ 2019-03-11T17:56:11+00:00 https://ascopost.com/issues/june-10-2014/remembering-selma-ruth-schimmel/ 2019-03-11T17:56:11+00:00 https://ascopost.com/issues/june-10-2014-supplement/ 2021-06-08T17:57:23+00:00 https://ascopost.com/issues/june-10-2014-supplement/an-early-calling-to-medicine-that-never-wavered-asco-president-peter-p-yu-md/ 2019-03-11T17:56:47+00:00 https://ascopost.com/issues/june-10-2014-supplement/international-leader-in-multiple-myeloma-was-inspired-by-an-early-mentor-s-lessons-in-wisdom-and-compassion/ 2019-03-11T17:56:47+00:00 https://ascopost.com/issues/june-10-2014-supplement/asco-past-president-and-breast-cancer-researcher-works-to-unite-the-oncology-community-in-the-fight-against-cancer/ 2019-03-11T17:56:47+00:00 https://ascopost.com/issues/june-10-2014-supplement/a-coast-to-coast-road-to-an-illustrious-career-in-radiation-oncology/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/barbara-l-mcaneny-md-is-dedicated-to-designing-a-better-health-care-system/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/nationally-renowned-surgeon-and-researcher-john-e-niederhuber-md-relishes-the-challenges-that-lie-ahead/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/internationally-renowned-oncologist-blazes-a-trail-in-breast-cancer-genetics-and-risk-assessment/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/enthusiasm-and-vision-guide-the-head-of-fda-s-oncology-office/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/understanding-the-relationship-between-the-lab-and-the-clinic-is-key-to-2014-karnofsky-memorial-award-honoree-s-success/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/david-a-karnofsky-the-man-behind-the-karnofsky-memorial-award-and-lecture/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/recipients-of-the-david-a-karnofsky-memorial-award-and-lecture/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/asco-s-visionary-founders/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/asco-through-the-years-past-presidents/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/peter-jacobs-md-phd-1934-2013/ 2019-03-11T17:56:48+00:00 https://ascopost.com/issues/june-10-2014-supplement/donald-l-morton-md-september-12-1934-january-10-2014/ 2019-03-11T17:56:49+00:00 https://ascopost.com/issues/june-10-2014-supplement/geoffrey-p-herzig-md-december-6-1941-december-20-2013/ 2019-03-11T17:56:49+00:00 https://ascopost.com/issues/june-10-2014-supplement/janet-l-rowley-md-april-5-1925-december-17-2013/ 2019-03-11T17:56:49+00:00 https://ascopost.com/issues/june-10-2014-supplement/jane-weeks-md-msc-august-12-1952-september-10-2013/ 2019-03-11T17:56:49+00:00 https://ascopost.com/issues/june-10-2014-supplement/ernest-louis-mazzaferri-sr-md-september-27-1936-may-14-2013/ 2019-03-11T17:56:49+00:00 https://ascopost.com/issues/june-10-2014-supplement/about-the-writer/ 2019-03-11T17:56:50+00:00 https://ascopost.com/issues/june-10-2014-supplement/about-the-artist/ 2019-03-11T17:56:50+00:00 https://ascopost.com/issues/may-15-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/may-15-2014/asco-releases-guideline-on-prevention-and-management-of-chemotherapy-induced-peripheral-neuropathy-in-survivors-of-adult-cancers/ 2019-03-11T17:57:28+00:00 https://ascopost.com/issues/may-15-2014/guidelines-for-chemotherapy-induced-neuropathy-the-known-unknowns/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/asco-develops-new-strategy-to-increase-value-in-cancer-care/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/reflecting-on-the-past-year-and-looking-ahead-to-the-next/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/nccn-clinical-practice-guidelines-in-oncology-2014-updates/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/survival-analysis-of-contralateral-prophylactic-mastectomy-sparks-discussion/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/fda-approves-ramucirumab-for-stomach-cancer/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/lymphedema-lingers-long-after-sentinel-lymph-node-dissection-for-early-breast-cancer/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/blood-test-can-identify-prostate-cancer-patients-who-are-not-likely-to-respond-to-enzalutamide/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/expert-point-of-view-daniel-petrylak-md/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/early-data-for-ag-221-show-unprecedented-activity-in-acute-myeloid-leukemia-and-myelodysplastic-syndrome/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/expert-point-of-view-john-c-byrd-md/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/fgfr-inhibitors-of-interest-in-bladder-and-lung-cancer/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/expert-point-of-view-paul-k-paik-md/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/i-spy-2-trial-graduates-neratinib-to-phase-iii-study-in-her2-positive-hormone-receptor-negative-breast-cancer/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/expert-point-of-view-edith-perez-md/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/promoting-health-behaviors-among-cancer-survivors/ 2019-03-11T17:57:29+00:00 https://ascopost.com/issues/may-15-2014/workshops-train-community-cancer-center-nurses-and-administrators-to-implement-clinical-trials/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/belinostat-moves-forward-in-trials-for-two-aggressive-cancers/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/andrew-d-zelenetz-md-phd-on-treating-the-elderly-lymphoma-patient-with-elevated-bilirubin/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/the-affordable-care-act-nccn-panelists-rate-it-average/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/challenges-in-creating-and-promoting-clinical-practice-guidelines/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/asco-releases-adapted-guideline-on-screening-assessment-and-care-of-anxiety-and-depressive-symptoms-in-adults-with-cancer/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/one-step-forward/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/postmastectomy-radiotherapy-benefits-women-with-breast-cancer-that-has-spread-to-one-to-three-lymph-nodes/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/meta-analysis-shows-survival-benefit-of-preoperative-chemotherapy-in-nsclc/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/asco-releases-adapted-guideline-on-screening-assessment-and-management-of-fatigue-in-adult-survivors-of-cancer/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/personalized-cancer-fatigue-care-asco-clinical-practice-guideline-adaptation/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/ceritinib-highly-active-in-patients-with-alk-rearranged-advanced-nsclc/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/fda-approves-ceritinib-for-late-stage-lung-cancer/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/fda-approves-siltuximab-for-rare-castleman-s-disease/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/fda-approves-first-hpv-test-for-primary-cervical-cancer-screening/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/fda-proposes-to-extend-its-tobacco-authority-to-additional-tobacco-products-including-e-cigarettes/ 2019-03-11T17:57:30+00:00 https://ascopost.com/issues/may-15-2014/fda-approves-mercaptopurine-oral-suspension-for-acute-lymphoblastic-leukemia/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/supplemental-new-drug-application-submitted-for-ibrutinib-in-cll/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/volasertib-granted-orphan-drug-designation-for-acute-myeloid-leukemia/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/cancer-chemotherapy-use-during-pregnancy/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/phase-iii-study-explores-addition-of-nintedanib-to-docetaxel-in-second-line-treatment-of-non-small-cell-lung-cancer/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/demanding-more-from-clinical-trials/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/continued-survival-benefits-seen-with-radical-prostatectomy-vs-watchful-waiting-in-long-term-follow-up-of-the-spcg-4-trial/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/beyond-the-cystoscope-thinkers-and-technicians/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/fda-discourages-use-of-laparoscopic-power-morcellation-for-removal-of-uterus-or-uterine-fibroids/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/neoadjuvant-chemotherapy-without-routine-radiotherapy-shows-promise-in-patients-with-locally-advanced-rectal-cancer/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/getting-it-right-in-the-end-individualization-of-care-for-patients-with-rectal-cancer/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/phase-iii-trial-reports-focused-ultrasound-reduces-cancer-pain/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/researchers-cornelia-ulrich-phd-and-bruce-a-edgar-phd-join-huntsman-cancer-institute/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/michael-s-gordon-md-named-medical-director-for-virginia-g-piper-cancer-center-clinical-trials-at-scottsdale-healthcare/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/project-data-sphere-megadata-in-the-cloud-could-speed-clinical-trials-here-on-earth/ 2019-03-11T17:57:31+00:00 https://ascopost.com/issues/may-15-2014/the-sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins-announces-faculty-appointments-grants/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/centers-for-disease-control-and-prevention-awards-grants-of-more-than-125-million-to-college-of-american-pathologists/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/american-society-of-clinical-oncology-honors-researchers-patient-advocates-and-leaders-of-the-global-oncology-community/ 2020-02-17T18:20:42+00:00 https://ascopost.com/issues/may-15-2014/conquer-cancer-foundation-and-strike-3-foundation-work-together-to-conquer-pediatric-cancers/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/conquer-cancer-foundation-of-asco-young-investigator-award-recipients-supported-by-the-strike-3-foundation/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/asco-launches-new-resources-for-providers-and-patients-to-address-link-between-obesity-and-cancer/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/visit-the-conquer-cancer-foundation-donor-lounge-at-the-asco-annual-meeting/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/help-your-patients-understand-the-latest-research-to-be-highlighted-at-the-2014-asco-annual-meeting/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/shelagh-tippet-fagyas-named-president-of-the-leukemia-lymphoma-society-of-canada/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/aacr-honors-douglas-hanahan-phd-with-aacr-lifetime-achievement-in-cancer-research-award/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/james-p-allison-phd-receives-2014-canada-gairdner-international-award/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/setting-a-moon-shots-goal-to-drastically-reduce-cancer-mortality-over-the-next-decade/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/forward-progress-in-myelodysplastic-syndromes-is-largely-in-genetics/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/asco-committee-defines-clinically-meaningful-goals-for-clinical-trials-in-pancreas-breast-lung-and-colorectal-cancers/ 2019-03-11T17:57:32+00:00 https://ascopost.com/issues/may-15-2014/discussions-about-the-cost-of-cancer-care-are-still-uncommon/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/the-role-of-psychosocial-supportive-services-in-palliative-care/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/maximizing-the-benefits-of-exercise-in-patients-with-cancer/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/surgical-resection-of-newly-diagnosed-glioblastoma-what-is-the-standard-of-care/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/increased-incidence-of-thyroid-cancer-an-epidemic-of-diagnosis/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/creating-a-comprehensive-catalog-of-cancer-genes-to-improve-patient-outcomes/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/genetic-testing-beneficial-in-melanoma-treatment-upci-study-shows/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/cancercare-names-patricia-j-goldsmith-chief-executive-officer/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/american-association-for-cancer-research-inaugurates-new-leadership-at-2014-annual-meeting/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/thirty-years-of-effort-has-led-to-the-mainstreaming-of-integrative-medicine-in-oncology-care/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/bookmark-survivorship-living-well-during-and-after-cancer/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/haiku-to-take-herbs-or-not-to/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/ongoing-clinical-trials-actively-recruiting-patients-with-ovarian-or-cervical-cancers/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/elevated-morbiditymortality-risks-for-childhood-cancer-survivors-further-increase-after-fourth-decade/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/improving-quality-of-life-in-cancer-survivors/ 2019-03-11T17:57:33+00:00 https://ascopost.com/issues/may-15-2014/personalizing-outreach-to-address-asian-cancer-health-disparities/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/becky-l-dekay-mba-becomes-president-of-accc/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/bert-howard-o-neil-md-joins-indiana-university-simon-cancer-center/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/ofatumumab-plus-chlorambucil-for-previously-untreated-cll-in-patients-not-treatable-with-fludarabine-based-regimens/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/irving-bone-marrow-transplant-unit-opens-at-newyork-presbyteriancolumbia/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/schwartz-center-rounds-programs-foster-clinical-teamwork-and-enhance-patient-care/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/sidebar-how-the-schwartz-center-rounds-program-works/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/connecting-to-asco-through-the-state-affiliate-council/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/may-is-national-skin-cancer-awareness-month/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/ramucirumab-for-advanced-or-metastatic-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/a-vision-of-independent-clinical-research-in-south-america/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/sidebar-research-groups-in-south-america/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/an-oncologic-surgeon-discusses-the-pros-and-cons-of-pursuing-a-business-degree/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/duquesne-university-awarded-14-million-nih-grant/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/the-leukemia-lymphoma-society-surpasses-1-billion-investment-in-blood-cancer-research/ 2019-03-11T17:57:34+00:00 https://ascopost.com/issues/may-15-2014/2014-oncology-meetings/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/celebrating-ascos-history-1964-2014/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/building-bridges-to-conquer-cancer/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/collaborating-to-conquer-cancer/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/the-promise-of-genomics/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/personalizing-cancer-care/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/one-community/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/sidebar-fda-approved-drugs-to-use-as-single-agents-or-in-combination-chemotherapy/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/multidisciplinary-interactions/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/quality-cancer-care/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/cancer-prevention/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/quality-of-cancer-care/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/aacr-asco-transition/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/science-vs-practice/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/journal-of-clinical-oncology/ 2019-03-11T17:57:35+00:00 https://ascopost.com/issues/may-15-2014/the-consequence-is-cure/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/the-camaraderie-of-asco/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/asco-s-visionary-founders/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/asco-cofounder-jane-cooke-wright-md-defied-racialgender-barriers-and-helped-usher-in-the-modern-age-of-chemotherapy/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/learning-to-live-in-the-moment/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/ppar-δβ-overexpression-increases-colon-tumorigenesis/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/inactivation-of-e3-ubiquitin-ligase-cbl-b-allows-natural-killer-cells-to-control-metastases/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/il-15-deletion-linked-to-reduced-local-proliferation-of-b-and-t-cells-and-poorer-outcome-in-colorectal-cancer/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/il-17a-promotes-and-gm-csf-suppresses-circulating-tumor-cells-and-metastasis-in-colorectal-cancer/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/epigenetic-reprogramming-of-hoxc10-results-in-endocrine-resistance-in-breast-cancer/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/dna-repair-pathway-recombination-proficiency-score-correlates-with-tumor-sensitivity-to-chemotherapy/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/new-p53-dependent-gene-cooperates-with-p53-in-tumor-suppressor-functions/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/breaking-bad-news-badly-can-add-to-upset/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/don-t-always-expect-questions-from-patients-about-prognosis/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/can-empathy-really-be-taught/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/genitourinary-toxicity-more-likely-with-stereotactic-body-radiotherapy-than-with-intensity-modulated-radiotherapy/ 2019-03-11T17:57:36+00:00 https://ascopost.com/issues/may-15-2014/tadalafil-did-not-prevent-erectile-dysfunction-among-men-receiving-radiotherapy/ 2019-03-11T17:57:37+00:00 https://ascopost.com/issues/may-15-2014/adjuvant-chemotherapy-accelerates-pace-of-physiologic-aging-in-women-treated-for-breast-cancer/ 2019-03-11T17:57:37+00:00 https://ascopost.com/issues/may-15-2014/food-and-drug-interactions-could-reduce-effectiveness-of-oral-chemotherapy/ 2019-03-11T17:57:37+00:00 https://ascopost.com/issues/may-15-2014/asco-issues-two-new-guidelines-on-treating-patients-with-advanced-her2-positive-breast-cancer/ 2019-03-11T17:57:37+00:00 https://ascopost.com/issues/may-1-2014-supplement/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/may-1-2014-supplement/ce-activity-instructions/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/meet-the-panel/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/methotrexate-and-fluorouracil-toxicities-a-collaborative-practice-approach-to-prevention-and-treatment/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/collaborative-exchange-indications-and-dosing/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/collaborative-exchange-leucovorin-and-glucarpidase/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/questions-answered-about-uridine-triacetate/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/collaborative-exchange-timing-of-uridine-triacetate/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/learning-more-about-expanded-access-programs/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/collaborative-exchange-the-expanded-access-program-and-uridine-triacetate/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014-supplement/case-studies-collaborative-practice-in-action/ 2019-03-11T17:58:50+00:00 https://ascopost.com/issues/may-1-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/may-1-2014/paloma-1-trial-finds-palbociclibletrozole-doubles-progression-free-survival-in-metastatic-breast-cancer/ 2019-03-11T17:59:25+00:00 https://ascopost.com/issues/may-1-2014/expert-point-of-view-josé-baselga-md-phd/ 2019-03-11T17:59:25+00:00 https://ascopost.com/issues/may-1-2014/maintenance-therapy-in-multiple-myeloma/ 2019-03-11T17:59:25+00:00 https://ascopost.com/issues/may-1-2014/asco-speaks-out-on-release-of-medicare-physician-payment-data/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/sidebar-statement-from-ash-president-linda-j-burns-md-on-release-of-medicare-physician-payment-data/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/asco-ceo-allen-s-lichter-md-on-data-issue/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/ly2835219-shows-strong-single-agent-activity-in-preliminary-study-in-metastatic-breast-cancer/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/expert-point-of-view-gary-schwartz-md/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/pd-l1-studied-as-biomarker-for-anti-pd-1-immunotherapy/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/expert-point-of-view-mario-sznol-md/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/patients-with-thin-melanoma-benefit-from-sentinel-lymph-node-biopsy/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/surgery-plus-radiation-offers-mixed-results-in-soft-tissue-sarcoma/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/sso-awarded-accme-s-highest-accreditation-status/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/promising-compounds-in-development-for-multiple-myeloma/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/sidebar-should-you-treat-smoldering-multiple-myeloma/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/nccn-receives-2-million-in-research-funding-to-study-nintedanib-in-colorectal-and-lung-cancers/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/fda-grants-orphan-drug-designation-for-anti-cd19-t-cell-cancer-immunotherapy-product/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/fda-approves-ofatumumab-for-previously-untreated-chronic-lymphocytic-leukemia/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/ethiodized-oil-approved-for-imaging-of-hepatocellular-carcinoma-tumors/ 2019-03-11T17:59:26+00:00 https://ascopost.com/issues/may-1-2014/gynecologic-cancer-treatment-at-high-volume-centers-may-be-lifesaving/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/expert-point-of-view-william-cliby-md/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/high-risk-uterine-cancers-found-in-brca1-mutation-carriers-who-had-preventive-oophorectomy-but-not-hysterectomy/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/bariatric-surgery-reduces-risk-of-uterine-cancer-in-obese-women/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/expert-point-of-view-david-m-o-malley-md/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/preliminary-study-suggests-veliparib-may-be-effective-in-resistant-brca-mutated-ovarian-cancers/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/expert-point-of-view-thomas-j-herzog-md/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/conquering-colorectal-cancer-with-sanjay-goel-md-the-2010-advanced-clinical-research-award-in-colorectal-cancer-recipient/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/we-need-your-vote-history-s-top-5-cancer-research-achievements/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/enhance-your-asco-annual-meeting-experience-with-attendee-resources/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/help-your-patients-learn-about-collecting-family-cancer-history/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/asco-urges-cms-to-require-medicare-advantage-coverage-for-clinical-trials/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/asco-releases-quality-assessment-tool-for-community-based-research-sites/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/asco-rolls-out-support-for-changes-in-maintenance-of-certification-requirements/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/aurelia-trial-adding-bevacizumab-to-chemotherapy-improves-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/expert-point-of-view-joyce-f-liu-md-mph-of-dana-farber-cancer-institute-and-stephen-a-cannistra-md/ 2019-03-11T17:59:27+00:00 https://ascopost.com/issues/may-1-2014/american-psychosocial-oncology-society-launches-psychosocial-distress-program/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/bringing-the-humanistic-approach-to-palliative-care-from-diagnosis-and-throughout-disease-course/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/american-association-for-cancer-research-inaugurates-2014-class-of-fellows/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/ongoing-clinical-trials-actively-recruiting-patients-with-hodgkin-lymphomas/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/lack-of-insurance-coverage-a-barrier-to-lung-cancer-screening/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/2014-oncology-meetings/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/exemestane-to-reduce-invasive-breast-cancer-risk-has-small-negative-impact-on-quality-of-life/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/desensitization-protocols-may-allow-reintroduction-of-chemotherapeutic-agents-after-hypersensitivity-reactions/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/brentuximab-vedotin-shows-antitumor-activity-in-patients-with-relapsed-peripheral-t-cell-lymphoma/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/may-1-2014/identifying-one-main-provider-and-involving-oncology-specialist-are-key-to-high-quality-rating-for-follow-up-care/ 2019-03-11T17:59:28+00:00 https://ascopost.com/issues/april-15-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/april-15-2014/sso-astro-consensus-guideline-on-margins-for-breast-conserving-surgery-in-stage-iii-invasive-breast-cancer/ 2019-03-11T17:59:51+00:00 https://ascopost.com/issues/april-15-2014/sso-astro-margin-guideline-why-now-and-what-does-it-mean/ 2019-03-11T17:59:51+00:00 https://ascopost.com/issues/april-15-2014/the-outlook-on-cancer-research-in-this-era-of-leaner-federal-funding/ 2019-03-11T17:59:51+00:00 https://ascopost.com/issues/april-15-2014/asco-releases-its-first-ever-report-on-the-state-of-cancer-care-in-america/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/state-of-the-art-update-on-renal-cell-carcinoma/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/a-conversation-with-david-i-quinn-mbbs-phd-fracp/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/a-conversation-with-arie-belldegrun-md-facs-and-allan-pantuck-md-ms-facs/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/bladder-cancer-patient-with-rare-genetic-mutations-shows-exceptional-response-to-everolimuspazopanib-combination/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/georgetown-researchers-study-nonsurgical-minimally-invasive-approach-to-benign-prostatic-hyperplasia/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/cetuximab-fails-to-improve-survival-in-nonoperable-esophageal-cancer/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/better-options-emerging-for-salvage-therapy-in-hodgkin-lymphoma/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/ash-awards-bridge-grants-to-15-investigators/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/double-hit-lymphomas-a-challenge-for-the-oncologist/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/aacr-awards-webster-cavenee-phd-award-for-leadership-achievements/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/no-mortality-benefit-of-mammography-screening-in-25-year-follow-up-of-canadian-national-breast-screening-study/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/flaws-in-cnbss-are-vast-impact-on-screening-recommendations-is-nil/ 2019-03-11T17:59:52+00:00 https://ascopost.com/issues/april-15-2014/the-canadian-national-breast-screening-trial-had-so-many-flaws-that-its-results-should-not-be-used-to-guide-screening-recommendations/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/overdiagnosis-of-breast-cancer-new-research-directions/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/facs-trial-intensive-follow-up-increases-surgical-treatment-of-recurrence-with-curative-intent-in-colorectal-cancer/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/will-colorectal-cancer-surveillance-change-based-on-the-results-of-the-facs-trial/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/complications-other-than-incontinence-or-erectile-dysfunction-after-prostatectomy-or-radiotherapy-for-prostate-cancer/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/prostatectomy-vs-radiotherapy-a-study-for-cautious-interpretation/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/long-term-complications-of-prostate-cancer-treatment-may-have-been-underappreciated/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/detecting-accelerated-aging-in-adult-survivors-of-childhood-cancer/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/targeting-cancer-stem-cells-in-breast-cancer-a-potential-clinical-strategy/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/overcoming-physician-bias-in-recommending-palliative-care/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/thyroid-cancer-on-the-rise-is-it-clinically-meaningful/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/recent-study-finds-tripling-in-thyroid-cancer/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/electronic-cigarette-use-and-smoking-among-adolescents/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/american-college-of-radiology-issues-statement-on-budgetary-efforts-to-curtail-imaging-and-radiation-oncology-self-referral/ 2019-03-11T17:59:53+00:00 https://ascopost.com/issues/april-15-2014/individualized-care-key-to-cancer-pain-management-at-sidney-kimmel-comprehensive-cancer-center/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/cancer-research-funding-still-tight-and-getting-tighter/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/raj-mantena-rph-makes-1-million-donation-to-conquer-cancer-foundation-to-help-build-the-future-of-cancer-care/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/amended-2013-conflicts-of-interest-policy-expands-requirements-for-financial-disclosures/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/become-a-cornerstone-of-the-conquer-cancer-foundation/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/april-is-the-conquer-cancer-foundation-s-make-a-will-month/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/science-and-society-register-to-attend-the-2014-asco-annual-meeting/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/asco-calls-for-clear-guidance-on-tobacco-cessation-benefits-in-the-affordable-care-act/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/asco-signs-joint-open-letter-to-end-tobacco-sales/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/help-your-patients-learn-about-their-cancer-care-team/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/nih-opens-its-doors-to-research-for-extramuralintramural-collaboration/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/informed-consent-not-just-about-blood-tests-and-procedures-anymore/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/nci-awards-for-extramuralintramural-research/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/accidental-extravasation-of-chemotherapy/ 2019-03-11T17:59:54+00:00 https://ascopost.com/issues/april-15-2014/determining-why-younger-women-with-breast-cancer-are-less-likely-to-survive-than-their-older-counterparts/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/utah-center-for-genetic-discovery-to-integrate-genome-data-into-patient-care/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/asbmt-honors-mary-horowitz-md-ms-with-lifetime-achievement-award-for-blood-and-marrow-transplant-research/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/awards-presented-at-annual-meeting-of-society-of-interventional-radiology/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/association-of-community-cancer-centers-honors-researcher-and-community-oncologist-with-national-award/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/hagop-kantarjian-md-and-victor-fazio-md-named-recipients-of-2014-lifetime-achievement-awards-presented-by-castle-connolly-medical-ltd/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/study-shows-pathologic-complete-response-to-neoadjuvant-therapy-for-breast-cancer-of-prognostic-value-but-not-for-use-as-surrogate-for-survival/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/how-am-i-doing-doc/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/decision-time-for-lung-cancer-screening-in-high-risk-populations/ 2019-03-11T17:59:55+00:00 https://ascopost.com/issues/april-15-2014/william-pao-md-phd-joins-roche-to-lead-oncology-research/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/shaw-t-chen-md-phd-joins-polaris-pharmaceuticals/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/does-specialist-bias-contribute-to-overtreatment-of-prostate-cancer/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/unraveling-the-molecular-complexity-of-multiple-myeloma/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/the-commpass-trial-in-multiple-myeloma/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/american-association-for-cancer-research-elects-josé-baselga-md-phd-as-president-elect-2014-2015/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/the-fda-s-bad-ad-program/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/yvonne-t-maddox-phd-appointed-acting-director-of-national-institute-on-minority-health-and-health-disparities/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/2014-oncology-meetings/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/two-behavioral-interventions-help-cancer-patients-struggling-with-sleep-issues-penn-medicine-study-finds/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/join-the-21st-annual-cancer-survivors-celebration-walk-5k/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/synergy-of-iap-antagonist-and-demethylating-agents-against-aml-stemprogenitor-cells/ 2019-03-11T17:59:56+00:00 https://ascopost.com/issues/april-15-2014/antioxidants-accelerate-lung-cancer-progression-and-reduce-survival-in-mice/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/idh-mutation-predicts-benefit-from-alkylating-chemotherapy-in-oligodendroglial-tumors/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/shrnas-can-identify-t-cell-inhibitory-mechanisms-in-tumor-microenvironment/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/lenalidomide-acts-in-myeloma-by-degrading-lymphoid-transcription-factors-ikzf1-and-ikzf3/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/ongoing-clinical-trials-actively-recruiting-adolescent-and-young-adult-survivors-of-childhood-cancer/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/md-anderson-honors-two-champions-for-women-in-medicine-and-research/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/reishi-mushroom/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/survivorship-living-well-during-and-after-cancer/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/have-you-heard/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/prostate-cancer-study-showing-increased-survival-for-younger-men-undergoing-prostatectomy-not-expected-to-increase-surgeries/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/expect-questions-from-patients/ 2019-03-11T17:59:57+00:00 https://ascopost.com/issues/april-15-2014/american-association-for-cancer-research-welcomes-new-board-of-directors-nominating-committee-members/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/uspstf-appoints-new-chair-and-co-vice-chair/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/city-of-hope-names-yuman-fong-md-chair-department-of-surgery/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/breast-reconstruction-has-increased-over-time-but-varies-widely-by-region/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/long-term-benefit-with-dasatinib-after-imatinib-failure-in-chronic-phase-chronic-myeloid-leukemia/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/adding-idelalisib-to-rituximab-improved-survival-in-patients-with-relapsed-cll/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/bendamustinerituximab-may-be-important-alternative-for-indolent-nhl-or-mcl/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/transition-from-busy-oncologist-to-retiree-challenges-and-opportunities/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/april-15-2014/greatly-frustrated-by-congressional-failure-to-act-on-sustainable-growth-rate/ 2019-03-11T17:59:58+00:00 https://ascopost.com/issues/march-15-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/march-15-2014/state-of-the-art-update-on-prostate-cancer/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/i-refuse-to-capitulate-to-cancer/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/the-evolution-of-us-cooperative-group-trials-publicly-funded-cancer-research-at-a-crossroads/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/sidebar-examples-of-advances-attributed-to-cooperative-group-trials/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/role-of-immunotherapy-explored-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-james-gulley-md-phd/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/five-key-studies-in-prostate-cancer-and-renal-cell-carcinoma/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/fine-tuning-bladder-preservation-trimodality-therapy-for-patients-with-muscle-invasive-bladder-cancer/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-thomas-w-flaig-md/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/colorectal-cancer-screening-quality-measures-should-focus-on-patient-benefit-over-age-alone-study-reports/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/aspirin-use-not-associated-with-survival-in-pik3ca-mutant-colorectal-cancer/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-neal-j-meropol-md/ 2019-03-11T18:02:03+00:00 https://ascopost.com/issues/march-15-2014/more-support-for-all-ras-testing-in-metastatic-colorectal-cancer/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-neal-j-meropol-md-1/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/outcomes-in-metastatic-colorectal-cancer-studies-examine-relative-merits-cost-effectiveness/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/colorectal-cancer-survivors-face-challenges-with-bowel-regulation/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/sidebar-colorectal-cancer-survivors-comments-on-strategies-to-regulate-bowel-function/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/for-progressive-neuroendocrine-tumors-clinical-benefit-is-high-with-capecitabine-plus-temozolomide/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-rebecca-a-miksad-md-mph/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/minimal-residual-disease-before-and-after-transplant-what-does-it-mean/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/novel-therapies-may-help-wipe-out-residual-acute-lymphoblastic-leukemia/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/immune-modulation-may-aid-some-breast-cancer-subtypes/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/adding-bevacizumab-to-adjuvant-chemotherapytrastuzumab-fails-to-improve-survival-in-her2-positive-breast-cancer/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/zoledronic-acid-fails-to-benefit-women-with-chemoresistant-breast-cancer/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-peter-ravdin-md/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/promising-results-demonstrated-for-brentuximab-vedotin-in-cutaneous-t-cell-lymphoma/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-anas-younes-md/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/idelalisib-plus-rituximab-in-heavily-pretreated-relapsed-cll-dawn-of-a-new-age/ 2019-03-11T18:02:04+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-jennifer-r-brown-md-phd/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/idelalisib-achieves-high-response-rates-in-double-refractory-indolent-nhl/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/gemtuzumab-ozogamicin-reduces-relapse-improves-event-free-survival-in-pediatric-aml/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/crizotinib-proves-effective-in-alk-positive-lymphoma/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/expert-point-of-view-anas-younes-md-1/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/omacetaxine-mepesuccinate-receives-full-fda-approval-for-cml/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/sidebar-oncology-drug-approvals-in-2014/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/fda-grants-orphan-drug-status-to-pracinostat-for-the-treatment-of-acute-myeloid-leukemia/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/fda-orders-cessation-of-sale-distribution-of-four-tobacco-products/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/advanced-practitioners-in-oncology-diverse-experiences-shared-challenges/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/sidebar-meet-the-panel/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/history-of-prostate-cancer-increases-risk-of-melanoma-in-white-men/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/melanoma-and-prostate-cancer-two-sides-of-one-coin/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/higher-copayment-associated-with-greater-discontinuation-of-and-nonadherence-to-tyrosine-kinase-inhibitor-treatment-in-cml/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/who-pays-for-noncompliance-the-hidden-costs-of-our-current-system/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/brigham-and-women-s-hospital-tumor-staging-for-cutaneous-squamous-cell-carcinoma-outperforms-ajcc-and-uicc-staging/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/staging-of-cutaneous-squamous-cell-carcinoma/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/charting-the-successes-cancerprogressnet-chronicles-more-than-50-years-of-asco-and-progress-against-cancer/ 2019-03-11T18:02:05+00:00 https://ascopost.com/issues/march-15-2014/asco-holds-leadership-summit-to-address-value-in-cancer-care-cost-of-cancer-drugs-and-technologies/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/support-from-1999-career-development-award-launched-dr-kornelia-polyak-s-quest-to-advance-understanding-of-dcis-of-the-breast/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/asco-s-membership-grows-to-nearly-35-000/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/stay-up-to-date-on-new-patient-materials-from-cancernet/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/national-program-to-screen-ashkenazi-women-in-israel-for-brca-mutations-is-being-explored/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/antitumor-activity-of-poly-ic-and-anti-pd-l1-monoclonal-antibody/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/dual-pi3kmtor-inhibitor-effective-as-radiosensitizer-for-glioblastoma/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/antitumor-immunity-affected-by-standard-lab-mouse-housing-temperature/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/decreased-diversity-of-gut-bacteria-associated-with-risk-of-colorectal-cancer/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/protein-expression-based-risk-model-for-recurrence-in-resected-nsclc/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/cd137-identifies-and-enriches-for-tumor-reactive-t-cells/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/delayed-adjuvant-chemotherapy-associated-with-poorer-overall-survival-in-breast-cancer/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/impact-of-delayed-initiation-of-adjuvant-chemotherapy-for-breast-cancer-varies-by-tumor-subtype/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/ibrutinib-for-previously-treated-chronic-lymphocytic-leukemia/ 2019-03-11T18:02:06+00:00 https://ascopost.com/issues/march-15-2014/asco-addresses-changes-in-medicare-for-2014/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/affordable-care-act-to-cover-chemoprevention-for-women-at-high-risk-for-breast-cancer/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/neuro-oncology-community-convenes-in-workshop-to-advance-imaging-related-endpoints-in-clinical-trials/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/st-jude-children-s-research-hospital-committee-identifies-eight-palliative-care-priorities-in-pediatric-oncology/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/president-obama-s-fy-2015-budget-proposal/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/how-decoding-the-genomes-of-exceptional-responders-is-leading-to-more-effective-treatment-for-all-patients-with-cancer/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/ssoastro-release-consensus-guideline-on-breast-cancer-treatment/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/telephone-education-and-counseling-effective-in-programs-targeting-familialgenetic-cancer-risk-screening/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/telemedicine-efficiency-in-cancer-screening-and-outreach/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/radiopharmaceutical-receives-orphan-drug-designation/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/the-ketogenic-diet-in-cancer-control/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/long-term-decline-in-neuropsychological-function-seen-after-cranial-radiotherapy-for-pediatric-lymphoid-malignancy/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/how-to-approach-the-problem-of-cns-metastasis-in-her2-positive-patients/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/music-therapy-yields-positive-effects-on-coping-skills-social-integration-and-family-environment-for-young-patients-with-cancer/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/cognitive-behavioral-therapy-plus-hypnosis-controls-fatigue-in-breast-cancer-patients-receiving-radiotherapy/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/cancer-has-allowed-me-to-put-my-goals-first/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/major-cancer-milestones-in-history-from-asco-s-cancerprogressnet/ 2019-03-11T18:02:07+00:00 https://ascopost.com/issues/march-15-2014/2014-oncology-meetings/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/focus-on-the-virginia-association-of-hematologists-and-oncologists/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/ongoing-clinical-trials-actively-recruiting-patients-with-gastrointestinal-cancers/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/national-colorectal-cancer-awareness-month/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/dermatologists-defend-mohs-surgery-as-effective-and-cost-efficient-with-low-rate-of-recurrence/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/expect-questions-about-the-appropriate-use-of-mohs-surgery/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/for-metastatic-colorectal-cancer-bevacizumab-is-more-commonly-included-than-anti-egfr-antibody-therapies/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/aspirin-associated-with-reduced-risk-of-ovarian-cancer-especially-in-low-daily-doses/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/dietary-lycopene-linked-to-reduced-risk-of-lethal-prostate-cancer-less-tumor-angiogenesis/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/epidemic-of-diagnosis-of-thyroid-cancer-is-most-acute-for-women/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/task-force-recommends-against-beta-carotene-or-vitamin-e-supplements-for-primary-cancer-prevention/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/cancer-genes-and-molecular-medicine-more-education-needed/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/the-author-replies/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-15-2014/after-next-generation-sequencing-guiding-patients-to-the-right-treatment/ 2019-03-11T18:02:08+00:00 https://ascopost.com/issues/march-1-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/march-1-2014/prevail-trial-shows-enzalutamide-to-be-a-promising-option-for-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-charles-ryan-md/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/the-future-of-biomedical-research/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/congress-agrees-on-repeal-of-sustainable-growth-rate/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/cytoreductive-nephrectomy-improves-survival-in-metastatic-renal-cell-carcinoma-patients-with-longer-life-expectancy/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-daniel-j-canter-md/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/sequencing-sorafenib-and-sunitinib-in-either-order-does-not-affect-survival-in-metastatic-renal-cell-carcinoma/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-daniel-j-canter-md-1/ 2019-03-11T19:04:20+00:00 https://ascopost.com/issues/march-1-2014/long-term-safety-data-on-radium-223-in-prostate-cancer-reassuring/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-michael-j-morris-md-and-maha-h-hussain-md-facp-fasco/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/irinotecan-drug-eluting-beads-improve-outcomes-in-colorectal-cancer-patients-with-liver-metastases/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-melanie-b-thomas-md/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/biomarker-defined-subgroup-benefits-from-novel-approach-to-advanced-hepatocellular-carcinoma/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-josep-m-llovet-md/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/capecitabine-acceptable-in-neoadjuvant-rectal-cancer-setting/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/us-government-accountability-office-issues-report-on-drug-shortages/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/asco-supports-reinforcing-fda-capacity-to-monitor-nation-s-drug-supply/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/gi-symposium-presentations-include-important-updates-in-treatment-and-prognosis-of-pancreatic-and-colorectal-cancers/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/asco-applauds-cvs-caremark-s-move-to-stop-selling-tobacco/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/her2-positive-breast-cancer-patients-with-small-tumors-benefit-from-low-toxicity-regimen/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-debu-tripathy-md/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/innovative-i-spy-2-trial-yields-first-results-in-triple-negative-breast-cancer/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/exercise-program-reduces-aromatase-inhibitor-associated-joint-pain/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-carlos-l-arteaga-md/ 2019-03-11T19:04:21+00:00 https://ascopost.com/issues/march-1-2014/amplifying-the-signal-foundation-donor-takes-his-advocacy-into-the-twittersphere/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/connecting-to-conquer-cancer/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/asco-to-release-report-on-the-state-of-cancer-care-in-america/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/cancer-progress-in-jeopardy-stories-from-the-front-lines/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/cancernet-expands-its-social-media-presence-with-launch-of-blog/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/updated-information-on-clinical-trials/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/in-stage-iv-breast-cancer-the-primary-may-not-need-to-be-removed/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-c-kent-osborne-md/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/haploidentical-stem-cell-transplantation-producing-good-outcomes-expanding-transplant-pool/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-jeffrey-miller-md/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/fda-approves-ibrutinib-for-the-treatment-of-chronic-lymphocytic-leukemia/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/first-line-obinutuzumabchlorambucil-improves-outcomes-over-rituximabchlorambucil-in-older-cll-patients-with-comorbidities/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/encouraging-early-results-with-novel-agents-in-cll/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/expert-point-of-view-jennifer-r-brown-md-phd/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/leaders-of-asco-ash-astro-and-nccn-embrace-collaboration-with-advanced-practitioners/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/apsho-new-society-for-advanced-practitioners/ 2019-03-11T19:04:22+00:00 https://ascopost.com/issues/march-1-2014/2014-oncology-meetings/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/no-mortality-benefit-of-mammography-screening-in-25-year-follow-up-of-canadian-national-breast-screening-study/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/flaws-in-cnbss-are-vast-impact-on-screening-recommendations-is-nil/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/the-canadian-national-breast-screening-trial-had-so-many-flaws-that-its-results-should-not-be-used-to-guide-screening-recommendations/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/overdiagnosis-of-breast-cancer-new-research-directions/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/short-term-follow-up-reveals-suboptimal-pain-relief-and-marked-pain-worsening-in-ambulatory-patients-with-cancer/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/cancer-pain-the-humbling-reality/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/advanced-practitioner-society-for-hematology-and-oncology-apsho-welcoming-members/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/president-s-cancer-panel-issues-urgent-call-to-action-for-hpv-vaccination/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/dana-farber-receives-900-000-grant-to-research-ovarian-cancer/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/cancer-treatment-centers-names-sr-vice-president-patient-care-services/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/david-a-fullerton-md-named-president-of-the-society-of-thoracic-surgeons/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/city-of-hope-s-new-chief-scientific-officer-and-cancer-center-director-reflects-on-his-career-path-and-the-future-of-cancer-care/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/about-city-of-hope/ 2019-03-11T19:04:23+00:00 https://ascopost.com/issues/march-1-2014/nintedanib-combined-with-docetaxel-is-effective-second-line-option-for-advanced-nsclc/ 2019-03-11T19:04:24+00:00 https://ascopost.com/issues/march-1-2014/r-gcvp-regimen-for-patients-with-diffuse-large-b-cell-lymphoma-and-cardiac-comorbidity/ 2019-03-11T19:04:24+00:00 https://ascopost.com/issues/february-15-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/february-15-2014/immunotherapy-duo-improves-survival-in-metastatic-pancreatic-cancer/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/expert-point-of-view-rebecca-miksad-md-mph/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/the-surgeon-general-s-report-on-tobacco-turns-50-much-success-much-work-ahead/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/highlights-of-the-american-lung-association-s-state-of-tobacco-control-2014/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/perspective-on-the-politics-of-tobacco/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/paving-the-way-for-the-surgeon-general-s-report/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/ascos-education-and-professional-development-services/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/jamie-h-von-roenn-md-and-asco-a-perfect-fit/ 2019-03-11T19:19:38+00:00 https://ascopost.com/issues/february-15-2014/ramucirumab-plus-paclitaxel-improves-overall-survival-after-first-progression-in-metastatic-gastric-cancer/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/expert-point-of-view-manish-shah-md/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/maintenance-treatment-with-capecitabine-and-bevacizumab-is-effective-in-metastatic-colorectal-cancer/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/expert-point-of-view-neal-j-meropol-md/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/fda-accepts-new-drug-application-for-idelalisib-in-refractory-indolent-non-hodgkin-lymphoma/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/fda-approves-clinimacs-cd34-reagent-system-for-the-prevention-of-graft-vs-host-disease-in-aml/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/margaret-a-tempero-md-named-editor-in-chief-of-jnccn/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/new-society-launched-for-advanced-practitioners-in-hematology-and-oncology/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/sabcs-highlights-include-findings-in-triple-negative-disease-protective-effects-of-exercise-and-the-adherence-copay-link/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/postmastectomy-pain-effectively-treated-with-a-simple-injection/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/addition-of-novel-antiangiogenic-agent-of-no-benefit-in-metastatic-breast-cancer/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/switching-chemotherapy-based-on-elevated-circulating-tumor-cells-does-not-change-outcome-in-metastatic-breast-cancer/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/expert-point-of-view-peter-ravdin-md-phd/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/ash-studies-refine-myeloma-treatment-and-show-promise-for-new-agents/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/novel-agents-show-activity-in-non-hodgkin-lymphoma/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/ash-studies-confirm-benefit-of-rituximab-maintenance-in-follicular-lymphoma/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/expert-point-of-view-andrew-d-zelenetz-md-phd/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/ibrutinib-induces-prompt-and-durable-responses-in-some-lymphomas/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/expert-point-of-view-bruce-cheson-md/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/breast-implant-associated-anaplastic-large-cell-lymphoma-shows-better-outcome-in-cases-with-no-distinct-tumor-mass/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/longer-term-follow-up-of-breast-implant-associated-anaplastic-large-cell-lymphoma-more-certainty-about-certain-uncertainties/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/asco-and-college-of-american-pathologists-guideline-update-recommendations-for-her2-testing-in-breast-cancer/ 2019-03-11T19:19:39+00:00 https://ascopost.com/issues/february-15-2014/her2-testing-the-next-chapter/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/university-of-pittsburgh-researchers-awarded-more-than-1-million-by-nih-to-study-new-treatments-for-pancreatic-cancer-patients/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/serving-the-underserved-dr-gina-villani-and-asco-s-health-disparities-committee-work-to-minimize-cancer-care-gaps/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/asco-turns-attention-to-community-researchers-with-community-research-forum/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/conquer-cancer-foundation-launches-new-planned-giving-website/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/the-latest-from-the-2014-genitourinary-symposium/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/charting-the-successes-cancerprogressnet-chronicles-more-than-50-years-of-asco-and-progress-against-cancer/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/it-s-time-to-reignite-our-nation-s-commitment-to-cancer-research/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/long-term-follow-up-indicates-increased-telomere-length-with-lifestyle-change-in-men-with-low-risk-prostate-cancer/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/impact-of-comprehensive-lifestyle-change-on-telomere-length-and-telomerase-activity-in-men-with-low-risk-prostate-cancer/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/indiana-university-simon-cancer-center-receives-15-million-pledge/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/nih-makes-palliative-care-more-attainable-for-pediatric-patients-and-their-families/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/trametinib-and-dabrafenib-in-combination-for-unresectable-or-metastatic-melanoma-with-braf-v600e-or-v600k-mutations/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/city-of-hope-receives-10-million-gift-to-launch-lymphoma-research-and-treatment-center/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/radiation-oncology-institute-awards-200-000-grant-to-christopher-slatore-md/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/fda-programs-to-expedite-drug-and-biologic-product-development/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/milestones-in-oncology-from-asco-s-cancerprogressnet/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/focus-on-the-michigan-society-of-hematology-and-oncology/ 2019-03-11T19:19:40+00:00 https://ascopost.com/issues/february-15-2014/an-early-chemotherapy-innovator-franco-m-muggia-md-now-focuses-on-advancing-therapies-for-ovarian-cancer/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/richard-j-gannotta-dha-fache-named-president-northwestern-memorial-hospital/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/ongoing-nci-funded-clinical-trials-actively-recruiting-patients-with-hematologic-cancers-multiple-myeloma/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/kava/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/guest-editor-barrie-r-cassileth-ms-phd/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/nih-names-first-chief-officer-for-scientific-workforce-diversity-hannah-valantine-md/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/lessons-learned-in-cancer-care-communication/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/oncology-meetings/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/nothing-prepared-me-for-cancer/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/un-agency-issues-world-cancer-report-2014/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/confronting-uncertainty-about-the-harms-and-benefits-of-screening-mammography/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/expect-questions-from-patients/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/intact-gut-microbe-populations-improve-response-to-chemotherapy/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/effect-of-cyclophosphamide-mediated-by-gut-microflora/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/cyb5a-induces-autophagy-and-higher-expression-improves-survival-in-pancreatic-cancer/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/high-plasma-alkylresorcinols-associated-with-reduced-risk-of-distal-colon-but-not-overall-colorectal-cancer/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/high-expression-of-hent1-can-predict-better-survival-among-patients-on-postsurgical-gemcitabine/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/in-cll-with-coexisting-conditions-chlorambucil-produces-better-outcomes-with-obinutuzumab-than-with-rituximab/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/pomalidomide-plus-low-dose-dexamethasone-important-new-option-in-relapsedrefractory-multiple-myeloma/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/anticipated-shortage-of-oncologists-will-strain-ability-to-provide-quality-cancer-care/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/donald-l-morton-md-an-icon-in-surgical-oncology-dies/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/leukemialymphoma-pioneer-geoffrey-p-herzig-md-dies/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/corrections-to-note/ 2019-03-11T19:19:41+00:00 https://ascopost.com/issues/february-15-2014/role-for-reduced-intensity-conditioning-regimen-in-aml-after-allogeneic-transplantation/ 2019-03-11T19:19:42+00:00 https://ascopost.com/issues/february-1-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/february-1-2014/addition-of-neoadjuvant-carboplatin-in-triple-negative-breast-cancer-supported-by-sabcs-studies/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/expert-point-of-view-lajos-pusztai-md-dphil/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/major-cancer-advances-in-2013-highlight-importance-of-federal-funding/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/cancer-genes-promiscuity-and-the-national-debt/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/lenalidomiderituximab-doublet-a-potential-front-line-treatment-in-some-lymphomas/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/expert-point-of-view-nathan-fowler-md/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/r-squared-lymphoma-treatment-possible-markers-of-response-identified/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/expert-point-of-view-andrew-d-zelenetz-md-phd/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/common-mutations-may-impact-neoadjuvant-treatment-outcomes-in-breast-cancer/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/lung-cancer-screening-facts/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/drugging-pi3k-in-breast-cancer-findings-from-sabcs-2013/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/expert-point-of-view-matthew-ellis-mb-phd/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/asco-president-issues-statement-on-major-decline-in-lung-cancer/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/iposaortic-conference-aims-to-bring-comprehensive-care-to-patients-in-africa/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/asco-member-helps-to-strengthen-cancer-care-internationally-through-philanthropy-and-volunteer-service/ 2019-03-11T19:20:35+00:00 https://ascopost.com/issues/february-1-2014/conquer-cancer-foundation-funds-research-in-low-and-middle-income-countries-for-the-first-time/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/asco-cosponsors-inaugural-palliative-care-in-oncology-symposium/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/cancernet-s-newest-resource-the-cancernet-blog/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/nearly-40-practices-receive-qopi-recertification-for-high-quality-cancer-care/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/asco-proposes-new-framework-for-medicare-reimbursement/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/expanded-options-for-age-and-donor-sources-for-transplant/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/dabrafenib-receives-fda-breakthrough-therapy-designation-for-braf-mutated-nsclc/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/fda-approves-combination-therapy-for-unresectable-or-metastatic-melanoma-with-braf-v600ek-mutations/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/health-it-safety-guide/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/50th-anniversary-of-the-first-us-surgeon-general-s-report-on-smoking-and-health/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/surgeon-general-s-new-report-attributes-smoking-as-cause-of-death-in-more-than-20-million-americans-over-past-50-years/ 2019-03-11T19:20:36+00:00 https://ascopost.com/issues/february-1-2014/reports-from-the-iposaortic-travel-scholars/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/gary-lyman-md-joins-scott-ramsey-md-phd-in-co-leading-hutchinson-institute-for-cancer-outcomes-research-at-fred-hutchinson/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/major-cancer-milestones-in-history-from-asco-s-cancerprogressnet-visit-cancerprogressnet-to-view-the-interactive-timeline/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/an-overview-of-the-regal-trial-and-anti-vegf-therapies-in-recurrent-glioblastoma/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/grant-to-develop-website-and-mobile-app-to-track-radiation-therapy-toxicity-awarded-to-radiation-oncology-resident/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/cancer-patients-are-at-increased-risk-of-complications-from-the-flu-and-should-receive-flu-shots-but-not-the-nasal-spray/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/expect-questions-and-some-reluctance-about-getting-a-flu-shot/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/texas-children-s-hospital-announces-new-chief-of-interventional-radiology/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/champions-oncology-names-chief-medical-officer/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/final-overall-survival-data-show-better-results-with-higher-dose-of-fulvestrant/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/some-lung-cancers-detected-by-low-dose-ct-in-national-lung-screening-trial-may-be-indolent/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/bosutinib-shows-acceptable-safety-in-philadelphia-chromosome-positive-leukemia/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/oncology-meetings/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/leukemia-pioneer-john-m-goldman-dm-dies-at-75/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/february-1-2014/artemis-project-for-a-preventive-breast-cancer-vaccine/ 2019-03-11T19:20:37+00:00 https://ascopost.com/issues/january-15-2014/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/january-15-2014/continuous-lenalidomidelow-dose-dexamethasone-a-new-option-for-older-patients-with-newly-diagnosed-myeloma/ 2019-03-11T19:21:16+00:00 https://ascopost.com/issues/january-15-2014/expert-point-of-view-joseph-r-mikhael-md/ 2019-03-11T19:21:16+00:00 https://ascopost.com/issues/january-15-2014/risk-based-breast-cancer-screening-studies-suggest-alternatives-to-age-based-guidelines/ 2019-03-11T19:21:16+00:00 https://ascopost.com/issues/january-15-2014/ascos-50th-anniversary-and-the-road-ahead/ 2019-03-11T19:21:16+00:00 https://ascopost.com/issues/january-15-2014/adjuvant-bisphosphonates-in-early-breast-cancer-practice-changing-findings/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/expert-point-of-view-peter-ravdin-md/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/mounting-success-in-trials-of-genetically-engineered-t-cells-to-treat-leukemias-and-lymphomas/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/expert-point-of-view-prashant-kapoor-md/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/anastrozole-halves-risk-of-first-breast-cancer-in-high-risk-postmenopausal-women/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/who-opts-for-chemoprevention/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/expert-point-of-view-carlos-l-arteaga-md-and-david-cameron-md-mrcp/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/international-society-of-geriatric-oncology-meeting-explores-multidisciplinary-tailored-treatment-of-older-patients-with-cancer/ 2020-02-17T18:14:20+00:00 https://ascopost.com/issues/january-15-2014/evaluating-and-screening-geriatric-patients-for-treatment/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/addressing-the-challenges-of-an-aging-population/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/novel-braf-fusions-identified-in-pan-negative-melanomas-subset-may-be-sensitive-to-mek-inhibition/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/philips-receives-fda-clearance-for-spectral-breast-density-measurement-application/ 2019-03-11T19:21:17+00:00 https://ascopost.com/issues/january-15-2014/seven-studies-at-sabcs-make-dr-jame-abrahams-list-of-practice-changing-talks/ 2019-03-11T19:21:18+00:00 https://ascopost.com/issues/january-15-2014/her2-positive-breast-cancer-patients-with-small-tumors-benefit-from-low-toxicity-regimen/ 2019-03-11T19:21:18+00:00 https://ascopost.com/issues/january-15-2014/expert-point-of-view-debu-tripathy-md/ 2019-03-11T19:21:18+00:00 https://ascopost.com/issues/january-15-2014/can-postoperative-radiotherapy-be-avoided-in-older-women-with-early-breast-cancer-and-high-estrogen-receptor-expression/ 2019-03-11T19:21:18+00:00 https://ascopost.com/issues/january-15-2014/expert-point-of-view-kent-osborne-md/ 2019-03-11T19:21:18+00:00 https://ascopost.com/issues/january-15-2014/younger-women-with-younger-children-less-likely-to-receive-radiation-therapy-after-breast-conserving-surgery-for-breast-cancer/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/genetic-flaw-that-drives-some-ovarian-cancers-identified/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/tivozanib-improves-progression-free-but-not-overall-survival-vs-sorafenib-in-metastatic-renal-cell-carcinoma/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/study-explores-protective-effect-of-aspirin-against-colorectal-cancer/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/overall-survival-improved-by-adding-panitumumab-to-folfox4-but-only-in-metastatic-colorectal-cancer-without-ras-mutation/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/surprising-findings-for-lenalidomide-maintenance-in-updated-ifm-2005-02-analysis/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/ifm-2005-02-update-differs-from-calgb-100104-why/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/inside-the-black-box-molecularly-targeted-therapy-for-lung-cancer/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/american-lung-association-applauds-us-preventive-services-task-force-recommendation-of-screening-for-those-at-high-risk-of-lung-cancer/ 2019-03-11T19:21:20+00:00 https://ascopost.com/issues/january-15-2014/targeted-intraoperative-radiotherapy-plus-lumpectomy-noninferior-to-external-beam-radiotherapy-in-preventing-breast-cancer-recurrence/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/cautious-comments-on-the-targit-a-trial/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/esmo-releases-position-paper-on-med-oncs-role-in-cancer-care/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/ongoing-nci-funded-clinical-trials-actively-recruiting-patients-with-advanced-cancer/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/asco-celebrates-50-years-of-advancing-progress-against-cancer/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/asco-aacr-and-campaign-for-tobacco-free-kids-urge-fda-prohibition-of-menthol-cigarettes/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/asco-honors-new-group-of-members-with-fasco-distinction/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/cancernet-launches-new-brand-of-printed-materials-with-four-guides-to-cancer/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/the-latest-gastrointestinal-cancer-news-for-patients/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/the-conquer-cancer-foundation-celebrates-15-years-of-funding-asco-and-cancer-progress/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/asco-resources-for-transitioning-to-icd-10/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/l-type-amino-acid-transporters-lat-inhibition-may-be-a-new-therapeutic-option-for-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/inhibition-of-lat-transporters-and-leucine-uptake-a-step-forward-for-therapeutic-strategies-in-prostate-cancer/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/julie-m-vose-md-mba-fasco-elected-asco-president-for-2015-2016-term/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/sorafenib-in-differentiated-thyroid-carcinoma/ 2019-03-11T19:21:21+00:00 https://ascopost.com/issues/january-15-2014/overcoming-drug-development-challenges-in-the-new-era-of-cancer-care/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/meta-analysis-upholds-benefit-in-progression-free-survival-but-not-overall-survival-with-lenalidomide-maintenance/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/asco-statement-on-annual-report-to-the-nation-on-the-status-of-cancer/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/statement-by-asco-president-clifford-a-hudis-md-facp-on-acs-report/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/iom-makes-clinical-data-available-for-research/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/adjuvant-gefitinib-in-patients-with-nsclc-bad-idea-or-wrong-patient-selection/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/asco-announces-election-results-for-terms-beginning-june-2014/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/diagnosing-and-treating-chronic-mucocutaneous-graft-vs-host-disease/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/activation-of-innovative-lung-cancer-master-protocol-officially-announced-enrollment-to-begin-in-march/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/developing-intermediate-endpoints-in-immunotherapy/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/friends-of-cancer-research-launches-new-online-forum-engaging-innovation/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/cancer-is-in-my-soul/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/donor-kirdl1-r245-allele-predicts-improved-survival-and-reduced-progression-in-pediatric-allogeneic-stem-cell-transplant/ 2019-03-11T19:21:22+00:00 https://ascopost.com/issues/january-15-2014/bill-melinda-gates-foundation-names-susan-desmond-hellman-new-ceo/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/stress-and-tumor-biology-insights-into-managing-stress-to-help-improve-cancer-care/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/assessing-patients-for-palliative-care/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/science-magazine-names-cancer-immunotherapy-as-scientific-breakthrough-of-the-year/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/improvements-needed-in-use-of-survivorship-care-plans/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/making-progress-in-survivorship-care-planning/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/newyork-presbyteriancolumbia-university-medical-center-names-gary-schwartz-md-new-chief-of-hematologyoncology/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/with-the-goal-of-curing-cancer-ezra-m-greenspan-md-helped-usher-in-the-modern-era-of-chemotherapy/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/ludwig-cancer-research-contributes-one-half-billion-in-new-funding-to-six-us-research-institutions/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/oncology-meetings/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/scientistentrepreneur-selected-to-lead-tri-institutional-therapeutics-discovery-institute/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/bernard-j-tyson-assumes-role-of-chairman-of-kaiser-permanente/ 2019-03-11T19:21:23+00:00 https://ascopost.com/issues/january-15-2014/pamela-m-mcinnes-named-deputy-director-of-national-center-for-advancing-translational-sciences/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/cell-mechanism-discovery-key-to-stopping-breast-cancer-metastasis/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/using-hyperthermia-for-cancer-treatment-proofs-promises-and-uncertainties/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/sidebar-expect-questions-from-your-patients-about-hyperthermia/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/january-is-national-pancreatic-cancer-clinical-trials-awareness-month/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/no-significant-improvement-with-decongestive-therapy-vs-more-conservative-approach-to-treating-arm-lymphedema/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/effects-of-oral-contraceptives-on-breastovarian-cancer-risks-are-similar-regardless-of-brca-mutation-status/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/increased-ultraviolet-radiation-exposure-may-protect-against-hl-particularly-in-those-with-ebv-positive-disease/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/african-americans-report-receiving-few-positive-recommendations-by-physicians-about-joining-clinical-trial/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/janet-l-rowley-md-matriarch-of-modern-cancer-genetics-dies-at-age-88/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/role-of-autologous-stem-cell-transplant-in-high-risk-nhl/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/january-15-2014/praise-for-the-asco-post/ 2019-03-11T19:21:24+00:00 https://ascopost.com/issues/december-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/december-15-2013/call-for-expanded-genetic-profiling-in-colorectal-cancer/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/expert-point-of-view-howard-hochster-md/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/sharing-treatment-decision-making-with-patients-where-s-the-evidence-of-value/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/sidebar-shared-decisions-what-should-we-expect/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/consent-is-informed-and-shared-but-is-it-compassionate/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/autologous-transplantation-as-consolidation-improves-progression-free-survival-in-aggressive-non-hodgkin-lymphoma/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/s9704-trial-autologous-transplantation-as-consolidation-in-aggressive-lymphoma/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/transplant-now-or-later-for-high-risk-aggressive-non-hodgkin-lymphoma/ 2019-03-11T19:22:19+00:00 https://ascopost.com/issues/december-15-2013/radiotherapy-benefit-in-young-women-with-node-positive-breast-cancer-may-vary-by-intrinsic-subtypes/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/expert-point-of-view-elzbieta-senkus-konefka-md-phd/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/global-oncology-2013-disparities-in-cancer-care/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/erratum/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/pik3ca-mutant-tumors-not-likely-to-respond-to-neoadjuvant-her2-blockade/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/expert-point-of-view-sibylle-loibl-md/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/extended-release-lanreotide-significantly-delays-disease-progression-in-patients-with-neuroendocrine-tumors-in-large-phase-iii-clarinet-trial/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/expert-point-of-view-kjell-oberg-md-phd/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/continuous-combined-hormone-replacement-therapy-protects-against-endometrial-cancer/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/now-available-communicating-with-cancer-patients/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/treating-earlier-to-avoid-progression-to-multiple-myeloma/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/expert-point-of-view-kenneth-c-anderson-md/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/centers-in-massachusetts-collaborate-in-joint-center-for-cancer-precision-medicine/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/breast-cancer-vaccines-for-primary-prevention-move-toward-clinical-use/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/long-term-follow-up-of-the-hera-trial-shows-no-benefit-of-2-years-vs-1-year-of-trastuzumab-in-early-breast-cancer/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/adjuvant-trastuzumab-duration-when-is-enough-enough/ 2019-03-11T19:22:20+00:00 https://ascopost.com/issues/december-15-2013/jame-abraham-md-moves-to-taussig-cancer-institute/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/similar-high-complete-response-rate-with-neoadjuvant-trastuzumab/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/adding-abiraterone-to-prednisone-significantly-prolongs-time-to-pain-progression-in-chemotherapy-naive-men-with-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/correctly-assessing-pain-progression-and-quality-of-life-deterioration-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/no-apparent-benefit-of-adjuvant-gefitinib-in-resected-nsclc-in-prematurely-closed-trial/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/investigators-report-valganciclovir-may-increase-survival-in-glioblastoma/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/valganciclovir-in-glioblastoma-selection-bias-and-flawed-conclusions/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/nci-led-scientists-develop-criteria-for-omics-tests-used-in-clinical-investigations/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/expert-point-of-view-daniel-f-hayes-md-fasco/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/clinical-cancer-advances-2013-ascos-annual-report-on-progress-against-cancer/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/newly-updated-managing-the-cost-of-cancer-care/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/conquer-cancer-foundation-funded-research-identified-among-top-cancer-advances-of-2013/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/a-new-gift-to-add-to-your-list-one-to-conquer-cancer/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/ascos-innovative-quality-improvement-programs-highlighted-at-symposium/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/oncology-drug-dosing-can-an-optimal-dose-be-fine-tuned-for-each-patient/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/american-association-for-advancement-of-science-elects-new-fellows/ 2019-03-11T19:22:21+00:00 https://ascopost.com/issues/december-15-2013/fda-approves-sorafenib-to-treat-late-stage-differentiated-thyroid-cancer/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/fda-grants-regular-approval-to-crizotinib-for-alk-positive-nsclc/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/patient-reported-outcomes-a-central-component-to-value-and-rapid-learning-systems/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/national-cancer-policy-summit-setting-priorities-for-the-next-3-years/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/how-to-measure-the-impact-of-dermatologic-and-mucosal-adverse-events-on-symptom-burden-and-quality-of-life/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/assessment-tools-to-measure-impact-of-dermatologic-and-mucosal-adverse-eventsa/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/highlights-from-the-10th-international-conference-of-the-society-for-integrative-oncology/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/the-best-of-sio/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/society-for-integrative-oncology-is-helping-to-advance-evidence-based-comprehensive-integrative-health-care/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/ginkgo-biloba/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/the-quest-to-optimize-personalized-therapies-for-cancer/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/ibrutinib-in-previously-treated-mantle-cell-lymphoma/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/oncology-meetings/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/cancer-has-given-me-a-greater-appreciation-for-life/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/nih-announces-new-co-chairs-of-panel-on-antiretroviral-guidelines/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/conflict-of-interest-reconsidered/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/dr-weisenthal-replies/ 2019-03-11T19:22:22+00:00 https://ascopost.com/issues/december-15-2013/focus-on-the-massachusetts-society-of-clinical-oncologists/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/disclosing-medical-costs-can-help-avoid-financial-toxicity/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/sidebar-expect-questions-from-patients/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/steven-t-rosen-md-named-provost-and-chief-scientific-officer-of-city-of-hope/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/disease-free-survival-is-acceptable-surrogate-for-overall-survival-in-trials-of-adjuvant-chemotherapy/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/three-drug-regimen-produces-high-response-rate-in-relapsedrefractory-myeloma/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/using-life-expectancy-not-age-to-make-cancer-screening-decisions-can-maximize-potential-benefits/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/oncologists-need-to-inform-primary-care-physicians-about-late-and-long-term-effects-of-chemotherapy/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/promoting-timely-referral-to-reproductive-specialists-for-patients-concerned-about-fertility/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/young-tobacco-consumers-frequently-use-products-other-than-cigarettes/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/peter-jacobs-md-storied-south-african-hematology-pioneer-dies/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/perception-of-bias/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-15-2013/the-asco-post-replies/ 2019-03-11T19:22:23+00:00 https://ascopost.com/issues/december-1-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/december-1-2013/gepartrio-long-term-data-show-response-guided-neoadjuvant-therapy-for-breast-cancer-improves-survival/ 2019-03-11T19:23:15+00:00 https://ascopost.com/issues/december-1-2013/response-guided-neoadjuvant-therapy-for-breast-cancer-a-promising-model-warranting-additional-investigation/ 2019-03-11T19:23:15+00:00 https://ascopost.com/issues/december-1-2013/innovative-payment-models-needed-to-sustain-quality-cancer-care/ 2019-03-11T19:23:15+00:00 https://ascopost.com/issues/december-1-2013/what-does-myeloma-mean/ 2019-03-11T19:23:15+00:00 https://ascopost.com/issues/december-1-2013/brentuximab-vedotin-improves-response-rates-to-abvd-in-hodgkin-lymphoma/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/sidebar-addition-of-novel-agents-may-improve-outcomes-with-abvd/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/brentuximab-and-pet-adapted-salvage-may-eliminate-toxic-chemotherapy-for-refractory-hodgkin-lymphoma/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/early-evidence-supports-novel-alk-inhibitor-in-patients-with-non-small-cell-lung-cancer-with-brain-metastases/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/expert-point-of-view-frances-a-shepherd-md-frcpc/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/fda-approves-ibrutinib-for-mantle-cell-lymphoma/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/sidebar-fda-drug-approvals-2013/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/metastatic-melanoma-encouraging-data-keep-coming/ 2019-03-11T19:23:16+00:00 https://ascopost.com/issues/december-1-2013/in-operable-rectal-cancer-no-support-found-for-adjuvant-chemotherapy/ 2019-03-11T19:23:17+00:00 https://ascopost.com/issues/december-1-2013/expert-point-of-view-david-sebag-montefiore-md/ 2019-03-11T19:23:17+00:00 https://ascopost.com/issues/december-1-2013/tp53-status-may-predict-benefit-from-cetuximab-in-locally-advanced-rectal-cancer/ 2019-03-11T19:23:17+00:00 https://ascopost.com/issues/december-1-2013/expert-point-of-view-eric-van-cutsem-md-phd/ 2019-03-11T19:23:17+00:00 https://ascopost.com/issues/december-1-2013/time-to-think-beyond-kras-in-metastatic-colorectal-cancer/ 2019-03-11T19:23:17+00:00 https://ascopost.com/issues/december-1-2013/cetuximab-confers-survival-benefit-in-all-ras-wild-type-colorectal-tumors/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/two-studies-highlight-communication-challenges-facing-medical-oncology/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/standardized-approach-improves-palliative-care-services-and-outcomes/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/benefits-and-controversies-in-survivorship-care-plans/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/adjuvant-gemcitabine-improves-long-term-survival-in-patients-with-resected-pancreatic-cancer/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/long-term-conko-001-results-adjuvant-therapy-improves-survival/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/addition-of-nab-paclitaxel-to-gemcitabine-improves-survival-in-previously-untreated-metastatic-pancreas-cancer/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/has-a-new-standard-of-care-for-metastatic-pancreatic-cancer-been-established/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/anti-vegfr-2-antibody-ramucirumab-prolongs-survival-in-previously-treated-advanced-gastric-or-gastroesophageal-cancer/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/gastric-cancer-time-to-revisit-angiogenesis/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/new-medical-device-treats-urinary-symptoms-related-to-benign-prostatic-hyperplasia/ 2019-03-11T19:23:18+00:00 https://ascopost.com/issues/december-1-2013/fda-grants-ofatumumab-breakthrough-therapy-designation-for-previously-untreated-cll/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/improving-fertility-options-for-patients-with-cancer/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/national-human-genome-research-institute-names-first-director-of-division-of-genomics-and-society/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/why-we-give-asco-staff-members-on-why-they-support-the-conquer-cancer-foundation/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/a-new-gift-to-add-to-your-list-one-to-conquer-cancer/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/sunshine-act-reporting-asco-encourages-members-to-get-prepared-stay-educated/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/more-than-200-practices-now-qopi-certified-for-delivering-high-quality-cancer-care/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/your-patients-can-learn-more-with-videos-on-specific-cancer-topics/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/obinutuzumab-in-previously-untreated-chronic-lymphocytic-leukemia/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/with-genetic-discoveries-breast-cancer-complexity-grows/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/university-of-chicago-names-ernst-lengyel-md-phd-chair-of-obstetrics-and-gynecology/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/asco-launches-formal-development-of-cancerlinq-system/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/amy-p-abernethy-md-phd-to-chair-cancerlinq-advisory-committee/ 2019-03-11T19:23:19+00:00 https://ascopost.com/issues/december-1-2013/rituximab-does-not-improve-outcome-in-b-cell-lymphoma-with-skeletal-involvement-but-radiotherapy-benefit-found/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/german-analysis-in-diffuse-large-b-cell-lymphoma-hypothesis-generating-rather-than-definitive/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/ctca-names-national-director-for-hipec-research/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/mount-sinai-health-system-appoints-new-director-and-faculty-to-division-of-gynecologic-oncology/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/no-survival-benefit-of-adjuvant-ibandronate-in-high-risk-early-breast-cancer-potential-activity-in-low-estrogen-patients/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/where-is-adjuvant-bisphosphonate-therapy-now/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/ocular-melanoma-research-fellowship-opportunity-announced/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/newyork-presbyteriancolumbia-university-medical-center-opens-irving-radiation-oncology-center/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/living-with-cancer-the-role-of-palliative-care-in-long-term-survivorship-care/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/alliance-trial-evaluates-sentinel-node-surgery-after-neoadjuvant-chemotherapy-for-node-positive-cn1-breast-cancer/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/expert-point-of-view-monica-morrow-md-and-chau-t-dang-md/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/university-of-michigan-cancer-center-founding-director-to-step-down/ 2019-03-11T19:23:20+00:00 https://ascopost.com/issues/december-1-2013/improving-quality-measurement-in-cancer-care-policy-recommendations/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/oncology-meetings/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/spanning-a-spectrum-of-issues-related-to-head-and-neck-cancers/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/novel-egfr-inhibitor-added-to-radiotherapy-fails-to-improve-outcomes-in-head-and-neck-cancer/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/expert-point-of-view-daniel-zips-md/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/phospho-cmet-inhibition-in-multiple-myeloma/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/cost-effectiveness-of-mri-screening-for-women-with-familial-risk-of-breast-cancer-in-the-netherlands/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/evaluation-of-breast-cancer-mri-screening-strategies/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/reasonable-but-not-required-for-women-with-brca-mutations-to-have-hysterectomy-concurrent-with-salpingo-oophorectomy/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/ash-as-part-of-ndd-united-releases-report-on-effects-of-sequestration/ 2019-03-11T19:23:21+00:00 https://ascopost.com/issues/december-1-2013/it-sounds-crazy-but-cancer-has-made-me-a-better-chef/ 2019-03-11T19:23:22+00:00 https://ascopost.com/issues/december-1-2013/one-in-three-american-adults-do-not-comply-with-screening-guidelines-for-colorectal-cancer/ 2019-03-11T19:23:22+00:00 https://ascopost.com/issues/december-1-2013/nodal-status-and-tumor-size-predicted-late-recurrences-of-er-positive-breast-cancer-in-postmenopausal-women/ 2019-03-11T19:23:22+00:00 https://ascopost.com/issues/december-1-2013/impact-of-pelvic-radiotherapy-and-lymphadenectomy-on-endometrial-cancer-mortality/ 2019-03-11T19:23:22+00:00 https://ascopost.com/issues/november-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/november-15-2013/ipilimumab-conveys-long-term-survival-in-pooled-analysis-of-metastatic-melanoma-patients/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/iom-report-illuminates-us-cancer-care-crisis-and-offers-framework-for-change/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/standardizing-the-interpretation-of-pet-scans-an-inr-equivalent/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/strong-showing-for-ado-trastuzumab-emtansine-in-advanced-her2-positive-heavily-pretreated-breast-cancer/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/expert-point-of-view-clifford-hudis-md/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/cediranib-achieves-groundbreaking-results-in-relapsed-ovarian-cancer/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/expert-point-of-view-cora-n-sternberg-md/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/trebananib-improves-progression-free-survival-in-recurrent-ovarian-cancer/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/expert-point-of-view-antonio-casado-md/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/two-trials-explore-the-evolving-role-of-bevacizumab-in-ovarian-cancer/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/expert-point-of-view-rebecca-kristeleit-md/ 2019-03-11T19:24:20+00:00 https://ascopost.com/issues/november-15-2013/institute-of-medicine-elects-new-members-foreign-associates/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/important-news-briefs-new-data-reported-in-breast-renal-cell-head-and-neck-and-lung-cancer/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/erratum/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/impact-of-deficient-dna-mismatch-repair-on-disease-free-survival-in-stage-iii-colon-cancer/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/in-mismatch-repair-deficient-colon-cancer-side-matters/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/one-dose-of-hpv-1618-vaccine-produces-durable-response-study-finds/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/long-term-colorectal-cancer-incidence-and-mortality-after-lower-endoscopy/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/fda-approves-first-extended-release-single-entity-hydrocodone-product/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/sale-of-ponatinib-suspended-due-to-risk-of-life-threatening-blood-clots/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/fda-grants-priority-review-to-ramucirumab-as-a-potential-single-agent-treatment-for-advanced-gastric-cancer/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/oncogene-addiction-and-the-rationale-for-molecular-targeted-therapy-in-lung-cancer/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/investigational-alk-inhibitor-shows-promise-in-patients-with-crizotinib-refractory-alk-positive-nsclc/ 2019-03-11T19:24:21+00:00 https://ascopost.com/issues/november-15-2013/pemetrexed-improves-progression-free-survival-vs-gefitinib-in-second-line-setting-for-egfr-wild-type-nonsquamous-nsclc/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/brivanib-studied-in-first-and-second-line-therapy-for-advanced-hepatocellular-carcinoma/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/brivanib-fails-to-live-up-to-the-promise-of-early-studies/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/sidebar-brian-j-druker-md-discusses-ponatinib/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/neoadjuvant-treatment-of-early-breast-cancer/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/institute-of-medicine-elects-new-foreign-associates/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/technologic-innovations-are-likely-to-transform-oncology-care/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/no-difference-in-long-term-survival-with-finasteride-or-placebo-in-the-prostate-cancer-prevention-trial/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/finasteride-for-prostate-cancer-prevention-long-term-results-disappointing-but-reassuring/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/fda-announces-strategic-plan-to-prevent-drug-shortages/ 2019-03-11T19:24:22+00:00 https://ascopost.com/issues/november-15-2013/pertuzumab-in-neoadjuvant-treatment-of-her2-positive-early-breast-cancer/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/interim-data-reported-from-phase-ib-study-of-investigational-anti-pd-1-immunotherapy-for-nsclc/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/asco-reconfirms-commitment-to-choosing-wisely-campaign/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/new-recommendations-on-her2-testing-and-colorectal-cancer-follow-up-care/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/celebrating-30-years-of-mentorship-that-makes-a-difference/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/asco-resources-for-transitioning-to-icd-10/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/asco-announces-inaugural-class-for-quality-training-program/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/asco-receives-additional-funding-for-virtual-learning-collaborative-from-california-healthcare-foundation/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/breast-cancer-index-assay-prognostic-for-distant-recurrence-in-estrogen-receptor-positive-node-negative-breast-cancer/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/illness-is-personal/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/new-report-examines-trends-in-end-of-life-care/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/multicenter-analysis-of-outcomes-of-lymphoma-in-pregnancy/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/two-patients-in-one-mom-and-baby-managing-coincident-pregnancy-and-lymphoma/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/vertebral-compression-fracture-risk-increased-after-spinal-stereotactic-body-radiotherapy/ 2019-03-11T19:24:23+00:00 https://ascopost.com/issues/november-15-2013/high-dose-spinal-stereotactic-body-radiotherapy-associated-with-increased-risk-of-vertebral-compression-fracture/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/nih-announces-15-clinical-and-translational-science-awards/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/advancing-psychosocial-oncology-care-over-the-next-decade/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/circulating-estrogens-and-androgens-associated-with-breast-cancer-risk-in-premenopausal-women/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/evidence-based-opportunity-to-personalize-breast-cancer-risk-the-data-are-building/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/in-international-study-patients-prefer-subcutaneous-over-intravenous-trastuzumab-for-breast-cancer/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/expert-point-of-view-edith-a-perez-md/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/no-progression-free-survival-difference-for-cediranib-or-cediraniblomustine-vs-lomustine-in-recurrent-glioblastoma/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/tumor-infiltrating-lymphocytes-in-glioblastoma-are-related-to-specific-genomic-alterations/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/fatty-acid-network-exerts-growth-inhibitory-effects-in-pancreatic-cancer/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/focal-adhesion-kinase-regulates-yb-1-mediated-paclitaxel-resistance-in-ovarian-cancer/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/oncology-meetings/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/yoga-improves-sleep-quality-in-patients-with-cancer-suffering-from-sleep-disruption/ 2019-03-11T19:24:24+00:00 https://ascopost.com/issues/november-15-2013/yoga-to-manage-sleep-disruption-in-cancer-survivors-a-low-risk-intervention-with-high-potential-for-benefit/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/focus-on-the-texas-society-of-clinical-oncology/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/iom-presents-2013-lienhard-award-to-leader-of-smoking-cessation-and-tobacco-prevention-efforts/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/fda-approves-transducer-array-layout-system-for-use-in-patients-with-recurrent-glioblastoma-multiforme/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/nih-awards-17-million-in-grants-to-augment-genomics-research-in-africa/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/fda-hears-proposals-on-codevelopment-of-companion-diagnostics-for-breakthrough-therapies/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/sidebar-five-proposals-for-the-fda/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/having-bladder-cancer-has-taught-me-important-life-lessons/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/omega-3/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/cancercare-launches-new-edition-of-financial-resource-guide-for-people-with-cancer/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/decoding-annie-parker-hunting-the-breast-cancer-gene/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/clear-and-consistent-protective-effect-of-marriage-found-in-patients-with-10-most-clinically-significant-cancers/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/sidebar-expect-questions-about-support-systems-for-unmarried-patients/ 2019-03-11T19:24:25+00:00 https://ascopost.com/issues/november-15-2013/the-power-of-human-attachment/ 2019-03-11T19:24:26+00:00 https://ascopost.com/issues/november-15-2013/variations-in-risk-factors-suggest-distinct-etiology-for-inflammatory-breast-cancer/ 2019-03-11T19:24:26+00:00 https://ascopost.com/issues/november-15-2013/impact-of-hormone-replacement-therapy-on-breast-cancer-risk-varies-by-race-weight-and-breast-density/ 2019-03-11T19:24:26+00:00 https://ascopost.com/issues/november-15-2013/patient-assistance-programs-provide-psychosocial-but-not-practical-help/ 2019-03-11T19:24:26+00:00 https://ascopost.com/issues/november-15-2013/ascos-2013-top-five-list-in-oncology-for-choosing-wisely-campaign/ 2019-03-11T19:24:26+00:00 https://ascopost.com/issues/november-15-2013/commentary-choosing-wisely-good-care-with-efficiency/ 2019-03-11T19:24:26+00:00 https://ascopost.com/issues/november-15-2013/fda-approves-obinutuzumab-for-chronic-lymphocytic-leukemia/ 2019-03-11T19:24:26+00:00 https://ascopost.com/issues/november-1-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/november-1-2013/novel-anti-pd-l1-antibody-produces-durable-responses-in-metastatic-nsclc-smokers-included/ 2019-03-11T19:25:54+00:00 https://ascopost.com/issues/november-1-2013/expert-point-of-view-paul-baas-md-phd/ 2019-03-11T19:25:54+00:00 https://ascopost.com/issues/november-1-2013/the-scientific-perils-of-sequestration/ 2019-03-11T19:25:54+00:00 https://ascopost.com/issues/november-1-2013/the-devastating-impact-of-sequestration-on-medical-research/ 2019-03-11T19:25:54+00:00 https://ascopost.com/issues/november-1-2013/optimizing-anti-her2-treatment-for-metastatic-breast-cancer-in-2013/ 2019-03-11T19:25:54+00:00 https://ascopost.com/issues/november-1-2013/women-undergoing-mammography-fail-to-understand-breast-cancer-risk/ 2019-03-11T19:25:54+00:00 https://ascopost.com/issues/november-1-2013/expert-point-of-view-steven-j-oday-md/ 2019-03-11T19:25:54+00:00 https://ascopost.com/issues/november-1-2013/program-co-directors-highlight-abstracts-of-interest-for-the-upcoming-2013-san-antonio-breast-cancer-symposium/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/sidebar-highlighted-abstracts-to-watch-in-san-antonio/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/esmo-president-martine-piccart-md-phd-on-the-importance-of-diagnostics-in-move-from-stratified-to-personalized-care/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/aspirin-protects-against-colorectal-cancer-recurrence-in-pik3ca-mutant-tumors/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/expert-point-of-view-alberto-sobrero-md/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/panitumumab-vs-cetuximab-in-chemorefractory-colorectal-cancer-survival-benefits-comparable/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/expert-point-of-view-josep-tabernero-md-phd-and-eric-van-cutsem-md-phd/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/bevacizumabcapecitabine-improves-progression-free-survival-in-older-patients-with-treatment-naive-metastatic-colorectal-cancer/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/the-avex-trial/ 2020-02-17T18:11:08+00:00 https://ascopost.com/issues/november-1-2013/gastric-cancer-foundation-announces-research-partnership-with-aga/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/roswell-park-cancer-institute-university-of-pittsburgh-cancer-institute-receive-11-million-spore-grant-for-joint-research-in-ovarian-cancer/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/new-strategies-for-relapsedrefractory-multiple-myeloma-explored/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/expert-point-of-view-andrew-d-zelenetz-md-phd/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/take-home-messages-from-the-nccn-hematologic-malignancies-conference/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/options-for-management-of-bone-health-in-patients-with-multiple-myeloma/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/sidebar-imwg-recommendations/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/international-cancer-corps-provides-valuable-first-time-volunteer-experience/ 2019-03-11T19:25:55+00:00 https://ascopost.com/issues/november-1-2013/asco-teams-up-with-the-getwell-network-to-provide-more-patients-with-education-resources/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/highlights-on-quality-cancer-care-for-patients/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/asco-submits-comments-on-numerous-federal-initiatives/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/zhe-bin-liu-md-phd-of-china-receives-2013-long-term-international-fellowship-in-breast-cancer/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/asco-develops-educational-article-series-on-research-funding/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/fda-grants-volasertib-breakthrough-therapy-designation-in-aml/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/fda-announces-class-wide-safety-labeling-changes-for-long-acting-opioid-analgesics-to-combat-abuse/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/penn-medicine-names-d-gary-gilliland-md-phd-first-leader-of-precision-medicine/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/surgeon-david-chang-md-joins-university-of-chicago-medicine/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/the-american-society-of-hematology-elects-new-leadership/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/president-elect-candidates-address-ascos-challenges-and-opportunities-in-the-coming-decades/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/asco-president-elect-candidate-lynn-m-schuchter-md-fasco/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/asco-president-elect-candidate-julie-m-vose-md-mba-fasco/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/a-look-ahead-how-the-fda-is-adapting-in-the-era-of-precision-medicine/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/sidebar-2013-new-drugindication-approvalsstar/ 2019-03-11T19:25:56+00:00 https://ascopost.com/issues/november-1-2013/master-protocol-could-revolutionalize-trials-in-lung-cancer-and-eventually-other-cancers/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/aacr-cancer-progress-report-2013-highlights-critical-importance-of-biomedical-research/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/modifiable-risk-factors-potentiate-therapy-associated-risk-for-major-cardiac-events-in-adult-survivors-of-childhood-cancer/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/cardiovascular-risk-factors-in-cancer-survivors/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/cabozantinib-improves-disease-free-survival-in-progressive-medullary-thyroid-cancer/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/cabozantinib-in-medullary-thyroid-cancer-a-landscape-shaping-new-treatment/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/having-breast-cancer-has-actually-been-a-positive-experience/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/nab-paclitaxel-in-metastatic-pancreas-cancer/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/innovation-impact-awards-support-efforts-to-advance-blood-cancer-research-priorities-and-lung-cancer-screening-adoption/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/low-dose-ct-screening-identifies-more-early-lung-cancer-but-has-lower-positive-predictive-value-vs-radiography/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/lung-cancer-screening-actionable-evidence/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/claudia-i-henschke-phd-md-took-a-circuitous-route-to-her-groundbreaking-work-in-lung-cancer-screening/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/cancercare-launches-new-edition-of-financial-resource-guide-for-people-with-cancer/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/new-editor-in-chief-named-for-molecular-cancer-therapeutics/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/oncology-meetings/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/shades-of-autumn/ 2019-03-11T19:25:57+00:00 https://ascopost.com/issues/november-1-2013/association-of-community-cancer-centers-2013-innovator-award-recipients-announced/ 2019-03-11T19:25:58+00:00 https://ascopost.com/issues/november-1-2013/better-risk-communication-strategies-needed-to-ensure-decision-to-have-contralateral-prophylactic-mastectomy-is-evidence-based/ 2019-03-11T19:25:58+00:00 https://ascopost.com/issues/november-1-2013/sidebar-expect-questions-about-contralateral-prophylactic-mastectomy-carefully-review-risks-and-alternatives/ 2019-03-11T19:25:58+00:00 https://ascopost.com/issues/november-1-2013/intralesional-cytokine-therapy-in-cutaneous-melanoma-a-call-for-clinical-trials/ 2019-03-11T19:25:58+00:00 https://ascopost.com/issues/november-1-2013/calcium-channel-blockers-linked-to-increased-risk-of-lobularductal-breast-cancer/ 2019-03-11T19:25:58+00:00 https://ascopost.com/issues/november-1-2013/front-line-treatment-strategies-to-achieve-long-term-control-of-cll-combined-with-optimal-quality-of-life/ 2019-03-11T19:25:58+00:00 https://ascopost.com/issues/november-1-2013/inequality-in-delivery-of-palliative-radiotherapy-among-black-patients-with-cancer-and-elderly-with-comorbidities/ 2019-03-11T19:25:58+00:00 https://ascopost.com/issues/october-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/october-15-2013/breast-cancer-radiotherapy-and-cardiotoxicity-what-is-the-true-risk/ 2019-03-11T19:29:48+00:00 https://ascopost.com/issues/october-15-2013/contemporary-studies-dispute-findings-of-radiation-induced-cardiotoxicity/ 2019-03-11T19:29:48+00:00 https://ascopost.com/issues/october-15-2013/breast-cancer-care-in-the-era-of-accountable-care-organizations/ 2019-03-11T19:29:48+00:00 https://ascopost.com/issues/october-15-2013/trying-to-improve-value-in-cancer-care-an-experiment/ 2019-03-11T19:29:48+00:00 https://ascopost.com/issues/october-15-2013/what-is-on-the-horizon-in-the-management-of-breast-cancer/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/dr-larry-norton-honored-at-2013-breast-cancer-symposium-calls-for-a-return-to-the-exploration-of-concepts/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/single-institution-study-evaluates-routine-use-of-perioperative-mri-in-patients-with-ductal-carcinoma-in-situ/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/expert-point-of-view-steven-j-o-day-md/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/expert-point-of-view-on-ductal-carcinoma-in-situ/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/radiation-therapy-is-safe-in-the-management-of-ductal-carcinoma-in-situ-no-increase-in-risk-of-cardiovascular-disease/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/expert-point-of-view-steven-j-o-day-md-1/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/could-mri-be-a-better-breast-cancer-screening-tool-than-mammography/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/expert-point-of-view-monica-morrow-md/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/pathologic-complete-response-as-a-test-bed-for-novel-therapies-proceed-with-caution/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/fda-approves-first-generic-capecitabine-to-treat-colorectal-and-breast-cancers/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/fda-approves-nab-paclitaxel-for-late-stage-pancreatic-cancer/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/applying-molecular-profiling-to-clinical-practice-promises-and-challenges/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/telomere-length-may-be-a-prognostic-marker-for-prostate-cancer/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/fda-grants-breakthrough-therapy-status-to-entinostat-for-advanced-breast-cancer/ 2019-03-11T19:29:49+00:00 https://ascopost.com/issues/october-15-2013/important-findings-in-metastatic-colorectal-cancer-studies-address-treatment-management-options/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/challenging-and-changing-the-standard-of-care-for-cervical-and-ovarian-cancers/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/study-shows-increased-risk-of-mental-disorders-in-childhood-cancer-survivors-and-potential-increased-risk-in-young-siblings/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/psychosocial-health-in-long-term-survivors-of-childhood-cancer/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/ancient-chinese-military-tactics-might-help-win-the-war-on-lung-cancer/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/stereotactic-body-radiation-therapy-offers-near-complete-tumor-control-for-medically-inoperable-early-stage-nsclc/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/asco-releases-statement-on-the-impact-of-the-government-shutdown-on-cancer-care/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/more-active-physician-intervention-needed-to-keep-patients-from-smoking/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/new-president-and-ceo-of-fox-chase-cancer-center-reflects-on-challenges-and-opportunities-ahead/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/sidebar-highlights-from-fox-chase-cancer-center/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/10-year-breast-cancer-survival-similar-regardless-of-brca1-mutation-status/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/germline-mutations-and-breast-cancer-prognosis-does-the-cause-matter/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/american-society-of-radiologic-technologists-mammography-checklist/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/myeloma-foundation-launches-open-access-gateways-to-accelerate-drug-development/ 2019-03-11T19:29:50+00:00 https://ascopost.com/issues/october-15-2013/comparative-effectiveness-research-its-time-has-arrived/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/association-of-community-cancer-centers-honors-paul-f-engstrom-md-with-annual-clinical-care-achievement-award/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/sheldon-davidson-md-helping-advance-the-field-of-oncology-through-philanthropy/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/a-great-idea-supporting-the-next-generation-of-oncology-leaders-in-low-and-middle-income-countries/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/asco-survey-drug-shortages-still-a-problem-despite-slight-improvement/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/discover-ascos-advanced-cancer-care-planning-booklet-for-patients-and-families/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/society-announces-candidates-for-asco-election/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/progression-free-survival-with-pazopanib-not-inferior-to-sunitinib-benefit-in-metastatic-renal-cell-carcinoma/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/pazopanib-vs-sunitinib-in-metastatic-renal-cell-carcinoma-how-do-we-choose/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/accelerated-partial-breast-irradiation-using-3d-conformal-radiation-therapy-causes-more-adverse-events-compared-with-whole-breast-irradiation/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/jean-b-owen-phd-named-2013-astro-honorary-member-at-annual-meeting/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/increased-alcohol-consumption-between-menarche-and-pregnancy-increases-breast-cancer-risk/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/alcohol-consumption-between-menarche-and-pregnancy-and-breast-cancer-risk-factors-in-risk-accumulation/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/fda-approves-neoadjuvant-pertuzumab-for-early-stage-breast-cancer/ 2019-03-11T19:29:51+00:00 https://ascopost.com/issues/october-15-2013/aftermath-of-the-aids-pandemic-cancer-care-in-botswana/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/view-from-a-cancer-ward-in-botswana/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/alsympca-trial-updated-analysis-of-survival-with-radium-223-treatment-in-metastatic-prostate-cancer/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/radium-223-and-beyond-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/long-term-androgen-deprivation-in-patients-with-intermediate-risk-prostate-cancer-does-not-improve-overall-survival/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/fewer-weeks-of-neoadjuvant-hormone-therapy-reduces-side-effects-in-patients-with-intermediate-risk-prostate-cancer-rtog-9910/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/protecting-hippocampus-during-whole-brain-radiation-substantially-reduces-rate-of-cognitive-decline/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/cisplatin-plus-radiation-therapy-for-advanced-cervical-cancer-improves-disease-free-survival-vs-radiotherapy-alone/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/astro-offers-five-recommendations-as-part-of-choosing-wisely-campaign/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/cancer-does-not-discriminate/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/advances-in-medical-oncology-over-the-next-decade/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/sidebar-understanding-the-panomics-of-cancer/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/herb-drug-interactions-in-oncology/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/americaninternational-psychosocial-oncology-societies-host-event-to-support-science-and-practice-of-psychosocial-care-for-patients-with-cancer/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/focus-on-the-wisconsin-association-of-hematology-oncology/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/felice-schnoll-sussman-md-named-director-of-jay-monahan-center-for-gastrointestinal-health-at-newyork-presbyterianweill-cornell/ 2019-03-11T19:29:52+00:00 https://ascopost.com/issues/october-15-2013/oncology-meetings/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/donatori-di-musica-initiative-creates-a-unique-environment-for-oncology-patients/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/sidebar-about-donatori-di-musica/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/for-2-decades-nancy-davenport-ennis-has-worked-to-ensure-access-to-health-care-for-all-patients-diagnosed-with-life-threatening-illness/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/sidebar-how-to-find-out-more-for-your-patients-with-cancer/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/st-jude-childrens-hospital-appoints-larry-kun-md-clinical-director/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/william-e-evans-md-director-st-jude-childrens-research-hospital-to-retire-in-july-2014/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/pcori-board-approves-114-million-for-patient-centered-outcomes-research/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/straight-talk-the-future-of-medical-and-health-research/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/how-to-recognize-and-manage-ipilimumab-induced-dermatologic-adverse-events/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/what-you-need-to-know-about-e-cigarettes/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/sidebar-expect-questions-about-e-cigarettes/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/smoking-app-for-teens/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/mindfulness-based-stress-reduction-therapy-for-patients-with-distress/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/pomalidomide-in-patients-with-disease-progression-who-are-refractory-to-bortezomib-and-lenalidomide/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/sunscreen-use-infrequently-discussed-with-patients/ 2019-03-11T19:29:53+00:00 https://ascopost.com/issues/october-15-2013/shiftworkers-likely-to-have-increased-risk/ 2019-03-11T19:29:54+00:00 https://ascopost.com/issues/october-15-2013/high-quality-diet-may-reduce-risk/ 2019-03-11T19:29:54+00:00 https://ascopost.com/issues/october-15-2013/doing-nothing-is-not-an-option/ 2019-03-11T19:29:54+00:00 https://ascopost.com/issues/october-15-2013/jane-weeks-md-msc-national-leader-in-outcomes-research-dies-at-61/ 2019-03-11T19:29:54+00:00 https://ascopost.com/issues/october-15-2013/to-die-beneath-an-open-sky/ 2019-03-11T19:29:54+00:00 https://ascopost.com/issues/october-15-2013/platinum-based-treatment-of-triple-negative-breast-cancer/ 2019-03-11T19:29:54+00:00 https://ascopost.com/issues/september-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/september-15-2013/platinum-agents-in-triple-negative-breast-cancer-encouraging-new-data/ 2019-03-11T19:31:00+00:00 https://ascopost.com/issues/september-15-2013/paging-dr-google-practicing-oncology-in-the-era-of-social-media-and-telemedicine/ 2019-03-11T19:31:00+00:00 https://ascopost.com/issues/september-15-2013/a-great-privilege-to-die-beneath-an-open-sky/ 2019-03-11T19:31:00+00:00 https://ascopost.com/issues/september-15-2013/veristrat-assay-helps-select-nsclc-patients-for-second-line-therapy/ 2019-03-11T19:31:00+00:00 https://ascopost.com/issues/september-15-2013/expert-point-of-view-heather-a-wakelee-md/ 2019-03-11T19:31:00+00:00 https://ascopost.com/issues/september-15-2013/prescribing-of-off-label-chemotherapy-is-common-and-most-off-label-drug-use-meets-nccn-compendium-criteria/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/sidebar-the-good-the-bad-and-the-ugly/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/three-game-changers-in-the-treatment-of-melanoma/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/high-tech-imaging-contributes-to-overdiagnosis-overtreatment-of-low-risk-thyroid-cancers/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/what-is-the-optimal-treatment-of-advanced-melanoma/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/undertreatment-of-cancer-pain-remains-a-persistent-problem-in-oncology/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/no-benefitdetriment-of-donor-change-in-second-stem-cell-transplant-for-leukemia-relapse/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/treatment-of-relapse-of-acute-leukemia-post-transplant-still-hope-for-patients-with-chemosensitive-disease/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/fda-approves-mechlorethamine-gel-for-cutaneous-t-cell-lymphoma/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/sorafenib-granted-priority-review-for-differentiated-thyroid-cancer/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/cohort-analysis-adjuvant-tamoxifen-reduces-risk-of-contralateral-breast-cancer-in-brca12-mutation-carriers/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/tamoxifen-in-women-with-brca1-and-brca2-mutations-another-option/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/what-para-aortic-nodal-involvement-predicts-about-survival-in-pet-ct-negative-locally-advanced-cervical-cancer/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/pretreatment-lymph-node-dissection-may-improve-survival-in-advanced-cervical-cancer-but-for-too-few/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/couple-pledges-10-million-gift-to-md-anderson-s-head-and-neck-cancer-center/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/breast-cancer-researchers-awarded-komen-for-the-cure-grants/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/progesterone-and-estrogen-receptor-expression-are-prognostic-markers-for-endometrioid-and-high-grade-serous-ovarian-cancer/ 2019-03-11T19:31:01+00:00 https://ascopost.com/issues/september-15-2013/timely-findings-from-the-ovarian-tumor-tissue-analysis-consortium/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/september-is-national-ovarian-cancer-awareness-month/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/cytokine-induced-killer-cells-effective-against-autologous-metastatic-melanoma-including-cells-with-stemness-features/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/resistance-to-anti-vegf-drugs-in-glioblastoma-is-linked-to-mesenchymal-transition/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/prognostic-significance-of-mtor-pathway-component-expression-in-neuroendocrine-tumors/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/no-invasive-disease-free-survival-benefit-for-bevacizumab-added-to-adjuvant-chemotherapy-in-triple-negative-breast-cancer/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/the-beatrice-study-where-does-targeting-breast-cancer-vasculature-stand-in-2013/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/lidia-schapira-md-bridging-communication-gaps-between-oncologists-and-patients/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/lung-cancer-alliance-launches-national-campaign-to-increase-public-awareness-of-lung-ct-screening/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/postresection-adenovirus-mediated-gene-therapy-improves-time-to-deathreintervention-but-not-survival-in-adult-glioblastoma/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/sitimagene-ceradenoveciv-ganciclovir-in-glioblastoma-legitimizing-the-gene-therapy-approach-for-brain-tumors/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/potential-prognostic-significance-shown-for-interaction-of-follicular-lymphoma-cells-with-immune-microenvironment/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/robert-s-miller-md-facp-appointed-editor-in-chief-of-cancernet/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/asco-congratulates-qopi-certified-practices/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/sustainable-growth-rate-bill-advances-in-the-house/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/order-updated-asco-answers-fact-sheets-for-your-office-or-waiting-room/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/communicating-the-promise-science-offers-to-society/ 2019-03-11T19:31:02+00:00 https://ascopost.com/issues/september-15-2013/conquering-cancer-by-encouraging-diversity-in-the-field-of-oncology/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/final-publication-of-iom-report-on-learning-health-systems-available/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/the-direction-of-immunotherapy-over-the-next-decade/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/celebrating-2-decades-as-a-cancer-survivor/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/cancer-survivors-in-focus-photo-exhibit-honors-cancer-survivors/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/the-trials-and-tribulations-of-a-revolutionary-cancer-drug/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/asco-launches-new-site-to-seek-feedback-from-cancer-community-on-clinical-practice-guidelines/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/oncology-meetings/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/st-jude-childrens-research-hospital-recognizes-childhood-cancer-awareness-month/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/the-oncologist-as-author-on-guiding-patients-through-cancer/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/genitourinary-cancer-expert-walter-m-stadler-md-named-section-chief-of-hematologyoncology-at-the-university-of-chicago-medicine/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/prominent-surgeon-and-teacher-lasalle-d-leffall-jr-md-promotes-hard-work-and-education-to-overcome-boundaries/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/tackling-overdiagnosis-and-overtreatment-by-words-and-by-deeds/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/california-stem-cell-agency-awards-more-than-40-million-in-new-research-grants-including-funds-for-prostate-cancer-research/ 2019-03-11T19:31:03+00:00 https://ascopost.com/issues/september-15-2013/cancercare-co-payment-assistance-foundation-launches-new-technology-to-provide-cancer-patients-with-same-day-approval/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/preventing-tobacco-use-in-children/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/clinical-trials-crossover-and-clinical-equipoise-a-patients-perspective/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/clinical-trials-crossover-and-clinical-equipoise-an-advocates-perspective/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/pharmacyclics-reply/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/fda-on-cll-drug-approval-and-expanded-access/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/low-risk-of-transformation-to-melanoma-for-biopsy-diagnosed-mildly-or-moderately-dysplastic-nevi/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/indoor-tanning-common-among-young-white-females-despite-skin-cancer-risk/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/more-prudent-interpretation-of-thyroid-ultrasound-could-reduce-unnecessary-biopsies/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/many-patients-with-head-and-neck-cancer-report-being-depressed-but-few-use-mental-health-services/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/panobinostat-combined-with-bortezomib-and-dexamethasone-can-recapture-responses-in-heavily-pretreated-patients/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-15-2013/cord-blood-transplantation-benefits-some-children-with-juvenile-myelomonocytic-leukemia/ 2019-03-11T19:31:04+00:00 https://ascopost.com/issues/september-1-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/september-1-2013/addressing-the-key-clinical-questions-in-advanced-melanoma/ 2019-03-11T19:31:34+00:00 https://ascopost.com/issues/september-1-2013/access-to-and-appropriate-use-of-oncology-drugs-called-into-question-by-asco-studies/ 2019-03-11T19:31:34+00:00 https://ascopost.com/issues/september-1-2013/will-funding-for-lung-cancer-ever-improve/ 2019-03-11T19:31:34+00:00 https://ascopost.com/issues/september-1-2013/paul-a-bunn-jr-md-offers-insights-about-a-hopeful-era-in-lung-cancer-treatment/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/researchers-identify-gene-variations-in-lung-cancer-patients-that-may-help-predict-an-individuals-treatment-response/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/olaparib-shows-robust-progression-free-survival-benefit-in-patients-with-brca-mutations/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/expert-point-of-view-paul-sabbatini-md/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/merkel-cell-carcinoma-hints-of-immune-mediation-may-enhance-treatment-options/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/molecular-profiling-improves-classification-of-nodal-peripheral-t-cell-lymphomas/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/molecular-profiling-improves-classification-of-nodal-peripheral-t-cell-lymphomas-1/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/obinutuzumab-shows-activity-in-relapsedrefractory-diffuse-large-b-cell-lymphoma-or-mantle-cell-lymphoma-and-indolent-non-hodgkin-lymphoma/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/can-obinutuzumab-benefit-patients-with-rituximab-refractory-non-hodgkin-lymphoma/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/no-event-free-survival-difference-with-chemotherapy-before-vs-after-radiotherapy-in-children-with-high-risk-medulloblastoma/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/ongoing-progress-in-treatment-of-medulloblastoma/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/significant-improvement-in-overall-survival-seen-with-pemetrexed-maintenance-after-pemetrexedcisplatin-induction-in-patients-with-advanced-nonsquamous-nsclc/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/pemetrexed-maintenance-in-paramount-continuation-proves-to-be-a-strong-option-for-advanced-nsclc-although-not-a-mandate/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/pattern-in-lung-cancer-pathology-may-predict-recurrence-after-surgery/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/bevacizumabpemetrexed-maintenance-increases-progression-free-survival-vs-bevacizumab-alone-in-advanced-nonsquamous-nsclc/ 2019-03-11T19:31:35+00:00 https://ascopost.com/issues/september-1-2013/non-small-cell-lung-cancer-maintenance-therapy-none-single-agent-multiple-agents/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/fda-approves-first-rapid-diagnostic-test-to-detect-both-hiv-1-antigen-and-hiv-12-antibodies/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/fertility-rates-in-childhood-cancer-survivors-suggest-strategies-for-follow-up-care/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/integrating-genomic-sequencing-into-clinical-care/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/enhanced-treatment-surveillance-needed-for-patients-with-braf-mutant-melanoma-to-prevent-secondary-cancers/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/study-suggests-low-grade-prostate-cancers-may-not-progress-over-time/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/dr-julie-vose-finds-the-best-of-both-worlds-patient-care-and-cutting-edge-research-in-academic-medicine/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/asco-examines-the-future-of-cancer-care-over-the-next-2-decades/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/meta-analysis-addition-of-taxane-to-cisplatin5-fu-induction-improves-outcome-in-locally-advanced-head-and-neck-cancers/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/american-ginseng-improves-cancer-related-fatigue/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/ginseng-in-the-spotlight/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/conquer-cancer-foundation-donor-and-asco-member-denis-hammond-md-spreading-the-word-to-help-conquer-cancer/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/legislative-endorsement-update-from-asco/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/asco-challenges-its-members-to-double-their-impact-during-the-month-of-september/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/what-the-latest-breast-cancer-news-means-for-patients/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/asco-university-appoints-first-editor-in-chief/ 2019-03-11T19:31:36+00:00 https://ascopost.com/issues/september-1-2013/ash-announces-2013-honorific-award-recipients/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/combining-community-practice-and-health-policy-advocacy/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/sidebar-american-medical-association-board-of-trustees/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/oncology-meetings/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/family-members-of-children-with-cancer-are-also-at-risk-for-the-disease/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/role-of-epithelial-to-mesenchymal-transition-in-ovarian-cancer/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/ginseng/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/im-not-the-person-i-was-before-cancer/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/active-surveillance-of-very-low-risk-prostate-cancer-might-not-be-suitable-option-for-african-american-men/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/expect-questions-from-patients-about-active-surveillance/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/role-of-erlotinib-in-egfr-wild-type-lung-cancer/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/nodal-metastases-more-likely-if-tumors-have-breast-cancer-stem-and-progenitor-cells-with-pi3kakt-signaling-defects/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/long-term-current-use-of-calcium-channel-blockers-is-associated-with-higher-risk-of-breast-cancer/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/best-ever-published-prognostic-factor-for-early-stage-type-1-endometrial-cancer/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/september-1-2013/printed-and-web-based-decision-aids-improved-informed-decision-making-but-didnt-alter-screening/ 2019-03-11T19:31:37+00:00 https://ascopost.com/issues/august-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/august-15-2013/maintenance-treatment-delays-progression-in-metastatic-colorectal-cancer/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/expert-point-of-view-tim-maughan-md/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/oncologists-speak-out-against-the-high-cost-of-cancer-drugs/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/molecular-tests-and-precision-medicine-not-so-fast-now/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/geparsixto-study-finds-benefit-for-neoadjuvant-carboplatin-in-triple-negative-breast-cancer/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/expert-point-of-view-judy-garber-md-mph/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/weekly-carboplatinpaclitaxel-improves-quality-of-life-toxicity-vs-every-3-week-regimen-in-advanced-ovarian-cancer/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/expert-point-of-view-jonathan-s-berek-md/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/neoadjuvant-chemotherapy-and-interval-debulking-may-be-appropriate-for-some-patients-with-poor-performance-status-advanced-ovarian-cancer/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/expert-point-of-view-jonathan-s-berek-md-1/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/us-preventive-services-task-force-recommends-ct-screening-for-lung-cancer-in-high-risk-individuals/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/sidebar-major-milestone-in-war-on-cancer/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/acquired-resistance-to-crizotinib-from-ros1-g2032r-mutation/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/tecemotide-vaccine-warrants-further-study-in-unresectable-stage-iii-non-small-cell-lung-cancer/ 2019-03-11T19:31:53+00:00 https://ascopost.com/issues/august-15-2013/expert-point-of-view-johan-f-vansteenkiste-md-phd/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/b-cell-receptor-signaling-inhibitors-moving-forward-in-lymphoma/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/expert-point-of-view-ranjana-advani-md/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/fda-invites-public-input-on-menthol-in-cigarettes/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/cdc-report-shows-stagnated-hpv-vaccination-rate-for-girls/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/high-rate-of-durable-remissions-with-ibrutinib-in-patients-with-relapsed-chronic-lymphocytic-leukemia/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/ibrutinib-produces-high-response-rate-in-patients-with-refractory-mantle-cell-lymphoma/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/petct-superior-to-bone-marrow-biopsy-for-diagnosis-prognosis-in-lymphoma/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/new-guidelines-issued-in-the-treatment-of-multiple-myeloma-related-bone-disease/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/crizotinib-improves-progression-free-survival-vs-pemetrexed-or-docetaxel-in-advanced-alk-positive-nsclc/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/where-are-we-with-alk-inhibition-in-lung-cancer/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/low-dose-ct-screening-for-lung-cancer-details-of-first-round-of-screening-in-national-lung-screening-trial/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/evolving-issues-in-low-dose-ct-lung-cancer-screening/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/diane-e-meier-md-from-early-lessons-in-critical-thinking-to-palliative-care-everywhere/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/oncofetal-protein-sall4-is-a-marker-of-aggressive-hepatocellular-carcinoma-and-a-potential-therapeutic-target/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/targeted-suppression-of-a-reactivated-developmental-pathway-in-hepatocellular-cancer/ 2019-03-11T19:31:54+00:00 https://ascopost.com/issues/august-15-2013/asco-studies-support-limited-use-of-routine-imaging/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/new-campaign-addresses-rise-in-young-onset-colon-cancer/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/sidebar-never-too-young-campaigns-collaborative-effort/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/afatinib-as-first-line-treatment-for-metastatic-nsclc-with-egfr-exon-19-deletions-or-exon-21-l858r-substitution-mutations/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/lux-lung-3-afatinib-prolongs-progression-free-survival-vs-cisplatinpemetrexed-in-advanced-lung-adenocarcinoma/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/further-support-for-front-line-targeted-egfr-therapy/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/age-not-linked-to-recurrence-in-observation-or-trastuzumab-groups-with-her2-positive-breast-cancer/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/is-age-truly-relative-in-her2-positive-breast-cancer/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/aacr-cautions-diminished-nih-funding-jeopardizes-ability-to-eradicate-cancer-health-disparities/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/whole-exome-sequencing-of-nci-60-cell-line-panel-provides-genomic-resource-for-cancer-biology-and-pharmacology/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/program-aims-to-overcome-barriers-to-early-cancer-care-in-colombia/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/sidebar-the-globocan-project/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/sidebar-program-background/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/american-association-for-cancer-research-foundation-appoints-new-executive-director/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/michael-j-stamos-md-elected-ascrs-president-terry-c-hicks-md-chosen-president-elect/ 2019-03-11T19:31:55+00:00 https://ascopost.com/issues/august-15-2013/infertility-in-men-raises-their-risk-for-cancer/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/tv-celebrity-valerie-harper-joins-lung-cancer-foundation-in-raising-awareness/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/a-look-ahead-the-next-decade-in-pediatric-oncology/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/study-evaluates-post-traumatic-stress-symptoms-in-young-adults-with-cancer/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/conquer-cancer-foundation-grant-recipient-pays-it-forward-through-philanthropic-support-volunteer-service/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/ascos-guideline-on-drugs-to-lower-breast-cancer-risk/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/policy-update-aims-to-advance-tobacco-cessation-and-control-worldwide/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/30-years-of-identifying-high-quality-research-with-breakthrough-potential/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/first-line-carboplatinpemetrexed-improves-survival-vs-pemetrexed-alone-in-advanced-lung-cancer/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/docetaxel-superior-to-erlotinib-in-second-line-treatment-of-advanced-non-small-cell-lung-cancer-with-wild-type-egfr/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/link-between-red-meat-consumption-and-mortality-clarified-in-patients-with-nonmetastatic-colorectal-cancer/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/intercalated-chemotherapyerlotinib-improves-progression-free-survival-in-advanced-nsclc/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/significant-improvement-in-overall-survival-seen-with-pemetrexed-maintenance-after-pemetrexedcisplatin-induction-in-patients-with-advanced-nsclc/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/focus-on-the-west-virginia-oncology-society/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/the-sunshine-act-calls-for-greater-transparency-in-industry-doctor-relationships/ 2019-03-11T19:31:56+00:00 https://ascopost.com/issues/august-15-2013/sidebar-key-dates/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/sidebar-covered-recipients/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/sidebar-required-reporting/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/adolescents-young-adults-with-cancer-often-challenged-by-unmet-needs-following-treatment/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/professional-societies-endorse-2015-standard-for-cancer-center-accreditation-by-commission-on-cancer/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/sidebar-key-issues-in-joint-commission-statement-by-american-psychosocial-oncology-society-association-of-oncology-social-work-and-oncology-nursing-society/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/david-penson-md-mph-receives-2-million-research-award-to-study-prostate-cancer/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/acupuncture-may-reduce-arm-lymphedema-in-patients-with-breast-cancer/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/western-science-catching-up-with-traditional-chinese-medicine/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/living-and-working-with-cancer/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/nih-commits-24-million-annually-for-big-data-centers-of-excellence/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/johns-hopkins-kimmel-cancer-center-announces-new-leadership-appointment/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/10th-international-conference-of-the-society-for-integrative-oncology-will-explore-translational-science-topics/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/leukemia-lymphoma-society-appoints-new-administrative-officer/ 2019-03-11T19:31:57+00:00 https://ascopost.com/issues/august-15-2013/fda-issues-warning-on-rare-but-serious-skin-reactions-with-acetaminophen/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/richard-i-fisher-md-named-president-and-ceo-of-fox-chase-cancer-center/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/cedars-sinai-medical-physicist-honored-by-american-association-of-physicists-in-medicine/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/oncology-meetings/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/dr-joseph-bertinos-breakthrough-work-in-methotrexate-resistance-led-to-understanding-why-cancer-drugs-work-or-fail/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/cedars-sinai-names-award-recipient-in-gifted-scholars-program/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/tomosynthesis-plus-digital-mammography-reduces-breast-cancer-screening-recall-rate-compared-to-mammography-alone/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/alarming-difference-in-survival-outcomes-for-young-white-men-with-melanoma/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/sidebar-ncaa-athletes-as-sunsport-ambassadors/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/sidebar-a-hot-season-for-skin-cancer-news-so-expect-more-questions/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/sidebar-key-features-of-melanoma-abcde/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/nazarbayev-university-selects-pittsburgh-school-of-medicine-as-strategic-partner-to-establish-medical-school-in-kazakhstan/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/making-the-science-of-cancer-understandable-to-a-broad-audience/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/pig-diagnosed-with-lymphoma-and-treated-at-cornell-university-hospital-for-animals/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/i-overcame-cervical-cancer-but-not-its-long-term-effects/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/women-with-primary-breast-cancer-diagnosed-during-pregnancy-have-overall-survival-similar-to-nonpregnant-patients/ 2019-03-11T19:31:58+00:00 https://ascopost.com/issues/august-15-2013/cisplatin-plus-cetuximab-vs-cisplatin-alone-in-patients-with-metastatic-triple-negative-disease/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/for-women-70-years-with-early-breast-cancer-adding-radiotherapy-to-lumpectomy-and-tamoxifen-does-not-increase-survival/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/androgen-deprivation-therapy-associated-with-increased-risk-of-acute-kidney-injury/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/anti-pd-1-antibody-lambrolizumab-produces-durable-responses-with-low-toxicity-in-patients-with-advanced-melanoma/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/ridaforolimus-delayed-tumor-progression-in-patients-with-previously-treated-metastatic-sarcoma/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/atra-and-arsenic-trioxide-may-be-even-better-than-atra-alone-in-treating-low-to-intermediate-risk-acute-promyelocytic-leukemia/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/support-group-offers-resources-for-patients-with-oralhead-and-neck-cancer/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/seeking-clarity-on-the-psa-story/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/august-15-2013/déjà-vu-redux-lessons-from-the-swog-8516-study-in-aggressive-lymphomas/ 2019-03-11T19:31:59+00:00 https://ascopost.com/issues/july-25-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/july-25-2013/some-successes-some-failures-reported-in-research-and-treatment-of-pancreatic-cancer/ 2019-03-11T19:32:33+00:00 https://ascopost.com/issues/july-25-2013/expert-point-of-view-hedy-lee-kindler-md/ 2019-03-11T19:32:33+00:00 https://ascopost.com/issues/july-25-2013/top-five-things-oncologists-need-to-know-about-cancer-in-older-adults/ 2019-03-11T19:32:33+00:00 https://ascopost.com/issues/july-25-2013/why-is-stem-cell-transplant-so-underused-in-follicular-lymphoma/ 2019-03-11T19:32:33+00:00 https://ascopost.com/issues/july-25-2013/enzalutamide-monotherapy-highly-active-in-patients-with-prostate-cancer-who-have-had-no-prior-hormone-therapy/ 2019-03-11T19:32:33+00:00 https://ascopost.com/issues/july-25-2013/expert-point-of-view-michael-a-carducci-md/ 2019-03-11T19:32:33+00:00 https://ascopost.com/issues/july-25-2013/shorter-duration-of-hormone-therapy-feasible-in-localized-high-risk-prostate-cancer/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/expert-point-of-view-anthony-v-damico-md-phd/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/dose-dense-chemotherapy-improves-outcomes-in-poor-prognosis-germ-cell-tumors/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/expert-point-of-view-carsten-bokemeyer-md/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/first-line-sunitinib-followed-by-everolimus-remains-standard-sequence-in-metastatic-renal-cell-carcinoma/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/expert-point-of-view-toni-k-choueiri-md/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/head-to-head-matchup-shows-adjuvant-taxane-schedules-equally-effective/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/expert-point-of-view-charles-vogel-md-larry-norton-md-and-andrew-d-seidman-md/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/new-drug-application-submitted-for-ibrutinib-in-the-treatment-of-two-b-cell-malignancies/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/roche-files-for-cervical-cancer-primary-screening-indication-for-cobas-hpv-test/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/new-research-on-combination-chemotherapy-prognostic-biomarkers-and-pet-guided-radiation-therapy-in-b-cell-malignancies/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/genomic-heterogeneity-can-lead-to-the-selection-of-incorrect-targeted-inhibitors/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/surveillance-sufficient-follow-up-for-most-patients-with-stage-i-seminoma/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/expert-point-of-view-clifford-a-hudis-md/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/examining-the-role-genetics-plays-in-breast-cancer-onset/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/asco-releases-updated-guideline-on-interventions-for-women-at-increased-risk-for-breast-cancer/ 2019-03-11T19:32:34+00:00 https://ascopost.com/issues/july-25-2013/lenalidomide-in-relapsedprogressed-mantle-cell-lymphoma-after-two-prior-therapies-including-bortezomib/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/asco-completes-electronic-data-sharing-standard-for-breast-cancer-treatment/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/cancernet-mobile-app-now-in-spanish/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/young-investigator-awards-and-career-development-awards-build-a-pipeline-of-cancer-researchers/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/asco-targets-health-disparities-need-for-research-in-achieving-health-equity/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/asco-urges-administration-to-provide-clear-affordable-care-act-guidance-on-protecting-patient-access-to-clinical-trials/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/sidebar-societies-call-for-protection-of-patient-access-to-clinical-trials/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/new-research-presented-in-breast-gastric-esophageal-cancers-melanoma-and-multiple-myeloma-plus-supportive-care/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/addition-of-brivanib-to-cetuximab-in-chemotherapy-refractory-metastatic-wild-type-kras-colorectal-cancer-key-results/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/looking-for-drivers-in-the-rearview-mirror/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/nearly-half-of-sarcoma-surgeries-performed-by-non-oncology-surgeons/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/critically-ill-hematology-patients-admitted-to-icu-have-good-survival-disease-control-and-quality-of-life/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/just-say-know/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/fda-grants-priority-review-to-obinutuzumab-in-cll-and-pertuzumab-in-neoadjuvant-therapy-for-her2-positive-early-stage-breast-cancer/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/fda-announces-decisions-on-new-tobacco-products/ 2019-03-11T19:32:35+00:00 https://ascopost.com/issues/july-25-2013/accc-institutes-network-to-provide-assistance-in-treating-uncommon-cancers/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/denosumab-in-adults-and-skeletally-mature-adolescents-with-giant-cell-tumor-of-bone/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/barriers-to-successful-hematopoietic-stem-cell-transplantation/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/new-guidelines-issued-in-the-treatment-of-multiple-myeloma-related-bone-disease/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/fda-approves-afatinib-for-late-stage-lung-cancer/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/management-of-anaplastic-oligodendroglial-tumors/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/university-of-michigan-cancer-center-names-new-medical-director/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/diagnosing-and-treating-acute-graft-vs-host-disease/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/oncology-meetings/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/rocky-mountain-cancer-centers-and-st-anthony-hospital-complete-affiliation-for-a-comprehensive-oncology-center/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/co-discoverer-of-dna-double-helix-james-watson-phd-offers-a-new-theory-on-cancer-progression/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/conversations-with-breast-cancer-patients/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/clinical-trials-for-patients-in-africa/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/medicalizing-physician-assisted-suicide/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/i-have-no-fear/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/pancreatic-cancer-action-network-names-7-year-survivor-chair-of-national-board-of-directors/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/more-than-98-of-childhood-cancer-survivors-have-chronic-health-conditions/ 2019-03-11T19:32:36+00:00 https://ascopost.com/issues/july-25-2013/encourage-questions-about-late-effects-of-treatment/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-25-2013/most-patients-receiving-radiotherapy-for-incurable-lung-cancer-do-not-realize-it-is-unlikely-to-cure-them/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-25-2013/use-of-advanced-technologies-has-increased-in-men-at-low-risk-of-dying-from-prostate-cancer/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-25-2013/pain-is-more-prevalent-and-severe-in-men-with-metastatic-disease-and-use-of-docetaxel/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-25-2013/two-studies-indicate-potential-predictors-of-survival-benefit-from-endocrine-therapy/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-25-2013/lenalidomide-induces-long-lasting-responses-in-elderly-patients/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-25-2013/some-excess-cancer-risk-in-men-may-be-related-to-greater-height/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-25-2013/keith-amos-md-surgical-oncologist-dies-at-42/ 2019-03-11T19:32:37+00:00 https://ascopost.com/issues/july-10-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/july-10-2013/studies-explore-role-of-bevacizumab-in-combination-therapies-for-glioblastoma/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-howard-a-fine-md-and-albert-lai-md-phd/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/bevacizumab-in-glioblastoma-another-perspective/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/supreme-court-rules-human-genes-may-not-be-patented/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/despite-a-recurrence-im-not-surrendering-my-life-to-cancer/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/sidebar-more-on-palliative-care-from-selma-schimmel/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/second-generation-alk-inhibitor-breakthrough-drug-promising-in-early-study-for-non-small-cell-lung-cancer/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-christine-m-lovly-md-phd/ 2019-03-11T19:33:19+00:00 https://ascopost.com/issues/july-10-2013/first-positive-trial-of-heat-shock-protein-90-inhibitor-in-lung-cancer-that-has-progressed-after-first-line-therapy/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-marjorie-g-zauderer-md-and-andrew-d-seidman-md/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/idelalisib-obinutuzumab-show-encouraging-results-in-cll-studies/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-kanti-r-rai-md/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/asco-will-change-with-the-times/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/search-for-biomarkers-of-mtor-inhibitor-benefit-in-breast-cancer-fails-to-pan-out/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-stephen-rd-johnston-ma-md-phd/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/asco-impact-report-indicates-strong-interest-in-new-treatments-for-melanoma-and-cervical-cancer/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/benefit-for-dual-her2-targeting-in-neoadjuvant-breast-cancer-regimen-restricted-to-subset-of-patients/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-priya-rastogi-md/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/two-new-genetic-tests-offer-progress-in-personalized-medicine-for-newly-diagnosed-prostate-cancer/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-oncotype-dx/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-prolaris/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/best-first-line-treatment-for-advanced-colorectal-cancer-remains-unclear/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-richard-goldberg-md/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/updated-asco-clinical-practice-guideline-for-venous-thromboembolism-prophylaxis-and-treatment/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/sidebar-venous-thromboembolism-expert-panel/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/venous-thromboembolism-in-patients-with-cancer-real-world-challenges-for-the-practicing-oncologist/ 2019-03-11T19:33:20+00:00 https://ascopost.com/issues/july-10-2013/study-reports-25-of-women-dont-complete-recommended-breast-cancer-treatment/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/genomic-and-epigenomic-characterization-of-acute-myeloid-leukemia/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/molecular-landscaping-of-acute-myeloid-leukemia-are-we-relearning-the-past-or-informing-the-future/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/radium-223-dichloride-for-castration-resistant-prostate-cancer-with-symptomatic-bone-metastases/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/2013-breast-cancer-symposium-to-offer-expanded-meet-the-professor-sessions-and-new-fellows-residents-and-junior-faculty-track/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/business-summit-fosters-innovative-solutions-to-oncology-market-challenges/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/institute-initiatives-help-oncologists-integrate-evidence-based-guidelines-in-practice/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/asco-issues-progress-report-on-blueprint-for-cancer-research/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/new-international-innovation-grant-directly-supports-research-projects-in-developing-countries/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/asco-answers-guides-to-breast-colorectal-prostate-and-lung-cancer-now-available-to-order/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/melanomas-induced-by-braf-inhibitors/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/measurement-of-circulating-tumor-dna-shows-promise-in-monitoring-metastatic-breast-cancer/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/expert-point-of-view-marc-lippman-md-and-c-kent-osborne-md/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/immunohistochemistry-effectively-detects-alk-rearrangement-in-non-small-cell-lung-cancer-study/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/outcomes-with-adjuvant-trastuzumab-in-her2-positive-breast-cancer-not-affected-by-pten-status/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/sidebar-notes-from-the-lead-investigator/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/investigational-new-drug-application-filed-for-cfi-400945/ 2019-03-11T19:33:21+00:00 https://ascopost.com/issues/july-10-2013/fda-approves-denosumab-to-treat-giant-cell-tumor-of-the-bone/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/erlotinib-in-first-line-treatment-of-metastatic-nsclc-with-egfr-exon-19-deletion-or-exon-21-l858r-substitution/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/study-shows-hpv-vaccine-reduced-rate-of-infection-in-teenage-girls-by-56/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/sidebar-hpv-vaccine-reduces-hpv-infection-rate-in-girls/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/integrated-genomic-characterization-of-endometrial-carcinomas-suggests-new-classification-scheme/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/learning-to-negotiate-the-genomic-complexities-of-cancer/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/seer-analysis-shows-increased-survival-with-surgery-and-radiation-therapy-in-metastatic-gastric-cancer/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/progression-of-renal-cell-carcinoma-linked-to-shifts-in-tumor-metabolism/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/results-of-axis-trial-indicate-a-significant-improvement-over-historical-survival-data-in-renal-cell-carcinoma/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/oncology-meetings/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/american-geriatrics-society-presents-diane-e-meier-the-edward-henderson-award/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/ama-announces-2013-2014-board-of-trustees-names-oncologist-barbara-mcaneny-md-chair-elect/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/molecular-imaging-improves-care-in-pediatric-glioma/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/gary-l-dillehay-md-is-new-president-society-of-nuclear-medicine-and-molecular-imaging/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/accountable-care-organizations-may-be-at-risk-for-new-medical-liabilities/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/newly-approved-drugs-and-indications/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/big-ten-universities-join-together-in-cancer-research-consortium/ 2019-03-11T19:33:22+00:00 https://ascopost.com/issues/july-10-2013/sidebar-big-ten-cancer-research-consortium/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/focus-on-the-society-of-rhode-island-clinical-oncologists/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/spectacular-results-with-immunotherapies-in-melanoma-galvanize-the-oncology-community/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/sidebar-expect-questions-about-programmed-death-receptors/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/treating-braf-v600e-colorectal-cancer-may-require-concomitant-braf-and-pi3kmtor-inhibition/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/effect-of-radium-223-dichloride-in-breast-cancer-bone-metastasis-model/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/driven-by-the-past/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/shiitake-mushroom/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/erratum/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/survival-benefits-of-dcis-management-strategies-compared/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/cognitive-complaints-after-breast-cancer-treatment-and-neuropsychological-testing/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/using-quality-indicators-can-improve-outcomes-among-patients-with-renal-cell-carcinoma/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/replacing-animal-fat-with-vegetable-fat-may-reduce-mortality-risk-in-men-with-nonmetastatic-disease/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/plasma-epstein-barr-virus-dna-a-potential-marker-for-treatment-response-in-advanced-hodgkin-lymphoma/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/july-10-2013/mskcc-community-mourns-the-death-of-trudy-nan-small-md/ 2019-03-11T19:33:23+00:00 https://ascopost.com/issues/june-25-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/june-25-2013/gm-csf-boosts-survival-benefit-of-ipilimumab-in-metastatic-melanoma/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/sidebar-gm-csf-plus-ipilimumab-ready-to-use-in-the-clinic/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/financial-revamping-of-medical-education/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/its-deja-vu-all-over-again/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/practice-changing-study-shows-survival-benefit-for-antiangiogenesis-in-advanced-cervical-cancer/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/expert-point-of-view-gottfried-konecny-md/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/simple-rapid-vinegar-test-cuts-cervical-cancer-death-rates-by-one-third-in-rural-india/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/expert-point-of-view-electra-d-paskett-phd/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/sorafenib-halts-disease-progression-in-metastatic-differentiated-thyroid-cancer/ 2019-03-11T19:33:54+00:00 https://ascopost.com/issues/june-25-2013/expert-point-of-view-ezra-cohen-md/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/asco-president-clifford-hudis-md-on-the-2013-asco-annual-meeting/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/mek-inhibitor-improves-outcomes-in-metastatic-uveal-melanoma/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/expert-point-of-view-lynn-mara-schuchter-md-and-michael-a-davies-md-phd/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/study-confirms-10-years-of-adjuvant-tamoxifen-is-superior-to-5-years/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/expert-point-of-view-ann-partridge-md/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/fda-approves-new-silicone-gel-filled-breast-implant/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/axillary-radiotherapy-new-standard-of-care-in-node-positive-breast-cancer/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/expert-point-of-view-andrew-seidman-md/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/brian-druker-md-and-charles-sawyers-md-receive-2013-taubman-prize-for-excellence-in-translational-medical-science/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/asco-joins-a-global-alliance-to-enable-responsible-sharing-of-genomic-and-clinical-data/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/pazopanib-maintenance-therapy-extends-progression-free-survival-in-patients-with-ovarian-cancer/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/expert-point-of-view-carol-aghajanian-md/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/radiation-sparing-dose-adjusted-epoch-rituximab-for-primary-mediastinal-b-cell-lymphoma/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/astro-to-award-societys-highest-honor-to-three-physicians-and-researchers/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/fda-approves-two-drugs-companion-diagnostic-test-for-advanced-skin-cancer/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/sgx942-gets-fast-track-status-for-treatment-of-oral-mucositis/ 2019-03-11T19:33:55+00:00 https://ascopost.com/issues/june-25-2013/kras-status-not-associated-with-survival-in-pooled-adjuvant-therapy-trials-in-early-stage-lung-cancer/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/study-shows-high-concordance-of-recurrent-somatic-alterations-in-primary-and-matched-metastatic-nsclc/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/mitigating-the-anxiety-over-tumor-heterogeneity/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/national-institutes-of-health-issues-projected-impact-of-sequestration-on-programs/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/reducing-unnecessary-and-high-dose-pediatric-ct-scans-could-cut-future-cancers-by-more-than-half/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/in-memoriam-asco-remembers-founding-member-jane-cooke-wright-md/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/journal-of-clinical-oncology-fosters-the-development-of-early-career-researchers-through-support-of-conquer-cancer-foundation-young-investigator-awards/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/asco-issues-guideline-update-and-videos-on-fertility-preservation/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/ascos-guideline-on-fertility-preservation/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/thirty-years-of-advancing-cancer-research-and-care/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/no-survival-benefit-of-ercc1-and-rrm1-expression-based-chemotherapy-in-patients-with-advanced-nsclc/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/college-of-american-pathologists-issues-statement-on-supreme-court-gene-patent-decision/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/similar-short-term-outcomes-with-laparoscopic-vs-open-surgery-for-rectal-cancer/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/identification-of-oncogenic-mutations-in-chronic-neutrophilic-leukemia-and-atypical-chronic-myeloid-leukemia/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/sidebar-new-insights-into-treatment-for-two-types-of-leukemia/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/celebrations-nationwide-recognize-cancer-survivorship-in-june/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/treating-both-the-physical-and-psychological-symptoms-of-cancer/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/improving-treatment-and-care-for-patients-with-primary-brain-cancers/ 2019-03-11T19:33:56+00:00 https://ascopost.com/issues/june-25-2013/dabrafenib-for-unresectable-or-metastatic-melanoma-with-braf-v600e-mutation/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/how-to-recognize-and-manage-hand-foot-syndrome-due-to-capecitabine-or-doxorubicin/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/vitamin-d-and-cancer-a-uniform-dose-is-unlikely-to-fit-all-patients/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/orphan-drug-status-granted-for-novel-targeted-therapy-to-treat-rare-hematologic-cancer/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/partnership-seeks-to-accelerate-development-of-innovative-therapies/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/oncology-meetings/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/trametinib-in-unresectable-or-metastatic-melanoma-with-braf-v600e-or-braf-v600k-mutation/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/focus-on-the-georgia-society-of-clinical-oncology/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/living-without-fear/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/fda-approves-lenalidomide-for-relapsedrefractory-mantle-cell-lymphoma/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/circulating-tumor-cells-with-alk-rearrangement-in-alk-positive-nsclc/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/elevated-serum-mir-1290-may-distinguish-early-pancreatic-cancer/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/serum-mir-21-as-diagnostic-and-prognostic-biomarker-in-colorectal-cancer/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/synergy-of-metformin-and-gefitinib-in-lkb1-wild-type-nsclc-cell-lines/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/epigenome-wide-study-of-dna-methylation-in-breast-cancer-using-prospectively-collected-samples/ 2019-03-11T19:33:57+00:00 https://ascopost.com/issues/june-25-2013/new-susceptibility-variants-for-childhood-all-in-ethnically-diverse-populations/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/angelina-jolies-disclosure-of-prophylactic-bilateral-mastectomy-a-positive-example-for-women-with-brca-mutations/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/sidebar-expect-questions-about-preventive-double-mastectomies/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/liver-first-approach-to-colorectal-cancer-with-synchronous-hepatic-metastases/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/chemotherapy-induced-peripheral-neuropathy-results-in-dose-limiting-and-less-chemotherapy-overall/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/no-added-benefit-from-radiotherapy-after-lumpectomytamoxifen-in-older-women/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/dcis-score-quantifies-risk-of-recurrence-after-excision/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/strength-of-patient-oncologist-alliance-linked-to-willingness-to-adhere-to-treatment-in-young-adults/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/matriarch-of-modern-cancer-genetics-janet-d-rowley-md-helped-propel-the-field-of-molecular-oncology/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-25-2013/fda-clears-multicenter-trial-of-treatment-for-hair-loss-related-to-chemotherapy/ 2019-03-11T19:33:58+00:00 https://ascopost.com/issues/june-10-2013-supplement/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/june-10-2013-supplement/anniversary-issue-narratives-in-oncology/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/emil-tom-frei-iii-md-1924-2013/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/the-road-to-asco-presidency-paved-by-education-and-persistence/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/prolific-surgical-oncologist-understands-the-true-value-of-mentorship/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/distinguished-researcher-changed-the-face-of-hematologic-malignancies/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/after-a-distinguished-career-trailblazing-swiss-oncologist-remains-devoted-to-addressing-the-global-cancer-challenge/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/pioneering-oncologists-research-on-cisplatin-revolutionized-testicular-cancer-treatment/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/uicc-president-balances-innovation-and-pragmatism-to-reduce-the-global-burden-of-cancer/ 2019-03-11T19:34:42+00:00 https://ascopost.com/issues/june-10-2013-supplement/expert-genitourinary-oncologists-drive-led-her-from-baghdad-to-the-united-states/ 2019-03-11T19:34:43+00:00 https://ascopost.com/issues/june-10-2013-supplement/the-power-of-listening-from-candy-striper-to-the-front-lines-of-the-early-aids-pandemic/ 2019-03-11T19:34:43+00:00 https://ascopost.com/issues/june-10-2013-supplement/innovative-leader-in-oncology-is-committed-to-tackling-the-most-critical-issues-in-managed-care/ 2019-03-11T19:34:43+00:00 https://ascopost.com/issues/june-10-2013-supplement/for-renowned-researcher-seeing-basic-science-turn-into-promising-therapies-is-the-holy-grail-of-oncology/ 2019-03-11T19:34:43+00:00 https://ascopost.com/issues/june-10-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/june-10-2013/sidebar-understanding-the-pd-1pd-l1-pathway-and-its-promise/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/caring-for-the-whole-patient-both-during-active-treatment-and-at-end-of-life/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/one-cancer-centers-approach-to-death-with-dignity/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/less-is-more-with-regard-to-adjuvant-radiation-in-stage-iii-non-small-cell-lung-cancer/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/impressive-results-shown-for-immune-checkpoint-inhibitors-anti-pd1-and-anti-pd-l1-antibodies/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/expert-point-of-view-roy-s-herbst-md-phd/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/potent-activity-shown-for-first-in-class-pi3k-delta-inhibitor-in-chronic-lymphocytic-leukemia/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/expert-point-of-view-clifford-a-hudis-md/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/expert-point-of-view-sandra-m-swain-md-facp/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/study-questions-routine-use-of-imaging-after-treatment-for-diffuse-large-b-cell-lymphoma/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/expert-point-of-view-andrew-d-zelenetz-md-phd/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/sidebar-physician-assisted-suicide/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/death-with-dignity-program-at-seattle-cancer-care-alliance/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/sidebar-notes-from-a-death-with-dignity-program/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/fda-approves-expanded-use-for-erlotinib-companion-diagnostic-to-detect-genetic-mutations-in-nsclc/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/radium-223-dichloride-approved-for-patients-with-castration-resistant-prostate-cancer/ 2019-03-11T19:35:16+00:00 https://ascopost.com/issues/june-10-2013/once-daily-moxifloxacin-for-low-risk-patients-with-febrile-neutropenia/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/expert-point-of-view-alison-freifeld-md/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/pulmonary-metastasectomy-in-patients-with-colorectal-cancer/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/double-the-mastectomy-double-the-complications/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/cancer-organizations-recognize-sen-shelby-and-rep-delauro-for-their-commitment-to-the-fight-against-cancer/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/postinduction-dexamethasone-and-individualized-dosing-of-asparaginase-improve-outcome-in-pediatric-all/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/intensified-liposomal-daunorubicin-may-offer-high-survival-rates-without-added-cardiotoxicity-for-children-with-leukemia/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/a-new-center-for-lymphoid-malignancies-aims-to-provide-precision-patient-care/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/higher-fruit-and-vegetable-consumption-associated-with-reduced-risk-of-er-negative-breast-cancer/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/determining-the-best-diet-for-patients-with-cancer/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/sidebar-online-resources-for-nutritional-guidance-during-and-after-cancer-treatment/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/john-p-leonard-md-leads-ncis-alliance-for-clinical-trials-in-oncology-lymphoma-committee/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/geriatric-factors-predict-severe-toxicity-in-elderly-patients-on-first-line-treatment-for-metastatic-colorectal-cancer/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/improving-the-care-and-study-of-older-patients-with-cancer/ 2020-02-17T18:09:39+00:00 https://ascopost.com/issues/june-10-2013/joseph-a-sparano-md-named-vice-chair-of-ecog-acrin-cancer-research-group/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/transforming-grand-rounds-into-chartrounds-technology-and-the-improving-cancer-care-grant-advance-patient-care/ 2019-03-11T19:35:17+00:00 https://ascopost.com/issues/june-10-2013/best-of-asco-meetings-provide-intimate-access-to-latest-research/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/asco-publishes-new-conflict-of-interest-policy/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/cancernet-features-patient-friendly-news-from-the-asco-annual-meeting/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/cancerprogressnet-patient-and-advocate-video-series-highlights-value-and-impact-of-cancer-research/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/simultaneous-egfr-mutations-and-her2-gene-amplifications-in-large-series-of-patients-with-non-small-cell-lung-cancer/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/meta-analysis-slightly-favors-platinum-based-first-line-treatment-in-patients-with-advanced-nsclc/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/expert-point-of-view-elisabeth-quoix-md/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/evaluation-of-lung-cancer-screening-strategy-in-the-first-three-rounds-of-the-nelson-trial/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/expert-point-of-view-giulia-veronesi-md/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/peregrine-pharmaceuticals-reaches-agreement-with-fda-on-phase-iii-trial-design-for-bavituximab-in-nsclc/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/no-difference-in-overall-survival-with-axitinib-or-sorafenib-in-second-line-treatment-for-advanced-renal-cell-carcinoma/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/low-dose-ct-detects-twice-as-many-early-stage-lung-cancers-as-chest-x-ray-according-to-additional-nlst-results/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/sidebar-low-dose-ct-screening/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/hiv-infection-does-not-adversely-affect-outcomes-of-liver-transplantation-for-hepatocellular-carcinoma/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/breaking-news-on-lymphoma-and-myeloma-to-be-reported-at-european-hematology-congress-in-stockholm/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/genetic-diversity-may-predict-outcomes-in-head-and-neck-cancer/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/utilizing-the-power-of-rapid-learning-health-care-systems-to-improve-patient-care/ 2019-03-11T19:35:18+00:00 https://ascopost.com/issues/june-10-2013/egfr-prevents-maturation-of-micrornas-under-hypoxic-conditions/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/smoking-linked-to-shorter-disease-free-survival-in-stage-iii-colon-cancer/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/phase-ii-trial-targeting-genetic-anomaly-in-castration-resistant-metastatic-prostate-cancer-underway/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/attention-to-patient-concerns-leads-to-customized-treatment-and-improved-care-explains-oncology-nurse-researcher/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/sidebar-mara-mogensen-flagherty-lecture/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/genetically-modified-t-cell-therapy-for-patients-with-cll-the-role-of-the-oncology-nurse/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/sidebar/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/tailored-intervention-protocol-for-oral-chemotherapy-adherence-studied/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/mayo-clinic-genomic-analysis-lends-insight-to-prostate-cancer/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/american-association-for-cancer-research-ceo-recognized-with-prestigious-award-from-fox-chase-cancer-center/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/ginger/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/making-prevention-and-early-detection-of-cancer-a-priority/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/american-cancer-society-marks-100th-year-anniversary/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/sidebar-how-to-help/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/gold-nanoparticles-can-help-fight-ovarian-cancer/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/university-of-new-mexico-health-sciences-and-cancer-centers-recruit-four-cancer-experts-to-top-positions/ 2019-03-11T19:35:19+00:00 https://ascopost.com/issues/june-10-2013/focus-on-the-delaware-society-for-clinical-oncology/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/innovative-state-program-reduces-colorectal-cancer-disparities-mortality-rates-among-african-american-patients/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/coping-with-tongue-cancer-a-lonely-journey/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/sidebar-support-and-resource-links/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/oncology-meetings/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/francis-cricks-discovery-of-the-structure-of-dna-transformed-20th-century-biologic-sciences/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/innovator-award-won-by-kenneth-tsai-md-phd-for-plan-to-map-molecular-path-to-skin-cancer/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/inflammatory-bowel-disease-raises-risk-of-melanoma/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/sidebar-ibd-and-melanoma/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/women-at-increased-risk-for-breast-cancer-should-be-offered-medications-to-reduce-risk-draft-recommendations-advise/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/expect-questions-from-your-patients/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/study-clarifies-appropriate-timing-of-follow-up-imaging-after-benign-breast-biopsies/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/sidebar-bi-rads-breast-imaging-reporting-and-data-systema/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/some-stage-iiiii-her2-positive-tumors-may-be-treated-with-targeted-therapy-without-chemotherapy/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/surgery-delays-longer-than-6-weeks-in-young-women-with-breast-cancer-decrease-survival/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/black-asian-and-younger-women-at-increased-risk-of-ptsd-after-diagnosis-of-localized-breast-cancer/ 2019-03-11T19:35:20+00:00 https://ascopost.com/issues/june-10-2013/smoking-early-in-life-is-more-strongly-associated-with-increased-risk-of-breast-cancer/ 2019-03-11T19:35:21+00:00 https://ascopost.com/issues/june-10-2013/older-patients-and-those-with-comorbidities-are-less-likely-to-receive-palliative-radiotherapy/ 2019-03-11T19:35:21+00:00 https://ascopost.com/issues/june-10-2013/patients-with-cancer-can-have-cachexia-related-poor-prognostic-factors-regardless-of-overall-weight/ 2019-03-11T19:35:21+00:00 https://ascopost.com/issues/june-10-2013/more-recollections-on-emil-tom-frei-iii-md/ 2019-03-11T19:35:21+00:00 https://ascopost.com/issues/may-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/may-15-2013/profound-and-rapid-molecular-remission-with-cd19-targeted-t-cells/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/proof-of-principle-for-adoptive-t-cell-therapy-in-cancer/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/sequestrations-impact-on-cancer-care/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/how-is-sequestration-affecting-health-care/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/on-the-potential-for-conflicts-of-interest/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/nccn-clinical-practice-guidelines-in-oncology-2013-updates/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/in-chicago-for-asco/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/refractory-liver-metastases-yield-to-yttrium-90-radioembolization/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/early-data-promising-for-concurrent-sorafenib-plus-embolization-in-metastatic-liver-cancer/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/interventional-radiologists-report-novel-approaches-for-metastatic-lesions/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/expert-point-of-view-charles-e-ray-jr-md-phd/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/asco-announces-new-conflict-of-interest-policy/ 2019-03-11T19:36:03+00:00 https://ascopost.com/issues/may-15-2013/ibrutinib-receives-third-breakthrough-therapy-designation-from-the-fda/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/breakthrough-therapy-designation-for-lambrolizumab-for-the-treatment-of-advanced-melanoma/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/novel-cancer-immunotherapy-set-to-enter-clinical-trials/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/fda-approves-antiemetic-drug-for-new-line-of-prefilled-generic-injectables/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/new-molecular-testing-guideline-for-selection-of-lung-cancer-patients-for/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/the-tissue-is-the-issue-choosing-therapy-for-lung-cancer/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/greater-prediagnosis-soy-food-consumption-associated-with-improved/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/congress-must-reverse-devastating-budget-cuts-to-cancer-care/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/tobacco-use-in-cancer-patients-often-overlooked-but-critical-to-address/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/expert-point-of-view-richard-hurt-md/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/novel-approaches-to-genetic-testing-and-overcoming-treatment/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/factors-increasing-risk-of-death-from-breast-cancer-identified/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/risk-for-ischemic-heart-disease-after-radiotherapy-for-breast-cancer/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/sidebar-critical-information-on-radiations-heart-effects/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/sidebar-left-sided-adjuvant-breast-radiotherapy-a-change-of-heart/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/reducing-incidental-cardiac-irradiation-during-breast-radiotherapy/ 2019-03-11T19:36:04+00:00 https://ascopost.com/issues/may-15-2013/university-of-michigan-launches-new-cardio-oncology-program/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/breast-cancer-survivors-not-likely-to-maintain-physical-activity-sufficient-for-benefits-of-exercise/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/breakthroughs-in-targeted-therapies-for-breast-cancer-are-improving-patient-survival-rates/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/women-in-oncology-trending-in-the-right-direction/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/autologous-stem-cell-transplant-improves-survival-in-transformed-follicular-lymphoma/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/role-of-stem-cell-transplantation-in-follicular-lymphoma/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/prevention-and-treatment-of-acneiform-rash-caused-by-egfr-inhibitors/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/promising-phase-ii-results-continue-to-support-ibrutinib-in-cll/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/expert-point-of-view-jan-a-burger-md-phd/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/daratumumab-receives-breakthrough-therapy-designation-in-multiple-myeloma/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/preliminary-progress-with-genetically-engineered-t-cells-in-treating-childhood-all/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/personal-testimonial-car-modified-t-cells-in-adults/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/expert-point-of-view-richard-bram-md-phd/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/nonmelanoma-skin-cancer-may-be-associated-with-modest-increased-risk/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/managing-female-reproductive-complications-after-cancer-treatment-in/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/majority-of-children-readmitted-to-hospital-following-stem-cell-transplant/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/disparities-in-cancer-care-how-a-deep-south-community-overcame-them/ 2019-03-11T19:36:05+00:00 https://ascopost.com/issues/may-15-2013/asco-president-s-personal-philanthropy-honors-founder-jane-c-wright-md/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/asco-presidents-priorities-aim-to-build-bridges-to-advance-cancer-care/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/asco-completes-prototype-for-cancerlinq-marking-first-demonstration-of-a/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/leading-investigators-honored-for-outstanding-contributions-to-the-field-of-oncology/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/new-asco-answers-guides-to-breast-prostate-and-lung-cancer-now-available-for-patients/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/visit-the-conquer-cancer-foundation-donor-lounge-at-the-asco-annual-meeting/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/new-labeling-for-reformulated-oxycontin-to-curb-abuse/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/cancer-treatment-pioneers-to-share-prize-in-medicine-and-biomedical-research/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/debt-and-the-oncology-fellow/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/ehealth-caregiver-use-of-online-system-reduces-symptom-distress-in-patients/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/lessons-of-2-decades-experience-with-chess/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/automated-telephone-monitoring-reduces-chemotherapy-related-symptoms/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/novel-regimen-produces-high-pathologic-complete-response-rates/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/nccn-patient-guidelines-for-adolescents-and-young-adults/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/sidebar-nccn-patient-guidelines-for-adolescents-and-young-adults/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/university-of-denver-and-exempla-healthcare-study-finds-patient-distress-screenings-practical-helpful/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/guideline-adherence-and-geriatric-assessment-studies-among-nccn-scientific-posters-of-interest/ 2019-03-11T19:36:06+00:00 https://ascopost.com/issues/may-15-2013/aua-releases-new-clinical-guideline-on-prostate-cancer-screening/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/12-gene-recurrence-score-predicts-recurrence-in-stage-ii-colon-cancer-in-calgb-9851-population/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/emerging-prognostic-markers-in-colon-cancer/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/sidebar-mismatch-repair-genes/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/combinatorial-immunologic-approach-yields-benefit-in-preliminary-study-of-recurrent-ovarian-cancer/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/expert-point-of-view-louis-m-weiner-md/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/women-with-lynch-syndrome-and-endometrial-cancer-are-at-increased-risk-of-other-cancers/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/lynch-syndrome-a-multitude-of-predispositions/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/oral-s-1-noninferior-to-gemcitabine-in-advanced-pancreatic-cancer-in-japan-and-taiwan/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/the-intriguing-potential-of-s-1-in-pancreatic-cancer/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/oncology-meetings/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/memorial-sloan-kettering-cancer-center-announces-new-appointments/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/focus-on-alaskas-denali-oncology-group/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/drug-approvals-in-acute-myeloid-leukemia-can-we-do-better/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/robert-s-miller-md-facp-appointed-editor-in-chief-of-ascos-patient-information-website-cancernet/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/dr-bernard-fishers-breast-cancer-research-left-a-lasting-legacy-of-improved-therapeutic-efficacy-and-survival/ 2019-03-11T19:36:07+00:00 https://ascopost.com/issues/may-15-2013/living-with-the-fear-of-cancer/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/george-salti-md-appointed-as-co-medical-director-of-edward-cancer-center-naperville-illinois/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/the-asco-post-up-close-our-reporters-and-contributors/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/seasons-a-series-of-haiku/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/fda-warns-about-potential-medication-errors/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/mammography-screening-and-dcis/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/control-of-autophagic-cell-death-by-caspase-10-in-multiple-myeloma/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/c-reactive-protein-downregulates-trail-a-cytokine-with-key-role-in-cancer-immune-surveillance/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/epithelial-to-mesenchymal-transition-and-autophagy-induction-in-breast-carcinoma/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/hdac-inhibition-circumvents-egfr-tyrosine-kinase-inhibitor-resistance-due-to-bim-polymorphism/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/common-deletion-in-apobec3-genes-associated-with-increased-risk-of-breast-cancer/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/society-of-interventional-radiology-2013-2014-officers-and-executive-council-members-assume-new-roles/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/symptom-management-with-complementary-therapies-for-patients-receiving-radiation-therapy/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/obese-men-with-benign-biopsy-at-high-risk-for-prostate-cancer/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/most-women-with-ovarian-cancer-do-not-get-guideline-specified-treatment-linked-to-survival-benefits/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/expect-questions-about-experience-and-outcomes/ 2019-03-11T19:36:08+00:00 https://ascopost.com/issues/may-15-2013/sidebar-going-public-with-ovarian-cancer-outcomes/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/exemestane-an-adjuvant-option-for-postmenopausal-hormone-receptor-positive-breast-cancer/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/higher-prediagnosis-body-mass-index-raises-mortality-risk-in-endometrial-cancer/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/high-dose-liposomal-vincristine-produces-durable-responses-in-advanced-all/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/cisplatin-and-radiotherapy-linked-to-increased-renal-cancer-risk-in-childhood-cancer-survivors/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/ruxolitinib-results-in-clinically-meaningful-symptom-improvement/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/high-levels-of-psychological-distress-are-common-among-parents-of-children-with-advanced-cancer/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/saul-n-weingart-md-phd-named-new-chief-medical-officer-of-tufts-medical-center/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-15-2013/emil-tom-frei-iii-md-trailblazer-in-the-development-of-combination-chemotherapy-dies-at-89/ 2019-03-11T19:36:09+00:00 https://ascopost.com/issues/may-1-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/may-1-2013/higher-her2-expression-linked-to-best-results-with-t-dm1-in-patients-with/ 2019-03-11T19:37:18+00:00 https://ascopost.com/issues/may-1-2013/sidebar-first-report-of-antibody-drug-conjugate-in-advanced-ovarian-cancer/ 2019-03-11T19:37:18+00:00 https://ascopost.com/issues/may-1-2013/expert-point-of-view-louis-m-weiner-md/ 2019-03-11T19:37:18+00:00 https://ascopost.com/issues/may-1-2013/does-every-melanoma-patient-with-a-positive-sentinel-node-need-more-lymph-nodes-removed/ 2019-03-11T19:37:18+00:00 https://ascopost.com/issues/may-1-2013/ibrutinib-cll-trial-where-is-the-equipoise/ 2019-03-11T19:37:18+00:00 https://ascopost.com/issues/may-1-2013/sidebar-the-ethical-imperative-of-clinical-equipoise/ 2019-03-11T19:37:18+00:00 https://ascopost.com/issues/may-1-2013/cancerlinq-prototype-demonstrates-use-of-big-data-in-clinical-care/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/medical-oncologists-underestimate-resectability-of-liver-metastases/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/sentinel-node-biopsy-in-melanoma-essential-or-optional/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/benefit-of-continued-antiangiogenic-treatment-with-bevacizumab-after-progression/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/sidebar-prolonged-vegf-inhibition/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/more-recreational-physical-activity-associated-with-reduced-all-cause-mortality/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/sidebar-take-home-message/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/access-to-care-who-gets-referred-to-a-medical-oncologist-andor-another-cancer/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/a-promising-new-agents-road-to-approval-in-cll-raises-questions-stirs-controversy/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/sidebar-three-breakthrough-therapy-designations-for-ibrutinib-from-the-fda/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/aacr-elects-carlos-l-arteaga-md-as-president-elect-2013-2014/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/new-ascoaahpm-project-will-harness-technology-to-foster-improved-palliative-care-in-oncology/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/ascos-pre-annual-meeting-seminar-series-to-offer-a-new-fourth-focus-genetics-and-genomics/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/from-one-to-many-here-and-around-the-world/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/help-your-patients-understand-the-latest-research-to-be-highlighted/ 2019-03-11T19:37:19+00:00 https://ascopost.com/issues/may-1-2013/spotlight-on-patient-advocacy-pavilion-at-the-asco-annual-meeting/ 2019-03-11T19:37:20+00:00 https://ascopost.com/issues/may-1-2013/sidebar-asco-sponsored-patient-advocacy-booth/ 2019-03-11T19:37:20+00:00 https://ascopost.com/issues/may-1-2013/rally-for-medical-research-draws-thousands-in-person-and-on-social-media/ 2019-03-11T19:37:20+00:00 https://ascopost.com/issues/may-1-2013/alopecia-a-common-but-underreported-side-effect-of-endocrine-agents/ 2019-03-11T19:37:20+00:00 https://ascopost.com/issues/may-1-2013/elekta-receives-fda-510-k-clearance-following-launch-of-new-versa-hd/ 2019-03-11T19:37:20+00:00 https://ascopost.com/issues/may-1-2013/oncology-meetings/ 2019-03-11T19:37:20+00:00 https://ascopost.com/issues/may-1-2013/fda-approves-assay-that-may-help-detect-the-progression-of-testicular-cancer/ 2019-03-11T19:37:20+00:00 https://ascopost.com/issues/may-1-2013/increase-in-advanced-breast-cancer-among-younger-women-is-small-but-significant/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/expect-questions-from-younger-women-about-breast-cancer/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/american-association-for-cancer-research-honors-award-recipients-at-annual-meeting/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/acts-of-kindness-were-key-to-my-survival/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/fred-hutchinson-cancer-research-center-survivorship-program-to-lead-new-study/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/neurosurgeon-eric-holland-md-phd-joins-fred-hutchinson-and-university-of-washington-medicine/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/progression-free-survival-in-her2-positive-metastatic-breast-cancer-improved-with-t-dm1/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/bortezomib-added-to-standard-induction-therapy-produced-encouraging-aml-remission-rate/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/successful-salvage-treatment-possible-in-some-patients-who-do-not-have-a-transplant/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/may-1-2013/duloxetine-reduced-painful-chemotherapy-induced-peripheral-neuropathy/ 2019-03-11T19:37:21+00:00 https://ascopost.com/issues/april-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/april-15-2013/is-aspirin-protective-against-colorectal-cancer/ 2019-03-11T19:37:47+00:00 https://ascopost.com/issues/april-15-2013/sexual-health-after-cancer-communicating-with-your-patients/ 2019-03-11T19:37:47+00:00 https://ascopost.com/issues/april-15-2013/resources-for-combating-sexual-dysfunction-after-cancer/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/homoharringtonineomacetaxine-the-little-drug-that-could/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/errata/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/new-findings-in-prostate-and-kidney-cancers-clarify-the-roles-of-abiraterone-finasteride/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/clinical-pathologic-stage-discrepancy-high-in-patients-with-bladder-cancer-undergoing-surgery/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/expert-point-of-view-dean-f-bajorin-md/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/important-data-and-treatment-advances-reported-in-gist-and-in-pancreatic-and-liver-cancers/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/society-of-surgical-oncology-fellow-receives-colorectal-cancer-research-scholar-award/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/braf-mutations-in-colorectal-cancer-the-next-frontier/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/three-molecular-subtypes-of-colorectal-cancer-identified/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/expert-point-of-view-axel-grothey-md-and-paula-r-pohlmann-md-phd/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/fda-approves-new-radioactive-diagnostic-imaging-agent-to-help-locate-lymph-nodes-in-patients-with-certain-cancers/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/philips-receives-fda-510-k-clearance-for-microdose-si-mammography-system/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/similar-15-year-functional-outcomes-after-prostatectomy-or-radiotherapy-for-localized-prostate-cancer/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/sidebar-two-caveats-on-the-pcos-follow-up/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/ado-trastuzumab-emtansine-in-metastatic-breast-cancer/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/does-all-dcis-need-treatment-debaters-take-sides-at-surgical-oncology-meeting/ 2019-03-11T19:37:48+00:00 https://ascopost.com/issues/april-15-2013/genomic-analysis-of-squamous-cell-lung-cancer-tumors-may-lead-to-more-targeted-therapies/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/study-shows-lung-cancer-ct-screening-could-save-12-000-lives-annually/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/the-risk-of-death-from-smoking-now-nearly-identical-for-men-and-women/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/new-data-reported-on-melanoma-cutaneous-t-cell-lymphoma-basal-cell-carcinoma-and-cancer-treatment-side-effects/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/new-nccn-guidelines-for-patients-available-for-adolescents-and-young-adults-with-cancer/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/sidebar-samuel-m-silver-md-phd-elected-chairman-of-nccn-board-of-directors/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/nccn-adds-two-new-member-institutions/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/siggar-trials-compare-ct-colonography-vs-barium-enema-and-colonoscopy-in-evaluation-for-colon-cancer/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/ct-colonography-reconsidered/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/similar-outcomes-for-18-vs-36-months-of-androgen-blockade-in-high-risk-prostate-cancer-treated-with-radiation/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/expert-point-of-view-anthony-v-damico-md-phd/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/american-association-for-cancer-research-inaugurates-the-first-class-of-fellows-of-the-aacr-academy/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/gene-transfer-therapy-is-producing-prolonged-remissions-in-patients-with-advanced-leukemia/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/asco-sep-3rd-edition-features-digital-formats-and-complementary-study-tools/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/asco-leadership-development-program-participants-give-back-by-supporting-the-conquer-cancer-foundation/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/ascos-state-oncology-societies-booth-provides-a-place-for-relationship-building-and-sharing-best-practices/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/conquer-cancer-foundation-arms-patients-with-knowledge-through-patientaccess/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/asco-develops-new-physician-payment-reform-webpage-and-four-part-educational-series/ 2019-03-11T19:37:49+00:00 https://ascopost.com/issues/april-15-2013/managing-side-effects-urinary-incontinence/ 2019-03-11T19:37:50+00:00 https://ascopost.com/issues/april-15-2013/c-everett-koop-md-surgeon-general-under-ronald-reagan-dies-at-96/ 2019-03-11T19:37:50+00:00 https://ascopost.com/issues/april-15-2013/new-partnership-will-harness-technology-to-foster-improved-palliative-care-in-oncology/ 2019-03-11T19:37:50+00:00 https://ascopost.com/issues/april-15-2013/indiana-university-researchers-earn-32-million-grant-to-develop-improve-therapies-for-pancreatic-cancer/ 2019-03-11T19:37:50+00:00 https://ascopost.com/issues/april-15-2013/dual-awards-pay-tribute-to-gender-equity-trailblazers/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/the-future-of-clinical-guidelines-in-oncology/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/it-takes-a-village-to-survive-ovarian-cancer/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/sidebar-patient-advocate-scholarship-program/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/implementing-a-national-cancer-clinical-trials-system-for-the-21st-century/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/highlights-of-accc-annual-meeting-include-discussion-of-trends-shaping-the-future-of-health-care/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/sidebar-achievement-award/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/aacr-briefs-congressional-staffers-on-importance-of-continued-funding-for-research/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/nci-guide-helps-providers-get-adolescent-and-young-adult-patients-involved-in-end-of-life-care/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/sidebar-apos-best-program-award/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/city-of-hope-investigators-find-young-breast-cancer-survivors-understudied-and-underserved/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/tobacco-cessation-treatment-needed-in-routine-cancer-care/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/pilot-study-seeks-to-offer-social-support-to-patients-with-mesothelioma/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/qigong-practice-associated-with-quality-of-life-benefits-in-women-undergoing-radiation-therapy-for-breast-cancer/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/expert-point-of-view-lorenzo-cohen-phd/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/addition-of-liposomal-daunorubicin-improves-early-outcome-in-patients-with-pediatric-relapsed-aml/ 2019-03-11T19:37:51+00:00 https://ascopost.com/issues/april-15-2013/sidebar-further-reflections-on-a-successful-trial/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/new-accc-officers-and-trustees/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/effects-of-menarche-and-menopause-on-breast-cancer-risk-meta-analysis-findings/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/jonathan-friedberg-md-named-director-of-the-james-p-wilmot-cancer-center/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/cdc-reports-racial-disparity-in-breast-cancer-mortality/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/p53-inactivation-in-the-tumor-microenvironment-promotes-tumor/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/effects-of-sirna-combining-tgf-β1-silencing-and-rig-i-activation-in-pancreas-cancer/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/mixed-lineage-kinase-4-interacts-with-activated-ras-signaling-in-colorectal-cancer/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/three-marker-assay-for-early-detection-of-renal-cancer/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/oncology-meetings/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/intraperitoneal-chemotherapy-gives-ovarian-cancer-patients-better-chance-of-survival/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/majority-of-ovarian-cancer-patients-do-not-receive-recommended-treatment-study-shows/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/new-vice-president-of-indiana-cancer-services/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/radiation-still-misunderstood-after-all-these-years/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/recently-reported-long-term-outcomes-could-motivate-more-men-with-prostate-cancer-to-consider-active-surveillance/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/immunoassay-test-may-help-identify-early-kidney-cancer/ 2019-03-11T19:37:52+00:00 https://ascopost.com/issues/april-15-2013/ramon-parsons-md-phd-named-chair-of-oncological-sciences-at-the-icahn-school-of-medicine-at-mount-sinai/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/focus-on-the-louisiana-oncology-society/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/alex-s-lemonade-stand-foundation-introduces-centers-of-excellence-program-to-further-childhood-cancer-research/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/another-perspective-on-accountable-care-organizations/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/conflicts-of-interest/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/disclosure-appropriate-or-not/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/barrie-r-cassileth-ms-phd-champion-of-integrative-oncology-continues-to-nurture-growth-of-the-field/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/sidebar-the-about-herbs-website/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/sidebar-sio-s-10th-international-conference/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/flaxseed/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/number-of-cancer-survivors-expected-to-increase-to-18-million-by-2022/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/two-studies-focus-on-treatment-strategies-for-preserving-the-larynx-while-increasing-survival/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/modified-and-updated-risk-prediction-model-is-more-efficient-in-identifying-persons-for-lung-cancer-screening/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/april-15-2013/thalidomideprednisone-maintenance-after-stem-cell-transplant-improves-progression-free-but-not-overall-survival/ 2019-03-11T19:37:53+00:00 https://ascopost.com/issues/march-15-2013/ 2021-06-08T17:57:24+00:00 https://ascopost.com/issues/march-15-2013/bevacizumab-plus-capecitabine-has-robust-effect-in-elderly-patients-with-colorectal-cancer/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-robert-a-wolff-md-and-jordan-berlin-md/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/building-cancerlinq-the-road-to-faster-more-efficient-treatment-delivery/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/cancer-has-made-me-a-better-doctor/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/t-dm1-for-her2-positive-metastatic-breast-cancer-receives-fda-approval/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/reduced-risk-of-psa-failure-with-adjuvant-radiotherapy-vs-wait-and-see-approach-in-stage-t3-prostate-cancer/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-anthony-d-amico-md/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/novel-antiandrogen-shows-encouraging-phase-ii-results-in-high-risk-nonmetastatic-castrate-resistant-prostate-cancer/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-william-oh-md/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/did-corticosteroids-worsen-survival-in-patients-with-metastatic-prostate-cancer-enrolled-in-the-affirm-trial/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-william-k-oh-md/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/targeted-therapy-gaining-ground-in-the-second-line-treatment-of-gastric-cancer/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-neal-j-meropol-md-and-johanna-c-bendell-md/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/second-line-docetaxel-improves-esophageal-and-gastric-cancer-survival/ 2019-03-11T19:38:27+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-johanna-c-bendell-md/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/colorectal-cancer-a-decade-of-progress/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/ibrutinib-receives-two-oncology-breakthrough-therapy-designations-from-fda/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/apogenix-receives-fda-orphan-drug-designation-for-apg101/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/obesity-physical-inactivity-linked-with-risk-for-subtype-of-colorectal-cancer/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/pomalidomide-in-previously-treated-multiple-myeloma/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/bendamustinerituximab-noninferior-to-standard-chemotherapy-for-advanced-indolent-nhl-and-mcl/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-martin-dreyling-md/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/quizartinib-data-encouraging-in-phase-ii-investigations-of-flt3-mutation-positive-acute-myeloid-leukemia/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/cytarabine-in-conditioning-regimen-for-younger-patients-with-mcl/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/patients-receiving-palliative-radiation-therapy-for-metastatic-non-small-cell-lung-cancer-may-be-overtreated/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/sidebar-value-based-effective-care/ 2019-03-11T19:38:28+00:00 https://ascopost.com/issues/march-15-2013/no-benefit-of-adding-carboplatin-to-pemetrexed-in-second-line-treatment-of-patients-with-advanced-nsclc/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-nasser-h-hanna-md/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/asco-international-expands-to-improve-cancer-care-worldwide/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/asco-congratulates-qopi-certified-practices/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/journal-of-oncology-practice-accepted-by-medline-for-indexing/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/safe-storage-of-cancer-medications/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/connecting-to-conquer-cancer/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/greater-representation-of-older-patients-in-phase-iii-trials-needed/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/finding-new-strategies-to-more-effectively-treat-pancreatic-cancer/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/the-pancreatic-cancer-action-network-welcomes-new-members-to-its-medical-advisory-board/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/evaluating-her2-status-in-esophageal-cancers-fish-vs-immunohistochemistry/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-j-randolph-hecht-md/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/oncogenic-pathway-signatures-may-guide-treatment-after-colorectal-cancer-resection/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-william-m-grady-md-and-jordan-berlin-md/ 2019-03-11T19:38:29+00:00 https://ascopost.com/issues/march-15-2013/subsets-of-young-patients-have-higher-pathologic-complete-response-rates/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-laura-j-van-t-veer-phd-and-andrew-seidman-md/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/21-gene-recurrence-score-does-not-predict-paclitaxel-benefit/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-clifford-a-hudis-md-and-daniel-f-hayes-md/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/role-of-sentinel-node-surgery-explored-in-node-positive-breast-cancer/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-seema-a-khan-md/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/black-women-less-likely-to-get-sentinel-lymph-node-biopsy-and-more-likely-to-have-lymphedema/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-elizabeth-mittendorf-md/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/foxp3-expression-linked-to-better-survival-with-adjuvant-anthracycline-not-followed-by-taxane-in-breast-cancer/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/inaugural-winners-of-3-million-breakthrough-prize-in-life-sciences-announced/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/fda-approves-regorafenib-for-advanced-gastrointestinal-stromal-tumors/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/preparing-for-the-next-superstorm-protecting-patients-during-natural-disasters/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/sidebar-damages-to-medical-center-estimated-at-1-billion/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/high-infection-rates-found-in-multiple-myeloma-patients-with-high-mortality/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/enhanced-electronic-module-aims-to-prevent-errors-in-oral-chemotherapy-prescribing/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/medication-safety-at-home/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/analysis-shows-no-10-year-survival-advantage-in-patients-with-ovarian-cancer-and-brca1-or-brca2-mutations/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/research-leader-helen-piwnica-worms-phd-appointed-vice-provost-science-at-ut-md-anderson-cancer-center/ 2019-03-11T19:38:30+00:00 https://ascopost.com/issues/march-15-2013/city-of-hope-names-robert-stone-jd-as-new-chief-executive-officer/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/jane-cooke-wright-md-asco-cofounder-dies-at-93/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/survey-shows-publics-knowledge-of-cancer-progress-is-rising-but-myths-persist/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/ibms-watson-goes-through-basic-training-in-oncology/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/study-shows-new-approach-connecting-smokers-to-quit-lines-increases-smoking-cessation-treatment-enrollment/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/oncology-meetings/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/focus-on-the-medical-oncology-association-of-southern-california/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/study-shows-little-association-of-multidisciplinary-tumor-boards-with-measures-of-care/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/expert-point-of-view-nancy-l-keating-md-mph/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/zora-brown-prominent-cancer-research-advocate-dies-at-63/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/my-life-will-never-be-normal/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/sidebar-patient-information-available-at-cancernet/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/fitness-can-exercise-lengthen-survival-in-patients-with-cancer/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/patients-with-cancer-need-to-know-that-it-is-never-too-late-to-quit-smoking/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/sidebar-ask-patients-about-their-smoking-status/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/trametinib-shows-activity-in-previously-treated-but-braf-inhibitor-naive-braf-mutant-melanoma/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/short-term-survival-advantage-of-carrying-brca-mutation-does-not-extend-to-long-term/ 2019-03-11T19:38:31+00:00 https://ascopost.com/issues/march-15-2013/older-patients-do-better-with-hematopoietic-transplants-from-siblings-of-similar-age/ 2019-03-11T19:38:32+00:00 https://ascopost.com/issues/march-15-2013/short-wait-for-lab-results-is-reasonable-strategy-to-better-characterize-aml-and-design-therapy/ 2019-03-11T19:38:32+00:00 https://ascopost.com/issues/march-15-2013/petct-with-124i-girentuximab-can-identify-clear-cell-renal-cell-carcinoma-while-minimizing-invasive-diagnostic-risks/ 2019-03-11T19:38:32+00:00 https://ascopost.com/issues/march-15-2013/large-epidemiologic-studies-re-examine-hazards-of-smoking/ 2019-03-11T19:38:32+00:00 https://ascopost.com/issues/march-15-2013/sequestration-will-have-shattering-impact-on-entire-us-cancer-enterprise/ 2019-03-11T19:38:32+00:00 https://ascopost.com/issues/march-1-2013/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/march-1-2013/folfoxiribevacizumab-is-superior-to-folfiribevacizumab-in-mcrc/ 2019-03-11T19:39:21+00:00 https://ascopost.com/issues/march-1-2013/expert-point-of-view-jordan-d-berlin-md/ 2019-03-11T19:39:21+00:00 https://ascopost.com/issues/march-1-2013/study-finds-young-cancer-survivors-often-skip-checkups/ 2019-03-11T19:39:21+00:00 https://ascopost.com/issues/march-1-2013/on-radiation-and-cancer-risk/ 2019-03-11T19:39:21+00:00 https://ascopost.com/issues/march-1-2013/fda-approves-pomalidomide-for-advanced-multiple-myeloma/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/outcomes-comparable-for-panitumumab-and-bevacizumab-in-metastatic-colorectal-cancer/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/expert-point-of-view-axel-grothey-md-and-eric-van-cutsem-md-phd/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/the-challenges-and-rewards-of-neuro-oncology/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/final-joint-analysis-confirms-life-saving-benefit-of-trastuzumab-in-patients-with-her2-positive-early-breast-cancer/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/dose-dense-chemotherapy-in-breast-cancer-epirubicin-based-regimens-studied-in-german-and-uk-trials/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/expert-point-of-view-sandra-swain-md-facp/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/pathologic-complete-response-yields-long-term-benefits-in-meta-analysis/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/expert-point-of-view-laura-vant-veer-phd/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/a-new-donor-shines-with-conquer-cancer-foundation/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/oncology-career-fair-at-asco-annual-meeting/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/new-asco-workforce-studies-release-preliminary-data-on-oncology-workforce-environment/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/now-in-spanish-stopping-tobacco-use-after-a-cancer-diagnosis/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/make-a-lasting-difference-choose-the-giving-option-that-works-for-you/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/no-rationale-for-eliminating-prophylactic-platelet-transfusions-in-patients-with-hematologic-malignancies/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/expert-point-of-view-david-j-kuter-md-phd/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/global-women-s-cancer-summit-collaboration-aims-to-reduce-breast-cervical-cancers/ 2019-03-11T19:39:22+00:00 https://ascopost.com/issues/march-1-2013/more-brief-reports-from-ash-including-new-data-in-leukemia-lymphoma-and-myelodysplastic-syndrome/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/use-of-beta-blockers-associated-with-improved-survival-in-patients-with-nsclc-receiving-definitive-radiation-therapy/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/sidebar-beta-adrenergic-signaling-pathway/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/bevacizumab-plus-chemotherapy-after-progression-of-metastatic-colorectal-cancer/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/genetics-mathematics-and-colorectal-cancer/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/solving-a-30-year-mystery/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/vemurafenib-resistant-braf-mutant-melanoma/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/genetic-and-epigenetic-alterations-in-colorectal-cancer-and-metastases/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/oncology-meetings/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/march-1-2013/imatinib-receives-new-indication-for-children-with-acute-lymphoblastic-leukemia/ 2019-03-11T19:39:23+00:00 https://ascopost.com/issues/february-15-2013/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/february-15-2013/nab-paclitaxelgemcitabine-combination-improves-overall-survival-in-pancreatic-cancer/ 2019-03-11T19:40:03+00:00 https://ascopost.com/issues/february-15-2013/expert-point-of-view-philip-agop-philip-md-and-alan-p-venook-md/ 2019-03-11T19:40:03+00:00 https://ascopost.com/issues/february-15-2013/integration-across-the-spectrum-community-perspective-on-the-medical-oncology-home-model/ 2019-03-11T19:40:03+00:00 https://ascopost.com/issues/february-15-2013/we-need-gemtuzumab-available-again-to-treat-aml/ 2019-03-11T19:40:03+00:00 https://ascopost.com/issues/february-15-2013/erratum/ 2019-03-11T19:40:03+00:00 https://ascopost.com/issues/february-15-2013/chemotherapy-free-regimen-successful-in-acute-promyelocytic-leukemia/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/expert-point-of-view-farhad-ravandi-md/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/th-302-plus-gemcitabine-delays-progression-in-untreated-advanced-pancreatic-adenocarcinoma/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/expert-point-of-view-michel-ducreux-md-phd/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/daunorubicin-free-induction-therapy-for-standard-risk-childhood-acute-lymphoblastic-leukemia/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/expert-point-of-view-william-g-woods-md/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/selumetinibdocetaxel-shows-promising-activity-in-previously-treated-kras-mutant-non-small-cell-lung-cancer/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/expert-point-of-view-sarah-b-goldberg-md-mph/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/chemotherapy-for-breast-cancer-carries-a-small-but-concerning-risk-for-leukemia/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/expert-point-of-view-sandra-m-swain-md-facp-and-eric-p-winer-md/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/novel-oral-agent-plus-letrozole-improves-progression-free-survival-in-er-positive-advanced-breast-cancer/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/for-lobular-carcinoma-letrozole-works-better-than-tamoxifen/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/expert-point-of-view-c-kent-osborne-md/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/bevacizumab-approved-as-combination-therapy-for-metastatic-colorectal-cancer/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/ash-highlights-included-new-data-in-myeloma-lymphoma-and-leukemia-plus-studies-of-mucositis-and-graft-vs-host-disease/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/ash-international-clinical-collaboration-replicates-high-cure-rate-of-apl-in-developing-countries/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/abiraterone-benefits-patients-with-metastatic-prostate-cancer-who-have-had-no-previous-chemotherapy/ 2019-03-11T19:40:04+00:00 https://ascopost.com/issues/february-15-2013/abiraterone-in-patients-with-metastatic-castration-resistant-prostate-cancer-and-no-prior-chemotherapy/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/research-roundup-from-san-antonio-new-data-on-triple-negative-her2-positive-local-and-advanced-breast-cancer/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/international-members-cite-networking-enhanced-patient-care-among-benefits-of-asco-membership/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/help-your-patients-find-the-latest-research-on-gu-cancers/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/young-investigator-awards-humble-beginnings-mark-the-start-of-something-big/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/as-computers-learn-to-talk-to-each-other-patient-care-will-improve/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/gene-in-eye-melanomas-linked-to-good-prognosis/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/the-doctor-who-championed-patient-navigation-in-harlem/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/sidebar-a-history-of-success/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/a-look-at-the-patient-navigator-program-in-breast-cancer/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/treatment-of-her2-positive-disease-in-2013/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/subcutaneous-trastuzumab-a-potential-alternative-to-intravenous-administration-in-breast-cancer/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/ponatinib-in-chronic-myeloid-leukemia-and-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia/ 2019-03-11T19:40:05+00:00 https://ascopost.com/issues/february-15-2013/hematologyoncology-team-joins-newyork-presbyterian-hospitalcolumbia-university-medical-center/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/turmeric/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/david-a-karnofskys-early-contributions-to-cancer-research-helped-establish-oncology-as-a-medical-discipline/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/genetic-basis-of-high-risk-childhood-cancer-points-to-possible-new-drug-treatment-strategy/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/important-messages-about-palliative-care-and-hospice-at-the-heart-of-new-end-of-life-memoir/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/researchers-develop-automated-breast-density-test-linked-to-cancer-risk/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/betting-against-the-odds/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/university-of-michigan-cancer-center-names-kathleen-cooney-md-to-head-clinical-operations/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/oncology-meetings/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/keeping-diabetes-under-control-is-critical-to-good-outcomes-for-patients-who-also-have-cancer/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/sidebar-expect-questions-from-patients-with-diabetes-and-cancer/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/sidebar-shout-out-to-policymakers-on-diabetes-education/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/even-at-nccn-institutions-a-sizable-minority-of-patients-with-rectal-cancer-are-not-treated-per-nccn-guidelines/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/surgery-of-primary-tumor-site-has-no-impact-on-local-control-and-outcome-in-patients/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/failure-to-screen-patients-for-hepatitis-b-virus-could-result-in-fatal-complications/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-15-2013/tremelimumab-not-better-than-standard-of-care-chemotherapy-in-patients-with-advanced-melanoma/ 2019-03-11T19:40:06+00:00 https://ascopost.com/issues/february-1-2013/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/february-1-2013/survival-benefit-achieved-with-four-drugs-plus-maintenance-in-myeloma/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-sagar-lonial-md/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/patient-expectations-of-benefit-in-early-phase-trials-ethics-issues-in-informed-consent/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-kevin-p-weinfurt-phd/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-neal-j-meropol-md/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/cost-of-cancer-drugs-what-price-for-what-benefit/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/acs-releases-lung-cancer-screening-guidelines/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/key-pathways-identified-in-triple-negative-breast-cancer/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-sandra-m-swain-md-facp/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/somatic-her2-mutations-that-drive-cancer-found-in-her2-negative-breast-cancer/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/ibrutinib-in-mantle-cell-lymphoma-yields-unprecedented-response-rates/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/sidebar-ibrutinib-in-other-hematologic-tumors/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-martin-dreyling-md/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/inotuzumab-moves-forward-in-relapsedrefractory-all/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-amir-t-fathi-md/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/primary-endpoint-not-met-for-eribulin-vs-capecitabine-in-breast-cancer/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-lisa-carey-md/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/sidebar-treating-earlier-with-eribulin/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/dune-medical-devices-receives-fda-approval-for-the-marginprobe-system/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/ezatiostat-gets-orphan-designation-for-treatment-of-myelodysplastic-syndrome/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/pet-negative-scan-after-short-course-chemotherapy-identifies-early-hodgkin-lymphoma-patients-who-can-forgo-radiation/ 2019-03-11T19:40:53+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-martin-dreyling-md-1/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/pediatric-cancer-foundation-names-four-recipients-of-2012-award-each-to-receive-grant-for-research/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/samuel-m-silver-elected-as-a-master-of-acp/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/postoperative-radiation-therapy-extends-progression-free-survival-in-men-with-high-risk-prostate-cancer/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/coalition-of-cancer-cooperative-groups-celebrates-10-years-of-clinical-trial-participation-awards/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/new-england-journal-of-medicine-article-reports-inferior-outcome-in-using-alternative-treatments-to-counter-mechlorethamine-shortage/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/asco-decision-aids-intersect-evidence-based-guidelines-productive-patient-communication/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/health-insurance-issues-for-young-cancer-survivors/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/ascos-cancerprogressnet-where-weve-come-from-where-we-are-and-where-were-going/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/the-conquer-cancer-foundation-announces-its-sustaining-donor-program/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/cabozantinib-in-metastatic-medullary-thyroid-cancer/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/sidebar-report-adverse-events/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/patients-receiving-higher-intensity-chemotherapy/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/cisplatin-linked-to-significantly-increased-risk-of-venous-thromboembolism/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/most-patients-do-not-report-that-cure-is-highly-unlikely-with-chemotherapy-for-advanced-cancer/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/expert-point-of-view-eduardo-bruera-md-faahpm/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/helping-patients-prepare-for-cancer-treatment-decisions/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/oncology-meetings/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/oncology-trailblazer-james-f-holland-md-recalls-a-time-of-unbridled-scientific-excitement/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/internationally-renowned-gynecologic-cancer-researcher-joins-ohio-state/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/social-media-is-helping-my-brother-fight-kidney-cancer/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/leon-and-norma-hess-center-for-science-and-medicine-opens-at-mount-sinai/ 2019-03-11T19:40:54+00:00 https://ascopost.com/issues/february-1-2013/practice-changing-atlas-study-supports-10-vs-5-years-of-tamoxifen-therapy-in-women-with-breast-cancer/ 2019-03-11T19:40:55+00:00 https://ascopost.com/issues/february-1-2013/sidebar-expect-questions-from-patients/ 2019-03-11T19:40:55+00:00 https://ascopost.com/issues/february-1-2013/younger-patients-with-family-history-of-breast-cancer-at-similar-risk/ 2019-03-11T19:40:55+00:00 https://ascopost.com/issues/february-1-2013/adding-temsirolimus-to-letrozole-did-not-improve-survival-but-might-benefit-patients-under-65/ 2019-03-11T19:40:55+00:00 https://ascopost.com/issues/february-1-2013/no-difference-in-toxicity-with-proton-radiotherapy-vs-less-costly-intensity-modulated-radiotherapy/ 2019-03-11T19:40:55+00:00 https://ascopost.com/issues/february-1-2013/e-mail-reminders-to-providers-may-improve-documentation-of-code-status-in-patients-with-advanced-disease/ 2019-03-11T19:40:55+00:00 https://ascopost.com/issues/february-1-2013/more-thoughts-on-rationing-cancer-care/ 2019-03-11T19:40:55+00:00 https://ascopost.com/issues/january-15-2013/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/january-15-2013/adjuvant-tamoxifen-for-women-with-er-positive-breast-cancer-10-years-superior-to-5-years/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/expert-point-of-view-peter-ravdin-md-and-sandra-m-swain-md-facp/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/are-we-winning-the-war-on-cancer/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/does-health-care-quality-translate-to-value/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/last-minute-fiscal-cliff-deal-by-congress-again-averts-medicare-cuts-to-physicians/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/pivotal-trial-shows-robust-activity-of-ponatinib-in-some-heavily-pretreated-leukemias/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/national-comprehensive-cancer-network-appoints-new-ceo/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/fda-approves-ponatinib-to-treat-cml-and-philadelphia-chromosome-positive-all/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/overall-survival-benefit-achieved-with-pomalidomide-in-advanced-myeloma/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/expert-point-of-view-shaji-k-kumar-md/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/radiation-therapy-for-patients-with-invasive-breast-cancer-3-weeks-proves-as-effective-as-5-weeks/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/oral-proteasome-inhibitor-may-be-a-game-changer-in-myeloma/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/expert-point-of-view-antonio-palumbo-md/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/umbilical-cord-blood-transplant-two-units-are-no-better-than-one-in-children-with-hematologic-malignancies/ 2019-03-11T19:41:19+00:00 https://ascopost.com/issues/january-15-2013/excellent-preliminary-results-for-ibrutinib-in-chronic-lymphocytic-leukemia/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/expert-point-of-view-claire-dearden-md/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/expert-point-of-view-martin-dreyling-md-and-joshua-brody-md/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/measuring-and-improving-quality-in-oncology-practices/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/ascos-approach-to-health-information-technology-and-the-rapid-learning-system/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/developing-cancer-care-pathways-for-the-new-environment/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/tumor-grade-is-associated-with-risk-for-venous-thromboembolism/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/fixed-dose-apixaban-reduces-risk-of-recurrent-venous-thromboembolism/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/expert-point-of-view-agnes-y-lee-md/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/omacetaxine-for-chronic-or-accelerated-phase-cml-patients-with-resistanceintolerance-to-tyrosine-kinase-inhibitors/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/faster-rituximab-infusion-for-previously-untreated-follicular-non-hodgkin-and-diffuse-large-b-cell-lymphomas/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/management-of-brain-metastases/ 2019-03-11T19:41:20+00:00 https://ascopost.com/issues/january-15-2013/peter-p-yu-md-elected-asco-president-2014-2015-others-named-to-asco-board/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/accountable-care-organizations-the-new-normal/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/gene-profiling-directs-site-specific-therapy-for-carcinoma-of-unknown-primary-site/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/new-drug-application-submitted-for-radium-223-for-the-treatment-of-castration-resistant-prostate-cancer-with-bone-metastases/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/elekta-receives-fda-510-k-clearance-for-clarity-4d-monitoring/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/fda-expands-abiraterones-use-for-late-stage-prostate-cancer/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/asco-top-five-list-highlighted-in-iom-workshop/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/asco-secures-major-funding-and-data-license-agreements-for-cancerlinq/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/new-asco-statement-outlines-agenda-to-advance-cancer-survivorship-care/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/call-for-abstracts-2013-asco-annual-meeting/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/give-your-patients-the-latest-gi-research-news/ 2019-03-11T19:41:21+00:00 https://ascopost.com/issues/january-15-2013/community-research-forum-addresses-conundrums-common-to-community-practices-that-conduct-research/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/asco-report-encourages-further-discussion-to-improve-rems-development-communication/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/online-prostate-cancer-information-is-written-at-reading-levels-above-many-americans-literacy-skills/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/lumpectomy-rates-inconsistent-with-response-rates-in-early-breast-cancer/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/expert-point-of-view-ian-smith-md/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/french-investigators-prospectively-test-genomically-driven-treatment-in-metastatic-breast-cancer/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/richard-i-fisher-md-to-join-fox-chase-cancer-center-and-temple-university-school-of-medicine/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/teens-and-young-adults-with-cancer-want-a-voice-in-end-of-life-care/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/sidebar-young-survival-coalition-launches-post-treatment-navigator/ 2019-03-11T19:41:22+00:00 https://ascopost.com/issues/january-15-2013/sidebar-asco-s-cancer-treatment-summaries-for-survivors/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/never-a-dull-moment-a-day-in-the-life-of-an-oncology-fellow/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/president-obama-signs-high-mortality-cancer-bill-into-law/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/nci-director-assesses-barriers-to-faster-progress-in-cancer-research/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/physician-scientist-judah-folkman-md-faced-years-of-skepticism-before-his-theory-of-angiogenesis-was-proven/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/new-appointments-at-cancer-centers-nationwide/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/the-rise-of-the-vintage-readers-book-club/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/i-m-not-the-same-person-i-was-before-cancer/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/six-presidential-appointees-named-to-national-cancer-advisory-board/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/oncology-meetings/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/asco-ceo-discusses-the-society-s-initiatives/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/green-tea/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/patients-treated-for-colon-cancer-can-reduce-risk-of-recurrence-with-balanced-diet-and-lower-carbohydrate-intake/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/sidebar-expect-questions-from-patients/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/screening-and-risk-reduction-without-testing-positive-for-brca-mutation/ 2019-03-11T19:41:23+00:00 https://ascopost.com/issues/january-15-2013/analysis-suggests-screening-mammography-results-in-substantial-overdiagnosis-with-small-effect-on-mortality/ 2019-03-11T19:41:24+00:00 https://ascopost.com/issues/january-15-2013/volume-doubling-time-may-help-distinguish-aggressive-cancer-from-slow-growing-tumors/ 2019-03-11T19:41:24+00:00 https://ascopost.com/issues/january-15-2013/chlorambucil-but-not-fludarabine-confers-significant-benefit-in-older-patients-with-cll/ 2019-03-11T19:41:24+00:00 https://ascopost.com/issues/january-15-2013/four-plus-cups-of-coffee-daily-linked-to-lower-risk-of-death-from-oralpharyngeal-cancer/ 2019-03-11T19:41:24+00:00 https://ascopost.com/issues/january-15-2013/persistent-survival-benefit-in-patients-with-untreated-disease-treated-with-bortezomib-added-to-melphalan-and-prednisone/ 2019-03-11T19:41:24+00:00 https://ascopost.com/issues/december-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/december-15-2012/bone-marrow-transplants-reduce-risk-of-graft-vs-host-disease-compared-to-peripheral-blood/ 2019-03-11T19:42:32+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-frederick-r-appelbaum-md/ 2019-03-11T19:42:32+00:00 https://ascopost.com/issues/december-15-2012/recognizing-and-managing-physician-burnout-in-oncology/ 2019-03-11T19:42:32+00:00 https://ascopost.com/issues/december-15-2012/sidebar-how-to-reduce-burnout/ 2019-03-11T19:42:32+00:00 https://ascopost.com/issues/december-15-2012/screening-for-ovarian-cancer-a-gynecologic-oncologist-s-perspective/ 2019-03-11T19:42:32+00:00 https://ascopost.com/issues/december-15-2012/cabozantinib-approved-for-treatment-of-progressive-metastatic-medullary-thyroid-cancer/ 2019-03-11T19:42:32+00:00 https://ascopost.com/issues/december-15-2012/current-perspectives-on-triple-negative-breast-cancers/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/gene-expression-profiles-of-triple-negative-breast-cancers-differ-between-african-american-and-native-african-women/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/memantine-provides-modest-improvement-in-cognition-after-cranial-irradiation/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-vinai-gondi-md/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/radiation-therapy-extends-survival-in-elderly-women-with-early-breast-cancer/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-meena-s-moran-md/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/astro-names-neurosurgeon-mark-p-carol-md-2012-honorary-member/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/bevacizumab-added-to-radiation-and-chemotherapy-improved-progression-free-survival-in-newly-diagnosed-glioblastoma/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/statin-use-associated-with-reduced-cancer-related-mortality-in-danish-study/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/medical-and-behavioral-variables-have-more-impact-on-physical-functioning-than-finasteride-treatment/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/combination-therapy-not-better-than-single-agent-bevacizumab-for-advanced-renal-cell-carcinoma-in-best-trial/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/what-combinations-should-be-tested/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/surgical-resection-for-colorectal-cancer-liver-metastases-who-when-how/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/richard-r-barakat-md-elected-2014-president-of-two-gynecologic-oncology-medical-societies/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/plenary-session-included-findings-on-partial-vs-whole-breast-techniques-and-patient-beliefs-about-radiotherapy/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/fox-chase-researchers-find-most-medicare-patients-wait-weeks-before-breast-cancer-surgery/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/how-sequestration-may-affect-cancer-research/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/effects-of-lkb1-mutation-and-mtor-inhibition-on-igfr1-pathway-in-non-small-cell-lung-cancer/ 2019-03-11T19:42:33+00:00 https://ascopost.com/issues/december-15-2012/molecular-breast-imaging-an-option-for-early-detection-in-high-risk-women/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/fda-grants-fast-track-designation-to-etirinotecan-pegol-for-the-treatment-of-metastatic-breast-cancer/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/surefire-medical-receives-fda-clearance-for-angiographic-catheters/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/supplemental-new-drug-application-submitted-for-erlotinib-as-a-first-line-therapy-in-genetically-distinct-nsclc/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/ima901-granted-orphan-drug-designation-by-fda/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/liposomal-vincristine-for-adult-patients-with-relapsedrefractory-acute-lymphoblastic-leukemia/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/sidebar-report-adverse-events/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/revised-everolimus-dosing-and-new-safetyefficacy-data-for-approval-in-subependymal-giant-cell-astrocytoma/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/2012-in-review-oncology-drugsindications-newly-approved-by-fda/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/significant-reduction-in-cancer-risk-seen-with-daily-multivitamin-use-in-middle-aged-and-older-men/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/oral-rinse-doxepin-relieves-painful-mucositis-in-head-and-neck-cancer/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-paul-harari-md/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/genetic-variation-in-vitamin-d-pathway-is-tied-to-colorectal-cancer-risk-among-african-americans/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/finding-lynch-syndrome-among-patients-with-colorectal-cancer-routine-tumor-testing-looks-best/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/shaping-the-future-of-oncology-envisioning-cancer-care-in-2030/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/clinical-cancer-advances-2012-asco-s-annual-report-on-progress-against-cancer/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/research-of-three-conquer-cancer-foundation-grantees-featured-among-top-cancer-advances-of-the-year/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/the-latest-news-on-quality-cancer-care-what-it-means-for-patients/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/asco-underscores-importance-of-quality-and-value-in-cancer-care-at-iom-workshop/ 2019-03-11T19:42:34+00:00 https://ascopost.com/issues/december-15-2012/asco-calls-on-congress-to-avoid-looming-fiscal-cliff/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/the-ethics-of-rationing-cancer-care/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/sidebar-how-other-countries-are-controlling-oncology-costs/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/androgen-deprivation-therapy-plus-radiation-proven-as-standard-of-care-for-high-risk-prostate-cancer/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-jason-a-efstathiou-md-dphil/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/sildenafil-improves-overall-sexual-function-in-men-with-prostate-cancer-treated-with-radiation/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-thomas-pisansky-md/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/stereotactic-body-radiation-therapy-produces-impressive-results-in-organ-confined-prostate-cancer/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-colleen-lawton-md/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/early-quality-of-life-better-with-proton-beam-therapy-but-late-effects-similar-to-other-treatment-modalities-for-prostate-cancer/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-jeffrey-bradley-md/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/combination-bevacizumabchemotherapy-improves-outcomes-in-platinum-resistant-ovarian-cancer/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-nicoletta-colombo-md/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/prevention-and-treatment-of-multikinase-inhibitor-induced-hand-foot-syndrome/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/top-10-most-viewed-articles-on-ascopostcom-for-2012/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/no-survival-advantage-for-combination-chemotherapy-in-advanced-soft-tissue-sarcoma/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-george-demetri-md/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/karen-e-knudsen-phd-named-new-editor-in-chief-of-aacr-journal-molecular-cancer-research/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/lenalidomide-trial-negative-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/expert-point-of-view-robert-jones-md/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/american-society-of-hematology-launches-ash-foundation/ 2019-03-11T19:42:35+00:00 https://ascopost.com/issues/december-15-2012/the-practice-of-more-than-one-art/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/ambitious-call-to-arms-seeks-a-shift-in-priorities-to-eradicate-cancer/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/american-cancer-society-honors-waun-ki-hong-md-for-outstanding-clinical-research/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/updates-on-ruxolitinib-from-asco-and-ash-2012-including-long-term-survival-data/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/the-true-history-of-the-discovery-of-prostate-specific-antigen/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/health-care-crisis-reconsidered/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/the-language-of-cancer/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/acupuncture-does-it-alleviate-symptoms-associated-with-cancer-care/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/oncology-meetings/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/study-explores-use-of-radiotherapy-in-last-30-days-of-life/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/dr-jimmie-c-holland-s-research-has-long-underscored-the-importance-of-caring-for-the-whole-patient/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/i-am-not-a-victim/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/dr-lewis-c-cantley-to-lead-new-cancer-center-at-weill-cornell-medical-college-and-newyork-presbyterian-hospital/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/mskcc-s-decision-not-to-purchase-new-cancer-drug-sparks-editorial-and-unprecedented-actions/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/sidebar-expect-questions-and-respond-with-reasoned-explanations/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/promoting-a-more-balanced-approach-to-cancer-prevention-and-treatment/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/early-surgical-treatment-of-low-grade-glioma-improves-survival-vs-watchful-waiting/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/small-increase-in-cardiac-events-for-trastuzumab-plus-anthracycline-in-her2-positive-disease/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/interval-compressed-chemotherapy-more-effective-with-no-increase-in-toxicity/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/lower-risk-of-recurrence-in-patients-with-hbv-related-liver-cancer-receiving-nucleoside-analogs/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/role-of-glutamate-and-effect-of-its-blockade-in-prostate-cancer/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/december-15-2012/past-asco-president-john-ridgway-durant-md-dies-at-82/ 2019-03-11T19:42:36+00:00 https://ascopost.com/issues/november-15-2012-supplement/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/november-15-2012-supplement/ce-activity-instructions/ 2019-03-11T19:43:33+00:00 https://ascopost.com/issues/november-15-2012-supplement/introduction/ 2019-03-11T19:43:33+00:00 https://ascopost.com/issues/november-15-2012-supplement/treatment-goals-molecular-monitoring-and-the-role-and-use-of-guideline-recommendations/ 2019-03-11T19:43:33+00:00 https://ascopost.com/issues/november-15-2012-supplement/beyond-molecular-monitoring-cytogenetic-testing-and-mutational-analysis-in-chronic-myeloid-leukemia/ 2019-03-11T19:43:33+00:00 https://ascopost.com/issues/november-15-2012-supplement/defining-and-recognizing-the-causes-of-imatinib-resistance-and-the-importance-of-adherence/ 2019-03-11T19:43:33+00:00 https://ascopost.com/issues/november-15-2012-supplement/managing-treatment-failure-in-chronic-myeloid-leukemia/ 2019-03-11T19:43:33+00:00 https://ascopost.com/issues/november-15-2012-supplement/defining-a-cure-for-chronic-myeloid-leukemia-and-strategies-to-achieve-this-goal/ 2019-03-11T19:43:33+00:00 https://ascopost.com/issues/november-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/november-15-2012/updated-results-from-t-dm1-and-regorafenib-trials-plus-other-highlights-from-esmo-2012/ 2019-03-11T19:44:10+00:00 https://ascopost.com/issues/november-15-2012/seeking-solutions-to-the-dilemmas-of-overdiagnosis-and-overtreatment/ 2019-03-11T19:44:10+00:00 https://ascopost.com/issues/november-15-2012/who-should-receive-first-line-beacopp-therapy-for-hodgkin-lymphoma/ 2019-03-11T19:44:10+00:00 https://ascopost.com/issues/november-15-2012/sidebar-mammography-study-stokes-overdiagnosis-debate/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/fda-approves-omacetaxine-for-chronic-myeloid-leukemia/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/no-survival-benefit-for-oxaliplatin-added-to-adjuvant-therapy-in-stage-ii-or-elderly-patients-with-colon-cancer/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/expert-point-of-view-john-l-marshall-md/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/trastuzumab-emtansine-improves-survival-vs-capecitabine-plus-lapatinib-in-second-line-her2-positive-breast-cancer/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/contralateral-breast-cancer-risk-is-highly-overestimated/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/new-drug-application-for-tivozanib-for-the-treatment-of-advanced-renal-cell-carcinoma/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/fda-approves-noninvasive-radiation-therapy-to-treat-pain-from-bone-metastases/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/regorafenib-multikinase-inhibitor-for-previously-treated-metastatic-colorectal-cancer/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/integrative-medicine-showing-benefits-in-cancer-management/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/highlights-from-the-ninth-international-conference-of-the-society-for-integrative-oncology/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/novel-agents-for-breast-cancer-and-prostate-cancer-impressive-in-early-trials/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/expert-point-of-view-nicholas-turner-md-phd/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/does-prophylaxis-prevent-catheter-related-thrombosis/ 2019-03-11T19:44:11+00:00 https://ascopost.com/issues/november-15-2012/expert-point-of-view-fausto-roila-md/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/adjuvant-chemotherapy-for-breast-cancer-predicted-by-disease-age-and-insurance-type-but-not-by-race/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/nab-paclitaxel-vs-solvent-based-paclitaxel-in-first-line-treatment-of-advanced-nsclc/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/albumin-bound-paclitaxel-in-first-line-treatment-of-advanced-nsclc/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/a-new-gift-to-add-to-your-list-one-to-conquer-cancer/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/sidebar-support-underfunded-areas-of-research/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/stereotactic-radiosurgery-may-offer-therapeutic-option-for-patients-with-primary-renal-cancer-early-study-indicates/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/options-shifting-for-first-line-treatment-of-renal-cell-carcinoma/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/fda-approves-new-use-of-pemetrexed-in-the-maintenance-setting-for-nsclc/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/rituximab-infusion-approved-for-nhl/ 2019-03-11T19:44:12+00:00 https://ascopost.com/issues/november-15-2012/cyberknife-m6-series-gets-fda-510-k-clearance/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/intermittent-androgen-suppression-in-prostate-cancer-noninferior-to-continuous-suppression/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/delivering-affordable-cancer-care-is-it-possible-and-what-will-it-entail/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/risk-reduction-for-patients-with-multiple-primary-cancers/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/ruxolitinib-novel-drug-for-myelofibrosis/ 2025-09-30T19:52:18+00:00 https://ascopost.com/issues/november-15-2012/iom-elects-new-members-foreign-associates/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/sorafenib-fails-to-improve-survival-as-third-or-fourth-line-treatment-of-advanced-non-small-cell-lung-cancer/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/explaining-research-to-patients/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/expert-point-of-view-jean-yves-pierga-md/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/pd-1-blockade-increases-transferred-t-cell-migration-to-tumors/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/effects-of-lkb1-mutation-and-mtor-inhibition-on-igfr1-pathway-in-nsclc/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/dong-quai/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/conquer-cancer-foundation-of-asco-honors-researchers-for-work-in-measuring-and-improving-quality-of-cancer-care/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/the-nuts-and-bolts-of-getting-into-an-oncology-fellowship/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/american-society-of-hematology-elects-new-leadership/ 2019-03-11T19:44:13+00:00 https://ascopost.com/issues/november-15-2012/astro-elects-new-officers/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/researchers-honored-at-2012-san-antonio-breast-cancer-symposium/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/richard-l-schilsky-md-chosen-to-serve-in-new-asco-leadership-position-chief-medical-officer/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/strong-association-increasingly-recognized-between-obesity-and-cancer-incidencepoor-prognosis/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/sidebar-expect-questions-from-patients-about-impact-of-weight-on-prognosis/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/sidebar-randomized-trial-of-weight-loss-and-cancer-risk-not-feasible/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/hiv-protease-inhibitor-nelfinavir-selectively-inhibits-her2-positive-breast-cancer-cells/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/mutational-activation-of-pi3k-akt-pathway-and-change-in-her2-expression-in-trastuzumab-resistant-breast-cancer/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/impaired-plasmacytoid-dendritic-cell-ifn-alfa-production-may-contribute-to-breast-cancer-progression/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/letter-to-the-editor-origins-of-psa-testing-the-conversation-continues/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/the-university-of-tennessee-medical-center-opens-new-cancer-institute/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/surrounded-by-breast-cancer/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/novel-mechlorethamine-gel-considered-safe-and-effective-for-treatment-of-mycosis-fungoides/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/media-campaign-with-real-smokers-a-success/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/pulmonary-radiotherapy-can-usually-be-omitted-for-nephroblastoma-and-pulmonary-metastases/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/nobel-laureate-e-donnall-thomas-md-dies-at-92/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-15-2012/2012-2013-oncology-meetings/ 2019-03-11T19:44:14+00:00 https://ascopost.com/issues/november-1-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/november-1-2012/combination-of-braf-and-mek-inhibitors-paves-way-for-phase-iii-studies-in-braf-mutated-metastatic-melanoma/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/expert-point-of-view-reinhard-dummer-md/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/ignoring-level-1-evidence-in-invasive-bladder-cancer-is-ignorance-bliss/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/challenging-times-a-day-in-the-life-of-a-community-oncologist/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/nab-paclitaxel-approved-in-first-line-metastatic-nsclc/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/one-year-of-trastuzumab-remains-the-standard-of-care-in-her2-positive-breast-cancer/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/expert-point-of-view-sandra-m-swain-md/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/sidebar-cardiac-events-evaluated-in-trastuzumab-studies/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/study-reveals-global-picture-of-obstacles-to-pain-control-in-patients-with-cancer/ 2019-03-11T19:44:42+00:00 https://ascopost.com/issues/november-1-2012/challenges-persist-in-treatment-of-elderly-patients-with-cll-but-novel-agents-hold-promise-for-future-strategies/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/phase-ii-study-suggests-advantage-of-irreversible-pan-her-inhibition-in-advanced-nsclc/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/sidebar-dacomitinib-better-in-whom-better-in-what/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/will-mtor-inhibitors-change-the-treatment-of-endocrine-sensitive-her2-negative-breast-cancer/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/sidebar-dealing-with-the-toxicity-of-everolimusexemestane/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/noninvasive-measurement-of-interstitial-fluid-pressure-as-marker-of-tumor-aggressiveness/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/whole-blood-rna-expression-profiles-as-prognostic-models-for-castration-resistant-prostate-cancer/ 2025-03-13T15:36:21+00:00 https://ascopost.com/issues/november-1-2012/genome-wide-analysis-reveals-molecular-pathway-aberrations-in-uterine-serous-cancer/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/role-of-crizotinib-in-previously-treated-alk-positive-advanced-nsclc/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/sidebar-european-database/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/pazopanib-noninferior-to-sunitinib-as-front-line-therapy-for-metastatic-renal-cell-carcinoma/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/expert-point-of-view-tim-eisen-md-and-robert-figlin-md/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/vismodegib-novel-agent-for-treating-advanced-basal-cell-carcinoma/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/aacr-s-cancer-progress-report-2012-highlights-advances-challenges-opportunities/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/expert-point-of-view-frank-mccormick-phd/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/american-association-for-cancer-research-mourns-the-loss-of-senator-arlen-specter/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/karnofsky-award-winner-honors-mentors-through-gift-to-conquer-cancer-foundation/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/fellowship-breathes-life-into-the-careers-of-young-oncologists-in-developing-countries/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/cancerprogressnet-adds-new-resources-to-highlight-progress-in-clinical-cancer-research/ 2019-03-11T19:44:43+00:00 https://ascopost.com/issues/november-1-2012/now-in-spanish-cancer-in-older-adults/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/trials-of-drug-combinations-present-new-hope-for-more-effective-treatments-in-multiple-myeloma/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/major-strides-seen-in-treatment-of-gynecologic-cancers/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/sidebar-future-of-parp-inhibitors-in-ovarian-cancer-hangs-in-balance/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/sidebar-all-eyes-on-trials-of-iv-vs-ip-chemotherapy-for-ovarian-cancer/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/socioeconomic-disparity-in-colorectal-cancer-rates-attributed-to-obesity-and-behavioral-risks/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/despite-the-rhetoric-cancer-care-costs-keep-skyrocketing-is-there-a-solution/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/a-series-of-medical-missteps/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/cancer-genome-atlas-network-reports-comprehensive-molecular-portraits-of-breast-tumors/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/pain-remains-prevalent-among-oncology-outpatients-with-odds-of-undertreatment-twice-as-high-among-minority-patients/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/sidebar-don-t-expect-direct-questions-from-patients-about-pain/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/daniel-von-hoff-md-recognized-with-award-as-research-leader-in-pancreatic-cancer/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/feminist-author-babette-rosmond-helped-propel-the-adoption-of-patients-rights-to-choose-their-cancer-treatment/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/pathologic-nodal-status-and-tumor-response-can-predict-risk-of-locoregional-recurrence/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/short-interval-between-initial-and-contralateral-breast-cancer-increases-risk-of-dying/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/november-1-2012/patients-with-lynch-syndrome-who-have-had-colorectal-cancer-are-at-increased-risk-of-other-cancers/ 2019-03-11T19:44:44+00:00 https://ascopost.com/issues/october-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/october-15-2012/breast-cancer-symposium-features-surgical-data-updated-results-from-bolero-2-and-other-important-news/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/despite-progress-chemotherapy-drug-shortages-still-vex-the-oncology-community/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/on-mentoring-looking-back-with-gratitude-and-paying-it-forward/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/regorafenib-approved-for-advanced-colorectal-cancer/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/developments-in-hematologic-cancers-include-new-considerations/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/nccn-appoints-dr-robert-carlson-as-chief-executive-officer/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/viral-infection-and-liver-cancer-a-global-health-crisis/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/noncolorectal-gi-cancer-evidence-incorporated-into-guidelines/ 2019-03-11T19:45:44+00:00 https://ascopost.com/issues/october-15-2012/anthracycline-use-steadily-declining-in-early-breast-cancer-population/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/expert-point-of-view-stephen-e-jones-md/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/novel-device-may-eliminate-need-for-re-excision-after-lumpectomy/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/21gene-recurrence-score-predicts-outcomes/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/expert-point-of-view-andrew-d-seidman-md/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/adjuvant-chemotherapy-for-breast-cancer-not-linked-to-acute-myeloid-leukemia-and-myelodysplastic-syndromes/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/expert-point-of-view-clifford-a-hudis-md/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/successful-use-of-cytoreduction-and-hyperthermic-intraperitoneal-chemotherapy-may-hinge-on-prior-experience/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/sidebar-from-small-centers-to-academic-centers/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/progress-slow-but-sure-seen-for-current-lung-cancer-therapies/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/sidebar-treatment-decisions-for-locally-advanced-nsclc-draw-on-art-of-medicine/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/in-dcis-radiotherapy-benefits-good-risk-patients/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/neuropathy-not-predictive-of-outcomes-with-adjuvant-taxane-therapy-in-breast-cancer/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/cognitive-impairment-in-patients-with-cancer/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/radiation-to-the-skin-and-later-risk-of-basal-cell-carcinoma-studied/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/pediatric-pathologist-sidney-farber-md-the-father-of-modern-chemotherapy-and-cofounder-of-the-jimmy-fund/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/kinase-inhibitors-compared-in-first-line-treatment-of-cml/ 2019-03-11T19:45:45+00:00 https://ascopost.com/issues/october-15-2012/bosutinib-in-chronic-myelogenous-leukemia-patients-with-resistance-or-intolerance-of-prior-therapy/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/investigators-perseverance-pays-off-in-treating-anaplastic-oligodendroglioma/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/sidebar-trials-establish-new-standard-of-care-for-anaplastic-oligodendroglioma/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/asco-achieves-highest-level-of-accreditation-for-continuing-medical-education-program/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/cancerlinq-addressing-institute-of-medicine-core-recommendations-for-learning-health-system/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/stay-up-to-date-on-new-patient-materials-from-cancernet/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/new-asco-tobacco-cessation-practice-resources-will-offer-help-for-providers-as-well-as-patients/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/conquer-cancer-foundation-honors-oncology-professionals-for-high-quality-research-in-breast-cancer/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/hormonal-therapy-with-enzalutamide-increases-survival-in-castrate-resistant-prostate-cancer-after-chemotherapy/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/enzalutamide-for-metastatic-castrate-resistant-prostate-cancer/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/pivotal-trials-in-head-and-neck-cancers-yield-mixed-results/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/sidebar-trials-shortcomings-leave-role-of-induction-chemotherapy-unclear/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/childhood-radiation-increases-breast-cancer-risk/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/new-drug-application-submitted-for-regorafenib-to-treat-gist/ 2019-03-11T19:45:46+00:00 https://ascopost.com/issues/october-15-2012/fda-approves-new-treatment-for-severe-neutropenia/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/fda-approves-first-ultrasound-imaging-system-for-dense-breast-tissue/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/fda-approves-production-of-imaging-agent-to-detect-prostate-cancer/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/for-advanced-sarcomas-new-agents-prolong-remission-but-not-survival/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/prone-position-during-radiation-therapy-for-breast-cancer-is-associated-with-reduced-irradiation-to-lung-and-heart/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/the-language-of-cancer/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/states-aim-to-increase-male-breast-cancer-awareness/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/new-studies-explore-exposure-to-cancer-causing-agents/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/tweeting-at-asco-annual-meetings-can-enhance-the-experience/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/american-psychosocial-oncology-society-provides-helpline-for-counseling-services/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/cancer-memoir-provides-inspiration-for-those-with-terminal-illness-and-their-caregivers/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/antioxidant-supplementation-in-patients-with-cancer-is-it-safe-and-effective/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/how-to-recognize-and-manage-vandetanib-induced-photosensitivity/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/memorial-sloan-kettering-cancer-center-appoints-josé-baselga-md-phd-new-physician-in-chief/ 2019-03-11T19:45:47+00:00 https://ascopost.com/issues/october-15-2012/lisa-carey-md-named-division-chief-of-hematology-oncology-unc-school-of-medicine-and-physician-in-chief-of-the-nc-cancer-hospital/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/levine-cancer-institute-opens-new-research-and-administrative-headquarters/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/einstein-montefiore-scientists-awarded-nci-grants-to-study-provocative-questions-in-cancer-research/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/starting-over-after-cancer-treatment/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/link-found-between-aspirin-and-reduced-risk-of-death-due-to-prostate-cancer/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/sidebar-expect-questions-from-patients/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/radiotherapy-not-helpful-in-early-stage-parotid-acinic-cell-cancer/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/2012-is-banner-year-for-research-on-symptom-management/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/sidebar-is-vitamin-d-supplementation-ready-for-prime-time/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/paclitaxel-poliglumex-gets-orphan-drug-designation-for-glioblastoma-multiforme/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/anthracyclinetrastuzumab-treatment-linked-to-increased-risk-of-heart-failure-cardiomyopathy/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/reduced-disease-progression-in-patients-with-continued-gemcitabine-maintenance-or-erlotinib-switch-maintenance/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/long-term-survivors-of-hodgkin-lymphoma-may-have-increased-risk-of-neurocognitive-impairment/ 2019-03-11T19:45:48+00:00 https://ascopost.com/issues/october-15-2012/letter-to-the-editor-individualism-in-clinical-decision-making/ 2019-03-11T19:45:49+00:00 https://ascopost.com/issues/october-15-2012/2012-2013-oncology-meetings-calendar/ 2019-03-11T19:45:49+00:00 https://ascopost.com/issues/october-15-2012/on-mentoring-looking-back-with-gratitude-and-paying-it-forward-1/ 2019-03-11T19:45:49+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/best-of-asco-meetings-offer-data-commentary-and-interaction-with-the-experts/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/new-therapies-capitalize-on-lung-cancer-s-molecular-vulnerabilities/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-molecular-testing-requires-planning-at-time-of-biopsy/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-should-egfr-tyrosine-kinase-inhibitors-be-continued-beyond-progression/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/cytotoxic-chemotherapy-for-breast-cancer-are-we-done-tweaking-it/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/refining-current-treatments-and-looking-ahead-in-her2-positive-breast-cancer/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-does-lapatinib-prevent-cns-metastases-in-her2-positive-breast-cancer/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-browsing-the-anti-her2-options/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-a-tough-call-the-t1a-her2-positive-tumor/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/which-rituximab-based-regimen-works-best-in-non-hodgkin-lymphoma/ 2019-03-11T19:46:41+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-is-watch-and-wait-the-best-strategy-for-indolent-nhl-in-the-rituximab-era/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/abvd-and-beacopp-yield-equivalent-survival-in-hodgkin-lymphoma/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/will-carfilzomib-add-value-to-multiple-myeloma-treatment/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/new-agents-are-achieving-deeper-responses-in-cml/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-maximizing-tyrosine-kinase-inhibitor-therapy-in-cml/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/encouraging-data-presented-for-monoclonal-antibodies-and-novel-oral-agent-in-lymphocytic-leukemias/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/evidence-is-changing-colorectal-cancer-treatment-landscape/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-progression-free-survival-curve-for-regorafenib-hints-at-subgroup-effect/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-is-microsatellite-instability-status-also-predictive-in-stage-ii-disease/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/continuous-androgen-deprivation-remains-standard-of-care-in-newly-diagnosed-metastatic-prostate-cancer/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-how-should-swog-9346-be-interpreted/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/novel-drugs-enhance-but-complicate-prostate-cancer-treatment/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-a-closer-look-at-radium-223/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/another-tyrosine-kinase-inhibitor-joins-the-lineup-in-renal-cell-carcinoma/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/exciting-new-agents-offer-further-treatment-options-for-metastatic-melanoma/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-boa-supplement/sidebar-melanoma-treatment-options-exploding-but-old-standbys-should-remain/ 2019-03-11T19:46:42+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/introduction-to-case-studies-in-rare-lymphomas/ 2019-03-11T19:47:09+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/management-of-a-patient-with-hodgkin-lymphoma-following-failure-of-autologous-stem-cell-transplant/ 2019-03-11T19:47:09+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/faculty-qa-discussion-communicating-with-patients/ 2019-03-11T19:47:09+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/management-of-a-patient-with-relapsed-and-refractory-hodgkin-lymphoma/ 2019-03-11T19:47:09+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/faculty-qa-discussion-brentuximab-vedotin/ 2019-03-11T19:47:09+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/management-of-a-patient-with-systemic-anaplastic-large-cell-lymphoma-following-failure-of-one-or-more-combination-regimens/ 2019-03-11T19:47:09+00:00 https://ascopost.com/issues/september-15-2012-lymph-supplement/faculty-qa-discussion-anaplastic-large-cell-lymphoma/ 2019-03-11T19:47:09+00:00 https://ascopost.com/issues/september-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/september-15-2012/biomarker-driven-adaptive-trial-design-proving-informative-in-non-small-cell-lung-cancer/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/contagious-cancer-and-an-unexplained-phenomenon-might-inspire-future-therapies/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/expert-point-of-view-dan-l-longo-md/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/importance-of-dermatologic-care-for-patients-with-cancer/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/predictors-and-treatment-for-transformed-lymphoma-current-paradigms/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/no-survival-benefit-of-radical-prostatectomy-vs-observation-for-localized-prostate-cancer-detected-by-psa-testing/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/expert-point-of-view-timothy-wilt-md-mph/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/expert-point-of-view-fritz-h-schroeder-md/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/fda-approves-new-orphan-drug-for-chronic-myelogenous-leukemia/ 2019-03-11T19:47:34+00:00 https://ascopost.com/issues/september-15-2012/first-drug-for-children-with-rare-brain-tumor-approved/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/fda-issues-new-safety-alert-on-reumofan-plus-and-reumofan-plus-premium/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/nda-for-chemosaturation-system-to-treat-melanoma-in-the-liver/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/anticancer-effect-of-diabetes-drug-metformin/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/sexual-dysfunction-in-female-cancer-survivors-is-prevalent/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/expert-point-of-view-michael-krychman-md/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/physical-activity-benefits-breast-cancer-survivors-but-role-in-reducing-breast-cancer-risk-is-less-clear/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/biomedical-research-faces-imminent-24-billion-budget-cut-unless-congress-acts/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/emilia-study-t-dm1-significantly-improves-overall-survival-in-her2-positive-metastatic-breast-cancer/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/dying-patients-with-cancer-who-avoid-aggressive-care-but-stay-connected-with-an-oncologist-have-better-quality-of-life/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/is-there-a-role-for-metronomic-chemotherapy-in-patients-with-highly-refractory-multiple-myeloma/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/expert-point-of-view-sergio-giralt-md/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/lack-of-sleep-found-to-be-risk-factor-for-aggressive-breast-cancers/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/a-leading-light-in-cancer-advances-mary-lasker-used-wealth-and-connections-to-increase-funding-for-medical-research/ 2019-03-11T19:47:35+00:00 https://ascopost.com/issues/september-15-2012/predictive-markers-for-outcome-with-pazopanib-in-metastatic-renal-cell-cancer/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/metastasis-promoted-by-cleaving-and-inhibiting-proapoptotic-effect-of-von-willebrand-factor/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/evolutionary-pathways-in-brca1-associated-breast-tumors/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/vegf-pathway-biomarker-for-outcome-with-bevacizumab/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/trim27-as-target-in-cancer-development/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/genitourinary-cancers-symposium-still-intimate-despite-record-growth/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/all-oncology-care-practices-urged-to-be-counted-in-groundbreaking-census/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/kidney-cancer-association-works-with-conquer-cancer-foundation-to-stimulate-breakthrough-research/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/what-the-latest-breast-cancer-news-means-for-patients/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/a-great-idea-supporting-the-next-generation-of-oncology-leaders-in-low-and-middle-income-countries/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/inaugural-quality-care-symposium-will-detail-how-to-pioneer-successful-quality-initiatives-in-your-practice/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/fda-grants-priority-review-to-supplemental-new-drug-application-for-abiraterone-acetate-in-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/new-indication-for-cetuximab-plus-folfiri-to-treat-egfr-positive-wild-type-kras-metastatic-colorectal-cancer/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/fda-approves-new-drug-for-late-stage-prostate-cancer/ 2019-03-11T19:47:36+00:00 https://ascopost.com/issues/september-15-2012/ziv-aflibercept-with-folfiri-in-metastatic-colorectal-cancer/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/getting-the-right-end-of-life-care-coming-to-terms-with-the-realities-of-advanced-disease-and-mortality/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/researchers-awarded-nci-grants-to-address-provocative-questions/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/ct-scans-in-childhood-can-triple-risk-of-leukemia-and-brain-cancer-later-in-life-study-finds/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/sidebar-expect-questions-from-parents/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/sidebar-unique-considerations-for-radiation-exposure-in-children/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/being-well-informed-helped-me-cope-with-breast-cancer/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/enzalutamide-significantly-prolonged-survival-in-men-with-castrate-resistant-metastatic-prostate-cancer/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/cetuximab-dose-escalation-may-increase-responses-among-patients-with-mild-or-no-initial-skin-reactions/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/patients-with-unresectable-metastases-can-be-spared-noncurative-resection-of-intact-primary-tumor/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/high-cost-imaging-used-frequently-in-elderly-with-stage-iv-cancer/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/letter-to-the-editor-more-thoughts-on-psa/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/letter-to-the-editor-dr-ablin-s-reply/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-15-2012/2012-meetings-calendar/ 2019-03-11T19:47:37+00:00 https://ascopost.com/issues/september-1-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/september-1-2012/no-advantage-to-longer-adjuvant-chemotherapy-in-women-with-early-breast-cancer-calgb-40101-trial/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/the-science-of-resilience-exploring-the-process-of-grieving-from-a-new-perspective/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/the-problem-of-monitoring-remission/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/liposomal-vincristine-approved-in-acute-lymphoblastic-leukemia/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/ongoing-and-future-directions-in-pancreatic-cancer-research/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/ipsilateral-radiotherapy-for-cervical-lymph-node-metastases/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/carfilzomib-new-drug-with-accelerated-approval-for-multiple-myeloma/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/preclinical-research-finds-gene-that-permanently-stops-cancer-cell-proliferation/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/despite-challenges-initiatives-bring-gradual-improvements-to-cancer-care-in-lebanon/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/coping-with-liver-cancer/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/chemotherapy-plus-radiation-improved-progression-free-survival-in-adults-with-low-grade-glioma/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/the-2013-gastrointestinal-cancers-symposium-will-observe-the-meeting-s-10-year-anniversary/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/asco-expert-panel-concludes-evidence-supports-physician-discussion-of-psa-testing-for-men-with-longer-life-expectancies/ 2019-03-11T19:48:03+00:00 https://ascopost.com/issues/september-1-2012/conquer-cancer-foundation-10k-challenge-multiply-your-donation-s-impact-in-september/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/it-s-time-to-get-ready-for-new-medicare-reporting-requirements/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/updated-for-2012-cancer-in-older-adults/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/new-agents-that-improve-efficacy-can-also-increase-morbidity-and-treatment-related-mortality/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/taxane-induced-neuropathy-does-not-correlate-with-improved-outcomes-in-operable-breast-cancer/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/kidney-transplant-recipients-switching-to-sirolimus-had-lower-risk-of-secondary-squamous-cell-carcinomas/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/adolescent-and-young-adult-patients-report-unmet-needs-for-cancer-information-and-psychosocial-support-services/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/sidebar-don-t-expect-questions-be-proactive-with-younger-patients/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/september-1-2012/sidebar-dating-among-adolescents-and-young-adults-with-cancer/ 2019-03-11T19:48:04+00:00 https://ascopost.com/issues/august-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/august-15-2012/study-shows-routine-ct-surveillance-overused-in-pediatric-hodgkin-lymphoma/ 2019-03-11T19:48:34+00:00 https://ascopost.com/issues/august-15-2012/expert-point-of-view-james-o-armitage-md/ 2019-03-11T19:48:34+00:00 https://ascopost.com/issues/august-15-2012/rethinking-the-role-of-psa-screening-in-public-health/ 2019-03-11T19:48:34+00:00 https://ascopost.com/issues/august-15-2012/maintenance-of-certification-one-size-should-not-fit-all/ 2019-03-11T19:48:34+00:00 https://ascopost.com/issues/august-15-2012/fda-approves-ziv-aflibercept-for-metastatic-colorectal-cancer/ 2019-03-11T19:48:34+00:00 https://ascopost.com/issues/august-15-2012/senate-legislation-urges-federal-research-support-to-improve-early-detection-of-prostate-cancer/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/biokine-therapeutics-awarded-fda-orphan-drug-designation-for-mobilization-of-stem-cells-in-patients-with-cancer/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/fda-approves-colon-cleansing-drug-for-prep-prior-to-colonoscopy/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/novel-agents-should-have-impact-in-lymphocytic-leukemias/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/expert-point-of-view-constantine-s-tam-mbbs-md/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/expert-point-of-view-bruno-c-medeiros-md/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/supportive-care-research-runs-the-gamut-from-genetic-markers-of-treatment-side-effects-to-neuropathic-pain-therapies/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/young-and-strong-program-addresses-multiple-needs-of-women-in-40s-and-younger-diagnosed-with-breast-cancer/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/differentiated-thyroid-cancer-who-when-and-how-to-treat/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/molecularly-targeted-treatment-of-thyroid-cancer-rapidly-evolving/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/striking-activity-shown-for-regorafenib-in-advanced-gist/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/expert-point-of-view-grant-mcarthur-mb-bs-phd/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/as-conflicting-guidelines-evolve-experts-continue-to-debate-the-merits-of-cancer-screening/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/fda-grants-accelerated-approval-to-carfilzomib-for-multiple-myeloma/ 2019-03-11T19:48:35+00:00 https://ascopost.com/issues/august-15-2012/everolimus-approved-for-advanced-breast-cancer/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/enzalutamide-gets-priority-review-for-castrate-resistant-prostate-cancer/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/radiotracer-targeting-of-free-prostate-specific-antigen/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/understanding-and-managing-pseudoprogression-in-glioblastoma-patients/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/adding-bevacizumab-to-chemotherapy-improves-progression-free-survival-in-platinum-sensitive-recurrent-ovarian-cancer/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/no-improvement-in-overall-survival-worse-toxicity-with-motesanib-added-to-chemotherapy-in-non-small-cell-lung-cancer/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/rush-s-new-hospital-building-listed-as-one-of-the-most-innovative-infrastructure-projects-in-the-world/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/clinicians-to-benefit-from-new-jco-initiatives/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/asco-university-s-e-seminars-offer-a-stimulating-way-to-stay-on-top-of-trends-as-well-as-meeting-highlights/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/asco-responds-to-supreme-court-ruling-on-health-care-law/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/asco-s-guideline-on-sentinel-lymph-node-biopsy-for-melanoma/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/former-foundation-grantee-pays-it-forward-building-a-legacy-for-the-next-generation/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/lapatinib-shows-value-similar-to-trastuzumab-in-neoadjuvant-regimens-for-breast-cancer-but-with-greater-toxicity/ 2019-03-11T19:48:36+00:00 https://ascopost.com/issues/august-15-2012/expert-point-of-view-gunter-von-minckwitz-md-phd/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/trailblazer-in-argentinean-oncology-remains-optimistic-about-war-on-cancer/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/improving-outcomes-and-prediction-in-ductal-carcinoma-in-situ/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/expert-point-of-view-eun-sil-shelley-hwang-md-mph/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/patient-preference-studied-in-treatment-selection-for-renal-cell-carcinoma/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/fdg-pet-falls-short-for-diagnosis-of-non-small-cell-lung-cancer/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/antidepressant-drug-has-clinically-meaningful-effect-on-chemotherapy-induced-painful-neuropathy/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/taking-family-history-and-referral-to-genetic-counseling-could-be-improved-survey-finds/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/older-chemotherapy-studies-in-breast-cancer-coming-of-age/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/supportive-care-experts-explore-30-years-of-progress-in-the-field/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/a-physician-who-is-also-a-cancer-patient-talks-about-medical-errors/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/new-assessment-tools-in-development-to-guide-care-for-older-patients/ 2020-02-17T18:07:10+00:00 https://ascopost.com/issues/august-15-2012/information-service-provides-innovative-resource-for-patients-and-providers/ 2019-03-11T19:48:37+00:00 https://ascopost.com/issues/august-15-2012/study-reports-strong-and-consistent-relation-between-exposure-to-diesel-exhaust-and-risk-of-dying-of-lung-cancer/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/response-rate-is-significantly-improved-with-nab-vs-solvent-based-paclitaxel-plus-carboplatin-in-advanced-nsclc/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/data-liquidity-coalition-takes-shape/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/sidebar-coalition-activities/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/symposium-focuses-on-policy-issues-in-personalized-cancer-care/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/pertuzumab-new-drug-for-her2-positive-metastatic-breast-cancer/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/living-with-the-aftermath-of-breast-cancer/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/astragalus/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/genomics-vs-site-of-cancer-origin-as-basis-for-treatment-of-cancer-is-false-dichotomy/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/children-with-favorable-risk-disease-and-complete-response-to-chemotherapy-have-high-survival-rates-without-radiotherapy/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/bevacizumabtemozolomide-combination-safe-and-active-against-advanced-neuroendocrine-tumors/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/strong-persistent-benefit-from-radiochemotherapy-after-curative-gastric-cancer-resection/ 2019-03-11T19:48:38+00:00 https://ascopost.com/issues/august-15-2012/adjuvant-chemotherapy-may-improve-survival-for-patients-with-periampullary-disease/ 2019-03-11T19:48:39+00:00 https://ascopost.com/issues/august-15-2012/regorafenib-has-notable-anticancer-activity-after-patients-develop-resistance-to-imatinib-and-sunitinib/ 2019-03-11T19:48:39+00:00 https://ascopost.com/issues/august-15-2012/most-hospitals-do-not-meet-benchmark-for-examining-lymph-nodes-following-esophagectomy/ 2019-03-11T19:48:39+00:00 https://ascopost.com/issues/august-15-2012/conquer-cancer-foundation-honors-oncology-professionals-for-high-quality-research-in-breast-cancer/ 2019-03-11T19:48:39+00:00 https://ascopost.com/issues/july-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/july-15-2012/second-line-treatments-tested-in-patients-with-non-small-cell-lung-cancer/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/expert-point-of-view-paramount/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/expert-point-of-view-tailor/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/the-affordable-care-act-stands-now-what/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/three-experts-weigh-in-on-the-health-care-reform-legislation/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/reflections-from-the-old-world/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/lung-cancer-death-rates-increase-among-white-women-in-some-states/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/landscape-for-treatment-of-metastatic-melanoma-is-expanding/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/expert-point-of-view-landscape-for-treatment-of-metastatic-melanoma-is-expanding/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/first-line-afatinib-superior-to-standard-chemotherapy-in-advanced-egfr-mutated-non-small-cell-lung-cancer/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/expert-point-of-view-benjamin-j-solomon-mbbs-phd/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/2013-certifying-examination-in-pediatric-hematology-oncology/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/asco-studies-point-to-risks-associated-with-treating-childhood-cancers/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/bevacizumab-beyond-progression-prolongs-survival-in-metastatic-colorectal-cancer/ 2019-03-11T19:49:06+00:00 https://ascopost.com/issues/july-15-2012/expert-point-of-view-axel-grothey-md/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/expert-point-of-view-alan-venook-md/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/other-colorectal-cancer-news-from-asco/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/increased-adjuvant-therapy-use-and-improved-survival-in-dutch-elderly-patients-with-stage-iii-colon-cancer-a-direct-correlation/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/new-study-on-communicating-bad-news-from-the-patient-s-perspective/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/richard-goldberg-md-gives-first-moertel-lecture/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/pace-trial-update-ponatinib-produces-high-response-rates-in-cml/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/updated-findings-further-define-role-of-tyrosine-kinase-inhibitors-in-cml/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/prognostic-value-of-integrated-cytogenetic-and-mutational-risk-classification-in-acute-myeloid-leukemia/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/after-a-decade-of-decline-in-smoking-rates-progress-has-stalled/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/gene-profiling-guided-therapy-may-improve-survival-in-patients-with-carcinoma-of-unknown-primary/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/sidebar-key-findings/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/fda-approves-cetuximab-plus-folfiritherascreen-in-colorectal-cancer/ 2019-03-11T19:49:07+00:00 https://ascopost.com/issues/july-15-2012/proton-therapy-system-granted-510-k-clearance/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/regorafenib-in-metastatic-colorectal-cancer/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/system-for-breast-cancer-surgeries-gets-positive-vote/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/blood-test-to-improve-prostate-cancer-detection/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/asco-launches-oncology-practice-census/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/asco-bookstore-revamped/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/prostate-cancer-screening-what-patients-need-to-know/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/yia-and-cda-abbreviations-of-great-importance-to-continued-progress-in-cancer-research/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/sarcoma-foundation-of-america-teams-with-conquer-cancer-foundation-to-fund-potentially-life-saving-research/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/sidebar-sfa-sponsored-research/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/cancer-care-in-rwanda-a-model-of-creative-partnerships/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/mitotane-containing-regimens-explored-for-a-rare-tumor/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/new-study-examines-racial-disparities-in-breast-cancer-mortality/ 2019-03-11T19:49:08+00:00 https://ascopost.com/issues/july-15-2012/alterations-in-pten-insufficient-to-predict-sensitivity-to-drugs-targeting-pi3kmtor-pathway/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/two-single-nucleotide-polymorphisms-associated-with-risk-for-paclitaxel-related-peripheral-neuropathy/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/single-nucleotide-polymorphisms-predict-severe-toxicity-of-adjuvant-therapy-in-colorectal-cancer/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/nk-cell-signature-associated-with-favorable-prognosis-in-breast-cancer/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/p53-mutation-in-advanced-solid-tumors-linked-to-aggressive-course/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/cabozantinib-prolongs-progression-free-survival-in-advanced-medullary-thyroid-cancer/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/expert-point-of-view-samuel-a-wells-md/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/soy-phytoestrogens-and-breast-cancer-an-enduring-dilemma/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/early-access-to-palliativesupportive-care-vs-usual-care-improves-pain-management/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/my-breast-cancer-had-been-coming-for-years/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/identification-of-novel-mechanism-for-suppression-of-antitumor-immunity/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/pazopanib-new-drug-for-advanced-soft-tissue-sarcoma/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/jesus-san-miguel-receives-josé-carreras-award/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/2012-oncology-meetings/ 2019-03-11T19:49:09+00:00 https://ascopost.com/issues/july-15-2012/mek-inhibitor-reduces-progression-of-braf-mutated-melanoma-and-might-also-benefit-others/ 2019-03-11T19:49:10+00:00 https://ascopost.com/issues/july-15-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:49:10+00:00 https://ascopost.com/issues/july-15-2012/pretreatment-tumor-hypoxia-predicts-biochemical-failure-after-radiotherapy-for-prostate-cancer/ 2019-03-11T19:49:10+00:00 https://ascopost.com/issues/july-15-2012/screening-should-begin-early-for-survivors-of-childhood-cancer/ 2019-03-11T19:49:10+00:00 https://ascopost.com/issues/july-15-2012/adjuvant-chemotherapy-may-confer-survival-benefit-in-patients-older-than-75-with-stage-iii-disease/ 2019-03-11T19:49:10+00:00 https://ascopost.com/issues/july-1-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/july-1-2012/expert-point-of-view-pd-1-immune-checkpoint-inhibitors-look-promising-in-multiple-solid-tumors/ 2019-03-11T19:50:00+00:00 https://ascopost.com/issues/july-1-2012/new-psa-recommendations-the-debate-over-prostate-cancer-screening-continues/ 2019-03-11T19:50:00+00:00 https://ascopost.com/issues/july-1-2012/breast-cancer-and-noncommunicable-diseases-where-in-the-world-do-we-start/ 2019-03-11T19:50:00+00:00 https://ascopost.com/issues/july-1-2012/prostate-cancer-management-a-day-late-and-a-dollar-short/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/german-study-finds-bendamustine-improves-progression-free-survival-in-patients-with-non-hodgkin-lymphoma/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/expert-point-of-view-richard-i-fisher-md/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/expert-point-of-view-michael-williams-md/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/continuous-androgen-deprivation-therapy-continues-to-be-standard-of-care-for-newly-diagnosed-metastatic-prostate-cancer/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/swog-9346-conclusions-debated-in-special-post-plenary-discussion/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/expert-point-of-view-william-k-oh-md/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/new-standard-of-care-for-anaplastic-oligodendroglial-tumors-with-1p19q-codeletions/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/expert-point-of-view-mark-gilbert-md/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/bevacizumab-and-olaparib-boost-progression-free-survival-in-ovarian-cancer/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/expert-point-of-view-michael-seiden-md/ 2019-03-11T19:50:01+00:00 https://ascopost.com/issues/july-1-2012/older-breast-cancer-drugs-prove-superior-to-newer-ones/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/expert-point-of-view-kathy-miller-md/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/asco-s-cancerlinq-building-a-transformation-in-cancer-care/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/a-decade-of-trusted-cancer-education/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/help-your-patients-understand-the-latest-research/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/medical-ethicists-reflect-on-their-personal-cancer-experiences/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/novel-agent-carfilzomib-receives-positive-vote-from-oncologic-drugs-advisory-committee-for-use-in-multiple-myeloma/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/multicenter-phase-ii-trial-supporting-approval-of-brentuximab-vedotin-in-anaplastic-large-cell-lymphoma/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/too-soon-to-know-how-circulating-tumor-cells-might-be-used-to-guide-treatment-of-breast-cancer/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/everolimus-new-indication-in-renal-angiomyolipoma-associated-with-tuberous-sclerosis-complex/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/to-scan-or-not-to-scan-for-colon-cancer-recurrence/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/after-complete-response-to-chemotherapy-ifrt-improves-event-free-survival-in-hodgkin-lymphoma/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/obese-patients-at-higher-risk-of-aggressive-thyroid-tumors/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/fda-approves-pertuzumab-for-her2-positive-metastatic-breast-cancer/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/july-1-2012/supplemental-new-drug-application-submitted-for-abiraterone/ 2019-03-11T19:50:02+00:00 https://ascopost.com/issues/june-15-2012-supplement/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/june-15-2012-supplement/special-anniversary-issue-narratives-in-oncology/ 2020-09-16T13:21:26+00:00 https://ascopost.com/issues/june-15-2012-supplement/from-small-town-house-calls-to-bone-marrow-transplants-nobel-laureate-continues-father-s-legacy/ 2019-03-11T19:50:21+00:00 https://ascopost.com/issues/june-15-2012-supplement/reflections-on-the-evolution-of-clinical-cancer-research-and-turning-points-in-a-distinguished-career/ 2019-03-11T19:50:21+00:00 https://ascopost.com/issues/june-15-2012-supplement/trailblazing-neurologist-leads-the-way-in-advancing-treatment-of-cancer-pain/ 2019-03-11T19:50:21+00:00 https://ascopost.com/issues/june-15-2012-supplement/on-the-early-days-of-breast-conserving-therapy-and-the-unique-relationship-between-oncologists-and-their-patients/ 2019-03-11T19:50:22+00:00 https://ascopost.com/issues/june-15-2012-supplement/tracing-breast-cancer-luminary-s-path-to-oncology-from-hungary-to-houston/ 2019-03-11T19:50:22+00:00 https://ascopost.com/issues/june-15-2012-supplement/after-3-decades-at-md-anderson-leukemia-researcher-shows-no-sign-of-slowing-down/ 2019-03-11T19:50:22+00:00 https://ascopost.com/issues/june-15-2012-supplement/trailblazing-oncologist-had-instrumental-role-in-france-s-war-on-cancer/ 2019-03-11T19:50:22+00:00 https://ascopost.com/issues/june-15-2012-supplement/dana-farber-researcher-s-work-with-partners-in-health-brings-quality-cancer-care-to-rwanda/ 2019-03-11T19:50:22+00:00 https://ascopost.com/issues/june-15-2012-supplement/new-asco-president-reflects-on-value-of-mentorship-and-addressing-health-care-disparities/ 2019-03-11T19:50:22+00:00 https://ascopost.com/issues/june-15-2012-supplement/when-it-comes-to-scientific-exploration-renowned-clinical-investigator-lets-the-work-guide-his-path/ 2019-03-11T19:50:22+00:00 https://ascopost.com/issues/june-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/june-15-2012/t-dm1-proves-more-effective-less-toxic-than-standard-treatment-for-metastatic-breast-cancer/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/expert-point-of-view-t-dm1-proves-more-effective-less-toxic-than-standard-treatment-for-metastatic-breast-cancer/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/decoding-the-genetic-blueprint-of-cancer-cells-findings-in-multiple-myeloma-and-breast-cancer/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/radiotherapy-in-early-stage-hodgkin-lymphoma/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/encouraging-results-with-neoadjuvant-therapy-for-high-risk-prostate-cancer/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/expert-point-of-view-encouraging-results-with-neoadjuvant-therapy-for-high-risk-prostate-cancer/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/crizotinib-yields-benefits-in-aggressive-pediatric-tumors/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/expert-point-of-view-crizotinib-yields-benefits-in-aggressive-pediatric-tumors/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/antipsychotic-effectively-controls-chemotherapy-induced-breakthrough-nausea-and-vomiting/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/dual-braf-and-mek-inhibition-is-active-in-advanced-melanoma/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/expert-point-of-view-dual-braf-and-mek-inhibition-is-active-in-advanced-melanoma/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/better-information-needed-for-primary-care-providers-who-treat-cancer-survivors/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/at-more-than-a-century-old-american-association-for-cancer-research-continues-to-evolve/ 2019-03-11T19:50:41+00:00 https://ascopost.com/issues/june-15-2012/can-whole-genome-sequencing-predict-cancer-risk-and-improve-public-health/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/maintenance-lenalidomide-improves-progression-free-survival-and-time-to-progression-in-patients-with-multiple-myeloma/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/postsurgical-local-breast-cancer-therapies-compared-in-two-large-studies/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/epidemiology-diagnosis-and-treatment-of-breast-cancer-explored-at-the-american-society-of-breast-surgeons-meeting/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/risk-stratification-and-targeted-therapy-abetted-by-collaboration-improve-outcomes-for-children-with-cancer/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/cancer-survivors-stand-up-give-thanks-and-give-back/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/study-validates-prognostic-role-of-tumor-lymphocytic-infiltration-in-resectable-non-small-cell-lung-cancer/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/best-of-asco-meetings-deliver-top-annual-meeting-abstracts-and-select-educational-sessions-in-an-intimate-setting/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/full-membership-what-it-means-what-it-offers-and-why-it-s-essential/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/patient-friendly-news-from-the-asco-annual-meeting/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/markers-in-cancer-2012-to-be-held-october-11-13-will-seek-to-move-the-field-of-biomarkers-to-the-next-phase/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/asco-participates-in-two-fda-meetings-on-improving-clinical-trials/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/multiple-myeloma-research-foundation-initiatives-are-leading-to-more-effective-targeted-treatments/ 2019-03-11T19:50:42+00:00 https://ascopost.com/issues/june-15-2012/sidebar-success-of-the-multiple-myeloma-research-consortium/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/marrow-cells-in-secondary-acute-myeloid-leukemia-are-highly-clonally-derived-raising-implications-for-treatment-strategies/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/strong-biomarker-candidates-for-predicting-clinical-response-to-bevacizumab/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/egidio-del-fabbro-named-program-director-of-palliative-care-at-virginia-commonwealth-university-massey-cancer-center/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/international-photodynamic-medicine-symposium-shedding-new-light-on-an-old-therapy/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/sidebar-photodynamic-therapy-for-cancer/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/drug-safety-communication-issued-regarding-lenalidomide-and-risk-of-new-malignancies/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/fda-approves-drugs-faster-than-canadian-and-european-counterparts/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/aflibercept-granted-priority-review-for-metastatic-colorectal-cancer/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/fda-led-research-team-discovers-autoimmune-mechanism-for-drug-induced-adverse-reactions/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/denosumab-delays-time-to-first-bone-metastasis-in-men-with-castration-resistant-prostate-cancer/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/new-drug-application-submitted-for-regorafenib-for-the-treatment-of-metastatic-colorectal-cancer/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/asco-reexamines-the-oncology-workforce-shortage/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/sidebar-choosing-wisely-campaign/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/newest-indication-for-rituximab-as-maintenance-treatment-in-non-hodgkin-lymphoma/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/what-you-need-to-know-about-glucarpidase-injection-for-toxic-methotrexate-levels-in-renal-impairment/ 2019-03-11T19:50:43+00:00 https://ascopost.com/issues/june-15-2012/will-study-showing-increased-complications-compared-to-whole-breast-irradiation-put-the-brakes-on-brachytherapy/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/sidebar-difference-between-efficacy-and-effectiveness/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/studies-report-findings-in-patient-centered-care/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/acai-berry/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/pain-remains-prevalent-and-often-inadequately-treated-among-cancer-outpatients/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/screening-for-distress-and-unmet-needs-in-patients-with-cancer/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/surviving-the-aftermath-of-cancer/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/pretreatment-tumor-hypoxia-predicts-biochemical-failure-after-radiotherapy-for-prostate-cancer/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/complex-relationship-between-metformin-and-braf-mutant-tumors/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/gab2-promotes-characteristics-of-epithelial-to-mesenchymal-transition-in-ovarian-cancer/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/anti-epcam-antibody-drug-conjugate-shows-high-activity-against-pancreatic-cancer/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/the-semantics-of-palliative-care/ 2019-03-11T19:50:44+00:00 https://ascopost.com/issues/june-15-2012/physicians-need-to-be-involved-in-reducing-costs/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/june-15-2012/regional-disparities-in-cancer-mortality/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/june-15-2012/low-dose-radioiodine-as-effective-as-high-dose-in-thyroid-ablation/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/june-15-2012/panobinostat-produces-objective-responses-in-patients-refractory-to-autologous-transplant/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/june-15-2012/pediatric-all-with-induction-failure-is-highly-heterogeneous-with-varying-outcomes/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/june-15-2012/scoring-system-based-on-dna-repair-pathways-predicts-outcomes-and-response-to-platinum-therapy/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/june-15-2012/oncology-meetings/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/june-15-2012/new-breast-biopsy-system-with-vacuum-technology-approved/ 2019-03-11T19:50:45+00:00 https://ascopost.com/issues/may-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/may-15-2012/asco-issues-new-guideline-on-chemotherapy-dosing-for-obese-patients/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/sidebar-obese-children-with-cancer-may-be-at-greater-risk-for-cancer-recurrence/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/maintenance-of-certification-in-medical-oncology/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/advances-in-prostate-cancer-accompanied-by-ongoing-debates/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/fda-approves-pazopanib-for-advanced-soft-tissue-sarcoma/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/managing-febrile-neutropenia-what-are-the-best-antibiotic-regimens/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/immunotherapy-clinical-trials-show-benefits-for-advanced-cancers/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/sidebar-learning-from-advanced-disease/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/regional-infusion-of-designer-t-cells-to-treat-intrahepatic-metastases/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/inhibition-of-sfrp2-inhibits-growth-of-triple-negative-breast-tumors/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/continued-benefit-of-psa-screening-in-reducing-prostate-cancer-mortality/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/expert-point-of-view-continued-benefit-of-psa-screening/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/progress-in-treating-cll-has-led-to-improvements-in-survival/ 2019-03-11T19:51:19+00:00 https://ascopost.com/issues/may-15-2012/study-shows-steady-increases-in-survival-for-children-with-all/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/cancer-care-in-india-complex-challenges-in-a-populous-nation/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/untreated-cancer-pain-remains-a-significant-global-problem/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/sidebar-health-care-divide-creates-disparity/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/genetic-signature-identifies-risk-of-relapse-in-completely-resected-early-nsclc/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/expert-point-of-view-genetic-signature-identifies-risk-of-relapse-in-completely-resected-early-nsclc/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/study-reports-on-biomarker-of-response-in-lung-cancer-chemoprevention-studies/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/biomarker-analysis-of-the-torch-study/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/expert-point-of-view-biomarker-analysis-of-the-torch-study/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/analysis-suggests-ct-screening-could-save-lives-at-relatively-low-cost/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/vandetanib-new-drug-for-unresectable-medullary-thyroid-cancer/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/ccf-board-member-cites-need-to-grow-research-capacity/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/new-video-series-addresses-challenges-facing-young-survivors/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/asco-professorship-focuses-on-teaching-drug-development-to-young-oncology-researchers/ 2019-03-11T19:51:20+00:00 https://ascopost.com/issues/may-15-2012/asco-launches-first-annual-quality-care-symposium-november-30/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/asco-past-president-highlights-qopi-efforts-to-improve-care-in-michigan/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/cancernet-celebrating-10-years-of-trusted-cancer-education/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/important-information-regarding-abstract-distribution-for-the-2012-asco-annual-meeting/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/jama-highlights-new-comparative-effectiveness-studies/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/fda-strengthens-international-collaboration-to-ensure-safety-of-imported-products/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/automated-her2-immunohistochemical-system-approved/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/fda-reminds-public-about-potential-for-life-threatening-harm-from-exposure-to-fentanyl-patches/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/fda-strengthens-monitoring-of-postapproval-drug-safety/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/more-new-data-support-use-of-daily-aspirin-to-prevent-cancers/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/expert-point-of-view-more-new-data-support-use-of-daily-aspirin-to-prevent-cancers/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/new-research-shows-promise-in-cachexia-a-persistent-clinical-challenge/ 2019-03-11T19:51:21+00:00 https://ascopost.com/issues/may-15-2012/american-lung-association-provides-guidance-on-lung-cancer-screening/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/chemoradiation-reduces-recurrence-of-muscle-invasive-bladder-cancer/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/expert-point-of-view-chemoradiation-reduces-recurrence-of-muscle-invasive-bladder-cancer/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/before-accepting-a-friend-request-on-social-media-carefully-consider-pitfalls/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/sidebar-social-media-a-generational-thing/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/geriatric-oncologists-a-small-but-passionate-group/ 2020-02-17T18:05:26+00:00 https://ascopost.com/issues/may-15-2012/state-oncology-societies-honored-for-new-programs-that-improve-patient-care/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/study-of-adjuvant-therapy-for-nsclc-shows-increased-use-in-elderly-patients/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/oncology-practices-recognized-for-important-work-in-clinical-trials/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/oral-rivaroxaban-is-noninferior-to-standard-anticoagulant-therapy-in-acute-pulmonary-embolism/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/asco-president-michael-p-link-md-on-passage-of-fda-safety-and-innovation-act/ 2019-03-11T19:51:22+00:00 https://ascopost.com/issues/may-15-2012/field-cancerization-in-normal-tissue-adjacent-to-breast-tumors/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/inhibition-of-il-8-receptor-reduces-colorectal-cancer-proliferation/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/brachytherapy-associated-with-increased-complications-compared-to-whole-breast-irradiation/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/novel-initiative-to-address-oncology-drug-crisis/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/fellows-of-the-asco-2012-recipients-will-be-honored-at-annual-meeting/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/oncology-professionals-and-leaders-to-be-honored-at-asco-annual-meeting/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/scott-m-lippman-md-named-new-director-of-uc-san-diego-moores-cancer-center/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/update-on-oncology-drug-shortage/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/sidebar-drug-development-in-the-era-of-personalized-medicine/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/collaborating-to-conquer-cancer-theme-of-2012-asco-annual-meeting/ 2019-03-11T19:51:23+00:00 https://ascopost.com/issues/may-15-2012/two-cycles-of-chemotherapy-plus-involved-field-radiation-improves-tumor-control/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/concepts-about-effects-of-menopausal-hormone-therapy-on-breast-cancer/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/women-treated-with-breast-conserving-surgery-more-likely-to-have-diagnostic-and-invasive-procedures/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/younger-patients-treated-with-systemic-carboplatin-at-higher-risk-of-ototoxicity/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/integrated-genetic-profiling-can-identify-predictors-of-outcome-in-aml/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/partial-nephrectomy-can-optimize-survival-in-patients-with-early-stage-disease/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/i-refuse-to-let-cancer-win/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/asco-continues-to-support-oncologists-in-ehr-adoption-at-2012-annual-meeting/ 2019-03-11T19:51:24+00:00 https://ascopost.com/issues/may-15-2012/2012-oncology-meetings/ 2019-03-11T19:51:25+00:00 https://ascopost.com/issues/may-1-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/may-1-2012/novel-multikinase-inhibitor-improves-survival-in-metastatic-colorectal-cancer/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/expert-point-of-view-novel-multikinase-inhibitor-improves-survival-in-metastatic-colorectal-cancer/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/caveat-oncologist-counterfeit-pharmaceuticals/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/defining-meaningful-benefit/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/letter-to-the-editor-patient-protection-and-affordable-care-act-reconsidered/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/nccn-clinical-practice-guidelines-important-updates-for-2012/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/novel-agents-and-genomic-sequencing-show-promise-in-multiple-myeloma/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/coloprint-gene-assay-can-guide-treatment-decisions-in-stage-ii-colon-cancer/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/expert-point-of-view-coloprint-gene-assay-can-guide-treatment-decisions-in-stage-ii-colon-cancer/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/clinical-findings-and-consequences-of-distributing-counterfeit-drugs/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/fda-approves-investigational-new-drug-application-for-me-344/ 2019-03-11T19:51:52+00:00 https://ascopost.com/issues/may-1-2012/jco-presents-new-training-seminar-for-authors/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/asco-guidelines-support-weight-based-chemotherapy-dosing/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/constructing-a-top-five-list-in-oncology/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/institute-of-medicine-report-on-omics-based-testing/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/pedf-has-cytotoxic-effect-on-breast-cancer-cells-and-neuron-protective-effect/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/targeting-human-endogenous-retrovirus-k-envelope-protein-inhibits-breast-cancer-growth/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/bone-morphogenesis-protein-4-pathway-as-treatment-target/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/smac-mimetics-induce-proinflammatory-cancer-cell-death/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/changing-the-course-of-human-health-through-bold-pursuits-in-science/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/using-imatinib-for-adjuvant-treatment-after-resection-of-kit-positive-gist/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/dr-ronald-d-alvarez-elected-president-of-the-sgo/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/new-guidelines-recommend-less-frequent-screening-for-cervical-cancer/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/sidebar-could-hpv-testing-be-used-alone/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/sidebar-women-who-received-hpv-vaccine-still-need-cervical-cancer-screening/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:51:53+00:00 https://ascopost.com/issues/may-1-2012/quality-of-life-is-whats-most-important-to-me/ 2019-03-11T19:51:54+00:00 https://ascopost.com/issues/may-1-2012/nearly-800-000-lung-cancer-deaths-averted-due-to-decline-in-smoking-rates/ 2019-03-11T19:51:54+00:00 https://ascopost.com/issues/may-1-2012/adding-cetuximab-to-adjuvant-therapy-with-modified-folfox6-does-not-improve-survival/ 2019-03-11T19:51:54+00:00 https://ascopost.com/issues/may-1-2012/2012-oncology-meetings/ 2019-03-11T19:51:54+00:00 https://ascopost.com/issues/april-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/april-15-2012/neoadjuvant-aromatase-inhibitor-therapy-converts-many-patients-to-candidates-for-breast-conserving-surgery/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/our-patients-our-teachers/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/accc-meeting-focuses-on-affordable-care-act-its-future-and-what-it-might-accomplish/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/we-need-an-index-of-biologic-aging/ 2020-02-17T18:02:26+00:00 https://ascopost.com/issues/april-15-2012/asco-releases-palliative-care-provisional-clinical-opinion/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/sidebar-asco-pco-expert-panel/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/targeting-kras-in-gi-cancers-the-hunt-for-the-holy-grail-in-cancer-research/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/survival-analysis-by-gastric-cancer-subtypes-in-avagast-phase-iii-trial/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/controlled-study-links-chemobrain-to-longitudinal-changes-in-brain/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/expert-point-of-view-controlled-study-links-chemobrain-to-longitudinal-changes-in-brain/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/george-kovach-md-named-as-president-of-the-accc/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/concurrent-chemoradiation-therapy-is-viable-strategy-for-bladder-cancer/ 2019-03-11T19:52:26+00:00 https://ascopost.com/issues/april-15-2012/expert-point-of-view-concurrent-chemoradiation-is-viable-strategy-for-bladder-cancer/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/short-term-hormone-therapy-did-not-increase-risk-of-cv-death-in-prostate-cancer/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/expert-point-of-view-short-term-hormone-therapy-did-not-increase-risk-of-cv-death-in-prostate-cancer/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/select-trial-update-vitamin-e-fails-to-prevent-prostate-cancer-in-healthy-men/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/expert-point-of-view-select-trial-update-vitamin-e-fails-to-prevent-prostate-cancer-in-healthy-men/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/nccn-announces-new-guidelines-for-adolescent-and-young-adult-oncology/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/radiation-oncologists-are-discussing-infertility-risks-with-young-patients/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/surgeon-general-releases-new-report-on-youth-smoking/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/major-conclusions-of-the-surgeon-generals-report-on-youth-tobacco-use/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/an-expert-shares-insight-into-the-future-of-lung-cancer-treatment/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/not-all-kras-mutations-are-alike-in-non-small-cell-lung-cancer/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/summary-of-asco-provisional-clinical-opinion-on-palliative-care/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/accc-releases-survey-on-oncology-medical-home/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/cancer-informatics-a-future-necessity-but-challenges-abound/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/sidebar-lessons-learned-from-cabig/ 2019-03-11T19:52:27+00:00 https://ascopost.com/issues/april-15-2012/2012-breast-cancer-symposium-to-expand-tumor-board-session/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/help-your-patients-understand-cost-of-care/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/asco-advocates-for-solutions-to-oncology-drug-shortage-crisis/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/research-of-two-2012-foundation-merit-award-recipients-highlighted/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/2012-annual-meeting-to-highlight-ncis-provocative-questions/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/aacr-inducts-dr-frank-mccormick-as-president/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/new-biomarker-predicts-survival-in-advanced-prostate-cancer/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/expert-point-of-view-new-biomarker-predicts-survival-in-advanced-prostate-cancer/ 2019-03-11T19:52:28+00:00 https://ascopost.com/issues/april-15-2012/advances-in-axillary-surgery-for-patients-with-breast-cancer/ 2019-03-11T19:52:29+00:00 https://ascopost.com/issues/april-15-2012/sidebar-international-study-confirms-acosog-z0011/ 2019-03-11T19:52:29+00:00 https://ascopost.com/issues/april-15-2012/treating-acute-promyelocytic-leukemia-without-chemotherapy/ 2019-03-11T19:52:29+00:00 https://ascopost.com/issues/april-15-2012/update-on-novel-anticoagulants-dabigatran-etexilate/ 2019-03-11T19:52:29+00:00 https://ascopost.com/issues/april-15-2012/odac-offers-recommendations-on-two-sarcoma-drugs/ 2019-03-11T19:52:29+00:00 https://ascopost.com/issues/april-15-2012/fda-commissioner-statement-surgeon-general-s-report-on-youth-smoking/ 2019-03-11T19:52:29+00:00 https://ascopost.com/issues/april-15-2012/fda-approves-new-silicone-gel-filled-breast-implant/ 2019-03-11T19:52:29+00:00 https://ascopost.com/issues/april-15-2012/erwinia-chrysanthemi-asparaginase-for-all/ 2019-03-11T19:52:30+00:00 https://ascopost.com/issues/april-15-2012/new-data-guide-treatment-for-rare-form-of-hodgkin-lymphoma/ 2019-03-11T19:52:30+00:00 https://ascopost.com/issues/april-15-2012/liposomal-vincristine-receives-positive-vote-from-odac/ 2019-03-11T19:52:30+00:00 https://ascopost.com/issues/april-15-2012/fda-drug-approvals-january-april-2012/ 2019-03-11T19:52:31+00:00 https://ascopost.com/issues/april-15-2012/cancer-does-not-have-to-be-a-death-sentence/ 2019-03-11T19:52:31+00:00 https://ascopost.com/issues/april-15-2012/asco-s-blueprint-sets-goals-for-accelerating-cancer-progress/ 2019-03-11T19:52:31+00:00 https://ascopost.com/issues/april-15-2012/sidebar-marking-40-years-of-cancer-progress/ 2019-03-11T19:52:31+00:00 https://ascopost.com/issues/april-15-2012/oncology-professionals-and-leaders-to-be-honored-at-asco-annual-meeting/ 2019-03-11T19:52:31+00:00 https://ascopost.com/issues/april-15-2012/thomas-j-smith-md-appointed-director-of-palliative-care-johns-hopkins/ 2019-03-11T19:52:32+00:00 https://ascopost.com/issues/april-15-2012/targeted-massively-parallel-sequencing-identifies-alterations-in-cancer-genes/ 2019-03-11T19:52:32+00:00 https://ascopost.com/issues/april-15-2012/targeted-mutations-in-atr-pathway-and-implications-for-combination-strategies/ 2019-03-11T19:52:32+00:00 https://ascopost.com/issues/april-15-2012/androgen-deprivation-therapy-may-lead-to-castration-resistance-in-prostate-cancer/ 2019-03-11T19:52:32+00:00 https://ascopost.com/issues/april-15-2012/sorafenib-plus-capecitabine-for-her2-negative-advanced-breast-cancer/ 2019-03-11T19:52:32+00:00 https://ascopost.com/issues/april-15-2012/benefit-of-adjuvant-tamoxifen-in-er-positive-dcis/ 2019-03-11T19:52:32+00:00 https://ascopost.com/issues/april-15-2012/psa-screening-reduced-prostate-cancer-specific-but-not-overall-mortality/ 2019-03-11T19:52:32+00:00 https://ascopost.com/issues/april-15-2012/salvage-chemotherapy-plus-best-supportive-care-in-advanced-gastric-cancer/ 2019-03-11T19:52:33+00:00 https://ascopost.com/issues/april-15-2012/higher-intake-of-red-meat-associated-with-increased-risk-of-mortality/ 2019-03-11T19:52:33+00:00 https://ascopost.com/issues/april-15-2012/options-for-preserving-fertility-should-be-considered-early/ 2019-03-11T19:52:33+00:00 https://ascopost.com/issues/april-15-2012/sidebar-expect-and-encourage-questions-from-your-patients/ 2019-03-11T19:52:33+00:00 https://ascopost.com/issues/april-15-2012/sidebar-internet-tool-to-calculate-risks-to-fertility/ 2019-03-11T19:52:33+00:00 https://ascopost.com/issues/april-15-2012/sidebar-oocyte-preservation/ 2019-03-11T19:52:33+00:00 https://ascopost.com/issues/april-15-2012/report-to-the-nation-finds-continuing-declines-in-cancer-death-rates/ 2019-03-11T19:52:33+00:00 https://ascopost.com/issues/april-15-2012/2012-oncology-meetings/ 2019-03-11T19:52:34+00:00 https://ascopost.com/issues/march-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/march-15-2012/re-analysis-of-radiant-2-finds-benefit-for-everolimus-in-patients-with-carcinoid-tumors/ 2019-03-11T19:53:22+00:00 https://ascopost.com/issues/march-15-2012/expert-point-of-view-radiant-2-finds-benefit-for-everolimus-in-carcinoid-tumors/ 2019-03-11T19:53:22+00:00 https://ascopost.com/issues/march-15-2012/searching-for-quality-in-an-increasingly-complex-health-care-environment/ 2019-03-11T19:53:22+00:00 https://ascopost.com/issues/march-15-2012/moving-the-field-of-geriatric-oncology-forward/ 2020-02-17T17:59:46+00:00 https://ascopost.com/issues/march-15-2012/prostate-cancer-studies-compare-outcomes-toxicities-and-costs/ 2019-03-11T19:53:22+00:00 https://ascopost.com/issues/march-15-2012/expert-point-of-view-prostate-cancer-studies-compare-outcomes-toxicities-costs/ 2019-03-11T19:53:22+00:00 https://ascopost.com/issues/march-15-2012/important-news-briefs-new-data-reported-in-prostate-bladder-and-kidney-cancers/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/new-assays-surveillance-techniques-reported-for-gi-malignancies/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/immune-changes-reported-with-early-use-of-sipuleucel-t-in-neoadjuvant-setting-for-prostate-cancer/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/adjuvant-therapy-for-stage-iii-colon-cancer/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/autologous-hematopoietic-cell-transplantation-for-adult-acute-myeloid-leukemia/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/autologous-transplant-vs-consolidation-chemotherapy-in-aml/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/next-generation-sequencing-in-metastatic-triple-negative-breast-cancer-yields-rewards/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/sidebar-genotype-and-treatment-outcomes/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/expert-point-of-view-next-gen-sequencing-in-metastatic-triple-neg-breast-cancer-yields-rewards/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/answer-to-secondary-cancers-with-raf-inhibitors-may-be-concomitant-mek-inhibition/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/expert-point-of-view-secondary-cancers-with-raf-inhibitors/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/rising-costs-in-radiation-oncology-linked-to-medicare-coverage/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/eating-problems-and-pain-prevalent-in-survivors-of-headneck-cancer/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/what-you-need-to-know-about-axitinib/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/asco-launches-community-research-forum-to-tackle-top-research-conundrums/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/research-of-former-foundation-grantee-james-yao-highlighted-at-the-gi-cancers-symposium/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/pre-annual-meeting-seminar-series-kicks-off/ 2019-03-11T19:53:23+00:00 https://ascopost.com/issues/march-15-2012/asco-submits-testimony-for-congressional-hearing-examining-quality-programs/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/help-your-patients-organize-their-cancer-care/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/fda-acts-to-bolster-supply-of-critically-needed-cancer-drugs/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/new-colonoscopy-system-cleared-by-fda/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/odac-votes-against-denosumab-to-delay-bone-metastasis/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/ki-67-image-analysis-and-digital-read-applications-cleared/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/first-urine-based-molecular-test-to-gauge-need-for-repeat-prostate-biopsies/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/fda-drug-approvals-january-march-2012/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/how-i-work-up-the-patient-with-thrombocytosis/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/researchers-map-potential-genetic-origins-pathways-of-lung-cancer-in-never-smokers/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/maintenance-with-lenalidomide-or-bortezomib-prolongs-remission-in-patients-with-myeloma/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/expert-point-of-view-maintenance-with-lenalidomide-or-bortezomib-in-multiple-myeloma/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/context-may-affect-benefit-of-adjuvant-clodronate-in-breast-cancer/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/risk-stratification-of-brca-mutation-carriers-may-help-guide-follow-up/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/research-funding-key-to-continued-progress-in-cancer-care/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/aacr-urges-congress-to-maintain-preferably-increase-cancer-research-funding/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/some-patients-using-complementary-and-alternative-therapies-may-be-receiving-parallel-care/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/ash-2011-presentations-include-novel-agents-and-new-strategies/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/adolescents-and-young-adults-with-cancer/ 2019-03-11T19:53:24+00:00 https://ascopost.com/issues/march-15-2012/sidebar-expect-and-ask-questions-about-sex-and-fertility-preservation/ 2019-03-11T19:53:25+00:00 https://ascopost.com/issues/march-15-2012/sidebar-should-aya-be-an-oncology-subspecialty/ 2019-03-11T19:53:25+00:00 https://ascopost.com/issues/march-15-2012/surviving-cancer-means-making-many-difficult-decisions/ 2019-03-11T19:53:25+00:00 https://ascopost.com/issues/march-15-2012/cost-of-cancer-therapy-the-elephant-in-the-room/ 2019-03-11T19:53:25+00:00 https://ascopost.com/issues/march-15-2012/survival-advantage-of-oxaliplatin-extends-to-diverse-group-of-patients/ 2019-03-11T19:53:25+00:00 https://ascopost.com/issues/march-15-2012/vegfr-tyrosine-kinase-inhibitors-linked-to-increased-risk-of-fatal-adverse-events/ 2019-03-11T19:53:25+00:00 https://ascopost.com/issues/march-15-2012/2012-oncology-meetings/ 2019-03-11T19:53:25+00:00 https://ascopost.com/issues/march-1-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/march-1-2012/two-novel-agents-prolong-survival-in-advanced-prostate-cancer/ 2019-03-11T19:53:53+00:00 https://ascopost.com/issues/march-1-2012/expert-point-of-view-two-novel-agents-prolong-survival-in-advanced-prostate-cancer/ 2019-03-11T19:53:53+00:00 https://ascopost.com/issues/march-1-2012/a-visionary-call-for-the-creative-destruction-of-medicine/ 2019-03-11T19:53:53+00:00 https://ascopost.com/issues/march-1-2012/inefficient-markets-impede-cancer-pain-relief/ 2019-03-11T19:53:53+00:00 https://ascopost.com/issues/march-1-2012/lung-cancer-alliance-announces-national-framework-for-lung-cancer-screening-excellence/ 2019-03-11T19:53:53+00:00 https://ascopost.com/issues/march-1-2012/what-were-the-take-home-messages-from-the-2012-gastrointestinal-cancers-symposium/ 2019-03-11T19:53:53+00:00 https://ascopost.com/issues/march-1-2012/sidebar-important-news-briefs-from-the-2012-gastrointestinal-cancers-symposium/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/atypical-breast-lesions-how-high-is-the-cancer-risk/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/genomics-projects-plumb-breast-cancers-inner-workings/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/expert-point-of-view-genomics-projects-plumb-breast-cancers-inner-workings/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/swog-s0226-findings-revive-interest-in-combination-hormonal-therapy/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/career-development-award-recipient-susan-k-parsons-md-supports-next-generation-of-researchers/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/sidebar-career-development-award/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/sidebar-leadership-to-legacy/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/asco-seeks-better-access-to-clinical-trials-for-patients-with-cancer/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/starting-down-the-path-toward-electronic-qopi-asco-and-us-oncology-collaborate-in-quality-measurement/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/cancernet-mobile-app-20-available-now/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/a-dose-of-destruction-and-tough-love-for-health-care/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/adding-thalidomide-to-chemo-increases-toxicities-but-not-survival-for-stage-iii-nsclc/ 2019-03-11T19:53:54+00:00 https://ascopost.com/issues/march-1-2012/challenges-progress-and-future-directions-in-head-and-neck-cancer/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/what-you-should-know-about-peginterferon-alfa-2b-for-adjuvant-treatment-of-melanoma/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/long-term-survival-benefit-and-safety-confirmed-for-vmp-regimen-in-multiple-myeloma/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/expert-point-of-view-long-term-survival-benefit-for-vmp-regimen-in-myeloma/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/which-is-better-peripheral-blood-or-bone-marrow-as-unrelated-donor-stem-cell-source/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/expert-point-of-view-peripheral-blood-vs-bone-marrow-as-unrelated-donor-stem-cell-source/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/similar-morbidity-higher-costs-for-robotic-vs-laparoscopic-hysterectomy-in-women-with-endometrial-cancer/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/carfilzomib-may-offer-advantages-in-patients-with-relapsedrefractory-multiple-myeloma/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/reexcision-rates-following-breast-conservation-surgery-vary-widely/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/a-patient-with-cancer-saw-a-need-and-left-a-living-legacy/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/pi3k-inhibitors-may-improve-response-to-cancer-immunotherapy/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/significant-differences-in-genetic-characteristics-of-primary-colorectal-cancer-and-hepatic-metastases/ 2019-03-11T19:53:55+00:00 https://ascopost.com/issues/march-1-2012/six1-eya2-interaction-a-potential-target-in-blocking-breast-cancer-metastasis/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/march-1-2012/combination-of-oncolytic-virus-and-chemotherapy-holds-promise-in-glioblastoma/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/march-1-2012/addition-of-bevacizumab-to-neoadjuvant-chemotherapy-increases-pcr-rate-in-her2-negative-disease/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/march-1-2012/nearly-identical-survival-for-laparoscopy-vs-laparatomy-in-patients-with-stage-iiia-disease/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/march-1-2012/facing-the-future-without-fear-of-breast-cancer-recurrence/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/march-1-2012/2012-oncology-meetings/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/march-1-2012/fda-issues-draft-guidance-on-biosimilar-product-development/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/march-1-2012/pertuzumab-gets-priority-review-for-metastatic-breast-cancer/ 2019-03-11T19:53:56+00:00 https://ascopost.com/issues/february-15-2012-supplement/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/february-15-2012-supplement/special-supplement-reports-from-sabcs-and-ash-annual-meeting/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/dual-her2-blockade-substantially-delays-disease-progression/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-dual-her2-blockade-substantially-delays-disease-progression/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/sidebar-lessons-learned-from-other-her2-trials/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/bevacizumab-progression-free-survival-benefit-upheld-in-averel-trial/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-bevacizumab-progression-free-survival-benefit-upheld-in-averel-trial/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/benefits-of-some-bisphosphonates-confirmed-in-breast-cancer-outcomes-but-questions-remain/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-benefits-of-some-bisphosphonates-confirmed-in-breast-cancer-outcomes-but-questions-remain/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/can-molecular-profiling-identify-er-positive-patients-destined-for-relapse/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-can-molecular-profiling-identify-er-positive-patients-destined-for-relapse/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-2-can-molecular-profiling-identify-er-positive-patients-destined-for-relapse/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/everolimus-plus-exemestane-significantly-prolongs-remission-in-bolero-2/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-everolimus-plus-exemestane-significantly-prolongs-remission-in-bolero-2/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/post-chop-radioimmunotherapy-comparable-to-rituximab-with-chop/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-post-chop-radioimmunotherapy-comparable-to-rituximab-with-chop/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/bela-trial-reborn-bosutinib-produces-improved-results-in-chronic-myeloid-leukemia/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-bela-trial-reborn-bosutinib-produces-improved-results-in-chronic-myeloid-leukemia/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/ponatinib-continues-to-impress-in-patients-with-leukemia/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-ponatinib-continues-to-impress-in-patients-with-leukemia/ 2019-03-11T19:56:38+00:00 https://ascopost.com/issues/february-15-2012-supplement/three-novel-agents-show-promise-in-acute-lymphoblastic-leukemia/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012-supplement/novel-agent-efficacious-in-chronic-lymphocytic-leukemia/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012-supplement/a-second-chance-for-gemtuzumab-in-acute-myeloid-leukemia/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012-supplement/monoclonal-antibody-promising-in-multiple-myeloma/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-monoclonal-antibody-promising-in-multiple-myeloma/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012-supplement/next-gen-proteasome-inhibitors-improves-outcomes-in-bortezomib-refractory-myeloma/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012-supplement/expert-point-of-view-next-gen-proteasome-inhibitors-improve-outcomes-in-bort-refractory-myeloma/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012-supplement/new-immunomodulatory-drug-produces-impressive-phase-ii-results-in-mm/ 2019-03-11T19:56:39+00:00 https://ascopost.com/issues/february-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/february-15-2012/maintenance-rituximab-vs-retreatment-rituximab-in-patients-with-low-tumor-burden-follicular-lymphoma/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/expert-point-of-view-maintenance-vs-retreatment-rituximab-in-pts-with-low-tumor-burden-fl/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/drug-shortages-hit-oncology-hard-experts-weigh-in-on-challenges-and-solutions/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/cost-of-care-a-multidisciplinary-responsibility/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/axitinib-receives-fda-approval-in-advanced-renal-cell-carcinoma/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/fda-approves-vismodegib-for-basal-cell-carcinoma/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/ingenol-mebutate-approved-for-topical-actinic-keratosis-therapy/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/glucarpidase-approved-to-treat-methotrexate-toxicity/ 2019-03-11T19:58:18+00:00 https://ascopost.com/issues/february-15-2012/shared-rems-approved-for-all-transmucosal-immediate-release-fentanyl-products/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/fda-completes-work-on-three-drug-user-fee-programs/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/subcutaneous-bortezomib-approved/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/averel-trial-shows-benefit-of-bevacizumab-in-her2-positive-locally-recurrent-or-metastatic-breast-cancer/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/study-questions-use-of-partial-breast-brachytherapy-in-older-women/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/new-anti-cd20-monoclonal-antibody-studied-in-b-cell-non-hodgkin-lymphoma/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/is-gemtuzumab-a-therapeutic-option-in-older-patients-with-acute-myeloid-leukemia/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/expert-point-of-view-is-gemtuzumab-a-therapeutic-option-in-older-patients-with-acute-myeloid-leukemia/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/ablation-of-small-primary-breast-tumors-the-next-step-in-local-therapy/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/i-never-expected-to-get-lung-cancer/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/lung-cancer-advocates-seek-to-raise-awareness-and-research-funding/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/epigenetic-therapy-shows-positive-results-in-late-stage-lung-cancer/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/qopi-certifies-100th-practice-for-delivering-high-quality-cancer-care/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/integration-of-qopi-helps-michigan-insurer-earn-best-of-blue-award/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/asco-membership-categories-offer-a-place-for-everyone/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/show-your-patients-the-latest-research-on-genitourinary-cancers/ 2019-03-11T19:58:19+00:00 https://ascopost.com/issues/february-15-2012/cancer-survivors-at-greater-risk-for-cutaneous-melanoma/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/tyrosine-kinase-inhibitor-therapy-yields-complete-remission-in-patients-with-metastatic-renal-cell-carcinoma/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/laparoscopic-liver-resections-can-be-safe-and-oncologically-efficient/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/abiraterone-new-drug-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/fda-approves-imatinib-for-expanded-use-in-gist/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/surgical-oncology-advances-and-challenges-in-breast-cancer-surgery/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/partial-breast-irradiation-with-brachytherapy-in-early-breast-cancer/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/jak2-and-mpl-mutation-screening-what-are-the-indications-and-how-to-interpret-the-results/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/cancerconnect-offers-online-alternative-networking-for-patients/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/oncologists-examine-promise-vs-reality-of-personalized-medicine/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/depression-is-dangerous-among-patients-with-cancer-but-talking-and-pharmacologic-treatments-can-be-effective/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/sidebar-expect-patients-from-your-patients/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/targeting-aktmtor-may-improve-response-to-monoclonal-antibodies-in-some-cancers/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/impact-of-p53-status-on-cancer-treatment-selection/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/overexpression-of-p16-does-not-indicate-increased-risk-of-breast-cancer-in-women-with-atypical-hyperplasia/ 2019-03-11T19:58:20+00:00 https://ascopost.com/issues/february-15-2012/risk-of-sexual-and-continence-problems-no-lower-with-robotic-than-with-open-surgery/ 2019-03-11T19:58:21+00:00 https://ascopost.com/issues/february-15-2012/high-egfr-expression-can-predict-survival-benefit-from-cetuximab-plus-first-line-chemotherapy-in-nsclc/ 2019-03-11T19:58:21+00:00 https://ascopost.com/issues/february-15-2012/vandetanib-demonstrates-therapeutic-efficacy-in-patients-with-advanced-medullary-thyroid-cancer/ 2019-03-11T19:58:21+00:00 https://ascopost.com/issues/january-15-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/january-15-2012/improved-survival-with-chemotherapy-alone-in-limited-stage-hodgkin-lymphoma/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/expert-point-of-view-improved-survival-with-chemotherapy-alone-in-limited-stage-hodgkin-lymphoma/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/favorable-early-stage-hodgkin-lymphoma-and-hd6-the-take-home-and-don-t-take-home-messages/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/bevacizumab-breast-cancer-indication-rescinded-what-are-the-downstream-implications/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/sidebar-bevacizumab-in-breast-cancer-additional-perspective/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/sentinel-lymph-node-biopsy-for-thin-melanomas/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/gene-classifier-spots-different-recurrence-patterns-in-patients-with-er-positive-breast-cancer/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/oncology-research-a-strong-presence-at-the-american-college-of-surg/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/resection-of-metastatic-lesions-extends-survival-in-multiple-tumor-types/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/further-individualizing-staging-offers-benefits-in-patients-with-colon-cancer/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/odac-backs-axitinib-for-kidney-cancer/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/new-system-for-cervical-cancer-screening-approved/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/investigational-new-drug-application-filed-for-ont-10/ 2019-03-11T19:58:59+00:00 https://ascopost.com/issues/january-15-2012/package-inserts-revised-for-iv-methotrexate-products/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/nih-panel-endorses-active-surveillance-in-low-risk-prostate-cancer/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/data-on-watchful-waiting-for-low-risk-prostate-cancer-may-swing-focus-to-higher-risk-tumors/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/sipuleucel-t-should-be-used-early-in-metastatic-castrate-resistant-prostate-cancer/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/expert-point-of-view-sipuleucel-t-should-be-used-early-in-metastatic-castrate-resistant-prostate/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/estrogen-for-vulvovaginal-atrophy-in-breast-cancer-debate-continues/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/new-science-new-solutions-explored-at-society-for-integrative-oncology-conference/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/nih-director-calls-for-rigorous-evaluation-of-integrative-medicine-to-provide-evidence/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/acupuncture-continues-to-secure-position-within-integrative-oncology/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/asco-launches-fasco-designation/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/joining-asco-s-act-network-offers-variety-of-advocacy-opportunities/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/renewing-our-commitment-to-conquering-cancer/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/give-your-patients-the-latest-gi-research-news/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/conquer-cancer-foundation-grantees-advance-cancer-care/ 2019-03-11T19:59:00+00:00 https://ascopost.com/issues/january-15-2012/jop-content-now-available-online-before-print/ 2019-03-11T19:59:01+00:00 https://ascopost.com/issues/january-15-2012/neoadjuvant-chemotherapy-or-surgery-first-outcome-not-affected/ 2019-03-11T19:59:01+00:00 https://ascopost.com/issues/january-15-2012/single-agent-lapatinib-arm-discontinued-in-altto/ 2019-03-11T19:59:01+00:00 https://ascopost.com/issues/january-15-2012/changes-in-receptor-status-during-breast-cancer-progression-warrant-rebiopsies-at-relapse/ 2019-03-11T19:59:01+00:00 https://ascopost.com/issues/january-15-2012/expert-point-of-view-us-perspective/ 2019-03-11T19:59:01+00:00 https://ascopost.com/issues/january-15-2012/expert-point-of-view-european-perspective/ 2019-03-11T19:59:01+00:00 https://ascopost.com/issues/january-15-2012/what-you-should-know-about-denosumab-prolia-for-increasing-bone-mass-during-breast/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/advances-in-gynecologic-cancer-surgery-continue-to-improve-outcomes/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/therapy-for-hodgkin-lymphoma-in-the-elderly-remains-undefined/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/expert-point-of-view-therapy-for-hodgkin-lymphoma-in-the-elderly-remains-undefined/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/shortening-the-learning-curve-of-the-us-health-care-system/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/first-genomic-based-pediatric-trials-launched-in-neuroblastoma/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/2012-oncology-meetings/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/studies-reveal-that-hormonal-factors-influence-lung-cancer-risk-in-women/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/outpatients-need-to-be-aware-of-high-risk-of-developing-venous-thromboembolism/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/sidebar-clinical-trials-of-vte-prophylaxis-for-outpatients/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/conquer-cancer-foundation-awards-oncology-fellows-for-gi-cancer-research/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/adding-alemtuzumab-to-fludarabine-in-cll/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/everolimus-for-tumors-associated-with-carcinoid-syndrome/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/chemoradiotherapy-for-early-stage-nasopharyngeal-disease/ 2019-03-11T19:59:02+00:00 https://ascopost.com/issues/january-15-2012/don-t-take-away-our-hope/ 2019-03-11T19:59:03+00:00 https://ascopost.com/issues/january-1-2012/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/january-1-2012/bolero-2-everolimus-thwarts-resistance-to-hormonal-therapy-in-advanced-breast-cancer/ 2019-03-11T19:59:30+00:00 https://ascopost.com/issues/january-1-2012/ruxolitinib-for-myelofibrosis-therapy-a-good-start-but-a-long-road-ahead/ 2019-03-11T19:59:30+00:00 https://ascopost.com/issues/january-1-2012/integrative-oncology-essential-to-cancer-care/ 2019-03-11T19:59:30+00:00 https://ascopost.com/issues/january-1-2012/presurgical-gemcitabinecisplatin-improves-survival-in-lung-cancer/ 2019-03-11T19:59:30+00:00 https://ascopost.com/issues/january-1-2012/cleopatra-trial-finds-dual-her2-blockade-improves-progression-free-survival-in-advanced-breast-cancer/ 2019-03-11T19:59:30+00:00 https://ascopost.com/issues/january-1-2012/highlights-of-bladder-cancer-research-include-novel-agents/ 2019-03-11T19:59:31+00:00 https://ascopost.com/issues/january-1-2012/expert-point-of-view-highlights-of-bladder-cancer-research-include-novel-agents/ 2019-03-11T19:59:32+00:00 https://ascopost.com/issues/january-1-2012/advances-in-lung-cancer-treatment-show-incremental-benefits-but-room-for-improvement-remains/ 2019-03-11T19:59:32+00:00 https://ascopost.com/issues/january-1-2012/update-on-novel-treatments-for-peripheral-t-cell-lymphoma/ 2019-03-11T19:59:32+00:00 https://ascopost.com/issues/january-1-2012/gastric-cancer-is-on-the-rise-screening-and-education-are-vital/ 2019-03-11T19:59:32+00:00 https://ascopost.com/issues/january-1-2012/sidebar-can-t-stomach-cancer-seeks-to-jump-start-research-raise-awareness/ 2019-03-11T19:59:32+00:00 https://ascopost.com/issues/january-1-2012/new-indication-for-cetuximab-in-squamous-cell-carcinoma-of-the-head-and-neck/ 2019-03-11T19:59:32+00:00 https://ascopost.com/issues/january-1-2012/michael-c-perry-md-1945-2011/ 2019-03-11T19:59:32+00:00 https://ascopost.com/issues/january-1-2012/conquer-cancer-foundation-programs-for-medical-students-and-residents-support-diversity-in-oncology-workforce/ 2019-03-11T19:59:33+00:00 https://ascopost.com/issues/january-1-2012/weekly-online-polls-help-define-key-concerns-of-asco-members/ 2019-03-11T19:59:33+00:00 https://ascopost.com/issues/january-1-2012/young-investigator-award-renamed-to-honor-asco-founder-jane-c-wright-md/ 2019-03-11T19:59:33+00:00 https://ascopost.com/issues/january-1-2012/asco-president-michael-p-link-md-joins-colleagues-in-honoring-a-friend-and-touching-the-future-through-philanthropy/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/sidebar-about-the-nachman-award/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/help-your-patients-start-off-healthy-in-2012/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/intensified-chemotherapy-with-r-acvbp-improves-survival-in-younger-patients-with-diffuse-b-cell-lymphoma/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/adjuvant-chemotherapy-with-s-1-improves-survival-in-stage-iiiii-gastric-cancer/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/physician-based-screening-leads-to-the-detection-of-thinner-melanomas-with-more-favorable-prognosis/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/the-newly-diagnosed-patient-with-cancer-and-access-to-care/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/md-anderson-cancer-center-s-new-president-has-a-bold-vision/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/benefits-of-radiation-after-breast-conserving-surgery-cut-risk-of-recurrence-in-half/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/january-1-2012/humor-is-helping-me-survive-cancer/ 2019-03-11T19:59:34+00:00 https://ascopost.com/issues/december-15-2011/ 2021-06-08T17:57:25+00:00 https://ascopost.com/issues/december-15-2011/fda-announces-bevacizumab-decision-agency-will-revoke-breast-cancer-indication/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/breast-cancer-experts-voice-opinion-and-express-disappointment-over-fda-decision/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/a-conversation-with-ezekiel-j-emanuel-md-phd/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/prostate-cancer-screening-reconsidered/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/optimizing-her2-directed-therapy-in-the-clinic/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/sidebar-adding-trastuzumab-to-adjuvant-chemotherapy/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/2011-in-review-oncology-drugsindications-newly-approved-by-fda/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/new-drug-approved-to-treat-acute-lymphoblastic-leukemia/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/how-should-we-treat-nodular-lymphocyte-predominant-hodgkin-lymphoma/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/ash-honors-janet-rowley-md-and-brian-druker-md/ 2019-03-11T19:59:52+00:00 https://ascopost.com/issues/december-15-2011/important-briefs-from-the-2011-european-multidisciplinary-cancer-congress/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/benefit-of-panitumumab-seen-primarily-in-patients-with-recurrent-or-metastatic-head-and-neck-cancer/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/expert-point-of-view-benefit-of-panitumumab-seen-primarily-in-patients-with-recurrent-or-metastatic-head-and-neck-cancer/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/gathering-data-point-to-potential-advantages-of-vismodegib-in-basal-cell-carcinoma-and-other-advanced-cancers/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/neutrophillymphocyte-ratio-can-upstage-patients-with-bladder-cancer/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/lessons-from-a-northern-neighbor-a-conversation-with-joseph-m-connors-md/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/medical-students-can-now-be-asco-members-thanks-to-an-intern-who-pressed/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/asco-helps-survivors-transition-into-life-after-treatment-with-new-booklet/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/asco-issues-blueprint-for-transforming-cancer-research-in-the-molecular-era/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/2012-gu-cancers-symposium-to-reflect-the-fields-focus-on-personalized-cancer-care/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/help-your-patients-understand-the-significant-research-from-2011/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/clinical-cancer-advances-2011-ascos-report-on-progress-against-cancer/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/journal-of-oncology-practice-explores-use-of-palliative-care-in-practice/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/fda-approves-first-drug-to-treat-myelofibrosis/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/510-k-clearance-granted-for-oncotrac/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/male-breast-cancer-differs-from-breast-cancer-in-women-but-little-data-informs-treatment/ 2019-03-11T19:59:53+00:00 https://ascopost.com/issues/december-15-2011/american-society-of-hematology-elects-new-officers/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/improving-quality-and-safety-with-health-information-technology/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/oncologists-need-hands-on-approach-in-developing-next-generation-of-ehrs/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/need-for-data-capture-crucial-now-and-after-meaningful-use/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/reflections-from-the-asco-post/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/twitter-dominates-social-media-buzz-at-stockholm-meeting/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/sidebar-patient-advocates-form-huge-presence-at-emcc-2011/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/researchers-find-remarkable-heterogeneity-in-sarcomas/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/expert-point-of-view-researchers-find-remarkable-heterogeneity-in-sarcomas/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/the-art-and-grace-of-just-letting-go/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/significantly-longer-survival-with-axitinib-compared-to-sorafenib-in-patients-with-renal-cell-carcinoma/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/significant-neurologic-and-executive-function-impairment-among-breast-cancer-survivors/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/evidence-of-improved-survival-for-lobectomy-vs-limited-resection-in-early-stage-lung-cancer/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/solid-organ-transplant-recipients-have-increased-risk-for-broad-range-of-malignancies/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/sidebar-expect-questions-from-your-patients/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/my-cancer-is-incurable-but-my-future-is-limitless/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/medicare-reimbursement-to-physicians-deja-vu-all-over-again/ 2019-03-11T19:59:54+00:00 https://ascopost.com/issues/december-15-2011/sidebar-key-dates-in-the-medicare-physician-reimbursement-saga/ 2019-03-11T19:59:55+00:00 https://ascopost.com/issues/december-15-2011/neural-stem-cell-transplantation-may-improve-cognitive-function-in-brain-cancer/ 2019-03-11T19:59:55+00:00 https://ascopost.com/issues/november-15-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/november-15-2011/aflibercept-improves-overall-survival-in-patients-with-metastatic-colorectal-cancer/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-aflibercept-improves-overall-survival-in-patients-with-metastatic-colorectal-cancer/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/important-lessons-for-oncology-from-the-front-lines-of-the-aids-pandemic/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/chemotherapy-drug-shortages-a-preventable-human-disaster/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/sidebar-white-house-issues-executive-order-on-drug-shortage/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/novel-hdac-inhibitor-may-restore-estrogen-sensitivity-in-breast-cancer/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-novel-hdac-inhibitor-may-restore-estrogen-sensitivity-in-breast-cancer/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/nccn-meeting-addresses-issues-in-hematologic-malignancies/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/fewer-rectal-side-effects-with-imrt-than-with-3d-crt-for-prostate-cancer/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-fewer-rectal-side-effects-with-imrt-than-with-3d-crt-for-prostate-cancer/ 2019-03-11T20:00:21+00:00 https://ascopost.com/issues/november-15-2011/preoperative-chemoradiotherapy-may-extend-survival-for-patients-with-esophagogastric-junction-adenocarcinoma/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-preoperative-chemoradiotherapy-may-extend-survival-for-patients-with-esophagogastric-junction-adenocarcinoma/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/despite-challenges-combined-modality-therapy-warranted-for-locally-recurrent-colorectal-cancer/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/predictive-biomarker-for-bevacizumab-are-we-getting-closer/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/nccn-guidelines-for-lung-cancer-screening-now-available/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/sunitinib-and-everolimus-new-indications-in-pancreatic-neuroendocrine-tumors/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/global-trials-do-benefits-outweigh-pitfalls/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/oncology-s-only-benchmark-report-national-practice-benchmark-is-now-a-yearly-jop-supplement/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/asco-journal-apps-now-available-for-ipad-and-iphone/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/asco-in-action-online-your-source-for-policy-news-and-information/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/help-your-patients-understand-lung-cancer/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/hypofractionated-radiotherapy-effectively-controls-high-risk-prostate-cancer/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-hypofractionated-radiotherapy-effectively-controls-high-risk-prostate-cancer/ 2019-03-11T20:00:22+00:00 https://ascopost.com/issues/november-15-2011/tamoxifen-vs-surgery-study-shows-older-patients-with-breast-cancer-can-achieve-a-personal-cure/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/fda-approves-molecular-test-to-detect-hpv/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/vgx-100-investigational-new-drug-application-approved/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/test-for-aml-prognosis-cleared-by-fda/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/biosimilars-in-cancer-treatment-what-should-the-oncology-community-expect/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/american-society-of-hematology-recognizes-christoph-klein-md-phd-with-william-dameshek-prize/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/investigators-unlocking-the-mysteries-of-merkel-cell-carcinoma/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/sidebar-impact-of-basic-science-advances-on-cancer-management-highlighted-at-aacr-conference/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/chemotherapy-generally-safe-in-pregnancy/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-chemotherapy-generally-safe-in-pregnancy/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/geriatric-oncology-a-much-needed-discipline-for-future-cancer-care/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/fda-approves-cetuximab-to-treat-metastatic-head-and-neck-cancer/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/a-conversation-with-judith-redwing-keyssar-rn/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-lessening-patients-suffering-at-the-end-of-life/ 2019-03-11T20:00:23+00:00 https://ascopost.com/issues/november-15-2011/improved-survival-with-concurrent-chemotherapy-plus-radiotherapy-for-patients-with-stage-iii-non-small-cell-lung-cancer/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/breakthrough-approach-to-advanced-basal-cell-carcinoma-via-inhibition-of-hedgehog-pathway/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/expert-point-of-view-breakthrough-approach-to-advanced-basal-cell-carcinoma-via-inhibition-of-hedgehog-pathway/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/fighting-to-get-back-control/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/researchers-explore-reasons-for-higher-risk-of-triple-negative-breast-cancer-in-underserved-african-american-women/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/a-conversation-with-craig-b-thompson-md/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/challenging-perceptions-about-treatment-options-for-younger-women-with-early-stage-breast-cancer/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/sidebar-expect-questions-from-your-patients/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/adjuvant-trastuzumab-in-nonanthracycline-regimen-studied/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/mri-helps-predict-survival-outcomes-in-patients-with-rectal-cancer/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/should-age-at-initial-screening-colonoscopy-be-younger-for-men/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/oxaliplatin-improved-overall-survival-in-patients-under-70/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/low-level-expression-of-esr1-tied-to-tamoxifen-resistance/ 2019-03-11T20:00:24+00:00 https://ascopost.com/issues/november-15-2011/fewer-false-positives-small-increased-risk-of-late-diagnosis-with-biennial-mammography/ 2019-03-11T20:00:25+00:00 https://ascopost.com/issues/november-15-2011/alternative-treatment-for-advanced-ovarian-cancer-reduces-neurotoxicity-and-alopecia/ 2019-03-11T20:00:25+00:00 https://ascopost.com/issues/november-15-2011/rates-of-surgery-and-survival-increasing-for-early-stage-cancers/ 2019-03-11T20:00:25+00:00 https://ascopost.com/issues/november-15-2011/asco-supports-the-united-nations-political-declaration-on-noncommunicable-diseases/ 2019-03-11T20:00:25+00:00 https://ascopost.com/issues/november-15-2011/fda-commissioner-announces-decision-on-bevacizumab/ 2019-03-11T20:00:25+00:00 https://ascopost.com/issues/november-1-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/november-1-2011/everolimus-overcomes-resistance-to-hormonal-therapy-in-advanced-breast-cancer/ 2019-03-11T20:00:57+00:00 https://ascopost.com/issues/november-1-2011/expert-point-of-view-everolimus-overcomes-resistance-to-hormonal-therapy-in-advanced-breast-cancer/ 2019-03-11T20:00:57+00:00 https://ascopost.com/issues/november-1-2011/nsclc-studies-bevacizumabpemetrexed-maintenance-improves-survival-kras-status-has-no-impact-on-outcomes-with-sorafenib/ 2019-03-11T20:00:57+00:00 https://ascopost.com/issues/november-1-2011/do-we-need-the-uspstf/ 2019-03-11T20:00:57+00:00 https://ascopost.com/issues/november-1-2011/helping-cancer-survivors-return-to-work/ 2019-03-11T20:00:57+00:00 https://ascopost.com/issues/november-1-2011/no-improvement-in-survival-with-high-dose-over-standard-dose-radiation-for-stage-iii-non-small-cell-lung-cancer/ 2019-03-11T20:00:57+00:00 https://ascopost.com/issues/november-1-2011/t-dm1-antibody-drug-conjugate-outperforms-standard-anti-her2-therapy-in-metastatic-her2-positive-breast-cancer/ 2019-03-11T20:00:57+00:00 https://ascopost.com/issues/november-1-2011/expert-point-of-view-european-perspective/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/expert-point-of-view-us-perspective/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/aacr-issues-landmark-report-on-cancer-progress/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/national-organization-offers-guidance-on-employment-and-financial-issues-for-patients-with-cancer-and-survivors/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/sidebar-the-hcp-manual-a-legal-resource-guide-for-oncology-health-care-professionals-2nd-edition-2011/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/a-conversation-with-richard-j-gilbertson-md-phd/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/susan-halabi-phd-is-helping-to-fund-future-of-cancer-research/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/gi-symposium-helps-oncologists-stay-abreast-of-fast-moving-research/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/asco-symposium-helps-practices-leverage-health-it-understand-ehr-policy-changes/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/coming-soon-survivorship-booklet-for-patients-and-their-families/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/new-technologies-are-driving-up-costs-are-they-worth-the-price/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/crizotinib-new-drug-for-alk-positive-advanced-non-small-cell-lung-cancer/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/time-to-reconsider-treatment-paradigm-for-elderly-patients-with-advanced-non-small-cell-lung-cancer/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/panitumumab-is-not-beneficial-in-kras-mutations-no-exceptions/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/expert-point-of-view-panitumumab-is-not-beneficial-in-kras-mutations-no-exceptions/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/fda-issues-safety-announcement-on-dasatinib/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/gel-for-blood-vessel-surgery-approved/ 2019-03-11T20:00:58+00:00 https://ascopost.com/issues/november-1-2011/bevacizumab-labeling-revised-to-include-new-risks/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/integrative-medicine-offers-added-value-for-patients-with-cancer/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/important-briefs-from-the-2011-breast-cancer-symposium/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/physicians-can-help-patients-set-realistic-expectations-for-sexual-functioning-after-treatment-for-prostate-cancer/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/sidebar-expect-and-encourage-questions-from-your-patients/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/sidebar-expect-more-answers-in-the-future/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/fear-of-the-unknown-cancer-treatment-can-be-scarier-than-the-disease-itself/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/brca-mutation-has-little-effect-on-outcome-with-neoadjuvant-therapy/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/tobacco-remains-the-dominant-global-risk-factor-underlying-cancer/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/november-1-2011/sidebar-american-association-for-cancer-research-on-tobacco-use/ 2019-03-11T20:00:59+00:00 https://ascopost.com/issues/october-15-2011-supplement/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/october-15-2011-supplement/special-supplement-reports-from-best-of-asco-annual-meeting-11/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/research-increasingly-points-to-the-role-of-molecular-diversity-in-metastatic-lung-cancer/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-molecular-heterogeneity-complicates-management-of-resistance/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/incremental-advances-demonstrated-in-management-of-locoregional-lung-cancer/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-searching-for-more-efficacious-less-toxic-adjuvant-chemotherapy-for-nsclc/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/breast-cancer-studies-explore-wide-variety-of-prevention-and-treatment-strategies/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-studies-sparked-questions-to-breast-cancer-specialists/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/other-breast-cancer-studies-of-note/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-stay-tuned-for-more-information-on-neuropathy-related-genes/ 2019-03-11T20:01:40+00:00 https://ascopost.com/issues/october-15-2011-supplement/standards-of-care-confirmed-in-latest-group-of-colorectal-cancer-trials/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-is-g13d-kras-mutational-status-ready-for-prime-time/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-will-aflibercept-break-dry-spell-in-new-agents-for-colorectal-cancer/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-risk-based-approach-needed-for-stage-ii-colorectal-cancer/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/practice-changing-evidence-in-treatment-of-noncolorectal-gi-cancers/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-will-east-west-differences-limit-transferability-of-clinical-trial-results/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/similar-outcomes-confirmed-in-variety-of-lymphoma-treatment-comparisons/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-research-is-taking-the-guesswork-out-of-lymphoma-management/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/multiple-myeloma-research-spotlights-treatment-concerns-and-advances/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-a-cautious-approach-to-maintenance-therapy/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/novel-management-strategies-assessed-in-renal-cell-and-prostate-cancers/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-using-axitinib-in-advanced-renal-cell-carcinoma/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/screening-for-ovarian-cancer-may-do-more-harm-than-good/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-can-society-afford-bevacizumab-in-ovarian-cancer/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/adjuvant-treatment-still-standard-in-melanoma/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/novel-approaches-and-agents-making-headway-against-sarcoma/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-questions-and-answers-about-adjuvant-imatinib-in-gist/ 2019-03-11T20:01:41+00:00 https://ascopost.com/issues/october-15-2011-supplement/new-therapies-and-prognostic-techniques-highlighted-in-head-and-neck-cancer/ 2019-03-11T20:01:42+00:00 https://ascopost.com/issues/october-15-2011-supplement/sidebar-expert-q-and-a/ 2019-03-11T20:01:42+00:00 https://ascopost.com/issues/october-15-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/october-15-2011/studies-validate-safety-of-breast-conserving-surgery-in-young-patients-with-breast-cancer/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/expert-point-of-view-studies-validate-safety-of-breast-conserving-surgery-in-young-patients-with-breast-cancer/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/health-care-policy-a-three-act-play/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/international-prostate-cancer-studies-report-inroads-in-managing-bone-metastases/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/expert-point-of-view-international-prostate-cancer-studies-report-inroads-in-managing-bone-metastases/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/can-bayesian-design-streamline-our-sluggish-clinical-trial-system/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/sidebar-a-snapshot-of-i-spy-2/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/no-value-for-axillary-dissection-in-patients-with-breast-cancer-and-occult-nodal-metastases/ 2019-03-11T20:02:18+00:00 https://ascopost.com/issues/october-15-2011/expert-point-of-view-no-value-for-axillary-dissection-in-patients-with-breast-cancer-and-occult-nodal-metastases/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/new-asco-focused-update-recommendation-on-maintenance-treatment-of-stage-iv-non-small-cell-lung-cancer/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/sidebar-the-march-of-progress-in-lung-cancer-treatment/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/fda-approves-denosumab-to-increase-bone-mass-in-patients-with-cancer/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/new-biomarker-test-cleared-to-evaluate-ovarian-cancer-likelihood/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/short-term-androgen-deprivation-plus-radiotherapy-improves-outcomes-in-intermediate-risk-prostate-cancer/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/asco-study-shows-integrating-nonphysician-providers-into-oncology-practices-is-a-win-for-patients-and-providers/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/help-inform-asco-policy-with-new-oncology-practice-survey/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/new-features-added-to-cancernets-popular-find-an-oncologist-database/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/jco-implements-rapid-review-program/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/novel-drugs-ipilimumab-and-vemurafenib-for-advanced-melanoma/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/newly-elected-astro-officers-installed-at-annual-meeting/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/improvements-highlighted-in-treatment-of-leukemias-and-preleukemias/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/sidebar-novel-agents-are-still-needed-to-address-cytopenias-in-myelofibrosis/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/yoga-geriatric-assessment-and-nauseavomiting-addressed-in-session-on-supportive-care-and-survivorship-issues/ 2019-03-11T20:02:19+00:00 https://ascopost.com/issues/october-15-2011/sidebar-who-should-manage-survivorship-care/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/asco-issues-policy-statement-to-reduce-cancer-care-disparities/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/fda-announces-changes-in-drug-center-s-oncology-office/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/oncology-community-faces-complex-challenges-in-evolving-policy-arena/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/sidebar-customary-prompt-pay/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/sidebar-letter-to-president-obama/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/hot-chemotherapy-generates-heated-debate-about-its-use-with-cytoreductive-surgery-to-manage-peritoneal-metastases/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/sidebar-expect-questions-from-patients-and-colleagues/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/sidebar-ascos-role-recognized/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/elderly-patients-with-ovarian-cancer-least-likely-to-receive-chemotherapy/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/doxorubicincyclophosphamide-with-docetaxel-equally-effective-in-combination-or-sequentially/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/comparing-therapies-for-managing-hot-flashes-in-women-with-breast-cancer/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/replacing-epirubicin-with-docetaxel-for-three-cycles-improved-outcomes-for-node-positive-breast-cancer/ 2019-03-11T20:02:20+00:00 https://ascopost.com/issues/october-15-2011/hepatic-resection-remains-preferred-strategy-for-colorectal-liver-metastases/ 2019-03-11T20:02:21+00:00 https://ascopost.com/issues/october-15-2011/cancer-information-on-wikipedia-as-accurate-as-on-pdq-but-harder-to-understand/ 2019-03-11T20:02:21+00:00 https://ascopost.com/issues/october-15-2011/letter-to-the-editor-treating-cancer-or-fear/ 2019-03-11T20:02:21+00:00 https://ascopost.com/issues/october-15-2011/letter-to-the-editor-unrealistic-optimism-or-losing-sight-of-the-forest-for-the-trees/ 2019-03-11T20:02:21+00:00 https://ascopost.com/issues/october-15-2011/susan-g-komen-for-the-cure-announces-2011-brinker-award-winners-for-scientific-distinction/ 2019-03-11T20:02:21+00:00 https://ascopost.com/issues/october-15-2011/giving-women-a-fighting-chance-when-they-have-breast-cancer/ 2019-03-11T20:02:21+00:00 https://ascopost.com/issues/september-15-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/september-15-2011/fda-approves-brentuximab-vedotin-in-two-lymphoma-indications/ 2019-03-11T20:03:03+00:00 https://ascopost.com/issues/september-15-2011/important-benefit-for-small-population-is-a-major-milestone-in-lymphoma/ 2019-03-11T20:03:03+00:00 https://ascopost.com/issues/september-15-2011/palliative-care-quality-of-life-and-cost/ 2019-03-11T20:03:03+00:00 https://ascopost.com/issues/september-15-2011/we-can-conduct-clinical-trials-of-protons/ 2019-03-11T20:03:03+00:00 https://ascopost.com/issues/september-15-2011/novel-braf-inhibitor-receives-fda-approval-in-metastatic-melanoma/ 2019-03-11T20:03:03+00:00 https://ascopost.com/issues/september-15-2011/using-the-new-melanoma-drugs-in-the-clinic/ 2019-03-11T20:03:03+00:00 https://ascopost.com/issues/september-15-2011/a-conversation-with-monica-morrow-md-facs/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/oncology-drug-shortage-an-unintended-consequence-of-the-medicare-modernization-act-and-free-market-forces/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/developing-targeted-agent-combinations-business-and-regulatory-issues-and-legal-obstacles/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/asco-support-of-training-expands-in-parallel-with-growth-of-oncology-as-subspecialty/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/asco-s-international-clinical-trials-workshop-educates-nascent-researchers-on-the-inner-workings-of-clinical-trials/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/new-asco-in-action-website/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/what-the-latest-breast-cancer-news-means-for-patients/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/fda-grants-orphan-drug-status-to-mm-398/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/action-date-set-for-denosumab-supplemental-application/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/fda-clears-genetic-fish-panel-for-leukemia-patient-prognosis/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/radium-223-chloride-gets-fast-track-designation/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/lifestyle-changes-can-benefit-patients-with-cancer/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/integrative-oncology-modalities-supported-by-varying-levels-of-evidence-but-more-research-needed-overall/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/treating-cancer-in-japan-a-conversation-with-kensei-tobinai-md/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/tissue-of-origin-test-evaluated-in-patients-with-cancer-of-unknown-primary/ 2019-03-11T20:03:04+00:00 https://ascopost.com/issues/september-15-2011/crizotinib-plus-companion-diagnostic-test-approved-in-nsclc/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/many-women-treated-for-high-risk-breast-cancer-do-not-receive-recommended-postmastectomy-radiation-therapy/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/sidebar-expect-questions-from-your-patients/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/sidebar-higher-postmastectomy-radiotherapy-rates-at-nccn-institutions/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/long-term-data-show-benefit-of-degarelix-beyond-3-years-in-advanced-hormone-dependent-prostate-cancer/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/wide-variation-in-use-of-radioactive-iodine-for-thyroid-cancer/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/androgen-deprivation-plus-radiotherapy-increases-survival-in-men-with-localized-prostate-cancer/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/comorbidities-can-be-as-important-as-stage-in-predicting-breast-cancer-survival-in-older-patients/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/patients-with-her2-positive-breast-cancer-benefit-from-trastuzumab-plus-chemotherapy/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/unexpected-results-may-push-breast-cancer-research-toward-more-productive-approaches/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/pathways-reconsidered-lets-not-stop-thinking-outside-the-box/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-15-2011/keeping-a-positive-attitude/ 2019-03-11T20:03:05+00:00 https://ascopost.com/issues/september-1-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/september-1-2011/world-conference-on-lung-cancer-personalized-approaches-to-treatment/ 2019-03-11T20:03:46+00:00 https://ascopost.com/issues/september-1-2011/expert-point-of-view-world-conference-on-lung-cancer/ 2019-03-11T20:03:46+00:00 https://ascopost.com/issues/september-1-2011/increased-use-of-hospital-services-boosts-oncology-spending/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/fixing-the-drug-shortage-its-about-time/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/a-conversation-with-samuel-silver-md-phd/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/genomic-researchers-identify-weak-points-in-breast-cancer-cells/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/adjuvant-immunotherapy-provides-no-clinical-benefit-in-patients-with-high-risk-renal-cell-carcinoma/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/expert-point-of-view-adjuvant-immunotherapy-provides-no-clinical-benefit-in-patients-with-high-risk-renal-cell-carcinoma/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/screening-for-ovarian-cancer-does-not-reduce-mortality-and-leads-to-unnecessary-tests-for-false-positives/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/expert-point-of-view-screening-for-ovarian-cancer-does-not-reduce-mortality/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/congressional-hearing-highlights-oncology-drug-shortages/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/a-conversation-with-constance-m-chen-md-mph/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/asco-connection-adds-new-columnists-launches-group-creation-option/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/measures-of-success-for-cooperative-group-reorganization/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/un-summit-to-focus-on-noncommunicable-diseases-this-month/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/asco-examines-impact-of-health-care-reform-on-cancer-care-disparities/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/pick-up-cancernet-materials-for-your-patients-at-the-breast-cancer-symposium/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/circulating-tumor-cell-assay-shows-potential-for-predicting-prognosis-in-head-and-neck-carcinoma/ 2019-03-11T20:03:47+00:00 https://ascopost.com/issues/september-1-2011/research-in-combining-targeted-agents-faces-numerous-challenges/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/cancer-care-in-the-uk-a-conversation-with-chris-parker-md/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/experts-address-cancer-related-distress-the-sixth-vital-sign/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/at-5-years-brachytherapy-shows-quality-of-life-advantages-over-radical-prostatectomy-for-favorable-risk-prostate-cancer/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/sidebar-the-anonymity-advantage/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/sidebar-age-at-diagnosis-and-importance-of-long-term-considerations/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/updated-drug-label-approved-for-pioglitazone-after-safety-review/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/unrealistic-optimism-poses-ethical-challenges-may-affect-informed-consent-process/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/sidebar-ny-state-law-mandates-discussion-on-end-of-life-care/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/identifying-genetic-factors-that-predict-response-to-chemotherapy-in-nsclc/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/androgen-deprivation-therapy-plus-radiotherapy-increases-survival-in-men-with-localized-prostate-cancer/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/neoadjuvant-chemotherapy-with-cmv-improves-outcome-for-invasive-bladder-cancer/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/september-1-2011/surgical-site-infections-after-colectomy-more-likely-in-obese-patients/ 2019-03-11T20:03:48+00:00 https://ascopost.com/issues/august-15-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/august-15-2011/a-landmark-lung-screening-trial-what-does-it-mean-for-clinicians-and-their-patients/ 2019-03-11T20:04:28+00:00 https://ascopost.com/issues/august-15-2011/a-clinician-weighs-in-on-the-national-lung-screening-trial/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/sidebar-american-lung-association-reflects-on-the-national-lung-screening-trial/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/acting-on-fear/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/rising-costs-of-cancer-care-its-more-than-drugs/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/patients-with-early-breast-cancer-benefit-from-regional-nodal-irradiation/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/expert-point-of-view-patients-with-early-breast-cancer-benefit-from-regional-nodal-irradiation/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/second-primary-malignancies-explored-in-multiple-myeloma/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/expert-point-of-view-second-primary-malignancies-explored-in-multiple-myeloma/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/bevacizumab-makes-inroads-against-ovarian-cancer/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/expert-point-of-view-bevacizumab-makes-inroads-against-ovarian-cancer/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/intermittent-or-continuous-androgen-suppression-produces-comparable-survival-after-radical-therapy-in-prostate-cancer/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/sorafenib-acceptable-in-child-pugh-b-patients-with-hepatocellular-carcinoma/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/expert-point-of-view-sorafenib-acceptable-in-child-pugh-b-patients-with-hepatocellular-carcinoma/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/sidebar-child-pugh-score/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/fda-issues-guidance-for-diagnostic-tests-used-with-targeted-therapies/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/odac-recommends-accelerated-approval-for-brentuximab/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/asco-s-international-cancer-corps-launches-initiatives-in-ethiopia-and-vietnam/ 2019-03-11T20:04:29+00:00 https://ascopost.com/issues/august-15-2011/oncology-community-briefs-members-of-congress-and-calls-for-action/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/asco-s-oncology-slide-library-functions-as-a-share-and-exchange-forum/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/help-your-patients-manage-the-cost-of-cancer-care/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/new-safety-information-reported-for-5-alpha-reductase-inhibitors/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/fda-outlines-oversight-of-mobile-medical-applications/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/evaluating-risk-for-suicide-in-people-diagnosed-or-living-with-cancer/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/combined-therapy-produces-good-outcomes-in-primary-testicular-diffuse-large-b-cell-lymphoma/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/optimizing-treatment-for-advanced-prostate-cancer-requires-shifting-focus-from-individual-drugs-to-integrated-therapies/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/sidebar-expect-questions-from-your-patients/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/sidebar-timing-of-prostate-cancer-drugs-earlier-but-not-too-early/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/a-conversation-with-barrie-r-cassileth-phd/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/sidebar-making-evidence-based-integrative-medicine-part-of-mainstream-cancer-care/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/sidebar-first-international-conference-on-integrative-care/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/point-of-view-should-patients-over-70-receive-aggressive-therapy-for-acute-myeloid-leukemia/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/despite-advances-little-overall-improvement-seen-in-treatment-of-older-adults-with-aml/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/conventional-induction-chemotherapy-beneficial-in-only-a-subset-of-older-adults-with-aml/ 2019-03-11T20:04:30+00:00 https://ascopost.com/issues/august-15-2011/venous-thromboembolism-more-frequent-after-open-colorectal-surgery-than-post-laparoscopy/ 2019-03-11T20:04:31+00:00 https://ascopost.com/issues/august-15-2011/endoscopic-excision-may-be-viable-alternative-to-surgical-resection-of-large-colorectal-polyps/ 2019-03-11T20:04:31+00:00 https://ascopost.com/issues/august-15-2011/higher-risk-of-recurrence-for-triple-negative-breast-cancer-after-modified-radical-mastectomy-without-radiation/ 2019-03-11T20:04:31+00:00 https://ascopost.com/issues/july-15-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/july-15-2011/exemestane-prevents-invasive-and-preinvasive-breast-cancers-in-map3-trial/ 2019-03-11T20:05:22+00:00 https://ascopost.com/issues/july-15-2011/expert-point-of-view-exemestane-prevents-invasive-and-preinvasive-breast-cancers-in-map3-trial/ 2019-03-11T20:05:22+00:00 https://ascopost.com/issues/july-15-2011/are-clinical-pathways-inevitable-in-oncology-s-future/ 2019-03-11T20:05:22+00:00 https://ascopost.com/issues/july-15-2011/conflicts-of-interest-in-health-care-reform/ 2019-03-11T20:05:22+00:00 https://ascopost.com/issues/july-15-2011/axitinib-improves-progression-free-survival-over-sorafenib-in-advanced-renal-cell-carcinoma/ 2019-03-11T20:05:22+00:00 https://ascopost.com/issues/july-15-2011/expert-point-of-view-axitinib-improves-progression-free-survival-over-sorafenib-in-advanced-renal-cell-carcinoma/ 2019-03-11T20:05:22+00:00 https://ascopost.com/issues/july-15-2011/final-decision-on-sipuleucel-t/ 2019-03-11T20:05:22+00:00 https://ascopost.com/issues/july-15-2011/odac-again-recommends-fda-withdraw-its-approval-of-bevacizumab-for-metastatic-breast-cancer/ 2019-03-11T20:05:23+00:00 https://ascopost.com/issues/july-15-2011/emerging-targeted-therapies-offer-glimmer-of-hope-for-nsclc-but-biomarkers-for-response-needed/ 2020-09-16T13:18:09+00:00 https://ascopost.com/issues/july-15-2011/maintenance-therapy-prolongs-progression-free-survival-in-nsclc/ 2019-03-11T20:05:23+00:00 https://ascopost.com/issues/july-15-2011/expert-point-of-view-maintenance-therapy-prolongs-progression-free-survival/ 2019-03-11T20:05:23+00:00 https://ascopost.com/issues/july-15-2011/novel-jak-inhibitor-may-be-an-option-for-patients-with-myelofibrosis/ 2025-09-30T19:50:18+00:00 https://ascopost.com/issues/july-15-2011/expert-point-of-view-novel-jak-inhibitor-may-be-an-option-for-patients-with-myelofibrosis/ 2019-03-11T20:05:23+00:00 https://ascopost.com/issues/july-15-2011/sidebar-early-clinical-findings-with-jak2-inhibition/ 2019-03-11T20:05:23+00:00 https://ascopost.com/issues/july-15-2011/breast-cancer-studies-focus-on-tailoring-therapy-for-patient-subsets/ 2019-03-11T20:05:23+00:00 https://ascopost.com/issues/july-15-2011/nci-clinical-investigator-team-leadership-awards-conversations-in-gynecologic-oncology/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/asco-university-launches-new-programs/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/special-award-recipients-honored-at-2011-asco-annual-meeting/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/stephen-cannistra-md-takes-over-as-editor-in-chief-of-journal-of-clinical-oncology/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/cancernet-mobile-app-for-patients/ 2020-09-16T13:16:21+00:00 https://ascopost.com/issues/july-15-2011/intergroup-study-evaluates-outcomes-of-elderly-vs-younger-patients-treated-for-advanced-hodgkin-lymphoma/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/studies-explore-potential-benefits-of-sunitinib-before-nephrectomy-in-metastatic-clear-cell-renal-cancer/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/a-prominent-oncologist-retraces-her-steps-from-baghdad/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/first-fentanyl-nasal-spray-approved-for-cancer-breakthrough-pain/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/fda-issues-updated-safety-data-on-silicone-gel-filled-breast-implants/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/is-subspecialization-an-option-or-a-necessity-in-community-practices/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/cabozantinib-shows-encouraging-activity-in-metastatic-castrate-resistant-prostate-cancer/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/my-first-of-many-asco-meetings/ 2019-03-11T20:05:24+00:00 https://ascopost.com/issues/july-15-2011/a-conversation-with-david-henry-md/ 2020-09-16T13:14:01+00:00 https://ascopost.com/issues/july-15-2011/cervical-cancer-screening-study-should-reassure-physicians/ 2019-03-11T20:05:25+00:00 https://ascopost.com/issues/july-15-2011/sidebar-expect-questions-from-your-patients/ 2019-03-11T20:05:25+00:00 https://ascopost.com/issues/july-15-2011/stalked-by-cancer-one-woman-s-story/ 2019-03-11T20:05:25+00:00 https://ascopost.com/issues/july-1-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/july-1-2011/novel-agents-improve-survival-in-patients-with-metastatic-melanoma/ 2019-03-11T20:06:06+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-novel-agents-improve-survival-in-patients-with-metastatic-melanoma/ 2019-03-11T20:06:06+00:00 https://ascopost.com/issues/july-1-2011/longer-imatinib-treatment-is-better-in-high-risk-gist/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-longer-imatinib-treatment-is-better-in-high-risk-gist/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/on-william-osler-the-old-art-and-the-new-science/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/sidebar-lessons-for-today/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/iniparib-fails-to-improve-outcomes-in-triple-negative-breast-cancer/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-iniparib-fails-to-improve-outcomes-in-triple-negative-breast-cancer/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/novel-agents-prolong-disease-free-survival-in-ovarian-cancer/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-novel-agents-prolong-disease-free-survival-in-ovarian-cancer/ 2019-03-11T20:06:07+00:00 https://ascopost.com/issues/july-1-2011/smoking-and-lack-of-exercise-increase-risk-of-some-cancers-but-moderate-alcohol-consumption-reduces-colon-cancer-risk/ 2019-03-11T20:06:08+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-smoking-and-lack-of-exercise-increase-risk/ 2019-03-11T20:06:08+00:00 https://ascopost.com/issues/july-1-2011/important-briefs-lymphoma-research-on-improved-chemotherapy-biomarker-associations-and-stem-cell-transplant-approaches/ 2019-03-11T20:06:09+00:00 https://ascopost.com/issues/july-1-2011/bequest-from-dr-nora-janjan-and-jack-calvin-supports-conquer-cancer-foundation-s-work-in-palliative-care/ 2019-03-11T20:06:09+00:00 https://ascopost.com/issues/july-1-2011/mark-g-kris-md-recipient-of-first-asco-humanitarian-award/ 2019-03-11T20:06:09+00:00 https://ascopost.com/issues/july-1-2011/accelerating-progress-vs-cancer/ 2019-03-11T20:06:09+00:00 https://ascopost.com/issues/july-1-2011/help-your-patients-understand-the-latest-research/ 2019-03-11T20:06:11+00:00 https://ascopost.com/issues/july-1-2011/newly-elected-society-officials-for-2011/ 2019-03-11T20:06:11+00:00 https://ascopost.com/issues/july-1-2011/plenary-report-high-dose-methotrexate-improves-outcome-for-high-risk-all-in-younger-patients/ 2019-03-11T20:06:11+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-high-dose-methotrexate-improves-outcome/ 2019-03-11T20:06:11+00:00 https://ascopost.com/issues/july-1-2011/plenary-report-bumel-improves-survival-in-high-risk-neuroblastoma-patients-phase-iii-study-shows/ 2019-03-11T20:06:11+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-bumel-improves-survival-in-high-risk-neuroblastoma-patients-phase-iii-study-shows/ 2019-03-11T20:06:11+00:00 https://ascopost.com/issues/july-1-2011/vanderbilt-oncologists-partner-with-cardiologists-to-research-chemotherapy-related-cardiac-toxicity/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/understanding-crizotinib-1-year-after-high-profile-presentation/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/sunitinibprednisone-improves-progression-free-survival/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-sunitinibprednisone-improves-progression-free-survival/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/test-approved-to-help-determine-candidacy-for-trastuzumab/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/changes-introduced-to-better-inform-consumers-about-sunscreen/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/capecitabine-noninferior-to-5-fu-with-improved-toxicity-profile/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/cancer-diagnosis-can-spark-worry-over-numerous-health-concerns/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/july-1-2011/expert-point-of-view-capecitabine-noninferior-to-5-fu-with-improved-toxicity-profile/ 2019-03-11T20:06:12+00:00 https://ascopost.com/issues/june-15-2011/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/june-15-2011/3-year-screening-interval-safe-for-women-with-hpv-negative-and-normal-pap-tests-data-show/ 2019-03-11T20:06:54+00:00 https://ascopost.com/issues/june-15-2011/expert-point-of-view-3-year-screening-interval-safe-for-women-with-hpv-negative-and-normal-pap-tests-data-show/ 2019-03-11T20:06:54+00:00 https://ascopost.com/issues/june-15-2011/the-fda-pharmaceutical-industry-complex/ 2019-03-11T20:06:54+00:00 https://ascopost.com/issues/june-15-2011/experts-seek-to-explain-the-survival-gap-in-adolescents-and-young-adults-with-cancer/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/a-conversation-with-brad-zebrack-phd-msw-mph/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/planning-survivorship-programs-an-international-endeavor/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/genes-may-predict-taxane-related-peripheral-neuropathy/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/expert-point-of-view-genes-may-predict-taxane-related-peripheral-neuropathy/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/a-conversation-with-patricia-a-ganz-md/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/sidebar-the-survivorship-care-plan-document-a-flexible-tool/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/cabozantinib-broadly-active-in-multiple-tumor-types/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/expert-point-of-view-cabozantinib-broadly-active-in-multiple-tumor-types/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/important-briefs-from-the-acog-59th-annual-clinical-meeting/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/paradoxical-result-tying-estrogen-to-reduced-risk-of-breast-cancer-is-consistent-with-laboratory-data/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/sidebar-essence-of-translational-research/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/sidebar-its-darwinian/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/new-drug-application-submitted-for-vemurafenib-in-melanoma/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/fda-approves-sunitinib-for-pancreatic-neuroendocrine-tumors/ 2019-03-11T20:06:55+00:00 https://ascopost.com/issues/june-15-2011/trabectedin-new-drug-application-withdrawn/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/radiotherapy-in-dcis-recurrence-patterns-are-different/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/sidebar-nonrandomized-analysis-viewed-with-skepticism/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/more-evidence-links-vitamin-d-deficiency-to-breast-cancer/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/expert-point-of-view-more-evidence-links-vitamin-d-deficiency-to-breast-cancer/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/asco-launches-initiative-to-showcase-progress-against-cancer/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/breast-cancer-symposium-to-offer-uniquely-interdisciplinary-approach-for-attendees/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/living-life-beyond-cancer-asco-s-focus-on-survivorship/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/subcutaneous-bortezomib-offers-improved-safety-profile-for-treating-patients-with-relapsed-multiple-myeloma/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/more-than-6-million-awarded-to-promising-cancer-researchers/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/fda-issues-revised-draft-guidance-on-financial-disclosure-by-clinical-investigators/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/death-rates-significantly-reduced-for-men-having-radical-prostatectomy-vs-watchful-waiting/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/adding-gemcitabine-to-chemoradiation-improves-survival-outcomes-for-locally-advanced-cervical-cancer/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/statistically-significant-decline-in-lung-cancer-incidence-and-death-rates-among-women/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/sunitinib-induced-hypertension-may-be-efficacy-biomarker-in-patients-with-metastatic-renal-cell-carcinoma/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/hormone-replacement-and-ovarian-cancer-competing-risks-in-decisions-about-bilateral-salpingo-oophorectomy/ 2019-03-11T20:06:56+00:00 https://ascopost.com/issues/june-15-2011/sidebar-expect-questions-from-your-patients-and-colleagues/ 2019-03-11T20:06:57+00:00 https://ascopost.com/issues/june-15-2011/adjuvant-therapy-in-cutaneous-melanoma-the-need-for-a-new-approach/ 2019-03-11T20:06:57+00:00 https://ascopost.com/issues/2010/ 2021-06-08T17:57:26+00:00 https://ascopost.com/issues/2010/why-the-asco-post/ 2020-05-28T18:50:04+00:00 https://ascopost.com/issues/2010/introducing-the-asco-post/ 2020-05-28T18:56:19+00:00 https://ascopost.com/issues/2010/asco-as-a-public-organization/ 2020-05-28T19:04:07+00:00 https://ascopost.com/issues/2010/lymphoma-many-questions-too-few-answers/ 2020-05-28T19:12:34+00:00 https://ascopost.com/issues/june-25-2021/ 2021-06-25T18:58:38+00:00 https://ascopost.com/issues/june-25-2021/cryoablation-in-low-risk-breast-cancers-minimally-invasive-procedure-with-minimal-risk/ 2021-06-25T18:58:38+00:00 https://ascopost.com/issues/june-25-2021/epov-henry-kuerer/ 2021-06-25T18:58:39+00:00 https://ascopost.com/issues/june-25-2021/with-the-exception-of-cervical-cancer-hpv-related-cancers-are-on-the-rise/ 2026-01-29T16:26:07+00:00 https://ascopost.com/issues/june-25-2021/immunotherapy-with-cemiplimab-rwlc-yields-survival-benefit-in-advanced-cervical-cancer/ 2021-07-01T17:56:58+00:00 https://ascopost.com/issues/june-25-2021/epov-mansoor-raza-mirza/ 2021-07-01T18:03:09+00:00 https://ascopost.com/issues/june-25-2021/de-escalating-surgery-for-women-with-breast-cancer/ 2021-06-25T18:58:43+00:00 https://ascopost.com/issues/june-25-2021/addition-of-copanlisib-to-rituximab-improves-progression-free-survival-in-relapsed-indolent-non-hodgkin-lymphoma/ 2021-06-25T18:58:44+00:00 https://ascopost.com/issues/june-25-2021/fda-approves-sotorasib-for-kras-g12c-mutated-nsclc/ 2021-06-25T18:58:45+00:00 https://ascopost.com/issues/june-25-2021/fda-grants-accelerated-approval-to-infigratinib-for-metastatic-cholangiocarcinoma-with-an-fgfr2-fusion-or-rearrangement/ 2021-06-25T18:58:46+00:00 https://ascopost.com/issues/june-25-2021/survivors-of-early-stage-breast-cancer-face-broad-range-of-symptoms-and-concerns/ 2021-06-25T18:58:47+00:00 https://ascopost.com/issues/june-25-2021/epov-sarah-blair-md-facs/ 2021-06-25T18:58:48+00:00 https://ascopost.com/issues/june-25-2021/low-response-rates-to-conjugate-pneumococcal-vaccine-in-patients-with-chronic-lymphocytic-leukemia/ 2021-07-22T17:43:04+00:00 https://ascopost.com/issues/june-25-2021/olympia-trial-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-breast-cancer/ 2021-06-25T18:58:51+00:00 https://ascopost.com/issues/june-25-2021/lessons-from-pneumococcal-vaccine-responses-in-patients-with-cll-in-an-evolving-vaccine-landscape/ 2021-07-19T18:53:14+00:00 https://ascopost.com/issues/june-25-2021/epov-nadine-tung/ 2021-06-25T18:58:53+00:00 https://ascopost.com/issues/june-25-2021/how-ras-mutations-in-early-onset-colorectal-cancer-may-impact-patient-survival/ 2021-07-07T19:44:56+00:00 https://ascopost.com/issues/june-25-2021/subgroup-analysis-of-phase-ii-trial-shows-activity-with-breakthrough-kras-inhibitor-in-lung-cancer/ 2021-07-22T20:14:54+00:00 https://ascopost.com/issues/june-25-2021/harnessing-a-worldwide-effort-to-combat-covid-19-and-cancer/ 2021-06-25T18:58:57+00:00 https://ascopost.com/issues/june-25-2021/mary-daly-receives-nccn-2021-rodger-winn-award/ 2021-06-25T18:58:58+00:00 https://ascopost.com/issues/june-25-2021/chanita-hughes-halbert-to-advance-cancer-equity-at-usc-norris-comprehensive-cancer-center/ 2021-06-25T18:59:00+00:00 https://ascopost.com/issues/june-25-2021/cynthia-yoshida-honored-nationally-for-increasing-colorectal-cancer-screening-rates/ 2021-06-25T18:59:01+00:00 https://ascopost.com/issues/june-25-2021/margaret-foti-to-receive-gallery-of-success-award-from-temple-university/ 2021-06-25T18:59:02+00:00 https://ascopost.com/issues/june-25-2021/young-urologist-of-the-year-award-winners/ 2021-06-25T18:59:03+00:00 https://ascopost.com/issues/june-25-2021/epov-mark-g-kris/ 2021-06-25T18:59:04+00:00 https://ascopost.com/issues/june-25-2021/whispers-over-my-shoulder/ 2021-07-08T19:54:35+00:00 https://ascopost.com/issues/june-25-2021/cancer-in-morocco-access-to-innovative-treatments-and-research-status/ 2021-07-01T17:20:15+00:00 https://ascopost.com/issues/june-25-2021/keynote-564-adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/ 2021-07-13T20:04:47+00:00 https://ascopost.com/issues/june-25-2021/epov-rana-r-mckay/ 2021-06-25T18:59:07+00:00 https://ascopost.com/issues/june-25-2021/do-community-oncologists-have-access-to-geriatric-specialty-care-for-older-patients/ 2021-06-25T18:59:08+00:00 https://ascopost.com/issues/june-25-2021/outback-no-benefit-for-adjuvant-chemotherapy-in-cervical-cancer/ 2021-06-25T18:59:09+00:00 https://ascopost.com/issues/june-25-2021/innovator-in-treatment-of-infectious-diseases-francisco-marty-md-dies-at-53/ 2021-06-25T18:59:10+00:00 https://ascopost.com/issues/june-25-2021/newly-diagnosed-multiple-myeloma/ 2021-10-26T19:23:45+00:00 https://ascopost.com/issues/june-25-2021/inaugural-vice-chair-for-diversity-health-equity-appointed-by-nyu-langonenyu-grossman-school-of-medicine/ 2021-06-25T18:59:13+00:00 https://ascopost.com/issues/june-25-2021/john-d-carpten-to-join-the-aacr-board-of-directors/ 2021-06-25T18:59:14+00:00 https://ascopost.com/issues/june-25-2021/md-anderson-and-broad-institute-launch-new-translational-research-platform-focused-on-rare-cancers/ 2021-06-25T18:59:15+00:00 https://ascopost.com/issues/june-25-2021/pancreatic-cancer-center-of-excellence-to-leverage-research-and-clinical-care-innovations-for-patients/ 2021-06-25T18:59:16+00:00 https://ascopost.com/issues/june-25-2021/addressing-sexuality-challenges-throughout-the-cancer-care-continuum/ 2021-06-25T18:59:17+00:00 https://ascopost.com/issues/june-25-2021/breast-cancer-has-taught-me-many-life-lessons/ 2021-06-25T18:59:18+00:00 https://ascopost.com/issues/june-25-2021/dana-farber-and-harvard-street-neighborhood-health-center-to-connect-patients-to-cancer-services/ 2021-06-25T18:59:19+00:00 https://ascopost.com/issues/june-25-2021/daratumumab-in-combination-with-carfilzomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma/ 2021-06-25T18:59:19+00:00 https://ascopost.com/issues/june-25-2021/first-line-immune-checkpoint-inhibitor-monotherapy-vs-chemoimmunotherapy-in-advanced-nsclc-according-to-kras-variant-status/ 2021-06-25T18:59:20+00:00 https://ascopost.com/issues/june-25-2021/contralateral-esophagus-sparing-radiotherapy-technique-reduces-rates-of-esophagitis-in-patients-with-lung-cancer-receiving-high-dose-chemoradiation/ 2021-06-25T18:59:21+00:00 https://ascopost.com/issues/june-25-2021/gauri-varadhachary-dies-at-52/ 2021-06-25T18:59:22+00:00 https://ascopost.com/issues/june-25-2021/epov-kunle-odunsi-and-lilian-gien/ 2021-06-25T18:59:23+00:00 https://ascopost.com/issues/june-25-2021/checkmate-648-first-line-nivolumab-regimens-improve-survival-in-esophageal-squamous-cell-carcinoma/ 2026-01-29T16:27:14+00:00 https://ascopost.com/issues/june-25-2021/epov-rui-hua-xu/ 2021-06-25T18:59:25+00:00 https://ascopost.com/issues/june-25-2021/nih-names-marie-a-bernard-md-chief-officer-for-scientific-workforce-diversity/ 2021-06-25T18:59:26+00:00 https://ascopost.com/issues/june-25-2021/sidney-kimmel-cancer-center-jefferson-health-names-andrew-aplin-phd-deputy-director-for-scientific-strategy/ 2021-06-25T18:59:26+00:00 https://ascopost.com/issues/june-25-2021/survey-finds-bullying-sexual-harassment-not-uncommon-for-women-in-gynecologic-oncology/ 2021-06-25T18:59:27+00:00 https://ascopost.com/issues/june-25-2021/epov-kemi-doll/ 2021-06-25T18:59:28+00:00 https://ascopost.com/issues/june-25-2021/pi3k-inhibition-with-copanlisib-plus-rituximab-in-relapsed-indolent-non-hodgkin-lymphoma/ 2021-07-21T18:32:21+00:00 https://ascopost.com/issues/june-25-2021/better-responses-to-hepatic-arterial-infusion-therapy-among-patients-with-kras-wild-type-metastatic-colorectal-cancer/ 2021-07-07T19:47:12+00:00 https://ascopost.com/issues/june-25-2021/how-to-talk-with-teens-and-young-adults-about-their-end-of-life-goals/ 2021-06-25T18:59:31+00:00 https://ascopost.com/issues/june-25-2021/emerging-reasons-for-optimism-in-lung-cancer/ 2021-07-22T20:12:54+00:00 https://ascopost.com/issues/june-25-2021/new-asco-journal-series-examines-disparities-in-cancer-care-for-black-people-in-the-united-states/ 2021-06-25T18:59:34+00:00 https://ascopost.com/issues/june-25-2021/asco-releases-recommendations-for-management-of-salivary-gland-malignancies/ 2026-01-29T15:59:21+00:00 https://ascopost.com/issues/june-25-2021/watch-now-discussion-on-eligibility-criteria-and-the-impact-on-access-to-clinical-trials/ 2021-06-25T18:59:36+00:00 https://ascopost.com/issues/june-25-2021/asco-accc-piloting-project-to-test-tools-to-diversify-cancer-clinical-trials/ 2021-06-25T18:59:38+00:00 https://ascopost.com/issues/june-25-2021/biden-administration-reverses-rule-limiting-access-to-equitable-cancer-care-for-sexual-and-gender-minority-community/ 2021-06-25T18:59:38+00:00 https://ascopost.com/issues/july-10-2021/ 2021-07-12T19:50:43+00:00 https://ascopost.com/issues/july-10-2021/caryn-lerman-phd-elected-president-of-the-aaci/ 2021-07-12T19:50:45+00:00 https://ascopost.com/issues/july-10-2021/the-wistar-institute-recruits-noam-auslander-phd-as-assistant-professor/ 2021-07-12T19:50:46+00:00 https://ascopost.com/issues/july-10-2021/new-medical-director-named-to-lead-clinical-cancer-research/ 2021-07-12T19:50:49+00:00 https://ascopost.com/issues/july-10-2021/disease-risk-associated-with-protein-truncating-and-rare-missense-variants-in-breast-cancer-risk-genes/ 2021-07-12T19:50:51+00:00 https://ascopost.com/issues/july-10-2021/postoperative-mortality-and-complications-after-cancer-surgery-in-high-vs-low-or-middle-income-countries/ 2021-07-12T19:50:52+00:00 https://ascopost.com/issues/july-10-2021/enfortumab-vedotin-ejfv-improves-overall-survival-vs-chemotherapy-in-previously-treated-advanced-urothelial-carcinoma/ 2021-07-12T19:50:54+00:00 https://ascopost.com/issues/july-10-2021/enfortumab-vedotin-represents-a-community-of-work-in-antibody-drug-conjugate-targeting-cancer/ 2021-07-13T20:10:33+00:00 https://ascopost.com/issues/july-10-2021/reducing-prostate-cancer-disparity-by-bringing-care-to-underserved-populations/ 2021-07-13T19:30:40+00:00 https://ascopost.com/issues/july-10-2021/sacituzumab-govitecan-hziy-in-urothelial-carcinoma-progressing-after-platinum-based-chemotherapy-and-checkpoint-inhibitor-therapy/ 2021-07-14T19:48:45+00:00 https://ascopost.com/issues/july-10-2021/sacituzumab-govitecan-hziy-welcome-addition-to-advanced-urothelial-cancer-treatments-but-time-to-figure-out-sequencing-and-combinations/ 2021-07-13T20:08:14+00:00 https://ascopost.com/issues/july-10-2021/adapt-trial-excellent-outcomes-reported-with-neoadjuvant-dual-her2-therapy-in-breast-cancer/ 2021-07-12T19:51:03+00:00 https://ascopost.com/issues/july-10-2021/predicting-global-cancer-trends-in-2021/ 2021-07-12T19:51:05+00:00 https://ascopost.com/issues/july-10-2021/lifileucel-after-disease-progression-in-metastatic-melanoma-durable-responses-achieved-in-phase-ii-trial/ 2021-08-26T17:44:05+00:00 https://ascopost.com/issues/july-10-2021/early-adopter-of-breast-conservation-surgical-oncologist-augusto-leon-md-reflects-on-cancer-care-in-chile/ 2021-07-12T19:51:08+00:00 https://ascopost.com/issues/july-10-2021/epov-jason-luke/ 2021-07-12T19:51:09+00:00 https://ascopost.com/issues/july-10-2021/fixed-dose-first-line-ibrutinibvenetoclax-combination-achieves-durable-remissions-in-cll/ 2021-07-21T19:16:51+00:00 https://ascopost.com/issues/july-10-2021/epov-jacqueline-barrientos/ 2021-07-12T19:51:12+00:00 https://ascopost.com/issues/july-10-2021/novel-bcl2-inhibitor-shows-activity-in-cll-in-phase-i-trial/ 2021-07-19T18:35:48+00:00 https://ascopost.com/issues/july-10-2021/novel-targeted-agents-for-the-treatment-of-myelofibrosis/ 2025-09-30T19:44:00+00:00 https://ascopost.com/issues/july-10-2021/epov-jacqueline-barrientos-1/ 2021-07-12T19:51:17+00:00 https://ascopost.com/issues/july-10-2021/amivantamablazertinib-combination-may-overcome-osimertinib-resistance-in-patients-with-egfr-positive-nsclc/ 2021-07-23T14:04:34+00:00 https://ascopost.com/issues/july-10-2021/epov-nicolas-girard/ 2021-07-12T19:51:19+00:00 https://ascopost.com/issues/july-10-2021/ea1131-trial-platinum-not-equal-to-capecitabine-for-residual-disease-in-triple-negative-breast-cancer/ 2021-07-12T19:51:21+00:00 https://ascopost.com/issues/july-10-2021/julio-aguirre-ghiso-phd-to-lead-new-cancer-dormancy-and-tumor-microenvironment-institute-at-albert-einstein-cancer-center/ 2021-07-12T19:51:22+00:00 https://ascopost.com/issues/july-10-2021/epov-melinda-telli/ 2021-07-12T19:51:23+00:00 https://ascopost.com/issues/july-10-2021/new-iaslc-leadership-to-assume-roles-at-2021-world-conference-on-lung-cancer/ 2021-07-12T19:51:24+00:00 https://ascopost.com/issues/july-10-2021/responses-to-pembrolizumab-and-ipilimumab-after-anti-pd-1l1-failure-in-advanced-melanoma/ 2021-08-26T18:12:25+00:00 https://ascopost.com/issues/july-10-2021/a-shift-in-the-treatment-of-advanced-melanoma/ 2021-07-12T19:51:27+00:00 https://ascopost.com/issues/july-10-2021/sarah-cannon-names-navneet-majhail-md-ms-fastct-deputy-physician-in-chief-of-blood-cancers/ 2021-07-12T19:51:28+00:00 https://ascopost.com/issues/july-10-2021/study-finds-bevacizumab-offers-no-boost-to-second-line-osimertinib-in-egfr-t790m-mutated-lung-cancer/ 2021-07-12T19:51:30+00:00 https://ascopost.com/issues/july-10-2021/patient-reported-outcomes-from-the-imbrave150-trial-in-advanced-hepatocellular-carcinoma/ 2021-07-12T19:51:31+00:00 https://ascopost.com/issues/july-10-2021/effect-of-time-to-surgery-on-recurrence-and-survival-in-clinical-stage-i-nsclc/ 2021-07-12T19:51:32+00:00 https://ascopost.com/issues/july-10-2021/epov-edward-garon/ 2021-07-12T19:51:34+00:00 https://ascopost.com/issues/july-10-2021/being-both-a-cancer-provider-and-a-cancer-survivor-is-a-rare-privilege/ 2021-07-12T19:51:35+00:00 https://ascopost.com/issues/july-10-2021/improving-screening-of-dense-breasts-with-newer-mri-technologies/ 2021-07-12T19:51:36+00:00 https://ascopost.com/issues/july-10-2021/fda-approves-avapritinib-for-advanced-systemic-mastocytosis/ 2021-07-12T19:51:37+00:00 https://ascopost.com/issues/july-10-2021/fda-oncology-center-of-excellence-launches-national-black-family-cancer-awareness-week/ 2021-07-12T19:51:38+00:00 https://ascopost.com/issues/july-10-2021/beyond-cdk46-inhibitors-in-metastatic-breast-cancer/ 2021-07-12T19:51:40+00:00 https://ascopost.com/issues/july-10-2021/modified-folfirinox-established-as-preferred-neoadjuvant-treatment-of-borderline-resectable-pancreatic-cancer/ 2021-07-12T19:51:41+00:00 https://ascopost.com/issues/july-10-2021/epov-rebecca-a-snyder/ 2021-07-12T19:51:43+00:00 https://ascopost.com/issues/july-10-2021/risk-of-atrial-fibrillation-after-allogeneic-hct-and-association-with-poor-outcomes/ 2021-07-22T17:41:44+00:00 https://ascopost.com/issues/july-10-2021/conquer-cancer-the-asco-foundation-awards-more-than-10-million-to-support-cancer-research/ 2021-07-12T19:51:45+00:00 https://ascopost.com/issues/july-10-2021/reflections-on-evolution-of-breast-cancer-care-in-india-over-the-past-4-decades/ 2021-07-13T19:48:17+00:00 https://ascopost.com/issues/july-10-2021/defining-cure-in-multiple-myeloma/ 2021-07-27T19:24:57+00:00 https://ascopost.com/issues/july-10-2021/asco-releases-rapid-guideline-recommendation-update-for-patients-with-high-risk-her2-negative-germline-brca-mutated-breast-cancer/ 2021-07-12T19:51:50+00:00 https://ascopost.com/issues/july-10-2021/asco-releases-new-recommendations-on-systemic-therapy-dosing-for-adults-with-obesity-and-cancer/ 2021-07-12T19:59:14+00:00 https://ascopost.com/issues/july-10-2021/asco-congratulates-chiquita-brooks-lasure-on-confirmation-as-cms-administrator/ 2021-07-12T20:06:31+00:00 https://ascopost.com/issues/july-10-2021/personalizing-treatment-of-early-her2-positive-breast-cancer/ 2021-07-12T20:10:32+00:00 https://ascopost.com/issues/july-10-2021/suresh-ramalingam-named-new-executive-director-at-winship-cancer-institute/ 2021-07-13T21:10:58+00:00 https://ascopost.com/issues/july-10-2021/breast-cancer-expert-joseph-sparano-to-join-mount-sinai-health-system/ 2021-07-13T21:13:46+00:00 https://ascopost.com/issues/july-25-2021/ 2021-07-26T19:40:38+00:00 https://ascopost.com/issues/july-25-2021/impact-of-covid-19-on-cancer-treatment-and-early-detection-data-driven-insights/ 2021-07-26T19:40:38+00:00 https://ascopost.com/issues/july-25-2021/epov-clifford-goodman/ 2021-07-26T19:40:39+00:00 https://ascopost.com/issues/july-25-2021/bevacizumab-in-advanced-ovarian-cancer-phase-iii-trial-finds-more-is-not-better/ 2021-07-26T19:40:40+00:00 https://ascopost.com/issues/july-25-2021/epov-carol-aghajanian/ 2021-07-26T19:40:41+00:00 https://ascopost.com/issues/july-25-2021/vision-trial-novel-psma-targeted-radiotherapy-improves-outcomes-in-metastatic-prostate-cancer/ 2021-07-26T19:40:42+00:00 https://ascopost.com/issues/july-25-2021/epov-mary-ellen-taplin/ 2021-07-26T19:40:43+00:00 https://ascopost.com/issues/july-25-2021/novel-monoclonal-antibody-emerges-as-potential-first-line-standard-in-nasopharyngeal-cancer/ 2026-01-29T16:06:41+00:00 https://ascopost.com/issues/july-25-2021/leap-004-trial-update-on-lenvatinib-plus-pembrolizumab-after-disease-progression-in-metastatic-melanoma/ 2021-08-26T17:46:38+00:00 https://ascopost.com/issues/july-25-2021/epov-jason-luke/ 2021-07-26T19:40:47+00:00 https://ascopost.com/issues/july-25-2021/fda-approves-expanded-indication-for-pembrolizumab-in-locally-advanced-cutaneous-squamous-cell-carcinoma/ 2021-07-26T19:40:48+00:00 https://ascopost.com/issues/july-25-2021/loncastuximab-tesirine-lpyl-for-relapsed-or-refractory-large-b-cell-lymphoma/ 2021-07-26T19:40:49+00:00 https://ascopost.com/issues/july-25-2021/addition-of-adavosertib-to-gemcitabine-improves-outcomes-in-high-grade-serous-ovarian-cancer/ 2021-07-26T19:40:51+00:00 https://ascopost.com/issues/july-25-2021/factoring-fertility-preservation-into-breast-cancer-treatment/ 2021-08-02T17:51:30+00:00 https://ascopost.com/issues/july-25-2021/dual-pi3kδck1ε-inhibitor-umbralisib-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/ 2021-07-26T19:40:54+00:00 https://ascopost.com/issues/july-25-2021/overall-survival-benefit-reported-with-daratumumab-plus-lenalidomide-in-myeloma/ 2021-07-26T19:40:55+00:00 https://ascopost.com/issues/july-25-2021/role-of-pi3k-inhibition-in-indolent-lymphomas/ 2021-07-27T20:59:21+00:00 https://ascopost.com/issues/july-25-2021/epov-philip-mccarthy/ 2021-07-26T19:40:57+00:00 https://ascopost.com/issues/july-25-2021/avapritinib-for-advanced-systemic-mastocytosis/ 2021-07-26T19:40:58+00:00 https://ascopost.com/issues/july-25-2021/bridging-the-gender-gap-in-oncology/ 2021-07-26T19:40:59+00:00 https://ascopost.com/issues/july-25-2021/oncology-community-mourns-the-loss-of-investigator-angelo-di-leo/ 2021-07-26T19:41:00+00:00 https://ascopost.com/issues/july-25-2021/phase-iii-glow-trial-improved-outcomes-with-first-line-ibrutinib-plus-venetoclax-in-elderly-patients-with-cll/ 2021-08-16T19:19:23+00:00 https://ascopost.com/issues/july-25-2021/bringing-palliative-care-to-native-american-patients-with-cancer/ 2021-07-26T20:09:21+00:00 https://ascopost.com/issues/july-25-2021/sukhmani-padda-to-direct-thoracic-medical-oncology-at-cedars-sinai-cancer-center/ 2021-07-26T19:41:03+00:00 https://ascopost.com/issues/july-25-2021/epov-kostas-stamatopoulos/ 2021-07-26T19:41:05+00:00 https://ascopost.com/issues/july-25-2021/ucsf-names-ajay-maker-chief-of-surgical-oncology/ 2021-07-26T19:41:06+00:00 https://ascopost.com/issues/july-25-2021/long-term-analysis-of-short-her-trial-of-adjuvant-trastuzumab/ 2021-07-26T19:41:08+00:00 https://ascopost.com/issues/july-25-2021/evandro-de-azambuja-discusses-the-short-her-trial/ 2021-07-26T19:41:09+00:00 https://ascopost.com/issues/july-25-2021/early-phase-trial-finds-mirvetuximab-soravtansine-plus-bevacizumab-active-in-recurrent-ovarian-cancer/ 2021-07-26T19:41:10+00:00 https://ascopost.com/issues/july-25-2021/b-cell-acute-lymphoblastic-leukemia-update-on-clinical-trials/ 2021-08-16T19:13:28+00:00 https://ascopost.com/issues/july-25-2021/lisocabtagene-maraleucel-for-relapsed-or-refractory-large-b-cell-lymphoma/ 2021-07-26T19:41:12+00:00 https://ascopost.com/issues/july-25-2021/axicabtagene-ciloleucel-for-relapsed-or-refractory-follicular-lymphoma/ 2021-07-26T19:41:13+00:00 https://ascopost.com/issues/july-25-2021/epov-amit-m-oza/ 2021-07-26T19:41:14+00:00 https://ascopost.com/issues/july-25-2021/canadian-oncologists-report-costly-delays-in-their-drug-regulatory-process/ 2021-07-26T19:41:15+00:00 https://ascopost.com/issues/july-25-2021/american-ginseng/ 2021-07-27T20:17:59+00:00 https://ascopost.com/issues/july-25-2021/memorial-sloan-kettering-announces-new-initiative-to-focus-on-lung-cancer-research/ 2021-07-26T19:41:18+00:00 https://ascopost.com/issues/july-25-2021/dostarlimab-gxly-for-mismatch-repair-deficient-recurrent-or-advanced-endometrial-cancer/ 2021-07-26T19:41:19+00:00 https://ascopost.com/issues/july-25-2021/small-study-suggests-alk-targeting-may-be-of-benefit-in-adult-neuroblastoma/ 2021-07-26T19:41:20+00:00 https://ascopost.com/issues/july-25-2021/epov-jaishri-o-blakeley/ 2021-07-26T19:41:21+00:00 https://ascopost.com/issues/july-25-2021/tivozanib-for-relapsed-or-refractory-advanced-renal-cell-carcinoma/ 2021-07-26T19:41:22+00:00 https://ascopost.com/issues/july-25-2021/bone-protecting-agents-shown-to-reduce-fracture-rate-in-men-with-metastatic-prostate-cancer/ 2021-08-09T18:44:32+00:00 https://ascopost.com/issues/july-25-2021/the-compelling-story-of-cystic-fibrosis-and-the-dawn-of-precision-medicine/ 2021-07-26T19:41:24+00:00 https://ascopost.com/issues/july-25-2021/epov-lisa-horvath/ 2021-07-26T19:41:25+00:00 https://ascopost.com/issues/july-25-2021/inclusion-of-patients-with-brain-metastases-in-phase-iii-trials-in-advanced-breast-cancer-lung-cancer-and-melanoma/ 2021-07-26T19:41:26+00:00 https://ascopost.com/issues/july-25-2021/adjuvant-metronomic-capecitabine-for-locoregionally-advanced-nasopharyngeal-carcinoma/ 2026-01-29T16:05:03+00:00 https://ascopost.com/issues/july-25-2021/i-m-alive-by-sheer-force-of-will-and-a-lot-of-luck/ 2021-07-26T19:41:29+00:00 https://ascopost.com/issues/july-25-2021/public-comment-on-national-coverage-analysis-of-screening-for-lung-cancer-with-low-dose-computed-tomography/ 2021-07-26T19:41:30+00:00 https://ascopost.com/issues/july-25-2021/mindact-trial-shows-excellent-outcomes-in-ultra-low-risk-breast-cancer/ 2021-07-26T19:41:31+00:00 https://ascopost.com/issues/july-25-2021/epov-fabrice-andré/ 2021-07-26T19:41:32+00:00 https://ascopost.com/issues/july-25-2021/sarah-tasian-md-appointed-chief-of-the-section-of-hematologic-malignancies-children-s-hospital-of-philadelphia/ 2021-07-26T19:41:33+00:00 https://ascopost.com/issues/july-25-2021/fox-chase-cancer-center-welcomes-peter-abdelmessieh-do-msc/ 2021-07-26T19:41:35+00:00 https://ascopost.com/issues/july-25-2021/cleveland-clinic-cancer-center-recognizes-shilpa-gupta-md-and-nima-sharifi-md/ 2021-07-26T19:41:36+00:00 https://ascopost.com/issues/july-25-2021/erica-sirrine-phd-named-director-of-social-work-at-st-jude-children-s-research-hospital/ 2021-07-26T19:41:37+00:00 https://ascopost.com/issues/july-25-2021/breast-cancer-in-2030-predictions-from-a-breast-cancer-luminary/ 2021-08-02T17:48:47+00:00 https://ascopost.com/issues/july-25-2021/how-covid-19-can-lead-to-improvements-in-cancer-care/ 2021-07-26T19:41:39+00:00 https://ascopost.com/issues/july-25-2021/road-map-to-more-equitable-care-from-the-centers-for-medicare-and-medicaid-services/ 2021-07-26T19:41:41+00:00 https://ascopost.com/issues/july-25-2021/epov-shonta-chambers/ 2021-07-26T19:41:42+00:00 https://ascopost.com/issues/july-25-2021/pembrolizumab-combined-with-chemotherapy-for-advanced-esophageal-or-gastroesophageal-junction-carcinoma/ 2021-07-26T19:41:43+00:00 https://ascopost.com/issues/july-25-2021/lorlatinib-for-metastatic-alk-positive-nsclc/ 2021-07-26T19:41:44+00:00 https://ascopost.com/issues/july-25-2021/adjuvant-pembrolizumab-improves-distant-metastasis-free-survival-in-resected-high-risk-stage-iii-melanoma/ 2021-08-26T17:39:28+00:00 https://ascopost.com/issues/july-25-2021/benefits-of-adjuvant-pembrolizumab-in-melanoma-reinforced-by-eortc-1325keynote-054-updates/ 2021-08-26T17:42:16+00:00 https://ascopost.com/issues/july-25-2021/asco-publishes-resource-stratified-guideline-on-assessment-and-treatment-of-ovarian-cancer/ 2021-07-26T19:41:47+00:00 https://ascopost.com/issues/july-25-2021/asco-calls-for-increased-funding-for-cancer-research-in-fiscal-year-2022/ 2021-07-26T19:42:26+00:00 https://ascopost.com/issues/july-25-2021/ascofriends-of-cancer-research-joint-position-statement-encourages-enrollment-of-patients-with-cancer-in-covid-19-vaccine-studies/ 2021-07-26T19:48:15+00:00 https://ascopost.com/issues/july-25-2021/asco-honors-john-v-cox-do-mba-facp-fasco-with-2021-joseph-v-simone-award/ 2021-07-26T19:53:42+00:00 https://ascopost.com/issues/august-10-2021/ 2021-08-10T20:20:04+00:00 https://ascopost.com/issues/august-10-2021/incidence-and-cancer-related-mortality-in-bahrain/ 2021-08-10T20:20:04+00:00 https://ascopost.com/issues/august-10-2021/adjuvant-nivolumab-improves-disease-free-survival-in-high-risk-muscle-invasive-urothelial-carcinoma/ 2021-08-10T20:20:05+00:00 https://ascopost.com/issues/august-10-2021/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma-is-disease-free-survival-the-best-endpoint/ 2021-08-10T20:20:06+00:00 https://ascopost.com/issues/august-10-2021/nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer/ 2021-08-10T20:20:07+00:00 https://ascopost.com/issues/august-10-2021/sacituzumab-govitecan-hziy-vs-single-agent-chemotherapy-in-relapsed-or-refractory-metastatic-triple-negative-breast-cancer/ 2021-08-10T21:02:05+00:00 https://ascopost.com/issues/august-10-2021/a-new-era-of-hope-for-patients-with-triple-negative-breast-cancer/ 2021-09-01T18:00:45+00:00 https://ascopost.com/issues/august-10-2021/fda-grants-regular-approval-to-pembrolizumablenvatinib-for-advanced-endometrial-carcinoma/ 2021-08-10T20:20:09+00:00 https://ascopost.com/issues/august-10-2021/car-t-cell-gene-therapy-in-non-hodgkin-lymphomas/ 2021-08-10T20:20:10+00:00 https://ascopost.com/issues/august-10-2021/from-istanbul-to-orange-county-an-oncologist-s-journey-to-a-leadership-role-in-quality-care/ 2021-08-10T20:20:11+00:00 https://ascopost.com/issues/august-10-2021/roswell-park-approved-to-provide-care-for-world-trade-center-911-first-responders/ 2021-08-10T20:20:12+00:00 https://ascopost.com/issues/august-10-2021/mount-sinai-welcomes-robotic-prostate-surgery-pioneer-mani-menon-md/ 2021-08-10T20:20:13+00:00 https://ascopost.com/issues/august-10-2021/nationally-recognized-biostatistician-joins-rutgers-to-focus-on-cancer-research/ 2021-08-10T20:20:14+00:00 https://ascopost.com/issues/august-10-2021/fda-grants-regular-approval-to-enfortumab-vedotin-ejfv-for-locally-advanced-or-metastatic-urothelial-cancer/ 2021-08-10T20:20:15+00:00 https://ascopost.com/issues/august-10-2021/2021-asco-annual-meeting-next-generation-oncology-highlights/ 2021-08-10T20:20:16+00:00 https://ascopost.com/issues/august-10-2021/aaci-members-choose-robert-winn-md-as-vice-presidentpresident-elect-and-other-new-leaders/ 2021-08-10T20:20:19+00:00 https://ascopost.com/issues/august-10-2021/ama-satcher-health-leadership-institute-announce-inaugural-recipients-of-health-equity-advocacy-fellowship/ 2021-08-10T20:20:21+00:00 https://ascopost.com/issues/august-10-2021/facing-the-trauma-of-colorectal-cancer/ 2021-08-10T20:20:22+00:00 https://ascopost.com/issues/august-10-2021/international-esodata-study-group-model-for-predicting-90-day-mortality-after-esophagectomy/ 2021-08-10T20:20:23+00:00 https://ascopost.com/issues/august-10-2021/predicting-chemotherapy-resistance-in-patients-with-gestational-trophoblastic-neoplasia/ 2021-08-10T20:20:24+00:00 https://ascopost.com/issues/august-10-2021/does-the-presence-of-neuronal-autoantibodies-contribute-to-cognitive-impairment-in-patients-with-lung-cancer/ 2021-08-10T20:20:26+00:00 https://ascopost.com/issues/august-10-2021/radiation-oncologists-urge-congress-to-create-more-equity-in-access-to-care/ 2021-08-10T20:20:27+00:00 https://ascopost.com/issues/august-10-2021/neoadjuvant-pembrolizumab-improves-event-free-survival-in-triple-negative-breast-cancer/ 2021-08-10T20:20:29+00:00 https://ascopost.com/issues/august-10-2021/epov-giuseppe-curigliano/ 2021-08-10T20:20:29+00:00 https://ascopost.com/issues/august-10-2021/how-climate-change-is-impacting-cancer-care/ 2021-08-17T13:22:05+00:00 https://ascopost.com/issues/august-10-2021/fda-approves-belumosudil-for-chronic-graft-vs-host-disease/ 2021-08-10T20:20:31+00:00 https://ascopost.com/issues/august-10-2021/no-subgroup-benefits-more-from-t-dm1-plus-chemotherapy-for-her2-positive-early-breast-cancer/ 2021-08-10T20:20:32+00:00 https://ascopost.com/issues/august-10-2021/epov-evandro-de-azambuja/ 2021-08-10T20:20:32+00:00 https://ascopost.com/issues/august-10-2021/bispecific-antibodies-advance-in-relapsed-or-refractory-multiple-myeloma/ 2021-08-10T20:20:34+00:00 https://ascopost.com/issues/august-10-2021/epov-surbhi-sidana/ 2021-08-24T18:30:16+00:00 https://ascopost.com/issues/august-10-2021/study-finds-cytarabine-prodrug-active-and-safe-in-older-compromised-patients-with-aml/ 2021-08-10T20:20:36+00:00 https://ascopost.com/issues/august-10-2021/epov-guru-subramanian-guru-murthy/ 2021-08-10T20:20:36+00:00 https://ascopost.com/issues/august-10-2021/fda-approves-daratumumab-and-hyaluronidase-fihj-with-pomalidomide-and-dexamethasone-for-pretreated-patients-with-multiple-myeloma/ 2021-08-10T20:20:37+00:00 https://ascopost.com/issues/august-10-2021/single-agent-talazoparib-shows-activity-in-the-neoadjuvant-treatment-of-triple-negative-breast-cancer/ 2021-08-10T20:20:38+00:00 https://ascopost.com/issues/august-10-2021/epov-lisa-carey/ 2021-08-10T20:20:39+00:00 https://ascopost.com/issues/august-10-2021/trilaciclib-to-reduce-chemotherapy-induced-bone-marrow-suppression-in-extensive-stage-small-cell-lung-cancer/ 2021-08-10T20:20:40+00:00 https://ascopost.com/issues/august-10-2021/an-egyptian-surgical-oncologist-urges-global-cooperation-to-achieve-equitable-cancer-care/ 2021-08-10T20:20:40+00:00 https://ascopost.com/issues/august-10-2021/apact-5-year-overall-survival-data-suggest-improved-outcomes-in-pancreatic-cancer-with-nab-paclitaxelgemcitabine/ 2021-09-09T18:27:37+00:00 https://ascopost.com/issues/august-10-2021/epov-thomas-seufferlein/ 2021-08-11T00:41:54+00:00 https://ascopost.com/issues/august-10-2021/tislelizumab-improves-overall-survival-as-second-line-treatment-of-esophageal-cancer/ 2021-09-09T18:30:22+00:00 https://ascopost.com/issues/august-10-2021/epov-kei-muro/ 2021-08-11T00:52:08+00:00 https://ascopost.com/issues/august-10-2021/zanubrutinib-superior-to-ibrutinib-for-cllsll-in-phase-iii-alpine-trial/ 2021-08-16T19:16:36+00:00 https://ascopost.com/issues/august-10-2021/novel-antibody-drug-conjugate-under-study-in-refractory-dlbcl/ 2021-08-12T19:12:02+00:00 https://ascopost.com/issues/august-10-2021/epov-leslie-popplewell/ 2021-08-10T20:20:48+00:00 https://ascopost.com/issues/august-10-2021/neoadjuvant-durvalumab-improves-long-term-outcomes-in-the-geparnuevo-trial/ 2021-09-01T18:44:44+00:00 https://ascopost.com/issues/august-10-2021/epov-melinda-telli/ 2021-08-11T00:56:36+00:00 https://ascopost.com/issues/august-10-2021/cabozantinib-potential-new-option-for-treatment-refractory-thyroid-cancer/ 2021-08-10T20:20:51+00:00 https://ascopost.com/issues/august-10-2021/epov-nicole-chau/ 2021-08-10T20:20:52+00:00 https://ascopost.com/issues/august-10-2021/nccn-foundation-announces-awards-for-rising-cancer-research-leaders/ 2021-08-10T20:20:53+00:00 https://ascopost.com/issues/august-10-2021/mortality-risk-with-adjuvant-vs-early-salvage-radiotherapy-in-men-with-adverse-pathology-at-radical-prostatectomy-for-prostate-cancer/ 2021-08-10T20:20:54+00:00 https://ascopost.com/issues/august-10-2021/salvage-and-adjuvant-radiotherapy-after-radical-prostatectomy-for-prostate-cancer/ 2021-08-11T15:51:46+00:00 https://ascopost.com/issues/august-10-2021/no-progression-free-survival-benefit-with-first-line-avelumab-plus-chemoradiotherapy-in-squamous-cell-carcinoma-of-the-head-and-neck/ 2026-01-29T15:49:49+00:00 https://ascopost.com/issues/august-10-2021/javelin-head-and-neck-100-trial-when-failure-seems-fatal-hope-is-not-lost/ 2026-01-29T15:46:36+00:00 https://ascopost.com/issues/august-10-2021/fred-hutchinson-cancer-research-center-seattle-childrens-and-uw-medicine-lay-groundwork-for-cancer-partnership/ 2021-08-10T20:20:57+00:00 https://ascopost.com/issues/august-10-2021/the-patient-we-see-and-the-person-we-may-not/ 2021-08-10T20:24:35+00:00 https://ascopost.com/issues/august-10-2021/asparaginase-erwinia-chrysanthemi-recombinant-rywn-for-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma/ 2021-08-10T20:34:57+00:00 https://ascopost.com/issues/august-10-2021/oncology-practices-nationwide-show-high-interest-in-diversifying-cancer-clinical-trials/ 2021-08-11T00:08:59+00:00 https://ascopost.com/issues/august-10-2021/asco-and-community-oncology-alliance-publish-standards-for-oncology-medical-home-model/ 2021-08-11T00:14:08+00:00 https://ascopost.com/issues/august-10-2021/conquer-cancer-announces-2021-israel-cancer-research-fund-career-development-award/ 2021-08-11T00:16:56+00:00 https://ascopost.com/issues/august-10-2021/olufunmilayo-olopade-to-receive-sabcs-2021-william-l-mcguire-memorial-lecture-award/ 2021-08-11T01:45:55+00:00 https://ascopost.com/issues/august-25-2021/ 2021-08-25T15:36:44+00:00 https://ascopost.com/issues/august-25-2021/tackling-the-challenge-of-pancreatic-cancer-new-approaches/ 2021-08-25T15:36:44+00:00 https://ascopost.com/issues/august-25-2021/durable-clinical-activity-reported-with-tislelizumab-in-advanced-liver-cancer/ 2021-08-25T15:36:45+00:00 https://ascopost.com/issues/august-25-2021/epov-chris-verslype/ 2021-08-25T15:36:46+00:00 https://ascopost.com/issues/august-25-2021/fda-approves-pembrolizumab-in-combination-for-high-risk-early-stage-triple-negative-breast-cancer/ 2021-08-25T15:36:47+00:00 https://ascopost.com/issues/august-25-2021/avelumab-under-study-as-adjunct-to-neoadjuvant-therapy-for-rectal-cancer/ 2021-08-25T15:36:48+00:00 https://ascopost.com/issues/august-25-2021/epov-eric-deutsch/ 2021-09-13T20:13:09+00:00 https://ascopost.com/issues/august-25-2021/more-widespread-biomarker-testing-for-nsclc-in-oncology-practices-and-more-testing-in-black-patients/ 2021-08-25T15:36:50+00:00 https://ascopost.com/issues/august-25-2021/epov-christine-lovly/ 2021-08-25T15:36:51+00:00 https://ascopost.com/issues/august-25-2021/axicabtagene-ciloleucel-improves-multiple-clinical-endpoints-in-relapsed-follicular-lymphoma/ 2021-11-09T23:02:22+00:00 https://ascopost.com/issues/august-25-2021/low-dose-ct-screening-for-lung-cancer-and-the-incidental-findings-that-may-improve-future-health/ 2021-08-25T16:59:44+00:00 https://ascopost.com/issues/august-25-2021/historic-present-and-future-perspectives-on-breast-cancer-in-egypt/ 2021-09-01T18:43:24+00:00 https://ascopost.com/issues/august-25-2021/winette-van-der-graaf-md-phd-named-eortc-president-elect-2021-2024/ 2021-08-25T15:36:55+00:00 https://ascopost.com/issues/august-25-2021/northwell-health-new-york-appoints-regional-director-of-urology/ 2021-08-25T15:36:56+00:00 https://ascopost.com/issues/august-25-2021/vanderbilt-university-appoints-karen-winkfield-md-phd-professor-of-radiation-oncology/ 2021-08-25T15:36:57+00:00 https://ascopost.com/issues/august-25-2021/heather-wakelee-md-fasco-honored-with-the-2021-bonnie-j-addario-lectureship-award/ 2021-08-25T15:36:58+00:00 https://ascopost.com/issues/august-25-2021/isatuximab-irfc-in-relapsed-or-refractory-multiple-myeloma/ 2021-08-25T15:36:59+00:00 https://ascopost.com/issues/august-25-2021/new-guideline-provides-clarity-on-timing-treatment-of-axilla-in-early-stage-breast-cancer/ 2021-08-25T15:37:00+00:00 https://ascopost.com/issues/august-25-2021/gut-microbiome-and-cancer/ 2021-08-25T15:37:01+00:00 https://ascopost.com/issues/august-25-2021/high-prevalence-of-previously-undiagnosed-emphysema-among-individuals-undergoing-low-dose-ct-screening-for-lung-cancer/ 2021-08-25T16:56:14+00:00 https://ascopost.com/issues/august-25-2021/beth-karlan-receives-lifetime-achievement-award-for-contributions-to-gynecologic-oncology/ 2021-08-25T15:37:03+00:00 https://ascopost.com/issues/august-25-2021/belumosudil-for-chronic-graft-vs-host-disease/ 2021-08-25T15:37:04+00:00 https://ascopost.com/issues/august-25-2021/sacituzumab-govitecan-hziy-for-locally-advanced-or-metastatic-urothelial-cancer/ 2021-08-25T15:37:04+00:00 https://ascopost.com/issues/august-25-2021/marcus-bosenberg-named-inaugural-director-of-yale-center-for-immuno-oncology/ 2021-08-25T15:37:05+00:00 https://ascopost.com/issues/august-25-2021/sacituzumab-govitecan-hziy-for-locally-advanced-or-metastatic-triple-negative-breast-cancer/ 2021-08-25T15:37:06+00:00 https://ascopost.com/issues/august-25-2021/neuroendocrine-tumor-specialist-pamela-kunz-looks-to-promote-equity-in-the-workforce/ 2021-08-27T16:31:10+00:00 https://ascopost.com/issues/august-25-2021/global-estimates-of-new-cancers-attributable-to-alcohol-use-in-2020/ 2021-08-25T15:37:08+00:00 https://ascopost.com/issues/august-25-2021/cancer-vs-non-cancer-related-deaths-among-older-patients-selected-for-surgical-treatment/ 2021-08-25T15:37:09+00:00 https://ascopost.com/issues/august-25-2021/i-m-a-two-time-breast-cancer-survivor-and-the-experience-has-been-life-altering/ 2021-08-25T15:37:10+00:00 https://ascopost.com/issues/august-25-2021/leland-chung-dies-at-80/ 2021-08-25T15:37:10+00:00 https://ascopost.com/issues/august-25-2021/asco-joins-statement-supporting-mandatory-health-employer-covid-19-vaccination/ 2021-08-25T15:48:06+00:00 https://ascopost.com/issues/august-25-2021/asco-and-masccisoo-publish-joint-guideline-on-prevention-treatment-of-salivary-gland-hypofunction-and-xerostomia/ 2021-08-25T15:55:48+00:00 https://ascopost.com/issues/september-10-2021/ 2021-09-10T18:11:50+00:00 https://ascopost.com/issues/september-10-2021/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-south-africa/ 2021-09-10T20:24:50+00:00 https://ascopost.com/issues/september-10-2021/annual-report-to-the-nation/ 2021-09-10T18:11:51+00:00 https://ascopost.com/issues/september-10-2021/gastrointestinal-oncologist-focuses-on-both-the-art-and-science-of-treating-patients-with-cancer/ 2021-09-10T18:11:52+00:00 https://ascopost.com/issues/september-10-2021/yale-cancer-center-names-barbara-burtness-md-interim-associate-director-for-diversity-equity-and-inclusion/ 2021-09-10T18:11:53+00:00 https://ascopost.com/issues/september-10-2021/lakshmanan-krishnamurti-md-joins-yale-school-of-medicine-in-department-of-pediatrics/ 2021-09-10T18:11:54+00:00 https://ascopost.com/issues/september-10-2021/judy-e-garber-md-phd-faacr-to-receive-aaci-distinguished-scientist-award/ 2021-09-10T18:11:55+00:00 https://ascopost.com/issues/september-10-2021/pembrolizumab-for-high-risk-early-stage-triple-negative-breast-cancer/ 2021-09-10T18:11:56+00:00 https://ascopost.com/issues/september-10-2021/enfortumab-vedotin-ejfv-in-urothelial-cancer/ 2021-09-10T18:11:57+00:00 https://ascopost.com/issues/september-10-2021/music-therapy-for-cancer-related-fatigue/ 2021-09-10T18:11:58+00:00 https://ascopost.com/issues/september-10-2021/fda-approves-lenvatinibpembrolizumab-for-advanced-renal-cell-carcinoma/ 2021-09-10T18:11:59+00:00 https://ascopost.com/issues/september-10-2021/fda-approves-nivolumab-for-adjuvant-treatment-of-urothelial-carcinoma/ 2021-09-10T18:12:00+00:00 https://ascopost.com/issues/september-10-2021/breakthrough-covid-19-infection-in-fully-vaccinated-health-care-workers/ 2021-09-10T18:12:02+00:00 https://ascopost.com/issues/september-10-2021/impact-of-nurse-navigation-program-on-outcomes-in-minority-patients-with-aggressive-lymphoma/ 2021-09-10T18:12:03+00:00 https://ascopost.com/issues/september-10-2021/highlights-from-transplantation-and-cellular-therapy-meetings-of-astct-and-cibmtr/ 2021-09-10T18:12:04+00:00 https://ascopost.com/issues/september-10-2021/dana-farber-cancer-institute-establishes-the-david-liposarcoma-research-initiative/ 2021-09-10T18:12:05+00:00 https://ascopost.com/issues/september-10-2021/fifty-for-fifty-campaign-to-commemorate-the-national-cancer-act-s-50th-anniversary/ 2021-09-10T18:12:06+00:00 https://ascopost.com/issues/september-10-2021/pembrolizumab-combined-with-trastuzumab-and-chemotherapy-for-her2-positive-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2021-09-10T18:12:07+00:00 https://ascopost.com/issues/september-10-2021/amivantamab-vmjw-for-previously-treated-advanced-nsclc-with-egfr-mutation/ 2021-09-10T18:12:08+00:00 https://ascopost.com/issues/september-10-2021/an-oncologist-s-prescription-humanity-and-love/ 2021-09-10T18:12:09+00:00 https://ascopost.com/issues/september-10-2021/a-scientific-detective-tale-with-consequences-for-the-future-of-our-species/ 2021-09-10T18:12:10+00:00 https://ascopost.com/issues/september-10-2021/reduced-intensity-chemotherapy-for-older-frail-patients-with-advanced-gastroesophageal-cancer/ 2021-10-07T22:38:24+00:00 https://ascopost.com/issues/september-10-2021/listen-to-patients-concerns-about-quality-of-life/ 2021-09-10T18:12:12+00:00 https://ascopost.com/issues/september-10-2021/cellular-therapy-pioneer-renier-brentjens-md-phd-joins-roswell-park-as-deputy-director-and-chair-of-medicine/ 2021-09-10T18:12:13+00:00 https://ascopost.com/issues/september-10-2021/accc-releases-annual-report-on-current-state-of-immuno-oncology/ 2021-09-10T18:12:14+00:00 https://ascopost.com/issues/september-10-2021/2021-basser-global-prize-presented-to-andré-nussenzweig-phd/ 2021-09-10T18:12:15+00:00 https://ascopost.com/issues/september-10-2021/maintained-benefit-of-apalutamide-plus-androgen-deprivation-therapy-shown-in-metastatic-castration-sensitive-prostate-cancer/ 2021-09-10T18:12:16+00:00 https://ascopost.com/issues/september-10-2021/study-finds-lower-income-eligibility-limits-for-medicaid-associated-with-worse-long-term-survival-for-newly-diagnosed-patients-with-cancer/ 2021-09-10T18:12:18+00:00 https://ascopost.com/issues/september-10-2021/improving-end-of-life-discussions-with-patients-who-have-advanced-cancer/ 2021-09-10T18:12:19+00:00 https://ascopost.com/issues/september-10-2021/recommendations-from-asco-for-discussing-patients-goals-of-care-through-survivorship-to-end-of-life/ 2021-09-10T18:12:20+00:00 https://ascopost.com/issues/september-10-2021/cancer-is-trying-to-steal-my-body-but-i-will-not-allow-it-to-steal-my-joy/ 2021-09-10T18:12:21+00:00 https://ascopost.com/issues/september-10-2021/assumptions-data-and-more-questions/ 2021-09-10T18:12:22+00:00 https://ascopost.com/issues/september-10-2021/safety-efficacy-of-neoadjuvant-pertuzumab-plus-trastuzumab-maintained-in-final-analysis-of-berenice-trial/ 2021-09-10T18:12:22+00:00 https://ascopost.com/issues/september-10-2021/evandro-de-azambuja-comments-on-the-berenice-trial/ 2021-09-10T18:12:23+00:00 https://ascopost.com/issues/september-10-2021/liquid-biopsy-is-changing-colon-cancer-management/ 2021-09-10T18:12:24+00:00 https://ascopost.com/issues/september-10-2021/prostate-cancer-diagnostics-novel-approaches-are-leaving-conventional-imaging-behind/ 2021-09-10T18:12:25+00:00 https://ascopost.com/issues/september-10-2021/are-triplets-necessary-for-braf-mutated-melanoma/ 2021-09-10T18:12:26+00:00 https://ascopost.com/issues/september-10-2021/daratumumab-and-hyaluronidase-fihj-with-pomalidomide-plus-dexamethasone-in-multiple-myeloma/ 2021-09-10T18:12:27+00:00 https://ascopost.com/issues/september-10-2021/study-finds-evidence-based-interventions-added-to-screening-did-not-improve-cancer-pain/ 2021-09-10T18:12:28+00:00 https://ascopost.com/issues/september-10-2021/early-phase-study-rediscovers-potential-alternative-to-methadone-for-cancer-pain/ 2021-09-10T18:12:28+00:00 https://ascopost.com/issues/september-10-2021/launch-of-mskcc-india-expands-access-to-oncologists-cancer-care-research-and-education/ 2021-09-10T18:12:29+00:00 https://ascopost.com/issues/september-10-2021/adding-lupsma-to-standard-care-improves-outcomes-in-castration-resistant-prostate-cancer/ 2021-09-10T18:12:30+00:00 https://ascopost.com/issues/september-10-2021/lutetium-177-psma-617-a-first-in-class-radioligand-therapeutic-in-metastatic-prostate-cancer/ 2021-09-10T18:12:31+00:00 https://ascopost.com/issues/september-10-2021/high-prevalence-of-germline-brca-mutations-in-indian-women-with-ovarian-cancer/ 2021-09-10T18:12:32+00:00 https://ascopost.com/issues/september-10-2021/prevalence-of-germline-brca-mutations-in-indian-women-with-ovarian-cancer/ 2021-09-10T18:12:33+00:00 https://ascopost.com/issues/september-10-2021/subcutaneous-daratumumab-added-to-pomalidomide-plus-dexamethasone-improves-progression-free-survival-in-multiple-myeloma/ 2021-09-28T19:44:33+00:00 https://ascopost.com/issues/september-10-2021/treatment-of-relapsed-myeloma-options-include-new-drugs-novel-combinations/ 2021-09-28T18:37:15+00:00 https://ascopost.com/issues/september-10-2021/fda-grants-approval-to-the-pfizer-biontech-covid-19-vaccine/ 2021-09-10T18:12:36+00:00 https://ascopost.com/issues/september-10-2021/elevate-rr-trial-acalabrutinib-as-effective-as-ibrutinib-with-fewer-cardiac-effects-in-resistant-cll/ 2021-09-10T18:12:37+00:00 https://ascopost.com/issues/september-10-2021/epov-jacqueline-barrientos/ 2022-05-06T16:02:36+00:00 https://ascopost.com/issues/september-10-2021/how-covid-19-is-spotlighting-the-role-of-palliative-medicine/ 2021-09-10T18:12:39+00:00 https://ascopost.com/issues/september-10-2021/former-medical-director-at-princess-margaret-cancer-centre-to-lead-new-commission-on-global-cancer-care/ 2021-09-10T18:12:40+00:00 https://ascopost.com/issues/september-10-2021/fda-approves-ivosidenib-for-advanced-or-metastatic-idh1-mutated-cholangiocarcinoma/ 2021-09-10T18:12:41+00:00 https://ascopost.com/issues/september-10-2021/titan-confirms-survival-benefit-of-apalutamide-plus-adt-in-metastatic-prostate-cancer/ 2021-09-10T20:20:20+00:00 https://ascopost.com/issues/september-10-2021/covid-19-pandemic-spurs-quick-uptick-in-telehealth-adoption-asco-provides-guidance-for-oncologists/ 2021-09-10T18:12:43+00:00 https://ascopost.com/issues/september-10-2021/guideline-update-addresses-treatments-for-her2-negative-advanced-breast-cancer/ 2021-09-10T18:12:44+00:00 https://ascopost.com/issues/september-10-2021/conquer-cancer-names-inaugural-recipients-of-asco-registry-research-grants/ 2021-09-10T18:12:45+00:00 https://ascopost.com/issues/september-10-2021/introducing-the-asco-plenary-series/ 2021-09-10T18:12:47+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/ 2021-09-16T17:18:04+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/highlights-from-the-2021-asco-annual-meeting/ 2022-01-18T22:22:35+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/amivantamablazertinib-combination-may-overcome-osimertinib-resistance-in-patients-with-egfr-positive-nsclc/ 2021-09-16T17:18:06+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-nicolas-girard/ 2021-09-16T17:18:07+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/cemiplimab-rwlc-improves-outcomes-in-first-line-treatment-of-nsclc-with-brain-metastases/ 2021-09-16T17:18:08+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/novel-monoclonal-antibody-emerges-as-potential-first-line-standard-in-nasopharyngeal-cancer/ 2026-01-29T16:29:12+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-anthony-tc-chan/ 2021-09-16T17:18:12+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/first-line-nivolumab-regimens-improve-survival-in-esophageal-squamous-cell-carcinoma/ 2021-09-16T17:18:13+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-david-cunningham/ 2021-09-16T17:18:15+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/novel-psma-targeted-radiotherapy-improves-outcomes-in-metastatic-prostate-cancer/ 2021-09-16T17:18:17+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-mary-ellen-taplin/ 2021-09-16T17:18:18+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/ 2021-09-16T17:18:20+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-rana-r-mckay/ 2021-09-16T17:18:21+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/no-benefit-for-adjuvant-chemotherapy-in-cervical-cancer/ 2021-09-16T17:18:22+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-kunle-odunsi-and-lilian-t-gien/ 2021-09-16T17:18:23+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/adavosertib-effective-in-parp-resistant-ovarian-cancer/ 2021-09-16T17:18:24+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/targeting-lag-3-and-pd-1-with-relatlimab-and-nivolumab-a-new-option-under-study-in-advanced-melanoma/ 2021-09-16T17:18:25+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/lifileucel-after-disease-progression-in-metastatic-melanoma-durable-responses-achieved-in-phase-ii-trial/ 2021-09-16T17:18:26+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-jason-j-luke/ 2021-09-16T17:18:28+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/bispecific-antibodies-advance-in-relapsed-or-refractory-multiple-myeloma/ 2021-09-16T17:18:29+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-surbhi-sidana/ 2021-09-16T17:18:30+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/olympia-trial-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-breast-cancer/ 2021-09-16T17:18:31+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/acalabrutinib-as-effective-as-ibrutinib-with-fewer-cardiac-effects-in-resistant-cll/ 2021-09-16T17:18:32+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-nadine-tung/ 2021-09-16T17:18:33+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-jacqueline-c-barrientos/ 2021-09-16T17:18:35+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/fixed-dose-first-line-ibrutinibvenetoclax-combination-achieves-durable-remissions-in-cll/ 2021-09-16T17:18:36+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/ea1131-trial-platinum-not-equal-to-capecitabine-for-residual-disease-in-triple-negative-breast-cancer/ 2021-09-16T17:18:37+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-jacqueline-c-barrientos-md-ms/ 2021-09-16T17:18:38+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-melinda-telli/ 2021-09-16T17:18:39+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/roundup-of-notable-abstracts-in-hematologic-malignancies/ 2021-09-16T17:18:41+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/adapt-trial-excellent-outcomes-reported-with-neoadjuvant-dual-her2-therapy-in-breast-cancer/ 2021-09-16T17:18:42+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/extended-follow-up-of-paloma-3-supports-survival-benefit-of-palbociclib-plus-fulvestrant-in-advanced-breast-cancer/ 2021-09-16T17:18:43+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/atezolizumab-reduces-risk-of-disease-progression-in-patients-with-pd-l1-expressing-early-stage-nsclc/ 2021-09-16T17:18:44+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/sotorasib-subgroup-analysis-of-phase-ii-trial-shows-activity-with-breakthrough-kras-inhibitor-in-lung-cancer/ 2021-09-16T18:32:58+00:00 https://ascopost.com/issues/september-10-2021-supplement-asco-highlights/epov-mark-kris/ 2021-09-16T17:18:46+00:00 https://ascopost.com/issues/september-25-2021/ 2021-09-24T17:26:22+00:00 https://ascopost.com/issues/september-25-2021/braf-mutant-colorectal-cancer-latest-findings-for-targeted-treatment/ 2021-09-24T17:26:23+00:00 https://ascopost.com/issues/september-25-2021/epov-elena-élez/ 2021-09-24T17:26:24+00:00 https://ascopost.com/issues/september-25-2021/overcoming-the-disparities-in-cancer-survival-among-aya-minority-patients/ 2021-09-24T17:26:25+00:00 https://ascopost.com/issues/september-25-2021/patients-first/ 2021-09-24T17:26:26+00:00 https://ascopost.com/issues/september-25-2021/bispecific-antibodies-find-a-place-in-b-cell-lymphoma-treatment/ 2021-10-20T19:44:33+00:00 https://ascopost.com/issues/september-25-2021/putting-radiotherapy-to-best-use-with-car-t-cell-therapy-in-lymphoma/ 2021-10-20T19:42:06+00:00 https://ascopost.com/issues/september-25-2021/lymphoid-malignancies-what-s-next-for-antibody-drug-conjugates/ 2021-10-20T19:40:41+00:00 https://ascopost.com/issues/september-25-2021/asco-2021-roundup-of-studies-you-may-have-missed/ 2021-09-24T17:26:31+00:00 https://ascopost.com/issues/september-25-2021/adding-first-line-nivolumab-to-chemotherapy-improves-survival-in-gastric-gastroesophageal-junction-and-esophageal-adenocarcinomas/ 2021-09-24T17:26:32+00:00 https://ascopost.com/issues/september-25-2021/nivolumab-plus-chemotherapy-improves-survival-in-advanced-gastric-and-esophageal-adenocarcinomas-now-to-figure-out-the-details-in-these-heterogeneous-diseases/ 2021-10-07T22:33:03+00:00 https://ascopost.com/issues/september-25-2021/dostarlimab-gxly-for-mismatch-repair-deficient-recurrent-or-advanced-solid-tumors/ 2021-09-24T17:26:34+00:00 https://ascopost.com/issues/september-25-2021/belzutifan-for-cancers-associated-with-von-hippel-lindau-disease/ 2021-09-24T17:26:35+00:00 https://ascopost.com/issues/september-25-2021/adoptive-cell-therapy-may-soon-be-available-for-patients-with-melanoma/ 2021-09-24T17:26:37+00:00 https://ascopost.com/issues/september-25-2021/outcomes-notably-improving-for-adult-all/ 2021-09-24T17:26:38+00:00 https://ascopost.com/issues/september-25-2021/myeloma-trial-updates-focus-on-high-risk-patients-and-measurable-residual-disease-negativity/ 2021-09-24T17:26:39+00:00 https://ascopost.com/issues/september-25-2021/epov-gordon-cook-mbchb-phd-and-sagar-lonial-md/ 2021-09-24T17:26:40+00:00 https://ascopost.com/issues/september-25-2021/building-a-better-normal-of-oncology-care-to-strengthen-global-health-security-after-the-covid-19-pandemic/ 2021-09-24T17:26:41+00:00 https://ascopost.com/issues/september-25-2021/minnesota-senator-amy-klobuchar-announces-breast-cancer-diagnosis/ 2021-09-24T17:26:42+00:00 https://ascopost.com/issues/september-25-2021/new-evidence-drives-need-for-revised-guideline-on-hormone-sensitive-advanced-breast-cancer/ 2021-09-24T17:26:43+00:00 https://ascopost.com/issues/september-25-2021/asco-applauds-administration-decision-to-withdraw-most-favored-nation-model/ 2021-09-24T17:26:44+00:00 https://ascopost.com/issues/september-25-2021/conquer-cancer-updates-mission-vision-adopts-values-inspired-by-its-donors/ 2021-09-24T17:26:46+00:00 https://ascopost.com/issues/september-25-2021/guideline-rapid-update-provides-new-direction-on-the-care-of-patients-with-residual-disease-in-locally-advanced-esophageal-cancer/ 2026-01-29T16:18:22+00:00 https://ascopost.com/issues/september-25-2021/disaster-assistance-resources-available-for-cancer-care-physicians-patients-impacted-by-hurricane-ida/ 2021-09-24T17:26:48+00:00 https://ascopost.com/issues/september-25-2021/iaslc-announces-lifetime-achievement-awards/ 2021-09-24T17:26:49+00:00 https://ascopost.com/issues/september-25-2021/fda-revises-label-for-pembrolizumab-in-patients-with-advanced-urothelial-carcinoma/ 2021-09-24T17:26:52+00:00 https://ascopost.com/issues/september-25-2021/fda-approves-zanubrutinib-for-waldenstroem-s-macroglobulinemia/ 2021-09-24T17:26:53+00:00 https://ascopost.com/issues/september-25-2021/fda-grants-accelerated-approval-to-dostarlimab-gxly-for-dmmr-advanced-solid-tumors/ 2021-09-24T17:26:55+00:00 https://ascopost.com/issues/september-25-2021/update-on-us-indication-for-atezolizumab-in-pd-l1-positive-metastatic-triple-negative-breast-cancer/ 2021-09-24T17:26:56+00:00 https://ascopost.com/issues/september-25-2021/update-to-nccn-cancer-and-covid-19-vaccination-guidance-announced/ 2021-09-24T17:26:57+00:00 https://ascopost.com/issues/september-25-2021/lenvatinib-plus-pembrolizumab-for-first-line-treatment-of-advanced-renal-cell-carcinoma/ 2021-09-24T17:26:59+00:00 https://ascopost.com/issues/september-25-2021/nivolumab-for-adjuvant-treatment-of-urothelial-carcinoma/ 2021-09-24T17:27:01+00:00 https://ascopost.com/issues/september-25-2021/gastrointestinal-oncologist-katherine-van-loon-a-pioneer-in-global-oncology/ 2021-12-08T18:30:27+00:00 https://ascopost.com/issues/september-25-2021/paradox-between-cost-and-hematopoietic-cell-transplant-rate-in-latin-america/ 2021-11-11T20:10:06+00:00 https://ascopost.com/issues/september-25-2021/kombucha/ 2021-09-24T18:10:41+00:00 https://ascopost.com/issues/september-25-2021/pembrolizumab-and-lenvatinib-in-advanced-endometrial-carcinoma/ 2021-09-24T17:27:06+00:00 https://ascopost.com/issues/september-25-2021/older-adults-with-primary-cns-lymphoma-treatment-opportunities-and-challenges/ 2021-10-20T19:46:33+00:00 https://ascopost.com/issues/september-25-2021/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-brunei-darussalam/ 2021-09-24T17:27:09+00:00 https://ascopost.com/issues/september-25-2021/a-deadly-superbug-launches-a-medical-life-and-death-drama/ 2021-09-24T17:27:10+00:00 https://ascopost.com/issues/september-25-2021/new-chief-of-thoracic-and-head-and-neck-medical-oncology-named-to-new-jersey-cancer-center/ 2021-09-24T17:27:11+00:00 https://ascopost.com/issues/september-25-2021/breathing-properly-may-help-you-live-longer/ 2021-09-24T17:27:13+00:00 https://ascopost.com/issues/september-25-2021/ivosidenib-for-previously-treated-idh1-mutant-advanced-or-metastatic-cholangiocarcinoma/ 2021-09-24T17:27:14+00:00 https://ascopost.com/issues/september-25-2021/the-wistar-institute-recruits-vaccine-researcher-amelia-escolanonand-immunologist-nan-zhang-as-assistant-professors/ 2021-09-24T17:27:15+00:00 https://ascopost.com/issues/september-25-2021/pulsed-vincristinedexamethasone-maintenance-in-pediatric-acute-lymphoblastic-leukemia/ 2021-09-24T17:27:17+00:00 https://ascopost.com/issues/september-25-2021/combination-of-lenvatinib-and-etoposideifosfamide-for-relapsed-or-refractory-osteosarcoma/ 2021-09-24T17:27:18+00:00 https://ascopost.com/issues/september-25-2021/acs-names-elvan-daniels-senior-vice-president-of-extramural-discovery-science/ 2021-09-24T17:27:19+00:00 https://ascopost.com/issues/september-25-2021/fox-chase-renewed-as-clinical-center-of-excellence-and-named-academic-center-of-excellence-for-pancreatic-cancer/ 2021-09-24T17:27:21+00:00 https://ascopost.com/issues/september-25-2021/2021-pan-pacific-lymphoma-conference-honors-outstanding-clinical-investigators/ 2021-09-24T17:27:22+00:00 https://ascopost.com/issues/september-25-2021/unmc-professor-emeritus-james-edney-dies-tragically-at-73/ 2021-09-24T17:27:23+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/ 2021-09-17T17:06:51+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/gynecologic-cancers-2020-2021-almanac/ 2021-09-17T17:06:52+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/outback-no-benefit-for-adjuvant-chemotherapy-in-cervical-cancer/ 2021-09-17T18:54:17+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-kunle-odunsi-and-lilian-gien/ 2021-09-17T17:06:54+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/immunotherapy-with-cemiplimab-rwlc-yields-survival-benefit-in-advanced-cervical-cancer/ 2021-09-17T17:06:55+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/fuzuloparib-maintenance-therapy-improves-progression-free-survival-in-patients-with-recurrent-ovarian-cancer/ 2021-09-17T17:06:56+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-thomas-herzog/ 2021-09-17T17:06:57+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/phase-iii-ariel4-trial-confirms-rucaparib-s-benefit-in-brca-mutated-relapsed-ovarian-cancer/ 2021-09-17T18:55:29+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-ursula-a-matulonis-and-konstantin-zakashansky/ 2021-09-17T17:06:59+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/overall-survival-with-olaparib-vs-placebo-maintenance-in-patients-with-platinum-sensitive-relapsed-ovarian-cancer-and-brca12-mutation/ 2021-09-17T17:07:01+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/imagyn050-trial-addition-of-atezolizumab-to-bevacizumab-and-chemotherapy-for-newly-diagnosed-stage-iii-or-iv-ovarian-cancer/ 2021-09-17T17:07:02+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/sustained-benefit-for-maintenance-olaparib-in-ovarian-cancer/ 2021-09-17T17:07:03+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-mansoor-raza-mirza/ 2021-09-17T17:07:04+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-deborah-armstrong/ 2021-09-17T17:07:05+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/niraparib-plus-bevacizumab-shows-clinical-benefit-in-advanced-ovarian-cancer/ 2021-09-17T17:07:06+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/with-the-exception-of-cervical-cancer-hpv-associated-cancers-are-on-the-rise-especially-in-older-adults/ 2021-09-17T17:07:07+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/benefit-of-niraparib-maintenance-therapy-extends-beyond-first-disease-progression-in-recurrent-ovarian-cancer/ 2021-09-17T17:07:09+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/recent-fda-approvals-in-endometrial-cancer/ 2021-09-17T17:07:11+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/novel-treatments-show-activity-in-advanced-cervical-cancer/ 2021-09-17T17:07:12+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/hormonal-intrauterine-device-under-study-for-managing-early-endometrial-cancer/ 2021-09-17T17:07:13+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-ana-oaknin/ 2021-09-17T17:07:14+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-angeles-alvarez-secord/ 2021-09-17T17:07:16+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/lenvatinibpembrolizumab-improves-survival-in-advanced-endometrial-cancer-in-a-phase-iii-trial/ 2021-09-17T17:07:17+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-ursula-a-matulonis/ 2021-09-17T17:07:18+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/study-shows-sentinel-lymph-node-biopsy-to-be-viable-option-for-surgical-staging-of-endometrial-cancer/ 2021-09-17T17:07:19+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/bevacizumab-in-advanced-ovarian-cancer-phase-iii-trial-finds-more-is-not-better/ 2021-09-17T17:07:20+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/strict-adherence-to-algorithm-required/ 2021-09-17T17:07:21+00:00 https://ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-carol-aghajanian/ 2021-09-17T17:07:22+00:00 https://ascopost.com/issues/october-10-2021/ 2021-10-10T15:30:01+00:00 https://ascopost.com/issues/october-10-2021/fda-grants-accelerated-approval-to-tisotumab-vedotin-tftv-for-recurrent-or-metastatic-cervical-cancer/ 2021-10-10T15:30:01+00:00 https://ascopost.com/issues/october-10-2021/ruxolitinib-granted-fda-approval-for-chronic-graft-vs-host-disease/ 2021-10-10T15:30:02+00:00 https://ascopost.com/issues/october-10-2021/the-evolution-of-liquid-biopsy-in-cancer-care/ 2021-10-20T20:02:19+00:00 https://ascopost.com/issues/october-10-2021/president-biden-appoints-members-to-national-cancer-advisory-board/ 2021-10-10T15:30:04+00:00 https://ascopost.com/issues/october-10-2021/zanubrutinib-for-waldenstroem-s-macroglobulinemia/ 2021-10-10T15:30:05+00:00 https://ascopost.com/issues/october-10-2021/resurgence-of-covid-19-infection-in-a-large-highly-vaccinated-us-health-system-workforce/ 2021-10-10T15:30:06+00:00 https://ascopost.com/issues/october-10-2021/adding-value-to-clinical-decision-making-in-nonmetastatic-castration-resistant-prostate-cancer/ 2021-10-10T15:30:07+00:00 https://ascopost.com/issues/october-10-2021/fda-approves-cabozantinib-for-patients-with-previously-treated-radioactive-iodine-refractory-differentiated-thyroid-cancer/ 2021-10-10T15:30:08+00:00 https://ascopost.com/issues/october-10-2021/donations-to-st-jude-children-s-research-center-soar-inspiration4-spacex-journey-exceeds-200-million-goal/ 2021-10-10T15:30:10+00:00 https://ascopost.com/issues/october-10-2021/how-asco-is-expanding-its-commitment-to-diversity-and-equity-in-cancer-care/ 2022-10-13T15:03:36+00:00 https://ascopost.com/issues/october-10-2021/fda-authorizes-booster-dose-of-pfizer-biontech-covid-19-vaccine-for-certain-populations/ 2021-10-10T15:30:12+00:00 https://ascopost.com/issues/october-10-2021/emily-bergsland-specializing-in-neuroendocrine-tumors-with-a-broad-focus-on-collaborative-research/ 2021-10-10T15:30:14+00:00 https://ascopost.com/issues/october-10-2021/glancing-back-and-looking-forward-in-the-fight-against-cancer/ 2021-10-19T13:37:37+00:00 https://ascopost.com/issues/october-10-2021/a-guide-to-end-of-life-care-by-a-veteran-in-hospice/ 2021-10-10T15:30:17+00:00 https://ascopost.com/issues/october-10-2021/overcoming-the-stigma-of-small-cell-lung-cancer/ 2021-10-10T15:30:18+00:00 https://ascopost.com/issues/october-10-2021/enhanced-surveillance-and-risk-reducing-intervention-options-for-individuals-with-palb2-variants/ 2021-10-10T15:30:19+00:00 https://ascopost.com/issues/october-10-2021/palb2-added-to-secondary-findings-list/ 2021-10-10T15:30:20+00:00 https://ascopost.com/issues/october-10-2021/ensartinib-shows-superior-efficacy-to-crizotinib-in-advanced-alk-positive-nsclc-exalt3-trial/ 2021-10-10T15:30:21+00:00 https://ascopost.com/issues/october-10-2021/hpv-vaccination-and-projected-oropharyngeal-cancer-incidence-through-the-year-2045/ 2026-01-29T16:34:27+00:00 https://ascopost.com/issues/october-10-2021/rates-of-newly-diagnosed-cancer-among-us-patients-during-the-first-full-year-of-the-covid-19-pandemic/ 2021-10-10T15:30:23+00:00 https://ascopost.com/issues/october-10-2021/franco-m-muggia-md-internationally-regarded-chemotherapy-pioneer-dies-at-85/ 2021-10-10T15:30:24+00:00 https://ascopost.com/issues/october-10-2021/destiny-breast03-trial-supports-second-line-use-of-t-dxd-in-metastatic-her2-positive-breast-cancer/ 2021-10-10T15:30:25+00:00 https://ascopost.com/issues/october-10-2021/epov-shanu-modi/ 2021-10-10T15:30:25+00:00 https://ascopost.com/issues/october-10-2021/impower010-benefits-observed-with-atezolizumab-regardless-of-stage-type-of-prior-treatment/ 2021-10-22T19:25:37+00:00 https://ascopost.com/issues/october-10-2021/epov-ichiro-yoshino/ 2021-10-10T15:30:27+00:00 https://ascopost.com/issues/october-10-2021/oncology-care-remains-under-strain-in-the-ongoing-covid-19-pandemic/ 2021-10-10T15:30:28+00:00 https://ascopost.com/issues/october-10-2021/phase-iii-trial-supports-adjuvant-endocrine-therapy-for-7-years-in-early-stage-breast-cancer/ 2021-10-10T15:30:29+00:00 https://ascopost.com/issues/october-10-2021/epov-monica-arnedos/ 2021-10-10T15:30:30+00:00 https://ascopost.com/issues/october-10-2021/study-shows-pembrolizumab-plus-chemotherapy-improves-survival-in-advanced-cervical-cancer/ 2021-10-10T15:30:31+00:00 https://ascopost.com/issues/october-10-2021/epov-mansoor-raza-mirza/ 2021-10-10T15:30:32+00:00 https://ascopost.com/issues/october-10-2021/adjuvant-pembrolizumab-shows-efficacy-in-high-risk-stage-ii-melanoma-in-adults-and-children-older-than-12/ 2021-10-10T15:30:33+00:00 https://ascopost.com/issues/october-10-2021/epov-omid-hamid/ 2021-10-10T15:30:34+00:00 https://ascopost.com/issues/october-10-2021/aacr-announces-2021-distinguished-lectureship-on-the-science-of-cancer-health-disparities/ 2021-10-10T15:30:35+00:00 https://ascopost.com/issues/october-10-2021/roswell-park-and-university-of-chicago-medicine-comprehensive-cancer-centers-awarded-nearly-9m-for-ovarian-cancer-research/ 2021-10-10T15:30:36+00:00 https://ascopost.com/issues/october-10-2021/msk-announces-new-senior-vice-president-chief-nurse-executive-and-chair-of-nursing/ 2021-10-10T15:30:36+00:00 https://ascopost.com/issues/october-10-2021/michael-boyer-honored-with-adi-gazdar-iaslc-merit-award/ 2021-10-10T15:30:37+00:00 https://ascopost.com/issues/october-10-2021/maintenance-durvalumab-increased-utilization-may-improve-outcomes-in-nsclc/ 2021-10-10T15:30:38+00:00 https://ascopost.com/issues/october-10-2021/epov-jyoti-patel-md/ 2021-10-10T15:30:39+00:00 https://ascopost.com/issues/october-10-2021/fda-grants-zanubrutinib-accelerated-approval-in-relapsed-or-refractory-marginal-zone-lymphoma/ 2021-10-10T15:30:40+00:00 https://ascopost.com/issues/october-10-2021/the-wistar-institute-appoints-italo-tempera-as-associate-director-for-cancer-research-career-enhancement/ 2021-10-10T15:30:40+00:00 https://ascopost.com/issues/october-10-2021/benefits-seen-with-lurbinectedin-plus-doxorubicin-in-small-cell-lung-cancer-but-primary-endpoint-missed/ 2021-10-10T15:30:41+00:00 https://ascopost.com/issues/october-10-2021/epov-charles-rudin/ 2021-10-10T15:30:42+00:00 https://ascopost.com/issues/october-10-2021/neoadjuvant-atezolizumab-under-study-in-mesothelioma/ 2021-10-15T20:04:16+00:00 https://ascopost.com/issues/october-10-2021/tackling-a-growing-need-options-after-car-t-cell-therapy-for-lymphoma/ 2021-10-10T15:30:44+00:00 https://ascopost.com/issues/october-10-2021/a-look-at-tomorrow-s-car-t-cell-therapy-today/ 2021-10-10T15:30:45+00:00 https://ascopost.com/issues/october-10-2021/cabozantinib-prolongs-progression-free-survival-in-previously-treated-radioiodine-refractory-differentiated-thyroid-cancer/ 2021-10-10T15:30:46+00:00 https://ascopost.com/issues/october-10-2021/totally-implanted-ports-associated-with-reduced-complication-rates-vs-other-central-venous-access-devices-used-in-anticancer-therapy/ 2021-10-10T15:30:47+00:00 https://ascopost.com/issues/october-10-2021/reduction-in-ipsilateral-recurrence-risk-with-radiotherapy-vs-observation-after-lumpectomy-for-good-risk-dcis/ 2021-10-10T15:30:48+00:00 https://ascopost.com/issues/october-10-2021/breast-cancer-research-foundation-conquer-cancer-and-asco-celebrate-20th-year-of-collaboration/ 2021-10-10T15:30:49+00:00 https://ascopost.com/issues/october-10-2021/administration-outlines-plan-to-address-high-prescription-drug-costs/ 2021-10-10T15:30:50+00:00 https://ascopost.com/issues/october-10-2021/340b-needs-reforms-not-cuts-to-improve-low-income-americans-access-to-care/ 2021-10-10T15:30:51+00:00 https://ascopost.com/issues/october-10-2021/new-certification-pilot-focuses-on-patient-centered-cancer-care/ 2021-10-10T15:30:52+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/ 2021-10-13T15:21:38+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/breast-cancer-2020-2021-almanac/ 2021-10-13T15:21:39+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/beyond-cdk46-inhibitors-in-metastatic-breast-cancer-what-s-next/ 2021-10-13T15:21:40+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/olympia-trial-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-breast-cancer/ 2021-10-13T15:21:41+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-nadine-tung/ 2021-10-13T15:21:42+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/addition-of-adjuvant-palbociclib-to-ongoing-endocrine-therapy-in-hr-positive-her2-negative-early-breast-cancer-pallas-trial/ 2021-10-13T15:21:44+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/a-tale-of-two-cdk46-inhibitors-in-early-breast-cancer/ 2021-10-13T15:21:45+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-osborne-and-oregan/ 2021-10-13T15:21:46+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/rxponder-many-postmenopausal-patients-with-node-positive-breast-cancer-can-avoid-chemotherapy/ 2021-10-13T15:21:48+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-c-kent-osborne/ 2021-10-13T15:21:49+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/novel-her2-targeted-therapies-pose-sequencing-challenges/ 2021-10-13T15:21:50+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/long-term-analysis-of-short-her-trial-of-adjuvant-trastuzumab/ 2021-10-13T15:21:52+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-evandro-de-azambuja/ 2021-10-13T15:21:53+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/excellent-outcomes-reported-with-neoadjuvant-dual-her2-therapy-in-breast-cancer/ 2021-10-13T15:21:54+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/margetuximab-cmkb-plus-chemotherapy-prolongs-progression-free-survival-in-heavily-pretreated-her2-positive-breast-cancer/ 2021-10-13T15:21:56+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/early-triple-negative-breast-cancer-are-checkpoint-inhibitors-ready-for-neoadjuvant-or-adjuvant-use/ 2021-10-13T15:21:57+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/neoadjuvant-pembrolizumab-improves-event-free-survival-in-triple-negative-breast-cancer/ 2021-10-13T15:21:58+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-giuseppe-curigliano/ 2021-10-13T15:21:59+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/neoadjuvant-durvalumab-improves-long-term-outcomes-in-the-geparnuevo-trial/ 2021-10-13T15:22:00+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-melinda-l-telli/ 2021-10-13T15:22:01+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/sacituzumab-govitecan-hziy-improves-survival-vs-single-agent-chemotherapy-in-metastatic-triple-negative-breast-cancer/ 2021-10-13T16:17:10+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/platinum-not-equal-to-capecitabine-for-residual-disease-in-triple-negative-breast-cancer/ 2021-10-13T15:22:03+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-melinda-l-telli-md/ 2021-10-13T15:22:05+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/pembrolizumab-plus-chemotherapy-improves-progression-free-survival-in-pd-l1-enriched-advanced-triple-negative-breast-cancer/ 2021-10-13T15:22:06+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/epov-yuan-yuan-md-phd-and-elizabeth-mittendorf-md-phd/ 2021-10-13T15:22:07+00:00 https://ascopost.com/issues/october-10-2021-supplement-breast-cancer-almanac/recent-fda-approvals-in-breast-cancer/ 2021-10-14T17:25:17+00:00 https://ascopost.com/issues/october-25-2021/ 2021-10-25T17:09:29+00:00 https://ascopost.com/issues/october-25-2021/monaleesa-2-overall-survival-benefit-with-first-line-ribociclib-plus-letrozole/ 2021-10-25T17:09:29+00:00 https://ascopost.com/issues/october-25-2021/epov-gonzalo-gomez-abuin-md-and-gabriel-n-hortobagyi-md-macp-fasco/ 2021-10-25T17:09:30+00:00 https://ascopost.com/issues/october-25-2021/btk-inhibition-in-cll-an-embarrassment-of-riches/ 2021-10-25T17:09:31+00:00 https://ascopost.com/issues/october-25-2021/national-cancer-act-and-lung-cancer-screening-an-example-of-intended-impact/ 2021-10-25T17:09:32+00:00 https://ascopost.com/issues/october-25-2021/did-change-in-psa-based-screening-recommendation-hinder-prostate-cancer-specific-survival/ 2021-10-25T17:09:33+00:00 https://ascopost.com/issues/october-25-2021/epov-johnie-rose-md-phd/ 2021-10-25T17:09:34+00:00 https://ascopost.com/issues/october-25-2021/study-finds-medicaid-expansion-may-be-associated-with-decrease-in-early-lung-cancer-mortality/ 2021-10-25T17:09:35+00:00 https://ascopost.com/issues/october-25-2021/epov-johnie-rose/ 2021-10-25T17:09:36+00:00 https://ascopost.com/issues/october-25-2021/parp-rechallenge-slows-ovarian-cancer-progression-in-platinum-sensitive-disease/ 2021-10-25T17:09:36+00:00 https://ascopost.com/issues/october-25-2021/epov-clare-scott/ 2021-10-25T17:09:37+00:00 https://ascopost.com/issues/october-25-2021/neoadjuvant-dd-mvac-improves-local-control-and-progression-free-survival-in-patients-with-muscle-invasive-bladder-cancer/ 2021-11-09T19:47:24+00:00 https://ascopost.com/issues/october-25-2021/epov-enrique-grande-md/ 2021-10-25T17:09:39+00:00 https://ascopost.com/issues/october-25-2021/another-antibody-drug-conjugate-enters-the-metastatic-breast-cancer-landscape/ 2021-10-25T17:09:40+00:00 https://ascopost.com/issues/october-25-2021/epov-barbara-pistilli/ 2021-10-25T17:09:41+00:00 https://ascopost.com/issues/october-25-2021/st-jude-names-shannon-dean-md-as-chief-medical-information-officer/ 2021-10-25T17:09:42+00:00 https://ascopost.com/issues/october-25-2021/checkmate-649-long-term-data-support-nivolumab-plus-chemotherapy-but-not-nivolumab-plus-ipilimumab-in-gastric-cancer/ 2021-10-25T17:09:43+00:00 https://ascopost.com/issues/october-25-2021/epov-florian-lordick/ 2021-10-25T17:09:44+00:00 https://ascopost.com/issues/october-25-2021/peace-1-abiraterone-plus-androgen-deprivation-therapy-and-docetaxel-boosts-survival-in-metastatic-castration-sensitive-prostate-cancer/ 2021-10-25T17:09:45+00:00 https://ascopost.com/issues/october-25-2021/epov-eleni-efstathiou/ 2021-10-25T17:09:46+00:00 https://ascopost.com/issues/october-25-2021/stampede-in-nonmetastatic-castration-sensitive-prostate-cancer-abiraterone-added-to-androgen-deprivation-therapy-improves-survival/ 2021-10-25T17:09:47+00:00 https://ascopost.com/issues/october-25-2021/epov-eleni-efstathiou-md/ 2021-10-25T17:09:48+00:00 https://ascopost.com/issues/october-25-2021/michael-diaz-md-named-president-and-managing-physician-at-florida-cancer-specialists-research-institute/ 2021-10-25T17:09:49+00:00 https://ascopost.com/issues/october-25-2021/iaslc-names-kristin-richeimer-cae-des-interim-chief-executive-officer/ 2021-10-25T17:09:49+00:00 https://ascopost.com/issues/october-25-2021/iaslc-presents-wclc-2021-lectureship-awards-to-international-array-of-lung-cancer-researchers/ 2021-10-25T17:09:50+00:00 https://ascopost.com/issues/october-25-2021/novel-urine-based-test-evaluated-in-prostate-cancer-detection-and-risk-stratification/ 2021-10-25T17:09:51+00:00 https://ascopost.com/issues/october-25-2021/epov-j-kellogg-parsons/ 2021-10-25T17:09:52+00:00 https://ascopost.com/issues/october-25-2021/msk-announces-appointment-of-deb-schrag-md-fasco-mph-as-chair-of-the-department-of-medicine/ 2021-10-25T17:09:53+00:00 https://ascopost.com/issues/october-25-2021/phase-ii-trial-finds-atezolizumab-of-benefit-in-patients-with-lung-cancer-and-brain-metastases/ 2021-10-25T17:09:54+00:00 https://ascopost.com/issues/october-25-2021/epov-heather-a-wakelee-md-fasco-and-erika-hlavacek/ 2021-10-25T17:09:55+00:00 https://ascopost.com/issues/october-25-2021/dual-checkpoint-blockade-plus-chemotherapy-improves-survival-in-first-line-metastatic-nsclc/ 2021-10-25T17:09:56+00:00 https://ascopost.com/issues/october-25-2021/epov-julie-brahmer/ 2021-10-25T17:09:58+00:00 https://ascopost.com/issues/october-25-2021/pretreatment-levels-of-circulating-tumor-dna-may-predict-long-term-survival-in-nsclc/ 2021-10-25T17:09:59+00:00 https://ascopost.com/issues/october-25-2021/epov-bruna-pellini/ 2021-10-25T17:10:00+00:00 https://ascopost.com/issues/october-25-2021/financial-toxicity-associated-with-atherosclerotic-cardiovascular-disease-cancer-and-both-in-us-adult-patients/ 2021-10-25T17:10:01+00:00 https://ascopost.com/issues/october-25-2021/tisotumab-vedotin-tftv-in-recurrent-or-metastatic-cervical-cancer/ 2021-10-25T17:10:03+00:00 https://ascopost.com/issues/october-25-2021/financial-impact-of-cardiovascular-disease-and-cancer-care-overlapping-toxicities/ 2023-09-01T18:41:10+00:00 https://ascopost.com/issues/october-25-2021/urge-congress-to-avoid-shutdown-increase-funding-for-cancer-research-in-fiscal-year-2022/ 2021-10-25T17:10:05+00:00 https://ascopost.com/issues/october-25-2021/cabozantinib-for-previously-treated-advanced-differentiated-thyroid-cancer/ 2021-10-25T17:10:06+00:00 https://ascopost.com/issues/october-25-2021/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-bhutan/ 2021-10-25T17:10:07+00:00 https://ascopost.com/issues/october-25-2021/caroline-chung-named-md-andersons-first-chief-data-officer/ 2021-10-25T17:10:09+00:00 https://ascopost.com/issues/october-25-2021/noninferior-progression-free-survival-and-reduced-cardiovascular-toxicity-with-acalabrutinib-vs-ibrutinib-in-previously-treated-cll/ 2021-10-25T17:10:10+00:00 https://ascopost.com/issues/october-25-2021/jco-op-special-series-disparities-in-cancer-care-for-hispanic-latinx-people/ 2021-10-25T17:10:11+00:00 https://ascopost.com/issues/october-25-2021/advance-care-planning-is-crucial-component-of-cancer-care/ 2021-10-25T17:10:12+00:00 https://ascopost.com/issues/october-25-2021/ruxolitinib-for-chronic-graft-vs-host-disease-after-failure-of-systemic-therapy/ 2021-10-25T17:10:13+00:00 https://ascopost.com/issues/october-25-2021/cleveland-clinic-launches-center-for-young-onset-colorectal-cancer/ 2021-10-25T17:10:14+00:00 https://ascopost.com/issues/october-25-2021/an-atypical-road-to-a-career-in-medicine-and-leading-a-cancer-center-for-robert-a-winn/ 2021-10-25T17:31:09+00:00 https://ascopost.com/issues/october-25-2021/mobocertinib-for-previously-treated-advanced-nsclc-with-egfr-exon-20-insertion-mutations/ 2021-10-25T17:10:16+00:00 https://ascopost.com/issues/october-25-2021/memorial-sloan-kettering-cancer-center-announces-new-early-career-physician-research-program-in-cancer-science/ 2021-10-25T17:10:17+00:00 https://ascopost.com/issues/october-25-2021/extended-open-enrollment-special-enrollment-periods-finalized-for-some-insurance-exchanges-increasing-access-to-cancer-care/ 2021-10-25T17:10:19+00:00 https://ascopost.com/issues/october-25-2021/urbanization-in-bangladesh-the-prevalence-of-breast-cancer-brings-unique-challenges/ 2021-11-01T17:33:19+00:00 https://ascopost.com/issues/october-25-2021/md-anderson-and-bostongene-announce-strategic-alliance-to-advance-personalized-cancer-diagnostics-and-treatments/ 2021-10-25T17:10:21+00:00 https://ascopost.com/issues/october-25-2021/fda-grants-accelerated-approval-to-mobocertinib-for-patients-with-metastatic-nsclc-and-egfr-exon-20-insertion-mutations/ 2021-10-25T17:10:22+00:00 https://ascopost.com/issues/october-25-2021/cardio-oncology/ 2023-09-01T18:39:17+00:00 https://ascopost.com/issues/october-25-2021/fda-expands-cetuximab-label-for-encorafenib-combination-in-braf-v600e-mutation-positive-metastatic-colorectal-cancer/ 2021-10-25T17:10:24+00:00 https://ascopost.com/issues/october-25-2021/acupuncture-vs-cognitive-behavioral-therapy-for-cognitive-function-in-cancer-survivors-with-insomnia/ 2021-10-25T19:39:30+00:00 https://ascopost.com/issues/october-25-2021/msk-launches-new-center-to-expand-commitment-to-meeting-the-unique-needs-of-adolescents-and-young-adults-with-cancer/ 2021-10-25T17:10:27+00:00 https://ascopost.com/issues/october-25-2021/zanubrutinib-for-relapsed-or-refractory-marginal-zone-lymphoma/ 2021-10-25T17:10:28+00:00 https://ascopost.com/issues/october-25-2021/md-anderson-and-siemens-healthineers-collaborate-to-enable-consistent-clinical-implementation-of-quantitative-mri/ 2021-10-25T17:10:29+00:00 https://ascopost.com/issues/october-25-2021/clayton-dunklin-pruett-business-professional-asco-member-dies-at-age-86/ 2021-10-25T17:10:30+00:00 https://ascopost.com/issues/october-25-2021/having-stage-iv-lung-cancer-has-refocused-my-life/ 2021-10-25T17:10:31+00:00 https://ascopost.com/issues/october-25-2021/ga-68-psma-11-pet-for-detection-of-pelvic-nodal-metastasis-in-intermediate-to-high-risk-prostate-cancer/ 2021-10-25T17:10:33+00:00 https://ascopost.com/issues/october-25-2021/risk-of-pancreatic-cancer-associated-with-germline-atm-pathogenic-variants/ 2021-10-25T17:10:34+00:00 https://ascopost.com/issues/october-25-2021/international-survey-on-access-to-cancer-medicines-considered-essential-by-oncologists/ 2021-10-25T17:10:34+00:00 https://ascopost.com/issues/october-25-2021/francis-collins-to-step-down-as-director-of-the-national-institutes-of-health/ 2021-10-25T17:10:35+00:00 https://ascopost.com/issues/november-10-2021/ 2021-11-10T20:38:50+00:00 https://ascopost.com/issues/november-10-2021/evidence-for-efficacy-of-sunitinib-in-malignant-pheochromocytoma-and-paraganglioma/ 2021-11-10T20:38:50+00:00 https://ascopost.com/issues/november-10-2021/epov-rocio-garcia-carbonero/ 2021-11-10T20:38:51+00:00 https://ascopost.com/issues/november-10-2021/impower010-adjuvant-atezolizumab-improves-disease-free-survival-and-nsclc-relapse-in-patients-whose-tumors-express-pd-l1/ 2021-12-17T20:00:38+00:00 https://ascopost.com/issues/november-10-2021/epov-benjamin-besse/ 2021-11-10T20:38:54+00:00 https://ascopost.com/issues/november-10-2021/fda-approves-pembrolizumab-combination-for-the-first-line-treatment-of-cervical-cancer/ 2021-11-10T20:38:56+00:00 https://ascopost.com/issues/november-10-2021/fox-chase-cancer-center-welcomes-teresa-y-lee-md-phd/ 2021-11-10T20:38:57+00:00 https://ascopost.com/issues/november-10-2021/hossein-borghaei-do-ms-honored-with-lung-cancer-heroes-award/ 2021-11-10T20:38:59+00:00 https://ascopost.com/issues/november-10-2021/fda-approves-brexucabtagene-autoleucel-for-relapsed-or-refractory-b-cell-precursor-all/ 2021-11-10T20:39:00+00:00 https://ascopost.com/issues/november-10-2021/early-experiences-in-the-united-states-helped-shape-an-international-oncology-career-for-aleix-prat-md-phd/ 2021-11-10T21:34:20+00:00 https://ascopost.com/issues/november-10-2021/aml-pioneer-and-gentle-soul-elihu-h-estey-md-dies-at-75/ 2021-11-10T20:39:03+00:00 https://ascopost.com/issues/november-10-2021/astro-honors-2021-gold-medalists-and-others/ 2021-11-10T20:39:04+00:00 https://ascopost.com/issues/november-10-2021/sidney-kimmel-cancer-center-jefferson-health-welcomes-marcia-brose-md-phd-fasco/ 2021-11-10T20:39:05+00:00 https://ascopost.com/issues/november-10-2021/aaci-recognizes-robert-a-winn-md-with-inaugural-cancer-health-equity-award/ 2021-11-10T20:39:07+00:00 https://ascopost.com/issues/november-10-2021/cancer-researcher-and-drug-developer-joseph-r-bertino-md-dies-at-91/ 2021-11-10T20:39:08+00:00 https://ascopost.com/issues/november-10-2021/susan-g-komen-announces-15-million-in-grants-for-metastatic-breast-cancer-research/ 2021-11-10T20:39:10+00:00 https://ascopost.com/issues/november-10-2021/addition-of-ramucirumab-or-merestinib-to-first-line-chemotherapy-in-advanced-biliary-tract-cancer/ 2021-11-10T20:39:12+00:00 https://ascopost.com/issues/november-10-2021/does-a-longer-interval-before-surgery-among-patients-with-locally-advanced-rectal-cancer-lead-to-worse-survival/ 2021-11-10T20:39:13+00:00 https://ascopost.com/issues/november-10-2021/effect-of-geriatric-assessment-driven-intervention-on-incidence-of-severe-chemotherapy-related-toxicity-in-older-patients-with-cancer/ 2021-11-10T20:39:15+00:00 https://ascopost.com/issues/november-10-2021/the-worst-part-of-having-cancer-was-the-guilt/ 2021-11-10T20:39:16+00:00 https://ascopost.com/issues/november-10-2021/who-director-general-grants-posthumous-award-to-henrietta-lacks/ 2021-11-10T20:39:18+00:00 https://ascopost.com/issues/november-10-2021/patients-with-hematologic-malignancies-how-robust-is-their-immunity-to-sars-cov-2/ 2021-11-19T16:35:40+00:00 https://ascopost.com/issues/november-10-2021/patient-reported-outcomes-in-gastrointestinal-cancers-predicting-treatment-response-and-survival-outcomes/ 2021-11-10T20:39:21+00:00 https://ascopost.com/issues/november-10-2021/epov-areej-el-jawahri/ 2021-11-10T20:39:22+00:00 https://ascopost.com/issues/november-10-2021/medication-nonadherence-among-cancer-survivors-are-indirect-health-care-costs-to-blame/ 2021-11-10T20:39:23+00:00 https://ascopost.com/issues/november-10-2021/epov-michaela-dinan/ 2021-11-10T20:39:26+00:00 https://ascopost.com/issues/november-10-2021/is-precision-oncology-an-unsustainable-promise/ 2021-11-10T20:39:28+00:00 https://ascopost.com/issues/november-10-2021/epov-arjun-gupta-mbbs/ 2021-11-10T20:39:29+00:00 https://ascopost.com/issues/november-10-2021/out-of-pocket-costs-on-the-rise-for-the-four-most-common-cancers-study-finds/ 2021-11-10T20:39:30+00:00 https://ascopost.com/issues/november-10-2021/epov-michaela-dinan-1/ 2021-11-10T20:39:31+00:00 https://ascopost.com/issues/november-10-2021/mary-pasquinelli-receives-2021-national-leadership-award-from-the-prevent-cancer-foundation/ 2021-11-10T20:39:32+00:00 https://ascopost.com/issues/november-10-2021/many-patients-with-solid-tumors-mount-an-adequate-response-to-sars-cov-2-vaccine/ 2021-11-10T20:39:34+00:00 https://ascopost.com/issues/november-10-2021/pamela-kunz-named-2021-woman-oncologist-of-the-year/ 2021-11-10T20:39:35+00:00 https://ascopost.com/issues/november-10-2021/kras-g12c-inhibitor-adagrasib-shows-activity-in-colorectal-cancer/ 2021-11-10T20:39:37+00:00 https://ascopost.com/issues/november-10-2021/epov-federica-di-nicolantonio/ 2021-11-10T20:39:38+00:00 https://ascopost.com/issues/november-10-2021/focus4-c-trial-hint-of-activity-reported-with-adavosertib-in-metastatic-colorectal-cancer/ 2021-11-10T20:39:38+00:00 https://ascopost.com/issues/november-10-2021/epov-pierre-laurent-puig/ 2021-11-10T20:39:40+00:00 https://ascopost.com/issues/november-10-2021/fda-approves-atezolizumab-as-adjuvant-treatment-for-nsclc/ 2021-11-10T20:39:41+00:00 https://ascopost.com/issues/november-10-2021/secombit-trial-evaluates-optimal-treatment-sequencing-in-braf-mutated-melanoma/ 2021-11-10T20:39:42+00:00 https://ascopost.com/issues/november-10-2021/epov-omid-hamid/ 2021-11-10T20:39:44+00:00 https://ascopost.com/issues/november-10-2021/brightness-neoadjuvant-carboplatin-improves-event-free-survival-in-triple-negative-breast-cancer/ 2021-11-10T20:39:45+00:00 https://ascopost.com/issues/november-10-2021/epov-monica-arnedos/ 2021-11-10T20:39:46+00:00 https://ascopost.com/issues/november-10-2021/fda-approves-abemaciclib-in-combination-with-endocrine-therapy-for-early-breast-cancer/ 2021-11-10T20:39:47+00:00 https://ascopost.com/issues/november-10-2021/lung-cancer-research-foundation-names-2021-recipients-of-grant-on-disparities-in-lung-cancer/ 2021-11-10T20:39:48+00:00 https://ascopost.com/issues/november-10-2021/david-morse-livingston-scientist-and-esteemed-mentor-dies-at-80/ 2021-11-10T20:39:49+00:00 https://ascopost.com/issues/november-10-2021/living-in-survival-mode/ 2021-11-10T20:39:51+00:00 https://ascopost.com/issues/november-10-2021/showcasing-50-years-of-advances-in-cancer-research-and-treatment/ 2021-11-10T20:39:52+00:00 https://ascopost.com/issues/november-10-2021/second-surprise-billing-rule-covers-dispute-resolution-processes-good-faith-estimates-for-the-uninsured/ 2021-11-10T20:44:03+00:00 https://ascopost.com/issues/november-10-2021/asco-quality-improvement-programs-helped-to-enhance-the-delivery-of-cancer-care-in-medically-underserved-communities-article-reports/ 2021-11-10T20:48:08+00:00 https://ascopost.com/issues/november-10-2021/asco-joins-effort-to-improve-covid-19-vaccination-rates-among-high-risk-adults-including-people-with-cancer/ 2021-11-10T20:53:31+00:00 https://ascopost.com/issues/november-25-2021/ 2021-11-24T18:41:41+00:00 https://ascopost.com/issues/november-25-2021/shorter-course-radiation-therapy-a-new-practice-standard-after-prostatectomy/ 2021-12-15T20:05:06+00:00 https://ascopost.com/issues/november-25-2021/epov-sophia-c-kamran-2/ 2021-11-24T18:41:43+00:00 https://ascopost.com/issues/november-25-2021/from-cancer-survivor-to-citizen-astronaut/ 2021-11-24T18:41:44+00:00 https://ascopost.com/issues/november-25-2021/durable-responses-in-metastatic-nsclc-are-we-getting-closer-to-a-cure/ 2021-11-30T21:11:39+00:00 https://ascopost.com/issues/november-25-2021/no-survival-benefit-but-improved-secondary-endpoints-with-radiotherapy-plus-androgen-suppression-in-intermediate-risk-prostate-cancer/ 2021-11-24T18:41:47+00:00 https://ascopost.com/issues/november-25-2021/epov-sophia-c-kamran/ 2021-11-24T18:41:48+00:00 https://ascopost.com/issues/november-25-2021/accelerated-radiation-therapies-move-forward-in-early-breast-cancer/ 2021-11-24T18:41:49+00:00 https://ascopost.com/issues/november-25-2021/epov-elizabeth-nichols/ 2021-11-24T18:41:51+00:00 https://ascopost.com/issues/november-25-2021/de-escalation-of-radiation-therapy-for-hpv-positive-intermediate-risk-oropharyngeal-cancer/ 2026-01-29T16:04:27+00:00 https://ascopost.com/issues/november-25-2021/epov-farzan-siddiqui/ 2021-11-24T18:41:53+00:00 https://ascopost.com/issues/november-25-2021/can-sbrt-to-selected-sites-of-limited-progression-or-oligoprogression-extend-progression-free-survival-in-advanced-lung-cancer-but-not-breast-cancer/ 2021-11-30T21:40:08+00:00 https://ascopost.com/issues/november-25-2021/epov-steven-j-chmura-md-phd/ 2021-11-24T18:41:55+00:00 https://ascopost.com/issues/november-25-2021/use-of-genomic-classifier-score-may-help-to-personalize-therapy-for-men-with-high-risk-prostate-cancer/ 2021-11-24T18:41:56+00:00 https://ascopost.com/issues/november-25-2021/epov-sophia-c-kamran-1/ 2021-11-24T18:41:59+00:00 https://ascopost.com/issues/november-25-2021/optimizing-adjuvant-therapy-for-women-with-estrogen-receptor-positive-node-positive-breast-cancer/ 2021-11-24T18:42:00+00:00 https://ascopost.com/issues/november-25-2021/newer-agents-on-the-horizon-for-refractory-or-relapsed-dlbcl/ 2021-11-24T18:42:01+00:00 https://ascopost.com/issues/november-25-2021/numerous-regimens-proposed-for-relapsed-or-refractory-myeloma/ 2021-11-24T18:42:02+00:00 https://ascopost.com/issues/november-25-2021/novel-therapies-under-study-in-acute-myeloid-leukemia/ 2021-11-24T18:42:04+00:00 https://ascopost.com/issues/november-25-2021/pembrolizumab-plus-chemotherapy-with-or-without-bevacizumab-in-first-line-treatment-of-advanced-cervical-cancer/ 2021-11-24T18:42:05+00:00 https://ascopost.com/issues/november-25-2021/fda-authorizes-pfizer-biontech-covid-19-vaccine-for-emergency-use-in-children-aged-5-through-11-years/ 2021-11-24T18:42:06+00:00 https://ascopost.com/issues/november-25-2021/in-case-you-missed-it-brief-highlights-from-esmo-congress-2021/ 2021-11-24T18:42:07+00:00 https://ascopost.com/issues/november-25-2021/for-liver-metastases-transarterial-radioembolization-with-yttrium-90-plus-chemotherapy-may-delay-disease-progression/ 2021-11-24T18:42:09+00:00 https://ascopost.com/issues/november-25-2021/thomas-gruenberger-md-shares-thoughts-on-radiotherapy-for-colorectal-liver-metastases/ 2021-11-24T18:42:10+00:00 https://ascopost.com/issues/november-25-2021/t-dxd-makes-inroads-in-the-treatment-of-her2-mutant-nsclc/ 2021-11-30T21:36:44+00:00 https://ascopost.com/issues/november-25-2021/epov-daniel-shao-weng-tan-bsc-md-phd/ 2021-11-24T18:42:12+00:00 https://ascopost.com/issues/november-25-2021/checkmate-743-supports-survival-benefit-of-nivolumab-plus-ipilimumab-in-malignant-pleural-mesothelioma/ 2021-11-24T18:42:13+00:00 https://ascopost.com/issues/november-25-2021/epov-pilar-garrido/ 2021-11-24T18:42:14+00:00 https://ascopost.com/issues/november-25-2021/ukls-trial-meta-analysis-confirms-mortality-reduction-with-low-dose-ct-screening-for-lung-cancer/ 2021-12-17T21:03:29+00:00 https://ascopost.com/issues/november-25-2021/epov-paul-wheatley-price/ 2021-11-24T18:42:17+00:00 https://ascopost.com/issues/november-25-2021/addition-of-ipatasertib-to-abiraterone-plus-prednisolone-improves-radiographic-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/ 2021-11-24T18:42:18+00:00 https://ascopost.com/issues/november-25-2021/taking-akt-ion-against-prostate-cancer/ 2021-12-15T20:16:09+00:00 https://ascopost.com/issues/november-25-2021/high-risk-multiple-myeloma-combination-regimens-and-car-t-cell-therapy/ 2021-11-24T18:42:20+00:00 https://ascopost.com/issues/november-25-2021/keynote-564-trial-adjuvant-pembrolizumab-improves-disease-free-survival-in-high-risk-renal-cell-carcinoma/ 2021-11-24T18:42:21+00:00 https://ascopost.com/issues/november-25-2021/adjuvant-immunotherapy-the-next-chapter-in-advancements-in-renal-cell-carcinoma/ 2021-12-15T20:08:17+00:00 https://ascopost.com/issues/november-25-2021/md-anderson-and-the-rare-cancer-research-foundation-announce-collaboration/ 2021-11-24T18:42:24+00:00 https://ascopost.com/issues/november-25-2021/no-disease-free-survival-difference-with-longer-anastrozole-treatment-after-endocrine-therapy-in-hr-positive-breast-cancer/ 2021-11-24T18:42:25+00:00 https://ascopost.com/issues/november-25-2021/achieving-equity-in-cancer-care-for-adolescents-and-young-adults-with-cancer/ 2021-11-24T18:42:26+00:00 https://ascopost.com/issues/november-25-2021/duration-of-endocrine-therapy-in-breast-cancer-how-much-of-a-good-thing-is-too-much/ 2021-12-06T18:09:18+00:00 https://ascopost.com/issues/november-25-2021/purdue-center-for-cancer-research-receives-15-million-for-endowed-professorship/ 2021-11-24T18:42:28+00:00 https://ascopost.com/issues/november-25-2021/msk-appoints-saad-usmani-chief-of-myeloma-service/ 2021-11-24T18:42:29+00:00 https://ascopost.com/issues/november-25-2021/craig-sauter-joins-cleveland-clinic/ 2021-11-24T18:42:31+00:00 https://ascopost.com/issues/november-25-2021/northwell-names-fidel-valea-to-leadership-roles-in-gynecologic-oncology/ 2021-11-24T18:42:32+00:00 https://ascopost.com/issues/november-25-2021/covid-19-resources-for-people-with-cancer/ 2021-11-24T18:42:33+00:00 https://ascopost.com/issues/november-25-2021/mortality-risk-in-patients-with-cancer-and-sars-cov-2-higher-among-older-patients-with-b-cell-malignancies-and-those-who-previously-or-currently-smoke/ 2021-11-24T18:42:34+00:00 https://ascopost.com/issues/november-25-2021/five-percent-overall-medicare-reimbursement-cut-estimated-for-medical-oncology-in-2022/ 2021-11-24T18:42:35+00:00 https://ascopost.com/issues/november-25-2021/the-role-of-spirituality-in-palliative-care/ 2021-11-24T18:42:36+00:00 https://ascopost.com/issues/november-25-2021/the-promise-and-the-challenge-experts-and-innovators-explore-the-impact-of-new-technologies-in-cancer-care/ 2021-11-24T18:42:38+00:00 https://ascopost.com/issues/november-25-2021/tools-for-high-quality-accessible-care/ 2021-11-24T18:42:39+00:00 https://ascopost.com/issues/november-25-2021/maintenance-daratumumab-prolongs-progression-free-survival-in-newly-diagnosed-multiple-myeloma/ 2021-11-24T18:42:40+00:00 https://ascopost.com/issues/november-25-2021/maintenance-daratumumab-after-initial-therapy-for-transplant-eligible-multiple-myeloma-more-questions-than-answers-from-cassiopeia-part-2/ 2021-12-23T20:30:45+00:00 https://ascopost.com/issues/november-25-2021/choosing-wisely-researchers-look-at-access-to-essential-cancer-drugs-on-a-global-scale/ 2021-11-24T18:42:43+00:00 https://ascopost.com/issues/november-25-2021/fda-approves-asciminib-for-philadelphia-chromosome-positive-cml/ 2021-11-24T18:42:43+00:00 https://ascopost.com/issues/november-25-2021/passionate-about-surgical-oncology-masakazu-toi-is-a-leader-in-japanese-clinical-trials/ 2021-11-24T18:42:44+00:00 https://ascopost.com/issues/november-25-2021/shiitake-mushroom/ 2021-11-24T18:42:46+00:00 https://ascopost.com/issues/november-25-2021/american-cancer-society-and-flatiron-health-announce-recipients-of-real-world-data-impact-award/ 2021-11-24T18:42:47+00:00 https://ascopost.com/issues/november-25-2021/possible-impact-of-nurse-navigation-program-in-achieving-equitable-care-and-outcomes-in-minority-vs-white-patients/ 2021-11-24T18:42:48+00:00 https://ascopost.com/issues/november-25-2021/eric-winer-to-lead-yale-cancer-center-and-smilow-cancer-hospital/ 2021-11-24T18:42:49+00:00 https://ascopost.com/issues/november-25-2021/new-breast-cancer-survivorship-program-launched-by-usc-norris-comprehensive-cancer-center/ 2021-11-24T18:42:50+00:00 https://ascopost.com/issues/november-25-2021/risk-reducing-medications-for-breast-cancer-are-becoming-safer-and-more-tolerable/ 2021-11-24T18:42:51+00:00 https://ascopost.com/issues/november-25-2021/fear-of-side-effects-and-lack-of-awareness-barriers-to-greater-use-of-risk-reducing-medications-for-breast-cancer/ 2021-11-24T18:42:52+00:00 https://ascopost.com/issues/november-25-2021/sarc-appoints-jonathan-fletcher-to-new-role-of-chief-scientific-officer/ 2021-11-24T18:42:53+00:00 https://ascopost.com/issues/november-25-2021/addition-of-liposomal-irinotecan-to-fluorouracil-and-leucovorin-as-second-line-treatment-for-metastatic-biliary-tract-cancer/ 2021-11-24T18:42:55+00:00 https://ascopost.com/issues/november-25-2021/is-cabozantinib-active-in-treating-brain-metastases-from-renal-cell-carcinoma/ 2021-11-24T18:42:55+00:00 https://ascopost.com/issues/december-10-2021/ 2021-12-10T16:04:08+00:00 https://ascopost.com/issues/december-10-2021/dreamseq-trial-in-advanced-melanoma-with-braf-mutations-start-with-immunotherapy/ 2021-12-10T16:04:09+00:00 https://ascopost.com/issues/december-10-2021/epov-adam-m-brufsky/ 2021-12-10T16:04:10+00:00 https://ascopost.com/issues/december-10-2021/establishing-a-health-equity-report-card-to-eradicate-disparities-in-cancer-care/ 2021-12-10T16:04:11+00:00 https://ascopost.com/issues/december-10-2021/how-medical-oncology-came-to-be/ 2022-01-06T01:48:23+00:00 https://ascopost.com/issues/december-10-2021/to-elect-or-forgo-radiation-therapy-an-informed-decision-for-patients-with-breast-cancer/ 2021-12-10T16:04:14+00:00 https://ascopost.com/issues/december-10-2021/keynote-355-final-analysis-reveals-survival-benefit-with-pembrolizumab-in-triple-negative-breast-cancer/ 2021-12-10T16:04:15+00:00 https://ascopost.com/issues/december-10-2021/large-declines-in-ki67-index-seen-with-oral-selective-estrogen-receptor-degrader/ 2021-12-10T16:04:16+00:00 https://ascopost.com/issues/december-10-2021/epov-charles-shapiro/ 2021-12-10T16:04:17+00:00 https://ascopost.com/issues/december-10-2021/long-term-follow-up-of-monarche-benefit-of-abemaciclib-plus-endocrine-therapy-maintained-in-early-high-risk-breast-cancer/ 2021-12-10T16:04:18+00:00 https://ascopost.com/issues/december-10-2021/epov-aditya-bardia/ 2021-12-10T16:04:19+00:00 https://ascopost.com/issues/december-10-2021/society-for-integrative-oncology-focuses-on-the-science-of-living-well-with-cancer/ 2021-12-20T14:58:21+00:00 https://ascopost.com/issues/december-10-2021/applying-research-data-to-clinical-practice-in-managing-head-and-neck-cancer/ 2026-01-29T16:01:20+00:00 https://ascopost.com/issues/december-10-2021/optimizing-the-use-of-checkpoint-inhibitors-in-recurrent-or-metastatic-head-and-neck-cancer/ 2026-01-29T15:59:26+00:00 https://ascopost.com/issues/december-10-2021/epov-nabil-f-saba/ 2021-12-10T16:04:25+00:00 https://ascopost.com/issues/december-10-2021/lungevity-foundation-launches-new-online-gateways-for-patients-with-lung-cancer-and-actionable-mutations/ 2021-12-10T16:04:26+00:00 https://ascopost.com/issues/december-10-2021/survey-shows-disparities-in-biomarker-testing-among-underserved-patients-with-lung-cancer/ 2021-12-10T16:04:27+00:00 https://ascopost.com/issues/december-10-2021/epov-joshua-k-sabari-md/ 2021-12-10T16:04:28+00:00 https://ascopost.com/issues/december-10-2021/cleveland-clinic-researcher-receives-nih-director-s-pioneer-award/ 2021-12-10T16:04:29+00:00 https://ascopost.com/issues/december-10-2021/radiation-therapy-for-hpv-related-oropharyngeal-squamous-cell-carcinoma-prospects-and-controversies/ 2026-01-29T15:58:03+00:00 https://ascopost.com/issues/december-10-2021/epov-nabil-f-saba/ 2021-12-10T16:04:32+00:00 https://ascopost.com/issues/december-10-2021/big-data-and-vulnerable-populations-addressing-the-gap-in-lung-cancer-screening/ 2021-12-17T20:11:21+00:00 https://ascopost.com/issues/december-10-2021/low-dose-computed-tomography-a-window-into-early-lung-disease/ 2021-12-17T14:59:23+00:00 https://ascopost.com/issues/december-10-2021/epov-lee-gazourian/ 2021-12-10T16:04:35+00:00 https://ascopost.com/issues/december-10-2021/patients-with-multiple-myeloma-may-lack-t-cell-responses-to-covid-19-vaccination/ 2021-12-10T16:04:36+00:00 https://ascopost.com/issues/december-10-2021/adding-pembrolizumab-to-chemotherapy-improves-overall-and-progression-free-survival-in-first-line-treatment-of-advanced-esophageal-cancer/ 2026-01-29T15:51:17+00:00 https://ascopost.com/issues/december-10-2021/pembrolizumab-for-adjuvant-treatment-of-renal-cell-carcinoma/ 2021-12-10T16:04:39+00:00 https://ascopost.com/issues/december-10-2021/update-on-the-incidence-of-nsclc-focus-on-need-to-implement-widescale-screening/ 2021-12-10T16:04:40+00:00 https://ascopost.com/issues/december-10-2021/atezolizumab-in-adjuvant-therapy-for-pd-l1-positive-nsclc/ 2021-12-10T16:04:42+00:00 https://ascopost.com/issues/december-10-2021/increased-risk-of-early-cardiac-toxicity-with-posttransplantation-cyclophosphamide-in-allogeneic-hsct/ 2021-12-10T16:04:43+00:00 https://ascopost.com/issues/december-10-2021/fda-approves-pembrolizumab-for-adjuvant-treatment-of-renal-cell-carcinoma/ 2021-12-10T16:04:44+00:00 https://ascopost.com/issues/december-10-2021/fda-expands-eligibility-for-covid-19-vaccine-boosters/ 2021-12-10T16:04:46+00:00 https://ascopost.com/issues/december-10-2021/jordan-s-queen-rania-presents-king-hussein-awards-for-cancer-research/ 2021-12-10T16:04:47+00:00 https://ascopost.com/issues/december-10-2021/addressing-the-global-challenges-of-cancer-prevention-and-treatment/ 2021-12-10T16:04:48+00:00 https://ascopost.com/issues/december-10-2021/asco-releases-new-guidelines-on-the-management-of-adverse-events-in-patients-treated-with-immune-checkpoint-inhibitors-and-car-t-cell-therapy/ 2021-12-10T16:04:49+00:00 https://ascopost.com/issues/december-10-2021/covid-19-vaccine-requirements-for-medicare-medicaid-facilities-and-employers-of-100-or-more-staff-released/ 2021-12-10T16:04:50+00:00 https://ascopost.com/issues/december-10-2021/help-test-performance-measures-to-advance-oncology-quality-of-care/ 2021-12-10T16:04:51+00:00 https://ascopost.com/issues/december-10-2021/friends-of-cancer-research-releases-white-paper-on-optimizing-dosing-in-oncology-drug-development/ 2021-12-10T16:04:52+00:00 https://ascopost.com/issues/december-10-2021/the-history-of-medical-oncology-in-europe-1955-1985/ 2021-12-10T16:04:53+00:00 https://ascopost.com/issues/december-10-2021/wendy-brewster-md-phd-named-associate-director-of-diversity-equity-and-inclusion/ 2021-12-10T16:04:55+00:00 https://ascopost.com/issues/december-10-2021/potential-impact-of-nurse-navigation-program-in-achieving-equitable-care-and-outcomes-in-patients-with-aggressive-large-b-cell-lymphoma/ 2021-12-22T21:35:12+00:00 https://ascopost.com/issues/december-10-2021/erratum/ 2021-12-10T16:04:57+00:00 https://ascopost.com/issues/december-10-2021/tara-o-henderson-md-mph-to-lead-programs-at-uchicago-medicine-chicagoland-children-s-health/ 2021-12-10T16:04:58+00:00 https://ascopost.com/issues/december-10-2021/mitchell-d-schnall-md-phd-re-elected-group-co-chair-of-the-ecog-acrin-cancer-research-group/ 2021-12-10T16:04:59+00:00 https://ascopost.com/issues/december-10-2021/cancer-researcher-and-biotech-founder-lewis-cantley-phd-joins-dana-farber/ 2021-12-21T20:20:42+00:00 https://ascopost.com/issues/december-10-2021/mammen-chandy-md-fracp-fracpa-a-pioneer-in-india-s-bone-marrow-transplantation-services/ 2021-12-10T16:05:01+00:00 https://ascopost.com/issues/december-10-2021/newer-cancer-therapies-offer-hope-but-also-may-confer-cardiac-risk/ 2023-09-01T18:32:25+00:00 https://ascopost.com/issues/december-10-2021/asciminib-for-philadelphia-chromosome-positive-chronic-myeloid-leukemia/ 2021-12-10T16:05:03+00:00 https://ascopost.com/issues/december-10-2021/abemaciclib-with-endocrine-therapy-in-adjuvant-treatment-of-early-breast-cancer/ 2021-12-10T16:05:05+00:00 https://ascopost.com/issues/december-10-2021/fda-approves-sirolimus-protein-bound-particles-for-rare-sarcoma/ 2021-12-10T16:05:06+00:00 https://ascopost.com/issues/december-10-2021/three-investigators-named-winners-of-msk-cancer-center-s-2021-paul-marks-prize-for-cancer-research/ 2021-12-10T16:05:06+00:00 https://ascopost.com/issues/december-10-2021/margaret-foti-phd-md-hc-honored-with-2021-tara-withington-public-service-award/ 2021-12-10T16:05:08+00:00 https://ascopost.com/issues/december-10-2021/mount-sinai-health-system-and-bronxcare-health-system-open-comprehensive-cancer-facility/ 2021-12-10T16:05:09+00:00 https://ascopost.com/issues/december-10-2021/accc-presents-2021-annual-awards-for-significant-contributions-to-oncology-care/ 2021-12-10T16:05:10+00:00 https://ascopost.com/issues/december-10-2021/msk-inaugurates-new-center-for-myelodysplastic-syndromes-and-announces-new-appointments/ 2021-12-10T16:05:11+00:00 https://ascopost.com/issues/december-10-2021/the-history-of-medical-oncology-in-europe-1955-1985-1/ 2021-12-10T16:05:12+00:00 https://ascopost.com/issues/december-10-2021/last-hug/ 2021-12-10T16:05:13+00:00 https://ascopost.com/issues/december-10-2021/early-operation-with-general-anesthesia/ 2021-12-10T16:05:14+00:00 https://ascopost.com/issues/december-10-2021/erudition-and-assessment-on-the-longest-war-in-the-modern-era/ 2021-12-10T16:05:15+00:00 https://ascopost.com/issues/december-10-2021/reclaiming-a-complicated-genius-who-pursued-cancer-with-single-minded-fury/ 2021-12-10T16:05:16+00:00 https://ascopost.com/issues/december-10-2021/the-high-price-of-pain/ 2021-12-10T16:05:17+00:00 https://ascopost.com/issues/december-10-2021/update-on-the-role-of-low-dose-aspirin-in-colorectal-cancer-prevention/ 2022-01-05T18:47:47+00:00 https://ascopost.com/issues/december-10-2021/expect-questions-on-use-of-low-dose-aspirin-to-help-prevent-colorectal-cancer/ 2021-12-10T16:05:19+00:00 https://ascopost.com/issues/december-10-2021/brexucabtagene-autoleucel-for-relapsed-or-refractory-b-cell-precursor-all/ 2021-12-10T16:05:20+00:00 https://ascopost.com/issues/december-10-2021/nagi-el-saghir-md-facp-receives-the-susan-bulkeley-butler-leadership-excellence-award/ 2021-12-10T16:05:21+00:00 https://ascopost.com/issues/december-10-2021/study-finds-patients-infected-with-covid-19-who-underwent-recent-cancer-treatment-are-at-higher-risk-of-adverse-outcomes/ 2021-12-10T16:05:22+00:00 https://ascopost.com/issues/december-10-2021/effect-of-geriatric-assessment-and-management-recommendations-on-adverse-events-related-to-cancer-treatment/ 2021-12-10T16:05:23+00:00 https://ascopost.com/issues/december-10-2021/pharmacovigilance-study-of-pancytopenia-in-patients-receiving-parp-inhibitors/ 2021-12-10T16:05:24+00:00 https://ascopost.com/issues/december-10-2021/i-m-living-and-thriving-with-stage-iv-non-small-cell-lung-cancer/ 2021-12-10T16:05:25+00:00 https://ascopost.com/issues/december-10-2021/the-national-cancer-act-of-1971/ 2021-12-10T16:05:27+00:00 https://ascopost.com/issues/december-25-2021/ 2021-12-21T20:38:53+00:00 https://ascopost.com/issues/december-25-2021/solving-the-conundrum-of-young-onset-colorectal-cancer/ 2022-01-04T22:18:39+00:00 https://ascopost.com/issues/december-25-2021/diversity-in-clinical-trials-career-development-program/ 2022-10-13T15:00:58+00:00 https://ascopost.com/issues/december-25-2021/ash-recognizes-choosing-wisely-champions-at-63rd-annual-meeting/ 2021-12-21T20:38:56+00:00 https://ascopost.com/issues/december-25-2021/uc-davis-brain-surgeon-appointed-to-co-lead-cancer-center-biomedical-technology-program/ 2021-12-21T20:38:57+00:00 https://ascopost.com/issues/december-25-2021/addition-of-first-line-veliparib-to-chemotherapy-in-advanced-squamous-cell-nsclc-no-survival-benefit-in-current-smokers-but-potential-benefit-among-biomarker-selected-patients/ 2021-12-21T20:38:58+00:00 https://ascopost.com/issues/december-25-2021/2021-fda-approvals-of-drugs-for-cancer-treatment/ 2021-12-21T20:38:59+00:00 https://ascopost.com/issues/december-25-2021/creating-a-more-equitable-health-care-system-for-patients-with-cancer/ 2021-12-21T20:39:00+00:00 https://ascopost.com/issues/december-25-2021/i-don-t-know-why-i-got-young-onset-colorectal-cancer/ 2021-12-21T20:39:01+00:00 https://ascopost.com/issues/december-25-2021/more-than-two-dozen-sabcs-presenters-receive-research-scholarships/ 2021-12-21T20:39:02+00:00 https://ascopost.com/issues/december-25-2021/impact-of-time-of-day-of-immune-checkpoint-inhibitor-infusion-on-overall-survival-in-patients-with-metastatic-melanoma/ 2021-12-21T20:39:03+00:00 https://ascopost.com/issues/december-25-2021/changes-in-psa-screening-after-2017-uspstf-guidance-revision/ 2021-12-21T20:39:04+00:00 https://ascopost.com/issues/december-25-2021/study-examines-treatment-related-regret-among-men-with-localized-prostate-cancer/ 2021-12-21T20:39:07+00:00 https://ascopost.com/issues/december-25-2021/san-antonio-breast-cancer-symposium/ 2021-12-21T20:39:10+00:00 https://ascopost.com/issues/december-25-2021/identifying-women-with-triple-negative-breast-cancer-who-may-benefit-from-pembrolizumab-plus-chemotherapy/ 2022-01-04T20:13:34+00:00 https://ascopost.com/issues/december-25-2021/epov-hope-rugo/ 2021-12-21T20:39:17+00:00 https://ascopost.com/issues/december-25-2021/measurable-residual-disease-kinetics-a-potential-new-tool-in-cll/ 2022-01-17T18:46:36+00:00 https://ascopost.com/issues/december-25-2021/epov-krish-patel/ 2021-12-21T20:39:19+00:00 https://ascopost.com/issues/december-25-2021/the-cancer-research-institute-in-morocco/ 2021-12-21T22:39:40+00:00 https://ascopost.com/issues/december-25-2021/final-analysis-of-pallas-trial-no-benefit-of-adjuvant-palbociclib-plus-endocrine-therapy-in-early-breast-cancer/ 2022-01-03T22:07:24+00:00 https://ascopost.com/issues/december-25-2021/epov-matthew-ellis/ 2021-12-21T20:39:25+00:00 https://ascopost.com/issues/december-25-2021/sirolimus-protein-bound-particles-for-malignant-perivascular-epithelioid-cell-tumor/ 2021-12-21T20:39:26+00:00 https://ascopost.com/issues/december-25-2021/orient-31-novel-four-drug-regimen-evaluated-in-egfr-mutated-nsclc/ 2022-01-26T20:13:03+00:00 https://ascopost.com/issues/december-25-2021/epov-myung-ju-ahn/ 2021-12-21T20:39:29+00:00 https://ascopost.com/issues/december-25-2021/cosmic-312-cabozantinib-plus-atezolizumab-improves-progression-free-survival-in-advanced-hepatocellular-carcinoma/ 2021-12-22T16:41:10+00:00 https://ascopost.com/issues/december-25-2021/epov-ian-chau/ 2021-12-21T20:39:31+00:00 https://ascopost.com/issues/december-25-2021/positive-practice-changes-after-the-covid-19-pandemic-from-the-advanced-practice-provider-perspective/ 2021-12-21T20:39:32+00:00 https://ascopost.com/issues/december-25-2021/maia-trial-daratumumab-added-to-lenalidomide-plus-dexamethasone-improves-overall-survival-in-transplant-ineligible-multiple-myeloma/ 2021-12-23T18:53:16+00:00 https://ascopost.com/issues/december-25-2021/fda-approves-pembrolizumab-for-the-adjuvant-treatment-of-stage-iib-or-iic-melanoma/ 2021-12-21T20:39:34+00:00 https://ascopost.com/issues/december-25-2021/fda-approves-maribavir-for-posttransplant-cmv/ 2021-12-21T20:39:36+00:00 https://ascopost.com/issues/december-25-2021/fda-approves-pafolacianine-to-help-identify-ovarian-cancer-lesions/ 2021-12-21T20:39:38+00:00 https://ascopost.com/issues/december-25-2021/fda-approves-triplet-therapy-for-previously-treated-patients-with-relapsed-or-refractory-multiple-myeloma/ 2021-12-21T20:39:39+00:00 https://ascopost.com/issues/december-25-2021/fda-approves-rituximab-plus-chemotherapy-for-several-pediatric-hematologic-malignancies/ 2021-12-21T20:39:41+00:00 https://ascopost.com/issues/december-25-2021/ash-recognizes-peter-marks-with-2021-outstanding-service-award/ 2021-12-21T20:39:43+00:00 https://ascopost.com/issues/december-25-2021/daratumumab-in-front-line-treatment-of-newly-diagnosed-transplant-ineligible-multiple-myeloma-questions-emerge-from-maia-trial/ 2021-12-23T19:36:24+00:00 https://ascopost.com/issues/december-25-2021/composite-biomarker-needed-to-predict-benefit-of-immunotherapy-in-triple-negative-breast-cancer/ 2021-12-21T20:39:45+00:00 https://ascopost.com/issues/december-25-2021/nccn-guidelines-for-prostate-cancer-panel-clarifies-role-of-active-surveillance-for-low-risk-prostate-cancer/ 2021-12-21T20:39:46+00:00 https://ascopost.com/issues/december-25-2021/nyu-langone-opens-center-dedicated-to-blood-and-marrow-transplants/ 2021-12-21T20:39:48+00:00 https://ascopost.com/issues/december-25-2021/the-oncology-center-of-excellence-encourages-submissions-of-applied-regulatory-science-research-proposals/ 2021-12-21T20:39:49+00:00 https://ascopost.com/issues/december-25-2021/novel-vaccine-platform-plus-pembrolizumab-may-boost-immune-response-in-advanced-hcc/ 2021-12-21T20:39:50+00:00 https://ascopost.com/issues/december-25-2021/eftilagimod-alpha-plus-paclitaxel-may-improve-survival-in-hr-positive-her2-negative-metastatic-breast-cancer-aipac-trial/ 2021-12-21T20:39:51+00:00 https://ascopost.com/issues/december-25-2021/sotigalimab-plus-nivolumab-in-anti-pd-1pd-l1-refractory-melanoma/ 2021-12-21T20:39:52+00:00 https://ascopost.com/issues/december-25-2021/build-back-better-act-passes-in-the-house-moves-to-senate/ 2021-12-21T20:45:54+00:00 https://ascopost.com/issues/december-25-2021/asco-calls-on-congress-to-prevent-steep-medicare-cuts-before-end-of-year/ 2021-12-21T20:51:40+00:00 https://ascopost.com/issues/december-25-2021/cures-20-bill-may-increase-diversity-in-clinical-trials-expand-access-to-telehealth-invest-in-research/ 2021-12-21T20:57:20+00:00 https://ascopost.com/issues/december-25-2021/recruiting-practices-to-help-test-performance-measures-to-advance-oncology-quality-of-care/ 2021-12-21T21:05:54+00:00 https://ascopost.com/issues/january-25-2022/ 2022-01-25T19:07:00+00:00 https://ascopost.com/issues/january-25-2022/axicabtagene-ciloleucel-quadruples-event-free-survival-in-large-b-cell-lymphoma/ 2022-01-25T19:07:01+00:00 https://ascopost.com/issues/january-25-2022/epov-laurie-h-sehn-and-alex-herrera/ 2022-01-25T19:07:02+00:00 https://ascopost.com/issues/january-25-2022/second-line-t-dxd-improves-progression-free-survival-across-her2-positive-metastatic-breast-cancer-subgroups/ 2022-01-25T19:07:03+00:00 https://ascopost.com/issues/january-25-2022/epov-ciara-o-sullivan/ 2022-01-25T19:07:04+00:00 https://ascopost.com/issues/january-25-2022/better-federal-agency-coordination-is-needed-to-accelerate-progress-against-cancer/ 2022-01-25T19:07:06+00:00 https://ascopost.com/issues/january-25-2022/pada-1-trial-with-early-identification-of-esr1-mutation-switch-to-fulvestrant-in-metastatic-breast-cancer/ 2022-01-25T19:07:07+00:00 https://ascopost.com/issues/january-25-2022/epov-amy-tiersten-and-carlos-l-arteaga/ 2022-01-25T19:07:08+00:00 https://ascopost.com/issues/january-25-2022/anthracycline-plus-taxane-reduces-risk-of-breast-cancer-recurrence-at-10-years/ 2022-01-25T19:07:09+00:00 https://ascopost.com/issues/january-25-2022/epov-anne-blaes/ 2022-01-25T19:07:10+00:00 https://ascopost.com/issues/january-25-2022/emerald-trial-oral-selective-estrogen-receptor-degrader-as-second-or-third-line-therapy-for-advanced-breast-cancer/ 2022-01-25T19:07:11+00:00 https://ascopost.com/issues/january-25-2022/pi3k-pathway-activation-may-underlie-tamoxifen-associated-uterine-cancer/ 2022-01-25T19:07:13+00:00 https://ascopost.com/issues/january-25-2022/epov-steven-isakoff/ 2022-01-25T19:07:14+00:00 https://ascopost.com/issues/january-25-2022/karen-l-kelly-md-named-chief-executive-officer-of-the-international-association-for-the-study-of-lung-cancer/ 2022-01-25T19:07:15+00:00 https://ascopost.com/issues/january-25-2022/rxponder-update-explores-benefit-of-chemotherapy-in-subgroups/ 2022-01-25T19:07:16+00:00 https://ascopost.com/issues/january-25-2022/epov-anne-blaes-and-virginia-kaklamani/ 2022-01-25T19:07:17+00:00 https://ascopost.com/issues/january-25-2022/lisocabtagene-maraleucel-improves-outcomes-in-relapsed-or-refractory-large-b-cell-lymphoma/ 2022-01-25T19:07:18+00:00 https://ascopost.com/issues/january-25-2022/epov-laurie-h-sehn/ 2022-01-25T19:07:20+00:00 https://ascopost.com/issues/january-25-2022/addition-of-polatuzumab-vedotin-piiq-to-standard-of-care-significantly-reduces-progression-of-diffuse-large-b-cell-lymphoma/ 2022-01-25T19:07:21+00:00 https://ascopost.com/issues/january-25-2022/epov-jane-n-winter-and-christopher-r-flowers/ 2022-01-25T19:07:22+00:00 https://ascopost.com/issues/january-25-2022/fda-approves-abatacept-based-combination-for-prophylaxis-of-acute-graft-vs-host-disease/ 2022-01-25T19:07:23+00:00 https://ascopost.com/issues/january-25-2022/mosunetuzumab-meets-primary-endpoint-of-phase-ii-trial-in-relapsed-or-refractory-follicular-lymphoma/ 2022-01-25T19:07:24+00:00 https://ascopost.com/issues/january-25-2022/epov-laurie-h-sehn-1/ 2022-01-25T19:07:26+00:00 https://ascopost.com/issues/january-25-2022/isatuximab-containing-induction-therapy-for-multiple-myeloma-increases-measurable-residual-disease-negativity/ 2022-05-23T18:05:46+00:00 https://ascopost.com/issues/january-25-2022/epov-joseph-mikhael/ 2022-01-25T19:07:28+00:00 https://ascopost.com/issues/january-25-2022/addition-of-ivosidenib-to-azacitidine-triples-median-overall-survival-in-difficult-to-treat-aml-population/ 2022-01-25T19:07:29+00:00 https://ascopost.com/issues/january-25-2022/epov-mikkael-a-sekeres/ 2022-01-25T19:07:31+00:00 https://ascopost.com/issues/january-25-2022/metastatic-melanoma-improved-overall-survival-reported-with-immunotherapy-infusions-given-earlier-in-the-day/ 2022-01-25T19:07:32+00:00 https://ascopost.com/issues/january-25-2022/aggressive-supportive-treatment-for-covid-19-may-be-needed-in-patients-with-hematologic-cancers/ 2022-01-25T19:07:33+00:00 https://ascopost.com/issues/january-25-2022/circadian-timing-of-immune-checkpoint-inhibitors-beyond-good-times-and-bad-times/ 2022-02-21T00:02:08+00:00 https://ascopost.com/issues/january-25-2022/epov-laura-c-michaelis/ 2022-01-25T19:07:36+00:00 https://ascopost.com/issues/january-25-2022/car-t-cell-therapy-fails-to-improve-outcomes-in-aggressive-non-hodgkin-lymphoma/ 2022-01-25T19:07:41+00:00 https://ascopost.com/issues/january-25-2022/epov-jane-n-winter/ 2022-01-25T19:07:42+00:00 https://ascopost.com/issues/january-25-2022/pembrolizumab-plus-chemotherapy-in-advanced-esophageal-cancer-good-news-for-some-but-more-work-to-be-done/ 2022-02-04T20:44:59+00:00 https://ascopost.com/issues/january-25-2022/lynn-m-schuchter-elected-asco-president-for-2023-2024-term/ 2022-01-25T19:07:45+00:00 https://ascopost.com/issues/january-25-2022/new-zealand-to-ban-cigarette-sales-for-future-generations/ 2022-01-25T19:07:49+00:00 https://ascopost.com/issues/january-25-2022/health-groups-make-recommendations-to-strengthen-the-us-drug-supply-chain-during-the-pandemic-and-beyond/ 2022-01-25T19:07:55+00:00 https://ascopost.com/issues/january-25-2022/jonathan-wesley-riess-to-lead-uc-davis-comprehensive-cancer-center-s-thoracic-oncology-program/ 2022-01-25T19:07:56+00:00 https://ascopost.com/issues/january-25-2022/ian-krop-named-chief-clinical-research-officer-associate-cancer-center-director-for-clinical-research-at-yale-cancer-center/ 2022-01-25T19:07:58+00:00 https://ascopost.com/issues/january-25-2022/asco-unveils-new-equity-diversity-and-inclusion-action-plan/ 2022-01-25T19:07:59+00:00 https://ascopost.com/issues/january-25-2022/asco-statement-on-50th-anniversary-of-signing-of-national-cancer-act/ 2022-01-25T19:08:00+00:00 https://ascopost.com/issues/january-25-2022/promise-and-need-for-more-progress-in-treatment-of-squamous-cell-nsclc/ 2022-01-26T20:03:49+00:00 https://ascopost.com/issues/january-25-2022/adjuvant-atezolizumab-improves-disease-free-survival-following-adjuvant-chemotherapy-in-pd-l1-positive-resected-stage-ii-iiia-nsclc/ 2022-01-25T19:08:02+00:00 https://ascopost.com/issues/january-25-2022/adjuvant-atezolizumab-in-impower010-moving-the-needle-in-early-stage-nsclc/ 2022-01-26T20:53:15+00:00 https://ascopost.com/issues/january-25-2022/roswell-park-receives-nearly-1-million-to-address-race-related-disparities-in-prostate-cancer/ 2022-01-25T19:08:05+00:00 https://ascopost.com/issues/january-25-2022/does-geography-play-a-role-in-early-onset-colorectal-cancer-in-young-black-men/ 2022-01-25T19:08:06+00:00 https://ascopost.com/issues/january-25-2022/tennessee-oncology-appoints-stephen-schleicher-as-chief-medical-officer-and-natalie-dickson-as-chief-strategy-officer/ 2022-01-25T19:08:08+00:00 https://ascopost.com/issues/january-25-2022/developing-a-comprehensive-system-for-personalized-survivorship-centered-care-plans/ 2022-01-25T19:08:09+00:00 https://ascopost.com/issues/january-25-2022/rituximab-plus-chemotherapy-for-pediatric-mature-b-cell-non-hodgkin-lymphoma-and-mature-b-cell-acute-leukemia/ 2022-01-25T19:08:14+00:00 https://ascopost.com/issues/january-25-2022/daratumumabhyaluronidase-fihj-and-carfilzomib-in-multiple-myeloma/ 2022-01-25T19:08:15+00:00 https://ascopost.com/issues/january-25-2022/pembrolizumab-for-adjuvant-treatment-of-stage-iib-or-iic-melanoma/ 2022-01-25T19:08:17+00:00 https://ascopost.com/issues/january-25-2022/project-catalyst-educating-industry-to-help-develop-successful-cancer-therapies/ 2022-01-25T19:08:19+00:00 https://ascopost.com/issues/january-25-2022/from-the-vietnam-war-to-the-stanford-cancer-institute-the-professional-journey-of-quynh-thu-le/ 2022-01-25T19:08:20+00:00 https://ascopost.com/issues/january-25-2022/an-adventurous-spirit-led-to-a-prominent-role-in-radiation-oncology-for-geraldine-jacobson/ 2022-01-25T19:08:21+00:00 https://ascopost.com/issues/january-25-2022/incidence-and-cancer-related-mortality-in-burundi/ 2022-01-25T19:08:23+00:00 https://ascopost.com/issues/january-25-2022/recent-study-aims-to-improve-the-quality-of-cancer-care-in-rural-areas/ 2022-01-25T19:08:24+00:00 https://ascopost.com/issues/january-25-2022/a-guide-for-patients-with-breast-cancer-their-families-and-their-oncologists/ 2022-01-25T19:08:26+00:00 https://ascopost.com/issues/january-25-2022/cancer-has-made-me-a-risk-taker-and-that-s-good/ 2022-01-25T19:08:30+00:00 https://ascopost.com/issues/january-25-2022/disconnect-between-expectations-and-outcomes-major-factor-in-treatment-related-regret-among-patients-with-localized-prostate-cancer/ 2022-01-25T19:08:32+00:00 https://ascopost.com/issues/january-25-2022/be-realistic-about-what-patients-can-expect-after-prostate-cancer-treatment/ 2022-01-25T19:08:33+00:00 https://ascopost.com/issues/january-25-2022/sotorasib-in-previously-treated-patients-with-kras-g12c-mutant-colorectal-cancer/ 2022-01-25T19:08:34+00:00 https://ascopost.com/issues/january-25-2022/effect-of-statin-use-on-outcomes-of-psa-screening-for-prostate-cancer/ 2022-01-25T19:08:35+00:00 https://ascopost.com/issues/january-25-2022/cancer-biologist-beatrice-mintz-dies-at-100/ 2022-01-25T19:08:37+00:00 https://ascopost.com/issues/february-10-2022/ 2022-02-10T19:09:41+00:00 https://ascopost.com/issues/february-10-2022/continued-progression-free-survival-benefit-with-carfilzomibdexamethasonedaratumumab-vs-carfilzomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2022-02-20T23:21:01+00:00 https://ascopost.com/issues/february-10-2022/in-all-candor-what-does-candor-bring-to-the-table-in-relapsed-or-refractory-multiple-myeloma/ 2022-02-11T19:29:41+00:00 https://ascopost.com/issues/february-10-2022/no-invasive-disease-free-survival-benefit-with-addition-of-adjuvant-palbociclib-to-endocrine-therapy-in-early-breast-cancer/ 2022-02-10T19:09:45+00:00 https://ascopost.com/issues/february-10-2022/pallas-trial-in-hormone-receptor-positive-her2-negative-breast-cancer-defining-the-role-of-adjuvant-cdk46-inhibition/ 2022-02-10T19:09:46+00:00 https://ascopost.com/issues/february-10-2022/ama-cdc-quarantine-and-isolation-guidance-is-confusing-counterproductive/ 2022-02-10T19:09:48+00:00 https://ascopost.com/issues/february-10-2022/pretreatment-cardiovascular-disease-and-events-in-patients-receiving-curative-intent-chemoradiation-for-esophageal-cancer/ 2022-02-10T19:09:49+00:00 https://ascopost.com/issues/february-10-2022/healthy-lifestyle-and-development-of-cardiovascular-disease-or-type-2-diabetes-in-patients-with-or-without-cancer/ 2022-02-10T19:09:51+00:00 https://ascopost.com/issues/february-10-2022/oncology-drugs-with-accelerated-approval-is-it-time-for-a-reset/ 2022-02-10T19:09:53+00:00 https://ascopost.com/issues/february-10-2022/city-of-hope-completes-strategic-acquisition-of-cancer-treatment-centers-of-america/ 2022-02-15T14:51:45+00:00 https://ascopost.com/issues/february-10-2022/assessing-value-in-gastrointestinal-cancer-treatments/ 2022-02-10T19:09:56+00:00 https://ascopost.com/issues/february-10-2022/topaz-1-overall-survival-prolonged-with-first-line-immunotherapy-plus-chemotherapy-in-biliary-tract-cancer/ 2022-02-10T19:09:57+00:00 https://ascopost.com/issues/february-10-2022/epov-nilofer-azad/ 2022-02-10T19:09:58+00:00 https://ascopost.com/issues/february-10-2022/amit-maity-md-phd-to-lead-department-of-radiation-oncology-at-the-university-of-utah/ 2022-02-10T19:09:59+00:00 https://ascopost.com/issues/february-10-2022/kerryn-reding-daughter-of-health-care-workers-chooses-a-career-in-breast-cancer-survivorship/ 2023-09-01T18:30:27+00:00 https://ascopost.com/issues/february-10-2022/himalaya-trial-first-line-tremelimumab-plus-durvalumab-improves-overall-survival-in-unresectable-hepatocellular-carcinoma/ 2022-02-10T19:10:02+00:00 https://ascopost.com/issues/february-10-2022/epov-anthony-el-khoueiry/ 2022-02-10T19:10:03+00:00 https://ascopost.com/issues/february-10-2022/fixed-duration-venetoclax-plus-ibrutinib-achieves-deep-and-durable-mrd-remissions-in-cll/ 2022-02-14T19:14:58+00:00 https://ascopost.com/issues/february-10-2022/epov-joshua-brody/ 2022-02-10T19:10:07+00:00 https://ascopost.com/issues/february-10-2022/study-finds-pediatric-based-treatment-regimen-feasible-and-effective-in-older-adults-with-all/ 2022-02-11T20:08:09+00:00 https://ascopost.com/issues/february-10-2022/epov-hanno-hock/ 2022-02-10T19:10:09+00:00 https://ascopost.com/issues/february-10-2022/studies-evaluate-screening-for-early-multiple-myeloma/ 2022-02-10T19:10:10+00:00 https://ascopost.com/issues/february-10-2022/epov-philip-mccarthy/ 2022-02-10T19:10:11+00:00 https://ascopost.com/issues/february-10-2022/monaleesa-analyses-show-widespread-benefit-for-ribociclib-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-02-10T19:10:12+00:00 https://ascopost.com/issues/february-10-2022/epov-david-cescon/ 2022-02-10T19:10:13+00:00 https://ascopost.com/issues/february-10-2022/siog-annual-conference-explores-the-past-present-and-future-of-geriatric-oncology/ 2022-02-10T19:10:14+00:00 https://ascopost.com/issues/february-10-2022/abatacept-for-prophylaxis-of-acute-graft-vs-host-disease/ 2022-02-10T19:10:15+00:00 https://ascopost.com/issues/february-10-2022/keynote-522-sensitivity-analyses-confirm-value-of-neoadjuvant-pembrolizumab-in-triple-negative-breast-cancer/ 2022-02-20T23:37:16+00:00 https://ascopost.com/issues/february-10-2022/epov-hope-rugo/ 2022-02-10T19:10:17+00:00 https://ascopost.com/issues/february-10-2022/challenges-for-oncologists-as-they-reach-retirement-age/ 2022-02-10T19:10:19+00:00 https://ascopost.com/issues/february-10-2022/evidence-supports-ovarian-function-suppression-plus-aromatase-inhibitor-in-premenopausal-women-with-early-breast-cancer/ 2022-02-10T19:10:20+00:00 https://ascopost.com/issues/february-10-2022/mindfulness-in-pediatric-and-adolescent-patients-with-cancer/ 2022-02-10T19:10:21+00:00 https://ascopost.com/issues/february-10-2022/epov-anne-blaes/ 2022-02-10T19:10:22+00:00 https://ascopost.com/issues/february-10-2022/datopotamab-deruxtecan-shows-activity-in-advanced-triple-negative-breast-cancer/ 2022-02-20T23:40:32+00:00 https://ascopost.com/issues/february-10-2022/after-two-cancer-diagnoses-i-m-grateful-for-another-day/ 2023-09-01T18:27:42+00:00 https://ascopost.com/issues/february-10-2022/epov-debu-tripathy-and-hope-rugo/ 2022-02-10T19:10:25+00:00 https://ascopost.com/issues/february-10-2022/association-of-hla-a03-with-outcomes-of-immune-checkpoint-inhibition-for-advanced-cancers/ 2022-02-10T19:10:26+00:00 https://ascopost.com/issues/february-10-2022/dual-checkpoint-inhibitor-therapy-elicits-responses-in-highly-mutated-breast-cancer/ 2022-02-10T19:10:27+00:00 https://ascopost.com/issues/february-10-2022/hematologist-and-bone-marrow-transplant-pioneer-tahir-shamsi-mbbs-mrcpath-frcpath-dies-at-59/ 2022-03-03T20:47:34+00:00 https://ascopost.com/issues/february-10-2022/epov-angela-demichele/ 2022-02-10T19:10:29+00:00 https://ascopost.com/issues/february-10-2022/lymphoma-expert-barbara-pro-joins-herbert-irving-comprehensive-cancer-center/ 2022-02-10T19:10:30+00:00 https://ascopost.com/issues/february-10-2022/jaye-gardiner-receives-inaugural-black-in-cancer-postdoctoral-fellowship-for-pancreatic-cancer-research/ 2022-02-10T19:10:32+00:00 https://ascopost.com/issues/february-10-2022/jeffrey-farma-elected-to-leadership-position-in-the-society-of-university-surgeons/ 2022-02-10T19:10:33+00:00 https://ascopost.com/issues/february-10-2022/jane-winter-begins-term-as-2022-ash-president/ 2022-02-10T19:10:34+00:00 https://ascopost.com/issues/february-10-2022/metformin-added-to-standard-adjuvant-chemotherapy-fails-to-improve-outcomes-in-early-breast-cancer/ 2022-02-10T19:10:35+00:00 https://ascopost.com/issues/february-10-2022/epov-charles-shapiro/ 2022-02-10T19:10:36+00:00 https://ascopost.com/issues/february-10-2022/study-identifies-black-race-as-risk-factor-for-lymphedema-after-axillary-dissection-in-women-with-breast-cancer/ 2022-02-10T19:10:37+00:00 https://ascopost.com/issues/february-10-2022/improved-outcomes-with-adjuvant-chemoendocrine-vs-endocrine-therapy-in-premenopausal-women-with-node-positive-breast-cancer-and-recurrence-score-25/ 2022-02-10T19:10:38+00:00 https://ascopost.com/issues/february-10-2022/rxponder-trial-another-step-in-defining-which-patients-with-breast-cancer-may-be-spared-adjuvant-cytotoxic-chemotherapy/ 2022-02-20T23:39:04+00:00 https://ascopost.com/issues/february-10-2022/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-the-russian-federation/ 2022-02-17T17:06:38+00:00 https://ascopost.com/issues/february-10-2022/how-to-rein-in-oncology-costs-and-save-physician-owned-practices/ 2022-02-10T19:10:41+00:00 https://ascopost.com/issues/february-10-2022/use-of-consolidation-durvalumab-and-adjuvant-osimertinib-among-key-recommendations-in-new-asco-guideline-on-stage-iii-nsclc-treatment/ 2022-02-10T19:18:46+00:00 https://ascopost.com/issues/february-10-2022/guideline-update-highlights-the-importance-of-shared-decision-making-regarding-the-use-of-adjuvant-therapy-in-stage-ii-colon-cancer/ 2022-02-10T19:23:19+00:00 https://ascopost.com/issues/february-25-2022/ 2022-02-21T20:00:52+00:00 https://ascopost.com/issues/february-25-2022/similar-efficacy-but-better-tolerability-for-ripretinib-vs-sunitinib-in-second-line-gist-therapy/ 2022-02-21T20:00:54+00:00 https://ascopost.com/issues/february-25-2022/epov-george-d-demetri-md-fasco/ 2022-02-21T20:00:55+00:00 https://ascopost.com/issues/february-25-2022/understanding-how-lgbtqiplus-cancer-survivors-experience-cancer-care/ 2022-10-13T14:57:37+00:00 https://ascopost.com/issues/february-25-2022/my-german-hodgkin-story/ 2022-03-16T19:27:13+00:00 https://ascopost.com/issues/february-25-2022/circulating-tumor-dna-appears-prognostic-in-resected-colorectal-cancer/ 2022-03-04T20:01:17+00:00 https://ascopost.com/issues/february-25-2022/epov-rona-yaeger/ 2022-02-21T20:01:00+00:00 https://ascopost.com/issues/february-25-2022/adagrasib-controls-disease-in-gastrointestinal-malignancies-beyond-colorectal-cancer/ 2022-02-21T20:01:02+00:00 https://ascopost.com/issues/february-25-2022/epov-mandana-kamgar/ 2022-02-21T20:01:03+00:00 https://ascopost.com/issues/february-25-2022/high-response-rate-seen-with-nivolumab-added-to-encorafenib-and-cetuximab-in-braf-v600e-mutated-metastatic-colorectal-cancer/ 2022-03-04T19:56:55+00:00 https://ascopost.com/issues/february-25-2022/epov-rona-yaeger-1/ 2022-02-21T20:01:06+00:00 https://ascopost.com/issues/february-25-2022/brief-highlights-from-the-2021-ash-annual-meeting-exposition/ 2022-02-21T20:01:07+00:00 https://ascopost.com/issues/february-25-2022/no-significant-benefit-for-pevonedistat-plus-azacitidine-in-higher-risk-myelodysplastic-syndrome/ 2022-02-21T20:01:08+00:00 https://ascopost.com/issues/february-25-2022/improved-outcomes-with-time-limited-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll/ 2022-04-18T18:38:07+00:00 https://ascopost.com/issues/february-25-2022/epov-susan-m-o-brien/ 2022-02-21T20:01:10+00:00 https://ascopost.com/issues/february-25-2022/trifluridinetipiracil-plus-bevacizumab-in-metastatic-colorectal-cancer/ 2022-03-04T19:55:23+00:00 https://ascopost.com/issues/february-25-2022/epov-demetris-papamichael/ 2022-02-21T20:01:13+00:00 https://ascopost.com/issues/february-25-2022/tebentafusp-tebn-for-unresectable-or-metastatic-uveal-melanoma/ 2022-02-21T20:01:14+00:00 https://ascopost.com/issues/february-25-2022/single-cell-spatial-connectivity-analysis-offers-unprecedented-information-in-breast-cancer/ 2022-02-21T20:01:16+00:00 https://ascopost.com/issues/february-25-2022/epov-jenny-c-chang/ 2022-02-21T20:01:17+00:00 https://ascopost.com/issues/february-25-2022/centralizing-care-for-adolescents-and-young-adults-with-cancer-to-improve-long-term-survivorship/ 2022-02-21T20:01:19+00:00 https://ascopost.com/issues/february-25-2022/asco-and-american-cancer-society-announce-collaboration-to-empower-people-with-cancer-information-they-can-trust/ 2022-02-21T20:01:20+00:00 https://ascopost.com/issues/february-25-2022/asco-updates-guidance-on-use-of-abemaciclib-and-endocrine-therapy-in-patients-with-high-risk-early-breast-cancer/ 2022-02-21T20:01:22+00:00 https://ascopost.com/issues/february-25-2022/amid-health-care-workforce-shortages-staffing-guidance-should-ensure-protection-of-individuals-with-cancer/ 2022-02-21T20:01:23+00:00 https://ascopost.com/issues/february-25-2022/moonshot-expansion-offers-opportunity-to-increase-equity-in-cancer-recover-progress-on-screening/ 2022-02-21T20:01:24+00:00 https://ascopost.com/issues/february-25-2022/new-guideline-offers-most-comprehensive-summary-to-date-of-therapies-for-brain-metastases/ 2022-02-21T20:01:25+00:00 https://ascopost.com/issues/february-25-2022/astro-issues-clinical-guideline-on-external-beam-radiation-therapy-for-primary-liver-cancers/ 2022-02-21T20:01:27+00:00 https://ascopost.com/issues/february-25-2022/fda-approves-tebentafusp-tebn-for-the-treatment-of-unresectable-or-metastatic-uveal-melanoma/ 2022-02-24T19:30:10+00:00 https://ascopost.com/issues/february-25-2022/studies-show-that-laws-to-limit-opioid-prescribing-have-hampered-pain-control-for-patients-with-cancer/ 2022-02-21T20:01:29+00:00 https://ascopost.com/issues/february-25-2022/m-eileen-dolan-named-deputy-director-of-the-university-of-chicago-medicine-comprehensive-cancer-center/ 2022-02-21T20:01:30+00:00 https://ascopost.com/issues/february-25-2022/reflecting-on-the-past-50-years-of-cancer-progress-and-looking-ahead-to-the-next-50-years-of-advances/ 2022-02-21T20:01:32+00:00 https://ascopost.com/issues/february-25-2022/bispecific-antibodies-with-multiple-targets-moving-forward-in-multiple-myeloma/ 2022-02-21T20:01:33+00:00 https://ascopost.com/issues/february-25-2022/epov-ajay-nooka/ 2022-02-21T20:01:35+00:00 https://ascopost.com/issues/february-25-2022/as-a-black-woman-i-knew-i-had-to-advocate-for-the-best-breast-cancer-care/ 2022-02-25T17:34:14+00:00 https://ascopost.com/issues/february-25-2022/why-some-patients-with-cancer-are-reluctant-to-receive-covid-19-vaccination-survey-shows-need-to-improve-patient-physician-communication/ 2022-02-21T20:01:37+00:00 https://ascopost.com/issues/february-25-2022/communication-is-key-to-overcoming-resistance-to-covid-19-vaccination/ 2022-02-21T20:01:40+00:00 https://ascopost.com/issues/february-25-2022/neoadjuvant-cemiplimab-rwlc-for-patients-with-resectable-hepatocellular-carcinoma/ 2022-02-21T20:01:41+00:00 https://ascopost.com/issues/february-25-2022/european-genome-wide-association-study-of-genetic-variants-in-alcohol-related-hepatocellular-carcinoma/ 2022-02-21T20:01:42+00:00 https://ascopost.com/issues/february-25-2022/effect-of-adt-use-and-duration-in-combination-with-definitive-radiotherapy-for-localized-prostate-cancer/ 2022-02-21T20:01:44+00:00 https://ascopost.com/issues/february-25-2022/patricia-turner-takes-helm-of-american-college-of-surgeons/ 2022-02-21T20:01:44+00:00 https://ascopost.com/issues/february-25-2022/the-greek-alphabet-in-waves/ 2022-02-21T20:01:46+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/ 2022-02-21T22:11:51+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/highlights-from-the-2021-ash-annual-meeting-exposition/ 2022-02-21T22:11:52+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/chip-mutations-associated-with-lower-risk-of-alzheimer-s-disease/ 2022-02-21T22:11:53+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-mikkael-a-sekeres/ 2022-02-21T22:11:54+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/aggressive-supportive-treatment-for-covid-19-may-be-needed-in-patients-with-hematologic-cancers/ 2022-02-21T22:11:55+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-laura-c-michaelis/ 2022-02-21T22:11:56+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/improved-outcomes-with-time-limited-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll/ 2022-02-21T22:11:57+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-susan-m-o-brien-md/ 2022-02-21T22:11:59+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/fixed-duration-venetoclax-plus-ibrutinib-achieves-deep-and-durable-mrd-remissions-in-cll/ 2022-02-21T22:12:00+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-joshua-brody/ 2022-02-21T22:12:01+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/agile-addition-of-ivosidenib-to-azacitidine-triples-median-overall-survival-in-difficult-to-treat-aml-population/ 2022-02-21T22:12:02+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-mikkael-a-sekeres-1/ 2022-02-21T22:12:04+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/belinda-car-t-cell-therapy-fails-to-improve-outcomes-in-aggressive-non-hodgkin-lymphoma/ 2022-02-21T22:12:05+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-jane-n-winter/ 2022-02-21T22:12:06+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/polarix-addition-of-polatuzumab-vedotin-piiq-to-standard-of-care-significantly-reduces-progression-of-diffuse-large-b-cell-lymphoma/ 2022-02-21T22:12:07+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-jane-winter-christopher-flowers/ 2022-02-21T22:12:08+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/transform-lisocabtagene-maraleucel-improves-outcomes-in-relapsed-or-refractory-large-b-cell-lymphoma/ 2022-02-21T22:12:09+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-laurie-sehn/ 2022-02-21T22:12:10+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/zuma-7-axicabtagene-ciloleucel-quadruples-event-free-survival-in-large-b-cell-lymphoma/ 2022-02-21T22:12:12+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-laurie-sehn-and-alex-herrera/ 2022-02-21T22:12:14+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/mosunetuzumab-meets-primary-endpoint-of-phase-ii-trial-in-relapsed-or-refractory-follicular-lymphoma/ 2022-02-21T22:12:15+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/panther-no-significant-benefit-for-pevonedistat-plus-azacitidine-in-higher-risk-myelodysplastic-syndrome/ 2022-02-21T22:12:17+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/studies-evaluate-screening-for-early-multiple-myeloma/ 2022-03-21T18:21:23+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-philip-mccarthy/ 2022-02-21T22:12:20+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/isatuximab-containing-induction-therapy-for-multiple-myeloma-increases-measurable-residual-disease-negativity/ 2022-03-21T18:22:20+00:00 https://ascopost.com/issues/february-25-2022-supplement-conference-highlights-ash-2021/epov-joseph-mikhael/ 2022-02-21T22:12:23+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/ 2022-02-28T20:00:29+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/highlights-from-the-2021-san-antonio-breast-cancer-symposium/ 2022-02-28T20:00:30+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/second-line-t-dxd-improves-progression-free-survival-across-her2-positive-metastatic-breast-cancer-subgroups/ 2022-02-28T20:00:31+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-ciara-o-sullivan/ 2022-02-28T20:00:32+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/t-dxd-shows-activity-in-her2-low-her2-undetectable-breast-cancer/ 2022-02-28T20:00:33+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-priyanka-sharma-md/ 2022-02-28T20:00:36+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/clinical-trials-underway-for-t-dxd-in-breast-cancer/ 2022-02-28T20:00:37+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/datopotamab-deruxtecan-shows-activity-in-advanced-triple-negative-breast-cancer/ 2022-02-28T20:00:39+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-debu-tripathy-and-hope-rugo/ 2022-02-28T20:00:40+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/keynote-522-sensitivity-analyses-confirm-value-of-neoadjuvant-pembrolizumab-in-triple-negative-breast-cancer/ 2022-02-28T20:00:42+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-hope-s-rugo/ 2022-02-28T20:00:44+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/identifying-women-with-triple-negative-breast-cancer-who-may-benefit-from-pembrolizumab-plus-chemotherapy/ 2022-02-28T20:00:46+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-hope-rugo/ 2022-02-28T20:00:47+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/dual-checkpoint-inhibitor-therapy-elicits-responses-in-highly-mutated-breast-cancer/ 2022-02-28T20:00:50+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-angela-demichele/ 2022-02-28T20:00:54+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/rxponder-update-explores-benefit-of-chemotherapy-in-subgroups/ 2022-02-28T20:00:56+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-anne-blaes-md-ms-and-virginia-kaklamani-md/ 2022-02-28T20:00:57+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/monaleesa-analyses-show-widespread-benefit-for-ribociclib-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-02-28T20:01:00+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-david-cescon/ 2022-02-28T20:01:03+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/evidence-supports-ovarian-function-suppression-plus-aromatase-inhibitor-in-premenopausal-women-with-early-breast-cancer/ 2022-02-28T20:01:06+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-anne-blaes/ 2022-02-28T20:01:09+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/final-analysis-of-pallas-trial-no-benefit-of-adjuvant-palbociclib-plus-endocrine-therapy-in-early-breast-cancer/ 2022-02-28T20:01:12+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-matthew-j-ellis/ 2022-02-28T20:01:14+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/metformin-added-to-standard-adjuvant-chemotherapy-fails-to-improve-outcomes-in-early-breast-cancer/ 2022-02-28T20:01:15+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-charles-shapiro-md/ 2022-02-28T20:01:19+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/emerald-trial-oral-selective-estrogen-receptor-degrader-as-second-or-third-line-therapy-for-advanced-breast-cancer/ 2022-02-28T20:01:20+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/pada-1-trial-with-early-identification-of-esr1-mutation-switch-to-fulvestrant-in-metastatic-breast-cancer/ 2022-02-28T20:01:21+00:00 https://ascopost.com/issues/march-10-2022-supplement-conference-highlights-sabcs-2021/epov-amy-tiersten-and-carlos-l-arteaga/ 2022-02-28T20:01:22+00:00 https://ascopost.com/issues/march-10-2022/ 2022-03-10T20:02:48+00:00 https://ascopost.com/issues/march-10-2022/humanitarian-paul-farmer-md-phd-dies-at-62/ 2022-03-10T21:36:15+00:00 https://ascopost.com/issues/march-10-2022/atul-gawande-md-mph-appointed-to-senior-post-at-us-agency-for-international-development/ 2022-03-11T14:15:03+00:00 https://ascopost.com/issues/march-10-2022/oneoncology-names-davey-daniel-md-chief-medical-officer/ 2022-03-11T14:16:40+00:00 https://ascopost.com/issues/march-10-2022/monica-bertagnolli-md-facs-fasco-joins-prevent-cancer-foundation-board-of-directors/ 2022-03-10T20:02:56+00:00 https://ascopost.com/issues/march-10-2022/linda-fleisher-phd-mph-appointed-co-chair-of-american-cancer-society-s-national-navigation-roundtable/ 2022-03-10T21:58:14+00:00 https://ascopost.com/issues/march-10-2022/cancer-physician-and-researcher-philip-philip-md-phd-to-join-henry-ford-cancer-institute/ 2022-03-10T20:02:59+00:00 https://ascopost.com/issues/march-10-2022/nci-office-of-cancer-survivorship-welcomes-michelle-mollica-phd-mph-rn-ocn-as-senior-advisor/ 2022-03-10T20:03:02+00:00 https://ascopost.com/issues/march-10-2022/president-s-cancer-panel-report-closing-gaps-in-cancer-screening-for-all-americans/ 2022-03-10T20:03:03+00:00 https://ascopost.com/issues/march-10-2022/car-t-cell-therapy-as-second-line-treatment-in-large-b-cell-lymphomas/ 2022-03-16T19:23:18+00:00 https://ascopost.com/issues/march-10-2022/robust-and-durable-responses-to-pembrolizumab-in-patients-with-previously-treated-msi-hdmmr-endometrial-cancer/ 2022-03-10T20:03:06+00:00 https://ascopost.com/issues/march-10-2022/nipicol-trial-promising-outcomes-with-shorter-duration-of-checkpoint-inhibition-in-metastatic-colorectal-cancer/ 2022-03-10T20:03:07+00:00 https://ascopost.com/issues/march-10-2022/epov-benoit-rousseau/ 2022-03-10T20:03:08+00:00 https://ascopost.com/issues/march-10-2022/potential-for-curative-intent/ 2022-03-10T20:03:10+00:00 https://ascopost.com/issues/march-10-2022/parp-inhibitor-plus-abiraterone-benefits-subgroups-of-patients-with-metastatic-castration-resistant-prostate-cancer/ 2022-03-10T20:03:11+00:00 https://ascopost.com/issues/march-10-2022/epov-celestia-higano/ 2022-03-10T20:03:12+00:00 https://ascopost.com/issues/march-10-2022/neoadjuvant-checkpoint-inhibitor-doublet-yields-complete-responses-in-gastroesophageal-cancers/ 2022-03-10T20:03:14+00:00 https://ascopost.com/issues/march-10-2022/epov-samuel-klempner/ 2022-03-10T20:03:16+00:00 https://ascopost.com/issues/march-10-2022/massage-for-pain-management-in-the-cancer-population/ 2022-03-10T20:03:18+00:00 https://ascopost.com/issues/march-10-2022/small-study-reports-neoadjuvant-pd-1-blockade-yields-100-clinical-complete-response-rate-in-locally-advanced-mismatch-repair-deficient-rectal-cancer/ 2022-03-11T19:45:31+00:00 https://ascopost.com/issues/march-10-2022/emerging-issues-regarding-artificial-intelligence-in-cancer-research-and-clinical-practice/ 2022-03-10T20:53:07+00:00 https://ascopost.com/issues/march-10-2022/epov-christopher-willett/ 2022-03-10T20:03:21+00:00 https://ascopost.com/issues/march-10-2022/cancercare-offers-patients-financial-assistance-for-transportation-pet-care/ 2022-03-10T20:03:23+00:00 https://ascopost.com/issues/march-10-2022/updated-findings-on-t-dxd-in-gastrointestinal-malignancies/ 2022-03-10T20:03:25+00:00 https://ascopost.com/issues/march-10-2022/leukemia-committee-of-national-cooperative-clinical-trials-group-names-new-co-chairs/ 2022-03-10T20:03:26+00:00 https://ascopost.com/issues/march-10-2022/report-on-covid-19-outlines-the-pandemics-negative-impact-on-patient-care-and-clinical-research-and-the-lessons-learned/ 2022-03-10T20:03:27+00:00 https://ascopost.com/issues/march-10-2022/cms-expands-coverage-of-lung-cancer-screening-with-low-dose-ct/ 2022-03-18T18:56:59+00:00 https://ascopost.com/issues/march-10-2022/from-a-low-income-family-in-puerto-rico-to-a-leadership-role-in-oncology-for-gerardo-colón-otero-md/ 2022-03-15T18:50:46+00:00 https://ascopost.com/issues/march-10-2022/checkpoint-inhibitors-in-esophagogastric-cancer-updates-of-landmark-trials/ 2022-03-10T20:03:31+00:00 https://ascopost.com/issues/march-10-2022/cancer-in-the-arab-world-addressing-challenges-to-improve-outcomes/ 2022-03-10T20:03:32+00:00 https://ascopost.com/issues/march-10-2022/study-identifies-factors-impacting-adherence-to-oral-medications-for-metastatic-breast-cancer/ 2022-03-10T20:03:33+00:00 https://ascopost.com/issues/march-10-2022/pyrotinib-and-capecitabine-in-her2-positive-breast-cancer-with-brain-metastases/ 2022-03-10T20:03:34+00:00 https://ascopost.com/issues/march-10-2022/association-of-breast-cancer-subtypes-with-pathogenic-germline-variants-in-nine-breast-cancer-susceptibility-genes/ 2022-03-10T20:03:36+00:00 https://ascopost.com/issues/march-10-2022/reduction-in-elective-radiotherapy-dose-and-field-in-definitive-chemoradiotherapy-for-hpv-associated-oropharyngeal-carcinoma/ 2026-01-29T15:28:36+00:00 https://ascopost.com/issues/march-10-2022/epov-stefano-cascinu/ 2022-03-10T20:03:39+00:00 https://ascopost.com/issues/march-10-2022/grieving-the-loss-of-sexual-intimacy-as-a-result-of-cancer-and-its-treatment/ 2022-03-10T20:03:40+00:00 https://ascopost.com/issues/march-10-2022/american-cancer-society-reports-breast-cancer-is-now-the-leading-cause-of-cancer-mortality-in-black-women/ 2022-03-10T20:03:42+00:00 https://ascopost.com/issues/march-10-2022/laura-bukavina-wins-asco-genitourinary-conquer-cancer-merit-award-for-microbiome-research-in-bladder-cancer/ 2022-03-11T17:55:45+00:00 https://ascopost.com/issues/march-10-2022/robert-califf-confirmed-as-fda-commissioner/ 2022-03-10T20:56:29+00:00 https://ascopost.com/issues/march-10-2022/noninvasive-diagnosis-of-cns-lymphoma-possible-through-ctdna/ 2022-03-16T19:20:05+00:00 https://ascopost.com/issues/march-10-2022/gupta-shankar-ctdna-cns-lymphoma/ 2022-03-10T20:03:46+00:00 https://ascopost.com/issues/march-10-2022/combinations-advance-the-power-of-pembrolizumab-in-hodgkin-lymphoma/ 2022-03-15T19:21:51+00:00 https://ascopost.com/issues/march-10-2022/epov-matthew-genyeh-mei/ 2022-03-10T20:03:48+00:00 https://ascopost.com/issues/march-10-2022/memorial-sloan-kettering-president-and-chief-executive-officer-craig-b-thompson-to-step-down/ 2022-03-10T20:03:49+00:00 https://ascopost.com/issues/march-10-2022/chip-mutations-surprisingly-associated-with-lower-risk-of-alzheimer-s-disease/ 2022-03-10T20:03:50+00:00 https://ascopost.com/issues/march-10-2022/epov-mikkael-a-sekeres/ 2022-03-10T20:03:52+00:00 https://ascopost.com/issues/march-10-2022/iberia-romina-sosa-appointed-new-chief-of-division-of-hematology-at-fox-chase/ 2022-03-10T20:03:53+00:00 https://ascopost.com/issues/march-10-2022/margaret-von-mehren-appointed-new-vice-chair-of-department-of-hematologyoncology-at-fox-chase/ 2022-03-10T22:02:39+00:00 https://ascopost.com/issues/march-10-2022/abc-sixth-international-consensus-conference-updates-guidelines-for-advanced-breast-cancer/ 2022-03-10T20:03:55+00:00 https://ascopost.com/issues/march-10-2022/clinical-trials-underway-for-t-dxd-in-breast-cancer/ 2022-03-10T20:03:57+00:00 https://ascopost.com/issues/march-10-2022/t-dxd-shows-activity-in-her2-low-her2-undetectable-breast-cancer/ 2022-03-10T20:03:58+00:00 https://ascopost.com/issues/march-10-2022/epov-priyanka-sharma-md/ 2022-03-10T20:03:59+00:00 https://ascopost.com/issues/march-10-2022/lenvatinibpembrolizumab-improves-progression-free-and-overall-survival-vs-chemotherapy-in-previously-treated-advanced-endometrial-cancer/ 2022-03-10T20:04:01+00:00 https://ascopost.com/issues/march-10-2022/time-for-a-radical-change-in-the-treatment-of-endometrial-cancer-keynote-775-and-beyond/ 2022-03-10T20:04:03+00:00 https://ascopost.com/issues/march-10-2022/the-road-to-a-career-in-breast-oncology-took-several-twists-and-turns-for-sara-hurvitz/ 2022-03-10T20:04:05+00:00 https://ascopost.com/issues/march-10-2022/project-confirm-an-initiative-to-promote-transparency-of-the-accelerated-approval-program-for-oncology-indications/ 2022-03-10T20:04:07+00:00 https://ascopost.com/issues/march-10-2022/managing-long-term-toxicity-from-pelvic-radiation-therapy/ 2022-03-10T20:04:09+00:00 https://ascopost.com/issues/march-10-2022/importing-oncology-trials-from-china-or-other-single-foreign-countries-for-consideration-of-us-regulatory-approvals/ 2022-03-10T20:04:12+00:00 https://ascopost.com/issues/march-10-2022/the-virtues-of-ruth-gratitude-advocacy-and-service/ 2022-03-10T20:14:05+00:00 https://ascopost.com/issues/march-10-2022/asco-and-ontario-health-provide-updated-recommendations-on-using-adjuvant-bone-modifying-treatments-in-nonmetastatic-breast-cancer/ 2022-03-10T20:17:19+00:00 https://ascopost.com/issues/march-10-2022/new-asco-report-clarifies-potential-value-and-utility-of-biosimilars-in-oncology/ 2022-03-10T20:23:06+00:00 https://ascopost.com/issues/march-10-2022/prevent-pandemics-act-would-improve-public-health-in-the-united-states/ 2022-03-10T20:26:58+00:00 https://ascopost.com/issues/march-10-2022/2023-aca-proposal-aims-to-advance-health-equity-and-improve-access-to-health-care-coverage/ 2022-03-10T20:29:18+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/ 2022-03-17T15:05:48+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/first-line-olaparib-plus-abiraterone-extends-radiographic-progression-free-survival-in-men-with-metastatic-castration-resistant-prostate-cancer/ 2022-03-17T15:05:49+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-celestia-higano/ 2022-03-17T15:05:50+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/sacituzumab-govitecan-hziy-in-urothelial-carcinoma-progressing-after-platinum-based-chemotherapy-and-checkpoint-inhibitor-therapy/ 2022-03-17T15:05:51+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/enfortumab-vedotin-ejfv-improves-overall-survival-vs-chemotherapy-in-previously-treated-advanced-urothelial-carcinoma/ 2022-03-17T15:05:51+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/adjuvant-nivolumab-improves-disease-free-survival-in-high-risk-muscle-invasive-urothelial-carcinoma/ 2022-03-17T15:05:52+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/neoadjuvant-dd-mvac-improves-local-control-and-progression-free-survival-in-patients-with-muscle-invasive-bladder-cancer/ 2022-03-17T15:05:53+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/neoadjuvant-enfortumab-vedotin-ejfv-shows-activity-in-muscle-invasive-bladder-cancer/ 2022-03-17T15:05:54+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-guru-p-sonpavde-md/ 2022-03-17T15:05:55+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/first-line-nivolumab-plus-cabozantinib-improves-progression-free-and-overall-survival-vs-sunitinib-in-advanced-renal-cell-carcinoma/ 2022-03-17T15:05:56+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/keynote-564-adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/ 2022-03-17T16:21:22+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/keynote-564-update-supports-benefit-of-adjuvant-pembrolizumab-in-high-risk-renal-cell-carcinoma/ 2022-03-17T15:05:58+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-daniel-geynisman/ 2022-03-17T15:05:59+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/vision-trial-novel-psma-targeted-radiotherapy-improves-outcomes-in-metastatic-prostate-cancer/ 2022-03-17T15:06:00+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-mary-ellen-taplin/ 2022-03-17T15:06:01+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/maintained-benefit-of-apalutamide-plus-androgen-deprivation-therapy-shown-in-metastatic-castration-sensitive-prostate-cancer/ 2022-03-17T15:06:02+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/peace-1-abiraterone-plus-androgen-deprivation-therapy-and-docetaxel-boosts-survival-in-metastatic-castration-sensitive-prostate-cancer/ 2022-03-17T15:06:03+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-eleni-efstathiou/ 2022-03-17T15:06:04+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/stampede-in-nonmetastatic-castration-sensitive-prostate-cancer-abiraterone-added-to-androgen-deprivation-therapy-improves-survival/ 2022-03-17T15:06:05+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-eleni-efstathiou-md/ 2022-03-17T15:06:05+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/shorter-course-radiation-therapy-a-new-practice-standard-after-prostatectomy/ 2022-03-17T15:06:06+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-sophia-c-kamran-2/ 2022-03-17T15:06:07+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/addition-of-ipatasertib-to-abiraterone-plus-prednisolone-improves-radiographic-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/ 2022-03-17T15:06:08+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/parp-inhibitor-plus-abiraterone-benefits-subgroups-of-patients-with-metastatic-castration-resistant-prostate-cancer/ 2022-03-17T15:06:09+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-celestia-higano-1/ 2022-03-17T15:06:10+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/triplet-combination-of-darolutamide-docetaxel-and-androgen-deprivation-therapy-extends-survival-in-metastatic-hormone-sensitive-prostate-cancer/ 2022-03-17T15:06:11+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/epov-elisabeth-heath-oliver-sartor/ 2022-03-17T15:06:12+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/study-reports-modest-gain-in-progression-free-survival-with-continued-enzalutamide-in-advanced-prostate-cancer/ 2022-03-17T15:06:13+00:00 https://ascopost.com/issues/digital-supplement-genitourinary-cancer-almanac-2021-2022/genitourinary-oncology-2021-2022-almanac/ 2022-03-17T15:32:42+00:00 https://ascopost.com/issues/march-25-2022/ 2022-03-25T18:55:21+00:00 https://ascopost.com/issues/march-25-2022/triplet-combination-of-darolutamide-docetaxel-and-androgen-deprivation-therapy-extends-survival-in-metastatic-hormone-sensitive-prostate-cancer/ 2022-04-06T18:19:01+00:00 https://ascopost.com/issues/march-25-2022/epov-elisabeth-heath-oliver-sartor/ 2022-03-25T18:55:23+00:00 https://ascopost.com/issues/march-25-2022/war-is-hell-it-s-also-a-public-health-disaster-especially-for-people-with-cancer/ 2022-03-25T18:55:24+00:00 https://ascopost.com/issues/march-25-2022/asco-stands-with-ukraine-s-cancer-community/ 2022-03-25T18:55:25+00:00 https://ascopost.com/issues/march-25-2022/first-line-olaparib-plus-abiraterone-extends-radiographic-progression-free-survival-in-men-with-metastatic-castration-resistant-prostate-cancer/ 2022-04-06T18:20:41+00:00 https://ascopost.com/issues/march-25-2022/epov-celestia-higano/ 2022-03-25T18:55:27+00:00 https://ascopost.com/issues/march-25-2022/study-reports-modest-gain-in-progression-free-survival-with-continued-enzalutamide-in-advanced-prostate-cancer/ 2022-03-25T18:55:28+00:00 https://ascopost.com/issues/march-25-2022/neoadjuvant-enfortumab-vedotin-ejfv-shows-activity-in-muscle-invasive-bladder-cancer/ 2022-03-25T18:55:28+00:00 https://ascopost.com/issues/march-25-2022/epov-guru-p-sonpavde-md/ 2022-03-25T18:55:29+00:00 https://ascopost.com/issues/march-25-2022/keynote-564-update-supports-benefit-of-adjuvant-pembrolizumab-in-high-risk-renal-cell-carcinoma/ 2022-03-25T18:55:30+00:00 https://ascopost.com/issues/march-25-2022/epov-daniel-geynisman/ 2022-03-25T18:55:31+00:00 https://ascopost.com/issues/march-25-2022/bj-rimel-named-medical-director-cancer-clinical-trials-office/ 2022-03-25T18:55:32+00:00 https://ascopost.com/issues/march-25-2022/avelumab-failed-to-improve-1-year-survival-in-pd-l1-positive-advanced-urothelial-cancer/ 2022-03-25T18:55:33+00:00 https://ascopost.com/issues/march-25-2022/epov-xin-gao/ 2022-03-25T18:55:34+00:00 https://ascopost.com/issues/march-25-2022/atezolizumab-induces-responses-in-advanced-penile-cancer-but-biomarkers-needed-to-improve-patient-selection/ 2022-03-25T18:55:35+00:00 https://ascopost.com/issues/march-25-2022/epov-hao-nguyen/ 2022-03-25T18:55:36+00:00 https://ascopost.com/issues/march-25-2022/adjuvant-therapy-for-colon-cancer-impact-of-stopping-treatment-early/ 2022-03-25T18:55:37+00:00 https://ascopost.com/issues/march-25-2022/epov-gabriel-brooks/ 2022-03-25T18:55:37+00:00 https://ascopost.com/issues/march-25-2022/sotorasib-shows-activity-in-kras-g12c-mutated-pancreatic-cancer/ 2022-03-25T18:55:38+00:00 https://ascopost.com/issues/march-25-2022/accc-welcomes-matt-devino-as-director-cancer-care-delivery-and-health-policy/ 2022-03-31T17:26:25+00:00 https://ascopost.com/issues/march-25-2022/lu-177-dotatate-plus-long-acting-octreotide-vs-high-dose-long-acting-octreotide-in-midgut-neuroendocrine-tumors/ 2022-03-25T18:55:40+00:00 https://ascopost.com/issues/march-25-2022/peptide-receptor-radionuclide-therapy-for-gastroenteropancreatic-neuroendocrine-tumors-implications-for-current-practice/ 2022-03-25T18:55:41+00:00 https://ascopost.com/issues/march-25-2022/epov-e-gabriela-chiorean/ 2022-03-25T18:55:42+00:00 https://ascopost.com/issues/march-25-2022/arul-chinnaiyan-awarded-sjoberg-prize-for-cancer-research/ 2022-03-25T18:55:43+00:00 https://ascopost.com/issues/march-25-2022/allogeneic-transplantation-for-hematologic-neoplasms-in-adults/ 2022-04-18T18:43:35+00:00 https://ascopost.com/issues/march-25-2022/study-evaluates-whether-ctdna-has-demonstrable-advantage-over-standard-surveillance-methods-for-colorectal-cancer/ 2022-03-25T18:55:45+00:00 https://ascopost.com/issues/march-25-2022/new-appointments-for-ecog-acrin-and-nci-committees/ 2022-03-25T18:55:45+00:00 https://ascopost.com/issues/march-25-2022/accc-appoints-david-penberthy-as-new-president/ 2022-03-25T18:55:46+00:00 https://ascopost.com/issues/march-25-2022/midtreatment-imaging-de-escalates-therapy-for-half-of-study-patients-with-oropharyngeal-cancer/ 2026-01-29T14:45:03+00:00 https://ascopost.com/issues/march-25-2022/epov-quynh-thu-le/ 2022-03-25T18:55:48+00:00 https://ascopost.com/issues/march-25-2022/robert-otto-valdez-named-director-of-the-ahrq/ 2022-03-25T18:55:49+00:00 https://ascopost.com/issues/march-25-2022/new-role-for-raymond-dubois-at-the-mark-foundation-for-cancer-research/ 2022-03-25T18:55:50+00:00 https://ascopost.com/issues/march-25-2022/fda-approves-ciltacabtagene-autoleucel-for-relapsed-or-refractory-multiple-myeloma/ 2022-03-25T18:55:51+00:00 https://ascopost.com/issues/march-25-2022/fda-approves-pacritinib-for-adult-patients-with-myelofibrosis-and-thrombocytopenia/ 2025-09-30T19:31:35+00:00 https://ascopost.com/issues/march-25-2022/i-enrolled-in-the-wisdom-study-and-learned-i-am-at-high-risk-for-cancer/ 2022-03-25T18:55:52+00:00 https://ascopost.com/issues/march-25-2022/tofacitinib-for-rheumatoid-arthritis-cancer-and-cardiovascular-event-risks/ 2022-03-25T18:55:53+00:00 https://ascopost.com/issues/march-25-2022/abemaciclib-for-previously-treated-patients-with-p16ink4a-deficient-mesothelioma/ 2022-03-25T18:55:54+00:00 https://ascopost.com/issues/march-25-2022/american-cancer-society-names-arif-kamal-first-chief-patient-officer/ 2022-03-25T18:55:55+00:00 https://ascopost.com/issues/march-25-2022/societies-team-up-to-provide-support-for-ukrainian-patients-with-cancer/ 2022-03-25T18:55:56+00:00 https://ascopost.com/issues/march-25-2022/blood-test-predicts-recurrence-of-hpv-driven-oropharyngeal-cancer-after-treatment/ 2022-03-25T18:55:56+00:00 https://ascopost.com/issues/march-25-2022/epov-quynh-thu-le-1/ 2022-03-25T18:55:57+00:00 https://ascopost.com/issues/march-25-2022/oncolytic-virus-plus-nivolumab-demonstrates-durable-response-in-nonmelanoma-skin-cancer-of-the-head-and-neck/ 2022-03-25T18:55:58+00:00 https://ascopost.com/issues/march-25-2022/outcomes-and-toxicity-with-single-agent-immune-checkpoint-inhibitor-treatment-in-geriatric-patients-with-cancer/ 2022-03-25T18:55:59+00:00 https://ascopost.com/issues/march-25-2022/should-patients-aged-80-and-older-receive-single-agent-immune-checkpoint-inhibitor-treatment/ 2022-03-25T18:56:00+00:00 https://ascopost.com/issues/march-25-2022/asco-provisional-clinical-opinion-offers-guidance-for-using-and-interpreting-genomic-testing-in-patients-with-advanced-cancer/ 2022-03-25T18:56:01+00:00 https://ascopost.com/issues/march-25-2022/most-favored-nation-model-s-withdrawal-complete-asco-applauds-decision-preserving-access-to-care/ 2022-03-25T18:56:02+00:00 https://ascopost.com/issues/march-25-2022/new-asco-sno-guideline-addresses-treatment-recommendations-tailored-to-glioma-subtypes/ 2022-03-25T18:56:03+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/ 2022-03-28T18:32:09+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/gastrointestinal-oncology-2021-2022-almanac/ 2022-03-28T18:32:10+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/addition-of-neoadjuvant-folfirinox-to-preoperative-chemoradiotherapy-in-locally-advanced-rectal-cancer/ 2022-03-28T18:32:11+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/braf-mutant-colorectal-cancer-latest-findings-for-targeted-treatment/ 2022-03-28T18:32:12+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/adding-first-line-nivolumab-to-chemotherapy-improves-survival-in-gastric-gastroesophageal-junction-and-esophageal-adenocarcinomas/ 2022-03-28T18:32:13+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-elena-élez/ 2022-03-28T18:32:14+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/adding-pembrolizumab-to-chemotherapy-improves-overall-and-progression-free-survival-in-first-line-treatment-of-advanced-esophageal-cancer/ 2022-03-28T18:32:15+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/neoadjuvant-checkpoint-inhibitor-doublet-yields-complete-responses-in-gastroesophageal-cancers/ 2022-03-28T18:32:16+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/sotorasib-in-previously-treated-patients-with-kras-g12c-mutant-colorectal-cancer/ 2022-03-28T18:32:16+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/promising-outcomes-with-shorter-duration-of-checkpoint-inhibition-in-metastatic-colorectal-cancer/ 2022-03-28T18:32:17+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-samuel-klempner/ 2022-03-28T18:32:18+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-benoit-rousseau-md-phd/ 2022-03-28T18:32:19+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/recent-fda-approvals-in-gastrointestinal-cancer/ 2022-03-28T18:32:20+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/keynote-811-pembrolizumab-plus-trastuzumab-and-chemotherapy-in-previously-untreated-advanced-her2-positive-gastric-adenocarcinoma/ 2022-03-28T18:32:21+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/high-response-rate-seen-with-nivolumab-added-to-encorafenib-and-cetuximab-in-braf-v600e-mutated-metastatic-colorectal-cancer/ 2022-03-28T18:32:22+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-rona-yaeger/ 2022-03-28T18:32:23+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/adjuvant-therapy-for-colon-cancer-impact-of-stopping-treatment-early/ 2022-03-28T18:32:24+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-gabriel-brooks/ 2022-03-28T18:32:25+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/adjuvant-nivolumab-improves-disease-free-survival-vs-placebo-in-resected-esophageal-or-gastroesophageal-junction-cancer-after-neoadjuvant-chemoradiotherapy/ 2022-03-28T18:32:26+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/ivosidenib-vs-placebo-for-previously-treated-advanced-idh1-mutated-cholangiocarcinoma-final-overall-survival-analysis-of-the-claridhy-trial/ 2022-03-28T18:32:27+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/topaz-1-overall-survival-prolonged-with-first-line-immunotherapy-plus-chemotherapy-in-biliary-tract-cancer/ 2022-03-28T18:32:28+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-nilofer-azad/ 2022-03-28T18:32:29+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/rationale-208-durable-clinical-activity-reported-with-tislelizumab-in-advanced-liver-cancer/ 2022-03-28T18:32:30+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-chris-verslype/ 2022-03-28T18:32:31+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/cosmic-312-cabozantinib-plus-atezolizumab-improves-progression-free-survival-in-advanced-hepatocellular-carcinoma/ 2022-03-28T18:32:32+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-ian-chau/ 2022-03-28T18:32:33+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/himalaya-trial-first-line-tremelimumab-plus-durvalumab-improves-overall-survival-in-unresectable-hepatocellular-carcinoma/ 2022-03-28T18:32:33+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-anthony-el-khoueiry/ 2022-03-28T18:32:34+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/krystal-1-adagrasib-controls-disease-in-gastrointestinal-malignancies-beyond-colorectal-cancer/ 2022-03-28T18:32:35+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-mandana-kamgar/ 2022-03-28T18:32:36+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/codebreak-100-sotorasib-shows-activity-in-kras-g12c-mutated-pancreatic-cancer/ 2022-03-28T18:32:37+00:00 https://ascopost.com/issues/march-25-2022-supplement-gastrointestinal-oncology-almanac/epov-e-gabriela-chiorean/ 2022-03-28T18:32:38+00:00 https://ascopost.com/issues/april-10-2022/ 2022-04-11T14:46:12+00:00 https://ascopost.com/issues/april-10-2022/olympia-trial-adjuvant-olaparib-significantly-improves-overall-survival-in-germline-brca-mutated-breast-cancer/ 2022-04-11T15:53:02+00:00 https://ascopost.com/issues/april-10-2022/deciphering-clinical-outcomes-through-molecular-profiling-the-immotion151-trial/ 2022-04-11T14:46:14+00:00 https://ascopost.com/issues/april-10-2022/reflections-on-the-evolution-of-clinical-care-since-the-passage-of-the-national-cancer-act-of-1971/ 2022-04-11T14:46:15+00:00 https://ascopost.com/issues/april-10-2022/fda-approves-olaparib-for-adjuvant-treatment-of-high-risk-early-breast-cancer/ 2022-04-11T14:46:17+00:00 https://ascopost.com/issues/april-10-2022/brazilian-oncologist-antônio-drauzio-varella-md-rises-from-the-streets-of-são-paulo-to-international-fame/ 2022-04-11T14:46:18+00:00 https://ascopost.com/issues/april-10-2022/no-overall-survival-benefit-with-atezolizumab-plus-bevacizumab-vs-sunitinib-in-previously-untreated-metastatic-renal-cell-carcinoma/ 2022-04-11T14:46:18+00:00 https://ascopost.com/issues/april-10-2022/second-line-combination-study-in-urothelial-cancer/ 2022-05-09T18:25:39+00:00 https://ascopost.com/issues/april-10-2022/epov-guru-sonpavde/ 2022-04-11T14:46:22+00:00 https://ascopost.com/issues/april-10-2022/emerging-endocrine-therapies-for-the-management-of-breast-cancer/ 2022-04-11T14:46:23+00:00 https://ascopost.com/issues/april-10-2022/parp-inhibitors-in-the-treatment-of-breast-cancer-what-s-next/ 2022-04-11T14:46:24+00:00 https://ascopost.com/issues/april-10-2022/improving-oral-anticancer-therapy-adherence-a-call-to-action-and-an-upcoming-fda-asco-workshop/ 2022-04-13T14:01:03+00:00 https://ascopost.com/issues/april-10-2022/american-cancer-society-awards-16-million-in-grants-to-establish-cancer-health-equity-research-centers/ 2022-04-11T14:46:26+00:00 https://ascopost.com/issues/april-10-2022/the-hamoui-foundation-and-lungevity-foundation-present-awards-for-ret-positive-lung-cancer-research/ 2022-04-11T14:46:27+00:00 https://ascopost.com/issues/april-10-2022/city-of-hope-completes-strategic-acquisition-of-cancer-treatment-centers-of-america/ 2022-04-11T14:46:28+00:00 https://ascopost.com/issues/april-10-2022/advances-in-managing-cardiac-side-effects-associated-with-breast-cancer-treatment/ 2022-04-11T14:46:29+00:00 https://ascopost.com/issues/april-10-2022/addition-of-anti-lag-3-antibody-relatlimab-to-nivolumab-improves-progression-free-survival-in-previously-untreated-advanced-melanoma/ 2022-06-23T18:58:53+00:00 https://ascopost.com/issues/april-10-2022/several-studies-evaluate-agents-in-the-first-line-second-line-and-later-treatment-of-advanced-kidney-cancer/ 2022-04-20T20:33:10+00:00 https://ascopost.com/issues/april-10-2022/relativity-047-relatlimab-plus-nivolumab-worthy-of-further-study-in-advanced-melanoma-and-beyond/ 2022-05-26T18:29:48+00:00 https://ascopost.com/issues/april-10-2022/seven-new-research-grants-awarded-by-the-prevent-cancer-foundation/ 2022-04-11T14:46:33+00:00 https://ascopost.com/issues/april-10-2022/jeffrey-peppercorn-named-editor-in-chief-of-jco-oncology-practice/ 2022-04-11T14:46:34+00:00 https://ascopost.com/issues/april-10-2022/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/ 2022-04-27T19:30:54+00:00 https://ascopost.com/issues/april-10-2022/conundrums-of-sars-cov-2-infection-in-cancer-care/ 2022-04-14T12:56:24+00:00 https://ascopost.com/issues/april-10-2022/a-lifetime-of-pioneering-biologic-research-leads-to-a-new-history-of-evolution/ 2022-04-11T14:46:36+00:00 https://ascopost.com/issues/april-10-2022/study-finds-ai-ultrasound-platform-can-predict-thyroid-malignancy-pathologic-stage-and-braf-mutation-status/ 2022-04-11T14:46:37+00:00 https://ascopost.com/issues/april-10-2022/epov-alexander-pearson/ 2022-04-11T14:46:38+00:00 https://ascopost.com/issues/april-10-2022/use-of-traditional-chinese-medicine-herbal-formula-xiao-yao-san-to-relieve-depression-and-anxiety/ 2022-04-11T14:46:39+00:00 https://ascopost.com/issues/april-10-2022/are-disadvantaged-patients-less-likely-to-receive-advanced-radiotherapy-techniques-for-head-and-neck-cancer/ 2026-01-29T14:34:23+00:00 https://ascopost.com/issues/april-10-2022/epov-gary-walker/ 2026-01-29T14:35:15+00:00 https://ascopost.com/issues/april-10-2022/having-metastatic-breast-cancer-has-led-me-to-focus-on-what-matters/ 2022-04-11T14:46:41+00:00 https://ascopost.com/issues/april-10-2022/national-brain-tumor-society-launches-dna-damage-response-consortium-with-yale-cancer-center/ 2022-04-28T20:56:55+00:00 https://ascopost.com/issues/april-10-2022/childhood-leukemia-pioneer-donald-p-pinkel-md-dies-at-95/ 2022-04-11T14:46:43+00:00 https://ascopost.com/issues/april-10-2022/aacr-and-mpm-oncology-charitable-foundation-announce-three-grants-to-support-transformative-cancer-research/ 2022-04-11T14:46:44+00:00 https://ascopost.com/issues/april-10-2022/leader-in-the-field-of-integrative-oncology-barrie-cassileth-phd-dies-at-83/ 2022-04-11T14:46:45+00:00 https://ascopost.com/issues/april-10-2022/fda-approves-pembrolizumab-for-advanced-endometrial-carcinoma/ 2022-04-11T14:46:46+00:00 https://ascopost.com/issues/april-10-2022/protecting-the-immunocompromised-from-covid-19-practical-information-for-physicians/ 2022-04-11T14:46:47+00:00 https://ascopost.com/issues/april-10-2022/asco-provisional-clinical-opinion-offers-guidance-for-using-and-interpreting-genomic-testing-in-patients-with-advanced-cancer/ 2022-04-11T14:46:48+00:00 https://ascopost.com/issues/april-10-2022/supporting-and-mobilizing-resources-asco-joins-worldwide-efforts-to-support-ukrainian-cancer-care/ 2022-04-11T14:46:48+00:00 https://ascopost.com/issues/april-10-2022/rapid-guideline-revises-recommendations-for-adjuvant-therapy-in-patients-with-early-stage-lung-cancer/ 2022-04-28T16:15:28+00:00 https://ascopost.com/issues/april-10-2022/congress-increases-federal-funding-for-cancer-research/ 2022-04-11T14:46:50+00:00 https://ascopost.com/issues/april-10-2022/epov-mark-robson/ 2022-04-11T15:55:46+00:00 https://ascopost.com/issues/april-25-2022/ 2022-04-25T18:56:00+00:00 https://ascopost.com/issues/april-25-2022/how-asco-eco-and-who-are-marshalling-resources-to-provide-care-for-ukrainian-civilians-and-refugees-with-cancer/ 2022-04-25T18:56:01+00:00 https://ascopost.com/issues/april-25-2022/novel-immunotherapy-duo-delays-disease-progression-in-advanced-melanoma/ 2022-04-25T18:56:01+00:00 https://ascopost.com/issues/april-25-2022/epov-adil-daud-and-georgina-long/ 2022-04-25T18:56:02+00:00 https://ascopost.com/issues/april-25-2022/phase-iii-trials-and-tribulations/ 2022-04-25T20:03:16+00:00 https://ascopost.com/issues/april-25-2022/is-neoadjuvant-pembrolizumab-underused-in-the-treatment-of-early-stage-triple-negative-breast-cancer/ 2022-04-25T18:56:04+00:00 https://ascopost.com/issues/april-25-2022/epov-julie-margenthaler/ 2022-04-25T18:56:05+00:00 https://ascopost.com/issues/april-25-2022/choice-01-toripalimab-plus-chemotherapy-improves-survival-in-advanced-nsclc-without-actionable-mutations/ 2022-04-25T18:56:06+00:00 https://ascopost.com/issues/april-25-2022/epov-charu-aggarwal/ 2022-04-25T18:56:08+00:00 https://ascopost.com/issues/april-25-2022/fox-chase-cancer-center-appoints-elizabeth-plimack-md-ms-as-deputy-director/ 2022-04-25T18:56:09+00:00 https://ascopost.com/issues/april-25-2022/andrew-chapman-do-facp-appointed-director-of-the-sidney-kimmel-cancer-center-jefferson-health-philadelphia/ 2022-04-25T18:56:10+00:00 https://ascopost.com/issues/april-25-2022/fda-approves-radioligand-for-metastatic-castration-resistant-prostate-cancer/ 2022-04-25T18:56:11+00:00 https://ascopost.com/issues/april-25-2022/selinexor-improves-progression-free-survival-in-endometrial-cancer/ 2022-04-25T18:56:12+00:00 https://ascopost.com/issues/april-25-2022/epov-amit-oza/ 2022-04-25T18:56:13+00:00 https://ascopost.com/issues/april-25-2022/why-are-many-women-overdue-for-cervical-cancer-screening/ 2022-04-25T18:56:14+00:00 https://ascopost.com/issues/april-25-2022/study-reports-adjuvant-pembrolizumab-improves-disease-free-survival-in-early-stage-nsclc/ 2022-04-25T18:56:14+00:00 https://ascopost.com/issues/april-25-2022/epov-martin-reck/ 2022-04-25T18:56:15+00:00 https://ascopost.com/issues/april-25-2022/phase-iii-trial-evaluates-the-role-of-aspirin-in-preventing-breast-cancer-recurrence/ 2022-04-25T18:56:16+00:00 https://ascopost.com/issues/april-25-2022/epov-angela-demichele/ 2022-04-25T18:56:17+00:00 https://ascopost.com/issues/april-25-2022/norman-sharpless-md-to-step-down-as-director-of-the-nci/ 2022-04-25T18:56:18+00:00 https://ascopost.com/issues/april-25-2022/trials-of-parp-inhibitors-in-urothelial-cancer-more-questions-than-answers/ 2022-04-25T18:56:19+00:00 https://ascopost.com/issues/april-25-2022/epov-sandy-srinivas/ 2022-04-25T18:56:20+00:00 https://ascopost.com/issues/april-25-2022/clinical-trials-updates-in-the-treatment-of-older-adults-with-gastrointestinal-malignancies/ 2022-04-25T18:56:20+00:00 https://ascopost.com/issues/april-25-2022/philip-d-greenberg-md-faacr-voted-aacr-president-elect-for-2022-2023/ 2022-04-25T18:56:21+00:00 https://ascopost.com/issues/april-25-2022/war-in-ukraine-statistics-do-not-keep-pace-with-reality/ 2022-04-25T18:56:22+00:00 https://ascopost.com/issues/april-25-2022/new-report-offers-guidance-for-standardizing-data-on-sex-gender-sexual-orientationnew-report-offers-guidance-for-standardizing-data-on-sex-gender-sexual-orientation/ 2022-04-25T18:56:23+00:00 https://ascopost.com/issues/april-25-2022/fixed-dose-nivolumab-and-relatlimab-rmbw-for-unresectable-or-metastatic-melanoma/ 2022-04-25T18:56:24+00:00 https://ascopost.com/issues/april-25-2022/study-shows-pemigatinib-activity-in-treatment-of-myeloid-or-lymphoid-neoplasms-with-fgfr1-rearrangement/ 2022-05-12T19:20:14+00:00 https://ascopost.com/issues/april-25-2022/epov-john-mascarenhas/ 2022-04-25T18:56:26+00:00 https://ascopost.com/issues/april-25-2022/trametinib-improves-progression-free-survival-vs-standard-of-care-treatment-in-recurrent-low-grade-serous-ovarian-carcinoma/ 2022-04-25T18:56:27+00:00 https://ascopost.com/issues/april-25-2022/mek-inhibition-is-now-a-standard-of-care-in-recurrent-low-grade-serous-ovarian-cancer-what-next/ 2022-04-25T18:56:28+00:00 https://ascopost.com/issues/april-25-2022/addition-of-pembrolizumab-to-chemotherapy-improves-event-free-survival-in-triple-negative-breast-cancer/ 2022-04-25T18:56:29+00:00 https://ascopost.com/issues/april-25-2022/immune-checkpoint-inhibitors-in-neoadjuvant-or-adjuvant-therapy-for-triple-negative-breast-cancer-the-paradigm-shifts/ 2022-04-28T16:44:23+00:00 https://ascopost.com/issues/april-25-2022/association-of-lifestyle-and-cardiovascular-risk-factors-with-hospitalization-for-heart-failure-subtypes-in-breast-cancer-survivors/ 2023-08-31T20:06:09+00:00 https://ascopost.com/issues/april-25-2022/idh12-inhibitors-show-activity-in-patients-with-myelodysplastic-syndrome/ 2022-05-12T19:57:14+00:00 https://ascopost.com/issues/april-25-2022/epov-mikkael-sekeres/ 2022-04-25T18:56:33+00:00 https://ascopost.com/issues/april-25-2022/aml-study-shows-benefit-of-cpx-351-vs-hypomethylating-agent-plus-venetoclax-in-subgroup-of-older-adults/ 2022-05-16T17:20:05+00:00 https://ascopost.com/issues/april-25-2022/epov-amandeep-salhotra/ 2022-04-25T18:56:35+00:00 https://ascopost.com/issues/april-25-2022/mantle-cell-lymphoma-previously-treated-with-btk-inhibitor-may-respond-to-a-newer-btk-inhibitor/ 2022-04-25T18:56:36+00:00 https://ascopost.com/issues/april-25-2022/incidental-findings-on-low-dose-ct-lung-cancer-screening-in-the-nlst-and-risk-of-respiratory-disease-mortality/ 2022-04-25T18:56:37+00:00 https://ascopost.com/issues/april-25-2022/new-breeze-of-immunotherapy-in-b-cell-non-hodgkin-lymphomas-off-the-shelf-bispecific-antibodies/ 2022-05-18T19:29:35+00:00 https://ascopost.com/issues/april-25-2022/fda-approves-axicabtagene-ciloleucel-for-the-second-line-treatment-of-large-b-cell-lymphoma/ 2022-04-25T18:56:39+00:00 https://ascopost.com/issues/april-25-2022/from-iran-to-silicon-valley-a-cancer-survivor-shares-her-story/ 2022-05-12T15:09:24+00:00 https://ascopost.com/issues/april-25-2022/tony-hunter-phd-faacr-honored-with-2022-aacr-award-for-lifetime-achievement-in-cancer-research/ 2022-04-25T18:56:41+00:00 https://ascopost.com/issues/april-25-2022/erratum/ 2022-04-25T18:56:42+00:00 https://ascopost.com/issues/april-25-2022/meta-analysis-of-aromatase-inhibitors-vs-tamoxifen-in-premenopausal-women-with-er-positive-early-stage-breast-cancer-receiving-ovarian-suppression/ 2022-04-25T18:56:43+00:00 https://ascopost.com/issues/april-25-2022/cardiovascular-mortality-and-cancer-mortality-over-time-among-cancer-survivors/ 2022-04-25T18:56:44+00:00 https://ascopost.com/issues/april-25-2022/antibody-response-to-sars-cov-2-mrna-1273-vaccination-in-patients-with-cancer-single-institution-study/ 2022-04-25T18:56:44+00:00 https://ascopost.com/issues/april-25-2022/st-jude-receives-first-group-of-ukrainian-children-with-cancer-for-care-in-the-united-states/ 2022-04-25T18:56:45+00:00 https://ascopost.com/issues/may-10-2022/ 2022-05-10T15:59:20+00:00 https://ascopost.com/issues/may-10-2022/demystifying-immunotherapy-for-early-stage-triple-negative-breast-cancer/ 2022-05-10T15:59:20+00:00 https://ascopost.com/issues/may-10-2022/some-recurrences-of-ductal-carcinoma-in-situ-may-be-genetically-distinct-from-the-primary-tumor-study-reports/ 2022-05-10T15:59:21+00:00 https://ascopost.com/issues/may-10-2022/epov-aditya-bardia/ 2022-05-10T15:59:22+00:00 https://ascopost.com/issues/may-10-2022/deborah-k-armstrong-md-on-the-rationale-for-intraperitoneal-treatment-of-ovarian-cancer/ 2022-05-10T15:59:23+00:00 https://ascopost.com/issues/may-10-2022/2-year-follow-up-shows-durable-responses-with-sotorasib-in-kras-g12c-mutated-non-small-cell-lung-cancer/ 2022-05-18T15:41:05+00:00 https://ascopost.com/issues/may-10-2022/epov-mark-awad/ 2022-05-10T15:59:25+00:00 https://ascopost.com/issues/may-10-2022/accelerating-delivery-of-multiple-myeloma-therapies-to-all-patients/ 2022-05-12T19:18:15+00:00 https://ascopost.com/issues/may-10-2022/natural-killer-cells-precomplexed-with-innate-cell-engager-show-activity-in-cd30-positive-lymphoma/ 2022-05-12T19:23:04+00:00 https://ascopost.com/issues/may-10-2022/epov-julio-chavez-and-hayder-saeed/ 2022-05-10T15:59:27+00:00 https://ascopost.com/issues/may-10-2022/aacr-honors-lee-ellis-md-for-contributions-to-education-and-training-in-cancer-research/ 2022-05-10T15:59:28+00:00 https://ascopost.com/issues/may-10-2022/neoadjuvant-nivolumab-and-platinum-doublet-chemotherapy-for-early-nsclc/ 2022-05-10T15:59:29+00:00 https://ascopost.com/issues/may-10-2022/j-paul-taylor-md-phd-named-scientific-director-and-executive-vice-president-of-st-jude/ 2022-05-10T15:59:30+00:00 https://ascopost.com/issues/may-10-2022/sam-mbulaiteye-mbchb-mphil-mmed-named-2022-scientist-of-the-year-by-lymphoma-foundation-of-america/ 2022-05-10T15:59:31+00:00 https://ascopost.com/issues/may-10-2022/david-braun-md-phd-joins-prostate-and-urologic-cancers-program-at-yale-cancer-center/ 2022-05-10T15:59:32+00:00 https://ascopost.com/issues/may-10-2022/penn-medicine-appoints-robert-vonderheide-md-dphil-to-second-5-year-term-as-director-of-abramson-cancer-center/ 2022-05-10T15:59:33+00:00 https://ascopost.com/issues/may-10-2022/nccn-announces-indiana-university-melvin-and-bren-simon-comprehensive-cancer-center-joins-member-institutions/ 2022-05-10T15:59:34+00:00 https://ascopost.com/issues/may-10-2022/fda-approves-nivolumabrelatlimab-rmbw-for-unresectable-or-metastatic-melanoma/ 2022-05-10T15:59:35+00:00 https://ascopost.com/issues/may-10-2022/intraperitoneal-carboplatin-plus-paclitaxel-vs-intravenous-chemotherapy-in-ovarian-cancer/ 2022-05-10T15:59:35+00:00 https://ascopost.com/issues/may-10-2022/niraparib-maintenance-therapy-improves-progression-free-survival-in-advanced-ovarian-cancer/ 2022-05-10T15:59:36+00:00 https://ascopost.com/issues/may-10-2022/epov-barbara-norquist/ 2022-05-10T15:59:37+00:00 https://ascopost.com/issues/may-10-2022/soraya-trial-mirvetuximab-soravtansine-improves-response-rate-in-drug-resistant-ovarian-cancer/ 2022-05-10T15:59:38+00:00 https://ascopost.com/issues/may-10-2022/epov-deborah-armstrong/ 2022-05-10T15:59:39+00:00 https://ascopost.com/issues/may-10-2022/asco-honors-2022-special-awards-recipients/ 2022-05-10T15:59:40+00:00 https://ascopost.com/issues/may-10-2022/msk-introduces-the-starr-foundation-program-for-discovery-science/ 2022-05-26T20:54:16+00:00 https://ascopost.com/issues/may-10-2022/destiny-lung01-t-dxd-shows-durable-activity-in-previously-treated-metastatic-her2-mutant-nsclc/ 2022-05-26T20:52:01+00:00 https://ascopost.com/issues/may-10-2022/destiny-lung01-is-trastuzumab-deruxtecan-the-answer-for-her2-mutant-lung-cancer/ 2022-05-20T18:46:23+00:00 https://ascopost.com/issues/may-10-2022/how-to-get-the-dose-right/ 2022-05-10T15:59:45+00:00 https://ascopost.com/issues/may-10-2022/from-a-small-village-in-china-to-cutting-edge-clinical-cancer-research-for-cynthia-ma/ 2022-05-10T15:59:46+00:00 https://ascopost.com/issues/may-10-2022/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2022-05-10T15:59:48+00:00 https://ascopost.com/issues/may-10-2022/break-through-cancer-announces-50-million-in-grants-to-researchers-from-five-top-cancer-research-centers/ 2022-05-10T15:59:49+00:00 https://ascopost.com/issues/may-10-2022/music-interventions-for-improving-psychological-and-physical-symptoms-in-people-with-cancer/ 2022-05-10T15:59:49+00:00 https://ascopost.com/issues/may-10-2022/assessing-food-insecurity-among-patients-with-cancer/ 2022-05-10T15:59:50+00:00 https://ascopost.com/issues/may-10-2022/short-and-shorter-screening-tools-for-food-insecurity/ 2022-05-10T15:59:51+00:00 https://ascopost.com/issues/may-10-2022/why-are-black-women-still-dying-at-higher-rates-than-white-women-from-breast-cancer/ 2022-05-10T15:59:52+00:00 https://ascopost.com/issues/may-10-2022/anetumab-ravtansine-vs-vinorelbine-in-relapsed-mesothelin-positive-advanced-malignant-pleural-mesothelioma/ 2022-05-10T15:59:53+00:00 https://ascopost.com/issues/may-10-2022/addition-of-carotuximab-to-pazopanib-in-advanced-angiosarcoma/ 2022-05-10T15:59:54+00:00 https://ascopost.com/issues/may-10-2022/atezolizumab-plus-bevacizumab-shows-activity-in-advanced-neuroendocrine-tumors/ 2022-05-10T15:59:55+00:00 https://ascopost.com/issues/may-10-2022/fda-takes-steps-to-increase-racial-and-ethnic-diversity-in-clinical-trials/ 2022-10-13T14:55:31+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/ 2022-05-06T18:15:49+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/hematologic-oncology-2021-2022-almanac/ 2022-05-06T18:39:38+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/elevate-rr-trial-acalabrutinib-as-effective-as-ibrutinib-with-fewer-cardiac-effects-in-resistant-cll/ 2022-05-06T18:15:50+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-jacqueline-barrientos/ 2022-05-06T18:15:51+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/zanubrutinib-superior-to-ibrutinib-for-cllsll-in-phase-iii-alpine-trial/ 2022-05-06T18:15:52+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-jacqueline-barrientos-1/ 2022-05-06T18:15:53+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/fixed-duration-venetoclax-plus-ibrutinib-achieves-deep-and-durable-mrd-remissions-in-cll/ 2022-05-06T18:15:54+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-joshua-brody/ 2022-05-06T18:15:55+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/improved-outcomes-with-time-limited-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll/ 2022-05-06T18:15:55+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-susan-m-o-brien/ 2022-05-06T18:15:56+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/addition-of-copanlisib-to-rituximab-improves-progression-free-survival-in-relapsed-indolent-non-hodgkin-lymphoma/ 2022-05-06T18:15:57+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/dual-pi3kδck1ε-inhibitor-umbralisib-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/ 2022-05-06T18:15:58+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/axicabtagene-ciloleucel-quadruples-event-free-survival-in-large-b-cell-lymphoma/ 2022-05-06T18:15:59+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-laurie-h-sehn-and-alex-herrera/ 2022-05-06T18:16:00+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/addition-of-polatuzumab-vedotin-piiq-to-standard-of-care-significantly-reduces-progression-of-diffuse-large-b-cell-lymphoma/ 2022-05-06T18:16:01+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-jane-n-winter-and-christopher-r-flowers/ 2022-05-06T18:16:02+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/mosunetuzumab-meets-primary-endpoint-of-phase-ii-trial-in-relapsed-or-refractory-follicular-lymphoma/ 2022-05-06T18:16:03+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-laurie-h-sehn-1/ 2022-05-06T18:16:04+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/transform-lisocabtagene-maraleucel-improves-outcomes-in-relapsed-or-refractory-large-b-cell-lymphoma/ 2022-05-06T18:16:04+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-laurie-sehn/ 2022-05-06T18:16:06+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/car-t-cell-therapy-fails-to-improve-outcomes-in-aggressive-non-hodgkin-lymphoma/ 2022-05-06T18:16:06+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-jane-n-winter/ 2022-05-06T18:16:07+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/bcma-directed-car-t-cell-therapy-ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/ 2022-05-06T18:16:09+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/fda-approvals-in-hematologic-oncology-2021-2022/ 2022-05-06T18:16:10+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/subcutaneous-daratumumab-added-to-pomalidomide-plus-dexamethasone-improves-progression-free-survival-in-multiple-myeloma/ 2022-05-06T18:16:11+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/maintenance-daratumumab-prolongs-progression-free-survival-in-newly-diagnosed-multiple-myeloma/ 2022-05-06T18:16:12+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/maia-trial-daratumumab-added-to-lenalidomide-plus-dexamethasone-improves-overall-survival-in-transplant-ineligible-multiple-myeloma/ 2022-05-06T18:16:13+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/isatuximab-containing-induction-therapy-for-multiple-myeloma-increases-measurable-residual-disease-negativity/ 2022-05-06T18:16:14+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/epov-joseph-mikhael/ 2022-05-06T18:16:15+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/candor-updated-analysis-carfilzomib-dexamethasone-and-daratumumab-vs-carfilzomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2022-05-06T18:16:16+00:00 https://ascopost.com/issues/may-10-2022-supplement-hematologic-oncology-almanac/bispecific-antibodies-with-multiple-targets-moving-forward-in-multiple-myeloma/ 2022-05-06T18:16:17+00:00 https://ascopost.com/issues/may-25-2022/ 2022-05-25T18:59:39+00:00 https://ascopost.com/issues/may-25-2022/sentinel-node-may-not-be-informative-in-making-treatment-decisions-for-some-breast-cancer-subsets/ 2022-05-25T18:59:40+00:00 https://ascopost.com/issues/may-25-2022/polygenic-score-may-enable-more-precise-psa-screening-for-prostate-cancer/ 2022-05-25T18:59:41+00:00 https://ascopost.com/issues/may-25-2022/fda-grants-regular-approval-to-fam-trastuzumab-deruxtecan-nxki-for-unresectable-or-metastatic-her2-positive-breast-cancer/ 2022-05-25T18:59:42+00:00 https://ascopost.com/issues/may-25-2022/an-early-love-of-science-led-to-a-career-in-breast-cancer-research-for-sara-m-tolaney-md-mph/ 2022-05-25T19:54:27+00:00 https://ascopost.com/issues/may-25-2022/novel-neoadjuvant-therapy-may-boost-response-in-resectable-nsclc/ 2022-05-25T18:59:45+00:00 https://ascopost.com/issues/may-25-2022/epov-edward-garon/ 2022-05-25T18:59:46+00:00 https://ascopost.com/issues/may-25-2022/covac-1-vaccination-studied-for-prevention-of-severe-covid-19-in-immune-deficient-patients-with-cancer/ 2022-05-25T18:59:47+00:00 https://ascopost.com/issues/may-25-2022/the-future-of-community-oncology-practice/ 2022-05-25T18:59:48+00:00 https://ascopost.com/issues/may-25-2022/beyond-immunotherapy-new-targeted-agents-for-advanced-nsclc/ 2022-05-25T18:59:49+00:00 https://ascopost.com/issues/may-25-2022/drug-developers-share-thoughts-on-the-oncology-pipeline-and-the-changes-in-clinical-trials/ 2022-05-26T15:16:13+00:00 https://ascopost.com/issues/may-25-2022/diversity-in-clinical-trials-training-program-renamed-to-honor-robert-winn/ 2022-10-13T14:52:23+00:00 https://ascopost.com/issues/may-25-2022/nccn-clinical-practice-guidelines-in-oncology-2022-updates/ 2022-05-25T18:59:53+00:00 https://ascopost.com/issues/may-25-2022/surgical-approach-and-overall-survival-in-younger-women-with-breast-cancer/ 2022-05-25T18:59:54+00:00 https://ascopost.com/issues/may-25-2022/how-st-jude-and-the-who-are-sparking-an-international-movement-to-increase-treatment-access-for-children-with-cancer/ 2022-05-25T18:59:55+00:00 https://ascopost.com/issues/may-25-2022/covid-19-restrictions-linked-to-delayed-breast-cancer-care-at-safety-net-hospital/ 2022-05-25T18:59:56+00:00 https://ascopost.com/issues/may-25-2022/uc-davis-launches-center-for-advancing-cancer-health-equity/ 2022-05-25T18:59:58+00:00 https://ascopost.com/issues/may-25-2022/axicabtagene-ciloleucel-for-second-line-treatment-of-large-b-cell-lymphoma/ 2022-05-25T18:59:59+00:00 https://ascopost.com/issues/may-25-2022/steven-rosenberg-recognized-with-2022-pezcoller-foundation-aacr-international-award/ 2022-05-25T19:00:00+00:00 https://ascopost.com/issues/may-25-2022/combination-therapy-of-olaparib-cyclophosphamide-and-metformin-under-study-in-advanced-endometrial-cancer/ 2022-05-25T19:00:02+00:00 https://ascopost.com/issues/may-25-2022/parp1-selective-inhibitor-offers-significant-benefits-over-older-predecessors-in-treatment-of-solid-tumors/ 2022-05-25T19:00:03+00:00 https://ascopost.com/issues/may-25-2022/approaches-to-potentiate-immune-response-in-patients-who-do-not-respond-to-anti-pd-1-therapy-for-melanoma/ 2022-05-26T18:32:34+00:00 https://ascopost.com/issues/may-25-2022/epov-mario-sznol-and-stefania-scala/ 2022-05-27T15:30:16+00:00 https://ascopost.com/issues/may-25-2022/elaine-jaffe-honored-with-inaugural-aacr-james-s-ewing-thelma-b-dunn-award-for-outstanding-achievement-in-pathology/ 2022-05-25T19:00:07+00:00 https://ascopost.com/issues/may-25-2022/pembrolizumab-for-msi-hdmmr-advanced-endometrial-carcinoma/ 2022-05-25T19:00:08+00:00 https://ascopost.com/issues/may-25-2022/tackling-the-global-burden-of-cancer-on-adolescents-and-young-adults-with-cancer/ 2022-05-25T19:00:10+00:00 https://ascopost.com/issues/may-25-2022/perlmutter-cancer-center-appoints-inaugural-director-of-center-for-blood-cancers/ 2022-05-25T19:00:12+00:00 https://ascopost.com/issues/may-25-2022/john-e-dick-phd-faacr-to-receive-inaugural-aacr-award-for-outstanding-achievement-in-blood-cancer-research/ 2022-05-27T15:17:45+00:00 https://ascopost.com/issues/may-25-2022/the-impact-of-war-on-patients-with-cancer/ 2022-05-25T19:00:14+00:00 https://ascopost.com/issues/may-25-2022/asco-sets-goals-to-advance-the-clinician-educator-career-pathway-in-oncology/ 2022-05-25T19:49:14+00:00 https://ascopost.com/issues/may-25-2022/understanding-oncologists-perceptions-about-palliative-care-and-the-barriers-preventing-its-use/ 2022-05-25T19:00:17+00:00 https://ascopost.com/issues/may-25-2022/overall-survival-benefit-with-nivolumab-plus-chemotherapy-or-ipilimumab-vs-chemotherapy-alone-in-esophageal-squamous-cell-carcinoma/ 2022-05-25T19:00:18+00:00 https://ascopost.com/issues/may-25-2022/5-year-survival-outcomes-with-consolidation-durvalumab-after-chemoradiotherapy-in-unresectable-stage-iii-nsclc/ 2022-05-25T19:00:19+00:00 https://ascopost.com/issues/may-25-2022/pd-1-inhibition-in-first-line-treatment-of-advanced-esophageal-squamous-cell-carcinoma-more-to-come-on-new-paradigm/ 2022-06-21T16:43:21+00:00 https://ascopost.com/issues/may-25-2022/chop-establishes-the-susan-s-and-stephen-p-kelly-center-for-cancer-immunotherapy/ 2022-05-25T19:00:21+00:00 https://ascopost.com/issues/may-25-2022/long-term-overall-survival-in-unresectable-stage-iii-nsclc-with-consolidation-durvalumab-in-the-pacific-trial-translation-to-real-world-outcomes/ 2022-05-25T19:00:23+00:00 https://ascopost.com/issues/may-25-2022/checkmate-816-neoadjuvant-nivolumab-plus-chemotherapy-improves-event-free-survival-over-chemotherapy-alone-in-resectable-nsclc/ 2022-05-25T19:00:24+00:00 https://ascopost.com/issues/may-25-2022/epov-david-paul-carbone/ 2022-05-25T19:00:25+00:00 https://ascopost.com/issues/may-25-2022/a-second-edition-adds-new-value-to-personalized-medicine/ 2022-05-25T19:00:26+00:00 https://ascopost.com/issues/may-25-2022/an-emergency-room-physician-offers-hands-on-perspective-for-treating-patients-with-cancer/ 2022-06-09T20:07:35+00:00 https://ascopost.com/issues/may-25-2022/innovation-can-advance-equitable-cancer-care/ 2022-05-25T19:00:28+00:00 https://ascopost.com/issues/may-25-2022/long-term-quality-of-life-measures-in-women-undergoing-breast-conservation-vs-mastectomy-and-reconstruction-for-early-breast-cancer/ 2022-05-25T19:47:05+00:00 https://ascopost.com/issues/may-25-2022/preoperative-radiotherapy-and-diep-flap-reconstruction-in-women-requiring-mastectomy-for-breast-cancer/ 2022-05-25T19:00:30+00:00 https://ascopost.com/issues/may-25-2022/rates-of-neurologic-adverse-events-in-randomized-trials-of-immune-checkpoint-inhibitors-in-patients-with-cancer/ 2022-05-25T19:00:31+00:00 https://ascopost.com/issues/may-25-2022/finding-a-new-normal-after-classical-hodgkin-lymphoma/ 2022-06-15T19:18:57+00:00 https://ascopost.com/issues/may-25-2022/asco-guideline-rapid-update-addresses-the-use-of-neoadjuvant-pembrolizumab-in-high-risk-early-stage-triple-negative-breast-cancer/ 2022-05-25T19:00:33+00:00 https://ascopost.com/issues/may-25-2022/new-england-cancer-specialists-to-become-affiliate-member-of-dana-farber-cancer-institute/ 2022-05-25T19:00:34+00:00 https://ascopost.com/issues/may-25-2022/asco-expands-oncology-summer-internship-program-with-aims-to-increase-workforce-diversity/ 2022-05-25T19:00:35+00:00 https://ascopost.com/issues/may-25-2022/representatives-diana-degette-and-fred-upton-named-asco-congressional-champions-for-cancer-care/ 2022-05-25T19:00:36+00:00 https://ascopost.com/issues/may-25-2022/incidental-respiratory-disease-found-in-low-dose-ct-screens-challenges-and-opportunities/ 2022-05-25T19:00:36+00:00 https://ascopost.com/issues/may-25-2022/president-biden-s-proposed-investment-for-cutting-edge-medical-research-should-not-jeopardize-funding-for-existing-cancer-research-enterprise/ 2022-05-25T19:00:37+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/ 2022-06-01T18:46:44+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/asco-s-president-elect-makes-partnering-with-patients-the-cornerstone-of-his-presidential-term/ 2022-06-01T18:46:45+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/after-rounds-on-the-leukemia-ward-a-young-doctor-finds-his-calling-in-stem-cell-transplantation/ 2022-06-01T20:32:57+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-personal-cancer-journey-shifts-a-career-in-the-arts-to-a-career-in-radiation-oncology/ 2022-06-01T20:39:13+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/asco-honors-2022-special-awards-recipients/ 2022-06-01T18:46:47+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-son-forges-a-noted-career-in-oncology-rather-than-follow-in-his-father-s-illustrious-footsteps-in-dermatology/ 2022-06-01T20:40:13+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-leader-in-oncology-balances-philosophy-medicine-and-humility/ 2022-06-02T20:17:42+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/aua-astro-release-new-clinically-localized-prostate-cancer-guideline/ 2022-06-01T18:46:50+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/from-the-segregated-tennis-courts-of-washington-dc-to-a-leadership-role-in-surgical-oncology/ 2022-06-01T20:45:53+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/missed-opportunities-in-geriatric-oncology-research/ 2022-06-01T18:46:52+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-descendant-of-midwest-pioneers-follows-a-path-to-academic-genitourinary-oncology/ 2022-06-01T20:47:10+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-fascination-with-bats-leads-to-a-career-in-oncology-and-a-role-in-championing-equity-in-the-workforce/ 2022-06-01T20:51:28+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/navigating-difficult-waters-a-cancer-journey/ 2022-06-01T18:46:55+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/sunil-verma-md-navigates-an-international-path-from-clinical-educator-in-oncology-to-leadership-in-industry/ 2022-06-01T18:46:56+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/asco-expands-oncology-summer-internship-program-with-aims-to-increase-workforce-diversity/ 2022-06-01T18:46:57+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/mount-sinai-and-samuel-waxman-cancer-research-foundation-to-collaborate-on-aging-related-cancer/ 2022-06-01T18:46:58+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-nationally-regarded-pediatric-oncologist-found-his-passion-early/ 2022-06-01T20:53:14+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-community-practitioner-and-policy-advocate-who-stresses-holistic-patient-centered-care/ 2022-06-01T21:02:16+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/asco-leadership-for-2022-2023-term-announced/ 2022-06-01T18:47:01+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/growing-up-in-a-house-filled-with-science-leads-to-a-career-in-breast-cancer-and-health-outcomes-research/ 2022-06-01T20:55:21+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/nci-launches-program-to-offer-molecular-characterization-of-childhood-cancers/ 2022-06-01T18:47:02+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/an-international-leader-bridges-the-political-divide-in-the-name-of-humanity-and-cancer-care/ 2022-06-01T20:31:58+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/turning-point/ 2022-06-01T18:47:04+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/city-of-hope-researcher-receives-margaret-l-kripke-legend-award-for-promotion-of-women-in-cancer/ 2022-06-01T18:47:05+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/lynn-m-schuchter-md-fasco-to-become-asco-president-elect-2022-2023-following-annual-meeting/ 2022-06-01T18:47:06+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/mourned-and-missed/ 2022-06-01T18:47:07+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/alex-choi-md-joins-palliative-care-program-at-smilow-cancer-hospital/ 2022-06-01T18:47:08+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/city-of-hope-s-department-of-surgery-chair-awarded-2022-flance-karl-award-given-by-the-american-surgical-association/ 2022-06-01T18:47:09+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/albert-einstein-cancer-center-announces-new-appointments-to-key-leadership-positions/ 2022-06-01T18:47:10+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/narratives-in-oncology-through-the-years/ 2022-06-01T18:47:11+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/asco-establishes-center-for-equity-diversity-and-inclusion-sybil-green-jd-rph-mha-to-serve-as-center-s-vice-president/ 2022-06-01T18:47:12+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/city-of-hope-receives-49-million-grant/ 2022-06-01T18:47:13+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/a-global-humanist-of-heroic-proportions-who-never-lost-sight-of-the-wounded-living-in-the-shadows-of-poverty/ 2022-06-01T18:47:13+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/new-fda-approved-oncology-drugs-2021-2022/ 2022-06-01T18:47:14+00:00 https://ascopost.com/issues/june-3-2022-narratives-special-issue/asco-recognizes-2022-fellows-of-the-american-society-of-clinical-oncology/ 2022-06-01T18:47:15+00:00 https://ascopost.com/issues/june-10-2022/ 2022-06-10T17:53:37+00:00 https://ascopost.com/issues/june-10-2022/ibrutinib-added-to-standard-therapy-prolongs-progression-free-survival-in-older-patients-with-mantle-cell-lymphoma/ 2022-06-14T21:25:19+00:00 https://ascopost.com/issues/june-10-2022/epov-jeremy-abramson/ 2022-06-10T17:53:38+00:00 https://ascopost.com/issues/june-10-2022/no-good-treatment-options-so-i-ll-eat-ice-cream/ 2022-06-10T17:53:39+00:00 https://ascopost.com/issues/june-10-2022/t-dxd-improves-progression-free-survival-vs-t-dm1-in-metastatic-her2-positive-breast-cancer/ 2022-06-10T17:53:40+00:00 https://ascopost.com/issues/june-10-2022/monaleesa-3-ribociclib-plus-fulvestrant-improves-overall-survival-over-fulvestrant-alone-in-the-first-line-setting/ 2022-10-17T16:06:00+00:00 https://ascopost.com/issues/june-10-2022/destiny-breast03-should-trastuzumab-deruxtecan-be-the-preferred-second-line-regimen-in-her2-positive-metastatic-breast-cancer/ 2022-06-10T17:53:42+00:00 https://ascopost.com/issues/june-10-2022/epov-mafalda-oliveira/ 2022-06-10T17:53:42+00:00 https://ascopost.com/issues/june-10-2022/begonia-trial-reports-activity-with-datopotamab-deruxtecan-plus-durvalumab-in-triple-negative-breast-cancer/ 2022-06-10T17:53:43+00:00 https://ascopost.com/issues/june-10-2022/epov-mafalda-oliveira-1/ 2022-06-10T17:53:44+00:00 https://ascopost.com/issues/june-10-2022/cemiplimab-rwlc-improves-overall-survival-vs-chemotherapy-in-recurrent-cervical-cancer-after-first-line-platinum-based-chemotherapy/ 2022-06-10T17:53:45+00:00 https://ascopost.com/issues/june-10-2022/cemiplimab-rwlc-following-platinum-based-chemotherapy-in-recurrent-or-metastatic-cervical-cancer-clinical-implications/ 2022-06-10T17:53:46+00:00 https://ascopost.com/issues/june-10-2022/nccn-honors-oncology-leaders-promoting-progress-in-cancer-care/ 2022-06-10T17:53:47+00:00 https://ascopost.com/issues/june-10-2022/how-social-media-is-fueling-an-epidemic-of-misinformation-and-disinformation-and-distrust-in-science/ 2022-06-10T17:53:48+00:00 https://ascopost.com/issues/june-10-2022/traditional-chinese-medicine-herbal-formula-ma-zi-ren-wan-for-constipation/ 2022-06-10T17:53:49+00:00 https://ascopost.com/issues/june-10-2022/use-of-t-dxd-in-previously-treated-patients-with-advanced-her2-positive-breast-cancer/ 2022-06-10T17:53:50+00:00 https://ascopost.com/issues/june-10-2022/topical-imiquimod-vs-surgery-for-vulvar-high-grade-squamous-intraepithelial-neoplasia/ 2022-06-10T17:53:51+00:00 https://ascopost.com/issues/june-10-2022/trends-in-hysterectomy-corrected-uterine-cancer-mortality-and-racialethnic-differences/ 2022-06-10T17:53:52+00:00 https://ascopost.com/issues/june-10-2022/ipilimumabnivolumab-in-patients-with-metastatic-pancreatic-or-biliary-cancer-and-hrd-pathogenic-germline-variants/ 2022-06-10T17:53:53+00:00 https://ascopost.com/issues/june-10-2022/t-dxd-shows-efficacy-against-active-brain-metastases-in-her2-positive-breast-cancer/ 2022-06-10T17:53:53+00:00 https://ascopost.com/issues/june-10-2022/annual-meeting-of-the-moroccan-cancer-society-an-opportunity-for-young-cancer-researchers-to-evolve/ 2022-06-13T14:08:01+00:00 https://ascopost.com/issues/june-10-2022/epov-mafalda-oliveira-2/ 2022-06-10T17:53:55+00:00 https://ascopost.com/issues/june-10-2022/emily-whitehead-first-pediatric-patient-to-receive-car-t-cell-therapy-celebrates-remission-10-years-later/ 2022-06-10T17:53:56+00:00 https://ascopost.com/issues/june-10-2022/tj-gan-md-frca-uk-to-join-md-anderson-as-division-head-of-anesthesiology-critical-care-and-pain-medicine/ 2022-06-10T17:53:57+00:00 https://ascopost.com/issues/june-10-2022/fda-approves-two-nivolumab-based-regimens-as-first-line-treatments-for-unresectable-advanced-or-metastatic-esophageal-squamous-cell-carcinoma/ 2022-06-10T17:53:58+00:00 https://ascopost.com/issues/june-10-2022/researcher-xiao-jing-wang-md-phd-joins-uc-davis-cancer-center-s-leadership-team/ 2022-06-10T17:53:59+00:00 https://ascopost.com/issues/june-10-2022/jennifer-willcox-jd-named-senior-vice-president-general-counsel-and-chief-governance-officer-at-dana-farber/ 2022-06-10T17:53:59+00:00 https://ascopost.com/issues/june-10-2022/multiple-myeloma-treatment-conundrums/ 2022-06-10T17:54:00+00:00 https://ascopost.com/issues/june-10-2022/robotic-surgery-improves-perioperative-outcomes-vs-open-radical-cystectomy-in-bladder-cancer-trial/ 2022-06-10T17:54:01+00:00 https://ascopost.com/issues/june-10-2022/epov-khurshid-guru/ 2022-06-10T17:54:02+00:00 https://ascopost.com/issues/june-10-2022/raceethnicity-and-poverty-are-associated-with-worse-outcomes-among-children-with-high-risk-neuroblastoma/ 2022-06-10T17:54:03+00:00 https://ascopost.com/issues/june-10-2022/study-finds-state-public-welfare-spending-was-associated-with-improved-5-year-overall-survival-in-black-patients-with-cancer/ 2022-06-10T17:54:04+00:00 https://ascopost.com/issues/june-10-2022/fda-approves-azacitidine-for-newly-diagnosed-juvenile-myelomonocytic-leukemia/ 2022-06-10T17:54:06+00:00 https://ascopost.com/issues/june-10-2022/fda-approves-ivosidenibazacitidine-for-certain-patients-with-newly-diagnosed-aml/ 2022-06-10T17:54:07+00:00 https://ascopost.com/issues/june-10-2022/fred-hutch-scca-seattle-children-s-and-uw-medicine-complete-restructure-of-partnership/ 2022-06-10T17:54:08+00:00 https://ascopost.com/issues/june-10-2022/cleveland-clinic-announces-new-appointments-to-oncology-staff/ 2022-06-10T17:54:09+00:00 https://ascopost.com/issues/june-10-2022/the-mark-foundation-for-cancer-research-appoints-ryan-schoenfeld-phd-as-chief-executive-officer/ 2022-06-10T17:54:10+00:00 https://ascopost.com/issues/june-10-2022/ralph-lauren-corporate-foundation-announces-25-million-commitment-to-five-us-cancer-centers-to-help-reduce-disparities-in-cancer-care-in-underserved-communities/ 2022-06-10T18:39:55+00:00 https://ascopost.com/issues/june-10-2022/asco-s-cancerlinq-and-atropos-health-collaborate-to-harness-real-world-data-to-provide-point-of-care-informatics-consult-to-oncologists/ 2022-06-10T18:46:55+00:00 https://ascopost.com/issues/june-10-2022/asco-refines-guidance-on-using-biomarkers-for-adjuvant-endocrine-and-chemotherapy-in-early-stage-breast-cancer/ 2022-06-10T18:57:14+00:00 https://ascopost.com/issues/june-10-2022/asco-and-accc-release-joint-recommendations-to-increase-equity-diversity-and-inclusion-in-clinical-trials/ 2022-06-10T19:50:49+00:00 https://ascopost.com/issues/june-25-2022/ 2022-06-24T14:03:22+00:00 https://ascopost.com/issues/june-25-2022/destiny-breast04-trial-t-dxd-significantly-improves-survival-in-patients-with-her2-low-metastatic-breast-cancer/ 2022-06-24T14:01:12+00:00 https://ascopost.com/issues/june-25-2022/epov-patricia-lorusso/ 2022-06-24T14:01:12+00:00 https://ascopost.com/issues/june-25-2022/100-percent-complete-response-rate-in-14-patients-with-rectal-cancer-treated-with-neoadjuvant-dostarlimab-gxly/ 2022-07-01T16:37:45+00:00 https://ascopost.com/issues/june-25-2022/epov-kimmie-ng/ 2022-06-24T14:01:14+00:00 https://ascopost.com/issues/june-25-2022/tropics-02-sacituzumab-govitecan-effective-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/ 2022-07-05T19:02:35+00:00 https://ascopost.com/issues/june-25-2022/epov-debu-tripathy/ 2022-06-24T14:01:17+00:00 https://ascopost.com/issues/june-25-2022/notable-trial-survival-in-pancreatic-kras-wild-type-cancer-improved-with-addition-of-nimotuzumab-to-gemcitabine/ 2022-06-24T14:01:18+00:00 https://ascopost.com/issues/june-25-2022/epov-thomas-seufferlein/ 2022-06-24T14:01:19+00:00 https://ascopost.com/issues/june-25-2022/american-cancer-society-investigators-present-studies-on-covid-19-pandemic-racialethnic-disparities-and-coverage-for-genomic-testing/ 2022-06-24T14:01:20+00:00 https://ascopost.com/issues/june-25-2022/cancer-death-rates-among-black-people-declined-over-time-but-remain-higher-than-other-racial-and-ethnic-groups/ 2022-06-24T14:01:21+00:00 https://ascopost.com/issues/june-25-2022/asco-s-cancerlinq-and-count-me-in-collaborate-to-empower-patient-participation-in-clinical-cancer-research/ 2022-06-24T14:01:22+00:00 https://ascopost.com/issues/june-25-2022/asco-relaunches-survivorship-compendium-with-new-features-and-resources/ 2022-06-24T14:01:23+00:00 https://ascopost.com/issues/june-25-2022/interventions-needed-to-improve-data-collection-on-sexual-orientation-and-gender-identity-in-oncology-practice-survey-finds/ 2022-06-24T14:01:24+00:00 https://ascopost.com/issues/june-25-2022/invest-in-the-unexpected-basic-research-enterprise-needs-adequate-funding-to-foster-treatment-innovation/ 2022-06-24T14:01:25+00:00 https://ascopost.com/issues/june-25-2022/ariela-l-marshall-md-advocates-for-equity-and-reproductive-health-in-the-hematology-oncology-community/ 2022-06-24T14:01:26+00:00 https://ascopost.com/issues/june-25-2022/rucaparib-improves-progression-free-survival-vs-chemotherapy-in-relapsed-ovarian-cancer-with-brca12-mutations/ 2022-06-24T14:01:28+00:00 https://ascopost.com/issues/june-25-2022/ariel4-confirms-rucaparib-s-efficacy-in-recurrent-brca-mutated-ovarian-cancer-does-it-tell-us-anything-new/ 2022-06-24T18:50:59+00:00 https://ascopost.com/issues/june-25-2022/history-of-radiation-oncology-in-the-united-states/ 2022-07-12T18:13:08+00:00 https://ascopost.com/issues/june-25-2022/an-oncology-surgeon-leads-mexico-s-melanoma-program/ 2022-06-24T14:01:31+00:00 https://ascopost.com/issues/june-25-2022/cancer-and-war-in-ukraine-how-the-world-can-help-win-this-battle/ 2023-08-31T20:02:52+00:00 https://ascopost.com/issues/june-25-2022/nivolumab-in-combination-with-chemotherapy-and-in-combination-with-ipilimumab-in-advanced-esophageal-squamous-cell-carcinoma/ 2022-06-24T14:01:33+00:00 https://ascopost.com/issues/june-25-2022/immunotherapy-has-given-me-back-my-life/ 2022-06-24T14:01:34+00:00 https://ascopost.com/issues/june-25-2022/addition-of-tiragolumab-to-atezolizumab-in-pd-l1-positive-nsclc/ 2022-06-24T14:01:35+00:00 https://ascopost.com/issues/june-25-2022/addition-of-denosumab-to-neoadjuvant-chemotherapy-containing-two-different-nab-paclitaxel-regimens-for-patients-with-breast-cancer/ 2022-06-24T14:01:36+00:00 https://ascopost.com/issues/june-25-2022/elevating-cancer-care-in-the-united-states-for-all-current-challenges-and-potential-solutions/ 2022-06-24T14:01:37+00:00 https://ascopost.com/issues/june-25-2022/looking-back-at-telemedicine-during-the-covid-19-era-lessons-learned-and-disparities-identified/ 2022-06-24T14:01:38+00:00 https://ascopost.com/issues/june-25-2022/checkmate-274-adjuvant-immunotherapy-improves-disease-free-survival-in-metastatic-urothelial-cancer/ 2022-06-24T14:01:38+00:00 https://ascopost.com/issues/june-25-2022/epov-guru-sonpavde/ 2022-06-24T14:01:39+00:00 https://ascopost.com/issues/june-25-2022/rates-of-active-surveillance-rising-among-men-with-low-risk-prostate-cancer-but-still-suboptimal/ 2022-07-12T17:35:42+00:00 https://ascopost.com/issues/june-25-2022/epov-william-catalona/ 2022-06-24T14:01:41+00:00 https://ascopost.com/issues/june-25-2022/new-interactive-map-of-oncology-puts-covid-19-equity-data-into-perspective/ 2022-06-24T14:01:42+00:00 https://ascopost.com/issues/july-10-2022/ 2022-07-11T17:51:16+00:00 https://ascopost.com/issues/july-10-2022/early-transplant-with-triplet-therapy-may-delay-progression-of-myeloma-but-individualized-approach-recommended/ 2022-07-11T17:51:17+00:00 https://ascopost.com/issues/july-10-2022/epov-joseph-mikhael/ 2022-07-11T17:51:18+00:00 https://ascopost.com/issues/july-10-2022/first-randomized-chemotherapy-study-in-relapsed-or-refractory-ewing-sarcoma-reports-modest-gains-in-survival-with-high-dose-ifosfamide/ 2022-07-11T17:51:20+00:00 https://ascopost.com/issues/july-10-2022/epov-katherine-janeway/ 2022-07-11T17:51:21+00:00 https://ascopost.com/issues/july-10-2022/death-and-clinical-trials-in-the-plague-years/ 2022-07-13T15:43:58+00:00 https://ascopost.com/issues/july-10-2022/in-metastatic-ras-wild-type-left-sided-colorectal-cancer-panitumumab-proves-superior-to-bevacizumab/ 2022-07-11T17:51:24+00:00 https://ascopost.com/issues/july-10-2022/epov-chiara-cremolini/ 2022-07-11T17:51:25+00:00 https://ascopost.com/issues/july-10-2022/rucaparib-maintenance-improves-pfs-in-patients-with-newly-diagnosed-advanced-ovarian-cancer-who-responded-to-platinum-based-therapy/ 2022-07-13T20:26:32+00:00 https://ascopost.com/issues/july-10-2022/epov-ernst-lengyel/ 2022-07-11T17:51:28+00:00 https://ascopost.com/issues/july-10-2022/cleveland-clinic-appoints-alex-a-adjei-md-phd-as-chair-of-taussig-cancer-institute/ 2023-01-20T20:37:23+00:00 https://ascopost.com/issues/july-10-2022/ash-statement-on-diversity-equity-and-inclusion-toolkit/ 2022-10-13T14:49:55+00:00 https://ascopost.com/issues/july-10-2022/francesca-m-gany-md-ms-receives-excellence-in-health-care-award-from-united-hospital-fund/ 2022-07-11T17:51:33+00:00 https://ascopost.com/issues/july-10-2022/jeffrey-m-rosen-phd-honored-with-2022-william-l-mcguire-memorial-lecture-award/ 2022-07-11T17:51:36+00:00 https://ascopost.com/issues/july-10-2022/dana-farber-cancer-institute-and-l-institut-servier-of-gustave-roussy-sign-an-oncology-cooperation-agreement/ 2022-07-11T17:51:37+00:00 https://ascopost.com/issues/july-10-2022/thomas-stricker-md-joins-oneoncology-as-medical-director-for-precision-medicine/ 2022-07-11T17:51:39+00:00 https://ascopost.com/issues/july-10-2022/chipping-away-at-targetable-mutations-in-nsclc-amivantamab-in-nsclc-with-met-exon-14-skipping-mutations/ 2022-07-11T17:51:40+00:00 https://ascopost.com/issues/july-10-2022/epov-ben-creelan/ 2022-07-11T17:51:42+00:00 https://ascopost.com/issues/july-10-2022/circulating-tumor-dna-guided-approach-to-treating-stage-ii-colon-cancer/ 2022-08-03T19:01:20+00:00 https://ascopost.com/issues/july-10-2022/inspired-by-the-tv-show-mash-lori-wilson-achieves-many-firsts-as-a-leader-in-oncology/ 2022-07-11T17:51:44+00:00 https://ascopost.com/issues/july-10-2022/raising-the-bar-rethinking-the-accelerated-drug-approval-process/ 2022-07-11T17:51:46+00:00 https://ascopost.com/issues/july-10-2022/fda-launches-campaign-aimed-at-preventing-e-cigarette-use-among-american-indianalaska-native-youth/ 2022-07-11T17:51:47+00:00 https://ascopost.com/issues/july-10-2022/astro-welcomes-new-vice-president-of-education-and-director-of-diversity-equity-and-inclusion/ 2022-07-11T17:51:48+00:00 https://ascopost.com/issues/july-10-2022/epov-ben-ho-park/ 2022-07-11T17:51:50+00:00 https://ascopost.com/issues/july-10-2022/new-hematology-chief-and-director-of-the-wesley-center-for-immunotherapy-named-for-uh-seidman-cancer-center/ 2022-07-11T17:51:51+00:00 https://ascopost.com/issues/july-10-2022/dual-targeted-therapy-improves-outcomes-vs-chemotherapy-for-some-pediatric-patients-with-low-grade-glioma/ 2022-07-11T17:51:53+00:00 https://ascopost.com/issues/july-10-2022/shaping-the-future-of-cancer-care-the-value-of-managing-aggregated-data-from-patients-online-communities/ 2022-07-11T17:51:54+00:00 https://ascopost.com/issues/july-10-2022/capecitabine-plus-temozolomide-for-advanced-pancreatic-neuroendocrine-tumors/ 2022-07-11T17:51:55+00:00 https://ascopost.com/issues/july-10-2022/cautious-optimism-about-mining-for-patient-centric-data/ 2022-07-11T17:51:57+00:00 https://ascopost.com/issues/july-10-2022/epov-marianne-pavel/ 2022-07-11T17:51:58+00:00 https://ascopost.com/issues/july-10-2022/moffitt-mourns-the-loss-of-research-giant-robert-gillies/ 2022-07-11T17:51:59+00:00 https://ascopost.com/issues/july-10-2022/car-t-cell-therapy-gave-me-back-a-high-quality-life/ 2022-07-26T18:00:10+00:00 https://ascopost.com/issues/july-10-2022/mount-sinai-researcher-receives-award-from-the-american-association-of-indian-scientists-in-cancer-research/ 2022-07-11T17:52:02+00:00 https://ascopost.com/issues/july-10-2022/dabrafenib-plus-trametinib-receives-fda-approval-for-braf-v600e-mutated-solid-tumors/ 2022-07-11T17:52:06+00:00 https://ascopost.com/issues/july-10-2022/germline-variants-in-types-of-cancer-without-hereditary-testing-guidelines/ 2022-07-11T17:52:08+00:00 https://ascopost.com/issues/july-10-2022/strides-are-being-made-in-the-treatment-of-brain-metastases-from-breast-cancer/ 2022-07-11T17:52:10+00:00 https://ascopost.com/issues/july-10-2022/overall-survival-in-metastatic-colorectal-cancer-in-phase-iii-trials-and-seer-database-over-a-30-year-period/ 2022-07-11T17:52:11+00:00 https://ascopost.com/issues/july-10-2022/asco-guideline-update-aims-to-improve-patient-outcomes-for-her2-positive-breast-cancer-with-brain-metastases/ 2022-07-19T18:35:51+00:00 https://ascopost.com/issues/july-10-2022/asco-guideline-update-for-systemic-melanoma-therapy-addresses-new-treatment-option-for-uveal-melanoma/ 2022-07-28T18:47:25+00:00 https://ascopost.com/issues/july-10-2022/asco-s-cancerlinq-and-healthverity-collaborate-to-accelerate-cancer-research/ 2022-07-11T17:52:16+00:00 https://ascopost.com/issues/july-10-2022/history-of-radiation-oncology-in-the-united-states/ 2022-07-12T18:11:21+00:00 https://ascopost.com/issues/july-10-2022/former-nci-director-takes-stock-of-his-accomplishments-and-looks-ahead-to-the-next-challenge/ 2022-07-11T17:52:20+00:00 https://ascopost.com/issues/july-25-2022/ 2022-07-25T16:58:25+00:00 https://ascopost.com/issues/july-25-2022/addition-of-ribociclib-to-letrozole-improves-survival-in-women-with-hr-positive-her2-negative-advanced-breast-cancer/ 2022-07-25T16:58:25+00:00 https://ascopost.com/issues/july-25-2022/time-restricted-eating-intervention-reduces-cardiovascular-risk-in-older-breast-cancer-survivors/ 2022-07-25T16:58:26+00:00 https://ascopost.com/issues/july-25-2022/two-early-career-cancer-researchers-from-africa-aim-to-make-a-difference-and-never-give-up/ 2022-07-25T16:58:27+00:00 https://ascopost.com/issues/july-25-2022/living-with-hereditary-cancer-oncologist-mark-a-lewis-shares-his-experiences-on-social-media-to-assist-others/ 2022-07-25T16:58:28+00:00 https://ascopost.com/issues/july-25-2022/who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2022-07-25T16:58:29+00:00 https://ascopost.com/issues/july-25-2022/deciphering-the-elusive-origin-and-pathways-of-brain-metastases/ 2022-07-25T16:58:30+00:00 https://ascopost.com/issues/july-25-2022/affirming-health-equity-a-model-for-integrative-health-care/ 2022-07-25T16:58:31+00:00 https://ascopost.com/issues/july-25-2022/postmarketing-ocular-toxicity-in-us-adults-treated-with-daratumumab/ 2022-07-25T16:58:31+00:00 https://ascopost.com/issues/july-25-2022/radiation-segmentectomy-for-very-early-and-early-stage-hepatocellular-carcinoma/ 2022-07-25T16:58:32+00:00 https://ascopost.com/issues/july-25-2022/study-points-to-expanded-genomic-testing-to-benefit-children-and-young-adults-with-cancer/ 2022-07-25T16:58:33+00:00 https://ascopost.com/issues/july-25-2022/phase-iii-trial-reports-quizartinib-doubles-overall-survival-in-flt3-itd-positive-aml/ 2022-07-25T16:58:35+00:00 https://ascopost.com/issues/july-25-2022/epov-amir-fathi/ 2022-07-25T16:58:35+00:00 https://ascopost.com/issues/july-25-2022/changing-the-natural-history-of-er-positive-her2-negative-breast-cancer-with-the-introduction-of-cdk46-inhibition/ 2022-07-25T16:58:36+00:00 https://ascopost.com/issues/july-25-2022/medical-costs-and-clinical-value-playing-the-long-game/ 2022-07-25T16:58:37+00:00 https://ascopost.com/issues/july-25-2022/study-finds-radiation-therapy-may-be-safely-omitted-for-some-older-patients-with-luminal-a-breast-cancer/ 2022-07-25T16:58:38+00:00 https://ascopost.com/issues/july-25-2022/adjuvant-everolimus-narrowly-misses-statistical-significance-in-rcc-except-for-very-high-risk-patients/ 2022-07-25T16:58:39+00:00 https://ascopost.com/issues/july-25-2022/responses-to-teclistamab-reported-in-early-phase-trial-of-highly-refractory-multiple-myeloma/ 2022-07-25T16:58:39+00:00 https://ascopost.com/issues/july-25-2022/epov-madhav-v-dhodapkar/ 2022-07-25T16:58:40+00:00 https://ascopost.com/issues/july-25-2022/cln-081-shows-selective-activity-in-nsclc-with-egfr-exon-20-insertions/ 2022-07-25T16:58:41+00:00 https://ascopost.com/issues/july-25-2022/lupsma-improves-progression-free-survival-vs-cabazitaxel-in-psma-positive-metastatic-castration-resistant-prostate-cancer/ 2022-07-25T16:58:42+00:00 https://ascopost.com/issues/july-25-2022/study-reports-time-limited-venetoclax-based-regimens-of-benefit-in-front-line-treatment-of-cll/ 2022-08-15T19:14:12+00:00 https://ascopost.com/issues/july-25-2022/fda-approves-lisocabtagene-maraleucel-for-the-second-line-treatment-of-large-b-cell-lymphoma/ 2022-07-25T16:58:43+00:00 https://ascopost.com/issues/july-25-2022/car-t-cell-reimbursement-measuring-health-disparities-digital-quality-in-focus-in-comments-on-2023-hospital-inpatient-payment-proposal/ 2022-07-25T16:58:44+00:00 https://ascopost.com/issues/july-25-2022/asco-statement-on-supreme-court-decision-in-dobbs-v-jackson-women-s-health-organization/ 2022-07-25T16:58:45+00:00 https://ascopost.com/issues/july-25-2022/asco-guideline-update-supports-new-second-and-third-line-treatments-for-her2-positive-breast-cancer/ 2022-07-25T16:58:46+00:00 https://ascopost.com/issues/july-25-2022/ama-house-of-delegates-approves-asco-backed-resolutions-on-ancillary-clinical-trial-costs-and-arpa-h-funding/ 2022-07-25T16:58:47+00:00 https://ascopost.com/issues/august-10-2022/ 2022-08-15T15:18:44+00:00 https://ascopost.com/issues/august-10-2022/noted-oncology-surgeon-kevin-billingsley-uses-life-experiences-to-mold-his-leadership-philosophy/ 2022-08-10T13:30:39+00:00 https://ascopost.com/issues/august-10-2022/atlas-trial-risk-adapted-triplet-maintenance-therapy-may-benefit-some-patients-with-multiple-myeloma/ 2022-08-11T20:10:22+00:00 https://ascopost.com/issues/august-10-2022/epov-peter-voorhees/ 2022-08-11T22:29:59+00:00 https://ascopost.com/issues/august-10-2022/brentuximab-vedotin-with-chemotherapy-offers-survival-benefit-in-stage-iii-or-iv-hodgkin-lymphoma/ 2022-08-10T13:30:42+00:00 https://ascopost.com/issues/august-10-2022/epov-alison-moskowitz/ 2022-08-10T13:30:43+00:00 https://ascopost.com/issues/august-10-2022/nivolumab-plus-t-dxd-under-study-in-her2-expressing-metastatic-breast-cancer/ 2022-09-06T20:10:41+00:00 https://ascopost.com/issues/august-10-2022/epov-rebecca-dent/ 2022-08-10T13:30:45+00:00 https://ascopost.com/issues/august-10-2022/cancer-knows-no-borders/ 2022-08-10T13:30:45+00:00 https://ascopost.com/issues/august-10-2022/cairo5-determines-optimal-approach-to-colorectal-liver-metastases/ 2022-08-10T13:30:46+00:00 https://ascopost.com/issues/august-10-2022/epov-cathy-eng/ 2022-08-10T13:30:47+00:00 https://ascopost.com/issues/august-10-2022/intermittent-folfiri-plus-panitumumab-proves-more-effective-less-toxic-than-continuous-treatment-in-metastatic-colorectal-cancer/ 2022-08-10T13:30:48+00:00 https://ascopost.com/issues/august-10-2022/epov-christina-wu/ 2022-08-10T13:30:49+00:00 https://ascopost.com/issues/august-10-2022/no-overall-survival-benefit-reported-with-palbociclibletrozole-in-advanced-breast-cancer/ 2022-08-10T14:33:25+00:00 https://ascopost.com/issues/august-10-2022/hematology-highlights-from-asco-2022/ 2022-08-10T13:30:52+00:00 https://ascopost.com/issues/august-10-2022/how-smoking-cessation-after-a-lung-cancer-diagnosis-improves-overall-survival/ 2022-08-10T13:30:53+00:00 https://ascopost.com/issues/august-10-2022/immunotherapy-for-gastrointestinal-malignancies-is-it-ready-for-prime-time/ 2022-08-10T16:00:03+00:00 https://ascopost.com/issues/august-10-2022/kimberly-hoggatt-krumwiede-phd-named-dean-of-md-anderson-s-school-of-health-professions/ 2022-08-10T13:30:55+00:00 https://ascopost.com/issues/august-10-2022/asco-endorses-new-astro-guideline-on-the-use-of-radiation-treatment-of-metastatic-brain-cancer/ 2026-01-29T04:18:35+00:00 https://ascopost.com/issues/august-10-2022/asco-releases-first-comprehensive-evidence-based-guidelines-for-metastatic-clear-cell-rcc/ 2022-08-22T17:47:39+00:00 https://ascopost.com/issues/august-10-2022/asco-and-who-to-collaborate-on-quality-indicators-for-cancer-facilities/ 2022-08-10T13:30:58+00:00 https://ascopost.com/issues/august-10-2022/cancerlinq-and-owkin-collaborate-to-use-federated-learning-on-real-world-oncology-data-to-better-understand-lung-cancer-treatment/ 2022-08-10T13:30:59+00:00 https://ascopost.com/issues/august-10-2022/initiatives-by-professional-oncology-organizations-focus-on-improving-equitable-cancer-care/ 2022-08-10T13:31:00+00:00 https://ascopost.com/issues/august-10-2022/selwyn-m-vickers-md-facs-named-president-and-ceo-of-memorial-sloan-kettering-cancer-center/ 2022-08-10T13:31:01+00:00 https://ascopost.com/issues/august-10-2022/howard-sandler-md-fastro-voted-president-elect-of-astro-along-with-other-new-officers/ 2022-08-10T13:31:02+00:00 https://ascopost.com/issues/august-10-2022/donna-hansel-md-phd-to-join-md-anderson-as-division-head-of-pathology-and-laboratory-medicine/ 2022-08-10T13:31:03+00:00 https://ascopost.com/issues/august-10-2022/how-asco-and-accc-aim-to-increase-diversity-in-clinical-trials-and-close-the-equity-gap-in-cancer-care/ 2022-10-13T14:44:32+00:00 https://ascopost.com/issues/august-10-2022/asco-accc-recommendations-to-reduce-barriers-to-clinical-trial-enrollment/ 2022-10-13T14:47:52+00:00 https://ascopost.com/issues/august-10-2022/his-grandmother-s-death-inspires-a-career-in-oncology-for-manmeet-s-ahluwalia-md-mba/ 2022-08-14T13:10:46+00:00 https://ascopost.com/issues/august-10-2022/an-oncology-nurse-becomes-a-cancer-survivor/ 2022-08-10T13:31:07+00:00 https://ascopost.com/issues/august-10-2022/pat-morin-phd-appointed-deputy-scientific-director-of-the-ludwig-institute-for-cancer-research/ 2022-08-11T21:45:37+00:00 https://ascopost.com/issues/august-10-2022/radiologist-claudia-henschke-phd-md-of-icahn-school-of-medicine-receives-the-37th-annual-alton-ochsner-award/ 2022-08-10T13:31:09+00:00 https://ascopost.com/issues/august-10-2022/jaye-gardiner-phd-receives-the-2022-eddie-méndez-award-honoring-underrepresented-scientists/ 2022-08-10T13:31:10+00:00 https://ascopost.com/issues/august-10-2022/dana-farber-s-irene-ghobrial-md-selected-as-william-dameshek-prize-winner/ 2022-08-10T13:31:11+00:00 https://ascopost.com/issues/august-10-2022/thriving-after-a-diagnosis-of-stage-ii-anal-cancer/ 2022-08-10T13:31:12+00:00 https://ascopost.com/issues/august-10-2022/aya-leukemia-survivors-have-higher-mortality-rates-than-the-general-population/ 2022-10-24T19:15:04+00:00 https://ascopost.com/issues/august-10-2022/age-at-initiation-of-colorectal-cancer-screening-and-risk-of-colorectal-cancer-among-us-women/ 2022-08-10T13:31:14+00:00 https://ascopost.com/issues/august-10-2022/are-virtual-frailty-assessments-for-older-patients-with-hematologic-malignancies-effective/ 2022-08-10T13:31:16+00:00 https://ascopost.com/issues/august-25-2022/ 2022-08-25T19:54:26+00:00 https://ascopost.com/issues/august-25-2022/mountaineer-tucatinib-plus-trastuzumab-active-in-metastatic-colorectal-cancer/ 2022-09-02T16:57:30+00:00 https://ascopost.com/issues/august-25-2022/epov-cathy-eng/ 2022-08-25T19:54:28+00:00 https://ascopost.com/issues/august-25-2022/is-science-getting-closer-to-preventing-multiple-myeloma/ 2022-09-27T16:55:37+00:00 https://ascopost.com/issues/august-25-2022/impact-of-the-dobbs-v-jackson-women-s-health-organization-ruling-on-patients-with-cancer/ 2022-08-25T19:54:30+00:00 https://ascopost.com/issues/august-25-2022/snapshots-of-studies-of-interest-presented-at-asco-2022/ 2022-08-25T19:54:31+00:00 https://ascopost.com/issues/august-25-2022/sequencing-therapies-may-improve-overall-survival-in-metastatic-pancreatic-cancer/ 2022-09-02T16:18:40+00:00 https://ascopost.com/issues/august-25-2022/epov-katrina-s-pedersen-md-ms/ 2022-08-25T19:54:34+00:00 https://ascopost.com/issues/august-25-2022/crizotinib-in-adult-and-pediatric-alk-positive-inflammatory-myofibroblastic-tumors/ 2022-08-25T19:54:35+00:00 https://ascopost.com/issues/august-25-2022/aphinity-trial-in-patients-with-her2-positive-early-breast-cancer-update-at-8-years/ 2022-08-25T19:54:36+00:00 https://ascopost.com/issues/august-25-2022/epov-javier-cortés-md-phd/ 2022-08-25T19:54:38+00:00 https://ascopost.com/issues/august-25-2022/epcoritamab-under-study-in-difficult-to-treat-large-b-cell-lymphoma/ 2022-08-25T19:54:39+00:00 https://ascopost.com/issues/august-25-2022/epov-alexey-danilov/ 2022-08-25T19:54:40+00:00 https://ascopost.com/issues/august-25-2022/lisocabtagene-maraleucel-in-second-line-treatment-of-large-b-cell-lymphoma/ 2022-08-25T19:54:41+00:00 https://ascopost.com/issues/august-25-2022/cardiovascular-mortality-and-cancer-mortality-over-time-among-cancer-survivors/ 2023-08-29T19:55:39+00:00 https://ascopost.com/issues/august-25-2022/biden-administration-announces-new-model-to-improve-cancer-care-for-medicare-patients/ 2022-08-25T19:54:44+00:00 https://ascopost.com/issues/august-25-2022/is-advance-care-planning-of-any-value/ 2022-08-25T19:54:45+00:00 https://ascopost.com/issues/august-25-2022/new-guideline-updates-address-stage-iv-non-small-cell-lung-cancer-with-and-without-driver-alterations/ 2022-08-25T19:54:46+00:00 https://ascopost.com/issues/august-25-2022/2023-hospital-outpatient-payment-proposal-does-not-reflect-scotus-ruling-on-340b-reimbursement/ 2022-08-25T19:54:48+00:00 https://ascopost.com/issues/august-25-2022/nine-oncology-practices-certified-through-asco-patient-centered-cancer-care-certification-pilot/ 2022-08-25T19:54:49+00:00 https://ascopost.com/issues/august-25-2022/azacitidine-for-newly-diagnosed-juvenile-myelomonocytic-leukemia/ 2022-08-25T19:54:50+00:00 https://ascopost.com/issues/august-25-2022/tisagenlecleucel-for-relapsed-or-refractory-follicular-lymphoma/ 2022-08-25T19:54:51+00:00 https://ascopost.com/issues/august-25-2022/a-surgical-oncologist-from-afghanistan-discusses-the-challenges-of-delivering-cancer-care-in-a-war-torn-nation/ 2022-11-01T18:16:36+00:00 https://ascopost.com/issues/august-25-2022/an-early-encounter-with-cancer-sets-a-path-to-a-career-in-oncology-research/ 2022-08-25T19:54:54+00:00 https://ascopost.com/issues/august-25-2022/asco-endorses-president-biden-s-pick-of-asco-past-president-monica-bertagnolli-as-incoming-head-of-nci/ 2022-08-25T19:54:55+00:00 https://ascopost.com/issues/august-25-2022/an-oncologist-and-his-patient-with-cancer-look-at-the-intimate-experience-of-life-and-death/ 2022-08-25T19:54:56+00:00 https://ascopost.com/issues/august-25-2022/the-sandra-and-edward-meyer-cancer-center-at-weill-cornell-medicine-appoints-new-directors/ 2022-08-25T19:54:57+00:00 https://ascopost.com/issues/august-25-2022/dong-quai/ 2022-09-20T21:02:05+00:00 https://ascopost.com/issues/august-25-2022/surviving-advanced-prostate-cancer-has-made-me-a-more-empathetic-physician/ 2022-08-25T19:55:00+00:00 https://ascopost.com/issues/august-25-2022/study-investigates-ruralurban-disparities-in-hospice-care-among-patients-with-hematologic-malignancies/ 2022-08-25T19:55:01+00:00 https://ascopost.com/issues/august-25-2022/varenicline-increases-smoking-cessation-rates-for-african-american-smokers/ 2022-08-25T19:55:02+00:00 https://ascopost.com/issues/august-25-2022/mri-guided-ultrasound-focal-therapy-may-delay-or-avoid-prostatectomy-or-radiotherapy-in-patients-with-intermediate-risk-prostate-cancer/ 2022-08-25T19:55:03+00:00 https://ascopost.com/issues/august-25-2022/success-story-in-prostate-cancer-for-many-men/ 2022-08-25T19:55:05+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/ 2022-08-31T18:20:37+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/head-and-neck-cancer-2021-2022-almanac/ 2026-01-29T04:13:45+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/tislelizumab-plus-chemotherapy-improves-progression-free-survival-in-nasopharyngeal-cancer/ 2026-01-29T04:10:48+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/are-disadvantaged-patients-less-likely-to-receive-advanced-radiotherapy-techniques-for-head-and-neck-cancer/ 2026-01-29T04:07:13+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/epov-gary-walker/ 2026-01-29T04:09:00+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/induction-chemotherapy-with-paclitaxel-cisplatin-and-capecitabine-vs-cisplatin-and-fluorouracil-for-nasopharyngeal-carcinoma/ 2026-01-29T04:04:36+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/blood-test-predicts-recurrence-of-hpv-driven-oropharyngeal-cancer-after-treatment/ 2026-01-29T04:02:24+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/epov-quynh-thu-le-1/ 2022-08-31T18:20:43+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/midtreatment-imaging-de-escalates-therapy-for-half-of-study-patients-with-oropharyngeal-cancer/ 2026-01-29T03:59:14+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/epov-quynh-thu-le/ 2022-08-31T18:20:45+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/de-escalation-of-radiation-therapy-for-hpv-positive-intermediate-risk-oropharyngeal-cancer/ 2026-01-29T03:53:44+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/epov-farzan-siddiqui/ 2022-08-31T18:20:47+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/primary-transoral-surgery-and-reduced-dose-adjuvant-radiation-therapy-for-hpv-positive-locally-advanced-oropharyngeal-cancer/ 2026-01-29T03:51:06+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/hpv-vaccination-and-projected-oropharyngeal-cancer-incidence-through-the-year-2045/ 2026-01-29T03:46:45+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/first-line-cisplatin-plus-gemcitabine-or-fluorouracil-for-advanced-nasopharyngeal-carcinoma/ 2026-01-29T03:40:56+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/study-finds-ai-ultrasound-platform-can-predict-thyroid-malignancy-pathologic-stage-and-braf-mutation-status/ 2022-08-31T18:20:51+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/epov-alexander-pearson/ 2022-08-31T18:20:52+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/thyroidectomy-with-or-without-radioiodine-for-low-risk-thyroid-cancer/ 2022-08-31T18:20:52+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/addition-of-selumetinib-to-adjuvant-radioactive-iodine-in-high-risk-differentiated-thyroid-cancer/ 2022-08-31T18:20:53+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/fda-approves-cabozantinib-for-patients-with-previously-treated-radioactive-iodine-refractory-differentiated-thyroid-cancer/ 2022-08-31T18:20:54+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/apatinib-for-advanced-radioactive-iodine-refractory-differentiated-thyroid-cancer/ 2022-08-31T18:20:55+00:00 https://ascopost.com/issues/august-25-2022-supplement-head-neck-almanac/cabozantinib-prolongs-progression-free-survival-in-previously-treated-radioiodine-refractory-differentiated-thyroid-cancer/ 2022-08-31T18:20:56+00:00 https://ascopost.com/issues/september-10-2022/ 2022-09-09T14:47:01+00:00 https://ascopost.com/issues/september-10-2022/concurrent-chemoradiation-therapy-with-weekly-cisplatin-for-locally-advanced-head-and-neck-squamous-cell-carcinoma/ 2026-01-29T03:36:58+00:00 https://ascopost.com/issues/september-10-2022/v-craig-jordan-cmg-obe-phd-dsc-fmedsci-the-father-of-tamoxifen-recounts-a-life-of-adventure-and-science/ 2024-06-11T21:25:59+00:00 https://ascopost.com/issues/september-10-2022/wall-street-doesn-t-believe-in-this-target/ 2022-09-09T14:47:04+00:00 https://ascopost.com/issues/september-10-2022/real-world-evidence-confirms-survival-benefit-of-durvalumab-in-locally-advanced-non-small-cell-lung-cancer/ 2022-09-09T14:47:04+00:00 https://ascopost.com/issues/september-10-2022/dart-trial-concurrent-radiotherapy-plus-durvalumab-active-in-older-patients-with-locally-advanced-lung-cancer/ 2022-09-09T14:47:06+00:00 https://ascopost.com/issues/september-10-2022/can-patients-with-low-risk-nasopharyngeal-cancer-be-treated-safely-with-radiotherapy-alone/ 2026-01-29T03:38:46+00:00 https://ascopost.com/issues/september-10-2022/fda-approves-first-targeted-therapy-for-her2-low-breast-cancer/ 2022-09-09T16:40:43+00:00 https://ascopost.com/issues/september-10-2022/sylvester-researchers-receive-95-million-grant-to-study-esophageal-cancer/ 2022-09-09T14:47:08+00:00 https://ascopost.com/issues/september-10-2022/activity-shown-for-novel-immunotherapy-combination-in-microsatellite-stable-colorectal-cancer/ 2022-09-09T14:47:09+00:00 https://ascopost.com/issues/september-10-2022/epov-ryan-corcoran/ 2022-09-09T14:47:10+00:00 https://ascopost.com/issues/september-10-2022/rationale-306-survival-benefit-attained-with-tislelizumab-in-advanced-esophageal-cancer/ 2022-09-09T14:47:11+00:00 https://ascopost.com/issues/september-10-2022/epov-michael-cecchini/ 2022-09-09T14:47:12+00:00 https://ascopost.com/issues/september-10-2022/fda-grants-accelerated-approval-to-trastuzumab-deruxtecan-for-her2-mutant-nsclc/ 2022-09-09T16:45:06+00:00 https://ascopost.com/issues/september-10-2022/fda-approves-crizotinib-for-alk-positive-inflammatory-myofibroblastic-tumors/ 2022-09-09T16:46:41+00:00 https://ascopost.com/issues/september-10-2022/fda-approves-darolutamide-for-metastatic-hormone-sensitive-prostate-cancer/ 2022-09-09T16:52:06+00:00 https://ascopost.com/issues/september-10-2022/companion-diagnostic-to-identify-patients-with-endometrial-cancer-eligible-for-pembrolizumab-therapy-approved-by-the-fda/ 2022-09-09T14:47:15+00:00 https://ascopost.com/issues/september-10-2022/fda-approves-capmatinib-for-metastatic-nsclc-with-met-exon-14-skipping-mutations/ 2022-09-09T16:54:11+00:00 https://ascopost.com/issues/september-10-2022/thomas-j-herzog-md-to-serve-as-board-president-elect-of-the-gog-foundation-inc-for-gynecologic-malignancies/ 2022-09-09T14:47:17+00:00 https://ascopost.com/issues/september-10-2022/asco-updated-guideline-of-biomarkers-in-metastatic-breast-cancer-supports-pik3ca-brca12-pd-l1-testing/ 2022-09-09T14:47:19+00:00 https://ascopost.com/issues/september-10-2022/reconciliation-bill-focuses-on-health-care-provisions/ 2022-09-09T14:47:19+00:00 https://ascopost.com/issues/september-10-2022/neurosurgeon-ashish-shah-md-returns-to-sylvester-to-head-clinical-trials-and-translational-research-on-brain-tumors/ 2022-09-09T14:47:21+00:00 https://ascopost.com/issues/september-10-2022/iaslc-names-co-chairs-of-the-2023-world-conference-on-lung-cancer/ 2022-09-09T14:47:22+00:00 https://ascopost.com/issues/september-10-2022/association-of-community-cancer-centers-announces-2022-innovator-award-winner-ochsner-cancer-institute/ 2022-09-09T14:47:23+00:00 https://ascopost.com/issues/september-10-2022/allison-institute-announces-creation-of-scientific-advisory-board/ 2022-09-09T14:47:23+00:00 https://ascopost.com/issues/september-10-2022/study-shows-2-million-life-years-lost-and-21-billion-in-lost-earnings-annually-from-smoking-associated-cancer/ 2022-09-09T14:47:24+00:00 https://ascopost.com/issues/september-10-2022/how-eqrx-aims-to-reengineer-the-health-care-system-to-produce-more-effective-less-costly-cancer-drugs/ 2022-09-09T14:47:25+00:00 https://ascopost.com/issues/september-10-2022/eqrx-pricing-strategy-not-a-win-for-everyone-but-a-key-first-step-to-expand-access-to-cancer-care/ 2022-09-09T14:47:26+00:00 https://ascopost.com/issues/september-10-2022/bispecific-antibodies-and-the-dawn-of-a-new-era-in-treatment-of-multiple-myeloma/ 2022-10-31T17:33:24+00:00 https://ascopost.com/issues/september-10-2022/an-aggressive-type-of-non-hodgkin-lymphoma-threatened-my-life/ 2022-09-21T19:39:55+00:00 https://ascopost.com/issues/september-10-2022/brca-gene-testing-for-men-msk-launches-cancer-screening-clinic/ 2022-09-09T14:47:29+00:00 https://ascopost.com/issues/september-25-2022/ 2022-09-26T16:33:54+00:00 https://ascopost.com/issues/september-25-2022/nadim-trial-neoadjuvant-chemoimmunotherapy-improved-survival-in-resectable-stage-iiia-nsclc/ 2022-09-26T16:33:56+00:00 https://ascopost.com/issues/september-25-2022/epov-corinne-faivre-finn-and-masahiro-tsuboi/ 2022-09-26T16:33:57+00:00 https://ascopost.com/issues/september-25-2022/is-germline-testing-warranted-for-all-patients-with-lung-cancer/ 2022-09-26T16:33:58+00:00 https://ascopost.com/issues/september-25-2022/epov-kara-n-maxwell/ 2022-09-26T16:34:00+00:00 https://ascopost.com/issues/september-25-2022/what-the-supreme-court-s-abortion-decision-means-for-patients-with-cancer-and-their-clinicians/ 2022-09-26T16:34:01+00:00 https://ascopost.com/issues/september-25-2022/impower010-early-survival-data-favor-atezolizumab-over-best-supportive-care-in-resected-nsclc-with-pd-l1-expression-50/ 2022-09-26T16:34:03+00:00 https://ascopost.com/issues/september-25-2022/epov-benjamin-besse/ 2022-09-26T16:34:04+00:00 https://ascopost.com/issues/september-25-2022/nelson-vs-nlst-nodule-management-based-on-volumetry-shows-increased-benefits/ 2022-09-26T16:34:05+00:00 https://ascopost.com/issues/september-25-2022/epov-anand-devaraj/ 2022-09-26T16:34:06+00:00 https://ascopost.com/issues/september-25-2022/practice-changing-studies-important-new-data-and-more-clinical-oncology-news-from-esmo-2022-paris/ 2022-09-26T16:34:07+00:00 https://ascopost.com/issues/september-25-2022/capmatinib-for-metastatic-nsclc-with-met-exon-14-skipping-mutation/ 2022-09-26T16:34:09+00:00 https://ascopost.com/issues/september-25-2022/loic-le-marchand-awarded-2022-aacr-lectureship-on-science-of-cancer-health-disparities/ 2022-09-26T16:34:10+00:00 https://ascopost.com/issues/september-25-2022/trastuzumab-deruxtecan-for-advanced-her2-mutant-nsclc/ 2022-09-26T16:34:11+00:00 https://ascopost.com/issues/september-25-2022/patients-with-multiple-myeloma-may-face-car-t-cell-shortages/ 2022-09-26T16:34:12+00:00 https://ascopost.com/issues/september-25-2022/geriatric-oncology-and-hematology-in-singapore/ 2022-09-27T16:13:13+00:00 https://ascopost.com/issues/september-25-2022/chemoimmunotherapy-regimen-may-offer-survival-benefit-in-subgroups-of-metastatic-nsclc/ 2022-09-26T16:34:14+00:00 https://ascopost.com/issues/september-25-2022/axicabtagene-ciloleucel-improves-event-free-survival-vs-standard-care-in-second-line-treatment-for-large-b-cell-lymphoma/ 2022-10-19T19:46:30+00:00 https://ascopost.com/issues/september-25-2022/epov-chia-puey-ling/ 2022-09-26T16:34:16+00:00 https://ascopost.com/issues/september-25-2022/fda-approves-durvalumab-based-combination-for-locally-advanced-or-metastatic-biliary-tract-cancer/ 2022-09-26T16:34:17+00:00 https://ascopost.com/issues/september-25-2022/fda-approves-ibrutinib-for-pediatric-patients-with-chronic-graft-vs-host-disease/ 2022-09-26T16:34:18+00:00 https://ascopost.com/issues/september-25-2022/determining-prognosis-in-aggressive-lymphomas-integrating-liquid-biopsy-into-imaging-assessment/ 2022-10-13T18:04:46+00:00 https://ascopost.com/issues/september-25-2022/diversify-cancer-clinical-trials-with-new-recruitment-and-retention-resources/ 2022-09-26T16:34:21+00:00 https://ascopost.com/issues/september-25-2022/changing-the-algorithm-for-relapsed-or-refractory-large-b-cell-lymphomas/ 2022-10-19T20:10:12+00:00 https://ascopost.com/issues/september-25-2022/exercise-therapy-across-the-cancer-care-continuum/ 2022-09-26T16:34:22+00:00 https://ascopost.com/issues/september-25-2022/a-physicist-father-inspired-a-love-of-science-in-oncology-researcher-stanton-gerson/ 2022-09-27T13:18:19+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/ 2022-10-04T15:30:22+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/highlights-from-the-iaslc-2022-world-conference-on-lung-cancer/ 2022-10-04T15:30:22+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/impower010-early-survival-data-favor-atezolizumab-over-best-supportive-care-in-resected-nsclc-with-pd-l1-expression-50/ 2022-10-04T15:30:23+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/epov-benjamin-besse/ 2022-10-04T15:30:24+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/exploratory-analysis-of-poseidon-chemoimmunotherapy-regimen-may-offer-survival-benefit-in-subgroups-of-patients-with-metastatic-nsclc/ 2022-10-04T15:30:25+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/epov-chia-puey-ling/ 2022-10-04T15:30:26+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/nadim-ii-trial-neoadjuvant-chemoimmunotherapy-improved-survival-in-resectable-stage-iiia-nsclc/ 2022-10-04T15:30:27+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/epov-corinne-faivre-finn-and-masahiro-tsuboi/ 2022-10-04T15:30:28+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/dart-trial-concurrent-radiotherapy-plus-durvalumab-active-in-older-patients-with-locally-advanced-lung-cancer/ 2022-10-04T15:30:29+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/nelson-vs-nlst-nodule-management-based-on-volumetry-shows-increased-benefits/ 2022-10-04T15:30:30+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/epov-anand-devaraj/ 2022-10-04T15:30:32+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/national-lung-screening-trial-results-highlight-importance-of-lifelong-follow-up/ 2022-10-04T15:30:33+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/epov-anand-devaraj-1/ 2022-10-04T15:30:34+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/study-finds-high-intensity-intervention-helped-one-third-of-participants-in-lung-cancer-screening-program-to-quit-smoking/ 2022-10-04T15:30:35+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/epov-jacek-jassem/ 2022-10-04T15:30:36+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/real-world-evidence-confirms-survival-benefit-of-durvalumab-in-locally-advanced-non-small-cell-lung-cancer/ 2022-10-04T15:30:37+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/real-world-experience-with-durvalumab-at-the-mayo-clinic-mirrors-pacific-trial-findings/ 2022-10-04T15:30:38+00:00 https://ascopost.com/issues/october-10-2022-supplement-conference-highlights-iaslc-2022/iaslc-names-co-chairs-of-the-2023-world-conference-on-lung-cancer/ 2022-10-04T15:30:39+00:00 https://ascopost.com/issues/october-10-2022/ 2022-10-10T18:59:29+00:00 https://ascopost.com/issues/october-10-2022/sublobar-resection-for-small-early-stage-nsclc-establishing-a-new-standard-of-care/ 2022-10-21T18:05:52+00:00 https://ascopost.com/issues/october-10-2022/epov-hisashi-saji/ 2022-10-10T18:59:31+00:00 https://ascopost.com/issues/october-10-2022/cristina-r-ferrone-md-named-chair-of-cedars-sinai-department-of-surgery/ 2022-10-10T18:59:32+00:00 https://ascopost.com/issues/october-10-2022/reshma-jagsi-md-dphil-fasco-named-new-chair-of-emory-radiation-oncology/ 2022-10-10T18:59:33+00:00 https://ascopost.com/issues/october-10-2022/shaji-k-kumar-md-named-editor-in-chief-of-the-hematologist/ 2022-10-10T18:59:35+00:00 https://ascopost.com/issues/october-10-2022/scott-m-welford-phd-named-sylvester-s-tumor-biology-research-program-co-leader/ 2022-10-10T18:59:36+00:00 https://ascopost.com/issues/october-10-2022/massey-cancer-center-and-vcu-health-appoint-paula-m-fracasso-md-phd-facp-to-leadership-roles/ 2022-10-10T18:59:37+00:00 https://ascopost.com/issues/october-10-2022/stephen-a-strickland-jr-md-msci-joins-the-sarah-cannon-transplant-cellular-therapy-network/ 2022-10-10T18:59:38+00:00 https://ascopost.com/issues/october-10-2022/update-on-the-impact-of-the-russian-invasion-of-ukraine-on-patients-with-cancer/ 2022-10-10T18:59:39+00:00 https://ascopost.com/issues/october-10-2022/darolutamide-combined-with-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/ 2022-10-10T18:59:41+00:00 https://ascopost.com/issues/october-10-2022/the-development-of-geriatric-oncology-in-france-an-outside-view/ 2022-10-10T18:59:44+00:00 https://ascopost.com/issues/october-10-2022/the-development-of-geriatric-oncology-in-france-timeline/ 2022-10-10T18:59:45+00:00 https://ascopost.com/issues/october-10-2022/living-with-metastatic-breast-cancer/ 2022-10-10T18:59:46+00:00 https://ascopost.com/issues/october-10-2022/saul-a-rosenberg-md-fasco-a-pioneer-in-the-field-of-lymphoma-dies-at-95/ 2022-10-10T18:59:48+00:00 https://ascopost.com/issues/october-10-2022/swog-s1801-addition-of-neoadjuvant-pembrolizumab-to-adjuvant-pembrolizumab-yields-benefits-in-high-risk-resectable-melanoma/ 2022-10-27T19:57:22+00:00 https://ascopost.com/issues/october-10-2022/epov-alexander-eggermont-omid-hamid-james-larkin/ 2022-10-27T19:54:55+00:00 https://ascopost.com/issues/october-10-2022/cancer-and-fertility-preservation-will-new-laws-leave-patients-without-options/ 2022-10-10T18:59:52+00:00 https://ascopost.com/issues/october-10-2022/what-is-the-best-induction-regimen-for-newly-diagnosed-pcnsl/ 2022-10-11T20:37:51+00:00 https://ascopost.com/issues/october-10-2022/mechanism-linking-air-pollution-to-lung-cancer-identified/ 2022-10-10T18:59:56+00:00 https://ascopost.com/issues/october-10-2022/epov-suzette-delaloge/ 2022-10-10T18:59:57+00:00 https://ascopost.com/issues/october-10-2022/5-year-follow-up-supports-survival-benefit-of-pembrolizumab-plus-chemotherapy-in-squamous-and-nonsquamous-nsclc/ 2022-10-10T19:00:00+00:00 https://ascopost.com/issues/october-10-2022/epov-mary-obrien/ 2022-10-10T19:00:01+00:00 https://ascopost.com/issues/october-10-2022/tropics-02-sacituzumab-govitecan-improves-overall-survival-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-10-10T19:00:03+00:00 https://ascopost.com/issues/october-10-2022/epov-meritxell-bellet-ezquerra/ 2022-10-10T19:00:04+00:00 https://ascopost.com/issues/october-10-2022/first-line-maintenance-with-olaparib-improved-overall-survival-in-subsets-of-patients-with-advanced-ovarian-cancer-in-two-phase-iii-trials/ 2022-10-10T19:00:05+00:00 https://ascopost.com/issues/october-10-2022/epov-jonathan-ledermann/ 2022-10-10T19:00:07+00:00 https://ascopost.com/issues/october-10-2022/vanderbilt-university-medical-center-selects-new-director-of-the-division-of-infectious-diseases/ 2022-10-10T19:00:08+00:00 https://ascopost.com/issues/october-10-2022/managing-lymphomas-in-the-future-some-bright-spots-are-emerging/ 2022-10-10T19:00:09+00:00 https://ascopost.com/issues/october-10-2022/ibrutinib-for-pediatric-patients-with-chronic-graft-vs-host-disease/ 2022-10-10T19:00:11+00:00 https://ascopost.com/issues/october-10-2022/asco-and-the-african-organisation-for-research-and-training-in-cancer-announce-innovative-collaboration-to-advance-cancer-research-in-africa/ 2022-10-10T19:00:12+00:00 https://ascopost.com/issues/october-10-2022/cancer-care-and-reproductive-health-resources-for-the-oncology-community/ 2022-10-10T19:00:13+00:00 https://ascopost.com/issues/october-10-2022/asco-treatment-guidelines-for-her2-negative-metastatic-breast-cancer-updated-to-reflect-new-trastuzumab-deruxtecan-data/ 2022-10-10T19:00:14+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/ 2022-10-17T15:49:47+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/breast-cancer-2021-2022-almanac/ 2022-10-17T19:53:27+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/recent-fda-approvals-in-breast-cancer/ 2022-10-17T15:49:49+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/long-term-follow-up-of-monarche-benefit-of-abemaciclib-plus-endocrine-therapy-maintained-in-early-high-risk-breast-cancer/ 2022-10-17T15:49:50+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-aditya-bardia/ 2022-10-17T15:49:51+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/emerald-trial-oral-selective-estrogen-receptor-degrader-as-second-or-third-line-therapy-for-advanced-breast-cancer/ 2022-10-17T15:49:52+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/strides-are-being-made-in-the-treatment-of-brain-metastases-from-breast-cancer/ 2022-10-17T15:49:53+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/olympia-trial-adjuvant-olaparib-significantly-improves-overall-survival-in-germline-brca-mutated-breast-cancer/ 2022-10-17T15:49:54+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-mark-robson/ 2022-10-17T15:49:55+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/dual-checkpoint-inhibitor-therapy-elicits-responses-in-highly-mutated-breast-cancer/ 2022-10-17T15:49:56+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-angela-demichele/ 2022-10-17T15:49:57+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/pada-1-trial-with-early-identification-of-esr1-mutation-switch-to-fulvestrant-in-metastatic-breast-cancer/ 2022-10-17T15:49:58+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-amy-tiersten-and-carlos-l-arteaga/ 2022-10-17T15:49:59+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/begonia-trial-reports-activity-with-datopotamab-deruxtecan-plus-durvalumab-in-triple-negative-breast-cancer/ 2022-10-17T15:50:01+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-mafalda-oliveira-1/ 2022-10-17T15:50:02+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/addition-of-pembrolizumab-to-chemotherapy-improves-event-free-survival-in-triple-negative-breast-cancer/ 2022-10-17T15:50:03+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/datopotamab-deruxtecan-shows-activity-in-advanced-triple-negative-breast-cancer/ 2022-10-17T15:50:04+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-debu-tripathy-and-hope-rugo/ 2022-10-17T15:50:05+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/destiny-breast04-trial-t-dxd-significantly-improves-survival-in-patients-with-her2-low-metastatic-breast-cancer/ 2022-10-17T15:50:07+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-patricia-lorusso/ 2022-10-17T15:50:08+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/t-dxd-shows-efficacy-against-active-brain-metastases-in-her2-positive-breast-cancer/ 2022-10-17T15:50:09+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-mafalda-oliveira-2/ 2022-10-17T15:50:10+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/t-dxd-improves-progression-free-survival-vs-t-dm1-in-metastatic-her2-positive-breast-cancer/ 2022-10-17T15:50:12+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/no-overall-survival-benefit-reported-with-palbociclibletrozole-in-advanced-breast-cancer/ 2022-10-17T15:50:13+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/tropics-02-sacituzumab-govitecan-effective-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/ 2022-10-17T15:50:15+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-debu-tripathy/ 2022-10-17T15:50:17+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/monaleesa-3-ribociclib-plus-fulvestrant-improves-overall-survival-over-fulvestrant-alone-in-the-first-line-setting/ 2022-10-17T16:02:51+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-mafalda-oliveira/ 2022-10-17T15:50:19+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/monaleesa-analyses-show-widespread-benefit-for-ribociclib-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-10-17T15:50:21+00:00 https://ascopost.com/issues/october-10-2022-supplement-breast-cancer-almanac/epov-david-cescon/ 2022-10-17T15:50:22+00:00 https://ascopost.com/issues/october-25-2022/ 2022-10-25T18:27:01+00:00 https://ascopost.com/issues/october-25-2022/platinum-ineligible-patients-with-nsclc-may-gain-survival-benefit-from-atezolizumab-therapy/ 2022-11-17T22:17:20+00:00 https://ascopost.com/issues/october-25-2022/epov-natasha-leighl/ 2022-10-25T18:27:02+00:00 https://ascopost.com/issues/october-25-2022/why-are-young-adult-women-developing-later-stage-more-aggressive-breast-cancer-than-older-women/ 2022-11-01T19:52:38+00:00 https://ascopost.com/issues/october-25-2022/a-call-for-creativity-the-shades-of-gray-in-delivery-of-goal-concordant-care/ 2022-10-25T18:27:04+00:00 https://ascopost.com/issues/october-25-2022/unprecedented-waterfall-plot-achieved-with-neoadjuvant-immunotherapy-in-dmmr-colon-cancer/ 2022-10-25T18:27:05+00:00 https://ascopost.com/issues/october-25-2022/epov-james-larkin-and-andrea-cercek/ 2022-10-25T18:27:06+00:00 https://ascopost.com/issues/october-25-2022/cosmic-313-triplet-therapy-is-active-in-renal-cell-carcinoma-but-toxicities-pose-a-challenge/ 2022-11-08T20:06:10+00:00 https://ascopost.com/issues/october-25-2022/epov-sumanta-k-pal/ 2022-10-25T18:27:08+00:00 https://ascopost.com/issues/october-25-2022/negative-phase-iii-trials-may-dampen-enthusiasm-for-immunotherapy-in-the-adjuvant-setting-in-kidney-cancer/ 2022-11-08T20:08:15+00:00 https://ascopost.com/issues/october-25-2022/epov-bernard-escudier-and-brian-i-rini/ 2022-10-25T18:27:10+00:00 https://ascopost.com/issues/october-25-2022/novel-gamma-secretase-inhibitor-halts-progression-of-desmoid-tumors/ 2022-10-25T18:27:11+00:00 https://ascopost.com/issues/october-25-2022/epov-jean-yves-blay/ 2022-10-25T18:27:12+00:00 https://ascopost.com/issues/october-25-2022/duration-of-androgen-deprivation-therapy-with-radiotherapy-after-radical-prostatectomy/ 2022-10-25T18:27:13+00:00 https://ascopost.com/issues/october-25-2022/incarceration-may-be-associated-with-higher-cancer-mortality-yale-study-shows/ 2022-10-25T18:27:14+00:00 https://ascopost.com/issues/october-25-2022/richter-transformation-remains-challenging-but-better-treatments-are-on-the-horizon/ 2022-11-14T17:58:02+00:00 https://ascopost.com/issues/october-25-2022/high-intensity-intervention-helps-one-third-of-participants-in-lung-cancer-screening-program-quit-smoking/ 2022-10-25T18:27:16+00:00 https://ascopost.com/issues/october-25-2022/epov-jacek-jassem/ 2022-10-25T18:27:17+00:00 https://ascopost.com/issues/october-25-2022/real-world-experience-with-durvalumab-at-the-mayo-clinic-mirrors-pacific-findings/ 2022-10-25T18:27:19+00:00 https://ascopost.com/issues/october-25-2022/for-william-l-dahut-md-a-career-of-service-in-oncology/ 2022-10-27T16:36:41+00:00 https://ascopost.com/issues/october-25-2022/sio-asco-guideline-proposes-evidence-based-approaches-to-pain-management-incorporating-integrative-medicine-interventions/ 2022-10-25T18:27:21+00:00 https://ascopost.com/issues/october-25-2022/future-leaders-selected-to-advance-gender-equality-through-the-leadership-programme-for-women-in-oncology/ 2022-10-25T18:27:22+00:00 https://ascopost.com/issues/october-25-2022/asco-applauds-president-biden-s-leadership-in-relaunching-the-cancer-moonshot/ 2022-10-25T18:27:23+00:00 https://ascopost.com/issues/october-25-2022/elacestrant-improves-progression-free-survival-vs-standard-endocrine-therapy-in-previously-treated-estrogen-receptor-positive-her2-negative-advanced-breast-cancer/ 2022-10-25T18:27:24+00:00 https://ascopost.com/issues/october-25-2022/novel-selective-estrogen-receptor-degraders-in-advanced-breast-cancer-use-of-elacestrant-in-the-phase-iii-emerald-trial/ 2022-12-01T15:08:12+00:00 https://ascopost.com/issues/october-25-2022/providing-a-tailored-approach-to-prostate-cancer-care-for-gay-and-bisexual-men/ 2022-11-08T18:31:10+00:00 https://ascopost.com/issues/october-25-2022/yes-oklahoma-project-created-to-improve-representation-of-native-americans-in-cancer-research/ 2022-10-25T18:27:27+00:00 https://ascopost.com/issues/october-25-2022/clinical-and-translational-researcher-rossana-berardi-works-to-overcome-the-gender-gap-in-oncology-in-italy/ 2022-10-25T18:27:28+00:00 https://ascopost.com/issues/october-25-2022/a-urologic-surgeon-shares-his-insights-on-robotic-radical-prostatectomy/ 2022-11-08T18:36:19+00:00 https://ascopost.com/issues/october-25-2022/selpercatinib-approved-for-locally-advanced-or-metastatic-ret-fusion-positive-solid-tumors/ 2022-10-25T18:27:30+00:00 https://ascopost.com/issues/october-25-2022/incidence-and-cancer-related-mortality-in-austria/ 2022-10-25T18:30:40+00:00 https://ascopost.com/issues/october-25-2022/fda-approves-sodium-thiosulfate-to-reduce-the-risk-of-ototoxicity-associated-with-cisplatin/ 2022-10-25T18:27:31+00:00 https://ascopost.com/issues/october-25-2022/leader-in-genitourinary-oncology-nicholas-vogelzang-dies-at-72/ 2022-11-08T18:42:52+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/ 2022-11-03T13:44:38+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/highlights-from-the-esmo-congress-2022/ 2022-11-03T13:44:38+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/longer-term-follow-up-from-adaura-supports-adjuvant-osimertinib-as-standard-of-care-for-egfr-mutated-stage-ib-to-iiia-nsclc/ 2022-11-03T13:44:39+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-sanjay-popat/ 2022-11-03T13:44:40+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/sotorasib-a-new-standard-of-care-for-second-or-third-line-treatment-of-kras-g12c-mutated-nsclc/ 2022-11-03T13:44:42+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-natasha-leighl/ 2022-11-03T13:44:43+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/platinum-ineligible-patients-with-nsclc-may-gain-survival-benefit-from-atezolizumab-therapy/ 2022-11-03T13:44:44+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-natasha-leighl-1/ 2022-11-03T13:44:45+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/poseidon-follow-up-suggests-chemoimmunotherapy-triplet-extends-survival-in-difficult-to-treat-nsclc-mutational-subtypes/ 2022-11-03T13:44:46+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-mary-o-brien/ 2022-11-03T13:44:47+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/cosmic-313-triplet-therapy-is-active-in-renal-cell-carcinoma-but-toxicities-pose-a-challenge/ 2022-11-03T13:44:48+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-sumanta-k-pal/ 2022-11-03T13:44:49+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/duration-of-androgen-deprivation-therapy-with-radiotherapy-after-radical-prostatectomy/ 2022-11-03T13:44:51+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/negative-phase-iii-trials-may-dampen-enthusiasm-for-immunotherapy-in-the-adjuvant-setting-in-kidney-cancer/ 2022-11-03T13:44:52+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-bernard-escudier-and-brian-i-rini/ 2022-11-03T13:44:53+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/unprecedented-waterfall-plot-achieved-with-neoadjuvant-immunotherapy-in-dmmr-colon-cancer/ 2022-11-03T13:44:54+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-james-larkin-and-andrea-cercek/ 2022-11-03T13:44:55+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/lenvatinib-plus-pembrolizumab-in-hepatocellular-carcinoma-leap-002-fails-to-meet-co-primary-endpoints/ 2022-11-03T13:44:56+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-robin-kate-kelley/ 2022-11-03T13:44:57+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/swog-s1801-addition-of-neoadjuvant-pembrolizumab-to-adjuvant-pembrolizumab-yields-benefits-in-high-risk-resectable-melanoma/ 2022-11-03T13:44:58+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-alexander-eggermont-omid-hamid-james-larkin/ 2022-11-03T13:44:59+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/novel-gamma-secretase-inhibitor-halts-progression-of-desmoid-tumors/ 2022-11-03T13:45:00+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-jean-yves-blay/ 2022-11-03T13:45:01+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/pembrolizumab-plus-chemoradiation-therapy-falls-short-in-locally-advanced-head-and-neck-cancer/ 2026-01-29T03:30:56+00:00 https://ascopost.com/issues/november-10-2022-supplement-conference-highlights-esmo-2022/epov-glenn-j-hanna-and-sherene-loi/ 2022-11-03T13:45:03+00:00 https://ascopost.com/issues/november-10-2022/ 2022-11-10T21:02:51+00:00 https://ascopost.com/issues/november-10-2022/transforming-our-thinking-about-second-line-therapy-for-high-risk-large-b-cell-lymphoma-bring-in-the-cars/ 2022-11-10T21:02:52+00:00 https://ascopost.com/issues/november-10-2022/newly-diagnosed-aml-induction-to-maintenance/ 2022-11-10T21:02:53+00:00 https://ascopost.com/issues/november-10-2022/increased-mortality-from-comorbid-cancer-and-cardiovascular-disease-associated-with-increased-social-vulnerability/ 2022-11-10T21:02:54+00:00 https://ascopost.com/issues/november-10-2022/how-to-advance-antiracist-approaches-to-patient-engagement-in-aya-oncology-and-research/ 2022-11-10T21:02:55+00:00 https://ascopost.com/issues/november-10-2022/study-finds-nearly-half-of-black-women-with-metastatic-breast-cancer-never-receive-information-about-clinical-trial-participation/ 2022-12-05T18:38:36+00:00 https://ascopost.com/issues/november-10-2022/sotorasib-a-new-standard-of-care-for-second-or-third-line-treatment-of-kras-g12c-mutated-nsclc/ 2022-11-10T21:02:57+00:00 https://ascopost.com/issues/november-10-2022/epov-natasha-leighl/ 2022-11-10T21:02:59+00:00 https://ascopost.com/issues/november-10-2022/integrative-approaches-to-managing-pain-in-patients-with-cancer-sio-asco-guideline/ 2022-11-10T21:03:00+00:00 https://ascopost.com/issues/november-10-2022/international-career-joins-cancer-research-and-clinical-care-of-patients-with-lung-cancer/ 2022-11-10T21:03:02+00:00 https://ascopost.com/issues/november-10-2022/new-directions-for-cancer-care-major-trends-in-us-health-policy/ 2022-11-10T21:03:03+00:00 https://ascopost.com/issues/november-10-2022/pediatric-surgeon-henri-r-ford-md-chosen-new-president-elect-of-american-college-of-surgeons/ 2022-11-10T21:03:04+00:00 https://ascopost.com/issues/november-10-2022/high-dose-chemotherapy-and-stem-cell-transplant-vs-car-t-cell-therapy-for-resistant-dlbcl/ 2022-11-11T19:25:54+00:00 https://ascopost.com/issues/november-10-2022/lutetium-lu-177-vipivotide-tetraxetan-for-psma-positive-metastatic-castration-resistant-prostate-cancer/ 2022-11-10T21:03:07+00:00 https://ascopost.com/issues/november-10-2022/with-newer-therapies-aml-diagnosis-and-prognosis-evolve/ 2022-11-11T19:19:37+00:00 https://ascopost.com/issues/november-10-2022/nci-honors-augusto-ochoa-md-for-contributions-to-community-based-cancer-clinical-trials/ 2022-11-10T21:03:09+00:00 https://ascopost.com/issues/november-10-2022/the-evolving-role-of-pi3k-inhibitors-in-double-refractory-cll/ 2022-11-14T18:01:15+00:00 https://ascopost.com/issues/november-10-2022/global-effort-to-eliminate-cervical-cancer-hpv-vaccinations-are-steadily-increasing-in-the-united-states-but-barriers-still-exist/ 2022-11-10T21:03:11+00:00 https://ascopost.com/issues/november-10-2022/echelon-1-shows-benefit-for-first-line-brentuximab-vedotin-plus-avd-in-advanced-hodgkin-lymphoma/ 2022-11-11T19:23:30+00:00 https://ascopost.com/issues/november-10-2022/hpv-vaccine-works-astonishingly-well/ 2022-11-10T21:03:13+00:00 https://ascopost.com/issues/november-10-2022/multilayered-approach-to-financial-toxicity-solutions-for-patients-with-cancer-and-their-families/ 2022-11-10T21:03:14+00:00 https://ascopost.com/issues/november-10-2022/i-ve-had-two-primary-lung-cancers-and-they-haven-t-defeated-me/ 2022-11-10T21:03:15+00:00 https://ascopost.com/issues/november-10-2022/erica-huelsmann-md-wins-a-conquer-cancer-annual-meeting-merit-award/ 2022-11-15T19:00:51+00:00 https://ascopost.com/issues/november-10-2022/overall-survival-in-two-monarch-trials-of-abemaciclib-in-advanced-breast-cancer/ 2022-12-05T17:41:22+00:00 https://ascopost.com/issues/november-10-2022/national-lung-screening-trial-results-highlight-importance-of-lifelong-follow-up/ 2022-11-10T21:03:18+00:00 https://ascopost.com/issues/november-10-2022/epov-anand-devaraj-1/ 2022-11-10T21:03:19+00:00 https://ascopost.com/issues/november-10-2022/epov-meritxell-bellet-ezquerra-and/ 2022-11-10T21:03:20+00:00 https://ascopost.com/issues/november-10-2022/uchicago-medicine-names-new-associate-director-of-cancer-prevention-and-population-sciences/ 2022-11-10T21:03:21+00:00 https://ascopost.com/issues/november-10-2022/prolonging-remission-in-anti-pd-1-refractory-melanoma-with-tumor-infiltrating-lymphocyte-therapy/ 2022-11-10T21:03:22+00:00 https://ascopost.com/issues/november-10-2022/epov-ignacio-melero/ 2022-11-10T21:03:23+00:00 https://ascopost.com/issues/november-10-2022/lisocabtagene-maraleucel-improves-event-free-survival-in-second-line-treatment-of-relapsed-or-refractory-lbcl/ 2022-11-10T21:03:24+00:00 https://ascopost.com/issues/november-10-2022/asco-treatment-guidance-for-metastatic-castration-resistant-prostate-cancer-updated-to-include-lupsma/ 2022-11-10T21:03:25+00:00 https://ascopost.com/issues/november-10-2022/poseidon-follow-up-suggests-chemoimmunotherapy-triplet-extends-survival-in-difficult-to-treat-nsclc-mutational-subtypes/ 2022-11-10T21:03:26+00:00 https://ascopost.com/issues/november-10-2022/study-sheds-light-on-need-for-optimal-dosing-standards-for-patients-with-metastatic-cancer/ 2022-11-10T21:03:26+00:00 https://ascopost.com/issues/november-10-2022/tropics-02-efficacy-of-sacituzumab-govitecan-within-her2-negative-subsets-of-breast-cancer/ 2022-11-11T18:57:25+00:00 https://ascopost.com/issues/november-10-2022/asco-releases-updated-resource-stratified-guideline-for-the-secondary-prevention-of-cervical-cancer/ 2022-11-10T21:03:28+00:00 https://ascopost.com/issues/november-10-2022/epov-shom-goel/ 2022-11-10T21:03:29+00:00 https://ascopost.com/issues/november-10-2022/phase-iii-fresco-2-trial-of-fruquintinib-meets-primary-endpoint-in-metastatic-colorectal-cancer/ 2022-12-07T19:13:07+00:00 https://ascopost.com/issues/november-10-2022/swog-names-don-s-dizon-md-vice-chair-for-diversity-equity-inclusion-and-professional-integrity/ 2022-11-10T21:03:31+00:00 https://ascopost.com/issues/november-10-2022/eytan-stein-appointed-chief-of-the-leukemia-service-at-msk/ 2022-11-10T21:03:32+00:00 https://ascopost.com/issues/november-10-2022/yuan-yuan-joins-cedars-sinai-cancer-medical-center-as-director-of-breast-oncology/ 2022-11-10T21:03:33+00:00 https://ascopost.com/issues/november-10-2022/fda-approves-pemigatinib-for-patients-with-myeloidlymphoid-neoplasms-and-fgfr1-rearrangement/ 2022-11-10T21:03:34+00:00 https://ascopost.com/issues/november-10-2022/keynote-412-pembrolizumab-plus-chemoradiation-falls-short-in-locally-advanced-head-and-neck-cancer/ 2026-01-29T03:19:17+00:00 https://ascopost.com/issues/november-10-2022/fda-approves-selpercatinib-for-locally-advanced-or-metastatic-ret-fusion-positive-nsclc/ 2022-11-10T21:03:36+00:00 https://ascopost.com/issues/november-10-2022/fda-grants-accelerated-approval-to-futibatinib-for-previously-treated-patients-with-fgfr2-mutated-cholangiocarcinoma/ 2022-11-10T21:03:37+00:00 https://ascopost.com/issues/november-10-2022/epov-glenn-hanna-and-sherene-loi/ 2026-01-29T03:21:14+00:00 https://ascopost.com/issues/november-10-2022/lenvatinib-plus-pembrolizumab-in-hepatocellular-carcinoma-leap-002-fails-to-meet-co-primary-endpoints/ 2022-11-10T21:03:39+00:00 https://ascopost.com/issues/november-10-2022/epov-robin-kate-kelley/ 2022-11-10T21:03:40+00:00 https://ascopost.com/issues/november-10-2022/my-white-coat-doesn-t-fit/ 2022-11-10T21:10:41+00:00 https://ascopost.com/issues/november-25-2022/ 2022-11-23T17:26:58+00:00 https://ascopost.com/issues/november-25-2022/first-line-maintenance-therapy-with-olaparib-improved-outcomes-in-brca-mutated-hrd-positive-advanced-ovarian-cancer/ 2022-11-23T17:26:59+00:00 https://ascopost.com/issues/november-25-2022/epov-jonathan-ledermann/ 2022-11-23T17:27:00+00:00 https://ascopost.com/issues/november-25-2022/how-asco-is-helping-members-navigate-the-cancer-care-terrain-for-pregnant-patients-since-the-reversal-of-roe-v-wade/ 2022-11-23T17:27:01+00:00 https://ascopost.com/issues/november-25-2022/the-nordicc-trial-the-devil-is-in-the-details/ 2022-11-23T17:27:01+00:00 https://ascopost.com/issues/november-25-2022/short-course-of-radiotherapy-with-concurrent-radiation-boost-for-high-risk-early-stage-breast-cancer/ 2022-12-05T18:42:01+00:00 https://ascopost.com/issues/november-25-2022/pallas-trial-no-benefit-reported-for-adjuvant-palbociclib-in-stage-iia-hormone-receptor-positive-her2-negative-breast-cancer/ 2022-11-25T20:59:43+00:00 https://ascopost.com/issues/november-25-2022/epov-fabrice-andré/ 2022-11-23T17:27:04+00:00 https://ascopost.com/issues/november-25-2022/trastuzumab-deruxtecan-for-advanced-her2-low-breast-cancer/ 2022-11-23T17:27:05+00:00 https://ascopost.com/issues/november-25-2022/new-leadership-elected-to-the-american-society-of-hematology/ 2022-11-23T17:27:06+00:00 https://ascopost.com/issues/november-25-2022/building-a-new-normal-symptom-self-management-intervention-may-benefit-cancer-survivors/ 2022-11-23T17:27:07+00:00 https://ascopost.com/issues/november-25-2022/epov-manali-i-patel-md-mph-ms/ 2022-11-23T17:27:08+00:00 https://ascopost.com/issues/november-25-2022/chronic-myelomonocytic-leukemia-treatment-and-prognosis-part-1/ 2022-11-29T15:48:39+00:00 https://ascopost.com/issues/november-25-2022/longer-term-follow-up-from-adaura-supports-adjuvant-osimertinib-as-standard-of-care-for-egfr-mutated-stage-ib-to-iiia-nsclc/ 2022-11-23T17:27:10+00:00 https://ascopost.com/issues/november-25-2022/epov-sanjay-popat/ 2022-11-23T17:27:11+00:00 https://ascopost.com/issues/november-25-2022/asco-publishes-rapid-guideline-update-on-parp-inhibitors-in-ovarian-cancer/ 2022-11-23T17:27:12+00:00 https://ascopost.com/issues/november-25-2022/fda-grants-accelerated-approval-to-teclistamab-cqyv-for-resistant-myeloma/ 2022-11-23T17:27:13+00:00 https://ascopost.com/issues/november-25-2022/before-becoming-a-leader-in-multiple-myeloma-research-sarah-a-holstein-md-phd-considered-a-career-in-music/ 2022-11-23T17:27:13+00:00 https://ascopost.com/issues/november-25-2022/effect-of-invitation-to-colonoscopy-screening-on-risk-of-colorectal-cancer-and-risk-of-mortality-the-nordicc-trial/ 2022-11-23T17:27:14+00:00 https://ascopost.com/issues/november-25-2022/cs-pramesh-seeks-to-bring-equity-to-india-s-sprawling-cancer-care-system/ 2022-11-23T17:27:15+00:00 https://ascopost.com/issues/november-25-2022/annual-report-to-the-nation-cancer-deaths-continue-downward-trend/ 2022-11-23T17:27:16+00:00 https://ascopost.com/issues/november-25-2022/pharmacology-researcher-james-turkson-to-become-director-for-diversity-inclusion-and-strategy-at-cedars-sinai/ 2022-11-23T17:27:17+00:00 https://ascopost.com/issues/november-25-2022/report-on-brain-cancer-crisis-in-the-childhood-and-adolescent-cancer-community/ 2022-11-23T17:27:18+00:00 https://ascopost.com/issues/november-25-2022/a-laryngectomy-altered-how-i-see-myself-in-the-world/ 2026-01-29T03:14:09+00:00 https://ascopost.com/issues/november-25-2022/breast-cancer-advocate-and-chief-of-surgical-oncology-at-howard-university-lori-wilson-dies/ 2022-11-23T17:27:20+00:00 https://ascopost.com/issues/december-10-2022/ 2022-12-09T15:01:18+00:00 https://ascopost.com/issues/december-10-2022/5-weeks-of-radiation-therapy-may-be-equivalent-to-8-weeks-in-high-risk-prostate-cancer/ 2022-12-09T15:01:19+00:00 https://ascopost.com/issues/december-10-2022/epov-sophia-c-kamran/ 2022-12-09T15:01:20+00:00 https://ascopost.com/issues/december-10-2022/how-the-pancreatic-cancer-early-detection-consortium-aims-to-advance-survival-rates-in-this-deadly-disease/ 2022-12-09T15:01:21+00:00 https://ascopost.com/issues/december-10-2022/cancer-drugs-and-price-controls-is-it-time/ 2022-12-09T15:01:22+00:00 https://ascopost.com/issues/december-10-2022/radiotherapy-added-to-sorafenib-improves-survival-in-advanced-hepatocellular-carcinoma/ 2022-12-09T15:01:23+00:00 https://ascopost.com/issues/december-10-2022/randomized-phase-ii-trial-shows-benefits-of-prophylactic-radiation-therapy-for-asymptomatic-bone-metastases/ 2022-12-09T15:01:24+00:00 https://ascopost.com/issues/december-10-2022/epov-benjamin-movsas-md/ 2022-12-09T15:01:25+00:00 https://ascopost.com/issues/december-10-2022/sexual-side-effects-of-radiotherapy-for-genitourinary-cancers-is-physician-assessment-equitable-for-women-and-men/ 2022-12-09T15:01:26+00:00 https://ascopost.com/issues/december-10-2022/epov-iris-c-gibbs-and-sophia-c-kamran/ 2022-12-09T15:01:28+00:00 https://ascopost.com/issues/december-10-2022/astro-celebrates-contributions-to-radiation-oncology-with-2022-gold-medals-and-other-awards/ 2022-12-09T15:01:30+00:00 https://ascopost.com/issues/december-10-2022/silicone-film-dressing-may-reduce-acute-radiation-dermatitis-in-some-patients-with-breast-cancer/ 2022-12-09T15:01:31+00:00 https://ascopost.com/issues/december-10-2022/epov-jean-lundberg-wright-md/ 2022-12-09T15:01:32+00:00 https://ascopost.com/issues/december-10-2022/study-finds-use-of-remote-interventions-improved-adherence-to-cancer-screenings-among-women-living-in-rural-areas/ 2022-12-09T15:01:33+00:00 https://ascopost.com/issues/december-10-2022/patient-reported-outcomes-study-finds-severe-symptoms-in-meaningful-minority-of-patients-with-cancer/ 2022-12-09T15:01:35+00:00 https://ascopost.com/issues/december-10-2022/epov-therese-m-mulvey/ 2022-12-09T15:01:36+00:00 https://ascopost.com/issues/december-10-2022/capturing-tumor-evolution-with-serial-biopsies-may-guide-treatment-changes-to-benefit-patients-with-breast-cancer/ 2022-12-22T22:03:06+00:00 https://ascopost.com/issues/december-10-2022/selpercatinib-approved-for-advanced-ret-fusion-positive-solid-tumors-and-advanced-ret-fusion-positive-nsclc/ 2022-12-09T15:01:40+00:00 https://ascopost.com/issues/december-10-2022/phase-ii-trial-reports-high-response-rates-with-neoadjuvant-cemiplimab-in-cutaneous-squamous-cell-carcinoma/ 2022-12-09T15:01:41+00:00 https://ascopost.com/issues/december-10-2022/epov-christian-blank/ 2022-12-09T15:01:42+00:00 https://ascopost.com/issues/december-10-2022/addition-of-neoadjuvant-nivolumab-to-chemotherapy-improves-complete-pathologic-response-rate-and-event-free-survival-in-resectable-nsclc/ 2023-01-11T20:47:10+00:00 https://ascopost.com/issues/december-10-2022/study-finds-patritumab-deruxtecan-active-in-her3-expressing-metastatic-breast-cancer/ 2022-12-09T15:01:45+00:00 https://ascopost.com/issues/december-10-2022/epov-véronique-diéras-md/ 2022-12-09T15:01:47+00:00 https://ascopost.com/issues/december-10-2022/pembrolizumab-plus-chemotherapy-for-triple-negative-breast-cancer-clinical-implications-of-residual-cancer-burden/ 2022-12-09T15:01:48+00:00 https://ascopost.com/issues/december-10-2022/epov-erica-michelle-stringer-reasor/ 2022-12-09T15:01:49+00:00 https://ascopost.com/issues/december-10-2022/fda-approves-cemiplimab-rwlc-in-combination-with-platinum-based-chemotherapy-for-nsclc/ 2022-12-09T15:01:51+00:00 https://ascopost.com/issues/december-10-2022/how-low-dose-oral-minoxidil-is-providing-hope-for-patients-with-later-stage-alopecia/ 2022-12-09T15:01:52+00:00 https://ascopost.com/issues/december-10-2022/futibatinib-for-cholangiocarcinoma-with-fgfr2-gene-fusion-or-other-rearrangements/ 2022-12-09T15:01:53+00:00 https://ascopost.com/issues/december-10-2022/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer/ 2022-12-09T15:01:54+00:00 https://ascopost.com/issues/december-10-2022/asco-guideline-highlights-newest-breakthroughs-in-the-treatment-of-metastatic-colorectal-cancer/ 2023-01-06T18:12:28+00:00 https://ascopost.com/issues/december-10-2022/ama-house-of-delegates-approves-asco-backed-resolutions-on-fertility-preservation-american-manufactured-personal-protective-equipment-and-third-party-pharmacy-benefit-administrators/ 2022-12-09T15:01:57+00:00 https://ascopost.com/issues/december-10-2022/legal-and-ethical-use-of-complementary-and-alternative-medicine-interventions-in-oncology/ 2022-12-09T15:01:58+00:00 https://ascopost.com/issues/december-10-2022/fda-approves-oral-mek-inhibitor-cobimetinib-for-histiocytic-neoplasms/ 2022-12-09T15:01:59+00:00 https://ascopost.com/issues/december-10-2022/fda-grants-accelerated-approval-to-mirvetuximab-soravtansine-gynx-for-fr-positive-platinum-resistant-epithelial-ovarian-fallopian-tube-or-peritoneal-cancer/ 2022-12-09T15:02:00+00:00 https://ascopost.com/issues/december-10-2022/dabrafenib-in-combination-with-trametinib-for-unresectable-or-metastatic-solid-tumors-with-braf-v600e-mutation/ 2022-12-09T15:02:01+00:00 https://ascopost.com/issues/december-10-2022/michael-a-caligiuri-md-traveled-from-humble-beginnings-to-a-notable-career-as-an-oncology-leader/ 2022-12-09T15:02:02+00:00 https://ascopost.com/issues/december-10-2022/the-effect-of-the-reversal-of-roe-v-wade-on-care-of-pregnant-women-with-cancer/ 2022-12-09T15:02:03+00:00 https://ascopost.com/issues/december-10-2022/teclistamab-in-the-treatment-of-relapsed-or-refractory-multiple-myeloma/ 2022-12-09T15:02:04+00:00 https://ascopost.com/issues/december-10-2022/cemiplimabchemotherapy-combination-in-advanced-nsclc-with-no-egfr-alk-or-ros1-aberrations/ 2022-12-09T15:02:06+00:00 https://ascopost.com/issues/december-10-2022/national-academy-of-medicine-elects-100-new-members/ 2022-12-09T15:02:07+00:00 https://ascopost.com/issues/december-10-2022/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-bolivia/ 2022-12-09T15:02:08+00:00 https://ascopost.com/issues/december-10-2022/2022-society-for-integrative-oncology-annual-international-conference/ 2022-12-09T15:02:09+00:00 https://ascopost.com/issues/december-10-2022/world-travel-helped-brittany-l-bychkovsky-md-msc-shape-her-global-commitment-to-breast-cancer-care/ 2022-12-09T15:02:10+00:00 https://ascopost.com/issues/december-10-2022/heartbreak-and-a-second-chance-at-love-and-life/ 2022-12-09T15:02:11+00:00 https://ascopost.com/issues/december-10-2022/pregnancy-confers-dual-effect-on-breast-cancer-risk/ 2022-12-22T21:58:48+00:00 https://ascopost.com/issues/december-10-2022/education-and-diligence-required-to-confront-the-challenges-of-pregnancy-associated-breast-cancer/ 2022-12-09T15:02:14+00:00 https://ascopost.com/issues/december-10-2022/liquid-biopsies-may-identify-patients-with-cancer-at-higher-risk-of-developing-additional-blood-cancers/ 2022-12-09T15:02:15+00:00 https://ascopost.com/issues/december-10-2022/akt-inhibitor-shows-signs-of-activity-in-a-trial-matching-drugs-to-tumor-gene-mutations/ 2022-12-09T15:02:17+00:00 https://ascopost.com/issues/december-10-2022/experimental-drug-under-study-in-liver-cancer/ 2022-12-09T15:02:18+00:00 https://ascopost.com/issues/december-10-2022/i-have-the-brca2-gene-mutation-here-s-what-i-m-doing-to-prevent-cancer/ 2022-12-09T15:02:19+00:00 https://ascopost.com/issues/december-10-2022/putting-the-patient-at-the-center-the-career-of-jeffery-ward-md-fasco/ 2022-12-09T15:02:20+00:00 https://ascopost.com/issues/december-25-2022/ 2022-12-22T18:18:23+00:00 https://ascopost.com/issues/december-25-2022/brentuximab-vedotin-combined-with-chemotherapy-in-pediatric-classical-hodgkin-lymphoma/ 2022-12-22T18:18:24+00:00 https://ascopost.com/issues/december-25-2022/indiana-university-names-music-therapy-researcher-sheri-robb-phd-as-new-walther-professor-of-supportive-oncology/ 2022-12-22T18:18:25+00:00 https://ascopost.com/issues/december-25-2022/understanding-the-health-provisions-in-the-inflation-reduction-act-and-their-implications-for-oncology-care/ 2022-12-22T18:18:26+00:00 https://ascopost.com/issues/december-25-2022/alex-herrera-md-finds-a-path-from-the-baseball-fields-of-miami-to-a-leadership-role-at-city-of-hope/ 2022-12-22T18:18:27+00:00 https://ascopost.com/issues/december-25-2022/tremelimumab-combined-with-durvalumab-and-platinum-based-chemotherapy-in-metastatic-nsclc/ 2022-12-22T18:18:28+00:00 https://ascopost.com/issues/december-25-2022/from-immigrant-roots-to-a-budding-career-in-oncology-gladys-magaly-rodriguez-md-aims-to-advance-health-equity-in-vulnerable-populations/ 2022-12-22T18:18:29+00:00 https://ascopost.com/issues/december-25-2022/traditional-chinese-medicine-herbal-formula-shen-ling-bai-zhu-san-for-chronic-diarrhea/ 2022-12-22T18:18:29+00:00 https://ascopost.com/issues/december-25-2022/sidney-kimmel-cancer-center-establishes-geriatric-oncology-center-of-excellence-at-jefferson-health/ 2022-12-22T18:18:30+00:00 https://ascopost.com/issues/december-25-2022/a-serendipitous-ride-along-a-highway-may-have-saved-my-life/ 2022-12-22T18:18:31+00:00 https://ascopost.com/issues/december-25-2022/new-approaches-still-needed-to-treat-patients-with-cancer-who-have-serious-mental-illness/ 2022-12-22T18:18:32+00:00 https://ascopost.com/issues/december-25-2022/fox-chase-receives-6-million-grant-as-founding-member-of-new-nci-prevention-initiative/ 2022-12-22T18:18:33+00:00 https://ascopost.com/issues/december-25-2022/how-do-you-move-forward-with-a-life-you-didn-t-choose-after-a-cancer-diagnosis/ 2022-12-22T18:18:34+00:00 https://ascopost.com/issues/december-25-2022/cedars-sinai-cancer-leaders-assume-new-roles/ 2022-12-22T18:18:35+00:00 https://ascopost.com/issues/december-25-2022/ivosidenibazacitidine-for-newly-diagnosed-idh1-mutant-acute-myeloid-leukemia-in-patients-aged-75-or-older-or-with-comorbidities/ 2022-12-22T18:18:36+00:00 https://ascopost.com/issues/december-25-2022/md-anderson-and-who-establish-a-new-international-collaboration-to-reduce-the-global-burden-of-women-s-cancers/ 2022-12-22T18:18:37+00:00 https://ascopost.com/issues/december-25-2022/sodium-thiosulfate-to-reduce-the-risk-of-cisplatin-related-ototoxicity-in-pediatric-patients-with-localized-solid-tumors/ 2022-12-22T18:18:37+00:00 https://ascopost.com/issues/december-25-2022/2021-jadpro-article-of-the-year-award-spotlights-management-of-adverse-events-in-immunotherapy/ 2022-12-22T18:18:38+00:00 https://ascopost.com/issues/december-25-2022/2022-san-antonio-breast-cancer-symposium-award-recipients-announced/ 2022-12-22T18:18:39+00:00 https://ascopost.com/issues/december-25-2022/ribociclib-plus-endocrine-therapy-vs-combination-chemotherapy-for-patients-with-breast-cancer-focus-on-those-in-visceral-crisis/ 2023-01-05T16:26:58+00:00 https://ascopost.com/issues/december-25-2022/epov-aditya-bardia/ 2022-12-22T18:18:41+00:00 https://ascopost.com/issues/december-25-2022/how-the-american-cancer-society-aims-to-improve-outcomes-in-breast-and-cervical-cancers-and-reduce-health-disparities/ 2022-12-22T18:18:42+00:00 https://ascopost.com/issues/december-25-2022/how-telemedicine-can-transform-clinical-research-and-practice/ 2022-12-22T18:18:43+00:00 https://ascopost.com/issues/december-25-2022/t-dxd-confirmed-as-preferred-second-line-therapy-for-metastatic-her2-positive-breast-cancer/ 2022-12-22T18:18:45+00:00 https://ascopost.com/issues/december-25-2022/epov-neelima-vidula/ 2022-12-22T18:18:46+00:00 https://ascopost.com/issues/december-25-2022/research-exposes-inequities-in-health-care-access-and-delivery-for-blood-disorders/ 2022-12-22T18:18:47+00:00 https://ascopost.com/issues/december-25-2022/study-finds-lifileucel-active-in-advanced-melanoma-after-disease-progression-on-immune-checkpoint-inhibitors/ 2023-01-23T20:48:17+00:00 https://ascopost.com/issues/december-25-2022/epov-ryan-sullivan/ 2022-12-22T18:18:49+00:00 https://ascopost.com/issues/december-25-2022/from-the-clinic-to-the-lab-overcoming-resistance-to-immune-checkpoint-therapy/ 2022-12-22T18:18:50+00:00 https://ascopost.com/issues/december-25-2022/study-finds-microbiome-derived-vaccine-plus-nivolumab-and-bevacizumab-may-improve-outcomes-in-recurrent-glioblastoma/ 2022-12-22T18:18:51+00:00 https://ascopost.com/issues/december-25-2022/epov-rimas-lukas/ 2022-12-22T18:18:52+00:00 https://ascopost.com/issues/december-25-2022/risk-reducing-bilateral-mastectomy-may-help-women-with-high-penetrance-genetic-mutations-to-avoid-cancer/ 2022-12-22T21:56:22+00:00 https://ascopost.com/issues/december-25-2022/changing-landscape-in-the-management-of-high-risk-lesions-for-breast-cancer/ 2022-12-22T21:55:57+00:00 https://ascopost.com/issues/december-25-2022/world-cancer-research-fund-international-launches-new-flagship-research-program/ 2022-12-22T18:19:00+00:00 https://ascopost.com/issues/december-25-2022/how-asco-and-the-oncology-community-came-together-to-discuss-progress-in-global-cancer-control-and-the-challenges-ahead/ 2022-12-22T18:19:02+00:00 https://ascopost.com/issues/december-25-2022/managing-severe-diarrhea-in-patients-with-cancer/ 2022-12-22T18:19:03+00:00 https://ascopost.com/issues/december-25-2022/lung-cancer-screening-perceptions-of-patients-and-clinicians-the-power-of-shared-decision-making/ 2023-01-11T20:47:06+00:00 https://ascopost.com/issues/december-25-2022/epov-joelle-fathi/ 2022-12-22T18:19:05+00:00 https://ascopost.com/issues/december-25-2022/chronic-myelomonocytic-leukemia-treatment-and-prognosis-part-2/ 2022-12-22T18:19:06+00:00 https://ascopost.com/issues/december-25-2022/a-lifelong-love-of-science-leads-to-a-leadership-role-in-oncology-for-laurie-glimcher/ 2022-12-22T18:19:07+00:00 https://ascopost.com/issues/december-25-2022/eyal-gottlieb-to-join-md-anderson-as-vice-president-for-research/ 2022-12-22T18:19:08+00:00 https://ascopost.com/issues/december-25-2022/barbara-burtness-named-chief-translational-research-officer-for-yale-cancer-center-and-smilow-cancer-hospital/ 2022-12-22T18:19:09+00:00 https://ascopost.com/issues/december-25-2022/mirvetuximab-soravtansine-for-frɑ-positive-platinum-resistant-epithelial-ovarian-fallopian-tube-or-peritoneal-cancer/ 2022-12-22T18:19:10+00:00 https://ascopost.com/issues/december-25-2022/aacr-and-asco-release-joint-policy-statement-on-electronic-nicotine-delivery-systems/ 2022-12-22T21:41:56+00:00 https://ascopost.com/issues/december-25-2022/uniting-on-shared-priorities-to-improve-cancer-care-asco-and-eco-formalize-collaboration-with-a-memorandum-of-understanding/ 2022-12-22T21:43:41+00:00 https://ascopost.com/issues/december-25-2022/nearly-all-oncology-providers-report-prior-authorization-causing-delayed-care-other-patient-harms/ 2022-12-22T21:48:25+00:00 https://ascopost.com/issues/december-25-2022/updated-position-statement-on-drug-repository-programs-aims-to-increase-access-to-treatment/ 2022-12-22T21:52:39+00:00 https://ascopost.com/issues/january-25-2023/ 2023-01-25T21:04:25+00:00 https://ascopost.com/issues/january-25-2023/study-shows-activity-of-talquetamab-in-highly-refractory-multiple-myeloma/ 2023-02-23T18:55:45+00:00 https://ascopost.com/issues/january-25-2023/epov-ajay-k-nooka/ 2023-01-25T21:04:27+00:00 https://ascopost.com/issues/january-25-2023/study-reports-activity-with-oncolytic-vaccine-plus-pembrolizumab-in-bcg-unresponsive-bladder-cancer/ 2023-01-25T21:04:28+00:00 https://ascopost.com/issues/january-25-2023/addressing-the-continued-existence-of-racial-inequities-in-cancer-care/ 2023-01-25T21:04:30+00:00 https://ascopost.com/issues/january-25-2023/capivasertib-plus-fulvestrant-doubles-progression-free-survival-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/ 2023-01-25T21:04:31+00:00 https://ascopost.com/issues/january-25-2023/epov-virginia-kaklamani/ 2023-01-25T21:04:32+00:00 https://ascopost.com/issues/january-25-2023/neoadjuvant-t-dxd-demonstrates-activity-in-phase-ii-study-of-patients-with-her2-low-breast-cancer/ 2023-01-25T21:04:33+00:00 https://ascopost.com/issues/january-25-2023/epov-jason-aboudi-mouabbi/ 2023-01-25T21:04:34+00:00 https://ascopost.com/issues/january-25-2023/camizestrant-improves-progression-free-survival-in-advanced-breast-cancer/ 2023-01-25T21:04:35+00:00 https://ascopost.com/issues/january-25-2023/epov-carlos-l-arteaga-and-william-sikov/ 2023-01-25T21:04:36+00:00 https://ascopost.com/issues/january-25-2023/can-women-with-two-or-three-ipsilateral-breast-cancer-sites-safely-undergo-breast-conserving-therapy/ 2023-01-25T21:04:37+00:00 https://ascopost.com/issues/january-25-2023/can-younger-women-with-hormone-receptor-positive-breast-cancer-safely-pause-endocrine-therapy-to-pursue-pregnancy/ 2023-01-25T21:04:38+00:00 https://ascopost.com/issues/january-25-2023/epov-virginia-kaklamani-md/ 2023-01-25T21:04:39+00:00 https://ascopost.com/issues/january-25-2023/palbociclibfulvestrant-does-not-improve-progression-free-survival-after-progression-on-a-cdk46-inhibitor-in-metastatic-breast-cancer/ 2023-01-25T21:04:40+00:00 https://ascopost.com/issues/january-25-2023/epov-debu-tripathy/ 2023-01-25T21:04:41+00:00 https://ascopost.com/issues/january-25-2023/ash-2022-multiple-myeloma-highlights/ 2023-01-26T19:10:54+00:00 https://ascopost.com/issues/january-25-2023/cabozantinib-plus-atezolizumab-warrants-further-study-in-treatment-of-advanced-head-and-neck-cancer/ 2026-01-29T03:08:26+00:00 https://ascopost.com/issues/january-25-2023/epov-renata-ferrarotto/ 2023-01-25T21:04:44+00:00 https://ascopost.com/issues/january-25-2023/study-finds-immune-checkpoint-inhibitors-safe-and-effective-for-patients-living-with-hiv-who-have-nsclc/ 2023-01-25T21:04:45+00:00 https://ascopost.com/issues/january-25-2023/epov-neil-j-shah/ 2023-01-25T21:04:46+00:00 https://ascopost.com/issues/january-25-2023/studies-explore-novel-triplet-combinations-in-acute-myeloid-leukemia/ 2023-02-15T19:00:03+00:00 https://ascopost.com/issues/january-25-2023/epov-mikkael-sekeres/ 2023-01-25T21:04:48+00:00 https://ascopost.com/issues/january-25-2023/tremelimumab-actl-in-combination-with-durvalumab-for-unresectable-hepatocellular-carcinoma/ 2023-01-25T21:04:49+00:00 https://ascopost.com/issues/january-25-2023/ruxolitinib-demonstrates-clinical-activity-in-a-phase-ii-trial-of-chronic-myelomonocytic-leukemia/ 2023-01-25T21:04:50+00:00 https://ascopost.com/issues/january-25-2023/epov-mrinal-s-patnaik-mbbs/ 2023-01-25T21:04:51+00:00 https://ascopost.com/issues/january-25-2023/blinatumomab-improves-survival-in-mrd-negative-b-cell-acute-lymphoblastic-leukemia/ 2023-01-25T21:04:52+00:00 https://ascopost.com/issues/january-25-2023/epov-joseph-c-alvarnas/ 2023-01-25T21:04:53+00:00 https://ascopost.com/issues/january-25-2023/cll2-give-trial-regimen-of-obinutuzumab-ibrutinib-and-venetoclax-effective-in-high-risk-cll/ 2023-05-12T21:16:17+00:00 https://ascopost.com/issues/january-25-2023/epov-bita-fakhri/ 2023-01-25T21:04:55+00:00 https://ascopost.com/issues/january-25-2023/is-zanubrutinib-poised-to-become-a-new-standard-of-care-in-relapsed-or-refractory-cll-and-sll/ 2023-01-25T21:04:56+00:00 https://ascopost.com/issues/january-25-2023/epov-alexey-danilov/ 2023-01-25T21:04:57+00:00 https://ascopost.com/issues/january-25-2023/magnolia-trial-zanubrutinib-yields-high-response-rates-with-low-rate-of-cardiac-events-in-marginal-zone-lymphoma/ 2023-01-25T21:04:58+00:00 https://ascopost.com/issues/january-25-2023/epov-julio-chavez/ 2023-01-25T21:04:59+00:00 https://ascopost.com/issues/january-25-2023/many-survivors-of-childhood-hodgkin-lymphoma-show-signs-of-neurocognitive-impairment/ 2023-01-25T21:05:00+00:00 https://ascopost.com/issues/january-25-2023/epov-jane-n-winter-and-catherine-bollard/ 2023-01-25T21:05:01+00:00 https://ascopost.com/issues/january-25-2023/study-suggests-ibrutinib-may-obviate-need-for-autologous-stem-cell-transplantation-in-some-younger-patients-with-mantle-cell-lymphoma/ 2023-01-25T21:05:02+00:00 https://ascopost.com/issues/january-25-2023/epov-jeremy-s-abramson/ 2023-01-25T21:05:03+00:00 https://ascopost.com/issues/january-25-2023/olutasidenib-for-relapsed-or-refractory-acute-myeloid-leukemia-with-a-susceptible-idh1-mutation/ 2023-01-25T21:05:04+00:00 https://ascopost.com/issues/january-25-2023/yale-cancer-center-presents-2022-research-awards/ 2023-01-25T21:05:05+00:00 https://ascopost.com/issues/january-25-2023/anti-tigit-antibody-may-boost-the-benefit-of-immunotherapy-in-stage-iv-lung-cancer/ 2023-01-25T21:05:05+00:00 https://ascopost.com/issues/january-25-2023/epov-solange-peters/ 2023-01-25T21:05:06+00:00 https://ascopost.com/issues/january-25-2023/northwell-cancer-institute-welcomes-new-chief-of-hematologic-malignancies/ 2023-01-25T21:05:07+00:00 https://ascopost.com/issues/january-25-2023/asco-guideline-offers-recommendations-on-prescribing-opioids-to-patients-with-cancer/ 2023-01-25T21:05:08+00:00 https://ascopost.com/issues/january-25-2023/former-asco-president-monica-bertagnolli-welcomed-as-nci-director-in-capitol-hill-reception/ 2023-01-25T21:05:09+00:00 https://ascopost.com/issues/january-25-2023/robin-zon-elected-asco-president-for-2024-2025-term-other-leadership-positions-filled/ 2023-01-25T21:05:10+00:00 https://ascopost.com/issues/january-25-2023/study-explores-the-addition-of-first-line-atezolizumab-in-braf-v600-mutant-advanced-melanoma/ 2023-01-25T21:05:11+00:00 https://ascopost.com/issues/january-25-2023/risks-of-cardiovascular-and-immune-related-adverse-events-in-immune-checkpoint-inhibitor-therapy/ 2023-01-25T21:05:12+00:00 https://ascopost.com/issues/january-25-2023/cardiovascular-events-before-and-after-initiation-of-immune-checkpoint-inhibitor-therapy-for-cancer/ 2023-01-25T21:05:13+00:00 https://ascopost.com/issues/january-25-2023/significant-benefit-with-addition-of-daratumumab-to-bortezomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/ 2023-02-23T18:54:13+00:00 https://ascopost.com/issues/january-25-2023/first-adenoviral-vector-based-gene-therapy-for-high-risk-bcg-unresponsive-non-muscle-invasive-bladder-cancer/ 2023-01-25T21:05:15+00:00 https://ascopost.com/issues/january-25-2023/maureen-murphy-named-deputy-director-of-the-wistar-institute-ellen-and-ronald-caplan-cancer-center/ 2023-01-25T21:05:16+00:00 https://ascopost.com/issues/january-25-2023/epov-urvi-shah/ 2023-01-25T21:05:18+00:00 https://ascopost.com/issues/january-25-2023/a-serendipitous-opportunity-steers-a-theater-major-into-oncology/ 2023-01-25T21:05:19+00:00 https://ascopost.com/issues/january-25-2023/being-on-the-other-side-an-oncologist-s-perspective-on-grieving/ 2023-01-25T21:05:20+00:00 https://ascopost.com/issues/january-25-2023/phase-iii-nora-trial-niraparib-maintenance-shows-overall-survival-trend-in-platinum-sensitive-recurrent-ovarian-cancer/ 2023-01-25T21:05:21+00:00 https://ascopost.com/issues/january-25-2023/epov-antonio-gonzalez-martin/ 2023-01-25T21:05:22+00:00 https://ascopost.com/issues/january-25-2023/nrg-oncology-announces-leadership-of-new-dei-committee-and-new-vice-chair-for-ancillary-projects-committee/ 2023-01-25T21:05:23+00:00 https://ascopost.com/issues/january-25-2023/determining-the-role-of-muscadine-grape-skin-extract-in-treating-prostate-cancer/ 2023-01-25T21:05:24+00:00 https://ascopost.com/issues/january-25-2023/how-experts-treat-mantle-cell-lymphoma-in-first-complete-response/ 2023-01-31T18:38:44+00:00 https://ascopost.com/issues/january-25-2023/northwell-receives-gift-from-trustee-roy-zuckerberg-to-create-first-cancer-hospital-and-cancer-campus-on-long-island/ 2023-01-25T21:05:28+00:00 https://ascopost.com/issues/january-25-2023/the-influence-of-structural-racism-and-poverty-on-outcomes-in-leukemia/ 2023-01-25T21:05:29+00:00 https://ascopost.com/issues/january-25-2023/ku-medical-center-researchers-receive-r01-grant-from-nci-to-improve-access-to-targeted-cancer-treatments-for-rural-patients/ 2023-01-25T21:05:32+00:00 https://ascopost.com/issues/january-25-2023/andrea-schietinger-to-present-2023-aacr-irving-weinstein-foundation-distinguished-lecture/ 2023-01-25T21:05:33+00:00 https://ascopost.com/issues/january-25-2023/intensive-remission-induction-chemotherapy-vs-less-intensive-approach-prior-to-transplant-for-relapsedrefractory-aml/ 2023-02-15T16:25:26+00:00 https://ascopost.com/issues/january-25-2023/epov-jaime-suarez-londono/ 2023-01-25T21:05:35+00:00 https://ascopost.com/issues/january-25-2023/emerald-trial-elacestrant-vs-standard-endocrine-monotherapy-for-advanced-breast-cancer-after-cdk46-inhibition/ 2023-01-25T21:05:36+00:00 https://ascopost.com/issues/january-25-2023/epov-seth-wander/ 2023-01-25T21:05:36+00:00 https://ascopost.com/issues/january-25-2023/update-from-monarche-benefit-of-abemaciclib-increases-over-time-in-early-stage-breast-cancer/ 2023-01-25T21:05:37+00:00 https://ascopost.com/issues/january-25-2023/epov-nancy-chan/ 2023-01-25T21:05:38+00:00 https://ascopost.com/issues/january-25-2023/remembering-breast-cancer-pioneer-isaac-craig-henderson/ 2023-01-25T21:05:39+00:00 https://ascopost.com/issues/january-25-2023/inaugural-recipients-of-the-lubin-family-foundation-scholar-award-named/ 2023-01-25T21:05:40+00:00 https://ascopost.com/issues/january-25-2023/communicating-prognosis-a-core-competency-of-patient-centered-oncology-care/ 2023-01-25T21:05:41+00:00 https://ascopost.com/issues/january-25-2023/ensuring-a-more-diverse-equitable-and-inclusive-workforce-within-the-swog-cancer-research-network/ 2023-01-25T21:05:42+00:00 https://ascopost.com/issues/january-25-2023/atrium-health-and-wake-forest-university-school-of-medicine-cancer-program-appoint-new-director/ 2023-01-25T21:05:43+00:00 https://ascopost.com/issues/january-25-2023/undaunted/ 2023-01-25T21:05:44+00:00 https://ascopost.com/issues/january-25-2023/sotorasib-in-previously-treated-patients-with-kras-g12c-mutated-advanced-pancreatic-cancer/ 2023-10-12T16:05:10+00:00 https://ascopost.com/issues/january-25-2023/risk-factors-for-local-failure-after-chemoradiation-and-mri-guided-brachytherapy-for-locally-advanced-cervical-cancer/ 2023-01-25T21:13:14+00:00 https://ascopost.com/issues/january-25-2023/outcomes-in-infants-and-young-children-with-relapsed-medulloblastoma-after-initial-craniospinal-irradiation-sparing-curative-intent-treatment/ 2023-01-25T21:17:49+00:00 https://ascopost.com/issues/january-25-2023/pollux-trial-final-overall-survival-analysis-addition-of-daratumumab-to-lenalidomidedexamethasone-in-previously-treated-patients-with-multiple-myeloma/ 2023-01-25T21:20:19+00:00 https://ascopost.com/issues/february-10-2023/ 2023-02-10T16:46:43+00:00 https://ascopost.com/issues/february-10-2023/subset-of-patients-with-advanced-gastric-cancer-may-benefit-from-claudin182-targeted-agent-zolbetuximab/ 2023-02-13T14:30:21+00:00 https://ascopost.com/issues/february-10-2023/epov-david-wang/ 2023-02-13T14:30:53+00:00 https://ascopost.com/issues/february-10-2023/car-t-cell-therapy-vs-chemoimmunotherapy-in-second-line-treatment-of-resistant-large-b-cell-lymphoma/ 2023-02-27T21:17:21+00:00 https://ascopost.com/issues/february-10-2023/epov-catherine-s-diefenbach-md/ 2023-02-10T16:46:47+00:00 https://ascopost.com/issues/february-10-2023/influence-of-the-mark-cuban-effect-on-cancer-drug-prices-in-the-united-states-focus-on-cml/ 2023-02-15T18:25:17+00:00 https://ascopost.com/issues/february-10-2023/soft-analysis-breast-cancer-index-may-identify-which-patients-need-ovarian-suppression/ 2023-02-10T16:46:48+00:00 https://ascopost.com/issues/february-10-2023/epov-polly-niravath-and-virginia-kaklamani/ 2023-02-10T16:46:49+00:00 https://ascopost.com/issues/february-10-2023/despite-similar-recurrence-scores-breast-cancer-outcomes-differ-by-race/ 2023-02-10T16:46:50+00:00 https://ascopost.com/issues/february-10-2023/epov-virginia-kaklamani-lori-j-pierce-and-eric-winer/ 2023-02-10T16:46:51+00:00 https://ascopost.com/issues/february-10-2023/is-efficacy-of-sacituzumab-govitecan-hziy-in-the-tropics-02-trial-dependent-on-trop-2-expression/ 2023-02-10T16:46:52+00:00 https://ascopost.com/issues/february-10-2023/epov-maryam-b-lustberg/ 2023-02-10T16:46:53+00:00 https://ascopost.com/issues/february-10-2023/complete-response-to-glofitamab-at-end-of-treatment-heralds-prolonged-remission-in-lymphoma/ 2023-02-27T21:16:30+00:00 https://ascopost.com/issues/february-10-2023/new-leaders-named-for-the-university-of-arkansas-for-medical-sciences/ 2023-02-10T16:46:56+00:00 https://ascopost.com/issues/february-10-2023/quick-takes-on-important-cancer-research-from-ash-2022/ 2023-02-10T16:46:57+00:00 https://ascopost.com/issues/february-10-2023/mosunetuzumab-axgb-for-relapsed-or-refractory-follicular-lymphoma/ 2023-02-10T16:46:58+00:00 https://ascopost.com/issues/february-10-2023/asco-formalizes-free-membership-for-physicians-in-lower-middle-income-countries/ 2023-02-10T16:46:59+00:00 https://ascopost.com/issues/february-10-2023/asco-publishes-new-guideline-on-immunotherapy-biomarker-testing-in-advanced-head-and-neck-cancer/ 2026-01-29T03:02:00+00:00 https://ascopost.com/issues/february-10-2023/new-jco-oncology-practice-special-series-highlights-current-state-of-team-based-care-innovations-and-future-direction/ 2023-02-10T16:47:00+00:00 https://ascopost.com/issues/february-10-2023/adagrasib-with-or-without-cetuximab-in-previously-treated-patients-with-metastatic-colorectal-cancer-and-a-kras-g12c-mutation/ 2023-02-10T16:47:01+00:00 https://ascopost.com/issues/february-10-2023/krystal-1-confirms-activity-of-adagrasib-in-kras-g12c-mutated-metastatic-colorectal-cancer-and-highlights-need-for-randomized-controlled-trials/ 2023-03-02T22:11:44+00:00 https://ascopost.com/issues/february-10-2023/terry-hyslop-joins-skcc-as-cancer-risk-and-control-program-co-leader-and-center-for-health-equity-director/ 2023-02-10T16:47:03+00:00 https://ascopost.com/issues/february-10-2023/common-immune-related-adverse-events-spotlight-on-gastrointestinal-and-hepatic-toxicities/ 2023-02-10T17:29:18+00:00 https://ascopost.com/issues/february-10-2023/guillermina-lozano-receives-aamc-award-for-distinguished-research-in-the-biomedical-sciences/ 2023-02-10T16:47:05+00:00 https://ascopost.com/issues/february-10-2023/traveling-the-world-at-an-early-age-gave-perspective-and-balance-to-future-oncology-leader-derek-raghavan/ 2023-02-10T16:47:06+00:00 https://ascopost.com/issues/february-10-2023/lenvatinib-and-pembrolizumab-in-previously-treated-patients-with-advanced-endometrial-carcinoma/ 2023-02-10T16:47:07+00:00 https://ascopost.com/issues/february-10-2023/ibrutinib-in-the-first-line-treatment-of-chronic-gvhd/ 2023-02-10T16:47:08+00:00 https://ascopost.com/issues/february-10-2023/raised-in-africa-surgeon-kristin-flowers-continues-the-tradition-of-service-in-a-rural-hospital-in-alaska/ 2023-02-10T16:47:08+00:00 https://ascopost.com/issues/february-10-2023/the-beauty-and-the-beast-of-cancer/ 2023-02-10T16:47:09+00:00 https://ascopost.com/issues/february-10-2023/acupuncture-for-chemotherapy-induced-peripheral-neuropathy-health-related-quality-of-life-outcomes-from-a-randomized-clinical-trial/ 2023-02-10T16:47:10+00:00 https://ascopost.com/issues/february-10-2023/fda-oncology-center-of-excellence-seeks-applications-for-new-research-funding-opportunities/ 2023-02-10T16:47:11+00:00 https://ascopost.com/issues/february-10-2023/continued-declines-in-cancer-mortality-and-reductions-in-cervical-cancer-incidence-but-increases-in-advanced-prostate-cancer-and-persistent-racial-disparities/ 2023-02-10T16:47:12+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/ 2023-02-16T18:54:21+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/highlights-from-the-2022-ash-annual-meeting-and-exposition/ 2023-02-16T18:54:22+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/blinatumomab-improves-survival-in-mrd-negative-b-cell-acute-lymphoblastic-leukemia/ 2023-02-16T18:54:24+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-joseph-c-alvarnas/ 2023-02-16T18:54:25+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/studies-explore-novel-triplet-combinations-in-acute-myeloid-leukemia/ 2023-02-16T18:54:27+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-mikkael-sekeres/ 2023-02-16T18:54:29+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/ruxolitinib-demonstrates-clinical-activity-in-a-phase-ii-trial-of-chronic-myelomonocytic-leukemia/ 2023-02-16T18:54:30+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-mrinal-s-patnaik-mbbs/ 2023-02-16T18:54:31+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/is-zanubrutinib-poised-to-become-a-new-standard-of-care-in-relapsed-or-refractory-cll-and-sll/ 2023-02-16T18:54:32+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-alexey-danilov/ 2023-02-16T18:54:33+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/magnolia-trial-zanubrutinib-yields-high-response-rates-with-low-rate-of-cardiac-events-in-marginal-zone-lymphoma/ 2023-02-16T18:54:34+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-julio-chavez/ 2023-02-16T18:54:35+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/addition-of-venetoclax-to-intensive-chemotherapy-yields-durable-responses-in-younger-patients-with-high-risk-aml/ 2023-02-16T18:54:36+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/car-t-cell-therapy-vs-chemoimmunotherapy-in-second-line-treatment-of-resistant-large-b-cell-lymphoma/ 2023-02-16T18:54:37+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-catherine-s-diefenbach-md/ 2023-02-16T18:54:39+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-amir-t-fathi/ 2023-02-16T18:54:40+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/many-survivors-of-childhood-hodgkin-lymphoma-show-signs-of-neurocognitive-impairment/ 2023-02-16T18:54:41+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-jane-n-winter-and-catherine-bollard/ 2023-02-16T18:54:41+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/ponatinib-and-blinatumomab-combination-safe-and-effective-in-patients-with-newly-diagnosed-ph-positive-all/ 2023-02-16T18:54:42+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-emily-k-curran/ 2023-02-16T18:54:43+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/cll2-give-trial-regimen-of-obinutuzumab-ibrutinib-and-venetoclax-effective-in-high-risk-cll/ 2023-05-12T21:20:27+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/study-suggests-ibrutinib-may-obviate-need-for-autologous-stem-cell-transplantation-in-some-younger-patients-with-mantle-cell-lymphoma/ 2023-02-16T18:54:45+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-bita-fakhri/ 2023-02-16T18:54:46+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-jeremy-s-abramson/ 2023-02-16T18:54:47+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/complete-response-to-glofitamab-at-end-of-treatment-heralds-prolonged-remission-in-lymphoma/ 2023-02-16T18:54:48+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-julio-c-chavez/ 2023-02-16T18:54:49+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/elranatamab-induces-responses-in-many-patients-with-resistant-multiple-myeloma-in-phase-ii-trial/ 2023-02-16T18:54:50+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-urvi-shah/ 2023-02-16T18:54:51+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/study-shows-activity-of-talquetamab-in-highly-refractory-multiple-myeloma/ 2023-02-16T18:54:52+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/epov-ajay-k-nooka/ 2023-02-16T18:54:53+00:00 https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/robert-brodsky-begins-term-as-2023-ash-president/ 2023-02-16T18:54:54+00:00 https://ascopost.com/issues/february-25-2023/ 2023-02-24T18:24:54+00:00 https://ascopost.com/issues/february-25-2023/yale-study-indicates-older-patients-are-excluded-from-progress-against-lung-cancer/ 2023-04-12T20:09:06+00:00 https://ascopost.com/issues/february-25-2023/updated-results-from-the-adaura-trial-continued-disease-free-survival-benefit-with-adjuvant-osimertinib-vs-placebo-in-egfr-mutated-stage-ib-iiia-nsclc/ 2023-02-24T18:24:56+00:00 https://ascopost.com/issues/february-25-2023/grateful-to-be-alive/ 2023-02-27T18:15:27+00:00 https://ascopost.com/issues/february-25-2023/fda-approves-sacituzumab-govitecan-hziy-for-pretreated-patients-with-hr-positive-her2-negative-breast-cancer/ 2023-03-01T22:28:54+00:00 https://ascopost.com/issues/february-25-2023/fda-grants-accelerated-approval-to-pirtobrutinib-for-relapsed-or-refractory-mantle-cell-lymphoma/ 2023-02-24T18:24:59+00:00 https://ascopost.com/issues/february-25-2023/fda-approves-elacestrant-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer/ 2023-12-27T17:13:07+00:00 https://ascopost.com/issues/february-25-2023/president-biden-announces-key-appointments-to-national-cancer-advisory-board/ 2023-02-24T18:25:01+00:00 https://ascopost.com/issues/february-25-2023/addition-of-bevacizumab-to-trifluridinetipiracil-new-standard-of-care-in-refractory-colorectal-cancer/ 2023-03-02T22:12:49+00:00 https://ascopost.com/issues/february-25-2023/epov-dustin-deming/ 2023-02-24T18:25:05+00:00 https://ascopost.com/issues/february-25-2023/understanding-the-health-disparities-that-sexual-and-gender-minorities-face-in-oncology-care/ 2023-02-24T18:25:08+00:00 https://ascopost.com/issues/february-25-2023/recommendations-for-promoting-sexual-and-gender-minority-inclusion-in-oncology-care/ 2023-02-24T18:25:12+00:00 https://ascopost.com/issues/february-25-2023/have-we-reached-the-limits-of-chemotherapy-for-burkitt-lymphoma/ 2023-03-06T19:25:10+00:00 https://ascopost.com/issues/february-25-2023/first-line-nalirifox-improves-survival-in-metastatic-pancreatic-cancer/ 2023-02-24T18:55:45+00:00 https://ascopost.com/issues/february-25-2023/epov-laura-goff/ 2023-02-24T18:25:16+00:00 https://ascopost.com/issues/february-25-2023/what-can-be-learned-from-negative-findings-of-two-trials-in-biliary-tract-cancer/ 2023-02-24T18:25:16+00:00 https://ascopost.com/issues/february-25-2023/epov-imane-el-dika/ 2023-02-24T18:25:18+00:00 https://ascopost.com/issues/february-25-2023/neo-aegis-trial-finds-two-approaches-comparable-in-treating-advanced-esophageal-cancer/ 2023-03-20T16:30:11+00:00 https://ascopost.com/issues/february-25-2023/epov-pretesh-patel/ 2023-02-24T18:25:22+00:00 https://ascopost.com/issues/february-25-2023/intrigue-study-circulating-tumor-dna-analysis-may-predict-optimal-treatment-of-patients-with-gist/ 2023-02-28T21:25:27+00:00 https://ascopost.com/issues/february-25-2023/epov-breelyn-wilky/ 2023-02-24T18:25:25+00:00 https://ascopost.com/issues/february-25-2023/neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-carboplatin-adds-benefit-new-study-shows/ 2023-02-24T18:25:26+00:00 https://ascopost.com/issues/february-25-2023/epov-adam-brufsky/ 2023-02-24T18:25:27+00:00 https://ascopost.com/issues/february-25-2023/challenges-of-accurately-identifying-her2-low-breast-cancers/ 2023-02-24T18:25:28+00:00 https://ascopost.com/issues/february-25-2023/asco-endorses-cap-guideline-to-better-define-who-benefits-from-immune-checkpoint-inhibitor-therapy/ 2023-02-24T18:25:30+00:00 https://ascopost.com/issues/february-25-2023/asco-updates-living-guidelines-on-stage-iv-nsclc-based-on-destiny-lung01-codebreak100-other-trials/ 2023-02-24T18:25:31+00:00 https://ascopost.com/issues/february-25-2023/urologic-oncologist-hyung-kim-named-chair-of-cedars-sinai-department-of-urology/ 2023-02-24T18:25:32+00:00 https://ascopost.com/issues/february-25-2023/zanubrutinib-for-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma/ 2023-02-24T18:25:33+00:00 https://ascopost.com/issues/march-10-2023/ 2023-03-10T17:43:45+00:00 https://ascopost.com/issues/march-10-2023/rucaparib-extends-progression-free-survival-in-selected-patients-with-metastatic-castration-resistant-prostate-cancer/ 2023-03-10T17:43:45+00:00 https://ascopost.com/issues/march-10-2023/epov-elena-castro/ 2023-03-10T17:43:47+00:00 https://ascopost.com/issues/march-10-2023/understanding-the-link-between-prognostic-perception-and-patient-oncologist-prognostic-discordance-in-the-advanced-cancer-setting/ 2023-03-10T17:43:48+00:00 https://ascopost.com/issues/march-10-2023/improving-physician-patient-communication/ 2023-03-10T17:43:49+00:00 https://ascopost.com/issues/march-10-2023/working-together-to-close-the-global-care-gap/ 2023-03-21T17:11:43+00:00 https://ascopost.com/issues/march-10-2023/extended-follow-up-supports-first-line-use-of-nivolumab-plus-cabozantinib-in-advanced-renal-cell-carcinoma/ 2023-03-16T22:02:47+00:00 https://ascopost.com/issues/march-10-2023/phase-iii-trials-confirm-benefit-of-first-line-anti-pd-1-plus-chemotherapy-in-gastric-cancer/ 2023-03-20T16:28:33+00:00 https://ascopost.com/issues/march-10-2023/epov-david-wang/ 2023-03-10T17:43:56+00:00 https://ascopost.com/issues/march-10-2023/novel-immunotherapy-combination-shows-activity-in-microsatellite-stable-metastatic-colorectal-cancer/ 2023-04-07T16:42:38+00:00 https://ascopost.com/issues/march-10-2023/epov-aparna-r-parikh/ 2023-03-10T17:43:58+00:00 https://ascopost.com/issues/march-10-2023/abstracts-of-interest-on-novel-therapies-for-gastrointestinal-cancers/ 2023-03-10T17:43:58+00:00 https://ascopost.com/issues/march-10-2023/studies-focusing-on-age-and-race-related-disparities-in-multiple-myeloma-and-sickle-cell-disease/ 2023-03-23T17:30:23+00:00 https://ascopost.com/issues/march-10-2023/elacestrant-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer/ 2023-03-10T17:44:01+00:00 https://ascopost.com/issues/march-10-2023/best-of-sabcs-top-7-picks-from-the-2022-meeting-by-jame-abraham-md-facp/ 2023-03-10T17:44:01+00:00 https://ascopost.com/issues/march-10-2023/sacituzumab-govitecan-hziy-in-hr-positive-her2-negative-advanced-or-metastatic-breast-cancer/ 2023-03-10T17:44:02+00:00 https://ascopost.com/issues/march-10-2023/highlights-of-the-2022-annual-conference-of-the-international-society-of-geriatric-oncology/ 2023-03-10T17:44:03+00:00 https://ascopost.com/issues/march-10-2023/neighborhood-social-vulnerability-and-its-influence-on-the-availability-of-clinical-trials-in-multiple-myeloma/ 2023-03-10T17:44:06+00:00 https://ascopost.com/issues/march-10-2023/pilot-program-shows-diversity-focused-clinical-trial-tools-are-useful-at-cancer-research-sites/ 2023-03-10T17:44:07+00:00 https://ascopost.com/issues/march-10-2023/oncologists-applaud-state-of-the-union-s-focus-on-ending-cancer-as-we-know-it/ 2023-03-10T17:44:08+00:00 https://ascopost.com/issues/march-10-2023/first-asco-guideline-for-immunotherapy-and-targeted-therapy-in-advanced-gastroesophageal-cancer-now-available/ 2023-03-14T16:49:23+00:00 https://ascopost.com/issues/march-10-2023/phallcon-study-ponatinib-superior-to-imatinib-in-combination-with-chemotherapy-in-newly-diagnosed-ph-positive-all/ 2023-03-10T17:44:10+00:00 https://ascopost.com/issues/march-10-2023/epov-anjali-advani/ 2023-03-10T17:44:12+00:00 https://ascopost.com/issues/march-10-2023/four-leading-upmcpitt-scientists-receive-funding-for-research-in-breast-cancer/ 2023-03-10T17:44:13+00:00 https://ascopost.com/issues/march-10-2023/unique-challenges-of-cancer-care-in-india/ 2023-03-10T17:44:14+00:00 https://ascopost.com/issues/march-10-2023/triplet-and-quadruplet-regimens-in-smoldering-multiple-myeloma/ 2023-03-10T17:44:18+00:00 https://ascopost.com/issues/march-10-2023/epov-robert-rifkin/ 2023-03-10T17:44:19+00:00 https://ascopost.com/issues/march-10-2023/ponatinib-and-blinatumomab-combination-safe-and-effective-in-patients-with-newly-diagnosed-ph-positive-all/ 2023-03-10T17:44:20+00:00 https://ascopost.com/issues/march-10-2023/epov-emily-k-curran/ 2023-03-10T17:44:21+00:00 https://ascopost.com/issues/march-10-2023/tucatinib-with-trastuzumab-in-previously-treated-ras-wild-type-her2-positive-advanced-colorectal-cancer/ 2023-03-10T17:44:21+00:00 https://ascopost.com/issues/march-10-2023/mirvetuximab-soravtansine-active-in-platinum-resistant-ovarian-cancer-with-high-fra-expression/ 2023-03-10T17:44:22+00:00 https://ascopost.com/issues/march-10-2023/how-patient-navigation-programs-are-helping-drive-equitable-care-for-patients-with-cancer-and-improve-outcomes/ 2023-03-10T17:44:23+00:00 https://ascopost.com/issues/march-10-2023/vanessa-sheppard-named-american-cancer-society-researcher-of-the-year/ 2023-03-10T17:44:24+00:00 https://ascopost.com/issues/march-10-2023/novel-herbal-oncology-program-for-management-of-cancer-symptoms-at-an-nci-designated-cancer-center/ 2023-03-10T17:44:25+00:00 https://ascopost.com/issues/march-10-2023/addition-of-avelumab-to-carboplatinpaclitaxel-in-first-line-treatment-of-advanced-or-recurrent-endometrial-cancer/ 2023-03-10T17:44:26+00:00 https://ascopost.com/issues/march-10-2023/encorafenib-binimetinib-and-cetuximab-in-previously-untreated-patients-with-braf-v600e-mutant-metastatic-colorectal-cancer/ 2023-03-10T17:44:27+00:00 https://ascopost.com/issues/march-10-2023/camrelizumabapatinib-in-recurrent-or-metastatic-nasopharyngeal-carcinoma/ 2026-01-29T02:54:52+00:00 https://ascopost.com/issues/march-10-2023/brexucabtagene-autoleucel-in-relapsed-or-refractory-mantle-cell-lymphoma-in-standard-of-care-practice/ 2023-03-10T17:44:29+00:00 https://ascopost.com/issues/march-10-2023/cancer-mortality-decreased-in-newest-data-reported-by-the-american-cancer-society/ 2023-03-10T17:44:30+00:00 https://ascopost.com/issues/march-10-2023/dont-blame-the-test/ 2023-03-10T17:44:31+00:00 https://ascopost.com/issues/march-10-2023/i-m-doing-my-part-to-erase-the-stigma-surrounding-lung-cancer/ 2023-03-10T17:44:31+00:00 https://ascopost.com/issues/march-10-2023/miguel-angel-perales-named-2023-2024-president-of-astct/ 2023-03-10T17:44:33+00:00 https://ascopost.com/issues/march-25-2023/ 2023-03-24T17:08:20+00:00 https://ascopost.com/issues/march-25-2023/walks-on-a-beach-with-an-inspiring-grandfather-led-to-a-career-in-cancer-research-and-drug-development-for-vivek-subbiah-md/ 2023-03-24T17:08:21+00:00 https://ascopost.com/issues/march-25-2023/zanubrutinib-improves-progression-free-survival-vs-ibrutinib-in-relapsed-or-refractory-cll-or-sll/ 2023-03-24T17:08:22+00:00 https://ascopost.com/issues/march-25-2023/a-pioneering-oncologist-a-pilot-and-a-choral-singer-among-other-things/ 2023-03-24T19:29:29+00:00 https://ascopost.com/issues/march-25-2023/cleveland-clinic-opens-new-cancer-center-in-abu-dhabi/ 2023-03-24T17:08:23+00:00 https://ascopost.com/issues/march-25-2023/rangaswamy-govindarajan-md-named-chief-of-uams-hematology-and-oncology-division/ 2023-03-24T17:08:24+00:00 https://ascopost.com/issues/march-25-2023/three-md-anderson-researchers-elected-aaas-fellows/ 2023-03-24T17:08:25+00:00 https://ascopost.com/issues/march-25-2023/northwell-health-names-richard-d-carvajal-md-to-lead-medical-oncology-programs/ 2023-03-24T17:08:26+00:00 https://ascopost.com/issues/march-25-2023/early-exposure-to-health-care-inequities-sets-the-stage-for-a-leadership-role-in-global-oncology-for-satish-gopal-md-mph/ 2023-03-24T17:08:27+00:00 https://ascopost.com/issues/march-25-2023/accc-releases-advocacy-agenda-at-49th-annual-meeting-cancer-center-business-summit/ 2023-03-24T17:08:28+00:00 https://ascopost.com/issues/march-25-2023/adjuvant-accelerated-partial-breast-irradiation-vs-whole-breast-irradiation-in-early-breast-cancer-10-year-outcomes-of-phase-iii-study/ 2023-03-24T17:08:29+00:00 https://ascopost.com/issues/march-25-2023/the-will-to-go-on/ 2023-03-24T17:08:30+00:00 https://ascopost.com/issues/march-25-2023/carl-h-june-md-faacr-to-be-honored-with-2023-aacr-award-for-lifetime-achievement-in-cancer-research/ 2023-03-24T17:08:31+00:00 https://ascopost.com/issues/march-25-2023/use-of-low-dose-naltrexone/ 2023-03-24T17:08:32+00:00 https://ascopost.com/issues/march-25-2023/i-haven-t-known-a-life-without-von-hippel-lindau-disease/ 2023-03-24T17:08:32+00:00 https://ascopost.com/issues/march-25-2023/first-line-pembrolizumab-in-older-patients-with-dmmr-metastatic-colorectal-cancer/ 2023-03-24T17:08:33+00:00 https://ascopost.com/issues/march-25-2023/savolitinib-and-durvalumab-in-metastatic-papillary-renal-cancer/ 2023-03-24T17:08:34+00:00 https://ascopost.com/issues/march-25-2023/axicabtagene-ciloleucel-in-refractory-large-b-cell-lymphoma-5-year-results-of-the-zuma-1-trial/ 2023-03-24T17:08:35+00:00 https://ascopost.com/issues/march-25-2023/neoadjuvant-plus-adjuvant-vs-adjuvant-pembrolizumab-in-advanced-melanoma/ 2023-03-24T17:08:36+00:00 https://ascopost.com/issues/march-25-2023/dinutuximab-beta-and-interleukin-2-after-haploidentical-stem-cell-transplantation-in-patients-with-relapsed-neuroblastoma/ 2023-03-24T17:08:37+00:00 https://ascopost.com/issues/march-25-2023/michael-taylor-md-phd-appointed-director-at-texas-children-s-hospital-and-baylor-college-of-medicine/ 2023-03-24T17:08:38+00:00 https://ascopost.com/issues/march-25-2023/talapro-2-talazoparib-plus-enzalutamide-extends-radiographic-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer/ 2023-03-24T17:08:39+00:00 https://ascopost.com/issues/march-25-2023/epov-elena-castro/ 2023-03-24T17:08:40+00:00 https://ascopost.com/issues/march-25-2023/colorectal-cancer-rates-are-rising-in-younger-adults-shifting-to-more-advanced-disease-across-all-ages/ 2023-03-24T17:08:40+00:00 https://ascopost.com/issues/march-25-2023/formula-509-intensified-postoperative-regimen-may-be-of-benefit-in-subset-of-high-risk-prostate-cancer/ 2023-03-24T17:08:41+00:00 https://ascopost.com/issues/march-25-2023/epov-tyler-seibert/ 2023-03-24T17:08:42+00:00 https://ascopost.com/issues/march-25-2023/continued-disease-free-survival-benefits-with-adjuvant-nivolumab-in-high-risk-urothelial-carcinoma/ 2023-08-15T15:31:47+00:00 https://ascopost.com/issues/march-25-2023/epov-michiel-s-van-der-heijden/ 2023-03-24T17:08:44+00:00 https://ascopost.com/issues/march-25-2023/sacituzumab-govitecan-hziy-achieves-response-after-disease-progression-on-immune-checkpoint-inhibitor-in-metastatic-urothelial-cancer/ 2023-03-24T17:08:45+00:00 https://ascopost.com/issues/march-25-2023/epov-xin-gao/ 2023-03-24T17:08:45+00:00 https://ascopost.com/issues/march-25-2023/rucaparib-vs-physicians-choice-of-single-agent-therapy-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-03-24T17:08:46+00:00 https://ascopost.com/issues/march-25-2023/keynote-859-interim-analysis-overall-survival-benefit-for-first-line-pembrolizumab-in-advanced-gastric-cancer/ 2023-03-24T17:08:47+00:00 https://ascopost.com/issues/march-25-2023/epov-elizabeth-smyth/ 2023-03-24T17:08:48+00:00 https://ascopost.com/issues/march-25-2023/racialethnic-disparities-in-all-cause-and-cardiovascular-mortality-among-us-patients-with-cancer/ 2023-03-24T17:08:49+00:00 https://ascopost.com/issues/march-25-2023/association-of-baseline-and-subsequent-cardiovascular-health-metrics-to-risk-for-incident-cancers/ 2023-03-24T17:08:50+00:00 https://ascopost.com/issues/march-25-2023/when-can-you-stop-lenalidomide-maintenance-in-myeloma/ 2023-04-27T18:59:04+00:00 https://ascopost.com/issues/march-25-2023/epov-dan-vogl/ 2023-03-24T17:08:51+00:00 https://ascopost.com/issues/march-25-2023/regular-approval-for-dostarlimab-gxly-in-dmmr-recurrent-or-advanced-endometrial-cancer/ 2023-03-24T17:08:52+00:00 https://ascopost.com/issues/march-25-2023/studies-of-novel-therapeutic-approaches-highlighted-during-colorectal-cancer-awareness-month-at-dana-farber/ 2023-03-24T17:08:53+00:00 https://ascopost.com/issues/march-25-2023/10-facts-about-colorectal-cancer-from-the-colorectal-cancer-alliance/ 2023-03-24T17:08:54+00:00 https://ascopost.com/issues/march-25-2023/pirtobrutinib-for-relapsed-or-refractory-mantle-cell-lymphoma/ 2023-04-26T19:02:33+00:00 https://ascopost.com/issues/march-25-2023/idecabtagene-vicleucel-vs-standard-regimens-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2023-04-27T19:09:28+00:00 https://ascopost.com/issues/march-25-2023/sotorasib-improves-progression-free-survival-vs-docetaxel-in-previously-treated-advanced-nsclc-with-kras-g12c-mutation/ 2023-03-24T17:08:56+00:00 https://ascopost.com/issues/march-25-2023/destiny-breast03-t-dxd-improves-overall-survival-vs-t-dm1-in-previously-treated-her2-positive-metastatic-breast-cancer/ 2023-03-24T17:08:57+00:00 https://ascopost.com/issues/march-25-2023/asco-updates-guideline-on-sacituzumab-govitecan-hziy-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/ 2023-03-24T17:08:58+00:00 https://ascopost.com/issues/march-25-2023/three-models-testing-ways-to-lower-drug-costs-outlined-in-health-and-human-services-report/ 2023-03-24T17:08:59+00:00 https://ascopost.com/issues/march-25-2023/2024-aca-proposal-aims-to-reduce-health-care-coverage-gaps/ 2023-03-24T17:09:00+00:00 https://ascopost.com/issues/march-25-2023/eight-oncology-health-systems-participating-in-efforts-to-improve-vaccination-rates-among-high-risk-adults/ 2023-03-24T17:09:01+00:00 https://ascopost.com/issues/march-25-2023/asco-celebrates-the-cancer-moonshot-on-its-relaunch-anniversary/ 2023-03-24T17:09:02+00:00 https://ascopost.com/issues/march-25-2023/it-is-time-to-close-the-gap-in-cancer-care/ 2023-03-24T21:00:45+00:00 https://ascopost.com/issues/april-10-2023/ 2023-04-07T16:58:38+00:00 https://ascopost.com/issues/april-10-2023/improvement-in-progression-free-survival-with-first-line-olaparib-plus-abiraterone-in-metastatic-prostate-cancer/ 2023-04-07T16:58:39+00:00 https://ascopost.com/issues/april-10-2023/epov-oliver-sartor/ 2023-04-07T16:58:39+00:00 https://ascopost.com/issues/april-10-2023/understanding-fertility-issues-in-young-patients-with-breast-cancer/ 2023-04-07T16:58:40+00:00 https://ascopost.com/issues/april-10-2023/addressing-health-disparities-in-oncology-care-legally-and-ethically/ 2023-04-07T16:58:41+00:00 https://ascopost.com/issues/april-10-2023/darolutamide-plus-androgen-deprivation-therapy-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/ 2023-04-07T16:58:42+00:00 https://ascopost.com/issues/april-10-2023/epov-monica-chatwal/ 2023-04-07T16:58:43+00:00 https://ascopost.com/issues/april-10-2023/highlights-of-novel-therapies-under-study-in-genitourinary-cancers/ 2023-04-07T16:58:44+00:00 https://ascopost.com/issues/april-10-2023/two-cancer-experts-to-head-new-tisch-cancer-hospital-at-mount-sinai-hospital/ 2023-04-07T16:58:45+00:00 https://ascopost.com/issues/april-10-2023/which-patients-with-breast-cancer-can-omit-radiotherapy/ 2023-05-04T17:29:34+00:00 https://ascopost.com/issues/april-10-2023/lymphoma-research-foundation-establishes-kanti-r-rai-md-clinical-scholar-program-for-the-ongoing-study-of-cll/ 2023-04-07T16:58:47+00:00 https://ascopost.com/issues/april-10-2023/nuances-in-breast-cancer-imaging-for-screening-and-surveillance/ 2023-04-07T16:58:47+00:00 https://ascopost.com/issues/april-10-2023/kerin-adelson-md-named-md-anderson-chief-quality-and-value-officer/ 2023-04-07T16:58:48+00:00 https://ascopost.com/issues/april-10-2023/eau-and-asco-release-collaborative-guidelines-on-penile-cancer/ 2023-04-07T16:58:49+00:00 https://ascopost.com/issues/april-10-2023/president-biden-prioritizes-cancer-research-access-to-care-in-fy-2024-budget-proposal/ 2023-04-07T16:58:50+00:00 https://ascopost.com/issues/april-10-2023/heavy-toll-from-prior-authorization-exceeds-alleged-benefits-according-to-ama-survey/ 2023-04-07T16:58:51+00:00 https://ascopost.com/issues/april-10-2023/abemaciclib-expanded-indication-for-adjuvant-use-in-hr-positive-her2-negative-node-positive-early-breast-cancer/ 2023-04-07T16:58:52+00:00 https://ascopost.com/issues/april-10-2023/poorer-survival-in-stage-iii-colon-cancer-with-greater-inflammation-after-surgery-and-prior-to-adjuvant-therapy/ 2023-04-07T16:58:53+00:00 https://ascopost.com/issues/april-10-2023/genetics-likely-caused-my-small-cell-lung-cancer/ 2023-04-07T16:58:54+00:00 https://ascopost.com/issues/april-10-2023/yes-you-should-attend-the-2023-asco-annual-meeting/ 2023-04-07T16:58:55+00:00 https://ascopost.com/issues/april-10-2023/nobel-laureate-carolyn-r-bertozzi-phd-to-receive-2023-aacr-award-for-outstanding-achievement-cancer-research/ 2023-04-07T16:58:55+00:00 https://ascopost.com/issues/april-10-2023/elizabeth-m-jaffee-md-faacr-to-receive-2023-aacr-margaret-foti-award-for-leadership-and-extraordinary-achievements-in-cancer-research/ 2023-04-07T16:58:56+00:00 https://ascopost.com/issues/april-10-2023/surgeon-and-cancer-researcher-kelly-m-mcmasters-md-phd-celebrates-the-miracle-of-translational-science/ 2023-04-07T16:58:57+00:00 https://ascopost.com/issues/april-10-2023/city-of-hope-to-rebrand-cancer-treatment-centers-of-america-locations-to-reflect-transition-to-national-system/ 2023-07-10T19:48:31+00:00 https://ascopost.com/issues/april-10-2023/uspstf-announces-new-leadership/ 2023-04-07T16:58:59+00:00 https://ascopost.com/issues/april-25-2023/ 2023-04-25T03:39:09+00:00 https://ascopost.com/issues/april-25-2023/checkpoint-inhibitors-poised-to-change-standard-of-care-in-advanced-endometrial-cancer/ 2023-04-25T03:39:10+00:00 https://ascopost.com/issues/april-25-2023/epov-rebecca-arend-and-ilaria-colombo/ 2023-04-25T03:39:11+00:00 https://ascopost.com/issues/april-25-2023/glow-trial-zolbetuximab-plus-chemotherapy-sets-new-treatment-standard-in-gastric-cancer-subset/ 2023-04-25T03:39:12+00:00 https://ascopost.com/issues/april-25-2023/epov-yelena-y-janjigian/ 2023-04-25T03:39:13+00:00 https://ascopost.com/issues/april-25-2023/social-drivers-of-health-grabbing-the-steering-wheel/ 2023-04-25T03:39:14+00:00 https://ascopost.com/issues/april-25-2023/neoadjuvant-pembrolizumab-in-desmoplastic-melanoma/ 2023-04-25T03:39:15+00:00 https://ascopost.com/issues/april-25-2023/epov-callisia-n-clarke/ 2023-04-25T03:39:16+00:00 https://ascopost.com/issues/april-25-2023/using-circulating-tumor-dna-to-predict-early-recurrence-of-soft-tissue-sarcomas/ 2023-04-25T03:39:17+00:00 https://ascopost.com/issues/april-25-2023/epov-callisia-n-clarke-1/ 2023-04-25T03:39:18+00:00 https://ascopost.com/issues/april-25-2023/emerging-success-with-novel-targeted-therapies-in-endocrine-resistant-metastatic-breast-cancer/ 2023-05-04T15:43:10+00:00 https://ascopost.com/issues/april-25-2023/early-stage-triple-negative-breast-cancer-optimizing-therapy/ 2023-04-25T03:39:19+00:00 https://ascopost.com/issues/april-25-2023/summing-it-up-neoadjuvant-therapy-in-triple-negative-disease/ 2023-04-25T03:39:20+00:00 https://ascopost.com/issues/april-25-2023/asco-member-testifies-before-congress-urging-significant-increase-in-federal-cancer-research-funding/ 2023-04-25T03:39:21+00:00 https://ascopost.com/issues/april-25-2023/i-m-brca-positive-and-survived-both-breast-and-pancreatic-cancers/ 2023-04-25T03:39:22+00:00 https://ascopost.com/issues/april-25-2023/patricia-m-lorusso-do-phd-hc-chosen-as-aacr-president-elect-for-2023-2024/ 2023-04-25T03:39:23+00:00 https://ascopost.com/issues/april-25-2023/how-effectively-are-you-helping-patients-with-cancer-at-the-end-of-life/ 2023-04-25T03:39:24+00:00 https://ascopost.com/issues/april-25-2023/dabrafenib-with-trametinib-for-pediatric-low-grade-glioma-with-braf-v600e-mutation/ 2026-01-28T19:47:58+00:00 https://ascopost.com/issues/april-25-2023/homage-to-a-giant-in-hematology-the-fascinating-story-of-the-quest-to-cure-leukemia/ 2023-04-25T03:39:26+00:00 https://ascopost.com/issues/may-10-2023/ 2023-05-10T16:14:42+00:00 https://ascopost.com/issues/may-10-2023/aegean-trial-shows-benefit-with-immunotherapy-based-combination-for-nsclc/ 2023-05-10T16:14:42+00:00 https://ascopost.com/issues/may-10-2023/epov-roy-s-herbst/ 2023-05-10T16:14:43+00:00 https://ascopost.com/issues/may-10-2023/lung-cancer-screening-and-possible-unappreciated-benefits/ 2023-06-07T16:47:43+00:00 https://ascopost.com/issues/may-10-2023/the-role-of-salpingectomy-in-ovarian-cancer-standard-of-care-or-targeted-therapy/ 2023-05-10T16:14:45+00:00 https://ascopost.com/issues/may-10-2023/study-shows-mrna-based-personalized-vaccine-plus-pembrolizumab-active-in-melanoma-for-the-first-time/ 2023-05-22T16:21:25+00:00 https://ascopost.com/issues/may-10-2023/epov-margaret-k-callahan/ 2023-05-10T16:14:48+00:00 https://ascopost.com/issues/may-10-2023/study-reveals-link-between-obesity-and-gastric-cancer-aggressiveness/ 2023-05-10T16:14:49+00:00 https://ascopost.com/issues/may-10-2023/epov-jaffer-a-ajani/ 2023-05-10T16:14:50+00:00 https://ascopost.com/issues/may-10-2023/final-soraya-analysis-supports-mirvetuximab-soravtansine-in-ovarian-cancer/ 2023-05-10T16:14:51+00:00 https://ascopost.com/issues/may-10-2023/epov-debra-l-richardson-and-joyce-f-liu/ 2023-05-10T16:14:52+00:00 https://ascopost.com/issues/may-10-2023/olivier-delattre-md-phd-honored-with-2023-aacr-st-baldrick-s-foundation-award/ 2023-05-10T16:14:53+00:00 https://ascopost.com/issues/may-10-2023/codebreak-200-sotorasib-offers-improved-quality-of-life-for-patients-with-previously-treated-nsclc/ 2023-06-07T16:49:35+00:00 https://ascopost.com/issues/may-10-2023/epov-jarushka-naidoo-mbbch-mhs/ 2023-05-10T16:14:55+00:00 https://ascopost.com/issues/may-10-2023/checkmate-816-3-year-update-shows-improved-event-free-survival-with-neoadjuvant-nivolumab-and-chemotherapy-for-resectable-nsclc/ 2023-06-07T16:52:10+00:00 https://ascopost.com/issues/may-10-2023/epov-antonio-passaro-md-phd/ 2023-05-10T16:14:57+00:00 https://ascopost.com/issues/may-10-2023/front-line-vs-sequential-use-of-osimertinib-in-egfr-mutant-nsclc-potential-impact-of-liquid-biopsies/ 2023-06-07T17:16:02+00:00 https://ascopost.com/issues/may-10-2023/epov-daniel-sw-tan/ 2023-05-10T16:14:59+00:00 https://ascopost.com/issues/may-10-2023/amivantamab-shows-efficacy-in-advanced-nsclc-with-egfr-exon-20-insertions/ 2023-06-07T16:57:06+00:00 https://ascopost.com/issues/may-10-2023/epov-jarushka-naidoo/ 2023-05-10T16:15:01+00:00 https://ascopost.com/issues/may-10-2023/aacr-announces-fellows-of-the-aacr-academy-class-of-2023/ 2023-05-10T16:15:02+00:00 https://ascopost.com/issues/may-10-2023/novel-hormone-receptor-driven-therapies-tackling-endocrine-resistance-in-breast-cancer/ 2023-06-15T15:43:23+00:00 https://ascopost.com/issues/may-10-2023/asco-releases-guideline-updates-for-stage-iv-nsclc-with-and-without-driver-alterations/ 2023-05-10T16:15:03+00:00 https://ascopost.com/issues/may-10-2023/detection-of-early-emphysema-during-lung-cancer-screening-opportunities-to-optimize-health/ 2023-05-10T16:15:04+00:00 https://ascopost.com/issues/may-10-2023/enfortumab-vedotin-ejfv-with-pembrolizumab-in-locally-advanced-or-metastatic-urothelial-carcinoma/ 2023-05-10T16:15:05+00:00 https://ascopost.com/issues/may-10-2023/cancer-immunology-and-immunotherapy-principles-and-practice/ 2023-05-10T16:15:06+00:00 https://ascopost.com/issues/may-10-2023/fda-approves-polatuzumab-vedotin-piiq-plus-r-chp-for-previously-untreated-dlbcl-not-otherwise-specified-and-high-grade-b-cell-lymphoma/ 2023-12-27T17:17:40+00:00 https://ascopost.com/issues/may-10-2023/fda-approves-omidubicel-onlv-to-reduce-time-to-neutrophil-recovery-and-infection-in-patients-with-hematologic-malignancies/ 2023-05-10T16:15:08+00:00 https://ascopost.com/issues/may-10-2023/study-finds-cancer-related-emergency-department-visits-increased-mainly-because-of-uncontrolled-pain/ 2023-05-10T16:15:09+00:00 https://ascopost.com/issues/may-10-2023/ed-visits-among-patients-with-cancer-three-main-messages/ 2023-05-10T16:15:10+00:00 https://ascopost.com/issues/may-10-2023/personalized-mind-body-medicine-in-integrative-oncology/ 2023-05-10T16:15:11+00:00 https://ascopost.com/issues/may-10-2023/city-of-hope-appoints-new-director-and-chief-scientific-officer/ 2023-05-10T16:15:12+00:00 https://ascopost.com/issues/may-10-2023/an-incidental-finding-of-cancer-likely-saved-my-life/ 2023-05-10T16:15:13+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/ 2023-05-11T17:42:41+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/highlights-of-the-sgo-2023-annual-meeting-on-women-s-cancer/ 2023-05-11T17:42:42+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/checkpoint-inhibitors-poised-to-change-standard-of-care-in-advanced-endometrial-cancer/ 2023-05-11T17:42:43+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/epov-rebecca-arend-and-ilaria-colombo/ 2023-05-11T17:42:43+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/gog-258-final-results-no-improvement-in-survival-by-adding-radiotherapy-to-chemotherapy-in-advanced-endometrial-cancer/ 2023-05-11T17:42:44+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/epov-kathleen-moore/ 2023-05-11T17:42:45+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/poor-tolerability-appears-to-hinder-benefit-of-adavosertib-in-uterine-serous-carcinoma/ 2023-05-11T17:42:46+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/epov-joshua-cohen/ 2023-05-11T17:42:47+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/sgo-presentations-explore-inequitable-access-to-clinical-trials-and-its-impact-on-survival/ 2023-05-11T20:00:37+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/final-soraya-analysis-supports-mirvetuximab-soravtansine-in-ovarian-cancer/ 2023-05-11T17:42:49+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/epov-debra-l-richardson-and-joyce-f-liu/ 2023-05-11T17:42:50+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/gog-3026-durable-responses-with-ribociclib-plus-letrozole-in-low-grade-serous-ovarian-cancer/ 2023-05-11T20:03:39+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/epov-amanda-nickles-fader/ 2023-05-11T17:42:51+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/nova-final-analysis-confirms-no-significant-overall-survival-benefit-for-maintenance-niraparib-in-recurrent-ovarian-cancer/ 2023-05-11T20:05:10+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/epov-carol-aghajanian/ 2023-05-11T17:42:53+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/in-pilot-study-neoadjuvant-olaparib-appears-feasible-effective-in-patients-with-ovarian-cancer-and-brca-mutation/ 2023-05-11T20:06:22+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/epov-kathleen-moore-1/ 2023-05-11T17:42:55+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/artistry-7-and-rosella-phase-iii-trials-to-evaluate-novel-agents-in-platinum-resistant-ovarian-cancer/ 2023-05-11T20:09:27+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/novel-immunotherapy-combination-explored-in-platinum-resistant-ovarian-cancer/ 2023-05-11T20:14:18+00:00 https://ascopost.com/issues/may-25-2023-supplement-conference-highlights-sgo-2023/prognostic-factors-associated-with-survival-in-platinum-resistant-ovarian-cancer/ 2023-05-11T20:15:57+00:00 https://ascopost.com/issues/may-25-2023/ 2023-05-25T14:54:02+00:00 https://ascopost.com/issues/may-25-2023/immunotherapychemotherapy-combination-prolongs-survival-in-advanced-biliary-tract-cancers/ 2023-05-25T14:54:03+00:00 https://ascopost.com/issues/may-25-2023/epov-rachna-t-shroff/ 2023-05-25T14:54:04+00:00 https://ascopost.com/issues/may-25-2023/krystal-1-update-adagrasib-yields-benefit-in-variety-of-kras-g12c-mutated-tumors/ 2023-05-25T14:54:05+00:00 https://ascopost.com/issues/may-25-2023/epov-elena-garralda/ 2023-05-25T14:54:06+00:00 https://ascopost.com/issues/may-25-2023/partnering-with-patients-the-cornerstone-of-cancer-care-and-research/ 2023-05-25T14:54:07+00:00 https://ascopost.com/issues/may-25-2023/novel-bispecific-antibody-for-multiple-myeloma-shows-high-response-rates-in-early-trial/ 2023-05-26T16:20:22+00:00 https://ascopost.com/issues/may-25-2023/epov-kenneth-c-anderson/ 2023-05-25T14:54:09+00:00 https://ascopost.com/issues/may-25-2023/adjuvant-regimen-of-atezolizumab-plus-bevacizumab-in-resectable-hepatocellular-carcinoma/ 2023-05-25T14:54:11+00:00 https://ascopost.com/issues/may-25-2023/epov-stephen-lam-chan/ 2023-05-25T14:54:12+00:00 https://ascopost.com/issues/may-25-2023/genetic-sequencing-may-identify-cancers-often-missed-by-traditional-screening-guidelines/ 2023-05-25T14:54:13+00:00 https://ascopost.com/issues/may-25-2023/gog-258-final-results-no-improvement-in-survival-by-adding-radiotherapy-to-chemotherapy-in-advanced-endometrial-cancer/ 2023-05-25T14:54:14+00:00 https://ascopost.com/issues/may-25-2023/epov-kathleen-moore/ 2023-05-25T14:54:15+00:00 https://ascopost.com/issues/may-25-2023/gog-3026-durable-responses-with-ribociclib-plus-letrozole-in-low-grade-serous-ovarian-cancer/ 2023-05-25T14:54:16+00:00 https://ascopost.com/issues/may-25-2023/epov-amanda-nickles-fader/ 2023-05-25T14:54:17+00:00 https://ascopost.com/issues/may-25-2023/poor-tolerability-appears-to-hinder-benefit-of-adavosertib-in-uterine-serous-carcinoma/ 2023-05-25T14:54:18+00:00 https://ascopost.com/issues/may-25-2023/epov-joshua-cohen/ 2023-05-25T14:54:19+00:00 https://ascopost.com/issues/may-25-2023/sgo-presentations-explore-inequitable-access-to-clinical-trials-and-its-impact-on-survival/ 2023-05-25T14:54:20+00:00 https://ascopost.com/issues/may-25-2023/uspstf-issues-draft-recommendation-statement-on-screening-for-breast-cancer/ 2023-06-15T15:37:15+00:00 https://ascopost.com/issues/may-25-2023/nova-final-analysis-confirms-no-significant-overall-survival-benefit-for-maintenance-niraparib-in-recurrent-ovarian-cancer/ 2023-05-25T14:54:22+00:00 https://ascopost.com/issues/may-25-2023/epov-carol-aghajanian/ 2023-05-25T14:54:23+00:00 https://ascopost.com/issues/may-25-2023/omidubicel-onlv-to-reduce-time-to-neutrophil-recovery-and-incidence-of-infection-in-hematologic-malignancies/ 2023-05-25T14:54:24+00:00 https://ascopost.com/issues/may-25-2023/retifanlimab-dlwr-for-metastatic-or-recurrent-locally-advanced-merkel-cell-carcinoma/ 2023-05-25T14:54:25+00:00 https://ascopost.com/issues/may-25-2023/e-john-wherry-phd-recognized-with-the-2023-aacr-cancer-research-institute-lloyd-j-old-award-in-cancer-immunology/ 2023-05-25T14:54:26+00:00 https://ascopost.com/issues/may-25-2023/exercise-wellness-interventions-in-early-breast-cancer-demonstrate-measurable-benefits-even-economic-ones/ 2023-05-25T14:54:28+00:00 https://ascopost.com/issues/may-25-2023/epov-sarah-blair/ 2023-05-25T14:54:29+00:00 https://ascopost.com/issues/may-25-2023/surveillance-mammography-rates-after-breast-cancer-treatment-remain-high-irrespective-of-life-expectancy/ 2023-06-15T15:46:20+00:00 https://ascopost.com/issues/may-25-2023/epov-elizabeth-a-morris/ 2023-05-25T14:54:31+00:00 https://ascopost.com/issues/may-25-2023/cancer-susceptibility-germline-pathogenic-variants-among-older-patients/ 2023-05-25T14:54:32+00:00 https://ascopost.com/issues/may-25-2023/organizations-team-up-to-improve-cancer-care-in-rural-appalachia/ 2023-05-25T14:54:33+00:00 https://ascopost.com/issues/may-25-2023/circulating-tumor-dna-identified-prior-to-and-during-treatment-is-associated-with-poorer-outcomes-in-primary-cns-lymphoma/ 2023-05-25T14:54:34+00:00 https://ascopost.com/issues/may-25-2023/who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2023-05-26T14:54:34+00:00 https://ascopost.com/issues/may-25-2023/radiation-oncology-workforce-expected-to-remain-stable-through-2030/ 2023-05-25T14:54:36+00:00 https://ascopost.com/issues/may-25-2023/nccn-clinical-practice-guidelines-in-oncology-2023-updates/ 2023-05-25T14:54:37+00:00 https://ascopost.com/issues/may-25-2023/asco-congratulates-2023-special-awards-recipients/ 2023-05-25T14:54:38+00:00 https://ascopost.com/issues/may-25-2023/new-roles-at-st-louis-siteman-cancer-center/ 2023-05-25T14:54:40+00:00 https://ascopost.com/issues/may-25-2023/highlighting-progress-in-myeloma-treatment-pollux-trial-final-overall-survival-results-with-daratumumab-based-therapy/ 2023-05-26T16:25:50+00:00 https://ascopost.com/issues/may-25-2023/american-college-of-surgeons-evaluates-the-impact-of-covid-19-pandemic-on-national-cancer-database-reporting/ 2023-05-25T14:54:42+00:00 https://ascopost.com/issues/may-25-2023/surviving-but-not-always-thriving-after-cancer-part-1/ 2023-05-25T14:54:43+00:00 https://ascopost.com/issues/may-25-2023/survival-in-patients-with-neuroblastoma-on-reduced-therapy-as-a-result-of-change-in-cog-risk-stratification/ 2023-05-25T14:54:44+00:00 https://ascopost.com/issues/may-25-2023/researchamerica-announces-new-board-members/ 2023-05-25T14:54:45+00:00 https://ascopost.com/issues/may-25-2023/asco-ceo-clifford-hudis-discusses-how-the-cancer-care-community-will-meet-the-daunting-challenges-ahead/ 2024-01-24T21:13:55+00:00 https://ascopost.com/issues/may-25-2023/israeli-surgical-oncology-leader-dov-zippel-considers-the-evolving-landscape-of-cancer-care-in-a-small-nation/ 2023-05-25T14:54:47+00:00 https://ascopost.com/issues/may-25-2023/surviving-but-not-always-thriving-after-cancer-part-2/ 2023-05-25T18:50:31+00:00 https://ascopost.com/issues/may-25-2023/northwell-launches-cancer-care-direct-pairing-nurse-navigators-with-patients-through-spectrum-of-care/ 2023-05-25T14:54:49+00:00 https://ascopost.com/issues/may-25-2023/mount-sinai-achieves-highest-rating-from-society-of-thoracic-surgeons-for-esophagectomy-program/ 2023-05-25T14:54:50+00:00 https://ascopost.com/issues/may-25-2023/tumor-genomic-profile-and-risk-for-arterial-thromboembolism-in-patients-with-solid-cancer/ 2023-05-25T14:54:51+00:00 https://ascopost.com/issues/may-25-2023/playing-a-doctor-in-a-school-play-sparked-an-early-desire-to-become-a-real-doctor-for-sibylle-loibl/ 2023-05-25T14:54:52+00:00 https://ascopost.com/issues/may-25-2023/disparities-in-cancer-care-a-bangladeshi-perspective/ 2023-05-25T18:57:25+00:00 https://ascopost.com/issues/may-25-2023/new-fellows-of-the-american-society-of-clinical-oncology-fasco/ 2023-05-25T14:54:54+00:00 https://ascopost.com/issues/may-25-2023/addition-of-bortezomib-to-first-line-dexamethasone-rituximab-and-cyclophosphamide-for-waldenstroem-s-macroglobulinemia/ 2023-05-25T14:54:55+00:00 https://ascopost.com/issues/may-25-2023/i-was-unprepared-for-a-diagnosis-of-mantle-cell-lymphoma/ 2023-05-30T18:57:08+00:00 https://ascopost.com/issues/may-25-2023/making-the-art-of-oncology-and-cancer-care-central-to-her-presidential-term/ 2023-05-25T14:54:57+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/ 2023-05-31T18:21:44+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/the-second-generation-son-of-greek-immigrants-the-first-to-go-to-college-becomes-a-leader-in-sarcoma-research-and-treatment/ 2023-06-02T14:38:48+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/an-oncologist-from-guam-devotes-his-career-to-the-care-of-pelvic-cancers-and-the-sexual-health-of-all-cancer-survivors/ 2023-05-31T18:21:46+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/involvement-in-swog-and-jco-leads-to-a-fulfilling-career-as-a-leader-in-oncology/ 2023-06-02T17:56:35+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/an-oncology-leader-whose-immigrant-parents-taught-him-by-example-about-life-and-service-to-humanity/ 2023-05-31T18:21:49+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/asco-congratulates-2023-special-awards-recipients/ 2023-05-31T18:21:50+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/daughter-of-immigrants-who-fled-the-pogroms-she-followed-a-love-of-science-into-a-noted-career-in-cancer-pathology/ 2023-05-31T18:21:51+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/finding-early-female-role-models-helped-shape-a-notable-career-in-oncology/ 2023-05-31T18:21:53+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/new-fellows-of-the-american-society-of-clinical-oncology/ 2023-05-31T18:21:54+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/a-free-spirited-childhood-on-a-dairy-farm-where-books-and-science-experiments-were-encouraged/ 2023-05-31T18:21:55+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/from-a-small-town-in-north-carolina-a-young-girl-finds-her-calling-in-battling-inequity-in-cancer-care/ 2023-05-31T18:21:57+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/inspired-by-an-uncle-who-was-a-compassionate-family-doctor-this-nonagenarian-continues-a-renowned-career-in-hematology/ 2023-06-21T17:16:35+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/a-love-of-immunology-leads-to-a-notable-career-in-dermatology-with-a-focus-on-melanoma-research-and-treatment/ 2023-06-30T17:42:18+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/a-leader-in-oncology-from-humble-beginnings-never-forgets-life-lessons-learned-along-the-way/ 2023-05-31T18:22:00+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/narratives-in-oncology-through-the-years/ 2023-12-27T20:19:00+00:00 https://ascopost.com/issues/june-3-2023-narratives-special-issue/mourned-and-missed/ 2023-05-31T18:22:03+00:00 https://ascopost.com/issues/june-10-2023/ 2023-06-09T13:33:15+00:00 https://ascopost.com/issues/june-10-2023/first-line-luspatercept-boosts-chance-of-transfusion-independence-in-lower-risk-mds/ 2023-06-09T13:33:16+00:00 https://ascopost.com/issues/june-10-2023/epov-mikkael-sekeres/ 2023-06-09T13:33:17+00:00 https://ascopost.com/issues/june-10-2023/involving-all-of-society-to-end-cancer-as-we-know-it/ 2023-06-09T13:33:18+00:00 https://ascopost.com/issues/june-10-2023/rethinking-prior-authorization/ 2023-06-09T13:33:19+00:00 https://ascopost.com/issues/june-10-2023/pembrolizumab-added-to-chemotherapy-improves-survival-in-advanced-cervical-cancer-regardless-of-pd-l1-expression/ 2023-06-09T13:33:20+00:00 https://ascopost.com/issues/june-10-2023/neotorch-trial-toripalimab-plus-chemotherapy-improves-event-free-survival-in-resectable-stage-iii-nsclc/ 2023-06-09T13:33:20+00:00 https://ascopost.com/issues/june-10-2023/epov-tina-cascone/ 2023-06-09T13:33:21+00:00 https://ascopost.com/issues/june-10-2023/two-studies-of-atezolizumab-based-regimens-in-early-stage-triple-negative-and-her2-positive-breast-cancers/ 2023-07-06T18:25:10+00:00 https://ascopost.com/issues/june-10-2023/epov-matteo-lambertini/ 2023-06-09T13:33:23+00:00 https://ascopost.com/issues/june-10-2023/her3-targeting-antibody-drug-conjugates-show-encouraging-results-in-breast-cancer-subtypes/ 2023-06-09T13:33:24+00:00 https://ascopost.com/issues/june-10-2023/epov-rebecca-dent/ 2023-06-09T13:33:25+00:00 https://ascopost.com/issues/june-10-2023/better-awareness-of-hpv-associated-cancers-is-still-needed-in-the-united-states-study-finds/ 2023-06-09T13:33:26+00:00 https://ascopost.com/issues/june-10-2023/epov-devraj-basu/ 2023-06-09T13:33:27+00:00 https://ascopost.com/issues/june-10-2023/asco-updates-guideline-for-management-of-anxiety-and-depression-in-adult-cancer-survivors/ 2023-06-09T13:33:28+00:00 https://ascopost.com/issues/june-10-2023/asco-member-testifies-before-congress-to-urge-significant-increase-in-federal-cancer-research-funding/ 2023-06-09T13:33:28+00:00 https://ascopost.com/issues/june-10-2023/can-bariatric-surgery-decrease-the-risk-of-obesity-related-cancers/ 2023-06-09T13:33:29+00:00 https://ascopost.com/issues/june-10-2023/epov-loren-laine-md/ 2023-06-09T13:33:30+00:00 https://ascopost.com/issues/june-10-2023/interruption-of-endocrine-therapy-to-attempt-pregnancy-in-women-with-hormone-receptor-positive-early-breast-cancer/ 2023-06-09T13:33:31+00:00 https://ascopost.com/issues/june-10-2023/addressing-racial-disparities-in-cancer-pain-management-a-potential-role-for-music-therapy/ 2023-06-09T13:33:32+00:00 https://ascopost.com/issues/june-10-2023/polatuzumab-vedotin-piiq-for-previously-untreated-dlbcl-not-otherwise-specified-and-high-grade-b-cell-lymphoma/ 2023-06-09T13:33:33+00:00 https://ascopost.com/issues/june-10-2023/tak-w-mak-phd-faacr-selected-for-2023-pezcoller-foundation-aacr-international-award-for-achievement-in-cancer-research/ 2023-06-09T13:33:34+00:00 https://ascopost.com/issues/june-10-2023/early-detection-of-pancreatic-cancer-saved-my-life/ 2023-06-09T13:33:35+00:00 https://ascopost.com/issues/june-25-2023/ 2023-06-23T17:05:44+00:00 https://ascopost.com/issues/june-25-2023/idh-inhibitor-improves-progression-free-survival-in-grade-2-idh12-mutated-gliomas/ 2026-01-28T19:43:23+00:00 https://ascopost.com/issues/june-25-2023/epov-rimas-vincas-lukas/ 2023-06-23T17:05:46+00:00 https://ascopost.com/issues/june-25-2023/prostate-cancer-disparities-and-the-last-mile-problem/ 2023-07-14T18:13:31+00:00 https://ascopost.com/issues/june-25-2023/first-targeted-therapy-for-platinum-resistant-ovarian-cancer-to-improve-survival-outcomes/ 2023-06-23T17:05:50+00:00 https://ascopost.com/issues/june-25-2023/epov-roisin-e-o-cearbhaill/ 2023-06-23T17:05:51+00:00 https://ascopost.com/issues/june-25-2023/minimally-invasive-distal-pancreatectomy-noninferior-to-open-surgery-for-early-stage-pancreatic-cancer/ 2023-07-17T17:11:52+00:00 https://ascopost.com/issues/june-25-2023/epov-chandrakanth-are/ 2023-06-23T17:05:53+00:00 https://ascopost.com/issues/june-25-2023/de-escalation-of-surgery-feasible-for-selected-patients-with-low-risk-early-stage-cervical-cancer/ 2023-06-23T17:05:53+00:00 https://ascopost.com/issues/june-25-2023/epov-jose-alejandro-rauh-hain/ 2023-06-23T17:05:54+00:00 https://ascopost.com/issues/june-25-2023/fda-approves-olaparib-plus-abiraterone-and-prednisone-or-prednisolone-for-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-12-27T17:19:56+00:00 https://ascopost.com/issues/june-25-2023/benefit-shown-for-durvalumab-plus-olaparib-in-advanced-ovarian-cancer/ 2023-08-23T17:05:09+00:00 https://ascopost.com/issues/june-25-2023/epov-christina-fotopoulou/ 2023-06-23T17:05:57+00:00 https://ascopost.com/issues/june-25-2023/medicaid-expansion-associated-with-a-reduction-in-mortality-for-black-patients-with-gastrointestinal-malignancies/ 2023-06-23T17:05:58+00:00 https://ascopost.com/issues/june-25-2023/building-a-more-equitable-oncology-practice-the-path-to-better-patient-outcomes/ 2023-06-23T17:05:59+00:00 https://ascopost.com/issues/june-25-2023/thinking-outside-the-box-embracing-innovation-and-collaboration-in-oncology/ 2023-06-23T17:06:00+00:00 https://ascopost.com/issues/june-25-2023/in-case-you-missed-it-brief-highlights-from-studies-presented-during-aacr-2023/ 2023-06-23T17:06:01+00:00 https://ascopost.com/issues/june-25-2023/asco-issues-clinical-guidance-for-treating-gastrointestinal-cancers-amid-acute-drug-shortages/ 2023-06-23T17:06:02+00:00 https://ascopost.com/issues/june-25-2023/guideline-update-provides-new-testing-and-treatment-recommendations-for-patients-with-er-positive-her2-negative-metastatic-breast-cancer-with-esr1-mutations/ 2023-06-23T17:06:03+00:00 https://ascopost.com/issues/june-25-2023/retrospective-study-finds-black-patients-with-colorectal-cancer-had-fewer-actionable-genomic-mutations-than-white-patients/ 2023-07-17T17:16:44+00:00 https://ascopost.com/issues/june-25-2023/epov-lisa-newman/ 2023-06-23T17:06:05+00:00 https://ascopost.com/issues/june-25-2023/swog-s1512-trial-pembrolizumab-achieves-high-response-rates-in-rare-type-of-melanoma/ 2023-06-23T17:06:06+00:00 https://ascopost.com/issues/june-25-2023/epov-zeynep-eroglu/ 2023-06-23T17:06:07+00:00 https://ascopost.com/issues/june-25-2023/immune-checkpoint-inhibitors-show-promise-for-people-living-with-hiv/ 2023-06-23T17:06:08+00:00 https://ascopost.com/issues/june-25-2023/certain-cancers-will-likely-rise-exponentially-because-of-covid-19-screening-delays-study-predicts/ 2023-06-23T17:06:09+00:00 https://ascopost.com/issues/june-25-2023/rwandas-vision-for-increasing-cervical-cancer-prevention-one-village-at-a-time/ 2023-06-23T17:06:10+00:00 https://ascopost.com/issues/june-25-2023/traditional-chinese-medicine-herbal-formula-suan-zao-ren-tang-for-insomnia/ 2023-06-23T17:06:11+00:00 https://ascopost.com/issues/june-25-2023/ivy-brain-tumor-center-appoints-new-chief-medical-officer/ 2023-06-29T20:39:13+00:00 https://ascopost.com/issues/july-10-2023/ 2023-07-10T17:04:02+00:00 https://ascopost.com/issues/july-10-2023/adaura-trial-adjuvant-osimertinib-improves-overall-survival-in-resectable-egfr-mutated-nsclc/ 2023-07-10T17:04:02+00:00 https://ascopost.com/issues/july-10-2023/epov-benjamin-j-solomon/ 2023-07-10T17:04:03+00:00 https://ascopost.com/issues/july-10-2023/pelvic-radiation-therapy-avoided-for-most-patients-with-intermediate-risk-locally-advanced-rectal-cancer/ 2023-08-02T22:32:00+00:00 https://ascopost.com/issues/july-10-2023/epov-pamela-l-kunz-md-and-corrie-marijnen-md-phd/ 2023-07-10T17:04:05+00:00 https://ascopost.com/issues/july-10-2023/a-call-for-tailored-medical-services-in-oncology-care-for-older-deaf-patients/ 2023-07-10T17:04:06+00:00 https://ascopost.com/issues/july-10-2023/ciltacabtagene-autoleucel-beneficial-in-early-myeloma-relapse/ 2023-07-10T17:04:07+00:00 https://ascopost.com/issues/july-10-2023/epov-ciara-l-freeman-and-asher-chanan-khan/ 2023-07-10T17:04:08+00:00 https://ascopost.com/issues/july-10-2023/perioperative-pembrolizumab-plus-chemotherapy-improves-outcomes-in-stage-ii-and-iii-nsclc/ 2023-07-12T18:40:34+00:00 https://ascopost.com/issues/july-10-2023/epov-mark-awad/ 2023-07-10T17:04:10+00:00 https://ascopost.com/issues/july-10-2023/nivolumab-plus-avd-surpasses-standard-of-care-combination-regimen-in-patients-with-advanced-hodgkin-lymphoma/ 2023-07-18T15:45:55+00:00 https://ascopost.com/issues/july-10-2023/epov-ann-s-lacasce/ 2023-07-10T17:04:12+00:00 https://ascopost.com/issues/july-10-2023/is-t-dxd-heading-for-tumor-agnostic-status/ 2023-07-10T17:04:12+00:00 https://ascopost.com/issues/july-10-2023/epov-kohei-shitara-and-bradley-alexander-mcgregor/ 2023-07-10T17:04:13+00:00 https://ascopost.com/issues/july-10-2023/study-finds-preoperative-mri-does-not-significantly-impact-margin-status-in-patients-with-breast-cancer/ 2023-07-10T17:04:14+00:00 https://ascopost.com/issues/july-10-2023/pathology-assessment-during-mastectomy-and-overtreatment-of-the-axilla-in-clinically-node-negative-breast-cancer/ 2023-07-10T17:38:58+00:00 https://ascopost.com/issues/july-10-2023/continued-survival-benefit-with-first-line-lenvatinib-plus-pembrolizumab-in-advanced-kidney-cancer/ 2023-07-14T16:10:54+00:00 https://ascopost.com/issues/july-10-2023/lobular-vs-ductal-breast-cancer-distinctions-in-management/ 2023-08-02T22:33:19+00:00 https://ascopost.com/issues/july-10-2023/addition-of-tislelizumab-to-chemotherapy-improves-survival-in-treatment-of-metastatic-esophageal-squamous-cell-carcinoma/ 2023-07-10T17:04:18+00:00 https://ascopost.com/issues/july-10-2023/epov-david-a-braun/ 2023-07-10T17:04:19+00:00 https://ascopost.com/issues/july-10-2023/a-european-leader-in-surgical-oncology-isabel-rubio-shares-her-story-and-sheds-light-on-the-challenges-ahead/ 2023-07-10T17:04:20+00:00 https://ascopost.com/issues/july-10-2023/primary-overall-survival-analysis-supports-axicabtagene-ciloleucel-as-second-line-therapy-in-advanced-lymphoma/ 2023-07-18T17:27:22+00:00 https://ascopost.com/issues/july-10-2023/second-annual-conference-at-the-nixon-presidential-library-and-museum-emphasizes-patients-concerns/ 2023-07-10T17:04:22+00:00 https://ascopost.com/issues/july-10-2023/epov-caron-jacobson/ 2023-07-10T17:04:23+00:00 https://ascopost.com/issues/july-10-2023/health-systems-strengthening-approach-in-the-united-states-mexico-border-region-improved-5-year-survival-for-children-with-all/ 2023-08-10T21:32:24+00:00 https://ascopost.com/issues/july-10-2023/a-telephone-based-weight-loss-intervention-induced-clinically-meaningful-weight-loss-in-patients-with-breast-cancer-and-overweight-or-obesity/ 2023-07-10T17:04:25+00:00 https://ascopost.com/issues/july-10-2023/how-asco-s-2023-breakthrough-meeting-is-putting-a-spotlight-on-cutting-edge-advances-in-cancer-care-technology-and-innovation/ 2023-07-10T17:04:26+00:00 https://ascopost.com/issues/july-10-2023/asco-updates-guideline-on-venous-thromboembolism-prophylaxis-and-treatment-in-patients-with-cancer/ 2023-07-10T17:04:27+00:00 https://ascopost.com/issues/july-10-2023/epcoritamab-bysp-in-treatment-of-relapsed-or-refractory-b-cell-lymphomas/ 2023-07-10T17:04:27+00:00 https://ascopost.com/issues/july-10-2023/olaparib-with-abiraterone-and-prednisone-or-prednisolone-for-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-07-10T17:04:28+00:00 https://ascopost.com/issues/july-10-2023/sara-hurvitz-joins-fred-hutch-university-of-washington-seattle/ 2023-07-10T17:04:29+00:00 https://ascopost.com/issues/july-10-2023/assessing-geriatric-oncology-practice-in-portugal/ 2023-07-10T17:04:30+00:00 https://ascopost.com/issues/july-10-2023/retrospective-view-of-medical-dissection-from-may-1896/ 2023-07-10T17:04:31+00:00 https://ascopost.com/issues/july-10-2023/targeting-depressive-symptoms-in-younger-breast-cancer-survivors/ 2023-08-02T22:36:03+00:00 https://ascopost.com/issues/july-10-2023/i-didn-t-want-my-past-to-become-my-future/ 2023-07-10T17:04:33+00:00 https://ascopost.com/issues/july-25-2023/ 2023-07-24T22:14:24+00:00 https://ascopost.com/issues/july-25-2023/in-ovarian-cancer-neoadjuvant-olaparib-feasible-appears-effective-in-pilot-study-among-patients-with-brca-mutation/ 2023-07-24T22:14:25+00:00 https://ascopost.com/issues/july-25-2023/epov-kathleen-moore/ 2023-07-24T22:14:26+00:00 https://ascopost.com/issues/july-25-2023/two-studies-highlight-benefits-in-quality-of-life-and-symptom-management-with-novel-treatments-of-advanced-breast-cancer/ 2023-07-24T22:14:27+00:00 https://ascopost.com/issues/july-25-2023/epov-gustavo-werutsky-and-lisa-a-carey/ 2023-07-24T22:14:30+00:00 https://ascopost.com/issues/july-25-2023/allison-institute-announces-appointment-of-inaugural-members/ 2023-07-24T22:14:31+00:00 https://ascopost.com/issues/july-25-2023/who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/ 2023-07-24T22:14:35+00:00 https://ascopost.com/issues/july-25-2023/alfredo-quiñones-hinojosa-md-from-migrant-farm-worker-to-neurosurgeon-in-search-of-a-cure-for-brain-cancer/ 2026-01-28T19:33:36+00:00 https://ascopost.com/issues/july-25-2023/berberine/ 2023-07-24T22:14:40+00:00 https://ascopost.com/issues/july-25-2023/damon-runyon-names-physician-scientist-awardees/ 2023-07-24T22:14:41+00:00 https://ascopost.com/issues/july-25-2023/study-of-cancer-metastasis-receives-35-million-boost-at-johns-hopkins-medicine/ 2023-07-24T22:14:42+00:00 https://ascopost.com/issues/july-25-2023/asco-remembers-former-board-of-directors-member-and-radiation-oncologist-a-william-blackstock-jr-md-fasco/ 2023-07-24T22:14:43+00:00 https://ascopost.com/issues/july-25-2023/sso-names-chandrakanth-are-mbbs-mba-chief-executive-officer-of-global-forum-of-cancer-surgeons/ 2023-07-24T22:14:43+00:00 https://ascopost.com/issues/july-25-2023/turning-fear-into-hope/ 2023-07-24T22:14:44+00:00 https://ascopost.com/issues/july-25-2023/association-of-alcohol-intake-with-risk-of-early-onset-colorectal-cancer/ 2023-07-24T22:14:45+00:00 https://ascopost.com/issues/july-25-2023/addition-of-neoadjuvant-nivolumab-to-platinum-based-chemotherapy-in-stage-iii-nsclc/ 2023-07-24T22:14:46+00:00 https://ascopost.com/issues/july-25-2023/addition-of-relacorilant-to-nab-paclitaxel-in-recurrent-platinum-resistant-ovarian-cancer/ 2023-07-24T22:14:47+00:00 https://ascopost.com/issues/july-25-2023/omitting-mediastinal-radiotherapy-in-some-patients-with-primary-mediastinal-b-cell-lymphoma-after-immunochemotherapy/ 2023-07-24T22:14:48+00:00 https://ascopost.com/issues/july-25-2023/epov-corey-speers-and-julie-gralow/ 2023-07-24T22:14:49+00:00 https://ascopost.com/issues/july-25-2023/thor-trial-erdafitinib-improves-outcomes-vs-chemotherapy-in-fgfr-altered-advanced-urothelial-carcinoma/ 2023-07-24T22:14:50+00:00 https://ascopost.com/issues/july-25-2023/epov-daniel-petrylak/ 2023-07-24T22:14:51+00:00 https://ascopost.com/issues/july-25-2023/roundup-of-abstracts-on-new-therapies-for-gastrointestinal-cancers-from-asco-2023/ 2023-07-24T22:14:52+00:00 https://ascopost.com/issues/july-25-2023/continuum-in-locally-advanced-nasopharyngeal-cancer-addition-of-sintilimab-to-chemoradiotherapy-offers-benefit/ 2023-07-24T22:14:54+00:00 https://ascopost.com/issues/july-25-2023/epov-barbara-burtness/ 2023-07-24T22:14:54+00:00 https://ascopost.com/issues/july-25-2023/epov-saba-and-choe/ 2026-01-28T19:23:01+00:00 https://ascopost.com/issues/july-25-2023/quarterback-trial-de-escalation-of-chemoradiotherapy-for-subset-of-patients-with-hpv-positive-oropharyngeal-cancer/ 2023-07-24T22:14:57+00:00 https://ascopost.com/issues/july-25-2023/epov-priyanka-bhateja/ 2023-07-24T22:14:58+00:00 https://ascopost.com/issues/july-25-2023/investigators-evaluate-the-effect-of-body-mass-index-on-outcomes-in-patients-with-head-and-neck-cancer/ 2026-01-28T19:20:39+00:00 https://ascopost.com/issues/july-25-2023/current-management-of-and-future-possibilities-for-triple-negative-breast-cancer/ 2025-08-01T18:17:46+00:00 https://ascopost.com/issues/july-25-2023/congress-sends-asco-astro-supported-letter-on-cancer-drug-shortages-to-the-hhs-and-the-fda/ 2023-07-24T22:15:02+00:00 https://ascopost.com/issues/july-25-2023/glofitamab-gxbm-for-select-relapsed-or-refractory-large-b-cell-lymphomas/ 2023-07-24T22:15:03+00:00 https://ascopost.com/issues/july-25-2023/asco-cap-guideline-update-confirms-previous-recommendations-for-her2-testing-in-breast-cancer/ 2023-07-24T22:15:04+00:00 https://ascopost.com/issues/july-25-2023/implementation-of-clinical-treatment-act-advances-increasing-access-to-cancer-clinical-trials/ 2023-07-24T22:15:05+00:00 https://ascopost.com/issues/july-25-2023/asco-blueprint-report-captures-steady-progress-toward-equity-diversity-and-inclusion/ 2023-07-24T22:15:07+00:00 https://ascopost.com/issues/july-25-2023/asco-issues-statements-on-recent-us-supreme-court-rulings-on-affirmative-action-lgbtq-rights/ 2023-07-24T22:15:08+00:00 https://ascopost.com/issues/july-25-2023/i-want-to-kill-you/ 2023-07-24T22:15:09+00:00 https://ascopost.com/issues/july-25-2023/keeping-staff-and-patients-safe-from-workplace-violence/ 2023-07-28T14:39:36+00:00 https://ascopost.com/issues/august-10-2023/ 2023-08-10T17:08:15+00:00 https://ascopost.com/issues/august-10-2023/her2-low-status-is-dynamic-for-patients-with-triple-negative-breast-cancer/ 2023-09-07T19:57:32+00:00 https://ascopost.com/issues/august-10-2023/epov-barbara-pistilli/ 2023-08-10T17:08:16+00:00 https://ascopost.com/issues/august-10-2023/how-multidisciplinary-specialties-are-coming-together-to-improve-the-quality-of-life-of-cancer-survivors/ 2023-08-29T19:32:44+00:00 https://ascopost.com/issues/august-10-2023/on-the-art-of-organizing-best-of-asco-meetings/ 2023-08-10T17:08:19+00:00 https://ascopost.com/issues/august-10-2023/ebctcg-meta-analysis-confirms-benefit-of-ovarian-ablation-or-suppression-in-preventing-breast-cancer-recurrence/ 2023-08-10T17:08:22+00:00 https://ascopost.com/issues/august-10-2023/epov-ines-vaz-luis/ 2023-08-10T17:08:23+00:00 https://ascopost.com/issues/august-10-2023/three-studies-from-asco-2023-focus-on-metastatic-castration-resistant-prostate-cancer/ 2023-08-10T17:08:25+00:00 https://ascopost.com/issues/august-10-2023/imerge-trial-use-of-imetelstat-reduces-transfusion-dependence-in-lower-risk-mds/ 2023-08-10T17:08:26+00:00 https://ascopost.com/issues/august-10-2023/epov-anand-ashwin-patel/ 2023-08-10T17:08:33+00:00 https://ascopost.com/issues/august-10-2023/novel-hpv-targeted-agents-boost-efficacy-of-pembrolizumab-in-head-and-neck-cancer-two-studies-show/ 2023-08-10T17:08:35+00:00 https://ascopost.com/issues/august-10-2023/epov-erminia-massarelli/ 2023-08-10T17:08:37+00:00 https://ascopost.com/issues/august-10-2023/talazoparib-with-enzalutamide-in-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-08-10T17:08:38+00:00 https://ascopost.com/issues/august-10-2023/for-advanced-nasopharyngeal-cancer-adjuvant-gemcitabine-plus-cisplatin-favored-over-fluorouracil-plus-cisplatin-study-reports/ 2023-08-10T17:08:39+00:00 https://ascopost.com/issues/august-10-2023/asco-awarded-11-million-to-study-oral-drug-dosing-strategies-in-older-adults-with-metastatic-breast-cancer-receiving-cdk46-inhibitors/ 2023-09-07T19:58:17+00:00 https://ascopost.com/issues/august-10-2023/cancer-care-providers-applaud-new-federal-rule-regulating-short-term-limited-duration-plans/ 2023-08-10T17:08:43+00:00 https://ascopost.com/issues/august-10-2023/new-world-economic-forum-research-identifies-top-ai-applications-that-could-revolutionize-global-health-care/ 2023-08-10T17:08:44+00:00 https://ascopost.com/issues/august-10-2023/cll14-long-term-results-of-fixed-duration-venetoclax-plus-obinutuzumab-in-elderly-patients-with-cll/ 2023-09-20T16:47:22+00:00 https://ascopost.com/issues/august-10-2023/potential-of-quizartinib-for-improving-outcomes-in-acute-myeloid-leukemia/ 2023-09-20T16:44:44+00:00 https://ascopost.com/issues/august-10-2023/car-t-cell-therapies-trends-and-indications/ 2023-08-10T17:08:47+00:00 https://ascopost.com/issues/august-10-2023/first-line-atezolizumab-vs-single-agent-chemotherapy-in-patients-with-advanced-nsclc-ineligible-for-platinum-based-chemotherapy/ 2023-08-10T17:08:51+00:00 https://ascopost.com/issues/august-10-2023/incorporation-of-gilteritinib-into-induction-and-consolidation-chemotherapy-and-as-maintenance-therapy-in-newly-diagnosed-patients-with-aml/ 2023-08-10T17:08:53+00:00 https://ascopost.com/issues/august-10-2023/adjuvant-nivolumab-vs-observation-for-patients-with-completely-resected-merkel-cell-carcinoma/ 2023-08-10T17:08:56+00:00 https://ascopost.com/issues/august-10-2023/first-line-pembrolizumablenvatinib-in-advanced-non-clear-cell-renal-cell-carcinoma/ 2023-08-10T17:08:57+00:00 https://ascopost.com/issues/august-10-2023/susan-love-breast-cancer-surgeon-researcher-and-advocate/ 2023-09-07T18:49:26+00:00 https://ascopost.com/issues/august-10-2023/overcoming-financial-toxicity-from-cancer/ 2023-08-10T17:09:00+00:00 https://ascopost.com/issues/august-10-2023/american-society-for-radiation-oncology-names-newly-elected-officers-to-board-of-directors/ 2023-08-10T17:09:01+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/ 2023-08-17T13:15:28+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/hematologic-oncology-2023-almanac/ 2023-08-17T15:54:38+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/primary-overall-survival-analysis-supports-axicabtagene-ciloleucel-as-second-line-therapy-in-advanced-lymphoma/ 2023-08-17T13:15:30+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-caron-jacobson/ 2023-08-17T13:15:31+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/nivolumab-plus-avd-surpasses-standard-of-care-combination-regimen-in-patients-with-advanced-hodgkin-lymphoma/ 2023-08-17T13:15:32+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-ann-s-lacasce/ 2023-08-17T13:15:33+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/magnolia-trial-zanubrutinib-yields-high-response-rates-with-low-rate-of-cardiac-events-in-marginal-zone-lymphoma/ 2023-08-29T19:04:32+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-julio-chavez/ 2023-08-17T13:15:35+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/car-t-cell-therapy-vs-chemoimmunotherapy-in-second-line-treatment-of-resistant-large-b-cell-lymphoma/ 2023-08-17T13:15:36+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-catherine-s-diefenbach-md/ 2023-08-17T13:15:37+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/blinatumomab-improves-survival-in-mrd-negative-b-cell-acute-lymphoblastic-leukemia/ 2023-08-17T13:15:38+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-joseph-c-alvarnas/ 2023-08-17T13:15:39+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/is-zanubrutinib-poised-to-become-a-new-standard-of-care-in-relapsed-or-refractory-cll-and-sll/ 2023-08-17T13:15:40+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-alexey-danilov/ 2023-08-17T13:15:41+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/ruxolitinib-demonstrates-clinical-activity-in-a-phase-ii-trial-of-chronic-myelomonocytic-leukemia/ 2023-08-17T13:15:42+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-mrinal-s-patnaik-mbbs/ 2023-08-17T13:15:43+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/ciltacabtagene-autoleucel-beneficial-in-early-myeloma-relapse/ 2023-08-17T13:15:44+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-ciara-l-freeman-and-asher-chanan-khan/ 2023-08-17T13:15:45+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/elranatamab-induces-responses-in-many-patients-with-resistant-multiple-myeloma-in-phase-ii-trial/ 2023-08-24T18:17:18+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-urvi-shah/ 2023-08-17T13:15:47+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/study-shows-activity-of-talquetamab-in-highly-refractory-multiple-myeloma/ 2023-08-24T17:38:36+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/epov-ajay-k-nooka/ 2023-08-17T13:15:49+00:00 https://ascopost.com/issues/august-10-2023-supplement-hematologic-oncology-almanac/recent-fda-approvals-in-hematologic-oncology/ 2023-08-17T13:15:50+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/ 2023-08-18T13:30:52+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/genitourinary-oncology-2023-almanac/ 2023-08-18T13:30:53+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/continued-survival-benefit-with-first-line-lenvatinib-plus-pembrolizumab-in-advanced-kidney-cancer/ 2023-08-18T13:30:54+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/epov-david-a-braun/ 2023-08-18T13:30:55+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/addition-of-atezolizumab-to-cabozantinib-in-renal-cell-carcinoma-progressing-during-or-after-prior-immune-checkpoint-inhibition/ 2023-08-18T13:30:56+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/extended-follow-up-supports-first-line-use-of-nivolumab-plus-cabozantinib-in-advanced-renal-cell-carcinoma/ 2023-08-18T13:30:57+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/cosmic-313-triplet-therapy-is-active-in-renal-cell-carcinoma-but-toxicities-pose-a-challenge/ 2023-08-18T13:30:58+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/epov-sumanta-k-pal/ 2023-08-18T13:30:59+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/adjuvant-atezolizumab-does-not-improve-disease-free-survival-in-patients-with-rcc/ 2023-08-18T13:31:00+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/three-studies-from-asco-2023-focus-on-metastatic-castration-resistant-prostate-cancer/ 2023-08-18T13:31:00+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/improvement-in-progression-free-survival-with-first-line-olaparib-plus-abiraterone-in-metastatic-prostate-cancer/ 2023-08-18T13:31:01+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/epov-oliver-sartor/ 2023-08-18T13:31:03+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/darolutamide-plus-androgen-deprivation-therapy-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/ 2023-08-18T13:31:04+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/epov-monica-chatwal/ 2023-08-18T13:31:05+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/rucaparib-vs-physicians-choice-of-single-agent-therapy-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-08-18T13:31:07+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/thor-trial-erdafitinib-improves-outcomes-vs-chemotherapy-in-fgfr-altered-advanced-urothelial-carcinoma/ 2023-08-18T13:31:08+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/epov-daniel-petrylak/ 2023-08-18T13:31:10+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/continued-disease-free-survival-benefits-with-adjuvant-nivolumab-in-high-risk-urothelial-carcinoma/ 2023-08-18T13:31:12+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/epov-michiel-s-van-der-heijden/ 2023-08-18T13:31:14+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/sacituzumab-govitecan-hziy-achieves-response-after-disease-progression-on-immune-checkpoint-inhibitor-in-metastatic-urothelial-cancer/ 2023-08-18T13:31:16+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/epov-xin-gao/ 2023-08-18T13:31:19+00:00 https://ascopost.com/issues/august-25-2023-supplement-genitourinary-oncology-almanac/enfortumab-vedotin-plus-pembrolizumab-in-cisplatin-ineligible-patients-with-advanced-urothelial-cancer/ 2023-08-18T13:31:20+00:00 https://ascopost.com/issues/august-25-2023/ 2023-08-24T20:28:44+00:00 https://ascopost.com/issues/august-25-2023/new-challenge-in-triple-negative-breast-cancer-optimizing-the-sequencing-of-treatments/ 2023-09-11T13:34:17+00:00 https://ascopost.com/issues/august-25-2023/chemotherapy-shortage-impacts-patients-physicians-costs-and-clinical-trials/ 2023-08-31T20:18:49+00:00 https://ascopost.com/issues/august-25-2023/the-future-priorities-of-the-national-cancer-institute/ 2023-09-29T16:01:47+00:00 https://ascopost.com/issues/august-25-2023/is-chemotherapy-shortage-setting-back-clinical-trials/ 2023-09-29T16:01:48+00:00 https://ascopost.com/issues/august-25-2023/phergain-adapted-response-trial-guides-treatment-with-dual-her2-blockade-alone/ 2023-08-24T20:28:49+00:00 https://ascopost.com/issues/august-25-2023/epov-kevin-kalinsky/ 2023-08-24T20:28:50+00:00 https://ascopost.com/issues/august-25-2023/study-finds-durvalumab-plus-carboplatin-and-paclitaxel-effective-tolerable-in-frail-patients-with-head-and-neck-cancer/ 2026-01-28T19:11:45+00:00 https://ascopost.com/issues/august-25-2023/epov-barbara-burtness/ 2023-08-24T20:28:52+00:00 https://ascopost.com/issues/august-25-2023/early-phase-study-reports-activity-of-cabozantinib-and-cetuximab-combination-in-refractory-head-and-neck-cancer/ 2026-01-28T19:12:55+00:00 https://ascopost.com/issues/august-25-2023/fda-approves-trifluridine-and-tipiracil-with-bevacizumab-for-previously-treated-metastatic-colorectal-cancer/ 2023-12-27T17:24:25+00:00 https://ascopost.com/issues/august-25-2023/md-anderson-names-christopher-flowers-md-msc-fasco-division-head-of-cancer-medicine/ 2023-08-24T20:28:59+00:00 https://ascopost.com/issues/august-25-2023/gilteritinib-maintenance-therapy-after-transplantation-in-patients-with-flt3-itd-aml-who-have-measurable-residual-disease/ 2023-09-05T17:23:15+00:00 https://ascopost.com/issues/august-25-2023/epov-joshua-zeidner/ 2023-08-24T20:29:01+00:00 https://ascopost.com/issues/august-25-2023/artistry-7-and-rosella-phase-iii-trials-to-evaluate-novel-agents-in-platinum-resistant-ovarian-cancer/ 2023-08-24T20:29:02+00:00 https://ascopost.com/issues/august-25-2023/liquid-biopsy-assay-demonstrated-effectiveness-in-early-cancer-detection-in-asymptomatic-individuals-in-vietnam/ 2023-08-24T20:29:03+00:00 https://ascopost.com/issues/august-25-2023/noninvasive-multitarget-stool-dna-methylation-assay-under-study-in-early-detection-of-multiple-gastrointestinal-cancers/ 2023-08-24T20:29:05+00:00 https://ascopost.com/issues/august-25-2023/rapid-guideline-update-offers-key-evidence-based-recommendations-for-stage-iii-nsclc-management/ 2023-08-24T20:29:08+00:00 https://ascopost.com/issues/august-25-2023/how-the-cancer-moonshot-aims-to-improve-the-quality-of-life-for-adolescent-and-young-adult-cancer-survivors/ 2023-09-01T15:35:50+00:00 https://ascopost.com/issues/august-25-2023/more-on-the-complexity-of-prior-authorization/ 2023-08-24T20:29:10+00:00 https://ascopost.com/issues/august-25-2023/developing-solutions-for-cancer-care-disparities-across-geography/ 2023-08-24T20:29:12+00:00 https://ascopost.com/issues/september-10-2023/ 2023-09-11T19:36:51+00:00 https://ascopost.com/issues/september-10-2023/selinexor-shows-activity-as-maintenance-therapy-for-tp53-wild-type-endometrial-cancer-in-phase-iii-trial/ 2023-09-11T19:36:51+00:00 https://ascopost.com/issues/september-10-2023/epov-martina-c-murphy/ 2023-09-11T19:36:53+00:00 https://ascopost.com/issues/september-10-2023/dostarlimab-gxly-with-chemotherapy-for-endometrial-cancer/ 2023-09-11T19:36:54+00:00 https://ascopost.com/issues/september-10-2023/no-significant-benefit-for-lenvatinib-plus-pembrolizumab-in-non-msi-hdmmr-metastatic-colorectal-cancer/ 2023-10-06T16:34:06+00:00 https://ascopost.com/issues/september-10-2023/epov-cathy-eng/ 2023-09-11T19:36:56+00:00 https://ascopost.com/issues/september-10-2023/addition-of-nivolumab-to-stereotactic-ablative-radiotherapy-in-early-stage-or-isolated-lung-parenchymal-recurrent-nsclc/ 2023-09-11T19:36:57+00:00 https://ascopost.com/issues/september-10-2023/trifluridinetipiracil-plus-bevacizumab-in-previously-treated-metastatic-colorectal-cancer/ 2023-09-11T19:36:58+00:00 https://ascopost.com/issues/september-10-2023/nicholas-petrelli-md-facs-receives-lifetime-achievement-award-from-tulane-university-medical-school/ 2023-09-11T19:36:59+00:00 https://ascopost.com/issues/september-10-2023/vivek-subbiah-md-joins-scri-to-advance-early-phase-clinical-research/ 2023-09-11T19:37:00+00:00 https://ascopost.com/issues/september-10-2023/jesse-m-ehrenfeld-md-mph-inaugurated-as-president-of-the-ama/ 2023-09-11T19:37:02+00:00 https://ascopost.com/issues/september-10-2023/instinct-and-perseverance-helped-save-me-from-two-cancers/ 2023-09-11T19:37:02+00:00 https://ascopost.com/issues/september-10-2023/there-s-an-app-for-that-digital-health-solutions-for-treating-insomnia-in-cancer-survivors/ 2023-09-11T19:37:03+00:00 https://ascopost.com/issues/september-10-2023/benjamin-besse-md-phd-chooses-a-career-in-medicine-over-music/ 2023-09-11T19:37:04+00:00 https://ascopost.com/issues/september-10-2023/new-updated-edition-of-a-classic-in-hematology-literature/ 2023-09-11T19:37:06+00:00 https://ascopost.com/issues/september-10-2023/thomas-j-herzog-md-takes-office-as-president-of-the-gog-foundation-inc/ 2023-09-11T19:37:07+00:00 https://ascopost.com/issues/september-10-2023/a-near-future-look-at-medicine-when-ai-has-a-mind-of-its-own/ 2023-09-11T19:37:08+00:00 https://ascopost.com/issues/september-10-2023/rising-after-struggle-surviving-my-first-asco-breakthrough-in-japan/ 2023-09-11T19:37:09+00:00 https://ascopost.com/issues/september-10-2023/asco-remembers-chemotherapy-pioneer-and-karnofsky-award-recipient-irwin-h-krakoff-md/ 2023-09-11T19:37:10+00:00 https://ascopost.com/issues/september-10-2023/crystal-s-denlinger-md-facp-named-new-chief-executive-officer-of-nccn/ 2023-09-11T19:37:11+00:00 https://ascopost.com/issues/september-10-2023/study-shows-exercise-may-improve-sexual-function-in-men-with-prostate-cancer/ 2023-09-11T19:37:12+00:00 https://ascopost.com/issues/september-10-2023/predicting-recurrence-in-colorectal-cancer-using-postoperative-circulating-tumor-dna-dynamics/ 2023-10-06T16:30:43+00:00 https://ascopost.com/issues/september-10-2023/epov-peter-paul-yu/ 2023-09-11T19:37:14+00:00 https://ascopost.com/issues/september-10-2023/updates-on-cancer-therapies-under-study-from-2023-asco-breakthrough/ 2023-09-11T19:37:16+00:00 https://ascopost.com/issues/september-10-2023/gut-microbiome-differs-in-responders-and-nonresponders-to-immune-checkpoint-inhibitors-in-patients-with-hcc/ 2023-09-11T19:37:16+00:00 https://ascopost.com/issues/september-10-2023/epov-peter-paul-yu-1/ 2023-09-11T19:37:17+00:00 https://ascopost.com/issues/september-10-2023/ai-based-tool-aids-in-diagnosis-of-cervical-cancers-and-precancers/ 2023-09-11T19:37:18+00:00 https://ascopost.com/issues/september-10-2023/phase-iii-trial-reports-chemoimmunotherapy-is-superior-to-chemotherapy-alone-in-malignant-pleural-mesothelioma/ 2023-09-11T19:37:19+00:00 https://ascopost.com/issues/september-10-2023/study-shows-benefit-with-addition-of-tumor-treating-fields-therapy-in-metastatic-non-small-cell-lung-cancer/ 2023-09-11T19:37:21+00:00 https://ascopost.com/issues/september-10-2023/more-on-multiple-myeloma-from-asco-2023-focus-on-bispecific-antibodies/ 2023-10-02T18:48:34+00:00 https://ascopost.com/issues/september-10-2023/more-on-melanoma-from-asco-2023-focus-on-two-different-treatment-strategies/ 2023-09-25T15:46:29+00:00 https://ascopost.com/issues/september-10-2023/more-on-treatments-under-study-in-non-small-cell-lung-cancer-from-asco-2023/ 2023-09-13T17:53:03+00:00 https://ascopost.com/issues/september-10-2023/first-in-class-bifunctional-antibody-plus-pembrolizumab-shows-activity-in-head-and-neck-squamous-cell-carcinoma/ 2023-09-11T19:37:26+00:00 https://ascopost.com/issues/september-10-2023/fda-grants-accelerated-approval-to-elranatamab-bcmm-for-patients-with-relapsed-or-refractory-multiple-myeloma/ 2023-09-11T19:37:28+00:00 https://ascopost.com/issues/september-10-2023/incremental-gains-toward-better-outcomes-in-small-cell-lung-cancer/ 2023-09-13T17:17:23+00:00 https://ascopost.com/issues/september-10-2023/quizartinib-in-newly-diagnosed-flt3-itd-positive-acute-myeloid-leukemia/ 2023-09-11T19:37:30+00:00 https://ascopost.com/issues/september-10-2023/ishwaria-subbiah-joins-scri-as-executive-director-cancer-care-equity-and-professional-wellness/ 2023-09-11T19:37:31+00:00 https://ascopost.com/issues/september-10-2023/atrium-health-levine-children-s-expands-to-include-new-outpatient-center-for-cancer-and-blood-disorders/ 2023-09-11T19:37:32+00:00 https://ascopost.com/issues/september-10-2023/perspectives-on-cancer-therapy-development/ 2023-09-11T19:37:33+00:00 https://ascopost.com/issues/september-10-2023/data-analysis-of-young-onset-lung-cancer-reveals-key-differences-compared-with-the-disease-in-older-adults/ 2023-09-11T19:37:35+00:00 https://ascopost.com/issues/september-10-2023/asco-updates-guideline-on-assessment-management-of-vulnerabilities-in-older-patients-receiving-systemic-cancer-therapy/ 2023-09-11T19:37:37+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/ 2023-09-14T16:44:57+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/head-and-neck-cancers-2022-2023-almanac/ 2026-01-28T18:36:39+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/pembrolizumab-plus-chemoradiation-therapy-falls-short-in-locally-advanced-head-and-neck-cancer/ 2026-01-28T18:49:39+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epov-glenn-j-hanna-and-sherene-loi/ 2023-09-14T16:45:00+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/cabozantinib-plus-atezolizumab-warrants-further-study-in-treatment-of-advanced-head-and-neck-cancer/ 2026-01-28T18:47:59+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epov-renata-ferrarotto/ 2023-09-14T16:45:02+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/could-fluorouracil-free-first-line-regimen-challenge-the-standard-of-care-in-advanced-head-and-neck-cancer/ 2026-01-28T18:45:59+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/first-in-class-bifunctional-antibody-plus-pembrolizumab-shows-activity-in-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T18:44:14+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/novel-hpv-targeted-agents-boost-efficacy-of-pembrolizumab-in-head-and-neck-cancer-two-studies-show/ 2026-01-28T18:41:55+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epov-erminia-massarelli/ 2026-01-28T18:40:42+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/ficlatuzumab-with-or-without-cetuximab-in-pan-refractory-recurrentmetastatic-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T19:52:22+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/first-in-class-agent-given-with-chemoradiotherapy-improves-survival-in-locally-advanced-head-and-neck-cancer-study-finds/ 2026-01-28T18:38:57+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/addition-of-pazopanib-to-concurrent-radiotherapy-and-paclitaxel-in-anaplastic-thyroid-cancer/ 2023-09-14T16:45:09+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/genomic-screening-may-help-detect-medullary-thyroid-cancer-study-finds/ 2023-09-14T16:45:10+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epigenetic-imprinted-biomarker-test-to-identify-malignant-thyroid-nodules/ 2023-09-14T16:45:12+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/continuum-in-locally-advanced-nasopharyngeal-cancer-addition-of-sintilimab-to-chemoradiotherapy-offers-benefit/ 2026-01-28T18:35:36+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epov-barbara-burtness/ 2026-01-28T18:34:19+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/jupiter-02-toripalimab-plus-chemotherapy-improved-survival-outcomes-for-some-patients-with-advanced-nasopharyngeal-carcinoma/ 2026-01-28T19:25:48+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epov-saba-and-choe/ 2026-01-28T18:32:43+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/for-advanced-nasopharyngeal-cancer-adjuvant-gemcitabine-plus-cisplatin-favored-over-fluorouracil-plus-cisplatin-study-reports/ 2026-01-28T18:29:55+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/study-finds-durvalumab-plus-carboplatin-and-paclitaxel-effective-tolerable-in-frail-patients-with-head-and-neck-cancer/ 2026-01-28T18:28:16+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epov-barbara-burtness-1/ 2023-09-14T16:45:18+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/quarterback-trial-de-escalation-of-chemoradiotherapy-for-subset-of-patients-with-hpv-positive-oropharyngeal-cancer/ 2026-01-28T18:25:42+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/epov-priyanka-bhateja/ 2026-01-28T18:23:26+00:00 https://ascopost.com/issues/september-10-2023-supplement-head-neck-cancer-almanac/dysphagia-optimized-vs-standard-imrt-in-newly-diagnosed-patients-with-head-and-neck-cancer/ 2026-01-28T18:15:47+00:00 https://ascopost.com/issues/september-25-2023/ 2023-09-25T16:33:51+00:00 https://ascopost.com/issues/september-25-2023/first-line-pembrolizumab-plus-lenvatinib-active-in-advanced-non-clear-cell-renal-cell-carcinoma/ 2023-09-25T16:33:52+00:00 https://ascopost.com/issues/september-25-2023/accelerating-progress-against-cancer-and-other-life-threatening-diseases/ 2023-09-25T16:33:53+00:00 https://ascopost.com/issues/september-25-2023/distributing-scarce-cancer-drugs-legally-and-ethically/ 2023-09-25T16:33:54+00:00 https://ascopost.com/issues/september-25-2023/understanding-the-treatment-of-waldenstroem-s-macroglobulinemia/ 2023-09-26T15:16:04+00:00 https://ascopost.com/issues/september-25-2023/highlights-in-cancer-and-aging-from-the-2023-asco-annual-meeting/ 2023-10-05T18:28:20+00:00 https://ascopost.com/issues/september-25-2023/focus-on-atezolizumab-plus-cabozantinib-vs-cabozantinib-alone/ 2023-10-13T16:46:55+00:00 https://ascopost.com/issues/september-25-2023/more-on-biliary-tract-cancer-from-asco-2023-focus-on-zanidatamab/ 2023-09-25T16:33:57+00:00 https://ascopost.com/issues/september-25-2023/ipilimumab-plus-nivolumab-may-improve-outcomes-in-refractory-metastatic-melanoma-study-suggests/ 2023-10-21T18:37:58+00:00 https://ascopost.com/issues/september-25-2023/new-assistant-program-director-for-complex-general-surgical-oncology-fellowship-at-fox-chase-cancer-center/ 2023-09-25T16:33:59+00:00 https://ascopost.com/issues/september-25-2023/fixed-dose-niraparib-and-abiraterone-plus-prednisone-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2023-09-25T16:34:00+00:00 https://ascopost.com/issues/september-25-2023/accelerated-approval-granted-for-talquetamab-tgvs-in-treatment-of-relapsed-or-refractory-multiple-myeloma/ 2023-09-25T16:34:02+00:00 https://ascopost.com/issues/september-25-2023/astro-names-fastro-recipients-for-2023/ 2023-09-25T16:34:03+00:00 https://ascopost.com/issues/september-25-2023/asco-releases-rapid-recommendation-update-on-use-of-olanzapine-to-treat-cancer-related-cachexia/ 2023-09-25T16:34:03+00:00 https://ascopost.com/issues/september-25-2023/asco-participates-in-president-s-cancer-panel/ 2023-09-25T16:34:04+00:00 https://ascopost.com/issues/september-25-2023/sio-and-asco-partner-to-develop-integrative-oncology-care-recommendations-for-anxiety-and-depression-in-patients-with-cancer/ 2023-09-25T16:34:05+00:00 https://ascopost.com/issues/september-25-2023/ibrutinib-included-among-the-10-drugs-slated-for-medicare-price-negotiations/ 2023-09-25T16:34:06+00:00 https://ascopost.com/issues/september-25-2023/from-texas-to-sweden-medical-oncologist-gil-morgan-enjoys-connecting-the-cancer-community/ 2023-09-25T16:34:07+00:00 https://ascopost.com/issues/september-25-2023/vorasidenib-in-idh1-or-idh2-mutant-grade-2-glioma/ 2023-09-25T16:34:08+00:00 https://ascopost.com/issues/september-25-2023/fda-approves-melphalan-hepatic-delivery-system-for-adult-patients-with-unresectable-hepatic-dominant-metastatic-uveal-melanoma/ 2023-09-25T16:34:09+00:00 https://ascopost.com/issues/september-25-2023/retrospective-study-reports-tyrosine-kinase-inhibitor-used-in-cml-associated-with-nephrotoxicity/ 2023-09-25T16:34:10+00:00 https://ascopost.com/issues/september-25-2023/acs-funds-uams-study-to-understand-treatment-resistance-in-pancreatic-cancer/ 2023-09-25T16:34:10+00:00 https://ascopost.com/issues/september-25-2023/surgical-oncologist-heber-salvador-offers-an-inside-look-at-cancer-care-in-brazil-complete-with-its-diversity-and-inequities/ 2023-09-25T16:34:11+00:00 https://ascopost.com/issues/september-25-2023/finding-a-new-life-purpose-after-cancer/ 2023-09-25T16:34:12+00:00 https://ascopost.com/issues/september-25-2023/catalyzing-change-young-moroccan-oncologists-spearhead-the-fight-against-sarcoma/ 2023-09-26T14:13:39+00:00 https://ascopost.com/issues/september-25-2023/27th-cancer-leadership-awards-recipients-announced-by-friends-of-cancer-research/ 2023-10-05T19:47:32+00:00 https://ascopost.com/issues/september-25-2023/city-of-hope-receives-323-million-from-cirm-to-advance-innovative-therapies/ 2023-09-25T16:34:15+00:00 https://ascopost.com/issues/september-25-2023/md-anderson-and-ochsner-health-partner-to-create-first-fully-integrated-cancer-program-in-louisiana/ 2023-09-25T16:34:16+00:00 https://ascopost.com/issues/october-10-2023/ 2023-10-10T16:23:18+00:00 https://ascopost.com/issues/october-10-2023/circulating-tumor-dna-identified-in-breast-milk-from-women-with-breast-cancer-first-results-published/ 2023-10-10T16:23:19+00:00 https://ascopost.com/issues/october-10-2023/national-inventors-hall-of-fame-recognizes-jennifer-doudna-phd-emmanuelle-charpentier-phd-and-angela-hartley-brodie-phd/ 2023-10-23T17:28:00+00:00 https://ascopost.com/issues/october-10-2023/from-a-sleepy-town-in-pakistan-seema-a-khan-md-mph-emerges-as-a-leader-in-surgical-oncology/ 2023-10-10T16:23:22+00:00 https://ascopost.com/issues/october-10-2023/psilocybin/ 2023-10-10T16:23:23+00:00 https://ascopost.com/issues/october-10-2023/a-diagnosis-of-ewing-sarcoma-altered-the-trajectory-of-my-life/ 2023-10-10T16:23:24+00:00 https://ascopost.com/issues/october-10-2023/flaura2-trial-osimertinib-plus-chemotherapy-improves-outcomes-in-advanced-egfr-positive-nsclc/ 2023-11-17T16:17:59+00:00 https://ascopost.com/issues/october-10-2023/epov-roy-herbst/ 2023-11-17T16:14:32+00:00 https://ascopost.com/issues/october-10-2023/tracking-the-progress-being-made-in-the-treatment-of-breast-cancer-and-the-challenges-ahead/ 2023-10-10T16:23:28+00:00 https://ascopost.com/issues/october-10-2023/decentralized-care-models-empower-equitable-pediatric-cancer-treatment/ 2023-10-10T16:23:30+00:00 https://ascopost.com/issues/october-10-2023/checkpoint-inhibitors-offer-limited-benefit-in-egfr-mutated-lung-cancer-after-disease-progression/ 2023-11-17T16:11:36+00:00 https://ascopost.com/issues/october-10-2023/epov-justin-gainor/ 2023-11-17T16:10:42+00:00 https://ascopost.com/issues/october-10-2023/nuc-1031cisplatin-fails-to-improve-outcomes-in-advanced-biliary-tract-cancer/ 2023-10-10T16:23:34+00:00 https://ascopost.com/issues/october-10-2023/epov-gentry-king/ 2023-10-10T16:23:35+00:00 https://ascopost.com/issues/october-10-2023/accelerated-approval-granted-for-use-of-elranatamab-bcmm-in-relapsed-or-refractory-multiple-myeloma/ 2023-10-10T16:23:36+00:00 https://ascopost.com/issues/october-10-2023/melphalan-based-liver-directed-therapy-for-metastatic-uveal-melanoma/ 2023-10-10T16:23:38+00:00 https://ascopost.com/issues/october-10-2023/patterns-in-early-onset-cancer-in-the-united-states-from-2010-to-2019/ 2023-10-10T16:23:39+00:00 https://ascopost.com/issues/october-10-2023/asco-and-state-affiliates-wrap-up-successful-state-sessions/ 2023-10-10T16:23:40+00:00 https://ascopost.com/issues/october-10-2023/guideline-update-reflects-recent-surge-of-new-data-in-systemic-therapy-for-melanoma/ 2023-10-10T16:23:41+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/ 2023-10-17T14:43:48+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/breast-cancer-2022-2023-almanac/ 2023-10-17T14:43:48+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/ebctcg-meta-analysis-confirms-benefit-of-ovarian-ablation-or-suppression-in-preventing-breast-cancer-recurrence/ 2023-10-17T14:43:49+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-ines-vaz-luis/ 2023-10-17T14:43:50+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/update-from-monarche-benefit-of-abemaciclib-increases-over-time-in-early-stage-breast-cancer/ 2023-10-17T14:43:51+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-nancy-chan/ 2023-10-17T14:43:52+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/emerald-trial-elacestrant-vs-standard-endocrine-monotherapy-for-advanced-breast-cancer-after-cdk46-inhibition/ 2023-10-17T14:43:53+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-seth-wander/ 2023-10-17T14:43:54+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/t-dxd-confirmed-as-preferred-second-line-therapy-for-metastatic-her2-positive-breast-cancer/ 2023-10-17T14:43:55+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-neelima-vidula/ 2023-10-17T14:43:57+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/palbociclibfulvestrant-does-not-improve-progression-free-survival-after-progression-on-a-cdk46-inhibitor-in-metastatic-breast-cancer/ 2023-10-17T14:43:58+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-debu-tripathy/ 2023-10-17T14:43:59+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/capivasertib-plus-fulvestrant-doubles-progression-free-survival-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/ 2023-10-17T14:44:00+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-virginia-kaklamani/ 2023-10-17T14:44:01+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/soft-analysis-breast-cancer-index-may-identify-which-patients-need-ovarian-suppression/ 2023-10-17T14:44:02+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-polly-niravath-and-virginia-kaklamani/ 2023-10-17T14:44:03+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/can-younger-women-with-hormone-receptor-positive-breast-cancer-safely-pause-endocrine-therapy-to-pursue-pregnancy/ 2023-10-17T14:44:04+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-virginia-kaklamani-md/ 2023-10-17T14:44:05+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/overall-survival-in-two-monarch-trials-of-abemaciclib-in-advanced-breast-cancer/ 2023-10-17T14:44:06+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-meritxell-bellet-ezquerra-and/ 2023-10-17T14:44:07+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/recent-fda-approvals-in-breast-cancer/ 2023-10-17T14:44:08+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/extended-follow-up-of-tropics-02-trial-sacituzumab-govitecan-in-metastatic-breast-cancer/ 2023-10-17T14:44:09+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-barbara-pistilli/ 2023-10-17T14:44:10+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/adjuvant-treatment-with-ribociclib-reduces-risk-of-recurrence-in-hormone-receptor-positive-her2-negative-early-stage-breast-cancer/ 2023-10-17T14:44:11+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-rita-nanda/ 2023-10-17T14:44:12+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/should-cdk46-inhibitors-be-a-first-line-option-for-advanced-hormone-receptor-positive-her2-negative-breast-cancer/ 2023-10-17T14:44:13+00:00 https://ascopost.com/issues/october-10-2023-supplement-breast-cancer-almanac/epov-daniel-g-stover/ 2023-10-17T14:44:14+00:00 https://ascopost.com/issues/october-25-2023/ 2023-10-25T15:08:39+00:00 https://ascopost.com/issues/october-25-2023/quality-of-life-maintained-for-many-patients-treated-with-ribociclib-for-early-stage-breast-cancer/ 2023-10-25T15:08:43+00:00 https://ascopost.com/issues/october-25-2023/epov-michail-ignatiadis-and-stephen-rd-johnston/ 2023-10-25T15:08:44+00:00 https://ascopost.com/issues/october-25-2023/gender-equity-in-academic-hematology-where-there-s-a-wil-there-s-a-way/ 2023-10-25T15:08:45+00:00 https://ascopost.com/issues/october-25-2023/the-new-era-of-perioperative-therapy-in-non-small-cell-lung-cancer/ 2023-10-25T15:08:51+00:00 https://ascopost.com/issues/october-25-2023/diagnosis-of-cardiovascular-disease-and-risk-of-subsequent-incident-cancer-diagnosis/ 2023-10-25T15:08:52+00:00 https://ascopost.com/issues/october-25-2023/annual-report-to-the-nation-on-covid-19-s-impact-on-cancer-diagnosis-finds-sharp-declines-in-new-diagnoses-of-six-major-cancers/ 2023-10-25T15:08:53+00:00 https://ascopost.com/issues/october-25-2023/overcoming-the-challenges-of-treating-adolescents-and-young-adults-with-cancer-living-in-rural-communities/ 2023-10-25T16:49:46+00:00 https://ascopost.com/issues/october-25-2023/asco-response-to-drug-shortages-request-for-information/ 2023-10-25T15:08:55+00:00 https://ascopost.com/issues/october-25-2023/cms-congress-must-work-together-to-support-access-to-cancer-care-and-physician-practice-health/ 2023-10-25T15:08:57+00:00 https://ascopost.com/issues/october-25-2023/from-humble-beginnings-elisabete-weiderpass-distinguishes-herself-as-first-woman-to-head-the-iarc/ 2023-10-25T15:08:58+00:00 https://ascopost.com/issues/october-25-2023/pembrolizumabolaparib-vs-next-generation-hormonal-agents-in-previously-treated-patients-with-biomarker-unselected-metastatic-castration-resistant-prostate-cancer/ 2023-10-25T15:08:59+00:00 https://ascopost.com/issues/october-25-2023/neoadjuvant-folfox-vs-chemoradiotherapy-in-locally-advanced-rectal-cancer/ 2023-10-25T15:09:00+00:00 https://ascopost.com/issues/october-25-2023/encorafenib-and-binimetinib-in-braf-v600e-mutant-metastatic-nsclc/ 2023-10-25T15:09:01+00:00 https://ascopost.com/issues/october-25-2023/trop-2-directed-antibody-drug-conjugate-datopotamab-deruxtecan-in-advanced-nsclc/ 2023-10-25T17:06:25+00:00 https://ascopost.com/issues/october-25-2023/breakthrough-prize-oscars-of-science-celebrates-2024-laureates-in-life-sciences/ 2023-10-25T15:09:04+00:00 https://ascopost.com/issues/october-25-2023/getting-a-cancer-diagnosis-at-age-16-has-taught-me-to-live-in-the-present/ 2023-10-25T15:09:05+00:00 https://ascopost.com/issues/october-25-2023/university-of-arizona-welcomes-thoracic-surgeon-praveen-sridhar/ 2023-10-25T15:09:06+00:00 https://ascopost.com/issues/october-25-2023/fda-approves-new-updated-indications-for-temozolomide/ 2023-10-25T15:09:07+00:00 https://ascopost.com/issues/november-10-2023/ 2023-11-10T16:26:18+00:00 https://ascopost.com/issues/november-10-2023/association-urges-congress-to-prioritize-childhood-cancer-funding-research/ 2023-11-10T16:26:21+00:00 https://ascopost.com/issues/november-10-2023/addition-of-tumor-treating-fields-therapy-to-standard-systemic-therapy-improves-survival-in-metastatic-nsclc-after-progression-on-platinum-based-therapy/ 2023-11-10T16:26:22+00:00 https://ascopost.com/issues/november-10-2023/british-pharmacological-society-names-v-craig-jordan-dsc-phd-recipient-of-the-sir-henry-wellcome-gold-medal/ 2023-11-10T16:26:23+00:00 https://ascopost.com/issues/november-10-2023/understanding-patient-engagement-in-virtual-mind-body-therapies/ 2023-11-10T16:26:25+00:00 https://ascopost.com/issues/november-10-2023/having-colorectal-cancer-at-32-changed-the-trajectory-of-my-life/ 2023-12-08T16:53:49+00:00 https://ascopost.com/issues/november-10-2023/asco-launches-asco-certified-to-ensure-the-delivery-of-high-quality-patient-centered-cancer-care-to-every-patient/ 2023-11-10T16:26:27+00:00 https://ascopost.com/issues/november-10-2023/how-asco-is-tackling-the-need-to-improve-workforce-diversity-and-the-looming-oncology-workforce-shortage/ 2023-11-13T18:47:16+00:00 https://ascopost.com/issues/november-10-2023/screening-for-lung-cancer-much-work-remains-to-be-done/ 2023-11-10T16:26:32+00:00 https://ascopost.com/issues/november-10-2023/pace-trials-support-stereotactic-body-radiotherapy-for-some-patients-with-localized-prostate-cancer/ 2023-11-10T16:26:33+00:00 https://ascopost.com/issues/november-10-2023/epov-neha-vapiwala/ 2023-11-10T16:26:34+00:00 https://ascopost.com/issues/november-10-2023/stereotactic-body-radiation-therapy-demonstrates-exceptional-control-in-primary-renal-cell-carcinoma/ 2023-11-10T16:26:35+00:00 https://ascopost.com/issues/november-10-2023/epov-rohann-correa/ 2023-11-10T16:26:36+00:00 https://ascopost.com/issues/november-10-2023/cardiovascular-disease-and-cancer-a-reciprocal-relationship/ 2023-11-10T16:26:38+00:00 https://ascopost.com/issues/november-25-2023/ 2023-11-22T16:09:43+00:00 https://ascopost.com/issues/november-25-2023/two-studies-show-improved-survival-with-novel-front-line-combinations-in-advanced-urothelial-carcinoma/ 2023-12-15T17:13:32+00:00 https://ascopost.com/issues/november-25-2023/epov-andrea-apolo/ 2023-11-22T16:09:44+00:00 https://ascopost.com/issues/november-25-2023/aacr-annual-cancer-progress-report-highlights-scientific-advances-against-cancer-challenges-and-opportunities-ahead/ 2023-11-22T16:09:45+00:00 https://ascopost.com/issues/november-25-2023/value-of-some-established-treatment-practices-in-chronic-myeloid-leukemia/ 2023-12-20T17:51:16+00:00 https://ascopost.com/issues/november-25-2023/tropion-breast01-and-destiny-breast04-antibody-drug-conjugates-of-benefit-in-patients-with-metastatic-breast-cancer/ 2023-12-07T20:31:59+00:00 https://ascopost.com/issues/november-25-2023/epov-sarat-chandarlapaty/ 2023-11-22T16:09:48+00:00 https://ascopost.com/issues/november-25-2023/in-recurrent-cervical-cancer-tisotumab-vedotin-tftv-improves-overall-survival-in-phase-iii-trial/ 2023-11-22T16:09:49+00:00 https://ascopost.com/issues/november-25-2023/epov-krishnansu-tewari/ 2023-11-22T16:09:50+00:00 https://ascopost.com/issues/november-25-2023/durvalumab-based-treatment-with-or-without-olaparib-boosts-progression-free-survival-in-endometrial-cancer/ 2023-11-22T16:09:51+00:00 https://ascopost.com/issues/november-25-2023/epov-domenica-lorusso/ 2023-11-22T16:09:51+00:00 https://ascopost.com/issues/november-25-2023/adjuvant-everolimus-improves-recurrence-free-survival-in-very-high-risk-renal-cell-carcinoma/ 2023-11-22T16:09:52+00:00 https://ascopost.com/issues/november-25-2023/perioperative-durvalumab-improves-surgical-outcomes-in-resectable-nsclc/ 2023-11-22T16:09:53+00:00 https://ascopost.com/issues/november-25-2023/epov-solange-peters-and-upal-basu-roy/ 2023-11-22T16:09:54+00:00 https://ascopost.com/issues/november-25-2023/combination-of-ceralasertib-and-durvalumab-shows-activity-in-phase-ii-trial-of-advanced-nsclc/ 2023-11-22T16:09:55+00:00 https://ascopost.com/issues/november-25-2023/short-course-radiotherapy-may-reduce-resource-burden-of-head-and-neck-cancer-treatment-in-low-and-middle-income-countries/ 2023-11-22T16:09:56+00:00 https://ascopost.com/issues/november-25-2023/epov-beth-beadle/ 2023-11-22T16:09:57+00:00 https://ascopost.com/issues/november-25-2023/survivors-of-childhood-cancer-study-shows-heart-related-ailments-linked-to-radiotherapy-dose/ 2023-11-22T16:09:58+00:00 https://ascopost.com/issues/november-25-2023/epov-bonnie-ky/ 2023-11-22T16:09:59+00:00 https://ascopost.com/issues/november-25-2023/hypofractionation-shows-comparable-results-to-conventional-postmastectomy-radiation-therapy-with-added-benefits/ 2023-11-22T16:10:00+00:00 https://ascopost.com/issues/november-25-2023/epov-lori-j-pierce/ 2023-11-22T16:10:01+00:00 https://ascopost.com/issues/november-25-2023/studies-explore-efficacy-of-venetoclax-in-t-1114-positive-myeloma/ 2024-09-27T17:01:46+00:00 https://ascopost.com/issues/november-25-2023/epov-faith-e-davies/ 2023-11-22T16:10:03+00:00 https://ascopost.com/issues/november-25-2023/olaparib-plus-abiraterone-in-metastatic-castration-resistant-prostate-cancer-unselected-for-hrr-mutation-status/ 2023-11-22T16:10:04+00:00 https://ascopost.com/issues/november-25-2023/asco-rapid-recommendation-update-cautions-against-triplet-therapy-for-metastatic-clear-cell-rcc/ 2023-11-22T16:10:05+00:00 https://ascopost.com/issues/november-25-2023/the-progress-of-delivering-high-quality-cancer-care-takes-center-stage-at-workshop/ 2023-11-22T16:10:06+00:00 https://ascopost.com/issues/november-25-2023/first-line-dabrafenib-plus-trametinib-vs-standard-chemotherapy-for-pediatric-low-grade-glioma-with-braf-v600-mutations/ 2023-11-22T16:10:07+00:00 https://ascopost.com/issues/november-25-2023/astrum-004-serplulimab-plus-chemotherapy-as-first-line-treatment-of-advanced-squamous-non-small-cell-lung-cancer/ 2023-11-22T16:10:08+00:00 https://ascopost.com/issues/november-25-2023/epov-justin-gainor/ 2023-11-22T16:10:08+00:00 https://ascopost.com/issues/november-25-2023/small-study-identifies-safe-effective-radiation-dose-to-add-to-neoadjuvant-chemotherapy-and-durvalumab/ 2023-11-22T16:10:09+00:00 https://ascopost.com/issues/november-25-2023/optimizing-treatment-selection-for-newly-diagnosed-and-secondary-aml-focus-on-cytogenetic-and-molecular-data/ 2023-11-22T16:10:10+00:00 https://ascopost.com/issues/november-25-2023/updates-in-lower-risk-myelodysplastic-syndromesneoplasms/ 2023-11-22T16:10:11+00:00 https://ascopost.com/issues/november-25-2023/cardiac-imaging-and-biomarkers-for-patients-receiving-cancer-treatment-what-oncologists-need-to-know/ 2023-11-22T16:10:12+00:00 https://ascopost.com/issues/november-25-2023/first-line-selpercatinib-vs-chemotherapy-with-or-without-pembrolizumab-in-ret-fusion-positive-nsclc/ 2023-11-22T16:10:13+00:00 https://ascopost.com/issues/november-25-2023/small-breast-cancer-omission-of-axillary-surgery-vs-sentinel-lymph-node-biopsy/ 2023-11-22T16:10:14+00:00 https://ascopost.com/issues/november-25-2023/addition-of-first-line-pembrolizumab-to-chemotherapy-in-her2-negative-advanced-gastric-cancer/ 2023-11-22T16:10:15+00:00 https://ascopost.com/issues/november-25-2023/from-a-small-town-in-the-rust-belt-dennis-slamon-plays-a-big-role-in-changing-the-face-of-breast-cancer-treatment/ 2023-12-07T18:43:18+00:00 https://ascopost.com/issues/november-25-2023/a-cancer-diagnosis-at-19-taught-me-that-it-takes-constant-vigilance-to-stay-mentally-healthy/ 2025-08-25T16:59:06+00:00 https://ascopost.com/issues/november-25-2023/society-for-integrative-oncology-celebrates-20-years-of-excellence/ 2023-11-22T16:10:17+00:00 https://ascopost.com/issues/november-25-2023/bosutinib-in-pediatric-chronic-myeloid-leukemia/ 2023-11-22T16:10:18+00:00 https://ascopost.com/issues/november-25-2023/national-academy-of-medicine-elects-new-members/ 2023-11-22T16:10:19+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/ 2023-11-27T18:04:39+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/highlights-from-the-2023-world-conference-on-lung-cancer/ 2023-11-27T18:04:39+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/extended-pleurectomy-decortication-plus-chemotherapy-for-mesothelioma-linked-to-increased-risk-of-death-in-mars-2-trial/ 2023-11-27T18:04:40+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-paula-antonia-ugalde/ 2023-11-27T18:04:42+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/taiwan-national-lung-cancer-early-detection-screening-program-targets-smokers-and-nonsmokers-with-family-history/ 2023-11-27T18:04:43+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/kras-g12c-inhibitors-durability-of-response-efficacy-in-combination-in-nsclc/ 2023-11-27T18:04:44+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-gerard-a-silvestri/ 2023-11-27T18:04:45+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/flaura2-trial-osimertinib-plus-chemotherapy-improves-outcomes-in-advanced-egfr-positive-nsclc/ 2023-11-27T18:04:46+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-roy-herbst/ 2023-11-27T18:04:47+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/antitumor-activity-shown-with-her3-dxd-in-egfr-mutated-nsclc/ 2023-11-27T18:04:49+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-helena-linardou/ 2023-11-27T18:04:50+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/iruplinalkib-demonstrates-improved-efficacy-and-tolerance-vs-crizotinib-in-alk-inhibitor-naive-advanced-alk-positive-nsclc/ 2023-11-27T18:04:51+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-hiroaki-akamatsu/ 2023-11-27T18:04:52+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/antibody-drug-conjugate-ifinatamab-deruxtecan-shows-robust-activity-in-refractory-small-cell-lung-cancer/ 2023-11-27T18:04:53+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-helena-linardou-1/ 2023-11-27T18:04:54+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/role-of-trop-2-directed-antibody-drug-conjugates-with-immune-checkpoint-inhibitors-in-advanced-nsclc/ 2023-11-27T18:04:55+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-helena-linardou-1-1/ 2023-11-27T18:04:56+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/results-of-pacific-trial-being-replicated-in-real-world-settings/ 2023-11-27T18:04:57+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/increase-trial-immunotherapy-plus-chemoradiotherapy-doubles-complete-pathologic-response-rate-in-nsclc/ 2023-11-27T18:04:58+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-upal-basu-roy/ 2023-11-27T18:04:59+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/phase-iii-trial-shows-novel-four-drug-immunotherapy-regimen-improves-survival-outcomes-in-extensive-stage-small-cell-lung-cancer/ 2023-12-12T20:13:04+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-noemi-reguart/ 2023-11-27T18:05:01+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/comparing-two-radiation-therapy-techniques-for-locally-advanced-nsclc-focus-on-toxicity/ 2023-12-12T20:18:34+00:00 https://ascopost.com/issues/november-25-2023-supplement-iaslc-highlights/epov-matthew-hatton-and-charles-simone/ 2023-11-27T18:05:03+00:00 https://ascopost.com/issues/december-10-2023/ 2023-12-11T18:20:33+00:00 https://ascopost.com/issues/december-10-2023/understanding-the-treatment-options-for-pd-1-refractory-melanoma/ 2023-12-11T18:20:33+00:00 https://ascopost.com/issues/december-10-2023/sustained-mrd-negativity-achieved-with-isa-krd-in-newly-diagnosed-multiple-myeloma/ 2023-12-11T18:20:34+00:00 https://ascopost.com/issues/december-10-2023/epov-s-vincent-rajkumar/ 2023-12-11T18:20:35+00:00 https://ascopost.com/issues/december-10-2023/antibody-drug-conjugate-makes-progress-as-second-line-therapy-for-advanced-nsclc/ 2023-12-11T18:20:37+00:00 https://ascopost.com/issues/december-10-2023/epov-sarat-chandarlapaty/ 2023-12-11T18:20:38+00:00 https://ascopost.com/issues/december-10-2023/increase-trial-immunotherapy-plus-chemoradiotherapy-doubles-complete-pathologic-response-rate-in-nsclc/ 2023-12-11T18:20:39+00:00 https://ascopost.com/issues/december-10-2023/epov-upal-basu-roy/ 2023-12-11T18:20:40+00:00 https://ascopost.com/issues/december-10-2023/american-cancer-society-releases-updated-lung-cancer-screening-guideline/ 2023-12-11T18:20:41+00:00 https://ascopost.com/issues/december-10-2023/remembering-cancer-prevention-and-health-equity-champion-worta-j-mccaskill-stevens-md-ms/ 2023-12-11T18:20:42+00:00 https://ascopost.com/issues/december-10-2023/supportive-parents-and-early-love-of-science-lead-to-a-career-in-hematology-oncology-for-nina-shah-md/ 2023-12-11T18:20:43+00:00 https://ascopost.com/issues/december-10-2023/early-data-show-novel-immunotherapy-regimen-may-improve-outcomes-in-advanced-gastric-cancer/ 2025-06-27T21:34:38+00:00 https://ascopost.com/issues/december-10-2023/epov-elizabeth-smyth/ 2025-06-27T21:33:55+00:00 https://ascopost.com/issues/december-10-2023/on-mark-cuban-and-the-chemotherapy-crisis/ 2023-12-11T18:20:48+00:00 https://ascopost.com/issues/december-10-2023/papillon-adding-amivantamab-to-first-line-chemotherapy-prolongs-progression-free-survival-in-nsclc-subset/ 2023-12-11T18:20:50+00:00 https://ascopost.com/issues/december-10-2023/epov-benjamin-besse/ 2023-12-11T18:20:51+00:00 https://ascopost.com/issues/december-10-2023/beatcc-trial-atezolizumab-based-regimen-improves-outcomes-in-first-line-setting-for-advanced-cervical-cancer/ 2023-12-11T18:20:52+00:00 https://ascopost.com/issues/december-10-2023/epov-bradley-monk/ 2023-12-11T18:20:53+00:00 https://ascopost.com/issues/december-10-2023/oncology-care-model-studies-find-significant-savings-but-minor-quality-improvement/ 2023-12-11T18:20:55+00:00 https://ascopost.com/issues/december-10-2023/epov-kerin-adelson/ 2023-12-11T18:20:56+00:00 https://ascopost.com/issues/december-10-2023/codebreak-300-sotorasib-plus-panitumumab-of-benefit-in-kras-mutated-metastatic-colorectal-cancer/ 2023-12-11T18:20:57+00:00 https://ascopost.com/issues/december-10-2023/epov-miriam-koopman/ 2023-12-11T18:20:58+00:00 https://ascopost.com/issues/december-10-2023/alina-trial-anticancer-activity-of-alectinib-reported-in-earlier-stage-alk-positive-nsclc/ 2024-01-16T17:24:42+00:00 https://ascopost.com/issues/december-10-2023/epov-marina-c-garassino/ 2023-12-11T18:21:01+00:00 https://ascopost.com/issues/december-10-2023/chemotherapy-induction-before-chemoradiotherapy-improves-survival-in-locally-advanced-cervical-cancer/ 2023-12-11T18:21:02+00:00 https://ascopost.com/issues/december-10-2023/epov-krishnansu-tewari/ 2023-12-11T18:21:04+00:00 https://ascopost.com/issues/december-10-2023/syed-ali-abutalib-moves-to-advocate-aurora-health-to-lead-hematology-transplant-programs/ 2023-12-27T17:55:49+00:00 https://ascopost.com/issues/december-10-2023/encorafenib-plus-binimetinib-in-metastatic-nsclc-with-braf-v600e-mutation/ 2023-12-11T18:21:06+00:00 https://ascopost.com/issues/december-10-2023/new-guideline-offers-much-needed-support-in-the-treatment-of-neuroendocrine-tumors/ 2023-12-11T18:21:08+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/ 2023-11-28T19:39:17+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/highlights-from-the-esmo-congress-2023/ 2023-11-30T15:22:50+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/perioperative-nivolumab-plus-chemotherapy-improves-event-free-survival-in-resectable-non-small-cell-lung-cancer/ 2023-11-30T15:14:57+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/epov-marina-garassino/ 2023-11-30T15:14:58+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/amivantamab-based-regimens-show-anticancer-activity-in-egfr-mutated-advanced-nsclc/ 2023-11-30T15:16:47+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/epov-zofia-piotrowska/ 2023-11-30T15:17:19+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/antibody-drug-conjugate-makes-progress-as-second-line-therapy-for-advanced-nsclc/ 2023-11-30T15:18:06+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/epov-sarat-chandarlapaty/ 2023-11-30T15:23:10+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/first-line-selpercatinib-new-standard-of-care-for-ret-positive-medullary-thyroid-cancer/ 2026-01-28T19:37:35+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/epov-laura-locati/ 2023-11-30T15:23:42+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/tropion-breast01-and-destiny-breast04-antibody-drug-conjugates-of-benefit-in-patients-with-metastatic-breast-cancer/ 2023-11-30T15:24:06+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/epov-sarat-chandarlapaty-1/ 2023-11-30T15:24:25+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/two-studies-show-improved-survival-with-novel-front-line-combinations-in-advanced-urothelial-carcinoma/ 2023-11-30T15:24:29+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/epov-andrea-apolo/ 2023-11-30T15:24:34+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/adding-checkpoint-inhibition-to-perioperative-chemotherapy-boosts-pathologic-complete-response-rates-in-gastric-cancers/ 2023-11-30T15:25:35+00:00 https://ascopost.com/issues/december-10-2023-supplement-esmo-highlights/epov-elizabeth-smyth/ 2023-11-30T15:26:11+00:00 https://ascopost.com/issues/december-25-2023/ 2023-12-21T20:30:47+00:00 https://ascopost.com/issues/december-25-2023/tucatinib-plus-t-dm1-extends-progression-free-survival-vs-t-dm1-alone-in-advanced-her2-positive-breast-cancer/ 2024-04-12T14:36:07+00:00 https://ascopost.com/issues/december-25-2023/epov-valentina-guarneri/ 2023-12-21T20:30:48+00:00 https://ascopost.com/issues/december-25-2023/cardiovascular-health-of-women-treated-for-cancer-understanding-the-long-term-risks/ 2023-12-21T20:30:49+00:00 https://ascopost.com/issues/december-25-2023/epov-susan-faye-dent/ 2023-12-21T20:30:51+00:00 https://ascopost.com/issues/december-25-2023/all-adult-oncologists-are-geriatric-oncologists/ 2023-12-21T20:30:52+00:00 https://ascopost.com/issues/december-25-2023/the-power-of-patient-advocacy-10-year-study-reveals-increased-survival-rates-with-enhanced-advance-care-planning/ 2023-12-22T01:14:22+00:00 https://ascopost.com/issues/december-25-2023/epov-bonny-morris/ 2023-12-21T20:30:54+00:00 https://ascopost.com/issues/december-25-2023/community-program-cuts-treatment-delays-in-half-for-minority-and-low-income-patients/ 2023-12-21T20:30:55+00:00 https://ascopost.com/issues/december-25-2023/epov-bonny-morris-1/ 2023-12-21T20:30:56+00:00 https://ascopost.com/issues/december-25-2023/another-treatment-option-for-metastatic-castration-resistant-prostate-cancer/ 2024-01-08T22:33:14+00:00 https://ascopost.com/issues/december-25-2023/epov-christopher-j-sweeney/ 2023-12-21T20:30:58+00:00 https://ascopost.com/issues/december-25-2023/novel-antibody-drug-conjugate-under-study-in-treatment-of-gastric-or-gastroesophageal-junction-cancers/ 2024-01-18T20:10:26+00:00 https://ascopost.com/issues/december-25-2023/epov-elizabeth-smyth-md/ 2023-12-21T20:31:01+00:00 https://ascopost.com/issues/december-25-2023/asco-and-ontario-health-publish-new-recommendations-for-systemic-therapy-in-sclc/ 2023-12-21T20:31:02+00:00 https://ascopost.com/issues/december-25-2023/improving-cancer-control-in-a-changing-world/ 2023-12-21T20:31:03+00:00 https://ascopost.com/issues/december-25-2023/steven-rosenberg-awarded-honor-for-technology-and-innovation/ 2023-12-21T20:31:04+00:00 https://ascopost.com/issues/december-25-2023/neoadjuvantadjuvant-pembrolizumab-in-resectable-nsclc/ 2023-12-21T20:31:05+00:00 https://ascopost.com/issues/december-25-2023/i-don-t-want-cancer-to-define-me/ 2023-12-21T20:31:06+00:00 https://ascopost.com/issues/january-25-2024/ 2024-01-25T18:47:38+00:00 https://ascopost.com/issues/january-25-2024/tackling-the-challenges-of-oncology-workforce-shortages-increased-patient-demand-and-rising-costs-of-care/ 2024-01-25T18:47:38+00:00 https://ascopost.com/issues/january-25-2024/beyond-lung-cancer-leveraging-machine-learning-techniques-to-understand-other-diseases/ 2024-05-13T15:03:59+00:00 https://ascopost.com/issues/january-25-2024/matthijs-oudkerk-phd-md-msc-honored-for-contributions-to-cancer-prevention-and-research/ 2024-05-13T15:03:05+00:00 https://ascopost.com/issues/january-25-2024/new-director-of-the-university-of-hawaii-cancer-center-naoto-t-ueno-md-phd-facp-is-also-a-two-time-cancer-survivor/ 2024-01-25T18:47:42+00:00 https://ascopost.com/issues/january-25-2024/medical-cannabis-patterns-of-use-among-patients-with-cancer/ 2024-01-25T18:47:43+00:00 https://ascopost.com/issues/january-25-2024/how-being-a-member-of-the-president-s-national-cancer-advisory-board-is-contributing-to-high-quality-oncology-care/ 2024-01-25T18:47:45+00:00 https://ascopost.com/issues/january-25-2024/2023-members-appointed-to-the-national-cancer-advisory-board/ 2024-01-25T18:47:47+00:00 https://ascopost.com/issues/january-25-2024/the-high-cost-of-oral-agents-for-relapsed-and-refractory-multiple-myeloma/ 2024-01-30T18:35:52+00:00 https://ascopost.com/issues/january-25-2024/use-of-enzalutamide-in-nonmetastatic-castration-sensitive-prostate-cancer-with-biochemical-recurrence/ 2024-01-25T18:47:49+00:00 https://ascopost.com/issues/january-25-2024/my-breast-cancer-experience-has-led-me-to-leverage-my-expertise-in-human-centered-design-to-transform-patient-care/ 2024-01-25T18:47:50+00:00 https://ascopost.com/issues/january-25-2024/george-d-demetri-md-fasco-earns-lifetime-achievement-award-in-medicine-from-stanford-medicine-alumni-association/ 2024-01-25T18:47:51+00:00 https://ascopost.com/issues/january-25-2024/perseus-daratumumab-regimen-significantly-improves-progression-free-survival-in-newly-diagnosed-multiple-myeloma/ 2024-01-25T18:47:52+00:00 https://ascopost.com/issues/january-25-2024/real-world-experience-mirrors-perseus-findings/ 2024-01-25T18:47:53+00:00 https://ascopost.com/issues/january-25-2024/epov-ajay-nooka-and-dan-vogl/ 2024-01-25T18:47:54+00:00 https://ascopost.com/issues/january-25-2024/long-term-follow-up-supports-postneoadjuvant-t-dm1-over-trastuzumab-in-early-high-risk-her2-positive-breast-cancer/ 2024-04-01T13:22:37+00:00 https://ascopost.com/issues/january-25-2024/sympatico-trial-ibrutinib-plus-venetoclax-improves-progression-free-survival-in-relapsed-mantle-cell-lymphoma/ 2024-01-25T18:47:59+00:00 https://ascopost.com/issues/january-25-2024/epov-andrew-zelenetz/ 2024-01-25T18:48:00+00:00 https://ascopost.com/issues/january-25-2024/canadian-study-shows-myeloma-outcomes-in-the-real-world-may-be-worse-than-clinical-trials-suggest/ 2024-01-30T18:13:51+00:00 https://ascopost.com/issues/january-25-2024/epov-cynthia-dunbar/ 2024-01-25T18:48:02+00:00 https://ascopost.com/issues/january-25-2024/patients-with-advanced-breast-cancer-may-gain-multiple-benefits-from-exercise-as-part-of-palliative-care/ 2024-01-25T18:48:03+00:00 https://ascopost.com/issues/january-25-2024/epov-carlos-arteaga/ 2024-01-25T18:48:04+00:00 https://ascopost.com/issues/january-25-2024/novel-pi3k-inhibitor-as-part-of-triplet-improves-outcomes-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2024-01-25T18:48:05+00:00 https://ascopost.com/issues/january-25-2024/natalee-trial-long-term-results-on-ribociclib-combination-therapy-in-early-stage-breast-cancer/ 2024-01-25T18:48:06+00:00 https://ascopost.com/issues/january-25-2024/epov-heather-han/ 2024-01-25T18:48:07+00:00 https://ascopost.com/issues/january-25-2024/neoadjuvant-chemoimmunotherapy-improves-pathologic-complete-response-rates-in-subgroup-analysis-of-keynote-756/ 2024-01-25T18:48:08+00:00 https://ascopost.com/issues/january-25-2024/epov-laura-huppert/ 2024-01-25T18:48:09+00:00 https://ascopost.com/issues/january-25-2024/integrated-medicine-and-collaborative-care-innovations-in-cancer-treatment-and-mental-health-care/ 2024-01-25T18:48:10+00:00 https://ascopost.com/issues/january-25-2024/epov-daniel-curtis-mcfarland/ 2024-01-25T18:48:11+00:00 https://ascopost.com/issues/january-25-2024/undocumented-cost-of-care-discussions-a-missed-opportunity-in-cancer-treatment/ 2024-04-08T17:27:04+00:00 https://ascopost.com/issues/january-25-2024/all-in-adults-trial-updates-and-clinical-considerations-for-selecting-consolidation-therapy/ 2024-01-25T18:48:13+00:00 https://ascopost.com/issues/january-25-2024/international-collaborative-research-efforts-in-cardio-oncology/ 2024-01-25T18:48:14+00:00 https://ascopost.com/issues/january-25-2024/ovhipec-1-trial-hyperthermic-intraperitoneal-chemotherapy-plus-interval-cytoreductive-surgery-improves-survival-in-advanced-ovarian-cancer/ 2024-01-25T18:48:15+00:00 https://ascopost.com/issues/january-25-2024/2023-asco-advocacy-highlights/ 2024-01-25T18:48:16+00:00 https://ascopost.com/issues/january-25-2024/eric-small-elected-asco-president-for-2025-2026-term/ 2024-01-25T18:48:17+00:00 https://ascopost.com/issues/january-25-2024/generic-drug-shortages-and-essential-cancer-medicines/ 2024-01-31T13:53:01+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/ 2024-02-16T17:14:56+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/highlights-from-the-2023-ash-annual-meeting-exposition/ 2024-02-16T17:14:57+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/in-npm1-mutated-aml-benefit-of-transplant-limited-to-patients-with-residual-disease/ 2024-02-16T17:14:58+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-william-g-blum-and-mikkael-sekeres/ 2024-02-16T17:15:00+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/menin-inhibitor-revumenib-shows-activity-in-kmt2a-rearranged-acute-leukemia/ 2024-02-16T17:15:02+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-rory-m-shallis/ 2024-02-16T17:15:03+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/all-oral-regimen-feasible-and-effective-in-acute-promyelocytic-leukemia-study-finds/ 2024-03-07T20:59:58+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-aaron-t-gerds/ 2024-02-16T17:15:06+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/addition-of-isatuximab-to-carfilzomib-based-regimen-doubles-mrd-negativity-rates-in-multiple-myeloma/ 2024-02-16T17:15:08+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-peter-voorhees/ 2024-02-16T17:15:09+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/perseus-daratumumab-regimen-significantly-improves-progression-free-survival-in-newly-diagnosed-multiple-myeloma/ 2024-02-16T17:15:11+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-ajay-nooka-and-dan-vogl/ 2024-02-16T17:15:12+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/real-world-experience-mirrors-perseus-findings/ 2024-02-26T17:50:47+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/canadian-study-shows-myeloma-outcomes-in-the-real-world-may-be-worse-than-clinical-trials-suggest/ 2024-02-16T17:15:15+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-cynthia-dunbar/ 2024-02-16T17:15:17+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/should-you-reconsider-transplant-for-relapsed-large-b-cell-lymphoma-in-complete-remission/ 2024-02-28T17:28:57+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-michael-crump/ 2024-02-16T17:15:20+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/personalized-ibrutinib-plus-venetoclax-therapy-new-treatment-standard-for-chronic-lymphocytic-leukemia/ 2024-02-16T17:15:21+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-paul-hampel/ 2024-02-16T17:15:23+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/study-examines-real-world-outcomes-with-ivosidenib-vs-venetoclax-in-acute-myeloid-leukemia/ 2024-02-16T17:15:24+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-harry-p-erba/ 2024-02-16T17:15:25+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/ultra-low-dose-of-radiotherapy-may-be-enough-in-gastric-malt-lymphoma/ 2024-02-16T17:15:26+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-carla-casulo/ 2024-02-16T17:15:27+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/study-finds-four-drug-targeted-treatment-reduces-chemotherapy-requirement-for-some-in-large-b-cell-lymphoma/ 2024-02-16T17:15:29+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-dipenkumar-modi/ 2025-10-31T16:56:59+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/first-line-ruxolitinib-combinations-boost-benefit-over-single-agent-in-myelofibrosis/ 2025-09-30T19:42:53+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-prithviraj-bose/ 2024-02-16T17:15:32+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/venetoclax-plus-azacitidine-evaluated-in-high-risk-myelodysplastic-syndromes/ 2024-02-23T20:18:20+00:00 https://ascopost.com/issues/digital-supplement-ash-meeting-highlights-2023/epov-david-sallman-and-mikkael-sekeres/ 2024-02-16T17:15:35+00:00 https://ascopost.com/issues/february-25-2024/ 2024-02-23T16:49:47+00:00 https://ascopost.com/issues/february-25-2024/first-line-radioligand-based-therapy-demonstrates-benefit-in-some-neuroendocrine-tumors/ 2024-02-23T16:49:47+00:00 https://ascopost.com/issues/february-25-2024/understanding-risk-stratification-in-monoclonal-gammopathy-of-undetermined-significance/ 2024-02-26T17:47:21+00:00 https://ascopost.com/issues/february-25-2024/sotorasib-the-poster-child-for-project-optimus-truths-and-fantasies/ 2024-02-23T16:49:49+00:00 https://ascopost.com/issues/february-25-2024/for-unresectable-liver-cancer-the-addition-of-durvalumab-and-bevacizumab-boosts-efficacy-of-transarterial-chemoembolization/ 2024-02-23T16:49:50+00:00 https://ascopost.com/issues/february-25-2024/evaluating-the-use-of-perioperative-chemoimmunotherapy-in-resectable-gastric-and-gastroesophageal-junction-cancers/ 2024-02-23T16:49:51+00:00 https://ascopost.com/issues/february-25-2024/high-risk-localized-prostate-cancer-survival-benefit-with-long-term-adt-and-dose-escalated-radiation-therapy/ 2024-03-05T18:12:28+00:00 https://ascopost.com/issues/february-25-2024/some-patients-with-breast-cancer-may-safely-avoid-locoregional-irradiation-after-neoadjuvant-chemotherapy/ 2024-02-23T16:49:53+00:00 https://ascopost.com/issues/february-25-2024/idea-trial-might-radiation-one-day-be-safely-omitted-for-younger-favorable-risk-postmenopausal-patients-with-breast-cancer/ 2024-02-23T16:49:54+00:00 https://ascopost.com/issues/february-25-2024/all-oral-regimen-feasible-and-effective-in-acute-promyelocytic-leukemia-study-finds/ 2024-02-23T16:49:55+00:00 https://ascopost.com/issues/february-25-2024/epov-aaron-t-gerds/ 2024-02-23T16:49:56+00:00 https://ascopost.com/issues/february-25-2024/how-asco-s-regional-councils-are-having-an-international-impact-on-patients-with-cancer/ 2024-02-23T16:49:57+00:00 https://ascopost.com/issues/february-25-2024/annual-report-to-the-nation-part-2-new-cancer-diagnoses-fell-abruptly-early-in-the-covid-19-pandemic/ 2024-02-23T16:49:58+00:00 https://ascopost.com/issues/february-25-2024/reflections-on-cancer-s-toll-on-my-family/ 2024-02-23T16:49:59+00:00 https://ascopost.com/issues/february-25-2024/asco-welcomes-new-rule-establishing-electronic-prior-authorization-in-federal-health-plans/ 2024-02-23T16:49:59+00:00 https://ascopost.com/issues/february-25-2024/rapid-guideline-update-on-radiotracers-for-determining-radioligand-treatment-eligibility-in-metastatic-castration-resistant-prostate-cancer/ 2024-02-23T16:50:00+00:00 https://ascopost.com/issues/february-25-2024/understanding-the-discordance-about-prognosis-between-clinicians-and-terminally-ill-patients-and-their-surrogates/ 2024-02-23T16:50:01+00:00 https://ascopost.com/issues/february-25-2024/belzutifan-new-standard-in-previously-treated-renal-cell-carcinoma/ 2025-06-30T01:24:29+00:00 https://ascopost.com/issues/february-25-2024/epov-lisa-pickering/ 2024-02-23T16:50:03+00:00 https://ascopost.com/issues/february-25-2024/preventing-cancer-should-not-mean-sacrificing-quality-of-life/ 2024-02-23T16:50:04+00:00 https://ascopost.com/issues/february-25-2024/asco-remembers-humanitarian-and-health-equity-champion-edith-mitchell/ 2024-02-23T16:50:05+00:00 https://ascopost.com/issues/february-25-2024/exploring-the-role-of-intravenous-mistletoe-extract-in-treating-metastatic-solid-tumors/ 2024-02-23T16:50:06+00:00 https://ascopost.com/issues/february-25-2024/aacr-cancer-centers-alliance-formed/ 2024-02-23T16:50:07+00:00 https://ascopost.com/issues/february-25-2024/american-cancer-society-annual-report-shows-cancer-mortality-still-declining-but-cancer-incidence-is-projected-to-top-2-million/ 2024-02-23T16:50:09+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/ 2024-03-01T15:59:25+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/highlights-from-the-2023-san-antonio-breast-cancer-symposium/ 2024-02-28T21:49:42+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/tucatinib-plus-t-dm1-extends-progression-free-survival-vs-t-dm1-alone-in-advanced-her2-positive-breast-cancer/ 2024-02-28T21:49:43+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/epov-valentina-guarneri/ 2024-02-28T21:49:44+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/novel-pi3k-inhibitor-as-part-of-triplet-improves-outcomes-in-hormone-receptor-positive-her2-negative-breast-cancer/ 2024-02-28T21:49:45+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/natalee-trial-long-term-results-on-ribociclib-combination-therapy-in-early-stage-breast-cancer/ 2024-02-28T21:49:45+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/epov-heather-han/ 2024-02-28T21:49:46+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/long-term-follow-up-supports-postneoadjuvant-t-dm1-over-trastuzumab-in-early-high-risk-her2-positive-breast-cancer/ 2024-02-28T21:49:47+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/neoadjuvant-chemoimmunotherapy-improves-pathologic-complete-response-rates-in-subgroup-analysis-of-keynote-756/ 2024-02-28T21:49:48+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/epov-laura-huppert/ 2024-02-28T21:49:49+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/idea-trial-might-radiation-one-day-be-safely-omitted-for-younger-favorable-risk-postmenopausal-patients-with-breast-cancer/ 2024-02-28T21:49:49+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/some-patients-with-breast-cancer-may-safely-avoid-locoregional-irradiation-after-neoadjuvant-chemotherapy/ 2024-02-28T21:49:50+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/patients-with-advanced-breast-cancer-may-gain-multiple-benefits-from-exercise-as-part-of-palliative-care/ 2024-02-28T21:49:51+00:00 https://ascopost.com/issues/digital-supplement-sabcs-meeting-highlights-2023/epov-carlos-arteaga/ 2024-02-28T21:49:52+00:00 https://ascopost.com/issues/march-10-2024/ 2024-03-11T17:25:43+00:00 https://ascopost.com/issues/march-10-2024/two-adjuvant-therapy-studies-show-divergent-outcomes-with-pd-1-inhibitors-in-renal-cell-carcinoma/ 2025-06-30T01:23:18+00:00 https://ascopost.com/issues/march-10-2024/epov-pedro-barata/ 2024-03-11T17:25:45+00:00 https://ascopost.com/issues/march-10-2024/reframing-dcis-as-an-opportunity-for-cancer-prevention/ 2024-04-29T18:23:35+00:00 https://ascopost.com/issues/march-10-2024/nivolumab-plus-ipilimumab-improves-progression-free-survival-in-first-line-setting-of-metastatic-colorectal-cancer/ 2024-03-11T17:25:47+00:00 https://ascopost.com/issues/march-10-2024/epov-alan-venook/ 2024-03-11T17:25:48+00:00 https://ascopost.com/issues/march-10-2024/studies-show-progress-in-using-ctdna-to-guide-colorectal-cancer-treatment/ 2024-03-11T17:25:50+00:00 https://ascopost.com/issues/march-10-2024/epov-aparna-parikh/ 2024-03-11T17:25:51+00:00 https://ascopost.com/issues/march-10-2024/should-you-reconsider-transplant-for-relapsed-large-b-cell-lymphoma-in-complete-remission/ 2024-03-11T17:25:52+00:00 https://ascopost.com/issues/march-10-2024/epov-michael-crump/ 2024-03-11T17:25:54+00:00 https://ascopost.com/issues/march-10-2024/newly-diagnosed-multiple-myeloma/ 2024-03-11T17:25:57+00:00 https://ascopost.com/issues/march-10-2024/relationship-between-second-malignant-neoplasm-and-heart-disease-studied-in-childhood-cancer-survivors/ 2024-03-11T17:25:58+00:00 https://ascopost.com/issues/march-10-2024/olaparib-plus-abiraterone-and-prednisone-improves-outcomes-over-single-agents-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2024-03-11T17:25:59+00:00 https://ascopost.com/issues/march-10-2024/celebrating-advances-in-cancer-care-and-a-look-at-how-ai-is-revolutionizing-oncology/ 2024-03-11T17:26:00+00:00 https://ascopost.com/issues/march-10-2024/epov-kim-chi/ 2024-03-11T17:26:02+00:00 https://ascopost.com/issues/march-10-2024/how-the-max-foundation-is-accelerating-equitable-cancer-care-globally/ 2024-03-11T17:26:03+00:00 https://ascopost.com/issues/march-10-2024/fruquintinib-in-refractory-metastatic-colorectal-cancer/ 2024-03-11T17:26:04+00:00 https://ascopost.com/issues/march-10-2024/fda-approves-irinotecan-liposome-for-the-first-line-treatment-of-metastatic-pancreatic-adenocarcinoma/ 2024-03-14T18:07:54+00:00 https://ascopost.com/issues/march-10-2024/benefit-of-belantamab-mafodotin-based-regimen-supported-in-multiple-myeloma/ 2024-03-11T17:26:07+00:00 https://ascopost.com/issues/march-10-2024/i-am-young-and-fit-and-have-stage-iv-alveolar-soft-part-sarcoma/ 2025-08-25T16:50:01+00:00 https://ascopost.com/issues/march-10-2024/geriatric-oncology-educational-opportunity-at-memorial-sloan-kettering-cancer-center/ 2024-03-11T17:26:10+00:00 https://ascopost.com/issues/march-10-2024/accc-changes-name-to-association-of-cancer-care-centers/ 2024-03-11T17:26:11+00:00 https://ascopost.com/issues/march-10-2024/epov-rachid-baz/ 2024-03-11T17:26:12+00:00 https://ascopost.com/issues/march-10-2024/patricia-lorusso-named-the-amy-and-joseph-perella-professor-of-medicine-at-yale-school-of-medicine/ 2024-03-11T17:26:14+00:00 https://ascopost.com/issues/march-10-2024/asco-and-sso-publish-new-guideline-on-germline-testing-in-breast-cancer/ 2024-03-11T17:26:15+00:00 https://ascopost.com/issues/march-10-2024/asco-chief-medical-officer-testifies-to-congress-about-ongoing-cancer-drug-shortage-crisis/ 2024-03-11T17:26:16+00:00 https://ascopost.com/issues/march-10-2024/long-term-follow-up-affirms-benefit-of-pembrolizumab-plus-chemotherapy-in-advanced-esophageal-cancer/ 2024-03-20T19:42:06+00:00 https://ascopost.com/issues/march-25-2024/ 2024-03-22T18:50:22+00:00 https://ascopost.com/issues/march-25-2024/lenvatinib-plus-pembrolizumab-fails-to-improve-overall-survival-in-advanced-head-and-neck-cancer/ 2026-01-28T19:13:01+00:00 https://ascopost.com/issues/march-25-2024/enfortumab-vedotin-plus-pembrolizumab-yields-benefit-in-key-subgroups-with-advanced-urothelial-cancer/ 2024-04-16T20:59:28+00:00 https://ascopost.com/issues/march-25-2024/cardio-oncology-is-a-growing-subspecialty-but-where-are-the-oncologists/ 2024-03-22T18:50:25+00:00 https://ascopost.com/issues/march-25-2024/esophageal-squamous-cell-cancer-overall-survival-improved-with-tiragolumab-and-atezolizumab-plus-chemotherapy/ 2024-03-22T18:50:27+00:00 https://ascopost.com/issues/march-25-2024/risks-of-cardiovascular-disease-in-patients-receiving-therapies-for-lung-cancer/ 2024-03-22T18:50:28+00:00 https://ascopost.com/issues/march-25-2024/osimertinib-with-chemotherapy-for-egfr-mutated-nsclc/ 2024-03-22T18:50:30+00:00 https://ascopost.com/issues/march-25-2024/repotrectinib-for-ros1-fusion-positive-advanced-nsclc/ 2024-03-22T18:50:31+00:00 https://ascopost.com/issues/march-25-2024/cabozantinib-plus-atezolizumab-improves-progression-free-survival/ 2024-03-22T18:50:32+00:00 https://ascopost.com/issues/march-25-2024/strategies-for-cardiovascular-risk-mitigation-and-monitoring-in-patients-with-cll/ 2024-03-22T18:50:34+00:00 https://ascopost.com/issues/march-25-2024/mantle-cell-lymphoma-front-line-therapy/ 2024-03-27T18:00:55+00:00 https://ascopost.com/issues/march-25-2024/use-of-combination-immunotherapy-before-lung-cancer-surgery/ 2024-04-16T16:38:38+00:00 https://ascopost.com/issues/march-25-2024/adjuvant-pembrolizumab-a-new-option-for-high-risk-muscle-invasive-urothelial-cancer/ 2024-04-16T19:41:20+00:00 https://ascopost.com/issues/march-25-2024/cancer-care-providers-urge-president-biden-to-make-health-care-a-state-of-the-union-priority/ 2024-03-22T18:50:39+00:00 https://ascopost.com/issues/march-25-2024/brachytherapy-boost-may-decrease-the-duration-of-androgen-deprivation-therapy-for-high-risk-prostate-cancer/ 2024-03-22T18:50:40+00:00 https://ascopost.com/issues/march-25-2024/liposomal-irinotecan-in-first-line-treatment-of-metastatic-pancreatic-adenocarcinoma/ 2024-03-22T18:50:42+00:00 https://ascopost.com/issues/march-25-2024/w-kimryn-rathmell-md-phd-selected-as-17th-director-of-the-nci/ 2024-03-22T18:50:43+00:00 https://ascopost.com/issues/march-25-2024/asco-releases-resource-stratified-guideline-for-the-treatment-of-metastatic-breast-cancer/ 2024-03-22T18:50:44+00:00 https://ascopost.com/issues/march-25-2024/fda-approves-amivantamab-vmjw-for-egfr-exon-20-insertion-mutated-nsclc/ 2024-03-22T18:50:46+00:00 https://ascopost.com/issues/march-25-2024/fruquintinib-plus-paclitaxel-under-study-as-second-line-treatment-of-gastroesophageal-cancer/ 2024-03-22T18:50:47+00:00 https://ascopost.com/issues/march-25-2024/in-resectable-non-small-cell-lung-cancer-perioperative-use-of-tislelizumab-alone-or-with-chemotherapy-improved-outcomes/ 2024-03-22T18:50:48+00:00 https://ascopost.com/issues/march-25-2024/epov-luis-paz-ares/ 2024-03-22T18:50:50+00:00 https://ascopost.com/issues/march-25-2024/from-fatal-to-fearless-how-patients-can-take-control-of-their-disease-and-fear-cancer-less/ 2024-04-26T15:32:59+00:00 https://ascopost.com/issues/march-25-2024/kathy-giusti-s-experience-with-stem-cell-transplant-for-multiple-myeloma/ 2024-03-22T18:50:52+00:00 https://ascopost.com/issues/march-25-2024/fda-approves-nivolumab-in-combination-with-cisplatin-and-gemcitabine-for-unresectable-or-metastatic-urothelial-carcinoma/ 2024-04-02T19:24:52+00:00 https://ascopost.com/issues/march-25-2024/fda-grants-accelerated-approval-to-zanubrutinib-plus-obinutuzumab-for-relapsed-or-refractory-follicular-lymphoma/ 2024-03-22T18:50:55+00:00 https://ascopost.com/issues/march-25-2024/erdafitinib-for-previously-treated-locally-advanced-or-metastatic-urothelial-carcinoma/ 2024-03-22T18:50:56+00:00 https://ascopost.com/issues/march-25-2024/enfortumab-vedotin-ejfv-plus-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-cancer/ 2024-03-22T18:50:57+00:00 https://ascopost.com/issues/march-25-2024/promoting-cardiovascular-health-in-adult-survivors-of-childhood-cancers/ 2024-03-22T18:50:59+00:00 https://ascopost.com/issues/march-25-2024/lifileucel-for-unresectable-or-metastatic-melanoma/ 2024-04-08T17:23:27+00:00 https://ascopost.com/issues/march-25-2024/adjuvant-nivolumab-in-stage-iibc-melanoma/ 2024-03-22T18:51:01+00:00 https://ascopost.com/issues/march-25-2024/integrative-approaches-to-managing-symptoms-of-anxiety-and-depression-in-adults-with-cancer/ 2024-03-22T18:51:02+00:00 https://ascopost.com/issues/march-25-2024/a-clinical-trial-for-bladder-cancer-gave-me-back-my-life/ 2025-06-27T18:26:16+00:00 https://ascopost.com/issues/march-25-2024/romidepsin-plus-chop-in-previously-untreated-peripheral-t-cell-lymphoma-final-analysis-of-ro-chop-trial/ 2024-03-22T18:51:07+00:00 https://ascopost.com/issues/march-25-2024/multitarget-fecal-immunochemical-test-in-stool-based-colorectal-cancer-screening/ 2024-03-22T18:51:08+00:00 https://ascopost.com/issues/march-25-2024/president-s-cancer-panel-report-highlights-opportunities-to-accelerate-progress-toward-the-national-cancer-plan/ 2024-03-22T18:51:09+00:00 https://ascopost.com/issues/april-25-2024/ 2024-04-25T18:29:15+00:00 https://ascopost.com/issues/april-25-2024/advanced-stage-classical-hodgkin-lymphoma/ 2024-04-26T18:51:55+00:00 https://ascopost.com/issues/april-25-2024/zanubrutinib-in-relapsed-or-refractory-follicular-lymphoma/ 2024-04-25T18:29:17+00:00 https://ascopost.com/issues/april-25-2024/comparative-effectiveness-of-acupuncture-vs-massage-for-relieving-pain-in-patients-with-advanced-cancer/ 2024-04-25T18:29:18+00:00 https://ascopost.com/issues/april-25-2024/a-pioneering-female-oncologist-in-morocco-helps-advance-the-global-shift-toward-gender-equity-in-academia/ 2024-04-25T18:29:20+00:00 https://ascopost.com/issues/april-25-2024/breast-cancer-stalked-my-family-for-generations-and-finally-came-for-me/ 2024-05-03T15:25:58+00:00 https://ascopost.com/issues/april-25-2024/treating-dcis-to-escalate-or-de-escalate/ 2024-04-25T18:29:23+00:00 https://ascopost.com/issues/april-25-2024/can-artificial-intelligence-predict-treatment-response-and-outcomes-in-breast-cancer/ 2024-05-03T15:23:59+00:00 https://ascopost.com/issues/april-25-2024/adagrasib-plus-cetuximab-potential-option-for-kras-g12c-mutated-colorectal-cancer/ 2024-05-16T17:14:03+00:00 https://ascopost.com/issues/april-25-2024/survival-benefit-emerges-with-use-of-dostarlimab-gxly-plus-chemotherapy-in-advanced-or-recurrent-endometrial-cancer/ 2024-04-25T18:29:27+00:00 https://ascopost.com/issues/april-25-2024/epov-gini-fleming/ 2024-04-25T18:29:28+00:00 https://ascopost.com/issues/april-25-2024/progression-free-survival-benefit-confirmed-with-triplet-combination-in-brca-wild-type-hrd-positive-ovarian-cancer/ 2024-04-25T18:29:29+00:00 https://ascopost.com/issues/april-25-2024/ai-analysis-of-cell-free-dna-fragments-and-protein-biomarkers-for-noninvasive-detection-of-ovarian-cancer/ 2024-04-25T18:29:31+00:00 https://ascopost.com/issues/april-25-2024/can-hpv-circulating-tumor-dna-guide-adjuvant-treatment-of-oropharyngeal-cancer/ 2026-01-28T21:29:27+00:00 https://ascopost.com/issues/april-25-2024/epov-glenn-hanna/ 2026-01-28T21:26:51+00:00 https://ascopost.com/issues/april-25-2024/novel-mdm2-inhibitor-shows-activity-in-salivary-gland-cancers/ 2026-01-28T21:31:04+00:00 https://ascopost.com/issues/april-25-2024/activity-shown-for-antibody-drug-conjugates-in-gynecologic-cancers/ 2024-04-25T18:29:36+00:00 https://ascopost.com/issues/april-25-2024/rapid-guideline-update-supports-capivasertib-for-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/ 2024-04-25T18:29:37+00:00 https://ascopost.com/issues/april-25-2024/pamela-kunz-named-editor-in-chief-of-new-jco-oncology-advances/ 2024-04-25T18:29:39+00:00 https://ascopost.com/issues/april-25-2024/insights-from-the-2023-international-society-of-geriatric-oncology-conference/ 2024-04-25T18:29:40+00:00 https://ascopost.com/issues/may-10-2024/ 2024-05-09T18:58:08+00:00 https://ascopost.com/issues/may-10-2024/two-studies-support-deintensification-of-treatment-for-hpv-associated-oropharyngeal-cancer/ 2026-01-28T21:25:26+00:00 https://ascopost.com/issues/may-10-2024/asco-survey-finds-oncologists-well-being-worsened-over-the-past-decade-but-steps-can-be-taken-to-mitigate-burnout/ 2024-05-09T18:58:10+00:00 https://ascopost.com/issues/may-10-2024/ai-in-cancer-care-embrace-the-change/ 2024-05-09T18:58:11+00:00 https://ascopost.com/issues/may-10-2024/bispecific-antibody-plus-chemotherapy-improves-survival-in-patients-with-gastric-or-gastroesophageal-junction-cancer/ 2024-05-09T18:58:13+00:00 https://ascopost.com/issues/may-10-2024/selective-targeting-of-parp1-in-early-phase-study-shows-activity-in-breast-cancer/ 2024-05-09T18:58:14+00:00 https://ascopost.com/issues/may-10-2024/for-detection-of-measurable-residual-disease-in-ovarian-cancer-are-two-methods-better-than-one/ 2024-05-09T18:58:15+00:00 https://ascopost.com/issues/may-10-2024/duo-e-trial-results-support-new-treatment-options-in-endometrial-cancer/ 2024-05-09T18:58:17+00:00 https://ascopost.com/issues/may-10-2024/keynote-756-additional-findings-pembrolizumab-shown-to-be-beneficial-regardless-of-age-menopausal-status/ 2024-05-09T18:58:18+00:00 https://ascopost.com/issues/may-10-2024/bishoy-faltas-md-named-chief-research-officer-of-the-englander-institute-for-precision-medicine-at-weill-cornell-medicine/ 2024-05-09T18:58:19+00:00 https://ascopost.com/issues/may-10-2024/america-s-cancer-doctors-demand-action-from-congress-address-drug-shortages/ 2024-05-09T18:58:21+00:00 https://ascopost.com/issues/may-10-2024/new-policy-statement-addresses-social-economic-and-environmental-factors-influencing-cancer-care-outcomes/ 2024-05-09T18:58:22+00:00 https://ascopost.com/issues/may-10-2024/cell-free-dna-blood-based-test-and-next-generation-multitarget-stool-dna-test-in-colorectal-cancer-screening/ 2024-05-09T18:58:23+00:00 https://ascopost.com/issues/may-10-2024/enfortumab-vedotin-ejfv-plus-pembrolizumab-improves-survival-vs-platinum-based-chemotherapy-in-advanced-urothelial-cancer/ 2025-06-27T18:18:02+00:00 https://ascopost.com/issues/may-10-2024/alectinib-approved-as-adjuvant-treatment-for-alk-positive-non-small-cell-lung-cancer/ 2024-05-09T18:58:26+00:00 https://ascopost.com/issues/may-10-2024/fda-grants-accelerated-approval-to-lifileucel-for-unresectable-or-metastatic-melanoma/ 2024-05-09T18:58:28+00:00 https://ascopost.com/issues/may-10-2024/belzutifan-in-previously-treated-advanced-renal-cell-carcinoma/ 2025-06-30T01:12:50+00:00 https://ascopost.com/issues/may-10-2024/pembrolizumab-and-chemotherapy-for-advanced-biliary-tract-cancer/ 2024-05-09T18:58:31+00:00 https://ascopost.com/issues/may-10-2024/pirtobrutinib-in-patients-with-previously-treated-cll-sll/ 2024-05-09T18:58:32+00:00 https://ascopost.com/issues/may-10-2024/nihs-new-cancer-screening-research-network-and-cancer-screening-technologies/ 2024-05-09T18:58:34+00:00 https://ascopost.com/issues/may-10-2024/breast-cancer-with-sentinel-node-metastases-axillary-dissection-vs-sentinel-node-biopsy-alone/ 2024-05-09T18:58:35+00:00 https://ascopost.com/issues/may-10-2024/model-for-predicting-outcomes-after-sentinel-lymph-node-biopsy-in-melanoma/ 2024-05-09T18:58:36+00:00 https://ascopost.com/issues/may-10-2024/a-delay-in-diagnosis-led-to-advanced-prostate-cancer/ 2024-05-09T18:58:38+00:00 https://ascopost.com/issues/may-25-2024/ 2024-05-24T15:06:43+00:00 https://ascopost.com/issues/may-25-2024/study-finds-the-financial-hardship-caused-by-cancer-is-long-lasting-for-many-working-age-adults/ 2024-05-24T15:06:43+00:00 https://ascopost.com/issues/may-25-2024/use-of-topical-diclofenac-gel-to-prevent-capecitabine-associated-hand-foot-syndrome/ 2024-05-24T15:06:45+00:00 https://ascopost.com/issues/may-25-2024/breast-conserving-therapy-in-brca-mutation-carriers-study-looks-at-long-term-outcomes/ 2024-05-24T15:06:46+00:00 https://ascopost.com/issues/may-25-2024/study-reveals-potential-overtreatment-of-dcis-in-older-women-with-limited-life-expectancy/ 2024-05-24T15:06:47+00:00 https://ascopost.com/issues/may-25-2024/novel-approaches-show-early-activity-in-endocrine-resistant-breast-cancer/ 2024-05-24T15:06:48+00:00 https://ascopost.com/issues/may-25-2024/uspstf-issues-final-recommendation-statement-on-screening-for-breast-cancer/ 2024-05-24T15:06:50+00:00 https://ascopost.com/issues/may-25-2024/atezolizumabcabozantinib-vs-docetaxel-in-previously-treated-metastatic-nsclc/ 2024-05-24T15:06:51+00:00 https://ascopost.com/issues/may-25-2024/understanding-the-legal-and-ethical-challenges-ai-poses-in-oncology/ 2024-05-24T15:06:52+00:00 https://ascopost.com/issues/may-25-2024/noninferiority-of-simple-vs-radical-hysterectomy-for-pelvic-recurrence-in-low-risk-cervical-cancer/ 2024-05-24T15:06:53+00:00 https://ascopost.com/issues/may-25-2024/adjuvant-alectinib-improves-survival-vs-platinum-based-chemotherapy-in-alk-positive-nsclc/ 2024-05-24T15:06:54+00:00 https://ascopost.com/issues/may-25-2024/study-explores-how-partner-relationships-impact-the-well-being-of-breast-cancer-survivors/ 2024-05-24T15:06:55+00:00 https://ascopost.com/issues/may-25-2024/apply-through-july-31-2024-for-survivorship-champion-s-prize/ 2024-05-24T15:06:56+00:00 https://ascopost.com/issues/may-25-2024/derek-raghavan-joins-perthera-as-chief-medical-officer/ 2024-05-24T15:06:57+00:00 https://ascopost.com/issues/may-25-2024/dancemovement-therapy-for-pediatric-oncology-patients-and-their-caregivers/ 2024-05-30T14:38:49+00:00 https://ascopost.com/issues/may-25-2024/partnering-with-patients-is-integral-for-a-good-outcome/ 2024-05-24T15:06:59+00:00 https://ascopost.com/issues/may-25-2024/we-have-an-idea-united-in-the-fight-against-cancer/ 2024-05-28T16:45:53+00:00 https://ascopost.com/issues/may-25-2024/keynote-564-adjuvant-pembrolizumab-improves-overall-survival-vs-placebo-in-renal-cell-carcinoma/ 2025-06-30T01:07:31+00:00 https://ascopost.com/issues/may-25-2024/applying-the-power-of-knowledge-to-drive-positive-change-in-oncology-care/ 2024-05-24T16:29:50+00:00 https://ascopost.com/issues/may-25-2024/a-look-back-on-an-impactful-and-inspiring-presidential-year/ 2024-05-24T15:07:03+00:00 https://ascopost.com/issues/may-25-2024/nccn-clinical-practice-guidelines-in-oncology-2024-updates/ 2024-05-24T15:07:04+00:00 https://ascopost.com/issues/may-25-2024/linvoseltamab-achieves-high-response-rates-in-relapsed-or-refractory-myeloma/ 2024-05-24T15:07:05+00:00 https://ascopost.com/issues/may-25-2024/crispr-edited-off-the-shelf-car-t-cell-therapy-shows-proof-of-concept-in-renal-cell-carcinoma/ 2025-06-30T01:09:08+00:00 https://ascopost.com/issues/may-25-2024/is-a-test-for-early-detection-of-pancreatic-cancer-on-the-horizon/ 2024-05-24T15:07:06+00:00 https://ascopost.com/issues/may-25-2024/the-future-of-cancer-care/ 2024-05-24T15:07:07+00:00 https://ascopost.com/issues/may-25-2024/nccn-appoints-chair-vice-chair-of-board-of-directors/ 2024-05-24T15:07:08+00:00 https://ascopost.com/issues/may-25-2024/rosai-dorfman-disease-sinus-histiocytosis-with-massive-lymphadenopathy/ 2024-05-29T17:25:24+00:00 https://ascopost.com/issues/may-25-2024/asco-issues-updated-guidelines-for-stage-iv-nsclc-with-and-without-driver-alterations/ 2024-05-24T15:07:10+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/ 2024-05-30T15:00:49+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/from-a-small-town-in-lebanon-a-young-doctor-follows-his-passion-to-an-international-career-in-cancer-research/ 2024-05-30T15:00:50+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/narratives-in-oncology-through-the-years/ 2024-05-30T15:00:51+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/multicultural-asco-president-elect-was-raised-in-mexico-by-parents-who-instilled-a-sense-of-duty-to-make-a-difference/ 2024-05-30T15:00:52+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/fda-s-crowdsourcing-initiative-to-benefit-patient-centric-clinical-trial-innovation/ 2024-05-30T15:00:53+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/a-daughter-of-first-generation-immigrants-follows-their-can-do-philosophy-in-her-research-efforts-in-hematologic-oncology/ 2024-05-30T15:00:55+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/a-mother-s-encouragement-and-a-husband-wife-doctor-team-set-the-stage-for-a-career-in-hematologic-oncology/ 2024-06-04T16:03:09+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/the-national-cancer-act-of-1971-inspired-a-career-in-service-to-and-advocacy-for-patients-with-cancer/ 2024-05-30T15:52:01+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/asco-congratulates-2024-special-awards-recipients/ 2024-05-30T15:00:58+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/born-in-a-small-village-in-india-a-breast-cancer-expert-assumes-a-leadership-role-in-oncology-in-cleveland-and-beyond/ 2024-06-14T18:00:31+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/immigrant-reared-during-the-lebanese-civil-war-by-parents-who-valued-education-becomes-a-leader-in-genitourinary-oncology/ 2024-08-19T18:17:54+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/motivated-by-his-mother-s-brain-cancer-and-his-own-life-threatening-disease-a-young-physician-works-to-pay-back-the-universe/ 2024-05-30T15:01:02+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/for-an-international-expert-in-gynecologic-cancer-being-reared-by-educators-who-stressed-knowledge-and-service-was-key/ 2024-05-30T15:01:03+00:00 https://ascopost.com/issues/june-3-2024-narratives-special-issue/a-fathers-advice-plus-a-desire-to-help-spur-a-career-in-oncology-and-a-leadership-role-in-african-cancer-care/ 2024-05-30T15:01:04+00:00 https://ascopost.com/issues/june-10-2024/ 2024-06-10T16:29:14+00:00 https://ascopost.com/issues/june-10-2024/osimertinib-therapy-poised-to-become-new-standard-of-care-for-unresectable-stage-iii-egfr-mutated-nsclc/ 2024-06-18T16:19:21+00:00 https://ascopost.com/issues/june-10-2024/optimizing-the-management-of-dcis/ 2024-06-10T16:29:16+00:00 https://ascopost.com/issues/june-10-2024/cardiotoxicity-how-far-have-we-come/ 2024-06-25T17:26:24+00:00 https://ascopost.com/issues/june-10-2024/a-new-international-initiative-for-faculty-collaboration-and-patient-advocacy-in-immune-related-adverse-events/ 2024-06-10T17:09:52+00:00 https://ascopost.com/issues/june-10-2024/hpv-vaccine-shows-prevention-efficacy-for-several-types-of-hpv-related-cancers-in-both-males-and-females/ 2024-06-10T16:29:21+00:00 https://ascopost.com/issues/june-10-2024/fda-grants-accelerated-approval-to-lisocabtagene-maraleucel-for-relapsed-or-refractory-follicular-lymphoma/ 2024-06-10T16:29:22+00:00 https://ascopost.com/issues/june-10-2024/aua-asco-and-suo-publish-2024-amendment-to-nonmetastatic-muscle-invasive-bladder-cancer-guidelines/ 2025-06-27T18:20:34+00:00 https://ascopost.com/issues/june-10-2024/pancreatic-surgeon-named-new-director-of-moores-cancer-center-at-uc-san-diego-health/ 2024-06-10T16:29:24+00:00 https://ascopost.com/issues/june-10-2024/nadina-trial-shows-robust-benefit-for-neoadjuvant-nivolumab-plus-ipilimumab-in-stage-iii-melanoma/ 2024-06-17T16:23:57+00:00 https://ascopost.com/issues/june-10-2024/fda-approves-lisocabtagene-maraleucel-for-relapsed-or-refractory-mantle-cell-lymphoma/ 2024-06-10T16:29:27+00:00 https://ascopost.com/issues/june-10-2024/tepotinib-for-metastatic-nsclc-with-met-exon-14-skipping-alterations/ 2024-06-10T16:29:28+00:00 https://ascopost.com/issues/june-10-2024/study-misses-endpoints-but-still-shows-benefit-for-lenvatinibpembrolizumab-in-endometrial-cancer-subsets/ 2024-06-10T16:29:30+00:00 https://ascopost.com/issues/june-10-2024/nogapendekin-alfa-inbakicept-pmln-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/ 2025-06-27T18:14:40+00:00 https://ascopost.com/issues/june-10-2024/how-the-museum-of-medicine-and-biomedical-discovery-aims-to-bring-scientific-achievements-of-the-past-present-and-future-to-life/ 2024-06-10T16:29:33+00:00 https://ascopost.com/issues/june-10-2024/multiple-myeloma-survivor-and-advocate-shares-12-step-program-how-not-to-die-of-cancer/ 2024-06-10T16:29:34+00:00 https://ascopost.com/issues/june-10-2024/in-celebration-of-a-remarkable-life-and-career-in-oncology/ 2024-06-10T16:29:36+00:00 https://ascopost.com/issues/june-10-2024/i-am-living-with-recurring-stage-iv-colorectal-cancer/ 2024-06-24T17:59:46+00:00 https://ascopost.com/issues/june-10-2024/fda-s-oncology-center-of-excellence-launches-project-5-in-5/ 2024-06-10T16:29:39+00:00 https://ascopost.com/issues/june-10-2024/guideline-update-seeks-to-aid-clinicians-in-the-selection-of-systemic-treatments-for-advanced-hepatocellular-carcinoma/ 2024-06-10T16:29:40+00:00 https://ascopost.com/issues/june-10-2024/innovative-staging-system-for-de-novo-metastatic-breast-cancer-validated-internationally/ 2024-06-14T15:32:44+00:00 https://ascopost.com/issues/june-25-2024/ 2024-06-25T16:47:11+00:00 https://ascopost.com/issues/june-25-2024/fda-approves-selpercatinib-for-ret-fusion-positive-thyroid-cancer/ 2024-06-25T16:47:12+00:00 https://ascopost.com/issues/june-25-2024/fda-grants-accelerated-approval-to-repotrectinib-for-ntrk-fusion-positive-solid-tumors/ 2024-06-25T16:47:13+00:00 https://ascopost.com/issues/june-25-2024/study-documents-decline-in-reimbursements-for-breast-cancer-surgery-from-2003-to-2023/ 2024-06-25T16:47:15+00:00 https://ascopost.com/issues/june-25-2024/adjuvant-use-of-alectinib-in-alk-positive-nsclc/ 2024-06-25T16:47:16+00:00 https://ascopost.com/issues/june-25-2024/eflornithine-for-adult-and-pediatric-patients-with-high-risk-neuroblastoma/ 2024-06-25T16:47:18+00:00 https://ascopost.com/issues/june-25-2024/pembrolizumabchemotherapy-in-first-line-treatment-of-her2-negative-advanced-gastric-or-gej-adenocarcinoma/ 2024-06-25T16:47:19+00:00 https://ascopost.com/issues/june-25-2024/study-finds-fewer-than-half-of-accelerated-approval-drugs-show-benefit-in-overall-survival-or-quality-of-life-within-5-years/ 2024-06-25T16:47:20+00:00 https://ascopost.com/issues/june-25-2024/addition-of-adjuvant-ribociclib-to-nonsteroidal-aromatase-inhibitor-therapy-improves-survival-in-early-breast-cancer/ 2024-06-25T16:47:22+00:00 https://ascopost.com/issues/june-25-2024/lu-177-dotatate-for-pediatric-patients-with-gastroenteropancreatic-neuroendocrine-tumors/ 2024-06-25T16:47:24+00:00 https://ascopost.com/issues/june-25-2024/cshl-and-northwell-health-extend-strategic-affiliation/ 2024-06-25T16:47:25+00:00 https://ascopost.com/issues/june-25-2024/be-prepared-a-patient-perspective/ 2024-06-25T16:47:27+00:00 https://ascopost.com/issues/june-25-2024/oral-serds-poised-to-impact-treatment-of-hormone-receptor-positive-breast-cancer/ 2024-07-03T17:25:07+00:00 https://ascopost.com/issues/june-25-2024/durvalumab-consolidation-therapy-extends-survival-in-limited-stage-small-cell-lung-cancer/ 2024-06-25T16:47:30+00:00 https://ascopost.com/issues/june-25-2024/accelerating-progress-in-melanoma-and-cancer-research/ 2024-06-25T16:47:31+00:00 https://ascopost.com/issues/june-25-2024/advanced-lung-cancer-studies-explore-palliative-care-delivered-by-telehealth-and-in-a-stepped-care-approach/ 2024-06-25T16:47:33+00:00 https://ascopost.com/issues/june-25-2024/dreamm-8-belantamab-mafodotin-blmf-shows-robust-benefit-in-early-relapse-of-myeloma/ 2024-06-28T16:55:23+00:00 https://ascopost.com/issues/june-25-2024/phase-i-study-in-nhl-use-of-armored-car-t-cells-may-be-feasible-after-standard-car-t-cell-failure/ 2025-10-31T17:02:02+00:00 https://ascopost.com/issues/june-25-2024/aacr-cancer-disparities-progress-report-2024-highlights-ongoing-health-inequities-experienced-by-racial-and-ethnic-minorities/ 2024-06-25T16:47:37+00:00 https://ascopost.com/issues/june-25-2024/tovorafenib-in-relapsed-or-refractory-braf-altered-pediatric-low-grade-glioma/ 2024-06-25T16:47:38+00:00 https://ascopost.com/issues/june-25-2024/mirvetuximab-soravtansine-gynx-for-epithelial-ovarian-fallopian-tube-or-peritoneal-cancer/ 2024-06-25T16:47:40+00:00 https://ascopost.com/issues/june-25-2024/retroperitoneal-lymphadenectomy-can-it-be-safely-omitted-for-some-patients-with-advanced-ovarian-cancer/ 2024-06-25T16:47:41+00:00 https://ascopost.com/issues/june-25-2024/long-term-study-finds-most-breast-cancer-survivors-were-able-to-preserve-fertility-and-achieve-pregnancy-after-diagnosis/ 2024-06-25T16:47:43+00:00 https://ascopost.com/issues/june-25-2024/asco-issues-new-guidance-on-cannabis-and-cannabinoid-use-in-adults-with-cancer/ 2024-06-25T16:47:44+00:00 https://ascopost.com/issues/june-25-2024/asco-sets-six-guiding-principles-for-ai-in-oncology/ 2025-05-16T17:07:35+00:00 https://ascopost.com/issues/june-25-2024/estrogen-alone-increased-ovarian-cancer-incidence-and-mortality-combination-hormone-therapy-did-not/ 2024-06-25T16:47:47+00:00 https://ascopost.com/issues/july-10-2024/ 2024-07-10T16:20:52+00:00 https://ascopost.com/issues/july-10-2024/switching-to-abemaciclib-may-improve-outcomes-after-disease-progression/ 2024-07-10T16:20:53+00:00 https://ascopost.com/issues/july-10-2024/breast-implant-related-cancers-should-our-patients-be-concerned/ 2024-07-10T16:20:54+00:00 https://ascopost.com/issues/july-10-2024/second-line-therapy-with-adagrasib-in-kras-g12c-mutated-non-small-cell-lung-cancer/ 2024-07-10T16:20:55+00:00 https://ascopost.com/issues/july-10-2024/in-gastroesophageal-cancer-switch-maintenance-improves-outcomes-over-chemotherapy-continuation/ 2024-07-10T16:20:56+00:00 https://ascopost.com/issues/july-10-2024/relativity-048-triplet-immunotherapy-shows-activity-in-untreated-advanced-melanoma/ 2024-07-10T16:20:58+00:00 https://ascopost.com/issues/july-10-2024/mast-trial-metformin-does-not-slow-disease-progression-of-low-risk-prostate-cancer/ 2024-07-10T16:20:59+00:00 https://ascopost.com/issues/july-10-2024/asco-issues-new-guidance-on-vaccinations-for-adults-with-cancer/ 2024-07-10T16:21:00+00:00 https://ascopost.com/issues/july-10-2024/ama-house-of-delegates-adopts-record-six-asco-led-resolutions/ 2024-07-10T16:21:02+00:00 https://ascopost.com/issues/july-10-2024/novel-antibody-drug-conjugate-extends-survival-vs-chemotherapy-in-triple-negative-breast-cancer/ 2024-07-10T16:21:03+00:00 https://ascopost.com/issues/july-10-2024/astro-names-new-chief-executive-officer/ 2024-07-10T16:21:04+00:00 https://ascopost.com/issues/july-10-2024/v-craig-jordan-a-founding-father-of-targeted-therapy-in-cancer-dies-at-age-76/ 2024-07-10T16:21:06+00:00 https://ascopost.com/issues/july-10-2024/breaking-the-silence-addressing-sexual-and-reproductive-health-in-cancer-care/ 2024-07-10T16:21:07+00:00 https://ascopost.com/issues/july-10-2024/chronic-graft-vs-host-disease-clinical-trial-updates/ 2024-07-10T16:21:08+00:00 https://ascopost.com/issues/july-10-2024/having-acute-lymphoblastic-leukemia-took-away-my-fear-of-death/ 2025-10-03T14:33:39+00:00 https://ascopost.com/issues/july-10-2024/capivasertib-with-fulvestrant-for-previously-treated-advanced-hormone-receptor-positive-her2-negative-breast-cancer/ 2024-07-10T16:21:11+00:00 https://ascopost.com/issues/july-25-2024/ 2024-07-25T18:54:15+00:00 https://ascopost.com/issues/july-25-2024/two-phase-iii-trials-report-benefit-with-isatuximab-based-regimens-in-newly-diagnosed-multiple-myeloma/ 2024-07-25T19:12:56+00:00 https://ascopost.com/issues/july-25-2024/lavern-s-law-and-its-implications-for-oncology/ 2024-07-25T18:54:17+00:00 https://ascopost.com/issues/july-25-2024/alliance-for-global-implementation-of-lung-and-cardiac-early-disease-detection-and-treatment-meeting-highlights/ 2024-07-25T18:54:18+00:00 https://ascopost.com/issues/july-25-2024/a-role-for-avelumab-in-triple-negative-breast-cancer/ 2024-07-25T18:54:19+00:00 https://ascopost.com/issues/july-25-2024/long-term-survival-possible-after-liver-transplant-for-colorectal-liver-metastases/ 2024-07-25T18:54:20+00:00 https://ascopost.com/issues/july-25-2024/esopec-trial-flot-protocol-proves-superior-to-cross-regimen-in-locally-advanced-esophageal-cancer/ 2024-07-25T18:54:21+00:00 https://ascopost.com/issues/july-25-2024/triplet-combination-improves-survival-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-in-third-line-setting/ 2025-10-31T16:55:02+00:00 https://ascopost.com/issues/july-25-2024/new-genetic-test-may-predict-response-to-immunotherapy-in-triple-negative-breast-cancer/ 2024-08-01T17:08:24+00:00 https://ascopost.com/issues/july-25-2024/amivantamab-vmjw-in-nsclc-with-egfr-exon-20-insertion-mutations/ 2024-07-25T18:54:24+00:00 https://ascopost.com/issues/july-25-2024/updated-asco-guidance-on-cancer-related-fatigue-expands-patient-options-for-interventions/ 2024-07-25T18:54:25+00:00 https://ascopost.com/issues/july-25-2024/phase-ii-study-shows-activity-for-novel-targeted-agent-in-kras-g12c-mutated-nsclc/ 2024-07-25T18:54:26+00:00 https://ascopost.com/issues/july-25-2024/addition-of-ibrutinib-to-immunochemotherapy-and-asct-improves-survival-in-mantle-cell-lymphoma/ 2024-07-25T18:54:27+00:00 https://ascopost.com/issues/july-25-2024/cancer-and-fatherhood-a-story-of-personal-power-in-the-face-of-a-mortal-disease/ 2024-07-25T18:54:28+00:00 https://ascopost.com/issues/july-25-2024/overcoming-the-disparity-in-cancer-incidence-and-mortality-rates-among-alaska-native-individuals/ 2024-07-25T18:54:30+00:00 https://ascopost.com/issues/july-25-2024/preserving-reproductive-health-for-patients-with-cancer-insights-from-an-oncofertility-patient-navigator/ 2024-07-25T18:54:31+00:00 https://ascopost.com/issues/july-25-2024/introducing-conexiant/ 2024-07-25T18:54:31+00:00 https://ascopost.com/issues/august-25-2024/ 2024-08-26T14:29:26+00:00 https://ascopost.com/issues/august-25-2024/what-is-the-optimal-first-line-therapy-for-chronic-lymphocytic-leukemia/ 2024-08-26T14:29:27+00:00 https://ascopost.com/issues/august-25-2024/lorlatinib-vs-crizotinib-in-advanced-alk-positive-nsclc-5-year-outcomes-from-phase-iii-crown-trial/ 2024-08-26T14:29:29+00:00 https://ascopost.com/issues/august-25-2024/gift-of-truth-reflections-on-a-father-s-cancer-journey/ 2024-08-26T14:29:30+00:00 https://ascopost.com/issues/august-25-2024/detecting-residual-disease-after-neoadjuvant-chemoradiation-in-esophageal-squamous-cell-carcinoma/ 2024-08-26T14:29:31+00:00 https://ascopost.com/issues/august-25-2024/libretto-431-trial-shows-selpercatinib-is-effective-in-east-asian-patients-with-ret-fusion-positive-non-small-cell-lung-cancer/ 2024-08-26T14:29:32+00:00 https://ascopost.com/issues/august-25-2024/an-integrated-approach-to-treating-cancer-and-cardiovascular-disease-when-oncologists-and-cardiologists-collaborate/ 2024-08-26T14:32:45+00:00 https://ascopost.com/issues/august-25-2024/asco-guideline-update-highlights-the-importance-of-early-integration-of-palliative-care-for-patients-with-cancer/ 2024-08-26T14:34:30+00:00 https://ascopost.com/issues/august-25-2024/scotus-ruling-upends-country-s-regulatory-framework-threatens-to-complicate-and-delay-health-care-delivery/ 2024-08-26T14:29:35+00:00 https://ascopost.com/issues/august-25-2024/acalabrutinib-plus-chemoimmunotherapy-improves-progression-free-survival-in-older-patients-with-mantle-cell-lymphoma/ 2025-03-26T18:02:17+00:00 https://ascopost.com/issues/august-25-2024/btk-degraders-and-celmods-novel-mechanisms-overcoming-resistance-in-hematologic-malignancies/ 2025-10-31T16:58:56+00:00 https://ascopost.com/issues/august-25-2024/glofitamab-combination-therapy-shows-survival-benefit-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2025-10-31T16:51:59+00:00 https://ascopost.com/issues/august-25-2024/car-t-cell-therapy-in-refractory-follicular-lymphoma/ 2024-09-23T17:49:38+00:00 https://ascopost.com/issues/august-25-2024/fda-approves-idh12-inhibitor-for-certain-patients-with-astrocytoma-or-oligodendroglioma/ 2024-08-26T14:29:40+00:00 https://ascopost.com/issues/august-25-2024/fda-approves-immunotherapy-for-relapsed-or-refractory-ctcl/ 2024-08-26T14:29:41+00:00 https://ascopost.com/issues/august-25-2024/inotuzumab-ozogamicin-for-pediatric-acute-lymphoblastic-leukemia/ 2025-10-03T14:31:08+00:00 https://ascopost.com/issues/august-25-2024/ponatinib-with-chemotherapy-for-newly-diagnosed-philadelphia-chromosome-positive-all/ 2025-10-03T16:21:19+00:00 https://ascopost.com/issues/august-25-2024/update-on-leaner-trial-in-patients-with-breast-cancer/ 2024-08-26T14:29:45+00:00 https://ascopost.com/issues/august-25-2024/gynecologic-oncologist-lynette-ann-denny-dies-at-age-66/ 2024-08-26T14:29:46+00:00 https://ascopost.com/issues/august-25-2024/in-remembrance-of-my-friend-lyn-denny/ 2024-08-26T14:29:47+00:00 https://ascopost.com/issues/august-25-2024/cancer-screening-estimated-to-cost-43-billion-dollars-annually-in-united-states/ 2024-08-26T14:29:48+00:00 https://ascopost.com/issues/august-25-2024/cancer-has-robbed-me-of-my-fertility-and-my-olympic-dreams/ 2024-09-12T17:50:26+00:00 https://ascopost.com/issues/september-10-2024/ 2024-09-09T13:47:10+00:00 https://ascopost.com/issues/september-10-2024/t-dxd-effective-for-breast-tumors-with-her2-low-and-her2-ultralow-expression-in-earlier-line-of-therapy/ 2024-09-09T13:47:11+00:00 https://ascopost.com/issues/september-10-2024/what-is-the-better-target-for-bispecific-antibodies-in-multiple-myeloma-bcma-or-gprc5d/ 2025-04-25T15:06:08+00:00 https://ascopost.com/issues/september-10-2024/discontinuation-of-cml-therapy-which-patients-are-ideal-candidates/ 2024-09-09T13:47:13+00:00 https://ascopost.com/issues/september-10-2024/chinese-study-finds-radiation-alone-may-be-as-effective-as-chemoradiation-in-patients-with-low-risk-nasopharyngeal-cancer/ 2026-01-28T20:18:45+00:00 https://ascopost.com/issues/september-10-2024/extranodal-marginal-zone-lymphoma-is-overtreatment-common/ 2024-09-09T13:47:15+00:00 https://ascopost.com/issues/september-10-2024/nivolumab-plus-chemotherapy-extends-survival-in-lymph-node-only-metastatic-urothelial-cancer/ 2025-06-30T17:16:20+00:00 https://ascopost.com/issues/september-10-2024/inoperable-stage-iii-nsclc-adaptive-radiotherapy-based-on-fdg-pet-tumor-residual-uptake/ 2024-09-09T13:47:17+00:00 https://ascopost.com/issues/september-10-2024/new-collaborative-guideline-highlights-the-importance-of-multidisciplinary-care-for-patients-with-osteoradionecrosis/ 2024-09-09T13:47:18+00:00 https://ascopost.com/issues/september-10-2024/nivolumab-in-combination-with-cisplatin-plus-gemcitabine-in-treatment-of-unresectable-or-metastatic-urothelial-carcinoma/ 2025-06-30T17:17:08+00:00 https://ascopost.com/issues/september-10-2024/fam-trastuzumab-deruxtecan-nxki-in-unresectable-or-metastatic-her2-positive-solid-tumors/ 2024-09-09T13:47:20+00:00 https://ascopost.com/issues/september-10-2024/idea-awardees-reflections-on-the-2024-asco-annual-meeting/ 2024-09-10T18:36:42+00:00 https://ascopost.com/issues/september-10-2024/new-studies-explore-relationships-between-heart-failure-and-lymphoma-arterial-thromboembolism-and-cancer/ 2024-09-23T17:56:51+00:00 https://ascopost.com/issues/september-10-2024/a-diagnosis-of-triple-negative-breast-cancer-was-not-on-my-radar/ 2024-09-09T13:47:24+00:00 https://ascopost.com/issues/september-10-2024/disparities-in-exposure-to-tobacco-content-on-streaming-platforms/ 2024-09-09T13:47:25+00:00 https://ascopost.com/issues/september-10-2024/remembering-a-pioneer-in-melanoma-and-immunotherapy-jeffrey-weber/ 2024-09-09T13:47:26+00:00 https://ascopost.com/issues/september-10-2024/optimizing-cancer-care-for-older-adults/ 2024-09-09T13:47:27+00:00 https://ascopost.com/issues/september-25-2024/ 2024-09-24T16:24:21+00:00 https://ascopost.com/issues/september-25-2024/iaslc-ivonescimab-vs-pembrolizumab-as-first-line-treatment-in-nsclc/ 2024-09-26T13:59:01+00:00 https://ascopost.com/issues/september-25-2024/prescription-for-progress-lancet-oncology-commissions-practical-strategies-for-global-cancer-surgery/ 2024-09-24T16:24:22+00:00 https://ascopost.com/issues/september-25-2024/the-formative-years-of-medical-oncology-in-the-united-states-a-rough-and-tumble-road-part-1/ 2024-09-24T17:12:39+00:00 https://ascopost.com/issues/september-25-2024/iaslc-ifinatamab-deruxtecan-in-extensive-stage-small-cell-lung-cancer/ 2024-10-28T19:16:20+00:00 https://ascopost.com/issues/september-25-2024/use-of-immune-checkpoint-inhibitors-under-study-in-high-risk-hormone-receptor-positive-early-stage-breast-cancer/ 2024-09-24T16:41:28+00:00 https://ascopost.com/issues/september-25-2024/optimizing-the-use-of-multicancer-early-detection-tests/ 2024-09-24T16:24:27+00:00 https://ascopost.com/issues/september-25-2024/phase-iii-alexandraimpassion030-any-survival-benefit-for-adjuvant-atezolizumab-in-triple-negative-breast-cancer/ 2024-09-24T16:24:29+00:00 https://ascopost.com/issues/september-25-2024/adjuvant-dabrafenib-plus-trametinib-for-stage-iii-braf-v600-mutated-melanoma-final-results-of-the-combi-ad-trial/ 2024-09-24T16:24:30+00:00 https://ascopost.com/issues/september-25-2024/asco-issues-first-guideline-specific-to-locally-advanced-rectal-cancer/ 2024-09-24T16:24:31+00:00 https://ascopost.com/issues/september-25-2024/asco-presents-ethan-basch-md-msc-fasco-with-the-joseph-simone-quality-care-award/ 2024-09-24T16:24:32+00:00 https://ascopost.com/issues/september-25-2024/combination-targeted-therapy-produces-durable-remissions-in-some-patients-with-relapsed-diffuse-large-b-cell-lymphoma/ 2025-10-31T16:50:15+00:00 https://ascopost.com/issues/september-25-2024/tisotumab-vedotin-tftv-for-recurrent-or-metastatic-cervical-cancer/ 2024-09-24T16:24:35+00:00 https://ascopost.com/issues/september-25-2024/a-clinical-trial-has-halted-progression-of-merkel-cell-carcinoma-and-allowed-me-to-pursue-my-love-of-music/ 2024-09-24T16:24:36+00:00 https://ascopost.com/issues/october-10-2024/ 2024-10-09T14:03:50+00:00 https://ascopost.com/issues/october-10-2024/himalaya-5-year-analysis-confirms-survival-benefit-of-stride-regimen-in-hepatocellular-carcinoma/ 2024-10-09T14:03:51+00:00 https://ascopost.com/issues/october-10-2024/the-formative-years-of-medical-oncology-in-the-united-states-a-rough-and-tumble-road-part-2/ 2024-10-09T14:03:52+00:00 https://ascopost.com/issues/october-10-2024/navigating-uncharted-waters-in-the-post-chevron-sea-change/ 2024-10-09T14:03:53+00:00 https://ascopost.com/issues/october-10-2024/amivantamab-vmjw-plus-lazertinib-improves-long-term-outcomes-in-first-line-setting-of-egfr-mutant-advanced-nsclc/ 2024-10-09T14:03:54+00:00 https://ascopost.com/issues/october-10-2024/distinguished-service-awards-presented-at-the-iaslc-world-conference-on-lung-cancer/ 2024-10-09T14:09:33+00:00 https://ascopost.com/issues/october-10-2024/encouraging-pathologic-responses-achieved-with-novel-combination-regimen-in-early-stage-nsclc/ 2024-10-09T14:03:56+00:00 https://ascopost.com/issues/october-10-2024/creating-a-culture-of-diversity-equity-and-inclusion-why-it-matters-clinically-and-ethically/ 2024-10-09T14:03:57+00:00 https://ascopost.com/issues/october-10-2024/keynote-a18-overall-survival-in-cervical-cancer-improved-by-pembrolizumab-plus-chemoradiotherapy/ 2024-10-09T14:03:58+00:00 https://ascopost.com/issues/october-10-2024/destiny-breast12-t-dxd-of-benefit-in-patients-with-breast-cancer-and-brain-metastases/ 2024-10-09T17:49:00+00:00 https://ascopost.com/issues/october-10-2024/asco-updates-stage-iii-nsclc-guideline-to-include-osimertinib-in-wake-of-laura-trial-data/ 2024-10-09T14:04:01+00:00 https://ascopost.com/issues/october-10-2024/cancer-provider-groups-across-the-country-urge-congress-to-pass-prior-authorization-reform/ 2024-10-09T14:04:02+00:00 https://ascopost.com/issues/october-10-2024/study-finds-nearly-70-billion-in-socioeconomic-losses-across-11-countries-attributable-to-ovarian-cancer/ 2024-10-09T14:04:03+00:00 https://ascopost.com/issues/october-10-2024/fda-approves-amivantamab-vmjw-with-carboplatin-and-pemetrexed-for-non-small-cell-lung-cancer-with-egfr-exon-19-deletions-or-l858r-mutations/ 2024-10-09T14:04:04+00:00 https://ascopost.com/issues/october-10-2024/fda-approves-osimertinib-in-stage-iii-nsclc-after-chemoradiotherapy/ 2024-10-09T14:04:06+00:00 https://ascopost.com/issues/october-10-2024/ann-partridge-md-mph-receives-esmo-award-for-significant-contributions-to-breast-cancer-research-and-patient-care/ 2024-10-09T14:04:07+00:00 https://ascopost.com/issues/october-10-2024/coping-with-the-risk-of-hereditary-cancer/ 2024-10-11T13:45:05+00:00 https://ascopost.com/issues/october-10-2024/shared-reflections-on-the-2024-asco-annual-meeting-from-networking-to-mentorship-and-more/ 2024-10-09T14:04:09+00:00 https://ascopost.com/issues/october-10-2024/more-than-half-of-aya-cancer-survivors-experience-financial-toxicity-and-are-unable-to-afford-food-and-housing/ 2024-10-09T14:20:06+00:00 https://ascopost.com/issues/october-10-2024/isatuximab-plus-vrd-approved-by-fda-for-newly-diagnosed-transplant-ineligible-multiple-myeloma/ 2024-10-09T14:04:11+00:00 https://ascopost.com/issues/october-10-2024/ayas-enrolled-in-a-cancer-program-were-more-likely-to-receive-guideline-recommended-care/ 2024-10-09T14:04:12+00:00 https://ascopost.com/issues/october-25-2024/ 2024-10-24T12:55:48+00:00 https://ascopost.com/issues/october-25-2024/adriatic-trial-durvalumab-consolidation-extends-survival-in-limited-stage-small-cell-lung-cancer/ 2024-10-24T12:55:49+00:00 https://ascopost.com/issues/october-25-2024/aacr-cancer-progress-report-features-breakthroughs-in-cancer-science-and-persistent-inequities-in-care/ 2024-10-24T12:55:50+00:00 https://ascopost.com/issues/october-25-2024/three-days-was-enough/ 2024-10-24T12:55:51+00:00 https://ascopost.com/issues/october-25-2024/keynote-811-pembrolizumab-combination-in-first-line-setting-improves-overall-survival-in-gastric-cancer/ 2024-10-24T12:55:52+00:00 https://ascopost.com/issues/october-25-2024/no-cut-trial-nonoperative-management-of-benefit-for-many-patients-with-rectal-cancer/ 2025-06-27T21:32:32+00:00 https://ascopost.com/issues/october-25-2024/overall-survival-analysis-confirms-pembrolizumab-regimen-as-standard-of-care-for-triple-negative-breast-cancer/ 2024-10-24T12:55:55+00:00 https://ascopost.com/issues/october-25-2024/peace-3-enzalutamide-plus-radium-223-significantly-improves-survival-in-metastatic-castration-resistant-prostate-cancer/ 2024-10-31T19:09:12+00:00 https://ascopost.com/issues/october-25-2024/leap-012-combination-of-therapies-extends-progression-free-survival-in-intermediate-stage-hepatocellular-carcinoma/ 2024-10-24T12:55:57+00:00 https://ascopost.com/issues/october-25-2024/osimertinib-plus-savolitinib-responses-reported-in-first-line-treatment-of-met-aberrant-egfr-mutant-nsclc/ 2024-10-24T12:55:59+00:00 https://ascopost.com/issues/october-25-2024/new-hope-for-patients-with-her2-mutant-nsclc-durable-responses-to-two-novel-targeted-therapies/ 2024-10-24T12:56:00+00:00 https://ascopost.com/issues/october-25-2024/cabinet-trial-supports-multitargeted-tyrosine-kinase-inhibitor-for-advanced-neuroendocrine-tumors/ 2024-10-24T12:56:01+00:00 https://ascopost.com/issues/october-25-2024/cancer-deaths-of-55-million-men-worldwide-have-led-to-141-million-new-paternal-orphans/ 2024-10-24T12:56:02+00:00 https://ascopost.com/issues/october-25-2024/trial-updates-in-stage-iii-melanoma-solidify-the-neoadjuvant-use-of-immunotherapy-as-the-current-standard-of-care/ 2024-10-24T12:56:03+00:00 https://ascopost.com/issues/october-25-2024/new-directions-in-all-cml-and-cll-treatment/ 2025-10-03T16:19:58+00:00 https://ascopost.com/issues/october-25-2024/cancer-clinical-trials-continue-to-be-out-of-reach-for-many-patients/ 2024-10-24T12:56:06+00:00 https://ascopost.com/issues/october-25-2024/ama-house-of-delegates-adopts-asco-sponsored-resolutions-on-interpretation-of-stark-law-and-prior-authorization-costs/ 2024-10-24T12:56:07+00:00 https://ascopost.com/issues/october-25-2024/raising-awareness-of-the-health-consequences-of-alcohol-consumption-during-and-after-a-cancer-diagnosis/ 2024-10-24T20:38:17+00:00 https://ascopost.com/issues/october-25-2024/shared-reflections-on-the-2024-asco-annual-meeting-from-networking-to-mentorship-and-more-part-2/ 2024-10-24T12:56:09+00:00 https://ascopost.com/issues/october-25-2024/meeting-the-long-term-challenge-of-achieving-equity-in-global-cancer-care/ 2024-10-24T12:56:10+00:00 https://ascopost.com/issues/october-25-2024/conversations-on-cancer-exploring-religious-literacy-and-spirituality-in-cancer-care/ 2024-10-24T12:56:11+00:00 https://ascopost.com/issues/october-25-2024/fda-approves-perioperative-nivolumab-for-resectable-nsclc/ 2024-10-24T12:56:12+00:00 https://ascopost.com/issues/october-25-2024/whole-person-cancer-care-a-transformative-vision-for-oncology/ 2024-10-24T12:56:13+00:00 https://ascopost.com/issues/october-25-2024/my-melanoma-could-have-been-prevented/ 2024-11-04T18:04:09+00:00 https://ascopost.com/issues/october-25-2024/acs-report-despite-overall-decreases-in-breast-cancer-mortality-incidence-rising-in-key-groups/ 2024-10-24T12:56:15+00:00 https://ascopost.com/issues/november-10-2024/ 2024-11-08T20:53:58+00:00 https://ascopost.com/issues/november-10-2024/evolving-role-of-mrd-status-in-multiple-myeloma/ 2024-11-08T20:53:58+00:00 https://ascopost.com/issues/november-10-2024/eyeing-the-future-of-oncology-highlights-from-the-presidential-symposium-at-esmo-congress-2024/ 2024-11-08T20:53:59+00:00 https://ascopost.com/issues/november-10-2024/when-cancer-and-cardiovascular-disease-intersect/ 2024-11-08T20:54:01+00:00 https://ascopost.com/issues/november-10-2024/durvalumab-plus-chemotherapy-improves-overall-survival-in-localized-muscle-invasive-bladder-cancer/ 2025-06-27T17:57:11+00:00 https://ascopost.com/issues/november-10-2024/unexpected-results-in-solid-tumors-what-we-learned-from-negative-findings/ 2024-11-08T20:54:03+00:00 https://ascopost.com/issues/november-10-2024/patient-level-data-support-perioperative-use-of-nivolumab-in-resectable-nsclc/ 2024-11-08T20:54:04+00:00 https://ascopost.com/issues/november-10-2024/advancing-diversity-equity-and-inclusion-through-a-challenging-policy-landscape/ 2024-11-08T20:54:05+00:00 https://ascopost.com/issues/november-10-2024/fda-approves-novel-combination-regimen-for-gi-cancers/ 2024-11-08T20:54:06+00:00 https://ascopost.com/issues/november-10-2024/tumor-treating-fields-therapy-receives-fda-approval-in-metastatic-nsclc/ 2024-11-08T20:54:07+00:00 https://ascopost.com/issues/november-10-2024/ashp-offers-new-guidance-for-managing-iv-fluid-shortages/ 2024-11-08T20:54:08+00:00 https://ascopost.com/issues/november-10-2024/hypog-01-trial-reducing-the-treatment-time-for-breast-cancer-nodal-irradiation/ 2024-11-08T20:54:09+00:00 https://ascopost.com/issues/november-10-2024/adding-durvalumab-to-neoadjuvant-regimen-improves-pathologic-complete-response-rate-in-high-risk-breast-cancer/ 2024-11-08T20:54:10+00:00 https://ascopost.com/issues/november-10-2024/tarlatamab-dlle-for-previously-treated-extensive-stage-sclc/ 2024-11-08T20:54:11+00:00 https://ascopost.com/issues/november-10-2024/physician-wellness-and-professional-burnout/ 2024-11-08T20:54:12+00:00 https://ascopost.com/issues/november-10-2024/18-researchers-and-mentors-selected-for-asco-s-inaugural-international-clinical-research-scholars-program-in-latin-america/ 2024-11-08T20:54:14+00:00 https://ascopost.com/issues/november-10-2024/study-finds-cisplatin-shortage-led-to-treatment-alternatives-for-head-and-neck-cancer-significantly-increasing-cost/ 2026-01-28T21:39:55+00:00 https://ascopost.com/issues/november-10-2024/from-gaps-to-bridges-cancer-care-rooted-in-equity-quality-and-value/ 2024-11-14T21:46:14+00:00 https://ascopost.com/issues/november-10-2024/a-diagnosis-of-lymphoma-has-changed-my-life/ 2024-12-16T18:40:19+00:00 https://ascopost.com/issues/november-10-2024/ensuring-an-inclusive-environment-for-female-minority-oncologists/ 2024-11-08T20:54:18+00:00 https://ascopost.com/issues/november-10-2024/how-end-of-life-dreams-and-visions-are-bringing-comfort-to-dying-patients/ 2024-11-08T20:54:19+00:00 https://ascopost.com/issues/november-10-2024/breast-cancer-in-2024-looking-back-and-moving-forward/ 2024-11-08T20:54:20+00:00 https://ascopost.com/issues/november-10-2024/nci-grant-may-facilitate-development-of-breast-ct-screening-technology/ 2024-11-08T20:54:22+00:00 https://ascopost.com/issues/november-10-2024/neoadjuvant-therapy-yields-notable-outcomes-in-triple-negative-breast-cancer/ 2024-11-11T18:22:32+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/ 2024-12-03T19:31:00+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/highlights-from-the-2024-world-conference-on-lung-cancer/ 2024-12-05T20:27:23+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/patient-level-data-support-perioperative-use-of-nivolumab-in-resectable-nsclc/ 2024-11-13T14:34:51+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/encouraging-pathologic-responses-achieved-with-novel-combination-regimen-in-early-stage-nsclc/ 2024-11-13T14:34:52+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/harmoni-2-ivonescimab-outperforms-pembrolizumab-as-first-line-treatment-in-nsclc/ 2024-11-13T14:34:53+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/amivantamab-vmjw-plus-lazertinib-improves-long-term-outcomes-in-first-line-setting-of-egfr-mutant-advanced-nsclc/ 2024-11-13T14:34:55+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/osimertinib-plus-savolitinib-responses-reported-in-first-line-treatment-of-met-aberrant-egfr-mutant-nsclc/ 2024-11-13T14:34:56+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/novel-egfr-inhibitor-firmonertinib-shows-activity-in-rare-subtype-of-nsclc/ 2024-11-13T14:34:57+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/new-hope-for-patients-with-her2-mutant-nsclc-durable-responses-to-two-novel-targeted-therapies/ 2024-11-13T14:34:59+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/carmen-lc03-tusamitamab-ravtansine-vs-docetaxel-in-previously-treated-advanced-nonsquamous-nsclc/ 2024-12-02T19:07:07+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/tropion-lung01-update-dato-dxd-shows-activity-in-previously-treated-advanced-nonsquamous-nsclc/ 2024-11-13T14:35:01+00:00 https://ascopost.com/issues/november-25-2024-supplement-conference-highlights-2024-wclc/ifinatamab-deruxtecan-shows-activity-in-extensive-stage-small-cell-lung-cancer/ 2024-11-13T14:35:02+00:00 https://ascopost.com/issues/november-25-2024/ 2024-11-24T13:39:26+00:00 https://ascopost.com/issues/november-25-2024/i-spy22-dato-dxd-plus-durvalumab-yields-high-pathologic-response-rate-in-breast-cancer-subset/ 2024-12-09T15:18:28+00:00 https://ascopost.com/issues/november-25-2024/project-facilitate-5-years-of-progress-outreach-and-service/ 2024-11-24T13:39:28+00:00 https://ascopost.com/issues/november-25-2024/medical-legal-partnerships-a-promising-innovation-in-oncology/ 2025-02-24T23:34:07+00:00 https://ascopost.com/issues/november-25-2024/tropion-lung01-update-dato-dxd-shows-activity-in-previously-treated-advanced-nonsquamous-nsclc/ 2024-11-24T13:39:29+00:00 https://ascopost.com/issues/november-25-2024/in-case-you-missed-it-roundup-from-esmo-congress-2024/ 2025-01-22T19:20:02+00:00 https://ascopost.com/issues/november-25-2024/determining-the-optimal-first-line-management-of-advanced-classical-hodgkin-lymphoma/ 2024-11-24T13:39:32+00:00 https://ascopost.com/issues/november-25-2024/exploring-issues-in-oncofertility/ 2024-11-24T13:39:33+00:00 https://ascopost.com/issues/november-25-2024/ash-to-present-2024-honorific-awards-at-annual-meeting/ 2024-11-24T13:56:13+00:00 https://ascopost.com/issues/november-25-2024/novel-p53-mdm2-inhibitor-plus-ribociclib-demonstrates-anticancer-activity-in-liposarcoma-subset/ 2025-08-25T16:06:57+00:00 https://ascopost.com/issues/november-25-2024/katherine-van-loon-named-editor-in-chief-of-jco-global-oncology/ 2024-11-24T13:39:36+00:00 https://ascopost.com/issues/november-25-2024/information-blocking-proposal-helps-protect-reproductive-health-information-patient-preferences/ 2024-11-24T13:39:37+00:00 https://ascopost.com/issues/november-25-2024/carmen-lc03-tusamitamab-ravtansine-vs-docetaxel-in-previously-treated-advanced-nonsquamous-nsclc/ 2024-11-24T13:39:38+00:00 https://ascopost.com/issues/november-25-2024/use-of-aumolertinib-extends-progression-free-survival-in-stage-iii-egfr-mutated-nsclc/ 2024-11-24T13:39:39+00:00 https://ascopost.com/issues/november-25-2024/how-functional-and-genomic-precision-medicine-are-getting-closer-to-matching-each-patient-to-the-right-therapy/ 2024-11-24T13:39:39+00:00 https://ascopost.com/issues/november-25-2024/participation-in-virtual-prehabilitation-and-outcomes-following-thoracic-cancer-surgery/ 2024-11-24T13:39:41+00:00 https://ascopost.com/issues/november-25-2024/impact-of-food-insecurity-on-the-incidence-of-hepatocellular-carcinoma/ 2024-11-24T13:39:42+00:00 https://ascopost.com/issues/november-25-2024/high-burden-of-chronic-health-conditions-disability-and-cognitive-and-physical-limitations-reported-in-lgbtqplus-cancer-survivors/ 2024-11-24T13:39:43+00:00 https://ascopost.com/issues/november-25-2024/nccn-guidelines-expanded-to-meet-growing-understanding-of-hereditary-risk/ 2024-11-24T13:39:44+00:00 https://ascopost.com/issues/november-25-2024/shared-reflections-on-the-2024-asco-annual-meeting-from-networking-to-mentorship-and-more/ 2024-11-24T13:39:44+00:00 https://ascopost.com/issues/november-25-2024/cancer-has-plagued-my-family/ 2024-12-23T21:30:21+00:00 https://ascopost.com/issues/november-25-2024/trastuzumab-duocarmazine-in-previously-treated-her2-positive-metastatic-breast-cancer/ 2024-12-06T19:50:19+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/ 2024-12-03T19:30:18+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/highlights-from-the-esmo-congress-2024/ 2024-11-26T14:33:46+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/i-spy22-dato-dxd-plus-durvalumab-yields-high-pathologic-response-rate-in-breast-cancer-subset/ 2024-12-09T15:20:26+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/hypog-01-trial-reducing-the-treatment-time-for-breast-cancer-nodal-irradiation/ 2024-11-26T14:33:48+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/overall-survival-analysis-confirms-pembrolizumab-regimen-as-standard-of-care-for-triple-negative-breast-cancer/ 2024-11-26T14:33:49+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/t-dxd-of-benefit-in-patients-with-breast-cancer-and-brain-metastases/ 2024-11-26T14:33:50+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/leap-012-combination-of-therapies-extends-progression-free-survival-in-intermediate-stage-hepatocellular-carcinoma/ 2024-11-26T14:33:51+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/himalaya-5-year-analysis-confirms-survival-benefit-of-stride-regimen-in-hepatocellular-carcinoma/ 2024-11-26T14:33:52+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/adriatic-trial-durvalumab-consolidation-extends-survival-in-limited-stage-small-cell-lung-cancer/ 2025-01-14T19:32:55+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/peace-3-enzalutamide-plus-radium-223-significantly-improves-survival-in-metastatic-castration-resistant-prostate-cancer/ 2024-11-26T14:33:54+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/trial-updates-in-stage-iii-melanoma-solidify-the-neoadjuvant-use-of-immunotherapy-as-the-current-standard-of-care/ 2024-11-26T14:33:55+00:00 https://ascopost.com/issues/december-10-2024-supplement-conference-highlights-esmo-2024/keynote-811-pembrolizumab-combination-in-first-line-setting-improves-overall-survival-in-gastric-cancer/ 2024-12-19T18:53:44+00:00 https://ascopost.com/issues/december-10-2024/ 2024-12-09T13:34:39+00:00 https://ascopost.com/issues/december-10-2024/daratumumab-induction-regimen-in-transplant-ineligible-patients-newly-diagnosed-with-multiple-myeloma/ 2025-02-24T18:22:15+00:00 https://ascopost.com/issues/december-10-2024/increase-in-young-onset-pancreatic-cancer-may-be-due-to-overdiagnosis-of-early-stage-endocrine-cancer/ 2024-12-09T13:34:41+00:00 https://ascopost.com/issues/december-10-2024/could-sars-cov-2-be-an-oncogenic-agent-and-cancer-initiator/ 2024-12-09T13:34:42+00:00 https://ascopost.com/issues/december-10-2024/in-treatment-of-transplant-ineligible-myeloma-addition-of-isatuximab-improves-outcomes/ 2024-12-20T19:41:15+00:00 https://ascopost.com/issues/december-10-2024/overall-survival-not-improved-with-maintenance-niraparib-in-advanced-ovarian-cancer/ 2024-12-09T13:34:44+00:00 https://ascopost.com/issues/december-10-2024/adding-chemoradiation-in-perioperative-gastric-cancer-treatment-improves-pathologic-response-rates-without-survival-benefit/ 2024-12-09T13:34:45+00:00 https://ascopost.com/issues/december-10-2024/novel-egfr-inhibitor-firmonertinib-shows-activity-in-rare-subtype-of-nsclc/ 2024-12-09T13:34:46+00:00 https://ascopost.com/issues/december-10-2024/understanding-the-link-between-obesity-and-cancer/ 2024-12-09T18:27:08+00:00 https://ascopost.com/issues/december-10-2024/study-evaluating-lung-cancer-screening-program-receives-margulis-award-for-scientific-excellence/ 2024-12-09T13:34:48+00:00 https://ascopost.com/issues/december-10-2024/ai-and-the-future-of-lung-cancer-screening-still-room-for-improvement/ 2024-12-09T18:31:29+00:00 https://ascopost.com/issues/december-10-2024/study-highlights-from-md-anderson-researchers/ 2024-12-09T13:34:50+00:00 https://ascopost.com/issues/december-10-2024/novel-combination-studied-in-hpv16-positive-relapsed-or-metastatic-head-and-neck-squamous-cell-carcinoma/ 2026-01-28T21:20:59+00:00 https://ascopost.com/issues/december-10-2024/temozolomide-plus-radiotherapy-for-low-grade-gliomas/ 2024-12-09T13:34:52+00:00 https://ascopost.com/issues/december-10-2024/understanding-the-assessment-and-treatment-of-high-risk-myelofibrosis/ 2024-12-09T13:34:53+00:00 https://ascopost.com/issues/december-10-2024/ash-announces-recipients-of-2024-ash-advocacy-awards/ 2024-12-09T13:34:54+00:00 https://ascopost.com/issues/december-10-2024/updated-findings-in-preventive-breast-cancer-vaccine-study/ 2024-12-09T13:34:56+00:00 https://ascopost.com/issues/december-10-2024/4-year-asian-subpopulation-data-from-the-checkmate-816-trial-of-neoadjuvant-nivolumab-plus-chemotherapy-in-resectable-nsclc/ 2024-12-09T13:34:57+00:00 https://ascopost.com/issues/december-10-2024/imf-welcomes-newly-elected-board-of-directors-members/ 2024-12-09T13:34:58+00:00 https://ascopost.com/issues/december-10-2024/addition-of-inavolisib-to-palbociclib-fulvestrant-in-pik3ca-mutated-advanced-breast-cancer/ 2024-12-09T13:34:58+00:00 https://ascopost.com/issues/december-10-2024/the-future-of-cancer-care-part-2/ 2024-12-09T13:34:59+00:00 https://ascopost.com/issues/december-10-2024/outcomes-of-immune-checkpoint-inhibitor-treatment-for-cancer-in-black-vs-white-patients-in-the-us-vha-system/ 2024-12-09T13:35:00+00:00 https://ascopost.com/issues/december-10-2024/pediatric-cancer-clinical-trial-research-should-include-social-determinants-of-health/ 2024-12-09T13:35:01+00:00 https://ascopost.com/issues/december-10-2024/deciphering-the-impact-of-the-2024-election-on-cancer-care/ 2024-12-09T13:35:02+00:00 https://ascopost.com/issues/december-10-2024/genitourinary-cancer-expert-yuksel-urun-md-shares-his-career-journey-and-the-importance-of-achieving-a-worklife-balance/ 2025-01-07T20:43:51+00:00 https://ascopost.com/issues/december-10-2024/neoadjuvant-chemoradiation-followed-by-immunochemotherapy-and-surgery-may-improve-outcomes-in-esophageal-cancer/ 2024-12-09T13:35:05+00:00 https://ascopost.com/issues/december-10-2024/cetuximab-vs-durvalumab-in-treatment-of-head-and-neck-cancers/ 2026-01-28T21:17:13+00:00 https://ascopost.com/issues/december-10-2024/addition-of-hyperthermic-intraperitoneal-chemotherapy-to-surgery-for-recurrent-ovarian-cancer/ 2024-12-09T19:05:34+00:00 https://ascopost.com/issues/december-10-2024/oral-liquid-imatinib-approved-by-the-fda-in-leukemia/ 2024-12-09T13:35:08+00:00 https://ascopost.com/issues/december-10-2024/accelerated-approval-granted-to-zanidatamab-hrii-for-her2-positive-biliary-tract-cancer/ 2024-12-09T13:35:09+00:00 https://ascopost.com/issues/december-10-2024/impact-of-ash-minority-recruitment-initiative-on-retaining-engaging-underrepresented-hematologists/ 2024-12-09T13:35:10+00:00 https://ascopost.com/issues/december-10-2024/pooled-analysis-of-long-term-outcomes-with-nivolumab-with-or-without-ipilimumab-in-advanced-melanoma/ 2024-12-09T13:35:11+00:00 https://ascopost.com/issues/december-10-2024/perioperative-toripalimab-in-locoregionally-advanced-nasopharyngeal-carcinoma/ 2026-01-28T21:36:29+00:00 https://ascopost.com/issues/december-10-2024/rwanda-s-progress-in-eradicating-hepatitis-c-virus-a-feasible-approach-to-reducing-liver-cancer-incidence-in-sub-saharan-africa/ 2024-12-09T13:35:13+00:00 https://ascopost.com/issues/december-10-2024/understanding-how-stigma-and-incorrect-physician-assumptions-about-lgbtq-patients-needs-contribute-to-medical-mistrust/ 2024-12-09T13:35:14+00:00 https://ascopost.com/issues/december-10-2024/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-cameroon/ 2024-12-09T13:35:15+00:00 https://ascopost.com/issues/december-10-2024/2024-sio-annual-international-conference-a-rich-program-of-cutting-edge-science-and-learning/ 2024-12-09T13:35:16+00:00 https://ascopost.com/issues/december-10-2024/fda-approves-novel-companion-diagnostic-assay/ 2024-12-09T13:35:17+00:00 https://ascopost.com/issues/december-10-2024/roswell-park-announces-centers-first-physician-in-chief/ 2024-12-09T13:35:18+00:00 https://ascopost.com/issues/december-10-2024/nccn-joins-international-cancer-organizations-during-oncology-event-in-china/ 2024-12-09T13:35:19+00:00 https://ascopost.com/issues/december-10-2024/metformin-may-impact-immunotherapy-in-nsclc/ 2025-01-14T19:38:33+00:00 https://ascopost.com/issues/december-10-2024/the-lindy-effect-and-open-cancer-surgery/ 2024-12-09T13:35:21+00:00 https://ascopost.com/issues/december-10-2024/nodal-burden-and-recurrence-in-patients-with-breast-cancer-with-residual-isolated-tumor-cells-after-neoadjuvant-chemotherapy/ 2024-12-09T13:35:22+00:00 https://ascopost.com/issues/december-10-2024/will-car-t-cell-therapy-be-the-magic-bullet-for-my-multiple-myeloma/ 2024-12-20T19:48:22+00:00 https://ascopost.com/issues/december-10-2024/is-there-a-role-for-neoadjuvant-chemotherapy-in-hr-positive-her2-negative-early-breast-cancer/ 2024-12-09T13:35:24+00:00 https://ascopost.com/issues/december-10-2024/award-recipients-announced-for-the-2024-san-antonio-breast-cancer-symposium/ 2025-01-07T18:38:55+00:00 https://ascopost.com/issues/january-25-2025/ 2025-01-23T17:56:44+00:00 https://ascopost.com/issues/january-25-2025/aall1731-trial-adding-blinatumomab-to-standard-chemotherapy-improves-outcomes-in-pediatric-b-cell-all/ 2025-10-03T14:09:25+00:00 https://ascopost.com/issues/january-25-2025/olympia-trial-long-term-benefits-of-olaparib-confirmed-in-high-risk-subgroup-of-breast-cancer/ 2025-12-29T13:44:32+00:00 https://ascopost.com/issues/january-25-2025/my-cancer-diagnosis-and-renewed-commitment-to-fight-for-patients/ 2025-01-23T17:56:47+00:00 https://ascopost.com/issues/january-25-2025/aquila-trial-daratumumab-proves-beneficial-in-smoldering-multiple-myeloma/ 2025-01-23T17:56:48+00:00 https://ascopost.com/issues/january-25-2025/studies-point-to-the-role-of-diet-in-hematologic-malignancies/ 2025-01-23T17:56:50+00:00 https://ascopost.com/issues/january-25-2025/addition-of-palbociclib-to-standard-therapy-in-metastatic-hormone-receptor-positive-her2-positive-breast-cancer/ 2025-05-01T17:26:53+00:00 https://ascopost.com/issues/january-25-2025/medicare-physician-reimbursement-cut-finalized-for-2025/ 2025-01-23T17:56:52+00:00 https://ascopost.com/issues/january-25-2025/balancing-pain-management-and-addiction-risks-in-oncology/ 2025-01-23T17:56:54+00:00 https://ascopost.com/issues/january-25-2025/managing-comorbidities-in-oncology-practical-strategies-for-optimized-patient-care/ 2025-01-23T17:56:55+00:00 https://ascopost.com/issues/january-25-2025/risk-reducing-surgeries-improve-survival-for-younger-patients-with-breast-cancer-who-are-brca-carriers-study-finds/ 2025-01-23T17:56:56+00:00 https://ascopost.com/issues/january-25-2025/adjuvant-tamoxifen-reduces-15-year-risk-of-recurrence-in-good-risk-dcis-without-radiation-therapy/ 2025-01-23T17:56:58+00:00 https://ascopost.com/issues/january-25-2025/age-is-just-a-number-treatment-considerations-for-endometrial-cancer-in-older-women/ 2025-01-23T17:56:59+00:00 https://ascopost.com/issues/january-25-2025/getting-a-lung-cancer-diagnosis-was-shocking/ 2025-01-23T17:57:01+00:00 https://ascopost.com/issues/january-25-2025/some-patients-with-low-risk-ductal-carcinoma-in-situ-may-be-able-to-avoid-surgery/ 2025-01-23T19:23:35+00:00 https://ascopost.com/issues/february-25-2025/ 2025-02-21T14:03:52+00:00 https://ascopost.com/issues/february-25-2025/experimental-regimen-demonstrates-benefit-in-braf-v600e-mutant-metastatic-colorectal-ca/ 2025-03-14T17:42:18+00:00 https://ascopost.com/issues/february-25-2025/only-half-of-young-adults-with-cancer-are-told-of-fertility-preservation-options-by-their-providers/ 2025-02-27T15:48:23+00:00 https://ascopost.com/issues/february-25-2025/lung-map-30-simplifying-the-process-to-meet-patients-needs/ 2025-03-18T16:28:48+00:00 https://ascopost.com/issues/february-25-2025/dual-immunotherapy-extended-progression-free-survival-in-metastatic-colorectal-cancer-subgroup/ 2025-11-25T18:57:26+00:00 https://ascopost.com/issues/february-25-2025/new-blood-based-screening-test-accurately-detects-colorectal-cancer-risk-in-adults-aged-45-and-older/ 2025-02-21T14:03:56+00:00 https://ascopost.com/issues/february-25-2025/novel-menin-inhibitors-show-safety-and-activity-in-several-clinical-trials/ 2025-02-21T14:03:57+00:00 https://ascopost.com/issues/february-25-2025/can-r-chop-like-therapy-effectively-treat-late-relapse-dlbcl/ 2025-10-31T16:46:36+00:00 https://ascopost.com/issues/february-25-2025/chatgpt-has-limitations-in-clinical-utility-for-colorectal-cancer-but-may-be-useful-for-patient-education/ 2026-01-07T20:18:09+00:00 https://ascopost.com/issues/february-25-2025/fda-approves-preparative-regimen-for-allogeneic-hsct-in-patients-with-aml-or-mds/ 2025-02-21T14:03:59+00:00 https://ascopost.com/issues/february-25-2025/early-stage-classic-hodgkin-lymphoma/ 2025-02-26T16:30:48+00:00 https://ascopost.com/issues/february-25-2025/jennifer-a-woyach-named-the-ohio-state-s-director-of-hematology/ 2025-02-21T14:04:01+00:00 https://ascopost.com/issues/february-25-2025/boreas-trial-navtemadlin-demonstrates-clinical-benefit-in-jak-inhibitor-refractory-myelofibrosis/ 2025-02-21T14:04:02+00:00 https://ascopost.com/issues/february-25-2025/bicistronic-car-t-cell-therapy-demonstrates-clinical-activity-in-relapsed-or-refractory-b-cell-all/ 2025-10-03T14:06:33+00:00 https://ascopost.com/issues/february-25-2025/asco-updates-guidelines-on-neoadjuvant-chemotherapy-in-advanced-ovarian-cancer/ 2025-06-27T20:22:32+00:00 https://ascopost.com/issues/february-25-2025/imlunestrant-alone-or-with-abemaciclib-an-all-oral-targeted-therapy-for-er-positive-advanced-breast-cancer/ 2025-02-21T14:04:05+00:00 https://ascopost.com/issues/february-25-2025/fda-approves-acalabrutinib-with-bendamustine-and-rituximab-for-previously-untreated-mantle-cell-lymphoma/ 2025-02-21T14:04:06+00:00 https://ascopost.com/issues/february-25-2025/t-dxd-approved-by-the-fda-for-pretreated-patients-with-her2-low-or-ultralow-metastatic-breast-cancer/ 2025-02-21T14:04:07+00:00 https://ascopost.com/issues/february-25-2025/fda-approves-first-companion-diagnostic-to-identify-patients-with-metastatic-breast-cancer-eligible-for-t-dxd/ 2025-02-21T14:04:08+00:00 https://ascopost.com/issues/february-25-2025/bruton-tyrosine-kinase-inhibitor-naive-relapsed-or-refractory-mantle-cell-lymphoma/ 2025-02-21T14:04:09+00:00 https://ascopost.com/issues/february-25-2025/car-t-cell-therapy-for-relapsed-or-refractory-mantle-cell-lymphoma-zuma-2/ 2025-02-21T14:04:10+00:00 https://ascopost.com/issues/february-25-2025/how-telehealth-is-broadening-access-to-early-palliative-care-and-improving-outcomes-for-patients-with-advanced-lung-cancer/ 2025-03-18T17:52:03+00:00 https://ascopost.com/issues/february-25-2025/exercise-therapy-as-candidate-anticancer-strategy/ 2025-02-21T14:04:11+00:00 https://ascopost.com/issues/february-25-2025/felix-feng-md-leader-in-genitourinary-cancer-dies-at-age-48/ 2025-02-21T14:04:13+00:00 https://ascopost.com/issues/february-25-2025/former-unmc-cancer-center-director-kenneth-h-cowan-md-phd-dies-at-77/ 2025-02-21T14:04:14+00:00 https://ascopost.com/issues/february-25-2025/i-m-a-20-version-of-myself-after-cancer/ 2025-02-21T14:04:15+00:00 https://ascopost.com/issues/february-25-2025/cancer-mortality-rates-continue-to-decline-incidence-rates-in-women-rise-and-racial-disparities-persist/ 2025-02-21T14:04:16+00:00 https://ascopost.com/issues/march-25-2025/ 2025-03-24T13:12:38+00:00 https://ascopost.com/issues/march-25-2025/exploratory-post-hoc-analysis-of-duo-e-reveals-olaparib-s-benefit-in-endometrial-cancer-subsets/ 2025-06-27T19:32:03+00:00 https://ascopost.com/issues/march-25-2025/two-decades-of-collaboration-the-accelerating-anticancer-agent-development-and-validation-aaadv-workshop/ 2025-03-24T13:12:40+00:00 https://ascopost.com/issues/march-25-2025/the-importance-of-diversity-in-clinical-research/ 2025-03-24T13:12:41+00:00 https://ascopost.com/issues/march-25-2025/testosterone-recovery-after-androgen-deprivation-therapy-linked-to-improved-survival-in-high-risk-prostate-cancer/ 2025-06-27T20:14:20+00:00 https://ascopost.com/issues/march-25-2025/nivolumab-plus-cabozantinib-continues-to-show-superior-long-term-outcomes-in-advanced-renal-cell-carcinoma/ 2025-06-27T16:06:53+00:00 https://ascopost.com/issues/march-25-2025/enfortumab-vedotin-plus-pembrolizumab-continues-to-show-benefit-in-metastatic-urothelial-carcinoma/ 2025-06-30T17:14:46+00:00 https://ascopost.com/issues/march-25-2025/intraperitoneal-paclitaxel-combination-regimen-improves-overall-survival-in-advanced-gastric-cancer/ 2025-03-24T13:12:46+00:00 https://ascopost.com/issues/march-25-2025/advancing-clinical-decisions-with-circulting-tumor-dna-insights-from-recent-clinical-trials/ 2025-03-24T13:12:47+00:00 https://ascopost.com/issues/march-25-2025/recent-fda-approvals-in-lymphoma-and-in-rarer-tumors/ 2025-10-31T16:45:24+00:00 https://ascopost.com/issues/march-25-2025/monica-m-bertagnolli-md-facs-fasco-joins-friends-of-cancer-research-board-of-directors/ 2025-03-24T13:12:49+00:00 https://ascopost.com/issues/march-25-2025/douglas-hanahan-phd-faacr-to-be-honored-at-2025-aacr-annual-meeting/ 2025-03-24T13:12:50+00:00 https://ascopost.com/issues/march-25-2025/icymi-abstracts-on-novel-therapies-in-gastrointestinal-cancers/ 2025-06-27T21:31:20+00:00 https://ascopost.com/issues/march-25-2025/neoadjuvant-chemoradiotherapy-plus-immunotherapy-in-esophageal-squamous-cell-carcinoma/ 2025-03-24T13:12:53+00:00 https://ascopost.com/issues/march-25-2025/benefit-of-regular-physical-activity-prior-to-cancer-diagnosis/ 2025-03-24T13:12:54+00:00 https://ascopost.com/issues/march-25-2025/partial-gland-removal-may-be-an-option-for-many-men-with-prostate-cancer/ 2025-06-27T20:08:19+00:00 https://ascopost.com/issues/march-25-2025/influencing-geriatric-oncology-practice-worldwide-2024-international-society-of-geriatric-oncology-conference/ 2025-03-24T13:12:56+00:00 https://ascopost.com/issues/march-25-2025/in-case-you-missed-it-additional-studies-of-interest-from-ash-2024/ 2025-06-27T17:30:10+00:00 https://ascopost.com/issues/march-25-2025/tafasitamab-plus-lenalidomide-and-rituximab-in-relapsed-or-refractory-follicular-lymphoma/ 2025-04-23T16:59:45+00:00 https://ascopost.com/issues/march-25-2025/early-research-evaluates-association-between-diet-and-lung-cancer-risk/ 2025-06-16T18:54:55+00:00 https://ascopost.com/issues/march-25-2025/discussing-breast-density-with-patients-following-the-fda-mammography-quality-standards-act-mandate/ 2025-04-04T19:02:47+00:00 https://ascopost.com/issues/march-25-2025/new-asco-guideline-addresses-germline-and-somatic-genomic-testing-in-metastatic-prostate-cancer/ 2025-06-27T19:50:15+00:00 https://ascopost.com/issues/march-25-2025/new-guideline-supports-transoral-robotic-surgery-in-the-multidisciplinary-management-of-patients-with-oropharyngeal-cancer/ 2025-03-24T13:13:03+00:00 https://ascopost.com/issues/march-25-2025/confronting-the-growing-global-threat-of-antimicrobial-resistance-in-cancer-care/ 2025-03-24T13:13:04+00:00 https://ascopost.com/issues/march-25-2025/ageism-and-its-role-in-the-treatment-of-cancer/ 2025-03-24T13:13:05+00:00 https://ascopost.com/issues/march-25-2025/stem-cell-transplant-may-not-be-necessary-in-first-remission-for-patients-with-mantle-cell-lymphoma-and-undetectable-mrd/ 2025-05-28T19:25:16+00:00 https://ascopost.com/issues/march-25-2025/conexiant-signs-partnership-deal-with-elsevier-to-enhance-society-marketing-and-member-engagement-solutions/ 2025-03-25T17:10:32+00:00 https://ascopost.com/issues/march-25-2025/digital-integrative-medicine-intervention-for-patients-undergoing-active-cancer-treatment/ 2025-03-24T13:13:09+00:00 https://ascopost.com/issues/march-25-2025/benefit-suggested-for-early-treatment-of-advanced-stage-very-low-tumor-burden-follicular-lymphoma/ 2025-04-23T17:04:22+00:00 https://ascopost.com/issues/march-25-2025/top-picks-from-sabcs-2024/ 2025-03-24T13:46:02+00:00 https://ascopost.com/issues/march-25-2025/chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma/ 2025-06-27T17:21:23+00:00 https://ascopost.com/issues/march-25-2025/bringing-palliative-care-to-every-patient-with-cancer/ 2025-03-24T13:13:13+00:00 https://ascopost.com/issues/march-25-2025/cms-expects-between-750-000-to-2-million-to-lose-coverage-if-aca-proposal-is-implemented/ 2025-03-24T13:13:14+00:00 https://ascopost.com/issues/march-25-2025/screening-was-key-to-the-early-detection-of-my-prostate-cancer/ 2025-06-27T19:48:30+00:00 https://ascopost.com/issues/march-25-2025/results-announced-from-phase-ii-veritac-2-clinical-trial-in-breast-cancer/ 2025-03-24T13:13:17+00:00 https://ascopost.com/issues/march-25-2025/study-finds-no-clear-evidence-that-red-wine-mitigates-cancer-risk/ 2025-03-24T13:13:18+00:00 https://ascopost.com/issues/march-25-2025/new-reports-assess-oncology-workforce-well-being-propose-solutions-to-address-burnout/ 2025-03-24T13:13:19+00:00 https://ascopost.com/issues/april-25-2025/ 2025-04-24T13:24:59+00:00 https://ascopost.com/issues/april-25-2025/pembrolizumab-plus-chemotherapy-new-standard-of-care-in-locally-advanced-cervical-cancer/ 2025-06-27T19:27:43+00:00 https://ascopost.com/issues/april-25-2025/several-trials-show-clinical-activity-with-osimertinib-in-advanced-egfr-mutant-non-small-cell-lung-cancer/ 2025-06-16T18:26:51+00:00 https://ascopost.com/issues/april-25-2025/hyperefficient-and-super-digitized-health-care/ 2025-04-24T13:25:02+00:00 https://ascopost.com/issues/april-25-2025/combination-therapy-for-newly-diagnosed-brca-nonmutated-advanced-epithelial-ovarian-cancer/ 2025-06-27T19:13:56+00:00 https://ascopost.com/issues/april-25-2025/sgo-s-president-elect-brings-professional-experience-and-passion-to-her-new-role/ 2025-04-24T13:25:04+00:00 https://ascopost.com/issues/april-25-2025/managing-dermatologic-reactions-to-combination-therapy-for-patients-with-egfr-mutated-nsclc/ 2025-06-16T18:25:27+00:00 https://ascopost.com/issues/april-25-2025/proton-therapy-and-intensity-modulated-radiation-therapy-for-localized-prostate-cancer/ 2025-04-24T13:25:07+00:00 https://ascopost.com/issues/april-25-2025/study-finds-standard-chemoradiation-therapy-superior-to-deintensification-approaches-for-hpv-related-oropharyngeal-cancer/ 2026-01-28T17:04:11+00:00 https://ascopost.com/issues/april-25-2025/use-of-investigational-tool-to-detect-advanced-stage-invasive-cervical-cancer/ 2025-06-27T18:43:15+00:00 https://ascopost.com/issues/april-25-2025/ai-integration-in-global-programs-of-ct-screening-for-lung-cancer-and-other-tobacco-related-illnesses/ 2026-01-07T19:54:04+00:00 https://ascopost.com/issues/april-25-2025/karen-e-knudsen-mba-phd-appointed-chief-executive-officer-of-the-parker-institute-for-cancer-immunotherapy/ 2025-04-24T13:25:11+00:00 https://ascopost.com/issues/april-25-2025/asco-updates-guideline-for-fertility-preservation-in-people-with-cancer/ 2025-04-24T13:25:12+00:00 https://ascopost.com/issues/april-25-2025/executive-orders-and-cancer-care/ 2025-04-24T13:25:14+00:00 https://ascopost.com/issues/april-25-2025/fda-approves-nivolumab-with-ipilimumab-for-unresectable-or-metastatic-msi-hdmmr-colorectal-cancer/ 2025-06-30T16:15:26+00:00 https://ascopost.com/issues/april-25-2025/fda-approves-perioperative-durvalumab-for-muscle-invasive-bladder-cancer/ 2025-06-27T17:38:55+00:00 https://ascopost.com/issues/april-25-2025/fda-expands-indication-for-lu-177-vipivotide-tetraxetan-in-mcrpc/ 2025-06-27T19:42:40+00:00 https://ascopost.com/issues/april-25-2025/cabozantinib-approved-for-treatment-of-neuroendocrine-tumors/ 2025-04-24T13:25:18+00:00 https://ascopost.com/issues/april-25-2025/combination-immunotherapy-approved-for-unresectable-or-metastatic-hepatocellular-carcinoma/ 2025-04-24T13:25:19+00:00 https://ascopost.com/issues/april-25-2025/final-results-of-libretto-001-selpercatinib-in-ret-fusion-positive-nsclc/ 2025-04-24T13:25:20+00:00 https://ascopost.com/issues/april-25-2025/raising-awareness-of-inflammatory-breast-cancer/ 2025-06-16T20:56:06+00:00 https://ascopost.com/issues/may-10-2025/ 2025-05-09T14:12:46+00:00 https://ascopost.com/issues/may-10-2025/addition-of-perioperative-pembrolizumab-to-standard-of-care-in-newly-diagnosed-locally-advanced-head-and-neck-cancer/ 2026-01-28T16:49:02+00:00 https://ascopost.com/issues/may-10-2025/addition-of-perioperative-pembrolizumab-to-standard-of-care-in-newly-diagnosed-locally-advanced-head-and-neck-cancer/summary/ 2025-05-12T19:07:34+00:00 https://ascopost.com/issues/may-10-2025/addition-of-perioperative-pembrolizumab-to-standard-of-care-in-newly-diagnosed-locally-advanced-head-and-neck-cancer/notecards/ 2025-05-12T20:54:29+00:00 https://ascopost.com/issues/may-10-2025/therapy-with-a-tki-for-egfr-variant-lung-adenocarcinoma-lessons-from-cml/ 2025-06-16T18:30:32+00:00 https://ascopost.com/issues/may-10-2025/cancer-aging-and-meaning-navigating-psychosocial-challenges/ 2025-05-09T15:27:38+00:00 https://ascopost.com/issues/may-10-2025/quick-takes-on-research-findings-on-novel-therapies-for-gynecologic-cancers/ 2025-06-27T18:34:52+00:00 https://ascopost.com/issues/may-10-2025/study-shows-disparities-in-diagnosing-endometrial-cancer-in-women-with-postmenopausal-bleeding/ 2025-06-27T18:34:09+00:00 https://ascopost.com/issues/may-10-2025/evolving-role-of-surgical-de-escalation-for-endometrial-ovarian-cervical-and-vulvar-cancers/ 2025-06-27T18:32:51+00:00 https://ascopost.com/issues/may-10-2025/is-active-monitoring-a-safe-option-for-patients-with-ductal-carcinoma-in-situ/ 2025-05-09T16:21:09+00:00 https://ascopost.com/issues/may-10-2025/richard-pazdur-md-honored-with-2025-aacr-enduring-impact-award-for-transformative-service-to-cancer-science-and-medicine/ 2025-05-09T14:12:53+00:00 https://ascopost.com/issues/may-10-2025/off-the-shelf-natural-killer-car-t-cell-therapy-shows-efficacy-in-small-study-of-relapsed-or-refractory-blood-cancers/ 2025-10-03T14:21:04+00:00 https://ascopost.com/issues/may-10-2025/amivantamab-vmjw-plus-lazertinib-vs-osimertinib-in-egfr-mutated-non-small-cell-lung-cancer/ 2025-06-16T18:07:19+00:00 https://ascopost.com/issues/may-10-2025/venetoclax-based-therapy-for-patients-with-newly-diagnosed-acute-myeloid-leukemia/ 2025-05-09T16:31:42+00:00 https://ascopost.com/issues/may-10-2025/fda-approves-anti-pd-1-antibody-for-nasopharyngeal-cancer/ 2026-01-28T16:58:33+00:00 https://ascopost.com/issues/may-10-2025/2024-annual-report-to-the-nation-on-the-status-of-cancer-finds-mortality-rates-continue-to-decline/ 2025-05-09T16:40:36+00:00 https://ascopost.com/issues/may-10-2025/joint-clinical-practice-guideline-addresses-opioid-conversion-for-patients-with-cancer/ 2025-05-09T16:42:26+00:00 https://ascopost.com/issues/may-10-2025/ash-studies-bolster-support-for-menin-inhibitor-in-acute-leukemia/ 2025-05-09T16:45:55+00:00 https://ascopost.com/issues/may-10-2025/is-clonal-cytopenia-of-undetermined-significance-distinct-from-lower-risk-myelodysplastic-syndrome/ 2025-05-09T16:50:10+00:00 https://ascopost.com/issues/may-10-2025/novel-btk-and-bcl2-inhibitors-redefine-cll-treatment-across-front-line-and-relapsed-settings/ 2025-06-27T17:32:33+00:00 https://ascopost.com/issues/may-10-2025/rakesh-k-jain-phd-faacr-honored-with-2025-aacr-award-for-lifetime-achievement-in-cancer-research/ 2025-05-09T16:53:44+00:00 https://ascopost.com/issues/may-10-2025/how-the-cancer-moonshot-is-making-a-difference-for-patients-here-and-across-the-world/ 2025-05-09T14:13:02+00:00 https://ascopost.com/issues/may-10-2025/keith-t-flaherty-md-faacr-elected-as-aacr-president-elect-for-2025-2026/ 2025-05-09T14:13:03+00:00 https://ascopost.com/issues/may-10-2025/building-and-sharing-dietary-evidence-in-cancer-care/ 2025-05-09T14:13:04+00:00 https://ascopost.com/issues/may-10-2025/remembering-roswell-park-leader-thomas-b-tomasi-jr-md-phd/ 2025-05-09T17:00:12+00:00 https://ascopost.com/issues/may-10-2025/how-could-so-many-physicians-have-failed-me/ 2025-05-27T18:37:02+00:00 https://ascopost.com/issues/may-10-2025/applications-are-now-open-for-the-2025-integrative-oncology-scholars-program-and-integrative-oncology-fellows-program/ 2025-05-09T17:11:19+00:00 https://ascopost.com/issues/may-10-2025/renowned-breast-cancer-physician-scientist-to-lead-womens-cancers-program-at-city-of-hope/ 2025-06-16T21:01:19+00:00 https://ascopost.com/issues/may-25-2025/ 2025-05-23T02:52:25+00:00 https://ascopost.com/issues/may-25-2025/early-phase-trial-shows-activity-and-safety-of-zongertinib-in-previously-treated-her2-mutant-nsclc/ 2025-06-17T17:05:47+00:00 https://ascopost.com/issues/may-25-2025/the-power-of-translational-science-to-transform-the-lives-of-patients-worldwide/ 2025-05-23T02:52:26+00:00 https://ascopost.com/issues/may-25-2025/together-we-re-building-a-better-future-for-people-with-cancer-and-for-our-profession/ 2025-05-23T02:52:27+00:00 https://ascopost.com/issues/may-25-2025/early-stage-nonrectal-mismatch-repair-deficient-tumors-respond-to-neoadjuvant-pd-1-blockade-facilitating-nonoperative-management/ 2025-05-23T02:52:29+00:00 https://ascopost.com/issues/may-25-2025/asco-proposed-changes-to-federal-health-agencies-threaten-future-cancer-research-advancements/ 2025-05-23T02:52:30+00:00 https://ascopost.com/issues/may-25-2025/asco-proposed-changes-to-federal-health-agencies-threaten-future-cancer-research-advancements/summary/ 2025-05-23T02:52:43+00:00 https://ascopost.com/issues/may-25-2025/asco-proposed-changes-to-federal-health-agencies-threaten-future-cancer-research-advancements/notecards/ 2025-05-23T02:52:44+00:00 https://ascopost.com/issues/may-25-2025/nccn-clinical-practice-guidelines-in-oncology-2025-updates/ 2025-07-15T19:33:07+00:00 https://ascopost.com/issues/may-25-2025/nccn-clinical-practice-guidelines-in-oncology-2025-updates/summary/ 2025-05-23T02:52:43+00:00 https://ascopost.com/issues/may-25-2025/nccn-clinical-practice-guidelines-in-oncology-2025-updates/notecards/ 2025-05-23T02:52:44+00:00 https://ascopost.com/issues/may-25-2025/fda-approves-doublet-for-kras-mutated-recurrent-low-grade-serous-ovarian-cancer/ 2025-06-27T18:29:45+00:00 https://ascopost.com/issues/may-25-2025/fda-approves-doublet-for-kras-mutated-recurrent-low-grade-serous-ovarian-cancer/summary/ 2025-05-23T02:52:42+00:00 https://ascopost.com/issues/may-25-2025/fda-approves-doublet-for-kras-mutated-recurrent-low-grade-serous-ovarian-cancer/notecards/ 2025-05-23T02:52:44+00:00 https://ascopost.com/issues/may-25-2025/additional-abstracts-of-interest-in-cancer-research/ 2025-05-23T02:52:32+00:00 https://ascopost.com/issues/may-25-2025/fellows-of-the-aacr-academy-class-of-2025/ 2025-05-23T02:52:33+00:00 https://ascopost.com/issues/may-25-2025/w-kimryn-rathmell-md-phd-fasco-named-ceo-of-osuccc-james/ 2025-05-23T02:52:34+00:00 https://ascopost.com/issues/may-25-2025/asco-congratulates-2025-special-awards-recipients/ 2025-05-23T02:52:35+00:00 https://ascopost.com/issues/may-25-2025/two-vs-8-week-course-of-radiotherapy-for-prostate-cancer-10-year-follow-up/ 2025-06-27T19:28:36+00:00 https://ascopost.com/issues/may-25-2025/two-vs-8-week-course-of-radiotherapy-for-prostate-cancer-10-year-follow-up/summary/ 2025-05-23T02:52:42+00:00 https://ascopost.com/issues/may-25-2025/two-vs-8-week-course-of-radiotherapy-for-prostate-cancer-10-year-follow-up/notecards/ 2025-05-23T02:52:43+00:00 https://ascopost.com/issues/may-25-2025/what-is-the-value-in-cost-and-lives-saved-of-cancer-screening-and-prevention/ 2025-05-23T02:52:37+00:00 https://ascopost.com/issues/may-25-2025/strategy-for-managing-immunotherapy-induced-parkinsonism-in-patients-with-multiple-myeloma/ 2025-05-27T18:35:32+00:00 https://ascopost.com/issues/may-25-2025/the-legal-impacts-on-oncology-care-of-prohibiting-diversity-equity-and-inclusion-efforts/ 2025-05-23T02:52:39+00:00 https://ascopost.com/issues/may-25-2025/bringing-evidence-based-integrative-medicine-into-everyday-oncology-practice/ 2025-05-23T02:52:40+00:00 https://ascopost.com/issues/may-25-2025/i-have-stage-iv-lung-cancer-and-still-consider-myself-the-luckiest-man-in-the-world/ 2025-06-17T17:06:55+00:00 https://ascopost.com/issues/june-10-2025/ 2025-06-10T04:09:47+00:00 https://ascopost.com/issues/june-10-2025/overall-survival-benefit-achieved-with-inavolisib-plus-palbociclib-and-fulvestrant-in-advanced-breast-cancer/ 2025-06-13T21:16:26+00:00 https://ascopost.com/issues/june-10-2025/maintenance-therapy-with-lurbinectedin-plus-atezolizumab-improves-survival-outcomes-in-extensive-stage-small-cell-lung-cancer/ 2025-06-17T17:04:52+00:00 https://ascopost.com/issues/june-10-2025/mark-cuban-does-it-again-reshuffling-the-deck-of-front-line-cml-therapy/ 2025-06-10T04:09:50+00:00 https://ascopost.com/issues/june-10-2025/study-finds-glp-1ras-may-lower-risk-of-obesity-related-cancers-vs-dpp-4-inhibitors-in-adults-with-diabetes-and-obesity/ 2025-08-18T19:45:31+00:00 https://ascopost.com/issues/june-10-2025/asco-and-google-cloud-ai-powered-tool/ 2025-10-30T13:58:30+00:00 https://ascopost.com/issues/june-10-2025/structured-exercise-program-improves-survival-outcomes-in-patients-with-stage-iii-or-high-risk-stage-ii-colon-cancer/ 2025-06-30T14:58:35+00:00 https://ascopost.com/issues/june-10-2025/study-shows-potential-benefits-of-ai-assisted-classification-in-her2-low-and-her2-ultralow-breast-cancer/ 2025-10-30T14:05:10+00:00 https://ascopost.com/issues/june-10-2025/revisiting-margin-width-guidelines-for-dcis-and-the-role-of-routine-reexcision/ 2025-12-29T13:46:38+00:00 https://ascopost.com/issues/june-10-2025/revisiting-margin-width-guidelines-for-dcis-and-the-role-of-routine-reexcision/summary/ 2025-06-10T04:10:37+00:00 https://ascopost.com/issues/june-10-2025/revisiting-margin-width-guidelines-for-dcis-and-the-role-of-routine-reexcision/notecards/ 2025-07-22T18:30:33+00:00 https://ascopost.com/issues/june-10-2025/pathology-machine-learning-models-and-diagnosis-of-nonmelanoma-skin-cancers-in-resource-limited-settings/ 2025-10-30T14:22:24+00:00 https://ascopost.com/issues/june-10-2025/digital-histopathology-and-automated-classification-of-pediatric-sarcomas/ 2025-10-30T14:15:06+00:00 https://ascopost.com/issues/june-10-2025/circulating-tumor-dna-guided-risk-stratification-in-colorectal-cancer-evolving-evidence-and-future-utility/ 2025-06-30T15:39:11+00:00 https://ascopost.com/issues/june-10-2025/circulating-tumor-dna-guided-risk-stratification-in-colorectal-cancer-evolving-evidence-and-future-utility/summary/ 2025-06-10T04:10:37+00:00 https://ascopost.com/issues/june-10-2025/circulating-tumor-dna-guided-risk-stratification-in-colorectal-cancer-evolving-evidence-and-future-utility/notecards/ 2025-06-10T04:10:40+00:00 https://ascopost.com/issues/june-10-2025/cellular-therapies-show-sustained-promise-in-hematologic-malignancies-but-access-remains-uneven/ 2025-06-12T18:22:20+00:00 https://ascopost.com/issues/june-10-2025/cellular-therapies-show-sustained-promise-in-hematologic-malignancies-but-access-remains-uneven/summary/ 2025-06-10T04:10:36+00:00 https://ascopost.com/issues/june-10-2025/cellular-therapies-show-sustained-promise-in-hematologic-malignancies-but-access-remains-uneven/notecards/ 2025-06-10T04:10:40+00:00 https://ascopost.com/issues/june-10-2025/improving-the-alliance-between-oncologists-and-primary-care-providers-a-call-for-collaborative-action/ 2025-06-10T04:10:03+00:00 https://ascopost.com/issues/june-10-2025/everolimus-plus-lanreotide-vs-everolimus-alone-in-aggressive-gastroenteropancreatic-neuroendocrine-tumors/ 2025-06-27T21:27:52+00:00 https://ascopost.com/issues/june-10-2025/everolimus-plus-lanreotide-vs-everolimus-alone-in-aggressive-gastroenteropancreatic-neuroendocrine-tumors/summary/ 2025-06-10T04:10:36+00:00 https://ascopost.com/issues/june-10-2025/everolimus-plus-lanreotide-vs-everolimus-alone-in-aggressive-gastroenteropancreatic-neuroendocrine-tumors/notecards/ 2025-06-10T04:10:39+00:00 https://ascopost.com/issues/june-10-2025/recent-advances-in-treating-diffuse-large-b-cell-lymphoma/ 2025-10-31T16:44:45+00:00 https://ascopost.com/issues/june-10-2025/recent-advances-in-treating-diffuse-large-b-cell-lymphoma/summary/ 2025-06-10T04:10:35+00:00 https://ascopost.com/issues/june-10-2025/recent-advances-in-treating-diffuse-large-b-cell-lymphoma/notecards/ 2025-06-10T04:10:39+00:00 https://ascopost.com/issues/june-10-2025/how-the-elimination-of-federal-gender-related-grants-and-dei-programs-is-impacting-lgbtqplus-health-research/ 2025-06-10T04:10:07+00:00 https://ascopost.com/issues/june-10-2025/fda-approves-therapy-for-nsclc-with-high-c-met-protein-overexpression/ 2025-06-16T17:27:59+00:00 https://ascopost.com/issues/june-10-2025/fda-approves-first-oral-therapy-for-pheochromocytoma-and-paraganglioma/ 2025-06-10T04:10:09+00:00 https://ascopost.com/issues/june-10-2025/expanded-treatment-options-for-metastatic-crpc-asco-guideline-addresses-somatic-genetic-testing-radiopharmaceuticals/ 2025-06-27T18:53:59+00:00 https://ascopost.com/issues/june-10-2025/retifanlimab-dlwr-approved-for-anal-cancer-in-combination-with-carboplatin-plus-paclitaxel-and-as-a-single-agent/ 2025-06-30T14:55:42+00:00 https://ascopost.com/issues/june-10-2025/astro-survey-data-illustrate-impact-of-continued-medicare-cuts-on-cancer-care/ 2025-06-10T04:10:13+00:00 https://ascopost.com/issues/june-10-2025/why-black-women-have-a-higher-risk-of-dying-of-all-types-of-breast-cancer-than-white-women/ 2025-06-13T21:11:36+00:00 https://ascopost.com/issues/june-10-2025/conundrums-in-treating-her2-positive-early-breast-cancer/ 2025-06-13T21:08:00+00:00 https://ascopost.com/issues/june-10-2025/conundrums-in-treating-her2-positive-early-breast-cancer/summary/ 2025-06-10T04:10:35+00:00 https://ascopost.com/issues/june-10-2025/conundrums-in-treating-her2-positive-early-breast-cancer/notecards/ 2025-06-10T04:10:39+00:00 https://ascopost.com/issues/june-10-2025/estro-2025-major-advances-in-radiotherapy-for-anal-and-rectal-cancers/ 2025-06-30T14:53:28+00:00 https://ascopost.com/issues/june-10-2025/crispr-cas9-edited-tumor-infiltrating-lymphocytes-in-metastatic-colorectal-cancer/ 2025-06-30T14:51:52+00:00 https://ascopost.com/issues/june-10-2025/castor-oil/ 2025-06-10T04:10:20+00:00 https://ascopost.com/issues/june-10-2025/castor-oil/summary/ 2025-06-10T04:10:32+00:00 https://ascopost.com/issues/june-10-2025/castor-oil/notecards/ 2025-06-10T04:10:33+00:00 https://ascopost.com/issues/june-10-2025/use-of-bispecific-antibody-in-older-patients-with-relapsed-or-refractory-multiple-myeloma/ 2025-06-10T04:10:21+00:00 https://ascopost.com/issues/june-10-2025/kindness-mercy-empathy-compassion-are-they-relevant-in-the-era-of-robotics-and-ai/ 2026-01-07T20:23:56+00:00 https://ascopost.com/issues/june-10-2025/kindness-mercy-empathy-compassion-are-they-relevant-in-the-era-of-robotics-and-ai/summary/ 2025-06-10T04:10:35+00:00 https://ascopost.com/issues/june-10-2025/kindness-mercy-empathy-compassion-are-they-relevant-in-the-era-of-robotics-and-ai/notecards/ 2025-06-10T04:10:38+00:00 https://ascopost.com/issues/june-10-2025/md-anderson-names-jeffrey-e-lee-md-chief-medical-executive/ 2025-06-10T04:10:24+00:00 https://ascopost.com/issues/june-10-2025/how-family-adventures-precision-oncology-and-living-purposefully-bring-balance-to-the-life-of-charu-aggarwal-md-mph-fasco/ 2025-06-10T04:10:25+00:00 https://ascopost.com/issues/june-10-2025/how-family-adventures-precision-oncology-and-living-purposefully-bring-balance-to-the-life-of-charu-aggarwal-md-mph-fasco/summary/ 2025-06-10T04:10:34+00:00 https://ascopost.com/issues/june-10-2025/how-family-adventures-precision-oncology-and-living-purposefully-bring-balance-to-the-life-of-charu-aggarwal-md-mph-fasco/notecards/ 2025-06-10T04:10:38+00:00 https://ascopost.com/issues/june-10-2025/i-was-an-n-of-1-in-a-car-t-cell-therapy-trial-for-ovarian-cancer/ 2025-06-27T18:18:06+00:00 https://ascopost.com/issues/june-10-2025/aacr-statement-on-former-president-joseph-biden-s-cancer-diagnosis/ 2025-06-27T18:52:02+00:00 https://ascopost.com/issues/june-10-2025/cutting-cancer-research-funding-is-a-costly-gamble-with-millions-of-lives/ 2025-06-10T04:10:29+00:00 https://ascopost.com/issues/june-10-2025/fda-oce-announces-project-interface-outreach-initiative/ 2025-06-10T04:10:30+00:00 https://ascopost.com/issues/june-10-2025/fda-oce-announces-project-interface-outreach-initiative/summary/ 2025-06-10T04:10:34+00:00 https://ascopost.com/issues/june-10-2025/fda-oce-announces-project-interface-outreach-initiative/notecards/ 2025-06-10T04:10:37+00:00 https://ascopost.com/issues/june-10-2025/early-onset-breast-colorectal-melanoma-thyroid-testicular-and-other-cancers-are-on-the-rise-in-the-united-states/ 2025-06-10T04:10:31+00:00 https://ascopost.com/issues/june-25-2025/ 2025-06-25T04:12:11+00:00 https://ascopost.com/issues/june-25-2025/phase-iii-trial-results-suggest-a-new-standard-of-care-in-metastatic-her2-positive-breast-cancer/ 2025-06-25T19:22:52+00:00 https://ascopost.com/issues/june-25-2025/adjuvant-use-of-atezolizumab-plus-chemotherapy-in-dna-mismatch-repair-deficient-colon-cancer/ 2025-11-25T18:39:36+00:00 https://ascopost.com/issues/june-25-2025/silence-is-complicity/ 2025-06-25T04:12:13+00:00 https://ascopost.com/issues/june-25-2025/early-esr1-mutation-detection-and-therapy-switch-in-advanced-hormone-receptor-positive-her2-negative-breast-cancer/ 2025-06-25T19:14:44+00:00 https://ascopost.com/issues/june-25-2025/updated-results-confirm-benefit-of-combination-regimen-in-braf-v600e-mutated-metastatic-colorectal-cancer/ 2025-07-22T15:55:42+00:00 https://ascopost.com/issues/june-25-2025/impact-of-dietary-patterns-on-survival-in-stage-iii-colon-cancer/ 2025-11-25T18:39:59+00:00 https://ascopost.com/issues/june-25-2025/impact-of-dietary-patterns-on-survival-in-stage-iii-colon-cancer/summary/ 2025-06-25T04:12:48+00:00 https://ascopost.com/issues/june-25-2025/impact-of-dietary-patterns-on-survival-in-stage-iii-colon-cancer/notecards/ 2025-06-25T04:12:50+00:00 https://ascopost.com/issues/june-25-2025/acs-study-focuses-on-effects-of-medicaid-expansion-in-low-income-older-adults-with-cancer/ 2025-06-25T04:12:18+00:00 https://ascopost.com/issues/june-25-2025/fda-approves-darolutamide-for-metastatic-castration-sensitive-prostate-cancer/ 2025-06-27T18:59:48+00:00 https://ascopost.com/issues/june-25-2025/fda-approves-darolutamide-for-metastatic-castration-sensitive-prostate-cancer/summary/ 2025-06-25T04:12:48+00:00 https://ascopost.com/issues/june-25-2025/fda-approves-darolutamide-for-metastatic-castration-sensitive-prostate-cancer/notecards/ 2025-06-25T04:12:49+00:00 https://ascopost.com/issues/june-25-2025/in-second-line-setting-t-dxd-improves-survival-outcomes-in-her2-positive-gastric-or-gastroesophageal-junction-cancer/ 2025-06-25T04:12:19+00:00 https://ascopost.com/issues/june-25-2025/asco-guideline-update-calls-for-omission-of-slnb-in-select-patients-with-early-stage-breast-cancer/ 2025-06-25T19:16:09+00:00 https://ascopost.com/issues/june-25-2025/asco-and-medicaid-advocacy-in-action/ 2025-06-25T04:12:22+00:00 https://ascopost.com/issues/june-25-2025/vepdegestrant-vs-fulvestrant-in-estrogen-receptor-positive-her2-negative-advanced-breast-cancer/ 2025-06-25T19:17:53+00:00 https://ascopost.com/issues/june-25-2025/asco-honors-karen-eubanks-jackson-of-sisters-network-inc-with-2025-patient-advocate-award/ 2025-06-25T04:12:23+00:00 https://ascopost.com/issues/june-25-2025/hla-matching-considerations-for-hematopoietic-cell-transplantation-in-hematologic-malignancies/ 2025-06-25T04:12:24+00:00 https://ascopost.com/issues/june-25-2025/use-of-adjuvant-aspirin-reduces-the-risk-of-recurrence-in-pi3k-mutated-colorectal-cancer/ 2025-06-30T17:47:12+00:00 https://ascopost.com/issues/june-25-2025/use-of-adjuvant-aspirin-reduces-the-risk-of-recurrence-in-pi3k-mutated-colorectal-cancer/summary/ 2025-06-25T04:12:43+00:00 https://ascopost.com/issues/june-25-2025/use-of-adjuvant-aspirin-reduces-the-risk-of-recurrence-in-pi3k-mutated-colorectal-cancer/notecards/ 2025-06-25T04:12:45+00:00 https://ascopost.com/issues/june-25-2025/trends-in-breast-cancer-incidence-for-women-between-the-ages-of-20-and-49/ 2025-06-25T04:12:27+00:00 https://ascopost.com/issues/june-25-2025/trends-in-breast-cancer-incidence-for-women-between-the-ages-of-20-and-49/summary/ 2025-06-25T04:12:47+00:00 https://ascopost.com/issues/june-25-2025/trends-in-breast-cancer-incidence-for-women-between-the-ages-of-20-and-49/notecards/ 2025-06-25T04:12:49+00:00 https://ascopost.com/issues/june-25-2025/establishing-novel-models-of-interdisciplinary-care-to-improve-survival-outcomes-in-patients-with-cancer/ 2025-07-17T16:50:37+00:00 https://ascopost.com/issues/june-25-2025/establishing-novel-models-of-interdisciplinary-care-to-improve-survival-outcomes-in-patients-with-cancer/summary/ 2025-06-25T04:12:47+00:00 https://ascopost.com/issues/june-25-2025/establishing-novel-models-of-interdisciplinary-care-to-improve-survival-outcomes-in-patients-with-cancer/notecards/ 2025-06-25T04:12:49+00:00 https://ascopost.com/issues/june-25-2025/preoperative-endocrine-therapy-for-older-women-with-estrogen-receptor-positive-breast-cancer/ 2025-06-25T19:19:13+00:00 https://ascopost.com/issues/june-25-2025/hypofractionation-vs-conventional-fractionation-in-patients-with-breast-cancer-planning-breast-reconstruction/ 2025-06-25T04:12:30+00:00 https://ascopost.com/issues/june-25-2025/hypofractionation-vs-conventional-fractionation-in-patients-with-breast-cancer-planning-breast-reconstruction/summary/ 2025-06-25T04:12:47+00:00 https://ascopost.com/issues/june-25-2025/hypofractionation-vs-conventional-fractionation-in-patients-with-breast-cancer-planning-breast-reconstruction/notecards/ 2025-06-25T04:12:48+00:00 https://ascopost.com/issues/june-25-2025/how-a-commonly-inherited-genetic-alteration-is-driving-breast-cancer-metastasis-and-predicting-survival/ 2025-06-25T04:12:30+00:00 https://ascopost.com/issues/june-25-2025/how-a-commonly-inherited-genetic-alteration-is-driving-breast-cancer-metastasis-and-predicting-survival/summary/ 2025-06-25T04:12:44+00:00 https://ascopost.com/issues/june-25-2025/how-a-commonly-inherited-genetic-alteration-is-driving-breast-cancer-metastasis-and-predicting-survival/notecards/ 2025-06-25T04:12:46+00:00 https://ascopost.com/issues/june-25-2025/chinese-herbal-medicine-for-improving-adjuvant-chemotherapy-completion-in-patients-with-colon-cancer/ 2025-07-22T15:39:45+00:00 https://ascopost.com/issues/june-25-2025/menopause-medication-may-help-to-prevent-invasive-breast-cancer-study-finds/ 2025-06-25T04:12:32+00:00 https://ascopost.com/issues/june-25-2025/menopause-medication-may-help-to-prevent-invasive-breast-cancer-study-finds/summary/ 2025-06-25T04:12:44+00:00 https://ascopost.com/issues/june-25-2025/menopause-medication-may-help-to-prevent-invasive-breast-cancer-study-finds/notecards/ 2025-06-25T04:12:45+00:00 https://ascopost.com/issues/june-25-2025/number-of-cancer-survivors-in-the-united-states-reaches-186-million-and-projected-to-exceed-22-million-by-2035/ 2025-06-25T04:12:33+00:00 https://ascopost.com/issues/june-25-2025/chronicling-the-extraordinary-career-of-stephen-r-grobmyer/ 2025-06-25T04:12:34+00:00 https://ascopost.com/issues/june-25-2025/chronicling-the-extraordinary-career-of-stephen-r-grobmyer/summary/ 2025-06-25T04:12:45+00:00 https://ascopost.com/issues/june-25-2025/chronicling-the-extraordinary-career-of-stephen-r-grobmyer/notecards/ 2025-06-25T04:12:46+00:00 https://ascopost.com/issues/june-25-2025/minnesota-society-of-clinical-oncology-recognized-for-advocacy-at-2025-asco-annual-meeting/ 2025-06-30T15:03:27+00:00 https://ascopost.com/issues/june-25-2025/malignant-hematology-expert-and-medicare-reimbursement-advocate-samuel-m-silver-md-phd-frcp-fasco-macp-dies-at-74/ 2025-06-25T04:12:36+00:00 https://ascopost.com/issues/june-25-2025/william-c-wood-md-fasco-renowned-surgeon-esteemed-mentor-global-academic-dean-dies-at-84/ 2025-06-25T04:12:38+00:00 https://ascopost.com/issues/june-25-2025/w-kimryn-rathmell-md-phd-fasco-selected-for-women-who-conquer-cancer-mentorship-award/ 2025-06-25T04:12:39+00:00 https://ascopost.com/issues/june-25-2025/i-was-expecting-to-hear-i-have-heart-disease-not-cancer/ 2025-06-25T19:22:12+00:00 https://ascopost.com/issues/june-25-2025/molecular-assay-identifies-patients-with-early-nsclc-likely-to-benefit-from-adjuvant-chemotherapy/ 2025-06-25T04:12:41+00:00 https://ascopost.com/issues/june-25-2025/molecular-assay-identifies-patients-with-early-nsclc-likely-to-benefit-from-adjuvant-chemotherapy/summary/ 2025-06-25T04:12:44+00:00 https://ascopost.com/issues/june-25-2025/molecular-assay-identifies-patients-with-early-nsclc-likely-to-benefit-from-adjuvant-chemotherapy/notecards/ 2025-06-25T04:12:46+00:00 https://ascopost.com/issues/june-25-2025/the-ohio-state-appoints-christian-rolfo-md-phd-mba-to-lead-division-of-medical-oncology/ 2025-06-25T04:12:42+00:00 https://ascopost.com/issues/june-25-2025/mailed-self-collection-hpv-tests-improve-cervical-cancer-screening-rates-study-finds/ 2025-07-28T17:28:49+00:00 https://ascopost.com/issues/july-25-2025/ 2025-07-24T15:34:40+00:00 https://ascopost.com/issues/july-25-2025/evidence-of-potential-cure-with-single-car-t-cell-infusion-for-some-patients-with-multiple-myeloma/ 2025-08-22T17:38:18+00:00 https://ascopost.com/issues/july-25-2025/phase-iii-polargo-addition-of-polatuzumab-vedotin-improves-overall-survival-in-refractory-dlbcl/ 2025-10-31T16:42:59+00:00 https://ascopost.com/issues/july-25-2025/phase-iii-polargo-addition-of-polatuzumab-vedotin-improves-overall-survival-in-refractory-dlbcl/summary/ 2025-07-24T15:34:56+00:00 https://ascopost.com/issues/july-25-2025/phase-iii-polargo-addition-of-polatuzumab-vedotin-improves-overall-survival-in-refractory-dlbcl/notecards/ 2025-07-24T15:34:57+00:00 https://ascopost.com/issues/july-25-2025/how-i-discuss-the-current-political-chaos-when-patients-ask-health-related-questions-about-it/ 2025-07-24T15:34:43+00:00 https://ascopost.com/issues/july-25-2025/how-i-discuss-the-current-political-chaos-when-patients-ask-health-related-questions-about-it/summary/ 2025-07-24T15:34:56+00:00 https://ascopost.com/issues/july-25-2025/how-i-discuss-the-current-political-chaos-when-patients-ask-health-related-questions-about-it/notecards/ 2025-07-24T15:34:56+00:00 https://ascopost.com/issues/july-25-2025/a-potential-new-standard-of-care-in-gastric-or-gastroesophageal-junction-cancer/ 2025-07-24T15:34:44+00:00 https://ascopost.com/issues/july-25-2025/plenary-highlights-across-tumor-types-reflect-advances-in-research-improvements-in-care-and-changes-in-practice/ 2025-08-18T19:31:20+00:00 https://ascopost.com/issues/july-25-2025/updates-in-systemic-light-chain-amyloidosis/ 2025-07-24T15:34:46+00:00 https://ascopost.com/issues/july-25-2025/nearly-50-percent-of-all-cancer-deaths-worldwide-attributable-to-modifiable-risk-factors/ 2025-08-18T18:45:40+00:00 https://ascopost.com/issues/july-25-2025/nearly-50-percent-of-all-cancer-deaths-worldwide-attributable-to-modifiable-risk-factors/summary/ 2025-07-24T15:34:57+00:00 https://ascopost.com/issues/july-25-2025/nearly-50-percent-of-all-cancer-deaths-worldwide-attributable-to-modifiable-risk-factors/notecards/ 2025-07-24T15:34:58+00:00 https://ascopost.com/issues/july-25-2025/medicare-advantage-audits-are-expanding/ 2025-08-18T19:13:13+00:00 https://ascopost.com/issues/july-25-2025/genitourinary-oncology-highlights-treatment-advances-in-renal-cell-bladder-urothelial-and-prostate-cancers/ 2025-07-24T15:34:50+00:00 https://ascopost.com/issues/july-25-2025/immunotherapy-combination-a-potential-new-standard-in-triple-negative-breast-cancer/ 2025-07-24T15:34:51+00:00 https://ascopost.com/issues/july-25-2025/does-exposure-to-wildfire-dominated-inhalable-fine-particulate-matter-impact-survival-in-nsclc/ 2025-08-14T15:48:41+00:00 https://ascopost.com/issues/july-25-2025/does-menopausal-hormone-therapy-increase-the-risk-of-death-in-women-with-brca-mutated-breast-cancer/ 2025-07-24T15:34:53+00:00 https://ascopost.com/issues/july-25-2025/surviving-pancreatic-cancer/ 2025-07-24T15:34:54+00:00 https://ascopost.com/issues/august-25-2025/ 2025-08-15T18:10:18+00:00 https://ascopost.com/issues/august-25-2025/tafasitamab-combined-with-lenalidomide-and-rituximab-improved-outcomes-in-relapsed-or-refractory-follicular-lymphoma/ 2025-08-27T16:19:35+00:00 https://ascopost.com/issues/august-25-2025/potential-new-second-line-standard-of-care-emerges-in-small-cell-lung-cancer/ 2025-08-15T18:10:20+00:00 https://ascopost.com/issues/august-25-2025/is-this-the-end-of-cancer-research-as-we-know-it/ 2025-09-04T17:52:35+00:00 https://ascopost.com/issues/august-25-2025/is-this-the-end-of-cancer-research-as-we-know-it/summary/ 2025-08-15T18:10:47+00:00 https://ascopost.com/issues/august-25-2025/is-this-the-end-of-cancer-research-as-we-know-it/notecards/ 2025-08-15T18:10:48+00:00 https://ascopost.com/issues/august-25-2025/upfront-radical-cytoreductive-surgery-extends-progression-free-survival-in-advanced-ovarian-cancer/ 2025-08-15T18:10:22+00:00 https://ascopost.com/issues/august-25-2025/upfront-radical-cytoreductive-surgery-extends-progression-free-survival-in-advanced-ovarian-cancer/summary/ 2025-08-15T18:10:45+00:00 https://ascopost.com/issues/august-25-2025/upfront-radical-cytoreductive-surgery-extends-progression-free-survival-in-advanced-ovarian-cancer/notecards/ 2025-08-15T18:10:46+00:00 https://ascopost.com/issues/august-25-2025/alcohol-associated-cancer-death-rates-are-climbing/ 2025-08-15T18:10:23+00:00 https://ascopost.com/issues/august-25-2025/alcohol-associated-cancer-death-rates-are-climbing/summary/ 2025-08-15T18:10:44+00:00 https://ascopost.com/issues/august-25-2025/alcohol-associated-cancer-death-rates-are-climbing/notecards/ 2025-08-15T18:10:45+00:00 https://ascopost.com/issues/august-25-2025/adding-nivolumab-to-adjuvant-chemoradiotherapy-reduces-risk-of-recurrence-in-patients-with-head-and-neck-cancer/ 2026-01-28T16:44:38+00:00 https://ascopost.com/issues/august-25-2025/emerging-pd-1-inhibitor-plus-chemotherapy-shows-efficacy-in-second-line-classical-hodgkin-lymphoma/ 2025-08-27T16:22:24+00:00 https://ascopost.com/issues/august-25-2025/asco-names-2025-q1-q2-fasco-recipients/ 2025-08-15T18:10:27+00:00 https://ascopost.com/issues/august-25-2025/similar-efficacy-improved-safety-achieved-without-concurrent-cisplatin-for-locoregionally-advanced-nasopharyngeal-cancer/ 2026-01-28T16:30:20+00:00 https://ascopost.com/issues/august-25-2025/studies-on-egfr-mutations-and-nrg1-fusions-included-in-asco-nsclc-living-guideline-update/ 2025-08-15T18:10:30+00:00 https://ascopost.com/issues/august-25-2025/new-report-supports-overhaul-of-cancer-drug-dosing/ 2025-08-15T18:10:32+00:00 https://ascopost.com/issues/august-25-2025/best-of-asco-20th-anniversary-advancing-medicine-and-patient-care-asco-style/ 2025-08-15T18:10:33+00:00 https://ascopost.com/issues/august-25-2025/experimental-approach-to-gvhd-prophylaxis-offers-alternative-to-standard-regimen/ 2025-08-15T18:10:34+00:00 https://ascopost.com/issues/august-25-2025/studies-explore-cardiac-risks-and-clinical-characteristics-associated-with-immune-checkpoint-inhibitor-related-myocarditis/ 2025-08-15T18:10:35+00:00 https://ascopost.com/issues/august-25-2025/immune-checkpoint-inhibitors-cardiovascular-health-and-a-potentially-protective-biomarker/ 2025-08-15T18:10:37+00:00 https://ascopost.com/issues/august-25-2025/the-inflation-reduction-act-and-ibrutinib/ 2025-08-15T18:10:38+00:00 https://ascopost.com/issues/august-25-2025/the-inflation-reduction-act-and-ibrutinib/summary/ 2025-08-15T18:10:45+00:00 https://ascopost.com/issues/august-25-2025/the-inflation-reduction-act-and-ibrutinib/notecards/ 2025-08-15T18:10:47+00:00 https://ascopost.com/issues/august-25-2025/ash-announces-2025-hematologists-to-be-honored-with-top-awards-and-distinguished-lectures/ 2025-08-15T18:10:40+00:00 https://ascopost.com/issues/august-25-2025/a-young-hematologist-s-take-on-icml-2025/ 2025-10-31T16:40:16+00:00 https://ascopost.com/issues/august-25-2025/a-young-hematologist-s-take-on-icml-2025/summary/ 2025-08-15T18:10:44+00:00 https://ascopost.com/issues/august-25-2025/a-young-hematologist-s-take-on-icml-2025/notecards/ 2025-08-15T18:10:46+00:00 https://ascopost.com/issues/august-25-2025/a-diagnosis-of-stage-iv-lung-cancer-at-18-has-tested-my-faith-and-made-it-stronger/ 2025-08-15T18:10:42+00:00 https://ascopost.com/issues/september-10-2025/ 2025-09-10T13:29:21+00:00 https://ascopost.com/issues/september-10-2025/parp-inhibition-plus-abiraterone-shows-benefit-in-hrr-altered-metastatic-castration-sensitive-prostate-cancer/ 2025-09-10T13:26:09+00:00 https://ascopost.com/issues/september-10-2025/living-with-the-real-world-consequences-of-federal-budget-cuts-on-cancer-research/ 2025-09-10T13:26:10+00:00 https://ascopost.com/issues/september-10-2025/optimizing-the-car-to-the-disease-in-b-cell-malignancies/ 2025-09-10T13:26:12+00:00 https://ascopost.com/issues/september-10-2025/treatment-rechallenge-after-interstitial-lung-disease-related-to-t-dxd/ 2025-09-10T13:26:13+00:00 https://ascopost.com/issues/september-10-2025/experts-share-their-perspectives-on-navigating-opioid-induced-constipation-in-oncology/ 2025-09-19T15:35:45+00:00 https://ascopost.com/issues/september-10-2025/radiation-oncology-leaders-name-2025-fellows-of-the-american-society-for-radiation-oncology/ 2025-09-10T13:26:15+00:00 https://ascopost.com/issues/september-10-2025/personalizing-first-line-therapy-in-nsclc-plasma-guided-adaptive-treatment-approach/ 2025-09-10T13:26:16+00:00 https://ascopost.com/issues/september-10-2025/use-of-cemiplimab-as-adjuvant-therapy-for-high-risk-cutaneous-squamous-cell-carcinoma/ 2025-09-17T17:54:15+00:00 https://ascopost.com/issues/september-10-2025/smoldering-multiple-myeloma-how-the-guidance-is-changing/ 2025-09-10T13:26:19+00:00 https://ascopost.com/issues/september-10-2025/is-cure-finally-achievable-in-multiple-myeloma/ 2025-09-15T18:31:37+00:00 https://ascopost.com/issues/september-10-2025/do-the-results-from-cartitude-1-represent-a-cure-for-patients-with-multiple-myeloma-we-need-longer-follow-up-to-know-for-sure/ 2025-09-26T16:47:26+00:00 https://ascopost.com/issues/september-10-2025/the-implications-of-the-results-from-cartitude-1-for-future-research-and-care-in-multiple-myeloma/ 2025-09-26T16:48:50+00:00 https://ascopost.com/issues/september-10-2025/update-to-asco-living-guideline-for-nsclc-without-driver-alterations-includes-first-comparison-of-immunotherapy-options/ 2025-09-10T13:26:24+00:00 https://ascopost.com/issues/september-10-2025/a-playbook-for-best-practices-asco-and-coa-release-updated-oncology-medical-home-standards/ 2025-09-10T13:26:25+00:00 https://ascopost.com/issues/september-10-2025/jeffrey-a-drebin-md-phd-named-chief-physician-executive-of-memorial-sloan-kettering-cancer-center/ 2025-09-10T13:26:26+00:00 https://ascopost.com/issues/september-10-2025/john-byrd-named-upmc-hillman-cancer-center-director/ 2025-09-10T13:26:27+00:00 https://ascopost.com/issues/september-10-2025/overcoming-the-challenges-of-safely-using-opioids-to-treat-patients-with-chronic-cancer-related-pain/ 2025-11-14T18:29:18+00:00 https://ascopost.com/issues/september-10-2025/realizing-the-full-potential-of-patient-engagement-in-clinical-research/ 2025-11-20T12:00:59+00:00 https://ascopost.com/issues/september-10-2025/ohsu-knight-cancer-institute-receives-2-billion-commitment-from-phil-and-penny-knight/ 2025-09-10T13:26:31+00:00 https://ascopost.com/issues/september-10-2025/bridging-the-gap-in-geriatric-oncology-education-a-global-imperative/ 2025-10-02T17:45:35+00:00 https://ascopost.com/issues/september-25-2025/ 2025-09-22T17:27:33+00:00 https://ascopost.com/issues/september-25-2025/osimertinib-plus-chemotherapy-significantly-prolongs-overall-survival-in-egfr-mutated-advanced-nsclc/ 2025-10-14T17:49:43+00:00 https://ascopost.com/issues/september-25-2025/how-the-ai-powered-asco-guidelines-assistant-is-improving-clinical-decision-making/ 2025-11-04T17:50:33+00:00 https://ascopost.com/issues/september-25-2025/how-the-ai-powered-asco-guidelines-assistant-is-improving-clinical-decision-making/summary/ 2025-09-22T17:28:06+00:00 https://ascopost.com/issues/september-25-2025/how-the-ai-powered-asco-guidelines-assistant-is-improving-clinical-decision-making/notecards/ 2025-09-22T17:28:08+00:00 https://ascopost.com/issues/september-25-2025/jco-authorship-guidelines-are-of-benefit-to-those-caring-for-older-patients/ 2025-09-22T17:27:36+00:00 https://ascopost.com/issues/september-25-2025/jco-authorship-guidelines-are-of-benefit-to-those-caring-for-older-patients/summary/ 2025-09-22T17:28:05+00:00 https://ascopost.com/issues/september-25-2025/jco-authorship-guidelines-are-of-benefit-to-those-caring-for-older-patients/notecards/ 2025-09-22T17:28:07+00:00 https://ascopost.com/issues/september-25-2025/overall-survival-benefit-shown-for-neoadjuvant-nivolumab-plus-chemotherapy-in-non-small-cell-lung-cancer/ 2025-09-22T17:27:37+00:00 https://ascopost.com/issues/september-25-2025/adding-the-hepcidin-mimetic-rusfertide-to-the-standard-of-care-yields-benefits-in-polycythemia-vera/ 2025-09-30T19:21:15+00:00 https://ascopost.com/issues/september-25-2025/adding-the-hepcidin-mimetic-rusfertide-to-the-standard-of-care-yields-benefits-in-polycythemia-vera/summary/ 2025-09-22T17:28:06+00:00 https://ascopost.com/issues/september-25-2025/adding-the-hepcidin-mimetic-rusfertide-to-the-standard-of-care-yields-benefits-in-polycythemia-vera/notecards/ 2025-09-22T17:28:09+00:00 https://ascopost.com/issues/september-25-2025/nivolumab-maintains-quality-of-life-and-reduces-symptom-deterioration-in-resectable-nsclc/ 2025-09-22T17:27:39+00:00 https://ascopost.com/issues/september-25-2025/nivolumab-maintains-quality-of-life-and-reduces-symptom-deterioration-in-resectable-nsclc/summary/ 2025-09-22T17:28:05+00:00 https://ascopost.com/issues/september-25-2025/nivolumab-maintains-quality-of-life-and-reduces-symptom-deterioration-in-resectable-nsclc/notecards/ 2025-09-22T17:28:08+00:00 https://ascopost.com/issues/september-25-2025/neoadjuvant-osimertinib-in-the-perioperative-setting-for-resectable-egfr-mutated-nsclc/ 2025-09-22T17:27:41+00:00 https://ascopost.com/issues/september-25-2025/neoadjuvant-osimertinib-in-the-perioperative-setting-for-resectable-egfr-mutated-nsclc/summary/ 2025-09-22T17:28:06+00:00 https://ascopost.com/issues/september-25-2025/neoadjuvant-osimertinib-in-the-perioperative-setting-for-resectable-egfr-mutated-nsclc/notecards/ 2025-09-22T17:28:09+00:00 https://ascopost.com/issues/september-25-2025/investigating-the-mechanisms-of-cardiovascular-adverse-events-linked-to-certain-cancer-treatments/ 2026-01-22T16:32:10+00:00 https://ascopost.com/issues/september-25-2025/cardiotoxicity-from-the-use-of-anthracyclines-in-cancer-survivors-preventive-strategies/ 2025-09-22T17:27:43+00:00 https://ascopost.com/issues/september-25-2025/perioperative-pembrolizumab-plus-surgery-and-risk-adapted-standard-adjuvant-therapy-shows-benefit-in-locally-advanced-head-and-neck-cancer/ 2026-01-28T16:25:42+00:00 https://ascopost.com/issues/september-25-2025/conversion-of-unresectable-into-resectable-pancreatic-cancer-chemoradiotherapy-vs-chemotherapy/ 2025-09-22T17:27:46+00:00 https://ascopost.com/issues/september-25-2025/conversion-of-unresectable-into-resectable-pancreatic-cancer-chemoradiotherapy-vs-chemotherapy/summary/ 2025-09-22T17:28:10+00:00 https://ascopost.com/issues/september-25-2025/conversion-of-unresectable-into-resectable-pancreatic-cancer-chemoradiotherapy-vs-chemotherapy/notecards/ 2025-09-22T17:28:11+00:00 https://ascopost.com/issues/september-25-2025/asco-approves-first-guideline-on-cancer-specific-geriatric-assessment-of-older-patients-in-resource-limited-settings/ 2025-09-22T17:27:47+00:00 https://ascopost.com/issues/september-25-2025/asco-remembers-past-president-harvey-m-golomb-md-fasco/ 2025-09-22T17:27:48+00:00 https://ascopost.com/issues/september-25-2025/asco-thanks-richard-l-schilsky-md-facp-fsct-fasco-for-his-vision-and-leadership-of-tapur/ 2025-09-22T17:27:49+00:00 https://ascopost.com/issues/september-25-2025/understanding-accelerated-aging-in-survivors-of-childhood-cancers/ 2025-09-22T17:27:51+00:00 https://ascopost.com/issues/september-25-2025/new-approvals-for-thrombocytopenia-lung-cancer-brain-cancer-and-multiple-myeloma/ 2025-09-22T17:27:52+00:00 https://ascopost.com/issues/september-25-2025/what-we-wish-we-knew-during-fellowship/ 2025-09-22T17:27:53+00:00 https://ascopost.com/issues/september-25-2025/what-we-wish-we-knew-during-fellowship/summary/ 2025-09-22T17:28:10+00:00 https://ascopost.com/issues/september-25-2025/what-we-wish-we-knew-during-fellowship/notecards/ 2025-09-22T17:28:10+00:00 https://ascopost.com/issues/september-25-2025/new-nih-funded-study-identifies-urine-based-assay-for-prostate-cancer/ 2025-09-22T17:27:55+00:00 https://ascopost.com/issues/september-25-2025/james-r-doty-md-pioneer-in-neurosurgical-innovation-and-the-scientific-study-of-compassion-dies-at-69/ 2025-09-22T17:27:56+00:00 https://ascopost.com/issues/september-25-2025/acute-myeloid-leukemia-with-runx1runx1t1-fusion/ 2025-09-24T19:04:14+00:00 https://ascopost.com/issues/september-25-2025/ayurveda-in-cancer-care/ 2025-09-22T17:27:59+00:00 https://ascopost.com/issues/september-25-2025/addition-of-sintilimab-to-total-neoadjuvant-treatment-in-locally-advanced-rectal-cancer/ 2025-09-22T17:28:01+00:00 https://ascopost.com/issues/september-25-2025/addition-of-sintilimab-to-total-neoadjuvant-treatment-in-locally-advanced-rectal-cancer/summary/ 2025-09-22T17:28:04+00:00 https://ascopost.com/issues/september-25-2025/addition-of-sintilimab-to-total-neoadjuvant-treatment-in-locally-advanced-rectal-cancer/notecards/ 2025-09-22T17:28:07+00:00 https://ascopost.com/issues/september-25-2025/city-of-hope-awarded-237-million-to-map-biomarkers-in-nsclc/ 2025-09-22T17:28:03+00:00 https://ascopost.com/issues/october-25-2025/ 2025-10-22T16:10:40+00:00 https://ascopost.com/issues/october-25-2025/federally-funded-clinical-trials-play-a-vital-role-in-cancer-research-especially-for-rare-and-pediatric-cancers/ 2025-10-22T16:10:40+00:00 https://ascopost.com/issues/october-25-2025/in-extensive-stage-small-cell-lung-cancer-novel-maintenance-regimen-boosts-overall-survival/ 2025-10-22T16:10:42+00:00 https://ascopost.com/issues/october-25-2025/considerations-on-cancer-drug-development/ 2025-10-22T16:10:43+00:00 https://ascopost.com/issues/october-25-2025/improved-outcomes-reported-with-second-line-regimen-of-ivonescimab-plus-chemotherapy-in-nsclc/ 2025-10-22T16:10:44+00:00 https://ascopost.com/issues/october-25-2025/zidesamtinib-shows-activity-in-pretreated-and-tyrosine-kinase-inhibitor-naive-patients-with-ros1-positive-nsclc/ 2025-10-22T16:10:45+00:00 https://ascopost.com/issues/october-25-2025/prior-authorization-is-burdensome-for-patients-resulting-in-treatment-delays-financial-strain-and-stress/ 2025-10-22T16:10:47+00:00 https://ascopost.com/issues/october-25-2025/early-study-results-with-novel-bruton-s-tyrosine-kinase-degrader-in-relapsed-or-refractory-chronic-lymphocytic-leukemia/ 2025-10-22T16:10:48+00:00 https://ascopost.com/issues/october-25-2025/early-study-results-with-novel-bruton-s-tyrosine-kinase-degrader-in-relapsed-or-refractory-chronic-lymphocytic-leukemia/summary/ 2025-10-22T16:11:11+00:00 https://ascopost.com/issues/october-25-2025/early-study-results-with-novel-bruton-s-tyrosine-kinase-degrader-in-relapsed-or-refractory-chronic-lymphocytic-leukemia/notecards/ 2025-10-22T16:11:12+00:00 https://ascopost.com/issues/october-25-2025/use-of-obecabtagene-autoleucel-car-t-cell-therapy-for-b-cell-acute-lymphocytic-leukemia/ 2025-10-22T16:10:49+00:00 https://ascopost.com/issues/october-25-2025/aacr-cancer-progress-report-highlights-breakthroughs-in-blood-cancers-and-how-nih-funding-uncertainty-threatens-advances/ 2025-10-22T16:10:51+00:00 https://ascopost.com/issues/october-25-2025/should-lung-cancer-screening-guidelines-be-expanded-to-include-female-asian-nonsmokers/ 2025-10-22T16:10:52+00:00 https://ascopost.com/issues/october-25-2025/contemporary-management-of-chronic-myeloid-leukemia-according-to-hagop-m-kantarjian-md-fasco/ 2025-10-22T16:10:53+00:00 https://ascopost.com/issues/october-25-2025/new-approvals-in-breast-and-bladder-cancers/ 2025-10-22T16:10:55+00:00 https://ascopost.com/issues/october-25-2025/how-embedding-an-algorithm-based-referral-system-into-electronic-health-records-is-increasing-access-to-palliative-care/ 2025-11-06T16:37:41+00:00 https://ascopost.com/issues/october-25-2025/a-year-of-global-progress-against-cancer-and-persistent-challenges/ 2025-10-22T16:10:57+00:00 https://ascopost.com/issues/october-25-2025/new-guideline-reflects-the-latest-evidence-in-support-of-postmastectomy-radiation-therapy-for-patients-with-breast-cancer/ 2025-10-22T16:10:59+00:00 https://ascopost.com/issues/october-25-2025/anthony-letai-sworn-in-as-new-nci-director/ 2025-10-22T16:11:00+00:00 https://ascopost.com/issues/october-25-2025/clonal-hematopoiesis/ 2025-10-22T16:11:01+00:00 https://ascopost.com/issues/october-25-2025/how-a-2-billion-gift-to-the-knight-cancer-institute-may-accelerate-cancer-advances-and-streamline-care-for-patients/ 2025-11-05T19:10:28+00:00 https://ascopost.com/issues/october-25-2025/medicine-is-in-the-genes-of-neelima-denduluri-md-fasco-a-third-generation-clinician/ 2025-10-22T16:11:04+00:00 https://ascopost.com/issues/october-25-2025/how-a-novel-coaching-intervention-is-building-resilience-and-hope-in-adolescents-and-young-adults-with-advanced-cancer/ 2025-10-22T16:11:06+00:00 https://ascopost.com/issues/october-25-2025/biomarker-driven-apalutamide-therapy-for-patients-with-recurrent-prostate-cancer/ 2025-10-22T16:11:07+00:00 https://ascopost.com/issues/october-25-2025/defying-the-odds/ 2025-10-22T16:11:08+00:00 https://ascopost.com/issues/october-25-2025/advancing-geriatric-oncology-where-we-have-been-and-where-we-are-going/ 2025-10-22T16:11:10+00:00 https://ascopost.com/issues/november-10-2025/ 2025-11-10T15:15:38+00:00 https://ascopost.com/issues/november-10-2025/perioperative-immunotherapy-regimen-improves-outcomes-in-cisplatin-ineligible-muscle-invasive-bladder-cancer/ 2025-11-10T15:15:39+00:00 https://ascopost.com/issues/november-10-2025/intensity-modulated-radiation-therapy-vs-proton-therapy-for-oropharyngeal-cancer/ 2026-01-27T17:21:52+00:00 https://ascopost.com/issues/november-10-2025/alcohol-and-cancer-risk-is-a-drop-too-much/ 2025-11-10T15:15:42+00:00 https://ascopost.com/issues/november-10-2025/her2-positive-early-breast-cancer-trastuzumab-deruxtecan-moves-into-earlier-clinical-settings/ 2025-12-29T13:45:55+00:00 https://ascopost.com/issues/november-10-2025/safety-and-benefit-of-radiation-therapy-for-high-risk-muscle-invasive-bladder-cancer/ 2025-12-12T16:26:28+00:00 https://ascopost.com/issues/november-10-2025/astro-announces-new-president-elect-officers-to-board-of-directors/ 2025-11-10T15:15:47+00:00 https://ascopost.com/issues/november-10-2025/cutaneous-t-cell-lymphoma-use-of-durvalumab-alone-or-with-lenalidomide-under-study-in-phase-ii-trial/ 2025-11-10T15:15:49+00:00 https://ascopost.com/issues/november-10-2025/immunotherapy-combination-active-in-patients-with-large-b-cell-lymphoma-who-are-not-eligible-for-autologous-stem-cell-transplant/ 2025-11-10T15:15:50+00:00 https://ascopost.com/issues/november-10-2025/variation-in-psa-levels-in-annual-testing-among-individuals-without-prostate-cancer-diagnosis/ 2025-11-10T15:15:52+00:00 https://ascopost.com/issues/november-10-2025/multidrug-resistant-ulcerative-colitis-response-to-cd19-car-t-cell-therapy-in-a-single-case/ 2025-11-10T15:15:54+00:00 https://ascopost.com/issues/november-10-2025/reducing-the-impact-of-climate-induced-events-on-patients-and-oncology-staff/ 2026-03-24T16:22:16+00:00 https://ascopost.com/issues/november-10-2025/the-consequences-of-climate-change-on-cancer-development-and-patient-care/ 2025-11-10T15:15:58+00:00 https://ascopost.com/issues/november-10-2025/making-clinical-trials-more-accessible-new-report-highlights-barriers-and-solutions/ 2025-11-10T15:15:59+00:00 https://ascopost.com/issues/november-10-2025/asco-and-ons-issue-first-collaborative-guideline-on-extravasation/ 2025-11-10T15:16:01+00:00 https://ascopost.com/issues/november-10-2025/armando-e-giuliano-md-to-be-honored-with-2025-william-l-mcguire-memorial-lecture-award-at-sabcs/ 2025-12-09T18:52:05+00:00 https://ascopost.com/issues/november-10-2025/creatine/ 2025-11-10T15:16:04+00:00 https://ascopost.com/issues/november-10-2025/diminishing-the-national-cancer-institute-threatens-americans/ 2025-11-10T15:16:06+00:00 https://ascopost.com/issues/november-10-2025/a-serendipitous-fall-may-have-saved-my-life/ 2025-11-10T15:16:07+00:00 https://ascopost.com/issues/november-25-2025/ 2025-11-25T01:02:50+00:00 https://ascopost.com/issues/november-25-2025/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/ 2026-01-22T17:19:32+00:00 https://ascopost.com/issues/november-25-2025/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/summary/ 2025-11-25T01:03:23+00:00 https://ascopost.com/issues/november-25-2025/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/notecards/ 2025-11-25T01:03:24+00:00 https://ascopost.com/issues/november-25-2025/treatment-advances-in-malignant-hematology-2025-updates/ 2025-11-25T01:02:52+00:00 https://ascopost.com/issues/november-25-2025/how-to-adapt-to-the-era-of-ai-and-the-changing-interactions-with-patients-lessons-from-a-low-resource-setting/ 2025-12-05T16:40:31+00:00 https://ascopost.com/issues/november-25-2025/long-term-survival-with-stereotactic-ablative-radiotherapy-vs-surgery-for-early-stage-nsclc/ 2025-12-05T16:42:07+00:00 https://ascopost.com/issues/november-25-2025/proton-vs-photon-radiation-therapy-for-nonmetastatic-breast-cancer/ 2025-12-17T16:10:22+00:00 https://ascopost.com/issues/november-25-2025/ivonescimab-a-dual-targeting-bispecific-antibody-improves-progression-free-survival-in-squamous-nsclc/ 2025-12-05T16:45:05+00:00 https://ascopost.com/issues/november-25-2025/fda-approves-daratumumab-and-hyaluronidase-fihj-for-high-risk-smoldering-multiple-myeloma/ 2025-11-25T01:02:58+00:00 https://ascopost.com/issues/november-25-2025/fda-approves-daratumumab-and-hyaluronidase-fihj-for-high-risk-smoldering-multiple-myeloma/summary/ 2025-11-25T01:03:19+00:00 https://ascopost.com/issues/november-25-2025/fda-approves-daratumumab-and-hyaluronidase-fihj-for-high-risk-smoldering-multiple-myeloma/notecards/ 2025-11-25T01:03:21+00:00 https://ascopost.com/issues/november-25-2025/icahn-school-of-medicine-family-center-for-caregiving-launches-website-to-further-reach-and-broaden-mission/ 2025-12-05T16:47:23+00:00 https://ascopost.com/issues/november-25-2025/zanzalintinib-plus-immune-checkpoint-inhibitor-in-metastatic-colorectal-cancer/ 2025-12-05T18:58:32+00:00 https://ascopost.com/issues/november-25-2025/cognitive-function-preserved-with-statin-administration-during-chemotherapy/ 2025-11-25T01:03:02+00:00 https://ascopost.com/issues/november-25-2025/cognitive-function-preserved-with-statin-administration-during-chemotherapy/summary/ 2025-11-25T01:03:19+00:00 https://ascopost.com/issues/november-25-2025/cognitive-function-preserved-with-statin-administration-during-chemotherapy/notecards/ 2025-11-25T01:03:21+00:00 https://ascopost.com/issues/november-25-2025/cognitive-function-preserved-with-statin-administration-during-chemotherapy/notecards-1/ 2025-11-25T01:03:23+00:00 https://ascopost.com/issues/november-25-2025/project-disarm-new-cancer-mission-emphasizes-risk-assessment-and-early-detection-of-ovarian-cancer/ 2025-12-05T17:10:37+00:00 https://ascopost.com/issues/november-25-2025/how-the-proliferation-of-fraudulent-scientific-papers-is-threatening-the-integrity-of-cancer-research/ 2025-12-05T17:13:55+00:00 https://ascopost.com/issues/november-25-2025/how-the-proliferation-of-fraudulent-scientific-papers-is-threatening-the-integrity-of-cancer-research/summary/ 2025-11-25T01:03:20+00:00 https://ascopost.com/issues/november-25-2025/how-the-proliferation-of-fraudulent-scientific-papers-is-threatening-the-integrity-of-cancer-research/notecards/ 2025-11-25T01:03:22+00:00 https://ascopost.com/issues/november-25-2025/significant-medicare-physician-reimbursement-methodology-changes-finalized-for-2026/ 2025-11-25T01:03:06+00:00 https://ascopost.com/issues/november-25-2025/asco-election-for-open-leadership-positions/ 2025-12-05T17:45:21+00:00 https://ascopost.com/issues/november-25-2025/memorial-sloan-kettering-names-recipients-of-2025-paul-marks-prize-for-cancer-research/ 2025-12-05T17:49:24+00:00 https://ascopost.com/issues/november-25-2025/preneoplastic-and-neoplastic-small-lymphocytic-proliferations/ 2025-12-11T14:45:21+00:00 https://ascopost.com/issues/november-25-2025/preneoplastic-and-neoplastic-small-lymphocytic-proliferations/summary/ 2025-11-25T01:03:19+00:00 https://ascopost.com/issues/november-25-2025/preneoplastic-and-neoplastic-small-lymphocytic-proliferations/notecards/ 2025-11-25T01:03:21+00:00 https://ascopost.com/issues/november-25-2025/how-an-endowed-chair-in-cord-blood-research-is-providing-new-hope-for-patients-with-high-risk-leukemia/ 2025-12-18T16:38:39+00:00 https://ascopost.com/issues/november-25-2025/astro-recognizes-2025-award-recipients-for-excellence-in-radiation-oncology/ 2025-12-05T18:03:19+00:00 https://ascopost.com/issues/november-25-2025/new-approvals-in-hematologic-malignancies-skin-cancer-and-small-cell-lung-cancer/ 2025-11-25T01:03:14+00:00 https://ascopost.com/issues/november-25-2025/reflections-of-a-medical-oncologist-empathy-matters-in-caring-for-patients-with-cancer/ 2025-11-25T01:03:15+00:00 https://ascopost.com/issues/november-25-2025/reflections-of-a-medical-oncologist-empathy-matters-in-caring-for-patients-with-cancer/summary/ 2025-11-25T01:03:20+00:00 https://ascopost.com/issues/november-25-2025/reflections-of-a-medical-oncologist-empathy-matters-in-caring-for-patients-with-cancer/notecards/ 2025-11-25T01:03:22+00:00 https://ascopost.com/issues/november-25-2025/as-a-cancer-survivor-my-main-worry-now-is-affording-health-insurance/ 2025-12-05T18:07:35+00:00 https://ascopost.com/issues/november-25-2025/postsurgical-ctdna-testing-in-stage-iii-colon-cancer-for-treatment-de-escalation/ 2025-12-05T19:00:38+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/ 2025-11-24T18:39:48+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/european-society-for-medical-oncology-congress-2025-meeting-highlights/ 2025-12-05T15:56:23+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/perioperative-immunotherapy-regimen-improves-outcomes-in-cisplatin-ineligible-muscle-invasive-bladder-cancer/ 2025-12-05T15:57:54+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/her2-positive-early-breast-cancer-trastuzumab-deruxtecan-moves-into-earlier-clinical-settings/ 2025-11-24T18:39:50+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/ivonescimab-a-dual-targeting-bispecific-antibody-improves-progression-free-survival-in-squamous-nsclc/ 2025-12-05T16:17:43+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/ 2025-11-24T18:39:52+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/summary/ 2025-11-24T18:39:59+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/notecards/ 2025-11-24T18:39:59+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/ 2025-12-05T16:19:34+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/summary/ 2025-11-24T18:39:59+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/notecards/ 2025-11-24T18:40:00+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/final-analysis-supports-use-of-durvalumab-plus-bcg-infusions-in-high-risk-non-muscle-invasive-bladder-cancer/ 2025-12-05T16:21:23+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/primary-analysis-shows-survival-benefit-with-bemarituzumab-plus-chemotherapy-in-gastric-or-gastroesophageal-junction-cancer/ 2025-12-18T16:30:30+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/lupsma-617-plus-hormone-therapy-improves-radiographic-progression-free-survival-in-metastatic-hormone-naive-prostate-cancer/ 2025-12-05T16:24:18+00:00 https://ascopost.com/issues/december-10-2025-supplement-conference-highlights-esmo-2025/sacituzumab-tirumotecan-improves-survival-in-egfr-mutated-nsclc-after-tyrosine-kinase-inhibitor-failure/ 2025-12-05T16:26:59+00:00 https://ascopost.com/issues/december-10-2025/ 2025-12-09T16:13:59+00:00 https://ascopost.com/issues/december-10-2025/benefits-mount-for-trop2-directed-antibody-drug-conjugates-in-triple-negative-breast-cancer/ 2026-01-02T16:19:55+00:00 https://ascopost.com/issues/december-10-2025/advancing-geriatric-oncology-a-personal-and-professional-journey/ 2025-12-09T16:14:00+00:00 https://ascopost.com/issues/december-10-2025/my-50-years-in-lymphoma-lessons-learned/ 2025-12-09T16:14:01+00:00 https://ascopost.com/issues/december-10-2025/final-analysis-supports-use-of-durvalumab-plus-bcg-infusions-in-high-risk-non-muscle-invasive-bladder-cancer/ 2025-12-09T16:14:02+00:00 https://ascopost.com/issues/december-10-2025/toxicity-concerns-for-parp-inhibition-given-concurrently-with-adjuvant-radiotherapy-for-breast-cancer/ 2025-12-09T16:14:03+00:00 https://ascopost.com/issues/december-10-2025/astro-marks-former-president-biden-s-prostate-cancer-treatment-milestone/ 2025-12-09T16:14:04+00:00 https://ascopost.com/issues/december-10-2025/lupsma-617-plus-hormone-therapy-improves-radiographic-progression-free-survival-in-metastatic-hormone-naive-prostate-cancer/ 2025-12-09T16:14:05+00:00 https://ascopost.com/issues/december-10-2025/no-overall-survival-benefit-for-lenvatinib-in-leap-014-trial-of-esophageal-cancer/ 2025-12-09T16:14:06+00:00 https://ascopost.com/issues/december-10-2025/soho-2025-keynote-speakers-highlight-progress-in-hematologic-oncology/ 2025-12-09T16:14:07+00:00 https://ascopost.com/issues/december-10-2025/sacituzumab-tirumotecan-improves-survival-in-egfr-mutated-nsclc-after-tyrosine-kinase-inhibitor-failure/ 2025-12-09T16:14:08+00:00 https://ascopost.com/issues/december-10-2025/external-validation-confirms-ability-of-ai-model-to-stratify-recurrence-risk-in-early-stage-lung-cancer/ 2025-12-09T16:14:09+00:00 https://ascopost.com/issues/december-10-2025/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/ 2026-01-15T15:44:28+00:00 https://ascopost.com/issues/december-10-2025/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/summary/ 2025-12-09T16:14:48+00:00 https://ascopost.com/issues/december-10-2025/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/notecards/ 2025-12-09T16:14:48+00:00 https://ascopost.com/issues/december-10-2025/validation-of-pathology-ai-integration-tool-for-risk-stratification-in-locally-advanced-colon-cancer-without-chemotherapy/ 2026-01-06T18:41:12+00:00 https://ascopost.com/issues/december-10-2025/building-the-cancer-care-africa-deserves/ 2025-12-17T16:12:25+00:00 https://ascopost.com/issues/december-10-2025/geriatric-assessment-guided-approach-to-treatment-intensity-in-older-adults-with-acute-myeloid-leukemia/ 2025-12-09T16:14:14+00:00 https://ascopost.com/issues/december-10-2025/new-fda-approved-oncology-drugs-and-label-updates-between-december-1-2024-and-november-19-2025/ 2025-12-09T16:14:16+00:00 https://ascopost.com/issues/december-10-2025/american-cancer-society-launches-nationwide-program-to-increase-equity-in-clinical-trials/ 2025-12-09T16:14:17+00:00 https://ascopost.com/issues/december-10-2025/research-supports-fda-approval-of-sevabertinib-for-her2-mutant-lung-cancer/ 2025-12-09T16:14:19+00:00 https://ascopost.com/issues/december-10-2025/ross-levine-md-named-chief-scientific-officer-of-memorial-sloan-kettering-cancer-center/ 2025-12-09T16:14:20+00:00 https://ascopost.com/issues/december-10-2025/armando-giuliano-honored-with-2025-william-l-mcguire-memorial-lecture-award/ 2025-12-09T21:27:49+00:00 https://ascopost.com/issues/december-10-2025/basser-center-for-brca-announces-two-award-winners/ 2025-12-09T16:14:22+00:00 https://ascopost.com/issues/december-10-2025/how-ai-is-ushering-in-a-new-era-in-cancer-care/ 2026-03-05T19:47:14+00:00 https://ascopost.com/issues/december-10-2025/montefiore-einstein-comprehensive-cancer-center-director-physician-scientist-edward-chu-md-mms-dies-at-66/ 2025-12-09T16:14:25+00:00 https://ascopost.com/issues/december-10-2025/aaci-issues-statement-on-death-of-dr-ed-chu/ 2025-12-09T16:14:26+00:00 https://ascopost.com/issues/december-10-2025/rainer-storb-md-receives-distinguished-wallace-h-coulter-award-at-ash-annual-congress/ 2025-12-09T16:14:27+00:00 https://ascopost.com/issues/december-10-2025/ash-recognizes-leaders-for-support-of-patient-care-and-research/ 2025-12-09T16:14:28+00:00 https://ascopost.com/issues/december-10-2025/eliminating-barriers-to-care-for-patients-with-intellectual-andor-developmental-disabilities/ 2025-12-22T16:21:08+00:00 https://ascopost.com/issues/december-10-2025/primary-analysis-shows-survival-benefit-with-bemarituzumab-plus-chemotherapy-in-gastric-or-gastroesophageal-junction-cancer/ 2025-12-09T16:14:30+00:00 https://ascopost.com/issues/december-10-2025/mount-sinai-tisch-cancer-center-receives-comprehensive-cancer-center-designation-and-funding-from-national-cancer-institute/ 2025-12-09T16:14:31+00:00 https://ascopost.com/issues/december-10-2025/the-diagnosis-i-couldn-t-deliver-an-oncologist-s-journey-between-roles/ 2026-01-09T18:08:07+00:00 https://ascopost.com/issues/december-10-2025/high-risk-of-metastatic-recurrence-among-young-patients-with-cancer/ 2025-12-09T16:14:33+00:00 https://ascopost.com/issues/december-10-2025/asco-and-ai-in-oncology-rooted-in-human-centered-care/ 2026-01-08T17:45:31+00:00 https://ascopost.com/issues/december-10-2025/asco-statement-hhs-revision-of-black-box-warning-for-hormone-replacement-therapy-and-its-implications-for-cancer-care/ 2025-12-09T16:14:36+00:00 https://ascopost.com/issues/december-10-2025/reducing-the-barriers-to-receiving-car-t-cell-therapy-for-patients-with-hematologic-malignancies/ 2025-12-09T16:14:37+00:00 https://ascopost.com/issues/december-10-2025/uicc-s-world-cancer-declaration-2025-2035/ 2025-12-22T16:22:54+00:00 https://ascopost.com/issues/december-10-2025/integrating-mental-health-into-cancer-care-a-community-oncology-imperative/ 2025-12-19T18:04:14+00:00 https://ascopost.com/issues/december-10-2025/christine-m-lovly-md-phd-fasco-named-head-thoracic-oncology-at-city-of-hope/ 2025-12-09T16:14:40+00:00 https://ascopost.com/issues/december-10-2025/sio-2025-the-future-of-integrative-oncology/ 2025-12-19T18:09:24+00:00 https://ascopost.com/issues/december-10-2025/gemcitabinenab-paclitaxel-vs-modified-folfirinox-in-metastatic-pancreatic-cancer/ 2025-12-09T16:14:42+00:00 https://ascopost.com/issues/december-10-2025/lifileucel-demonstrates-feasibility-and-disease-stability-in-advanced-head-and-neck-squamous-cell-carcinoma/ 2026-01-27T17:19:43+00:00 https://ascopost.com/issues/december-10-2025/neoadjuvant-dual-ici-blockade-vs-perioperative-flot-in-dmmrmsi-h-gastroesophageal-adenocarcinoma/ 2026-01-15T15:40:51+00:00 https://ascopost.com/issues/december-10-2025/hear-hear-to-advancing-geriatric-oncology-where-we-have-been-and-where-we-are-going/ 2025-12-09T16:14:45+00:00 https://ascopost.com/issues/december-10-2025/ironically-smoking-may-have-saved-my-life/ 2026-01-13T18:54:33+00:00 https://ascopost.com/issues/december-10-2025/ai-tops-density-in-predicting-breast-cancer-risk/ 2026-01-06T18:42:05+00:00 https://ascopost.com/issues/january-25-2026/ 2026-01-26T19:24:33+00:00 https://ascopost.com/issues/january-25-2026/in-head-to-head-comparison-fixed-duration-treatment-noninferior-to-continuous-for-previously-untreated-cll/ 2026-01-22T19:25:04+00:00 https://ascopost.com/issues/january-25-2026/novel-her2-targeted-bispecific-improves-outcomes-in-patients-with-gastroesophageal-cancer/ 2026-01-22T19:25:05+00:00 https://ascopost.com/issues/january-25-2026/a-battle-with-my-blood/ 2026-02-05T19:43:10+00:00 https://ascopost.com/issues/january-25-2026/novel-endocrine-therapy-giredestrant-improves-invasive-disease-free-survival-in-estrogen-receptor-positive-her2-negative-early-breast-cancer/ 2026-01-22T19:25:07+00:00 https://ascopost.com/issues/january-25-2026/study-finds-patients-with-colon-cancer-and-obesity-receiving-glp-1-ras-had-significantly-reduced-risk-of-mortality/ 2026-01-22T19:25:09+00:00 https://ascopost.com/issues/january-25-2026/majestec-3-unprecedented-benefit-in-previously-treated-multiple-myeloma/ 2026-03-20T16:52:53+00:00 https://ascopost.com/issues/january-25-2026/acs-guidelines-for-cervical-cancer-self-collected-hpv-testing-now-included/ 2026-01-22T19:25:11+00:00 https://ascopost.com/issues/january-25-2026/using-ai-to-ensure-that-all-patients-with-cancer-have-access-to-precision-oncology-care/ 2026-01-22T19:25:12+00:00 https://ascopost.com/issues/january-25-2026/survey-finds-most-people-trust-ai-less-than-physicians-but-see-its-potential-for-cancer-diagnosis/ 2026-01-29T18:08:01+00:00 https://ascopost.com/issues/january-25-2026/evolving-treatment-landscape-spurs-living-guideline-update-on-multiple-myeloma/ 2026-01-22T19:25:15+00:00 https://ascopost.com/issues/january-25-2026/new-asco-guideline-addresses-management-of-cancer-during-pregnancy-from-diagnosis-through-survivorship/ 2026-01-22T19:25:16+00:00 https://ascopost.com/issues/january-25-2026/deb-schrag-md-mph-fasco-elected-2027-2028-asco-president/ 2026-01-22T19:25:17+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/ 2026-02-11T05:15:27+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/highlights-from-the-2025-ash-annual-meeting-exposition/ 2026-02-11T05:15:28+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/in-head-to-head-comparison-fixed-duration-treatment-noninferior-to-continuous-for-previously-untreated-cll/ 2026-02-11T05:15:29+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/pirtobrutinib-improves-progression-free-survival-vs-bendamustinerituximab-in-front-line-cllsll/ 2026-02-11T05:15:30+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/benefit-of-azacitidine-plus-venetoclax-confirmed-in-aml/ 2026-02-11T05:15:32+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/gimema-all2820-chemotherapy-free-regimen-studied-in-front-line-setting/ 2026-03-04T18:55:04+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/epcoritamab-plus-r2-in-follicular-lymphoma-a-potential-new-treatment-standard/ 2026-02-20T19:55:43+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/early-results-demonstrate-safety-and-efficacy-of-mutant-calreticulin-specific-monoclonal-antibody-in-myelofibrosis/ 2026-02-11T05:15:36+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/ash-2025-myelofibrosis-roundup/ 2026-03-24T21:23:07+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/early-findings-from-first-human-study-of-in-vivo-car-t-in-myeloma/ 2026-03-20T16:51:48+00:00 https://ascopost.com/issues/february-25-2026-supplement-ash-meeting-highlights-2025/majestec-3-unprecedented-benefit-in-previously-treated-multiple-myeloma/ 2026-02-11T05:15:40+00:00 https://ascopost.com/issues/february-25-2026/ 2026-02-24T18:27:14+00:00 https://ascopost.com/issues/february-25-2026/adding-encorafenib-and-cetuximab-to-folfiri-shows-benefit-in-braf-mutant-colorectal-cancer/ 2026-02-24T18:27:14+00:00 https://ascopost.com/issues/february-25-2026/what-is-causing-a-rise-in-early-onset-gastrointestinal-cancers-including-pancreatic-cancer/ 2026-02-24T18:27:16+00:00 https://ascopost.com/issues/february-25-2026/a-paradigm-shift-in-treating-adult-aml/ 2026-03-05T20:14:34+00:00 https://ascopost.com/issues/february-25-2026/commit-first-line-atezolizumab-plus-folfox-and-bevacizumab-regimen-in-metastatic-colorectal-cancer/ 2026-02-24T18:27:19+00:00 https://ascopost.com/issues/february-25-2026/ai-selected-biomarker-guides-first-line-treatment-selection-in-advanced-pancreatic-cancer/ 2026-02-26T15:11:39+00:00 https://ascopost.com/issues/february-25-2026/fda-approves-pembrolizumab-with-paclitaxel-for-platinum-resistant-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-carcinoma/ 2026-02-24T18:27:22+00:00 https://ascopost.com/issues/february-25-2026/colorectal-cancer-liver-metastases-transplant-or-resect/ 2026-02-24T18:27:23+00:00 https://ascopost.com/issues/february-25-2026/breast-cancer-recurrence-risk-determined-by-deep-learning-model-trained-on-histopathologic-slides/ 2026-02-24T18:27:24+00:00 https://ascopost.com/issues/february-25-2026/first-results-of-phase-iii-olympia-3-odronextamab-plus-chop-in-untreated-dlbcl/ 2026-02-24T18:27:25+00:00 https://ascopost.com/issues/february-25-2026/asco-s-first-living-guideline-in-gu-cancers-reflects-recent-practice-changing-trials-on-systemic-treatment-of-mcrpc/ 2026-02-24T18:27:27+00:00 https://ascopost.com/issues/february-25-2026/introducing-asco-ai-in-oncology/ 2026-02-24T18:27:28+00:00 https://ascopost.com/issues/february-25-2026/ash-2025-highlights-in-relapsedrefractory-multiple-myeloma/ 2026-02-24T18:27:30+00:00 https://ascopost.com/issues/february-25-2026/ultra-low-dose-immunotherapy-in-relapsed-or-refractory-solid-tumors/ 2026-02-24T18:27:31+00:00 https://ascopost.com/issues/february-25-2026/leader-in-global-cancer-care-paul-e-goss-md-phd-frcpc-frcp-dies-at-70/ 2026-02-24T18:27:33+00:00 https://ascopost.com/issues/february-25-2026/i-used-ai-to-supplement-my-oncology-care-it-reshaped-my-treatment-plan/ 2026-03-03T17:07:24+00:00 https://ascopost.com/issues/february-25-2026/acs-report-shows-5-year-survival-rate-for-all-cancers-combined-has-reached-70/ 2026-02-24T18:27:36+00:00 https://ascopost.com/issues/march-25-2026/ 2026-03-24T21:54:18+00:00 https://ascopost.com/issues/march-25-2026/adjuvant-pembrolizumab-plus-belzutifan-may-provide-a-new-standard-of-care-for-patients-with-renal-cell-carcinoma-at-increased-risk-of-recurrence/ 2026-03-24T21:54:18+00:00 https://ascopost.com/issues/march-25-2026/how-the-outlook-on-fertility-preservation-for-patients-with-cancer-is-improving/ 2026-03-24T21:54:19+00:00 https://ascopost.com/issues/march-25-2026/forgotten-lessons-from-south-africa/ 2026-03-24T21:54:21+00:00 https://ascopost.com/issues/march-25-2026/for-most-men-with-prostate-cancer-hormone-therapy-with-postprostatectomy-radiotherapy-confers-no-survival-benefit/ 2026-03-24T21:54:22+00:00 https://ascopost.com/issues/march-25-2026/neoadjuvantadjuvant-doublet-significantly-improved-survival-in-patients-with-muscle-invasive-bladder-cancer/ 2026-03-24T21:54:23+00:00 https://ascopost.com/issues/march-25-2026/gemcitabine-intravesical-system-shows-high-disease-free-survival-rates-in-bcg-unresponsive-papillary-only-nmibc/ 2026-03-24T21:54:24+00:00 https://ascopost.com/issues/march-25-2026/imvigor011-subgroup-analysis-role-of-ctdna-in-guiding-adjuvant-treatment-for-muscle-invasive-bladder-cancer/ 2026-03-24T21:54:26+00:00 https://ascopost.com/issues/march-25-2026/activity-observed-with-novel-kras-inhibitor-in-pancreatic-cancer/ 2026-03-24T21:54:27+00:00 https://ascopost.com/issues/march-25-2026/three-ai-enabled-analyses-highlight-context-dependent-biomarkers-in-early-onset-colorectal-cancer/ 2026-03-24T21:54:28+00:00 https://ascopost.com/issues/march-25-2026/no-recurrence-free-survival-benefit-with-adjuvant-pembrolizumab-in-hepatocellular-carcinoma/ 2026-03-24T21:54:29+00:00 https://ascopost.com/issues/march-25-2026/no-recurrence-free-survival-benefit-with-adjuvant-pembrolizumab-in-hepatocellular-carcinoma/summary/ 2026-03-24T21:54:55+00:00 https://ascopost.com/issues/march-25-2026/no-recurrence-free-survival-benefit-with-adjuvant-pembrolizumab-in-hepatocellular-carcinoma/notecards/ 2026-03-24T21:54:57+00:00 https://ascopost.com/issues/march-25-2026/intravesical-immunotherapy-shows-recurrence-control-in-bcg-unresponsive-papillary-only-non-muscle-invasive-bladder-cancer/ 2026-03-24T21:54:30+00:00 https://ascopost.com/issues/march-25-2026/intravesical-immunotherapy-shows-recurrence-control-in-bcg-unresponsive-papillary-only-non-muscle-invasive-bladder-cancer/summary/ 2026-03-24T21:54:54+00:00 https://ascopost.com/issues/march-25-2026/intravesical-immunotherapy-shows-recurrence-control-in-bcg-unresponsive-papillary-only-non-muscle-invasive-bladder-cancer/notecards/ 2026-03-24T21:54:57+00:00 https://ascopost.com/issues/march-25-2026/new-first-line-targeted-therapy-recommendations-among-updated-asco-guidance-on-gastroesophageal-cancer-management/ 2026-03-24T21:54:32+00:00 https://ascopost.com/issues/march-25-2026/a-decade-of-research-leads-to-new-guidance-on-using-colony-stimulating-factors-in-anticancer-treatment/ 2026-03-24T21:54:33+00:00 https://ascopost.com/issues/march-25-2026/adding-tucatinib-to-first-line-maintenance-therapy-delays-disease-progression-in-her2-positive-metastatic-breast-cancer/ 2026-04-03T16:35:55+00:00 https://ascopost.com/issues/march-25-2026/siog-2025-celebrating-25-years-of-leadership-in-geriatric-oncology/ 2026-03-24T21:54:36+00:00 https://ascopost.com/issues/march-25-2026/responses-to-initial-pembrolizumab-support-treatment-de-escalation-in-cutaneous-squamous-cell-carcinoma/ 2026-03-24T21:54:37+00:00 https://ascopost.com/issues/march-25-2026/responses-to-initial-pembrolizumab-support-treatment-de-escalation-in-cutaneous-squamous-cell-carcinoma/summary/ 2026-03-24T21:54:54+00:00 https://ascopost.com/issues/march-25-2026/responses-to-initial-pembrolizumab-support-treatment-de-escalation-in-cutaneous-squamous-cell-carcinoma/notecards/ 2026-03-24T21:54:56+00:00 https://ascopost.com/issues/march-25-2026/how-ai-is-already-having-a-significant-impact-on-cancer-care/ 2026-03-24T21:54:38+00:00 https://ascopost.com/issues/march-25-2026/poems-syndrome-diagnostic-clues-from-neuropathy-to-bone-marrow-findings/ 2026-03-24T21:54:40+00:00 https://ascopost.com/issues/march-25-2026/2026-pezcoller-foundation-aacr-international-award-for-extraordinary-achievement-in-cancer-research/ 2026-03-27T16:51:30+00:00 https://ascopost.com/issues/march-25-2026/2026-pezcoller-foundation-aacr-international-award-for-extraordinary-achievement-in-cancer-research/summary/ 2026-03-24T21:54:59+00:00 https://ascopost.com/issues/march-25-2026/2026-pezcoller-foundation-aacr-international-award-for-extraordinary-achievement-in-cancer-research/notecards/ 2026-03-24T21:54:59+00:00 https://ascopost.com/issues/march-25-2026/fda-approves-teclistamab-and-daratumumab-for-relapsed-or-refractory-multiple-myeloma/ 2026-03-24T21:54:42+00:00 https://ascopost.com/issues/march-25-2026/fda-approves-teclistamab-and-daratumumab-for-relapsed-or-refractory-multiple-myeloma/summary/ 2026-03-24T21:54:53+00:00 https://ascopost.com/issues/march-25-2026/fda-approves-teclistamab-and-daratumumab-for-relapsed-or-refractory-multiple-myeloma/notecards/ 2026-03-24T21:54:56+00:00 https://ascopost.com/issues/march-25-2026/in-celebration-of-a-decades-long-journey-of-discovery-and-innovation/ 2026-03-24T21:54:44+00:00 https://ascopost.com/issues/march-25-2026/integrative-oncology-scholars-program/ 2026-03-24T21:54:45+00:00 https://ascopost.com/issues/march-25-2026/stanford-names-leader-for-drug-development-and-precision-oncology/ 2026-03-24T21:54:46+00:00 https://ascopost.com/issues/march-25-2026/stanford-names-leader-for-drug-development-and-precision-oncology/summary/ 2026-03-24T21:54:53+00:00 https://ascopost.com/issues/march-25-2026/stanford-names-leader-for-drug-development-and-precision-oncology/notecards/ 2026-03-24T21:54:56+00:00 https://ascopost.com/issues/march-25-2026/ash-2025-myelofibrosis-roundup/ 2026-03-24T21:54:48+00:00 https://ascopost.com/issues/march-25-2026/ash-2025-myelofibrosis-roundup/summary/ 2026-03-24T21:54:51+00:00 https://ascopost.com/issues/march-25-2026/ash-2025-myelofibrosis-roundup/notecards/ 2026-03-24T21:54:52+00:00 https://ascopost.com/issues/march-25-2026/ash-2025-myelofibrosis-roundup/notecards-1/ 2026-03-24T21:54:52+00:00 https://ascopost.com/issues/march-25-2026/peter-wt-pisters-honored-with-top-award-from-society-of-surgical-oncology/ 2026-03-24T21:54:49+00:00 https://ascopost.com/issues/march-25-2026/peter-wt-pisters-honored-with-top-award-from-society-of-surgical-oncology/summary/ 2026-03-24T21:54:52+00:00 https://ascopost.com/issues/march-25-2026/peter-wt-pisters-honored-with-top-award-from-society-of-surgical-oncology/notecards/ 2026-03-24T21:54:55+00:00 https://ascopost.com/issues/march-25-2026/female-reproductive-cancers-linked-to-reduced-survival-advantage-over-males/ 2026-03-24T21:54:50+00:00 https://ascopost.com/issues/march-25-2026/female-reproductive-cancers-linked-to-reduced-survival-advantage-over-males/summary/ 2026-03-24T21:54:58+00:00 https://ascopost.com/issues/march-25-2026/female-reproductive-cancers-linked-to-reduced-survival-advantage-over-males/notecards/ 2026-03-24T21:54:58+00:00 https://ascopost.com/videos/ 2025-07-21T21:39:40+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/ 2021-07-28T20:29:27+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/jingxuan-zhao-on-how-medicaid-expansion-affects-long-term-cancer-survival/ 2023-09-07T15:21:42+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/heather-wakelee-on-nsclc-atezolizumab-vs-best-supportive-care-after-chemotherapy/ 2021-05-19T21:06:44+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/narjust-duma-and-gladys-i-rodriguez-formation-of-a-yia-for-latinas/ 2021-05-24T18:51:29+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/evan-lipson-on-melanoma-relatlimab-and-nivolumab-in-first-line-treatment-of-advanced-disease/ 2021-05-27T16:46:13+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/andrew-tutt-on-olaparib-after-chemotherapy-in-germline-brca12-mutated-breast-cancer/ 2021-06-04T18:59:57+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/toni-choueiri-on-renal-cell-carcinoma-pembrolizumab-vs-placebo-in-adjuvant-treatment/ 2021-06-04T16:51:52+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/ian-chau-on-esophageal-squamous-cell-carcinoma-nivolumab-ipilimumab-and-chemotherapy/ 2021-06-04T16:56:18+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/michael-morris-on-prostate-cancer-lupsma-in-the-metastatic-setting/ 2021-06-05T15:34:54+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/linda-mileshkin-on-cervical-cancer-adjuvant-chemotherapy-after-chemoradiation/ 2021-06-05T15:33:44+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/debora-bruno-on-nsclc-racial-disparities-in-biomarker-testing-and-clinical-trial-enrollment/ 2021-06-04T17:08:17+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/taiga-nishihori-on-multiple-myeloma-maintenance-ixazomib-after-transplant/ 2021-06-04T19:43:15+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/pasi-janne-on-nsclc-patritumab-deruxtecan-to-target-her3/ 2021-06-04T19:46:39+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/byoung-chul-cho-on-nsclc-amivantamab-plus-lazertinib-for-treatment-of-relapsed-disease/ 2021-06-04T20:33:02+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/vamsidhar-velcheti-on-nsclc-sotorasib-in-kras-mutated-disease/ 2021-06-07T16:32:02+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/brian-rini-on-rcc-pembrolizumab-plus-axitinib-vs-sunitinib-as-first-line-therapy/ 2021-06-07T16:34:57+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/massimo-cristofanilli-on-breast-cancer-updated-analysis-on-palbociclib-plus-fulvestrant/ 2021-06-07T16:37:34+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/robert-motzer-on-rcc-quality-of-life-for-patients-treated-with-lenvatinib-based-therapy-vs-sunitinib/ 2021-06-07T16:44:27+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/karim-fizazi-on-prostate-cancer-abiraterone-acetate-prednisone-and-radiotherapy-in-metastatic-disease/ 2021-06-07T17:09:37+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/ingrid-mayer-on-triple-negative-breast-cancer-platinum-based-chemotherapy-vs-capecitabine/ 2021-06-07T17:12:33+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/nadia-harbeck-on-early-breast-cancer-benefit-of-a-de-escalated-regimen/ 2021-06-09T18:07:48+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/thierry-andre-on-pembrolizumab-vs-chemotherapy-in-msi-high-colorectal-cancer/ 2021-06-09T18:11:48+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/cathy-eng-on-colorectal-cancer-folfoxiri-cetuximab-and-bevacizumab-as-first-line-treatment/ 2021-06-09T18:16:40+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/sumanta-pal-on-urothelial-carcinoma-comparing-cisplatin-and-gemcitabine-with-or-without-berzosertib/ 2021-06-15T20:04:46+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/nadia-harbeck-on-luminal-breast-cancer/ 2021-06-15T20:09:18+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/ann-lacasce-on-hodgkin-lymphoma-pet-adapted-therapy-for-bulky-disease/ 2021-06-15T21:35:17+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/nicholas-short-on-all-ponatinib-plus-blinatumomab-may-help-patients-avoid-transplants/ 2021-06-15T21:50:57+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/geoffrey-lindeman-on-breast-cancer-venetoclax-and-fulvestrant-in-er-positive-her2-negative-disease/ 2021-06-15T21:57:47+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/peter-black-on-prostate-cancer-health-care-disparities/ 2021-06-18T17:15:51+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/sibylle-loibl-on-triple-negative-breast-cancer-improving-long-term-outcomes-with-durvalumab/ 2021-06-21T14:41:54+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/neeraj-agarwal-on-prostate-cancer-androgen-deprivation-therapy-with-orteronel-or-bicalutamide/ 2022-01-20T15:57:04+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/matt-galsky-on-bladder-cancer-neoadjuvant-therapy-with-gemcitabine-cisplatin-and-nivolumab/ 2021-06-22T18:02:50+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/paolo-ghia-on-cllsll-and-ibrutinib-plus-venetoclax-a-primary-analysis-of-the-captivate-trial/ 2021-06-22T18:06:24+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/brian-link-on-mantle-cell-lymphoma-expert-perspective-on-treatments-now-and-those-to-come/ 2021-06-22T19:53:01+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/peter-o-donnell-on-urothelial-cancer-first-line-pembrolizumab-in-cisplatin-ineligible-patients/ 2021-06-22T19:56:48+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/priya-rastogi-on-breast-cancer-predicting-the-benefit-of-extended-letrozole-therapy/ 2021-06-22T20:08:45+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/martin-reck-on-nsclc-nivolumab-ipilimumab-and-chemotherapy-for-advanced-disease/ 2021-06-22T20:12:04+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/bijal-shah-on-cll-car-t-cell-therapy-with-brexucabtagene-autoleucel/ 2021-06-22T20:14:31+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/neeraj-agarwal-on-treatment-patterns-and-disparities-in-patients-with-prostate-cancer/ 2021-06-22T20:22:49+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/melinda-telli-on-breast-cancer-neoadjuvant-talazoparib-for-early-her2-negative-disease/ 2021-07-15T17:40:16+00:00 https://ascopost.com/videos/2021-asco-annual-meeting/terry-mamounas-on-extended-aromatase-inhibitor-therapy/ 2021-07-15T21:34:19+00:00 https://ascopost.com/videos/esmo-breast-cancer-virtual-congress-2021/ 2021-06-16T19:36:47+00:00 https://ascopost.com/videos/22nd-asbrs-annual-meeting/ 2025-08-18T18:40:20+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/ 2021-06-16T19:41:58+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/rita-nanda-on-triple-negative-breast-cancer-emerging-therapeutic-strategies/ 2021-04-12T19:17:18+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/vivek-subbiah-on-ret-fusion-positive-cancers-efficacy-of-selpercatinib/ 2021-04-12T19:27:42+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/patrick-forde-on-nsclc-nivolumab-and-chemotherapy-as-neoadjuvant-treatment/ 2021-05-03T20:33:56+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/matthew-matasar-on-indolent-nhl-new-data-on-copanlisib-plus-rituximab/ 2021-04-12T19:41:32+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/jessica-hassel-on-uveal-melanoma-comparing-tebentafusp-with-standard-therapies/ 2021-04-12T19:46:34+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/brian-rini-on-rcc-data-on-atezolizumab-bevacizumab-and-sunitinib/ 2021-04-13T18:09:43+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/samra-turajlic-on-understanding-metastatic-disease-in-renal-cancer-and-melanoma/ 2021-04-13T18:12:09+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/enrique-grande-on-urothelial-carcinoma-treatment-with-atezolizumab-platinum-and-gemcitabine/ 2021-04-13T19:07:50+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/carey-anders-on-brain-metastases-integrating-immunotherapy-into-clinical-care/ 2022-08-10T15:20:02+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/katelyn-byrne-on-the-clinical-impact-of-t-cell-inflammation-in-the-tumor-microenvironment/ 2021-04-23T15:00:35+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/dennis-slamon-on-exploiting-cancer-biology-in-developing-new-treatment-paradigms/ 2021-04-14T19:33:46+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/richard-finn-on-treating-hepatocellular-carcinoma-with-atezolizumab-bevacizumab-and-sorafenib/ 2021-04-14T19:42:23+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/linda-vahdat-on-triple-negative-breast-cancer-targeting-the-tumor-microenvironment/ 2021-04-14T19:45:27+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/joann-elmore-on-cancer-diagnosis-when-pathologists-disagree-artificial-intelligence-may-help/ 2021-04-15T19:31:02+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/jeanne-tie-on-circulating-tumor-dna-minimal-residual-disease-and-adjuvant-treatment/ 2021-04-15T19:35:15+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/charlotte-ariyan-on-metastasectomy-after-immunotherapy/ 2021-04-15T19:40:16+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/ralph-weichselbaum-on-oligometastasis-biologic-basis-and-therapeutic-opportunities/ 2021-04-15T19:48:19+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/matthew-vander-heiden-and-karen-vousden-a-conversation-about-the-role-of-diet-in-cancer/ 2021-04-16T17:54:54+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/michel-sadelain-on-the-road-to-synthetic-immunity-novel-car-designs/ 2021-04-16T17:57:18+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/lipika-goyal-on-treating-intrahepatic-cholangiocarcinoma-with-futibatinib/ 2021-04-16T17:59:40+00:00 https://ascopost.com/videos/aacr-annual-meeting-2021/georgina-long-on-melanoma-nivolumab-plus-ipilimumab-vs-nivolumab-alone/ 2021-04-16T18:03:13+00:00 https://ascopost.com/videos/2021-acc-conference-on-advancing-the-cardiovascular-care-of-the-oncology-patient/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/european-lung-cancer-virtual-congress-2021/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/vicky-makker-on-endometrial-cancer-lenvatinib-plus-pembrolizumab/ 2021-04-01T18:26:40+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/rebecca-kristeleit-on-relapsed-ovarian-cancer-rucaparib-vs-chemotherapy/ 2021-03-20T15:58:21+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/william-bradley-on-ovarian-cancer-5-year-follow-up-on-maintenance-olaparib/ 2021-03-20T15:59:29+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/edward-trimble-on-cervical-cancer-a-global-who-initiative/ 2021-03-20T16:01:40+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/brian-slomovitz-on-the-impact-of-covid-19-on-gynecologic-cancer-research/ 2021-03-21T17:37:27+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/morcos-nakhla-on-surgical-outcomes-for-frail-patients-with-ovarian-cancer/ 2021-03-20T16:45:47+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/ursula-matulonis-on-ovarian-cancer-niraparib-as-maintenance-therapy/ 2021-03-21T14:47:44+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/shannon-westin-on-treating-endometrial-cancer-with-enzalutamide-paclitaxel-and-carboplatin/ 2021-03-21T15:18:26+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/hyun-chung-on-pembrolizumab-for-advanced-cervical-cancer-update-from-keynote-158/ 2021-03-21T15:56:15+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/charles-landen-on-newly-diagnosed-ovarian-cancer-brca-mutations-pd-l1-expression-and-combination-chemoimmunotherapy/ 2021-03-21T16:55:50+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/alice-barr-on-advanced-ovarian-cancer-minimally-invasive-vs-open-surgery-after-chemotherapy/ 2021-03-22T19:46:30+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/sandro-pignata-on-brca-mutated-ovarian-cancer-maintenance-olaparib-outcomes/ 2021-03-22T20:02:25+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/emily-hinchcliff-on-treating-non-clear-cell-ovarian-cancer-with-durvalumab-and-tremelimumab/ 2021-03-22T20:05:06+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/lauren-thomaier-on-predicting-chemotherapy-induced-peripheral-neuropathy/ 2021-03-22T20:09:05+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/supriya-chopra-on-cervical-cancer-reducing-late-effects-of-bowel-toxicity/ 2021-03-22T20:15:03+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/laura-chambers-on-treating-epithelial-ovarian-cancer-with-cisplatin-and-paclitaxel-during-surgery/ 2021-03-25T18:04:39+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/dana-roque-on-ovarian-fallopian-tube-and-peritoneal-cancers/ 2021-03-25T18:08:46+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/brittany-davidson-on-a-model-to-predict-the-need-for-opioids-after-gynecologic-surgery/ 2021-03-25T19:20:54+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/eric-pujade-lauraine-on-first-line-maintenance-therapy-in-ovarian-cancer/ 2021-03-25T19:24:01+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/amir-jazaeri-on-metastatic-cervical-cancer-the-role-of-immunotherapy/ 2021-03-25T19:30:46+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/andreas-obermair-on-treating-endometrial-adenocarcinoma-with-a-levonorgestrel-intrauterine-device/ 2021-03-25T19:37:02+00:00 https://ascopost.com/videos/sgo-2021-virtual-annual-meeting-on-womens-cancer/anthony-costales-on-advanced-ovarian-cancer-predicting-the-benefits-of-minimally-invasive-surgery/ 2021-04-01T20:03:58+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/sandy-srinivas-on-managing-metastatic-castration-resistant-prostate-cancer/ 2021-03-18T19:32:59+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/shivan-mehta-on-preventing-and-controlling-hpv-associated-cancers/ 2021-03-18T19:35:11+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/william-gradishar-on-triple-negative-breast-cancer-nccn-guidelines-update/ 2021-03-19T18:09:22+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/robert-winn-on-strategies-for-reducing-racial-disparities-in-oncology/ 2021-03-19T18:12:19+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/arlene-siefker-radtke-on-urothelial-bladder-cancer-new-settings-for-immune-checkpoint-inhibitors/ 2021-03-19T18:47:55+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/susan-swetter-on-molecular-testing-for-cutaneous-melanoma/ 2021-03-22T20:17:18+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/gabrielle-zecha-and-aaron-begue-on-the-role-of-advanced-practice-providers-in-oncology-care/ 2021-03-22T20:19:56+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/shaji-kumar-on-multiple-myeloma-nccn-guidelines-update/ 2021-03-23T18:47:08+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/lori-wirth-on-advanced-thyroid-carcinoma-evolving-systemic-therapy-options/ 2021-03-30T21:22:11+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/alexander-perl-on-acute-myeloid-leukemia-treatment-updates/ 2021-04-01T19:56:17+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/eric-jonasch-md-on-hereditary-renal-cell-carcinoma-screening-diagnosis-and-management/ 2021-04-01T19:59:15+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/mary-mulcahy-and-crystal-denlinger-on-nccn-guidelines-updates-gastric-and-esophageal-cancers/ 2021-04-05T20:26:58+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/thomas-varghese-on-the-effects-of-the-covid-19-pandemic-on-cancer-care/ 2021-04-05T20:30:32+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/david-pfister-on-supportive-care-in-head-and-neck-cancers-multidisciplinary-management/ 2021-04-06T19:41:10+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/april-salama-on-managing-melanoma-brain-metastases/ 2021-04-07T18:28:17+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/jennifer-brown-on-managing-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma/ 2021-04-07T18:37:02+00:00 https://ascopost.com/videos/nccn-2021-virtual-annual-conference/melinda-telli-on-her2-positive-breast-cancer-nccn-guidelines-update/ 2021-04-14T19:48:32+00:00 https://ascopost.com/videos/sso-2021-international-conference-on-surgical-cancer-care/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/quick-chats/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/quick-chats/heinz-josef-lenz-and-axel-grothey-on-colorectal-cancer-molecular-testing-and-interpreting-an-ngs-report/ 2021-04-08T15:59:00+00:00 https://ascopost.com/videos/quick-chats/heinz-josef-lenz-and-axel-grothey-on-liquid-biopsies-for-colorectal-and-other-gi-cancers/ 2021-04-08T16:03:41+00:00 https://ascopost.com/videos/quick-chats/paul-richardson-and-peter-voorhees-on-multiple-myeloma-surveying-the-evolving-landscape-of-up-front-drugs/ 2021-04-27T15:52:00+00:00 https://ascopost.com/videos/quick-chats/andrew-zelenetz-and-stephen-schuster-on-car-t-cells-for-hematologic-malignancies/ 2021-04-28T16:44:18+00:00 https://ascopost.com/videos/38th-annual-miami-breast-cancer-conference/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/christopher-sweeney-on-prostate-cancer-analyzing-biomarkers-ipatasertib-plus-abiraterone/ 2021-02-12T18:52:47+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/thomas-powles-on-urothelial-carcinoma-enfortumab-vedotin-ejfv-vs-chemotherapy/ 2021-02-12T18:54:51+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/toni-choueiri-on-rcc-treatment-with-lenvatinib-plus-pembrolizumab-or-everolimus-vs-sunitinib/ 2021-02-16T20:15:11+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/daniel-geynisman-on-bladder-cancer-risk-enabled-treatment-after-neoadjuvant-chemotherapy/ 2021-02-16T20:18:43+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/monika-joshi-on-urothelial-cancer-of-the-bladder-durvalumab-and-radiotherapy-for-localized-disease/ 2021-02-17T21:11:17+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/toni-choueiri-on-clear-cell-rcc-treatment-with-belzutifan-plus-cabozantinib/ 2021-02-17T21:16:31+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/christopher-sweeney-and-thomas-powles-on-treating-gu-malignancies/ 2021-02-18T19:45:45+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/sumanta-pal-on-papillary-rcc-sunitinib-vs-cabozantinib-crizotinib-or-savolitinib-in-metastatic-disease/ 2021-02-18T21:32:09+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/sumanta-pal-on-advanced-rcc-tivozanib-to-treat-disease-progression-after-axitinib/ 2021-02-18T21:53:42+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/neeraj-agarwal-on-prostate-cancer-apalutamide-vs-placebo-in-treatment-of-metastatic-disease/ 2021-02-22T18:32:06+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/felix-feng-on-prostate-cancer-choosing-patients-who-may-benefit-from-apalutamide/ 2021-02-22T22:47:19+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/elizabeth-plimack-on-rcc-outcomes-with-pembrolizumab-plus-axitinib/ 2021-02-23T16:43:25+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/elizabeth-plimack-on-renal-cell-cancer-highlights-from-the-2021-genitourinary-cancers-symposium/ 2021-02-24T19:55:04+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/elizabeth-plimack-on-bladder-cancer-highlights-from-the-2021-genitourinary-cancers-symposium/ 2021-02-25T19:27:18+00:00 https://ascopost.com/videos/2021-genitourinary-cancers-symposium/tracy-rose-on-bladder-cancer-gemcitabine-cisplatin-and-pembrolizumab-as-neoadjuvant-therapy/ 2021-02-26T00:17:00+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2021/ 2021-05-19T18:09:39+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2021/toni-choueiri-on-the-effects-of-cancer-treatments-on-patients-infected-with-covid-19/ 2021-02-18T21:40:58+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2021/antoni-ribas-on-highlights-of-aacr-s-covid-19-and-cancer-meeting/ 2021-05-11T19:24:37+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2021/giuseppe-curigliano-in-the-face-of-covid-continuity-in-cancer-care/ 2021-03-05T19:11:31+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2021/david-fajgenbaum-on-repurposing-cancer-drugs-to-treat-covid-19/ 2021-03-08T17:58:00+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/giorgio-scagliotti-on-doubling-the-lung-cancer-cure-rate-by-2025/ 2021-05-03T20:34:39+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/dean-fennell-on-mesothelioma-nivolumab-vs-placebo-in-relapsed-disease/ 2021-05-03T20:35:55+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/silvia-novello-on-nsclc-pharmacogenomics-driven-vs-standard-adjuvant-chemotherapy/ 2021-05-03T20:37:35+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/prasad-adusumilli-on-cell-therapy-for-solid-tumors/ 2021-02-04T20:33:47+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/fred-hirsch-on-lung-cancer-survival-and-tumor-mutation-burden/ 2021-05-03T20:38:10+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/jill-feldman-on-diversifying-the-criteria-for-inclusion-in-clinical-trials/ 2021-02-08T19:27:54+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/martin-reck-on-nsclc-pembrolizumab-plus-ipilimumab-in-first-line-treatment/ 2021-02-09T20:13:43+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/justin-gainor-on-nsclc-study-results-on-nivolumab-vs-ipilimumab-bemcentinib-plus-pembrolizumab/ 2021-02-09T20:21:55+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/roy-herbst-on-nsclc-osimertinib-and-patient-reported-outcomes/ 2021-02-09T20:24:42+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/bruce-johnson-on-evolving-challenges-in-lung-cancer-drug-development/ 2021-02-09T20:32:48+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/luis-montuenga-on-noninvasive-biomarkers-in-lung-cancer-screening/ 2021-02-09T21:26:13+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/jill-feldman-a-determined-cancer-survivor-shares-her-story-of-a-family-devastated-by-lung-cancer/ 2021-02-09T21:31:38+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/martin-reck-on-nsclc-pembrolizumab-platinum-chemotherapy-and-radiotherapy-in-advanced-disease/ 2021-02-11T20:36:02+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/martin-reck-on-sclc-maintenance-therapy-for-patients-with-extensive-stage-disease/ 2021-02-11T20:40:48+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/roy-herbst-on-lung-map-circulating-tumor-dna-and-tissue-molecular-analysis/ 2021-02-18T21:56:33+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/hossein-borghaei-on-bispecific-t-cell-engager-immune-therapy-for-small-cell-lung-cancer/ 2021-03-19T18:19:14+00:00 https://ascopost.com/videos/iaslc-2020-world-conference-on-lung-cancer-in-singapore/fred-hirsch-on-therapeutic-strategies-for-patients-with-lung-cancer-and-covid-19-infection/ 2021-03-09T20:08:07+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/zev-wainberg-on-gastricgastroesophageal-junction-adenocarcinoma-bemarituzumab-and-folfox/ 2021-01-15T19:46:45+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/wasat-mansoor-on-esophageal-cancer-quality-of-life-with-pembrolizumab-and-chemotherapy/ 2021-01-18T18:13:23+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/afsaneh-barzi-on-disparities-in-access-to-screening-and-treatment-of-gi-cancers/ 2021-01-18T18:19:11+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/rutika-mehta-on-gastric-cancer-adjuvant-chemotherapy-with-s-1-and-docetaxel/ 2021-01-18T18:21:24+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/romain-cohen-md-phd-on-colon-cancer-prognostic-value-of-tumor-deposits/ 2021-01-18T18:27:26+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/kai-keen-shiu-on-colorectal-cancer-pembrolizumab-vs-chemotherapy-for-microsatellite-instability-high-disease/ 2021-02-09T21:33:24+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/milind-javle-on-cholangiocarcinoma-treatment-with-infigratinib/ 2021-01-20T19:33:05+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/tenna-henriksen-on-colorectal-cancer-circulating-tumor-dna-analysis-to-improve-treatment/ 2021-01-21T19:04:38+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/richard-finn-on-hcc-atezolizumab-plus-bevacizumab-vs-sorafenib/ 2021-01-21T19:20:24+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/talia-golan-on-pancreatic-cancer-olaparib-for-brca-mutated-disease/ 2021-01-21T19:25:44+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/matthew-katz-on-pancreatic-cancer-preoperative-mfolfirinox-for-resectable-disease/ 2021-01-21T19:28:21+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/andrew-zhu-on-idh1-mutant-cholangiocarcinoma-ivosidenib-vs-placebo/ 2021-01-21T19:36:19+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/thierry-andre-on-mismatch-repair-deficient-solid-cancers-safety-and-efficacy-of-dostarlimab/ 2021-01-21T19:39:11+00:00 https://ascopost.com/videos/2021-gastrointestinal-cancers-symposium/rocio-garcia-carbonero-on-treating-neuroendocrine-tumors-of-nonpancreatic-origin-with-octreotide-acetate-and-axitinib/ 2021-01-28T19:09:37+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/chirag-shah-on-assessing-dcis-recurrence-risk/ 2020-12-10T22:01:09+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/debra-pratt-on-time-to-completion-of-breast-cancer-treatment-and-survival/ 2020-12-10T22:07:07+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/nadia-harbeck-on-early-breast-cancer-endocrine-therapy-after-preoperative-treatment/ 2020-12-15T20:10:42+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/joseph-sparano-on-hrplus-her2-breast-cancer-individualizing-prognosis-and-predicting-treatment-success/ 2021-02-01T21:07:21+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/patricia-ganz-on-younger-breast-cancer-survivors-managing-depression/ 2020-12-16T18:50:49+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/sara-hurvitz-on-triple-negative-breast-cancer-sacituzumab-govitecan-and-chemotherapy/ 2021-03-04T20:14:16+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/lee-schwartzberg-on-her2-hrplus-breast-cancer-tesetaxel-and-capecitabine/ 2021-03-24T21:07:21+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/roisin-connolly-on-hrplus-advanced-breast-cancer-endocrine-therapy-and-entinostat/ 2020-12-17T19:50:14+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/joyce-lee-on-triple-negative-breast-cancer-myc-as-a-predictor-of-treatment-response/ 2020-12-17T22:55:07+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/sibylle-loibl-on-hrplus-her2-primary-breast-cancer-palbociclib-and-endocrine-therapy/ 2020-12-17T23:02:49+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/elizabeth-mittendorf-on-local-regional-management-following-neoadjuvant-therapy/ 2021-01-11T18:47:50+00:00 https://ascopost.com/videos/2020-san-antonio-breast-cancer-symposium/ann-partridge-on-erplus-her2-breast-cancer-more-effective-treatments-needed/ 2021-01-12T18:40:35+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/ann-kathrin-eisfeld-on-aml-in-black-patients-racial-disparities-in-survival-outcomes/ 2020-12-16T19:20:48+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/corey-cutler-on-evaluating-treatments-in-older-patients-with-advanced-mds/ 2020-12-05T19:11:32+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/emmanuel-bachy-on-peripheral-t-cell-lymphoma-romidepsin-plus-chop/ 2021-02-17T21:04:24+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/radhika-gangaraju-and-smita-bhatia-on-coronary-heart-disease-risk-in-blood-or-marrow-transplant-survivors/ 2020-12-05T20:14:39+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/curtis-lachowiez-on-venetoclax-in-combination-with-standard-intensive-inductionconsolidation-therapy-in-aml/ 2021-04-19T17:33:00+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/sagar-lonial-on-car-t-cell-therapies-for-myeloma-novel-approaches-and-longer-term-follow-up-data/ 2020-12-07T21:09:47+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/jyoti-nangalia-on-mpn-a-new-paradigm-for-the-development-of-blood-cancer/ 2020-12-08T17:19:33+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/david-teachey-on-pediatric-leukemia-and-lymphoma-new-findings-on-cranial-radiation-and-bortezomib/ 2020-12-08T20:43:47+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/paul-richardson-on-multiple-myeloma-roundup-of-three-key-studies/ 2020-12-08T20:51:18+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/matthew-davids-on-cllsll-new-data-on-ibrutinib-venetoclax-and-rituximab-therapies/ 2020-12-08T20:59:17+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/caron-jacobson-on-treating-large-b-cell-lymphoma-with-axicabtagene-ciloleucel/ 2020-12-08T21:08:16+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/ari-melnick-on-activated-b-cell-like-dlbcl-gain-of-function-mutations-and-resistance-to-ibrutinib/ 2020-12-10T22:02:50+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/meletios-dimopoulos-on-multiple-myeloma-daratumumab-pomalidomide-and-dexamethasone/ 2020-12-10T22:03:55+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/andrew-zelenetz-on-mantle-cell-lymphoma-immunochemotherapy-plus-lenalidomide/ 2020-12-10T22:10:02+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/andrew-zelenetz-on-mantle-cell-lymphoma-expert-perspective-on-key-clinical-trials/ 2020-12-10T22:15:39+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/hassan-awada-on-aml-and-machine-learning-improving-prognostication/ 2020-12-15T19:53:52+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/jorge-cortes-on-cml-expert-perspective-on-key-ash-abstracts/ 2020-12-22T20:05:02+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/farhad-ravandi-on-aml-novel-combination-therapies-for-newly-diagnosed-disease/ 2020-12-15T20:08:34+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/nitin-jain-on-b-cell-all-expert-perspective-on-key-car-t-cell-treatment-advances/ 2020-12-16T19:06:52+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/steven-horwitz-on-t-cell-lymphoma-update-on-allogeneic-hematopoietic-transplant/ 2021-01-04T19:58:33+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/tycel-phillips-on-marginal-zone-lymphoma-efficacy-and-safety-of-parsaclisib/ 2021-01-05T18:07:33+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/steven-horwitz-on-ptcl-update-on-efficacy-of-duvelisib-dose-optimization/ 2021-01-05T18:09:50+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/christian-marinaccio-genetic-driver-may-play-a-role-in-progression-of-myeloproliferative-neoplasms-to-aml/ 2021-01-06T21:06:46+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/lena-winestone-on-health-care-disparities-in-hematologic-cancers-real-world-data/ 2021-01-07T19:39:59+00:00 https://ascopost.com/videos/2020-ash-annual-meeting-exposition/sara-zarnegar-lumley-on-aml-prognostic-effects-of-idh-mutations/ 2021-01-08T19:09:01+00:00 https://ascopost.com/videos/esmo-immuno-oncology-virtual-congress-2020/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/esmo-asia-virtual-congress-2020/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/american-society-of-human-genetics-2020-virtual-meeting/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/neha-vapiwala-on-prostate-cancer-imaging-and-the-decision-to-treat-with-radiation/ 2020-10-27T18:37:34+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/arjun-sahgal-on-reducing-the-pain-of-spinal-metastases-sbrt-vs-palliative-radiotherapy/ 2020-10-27T19:15:29+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/juliane-horner-rieber-on-breast-cancer-boosting-intensity-modulated-and-conventional-radiotherapies/ 2020-10-28T14:25:15+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/paul-sargos-on-prostate-cancer-adjuvant-or-early-salvage-radiotherapy-plus-androgen-deprivation/ 2020-10-28T14:27:54+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/youssef-zeidan-on-her2-positive-breast-cancer-deintensifying-radiation-therapy/ 2020-11-17T20:24:42+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/cynthia-menard-on-prostate-cancer-psma-pet-and-ct-guided-intensification-of-radiotherapy/ 2020-10-28T19:16:10+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/daniel-spratt-on-prostate-cancer-short-term-adjuvant-vs-neoadjuvant-hormone-therapy/ 2020-10-28T19:20:36+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/daniel-spratt-on-prostate-cancer-relugolix-vs-leuprolide/ 2020-10-28T19:25:19+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/alphonse-taghian-on-irradiation-for-breast-cancer-defining-the-optimal-dose/ 2020-11-02T20:27:39+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/vinai-gondi-on-glioblastoma-dose-intensification-imrt-standard-radiotherapy-and-temozolomide/ 2020-11-02T20:33:32+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/jing-li-on-brain-metastases-stereotactic-radiosurgery-vs-whole-brain-radiation-therapy/ 2020-11-02T20:29:20+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/justin-oh-on-prostate-cancer-brachytherapy-vs-external-beam-radiation-therapy/ 2020-11-03T19:04:16+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/jeff-michalski-on-medulloblastoma-and-radiation-treatment-in-pediatric-patients/ 2020-11-04T18:39:31+00:00 https://ascopost.com/videos/2020-astro-annual-meeting/linda-kerkmeijer-on-prostate-cancer-adding-a-focal-boost-to-external-beam-radiotherapy/ 2021-02-09T21:46:58+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/masahiro-tsuboi-on-adjuvant-osimertinib-in-egfr-mutated-nsclc/ 2020-09-20T18:12:50+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/toni-choueiri-on-nivolumab-plus-cabozantinib-vs-sunitinib-in-first-line-treatment-of-rcc/ 2020-09-19T16:56:27+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/mansoor-raza-mirza-on-palbociclib-plus-letrozole-in-er-positive-endometrial-cancer/ 2020-09-19T16:48:39+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/andreas-schneeweiss-on-comparing-neoadjuvant-chemotherapy-with-paclitaxel-doxorubicin-and-carboplatin/ 2020-09-22T18:37:14+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/erika-hamilton-on-abemaciclib-with-or-without-tamoxifen-in-hr-positive-her2-negative-metastatic-breast-cancer/ 2020-09-20T15:46:10+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/ezra-cohen-on-avelumab-and-chemoradiotherapy-in-locally-advanced-head-and-neck-cancer/ 2020-10-06T18:51:17+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/david-hong-on-durability-of-clinical-benefit-and-biomarkers-in-patients-treated-with-sotorasib/ 2020-09-20T16:08:55+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/sumanta-pal-on-cabozantinib-plus-atezolizumab-as-first-line-therapy-for-rcc/ 2020-09-21T15:42:10+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/nicholas-james-on-abiraterone-acetate-plus-prednisolone-for-hormone-naive-prostate-cancer/ 2020-09-23T15:08:32+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/stephen-johnston-on-abemaciclib-in-high-risk-early-breast-cancer/ 2020-09-21T15:40:34+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/thierry-andre-on-hrqol-with-pembrolizumab-vs-chemotherapy-in-colorectal-cancer/ 2020-09-24T18:08:15+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/paolo-ascierto-on-sequencing-targeted-treatments-and-immunotherapy-in-melanoma/ 2020-09-22T18:37:54+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/benjamin-besse-on-neoadjuvant-atezolizumab-for-resectable-nsclc/ 2020-09-22T18:23:42+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/cecile-le-pechoux-on-comparing-postoperative-radiotherapy-with-no-radiotherapy-in-nsclc/ 2020-09-23T20:04:34+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/erica-mayer-on-early-breast-cancer-palbociclib-with-endocrine-therapy-vs-endocrine-therapy-alone/ 2020-09-24T18:07:33+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/aditya-bardia-on-triple-negative-breast-cancer-sacituzumab-govitecan-vs-treatment-of-physician-s-choice/ 2020-10-06T20:37:50+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/alexander-eggermont-on-melanoma-pembrolizumab-vs-placebo-after-complete-resection/ 2020-09-28T18:54:51+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/lisa-carey-on-triple-negative-breast-cancer-paclitaxel-nab-paclitaxel-and-atezolizumab-in-impassion-trials/ 2020-09-29T18:13:07+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/monika-krzyzanowska-on-ambulatory-toxicity-management-in-early-stage-breast-cancer/ 2020-10-13T18:53:33+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/jeffrey-weber-on-adjuvant-nivolumab-vs-ipilimumab-in-melanoma/ 2020-10-02T18:03:11+00:00 https://ascopost.com/videos/esmo-virtual-congress-2020/andreas-du-bois-on-niraparib-trabectedin-plus-doxorubicin-platinum-and-carboplatin-in-ovarian-cancer/ 2020-10-06T18:32:59+00:00 https://ascopost.com/videos/32nd-eortc-nci-aacr-symposium/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/jadpro-live-2020/ 2021-05-19T18:09:40+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/melissa-accordino-on-breast-cancer-care-delivery-impact-of-the-covid-19-pandemic/ 2020-10-14T18:19:33+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/veena-shankaran-on-colorectal-cancer-cumulative-financial-hardship-of-treatment/ 2020-10-15T19:27:28+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/joseph-unger-on-patient-interest-in-clinical-trial-enrollment/ 2020-10-19T16:57:20+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/katherine-enright-on-improving-the-quality-of-oral-cancer-drug-delivery/ 2020-10-20T13:16:06+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/marie-flannery-and-eva-culakova-on-managing-symptoms-in-older-adults-with-advanced-cancer/ 2020-10-22T18:50:10+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/anne-barry-weers-on-decreasing-hospitalizations-for-patients-receiving-iv-chemotherapy/ 2020-10-21T16:17:04+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/cardinale-smith-on-telehealth-disparities-during-the-covid-19-pandemic/ 2020-10-22T18:14:28+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/cardinale-smith-on-redesigning-care-coordination-from-the-patient-perspective/ 2020-10-23T20:25:26+00:00 https://ascopost.com/videos/2020-asco-quality-care-symposium/james-murphy-on-opioid-use-among-patients-with-cancer/ 2020-10-23T17:33:49+00:00 https://ascopost.com/videos/2020-aacr-virtual-special-conference-pancreatic-cancer/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xvii/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xvii/daniel-petereit-on-disparities-in-lung-cancer-care-for-northern-plains-american-indians/ 2020-11-05T18:41:51+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xvii/fred-hirsch-on-early-stage-lung-cancer-targeted-treatment-and-screening/ 2020-11-05T23:19:19+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xvii/david-yankelevitz-on-early-stage-lung-cancer-renewed-interest-in-combined-modality-treatment/ 2020-11-09T17:12:19+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xvii/james-mulshine-on-advancing-quantitative-low-dose-ct-imaging-in-thoracic-disease/ 2020-11-11T19:07:18+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xvii/mary-pasquinelli-on-addressing-lung-cancer-care-equity-in-vulnerable-communities/ 2020-11-12T17:27:01+00:00 https://ascopost.com/videos/2020-sso-international-conference-on-surgical-cancer-care/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/12th-european-breast-cancer-conference/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/a-message-from-asco-president-howard-burris/ 2020-07-07T14:04:34+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/david-fajgenbaum-on-chasing-his-cure-for-castleman-disease/ 2020-07-29T20:40:10+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/richard-schilsky-on-this-year-s-practice-changing-findings/ 2020-07-29T20:42:18+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/roy-herbst-on-osimertinib-in-stage-ib-iiia-egfr-mutation-positive-nsclc/ 2020-09-03T20:39:25+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/christopher-sweeney-and-thomas-powles-on-avelumab-vs-best-supportive-care-in-urothelial-cancer/ 2020-09-14T19:09:56+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/seema-khan-on-systemic-vs-locoregional-therapies-for-metastatic-breast-cancer/ 2020-07-07T14:04:35+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/shaji-kumar-on-carfilzomib-lenalidomide-bortezomib-and-dexamethasone-in-multiple-myeloma/ 2021-05-11T19:28:22+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/thierry-andre-on-pembrolizumab-vs-chemotherapy-for-metastatic-colorectal-cancer/ 2020-07-07T14:04:35+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/andres-poveda-on-maintenance-olaparib-in-ovarian-cancer/ 2020-07-07T14:04:35+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/leora-horn-on-thoracic-cancer-and-covid-19/ 2020-07-07T14:04:35+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/merry-jennifer-markham-perspectives-on-three-abstracts/ 2020-07-07T14:04:36+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/metastatic-urothelial-cancer-a-conversation-before-the-asco20-virtual-scientific-program/ 2020-07-07T14:04:36+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/howard-burris-on-highlights-of-the-asco20-virtual-scientific-program/ 2020-07-07T14:04:36+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/nancy-lin-on-tucatinib-trastuzumab-and-capecitabine-for-metastatic-breast-cancer/ 2020-07-07T14:04:36+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/scott-kopetz-on-encorafenib-plus-cetuximab-with-or-without-binimetinib-in-colorectal-cancer/ 2020-07-07T14:04:36+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/fatima-cardoso-on-mammaprint-as-guidance-for-adjuvant-chemotherapy/ 2020-07-07T14:04:37+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/jeffrey-meyerhardt-on-celecoxib-and-folfox-for-stage-iii-colon-cancer/ 2020-07-07T14:04:37+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/michael-hofman-on-lupsma-vs-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer/ 2020-09-15T17:39:25+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/david-wise-on-novel-biomarkers-in-prostate-cancer/ 2020-07-07T14:04:37+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/rana-mckay-on-intense-adt-before-radical-prostatectomy/ 2020-07-07T14:04:37+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/alberto-sobrero-on-adjuvant-oxaliplatin-and-fluoropyrimidine-based-therapy-for-stage-iii-colon-cancer/ 2020-07-07T14:04:37+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/neal-shore-on-relugolix-vs-leuprolide-for-advanced-prostate-cancer/ 2020-09-09T18:36:11+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/cynthia-ma-on-neoadjuvant-endocrine-treatment-for-er-positive-her2-negative-breast-cancer/ 2020-07-07T14:04:38+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/eric-jonasch-on-a-novel-therapy-for-von-hippel-lindau-disease-associated-rcc/ 2021-09-03T16:36:07+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/meletios-dimopoulos-on-selinexor-bortezomib-and-dexamethasone-for-previously-treated-multiple-myeloma/ 2020-07-07T14:04:38+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/sara-hurvitz-on-four-major-studies-in-breast-cancer/ 2020-07-07T14:04:38+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/michael-morris-on-the-impact-of-psma-targeted-imaging-on-clinical-management-of-prostate-cancer/ 2020-07-07T14:04:38+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/tingyan-shi-on-secondary-cytoreductive-surgery-for-recurrent-ovarian-cancer/ 2020-07-07T14:04:38+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/daniel-petrylak-on-arv-110-in-prostate-cancer/ 2020-09-18T18:22:08+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/ursula-matulonis-on-olaparib-cediranib-mirvetuximab-soravtansine-bevacizumab-and-pembrolizumab-in-ovarian-cancer/ 2020-07-07T14:04:39+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/lourdes-gil-deza-on-caring-for-transgender-patients-with-cancer/ 2020-07-07T14:04:39+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/mikkael-sekeres-on-pevonedistat-and-azacitidine-for-mds-cmml-or-aml/ 2020-07-07T14:04:39+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/farhad-ravandi-kashani-on-amg-330-in-patients-with-relapsed-or-refractory-aml/ 2020-07-07T14:04:39+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/reshma-jagsi-and-narjust-duma-on-diversity-in-oncology/ 2020-07-07T14:04:39+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/jeremy-warner-on-the-clinical-impact-of-covid-19-on-patients-with-cancer/ 2020-07-07T14:04:39+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/douglas-johnson-on-melanoma-clinical-trials-update-on-pd-1-and-ctla-4-blockade/ 2020-07-07T14:04:40+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/christopher-nutting-on-dysphagia-optimized-vs-standard-imrt-for-head-and-neck-cancer/ 2020-07-07T14:04:40+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/rachel-sanborn-on-maximizing-the-benefits-of-targeted-therapies-for-egfr-mutated-nsclc/ 2020-07-07T14:04:40+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/nirav-niranjan-shah-on-autologous-transplant-vs-car-t-cell-therapy-for-dlbcl/ 2020-07-07T14:04:40+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/suresh-ramalingam-on-nivolumab-plus-ipilimumab-vs-chemotherapy-in-nsclc/ 2020-07-07T14:04:40+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/lakshmi-nayak-on-primary-cns-lymphoma-first-line-treatment/ 2020-07-07T14:04:40+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/egbert-smit-on-treatment-with-fam-trastuzumab-deruxtecan-for-nsclc/ 2020-07-07T14:04:41+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/peter-reichardt-on-adjuvant-imatinib-for-high-risk-gist/ 2021-01-08T19:49:16+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/parameswaran-hari-on-post-autologous-hematopoietic-cell-transplantation-strategies-in-upfront-treatment-for-multiple-myeloma/ 2021-02-23T16:33:49+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/nikhil-munshi-on-idecabtagene-vicleucel-in-patients-with-relapsed-or-refractory-multiple-myeloma/ 2020-07-07T14:04:41+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/patricia-pautier-on-doxorubicin-and-trabectedin-for-first-line-treatment-of-leiomyosarcoma/ 2020-07-07T14:04:41+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/paul-richardson-on-first-in-human-study-of-the-novel-agent-cc-92480/ 2020-07-07T14:04:41+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/parameswaran-hari-on-multiple-myeloma-expert-commentary-on-four-key-abstracts/ 2020-07-07T14:04:42+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/sarah-holstein-on-multiple-myeloma-expert-perspective-on-five-key-asco20-abstracts/ 2020-07-07T14:04:42+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/howard-burris-on-the-asco20-virtual-scientific-program-after-action-report/ 2020-07-07T14:04:42+00:00 https://ascopost.com/videos/asco20-virtual-scientific-program/eric-zhou-on-insomnia-in-young-cancer-survivors/ 2020-07-30T21:06:15+00:00 https://ascopost.com/videos/asco20-virtual-education-program/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/asco20-virtual-education-program/matti-aapro-on-curing-sarcomas-an-expert-review/ 2020-10-12T17:06:55+00:00 https://ascopost.com/videos/2020-lynn-sage-breast-cancer-symposium/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/iaslc-world-conference-on-lung-cancer/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/iaslc-world-conference-on-lung-cancer/paul-baas-on-first-line-nivolumab-plus-ipilimumab-vs-chemotherapy-for-mesothelioma/ 2020-08-22T00:59:20+00:00 https://ascopost.com/videos/iaslc-world-conference-on-lung-cancer/misako-nagasaka-md-on-nsclc-sintilimab-pemetrexed-and-platinum-as-first-line-therapy/ 2020-08-26T18:12:49+00:00 https://ascopost.com/videos/iaslc-world-conference-on-lung-cancer/leora-horn-md-on-nsclc-ensartinib-vs-crizotinib-in-alk-positive-disease/ 2020-08-27T18:54:11+00:00 https://ascopost.com/videos/iaslc-world-conference-on-lung-cancer/marina-c-garassino-md-on-covid-19-and-thoracic-malignancies-teravolt-registry/ 2020-08-28T17:04:52+00:00 https://ascopost.com/videos/2020-debates-and-didactics-in-hematology-and-oncology-virtual-conference/ 2021-05-19T18:09:41+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/arthur-caplan-on-ethics-cancer-and-covid-19/ 2020-08-06T19:11:49+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/karen-knudsen-on-the-challenges-of-using-telehealth-in-cancer-care/ 2020-08-05T21:08:02+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/catherine-marshall-on-promoting-recovery-from-covid-19-infection-with-endocrine-therapy/ 2020-08-06T19:11:32+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/antoni-ribas-on-meeting-highlights/ 2020-08-05T21:16:30+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/nancy-davidson-on-bringing-patients-with-cancer-back-to-the-clinic-during-the-covid-19-pandemic/ 2020-08-07T16:17:18+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/jessica-islam-on-covid-19-preventive-behaviors-among-cancer-survivors/ 2020-08-07T16:21:36+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/gabriella-pravettoni-on-psychological-effects-of-covid-19-on-patients-and-oncologists/ 2020-08-14T18:27:32+00:00 https://ascopost.com/videos/aacr-virtual-meeting-covid-19-and-cancer-2020/dafna-bar-sagi-on-covid-19-and-how-cancer-researchers-can-help-address-the-challenges/ 2020-11-18T19:55:37+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/nasser-altorki-on-lung-cancer-radiotherapy-and-immune-checkpoint-blockade-in-the-neoadjuvant-setting/ 2020-08-03T04:18:15+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/adam-palmer-on-immune-checkpoint-inhibitors-additive-to-or-synergistic-with-other-treatments/ 2020-07-22T19:57:48+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/stacey-fedewa-on-cancers-in-younger-populations/ 2020-07-27T17:22:29+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/alfonso-bencomo-álvarez-on-survival-for-hispanic-patients-with-all-aml-and-cml-living-near-the-usmexico-border/ 2020-07-28T20:16:20+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/antoni-ribas-on-racism-and-racial-inequities-in-cancer-research/ 2020-07-29T18:53:56+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/xavier-llor-on-why-are-more-younger-people-are-being-affected-by-colorectal-cancer/ 2020-07-30T19:24:09+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/silvia-formenti-on-testing-radiation-and-immune-checkpoint-blockade-in-different-tumor-settings/ 2020-08-04T17:56:00+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/ramaswamy-govindan-on-differences-among-male-and-female-patients-with-lung-cancer/ 2020-08-04T19:47:54+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/ralph-weichselbaum-on-radiotherapy-and-immunotherapy-in-oligometastatic-disease/ 2020-08-05T01:53:24+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/antoni-ribas-on-turning-science-into-life-saving-care/ 2020-08-05T21:23:43+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/kala-visvanathan-on-lowering-ovarian-cancer-mortality-with-lipophilic-statins/ 2020-08-11T19:03:50+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/robert-winn-on-the-impact-of-covid-19-on-cancer-care-among-racial-and-ethnic-minorities/ 2020-08-11T19:10:32+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-ii/elizabeth-stover-on-nivolumab-plus-bevacizumab-for-relapsed-ovarian-cancer/ 2020-08-13T19:19:00+00:00 https://ascopost.com/videos/eha25-virtual/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/eha25-virtual/abhishek-maiti-on-decitabine-and-venetoclax-vs-intensive-chemotherapy-in-aml/ 2020-07-08T18:46:14+00:00 https://ascopost.com/videos/eha25-virtual/courtney-dinardo-on-venetoclax-and-azacitidine-for-treatment-naive-patients-with-aml/ 2020-08-20T18:37:15+00:00 https://ascopost.com/videos/eha25-virtual/anthony-moorman-improving-all-outcomes-with-a-tyrosine-kinase-inhibitor-plus-chemotherapy/ 2020-07-07T14:05:50+00:00 https://ascopost.com/videos/eha25-virtual/michael-dickinson-on-a-novel-t-cell-engaging-bispecific-antibody-for-non-hodgkin-lymphoma/ 2020-07-07T13:59:20+00:00 https://ascopost.com/videos/eha25-virtual/elias-jabbour-on-venetoclax-and-navitoclax-in-relapsed-or-refractory-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma/ 2020-07-07T14:01:18+00:00 https://ascopost.com/videos/eha25-virtual/john-byrd-on-acalabrutinib-in-treatment-naive-patients-with-cllsll/ 2020-07-08T18:48:40+00:00 https://ascopost.com/videos/eha25-virtual/elizabeth-phillips-on-inotuzumab-ozogamicin-plus-chemotherapy-in-front-line-setting-for-dlbcl/ 2020-07-08T18:53:06+00:00 https://ascopost.com/videos/eha25-virtual/efstathios-kastritis-on-daratumumab-plus-cyclophosphamide-bortezomib-and-dexamethasone-for-amyloidosis/ 2020-07-09T18:39:17+00:00 https://ascopost.com/videos/eha25-virtual/jorge-cortes-on-comparing-three-starting-doses-of-ponatinib-for-chronic-phase-cml/ 2020-09-11T20:26:16+00:00 https://ascopost.com/videos/eha25-virtual/arnon-kater-on-efficacy-of-venetoclax-in-relapsed-or-refractory-cll/ 2020-07-09T19:08:33+00:00 https://ascopost.com/videos/eha25-virtual/andrew-wei-on-venetoclax-plus-cytarabine-in-older-patients-with-aml/ 2020-07-20T18:48:53+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/blase-polite-on-optimizing-cancer-policies-in-the-united-states/ 2020-10-03T21:21:48+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/r-donald-harvey-on-cutting-cancer-care-costs-with-alternative-pharmacologic-options/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/mark-ratain-on-making-a-case-for-low-dose-ibrutinib-for-cll/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/deborah-schrag-on-clinical-trial-design/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/mark-ratain-and-daniel-goldstein-on-value-in-cancer-care/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/clifford-hudis-and-allen-lichter-on-oncology-drug-pricing-in-the-united-states/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/leonard-saltz-on-interventional-pharmacoeconomics/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/welcome-and-introduction-to-vi3c/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/clifford-hudis-are-cancer-drug-prices-in-the-us-the-problem-or-the-symptom/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/daniel-goldstein-interventional-pharmacoeconomics-why-and-how/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/opening-session-panel-discussion/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/russell-szmulewitz-on-alternative-dosing-of-abiraterone-in-prostate-cancer-pharmacoeconomic-proof-of-concept/ 2020-10-03T21:21:49+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/varsha-gandhi-on-ibrutinib/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/cody-peer-on-simulating-alternative-schedules-for-checkpoint-inhibitors/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/s-vincent-rajkumar-on-cost-effective-treatment-of-multiple-myeloma/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/charles-schiffer-on-cost-effective-use-of-tyrosine-kinase-inhibitors-for-chronic-myelogenous-leukemia/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/garth-strohbehn-on-interventional-pharmacoeconomics-and-covid-19/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/ian-tannock-on-near-equivalence/ 2020-10-05T13:55:02+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/gary-rosner-on-bayesian-non-inferiority/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/mark-sculpher-on-assessing-the-value-of-cancer-drug-optimization/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/clinical-trial-design-statistical-optionschallenges-panel-discussion/ 2020-10-03T21:21:50+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/sarah-yim-on-clinical-development-of-biosimilars/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/david-rubin-on-biosimilars-for-inflammatory-bowel-disease/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/robin-feldman-are-dubious-patents-a-large-or-small-issue/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/peter-clark-a-payer-perspective/ 2020-10-04T22:03:53+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/amit-sanyal-a-clinician-s-perspective/ 2020-10-05T22:09:39+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/matthew-seymour-a-clinical-trialist-s-perspective/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/cs-pramesh-on-opportunities-in-india/ 2020-10-06T13:21:19+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/blase-polite-on-transforming-the-drug-cost-curve-in-the-united-states/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/kelvin-chan-on-opportunities-to-optimize-cancer-drug-policies-the-canadian-perspective/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/boon-cher-goh-on-cancer-drugs-in-singapore/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/opportunities-to-optimize-cancer-policies-panel-discussion/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/victoria-brown-on-payer-intervention-the-example-of-abiraterone/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/david-hyman-on-inclusive-shared-savings/ 2020-10-03T21:21:51+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/r-donald-harvey-on-alternative-dispensing-strategies/ 2020-10-05T14:04:16+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/deborah-collyar-whats-in-it-for-patients/ 2020-10-03T21:21:52+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/the-interventional-pharmacoeconomic-toolbox-panel-discussion/ 2020-10-03T21:21:52+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/javid-moslehi-on-cardiovascular-and-thrombotic-considerations-of-kinase-inhibitors/ 2020-10-03T21:21:52+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/mark-ratain-on-the-justification-for-a-randomized-trial-of-low-dose-ibrutinib/ 2020-10-03T21:21:52+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/focus-on-optimized-dosing-of-ibrutinib-panel-discussion/ 2020-10-03T21:21:52+00:00 https://ascopost.com/videos/first-international-summit-on-interventional-pharmacoeconomics/leonard-saltz-on-the-future-of-interventional-pharmacoeconomics/ 2020-10-03T21:21:52+00:00 https://ascopost.com/videos/snmmi-2020-annual-meeting-virtual-edition/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/esmo-world-congress-on-gastrointestinal-cancer-2020-virtual/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/lajos-pusztai-on-i-spy2-trial-on-durvalumab-olaparib-and-paclitaxel/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/steven-o-day-on-pembrolizumab-plus-imprime-pgg-in-tnbc/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/grant-mcarthur-on-atezolizumab-cobimetinib-and-vemurafenib-for-melanoma/ 2020-08-03T04:19:12+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/ryan-sullivan-on-com701-plus-nivolumab-in-advanced-solid-tumors/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/kimlin-ashing-on-tobacco-and-vape-shops-in-neighborhoods-with-lower-income-and-minority-populations/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/byoung-chul-cho-genetic-mutations-in-nsclc-and-immunotherapy-vs-chemotherapy/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/nickolas-papadopoulos-on-liquid-biopsy-to-screen-for-multiple-cancer-types/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/edward-garon-on-long-term-use-of-pemetrexed-plus-platinum-with-pembrolizumab-in-nsclc/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/edward-garon-on-geometry-mono-1-trial-of-capmatinib/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/jennifer-litton-on-embraca-trial-on-talazoparib-vs-chemotherapy/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/qi-liu-on-pneumonitis-immunotherapy-and-chemotherapy-in-nsclc/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/aacr-virtual-annual-meeting-2020-i/andrew-zhu-on-atezolizumabbevacizumab-in-hcc/ 2020-06-22T16:42:01+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/miguel-angel-perales-and-syed-abutalib-on-bone-marrow-transplants-during-the-covid-19-pandemic/ 2020-07-21T20:02:24+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/mikkael-sekeres-on-cancer-treatment-in-the-age-of-covid-19/ 2020-07-21T19:21:40+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/william-dale-on-best-practices-for-special-populations-during-the-covid-19-pandemic/ 2020-07-21T19:21:40+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/laura-michaelis-on-selecting-tkis-for-patients-with-cml-during-the-pandemic/ 2020-07-21T19:21:40+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/laura-michaelis-on-treating-advanced-cml-during-the-pandemic/ 2020-07-21T19:21:40+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/laura-michaelis-on-best-practices-for-treating-cll-during-the-pandemic/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/laura-michaelis-on-pausing-therapy-for-cll/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/laura-michaelis-on-treating-cll-and-cml-in-the-community-oncology-setting/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/mehdi-hamadani-on-administering-outpatient-lymphoma-therapy-during-the-pandemic/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/mehdi-hamadani-on-delaying-autologous-transplant-in-patients-with-dlbcl-during-the-pandemic/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/mehdi-hamadani-on-immediate-upfront-autologous-transplant-for-t-cell-nhl/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/mehdi-hamadani-on-cibmtr-in-the-pandemic/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/mehdi-hamadani-on-treating-nhl-in-the-community-oncology-setting-during-the-pandemic/ 2020-07-21T19:21:41+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/mehdi-hamadani-on-transplant-for-mantle-cell-lymphoma/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/saad-usmani-on-decision-models-for-front-line-multiple-myeloma-therapy-in-the-era-of-covid-19/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/saad-usmani-on-delaying-upfront-autologous-transplant-in-the-era-of-covid-19/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/saad-usmani-on-posttransplant-care-during-covid-19/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/saad-usmani-on-myeloma-clinical-trials-during-covid-19/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/saad-usmani-on-community-oncologists-treating-myeloma-during-the-covid-19-pandemic/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/rafal-dziadziuszko-on-using-telemedicine-during-the-pandemic/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/rafal-dziadziuszko-on-helping-ease-patients-fears-of-contracting-covid-19/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/jacek-jassem-on-fighting-covid-19-and-cancer-in-poland/ 2020-07-21T19:21:42+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/paolo-ascierto-on-cancer-treatment-during-the-covid-19-pandemic-in-southern-italy/ 2020-07-21T19:21:43+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/joseph-alvarnas-on-increased-risk-of-side-effects-for-some-patients-with-cancer-and-covid-19/ 2020-07-21T19:21:43+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/giorgio-scagliotti-on-the-oncoming-waves-of-covid-19/ 2020-07-21T19:21:43+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/giorgio-scagliotti-on-the-ongoing-battle-against-covid-19-update-from-italy/ 2020-07-21T19:21:43+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/eduardo-cazap-on-covid-19-the-view-from-south-america/ 2020-07-21T19:21:43+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/derek-raghavan-on-covid-19-and-cancer-care-the-view-from-north-carolina/ 2020-07-21T19:21:43+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/nancy-davidson-on-covid-19-and-cancer-care/ 2020-07-21T19:21:44+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/william-wood-on-the-new-ash-covid-19-registry/ 2020-07-21T19:21:44+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/irene-ghobrial-on-how-covid-19-is-changing-the-conduct-of-clinical-trials/ 2020-07-21T19:21:44+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/giuseppe-curigliano-on-how-covid-19-is-affecting-cancer-care-in-italy/ 2020-12-12T22:23:35+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/karen-knudsen-on-delivering-cancer-care-during-the-covid-19-pandemic-report-from-philadelphia/ 2020-07-21T19:21:44+00:00 https://ascopost.com/videos/covid-19-and-cancer-care/paul-richardson-on-multiple-myeloma-and-covid-19-an-update/ 2021-07-14T19:12:46+00:00 https://ascopost.com/videos/esmo-breast-cancer-virtual-meeting-2020/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/asbrs-2020-scientific-session/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/sgo-2020-annual-meeting-on-women-s-cancer/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/elizabeth-reed-on-helping-providers-in-rural-areas-meet-the-needs-of-younger-patients-with-breast-cancer/ 2020-04-13T19:24:06+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/william-gradishar-on-innovating-pathways-for-patient-self-management-in-breast-cancer/ 2020-04-13T19:28:59+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/karen-wonders-on-benefits-of-exercise-during-cancer-treatment/ 2020-04-14T17:23:34+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/apar-kishor-ganti-on-real-world-adherence-and-persistence-of-alk-inhibitors-in-nsclc/ 2020-04-14T17:27:00+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/sara-hurvitz-on-talazoparib-vs-chemotherapy-for-breast-cancer/ 2020-04-21T18:34:31+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/hope-rugo-on-talazoparib-for-advanced-solid-tumors/ 2020-04-21T18:41:13+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/barbara-devivo-on-tumor-boards-and-influence-of-social-hierarchy-on-cancer-treatment-decision-making/ 2020-04-29T20:00:40+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/pam-baker-deguzman-on-assessing-distress-during-telemedicine-visits-with-rural-survivors-of-head-and-neck-cancer/ 2020-05-04T17:31:01+00:00 https://ascopost.com/videos/nccn-2020-virtual-annual-conference/christopher-davella-on-a-specialized-urgent-care-center-for-patients-with-cancer/ 2020-05-04T17:29:05+00:00 https://ascopost.com/videos/2020-miami-breast-cancer-conference/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/francis-worden-on-the-role-of-induction-chemotherapy-in-laryngeal-preservation/ 2020-03-02T19:58:22+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/carryn-anderson-on-reducing-severe-oral-mucositis-and-its-effect-on-patient-outcomes/ 2020-03-04T19:42:17+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/nadeem-riaz-on-established-and-emerging-biomarkers-for-immunotherapy-in-head-and-neck-cancer/ 2020-03-03T19:06:00+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/assuntina-sacco-on-pembrolizumab-and-cetuximab-in-hnscc/ 2020-03-03T19:13:49+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/jill-gilbert-on-challenges-in-de-intensifying-systemic-therapies-for-hpv-associated-oropharyngeal-cancer/ 2020-03-03T21:46:58+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/david-adelstein-on-guidelines-for-treating-hpv-associated-oropharyngeal-squamous-cell-carcinoma/ 2020-03-03T21:58:21+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/gopal-bajaj-on-reducing-opioid-use-in-patients-with-head-and-neck-cancer/ 2020-03-03T22:03:01+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/jonathan-schoenfeld-on-neoadjuvant-nivolumab-with-or-without-ipilimumab-for-oral-cavity-cancer/ 2020-03-03T22:07:25+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/jared-weiss-on-radioimmunotherapy-for-squamous-cell-carcinoma-of-the-head-and-neck/ 2020-03-03T22:14:46+00:00 https://ascopost.com/videos/2020-multidisciplinary-head-and-neck-cancers-symposium/sue-sun-yom-on-challenges-in-deintensifying-radiation-therapy-for-hpv-associated-oropharyngeal-cancer/ 2020-03-11T15:47:27+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/jonathan-rosenberg-on-enfortumab-vedotin-plus-pembrolizumab-for-urothelial-carcinoma/ 2020-02-19T20:30:25+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/syed-hussain-on-neo-blade-trial-of-nintedanib-plus-chemotherapy/ 2020-02-19T20:30:26+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/david-dearnaley-on-conventional-vs-hypofractionated-high-dose-radiotherapy-for-prostate-cancer/ 2020-02-19T20:30:27+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/julie-graff-results-from-keynote-199-on-pembrolizumab-plus-enzalutamide/ 2020-02-19T20:30:27+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/ziad-bakouny-on-defining-the-role-of-cytoreductive-nephrectomy/ 2020-02-19T20:30:27+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/toni-choueiri-on-an-hif2a-inhibitor-for-advanced-clear-cell-rcc/ 2020-02-19T21:18:59+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/neeraj-agarwal-on-results-from-the-cosmic-021-study-of-cabozantinib-and-atezolizumab/ 2020-02-19T21:28:25+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/maha-hussain-on-next-generation-sequencing-of-prostate-tumor-tissue/ 2020-02-19T21:44:45+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/nicholas-james-on-cetuximab-with-chemoradiotherapy-for-bladder-cancer/ 2020-02-19T21:58:26+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/karim-fizazi-on-pain-and-quality-of-life-in-patients-receiving-cabazitaxel-vs-abiraterone-or-enzalutamide/ 2020-02-19T22:17:50+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/thomas-powles-on-adding-radiation-to-immunotherapy-for-rcc/ 2020-02-19T22:21:45+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/nizar-tannir-on-nivolumab-plus-ipilimumab-vs-sunitinib-in-advanced-kidney-cancer/ 2020-02-19T22:31:57+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/hannah-rush-on-quality-of-life-in-patients-receiving-docetaxel-or-abiraterone/ 2020-02-19T22:48:48+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/toni-choueiri-on-cosmic-313/ 2020-02-19T22:52:25+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/ziad-bakouny-on-sarcomatoid-and-rhabdoid-rcc/ 2020-02-19T22:56:00+00:00 https://ascopost.com/videos/2020-genitourinary-cancers-symposium/nicholas-james-on-cost-effectiveness-in-the-stampede-trial/ 2020-02-20T20:28:49+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/elizabeth-mittendorf-on-mobilizing-the-immune-system-to-treat-select-solid-tumors/ 2020-02-12T19:49:32+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/dario-vignali-on-immune-resistance-mechanisms-in-cancer/ 2020-02-12T19:52:17+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/luis-ruffolo-on-augmenting-immunotherapy-with-antibody-blockade-of-semaphorin-4d/ 2020-02-12T19:58:34+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/philippa-corrie-on-patient-outcomes-in-melanoma-after-immune-checkpoint-inhibition/ 2020-02-12T20:18:23+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/martin-mccarter-on-refinement-of-surgical-treatment-2020-advance-of-the-year/ 2020-02-13T20:17:44+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/jacob-adashek-on-immunoregulatory-molecules-cancer-genes-and-therapeutic-insights/ 2020-02-12T20:24:55+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/kevin-tyan-on-colitis-induced-by-immune-checkpoint-inhibitors/ 2020-02-12T20:41:46+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/christopher-cole-on-interferon-activated-autologous-monocytes-in-ovarian-cancer/ 2022-02-18T20:17:14+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/john-lukens-on-antibiotics-survival-and-colitis-in-patients-with-melanoma-receiving-immunotherapy/ 2020-02-12T21:06:38+00:00 https://ascopost.com/videos/2020-asco-sitc-clinical-immuno-oncology-symposium/jarrett-failing-on-human-leukocyte-antigen-expression-in-nsclc-with-brain-metastases/ 2020-02-12T21:11:02+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/eileen-o-reilly-on-gemcitabine-cisplatin-and-veliparib-for-pancreatic-adenocarcinoma/ 2020-01-29T21:39:42+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/scott-kopetz-on-quality-of-life-results-on-encorafenib-cetuximab-and-binimetinib-in-crc/ 2020-01-29T21:39:42+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/brian-wolpin-on-performance-of-a-blood-based-test-for-the-detection-of-multiple-cancers/ 2020-01-29T21:39:46+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/heinz-josef-lenz-on-nivolumab-plus-low-dose-ipilimumab-as-first-line-therapy-for-metastatic-crc/ 2020-01-29T21:39:46+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/zev-wainberg-on-pd-l1-positive-advanced-gastric-cancer/ 2020-01-29T21:39:47+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/peter-galle-on-patient-reported-outcomes-for-atezolizumabbevacizumab-vs-sorafenib-in-hcc/ 2020-01-29T21:39:47+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/van-morris-on-ctdna-as-a-predictive-biomarker-for-adjuvant-chemotherapy-in-colon-cancer/ 2020-01-29T21:39:47+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/franck-pagès-on-the-idea-study-on-a-risk-assessment-tool/ 2020-01-29T21:39:47+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/eyal-meiri-on-pembrolizumab-in-colorectal-cancer/ 2020-01-29T21:39:47+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/thibaud-koessler-on-neoadjuvant-pembrolizumab-and-radiotherapy-for-localized-rectal-cancer/ 2020-01-29T21:39:48+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/danielle-bitterman-on-plasma-ctdna-in-pancreatic-cancer/ 2020-01-29T21:39:48+00:00 https://ascopost.com/videos/2020-gastrointestinal-cancers-symposium/thomas-yau-on-nivolumab-ipilimumab-and-cabozantinib-for-advanced-hcc/ 2020-01-29T21:39:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/rashmi-murthy-on-the-her2climb-trial-of-tucatinib/ 2019-12-13T21:00:45+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/ian-krop-on-trastuzumab-deruxtecan-for-previously-treated-her2-positive-metastatic-breast-cancer/ 2019-12-13T21:00:45+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/hope-rugo-on-sophia-trial-of-chemotherapy-plus-margetuximab-or-trastuzumab/ 2019-12-13T21:00:45+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/sara-tolaney-on-the-atempt-trial-in-her2-positive-breast-cancer/ 2020-09-16T19:30:34+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/miguel-martín-on-the-pearl-trial-of-palbociclib-plus-endocrine-therapy-vs-capecitabine/ 2019-12-13T21:00:45+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/icro-meattini-on-breast-irradiation-after-breast-conservation-surgery/ 2019-12-13T21:35:58+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/priyanka-sharma-on-the-potent-trial/ 2019-12-13T21:00:45+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/nicholas-turner-on-ctdna-testing-to-direct-targeted-therapies-in-advanced-breast-cancer/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/milan-radovich-on-ctdna-after-neoadjuvant-chemotherapy-and-recurrence-in-tnbc/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/jack-cuzick-on-the-international-breast-cancer-intervention-study-ii/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/gerardo-antonio-umanzor-funez-md-on-comparing-iv-and-oral-formulations-of-paclitaxel/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/rowan-chlebowski-on-findings-from-the-women-s-health-initiative/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/ralph-weichselbaum-on-oligometastatic-cancer-and-the-role-of-radioimmunotherapy/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/tari-king-on-molecular-differences-between-primary-and-metastatic-breast-tumors/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/belinda-kingston-on-the-genomic-landscape-of-breast-cancer-based-on-ctdna-analysis/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/joseph-sparano-the-william-l-mcguire-memorial-lecture/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/javier-cortes-on-keynote-119-trial-of-pembrolizumab-vs-chemotherapy-in-tnbc/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/joerg-heil-on-image-guided-vacuum-assisted-breast-biopsy/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/madeleine-tilanus-linthorst-on-mri-vs-mammography/ 2019-12-13T21:00:46+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/ariella-b-hanker-phd-on-therapeutic-implications-of-her2-and-her3-mutations-in-breast-cancer/ 2019-12-13T21:00:45+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/marie-jeanne-vrancken-peeters-on-omitting-breast-surgery/ 2019-12-13T22:30:34+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/ivana-sestak-on-clinical-treatment-score-from-tailorx/ 2019-12-13T22:38:29+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/nadine-tung-on-inform-trial-of-cisplatin-vs-doxorubicincyclophosphamide/ 2019-12-13T22:46:09+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/hongchao-pan-on-an-update-on-5-years-of-endocrine-therapy-for-early-breast-cancer/ 2019-12-13T22:52:20+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/luca-gianni-on-the-neoadjuvant-treatment-of-triple-negative-breast-cancer/ 2019-12-13T23:38:11+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/terry-mamounas-on-extending-letrozole-treatment-in-hormone-receptor-positive-breast-cancer/ 2019-12-13T23:47:27+00:00 https://ascopost.com/videos/2019-san-antonio-breast-cancer-symposium/hope-rugo-on-a-retrospective-analysis-of-pd-l1-immunohistochemistry-assays/ 2020-01-13T22:42:09+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/patrick-brown-on-blinatumomab-vs-chemotherapy-in-pediatric-b-all/ 2019-12-11T22:05:10+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/andrew-wei-on-the-quazar-trial-on-oral-azacitidine/ 2020-09-02T18:57:16+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/saad-usmani-on-the-candor-trial-in-myeloma/ 2020-09-01T19:51:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/ilaria-iacobucci-on-genetic-subtypes-of-aml-and-mds/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/edward-stadtmauer-on-a-first-in-human-assessment-of-crispr-edited-t-cells/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/mikkael-sekeres-on-early-trial-findings-on-glasdegib-plus-azacitidine/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/loretta-nastoupil-on-obinutuzumablenalidomide-for-follicular-lymphoma/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/nitin-jain-on-first-line-ibrutinib-plus-venetoclax-in-cll/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/mhairi-copland-on-blast-phase-cml/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/tait-shanafelt-on-comparing-ibrutinib-and-rituximab-with-fcr-in-younger-patients-with-cll/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/david-steensma-on-myeloid-neoplasms-and-a-splicing-modulator/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/catherine-diefenbach-on-polatuzumab-vedotin-plus-obinutuzumablenalidomide-for-follicular-lymphoma/ 2019-12-11T22:05:11+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/jennifer-crombie-on-duvelisib-and-venetoclax-for-relapsed-or-refractory-cllsll/ 2019-12-11T22:05:12+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/mark-bustoros-on-ixazomiblenalidomidedexamethasone-for-high-risk-smoldering-multiple-myeloma/ 2019-12-11T22:05:12+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/jerald-radich-on-predicting-deep-molecular-response-to-treatment-for-cml/ 2019-12-11T22:05:12+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/c-ola-landgren-on-carfilzomib-lenalidomide-dexamethasone-and-daratumumab-for-newly-diagnosed-multiple-myeloma/ 2019-12-13T17:23:23+00:00 https://ascopost.com/videos/2019-ash-annual-meeting-exposition/jeff-sharman-on-acalabrutinib-obinutuzumab-and-chlorambucil-for-cll/ 2019-12-11T22:05:12+00:00 https://ascopost.com/videos/esmo-immuno-oncology-congress-2019/ 2021-05-19T18:09:42+00:00 https://ascopost.com/videos/2019-lynn-sage-breast-cancer-symposium/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/chest-2019/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-chemotherapy-foundation-symposium/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/rsna-2019/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/esmo-asia-2019-congress/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/esmo-2019-congress/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/esmo-2019-congress/antonio-gonzález-martín-on-primaengot-ov26gog-3012-trial-of-niraparib-in-ovarian-cancer/ 2019-10-08T21:08:19+00:00 https://ascopost.com/videos/esmo-2019-congress/isabelle-ray-coquard-md-phd-on-olaparib-plus-bevacizumab-in-ovarian-cancer/ 2019-10-08T21:08:20+00:00 https://ascopost.com/videos/esmo-2019-congress/suresh-ramalingam-on-the-flaura-trial/ 2019-10-08T21:08:20+00:00 https://ascopost.com/videos/esmo-2019-congress/mansoor-mirza-and-robert-coleman-on-integrating-velaparib-with-chemotherapy-and-maintenance-therapy-in-gynecologic-cancers/ 2019-10-08T21:08:20+00:00 https://ascopost.com/videos/esmo-2019-congress/thomas-powles-and-enrique-grande-on-atezolizumab-and-platinum-based-chemotherapy-for-urothelial-carcinoma/ 2019-10-08T21:08:20+00:00 https://ascopost.com/videos/esmo-2019-congress/ronald-de-wit-on-cabazitaxel-abiraterone-and-enzalutamide-in-prostate-cancer/ 2019-10-08T21:08:20+00:00 https://ascopost.com/videos/esmo-2019-congress/peter-schmid-on-pembrolizumab-plus-chemotherapy-in-tnbc/ 2021-07-28T18:22:14+00:00 https://ascopost.com/videos/esmo-2019-congress/véronique-diéras-on-brocade-3-results/ 2019-10-08T21:08:21+00:00 https://ascopost.com/videos/esmo-2019-congress/laura-qm-chow-on-ceritinib-in-metastatic-nsclc/ 2019-10-08T21:08:21+00:00 https://ascopost.com/videos/esmo-2019-congress/ghassan-abou-alf-on-the-claridhy-trial-of-ivosidenib-vs-placebo-in-cholangiocarcinoma/ 2019-10-08T21:08:21+00:00 https://ascopost.com/videos/esmo-2019-congress/solange-peters-on-the-checkmate-227-trial-of-nivolumab-and-ipilimumab-vs-chemotherapy-in-nsclc/ 2019-10-09T17:45:06+00:00 https://ascopost.com/videos/esmo-2019-congress/sherene-loi-and-leisha-emens-on-atezolizumabtrastuzumab-emtansine-for-her2-positive-breast-cancer/ 2019-10-08T21:08:21+00:00 https://ascopost.com/videos/esmo-2019-congress/paolo-ascierto-on-adjuvant-nivolumab-vs-ipilimumab-in-melanoma/ 2019-10-08T21:08:21+00:00 https://ascopost.com/videos/esmo-2019-congress/maha-hussain-on-olaparibenzalutamideabiraterone-for-crpc/ 2019-10-08T21:08:22+00:00 https://ascopost.com/videos/esmo-2019-congress/robin-jones-on-tappas-trial-in-advanced-angiosarcoma/ 2019-10-08T21:08:22+00:00 https://ascopost.com/videos/esmo-2019-congress/nicholas-james-on-a-long-term-subgroup-analysis-of-the-stampede-trial/ 2019-10-08T21:08:24+00:00 https://ascopost.com/videos/esmo-2019-congress/aleix-prat-on-a-her2-positive-breast-cancer-biomarker/ 2019-10-08T21:08:24+00:00 https://ascopost.com/videos/esmo-2019-congress/angela-lamarca-on-liver-metastases-from-intrahepatic-cholangiocarcinoma/ 2019-10-08T21:08:24+00:00 https://ascopost.com/videos/esmo-2019-congress/thomas-powles-on-durvalumab-plus-targeted-treatments-for-metastatic-urothelial-cancer/ 2019-10-08T21:08:24+00:00 https://ascopost.com/videos/esmo-2019-congress/tim-meyer-and-lorenza-rimassa-on-the-celestial-trial-in-advanced-hcc/ 2019-10-08T21:08:24+00:00 https://ascopost.com/videos/esmo-2019-congress/volker-kunzmann-on-nab-paclitaxelgemcitabine-and-folfirinox-for-pancreatic-cancer/ 2019-10-08T21:08:24+00:00 https://ascopost.com/videos/esmo-2019-congress/sungjune-kim-on-nivolumabipilimumab-plus-sbrt-for-merkel-cell-carcinoma/ 2019-10-08T21:08:25+00:00 https://ascopost.com/videos/esmo-2019-congress/georgina-long-on-melanoma-brain-metastases/ 2019-10-08T21:08:25+00:00 https://ascopost.com/videos/esmo-2019-congress/ana-maria-arance-fernandez-on-cobimetinibatezolizumab-vs-pembrolizumab-in-melanoma/ 2019-10-08T21:08:25+00:00 https://ascopost.com/videos/esmo-2019-congress/mansoor-mirza-on-ovarian-cancer-esmo-2019-top-abstracts/ 2019-10-08T21:08:25+00:00 https://ascopost.com/videos/esmo-2019-congress/nicoletta-colombo-on-lenvatinibpembrolizumab-for-advanced-endometrial-cancer/ 2019-10-08T21:08:25+00:00 https://ascopost.com/videos/esmo-2019-congress/nicholas-james-on-the-stampede-trial-m1-rt-comparison-of-radiotherapy/ 2019-10-08T21:08:25+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/andrew-zelenetz-on-the-era-of-therapeutic-biosimilars/ 2019-10-08T19:40:27+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/william-wierda-on-evolving-strategies-for-first-line-treatment-of-cll/ 2019-10-10T18:14:33+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/nitin-jain-on-the-role-for-chemoimmunotherapy-for-cll/ 2019-10-08T20:10:16+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/richard-fisher-on-optimizing-first-line-therapy-for-follicular-lymphoma/ 2019-10-08T20:16:29+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/nina-shah-md-on-how-long-should-initial-treatment-for-myeloma-should-last/ 2019-10-08T20:40:31+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/rafael-bejar-on-myelodysplastic-syndromes/ 2019-10-08T20:44:14+00:00 https://ascopost.com/videos/nccn-2019-annual-congress-hematologic-malignancies/jorge-castillo-on-evolution-of-therapy-for-relapsedrefractory-multiple-myeloma/ 2019-10-08T20:55:47+00:00 https://ascopost.com/videos/2019-supportive-care-in-oncology-symposium/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-ncri-cancer-conference/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/asco-breakthrough-a-global-summit-for-oncology-innovators/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/andreas-rimner-on-the-pacific-trial/ 2019-09-23T19:05:01+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/daniel-spratt-on-the-impact-of-antiandrogen-treatment-in-prostate-cancer/ 2019-09-24T19:53:51+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/steven-lin-on-proton-beam-vs-intensity-modulated-radiation-therapy-for-esophageal-cancer/ 2019-09-23T19:05:08+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/justin-barnes-on-the-aca-and-risk-of-suicide-in-patients-with-cancer/ 2019-09-23T19:06:26+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/ryan-phillips-on-the-oriole-trial-in-oligometastatic-prostate-cancer/ 2019-09-23T19:07:06+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/youssef-zeidan-on-the-hera-trial-of-postmastectomy-radiation-therapy/ 2019-09-24T19:57:16+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/daniel-trifiletti-on-optimizing-wbrt-dose-and-fractionation-for-patients-with-brain-metastases/ 2019-09-24T19:57:21+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/david-routman-on-oropharyngeal-squamous-cell-carcinoma-and-hpv-ctdna/ 2019-09-24T19:58:29+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/alejandra-méndez-romero-on-liver-metastases-and-sbrt/ 2019-09-24T20:00:52+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/sue-sun-yom-on-deintensifying-radiation-therapy-plus-chemotherapy-for-oropharyngeal-cancer/ 2019-09-24T20:03:01+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/michael-lariviere-on-non-hodgkin-lymphoma-induction-radiation-before-car-t-cell-therapy/ 2019-09-24T20:03:10+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/erica-bell-on-radiotherapy-in-low-grade-gliomas/ 2019-09-24T20:03:54+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/robert-olson-on-qol-outcomes-after-sabr-vs-standard-of-care-palliative-treatments/ 2019-09-24T20:05:26+00:00 https://ascopost.com/videos/2019-astro-annual-meeting/andrew-kneebone-on-adjuvant-vs-early-salvage-radiotherapy-after-prostatectomy/ 2019-09-24T20:06:44+00:00 https://ascopost.com/videos/iaslc-2019-world-conference-on-lung-cancer/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-quality-care-symposium/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-quality-care-symposium/linda-bosserman-on-pathways-for-personalized-precision-medicine-and-value/ 2019-09-09T19:27:30+00:00 https://ascopost.com/videos/2019-quality-care-symposium/karen-winkfield-on-policy-and-business-solutions-to-address-disparities-in-cancer-care/ 2019-09-09T19:32:09+00:00 https://ascopost.com/videos/2019-quality-care-symposium/bernardo-goulart-on-high-drug-costs-in-stage-iv-nsclc/ 2019-09-11T17:29:14+00:00 https://ascopost.com/videos/2019-quality-care-symposium/cristina-merkhofer-on-the-survival-impact-of-taking-part-in-a-clinical-trial/ 2019-09-11T18:22:46+00:00 https://ascopost.com/videos/2019-quality-care-symposium/ryan-huey-on-the-financial-toxicity-of-early-phase-clinical-trials/ 2019-09-11T18:49:04+00:00 https://ascopost.com/videos/2019-quality-care-symposium/elena-martinez-on-diversity-in-precision-oncology/ 2019-09-11T19:18:14+00:00 https://ascopost.com/videos/2019-quality-care-symposium/grace-hillyer-on-improving-clinician-patient-communication/ 2019-09-11T19:22:12+00:00 https://ascopost.com/videos/2019-quality-care-symposium/mallika-sharma-on-eliminating-prior-authorizations-anxiety-delay-in-care-higher-costs/ 2019-09-11T19:25:22+00:00 https://ascopost.com/videos/2019-quality-care-symposium/lauren-hamel-on-race-and-doctor-patient-behavior/ 2019-09-11T19:30:34+00:00 https://ascopost.com/videos/2019-quality-care-symposium/angela-stover-on-patient-reported-outcome-performance-measures-for-oncology-practice/ 2019-09-25T19:07:19+00:00 https://ascopost.com/videos/2019-quality-care-symposium/matthew-schabath-on-addressing-cultural-barriers-to-equality-in-oncology-among-lgbtq/ 2019-09-18T14:20:11+00:00 https://ascopost.com/videos/2019-quality-care-symposium/nadine-housri-on-online-tumor-boards/ 2019-09-20T14:13:41+00:00 https://ascopost.com/videos/2019-quality-care-symposium/joseph-jacobson-the-joseph-v-simone-award-lecture/ 2019-09-11T22:13:36+00:00 https://ascopost.com/videos/2019-quality-care-symposium/cary-gross-on-creating-and-implementing-clinical-pathways/ 2019-09-11T22:23:36+00:00 https://ascopost.com/videos/2019-quality-care-symposium/manali-patel-on-enhancing-delivery-of-value-based-cancer-care-in-community-practices/ 2019-09-11T22:27:41+00:00 https://ascopost.com/videos/2019-quality-care-symposium/michael-kenneth-keng-on-an-asco-quality-training-program/ 2019-09-11T22:31:09+00:00 https://ascopost.com/videos/2019-debates-and-didactics-in-hematology-and-oncology/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-nccn-policy-summit/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-masccisoo-annual-meeting/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/amy-davidoff-on-effect-of-medicaid-expansion-on-treatment-disparities/ 2019-06-04T16:18:08+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/alok-khorana-and-hedy-kindler-on-the-polo-trial/ 2019-06-04T16:18:09+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/ian-davis-and-christopher-sweeney-on-the-enzamet-trial/ 2019-06-04T16:18:09+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/sara-hurvitz-on-monaleesa-7/ 2019-06-04T16:18:09+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/josep-tabernero-on-pembrolizumab-in-gastric-or-gej-adenocarcinoma/ 2019-06-04T16:18:09+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/edward-garon-on-keynote-001-trial-of-pembrolizumab-in-nsclc/ 2019-06-04T16:18:09+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/kamal-chamoun-on-insurance-status-and-survival-in-multiple-myeloma/ 2019-06-04T16:18:09+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/richard-schilsky-and-r-donald-harvey-on-expanding-criteria-for-clinical-trial-eligibility/ 2019-06-04T16:18:10+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/william-tap-on-the-announce-trial-in-soft-tissue-sarcomas/ 2019-06-04T16:18:10+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/danny-rischin-on-keynote-048-trial-on-pembrolizumab-in-hnscc/ 2019-06-04T16:18:10+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/richard-pazdur-on-the-launch-of-project-facilitate/ 2019-06-26T21:40:46+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/lee-schwartzberg-2019-update-on-the-accc-immuno-oncology-institute/ 2019-06-10T13:43:10+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/kamran-ahmed-on-sbrt-plus-atezolizumab-in-cervical-cancer/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/manmeet-ahluwalia-on-glioblastoma-novel-cancer-vaccine-with-standard-therapy/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/taofeek-kunle-owonikoko-on-tremelimumab-and-durvalumab-with-or-without-radiation-in-sclc/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/margaret-tempero-on-adjuvant-nab-paclitaxel-and-gemcitabine-in-pancreatic-cancer/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/mark-j-levis-md-phd-on-acute-myeloid-leukemia-gilteritinib-in-flt3-mutated-disease/ 2019-06-04T21:07:47+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/karim-fizazi-md-phd-on-the-aramis-trial-in-prostate-cancer-impact-of-darolutamide-on-pain-and-quality-of-life/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/rowan-chlebowski-on-breast-cancer-incidence-and-mortality-and-effects-of-a-low-fat-diet/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/hirotsugu-kenmotsu-on-pemetrexed-plus-cisplatin-vs-vinorelbine-plus-cisplatin-in-nsclc/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/david-kwiatkowski-on-neoadjuvant-immunotherapy-for-resectable-nsclc/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/daniel-petrylak-on-enfortumab-vedotin-for-urothelial-cancer/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/neeraj-agarwal-and-thomas-flaig-on-predicting-response-in-muscle-invasive-bladder-cancer/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/neeraj-agarwal-and-thomas-powles-on-first-line-pembrolizumab-plus-axitinib-vs-sunitinib-in-rcc/ 2019-06-04T16:18:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/neeraj-agarwal-and-arnaud-méjean-on-cytoreductive-nephrectomy-followed-by-sunitinib/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/jonathan-rosenberg-on-adding-bevacizumab-to-gemcitabine-and-cisplatin-in-urothelial-carcinoma/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/matt-galsky-on-switch-maintenance-with-pembrolizumab-in-urothelial-cancer/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/suresh-ramalingam-on-maintenance-pemetrexed-andor-bevacizumab-in-nsclc/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/yoland-antill-on-the-phaedra-trial-on-durvalumab-in-endometrial-cancer/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/miriam-knoll-and-richard-white-on-predicting-radiotherapyimmunotherapy-treatment-outcomes-in-nsclc/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/miriam-knoll-and-zachery-reichert-on-focal-radiation-for-oligometastatic-castration-resistant-prostate-cancer/ 2019-06-19T14:17:12+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/paul-richardson-on-the-icaria-mm-trial/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/sarah-abou-alaiwi-and-toni-choueiri-on-checkpoint-inhibitors-and-polybromo-associated-mutations/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/patricia-ganz-on-breast-cancer-whole-vs-partial-breast-irradiation/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/thomas-george-on-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/ 2019-06-04T16:18:17+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/brian-baumann-on-proton-vs-photon-therapy-in-locally-advanced-cancer/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/brian-baumann-on-adjuvant-radiotherapy-after-radical-cystectomy/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/michael-morris-on-adding-abiraterone-acetate-to-enzalutamide-in-metastatic-prostate-cancer/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/ziad-bakouny-and-toni-choueiri-on-genomic-characterization-of-sarcomatoidrhabdoid-rcc/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/kim-chi-on-cabazitaxel-vs-abiraterone-or-enzalutamide-in-prostate-cancer/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/kim-chi-on-first-results-from-the-titan-trial/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/francesca-gay-on-the-forte-trial-in-multiple-myeloma/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/michael-thompson-on-reassessing-risk-stratification-models-in-myeloma/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/gilberto-lopes-on-the-relay-trial-in-metastatic-nsclc/ 2019-06-04T21:09:05+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/richard-penson-and-don-dizon-on-solo3-trial-in-ovarian-cancer/ 2019-06-04T16:18:18+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/angela-lamarca-on-oxaliplatin-and-fluorouracil-biliary-tract-cancers/ 2019-06-04T16:18:19+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/panagiotis-konstantinopoulos-on-avelumab-in-endometrial-cancer/ 2019-06-04T16:18:19+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/sagar-lonial-on-delaying-disease-progression-of-smoldering-myeloma/ 2019-06-04T16:18:19+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/javier-sastre-on-bevacizumab-and-folfoxiri-in-metastatic-colorectal-cancer/ 2019-06-04T16:18:19+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/ahmad-a-tarhini-on-adjuvant-ipilimumab-vs-high-dose-interferon-α2b-in-melanoma/ 2019-06-04T17:36:57+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/yeon-hee-park-on-palbociclib-exemestane-and-gnrh-agonist-in-metastatic-breast-cancer/ 2019-06-04T17:48:04+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/william-wierda-on-transcend-cll-004/ 2019-06-04T17:52:31+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/kerry-a-rogers-md-on-acalabrutinib-with-obinutuzumab-in-cll/ 2019-06-04T17:57:51+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/jame-abraham-on-nala-trial-findings-in-her2-positive-metastatic-breast-cancer/ 2019-06-04T18:01:14+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/jason-westin-on-the-smart-start-study-in-dlbcl/ 2019-06-04T18:07:57+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/adam-brufsky-on-the-nala-trial/ 2019-06-04T18:16:39+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/matthew-powell-and-don-dizon-on-paclitaxel-plus-carboplatin-vs-ifosfamide-in-uterine-or-ovarian-cancer/ 2019-06-12T20:39:35+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/luis-paz-ares-on-lurbinectedin-in-small-cell-lung-cancer/ 2019-06-12T20:44:38+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/sara-hurvitz-on-the-kristine-trial-in-her2-positive-breast-cancer/ 2019-06-12T20:49:28+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/christopher-sweeney-and-ian-davis-on-anzup/ 2019-06-12T20:54:34+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/leonard-joseph-appleman-on-pazopanib-vs-placebo-after-metastasectomy-in-rcc/ 2019-06-20T14:59:23+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/matteo-lambertini-md-phd-on-safety-of-pregnancy-after-treatment-for-brca-mutated-breast-cancer/ 2019-06-12T21:40:41+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/joseph-sparano-on-predicting-prognosis-and-treatment-benefit-in-tailorx/ 2019-06-12T21:53:48+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/justin-gainor-on-a-selective-ret-inhibitor-in-nsclc/ 2019-06-12T21:58:02+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/mansoor-raza-mirza-and-don-dizon-on-niraparib-plus-bevacizumab-in-ovarian-cancer/ 2019-06-12T22:02:49+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/hani-babiker-on-tumor-treating-fields/ 2019-06-12T22:06:09+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/åsmund-fretland-on-laparoscopic-vs-open-resection-for-colorectal-cancer-liver-metastases/ 2019-06-12T22:11:16+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/hope-rugo-and-matteo-lambertini-on-the-sophia-trial/ 2019-06-12T22:17:34+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/peter-schmid-and-hope-rugo-on-impassion130/ 2019-06-13T16:16:22+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/peter-schmid-and-hope-rugo-on-next-steps-in-immunotherapy-in-breast-cancer/ 2019-06-14T16:30:32+00:00 https://ascopost.com/videos/2019-asco-annual-meeting/françois-xavier-mahon-on-treatment-free-remission-after-second-line-treatment-in-cml/ 2019-06-17T16:27:12+00:00 https://ascopost.com/videos/esmo-world-gi-2019/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-annual-meeting-of-the-society-of-nuclear-medicine-and-molecular-imaging/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/15th-international-conference-on-malignant-lymphoma/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/24th-congress-of-eha/ 2021-05-19T18:09:43+00:00 https://ascopost.com/videos/2019-aacr-ahns-head-and-neck-cancer-conference/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/aacr-environmental-carcinogenesis/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/asbrs-2019/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/aacr-annual-meeting-2019/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/aua-2019/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/frederick-locke-on-innovative-car-t-cell-therapies/ 2019-03-21T18:49:13+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/william-gradishar-on-nccn-guidelines-updates-in-breast-cancer/ 2019-03-21T18:57:33+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/matthew-gubens-on-the-nsclc-nccn-guidelines/ 2019-03-21T19:10:30+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/eric-jonasch-on-kidney-cancer-a-year-in-review/ 2019-03-21T21:24:19+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/melinda-telli-on-nccn-guidelines-updates-for-breast-cancer/ 2019-03-21T21:29:09+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/neil-shah-on-cml-nccn-guidelines-updates/ 2019-03-22T15:22:44+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/gary-lyman-on-myeloid-growth-factors-and-biosimilars/ 2019-03-22T15:37:20+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/margaret-tempero-on-pancreatic-cancer-nccn-guidelines-updates/ 2019-03-22T18:51:30+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/james-mohler-on-managing-prostate-cancer-nccn-guidelines-updates/ 2019-03-22T19:03:14+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/michelle-riba-on-screening-for-distress-in-cancer/ 2019-03-22T19:26:13+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/wells-messersmith-on-colorectal-cancer-nccn-guidelines-update/ 2019-03-23T12:06:21+00:00 https://ascopost.com/videos/nccn-annual-conference-2019/chrysalyne-schmults-on-basal-and-squamous-cell-carcinoma/ 2019-03-23T12:20:07+00:00 https://ascopost.com/videos/arrs-2019-annual-meeting/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/esmo-breast-cancer-congress-2019/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-miami-breast-cancer-conference/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/estro-38/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-transplantation-and-cellular-therapy-tct-meetings/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-annual-scientific-meeting-of-the-american-association-of-neurological-surgeons-aans/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/elcc-2019-european-lung-cancer-congress/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-sgo-annual-meeting-on-womens-cancer/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/leora-horn-on-sclc-and-immuno-oncology/ 2019-03-19T19:22:05+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/heather-wakelee-on-egfr-and-alk-positive-advanced-nsclc/ 2019-03-19T19:27:17+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/aaron-mansfield-on-treating-rare-thoracic-cancers/ 2019-03-19T19:34:29+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/shraddha-dalwadi-on-disparities-in-treating-stage-i-nsclc/ 2019-03-19T19:56:15+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/j-fletcher-drogos-on-multiple-courses-of-sbrt-in-patients-with-lung-cancer/ 2019-03-19T20:02:17+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/kyle-concannon-on-lung-cancer-in-homeless-patients/ 2019-03-19T20:20:14+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/ruqin-chen-on-survival-outcomes-and-clinical-and-molecular-features-in-lung-cancer/ 2019-03-19T20:28:00+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/martin-edelman-on-immunotherapy-for-patients-with-autoimmune-disease/ 2019-03-19T20:27:51+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/jing-zeng-on-therapeutic-implications-of-proper-disease-staging-in-nsclc/ 2019-03-19T20:31:15+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/mark-ferguson-on-mitigating-frailty-and-sarcopenia/ 2019-03-19T20:34:41+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/susan-wu-on-using-an-online-tool-in-nsclc-treatment/ 2019-03-19T20:39:09+00:00 https://ascopost.com/videos/2019-multidisciplinary-thoracic-cancers-symposium/jyoti-patel-on-new-systemic-treatments-in-stage-iii-nsclc/ 2019-03-29T17:43:54+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/jedd-wolchok-on-the-future-of-immunotherapy/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/toni-choueiri-and-ziad-bakouny-on-next-generation-immuno-oncology-therapies-in-rcc/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/elizabeth-mittendorf-on-breast-cancer-immunotherapy/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/nicolas-guibert-on-predicting-response-to-pd-1-inhibitors-with-cfdna/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/madhav-dhodapkar-on-cancer-vaccines/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/kim-margolin-on-promising-immunotherapy-strategies/ 2019-08-01T19:14:55+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/nicholas-vogelzang-on-lenvatinib-plus-pembrolizumab-in-urothelial-cancer/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/g-travis-clifton-on-nelipepimut-s-gm-csf-and-trastuzumab/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/edward-garon-on-nivolumab-dosing-in-nsclc/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2019-asco-sitc-clinical-immuno-oncology-symposium/stefan-ciurea-on-infusing-natural-killer-cells-and-enhanced-antitumor-effect/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/brian-rini-and-thomas-powles-on-pembrolizumab-plus-axitinib-vs-sunitinib/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/karim-fizazi-on-results-from-the-latitude-trial/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/toni-choueiri-on-avelumab-plus-axitinib-vs-sunitinib/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/nicholas-van-as-on-pace-b-trial-comparing-radiotherapy-techniques/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/brian-baumann-on-adjuvant-chemoradiotherapy-vs-adjuvant-radiotherapy-alone/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/laurence-albiges-on-nivolumab-in-renal-cell-carcinoma/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/ignacio-duran-on-results-from-the-meteor-trial-on-cabozantinib-vs-everolimus/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/karim-fizazi-on-the-aramis-trial-on-darolutamide/ 2020-09-17T17:28:26+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/silke-gillessen-on-results-from-the-reduse-trial-on-denosumab/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/brian-rini-on-the-tivo3-trial-on-tivozanib-vs-sorafenib/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/stefanie-fischer-on-nonseminoma-outcomes-after-adjuvant-bleomycin-etoposide-cisplatin/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/jason-efstathiou-on-bladder-cancer-what-is-the-best-treatment-option/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/rana-mckay-on-results-from-a-trial-on-atezolizumab-and-bevacizumab/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/thomas-powles-on-the-range-trial-on-ramucirumab-and-docetaxel/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/craig-nichols-on-testicular-cancer-cases-and-high-volume-centers/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/howard-scher-on-circulating-tumor-cells-as-a-surrogate-endpoint-for-survival/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/brian-rini-on-risk-stratification-after-resection-of-localized-disease/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/sumanta-pal-on-clinical-cancer-advances/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2019-genitourinary-cancers-symposium/sumit-subudhi-on-the-checkmate-650-trial-on-nivolumab-and-ipilimumab/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/david-ilson-on-trifluridine-tipiracil-in-gastric-cancer/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/manish-shah-on-the-gamma-1-study-in-gastric-cancer/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/ahmed-omar-kaseb-on-results-from-an-immunotherapy-trial-in-liver-cancer/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/heinz-josef-lenz-on-braf-v600e-mutated-biliary-tract-cancer/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/carl-schimanski-on-tecemotide-after-colorectal-cancer-liver-metastasectomy/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/heinz-josef-lenz-on-pancreatic-cancer-tumor-profiling/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/jeffrey-meyerhardt-on-adjuvant-chemotherapy-in-colon-cancer/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/andrew-zhu-on-outcomes-in-the-reflect-study-on-lenvatinib/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/jonathan-strosberg-on-neuroendocrine-tumors-results-from-the-keynote-158-trial/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/takashi-kojima-on-esophageal-cancer-results-from-the-keynote-181-trial/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/francesca-battaglin-on-colorectal-cancer-using-genetic-variants-to-predict-treatment-efficacy/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/pieter-tanis-on-the-colopec-trial-on-adjuvant-hipec/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/andrew-zhu-on-the-prep-02jsap-05-trial-in-pancreatic-cancer/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2019-gastrointestinal-cancers-symposium/rongbo-lin-on-gastric-cancer-results-from-the-fnf-004-trial/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/tat-2019-international-congress-on-targeted-anticancer-therapies/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/esmo-immuno-oncology-congress-2018/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/sara-hurvitz-on-novel-treatments-and-markers-in-her2-positive-breast-cancer/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/xavier-pivot-on-results-from-the-phare-trial/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/kathryn-ruddy-on-breast-cancer-and-quality-of-life/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/shoichiro-ohtani-on-extending-adjuvant-aromatase-inhibitor-therapy/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/zaida-morante-md-on-delaying-adjuvant-chemotherapy-in-triple-negative-breast-cancer/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/eva-ciruelos-on-the-patricia-trial-in-her2-positive-breast-cancer/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/andrew-seidman-and-charles-geyer-on-the-katherine-trial/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/andrew-seidman-and-miguel-martín-on-the-cibomageicam-trial/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/andrew-seidman-and-richard-gray-on-long-term-aromatase-inhibitor-therapy/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/françois-clément-bidard-on-using-circulating-tumor-cells-to-direct-treatment/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/harold-burstein-and-daniel-hayes-on-breast-cancer-with-positive-lymph-nodes/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/shoshana-rosenberg-on-quality-of-life-and-the-impact-of-breast-cancer-surgery/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/judy-garber-on-cancer-genetics/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/laura-dominici-on-young-women-with-breast-cancer/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/dejan-juric-md-on-results-from-the-solar-1-trial/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/roberto-leon-ferre-on-decreasing-hot-flashes/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/allison-magnuson-on-a-new-tool-to-help-guide-treatment-decisions-in-older-patients-with-breast-cancer/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/kathy-albain-on-breast-cancer-ethnicity-and-clinical-outcomes/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/reshma-jagsi-and-rachel-freedman-on-over-and-undertreatment/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/roisin-connolly-on-breast-cancer-treatment-advances-in-2018/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/shom-goel-on-impact-of-cdk46-inhibitors-on-immunity/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/monica-morrow-on-view-from-the-trenches-what-will-you-do-on-monday-morning/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/hope-rugo-on-immunotherapy-for-breast-cancer/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/shanu-modi-on-low-her2-expressing-breast-cancer/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2018-san-antonio-breast-cancer-symposium/hope-rugo-on-treatment-for-pretreated-hormone-receptor-positive-disease/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/ 2021-05-19T18:09:44+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/gilles-salles-on-results-from-the-l-mind-trial/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/jennifer-woyach-on-cll-results-from-the-alliance-north-american-intergroup-study/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/john-leonard-on-nhl-results-from-the-augment-trial/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/mikkael-sekeres-on-mds-results-from-the-medalist-trial/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/norman-sharpless-director-of-the-national-cancer-institute-articulating-a-vision/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/andreas-burchert-on-aml-results-from-the-sormain-trial/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/francesca-gay-on-results-from-the-forte-trial-in-multiple-myeloma/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/julie-vose-and-merav-bar-on-late-effects-of-cd19-targeted-treatment/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/julie-vose-and-loretta-nastoupil-on-car-t-cell-therapy-in-large-b-cell-lymphoma/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/saar-gill-on-anti-cd19-car-t-cells-in-cll/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/anas-younes-on-dlbcl-phase-iii-trial-results/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/steven-horwitz-on-cerdulatinib-in-ptcl-and-ctcl/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/steven-horwitz-on-results-from-the-echelon-2-trial/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/paul-richardson-on-multiple-myeloma-the-op-106-horizon-trial/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/alok-khorana-on-reducing-vte-associated-with-systemic-cancer-therapy/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/shaji-kumar-on-newly-diagnosed-multiple-myeloma/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/tait-shanafelt-on-cll-results-from-a-trial-of-the-ecog-acrin-cancer-research-group/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/laurie-sehn-on-prognostic-significance-of-myc-in-dlbcl/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2018-ash-annual-meeting-exposition/alexander-pine-on-anticoagulant-therapy-in-treating-vte/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/in-my-opinion/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/in-my-opinion/improving-cancer-care-and-value/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/in-my-opinion/embracing-computer-assisted-decision-making/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/in-my-opinion/owen-o-connor-issues-in-immunotherapy/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/in-my-opinion/oliver-sartor-issues-in-immunotherapy/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/in-my-opinion/we-need-to-find-a-way-to-make-cancer-drugs-affordable/ 2019-03-18T19:50:19+00:00 https://ascopost.com/videos/in-my-opinion/lets-get-more-patients-with-rare-tumors-into-clinical-trials/ 2019-03-18T19:50:15+00:00 https://ascopost.com/videos/patients-speak/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/patients-speak/facing-death-having-the-difficult-conversation-with-your-patients/ 2019-07-10T15:45:18+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/leslie-blackhall-on-unregulated-opioid-access/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/suleika-jaouad-on-making-the-most-of-a-life-interrupted/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/mary-buss-and-candice-johnstone-on-financial-toxicity/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/elizabeth-cathcart-rake-on-immunotherapy-related-toxicities/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/betty-ferrell-on-quality-of-life-in-the-era-of-immunotherapy/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/mary-e-johnson-on-holding-vigil-with-dying-loved-ones/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/mihir-kamdar-on-managing-cancer-related-pain-with-ai/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/katherine-lee-on-emergency-surgery-and-end-of-life-care/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/eric-roeland-on-preventing-chemotherapy-induced-vomiting/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/charles-von-gunten-on-protecting-opioid-access-for-patients-in-need/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/allison-betof-warner-on-managing-immune-related-adverse-events/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2018-palliative-and-supportive-care-in-oncology-symposium/nosayaba-osazuwa-peters-on-suicide-among-male-patients-with-cancer/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/bhisham-chera-on-oropharyngeal-cancer-and-surveillance/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/daniel-gomez-on-findings-from-a-phase-ii-nsclc-treatment-trial/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/vinai-gondi-on-treating-brain-metastases-and-preserving-cognitive-function/ 2021-01-14T19:09:20+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/thomas-galloway-on-oropharyngeal-cancer-improving-outcomes-and-reducing-toxicity/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/david-palma-on-oligometastatic-tumors/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/alan-pollack-on-results-from-the-spport-trial/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/david-raben-on-nsclc-results-from-the-pacific-trial/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/howard-sandler-on-prostate-cancer-prospective-trials-update/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/michael-soike-on-brain-metastases-radiosurgery-vs-radiotherapy/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/daniel-spratt-on-prostate-cancer-in-african-american-men/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2018-astro-annual-meeting/howard-sandler-on-localized-prostate-cancer-radiation-therapy-guidelines/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/esmo-2018-congress/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/esmo-2018-congress/paolo-ascierto-on-melanoma-acute-and-chronic-toxicities/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/esmo-2018-congress/alexander-eggermont-on-advances-in-melanoma-adjuvant-therapy/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/esmo-2018-congress/matthew-ellis-neoadjuvant-endocrine-therapy-in-breast-cancer/ 2021-12-09T22:38:45+00:00 https://ascopost.com/videos/esmo-2018-congress/matti-aapro-on-immunotherapy-in-older-patients/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/esmo-2018-congress/matti-aapro-on-reducing-use-of-futile-treatments/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/esmo-2018-congress/ezra-cohen-on-using-curative-immunotherapy-in-head-and-neck-cancer/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/esmo-2018-congress/martin-reck-on-immunotherapy-for-thoracic-malignancies/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/esmo-2018-congress/johan-vansteenkiste-on-immunotherapy-and-targeted-treatments-in-nsclc/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/esmo-2018-congress/jeffrey-weber-on-discontinuing-immunotherapy/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/esmo-2018-congress/ronald-de-wit-on-results-from-keynote057/ 2021-01-25T22:19:07+00:00 https://ascopost.com/videos/esmo-2018-congress/eileen-oreilly-on-multimodality-approaches-in-hepatobiliary-cancer/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/esmo-2018-congress/karl-lewis-md-on-an-ongoing-study-of-basal-cell-carcinoma/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/esmo-2018-congress/cora-sternberg-on-renal-and-bladder-cancers/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/esmo-2018-congress/lisa-carey-and-sherene-loi-on-impassion-130-in-tnbc/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/esmo-2018-congress/sibylle-loibl-on-metastatic-breast-cancer-research-highlights/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/esmo-2018-congress/laurence-albiges-on-challenging-established-front-line-treatment-in-rcc/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/esmo-2018-congress/suresh-ramalingam-on-lung-cancer-research-highlights/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/esmo-2018-congress/tony-mok-md-on-nsclc-targeted-treatment-update/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/esmo-2018-congress/nicholas-james-on-prostate-cancer-updates-from-the-stampede-trial/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/esmo-2018-congress/caroline-robert-on-advanced-melanoma-research-highlights/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/esmo-2018-congress/caroline-robert-on-immunotherapy-toxicities/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/eortc-nci-aacr-molecular-targets-and-cancer-therapeutics-symposium/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-ncri-cancer-conference/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-nccn-oncology-policy-summit/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-debates-and-didactics-in-hematology-and-oncology-conference/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/masccisoo-2018/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-aacr-conference-on-advances-in-malignant-lymphoma/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-friends-of-cancer-research-meeting/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-society-of-surgical-oncology-annual-meeting/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/34th-annual-meeting-of-the-european-society-of-human-reproduction-and-embryology/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-hopa-annual-conference/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-hematologyoncology-pharmacy-association-annual-conference/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-miami-breast-cancer-conference/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-american-psychosocial-oncology-society-meeting/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2018-multidisciplinary-head-and-neck-cancers-symposium/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/nccn-patient-advocacy-summit-addressing-survivorship-in-cancer-care/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2017-oncofertility-consortium-conference/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2nd-global-adolescent-young-adult-aya-cancer-congress/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/friends-of-cancer-research-annual-meeting/ 2021-05-19T18:09:45+00:00 https://ascopost.com/videos/2017-fda-asco-geriatric-oncology-workshop/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-jadpro-live/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-aacr-conference-on-cancer-health-disparities/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-aortic-conference-on-cancer-in-africa/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-eso-esmo-advanced-breast-cancer-conference/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-14th-quantitative-imaging-workshop/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-palliative-and-supportive-care-in-oncology-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-new-orleans-summer-cancer-meeting/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-aacr-international-conference-on-new-frontiers-in-cancer-research/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-oncoset-symposium-emerging-approaches-to-precision-medicine/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-emory-university-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-international-workshop-on-cll/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-miami-breast-cancer-conference/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-american-society-of-breast-surgeons-annual-meeting/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-american-association-of-neurological-surgeons-annual-scientific-meeting/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-european-society-for-radiotherapy-oncology-estro-conference/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-impakt-breast-cancer-conference/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-european-lung-cancer-conference/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-european-cancer-congress/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-american-urological-association-annual-meeting/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-city-of-hope-hematologic-malignancies-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-society-of-surgical-oncology/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-multidisciplinary-head-neck-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-aacr-annual-meeting/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-apos-annual-conference/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-society-of-gynecologic-oncology-annual-meeting/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/karyn-a-goodman-md-on-esophageal-cancer-results-of-calgb-80803/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/geoffrey-ku-md-mba-on-gastric-and-esophageal-cancers-expert-perspectives-on-immunotherapy/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/salah-eddin-al-batran-md-on-gastric-cancer-radpac-trial-results/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/ian-chau-md-on-esophageal-and-gastric-cancers-systemic-agents-and-options/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/julien-edeline-md-on-biliary-tract-cancer-results-of-the-prodigy-12-accord-18-trial/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/julien-edeline-md-on-biliary-tract-cancer-results-of-the-prodigy-12-accord-18-trial-french-language-version/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/scott-kopetz-md-on-colorectal-cancer-results-of-the-swog-1406-trial/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/cathy-eng-md-on-anal-squamous-cell-cancer-management-strategies/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/michael-j-overman-md-on-colorectal-cancer-updated-results-from-checkmate-142/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/mark-talamonti-md-on-pancreatic-cancer-minimally-invasive-resection/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/ignacio-melero-md-phd-on-hepatocellular-carcinoma-results-of-the-checkmate-040-trial/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/ignacio-melero-md-phd-on-hepatocellular-carcinoma-results-of-the-checkmate-040-trial-spanish-language-version/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/eileen-m-o-reilly-md-on-pancreatic-and-hepatobiliary-cancers-selecting-high-impact-targets/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/cornelis-van-de-velde-md-phd-on-rectal-cancer-a-database-update/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/brendan-j-guercio-md-on-colorectal-cancer-and-physical-activity-impact-on-survival/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/masanori-terashima-md-phd-on-gastric-cancer-results-of-the-jcog1001-trial/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/sarah-e-hoffe-md-on-pancreatic-cancer-and-sbrt-pros-and-cons/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2017-gastrointestinal-cancers-symposium/cynthia-l-sears-md-on-colon-cancer-keynote-lecture/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/shawna-v-hudson-phd-on-breast-cancer-a-quality-of-life-program/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/k-holly-mead-phd-on-identifying-models-of-cancer-survivorship-care/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/emily-s-tonorezos-md-on-childhood-cancer-survivors-and-late-occurring-effects/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/mohammad-abu-zaid-md-on-testicular-cancer-study-results-on-metabolic-syndrome/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/dong-wook-shin-md-drph-mba-on-thyroid-cancer-risk-of-side-effects/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/ann-h-partridge-md-mph-on-adolescent-and-young-adult-patients-their-survivorship-challenges/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/electra-d-paskett-phd-on-preventing-lymphedema-results-of-a-calgb-study/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/sophia-kustas-smith-phd-msw-on-depression-and-fatigue-self-managed-in-reimagine/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/lauren-p-wallner-phd-mph-on-breast-cancer-survivorship-care-patient-preferences/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/shoshana-m-rosenberg-scd-mph-on-young-breast-cancer-survivors-helping-them-cope/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/allison-harvey-mph-ches-on-teaching-providers-about-survivorship/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/angela-r-bradbury-md-on-genetic-information-and-clinical-care/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2017-cancer-survivorship-symposium/arti-hurria-md-on-senior-citizens-living-through-and-beyond-cancer/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/brian-c-allen-md-on-assessing-tumor-response-standard-of-care-vs-computer-assisted-evaluation/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/joshua-armenia-phd-on-prostate-cancer-recent-discoveries/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/toni-k-choueiri-md-on-urothelial-cancer-trial-results-from-borealis-2/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/lawrence-h-einhorn-md-on-testicular-cancer-the-keynote-lecture/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/sumanta-k-pal-md-on-rcc-and-tumor-profiling/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/charles-g-drake-md-phd-on-prostate-cancer-and-immunology-expert-perspective/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/paul-l-nguyen-md-on-predicting-metastasis-and-mortality/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/toni-k-choueiri-md-on-papillary-rcc-phase-ii-trial-results/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/george-j-bosl-md-and-karim-fizazi-md-phd-on-germ-cell-tumors-and-treatment-intensification-pros-and-cons/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/l-michael-glodé-md-on-prostate-cancer-results-from-swog-s9921/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/emma-hall-phd-on-bladder-cancer-results-from-the-bc2001-trial/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/joshua-m-lang-md-on-prostate-cancer-best-of-the-journals/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/toni-k-choueiri-md-on-untreated-rcc-phase-ii-trial-results/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/w-marston-linehan-md-on-renal-cell-carcinoma-genetic-predisposition/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/rana-r-mckay-md-on-rcc-continuing-benefit-after-halting-treatment/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/paul-l-nguyen-md-on-prostate-cancer-active-surveillance/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/roland-seiler-md-on-bladder-cancer-subtypes-and-treatment-response/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/roland-seiler-md-on-bladder-cancer-subtypes-and-treatment-response-german-language-version/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/guru-sonpavde-md-on-prostate-cancer-targeting-dna-alterations/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/karim-chamie-md-on-bladder-cancer-optimizing-surgical-and-medical-therapies/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-genitourinary-cancers-symposium/sumanta-k-pal-md-on-advanced-renal-cancer-treatment-challenges/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/ 2021-05-19T18:09:46+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/stephen-gottschalk-md-on-car-t-cells-for-solid-tumors-what-are-the-challenges/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/elizabeth-ann-mittendorf-md-phd-on-meeting-highlights-expert-perspective/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/holger-n-lode-md-neuroblastoma-survival-update/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/holger-n-lode-md-neuroblastoma-survival-update-german-language-version/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/howard-kaufman-md-on-merkel-cell-carcinoma-treatment-update/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/lawrence-fong-md-on-novel-t-cell-checkpoint-combinations/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/limo-chen-phd-on-lung-cancer-and-cd38-resistance-to-immunotherapy/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/marie-andrée-forget-phd-on-metastatic-melanoma-update-from-md-anderson/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/prasad-s-adusumilli-md-on-solid-tumors-car-t-cells-and-immune-checkpoint-blockade/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/roy-s-herbst-md-phd-on-lung-cancer-with-immune-checkpoints-promising-combinations/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/shridar-ganesan-md-phd-on-mutation-burden-and-immunotherapy/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2017-quality-care-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-quality-care-symposium/ethan-m-basch-md-on-symptom-control-and-quality-the-patient-s-voice/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2017-quality-care-symposium/john-v-cox-do-mba-on-2017-quality-care-symposium-highlights-expert-perspective/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-quality-care-symposium/caleb-dulaney-md-on-breast-cancer-improving-online-patient-information/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-quality-care-symposium/diana-d-jeffery-phd-on-mental-health-co-morbidities-predictors-of-cost-and-utilization/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2017-quality-care-symposium/greg-d-judy-md-on-safety-incidents-in-radiotherapy/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-quality-care-symposium/robert-s-miller-md-on-cancerlinq-big-data-and-clinical-effectiveness/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-quality-care-symposium/nicole-mittmann-phd-on-breast-cancer-well-follow-up/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2017-quality-care-symposium/laura-e-panattoni-phd-on-costs-of-preventable-emergency-department-use/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2017-quality-care-symposium/blase-n-polite-md-mpp-the-oncology-care-model-in-academia/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2017-quality-care-symposium/julie-bryar-porter-ms-on-improving-care-one-center-s-experience/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/2017-quality-care-symposium/gwendolyn-p-quinn-phd-on-underserved-cancer-patients-and-survivors-are-we-listening-to-them/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2017-quality-care-symposium/gabrielle-rocque-md-on-the-oncology-care-model-transforming-practices/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2017-quality-care-symposium/thomas-j-smith-md-on-oral-abstract-session-b-2017-quality-care-symposium/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2017-quality-care-symposium/brian-weiss-md-on-reducing-treatment-errors-with-improvement-science/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/kamran-ahmed-md-on-lung-cancer-radiation-and-immune-checkpoint-inhibitors/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/richard-j-cassidy-iii-md-on-nsclc-and-sbrt-in-older-patients/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/shraddha-m-dalwadi-mba-on-stage-i-nsclc-racial-disparities-in-treatment-and-outcome/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/maximilian-diehn-md-phd-on-liquid-biopsiescell-free-dna-clinical-uses/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/martin-j-edelman-md-on-nsclc-final-results-of-a-calgb-alliance-trial/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/tracey-l-evans-md-on-nsclc-combined-modality-therapy/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/jennifer-ho-md-on-thoracic-cancers-reirradiation-with-impt/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/zhongxing-liao-md-on-proton-beam-radiotherapy-for-locally-advanced-disease/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/zofia-piotrowska-md-on-nsclc-resistance-mechanisms/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/boris-sepesi-md-on-nsclc-tils-and-overall-survival/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/charles-b-simone-ii-md-on-nsclc-ctcs-as-a-biomarker-for-early-detection/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2017-multidisciplinary-thoracic-cancers-symposium/douglas-e-wood-md-on-lung-cancer-screening/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/soft-tissue-sarcoma-evolving-treatment/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/myeloproliferative-neoplasms-and-myelofibrosis-new-treatment-guidelines/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/christina-s-chu-md-on-hpv-and-cervicalvulvar-cancer/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/david-g-pfister-md-on-hpv-and-head-and-neck-cancer/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/paul-m-cinciripini-phd-on-smoking-cessation-in-patients-with-cancer/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/leo-i-gordon-md-on-hodgkin-lymphoma-management-strategies/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/elizabeth-r-plimack-md-on-bladder-cancer-management-updates/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-nccn-annual-conference/margaret-a-tempero-md-on-pancreatic-cancer-active-systemic-treatment/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-accc-annual-meeting/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-society-of-nuclear-medicine-and-molecular-imaging-annual-meeting/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-international-conference-on-malignant-lymphoma/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-european-hematology-association-annual-congress/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-esmo-world-congress-on-gastrointestinal-cancer/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/todd-m-gibson-phd-on-childhood-cancer-survivors-chronic-disease-trends/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/peter-hoskin-md-on-spinal-compression-results-from-the-scorad-iii-trial/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/gary-rodin-md-on-advanced-cancer-the-calm-psychological-intervention/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/viviane-hess-md-on-managing-stress-in-newly-diagnosed-patients/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/jane-mcneil-beith-md-phd-on-reducing-fear-in-cancer-survivors/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/karim-fizazi-md-phd-on-prostate-cancer-results-from-the-latitude-trial/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/nicholas-d-james-mbbs-phd-on-prostate-cancer-results-from-the-stampede-trial/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/matteo-lambertini-md-on-pregnancy-in-breast-cancer-patients-results-from-a-multicenter-study/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/erin-van-blarigan-scd-on-colon-cancer-the-effect-of-diet-and-exercise-results-from-calgb-89803/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/olivier-tredan-md-phd-on-advanced-refractory-cancer-and-molecular-screening/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/david-m-hyman-md-on-larotrectinib-in-trk-fusion-cancers-trial-results/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/gerhardt-attard-md-phd-on-prostate-cancer-results-from-an-after-market-study-on-enzalutamide/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/maura-l-gillison-md-phd-on-hpv-and-the-value-of-the-vaccine/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/temidayo-fadelu-md-on-colon-cancer-results-from-the-calgb-89803-trial/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/ronald-j-buckanovich-md-phd-on-ovarian-cancer-expert-perspective-on-the-icon6-trial/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/jame-abraham-md-on-breast-cancer-expert-perspective-on-the-monarch-2-trial/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/ronald-j-buckanovich-md-phd-on-ovarian-cancer-expert-perspective-on-the-solo2-trial/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/ethan-m-basch-md-on-symptom-monitoring-findings-on-overall-survival-rates/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/ann-lii-cheng-md-phd-on-hepatocellular-carcinoma-trial-results-on-lenvatinib-vs-sorafenib/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/daniel-a-goldstein-md-on-pembrolizumab-for-lung-cancer-saving-costs-by-adjusting-dosage/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/axel-grothey-md-on-colon-cancer-results-of-the-idea-collaboration/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/salah-eddin-al-batran-md-on-gej-adenocarcinoma-results-from-the-flot4-aio-trial/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/xuesong-han-phd-on-early-stage-diagnosis-and-the-affordable-care-act-an-epidemiologic-study/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/lee-s-schwartzberg-md-2017-update-on-iclio-adopting-immunotherapy-in-the-community-setting/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/bruce-e-johnson-md-and-julie-vose-md-mba-a-conversation-with-asco-s-2017-2018-president/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/clifford-a-hudis-md-and-julie-vose-md-mba-a-conversation-with-asco-s-ceo/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/julie-vose-md-mba-on-dlbcl-and-fl-expert-commentary-on-two-studies/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/dean-f-bajorin-md-and-peter-h-o-donnell-md-on-urothelial-cancer-results-from-two-keynote-trials/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/david-i-quinn-mbbs-phd-on-urothelial-cancer-results-from-keynote-045/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/primo-lara-md-on-rcc-expert-perspective-on-three-key-papers/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/matthew-d-hellmann-md-on-sclc-results-from-checkmate-032/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/taofeek-k-owonikoko-md-phd-on-sclc-results-of-the-ecog-acrin-2511-trial/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/gunter-von-minckwitz-md-on-her2plus-breast-cancer-results-from-the-aphinity-trial/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/elizabeth-j-shpall-md-and-nina-shah-md-mentor-and-mentee-a-conversation/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/solange-peters-md-phd-on-sclc-expert-perspective-on-checkmate-032/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/solange-peters-md-phd-and-mary-gospodarowicz-md-on-mentoring-women-in-oncology-an-international-perspective/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/toni-k-choueiri-md-and-sumanta-k-pal-md-on-top-kidney-cancer-abstracts-expert-perspectives/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/lisa-a-carey-md-and-mark-e-robson-md-on-her2-negative-breast-cancer-results-from-the-olympiad-trial/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/neeraj-agarwal-md-on-sumanta-k-pal-md-on-prostate-cancer-expert-perspectives-on-the-latitude-trial/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/tanya-b-dorff-md-and-sumanta-k-pal-md-on-prostate-cancer-expert-perspectives-on-stampede-and-a-phase-iv-trial/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/bernard-j-escudier-md-and-sumanta-k-pal-md-on-rcc-trial-results-on-sunitinib/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/eric-jonasch-md-on-von-hippel-lindau-disease-pazopanib-trial/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/daniel-heng-md-mph-and-sumanta-k-pal-md-on-renal-cell-carcinoma-expert-perspectives/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/david-h-henry-md-and-ruben-a-mesa-md-on-myelofibrosis-trial-results-from-a-best-of-asco-abstract/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/lisa-a-carey-md-and-nadia-harbeck-md-phd-on-early-her2-negative-breast-cancer-results-of-the-planb-trial/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/john-marshall-md-and-john-neil-primrose-phd-mbbs-on-biliary-tract-cancer-results-from-the-bilcap-trial/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/alice-tsang-shaw-md-phd-and-tony-mok-md-on-nsclc-results-from-the-alex-and-archer-1050-trials/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/john-marshall-md-and-qian-shi-phd-on-colon-cancer-results-of-the-idea-trial/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/elizabeth-r-plimack-md-on-advanced-urothelial-cancer-expert-perspective/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/rakesh-chopra-md-on-global-health-care-expert-perspective/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/arnaud-scherpereel-md-phd-on-mesothelioma-results-from-the-ifct-1501-maps2-trial/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/arnaud-scherpereel-md-phd-on-mesothelioma-results-from-the-ifct-1501-maps2-trial-french-language-version/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/lisa-a-carey-md-and-richard-s-finn-md-on-breast-cancer-findings-from-the-paloma-1trio-18-trial/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/david-h-henry-md-on-advances-in-lung-cancer-colorectal-cancer-expert-perspective/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2017-asco-annual-meeting/greta-stifel-on-neuroendocrine-tumors-a-patients-message-to-physicians/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2017-best-of-asco/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-debates-and-didactics-in-hematology-and-oncology-conference/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-esmo-congress/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-esmo-congress/mansoor-mirza-md-ovarian-cancer-treatment-and-quality-of-life/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-esmo-congress/sibylle-loibl-md-phd-on-metastatic-breast-cancer-expert-perspective-on-cdk4-inhibitors/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-esmo-congress/david-a-tuveson-md-phd-on-progress-in-pancreatic-cancer-expert-perspective/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-esmo-congress/jaafar-bennouna-md-on-colorectal-cancer-clinical-trial-findings-on-targeted-treatments-and-chemotherapy/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2017-esmo-congress/robert-i-haddad-md-on-head-and-neck-cancer-results-of-the-checkmate-141-trial/ 2021-11-18T21:30:33+00:00 https://ascopost.com/videos/2017-esmo-congress/manuel-hidalgo-md-phd-on-biliary-tract-cancer-results-from-the-prodigy-12-accord-18-trial/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-esmo-congress/marleen-kok-md-phd-on-triple-negative-breast-cancer-results-from-the-tonic-trial/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-esmo-congress/caroline-robert-md-phd-on-melanoma-treatment-with-nivolumab-and-ipilimumab/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-esmo-congress/simone-koole-md-on-ovarian-cancer-results-of-the-ovhipec-trial/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2017-esmo-congress/sandro-pignata-md-phd-on-ovarian-and-related-gynecologic-cancers-expert-perspective-on-three-key-trials/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2017-esmo-congress/andrew-r-clamp-phd-on-gynecologic-cancers-results-of-the-icon8-trial/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-esmo-congress/karl-d-lewis-md-on-melanoma-results-from-the-brim8-trial/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2017-esmo-congress/bernard-j-escudier-md-on-rcc-results-from-the-checkmate-214-trial/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2017-esmo-congress/robert-a-figlin-md-on-rcc-results-from-the-adapt-trial/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2017-esmo-congress/domenica-lorusso-md-phd-on-cervical-cancer-results-from-a-trial-on-treatment-regimens/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2017-esmo-congress/cora-n-sternberg-md-on-prostate-cancer-treatment-findings-expert-perspective/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2017-esmo-congress/bernard-j-escudier-md-on-rcc-expert-perspective-on-key-papers/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2017-esmo-congress/jeffrey-s-weber-md-phd-on-melanoma-results-of-the-checkmate-238-trial/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-esmo-congress/michèle-beau-faller-md-phd-on-nsclc-biomarker-findings-from-the-french-cooperative-thoracic-intergroup/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-esmo-congress/eric-pujade-lauraine-md-phd-on-ovarian-cancer-results-from-the-solo2-trial/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2017-esmo-congress/luis-g-paz-ares-md-phd-on-nsclc-results-of-the-pacific-trial/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2017-esmo-congress/toni-k-choueiri-md-on-rcc-results-from-the-cabosun-trial/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-esmo-congress/judy-e-garber-md-mph-on-triple-negative-breast-cancer-an-update/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-esmo-congress/bonnie-s-glisson-md-on-hpv-16plus-cancer-study-results/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/james-e-bates-md-on-pediatric-cancer-survivors-new-findings-on-late-effects/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/juanita-crook-md-on-prostate-cancer-results-from-an-nrgrtog-brachytherapy-trial/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/marcus-e-randall-md-on-endometrial-cancer-results-from-a-gynecology-oncology-group-study/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/jeffrey-d-bradley-md-on-nsclc-results-of-the-rtog-0617-trial/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/maria-werner-wasik-md-on-lung-cancer-highlights-expert-perspective/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/tamim-niazi-mdcm-on-prostate-cancer-results-from-a-trial-on-dose-escalation/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/shulian-wang-md-and-benjamin-movsas-md-on-breast-cancer-radiation-therapy-after-mastectomy/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/bhishamjit-s-chera-md-on-oropharyngeal-squamous-cell-carcinoma-and-hpv-16-expert-perspective/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/shrinivas-rathod-md-on-nsclc-quality-of-life-outcomes-from-an-iaea-trial/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/gerard-morton-md-on-gu-highlights-expert-perspective/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/christopher-r-kelsey-md-on-dlbcl-study-results-on-consolidation-radiotherapy/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2017-astro-annual-meeting/william-a-hall-md-on-prostate-cancer-results-from-a-study-of-three-treatment-modalities/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/ruben-a-mesa-md-on-myeloproliferative-neoplasms-managing-pv-and-et/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/william-g-wierda-md-phd-on-cll-how-to-sequence-therapy/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/david-g-maloney-md-phd-on-all-new-therapeutic-agents/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/sharyn-l-kurtz-pa-c-mpas-ma-on-managing-lymphoma-survivors/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/ranjana-h-advani-md-on-hodgkin-lymphoma-new-management-options/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/jane-n-winter-md-on-follicular-lymphoma-treatment-updates/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-nccn-hematologic-malignancies-congress/bruno-c-medeiros-md-on-aml-targeted-treatment/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/iaslc-18th-world-conference-on-lung-cancer/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/9th-world-congress-of-melanoma/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/eric-roeland-md-on-symptom-management-expert-perspective/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/charles-f-von-gunten-md-phd-on-palliative-care-in-oncology-a-fellows-curriculum/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/thomas-j-smith-md-on-palliative-care-and-outpatient-treatment-expert-perspective/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/jacob-j-strand-md-on-dealing-with-opioid-use-disorders/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/michael-hoerger-phd-on-early-palliative-care-study-results/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/anthony-l-back-md-on-physician-burnout-the-response-that-s-needed/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/jamie-jacobs-phd-on-early-integrated-palliative-care-the-positive-effects/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/sandip-patel-md-on-immunotherapy-new-developments-and-toxicity-challenges/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/areej-el-jawahri-md-on-a-revolutionary-plan-for-end-of-life-care/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/abby-r-rosenberg-md-on-promoting-resilience-in-young-cancer-patients-results-from-the-prism-trial/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/jeremy-hirst-md-on-my-patient-needs-opiates-and-benzodiazepines-what-should-i-do/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2017-palliative-care-in-oncology-symposium/jenske-geerling-np-on-painful-bone-metastases-study-results-on-nurse-led-pain-education/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/esmo-asia-2017-congress/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-lynn-sage-breast-cancer-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/keynote-lecture-silvia-c-formenti-md-on-converting-tumors-into-in-situ-vaccines-with-radiation-therapy/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/sabcs-40th-anniversary-award-lecture-richard-pazdur-md-on-cancer-drug-development/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/wolfgang-janni-md-phd-on-early-breast-cancer-and-bisphosphonate-treatment-results-from-the-success-a-trial/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/debu-tripathy-md-on-hrplus-her2-breast-cancer-results-from-the-monaleesa-7-trial/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/louis-fehrenbacher-md-on-invasive-breast-cancer-results-from-the-nsabp-b-47-trial/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/richard-g-gray-msc-on-adjusting-adjuvant-chemotherapy-dosing-results-from-an-ebctcg-analysis/ 2019-03-11T15:58:10+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/elizabeth-a-mittendorf-md-phd-on-immunotherapy-in-breast-cancer-expert-perspective-1/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/matteo-lambertini-md-on-preserving-fertility-in-patients-with-early-breast-cancer-pooled-analysis/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/sherene-loi-md-phd-and-roberto-salgado-md-phd-on-her2plus-metastatic-breast-cancer-results-from-the-panaceakeynote-014-trial/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/lee-s-schwartzberg-md-on-hrplus-breast-cancer-treatment-trial-results/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/vered-stearns-md-and-prudence-a-francis-md-on-erplus-breast-cancer-controversies-in-adjuvant-treatment/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/michael-gnant-md-on-duration-of-anastrozole-treatment-results-of-the-abcsg-16-trial/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/lisa-a-carey-md-on-locally-recurrent-or-metastatic-breast-cancer-results-of-a-calgbncctg-trial/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/melinda-telli-md-on-triple-negative-breast-cancer-new-clinical-approaches/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/harold-j-burstein-md-phd-on-hrplus-early-breast-cancer-update-of-the-soft-trial/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/lynn-j-howie-md-on-erplus-metastatic-breast-cancer-an-fda-treatment-analysis/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/eun-sil-shelley-hwang-md-on-dcis-results-of-the-calgb-40903-trial/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/joseph-a-sparano-md-on-stage-ii-iii-breast-cancer-and-ctcs/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/nicholas-c-turner-md-phd-on-tackling-breast-cancer-diversity/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/rowan-t-chlebowski-md-phd-on-weight-loss-and-breast-cancer-risk-results-from-the-women-s-health-initiative/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/sibylle-loibl-md-phd-on-metastatic-breast-cancer-the-padma-trial/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2017-san-antonio-breast-cancer-symposium/eric-s-winer-md-on-metastatic-breast-cancer-debate-on-a-research-tool/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/tanaya-shree-md-phd-on-dlbcl-survivors-long-term-effects/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/carla-casulo-md-on-follicular-lymphoma-results-from-the-flash-study/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/nitin-jain-md-on-cll-results-from-a-venetoclaxibrutinib-trial/ 2019-03-11T15:58:03+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/jia-ruan-md-on-mantle-cell-lymphoma-study-results-on-lenalidomide-and-rituximab/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/alok-a-khorana-md-on-the-costs-of-vte-in-cancer-patients-expert-perspective/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/michael-unterhalt-md-on-mantle-cell-lymphoma-long-term-follow-up-results/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/andrew-d-zelenetz-md-phd-and-stephen-j-schuster-md-on-dlbcl-results-of-the-juliet-trial/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/andrew-d-zelenetz-md-phd-and-sattva-s-neelapu-md-on-nhl-results-from-the-zuma-1-trial/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/laurie-h-sehn-md-mph-on-dlbcl-radiation-therapy-findings/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/tycel-j-phillips-md-on-intravascular-dlbcl-study-of-patient-features-and-outcomes/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/andrew-m-evens-do-on-gray-zone-lymphoma-results-from-a-multicenter-study/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/jakub-svoboda-md-on-primary-mediastinal-large-b-cell-diffuse-large-b-cell-and-gray-zone-lymphomas-early-phase-treatment-findings/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/mark-j-roschewski-md-on-burkitt-lymphoma-clinical-trial-results-on-da-epoch-r/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/gilles-a-salles-md-phd-on-follicular-lymphoma-long-term-results-from-the-prima-trial/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/joseph-m-connors-md-on-untreated-hodgkin-lymphoma-results-from-the-echelon-1-trial/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/john-f-seymour-mbbs-phd-on-cll-results-from-the-murano-study/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/maria-victoria-mateos-md-phd-on-multiple-myeloma-results-from-the-alcyone-trial/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2017-ash-annual-meeting/brian-t-hill-md-phd-on-mantle-cell-lymphoma-in-younger-patients-improvement-in-overall-survival/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/ghassan-k-abou-alfa-md-on-hcc-results-from-the-celestial-trial/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/khaldoun-almhanna-md-mph-on-gastric-cancer-results-from-the-ccog-1102-trial/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/kyaw-l-aung-mbbs-phd-on-pancreatic-cancer-results-from-the-compass-trial/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/basem-azab-md-on-esophageal-cancer-study-survival-results/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/david-h-ilson-md-phd-on-improving-esophageal-cancer-outcomes-future-directions/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/steven-d-leach-md-on-pancreatic-cancer-keynote-lecture/ 2019-03-11T15:58:08+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/florian-lordick-md-on-gastric-cancer-final-results-from-the-aio-trial/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/manish-a-shah-md-on-gastric-cancer-results-from-the-rainfall-trial/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/pieter-van-der-sluis-md-phd-on-esophageal-cancer-results-from-a-surgical-treatment-trial/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/maria-svensson-md-phd-candidate-on-esophageal-and-gastric-cancers-significance-of-pd-1-and-pd-l1-expression/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/abraham-j-wu-md-on-esophageal-cancer-impact-of-lung-and-heart-dose-on-survival-after-radiotherapy/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/thierry-andré-md-and-michael-j-overman-md-on-colorectal-cancer-results-from-two-checkmate-142-trials/ 2019-03-11T15:58:21+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/andrew-x-zhu-md-phd-on-hcc-results-from-keynote-224/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/mark-saunders-md-phd-on-colorectal-cancer-results-from-the-scot-trial/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/2018-gastrointestinal-cancers-symposium/ramesh-k-ramanathan-md-on-metastatic-pancreatic-cancer-results-from-a-swog-study/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/stephen-m-ansell-md-phd-on-hematologic-malignancies-immunotherapy-update/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/joaquim-bellmunt-md-phd-on-bladder-cancer-the-future-of-immunotherapies/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/mary-l-disis-md-on-basics-of-immunology-an-overview/ 2019-03-11T15:58:01+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/kristen-fousek-phd-candidate-on-b-cell-all-car-t-cell-treatment/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/aaron-goodman-md-on-immune-checkpoint-blockade-clinical-implications/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/james-l-gulley-md-phd-on-prostate-cancer-expanding-immunotherapy-options/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/roy-s-herbst-md-phd-on-personalized-immunotherapy-for-lung-cancer-expert-perspective/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/jeffrey-m-lemons-md-on-solid-tumors-safety-data-on-sbrt-and-immunotherapy/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/linda-mileshkin-mbbs-on-solid-tumors-early-treatment-study-results/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/sumanta-k-pal-md-on-renal-cancer-immunotherapy-latest-developments/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2018-asco-sitc-clinical-immuno-oncology-symposium/ann-w-silk-md-and-katy-k-tsai-md-meeting-highlights/ 2019-03-11T15:58:19+00:00 https://ascopost.com/videos/obesity-and-cancer-mechanisms-underlying-etiology-and-outcomes/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/laurence-albiges-md-phd-on-rcc-results-from-the-nivoren-getug-afu-26-trial/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/joaquim-bellmunt-md-phd-on-urothelial-cancer-results-from-the-keynote-045-trial/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/robert-g-bristow-md-phd-on-prostate-cancer-keynote-lecture/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/john-j-coen-md-on-bladder-cancer-results-from-the-nrgrtog-0712-trial/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/thomas-powles-md-on-urothelial-carcinoma-results-from-the-imvigor211-trial/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/daniel-j-george-md-on-rcc-results-from-the-alliance-a031203-cabosun-trial/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/jeffrey-m-holzbeierlein-md-on-penile-urethral-and-testicular-cancers-abstract-roundup/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/maha-hussain-md-on-prostate-cancer-results-from-the-prosper-trial/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/nicholas-d-james-mbbs-phd-on-prostate-cancer-results-from-the-stampede-trial/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/fatima-karzai-md-on-prostate-cancer-treatment-study-results/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/paul-l-nguyen-md-on-prostate-cancer-abstract-roundup/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/sumanta-k-pal-md-on-rcc-results-from-two-clinical-trials/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/jonathan-e-rosenberg-md-on-urothelial-carcinoma-results-from-the-checkmate-032-trial/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/eric-j-small-md-on-prostate-cancer-results-from-the-spartan-trial/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/patrick-schoeffski-md-mph-on-rcc-final-results-of-the-eortc-90101-create-trial/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/gregory-r-pond-phd-on-urothelial-cancer-advance-in-prognosis/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2018-genitourinary-cancers-symposium/daniel-j-george-md-on-rcc-study-results-on-adjuvant-treatment/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/christopher-j-recklitis-phd-mph-on-mental-health-in-cancer-survivors/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/lynda-m-beaupin-md-on-adhering-to-follow-up-care-an-analysis/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/genevieve-chaput-md-on-teaching-primary-care-providers-about-survivorship/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/patricia-a-ganz-md-on-progress-in-cancer-survivorship-care/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/carrie-r-howell-phd-on-reducing-risks-for-childhood-cancer-survivors-trial-results/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/arti-hurria-md-on-survivorship-care-for-the-aging-population/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/paul-b-jacobsen-phd-on-the-impact-of-survivorship-care-plans-expert-perspective/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/electra-d-paskett-phd-on-breast-cancer-and-arm-mobility-clinical-trial-results/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/christopher-j-recklitis-phd-mph-on-sexual-aids-and-supportive-care-study-findings/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/lawrence-n-shulman-md-on-the-new-survivorship-standard-expert-perspective/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/flora-e-van-leeuwen-phd-on-hodgkin-lymphoma-treatment-toxicities-in-female-survivors/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2018-cancer-survivorship-symposium-advancing-care-and-research/david-baraghoshi-on-colorectal-cancer-and-cardiovascular-disease-risk/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/tat-2018-targeted-anticancer-therapies/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/european-association-of-urology-conference/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/71st-sso-annual-cancer-symposium/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/2018-sgo-annual-meeting-on-women-s-cancer/ 2021-05-19T18:09:47+00:00 https://ascopost.com/videos/11th-european-breast-cancer-conference/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/ellin-berman-md-on-cml-disease-management-during-pregnancy/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/alan-p-venook-md-on-selecting-treatment-for-advanced-colorectal-cancer/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/james-l-mohler-md-on-prostate-cancer-management-approaches/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/april-ks-salama-md-on-melanoma-treating-recurrent-or-progressive-distant-disease/ 2019-03-11T15:58:05+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/lee-n-newcomer-md-on-managed-care-in-america-expert-perspective/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/william-j-gradishar-md-on-hormone-sensitive-breast-cancer-treatment-update/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/anthony-d-elias-md-on-triple-negative-breast-cancer-treatment-update/ 2019-03-11T15:58:12+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/anne-m-covey-md-on-hcc-screening-and-diagnosis-updates/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/nccn-2018-annual-conference/bijal-d-shah-md-on-what-all-tells-us-about-car-t-cells/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/elcc-2018-european-lung-cancer-congress/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/estro-37/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/nancy-goodman-federal-government-cancer-policy-2/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/richard-schilsky-federal-government-cancer-policy/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/abe-lopman-the-business-of-cancer/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/ed-benz-the-business-of-cancer/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/randall-oyer-md-on-the-business-of-cancer/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/lee-newcomer-the-business-of-cancer/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/barbara-mcaneny-business-of-cancer/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/otis-brawley-cancer-health-justice-disparities/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/blase-polite-cancer-health-justice-disparities/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/deborah-schrag-cancer-health-justice-disparities/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/levi-garraway-drug-development-cost/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/jeffrey-schwartz-drug-development-cost/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/amy-kapczynski-drug-development-cost/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/peter-bach-drug-development-cost/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/roy-herbst-legal-policy-cutting-edge/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/charles-sawyers-legal-policy-cutting-edge/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/siddhartha-mukherjee-keynote-address/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/the-policy-politics-law-of-cancer/norman-sharpless-keynote-address/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/aacr-annual-meeting-2018/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/asbrs-2018/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/aua-2018/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/23rd-congress-of-eha/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/julie-vose-on-novel-pathways-for-targeted-agents/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/andrew-zelenetz-on-clinical-applications-of-genomic-studies/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/sagar-lonial-on-sequencing-multiple-myeloma-therapies/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/stephen-ansell-on-checkpoint-inhibitors-in-hodgkin-lymphoma/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/r-gregory-bociek-on-ethical-considerations-of-cancer-treatment/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/kieron-dunleavy-on-b-cell-malignancy-combinations/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/john-gribben-on-the-tumor-microenvironment/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/steven-m-horwitz-on-ptcl-subtypes/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/susan-obrien-on-sequencing-therapy-options-in-cll/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/laurie-sehn-on-hgbcl-with-comorbidities/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/philip-bierman-on-cns-involvement-and-systemic-disease/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/susan-blumel-and-laura-zitella-on-managing-toxicities-of-immunotherapy/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/bruce-cheson-and-richard-fisher-on-lymphoma-treatment-considerations/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/jonathan-friedberg-md-on-novel-combination-therapies-in-follicular-lymphoma/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/julie-vose-and-david-maloney-on-update-on-nhl-car-t-cell-therapies/ 2019-03-11T15:58:25+00:00 https://ascopost.com/videos/pan-pacific-lymphoma-conference-2018/peggy-burhenn-on-managing-older-adults-with-lymphoma/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/nccn-2018-annual-congress-hematologic-malignancies/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/nccn-2018-annual-congress-hematologic-malignancies/natalie-callander-on-newly-diagnosed-myeloma/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/nccn-2018-annual-congress-hematologic-malignancies/reem-karmali-on-lymphomas-and-car-tcell-therapy/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/nccn-2018-annual-congress-hematologic-malignancies/shaji-k-kumar-on-multiple-myeloma-treatment-update/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/nccn-2018-annual-congress-hematologic-malignancies/frederick-locke-on-major-milestones-in-car-tcell-therapy/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/nccn-2018-annual-congress-hematologic-malignancies/jerald-radich-on-chronic-phase-cml-optimizing-tki/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/neeraj-arora-on-patient-centered-care-in-clinical-practice/ 2019-03-11T15:57:57+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/douglas-blayney-on-quality-care/ 2019-03-11T15:57:59+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/fumiko-ladd-chino-on-opioid-associated-deaths-in-patients-with-cancer/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/aaron-lyss-on-getting-the-highest-value-quality-intervention/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/jay-shah-on-reducing-opioid-use-after-urologic-oncology-surgery/ 2019-03-11T15:58:06+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/simron-singh-on-measuring-patient-experience/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/angela-stover-on-the-star-and-pro-tect-trials/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/lauren-wallner-on-reducing-overtreatment-with-radioactive-iodine/ 2019-03-11T15:58:13+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/jeremy-warner-on-patient-navigation/ 2019-03-11T15:58:15+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/lalan-wilfong-on-limiting-low-value-care/ 2019-03-11T15:58:17+00:00 https://ascopost.com/videos/2018-asco-quality-care-symposium/monika-krzyzanowska-on-quality-improvement/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/cri-cimt-eati-aacr-immunotherapy-conference/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-world-cancer-congress/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/daniel-george-prostate-cancer-outcomes-for-black-and-white-patients/ 2019-03-11T15:57:58+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/susan-halabi-prostate-cancer-overall-survival-for-black-vs-white-men/ 2019-03-11T15:58:00+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/jed-katzel-head-and-neck-cancer-findings-on-treatment-of-female-patients/ 2019-03-11T15:58:02+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/supriya-mohile-communicating-with-older-cancer-patients/ 2019-03-11T15:58:04+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/meletios-dimopoulos-on-waldenstroms-macroglobulinemia/ 2019-03-11T15:58:07+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/robert-jotte-on-nsclc-results-from-the-impower131-trial/ 2019-03-11T15:58:09+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/robert-kreitman-hairy-cell-leukemia/ 2019-03-11T15:58:11+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/geoffrey-oxnard-the-circulating-cancer-genome-atlas-study/ 2019-03-11T15:58:14+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/gabriel-hortobagyi-on-breast-cancer-staging/ 2019-03-11T15:58:16+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/nancy-davidson-serendipity-and-purpose/ 2019-03-11T15:58:18+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/manisha-shah-on-thyroid-cancer-advances-in-precision-medicine/ 2019-03-11T15:58:20+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/gianni-bisogno-on-rhabdomyosarcoma/ 2019-03-11T15:58:22+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/gilberto-lopes-on-nsclc-results-from-the-keynote-042-trial/ 2019-03-11T15:58:23+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/arnaud-méjean-on-rcc-results-from-the-carmena-trial/ 2019-03-11T15:58:24+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/joseph-a-sparano-on-breast-cancer-results-of-the-tailorx-trial/ 2019-03-11T15:58:26+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/rita-elias-assi-on-aml-and-genomics/ 2019-03-11T15:58:27+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/ryan-nipp-on-electronic-symptom-monitoring/ 2019-03-11T15:58:28+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/peter-schmid-on-triple-negative-breast-cancer/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/laurence-albiges-and-toni-choueiri-on-metastatic-rcc-perspectives-on-the-carmena-trial/ 2019-03-11T15:58:29+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/laurence-albiges-and-toni-choueiri-on-novel-combinations-for-advanced-rcc/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/thaddeus-mason-pope-on-right-to-try/ 2019-03-11T15:58:30+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/nathan-hale-fowler-and-julie-vose-on-follicular-lymphoma-the-relevance-trial/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/william-wierda-and-julie-vose-on-cll-results-from-the-captivate-trial/ 2019-03-11T15:58:31+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/jeremy-abramson-on-results-from-the-transcend-nhl-001-trial/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/danh-pham-lung-cancer-screening-rates-still-too-low/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/lee-schwartzberg-on-using-immunotherapy-in-the-community-setting/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/apostolia-maria-tsimberidou-on-the-impact-study/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/sumanta-pal-and-neeraj-agarwal-on-talapro2-trial/ 2019-03-11T15:58:32+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/aviva-krauss-on-multiple-myeloma/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/sumanta-pal-and-a-oliver-sartor-on-prostate-cancer-outcomes/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/nathan-pennell-on-lowering-nsclc-genetic-testing-costs/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/david-mcdermott-on-results-of-the-keynote-427-trial/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/jun-mao-on-insomnia-in-cancer-survivors/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/peter-hillmen-on-cll-the-murano-trial/ 2019-03-11T15:58:33+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/sherry-shen-on-breast-cancer-and-obesity/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/tony-mok-on-results-from-the-archer-1050-trial/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/kathleen-moore-on-results-from-the-quadra-study/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/naoki-furuya-results-from-the-nej026-study/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/raymond-osarogiagbon-on-nsclc-lymph-node-collection-kit/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/helena-margaret-earl-on-results-from-the-persephone-trial/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/danny-rischin-on-squamous-cell-carcinoma/ 2019-03-11T15:58:34+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/geertjan-van-tienhoven-on-the-preopanc1-trial/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/emily-ruiz-on-squamous-cell-carcinoma/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/david-omalley-on-ovarian-cancer-the-forward-ii-study/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/pirkko-liisa-irmeli-kellokumpu-lehtinen-on-the-spcg13-trial/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/paolo-ascierto-on-the-columbus-trial/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/rebecca-dent-on-tnbc-results-from-the-lotus-trial/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/courtney-denton-dinardo-on-aml-treatment-study-results/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/laurie-sehn-on-follicular-lymphoma-and-dlbcl/ 2019-03-11T15:58:35+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/ursula-matulonis-and-stéphanie-gaillard-on-ovarian-cancer/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/ursula-matulonis-daniel-margul-on-cervical-cancer-and-minimally-invasive-surgery/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/michael-overman-and-françois-quenet-on-the-prodige-7-trial/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/bernard-escudier-on-the-immotion151-trial/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/thierry-conroy-on-the-prodige-24-trial/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/toni-choueiri-and-lauren-harshman-on-the-prosper-trial/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/toni-choueiri-and-jonathan-rosenberg-bladder-cancer-roundup/ 2019-03-11T15:58:36+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/sibylle-loibl-on-results-from-the-geparnuevo-trial/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/bruce-johnson-and-monica-bertagnolli-on-the-asco-presidency/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/elizabeth-mittendorf-and-lisa-carey-on-tailorx/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/martee-hensley-on-leiomyosarcoma/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/michael-gnant-on-the-abcsg-18-trial/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/howard-hochster-on-the-e7208-trial/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/robert-coleman-on-ovarian-cancer/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/juliet-elizabeth-wolford-on-ovarian-cancer-the-cost-of-care/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/toni-choueiri-and-elizabeth-plimack-on-keynote-427-and-immotion151/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/andrew-seidman-and-aditya-bardia-on-an-antibody-drug-conjugate/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/andrew-seidman-and-susan-dent-on-the-sandpiper-trial/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/2018-asco-annual-meeting/andrew-seidman-and-meredith-regan-on-the-text-and-soft-trials/ 2019-03-11T15:58:37+00:00 https://ascopost.com/videos/iaslc-19th-world-conference-on-lung-cancer/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-lynn-sage-breast-cancer-symposium/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-jadpro-live/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-sitc-annual-meeting/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-annual-chemotherapy-foundation-symposium/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/rsna-2018/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2018-quantitative-imaging-workshop-xv/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/34th-annual-eau-congress/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/world-congress-on-advanced-treatments-and-technologies-in-skin-cancer-2019/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2019-society-of-surgical-oncology-annual-cancer-symposium/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2019-best-of-asco/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/soho-2019/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/12th-aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/american-chemical-society-fall-2019-national-meeting-exposition/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/updates-in-the-management-of-head-and-neck-cancer-symposium/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/the-liver-meeting/ 2021-05-19T18:09:48+00:00 https://ascopost.com/videos/2019-jadpro-live/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/2019-annual-oncofertility-conference/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/society-for-integrative-oncologys-16th-international-conference/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/2019-nccn-patient-advocacy-summit/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/sts-56th-annual-meeting/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/molecular-analysis-for-precision-oncology-map-congress-2020/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/nccn-2020-virtual-congress-hematologic-malignancies/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/acg-2020-annual-scientific-meeting/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/2020-chemotherapy-foundation-symposium/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/2020-annual-meeting-of-the-society-for-immunotherapy-of-cancer/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/iaslc-2020-north-america-conference-on-lung-cancer/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/special-messages/ 2021-05-19T18:09:49+00:00 https://ascopost.com/videos/special-messages/julie-gralow-on-goals-as-asco-cmo/ 2021-01-25T19:12:40+00:00 https://ascopost.com/videos/special-messages/karen-knudsen-the-american-cancer-society-s-first-female-ceo-speaks-out/ 2021-05-05T19:13:00+00:00 https://ascopost.com/videos/special-messages/john-marshall-and-liza-marshall-when-cancer-strikes-an-oncologist-s-family/ 2021-05-11T19:14:12+00:00 https://ascopost.com/videos/special-messages/s-vincent-rajkumar-on-multiple-myeloma-defining-cure/ 2021-08-12T17:00:49+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/ 2021-06-25T16:15:08+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/efstathios-kastritis-on-amyloidosis-standard-of-care-plus-daratumumab/ 2021-06-25T16:15:08+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/keith-pratz-on-aml-venetoclax-azacitidine-and-disease-response/ 2021-06-25T16:15:10+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/arnon-kater-on-cll-fixed-duration-ibrutinib-and-venetoclax-vs-chlorambucil-plus-obinutuzumab/ 2021-06-25T16:15:11+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/gaurav-goyal-on-dlbcl-comparing-r-chop-and-r-epoch-for-overall-survival-benefits/ 2021-06-25T16:15:12+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/martin-kaiser-on-myeloma-and-plasma-cell-leukemia-transplantation-plus-daratumumabcvrd-therapy/ 2021-06-25T16:15:13+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/philippe-moreau-on-newly-diagnosed-multiple-myeloma-daratumumab-maintenance-vs-observation/ 2021-06-25T16:15:14+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/martin-hutchings-on-hodgkin-lymphoma-brentuximab-vedotin-with-chemotherapy/ 2021-06-25T16:15:15+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/claire-harrison-on-myelofibrosis-fedratinib-as-first-line-therapy-after-prior-ruxolitinib/ 2021-06-25T16:15:16+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/ruben-mesa-on-myelofibrosis-transfusion-independence-and-momelotinib/ 2021-06-25T16:15:17+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/cristina-gasparetto-on-multiple-myeloma-selinexor-carfilzomib-and-dexamethasone-in-carfilzomib-nonrefractory-patients/ 2021-06-25T16:15:18+00:00 https://ascopost.com/videos/eha-2021-virtual-congress/martin-dreyling-on-follicular-lymphoma-safety-and-efficacy-of-tisagenlecleucel/ 2021-07-13T18:14:22+00:00 https://ascopost.com/videos/esmo-world-congress-on-gastrointestinal-cancer-2021/ 2021-07-08T16:29:06+00:00 https://ascopost.com/videos/nccn-virtual-oncology-policy-summit/ 2021-07-23T14:16:33+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/ 2021-08-11T15:01:08+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/peihua-peggy-lu-on-car-t-cell-therapy-research-in-china/ 2021-08-11T15:03:44+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/david-kroll-on-recognizing-and-treating-depression-and-anxiety-in-patients-with-lymphoma/ 2021-08-11T15:06:19+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/jared-matya-on-supportive-therapies-for-side-effects-related-to-novel-oral-treatments/ 2021-08-11T15:10:19+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/andrew-zelenetz-on-mrd-testing-in-the-management-of-non-hodgkin-lymphoma/ 2021-08-12T18:24:33+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/jonathan-friedberg-on-managing-indolent-nhl-with-oral-therapies/ 2021-08-12T18:27:08+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/alexey-danilov-on-lymphoid-malignancies-novel-agents-targeting-btk-inhibitor-resistant-disease/ 2021-08-16T17:58:37+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/alison-moskowitz-on-abvd-in-hodgkin-lymphoma-adding-brentuximab-vedotin-and-checkpoint-inhibitors-to-standard-treatment/ 2021-08-16T20:54:32+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/bruce-cheson-and-stephen-ansell-on-non-hodgkin-and-follicular-lymphomas-integrating-non-car-t-based-treatments/ 2021-08-18T18:46:43+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/sonali-smith-can-cns-prophylaxis-prevent-secondary-high-grade-b-cell-lymphomas/ 2021-08-16T21:08:45+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/james-armitage-on-advanced-hodgkin-lymphoma-choosing-among-beacopp-a-avd-and-checkpoint-inhibitors/ 2021-08-18T13:14:17+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/steven-horwitz-on-advanced-stage-mycosis-fungoides-and-sezary-syndrome/ 2021-08-20T16:06:13+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/nina-shah-on-newly-diagnosed-multiple-myeloma-novel-combination-therapies/ 2021-08-16T21:27:22+00:00 https://ascopost.com/videos/2021-pan-pacific-lymphoma-conference/muhamed-baljevic-on-multiple-myeloma-review-of-novel-management-strategies/ 2021-08-30T19:26:33+00:00 https://ascopost.com/videos/2021-masccisoo-annual-meeting/ 2021-08-20T15:08:54+00:00 https://ascopost.com/videos/2021-debates-and-didactics-in-hematology-and-oncology/ 2021-08-20T16:36:49+00:00 https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/ 2021-09-09T15:13:01+00:00 https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/matthew-smeltzer-on-international-lung-cancer-clinical-trials-the-impact-of-covid-19/ 2021-09-09T17:21:06+00:00 https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/alex-adjei-on-disparities-in-lung-cancer-care-the-global-burden/ 2021-09-09T18:00:46+00:00 https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/christine-berg-on-lung-cancer-deaths-attributable-to-air-pollution/ 2021-09-10T21:01:54+00:00 https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/jamie-studts-on-the-stigma-of-lung-cancer/ 2021-09-14T18:21:50+00:00 https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/prasad-adusumilli-on-car-t-cell-therapy-for-mesothelioma/ 2021-09-14T18:27:22+00:00 https://ascopost.com/videos/iaslc-2021-world-conference-on-lung-cancer/nasser-altorki-on-nsclc-adjuvant-atezolizumab-for-stage-ib-iiia-disease/ 2021-10-22T19:30:35+00:00 https://ascopost.com/videos/aua-2021/ 2021-09-13T14:57:25+00:00 https://ascopost.com/videos/soho-2021/ 2021-09-15T17:53:58+00:00 https://ascopost.com/videos/soho-2021/curtis-lachowiez-on-aml-venetoclax-combined-with-flag-ida/ 2021-09-15T17:57:03+00:00 https://ascopost.com/videos/soho-2021/saad-usmani-on-multiple-myeloma-updated-results-from-the-cartitude-1-study-of-ciltacabtagene-autoleucel/ 2021-09-23T18:40:30+00:00 https://ascopost.com/videos/soho-2021/kieron-dunleavy-update-on-primary-mediastinal-b-cell-lymphoma/ 2021-09-30T18:10:21+00:00 https://ascopost.com/videos/soho-2021/luis-aguirre-on-chronic-myelomonocytic-leukemia-keys-to-assessment-and-treatment/ 2021-09-30T18:21:54+00:00 https://ascopost.com/videos/esmo-congress-2021/ 2021-09-17T20:20:14+00:00 https://ascopost.com/videos/esmo-congress-2021/helena-earl-on-her2-positive-early-breast-cancer-a-meta-analysis-of-trastuzumab-trials/ 2021-09-17T21:14:19+00:00 https://ascopost.com/videos/esmo-congress-2021/nicoletta-colombo-md-on-cervical-cancer-keynote-826-trial-of-pembrolizumab-plus-chemotherapy/ 2021-09-19T15:05:20+00:00 https://ascopost.com/videos/esmo-congress-2021/javier-cortes-on-her2-positive-breast-cancer-trastuzumab-deruxtecan-vs-trastuzumab-emtansine/ 2021-09-19T15:09:31+00:00 https://ascopost.com/videos/esmo-congress-2021/jason-luke-on-melanoma-keynote-716-trial-of-pembrolizumab-vs-placebo/ 2021-09-19T15:39:50+00:00 https://ascopost.com/videos/esmo-congress-2021/gabriel-hortobagyi-on-advanced-breast-cancer-treated-with-endocrine-therapy-and-ribociclib/ 2021-09-20T18:01:24+00:00 https://ascopost.com/videos/esmo-congress-2021/toni-choueiri-on-renal-cell-carcinoma-quality-of-life-data-from-keynote-564-on-pembrolizumab-vs-placebo/ 2021-09-20T18:06:27+00:00 https://ascopost.com/videos/esmo-congress-2021/naveen-vasudev-on-rcc-changing-the-dosing-schedule-of-ipilimumab-plus-nivolumab/ 2021-09-21T19:26:06+00:00 https://ascopost.com/videos/esmo-congress-2021/gerhardt-attard-on-prostate-cancer-abiraterone-and-prednisolone-in-the-stampede-protocol/ 2021-09-21T19:33:02+00:00 https://ascopost.com/videos/esmo-congress-2021/karim-fizazi-on-prostate-cancer-newly-reported-survival-rates-with-abiraterone-docetaxel-and-prednisone/ 2021-09-22T18:38:24+00:00 https://ascopost.com/videos/esmo-congress-2021/benjamin-besse-on-nsclc-a-vaccine-under-study-to-treat-advanced-disease/ 2021-09-22T18:41:13+00:00 https://ascopost.com/videos/esmo-congress-2021/robin-cornelissen-on-her2-exon-20-mutated-nsclc-poziotinib-in-treatment-naive-disease/ 2021-09-23T18:37:17+00:00 https://ascopost.com/videos/esmo-congress-2021/jenny-seligmann-on-colorectal-cancer-adavosertib-compared-with-active-monitoring/ 2021-10-04T16:51:09+00:00 https://ascopost.com/videos/esmo-congress-2021/jonathan-lim-the-future-of-the-oncology-workforce-since-the-covid-19-pandemic/ 2021-10-13T18:17:28+00:00 https://ascopost.com/videos/esmo-congress-2021/joseph-unger-on-the-impact-of-nci-sponsored-treatment-trials/ 2021-10-13T18:20:10+00:00 https://ascopost.com/videos/esmo-congress-2021/thomas-powles-on-urothelial-carcinoma-erdafitinib-cetrelimab-and-fgfr-alterations/ 2021-10-13T18:24:13+00:00 https://ascopost.com/videos/esmo-congress-2021/neeraj-agarwal-on-advanced-prostate-cancer-data-on-cabozantinib-plus-atezolizumab/ 2021-10-15T20:07:36+00:00 https://ascopost.com/videos/esmo-congress-2021/filippo-pietrantonio-and-federica-morano-on-colorectal-cancer-and-the-maya-trial-strategy-temozolomide-ipilimumab-and-nivolumab/ 2021-10-19T19:17:24+00:00 https://ascopost.com/videos/esmo-congress-2021/dieter-horsch-for-patients-with-bronchopulmonary-neuroendocrine-tumors-lanreotide-autogel-may-be-beneficial/ 2021-10-19T19:22:58+00:00 https://ascopost.com/videos/esmo-congress-2021/susana-banerjee-on-ovarian-fallopian-tube-or-primary-peritoneal-adenocarcinoma-treatment-findings-from-the-eortc-1508-trial/ 2021-10-19T19:36:56+00:00 https://ascopost.com/videos/esmo-congress-2021/susana-banerjee-on-ovarian-cancer-novel-combination-therapy-under-study/ 2021-10-19T19:42:24+00:00 https://ascopost.com/videos/esmo-congress-2021/hope-rugo-on-triple-negative-breast-cancer-treatment-findings-from-keynote-355-on-pembrolizumab-and-chemotherapy/ 2021-10-22T20:23:06+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/ 2021-09-20T17:14:32+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/tina-shih-on-trends-in-total-and-out-of-pocket-costs-of-cancer-care/ 2021-09-27T17:56:57+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/manali-patel-on-community-based-intervention-and-cancer-care-disparity/ 2021-09-27T18:03:26+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/leticia-nogueira-on-the-association-of-medicaid-expansion-and-early-mortality-following-lung-cancer-surgery/ 2021-09-29T16:12:05+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/sarah-mougalian-on-a-next-day-access-program-for-patients-with-cancer/ 2021-09-29T16:15:56+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/benjamin-corn-on-integrating-hope-into-clinical-oncology/ 2021-10-05T18:11:11+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/courtney-williams-on-cancer-survivors-working-together-to-improve-patient-adherence/ 2021-10-06T17:06:10+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/divya-parikh-on-improving-care-documentation-with-a-patient-conversation-guide/ 2021-10-07T18:48:13+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/divya-gupta-on-improving-advance-care-planning-conversations-with-patients/ 2021-10-08T19:16:15+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/john-cox-on-reshaping-practice-models-to-better-care-for-patients-with-cancer/ 2021-10-11T19:07:27+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/jenny-jing-xiang-on-improving-clinical-trial-recruitment-with-a-universal-prescreening-protocol/ 2021-10-22T20:28:34+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/aakash-desai-on-the-precision-oncology-promise/ 2021-10-22T20:33:29+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/katherine-reeder-hayes-on-geography-breast-cancer-treatment-and-racial-disparities/ 2021-10-22T20:38:57+00:00 https://ascopost.com/videos/2021-asco-quality-care-symposium/morgan-lichtenstein-on-insurance-plan-prior-authorization-and-time-to-receipt-of-oral-anticancer-drugs/ 2021-10-29T18:56:36+00:00 https://ascopost.com/videos/14th-aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2021-10-06T15:05:58+00:00 https://ascopost.com/videos/2021-society-for-integrative-oncology-sio-international-conference/ 2021-12-11T17:26:16+00:00 https://ascopost.com/videos/2021-winship-cancer-institute-of-emory-university-symposium-updates-in-the-management-of-head-and-neck-cancer/ 2021-12-11T17:26:17+00:00 https://ascopost.com/videos/aacr-nci-eortc-virtual-international-conference-on-molecular-targets-and-cancer-therapeutics/ 2021-12-11T17:26:17+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/ 2021-12-11T17:26:17+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/robert-olson-on-oligometastases-new-data-on-stereotactic-ablative-radiotherapy/ 2021-10-26T18:43:44+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/diana-shi-on-idh-mutant-gliomas-de-novo-pyrmidine-synthesis-inhibitor-under-study/ 2021-10-26T18:50:07+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/david-palma-on-hpv-associated-oropharyngeal-squamous-cell-carcinoma-radiotherapy-vs-surgery/ 2021-10-27T18:29:38+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/youssef-zeidan-on-her2-positive-breast-cancer-treatment-related-cardiotoxicity/ 2021-10-27T18:39:13+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/aadel-chaudhuri-on-personalizing-treatment-for-oligometastatic-cancer/ 2021-10-28T19:05:23+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/c-jillian-tsai-on-using-radiotherapy-to-thwart-tumor-growth-in-advanced-cancers/ 2021-11-02T14:51:43+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/daniel-ma-on-hpv-associated-oropharyngeal-squamous-cell-carcinoma-comparing-longer-and-shorter-courses-of-radiotherapy/ 2021-10-29T18:41:56+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/benjamin-movsas-on-prostate-cancer-patient-reported-outcomes-on-radiotherapy-and-androgen-suppression/ 2021-11-02T16:04:12+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/mark-buyyounouski-on-prostate-cancer-hypofractionated-vs-conventional-radiotherapy-after-surgery/ 2021-11-02T16:06:30+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/karen-winkfield-on-digital-health-to-improve-patient-outcomes-and-experience/ 2021-11-02T16:10:37+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/matthew-manning-on-resolving-racial-disparities-in-the-treatment-of-breast-and-lung-cancers/ 2021-11-02T16:14:28+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/amar-kishan-on-prostate-cancer-impact-of-androgen-deprivation-therapy-with-radiotherapy/ 2021-11-03T16:18:29+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/erin-murphy-on-low-grade-glioma-neurocognitive-function-following-treatment/ 2021-11-05T13:12:56+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/shauna-campbell-on-head-and-neck-cancer-toxicity-associated-with-hypofractionated-imrt/ 2021-11-08T20:02:35+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/daniel-hayes-on-liquid-biopsies-to-detect-and-monitor-oligometastases/ 2021-11-09T19:19:46+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/howard-sandler-on-prostate-cancer-highlights-an-expert-perspective/ 2021-11-09T23:23:30+00:00 https://ascopost.com/videos/2021-astro-annual-meeting/yongbae-kim-on-node-irradiation-in-women-with-node-positive-breast-cancer/ 2021-11-29T20:09:44+00:00 https://ascopost.com/videos/2021-lynn-sage-breast-cancer-symposium/ 2021-12-11T17:26:18+00:00 https://ascopost.com/videos/nccn-2021-virtual-congress-hematologic-malignancies/ 2021-12-11T17:26:18+00:00 https://ascopost.com/videos/nccn-2021-virtual-congress-hematologic-malignancies/alice-mims-on-aml-updates-on-managing-newly-diagnosed-disease/ 2021-11-09T23:30:03+00:00 https://ascopost.com/videos/nccn-2021-virtual-congress-hematologic-malignancies/jennifer-woyach-on-cll-sll-using-minimal-residual-disease-assessment-in-clinical-practice/ 2021-11-09T23:33:38+00:00 https://ascopost.com/videos/nccn-2021-virtual-congress-hematologic-malignancies/shaji-kumar-on-newly-diagnosed-multiple-myeloma-how-many-drugs-are-enough/ 2021-11-18T20:00:06+00:00 https://ascopost.com/videos/nccn-2021-virtual-congress-hematologic-malignancies/ronald-go-on-managing-histiocytic-neoplasms-new-nccn-guidelines/ 2021-11-19T17:57:24+00:00 https://ascopost.com/videos/sitc-2021/ 2021-12-11T17:26:18+00:00 https://ascopost.com/videos/sitc-2021/stephanie-schmidt-on-nsclc-the-immunomodulatory-impact-of-neoadjuvant-chemotherapy-and-immune-based-treatments/ 2021-11-29T19:22:28+00:00 https://ascopost.com/videos/sitc-2021/kim-reiss-on-her2-overexpressing-solid-tumors-first-in-human-study-of-anti-her2-car-macrophages/ 2021-11-30T19:40:07+00:00 https://ascopost.com/videos/sitc-2021/emily-keung-on-interactions-of-sarcoma-immune-infiltrates-and-checkpoint-blockade/ 2021-12-01T15:11:44+00:00 https://ascopost.com/videos/sitc-2021/yuki-muroyama-on-a-novel-marker-of-clinical-response-to-pd-1-blockade-under-study/ 2021-12-02T18:29:58+00:00 https://ascopost.com/videos/sitc-2021/hans-wildiers-on-metastatic-breast-cancer-comparing-addition-of-eftilagimod-alpha-vs-placebo-to-paclitaxel/ 2021-12-02T21:16:31+00:00 https://ascopost.com/videos/sitc-2021/hannah-dzimitrowicz-on-covid-19-vaccination-in-patients-with-cancer-receiving-immune-checkpoint-inhibitors/ 2021-12-02T21:19:31+00:00 https://ascopost.com/videos/sitc-2021/john-kirkwood-on-melanoma-early-study-results-on-vidutolimod-and-pembrolizumab/ 2021-12-03T17:48:46+00:00 https://ascopost.com/videos/sitc-2021/jeffrey-weber-on-coronavirus-cancer-and-immunotherapy-navigating-clinical-trials-and-treatment/ 2021-12-03T20:48:44+00:00 https://ascopost.com/videos/sitc-2021/sean-khozin-on-delivering-precision-cancer-care-in-the-era-of-digital-medicine/ 2021-12-03T20:40:49+00:00 https://ascopost.com/videos/sitc-2021/patrick-hwu-and-mary-dean-on-what-s-ahead-for-cancer-immunology-and-sitc/ 2022-01-04T19:38:59+00:00 https://ascopost.com/videos/sitc-2021/lynda-chin-on-the-landscape-and-future-of-digital-medicine/ 2022-01-13T16:47:16+00:00 https://ascopost.com/videos/sitc-2021/mehmet-altan-on-solid-tumors-interim-safety-and-efficacy-results-on-nktr-255-plus-cetuximab/ 2022-01-13T16:50:10+00:00 https://ascopost.com/videos/sitc-2021/yevgeniy-semenov-on-cutaneous-immune-related-adverse-events-and-response-to-immune-checkpoint-inhibitors/ 2022-01-18T18:43:58+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/ 2021-12-11T17:26:19+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/peter-schmid-on-early-stage-triple-negative-breast-cancer-neoadjuvant-treatment-with-pembrolizumab-and-chemotherapy/ 2021-12-08T19:28:21+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/kevin-kalinsky-on-hr-positive-her2-negative-breast-cancer-endocrine-therapy-and-chemotherapy/ 2021-12-09T20:24:52+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/javier-cortes-on-previously-untreated-triple-negative-breast-cancer-pembrolizumab-plus-chemotherapy/ 2022-02-18T20:38:58+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/francois-clement-bidard-on-metastatic-breast-cancer-endocrine-therapy-and-palbociclib/ 2021-12-09T22:00:14+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/michael-gnant-on-hr-positive-her2-negative-early-breast-cancer-trial-results-with-palbociclib-treatment/ 2021-12-09T22:09:52+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/komal-jhaveri-on-triple-negative-and-metastatic-breast-cancers-new-data-on-neratinib-fulvestrant-and-trastuzumab/ 2021-12-11T21:03:07+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/patricia-ganz-on-early-breast-cancer-olaparib-chemotherapy-and-quality-of-life/ 2021-12-11T21:09:29+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/charles-coombes-on-hormone-receptor-positive-her2-negative-breast-cancer-use-of-samuraciclib-plus-fulvestrant/ 2021-12-22T20:20:25+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/lisa-carey-on-hr-positive-and-her2-negative-advanced-breast-cancer-overall-survival-by-subtype-across-three-monaleesa-studies/ 2021-12-22T20:24:19+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/ann-partridge-on-sabcs-meeting-highlights-expert-perspective/ 2022-01-03T19:17:36+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/banu-arun-on-fine-tuning-risk-assessment-and-risk-reduction-in-breast-cancer/ 2022-01-05T19:10:05+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/elizabeth-mittendorf-on-making-strides-in-managing-triple-negative-breast-cancer/ 2022-01-12T19:35:10+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/meredith-regan-on-early-breast-cancer-updated-results-from-the-text-and-soft-trials/ 2022-01-12T19:39:24+00:00 https://ascopost.com/videos/2021-san-antonio-breast-cancer-symposium/sara-hurvitz-on-her2-positive-metastatic-breast-cancer-t-dxd-vs-t-dm1/ 2022-02-11T17:09:42+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/ 2021-12-11T17:33:01+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/paolo-ghia-on-cll-new-data-on-treatment-with-ibrutinib-plus-venetoclax/ 2021-12-11T19:01:43+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/l-elizabeth-budde-on-relapsedrefractory-follicular-lymphoma-early-results-on-mosunetuzumab-monotherapy/ 2021-12-12T18:13:24+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/daniel-ermann-on-dlbcl-outcomes-with-consolidative-radiation-therapy/ 2021-12-12T18:25:38+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/talha-bada-on-tp53-mutated-aml-and-the-impact-of-allogeneic-stem-cell-transplantation-on-survival/ 2021-12-14T19:14:13+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/tarek-mouhieddine-on-relapsedrefractory-multiple-myeloma-and-bispecific-antibodies/ 2021-12-14T19:19:28+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/masayuki-umeda-on-pediatric-aml-identifying-a-key-subtype-defining-lesion/ 2021-12-15T18:11:16+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/carsten-utoft-niemann-on-cll-time-limited-venetoclax-and-ibrutinib-for-patients-with-relapsed-or-refractory-disease/ 2021-12-15T18:25:22+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/michael-bishop-on-aggressive-b-cell-nhl-tisagenlecleucel-vs-standard-of-care-as-second-line-therapy/ 2021-12-16T17:22:33+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/roni-shouval-on-tp53-mutant-large-b-cell-lymphoma-and-car-t-cell-therapy/ 2021-12-16T20:00:50+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/eunice-wang-on-flt3-mutated-aml-gilteritinib-and-azacitidine-for-intensive-induction-chemotherapy-ineligible-patients/ 2021-12-17T20:29:16+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/leslie-kean-on-bone-marrow-transplantation-using-abatacept-to-prevent-graft-vs-host-disease/ 2021-12-21T21:12:50+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/alba-rodriguez-meira-on-tp53-mutated-leukemic-transformation-in-myeloproliferative-neoplasms/ 2021-12-20T20:15:58+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/andrew-matthews-on-aml-cpx-351-vs-venetoclaxazacitidine-for-initial-therapy/ 2021-12-23T19:42:01+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/sangeetha-venugopal-on-secondary-aml-impact-of-front-line-treatment-approach/ 2021-12-23T19:44:21+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/nikhil-munshi-on-covid-19-vaccine-effectiveness-in-patients-with-multiple-myeloma/ 2022-01-03T19:27:42+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/joe-schroers-martin-on-follicular-lymphoma-precursor-mutations-may-be-detectable-years-before-diagnosis/ 2022-01-04T19:26:33+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/manali-kamdar-on-large-b-cell-lymphoma-lisocabtagene-maraleucel-vs-the-standard-of-care/ 2022-01-10T18:49:22+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/musa-yilmaz-on-flt3-itd-mutated-aml-findings-on-quizartinib-with-decitabine-and-venetoclax/ 2022-01-10T18:58:20+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/anil-aktas-samur-on-identifying-low-risk-smoldering-multiple-myeloma/ 2022-01-11T16:48:57+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/romanos-sklavenitis-pistofidis-on-smoldering-myeloma-identifying-biomarkers-of-response-to-immunotherapy/ 2022-01-11T16:51:49+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/tycel-phillips-on-marginal-zone-lymphoma-efficacy-and-safety-of-parsaclisib/ 2022-01-17T18:12:17+00:00 https://ascopost.com/videos/2021-ash-annual-meeting-exposition/matthew-s-davids-md-on-younger-patients-with-cll-ibrutinib-plus-fludarabine-cyclophosphamide-and-rituximab-as-initial-therapy/ 2022-01-25T22:05:29+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/ 2022-01-20T21:29:53+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/kohei-shitara-on-gastric-and-esophageal-cancers-long-term-follow-up-on-nivolumab-plus-chemotherapy/ 2022-01-21T16:35:16+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/yu-sunakawa-on-gastric-cancer-predicting-treatment-related-toxicities-with-biomarkers/ 2022-01-21T16:42:53+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/heinz-josef-lenz-on-colorectal-cancer-update-from-the-checkmate-9x8-trial-on-nivolumab-mfolfox6-and-bevacizumab/ 2022-01-24T19:23:43+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/nilofer-saba-azad-on-novel-treatment-combinations-under-study-in-biliary-tract-cancers/ 2022-01-25T21:36:21+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/ghassan-abou-alfa-on-hepatocellular-carcinoma-open-label-trial-of-tremelimumab-and-durvalumab/ 2022-01-25T21:44:05+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/tanios-bekaii-saab-on-pancreatic-and-other-tumors-with-kras-g12c-mutation-updated-data-on-use-of-adagrasib/ 2022-01-25T21:49:08+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/afsaneh-barzi-on-colorectal-cancer-early-data-on-regorafenib-and-pembrolizumab/ 2022-01-25T21:57:46+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/zev-wainberg-on-gastric-or-gastroesophageal-junction-adenocarcinoma-follow-up-data-on-pembrolizumab-and-chemotherapy/ 2022-01-27T19:34:15+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/francesca-battaglin-on-upper-gi-cancers-and-the-potential-value-of-recurrent-neoantigens/ 2022-01-27T19:37:25+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/anthony-el-khoueiry-on-hepatocellular-carcinoma-expert-perspective-on-novel-additive-strategies/ 2022-01-28T17:55:05+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/gabriel-brooks-on-colorectal-cancer-expert-perspective-on-the-need-to-deintensify-oxaliplatin/ 2022-01-28T17:59:00+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/van-morris-on-metastatic-colorectal-cancer-early-trial-results-on-encorafenib-cetuximab-and-nivolumab/ 2022-02-01T16:54:50+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/melissa-amy-lumish-on-rectal-cancer-pd-1-blockade-for-mismatch-repair-deficient-disease/ 2022-02-01T16:57:46+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/romain-cohen-on-metastatic-colorectal-cancer-long-term-follow-up-on-nivolumab-plus-ipilimumab/ 2022-02-02T20:58:17+00:00 https://ascopost.com/videos/2022-asco-gastrointestinal-cancers-symposium/thierry-andre-on-esophagogastric-adenocarcinoma-new-findings-on-nivolumab-and-ipilimumab/ 2022-02-03T16:49:53+00:00 https://ascopost.com/videos/2021-multidisciplinary-thoracic-cancers-symposium/ 2022-01-26T19:50:18+00:00 https://ascopost.com/videos/2021-multidisciplinary-thoracic-cancers-symposium/julia-rotow-on-patient-selection-in-treating-thoracic-cancers-looking-to-driver-mutations-and-biomarkers/ 2022-01-26T19:53:13+00:00 https://ascopost.com/videos/2021-multidisciplinary-thoracic-cancers-symposium/carolyn-presley-on-dementia-in-patients-treated-for-thoracic-cancer/ 2022-01-26T19:56:22+00:00 https://ascopost.com/videos/2021-multidisciplinary-thoracic-cancers-symposium/pranshu-mohindra-on-nsclc-benefits-of-intensity-modulated-proton-therapy-based-reirradiation/ 2022-02-04T20:04:34+00:00 https://ascopost.com/videos/2021-multidisciplinary-thoracic-cancers-symposium/mirek-fatyga-on-nsclc-new-data-on-stereotactic-body-radiotherapy-vs-conventionally-fractionated-radiotherapy/ 2022-02-08T17:18:48+00:00 https://ascopost.com/videos/2021-multidisciplinary-thoracic-cancers-symposium/narjust-duma-on-advanced-nsclc-reducing-racial-disparities-in-outcomes/ 2022-02-09T17:19:20+00:00 https://ascopost.com/videos/2021-multidisciplinary-thoracic-cancers-symposium/ara-klijian-on-lung-cancer-operability-in-patients-with-poor-pulmonary-function/ 2022-05-12T17:54:11+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/ 2022-02-14T17:45:23+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/matthew-zibelman-on-renal-cell-carcinoma-new-results-on-combination-of-nivolumab-and-axitinib/ 2022-02-17T19:13:54+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/hielke-martijn-de-vries-on-penile-cancer-new-data-on-atezolizumab-and-radiotherapy/ 2022-02-22T20:06:56+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/alfredo-berruti-on-adrenocortical-carcinoma-preliminary-study-results-with-adjuvant-mitotane/ 2022-02-22T20:18:45+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/daniel-petrylak-on-bladder-cancer-study-ev-103-cohort-h-findings-on-enfortumab-vedotin-ejfv/ 2022-02-22T21:38:48+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/axel-bex-on-renal-cell-carcinoma-new-findings-from-the-neoavax-trial-on-avelumab-and-axitinib/ 2022-02-22T21:41:17+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/fred-saad-on-prostate-cancer-results-from-the-propel-trial-on-olaparib-and-abiraterone/ 2022-03-02T18:29:07+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/axel-merseburger-on-prostate-cancer-new-data-from-the-preside-trial-on-enzalutamide-docetaxel-and-prednisolone/ 2022-03-02T18:31:25+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/simon-crabb-on-urothelial-carcinoma-switch-maintenance-therapy-with-rucaparib-following-chemotherapy/ 2022-03-03T17:32:32+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/wesley-yip-on-urothelial-carcinoma-new-data-on-neoadjuvant-gemcitabine-and-cisplatin/ 2022-03-03T17:36:53+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/karen-knudsen-on-addressing-disparities-in-genitourinary-cancers/ 2022-03-04T19:35:15+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/karim-fizazi-on-prostate-cancer-early-results-from-the-cypides-trial-of-odm-208/ 2022-03-04T19:41:34+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/kim-nguyen-chi-on-prostate-cancer-new-findings-on-niraparib-abiraterone-and-prednisone/ 2022-03-07T17:58:23+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/jonathan-rosenberg-on-urothelial-cancer-new-conclusions-about-durvalumab-plus-olaparib/ 2022-03-07T18:39:19+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/toni-choueiri-on-renal-cell-carcinoma-follow-up-data-on-pembrolizumab/ 2022-03-08T20:39:53+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/massimo-di-maio-on-urothelial-cancer-data-on-niraparib-and-best-supportive-care-as-maintenance-therapy/ 2022-03-08T20:43:30+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/alicia-morgans-on-prostate-cancer-profiles-of-patients-and-their-journeys/ 2022-03-09T19:18:13+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/petros-grivas-on-urothelial-cancer-new-data-on-sacituzumab-govitecan-hziy-and-pembrolizumab/ 2022-03-09T19:21:15+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/sumanta-k-pal-md-on-advances-in-genitourinary-cancer-treatment-expert-perspective/ 2022-03-14T19:55:27+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/neil-fleshner-on-high-risk-prostate-cancer-new-data-on-abiraterone-and-cabazitaxel/ 2022-03-23T18:26:24+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/tanya-dorff-on-prostate-cancer-early-data-on-psca-targeted-car-t-cell-therapy/ 2022-03-23T18:44:24+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/xin-gao-on-prostate-cancer-early-phase-results-on-bavdegalutamide/ 2022-03-24T18:14:08+00:00 https://ascopost.com/videos/2022-asco-genitourinary-cancers-symposium/matthew-smith-on-prostate-cancer-phase-iii-data-on-darolutamide-androgen-deprivation-and-docetaxel/ 2022-04-27T19:53:26+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/ 2022-03-01T18:39:35+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/phillip-pifer-on-head-and-neck-squamous-cell-carcinoma-new-data-on-focal-adhesion-kinase/ 2022-03-01T18:42:31+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/glenn-hanna-on-oropharyngeal-squamous-cell-carcinoma-detecting-occult-recurrence/ 2022-03-15T18:27:39+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/nancy-lee-toward-personalization-of-radiotherapy-for-hpv-related-oropharyngeal-carcinoma/ 2022-03-15T18:30:21+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/peter-zeng-immune-cell-signature-predicts-survival-in-hpv-associated-head-and-neck-cancer/ 2022-03-16T15:40:53+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/david-hong-on-new-findings-on-tisotumab-vedotin-tftv-in-patients-with-head-and-neck-squamous-cell-carcinoma/ 2022-03-16T15:43:44+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/michelle-mierzwa-on-oropharyngeal-cancer-early-results-on-de-escalated-radiotherapy/ 2022-03-21T18:07:14+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/elizabeth-cash-on-addressing-the-psychological-aspects-of-head-and-neck-cancer/ 2022-03-21T18:09:53+00:00 https://ascopost.com/videos/2022-multidisciplinary-head-and-neck-cancers-symposium/sue-yom-on-thyroid-cancer-expert-perspective-on-the-state-of-the-field/ 2022-03-22T15:49:55+00:00 https://ascopost.com/videos/sgo-2022-annual-meeting-on-women-s-cancer/ 2022-03-22T14:51:58+00:00 https://ascopost.com/videos/sgo-2022-annual-meeting-on-women-s-cancer/ursula-matulonis-on-ovarian-cancer-new-data-on-mirvetuximab-soravtansine/ 2022-05-16T17:24:22+00:00 https://ascopost.com/videos/sgo-2022-annual-meeting-on-women-s-cancer/pedro-ramirez-on-hysterectomy-for-early-cervical-cancer-new-findings-on-open-vs-minimally-invasive-surgery/ 2022-05-16T17:31:19+00:00 https://ascopost.com/videos/39th-annual-miami-breast-cancer-conference/ 2022-03-23T16:15:01+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/ 2022-04-05T16:23:16+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/julio-pow-sang-on-nonmetastatic-prostate-cancer-update-on-best-management-practices/ 2022-04-05T16:28:11+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/margaret-tempero-on-pancreatic-adenocarcinoma-emerging-systemic-therapy-options/ 2022-04-08T16:07:30+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/thomas-flaig-on-bladder-cancer-new-treatment-options/ 2022-04-08T16:12:38+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/reid-ness-on-colorectal-cancer-updates-in-screening-recommendations/ 2022-04-08T16:18:51+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/genevieve-boland-on-advanced-melanoma-best-management-practices/ 2022-04-19T19:44:48+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/ann-lacasce-on-relapsedrefractory-indolent-follicular-lymphoma-management-updates/ 2022-04-19T19:55:02+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/maria-alma-rodriguez-on-vaccinations-for-patients-with-cancer-and-cancer-survivors/ 2022-05-13T17:24:50+00:00 https://ascopost.com/videos/nccn-2022-annual-conference/smitha-krishnamurthi-on-colorectal-cancer-treatment-updates/ 2022-05-19T17:25:45+00:00 https://ascopost.com/videos/23rd-asbrs-annual-meeting/ 2022-04-07T15:35:35+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/ 2022-04-11T19:55:57+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/john-haanen-on-solid-tumors-early-study-results-on-car-t-cells-and-the-carvac-vaccine-strategy/ 2022-04-11T19:59:16+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/yaqi-zhao-on-all-molecular-profile-and-efficacy-of-inotuzumab-ozogamicin/ 2022-04-11T20:24:50+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/alana-welm-on-metastatic-outgrowth-in-the-lungs-identifying-a-new-immune-mediated-pathway/ 2022-04-11T22:49:46+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/josh-neman-on-brain-metastasis-a-neuroscience-perspective/ 2022-04-11T23:37:27+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/benoit-you-on-endometrial-cancer-new-data-on-combining-olaparib-cyclophosphamide-and-metformin/ 2022-04-11T23:44:05+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/vivek-subbiah-on-designing-clinical-trials-for-precision-oncology/ 2022-04-12T17:42:17+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/ari-vanderwalde-on-melanoma-new-data-on-ipilimumab-and-nivolumab/ 2022-04-12T17:49:40+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/klaus-pantel-on-liquid-biopsy-research-opportunities-and-challenges/ 2022-04-12T17:52:33+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/patricia-lorusso-on-targeting-kras-clinical-successes-and-challenges/ 2022-04-12T19:47:16+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/tina-cascone-on-nsclc-new-findings-from-the-neocoast-trial-on-durvalumab-based-therapy/ 2022-04-12T20:22:56+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/silvia-formenti-on-adapting-radiation-therapy-to-immune-checkpoint-blockade/ 2022-04-12T20:37:00+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/ivan-marquez-rodas-on-advanced-melanoma-efficacy-of-intratumoral-bo-112-with-systemic-pembrolizumab/ 2022-04-13T00:37:18+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/meenakshi-anurag-on-breast-cancer-new-data-on-combining-anastrozole-and-fulvestrant/ 2022-04-13T00:39:59+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/electra-paskett-on-social-stresses-and-cancer-treatment-an-expert-perspective/ 2022-04-13T00:48:45+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/maria-elena-martinez-on-colorectal-cancer-screening-in-underserved-populations/ 2022-04-13T00:56:01+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/nicolas-girard-on-nsclc-new-data-on-event-free-survival-with-nivolumab-plus-platinum-doublet-chemotherapy/ 2022-04-19T19:37:25+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/gautam-mehta-on-precision-oncology-an-overview-of-the-accelerated-approval-program/ 2022-04-19T19:40:40+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/jia-luo-on-nsclc-clinicopathologic-and-molecular-characterization-of-kras-g12d-mutated-disease/ 2022-04-20T23:17:37+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/david-barbie-on-mesothelioma-activating-the-sting-pathway-may-promote-antitumor-immunity/ 2022-04-20T23:26:07+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/zev-wainberg-on-gastroesophageal-junction-adenocarcinoma-early-results-with-anti-cd39-antibody-plus-chemoimmunotherapy/ 2022-04-20T23:30:52+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/cheryl-willman-on-cancer-genomic-sequencing-in-tribal-nations-of-the-american-southwest/ 2022-04-20T23:42:34+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/marcia-cruz-correa-on-a-vision-for-the-future-of-cancer-research-and-treatment/ 2022-04-27T18:53:40+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/lillian-siu-on-looking-toward-the-future-of-clinical-research-and-clinical-trials/ 2022-04-27T18:57:20+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/gulam-manji-on-gastric-and-gastroesophageal-junction-adenocarcinomas-new-data-on-pembrolizumab-plus-capecitabine-and-oxaliplatin/ 2022-04-27T19:03:34+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/timothy-yap-on-advanced-solid-tumors-with-dna-damage-response-defects-early-data-on-elimusertib/ 2022-04-27T19:07:16+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/timothy-yap-on-developing-novel-therapeutic-strategies-to-target-dna-damage-response-in-the-clinic/ 2022-04-27T19:10:12+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/timothy-yap-on-ovarian-breast-pancreatic-and-prostate-cancers-with-genetic-mutations-a-first-in-human-trial-of-azd5305/ 2022-04-27T19:15:38+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/priscilla-brastianos-on-cns-metastases-understanding-their-evolution-and-the-clinical-implications/ 2022-04-27T19:18:51+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/charles-sawyers-on-transforming-patient-outcomes-the-future-of-cancer-research/ 2022-05-04T19:45:30+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/christine-iacobuzio-donahue-on-pancreatic-cancer-novel-insights-into-genetics-and-evolution/ 2022-05-11T18:16:19+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/nickolas-papadopoulos-on-multicancer-early-detection-opportunities-and-challenges/ 2022-05-13T17:28:02+00:00 https://ascopost.com/videos/aacr-annual-meeting-2022/matthew-meyerson-on-lung-adenocarcinoma-somatic-mutations-germline-risk-and-ancestry/ 2022-05-18T18:35:53+00:00 https://ascopost.com/videos/2022-society-of-surgical-oncology-international-conference-on-surgical-care/ 2022-04-22T14:49:40+00:00 https://ascopost.com/videos/esmo-breast-cancer-congress-2022/ 2022-05-09T16:43:49+00:00 https://ascopost.com/videos/2022-community-oncology-alliance-annual-meeting/ 2022-05-11T18:22:36+00:00 https://ascopost.com/videos/2022-american-society-of-breast-surgeons-annual-meeting/ 2022-05-12T17:19:44+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ 2022-05-26T16:42:28+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/pamela-l-kunz-on-pancreatic-neuroendocrine-tumors-a-final-analysis-of-temozolomide-or-temozolomide-plus-capecitabine/ 2022-07-20T20:26:17+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ruben-a-mesa-on-myelofibrosis-phase-iii-results-on-momelotinib-vs-danazol/ 2022-07-20T21:09:28+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/paul-g-richardson-on-multiple-myeloma-new-data-on-lenalidomide-bortezomib-and-dexamethasone-with-or-without-asct/ 2022-07-21T18:23:41+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/karim-chamie-on-bladder-cancer-final-results-on-n-803-and-bacillus-calmette-guérin/ 2022-07-21T19:11:31+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/sriram-yennu-on-cancer-related-fatigue-is-open-labeled-placebo-an-effective-treatment/ 2022-07-21T20:22:05+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/stephanie-walker-on-increasing-the-participation-of-black-women-with-metastatic-breast-cancer-in-clinical-trials/ 2022-07-21T20:41:24+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/benoit-you-on-ovarian-cancer-who-benefits-from-bevacizumab-in-the-first-line-setting/ 2022-07-21T21:08:37+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/michael-j-overman-and-takayuki-yoshino-on-colorectal-cancer-phase-iii-data-on-panitumumab-or-bevacizumab-plus-mfolfox6/ 2022-07-21T21:39:00+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/lisa-a-carey-and-hope-s-rugo-on-advanced-breast-cancer-new-data-on-sacituzumab-govitecan-hziy-vs-treatment-of-physician-s-choice/ 2022-07-22T00:03:12+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/courtney-d-dinardo-and-jorge-e-cortes-on-cml-new-efficacy-and-safety-results-for-asciminib/ 2022-07-22T01:44:39+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ursula-a-matulonis-and-nicoletta-colombo-on-ovarian-cancer-overall-survival-data-on-relacorilant-plus-nab-paclitaxel/ 2022-07-22T20:07:34+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/stephen-m-ansell-on-hodgkin-lymphoma-an-updated-analysis-on-first-line-brentuximab-vedotin-plus-chemotherapy/ 2022-07-22T20:22:56+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/carryn-anderson-on-head-and-neck-cancer-new-data-on-avasopasem-manganese-for-oral-mucositis/ 2022-07-22T20:37:30+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/courtney-dinardo-and-stephane-de-botto-on-aml-new-data-on-idh2-mutant-alleles-enasidenib-and-conventional-care/ 2022-07-22T20:56:36+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/shilpa-gupta-on-urothelial-cancer-defining-who-is-platinum-ineligible/ 2022-07-22T21:06:12+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/georgina-long-on-melanoma-new-data-on-pembrolizumab-dabrafenib-and-trametinib/ 2022-07-27T20:19:28+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/robert-hugh-jones-on-breast-cancer-updated-overall-survival-data-on-fulvestrant-plus-capivasertib/ 2022-07-27T17:47:04+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/mairead-mcnamara-on-neuroendocrine-carcinoma-findings-on-liposomal-irinotecan-plus-fluorouracil-and-folinic-acid-or-docetaxel/ 2022-07-27T19:10:16+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/alfredo-carrato-on-pancreatic-cancer-nab-paclitaxel-gemcitabine-and-folfox-for-metastatic-disease/ 2022-07-27T19:59:19+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/georgina-long-on-melanoma-distant-metastasis-free-survival-with-adjuvant-pembrolizumab/ 2022-07-27T20:06:26+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ursula-matulonis-and-ignace-vergote-on-cervical-cancer-interim-results-on-tisotumab-vedotin-tftv-plus-pembrolizumab/ 2022-07-27T22:19:40+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/richard-finn-on-advanced-breast-cancer-new-data-on-palbociclib-plus-letrozole-from-paloma-2/ 2022-07-27T22:30:40+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/sumanta-pal-on-urothelial-carcinoma-new-results-on-cabozantinib-plus-atezolizumab/ 2022-07-27T23:12:58+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/alicia-morgans-and-ian-davis-on-prostate-cancer-updated-overall-survival-outcomes-with-enzalutamide/ 2022-07-28T01:23:44+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/alicia-morgans-and-michael-hofman-on-prostate-cancer-new-data-on-lupsma-vs-cabazitaxel/ 2022-07-28T03:06:52+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/tara-sanft-on-how-diet-and-exercise-may-affect-completion-of-chemotherapy-for-breast-cancer/ 2022-07-28T19:11:58+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/michael-overman-and-jeanne-tie-on-colon-cancer-guiding-adjuvant-chemotherapy-with-ctdna/ 2022-07-28T19:38:10+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/jenny-guadamuz-on-racial-and-socioeconomic-disparities-in-telemedicine-use-among-us-patients-with-cancer-during-the-covid-19-pandemic/ 2022-07-28T19:50:09+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/sue-yom-on-oropharyngeal-cancer-and-the-feasibility-of-a-cell-free-dna-plasma-assay/ 2022-07-28T20:08:12+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/neal-shore-on-germline-genetic-testing-and-its-impact-on-prostate-cancer-clinical-decision-making/ 2022-07-28T20:21:41+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/timothy-whelan-when-can-radiotherapy-be-avoided-after-breast-conserving-surgery/ 2022-07-13T17:14:17+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/manali-patel-on-equitable-value-based-care-the-effectiveness-of-community-health-worker-led-interventions/ 2022-07-14T18:47:34+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/thomas-powles-and-jonathan-rosenberg-on-urothelial-carcinoma-long-term-outcomes-with-enfortumab-vedotin-ejfv-vs-chemotherapy/ 2022-07-14T19:05:13+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/jonathan-rosenberg-and-thomas-powles-on-renal-cell-carcinoma-new-data-on-pembrolizumab-plus-axitinib-vs-sunitinib-as-first-line-therapy/ 2022-07-14T19:13:07+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/nabil-saba-on-head-and-neck-squamous-cell-carcinoma-phase-ii-findings-on-pembrolizumab-and-cabozantinib/ 2022-07-14T19:20:15+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/clifford-hudis-and-karen-knudsen-on-how-asco-and-the-american-cancer-society-are-collaborating-to-help-patients-with-cancer/ 2022-07-14T19:22:11+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/nancy-davidson-in-it-for-the-long-haul-outcomes-in-hormone-receptor-positive-breast-cancer/ 2022-07-19T13:58:18+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ursula-matulonis-and-domenica-lorusso-on-gynecologic-cancers-new-findings-on-trabectedin-vs-clinician-s-choice-chemotherapy/ 2022-07-19T14:16:21+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ann-partridge-and-kevin-kalinsky-on-breast-cancer-latest-findings-on-fulvestrant-or-exemestane-with-or-without-ribociclib/ 2022-07-19T14:06:36+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/andrew-zelenetz-and-michael-wang-on-mantle-cell-lymphoma-new-data-on-ibrutinib-in-combination-with-bendamustinerituximab-and-rituximab-maintenance/ 2022-07-19T14:26:18+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/gilberto-de-lima-lopes-and-karen-reckamp-on-nsclc-overall-survival-results-with-ramucirumab-plus-pembrolizumab-vs-standard-of-care/ 2022-07-21T18:25:13+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/lisa-carey-and-shanu-modi-on-breast-cancer-is-t-dxd-a-potential-new-standard-of-care-for-her2-low-disease/ 2022-07-21T18:27:24+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/eunice-wang-on-aml-long-term-results-with-crenolanib-plus-chemotherapy/ 2022-07-21T18:31:19+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/apar-kishor-ganti-on-sclc-comparing-quality-of-life-with-once-and-twice-daily-thoracic-radiotherapy/ 2022-07-21T18:32:33+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/michael-overman-and-smitha-krishnamurthi-on-ras-wild-type-metastatic-colorectal-cancer-refining-treatment-strategy/ 2022-07-21T18:33:57+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/erika-hamilton-on-metastatic-breast-cancer-safety-follow-up-data-on-t-dxd-vs-t-dm1/ 2022-07-26T18:02:10+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ann-partridge-and-ian-krop-on-metastatic-breast-cancer-new-early-data-on-patritumab-deruxtecan/ 2022-07-26T18:05:18+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/gilberto-de-lima-lopes-and-matthew-krebs-on-nsclc-updated-results-with-amivantamab-vmjw/ 2022-07-26T18:08:37+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/ann-partridge-and-véronique-dieras-on-the-future-of-cytotoxic-therapy-antibody-drug-conjugates/ 2022-07-26T18:12:37+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/etienne-brain-on-breast-cancer-adjuvant-endocrine-therapy-with-or-without-chemotherapy-in-older-patients/ 2022-07-26T18:14:45+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/rainer-fietkau-on-pancreatic-cancer-initial-trial-results-on-sequential-chemotherapy-and-chemoradiotherapy/ 2022-07-27T21:45:38+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/akihiro-ohba-on-biliary-tract-cancer-new-findings-on-fam-trastuzumab-deruxtecan-nxki/ 2022-07-27T21:47:51+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/martin-mccabe-on-ewing-sarcoma-assessment-of-topotecan-cyclophosphamide-and-high-dose-ifosfamide/ 2022-07-27T21:49:35+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/gilberto-de-lima-lopes-and-oladimeji-akinboro-on-nsclc-outcomes-of-anti-pd-l-1-therapy-with-or-without-chemotherapy-in-the-first-line-setting/ 2022-07-27T21:53:14+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/maxwell-oluwole-akanbi-on-lung-cancer-the-effect-of-screening-on-the-incidence-of-advanced-disease/ 2022-07-27T21:55:10+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/bradley-monk-on-ovarian-cancer-new-data-on-rucaparib-monotherapy-vs-placebo-as-maintenance-treatment/ 2022-07-27T21:56:45+00:00 https://ascopost.com/videos/2022-asco-annual-meeting/rami-manochakian-on-nsclc-clinical-implications-of-findings-on-nivolumab-plus-chemotherapy/ 2022-07-27T21:59:44+00:00 https://ascopost.com/videos/digestive-disease-week-2022/ 2022-05-27T13:51:13+00:00 https://ascopost.com/videos/eha2022-congress/ 2022-06-13T16:04:09+00:00 https://ascopost.com/videos/eha2022-congress/michael-dickinson-on-dlbcl-phase-ii-expansion-results-on-glofitamab/ 2022-08-10T17:43:13+00:00 https://ascopost.com/videos/eha2022-congress/nicholas-short-on-all-updated-phase-ii-study-results-on-ponatinib-and-blinatumomab/ 2022-08-10T17:46:08+00:00 https://ascopost.com/videos/eha2022-congress/harry-erba-on-aml-new-data-on-quizartinib-plus-standard-chemotherapy/ 2022-08-30T17:02:22+00:00 https://ascopost.com/videos/eha2022-congress/anna-sureda-on-large-b-cell-lymphoma-new-data-on-axicabtagene-ciloleucel-vs-standard-of-care/ 2022-08-30T17:07:18+00:00 https://ascopost.com/videos/eha2022-congress/barbara-eichhorst-on-cll-venetoclax-and-obinutuzumab-with-or-without-ibrutinib-vs-chemoimmunotherapy/ 2022-10-10T18:47:21+00:00 https://ascopost.com/videos/2022-summit-on-cancer-health-disparities/ 2022-06-16T16:54:06+00:00 https://ascopost.com/videos/2022-aua-annual-meeting/ 2022-06-17T15:16:35+00:00 https://ascopost.com/videos/37th-annual-eau-congress/ 2022-07-12T15:50:54+00:00 https://ascopost.com/videos/2022-esmo-world-congress-on-gastrointestinal-cancers/ 2022-08-08T17:27:15+00:00 https://ascopost.com/videos/iaslc-world-conference-on-lung-cancer-2022/ 2022-08-11T16:07:30+00:00 https://ascopost.com/videos/esmo-congress-2022/ 2022-09-10T08:08:55+00:00 https://ascopost.com/videos/esmo-congress-2022/paul-disilvestro-on-ovarian-cancer-new-data-on-olaparib-in-newly-diagnosed-disease/ 2022-09-16T18:12:14+00:00 https://ascopost.com/videos/esmo-congress-2022/bernd-kasper-on-desmoid-tumors-results-on-nirogacestat-vs-placebo/ 2022-09-16T18:17:14+00:00 https://ascopost.com/videos/esmo-congress-2022/christelle-de-la-fouchardiere-on-pancreatic-ductal-adenocarcinoma-phase-iii-trial-results-with-gemcitabine-plus-paclitaxel/ 2022-09-16T18:13:24+00:00 https://ascopost.com/videos/esmo-congress-2022/ana-oaknin-on-cervical-cancer-new-findings-on-cemiplimab-in-recurrent-or-metastatic-disease/ 2022-09-16T18:14:53+00:00 https://ascopost.com/videos/esmo-congress-2022/ana-oaknin-on-cervical-cancer-safety-and-efficacy-results-with-nivolumab-and-ipilimumab/ 2022-09-16T18:21:37+00:00 https://ascopost.com/videos/esmo-congress-2022/antonio-marra-on-metastatic-breast-cancer-patterns-of-genomic-instability-and-their-effect-on-treatment/ 2022-09-20T15:50:39+00:00 https://ascopost.com/videos/esmo-congress-2022/sapna-patel-on-melanoma-new-data-on-pembrolizumab-adjuvant-vs-neoadjuvant/ 2022-09-20T15:48:54+00:00 https://ascopost.com/videos/esmo-congress-2022/marinde-bond-on-colorectal-liver-metastases-folfoxfolfiri-bevacizumab-and-panitumumab/ 2022-12-07T19:53:54+00:00 https://ascopost.com/videos/esmo-congress-2022/charles-swanton-on-non-small-cell-lung-cancer-induced-by-air-pollution/ 2022-09-20T15:53:23+00:00 https://ascopost.com/videos/esmo-congress-2022/rcc-review-of-two-key-abstracts-on-belzutifan-plus-cabozantinib-and-pembrolizumab-plus-lenvatinib/ 2022-09-20T15:54:52+00:00 https://ascopost.com/videos/esmo-congress-2022/richard-finn-on-hepatocellular-carcinoma-recent-data-on-lenvatinib-plus-pembrolizumab/ 2022-09-20T15:56:55+00:00 https://ascopost.com/videos/esmo-congress-2022/martin-reck-md-phd-on-nsclc-new-findings-on-cemiplimab-nivolumab-and-ipilimumab/ 2022-09-20T15:55:51+00:00 https://ascopost.com/videos/esmo-congress-2022/axel-bex-on-renal-cell-carcinoma-phase-iii-results-with-atezolizumab-as-adjuvant-therapy/ 2022-09-22T15:44:41+00:00 https://ascopost.com/videos/esmo-congress-2022/rcc-recent-phase-iii-data-on-cabozantinib-nivolumab-and-ipilimumab-from-the-cosmic-313-trial/ 2022-09-22T15:48:56+00:00 https://ascopost.com/videos/esmo-congress-2022/neal-shore-on-prostate-cancer-biomarker-analysis-enzalutamide-and-active-surveillance/ 2022-09-22T15:46:55+00:00 https://ascopost.com/videos/esmo-congress-2022/jean-pascal-machiels-on-head-and-neck-cancer-recent-data-on-pembrolizumab-and-chemoradiation-therapy/ 2022-09-22T15:45:42+00:00 https://ascopost.com/videos/esmo-congress-2022/gerard-zalcman-on-non-small-cell-lung-cancer-phase-iii-trial-findings-on-nivolumab-and-ipilimumab/ 2022-09-20T15:58:57+00:00 https://ascopost.com/videos/esmo-congress-2022/neil-gross-on-cutaneous-squamous-cell-carcinoma-recent-findings-on-cemiplimab/ 2022-09-22T15:50:45+00:00 https://ascopost.com/videos/esmo-congress-2022/georgina-long-on-melanoma-findings-on-circulating-tumor-dna-disease-recurrence-and-immunotherapy/ 2022-09-22T15:52:22+00:00 https://ascopost.com/videos/esmo-congress-2022/matteo-lambertini-on-oncofertility-care-for-young-women-with-breast-cancer/ 2022-09-22T15:54:04+00:00 https://ascopost.com/videos/esmo-congress-2022/tony-mok-on-nsclc-review-of-recent-data-from-the-sunrise-and-orient-31-trials/ 2022-09-22T15:58:15+00:00 https://ascopost.com/videos/esmo-congress-2022/nizar-tannir-on-rcc-data-on-bempegaldesleukin-plus-nivolumab-vs-tyrosine-kinase-inhibitors-in-untreated-disease/ 2022-10-11T15:08:12+00:00 https://ascopost.com/videos/esmo-congress-2022/julien-taieb-on-colorectal-cancer-recent-findings-on-avelumab-vs-standard-second-line-chemotherapy/ 2022-10-11T15:09:00+00:00 https://ascopost.com/videos/esmo-congress-2022/laurence-buisseret-on-triple-negative-breast-cancer-chemoimmunotherapy-with-or-without-an-anti-cd73-antibody/ 2022-10-11T15:09:49+00:00 https://ascopost.com/videos/esmo-congress-2022/marleen-kok-on-triple-negative-breast-cancer-nivolumab-monotherapy-or-in-combination-therapy/ 2022-10-10T18:43:59+00:00 https://ascopost.com/videos/esmo-congress-2022/john-haanen-on-melanoma-phase-iii-data-on-treatment-with-tumor-infiltrating-lymphocytes-vs-ipilimumab/ 2022-10-10T18:50:11+00:00 https://ascopost.com/videos/esmo-congress-2022/robert-motzer-on-renal-cell-carcinoma-new-results-with-nivolumab-and-ipilimumab/ 2022-11-28T16:51:51+00:00 https://ascopost.com/videos/esmo-congress-2022/jonathan-rosenberg-on-urothelial-cancer-results-from-ev-103-cohort-k-on-enfortumab-vedotin-and-pembrolizumab/ 2022-11-28T16:53:10+00:00 https://ascopost.com/videos/esmo-congress-2022/matthew-goetz-on-breast-cancer-interim-survival-results-with-abemaciclib-plus-a-nonsteroidal-aromatase-inhibitor/ 2023-03-31T16:37:24+00:00 https://ascopost.com/videos/esmo-congress-2022/rahul-aggarwal-on-prostate-cancer-phase-iii-data-on-apalutamide-and-androgen-deprivation-in-relapsed-disease/ 2023-03-23T18:44:11+00:00 https://ascopost.com/videos/esmo-congress-2022/myriam-chalabi-on-colon-cancer-new-findings-on-neoadjuvant-immune-checkpoint-inhibition/ 2023-03-23T18:49:02+00:00 https://ascopost.com/videos/esmo-congress-2022/thomas-powles-and-christopher-sweeney-on-rcc-expert-review-of-two-key-studies-on-atezolizumab-nivolumab-and-ipilimumab/ 2023-03-23T18:52:50+00:00 https://ascopost.com/videos/15th-aacr-conference-on-the-science-of-cancer-health-disparities-in-racial-and-ethnic-minorities-and-the-medically-underserved/ 2022-09-20T15:07:26+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/ 2022-09-27T14:29:59+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/justin-barnes-on-medicaid-expansion-and-changes-in-cancer-mortality-rates/ 2022-10-31T14:11:11+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/dawn-hershman-on-prophylactic-colony-stimulating-factors-for-neutropenia-improving-clinicians-prescribing-practices/ 2022-11-03T15:15:44+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/christopher-jensen-on-older-adults-with-aml-a-price-paid-for-high-intensity-chemotherapy/ 2022-11-03T14:57:26+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/changchuan-jiang-on-transportation-barriers-delays-in-cancer-care-and-increased-mortality-for-patients-with-cancer/ 2022-11-03T14:50:54+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/joannie-ivory-on-increasing-participation-of-black-patients-with-cancer-in-clinical-trials/ 2022-11-03T14:53:15+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/qinjin-fan-on-equitable-lung-cancer-care-and-mortgage-discrimination/ 2022-11-03T15:07:59+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/sandra-wong-on-severe-symptom-reporting-in-patients-with-cancer-who-have-undergone-surgery/ 2022-11-03T15:05:17+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/sm-qasim-hussaini-on-colon-cancer-treatment-outcomes-and-historical-housing-discrimination/ 2022-11-03T15:02:49+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/jensa-morris-on-oncology-hospitalist-co-management/ 2022-11-03T14:55:20+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/regina-barragan-carrillo-on-breast-cancer-screening-in-the-transgender-population/ 2022-11-03T15:13:03+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/samyukta-mullangi-on-predictors-of-compliance-with-payer-led-oncology-clinical-pathways/ 2022-11-03T15:00:46+00:00 https://ascopost.com/videos/2022-asco-quality-care-symposium/xuesong-han-on-medicaid-expansion-and-receipt-of-palliative-care-among-individuals-newly-diagnosed-with-advanced-stage-cancers/ 2022-10-31T14:13:51+00:00 https://ascopost.com/videos/2022-pan-pacific-lymphoma-conference/ 2022-10-10T16:13:46+00:00 https://ascopost.com/videos/american-college-of-surgeons-clinical-congress-2022/ 2022-10-19T15:05:08+00:00 https://ascopost.com/videos/2022-astro-annual-meeting/ 2022-10-24T16:01:28+00:00 https://ascopost.com/videos/2022-astro-annual-meeting/emily-daugherty-on-flash-radiotherapy-efficacy-and-safety-results-from-the-first-in-human-study/ 2023-01-25T21:33:48+00:00 https://ascopost.com/videos/2022-astro-annual-meeting/alex-k-bryant-on-psa-screening-and-metastatic-prostate-cancer-in-the-va-health-care-system/ 2023-03-23T18:57:22+00:00 https://ascopost.com/videos/2022-astro-annual-meeting/jamie-takayesu-on-genitourinary-cancer-disparity-in-physicians-assessment-of-sexual-dysfunction-in-women-vs-men/ 2023-03-29T16:29:16+00:00 https://ascopost.com/videos/34th-eortc-nci-aacr-symposium/ 2022-11-07T17:18:48+00:00 https://ascopost.com/videos/2022-nccn-annual-congress-hematologic-malignancies/ 2022-11-10T16:48:46+00:00 https://ascopost.com/videos/sitc-2022/ 2022-11-11T18:36:39+00:00 https://ascopost.com/videos/sitc-2022/for-patients-living-with-hiv-and-cancer-new-data-on-immune-checkpoint-inhibitors/ 2022-12-08T22:55:31+00:00 https://ascopost.com/videos/sitc-2022/wade-iams-on-nsclc-combining-an-antigen-presenting-cell-activator-with-pembrolizumab/ 2022-12-05T20:22:28+00:00 https://ascopost.com/videos/sitc-2022/david-reardon-on-glioblastoma-a-microbiome-based-vaccine-nivolumab-and-bevacizumab/ 2022-11-23T14:39:43+00:00 https://ascopost.com/videos/sitc-2022/michael-postow-on-using-the-novel-radiotracer-crefmirlimab-berdoxam-for-imaging-to-assess-immunotherapy-responsiveness/ 2022-12-08T22:57:45+00:00 https://ascopost.com/videos/sitc-2022/antoni-ribas-on-solid-tumors-safety-and-efficacy-of-tcr-t-cell-therapy/ 2022-12-08T22:50:34+00:00 https://ascopost.com/videos/sitc-2022/julia-tchou-on-triple-negative-breast-cancer-radiation-boost-plus-pembrolizumab/ 2022-12-05T20:20:45+00:00 https://ascopost.com/videos/sitc-2022/saman-maleki-on-melanoma-reducing-primary-resistance-to-immunotherapy/ 2022-12-08T22:56:55+00:00 https://ascopost.com/videos/sitc-2022/jonathan-chen-on-nsclc-predicting-response-to-immunotherapy/ 2022-12-08T22:53:03+00:00 https://ascopost.com/videos/sitc-2022/kishu-ranjan-on-non-small-cell-lung-cancer-new-findings-on-a-biomarker-and-immunotherapy-resistance/ 2022-12-13T19:41:43+00:00 https://ascopost.com/videos/sitc-2022/michael-atkins-on-reconciling-differences-in-phase-ii-and-iii-immuno-oncology-trial-data/ 2022-12-14T21:11:13+00:00 https://ascopost.com/videos/sitc-2022/roger-li-on-bladder-cancer-boosting-immune-checkpoint-blockade-with-an-oncolytic-adenovirus/ 2022-12-13T19:39:42+00:00 https://ascopost.com/videos/sitc-2022/sumanta-pal-md-on-renal-cell-carcinoma-crispr-engineered-car-t-cells-in-advanced-disease/ 2022-12-13T19:35:08+00:00 https://ascopost.com/videos/13th-european-breast-cancer-conference/ 2022-11-21T18:05:42+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/ 2022-12-06T21:59:14+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/yara-abdou-on-race-and-clinical-outcomes-in-the-rxponder-breast-cancer-trial/ 2022-12-16T18:30:51+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/ruth-oregan-on-evaluation-of-the-breast-cancer-index-in-early-stage-breast-cancer/ 2022-12-16T18:33:13+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/sara-hurvitz-on-updated-survival-results-on-t-dxd-vs-t-dm1-in-metastatic-breast-cancer/ 2022-12-19T19:31:03+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/sara-hurvitz-new-findings-on-neoadjuvant-trastuzumab-deruxtecan-and-anastrozole-in-early-stage-breast-cancer/ 2022-12-19T19:20:41+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/joseph-sparano-on-long-term-breast-cancer-recurrence-and-survival-data-from-tailorx/ 2022-12-19T19:32:19+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/nicholas-turner-on-new-data-on-capivasertib-and-fulvestrant-for-advanced-breast-cancer/ 2022-12-16T18:39:56+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/mariana-chavez-macgregor-on-adjuvant-endocrine-therapy-and-everolimus-in-hr-positive-her2-negative-breast-cancer/ 2022-12-21T17:59:51+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/joannie-ivory-and-lisa-carey-on-pam50-subtype-and-21-gene-recurrence-scores-in-younger-and-black-women-with-breast-cancer/ 2022-12-21T18:11:32+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/per-karlsson-new-data-on-breast-conserving-surgery-with-or-without-radiotherapy/ 2022-12-16T18:44:48+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/judy-boughey-on-new-findings-on-the-impact-of-breast-conservation-therapy-on-local-recurrence/ 2022-12-16T18:26:13+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/aditya-bardia-on-elacestrant-vs-standard-of-care-endocrine-therapy-in-er-positive-her2-negative-breast-cancer/ 2023-01-05T20:15:21+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/erica-mayer-on-metastatic-breast-cancer-new-findings-on-palbociclib-after-prior-cdk46-inhibitor-and-endocrine-therapy/ 2022-12-21T00:38:24+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/francois-clement-bidard-circulating-tumor-cells-may-help-improve-outcomes-in-metastatic-disease/ 2022-12-19T19:33:34+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/marleen-kok-year-in-review-early-breast-cancer/ 2022-12-21T17:56:32+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/mafalda-oliveira-on-camizestrant-vs-fulvestrant-in-advanced-breast-cancer/ 2022-12-19T19:37:13+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/ann-partridge-on-interrupting-breast-cancer-treatment-to-attempt-pregnancy/ 2022-12-19T19:18:02+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/andrea-de-censi-on-noninvasive-breast-cancer-10-year-results-on-low-dose-tamoxifen/ 2022-12-21T00:40:34+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/prudence-francis-on-premenopausal-er-positive-breast-cancer/ 2022-12-21T18:15:08+00:00 https://ascopost.com/videos/2022-san-antonio-breast-cancer-symposium/sean-khozin-on-randomized-trials-vs-real-world-evidence-in-patients-with-advanced-cancer/ 2022-12-21T00:41:12+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/ 2022-12-11T17:14:48+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/paolo-caimi-on-dlbcl-outcomes-after-r-ice-chemoimmunotherapy/ 2022-12-22T18:29:23+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/tycel-phillips-on-mantle-cell-lymphoma-new-findings-on-glofitamab-monotherapy/ 2022-12-22T18:38:29+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/eunice-wang-on-aml-gemtuzumab-ozogamicin-plus-standard-induction-chemotherapy-improves-outcomes/ 2022-12-22T18:46:38+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/tomohiro-aoki-on-the-spatial-tumor-microenvironment-and-outcome-of-relapsedrefractory-classic-hodgkin-lymphoma/ 2023-01-10T19:08:19+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/joseph-schroers-martin-on-posttransplant-lymphoproliferative-disorders-tumor-microenvironment-determinants-of-immunotherapy-response/ 2022-12-22T18:57:52+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/stephen-ansell-and-patrizia-mondello-new-findings-on-how-the-irf4-gene-shapes-tumor-immunity-in-follicular-lymphoma/ 2022-12-22T20:37:32+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/elias-jabbour-on-cml-and-all-olverembatinib-overcomes-ponatinib-resistance/ 2022-12-22T18:49:20+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/jorge-cortes-on-cml-efficacy-and-safety-of-vodobatinib/ 2022-12-22T18:56:29+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/jia-ruan-on-mantle-cell-lymphoma-phase-ii-findings-on-acalabrutinib-lenalidomide-rituximab/ 2022-12-22T19:05:14+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/eva-hoster-on-mantle-cell-lymphoma-predictive-value-of-minimal-residual-disease-on-efficacy-of-rituximab-maintenance/ 2022-12-22T19:07:15+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/andrew-matthews-on-aml-real-world-effectiveness-of-7-3-intensive-chemotherapy-vs-venetoclax-and-a-hypomethylating-agent/ 2022-12-22T19:10:14+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/kathryn-tringale-on-primary-cns-lymphoma-initial-treatment-response-in-more-than-500-patients/ 2022-12-22T19:12:50+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/julie-cote-on-multiple-myeloma-real-world-results-of-autologous-stem-cell-transplantation-in-newly-diagnosed-patients/ 2022-12-22T19:15:28+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/smita-bhatia-some-clonal-mutations-may-predict-therapy-related-myeloid-neoplasms/ 2022-12-22T19:17:16+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/eileen-boyle-on-multiple-myeloma-sustained-mrd-negativity-in-newly-diagnosed-disease-treated-with-immunotherapy-regimens/ 2022-12-22T19:19:16+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/anand-jillella-on-acute-promyelocytic-leukemia-a-simplified-patient-care-strategy-to-decrease-early-deaths/ 2022-12-22T19:21:13+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/abdul-rahman-al-armashi-on-aml-racial-disparities-in-mortality-trends/ 2022-12-22T19:22:53+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/francesco-maura-on-genomic-determinants-of-resistance-in-newly-diagnosed-multiple-myeloma-treated-with-targeted-immunotherapy/ 2022-12-22T19:24:40+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/jiye-liu-on-multiple-myeloma-genome-wide-crispr-cas9-screening-identifies-kdm6a-as-a-modulator-of-daratumumab-sensitivity/ 2022-12-22T19:25:39+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/irene-roberts-on-leukemogenesis-in-infants-with-trisomy-21/ 2022-12-22T19:26:44+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/mark-litzow-on-all-consolidation-therapy-with-blinatumomab-improves-overall-survival/ 2022-12-22T19:28:01+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/jennifer-brown-on-cll-sll-new-findings-on-zanubrutinib-vs-ibrutinib-for-relapsed-or-refractory-disease/ 2022-12-22T19:30:30+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/paul-richardson-on-multiple-myeloma-mezigdomide-plus-dexamethasone-in-relapsed-and-refractory-disease/ 2022-12-22T19:29:31+00:00 https://ascopost.com/videos/2022-ash-annual-meeting-and-exposition/alex-f-herrera-on-previously-untreated-dlbcl-circulation-tumor-dna-and-risk-profiling/ 2023-03-30T19:19:39+00:00 https://ascopost.com/videos/2022-lynn-sage-breast-cancer-symposium/ 2022-12-22T21:54:07+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/ 2023-01-20T17:28:01+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/rachna-shroff-on-biliary-tract-cancers-recent-findings-on-use-of-gemcitabine-cisplatin-and-nab-paclitaxel/ 2023-02-09T20:42:10+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/josep-tabernero-on-colorectal-cancer-recent-data-on-treatment-with-trifluridine-and-tipiracil-plus-bevacizumab/ 2023-01-27T19:40:40+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/richard-finn-on-hcc-tislelizumab-vs-sorafenib-and-their-impact-on-quality-of-life/ 2023-01-27T19:44:30+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/nick-pavlakis-on-gastroesophageal-cancer-new-findings-on-the-use-of-regorafenib/ 2023-01-27T19:45:48+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/manik-amin-on-novel-immune-therapies-in-gi-cancers/ 2023-01-27T19:42:26+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/julien-taieb-on-treating-colorectal-cancer-with-trifluridine-and-tipiracil-plus-bevacizumab/ 2023-02-03T18:03:12+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/filippo-pietrantonio-on-gastric-or-gastroesophageal-junction-adenocarcinoma-recent-data-on-treatment-with-tremelimumab-and-durvalumab/ 2023-02-03T18:01:22+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/laura-dawson-on-hepatocellular-carcinoma-and-liver-metastases-recent-treatment-data-on-palliative-radiotherapy/ 2023-02-03T17:52:41+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/souya-nunobe-on-gastric-cancer-5-year-follow-up-on-s-1-chemotherapy-for-stage-ii-disease/ 2023-02-03T17:54:25+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/kohei-shitara-on-gastric-or-gastroesophageal-junction-adenocarcinoma-recent-data-on-zolbetuximab-plus-mfolfox6/ 2023-02-03T17:57:47+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/laura-dawson-on-hepatocellular-carcinoma-phase-iii-data-on-sorafenib-vs-stereotactic-body-radiation-therapy/ 2023-02-03T18:04:43+00:00 https://ascopost.com/videos/2023-asco-gastrointestinal-cancers-symposium/zev-wainberg-on-pancreatic-ductal-adenocarcinoma-recent-findings-on-nalirifox-vs-nab-paclitaxel-plus-gemcitabine/ 2023-02-22T20:05:04+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/ 2023-02-17T15:27:36+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/toni-choueiri-on-renal-cell-carcinoma-potential-predictive-biomarkers-of-treatment-efficacy/ 2023-02-22T20:01:20+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/thomas-powles-on-renal-cell-carcinoma-phase-iii-results-on-cabozantinib-nivolumab-and-ipilimumab/ 2023-03-15T21:27:55+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/neeraj-agarwal-on-prostate-cancer-new-data-on-talazoparib-and-enzalutamide/ 2023-03-15T21:29:55+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/aristotelis-bamias-on-urothelial-carcinoma-final-overall-survival-analysis-of-atezolizumab-monotherapy-vs-chemotherapy/ 2023-03-15T21:30:52+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/paul-nguyen-on-prostate-cancer-new-findings-on-treatment-with-salvage-radiotherapy-gnrh-agonist-abiraterone-prednisone-and-apalutamide/ 2023-03-16T18:21:27+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/daniel-petrylak-on-prostate-cancer-latest-data-on-pembrolizumab-plus-docetaxel/ 2023-03-16T18:23:21+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/alan-bryce-on-prostate-cancer-phase-iii-results-on-rucaparib-docetaxel-and-androgen-pathway-inhibitor-therapy/ 2023-03-16T18:24:40+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/andrea-necchi-on-bladder-cancer-phase-ii-results-with-pembrolizumab-monotherapy/ 2023-03-16T18:30:01+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/matt-galsky-on-urothelial-carcinoma-new-study-results-on-atezolizumab-platinum-and-gemcitabine/ 2023-03-16T18:30:49+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/scott-tagawa-on-prostate-cancer-phase-ii-results-on-ketoconazole-hydrocortisone-and-an-anti-psma-antibody/ 2023-03-16T22:01:44+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/matt-galsky-on-bladder-or-upper-urinary-tract-cancer-extended-follow-up-results-from-checkmate-274/ 2023-03-16T22:02:43+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/michael-atkins-on-renal-cell-carcinoma-phase-ii-findings-on-nivolumab-and-ipilimumab/ 2023-03-16T22:05:02+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/daniel-petrylak-on-urothelial-cancer-phase-ii-trial-analysis-of-sacituzumab-govitecan-hziy-in-metastatic-disease/ 2023-03-16T22:06:13+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/laurence-albiges-on-renal-cell-carcinoma-new-phase-ii-data-on-cabozantinib-and-checkpoint-inhibitor-therapy/ 2023-03-16T22:07:14+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/updates-from-city-of-hope-on-renal-cell-prostate-and-urothelial-cancers/ 2023-03-16T22:10:09+00:00 https://ascopost.com/videos/2023-asco-genitourinary-cancers-symposium/vadim-koshkin-and-tanya-jindal-on-urothelial-carcinoma-biomarkers-of-response-to-enfortumab-vedotinejfv/ 2023-03-16T22:11:54+00:00 https://ascopost.com/videos/2023-eau-annual-congress/ 2023-03-13T19:36:07+00:00 https://ascopost.com/videos/2023-miami-breast-cancer-conference/ 2023-03-22T14:56:42+00:00 https://ascopost.com/videos/sgo-2023-annual-meeting-on-women-s-cancer/ 2023-03-28T21:17:39+00:00 https://ascopost.com/videos/sgo-2023-annual-meeting-on-women-s-cancer/shannon-n-westin-on-endometrial-and-ovarian-cancers-new-data-on-selumetinib-and-olaparib-from-the-solar-trial/ 2023-04-25T18:33:11+00:00 https://ascopost.com/videos/sgo-2023-annual-meeting-on-women-s-cancer/shannon-n-westin-on-ovarian-cancer-results-from-the-now-trial-of-neoadjuvant-olaparib-in-brca-palb-or-rad51c-mutant-disease/ 2023-04-25T18:35:34+00:00 https://ascopost.com/videos/sgo-2023-annual-meeting-on-women-s-cancer/ursula-a-matulonis-on-ovarian-cancer-new-data-on-niraparib-from-the-engot-ov16-nova-trial/ 2023-05-04T19:28:43+00:00 https://ascopost.com/videos/sgo-2023-annual-meeting-on-women-s-cancer/mansoor-r-mirza-on-endometrial-cancer-new-findings-on-dostarlimab-gxly-plus-chemotherapy/ 2023-05-08T18:28:54+00:00 https://ascopost.com/videos/european-lung-cancer-congress-2023/ 2023-04-03T17:18:26+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/ 2023-04-03T17:31:02+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/michael-gibson-on-metastatic-esophageal-squamous-cell-carcinoma-new-first-line-systemic-treatment-options/ 2023-04-27T18:11:17+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/louis-nabors-on-nccn-clinical-practice-guidelines-in-oncology-updates-for-cns-cancers-in-adults/ 2023-04-27T17:37:11+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/midhun-malla-on-metastatic-colorectal-cancer-treatment-updates/ 2023-04-27T19:03:48+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/mandi-pratt-chapman-on-oncology-care-in-the-lgbtqiplus-community-best-practices-for-addressing-health-needs/ 2023-04-27T20:19:23+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/deborah-stephens-on-cllsll-nccn-clinical-practice-guidelines-in-oncology-update/ 2023-04-27T19:41:10+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/jordan-mcpherson-pharmd-ms-bcop-on-managing-immunotherapy-related-toxicities/ 2023-04-27T20:55:36+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/ella-kazerooni-on-lung-cancer-screening-benefits-and-challenges/ 2023-04-27T21:06:30+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/elena-ratner-md-mba-on-sexual-identity-and-function-in-cancer-survivors/ 2023-04-27T19:50:21+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/arlene-siefker-radtke-on-urothelial-cancer-emerging-therapies/ 2023-04-27T19:40:51+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/mitesh-borad-on-hepatobiliary-cancers-management-updates/ 2023-04-27T19:30:44+00:00 https://ascopost.com/videos/nccn-2023-annual-conference/natalie-moryl-md-on-managing-pain-in-patients-with-cancer/ 2023-05-08T20:46:46+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/ 2023-04-28T16:23:20+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/john-v-heymach-on-nsclc-new-data-on-durvalumab-plus-chemotherapy-from-the-aegean-trial/ 2023-05-12T20:40:49+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/diana-azzam-on-pediatric-cancers-efficacy-of-a-precision-medicine-approach/ 2023-05-12T20:43:10+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/pierce-k-h-chow-on-hepatocellular-carcinoma-new-data-from-the-imbrave050-trial-of-atezolizumab-bevacizumab-and-active-surveillance/ 2023-05-12T20:45:41+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/timothy-a-yap-on-new-findings-on-treating-solid-tumors-with-parp-and-atr-inhibitors/ 2023-05-12T20:47:34+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/sherry-x-yang-on-breast-cancer-new-recurrence-score-data-from-the-tailorx-trial/ 2023-06-09T20:42:34+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/karriem-s-watson-on-early-engagement-in-clinical-trials-for-underrepresented-communities/ 2023-06-09T20:43:18+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/harry-klein-on-matchminer-an-open-source-ai-precision-medicine-trial-matching-platform/ 2023-06-09T20:44:44+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/r-katie-kelley-on-biliary-tract-cancer-data-from-keynote-966-on-pembrolizumab-gemcitabine-and-cisplatin/ 2023-06-09T20:45:42+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/christina-m-dieli-conwright-on-resistance-exercise-as-medicine-improving-health-and-cancer-outcomes/ 2023-06-09T20:47:23+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/jeffrey-s-weber-on-melanoma-new-data-on-a-cancer-vaccine-combined-with-pembrolizumab/ 2023-06-09T20:51:45+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/dario-avignali-on-lag3-the-third-checkpoint-inhibitor/ 2023-06-09T20:50:46+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/carmen-e-guerra-on-strategies-for-equitable-access-to-cancer-clinical-trials/ 2023-06-09T20:49:00+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/lindsay-l-peterson-on-exercise-and-cancer-outcomes/ 2023-06-09T20:53:32+00:00 https://ascopost.com/videos/aacr-annual-meeting-2023/marcus-o-butler-on-uveal-melanoma-tebentafusp-and-evidence-of-tumor-response/ 2023-06-09T20:54:20+00:00 https://ascopost.com/videos/24th-asbrs-annual-meeting/ 2023-05-01T15:32:26+00:00 https://ascopost.com/videos/2023-society-of-surgical-oncology-international-conference-on-surgical-cancer-care/ 2023-05-05T17:51:55+00:00 https://ascopost.com/videos/2023-society-of-surgical-oncology-international-conference-on-surgical-cancer-care/judy-boughey-on-changes-in-axillary-surgical-management-an-ispy2-analysis/ 2023-05-29T22:48:02+00:00 https://ascopost.com/videos/2023-society-of-surgical-oncology-international-conference-on-surgical-cancer-care/kari-rosenkranz-on-breast-cancer-impact-of-breast-conservation-on-local-recurrence/ 2023-05-12T20:35:02+00:00 https://ascopost.com/videos/2023-society-of-surgical-oncology-international-conference-on-surgical-cancer-care/anita-mamtani-on-axillary-dissection-for-what-types-of-breast-cancer-can-it-be-avoided/ 2023-05-12T20:32:42+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/ 2023-05-26T13:49:49+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/marie-plante-on-cervical-cancer-new-data-on-hysterectomy-and-pelvic-node-dissection/ 2023-06-12T20:46:47+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/laquisa-c-hill-on-relapsed-or-refractory-t-all-new-data-on-cd5-car-t-cells/ 2023-06-23T18:03:32+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/sebastian-stintzing-on-colorectal-cancer-influence-of-liquid-biopsy-in-first-line-combination-treatment/ 2023-06-16T19:33:20+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/muhit-ozcan-on-dlbcl-early-results-on-zilovertamab-vedotin/ 2023-06-14T19:27:27+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/muhit-ozcan-on-dlbcl-now-recruiting-previously-untreated-patients-for-a-study-of-zilovertamab-vedotin-plus-chemotherapy/ 2023-06-14T19:34:14+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/eunice-s-wang-and-gregory-roloff-on-b-all-outcomes-with-brexucabtagene-autoleucel-in-adult-patients/ 2023-07-11T19:07:15+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/claire-roddie-on-b-all-safety-and-efficacy-data-of-obecabtagene-autoleucel/ 2023-06-15T21:02:02+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/thomas-e-hutson-on-rcc-overall-survival-analysis-of-lenvatinib-pembrolizumab-and-sunitinib/ 2023-06-23T18:13:19+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/thierry-conroy-on-rectal-cancer-long-term-results-on-mfolfirinox-vs-preoperative-chemoradiation-therapy/ 2023-06-20T21:27:12+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/alberto-bossi-on-prostate-cancer-peace-1-trial-findings-on-radiotherapy-plus-systemic-treatment/ 2023-06-28T19:29:37+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/tycel-j-phillips-and-alex-f-herrera-on-dlbcl-new-data-on-ctdna-status-and-clinical-outcomes/ 2023-06-16T19:26:30+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/tycel-j-phillips-and-alex-f-herrera-on-classical-hodgkin-lymphoma-new-data-on-nivolumab-avd-and-brentuximab-vedotin/ 2023-06-16T19:40:12+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/guillermo-garcia-manero-on-myelodysplastic-syndromes-luspatercept-and-epoetin-alfa-in-lower-risk-disease/ 2023-06-21T20:53:33+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/narjust-florez-and-roy-s-herbst-on-nsclc-overall-survival-analysis-from-the-adaura-trial-of-osimertinib/ 2023-07-10T18:34:27+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/manali-kamdar-on-primary-refractory-and-early-relapsing-dlbcl-therapeutic-options/ 2023-06-23T18:20:16+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/enrique-grande-on-metastatic-urothelial-carcinoma-updated-data-from-imvigor130/ 2023-06-21T15:54:43+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/shilpa-gupta-on-urothelial-carcinoma-long-term-outcome-of-enfortumab-vedotin-plus-pembrolizumab/ 2023-06-14T20:51:30+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/bradley-monk-on-cervical-cancer-findings-on-pembrolizumab-plus-chemotherapy/ 2023-06-16T19:24:49+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/amer-methqal-zeidan-on-myelodysplastic-syndromes-new-data-from-the-imerge-study-of-imetelstat/ 2023-06-23T19:44:11+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/narjust-florez-and-filippo-gustavo-dallolio-on-nsclc-new-findings-on-tumor-fraction-durvalumab-and-survival/ 2023-06-26T20:31:20+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/paula-aristizabal-on-surviving-childhood-leukemia-near-the-border-of-the-united-states-and-mexico/ 2023-06-23T18:45:41+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/jennifer-ligibel-on-early-breast-cancer-and-weight-loss-results-from-the-bwel-trial/ 2023-06-04T18:01:34+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/nagla-abdel-karim-on-small-cell-lung-cancer-swog-s1929-results-on-atezolizumab-plus-talazoparib/ 2023-06-20T21:25:13+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/tycel-phillips-and-swetha-kambhampati-on-mantle-cell-lymphoma-real-world-outcomes-with-brexucabtagene-autoleucel/ 2023-06-16T19:30:22+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/omid-hamid-on-advanced-melanoma-durable-response-with-fianlimab-plus-cemiplimab/ 2023-06-23T18:50:36+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/georgina-long-on-resected-melanoma-biomarkers-for-and-efficacy-of-adjuvant-nivolumab-vs-placebo/ 2023-06-23T19:06:59+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/christian-pfister-on-bladder-cancer-new-overall-survival-data-on-perioperative-chemotherapy/ 2023-06-21T20:55:57+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/bobbie-j-rimel-and-kathleen-n-moore-on-ovarian-cancer-new-findings-on-mirvetuximab-soravtansine-vs-chemotherapy/ 2023-06-16T19:32:42+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/bobbie-j-rimel-and-isabelle-l-ray-coquard-on-cervical-squamous-carcinoma-neoadjuvant-nivolumab-plus-ipilimumab/ 2023-06-16T19:35:15+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/bobbie-j-rimel-and-mansoor-r-mirza-on-endometrial-cancer-patient-reported-outcomes-with-dostarlimab-carboplatin-and-paclitaxel/ 2023-06-16T19:34:21+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/rana-r-mckay-and-toni-k-choueiri-on-rcc-new-findings-on-efficacy-and-safety-of-atezolizumab-plus-cabozantinib/ 2023-08-07T21:38:37+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/rana-r-mckay-and-brian-i-rini-on-clear-cell-rcc-new-data-from-keynote-426-on-pembrolizumab-plus-axitinib-vs-sunitinib/ 2023-06-23T20:48:37+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/allison-betof-warner-and-adnan-khattak-on-high-risk-resected-melanoma-survival-results-with-mrna-4157-and-pembrolizumab-in-keynote-942/ 2023-06-27T21:04:09+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/catherine-c-coombs-md-on-b-cell-malignancies-and-long-term-safety-of-pirtobrutinib/ 2023-06-27T13:56:25+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/funda-meric-bernstam-md-on-her2-expressing-solid-tumors-efficacy-and-safety-of-trastuzumab-deruxtecan/ 2023-06-26T20:46:18+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/nirav-n-shah-on-dlbcl-new-data-on-split-dose-r-chop-for-older-patients/ 2023-06-20T21:22:50+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/niravnshah-on-mantle-cell-lymphoma-follow-up-data-on-pirtobrutinib-in-pretreated-disease/ 2023-06-27T15:24:38+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/lisa-carey-and-dennis-slamon-on-early-breast-cancer-findings-from-the-natalee-trial-on-ribociclib-plus-endocrine-therapy/ 2023-06-12T21:01:26+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/lisa-deangelis-and-ingo-mellinghoff-on-glioma-phase-iii-results-on-vorasidenib/ 2023-06-26T20:00:31+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/lisa-carey-and-javier-cortes-on-her2-positive-early-breast-cancer-chemotherapy-de-escalation-under-study-in-phergain-trial/ 2023-08-03T19:53:38+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/narjust-florez-and-heather-wakelee-on-early-stage-nsclc-phase-iii-findings-from-keynote-671-on-pembrolizumab-and-platinum-based-chemotherapy/ 2023-06-14T15:55:51+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/jennifer-crombie-on-dlbcl-real-world-outcomes-with-novel-therapies-in-relapsed-or-refractory-disease/ 2023-06-28T15:39:39+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/jonathan-riess-on-egfr-mutated-non-small-cell-lung-cancer-whats-next/ 2023-07-12T18:39:14+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/jason-luke-on-melanoma-adjuvant-therapy-final-analysis-of-keynote-716/ 2023-06-16T19:31:38+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/sarah-tasian-on-hematologic-malignancies-in-children-expert-commentary/ 2023-06-26T19:43:23+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/arlene-siefker-radtke-on-metastatic-urothelial-carcinoma-new-data-on-erdafitinib-vs-chemotherapy-from-the-thor-study/ 2023-06-27T13:35:13+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/penelope-bradbury-on-pleural-mesothelioma-new-results-from-the-ind227-trial-of-cisplatin-and-pemetrexed-with-or-without-pembrolizumab/ 2023-06-05T21:24:46+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/alicia-morgans-and-praful-ravi-on-localized-prostate-cancer-prognostic-impact-of-psa-nadir/ 2023-06-28T20:53:53+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/arlene-siefker-radtke-on-metastatic-urothelial-carcinoma-new-data-on-erdafitinib-and-cetrelimab-from-the-norse-study/ 2023-06-23T21:03:01+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/cathy-eng-and-lars-henrik-jensen-on-locally-advanced-colon-cancer-efficacy-of-neoadjuvant-chemotherapy-and-standard-treatment/ 2023-06-28T20:36:31+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/smitha-krishnamurthi-and-deb-schrag-on-rectal-cancer-new-findings-on-chemoradiation-chemotherapy-and-excision/ 2023-06-12T20:58:20+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/allison-betof-warner-and-zeynep-eroglu-on-metastatic-melanoma-new-data-on-dabrafenib-trametinib-and-navitoclax/ 2023-06-28T18:38:43+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/james-chih-hsin-yang-on-metastatic-nonsquamous-nsclc-evaluating-pemetrexed-and-platinum-with-or-without-pembrolizumab/ 2023-06-28T15:48:39+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/tycelphillips-and-emanuele-zucca-on-primary-mediastinal-b-cell-lymphoma-new-data-on-observation-vs-radiotherapy/ 2023-06-12T21:04:53+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/alicia-morgans-and-karim-fizazi-on-prostate-cancer-phase-iii-results-on-talazoparib-plus-enzalutamide-as-first-line-treatment/ 2023-06-21T21:00:33+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/narjust-florez-and-ticiana-leal-on-metastatic-nsclc-tumor-treating-fields-therapy-after-platinum-resistance/ 2023-06-28T16:01:06+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/jennifer-woyach-on-new-findings-on-cll-covid-19-and-treatment-with-obinutuzumab-plus-venetoclax/ 2023-06-20T21:21:10+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/cathy-eng-and-thejus-jayakrishnan-on-colorectal-cancer-metabolomic-differences-in-young-onset-vs-average-onset-disease/ 2023-06-21T20:51:21+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/rami-manochakian-on-nsclc-commentary-on-the-adaura-trial-of-osimertinib/ 2023-06-29T19:31:59+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/narjust-florez-and-ferdinandos-skoulidis-on-nsclc-findings-on-sotorasib-vs-docetaxel-in-the-codebreak-200-trial/ 2023-06-13T13:50:43+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/reid-merryman-on-high-risk-follicular-lymphoma-new-data-on-epcoritamab-rituximab-and-lenalidomide/ 2023-06-26T19:48:27+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/clifford-hudis-on-asco-2023-perspectives-the-power-of-connecting-and-collaborating/ 2023-06-29T20:45:35+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/shailender-bhatia-on-merkel-cell-carcinoma-results-from-checkmate-358-on-nivolumab-with-or-without-ipilimumab/ 2023-07-05T19:06:47+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/carmen-guerra-on-diversity-equity-and-inclusion-in-clinical-trials/ 2023-06-29T13:54:41+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/aaron-gerds-on-anemia-in-myelofibrosis-new-data-on-treatment-with-luspatercept/ 2023-07-06T20:27:39+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/ajay-k-nooka-mbbs-high-risk-myeloma-data-on-carfilzomib-pomalidomide-and-dexamethasone/ 2023-09-22T16:34:14+00:00 https://ascopost.com/videos/2023-asco-annual-meeting/ajay-k-nooka-mbbs-relapsed-or-refractory-multiple-myeloma-efficacy-and-safety-data-for-elranatamab/ 2023-09-21T20:58:50+00:00 https://ascopost.com/videos/esmo-breast-cancer-annual-congress-2023/ 2023-05-31T14:45:31+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/ 2023-07-13T16:52:26+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/jennifer-brown-on-cll-resistance-to-pirtobrutinib-in-pretreated-disease/ 2023-07-13T17:00:24+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/matthew-j-frank-on-large-b-cell-lymphoma-new-data-on-cd22-car-t-cell-therapy/ 2023-08-01T19:23:18+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/arnon-kater-md-phd-on-cll-recent-data-on-venetoclax-ibrutinib-and-undetectable-mrd/ 2023-08-10T21:35:58+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/paolo-corradini-md-on-pmbcl-and-dlbcl-comparing-outcomes-with-axicabtagene-ciloleucel/ 2023-08-03T17:50:46+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/nigel-russell-on-acute-myeloid-leukemia-new-findings-on-flag-ida-and-gemtuzumab-ozogamicin/ 2023-08-09T17:17:04+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/rami-s-komrokji-on-myelodysplastic-neoplasms-classifying-risks-among-subsets-of-disease/ 2023-08-22T13:33:43+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/nikhil-munshi-on-multiple-myeloma-data-from-the-cartitude-1-study-of-ciltacabtagene-autoleucel/ 2023-09-06T19:41:53+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/nicholas-j-short-on-acute-lymphoblastic-leukemia-new-analysis-of-ponatinib-and-blinatumomab/ 2023-09-07T18:17:11+00:00 https://ascopost.com/videos/eha-hybrid-congress-2023/nicholas-j-short-on-acute-lymphoblastic-leukemia-phase-ii-findings-on-mini-hcvd-inotuzumab-and-blinatumomab/ 2023-09-08T16:51:04+00:00 https://ascopost.com/videos/2023-asco-breakthrough-meeting/ 2023-08-01T19:22:45+00:00 https://ascopost.com/videos/2023-asco-breakthrough-meeting/aaron-c-tan-phd-mbbs-on-circulating-tumor-dna-early-biomarker-of-therapeutic-response-in-phase-i-trials/ 2023-09-12T17:24:06+00:00 https://ascopost.com/videos/2023-asco-breakthrough-meeting/wei-wu-md-phd-on-lung-cancer-deep-learning-as-a-tool-for-identifying-drug-tolerant-persister-cells/ 2023-09-13T16:52:13+00:00 https://ascopost.com/videos/2023-asco-breakthrough-meeting/aki-morikawa-md-phd-on-brain-metastases-new-findings-on-predictive-drug-testing/ 2023-09-15T17:03:50+00:00 https://ascopost.com/videos/2023-asco-breakthrough-meeting/desheng-liang-md-phd-on-genetic-engineering-of-mesenchymal-stem-cells-for-cancer-therapy/ 2023-10-27T15:13:04+00:00 https://ascopost.com/videos/iaslc-2023-wclc/ 2023-11-16T22:54:32+00:00 https://ascopost.com/videos/iaslc-2023-wclc/tom-e-stinchcombe-md-on-nsclc-strategies-for-managing-secondary-primary-disease/ 2023-11-16T22:58:06+00:00 https://ascopost.com/videos/iaslc-2023-wclc/ticiana-a-leal-md-on-tumor-treating-fields-and-immune-checkpoint-inhibition-in-metastatic-nsclc/ 2023-11-16T22:58:11+00:00 https://ascopost.com/videos/iaslc-2023-wclc/david-h-harpole-jr-md-on-perioperative-durvalumab-plus-chemotherapy-in-resectable-nsclc/ 2023-11-16T22:58:53+00:00 https://ascopost.com/videos/iaslc-2023-wclc/chee-k-lee-phd-mbbs-on-durvalumab-tremelimumab-and-chemotherapy-in-nsclc/ 2023-11-16T23:00:11+00:00 https://ascopost.com/videos/iaslc-2023-wclc/yasir-y-elamin-md-on-brigatinib-in-alk-rearranged-metastatic-non-small-cell-lung-cancer/ 2023-11-16T23:00:17+00:00 https://ascopost.com/videos/iaslc-2023-wclc/shirish-m-gadgeel-md-on-pembrolizumab-plus-chemotherapy-for-metastatic-nsclc-5-year-follow-up/ 2023-11-16T23:00:48+00:00 https://ascopost.com/videos/iaslc-2023-wclc/seshiru-nakazawa-md-phd-on-nsclc-and-point-mutations-as-de-novo-oncogenic-drivers/ 2023-11-16T23:01:21+00:00 https://ascopost.com/videos/iaslc-2023-wclc/ilias-houda-md-phd-candidate-on-results-of-an-eortc-survey-on-nsclc-resectability/ 2023-11-16T23:01:53+00:00 https://ascopost.com/videos/iaslc-2023-wclc/xiuning-le-md-phd-on-update-on-the-use-of-tepotinib-to-treat-an-nsclc-subset/ 2023-11-16T23:03:36+00:00 https://ascopost.com/videos/iaslc-2023-wclc/gilberto-de-lima-lopes-jr-md-mba-on-lung-cancer-management-expert-update/ 2023-11-16T23:03:41+00:00 https://ascopost.com/videos/iaslc-2023-wclc/benjamin-besse-on-egfr-mutated-nsclc-update-on-patritumab-deruxtecan-in-previously-treated-disease/ 2023-11-16T23:05:02+00:00 https://ascopost.com/videos/2023-debates-and-didactics-in-hematology-and-oncology-conference/ 2023-09-21T15:58:18+00:00 https://ascopost.com/videos/2023-astro-annual-meeting/ 2023-10-03T14:17:30+00:00 https://ascopost.com/videos/2023-esmo-virtual-plenary/ 2023-10-13T14:30:59+00:00 https://ascopost.com/videos/esmo-congress-2023/ 2023-10-19T14:31:56+00:00 https://ascopost.com/videos/esmo-congress-2023/tina-cascone-on-nsclc-phase-iii-results-on-nivolumab-chemotherapy-and-surgery/ 2023-10-21T17:23:24+00:00 https://ascopost.com/videos/esmo-congress-2023/jonathan-spicer-on-early-stage-nsclc-survival-results-with-pembrolizumab/ 2023-10-30T15:53:25+00:00 https://ascopost.com/videos/esmo-congress-2023/ze-rui-zhao-on-resectable-nsclc-sbrt-with-sequential-immunochemotherapy/ 2023-10-31T15:13:43+00:00 https://ascopost.com/videos/esmo-congress-2023/hossein-borghaei-on-nonsquamous-nsclc-findings-on-sitravatinib-plus-nivolumab-vs-docetaxel/ 2023-11-01T14:56:53+00:00 https://ascopost.com/videos/esmo-congress-2023/mark-awad-on-nsclc-neoadjuvant-nivolumab-plus-ipilimumab-vs-chemotherapy/ 2023-11-06T19:58:41+00:00 https://ascopost.com/videos/esmo-congress-2023/peter-schmid-on-triple-negative-breast-cancer-updated-results-on-pembrolizumab-plus-chemotherapy/ 2023-11-07T15:32:24+00:00 https://ascopost.com/videos/esmo-congress-2023/nadia-harbeck-on-high-risk-early-breast-cancer-overall-survival-data-on-abemaciclib-plus-endocrine-therapy/ 2023-11-07T17:33:08+00:00 https://ascopost.com/videos/esmo-congress-2023/benjamin-besse-on-nsclc-safety-and-efficacy-data-on-novel-bispecific-antibody/ 2023-11-20T17:51:01+00:00 https://ascopost.com/videos/esmo-congress-2023/jarushka-naidoo-on-lung-cancer-practice-changing-advances-reported-at-esmo-2023/ 2023-11-21T19:25:25+00:00 https://ascopost.com/videos/2023-asco-quality-care-symposium/ 2023-10-26T14:07:44+00:00 https://ascopost.com/videos/2023-global-cardio-oncology-summit/ 2023-10-30T16:48:51+00:00 https://ascopost.com/videos/2023-nccn-annual-congress-hematologic-malignancies/ 2023-11-22T14:57:03+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/ 2023-12-04T16:39:03+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/william-catalona-on-genetic-testing-in-prostate-cancer/ 2023-12-04T16:41:00+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/samson-fine-on-clinical-significance-of-atypical-small-acinar-and-intraductal-proliferations-in-the-prostate/ 2023-12-05T17:21:04+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/mark-tyson-on-high-risk-non-muscle-invasive-bladder-cancer-a-potential-new-treatment/ 2023-12-06T16:48:25+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/stephen-freedland-on-managing-prostate-cancer-in-transgender-women/ 2023-12-07T16:29:50+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/rana-mckay-on-mutated-prostate-cancer-parp-inhibition-and-radical-prostatectomy/ 2024-01-02T17:42:52+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/sumanta-pal-on-prostate-cancer-impact-of-the-microbiome-on-immune-therapy/ 2024-02-02T18:47:00+00:00 https://ascopost.com/videos/24th-suo-annual-meeting/bishoy-faltas-on-upper-tract-urothelial-carcinoma-how-biology-shapes-therapy/ 2024-02-05T20:39:45+00:00 https://ascopost.com/videos/2023-sabcs/ 2023-12-07T18:45:35+00:00 https://ascopost.com/videos/2023-sabcs/sara-hurvitz-on-metastatic-breast-cancer-new-data-on-tucatinib-and-trastuzumab-emtansine/ 2023-12-07T18:47:06+00:00 https://ascopost.com/videos/2023-sabcs/amy-tiersten-on-metastatic-breast-cancer-a-possible-chemotherapy-free-front-line-regimen/ 2023-12-07T18:51:46+00:00 https://ascopost.com/videos/2023-sabcs/aditya-bardia-on-hr-positive-her2-negative-advanced-breast-cancer-datopotamab-deruxtecan-vs-chemotherapy/ 2023-12-11T19:46:08+00:00 https://ascopost.com/videos/2023-sabcs/gabriel-hortobagyi-on-final-invasive-disease-free-analysis-from-the-natalee-trial/ 2023-12-11T19:54:42+00:00 https://ascopost.com/videos/2023-sabcs/nicholas-turner-on-high-risk-early-stage-breast-cancer-profiling-primary-tumors/ 2023-12-11T20:03:28+00:00 https://ascopost.com/videos/2023-sabcs/senthil-damodaran-on-locally-advanced-or-metastatic-breast-cancer-phase-ii-results-on-futibatinib/ 2023-12-12T18:15:57+00:00 https://ascopost.com/videos/2023-sabcs/daniel-stover-on-early-stage-breast-cancer-a-biomarker-analysis-from-the-pallas-trial/ 2023-12-12T18:19:39+00:00 https://ascopost.com/videos/2023-sabcs/aditya-bardia-early-stage-high-risk-breast-cancer-new-data-on-pembrolizumab-plus-chemotherapy/ 2023-12-12T18:52:42+00:00 https://ascopost.com/videos/2023-sabcs/sherene-loi-on-triple-negative-breast-cancer-phase-ii-study-results-of-nivolumab-carboplatin-and-paclitaxel/ 2023-12-12T19:02:33+00:00 https://ascopost.com/videos/2023-sabcs/sherene-loi-on-biomarker-results-in-er-positive-her2-negative-primary-breast-cancer/ 2023-12-13T20:29:47+00:00 https://ascopost.com/videos/2023-sabcs/barbara-pistilli-update-on-capivasertib-plus-a-cdk46-inhibitor-and-fulvestrant/ 2023-12-13T20:40:29+00:00 https://ascopost.com/videos/2023-sabcs/oleg-gluz-on-response-to-endocrine-therapy-findings-from-the-adaptcycle-trial/ 2023-12-18T18:30:14+00:00 https://ascopost.com/videos/2023-sabcs/luca-gianni-on-locally-advanced-her2-positive-breast-cancer-new-data-on-neoadjuvant-therapy-and-atezolizumab/ 2024-01-04T14:36:06+00:00 https://ascopost.com/videos/2023-sabcs/daniel-kates-harbeck-and-nadia-harbeck-on-personalizing-breast-cancer-management-with-ai/ 2023-12-18T19:09:12+00:00 https://ascopost.com/videos/2023-sabcs/eleftherios-mamounas-on-locoregional-irradiation-axillary-lymph-node-involvement-and-conversion-to-negative-nodes/ 2023-12-18T19:52:10+00:00 https://ascopost.com/videos/2023-sabcs/hope-rugo-on-advanced-breast-cancer-patient-reported-outcomes-from-the-capitello-291-trial/ 2024-01-03T15:07:04+00:00 https://ascopost.com/videos/2023-sabcs/cynthia-ma-on-metastatic-breast-cancer-early-results-on-copanlisib-fulvestrant-and-abemaciclib/ 2024-01-02T19:22:04+00:00 https://ascopost.com/videos/2023-sabcs/peter-schmid-on-early-stage-tnbc-updated-survival-results-from-keynote-522/ 2024-01-03T17:21:55+00:00 https://ascopost.com/videos/2023-sabcs/seema-khan-on-ductal-carcinoma-in-situ-central-mri-and-a-12-gene-expression-assay-to-optimize-local-therapy/ 2024-01-12T18:46:49+00:00 https://ascopost.com/videos/2023-sabcs/reshma-jagsi-on-early-stage-breast-cancer-5-year-outcomes-with-endocrine-therapy-and-breast-conserving-surgery/ 2024-01-12T18:51:30+00:00 https://ascopost.com/videos/2023-sabcs/tnbc-trial-update-on-pembrolizumab-plus-olaparib-vs-pembrolizumab-plus-chemotherapy/ 2024-01-12T21:16:21+00:00 https://ascopost.com/videos/2023-ash/ 2023-12-11T20:53:14+00:00 https://ascopost.com/videos/2023-ash/jonathon-cohen-on-mantle-cell-lymphoma-new-data-on-pirtobrutinib/ 2023-12-14T18:46:23+00:00 https://ascopost.com/videos/2023-ash/danai-dima-on-multiple-myeloma-update-on-safety-and-efficacy-of-teclistamab/ 2023-12-14T19:17:53+00:00 https://ascopost.com/videos/2023-ash/bijal-shah-on-previously-treated-mantle-cell-lymphoma-brexucabtagene-autoleucel-and-pirtobrutinib/ 2023-12-18T14:40:51+00:00 https://ascopost.com/videos/2023-ash/pieter-sonneveld-on-newly-diagnosed-multiple-myeloma-daratumumab-plus-bortezomib-lenalidomide-and-dexamethasone/ 2023-12-18T17:42:50+00:00 https://ascopost.com/videos/2023-ash/darren-denjay-pan-on-multiple-myeloma-inflammatory-biomarkers-and-outcomes-after-car-t-cell-therapy/ 2023-12-18T21:56:34+00:00 https://ascopost.com/videos/2023-ash/mikkael-sekeres-on-therapies-for-hematologic-cancers/ 2023-12-18T22:00:09+00:00 https://ascopost.com/videos/2023-ash/william-wierda-on-use-of-pirtobrutinib-for-richter-transformation/ 2023-12-18T22:06:01+00:00 https://ascopost.com/videos/2023-ash/potential-clinical-uses-of-identifying-new-hematologic-malignancy-predisposition-gene/ 2024-01-02T20:29:36+00:00 https://ascopost.com/videos/2023-ash/sarah-rutherford-on-hodgkin-lymphoma-nivolumab-plus-avd-in-older-patients-with-advanced-stage-disease/ 2024-01-03T18:56:57+00:00 https://ascopost.com/videos/2023-ash/jennifer-woyach-on-cllsll-30-month-follow-up-and-subgroup-analysis-of-pirtobrutinib/ 2024-01-04T16:03:06+00:00 https://ascopost.com/videos/2023-ash/michael-wang-on-mantle-cell-lymphoma-new-results-on-ibrutinib-plus-venetoclax/ 2024-01-05T16:05:37+00:00 https://ascopost.com/videos/2023-ash/adam-kittai-on-richters-transformation-anti-cd19-car-t-cell-therapy/ 2024-01-08T15:55:54+00:00 https://ascopost.com/videos/2023-ash/sara-khan-on-the-gender-gap-in-receiving-nih-grants-for-hematology-research/ 2024-01-10T15:32:32+00:00 https://ascopost.com/videos/2023-ash/sanjal-desai-on-classical-hodgkin-lymphoma-improving-outcomes-with-pd-1-blockade/ 2024-01-10T18:42:32+00:00 https://ascopost.com/videos/2023-ash/andrew-srisuwananukorn-on-myelofibrosis-vs-essential-thrombocythemia-a-potential-new-clinical-decision-tool/ 2024-01-12T16:08:08+00:00 https://ascopost.com/videos/2023-ash/jeffrey-rubnitz-on-pediatric-aml-outcomes-and-racial-disparities/ 2024-01-12T20:24:42+00:00 https://ascopost.com/videos/2023-ash/mazyar-shadman-on-large-b-cell-lymphoma-autologous-transplantation-vs-car-t-cell-therapy/ 2024-01-12T20:33:08+00:00 https://ascopost.com/videos/2023-ash/harinder-gill-on-acute-promyelocytic-leukemia-assessing-the-use-of-oral-arsenic-trioxide-retinoic-acid-and-ascorbic-acid/ 2024-01-12T20:49:14+00:00 https://ascopost.com/videos/2023-ash/ibrahim-aldoss-on-kmt2a-rearranged-acute-leukemia-new-data-on-revumenib-monotherapy/ 2024-01-12T21:13:24+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/ 2024-01-19T15:35:53+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/michael-gibson-on-esophageal-cancer-expert-commentary-on-two-key-studies/ 2024-01-23T16:18:34+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/ken-kato-on-advanced-esophageal-cancer-biomarker-analyses-from-checkmate-648/ 2024-01-23T17:47:48+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/ian-chau-on-esophageal-squamous-cell-carcinoma-new-data-on-nivolumab-ipilimumab-and-chemotherapy/ 2024-01-24T19:36:42+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/manish-shah-on-esophageal-cancer-long-term-outcomes-of-pembrolizumab-and-chemotherapy/ 2024-01-26T19:44:54+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/frank-kullmann-on-metastatic-pancreatic-cancer-recent-data-on-gemcitabine-and-nab-paclitaxel/ 2024-01-26T19:57:41+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/anant-ramaswamy-on-advanced-gastric-cancers-new-findings-on-adding-docetaxel-to-doublet/ 2024-01-26T20:01:29+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/van-morris-on-colon-cancer-ctdna-as-a-predictive-biomarker/ 2024-01-29T17:56:36+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/riccardo-lencioni-on-hcc-tace-durvalumab-and-bevacizumab/ 2024-01-29T18:01:07+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/jennifer-yon-li-wo-on-colorectal-and-pancreatic-cancers-new-findings-on-sbrt-with-ipilimumab-and-nivolumab/ 2024-01-29T18:06:21+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/lorraine-chantrill-on-gastrointestinal-neuroendocrine-carcinomas-first-line-treatment-with-nab-paclitaxel-plus-carboplatin/ 2024-02-06T19:39:58+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/milind-javle-on-cholangiocarcinoma-new-data-on-tinengotinib-as-monotherapy/ 2024-01-29T18:21:08+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/yasunobu-ishizuka-on-gastric-cancer-does-nivolumab-infusion-time-of-day-matter/ 2024-01-29T18:24:46+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/dominik-modest-on-colorectal-cancer-health-related-quality-of-life-findings-from-codebreak-300/ 2024-01-29T18:30:18+00:00 https://ascopost.com/videos/2024-asco-gi-cancers-symposium/ian-chau-on-gastrointestinal-cancers-real-world-effectiveness-of-nivolumab-plus-chemotherapy/ 2024-01-29T18:49:54+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/ 2024-01-26T15:13:21+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/neeraj-agarwal-on-prostate-cancer-phase-iii-trial-update-on-cabozantinib-atezolizumab-and-hormonal-therapy/ 2024-01-29T20:54:53+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/maha-hussain-on-prostate-cancer-new-data-on-abiraterone-and-prednisone-plus-olaparib/ 2024-01-30T16:58:00+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/amanda-nizam-on-urothelial-carcinoma-study-results-on-enfortumab-vedotin-and-avelumab/ 2024-01-30T17:57:21+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/thomas-powles-on-rcc-patient-reported-outcomes-with-belzutifan-vs-everolimus/ 2024-01-30T18:03:32+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/syed-muneeb-alam-on-urothelial-carcinoma-microsatellite-instability-and-response-to-immune-checkpoint-blockade/ 2024-02-02T16:18:27+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/umang-swami-on-prostate-cancer-differences-in-genomic-transcriptomic-and-immune-landscape-based-on-site-of-metastasis/ 2024-02-02T16:35:12+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/saby-george-on-clear-cell-kidney-cancer-subcutaneous-vs-intravenous-nivolumab/ 2024-02-02T17:42:19+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/michiel-van-der-heijden-on-metastatic-urothelial-carcinoma-enfortumab-vedotin-plus-pembrolizumab-vs-chemotherapy/ 2024-02-05T18:28:38+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/enrique-grande-on-adrenocortical-carcinoma-phase-ii-results-on-cabozantinib-plus-atezolizumab/ 2024-02-05T20:09:26+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/david-aggen-on-advanced-bladder-cancer-her2-and-pd-l1-immunohistochemistry-and-her2-genomic-alterations/ 2024-02-05T20:13:44+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/andrew-johns-on-clear-cell-renal-cell-carcinoma-data-on-tivozanib-in-pretreated-patients/ 2024-02-05T20:20:52+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/thomas-powles-on-clear-cell-kidney-cancer-overall-survival-update-with-adjuvant-pembrolizumab/ 2024-02-05T20:26:24+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/rohit-jain-on-urothelial-carcinoma-new-data-on-cabozantinib-plus-pembrolizumab/ 2024-02-06T20:59:55+00:00 https://ascopost.com/videos/2024-asco-gu-cancers-symposium/andrea-apolo-on-urothelial-carcinoma-phase-iii-findings-on-pembrolizumab-vs-observation/ 2024-02-06T21:11:06+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/ 2024-02-29T15:12:14+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/nabil-saba-on-head-and-neck-cancer-long-term-survival-findings-with-pembrolizumab-and-cabozantinib/ 2024-03-06T17:51:55+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/christopher-barker-on-new-data-on-vismodegib-and-radiotherapy-for-basal-cell-carcinoma-of-the-head-and-neck/ 2024-03-06T17:52:15+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/nabil-saba-on-preventing-radiation-induced-mucositis-in-patients-with-squamous-cell-carcinoma-of-the-head-and-neck/ 2024-03-06T17:52:33+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/pooja-karukonda-on-coping-with-financial-toxicity-in-head-and-neck-cancer/ 2024-03-06T17:53:15+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/evan-graboyes-on-addressing-body-image-distress-critical-care-for-head-and-neck-cancer-survivors/ 2024-03-06T17:54:29+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/evan-graboyes-on-decreasing-delays-in-adjuvant-therapy-for-head-and-neck-cancer/ 2024-03-06T17:57:20+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/eleni-rettig-on-hpv-related-oropharyngeal-cancers-early-detection-and-disease-surveillance/ 2024-03-06T18:49:22+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/samuel-regan-and-benjamin-rosen-on-de-escalating-radiotherapy-for-hpv-related-oropharyngeal-cancer/ 2024-03-06T18:55:41+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/dan-zandberg-on-personalized-immunotherapy-for-hnscc-progress-report/ 2024-04-08T14:16:54+00:00 https://ascopost.com/videos/2024-multidisciplinary-head-and-neck-cancers-symposium/marcin-dzienis-on-update-on-pembrolizumab-carboplatin-and-paclitaxel-in-hnscc/ 2024-04-08T14:17:50+00:00 https://ascopost.com/videos/sgo-2024-annual-meeting-on-womens-cancer/ 2024-03-19T16:20:06+00:00 https://ascopost.com/videos/sgo-2024-annual-meeting-on-womens-cancer/brian-slomovitz-on-cervical-cancer-update-on-tisotumab-vedotin-vs-chemotherapy/ 2024-03-19T16:21:26+00:00 https://ascopost.com/videos/sgo-2024-annual-meeting-on-womens-cancer/mansoor-mirza-on-endometrial-cancer-update-on-combination-regimen-of-dostarlimab-chemotherapy-and-niraparib/ 2024-03-19T16:37:08+00:00 https://ascopost.com/videos/sgo-2024-annual-meeting-on-womens-cancer/mary-mccormack-on-locally-advanced-cervical-cancer-results-from-the-interlace-trial/ 2024-03-22T15:51:25+00:00 https://ascopost.com/videos/sgo-2024-annual-meeting-on-womens-cancer/anne-knisely-on-ovarian-cancer-and-the-implications-of-detecting-residual-disease-and-ctdna/ 2024-03-26T16:14:03+00:00 https://ascopost.com/videos/sgo-2024-annual-meeting-on-womens-cancer/matthew-powell-on-endometrial-cancer-overall-survival-update-on-dostarlimab-gxly-plus-chemotherapy/ 2024-03-27T17:39:44+00:00 https://ascopost.com/videos/sgo-2024-annual-meeting-on-womens-cancer/ana-oaknin-on-recurrent-cervical-cancer-new-findings-on-atezolizumab-bevacizumab-and-chemotherapy/ 2024-04-10T15:22:42+00:00 https://ascopost.com/videos/2024-ebcc/ 2024-03-21T14:53:02+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/ 2024-04-01T20:03:54+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/natalia-polidorio-on-triple-negative-breast-cancer-impact-of-race-on-treatment-efficacy/ 2024-04-01T20:09:33+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/heather-mcarthur-on-early-stage-high-risk-er-positive-her2-negative-breast-cancer-new-pcr-results-for-pembrolizumab-and-chemotherapy/ 2024-04-02T19:34:17+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/kerollos-wanis-on-risks-for-brca-mutation-carriers-treated-with-breast-conserving-therapy/ 2024-04-04T17:38:13+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/akhil-pachimatla-on-nsclc-a-link-between-image-based-measures-of-obesity-and-metabolic-pathways/ 2024-04-09T15:53:17+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/judy-boughey-on-de-escalating-axillary-surgery-after-chemotherapy-for-breast-cancer/ 2024-04-05T18:30:55+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/jenny-chang-on-new-findings-on-merkel-cell-carcinoma-and-neoadjuvant-immunotherapy/ 2024-04-23T17:45:45+00:00 https://ascopost.com/videos/2024-society-of-surgical-oncology-annual-meeting/sophia-mckinley-on-cutaneous-melanoma-outcomes-with-adjuvant-immunotherapy/ 2024-04-17T16:38:47+00:00 https://ascopost.com/videos/2024-miami-breast-cancer-conference/ 2024-04-04T14:52:04+00:00 https://ascopost.com/videos/aacr-annual-meeting-2024/ 2024-04-08T13:42:47+00:00 https://ascopost.com/videos/aacr-annual-meeting-2024/kelly-hunt-on-breast-cancer-and-neoadjuvant-therapy-expert-commentary/ 2024-04-30T18:08:17+00:00 https://ascopost.com/videos/aacr-annual-meeting-2024/pasi-janne-on-nsclc-osimertinib-chemotherapy-update-from-flaura2/ 2024-05-01T16:42:38+00:00 https://ascopost.com/videos/european-association-of-urology-congress-2024/ 2024-04-12T13:43:38+00:00 https://ascopost.com/videos/2024-nccn-annual-conference/ 2024-04-17T18:15:05+00:00 https://ascopost.com/videos/2024-nccn-annual-conference/william-gradishar-on-hr-positive-her2-negative-breast-cancer-management-update/ 2024-04-17T18:24:03+00:00 https://ascopost.com/videos/2024-nccn-annual-conference/natalie-callander-on-multiple-myeloma-management-updates/ 2024-04-17T18:26:54+00:00 https://ascopost.com/videos/2024-nccn-annual-conference/wendy-vogel-on-the-evolving-role-of-advanced-practice-providers-in-oncology-care/ 2024-04-23T17:10:01+00:00 https://ascopost.com/videos/2024-nccn-annual-conference/douglas-johnson-on-cutaneous-melanoma-treatment-updates/ 2024-04-25T19:03:42+00:00 https://ascopost.com/videos/digestive-disease-week-2024/ 2024-05-13T13:40:06+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xx/ 2024-05-13T15:00:13+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/ 2024-05-23T14:41:41+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/muhit-ozcan-on-cllsll-study-of-nemtabrutinib-venetoclax-and-rituximab/ 2024-06-17T19:24:32+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/toni-choueiri-on-rcc-biomarker-analysis-from-the-clear-trial/ 2024-07-19T18:57:24+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/xavier-leleu-on-multiple-myeloma-update-on-isatuximab-lenalidomide-dexamethasone-and-bortezomib/ 2024-06-17T19:27:30+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/tomasz-jankowski-on-non-small-cell-lung-cancer-new-data-on-a-telomere-targeting-agent/ 2024-06-17T19:34:45+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/fabrice-andre-on-breast-cancer-interim-analysis-from-destiny-breast07/ 2024-06-17T19:03:00+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/katherine-c-fuh-on-ovarian-cancer-new-data-on-batiraxcept-and-paclitaxel/ 2024-06-17T19:16:21+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/mazyar-shadman-on-chronic-lymphocytic-leukemia-update-on-btk-inhibitors/ 2024-06-12T20:48:03+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/mazyar-shadman-on-chronic-lymphocytic-leukemia-recruiting-for-the-celestial-tncll-study/ 2024-06-17T21:12:47+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/ana-c-garrido-castro-on-metastatic-breast-cancer-trial-update-on-sacituzumab-govitecan-with-or-without-pembrolizumab/ 2024-06-13T22:56:00+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/ana-c-garrido-castro-on-managing-metastatic-breast-cancer-in-2024/ 2024-06-13T22:54:21+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/denise-a-yardley-on-early-breast-cancer-findings-from-the-natalee-trial-on-patients-with-node-negative-disease/ 2024-06-17T21:08:35+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/anthony-m-joshua-on-low-risk-prostate-cancer-and-metformin-new-trial-data/ 2024-06-17T18:50:11+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/lisa-a-carey-and-kevin-kalinsky-on-advanced-breast-cancer-new-data-on-abemaciclib-and-fulvestrant-from-the-postmonarch-trial/ 2024-06-14T20:43:00+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/jens-marquardt-and-jens-hoeppner-on-esophageal-cancer-phase-iii-findings-on-chemotherapy-vs-chemoradiation/ 2024-06-12T20:37:44+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/lisa-a-carey-and-dejan-juric-on-breast-cancer-updates-from-the-inavo120-trial/ 2024-06-14T20:41:41+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/christian-u-blank-on-melanoma-potentially-practice-changing-results-from-the-nadina-trial/ 2024-06-17T19:22:15+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/don-s-dizon-on-ovarian-and-other-extrarenal-clear-cell-carcinomas-update-on-nivolumab-and-ipilimumab/ 2024-06-17T18:59:57+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/joseph-a-greer-phd-on-lung-cancer-telehealth-vs-in-person-palliative-care/ 2024-06-17T21:11:27+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/reshma-jagsi-and-christian-f-singer-on-early-stage-breast-cancer-adding-a-vaccine-to-neoadjuvant-systemic-therapy/ 2024-06-13T22:58:29+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/belinda-lee-on-early-stage-pancreatic-cancer-new-data-on-guiding-adjuvant-chemotherapy/ 2024-06-11T20:19:10+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/clifford-a-hudis-a-message-from-asco-s-ceo/ 2024-06-17T19:06:46+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/clifford-a-hudis-and-karen-e-knudsen-an-asco-american-cancer-society-partnership-to-benefit-patients/ 2024-06-17T19:05:41+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/melanoma-new-data-on-encorafenib-binimetinib-ipilimumab-and-nivolumab/ 2024-06-14T20:51:19+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/pauline-funchain-and-paolo-ascierto-on-advanced-melanoma-results-from-the-relativity-048-trial/ 2024-08-07T18:04:20+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/prostate-cancer-new-findings-on-classifying-patients-into-risk-groups/ 2024-06-14T20:35:48+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/david-andorsky-on-dlbcl-and-fl-new-data-on-use-of-subcutaneous-epcoritamab/ 2024-06-17T19:00:33+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/jean-marc-classe-on-ovarian-cancer-new-data-on-lymphadenectomy-from-the-caraco-trial/ 2024-06-17T19:10:51+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/suzanne-trudel-on-multiple-myeloma-results-from-the-dreamm-8-study/ 2024-06-17T21:09:54+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/luciano-j-costa-md-phd-on-multiple-myeloma-subgroup-analysis-of-cartitude-4-on-ciltacabtagene-autoleucel/ 2024-06-17T19:17:28+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/eva-ciruelos-on-her2-positive-and-pam50-luminal-breast-cancer-patricia-trial/ 2024-06-17T18:59:02+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/mostafa-eyada-on-oral-cyclophosphamide-plus-bevacizumab-in-recurrent-ovarian-cancer/ 2024-06-17T19:22:39+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/axel-hauschild-on-melanoma-findings-from-the-pivotal-trial-of-daromun-vs-surgery/ 2024-06-17T18:47:50+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/yucai-wang-md-phd-on-richter-transformation-of-cll-findings-on-combination-therapy-with-an-immune-checkpoint-inhibitor/ 2024-06-14T20:46:50+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/emily-podany-on-metastatic-breast-cancer-racial-differences-in-genomic-profiles-and-targeted-treatment-use/ 2024-06-17T18:56:32+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/peter-riedell-on-the-deb-study-dlbcl/ 2024-06-14T20:57:20+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/thierry-facon-on-multiple-myeloma-results-from-the-imroz-study-on-isatuximab-bortezomib-lenalidomide-and-dexamethasone/ 2024-06-17T19:33:33+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/peter-riedell-on-the-echelon-3-study-in-dlbcl/ 2024-06-14T20:56:12+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/allison-winter-on-richter-transformation-new-data-on-a-car-t-cell-treatment/ 2024-06-17T21:05:15+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/joshua-d-brody-on-follicular-lymphoma-new-data-on-epcoritamab-rituximab-and-lenalidomide/ 2024-06-17T19:15:07+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/sherene-loi-on-early-stage-breast-cancer-weighing-the-prognostic-value-of-ctdna-detection/ 2024-06-13T22:59:07+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/pierfranco-conte-on-early-stage-triple-negative-breast-cancer-trial-update-on-avelumab-as-adjuvant-treatment/ 2024-06-26T21:19:02+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/reshma-jagsi-and-tarah-j-ballinger-on-early-stage-breast-cancer-in-black-women-docetaxel-and-peripheral-neuropathy/ 2024-06-13T22:57:44+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/heather-wakelee-on-nsclc-impower010-survival-results-after-long-term-follow-up-of-atezolizumab-vs-best-supportive-care/ 2024-06-17T19:09:30+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/tony-mok-on-nsclc-adagrasib-vs-docetaxel-in-kras-g12c-mutated-disease/ 2024-06-14T20:45:21+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/alex-andrea-francoeur-on-endometrial-cancer-and-obesity-trends/ 2024-06-14T20:32:02+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/brian-rini-on-renal-cell-carcinoma-exploratory-biomarker-results/ 2024-06-14T20:36:11+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/narjust-florez-and-david-spigel-on-limited-stage-small-cell-lung-cancer-results-from-the-adriatic-study/ 2024-06-13T23:01:24+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/christos-kyriakopoulos-on-prostate-cancer-chaarted2-trial-results-on-cabazitaxel-and-abiraterone/ 2024-06-14T20:37:55+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/omid-hamid-on-cutaneous-melanoma-update-on-a-bispecific-protein-under-study/ 2024-07-02T16:39:02+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/urothelial-carcinoma-the-destiny-pan-tumor02-study-and-new-findings-on-sacituzumab-govitecan/ 2024-06-19T16:11:11+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/minesh-p-mehta-on-nsclc-tumor-treating-fields-for-brain-metastases/ 2024-06-17T19:20:05+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/jonathan-rosenberg-and-thomas-powles-on-urothelial-carcinoma-expert-commentary-on-two-key-abstracts/ 2024-06-12T20:41:14+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/narjust-florez-and-suresh-s-ramalingam-on-egfr-mutated-nsclc-update-on-osimertinib-and-chemoradiotherapy/ 2024-06-13T23:02:59+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/jeanne-tie-on-colon-cancer-new-data-on-ctdna-guiding-adjuvant-therapy/ 2024-06-17T19:13:34+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/efrat-dotan-on-pancreatic-cancer-in-older-adults-defining-the-optimal-treatment-approach/ 2024-06-17T18:54:05+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/yeon-hee-park-on-metastatic-breast-cancer-updated-survival-results-of-the-young-pearl-study/ 2024-06-17T19:29:14+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/laurence-albiges-on-renal-cell-carcinoma-biomarker-analysis-of-the-immotion010-study/ 2024-06-14T20:40:01+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/prostate-cancer-study-findings-on-health-related-quality-of-life-and-pain/ 2024-06-14T20:34:35+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/yukio-suzuki-on-endometrial-cancer-long-term-survival-outcomes-with-hormonal-therapy-in-reproductive-age-patients/ 2024-06-17T21:15:32+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/william-g-wierda-on-cllsll-updated-findings-on-ibrutinib-and-venetoclax/ 2024-06-17T21:14:25+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/multiple-myeloma-findings-from-the-perseus-trial-on-a-regimen-for-transplant-eligible-patients/ 2024-07-11T17:56:28+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/multiple-myeloma-moving-bcma-directed-therapies-to-earlier-use/ 2024-06-12T21:17:19+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/alicia-morgans-and-samuel-denmeade-on-prostate-cancer-results-from-the-transformer-trial/ 2024-06-14T20:32:39+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/yasmin-h-karimi-on-diffuse-large-b-cell-lymphoma-update-on-use-of-epcoritamab-plus-chemotherapy/ 2024-06-14T20:53:37+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/yasmin-h-karimi-on-large-b-cell-lymphoma-follow-up-on-subcutaneous-epcoritamab-monotherapy/ 2024-06-14T20:55:09+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/georgina-long-on-braf-mutated-melanoma-long-term-follow-up-of-adjuvant-dabrafenib-plus-trametinib-vs-placebo/ 2024-06-17T19:04:42+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/andrea-cercek-on-rectal-cancer-durable-complete-responses-to-pd-1-blockade-alone/ 2024-06-17T18:43:59+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/ai-in-the-clinic-understanding-how-to-use-this-21st-century-tool/ 2024-06-17T21:07:44+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/claudio-cerchione-on-staging-multiple-myeloma-new-findings-on-fdg-petct-scans-and-whole-body-mri/ 2024-06-17T18:52:11+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/her2-positive-breast-cancer-expert-commentary-on-treatments-under-study/ 2024-06-27T19:19:34+00:00 https://ascopost.com/videos/2024-asco-annual-meeting/molecular-profiling-prognosis-and-treatment-options-in-her2-positive-early-stage-breast-cancer/ 2024-06-27T19:25:37+00:00 https://ascopost.com/videos/endo-2024/ 2024-06-04T13:52:27+00:00 https://ascopost.com/videos/2024-american-society-of-breast-surgeons-annual-meeting/ 2024-06-14T14:29:09+00:00 https://ascopost.com/videos/2024-snmmi-annual-meeting/ 2024-06-17T14:06:52+00:00 https://ascopost.com/videos/2024-european-breast-cancer-conference/ 2024-07-18T15:34:06+00:00 https://ascopost.com/videos/ibc-west-2024/ 2024-07-18T19:55:02+00:00 https://ascopost.com/videos/ibc-west-2024/aditya-bardia-on-on-the-current-and-future-landscape-of-antibody-drug-conjugates/ 2024-07-24T19:51:02+00:00 https://ascopost.com/videos/ibc-west-2024/heather-mcarthur-on-immunotherapy-for-high-risk-early-stage-breast-cancer/ 2024-07-24T19:49:45+00:00 https://ascopost.com/videos/ibc-west-2024/aditya-bardia-on-novel-therapies-targeting-the-estrogen-receptor/ 2024-07-24T19:52:03+00:00 https://ascopost.com/videos/ibc-west-2024/sara-hurvitz-on-new-therapeutic-strategies-for-her2-positive-metastatic-disease-including-brain-metastases/ 2024-07-31T18:50:40+00:00 https://ascopost.com/videos/ibc-east-2024/ 2024-07-22T15:50:33+00:00 https://ascopost.com/videos/ibc-east-2024/paolo-tarantino-on-current-and-future-landscape-of-antibody-drug-conjugates/ 2024-07-24T19:53:20+00:00 https://ascopost.com/videos/ibc-east-2024/joseph-sparano-on-premenopausal-hr-positive-early-breast-cancer/ 2024-08-05T18:01:57+00:00 https://ascopost.com/videos/ibc-east-2024/kristin-rojas-on-improving-sexual-health-during-breast-cancer-treatment/ 2024-07-24T19:19:25+00:00 https://ascopost.com/videos/european-hematology-association-2024-congress/ 2024-08-01T13:59:18+00:00 https://ascopost.com/videos/2024-pan-pacific-lymphoma-conference/ 2024-08-01T18:44:47+00:00 https://ascopost.com/videos/2024-asco-breakthrough/ 2024-08-06T15:02:03+00:00 https://ascopost.com/videos/european-association-for-the-study-of-diabetes-annual-meeting-2024/ 2024-08-09T15:11:36+00:00 https://ascopost.com/videos/2024-debates-and-didactics-in-hematology-and-oncology/ 2024-08-13T16:35:40+00:00 https://ascopost.com/videos/2024-iaslc-wclc/ 2024-09-09T14:57:18+00:00 https://ascopost.com/videos/esmo-congress-2024/ 2024-09-13T17:00:19+00:00 https://ascopost.com/videos/esmo-congress-2024/ghassan-abou-alfa-and-lorenza-rimassa-on-unresectable-hepatocellular-carcinoma-5-year-overall-survival-results-from-the-himalaya-trial/ 2024-11-14T18:05:37+00:00 https://ascopost.com/videos/esmo-congress-2024/ghassan-abou-alfa-and-lorenza-rimassa-on-doublet-immunotherapy-for-unresectable-hcc/ 2024-11-14T18:06:53+00:00 https://ascopost.com/videos/esmo-congress-2024/josep-llovet-on-intermediate-stage-hepatocellular-carcinoma-addition-of-lenvatinib-plus-pembrolizumab-to-tace/ 2024-11-14T18:08:26+00:00 https://ascopost.com/videos/esmo-congress-2024/josep-llovet-on-treatment-options-in-hepatocellular-carcinoma/ 2024-11-14T18:11:06+00:00 https://ascopost.com/videos/esmo-congress-2024/rachna-shroff-on-advanced-hepatocellular-carcinoma-anlotinib-plus-penpulimab-vs-sorafenib/ 2024-11-14T17:57:45+00:00 https://ascopost.com/videos/esmo-congress-2024/maeve-lowery-on-a-novel-bifunctional-antibody-in-advanced-hepatocellular-carcinoma/ 2024-11-14T18:17:30+00:00 https://ascopost.com/videos/2024-world-cancer-congress/ 2024-09-17T15:57:25+00:00 https://ascopost.com/videos/2024-aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2024-09-23T15:46:13+00:00 https://ascopost.com/videos/2024-asco-quality-care-symposium/ 2024-09-24T16:52:11+00:00 https://ascopost.com/videos/nccn-oncology-policy-summit/ 2024-09-30T17:00:44+00:00 https://ascopost.com/videos/2024-astro-annual-meeting/ 2024-10-01T18:36:11+00:00 https://ascopost.com/videos/timely-topics/ 2024-10-11T17:05:47+00:00 https://ascopost.com/videos/timely-topics/julie-gralow-on-managing-iv-fluid-shortages-and-conserving-supply/ 2024-10-11T18:19:01+00:00 https://ascopost.com/videos/soho-2024/ 2024-10-14T14:34:09+00:00 https://ascopost.com/videos/acs-clinical-congress-2024/ 2024-10-21T15:52:16+00:00 https://ascopost.com/videos/36th-eortc-nci-aacr-symposium/ 2024-10-28T15:46:16+00:00 https://ascopost.com/videos/lynn-sage-breast-cancer-symposium-2024/ 2024-10-31T14:55:10+00:00 https://ascopost.com/videos/lynn-sage-breast-cancer-symposium-2024/frederick-howard-md-on-targeted-therapy-and-endocrine-therapy-in-the-patient-with-breast-cancer/ 2024-11-01T18:00:39+00:00 https://ascopost.com/videos/lynn-sage-breast-cancer-symposium-2024/charles-e-geyer-jr-on-management-of-the-patient-with-her2-positive-breast-cancer-in-2024/ 2024-11-07T18:12:34+00:00 https://ascopost.com/videos/lynn-sage-breast-cancer-symposium-2024/sunil-s-badve-md-frcpath-on-tumor-infiltrating-lymphocytes-in-the-patient-with-breast-cancer/ 2024-11-05T13:33:08+00:00 https://ascopost.com/videos/lynn-sage-breast-cancer-symposium-2024/william-gradishar-md-on-advances-in-endocrine-therapeutic-options-for-patients-with-er-positive-her2-negative-breast-cancer/ 2024-11-05T22:21:21+00:00 https://ascopost.com/videos/2024-international-myeloma-society-annual-meeting/ 2024-11-05T14:23:39+00:00 https://ascopost.com/videos/2024-global-cardio-oncology-summit/ 2024-11-05T15:32:19+00:00 https://ascopost.com/videos/2024-sitc-annual-meeting/ 2024-11-07T15:41:37+00:00 https://ascopost.com/videos/fda-asco-virtual-workshop-measuring-toxicity-in-reproductive-organs-during-oncology-drug-development/ 2024-11-14T14:16:28+00:00 https://ascopost.com/videos/iaslc-2024-asia-conference-on-lung-cancer/ 2024-11-19T14:52:32+00:00 https://ascopost.com/videos/2024-nccn-annual-congress-hematologic-malignancies/ 2024-11-19T15:44:18+00:00 https://ascopost.com/videos/42nd-annual-chemotherapy-foundation-symposium/ 2024-11-19T18:33:40+00:00 https://ascopost.com/videos/42nd-annual-chemotherapy-foundation-symposium/vered-stearns-on-shifting-patient-outcomes-updates-in-triple-negative-breast-cancer/ 2024-11-20T21:52:20+00:00 https://ascopost.com/videos/42nd-annual-chemotherapy-foundation-symposium/komal-jhaveri-on-antibody-drug-conjugates-in-breast-cancer/ 2024-12-03T20:00:25+00:00 https://ascopost.com/videos/42nd-annual-chemotherapy-foundation-symposium/tiffany-traina-on-advances-in-the-treatment-of-hr-positive-breast-cancer/ 2024-12-11T20:06:15+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/ 2024-12-11T18:37:45+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/nikolaos-katsivelos-and-john-levine-on-how-serial-clinical-and-biomarker-monitoring-during-treatment-can-stratify-patients-with-low-risk-gvhd/ 2024-12-18T17:07:57+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/maayan-levy-and-marco-ruella-on-how-a-ketogenic-diet-enhances-car-t-cell-antitumor-function-via-beta-hydroxybutyrate-bhb/ 2025-02-26T16:35:58+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/jennifer-r-brown-on-fixed-duration-acalabrutinibvenetoclax-in-fit-patients-with-cll-amplify-trial/ 2024-12-11T23:18:15+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/anne-sophie-michallet-on-mrd-guided-vs-standard-combination-therapy-for-select-untreated-patients-with-cll/ 2024-12-11T23:54:08+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/danielle-wolfe-cohen-on-mechanisms-of-relapse-in-b-cell-acute-lymphoblastic-leukemia/ 2024-12-16T18:37:31+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/nitin-jain-on-first-line-treatment-with-pirtobrutinib-based-regimen-in-cll/ 2024-12-19T19:08:36+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/rachel-e-rau-and-sumit-gupta-on-pediatric-b-cell-all-blinatumomab-added-to-chemotherapy-in-newly-diagnosed-disease/ 2024-12-12T00:13:26+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/timothy-s-fenske-on-lack-of-benefit-of-autologous-hematopoietic-cell-transplantation-in-mantle-cell-lymphoma-patients/ 2024-12-11T23:48:17+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/john-o-mascarenhas-on-relapsed-refractory-myelofibrosis-navtemadlin-vs-best-available-therapy-after-jak-inhibitor-treatment/ 2024-12-11T23:41:59+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/john-o-mascarenhas-md-on-myelofibrosis-novel-combination-of-imetelstat-plus-ruxolitinib/ 2024-12-11T23:57:53+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/matthew-s-davids-on-triplet-therapy-of-acalabrutinib-venetoclax-and-obinutuzumab-focus-on-tp53-aberrant-cll/ 2024-12-18T17:06:46+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/jenny-paredes-on-how-increased-fiber-intake-results-in-better-overall-survival-and-lower-gi-agvhd-in-allo-hct-recipients-and-pre-clinical-gvhd-models/ 2024-12-12T00:33:22+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/natalie-wuliji-and-mohamed-sorror-on-the-impact-of-socioeconomic-factors-on-access-to-and-outcomes-of-allogeneic-hematopoietic-cell-transplantation-for-aml/ 2024-12-23T20:10:59+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/hannah-choe-md-on-dynamics-of-overall-and-organ-specific-responses-to-axatilimab-in-chronic-graft-versus-host-disease-analysis-from-the-agave-201-study/ 2024-12-12T00:30:14+00:00 https://ascopost.com/videos/2024-ash-annual-meeting/erik-thiele-orberg-on-recovery-of-the-intestinal-microbiome-in-patients-at-day-100-after-allogeneic-stem-cell-transplantation-is-defined-by-microbial-metabolite-profiles-and-linked-to-long-term-outcomes/ 2024-12-12T00:37:22+00:00 https://ascopost.com/videos/thematic-newsreels/ 2024-12-20T01:31:48+00:00 https://ascopost.com/videos/thematic-newsreels/ovarian-cancer-2024-year-at-a-glance-part-1/ 2024-11-27T20:14:00+00:00 https://ascopost.com/videos/thematic-newsreels/ovarian-cancer-2024-year-at-a-glance-part-2/ 2024-11-27T19:43:02+00:00 https://ascopost.com/videos/thematic-newsreels/til-therapy-for-advanced-melanoma-innovative-clinical-advances-in-treatment/ 2025-03-04T19:48:00+00:00 https://ascopost.com/videos/thematic-newsreels/oral-serds-in-breast-cancer-state-of-the-science/ 2025-07-01T14:46:28+00:00 https://ascopost.com/videos/thematic-newsreels/mrd-testing-recent-data-and-ongoing-efforts/ 2026-01-14T20:56:53+00:00 https://ascopost.com/videos/thematic-newsreels/ctdna-monitoring-in-standard-of-care-crc-surveillance/ 2025-08-01T15:10:23+00:00 https://ascopost.com/videos/thematic-newsreels/oral-vs-injectable-agents-for-androgen-deprivation-therapy-in-prostate-cancer/ 2026-01-26T16:27:23+00:00 https://ascopost.com/videos/thematic-newsreels/combination-treatment-and-patient-selection-for-relugolix-vs-leuprolide/ 2026-01-06T19:24:00+00:00 https://ascopost.com/videos/thematic-newsreels/managing-anemia-and-thrombocytopenia-in-patients-with-myelofibrosis/ 2025-10-30T14:28:51+00:00 https://ascopost.com/videos/thematic-newsreels/jak-inhibitors-and-beyond/ 2025-10-30T14:36:46+00:00 https://ascopost.com/videos/thematic-newsreels/immunotherapy-in-advanced-unresectable-cscc/ 2025-12-11T15:39:13+00:00 https://ascopost.com/videos/thematic-newsreels/neoadjuvant-and-adjuvant-treatment-in-cscc/ 2025-12-11T15:42:58+00:00 https://ascopost.com/videos/thematic-newsreels/adjuvant-therapy-in-melanoma-how-does-gep-testing-factor-in/ 2026-03-16T15:06:25+00:00 https://ascopost.com/videos/thematic-newsreels/use-of-gep-for-slnb-and-follow-up-planning-in-melanoma/ 2026-03-16T15:14:17+00:00 https://ascopost.com/videos/quantitative-imaging-workshop-xxi/ 2024-12-05T15:32:45+00:00 https://ascopost.com/videos/2024-jadpro-live/ 2024-12-05T16:48:57+00:00 https://ascopost.com/videos/2024-jadpro-live/justin-arnall-on-complicating-factors-when-malignancy-and-non-malignant-hematology-collide/ 2024-12-12T16:31:27+00:00 https://ascopost.com/videos/2024-jadpro-live/kathryn-newlin-on-updates-in-hr-positive-her2-negative-metastatic-breast-cancer/ 2024-12-13T21:40:06+00:00 https://ascopost.com/videos/2024-jadpro-live/cara-norelli-on-managing-dermatologic-side-effects-in-patients-with-cancer/ 2024-12-16T18:17:21+00:00 https://ascopost.com/videos/rsna-2024-annual-meeting/ 2024-12-06T14:28:21+00:00 https://ascopost.com/videos/2024-sabcs/ 2025-01-07T16:12:11+00:00 https://ascopost.com/videos/2024-sabcs/sibylle-loibl-on-primary-results-of-the-randomized-phase-iii-padma-study-in-her2-negative-hr-positive-metastatic-breast-cancer/ 2025-01-07T16:21:23+00:00 https://ascopost.com/videos/2024-sabcs/mafalda-oliveira-on-primary-results-of-solti-valentine/ 2025-01-07T16:22:58+00:00 https://ascopost.com/videos/2024-sabcs/aditya-bardia-on-destiny-breast06-an-additional-analysis/ 2025-01-07T16:24:02+00:00 https://ascopost.com/videos/2024-sabcs/adrienne-waks-on-margot-tbcrc052-phase-ii-trial-in-her2-positive-breast-cancer/ 2025-01-07T16:24:06+00:00 https://ascopost.com/videos/2024-sabcs/nan-chen-on-impact-of-anthracyclines-in-high-genomic-risk-node-negative-hr-positive-her2-negative-breast-cancer/ 2025-01-10T19:54:26+00:00 https://ascopost.com/videos/2024-sabcs/andrew-tutt-on-olympia-high-risk-brca-positive-breast-cancer/ 2025-02-03T20:49:29+00:00 https://ascopost.com/videos/2024-sabcs/jame-abraham-md-facp-on-the-phase-iii-zest-trial/ 2025-03-19T18:41:42+00:00 https://ascopost.com/videos/2024-sabcs/jame-abraham-md-facp-on-the-patina-trial/ 2025-01-14T18:55:02+00:00 https://ascopost.com/videos/2024-sabcs/komal-jhaveri-md-facp-on-the-phase-iii-ember-trial/ 2025-03-21T17:49:52+00:00 https://ascopost.com/videos/2024-sabcs/sherko-kuemmel-md-on-final-survival-results-from-the-wsg-adapt-hrplusher2-negative-chemotherapy-trial/ 2025-01-09T21:16:33+00:00 https://ascopost.com/videos/2025-asco-gi/ 2025-01-24T18:28:02+00:00 https://ascopost.com/videos/2025-asco-gi/a-blood-based-test-for-colorectal-cancer-screening/ 2025-01-24T21:06:32+00:00 https://ascopost.com/videos/2025-asco-gi/first-results-from-checkmate-8hw/ 2025-01-27T15:49:54+00:00 https://ascopost.com/videos/2025-asco-gi/phase-iii-starter-net-study-in-gep-net/ 2025-01-27T15:55:38+00:00 https://ascopost.com/videos/2025-asco-gi/breakwater-study-in-braf-v600-mutant-metastatic-colorectal-cancer/ 2025-01-27T17:08:20+00:00 https://ascopost.com/videos/2025-asco-gi/fresco-2-study-in-metastatic-colorectal-cancer/ 2025-01-30T20:34:48+00:00 https://ascopost.com/videos/2025-asco-gi/alascca-trial-in-colorectal-cancer/ 2025-01-30T20:33:19+00:00 https://ascopost.com/videos/2025-sts-annual-meeting/ 2025-01-28T15:26:24+00:00 https://ascopost.com/videos/2025-asco-gu/ 2025-02-13T17:05:36+00:00 https://ascopost.com/videos/2025-asco-gu/exercise-therapy-for-patients-with-advanced-prostate-cancer/ 2025-02-13T17:09:14+00:00 https://ascopost.com/videos/2025-asco-gu/adt-option-transdermal-estradiol-patches/ 2025-02-13T17:31:29+00:00 https://ascopost.com/videos/2025-asco-gu/mrcpc-lupsma-with-or-without-arpis/ 2025-02-19T18:31:32+00:00 https://ascopost.com/videos/2025-asco-gu/mobile-prostate-cancer-clinical-unit/ 2025-02-19T20:05:18+00:00 https://ascopost.com/videos/2025-asco-gu/specialized-diet-in-men-on-active-surveillance-for-prostate-cancer/ 2025-02-20T19:25:57+00:00 https://ascopost.com/videos/2025-asco-gu/hrr-deficient-mcrpc-final-overall-survival-in-talapro-2/ 2025-02-21T17:09:44+00:00 https://ascopost.com/videos/2025-asco-gu/mcrpc-talazoparib-plus-enzalutamide-as-first-line-treatment/ 2025-02-21T17:15:42+00:00 https://ascopost.com/videos/2025-asco-gu/ezh2-inhibitor-plus-enzalutamide-in-mcrpc/ 2025-02-24T17:01:29+00:00 https://ascopost.com/videos/2025-tandem-meetings/ 2025-02-20T19:30:18+00:00 https://ascopost.com/videos/2025-tandem-meetings/research-highlights-in-gvhd/ 2025-02-20T19:33:53+00:00 https://ascopost.com/videos/2025-tandem-meetings/rock12-inhibition-and-gvhd/ 2025-02-21T19:18:41+00:00 https://ascopost.com/videos/2025-tandem-meetings/alpha-1-antitrypsin-for-high-risk-acute-gvhd/ 2025-02-24T16:45:20+00:00 https://ascopost.com/videos/2025-tandem-meetings/posttransplant-gvhd-prophylaxis-strategy/ 2025-02-24T16:50:32+00:00 https://ascopost.com/videos/aha-epi-lifestyle-scientific-sessions-2025/ 2025-03-12T14:48:42+00:00 https://ascopost.com/videos/sgo-2025-annual-meeting-on-womens-cancer/ 2025-03-17T15:17:33+00:00 https://ascopost.com/videos/2025-miami-breast-cancer-conference/ 2025-03-19T14:24:32+00:00 https://ascopost.com/videos/eau-congress-2025/ 2025-03-25T14:19:15+00:00 https://ascopost.com/videos/eco-2025/ 2025-03-26T14:12:24+00:00 https://ascopost.com/videos/2025-sso-annual-meeting/ 2025-04-04T13:54:47+00:00 https://ascopost.com/videos/2025-aacr-annual-meeting/ 2025-04-28T14:12:43+00:00 https://ascopost.com/videos/ddw-2025/ 2025-04-30T19:51:40+00:00 https://ascopost.com/videos/estro-2025/ 2025-05-08T15:21:28+00:00 https://ascopost.com/videos/2025-asbrs-annual-meeting/ 2025-05-13T14:11:32+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/ 2025-05-30T13:28:59+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/william-g-wierda-on-fixed-duration-ibrutinib-and-venetoclax-in-first-line-cll/ 2025-06-01T12:43:16+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/william-wierda-on-lisocabtagene-maraleucel-in-relapsed-refractory-cll-transcend-cll-004/ 2025-06-01T12:48:11+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/giuseppe-curigliano-on-patient-reported-outcomes-from-ember-3/ 2025-05-31T18:47:07+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/nicholas-c-turner-on-inavo120-final-overall-survival-analysis/ 2025-06-01T14:47:16+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/constantine-si-lun-tam-on-cll-sll-first-line-zanubrutinib-monotherapy-in-patients-with-del17p/ 2025-06-01T04:07:23+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/christopher-m-booth-on-a-structured-exercise-program-for-patients-with-colon-cancer/ 2025-06-01T12:19:31+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/andrew-kuykendall-on-hepcidin-mimetic-for-polycythemia-vera/ 2025-06-01T12:26:51+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/stuart-j-wong-on-adjuvant-regimen-in-resected-hnscc/ 2025-06-01T14:29:46+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/nicholas-c-turner-on-treating-emergent-esr1-mutations-in-advanced-breast-cancer/ 2025-06-02T16:41:03+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/raffaele-califano-on-egfr-mutant-advanced-nsclc-mariposa-2/ 2025-08-15T18:01:49+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/yelena-y-janjigian-on-gastric-gej-cancer-immunotherapy-plus-flot/ 2025-06-01T19:00:34+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/mazyar-shadman-on-doublet-for-treatment-naive-cll-sll/ 2025-06-02T03:33:36+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/heinz-josef-lenz-on-msihdmmr-metastatic-colorectal-cancer-expanded-analyses-from-checkmate-8hw/ 2025-06-02T02:49:01+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/clifford-a-hudis-on-asco-guidelines-assistant/ 2025-10-30T14:35:32+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/andrew-j-armstrong-md-ms-on-arches-5-year-overall-survival-follow-up/ 2025-06-04T15:02:17+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/david-allen-barbie-on-clinical-and-molecular-features-of-participants-in-the-adriatic-trial/ 2025-06-01T21:27:39+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/mafalda-oliveira-on-how-does-hyperglycemia-affect-treatment-of-advanced-breast-cancer/ 2025-06-23T16:29:06+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/arelis-esther-martir-negron-on-prevalence-of-brca-variants-in-hispanic-residents-of-south-florida/ 2025-06-20T17:25:15+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/sara-m-tolaney-on-pd-l1-positive-advanced-tnbc-first-line-doublet-comparison/ 2025-06-02T02:13:45+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/elena-elez-on-updated-survival-data-from-the-breakwater-trial/ 2025-06-02T02:17:49+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/karen-eubanks-jackson-on-receiving-the-2025-asco-patient-advocate-award/ 2025-06-02T02:23:55+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/manmeet-singh-ahluwalia-on-liquid-biopsy-in-glioblastoma/ 2025-06-02T02:30:20+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/sameek-roychowdhury-on-telemedicine-in-clinical-trials/ 2025-06-02T02:41:49+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/angela-r-bradbury-on-genetic-testing-approach-in-patients-with-metastatic-cancers/ 2025-06-02T03:30:09+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/david-r-spigel-on-nsclc-treatment-planning-role-of-14-gene-molecular-assay/ 2025-06-02T03:28:54+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/stephen-kl-chia-on-advanced-her2-negative-and-er-positive-breast-cancer-serd-and-akt-inhibitor/ 2025-06-02T03:27:11+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/alicia-latham-on-using-ctdna-to-detect-endometrial-cancer/ 2025-06-05T16:59:10+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/frank-a-sinicrope-on-adjuvant-treatment-strategies-for-stage-iii-dmmr-colon-cancer/ 2025-06-26T14:11:53+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/martin-reck-on-postsurgical-mrd-genomic-mutations-and-outcomes-in-resectable-nsclc-aegean-trial/ 2025-06-05T17:00:31+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/asaf-maoz-on-pancreatic-surveillance-eligibility-criteria/ 2025-06-04T14:35:48+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/asaf-maoz-on-li-fraumeni-syndrome-multimodality-screening-program/ 2025-06-04T14:37:38+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/rami-manochakian-on-tarlatamab-vs-chemotherapy-for-second-line-treatment-of-sclc-expert-point-of-view/ 2025-06-26T14:29:05+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/alicia-k-morgans-on-how-does-androgen-receptor-inhibition-affect-quality-of-life/ 2025-06-11T17:19:07+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/d-james-on-using-ai-to-identify-benefit-from-prostate-cancer-therapy/ 2025-10-30T14:33:53+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/bjorn-henning-gronberg-md-phd-on-sclc-adjuvant-immunotherapy-after-crt/ 2025-06-08T00:51:07+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/jamie-e-chaft-on-resectable-egfr-mutated-nsclc-neoadaura-results/ 2025-07-17T18:06:00+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/shahzad-raza-on-relapsed-or-refractory-al-amyloidosis-first-us-trial-of-car-t-cell-therapy/ 2025-07-18T18:33:36+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/nitin-jain-on-front-line-therapies-for-cll-research-highlights-from-asco-2025/ 2025-06-08T00:53:24+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/luis-g-paz-ares-on-imforte-trial-in-extensive-stage-sclc/ 2025-06-08T01:15:59+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/luis-g-paz-ares-on-extensive-stage-sclc-comparison-of-first-line-regimens/ 2025-06-05T21:17:07+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/suneel-kamath-on-disparities-in-nih-and-federal-funding-across-different-cancer-types/ 2025-06-06T14:40:02+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/praful-ravi-on-high-risk-localized-prostate-cancer-docetaxel-with-adt-and-radiotherapy/ 2025-06-26T14:24:33+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/eric-bent-on-oligometastatic-prostate-cancer-intensified-hormonal-blockade/ 2025-06-26T14:31:02+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/neil-iyengar-on-cancer-risk-reduction-effects-of-menopausal-hrt-and-glp-1-ras/ 2025-06-06T15:39:47+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/breast-cancer-data-highlights-sequencing-of-endocrine-therapy/ 2025-06-06T16:18:41+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/violaine-randrian-on-lynch-syndrome-genetics-and-immunotherapy/ 2025-06-26T14:27:14+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/ruben-a-mesa-on-essential-thrombocythemia-surpass-et-trial/ 2025-06-26T14:08:08+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/gerhardt-attard-on-the-amplitude-trial/ 2025-06-16T15:46:21+00:00 https://ascopost.com/videos/2025-asco-annual-meeting/erika-hamilton-on-the-veritac-2-trial/ 2025-06-16T15:54:46+00:00 https://ascopost.com/videos/eha-2025-congress/ 2025-06-19T14:32:49+00:00 https://ascopost.com/videos/soho-2025/ 2025-09-05T14:12:17+00:00 https://ascopost.com/videos/soho-2025/car-t-cell-therapy-for-adult-patients-with-rr-b-cell-all/ 2025-09-05T14:15:35+00:00 https://ascopost.com/videos/soho-2025/aml-highlights-of-ongoing-research/ 2025-09-05T14:19:18+00:00 https://ascopost.com/videos/soho-2025/btk-degrader-in-relapsed-or-refractory-cll/ 2025-09-09T17:57:30+00:00 https://ascopost.com/videos/soho-2025/enable-study-in-heavily-pretreated-patients-with-cml/ 2025-09-15T14:51:50+00:00 https://ascopost.com/videos/soho-2025/debate-lower-intensity-regimens-in-aml/ 2025-09-16T19:08:11+00:00 https://ascopost.com/videos/soho-2025/focus-on-tp53-mutated-all/ 2025-10-13T17:28:26+00:00 https://ascopost.com/videos/soho-2025/car-t-cell-therapy-in-all/ 2025-10-02T15:52:11+00:00 https://ascopost.com/videos/iaslc-wclc-2025/ 2025-09-08T14:51:35+00:00 https://ascopost.com/videos/iaslc-wclc-2025/aumolertinib-plus-chemotherapy-in-egfr-mutated-nsclc/ 2025-09-09T16:52:43+00:00 https://ascopost.com/videos/iaslc-wclc-2025/concurrent-and-consolidation-durvalumab-for-unresectable-stage-iii-nsclc/ 2025-09-10T15:26:22+00:00 https://ascopost.com/videos/iaslc-wclc-2025/perioperative-immunotherapy-for-resectable-nsclc-hrqol-outcomes/ 2025-09-11T19:40:10+00:00 https://ascopost.com/videos/iaslc-wclc-2025/egfr-mutated-nsclc-subcutaneous-amivantamab-plus-lazertinib/ 2025-09-15T14:34:42+00:00 https://ascopost.com/videos/iaslc-wclc-2025/ros1-fusion-positive-nsclc-efficacy-of-zidesamtinib/ 2025-09-15T14:46:26+00:00 https://ascopost.com/videos/iaslc-wclc-2025/extensive-stage-sclc-tarlatamab-plus-anti-pd-l1-as-maintenance-therapy/ 2025-09-18T16:45:05+00:00 https://ascopost.com/videos/iaslc-wclc-2025/alk-positive-nsclc-crizotinib-vs-observation-for-surgically-resected-early-stage-disease/ 2025-09-18T15:42:54+00:00 https://ascopost.com/videos/iaslc-wclc-2025/zongertinib-in-patients-with-previously-treated-her2-mutant-nsclc-and-baseline-brain-metastases/ 2025-09-23T19:16:10+00:00 https://ascopost.com/videos/iaslc-wclc-2025/what-is-the-optimal-upper-age-limit-for-lung-cancer-screening/ 2025-09-30T15:59:48+00:00 https://ascopost.com/videos/2025-debates-and-didactics-in-hematology-and-oncology/ 2025-09-17T17:15:17+00:00 https://ascopost.com/videos/2025-astro-annual-meeting/ 2025-09-30T14:44:40+00:00 https://ascopost.com/videos/2025-asco-quality-care-symposium/ 2025-10-07T16:14:30+00:00 https://ascopost.com/videos/acs-clinical-congress-2025/ 2025-10-09T18:37:40+00:00 https://ascopost.com/videos/esmo-congress-2025/ 2025-10-17T13:44:24+00:00 https://ascopost.com/videos/esmo-congress-2025/platinum-resistant-recurrent-ovarian-cancer-pembrolizumab-plus-weekly-paclitaxel/ 2025-11-19T19:38:13+00:00 https://ascopost.com/videos/esmo-congress-2025/high-risk-ovarian-cancer-weekly-dose-dense-and-every-3-week-chemotherapy-plus-bevacizumab/ 2025-11-26T14:56:38+00:00 https://ascopost.com/videos/esmo-congress-2025/platinum-resistant-ovarian-cancer-relacorilant-and-nab-paclitaxel-in-pretreated-patients/ 2025-12-02T15:22:25+00:00 https://ascopost.com/videos/jadpro-live-2025/ 2025-11-25T15:58:57+00:00 https://ascopost.com/videos/jadpro-live-2025/jadpro-live-2025-united-in-care/ 2025-11-25T16:00:46+00:00 https://ascopost.com/videos/ash-2025/ 2025-12-08T16:28:05+00:00 https://ascopost.com/videos/ash-2025/multiple-myeloma-burixafor-and-propranolol-with-g-csf-before-transplant/ 2025-12-07T15:28:31+00:00 https://ascopost.com/videos/ash-2025/r-r-b-cell-all-real-world-data-on-brexucabtagene-autoleucel-and-transplant/ 2025-12-07T17:17:09+00:00 https://ascopost.com/videos/ash-2025/b-cell-all-brexucabtagene-autoleucel-as-consolidation-therapy/ 2025-12-07T17:21:07+00:00 https://ascopost.com/videos/ash-2025/imetelstat-for-lower-risk-mds-long-term-outcomes-from-the-imerge-trial/ 2025-12-07T20:20:54+00:00 https://ascopost.com/videos/ash-2025/older-adults-with-b-cell-all-cd19-car-t-cell-therapy/ 2025-12-07T22:16:51+00:00 https://ascopost.com/videos/ash-2025/ph-positive-all-tki-plus-inotuzumab-ozogamicin-based-therapy/ 2025-12-17T16:15:14+00:00 https://ascopost.com/videos/ash-2025/previously-untreated-cll-fixed-duration-vs-continuous-targeted-treatment/ 2025-12-08T15:11:04+00:00 https://ascopost.com/videos/ash-2025/newly-diagnosed-aml-azacitidine-and-venetoclax-vs-conventional-induction-chemotherapy/ 2025-12-08T15:24:43+00:00 https://ascopost.com/videos/ash-2025/anitocabtagene-autoleucel-for-relapsedrefractory-multiple-myeloma/ 2025-12-08T15:27:37+00:00 https://ascopost.com/videos/ash-2025/novel-quadruplet-for-relapsedrefractory-multiple-myeloma/ 2025-12-08T16:03:59+00:00 https://ascopost.com/videos/ash-2025/mds-research-highlights-from-ash-2025/ 2025-12-08T16:08:51+00:00 https://ascopost.com/videos/ash-2025/newly-diagnosed-multiple-myeloma-ultradeep-whole-genome-sequencing-of-cfdna/ 2025-12-08T16:12:21+00:00 https://ascopost.com/videos/ash-2025/using-an-ai-system-to-identify-patients-eligible-for-a-polycythemia-vera-trial/ 2025-12-08T16:22:25+00:00 https://ascopost.com/videos/ash-2025/relapsedrefractory-multiple-myeloma-novel-doublet-in-patients-with-extramedullary-disease/ 2025-12-08T16:30:54+00:00 https://ascopost.com/videos/ash-2025/ultra-high-risk-multiple-myeloma-radar-trial-in-newly-diagnosed-transplant-eligible-patients/ 2025-12-08T18:14:53+00:00 https://ascopost.com/videos/ash-2025/pausing-or-discontinuing-elranatamab/ 2025-12-08T19:21:15+00:00 https://ascopost.com/videos/ash-2025/higher-risk-mds-bexmarilimab-and-azacitidine/ 2025-12-08T19:24:48+00:00 https://ascopost.com/videos/ash-2025/cllsll-pirtobrutinib-vs-ibrutinib-in-treatment-naive-and-relapsedrefractory-disease/ 2025-12-08T19:56:31+00:00 https://ascopost.com/videos/ash-2025/relapsedrefractory-cll-next-generation-btk-inhibitor/ 2025-12-08T19:59:43+00:00 https://ascopost.com/videos/ash-2025/lower-risk-mds-treatment-emergent-cytopenias-and-clinical-response/ 2025-12-12T18:51:01+00:00 https://ascopost.com/videos/ash-2025/tp53-mutated-higher-risk-mds-bexmarilimab-plus-azacitidine/ 2025-12-12T21:44:59+00:00 https://ascopost.com/videos/ash-2025/multiple-myeloma-real-world-outcomes-with-elranatamab/ 2025-12-15T19:49:01+00:00 https://ascopost.com/videos/ash-2025/triplet-regimen-for-richter-transformation/ 2025-12-18T15:47:14+00:00 https://ascopost.com/videos/ash-2025/mds-and-exposure-to-agent-orange/ 2025-12-18T16:12:05+00:00 https://ascopost.com/videos/sabcs-2025/ 2025-12-11T15:23:00+00:00 https://ascopost.com/videos/sabcs-2025/novel-oral-serd-for-er-positive-her2-negative-early-breast-cancer/ 2026-02-02T20:31:15+00:00 https://ascopost.com/videos/sabcs-2025/t-dxd-in-her2-positive-early-breast-cancer-follow-up-data/ 2026-02-02T20:35:11+00:00 https://ascopost.com/videos/sabcs-2025/her2-positive-metastatic-breast-cancer-choosing-a-regimen-in-clinical-practice/ 2026-02-04T19:30:35+00:00 https://ascopost.com/videos/sabcs-2025/multimodal-ai-models-for-predicting-breast-cancer-recurrence/ 2026-02-04T21:01:42+00:00 https://ascopost.com/videos/suo-2025/ 2025-12-17T19:28:59+00:00 https://ascopost.com/videos/2026-asco-gi/ 2026-01-06T18:31:08+00:00 https://ascopost.com/videos/2026-asco-gi/novel-first-line-regimen-for-unresectable-hcc-under-study/ 2026-01-08T15:15:28+00:00 https://ascopost.com/videos/2026-asco-gi/tremelimumab-rechallenge-in-unresectable-hcc-safety-outcomes/ 2026-01-08T15:18:05+00:00 https://ascopost.com/videos/2026-asco-gi/advanced-gastric-gej-cancer-zolbetuximab-plus-mfolfox6-and-nivolumab/ 2026-01-08T19:51:30+00:00 https://ascopost.com/videos/2026-asco-gi/flot-administration-in-the-matterhorn-trial/ 2026-01-08T20:03:55+00:00 https://ascopost.com/videos/2026-asco-gi/her2-positive-gastroesophageal-cancer-zanidatamab-plus-chemotherapy/ 2026-01-09T17:16:24+00:00 https://ascopost.com/videos/2026-asco-gi/surgical-journey-in-the-matterhorn-trial/ 2026-01-12T15:48:57+00:00 https://ascopost.com/videos/2026-asco-gi/disparities-in-hcc-do-they-affect-systemic-care/ 2026-01-16T14:19:01+00:00 https://ascopost.com/videos/2026-asco-gi/locally-advanced-gastric-gej-cancer-tislelizumab-plus-chemoradiotherapy/ 2026-01-20T18:20:19+00:00 https://ascopost.com/videos/2026-asco-gi/hcc-pembrolizumab-after-resection-or-local-ablation/ 2026-01-21T17:11:30+00:00 https://ascopost.com/videos/2026-asco-gi/resectable-gastric-cancer-comparing-three-preoperative-regimens/ 2026-01-22T17:30:11+00:00 https://ascopost.com/videos/2026-asco-gu/ 2026-02-24T15:48:26+00:00 https://ascopost.com/videos/2026-asco-gu/localized-prostate-cancer-external-beam-vs-brachytherapy-boost-rt/ 2026-02-26T16:11:36+00:00 https://ascopost.com/videos/2026-asco-gu/localized-prostate-cancer-mmai-derived-biomarker/ 2026-02-26T16:22:15+00:00 https://ascopost.com/videos/2026-asco-gu/mcrpc-enzalutamide-with-or-without-radium-223/ 2026-02-26T16:31:20+00:00 https://ascopost.com/videos/2026-asco-gu/recurrent-prostate-cancer-hormone-therapy-and-postoperative-radiotherapy/ 2026-02-26T17:07:33+00:00 https://ascopost.com/videos/2026-asco-gu/novel-antibody-drug-conjugate-in-previously-treated-advanced-urothelial-cancer/ 2026-03-04T15:15:04+00:00 https://ascopost.com/videos/2026-asco-gu/muscle-invasive-bladder-cancer-enfortumab-vedotin-and-pembrolizumab/ 2026-03-04T15:47:28+00:00 https://ascopost.com/videos/2026-asco-gu/mcrpc-brcaaway-trial-in-patients-with-dna-repair-defects/ 2026-03-12T18:46:41+00:00 https://ascopost.com/videos/2026-asco-gu/highlights-in-prostate-cancer-from-asco-gu-2026/ 2026-03-16T14:57:15+00:00 https://ascopost.com/videos/ebcc15/ 2026-03-30T20:50:21+00:00 https://ascopost.com/podcasts/ 2025-07-21T21:39:40+00:00 https://ascopost.com/podcasts/news-from-the-eha-2021-virtual-congress-multiple-myeloma-myelofibrosis-and-leukemia/ 2023-07-18T18:33:19+00:00 https://ascopost.com/podcasts/news-in-genitourinary-cancers-from-the-2021-asco-annual-meeting/ 2023-07-18T18:33:53+00:00 https://ascopost.com/podcasts/lung-cancer-data-from-the-2021-asco-annual-meeting/ 2023-07-18T18:35:57+00:00 https://ascopost.com/podcasts/2021-asco-annual-meeting-reports-on-kidney-esophageal-and-cervical-cancers/ 2023-07-18T18:36:47+00:00 https://ascopost.com/podcasts/100th-episode-reports-from-the-2021-asco-annual-meeting-in-breast-prostate-and-lung-cancers/ 2023-07-18T18:37:42+00:00 https://ascopost.com/podcasts/uspstf-recommendation-on-colorectal-cancer-screening-beginning-at-age-45/ 2023-07-18T18:38:25+00:00 https://ascopost.com/podcasts/2021-asco-annual-meeting-data-from-a-premeeting-presscast/ 2023-07-18T18:39:23+00:00 https://ascopost.com/podcasts/comparison-of-adjuvant-trastuzumab-courses-for-early-her2-positive-breast-cancer/ 2023-07-18T18:39:58+00:00 https://ascopost.com/podcasts/dr-john-and-liza-marshall-on-their-new-book-off-our-chests-a-candid-tour-through-the-world-of-cancer/ 2023-07-18T18:40:40+00:00 https://ascopost.com/podcasts/intensified-preoperative-therapy-for-patients-with-newly-diagnosed-locally-advanced-rectal-cancer/ 2023-07-18T18:41:52+00:00 https://ascopost.com/podcasts/short-term-safety-of-the-covid-19-vaccine-in-patients-with-cancer-receiving-immunotherapy/ 2023-07-18T18:42:24+00:00 https://ascopost.com/podcasts/more-news-from-the-aacr-annual-meeting-cancer-biology-brain-metastases-and-diet/ 2023-07-18T18:43:54+00:00 https://ascopost.com/podcasts/news-from-the-aacr-annual-meeting-nsclc-lymphoma-and-uveal-melanoma/ 2023-07-18T18:45:00+00:00 https://ascopost.com/podcasts/differences-in-disease-between-younger-and-older-women-with-breast-cancer/ 2023-07-18T18:45:28+00:00 https://ascopost.com/podcasts/more-from-sgo-news-in-ovarian-and-cervical-cancers/ 2023-07-18T18:45:58+00:00 https://ascopost.com/podcasts/news-from-the-sgo-2021-annual-meeting-on-women-s-cancer/ 2023-07-18T18:46:41+00:00 https://ascopost.com/podcasts/increase-in-breast-cancer-diagnoses-after-pandemic-related-screening-interruptions/ 2023-07-18T18:47:47+00:00 https://ascopost.com/podcasts/recent-regulatory-decisions-in-multiple-myeloma-and-lung-cancer/ 2023-07-18T18:48:35+00:00 https://ascopost.com/podcasts/genitourinary-cancers-symposium-immunotherapy-for-rcc-neoadjuvant-therapy-for-bladder-cancer/ 2023-07-18T18:49:14+00:00 https://ascopost.com/podcasts/genitourinary-cancers-symposium-bladder-and-kidney-cancers-research/ 2023-07-18T18:49:51+00:00 https://ascopost.com/podcasts/iaslc-wclc-2020-research-in-mesothelioma-small-cell-lung-cancer-and-drug-development/ 2023-07-17T18:35:56+00:00 https://ascopost.com/podcasts/iaslc-wclc-2020-updates-from-the-adaura-trial-and-more/ 2023-07-17T18:41:48+00:00 https://ascopost.com/podcasts/prevalence-of-kras-g12c-mutations-across-different-populations/ 2023-07-17T18:42:24+00:00 https://ascopost.com/podcasts/more-from-gi21-findings-in-gastric-cancer-cholangiocarcinoma-and-pancreatic-cancer/ 2023-07-17T18:47:05+00:00 https://ascopost.com/podcasts/findings-from-the-2021-gastrointestinal-cancers-symposium/ 2023-07-17T18:49:07+00:00 https://ascopost.com/podcasts/idea-collaboration-3-vs-6-months-of-adjuvant-chemotherapy-for-patients-with-advanced-colon-cancer/ 2023-07-17T18:50:14+00:00 https://ascopost.com/podcasts/news-from-the-2020-san-antonio-breast-cancer-symposium/ 2023-07-17T18:53:08+00:00 https://ascopost.com/podcasts/more-news-from-ash-whole-genome-sequencing-of-myeloproliferative-neoplasms-and-more/ 2023-07-17T18:53:52+00:00 https://ascopost.com/podcasts/news-from-the-2020-ash-annual-meeting-exposition/ 2023-07-17T18:54:26+00:00 https://ascopost.com/podcasts/covid-19-infection-rate-among-patients-undergoing-anticancer-therapy-and-its-effect-on-cancer-clinical-trials/ 2023-07-17T18:58:45+00:00 https://ascopost.com/podcasts/immune-related-adverse-events-and-survival-outcomes-in-nsclc/ 2023-07-17T19:27:47+00:00 https://ascopost.com/podcasts/prostate-cancer-highlights-from-the-2020-astro-annual-meeting/ 2023-07-17T19:32:13+00:00 https://ascopost.com/podcasts/2020-astro-annual-meeting-high-impact-research/ 2023-07-17T19:33:14+00:00 https://ascopost.com/podcasts/recent-fda-approvals-in-leukemia-and-lymphoma/ 2023-07-17T20:09:55+00:00 https://ascopost.com/podcasts/first-line-atezolizumab-vs-chemotherapy-for-pd-l1-positive-metastatic-nsclc/ 2023-07-17T20:10:43+00:00 https://ascopost.com/podcasts/breast-cancer-news-from-the-esmo-virtual-congress-2020/ 2023-07-17T20:12:33+00:00 https://ascopost.com/podcasts/lung-cancer-reports-from-the-esmo-virtual-congress-2020/ 2023-07-17T20:13:19+00:00 https://ascopost.com/podcasts/esmo-virtual-congress-2020-spotlight-on-genitourinary-cancers/ 2023-07-17T20:30:00+00:00 https://ascopost.com/podcasts/esmo-virtual-congress-2020-findings-in-breast-and-head-and-neck-cancers/ 2023-07-17T20:34:39+00:00 https://ascopost.com/podcasts/veliparib-plus-carboplatinpaclitaxel-in-brca-mutated-her2-negative-advanced-breast-cancer/ 2023-07-17T20:37:09+00:00 https://ascopost.com/podcasts/from-the-archive-insights-on-young-onset-colorectal-cancer/ 2023-07-17T20:40:25+00:00 https://ascopost.com/podcasts/highlights-from-the-iaslc-virtual-presidential-symposium/ 2023-07-17T20:42:31+00:00 https://ascopost.com/podcasts/decline-in-non-small-cell-lung-cancer-mortality-from-2013-to-2016/ 2023-07-17T20:43:28+00:00 https://ascopost.com/podcasts/pathologic-complete-response-in-the-i-spy2-trial/ 2023-07-17T20:48:35+00:00 https://ascopost.com/podcasts/new-guidelines-on-cervical-cancer-screening/ 2023-07-17T20:55:42+00:00 https://ascopost.com/podcasts/comparison-of-two-combination-treatments-in-localized-pancreatic-cancer/ 2023-07-18T13:09:16+00:00 https://ascopost.com/podcasts/cabozantinib-for-patients-with-advanced-bladder-cancer/ 2023-07-18T13:13:38+00:00 https://ascopost.com/podcasts/lenvatinib-plus-pembrolizumab-for-patients-with-advanced-gastric-cancer/ 2023-07-18T13:17:23+00:00 https://ascopost.com/podcasts/spotlight-on-two-breast-cancer-studies-from-the-asco20-virtual-scientific-program/ 2023-07-18T13:41:52+00:00 https://ascopost.com/podcasts/multiple-myeloma-research-from-the-asco20-virtual-scientific-program/ 2023-07-18T13:46:15+00:00 https://ascopost.com/podcasts/covid-19-research-from-the-asco20-virtual-scientific-program/ 2023-07-18T13:47:11+00:00 https://ascopost.com/podcasts/findings-in-prostate-cancer-from-the-asco20-virtual-scientific-program/ 2023-07-18T13:47:50+00:00 https://ascopost.com/podcasts/plenary-research-from-the-asco20-virtual-scientific-program-part-2/ 2023-07-18T13:55:10+00:00 https://ascopost.com/podcasts/plenary-research-from-the-asco20-virtual-scientific-program-part-1/ 2023-07-18T14:02:57+00:00 https://ascopost.com/podcasts/coagulation-issues-in-patients-with-covid-19-part-2/ 2023-07-18T19:44:29+00:00 https://ascopost.com/podcasts/coagulation-issues-in-patients-with-covid-19-part-1/ 2023-07-18T19:45:05+00:00 https://ascopost.com/podcasts/highlights-from-the-aacr-virtual-annual-meeting/ 2023-07-18T19:45:51+00:00 https://ascopost.com/podcasts/does-ibrutinib-offer-a-protective-effect-against-pulmonary-injury-in-patients-with-covid-19/ 2023-07-18T19:46:56+00:00 https://ascopost.com/podcasts/recent-fda-oncologyhematology-approvals/ 2023-07-18T19:47:36+00:00 https://ascopost.com/podcasts/characteristics-and-outcomes-of-patients-with-both-covid-19-and-cancer/ 2023-07-18T19:48:12+00:00 https://ascopost.com/podcasts/report-on-the-ash-covid-19-registry-for-malignant-hematology/ 2023-07-18T19:56:18+00:00 https://ascopost.com/podcasts/end-of-trial-findings-from-cleopatra/ 2023-07-18T19:57:06+00:00 https://ascopost.com/podcasts/cancer-care-amid-the-covid-19-pandemic/ 2023-07-18T20:09:20+00:00 https://ascopost.com/podcasts/coronavirus-patients-with-cancer-and-the-preparedness-of-the-institutions-that-care-for-them/ 2023-07-18T20:11:48+00:00 https://ascopost.com/podcasts/pulmonary-pathology-of-the-novel-coronavirus-in-two-patients-with-lung-cancer/ 2023-07-18T20:16:45+00:00 https://ascopost.com/podcasts/news-from-the-2020-multidisciplinary-head-and-neck-cancers-symposium/ 2023-07-18T20:26:17+00:00 https://ascopost.com/podcasts/news-from-the-genitourinary-cancers-symposium/ 2023-07-18T20:28:00+00:00 https://ascopost.com/podcasts/pembrolizumab-plus-chemotherapy-in-her2-negative-breast-cancer/ 2023-07-18T20:40:33+00:00 https://ascopost.com/podcasts/h-pylori-infection-and-gastric-cancer-risk/ 2023-07-18T20:52:08+00:00 https://ascopost.com/podcasts/beacon-crc-patient-reported-quality-of-life-results/ 2023-07-18T20:52:56+00:00 https://ascopost.com/podcasts/news-from-the-gastrointestinal-cancers-symposium/ 2023-07-18T20:53:41+00:00 https://ascopost.com/podcasts/elevations-in-cancer-incidence-among-responders-to-the-wtc-site-after-the-september-11-attacks/ 2023-07-18T20:56:45+00:00 https://ascopost.com/podcasts/luspatercept-in-transfusion-dependent-lower-risk-myelodysplastic-syndromes/ 2021-07-02T15:07:17+00:00 https://ascopost.com/podcasts/recent-approvals-from-the-fda/ 2023-07-19T18:55:17+00:00 https://ascopost.com/podcasts/news-from-the-san-antonio-breast-cancer-symposium/ 2023-07-19T19:03:04+00:00 https://ascopost.com/podcasts/plenary-presentations-from-the-2019-ash-annual-meeting-exposition/ 2023-07-19T19:10:08+00:00 https://ascopost.com/podcasts/sequence-of-therapies-for-metastatic-castration-resistant-prostate-cancer/ 2023-07-19T19:19:12+00:00 https://ascopost.com/podcasts/reports-from-the-esmo-asia-congress-2019/ 2023-07-19T19:28:43+00:00 https://ascopost.com/podcasts/nivolumab-plus-bevacizumab-for-relapsed-ovarian-cancer/ 2023-07-19T19:29:40+00:00 https://ascopost.com/podcasts/admiral-trial-of-gilteritinib-vs-salvage-chemotherapy-in-flt3-mutated-acute-myeloid-leukemia/ 2023-07-19T19:30:45+00:00 https://ascopost.com/podcasts/addition-of-durvalumab-to-etoposide-plus-platinum-chemotherapy-for-extensive-stage-sclc/ 2023-07-19T19:33:40+00:00 https://ascopost.com/podcasts/gastrointestinal-cancer-research-from-esmo-2019/ 2023-07-19T19:34:40+00:00 https://ascopost.com/podcasts/news-in-genitourinary-cancers-from-esmo-2019/ 2023-07-19T19:37:40+00:00 https://ascopost.com/podcasts/selected-breast-cancer-abstracts-from-esmo-2019/ 2023-07-19T19:38:30+00:00 https://ascopost.com/podcasts/lung-cancer-research-highlights-from-esmo-2019/ 2023-07-19T19:39:19+00:00 https://ascopost.com/podcasts/news-in-ovarian-cancer-from-esmo-2019/ 2023-07-19T19:40:01+00:00 https://ascopost.com/podcasts/benefit-of-daratumumab-across-populations-with-newly-diagnosed-multiple-myeloma/ 2023-07-19T19:41:09+00:00 https://ascopost.com/podcasts/news-from-the-astro-annual-meeting/ 2023-07-19T19:42:29+00:00 https://ascopost.com/podcasts/news-from-the-iaslc-wclc-and-the-asco-quality-care-symposium/ 2023-07-19T19:43:44+00:00 https://ascopost.com/podcasts/first-line-nivolumab-and-ipilimumab-vs-sunitinib-in-advanced-rcc/ 2023-07-19T19:44:35+00:00 https://ascopost.com/podcasts/pooled-survival-analysis-of-patients-with-nsclc-treated-with-nivolumab/ 2023-07-19T20:25:13+00:00 https://ascopost.com/podcasts/uspstf-recommendation-against-pancreatic-cancer-screening-in-asymptomatic-adults/ 2023-07-19T20:26:34+00:00 https://ascopost.com/podcasts/ibrutinib-and-rituximab-vs-standard-chemoimmunotherapy-in-cll/ 2023-07-19T20:34:03+00:00 https://ascopost.com/podcasts/overall-survival-in-monaleesa-7/ 2023-07-19T20:43:13+00:00 https://ascopost.com/podcasts/rates-of-early-onset-colorectal-cancer/ 2023-07-19T20:43:44+00:00 https://ascopost.com/podcasts/erdafitinib-for-fgfr-altered-advanced-urothelial-carcinoma/ 2023-07-19T20:34:51+00:00 https://ascopost.com/podcasts/long-term-results-from-the-national-lung-screening-trial/ 2023-07-19T20:44:57+00:00 https://ascopost.com/podcasts/esmo-world-gi-findings-from-the-beacon-crc-trial-and-more/ 2023-07-19T20:45:52+00:00 https://ascopost.com/podcasts/icml-2019-role-of-liquid-biopsy-in-lymphoma/ 2023-07-19T20:46:44+00:00 https://ascopost.com/podcasts/cassiopeia-trial-in-multiple-myeloma/ 2023-07-19T20:48:00+00:00 https://ascopost.com/podcasts/2019-asco-resection-of-liver-metastases/ 2023-07-19T20:49:09+00:00 https://ascopost.com/podcasts/2019-asco-pancreatic-urothelial-and-cervical-cancers/ 2023-07-19T20:50:14+00:00 https://ascopost.com/podcasts/selected-studies-from-the-2019-asco-annual-meeting/ 2023-07-19T20:54:23+00:00 https://ascopost.com/podcasts/coming-soon/ 2021-07-02T15:07:34+00:00 https://ascopost.com/podcasts/pd-l1-expression-testing/ 2021-07-02T15:07:34+00:00 https://ascopost.com/podcasts/the-evolving-role-of-biomarkers-in-oncology/ 2021-07-02T15:07:35+00:00 https://ascopost.com/podcasts/tumor-mutation-burden-testing/ 2021-07-02T15:07:35+00:00 https://ascopost.com/podcasts/testing-for-microsatellite-instability-and-deficient-dna-mismatch-repair/ 2021-07-02T15:07:36+00:00 https://ascopost.com/podcasts/five-vs-2-year-course-of-zoledronate-for-patients-with-early-breast-cancer/ 2023-07-18T18:31:14+00:00 https://ascopost.com/podcasts/fda-approval-in-urothelial-cancer-plus-mechanisms-of-acquired-resistance-in-kras-g12c-mutant-cancers/ 2023-07-18T18:30:30+00:00 https://ascopost.com/podcasts/recommendations-on-the-use-of-liquid-biopsy-for-lung-cancer/ 2023-07-18T18:29:38+00:00 https://ascopost.com/podcasts/defining-cure-in-multiple-myeloma/ 2023-07-18T18:24:02+00:00 https://ascopost.com/podcasts/presentations-from-the-2021-pan-pacific-lymphoma-conference/ 2023-07-18T18:22:29+00:00 https://ascopost.com/podcasts/breakthrough-covid-19-infection-in-vaccinated-health-care-workers/ 2023-07-18T18:20:13+00:00 https://ascopost.com/podcasts/recent-fda-approvals-in-dmmr-solid-tumors-and-von-hippel-lindau-associated-cancers/ 2023-07-18T18:19:31+00:00 https://ascopost.com/podcasts/withdrawal-of-atezolizumabs-indication-for-metastatic-triple-negative-breast-cancer/ 2023-07-18T18:18:57+00:00 https://ascopost.com/podcasts/news-from-the-iaslc-2021-world-conference-on-lung-cancer/ 2023-07-18T13:15:34+00:00 https://ascopost.com/podcasts/high-impact-research-from-the-esmo-congress-2021/ 2023-07-18T13:14:34+00:00 https://ascopost.com/podcasts/esmo-congress-2021-news-in-genitourinary-cancers/ 2023-07-18T13:13:29+00:00 https://ascopost.com/podcasts/lung-cancer-data-from-the-esmo-congress-2021/ 2023-07-17T23:44:22+00:00 https://ascopost.com/podcasts/fda-approvals-in-breast-and-cervical-cancers/ 2023-07-17T23:40:11+00:00 https://ascopost.com/podcasts/oncology-care-in-the-ongoing-covid-19-pandemic-expert-commentary/ 2023-07-17T23:39:17+00:00 https://ascopost.com/podcasts/news-from-the-2021-astro-annual-meeting/ 2023-07-17T23:35:02+00:00 https://ascopost.com/podcasts/prostate-cancer-research-from-the-2021-astro-annual-meeting/ 2023-07-17T23:31:55+00:00 https://ascopost.com/podcasts/nccn-2021-virtual-congress-on-hematologic-malignancies-round-up/ 2023-07-17T23:31:23+00:00 https://ascopost.com/podcasts/sitc-2021-new-data-in-immunotherapy/ 2023-07-17T23:30:42+00:00 https://ascopost.com/podcasts/impact-of-time-of-day-of-immune-checkpoint-inhibitor-infusion-on-overall-survival-in-advanced-melanoma/ 2023-07-17T23:29:37+00:00 https://ascopost.com/podcasts/research-from-the-2021-san-antonio-breast-cancer-symposium/ 2023-07-17T23:28:59+00:00 https://ascopost.com/podcasts/research-from-the-2021-ash-annual-meeting-exposition/ 2023-07-17T23:28:05+00:00 https://ascopost.com/podcasts/apatinib-for-advanced-radioactive-iodine-refractory-differentiated-thyroid-cancer/ 2023-07-17T23:26:17+00:00 https://ascopost.com/podcasts/relatlimab-plus-nivolumab-improves-pfs-in-patients-with-previously-untreated-metastatic-or-unresectable-melanoma/ 2023-07-17T23:25:00+00:00 https://ascopost.com/podcasts/highlighted-presentations-from-the-2022-asco-gastrointestinal-cancers-symposium/ 2023-07-17T23:23:28+00:00 https://ascopost.com/podcasts/fda-approval-in-metastatic-uveal-melanoma/ 2023-07-17T23:22:28+00:00 https://ascopost.com/podcasts/president-biden-relaunches-the-cancer-moonshot/ 2023-07-17T23:21:25+00:00 https://ascopost.com/podcasts/efficacy-of-adagrasib-in-various-gastrointestinal-cancers/ 2023-07-17T23:17:44+00:00 https://ascopost.com/podcasts/news-from-the-2022-asco-genitourinary-cancers-symposium/ 2023-07-17T23:16:21+00:00 https://ascopost.com/podcasts/more-from-the-asco-genitourinary-cancers-symposium-data-on-bladder-cancer-prostate-cancer-and-treatment-disparities/ 2023-07-17T23:15:32+00:00 https://ascopost.com/podcasts/reports-from-the-2022-multidisciplinary-head-and-neck-cancers-symposium/ 2023-07-17T23:14:30+00:00 https://ascopost.com/podcasts/first-fda-approval-for-neoadjuvant-therapy-for-early-stage-non-small-cell-lung-cancer/ 2023-07-17T23:08:27+00:00 https://ascopost.com/podcasts/fda-approval-in-germline-brca-mutated-her2-negative-high-risk-early-stage-breast-cancer/ 2023-07-17T23:07:47+00:00 https://ascopost.com/podcasts/fda-approvals-in-prostate-and-endometrial-cancers/ 2023-07-17T23:06:58+00:00 https://ascopost.com/podcasts/highlights-from-the-nccn-2022-annual-conference/ 2023-07-17T23:06:09+00:00 https://ascopost.com/podcasts/data-from-the-aacr-annual-meeting-2022/ 2022-04-18T18:59:48+00:00 https://ascopost.com/podcasts/more-from-the-aacr-annual-meeting-2022-future-research-trends/ 2023-07-17T23:04:28+00:00 https://ascopost.com/podcasts/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-adult-patients-with-unresectable-or-metastatic-her2-positive-breast-cancer/ 2023-07-17T23:02:21+00:00 https://ascopost.com/podcasts/monaleesa-3-updated-overall-survival-analysis/ 2023-07-17T23:01:02+00:00 https://ascopost.com/podcasts/reports-from-the-society-of-gynecologic-oncology-annual-meeting-on-women-s-cancer/ 2023-07-17T23:00:00+00:00 https://ascopost.com/podcasts/fda-approval-for-newly-diagnosed-acute-myeloid-leukemia/ 2023-07-17T22:58:35+00:00 https://ascopost.com/podcasts/fda-approvals-in-esophageal-cancer-and-follicular-lymphoma/ 2023-07-17T22:58:03+00:00 https://ascopost.com/podcasts/asco-2022-high-impact-research-in-breast-and-colon-cancers/ 2023-07-17T22:56:10+00:00 https://ascopost.com/podcasts/asco-2022-major-studies-in-breast-cancer-and-mantle-cell-lymphoma/ 2023-07-17T22:54:33+00:00 https://ascopost.com/podcasts/asco-2022-data-in-ewing-sarcoma-and-non-small-cell-lung-cancer/ 2023-07-17T22:53:32+00:00 https://ascopost.com/podcasts/asco-2022-research-in-multiple-myeloma-and-breast-cancer/ 2023-07-17T22:52:59+00:00 https://ascopost.com/podcasts/asco-2022-plenary-presentation-in-colorectal-cancer/ 2023-07-17T22:51:39+00:00 https://ascopost.com/podcasts/asco-2022-conversations-in-genitourinary-oncology/ 2023-07-17T22:50:10+00:00 https://ascopost.com/podcasts/asco-2022-conversations-in-gynecologic-oncology/ 2023-07-17T22:49:20+00:00 https://ascopost.com/podcasts/asco-2022-conversations-in-breast-cancer/ 2023-07-17T22:47:38+00:00 https://ascopost.com/podcasts/asco-2022-conversations-in-lung-cancer/ 2023-07-17T22:46:58+00:00 https://ascopost.com/podcasts/asco-2022-conversations-in-leukemia/ 2023-07-17T22:45:40+00:00 https://ascopost.com/podcasts/asco-2022-conversations-in-colorectal-cancer/ 2023-07-17T22:44:47+00:00 https://ascopost.com/podcasts/highlights-from-the-european-hematology-association-2022-congress/ 2023-07-17T22:43:57+00:00 https://ascopost.com/podcasts/fda-approval-of-pemigatinib-and-update-from-the-stampede-trial/ 2023-07-17T22:42:33+00:00 https://ascopost.com/podcasts/highlights-from-the-esmo-congress-2022/ 2023-07-17T22:41:20+00:00 https://ascopost.com/podcasts/esmo-2022-updates-in-breast-cancer/ 2023-07-17T22:39:31+00:00 https://ascopost.com/podcasts/highlights-from-the-2022-asco-quality-care-symposium/ 2023-07-17T22:38:40+00:00 https://ascopost.com/podcasts/esmo-2022-updates-in-skin-cancer/ 2023-07-17T22:37:57+00:00 https://ascopost.com/podcasts/effects-of-mortgage-discrimination-on-cancer-care-outcomes/ 2023-07-17T22:26:15+00:00 https://ascopost.com/podcasts/fda-approvals-in-hepatocellular-carcinoma-and-multiple-myeloma/ 2023-07-17T22:24:42+00:00 https://ascopost.com/podcasts/recent-trial-findings-in-genitourinary-oncology/ 2023-07-17T22:22:13+00:00 https://ascopost.com/podcasts/findings-from-sitc-2022/ 2023-07-17T22:21:26+00:00 https://ascopost.com/podcasts/fda-approvals-november-2022/ 2023-07-17T22:20:48+00:00 https://ascopost.com/podcasts/highlights-from-the-2022-san-antonio-breast-cancer-symposium/ 2023-07-17T22:19:45+00:00 https://ascopost.com/podcasts/2022-ash-annual-meeting-and-exposition-focus-on-leukemia/ 2023-07-17T22:16:01+00:00 https://ascopost.com/podcasts/2022-ash-annual-meeting-and-exposition-focus-on-multiple-myeloma/ 2023-07-17T22:15:25+00:00 https://ascopost.com/podcasts/2022-ash-annual-meeting-and-exposition-focus-on-lymphoma/ 2023-07-17T22:13:47+00:00 https://ascopost.com/podcasts/sotorasib-in-previously-treated-patients-with-kras-g12c-mutated-advanced-pancreatic-cancer-in-conversation-with-the-asco-post/ 2023-07-17T22:13:11+00:00 https://ascopost.com/podcasts/highlights-from-the-2023-asco-gastrointestinal-cancers-symposium/ 2023-07-17T22:12:29+00:00 https://ascopost.com/podcasts/recent-fda-approvals-for-patients-with-breast-cancer/ 2023-07-17T22:11:27+00:00 https://ascopost.com/podcasts/2023-asco-genitourinary-cancers-symposium-focus-on-rcc/ 2023-07-17T22:10:49+00:00 https://ascopost.com/podcasts/2023-asco-genitourinary-cancers-symposium-focus-on-prostate-cancer/ 2023-07-17T22:08:50+00:00 https://ascopost.com/podcasts/2023-asco-genitourinary-cancers-symposium-focus-on-bladder-cancer/ 2023-07-17T22:07:59+00:00 https://ascopost.com/podcasts/colorectal-cancer-awareness-month-spotlight-on-recent-research-in-gastrointestinal-oncology/ 2023-07-17T22:06:16+00:00 https://ascopost.com/podcasts/highlights-from-the-sso-2023-international-conference-on-surgical-cancer-care/ 2023-07-17T22:05:11+00:00 https://ascopost.com/podcasts/ruby-trial-in-endometrial-cancer-and-breast-cancer-screening-after-treatment/ 2023-07-17T22:03:09+00:00 https://ascopost.com/podcasts/highlights-from-the-nccn-2023-annual-conference/ 2023-07-17T21:59:48+00:00 https://ascopost.com/podcasts/nccn-2023-annual-conference-quality-of-life-issues/ 2023-07-17T21:54:10+00:00 https://ascopost.com/podcasts/highlights-from-the-aacr-annual-meeting-2023/ 2023-07-17T21:53:32+00:00 https://ascopost.com/podcasts/more-from-the-aacr-annual-meeting-2023-novel-therapeutics-immunotherapy-for-liver-cancer-and-more/ 2023-07-17T20:02:11+00:00 https://ascopost.com/podcasts/updates-in-the-surgical-management-of-breast-cancer/ 2023-07-17T19:50:02+00:00 https://ascopost.com/topics/ 2025-07-21T21:39:41+00:00 https://ascopost.com/topics/issues-in-oncology/ 2025-10-28T20:51:53+00:00 https://ascopost.com/topics/issues-in-oncology/ai-in-oncology/ 2025-10-28T20:50:13+00:00 https://ascopost.com/topics/issues-in-oncology/cardio-oncology/ 2025-10-28T20:50:13+00:00 https://ascopost.com/topics/issues-in-oncology/cost-of-care/ 2025-10-28T20:50:14+00:00 https://ascopost.com/topics/issues-in-oncology/covid-19/ 2025-10-28T20:50:14+00:00 https://ascopost.com/topics/issues-in-oncology/genomicsgenetics/ 2025-10-28T20:50:14+00:00 https://ascopost.com/topics/issues-in-oncology/geriatric-oncology/ 2025-10-28T20:50:15+00:00 https://ascopost.com/topics/issues-in-oncology/global-cancer-care/ 2025-10-28T20:50:15+00:00 https://ascopost.com/topics/issues-in-oncology/health-care-policy/ 2025-10-28T20:50:15+00:00 https://ascopost.com/topics/issues-in-oncology/immunotherapy/ 2025-10-28T20:50:16+00:00 https://ascopost.com/topics/issues-in-oncology/legislation/ 2025-10-28T20:50:16+00:00 https://ascopost.com/topics/issues-in-oncology/survivorship/ 2025-10-28T20:50:16+00:00 https://ascopost.com/topics/solid-tumors/ 2025-10-28T14:10:04+00:00 https://ascopost.com/topics/solid-tumors/bladder-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/cns-cancers/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/colorectal-cancer/ 2023-03-16T14:29:09+00:00 https://ascopost.com/topics/solid-tumors/gastroesophageal-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/gastrointestinal-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/gynecologic-cancers/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/head-and-neck-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/hepatobiliary-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/kidney-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/pancreatic-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/sarcoma/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/skin-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/thyroid-cancer/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/neuroendocrine-tumors/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/ 2022-06-24T16:50:47+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/narjust-florez-md-and-heather-a-wakelee-md-on-early-stage-nsclc-phase-iii-findings-from-keynote-671-on-pembrolizumab-and-platinum-based-chemotherapy/ 2023-07-28T16:50:08+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/nagla-abdel-karim-md-on-small-cell-lung-cancer-swog-s1929-results-on-atezolizumab-plus-talazoparib/ 2023-07-28T16:53:08+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/narjust-florez-md-and-ticiana-leal-md-on-metastatic-nsclc-tumor-treating-fields-therapy-after-platinum-resistance/ 2023-07-28T16:55:10+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/penelope-bradbury-mbchb-on-pleural-mesothelioma-new-results-from-the-ind227-trial-of-cisplatin-and-pemetrexed-with-or-without-pembrolizumab/ 2023-07-28T16:57:16+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/adjuvant-osimertinib-improves-overall-survival-in-resectable-egfr-mutated-nsclc/ 2023-07-28T17:03:11+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/keynote-671-trial-perioperative-pembrolizumab-plus-chemotherapy-improves-outcomes-in-stage-ii-and-iii-nsclc/ 2023-07-28T17:06:01+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/toripalimab-plus-chemotherapy-improves-event-free-survival-in-resectable-stage-iii-nsclc/ 2023-07-28T17:07:36+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/adjuvant-osimertinib-in-resected-egfr-mutant-nsclc-overall-survival-analysis-of-the-adaura-trial/ 2023-07-28T17:08:52+00:00 https://ascopost.com/topics/solid-tumors/lung-cancer-highlights/lazertinib-vs-gefitinib-in-the-first-line-treatment-of-egfr-mutated-advanced-nsclc/ 2023-07-28T17:11:27+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/alicia-k-morgans-md-mph-and-karim-fizazi-md-on-prostate-cancer-phase-iii-results-on-talazoparib-plus-enzalutamide-as-first-line-treatment/ 2023-07-28T17:19:03+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/alberto-bossi-md-on-prostate-cancer-peace-1-trial-findings-on-radiotherapy-plus-systemic-treatment/ 2023-07-28T17:20:59+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/alicia-k-morgans-md-mph-and-praful-ravi-mrcp-mbbchir-on-localized-prostate-cancer-prognostic-impact-of-psa-nadir/ 2023-07-28T17:22:08+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/prostate-cancer-disparities-and-the-last-mile-problem/ 2023-07-28T17:23:59+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/meta-analysis-of-the-addition-of-docetaxel-to-adt-in-metastatic-hormone-sensitive-prostate-cancer/ 2023-07-28T17:28:10+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/addition-of-external-beam-radiation-therapy-to-brachytherapy-in-intermediate-risk-prostate-cancer/ 2023-07-28T17:31:11+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/vision-trial-health-related-quality-of-life-with-the-addition-of-lu-177-vipivotide-tetraxetan-to-standard-of-care-in-patients-with-advanced-prostate-cancer/ 2023-07-28T17:33:37+00:00 https://ascopost.com/topics/solid-tumors/prostate-cancer-highlights/diversity-may-play-a-key-role-in-black-patients-trust-of-videos-about-prostate-cancer/ 2023-07-28T17:35:05+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/lisa-a-carey-md-and-dennis-j-slamon-md-phd-on-early-breast-cancer-findings-from-the-natalee-trial-on-ribociclib-plus-endocrine-therapy/ 2023-07-28T14:26:52+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/lisa-a-carey-md-and-javier-cortes-md-phd-on-her2-positive-early-breast-cancer-chemotherapy-de-escalation-under-study-in-phergain-trial/ 2023-07-28T14:29:16+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/jennifer-a-ligibel-md-on-early-breast-cancer-and-weight-loss-results-from-the-bwel-trial/ 2023-07-28T14:30:34+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/anita-mamtani-md-on-axillary-dissection-for-what-types-of-breast-cancer-can-it-be-avoided/ 2023-07-28T14:32:19+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/current-management-of-and-future-possibilities-for-triple-negative-breast-cancer/ 2023-07-28T14:36:44+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/adjuvant-treatment-with-ribociclib-reduces-risk-of-recurrence-in-hormone-receptor-positive-her2-negative-early-stage-breast-cancer/ 2023-07-28T14:45:36+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/ebctcg-meta-analysis-confirms-benefit-of-ovarian-ablation-or-suppression-in-preventing-breast-cancer-recurrence/ 2023-07-28T14:55:49+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/phergain-adapted-response-trial-guides-treatment-with-dual-her2-blockade-alone/ 2023-07-28T14:57:32+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/extended-follow-up-of-tropics-02-trial-sacituzumab-govitecan-in-metastatic-breast-cancer/ 2023-07-28T14:59:57+00:00 https://ascopost.com/topics/solid-tumors/breast-cancer-highlights/two-studies-highlight-benefits-in-quality-of-life-and-symptom-management-with-novel-treatments-of-advanced-breast-cancer/ 2023-07-28T16:12:07+00:00 https://ascopost.com/topics/solid-tumors/lung-curated-test/ 2021-05-05T19:47:47+00:00 https://ascopost.com/topics/solid-tumors/lung-curated-test/younger-vs-older-women-with-breast-cancer-understanding-the-differences/ 2021-04-26T19:16:37+00:00 https://ascopost.com/topics/solid-tumors/lung-curated-test/william-j-gradishar-md-on-triple-negative-breast-cancer-nccn-guidelines-update/ 2021-04-26T19:17:58+00:00 https://ascopost.com/topics/hematologic-malignancies/ 2025-10-28T14:10:04+00:00 https://ascopost.com/topics/hematologic-malignancies/leukemia/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/hematologic-malignancies/multiple-myeloma/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/hematologic-malignancies/myelodysplastic-syndromes/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/tycel-j-phillips-md-and-alex-f-herrera-md-on-classical-hodgkin-lymphoma-new-data-on-nivolumab-avd-and-brentuximab-vedotin/ 2023-07-28T17:40:21+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/jennifer-l-crombie-md-on-dlbcl-real-world-outcomes-with-novel-therapies-in-relapsed-or-refractory-disease/ 2023-07-28T17:42:35+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/tycel-j-phillips-md-and-emanuele-zucca-md-on-primary-mediastinal-b-cell-lymphoma-new-data-on-observation-vs-radiotherapy/ 2023-07-28T17:44:31+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/reid-merryman-md-on-high-risk-follicular-lymphoma-new-data-on-epcoritamab-rituximab-and-lenalidomide/ 2023-07-28T17:46:49+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/omitting-mediastinal-radiotherapy-in-some-patients-with-primary-mediastinal-b-cell-lymphoma-after-immunochemotherapy/ 2023-07-28T17:49:19+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/zuma-7-primary-overall-survival-analysis-supports-axicabtagene-ciloleucel-as-second-line-therapy-in-advanced-lymphoma/ 2023-07-28T17:51:47+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/swog-s1826-nivolumab-plus-avd-surpasses-standard-of-care-combination-regimen-in-patients-with-advanced-hodgkin-lymphoma/ 2023-07-28T17:54:26+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/pirtobrutinib-after-covalent-btk-inhibitor-treatment-in-relapsed-or-refractory-cllsll/ 2023-07-28T18:01:02+00:00 https://ascopost.com/topics/hematologic-malignancies/lymphoma-highlights/patients-with-lymphoma-who-have-depression-or-anxiety-may-experience-worse-survival-outcomes/ 2023-07-28T18:05:08+00:00 https://ascopost.com/topics/supportive-care/ 2025-10-28T20:51:54+00:00 https://ascopost.com/topics/supportive-care/integrative-oncology/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/supportive-care/pain-management/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/supportive-care/palliative-care/ 2019-03-11T15:51:35+00:00 https://ascopost.com/topics/supportive-care/symptom-management/ 2019-03-11T15:51:35+00:00 https://ascopost.com/archive/ 2025-07-21T21:39:42+00:00 https://ascopost.com/archive/meetings/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/laurie-helen-sehn-md-mph-summarizes-results-of-the-gadolin-trial-on-indolent-nhl/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/luis-g-paz-ares-md-phd-summarizes-results-of-the-checkmate-057-trial-on-nonsquamous-cell-nsclc/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/asher-chanan-khan-md-summarizes-ibrutinib-bendamustine-and-rituximab-in-previously-treated-cllsll/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/jame-abraham-md-summarizes-results-from-the-neosphere-and-extenet-trials-for-breast-cancer/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/ruben-a-mesa-md-summarizes-results-of-the-persist-1-study-on-myelofibrosis/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/christopher-sweeney-mbbs-summarizes-the-enzamet-and-enzarad-trials-for-prostate-cancer/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/richard-g-margolese-md-summarizes-nsabp-b-35-trial-results-for-postmenopausal-women-with-dcis/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/nicholas-c-turner-md-phd-summarizes-results-of-the-paloma3-breast-cancer-study/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/howard-m-sandler-md-summarizes-results-of-the-rtog-0521-trial-on-localized-high-risk-prostate-cancer/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/claus-garbe-md-summarizes-results-of-the-decog-trial-on-slnb-positive-melanoma/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/asco-president-elect-julie-vose-md-mba/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/charles-f-von-gunten-md-phd-discusses-anamorelin-and-olanzapine-for-palliative-care/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/leonard-saltz-md-on-issues-of-value-in-melanoma-treatment/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/jan-c-buckner-md-on-whole-brain-radiation-and-radiosurgery-in-patients-with-brain-metastases/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/jedd-wolchok-md-phd-summarizes-results-from-the-checkmate-067-trial-in-advanced-melanoma/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/gregory-t-armstrong-md-msce-on-late-mortality-in-childhood-cancer-survivors/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/andrew-james-martin-phd-on-oral-nicotinamide-for-nonmelanoma-skin-cancer/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/howard-i-scher-md-on-the-prostate-cancer-working-group-3-consensus/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/saad-usmani-md-on-daratumumab-as-monotherapy-for-multiple-myeloma/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/patrick-schoeffski-md-on-eribulin-for-soft-tissue-sarcomas/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/lee-s-schwartzberg-md-on-iclio-adopting-immunotherapy-in-the-community-setting/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/anil-dcruz-md-on-elective-neck-dissection-in-node-negative-early-oral-cancer/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/lawrence-n-shulman-md-and-clifford-a-hudis-md-on-cancer-care-in-resource-challenged-areas/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/john-l-marshall-md-on-issues-of-value-in-colorectal-cancer-treatment/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/john-smyth-md-on-the-current-state-of-cancer-research-and-treatment-the-european-perspective/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/maura-n-dickler-md-and-clifford-a-hudis-md-on-results-from-the-calgb-alliance-trial-on-hormone-receptor-positive-advanced-breast-cancer/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/julie-gralow-md-and-clifford-a-hudis-md-on-bisphosphonates-as-adjuvant-therapy-in-primary-breast-cancer/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/eduardo-cazap-md-phd-and-james-o-armitage-md-on-the-current-state-of-cancer-research-and-treatment-the-latin-american-perspective/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/christian-carrie-md-and-celestia-s-higano-md-on-results-of-the-getug-afu-16-trial-on-prostate-cancer/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/andrew-d-seidman-md-and-clifford-a-hudis-md-on-breast-cancer-decision-analysis/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/andrew-james-martin-phd-and-anthony-j-olszanski-rph-md-on-oral-nicotinamide-to-reduce-nonmelanoma-skin-cancers/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/chloe-evelyn-atreya-md-phd-and-axel-grothey-md-on-efficacy-of-targeted-treatments-in-braf-mutated-metastatic-colorectal-cancer/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/claus-garbe-md-and-anthony-j-olszanski-rph-md-on-the-decog-trial-on-sentinel-lymph-node-positive-melanoma/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/dung-t-le-md-and-axel-grothey-md-on-pd-1-blockade-in-tumors-with-mismatch-repair-deficiency/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/gregory-t-armstrong-md-msce-and-lisa-diller-md-on-reduction-of-late-mortality-in-childhood-cancer-survivors/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/jedd-wolchok-md-phd-and-anthony-j-olszanski-rph-md-on-results-from-the-checkmate-067-trial-on-nivolumab-ipilimumab-and-advanced-melanoma/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/james-o-armitage-md-and-asher-chanan-khan-md-on-ibrutinib-bendamustine-and-rituximab-in-previously-treated-cll-sll/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/areej-el-jawahri-md-and-eric-roeland-md-faahpm-on-quality-of-life-and-satisfaction-with-care/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/carolyn-jean-presley-md-and-james-l-mulshine-md-on-new-lung-cancer-ct-screening-guidelines-and-treatment-burden/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/david-e-gerber-md-and-james-l-mulshine-md-on-bringing-genomic-discovery-and-targeted-therapies-to-early-stage-lung-cancer/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/laurie-h-sehn-md-mph-and-james-o-armitage-md-on-results-of-the-gadolin-trial-on-indolent-non-hodgkin-lymphoma/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/ruben-a-mesa-md-and-james-o-armitage-md-results-of-the-persist-1-study-on-myelofibrosis/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/howard-m-sandler-md-and-christopher-sweeney-mbbs-on-results-of-the-rtog-0521-trial-on-localized-high-risk-prostate-cancer/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/tony-mok-md-and-james-o-armitage-md-on-the-current-state-of-cancer-research-and-treatment-the-asian-perspective/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/sagar-lonial-md-and-james-o-armitage-md-on-relapsedrefractory-multiple-myeloma-the-eloquent-2-trial-and-a-phase-ii-study-of-daratumumab/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/richard-g-margolese-md-and-robert-w-carlson-md-on-nsabp-b-35-trial-results-for-postmenopausal-women-with-dcis/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/nicholas-c-turner-md-phd-and-clifford-a-hudis-md-on-results-of-the-paloma3-study-on-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/nicholas-david-james-md-phd-and-celestia-s-higano-md-on-results-from-the-stampede-trial-on-hormone-naive-prostate-cancer/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/thomas-w-leblanc-md-and-eric-roeland-md-faahpm-on-palliative-care-for-patients-with-hematologic-malignancies/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/eric-van-cutsem-md-phd-and-axel-grothey-md-on-heracles-and-other-colorectal-cancer-findings/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/derek-raghavan-md-phd-roundup-of-clinical-trial-results-on-genitourinary-cancers/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/james-h-doroshow-md-on-the-nci-s-match-trial/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/andrew-zelenetz-md-phds-expert-analysis-of-two-key-lymphoma-trials-flash-and-gadolin/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/daniel-a-vorobiof-md-and-bernardo-leon-rapoport-md-on-nk-1-inhibitors-for-cinv-potentially-practice-changing-data/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2015-asco-annual-meeting/charles-l-bennett-md-phd-mpp-and-james-o-armitage-md-on-biosimilars-in-oncology/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-introduction/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-1/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-2/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-3/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-4/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-5/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-6/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-7/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-8/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-9/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-10/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/biosimilars-roundtable/biosimilars-chapter-11/ 2019-03-19T20:05:27+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/ronald-go-md-on-survival-in-nhl-and-treatment-facility-volume/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/olivier-casasnovas-md-on-advanced-stage-hodgkin-lymphoma-interim-analysis-of-the-lysa-study/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/olivier-casasnovas-md-on-advanced-stage-hodgkin-lymphoma-interim-analysis-of-the-lysa-study-french-language-version/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/richard-m-stone-md-on-aml-results-of-the-ratify-trial/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/jonathon-cohen-md-on-deferring-mcl-treatment/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/julie-vose-md-mba-and-cameron-j-turtle-mbbs-phd-on-b-cell-nhl-and-cll-clinical-trial-results-on-t-cell-therapy/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/james-n-kochenderfer-md-on-preventing-progressive-malignancy-after-stem-cell-transplant/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/sébastien-maury-md-on-all-results-of-the-graall-r-2005-study/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/sébastien-maury-md-on-all-results-of-the-graall-r-2005-study-french-language-version/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/julie-vose-md-mba-on-all-overall-survival-academic-vs-nonacademic-hospitals/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/andrew-d-zelenetz-md-phd-on-cll-idelalisib-plus-bendamustine-and-rituximab/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/david-a-williams-md-on-the-goals-and-highlights-of-ash-2015/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/julie-vose-md-mba-and-rafat-abonour-md-on-multiple-myeloma-the-path-to-a-cure/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/julie-vose-md-mba-and-david-straus-md-on-hodgkin-lymphoma-study-results-calgballiance-50604/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/andrew-d-zelenetz-md-phd-and-stephan-stilgenbauer-md-phd-on-cll-and-venetoclax-clinical-trial-results/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/andrew-j-davies-mrcp-phd-on-dlbcl-the-remodl-b-clinical-trial-results/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/david-henry-md-on-multiple-myeloma-expert-perspective/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/s-vincent-rajkumar-md-on-advances-in-myeloma/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/john-leonard-md-on-dlbcl-results-from-the-pyramid-trial/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/laurie-h-sehn-md-mph-on-classical-hl-new-findings-on-the-need-for-radiotherapy/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/stephen-j-schuster-md-on-cd19plus-lymphomas-sustained-remissions-in-relapsed-or-refractory-disease/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/simon-rule-md-on-mcl-ibrutinib-vs-temsirolimus/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/craig-h-moskowitz-md-on-nhl-early-study-results-on-denintuzumab-mafodotin/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/margaret-odonnell-md-on-novel-approaches-to-treatment-for-older-aml-patients/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/alok-a-khorana-md-on-preventing-venous-thromboembolism/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/s-vincent-rajkumar-md-on-multiple-myeloma-newly-approved-drugs/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/hagop-m-kantarjian-md-on-aml-safety-and-efficacy-of-guadecitabine/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/nathan-hale-fowler-md-on-follicular-lymphoma-ibrutinib-plus-rituximab-study-results/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/james-foran-md-on-clofarabine-for-aml-clinical-trial-results-of-ecog-acrin-and-alfaclara/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/james-n-kochenderfer-md-on-multiple-myeloma-results-of-a-first-in-humans-clinical-trial/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/kieron-dunleavy-md-on-burkitt-lymphoma-preliminary-report-of-the-da-epoch-r-trial/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/mikkael-a-sekeres-md-on-mds-and-cmml-study-results-swog-s1117/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/sagar-lonial-md-and-torben-plesner-md-on-multiple-myeloma-updated-results-of-the-phase-iii-gen503-study/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/sagar-lonial-md-on-multiple-myeloma-how-i-treat-newly-diagnosed-patients/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/sagar-lonial-md-and-alessandra-tedeschi-md-on-cllsll-results-from-the-resonate-2-trial/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/david-henry-md-on-anticoagulants-expert-perspective/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2015-ash-annual-meeting/julie-vose-md-mba-and-john-f-gerecitano-md-phd-on-venetoclax-for-nhl/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/benjamin-d-smith-md-on-mastectomy-vs-lumpectomy-complications-and-costs/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/sherene-loi-md-on-triple-negative-breast-cancer-a-pooled-data-analysis/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/michael-gnant-md-on-hrplus-breast-cancer-results-from-the-abcsg-18-trial/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/sarat-chandarlapaty-md-phd-on-bolero-2-clinical-trial-results/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/harold-j-burstein-md-phd-on-results-of-the-create-x-clinical-trial-on-higher-risk-disease/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/hans-wildiers-md-phd-on-the-th3resa-study-final-os-results/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/lisa-carey-md-and-sibylle-loibl-md-phd-update-on-metastatic-disease/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/lisa-carey-md-and-kathy-albain-md-on-results-of-the-swog-8814-trial/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/patricia-ganz-md-on-results-from-nsabp-b-35-patient-reported-outcomes/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/matthew-j-ellis-phd-frcp-update-on-translational-research/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/gunter-von-minckwitz-md-early-survival-analysis-of-geparsixto/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/lisa-carey-md-and-jay-harris-md-on-critical-decision-making-in-radiation-therapy-for-breast-cancer/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/william-m-sikov-md-facp-on-triple-negative-breast-cancer-results-of-the-calgb-alliance-trial/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/mitchell-dowsett-phd-on-estimating-residual-distant-recurrence-risk-endopredict-and-oncotype-dx/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/judy-e-garber-md-mph-on-clinical-applications-of-hereditary-multigene-panels/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/jame-abraham-md-on-the-javelin-and-keynote-028-study-results/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/jame-abraham-md-on-her2-positive-breast-cancer-results-of-the-bcirg-006-study/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/clifford-hudis-md-and-william-gradishar-md-expert-perspective/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/clifford-hudis-md-and-julia-white-md-on-early-stage-breast-cancer-hypofractionated-radiotherapy/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/clifford-hudis-md-and-carlos-arteaga-md-on-metabolic-syndrome-and-obesity-in-breast-cancer/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-seema-khan-md-mph-on-controversies-in-the-management-of-dcis/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-ruth-oregan-md-update-on-early-breast-cancer/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-hope-rugo-md-less-is-more-scaling-back-breast-cancer-treatment/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-eric-winer-md-on-triple-negative-breast-cancer-results-of-the-calgb-alliance-trial/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/clifford-hudis-md-and-joseph-sparano-md-on-results-from-dbcg778-expert-perspective/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-hope-rugo-md-on-reducing-alopecia-fda-approves-new-device/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-sabine-seisling-phd-on-early-stage-breast-cancer-outcomes-breast-conserving-therapy-vs-mastectomy/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-erica-mayer-md-mph-on-results-of-the-pallas-clinical-trial/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-hope-rugo-md-on-advanced-breast-cancer-keynote-028-study-results/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/lori-pierce-md-on-breast-cancer-radiotherapy-late-side-effects/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/andrew-seidman-md-and-norman-wolmark-md-on-nsabp-clinical-trials-and-management-of-early-breast-cancer/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-san-antonio-breast-cancer-symposium/jack-cuzick-phd-fmedsci-on-dcis-recurrence-rates-anastrozole-vs-tamoxifen/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/alysa-m-fairchild-md-on-preventing-radiation-induced-pain-flare/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/samuel-chao-md-on-improving-the-consistency-of-radiation-oncology-processes/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/jay-harris-md-on-making-sense-of-conflicting-data-on-breast-irradiation/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/vratislav-strnad-md-phd-on-multicatheter-brachytherapy-after-breast-conserving-surgery/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/bridgett-harr-cnp-on-reducing-er-visits-and-admissions-in-high-risk-head-and-neck-cancer-patients/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/howard-m-sandler-md-on-prostate-cancer-results-from-rtog-0415/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/james-b-yu-md-on-rtog-0415-fractionation-schedules-in-patients-with-low-risk-prostate-cancer/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/supriya-chopra-md-on-reducing-late-bowel-toxicity-in-cervical-cancer/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/howard-m-sandler-md-on-prostate-cancer-results-of-nrg-oncologyrtog-9601/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/catherine-c-park-md-on-novel-clinical-paradigms/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/robert-kuske-md-on-promis-registry-results/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/roy-decker-md-phd-on-chemoradiation-in-elderly-patients-with-limited-stage-sclc/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/anita-mahajan-md-on-radiotherapy-advances-in-the-cns-and-aerodigestive-tract/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/anthony-zietman-md-on-hormonal-therapy-and-salvage-radiation-results-of-rtog-9601/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/anthony-zietman-md-on-accelerating-treatment-rtog-0415-study-on-prostate-cancer/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/bruce-minksy-mds-expert-perspective-radiotherapy-in-2015/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/bruce-minsky-md-on-clinical-trial-results-the-ascende-rt-trial-and-a-multicenter-study-on-prostate-cancer/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/brian-d-kavanagh-md-on-improving-value-and-elevating-the-patient-care-experience/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/reshma-jagsi-md-dphil-on-the-initial-results-of-the-tbcrc-024-study-on-breast-cancer/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/stephen-g-chun-md-on-nsclc-results-from-nrg-oncologyrtog-0617/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/joel-e-tepper-md-on-radiotherapy-in-liver-and-pancreatic-cancers/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2015-astro-annual-meeting/leonard-gunderson-md-on-the-presidential-symposium-lecture-on-upper-and-lower-gi-cancers/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2016-oncofertility-conference/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-iaslc-world-conference-on-lung-cancer/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-world-cancer-congress/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-international-conference-of-the-society-of-integrative-oncology/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-eortc-nci-aacr-symposium/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-new-therapeutics-in-oncology/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-jadpro-live-at-apsho/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2019-03-19T20:04:33+00:00 https://ascopost.com/archive/meetings/2016-international-cancer-immunotherapy-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-international-head-and-neck-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-nih-concensus-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-european-hematology-association-congress/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-masccisoo-international-symposium/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-esmo-world-congress-on-gastrointestinal-center/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-national-cancer-policy-forum/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-community-oncology-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-digestive-disease-week/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-american-urological-association-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-meeting-of-the-american-society-of-breast-surgeons/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-american-society-of-breast-surgeons-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-annual-clinical-meeting-of-the-american-college-of-obstetricians-and-gynecologists/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-international-conference-on-malignant-lymphoma/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-association-of-community-cancer-centers-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2010-ash-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-world-conference-on-lung-cancer/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-best-of-asco-miami/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-best-of-asco-seattle/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-aacr-annual-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-aacr-frontiers-in-basic-cancer-research/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-astro-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-nccn-annual-congress-on-hematologic-malignancies/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-asco-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-asco-health-itehr-health-information-technologyelectronic-health-records-symposium/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-pan-pacific-lymphoma-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-european-multidisciplinary-cancer-congress/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-society-for-integrative-oncology-sio-international-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-breast-cancer-symposium/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-chemotherapy-foundation-symposium/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-nih-state-of-the-science-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-accc-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-miami-breast-cancer-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2016-society-of-gynecologic-oncology-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-annual-american-college-of-surgeons-clinical-congress/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-ash-annual-meeting/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2012-aacr-iaslc-joint-conference-on-molecular-origins-of-lung-cancer/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2011-san-antonio-breast-cancer-symposium/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2012-ncpf-workshop-informatics-needs-and-challenges-in-cancer-research/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2012-nccn-annual-conference/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2012-gastrointestinal-cancers-symposium/ 2019-03-19T20:04:34+00:00 https://ascopost.com/archive/meetings/2012-accc-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-european-lung-cancer-conference/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-society-of-surgical-oncology-cancer-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-genitourinary-cancers-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-aacr-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-annual-meeting-of-the-american-society-of-breast-surgeons/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-masccisoo/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2016-society-of-surgical-oncology-cancer-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-pan-pacific-lymphoma-conference/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-asco-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-best-of-asco-boston/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-best-of-asco-san-diego/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-nccn-annual-congress-on-hematologic-malignancies/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-international-conference-of-the-society-for-integrative-oncology/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-breast-cancer-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-rsna-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-international-kidney-cancer-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-annual-meeting-of-the-society-for-neuro-oncology/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-astro-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-aacr-conference-on-the-science-of-cancer-health-disparities/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-quality-care-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-esmo-congress/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-global-women-s-cancer-summit/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-sgo-annual-meeting-on-womens-cancer/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-san-antonio-breast-cancer-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-apos-annual-conference/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-accc-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-ncpf-workshop-implementing-a-national-cancer-clinical-trials-system-for-the-21st-century/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2012-ash-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-american-academy-of-dermatology-annual-meeting-1/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-genitourinary-cancers-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-gastrointestinal-cancers-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-american-academy-of-dermatology-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-society-of-surgical-oncology-cancer-symposium/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-american-society-of-pediatric-hematology-oncology-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-aacr-annual-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-society-of-interventional-radiology-annual-scientific-meeting/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-annual-congress-of-the-oncology-nursing-society/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-annual-meeting-of-the-american-society-of-breast-surgeons/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-european-multidisciplinary-conference-in-thoracic-oncology/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-international-conference-on-malignant-lymphoma/ 2019-03-19T20:04:35+00:00 https://ascopost.com/archive/meetings/2013-society-of-nuclear-medicine-and-molecular-imaging-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-cancer-center-business-summit/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-ncpflivestrong-workshop-on-addressing-the-needs-of-adolescents-and-young-adults-with-cancer/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-astro-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-international-lung-cancer-congress/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-asco-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-world-cutaneous-malignancies-congress/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-best-of-asco-chicago/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-nccn-annual-congress-on-hematologic-malignancies/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-breast-cancer-symposium/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-best-of-asco-los-angeles/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-international-symposium-on-hodgkin-lymphoma/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-quality-care-symposium/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-international-conference-of-the-society-for-integrative-oncology/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-national-cancer-policy-summit/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-european-cancer-congress/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-chemotherapy-foundation-symposium/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-friends-brookings-conference-on-clinical-cancer-research/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-siog-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-aacr-annual-international-conference-on-frontiers-in-cancer-prevention-research/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-aortic-international-conference-on-cancer-in-africa/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-jadpro-live/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-society-of-gynecologic-oncology-sgo-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-san-antonio-breast-cancer-symposium/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-society-of-interventional-radiology-annual-scientific-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-ncpf-workshop-contemporary-issues-in-human-subjects-protection-in-cancer-research/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-gastrointestinal-cancers-symposium/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-genitourinary-cancers-symposium/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-american-society-of-breast-surgeons-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-highlights-of-ash-in-north-america-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-ash-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2013-nccn-annual-conference/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-international-congress-on-targeted-anticancer-therapies/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-american-society-of-preventive-oncology-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-aacr-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-society-of-surgical-oncology-cancer-symposium/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-annual-nccn-conference/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-digestive-disease-week/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-aspho-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2014-american-roentgen-ray-society-annual-meeting/ 2019-03-19T20:04:36+00:00 https://ascopost.com/archive/meetings/2016-head-and-neck-cancer-symposium/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-rev/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-esmo-world-congress-on-gi-cancer/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-american-society-of-pediatric-hematologyoncology-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-masccisoo/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-world-congress-of-the-international-federation-of-head-and-neck-oncologic-societies/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-annual-meeting-of-the-american-society-of-pediatric-hematology-oncology/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-new-orleans-summer-cancer-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-pan-pacific-lymphoma-conference/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-annual-international-lung-cancer-congress/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-aacr-special-conference-on-pancreatic-cancer/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-debates-and-didactics-in-hematology-and-oncology/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-best-of-asco-seattle/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-therapeutics/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-aacr-international-conference-on-frontiers-in-cancer-prevention-research/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-blueprint-for-drugdiagnostic-co-development-forum/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-astro-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-turning-the-tide-against-cancer-national-conference/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-breast-cancer-symposium/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-nccn-annual-congress-on-hematologic-malignancies/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-best-of-asco-chicago/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-esmo-congress/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-ncpf-workshop-policy-issues-in-the-development-and-adoption-of-molecularly-targeted-therapies-for-cancer/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-chemotherapy-foundation-symposium/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-radiological-society-of-north-america-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-society-of-integrative-oncology-international-conference/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-annual-world-cutaneous-malignancies-congress/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-association-of-molecular-pathology-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-chicago-multidisciplinary-symposium-in-thoracic-oncology/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-american-college-of-surgeons-clinical-congress/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-siog-annual-conference/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-american-college-of-surgeons-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-the-international-liver-congress/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-palliative-care-in-oncology-symposium/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-asco-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-endocrine-society-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-gastrointestinal-cancers-symposium/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-national-cancer-policy-forum-comprehensive-cancer-care-for-children-and-their-families/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-sgo-annual-meeting-on-womens-cancer/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-miami-breast-cancer-conference/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/james-o-armitage-md-and-hagop-m-kantarjian-md-on-advances-in-the-treatment-of-all/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/james-o-armitage-and-richard-m-stone-on-progress-made-against-aml-and-apl/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/james-o-armitage-md-and-richard-m-stone-md-on-clinical-trial-results-for-aml-mds-and-cmml-treatment/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/james-o-armitage-md-facp-frcp-and-bertrand-coiffier-md-phd-on-managing-lymphoma/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/alan-f-list-md-and-james-o-armitage-md-facp-frcp-on-advances-in-myelodysplastic-syndrome/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/richard-m-stone-md-on-the-sal-soraml-trial/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/richard-m-stone-md-on-the-uk-ncri-aml17-trial/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/linda-j-burns-md-on-the-blast-study/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/linda-j-burns-md-on-car-t-cell-therapy-in-all/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/bertrand-coiffier-md-phd-on-the-ro-chop-study/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/alan-f-list-md-on-rigosertib-in-relapsed-refractory-higher-risk-myelodysplastic-syndrome/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/alan-f-list-md-on-the-cc-5013-mds-005-study/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/hagop-kantarjian-md-on-treating-philadelphia-chromosome-positive-all/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/julie-m-vose-md-mba-fasco-on-the-aethera-trial/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/richard-m-stone-md-on-the-swog-s1117-study/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/hagop-kantarjian-md-on-blinatumomab-in-precursor-b-cell-all/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/alan-f-list-md-on-sotatercept-in-lower-risk-myelodysplastic-syndromes/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/hagop-kantarjian-md-on-inotuzumab-ozogamicin-plus-low-intensity-chemotherapy-in-all/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/hagop-kantarjian-md-on-car-t-cells-in-relapsed-refractory-all/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/linda-j-burns-md-on-a-phase-ii-study-of-ace-536-in-beta-thalassemia/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/julie-m-vose-md-mba-fasco-on-ublituximab-plus-tgr-1202-in-lymphoma/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/keith-mccrae-md-on-managing-heparin-induced-thrombocytopenia/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/bertrand-coiffier-md-phd-on-radiotherapy-plus-r-chop-in-localized-diffuse-large-b-cell-lymphoma/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/julie-m-vose-md-mba-fasco-on-nivolumab-in-relapsedrefractory-hodgkin-lymphoma/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/sagar-lonial-md-on-monoclonal-antibodies-in-multiple-myeloma/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/bertrand-coiffier-md-phd-on-the-phase-iii-lyma-trial/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/keith-mccrae-md-on-caplacizumab-in-thrombotic-thrombocytopenic-purpura/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/keith-mccrae-md-on-splenectomy-in-immune-thrombocytopenia/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/sagar-lonial-md-on-the-phase-iii-aspire-trial/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/matthew-lunning-do-on-ublituximab-plus-tgr-1202-in-lymphoma/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/laurie-sehn-md-on-radiotherapy-in-limited-stage-dlbcl/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/laurie-sehn-md-on-brentuximab-vedotin-in-dlbcl-with-undetectable-cd30/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/laurie-sehn-md-on-lenalidomide-plus-rituximab-in-previously-untreated-mantle-cell-lymphoma/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/laurie-sehn-md-on-nivolumab-in-relapsedrefractory-hodgkin-lymphoma/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/ayalew-tefferi-md-on-new-models-of-prognostication-for-myelofibrosis/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2014-ash-annual-meeting/ayalew-tefferi-md-on-imetelstat-as-therapy-for-myelofibrosis/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/larry-wickerham-md-and-charles-e-geyer-jr-md-facp-on-results-from-nsabp-b-36-and-soft-trials/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/ismail-jatoi-md-phd-facs-and-ann-h-partridge-md-mph-on-the-movement-toward-bilateral-surgical-procedures/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/matthew-j-ellis-md-phd-and-harold-j-burstein-md-phd-on-genome-directed-therapeutics-for-endocrine-therapy-resistant-erplus-breast-cancer/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/william-j-gradishar-md-and-edith-a-perez-md-on-immunotherapy-and-highlights-of-the-bolero-1-and-soft-trials/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/larry-wickerham-md-and-harry-d-bear-md-phd-on-nsabp-neoadjuvant-chemo-trials/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/ismail-jatoi-md-phd-facs-and-clifford-a-hudis-md-facs-discuss-the-soft-trial/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/lee-s-schwartzberg-md-facp-and-ian-e-krop-md-phd-on-pi3k-and-pd-l1-inhibition-data/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/harold-j-burstein-md-phd-and-lisa-a-carey-md-on-innovations-in-triple-neg-bc/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/lisa-a-carey-md-on-pembrolizumab-in-triple-negative-breast-cancer/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/lisa-a-carey-md-on-the-tnt-trial/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/william-m-sikov-md-on-the-calgb-40603-trial/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/jack-cuzick-phd-on-the-ibis-i-trial/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/gunter-von-minckwitz-md-on-the-phase-iii-ice-trial/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/matthew-j-ellis-md-on-endocrine-therapy-resistant-breast-cancer/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/jame-abraham-md-facp-on-immunotherapy-in-triple-negative-breast-cancer/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/prudence-francis-md-and-hope-rugo-md-on-the-soft-trial/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/clifford-a-hudis-md-facp-on-enzalutamide-in-triple-negative-breast-cancer/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/edith-a-perez-md-on-stromal-tumor-infiltrating-lymphocytes-in-early-stage-her2-positive-breast-cancer/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/charles-e-geyer-jr-md-facp-on-the-nsabp-b-36-trial/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/lisa-a-carey-md-on-the-calgb-40603-trial/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/clifford-a-hudis-md-facp-on-the-soft-trial/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/harry-d-bear-md-phd-on-the-nsabp-b-40-study/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/hope-s-rugo-md-on-dietary-intervention-as-adjuvant-breast-cancer-therapy/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/harry-d-bear-md-phd-on-the-nsabp-b-51rtog-1304-trial/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/charles-e-geyer-jr-md-facp-on-the-soft-trial/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/hope-s-rugo-md-on-the-phase-ii-first-study/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/ann-h-partridge-md-mph-on-patient-reported-outcomes-from-the-soft-trial/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2014-san-antonio-breast-cancer-symposium/ian-e-krop-md-phd-on-pictilisib-in-metastatic-breast-cancer/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/john-thompson-md-on-advanced-melanoma-treatment-options/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/jerald-radich-md-treatment-milestones-in-cml-stay-course-or-change-therapy/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/mario-lacouture-md-on-management-of-dermatologic-toxicities-associated-with-targeted-therapies/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/william-wierda-md-on-updates-to-cll-management/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/mary-lou-smith-jd-mba-on-the-value-of-nccn-guidelines-to-patients-and-advocates/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/eric-jonasch-md-on-kidney-cancer-treatment-options/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/amy-cyr-md-on-advances-in-the-management-of-early-stage-breast-cancer/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/gregory-otterson-md-on-adjuvant-therapy-and-immunotherapy-for-lung-cancer/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/melinda-telli-md-on-evolving-treatment-strategies-for-triple-negative-breast-cancer/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/andrew-zelenetz-md-phd-on-emerging-treatment-options-for-lymphomas/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/ingrid-mayer-md-on-new-therapies-hormone-sensitive-advanced-breast-cancer/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/leora-horn-md-msc-on-targeted-and-emerging-therapies-for-metastatic-nsclc/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/hans-gerdes-md-on-endoscopic-therapies-for-early-stage-esophageal-cancers/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/wui-jin-koh-md-on-making-nccn-guidelines-relevant-around-the-globe/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/peter-clark-md-on-a-guideline-update-in-the-management-of-bladder-cancer/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/peter-shields-md-on-new-nccn-guidelines-for-smoking-cessation-for-patients-with-cancer/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/rebecca-johnson-md-on-fertility-preservation-and-cancer/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/anthony-olszanski-rph-md-on-immunotherapy-and-melanoma/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/thomas-damico-md-on-diagnosis-and-treatment-of-nsclc-using-minimally-invasive-techniques/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/kenneth-anderson-md-on-multiple-myeloma-current-treatment-approaches-and-future-directions/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/axel-grothey-md-on-optimizing-systemic-therapy-selection-in-metastatic-colorectal-cancer/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/andrew-armstrong-md-scm-on-new-treatment-options-in-castration-resistant-prostate-cancer/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/john-grecula-md-on-the-role-of-radiation-therapy-in-management-of-sclc/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/robert-carlson-md-and-john-gentile-on-milestones-of-nccn/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/robert-carlson-md-and-lee-newcomer-md-mha-on-20-years-of-improving-cancer-care-together-a-payer-s-perspective/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/samuel-silver-md-phd-and-margaret-tempero-md-on-multidisciplinary-management-of-pancreatic-cancer/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/samuel-silver-md-phd-and-david-ettinger-md-on-the-characteristics-of-an-optimal-clinical-practice-guideline/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/samuel-silver-md-phd-and-al-benson-md-facp-fasco-on-20-years-of-improving-cancer-care-together-a-clinical-perspective/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/robert-carlson-md-and-william-gradishar-md-on-optimizing-treatment-of-her2-positive-breast-cancer/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/clifford-goodman-phd-and-peter-bach-md-mapp-on-value-based-decision-making-at-the-bedside/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-conference/crystal-denlinger-md-on-management-of-anthracycline-induced-cardiac-toxicity/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-aacr-annual-meeting/ 2019-03-19T20:04:37+00:00 https://ascopost.com/archive/meetings/2015-american-urological-association-annual-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-american-society-of-breast-surgeons-annual-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-genitourinary-cancers-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-iom-workshop-improving-breast-imaging-quality-standards/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-asgct-annual-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-preventing-overdiagnosis-conference/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-best-of-asco-chicago/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-new-orleans-summer-cancer-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-ncpf-workshop-advanced-technologies-for-radiation-therapy-and-surgery-in-oncology/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2014-quality-care-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-best-of-asco-boston/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-masccisoo/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-big-data-workshop/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-debates-and-didactics-in-hematology-and-oncology-conference/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-friends-brookings-conference-on-clinical-cancer-research/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-cga-on-inherited-colorectal-cancer/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-nccn-annual-congress-on-hematologic-malignancies/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-national-cancer-policy-forum/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-society-of-integrative-oncology/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-jadpro/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-breast-cancer-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-lynn-sage-breast-cancer-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/bradley-j-zebrack-phd-and-ursula-sansom-daly-phd-on-global-psychosocial-standards-of-care-for-adolescents-and-young-adults-with-cancer/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/lori-wiener-phd-dcsw-lcsw-c-and-paul-b-jacobsen-phd-on-ipos-apos-themes-of-this-year-s-meeting/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/lori-wiener-phd-dcsw-lcsw-c-and-karen-fasciano-psyd-on-psycho-oncology-where-the-field-is-headed/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/julia-h-rowland-phd-on-the-psychosocial-challenges-cancer-survivors-face/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/christopher-j-recklitis-phd-mph-on-the-risk-of-suicide-after-a-cancer-diagnosis/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/andrea-f-patenaude-phd-on-standards-for-psychosocial-care-of-children-with-cancer/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/wendy-lichtenthal-phd-and-david-kissane-md-on-models-of-family-centered-care-during-palliative-care-and-bereavement/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/irene-higginson-md-on-palliative-and-end-of-life-care-an-international-perspective/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/patricia-a-ganz-md-on-incorporating-psychosocial-services-for-quality-cancer-care/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/robert-t-croyle-phd-on-the-2015-nci-initiative-expanding-health-care-delivery-research/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/allison-j-applebaum-phd-and-william-s-breitbart-md-on-meaning-centered-psychotherapy-for-cancer-patients/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/jeff-dunn-ao-phd-gaicd-on-community-based-response-to-cancer/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/mark-lazenby-phd-aprn-fapos-on-distress-screening-in-the-community-setting/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/jimmie-c-holland-md-and-tammy-a-schuler-phd-on-talking-with-patients-about-their-distress-a-demonstration/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/allison-j-applebaum-phd-and-william-s-breitbart-md-on-adapting-meaning-centered-psychotherapy-for-caregivers/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/allison-j-applebaum-phd-and-william-s-breitbart-md-on-workshops-in-meaning-centered-psychotherapy/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/allison-j-applebaum-phd-and-william-s-breitbart-md-on-creating-meaning-centered-psychotherapy-for-cancer-patients/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2015-ipos-apos-world-congress-of-psycho-oncology/matthew-j-loscalzo-lcsw-on-the-effects-of-gender-on-patients/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/lorraine-cheryl-pelosof-md-phd-on-never-smokers-in-nsclc/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/eric-lim-md-on-increasing-incidence-of-non-smoking-lung-cancer/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/howard-jack-west-md-on-new-kinase-targets-for-treating-advanced-nsclc/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/barbara-j-gitlitz-md-genomics-of-young-lung-cancer-study/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/silvia-novello-md-phd-lung-cancer-is-a-womens-disease-too/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/roy-s-herbst-md-phd-on-results-from-swog-s0819/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/tony-mok-md-and-fred-r-hirsch-md-phd-summary-of-the-iaslc-presidential-symposium/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/heather-a-wakelee-md-on-results-of-the-e1505-clinical-trial/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/alice-t-shaw-md-phd-on-alk-crizotinib-and-alectinib/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/christine-d-berg-md-on-screening-for-lung-cancer-in-those-at-high-risk/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/james-l-mulshine-md-on-lung-cancer-screening-in-the-united-states-can-it-happen/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/vassiliki-papadimitrakopoulou-md-on-the-lung-map-clinical-trial/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/james-r-jett-md-on-screening-with-early-cdt-and-ct/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/pasi-a-jaenne-md-phd-on-integration-of-next-generation-data-into-the-clinic/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/ugo-pastorino-md-on-reducing-lung-cancer-mortality/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/philip-bonomi-md-on-results-of-the-romana-1-and-romana-2-trials/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/philip-bonomi-md-on-sbrt-and-surgery-for-localized-disease/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/karen-kelly-md-on-pd-1-axis-inhibition-and-the-treatment-of-advanced-disease/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/fred-r-hirsch-md-phd-and-paul-a-bunn-jr-md-on-the-highlights-of-the-world-conference-on-lung-cancer/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/william-d-travis-md-on-pathology-and-genetics-of-lung-tumors-2015-who-classification/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/nagashree-seetharamu-md-on-anti-glycan-antibody-profiling-in-de-novo-stage-iv-non-small-cell-lung-cancer/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/naiyer-a-rizvi-md-on-immune-checkpoint-inhibitors/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/everett-e-vokes-md-on-controversies-in-stage-iiia-disease/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/jennifer-king-phd-scientific-perspectives-from-the-lung-cancer-alliance/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/guneet-walia-phd-on-central-issues-in-lung-cancer-care/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2015-iaslc-world-conference-on-lung-cancer/ramaswamy-govindan-md-roundup-of-lung-cancer-findings/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/toni-k-choueiri-md-on-cabozantinib-vs-everolimus-in-patients-with-advanced-renal-cell-carcinoma/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/milena-sant-md-on-the-latest-findings-from-the-eurocare-5-study/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/martine-j-piccart-gebhart-md-phd-on-new-frontiers-in-imaging/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/robert-j-motzer-md-on-phase-iii-results-of-checkmate-025-nivolumab-vs-everolimus-in-advanced-rcc/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/lisa-carey-md-on-molecular-screening-for-breast-cancer/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/rolf-a-stahel-md-on-results-from-the-belief-trial/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/brian-i-rini-md-on-a-cancer-vaccine-for-renal-cell-carcinoma/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/martine-j-piccart-gebhart-md-phd-on-reducing-the-cost-and-increasing-access-to-cancer-drugs/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/jean-charles-soria-md-phd-on-results-of-the-lux-lung-8-clinical-trial/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/jean-charles-soria-md-phd-on-results-of-the-keynote-001-clinical-trial/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/ignacio-melero-md-phd-on-developing-and-implementing-new-immunotherapies/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/michael-pfreundschuh-md-on-treating-lymphoid-malignancies-in-children-and-adults-with-the-same-protocols/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/shailender-bhatia-md-on-merkel-cell-carcinoma-final-results-of-a-phase-ii-study/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/matteo-lambertini-md-on-preserving-women-s-fertility-through-hormonal-therapy/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/matti-s-aapro-md-on-geriatric-oncology-a-multidisciplinary-approach-for-positive-outcomes/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/a-oliver-sartor-md-on-results-of-the-alsympca-trial-for-castration-resistant-prostate-cancer/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/tony-mok-md-and-alice-shaw-md-phd-expert-perspectives-on-alk-inhibition-and-brigatinib/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/looking-ahead-with-the-new-ecco-president-peter-l-j-naredi-md-phd/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/frederic-amant-md-phd-on-cancer-and-pregnancy/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/clifford-a-hudis-md-on-results-of-the-tailorx-clinical-trial/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/priscilla-k-brastianos-md-on-genetic-screening-of-brain-metastases/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/clifford-a-hudis-md-on-obesity-inflammation-and-cancer/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/cora-n-sternberg-md-on-new-targets-in-renal-cell-carcinoma/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/mary-k-gospodarowicz-md-on-challenges-in-cancer-control/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/jonathan-e-rosenberg-md-on-results-of-the-imvigor-210-study-on-atezolizumab-in-locally-advanced-or-metastatic-urothelial-cancer/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/christoph-zielinski-md-highlights-of-2015-european-cancer-congress/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/jean-yves-douillard-md-phd-on-new-perspectives-in-small-cell-lung-cancer/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/michel-ducreux-md-phd-on-results-of-the-phase-ii-colo-001-clinical-trial/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/federico-cappuzzo-md-and-tony-mok-md-on-managing-egfr-resistance-in-lung-cancer/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/martine-frouws-msc-phd-on-postdiagnosis-aspirin-and-improved-survival-in-all-gi-cancers/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/benjamin-besse-md-phd-and-tony-mok-md-on-results-of-the-birch-clinical-trial/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2015-european-cancer-congress/m-catherine-pietanza-md-on-a-promising-new-agent-for-sclc/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/judith-paice-phd-rn-on-neuropathic-pain/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/charles-l-loprinzi-md-on-olanzapine-for-prevention-of-cinv/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/eric-roeland-md-toward-better-treatment-for-cachexia/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/amelie-harle-md-on-aprepitant-for-cough-in-lung-cancer/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/jennifer-s-temel-mds-expert-perspective-palliative-care-in-2015/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/betty-ferrell-phd-rn-on-depression-and-cancer-care/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/ralph-j-hauke-md-toward-improved-quality-of-life/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/lawrence-h-einhorn-md-on-palliative-radiation-for-advanced-cancer-and-symptomatic-bone-metastases/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/kathleen-elizabeth-bickel-md-mphil-on-defining-high-quality-palliative-care-in-oncology-practice/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/kathleen-foley-md-on-palliative-care-in-low-resource-settings/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/lawrence-h-einhorn-md-on-cinv-clinical-trial-results-the-alliance-a221301-study/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/vicki-jackson-md-mph-on-effective-care-integration-and-the-comanagement-model/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/anthony-l-back-md-on-improving-communication-between-patient-and-provider/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/diane-portman-md-on-integrating-palliative-care-in-cancer-treatment/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/judith-vick-md-candidate-and-rachelle-e-bernacki-md-on-a-new-clinical-tool-the-surprise-question/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/lorenzo-cohen-md-on-acupuncture-and-other-non-drug-pain-management-techniques/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2015-palliative-care-in-oncology-symposium/eduardo-bruera-md-on-cachexia-assessment-and-management-state-of-the-art/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/patricia-a-ganz-md-on-looking-beyond-the-scans-what-to-look-for-and-how/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/tim-a-ahles-phd-on-neurocognitive-late-effects/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/kerri-m-winters-stone-phd-on-peripheral-neuropathy-high-prevalence-among-female-survivors/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/rachel-lynn-yung-md-on-weight-loss-intervention-in-obese-survivors/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/erin-elizabeth-hahn-phd-mph-on-hodgkin-lymphoma-post-treatment-services/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/tara-o-henderson-md-mph-on-cancer-survivors-with-complex-medical-needs/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/mary-s-mccabe-rn-on-risk-based-health-care-of-cancer-survivors/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/dana-barnea-md-on-screening-survivors-for-thyroid-cancer/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/christopher-j-recklitis-phd-mph-on-fatigue-and-sleep-disturbances/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/kevin-c-oeffinger-md-on-highlights-of-the-asco-survivorship-symposium/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/smita-bhatia-md-mph-on-the-science-of-survivorship/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/lewis-e-foxhall-md-on-communication-and-coordination-of-survivorship-care/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/jennifer-a-ligibel-md-on-breast-cancer-survivorship-in-young-women/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2016-cancer-survivorship-symposium/craig-e-pollack-md-on-low-income-breast-cancer-survivors-clinical-trial-results/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/james-l-abbruzzese-md-on-pancreatic-cancer-expert-perspective/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/eric-francois-md-on-rectal-cancer-findings-from-the-accord12-trial/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/eric-francois-md-on-rectal-cancer-findings-from-the-accord12-trial-french-language-version/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/dung-t-le-md-on-noncolorectal-gi-cancers-results-from-a-phase-ii-study-of-pembrolizumab/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/richard-s-finn-md-on-advanced-hepatocellular-carcinoma-expert-perspective/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/toshihiko-doi-md-phd-on-esophageal-carcinoma-study-results-from-keynote-028/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/daniel-g-haller-md-on-colon-and-rectal-cancers-a-global-overview/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/krzysztof-bujko-md-on-rectal-cancer-results-of-a-phase-iii-trial/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/somnath-mukherjee-md-on-esophageal-adenocarcinoma-results-of-the-neoscope-trial/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/simron-singh-md-on-neuroendocrine-tumors-of-the-gi-tract-results-from-the-radiant-4-trial/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/yoon-koo-kang-md-phd-on-gastricgastroesophageal-junction-adenocarcinoma-trial-results-for-t-dm1-vs-a-taxane/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/jonathan-r-strosberg-md-on-neuroendocrine-tumors-results-of-the-netter-1-trial/ 2019-07-11T20:27:30+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/dung-t-le-md-on-gastric-or-gastroesophageal-junction-cancer-results-from-the-checkmate-032-trial/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/heinz-josef-lenz-md-on-metastatic-colorectal-cancer-results-of-the-mavericc-study/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-gastrointestinal-cancers-symposium/heinz-josef-lenz-md-on-metastatic-colorectal-cancer-results-of-the-mavericc-study-german-language-version/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/a-oliver-sartor-md-on-advanced-prostate-cancer-predicting-treatment-resistance/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/matthew-smith-md-phd-on-bone-metastases-treatment-update/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/bernard-j-escudier-md-on-renal-cell-carcinoma-results-from-the-meteor-trial/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/bernard-j-escudier-md-on-renal-cell-carcinoma-results-from-the-meteor-trial-french-language-version/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/david-p-dearnaley-md-on-prostate-cancer-results-from-the-chhip-trial/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/dean-f-bajorin-md-on-rare-urinary-tract-cancers-expert-perspectives-on-treatment/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/bishoy-m-faltas-md-on-advanced-urothelial-carcinoma-generating-a-neoantigen-map/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/hans-joerg-hammers-md-phd-on-renal-cancer-using-immune-checkpoint-blockers-in-the-clinic/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/toni-choueiri-md-renal-cancer-update/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/fred-saad-md-on-prostate-cancer-the-year-in-review/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/fred-saad-md-on-prostate-cancer-the-year-in-review-french-language-version/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/srikala-s-sridhar-md-bladder-cancer-update/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/paul-l-nguyen-md-on-prostate-cancer-results-of-the-nrg-oncologyrtog-9601-study/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/nicholas-d-james-bsc-mbbs-phd-on-urothelial-carcinomas-year-in-review/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/w-robert-lee-md-on-prostate-cancer-results-of-the-nrg-oncology-rtog-0415-study/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/maha-hussain-md-on-prostate-cancer-keynote-lecture/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/christopher-j-sweeney-mbbs-testicular-cancer-update/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2016-genitourinary-cancers-symposium/christopher-brian-allard-md-on-prostate-cancer-risk-and-regular-aspirin-use/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/dawn-l-hershman-md-on-improving-quality-and-safety-with-multidisciplinary-teams/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/kerin-b-adelson-md-on-improving-end-of-life-planning-and-reducing-futile-care/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/kerin-b-adelson-md-on-improving-cancer-staging/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/craig-earle-md-on-the-science-of-quality/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/joseph-v-simone-md-on-safety-and-quality-in-cancer-care-the-big-picture/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/sarina-isenberg-phd-candidate-on-better-care-at-a-better-cost/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/patricia-a-ganz-md-on-improving-quality-and-value-in-cancer-care/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/lawrence-n-shulman-md-on-survival-as-a-measure-of-quality-and-advances-in-therapy/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/sandra-l-wong-mds-oral-abstract-discussion-expert-perspective/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/joseph-o-jacobson-md-on-improving-cancer-care-what-works-what-doesn-t-and-why/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/allison-kurian-md-on-assessing-quality-in-the-age-of-precision-medicine/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/robert-miller-md-cancerlinq-update/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/lee-n-newcomer-md-on-assessing-quality-payer-perspective/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/randall-f-holcombe-md-on-delivering-quality-in-a-large-urban-institution/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/monika-k-krzyzanowska-md-mph-on-patient-centered-outcomes-research-expert-perspective/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/ethan-basch-md-on-assessing-quality-patient-reported-data/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2016-quality-care-symposium/steven-shak-md-on-breast-cancer-specific-mortality/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/alan-venook-md-on-metastatic-colorectal-cancer-choosing-optimal-treatment-strategies/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/nadeem-abu-rustum-md-on-cervical-cancer-evolving-treatment-strategies/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/toby-c-campbell-md-on-palliative-care-patient-and-provider-perspectives/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/daniel-t-chang-md-on-hepatocellular-carcinoma-guideline-updates-for-locoregional-treatment/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/anne-covey-md-on-hepatocellular-carcinoma-guideline-updates-for-locoregional-treatment/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/wui-jin-koh-md-on-vulvar-cancer-guidelines-update/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/joseph-simone-md-highlights-of-the-21st-annual-nccn-conference/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/william-gradishar-md-on-breast-cancer-guideline-updates/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/jaffer-ajani-md-on-metastatic-gastroesophageal-cancers-expert-perspective/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/joseph-b-narus-dnp-gnp-bc-anp-on-sexual-function-in-survivors-guideline-update/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/rogerio-lilenbaum-md-on-metastatic-nsclc-managing-egfr-mutationplus-disease/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/jerald-radich-md-on-chronic-myeloid-leukemia-managing-advanced-phase-disease/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/kevin-c-oeffinger-md-on-controversies-in-breast-cancer-screening-strategies/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/christopher-willett-md-on-localized-rectal-cancer-emerging-treatment-paradigms/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/mahmoud-al-hawary-md-on-pancreatic-cancer-the-role-of-imaging/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/jeffrey-jones-md-mph-on-chronic-lymphocytic-leukemia-optimizing-treatment-with-new-agents/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/douglas-e-wood-md-on-lung-cancer-screening-status-and-patient-selection/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/douglas-e-wood-md-on-lung-cancer-workup-and-staging/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/judith-paice-phd-rn-on-managing-cancer-pain-strategies-for-prescribing-opioids/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/kenneth-anderson-md-on-multiple-myeloma-guideline-updates/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/louis-burt-nabors-md-on-primary-and-recurrent-gliomas-notable-developments-in-management/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference-1/sarah-l-blair-md-on-early-stage-breast-cancer-in-older-women-surgical-management/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2016-aacr-annual-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/helen-mackay-md-on-epithelial-ovarian-cancer-results-from-the-ov21petroc-trial/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/hope-s-rugo-md-on-her2plus-breast-cancer-findings-on-a-trastuzumab-biosimilar/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/john-p-neoptolemos-md-phd-on-pancreatic-ductal-adenocarcinoma-results-of-the-espac-4-trial/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/martin-j-van-den-bent-md-phd-on-anaplastic-glioma-results-from-the-catnon-trial/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/yousuf-zafar-md-on-the-financial-burden-of-cancer-care/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/lee-s-schwartzberg-md-on-progress-of-the-institute-for-clinical-immuno-oncology/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/john-d-hainsworth-md-on-advanced-solid-tumors-results-from-the-mypathway-trial/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/nikhil-wagle-md-on-the-metastatic-breast-cancer-project-progress-report/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/luis-g-paz-ares-md-phd-on-nsclc-results-from-the-squire-trial/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/luis-g-paz-ares-md-phd-on-nsclc-results-from-the-squire-trial-spanish-language-version/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/ghassan-k-abou-alfa-md-on-sorafenib-and-doxorubicin-for-advanced-hepatocellular-carcinoma/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/lawrence-n-shulman-md-and-daniel-a-goldstein-md-expert-perspectives-on-issues-in-global-cancer-care/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/maria-clemence-schwaederle-pharmd-on-precision-medicine-its-impact-in-refractory-malignancies/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/michele-cavo-md-on-multiple-myeloma-results-from-a-european-myeloma-network-trial/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/michele-cavo-md-on-multiple-myeloma-results-from-a-european-myeloma-network-trial-italian-language-version/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/usha-menon-md-on-ovarian-cancer-advances-in-early-detection/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/antonio-palumbo-md-on-multiple-myeloma-results-from-the-castor-trial-italian-language-version/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/antonio-palumbo-md-on-multiple-myeloma-results-from-the-castor-trial/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/james-r-perry-md-on-glioblastoma-study-results-on-treating-elderly-patients/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/julie-lemieux-md-on-letrozole-in-post-menopausal-early-stage-breast-cancer-patient-reported-outcomes-french-language/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/julie-lemieux-md-on-letrozole-in-post-menopausal-early-stage-breast-cancer-patient-reported-outcomes/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/julie-r-park-md-on-neuroblastoma-results-of-a-children-s-oncology-group-study/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/paul-e-goss-md-phd-on-postmenopausal-early-stage-breast-cancer-extending-letrozole-treatment/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/daniel-f-hayes-md-asco-president-2016-2017-on-his-goals-for-the-coming-year/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/eric-roeland-md-and-jennifer-s-temel-md-on-integrative-palliative-and-oncology-care/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/eric-roeland-md-and-linda-van-le-md-on-gynecologic-cancers-managing-menopausal-symptoms-in-survivors/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/eric-roeland-md-and-timothy-e-quill-md-on-the-debate-on-physician-assisted-death/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/mary-gospodarowicz-md-and-eduardo-l-cazap-md-phd-on-the-south-american-perspective-of-cancer-research/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/mary-gospodarowicz-md-and-nagi-s-el-saghir-md-phd-on-the-middle-eastern-perspective-of-cancer-research/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/mary-gospodarowicz-md-and-rakesh-chopra-md-on-the-indian-perspective-of-the-current-state-of-cancer-research-and-treatment/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/james-kochenderfer-md-on-inducing-remissions-in-b-cell-lymphoma/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/richard-l-schilsky-md-on-highlights-of-the-2016-asco-annual-meeting/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/arjun-vasant-balar-md-on-urothelial-carcinoma-analysis-of-the-imvigor210-cohort-1/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/charles-m-rudin-md-phd-on-sclc-findings-on-rovalpituzumab-tesirine/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/ronald-c-chen-md-mph-on-end-of-life-care-impact-of-the-choosing-wisely-campaign/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/salah-eddin-al-batran-md-on-gastric-and-gej-adenocarcinoma-results-from-the-fast-trial/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/john-marshall-md-and-alan-p-venook-md-on-metastatic-colorectal-cancer-analysis-of-calgb-swog-80405/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/john-marshall-md-and-marcel-verheij-phd-on-gastric-cancer-first-results-from-the-critics-trial/ 2019-03-19T20:05:23+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/michael-j-overman-md-and-john-marshall-md-on-metastatic-colorectal-cancer-interim-results-of-the-checkmate-142-trial/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/toni-k-choueiri-md-and-david-f-mcdermott-md-on-advanced-rcc-nivolumab-in-previously-treated-patients/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/jonathan-e-rosenberg-md-and-toni-k-choueiri-md-on-bladder-cancer-mutation-burden-and-atezolizumab/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/sumanta-k-pal-md-and-toni-k-choueiri-md-on-urothelial-carcinoma-efficacy-of-an-fgfr-inhibitor/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/celestia-s-higano-md-and-a-oliver-sartor-md-on-findings-of-the-firstana-trial-for-prostate-cancer/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/helen-mackay-md-and-ursula-a-matulonis-md-on-epithelial-ovarian-cancer-results-from-the-ov21-petroc-trial/ 2019-03-19T20:05:24+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/ursula-a-matulonis-md-and-jonathan-a-ledermann-md-on-olaparib-maintenance-monotherapy-for-ovarian-cancer/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/patricia-j-goldsmith-on-patient-access-and-engagement-results-of-the-cancercare-report/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/vali-a-papadimitrakopoulou-md-and-fabrice-denis-md-phd-on-lung-cancer-improving-os-with-an-app/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/fabrice-denis-md-phd-on-lung-cancer-improving-os-with-an-app-french-language-version/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/vali-a-papadimitrakopoulou-md-and-gideon-michael-blumenthal-md-on-nsclc-an-updated-pooled-analysis/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/vali-a-papadimitrakopoulou-md-and-heather-a-wakelee-md-on-bevacizumab-for-early-stage-nsclc/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/lisa-a-carey-md-and-julie-gralow-md-top-breast-cancer-papers-presented-at-the-2016-asco-annual-meeting/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/lisa-a-carey-md-and-tuya-pal-md-on-brca-carriers-the-disparities-in-management/ 2019-03-19T20:05:25+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/anthony-j-olszanski-rph-md-and-caroline-robert-md-phd-on-results-from-the-keynote-001-melanoma-trial/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/anthony-j-olszanski-rph-md-and-michael-a-postow-md-on-results-from-the-checkmate-067-melanoma-trial/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/anthony-j-olszanski-rph-md-and-michael-a-davies-md-phd-on-the-combi-d-study-on-cutaneous-melanoma/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/heinz-josef-lenz-md-and-jonathan-r-strosberg-md-on-the-netter-1-trial-for-midgut-neuroendocrine-tumors/ 2019-07-11T20:32:28+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/heinz-josef-lenz-md-and-marc-ychou-md-on-treating-mcrc-with-initially-non-resectable-liver-metastases/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/richard-l-schilsky-md-allen-s-lichter-md-and-clifford-a-hudis-md-on-passing-the-torch/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/lisa-a-carey-md-and-nicholas-c-turner-md-phd-on-paloma-2-and-3-study-findings-in-advanced-breast-cancer/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/celestia-s-higano-md-and-chris-parker-md-on-the-promis-study-of-elevated-psa/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/sagar-lonial-md-and-paul-g-richardson-md-on-multiple-myeloma-expert-perspectives-on-treatment-advances/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/sagar-lonial-md-and-andrew-zelenetz-md-phd-on-mcl-dlbcl-cll-how-much-rituximab-is-enough/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-asco-annual-meeting/toni-k-choueiri-md-and-paul-l-nguyen-md-on-prostate-cancer-expert-perspectives-on-four-studies/ 2019-03-19T20:05:26+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/andrew-d-zelenetz-md-on-diffuse-large-b-cell-lymphoma-chop-r-and-epoch-r/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/kieron-m-dunleavy-md-on-lymphomas-genomics-and-genetics/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/susan-m-o-brien-md-on-alllymphoma-upfront-and-salvage-treatments-in-older-patients/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/stephen-m-ansell-md-phd-on-precision-immunotherapy-for-refractory-hodgkin-lymphoma/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/david-g-maloney-md-phd-on-lymphomas-treatment-with-car-t-cells/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/bruce-d-cheson-md-and-julie-m-vose-md-mba-on-staging-lymphoma/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/julie-m-vose-md-mba-on-highlights-of-pan-pacific-lymphoma-2016/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/beth-m-faiman-phd-msn-cnp-aocn-on-managing-multiple-myeloma/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/john-g-gribben-md-dsc-on-follicular-lymphoma-still-a-role-for-transplant/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/julie-m-vose-md-mba-on-basket-trials/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/fredrick-b-hagemeister-jr-md-on-using-rituximab-maintenance/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/wyndham-h-wilson-md-phd-on-treating-diffuse-large-b-cell-lymphoma/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/richard-i-fisher-md-on-defining-and-treating-grey-zone-lymphoma/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/steven-m-horwitz-md-on-sequencing-new-agents-in-relapsed-peripheral-t-cell-lymphoma/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/jonathan-w-friedberg-md-marginal-zone-lymphoma-therapy-update/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/steven-p-treon-md-phd-on-treating-lymphoplasmacytic-lymphomawaldenstroem-s-macroglobulinemia/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/nathan-fowler-md-and-sagar-lonial-md-on-treating-follicular-lymphoma/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/s-vincent-rajkumar-md-and-sagar-lonial-md-on-treating-multiple-myeloma/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2016-pan-pacific-lymphoma-conference/james-o-armitage-md-on-improving-lymphoma-treatment/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2016-nccn-annual-conference/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-prevent-cancer-foundation-workshop/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-society-of-nuclear-medicine-annual-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/charles-d-blanke-md-on-oregon-s-death-with-dignity-act/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/eduardo-bruera-md-on-managing-opioid-use-in-patients-with-a-history-of-addiction/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/tracy-a-balboni-md-mph-on-managing-spinal-metastases-with-radiation-therapy/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/james-f-cleary-md-on-global-access-to-opioids/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/j-nicholas-dionne-odom-phd-on-supporting-family-caregivers-the-enable-model/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/areej-el-jawahri-md-on-hematologic-malignancies-integrating-palliative-care-in-treatment/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/joseph-a-greer-phd-on-an-app-for-adherence-to-oral-chemotherapy/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/charles-f-von-gunten-md-phd-on-referrals-for-hospice-care-a-quality-improvement-approach/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/eileen-danaher-hacker-phd-apn-aocn-after-stem-cell-transplant-enhancing-recovery-with-strength-training/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/emily-haozous-phd-rn-on-cultural-differences-in-end-of-life-care/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/eric-roeland-mds-palliative-care-in-oncology-meeting-highlights-expert-perspective/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/scott-a-irwin-md-phd-on-dealing-with-delirium/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/jennifer-s-temel-md-on-the-changing-conversation-around-prognostication/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/stephen-t-sonis-dmd-dmsc-on-radiotherapy-induced-oral-complications/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/sriram-yennu-md-on-patient-perception-of-curability/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-palliative-care-in-oncology-symposium/randy-l-wei-md-phd-on-radiation-oncologists-and-palliative-care/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/ 2019-03-19T20:04:38+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/douglas-w-arthur-md-on-breast-preserving-surgery-results-from-nrg-oncologyrtog-1014/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/bruce-d-minsky-mds-meeting-highlights-an-expert-perspective/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/brian-kavanagh-md-mph-looking-ahead-with-astro-s-president-elect/ 2019-03-19T20:04:40+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/daniel-hamstra-md-phd-on-prostate-cancer-decreasing-rectal-toxicity/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/howard-m-sandler-md-on-rtog-s-past-and-nrg-s-future/ 2019-03-19T20:04:41+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/lia-m-halasz-md-on-disparities-in-radiotherapy-delivery/ 2019-03-19T20:04:42+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/louis-harrison-md-on-radiation-oncology-and-the-future-of-health-care/ 2019-03-19T20:04:43+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/takeshi-kodaira-md-phd-on-glottic-cancer-results-of-a-japan-clinical-oncology-group-study/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/anders-widmark-md-phd-on-intermediate-risk-prostate-cancer-results-from-the-hypo-rt-pc-trial/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/joanne-b-weidhaas-md-phd-on-head-and-neck-cancer-results-of-the-nrg-oncologyrtog-0522-study/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/alan-pollack-md-phd-on-prostate-cancer-post-prostatectomy-radiotherapy/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/bradley-r-prestidge-md-on-prostate-cancer-initial-findings-of-nrg-oncologyrtog-0232/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/richard-t-hoppe-md-on-lymphoma-improving-outcomes/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/thomas-j-lynch-jr-md-on-personalized-care-and-radiation-oncology-in-lung-cancer/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/maria-werner-wasik-md-on-issues-in-lung-toxicity/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/paul-l-nguyen-md-on-prostate-cancer-high-risk-disease-brachytherapy-and-hormones/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2016-astro-annual-meeting/meena-moran-md-on-ductal-carcinoma-in-situ-improving-local-control/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/jung-min-lee-md-on-ovarian-cancer-study-results-on-checkpoint-kinase-inhibitors/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/tony-mok-md-on-nsclc-results-of-the-impress-study/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/shou-ching-tang-md-phd-on-recurrent-cns-metastases-in-breast-cancer-study-results-on-a-novel-conjugate/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/omid-hamid-md-on-melanoma-results-from-the-keynote-002-study/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/arjun-v-balar-md-on-urothelial-cancer-results-from-keynote-052/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/janessa-j-laskin-md-on-tumor-gene-expression-and-advanced-cancers/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/judith-balmaña-md-phd-on-metastatic-breast-cancer-study-results-on-lurbinectedin/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/philippe-rochigneux-md-on-solid-tumors-use-of-chemotherapy-near-the-end-of-life/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/katja-weisel-md-on-multiple-myeloma-results-of-the-castor-study/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/martin-h-schuler-md-on-gastric-and-gastroesophageal-junction-adenocarcinoma-results-of-the-fast-study/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/toni-k-choueiri-md-on-metastatic-rcc-results-from-the-alliance-a031203-trial/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/luis-g-paz-ares-md-phd-on-nsclc-results-from-the-lux-lung-7-trial/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/giorgio-v-scagliotti-md-phd-on-alk-rearranged-nsclc-results-from-the-ascend-5-trial/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/paolo-a-ascierto-md-on-metastatic-melanoma-ipilimumab-study-results/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/teresa-calimeri-md-phd-on-dlbcl-findings-on-high-dose-methotrexate/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/sara-a-hurvitz-md-on-breast-cancer-results-from-the-neomonarch-trial/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/sian-a-pugh-mbbs-on-colorectal-cancer-long-term-results-of-the-facs-trial/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/melanie-royce-md-phd-on-breast-cancer-results-from-the-bolero-4-trial/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/matthew-j-ellis-phd-mb-bch-on-breast-cancer-results-of-the-falcon-trial/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/yung-jue-bang-md-phd-on-gastric-cancer-results-from-the-gold-trial/ 2019-03-19T20:05:15+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/alain-ravaud-md-phd-on-rcc-results-of-the-s-trac-trial/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/sumanta-k-pal-md-on-urothelial-cancer-results-from-the-checkmate-275-trial/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/ezra-ew-cohen-md-on-head-and-neck-cancer-results-of-the-active8-trial/ 2019-03-19T20:05:16+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/martin-reck-md-phd-on-nsclc-results-of-keynote-024/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/christian-u-blank-md-phd-on-melanoma-initial-data-from-the-opacin-trial/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/fabrice-barlesi-md-phd-on-nsclc-results-from-the-oak-trial/ 2019-03-19T20:05:17+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/alexander-eggermont-md-phd-on-melanoma-results-from-the-eortc-18071-trial/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/susana-n-banerjee-mbbs-phd-on-ovarian-cancer-results-of-the-coral-trial/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/heinz-josef-lenz-md-on-colon-cancer-sidedness-and-treatment-update/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/mansoor-raza-mirza-md-on-ovarian-cancer-results-from-the-engot-ov16nova-trial/ 2019-03-19T20:05:18+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/christopher-j-sweeney-mbbs-on-localized-prostate-cancer-metastasis-free-survival-as-a-surrogate-for-overall-survival/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/christopher-j-sweeney-mbbs-on-prostate-cancer-chaarted-trial-follow-up/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/derek-j-jonker-md-on-colorectal-cancer-results-from-the-cctgagitg-co23-trial/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/fabrice-barlesi-md-phd-on-nsclc-results-from-the-oak-trial-french-language-version/ 2019-03-19T20:05:19+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/alain-ravaud-md-phd-on-rcc-results-of-the-s-trac-trial-french-language-version/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/philippe-rochigneux-md-on-solid-tumors-use-of-chemotherapy-near-end-of-life-french-language-version/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/teresa-calimeri-md-phd-on-dlbcl-findings-on-high-dose-methotrexate-italian-language-version/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/giorgio-v-scagliotti-md-phd-on-alk-rearranged-nsclc-results-from-the-ascend-5-trial-italian-language-version/ 2019-03-19T20:05:20+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/paolo-a-ascierto-md-on-metastatic-melanoma-ipilimumab-study-results-italian-language-version/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/luis-g-paz-ares-md-phd-on-nsclc-results-from-the-lux-lung-7-trial-spanish-language-version/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/judith-balmaña-md-phd-on-metastatic-breast-cancer-study-results-on-lurbinectedin-spanish-language-version/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/martin-reck-md-phd-on-nsclc-results-of-keynote-024-german-language-version/ 2019-03-19T20:05:21+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/katja-weisel-md-on-multiple-myeloma-results-of-the-castor-study-german-language-version/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/martin-h-schuler-md-on-gastric-and-gej-adenocarcinoma-results-of-the-fast-study-german-language-version/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-esmo-congress/christian-u-blank-md-phd-on-melanoma-initial-data-from-the-opacin-trial-german-language-version/ 2019-03-19T20:05:22+00:00 https://ascopost.com/archive/meetings/2016-lynn-sage-breast-cancer-symposium/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-world-congress-of-cutaneous-lymphomas/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/jonathon-cohen-md-and-sagar-lonial-md-on-dlbcl-results-of-the-calgballiance-50303-trial/ 2019-03-19T20:04:44+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/jean-m-connors-md-and-julie-vose-md-mba-on-thrombosis-and-anticoagulation-best-of-ash-clinical-data/ 2019-03-19T20:04:45+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/joshua-brody-md-on-lymphoid-malignancies-immunotherapy-update/ 2019-03-19T20:04:46+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/jose-f-leis-md-phd-and-sagar-lonial-md-on-cll-ibrutinib-insights/ 2019-03-19T20:04:47+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/brenda-m-sandmaier-md-and-sagar-lonial-md-on-preventing-gvhd-clinical-trial-results/ 2019-03-19T20:04:48+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/umberto-vitolo-md-and-sagar-lonial-md-on-dlbcl-final-results-from-the-goya-trial/ 2019-03-19T20:04:49+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/laurie-h-sehn-md-mph-on-follicular-lymphoma-choosing-the-best-target/ 2019-03-19T20:04:50+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/andrew-d-zelenetz-md-on-cll-emerging-treatments/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/catherine-thieblemont-md-phd-and-julie-vose-md-mba-on-dlbcl-results-from-the-lysa-remarc-study/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/catherine-thieblemont-md-phd-on-dlbcl-results-from-the-lysa-remarc-study-french-language-version/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/syed-a-abutalib-md-and-alex-f-herrera-md-on-double-hit-and-double-expressor-lymphomas-a-retrospective-analysis/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/syed-a-abutalib-md-and-nelli-bejanyan-md-on-adult-all-and-consolidation-chemotherapy-results-from-a-cibmtr-study/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/smita-bhatia-md-mph-and-jessica-wu-ba-on-cml-a-report-from-the-bone-marrow-transplant-survivor-study/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/marie-bleakley-md-phd-on-gvhd-reducing-rates-and-increasing-survival/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/steven-le-gouill-md-phd-on-mantle-cell-lymphoma-final-results-from-the-lyma-trial/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/steven-le-gouill-md-phd-on-mantle-cell-lymphoma-final-results-from-the-lyma-trial-french-language-version/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/martin-schrappe-md-on-childhood-all-study-results-on-reducing-treatment-burden/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/martin-schrappe-md-on-childhood-all-study-results-on-reducing-treatment-burden-german-language-version/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/terry-j-fry-md-on-all-mrd-and-car-therapy/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/stephen-m-ansell-md-phd-on-hematologic-malignancies-results-of-the-checkmate-039-trial/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/jeffrey-e-lancet-md-on-aml-subgroup-analysis-of-a-phase-iii-trial/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/harry-p-erba-md-phd-on-aml-early-study-results-on-vadastuximab-talirine/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/julie-vose-md-mba-and-mhairi-copland-mb-chb-phd-on-cml-data-from-the-british-destiny-study/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/julie-vose-md-mba-and-anjali-advani-md-on-aml-results-of-two-trials-on-vadastuximab-talirine/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2016-ash-annual-meeting-exposition/robert-e-marcus-md-on-follicular-lymphoma-results-from-the-gallium-trial/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/ 2019-03-19T20:04:39+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/sonja-vliek-md-and-sabine-linn-md-phd-on-early-breast-cancer-results-of-the-team-iib-trial/ 2019-03-19T20:04:51+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/diana-m-eccles-md-on-young-breast-cancer-patients-results-from-the-posh-study/ 2019-03-19T20:04:52+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/rowan-t-chlebowski-md-phd-on-diet-and-breast-cancer-trial-results/ 2019-03-19T20:04:53+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/jennifer-a-ligibel-md-on-gene-expression-study-findings/ 2019-03-19T20:04:54+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/dawn-hershman-md-on-breast-cancer-survivorship-poster-discussion/ 2019-03-19T20:04:55+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/jennifer-k-litton-md-and-ann-h-partridge-md-on-breast-cancer-in-young-women/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/stephen-rd-johnston-mbbs-phd-and-ann-h-partridge-md-on-breast-cancer-managing-metastatic-erplus-disease/ 2019-03-19T20:04:56+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/ruth-o-regan-md-and-ann-h-partridge-md-on-her2plus-breast-cancer-results-from-the-cleopatra-trial/ 2019-03-19T20:04:57+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/aleix-prat-md-phd-on-her2plus-breast-cancer-first-results-of-the-pamela-trial/ 2019-03-19T20:04:58+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/aleix-prat-md-phd-on-her2plus-breast-cancer-first-results-of-the-pamela-trial-spanish-language-version/ 2019-03-19T20:04:59+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/sara-a-hurvitz-md-on-hrplus-her2-breast-cancer-results-of-the-neomonarch-trial/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/harold-j-burstein-md-phd-on-adjuvant-endocrine-therapy-expert-perspective/ 2019-03-19T20:05:00+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/samuel-smith-phd-on-tamoxifen-adherence-results-of-the-ibis-1-study/ 2019-03-19T20:05:01+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/ruth-o-regan-md-and-ann-h-partridge-md-on-the-nrg-oncologynsabp-b-42-ideal-and-data-studies/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/jame-abraham-md-on-erplus-breast-cancer-expert-perspective-on-initial-results-of-nrg-oncologynsabp-b-42/ 2019-03-19T20:05:02+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/jame-abraham-md-on-hair-loss-scalp-trial-results/ 2019-03-19T20:05:03+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/anne-hudson-blaes-md-on-aromatase-inhibitors-and-cardiovascular-disease/ 2019-03-19T20:05:04+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/hyo-sook-han-md-on-metastatic-breast-cancer-trial-results-on-veliparib-carboplatin-and-paclitaxel/ 2019-03-19T20:05:05+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/joseph-a-sparano-md-on-early-stage-breast-cancer-findings-on-the-tumor-microenvironment/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/nikhil-wagle-md-on-breast-cancer-advances-in-genomics/ 2019-03-19T20:05:06+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/peter-bach-md-on-the-global-cost-of-cancer-care/ 2019-03-19T20:05:07+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/lisa-a-carey-md-on-sabcs-meeting-highlights-expert-perspective/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/lisa-a-carey-md-and-ingrid-a-mayer-md-on-triple-negative-breast-cancer-treatment-challenges/ 2019-03-19T20:05:08+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/lisa-a-carey-md-and-maki-tanioka-md-on-her2plus-breast-cancer-results-from-the-calgb-40601-alliance-trial/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/ruth-oregan-md-on-locally-advanced-and-metastatic-breast-cancer-results-of-the-belle-3-trial/ 2019-03-19T20:05:09+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/matthew-p-goetz-md-on-advanced-breast-cancer-expert-perspectives/ 2019-03-19T20:05:10+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/patricia-a-ganz-md-aromatase-inhibitors-data-review/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/mothaffar-rimawi-md-on-hrplus-her2plus-breast-cancer-results-of-the-nrg-oncologynsabp-b-52-trial/ 2019-03-19T20:05:11+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/eric-p-winer-md-the-mcguire-lecture/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/sp-somashekhar-mbbs-mch-onco-on-watson-for-oncology-a-validation-study-for-breast-cancer/ 2019-03-19T20:05:12+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/monica-morrow-md-brinker-award-lecture-summary-on-changing-paradigms-in-local-therapy-of-breast-cancer/ 2019-03-19T20:05:13+00:00 https://ascopost.com/archive/meetings/2016-san-antonio-breast-cancer-symposium/virginia-g-kaklamani-md-dsc-on-early-breast-cancer-year-in-review/ 2019-03-19T20:05:14+00:00 https://ascopost.com/archive/issues/ 2018-12-06T15:17:21+00:00 https://ascopost.com/about-us/ 2025-08-18T19:44:08+00:00 https://ascopost.com/search-results/ 2025-07-21T21:39:44+00:00 https://ascopost.com/departments/ 2025-07-21T21:39:44+00:00 https://ascopost.com/departments/2016-asco-annual-meeting/ 2019-03-11T16:00:16+00:00 https://ascopost.com/disclosures/ 2025-07-21T21:39:46+00:00 https://ascopost.com/disclosures/the-asco-post-evening-news-terms-and-conditions/ 2019-03-11T16:00:41+00:00 https://ascopost.com/disclosures/the-asco-post-etoc-terms-and-conditions/ 2019-03-11T16:00:45+00:00 https://ascopost.com/disclaimer/ 2025-07-21T21:39:47+00:00 https://ascopost.com/meetings/ 2025-07-21T21:39:48+00:00 https://ascopost.com/meetings/2016-asco-annual-meeting/ 2019-03-11T15:52:16+00:00 https://ascopost.com/digital-issues/ 2025-07-21T21:39:49+00:00 https://ascopost.com/404-page/ 2025-07-21T21:39:50+00:00 https://ascopost.com/thank-you/ 2025-07-21T21:39:51+00:00 https://ascopost.com/test/ 2025-07-21T21:39:52+00:00 https://ascopost.com/sitemap/ 2025-07-21T21:39:52+00:00 https://ascopost.com/news-pages-index/ 2025-07-21T21:39:53+00:00 https://ascopost.com/biosimilarsroundtable/ 2025-07-21T21:39:54+00:00 https://ascopost.com/brc_renewal/ 2025-07-21T21:39:55+00:00 https://ascopost.com/tap-meeting-list-page/ 2025-07-21T21:39:56+00:00 https://ascopost.com/calendar/ 2025-07-21T21:39:57+00:00 https://ascopost.com/calendar/2017-american-college-of-medical-genetics-and-genomics-annual-clinical-genetics-meeting/ 2025-02-21T19:00:38+00:00 https://ascopost.com/calendar/nccn-annual-conference-advancing-the-standard-of-cancer-care/ 2025-02-21T19:00:38+00:00 https://ascopost.com/calendar/the-endocrine-society-s-99th-annual-meeting-and-expo/ 2025-02-21T19:00:39+00:00 https://ascopost.com/calendar/aacr-annual-meeting/ 2025-02-21T19:00:40+00:00 https://ascopost.com/calendar/international-federation-of-cervical-pathology-and-colposcopy-ifcpc-2017-world-congress/ 2025-02-21T19:00:40+00:00 https://ascopost.com/calendar/4th-annual-miami-lung-cancer-conference/ 2025-02-21T19:00:41+00:00 https://ascopost.com/calendar/american-head-neck-society-annual-meeting/ 2025-02-21T19:00:41+00:00 https://ascopost.com/calendar/accelerating-anticancer-agent-development-and-validation-aaadv-2017-workshop/ 2025-02-21T19:00:42+00:00 https://ascopost.com/calendar/impakt-2017-breast-cancer-conference/ 2025-02-21T19:00:43+00:00 https://ascopost.com/calendar/oncology-nursing-society-42nd-annual-congress/ 2025-02-21T19:00:43+00:00 https://ascopost.com/calendar/elcc-2017-european-lung-cancer-conference/ 2025-02-21T19:00:44+00:00 https://ascopost.com/calendar/xvii-international-workshop-on-chronic-lymphocytic-leukemia/ 2025-02-21T19:00:44+00:00 https://ascopost.com/calendar/asco-annual-meeting/ 2025-02-21T19:00:45+00:00 https://ascopost.com/calendar/society-of-nuclear-medicine-and-molecular-imaging-annual-meeting/ 2025-02-21T19:00:45+00:00 https://ascopost.com/calendar/14th-international-conference-on-malignant-lymphoma-icml/ 2025-02-21T19:00:46+00:00 https://ascopost.com/calendar/best-of-asco-san-francisco/ 2025-02-21T19:00:47+00:00 https://ascopost.com/calendar/24th-asia-pacific-cancer-conference/ 2025-02-21T19:00:47+00:00 https://ascopost.com/calendar/esmo-19th-world-congress-on-gastrointestinal-cancer/ 2025-02-21T19:00:48+00:00 https://ascopost.com/calendar/best-of-asco-boston/ 2025-02-21T19:00:48+00:00 https://ascopost.com/calendar/16th-annual-international-congress-on-the-future-of-breast-cancer/ 2025-02-21T19:00:49+00:00 https://ascopost.com/calendar/japanese-society-of-medical-oncology-annual-meeting-jsmo2017/ 2025-02-21T19:00:50+00:00 https://ascopost.com/calendar/18th-annual-international-lung-cancer-congress/ 2025-02-21T19:00:50+00:00 https://ascopost.com/calendar/3rd-world-congress-on-thyroid-cancer/ 2025-02-21T19:00:51+00:00 https://ascopost.com/calendar/best-of-asco-new-orleans/ 2025-02-21T19:00:52+00:00 https://ascopost.com/calendar/5th-international-conference-on-advances-in-hematology-and-oncology-icaho-2017/ 2025-02-21T19:00:52+00:00 https://ascopost.com/calendar/2017-american-society-of-hematology-meeting-on-hematologic-malignancies/ 2025-02-21T19:00:53+00:00 https://ascopost.com/calendar/esmo-2017-congress/ 2025-02-21T19:00:53+00:00 https://ascopost.com/calendar/ilca-2017-the-international-liver-cancer-association-s-11th-annual-conference/ 2025-02-21T19:00:54+00:00 https://ascopost.com/calendar/astro-s-59th-annual-meeting/ 2025-02-21T19:00:55+00:00 https://ascopost.com/calendar/7th-interamerican-oncology-conference-current-status-and-future-of-anti-cancer-targeted-therapies/ 2025-02-21T19:00:55+00:00 https://ascopost.com/calendar/2017-american-society-of-human-genetics-annual-meeting/ 2025-02-21T19:00:56+00:00 https://ascopost.com/calendar/9th-world-congress-of-melanoma/ 2025-02-21T19:00:56+00:00 https://ascopost.com/calendar/55th-annual-meeting-of-the-japanese-society-of-clinical-oncology-jsco/ 2025-02-21T19:00:58+00:00 https://ascopost.com/calendar/american-college-of-surgeons-clinical-congress/ 2025-02-21T19:00:58+00:00 https://ascopost.com/calendar/3rd-world-congress-on-controversies-in-breast-cancer-cobrca/ 2025-02-21T19:00:59+00:00 https://ascopost.com/calendar/palliative-care-in-oncology-symposium/ 2025-02-21T19:01:00+00:00 https://ascopost.com/calendar/2017-jadpro-live-at-apsho/ 2025-02-21T19:01:00+00:00 https://ascopost.com/calendar/society-for-immunotherapy-of-cancer-sitc-32nd-annual-meeting/ 2025-02-21T19:01:01+00:00 https://ascopost.com/calendar/12th-annual-new-york-lung-cancer-symposium/ 2025-02-21T19:01:01+00:00 https://ascopost.com/calendar/annual-oncofertility-consortium-conference/ 2025-02-21T19:01:02+00:00 https://ascopost.com/calendar/2017-american-society-for-cell-biology-annual-meeting/ 2025-02-21T19:01:03+00:00 https://ascopost.com/calendar/40th-annual-san-antonio-breast-cancer-symposium/ 2025-02-21T19:01:03+00:00 https://ascopost.com/calendar/2nd-annual-international-congress-on-immunotherapies-in-cancer-focus-on-practice-changing-application/ 2025-02-21T19:01:04+00:00 https://ascopost.com/calendar/59th-american-society-of-hematology-ash-annual-meeting-exposition/ 2025-02-21T19:01:04+00:00 https://ascopost.com/calendar/2017-multidisciplinary-spine-oncology-symposium/ 2025-02-21T19:01:05+00:00 https://ascopost.com/calendar/2nd-annual-msk-symposium-on-lymphoma-state-of-the-art-in-biology-therapy-and-patient-care/ 2025-02-21T19:01:06+00:00 https://ascopost.com/calendar/2017-msk-cardio-oncology-symposium-cardiovascular-health-and-disease-during-and-after-cancer-therapy-a-case-based-curriculum/ 2025-02-21T19:01:06+00:00 https://ascopost.com/calendar/updates-in-the-management-of-head-and-neck-cancer-symposium/ 2025-02-21T19:01:07+00:00 https://ascopost.com/calendar/cancer-metastasis-through-the-lymphovascular-system-biology-treatment/ 2025-02-21T19:01:07+00:00 https://ascopost.com/calendar/12th-european-international-kidney-symposium/ 2025-02-21T19:01:08+00:00 https://ascopost.com/calendar/the-american-society-of-breast-surgeons-annual-meeting/ 2025-02-21T19:01:09+00:00 https://ascopost.com/calendar/aacr-international-conference-on-translational-cancer-medicine/ 2025-02-21T19:01:09+00:00 https://ascopost.com/calendar/hematologic-malignancies-translating-discoveries-to-novel-therapies/ 2025-02-21T19:01:10+00:00 https://ascopost.com/calendar/5th-international-cns-germ-cell-tumor-symposium/ 2025-02-21T19:01:10+00:00 https://ascopost.com/calendar/pediatric-palliative-oncology-symposium/ 2025-02-21T19:01:11+00:00 https://ascopost.com/calendar/pediatric-neuro-oncology-basic-and-translational-research-conference/ 2025-02-21T19:01:11+00:00 https://ascopost.com/calendar/world-conference-on-interventional-oncology/ 2025-02-21T19:01:12+00:00 https://ascopost.com/calendar/ecco-aacr-eortc-esmo-workshop-on-methods-in-clinical-cancer-research/ 2025-02-21T19:01:13+00:00 https://ascopost.com/calendar/european-hematology-association-annual-congress/ 2025-02-21T19:01:13+00:00 https://ascopost.com/calendar/integrative-molecular-epidemiology-workshop-bridging-cancer-biology-and-precision-medicine/ 2025-02-21T19:01:14+00:00 https://ascopost.com/calendar/ascoaacr-methods-in-clinical-cancer-research/ 2025-02-21T19:01:14+00:00 https://ascopost.com/calendar/esmo-academy/ 2025-02-21T19:01:15+00:00 https://ascopost.com/calendar/best-of-asco-philadelphia/ 2025-02-21T19:01:15+00:00 https://ascopost.com/calendar/win-2017-symposium/ 2025-02-21T19:01:16+00:00 https://ascopost.com/calendar/2017-international-cancer-education-conference/ 2025-02-21T19:01:17+00:00 https://ascopost.com/calendar/asco-research-community-forum-annual-meeting/ 2025-02-21T19:01:17+00:00 https://ascopost.com/calendar/2017-congress-of-the-international-society-of-paediatric-oncology/ 2025-02-21T19:01:18+00:00 https://ascopost.com/calendar/9th-european-multidisciplinary-meeting-on-urological-cancers/ 2025-02-21T19:01:18+00:00 https://ascopost.com/calendar/aacr-ahns-head-and-neck-cancer-conference-optimizing-survival-and-quality-of-life-through-basic-clinical-and-translational-research/ 2025-02-21T19:01:19+00:00 https://ascopost.com/calendar/cdc-national-cancer-conference/ 2025-02-21T19:01:20+00:00 https://ascopost.com/calendar/cri-cimt-eati-aacr-international-cancer-immunotherapy-conference/ 2025-02-21T19:01:20+00:00 https://ascopost.com/calendar/msk-first-annual-treatment-related-adverse-events-symposium-focus-on-management/ 2025-02-21T19:01:21+00:00 https://ascopost.com/calendar/colorectal-cancer-conference/ 2025-02-21T19:01:21+00:00 https://ascopost.com/calendar/best-of-asco-caribbean/ 2025-02-21T19:01:22+00:00 https://ascopost.com/calendar/aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2025-02-21T19:01:22+00:00 https://ascopost.com/calendar/iaslc-18th-world-conference-on-lung-cancer/ 2025-02-21T19:01:23+00:00 https://ascopost.com/calendar/prostate-cancer-conference/ 2025-02-21T19:01:24+00:00 https://ascopost.com/calendar/oral-oncology-symposium/ 2025-02-21T19:01:24+00:00 https://ascopost.com/calendar/pca17-critical-update-on-prostate-cancer/ 2025-02-21T19:01:25+00:00 https://ascopost.com/calendar/cancer-inflammation-and-immunity/ 2025-02-21T19:01:26+00:00 https://ascopost.com/calendar/american-thyroid-association-annual-meeting/ 2025-02-21T19:01:26+00:00 https://ascopost.com/calendar/best-of-asco-florida-hospital-cancer-institute/ 2025-02-21T19:01:27+00:00 https://ascopost.com/calendar/best-of-asco-ut-health-science-center-at-san-antonio/ 2025-02-21T19:01:28+00:00 https://ascopost.com/calendar/best-of-asco-memorial-cancer-institutememorial-health-system/ 2025-02-21T19:01:28+00:00 https://ascopost.com/calendar/best-of-asco-total-health-information-services/ 2025-02-21T19:01:29+00:00 https://ascopost.com/calendar/best-of-asco-total-health-information-services-1/ 2025-02-21T19:01:29+00:00 https://ascopost.com/calendar/best-of-asco-association-of-physician-assistants-in-oncology/ 2025-02-21T19:01:30+00:00 https://ascopost.com/calendar/best-of-asco-total-health-information-services-2/ 2025-02-21T19:01:31+00:00 https://ascopost.com/calendar/global-cardio-oncology-summit-2017/ 2025-02-21T19:01:31+00:00 https://ascopost.com/calendar/2017-international-cancer-imaging-society-meeting-and-annual-teaching-course/ 2025-02-21T19:01:32+00:00 https://ascopost.com/calendar/2017-champalimaud-research-symposium-physiology-from-development-to-disease/ 2025-02-21T19:01:33+00:00 https://ascopost.com/calendar/2017-molecular-biology-in-clinical-oncology-workshop/ 2025-02-21T19:01:33+00:00 https://ascopost.com/calendar/advances-in-modeling-cancer-in-mice-technology-biology-and-beyond/ 2025-02-21T19:01:34+00:00 https://ascopost.com/calendar/aacr-tumor-immunology-and-immunotherapy/ 2025-02-21T19:01:34+00:00 https://ascopost.com/calendar/addressing-critical-questions-in-ovarian-cancer-research-and-treatment/ 2025-02-21T19:01:35+00:00 https://ascopost.com/calendar/translational-cancer-research-for-basic-scientists-workshop/ 2025-02-21T19:01:35+00:00 https://ascopost.com/calendar/aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics-discovery-biology-and-clinical-applications/ 2025-02-21T19:01:36+00:00 https://ascopost.com/calendar/2017-american-association-of-blood-banks-annual-meeting/ 2025-02-21T19:01:37+00:00 https://ascopost.com/calendar/2017-north-american-association-of-central-cancer-registries-annual-conference/ 2025-02-21T19:01:37+00:00 https://ascopost.com/calendar/current-and-future-perspectives-in-primary-liver-tumors/ 2025-02-21T19:01:38+00:00 https://ascopost.com/calendar/critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology/ 2025-02-21T19:01:39+00:00 https://ascopost.com/calendar/27th-world-congress-of-the-international-association-of-surgeons-gastroenterologists-and-oncologists/ 2025-02-21T19:01:39+00:00 https://ascopost.com/calendar/implementing-biopsychosocial-screening-training-program/ 2025-02-21T19:01:40+00:00 https://ascopost.com/calendar/targeted-anti-cancer-therapies-immunotherapy-and-drug-delivery-world-congress/ 2025-02-21T19:01:40+00:00 https://ascopost.com/calendar/siog-2017-advanced-course/ 2025-02-21T19:01:41+00:00 https://ascopost.com/calendar/2017-annual-meeting-and-education-day-society-for-neuro-oncology/ 2025-02-21T19:01:42+00:00 https://ascopost.com/calendar/2017-society-of-hematologic-oncology-annual-meeting/ 2025-02-21T19:01:42+00:00 https://ascopost.com/calendar/iaslc-2017-chicago-multidisciplinary-symposium-in-thoracic-oncology/ 2025-02-21T19:01:43+00:00 https://ascopost.com/calendar/map-2017-molecular-analysis-for-personalised-therapy/ 2025-02-21T19:01:43+00:00 https://ascopost.com/calendar/2017-association-of-community-cancer-centers-national-oncology-conference/ 2025-02-21T19:01:44+00:00 https://ascopost.com/calendar/2017-international-kidney-cancer-symposium/ 2025-02-21T19:01:45+00:00 https://ascopost.com/calendar/mycancerconnection-cancer-survivorship-conference/ 2025-02-21T19:01:45+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-the-42nd-annual-alumni-meeting-advances-in-the-management-of-prostate-cancer-a-multidisciplinary-approach/ 2025-02-21T19:01:46+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-genomicsgenetics/ 2025-02-21T19:01:46+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-genomicsgenetics-1/ 2025-02-21T19:01:47+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic-malignancies/ 2025-02-21T19:01:48+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic-malignancies-1/ 2025-02-21T19:01:48+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-immunotherapy/ 2025-02-21T19:01:49+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-immunotherapy-1/ 2025-02-21T19:01:49+00:00 https://ascopost.com/calendar/2017-aortic-conference-cancer-in-africa-making-strides-creating-solutions/ 2025-02-21T19:01:50+00:00 https://ascopost.com/calendar/2018-gastrointestinal-cancers-symposium/ 2025-02-21T19:01:51+00:00 https://ascopost.com/calendar/2018-asco-sitc-clinical-immuno-oncology-symposium/ 2025-02-21T19:01:51+00:00 https://ascopost.com/calendar/colorectal-cancer-conference-2017/ 2025-02-21T19:01:52+00:00 https://ascopost.com/calendar/pediatric-cancer-research-from-basic-science-to-the-clinic/ 2025-02-21T19:01:52+00:00 https://ascopost.com/calendar/2017-nccn-global-academy-for-excellence-leadership-in-oncology/ 2025-02-21T19:01:53+00:00 https://ascopost.com/calendar/academy-of-oncology-nurse-patient-navigators-8th-annual-navigation-survivorship-conference/ 2025-02-21T19:01:53+00:00 https://ascopost.com/calendar/2018-genitourinary-cancers-symposium/ 2025-02-21T19:01:54+00:00 https://ascopost.com/calendar/2018-cancer-survivorship-symposium-advancing-care-and-research/ 2025-02-21T19:01:55+00:00 https://ascopost.com/calendar/2018-chemotherapy-foundation-symposium/ 2025-02-21T19:01:56+00:00 https://ascopost.com/calendar/immunobiology-of-primary-and-metastatic-cns-cancer-multidisciplinary-science-to-advance-cancer-immunotherapy/ 2025-02-21T19:01:56+00:00 https://ascopost.com/calendar/targeting-dna-methylation-and-chromatin-for-cancer-therapy/ 2025-02-21T19:01:57+00:00 https://ascopost.com/calendar/working-together-against-oropharyngeal-cancer/ 2025-02-21T19:01:57+00:00 https://ascopost.com/calendar/2nd-global-aya-cancer-congress/ 2025-02-21T19:01:58+00:00 https://ascopost.com/calendar/american-roentgen-ray-society-annual-meeting/ 2025-02-21T19:01:59+00:00 https://ascopost.com/calendar/14th-international-conference-of-the-society-for-integrative-oncology/ 2025-02-21T19:01:59+00:00 https://ascopost.com/calendar/35th-annual-miami-breast-cancer-conference/ 2025-02-21T19:02:00+00:00 https://ascopost.com/calendar/nccn-12th-annual-congress-hematologic-malignancies/ 2025-02-21T19:02:00+00:00 https://ascopost.com/calendar/nccn-annual-conference-improving-the-quality-effectiveness-and-efficiency-of-cancer-care/ 2025-02-21T19:02:01+00:00 https://ascopost.com/calendar/society-of-gynecologic-oncology-annual-meeting-on-women-s-cancer/ 2025-02-21T19:02:01+00:00 https://ascopost.com/calendar/society-of-surgical-oncology-annual-cancer-symposium/ 2025-02-21T19:02:02+00:00 https://ascopost.com/calendar/nccn-global-academy-for-excellence-leadership-in-oncology-school-of-pharmaceutical-biotech-business/ 2025-02-21T19:02:03+00:00 https://ascopost.com/calendar/nccn-patient-advocacy-summit-addressing-survivorship-in-cancer-care/ 2025-02-21T19:02:03+00:00 https://ascopost.com/calendar/11th-european-breast-cancer-conference-ebcc-11/ 2025-02-21T19:02:04+00:00 https://ascopost.com/calendar/lung-cancer-translational-science-from-the-bench-to-the-clinic/ 2025-02-21T19:02:04+00:00 https://ascopost.com/calendar/obesity-and-cancer/ 2025-02-21T19:02:05+00:00 https://ascopost.com/calendar/state-of-the-art-molecular-imaging-in-cancer-biology-and-therapy/ 2025-02-21T19:02:06+00:00 https://ascopost.com/calendar/tat-2018-international-congress-on-targeted-anticancer-therapies/ 2025-02-21T19:02:06+00:00 https://ascopost.com/calendar/great-debates-updates-in-gi-malignancies/ 2025-02-21T19:02:07+00:00 https://ascopost.com/calendar/international-liver-congress/ 2025-02-21T19:02:07+00:00 https://ascopost.com/calendar/sages-2018/ 2025-02-21T19:02:08+00:00 https://ascopost.com/calendar/great-debates-updates-in-hematologic-malignancies/ 2025-02-21T19:02:08+00:00 https://ascopost.com/calendar/esmo-update-for-practicing-oncologists/ 2025-02-21T19:02:09+00:00 https://ascopost.com/calendar/4m-symposium-on-robotic-thoracic-surgery/ 2025-02-21T19:02:10+00:00 https://ascopost.com/calendar/contemporary-management-of-complex-skin-cancers/ 2025-02-21T19:02:10+00:00 https://ascopost.com/calendar/advanced-hepato-pancreato-biliary-surgery-course/ 2025-02-21T19:02:11+00:00 https://ascopost.com/calendar/uicc-world-cancer-leaders-summit/ 2025-02-21T19:02:11+00:00 https://ascopost.com/calendar/antibody-drug-conjugates-oncology-and-beyond/ 2025-02-21T19:02:12+00:00 https://ascopost.com/calendar/esmo-asia-2017-congress/ 2025-02-21T19:02:13+00:00 https://ascopost.com/calendar/esmo-immuno-oncology-congress-2017/ 2025-02-21T19:02:13+00:00 https://ascopost.com/calendar/2nd-annual-intraoperative-imaging-technologies-for-cancer-detection-and-treatment/ 2025-02-21T19:02:14+00:00 https://ascopost.com/calendar/mayo-clinic-radiation-oncology-current-practice-and-future-direction-2018/ 2025-02-21T19:02:14+00:00 https://ascopost.com/calendar/esmo-sarcoma-and-gist-symposium-2018/ 2025-02-21T19:02:15+00:00 https://ascopost.com/calendar/enhanced-recovery-after-surgery-symposium-implementing-change-and-new-standard-of-care-in-surgery/ 2025-02-21T19:02:15+00:00 https://ascopost.com/calendar/the-18th-multidisciplinary-management-of-cancers-a-case-based-approach/ 2025-02-21T19:02:16+00:00 https://ascopost.com/calendar/esmo-symposium-on-signalling-pathways-in-cancer-2018/ 2025-02-21T19:02:17+00:00 https://ascopost.com/calendar/elcc-2018-european-lung-cancer-congress/ 2025-02-21T19:02:17+00:00 https://ascopost.com/calendar/aacr-annual-meeting-2018/ 2025-02-21T19:02:18+00:00 https://ascopost.com/calendar/esmo-update-for-practising-oncologists-2018/ 2025-02-21T19:02:18+00:00 https://ascopost.com/calendar/2018-asco-annual-meeting/ 2025-02-21T19:02:19+00:00 https://ascopost.com/calendar/association-of-northern-california-oncologists/ 2025-02-21T19:02:20+00:00 https://ascopost.com/calendar/advancing-the-science-of-cancer-in-latinos/ 2025-02-21T19:02:20+00:00 https://ascopost.com/calendar/city-of-hope-how-the-experts-treat-hematologic-malignancies/ 2025-02-21T19:02:21+00:00 https://ascopost.com/calendar/ajcc-physician-to-physician-webinar-prostate/ 2025-02-21T19:02:21+00:00 https://ascopost.com/calendar/ajcc-physician-to-physician-webinar-melanoma/ 2025-02-21T19:02:22+00:00 https://ascopost.com/calendar/28th-annual-interdisciplinary-breast-center-conference-ncobc2018/ 2025-02-21T19:02:23+00:00 https://ascopost.com/calendar/how-the-experts-treat-hematologic-malignancies/ 2025-02-21T19:02:23+00:00 https://ascopost.com/calendar/the-american-society-of-breast-surgeons-annual-meeting-1/ 2025-02-21T19:02:24+00:00 https://ascopost.com/calendar/american-thoracic-society-international-conference/ 2025-02-21T19:02:25+00:00 https://ascopost.com/calendar/american-society-of-colon-and-rectal-surgeons-ascrs-annual-scientific-meeting/ 2025-02-21T19:02:26+00:00 https://ascopost.com/calendar/2nd-annual-international-congress-on-oncology-pathology-towards-harmonization-of-pathology-and-oncology-standards/ 2025-02-21T19:02:26+00:00 https://ascopost.com/calendar/18th-international-symposium-on-pediatric-neuro-oncology-ispno-2018/ 2025-02-21T19:02:27+00:00 https://ascopost.com/calendar/2018-pan-pacific-lymphoma-conference/ 2025-02-21T19:02:28+00:00 https://ascopost.com/calendar/ash-meeting-on-lymphoma-biology/ 2025-02-21T19:02:28+00:00 https://ascopost.com/calendar/the-policy-politics-and-law-of-cancer/ 2025-02-21T19:02:29+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-6th-annual-hematology-and-medical-oncology-board-review-contemporary-practice/ 2025-02-21T19:02:30+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-2018-multidisciplinary-spine-oncology-symposium/ 2025-02-21T19:02:31+00:00 https://ascopost.com/calendar/3rd-annual-memorial-sloan-kettering-cancer-alliance-symposium-innovations-in-personalized-oncology-a-case-based-approach/ 2025-02-21T19:02:32+00:00 https://ascopost.com/calendar/3rd-annual-memorial-sloan-kettering-symposium-on-lymphoma/ 2025-02-21T19:02:33+00:00 https://ascopost.com/calendar/best-of-asco-san-diego/ 2025-02-21T19:02:34+00:00 https://ascopost.com/calendar/esmo-eso-course-on-medical-oncology-for-medical-students/ 2025-02-21T19:02:34+00:00 https://ascopost.com/calendar/2018-japanese-society-of-medical-oncology-annual-meeting/ 2025-02-21T19:02:35+00:00 https://ascopost.com/calendar/best-of-asco-washington-dc/ 2025-02-21T19:02:36+00:00 https://ascopost.com/calendar/best-of-asco-chicago/ 2025-02-21T19:02:37+00:00 https://ascopost.com/calendar/ecco2018-european-cancer-summit/ 2025-02-21T19:02:37+00:00 https://ascopost.com/calendar/2018-asco-research-community-forum-annual-meeting/ 2025-02-21T19:02:38+00:00 https://ascopost.com/calendar/2018-asco-oncology-practice-conference/ 2025-02-21T19:02:39+00:00 https://ascopost.com/calendar/asco-quality-care-symposium/ 2025-02-21T19:02:40+00:00 https://ascopost.com/calendar/melbourne-international-breast-congress/ 2025-02-21T19:02:41+00:00 https://ascopost.com/calendar/the-56th-annual-meeting-of-the-japan-society-of-clinical-oncology-jsco/ 2025-02-21T19:02:41+00:00 https://ascopost.com/calendar/esmo-2018-congress/ 2025-02-21T19:02:42+00:00 https://ascopost.com/calendar/ishl11-international-symposium-on-hodgkin-lymphoma/ 2025-02-21T19:02:43+00:00 https://ascopost.com/calendar/2018-palliative-and-supportive-care-in-oncology-symposium/ 2025-02-21T19:02:43+00:00 https://ascopost.com/calendar/60th-ash-annual-meeting-exposition/ 2025-02-21T19:02:44+00:00 https://ascopost.com/calendar/2018-oncologic-emergency-medicine-conference/ 2025-02-21T19:02:45+00:00 https://ascopost.com/calendar/3rd-annual-ucla-state-of-the-art-in-neuro-oncology/ 2025-02-21T19:02:45+00:00 https://ascopost.com/calendar/multidisciplinary-symposium-on-breast-disease/ 2025-02-21T19:02:46+00:00 https://ascopost.com/calendar/advancing-cardiovascular-care-of-the-oncology-patient/ 2025-02-21T19:02:46+00:00 https://ascopost.com/calendar/scripps-cancer-centers-38th-annual-conference-clinical-hematology-oncology-2018/ 2025-02-21T19:02:47+00:00 https://ascopost.com/calendar/11th-annual-international-symposium-on-stereotactic-body-radiation-therapy-and-stereotactic-radiosurgery/ 2025-02-21T19:02:48+00:00 https://ascopost.com/calendar/bcs-breast-cancer-coordinated-care-conference-2018/ 2025-02-21T19:02:48+00:00 https://ascopost.com/calendar/the-15th-annual-winter-lung-cancer-conference/ 2025-02-21T19:02:49+00:00 https://ascopost.com/calendar/the-ninth-biennial-johns-hopkins-breast-cancer-conference-a-multidisciplinary-perspective/ 2025-02-21T19:02:50+00:00 https://ascopost.com/calendar/american-society-for-colposcopy-and-cervical-pathology-asccp-2018-annual-meeting/ 2025-02-21T19:02:50+00:00 https://ascopost.com/calendar/stanford-cancer-immunotherapy-and-blood-and-marrow-transplant-symposium-update-on-current-advances-in-bmt-and-cancer-immunotherapy/ 2025-02-21T19:02:51+00:00 https://ascopost.com/calendar/chicago-breast-symposium-and-7th-world-symposium-on-lymphedema-surgery/ 2025-02-21T19:02:51+00:00 https://ascopost.com/calendar/practical-considerations-and-rationale-for-immunotherapy-2018/ 2025-02-21T19:02:52+00:00 https://ascopost.com/calendar/2018-summit-on-national-and-global-cancer-health-disparities/ 2025-02-21T19:02:53+00:00 https://ascopost.com/calendar/american-radium-society-100th-annual-meeting/ 2025-02-21T19:02:53+00:00 https://ascopost.com/calendar/2018-ash-meeting-on-hematologic-malignancies/ 2025-02-21T19:02:54+00:00 https://ascopost.com/calendar/metabolism-and-cancer/ 2025-02-21T19:02:55+00:00 https://ascopost.com/calendar/esmo-summit-middle-east-2018/ 2025-02-21T19:02:55+00:00 https://ascopost.com/calendar/association-of-community-cancer-centers-35th-national-oncology-conference/ 2025-02-21T19:02:56+00:00 https://ascopost.com/calendar/association-of-community-cancer-centers-44th-annual-meeting-cancer-center-business-summit/ 2025-02-21T19:02:56+00:00 https://ascopost.com/calendar/association-of-community-cancer-centers-oncology-reimbursement-meeting/ 2025-02-21T19:02:58+00:00 https://ascopost.com/calendar/aua2018/ 2025-02-21T19:02:59+00:00 https://ascopost.com/calendar/2018-aans-annual-scientific-meeting/ 2025-02-21T19:02:59+00:00 https://ascopost.com/calendar/15th-annual-apos-conference/ 2025-02-21T19:03:00+00:00 https://ascopost.com/calendar/2018-astro-annual-meeting/ 2025-02-21T19:03:01+00:00 https://ascopost.com/calendar/23rd-congress-of-the-european-hematology-association/ 2025-02-21T19:03:02+00:00 https://ascopost.com/calendar/2018-jadpro-live/ 2025-02-21T19:03:02+00:00 https://ascopost.com/calendar/snmmi-2018-annual-meeting/ 2025-02-21T19:03:03+00:00 https://ascopost.com/calendar/the-iaslc-19th-world-conference-on-lung-cancer-wclc2018/ 2025-02-21T19:03:03+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic-malignancies-2/ 2025-02-21T19:03:04+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic-malignancies-3/ 2025-02-21T19:03:05+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic-malignancies-4/ 2025-02-21T19:03:05+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic-malignancies-5/ 2025-02-21T19:03:06+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic-malignancies-6/ 2025-02-21T19:03:06+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-immunotherapy-2/ 2025-02-21T19:03:07+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-immunotherapy-3/ 2025-02-21T19:03:07+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-immunotherapy-4/ 2025-02-21T19:03:08+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-immunotherapy-5/ 2025-02-21T19:03:09+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-immunotherapy-6/ 2025-02-21T19:03:09+00:00 https://ascopost.com/calendar/2018-san-antonio-breast-cancer-symposium/ 2025-02-21T19:03:10+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-psychopharmacology-in-cancer-care-an-update-for-clinicians-of-all-disciplines/ 2025-02-21T19:03:11+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-critical-care-symposium/ 2025-02-21T19:03:11+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-cancer-rehabilitation-symposium-a-collaborative-approach-to-enhance-quality-of-life/ 2025-02-21T19:03:12+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-perioperative-management-of-the-cancer-patient/ 2025-02-21T19:03:12+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-1st-international-symposium-on-hematopoietic-cell-transplantation-related-toxicities/ 2025-02-21T19:03:13+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-sleep-for-health-approaches-from-integrative-medicine-and-psycho-oncology/ 2025-02-21T19:03:14+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-cardio-oncology-symposium-cardiovascular-health-and-disease-during-and-after-cancer-therapy-a-case-based-curriculum/ 2025-02-21T19:03:14+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-cancer-center-cancer-treatment-update/ 2025-02-21T19:03:15+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-emergencies-in-the-cancer-patient/ 2025-02-21T19:03:15+00:00 https://ascopost.com/calendar/european-colorectal-congress-2018/ 2025-02-21T19:03:16+00:00 https://ascopost.com/calendar/2018-international-congress-for-anti-cancer-treatment-japan-icact/ 2025-02-21T19:03:17+00:00 https://ascopost.com/calendar/siog-2018-annual-conference/ 2025-02-21T19:03:17+00:00 https://ascopost.com/calendar/9th-annual-comprehensive-hematology-and-oncology-review-course/ 2025-02-21T19:03:18+00:00 https://ascopost.com/calendar/2018-world-cancer-congress/ 2025-02-21T19:03:18+00:00 https://ascopost.com/calendar/mayo-clinic-neuroscience-and-oncology-innovation-summit-2018/ 2025-02-21T19:03:19+00:00 https://ascopost.com/calendar/2018-dialogue-for-action-on-cancer-screening-prevention/ 2025-02-21T19:03:20+00:00 https://ascopost.com/calendar/2nd-annual-spine-tumor-seminar/ 2025-02-21T19:03:20+00:00 https://ascopost.com/calendar/the-inaugural-north-carolina-adolescent-and-young-adult-oncology-symposium/ 2025-02-21T19:03:21+00:00 https://ascopost.com/calendar/interdisciplinary-opioid-crisis-seminar-navigating-the-current-opioid-crisis-in-cancer-patients/ 2025-02-21T19:03:21+00:00 https://ascopost.com/calendar/pancreas-2018-innovations-in-the-care-of-pancreatic-cancer/ 2025-02-21T19:03:22+00:00 https://ascopost.com/calendar/the-30-year-anniversary-annual-world-congress-of-the-international-association-of-surgeons-gastroenterologists-and-oncologists-iasgo/ 2025-02-21T19:03:22+00:00 https://ascopost.com/calendar/critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology-1/ 2025-02-21T19:03:23+00:00 https://ascopost.com/calendar/nccn-oncology-policy-summit-policy-strategies-for-the-new-normal-in-health-care-to-ensure-access-to-high-quality-cancer-care/ 2025-02-21T19:03:24+00:00 https://ascopost.com/calendar/multidisciplinary-approaches-to-cancer-symposium/ 2025-02-21T19:03:24+00:00 https://ascopost.com/calendar/neoplastic-hematopathology-update/ 2025-02-21T19:03:25+00:00 https://ascopost.com/calendar/8th-interamerican-oncology-conference-current-status-and-future-of-anti-cancer-therapies/ 2025-02-21T19:03:26+00:00 https://ascopost.com/calendar/win-2018-symposium/ 2025-02-21T19:03:26+00:00 https://ascopost.com/calendar/brececan-2018/ 2025-02-21T19:03:27+00:00 https://ascopost.com/calendar/transitions-in-oncology-care-pearls-for-the-primary-care-team/ 2025-02-21T19:03:27+00:00 https://ascopost.com/calendar/8th-annual-pnw-head-neck-symposium/ 2025-02-21T19:03:28+00:00 https://ascopost.com/calendar/36th-annual-chemotherapy-foundation-symposium-innovative-cancer-therapy-for-tomorrow/ 2025-02-21T19:03:28+00:00 https://ascopost.com/calendar/partners-in-progress-2018-cancer-patient-advocates-and-fda/ 2025-02-21T19:03:29+00:00 https://ascopost.com/calendar/5th-annual-metastatic-breast-cancer-conference/ 2025-02-21T19:03:30+00:00 https://ascopost.com/calendar/map-2018-molecular-analysis-for-personalised-therapy/ 2025-02-21T19:03:30+00:00 https://ascopost.com/calendar/ilca-2018-the-international-liver-cancer-association-s-12th-annual-conference/ 2025-02-21T19:03:31+00:00 https://ascopost.com/calendar/nccn-13th-annual-congress-hematologic-malignancies/ 2025-02-21T19:03:31+00:00 https://ascopost.com/calendar/nccn-2019-annual-conference-improving-the-quality-effectiveness-efficiency-of-cancer-care/ 2025-02-21T19:03:32+00:00 https://ascopost.com/calendar/society-for-integrative-oncology-15th-international-conference/ 2025-02-21T19:03:33+00:00 https://ascopost.com/calendar/17th-international-kidney-cancer-symposium/ 2025-02-21T19:03:33+00:00 https://ascopost.com/calendar/esmo-academy-1/ 2025-02-21T19:03:34+00:00 https://ascopost.com/calendar/esmo-eso-course-on-medical-oncology-for-medical-students-1/ 2025-02-21T19:03:35+00:00 https://ascopost.com/calendar/10th-european-multidisciplinary-congress-on-urological-cancers-emuc-2018/ 2025-02-21T19:03:36+00:00 https://ascopost.com/calendar/esmo-asia-2018-congress/ 2025-02-21T19:03:36+00:00 https://ascopost.com/calendar/esmo-immuno-oncology-congress-2018/ 2025-02-21T19:03:37+00:00 https://ascopost.com/calendar/masccisoo-2019/ 2025-02-21T19:03:37+00:00 https://ascopost.com/calendar/ons-44th-annual-congress/ 2025-02-21T19:03:38+00:00 https://ascopost.com/calendar/nccn-global-academy-for-excellence-leadership-in-oncology-school-of-pharmaceutical-biotech-business-1/ 2025-02-21T19:03:38+00:00 https://ascopost.com/calendar/nccn-oncology-policy-summit-policy-challenges-and-opportunities-to-address-changing-paradigms-in-cancer-care-delivery/ 2025-02-21T19:03:39+00:00 https://ascopost.com/calendar/14th-annual-african-american-prostate-cancer-disparity-summit/ 2025-02-21T19:03:40+00:00 https://ascopost.com/calendar/american-college-of-surgeons-clinical-congress-1/ 2025-02-21T19:03:41+00:00 https://ascopost.com/calendar/cri-cimt-eati-aacr-international-cancer-immunotherapy-conference-1/ 2025-02-21T19:03:41+00:00 https://ascopost.com/calendar/ash-meeting-on-hematologic-malignancies/ 2025-02-21T19:03:42+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-interventional-cancer-pain-symposium-technical-workshop-in-advanced-therapies/ 2025-02-21T19:03:42+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-current-paradigms-in-interventional-pulmonology-endobronchial-ultrasound-and-lung-cancer-staging/ 2025-02-21T19:03:43+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-7th-annual-state-of-the-art-in-thrombosis-and-hemostasis-symposium/ 2025-02-21T19:03:44+00:00 https://ascopost.com/calendar/navigating-challenging-conversations-through-the-cancer-trajectory-a-practical-evidence-based-approach-for-oncology-clinicians/ 2025-02-21T19:03:45+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-state-of-the-art-gynecologic-surgery-ovarian-cancer-management-conference-2018/ 2025-02-21T19:03:45+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-14th-annual-dermoscopy-intermediate-course/ 2025-02-21T19:03:46+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-1st-annual-basic-course-in-reflectance-confocal-microscopy-non-invasive-diagnosis-of-skin-cancer/ 2025-02-21T19:03:47+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-6th-annual-course-in-musculoskeletal-tumor-pathology-and-clinical-oncology/ 2025-02-21T19:03:47+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-transforming-dermatology-in-the-digital-era/ 2025-02-21T19:03:48+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-annual-cancer-treatment-related-adverse-events-symposium/ 2025-02-21T19:03:48+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-4th-annual-oncologic-fdg-petct-cme-course/ 2025-02-21T19:03:49+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-contemporary-management-of-complex-skin-cancers/ 2025-02-21T19:03:49+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-3rd-annual-advances-in-colorectal-oncology/ 2025-02-21T19:03:50+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-rectal-mri-workshop/ 2025-02-21T19:03:51+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-oral-oncology-symposium-a-multidisciplinary-approach/ 2025-02-21T19:03:51+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-pancreas-cancer-symposium-state-of-the-art-2018-and-beyond/ 2025-02-21T19:03:52+00:00 https://ascopost.com/calendar/international-cancer-education-conference-icec/ 2025-02-21T19:03:52+00:00 https://ascopost.com/calendar/acg-2018-annual-meeting/ 2025-02-21T19:03:53+00:00 https://ascopost.com/calendar/american-society-of-human-genetics-annual-meeting/ 2025-02-21T19:03:54+00:00 https://ascopost.com/calendar/3rd-annual-mayo-clinic-cutaneous-oncology-symposium/ 2025-02-21T19:03:54+00:00 https://ascopost.com/calendar/jadpro-regional-lectures-hematologic/ 2025-02-21T19:03:55+00:00 https://ascopost.com/calendar/11th-aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2025-02-21T19:03:55+00:00 https://ascopost.com/calendar/tumor-immunology-and-immunotherapy/ 2025-02-21T19:03:56+00:00 https://ascopost.com/calendar/27th-world-oncologists-annual-conference-on-medical-oncology-radiation-oncology-surgical-oncology/ 2025-02-21T19:03:57+00:00 https://ascopost.com/calendar/13th-annual-practical-course-in-dermoscopy-update-on-malignant-melanoma-2018/ 2025-02-21T19:03:57+00:00 https://ascopost.com/calendar/american-society-for-cell-biology-annual-meeting/ 2025-02-21T19:03:58+00:00 https://ascopost.com/calendar/nccn-policy-summit-advocating-for-equity-in-cancer-care/ 2025-02-21T19:03:58+00:00 https://ascopost.com/calendar/expert-forum-on-breast-cancer/ 2025-02-21T19:03:59+00:00 https://ascopost.com/calendar/mayo-clinic-radiation-oncology-current-practice-and-future-direction-2019/ 2025-02-21T19:04:00+00:00 https://ascopost.com/calendar/11th-annual-t-cell-lymphoma-forum/ 2025-02-21T19:04:00+00:00 https://ascopost.com/calendar/second-annual-miami-brain-symposium/ 2025-02-21T19:04:01+00:00 https://ascopost.com/calendar/how-the-experts-treat-hematologic-malignancies-1/ 2025-02-21T19:04:01+00:00 https://ascopost.com/calendar/adaptive-mr-image-guided-radiotherapy-symposium-experience-application-in-routine-clinical-practice/ 2025-02-21T19:04:02+00:00 https://ascopost.com/calendar/nccn-global-academy-for-excellence-leadership-in-oncology-school-of-pharmaceutical-biotech-business-2/ 2025-02-21T19:04:02+00:00 https://ascopost.com/calendar/symposia-on-cancer-research-2018-the-leading-edge-of-cancer-research/ 2025-02-21T19:04:03+00:00 https://ascopost.com/calendar/breast-health-global-initiative-global-summit-2018/ 2025-02-21T19:04:04+00:00 https://ascopost.com/calendar/melanoma-biology-patient-management-2018/ 2025-02-21T19:04:04+00:00 https://ascopost.com/calendar/clinical-pathways-congress/ 2025-02-21T19:04:05+00:00 https://ascopost.com/calendar/5th-annual-multidisciplinary-colorectal-oncology-course/ 2025-02-21T19:04:05+00:00 https://ascopost.com/calendar/19th-annual-meeting-of-the-society-of-urologic-oncology/ 2025-02-21T19:04:06+00:00 https://ascopost.com/calendar/2018-onco-nephrology-symposium/ 2025-02-21T19:04:06+00:00 https://ascopost.com/calendar/2019-gastrointestinal-cancers-symposium/ 2025-02-21T19:04:07+00:00 https://ascopost.com/calendar/the-annual-assembly-hospice-and-palliative-care/ 2025-02-21T19:04:08+00:00 https://ascopost.com/calendar/multidisciplinary-thoracic-cancers-symposium/ 2025-02-21T19:04:08+00:00 https://ascopost.com/calendar/current-trends-in-urologic-oncology-cme-conference/ 2025-02-21T19:04:09+00:00 https://ascopost.com/calendar/5th-annual-course-on-proton-therapy/ 2025-02-21T19:04:09+00:00 https://ascopost.com/calendar/gayle-brinkenhoff-breast-cancer-symposium/ 2025-02-21T19:04:10+00:00 https://ascopost.com/calendar/car-tcr-summit-2018/ 2025-02-21T19:04:11+00:00 https://ascopost.com/calendar/asco-sitc-clinical-immuno-oncology-symposium/ 2025-02-21T19:04:12+00:00 https://ascopost.com/calendar/atlanta-lung-cancer-symposium/ 2025-02-21T19:04:12+00:00 https://ascopost.com/calendar/13th-update-on-the-management-of-genitourinary-malignancies/ 2025-02-21T19:04:13+00:00 https://ascopost.com/calendar/2019-genitourinary-cancers-symposium/ 2025-02-21T19:04:13+00:00 https://ascopost.com/calendar/16th-st-gallen-international-breast-cancer-conference/ 2025-02-21T19:04:14+00:00 https://ascopost.com/calendar/society-of-surgical-oncology-annual-cancer-symposium-1/ 2025-02-21T19:04:14+00:00 https://ascopost.com/calendar/aacr-annual-meeting-2019/ 2025-02-21T19:04:15+00:00 https://ascopost.com/calendar/elcc-2019-european-lung-cancer-congress/ 2025-02-21T19:04:16+00:00 https://ascopost.com/calendar/esmo-breast-cancer/ 2025-02-21T19:04:16+00:00 https://ascopost.com/calendar/digestive-disease-week/ 2025-02-21T19:04:17+00:00 https://ascopost.com/calendar/digestive-disease-week-1/ 2025-02-21T19:04:17+00:00 https://ascopost.com/calendar/2019-asco-annual-meeting/ 2025-02-21T19:04:18+00:00 https://ascopost.com/calendar/nccn-patient-advocacy-summit-advocating-for-equity-in-cancer-care/ 2025-02-21T19:04:18+00:00 https://ascopost.com/calendar/15th-annual-symposium-on-pancreatic-cancer/ 2025-02-21T19:04:19+00:00 https://ascopost.com/calendar/36th-annual-miami-breast-cancer-conference/ 2025-02-21T19:04:20+00:00 https://ascopost.com/calendar/acro-proton-therapy-symposium-miami/ 2025-02-21T19:04:20+00:00 https://ascopost.com/calendar/29th-annual-interdisciplinary-breast-center-conference-2019-ncobc-2019/ 2025-02-21T19:04:21+00:00 https://ascopost.com/calendar/international-workshop-on-chronic-lymphocytic-leukemia/ 2025-02-21T19:04:21+00:00 https://ascopost.com/calendar/2019-mayo-clinic-urology-review/ 2025-02-21T19:04:22+00:00 https://ascopost.com/calendar/men-2019-16th-international-workshop-on-multiple-endocrine-neoplasia/ 2025-02-21T19:04:23+00:00 https://ascopost.com/calendar/2019-summit-on-national-global-cancer-health-disparities/ 2025-02-21T19:04:23+00:00 https://ascopost.com/calendar/cimt-2019-annual-meeting/ 2025-02-21T19:04:24+00:00 https://ascopost.com/calendar/best-of-asco-bellevue-on-seattles-east-side/ 2025-02-21T19:04:24+00:00 https://ascopost.com/calendar/best-of-asco-austin/ 2025-02-21T19:04:25+00:00 https://ascopost.com/calendar/best-of-asco-austin-2/ 2025-02-21T19:04:25+00:00 https://ascopost.com/calendar/best-of-asco-baltimore/ 2025-02-21T19:04:26+00:00 https://ascopost.com/calendar/iaslc-19th-lung-cancer-targeted-therapies-meeting/ 2025-02-21T19:04:27+00:00 https://ascopost.com/calendar/iaslc-2019-small-cell-lung-cancer-meeting/ 2025-02-21T19:04:27+00:00 https://ascopost.com/calendar/iaslc-2019-mesothelioma-meeting/ 2025-02-21T19:04:28+00:00 https://ascopost.com/calendar/19th-multidisciplinary-management-of-cancers-a-case-based-approach/ 2025-02-21T19:04:29+00:00 https://ascopost.com/calendar/psychopharmacology-in-cancer-care-an-update-for-clinicians-of-all-disciplines/ 2025-02-21T19:04:30+00:00 https://ascopost.com/calendar/7th-annual-hematology-and-medical-oncology-board-review-contemporary-practice/ 2025-02-21T19:04:30+00:00 https://ascopost.com/calendar/clinical-application-of-car-t-cells-2019/ 2025-02-21T19:04:31+00:00 https://ascopost.com/calendar/update-on-the-treatment-of-pituitary-diseases-emerging-therapies/ 2025-02-21T19:04:32+00:00 https://ascopost.com/calendar/4th-annual-msk-symposium-on-lymphoma/ 2025-02-21T19:04:32+00:00 https://ascopost.com/calendar/2019-msk-cardio-oncology-symposium/ 2025-02-21T19:04:33+00:00 https://ascopost.com/calendar/8th-annual-state-of-the-art-in-thrombosis-and-hemostasis-symposium/ 2025-02-21T19:04:34+00:00 https://ascopost.com/calendar/15th-annual-dermoscopy-intermediate-course/ 2025-02-21T19:04:34+00:00 https://ascopost.com/calendar/personalized-psycho-oncology-a-case-based-approach/ 2025-02-21T19:04:35+00:00 https://ascopost.com/calendar/7th-annual-lung-cancer-symposium/ 2025-02-21T19:04:35+00:00 https://ascopost.com/calendar/mayo-clinic-gastrointestinal-cancers-2019/ 2025-02-21T19:04:36+00:00 https://ascopost.com/calendar/principles-of-pain-management-and-palliative-care-essential-tools-for-the-clinician-2019/ 2025-02-21T19:04:36+00:00 https://ascopost.com/calendar/society-of-gynecologic-oncology-annual-meeting-on-women-s-cancer/ 2025-02-21T19:04:37+00:00 https://ascopost.com/calendar/3rd-global-summit-on-oncology-cancer/ 2025-02-21T19:04:39+00:00 https://ascopost.com/calendar/15th-world-congress-on-blood-cancer/ 2025-02-21T19:04:39+00:00 https://ascopost.com/calendar/34th-euro-global-summit-on-cancer-therapy-radiation-oncology/ 2025-02-21T19:04:40+00:00 https://ascopost.com/calendar/bladder-cancer-transforming-the-field/ 2025-02-21T19:04:40+00:00 https://ascopost.com/calendar/world-congress-on-cancer-science-and-therapy/ 2025-02-21T19:04:41+00:00 https://ascopost.com/calendar/7th-international-conference-on-advances-in-hematology-and-oncology-icaho19/ 2025-02-21T19:04:42+00:00 https://ascopost.com/calendar/pancreatic-cancer-advances-in-science-and-clinical-care/ 2025-02-21T19:04:42+00:00 https://ascopost.com/calendar/aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved-1/ 2025-02-21T19:04:43+00:00 https://ascopost.com/calendar/european-society-for-medical-oncology-congress/ 2025-02-21T19:04:43+00:00 https://ascopost.com/calendar/scripps-cancer-center-s-39th-annual-conference/ 2025-02-21T19:04:44+00:00 https://ascopost.com/calendar/society-of-interventional-radiology-sir-2019/ 2025-02-21T19:04:44+00:00 https://ascopost.com/calendar/6th-immunotherapy-of-cancer-conference-itoc6/ 2025-02-21T19:04:45+00:00 https://ascopost.com/calendar/eortc-esmo-ecco-aacr-methods-in-clinical-cancer-research/ 2025-02-21T19:04:46+00:00 https://ascopost.com/calendar/international-conference-on-malignant-lymphoma/ 2025-02-21T19:04:47+00:00 https://ascopost.com/calendar/environmental-carcinogenesis-potential-pathway-to-cancer-prevention/ 2025-02-21T19:04:47+00:00 https://ascopost.com/calendar/integrative-molecular-epidemiology-bridging-cancer-biology-and-precision-medicine/ 2025-02-21T19:04:48+00:00 https://ascopost.com/calendar/ascoaacr-methods-in-clinical-cancer-research-workshop/ 2025-02-21T19:04:48+00:00 https://ascopost.com/calendar/2019-astro-annual-meeting/ 2025-02-21T19:04:49+00:00 https://ascopost.com/calendar/symposium-on-clinical-interventional-oncology/ 2025-02-21T19:04:49+00:00 https://ascopost.com/calendar/american-society-of-human-genetics-annual-meeting/ 2025-02-21T19:04:50+00:00 https://ascopost.com/calendar/cri-cimt-eati-aacr-international-cancer-immunotherapy-conference-translating-science-into-survival/ 2025-02-21T19:04:51+00:00 https://ascopost.com/calendar/aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutic/ 2025-02-21T19:04:51+00:00 https://ascopost.com/calendar/american-college-of-surgeons-clinical-congress-2/ 2025-02-21T19:04:52+00:00 https://ascopost.com/calendar/san-antonio-breast-cancer-symposium/ 2025-02-21T19:04:52+00:00 https://ascopost.com/calendar/61st-ash-annual-meeting-exposition/ 2025-02-21T19:04:53+00:00 https://ascopost.com/calendar/fourteenth-annual-european-international-kidney-cancer-symposium/ 2025-02-21T19:04:53+00:00 https://ascopost.com/calendar/2019-japanese-society-of-medical-oncology-annual-meeting/ 2025-02-21T19:04:54+00:00 https://ascopost.com/calendar/phase-i-where-science-becomes-medicine/ 2025-02-21T19:04:55+00:00 https://ascopost.com/calendar/asco-oncology-practice-symposium/ 2025-02-21T19:04:55+00:00 https://ascopost.com/calendar/asco-quality-care-symposium-1/ 2025-02-21T19:04:56+00:00 https://ascopost.com/calendar/20th-annual-meeting-of-the-society-of-urologic-oncology/ 2025-02-21T19:04:56+00:00 https://ascopost.com/calendar/2019-supportive-care-in-oncology-symposium/ 2025-02-21T19:04:57+00:00 https://ascopost.com/calendar/breakthrough-a-global-summit-for-oncology-innovators/ 2025-02-21T19:04:58+00:00 https://ascopost.com/calendar/ilca-2019/ 2025-02-21T19:04:58+00:00 https://ascopost.com/calendar/10th-annual-comprehensive-hematology-oncology-review-course/ 2025-02-21T19:04:59+00:00 https://ascopost.com/calendar/iaslc-20th-world-conference-on-lung-cancer/ 2025-02-21T19:04:59+00:00 https://ascopost.com/calendar/iaslc-2019-north-america-conference-on-lung-cancer/ 2025-02-21T19:05:00+00:00 https://ascopost.com/calendar/iaslc-2019-latin-america-conference-on-lung-cancer/ 2025-02-21T19:05:00+00:00 https://ascopost.com/calendar/2019-health-disparities-research-institute/ 2025-02-21T19:05:01+00:00 https://ascopost.com/calendar/updates-in-the-management-of-head-and-neck-cancer/ 2025-02-21T19:05:02+00:00 https://ascopost.com/calendar/snmmi-annual-meeting/ 2025-02-21T19:05:02+00:00 https://ascopost.com/calendar/lymphoma-myeloma-an-international-congress-on-hematologic-malignancies/ 2025-02-21T19:05:03+00:00 https://ascopost.com/calendar/8th-world-congress-on-oncology-nursing-and-cancer-care/ 2025-02-21T19:05:03+00:00 https://ascopost.com/calendar/greater-atlanta-metastatic-breast-cancer-conference/ 2025-02-21T19:05:04+00:00 https://ascopost.com/calendar/emergencies-in-the-cancer-patient/ 2025-02-21T19:05:05+00:00 https://ascopost.com/calendar/2019-international-cancer-education-conference/ 2025-02-21T19:05:05+00:00 https://ascopost.com/calendar/2019-ncri-cancer-conference/ 2025-02-21T19:05:06+00:00 https://ascopost.com/calendar/sitc-annual-meeting-pre-conference-programs/ 2025-02-21T19:05:06+00:00 https://ascopost.com/calendar/map-2019-molecular-analysis-for-personalised-therapy/ 2025-02-21T19:05:07+00:00 https://ascopost.com/calendar/27th-international-symposium-advances-in-the-treatment-of-digestive-tumors/ 2025-02-21T19:05:07+00:00 https://ascopost.com/calendar/society-of-interventional-oncology-annual-scientific-meeting/ 2025-02-21T19:05:08+00:00 https://ascopost.com/calendar/european-hematology-association-congress/ 2025-02-21T19:05:09+00:00 https://ascopost.com/calendar/win-symposium-2019/ 2025-02-21T19:05:09+00:00 https://ascopost.com/calendar/esmo-21st-world-congress-on-gastrointestinal-cancer/ 2025-02-21T19:05:10+00:00 https://ascopost.com/calendar/immune-cell-therapies-for-cancer-successes-and-challenges-of-car-t-cells-and-other-forms-of-adoptive-therapy/ 2025-02-21T19:05:10+00:00 https://ascopost.com/calendar/advanced-prostate-cancer-consensus-conference-apccc-2019/ 2025-02-21T19:05:11+00:00 https://ascopost.com/calendar/advances-in-ovarian-cancer-research/ 2025-02-21T19:05:11+00:00 https://ascopost.com/calendar/great-debates-updates-in-gastrointestinal-malignancies/ 2025-02-21T19:05:12+00:00 https://ascopost.com/calendar/collaborative-group-of-the-americas-on-inherited-colorectal-cancer/ 2025-02-21T19:05:13+00:00 https://ascopost.com/calendar/perspectives-in-thoracic-oncology/ 2025-02-21T19:05:13+00:00 https://ascopost.com/calendar/perspectives-in-thoracic-oncology-1/ 2025-02-21T19:05:14+00:00 https://ascopost.com/calendar/jadpro-live-2019/ 2025-02-21T19:05:15+00:00 https://ascopost.com/calendar/adventhealth-cancer-institute-asco-direct-highlights/ 2025-02-21T19:05:16+00:00 https://ascopost.com/calendar/16th-annual-accelerating-anticancer-agent-development-and-validation-aaadv-workshop/ 2025-02-21T19:05:16+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-cancer-treatment-update-2019/ 2025-02-21T19:05:17+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-palliative-care-symposium-for-advanced-practice-providers/ 2025-02-21T19:05:17+00:00 https://ascopost.com/calendar/5th-annual-oncologic-fdg-petct-cme-course/ 2025-02-21T19:05:18+00:00 https://ascopost.com/calendar/ecco2019-european-cancer-summit/ 2025-02-21T19:05:19+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-s-2nd-congress-interventional-cancer-pain-symposium/ 2025-02-21T19:05:19+00:00 https://ascopost.com/calendar/the-22nd-annual-meeting-of-chinese-society-of-clinical-oncology/ 2025-02-21T19:05:20+00:00 https://ascopost.com/calendar/2nd-annual-basic-course-in-reflectance-confocal-microscopy-non-invasive-diagnosis-of-skin-cancer/ 2025-02-21T19:05:21+00:00 https://ascopost.com/calendar/the-57th-annual-meeting-of-japan-society-of-clinical-oncology/ 2025-02-21T19:05:21+00:00 https://ascopost.com/calendar/advances-in-the-management-of-bladder-and-kidney-cancer-a-multidisciplinary-approach/ 2025-02-21T19:05:22+00:00 https://ascopost.com/calendar/aortic-2019-cancer-in-africa-innovation-strategies-implementation/ 2025-02-21T19:05:22+00:00 https://ascopost.com/calendar/esmo-asia-2019-congress/ 2025-02-21T19:05:23+00:00 https://ascopost.com/calendar/4th-annual-intraoperative-imaging-technologies-for-cancer-detection-treatment/ 2025-02-21T19:05:24+00:00 https://ascopost.com/calendar/european-colorectal-congress/ 2025-02-21T19:05:24+00:00 https://ascopost.com/calendar/31st-annual-world-congress-of-the-international-association-of-surgeons-gastroenterologists-and-oncologists-iasgo/ 2025-02-21T19:05:25+00:00 https://ascopost.com/calendar/critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology-2/ 2025-02-21T19:05:26+00:00 https://ascopost.com/calendar/multidisciplinary-approaches-to-cancer-symposium-1/ 2025-02-21T19:05:26+00:00 https://ascopost.com/calendar/hematology-and-medical-oncology-review-2019/ 2025-02-21T19:05:27+00:00 https://ascopost.com/calendar/ptcog-north-america-6th-annual-conference-new-frontiers-in-particle-therapy/ 2025-02-21T19:05:27+00:00 https://ascopost.com/calendar/2019-aicr-research-conference/ 2025-02-21T19:05:29+00:00 https://ascopost.com/calendar/27th-annual-congress-on-cell-signaling-cancer-science-and-therapeutics/ 2025-02-21T19:05:29+00:00 https://ascopost.com/calendar/2nd-international-symposium-of-colorectal-cancer/ 2025-02-21T19:05:30+00:00 https://ascopost.com/calendar/xxii-congress-of-the-polish-society-of-clinical-oncology/ 2025-02-21T19:05:31+00:00 https://ascopost.com/calendar/cancer-immune-responsiveness-workshop/ 2025-02-21T19:05:31+00:00 https://ascopost.com/calendar/adoptive-cellular-therapies-workshop/ 2025-02-21T19:05:32+00:00 https://ascopost.com/calendar/digestive-disease-interventions-2019/ 2025-02-21T19:05:32+00:00 https://ascopost.com/calendar/cancer-and-inflammation-from-micro-to-macro/ 2025-02-21T19:05:33+00:00 https://ascopost.com/calendar/society-for-integrative-oncology-16th-international-conference/ 2025-02-21T19:05:34+00:00 https://ascopost.com/calendar/2020-gastrointestinal-cancers-symposium/ 2025-02-21T19:05:34+00:00 https://ascopost.com/calendar/2020-asco-sitc-clinical-immuno-oncology-symposium/ 2025-02-21T19:05:35+00:00 https://ascopost.com/calendar/2020-genitourinary-cancers-symposium/ 2025-02-21T19:05:36+00:00 https://ascopost.com/calendar/standard-of-cure-cancer-symposium/ 2025-02-21T19:05:36+00:00 https://ascopost.com/calendar/2019-debates-and-didactics-in-hematology-and-oncology/ 2025-02-21T19:05:37+00:00 https://ascopost.com/calendar/2019-restorative-medicine-conference/ 2025-02-21T19:05:38+00:00 https://ascopost.com/calendar/understanding-car-t-cell-therapy-as-a-treatment-option-for-blood-cancer-patients/ 2025-02-21T19:05:38+00:00 https://ascopost.com/calendar/understanding-car-t-cell-therapy-as-a-treatment-option-for-blood-cancer-patients-1/ 2025-02-21T19:05:39+00:00 https://ascopost.com/calendar/an-extra-layer-of-support-psychosocial-oncology-s-role-in-palliative-care/ 2025-02-21T19:05:40+00:00 https://ascopost.com/calendar/2019-international-cancer-metastasis-congress/ 2025-02-21T19:05:40+00:00 https://ascopost.com/calendar/biology-of-cancer-microenvironment-metastasis/ 2025-02-21T19:05:41+00:00 https://ascopost.com/calendar/care-for-the-older-cancer-patient-cognition-and-communication/ 2025-02-21T19:05:41+00:00 https://ascopost.com/calendar/12th-annual-meeting-of-ksmo/ 2025-02-21T19:05:42+00:00 https://ascopost.com/calendar/xxiii-russian-oncological-congress/ 2025-02-21T19:05:43+00:00 https://ascopost.com/calendar/cosa-s-46th-annual-scientific-meeting/ 2025-02-21T19:05:43+00:00 https://ascopost.com/calendar/15th-annual-personalized-medicine-conference/ 2025-02-21T19:05:44+00:00 https://ascopost.com/calendar/cancer-survivorship-fundamentals-for-primary-care/ 2025-02-21T19:05:45+00:00 https://ascopost.com/calendar/2019-onco-nephrology-symposium/ 2025-02-21T19:05:45+00:00 https://ascopost.com/calendar/esmo-sarcoma-and-gist-symposium-2020/ 2025-02-21T19:05:46+00:00 https://ascopost.com/calendar/2020-multidisciplinary-head-and-neck-cancers-symposium/ 2025-02-21T19:05:46+00:00 https://ascopost.com/calendar/aacr-international-conference-infection-and-cancer/ 2025-02-21T19:05:47+00:00 https://ascopost.com/calendar/translational-cancer-research-for-basic-scientists-workshop-1/ 2025-02-21T19:05:48+00:00 https://ascopost.com/calendar/advances-in-liquid-biopsies/ 2025-02-21T19:05:48+00:00 https://ascopost.com/calendar/the-evolving-landscape-of-cancer-modeling/ 2025-02-21T19:05:49+00:00 https://ascopost.com/calendar/11th-european-multidisciplinary-congress-on-urological-cancers/ 2025-02-21T19:05:49+00:00 https://ascopost.com/calendar/esmo-immuno-oncology-congress-2019/ 2025-02-21T19:05:50+00:00 https://ascopost.com/calendar/esmo-targeted-anticancer-therapies-congress-2020/ 2025-02-21T19:05:50+00:00 https://ascopost.com/calendar/current-paradigms-in-interventional-pulmonology-endobronchial-ultrasound-and-advanced-bronchoscopy-in-the-era-of-robotics-a-team-approach/ 2025-02-21T19:05:51+00:00 https://ascopost.com/calendar/a-multidisciplinary-approach-to-thoracic-pathology-with-clinical-molecular-and-radiologic-correlations/ 2025-02-21T19:05:52+00:00 https://ascopost.com/calendar/2nd-international-symposium-on-biology-prevention-and-treatment-of-toxicities-after-transplantation-and-cellular-therapy/ 2025-02-21T19:05:52+00:00 https://ascopost.com/calendar/2019-annual-cancer-treatment-related-adverse-events-symposium/ 2025-02-21T19:05:54+00:00 https://ascopost.com/calendar/transforming-dermatology-in-the-digital-era-2019/ 2025-02-21T19:05:54+00:00 https://ascopost.com/calendar/contemporary-management-of-complex-skin-cancers-2019/ 2025-02-21T19:05:55+00:00 https://ascopost.com/calendar/chest-annual-meeting-2019/ 2025-02-21T19:05:55+00:00 https://ascopost.com/calendar/37th-annual-miami-breast-cancer-conference/ 2025-02-21T19:05:56+00:00 https://ascopost.com/calendar/society-of-gynecologic-oncology-annual-meeting-on-women-s-cancer/ 2025-02-21T19:05:57+00:00 https://ascopost.com/calendar/nccn-annual-conference-improving-the-quality-effectiveness-and-efficiency-of-cancer-care-1/ 2025-02-21T19:05:58+00:00 https://ascopost.com/calendar/sir-annual-meeting/ 2025-02-21T19:05:58+00:00 https://ascopost.com/calendar/advances-in-prostate-cancer-research/ 2025-02-21T19:05:59+00:00 https://ascopost.com/calendar/end-of-life-symposium/ 2025-02-21T19:05:59+00:00 https://ascopost.com/calendar/sixth-annual-gayle-brinkenhoff-breast-cancer-symposium/ 2025-02-21T19:06:00+00:00 https://ascopost.com/calendar/2019-collaborative-group-of-the-americas-on-inherited-colorectal-cancer-annual-meeting/ 2025-02-21T19:06:01+00:00 https://ascopost.com/calendar/lead-2019/ 2025-02-21T19:06:01+00:00 https://ascopost.com/calendar/third-annual-miami-brain-symposium/ 2025-02-21T19:06:02+00:00 https://ascopost.com/calendar/msk-alumni-conference-clinical-issues-in-patients-treated-with-immune-checkpoint-blockade-challenges-and-controversies/ 2025-02-21T19:06:02+00:00 https://ascopost.com/calendar/prediction-prevention-and-treatment-of-cancer-associated-thrombosis/ 2025-02-21T19:06:03+00:00 https://ascopost.com/calendar/4th-annual-advances-in-colorectal-oncology/ 2025-02-21T19:06:03+00:00 https://ascopost.com/calendar/2019-rectal-mri-workshop/ 2025-02-21T19:06:04+00:00 https://ascopost.com/calendar/9th-annual-global-conference-on-perioperative-care-of-the-cancer-patient/ 2025-02-21T19:06:05+00:00 https://ascopost.com/calendar/ai-and-big-data-in-cancer-from-innovation-to-impact/ 2025-02-21T19:06:05+00:00 https://ascopost.com/calendar/immunotherapy-of-cancer-car-t-cell-to-checkpoint-inhibitors/ 2025-02-21T19:06:06+00:00 https://ascopost.com/calendar/chronic-leukemia-rounds/ 2025-02-21T19:06:07+00:00 https://ascopost.com/calendar/chronic-leukemia-rounds-1/ 2025-02-21T19:06:08+00:00 https://ascopost.com/calendar/10th-annual-texas-adolescent-and-young-adult-aya-oncology-conference/ 2025-02-21T19:06:08+00:00 https://ascopost.com/calendar/masccisoo-annual-meeting-on-supportive-care-in-cancer/ 2025-02-21T19:06:09+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-8th-annual-hematology-and-medical-oncology-board-review-contemporary-practice/ 2025-02-21T19:06:10+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-tobacco-treatment-specialist-training-program/ 2025-02-21T19:06:10+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-pancreas-cancer-symposium-2020-current-and-future/ 2025-02-21T19:06:11+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-2020-psychopharmacology-in-cancer-care-an-update-for-clinicians-of-all-disciplines/ 2025-02-21T19:06:11+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-cancer-alliance-2nd-annual-advanced-practice-provider-oncology-symposium/ 2025-02-21T19:06:12+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-controversies-in-gastrointestinal-premalignant-and-malignant-disorders-2020/ 2025-02-21T19:06:13+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-2020-critical-care-symposium/ 2025-02-21T19:06:13+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-oncology-acupuncture-from-neuroscience-to-patient-wellbeing/ 2025-02-21T19:06:14+00:00 https://ascopost.com/calendar/5th-annual-memorial-sloan-kettering-symposium-on-lymphoma/ 2025-02-21T19:06:14+00:00 https://ascopost.com/calendar/2020-memorial-sloan-kettering-cardio-oncology-symposium/ 2025-02-21T19:06:15+00:00 https://ascopost.com/calendar/2020-memorial-sloan-kettering-cardio-oncology-symposium-computer-based-learning-lab/ 2025-02-21T19:06:15+00:00 https://ascopost.com/calendar/imaging-of-alimentary-tract-cancers-an-interactive-clinico-radiologic-symposium-at-memorial-sloan-kettering/ 2025-02-21T19:06:16+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-2020-update-on-the-treatment-of-pituitary-tumors-emerging-therapies/ 2025-02-21T19:06:17+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-emergencies-in-the-cancer-patient-2020/ 2025-02-21T19:06:17+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-2nd-annual-palliative-care-symposium-for-advance-practice-providers/ 2025-02-21T19:06:18+00:00 https://ascopost.com/calendar/esmo-virtual-congress-2020/ 2025-02-21T19:06:18+00:00 https://ascopost.com/calendar/asco-annual-meeting-1/ 2025-02-21T19:06:19+00:00 https://ascopost.com/calendar/jadpro-live-2020/ 2025-02-21T19:06:20+00:00 https://ascopost.com/calendar/2020-astro-annual-refresher-course/ 2025-02-21T19:06:20+00:00 https://ascopost.com/calendar/2020-advocacy-day/ 2025-02-21T19:06:21+00:00 https://ascopost.com/calendar/2020-research-workshop-harnessing-the-power-of-artificial-intelligence-to-improve-radiation-therapy/ 2025-02-21T19:06:21+00:00 https://ascopost.com/calendar/2020-astro-annual-meeting/ 2025-02-21T19:06:22+00:00 https://ascopost.com/calendar/2020-multidisciplinary-thoracic-cancers-symposium/ 2025-02-21T19:06:22+00:00 https://ascopost.com/calendar/ash-annual-meeting-exposition/ 2025-02-21T19:06:23+00:00 https://ascopost.com/calendar/san-antonio-breast-cancer-symposium-1/ 2025-02-21T19:06:24+00:00 https://ascopost.com/calendar/aacr-annual-meeting-2020/ 2025-02-21T19:06:24+00:00 https://ascopost.com/calendar/2020-aspho-conference/ 2025-02-21T19:06:25+00:00 https://ascopost.com/calendar/controversies-in-thyroidology-spring-2020-meeting-of-the-american-thyroid-association/ 2025-02-21T19:06:26+00:00 https://ascopost.com/calendar/oral-oncology-symposium-1/ 2025-02-21T19:06:26+00:00 https://ascopost.com/calendar/second-aacr-international-meeting-advances-in-malignant-lymphoma-maximizing-the-basic-translational-interface-for-clinical-application/ 2025-02-21T19:06:27+00:00 https://ascopost.com/calendar/8th-annual-genetics-education-symposium-genetics-genomics-applications-for-the-prevention-detection-and-treatment-of-cancer/ 2025-02-21T19:06:27+00:00 https://ascopost.com/calendar/symposium-on-clinical-interventional-oncology-cio2020/ 2025-02-21T19:06:28+00:00 https://ascopost.com/calendar/iaslc-2020-north-america-conference-on-lung-cancer/ 2025-02-21T19:06:29+00:00 https://ascopost.com/calendar/14th-european-colorectal-congress-of-st-gallen/ 2025-02-21T19:06:29+00:00 https://ascopost.com/calendar/asco20-virtual-education-program/ 2025-02-21T19:06:30+00:00 https://ascopost.com/calendar/2020-midwest-radiation-oncology-symposium/ 2025-02-21T19:06:31+00:00 https://ascopost.com/calendar/17th-annual-international-ultmann-chicago-lymphoma-symposium/ 2025-02-21T19:06:31+00:00 https://ascopost.com/calendar/asco-quality-care-symposium-2/ 2025-02-21T19:06:32+00:00 https://ascopost.com/calendar/sitc-2020/ 2025-02-21T19:06:32+00:00 https://ascopost.com/calendar/msk-cardio-oncology-online-lecture-series/ 2025-02-21T19:06:33+00:00 https://ascopost.com/calendar/new-york-hematopathology-group-september-2020/ 2025-02-21T19:06:34+00:00 https://ascopost.com/calendar/klaus-mayer-symposium-in-laboratory-medicine-laboratory-test-results-fact-or-fiction-interpretation-of-common-laboratory-tests-results/ 2025-02-21T19:06:34+00:00 https://ascopost.com/calendar/advances-in-neurofibromatosis-integrating-multi-modality-therapy/ 2025-02-21T19:06:35+00:00 https://ascopost.com/calendar/contemporary-management-of-complex-skin-cancers-2020/ 2025-02-21T19:06:35+00:00 https://ascopost.com/calendar/9th-annual-state-of-the-art-in-thrombosis-and-hemostasis-symposium/ 2025-02-21T19:06:36+00:00 https://ascopost.com/calendar/assessment-and-treatment-of-tobacco-dependence-in-cancer-care/ 2025-02-21T19:06:36+00:00 https://ascopost.com/calendar/management-of-treatment-related-adverse-events-symposium/ 2025-02-21T19:06:37+00:00 https://ascopost.com/calendar/oncology-acupuncture-from-neuroscience-to-patient-wellbeing/ 2025-02-21T19:06:38+00:00 https://ascopost.com/calendar/msk-tobacco-treatment-specialist-training-program/ 2025-02-21T19:06:38+00:00 https://ascopost.com/calendar/cancer-survivorship-fundamentals-for-primary-care-2020/ 2025-02-21T19:06:39+00:00 https://ascopost.com/calendar/geriatric-oncology-cognition-and-communication/ 2025-02-21T19:06:39+00:00 https://ascopost.com/calendar/2020-update-on-the-treatment-of-pituitary-tumors-emerging-therapies/ 2025-02-21T19:06:40+00:00 https://ascopost.com/calendar/9th-annual-global-conference-on-perioperative-care-of-the-cancer-patient-1/ 2025-02-21T19:06:41+00:00 https://ascopost.com/calendar/cancer-evolution-symposium-2020/ 2025-02-21T19:06:41+00:00 https://ascopost.com/calendar/2020-chronic-gvhd-consensus-conference/ 2025-02-21T19:06:42+00:00 https://ascopost.com/calendar/erdheim-chester-disease-a-review-of-updated-guidelines-in-the-molecular-era/ 2025-02-21T19:06:42+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-in-collaboration-with-university-of-hawaii-present-apples-single-topic-conference-hepatocellular-carcinoma-tumor-immune-microenvironment/ 2025-02-21T19:06:43+00:00 https://ascopost.com/calendar/9th-interamerican-oncology-conference/ 2025-02-21T19:06:44+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-9th-annual-hematology-and-medical-oncology-board-review-contemporary-practice/ 2025-02-21T19:06:44+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-the-5th-annual-symposium-in-translational-research-in-pathology/ 2025-02-21T19:06:45+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-4-day-msk-tobacco-treatment-specialist-training-program/ 2025-02-21T19:06:45+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-2021-psychopharmacology-in-cancer-care-an-update-for-clinicians-of-all-disciplines/ 2025-02-21T19:06:46+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-2021-critical-care-symposium/ 2025-02-21T19:06:47+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-the-pathology-of-neoplastic-diseases-2021/ 2025-02-21T19:06:47+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-imaging-of-alimentary-tract-cancers-an-interactive-clinico-radiologic-symposium/ 2025-02-21T19:06:48+00:00 https://ascopost.com/calendar/5th-annual-memorial-sloan-kettering-symposium-on-lymphoma-1/ 2025-02-21T19:06:48+00:00 https://ascopost.com/calendar/memorial-sloan-kettering-geriatric-oncology-cognition-and-communication-course/ 2025-02-21T19:06:49+00:00 https://ascopost.com/calendar/advancing-the-cardiovascular-care-of-the-oncology-patient-virtual-on-demand/ 2025-02-21T19:06:49+00:00 https://ascopost.com/calendar/63rd-ash-annual-meeting-exposition/ 2025-02-21T19:06:50+00:00 https://ascopost.com/calendar/jadpro-live-virtual-2021/ 2025-02-21T19:06:51+00:00 https://ascopost.com/calendar/jadpro-live-virtual-2021-1/ 2025-02-21T19:06:51+00:00 https://ascopost.com/calendar/oncology-clinical-trials-what-you-need-to-know/ 2025-02-21T19:06:52+00:00 https://ascopost.com/calendar/2021-current-paradigms-in-interventional-pulmonology-robotic-assisted-bronchoscopy-a-team-approach/ 2025-02-21T19:06:52+00:00 https://ascopost.com/calendar/2nd-annual-us-celebration-of-world-hospice-palliative-care-day-a-virtual-coming-together/ 2025-02-21T19:06:53+00:00 https://ascopost.com/calendar/emergencies-in-the-cancer-patient-2021/ 2025-02-21T19:06:54+00:00 https://ascopost.com/calendar/a-multidisciplinary-approach-to-thoracic-pathology-with-clinical-molecular-and-radiologic-correlations-1/ 2025-02-21T19:06:54+00:00 https://ascopost.com/calendar/transplant-and-cellular-therapy-options-for-non-malignant-hematologic-disorders/ 2025-02-21T19:06:55+00:00 https://ascopost.com/calendar/africa-liver-cancer-guidelines/ 2025-02-21T19:06:55+00:00 https://ascopost.com/calendar/2nd-annual-advanced-practice-provider-oncology-symposium/ 2025-02-21T19:06:56+00:00 https://ascopost.com/calendar/pancreas-cancer-the-current-and-the-future/ 2025-02-21T19:06:57+00:00 https://ascopost.com/calendar/communication-skills-training-for-oncology-clinicians/ 2025-02-21T19:06:58+00:00 https://ascopost.com/calendar/4-day-msk-tobacco-treatment-specialist-training-program/ 2025-02-21T19:06:58+00:00 https://ascopost.com/calendar/4th-annual-basic-course-in-reflectance-confocal-microscopy-non-invasive-diagnosis-of-skin-cancer/ 2025-02-21T19:06:59+00:00 https://ascopost.com/calendar/geriatric-oncology-cognition-and-communication-1/ 2025-02-21T19:06:59+00:00 https://ascopost.com/calendar/lynn-sage-breast-cancer-symposium/ 2025-02-21T19:07:00+00:00 https://ascopost.com/calendar/astro-annual-meeting/ 2025-02-21T19:07:01+00:00 https://ascopost.com/calendar/asco-quality-care-symposium-3/ 2025-02-21T19:07:01+00:00 https://ascopost.com/calendar/esmo-congress-2021/ 2025-02-21T19:07:02+00:00 https://ascopost.com/calendar/2021-san-antonio-breast-cancer-symposium/ 2025-02-21T19:07:03+00:00 https://ascopost.com/calendar/4th-global-adolescent-and-young-adult-cancer-congress/ 2025-02-21T19:07:03+00:00 https://ascopost.com/calendar/miami-brain-virtual-symposium/ 2025-02-21T19:07:04+00:00 https://ascopost.com/calendar/cv-safety-in-oncology-clinical-trials-providing-clarity-for-a-new-era-of-cancer-therapeutics/ 2025-02-21T19:07:04+00:00 https://ascopost.com/calendar/cancer-epigenetics-institute-symposium-from-genes-to-chromatin-to-therapeutics/ 2025-02-21T19:07:05+00:00 https://ascopost.com/calendar/14th-international-congress-on-myeloproliferative-neoplasms/ 2025-02-21T19:07:06+00:00 https://ascopost.com/calendar/pan-pacific-lymphoma-conference/ 2025-02-21T19:07:06+00:00 https://ascopost.com/calendar/bcma-targeted-therapies-summit/ 2025-02-21T19:07:07+00:00 https://ascopost.com/calendar/jadpro-live-2022/ 2025-02-21T19:07:08+00:00 https://ascopost.com/calendar/the-33rd-annual-world-congress-of-the-international-association-of-surgeons-gastroenterologists-and-oncologists-iasgo/ 2025-02-21T19:07:08+00:00 https://ascopost.com/calendar/37th-annual-harvard-critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology/ 2025-02-21T19:07:09+00:00 https://ascopost.com/calendar/annual-mayo-clinic-hepato-pancreatico-biliary-cancer-symposiumiasgo/ 2025-02-21T19:07:10+00:00 https://ascopost.com/calendar/pan-pacific-lymphoma-conference-1/ 2025-02-21T19:07:10+00:00 https://ascopost.com/calendar/iaslc-2022-north-america-conference-on-lung-cancer/ 2025-02-21T19:07:11+00:00 https://ascopost.com/calendar/iaslc-2022-world-conference-on-lung-cancer/ 2025-02-21T19:07:11+00:00 https://ascopost.com/calendar/ai-in-cancer-research-and-clinical-care-turning-promise-into-reality/ 2025-02-21T19:07:12+00:00 https://ascopost.com/calendar/global-palliative-care-and-pain-relief-research-hub-webinar-series/ 2025-02-21T19:07:13+00:00 https://ascopost.com/calendar/2022-current-paradigms-in-interventional-pulmonology-endobronchial-ultrasound-and-advanced-bronchoscopy-in-era-of-robotics-a-team-approach/ 2025-02-21T19:07:13+00:00 https://ascopost.com/calendar/geriatric-oncology-cognition-and-communication-2/ 2025-02-21T19:07:14+00:00 https://ascopost.com/calendar/emergencies-in-the-cancer-patient-2022/ 2025-02-21T19:07:15+00:00 https://ascopost.com/calendar/hereditary-cancer-genetics-incorporation-into-clinical-care/ 2025-02-21T19:07:15+00:00 https://ascopost.com/calendar/3rd-annual-us-celebration-of-world-hospice-palliative-care-day-a-virtual-coming-together/ 2025-02-21T19:07:16+00:00 https://ascopost.com/calendar/2022-dermoscopy-intermediate-course/ 2025-02-21T19:07:17+00:00 https://ascopost.com/calendar/advances-in-the-management-of-prostate-cancer-a-multidisciplinary-approach/ 2025-02-21T19:07:17+00:00 https://ascopost.com/calendar/assessment-and-treatment-of-tobacco-dependence-in-cancer-care-1/ 2025-02-21T19:07:18+00:00 https://ascopost.com/calendar/4-day-tobacco-treatment-specialist-training-program/ 2025-02-21T19:07:18+00:00 https://ascopost.com/calendar/contemporary-management-of-complex-skin-cancers-2022/ 2025-02-21T19:07:19+00:00 https://ascopost.com/calendar/2022-hands-on-rectal-mri-workshop/ 2025-02-21T19:07:19+00:00 https://ascopost.com/calendar/6th-annual-advances-in-colorectal-oncology-improving-practice-through-new-discoveries/ 2025-02-21T19:07:20+00:00 https://ascopost.com/calendar/pancreas-cancer-update-on-cancer-biology-treatment-and-outcome/ 2025-02-21T19:07:21+00:00 https://ascopost.com/calendar/geriatric-oncology-cognition-and-communication-3/ 2025-02-21T19:07:21+00:00 https://ascopost.com/calendar/5th-annual-workshop-on-confocal-microscopy-for-cutaneous-diagnostics/ 2025-02-21T19:07:22+00:00 https://ascopost.com/calendar/miami-brain-symposium/ 2025-02-21T19:07:22+00:00 https://ascopost.com/calendar/9th-international-congress-on-cancer-metastasis/ 2025-02-21T19:07:23+00:00 https://ascopost.com/calendar/9th-international-congress-on-cancer-metastatis/ 2025-02-21T19:07:24+00:00 https://ascopost.com/calendar/1st-annual-symposium-on-advanced-therapeutics-for-brain-metastasis/ 2025-02-21T19:07:24+00:00 https://ascopost.com/calendar/11th-annual-hematology-and-medical-oncology-board-review/ 2025-02-21T19:07:25+00:00 https://ascopost.com/calendar/2023-robert-steel-symposium-in-developmental-oncology/ 2025-02-21T19:07:25+00:00 https://ascopost.com/calendar/2023-msk-cardio-oncology-symposium/ 2025-02-21T19:07:26+00:00 https://ascopost.com/calendar/asco-breakthrough-shining-a-light-on-advances-in-cancer-care/ 2025-02-21T19:07:27+00:00 https://ascopost.com/calendar/the-34th-annual-world-congress-of-the-international-association-of-surgeons-gastroenterologists-and-oncologists-iasgo/ 2025-02-21T19:07:27+00:00 https://ascopost.com/calendar/38th-annual-harvard-critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology/ 2025-02-21T19:07:28+00:00 https://ascopost.com/calendar/annual-mayo-clinic-hepato-pancreatico-biliary-cancer-symposiumiasgo-1/ 2025-02-21T19:07:28+00:00 https://ascopost.com/calendar/updates-in-the-management-of-head-neck-cancer/ 2025-02-21T19:07:29+00:00 https://ascopost.com/calendar/2nd-annual-cancer-center-survivorship-research-forum-implementing-equitable-cancer-survivorship-care-stanford-center-for-continuing-medical-education-continuing-education-ce/ 2025-02-21T19:07:30+00:00 https://ascopost.com/calendar/17th-european-colorectal-congress/ 2025-02-21T19:07:30+00:00 https://ascopost.com/calendar/2023-jadpro-live/ 2025-02-21T19:07:31+00:00 https://ascopost.com/calendar/3rd-indian-cancer-congress-2023/ 2025-02-21T19:07:32+00:00 https://ascopost.com/calendar/2023-debates-didactics-in-hematology-oncology-conference/ 2025-02-21T19:07:32+00:00 https://ascopost.com/calendar/24th-ipos-world-congress-of-psycho-oncology/ 2025-02-21T19:07:33+00:00 https://ascopost.com/calendar/7th-world-congress-on-controversies-in-breast-cancer-cobrca/ 2025-02-21T19:07:33+00:00 https://ascopost.com/calendar/25th-annual-lynn-sage-breast-cancer-symposium/ 2025-02-21T19:07:34+00:00 https://ascopost.com/calendar/ash-meeting-on-hematologic-malignancies-2023/ 2025-02-21T19:07:35+00:00 https://ascopost.com/calendar/iaslc-world-conference-on-lung-cancer/ 2025-02-21T19:07:35+00:00 https://ascopost.com/calendar/society-for-integrative-oncology-sio-20th-international-conference/ 2025-02-21T19:07:36+00:00 https://ascopost.com/calendar/2023-annual-summit-on-hematologic-cancers-incorporation-of-novel-therapies-in-clinical-practice/ 2025-02-21T19:07:37+00:00 https://ascopost.com/calendar/advances-in-cancer-immunotherapy-a-focus-on-monoclonal-antibodies-and-antibody-drug-conjugates/ 2025-02-21T19:07:37+00:00 https://ascopost.com/calendar/nccn-2023-annual-congress-hematologic-malignancies/ 2025-02-21T19:07:38+00:00 https://ascopost.com/calendar/16th-aacr-conference-on-the-science-of-cancer-health-disparities-in-racialethnic-minorities-and-the-medically-underserved/ 2025-02-21T19:07:38+00:00 https://ascopost.com/calendar/astro-2023-annual-meeting/ 2025-02-21T19:07:39+00:00 https://ascopost.com/calendar/aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/ 2025-02-21T19:07:39+00:00 https://ascopost.com/calendar/5th-adolescent-and-young-adult-oncology-symposium-more-than-cancer-comprehensive-care-for-ayas/ 2025-02-21T19:07:40+00:00 https://ascopost.com/calendar/esmo-congress-2023/ 2025-02-21T19:07:41+00:00 https://ascopost.com/calendar/38th-annual-critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology/ 2025-02-21T19:07:41+00:00 https://ascopost.com/calendar/asco-quality-care-symposium-4/ 2025-02-21T19:07:42+00:00 https://ascopost.com/calendar/world-cancer-leaders-summit-2023/ 2025-02-21T19:07:42+00:00 https://ascopost.com/calendar/2023-san-antonio-breast-cancer-symposium/ 2025-02-21T19:07:43+00:00 https://ascopost.com/calendar/65th-ash-annual-meeting-and-exposition/ 2025-02-21T19:07:44+00:00 https://ascopost.com/calendar/astro-annual-meeting-1/ 2025-02-21T19:07:44+00:00 https://ascopost.com/calendar/miami-cancer-institute-head-and-neck-cancer-conference/ 2025-02-21T19:07:45+00:00 https://ascopost.com/calendar/sixth-annual-miami-brain-symposium/ 2025-02-21T19:07:45+00:00 https://ascopost.com/calendar/fifth-annual-global-summit-on-immunotherapy-for-hematologic-malignancies/ 2025-02-21T19:07:46+00:00 https://ascopost.com/calendar/second-annual-precision-oncology-solid-tumors-symposium/ 2025-02-21T19:07:47+00:00 https://ascopost.com/calendar/fifth-annual-global-summit-on-immunotherapy-for-hematologic-malignancies-1/ 2025-02-21T19:07:47+00:00 https://ascopost.com/calendar/american-college-of-cardiology-advancing-the-cardiovascular-care-of-the-cancer-patient/ 2025-02-21T19:07:48+00:00 https://ascopost.com/calendar/caring-for-kids-with-cancer-symposium/ 2025-02-21T19:07:48+00:00 https://ascopost.com/calendar/esmo-targeted-anticancer-therapies-tat-congress-2024/ 2025-02-21T19:07:49+00:00 https://ascopost.com/calendar/eacr-aacr-basic-and-translational-research-conference-how-to-bring-basic-science-discoveries-to-the-clinic/ 2025-02-21T19:07:49+00:00 https://ascopost.com/calendar/association-of-community-cancer-centers-accc-50th-annual-meeting-cancer-center-business-summit/ 2025-02-21T19:07:50+00:00 https://ascopost.com/calendar/2024-multidisciplinary-head-and-neck-cancers-symposium/ 2025-02-21T19:07:51+00:00 https://ascopost.com/calendar/28th-annual-international-congress-on-hematologic-malignancies-focus-on-leukemias-lymphomas-and-myeloma/ 2025-02-21T19:07:51+00:00 https://ascopost.com/calendar/12th-annual-lung-cancer-symposium/ 2025-02-21T19:07:52+00:00 https://ascopost.com/calendar/41st-annual-miami-breast-cancer-conference/ 2025-02-21T19:07:52+00:00 https://ascopost.com/calendar/society-for-immunotherapy-of-cancer-sitc-2024-spring-scientific-metabolism-at-the-hub-of-cancer-and-immunity/ 2025-02-21T19:07:53+00:00 https://ascopost.com/calendar/21st-annual-world-congress-of-society-for-brain-mapping-and-therapeutics-sbmt-2024/ 2025-02-21T19:07:54+00:00 https://ascopost.com/calendar/society-of-gynecologic-oncology-sgo-annual-meeting-on-women-s-cancer/ 2025-02-21T19:07:54+00:00 https://ascopost.com/calendar/14th-european-breast-cancer-conference-ebcc14/ 2025-02-21T19:07:55+00:00 https://ascopost.com/calendar/european-lung-cancer-congress-elcc-2024/ 2025-02-21T19:07:55+00:00 https://ascopost.com/calendar/society-of-surgical-oncology-sso-2024-annual-meeting/ 2025-02-21T19:07:56+00:00 https://ascopost.com/calendar/9th-international-congress-on-innovative-approaches-in-head-neck-oncology-ichno-2024/ 2025-02-21T19:07:56+00:00 https://ascopost.com/calendar/national-comprehensive-cancer-network-nccn-2024-annual-conference/ 2025-02-21T19:07:58+00:00 https://ascopost.com/calendar/4th-annual-perspectives-in-lung-cancer-care/ 2025-02-21T19:07:58+00:00 https://ascopost.com/calendar/american-association-for-cancer-research-aacr-annual-meeting/ 2025-02-21T19:07:59+00:00 https://ascopost.com/calendar/advances-in-the-treatment-of-hematologic-malignancies-and-cellular-therapeutics-2024-symposium/ 2025-02-21T19:07:59+00:00 https://ascopost.com/calendar/the-european-society-for-radiotherapy-and-oncology-congress-estro-2024/ 2025-02-21T19:08:00+00:00 https://ascopost.com/calendar/european-society-for-medical-oncology-esmo-breast-cancer-annual-congress-2024/ 2025-02-21T19:08:01+00:00 https://ascopost.com/calendar/frontiers-in-cancer-immunotherapy-2024/ 2025-02-21T19:08:01+00:00 https://ascopost.com/calendar/american-society-of-clinical-oncology-annual-meeting/ 2025-02-21T19:08:02+00:00 https://ascopost.com/calendar/eortc-esmo-aacr-24th-workshop-on-methods-in-clinical-cancer-research/ 2025-02-21T19:08:02+00:00 https://ascopost.com/calendar/26th-annual-world-congress-on-gastrointestinal-cancer/ 2025-02-21T19:08:03+00:00 https://ascopost.com/calendar/pan-pacific-lymphoma-conference-2/ 2025-02-21T19:08:04+00:00 https://ascopost.com/calendar/advances-in-genitourinary-oncology/ 2025-02-21T19:08:04+00:00 https://ascopost.com/calendar/2024-debates-and-didactics-in-hematology-and-oncology-ddho/ 2025-02-21T19:08:05+00:00 https://ascopost.com/calendar/2024-geriatric-oncology-for-the-advanced-practice-provider-delivering-person-centered-care/ 2025-02-21T19:08:06+00:00 https://ascopost.com/calendar/2nd-annual-symposium-on-advanced-therapeutics-for-brain-metastasis/ 2025-02-21T19:08:06+00:00 https://ascopost.com/calendar/2024-msk-update-in-hematology-and-medical-oncology/ 2025-02-21T19:08:07+00:00 https://ascopost.com/calendar/msk-approach-to-gastrointestinal-premalignant-and-malignant-disorders-course/ 2025-02-21T19:08:08+00:00 https://ascopost.com/calendar/2024-msk-musculoskeletal-oncology-symposium-for-the-advanced-practice-provider/ 2025-02-21T19:08:09+00:00 https://ascopost.com/calendar/2024-msk-update-on-the-treatment-of-pituitary-tumors-conference/ 2025-02-21T19:08:09+00:00 https://ascopost.com/calendar/2024-msk-psychopharmacology-in-cancer-care-course/ 2025-02-21T19:08:10+00:00 https://ascopost.com/calendar/2024-msk-critical-care-oncology-symposium/ 2025-02-21T19:08:11+00:00 https://ascopost.com/calendar/8th-annual-msk-symposium-on-lymphoma/ 2025-02-21T19:08:11+00:00 https://ascopost.com/calendar/2024-msk-robert-steel-symposium-in-developmental-oncology/ 2025-02-21T19:08:12+00:00 https://ascopost.com/calendar/2024-msk-cardio-oncology-symposium/ 2025-02-21T19:08:13+00:00 https://ascopost.com/calendar/celebrating-25-years-of-innovation-in-integrative-oncology-recent-advances-and-future-opportunities/ 2025-02-21T19:08:13+00:00 https://ascopost.com/calendar/12th-international-pediatric-renal-tumor-biology-meeting/ 2025-02-21T19:08:14+00:00 https://ascopost.com/calendar/2024-jadpro-live/ 2025-02-21T19:08:14+00:00 https://ascopost.com/calendar/asco-breakthrough/ 2025-02-21T19:08:15+00:00 https://ascopost.com/calendar/sgo-annual-meeting-on-womens-cancer/ 2025-02-26T16:41:21+00:00 https://ascopost.com/calendar/society-of-surgical-oncology-annual-meeting/ 2025-02-26T16:46:15+00:00 https://ascopost.com/calendar/nccn-annual-conference/ 2025-02-26T16:50:09+00:00 https://ascopost.com/calendar/american-association-for-cancer-research-annual-meeting/ 2025-02-26T19:52:36+00:00 https://ascopost.com/calendar/asco-annual-meeting-3/ 2025-02-26T20:00:56+00:00 https://ascopost.com/calendar/european-hematology-association-eha-congress/ 2025-02-26T20:03:38+00:00 https://ascopost.com/calendar/society-of-hematologic-oncology-soho-annual-meeting/ 2025-02-26T20:08:29+00:00 https://ascopost.com/calendar/world-conference-on-lung-cancer/ 2025-02-26T20:11:01+00:00 https://ascopost.com/calendar/astro-annual-meeting-2/ 2025-02-26T20:23:27+00:00 https://ascopost.com/calendar/nccn-2025-annual-congress-hematologic-malignancies/ 2025-02-26T20:26:21+00:00 https://ascopost.com/calendar/asco-quality-care-symposium-5/ 2025-02-26T20:28:37+00:00 https://ascopost.com/calendar/esmo-congress/ 2025-02-26T20:30:47+00:00 https://ascopost.com/calendar/jadpro-live/ 2025-02-26T20:32:43+00:00 https://ascopost.com/calendar/society-for-immunotherapy-of-cancer-sitc-annual-meeting/ 2025-02-26T20:35:07+00:00 https://ascopost.com/calendar/ash-annual-meeting/ 2025-02-26T20:37:03+00:00 https://ascopost.com/calendar/san-antonio-breast-cancer-symposium-2/ 2025-02-26T20:39:40+00:00 https://ascopost.com/calendar/pan-pacific-lymphoma-conference-3/ 2025-02-26T20:49:55+00:00 https://ascopost.com/calendar/42nd-annual-miami-breast-cancer-conference/ 2025-03-03T20:30:40+00:00 https://ascopost.com/calendar/10th-annual-cancer-health-disparities-symposium/ 2025-03-03T20:33:05+00:00 https://ascopost.com/calendar/aacr-special-conference-in-cancer-research-acute-lymphoblastic-leukemia/ 2025-03-03T20:35:26+00:00 https://ascopost.com/calendar/emerging-paradigms-in-liver-cancer-diagnosis-and-treatment/ 2025-03-03T20:38:52+00:00 https://ascopost.com/calendar/7th-international-cancer-congress-icc2025/ 2025-03-03T20:45:56+00:00 https://ascopost.com/calendar/european-lung-cancer-congress-2025/ 2025-03-03T20:50:33+00:00 https://ascopost.com/calendar/european-society-for-radiotherapy-and-oncology-congress-estro-2025/ 2025-03-03T21:02:17+00:00 https://ascopost.com/calendar/the-tapur-study-third-annual-grand-rounds/ 2025-03-04T20:51:09+00:00 https://ascopost.com/calendar/aua-annual-meeting/ 2025-03-13T13:38:01+00:00 https://ascopost.com/calendar/pan-pacific-leukemia-conference/ 2025-04-01T15:05:57+00:00 https://ascopost.com/calendar/london-global-cancer-week/ 2025-06-12T21:24:26+00:00 https://ascopost.com/calendar/updates-in-the-management-of-head-and-neck-cancer-1/ 2025-08-08T19:17:44+00:00 https://ascopost.com/calendar/27th-annual-lynn-sage-breast-cancer-symposium/ 2025-09-29T13:42:12+00:00 https://ascopost.com/calendar/43rd-annual-cfs-innovative-cancer-therapy-for-tomorrow/ 2025-09-29T14:01:28+00:00 https://ascopost.com/calendar/2025-international-kidney-cancer-symposia-ikcs-north-america/ 2025-09-29T14:07:31+00:00 https://ascopost.com/calendar/asco-gastrointestinal-cancers-symposium/ 2025-09-29T14:40:56+00:00 https://ascopost.com/calendar/asco-genitourinary-cancers-symposium/ 2025-09-29T17:44:38+00:00 https://ascopost.com/calendar/society-of-surgical-oncology-sso-annual-meeting/ 2025-09-29T17:49:30+00:00 https://ascopost.com/calendar/miami-breast-cancer-conference/ 2025-09-29T17:51:51+00:00 https://ascopost.com/calendar/national-comprehensive-cancer-network-annual-conference/ 2025-09-29T17:57:28+00:00 https://ascopost.com/calendar/society-of-gynecologic-oncology-annual-meeting-on-womens-cancer/ 2025-09-29T18:31:58+00:00 https://ascopost.com/calendar/american-association-for-cancer-research-annual-meeting-1/ 2025-09-29T18:34:05+00:00 https://ascopost.com/calendar/51st-annual-ons-congress/ 2025-09-29T18:39:51+00:00 https://ascopost.com/calendar/lymphoma-leukemia-myeloma-congress-2025/ 2025-09-30T14:09:06+00:00 https://ascopost.com/calendar/aacr-special-conference-in-cancer-research-advances-in-pancreatic-cancer-research-emerging-science-driving-transformative-solutions/ 2025-09-30T14:13:23+00:00 https://ascopost.com/calendar/24th-cancer-center-workshop-precision-oncology-powered-by-data-intelligence/ 2025-10-23T14:56:07+00:00 https://ascopost.com/calendar/cancer-ai-symposium-a-new-era-of-care/ 2025-10-23T14:59:01+00:00 https://ascopost.com/calendar/asia-pacific-breast-cancer-summit-apbcs/ 2026-01-26T19:34:02+00:00 https://ascopost.com/calendar/iaslc-targeted-therapies-of-lung-cancer-ttlc-2026/ 2026-01-26T19:37:13+00:00 https://ascopost.com/calendar/30th-annual-international-congress-on-hematologic-malignancies-focus-on-leukemias-lymphomas-and-myeloma/ 2026-01-26T19:40:26+00:00 https://ascopost.com/calendar/41st-annual-eau-congress/ 2026-01-26T19:43:23+00:00 https://ascopost.com/calendar/esmo-targeted-anticancer-therapies-tat-congress-2026/ 2026-01-26T19:45:34+00:00 https://ascopost.com/calendar/international-congress-on-innovative-approaches-in-head-neck-oncology/ 2026-01-26T19:49:59+00:00 https://ascopost.com/calendar/european-lung-cancer-congress/ 2026-01-26T19:52:29+00:00 https://ascopost.com/calendar/astro-68th-annual-meeting/ 2026-01-26T20:00:19+00:00 https://ascopost.com/calendar/asco-annual-meeting-4/ 2026-01-26T20:04:08+00:00 https://ascopost.com/calendar/eha-congress-2026/ 2026-01-26T20:09:21+00:00 https://ascopost.com/calendar/european-association-for-cancer-research-annual-congress/ 2026-01-26T20:13:22+00:00 https://ascopost.com/calendar/asco-breakthrough-2026/ 2026-01-26T20:19:31+00:00 https://ascopost.com/nsclc_ce/ 2025-07-21T21:39:57+00:00 https://ascopost.com/cdk_ce/ 2025-07-21T21:39:58+00:00 https://ascopost.com/editorial-coi/ 2025-07-21T21:39:58+00:00 https://ascopost.com/perspectives/ 2025-08-05T18:58:52+00:00 https://ascopost.com/calendar-test/ 2025-07-21T21:40:02+00:00 https://ascopost.com/5-years-of-the-asco-post-evening-news/ 2025-07-21T21:40:02+00:00 https://ascopost.com/most-read-stories/ 2025-07-21T21:40:03+00:00 https://ascopost.com/most-viewed-videos/ 2025-07-21T21:40:04+00:00 https://ascopost.com/narratives-2012-2018/ 2025-07-21T21:40:04+00:00 https://ascopost.com/treatment-lexicon/ 2025-07-21T21:40:05+00:00 https://ascopost.com/news-v2/ 2025-07-21T21:40:06+00:00 https://ascopost.com/news-v2/august-2019/ 2019-08-23T13:48:36+00:00 https://ascopost.com/news-v2/august-2019/what-causes-liver-injury-during-treatment-with-pembrolizumab-online-first-test/ 2020-07-06T16:45:56+00:00 https://ascopost.com/jadpro-top-news/ 2025-07-21T21:40:07+00:00 https://ascopost.com/jsonoutput/ 2025-07-21T21:40:07+00:00 https://ascopost.com/jsonoutput2/ 2025-07-21T21:40:08+00:00 https://ascopost.com/video-roundtable/ 2025-10-30T18:55:43+00:00 https://ascopost.com/tap-topic-video-test-page/ 2025-07-21T21:40:09+00:00 https://ascopost.com/searchresultsexport/ 2025-07-21T21:40:09+00:00 https://ascopost.com/gateexample/ 2025-07-21T21:40:10+00:00 https://ascopost.com/tapen/ 2025-07-21T21:40:12+00:00 https://ascopost.com/tap-en-preview/ 2025-07-21T21:40:12+00:00 https://ascopost.com/logtest/ 2025-07-21T21:40:13+00:00 https://ascopost.com/news2/ 2025-07-21T21:40:13+00:00 https://ascopost.com/today-in-oncology-curated-test/ 2025-07-21T21:40:14+00:00 https://ascopost.com/tap-en-preview-intl/ 2025-07-21T21:40:15+00:00 https://ascopost.com/jcosponconwidget/ 2025-07-21T21:40:15+00:00 https://ascopost.com/tap-today-in-oncology-curated/ 2025-07-21T21:40:16+00:00 https://ascopost.com/perspectives-2020-2021/ 2025-07-21T21:40:17+00:00 https://ascopost.com/tag-test/ 2025-07-21T21:40:18+00:00 https://ascopost.com/institutional-highlights/ 2025-07-21T21:40:19+00:00 https://ascopost.com/institutional-highlights/memorial-sloan-kettering-cancer-center/ 2022-05-26T13:39:33+00:00 https://ascopost.com/institutional-highlights/memorial-sloan-kettering-cancer-center/list/ 2022-05-26T14:24:13+00:00 https://ascopost.com/institutional-highlights/dana-farber/ 2022-05-26T13:41:29+00:00 https://ascopost.com/institutional-highlights/dana-farber/list/ 2022-05-26T15:08:03+00:00 https://ascopost.com/gate-test/ 2025-07-21T21:40:19+00:00 https://ascopost.com/tapvideoexport/ 2025-07-21T21:40:20+00:00 https://ascopost.com/user/ 2025-07-21T21:40:21+00:00 https://ascopost.com/user/register/ 2023-07-14T17:15:56+00:00 https://ascopost.com/user/register-handler/ 2023-07-14T17:16:59+00:00 https://ascopost.com/user/login/ 2023-07-14T17:21:56+00:00 https://ascopost.com/user/login-handler/ 2023-07-14T17:19:01+00:00 https://ascopost.com/user/logout/ 2023-07-17T14:41:34+00:00 https://ascopost.com/user/forgot-password/ 2023-07-18T13:58:37+00:00 https://ascopost.com/user/reset-password/ 2024-07-31T21:12:37+00:00 https://ascopost.com/user/user-success/ 2024-06-20T14:40:42+00:00 https://ascopost.com/user/gate/ 2024-07-31T16:30:56+00:00 https://ascopost.com/tap-animated-historical-timeline-test/ 2025-07-21T21:40:24+00:00 https://ascopost.com/timeline-demo/ 2025-07-21T21:40:25+00:00 https://ascopost.com/timeline-demo/2017/ 2025-05-16T17:11:26+00:00 https://ascopost.com/timeline-demo/2017/second-line-therapy/ 2025-05-16T17:59:37+00:00 https://ascopost.com/timeline-demo/2017/second-line-therapy/tdm1/ 2025-05-16T17:56:20+00:00 https://ascopost.com/timeline-demo/2017/second-line-therapy/videoitem/ 2025-05-16T18:43:02+00:00 https://ascopost.com/timeline-demo/2018/ 2025-05-16T18:45:22+00:00 https://ascopost.com/timeline-demo/2018/third-line-therapy/ 2025-05-16T18:46:33+00:00 https://ascopost.com/timeline-demo/2018/third-line-therapy/tdm1/ 2025-05-16T18:51:45+00:00 https://ascopost.com/timeline-demo/2018/third-line-therapy/videoitem/ 2025-05-16T18:52:39+00:00 https://ascopost.com/timeline-demo/2018/third-line-therapy/third-item-example/ 2025-05-16T18:55:53+00:00 https://ascopost.com/timeline-demo/2018/4th-line-therapy/ 2025-05-16T19:10:34+00:00 https://ascopost.com/timeline-demo/2018/4th-line-therapy/tdm1/ 2025-05-16T18:58:29+00:00 https://ascopost.com/timeline-demo/2018/4th-line-therapy/videoitem/ 2025-05-16T19:07:40+00:00